Used with organs, animals, and higher plants and with diseases for virologic studies. For bacteria, rickettsia, and fungi, "microbiology" is used; for parasites, "parasitology" is used. Used for naturally occurring diseases in animals, or for diagnostic, preventive, or therapeutic procedures used in veterinary medicine. Used with equipment, facilities, programs, services, and health personnel for discussions, usually with data, of how much they are used. It includes discussions of overuse and underuse. Used for the presence or analysis of substances in the urine, and also for the examination of, or changes in, the urine in disease. Used with tissues and cells (including neoplasms) and microorganisms for microanatomic structures, generally below the size visible by light microscopy. ;Used with organs and regions for ultrasonic imaging and with diseases for ultrasonic diagnosis. Does not include ultrasonic therapy. Used for the manner in which a subject changes, qualitatively or quantitatively, with time, whether past, present, or future. It excludes discussions of the course of disease in particular patients. Used with organs, tissues, or cells for transplantation from one site to another within the same subject, or from one subject to another of the same species or different species. Used with diseases for studies of the modes of transmission. JUsed with drugs and chemicals for experimental human and animal studies of their ill effects. It includes studies to determine the margin of safety or the reactions accompanying administration at various dose levels. It is used also for experimental studies of exposure to environmental agents. ZUsed with diseases for therapeutic interventions except drug therapy, diet therapy, radiotherapy, and surgery, for which specific subheadings exist. The concept is also used for articles and books dealing with multiple therapies. Z Used with drugs, biological preparations, and physical agents for their use in the prophylaxis and treatment of disease. It includes veterinary use.  wUsed for operative procedures on organs, regions, or tissues in the treatment of diseases, including tissue section by lasers. It excludes transplantation, for which "transplantation" is used.  9Used for the quantitative availability and distribution of material, equipment, health services, personnel, and facilities. It excludes food supply and water supply in industries and occupations.  ,Used with non-disease headings for the expression of numerical values which describe particular sets or groups of data. It excludes manpower distribution for which "manpower" is used and excludes supply or demand for which "supply and distribution" is used.  !.Used with facilities, personnel, and program headings for the development, testing, and application of standards of adequacy or acceptable performance and with chemicals and drugs for standards of identification, quality, and potency. It includes health or safety standards in industries and occupations.  b`Used for the discharge across the cell membrane, into the intracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs. Used with neoplasms to indicate the secondary location to which the neoplastic process has metastasized. {Used with diseases and surgical procedures for restoration of function of the individual. RjUsed with disease headings for the therapeutic use of ionizing and nonionizing radiation. It includes the use of radioisotope therapy. Used for radionuclide imaging of any anatomical structure, or for the diagnosis of disease. mUsed with organs, regions, and diseases for x-ray examinations. It does not include radionuclide imaging for which "radionuclide imaging" is used. Used for effects of ionizing and nonionizing radiation upon living organisms, organs and tissues, and their constituents, and upon physiologic processes. It includes the effect of irradiation on drugs and chemicals. Used with non-psychiatric diseases, techniques, and named groups for psychologic, psychiatric, psychosomatic, psychosocial, behavioral, and emotional aspects, and with psychiatric disease for psychologic aspects; used also with animal terms for animal behavior and psychology. <Used with disease headings for increasing human or animal resistance against disease (e.g. immunization), for control of transmission agents, for prevention and control of environmental hazards, or for prevention and control of social factors leading to disease. It includes preventive measures in individual cases. oUsed with drugs, chemicals, and industrial materials for human or animal poisoning, acute or chronic, whether the poisoning is accidental, occupational, suicidal, by medication error, or by environmental exposure. Used with organs and diseases for disordered function in disease states. WUsed with organs, tissues, and cells of unicellular and multicellular organisms for normal function. It is used also with biochemical substances, endogenously produced, for their physiologic role. Used with drugs and exogenously administered chemical substances for their effects on living tissues and organisms. It includes acceleration and inhibition of physiological and biochemical processes and other pharmacologic mechanisms of action.  Used for the mechanism, dynamics and kinetics of exogenous chemical and drug absorption, biotransformation, distribution, release, transport, uptake and elimination as a function of dosage, extent and rate of metabolic processes. 5Used for organ, tissue, or cell structure in disease states. PJUsed with microorganisms, viruses, and parasites for studies of their ability to cause disease in man or animals. Used with animals, higher plants, organs, and diseases for parasitic factors. In diseases, it is not used if the parasitic involvement is implicit in the diagnosis. GUsed for administrative structure and management. ;Used with diseases for nursing care and techniques in their management. It includes the nursing role in diagnostic, therapeutic, and preventive procedures. kUsed with human and veterinary diseases for mortality statistics. For deaths resulting from various procedures statistically but for a death resulting in a specific case, use FATAL OUTCOME, not /mortality. 4Used with organs, animals, and higher plants and with diseases for microbiologic studies. For parasites, "parasitology" is used; for viruses, "virology" is used. 7Used with techniques, procedures, and programs for methods.  GUsed with organs, cells and subcellular fractions, organisms, and diseases for biochemical changes and metabolism. It is used also with drugs and chemicals for catabolic changes (breakdown of complex molecules into simpler ones). For anabolic processes (conversion of small molecules into large), biosynthesis is used. For enzymology, pharmacokinetics, and secretion use the specific subheadings.  bUsed with disciplines and programs for the demand, supply, distribution, recruitment, and use of personnel. "A~Used for laws, statutes, ordinances, or government regulations, as well as for legal controversy and court decisions. "Used with bacteria, viruses, fungi, protozoa, and helminths for the obtaining of pure strains or for the demonstration of the presence of or identification of organisms by DNA analyses, immunologic, or other methods, including culture techniques. It is used also with biological substances and chemicals for the isolation and purification of the constituents. #oUsed with diagnostic or therapeutic procedures, analytic techniques, and specialties or disciplines, for the development or modification of apparatus, instruments, or equipment. %$Used with organs, regions, or tissues for their nerve supply. &KUsed with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which "pathology" is used. &`Used for immunologic studies of tissues, organs, microorganisms, fungi, viruses, and animals. It includes immunologic aspects of diseases but not immunologic procedures used for diagnostic, preventive, or therapeutic purposes, for which "diagnosis", "prevention and control", or "therapy" are used. The concept is also used for chemicals as antigens or haptens. ' Used for the historical aspects of any subject. It includes brief historical notes but excludes case histories. (Used with microorganisms, plants, and the postnatal period of animals for growth and development. It includes also the postnatal growth or development of organs or anatomical parts. )VUsed for mechanisms of heredity and the genetics of organisms, for the genetic basis of normal and pathologic states, and for the genetic aspects of endogenous chemicals. It includes biochemical and molecular influence on genetic material. *>Used with diseases for causative agents including microorganisms and includes environmental and social factors and personal habits as contributing factors. It includes pathogenesis. +iUsed with diseases and selected terms for ethnic, cultural, anthropological, or racial aspects, and with geographic headings to indicate the place of origin of a group of people. ,MUsed with human and veterinary diseases for the distribution of disease, factors which cause disease, and the attributes of disease in defined populations; includes incidence, frequency, prevalence, endemic and epidemic outbreaks; also surveys and estimates of morbidity in geographic areas and in specified populations. Used also with geographical headings for the location of epidemiologic aspects of a disease. Excludes mortality for which "mortality" is used. -2Used with organisms, except vertebrates, and with organs and tissues. It is also used with diseases for enzymes during the course of the disease, but excludes diagnostic enzyme tests, for which "diagnosis" is used. /^Used with organs, regions, and animal headings for embryologic and fetal development. It is used also with diseases for embryologic factors contributing to postnatal disorders. 0nUsed for education, training programs, and courses in various fields and disciplines, and for training groups of persons. 1OUsed for the economic aspects of any subject, as well as for all aspects of financial management. It includes the raising or providing of funds. 1Used with disease headings for the treatment of disease by the administration of drugs, chemicals, and antibiotics. For diet therapy and radiotherapy, use specific subheadings. Excludes immunotherapy and treatment with biologicals for which "therapy" is used. 2.Used with organs, regions, tissues, or organisms and physiological and psychological processes for the effects of drugs and chemicals. 3Used with disease headings for dietary and nutritional management of the disease. The concept does not include vitamin or mineral supplements, for which "drug therapy" may be used. 4Used with chemical compounds, drugs, and physical agents when these substances are used for studies of clinical function of an organ, or for the diagnosis of human or animal diseases. 5Used with diseases for all aspects of diagnosis, including examination, differential diagnosis and prognosis; excludes mass screening for which "prevention and control" is used. Excludes radiographic diagnosis for which "radiography" is used; excludes scintigraphic diagnosis for which "radionuclide imaging" is used; excludes ultrasonic diagnosis for which "ultrasonography" is used. 6wUsed with endogenous and exogenous substances which are absent or in diminished amount relative to the normal requirement of an organism or a biologic system. 8DUsed for normal cellular morphology of unicellular and multicellular organisms. 9]Used with drugs, chemicals, and biological and physical agents in any disease or physical state that might render their use improper, undesirable, or inadvisable. Used also with contraindicated diagnostic, therapeutic, prophylactic, anesthetic, surgical or other procedures. 9<Used with disease headings to indicate those conditions existing at, and usually before, birth. It excludes morphologic abnormalities and birth injuries, for which "abnormalities" and "injuries" are used. :Used with diseases to indicate conditions that co-exist or follow, i.e., co-existing diseases, complications, or sequelae. ;Used for taxonomic or other systematic or hierarchical classification systems. '8-Hydroxy-2-(di-n-propylamino)tetralin D04.615.638.960.400; D14.100.850.800.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Tetrahydronaphthalenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists 7-(Dipropylamino)-5,6,7,8-tetrahydro-1-naphthalenol. A serotonin 1A-receptor agonist that is being used experimentally to test the effects of serotonin. Tetrahydronaphthalenes (82-92) R|,.:#8-Bromo Cyclic Adenosine Monophosphate D13.695.462.200.225; D13.695.667.138.395.225; D13.695.827.068.395.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic; Cyclic AMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Cyclic AMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Cyclic AMP 8-Bromoadenosine cyclic 3',5'-(hydrogen phosphate). A long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase. Adenine Nucleotides (66-68); Adenosine Cyclic Monophosphate (68-83) U-M:O7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide D04.615.799.306.400.350; D26.191.262.280 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Pyrenes; Benzopyrenes; Dihydroxydihydrobenzopyrenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Dihydroxydihydrobenzopyrenes 7,8,8a,9a-Tetrahydrobenzo(10,11)chryseno (3,4-b)oxirene-7,8-diol. Benzopyrene derivative with carcinogenic or mutagenic activity. Benzopyrenes (66-86) X9..7-Alkoxycoumarin O-Dealkylase D08.586.682.690.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases A drug-metabolizing enzyme found in hepatic, placental and intestinal microsomes that metabolizes 7-alkoxycoumarin to 7-hydroxycoumarin. The enzyme is cytochrome P-450- dependent. EC 1.14.13.- . Oxygenases (66-89) ["Ff6-Phytase D08.586.277.352.650.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26. ] F6-Phosphofructokinase D08.586.913.696.620.225.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Glycogen Storage Disease Type VII Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Fructokinases An enzyme that catalyzes the conversion of a nucleotide triphosphate and a sugar phosphate to a nucleotide diphosphate and a sugar diphosphate. D-fructose 6-phosphate, D-tagatose 6-phosphate, and sedoheptulose 7-phosphate can act as acceptors; ATP, UTP, CTP, and ITP can act as donors. A deficiency of this enzyme is the cause of GLYCOGEN STORAGE DISEASE TYPE VII. EC 2.7.1.11. ^F)6-Mercaptopurine D02.886.489.534; D03.438.759.534; D22.204.144.713; D26.087.582 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites  Azathioprine 1,7-Dihydro-6H-purine-6-thione. An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. b'H:g86-Ketoprostaglandin F1 alpha D02.241.081.436.275.450; D02.241.081.436.687.250.350; D10.516.251.355.325.450; D10.516.251.355.708.400.350; D17.350.050.175.725.790.450 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins F Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins F Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandins F The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. Prostaglandins (66-74); Prostaglandins F (75-8l) e"D:6-Cyano-7-nitroquinoxaline-2,3-dione D03.438.857.160; D14.100.190.300.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinoxalines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists A potent excitatory amino acid antagonist with a preference for non-NMDA ionotropic receptors. It is used primarily as a research tool. j(*: 6-Aminonicotinamide D11.786.708.547.565.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Nicotinic Acids; Niacinamide 6-Aminonicotinamide. A vitamin antagonist which has teratogenic effects. Amines (72-75); Nicotinamide (68-74) /AA (75) l:U86-Aminocaproic Acid D02.241.081.193.150.075; D12.125.213.075; D19.461.270.463.091.276 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Caproates; Aminocaproic Acids Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Aminocaproic Acids Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics; Antifibrinolytic Agents 6-Aminohexanoic acid. An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties. Aminocaproic Acids (66-76) n~I:n 5'-Nucleotidase D08.586.277.352.650.600.600; D24.185.101.100.110.425; D24.611.216.301.264.035.425 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases; Nucleotidases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD A glycoprotein enzyme present in various organs and in many cells. The enzyme catalyzes the hydrolysis of a 5'-ribonucleotide to a ribonucleoside and orthophosphate in the presence of water. It is cation-dependent and exists in a membrane-bound and soluble form. EC 3.1.3.5. Nucleotidases (66-89) qdYFC5'-Guanylic Acid D13.695.667.454.525; D13.695.827.426.525 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides Guanosine 5'-monophosphate. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. Guanine Nucleotides (66-74) uj.D!5,8,11,14,17-Eicosapentaenoic Acid D02.241.081.436.292.250; D10.516.212.302.380.410.385; D10.516.251.355.337.290; D10.516.627.430.450.390; J01.740.250.410.290; J01.740.350.450.370 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Fish Oils; Fatty Acids, Omega-3 Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated; Fatty Acids, Omega-3 Technology, Industry, Agriculture (Non MeSH); Oils; Fish Oils; Fatty Acids, Omega-3 Important polyunsaturated fatty acid found in fish oils. It serves as the precursor for the prostaglandin-3 and thromboxane-3 families. A diet rich in eicosapentaenoic acid lowers serum lipid concentration, reduces incidence of cardiovascular disorders, prevents platelet aggregation, and inhibits arachidonic acid conversion into the thromboxane-2 and prostaglandin-2 families. Fatty Acids (66-72); Fatty Acids, Unsaturated (73-85) w'@A5,8,11,14-Eicosatetraynoic Acid D02.241.081.436.220; D10.516.251.355.270 AAADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a). Fatty Acids, Unsaturated (73-74) }$.>'5,7-Dihydroxytryptamine D03.438.473.914.201.263; D14.100.850.875.210 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; Dihydroxytryptamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Tryptamine substituted with two hydroxyl groups in positions 5 and 7. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacology as a tool. Tryptamines (66-77) E2:#5,6-Dihydroxytryptamine D03.438.473.914.201.259; D14.100.850.875.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; Dihydroxytryptamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Tryptamine substituted with two hydroxyl groups in positions 5 and 6. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacologic research. Tryptamines (66-74) 2:#5-Methoxytryptamine D02.092.211.215.801.852.611; D03.438.473.914.814.400 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Tryptamines; Serotonin Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; Serotonin 5-Methoxy-1H-indole-3-ethanamine. Serotonin derivative proposed as potentiator for hypnotics and sedatives. :>z5-Hydroxytryptophan D12.125.072.859.479 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Tryptophan Precursor of serotonin used as antiepileptic and antidepressant. F}L5-Androstene-3,17-diol D04.808.054.079.429.154.050; D06.597.100.194.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Androstenediols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids 5-Androstene-3 beta,17 beta-diol. An anabolic steroid. Synonyms: Bisexovis; Stenandiol. Androstenediols (75) X6:g5-Androstane-3,17-diol D04.808.054.040.080; D06.472.079.080 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Pipecuronium Pipecuronium 5 alpha-Androstane-3 beta,17 beta-diol. A naturally occurring steroid with androgenic activity. Androstanes (73-75); Hydroxysteroids (73-74)  m*Do54-Nitroquinoline-1-oxide D02.640.820.600; D03.438.810.470.450; D03.661.243.500; D05.569.468.600; D26.191.641 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitro Compounds; Nitroquinolines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Nitroquinolines Heterocyclic Compounds; Heterocyclic Oxides; Cyclic N-Oxides Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Mutagens Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 4-Nitroquinoline 1-oxide. A potent mutagen and carcinogen. This compound and its metabolite 4-HYDROXYAMINOQUINOLINE-1-OXIDE bind to nucleic acids. It inactivates bacteria but not bacteriophage. Cyclic N-Oxides (72-74); Nitro Compounds (72-74); Quinolines (70-74) v_.S4-Nitrophenylphosphatase D08.586.277.352.650.575 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the hydrolysis of nitrophenyl phosphates to nitrophenols. At acid pH it is probably ACID PHOSPHATASE (EC 3.1.3.2); at alkaline pH it is probably ALKALINE PHOSPHATASE (EC 3.1.3.1). EC 3.1.3.41. Alkaline Phosphatase (72-74); Nitrophenols (72-74); Organophosphorus Compounds (73-74) Fe4-Hydroxyphenylpyruvate Dioxygenase D08.586.682.690.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases An enzyme that catalyzes the conversion of 4-hydroxyphenylpyruvate plus oxygen to homogentisic acid and carbon dioxide. EC 1.13.11.27. Oxygenases (74); Phenylpyruvic Acids (74) (Ff34-Hydroxycoumarins D03.438.150.446.520; D19.461.119.196.475 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Coumarins Acenocoumarol; Bishydroxycoumarin; Ethyl Biscoumacetate; Phenprocoumon; Warfarin Acenocoumarol; Bishydroxycoumarin; Ethyl Biscoumacetate; Phenprocoumon; Warfarin Substances found in many plants, containing the 4-hydroxycoumarin radical. They interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound, inhibit mitochondrial and microsomal enzymes, and are used as oral anticoagulants. Coumarins (72-76) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ${.:<4-Hydroxybenzoate-3-Monooxygenase D08.586.682.420.425 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases A flavoprotein that catalyzes the synthesis of protocatechuic acid from 4-hydroxybenzoate in the presence of molecular oxygen. EC 1.14.13.2. Benzoates (71-74); Hydroxylases (71-74); Phenols (71-74) -%FhE4-Hydroxyaminoquinoline-1-oxide D02.092.570.450; D03.438.810.050.440; D03.661.243.320; D05.569.468.400; D26.191.474 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Hydroxylamines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Aminoquinolines Heterocyclic Compounds; Heterocyclic Oxides; Cyclic N-Oxides Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Mutagens Miscellaneous Drugs and Agents (Non MeSH); Carcinogens N-Hydroxy-4-quinolineamine 1-oxide. A potent mutagen and carcinogen. It is a reduction product of 4-NITROQUINOLINE-1-OXIDE. It binds with nucleic acids and inactivates both bacteria and bacteriophage. Cyclic N-Oxides (72-74); Hydroxylamines (74); Quinolines (72-74) '#_.N4-Chloromercuribenzenesulfonate D02.455.426.559.389.097.150; D02.691.750.740.250; D02.886.645.600.080.050.100.100; D08.373.830.220; D26.550.844.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzenesulfonates Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Phenylmercury Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Benzenesulfonates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Sulfhydryl Reagents Hydrogen chloro(4-sulfonatophenyl)mercurate(1-). A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology. Benzene (66-67); Benzenesulfonates (74); Mercury (66-74); Organometallic Compounds (68-74); Sulfonic Acids (66-73) #:4-Butyrolactone D02.540.150; D03.383.312.150; D14.100.240.500.130 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Lactones Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Dihydro-2(3H)-furanone. An endogenous compound, made from gamma-aminobutyrate and the precursor of gamma-hydroxybutyrate, it is also used as a pharmacological agent. It apparently acts as a modulator at the picrotoxin binding site of GABA-A receptors, and may also affect GABA-B receptors. It is used mainly as an experimental tool. Among other systemic effects, it causes increase of brain dopamine by inhibiting its release from nerve terminals. It is also used as an industrial solvent and precursor. Furans (69-75); Lactones (69-75) 9DM)4-Aminopyridine D02.092.080.060; D03.383.725.050.060 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aminopyridines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Aminopyridines A potassium channel blocker. It is used primarily as a research tool and is helpful in characterizing subtypes of potassium channels. It has been used clinically in Lambert-Eaton syndrome and multiple sclerosis because by blocking potassium channels it prolongs action potentials thereby increasing transmitter release at the neuromuscular junction (and elsewhere). Aminopyridines (79-89); Pyridines (66-78) *:24-Aminobenzoic Acid D02.241.223.106.061.075; D11.786.708.054.075; D23.695.050; D26.763.750.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Aminobenzoic Acids Dermatologic Agents; Sunscreening Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents; Sunscreening Agents Acetylprocainamide; Benzocaine; Procainamide; Procaine; Propoxycaine; Tetracaine 4-Aminobenzoic acid. A member of the vitamin B complex. It is also employed as a sunscreening agent. The potassium salt is used therapeutically in fibrotic skin disorders. Aminobenzoic Acids (66-76)  T:a 3T3 Cells A11.251.210.900; A11.329.228.900 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Cells; Connective Tissue Cells (Non MeSH); Fibroblasts A cell line derived from fibroblasts of disaggregated Swiss mouse embryos. The line is a valuable in vitro host system for oncogenic virus transformation studies since 3T3 cells possess a high sensitivity to contact inhibition. Cell Line (66-91) &*l 3',5'-Cyclic-Nucleotide Phosphodiesterase D08.586.277.352.640.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases An enzyme that catalyzes the hydrolysis of cyclic AMP to form adenosine 5'-phosphate. The enzyme is widely distributed in animal tissue and controls the level of intracellular cyclic AMP. Also acts on 3',5'-cyclic IMP and 3',5'-cyclic GMP. EC 3.1.4.17. Adenosine Cyclic Monophosphate (73-74); Phosphodiesterases (73-74) .F*M3',5'-Cyclic-GMP Phosphodiesterase D08.586.277.352.640.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases An enzyme that catalyzes the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate. EC 3.1.4.35. Guanosine Cyclic Monophosphate (71-77); Phosphodiesterases (72-77) s'FvM3,4-Methylenedioxyamphetamine D02.092.471.683.152.660; D14.100.050.600.050.530; D14.100.600.050.530; D14.100.850.875.500; D15.300.515; D15.700.372.632 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. Amphetamine (73-76); Dioxoles (74-75); Methyl Ether (73) h!:6F3,4-Dihydroxyphenylserine D12.125.837.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Serine 3-(3,4-Dihydroxyphenyl)serine. Catechol (71-74); Serine (71-74) :R%)3,4-Dihydroxyphenylacetic Acid D02.241.223.601.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates 3,4-Dihydroxyphenylacetic acid. A metabolite of L-DOPA. Catechol (72-74); Phenylacetates (72-74) #:pB13,3'-Dichlorobenzidine D02.455.426.559.389.185.226; D26.191.111.267 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Benzidines 3,3'-Dichloro-4,4'-diaminodiphenyl. A material used in the manufacture of azo dyes; toxic to skin and carcinogenic in several species. Aniline Compounds (69-74); Benzidines/AA (75-76); Biphenyl Compounds (69-74) 2.\3,3'-Diaminobenzidine D02.455.426.559.389.185.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds 3,3',4,4' Biphenyltetramine. Biphenyl Compounds (70-74); Phenylenediamines (74) 1:"<3-Oxoacyl (Acyl Carrier Protein) Synthase D08.586.913.050.770 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide. EC 2.3.1.41. Acyltransferases (70-74); Carrier Proteins (73-74); Malonates (70-74) 1Fi4S3-Methoxy-4-hydroxyphenylethanol D02.755.166.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Catechols 3-Methoxy-4-hydroxyphenylethanol. Metabolite of serotonin and norepinephrine. Alcohol, Ethyl (72-74); Catechols (72-74) Ā$:<X33-Mercaptopropionic Acid D02.241.081.751.700.550; D02.886.489.520; D08.373.560; D14.100.240.600; D15.220.224.582 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Propionates; Propionic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents Central Nervous System Agents; Central Nervous System Stimulants; Convulsants 3-Mercaptopropionic acid. An inhibitor of glutamate decarboxylase, it decreases the GABA concentration in the brain, thereby causing convulsions. Propionates (66-77); Sulfhydryl Compounds (66-77) c:;3-Hydroxysteroid Dehydrogenases D08.586.682.047.436.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases Cholesterol Oxidase; Progesterone Reductase Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids. Hydroxysteroid Dehydrogenases (66-77)  ɟ$F3I+3-Hydroxyanthranilic Acid D02.241.223.106.061.105.460; D26.191.480 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; Anthranilic Acids Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 3-Hydroxyanthranilic acid. Carcinogen. Anthranilic Acids (70-74); Phenols (72-74) ˌ...43-Hydroxyacyl CoA Dehydrogenases D08.586.682.047.385 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases Hydroxymethylglutaryl CoA Reductases Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis. EC 1.1.1.35. Alcohol Oxidoreductases (66-77); Coenzyme A (66-77)  g&Ft*>3-Hydroxy-3-Methylglutaric Acid D02.241.081.337.351.400; D10.162.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Glutarates Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents 3-Hydroxy-3-methylpentanedioic acid. An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of hydroxymethylglutaryl CoA reductase which is the rate limiting enzyme in the biosynthesis of cholesterol. Anticholesteremic Agents (66-79); Antilipemic Agents (66-72); Glutarates (66-79); Hydroxy Acids (75-79) $*:{3-Deazauridine D13.570.685.852.250; D13.570.800.892.250; D22.204.144.400; D26.087.262 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Uridine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent. Pyridones (73-74); Uridine (72-74) ӸP:+25-Hydroxyvitamin D 2 D04.808.247.222.474.500; D04.808.247.808.412.500; D04.808.812.537.500; D10.516.851.439.500; D11.786.763.462.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Ergocalciferols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Ergocalciferols Polycyclic Hydrocarbons; Steroids; Secosteroids; Ergocalciferols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Ergocalciferols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D; Ergocalciferols 9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3. Ergocalciferols (66-89) {D 25-Hydroxycholecalciferol 1-Hydroxylase D08.586.682.420.783.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Steroid Hydroxylases An enzyme that catalyzes the formation of 1,25-dihydroxycholecalciferol from 25-hydroxycholecalciferol. The reaction requires oxygen, magnesium, and NAD(P)H. EC 1.14.13.13. Hydroxycholecalciferols (73-74); Steroid Hydroxylases (73-74) ,FG24,25-Dihydroxyvitamin D 3 D04.808.247.222.159.478.387.400; D04.808.247.808.146.478.387.400; D04.808.812.221.478.387.400; D10.516.851.152.478.387.400; D11.786.763.196.478.387.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Secosteroids; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols 9,10-Secocholesta-5,7,10(19)-triene 3,24,25-triol. A physiologically active metabolite of vitamin D. The compound is involved in the regulation of calcium metabolism, alkaline phosphatase activity, and enhances the calcemic effect of calcitriol. Dihydroxycholecalciferols (73-89)  D&20-Hydroxysteroid Dehydrogenases D08.586.682.047.436.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases Cortisone Reductase Catalyze the oxidation of 20-hydroxysteroids to 20-ketosteroids. Includes EC 1.1.1.149 and EC 1.1.1.53. Hydroxysteroid Dehydrogenases (66-77)  P%Fy+2',5'-Oligoadenylate Synthetase D08.586.913.696.445.625 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases An enzyme that catalyzes the conversion of ATP into a series of (2'-5') linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease (RNase L) which cleaves single-stranded RNA. Interferons can act as inducers of these reactions. EC 2.7.7.-. Nucleotidyltransferases (66-82) S$Fl$2',3'-Cyclic-Nucleotide Phosphodiesterases D08.586.277.352.640.160 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-. Adenosine Cyclic Monophosphate (73-74); Phosphodiesterases (73-74) /FM2,6-Dichloroindophenol D02.755.446.250; D26.550.200 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Phenols; Indophenol Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 2,6-Dichloroindophenol sodium. A dye used as a reagent in the determination of vitamin C. Chlorine (72-74); Indophenol (72-74) ".k-2,4,5-Trichlorophenoxyacetic Acid D02.241.511.316.881; D05.723.366.901 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides (2,4,5-Trichlorophenoxy)acetic acid. An herbicide with strong irritant properties. According to Merck Index, 11th ed, use of this compound on rice fields, orchards, sugarcane, rangeland, and other noncrop sites was terminated by the EPA in 1985. Acetic Acids (66-70); Herbicides (66-70); Phenols (66-70) o&*:G2,4-Dichlorophenoxyacetic Acid D02.241.511.316.300; D05.723.366.279 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides (2,4-Dichlorophenoxy)acetic acid. An herbicide with irritant effects on the eye and the gastrointestinal system. Acetic Acids (66-70); Herbicides (66-70); Phenols (66-70) 1#*:G2,3-Diketogulonic Acid D02.241.081.844.200; D02.241.511.902.200; D09.203.811.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids threo-2,3-Hexodiulosonic acid. Metabolite of ASCORBIC ACID and the oxidized form of the lactone DEHYDROASCORBIC ACID. Ketoses (74); Sugar Acids (73-74) UA:+2,2'-Dipyridyl D03.383.725.220; D26.550.269 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents alpha,alpha-Dipyridyl. Used as a reagent for the determination of iron. Pyridines (69-74) ".V2-Naphthylamine D02.092.710; D04.615.638.850; D26.191.634 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens A naphthalene derivative with carcinogenic action. Amines (71-74); Naphthalenes (71-74) z1.<-2-Isopropylmalate Synthase D08.586.520.567.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases An enzyme that catalyzes the first step in the biosynthetic pathway to leucine, forming isopropyl malate from acetyl-CoA and alpha-ketoisovaleric acid. EC 4.1.3.12. Ketoacid-Lyases (73-74); Ketoacids (73-74); Malates (73-74) IFbH2-Hydroxyphenethylamine D02.033.329.291.410; D02.092.063.291.410; D02.092.211.215.581; D02.092.471.683.545 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines alpha-(Aminomethyl)benzyl alcohol. Simple amine found in the brain. It may be modulator of sympathetic functions. Its derivatives are adrenergic agonists and antagonists. It is also used in chemical industry. Amino Alcohols (66-72); Ethanolamines (73-77); Phenethylamines (66-73) V\>JT2-Hydroxy-5-nitrobenzyl Bromide D02.455.426.559.389.140.400; D02.640.743.400; D02.755.566.400; D26.550.405 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzyl Compounds Organic Chemicals (Non MeSH); Nitro Compounds; Nitrophenols Organic Chemicals (Non MeSH); Phenols; Nitrophenols Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 2-(Bromomethyl)-5-nitrophenol. A chemical reagent that reacts with and modifies chemically the tryptophan portion of protein molecules. Used for 'active site' enzyme studies and other protein studies. Sometimes referred to as Koshland's reagent. Benzyl Compounds (73-74); Nitrophenols (73-74) $T.82-Chloroadenosine D13.570.583.138.300; D13.570.800.096.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Adenosine Cladribine Cladribine 2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system. Adenosine (66-89)  l.:2-Aminopurine D03.438.759.138.050; D26.087.018 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Adenine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites A purine which is an isomer of adenine. Amines (72-74); Purines (72-74) &:3(2-Aminoadipic Acid D02.241.081.337.052.075; D12.125.119.075 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Adipic Acids Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic 2-Aminohexanedioic acid. An amino acid isolated from Vibrio cholera. Adipic Acids (69-75); Amino Acids, Dicarboxylic (74-75) .FRC2-Amino-5-phosphonovalerate D12.125.070.950.100; D14.100.190.300.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Branched-Chain; Valine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists A potent and specific antagonist of NMDA receptors (RECEPTORS, NMDA) in the D-enantiomeric form. The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors. Anticonvulsants (66-89); Valine (66-74); Valine/analogs and derivatives (75-89) .:( _2-Acetylaminofluorene D02.065.064.150; D02.241.081.038.108.080; D04.615.389.050; D26.191.372.016 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Acetamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Fluorenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Fluorenes Acetoxyacetylaminofluorene; Hydroxyacetylaminofluorene Acetoxyacetylaminofluorene; Hydroxyacetylaminofluorene Acetoxyacetylaminofluorene; Hydroxyacetylaminofluorene Acetoxyacetylaminofluorene; Hydroxyacetylaminofluorene N-Fluoren-2-yl-acetamide. A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the arylhydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. Acetamides (71-74); Fluorenes (66-74)   T:\.2-Acetolactate Mutase D08.586.399.040 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases An enzyme involved in the biosynthesis of isoleucine and valine. It converts 2-acetolactate into 3-hydroxy-2-oxo-isovalerate. Also acts on 2-hydroxy-2-acetobutyrate to form 2-hydroxy-2-oxo-3-methylvalerate. EC 5.4.99.3. Hydroxybutyrates (73-74); Isomerases (73-74); Lactates (73-74)  $FSK19-Iodocholesterol D04.808.247.222.284.510; D04.808.247.808.197.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholesterol Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol 19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy. Cholesterol (68-74) /AA (75-78); Iodine Radioisotopes (66-78) V6:{I18-Hydroxydesoxycorticosterone D04.808.745.745.654.339.400; D06.472.040.668.478.298.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Desoxycorticosterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Mineralocorticoids; Hydroxycorticosteroids; Desoxycorticosterone An analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position. Desoxycorticosterone (73-74) k">:s!18-Hydroxycorticosterone D04.808.745.745.654.237.400; D06.472.040.322.478.353.500; D06.472.040.668.478.561.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Corticosterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Mineralocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids 11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione. Hydrocortisone (73-74) ]:517-Ketosteroids D04.808.578.502; D06.472.040.502; D06.597.481.561.627 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic Androstenedione; Androsterone; Equilenin; Equilin; Estrone (+ 1); Etiocholanolone; Prasterone Androstenedione; Androsterone; Estrone; Etiocholanolone; Prasterone AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR =8&D17-Hydroxysteroid Dehydrogenases D08.586.682.047.436.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases Estradiol Dehydrogenases A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-. Hydroxysteroid Dehydrogenases (66-77)  %Fv+17-Hydroxycorticosteroids, Synthetic D06.597.481.561.478 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic Beclomethasone; Betamethasone (+ 2); Dexamethasone (+ 1); Fludrocortisone; Flumethasone; Fluocinolone Acetonide (+ 1); Fluorometholone; Flurandrenolone; Paramethasone; Prednisolone (+ 3); Prednisone; Triamcinolone (+ 1) Synthetic chemical steroids that mimic the activity of 17-hydroxycorticosteroids obtained from the adrenal cortex, but differ in structure from the naturally occurring 17-hydroxycorticosteroids. They must have a hydroxy group in the 17-position of the steroid configuration. Hydroxycorticosteroids (72-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $)8;#:17-Hydroxycorticosteroids D06.472.040.322.478.478 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids Cortisone; Cortodoxone; Hydrocortisone; Hydroxypregnenolone; Tetrahydrocortisol; Tetrahydrocortisone A group of hydroxycorticosteroids bearing a hydroxy group at the 17-position. Urinary excretion of these compounds is used as an index of adrenal function. They are used systemically in the free alcohol form, but with esterification of the hydroxy groups, topical effectiveness is increased. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR   d>rUD16,16-Dimethylprostaglandin E2 D02.241.081.436.687.700.450.300; D10.516.251.355.708.700.450.300; D17.350.700.660.200; D19.316.203.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents (5Z,11 alpha,13E,15R)-11,15-Dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid. A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors. Prostaglandins (66-74); Prostaglandins E (75-77); Prostaglandins E, Synthetic (78-79); Prostaglandins, Synthetic (77) ##p:15-Oxoprostaglandin 13-Reductase D08.586.682.680 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases (5Z)-(15S)-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD(P)+ delta(13)-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48. Oxidoreductases (66-77); Prostaglandins (66-77); specific prostaglandin (75-77) )]%FXB]11-Hydroxycorticosteroids, Synthetic D06.597.481.561.353 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic Beclomethasone; Betamethasone (+ 2); Dexamethasone (+ 2); Fludrocortisone; Flumethasone; Fluocinolone Acetonide (+ 1); Fluocortolone (+ 1); Fluorometholone; Flurandrenolone; Paramethasone; Prednisolone (+ 3); Triamcinolone (+ 1) Synthetic chemical steroids that mimic the activity of 11-hydroxycorticosteroids obtained from the adrenal cortex, but differ in structure from the naturally occurring 11-hydroxycorticosteroids. They must have a hydroxy group in the 11-position of the steroid configuration. 11-Hydroxycorticosteroids (72-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $+)8;&:11-Hydroxycorticosteroids D06.472.040.322.478.353; D06.472.040.668.478.561 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Mineralocorticoids; Hydroxycorticosteroids Corticosterone; Hydrocortisone; 18-Hydroxycorticosterone; Tetrahydrocortisol Aldosterone; Corticosterone; 18-Hydroxycorticosterone A group of corticosteroids bearing a hydroxy group at the 11-position. Glucocorticoids (67-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $/6>UD1,4-alpha-Glucan Branching Enzyme D08.586.913.400.450.460.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases In glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC 2.4.1.18. Glucosyltransferases (73-75); Polysaccharides (73-75); specific polysaccharide (73-75) 2'Fd1,2-Dipalmitoylphosphatidylcholine D10.516.695.300.700.710.210; D24.185.701.210 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids; Phosphatidylcholines Immunologic and Biologic Factors (Non MeSH); Biological Factors; Pulmonary Surfactants Synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS. Pulmonary Surfactant (71-86); Surface-Active Agents (66-70) 5&2DF1-Sarcosine-8-Isoleucine Angiotensin II D08.373.745.085.820; D12.644.456.073.041.815; D17.350.050.050.050.725; D18.162.050.820 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins; Angiotensin II Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Angiotensins; Angiotensin II Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors 1-(N-Methylglycine)-8-L-isoleucineangiotensin II. An angiotensin II analog which acts as a highly specific inhibitor of angiotensin II. Angiotensin II (66-74)/analogs and derivatives (75-79); Glycine (66-67); Isoleucine (66-74)/analogs and derivatives (75-79); Sarcosine (68-74)/analogs and derivatives (75-79) 86-`:1-Naphthylisothiocyanate D02.500.375.625; D02.886.250.625; D04.615.638.870 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Isocyanates; Isothiocyanates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Isothiocyanates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes 1-Isothiocyanatonaphthalene. A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage. Naphthalenes (72-75); Thiocyanates (72-75) <9:*31-Naphthylamine D02.092.705; D04.615.638.845; D26.191.630 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 1-Naphthalenamine. A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic. Amines (69-75); Naphthalenes (69-75) ?1.-1-Methyl-4-phenylpyridinium D03.383.725.762.550; D05.723.366.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides 1-Methyl-4-phenylpyridinium (MPP+). An active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to paraquat, has also been used as an herbicide. Pyridinium Compounds (68-89) A*:"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine D03.383.725.450; D14.100.150.600.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) 1,2,3,6-Tetrahydro-1-methyl-4-phenylpyridine. A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. These toxic effects can be prevented by the administration of selective monoamine oxidase inhibitors. Since the cellular toxicity of the compound is similar to that observed in idiopathic Parkinson disease, experimental studies with this compound can suggest new opportunities for effective therapy. The compound also induces duodenal ulcers. Pyridines (66-89) E0*:m1-Methyl-3-Isobutylxanthine D03.438.759.758.824.751.500; D08.373.735.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines; Theophylline Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors 3,7-Dihydro-1-methyl-3-(2-methylpropyl)-1H-purine-2,6-dione. A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates cyclic nucleotide-dependent protein kinases. Synonym: SC-2964. Phosphodiesterase Inhibitors (78); Phosphodiesterases/AI (72-77); Xanthines (66-78) I2:?b1-Deoxynojirimycin D03.383.621.180; D20.388.325 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Anti-Infective Agents; Antiviral Agents (2R-(2 alpha,3 beta,4 alpha,5 beta))-2-(Hydroxymethyl)-3,4,5-piperidinetriol. An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. Glucosamine/analogs and derivatives (81-92) M":31-Carboxyglutamic Acid D02.241.081.901.400; D12.125.119.450.150 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Tricarboxylic Acids Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Glutamic Acid 3-Amino-1,1,3-propanetricarboxylic acid. Found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications. Glutamates (66-78) O>.F Zymosan D09.203.698.964 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Q F^Zymomonas B03.440.450.980 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that is not known to be pathogenic for man, animals, or plants. Its organisms are spoilers for beers and ciders and in sweet English ciders they are the causative agents of a secondary fermentation known as "cider sickness." The species Z. mobilis is used for experiments in molecular genetic studies. Bacteria (67-83); Gram-Negative Anaerobic Bacteria (87-92); Gram-Negative Bacteria (84-92) R "XjZygote Intrafallopian Transfer E05.820.980 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Reproduction Techniques An assisted reproduction technique consisting of hormonal stimulation of the ovaries, laparoscopic follicular aspiration of oocytes, in-vitro fertilization, and intrafallopian transfer of the zygote by transabdominal cannulation at the pronuclear stage (before cleavage). Embryo Transfer (88-92); Fertilization in Vitro (88-92); Gamete Intrafallopian Transfer (88-92); Zygote (88-92) U$"G5Zygote A05.360.490.690.970; A11.497.497.950; A16.950 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Ovum Cells; Germ Cells; Ovum Embryonic Structures (Non MeSH) The fertilized ovum. Ovum (66-74) X9 5,|Zygomycotina B05.354.730.944 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes Entomophthora; Mucorales (+ 3) A subdivision of fungi, formerly included in the Phycomycetes, usually saprophytic or parasitic, especially for insects. Phycomycetes (66-74)  Ys"<&Zygomatic Fractures C21.866.405.762.959; C21.866.460.589.338.827; C21.866.460.836.827 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Skull Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Skull Fractures Fractures of the zygoma. Fractures (66-70) ZINw Zygoma A02.835.232.781.324.995 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones ]m :UZoxazolamine D03.438.221.950; D15.525.990; D16.700.600.990; D17.050.337.900.975 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzoxazoles Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants; Uricosuric Agents A uricosuric and muscle relaxant. Zoxazolamine acts centrally as a muscle relaxant, but the mechanism of its action is not understood. ^@L:Zooplankton B01.766.743 CHCLCYDEENGDGEIMIPMEPHPYREULVI Invertebrates; Plankton Minute free-floating animal organisms which live in practically all natural waters. Plankton (66-70) aB"bZoonoses C01.908; C02.968; C03.908; C22.969 CLEPETHIMIPCPSTM Disease Reservoirs Public Health Bacterial and Fungal Diseases (Non MeSH) Virus Diseases Parasitic Diseases Animal Diseases Diseases of non-human animals that may be transmitted to man or may be transmitted from man to non-human animals.  b= ,iZoomastigophora B01.841.750.443.950 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora Diplomonadida (+ 2); Kinetoplastida (+ 20); Trichomonadida (+ 5) A class of protozoa consisting of animal-like flagellates. Its organisms are heterotrophic and have one-to-many flagella. This class includes one superorder, Parabasalidea, and six orders: Choanoflagellida, KINETOPLASTIDA, Proteromonadida, Retortamonadida, DIPLOMONADIDA, and Oxymonadida. c&BPFZoology G01.273.943 CLECEDHIISLJMAMTOGSNSTTD Animals Biological Sciences; Biology Entomology f  #Zoogloea B03.440.400.425.625.931 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae A genus of PSEUDOMONADACEAE occurring as rod-shaped cells embedded in a gelatinous matrix. It includes two species: Z. filipendula and Z. ramigera. Bacteria (66-71) f "Zona Reticularis A06.407.071.140.970 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands; Adrenal Glands; Adrenal Cortex The inner zone of the adrenal cortex. This zone consists of an anastomosing network of cells which resemble those of the zona fasciculata except for the fact that they contain less lipid. The mitochondria are elongated and contain a mixture of tubular and flattened cristae. Adrenal Cortex (75-88); Adrenal Glands (66-88) h:^E9Zona Pellucida A05.360.490.690.950; A11.497.497.900; A16.631.900 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Ovum Cells; Germ Cells; Ovum Embryonic Structures (Non MeSH); Ovum The transport non-cellular envelope surrounding the mammalian ovum. j9(OZona Glomerulosa A06.407.071.140.960 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands; Adrenal Glands; Adrenal Cortex The narrow subcapsular outer zone of the adrenal cortex. This zone consists of granular cells which stain deeply and are arranged in rounded groups. It converts pregnenolone to aldosterone by a series of enzymatically regulated steps. Adrenal Cortex (75-88); Adrenal Glands (66-88) lV:^9Zona Fasciculata A06.407.071.140.950 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands; Adrenal Glands; Adrenal Cortex The wide middle zone of the adrenal cortex. This zone consists of large lipid-laden cells radially arranged in parallel cords. It converts pregnenolone to cortisol by a series of enzymatically regulated steps. A small amount of corticosterone is formed as a by-product of cortisol synthesis. Adrenal Cortex (75-88); Adrenal Glands (66-88) n:^W9Zollinger-Ellison Syndrome C04.557.470.035.100.320.988; C04.588.322.443.988; C04.730.713.988; C06.405.613.988; C19.344.443.988; C19.576.983 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Multiple Endocrine Neoplasia Type 1 Peptic Ulcer; Gastrinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Islet Cell; Gastrinoma Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Neoplastic Endocrine-Like Syndromes Neoplasms; Paraneoplastic Syndromes; Neoplastic Endocrine-Like Syndromes Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer Endocrine Diseases; Endocrine Gland Neoplasms; Neoplastic Endocrine-Like Syndromes Endocrine Diseases; Neoplastic Endocrine-Like Syndromes A triad comprising intractable, sometimes fulminating, and in many ways, atypical ulcers; extremely elevated gastric acidity; and gastrin-secreting non-beta islet cell tumors, usually of the pancreas, but sometimes in other sites (e.g., the duodenum), which may be single or multiple, large or small, benign or malignant. (Dorland, 27th ed).  q ~N+JZolazepam D03.383.066.985; D15.210.350.800.975; D15.325.875.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate 4-(2-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo(3,4-e)(1,4)diazepin-7(1H)-one. A pyrazolodiazepinone with pharmacological actions similar to anti-anxiety agents. It is commonly used in combination with TILETAMINE to obtain immobilization and anesthesia in animals. Azepines (73-76); Fluorobenzenes (74-75); Pyrazoles (74-75) vB =:75HZirconium D01.268.973; D01.552.977 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals y :`Ziram D02.241.081.251.869.210.925; D02.886.706.175.950; D05.723.288.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates; Dimethyldithiocarbamate Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates; Dimethyldithiocarbamate Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial (T-4)-Bis(dimethylcarbamodithioato-S,S')zinc. An industrial fungicide with low mammalian toxicity, although it does possess an irritant capacity for skin and mucous membranes. Thiocarbamates (69-74); Zinc (69-74) z I:f-Zinostatin D12.776.097.910; D20.085.075.987; D22.204.106.965 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic An antitumor isolate from the culture filtrate of the F-41 variant of Streptomyces carzinostaticus. It is a protein of known amino acid sequence with a molecular weight of approximately 11,500 and possessing a regulatory function on the metabolism of DNA. In this process, which is first an inhibition of DNA biosynthesis followed by the degradation of DNA, zinostatin functions in a manner analogous to that of the much higher molecular weight antibiotic mitomycin C. Zinostatin is also a potent cytostatic agent active against gram-positive organisms. Antibiotics, Antineoplastic (71-74); Bacterial Proteins (74) }9<GZineb D02.241.081.251.869.265.908; D02.691.975; D02.886.706.250.950; D05.723.288.931 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates; Ethylenebis(dithiocarbamates) Organic Chemicals (Non MeSH); Organometallic Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates; Ethylenebis(dithiocarbamates) Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial ((1,2-Ethanediylbis(carbamodithioato))(2-))zinc. An agricultural fungicide of the dithiocarbamate class. It has relatively low toxicity and there is little evidence of human injury from exposure. Antifungal Agents (66-71); Pesticides (66-71); Thiocarbamates (66-71); Zinc (66-71)  X:eZinc Radioisotopes D01.496.749.980; D01.496.966.800 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Zinc Isotopes Unstable isotopes of zinc that decay or disintegrate emitting radiation. Zn atoms with atomic weights 60-63, 65, 69, 71, and 72 are radioactive zinc isotopes. Zinc Isotopes (66-74); Radioisotopes (66-74) &46Zinc Phosphate Cement D25.339.291.893 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements A material used for cementation of inlays, crowns, bridges, and orthodontic appliances and occasionally as a temporary restoration. It is prepared by mixing zinc oxide and magnesium oxide powders with a liquid consisting principally of phosphoric acid, water, and buffers. (From Bouchers' Clinical Dental Terminology, 3d ed). ,\{Zinc Oxide-Eugenol Cement D25.339.291.793 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements ;,\Zinc Oxide D01.650.550.975; D01.975.975; D23.695.975; D23.990; D26.763.750.901 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Inorganic Chemicals (Non MeSH); Zinc Compounds Dermatologic Agents; Sunscreening Agents Dermatologic Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents; Sunscreening Agents A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock. Oxides (66-74); Zinc (66-74) O:7%Zinc Isotopes D01.496.966 Inorganic Chemicals (Non MeSH); Isotopes Zinc Radioisotopes Stable zinc atoms that have the same atomic number as the element zinc, but differ in atomic weight. Zn-66-68, and 70 are stable zinc isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 24Zinc Fingers G05.331.599.056.980; G06.184.599.056.980 DEGEIMPHRE DNA-Binding Proteins Genetics; Genetics, Biochemical; Molecular Sequence Data; Amino Acid Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Amino Acid Sequence Domains in DNA- and RNA-binding proteins that contain amino acids which are folded into a single structural unit around a zinc atom that links two cysteines and two histidines. Each finger is postulated to recognize a specific sequence of about five nucleotide pairs. Amino Acid Sequence (87-90); DNA-Binding Proteins (87-90); Molecular Sequence Data (88-90)  V.;lZinc Compounds D01.975 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Zinc Oxide Inorganic compounds that contain zinc as an integral part of the molecule. Zinc (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ 8%Z:Zinc D01.268.912.975; D01.552.966 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Zinc. A metallic trace element that has the atomic symbol Zn, atomic number 30, and atomic weight 65.38. It is necessary in the diet, forms an essential part of many enzymes, and plays an important role in protein synthesis and in cell division. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. (From Dorland, 27th ed). ":sZimeldine D03.383.725.620.129.960; D14.100.600.850.980; D14.100.850.875.800.980 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pheniramine; Brompheniramine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors 3-(4-Bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-2-propen-1-amine. An inhibitor of serotonin uptake formerly used in the treatment of depression in doses of 200-300 mg daily. It was withdrawn worldwide in September 1983 because of the risk of Guillain-Barre syndrome associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p.385). Brompheniramine (66-83); Pyridines (66-83)  M:3Zimbabwe Z01.058.290.175.960 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern  `Zidovudine D13.570.230.500.950; D13.570.230.855.950; D13.570.685.705.950; D20.388.330.950; D26.087.295.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Dideoxynucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Thymidine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Thymidine Anti-Infective Agents; Antiviral Agents; Dideoxynucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Dideoxynucleosides 3'-Azido-3'-deoxythymidine. A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. Thymidine/analogs and derivatives (75-88) k:1Zeranol D02.540.950.975; D02.755.852.900.975; D06.597.378.359.980 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Lactones; Zearalenone Organic Chemicals (Non MeSH); Phenols; Resorcinols; Zearalenone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Estrogens, Non-Steroidal (3S,7X)-3,4,5,6,7,8,9,10,11,12-Decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one. A non-steroidal estrogen analog. Lactones (73-74); Resorcinols (73-74)  A: .Zeolites D01.056.050.075.975; D01.578.725.025.975; D01.650.550.050.075.975; D01.837.725.700.760.050.950 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Aluminum Compounds; Aluminum Oxide; Aluminum Silicates Inorganic Chemicals (Non MeSH); Minerals; Silicates; Aluminum Silicates Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Aluminum Oxide; Aluminum Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Aluminum Silicates Zeolites. A group of crystalline, hydrated alkali-aluminum silicates. They occur naturally in sedimentary and volcanic rocks, altered basalts, ores, and clay deposits. Some 40 known zeolite minerals and a great number of synthetic zeolites are available commercially. (From Merck Index, 11th ed). Aluminum Silicates (80-93); Sodium Hydroxide (72-80) T h8[?Zenker's Diverticulum C06.306.354.500; C23.329.695.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Diverticulum Symptoms and General Pathology (Non MeSH); Diverticulum; Esophageal Diverticulum A diverticulum at the junction of the pharynx and esophagus. It is caused by continuous irritation of an anatomically weak area of the posterior hypopharynx by food bolus and neuromuscular incoordination of the swallowing mechanism. (Dorland, 27th ed.; CMIT, 5th ed.). Esophageal Diverticulum (66-91) z&N=%Zellweger Syndrome C06.552.970; C10.228.140.970; C12.777.419.978; C16.131.077.970 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple A rare, autosomal recessive congenital syndrome of multiple abnormalities. Some of the principal characteristics are cerebral dysfunction, defective myelinization, craniofacial abnormalities, renal cysts, hepatomegaly, and biliary dysgenesis. Abnormalities, Multiple (68-88); Brain Diseases (66-88); Kidney Diseases (66-88); Liver Diseases (66-88) AHLI}Zein D12.776.765.919 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins DWZebrafish B02.493.200.244.828 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cypriniformes; Cyprinidae A species of North American fishes of the family Cyprinidae. They are used in embryological studies and to study the effects of certain chemicals on development. Fishes (66-86)  &8Zeatin D03.438.759.950; D11.303.760.265.400.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators; Cytokinins; Kinetins 6-(4-Hydroxy-3-methylbut-2-enylamino)purine. Plant growth regulator. Amino Alcohols (73-74); Purines (73-74) < .:O1Zearalenone D02.540.950; D02.755.852.900; D06.472.265.540.975; D06.472.866.540.540.975; D24.185.926.587.989 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Lactones Organic Chemicals (Non MeSH); Phenols; Resorcinols Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens; Estrogens, Non-Steroidal Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens; Estrogens, Non-Steroidal Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Zeranol Zeranol (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione. One of a group of compounds known under the general designation of resorcylic acid lactones. Cis, trans, dextro and levo forms have been isolated from the fungus Gibberella zeae (formerly Fusarium graminearum). They have estrogenic activity, cause toxicity in livestock as feed contaminant, and have been used as anabolic or estrogen substitutes. Lactones (66-74); Resorcinols (66-74)  -k@.Zambia Z01.058.290.175.920 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern  `Zalcitabine D13.570.230.329.950; D13.570.230.500.925; D13.570.685.245.500.950; D20.388.330.925; D26.087.295.925 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxycytidine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Dideoxynucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Cytidine; Deoxycytidine Anti-Infective Agents; Antiviral Agents; Dideoxynucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Dideoxynucleosides 2',3'-Dideoxycytidine. A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. Deoxycytidine/analogs and derivatives (86-89); Dideoxynucleosides (89) o:NRZaire Z01.058.290.100.975 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central G _Yukon Territory Z01.107.567.176.929 EHEP Geographicals (Non MeSH); America; North America; Canada Canada (66-89) FYugoslavia Z01.542.248.980; Z01.586.980 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH)  Bosnia-Herzegovina; Croatia; Macedonia (Republic); Slovenia Created as the Kingdom of Serbs, Croats, and Slovenes in 1918. Yugoslavia became the official name in 1929. BOSNIA-HERZEGOVINA, CROATIA, and SLOVENIA formed independent countries and split from Yugoslavia 7 April 1992. Macedonia, one of the Yugoslav republics, became an independent country 8 February 1994 as The Former Yugoslav Republic of Macedonia (MACEDONIA (REPUBLIC)). "HYttrium Radioisotopes D01.496.749.960; D01.496.943.800 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Yttrium Isotopes Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes. Yttrium Isotopes (66-74); Radioisotopes (66-74) |&49Yttrium Isotopes D01.496.943 Inorganic Chemicals (Non MeSH); Isotopes Yttrium Radioisotopes Stable yttrium atoms that have the same atomic number as the element yttrium, but differ in atomic weight. Y-89 is the only naturally occurring stable isotope of yttrium. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR č24Yttrium D01.268.558.975; D01.552.550.975 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Yttrium. An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers. # &:RYtterbium D01.268.558.950; D01.552.550.958 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Ytterbium. An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source. ȓ &:Yolk Sac A16.254.403.981 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo; Fetal Membranes An embryonic membrane formed from endoderm and mesoderm. In reptiles and birds it incorporates the yolk into the digestive tract for nourishing the embryo. In placental mammals its nutritional function is vestigial; however, it is the source of most of the intestinal mucosa and the site of formation of the germ cells. It is sometimes called the vitelline sac, which should not be confused with the vitelline membrane of the egg. Chick Embryo (66-72); Fetal Membranes (66-72); Vitelline Membrane (66-74) ʞ :EYYohimbine D03.132.973.641.893; D03.549.937.641.868; D14.100.050.200.100.980; D16.050.500.980; D16.050.850.980; D26.115.975 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Yohimbans; Rauwolfia Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Yohimbans; Rauwolfia Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Miscellaneous Drugs and Agents (Non MeSH); Aphrodisiacs A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. ͺ ~:qYohimbans D03.132.973; D03.549.937 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Rauwolfia Alkaloids (+ 4) Rauwolfia Alkaloids (+ 4) Rauwolfia (66-68); Yohimbine (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR   8y>-@Yogurt J01.341.273.990 AEANCLECHIMIPOPSRESDSNSTTOUT Technology, Industry, Agriculture (Non MeSH); Food; Dairy Products A slightly acid milk food produced by fermentation due to the combined action of Lactobacillus acidophilus and Streptococcus thermophilus. Dairy Products (66-77) ӕ  PYoga K01.844.799.867 HIPX Humanities; Religion; Religious Philosophies (Non MeSH) A major orthodox system of Hindu philosophy based on Sankhya (metaphysical dualism) but differing from it in being theistic and characterized by the teaching of raja-yoga as a practical method of liberating the self. It includes a system of exercises for attaining bodily or mental control and well-being with liberation of the self and union with the universal spirit. (From Webster, 3d ed). BYin-Yang E02.040.515.660.520.967; I01.076.201.450.654.660.520.967; K01.752.967 HI Medicine, Chinese Traditional Therapeutics; Alternative Medicine; Medicine, Traditional; Medicine, Oriental Traditional; Medicine, Chinese Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional; Medicine, Oriental Traditional; Medicine, Chinese Traditional Humanities; Philosophy In Chinese philosophy and religion, two principles, one negative, dark, and feminine (yin) and one positive, bright, and masculine (yang), from whose interaction all things are produced and all things are dissolved. As a concept the two polar elements referred originally to the shady and sunny sides of a valley or a hill but it developed into the relationship of any contrasting pair: those specified above (female-male, etc.) as well as cold-hot, wet-dry, weak-strong, etc. It is not a distinct system of thought by itself but permeates Chinese life and thought. A balance of yin and yang is essential to health. A deficiency of either principle can manifest as disease. (Encyclopedia Americana). Medicine, Chinese Traditional (68-91)  \ M#M7,Yin Deficiency C23.944 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Medicine, Chinese Traditional Symptoms and General Pathology (Non MeSH) In the yin-yang system of philosophy and medicine, an insufficiency of body fluid (called yinxu), manifesting often as irritability, thirst, constipation, etc. (The Pinyin Chinese-English Dictionary, 1979). Medicine, Chinese Traditional (83-91)  ܹ N#2,Yersinia pseudotuberculosis Infections C01.252.400.310.980.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Yersinia Infections Infections with bacteria of the species YERSINIA PSEUDOTUBERCULOSIS. Pasteurella Infections (66-74) ,PP$Yersinia pseudotuberculosis B03.440.450.425.900.615 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Yersinia A human and animal pathogen causing mesenteric lymphadenitis, diarrhea, and bacteremia. Yersinia (75-86)  "zfYersinia pestis B03.440.450.425.900.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Yersinia The etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents. "zaYersinia Infections C01.252.400.310.980 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Arthritis, Reactive Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Plague; Yersinia pseudotuberculosis Infections Infections with bacteria of the genus YERSINIA. Pasteurella Infections (66-76) $hP6:$Yersinia enterocolitica B03.440.450.425.900.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Yersinia A species of the genus YERSINIA, isolated from both man and animal. It is a frequent cause of bacterial gastroenteritis in children. Pasteurella (72-74); Yersinia (75-82) W"z.Yersinia B03.440.450.425.900 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Yersinia enterocolitica; Yersinia pestis; Yersinia pseudotuberculosis A genus of gram-negative, facultatively anaerobic rod- to coccobacillus-shaped bacteria that occurs in a broad spectrum of habitats.  "nPYemen Z01.252.245.500.950; Z01.586.500.950 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East  *Yellow Fever Virus B04.820.250.350.990; B04.909.777.310.350.990 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus The type species of the Flavivirus genus. Principal vector transmission to humans is by Aedes spp. mosquitoes. 2Yellow Fever C02.081.980; C02.782.350.250.980 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. &PYeasts B05.354.930 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Candida (+ 1); Cryptococcus (+ 1); Hansenula; Kluyveromyces; Malassezia; Pichia; Rhodotorula; Saccharomyces (+ 1); Saccharomycopsis; Schizosaccharomyces; Trichosporon A general term for single-celled rounded fungi that reproduce by budding. Brewers' and bakers' yeasts are SACCHAROMYCES CEREVISIAE; therapeutic dried yeast is YEAST, DRIED. s ",Yeast, Dried D11.892 ADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Saccharomyces cerevisiae Growth Substances, Pigments, Vitamins (Non MeSH) The dry cells of any suitable strain of Saccharomyces cerevisiae or Candida utilis. It can be obtained as a by-product from the brewing of beer or by growing on media not suitable for beer production. Dried yeast serves as a source of protein and vitamin B complex.  <9>Yaws C01.252.400.840.892; C01.252.825.910; C01.252.847.840.892; C01.539.800.720.910; C17.800.838.765.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial A systemic non-venereal infection of the tropics caused by Treponema pallidum subspecies pertenue. oPusYawning G09.772.521.700.983 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics An involuntary deep inspiration with the mouth open, often accompanied by the act of stretching. w sYatapoxvirus B04.280.650.160.980; B04.909.204.210.950; B04.909.204.783.160.980; B04.909.574.204.950 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses Yaba Monkey Tumor Virus Yaba Monkey Tumor Virus Yaba Monkey Tumor Virus Yaba Monkey Tumor Virus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, causing tumors in primates. The type species is YABA MONKEY TUMOR VIRUS. `MrYang Deficiency C23.916 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Medicine, Chinese Traditional Symptoms and General Pathology (Non MeSH) In the yin-yang system of philosophy and medicine, a lack of vital energy (called yangxu in Chinese). It manifests itself in various systemic and organic diseases. (The Pinyin Chinese-English Dictionary, 1979). Medicine, Chinese Traditional (83-91)   N#2,Yaba Monkey Tumor Virus B04.280.650.160.980.950; B04.909.204.210.950.950; B04.909.204.783.160.980.950; B04.909.574.204.950.950 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Yatapoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Yatapoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Yatapoxvirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Yatapoxvirus The type species of YATAPOXVIRUS, a tumor-producing DNA virus discovered in monkeys in Yaba, Nigeria. It has been found to produce histiocytomas in monkeys and humans. pY Chromosome A11.223.475.865.983 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Cells; Cell Nucleus; Chromosomes; Sex Chromosomes The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in man and in some other male-heterogametic species in which the homologue of the X chromosome has been retained. Chromosomes (66-67); Karyotyping (67); Sex Chromosomes (68-77) (=LXYY Karyotype C16.131.280.748.980 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Abnormal genetic constitution in males characterized by an extra Y chromosome. Chromosome Abnormalities (66-67); Sex Chromosome Abnormalities (68-77) 0F]RXylulose D09.203.546.465.920; D09.203.546.627.885 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Ketoses Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Pentoses threo-2-Pentulose. A 5-carbon keto sugar. Ketoses (74); Pentoses (72-74); Xylose (74)  .D38Xylosidases D08.586.277.450.950 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases A group of enzymes that catalyze the hydrolysis of alpha- or beta-xylosidic linkages. EC 3.2.1.8 catalyzes the endo-hydrolysis of 1,4-beta-D-xylosidic linkages; EC 3.2.1.32 catalyzes the endo-hydrolysis of 1,3-beta-D-xylosidic linkages; EC 3.2.1.37 catalyzes the exo-hydrolysis of 1,4-beta-D-linkages from the non-reducing termini of xylans; and EC 3.2.1.72 catalyzes the exo-hydrolysis of 1,3-beta-D-linkages from the non-reducing termini of xylans. Other xylosidases have been identified that catalyze the hydrolysis of alpha-xylosidic bonds. Glycoside Hydrolases (66-77) Flm"Xylose D09.203.546.627.867 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Pentoses l DjXylitol D09.203.853.936; D02.033.800.936 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols  Z &DXylenes D02.455.426.559.389.948 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives   8Xylazine D03.383.855.985 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazines  Proposed as sedative, analgesic, and muscle relaxant in cattle. Aniline Compounds (71-74); Thiazines (69-74); Xylene (71-74)   :UMJXylans D09.203.698.925 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Polysaccharides consisting of xylose units. Carbohydrates (66-74); Cellulose (66-74); Polysaccharides (66-74)   @^4NXiphoid Bone A02.835.232.904.766.825 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Thorax; Sternum v:PXipamide D02.065.884.975; D02.886.590.700.975; D19.770.224.516.982 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl 4-Chloro-5-sulfamoyl-2',6'-salicyloxylidide. Sulfamoyl diuretic and saluretic with antihypertensive activity; it is bound to plasma proteins, thus has a delayed onset and prolonged action. Synonyms: Aquaphor; BE 1293; BEI 1293. Diuretics, Sulfamyl (74-76); Salicylamides (73-76); Xylenes (74-75) K A:QXerostomia C07.465.815.929 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Salivation Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Sjogren's Syndrome Decreased salivary flow.  jNLXeroradiography E01.357.818.985 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Xeromammography A photoelectric method of recording an X-ray image on a coated metal plate, using low-energy photon beams, long exposure time and dry chemical developers. specific heading/radiography (66); specific radiography heading (66); Radiography (66)  "3gXerophthalmia C11.187.810; C11.496.260.892 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vitamin A Deficiency Eye Diseases; Conjunctival Diseases Eye Diseases; Lacrimal Apparatus Diseases; Dry Eye Syndromes Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely. j"NrXeromammography E01.357.818.578.982; E01.357.818.985.980 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography; Mammography Diagnosis; Diagnostic Imaging; Radiography; Xeroradiography Xeroradiography of the breast. Breast Neoplasms/radiography (66-76); Mammography (66-76); Xeroradiography (68-76) ."&aXeroderma Pigmentosum C04.834.867; C16.131.831.936; C17.800.600.925; C17.800.621.936; C17.800.827.800.936 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Precancerous Conditions Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Photosensitivity Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) A rare, pigmentary, and atrophic autosomal recessive disease affecting all races. It is manifested as an extreme photosensitivity to ultraviolet light as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA. '_X'Xenopus laevis B02.090.180.610.500.562 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Pipidae; Xenopus The commonest and widest ranging species of the clawed "frog" (Xenopus) in Africa. This species is used extensively in research. There is now a significant population in California derived from escaped laboratory animals. Xenopus (72-80) 9&:Xenopus B02.090.180.610.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Pipidae Xenopus laevis An aquatic genus of the family, Pipidae, occurring in Africa and distinguished by having black horny claws on three inner hind toes. Anura (66-71)   &/Xenon Radioisotopes D01.496.749.945; D01.496.920.700 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Xenon Isotopes Unstable isotopes of xenon that decay or disintegrate emitting radiation. Xe atoms with atomic weights 121-123, 125, 127, 133, 135, 137-145 are radioactive xenon isotopes. Xenon (66-74); Radioisotopes (66-74)  k&4-Xenon Isotopes D01.496.920 Inorganic Chemicals (Non MeSH); Isotopes Xenon Radioisotopes Stable xenon atoms that have the same atomic number as the element xenon, but differ in atomic weight. Xe-124, 126, 128-131, 134, and 136 are stable xenon isotopes. Xenon (66-74); Isotopes (66-74) ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  "2(4Xenon D01.268.613.900; D01.362.641.918; D15.050.035.060.950; D15.210.100.175.060.950 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Noble Gases Inorganic Chemicals (Non MeSH); Gases; Noble Gases Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation A noble gas with the atomic symbol Xe, atomic number 54, and atomic weight 131.30. It is found in the earth's atmosphere and has been used as an anesthetic. $8 X:tXenobiotics D05.569.970; D26.970 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH) Chemical substances that are foreign to the biological system. They include naturally occurring compounds, drugs, environmental agents, carcinogens, insecticides, etc. '(8~Xanthurenates D03.066.942 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Kynurenic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8@:Xanthopterin D03.438.733.631.825; D11.557.831.742 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Pterins 2-Amino-1,5-dihydro-4,6-pteridinedione. Pigment first discovered in butterfly wings and widely distributed in plants and animals. )*@Xanthophyll D02.455.849.131.824; D11.557.261.206.741 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Carotenoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Carotene beta,epsilon-Carotene-3,3'-diol. A carotenoid alcohol widespread in nature. It is present in egg yolk, algae, and petals of yellow flowers, among other sources. +.@Xanthomonas campestris B03.440.400.425.625.866.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae; Xanthomonas A species of gram-negative, aerobic bacteria that is pathogenic for plants. Xanthomonas (66-91) -"ZXanthomonas B03.440.400.425.625.866 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae Xanthomonas campestris A genus of PSEUDOMONADACEAE whose cells produce a yellow pigment (Gr. xanthos - yellow). It is pathogenic to plants. /~"Xanthomatosis C17.800.849.929; C18.452.981 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH) Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Wolman Disease Wolman Disease A condition of morphologic change in which there is accumulation of lipids in the large foam cells of tissues. It is the cutaneous manifestation of lipidosis in which plasma fatty acids and lipoproteins are quantitatively changed. The xanthomatous eruptions have several different distinct morphologies dependent upon the specific form taken by the disease. 12"N$Xanthogranuloma, Juvenile C15.604.667.400.410.900; C17.800.849.866 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytosis, Non-Langerhans-Cell Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH) Benign disorder of infants and children characterized by multiple nodules with lipid-laden, non-Langerhans-cell histiocytes. 4`.N Xanthinol Niacinate D03.066.515.950; D03.132.956.826.950; D03.383.725.547.950; D03.438.759.758.824.751.950; D18.918.982 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids; Theophylline Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines; Theophylline Cardiovascular Agents; Vasodilator Agents 3-Pyridinecarboxylic acid compound with 3,7-dihydro-7- (2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3- dimethyl-1H-purine-2,6-dione (1:). Vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension. Amino Alcohols (74); Nicotinic Acid (69-74); Theophylline (69-74) 6o:(PXanthines D03.438.759.758.824 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones Caffeine; Theobromine (+ 1); Theophylline (+ 5); Uric Acid AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR : 8`KDXanthine Oxidase D08.586.682.472.866 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Ketone Oxidoreductases An iron-molybdenum flavoprotein containing FAD that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. EC 1.1.3.22. <=FsXanthine Dehydrogenase D08.586.682.472.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Ketone Oxidoreductases An enzyme that catalyzes the oxidation of xanthine in the presence of NAD+ to form urate and NADH. It acts also on a variety of other purines and aldehydes. EC 1.1.1.204. Ketone Oxidoreductases (73-74); Xanthines (73-74) >8Fs;Xanthine Alkaloids D03.132.956 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Caffeine; Theobromine (+ 1); Theophylline (+ 3) Alkaloids, which contain xanthine as their nitrogenous base. Alkaloids (66-74); Xanthines (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $@T8(<H-DXanthenes D03.494.953 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Fluoresceins (+ 5); Propantheline; Pyronine; Rhodamines; Sterigmatocystin; Thioxanthenes (+ 6) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR A 8Gq<Xamoterol D02.033.329.624.972; D02.092.063.624.972; D14.100.050.100.200.980; D16.050.870.980; D18.222.931 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents A selective beta-1-adrenergic partial agonist. Because it is a partial agonist it acts like an agonist when sympathetic activity is low and as an antagonist when sympathetic activity is high. It reduces myocardial ischemia and improves ventricular function in patients with mild to moderate heart failure. In patients with severe heart failure it has been shown to produce benefits in systolic and diastolic function. Propanolamines (84-92) Cm k:X-Rays H01.671.768.513.918 AE Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Ionizing Penetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release energy - in the same energy range as gamma rays (0.010-10 Mev), but of non-nuclear origin, of shorter wavelength than ultraviolet; soft x-rays or Grenz rays are less penetrating and longer in wavelength than hard x-rays. H/ TX-Ray Therapy E02.810.907 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Radiotherapy JT" X-Ray Intensifying Screens E07.970 AECLCTECHISDSNSTTDUTVE Radiographic Image Enhancement Equipment and Supplies Screens which absorb the energy in the x-ray beam that has penetrated the patient and convert this energy into a light pattern which has as nearly as possible the same information as the original x-ray beam. The more light a screen produces for a given input of x-radiation, the less x-ray exposure and thus shorter exposure time are needed to expose the film. In most film-screen systems, the film is sandwiched between two screens in a cassette so that the emulsion on each side is exposed to the light from its contiguous screen. Angiography (77-81); Mammography (77-81); Radiographic Image Enhancement (77-81); Radiography (77-81); Technology, Radiologic (77-81)  J  $wX-Ray Film E07.960 AECLCTECHISDSNSTTDUTVE Equipment and Supplies A film base coated with an emulsion designed for use with x-rays. Radiography (66-81); specific radiography heading (66-81); Technology, Radiologic (66-81) N QiX-Ray Diffraction E05.196.309.742; H01.181.529.240.742 HIISMT Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Crystallography Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Crystallography Crystallography, X-Ray Crystallography, X-Ray The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). O* 4X Chromosome A11.223.475.865.982 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Cells; Cell Nucleus; Chromosomes; Sex Chromosomes The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in man and other male-heterogametic species. Chromosomes (66-67); Karyotyping (67); Sex Chromosomes (68-77) R(=LWyoming Z01.107.567.875.100.959; Z01.107.567.875.600.656.959 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Northwestern United States T :Wuchereria bancrofti B01.500.294.700.750.700.300.708.150 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea; Wuchereria A white threadlike worm which causes elephantiasis, lymphangitis, and chyluria by interfering with the lymphatic circulation. The microfilaria are found in the circulating blood and are carried by mosquitoes. V'*pWuchereria B01.500.294.700.750.700.300.708 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea Wuchereria bancrofti A genus of filarial nematodes. X#*b'Wrongful Life I01.880.604.583.963; N03.706.535.803 HI Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence In civil law a cause of action which alleges that a defendant has wrongfully caused a child to be born. Jurisprudence (78-89); Malpractice (73-89) Y(*3Writing L01.143.506.423.906 HIST Information Science; Communication; Language; Language Arts (Non MeSH) Authorship; Correspondence; Handwriting (+ 2) The act or practice of literary composition, the occupation of writer, or producing or engaging in literary work as a profession. HIISST  Z T7 Wrist Joint A02.835.583.959 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints \u61Wrist Injuries C21.866.088.906 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hand Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries Injuries to the wrist or the wrist joint. ]Nb5Wrist A01.378.209.906 ABAHBSEMGDIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Arm ^b &5Wrestling I03.450.642.845.975 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A sport consisting of hand-to-hand combat between two unarmed contestants seeking to pin or press each other's shoulders to the ground. Sports (66-75) ^ RWounds, Stab C21.866.986.950 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Wounds, Penetrating Needlestick Injuries Penetrating wounds caused by a pointed object. specific heading/injuries (66-75)  `bNi9(Wounds, Penetrating C21.866.986 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Eye Injuries, Penetrating; Wounds, Gunshot; Wounds, Stab (+ 1) Wounds caused by objects penetrating the skin. specific heading/injuries (66-75)  aNQL9(Wounds, Nonpenetrating C21.866.974 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Brain Concussion; Head Injuries, Closed Injuries caused by impact with a blunt object where there is no penetration of the skin. Abdominal Injuries (66-75); Head Injuries (66-75); Heart Injuries (66-75); Thoracic Injuries (66-75)  cNQ0lyWounds, Gunshot C21.866.986.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Firearms Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Wounds, Penetrating Disruption of structural continuity of the body as a result of the discharge of firearms. eN ilWounds and Injuries C21.866 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI First Aid; Transportation of Patients Traumatology Injury, Occupational Dis, Poisoning (Non MeSH) Abdominal Injuries (+ 4); Amputation, Traumatic; Arm Injuries (+ 8); Asphyxia; Athletic Injuries; Barotrauma (+ 2); Birth Injuries (+ 1); Bites and Stings (+ 1); Burns (+ 6); Contusions; Dislocations (+ 2); Drowning (+ 1); Electric Injuries (+ 2); Esophageal Perforation; Extravasation of Diagnostic and Therapeutic Materials; Foreign Bodies (+ 5); Fractures (+ 26); Frostbite (+ 1); Hand Injuries (+ 1); Head Injuries (+ 25); Heat Exhaustion (+ 1); Leg Injuries (+ 8); Motion Sickness (+ 1); Multiple Trauma; Radiation Injuries (+ 7); Retropneumoperitoneum; Rupture (+ 6); Self Mutilation; Shock, Traumatic (+ 1); Soft Tissue Injuries; Spinal Cord Injuries (+ 1); Spinal Injuries (+ 2); Sprains and Strains (+ 1); Tendon Injuries; Thoracic Injuries (+ 3); Tooth Injuries (+ 3); Tympanic Membrane Perforation; Wound Infection; Wounds, Nonpenetrating (+ 2); Wounds, Penetrating (+ 4) Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI (g N.7;ZWound Infection C01.539.947; C21.866.951 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Surgical Wound Infection Invasion of the site of trauma by pathogenic microorganisms. mWPIWound Healing G04.185.753.891 DEGEIMPHRE Cicatrix; Granulation Tissue Regeneration Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration Fracture Healing Restoration of integrity to traumatized tissue. $n#|9World Health Organization N03.540.514.718.800 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; International Agencies; United Nations Pan American Health Organization A specialized agency of the United Nations designed as a coordinating authority on international health work; its aim is to promote the attainment of the highest possible level of health by all peoples. pU t'World Health N01.407.540.800 Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health For articles pertaining to the health status of inhabitants of the world. rG]YWorkplace N01.824.245.925; N04.452.677.975 CLECHILJOGPXSNST Occupations; Industry Population Characteristics (Non MeSH); Socioeconomic Factors; Employment Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Place or physical location of work or employment. s@ &=Workload N04.452.677.950 CLECLJPXSNST Task Performance and Analysis Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The total amount of work to be performed by an individual, a department, or other group of workers in a period of time. Personnel Management (67-91); Personnel Staffing and Scheduling (81-91); Task Performance and Analysis (71-91)  t $pWorkers' Compensation N03.219.521.346.866 CLECHILJOGSNSTTDUT Disability Evaluation Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government Insurance coverage providing compensation and medical benefits to individuals because of work-connected injuries or disease. vuWork Simplification J01.293.556.779.824 Technology, Industry, Agriculture (Non MeSH); Engineering; Human Engineering; Task Performance and Analysis The construction or arrangement of a task so that it may be done with the greatest possible efficiency. Efficiency (66-74); Task Performance and Analysis (72-74) xW~}EWork Schedule Tolerance I03.946.900 PHPX Human Activities (Non MeSH); Work Physiological or psychological effects of periods of work which may be fixed or flexible such as flexitime, work shifts, and rotating shifts. Circadian Rhythm (66-82); Occupational Medicine (66-82); Work (66-82) y+TWork of Breathing E01.302.796.947; G09.772.521.700.941 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Respiration (66-70) {j*Work Capacity Evaluation E01.373.741 Diagnosis; Disability Evaluation Assessment of physiological capacities in relation to job requirements. It is usually done by measuring certain physiological (e.g., circulatory and respiratory) variables during a gradually increasing workload until specific limitations occur with respect to those variables. Disability Evaluation (66-74) |'=#Work I03.946 CLECHILJPHPXSNSTTD Efficiency; Employment Exertion Human Activities (Non MeSH) Work Schedule Tolerance Productive or purposeful activities. $~  ",Word Processing L01.700.508.300.680.708.950; L01.700.568.810.950; N04.452.515.708.950 CLECEDHIISLJMTSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems; Office Automation Information Science; Medical Informatics; Medical Informatics Computing; Software Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems; Office Automation Automated production of typewritten documents with text editing and storage functions using computer software. Computers (81-88); Software ((83)-88) M/Word Association Tests F04.711.647.905 HISNST Association Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests Lists of words to which individuals are asked to respond ascertaining the conceptual meaning held by the individual. Asociation (66-68)   hWool A13.970; J01.637.879.865 ABAEAHBSCHCYDEECEMENGDHIIMINIRMEMIPAPHPPPSRARERISDSESTTRULUSVI Animal Terms (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH); Textiles BxWood J01.637.952 Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) OWomen's Rights I01.880.604.473.850; N03.706.437.850 CLECEDHILJMAMTOGSDSNSTTDUT Human Rights Social Sciences; Sociology; Social Control, Formal; Human Rights Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights The rights of women to equal status pertaining to social, economic, and educational opportunities afforded by society. Civil Rights (68-76); Human Rights (73-76)  *5Women's Health Services N02.421.920 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services Preconception Care Organized services to provide health care to women. It excludes maternal care services for which MATERNAL HEALTH SERVICES is available. CLECHILJMAMTOGSDSNSTTDUT  JWomen's Health N01.407.540.785 Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health The concept covering the physical and mental conditions of women. ]OWomen, Working M01.975.825 CLEDHILJPXSN Named Groups (Non MeSH); Women Women who are engaged in gainful activities usually outside the home. Women (66-83)  (TWomen M01.975 EDHIPX Named Groups (Non MeSH) Battered Women; Dentists, Women; Physicians, Women; Women, Working Human adult females as cultural, psychological, sociological, political, and economic entities. CLECEDHILJOGPXSDSNSTTDUT     PnWolman Disease C16.614.947; C17.800.849.929.950; C18.452.648.556.641.923; C18.452.648.595.923; C18.452.981.923 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH); Xanthomatosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Xanthomatosis The severe infantile form of inherited lysosomal lipid storage diseases, due to deficiency of acid lipase. It results in accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells). An allelic variant of CHOLESTEROL ESTER STORAGE DISEASE, it is also known as Wolman's xanthomatosis. Cholesterol Esters (78-88); Lipase (66-88); Lipoidosis (66-88); Lipid Metabolism, Inborn Errors (66-88); Xanthomatosis (66-88) 1kLdWolinella B03.440.425.410.194.900 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae A genus of gram-negative, anaerobic, rod-shaped bacteria isolated from the bovine rumen, the human gingival sulcus, and dental root canal infections. Bacteroidaceae (86-91)  "Wolfram Syndrome C16.131.077.951; C18.452.264.500; C18.452.297.267.500; C19.246.267.500; C19.700.482.215.500 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Insipidus Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Diabetes Mellitus, Insulin-Dependent Endocrine Diseases; Diabetes Mellitus; Diabetes Mellitus, Insulin-Dependent Endocrine Diseases; Pituitary Diseases; Hypopituitarism; Diabetes Insipidus Hereditary association of diabetes mellitus, diabetes insipidus, optic atrophy, and neural deafness. Deafness (66-85); Diabetes Insipidus (66-85); Diabetes Mellitus, Insulin-Dependent (84-85); Optic Atrophy (66-85) gLtWolffian Duct A16.254.940 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo An excretory duct of the embryonic kidney. :15Wolff-Parkinson-White Syndrome C14.280.067.780.977 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Pre-Excitation Syndromes A form of pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. p#NZWitchcraft I01.076.201.450.897.439.925 HIPX Social Sciences; Anthropology; Anthropology, Cultural; Culture; Superstitions; Magic An act of employing sorcery (the use of power gained from the assistance or control of spirits), especially with malevolent intent, and the exercise of supernatural powers and alleged intercourse with the devil or a familiar. (From Webster, 3d ed). Magic (66-94) d'Wit and Humor K01.517.946 HIPX Humanities; Literature Wissler's Syndrome C05.550.114.843.823; C05.799.825.823; C20.543.928 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Exanthema Musculoskeletal Diseases; Joint Diseases; Arthritis; Rheumatic Fever Musculoskeletal Diseases; Rheumatic Diseases; Rheumatic Fever Immunologic Diseases; Hypersensitivity A rheumatic syndrome of possibly allergic origin, usually affecting children and adolescents, and characterized by high fever, exanthema, arthralgia, leukocytosis, and increased sedimentation rate. R9N Wiskott-Aldrich Syndrome C15.378.463.205.855.972; C15.378.463.597.972; C20.673.972 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders; Thrombocytopenia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Purpura Immunologic Diseases; Immunologic Deficiency Syndromes A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenia, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IgM levels are low and IgA and IgE levels are elevated. Lymphoreticular malignancies are common. AN@4Wisconsin Z01.107.567.875.100.949; Z01.107.567.875.600.313.949; Z01.107.567.875.600.516.949 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States   YWing A13.395.823 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Forelimb Birds (66-67) A:+Wine J01.125.091.823 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Beverages; Alcoholic Beverages "ZWind G03.230.300.100.150.185.200; G03.230.300.100.725.780 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Air; Air Movements Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather :Wills I01.880.604.583.927 CLECEHHILJPCPXSNTD Social Sciences; Sociology; Social Control, Formal; Jurisprudence Living Wills A legal declaration of a person's mind as to the manner in which he would have his property or estate disposed of after his death. (Webster 3d ed.) The application of the concept of a will in bioethics regarding the termination of his life is the heading LIVING WILLS.  NDWidowhood F01.829.263.315.500.862; I01.240.361.500.862; I01.880.225.423.500.862; N01.224.361.500.862; N01.824.308.500.862 ECEHHILJPXSN Single Person Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Characteristics; Marital Status Social Sciences; Demography; Family Characteristics; Marital Status Social Sciences; Sociology; Family; Family Characteristics; Marital Status Population Characteristics (Non MeSH); Demography; Family Characteristics; Marital Status Population Characteristics (Non MeSH); Socioeconomic Factors; Family Characteristics; Marital Status The state of having lost a marital partner by death. Death (66-67); Marriage (66-67); Single Person (68-93)   {BDWhooping Cough C01.252.400.143.740; C01.539.739.969; C08.730.969 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Pertussis Vaccine Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Bordetella Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Respiratory Tract Infections Respiratory Tract Diseases; Respiratory Tract Infections A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath. Y9P,Whole-Body Irradiation E02.810.814; E05.980 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hemibody Irradiation; Lymphatic Irradiation Hemibody Irradiation Therapeutics; Radiotherapy Miscellaneous Techniques (Non MeSH) Irradiation of the whole body with ionizing or non-ionizing radiation. It is applicable to humans or animals but not to microorganisms.  "3HWhole-Body Counting E05.799.950; H01.671.768.765.710.740 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Radiometry Physical Sciences (Non MeSH); Physics; Radiation; Radiometry; Scintillation Counting Measurement of radioactivity in the entire human body. Radiometry (66-70) *"BWhole Blood Coagulation Time E01.223.459.153.950 VE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Coagulation Tests Measurement of the time required by whole blood to produce a visible clot. Factors that could influence the test are all but III, VII, and XIII. Activation may be by contact with the glass tube or exposure to diatomaceous earth. Delay of onset of coagulation may be achieved by use of nonwettable plastic or silicone-coated glass tubes. It is used for monitoring heparin therapy and as a bedside screening test for deficiencies in the intrinsic coagulation pathway. "Activated coagulation time" is sometimes referred to as ACT. Blood Coagulation (66-79); Blood Coagulation Tests (66-79) <#ZnFWhites I01.076.201.450.416.650; I01.880.143.522.700; M01.194.980 CLEDHILJPXSN Caucasoid Race Caucasoid Race Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group of the Caucasoid Race. Caucasoid Race (66-77); Ethnic Groups (68-77) $ A18White Muscle Disease C22.595.740 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Muscular Dystrophy, Animal A myodegeneration most frequent in calves and lambs whose dams have been fed during gestation or longer on feeds, especially legumes, grown in certain areas where selenium is either deficient or unavailable in the soil. It has been recorded in many countries. It has been produced experimentally in several species of animals on low-selenium intake. A similar myopathy occurs naturally in goats, deer, foals, and dogs but proof of the etiology is lacking. (Merck Veterinary Manual, 5th ed). J4AWhiplash Injuries C21.866.831.740 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Spinal Injuries Injuries to the spine and spinal cord at the junction of the fourth and fifth cervical vertebrae, occurring as the result of rapid acceleration or deceleration of the body. NeWheelchairs E07.796.980 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Self-Help Devices Chairs mounted on wheels and designed to be propelled by the occupant. h2VWheat Germ Agglutinins D12.776.765.850; D24.185.526.545.973; D24.310.545.973; D24.611.125.044.545.973 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens; Lectins Immunologic and Biologic Factors (Non MeSH); Biological Products; Lectins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Lectins Lectins purified from the germinating seeds of common wheat (Triticum vulgare); these bind to certain carbohydrate moieties on cell surface glycoproteins and are used to identify certain cell populations and inhibit or promote some immunological or physiological activities. There are at least two isoforms of this lectin. Lectins (66-86) MXDxWheat B06.510.253.927; J01.341.182.927 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals The most nutritious of the cereal grasses, Triticum vulgare, grown mostly in the temperate climates. It also includes other triticum species. Several lectins, starch, and medium quality proteins are obtained from the seeds. Triticale is a hybrid between wheat and rye. G &4n<Whales B02.649.189.865 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Ambergris Vertebrates; Mammals; Cetacea Large marine mammals of the order Cetacea. In the past, they were commercially valued for whale oil, for their flesh as human food and in animal feed and fertilizer, and for baleen. The sperm whale produces AMBERGRIS, an intestinal secretion used in perfumery. (From Webster, 3d ed). w ( %RWetting Agents D26.866.974 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface; used in foods and cosmetics; important in contrast media; also with contact lenses, dentures, and some prostheses. Synonyms: humectants; hydrating agents. g,M5Wettability H01.181.529.875.908 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Surface Properties The quality or state of being wettable or the degree to which something can be wet. This is also the ability of any solid surface to be wetted when in contact with a liquid whose surface tension is reduced so that the liquid spreads over the surface of the solid. Surface Properties (68-92) Z`> Western Samoa Z01.782.815.921 EHEP Geographicals (Non MeSH); Pacific Islands; Polynesia m@Western Australia Z01.338.800 EHEP Geographicals (Non MeSH); Australia A state in western AUSTRALIA. Australia (66-87) ,&West Virginia Z01.107.567.875.100.940; Z01.107.567.875.600.066.940; Z01.107.567.875.600.820.940 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Appalachian Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States ʵYWest Nile Virus B04.820.250.350.300.950; B04.909.777.270.475.950; B04.909.777.310.350.300.950 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese A species of Flavivirus, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which produces encephalitis experimentally when inoculated into some rodents, chicks, birds, or monkeys. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). It is transmitted by Culex spp mosquitoes. UXWest Nile Fever C02.081.343.950; C02.081.960; C02.290.310.950; C02.782.310.950; C02.782.350.250.900; C10.228.140.437.340.310.950; C10.228.228.245.340.310.950 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Encephalitis, Epidemic Virus Diseases; Arbovirus Infections Virus Diseases; Encephalitis, Viral; Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic A mild, febrile, sporadic disease produced by infection with West Nile Virus, a FLAVIVIRUS. It is characterized by drowsiness, headache, rash, abdominal pain, nausea and lymphadenopathy, and sometimes leads to encephalitis. PWest Indies Z01.107.084.900 EHEP Geographicals (Non MeSH); America; Caribbean Region Antigua; Bahamas; Barbados; Cuba; Dominican Republic; Haiti; Jamaica; Martinique; Netherlands Antilles; Puerto Rico; Trinidad and Tobago; Virgin Islands of the United States ղ?Wernicke's Encephalopathy C10.228.140.163.946; C18.654.223.133.699.827.822 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency; Thiamine Deficiency A neurological disorder characterized by confusion, apathy, drowsiness, ataxia, nystagmus, and ophthalmoplegia. It often results from chronic alcohol abuse and is almost always accompanied or followed by KORSAKOFF'S SYNDROME. 6NWerner's Syndrome C19.753.739 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Progeria Premature aging in adults. It is transmitted as an autosomal recessive trait and characterized principally by sclerodermal skin changes (especially of the extremities), cataracts, subcutaneous calcification, muscular atrophy, a tendency to diabetes mellitus, aged appearance of the face, baldness, and a high incidence of neoplastic disease. (From Dorland, 27th ed). N#Werdnig-Hoffmann Disease C05.651.518.620.973; C05.651.661.468.620.973; C10.228.854.468.973; C10.500.686.900; C10.668.468.620.973; C10.772.587.900; C16.131.666.686.900 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Muscular Atrophy; Muscular Atrophy, Spinal Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases; Muscular Atrophy; Muscular Atrophy, Spinal Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases; Muscular Atrophy, Spinal Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory Nervous System Diseases; Neuromuscular Diseases; Muscular Atrophy; Muscular Atrophy, Spinal Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Motor and Sensory Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory A recessively inherited acute infantile form of motor neuropathy with proximal muscle wasting particularly of the upper extremities. The chronic childhood form may be an arrested Werdnig-Hoffmann disorder. Muscular Atrophy (66-87); Spinal Cord Diseases (66-87) ULcBWelding J01.576.953 CLECHIISLJMAMTSNSTUT Technology, Industry, Agriculture (Non MeSH); Industry  AWeil's Disease C01.252.400.511.739; C01.252.847.511.739 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Leptospirosis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Leptospirosis A severe form of LEPTOSPIROSIS caused by Leptospira interrogans serogroup icterohaemorrhagica and transmitted to man by the rat. .PWeights and Measures H01.939 HIST Physical Sciences (Non MeSH) Calibration; International System of Units; Metric System; Reference Standards; Reference Values CLHIISST  #r Weightlessness Simulation E05.977; G03.230.150.440.950 AECLCTECHIISMOMTNUPXSNSTTDUTVE Space Simulation Miscellaneous Techniques (Non MeSH) Environment and Public Health (Non MeSH); Environment; Environment, Controlled; Space Simulation Condition under normal Earth gravity where the force of gravity itself is not actually altered but its influence or effect may be modified and studied. (From ASGSB Bull 1992;5(2):27). Weightlessness (66-94)  ""Weightlessness Countermeasures E05.974 Cardiovascular Deconditioning Miscellaneous Techniques (Non MeSH) Techniques and routines designed to prevent or reverse unwanted effects of weightlessness experienced during actual and simulated space flight, including physiologic changes related to removal of gravitational loading. Specific measures include creation of artificial gravity, exercise, low-level lower body negative pressure, and use of anti-deconditioning devices. (From Nicogossian, Space Physiology and Medicine, 2d ed, p. 294-297). Space Flight (66-94) # "*Weightlessness H01.671.323.369.400.900 AE Hypogravity; Space Flight Physical Sciences (Non MeSH); Physics; Gravitation; Gravity, Altered; Hypogravity Condition in which no acceleration, whether due to gravity or any other force, can be detected by an observer within a system. It also means the absence of weight or the absence of the force of gravity acting on a body. Microgravity, gravitational force between 0 and 10 -6 g, is included here. (From NASA Thesaurus, 1988).  bWeight-Bearing G11.427.050.925; H01.671.100.131.925 PH Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Biomechanics Physical Sciences (Non MeSH); Physics; Biophysics; Biomechanics The physical state of supporting an applied load. This often refers to the weight-bearing bones or joints that support the body's weight, especially those in the spine, hip, knee, and foot. #*Weight Perception F02.463.593.959 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Recognition and discrimination of the heaviness of a lifted object. 5 \QWeight Loss G07.553.481.398.915 DEGEIMPHRE Emaciation; Thinness Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth; Body Weight Decrease in existing body weight. Body Weight (66-88)  :u*Weight Lifting I03.450.642.845.950 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A sport in which weights are lifted competitively or as an exercise. Sports (66-75) lRTWeight Gain G07.553.481.398.910 DEGEIMPHRE Obesity Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth; Body Weight Increase in body weight over existing weight. Body Weight (66-88)   u8Wegener's Granulomatosis C08.381.483.950; C12.777.419.969; C14.907.940.950; C23.484.500.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Cardiovascular Diseases; Vascular Diseases; Vasculitis Symptoms and General Pathology (Non MeSH); Granuloma; Granuloma, Respiratory Tract (Non MeSH) A multisystem disease chiefly affecting males, characterized by necrotizing granulomatous vasculitis involving the upper and lower respiratory tracts, glomerulonephritis, and variable degrees of systemic, small vessel vasculitis, which is generally considered to represent an aberrant hypersensitivity reaction to an unknown antigen. (Dorland, 27th ed). LN^Wedensky Inhibition G11.561.537.910 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Neural Conduction Effects of a partial block to nerve conduction which may result in the transmission of impulses at low frequencies but not at higher frequencies. (Dorland, 27th ed.). Wechsler Scales F04.711.141.493.822 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Aptitude Tests; Intelligence Tests Tests designed to measure intellectual functioning in children and adults. Intelligence Tests ( 66-74) . |X!Weather G03.230.300.100.725 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere Humidity; Lightning; Rain (+ 1); Snow; Sunlight (+ 2); Temperature (+ 2); Wind AEANCLDUECHILJPCPOSNSTTOTU  jgWeaning G06.696.259.750.750 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Child Nutrition; Infant Nutrition  wWaxes D10.516.945 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inlay Casting Wax; Cerumen Lipids and Antilipemic Agents (Non MeSH); Lipids Ambergris; Lanolin A plastic substance deposited by insects or obtained from plants. Waxes are esters of various fatty acids with higher, usually monohydric alcohols. The wax of pharmacy is principally yellow wax (beeswax), the material of which honeycomb is made. It consists chiefly of cerotic acid and myricin and is used in making ointments, cerates, etc. (Dorland, 27th ed). AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $g *"<.Waterhouse-Friderichsen Syndrome C01.252.400.625.549.449.904; C01.252.580.505.904; C10.228.228.507.280.505.904; C19.053.904 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Neisseriaceae Infections; Meningococcal Infections; Meningitis, Meningococcal Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Meningitis, Bacterial; Meningitis, Meningococcal Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Bacterial; Meningitis, Meningococcal Endocrine Diseases; Adrenal Gland Diseases Rapidly fulminating cerebrospinal meningococcal meningitis, characterized by sudden onset, fever, purpura, adrenal hemorrhage, shock, and death. It is seen also with other infections. In a large majority of cases the etiology is meningococcemia. (From Dorland, 27th ed; Magalini, Dictionary of Medical Syndromes, 3d ed). '%dP:uWater-Electrolyte Imbalance C18.452.950 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fluid Therapy; Rehydration Solutions Water-Electrolyte Balance; Electrolytes; Water Intoxication Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Dehydration; Hypercalcemia; Hyperkalemia; Hypernatremia; Hypocalcemia; Hypokalemia; Hyponatremia; Inappropriate ADH Syndrome; Water Intoxication Disturbances in the body's water-electrolyte metabolism. Water-Electrolyte Balance (66-75) ( N,ENB'Water-Electrolyte Balance G06.184.963; G07.621.888 DEGEIMPHRE Fluid Therapy; Osmolar Concentration; Rehydration Solutions; Water-Electrolyte Imbalance Electrolytes Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physiology, General (Non MeSH); Homeostasis Kallikrein-Kinin System Kallikrein-Kinin System The state of the body in relation to the intake and excretion of water and electrolytes, particularly sodium and potassium. It exists in a metabolic balance internally with BODY FLUID COMPARTMENTS, total BODY WATER, BLOOD VOLUME, EXTRACELLULAR SPACE, etc., externally through sensible and insensible SWEATING. The hypothalamus controls water balance. (Dorland, 27th ed; Mountcastle, Medical Physiology, 14th ed, 1980). $Qf6Water Supply G03.850.860.510.915 ANECHILJSNST Water Purification Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering Fluoridation; Water Purification AEANCLCTECHIISLJMAMOMTNUPXSNSTTDUTVE   k'(Water Softening G03.850.860.510.910 AEECISLJMTSNST Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering  +kWater Purification G03.850.780.200.800.800.900.900; G03.850.860.510.900.900; G03.850.860.510.915.900 ECHIISLJMTSNST Water Supply Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation; Sanitary Engineering; Waste Management Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Water Supply Any of several processes in which undesirable impurities in water are removed or neutralized; for example, chlorination, filtration, primary treatment, ion exchange, and distillation. It includes treatment of waste water to provide potable and hygiene water in a controlled or closed environment as well as provision of public drinking water supplies. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Water (66-94); Water Pollution (66-94)   Y0Water Pollution, Thermal G03.850.460.790.510 AEANECHILJPCSN Heat Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Water Pollution Heat (66-70); Water Pollution (66-70) t/Water Pollution, Radioactive G03.850.810.530; G03.850.460.790.460 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Water Pollution "*Water Pollution, Chemical G03.850.460.790.410 AEANECHILJPCSN Eutrophication Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Water Pollution Acid Rain specific chemical (66-70); Water Pollution (66-70) AEANECHILJPCPOSNTO $t=Water Pollution G03.850.460.790 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Water Pollution, Chemical (+ 1); Water Pollution, Radioactive; Water Pollution, Thermal AEANECHILJPCPOSNTO ^`hWater Pollutants, Radioactive D05.284.638.903; D05.284.903.821 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Radioactive Pollutants Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Water Pollutants Pollutants, present in water or bodies of water, which exhibit radioactivity. #&6\Water Pollutants, Chemical D05.284.903.655 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Water Pollutants Acid Rain Chemical compounds which pollute the water of rivers, streams, lakes, the sea, reservoirs, or other bodies of water. ADAEAGAIANBLCFCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR  r 6j<Water Pollutants D05.284.903 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Water Pollutants, Chemical (+ 1); Water Pollutants, Radioactive Substances which pollute the water or bodies of water. Use for water pollutants in general or for which there is no specific heading. Water Pollution (66-74) ADAEAGAIANBLCFCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR $D6UL<Water Movements G03.230.700.485 Environment and Public Health (Non MeSH); Environment; Water Oceanography (66-71); Water (66-71) hJ,Water Microbiology G01.273.540.274.777; G03.850.425.450 ST Biological Sciences; Biology; Microbiology; Environmental Microbiology Environment and Public Health (Non MeSH); Public Health; Environmental Microbiology The presence of bacteria, viruses, and fungi in water. This term is not restricted to pathogenic organisms. $*Water Loss, Insensible G07.315.232.863; G10.795.869.821 DEGEIMPHRE Physiology, General (Non MeSH); Body Temperature; Body Temperature Regulation Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH); Sweating Respiration (66-71); Sweating (66-71) &.Water Intoxication C18.452.950.932 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Water-Electrolyte Imbalance Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance The condition induced by the undue retention of water with sodium depletion. It is marked by lethargy, nausea, vomiting, and mild mental aberrations, and in severe cases by convulsions and coma. (Dorland, 27th ed).  N nWater Deprivation F01.658.938 PH Thirst Thirst Behavior and Behavior Mechanisms (Non MeSH); Motivation The withholding of water in a structured experimental situation. Motivation (66-68); Thirst (66-68) $!L  CM+Water D01.455.900; D01.650.550.925; G03.230.700 ADAEANCHDUMEPDPHPS Body Water; Fresh Water; Mineral Waters; Seawater Inorganic Chemicals (Non MeSH); Hydroxides Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Environment and Public Health (Non MeSH); Environment Deuterium Oxide Fresh Water; Ice; Seawater; Steam; Water Movements Water. A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPOPSRESDSTTOTUUR $"u 1>S<Waste Products G03.850.460.710 AEANCLECSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Hazardous Waste (+ 1); Industrial Waste; Medical Waste (+ 2); Sewage Debris resulting from a process that is of no further use to the system producing it. The concept includes materials discharged from or stored in a system in inert form as a by-product of vital activities. (From Webster's New Collegiate Dictionary, 1981). AEANCLECHIISLJMTPCSNST  %|`W0Waste Management G03.850.780.200.800.800.900; G03.850.860.510.900 ECHIISLJMTSNST Ecological Systems, Closed Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation; Sanitary Engineering Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering Water Purification Refuse Disposal (+ 4); Sewage (+ 1); Water Purification Disposal, processing, controlling, recycling, and reusing the solid, liquid, and gaseous wastes of plants, animals, humans, and other organisms. It includes control within a closed ecological system to maintain a habitable environment. Refuse Disposal (66-94) AEANECHIISLJMTSNST ('6  \Waste Disposal, Fluid G03.850.780.200.800.800.890; G03.850.860.510.900.600.900; G03.850.860.510.900.700.900 ECHIISLJMTSNST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation; Sanitary Engineering Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management; Refuse Disposal Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management; Sewage The discarding or destroying of liquid waste products or their transformation into something useful or innocuous. +K]Wassermann Reaction E01.223.495.826.208.738; E01.223.495.826.895.863 Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Complement Fixation Tests Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Syphilis Serodiagnosis A complement fixation test for syphilis. .N62Wasps B01.131.617.479.900 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hymenoptera Any of numerous winged hymenopterous insects of social as well as solitary habits and having formidable stings. / (9Wasp Venoms D24.185.965.065.970 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Arthropod Venoms Venoms produced by the wasp (Vespid) family of stinging insects, including hornets; the venoms contain enzymes, biogenic amines, histamine releasing factors, kinins, toxic polypeptides, etc., and are similar to bee venoms. Bees (66-74); Insect Bites and Stings (66-74); Insects (66-75); Venoms (66-77); Wasps (75-77) 0<kuWashington Z01.107.567.875.100.930; Z01.107.567.875.600.656.930 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Northwestern United States 3U:Warts C02.256.690.810; C02.825.810; C02.928.914; C04.925.744; C17.800.838.790.810 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Papilloma Virus Diseases; DNA Virus Infections (Non MeSH); Papovaviridae Infections Virus Diseases; Skin Diseases, Viral Virus Diseases; Tumor Virus Infections Neoplasms; Tumor Virus Infections Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral Condylomata Acuminata; Epidermodysplasia Verruciformis Condylomata Acuminata; Epidermodysplasia Verruciformis Condylomata Acuminata; Epidermodysplasia Verruciformis Epidermodysplasia Verruciformis Condylomata Acuminata; Epidermodysplasia Verruciformis Benign epidermal proliferations or tumors; some are viral in origin.  4 WP YSWarfarin D03.438.150.446.520.914; D05.723.853.738; D19.461.119.196.475.971; D19.461.119.975 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; 4-Hydroxycoumarins Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Rodenticides Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Coumarins; 4-Hydroxycoumarins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one. An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 8 \: War Crimes I01.198.240.903; I01.880.735.944.903 CLECEHHILJPCPXSNTD Social Sciences; Criminology; Crime Social Sciences; Sociology; Social Problems; War Holocaust Holocaust Criminal acts committed during, or in connection with, war, e.g., maltreatment of prisoners, willful killing of civilians, etc. =#*fWar I01.880.735.944 HI Combat Disorders Social Sciences; Sociology; Social Problems Biological Warfare; Chemical Warfare; Nuclear Warfare; Psychological Warfare; War Crimes (+ 1) Hostile conflict between organized groups of people. CLECEHHILJMTPCPXSNTD $>5q?Walrus B02.649.754.821 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Pinnipedia @  ((Wallerian Degeneration G11.561.491.863 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Nerve Degeneration @Wallenberg's Syndrome C10.228.140.300.378.863; C14.907.253.378.821; C14.907.355.350.850.213.863; C14.907.355.830.850.213.863 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism; Thromboembolism; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis; Thromboembolism; Cerebral Embolism and Thrombosis Syndrome caused by occlusion of the posterior inferior cerebellar artery, marked by ipsilateral loss of facial pain and temperature sensations, ipsilateral limb ataxia, and contralateral loss of pain and temperature sensations in the trunk and extremities. AtpNT(Walking I03.450.642.845.940 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports An activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking. Exercise (89-90); Exertion (66-90) E R+Walkers E07.858.442.980 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Orthopedic Equipment Walking aids generally having two handgrips and four legs. G LGWales Z01.542.363.914 EHEP Geographicals (Non MeSH); Europe; Great Britain H ;Waldenstrom's Macroglobulinemia C15.378.147.780.925; C15.604.515.925; C20.683.780.925 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias A malignant neoplasm of cells with lymphocytic, plasmacytic, or intermediate morphology, which secrete an IgM M component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 27th ed). I $=N0Wakefulness F02.830.104.821; G11.561.065.738 CLDEGEPHRE Insomnia Psychologic Processes and Principles (Non MeSH); Psychophysiology; Arousal Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Arousal A state in which the individual is fully aware of his environment. Cerebral Cortex/physiology (66); Consciousness (66)  M$& R>Waiting Lists N04.452.095.738 Health Services Administration (Non MeSH); Organization and Administration; Appointments and Schedules Prospective patient listings for appointments. Nw7WAGR Syndrome C04.557.435.595.950; C10.496.966; C11.250.060.950; C11.270.060.950; C11.941.375.060.950; C12.740.700.921; C13.371.820.700.921; C16.131.384.079.950; C16.131.410.078.950; C16.131.939.921; F03.709.346.972 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH); Nephroblastoma Nervous System Diseases; Mental Retardation Eye Diseases; Eye Abnormalities; Aniridia Eye Diseases; Eye Diseases, Hereditary; Aniridia Eye Diseases; Uveal Diseases; Iris Diseases; Aniridia Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities; Aniridia Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary; Aniridia Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Wilms' tumor with aniridia, genitourinary abnormalities, and mental retardation. It is associated with hemizygous deletions of chromosome region 11p13. Chromosomes, Human, Pair 11 (86-93); Chromosomes, Human, 6-12 (80-85); Iris/abnormalities (80-93); Mental Retardation (84-93); Nephroblastoma (80-93); Urogenital System/abnormalities (84-93) ON&Waardenburg's Syndrome C16.131.077.938 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Piebaldism Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Rare, autosomal dominant disease with variable penetrance and several known clinical types. Characteristics may include depigmentation of the hair and skin, congenital deafness, heterochromia iridis, medial eyebrow hyperplasia, hypertrophy of the nasal root, and especially dystopia canthorum. The underlying cause may be defective development of the neural crest (neurocristopathy). Waardenburg's syndrome may be closely related to piebaldism. Klein-Waardenburg Syndrome refers to a disorder that also includes upper limb abnormalities. WLegVulvovaginitis C13.371.894.906.820; C13.371.944.902.737 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases; Vaginitis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vulvar Diseases; Vulvitis Inflammation of the vulva and vagina or vulvovaginal glands. (Dorland, 27th ed). Z.NbVulvitis C13.371.944.902 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vulvar Diseases Vulvovaginitis Inflammation of the vulva. (Dorland, 27th ed). \ N|;Vulvar Neoplasms C04.588.945.418.968; C13.371.270.968; C13.371.820.800.418.968; C13.371.944.819 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vulvar Diseases ^XXVulvar Diseases C13.371.944 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Candidiasis, Vulvovaginal; Kraurosis Vulvae; Pruritus Vulvae; Vulvar Neoplasms; Vulvitis (+ 1) Diseases of the vulva. Vulva (66-75); specific vulvar disease BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $aNhp0ZVulva A05.360.319.887 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Female Bartholin's Glands; Clitoris c% :9#Voyeurism F03.709.597.608.700.800 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias A paraphilia characterized by repetitive looking at unsuspecting people, usually strangers, who are either naked, in the act of disrobing, or engaging in sexual activity, as the method for achieving sexual excitement. c Fvon Willebrand's Disease C15.378.463.913 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis Group of hemorrhagic disorders in which the von Willebrand factor is either quantitatively or qualitatively abnormal. Usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. fLdvon Willebrand Factor D12.776.124.125.920; D19.461.270.229.953 AAADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in von Willebrand's disease is due to the deficiency of this factor. Blood Coagulation Factors (66-74); Blood Platelets (66-74); von Willebrand's Disease (66-75) h.D/nVomiting, Anticipatory C23.888.821.937.080 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH); Vomiting Vomiting caused by expectation of discomfort or unpleasantness. Vomiting (66-87) m NKVomiting C06.405.937; C23.888.821.937 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antiemetics; Emetics Digestive System Diseases; Gastrointestinal Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) Hematemesis; Hyperemesis Gravidarum Vomiting, Anticipatory The forcible expulsion of the contents of the stomach through the mouth.  n "NCXVolvocida B01.841.750.443.575.900 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea Chlamydomonas (+ 1) An order of plantlike, flagellate protozoa commonly found in freshwater habitats. Characteristics include the presence of a cellulose wall and two-to-four equal, smooth, apical flagella. p &XVoluntary Workers M01.955 CLEDHILJOGPXSN Named Groups (Non MeSH) Hospital Volunteers (+ 1) Persons who donate their services. specific service (66-67) CLECEDHILJOGPXSDSNSTTDUT $r  +Voluntary Health Agencies N03.540.630.780 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit American Cancer Society; American Heart Association; Mental Health Associations; Red Cross; Tuberculosis Societies Non-profit organizations concerned with various aspects of health, e.g., education, promotion, treatment, services, etc. scVolition F02.463.902 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes Voluntary activity without external compulsion. uq  N8Volcanic Eruption G03.230.100.200.900 AEANCLECHILJSN Environment and Public Health (Non MeSH); Environment; Disasters; Natural Disasters The ash, dust, gases, and lava released by volcanic explosion. The gases are volatile matter composed principally of about 90% water vapor, and carbon dioxide, sulfur dioxide, hydrogen, carbon monoxide, and nitrogen. The ash or dust is pyroclastic ejecta and lava is molten extrusive material consisting mainly of magnesium silicate. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Air Pollutants, Environmental (82-94); Geology (66-79); Natural Disasters (82-94) vAdaVolatilization H01.181.529.952 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Chemistry, Physical (66-70); Gases (66-70); appropriate chemical heading yFIWVoice Training E02.831.727.862 Speech Therapy Therapeutics; Rehabilitation; Rehabilitation, Speech and Language (Non MeSH) z6YVoice Quality G09.772.862.960 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Voice Voice quality is that component of speech which gives the primary distinction to a given speaker's voice when pitch and loudness are excluded. It involves both phonatory and resonatory characteristics. Some of the descriptions of voice quality are harshness, breathiness and nasality. Voice (66-78) zpLVoice Disorders C08.360.940; C09.400.940; C10.597.257.960; C23.888.592.257.960; F03.126.219.960 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Otorhinolaryngologic Diseases; Laryngeal Diseases Nervous System Diseases; Neurologic Manifestations; Communicative Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders Aphonia; Hoarseness Aphonia; Hoarseness Aphonia; Hoarseness Aphonia; Hoarseness Aphonia Disorders of voice pitch, loudness, or quality. Diseases which present as voice disorders include laryngeal carcinoma, sarcoma, and polyps; vocal cord nodules, contact ulcers, polyps, and paralysis; and neuromuscular diseases. Voice (66-78)  }[NgVoice G09.772.862 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH) Phonation; Voice Quality The sounds produced by humans by the passage of air through the larynx and over the vocal cords, and then modified by the resonance organs, the nasopharynx, and the mouth. ? fVocational Guidance F02.784.629.937; F02.784.692.887; I02.233.924 CLECHILJMAMTOGSNSTTD Counseling Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial Education; Education, Nonprofessional (Non MeSH) Systematic efforts to assist individuals in selecting an occupation or suitable employment on the basis of aptitude, education, etc. 5Vocational Education I02.233.862 CLECHILJMAMTOGSNSTTD Education; Education, Nonprofessional (Non MeSH) Education for specific trades or occupations. !97Vocalization, Animal F01.145.209.103.862 CLDEPHRE Animal Communication Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Animal Communication Vocal sounds used in animal communication. Communication (66-67); Voice (66-67)   k4-Vocal Cords A04.329.364.737 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Respiratory System; Larynx; Glottis The folds of mucous membrane along either wall of the larynx from the angle between the laminae of the thyroid cartilage to the vocal process of the arytenoid cartilage. @:,Vocal Cord Paralysis C08.360.931; C09.400.931; C10.597.622.943; C10.772.204.924; C23.888.592.636.943 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Otorhinolaryngologic Diseases; Laryngeal Diseases Nervous System Diseases; Neurologic Manifestations; Paralysis Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Paralysis of one or both of the vocal cords. [N9Vocabulary L01.143.506.598.901 Information Science; Communication; Language; Linguistics kDVivisection E05.969 AECLCTECHIISMOMTNUPXSNSTTDUTVE Animal Welfare Miscellaneous Techniques (Non MeSH)  "*Vitreous Hemorrhage C11.290.960; C23.542.290.960 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Eye Hemorrhage Hemorrhage into the vitreous body. Hemorrhage (66-86); Vitreous Body (66-86) "Nv+3Vitreous Body A09.371.943 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Vitrectomy Sense Organs; Eye :Vitreoretinopathy, Proliferative C11.768.890; C11.975 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Eye Diseases Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes. Eye Diseases (81-94); Retinal Diseases (83-94); Vitreous Body (81-94) %N5UVitrectomy E04.792.960 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Vitreous Body Surgery, Operative; Surgery, Eye (Non MeSH) Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma. Vitreous Body/SU (66-83)  $5Vitiligo C17.800.621.440.895 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hypopigmentation A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached. 1 NzdVitellogenin D10.516.532.900; D12.776.256.317.925; D12.776.290.925; D12.776.521.925; D12.776.744.925 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Egg Proteins, Dietary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Phosphoproteins A serum and yolk protein which has been characterized as a calcium-binding glycolipophosphoprotein. It is induced by estrogen or juvenile hormone and is essential for yolk formation in various insect species. Egg Proteins (73-74); Lipoproteins (72-74); Phosphoproteins (73-74) cHQVitellogenesis G08.520.310.500.880 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Gametogenesis; Oogenesis The production and storage of yolk in the oocyte which is usually initiated after the first meiotic division. eVitelline Membrane A16.631.886 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Ovum The plasma membrane of the egg. :/)Vitelline Duct A16.254.891 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo The narrow tube connecting the yolk sac with the midgut of the embryo; persistence of all or part of it in post-fetal life produces abnormalities, of which the commonest is MECKEL'S DIVERTICULUM. :1Vitamins D11.786 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH) Ascorbic Acid (+ 1); Bioflavonoids (+ 4); Vitamin A; Vitamin B Complex (+ 30); Vitamin D (+ 10); Vitamin E; Vitamin K (+ 1); Vitamin U AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 7  @9HVitamin U D11.786.950; D12.125.166.676.950; D19.316.203.957 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Methionine Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents L-(3-Amino-3-carboxypropyl)dimethylsulfonium chloride. A vitamin found in green vegetables. It is used in the treatment of peptic ulcers, colitis, and gastritis and has an effect on secretory, acid-forming, and enzymatic functions of the intestinal tract. Methionine (73-76); Vitamins (73-76) 9F)-Vitamin K Deficiency C15.378.463.841; C18.654.223.133.912 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis Hemorrhagic Disease of Newborn A nutritional condition produced by a deficiency of VITAMIN K in the diet, characterized by an increased tendency to hemorrhage (HEMORRHAGIC DIATHESIS). Such bleeding episodes may be particularly severe in newborn infants. (From Cecil Textbook of Medicine, 19th ed, p. 1182).  *N&DVitamin K D11.786.875; D19.461.270.546.861 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Heparin Antagonists Phytonadione Phytonadione 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4- naphthalenedione. A fat-soluble vitamin occurring naturally as the trans-isomer and first isolated from alfalfa. It also shows widespread distribution in higher green plants. It is used therapeutically as a coagulant. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  &B7DVitamin E Deficiency C18.654.223.133.841 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis Steatitis A nutritional condition produced by a deficiency of VITAMIN E in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin E deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin E metabolism, named familial isolated vitamin E deficiency, has recently been identified. (Cecil Textbook of Medicine, 19th ed, p. 1181). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  Nw PVitamin E D11.786.819 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12- trimethyltridecyl)-2H-1-benzopyran-6-ol. Vitamin found largely in plant materials, especially wheat germ, corn, sunflower seed, rapeseed, soybean oils, alfalfa, and lettuce. It is used as an antioxidant in vegetable oils and shortenings and in the prevention and treatment of vitamin E deficiency. EBFVitamin D-Binding Protein D12.776.157.920 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins An alpha-globulin found in the plasma of man and other vertebrates. It is apparently synthesized in the liver and carries vitamin D and its metabolites through the circulation and mediates the response of tissue. It is also known as group-specific component (Gc). Gc subtypes are used to determine specific phenotypes and gene frequencies. These data are employed in the classification of population groups, paternity investigations, and in forensic medicine. Alpha Globulins (66-84); Carrier Proteins (71-84); Proteins (66-71); Vitamin D (66-84) HYjVitamin D Deficiency C18.654.223.133.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Rickets Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis Osteomalacia; Rickets A nutritional condition produced by a deficiency of VITAMIN D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as RICKETS in children and OSTEOMALACIA in adults. (From Cecil Textbook of Medicine, 19th ed, p. 1406).  N wVitamin D D11.786.763 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Calcitriol Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins Cholecalciferol (+ 5); Dihydrotachysterol; Ergocalciferols (+ 1); Ergosterol Vitamin D. The vitamin that mediates intestinal calcium absorption, bone calcium metabolism, and probably muscle activity. It usually acts as a hormone precursor, requiring 2 stages of metabolism before reaching actual hormonal form. It is isolated from fish liver oils and used in the treatment and prevention of rickets. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $BF\yDVitamin B 12 Deficiency C18.654.223.133.699.923 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency Anemia, Pernicious A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (From Cecil Textbook of Medicine, 19th ed, p. 848). NfVitamin B 12 D11.786.708.950; D19.461.543.901 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Schilling Test Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics Cobamides; Hydroxocobalamin; Transcobalamins Hydroxocobalamin A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $&BF&HVitamin B Deficiency C18.654.223.133.699 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pellagra Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis Choline Deficiency; Folic Acid Deficiency; Pellagra; Pyridoxine Deficiency; Riboflavin Deficiency; Thiamine Deficiency (+ 2); Vitamin B 12 Deficiency (+ 1) N wVitamin B Complex D11.786.708 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins Aminobenzoic Acids (+ 1); Biotin; Carnitine (+ 2); Folic Acid (+ 4); Inositol; Nicotinic Acids (+ 3); Pantothenic Acid; Pyridoxal; Pyridoxamine; Pyridoxine; Riboflavin; Thiamine (+ 3); Thioctic Acid; Vitamin B 12 (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR @FHVitamin A Deficiency C18.654.223.133.628 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Night Blindness; Xerophthalmia Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis A nutritional condition produced by a deficiency of VITAMIN A in the diet, characterized by NIGHT BLINDNESS and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (XEROPHTHALMIA). Vitamin A deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin A-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. (From Cecil Textbook of Medicine, 19th ed, p. 1179). N%wyVitamin A D02.455.849.291.700.818; D11.557.261.700.860; D11.786.652 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKRESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins A@Vitallium D01.220.175.950; D01.552.033.182.900; D25.058.224.735; D25.339.208.224.959 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Chromium Compounds; Chromium Alloys Inorganic Chemicals (Non MeSH); Metals; Alloys; Chromium Alloys Biomedical and Dental Materials (Non MeSH); Alloys; Chromium Alloys Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Alloys; Chromium Alloys An alloy of 60% cobalt, 20% chromium, 5% molybdenum, and traces of other substances. It is used in dentures, certain surgical appliances, prostheses, implants, and instruments. { T,ZVitalism K01.752.935 HIPX Humanities; Philosophy T Vital Statistics E05.318.308.985; G03.850.505.400.975; G03.850.520.308.985; L01.280.975; N01.224.935 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Information Science; Data Collection Population Characteristics (Non MeSH); Demography Birth Rate; Life Expectancy; Life Tables; Morbidity (+ 2); Mortality (+ 6) Birth Rate; Life Expectancy; Life Tables; Morbidity (+ 2); Mortality (+ 6) Birth Rate; Life Expectancy; Life Tables; Morbidity (+ 2); Mortality (+ 6) Birth Rate; Life Expectancy; Life Tables; Morbidity (+ 2); Mortality (+ 6) Birth Rate; Life Expectancy; Life Tables; Morbidity (+ 2); Mortality (+ 7); Sex Ratio Used for general articles concerning statistics of births, deaths, marriages, etc. BLCFCICLCODIECEHEMENEPETGEHIIMMEMIPAPCPPPSRARISUTDTHURUSVEVI ˲_a@Vital Capacity E01.302.796.420.810.970; G09.772.521.700.810.970 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity Expiratory Reserve Volume; Inspiratory Capacity (+ 2) Expiratory Reserve Volume; Inspiratory Capacity (+ 2) The volume of air that is exhaled by a maximal expiration following a maximal inspiration. Spirometry (66-68)  t6<~mVisual Perception F02.463.593.932; G11.697.911.860 CLDEGEPHRE Vision Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision Afterimage; Color Perception; Field Dependence-Independence; Figural Aftereffect; Flicker Fusion; Motion Perception; Perceptual Closure; Perceptual Masking; Space Perception (+ 7) Afterimage; Color Perception; Depth Perception (+ 1); Distance Perception; Figural Aftereffect; Flicker Fusion; Form Perception (+ 1); Motion Perception The selecting and organizing of visual stimuli based on the individual's past experience. CLDEGEIMPHRE $4& jVisual Pathways A08.612.220.860 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Neural Pathways; Afferent Pathways Central Nervous System (66-70); Vision (66-70) {6=9Visual Fields G11.697.911.830 DEGEIMPHRE Perimetry Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision q jVisual Cortex A08.186.211.730.885.213.571.735 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex; Occipital Lobe Area of the occipital lobe concerned with vision. Cerebral Cortex (66-67); Vision (66-67) >#8=1Visual Acuity G11.697.911.800 DEGEIMPHRE Form Perception; Refraction, Ocular; Refractive Errors Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision Contrast Sensitivity Acuteness or clearness of vision, especially of form vision, which is dependent mainly on the sharpness of the retinal focus. Vision (66-67) $AjVisna-Maedi Virus B04.820.650.589.600.900; B04.909.777.731.589.600.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Ovine-Caprine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Ovine-Caprine A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), that can cause chronic pneumonia (maedi), mastitis, arthritis, and encephalomyelitis (visna) in sheep. Maedi is a progressive pneumonia of sheep which is similar to but not the same as jaagsiekte (PULMONARY ADENOMATOSIS, OVINE). Visna is a demyelinating leukoencephalomyelitis of sheep which is similar to but not the same as SCRAPIE. Pulmonary Adenomatosis, Ovine (68-72); Scrapie (68-72) ې:AVisna C02.782.815.616.900; C02.839.900; C10.228.228.291.900; C10.228.440.900; C22.836.900 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections Virus Diseases; Slow Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalomyelitis Nervous System Diseases; Central Nervous System Diseases; Encephalomyelitis Animal Diseases; Sheep Diseases Demyelinating leukoencephalomyelitis of sheep caused by the VISNA-MAEDI VIRUS. It is similiar to but not the same as SCRAPIE. ) _JVisitors to Patients M01.935 CLEDHILJPXSN Named Groups (Non MeSH) Patients' guests and rules for visiting. 5 2Vision, Subnormal C10.597.751.941.905; C11.966.905; C23.888.592.763.941.848 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blindness Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Eye Diseases; Vision Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Visual Acuity (69-88); Vision Disorders (67-88)  AN .:Vision, Monocular G11.697.911.780 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision Vision with one eye or the affecting of one eye. Sensory Deprivation (72-88); Vision (66-88) j>5Vision, Entoptic F02.830.816.929.800; G11.561.796.929.800; G11.697.911.730 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation; Vision Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Vision Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision Visual sensation due to shadows or optical effects of structures within the eye or to excitation of the receptor system by stimuli other than light. AJVision, Binocular G11.697.911.700 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision The blending of separate images seen by each eye into one composite image. Accommodation, Ocular (67-88); Convergence, Ocular (85-88); Vision (66-88); Visual Perception (66-88) vj[yVision Tests E01.210.935 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Eye (Non MeSH) Color Perception Tests; Perimetry; Refraction, Ocular; Vision Screening AECLCTECHIISLJMOMTNUOGPXSNSTTDUTVE "-U&Vision Screening E01.210.935.800; E05.318.308.250.580.925; G03.850.520.308.250.580.925; G03.850.780.500.950; N05.715.360.300.375.500.825 AECLCTECHIISLJMOMTNUOGPXSTTDUTVE Diagnosis; Diagnosis, Eye (Non MeSH); Vision Tests Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Mass Screening Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from VISION TESTS, which are given to evaluate/measure individual visual performance not related to a specific population. Mass Screening (66-88); Vision Tests (66-88) #$a7Vision Disparity F02.463.593.932.869.255.780; G11.697.384.780; G11.697.911.860.317.780 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception; Space Perception; Depth Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception; Depth Perception The difference between two images on the retina when looking at a visual stimulus. This occurs since the two retinas do not have the same view of the stimulus because of the location of our eyes. Thus the left eye does not get exactly the same view as the right eye. *MCVision Disorders C10.597.751.941; C11.966; C23.888.592.763.941 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Eye Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Amblyopia; Blindness; Color Vision Defects; Diplopia; Hemianopsia; Scotoma; Vision, Subnormal Amblyopia; Blindness (+ 1); Color Vision Defects; Diplopia; Night Blindness; Scotoma; Vision, Subnormal Amblyopia; Blindness; Color Vision Defects; Diplopia; Hemianopsia; Scotoma; Vision, Subnormal Visual impairment limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. Visual disability refers to inability of the individual to perform specific visual tasks, such as reading, writing, orientation, or traveling unaided. It is to be differentiated from EYE DISEASES which are restricted to diseases of the eye, the organ and its anatomical parts. (From Newell, Ophthalmology: Principles and Concepts, 7th ed). Vision (66)  5NZ2Vision F02.830.816.929; G11.561.796.929; G11.697.911 DEGEIMPHRE Visual Perception Optics; Eye; Ophthalmology Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) Phosphenes; Vision, Entoptic Phosphenes; Vision, Entoptic Phosphenes; Vision, Binocular; Vision, Entoptic; Vision, Monocular; Visual Acuity (+ 1); Visual Fields; Visual Perception (+ 10) The sensation of sight. CLDEGEIMPHRE ( 5"+Viscum B06.560.975 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A genus of Old World parasitic plants of the Loranthaceae. Viscum album and Phorandendron flavescens were formerly used as emmenagogues, cardiac stimulants, and vasodilators. The plants contain toxins, lectins, tyramine, phenethylamines, and other useful or dangerous compounds.  & AViscosity H01.181.529.934 DERE Blood Viscosity Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical  IVisceroptosis C06.405.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases The prolapse or downward displacement of the viscera. GN=AVisceral Afferents A08.612.220.830 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Autonomic Nervous System Nervous System; Neural Pathways; Afferent Pathways The sensory fibers innervating the viscera. Viscera/innervation (86-93)  V6=5!Viscera A01.960 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Body Regions (Non MeSH) Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen. consider also terms at SPLANCHN-.   :Viruses, Unclassified B04.970 CHCLDEENGDGEIMIPMEPHPYREUL Viruses African Swine Fever Virus; Arterivirus (+ 3); Astroviruses; Picobirnavirus Viruses whose taxonomic relationships have not been established.   ZLViruses B04 CHCLDEENGDGEIMIPMEPHPYREUL Antiviral Agents; Inclusion Bodies, Viral; Receptors, Virus Microbiology Arboviruses; Bacteriophages (+ 53); Defective Viruses (+ 8); DNA Viruses (+ 114); Genetic Vectors; Helper Viruses; Hepatitis Viruses (+ 13); Insect Viruses (+ 6); Plant Viruses (+ 20); Reassortant Viruses; RNA Viruses (+ 239); Vertebrate Viruses (Non MeSH) (+ 410); Virion (+ 1); Viroids; Viruses, Unclassified (+ 7) Minute infectious agents whose genomes are composed of DNA or RNA, but not both. They are characterized by a lack of independent metabolism and the inability to replicate outside living host cells. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGDGEHIIMIPMEPDPHPKPOPYRESDSESTTOTUULUR $ GLVirus Shedding G04.185.515.880.960 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) The expelling of virus particles from the body. Important routes include the respiratory tract, genital tract, and intestinal tract. Virus shedding is an important means of vertical transmission (DISEASE TRANSMISSION, VERTICAL). ` Virus Replication G04.185.515.880.941; G06.184.941 DEGEIMPHRE DNA Replication Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Virus Activation The process of intracellular viral multiplication, consisting of the synthesis of proteins, nucleic acids, and sometimes lipids, and their assembly into a new infectious particle. specific virus (66-67); Viruses (66-67) $ |&1Virus Latency G04.185.515.880.935 DEGEIMPHRE Virus Activation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) The ability of a pathogenic virus to lie dormant within a cell (latent infection). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors. Virus Activation (80-93); Virus Replication (68-93)   =q>Virus Integration G04.185.515.880.930; G05.386.930 DEGEIMPHRE Proviruses Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) Genetics; Genetics, Microbial Lysogeny (+ 1) Lysogeny (+ 1) Insertion of viral DNA into host-cell DNA. This includes integration of phage DNA into bacterial DNA (LYSOGENY) to form a prophage or integration of retroviral DNA into cellular DNA to form a provirus. DNA, Viral (66-91); Proviruses (88-91) $&&0Virus Inhibitors D24.611.935 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) BZVirus Diseases C02 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antiviral Agents Arbovirus Infections (+ 24); Arthritis, Infectious (+ 1); Bronchiolitis, Viral; DNA Virus Infections (Non MeSH) (+ 49); Encephalitis, Viral (+ 5); Eye Infections, Viral (+ 6); Fatigue Syndrome, Chronic; Hepatitis, Viral, Animal (+ 2); Hepatitis, Viral, Human (+ 6); Meningitis, Viral (+ 1); Opportunistic Infections (+ 2); Pneumonia, Viral; RNA Virus Infections (Non MeSH) (+ 134); Sexually Transmitted Diseases (+ 6); Skin Diseases, Viral (+ 9); Slow Virus Diseases (+ 11); Tumor Virus Infections (+ 7); Viremia; Zoonoses A general term for diseases produced by viruses. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  P{<ZVirus Cultivation E05.909.560.970 AECLCTECHIISMOMTNUPXSNSTTDUTVE Tissue Culture Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques Plaque Assay Y"bVirus Activation G04.185.515.880.941.940 DEGEIMPHRE Virus Latency Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH); Virus Replication The mechanism by which latent viruses, such as genetically transmitted tumor viruses or prophages of lysogenic bacteria, are induced to replicate and are released as infectious viruses. It may be effected by various endogenous and exogenous stimuli, including B-cell lipopolysaccharides, glucocorticoid hormones, halogenated pyrimidines, ionizing radiation, ultraviolet light, and superinfecting viruses. Lysogeny (68-79); Virus Replication (68-79); specific virus (66-67)  QRVirulence G04.185.515.910 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host.  Virology G01.273.540.859 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology; Microbiology Virus Diseases (66); Viruses (66)  3+Viroids B04.956 CHCLDEENGDGEIMIPMEPHPYREUL Viruses A group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected. Plant Viruses (71-80); RNA, Viral (71-80) ;   4Virion B04.950 CHCLDEENGDGEIMIPMEPHPYREUL Viruses Capsid The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Viral Proteins (66-77); specific virus ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGDGEHIIMIPMEPDPHPKPOPYRESDSESTTOTUULUR $_    0LVirilism C19.391.922 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Adrenal Hyperplasia, Congenital; Hyperandrogenism Endocrine Diseases; Gonadal Disorders (Non MeSH) Hirsutism Development of masculine traits in the female.  !6 N9: 9Virginiamycin D20.085.116.915 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, virginiamycin Factor M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry. "<BVirginia Z01.107.567.875.100.918; Z01.107.567.875.600.820.918 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States $ :Virgin Islands of the United States Z01.107.084.900.970 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies An unincorporated territory of the United States comprising the western Virgin Islands. The three main islands are St. Croix, St. Thomas, and St. John. West Indies (66-81) &k,OViremia C01.539.757.720.937; C02.937 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia Virus Diseases The presence of viruses in the blood. specific virus (66); specific virus disease/blood (67-79) ' "Ph0FViral Vaccines D24.310.894.899 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines AIDS Vaccines; Influenza Vaccine; Measles Vaccine; Mumps Vaccine; Poliovirus Vaccine (+ 1); Rabies Vaccine; Rubella Vaccine; SAIDS Vaccines; Smallpox Vaccine; Viral Hepatitis Vaccines (+ 1) Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. )~>YViral Tail Proteins D12.776.964.970.910 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins Proteins found in the tail sections of DNA and RNA viruses. It is believed that these proteins play a role in directing chain folding and assembly of polypeptide chains. Viral Proteins (80-92) +FvViral Structural Proteins D12.776.964.970 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins Capsid; Viral Core Proteins (+ 7); Viral Envelope Proteins (+ 8); Viral Tail Proteins Viral proteins that do not regulate transcription. They are coded by viral structural genes and include nucleocapsid core proteins (gag proteins), enzymes (pol proteins), and membrane components (env proteins). Transcription of viral structural genes is regulated by viral regulatory proteins. Viral Proteins (73-89)  -FWkVViral Regulatory Proteins D12.776.260.900; D12.776.964.950 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins Gene Products, nef; Gene Products, rex; Gene Products, vif; Gene Products, vpu; Immediate-Early Proteins; Trans-Activators (+ 1) Gene Products, nef; Gene Products, rex; Gene Products, vif; Gene Products, vpu; Immediate-Early Proteins; Trans-Activators (+ 5) Proteins which regulate the rate of transcription of viral structural genes. Repressor Proteins (79-89); Transcription Factors (77-89); Viral Proteins (72-89) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $0&F0[aHViral Proteins D12.776.964 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, Viral Amino Acids, Peptides and Proteins (Non MeSH); Proteins Oncogene Proteins, Fusion (+ 2); Oncogene Proteins, Viral (+ 22); Retroviridae Proteins (+ 26); Viral Nonstructural Proteins; Viral Regulatory Proteins (+ 11); Viral Structural Proteins (+ 19) Proteins found in any species of virus. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $4?DD2HViral Phenomena (Non MeSH) G04.185.515.880 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) Cell Transformation, Viral; Cytopathogenic Effect, Viral; Hemagglutination, Viral; Inclusion Bodies, Viral; Viral Interference; Virus Integration (+ 2); Virus Latency; Virus Replication (+ 1); Virus Shedding CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI 6!*Viral Nonstructural Proteins D12.776.964.900 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins Viral proteins that are coded by nonstructural genes and usually have an unknown function. Some of these proteins may play structural roles within the infected cell during replication or act in virus regulation. Capsid (88-92); Viral Core Proteins (88-92); Viral Proteins (80-88) 8"DWSViral Matrix Proteins D12.776.964.970.880.940 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins Gene Products, vpu Nonglycosylated proteins associated with the inner surface of the lipid bilayer of the viral envelope. These proteins have been implicated in control of viral transcription and may possibly serve as the "glue" that binds the nucleocapsid to the appropriate membrane site during viral budding from the host cell. Viral Proteins (66-87)  :FlViral Interference G04.185.515.880.910 DEGEIMPHRE Interferons Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus. =Viral Hepatitis Vaccines D24.310.894.899.955 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines Hepatitis B Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Viral Vaccines (66-84); Hepatitis, Viral, Animal (77-84); Hepatitis, Viral, Human (77-84)  ?{>l_kViral Fusion Proteins D12.776.964.970.880.910 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins HIV Envelope Protein gp41 Proteins, usually glycoproteins, found in the viral envelopes of a variety of viruses. They promote cell membrane fusion and thereby may function in the uptake of the virus by cells. Viral Envelope Proteins (84-86); Viral Proteins (66-83)  AiF CViral Envelope Proteins D12.776.964.970.880 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins Gene Products, env (+ 2); HN Protein; Viral Fusion Proteins (+ 1); Viral Matrix Proteins (+ 1) Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins. Viral Proteins (66-83)  CFvwViral Core Proteins D12.776.964.970.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins Gene Products, gag (+ 2); Gene Products, pol (+ 3) Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the capsid. Capsid (75-85); Viral Proteins (66-85)  GLFvA0Vipoma C04.557.465.625.650.240.285.925; C04.557.470.200.025.370.285.925; C04.557.580.625.650.240.285.925 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Islet Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Neuroendocrine; Carcinoma, Islet Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Islet Cell An endocrine tumor, usually arising in the pancreas, that produces vasoactive intestinal polypeptide, which is the mediator of a syndrome of watery diarrhea, hypokalemia, and hypochlorhydria, leading to renal failure and death. (Dorland, 27th ed). Diarrhea (66-81); Gastrointestinal Hormones (66-81); Islet Cell Tumor (66-81); Pancreatic Neoplasms (66-81); Vasoactive Intestinal Peptide (77-81) I~ iX[ Viperidae B02.833.672.875 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Viper Venoms Vertebrates; Reptiles; Snakes Agkistrodon; Bothrops; Crotalus; Russell's Viper; Trimeresurus A family of snakes comprising three subfamilies: Azemiopinae (the mountain viper, the sole member of this subfamily), Viperinae (true vipers), and Crotalinae (pit vipers). They are widespread throughout the world, being found in the United States, Central and South America, Europe, Asia and Africa. Their venoms act on the blood (hemotoxic) as compared to the venom of elapids which act on the nervous system (neurotoxic). (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed). Snakes (68-93) $N &%K8Viper Venoms D24.185.965.850.960 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Viperidae Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms Crotalid Venoms (+ 3) Venoms from snakes of the viperid family. They tend to be less toxic than elapid or hydrophid venoms and act mainly on the vascular system, interfering with coagulation and capillary membrane integrity and are highly cytotoxic. They contain large amounts of several enzymes, other factors, and some toxins. Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (Q< ghBJViomycin D20.085.089.910; D20.085.116.900; D20.338.135.922 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular Enviomycin Enviomycin Enviomycin Viomycin. Strongly basic, complex antibiotics from several strains of Streptomyces. They are allergenic and toxic to kidneys and the labyrinth. Viomycins are used in tuberculosis as several different salts and in combination with other agents. T 9<&Viologens D03.383.725.762.925 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Benzyl Viologen A group of dipyridinium chloride derivatives that are used as oxidation-reduction indicators. The general formula is 1,1'-di-R-4,4'-bipyridinium chloride, where R = methyl, ethyl, benzyl or, betaine. Pyridinium Compounds (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $W 8n":Violence F03.126.842.089.734; I01.198.240.856; I01.880.735.900 CLECEHHILJPCPXSNTD Battered Child Syndrome; Battered Women Riots Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression Social Sciences; Criminology; Crime Social Sciences; Sociology; Social Problems Dangerous Behavior; Domestic Violence (+ 5) Domestic Violence (+ 5) Domestic Violence (+ 5) Individual or group aggressive behavior which is socially non-acceptable, turbulent, and often destructive. It is precipitated by frustrations, hostility, prejudices, etc. Aggression (66-67); Psychology, Social (66-67) BLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISNSUTDTHURUSVI ,Z  =0 m8LVinyl Compounds D02.455.326.271.884 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes Polyvinyls (+ 5); Vinyl Chloride specific component in the molecule (7l-73); Alkenes (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ]r8g*H:Vinyl Chloride D02.455.326.271.884.750; D02.455.526.439.975; D26.191.962 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Vinyl Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Miscellaneous Drugs and Agents (Non MeSH); Carcinogens A gas which has been used as an aerosol propellant and is the starting material for polyvinyl resins. Toxicity studies have shown various adverse effects, particularly the occurrence of liver neoplasms. Hydrocarbons, Chlorinated (74); Vinyl Compounds (74) _A.)?Vindesine D03.132.934.830; D22.204.179.899.820 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Vinca Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Vinca Alkaloids 23-Amino-O(4)-deacetyl-23-demethoxyvincaleukoblastine. Vinblastine derivative with antineoplastic activity against acute leukemia, lung cancer, carcinoma of the breast, squamous cell carcinoma of the esophagus, head, and neck, and Hodgkin's and non-Hodgkin's lymphomas. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols. Vinblastine/analogs and derivatives (80-85); Vinca Alkaloids (73-79) b *:QVinculin D12.776.220.990 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins A cytoskeletal protein associated with cell-cell and cell-matrix interactions. The amino acid sequence of human vinculin has been determined. The protein consists of 1066 amino acid residues and its gene has been assigned to chromosome 10. Cytoskeletal Proteins (90-91); Muscle Proteins (80-89) eu H^AVincristine D03.132.934.817; D22.204.179.899.817 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Vinca Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Vinca Alkaloids g*<Vincamine D03.132.934.750; D18.918.935 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Vinca Alkaloids Cardiovascular Agents; Vasodilator Agents 14,15-Dihydro-14 beta-hydroxy-(3 alpha,16 alpha)eburnamenine-14-carboxylic acid methyl ester. Major alkaloid of Vinca minor L., Apocynaceae. Used therapeutically as a vasodilator and antihypertensive agent; particularly effective in cerebrovascular disorders. Synonyms: Arteriovinca, Perval, Pervincamine, Vincapront. Alkaloids (66-72); Vinca Alkaloids (73-78) i ":kg4Vinca Alkaloids D03.132.934; D22.204.179.899 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Vinblastine; Vincamine; Vincristine; Vindesine Vinblastine; Vincristine; Vindesine Alkaloids (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  k":a<Vinblastine D03.132.934.650; D22.204.179.899.650 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Vinca Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Vinca Alkaloids m*<Vimentin D12.776.220.475.900 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Intermediate Filament Proteins An intermediate filament protein found in most differentiating cells, in cells grown in tissue culture, and in certain fully differentiated cells. Its insolubility suggests that it serves a structural function in the cytoplasm. MW 52,000. Intermediate Filament Proteins (83-84); Muscle Proteins (66-82) n HKViloxazine D03.383.533.640.900; D14.100.050.600.050.960; D14.100.600.050.960; D15.085.025.960; D15.700.122.050.960 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines; Morpholines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation A morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE. Ethers (72-75); Morpholines (76); Oxazines (72-75) qds:l?Vietnam Z01.252.145.945 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern u >Videotape Recording L01.178.147.846.734; L01.178.147.898.840; L01.240.940.840; L01.240.960.880 CLECHIISLJMTSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Tape Recording Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Television Information Science; Copying Processes; Tape Recording Information Science; Copying Processes; Video Recording Recording of visual and sometimes sound signals on magnetic tape. v6THOVideodisc Recording L01.178.147.668.800; L01.178.147.898.800; L01.240.960.800 CLECHIISLJMTSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Optical Storage Devices Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Television Information Science; Copying Processes; Video Recording Compact Disks (+ 1) Compact Disks (+ 1) Compact Disks (+ 1) The storing of visual and usually sound signals on discs for later reproduction on a television screen or monitor. Audio-Visual Aids (66-83); Videotape Recording (74-83)  xvAJAVideo Recording L01.240.960 CLECHIISLJMTSDSNSTTDUT Information Science; Copying Processes Videodisc Recording (+ 2); Videotape Recording The storing or preserving of video signals for television to be played back later via a transmitter or receiver. Recordings may be made on magnetic tape or discs (VIDEODISC RECORDING). Videotape Recording (74-83)  {;.9!Vidarabine D13.570.065.950; D13.570.583.138.900; D20.388.975; D26.087.975 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Arabinonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Anti-Infective Agents; Antiviral Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites  Arabinofuranosyladenine Monophosphate Arabinofuranosyladenine Monophosphate 9-beta-D-Arabinofuranosyladenine. A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the vaccinia virus and varicella zoster virus. Adenine (72-74); Arabinose (72-74); Nucleosides (72-74); Purines (66-73)  }H@ITYVictoria Z01.338.740 EHEP Geographicals (Non MeSH); Australia A state in southeastern AUSTRALIA. Australia (66-87) a ,+Vibrissae A13.950 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPSRARERITRULUSVI Animal Terms (Non MeSH) Stiff hairs projecting from the face around the nose of most mammals, acting as touch receptors. Afferent Pathways (76-84); Hair (66-84); Mechanoreceptors (71-84)   2tOVibrionaceae B03.440.450.900 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods Aeromonas (+ 1); Photobacterium; Plesiomonas; Vibrio (+ 2) A family of gram-negative bacteria usually found in fresh or sea water, occasionally in fish or man. Bacteria (66-74); Pseudomonadaceae (75); Spirillaceae (75)  j"XIyGVibrio parahaemolyticus B03.440.450.900.859.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae; Vibrio A species of bacteria found in the marine environment, sea foods, and the feces of patients with acute enteritis. Vibrio (66-75) ;"rVibrio Infections C01.252.400.959 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Cholera Infections with bacteria of the genus VIBRIO. Vibrio (66-67)  Ps 8Vibrio cholerae B03.440.450.900.859.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Cholera Toxin Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae; Vibrio The etiologic agent of CHOLERA. Vibrio (66-71)  5"r(Vibrio B03.440.450.900.859 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae Vibrio cholerae; Vibrio parahaemolyticus A genus of VIBRIONACEAE, made up of short, slightly curved, motile, gram-negative rods. Various species produce cholera and other gastrointestinal disorders as well as abortion in sheep and cattle. p "h0Vibration H01.671.963 AETU Physical Sciences (Non MeSH); Physics Y /Veterinary Service, Military G02.956.858 CLECHIISLJMAMTOGSNSTTD Health Occupations; Veterinary Medicine "/Veterinary Medicine G02.956 CLECHIISMAMTOGSNSTTD Animal Diseases; Animal Technicians; Laboratory Animal Science Animal Husbandry Health Occupations Pathology, Veterinary; Surgery, Veterinary; Veterinary Service, Military The medical science concerned with the prevention, diagnosis, and treatment of diseases in animals. CLECEDHIISLJMAMTOGSNSTTD (d JTuVeterinarians M01.526.485.905; N02.360.905 CLECHILJOGPXSDSNSTTDUT Animal Technicians Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Persons trained and authorized to practice veterinary medicine and surgery; doctors of veterinary medicine (D.V.M.). (Dorland, 27th ed). Veterinary Medicine (66-94)  -"!Veterans Disability Claims N03.219.521.346.733 CLECHILJOGSNSTTDUT Disability Evaluation Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government Disorders claimed as a result of military service. + u>Veterans M01.930 CLEDHILJPXSN Military Personnel Named Groups (Non MeSH) Former members of the armed services. l  /Vestibuloplasty E04.833.800.950; E06.892.800.950 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic Those procedures designed to widen the zone of attached gingiva and deepen the vestibular depth which will facilitate the clearance of the area for natural food passage, and provide access for toothbrushing and interdental stimulation. Surgery, Oral (66-67) &$Vestibule A09.246.631.909 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth Oval Window; Saccule and Utricle (+ 3); Vestibular Aqueduct (+ 2) A small, oval, bony chamber of the labyrinth. The vestibule contains the utricle and saccule, organs which are part of the balancing apparatus of the ear. Y :%RVestibular Nuclei A08.186.211.132.810.450.733 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon; Pons The four cellular masses in the floor of the fourth ventricle giving rise to a widely dispersed special sensory system. (From Dorland, 27th ed).  6bVestibular Nerve A08.800.800.120.090.900 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Acoustic Nerve The vestibular part of the acoustic (8th cranial) nerve. The vestibular nerve fibers arise from neurons of Scarpa's ganglion and project peripherally to vestibular hair cells and centrally to the vestibular nuclei of the brain stem. These fibers mediate the sense of balance and head position. 8nYVestibular Function Tests E01.276.299.816 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH) Caloric Tests; Electronystagmography AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE "_+&Vestibular Diseases C09.218.568.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases Motion Sickness (+ 1); Vertigo Diseases of the vestibule, the part of the inner ear that contains organs involved with balance. Labyrinth Diseases (66-89)  %NJ(t Vestibular Aqueduct A09.246.631.909.957 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule Endolymphatic Duct (+ 1) A small bony canal linking the vestibule of the inner ear to the posterior part of the internal surface of the petrous temporal bone. It surrounds the endolymphatic duct. Vestibular Apparatus (66-78)  :2"Vesiculovirus B04.820.455.750.900; B04.909.777.455.750.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Rhabdoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Rhabdoviridae Vesicular Stomatitis-Indiana Virus Vesicular Stomatitis-Indiana Virus A genus of the family RHABDOVIRIDAE that infects a wide range of vertebrates and invertebrates. The type species is VESICULAR STOMATITIS-INDIANA VIRUS. Rhabdoviridae (79-93)  2NVesicular Stomatitis-Indiana Virus B04.820.455.750.900.900; B04.909.777.455.750.900.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Rhabdoviridae; Vesiculovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Rhabdoviridae; Vesiculovirus The type species of VESICULOVIRUS causing a disease symptomatically similar to foot-and-mouth disease in cattle, horses, and pigs. It may be transmitted to other species including humans, where it causes influenza-like symptoms. (: Vesicular Exanthema of Swine Virus B04.820.095.250.900; B04.909.777.162.250.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Caliciviridae; Calicivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Caliciviridae; Calicivirus The type species of the genus CALICIVIRUS, an RNA virus infecting pigs. The resulting infection is an acute febrile disease which is clinically indistinguishable from FOOT AND MOUTH DISEASE. Transmission is by contaminated food. Caliciviridae (78-93); Picornaviridae (66-78) X*2 6Vesicular Exanthema of Swine C02.782.160.927; C22.905.927 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Caliciviridae Infections Animal Diseases; Swine Diseases A calicivirus infection of swine characterized by hydropic degeneration of the oral and cutaneous epithelia. Swine Diseases (66-70); Virus Diseases/veterinary (66-70) #"J}EVesicovaginal Fistula C12.777.103.187.733; C12.777.850.312.733; C13.371.894.763.816; C23.439.731.312.733; C23.439.775.816 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases; Bladder Fistula Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Fistula; Bladder Fistula Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases; Vaginal Fistula Symptoms and General Pathology (Non MeSH); Fistula; Urinary Fistula; Bladder Fistula Symptoms and General Pathology (Non MeSH); Fistula; Vaginal Fistula An abnormal passage between the bladder and the vagina. oN.DVesico-Ureteral Reflux C12.777.103.920 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases The passage of urine from the bladder back into a ureter. (Dorland, 27th ed). 7NcaVertigo C09.218.568.900.883; C10.597.951; C23.888.592.958 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases; Vestibular Diseases Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations An illusion of movement, either of the external world revolving around the patient or of the patient himself revolving in space. Vertigo is not the same as dizziness, which is a disturbed sense of relation to space.  9NVertical Dimension E06.276.459.733 Dentistry; Dental Occlusion; Dental Occlusion, Centric `AVertebrobasilar Insufficiency C10.228.140.300.459.956; C14.907.253.956 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Ischemia Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Obstruction or stenosis of the vertebral-basilar system manifested by disturbances of consciousness, vertigo, headache, hemi- or quadriplegia, dysarthria, and facial paralysis. Basilar Artery (66-79); Cerebrovascular Disorders (66-79); Vertebral Artery (66-79) ".NcVertebrates B02 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Amphibia (+ 26); Animals (+ 38); Birds (+ 13); Disease Vectors; Fishes (+ 41); Mammals (+ 164); Reptiles (+ 17) ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI &(Vertebrate Viruses (Non MeSH) B04.909 Viruses Blood-Borne Pathogens; DNA Viruses (+ 107); Oncogenic Viruses (+ 68); RNA Viruses (+ 231) CHCLDEENGDGEIMIPMEPHPYREUL $  oVertebral Artery A07.231.114.955 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The first branch of the subclavian artery with distribution to muscles of the neck, vertebrae, spinal cord, cerebellum and interior of the cerebrum. 88Version, Fetal E04.819.774.457.927 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery $lVero Cells A11.251.210.955 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line A cell line derived from the kidney of the African green (vervet) monkey, Cercopithecus aethiops; used primarily in virus replication studies and plaque assays. Cell Line (69-86); Cercopithecus (75-80); Cercopithecus aethiops (81-86); Kidney (66-86) *+kVernix Caseosa A12.838.946; A16.378.857 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH) Embryonic Structures (Non MeSH); Fetus An unctuous substance composed of sebum and desquamated epithelial cells, which covers the skin of the fetus. "rVermont Z01.107.567.875.100.907; Z01.107.567.875.600.595.907 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); New England $ : Verbal Learning F02.463.425.952 CLDEPHRE Language Disorders Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Paired-Associate Learning; Serial Learning Learning to respond verbally to a verbal stimulus cue.   Z2CVerbal Behavior F01.145.209.908 CLDEPHRE Language Disorders; Speech Disorders Speech Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Speech (+ 1) Includes both producing and responding to words, either written or spoken. $ , RYVeratrum Alkaloids D03.132.920; D18.162.955 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Cardiovascular Agents; Antihypertensive Agents Cevanes (+ 4) Protoveratrines Alkaloids with powerful hypotensive effects isolated from American or European Hellebore (Veratrum viride Ait. Liliaceae and Veratrum album L. Liliaceae). They increase cholinergic and decrease adrenergic tone with appropriate side effects and at higher doses depress respiration and produce cardiac arrhythmias; only the ester alkaloids have been used as hypotensive agents in specific instances. Veratrum (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $58\$<Veratrum B06.560.965; B06.660.932 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic A genus of coarse herbs of the lily family with poisonous roots that contain many alkaloids and are used as emetics, parasiticides, antihypertensives, and other drugs. The specific chemicals isolated from Veratrum viride or V. album are VERATRUM ALKALOIDS. m &:,Veratrine D03.132.920.256.815; D03.549.256.815 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Veratrum Alkaloids; Cevanes Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Cevanes Veratridine Veratridine F *:Veratridine D03.132.920.256.815.850; D03.549.256.815.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Veratrum Alkaloids; Cevanes; Veratrine Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Cevanes; Veratrine 3-Veratroylveracevine. One of the components in the veratrine mixture of alkaloids. Found in the seed of Schoenocaulon officinale and in rhizome of Veratrum album L., Liliaceae. Veratrine (73-74) ĝ2:Verapamil D02.092.471.683.953; D18.097.953; D18.192.953; D18.918.173.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers Gallopamil Gallopamil Gallopamil Gallopamil 5[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)isopropyl-valeronitrile. Blocks the transmembrane carrier of calcium and uncouples excitation from contraction, especially in smooth and cardiac muscle.  H:2Venus H01.091.800.700.900 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The second planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system. Extraterrestrial Environment (66-90); Planets (91-94)  M?Venules A07.231.432.952; A07.231.908.952 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Microcirculation Cardiovascular System; Blood Vessels; Veins The minute vessels that collect blood from the capillary plexuses and join together to form veins. Veins (66-77) K &8svVenturicidins D02.540.800; D08.373.936.955 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Lactones Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents Toxic substances isolated from various strains of Streptomyces. They are 20-membered macrolides that inhibit oxidative phosphorylation and mitochondrial ATPases. Venturicidins A and B are glycosides. Used mainly as tools in the study of mitochondrial function. Antibiotics, Antifungal (73-76); Glycosides (73-74); Lactones (73-76); Rhamnose (73-74) ":.iVentromedial Hypothalamic Nucleus A08.186.211.730.385.357.352.953 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Middle A nucleus of the middle hypothalamus, the largest cell group of the tuberal region with small-to-medium size cells. Hypothalamus (66-82); Hypothalamus, Middle (75-82) ϕ'#6<Ventriculostomy E04.035.188.957; E04.530.188.957 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cisterna Magna; Cerebral Ventricles Surgery, Operative; Anastomosis, Surgical; Cerebrospinal Fluid Shunts Surgery, Operative; Neurosurgery; Cerebrospinal Fluid Shunts Surgical creation of an opening in a cerebral ventricle. Cerebral Ventricles/surgery (66-87); Cerebrospinal Fluid Shunts (72-87)  ф&$+ETVentriculoperitoneal Shunt E04.035.188.850; E04.530.188.850 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Anastomosis, Surgical; Cerebrospinal Fluid Shunts Surgery, Operative; Neurosurgery; Cerebrospinal Fluid Shunts Surgical creation of a communication between a cerebral ventricle and the peritoneum by means of a plastic tube to permit drainage of cerebrospinal fluid for relief of hydrocephalus. (Dorland, 27th ed). Cerebrospinal Fluid Shunts (69-92) f&$)Ventriculography, First-Pass E01.145.077.805.902.950; E01.145.569.820.950; E01.289.806.800.902.950; E01.357.820.800.902.950 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Gated Blood-Pool Imaging Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography; Radionuclide Angiography; Radionuclide Ventriculography Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Radionuclide Ventriculography Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging; Radionuclide Angiography; Radionuclide Ventriculography Diagnosis; Diagnostic Imaging; Radionuclide Imaging; Radionuclide Angiography; Radionuclide Ventriculography Radionuclide ventriculography where a bolus of radionuclide is injected and data are recorded from one pass through the heart ventricle. Left and right ventricular function can be analyzed independently during this technique. First-pass ventriculography is preferred over GATED BLOOD-POOL IMAGING for assessing right ventricular function. Heart (77-89); Heart Ventricle (77-89); Radionuclide Angiography (83-89)  դ!h&WVentricular Septal Rupture C14.280.470.475.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Rupture; Heart Rupture, Post-Infarction Rupture of the intraventricular septum of the heart, usually secondary to myocardial infarction. Heart Rupture (78-90); Heart Rupture, Post-Infarction (91-94); Rupture, Spontaneous (68-77) k NeqlVentricular Pressure G09.330.612.977; G09.330.970.950 DEGEIMPHRE Heart Ventricle Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Ventricular Function The pressure within a cardiac ventricle. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques (e.g., Doppler echocardiography). The information is useful in evaluating the function of the myocardium, cardiac valves, and pericardium, particularly with simultaneous measurement of other (e.g., aortic or atrial) pressures. Y&Ventricular Outflow Obstruction C14.280.955 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Occlusion of the ventricular outflow or inflow tract on either side of the heart. It may result from a congenital defect or predisposing heart disease, or as a complication of surgery or tumors of the heart or its vessels. Heart Ventricle (66-87) ߡ%N/ Ventricular Function, Right G09.330.970.900 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Ventricular Function The hemodynamic and electrophysiological action of the right ventricle. Heart/physiology (66-90); Heart Ventricle/physiology (68-90) !THVentricular Function, Left G09.330.970.800 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Ventricular Function The hemodynamic and electrophysiological action of the left ventricle. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Heart/physiology (66-90); Heart Ventricle/physiology (68-90) ) HVentricular Function G09.330.970 DEGEIMPHRE Heart Function Tests Heart Ventricle Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Ventricular Function, Left; Ventricular Function, Right; Ventricular Pressure The hemodynamic and electrophysiological action of the ventricles. Heart/physiology (66-90); Heart Ventricle/physiology (68-90) (kjZNHVentricular Fibrillation C14.280.067.932 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia \N=Ventricular Dysfunction, Right C14.280.945.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Ventricular Dysfunction A condition in which the right ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the right ventricular wall. 6$NKVentricular Dysfunction, Left C14.280.945.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Ventricular Dysfunction A condition in which the left ventricle of the heart exhibits a decreased functionality. This decreased function could lead to congestive heart failure or myocardial infarction, among other cardiovascular diseases. Diagnostic measurements that indicate this condition include a diminished ejection fraction and a depressed level of motility of the left ventricular wall. #NKVentricular Dysfunction C14.280.945 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Ventricular Dysfunction, Left; Ventricular Dysfunction, Right A condition in which the ventricles of the heart exhibit a decreased functionality. uN/GdVentral Tegmental Area A08.186.211.132.659.822.820 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon; Tegmentum Mesencephali A region in the mesencephalon which is dorsomedial to the substantia nigra and ventral to the red nucleus. The mesocortical and mesolimbic dopaminergic systems originate here, including an important projection to the nucleus accumbens. Overactivity of the cells in this area has been suspected to contribute to the positive symptoms of schizophrenia. Mesencephalon (68-70); Tegmentum Mesencephali (71-93) 8s?Ventilators, Negative-Pressure E07.950.500 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Ventilators, Mechanical Body ventilators that assist ventilation by applying intermittent subatmospheric pressure around the thorax, abdomen, or airway and periodically expand the chest wall and inflate the lungs. They are relatively simple to operate and do not require tracheostomy. These devices include the tank ventilators ("iron lung"), Portalung, Pneumowrap, and chest cuirass ("tortoise shell"). Respiration, Artificial (66-89); Ventilators, Mechanical (66-89) #8KVentilators, Mechanical E07.950 AECLCTECHISDSNSTTDUTVE Respiration, Artificial Equipment and Supplies Ventilators, Negative-Pressure Mechanical devices used to produce or assist pulmonary ventilation.   #PVentilator Weaning E02.880.820.950 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy; Respiration, Artificial Techniques for effecting the transition of the respiratory-failure patient from mechanical ventilation to spontaneous ventilation, while meeting the criteria that tidal volume be above a given threshold (greater than 5 ml/kg), respiratory frequency be below a given count (less than 30 breaths/min), and oxygen partial pressure be above a given threshold (PaO2 greater than 50mm Hg). Weaning studies focus on finding methods to monitor and predict the outcome of mechanical ventilator weaning as well as finding ventilatory support techniques which will facilitate successful weaning. Present methods include intermittent mandatory ventilation, intermittent positive pressure ventilation, and mandatory minute volume ventilation. Respiration (66-88); Respiration, Artificial (66-88) "DG>Ventilation-Perfusion Ratio E01.302.796.568.862; G09.772.521.900.602.953 DEGEIMPHRE Pulmonary Circulation Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Pulmonary Gas Exchange Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Transport; Pulmonary Gas Exchange Respiratory Function Tests (66-67)  2$)Ventilation G03.230.150.520 ECISLJMTSNST Environment and Public Health (Non MeSH); Environment; Environment, Controlled ]Venous Pressure G09.330.612.114.732 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Blood Pressure Central Venous Pressure; Portal Pressure The blood pressure in a vein. It is usually measured to assess the filling pressure to the ventricle. Blood Pressure (66-69); Veins (66-69)  o1|/Venous Insufficiency C14.907.952 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Postphlebitic Syndrome Inadequacy of the venous valves and impairment of venous return (venous stasis) usually from the legs, often with edema and sometimes with stasis ulcers at the ankle. Vascular Diseases (66-72)  =N2Venous Cutdown E04.752.814.895 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Catheterization, Central Venous; Catheterization Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Creation of a small incised opening in a vein to permit the passage of a needle or cannula for withdrawal of blood, administration of medication, or in diagnostic or therapeutic catheterization. (Dorland, 27th ed.; Stedman, 25th ed.). $8VVenoms A12.838.935; D24.185.965 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Antivenins Fluids and Secretions (Non MeSH); Secretions (Non MeSH) Immunologic and Biologic Factors (Non MeSH); Biological Factors  Amphibian Venoms (+ 4); Arthropod Venoms (+ 7); Cnidarian Venoms; Fish Venoms; Mollusk Venoms (+ 1); Snake Venoms (+ 12) Poisonous animal secretions forming fluid mixtures of many different enzymes, toxins, and other substances. These substances are produced in specialized glands and secreted through specialized delivery systems (nematocysts, spines, fangs, etc.) for disabling prey or predator. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $$ <>JVenezuela Z01.107.757.943 EHEP Geographicals (Non MeSH); America; South America s <Venereology G02.403.776.680 CLECEDHIISLJMAMTOGSNSTTD Sexually Transmitted Diseases Health Occupations; Medicine; Specialties, Medical A branch of medicine which deals with sexually transmitted disease. Venereal Diseases (66-82)  #<QVenereal Tumors, Veterinary C04.588.945.956; C22.950 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms Animal Diseases Tumors most commonly seen on or near the genitalia. They are venereal, most likely transmitted through transplantation of cells by contact. Metastases have been reported. Spontaneous regression may occur. Dog Diseases (66-78); Neoplasms (66-78); Venereal Diseases (66-78) .!R]QVenae Cavae A07.231.908.949 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins Vena Cava, Inferior; Vena Cava, Superior The inferior and superior venae cavae.  8520Vena Cava, Superior A07.231.908.949.815 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Superior Vena Cava Syndrome Cardiovascular System; Blood Vessels; Veins; Venae Cavae The venous trunk which returns blood from the head, neck, upper extremities and chest.  8"EhVena Cava, Inferior A07.231.908.949.648 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins; Venae Cavae The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs.  8EVena Cava Filters E07.450.980 AECLCTECHISDSNSTTDUTVE Thrombophlebitis Equipment and Supplies; Implants, Artificial Mechanical devices inserted in the inferior vena cava that prevent the migration of blood clots from deep venous thrombosis of the leg. Filtration/instrumentation (72-90); Pulmonary Embolism (72-90); Vena Cava, Inferior (72-90)   J5lVelopharyngeal Insufficiency C07.465.525.955; C07.550.966; C07.650.525.955; C09.775.955; C16.131.850.525.955 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Speech Disorders Stomatognathic Diseases; Mouth Diseases; Mouth Abnormalities Stomatognathic Diseases; Pharyngeal Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Otorhinolaryngologic Diseases; Pharyngeal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Failure of the soft palate to reach the posterior pharyngeal wall. It may be caused by cleft palate surgery, palatal or pharyngeal abnormalities or injury, or neuromuscular dysfunction of the velopharyngeal sphincter. It causes hypernasality of speech. Cleft Palate (66-77); Palate (66-77); Pharynx (66-77)   ![N'CVeins A07.231.908 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Phlebography Cardiovascular System; Blood Vessels Axillary Vein; Azygos Vein; Brachiocephalic Veins; Cerebral Veins; Coronary Vessels; Cranial Sinuses (+ 1); Femoral Vein; Hepatic Veins; Iliac Vein; Jugular Veins; Popliteal Vein; Portal System (+ 4); Pulmonary Veins; Renal Veins; Retinal Vein; Saphenous Vein; Subclavian Vein; Venae Cavae (+ 2); Venules The vessels carrying blood toward the heart. consider also terms at PHLEB-. ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $/ 6,s\8Veillonellaceae B03.440.425.400.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Cocci Veillonella A family of gram-negative bacteria that are parasites of warm-blooded animals such as man, ruminants, rodents and pigs, particularly in the alimentary tract. Bacteria (66-74); Neisseriaceae (75)  "p-Veillonella B03.440.425.400.800.814 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Cocci; Veillonellaceae A genus of gram-negative, anaerobic cocci parasitic in the mouth and in the intestinal and respiratory tracts of man and other animals. "Vehicles D26.698.931 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Excipients (+ 3) ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR ] ,I@Vegetarianism E05.272.731; G06.696.384.731 AEECHIPXSN Miscellaneous Techniques (Non MeSH); Diet Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Diet Dietary practice of consuming only vegetables, grains, and nuts. j"MVegetables B06.510.956; J01.341.956 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food Carrots; Cucumbers; Lettuce; Peas; Potatoes; Spinach; Tomatoes Carrots; Cucumbers; Legumes (+ 3); Lettuce; Peas; Potatoes; Rhubarb; Spinach; Tomatoes 4XVegetable Proteins D12.776.256.920; D12.776.765.836 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Proteins which are present in or isolated from vegetables or vegetable products used as food. The concept is distinguished from PLANT PROTEINS which refers to non-dietary proteins from plants. Plant Proteins (66-74) 6&BVecuronium Bromide D04.808.054.040.920; D14.100.120.200.600.937; D16.700.710.575.937 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents Monoquaternary homolog of PANCURONIUM. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other established neuromuscular blocking agents. Androstanes (68-71); Pancuronium/analogs and derivatives (72-86) I:LVectorcardiography E01.145.569.359.731; E01.399.214.731 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Electrocardiography Diagnosis; Electrodiagnosis; Electrocardiography Body Surface Potential Mapping; Polarcardiography Body Surface Potential Mapping; Polarcardiography Recording of the moment-to-moment electromotive forces of the heart on a plane of the body surface delineated as a vector function of time. #*&rVatican City Z01.542.961 EHEP Geographicals (Non MeSH); Europe &@)Vater's Ampulla A03.159.183.079.300.900; A03.492.411.620.270.731 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cholangiopancreatography, Endoscopic Retrograde; Sphincterotomy, Endoscopic; Sphincterotomy, Transhepatic Digestive System; Biliary Tract; Bile Ducts; Bile Ducts, Extrahepatic; Common Bile Duct Digestive System; Gastrointestinal System; Intestines; Intestine, Small; Duodenum Oddi's Sphincter Oddi's Sphincter The dilatation formed by junction of the common bile duct and the pancreatic ducts proximal to their opening into the lumen of the duodenum. (Dorland, 27th ed).  &6:u(Vasovasostomy E04.035.956; E04.887.774.692.956 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Vas Deferens Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Surgery, Urologic, Male (Non MeSH) Surgical anastomosis or fistulization of the spermatic ducts to restore fertility in a previously vasectomized male. Vas Deferens/surgery (66-87)  )&$#Vasotocin D06.472.734.692.881; D12.644.456.925.940; D12.776.641.650.900.900; D14.600.600.920.900 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Vasopressins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Vasopressins Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly, cyclic 1-6 disulfide. The non-mammalian hormone that controls water and salt metabolism. It is the phylogenetic precursor of both antidiuretic hormones and oxytocins and a possible neuroendocrine mediator in mammals. Vasotocin has oxytocic and vasopressor actions. + `FYVasopressins D06.472.734.692.781; D12.644.456.925; D12.776.641.650.900; D14.600.600.920; D19.770.896 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Inappropriate ADH Syndrome; Receptors, Vasopressin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH) Argipressin (+ 1); Lypressin (+ 1); Ornipressin Argipressin; Desmopressin; Felypressin; Lypressin; Ornipressin; Oxytocin; Vasotocin Argipressin; Lypressin; Oxytocin; Vasotocin Argipressin; Lypressin; Oxytocin; Vasotocin Argipressin (+ 1); Lypressin (+ 1); Ornipressin Octapeptide antidiuretic hormones released by the neurohypophysis of all vertebrates (chemical composition varies with species). They control water metabolism and balance by regulating lung, gill, kidney, etc., and water loss, and also contract smooth muscle. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $/cD;?,FVasomotor System A08.800.050.800.900 ABAHCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Baroreflex; Muscle, Smooth, Vascular; Vasoconstrictor Agents; Vasodilator Agents Blood Vessels Nervous System; Peripheral Nervous System; Autonomic Nervous System; Sympathetic Nervous System Pressoreceptors The neural systems which act on vascular smooth muscle to control blood vessel diameter. The major neural control is through the sympathetic nervous system. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI (5K4^p6Vasodilator Agents D18.918 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Vasodilation; Vasomotor System Cardiovascular Agents Amiodarone; Amyl Nitrite; Betahistine; Calcium Channel Blockers (+ 18); Celiprolol; Chromonar; Cyclandelate; Dilazep; Dipyridamole; Doxazosin; Enoximone; Erythrityl Tetranitrate; Fenoldopam; Hexobendine; Iloprost; Isosorbide Dinitrate; Isoxsuprine; Kallidin; Khellin; Lidoflazine; Molsidomine; Moxisylyte; Nafronyl; Nicergoline; Nicotinyl Alcohol; Nitroglycerin; Nitroprusside; Nonachlazine; Nylidrin; Oxyfedrine; Papaverine; Pentaerythritol Tetranitrate; Phenoxybenzamine; Propranolol; Suloctidil; Theobromine (+ 1); Theophylline (+ 2); Tolazoline; Trapidil; Trimetazidine; Vincamine; Xanthinol Niacinate AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  7 8%FVasodilation G09.330.612.955 DEGEIMPHRE Vasodilator Agents Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Dilation of the blood vessels without anatomic change, for which DILATATION, PATHOLOGIC or ANEURYSM (or specific aneurysm) is used. tissue or organ/blood supply (66-77); Vasomotor System (66-77)  ;{LVasoconstrictor Agents, Nasal D18.793.952 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cardiovascular Agents; Vasoconstrictor Agents Naphazoline; Oxymetazoline; Phenylephrine; Phenylpropanolamine Sympathomimetics (66) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  =b#85H:Vasoconstrictor Agents D18.793 ADAEAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Vasoconstriction; Vasomotor System Cardiovascular Agents Angiotensin II (+ 1); Calcium Channel Agonists (+ 1); Dihydroergotamine; Ephedrine; Epinephrine; Ergotamine; Etilefrine; Felypressin; Mephentermine; Metaraminol; Methoxamine; Nordefrin; Ornipressin; Phenylephrine; Sumatriptan; Vasoconstrictor Agents, Nasal (+ 4) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  > 6)5FVasoconstriction G09.330.612.950 DEGEIMPHRE Vasoconstrictor Agents Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Narrowing of the blood vessels without anatomic change, for which CONSTRICTION, PATHOLOGIC is used. specific blood vessel/physiology (66-77); Vascular Resistance (66-77); Vasomotor System (66-77)  A {uqVasoactive Intestinal Peptide D06.472.317.950; D12.644.920; D12.776.641.650.875; D14.600.600.910; D19.316.629.954 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Vasoactive Intestinal Peptide Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones A highly basic, single-chain polypeptide isolated from the intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems. It is also found in several parts of the central and peripheral nervous systems and is a neurotransmitter. Gastrointestinal Hormones (74-76); Peptides (74-76)  B#_F/\=Vasectomy E04.887.774.692.856; E04.887.599.900 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sterilization Reversal Vas Deferens Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Surgery, Urologic, Male (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH); Sterilization, Sexual Vas Deferens/surgery (66-72)  G *$#Vasculitis, Hypersensitivity C14.907.940.910; C20.543.520.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Vasculitis Immunologic Diseases; Hypersensitivity; Immune Complex Diseases Purpura, Schoenlein-Henoch; Vasculitis, Allergic Cutaneous Purpura, Schoenlein-Henoch; Vasculitis, Allergic Cutaneous Heterogeneous group of disorders characterized by a vasculitic syndrome presumed to be associated with a hypersensitivity reaction following exposure to an antigen such as an infectious agent, a drug, or other foreign or endogenous substance (Wilson et al, Harrison's Principles of Internal Medicine, 12th ed, p. 1459). Vasculitis, Allergic Cutaneous (78-94)  I>!&Ns-Vasculitis, Allergic Cutaneous C14.907.940.910.952; C17.800.862.952; C20.543.520.910.952 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Vasculitis; Vasculitis, Hypersensitivity Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular Immunologic Diseases; Hypersensitivity; Immune Complex Diseases; Vasculitis, Hypersensitivity Vasculitis due to allergic reaction, marked by such cutaneous lesions as papules, macules, vesicles, urticarial wheals, purpura, and small ulcers, and accompanied by itching and usually a slight fever and malaise. Purpura (66-77); Skin Diseases (66-77); Skin/blood supply (66-77); Vascular Diseases (66-77) L$AN0qVasculitis C14.907.940 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Aortitis; Arteritis (+ 4); Behcet's Syndrome; Churg-Strauss Syndrome; Mucocutaneous Lymph Node Syndrome; Phlebitis (+ 1); Thromboangiitis Obliterans; Vasculitis, Hypersensitivity (+ 2); Wegener's Granulomatosis Inflammation of a blood vessel. Arteritis (66-77); Periarteritis Nodosa (66-77)  PN2(9Vascular Surgery E04.752.814 AECLCTECEDHIISLJMAMOMTOGPXRHSNSTTDUT Blood Vessels Surgery, Operative; Surgery, Cardiovascular (Non MeSH) Angioplasty (+ 7); Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis; Cerebral Revascularization; Embolectomy; Endarterectomy (+ 1); Peritoneovenous Shunt; Portasystemic Shunt, Surgical (+ 2); Thrombectomy; Venous Cutdown Operative procedures for the treatment of vascular disorders. AECLCTECEDHIISLJMAMIMOMTNUOGPSPXRHSNSTTDUTVEVI $R=(@ I2Vascular Resistance G09.330.612.931 DEGEIMPHRE Blood Vessels; Hypertension Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Capillary Resistance An expression of the resistance offered by the systemic arterioles, and to a lesser extent by the capillaries, to the flow of blood.  T"{Vascular Patency G09.330.950 DEGEIMPHRE Graft Occlusion, Vascular Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) The condition of blood vessels not being blocked or obstructed. Graft Occlusion, Vascular (85-86)  VHjM(Vascular Headache C10.228.140.300.937; C14.907.253.937; C23.888.592.612.429.814 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Headache Cluster Headache; Migraine Cluster Headache; Migraine Cluster Headache; Migraine Throbbing headache due to abnormal pulsation of cranial arteries. WENK_NVascular Fistula (Non MeSH) C14.907.933; C23.439.850 Cardiovascular Diseases; Vascular Diseases Symptoms and General Pathology (Non MeSH); Fistula Arterio-Arterial Fistula; Arteriovenous Fistula Arterio-Arterial Fistula; Arteriovenous Fistula BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Zk"nlNVascular Diseases C14.907 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiology Cardiovascular Diseases Aneurysm (+ 13); Angiodysplasia; Angiomatosis (+ 4); Angioneurotic Edema; Aortic Diseases (+ 8); Arterial Occlusive Diseases (+ 14); Arteriovenous Malformations (+ 2); Arteritis (+ 4); Cerebrovascular Disorders (+ 27); Diabetic Angiopathies (+ 2); Embolism and Thrombosis (Non MeSH) (+ 22); Erythromelalgia; Hemorrhoids; Hepatic Veno-Occlusive Disease; Hypertension (+ 8); Hypotension (+ 2); Ischemia (+ 21); Peripheral Vascular Diseases; Phlebitis (+ 2); Pulmonary Veno-Occlusive Disease; Raynaud's Disease (+ 1); Retinal Vein Occlusion; Scimitar Syndrome; Superior Vena Cava Syndrome; Telangiectasis (+ 3); Varicocele; Varicose Veins (+ 1); Vascular Fistula (Non MeSH) (+ 2); Vasculitis (+ 16); Venous Insufficiency (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  [ NfPVasa Vasorum A07.231.836 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels Nutrient blood vessels which supply the walls of large arteries or veins. `p8,YVasa Nervorum A07.231.765 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels Blood vessels supplying the nerves. ap8,,Vas Deferens A05.360.444.930 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Vasectomy; Vasovasostomy Urogenital System; Genitalia; Genitalia, Male bD:7Variola Virus B04.280.650.160.650.930; B04.909.204.783.160.650.930 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus A species of ORTHOPOXVIRUS causing infections in humans. No infections have been reported since 1977 and the virus is now believed to be virtually extinct. c:Varicose Veins C14.907.927 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Esophageal and Gastric Varices; Sclerosing Solutions; Sclerotherapy Cardiovascular Diseases; Vascular Diseases Varicose Ulcer eNO2Varicose Ulcer C14.907.927.730; C17.800.893.592.730 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Varicose Veins Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Ulcer; Leg Ulcer Ulcer due to varicose veins. Chronic venous insufficiency in the deep veins of the legs leads to shunting the venous return into the superficial veins, in which pressure and flow rate, as well as oxygen content, are increased. fJ*N Varicocele C12.294.936; C14.907.903 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Cardiovascular Diseases; Vascular Diseases A varicose condition of the veins of the pampiniform plexus, forming a swelling that feels like a "bag of worms," appearing bluish through the skin of the scrotum, and accompanied by a constant pulling, dragging, or dull pain in the scrotum. (Dorland, 27th ed). hN7Varicellovirus B04.280.382.100.900; B04.909.204.382.100.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae Herpesvirus 1, Bovine; Herpesvirus 1, Canid; Herpesvirus 1, Cercopithecine; Herpesvirus 1, Equid; Herpesvirus 1, Gallid; Herpesvirus 1, Suid; Herpesvirus 3, Equid; Herpesvirus 3, Human Herpesvirus 1, Bovine; Herpesvirus 1, Canid; Herpesvirus 1, Cercopithecine; Herpesvirus 1, Equid; Herpesvirus 1, Gallid; Herpesvirus 1, Suid; Herpesvirus 3, Equid; Herpesvirus 3, Human A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE. Its species include those causing CHICKENPOX and HERPES ZOSTER in humans (HERPESVIRUS 3, HUMAN), as well as several animal viruses. k2Variation (Genetics) G05.414.918 DEGEIMPHRE Genetics; Genetics, Population Antigenic Variation The phenotypic differences among individuals in a population. Genetics (66-67); Genetics, Population (66-67)  n%I8Variant Surface Glycoproteins, Trypanosoma D12.776.395.550.990; D12.776.543.550.990; D24.611.216.293.900; D24.611.216.301.900 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Protozoan Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface Glycoproteins attached to the surface coat of the trypanosome. Many of these glycoproteins show amino acid sequence diversity expressed as antigenic variations. This continuous development of antigenically distinct variants in the course of infection ensures that some trypanosomes always survive the development of immune response to propagate the infection. Glycoproteins (66-87); Membrane Proteins (77-87) o1\6:Variable Number of Tandem Repeats G05.331.599.110.708.900; G06.184.599.110.708.900 DEGEIMPHRE DNA Fingerprinting Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid Multiple copies of the same DNA sequence lying in series in alleles containing different numbers of tandemly repeated oligonucleotide sequences. Such alleles when cleaved by a specific restriction endonuclease will produce fragments that differ in length. Such restriction-length polymorphisms serve as convenient markers in linkage studies. (From King, Dictionary of Genetics, 4th ed). Repetitive Sequences, Nucleic Acid (85-94)  t)6=2Vanuatu Z01.782.590.736 EHEP Geographicals (Non MeSH); Pacific Islands; Melanesia xk @Vanilmandelic Acid D02.241.223.475.730; D02.241.511.536.730 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Mandelic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Mandelic Acids Mandelic Acids (66-67) x.:Vanillic Acid D02.241.223.106.505.850; D02.241.511.390.850; D02.755.410.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids z{E:,Vancomycin D20.085.116.095.900 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Antibiotics, Glycopeptide Vancomycin. Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. |W<`Vanadium Compounds D01.960 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Vanadates Inorganic compounds that contain vanadium as an integral part of the molecule. Vanadium (66-93)  ~ 8% ^Vanadium D01.268.912.950; D01.552.931 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Vanadium. A metallic element with the atomic symbol V, atomic number 23, and atomic weight 50.94. It is used in the manufacture of vanadium steel. Prolonged exposure can lead to chronic intoxication caused by absorption usually via the lungs. H ":s Vanadates D01.248.497.158.952; D01.960.960 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Vanadium Compounds Oxyvanadium ions in various states of oxidation. They act primarily as ion transport inhibitors due to their inhibition of Na(+)-, K(+)-, and Ca(+)-ATPase transport systems. They also have insulin-like action, positive inotropic action on cardiac ventricular muscle, and other metabolic effects. Vanadium (66-87) f &8]Valyl T RNA Synthetase D08.586.464.136.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates valine with its specific transfer RNA. EC 6.1.1.9. Amino Acyl T RNA Synthetases (72-74); Valine (72-74) Ft\AValsalva's Maneuver E01.145.569.936; E01.302.796.822; G09.330.612.925; G09.772.521.700.875 DEGEIMPHRE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Forced expiratory effort against a closed airway. It is used to study cardiovascular effects of increased peripheral venous pressure and decreased cardiac filling and output. PValproic Acid D02.241.081.465.895.593.900; D02.241.081.944.509.900; D08.373.966; D10.516.251.400.895.593.900; D15.080.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Valerates; Pentanoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Valerates; Pentanoic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Valerates; Pentanoic Acids Central Nervous System Agents; Anticonvulsants 2-Propylpentanoic acid. A fatty acid with anticonvulsant properties used in the treatment of epilepsy. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GABA levels in the brain or by altering the properties of voltage dependent sodium channels. Valerates (66-74) w:RValinomycin D08.373.936.500.900; D20.085.116.885 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Ionophores Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Valinomycin. A cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately to form a 36-membered ring. (From Merck Index, 11th ed). Antibiotics (66-70) $*<cValine D12.125.142.930; D12.125.070.950 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Branched-Chain  2-Amino-5-phosphonovalerate  &F Valerian B06.560.956 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Valeriana officinale, an ancient, sedative herb of the large family Valerianaceae. The roots were formerly used to treat hysterias and other neurotic states and are presently used to treat sleep disorders. s & Valerates D02.241.081.465.895; D02.241.081.944; D10.516.251.400.895 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile Pentanoic Acids (+ 2) Pentanoic Acids (+ 2); Proadifen Pentanoic Acids (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  A81^:Vagus Nerve A08.800.050.050.925; A08.800.050.600.825; A08.800.800.060.920; A08.800.800.120.900 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Vagotomy Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Autonomic Nervous System; Parasympathetic Nervous System Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves Laryngeal Nerves (+ 1); Nodose Ganglion Laryngeal Nerves (+ 1); Nodose Ganglion Laryngeal Nerves (+ 1); Nodose Ganglion Laryngeal Nerves (+ 1); Nodose Ganglion The tenth cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx).  ^\8 Vagotomy, Truncal E04.530.324.084.700.850.850; E04.530.324.906.960 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation; Parasympathectomy; Vagotomy Surgery, Operative; Neurosurgery; Denervation; Vagotomy Bilateral dissection of the abdominal branches of the vagus nerve. It is used frequently in the surgical management of duodenal and gastric ulcers, as well as in physiologic studies of gastrointestinal secretion and motility. Vagotomy (66-88) 6$Vagotomy, Proximal Gastric E04.530.324.084.700.850.750; E04.530.324.906.952 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation; Parasympathectomy; Vagotomy Surgery, Operative; Neurosurgery; Denervation; Vagotomy Vagal denervation of that part of the stomach lined with acid secreting mucosa. Since the procedure leaves the vagal branches to the antrum and pylorus intact, it circumvents gastric drainage required with truncal vagotomy techniques. Duodenal Ulcer/surgery (66-80); Vagotomy (66-80) z 6$;Vagotomy E04.530.324.084.700.850; E04.530.324.906 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Vagus Nerve Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation; Parasympathectomy Surgery, Operative; Neurosurgery; Denervation Vagotomy, Proximal Gastric; Vagotomy, Truncal Vagotomy, Proximal Gastric; Vagotomy, Truncal The interruption or removal of any part of the vagus (10th cranial) nerve. Vagotomy may be performed for research or for therapeutic purposes.   .$jVaginosis, Bacterial C01.252.954; C13.371.894.906.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases; Vaginitis Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli. Bacterial Infections (83-91); Vaginitis (83-91) _&PN9Vaginitis C13.371.894.906 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases Trichomonas Vaginitis; Vaginosis, Bacterial; Vulvovaginitis Inflammation of the vagina characterized by pain and a purulent discharge. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  o N}EYPVaginal Smears E01.223.230.730; E01.223.894.895; E01.249.917 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Cytodiagnosis Diagnosis; Diagnosis, Laboratory; Specimen Handling Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Collection of pooled secretions of the posterior vaginal fornix for cytologic examination. s5"jVaginal Neoplasms C04.588.945.418.955; C13.371.270.937; C13.371.820.800.418.937; C13.371.894.834 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases  XX Vaginal Fistula C13.371.894.763; C23.439.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases Symptoms and General Pathology (Non MeSH); Fistula Rectovaginal Fistula; Vesicovaginal Fistula Rectovaginal Fistula; Vesicovaginal Fistula An abnormal passage communicating with the vagina. "Nd=Vaginal Diseases C13.371.894 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Candidiasis, Vulvovaginal; Dyspareunia; Hematocolpos; Leukorrhea; Vaginal Fistula (+ 2); Vaginal Neoplasms; Vaginitis (+ 3) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI NhZVaginal Creams, Foams and Jellies D26.394.225.970 ADAEANCHCLCTDUECHIIPMEPDPKPORESDSTTOTU Administration, Intravaginal; Contraceptive Agents, Female Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Medicated dosage forms for topical application in the vagina. A cream is a semisolid emulsion containing suspended or dissolved medication; a foam is a dispersion of a gas in a medicated liquid resulting in a light, frothy mass; a jelly is a colloidal semisolid mass of a water soluble medicated material, usually translucent. The concept includes vaginal creams, foams and jellies in general or for which there is no other specific heading. Dosage Forms (66-74)  )*CM Vaginal Birth after Cesarean E04.819.774.457.900 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cesarean Section Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery Delivery of an infant through the vagina in a female who has had a prior cesarean section. Cesarean Section (80-90); Delivery (80-90); Labor (80-87)  G#$loGVagina A05.360.319.779 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Colposcopy Urogenital System; Genitalia; Genitalia, Female Hymen consider also terms at COLPO-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $ 89 ':Vacuum Extraction, Obstetrical E04.819.774.457.392.729 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery; Extraction, Obstetrical <$$Vacuum Curettage E04.157.310.970; E04.819.608.310.970 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Curettage; Dilatation and Curettage Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH); Dilatation and Curettage Aspiration of the contents of the uterus with a vacuum curette. F*$NVacuum G03.230.300.100.185.902; H01.671.691.902 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Atmospheric Pressure Physical Sciences (Non MeSH); Physics; Pressure A space in which the pressure is far below atmospheric pressure so that the remaining gases do not affect processes being carried on in the space.  .Vacuoles A11.368.702.929 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Any spaces or cavities within a cell. They may function in digestion, storage, secretion, or excretion.  *$|Vaccinia Virus B04.280.650.160.650.900; B04.909.204.783.160.650.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against smallpox. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of vaccinia virus. :>Vaccinia C02.256.743.929 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections The cutaneous and occasional systemic reactions associated with vaccination using smallpox (variola) vaccine. 2 PU~Vaccines, Synthetic D12.776.828.868; D24.310.894.865; D24.611.216.865 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPORESDSTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens ISCOMs; Malaria Vaccines ISCOMs; Malaria Vaccines; Vaccines, Conjugate ISCOMs; Malaria Vaccines; Vaccines, Conjugate Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens (66-86) ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR $98BVaccines, Inactivated D24.310.894.830 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. Vaccines, Attenuated (73-88) bBYD"Vaccines, Conjugate D24.310.894.865.900; D24.611.216.865.900 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPORESTTOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Vaccines, Synthetic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Vaccines, Synthetic Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. vaccine components/immunology (84-93); Vaccines, Synthetic (88-93) ķ.6NVaccines, Combined D24.310.894.815 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines Diphtheria-Tetanus-Pertussis Vaccine Two or more vaccines in a single dosage form. OBY):Vaccines, Attenuated D24.310.894.811 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. specific vaccine (66-72); Vaccines (66-72) ɞBYU4Vaccines D24.310.894 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOUR Immunologic and Biologic Factors (Non MeSH); Biological Products Bacterial Vaccines (+ 11); Fungal Vaccines; Protozoan Vaccines (+ 1); Vaccines, Attenuated; Vaccines, Combined (+ 1); Vaccines, Inactivated; Vaccines, Synthetic (+ 3); Viral Vaccines (+ 12) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  @MFVaccination E02.095.520.400.530.890; G03.770.670.310.890; G03.850.780.200.425.900 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunization; Immunotherapy, Active Environment and Public Health (Non MeSH); Preventive Medicine; Primary Prevention; Immunization Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Immunization Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. M$}Uzbekistan Z01.252.100.975; Z01.586.200.975; Z01.586.950.975 EHEP Geographicals (Non MeSH); Asia; Asia, Central Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR 9Uvula A14.549.617.780.729 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Mouth; Palate; Palate, Soft > :>Uveoparotid Fever C15.604.515.827.865; C23.484.739.865 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Sarcoidosis Symptoms and General Pathology (Non MeSH); Granuloma; Sarcoidosis A manifestation of sarcoidosis marked by chronic inflammation of the parotid gland and the uvea. *NsUveomeningoencephalitic Syndrome C10.228.140.437.615.729; C10.228.228.245.615.729; C10.228.228.553.729; C11.941.879.980 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis; Meningoencephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis; Meningoencephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningoencephalitis Eye Diseases; Uveal Diseases; Uveitis Disease characterized by bilateral uveitis with iritis and secondary glaucoma, premature alopecia, symmetrical vitiligo, and hearing disorders, and accompanied by meningeal signs. %`NUveitis, Suppurative C01.252.354.900; C01.539.375.725; C11.294.900; C11.941.879.960 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections Eye Diseases; Eye Infections Eye Diseases; Uveal Diseases; Uveitis Endophthalmitis Endophthalmitis; Panophthalmitis Endophthalmitis; Panophthalmitis Endophthalmitis; Panophthalmitis Intraocular infection caused mainly by pus-producing bacteria and rarely by fungi. The infection may be caused by an injury or surgical wound (exogenous) or by endogenous septic emboli in such diseases as bacterial endocarditis or meningococcemia. Uveitis (66-89)  xHP  Uveitis, Posterior C11.941.879.780.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Uveitis; Panuveitis Choroiditis (+ 2) Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis. Uveitis (66-89)  N=Uveitis, Intermediate C11.941.879.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Uveitis Pars Planitis Inflammation of the pars plana, ciliary body, and adjacent structures. Uveitis (71-89)  0N/TUveitis, Anterior C11.941.879.780.880 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Uveitis; Panuveitis Behcet's Syndrome; Iridocyclitis; Iritis Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced. N=1pUveitis C11.941.879 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases Panuveitis (+ 9); Uveitis, Intermediate (+ 1); Uveitis, Suppurative (+ 2); Uveomeningoencephalitic Syndrome Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI   N$PUveal Neoplasms C04.588.364.978; C11.319.494; C11.941.855 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Eye Neoplasms Eye Diseases; Eye Neoplasms Eye Diseases; Uveal Diseases Choroid Neoplasms; Iris Neoplasms Choroid Neoplasms; Iris Neoplasms Choroid Neoplasms; Iris Neoplasms Ciliary Body (66-80); Eye Neoplasms (66-80); Iris (66-80); Uvea (66-75); Uveal Diseases (76-80) ]1XwwUveal Diseases C11.941 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Choroid Diseases (+ 7); Iris Diseases (+ 6); Uveal Neoplasms (+ 2); Uveitis (+ 16) Diseases of the uvea. Uvea (66-75); specific uveal disease BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $ Nj.ZUvea A09.371.894 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye Choroid (+ 1); Ciliary Body; Iris (+ 1) Q:5Uukuniemi Group Viruses B04.820.087.710.900; B04.909.777.147.710.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Phlebovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Phlebovirus A group of viruses in the genus PHLEBOVIRUS of the family BUNYAVIRIDAE, infecting vertebrates and vectored by ticks. Its members have not been associated with human disease though antibodies have been isolated from human sera. Arboviruses (68-80); Bunyaviridae (81-93); Phlebovirus (92) 2 HUtopias K01.752.884 HI Humanities; Philosophy  Utilization Review N04.761.879; N05.700.900 CLECHILJMTOGSNSTTDUT Insurance Claim Review Professional Staff Committees Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Concurrent Review; Drug Utilization Review Concurrent Review; Drug Utilization Review An organized procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use. $#dUterus A05.360.319.679 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Hysterectomy; Hysterosalpingography; Hysteroscopy Urogenital System; Genitalia; Genitalia, Female Cervix Uteri; Endometrium (+ 1); Myometrium consider also terms at HYSTER-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $ 8997(:Uteroplacental Circulation G09.330.163.910 DEGEIMPHRE Placenta Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation The circulation of blood through the uterus and placenta. Maternal-Fetal Exchange (68-94); Placenta/blood supply (68-94)  8 FJUteroglobin D12.776.395.960 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins A protein fraction of pregnant uterine fluid which can induce and regulate blastocystic development. Blastokinin is thought to be similar or identical to uteroglobin. Presence in uterine fluid regulated by progesterone. Glycoproteins (71-74) HUUterine Rupture C13.371.852.904; C13.703.420.904; C21.866.761.853 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Rupture Uterine Perforation Uterine Perforation A tearing of uterine tissue; it may be traumatic or spontaneous due to multiple pregnancy, large fetus, previous scarring, or obstruction. 9NS/Uterine Prolapse C13.371.852.833; C23.835.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Symptoms and General Pathology (Non MeSH); Prolapse Downward displacement of the uterus. It is classified in various degrees: in the first degree the cervix is within the vaginal orifice; in the second degree the cervix is outside the orifice; in the third degree the entire uterus is outside the orifice. "N/Uterine Perforation C13.371.852.904.500; C21.866.761.853.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Uterine Rupture Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Rupture; Uterine Rupture Penetration through the uterine wall. 9.N.Uterine Neoplasms C04.588.945.418.948; C13.371.270.875; C13.371.820.800.418.875; C13.371.852.762 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Cervix Neoplasms; Endometrial Neoplasms Cervix Neoplasms; Endometrial Neoplasms Cervix Neoplasms; Endometrial Neoplasms Cervix Neoplasms; Endometrial Neoplasms Neoplasms of the uterus. XX  Uterine Monitoring E01.249.874; E01.621.848 AECLCTECHIISMOMTNUPXSNSTTDUTVE Uterine Contraction Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Monitoring, Physiologic Measurement or recording of contraction activity of the uterine muscle. It is used to determine progress of labor and assess status of pregnancy. It is also used in conjunction with FETAL MONITORING to determine fetal response to stress of maternal uterine contractions. Monitoring, Physiologic (72-94); Uterine Contraction (76-94)  "W>GUterine Inertia C13.703.420.288.728 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications; Dystocia Failure of the uterus to contract with normal strength and duration and at normal intervals during labor. It is also called uterine atony. vNUterine Hemorrhage C13.371.852.691; C23.542.946 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Menorrhagia; Metrorrhagia Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Menorrhagia; Metrorrhagia Menorrhagia; Metrorrhagia; Postpartum Hemorrhage B"NVUterine Diseases C13.371.852 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Cervix Diseases (+ 5); Endometrial Hyperplasia; Endometritis; Uterine Hemorrhage (+ 2); Uterine Neoplasms (+ 2); Uterine Prolapse; Uterine Rupture (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI !NhXUterine Contraction G08.520.769.326.700 BLCFDEEHGEIMMEPHPXREUR Cardiotocography; Labor, Premature; Oxytocics; Tocolytic Agents; Uterine Monitoring Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor Contraction of the uterine muscle. Uterus (66-74)  3b]+Utah Z01.107.567.875.100.895; Z01.107.567.875.600.822.895 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States :Ustilago B05.354.179.853.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes; Ustilaginales A genus of basidiomycetous smut fungi comprising the loose smuts.  ) "OOUstilaginales B05.354.179.853 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes Ustilago An order of basidiomycetous fungi; some species are parasitic on grasses and maize.  /"> eUSSR Z01.586.950 EHEP Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Armenia; Azerbaijan; Baltic States (+ 3); Byelarus; Georgia (Republic); Kazakhstan; Kyrgyzstan; Moldova; Russia (+ 4); Tajikistan; Turkmenistan; Ukraine; Uzbekistan  KIUser-Computer Interface L01.700.568.810.910 Information Science; Medical Informatics; Medical Informatics Computing; Software The portion of an interactive computer program that issues messages to and receives commands from a user.  _~Uruguay Z01.107.757.904 EHEP Geographicals (Non MeSH); America; South America  <Urticaria Pigmentosa C17.800.508.948; C17.800.621.893 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Mastocytosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders The most common form of mastocytosis. It occurs primarily in children and is typically characterized by multiple persistent small, reddish-brown, hyperpigmented, pruritic macules and papules. They are located most commonly on the trunk, but seen also on the extremities, head, and neck. (Dorland, 27th ed). O&NgUrticaria C17.800.862.945; C20.543.480.904 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate Angioneurotic Edema Angioneurotic Edema A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. % &N.Ursodeoxycholic Acid D04.808.221.430.342.925; D19.316.246.175.947 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Chenodeoxycholic Acid 3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic acid. Epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. Bile Acids and Salts (66-72); Chenodeoxycholic Acid (73-79); Deoxycholic Acid (73-74) /analogs and derivatives (75-79) 2DUrotensins D12.644.910; D17.350.050.375.925 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins Teleost hormones. A family of small peptides isolated from urophyses of bony fishes. They have many different physiological effects, including long-lasting hypotensive activity and have been proposed as antihypertensives. There are at least four different compounds: urotensin I, urotensin II, urotensin III, and urotensin IV. Fishes (66-78); Peptides (66-78) 5&Bz)Uroporphyrins D11.557.727.880 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Porphyrins with four acetic acid and four propionic acid side chains attached to the pyrrole rings. Porphyrins (68-74) KBTwUroporphyrinogens D11.557.727.700.900 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Porphyrinogens Porphyrinogens which are intermediates in heme biosynthesis. They have four acetic acid and four propionic acid side chains attached to the pyrrole rings. Uroporphyrinogen I and III are formed from polypyrryl methane in the presence of uroporphyrinogen III cosynthetase and uroporphyrin I synthetase, respectively. They can yield uroporphyrins by autooxidation or coproporphyrinogens by decarboxylation. Porphyrinogens (75); Porphyrins (71-74) Bf0Uroporphyrinogen III Synthase D08.586.520.497.940 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the cyclization of hydroxymethylbilane to yield uroporphyrinogen III and water. EC 4.2.1.75. Isomerases (71-74); Porphobilinogen (73-74) #F_4Uroporphyrinogen Decarboxylase D08.586.520.258.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases One of the enzymes active in heme biosynthesis. It catalyzes the decarboxylation of uroporphyrinogen III to coproporphyrinogen III by the conversion of four acetic acid groups to four methyl groups. EC 4.1.1.37. Carboxy-Lyases (74-75); Porphyrinogens (75); Porphyrins (74) !y#FaIUronic Acids D02.241.081.844.915; D02.241.152.811; D02.241.511.902.915; D09.203.811.922 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Aldehydic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids Hexuronic Acids (+ 2) Hexuronic Acids (+ 2) Hexuronic Acids (+ 2) Hexuronic Acids (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR #T8uj:Urology Department, Hospital N02.278.354.422.790; N04.452.442.422.790 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the administration and provision of diagnostic and therapeutic services for the urologic patient. Hospital Departments (68-Jul 77); Urology (66-Jul 77) &". AUrology G02.403.810.860 CLECEDHIISLJMAMTOGSNSTTD Urologic Diseases Health Occupations; Medicine; Specialties, Surgical A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes and the genital tract in the male. It includes the specialty of andrology which addresses both male genital diseases and male infertility. ) =/Urologic Neoplasms C04.588.945.947; C12.740.800.820; C13.371.820.800.820 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms Bladder Neoplasms; Kidney Neoplasms; Ureteral Neoplasms; Urethral Neoplasms Bladder Neoplasms; Kidney Neoplasms; Ureteral Neoplasms; Urethral Neoplasms Bladder Neoplasms; Kidney Neoplasms; Ureteral Neoplasms; Urethral Neoplasms Neoplasms of the urinary tract in both male and female. It does not include the male genitalia for which UROGENITAL NEOPLASMS is used for general discussions of neoplasms of both the urinary tract and the genitalia. Urogenital Neoplasms (66-77)  *=XI"Urologic Diseases C12.777 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urology Urologic and Male Genital Diseases (Non MeSH) Bladder Diseases (+ 9); Hematuria; Hemoglobinuria; Kidney Diseases (+ 65); Proteinuria (+ 1); Ureteral Diseases (+ 4); Urethral Diseases (+ 7); Urinary Calculi (+ 3); Urinary Fistula (+ 2); Urinary Tract Infections (+ 3); Urination Disorders (+ 5) Diseases of the urinary tract in both male and female. It does not include the male genitalia for which UROGENITAL DISEASES is used for general discussions of diseases of both the urinary tract and the genitalia. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $/C N 72ZUrologic and Male Genital Diseases (Non MeSH) C12 Genital Diseases, Male (+ 34); Tuberculosis, Urogenital (+ 2); Urogenital Diseases (+ 28); Urologic Diseases (+ 110) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI 27ZUrokinase D08.586.277.656.732.760.910; D19.461.427.600.620.928 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Plasminogen; Plasminogen Activators Proteolytic enzyme that converts plasminogen to plasmin where the preferential cleavage is between arginine and valine. It was isolated originally from human urine, but is found in most tissues of most vertebrates. Urokinase is used in the therapy of thromboembolic conditions. Fibrinolytic Agents (66-74) 3 :F;D!Urography E01.341.878; E01.357.818.946 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Urogenital System; Urinary Tract Diagnosis; Diagnosis, Urologic (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography Radiography of any part of the urinary tract. 7E "&(c9Urogenital System A05 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUULUSVI Urography Genitalia (+ 55); Urinary Tract (+ 17) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI 86 2<Urogenital Neoplasms C04.588.945; C12.740.800; C13.371.820.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases Genital Neoplasms, Female (+ 8); Genital Neoplasms, Male (+ 3); Urologic Neoplasms (+ 4); Venereal Tumors, Veterinary Genital Neoplasms, Male (+ 3); Urologic Neoplasms (+ 4) Genital Neoplasms, Female (+ 8); Urologic Neoplasms (+ 4) Neoplasms of the urogenital tract. 9z1X+Urogenital Diseases C12.740; C13.371.820 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH) Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Urogenital Abnormalities (Non MeSH) (+ 17); Urogenital Neoplasms (+ 9) Urogenital Abnormalities (Non MeSH) (+ 15); Urogenital Neoplasms (+ 14) Diseases of the urogenital tract. specific urologic and genital diseases (66-90); Urologic Diseases (66-90) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $<N*WXUrogenital Abnormalities (Non MeSH) C12.740.700; C13.371.820.700; C16.131.939 Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Bladder Exstrophy; Cryptorchidism; Epispadias; Hypospadias; Kidney, Polycystic (+ 2); Nephritis, Hereditary; Sex Differentiation Disorders (+ 7); WAGR Syndrome Bladder Exstrophy; Epispadias; Kidney, Polycystic (+ 2); Nephritis, Hereditary; Sex Differentiation Disorders (+ 7); WAGR Syndrome Bladder Exstrophy; Cryptorchidism; Epispadias; Hypospadias; Kidney, Polycystic (+ 2); Nephritis, Hereditary; Sex Differentiation Disorders (+ 9); WAGR Syndrome BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI ?P*1VUrodynamics G08.852.950 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Urinary Tract Physiology (Non MeSH) The mechanical laws of fluid dynamics as they apply to urine transport. Urinary Tract (72-77); specific urinary tract heading; Urination (66-77); Urologic Diseases (66-77); specific urologic disease CKbWUrodela B02.090.608 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia Ambystomatidae (+ 2); Proteidae (+ 2); Salamandridae (+ 4) An order of the Amphibia class which includes salamanders and newts. They are characterized by usually having slim bodies and tails, four limbs of about equal size (except in Sirenidae), and a reduction in skull bones. D &JUrochordata B01.272.727 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Chordata Ciona intestinalis A subphylum of chordates intermediate between the invertebrates and the true vertebrates. Chordata (66-72)  F(iUrocanic Acid D02.241.081.069.920; D03.383.374.960 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles 4-Imidazoleacrylic acid. Acrylates (69-74); Imidazoles (69-74) G*:.Urocanate Hydratase D08.586.520.497.921 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the conversion of 4,5-dihydro-4-oxo-5-imidazolepropanoate to urocanate and water. EC 4.2.1.49. Hydro-Lyases (66-71) IF_Urobilinogen D11.557.193.852 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Bile Pigments A colorless compound formed in the intestines by the reduction of bilirubin. Some is excreted in the feces where it is oxidized to urobilin. Some is reabsorbed and re-excreted in the bile as bilirubin. At times, it is re-excreted in the urine, where it may be later oxidized to urobilin. K#BXXUrobilin D11.557.193.727 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Bile Pigments M[ DXUrine A12.207.927 CHCYMIPHPS Albuminuria; Alkaptonuria; Aminoaciduria, Renal; Anuria; Bacteriuria; Cystinuria; Glycosuria; Hematuria; Hemoglobinuria; Maple Syrup Urine Disease; Phenylketonuria; Polyuria; Proteinuria; Pyuria Fluids and Secretions (Non MeSH); Body Fluids N5 9Urination Disorders C12.777.934 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Enuresis; Polyuria; Urinary Incontinence (+ 1); Urinary Retention Disorders in the frequency of urination, the volume of urine produced or eliminated, or the ability to retain or void urine in normal fashion. ONNPUrination G08.852.877 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Urinary Tract Physiology (Non MeSH) Q bUrinary Tract Physiology (Non MeSH) G08.852 Reproduction, Urogenital Physiology (Non MeSH) Diuresis (+ 1); Glomerular Filtration Rate; Kidney Concentrating Ability; Urination; Urodynamics DEGEIMPHREVE R*+ 6sUrinary Tract Infections C01.539.895; C12.777.892 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Anti-Infective Agents, Urinary Bacterial and Fungal Diseases (Non MeSH); Infection Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Bacteriuria; Pyuria; Schistosomiasis haematobia Bacteriuria; Pyuria; Schistosomiasis haematobia Infections affecting those structures of the body which participate in the secretion and elimination of urine, i.e., the kidney, the ureters, the urinary bladder, and the urethra.  S<P$nUrinary Tract A05.810 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUULUSVI Urography Urogenital System Bladder; Kidney (+ 13); Ureter; Urethra Urogenital System (66-71) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $U 6 4:Urinary Sphincter, Artificial E07.450.950; E07.858.082.874 AECLCTECHIPXSDSNSTTDUTVE Urinary Incontinence Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Artificial Organs An artifical implanted device, usually in the form of an inflatable silicone cuff, inserted in or around the bladder neck in the surgical treatment of urinary incontinence caused by sphincter weakness. Often it is placed around the bulbous urethra in adult males. The artificial urinary sphincter is considered an alternative to urinary diversion. Implants, Artificial (76-91); Urinary Incontinence/surgery (69-91)  W#"|NUrinary Retention C12.777.934.880 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urinary Catheterization Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urination Disorders Inability to urinate. The etiology of this disorder includes obstructive, neurogenic, pharmacologic, and psychogenic causes. Urination Disorders (66-90)  ZNf!Urinary Reservoirs, Continent E04.887.774.852.973 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Urinary Diversion Structures which collect and store urine and are emptied by catheterization of a cutaneous stoma or internal diversion to the urethra. The reservoirs are surgically created during procedures for urinary diversion. Urinary Diversion (72-91) [#$wUrinary Incontinence, Stress C12.777.934.852.727 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urination Disorders; Urinary Incontinence The involuntary discharge of urine as a result of anatomic displacement which exerts an opening pull on the bladder orifice. It often occurs during coughing or other forceful stresses. (From Dorland, 27th ed). ^"NUrinary Incontinence C12.777.934.852 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Incontinence Pads; Urinary Sphincter, Artificial Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urination Disorders Urinary Incontinence, Stress `$N9f"Urinary Fistula C12.777.850; C23.439.731 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Symptoms and General Pathology (Non MeSH); Fistula Bladder Fistula (+ 1) Bladder Fistula (+ 1) An abnormal passage communicating with the urinary tract. (Dorland, 27th ed). aN6^Urinary Diversion E04.887.774.852 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cystectomy Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH) Cystostomy; Nephrostomy, Percutaneous; Ureterostomy; Urinary Reservoirs, Continent cK$`_Urinary Catheterization E01.341.777; E02.148.947 AECLCTECHIISMOMTNUPXSNSTTDUTVE Urinary Retention; Bladder Diagnosis; Diagnosis, Urologic (Non MeSH) Therapeutics; Catheterization Employment or passage of a catheter into the bladder (urethral c.) or kidney (ureteral c.) for therapeutic or diagnostic purposes. d"!SUrinary Calculi C12.777.809; C23.146.935 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Symptoms and General Pathology (Non MeSH); Calculi Bladder Calculi; Kidney Calculi; Ureteral Calculi Bladder Calculi; Kidney Calculi; Ureteral Calculi Calculi in any part of the urinary tract. Vesical calculi (BLADDER CALCULI) are those found in the urinary bladder; renal calculi (KIDNEY CALCULI) are those found in the pelvis of the kidney. Types of urinary calculi are often classified by chemical composition or pattern of chemical composition distribution. Urinary calculi types include alternating or combination, cystine, decubitus, encysted, fibrin, hemp seed, matrix, mulberry, oxalate, struvite, urostealith, and xanthic calculi. fRv5Urinalysis E01.223.960; E01.341.760 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory Diagnosis; Diagnosis, Urologic (Non MeSH) Examination of urine by chemical, physical, or microscopic means. Routine urinalysis usually includes performing chemical screening tests, determining specific gravity, observing any unusual color or odor, screening for bacteriuria, and examining the sediment microscopically. Urine/analysis (66-91) i"W;Uridine Triphosphate D13.695.740.850.950; D13.695.827.919.950 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides Uridine 5'-(tetrahydrogen triphosphate). A uracil nucleotide containing three phosphate groups esterified to the sugar moiety. Uracil Nucleotides (66-77) l".D Uridine Phosphorylase D08.586.913.400.725.950 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme that catalyzes the transfer of ribose from uridine to orthophosphate, forming uracil and ribose 1-phosphate. EC 2.4.2.3. Pentosyltransferases (73-74); Phosphates (73-74); Uridine (73-74) nFNUridine Monophosphate D13.695.740.850.877; D13.695.827.919.877 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. Synonym: UMP. Uracil Nucleotides (66-74) p.D Uridine Kinase D08.586.913.696.620.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes the phosphorylation of uridine and cytidine to uridine 5'-phosphate and cytidine 5'-phosphate, respectively. ATP, dUTP, dGTP, and dATP are effective phosphate donors. EC 2.7.1.48. Phosphotransferases, ATP (74); Uridine (74) s F5Uridine Diphosphate Xylose D09.203.408.620.569.727.800; D13.695.740.850.600.677.800; D13.695.827.708.727.800; D13.695.827.919.600.677.800 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars The decarboxylation product of UDPglucuronic acid, which is used for formation of the xylosides of seryl hydroxyl groups in mucoprotein synthesis. Also forms plant xylans. Uridine Diphosphate Sugars (73-74); Xylose (73-74) ug xD=Uridine Diphosphate Sugars D09.203.408.620.569.727; D13.695.740.850.600.677; D13.695.827.708.727; D13.695.827.919.600.677 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate Uridine Diphosphate N-Acetylgalactosamine; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate N-Acetylmuramic Acid; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Xylose Uridine Diphosphate N-Acetylgalactosamine; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate N-Acetylmuramic Acid; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Xylose Uridine Diphosphate N-Acetylgalactosamine; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate N-Acetylmuramic Acid; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Xylose Uridine Diphosphate N-Acetylgalactosamine; Uridine Diphosphate N-Acetylglucosamine; Uridine Diphosphate N-Acetylmuramic Acid; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Xylose specific carbohydrate (66-72); Uracil Nucleotides (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  z' hB7^DDUridine Diphosphate N-Acetylmuramic Acid D09.203.408.620.569.727.150; D13.695.740.850.600.677.150; D13.695.827.708.727.150; D13.695.827.919.600.677.150 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars A nucleoside diphosphate sugar which is formed from UDP-N-acetylglucosamine and phosphoenolpyruvate. It serves as the building block upon which peptidoglycan is formed. Muramic Acid (73-74); Uridine Diphosphate Sugars (73-74) 9/xDDUridine Diphosphate N-Acetylglucosamine D09.203.408.620.569.727.120; D13.695.740.850.600.677.120; D13.695.827.708.727.120; D13.695.827.919.600.677.120 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Serves as the biological precursor of insect chitin, of muramic acid in bacterial cell walls, and of sialic acids in mammalian glycoproteins. Uridine Diphosphate Sugars (74); Glucosamine (74)  -xD<Uridine Diphosphate N-Acetylgalactosamine D09.203.408.620.569.727.100; D13.695.740.850.600.677.100; D13.695.827.708.727.100; D13.695.827.919.600.677.100 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars A nucleoside diphosphate sugar which serves as a source of N-acetylgalactosamine for glycoproteins, sulfatides and cerebrosides. Galactosamine (73-74); Uridine Diphosphate Sugars (73-74) /xDDUridine Diphosphate Glucuronic Acid D09.203.408.620.569.727.375; D13.695.740.850.600.677.375; D13.695.827.708.727.375; D13.695.827.919.600.677.375 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars A nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP iduronic acid, which donates iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. Glucuronates (73-74); Uridine Diphosphate Sugars (73-74) T*xDeCUridine Diphosphate Glucose Epimerase D08.586.399.278.900; D08.586.399.461.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Carbohydrate Isomerases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Epimerases A necessary enzyme in the metabolism of galactose. It reversibly catalyzes the conversion of UDPglucose to UDPgalactose. NAD+ is an essential component for enzymatic activity. EC 5.1.3.2. Carbohydrate Isomerases (73-74); Galactose (73-74); Glucose (73-74); Uridine Diphosphate Sugars (73-74 ,.FzUridine Diphosphate Glucose Dehydrogenase D08.586.682.047.150.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases An enzyme that catalyzes the oxidation of UDPglucose to UDPglucuronate in the presence of NAD+. EC 1.1.1.22. Alcohol Oxidoreductases (73-74); Glucose (73-74); Uridine Diphosphate Sugars (73-74) 0FdUridine Diphosphate Glucose D09.203.408.620.569.727.350; D13.695.740.850.600.677.350; D13.695.827.708.727.350; D13.695.827.919.600.677.350 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars A key intermediate in carbohydrate metabolism. Serves as a precursor of glycogen, can be metabolized into UDPgalactose and UDPglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. Also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids. Glucose (73-74); Uridine Diphosphate Sugars (73-74) !xDf>Uridine Diphosphate Galactose D09.203.408.620.569.727.300; D13.695.740.850.600.677.300; D13.695.827.708.727.300; D13.695.827.919.600.677.300 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Uridine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides; Uridine Diphosphate; Uridine Diphosphate Sugars A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose. Galactose (73-74); Uridine Diphosphate Sugars (73-74) =#xD @Uridine Diphosphate D13.695.740.850.600; D13.695.827.919.600 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Uracil Nucleotides Uridine Diphosphate Sugars (+ 7) Uridine Diphosphate Sugars (+ 7) Uridine 5'-(trihydrogen diphosphate). A uracil nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: uridine pyrophosphate; URPP. Uracil Nucleotides (66-77)  C.DN Uridine D13.570.685.852; D13.570.800.892 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Arabinofuranosyluracil; Azauridine; 3-Deazauridine; Deoxyuridine (+ 3); Pseudouridine; Tetrahydrouridine; Thiouridine Azauridine; 3-Deazauridine; Pseudouridine; Tetrahydrouridine; Thiouridine  &DUricosuric Agents D17.050.337.900 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants Apazone; Benzbromarone; Probenecid; Sulfinpyrazone; Zoxazolamine Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  \8L:Uric Acid D03.438.759.758.824.877 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines :mUrethritis C12.777.767.851 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases Reiter's Disease Inflammation of the urethra. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  Nd=PUrethral Stricture C12.777.767.700.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases; Urethral Obstruction 3N}Urethral Obstruction C12.777.767.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases Bladder Neck Obstruction; Urethral Stricture Obstruction anywhere along the urethra. Urethral Diseases (66-78); Urethral Stricture (66-78)  KNd50@Urethral Neoplasms C04.588.945.947.945; C12.740.800.820.937; C12.777.767.601; C13.371.820.800.820.890 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Neoplasms or tumors of the urethra. This condition is relatively uncommon and is the only cancer of the urinary system that has a higher incidence rate in females than males. Squamous cell carcinoma is the most frequent histologic type. \XUrethral Diseases C12.777.767 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Epispadias; Urethral Neoplasms; Urethral Obstruction (+ 2); Urethritis (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI NN]ZUrethra A05.360.444.492.726; A05.810.876 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male; Penis Urogenital System; Urinary Tract  &:fUrethane D02.241.081.251.944; D15.050.035.075.950; D15.210.100.175.075.950; D22.204.938; D26.191.947 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polyurethanes Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Nitrosomethylurethane Carbamic acid ethyl ester. Antineoplastic agent that is also used as a veterinary anesthetic.   g:qUreterostomy E04.579.947; E04.887.774.852.947 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ureter Surgery, Operative; Ostomy Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Urinary Diversion Surgical formation of an opening in the ureter for external drainage of the urine; cutaneous route utilizes a ureteral orifice emerging through the skin. Ureter/surgery (66-87); Urinary Diversion (66-87)  &$ <Ureteroscopy E01.341.750; E01.418.950 AECLCTECHIISMOMTNUPXSNSTTDUTVE Ureter Diagnosis; Diagnosis, Urologic (Non MeSH) Diagnosis; Endoscopy Endoscopic examination of the ureter. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material, and to perform other surgical interventions. Endoscopy (70-94)  " JUreterocele C12.777.725.876 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Ureteral Diseases Cystic dilatation of the ureter with ballooning of the ureteral orifice into the lumen of the bladder. Nd{Ureteral Obstruction C12.777.725.776 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Ureteral Diseases %NdUreteral Neoplasms C04.588.945.947.940; C12.740.800.820.875; C12.777.725.676; C13.371.820.800.820.875 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Ureteral Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Neoplasms or tumors of the ureter. Hematuria, which occurs in 75% of patients with ureteral carcinoma, is the most common presenting symptom. The most common site for the occurrence of a ureteral tumor is in the lower third of the ureter, with a lesser incidence higher up. "\XFUreteral Diseases C12.777.725 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Ureteral Calculi; Ureteral Neoplasms; Ureteral Obstruction; Ureterocele BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI FNNTXUreteral Calculi C12.777.725.576; C12.777.809.851; C23.146.935.905 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Ureteral Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Calculi Symptoms and General Pathology (Non MeSH); Calculi; Urinary Calculi Calculi of the ureter. The calculus in the ureter is usually the result of the passage of one originating in the kidney. It occurs usually in mid-life, rarely in children; it occurs more frequently in males than females. (From CMIT, 5th ed). 9R$Ureter A05.810.776 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ureteroscopy; Ureterostomy Urogenital System; Urinary Tract The fibromuscular tube which conveys the urine from the kidney to the bladder. It begins with the pelvis of the kidney and empties into the base of the bladder, being 16 to 18 inches long. It is divided into a pars abdominalis and a pars pelvina. (Dorland, 27th ed).  : (CUreohydrolases D08.586.277.913 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Arginase FS Uremia C12.777.419.936 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Kidney Failure, Chronic Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Hemolytic-Uremic Syndrome  NbUrease D08.586.277.087.902 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5.  FfzUreaplasma urealyticum B03.440.560.580.553.900.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Ureaplasma A species of gram-negative bacteria found in the human genitourinary tract, oropharynx, and anal canal. Ureaplasma (76-91) `"jzUreaplasma Infections C01.252.400.610.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Mycoplasmatales Infections Infections with bacteria of the genus UREAPLASMA. Mycoplasma Infections (77-79); Mycoplasmatales Infections (80-91); Ureaplasma (77-91) P<dUreaplasma B03.440.560.580.553.900 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae Ureaplasma urealyticum A genus of gram-negative, nonmotile bacteria which are common parasitic inhabitants of the urogenital tracts of man, cattle, dogs, and monkeys. Mycoplasma (66-75)  Ӹ"\Urea D02.948 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Blood Urea Nitrogen Organic Chemicals (Non MeSH) Biureas; Biuret; Bromisovalum; Hydroxyurea; Methylurea Compounds (+ 2); Nitrosourea Compounds (+ 7); Phenylurea Compounds (+ 5); Sulfonylurea Compounds (+ 8); Thiourea (+ 11) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  d :#<Urbanization I01.880.526.726 HILJTD Social Sciences; Sociology; Social Change The process whereby a society changes from a rural to an urban way of life. It refers also to the gradual increase in the proportion of people living in urban areas. Population (66-67); Sociology (66-67) ( 3.Urban Renewal I01.880.709.876 CLECEDHILJMAMTOGSDSNSTTDUT Housing Social Sciences; Sociology; Social Planning The planned upgrading of a deteriorating urban area, involving rebuilding, renovation, or restoration. It frequently refers to programs of major demolition and rebuilding of blighted areas. Housing (66-67); Social Conditions (66-67)  ئ 54Urban Population N01.600.900 CLHISNTD Suburban Population Population Characteristics (Non MeSH); Population The inhabitants of a city or town, including metropolitan and suburban areas. Population (66-67)  d ;]Urban Health N01.407.540.770 CLHISNSTTD Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health Use for articles concerning health problems in an urban population. Health (66-78) ۆ]QUrate Oxidase D08.586.682.943 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme that catalyzes the conversion of urate and unidentified products. It is a copper protein. The initial products decompose to form allantoin. EC 1.7.3.3. ܠFXUranyl Nitrate D01.625.525.550.950; D01.950.950 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitric Acid; Nitrates Inorganic Chemicals (Non MeSH); Uranium Compounds Bis(nitrato-O)dioxouranium. A compound used in photography and the porcelain industry. It causes severe renal insufficiency and renal tubular necrosis in mammals and is an effective lymphocyte mitogen. Nitrates (73-75); Uranium (73-75) G&8*Uranus H01.091.800.700.865 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The seventh planet in order from the sun. It is one of the five outer planets of the solar system. It has five known natural satellites. Extraterrestrial Environment (66-90); Planets (91-94)  M?Uranium Compounds D01.950 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Uranyl Nitrate Inorganic compounds that contain uranium as an integral part of the molecule. Uranium (66-93)   8%]Uranium D01.268.271.545.950; D01.552.517.940 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Uranium. A radioactive element of the actinide series of metals. It has an atomic symbol U, atomic number 92, and atomic weight 238.03. U-235 is used as the fissionable fuel in nuclear weapons and as fuel in nuclear power reactors. - *4Uracil Nucleotides D13.695.740.850; D13.695.827.919 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Deoxyuracil Nucleotides (+ 1); Uridine Diphosphate (+ 8); Uridine Monophosphate; Uridine Triphosphate Uridine Diphosphate (+ 8); Uridine Monophosphate; Uridine Triphosphate AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR &BDUracil Mustard D02.455.526.728.650.913; D22.204.585.941 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds 5-(Bis(2-chloroethyl)amino)2,4-(1H,3H)pyrimidinedione. Nitrogen mustard derivative of uracil; alkylating antineoplastic agent used in lymphatic malignancies; causes mainly gastrointestinal and bone marrow damage. Synonyms: chlorethaminacil; de(s)methyldopan; Nordopan; NSC 34462; U 8344. .:OUracil D03.383.742.698.875 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones Bromouracil; Fluorouracil (+ 1); Hydroxyphenylazouracil; Orotic Acid; Pentoxyl; Thiouracil (+ 2); Thymine  >hUrachus A16.254.835 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo The urinary canal of the fetus; postnatally it is usually a fibrous cord but occasionally persists as a vesicoumbilical fistula. O :1Urachal Cyst C04.182.946 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Cyst occurring in a persistent portion of the urachus, presenting as an extraperitoneal mass in the umbilical region. It is characterized by abdominal pain, and fever if infected. It may rupture, leading to peritonitis, or it may drain through the umbilicus. V1Up-Regulation (Physiology) G05.331.370.380.930; G06.184.910; G12.955 DEGEIMPHRE Down-Regulation (Physiology) Down-Regulation (Physiology) Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Chemical, Pharmacologic Phenomena (Non MeSH) Process that increases ligand/receptor interactions due to an increase in the number of available receptors.  p1!!Universities I02.783.850 CLECHILJMAOGSNSTTD Education; Schools Educational institutions providing facilities for teaching and research and authorized to grant academic degrees. Universal Precautions G03.850.780.200.925 CLECHIISLJMTSNTD Blood-Borne Pathogens Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Prudent standard preventive measures to be taken by professional and other health personnel in contact with persons afflicted with a communicable disease, to avoid contracting the disease by contagion or infection. Precautions are especially applicable in the diagnosis and care of AIDS patients. specific disease/prevention and control (88-91)  X8Unithiol D02.886.489.180.900; D26.241.245.945 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds; Dimercaprol Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents; Dimercaprol 2,3-Dimercapto-1-propanesulfonic acid, sodium salt. A chelating agent used as an antidote to heavy metal poisoning. Alkyl Sulfonates (74-75); Sulfhydryl Compounds (74-75) J *.AUnited States Substance Abuse and Mental Health Services Administration N03.540.427.300.650.920 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service National Institute of Mental Health (U.S.) An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym SAMHSA. On 1 October 1992, the United States Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA) became SAMHSA. (Telephone communication with SAMHSA 7 April 1992). aS3United States Public Health Service N03.540.427.300.650 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services Centers for Disease Control and Prevention (U.S.) (+ 1); National Center for Health Care Technology; National Center for Health Statistics (U.S.); National Institutes of Health (U.S.) (+ 1); United States Agency for Health Care Policy and Research; United States Food and Drug Administration; United States Health Resources and Services Administration (+ 1); United States Indian Health Service; United States Office of Research Integrity; United States Substance Abuse and Mental Health Services Administration (+ 1) A constituent organization of the DEPARTMENT OF HEALTH AND HUMAN SERVICES concerned with protecting and improving the health of the nation. +_United States Office of Technology Assessment N03.540.427.550 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies An office established to help Congress participate and plan for the consequences of uses of technology. It provides information on both the beneficial and adverse effects of technological applications. Government Agencies (68-87); Technology Assessment, Biomedical (80-87) 6^RUnited States Office of Research Integrity N03.540.427.300.650.912 CLECHILJOGSNSTTDUT Scientific Misconduct Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service An office of the UNITED STATES PUBLIC HEALTH SERVICE organized in June 1992 to promote research integrity and investigate misconduct in research supported by the Public Health Service. It consolidates the Office of Scientific Integrity of the National Institutes of Health and the Office of Scientific Integrity Review in the Office of the Assistant Secretary for Health. The ORI is in the Office of the Assistant Secretary for Health and its director reports directly to the Assistant Secretary for Health, Department of Health and Human Services. (RI Newsletter, 1993 Jan; 1(1):1). 3United States Office of Economic Opportunity N03.540.427.500 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs relative to the provision of opportunities for economic advancement. Government (66-67) 5^United States Occupational Safety and Health Administration N03.540.427.480 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies An office in the Department of Labor responsible for developing and establishing occupational safety and health standards. Government Agencies (68-81) E^!United States National Aeronautics and Space Administration N03.540.427.430 Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies An independent Federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the Earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles. (From U.S. Government Manual, 1993). E^:United States Indian Health Service N03.540.427.300.650.825 CLECHILJOGSNSTTDUT Indians, North American Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service A division of the UNITED STATES PUBLIC HEALTH SERVICE that is responsible for the public health and the provision of medical services to native American Indian populations in the United States, primarily those residing on reservation lands. Indians, North American (75-91); United States Public Health Service (75-91)   +[United States Health Resources and Services Administration N03.540.427.300.650.790 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service National Health Planning Information Center A component of the PUBLIC HEALTH SERVICE that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.  D3United States Health Care Financing Administration N03.540.427.300.310 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services A component of the Department of Health and Human Services to oversee and direct the Medicare and Medicaid programs and related Federal medical care quality control staffs. ;United States Food and Drug Administration N03.540.427.300.650.760 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc. 3United States Federal Trade Commission N03.540.427.380 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies An independent administrative agency concerned with maintaining competitive free enterprise by prohibiting unfair methods of competition and unfair deceptive acts or practices. Government Agencies (68-81) /.^!United States Environmental Protection Agency N03.540.427.340 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies An agency in the executive branch which endeavors to abate and control pollution in the areas of air, water, solid waste, noise, radiation, and toxic substances. Government Agencies (68-81) 5^!United States Dept. of Health and Human Services N03.540.427.300 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies United States Health Care Financing Administration; United States Public Health Service (+ 14) A department of the United States government concerned with administering those agencies and offices having programs pertaining to health and human services. Government Agencies (68-75); specific agency  ;^o6United States Department of Veterans Affairs N03.540.427.250 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies A division of the Executive Branch of the United States government concerned with overall planning, promoting, and administering programs pertaining to veterans. 5^United States Department of Agriculture N03.540.427.125 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies A department of the United States Government concerned with improving and maintaining farm income and developing and expanding markets for agricultural products. It also helps landowners in protecting the soil, water, forest, and other natural resources. It carries out rural development and conservation programs. Through inspection and grading services it safeguards and insures standards of quality in food supply and production. Government Agencies (66-91) /^!United States by Region (Non MeSH) Z01.107.567.875.600 Geographicals (Non MeSH); America; North America; United States Appalachian Region (+ 5); Great Lakes Region (+ 11); Mid-Atlantic Region (+ 9); Midwestern United States (+ 15); New England (+ 7); Northwestern United States (+ 5); Southeastern United States (+ 10); Southwestern United States (+ 9) EHEP +NUnited States by Individual State (Non MeSH) Z01.107.567.875.100 Geographicals (Non MeSH); America; North America; United States Alabama; Alaska; Arizona; Arkansas; California (+ 2); Colorado; Connecticut; Delaware; District of Columbia; Florida; Georgia; Hawaii; Idaho; Illinois (+ 1); Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland (+ 1); Massachusetts (+ 1); Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York (+ 1); North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania (+ 1); Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington; West Virginia; Wisconsin; Wyoming EHEP  h6NUnited States Agency for Health Care Policy and Research N03.540.427.300.650.700 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service An agency of the PUBLIC HEALTH SERVICE established in 1990 to "provide indexing, abstracting, translating, publishing, and other services leading to a more effective and timely dissemination of information on research, demonstration projects, and evaluations with respect to health care to public and private entities and individuals engaged in the improvement of health care delivery..." It supersedes the National Center for Health Services Research. #DUnited States Z01.107.567.875 EHEP Geographicals (Non MeSH); America; North America United States by Individual State (Non MeSH) (+ 58); United States by Region (Non MeSH) (+ 79) 'Z<tUnited Nations N03.540.514.718 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; International Agencies World Health Organization (+ 1) An international organization whose members include most of the sovereign nations of the world with headquarters in New York City. The primary objectives of the organization are to maintain peace and security and to achieve international cooperation in solving international economic, social, cultural, or humanitarian problems. International Agencies (66-79)  (Za'{$United Arab Emirates Z01.252.245.500.900; Z01.586.500.900 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East **Unified Medical Language System L01.700.508.300.895 CLECHIISLJMAOGSDSNSTTDUT Nomenclature; Subject Headings National Library of Medicine (U.S.) Information Science; Medical Informatics; Medical Informatics Applications; Information Systems A research and development program initiated by the National Library of Medicine to build an intelligent automated system that can understand biomedical concepts, words, and expressions and their interrelationships, and use this understanding to help users retrieve and organize information from a variety of machine-readable sources. The goal of the UMLS is to compensate for differences in the terminology of the disparate systems and for variations in user modes of expression. The UMLS project has produced three knowledge sources meant to be used by user interface programs. These are: the Metathesaurus, the Semantic Network, and the Information Sources Map.  +&%+nUnemployment N01.824.245.850 CLHIPXSNTD Employment Population Characteristics (Non MeSH); Socioeconomic Factors; Employment The state of not being engaged in a gainful occupation. 08UEUnderachievement F02.784.629.880 Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Performance, usually in school work, poorer than that predicted from aptitude and/or intelligence testing. Learning Disorders (66-67) 18m} Undecylenic Acids D02.241.081.436.275.919; D10.516.251.355.325.919; D20.136.931; D20.187.942 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Anti-Infective Agents; Antifungal Agents Anti-Infective Agents; Anti-Infective Agents, Local 2T8Uncoupling Agents D08.373.936 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Oxidative Phosphorylation Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Aurovertins; Bishydroxycoumarin; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Dinitrophenols; Ionophores (+ 6); Oligomycins (+ 1); Pentachlorophenol; Venturicidins Oxidative Phosphorylation/DE (66-68); Oxidoreductases/AI (68) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $48PI<Unconsciousness C10.597.917; C23.888.592.925 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Syncope Consciousness Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Coma; Persistent Vegetative State; Syncope Coma; Persistent Vegetative State; Syncope A physiological state in which the patient is incapable of responding to usual environmental stimuli; it is an imprecise term but usually refers to impairment of consciousness less profound than COMA, in which no response can be elicited even at the reflex level. $7L"N f7Unconscious (Psychology) F01.752.747.930; F02.739.794.942 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Those forces and content of the mind which are not ordinarily available to conscious awareness or to immediate recall. :g&Uncompensated Care N04.590.374.900; N05.300.830 CLECHILJSNTD Medically Uninsured Medical Indigency; Charities; Medically Uninsured Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Medical services for which no payment is received. Uncompensated care includes charity care and bad debts.  < ";Umbridae B02.493.817.900 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes A family of SALMONIFORMES comprising the mudminnows. There are three genera: Dallia, Novumbra, and Umbra with much disagreement about their taxonomic interrelations. The Umbridae are freshwater fish inhabiting parts of the Northern Hemisphere. (Nelson: Fishes of the World). >, &*@Umbilicus A01.047.849 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Abdomen The pit in the center of the abdominal wall marking the point where the umbilical cord entered in the fetus. consider also terms at OMPHALO-. ? (*Umbilical Veins A07.231.908.670.874; A16.254.789.807 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins; Portal System Embryonic Structures (Non MeSH); Embryo; Umbilical Cord Veins which carry oxygenated, nutrient-rich blood from the placenta and which are obliterated in the first few days after birth. A:*8Umbilical Cord A16.254.789 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo Umbilical Arteries; Umbilical Veins The flexible structure, giving passage to the umbilical arteries and vein, which connects the embryo or fetus to the placenta. B:1+Umbilical Arteries A07.231.114.929; A16.254.789.641 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Embryonic Structures (Non MeSH); Embryo; Umbilical Cord Either of a pair of arteries originating from the internal iliac artery and passing through the umbilical cord to carry blood from the fetus to the placenta. Umbilical Cord/BS (66-67) Di&8z Umbelliferones D03.438.150.446.912 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins Coumaphos; Hymecromone; Scopoletin 7-Hydroxycoumarins. Substances present in many plants, especially umbelliferae. Umbelliferones are used in sunscreen preparations and may be mutagenic. Their derivatives are used in liver therapy, as reagents, plant growth factors, sunscreens, insecticides, parasiticides, choleretics, spasmolytics, etc. Coumarins (69-76) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $F[:d*[<Ultraviolet Therapy E02.780.750.945 AECLCTECHIISMOMTNUPXSNSTTDUTVE Photochemotherapy Light Therapeutics; Physical Therapy; Phototherapy The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing.  I(" 5PUltraviolet Rays G03.230.300.100.725.525.600; H01.671.768.638.943 AECLDUHI Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather; Sunlight Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Non-Ionizing That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. KC6 Ultrasonography, Prenatal E01.249.746.725; E01.357.947.662 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Prenatal Diagnosis Diagnosis; Diagnostic Imaging; Ultrasonography The visualization of tissues during pregnancy through recording of the echoes of ultrasonic waves directed into the body. The procedure may be applied with reference to the mother or the fetus and with reference to organs or the detection of maternal or fetal disease. Prenatal Diagnosis (73-90); Ultrasonics/diagnostic use (68-84); Ultrasonography (85-90) N&"}=gUltrasonography, Mammary E01.249.831; E01.357.947.493 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Diagnostic Imaging; Ultrasonography Use of ultrasound for imaging the breast. The most frequent application is the diagnosis of neoplasms of the female breast. Breast Neoplasms (66-90); Ultrasonics/diagnostic use (68-84); Ultrasonography (85-90) Q9""eeUltrasonography, Interventional E01.357.947.408 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnostic Imaging; Ultrasonography Ultrasonography using invasive or surgical procedures. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions. Ultrasonography (85-93) S$&7Ultrasonography, Doppler, Transcranial E01.236.257.314.850; E01.357.947.324.850; E01.357.947.390.850 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH); Echoencephalography Diagnosis; Diagnostic Imaging; Ultrasonography; Echoencephalography Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler A non-invasive technique using ultrasound for the measurement of cerebrovascular hemodynamics, particularly cerebral blood flow velocity and cerebral collateral flow. With a high-intensity, low-frequency pulse probe, the intracranial arteries may be studied transtemporally, transorbitally, or from below the foramen magnum. Blood Flow Velocity (82-93); Cerebral Arteries (84-93); Cerebrovascular Circulation (82-93); Ultrasonics/diagnostic use (74-84); Ultrasonography (85-93) T,E& qUltrasonography, Doppler, Pulsed E01.357.947.390.800 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler Echocardiography, Doppler, Pulsed Ultrasonography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return. Blood Flow Velocity (74-94); Ultrasonics (74-94); Ultrasonography (85-94)  X&&T'XUltrasonography, Doppler, Duplex E01.357.947.390.775 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler Ultrasonography, Doppler, Color (+ 1) Ultrasonography applying the Doppler effect combined with real-time imaging. The real-time image is created by rapid movement of the ultrasound beam. A powerful advantage of this technique is the ability to estimate the velocity of flow from the Doppler shift frequency. Blood Flow Velocity (82-94); Ultrasonics/diagnostic use (81-84); Ultrasonography (84-94)  [ &&T-=iUltrasonography, Doppler, Color E01.357.947.390.775.750 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler; Ultrasonography, Doppler, Duplex Echocardiography, Doppler, Color Ultrasonography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. This type of ultrasonography is well-suited to identifying the location of high-velocity flow (such as in a stenosis) or of mapping the extent of flow in a certain region. Blood Flow Velocity (85-94); Ultrasonography (85-94)  ]%&z&j?Ultrasonography, Doppler E01.357.947.390 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnostic Imaging; Ultrasonography Echocardiography, Doppler (+ 2); Ultrasonography, Doppler, Duplex (+ 2); Ultrasonography, Doppler, Pulsed (+ 1); Ultrasonography, Doppler, Transcranial Ultrasonography applying the Doppler effect, with frequency-shifted ultrasound reflections produced by moving targets (usually red blood cells) in the bloodstream along the ultrasound axis in direct proportion to the velocity of movement of the targets, to determine both direction and velocity of blood flow. (Stedman, 25th ed). Blood Flow Velocity (74-94); Ultrasonics/diagnostic use (74-84); Ultrasonography (85-94)  `&7~iUltrasonography E01.357.947 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging Echocardiography (+ 4); Echoencephalography (+ 1); Ultrasonography, Doppler (+ 9); Ultrasonography, Interventional; Ultrasonography, Mammary; Ultrasonography, Prenatal The visualization of deep structures of the body by recording the reflections of echoes of pulses of ultrasonic waves directed into the tissues. Use of ultrasound for imaging or diagnostic purposes employs frequencies ranging from 1.6 to 10 megahertz. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  c"$'&Ultrasonics H01.671.031.849 AECLHI Physical Sciences (Non MeSH); Physics; Acoustics Phonophoresis; Sonication AECLCTDUECHIISMOMTNUPXSNSTTDUTVE f <$Ultrasonic Therapy E02.780.480.280.945 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Hyperthermia, Induced; Diathermy The use of focused, high-frequency sound waves to produce local hyperthermia in certain diseased or injured parts of the body or to destroy the diseased tissue. g`"LUltrafiltration E04.292.975; E05.196.454.807; H01.181.529.365.807; H01.671.100.534.807 ISMT Hemofiltration; Micropore Filters Surgery, Operative; Extracorporeal Circulation Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Filtration Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Filtration Physical Sciences (Non MeSH); Physics; Biophysics; Filtration Hemofiltration (+ 1) Hemofiltration (+ 1) Hemofiltration (+ 1) Hemofiltration (+ 1) The separation of particles from a suspension by passage through a filter with very fine pores. In ultrafiltration the separation is accomplished by convective transport; in DIALYSIS separation relies instead upon differential diffusion. Ultrafiltration occurs naturally and is a laboratory procedure. Artificial ultrafiltration of the blood is referred to as HEMOFILTRATION or HEMODIAFILTRATION (if combined with HEMODIALYSIS). Filtration (70-72) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE (hP(%b$Ultracentrifugation E05.181.724; E05.196.941 AECLCTECHIISMOMTNUPXSNSTTDUTVE Centrifugation Miscellaneous Techniques (Non MeSH); Centrifugation Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Centrifugation, Density Gradient (+ 2) Centrifugation, Density Gradient (+ 2) Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed).  mS"ZUltimobranchial Body A13.939 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Calcitonin Thyroid Gland Animal Terms (Non MeSH) Calcitonin (66-72); Thyroid Gland (66-72)  o :3Ulnar Nerve Compression Syndrome C10.772.491.957 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Nerve Compression Syndromes A condition caused by compression or entrapment of the ulnar nerve. It may involve both sensory and motor problems and most often results from compression or entrapment of the ulnar nerve at the elbow (cubital tunnel syndrome). Compression of the nerve may occur during normal activities or as a complication of general anesthesia. Nerve Compression Syndromes (68-93); Ulnar Nerve (66-93) p'NgDUlnar Nerve A08.800.800.720.050.850 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Brachial Plexus A major nerve of the upper extremity. In humans, the fibers of the ulnar nerve originate in the lower cervical and upper thoracic spinal cord (usually C7 to T1), travel via the medial cord of the brachial plexus, and supply sensory and motor innervation to parts of the hand and forearm. sb8nXUlnar Artery A07.231.114.139.850 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Brachial Artery The larger of the two terminal branches of the brachial artery, beginning about one centimeter distal to the bend of the elbow. Like the RADIAL ARTERY, its branches may be divided into three groups corresponding to their locations in the forearm, wrist, and hand. Arteries (66-92); Forearm/blood supply (66-92); Hand/blood supply (66-92) u8L8ZUlna Fractures C21.866.088.268.807; C21.866.405.908 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries; Forearm Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures  Monteggia's Fracture Fractures of the larger bone of the forearm. Forearm Injuries (66-72); Fractures (66-72); Ulna (66-72)  x*N8GUlna A02.835.232.087.911 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH) z5:VUlcer C23.739.941 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Corneal Ulcer; Peptic Ulcer; Skin Ulcer Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue. { N2YUkraine Z01.542.248.960; Z01.586.200.960; Z01.586.950.960 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR | 9Uganda Z01.058.290.120.880 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern ~ _Ubiquitin D12.776.660.235.400.800; D12.776.664.235.400.850 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins; Chromosomal Proteins, Non-Histone; High Mobility Group Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Chromosomal Proteins, Non-Histone; High Mobility Group Proteins A family of proteins found in all eukaryotes that is widely distributed in the organism. It contains a highly conserved sequence of 76 amino acids that is identical in a wide variety of sources including humans, fish, and insects. It participates in diverse cellular functions, such as protein degradation, chromatin structure, and heat shock, by conjugation to other proteins through the carboxy terminus. (From Merck Index, 11th ed). Chromosomal Proteins, Non-Histone (77-84); Nucleoproteins (66-77); Peptides (75-80) ~ 6HAbUbiquinone D02.806.250.900; D08.176.935 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Organic Chemicals (Non MeSH); Quinones; Benzoquinones Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes A lipid-soluble benzoquinone which is involved in electron transport in mitochondrial preparations. The compound occurs in the majority of aerobic organisms, from bacteria to higher plants and animals.  "FUbiquinol-Cytochrome-c Reductase D08.586.600.925; D08.586.682.925 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An 11-subunit enzyme complex that acts as an electron transferring protein in the mitochondrial respiratory chain. The enzyme complex catalyzes the oxidation of ubiquinol to ubiquinone and ferrocytochrome c in the presence of ferricytochrome c. It contains cytochromes b-562, b-566, and c1 as well as an iron ferredoxin. EC 1.10.2.2. Cytochrome Reductases (74-79); Multienzyme Complexes (73-86); Oxidoreductases (66-73); Quinone Reductases (75-86) %&FTyrothricin D20.085.116.875; D20.187.925 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Anti-Infective Agents; Anti-Infective Agents, Local Gramicidins; Tyrocidine Gramicidins; Tyrocidine A polypeptide antibiotic mixture obtained from Bacillus brevis. It consists of a mixture of three tyrocidines (60%) and several gramicidins (20%) and is very toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. It is used topically. "<|8&Tyrosyl T RNA Synthetase D08.586.464.136.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates tyrosine with its specific transfer RNA. EC 6.1.1.1. Amino Acyl T RNA Synthetases (72-74); Tyrosine (72-74) Ft^CTyrosine 3-Monooxygenase D08.586.682.420.923 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2. Hydroxylases (66-70) FhTyrosine Transaminase D08.586.913.140.873 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Aminotransferases An enzyme that catalyzes the conversion of L-tyrosine and 2-oxoglutarate to 4-hydroxyphenylpyruvate and L-glutamate. It is a pyridoxal-phosphate protein. L-Phenylalanine can act instead of L-tyrosine. The mitochondrial enzyme may be identical with aspartate transaminase (EC 2.6.1.1.). EC 2.6.1.5. FjXTyrosine Phenol-Lyase D08.586.520.940 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that catalyzes the cleavage of tyrosine to phenol, pyruvate, and ammonia. It is a pyridoxal phosphate protein. The enzyme also slowly catalyzes pyruvate formation from D-tyrosine, L-cysteine, S-methyl-L-cysteine, L-serine, and D-serine. EC 4.1.99.2. Lyases (72-74); Phenols (74); Tyrosine (72-74) FO-;Tyrosine Decarboxylase D08.586.520.258.090.848 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases; Aromatic Amino Acid Decarboxylases A pyridoxal-phosphate protein that catalyzes the conversion of L-tyrosine to tyramine and carbon dioxide. The bacterial enzyme also acts on 3-hydroxytyrosine and, more slowly, on 3-hydroxyphenylalanine. (From Enzyme Nomenclature, 1992) EC 4.1.1.25. 9FTyrosine D12.125.072.917 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) Diiodotyrosine; Iodotyrosine; Methyltyrosines AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  Fn5HTyropanoate D02.455.426.559.389.454.950; D02.455.526.581.496.950; D26.298.950 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Iodobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Iodinated; Iodobenzenes Miscellaneous Drugs and Agents (Non MeSH); Contrast Media Sodium 3-butyramido-alpha-ethyl-2,4,6-triiodohydro-cinnamate. A diagnostic aid as a radiopaque medium in cholecystography. Synonyms: WIN 8851-2; Bilopaque. Butyrates (74); Iodobenzoates (74) I.l+Tyrocidine D20.085.116.875.875; D20.187.925.927 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Tyrothricin Anti-Infective Agents; Anti-Infective Agents, Local; Tyrothricin An antibiotic mixture produced by Bacillus brevis which may be separated into three components, tyrocidines A, B, and C. It is the major constituent (40-60 per cent) of tyrothricin, gramicidin accounting for the remaining 10-20 per cent active material. It is a topical antimicrobial agent, that is very toxic parenterally. Peptides, Cyclic (74); Tyrothricin (66-74) *<z4Tyramine D02.092.211.215.811; D14.100.050.600.050.940; D14.100.050.600.940; D14.100.600.050.940; D14.600.100.900; D16.050.870.940 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Octopamine; Synephrine An indirect sympathomimetic. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine may be a neurotransmitter in some invertebrate nervous systems. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR   >C!DTyphus, Epidemic Louse-Borne C01.252.400.810.700.810.800.950 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rickettsia Infections Brill's Disease The classic form of typhus, caused by RICKETTSIA PROWAZEKII, which is transmitted from man to man by the louse Pediculus humanus corporis. This disease is characterized by the sudden onset of intense headache, malaise, and generalized myalgia followed by the formation of a macular skin eruption and vascular and neurologic disturbances. "#PTyphus, Endemic Flea-Borne C01.252.400.810.700.810.800.943 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rickettsia Infections An infectious disease clinically similar to epidemic louse-borne typhus (TYPHUS, EPIDEMIC LOUSE-BORNE), but caused by RICKETTSIA TYPHI, which is transmitted from rat to man by the rat flea, Xenopsylla cheopis. p #PTyphoid-Paratyphoid Vaccines D24.310.894.135.910 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines !>pTyphoid C01.252.400.310.821.873 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Salmonella Infections An acute enteric infection caused by SALMONELLA TYPHI. ! PBType A Personality F01.752.747.880 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Established behavior pattern characterized by excessive drive and ambition, impatience, competitiveness, sense of time urgency, and poorly contained aggression. Coronary Disease (66-84); Personality (66-84) `7Tympanoplasty E04.847.774.873 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Myringoplasty Ear, Middle; Tympanic Membrane; Myringoplasty Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Surgical reconstruction of the hearing mechanism of the middle ear, with restoration of the drum membrane to protect the round window from sound pressure, and establishment of ossicular continuity between the tympanic membrane and the oval window. (Dorland, 27th ed.).  G$7e:Tympanic Membrane Perforation C09.218.903; C21.866.930 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries An opening in the tympanic membrane usually caused by trauma. There are four general categories: compression injuries (the most common and usually the result of a blow to the ear); instrumentation injuries (the second most common, usually inadvertent, caused often by cotton swabs or bobby-pins); burn-slag injuries (frequently seen in industry, from hot metal from machines or welding); and blast injuries (usually seen during war or as a result of terrorist bombing). In the absence of infection, most traumatic tympanic membrane perforations heal spontaneously. Persistent perforation is usually a manifestation of tubotympanitis, an inflammation of the eustachian tube and tympanic cavity (middle ear). (From Paparella, Shumrick, Gluckman, and Meyerhoff: Otolaryngology, vol. II, 3d ed). Tympanic Membrane/injuries (66-93) #N)Tympanic Membrane A09.246.397.873 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Myringoplasty; Tympanoplasty Sense Organs; Ear; Ear, Middle :"(Tymovirus B04.715.464.750; B04.820.464.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses A group of plant viruses with a narrow host range that includes crucifers. Transmission occurs by beetles and mechanical inoculation. Plant Viruses (66-93) m &\Tylosin D20.085.115.362.850 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Leucomycins Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans. Antibiotics (66-80); Leucomycins (81-89)  <S1Tylenchoidea B01.500.294.700.825.825 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Tylenchida A superfamily of nematodes whose members are free-living saprophytes or parasites of plants. Ova are sometimes found in human feces after ingestion of infected plants. *GTylenchida B01.500.294.700.825 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea Tylenchoidea An order of nematodes consisting of many species which are plant parasites. Female worms lay eggs that hatch either in soil or in the host plant. 5*9Twins, Monozygotic G08.520.800.708.838; M01.438.873.940 CLEDGEHILJPXSN Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple; Twins Named Groups (Non MeSH); Multiple Birth Named Groups (Non MeSH); Twins Two offspring developed from one fertilized ovum. *<Twins, Dizygotic G08.520.800.708.800; M01.438.873.920 CLEDGEHILJPXSN Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple; Twins Named Groups (Non MeSH); Multiple Birth Named Groups (Non MeSH); Twins Two offspring produced in the same pregnancy from separate ova fertilized at the same time. *nTwins, Conjoined C16.131.581.806 CLEMPAPPPXSU Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Monsters UTwins G08.520.800.708; M01.438.873 CLEDGEHILJPXSN Diseases in Twins Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple Named Groups (Non MeSH); Multiple Birth Named Groups (Non MeSH) Twins, Dizygotic; Twins, Monozygotic Twins, Dizygotic; Twins, Monozygotic ` "VTwin Studies E05.318.760.900; G03.850.520.835.900; N05.715.360.775.750 CLECHIISLJMTSDSNSTTDUT Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH) Methods of detecting genetic etiology in human traits. The basic premise of twin studies is that monozygotic twins, being formed by the division of a single fertilized ovum, carry identical genes, while dizygotic twins, being formed by the fertilization of two ova by two different spermatozoa, are genetically no more similar than two siblings born after separate pregnancies. (Last, J.M., A Dictionary of Epidemiology, 2d ed). Diseases in Twins (66-94); Twins (66-94) A3Turtles B02.833.848 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles Reptiles (66-67) . &Turpentine D26.948 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH)  ,2Turner's Syndrome C13.371.820.700.842.309.872; C16.131.280.748.805; C16.131.939.842.309.872; C19.391.775.309.872 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis A disorder of gonadal differentiation, marked by short stature, undifferentiated (streak) gonads, and variable abnormalities that may include webbing of the neck, low posterior hair line, increased carrying angle of the elbow, cubitus valgus, and cardiac defects. It is typically associated with absence of the second sex chromosome (XO, or 45,X), although structural abnormality of one X chromosome or mosaicism (e.g., XX/XX or X/XXX) may also be responsible. The phenotype is female and patients are usually sterile. (Dorland, 27th ed). WhLuTurkmenistan Z01.252.100.940; Z01.586.200.940; Z01.586.950.940 EHEP Geographicals (Non MeSH); Asia; Asia, Central Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR C9Turkeys B02.248.617.872 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Poultry Poultry (66-67) ͭ &#Turkey Z01.252.245.500.850; Z01.586.500.850 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East K *Turbinates A02.835.232.781.324.948; A04.531.898 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones Respiratory System; Nose The scroll-like bony plates with curved margins on the lateral wall of the nasal cavity. G*:rkTurbellaria B01.500.736.847 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths Planarians A class of free-living freshwater flatworms of North America. й*0JTupaiidae B02.649.875.770 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Scandentia Tupaia The only family of the order SCANDENTIA, variously included in the order Insectivora or in the order Primates, and often in the order Microscelidea, consisting of five genera. They are TUPAIA, Ananthana (Indian tree shrew), Dendrogale (small smooth-tailed tree shrew), Urogale (Mindanao tree shrew), and Ptilocercus (pen-tailed tree shrew). The tree shrews inhabit the forest areas of eastern Asia from India and southwestern China to Borneo and the Philippines. Ѵ (( Tupaia B02.649.875.770.770 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Scandentia; Tupaiidae A genus of tree shrews of the family TUPAIIDAE which consists of about 12 species. One of the most frequently encountered species is T. glis. Members of this genus inhabit rain forests and secondary growth areas in southeast Asia. Primates (72-74); Tupaiidae (75-80) r (5,Tunisia Z01.058.266.887 EHEP Geographicals (Non MeSH); Africa; Africa, Northern V >Tunicamycin D20.085.900; D20.388.913 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Anti-Infective Agents; Antibiotics Anti-Infective Agents; Antiviral Agents An N-acetylglycosamine containing antiviral antibiotic obtained from Streptomyces lysosuperificus. It is also active against some bacteria and fungi, because it inhibits the glucosylation of proteins. Tunicamycin is used as tool in the study of microbial biosynthetic mechanisms. Antibiotics (66-78); Glucosamine (66-78) DVB1Tunica Media A02.633.570.491.800; A07.231.491.800; A10.690.467.491.800 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Smooth; Muscle, Smooth, Vascular Cardiovascular System; Blood Vessels; Muscle, Smooth, Vascular Tissue Types (Non MeSH); Muscles; Muscle, Smooth; Muscle, Smooth, Vascular The middle coat of blood vessel walls, composed principally of thin, cylindrical, smooth muscle cells and elastic tissue. It accounts for the bulk of the wall of most arteries. The smooth muscle cells are arranged in circular layers around the vessel, and the thickness of the coat varies with the size of the vessel. specific blood vessel (66-92); Muscle, Smooth (66-79); Muscle, Smooth, Vascular (80-92) :A8yiTunica Intima A07.231.330.800; A07.231.700; A10.272.491.355.800 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Endothelium, Vascular Cardiovascular System; Blood Vessels Tissue Types (Non MeSH); Epithelium; Endothelium; Endothelium, Vascular The innermost coat of blood vessels, consisting of a thin lining of endothelial cells longitudinally oriented and continuous with the endothelium of capillaries on the one hand and the endocardium of the heart on the other. specific blood vessel (66-87); Endothelium, Vascular (88-92) 98HTungsten Compounds D01.940 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Phosphotungstic Acid Inorganic compounds that contain tungsten as an integral part of the molecule. Tungsten (66-93)  ߂ 8%^Tungsten D01.268.930; D01.552.912 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Tungsten. A metallic element with the atomic symbol W, atomic number 74, and atomic weight 183.85. It is used in many manufacturing applications, including increasing the hardness, toughness, and tensile strength of steel; manufacture of filaments for incandescent light bulbs; and in contact points for automotive and electrical apparatus.  :`Tuna B02.493.900 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Large, vigorous ocean fishes. ,&%Tumor Viruses, Murine B04.820.650.730.730.900; B04.909.574.807.730.730.900; B04.909.777.731.730.730.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Leukemia Viruses, Murine (+ 9); Sarcoma Viruses, Murine (+ 3) Leukemia Viruses, Murine (+ 9); Sarcoma Viruses, Murine (+ 3) Leukemia Viruses, Murine (+ 9); Sarcoma Viruses, Murine (+ 3) Species of mammalian type C retroviruses (RETROVIRUSES TYPE C, MAMMALIAN) that cause solid tumors or leukemias in mice. YTumor Virus Infections C02.928; C04.619.935; C04.925 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Oncogenic Viruses; Neoplasms, Experimental Virus Diseases Neoplasms; Neoplasms, Experimental Neoplasms Avian Leukosis; Marek's Disease; Murine Acquired Immunodeficiency Syndrome; Sarcoma, Avian; Warts (+ 2) Avian Leukosis; Marek's Disease; Sarcoma, Avian Avian Leukosis; Marek's Disease; Sarcoma, Avian; Warts (+ 1) Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Oncogenic Viruses (66-71); Virus Diseases (66-71) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI (%P2E<ZTumor Stem Cells A11.872.910 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Stem Cells Colony-forming cells which give rise to neoplasms. Cell Line (69-85); Clone Cells (75-83); Colony-Forming Units Assay (79-83); Neoplasms, Experimental (75-83); Neoplasms/pathology (75-83); Stem Cells (84-85); specific neoplasm/PA (75-83) *=Tumor Stem Cell Assay E05.337.300.250.200.800; E05.909.262.383.910; E05.909.262.388.930 ECHIISMTSNSTUTVE Miscellaneous Techniques (Non MeSH); Evaluation Studies; Drug Approval; Drug Screening; Drug Screening Assays, Antitumor Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Colony-Forming Units Assay Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Drug Screening Assays, Antitumor A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents. Colony-Forming Units Assay (79-83); specific neoplasm (72-83) IITumor Necrosis Factor D12.776.124.900; D12.776.395.930; D24.185.926.235.930; D24.611.350.500.800 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Tumor Lysis Syndrome; Necrosis Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Cytotoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Monokines Serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes which has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. It mimics the action of endotoxin but differs from it. It has a molecular weight of less than 70,000 kDa. Endotoxins (75-87); Glycoproteins (75-87); Necrosis (75-87)  TD&hHTumor Markers, Biological D24.185.101.840 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers alpha Fetoproteins; Antigens, CD30; Antigens, Tumor-Associated, Carbohydrate (+ 4); Autocrine Motility Factor; Carcinoembryonic Antigen; Membrane Metallo-Endopeptidase; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Proto-Oncogene Proteins c-erbB-2; Synaptophysin Molecular products which are metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  :Bc>HTumor Lysis Syndrome C15.604.515.880; C20.683.515.950 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tumor Necrosis Factor Antineoplastic Agents Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia. Antineoplastic Agents/therapeutic use (84-88); Antineoplastic Agents, Combined/adverse effects/therapeutic use (80-88); Burkitt's Lymphoma/complications (80-88) $&LTumor Cells, Cultured A11.251.928 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Drug Screening Assays, Antitumor Tissue Culture Cells; Cells, Cultured Hela Cells; KB Cells; PC12 Cells Cells grown in vitro from neoplastic tissue for use in studying the proliferative and metabolic capacities of tumor cells, in predicting clinical responses to chemotherapy, in screening new antitumor agents, and in basic biological research. They include carcinoma cell lines. Cell Line (66-87); Cells, Cultured (72-87); Clone Cells (70-83); Tissue Culture (66-82) (1*'+AlTularemia C01.252.400.825.900; C01.252.400.939 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections A plague-like disease of rodents, transmissible to man. It is caused by FRANCISELLA TULARENSIS and is characterized by fever, chills, headache, backache, and weakness.  *PTuftsin D12.644.456.840; D24.611.924 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) N(2)-(1-(N(2)-L-Threonyl)-L-lysyl)-L-prolyl)-L-arginine. A tetrapeptide produced in the spleen by enzymatic cleavage of a leukophilic gamma globulin. It stimulates the phagocytic activity of blood polymorphonuclear leukocytes and neutrophils in particular. The peptide is located in the Fd fragment of the gamma globulin molecule. Immunoglobulins, Fd (73-74); Oligopeptides (73-74) Q "F<Tubulina B01.841.750.656.475.100.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida Amoeba; Endolimax; Entamoeba (+ 1); Hartmannella A suborder of ameboid protozoa characterized by a branched or unbranched cylindrical body and the absence of bidirectional cytoplasmic flow. Nuclear division is mesomitotic. V &V=Tubulin D12.776.220.600.800; D12.776.641.920 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microtubule Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from sperm flagella, cilia, and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to colchicine, vincristine, and vinblastine. Microtubules (70-74); Nerve Tissue Proteins (66-74) + *H>Tubocurarine D02.092.102.922; D02.675.276.922; D03.132.267.847; D14.100.120.200.600.170.860; D16.700.710.575.130.900 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Heterocyclic Compounds; Alkaloids; Curare Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists; Curare Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Curare An alkaloid isolated from the bark and stem of Chondrodendron tomentosum R. and P. (Menispermaceae). It is the active principle of CURARE. The chloride salt, a neuromuscular blocking agent, is administered intravenously to relax skeletal muscles in surgery, tetanus, and shock therapy, and may be used for diagnosis of myasthenia gravis in certain cases. (From Dorland, 27th ed).  bs@&Tuberous Sclerosis C10.496.933; C16.131.445.810; F03.709.346.944 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fibroma Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Hamartoma Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An autosomal disorder characterized pathologically by multiple nodular tumors throughout the cerebral cortex and clinically manifested by mental retardation and epileptic convulsions. ,5N Tuberculosis, Urogenital C01.252.410.040.552.846.944; C12.672; C13.371.803 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Urologic and Male Genital Diseases (Non MeSH) Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Tuberculosis, Female Genital; Tuberculosis, Male Genital; Tuberculosis, Renal Tuberculosis, Male Genital; Tuberculosis, Renal Tuberculosis, Female Genital A general term for tuberculosis of the urinary and/or genital systems or urinary organs other than the kidney, which is TUBERCULOSIS, RENAL. 9PZTuberculosis, Splenic C01.252.410.040.552.846.922; C15.604.744.909 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases Infection of the spleen with species of MYCOBACTERIUM. -2PBTuberculosis, Spinal C01.252.410.040.552.846.831.722; C05.116.165.886.722; C05.116.900.902 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Osteoarticular Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH); Tuberculosis, Osteoarticular Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Osteitis or caries of the vertebrae, usually occurring as a complication of tuberculosis of the lungs. HMPzTuberculosis, Renal C01.252.410.040.552.846.944.847; C12.672.847; C12.777.419.912 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Urogenital Urologic and Male Genital Diseases (Non MeSH); Tuberculosis, Urogenital Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Infection of the kidney with species of MYCOBACTERIUM. 7EPBTuberculosis, Pulmonary C01.252.410.040.552.846.899; C08.381.922; C08.730.939 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Collapse Therapy; Mass Chest X-Ray; Pneumonectomy Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory Tract Infections Silicotuberculosis Silicotuberculosis Silicotuberculosis Tuberculosis of the lungs.  =P</>"Tuberculosis, Pleural C01.252.410.040.552.846.877; C08.528.928; C08.730.912 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Respiratory Tract Diseases; Pleural Diseases Respiratory Tract Diseases; Respiratory Tract Infections Empyema, Tuberculous Empyema, Tuberculous Empyema, Tuberculous Tuberculosis of the serous membrane lining the thoracic cavity and surrounding the lungs. w=P2GjTuberculosis, Peritoneal C01.252.410.040.552.846.854; C06.772.922 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Digestive System Diseases; Peritoneal Diseases Tuberculosis of the serous lining of the abdomen. !(.P=Tuberculosis, Osteoarticular C01.252.410.040.552.846.831; C05.116.165.886 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH) Tuberculosis, Spinal Tuberculosis, Spinal Tuberculosis of the bones or joints. #!2P0.Tuberculosis, Oral C01.252.410.040.552.846.809; C07.465.943 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Stomatognathic Diseases; Mouth Diseases Tuberculosis of the mouth, tongue, and salivary glands. Mouth Diseases (66-71); specific oral disease (66-71); Tuberculosis (66-71) %W.PC[Tuberculosis, Ocular C01.252.354.800; C01.252.410.040.552.846.786; C01.539.375.354.800; C11.294.354.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial Eye Diseases; Eye Infections; Eye Infections, Bacterial Tuberculous infection of the eye, primarily the iris, ciliary body, and choroid. '\P`Tuberculosis, Multidrug-Resistant C01.252.410.040.552.846.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Drug Resistance, Microbial; Antitubercular Agents; Drug Resistance, Multiple Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Tuberculosis resistant to chemotherapy with two or more antitubercular agents. The problem of resistance is particularly troublesome in tuberculosis as an opportunistic disease in HIV infection. Drug Resistance, Microbial (90-93); Tuberculosis (90-93); Tuberculosis, Pulmonary (90-93)  *&PYiTuberculosis, Miliary C01.252.410.040.552.846.764 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis An acute form of TUBERCULOSIS in which minute tubercles are formed in a number of organs of the body due to dissemination of the bacilli through the blood stream. -PTuberculosis, Meningeal C01.252.410.040.552.846.741; C01.252.580.915; C10.228.228.507.280.915 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Meningitis, Bacterial Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Bacterial Tuberculous meningitis. The causative agent is MYCOBACTERIUM TUBERCULOSIS. 0 MPWTuberculosis, Male Genital C01.252.410.040.552.846.944.721; C12.294.889; C12.672.721 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Urogenital Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Urologic and Male Genital Diseases (Non MeSH); Tuberculosis, Urogenital Tuberculosis of the genitalia in men. 3 AP/Tuberculosis, Lymph Node C01.252.410.040.552.846.719; C15.604.921 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI King's Evil Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases King's Evil King's Evil Infection of the lymph nodes by tuberculosis. Tuberculous infection of the cervical lymph nodes is scrofula.  5.PTuberculosis, Laryngeal C01.252.410.040.552.846.696; C08.360.860; C08.730.860; C09.400.860 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Respiratory Tract Diseases; Laryngeal Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Laryngeal Diseases Tuberculosis involving the larynx, producing ulceration of the vocal cords and laryngeal mucosa. It is commonly attended by hoarseness, cough, pain on swallowing, and hemoptysis. 7LPkTuberculosis, Hepatic C01.252.410.040.552.846.651; C06.552.933 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Digestive System Diseases; Liver Diseases Infection of the liver with tubercle bacilli producing localized granulomata, miliary lesions, or tuberculoma. ;.PTuberculosis, Gastrointestinal C01.252.410.040.552.846.628; C06.405.831 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Digestive System Diseases; Gastrointestinal Diseases Gastric and/or enteric tuberculosis. This condition is marked by spreading ulcers and diarrhea. =?#.PrTuberculosis, Female Genital C01.252.410.040.552.846.944.596; C13.371.803.940 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Urogenital Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Tuberculosis, Urogenital Tuberculosis of the genitalia in women. ?o"6P_1Tuberculosis, Endocrine C01.252.410.040.552.846.606; C19.927 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Endocrine Diseases Tuberculous infection of the endocrine glands. A*P8Tuberculosis, Cutaneous C01.252.410.040.552.846.583; C01.252.825.820; C01.539.800.720.820; C17.800.838.765.820 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Erythema Induratum; Lupus Erythema Induratum; Lupus Erythema Induratum; Lupus Erythema Induratum; Lupus Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not lupus vulgaris, which is LUPUS. C`P&zTuberculosis, Cardiovascular C01.252.410.040.552.846.561; C14.826 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Cardiovascular Diseases Pericarditis, Tuberculous Pericarditis, Tuberculous Tuberculosis of the heart, pericardium, or blood vessels. G!*P:ETuberculosis, Bovine C01.252.410.040.552.846.538; C22.196.927 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Animal Diseases; Cattle Diseases An infection of cattle caused by MYCOBACTERIUM BOVIS. It is transmissible to man and other animals. I.JxTuberculosis, Avian C01.252.410.040.552.846.516; C22.131.921 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Animal Diseases; Bird Diseases A variety of TUBERCULOSIS affecting various birds, including chickens and ducks. It is caused by MYCOBACTERIUM AVIUM and characterized by tubercles consisting principally of epithelioid cells. It may be transmitted to other animals including man. K.JTuberculosis Societies N03.540.630.780.850 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit; Voluntary Health Agencies Voluntary agencies concerned with prevention and treatment of tuberculosis. NXTuberculosis C01.252.410.040.552.846 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antitubercular Agents; Tuberculin Test Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections Tuberculoma (+ 1); Tuberculosis, Avian; Tuberculosis, Bovine; Tuberculosis, Cardiovascular (+ 1); Tuberculosis, Cutaneous (+ 2); Tuberculosis, Endocrine; Tuberculosis, Gastrointestinal; Tuberculosis, Hepatic; Tuberculosis, Laryngeal; Tuberculosis, Lymph Node (+ 1); Tuberculosis, Meningeal; Tuberculosis, Miliary; Tuberculosis, Multidrug-Resistant; Tuberculosis, Ocular; Tuberculosis, Oral; Tuberculosis, Osteoarticular (+ 1); Tuberculosis, Peritoneal; Tuberculosis, Pleural (+ 1); Tuberculosis, Pulmonary (+ 1); Tuberculosis, Splenic; Tuberculosis, Urogenital (+ 3) Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM.  OP.nTuberculoma, Intracranial C01.252.410.040.552.846.493.400; C10.228.140.950 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculoma Nervous System Diseases; Central Nervous System Diseases; Brain Diseases A well-circumscribed mass found cortically or subcortically in the cerebral or cerebellar hemispheres. In under-developed countries where tuberculosis is endemic these lesions are quite common. Management of intracranial tuberculomas includes antituberculosis chemotherapy and neurosurgical evacuation of tuberculomas singly or in combination. Brain Diseases (68-91); Tuberculoma (68-91) TF6P"5Tuberculoma C01.252.410.040.552.846.493 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Granuloma Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis Tuberculoma, Intracranial A tumor-like mass resulting from the enlargement of a tuberculous lesion.  WP XTuberculin Test E01.223.495.862.870; E01.862.870 AECLCTECHIISMOMTNUPXSNSTTDUTVE Tuberculosis Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Skin Tests Diagnosis; Skin Tests Any of a large number of skin tests for tuberculosis using various types of TUBERCULIN and various methods of application. Tuberculin or its purified protein derivative is injected into the skin or applied as a patch. The diagnosis of tuberculosis is based on the degree of induration and erythema. The tuberculin test, however, does not distinguish between infection in a resistant person without disease and a person with clinical manifestations of tuberculosis. (Dorland, 27th ed; Stedman, 25th ed). Y&"fNTuberculin D24.611.216.161.845 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial ] 6Tubercidin D13.570.583.910; D13.570.800.850; D20.085.075.975; D22.204.144.975; D26.087.939 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine. An antibiotic purine ribonucleoside which readily substitutes for adenosine in the biological system, but its incorporation into DNA and RNA has an inhibitory effect on the metabolism of these nucleic acids. Pyrimidines (73-74); Pyrroles (73-74); Ribonucleosides (73-74) ^[<3KTuber Cinereum A08.186.211.730.385.357.870 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus Layer of gray matter in the hypothalamus that also forms part of the floor of the third ventricle. b(8jxTsetse Flies B01.131.617.289.400.700 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Glossinidae Bloodsucking flies of the genus Glossina, found primarily in equatorial Africa. Several species are intermediate hosts of trypanosomes. c(DTryptophanyl T RNA Synthetase D08.586.464.136.790 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates tryptophan with its specific transfer RNA. EC 6.1.1.2. Amino Acyl T RNA Synthetases (74); Tryptophan (74) d$Ft`?Tryptophanase D08.586.520.920 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that catalyzes the conversion of L-tryptophan and water to indole, pyruvate, and ammonia. It is a pyridoxal-phosphate protein, requiring K+. It also catalyzes 2,3-elimination and beta-replacement reactions of some indole-substituted tryptophan analogs of L-cysteine, L-serine, and other 3-substituted amino acids. (From Enzyme Nomenclature, 1992) EC 4.1.99.1. Hydro-Lyases (66-71) fFOTryptophan Synthase D08.586.520.497.859; D08.586.600.896 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes An enzyme that catalyzes the conversion of L-serine and 1-(indol-3-yl)glycerol 3-phosphate to L-tryptophan and glyceraldehyde 3-phosphate. It is a pyridoxal phosphate protein that also catalyzes the conversion of serine and indole into tryptophan and water and of indoleglycerol phosphate into indole and glyceraldehyde phosphate. (From Enzyme Nomenclature, 1992) EC 4.2.1.20. Hydro-Lyases (66-71) iK*FTryptophan Oxygenase D08.586.682.690.803 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases A protohemoprotein. Forms formylkynurenine from L-tryptophan and molecular oxygen. EC 1.13.11.11. lFfrTryptophan Hydroxylase D08.586.682.420.870 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases An enzyme that catalyzes the hydroxylation of tryptophan to 5-hydroxytryptophan in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of serotonin. EC 1.14.16.4. Hydroxylases (66-72) mFhTryptophan D12.125.072.859; D12.125.142.875 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Eosinophilia-Myalgia Syndrome Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential 5-Hydroxytryptophan An amino acid which, in its L-form, is classified as an essential component in human nutrition. It is not synthesized by the human body.  o&F"Tryptamines D02.092.211.215.801; D03.438.473.914 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Receptors, Serotonin Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles N,N-Dimethyltryptamine (+ 1); Serotonin (+ 1) Dihydroxytryptamines (+ 2); N,N-Dimethyltryptamine (+ 2); Melatonin; Psilocybine; Serotonin (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  rF*<DTrypsinogen D08.444.885 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Pancreatic Juice Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors tFPTrypsin Inhibitors D08.373.745.800.900; D12.776.950 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins alpha 1-Antitrypsin; Aprotinin; Ovomucin; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitor, Kazal Pancreatic; Trypsin Inhibitor, Kunitz Soybean Aprotinin; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitor, Kazal Pancreatic; Trypsin Inhibitor, Kunitz Soybean Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  u&D:tHTrypsin Inhibitor, Kunitz Soybean D08.373.745.800.900.890; D12.776.950.920 ADAEAGANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Trypsin Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Trypsin Inhibitors A high-molecular-weight protein (approximately 22,500) containing 198 amino acid residues. It is a strong inhibitor of trypsin and human plasmin. Plant Proteins (72-74); Soybeans (72-74) x(.@2Trypsin Inhibitor, Kazal Pancreatic D08.373.745.800.900.880; D12.776.950.910 ADAEAGANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Trypsin Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Trypsin Inhibitors A pancreatic trypsin inhibitor common to all mammals. It is secreted with the zymogens into the pancreatic juice. It is a protein composed of 56 amino acid residues and is different in amino acid composition and physiological activity from the Kunitz bovine pancreatic trypsin inhibitor (APROTININ). Pancreatic Juice (72-74); Trypsin Inhibitors (72-74) {*.@`?Trypsin Inhibitor, Bowman-Birk Soybean D08.373.745.800.900.850; D12.776.950.900 ADAEAGANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Trypsin Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Trypsin Inhibitors A low-molecular-weight protein (minimum molecular weight 8000) which has the ability to inhibit trypsin as well as chymotrypsin at independent binding sites. It is characterized by a high cystine content and the absence of glycine. Plant Proteins (72-74); Soy Beans (72-74) ~-.@4Trypsin D08.586.277.656.732.760.895 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Pancreatic Juice Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases An enzyme of the hydrolase class that catalyzes the cleavage of peptide linkages involving the carboxyl group of either arginine or lysine. It is secreted by the pancreas as trypsinogen and converted to the active form in the small intestine. (From Dorland, 27th ed) EC 3.4.21.4.  DKTrypanosomiasis, Bovine C03.701.688.896; C03.752.625.896; C03.752.700.500.935.802; C22.196.888; C22.674.710.896 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Trypanosomiasis Animal Diseases; Cattle Diseases Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Infection in cattle caused by various species of trypanosomes. Trypanosomiasis (66-67); Trypanosomiasis, African (66-67) qcJKCTrypanosomiasis, African C03.752.700.500.935.719 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Trypanosomiasis A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the tsetse fly. Involvement of the central nervous system produces "African sleeping sickness." Nagana is a rapidly fatal trypanosomiasis of horses and other animals. PTrypanosomiasis C03.752.700.500.935 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Trypanocidal Agents Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections Chagas Disease (+ 1); Dourine; Trypanosomiasis, African; Trypanosomiasis, Bovine Infection with protozoa of the genus TRYPANOSOMA.  Pm`<Trypanosomatina B01.841.750.443.950.450.868 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida Crithidia (+ 1); Leishmania (+ 8); Trypanosoma (+ 7) A suborder of monoflagellate parasitic protozoa that lives in the blood and tissues of man and animals. Representative genera include: Blastocrithidia, Leptomonas, CRITHIDIA, Herpetomonas, LEISHMANIA, Phytomonas, and TRYPANOSOMA. Species of this suborder may exist in two or more morphologic stages formerly named after genera exemplifying these forms - amastigote (LEISHMANIA), choanomastigote (CRITHIDIA), promastigote (Leptomonas), opisthomastigote (Herpetomonas), epimastigote (Blastocrithidia), and trypomastigote (TRYPANOSOMA). Trypanosoma (66-85)  U&gD]Trypanosoma vivax B01.841.750.443.950.450.868.887.850 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma An active blood parasite that is present in practically all domestic animals in Africa, the West Indies, and parts of Central and South America. In Africa, the insect vector is the tsetse fly. In other countries, infection is by mechanical means indicating that the parasites have been introduced to these countries and have been able to maintain themselves in spite of the lack of a suitable intermediate host. It is a cause of nagana, the severity of which depends on the species affected. Trypanosoma (66-91) '&ETrypanosoma lewisi B01.841.750.443.950.450.868.887.410 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma A trypanosome found in the blood of adult rats and transmitted by the rat flea. It is generally non-pathogenic in adult rats but can cause lethal infection in suckling rats. Trypanosoma (66-71) h'&Trypanosoma cruzi B01.841.750.443.950.450.868.887.140 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma (66-71) d'&Trypanosoma congolense B01.841.750.443.950.450.868.887.128 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma A species of Trypanosome hemoflagellates that is carried by tsetse flies and causes severe anemia in cattle. These parasites are also found in horses, sheep, goats, and camels. Trypanosoma (66-83) Y'&Trypanosoma brucei rhodesiense B01.841.750.443.950.450.868.887.115 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma A hemoflagellate subspecies of parasitic protozoa that causes Rhodesian sleeping sickness in humans. It is carried by Glossina pallidipes, G. morsitans and occasionally other species of game-attacking tsetse flies. Trypanosoma (66-86); Trypanosoma brucei brucei (72-91) Z$'&ATrypanosoma brucei gambiense B01.841.750.443.950.450.868.887.110 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma A hemoflagellate subspecies of parasitic protozoa that causes Gambian or West African sleeping sickness in humans. The vector host is usually the tsetse fly (Glossina). Trypanosoma (66-71) "'&Trypanosoma brucei brucei B01.841.750.443.950.450.868.887.080 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Trypanosoma A hemoflagellate subspecies of parasitic protozoa that causes nagana in domestic and game animals in Africa. It apparently does not infect humans. It is transmitted by bites of tsetse flies (Glossina). Trypanosoma (66-71) '&Trypanosoma B01.841.750.443.950.450.868.887 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Trypanocidal Agents Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina Trypanosoma brucei brucei; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Trypanosoma congolense; Trypanosoma cruzi; Trypanosoma lewisi; Trypanosoma vivax A genus of flagellate protozoans found in the blood and lymph of vertebrates and invertebrates, both hosts being required to complete the life cycle.  #&zTrypanocidal Agents D21.370.884 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Trypanosoma; Trypanosomiasis Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Diminazene; Eflornithine; Ethidium; Melarsoprol; Pentamidine; SQ 18506; Stilbamidines; Suramin Agents destructive to the protozoal organisms belonging to the suborder Trypanosmatina. specific disease (66-71); Antiprotozoal Agents (66-71); Trypanosoma (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (^8"@qfZ:Trypan Blue D26.408.926 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes .;Truth Disclosure F01.145.209.800 Physician-Patient Relations; Professional-Patient Relations; Informed Consent Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Oral or written communication of the actual facts. dXR>Trustees M01.526.070.940; N04.452.394.600 CLECHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Administrative Personnel Health Services Administration (Non MeSH); Organization and Administration; Governing Board Board members of an institution or organization who are entrusted with the administering of funds and the directing of policy. Governing Board (68-79)  &Trusses E07.858.925 AECLCTECHISDSNSTTDUTVE Hernia Equipment and Supplies; Surgical Equipment   3Truncus Arteriosus, Persistent C14.240.400.929; C14.280.400.929; C16.131.240.400.929 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital A congenital anomaly resulting from the failure of the aorticopulmonary system to develop and divide the truncus arteriosus into the aorta and the pulmonary trunk. Heart Defects, Congenital (66-76) %$=LK(Truncus Arteriosus A07.541.278.930; A16.378.303.930 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Fetal Heart Embryonic Structures (Non MeSH); Fetus; Fetal Heart The embryonic arterial trunk arising from the heart which then divides into the aorta and the main pulmonary artery. Aorta (66-76); Pulmonary Artery (66-76) ,&8q1Trout B02.493.817.750.825 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes; Salmonidae Oncorhynchus mykiss Various fish of the family SALMONIDAE, usually smaller than salmon. They are mostly restricted to cool clear freshwater. Some are anadromous. They are highly regarded for their handsome colors, rich well-flavored flesh, and gameness as an angling fish. The genera Salvelinus, Salmo, and ONCORHYNCHUS have been introduced virtually throughout the world.  &8Troponin D12.776.210.500.910; D12.776.220.525.825 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins One of the minor protein components of skeletal muscle. Its function is to serve as the calcium-binding component in the troponin-tropomyosin B-actin-myosin complex by conferring calcium sensitivity to the cross-linked actin and myosin filaments. Muscle Proteins (73-74) M .HTropomyosin D12.776.210.500.895; D12.776.220.525.800 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins A protein found in the thin filaments of muscle fibers. It inhibits contraction of the muscle unless its position is modified by troponin. Muscle Proteins (66-70) .HTropolone D02.455.426.392.368.284.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cycloheptanes 2-Hydroxy-2,4,6-cycloheptatrien-1-one. Alcohols (72-74); Cycloheptanes (70-74) o :+0Tropoelastin D12.776.811.850; D12.776.860.300.350.700 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins; Elastin A salt-soluble precursor of elastin. Lysyl oxidase is instrumental in converting it to elastin in connective tissue. Elastin (66-76); Protein Precursors (73-76) .H5Tropocollagen D12.776.860.300.250.700 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins; Collagen Collagen (66-71) VHTropism G04.742.800; G07.950 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH) Physiology, General (Non MeSH) Gravitropism; Phototropism Gravitropism; Phototropism The directional growth of an organism in response to an external stimulus such as light, touch, or gravity. Growth towards the stimulus is a positive tropism; growth away from the stimulus is a negative tropism. (From Concise Dictionary of Biology, 1990).  >0Tropicamide D03.383.725.942; D14.100.120.200.500.900; D16.050.500.935; D16.050.650.942 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A muscarinic antagonist with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic. It may cause closed-angle glaucoma. Pyridines (66-78) T:Tropical Medicine G02.403.919 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions. H#Tropical Climate G03.230.300.100.250.600 AE Heat Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Climate A climate which is typical of equatorial and tropical regions, i.e., one with continually high temperatures with considerable precipitation, at least during part of the year. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). [uTrophoblastic Tumor, Placental Site C04.557.465.955.950; C04.850.908.950; C13.703.720.949.950 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Trophoblastic Neoplasms Neoplasms; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms A tumor that arises from the trophoblast of the placental bed and is composed mainly of cytotrophoblastic cells. It encompasses lesions of low- and high-grade malignancy. (Holland et al., Cancer Medicine, 3d ed). Trophoblastic Neoplasms (80-93) P*AX}%Trophoblastic Neoplasms C04.557.465.955; C04.850.908; C13.703.720.949 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal Neoplasms; Pregnancy Complications, Neoplastic Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Neoplastic Choriocarcinoma; Hydatidiform Mole (+ 1); Trophoblastic Tumor, Placental Site Choriocarcinoma; Hydatidiform Mole (+ 1); Trophoblastic Tumor, Placental Site Choriocarcinoma; Hydatidiform Mole (+ 1); Trophoblastic Tumor, Placental Site Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed). 5X)UTrophoblast A16.759.802; A16.254.085.162 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Placenta Embryonic Structures (Non MeSH); Embryo; Blastocyst The outer layer of cells of the blastocyst which works its way into the endometrium during ovum implantation and grows rapidly, later combining with mesoderm. 6"*pTropanes D03.132.889; D03.605.869 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH) Belladonna Alkaloids (+ 3); Benztropine; Cocaine (+ 1); Scopolamine (+ 2) Atropine (+ 2); Benztropine; Cocaine (+ 1); Nortropanes; Scopolamine (+ 2) Atropine (66-68); Belladonna (66-68); Cocaine (66-68); Nortropanes (66-68); Scopolamine (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR   8st@Tromethamine D02.033.618.706.900; D26.172.719 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Propanediols Miscellaneous Drugs and Agents (Non MeSH); Buffers K&.Trombiculid Mites B01.131.166.132.419.875 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida; Acari; Mites The larva of mites of the genus Trombicula which attack man and other vertebrates, causing dermatitis and severe allergic reactions. One species is the carrier of SCRUB TYPHUS or tsutsugamushi disease. U(>Trombiculiasis C03.211.394.869 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations; Mite Infestations Infestation with mites of the genus Trombicula, whose larvae carry the rickettsial agent of scrub typhus. PL}Troleandomycin D20.085.115.662.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Oleandomycin Oleandomycin triacetate ester. ]:T%Troglotrematidae (Non MeSH) B01.500.736.715.800 Invertebrates; Helminths; Platyhelminths; Trematoda Paragonimus AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI \!=*Trochlear Nerve A08.800.800.120.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 4th cranial nerve. The trochlear nerve carries the motor innervation of the superior oblique muscles of the eye. -8[Trityl Compounds D02.455.426.559.389.884 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives ך8Triturus B02.090.608.700.670 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Salamandridae A genus of aquatic newts in the Salamandridae family. During breeding season many Triturus males have a dorsal crest which also serves as an accessory respiratory organ. One of the common Triturus species is Triturus cristatus (crested newt). Urodela (66-71) ؽ &7Tritrichomonas foetus B01.841.750.443.950.725.849.325 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Trichomonadida; Tritrichomonas A species of flagellate parasitic protozoa. It possesses a long undulating membrane that is bordered on its outer margin by a flagellum that becomes free posteriorly. This organism causes infections in cows that could lead to temporary infertility or abortion. Mastigophora (67-71); Tritrichomonas (72-91) ڗ#&y25Tritrichomonas B01.841.750.443.950.725.849 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Trichomonadida Tritrichomonas foetus A genus of flagellate protozoans possessing three long anterior flagella. Mastigophora (66-71)  &gWTritolyl Phosphates D02.705.960; D02.755.239.900 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Organic Chemicals (Non MeSH); Phenols; Cresols Phosphoric acid tri(methylphenyl) ester. A mixture of isomeric tritolyl phosphates. Used in the sterilization of certain surgical instruments and in many industrial processes. Synonyms: TCP; Celluflux; Kronitex; Lindol. Cresols (66-74); Organophosphorus Compounds (72-74) t"8{=Tritium D01.435.719; D01.496.749.925 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Hydrogen Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes  "4sTriterpenes D02.455.849.919 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Glycyrrhetinic Acid (+ 1); Gossypol; Sapogenins (+ 1); Squalene AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8@P<Trisomy G05.148.266.131.750 DIGEIMPAPP Genetics; Cytogenetics; Chromosome Aberrations; Aneuploidy The possession of a third chromosome of any one type in an otherwise diploid cell.  EeTrismus C10.597.816.802; C23.888.592.826.802 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tetanus Nervous System Diseases; Neurologic Manifestations; Spasm Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Spasm A spasm of the masticatory muscles producing "lockjaw" characteristic of tetanus.  *N `Trisaccharides D09.203.698.629.802 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides Raffinose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR >r DTriptorelin D06.472.709.429.800; D07.610.700; D22.204.928 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones; Gonadorelin Reproductive Control Agents (Non MeSH); Luteolytic Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 6-D-Tryptophanluteinizing hormone-releasing factor (pig). A long-acting GONADORELIN analog agonist. It has been used in the treatment of prostatic cancer, ovarian cancer, precocious puberty, endometriosis, and to induce ovulation for in vitro fertilization. Gonadorelin/analogs and derivatives (78-92) ,5: (3Triprolidine D03.383.725.932; D14.100.375.425.400.870 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Histamine H1 antagonist used in allergic rhinitis, asthma, and urticaria. It may cause drowsiness. 8.: uTriplets G08.520.800.680; M01.438.768 CLEDGEHILJPXSN Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple Named Groups (Non MeSH); Multiple Birth Named Groups (Non MeSH) T "Tripelennamine D02.092.782.258.368.900; D03.383.725.050.920; D14.100.375.425.400.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Ethylenediamines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Aminopyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat asthma, hay fever, urticaria, and rhinitis, and also in veterinary applications. Tripelennamine is administered by various routes, including topically. ^M:x2Triparanol D10.162.202.906 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents 4-Chloro-alpha-(4-(2-(diethylamino)ethyoxy)phenyl)-alpha- (4-methylphenyl)benzeneethanol. Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. :fWTrioxsalen D03.438.150.446.750.480.910; D23.600.875; D26.776.819.750 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; Psoralens; Ficusin Dermatologic Agents; Photosensitizing Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents; Photosensitizing Agents Pigmenting photosensitizing agent obtained from several plants, mainly Psoralea corylifolia. It is administered either topically or orally in conjunction with ultraviolet light in the treatment of vitiligo. Coumarins (66-74); Furans (66-74) A.*Trioses D09.203.546.894 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides Dihydroxyacetone; Glyceraldehyde (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  >^.DTriosephosphate Isomerase D08.586.399.278.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Anemia, Hemolytic, Congenital Nonspherocytic Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Carbohydrate Isomerases An enzyme that catalyzes reversibly the conversion of D-glyceraldehyde 3-phosphate to dihydroxyacetone phosphate. A deficiency in humans causes nonspherocytic hemolytic disease. EC 5.3.1.1. Carbohydrate Isomerases (73-74); Organophosphorus Compounds (73-74); Trioses (73-74)  *F3ocTriolein D10.516.212.507.850; D10.516.351.801.801 AAADAEAGAIANCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycerides; Triglycerides (Z)-9-Octadecenoic acid 1,2,3-propanetriyl ester.  .4:Trinitrotoluene D02.455.426.559.389.832.868 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene -:Trinitrobenzenesulfonic Acid D02.455.426.559.389.565.880.880; D02.640.529.880.900; D02.886.645.600.080.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Nitrobenzenes; Trinitrobenzenes Organic Chemicals (Non MeSH); Nitro Compounds; Nitrobenzenes; Trinitrobenzenes Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids 2,4,6-Trinitrobenzenesulfonic acid. A reagent that is used to neutralize peptide terminal amino groups. Benzenesulfonates (74); Nitrobenzenes (71-74) _!U:y6Trinitrobenzenes D02.455.426.559.389.565.880; D02.640.529.880 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Nitrobenzenes Organic Chemicals (Non MeSH); Nitro Compounds; Nitrobenzenes Trinitrobenzenesulfonic Acid Picryl Chloride; Trinitrobenzenesulfonic Acid Benzene derivatives which are substituted with three nitro groups in any position. Nitrobenzenes (66-76); Nitrophenols (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $28Tb4:Trinidad and Tobago Z01.107.084.900.900 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies  FOTrimipramine D03.494.240.918; D14.100.050.600.050.850; D14.100.600.050.850; D15.085.050.850; D15.700.122.055.918 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic Tricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties.  o:uTrimetrexate D03.438.786.925; D22.204.144.579.925; D26.087.393.961 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinazolines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic; Folic Acid Antagonists Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Folic Acid Antagonists 5-Methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-2,4-quinazolinediamine. A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against Pneumocystis carinii pneumonia in AIDS patients. Myelosuppression is its dose-limiting toxic effect. Antineoplastic Agents (66-91); Folic Acid Antagonists (66-91); Quinazolines (66-91)  =:FcTrimethyltin Compounds D02.691.850.900.950 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organotin Compounds; Trialkyltin Compounds Organic compounds composed of tin and three methyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes. Organometallic Compounds (72-74); Tin (72-74)  8s7Trimethylsilyl Compounds D02.715.715 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organosilicon Compounds Organic silicon derivatives used to characterize hydroxysteroids, nucleosides, and related compounds. Trimethylsilyl esters of amino acids are used in peptide synthesis. Methane (74); Silicon (74)  8@#Trimethoprim-Sulfamethoxazole Combination D02.065.884.725.867.500; D02.886.590.700.725.867.500; D03.383.742.906.500; D20.237.912.500; D20.890.725.867.500; D21.370.286.918.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides; Sulfamethoxazole Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides; Sulfamethoxazole Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Trimethoprim Anti-Infective Agents; Anti-Infective Agents, Urinary; Trimethoprim Anti-Infective Agents; Sulfonamides; Sulfanilamides; Sulfamethoxazole Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials; Trimethoprim 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide mixture with 5-((3,4,5-trimethoxyphenyl)methyl)- 2,4-pyrimidinediamine. This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including Pneumocystis carinii pneumonia in AIDS, but is the drug of choice for urinary infection. Drug Combinations (71-89); Sulfamethoxazole (66-89); Trimethoprim (72-89)  .8IWTrimethoprim Resistance G04.185.515.286.925; G05.386.310.925; G05.706.310.925; G12.392.269.925 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial Genetics; Genetics, Microbial; Drug Resistance, Microbial Genetics; Pharmacogenetics; Drug Resistance, Microbial Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial Nonsusceptibility of a bacterium to the action of TRIMETHOPRIM. Drug Resistance, Microbial (71-87); Pyrimidines (66-71); Trimethoprim (72-87)  [P L\Trimethoprim D03.383.742.906; D20.237.912; D21.370.286.918; D26.087.393.922 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Anti-Infective Agents; Anti-Infective Agents, Urinary Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Folic Acid Antagonists Trimethoprim-Sulfamethoxazole Combination Trimethoprim-Sulfamethoxazole Combination Trimethoprim-Sulfamethoxazole Combination Anti-Infective Agents (66-71); Folic Acid Antagonists (66-71); Pyrimidines (66-71)  ?H:BbTrimethaphan D03.383.374.935; D14.100.120.200.600.875; D16.050.340.870; D18.162.895 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Blockers Cardiovascular Agents; Antihypertensive Agents A nicotinic antagonist that has been used as a ganglionic blocker in hypertension, as an adjunct to anesthesia, and to induce hypotension during surgery.  #P:Trimethadione D03.383.548.883; D15.080.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Central Nervous System Agents; Anticonvulsants An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378).  6":Trimetazidine D03.383.606.920; D18.918.919 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Cardiovascular Agents; Vasodilator Agents 1-(2,3,4-Trimethoxybenzyl)piperazine. Vasodilator used in angina of effort or ischemic heart disease. Synonyms: Vasodil; Vastarel. Benzyl Compounds (71-75); Methyl Ethers (74-75); Piperazines (69-75)  ":STrimeresurus B02.833.672.875.875 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes; Viperidae A genus of snakes of the family VIPERIDAE. About 30 species are currently recognized, found in southeast Asia and adjacent island chains. The Okinawa habu frequently enters dwellings in search of rats and mice; the Chinese habu is often found in suburban and agricultural areas. They are quite irritable. (Moore: Poisonous Snakes of the World, 1980). Snakes (66-93)  !&2Trimeprazine D03.494.741.939; D23.075.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Dermatologic Agents; Antipruritics A phenothiazine derivative that is effective as an antipruritic.  #p":MTrimedoxime D02.092.570.665.850; D03.383.725.762.900; D08.515.347.800; D14.100.120.400.800; D26.061.962 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Oximes Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Reactivators; Cholinesterase Reactivators Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Reactivators Miscellaneous Drugs and Agents (Non MeSH); Antidotes 1,1'-Trimethylenebis(4-formylpyridiniumdioxime)dibromide. Cholinesterase reactivator used as an antidote in alkyl phosphate poisoning. Oximes (72-74); Pyridinium Compounds (69-74)  $g:6Trimecaine D02.065.199.092.900; D15.050.050.840; D15.210.100.200.840; D16.850.025.840 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local Acetanilide derivative used as a local anesthetic. Acetanilides (70-74); Diethylamines (74)  (wT:v=1Trimebutine D02.241.223.106.900; D19.316.929 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents beta-Ethyl-beta-dimethylaminophenylethyl-3,4,5-trimethoxybenzoate. Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders. Synonyms: Debridat; Dromostat; JO 475. Benzoates (66-76); Butylamines (66-76)  +&:/Trilogy of Fallot C14.240.400.560.375.702; C14.280.400.560.375.702; C16.131.240.400.560.375.702 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial Combination of pulmonary valve stenosis and atrial septal defect with right ventricular hypertrophy.  -ULuTriiodothyronine, Reverse D06.472.931.812.741.894.900; D12.125.072.734.741.894.900 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones; Thyroxine; Thyronines; Triiodothyronine Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Thyroxine; Thyronines; Triiodothyronine 0-(4-Hydroxy-3,5-diiodophenyl)-3-iodo-L-tyrosine. A metabolite of thyroxine formed by the peripheral degradation of thyroxine as a result of the tyrosyl or inner ring 5-deiodination. In systemic disease states or in neonates, levels of triiodothyronine are low and those of reverse triiodothyronine are elevated. Reverse T3 is therefore useful as a diagnostic aid and in the treatment of fetal and infantile hypothyroidism. Isomerism (71-78); Triiodothyronine (66-78)  0>F"4Triiodothyronine D06.472.931.812.741.894; D12.125.072.734.741.894 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Thyroid Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones; Thyroxine; Thyronines Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Thyroxine; Thyronines Triiodothyronine, Reverse Triiodothyronine, Reverse  46F :Triiodobenzoic Acids D02.241.223.106.530.718; D11.303.760.894 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators Diatrizoate; Diatrizoate Meglumine; Iodamide; Ioglycamic Acid; Iohexol; Iopamidol; Iothalamate Meglumine; Iothalamic Acid; Ioxaglic Acid; Metrizamide; Metrizoate Benzoates (66-71); Plant Growth Regulators (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  6.8=:Trihexyphenidyl D03.383.621.900; D14.100.120.200.500.890; D15.090.050.850; D16.050.650.935 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A centrally acting muscarinic antagonist used in the treatment of parkinsonism and drug-induced extrapyramidal movement disorders and as an antispasmodic.  9T:Trihexosylceramides D10.516.390.470.820; D10.516.808.530.820 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids Glycosphingolipids which contain as their polar head group a trisaccharide (galactose-galactose-glucose) moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in ceramide trihexosidase, is the cause of angiokeratoma corporis diffusum (Fabry's disease). Ceramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78)  <.BjPTriglycerides D10.516.351.801 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycerides Triacetin; Triolein AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  @BJDTrigeminal Nucleus, Spinal A08.186.211.132.931.920 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Trigeminal Nuclei Trigeminal Caudal Nucleus Nucleus of the spinal tract of the trigeminal nerve. It is divided cytoarchitectonically into three parts: oralis, caudalis (TRIGEMINAL CAUDAL NUCLEUS), and interpolaris. Spinal Cord (66-81); Trigeminal Nerve (66-79); Trigeminal Nuclei (80-81)  AE 6]XTrigeminal Nuclei A08.186.211.132.931 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem Trigeminal Nucleus, Spinal (+ 1) Nuclei of the trigeminal nerve situated in the brain stem. They include the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), the principal sensory nucleus, the mesencephalic nucleus, and the motor nucleus. Trigeminal Nerve (66-79)  C|6G(Trigeminal Neuralgia C10.772.204.843; C10.772.537.868 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Facial Pain; Trigeminal Nerve Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Neuralgia Excruciating episodic pain in the area supplied by the trigeminal nerve, often precipitated by stimulation of well-defined trigger points. (Dorland, 27th ed).  E&N%Trigeminal Nerve A08.800.800.120.760 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Trigeminal Neuralgia Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves Mandibular Nerve (+ 1); Maxillary Nerve; Ophthalmic Nerve; Trigeminal Ganglion The 5th and largest cranial nerve. The trigeminal nerve is a mixed motor and sensory nerve. The larger sensory part forms the ophthalmic, mandibular, and maxillary nerves which carry afferents sensitive to external or internal stimuli from the skin, muscles, and joints of the face and mouth and from the teeth. Most of these fibers originate from cells of the trigeminal ganglion and project to the trigeminal nucleus of the brain stem. The smaller motor part arises from the brain stem trigeminal motor nucleus and innervates the muscles of mastication.  G8[_Trigeminal Ganglion A08.340.390.850; A08.800.350.850; A08.800.800.120.760.825 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Sensory Nervous System; Peripheral Nervous System; Ganglia, Sensory Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Trigeminal Nerve The semilunar-shaped ganglion containing the cells of origin of most of the sensory fibers of the trigeminal nerve. It is situated within the dural cleft on the cerebral surface of the petrous portion of the temporal bone and gives off the ophthalmic, maxillary, and part of the mandibular nerves.  KA8_Trigeminal Caudal Nucleus A08.186.211.132.931.920.927 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Trigeminal Nuclei; Trigeminal Nucleus, Spinal The caudal portion of the nucleus of the spinal trigeminal tract (TRIGEMINAL NUCLEUS, SPINAL), a nucleus involved with pain and temperature sensation. Trigeminal Nerve (66-79)  N6}Trifluridine D13.570.230.855.900; D13.570.685.705.900; D20.388.902; D26.087.931 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Thymidine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Thymidine Anti-Infective Agents; Antiviral Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites alpha,alpha,alpha-Trifluorothymidine. An antiviral derivative of thymidine used mainly in the treatment of ophthalmic infections. Fluorine (72-74); Thymidine (72-74)  PL:\,Trifluralin D02.092.146.859.717; D02.455.426.559.389.832.767; D05.723.366.931 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds; Toluidines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Herbicides (66-71); Toluene (66-71)  SI:I,Triflupromazine D03.494.741.918; D14.100.150.175.970; D15.095.970; D15.150.025.900; D15.210.950.040.025.900; D15.700.872.331.025.917 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine used as an antipsychotic agent and as an antiemetic.  U:STrifluperidol D02.522.352.867; D14.100.150.175.969; D15.150.015.875; D15.210.950.040.015.875; D15.700.872.331.015.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butyrophenones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of psychoses including mania and schizophrenia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.621).  Ys:vTrifluoroethanol D02.033.057.880 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Ethyl 2,2,2-Trifluroethanol. Alcohol, Ethyl (72-74); Fluorine (72-74)  ^:C2Trifluoroacetic Acid D02.241.081.038.209.348.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetates; Fluoroacetates Trifluoro substituted acetic acid. Fluoroacetates (72-74)  _ :*Trifluoperazine D03.494.741.898; D14.100.150.175.968; D15.095.957; D15.150.025.875; D15.210.950.040.025.875; D15.700.872.331.025.895 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic.  `:~Triethyltin Compounds D02.691.850.900.910 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organotin Compounds; Trialkyltin Compounds Organic compounds composed of tin and three ethyl groups. Affect mitochondrial metabolism and inhibit oxidative phosphorylation by acting directly on the energy conserving processes. Organometallic Compounds (72-74); Tin (72-74)  d8s7Triethylenetetramine D02.092.782.258.368.880; D26.241.932 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Ethylenediamines Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents N,N'-Bis(2-aminoethyl)-1,2-ethanediamine. Used as stabilizer for epoxy resins, as ampholyte for isoelectric focusing and as chelating agent for copper in hepatolenticular degeneration; may cause liver damage. Synonyms: Trien; TETA. Ammonium Compounds (66-74); Ethylenediamines (75-77); Piperidines (66-74)  f*: WTriethylenemelamine D03.383.097.217.924; D22.204.924 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines; Aziridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 2,4,6-tris(1-Aziridinyl)5-triazine. Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers. Synonyms: NSC 9706; Persistol HOE 1/139; SK 1133; TEM; Triamelin; triethanomelamine.  im&:&Tricuspid Valve Stenosis C14.280.484.911 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases  kNITricuspid Valve Prolapse C14.280.484.400.875; C23.835.400.875 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases; Heart Valve Prolapse Symptoms and General Pathology (Non MeSH); Prolapse; Heart Valve Prolapse Abnormal protrusion of one or more of the leaflets of the tricuspid valve into the right atrium during systole. Heart Valve Diseases (67-82); Tricuspid Valve (66-82)  l*NATricuspid Valve Insufficiency C14.280.484.856 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Backflow of blood from the right ventricle into the right atrium, owing to imperfect functioning of the tricuspid valve.  o#NITricuspid Valve A07.541.510.893 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Valves The valve consisting of three cusps situated between the right atrium and right ventricle of the heart.  p84|Tricuspid Atresia C14.240.400.920; C14.280.400.920; C14.280.484.845; C16.131.240.400.920 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fontan Procedure Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Absence of the orifice between the right atrium and ventricle, with the presence of an atrial defect through which all the systemic venous return reaches the left heart. As a result, there is left ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR) because the right ventricle is absent or not functional. Tricuspid Valve/abnormalities (66-94)  qPLj,Triclosan D02.355.726.900; D20.187.916 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers Anti-Infective Agents; Anti-Infective Agents, Local 5-Chloro-2-(2,4-dichlorophenoxy)phenol. A diphenyl ether derivative used in cosmetics and toilet soaps as antiseptic; it has some bacteriostatic and fungistatic action. Chlorobenzenes (74-75); Phenyl Ethers (74-75)  u ":z7Trichuroidea B01.500.294.100.275.780 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida Capillaria; Trichinella (+ 1); Trichuris A superfamily of nematodes of the order ENOPLIDA. Its organisms have a well developed intestine and rectum.  w*E3Trichuris B01.500.294.100.275.780.628 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida; Trichuroidea A genus of nematode worms comprising the whipworms.  yG *U?Trichuriasis C03.335.508.100.275.895 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Adenophorea Infections; Enoplida Infections Infection with nematodes of the genus TRICHURIS, formerly called Trichocephalus.  zTPs^Trichotillomania F03.709.438.180.490.600 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders; Obsessive-Compulsive Disorder Compulsion to pull out one's hair.  {F,Trichothecenes D02.455.849.765.850; D24.185.926.587.933 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Sesquiterpenes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins T-2 Toxin; Trichodermin T-2 Toxin; Trichodermin Usually 12,13-epoxytrichothecenes, produced by Fusaria, Stachybotrys, Trichoderma and other fungi, and some higher plants. They may contaminate food or feed grains, induce emesis and hemorrhage in lungs and brain, and damage bone marrow due to protein and DNA synthesis inhibition. Benzoxepins (68-74); Ethers, Cyclic (66-74); Sesquiterpenes (74); Terpenes (66-73) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $ }.>:Fd@Trichostrongylus B01.500.294.700.775.746.610 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Trichostrongyloidea A genus of nematodes parasitic in the digestive tract of herbivorous animals. They occur only as incidental infections in humans. The following species have been reported in man: TRICHOSTRONGYLUS COLUBRIFORMIS, T. orientalia, T. axei, and T. probolurus. Trichostrongyloidea (66-85)  *_( Trichostrongylosis C03.335.508.700.775.825.842 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections; Trichostrongyloidiasis Infestation with nematode worms of the genus TRICHOSTRONGYLUS. Man and animals become infected by swallowing larvae, usually with contaminated food or drink, although the larvae may penetrate human skin.  PTrichostrongyloidiasis C03.335.508.700.775.825 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections Dictyocaulus Infections; Haemonchiasis; Ostertagiasis; Trichostrongylosis Infection by roundworms of the superfamily TRICHOSTRONGYLOIDEA, including the genera TRICHOSTRONGYLUS, OSTERTAGIA, Cooperia, HAEMONCHUS, Nematodirus, Hyostrongylus, and DICTYOCAULUS. Nematode Infections (66-67)  PvT!Trichostrongyloidea B01.500.294.700.775.746 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida Dictyocaulus; Haemonchus; Ostertagia; Trichostrongylus A superfamily of nematodes. Most are intestinal parasites of ruminants and accidentally in humans. This superfamily includes seven genera: DICTYOCAULUS, HAEMONCHUS, Cooperia, OSTERTAGIA, Nematodirus, TRICHOSTRONGYLUS, and Hyostrongylus.  [*H@ Trichostomatina B01.841.185.375.650.650 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Kinetofragminophorea; Trichostomatida Balantidium A suborder of ciliate protozoa characterized by non-reduction of the somatic ciliature.  s&VgTrichostomatida B01.841.185.375.650 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Kinetofragminophorea Trichostomatina (+ 1) An order of ciliate protozoa in which the cytostome is usually situated at the base of an oral groove, the wall of which bears dense cilia.  &CTrichosporon B05.354.381.546.940; B05.354.930.930 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Algae and Fungi (Non MeSH); Fungi; Yeasts A deuteromycetous fungal genus causing opportunistic infections, endocarditis, fungemia, and white piedra (T. beigelii). Hyphomycetes (66-85)  8*"Trichosanthin D07.131.100.760; D12.776.765.760 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Reproductive Control Agents (Non MeSH); Abortifacient Agents; Abortifacient Agents, Non-Steroidal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Plant-derived ribosome-inactivating protein purified from the Chinese medicinal herb tian-hua-fen which is obtained from the root tubers of Trichosanthes kirilowii. It has been used as an abortifacient and in the treatment of trophoblastic tumors. GLQ223 (Compound Q), a highly purified form of trichosanthin, has been proposed as antiviral treatment for AIDS. Abortifacient Agents, Non-Steroidal (77-89); Plant Proteins (76-89)  &DOTrichophyton B05.354.318.842; B05.354.381.546.928 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Dermatophytes Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus of the class Hyphomycetes. Various species attack the skin, nails, and hair.  :*"Trichophytin D20.136.885; D24.611.216.202.800 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Anti-Infective Agents; Antifungal Agents Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Fungal  &6Trichomonas Vaginitis C03.752.700.500.900.633; C13.371.894.906.633 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Trichomonas Infections Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases; Vaginitis Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.  2PTrichomonas vaginalis B01.841.750.443.950.725.808.717 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Trichomonadida; Trichomonas A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males. Trichomonas (66-71)  W#&vTrichomonas Infections C03.752.700.500.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antitrichomonal Agents Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections Trichomonas Vaginitis Infections in birds and mammals produced by various species of Trichomonas.  PmZTrichomonas B01.841.750.443.950.725.808 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Antitrichomonal Agents Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Trichomonadida Trichomonas vaginalis A genus of parasitic flagellate protozoans distinguished by the presence of four anterior flagella, an undulating membrane, and a trailing flagellum.  &gTrichomonadida B01.841.750.443.950.725 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora Dientamoeba; Trichomonas (+ 1); Tritrichomonas (+ 1) An order of parasitic protozoa typically having four to six flagella. True cysts are known in very few species.  &UATrichodermin D02.455.849.765.850.900; D24.185.926.587.933.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Sesquiterpenes; Trichothecenes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins; Trichothecenes 12,13-Epoxytrichothec-9-en-4-ol acetate. Antifungal metabolite from several fungi, mainly Trichoderma viride; inhibits protein synthesis by binding to ribosomes; proposed as antifungal and antineoplastic; used as tool in cellular biochemistry. Synonym: WG 696. Sesquiterpenes (74)  6:,Trichoderma B05.354.381.546.910 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus of the class Hyphomycetes frequently found in soil and sometimes of use for controlling pathogenic fungi.  "NTrichloroethylene D02.455.526.439.939; D15.050.035.060.900; D15.210.100.175.060.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation A highly volatile inhalation anesthetic used mainly in short surgical procedures where light anesthesia with good analgesia is required. It is also used as an industrial solvent. Prolonged exposure to high concentrations of the vapor can lead to cardiotoxicity and neurological impairment.  3I:eQTrichloroethanes D02.455.526.439.927 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Chlorinated ethanes which are used extensively as industrial solvents. They have been utilized in numerous home-use products including spot remover preparations and inhalant decongestant sprays. These compounds cause central nervous system and cardiovascular depression and are hepatotoxic. Include 1,1,1- and 1,1,2-isomers. Ethane (74-75); Hydrocarbons, Chlorinated (74-76)  8pt;Trichloroepoxypropane D02.355.291.411.900; D02.455.526.439.920; D08.373.880 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Ethers, Cyclic; Epoxy Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors 1,1,1-Trichloro-2,3-epoxypropane. A potent epoxide hydrase and aryl hydrocarbon hydroxylase inhibitor. It enhances the tumor-initiating ability of certain carcinogens. Epoxy Compounds (75-79); Ethers, Cyclic (66-74); Hydrocarbons, Chlorinated (74-79); Hydrocarbons, Halogenated (66-73)  M=:Trichloroacetic Acid D02.241.081.038.866 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids  ^:kTrichlormethiazide D03.438.174.261.476.716; D18.162.276.237.476.892; D19.770.224.578.237.476.892 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines; Chlorothiazide; Hydrochlorothiazide Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide; Chlorothiazide; Hydrochlorothiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide; Chlorothiazide; Hydrochlorothiazide  RU:Trichlorfon D02.705.930; D05.723.491.574.910 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate Insecticides (66-71)  &:Trichinosis C03.335.508.100.275.882 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Adenophorea Infections; Enoplida Infections A disease due to infection with TRICHINELLA SPIRALIS. It is caused by eating undercooked meat, usually pork.  PsTrichinella spiralis B01.500.294.100.275.780.608.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida; Trichuroidea; Trichinella A parasite of carnivorous mammals that causes TRICHINOSIS. It is especially common in rats and in swine fed uncooked garbage. Human infection is initiated by the consumption of raw or insufficiently cooked pork or other meat containing the encysted larvae. Trichinella (66-92)  #*d.Trichinella B01.500.294.100.275.780.608 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida; Trichuroidea Trichinella spiralis A genus of parasitic nematodes that causes TRICHINOSIS in man and carnivores.  *U]Tricarboxylic Acids D02.241.081.901 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Aconitic Acid; 1-Carboxyglutamic Acid; Citrates (+ 1) Acids (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  *8YAFTribolium B01.131.617.155.304.799 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Coleoptera; Beetles A genus of small beetles of the family Tenebrionidae; T. confusum is the "confused flour beetle". Beetles (66-71)   (CvTriazoles D03.383.129.799; D03.383.946 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Amitrole; Fluconazole; Guanazole; Itraconazole; Trapidil Amitrole; Fluconazole; Guanazole; Itraconazole; Trapidil AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   "8:Triazolam D03.438.079.080.900; D14.100.240.500.920; D15.045.930; D15.210.350.800.850; D15.325.875.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries. Benzazepines (74); Benzodiazepines (75-76); Triazoles (74-76)   g:JTriaziquone D03.383.097.217.900; D22.204.902 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines; Aziridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 2,3,5-tris(1-Aziridinyl)-2,5-cyclohexadiene-1,4-dione. Alkylating antineoplastic agent used mainly for ovarian tumors; toxic to skin, gastrointestinal tract, bone marrow and kidneys. Synonyms: Bayer 3231; NSC 29215; Oncoredox; Riker 601; Trenimon.  &:Triazines D03.383.931 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Almitrine; Altretamine; Apazone; Atrazine; Ferrozine; Oxonic Acid; Prometryne; Simazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   8Gj:Triazenes D02.925 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Dacarbazine; Diminazene Azo Compounds (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  `  8#:Triatominae B01.131.617.412.841 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hemiptera Panstrongylus; Rhodnius; Triatoma A subfamily of true bugs (HEMIPTERA) including the genera TRIATOMA, RHODNIUS, and PANSTRONGYLUS, which are vectors of TRYPANOSOMA CRUZI, the agent of CHAGAS DISEASE. Insect Vectors (66); Insects (66)  p(7)+Triatoma B01.131.617.412.841.841 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hemiptera; Triatominae A genus of bugs of the subfamily Triatominae (Reduviidae). Several species are vectors of Trypanosoma cruzi.  5 (FTriamterene D03.438.733.900; D19.770.224.902 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics  o&:Triamcinolone Acetonide D04.808.745.432.915.715; D04.808.908.891.927; D06.597.481.561.353.903.715; D06.597.481.561.478.909.715; D17.025.050.825.875; D17.025.080.200.925.860; D23.037.200.925.860 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Triamcinolone Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated; Triamcinolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Triamcinolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic; Triamcinolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Triamcinolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Triamcinolone Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Triamcinolone An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions.  ƴ:1Triamcinolone D04.808.745.432.915; D04.808.908.891; D06.597.481.561.353.903; D06.597.481.561.478.909; D17.025.050.825; D17.025.080.200.925; D17.050.040.825; D23.037.200.925 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Triamcinolone Acetonide Triamcinolone Acetonide Triamcinolone Acetonide Triamcinolone Acetonide Triamcinolone Acetonide Triamcinolone Acetonide Triamcinolone Acetonide A glucocorticoid given, as the free alcohol or in esterified form, orally, intramuscularly, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.739).  1:\LTriallate D02.241.081.251.869.820; D02.886.706.850; D05.723.366.448.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Carbamate Bis(1-methylethyl)carbamothioic acid S-(2,3,3-trichloro-2-propenyl) ester. A pre-emergence, selective herbicide for the control of wild oats in various crops. Allyl Compounds (73-74); Thiocarbamates (70-74)  Դ E:=9Trialkyltin Compounds D02.691.850.900 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organotin Compounds Triethyltin Compounds; Trimethyltin Compounds Organometallic compounds which contain tin and three alkyl groups. Organometallic Compounds (68-74); Tin (68-74)  ה8Y5O7Trial of Labor G08.520.769.326.280 Cesarean Section; Delivery Labor Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor Allowing a woman to be in labor long enough to determine if vaginal birth may be anticipated.  8! ]rTriage N02.421.297.900 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services The sorting out and classification of patients or casualties to determine priority of need and proper place of treatment. Emergencies (66-75); Emergency Service, Hospital (66-75)  ڃ jCTriacetoneamine-N-Oxyl D02.389.678.900; D03.383.621.808.930; D03.661.243.930 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Free Radicals; Spin Labels Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Piperidones Heterocyclic Compounds; Heterocyclic Oxides; Cyclic N-Oxides 2,2,6,6-Tetramethyl-4-piperidone-N-oxyl. Cyclic N-oxide radical functioning as a spin label and radiation-sensitizing agent. Cyclic N-Oxides (72-74); Piperidones (73-74)  =:6Triacetin D10.516.351.801.632; D20.136.845; D20.187.878 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycerides; Triglycerides Anti-Infective Agents; Antifungal Agents Anti-Infective Agents; Anti-Infective Agents, Local  ފ 5DTretoquinol D03.438.531.870; D14.100.050.100.200.900; D16.050.110.880; D16.050.870.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics An adrenergic beta-agonist used as a bronchodilator agent in asthma therapy. Benzyl Compounds (72-74); Isoquinolines (71-74)  T:[9Tretinoin D02.455.849.291.700.780; D06.472.950; D11.557.261.700.780; D23.400.775 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, Retinoic Acid Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Hormones, Substitutes, Antagonists (Non MeSH); Hormones Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids Dermatologic Agents; Keratolytic Agents Retinoic acid. An important regulator of gene expression, particularly during growth and development and in neoplasms. Retinoic acid derived from maternal vitamin A is essential for normal gene expression during embryonic development and either a deficiency or an excess can be teratogenic. It is also a topical dermatologic agent which is used in the treatment of psoriasis, acne vulgaris, and several other skin diseases. Carotenoids (69-74); Vitamin A (66-74)   P:(0Treponemal Infections C01.252.400.840; C01.252.847.840 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections Bejel; Pinta; Syphilis (+ 7); Yaws Bejel; Pinta; Syphilis (+ 7); Yaws Infections with bacteria of the genus TREPONEMA.  <&P\;Treponema pallidum B03.851.595.795.840 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales; Spirochaetaceae; Treponema The causative agent of venereal and non-venereal syphilis as well as yaws.  d">ZTreponema Immobilization Test E01.223.495.826.895.715 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Syphilis Serodiagnosis Syphilis serodiagnosis employing as the antigen Treponema pallidum obtained from rabbit syphilis orchitis. Treponemes are kept alive for a few hours in a special medium. When syphilitic serum and complement are added and incubated, the treponemes are immobilized, i.e., stop moving.  o#"iITreponema B03.851.595.795 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales; Spirochaetaceae Treponema pallidum A genus of microorganisms of the order SPIROCHAETALES, many of which are pathogenic and parasitic for man.   "1Trephining E04.530.915 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Skull Surgery, Operative; Neurosurgery  $ 'Trench Fever C01.252.400.810.700.810.815.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rochalimaea Infections An intermittent fever characterized by intervals of chills, fever, and splenomegaly each of which may last as long as 40 hours. It is caused by ROCHALIMAEA QUINTANA and transmitted by the human louse.  h#PTrenbolone D04.808.365.415.930; D06.597.100.194.930 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids 17-beta-Hydroxyestra-4,9,11-trien-3-one. An anabolic steroid used mainly as a growth substance in animals. Anabolic Steroids (66-78); Estranes (68-74); Estrenes (75-78)  .:{KTremorine D03.383.773.906 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines   :XTremor C10.597.559.930; C23.888.592.574.921 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders An involuntary trembling or quivering.   *N/Trematode Infections C03.335.865 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antiplatyhelmintic Agents Parasitic Diseases; Helminthiasis Clonorchiasis; Dicrocoeliasis; Echinostomiasis; Fascioliasis; Fascioloidiasis; Opisthorchiasis; Paragonimiasis; Schistosomiasis (+ 3) Infections caused by infestation with worms of the class Trematoda.  P(QTrematoda B01.500.736.715 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Antiplatyhelmintic Agents Invertebrates; Helminths; Platyhelminths Dicrocoeliidae (Non MeSH) (+ 1); Echinostomatidae (Non MeSH) (+ 1); Fasciolidae (+ 2); Heterophyidae; Opisthorchidae (+ 2); Paramphistomatidae; Schistosomatidae (+ 4); Troglotrematidae (Non MeSH) (+ 1) Class of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea. The digenetic trematodes are the only ones found in man. They are endoparasites and require two hosts to complete their life cycle.  t *0 Trehalose D09.203.698.365.900; D09.203.698.629.305.880 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides  5 2DTrehalase D08.586.277.450.329.865 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Disaccharidases An enzyme that catalyzes the conversion of alpha,alpha-trehalose and water to D-glucose. EC 3.2.1.28. Glycoside Hydrolases (66-70)   Fx"Trees B06.915 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Forestry Plants Acacia; Cinchona; Eucalyptus; Juniper; Rhamnus Woody, usually tall, perennial higher plants (Angiosperms, Gymnosperms, and some Pterophyta) having usually a main stem and numerous branches.  o  &  :Treatment Refusal F01.145.076.347.570.800; N05.300.150.600.800 EHLJPXSN Patient Dropouts Patient Compliance Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude to Health; Patient Acceptance of Health Care Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health; Patient Acceptance of Health Care Refusal of a person to accept medical or psychiatric treatment or his unwillingness to comply with the physician's instructions or prescribed regimens. In the case of a legally incompetent person the concept may include a third party authorized to make decisions on his behalf. Cooperative Behavior (71-74); Patient Compliance (75-90) $ 2 FCTreatment Outcome E01.789.800; N04.761.559.590.800; N05.715.360.575.575.800 Diagnosis; Prognosis Health Services Administration (Non MeSH); Quality of Health Care; Outcome and Process Assessment (Health Care); Outcome Assessment (Health Care) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Outcome and Process Assessment (Health Care); Outcome Assessment (Health Care) Medical Futility; Treatment Failure Medical Futility; Treatment Failure Medical Futility; Treatment Failure Studies undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, practicability, etc., of these interventions.  A}Treatment Failure E01.789.800.760; N04.761.559.590.800.760; N05.715.360.575.575.800.760 Diagnosis; Prognosis; Treatment Outcome Health Services Administration (Non MeSH); Quality of Health Care; Outcome and Process Assessment (Health Care); Outcome Assessment (Health Care); Treatment Outcome Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Outcome and Process Assessment (Health Care); Outcome Assessment (Health Care); Treatment Outcome A measure of the quality of health care by assessing the unsuccessful results or consequences of management and procedures used in combating disease.  MTrazodone D03.383.606.900; D03.383.725.791.900; D14.100.600.850.850; D14.100.850.875.800.850; D15.075.865; D15.085.025.925; D15.210.950.012.865; D15.700.122.050.925; D15.700.872.015.865 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents 2-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2H)-one. A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA, Drug Evaluations Annual, 1994, p.309). Piperazines (71-74); Pyridines (71-74); Triazoles (71-74)   :@cFTravel I03.883 CLECHILJPXSNTD Human Activities (Non MeSH) Expeditions Aspects of health and disease related to travel. It includes the physiologic and psychologic beneficial or adverse effects of travel in general or with regard to specific diseases. It includes also emporiatrics, the specialty devoted to the medical aspects of travel. It excludes study tours. CLECHILJPXSNSTTD    "XTraumatology G02.403.850 CLECEDHIISLJMAMTOGSNSTTD Wounds and Injuries Health Occupations; Medicine The branch of surgery which deals with wounds and disability from injuries.  #[Trauma Severity Indices E05.318.308.940.968.875; E05.944; G03.850.520.308.940.968.875; L01.280.900.968.875; N04.452.859.564.800; N05.715.360.300.715.500.800 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records; Medical Records Miscellaneous Techniques (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records; Medical Records Information Science; Data Collection; Records; Medical Records Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records Abbreviated Injury Scale; Glasgow Coma Scale; Injury Severity Score Abbreviated Injury Scale; Glasgow Coma Scale; Injury Severity Score Abbreviated Injury Scale; Glasgow Coma Scale; Injury Severity Score Abbreviated Injury Scale; Glasgow Coma Scale; Injury Severity Score Abbreviated Injury Scale; Glasgow Coma Scale; Injury Severity Score Systems for assessing, classifying, and coding injuries. These systems are used in medical records, surveillance systems, and state and national registries to aid in the collection and reporting of trauma. Wounds and Injuries/classification (66-89)  2Trauma Centers N02.278.354.422.336.500; N02.421.297.195.480; N04.452.442.422.336.400 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments; Emergency Service, Hospital Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services; Emergency Service, Hospital Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments; Emergency Service, Hospital Specialized hospital facilities which provide diagnostic and therapeutic services for trauma patients. Emergency Service, Hospital (66-74)  Mv*Trapidil D03.383.129.799.900; D03.383.742.875; D03.383.946.900; D18.918.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Triazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazoles Cardiovascular Agents; Vasodilator Agents N,N-Diethyl-5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7-amine. A coronary vasodilator agent. Synonyms: Rocornal; AR 12008. Pyrimidines (66-74); Triazoles (66-74)   L:6/Tranylcypromine D02.092.831.845; D08.373.616.914; D15.075.830; D15.085.850; D15.210.950.012.830; D15.700.122.850; D15.700.872.015.830 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Propylamines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, p311).  :][Transvestism F03.709.597.608.700.708 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias Sexual pleasure derived from dressing or masquerading in the clothing of the opposite sex. It is usually seen in men.  $WFTranssexualism F03.709.597.608.810 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Sex Differentiation Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders Overwhelming desire for conversion of sex. Paraphilias (66-67); Transvestism (66-67)  &F#~42Transposition of Great Vessels C14.240.400.915; C14.280.400.915; C16.131.240.400.915 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Double Outlet Right Ventricle Double Outlet Right Ventricle Double Outlet Right Ventricle A congenital cardiovascular malformation in which the aorta arises entirely from the right ventricle and the pulmonary artery from the left ventricle, so that the venous return from the peripheral circulation is recirculated by the right ventricle via the aorta to the systemic circulation without being oxygenated in the lungs.  '%=LKh~Transportation of Patients E02.365.839; N02.421.297.879 CLECHILJMAMTOGSNSTTDUT Wounds and Injuries Therapeutics; Emergency Treatment (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services  Ambulances (+ 1) Conveying ill or injured individuals from one place to another. CLECHILJMAMTOGSDSNSTTDUT $ + "MTransportation J01.937 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH) Aircraft (+ 1); Automobiles; Motorcycles; Off-Road Motor Vehicles; Railroads; Ships The means of moving persons, animals, goods, or materials from one place to another. CLECHIISLJMAMTSDSNSTTDUT  -n 4ffTransplantation, Isogeneic E04.936.864.700 AECLCTECHIIMISMOMTNUPAPHPXRHSNSTTDUTVE Surgery, Operative; Transplantation; Transplantation, Homologous Transplantation between genetically identical individuals, i.e., members of the same species with identical histocompatibility antigens, such as monozygotic twins, members of the same inbred strain, or members of a hybrid population produced by crossing certain inbred strains. Transplantation, Homologous (66-74)  .*J>)Transplantation, Homologous E04.936.864 AECLCTECHIIMISMOMTNUPAPHPXRHSNSTTDUTVE Surgery, Operative; Transplantation Transplantation, Isogeneic Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.  1 **Transplantation, Heterotopic E04.936.800 AECLCTECHIIMISMOMTNUPAPHPXRHSNSTTDUTVE Surgery, Operative; Transplantation Transplantation of tissue typical of one area to a different recipient site. The tissue may be autologous, heterologous, or homologous. Transplantation, Homologous (66-89)  2!**)Transplantation, Heterologous E04.936.764 AECLCTECHIIMISMOMTNUPAPHPXRHSNSTTDUTVE Surgery, Operative; Transplantation  49"**Transplantation, Autologous E04.936.664 AECLCTECHIIMISMOMTNUPAPHPXRHSNSTTDUTVE Surgery, Operative; Transplantation Surgical Flaps  4 **Transplantation Immunology G04.610.555.714 DEGEIMPHRE Histocompatibility Testing; Immunosuppression Cell Transplantation; Organ Transplantation; Tissue Transplantation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular Graft vs Host Reaction; Histocompatibility; Host vs Graft Reaction (+ 2) A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. BLCFCICLCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI ( 54NhXZRTransplantation Chimera G05.148.630.218.750 DEGEIMPHRE Animals, Transgenic Transplantation Genetics; Cytogenetics; Mosaicism; Chimera An organism that, as a result of transplantation of donor genetic material, consists of two or more cell lines descended from at least two zygotes. This state results in the induction of donor-specific transplantation tolerance. Chimera (78-93) $ 84 Transplantation E04.936 AECLCTECHIISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Histocompatibility Testing; Neoplasm Transplantation; Organ Transplantation; Tissue Transplantation; Transplantation Chimera Surgery, Operative Cell Transplantation (+ 2); Organ Transplantation (+ 8); Replantation (+ 1); Tissue Transplantation (+ 8); Transplantation, Autologous (+ 1); Transplantation, Heterologous; Transplantation, Heterotopic; Transplantation, Homologous (+ 1) Transference of a tissue or organ, alive or dead, within an individual, between individuals of the same species, or between individuals of different species. AECLCTECHIIMISLJMAMOMTNUPAPHPXRARHRISNSTTDUSUTVE $ : 04Translocation (Genetics) G05.148.266.764 DEGEIMPHRE Genetics; Cytogenetics; Chromosome Aberrations Philadelphia Chromosome A type of aberration characterized by fragmentation of a chromosome and transfer of the broken-off portion to another chromosome, often of a different pair. Chromosome Aberrations (68-74); Chromosome Abnormalities (66-67)  > 7KTranslations L01.178.682.920 Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Products resulting from the conversion of one language to another.  ?\PTranslation, Genetic G05.331.370.725 DEGEIMPHRE Codon, Initiator; Codon, Terminator Genetics; Genetics, Biochemical; Gene Expression Amino Acid Activation; Peptide Chain Elongation; Peptide Chain Initiation; Peptide Chain Termination; Polarity of Translation Formation of peptides on ribosomes, directed by messenger RNA. Ribosomes (66-72) $ @+:KTranslating L01.143.506.423.796 Information Science; Communication; Language; Language Arts (Non MeSH) Conversion from one language to another language.  ByT<Transketolase D08.586.913.920 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme of the transferase class that catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate in the pentosephosphate pathway. (Dorland, 27th ed) EC 2.2.1.1. Transferases (66-71)  CNFUTransistors H01.288.745.714 AECLCTECHISDSNSTTDUTVE Physical Sciences (Non MeSH); Electronics; Semiconductors  EbETransillumination E01.357.935 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging Passage of light through body tissues or cavities for examination of internal structures.  F"$jTransients and Migrants M01.920 CLEDHILJPXSN Homeless Persons Emigration and Immigration Named Groups (Non MeSH) Mobile, short-term residents who move usually to find work.  F  HTransforming Growth Factors D11.303.900; D12.644.900; D24.185.348.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Peptides Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Transforming Growth Factor alpha; Transforming Growth Factor beta Transforming Growth Factor alpha; Transforming Growth Factor beta Transforming Growth Factor alpha; Transforming Growth Factor beta Hormonally active polypeptides that can induce the transformed phenotype when added to normal, non-transformed cells. They have been found in culture fluids from retrovirally transformed cells and in tumor-derived cells as well as in non-neoplastic sources. Their transforming activities are due to the simultaneous action of two otherwise unrelated factors, TRANSFORMING GROWTH FACTOR ALPHA and TRANSFORMING GROWTH FACTOR BETA. Growth Substances (66-88); Peptides (66-88)  G!1D5Transforming Growth Factor beta D11.303.900.720; D12.644.900.720; D24.185.348.900.720; D24.611.350.400.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Transforming Growth Factors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Transforming Growth Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Transforming Growth Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances Factor synthesized in a wide variety of tissues including platelets, placenta, and both normal and transformed cell lines. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta also has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. There are at least three forms of TGF-beta: TGF-beta1, TGF-beta2, and TGF-beta1.2. The latter is a heterodimer made up of both TGF-beta1 and TGF-beta2. Peptides (83-88); Transforming Growth Factors (89-90)  L&TDk@Transforming Growth Factor alpha D11.303.900.700; D12.644.900.700; D24.185.348.900.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Transforming Growth Factors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Transforming Growth Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Transforming Growth Factors Factor isolated in a variety of tissues including epithelium, and maternal decidua. It is closely related to epidermal growth factor (EPIDERMAL GROWTH FACTOR-UROGASTERONE) and binds to the EGF receptor. TGF-alpha acts synergistically with TGF-beta in inducing phenotypic transformation, but its physiological role is unknown. Peptides (83-88); Transforming Growth Factors (89-90)  R'=DUw@Transformation, Genetic G05.825.700 DEGEIMPHRE DNA, Recombinant Crosses, Genetic Genetics; Recombination, Genetic Cell Transformation, Viral; Transduction, Genetic; Transfection; Transformation, Bacterial The unidirectional transfer and incorporation of foreign DNA by prokaryotic or eukaryotic cells and the subsequent recombination of part or all of that DNA into the cell's genome. (Glossary of Genetics: Classical and Molecular, 5th ed). Genetics (66-67) DEGEIMMTPHRE , U'hTransformation, Bacterial G05.386.872; G05.825.700.820 DEGEIMPHRE Genetics; Genetics, Microbial Genetics; Recombination, Genetic; Transformation, Genetic The heritable modification of the properties of a competent bacterium by DNA from another bacterial strain. Genetics (66-67); Transformation, Genetic (68-77)  XO"e;Transferrin D12.776.124.050.800; D12.776.124.790.223.839; D12.776.157.890; D12.776.377.715.182.839; D12.776.556.901 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Transferrin Iron Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins  YsFTransference (Psychology) F04.754.919.864 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Therapeutic Processes (Non MeSH) Countertransference (Psychology) The unconscious transfer to others (including psychotherapists) of feelings and attitudes which were originally associated with important figures (parents, siblings, etc.) in one's early life.  ]r%Transferases (Other Substituted Phosphate Groups) D08.586.913.696.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases CDP Diacylglycerol-Serine O-Phosphatidyltransferase; Diacylglycerol Cholinephosphotransferase; Ethanolaminephosphotransferase A class of enzymes that transfers substituted phosphate groups. EC 2.7.8. Phosphotransferases (66-93)  ^9FlY Transferases D08.586.913 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Acyltransferases (+ 22); Amidinotransferases; Aminotransferases (+ 6); Aspartate Carbamoyltransferase; Coenzyme A-Transferases; Dihydropteroate Synthase; Dimethylallyltransferase; Glutathione Transferases; Glycosyltransferases (+ 34); Methionine Adenosyltransferase; Methyltransferases (+ 15); Ornithine Carbamoyltransferase; Phosphotransferases (+ 82); Propylamine Transferase; Riboflavin Synthase; Serine Hydroxymethyltransferase; Spermine Synthase; Sulfotransferases (+ 1); Sulfurtransferases (+ 1); Transaldolase; Transketolase AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  `FE^HTransfer Factor D24.611.350.480.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. Immunity, Maternally-Acquired (66-74); Immunization, Passive (70-74); Lymphokines (74)  drFweTransfer Agreement N04.452.602.713 CLECHILJOGSNSTTDUT Patient Transfer Health Services Administration (Non MeSH); Organization and Administration; Organizational Affiliation A written agreement for the transfer of patients and their medical records from one health care institution to another. specific organization  fvTransfer (Psychology) F02.463.425.910 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Change in learning in one situation due to prior learning in another situation. The transfer can be positive (with second learning improved by first) or negative (where the reverse holds).  h( ZTransfection E05.393.350.810; G04.185.515.860; G05.386.860; G05.825.700.810 DEGEIMMTPHRE Electroporation Miscellaneous Techniques (Non MeSH); Genetic Techniques; Gene Transfer Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) Genetics; Genetics, Microbial Genetics; Recombination, Genetic; Transformation, Genetic The introduction of DNA into a recipient eukaryote cell and its subsequent integration into the recipient cell's chromosomal DNA. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL), but in eukaryotes, transformation is restricted to the changes in cultured cells caused by tumor viruses. Transformation, Genetic (68-74)  iHJe%Transduction, Genetic G05.386.795; G05.825.700.795 DEGEIMPHRE Crosses, Genetic Genetics; Genetics, Microbial Genetics; Recombination, Genetic; Transformation, Genetic Transfer of bacterial DNA by phages from the infected bacterium in which the DNA originates to another bacterium. Genetics (66-67)  m8"eTransducin D12.776.543.350.850 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; G-Proteins A guanine nucleotide regulatory protein that mediates the light activation signal from photolyzed rhodopsin to cyclic GMP phosphodiesterase and is pivotal in the visual excitation process. Activation of rhodopsin on the outer membrane of rod and cone cells causes GTP to bind to transducin followed by dissociation of the alpha subunit-GTP complex from the beta/gamma subunits of transducin. The alpha subunit-GTP complex activates the cyclic GMP phosphodiesterase which catalyzes the hydrolysis of cyclic GMP to 5'-GMP. This leads to closure of the sodium and calcium channels and therefore hyperpolarization of the rod cells. Guanine Nucleotide Regulatory Protein (85-88); Membrane Proteins (80-88)  nHhUTransducers, Pressure E07.943.901; H01.288.878.901 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Transducers Physical Sciences (Non MeSH); Electronics; Transducers Transducers that are activated by pressure changes, e.g. blood pressure. Manometry (66-79); Transducers (66-79)  r"kW/Transducers E07.943; H01.288.878 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Physical Sciences (Non MeSH); Electronics Transducers, Pressure Transducers, Pressure  tZM2Transcutaneous Electric Nerve Stimulation E02.040.335.800; E02.780.335.800; E03.091.823 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine; Electric Stimulation Therapy Therapeutics; Physical Therapy; Electric Stimulation Therapy Anesthesia and Analgesia (Non MeSH); Analgesia Electrical stimulation of nerves and/or muscles to relieve pain; it is used less frequently to produce anesthesia. The optimal placements of electrodes or "trigger points" may correspond with acupuncture analgesia points. TENS is sometimes referred to as acupuncture-like when using a low frequency stimulus. Electric Stimulation (66-83); Electric Stimulation Therapy (66-83)  u?05"hNTranscultural Nursing G02.478.676.920 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing A nursing specialty created to answer the need for developing a global perspective in the practice of nursing in a world of interdependent nations and people. The focus of this nursing discipline is on the integration of international and transcultural content into the training. Courses include study in the area of cultural differences, nursing in other countries, and international health issues and organizations, as an example. Nursing (77-91); Nursing Care (75-91); Primary Nursing Care (77-91)  xj;STranscription, Genetic G05.331.370.700 DEGEIMPHRE Gene Products, rev; Gene Products, tat; Gene Products, tax; Genes, pX; Genes, rev; Genes, tat; Trans-Activators; Transcription Factors DNA, Ribosomal; Antisense Elements (Genetics) Genetics; Genetics, Biochemical; Gene Expression The transfer of genetic information from DNA to messenger RNA by DNA-directed RNA polymerase. It includes reverse transcription and transcription of early and late genes expressed early in an organism's life cycle or during later development. RNA, Messenger (66-72) $ {`6:Transcription Factors D12.776.930 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Trans-Activators Transcription, Genetic; Receptors, Cytoplasmic and Nuclear; Gene Expression Regulation Amino Acids, Peptides and Proteins (Non MeSH); Proteins Adenovirus E1A Proteins; Adenovirus E1B Proteins; Cyclic AMP Receptor Protein; DNA-Binding Protein, Cyclic AMP-Responsive; Myogenic Regulatory Factors (+ 2); NF-kappa B; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Aryl Hydrocarbon; Receptors, Retinoic Acid; Receptors, Steroid (+ 8); Receptors, Thyroid Hormone; Repressor Proteins; Rho Factor; Sigma Factor; Trans-Activators (+ 1); Transcription Factor AP-1; Transcription Factor, Sp1 Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Bacterial Proteins (73-76); Proteins (66-76); Transcription, Genetic (73-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR , ~FdD[HTranscription Factor, Sp1 D12.776.260.835; D12.776.930.910 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR HIV Long Terminal Repeat Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Promoter-specific RNA polymerase II transcription factor that binds to the GC box, one of the upstream promoter elements (UPE) in mammalian cells. The binding of Sp1 is necessary to initiate transcription in the promoters of a variety of cellular and viral genes including c-Ha-ras and HIV. DNA-Binding Proteins (86-90); Transcription Factors (86-90)  &FUFTranscription Factor AP-1 D12.776.930.905 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors A multiprotein complex composed of the products of c-jun and c-fos proto-oncogenes. These proteins must dimerize in order to bind to the AP-1 recognition site, also known as the TPA-responsive element (TRE). AP-1 controls both basal and inducible transcription of several genes. Proto-Oncogene Proteins c-jun (92-94); Transcription Factors (88-94) $ FFF^GPTranscortin D12.776.124.790.106.901; D12.776.157.818; D12.776.377.715.085.901; D12.776.395.901 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins  .\FTranscobalamins D11.786.708.950.900; D12.776.124.790.900; D12.776.157.800; D12.776.377.715.900 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Vitamin B 12 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins A group of carrier proteins which bind with vitamin B12 in the blood and aid in its transport. Transcobalamin I migrates electrophoretically as a beta globulin, while transcobalamins II and III migrate as alpha globulins. Blood Proteins (73-74); Carrier Proteins (73-74); Vitamin B 12 (73-74)  XDWTranscaucasia Z01.542.900 EHEP Geographicals (Non MeSH); Europe Armenia; Azerbaijan; Georgia (Republic) Area of Europe that includes ARMENIA, AZERBAIJAN, and the Republic of GEORGIA.  b)0^Transaldolase D08.586.913.881 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme of the transferase class that catalyzes the reaction sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to yield D-erythrose 4-phosphate and D-fructose phosphate in the pentosephosphate pathway. (Dorland, 27th ed) EC 2.2.1.2. Transferases (66-71)  hFUTransactional Analysis F04.754.709.838 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Psychoanalytic Therapy A psychoanalytic therapy wherein each social transaction is analyzed to determine the involved ego state (whether parent-like, child-like, or adult-like) as a basis for understanding behavior. Psychoanalytic Therapy (73-78)  ~f$Trans-Activators D12.776.260.900.800; D12.776.930.900; D12.776.964.950.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription, Genetic; Transcription Factors; Gene Expression Regulation Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins Herpes Simplex Virus Protein Vmw65 Herpes Simplex Virus Protein Vmw65 Gene Products, rev; Gene Products, tat; Gene Products, tax; Gene Products, vpr; Herpes Simplex Virus Protein Vmw65 Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Retroviridae Proteins (86-89); Transcription Factors (86-89); Viral Proteins (86-89) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ( WAFULdHTrans-Activation (Genetics) G05.331.370.380.906; G05.331.855 DEGEIMPHRE Genes, Regulator Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Genetics; Genetics, Biochemical Increased rate of gene expression directed by either viral or cellular proteins. These regulatory factors (diffusible gene products) act in trans -- that is, act on homologous or heterologous molecules of DNA. (Cis-acting factors act only on homologous molecules.). Gene Expression Regulation (83-89); Virus Activation (83-87)   &~6HTranquilizing Agents D15.210.950; D15.700.872 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hypnotics And Sedatives Hypnotics and Sedatives Central Nervous System Agents; Central Nervous System Depressants Central Nervous System Agents; Psychotropic Drugs Anti-Anxiety Agents (+ 26); Antimanic Agents (+ 1); Antipsychotic Agents (+ 37) Anti-Anxiety Agents (+ 26); Antimanic Agents (+ 1); Antipsychotic Agents (+ 37) A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( 8:Tranexamic Acid D02.241.223.268.860; D19.461.270.463.091.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics; Antifibrinolytic Agents 4-(Aminomethyl)cyclohexanecarboxylic acid. Antifibrinolytic hemostatic used in severe hemorrhage. Amines (66-73); Cyclohexanecarboxylic Acids (68-74); Methylamines (73-74)  \2:pWTramadol D02.033.460.850; D15.040.150.925; D15.210.600.870 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Cyclohexanols Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics A narcotic analgesic proposed for severe pain. It may be habituating. Anisoles (74); Cyclohexanols (74); Dimethylamines (74)   9:UCTraining Support H01.770.878; N03.219.483.838 CLECHILJMTOGSNSTTD Education Physical Sciences (Non MeSH); Science Economics, Organizations, Control (Non MeSH); Economics; Financial Support (Non MeSH) Fellowships and Scholarships Fellowships and Scholarships Financial support for training including both student stipends and loans and training grants to institutions.  " BTrail Making Test F04.711.513.838 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Neuropsychological Tests The subject's ability to connect 25 numbered and lettered circles in sequence in a specific length of time. A score of 12 or below is suggestive of organic brain damage. Psychological Tests (66-70)   o!Tragacanth D09.203.698.900; D19.316.396.902; D26.698.931.419.902 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids; Vehicles; Excipients Powdered exudate from Astragalus gummifer and related plants; forms gelatinous mass in water; used as suspending agent, excipient or emulsifier in foods, cosmetics and pharmaceuticals; also as bulk-forming laxative. Synonyms: Gum Dragon; Traganth. Pharmaceutic Aids (68-77); Pharmacy (66-67); Polysaccharides (66-77); Resins (66-77)  =@!fTraction E04.557.919 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Orthopedics   $&Track and Field I03.450.642.845.925 CLECEDHIINLJPHPXSNSTTD Running Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Sports performed on a track, field, or arena and including running events and other competitions, such as the pole vault, shot put, etc. Sports (66-75)  d RTrachoma C01.252.354.225.800; C01.252.400.810.200.195.920; C01.539.375.354.220.800; C11.187.183.220.889; C11.204.813; C11.294.354.220.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Chlamydiaceae Infections; Chlamydia Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Eye Diseases; Conjunctival Diseases; Conjunctivitis; Conjunctivitis, Bacterial Eye Diseases; Corneal Diseases Eye Diseases; Eye Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial A chronic infection of the conjunctiva and cornea caused by CHLAMYDIA TRACHOMATIS.   PbTracheotomy E04.847.907; E04.920.970 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Trachea Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) Surgery, Operative; Thoracic Surgery Surgical incision of the trachea.  )$ p*Tracheostomy E04.579.935; E04.847.900; E04.920.960 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Trachea Surgery, Operative; Ostomy Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) Surgery, Operative; Thoracic Surgery Surgical formation of an opening into the trachea through the neck, or the opening so created. Tracheotomy (66-87)  F-$ rTracheoesophageal Fistula C06.185.400.750; C06.306.392.713; C08.702.750; C08.907.863; C23.439.185.400.750; C23.439.687.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Fistula (Non MeSH); Esophageal Fistula Digestive System Diseases; Esophageal Diseases; Esophageal Fistula Respiratory Tract Diseases; Respiratory Tract Fistula (Non MeSH) Respiratory Tract Diseases; Tracheal Diseases Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH); Esophageal Fistula Symptoms and General Pathology (Non MeSH); Fistula; Respiratory Tract Fistula (Non MeSH) Abnormal communication between the esophagus and the trachea which is often associated with ESOPHAGEAL ATRESIA. This abnormality may be acquired, but is frequently congenital.  nNTracheobronchomegaly C08.127.930; C08.695.830; C08.907.830; C16.131.740.830 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Respiratory Tract Diseases; Tracheal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) A rare and probably congenital condition characterized by great enlargement of the lumen of the trachea and the larger bronchi. Bronchi/abnormalities (66-86); Trachea/abnormalities (66-86)  @L6GTracheitis C08.730.848; C08.907.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiratory Tract Infections Respiratory Tract Diseases; Tracheal Diseases  NvTracheal Stenosis C08.907.663 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Tracheal Diseases  N6Tracheal Neoplasms C04.588.443.925; C04.588.894.797.760; C08.785.760; C08.907.563 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms Respiratory Tract Diseases; Tracheal Diseases  HX+Tracheal Diseases C08.907 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases Tracheal Neoplasms; Tracheal Stenosis; Tracheitis; Tracheobronchomegaly; Tracheoesophageal Fistula Respiratory Tract Diseases (66-67); Trachea (66-67) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI   N q>XTrachea A04.889 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Anesthesia, Intratracheal; Intubation, Intratracheal; Tracheostomy; Tracheotomy Respiratory System The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.  J  :[Trace Elements D01.268.912 ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Arsenic; Boron; Chromium; Cobalt; Copper; Fluorine; Iodine; Iron; Manganese; Molybdenum; Nickel; Selenium; Silicon; Tin; Vanadium; Zinc A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed).  <2Trabeculectomy E04.792.450.700 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ciliary Body; Glaucoma Surgery, Operative; Surgery, Eye (Non MeSH); Filtering Surgery Any surgical procedure for treatment of glaucoma by means of puncture or reshaping of the trabecular meshwork. It includes goniotomy, trabeculotomy, and laser perforation. Ciliary Body/surgery (66-87); Glaucoma/surgery (66-87); Sclera/surgery (66-87); Trabecular Meshwork/surgery (77-87)  $LTrabecular Meshwork A09.371.060.932 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Anterior Eye Segment A porelike structure surrounding the entire circumference of the anterior chamber through which aqueous humor circulates to the canal of Schlemm. Anterior Chamber (66-76); Ciliary Body (66-76); Uvea (66-76)  >:2KToyocamycin D13.570.800.840; D20.085.075.950; D22.204.106.930; D22.204.144.930; D26.087.922 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry. Nitriles (66-74); Nucleosides (66-72); Pyrimidine Nucleosides (74); Pyrroles (66-74); Ribonucleosides (73-74)  [<,Toxoplasmosis, Ocular C03.300.781; C03.752.750.259.800.640; C11.294.725.781 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Eye Infections, Parasitic Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Toxoplasmosis Eye Diseases; Eye Infections; Eye Infections, Parasitic Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.  ;=PToxoplasmosis, Congenital C03.752.750.259.800.280; C16.614.909 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Toxoplasmosis Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Congenital infection with Toxoplasma gondii characterized by lesions of the central nervous system.  Ϣ*LtToxoplasmosis, Cerebral C03.752.750.259.800.250; C10.228.140.940; C10.228.228.940 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Toxoplasmosis Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Infection caused by the protozoan TOXOPLASMA that presents itself in a subacute fashion with headache, focal neurologic signs, seizures, or altered mental status which can progress to coma. This condition is a commonly encountered opportunistic infection in AIDS patients. Brain Diseases (66-91); Toxoplasmosis (66-91)  ыAP3<7Toxoplasmosis, Animal C03.701.688.817; C03.752.625.817; C03.752.750.259.800.110; C22.674.710.817 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Toxoplasmosis Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.  TJ\Toxoplasmosis C03.752.750.259.800 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis Toxoplasmosis, Animal; Toxoplasmosis, Cerebral; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular The acquired form of infection by Toxoplasma gondii in animals and man. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  LXnWPToxoplasma B01.841.075.762.167.275.250.650 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.  #&bToxoids D24.310.794 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products Diphtheria Toxoid (+ 1); Staphylococcal Toxoid; Tetanus Toxoid (+ 1) Preparations of pathogenic organisms or their derivatives made nontoxic and intended for active immunologic prophylaxis. They include deactivated toxins. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  m BMTDToxocariasis C03.335.349.868; C03.335.508.700.100.868; C03.701.377.868; C22.674.377.868 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Ascaridida Infections Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH)  Larva Migrans, Visceral Infection by round worms of the genus TOXOCARA, usually found in wild and domesticated cats and dogs and foxes, except for the larvae, which may produce visceral and ocular larva migrans in man. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  ݊TJ PToxocara canis B01.500.294.700.100.100.780.225 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea; Toxocara A species of parasitic nematode found in the intestine of dogs. Lesions in the brain, liver, eye, kidney, and lung are caused by migrating larvae. In humans, these larvae do not follow normal patterns and may produce visceral larva migrans (LARVA MIGRANS, VISCERAL). Toxocara (66-92)  M#*c<Toxocara B01.500.294.700.100.100.780 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea Toxocara canis A genus of ascarid nematodes commonly parasitic in the intestines of cats and dogs.   *WeToxins D24.185.926 ADAEAGANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Antitoxins Immunologic and Biologic Factors (Non MeSH); Biological Factors Bacterial Toxins (+ 9); Cytotoxins (+ 5); Dermotoxins (+ 2); Endotoxins; Enterotoxins; Exotoxins; Hypoglycins; Immunotoxins; Marine Toxins (+ 9); Mycotoxins (+ 20); Neurotoxins (+ 1); Ricin Specific, characterizable, poisonous chemicals, often proteins, with specific biological properties, including immunogenicity, produced by microbes, higher plants, or animals. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $  <LJToxiferine D02.092.102.844; D02.675.276.844; D03.132.267.712; D14.100.120.200.600.170.840; D16.700.710.575.130.840 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Heterocyclic Compounds; Alkaloids; Curare Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists; Curare Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Curare Alcuronium Alcuronium Alcuronium A curare alkaloid that is a very potent competitive nicotinic antagonist at the neuromuscular junction.  s@&(zToxicology G01.703.795; G02.628.795 CLECEDHIISLJMAMTOGSNSTTD Poisons Biological Sciences; Pharmacology Health Occupations; Pharmacology The science concerned with the detection, chemical composition, and pharmacologic action of toxic substances or poisons and the treatment and prevention of toxic manifestations.  \ MToxicodendron B06.660.925 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Dermatitis, Toxicodendron Plants; Plants, Toxic A genus (formerly Rhus) of shrubs, vines, or trees that yields a highly allergenic oleoresin which causes a severe contact dermatitis. The most toxic species are Toxicodendron vernix (poison sumac), T. diversilobum (poison oak), and T. radicans (poison ivy). T. vernicifera yields a useful varnish from which certain enzymes (laccases) are obtained.  &Toxicity Tests E05.940 AECLCTECHIISMOMTNUPXSNSTTDUTVE Drug Screening Miscellaneous Techniques (Non MeSH) Carcinogenicity Tests; Cytotoxicity Tests, Immunologic; Mutagenicity Tests Tests that determine the toxicity of a substance. These include tests of clinical drugs, foods, environmental pollutants, etc. specific substance/toxicity (66-94); Toxicology/methods (75-94) $ 1 "*VKToxemia C01.539.861 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Pregnancy Toxemias Bacterial and Fungal Diseases (Non MeSH); Infection A generalized intoxication produced by toxins and other substances elaborated by an infectious agent.   P?wToxascaris B01.500.294.700.100.100.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea An ascarid nematode found primarily in the small intestine of the larger Felidae as well as dogs and cats. It differs from TOXOCARA in that the larvae do not migrate through the lungs. It does occasionally produce visceral larva migrans (LARVA MIGRANS, VISCERAL) in man, although more rarely than does Toxocara. Nematoda (66-71)  q*WpToxascariasis C03.335.508.700.100.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Ascaridida Infections Infections with nematodes of the genus TOXASCARIS.  Pu=Toxaphene D02.455.526.439.913; D02.455.849.618.795; D05.723.491.491.924 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Norbornanes Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Insecticides (66-72)   E:2Tourniquets E07.926 AECLCTECHISDSNSTTDUTVE Equipment and Supplies   Tourette Syndrome C10.228.140.079.898; F03.126.720.894.898 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders; Tic Disorders characterized by the exhibition of repetitive motor tics which may become violent stereotyped tics. They may be expressed by skipping, hopping, grinding of teeth, etc., and involve the whole body. The distinctive diagnostic characteristic of this disorder is the compulsion to spontaneous, repetitive expression of 4-letter words or profanities. Symptoms of this disorder begin usually between the ages of 2 and 12 years.  .LTouch F02.463.593.885; F02.830.816.850; G11.561.796.850 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation Stereognosis Stereognosis Sensation or perception by which contact with objects, animate or inanimate, gives evidence as to certain qualities or characteristics.   9(Total Quality Management N04.452.955; N04.761.700.675; N05.700.792 CLECHILJMAMTOGSNSTTDUT Quality Control Quality Control Health Services Administration (Non MeSH); Organization and Administration Health Services Administration (Non MeSH); Quality of Health Care; Quality Assurance, Health Care Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care The application of industrial management practice to systematically maintain and improve organization-wide performance. Effectiveness and success are determined and assessed by quantitative quality measures. Quality Assurance, Health Care (89-93) $ u1.Total Lung Capacity E01.302.796.420.810; G09.772.521.700.810 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Closing Volume; Functional Residual Capacity (+ 2); Vital Capacity (+ 4) Closing Volume; Functional Residual Capacity (+ 2); Vital Capacity (+ 4) The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: vital capacity plus residual volume; inspiratory capacity plus functional residual capacity; tidal volume plus inspiratory reserve volume plus functional residual capacity; tidal volume plus inspiratory reserve volume plus expiratory reserve volume plus residual volume.  j. Tosylphenylalanyl Chloromethyl Ketone D02.455.426.559.389.832.710; D02.886.590.887.660; D08.373.745.075.930; D12.125.065.930 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Amino Acid Chloromethyl Ketones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acid Chloromethyl Ketones N-[alpha-(chloroacetyl)phenethyl]-L-p-toluenesulfonamide. An inhibitor of serine proteinases. Acts as alkylating agent and is known to interfere with the translation process. Chlorine (74); Phenylalanine (72-74); Tosyl Compounds (73-74)  s+`:KTosyllysine Chloromethyl Ketone D02.455.426.559.389.832.690; D02.886.590.887.600; D08.373.745.075.850; D12.125.065.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Amino Acid Chloromethyl Ketones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acid Chloromethyl Ketones N-[5-amino-1-(chloroacetyl)pentyl]-p-toluenesulfonamide. An inhibitor of serine proteinases. Acts as an alkylating agent and is known to interfere with the translation process. Chlorine (74); Lysine (74); Tosyl Compounds (74)  w%`:>Tosylarginine Methyl Ester D02.455.426.559.389.832.670; D02.886.590.887.570; D12.125.095.104.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Arginine N(2)-(p-Tolylsulfonyl)-L-arginine, methyl ester. Arginine derivative which is a substrate for many proteolytic enzymes. As a substrate for the esterase from the first component of complement, it inhibits the action of C(l) on C(4). Arginine (72-74); Tosyl Compounds (72-74)  k M:x3Tosyl Compounds D02.455.426.559.389.832.661; D02.886.590.887 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones  Bromcresol Green; Bromcresol Purple; Bromphenol Blue; Bromthymol Blue; Tosylarginine Methyl Ester; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone Sulfones (66-71); Toluene (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  28*:Tospovirus B04.715.820; B04.820.087.730 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses; Bunyaviridae A genus of plant viruses in the family BUNYAVIRIDAE. Tomato spotted wilt virus is the type species and only confirmed member, but there are many other possible members. Transmission occurs by at least nine species of thrips. Plant Viruses (66-93)  "F Torture F03.126.842.089.700 CLHILJPXSN Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression The intentional infliction of physical or mental suffering upon an individual or individuals, including the torture of animals.   Torticollis C05.651.925; C10.597.559.895; C23.888.592.574.879 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders A contraction of the cervical muscles producing twisting of the neck and an unnatural position of the head.  9NTorsion C23.739.901 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) A twisting or rotation of a bodily part or member on its axis.  Z NYOTorsades de Pointes C14.280.067.845.880.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A supraventricular tachycardia characterized by periodic twisting of the points of the QRS complexes and rates between 200 and 250 beats per minute. It may be self-limited or may progress to ventricular fibrillation. Arrhythmia (74-82); Tachycardia (74-90)  Nn0Torpedo B02.493.378.722 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Electric Fish A genus of the Torpedinidae family consisting of several species. This genus as well as all the other genera of this family have powerful electric organs and are commonly called electric rays. Fishes (68-81)   &+Torovirus Infections C02.782.225.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Coronaviridae Infections Infections with viruses of the genus TOROVIRUS, family CORONAVIRIDAE.  `PXRTorovirus B04.820.155.800; B04.909.777.199.800 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae A genus of the family CORONAVIRIDAE characterized by enveloped, peplomer-bearing particles containing an elongated tubular nucleocapsid with helical symmetry. Toroviruses have been found in association with enteric infections in horses (Berne virus), cattle (Breda virus), and humans. Transmission takes place probably via the fecal-oral route. RNA Viruses (84-91)   *{Toremifene D02.455.426.559.389.150.700.900.900; D06.347.300.760.900; D22.204.865.909 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes; Tamoxifen Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists; Tamoxifen Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Tamoxifen (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine. A nonsteroidal antiestrogenic antitumor agent with rare or mild side effects. It has been shown to be effective in the treatment of advanced breast cancer. Tamoxifen/analogs and derivatives (85-92)  "FQ: 1Toothpaste D25.376.711; D26.313.211.711; J01.516.278.711 AEANCLCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dentifrices Miscellaneous Drugs and Agents (Non MeSH); Cosmetics; Dentifrices Technology, Industry, Agriculture (Non MeSH); Household Products; Dentifrices A dentifrice in paste form; usually contains binder, humectant, an abrasive, a detergent, flavoring agent and often caries preventives, anti-infective agents or other medicaments.  %5&Toothbrushing E06.761.726.794 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Oral Hygiene; Dental Devices, Home Care Dentistry; Preventive Dentistry; Oral Hygiene  ($$17Toothache C07.793.929; C23.888.592.612.905 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain  ( &NTooth, Unerupted A14.254.860.923; C07.793.915 AHBLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARERHRIRTSUTHTRULURUSVEVI Tooth, Impacted Stomatognathic System; Dentition; Tooth Stomatognathic Diseases; Tooth Diseases A tooth that fails to erupt or fails to erupt in the normal sequence or time interval expected for the type of tooth in a given gender, age, or population group. Tooth Eruption (66-72)  *C"X]Tooth, Supernumerary C07.650.800.850; C07.793.700.850; C16.131.850.800.850 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities An extra tooth, erupted or unerupted, resembling or unlike the other teeth in the group to which it belongs. Its presence may cause malposition of adjacent teeth or prevent their eruption.  ,N=LFTooth, Impacted C07.793.846 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tooth, Unerupted Stomatognathic Diseases; Tooth Diseases A tooth that is prevented from erupting by a physical barrier, usually other teeth. Impaction may also result from orientation of the tooth in an other than vertical position in the periodontal structures.  /9N/Tooth, Deciduous A14.254.860.815 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Dentition, Primary Stomatognathic System; Dentition; Tooth Natal Teeth The 20 teeth of the first dentition, which are shed and replaced by the permanent teeth. All deciduous teeth are normally expected to erupt by the age of two and a half years.  1:0Tooth, Artificial E06.780.345.875 AECLCTECHIPXSDSNSTTDUTVE Acrylic Resins; Dental Porcelain Dental Implants Dentistry; Prosthodontics; Dental Prosthesis A fabricated tooth substituting for a natural tooth in a prosthesis. It is usually made of porcelain or plastic.  2(5Tooth Root A14.254.860.887 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Apicoectomy; Root Resorption Stomatognathic System; Dentition; Tooth  4*:#0Tooth Resorption C07.793.901; G10.549.917 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) Root Resorption Root Resorption Resportion of calcified dental tissue, involving demineralization due to reversal of the cation exchange and lacunar resportion by osteoclasts. There are two types: external (as a result of tooth pathology) and internal (apparently initiated by a peculiar inflammatory hyperplasia of the pulp). (From Jablonski: Illustrated Dictionary of Dentistry).  4N&Tooth Replantation E04.833.876; E04.936.494.711; E06.397.898; E06.892.876 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Surgery, Operative; Surgery, Oral Surgery, Operative; Transplantation; Replantation Dentistry; Endodontics Dentistry; Surgery, Oral Reinsertion of a tooth into the alveolus from which it was removed or otherwise lost.  7@$hTooth Remineralization E06.950 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry Therapeutic technique for replacement of minerals in partially decalcified teeth. Tooth Calcification (66-84)  9 $ _!Tooth Permeability G10.549.879 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) Dental Enamel Permeability; Dentin Permeability  :W8Tooth Movement, Minor E06.658.578.836 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Orthodontics; Orthodontics, Corrective Orthodontic techniques used to correct minor degrees of tooth malposition. Orthodontics, Corrective (66-72)  ;e$:X&Tooth Mobility C07.465.714.898; G10.549.841 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH)  <"NTooth Migration C07.465.714.836; G10.549.803 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) Mesial Movement of Teeth Mesial Movement of Teeth  ="N<Tooth Luxation C07.793.850.800; C21.866.900.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Tooth Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Tooth Injuries Partial or complete displacement of a tooth from its socket. specific tooth (66-69)  ?U&NJTooth Loss C07.465.714.804; C07.793.870 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Stomatognathic Diseases; Tooth Diseases The failure to retain teeth as a result of disease or injury.  A "NuMTooth Injuries C07.793.850; C21.866.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Tooth Fractures (+ 1); Tooth Luxation Tooth Fractures (+ 1); Tooth Luxation Traumatic or other damage to teeth including fractures (TOOTH FRACTURES) or displacements (TOOTH LUXATION). Tooth/injuries (66-94)  BqN~^~Tooth Germ A14.254.860.851 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Odontogenesis Stomatognathic System; Dentition; Tooth Dental Papilla; Dental Sac; Enamel Organ  D:03Tooth Fractures C07.793.850.750; C21.866.900.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Tooth Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Tooth Injuries Cracked Tooth Syndrome Cracked Tooth Syndrome Break or rupture of a tooth or tooth root.  E&N67Tooth Extraction E04.833.834; E06.892.834 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dry Socket Surgery, Operative; Surgery, Oral Dentistry; Surgery, Oral  Serial Extraction  GH$FTooth Exfoliation C07.465.714.773; G10.549.764 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) Periodontal Diseases (66-67); Tooth, Deciduous (66-67)  H2"NATooth Eruption, Ectopic C07.793.790 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases  IN/Tooth Eruption G10.549.726 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH)  JWTooth Erosion C07.793.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases  K'N/Tooth Diseases C07.793 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mouth Rehabilitation Stomatognathic Diseases Bruxism; Dental Deposits (+ 2); Dental Leakage; Dental Pulp Diseases (+ 6); Dentin Sensitivity; Focal Infection, Dental; Hypercementosis; Malocclusion (+ 5); Mottled Enamel; Tooth Abnormalities (+ 9); Tooth Abrasion; Tooth Demineralization (+ 3); Tooth Discoloration; Tooth Erosion; Tooth Eruption, Ectopic; Tooth, Impacted; Tooth Injuries (+ 3); Tooth Loss; Tooth Resorption (+ 1); Tooth, Unerupted; Toothache ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTMTRULURUSVEVI  K NlTooth Discoloration C07.793.735 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases  O N/Tooth Demineralization C07.793.720 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dental Caries Decalcification, Pathologic; Dental Caries Stomatognathic Diseases; Tooth Diseases Dental Caries (+ 2) A tooth's loss of minerals, such as calcium in hydroxyapatite from the tooth matrix, caused by acidic exposure. An example of the occurrence of demineralization is in the formation of DENTAL CARIES. $ ON2/Tooth Calcification G06.184.227.710; G10.549.688 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Calcification, Physiologic Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH)  Q"Tooth Bleaching E06.940 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry Mottled Enamel/TH (66-70); Root Canal Therapy (66-70); Tooth Discoloration/TH (66-70)  S1 $ hTooth Abrasion C07.793.707 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases  T N/Tooth Abnormalities C07.650.800; C07.793.700; C16.131.850.800 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH) Stomatognathic Diseases; Tooth Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH) Amelogenesis Imperfecta (+ 1); Anodontia; Dens in Dente; Dentin Dysplasia; Dentinogenesis Imperfecta; Fused Teeth; Odontodysplasia; Tooth, Supernumerary Amelogenesis Imperfecta (+ 1); Anodontia; Dens in Dente; Dentin Dysplasia; Dentinogenesis Imperfecta; Fused Teeth; Odontodysplasia; Tooth, Supernumerary Amelogenesis Imperfecta (+ 1); Anodontia; Dens in Dente; Dentin Dysplasia; Dentinogenesis Imperfecta; Fused Teeth; Odontodysplasia; Tooth, Supernumerary Congenital absence of or defects in structures of the teeth.  T1LJTooth A14.254.860 AHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Dentition; Malocclusion; Mastication; Odontogenesis; Paleodontology Stomatognathic System; Dentition Bicuspid; Cuspid; Dental Cementum; Dental Enamel (+ 1); Dental Pulp; Dental Pulp Cavity; Dentin (+ 1); Incisor; Molar (+ 1); Tooth, Deciduous (+ 1); Tooth Germ (+ 3); Tooth Root; Tooth, Unerupted consider also terms at DENT- and ODONTO-. ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI $ X 8O'4jTonsillitis C07.550.935; C08.730.817; C09.775.860 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Pharyngeal Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Pharyngeal Diseases  Peritonsillar Abscess Inflammation of the tonsils, especially the palatine tonsils. It is often caused by a bacterium. Tonsillitis may be acute, chronic, or recurrent. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  [n-NPTonsillectomy E04.847.848 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Tonsil Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH)  ]$ FTonsillar Neoplasms C04.588.443.665.710.684.800; C07.550.745.671.800; C09.647.710.685.800; C09.775.549.685.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms; Oropharyngeal Neoplasms Stomatognathic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms; Oropharyngeal Neoplasms Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms; Oropharyngeal Neoplasms Otorhinolaryngologic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms; Oropharyngeal Neoplasms  ^dXTonsil A14.724.603.925; A15.382.520.604.886 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tonsillectomy Stomatognathic System; Pharynx; Oropharynx Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphoid Tissue Either of two small, almond-shaped masses located between the palatoglossal and palatopharyngeal arches, one on either side of the oropharynx. It is composed mainly of lymphoid tissue, covered with mucous membrane, and containing various crypts and many lymph follicles. It is believed to act as the source which supplies the mouth and pharynx with phagocytes which destroy bacteria entering the mouth. (Dorland, 27th ed).  a *:Tonometry E01.210.860 AECLCTECHIISMOMTNUPXSNSTTDUTVE Intraocular Pressure Diagnosis; Diagnosis, Eye (Non MeSH)  d "-Tonic Pupil C11.710.090.800; C11.710.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Pupillary Functions, Abnormal; Anisocoria Eye Diseases; Pupillary Functions, Abnormal Adie's Syndrome Adie's Syndrome; Horner's Syndrome Usually a unilateral abnormality of the eye characterized by slow pupillary constriction to light and in which there is a delayed reaction to changes in accommodation and convergence. The affected pupil is usually larger. Photic Stimulation (72-89); Pupil (67-89)  eZ"Nt<3Tongue, Hairy C07.465.910.791 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Leukoplakia, Hairy Stomatognathic Diseases; Mouth Diseases; Tongue Diseases A benign condition of the tongue characterized by hypertrophy of the filiform papillae that give the dorsum of the tongue a furry appearance. The color of the elongated papillae varies from yellowish white to brown or black, depending upon staining by substances such as tobacco, food, or drugs. (Dorland, 27th ed).  gNCuTongue, Fissured C07.465.910.708 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Melkersson-Rosenthal Syndrome Stomatognathic Diseases; Mouth Diseases; Tongue Diseases  jUN"CTongue Neoplasms C04.588.443.591.925; C07.465.565.925; C07.465.910.874 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Tongue Diseases  kS=XTongue Habits F01.145.466.874; F03.234.193.308.680 AEPXTH Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders; Child Reactive Disorders; Habits Acquired responses regularly manifested by tongue movement or positioning.  m* WTongue Diseases C07.465.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Glossalgia; Glossitis (+ 1); Macroglossia; Tongue, Fissured; Tongue, Hairy; Tongue Neoplasms BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  nN/pXTongue A14.549.885 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Glossectomy Stomatognathic System; Mouth Lingual Frenum; Taste Buds consider also terms at GLOSS- and LINGUAL.  p :#"5Tonga Z01.782.815.890 EHEP Geographicals (Non MeSH); Pacific Islands; Polynesia  q @Tomography, X-Ray Computed E01.357.505.880; E01.357.710.500.802.935; E01.357.818.802.935; E01.357.818.927.935; E01.357.927.907.935; H01.671.606.799.484.802.935 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Image Interpretation, Computer-Assisted Diagnosis; Diagnostic Imaging; Photography; Image Enhancement; Radiographic Image Enhancement Diagnosis; Diagnostic Imaging; Radiography; Radiographic Image Enhancement Diagnosis; Diagnostic Imaging; Radiography; Tomography, X-Ray Diagnosis; Diagnostic Imaging; Tomography; Tomography, X-Ray Physical Sciences (Non MeSH); Physics; Optics; Photography; Image Enhancement; Radiographic Image Enhancement Tomography using x-ray transmission and a computer algorithm to reconstruct the image; called tomodensitometry in Romance language journals. Tomography, X-Ray (73-76)  q "Tomography, X-Ray E01.357.818.927; E01.357.927.907 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Diagnosis; Diagnostic Imaging; Tomography Tomography, X-Ray Computed Tomography, X-Ray Computed Tomography using x-ray transmission. Tomography (66-72)  uy&"c>,Tomography, Emission-Computed, Single-Photon E01.289.806.915.900; E01.357.505.860.900; E01.357.710.500.901.900; E01.357.820.915.900; E01.357.927.900.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging; Tomography, Emission-Computed Diagnosis; Diagnostic Imaging; Image Interpretation, Computer-Assisted; Tomography, Emission-Computed Diagnosis; Diagnostic Imaging; Photography; Image Enhancement; Tomography, Emission-Computed Diagnosis; Diagnostic Imaging; Radionuclide Imaging; Tomography, Emission-Computed Diagnosis; Diagnostic Imaging; Tomography; Tomography, Emission-Computed A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. Tomography, Emission-Computed (80-89); Tomography, X-Ray Computed (77-79)  v2w"UTomography, Emission-Computed E01.289.806.915; E01.357.505.860; E01.357.710.500.901; E01.357.820.915; E01.357.927.900; H01.671.606.799.484.901 AECLCTECHIISMOMTNUPXSNSTTDUTVE Gamma Cameras Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging Diagnosis; Diagnostic Imaging; Image Interpretation, Computer-Assisted Diagnosis; Diagnostic Imaging; Photography; Image Enhancement Diagnosis; Diagnostic Imaging; Radionuclide Imaging Diagnosis; Diagnostic Imaging; Tomography Physical Sciences (Non MeSH); Physics; Optics; Photography; Image Enhancement Tomography, Emission-Computed, Single-Photon Tomography, Emission-Computed, Single-Photon Tomography, Emission-Computed, Single-Photon Tomography, Emission-Computed, Single-Photon Tomography, Emission-Computed, Single-Photon Tomography using emissions from radionuclides and a computer algorithm to reconstruct the image. Tomography (66-79); Tomography, X-Ray Computed (77-79) $ }"~"qATomography Scanners, X-Ray Computed E07.913 AECLCTECHISDSNSTTDUTVE Radiographic Image Enhancement Equipment and Supplies X-ray image-detecting devices that make a focused image of body structures lying in a predetermined plane from which more complex images are computed. Tomography, X-Ray/instrumentation (74-76); Tomography, X-Ray Computed/instrumentation (77-89)  #* $kTomography E01.357.927 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging Magnetic Resonance Imaging (+ 2); Tomography, Emission-Computed (+ 1); Tomography, X-Ray (+ 1) Imaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  "$r&Tombusvirus B04.715.800; B04.820.870 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses A group of plant viruses that infect angiosperms. Transmission occurs mechanically though seed and soil are a possible route for some members. Plant Viruses (75-93)  6Tomatoes B06.510.956.800; J01.341.956.945 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables Plants, Lycopersicon esculentum, native to South America, widely cultivated for their edible, fleshy, usually red fruit and also the fruit itself. (From American Heritage Dictionary, 1982). Plants (66-94); Plants, Edible (66-94); Vegetables (66-94)  + &4tHTomatine D03.132.760.864; D09.203.408.934; D20.136.801 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Solanaceous Alkaloids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Anti-Infective Agents; Antifungal Agents  Q 5:Toluidines D02.092.146.859; D02.455.426.559.389.832.559 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Trifluralin Toluene (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  28:Toluene 2,4-Diisocyanate D02.455.426.559.389.832.500; D02.500.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Isocyanates 2,4-Diisocyanato-1-methylbenzene. Skin irritant and allergen used in the manufacture of polyurethane foams and other elastomers. Cyanates (70-74); Toluene (73-74)  .:*Toluene D02.455.426.559.389.832 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Bromcresol Green; Bromcresol Purple; Bromphenol Blue; Bromthymol Blue; Toluene 2,4-Diisocyanate; Toluidines; Tosyl Compounds; Tosylarginine Methyl Ester; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Trifluralin; Trinitrotoluene   :$Tolperisone D02.522.818.950; D15.525.850; D16.700.600.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1211). Piperidines (66-78); Propiophenones (66-78)  !5:4Tolonium Chloride D03.494.741.869; D19.461.270.546.709; D26.408.874 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Heparin Antagonists Miscellaneous Drugs and Agents (Non MeSH); Dyes  9.Tolnaftate D02.241.081.251.869.791; D02.886.706.825; D04.615.638.975; D20.136.763 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Anti-Infective Agents; Antifungal Agents Methyl(3-methylphenyl)carbamothioic acid O-2-naphthalenyl ester. A synthetic antifungal agent. Antifungal Agents (66-71); Thiocarbamates (66-71)  fP:^m;Tolmetin D03.383.757.910; D08.373.310.925; D16.850.015.050.930; D17.025.030.875; D17.050.030.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrroles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 1-Methyl-5-(4-methylbenzoyl) pyrrole-2-acetic acid. An anti-inflammatory antipyretic and analgesic similar in mode of action to INDOMETHACIN. It has been proposed as an antirheumatic agent. Benzoates (73-75); Pyrroles (73-75)  + c:,Tolbutamide D02.886.590.795.896; D02.948.828.896; D09.482.909 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents  9:Tolazoline D03.383.374.924; D14.100.050.200.100.850; D14.100.375.400.840; D16.050.850.870; D18.162.894; D18.918.891 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Vasodilator Agents A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.  \v:eTolazamide D02.886.590.795.834; D02.948.828.834; D09.482.859 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents  %9:Tokyo Z01.252.474.463.709; Z01.433.900 EHEP Geographicals (Non MeSH); Asia; Far East; Japan Geographicals (Non MeSH); Cities (Non MeSH)   &qToken Economy F02.463.425.770.836.500 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology); Reward A practice whereby tokens representing money, toys, candy, etc., are given as secondary reinforcers contingent upon certain desired behaviors or performances. Reward (66-74)  Toilet Training F01.318.709 Behavior and Behavior Mechanisms (Non MeSH); Child Rearing Conditioning to defecate and urinate in culturally acceptable places. Child Care (66-67)  -GRToilet Facilities G03.850.860.410.560; G03.850.860.510.490 CLECHILJSNST Environment and Public Health (Non MeSH); Public Health; Sanitation; Public Facilities (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering Facilities provided for human excretion, often with accompanying handwashing facilities.  $.fTogo Z01.058.290.190.800 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western  _Togaviridae Infections C02.782.930 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Alphavirus Infections (+ 2); Rubivirus Infections (+ 2) Virus diseases caused by the TOGAVIRIDAE. Arbovirus Infections (66-80)  P:D3"Togaviridae B04.820.850; B04.909.777.923 CHCLDEENGDGEIMIPMEPHPYREUL Arboviruses Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Alphavirus (+ 7); Rubivirus (+ 1) Alphavirus (+ 7); Rubivirus (+ 1) A family of RNA viruses, mainly arboviruses, consisting of two genera: ALPHAVIRUS (group A arboviruses), and RUBIVIRUS. Virions are spherical, 60-70 nm in diameter, with a lipoprotein envelope tightly applied to the icosahedral nucleocapsid. Arboviruses (66-80) $ "YVToes A01.378.592.350.300.792 ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Extremities; Leg; Foot; Forefoot, Human Hallux  i*Q Toe Joint A02.835.583.899 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Joints Metatarsophalangeal Joint  4:1Todralazine D02.442.925; D03.383.710.605.925; D18.162.893 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines; Phthalazines Cardiovascular Agents; Antihypertensive Agents N'-(1-Phthalazinyl)-hydrazinecarboxylic acid ethyl ester. An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects. Carboxylic Acids (72-74); Heterocyclic Compounds (71-74); Hydrazines (71-74)  5:[Tocolytic Agents D06.347.930; D26.930 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Labor, Premature; Uterine Contraction Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Miscellaneous Drugs and Agents (Non MeSH) Albuterol; Fenoterol; Hexoprenaline; Indomethacin; Isoxsuprine; Magnesium Sulfate; Nifedipine; Nylidrin; Ritodrine; Terbutaline Albuterol; Fenoterol; Hexoprenaline; Indomethacin; Isoxsuprine; Magnesium Sulfate; Nifedipine; Nylidrin; Ritodrine; Terbutaline Drugs that prevent preterm labor and immature birth by suppressing uterine contractions. Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. Labor, Premature (73-88); Muscle Contraction (66-74); Uterine Contraction (75-88); Uterus (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( 8-~*{u:Tocolysis E02.961 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Any drug treatment modality designed to inhibit uterine contractions in pregnant women at risk for preterm labor. Labor, Premature (73-88); Muscle Contraction (66-74); Uterine Contraction (75-88); Uterus (66-74)  5  "uTocainide D02.065.199.920; D18.097.920 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Cardiovascular Agents; Anti-Arrhythmia Agents 2-Amino-N-(2,6-dimethylphenyl)propanamide. An antiarrhythmic agent which exerts a potential- and frequency-dependent block of sodium channels. It is generally well tolerated but induces pulmonary complications in some patients. Anilides (74-81); Anti-Arrhythmia Agents (66-91); Lidocaine/analogs and derivatives (82-91)   ":mlTobramycin D09.203.408.051.476.600.800; D20.085.060.425.600.800 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Kanamycin; Nebramycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Kanamycin; Nebramycin O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6- diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2- deoxy-D-streptamine. An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the Pseudomonas species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species. Antibiotics (66-74); Aminoglycosides (74); Glycosides (66-73)  :<JTobamovirus B04.715.464.725; B04.820.464.725 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses Tobacco Mosaic Virus Tobacco Mosaic Virus A group of plant viruses in which the virion is a rigid filament. Transmission is by mechanical inoculation or seed. The type member is TOBACCO MOSAIC VIRUS. Plant Viruses (90-93); RNA Viruses (90-93)  &\25Tobacco, Smokeless D26.922 AEANCHCLDUECHIIPMEPDPKPORESDSTTO Miscellaneous Drugs and Agents (Non MeSH) The powdered leaves of Nicotiana tabacum which are either inhaled through the nose, chewed, or stored in cheek pouches. It includes any product of tobacco that is not smoked.   $2Tobacco Use Disorder F03.709.597.780.810 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Smoking Cessation Tobacco; Smoking Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included. Smoking (66-80) $ D~Tobacco Smoke Pollution G03.850.460.100.340.680 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution; Smoke Contamination of the air by tobacco smoke. Air Pollutants (75-81); Air Pollutants, Environmental (75-81); Air Pollution (72-81); Environmental Exposure (72-81); Smoke (72-81); Smoking (72-81); Ventilation (72-81)  {5Tobacco Mosaic Virus B04.715.464.725.800; B04.820.464.725.800 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses; Tobamovirus Viruses; RNA Viruses; Mosaic Viruses; Tobamovirus The type member of Tobamovirus which causes mosaic disease of tobacco. Transmission occurs by mechanical innoculation.  .zTobacco B06.660.920 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Nicotine; Smoking; Tobacco Use Disorder Plants; Plants, Toxic The toxic solanaceous American plant Nicotiana tabacum. It yields NICOTINE and other biologically active chemicals; its dried leaves are used for smoking.  k &1Titrimetry E05.196.922 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Colorimetry; Complement Hemolytic Activity Assay; Conductometry; Neutralization Tests; Potentiometry; Skin Test End-Point Titration Chemical analysis by titration, the determination of a given component in solution by addition of a liquid reagent of known strength until a given endpoint (e.g., a change in color) is reached. specific technique (66-92)  "E Titanium D01.268.902; D01.552.887 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals  ! :`Tissue Types (Non MeSH) A10 Connective Tissue (+ 10); Epithelium (+ 10); Exocrine Glands (+ 18); Granulation Tissue (+ 1); Lymphoid Tissue (+ 1); Membranes (+ 14); Muscles (+ 7); Nerve Tissue (+ 5) ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI  jTissue Transplantation E04.936.580 AECLCTECHIISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Tissue Donors; Tissue Preservation; Transplantation Immunology Transplantation Surgery, Operative; Transplantation Bone Marrow Transplantation; Brain Tissue Transplantation; Corneal Transplantation (+ 2); Fetal Tissue Transplantation; Liver Transplantation; Skin Transplantation Transference of tissue within an individual, between individuals of the same species, or between individuals of different species. specific tissue/transplantation (66-90); Transplantation (66-90) AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE , ͉0I*K2Tissue Therapy E02.040.884; E02.095.884 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine Therapeutics; Biological Therapy (Non MeSH)  r"[Tissue Survival G04.185.908 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) The span of viability of a tissue or an organ. Preservation, Biological (66-70); Tissue Culture (66-70); Tissue Preservation (66-70); Transplantation (66-70); specific organ or tissue  ?k<Tissue Preservation E05.760.833; E05.909.262.620.760; E05.909.432.600.760 CLECHIISMTSNSTTDUTVE Tissue Transplantation Miscellaneous Techniques (Non MeSH); Preservation, Biological Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques Blood Preservation; Organ Preservation; Semen Preservation Cryopreservation (+ 2); Tissue Fixation Cryopreservation (+ 2); Tissue Fixation The process by which a tissue or aggregate of cells is kept alive outside of the organism from which it was derived (i.e., to keep from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Tissue Banks (66) AECLCTECHIISMOMTNUPXSNSTTDUTVE ( =[1"Tissue Fixation E05.909.262.620.760.720; E05.909.432.600.760.720 CLECHIISMTSNSTTDUTVE Fixatives Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Tissue Preservation Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Tissue Preservation The technique of using FIXATIVES in the preparation of cytologic, histologic, or pathologic specimens for the purpose of maintaining the existing form and structure of all the constituent elements.  6 ETissue Extracts D24.185.893 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors Actihaemyl; Cell Extracts; Liver Extracts; Pancreatic Extracts (+ 1); Placental Extracts; Thymus Extracts Preparations made from animal tissues or organs; they usually contain many components, any one of which may be pharmacologically or physiologically active; extracts may contain specific, but uncharacterized factors or proteins with specific actions. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  BL!FTissue Expansion E04.860.920 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Plastic Process whereby tissue adjacent to a soft tissue defect is expanded by means of a subcutaneously implanted reservoir. The procedure is used in reconstructive surgery for injuries caused by trauma, burns, or ablative surgery. Surgery, Plastic (80-89); Surgical Flaps (83-89)  ܆$,;Tissue Expanders E07.450.921; E07.858.886 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment Inflatable reservoirs, usually made of silicone, which are implanted subcutaneously in order to generate tissue needed for surgical reconstruction. After implantation, the reservoir is inflated over several weeks by percutaneous injection of fluid. Once the tissue has grown, the expander is surgically removed and the expanded skin is used to cover the area being reconstructed. Implants, Artificial (83-89)  cf"Tissue Embedding E05.909.262.620.720; E05.909.432.600.720 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques Paraffin Embedding; Plastic Embedding Paraffin Embedding; Plastic Embedding The technique of placing cells or tissue in a supporting medium so that thin sections can be cut using a microtome. The medium can be paraffin wax (PARAFFIN EMBEDDING) or plastics (PLASTIC EMBEDDING) such as epoxy resins.  .XTissue Donors M01.898 CLEDHILJPXSDSN Organ Procurement; Tissue Transplantation Named Groups (Non MeSH) Blood Donors Individuals suppling living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients.   1Tissue Distribution G06.535.780.917 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Pharmacokinetics Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution are usually expressed as tissue to plasma ratios. Organ Specificity (66-77)  gcTissue Culture E05.909.813 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cell Line; Cells, Cultured; Clone Cells; Tumor Cells, Cultured; Virus Cultivation Organ Culture Miscellaneous Techniques (Non MeSH); Technology, Medical Diffusion Chambers, Culture; Organ Culture  "cC3Tissue Conditioning (Dental) E06.780.895 AECLCTECHIISMTNUPXSNSTTDUTVE Dentistry; Prosthodontics The use of a treatment material (tissue conditioner) to re-establish tone and health to irritated oral soft tissue, usually applied to the edentulous alveolar ridge. Periodontics (66-67); Prosthodontics (66-67)  U" 5Tissue Banks N02.278.065.900 CLECHILJOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Biological Specimen Banks Bone Banks; Eye Banks Centers for acquiring, characterizing, and storing organs or tissue for future use. CLECHILJMAMTOGSDSNSTTDUT  kcTissue Adhesives D25.919; D26.016.920; E07.858.876 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Bone Cements Adhesives Biomedical and Dental Materials (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Adhesives Equipment and Supplies; Surgical Equipment Cyanoacrylates (+ 2); Fibrin Tissue Adhesive Fibrin Tissue Adhesive AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ Q)* R:Tiron D02.455.426.559.389.097.870; D02.755.166.850; D02.886.645.600.080.050.100.900; D26.550.950 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzenesulfonates Organic Chemicals (Non MeSH); Phenols; Catechols Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Benzenesulfonates Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 4,5-Dihydroxy-1,3-benzenedisulfonic acid disodium salt. A colorimetric reagent for iron, manganese, titanium, molybdenum, and complexes of zirconium. (From Merck Index, 11th ed). Benzenesulfonates (74); Catechol (74)  4 d..Tinnitus C09.218.458.791; C10.597.257.443.915; C23.888.592.257.443.915 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Hearing Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Hearing Disorders A noise in the ears, as ringing, buzzing, roaring, clicking, etc. Such sounds may at times be heard by others than the patient. (Dorland, 27th ed).   EN[Tinidazole D02.640.672.900; D03.383.374.658.900; D21.370.370.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antitrichomonal Agents 1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole. A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections. Nitroimidazoles (71-74); Sulfones (71-74)  =: 2Tinea Versicolor C01.539.800.200.860; C01.703.295.936; C17.800.838.208.941 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses A common chronic, noninflammatory and usually symptomless disorder, characterized by the occurrence of multiple macular patches of all sizes and shapes, and varying in pigmentation from fawn-colored to brown. It is seen most frequently in hot, humid, tropical regions, and is caused by Pityrosporon orbiculare. (Dorland, 27th ed).  dAP7Tinea Pedis C01.539.800.200.720.760; C01.703.295.872.707; C17.800.305.728; C17.800.838.208.883.658; C23.304.351.434.708 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses; Tinea Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses; Tinea Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Foot Dermatoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses; Tinea Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases; Foot Dermatoses Tinea involving the feet, particularly the interdigital spaces and soles. It is most often caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum, and characterized by intensely pruritic lesions. (Dorland, 27th ed.).  wP3Tinea Favosa C01.539.800.200.720.730.740; C01.703.295.872.541.500; C17.800.738.708.708; C17.800.838.208.883.558.708 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses; Tinea; Tinea Capitis Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses; Tinea; Tinea Capitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Scalp Dermatoses; Tinea Capitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses; Tinea; Tinea Capitis A disease of the scalp that may affect the glabrous skin and the nails and is recognized by the concave sulfur-yellow crusts that form around loose, wiry hairs. Atrophy ensues, leaving a smooth, glossy, thin, paper-white patch. This type of disease is rare in the United States and more frequently seen in the Middle East, Africa, Southeastern Europe, and other countries bordering the Mediterranean Sea. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p319).  (pP1Tinea Capitis C01.539.800.200.720.730; C01.703.295.872.541; C17.800.738.708; C17.800.838.208.883.558 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses; Tinea Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses; Tinea Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Scalp Dermatoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses; Tinea Tinea Favosa Tinea Favosa Tinea Favosa Tinea Favosa Ringworm of the scalp caused by species of Microsporum and Trichophyton, which may occasionally involve the eyebrows and eyelashes. (Dorland, 27th ed).  E`P>Tinea C01.539.800.200.720; C01.703.295.872; C17.800.838.208.883 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses Onychomycosis; Tinea Capitis (+ 1); Tinea Pedis Onychomycosis; Tinea Capitis (+ 1); Tinea Pedis Onychomycosis; Tinea Capitis (+ 1); Tinea Pedis A general term describing various dermatophytoses. Specific types include TINEA CAPITIS (ringworm of the scalp), TINEA FAVOSA (of scalp and skin), TINEA PEDIS (athlete's foot), and tinea unguium (see ONYCHOMYCOSIS, ringworm of the nails). (Dorland, 27th ed).   AP72Tin Radioisotopes D01.496.749.910 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of tin that decay or disintegrate emitting radiation. Sn atoms with atomic weights 108-111, 113, 120-121, 123 and 125-128 are tin radioisotopes. Radioisotopes (66-87); Tin (66-87)  4C+Tin Polyphosphates D01.695.625.675.650.775.950; D01.935.950 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Polyphosphates Inorganic Chemicals (Non MeSH); Tin Compounds Poly or pyrophosphates of tin. In conjunction with radioactive technetium these compounds are used as bone-scanning agents and in scintigraphy to diagnose myocardial and cerebral infarction. Phosphates (66-76); Pyrophosphates (66-76); Tin (66-76)  Z.8DTin Fluorides D01.303.350.300.950; D01.935.925; D25.223.432.908 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Fluorine Compounds; Hydrofluoric Acid; Fluorides Inorganic Chemicals (Non MeSH); Tin Compounds Biomedical and Dental Materials (Non MeSH); Cariostatic Agents; Fluorides, Topical Inorganic fluorides of tin. They include both stannic fluoride (tin tetrafluoride) and stannous fluoride (tin difluoride). The latter is used in the prevention of dental caries. Fluorides (66-76); Fluorides, Topical (66-76); Tin (66-76)  9,HTin Compounds D01.935 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Tin Fluorides; Tin Polyphosphates Inorganic compounds that contain tin as an integral part of the molecule. Tin (66-93)   8%)YTin D01.268.912.900; D01.552.875 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organotin Compounds Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Tin. A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.  ":sTimolol D02.033.329.624.915; D02.092.063.624.915; D14.100.050.200.200.930; D16.050.850.855; D18.097.898; D18.162.889 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents A beta-adrenergic antagonist similar in action to PROPRANOLOL. The levo-isomer is the more active. Timolol has been proposed as an antihypertensive, antiarrhythmic, antiangina, and antiglaucoma agent. It is also used in the treatment of migraine and tremor. Amino Alcohols (72-73); Morpholines (72-75); Propanolamines (74-76); Thiadiazoles (72-76)   z:"-kTime Perception F02.463.593.857 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception The ability to estimate periods of time lapsed or duration of time.  $ \STime Management F02.784.412.923; F02.784.692.816; F04.096.628.779.900; J01.293.556.889; N04.452.932 ECMTOGPX Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Human Engineering Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology; Psychology, Industrial Technology, Industry, Agriculture (Non MeSH); Engineering; Human Engineering Health Services Administration (Non MeSH); Organization and Administration Planning and control of time to improve efficiency and effectiveness.  )_ STime Factors H01.862.857 Physical Sciences (Non MeSH); Time  ,Time and Motion Studies F02.784.412.846.707; F02.784.692.746.707; J01.293.556.779.624 Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Human Engineering; Task Performance and Analysis Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial; Task Performance and Analysis Technology, Industry, Agriculture (Non MeSH); Engineering; Human Engineering; Task Performance and Analysis The observation and analysis of movements in a task with an emphasis on the amount of time required to perform the task.  |ETime H01.862 Physical Sciences (Non MeSH) Chronology; Half-Life; Periodicity (+ 1); Photoperiod; Time Factors  !% #STilt-Table Test E01.145.905 AECLCTECHIISMOMTNUPXSNSTTDUTVE Head-Down Tilt Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Tilt tables are used to maintain a head-down body posture during testing of cardiac response to identify patients with a vasodepressive or cardioinhibitory response as a cause of syncope. (From Braunwald, Heart Disease, 4th ed, p621). Posture (85-94)  !"8Tilorone D04.615.389.850; D20.388.630.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Fluorenes Anti-Infective Agents; Antiviral Agents; Interferon Inducers 2,7-Bis(2-(diethylamino)ethoxy)fluoren-9H-one. An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic action. Diethylamines (74); Fluorenes (71-74)  # &:*.Tilidine D02.241.223.268.825; D15.040.150.900; D15.210.600.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics 2-(Dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester. An opioid analgesic used similarly to MORPHINE in the control of moderate to severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1097). Cyclohexanecarboxylic Acids (71-74); Dimethylamines (74)  &> =:BTiletamine D02.455.426.392.368.367.850; D02.522.400.850; D03.383.903.850; D15.050.035.075.035.900; D15.080.860; D15.210.100.175.075.035.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Organic Chemicals (Non MeSH); Ketones; Cyclohexanones Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Anesthetics, Dissociative Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Anesthetics, Dissociative Proposed anesthetic with possible anticonvulsant and sedative properties. Cyclohexanes (72-74); Ethylamines (72-74); Thiophenes (72-74)  )H:UJTilapia B02.493.602.700 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Perciformes A freshwater fish used as an experimental organism and for food. This genus of the family Cichlidae inhabits Central and South America (one species extends north into Texas), West Indies, Africa, Madagascar, Syria, and coastal India. Fishes (66-92)  - &(Tietze's Syndrome C05.182.790; C17.300.182.790 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ribs Musculoskeletal Diseases; Cartilage Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Cartilage Diseases Idiopathic painful nonsuppurative swellings of one or more costal cartilages, especially of the second rib. The anterior chest pain may mimic that of coronary artery disease. (Dorland, 27th ed.).  /?"NTidal Volume E01.302.796.420.810.970.500.700; G09.772.521.700.810.970.500.700 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity; Vital Capacity; Inspiratory Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity; Vital Capacity; Inspiratory Capacity The volume of air inspired or expired during each normal, quiet respiratory cycle. Common abbreviations are TV or V with subscript T.  1}FTicrynafen D02.241.511.316.682.900; D03.383.903.840; D18.162.880; D19.770.224.891 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates; Phenoxyacetates Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Cardiovascular Agents; Antihypertensive Agents Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics 2,3-Dichloro-4-(2-thienylcarbonyl)phenoxyacetic acid. A novel diuretic with uricosuric action. It has been proposed as an antihypertensive agent. Phenoxyacetates (66-79); Thiophenes (66-79)  48P8U4Ticlopidine D03.383.903.834; D19.461.780.834 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Platelet Aggregation Inhibitors 5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine. Ticlopidine is an effective inhibitor of platelet aggregation. The drug has been found to significantly reduce infarction size in acute myocardial infarcts and is an effective antithrombotic agent in arteriovenous fistulas, aorto-coronary bypass grafts, ischemic heart disease, venous thrombosis, and arteriosclerosis. Thiophenes (66-86)  7'&:Ticks B01.131.166.132.832 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida; Acari Dermacentor Blood-sucking acarid parasites of the suborder Ixodedes, superfamily Ixodoidea. The ticks are larger than their relatives, the mites. They penetrate the skin of their host by means of highly specialized, hooked mouth parts and feed on its blood. Many species can live for long periods, well over a year, between feedings. Ticks attack all groups of terrestrial vertebrates. In man they are responsible for many TICK-BORNE DISEASES, including the transmission of ROCKY MOUNTAIN SPOTTED FEVER, TULAREMIA, BABESIOSIS, and RELAPSING FEVER. (From Dorland, 27th ed; Barnes, Invertebrate Zoology, 5th ed).  :` (5Tick-Borne Diseases C01.252.400.825; C02.081.885; C03.752.875 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Virus Diseases; Arbovirus Infections Parasitic Diseases; Protozoan Infections Anaplasmosis; Boutonneuse Fever; Ehrlichiosis; Heartwater Disease; Lyme Disease (+ 1); Relapsing Fever; Rocky Mountain Spotted Fever; Tularemia African Swine Fever; Colorado Tick Fever; Encephalitis, Tick-Borne; Hemorrhagic Fever, Crimean; Hemorrhagic Fever, Omsk; Kyasanur Forest Disease; Nairobi Sheep Disease Babesiosis; Theileriasis Bacterial, viral, or parasitic diseases transmitted to humans and animals by the bite of infected ticks. The families Ixodidae and Argasidae contain many bloodsucking species that are important pests of man and domestic birds and mammals and probably exceed all other arthropods in the number and variety of disease agents they transmit. Many of the tick-borne diseases are zoonotic.  =1PTick Toxicoses C21.613.127.857 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Bites and Stings Tick Paralysis Toxicoses caused by toxic substances secreted by the salivary glands of ticks; include tick paralysis (neurotropic toxin), sweating sickness (dermotropic toxin), and Rhipicephalus appendiculatus toxicosis (leukotropic toxin). Ticks (66-67)  BN[Tick Paralysis C21.613.127.857.707 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Bites and Stings; Tick Toxicoses Paralysis caused by a neurotropic toxin secreted by the salivary glands of ticks.  DNnbTick Infestations C03.211.857 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations Infestations with soft-bodied (Argasidae) or hard-bodied (Ixodidae) ticks. Ticks (66-67)  F0P6VTick Control G03.850.780.200.650.850 ECHIISLJMTOGSNSTTD Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Pest Control Chemical, biological, or medical measures designed to prevent the spread of ticks or the concomitant infestations which result in tick-borne diseases. It includes the veterinary as well as the public health aspects of tick and mite control. Insect Control (66-72); Ticks (66-72)  Gj/Ticarcillin D20.085.099.739.916 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins 6-((Carboxy-3-thienylacetyl)amino)-3,3-dimethyl-7-oxo-4- thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. An antibiotic derived from penicillin similar to carbenicillin in action. Carboxylic Acids (73-74); Penicillins (73-74); Thiophenes (73-74)  I:POTic C10.597.559.860; C23.888.592.574.837; F03.126.720.894 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders  Tourette Syndrome Any brief, recurrent, inappropriate, irresistible movement involving a relatively small segment of the body; also known as habit spasm or habit contraction.  K=NPTibial Nerve A08.800.800.720.450.760.820 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Tarsal Tunnel Syndrome Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Lumbosacral Plexus; Sciatic Nerve Sural Nerve The medial terminal branch of the sciatic nerve. The tibial nerve fibers originate in lumbar and sacral spinal segments (L4 to S2). They supply motor and sensory innervation to parts of the calf and foot. Spinal Nerves (66-70) $ N8Tibial Fractures C21.866.405.829; C21.866.558.857 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries  P&NTibial Arteries A07.231.114.895 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The anterior and posterior arteries created at the bifurcation of the popliteal artery. The anterior tibial artery begins at the lower border of the popliteus muscle and lies along the tibia at the distal part of the leg to surface superficially anterior to the ankle joint. Its branches are distributed throughout the leg, ankle, and foot. The posterior tibial artery begins at the lower border of the popliteus muscle, lies behind the tibia in the lower part of its course, and is found situated between the medial malleolus and the medial process of the calcaneal tuberosity. Its branches are distributed throughout the leg and foot. Leg/blood supply (77-91); Popliteal Artery (66-91); Tibia (72-91)  RD88QTibia A02.835.232.484.883 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Leg Bones (Non MeSH)  V@ :VTibet Z01.252.474.164.900 EHEP Geographicals (Non MeSH); Asia; Far East; China A country of central Asia, nominally an autonomous region within Communist China. It first came under Chinese control during the Manchu dynasty in 1720 and was generally closed to foreigners until late in the nineteenth century. Tibetans are an ancient race of Mongolian type and their ruler is the Dalai Lama. Buddhism was introduced in the seventh century A.D. and most Tibetans are Buddhists. (From Webster's New Geographical Dictionary, 1988). China (70-94)  W =Tiapride D02.065.277.882; D02.241.223.106.162.882; D14.100.150.175.950; D15.090.875; D15.150.935; D15.210.950.040.935; D15.700.872.331.917 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents Benzamide derivative with dopamine antagonist actions similar to SULPIRIDE. It has been used as an antipsychotic and in the treatment of various movement disorders. Amides (66-72); Benzamides (73-79); Benzoates (66-72)  Y :BTh2 Cells A11.118.637.555.567.569.200.400.905; A15.145.229.637.555.567.569.200.905; A15.382.490.555.567.569.200.400.905; A15.382.520.520.604.200.400.905 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses. T-Lymphocyte Subsets (89-94); T-Lymphocytes (80-81); T-Lymphocytes, Helper-Inducer (85-94)  ^g*iTh1 Cells A11.118.637.555.567.569.200.400.900; A15.145.229.637.555.567.569.200.900; A15.382.490.555.567.569.200.400.900; A15.382.520.520.604.200.400.900 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes; T-Lymphocytes, Helper-Inducer Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions. T-Lymphocyte Subsets (91-94); T-Lymphocytes, Helper-Inducer (85-94)  c*VNThyroxine-Binding Proteins D08.373.745.800.810.825; D12.776.124.885; D12.776.157.785; D12.776.395.832 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein-Bound Iodine Test Protein Binding Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins A group of proteins that includes thyroxine-binding globulin, a glycoprotein that serves as the major and specific carrier of thyroxine in plasma, accounting for 70-75% of the bound thyroxine; thyroxine-binding prealbumin, an albumin that serves as the secondary carrier, accounting for between 20 and 25% of the bound thyroxine; and serum albumin, which accounts for the remaining bound thyroxine.  hTDThyroxine D06.472.931.812; D12.125.072.734 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hyperthyroxinemia; Receptors, Thyroid Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) Dextrothyroxine; Levothyroxine; Thyronines (+ 3) Dextrothyroxine; Levothyroxine; Thyronines (+ 3) O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine. An amino acid of the thyroid gland which exerts a stimulating effect on thyroid metabolism. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ ms &F5rHThyrotropin D06.472.734.525.883; D12.776.641.650.810; D14.600.600.880 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Thyrotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A peptide hormone secreted by the anterior pituitary. It promotes the growth of the thyroid gland and stimulates the synthesis of thyroid hormones and the release of thyroxine by the thyroid gland.  prAFOThyrotoxicosis C19.874.902 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases Thyroid Crisis The clinical syndrome that reflects the response of the peripheral tissues to an excess of thyroid hormone. Hyperthyroidism (66-86)  sN,Thyronines D06.472.931.812.741; D12.125.072.734.741 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones; Thyroxine Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Thyroxine Diiodothyronines; Triiodothyronine (+ 1) Diiodothyronines; Triiodothyronine (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  t.D^HThyroiditis, Suppurative C01.539.840; C19.874.871.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Endocrine Diseases; Thyroid Diseases; Thyroiditis Inflammatory disease of the thyroid gland caused by bacteria, fungi, protozoa, or flatworms. Suppuration (66-86); Thyroiditis (66-86)  w#"Pxm1Thyroiditis, Subacute C19.874.871.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases; Thyroiditis Spontaneously remitting inflammatory condition of the thyroid gland characterized by fever, weakness, sore throat, and painful enlargement of the thyroid gland. Thyroiditis (66-86)  xN;Thyroiditis, Autoimmune C19.874.871.102; C20.111.809 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases; Thyroiditis Immunologic Diseases; Autoimmune Diseases Progressive enlargement of the thyroid gland, often associated with hypothyroidism.  z"NjaThyroiditis C19.874.871 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases Thyroiditis, Autoimmune; Thyroiditis, Subacute; Thyroiditis, Suppurative BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  |N,SPThyroidectomy E04.779.856 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Thyroid Gland Surgery, Operative; Surgery, Endocrine (Non MeSH)  }y$;Thyroid Nodule C04.588.322.894.800; C04.588.443.915.800; C19.344.894.800; C19.874.788.800; C19.874.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Goiter, Nodular Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Thyroid Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Thyroid Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms; Thyroid Neoplasms Endocrine Diseases; Thyroid Diseases; Thyroid Neoplasms Endocrine Diseases; Thyroid Diseases A small circumscribed mass of differentiated tissue associated with the thyroid gland. It can be pathogenic or non-pathogenic. The growth of nodules can lead to a condition of GOITER, NODULAR. Most nodules appear between the ages of 30 and 50 years and most are benign. Thyroid Diseases (66-91); Thyroid Neoplasms (66-91)  ~-cVA>Thyroid Neoplasms C04.588.322.894; C04.588.443.915; C19.344.894; C19.874.788 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms Endocrine Diseases; Thyroid Diseases Thyroid Nodule Thyroid Nodule Thyroid Nodule Thyroid Nodule  6DXFThyroid Hormones D06.472.931 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hyperthyroidism; Hypothyroidism; Receptors, Thyroid Hormone; Thyroglobulin Hormones, Substitutes, Antagonists (Non MeSH); Hormones Diiodotyrosine; Iodotyrosine; Thyroid Gland, Desiccated; Thyroxine (+ 6) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  N@VBVHThyroid Hormone Resistance Syndrome C19.874.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Euthyroid Sick Syndromes Euthyroid Sick Syndromes; Receptors, Thyroid Hormone Endocrine Diseases; Thyroid Diseases An inherited syndrome of peripheral resistance to thyroid hormones, transmitted as an autosomal recessive trait, characterized by increased serum concentrations of thyroxine and triiodothyronine, increased thyroid hormone binding ratio, and normal to slightly increased thyroid-stimulating hormone and its response to thyrotropin-releasing hormone. The affected persons are euthyroid to slightly hypothyroid. The absence of hypermetabolism and the presence of possible hypothyroidism indicate the existence of partial resistance to the peripheral action of thyroid hormone. (From Jablonski's Dictionary of syndromes and eponymic diseases, 1991).  *N>,Thyroid Gland, Desiccated D06.472.931.669 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones  ,8WThyroid Gland A06.407.900 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Struma Ovarii; Thyroidectomy; Ultimobranchial Body Endocrine System (Non MeSH); Endocrine Glands A highly vascular endocrine gland consisting of two lobes, one on either side of the trachea, joined by a narrow isthmus; it produces the thyroid hormones which are concerned in regulating the metabolic rate of the body.  :<8Thyroid Function Tests E01.197.882 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Endocrine (Non MeSH) Basal Metabolism; Protein-Bound Iodine Test AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE  "34,Thyroid Diseases C19.874 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases Euthyroid Sick Syndromes; Goiter (+ 4); Hyperthyroidism (+ 1); Hyperthyroxinemia; Hypothyroidism (+ 2); Thyroid Hormone Resistance Syndrome; Thyroid Neoplasms (+ 1); Thyroid Nodule; Thyroiditis (+ 3); Thyrotoxicosis (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI   N ZThyroid Crisis C19.874.902.905 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases; Thyrotoxicosis Sudden and dangerous increase of the symptoms of thyrotoxicosis.  N>MThyroid Cartilage A02.165.507.870; A04.329.591.870 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage; Laryngeal Cartilages Respiratory System; Larynx; Laryngeal Cartilages The largest cartilage of the larynx consisting of two laminae fusing anteriorly at an acute angle in the midline of the neck. The point of fusion forms a subcutaneous projection known as the Adam's apple. Laryngeal Cartilages (66-78)  B&:y"Thyroid Antagonists D06.347.789 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Carbimazole; Methimazole; Methylthiouracil; Propylthiouracil; Thiouracil; Thiourea AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  n6N`:Thyroglossal Cyst C04.182.902 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. It is also called thyrolingual cyst. (Dorland, 27th ed).  VThyroglobulin D12.776.377.856; D12.776.395.768; D12.776.486.706 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Thyroid Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Iodoproteins  _9HThymus Neoplasms C04.588.322.831; C15.604.861; C19.344.831 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Endocrine Diseases; Endocrine Gland Neoplasms  1XThymus Hyperplasia C15.604.816; C19.813 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Endocrine Diseases Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis. (From Segen, Dictionary of Modern Medicine, 1992, p. 693; Cecil Textbook of Medicine, 19th ed, p. 1486).  N]Thymus Hormones D06.472.910 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Thymic Factor, Circulating; Thymopoietins (+ 1); Thymosin Humoral factors secreted by the thymus gland. They participate in the development of the lymphoid system and the maturation of the cellular immune response. Hormones (66-76); Thymus Gland (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ xBBF0FThymus Gland A06.407.850; A15.382.520.604.811 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Bursa of Fabricius; Thymectomy Endocrine System (Non MeSH); Endocrine Glands Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphoid Tissue A bilaterally symmetric lymphoid organ situated in the anterior superior mediastinum. Each of its two lobes consists of an outer zone, the cortex, relatively rich in lymphocytes (thymocytes), and an inner zone, the medulla, relatively rich in epithelial cells. The thymus is the site of the production of T-lymphocytes. The thymus reaches its maximal development at about puberty and then undergoes a gradual process of involution resulting in a slow decline of immune function throughout adulthood. (From Dorland, 27th ed).  &:&fThymus Extracts D24.185.893.871 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts Extracts of the thymus that contain specific, but uncharacterized factors or proteins with specific activities; three distinct substances are already known: thymotoxin, thymin and thymosin.  B`Thymosin D06.472.910.850; D12.776.922 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thymus Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins Thymosin. A family of heat-stable, polypeptide hormones secreted by the thymus gland. Their biological activities include lymphocytopoiesis, restoration of immunological competence and enhancement of expression of T-cell characteristics and function. They have therapeutic potential in patients having primary or secondary immunodeficiency diseases, cancer or diseases related to aging. Glycoproteins (73-74); Thymus Extracts (74); Thymus Gland (73-74); Tissue Extracts (73-74)  L "DnThymopoietins D06.472.910.800 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thymus Hormones Thymopentin Two closely related polypeptides (molecular weight 7,000) isolated from the thymus gland. These hormones induce the differentiation of prothymocytes to thymocytes within the thymus. They also cause a delayed impairment of neuromuscular transmission in vivo and are therefore believed to be the agent responsible for myasthenia gravis. Hormones (66-76); Thymus Extracts (74); Thymus Gland (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ BVKDThymopentin D06.472.910.800.850; D24.611.062.850 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thymus Hormones; Thymopoietins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic N-(N-(N-(N2-L-Arginyl-L-lysyl)-L-alpha-aspartyl)-L-valyl)-L-tyrosine. Synthetic pentapeptide corresponding to the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. It is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies. Oligopeptides (80-81); Peptide Fragments (81-90); Thymopoietins (81-90)  *DUThymoma C04.557.435.850 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (Stedman, 25th ed).  ) XnThymolphthalein D26.408.646.600.810; D26.550.620.810 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes; Phthalein Dyes; Phenolphthaleins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Phenolphthaleins 5',5''-Diisopropyl-2',2''-dimethylphenolphthalein. Used as a pH indicator and as a reagent for blood after decolorizing the alkaline solution by boiling with zinc dust. Phenolphthaleins (69-74)  L*.Thymol D02.455.849.856 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Bromthymol Blue   :@Thymine Nucleotides D13.695.201.789; D13.695.740.706 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides Thymidine Monophosphate Thymidine Monophosphate Nucleotides (66-70); Thymine (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  P&B6-DThymine D03.383.742.698.875.899 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil  s >rThymidylate Synthetase D08.586.913.517.855 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45. Ligases (66-70); Methyltransferases (71-72); Transferases (69-72)  hFkNThymidine Phosphorylase D08.586.913.400.725.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases The enzyme catalyzing the transfer of 2-deoxy-D-ribose from thymidine to orthophosphate, thereby liberating thymidine. EC 2.4.2.4. Pentosyltransferases (73-74); Phosphates (73-74); Thymidine (73-74)  FPThymidine Monophosphate D13.695.201.789.788; D13.695.740.706.788 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides; Thymine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Thymine Nucleotides 5-Thymidylic acid. A thymine nucleotide containing one phosphate group esterified to the deoxyribose moiety. Nucleotides (66-71); Thymine Nucleotides (72-74)  .D:Thymidine Kinase D08.586.913.696.620.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21.  2FThymidine D13.570.230.855; D13.570.685.705 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides Stavudine; Trifluridine; Zidovudine Stavudine; Trifluridine; Zidovudine  \ &DTThymic Factor, Circulating D06.472.910.750; D12.644.456.835 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thymus Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides A thymus-dependent nonapeptide found in normal blood. Stimulates the formation of E rosettes and is believed to be involved in T-cell differentiation. Hormones (66-76); Oligopeptides (73-79); Peptides (66-72); Thymus Gland (66-76); Thymus Hormones (77-79)   &DThymectomy E04.920.940 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Thymus Gland Surgery, Operative; Thoracic Surgery  ť$,Thumb A01.378.209.455.430.705 ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Extremities; Arm; Hand; Fingers  F *HThulium D01.268.558.875; D01.552.550.889 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Thulium. An element of the rare earth family of metals. It has the atomic symbol Tm, atomic number 69, and atomic weight 168.93.   &:Thromboxanes D02.241.081.436.213.100.825; D02.241.081.436.880; D10.516.251.355.255.100.825; D10.516.251.355.880; D17.350.050.175.800 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Thromboxane Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids Thromboxane A2; Thromboxane B2 Thromboxane A2; Thromboxane B2 Thromboxane A2; Thromboxane B2 Physiologically active compounds found in many organs of the body. They are formed in vivo from the prostaglandin endoperoxides and cause platelet aggregation, contraction of arteries, and other biological effects. Thromboxanes are important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. Fatty Acids, Unsaturated (73-74); Hydroxy Acids (75-77); Pyrans (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ( ȶBpzWDThromboxane Synthetase D08.586.399.910 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5. Hydroxy Acids (75-77); Oxidoreductases (66-77); Pyrans (66-77)  FSLThromboxane B2 D02.241.081.436.213.100.825.810; D10.516.251.355.255.100.825.810; D17.350.050.175.800.810 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Thromboxanes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Thromboxanes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Thromboxanes A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). Fatty Acids, Unsaturated (73-74); Hydroxy Acids (75-77); Pyrans (66-77)  aDWThromboxane A2 D02.241.081.436.213.100.825.800; D10.516.251.355.255.100.825.800; D17.350.050.175.800.800 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Thromboxanes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Thromboxanes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Thromboxanes An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS). Fatty Acids, Unsaturated (73-74); Hydroxy Acids (75-77); Pyrans (66-77)  aDNWThrombosis C14.907.355.830 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Thrombectomy Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH) Coronary Thrombosis; Hepatic Vein Thrombosis; Retinal Vein Occlusion; Thromboembolism (+ 4); Thrombophlebitis Formation, development, or presence of a thrombus. (Dorland 27th ed).  bN\UThrombopoietin D12.776.395.720; D24.185.861 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Immunologic and Biologic Factors (Non MeSH); Biological Factors A humoral factor that controls blood platelet production through stimulation of megakaryocyte populations. Bone marrow megakaryocytes increase in both size and number in response to exposure to thrombopoietin.  >"HThromboplastin D12.776.124.125.900; D19.461.270.229.901; D19.461.270.463.899 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation.  nEFtThrombophlebitis C14.907.355.830.855; C14.907.681.788; C14.907.940.740.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vena Cava Filters Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis Cardiovascular Diseases; Vascular Diseases; Phlebitis Cardiovascular Diseases; Vascular Diseases; Vasculitis; Phlebitis Inflammation of a vein associated with thrombus formation.  ANFThrombomodulin D12.776.124.125.786.800.800; D12.776.395.550.625.800.800; D12.776.543.550.625.800.800; D12.776.543.750.705.408.450.800.800; D12.776.543.750.750.850.800; D24.611.834.408.450.800.800 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Platelet Membrane Glycoproteins; Receptors, Thrombin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Platelet Membrane Glycoproteins; Receptors, Thrombin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Platelet Membrane Glycoproteins; Receptors, Thrombin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Platelet Membrane Glycoproteins; Receptors, Thrombin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Thrombin Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Platelet Membrane Glycoproteins; Receptors, Thrombin A cell surface glycoprotein of endothelial cells that binds thrombin and serves as a cofactor in the activation of protein C and its regulation of blood coagulation. Receptors, Cell Surface (81-93)  $J&Thrombolytic Therapy E02.319.913 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Drug Therapy Use of infusions of fibrinolytic agents to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolysis (66-89); Fibrinolytic Agents (66-89); Thromboembolism/drug therapy (66-89); Thrombosis/drug therapy (66-89)  "!~Thromboembolism C14.907.355.350.850; C14.907.355.830.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis Cerebral Embolism and Thrombosis (+ 3) Cerebral Embolism and Thrombosis (+ 3) Obstruction of a vessel by a blood clot that has been transported from a distant site by the blood stream.  .N\Thrombocytosis C15.378.190.636.899 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Platelets Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed).  N\Thrombocytopenia C15.378.463.205.855 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Platelets Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders Purpura, Thrombocytopenic (+ 1); Purpura, Thrombotic Thrombocytopenic; Wiskott-Aldrich Syndrome Decrease in the number of blood platelets.  Nn5Thrombocythemia, Hemorrhagic C15.378.190.636.825; C15.378.463.205.825 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.  q!.NThromboangiitis Obliterans C14.907.137.870; C14.907.940.905 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Cardiovascular Diseases; Vascular Diseases; Vasculitis  &NThrombin Time E01.223.459.153.870 VE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Coagulation Tests Test of the conversion of fibrinogen to fibrin by thrombin in which clotting time of plasma mixed with a thrombin solution is measured. Time is prolonged by afibrinogenemia, abnormal fibrinogen, or the presence of inhibitory substances, e.g., fibrin-fibrinogen degradation products, heparin. Reptilase, a thrombin-like enzyme unaffected by the presence of heparin, may be used in place of thrombin. Blood Coagulation Tests (66-79); Fibrinogen (66-79); Thrombin (66-79)  ZTThrombin D08.586.277.656.732.760.855; D12.776.124.125.885; D19.461.270.463.843 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics An enzyme formed from prothrombin that converts fibrinogen to fibrin. (Dorland, 27th ed) EC 3.4.2.16.   MDyThrombelastography E01.223.459.153.830 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Coagulation Tests Use of a thrombelastograph, which provides a continuous graphic record of the physical shape of a clot during fibrin formation and subsequent lysis.  &ZThrombectomy E04.752.814.842 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Embolectomy Thrombosis; Embolectomy Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Surgical removal of an obstructing clot or foreign material from a blood vessel at the point of its formation. Removal of a clot arising from a distant site is called EMBOLECTOMY. Thrombophlebitis/surgery (66-92); Thrombosis/surgery (66-92) $ *$VGThrombasthenia C15.378.463.205.810 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, expecially ADP, and impaired or absent clot retraction. Blood Platelet Disorders (67-85)  @N'Threonyl T RNA Synthetase D08.586.464.136.780 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates threonine with its specific transfer RNA. EC 6.1.1.3. Amino Acyl T RNA Synthetases (73-74); Threonine (73-74)  Y Ft_DThreonine Dehydratase D08.586.520.497.820 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases A pyridoxal-phosphate protein that catalyzes the deamination of threonine to 2-ketobutyrate and ammonia. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for isoleucine biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. EC 4.2.1.16. Hydro-Lyases (66-74); Threonine (66-74)  F_0Threonine D12.125.142.815; D12.125.901 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids  Phosphothreonine L-Threonine. An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.   "FThorium Dioxide D01.650.550.875; D01.930.930; D26.191.932 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Inorganic Chemicals (Non MeSH); Thorium Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Thorium oxide (ThO2). A radiographic contrast agent that was used in the early 1930s through about 1954. High rates of mortality have been linked to its use and it has been shown to cause liver cancer.  1.Thorium Compounds D01.930 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Thorium Dioxide Inorganic compounds that contain thorium as an integral part of the molecule. Thorium (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ G 8%]:Thorium D01.268.271.545.900; D01.552.517.889 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Thorium. A radioactive element of the actinide series of metals. It has an atomic symbol Th, atomic number 90, and atomic weight 232.04. It is used as fuel in nuclear reactors to produce fissionable uranium isotopes. Because of its radioopacity, various thorium compounds are used to facilitate visualization in roentgenography.   *4Thorax A01.911; A02.835.232.904 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRERISETRULUSVI Mass Chest X-Ray; Thoracic Radiography; Thoracic Surgery; Thoracoplasty; Thoracoscopy; Thoracostomy; Thoracotomy Body Regions (Non MeSH) Musculoskeletal System; Skeleton; Bone and Bones Mediastinum Ribs; Sternum (+ 2) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  s 4W(:Thoracotomy E04.920.925 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Thorax Surgery, Operative; Thoracic Surgery Surgical incision into the chest wall. Thoracic Surgery (80-87); Thorax/surgery (66-79)  7$ ,0;Thoracostomy E04.579.918; E04.920.918 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Chest Tubes Thorax Surgery, Operative; Ostomy Surgery, Operative; Thoracic Surgery Surgical creation of an opening (stoma) into the chest cavity for drainage; used in the treatment of pleural effusion, pneumothorax, hemothorax and empyema. Thoracic Surgery (66-87) $ E$ KThoracoscopy E01.418.910 AECLCTECHIISMOMTNUPXSNSTTDUTVE Thorax Diagnosis; Endoscopy Endoscopic examination of the pleural cavity. Syn: pleural endoscopy.  " SThoracoplasty E04.920.910 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Thorax Surgery, Operative; Thoracic Surgery  $ ,Thoracic Vertebrae A02.835.232.834.892 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine  }:DThoracic Surgery E04.920; G02.403.810.803 CLECEDHIISLJMAMTNUOGPXRHSNSTTD Thorax Surgery, Operative Health Occupations; Medicine; Specialties, Surgical Heart Surgery (+ 16); Surgery, Lung (Non MeSH) (+ 6); Thoracoplasty; Thoracostomy; Thoracotomy; Thymectomy; Tracheostomy; Tracheotomy A surgical specialty concerned with diagnosis and treatment of disorders of the heart, lungs, and esophagus. Two major types of thoracic surgery are classified as pulmonary and cardiovascular. The concept includes techniques of thoracic surgery in general. AECLCTECEDHIIMISLJMAMIMOMTNUOGPAPHPSPXRARHRISDSNSTTDUSUTVEVI $ H" R+@Thoracic Radiography E01.357.818.910 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Thorax Diagnosis; Diagnostic Imaging; Radiography Bronchography; Mass Chest X-Ray X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs.  5& 3'Thoracic Outlet Syndrome C10.772.491.915 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Brachial Plexus Nervous System Diseases; Peripheral Nervous System Diseases; Nerve Compression Syndromes Cervical Rib Syndrome Compression of the brachial plexus nerve trunks due to a variety of anomalies at the superior thoracic outlet such as cervical rib (CERVICAL RIB SYNDROME), abnormal scalene muscles, first rib abnormalities, and fibrous bands.  NgThoracic Nerves A08.800.800.720.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves Intercostal Nerves The twelve pairs of spinal nerves that arise from the thoracic segments of the spinal cord, each pair leaving the vertebral column below the correspondingly numbered vertebra. They innervate the body wall of the thorax and abdomen. (Dorland, 27th ed).  8Z*Thoracic Neoplasms C04.588.894 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Heart Neoplasms; Mediastinal Neoplasms; Respiratory Tract Neoplasms (+ 8) BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  X1WZThoracic Injuries C21.866.891 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Flail Chest; Heart Injuries; Rib Fractures General or unspecified injuries to the chest area.  NQ5>Thoracic Duct A15.382.520.869 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System  :TThoracic Diseases C23.304.898 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH)  N_Thoracic Arteries A07.231.114.891 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Mammary Arteries Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles, mammary gland and the axillary aspect of the chest wall.  88Thirst F01.658.293.787 CLDEPHRE Water Deprivation Water Deprivation; Dehydration Behavior and Behavior Mechanisms (Non MeSH); Motivation; Drive A drive stemming from a physiological need for water.  "  %LBThiram D02.241.081.251.869.210.800; D02.886.706.175.900; D05.723.288.829; D20.136.720; D20.187.839 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates; Dimethyldithiocarbamate Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates; Dimethyldithiocarbamate Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Anti-Infective Agents; Antifungal Agents Anti-Infective Agents; Anti-Infective Agents, Local Tetramethylthioperoxydicarbonic diamide. An antifungal agent used in medicine and agriculture.  # g:nThioxanthenes D03.494.953.704 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes Chlorprothixene; Clopenthixol; Flupenthixol; Hycanthone; Lucanthone; Thiothixene AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  &8U^:Thiouridine D13.570.685.852.829; D13.570.800.892.829; D13.570.900.829; D26.087.920 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Uridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Thionucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Uridine (66-71)  ($P:Thiourea D02.886.904; D02.948.898; D06.347.789.891 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Organic Chemicals (Non MeSH); Urea Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Thyroid Antagonists AET; Burimamide; Dimaprit; Guanylthiourea; Isothiuronium; Methallibure; Metiamide; Noxythiolin; Phenylthiourea (+ 2) AET; Burimamide; Dimaprit; Guanylthiourea; Isothiuronium; Methallibure; Metiamide; Noxythiolin; Phenylthiourea (+ 2) Thiourea. A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed).  *{ 1:Thiouracil D03.383.742.698.875.842; D06.347.789.829; D26.087.917 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Thyroid Antagonists Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Methylthiouracil; Propylthiouracil 2-Mercapto-4-hydroxypyrimidine. Occurs in seeds of Brassica and Crucifera species; has been used as antithyroid, coronary vasodilator and in congestive heart failure; known to cause blood dyscrasias and suspected of terato- and carcinogenesis. Synonyms: Antagothyroil; Deracil; Noliben.  .=:*LThiothixene D03.494.953.704.787; D14.100.150.175.942; D15.150.925; D15.210.950.040.925; D15.700.872.331.898 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Thioxanthenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics. Tranquilizing Agents (66-69); Xanthenes (66-69)  1Rk: 9Thiotepa D02.719.950; D03.383.097.217.864.960; D05.723.141.749.960; D22.204.880 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines; Aziridines; Tepa Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Chemosterilants; Tepa Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,1',1''-Phosphinothioylidynetrisaziridine. A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).  5 P:\Thiosulfonic Acids D01.029.260.877.740.900; D01.875.800.740.900; D02.886.645.600.925 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Sulfur Acids; Sulfonic Acids Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids Inorganic or organic oxy acids of sulfur which contain the general formula RS2O2H.  8I8NcThiosulfates D01.248.497.158.845.703; D01.875.800.800.850.900 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Sulfates Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates  Gold Sodium Thiosulfate Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.  ;68YThiosulfate Sulfurtransferase D08.586.913.820.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Sulfurtransferases An enzyme that catalyzes the transfer of the planetary sulfur atom of thiosulfate ion to cyanide ion to form thiocyanate ion. EC 2.8.1.1. Cyanides (73-74); Sulfurtransferases (72-74); Thiosulfates (72-74)  <"FkOThiostrepton D20.085.116.850 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Polypeptide-containing antibiotic isolated from a species of Streptomyces in New Mexican soil. It appears to be highly active against gram-positive bacteria. In veterinary medicine, thiostrepton has been used in mastitis caused by gram-negative organisms and in dermatologic disorders. Antibiotics (71-74); Peptides (71-74)  ><BI.Thiosemicarbazones D02.845.746.703; D02.886.803; D20.338.903 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Semicarbazides; Semicarbazones Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Anti-Infective Agents; Antitubercular Agents Methisazone; Thiacetazone Methisazone; Thiacetazone Thiacetazone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  A<18J:Thiorphan D08.373.745.870; D12.125.166.650.900; D12.125.481.600.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Mercaptopropionylglycine Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine; Mercaptopropionylglycine (+-)-N-(2-(Mercaptomethyl)-1-oxo-3-phenylpropyl)glycine. A potent inhibitor of membrane metalloendopeptidase (enkephalinase). Thiorphan potentiates morphine-induced analgesia and attenuates naloxone-precipitated withdrawal symptoms. Mercaptopropionylglycine/analogs and derivatives (80-88)  C$ A:P@Thioridazine D03.494.741.843; D14.100.150.175.937; D15.150.025.850; D15.210.950.040.025.850; D15.700.872.331.025.858 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than CHLORPROMAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed., p.618).  Fhs:Thioredoxin Reductase (NADPH) D08.586.682.608.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases NADPH:oxidized thioredoxin oxidoreductase. Bacterial Proteins (72-74); NADH, NADPH Oxidoreductases (74); Oxidoreductases (72-74)  K#Fy1eThioredoxin D12.776.915 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins A hydrogen-carrying protein that participates in a variety of biochemical reactions including ribonucleotide reduction. Thioredoxin is oxidized from a dithiol to a disulfide during ribonucleotide reduction. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE. Bacterial Proteins (68-74)  MHBD[ Thiophosphoric Acid Esters D02.719.926 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds  O 8GThiophenes D03.383.903 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Carticaine; Ketotifen; Morantel; Pizotyline; Pyrantel (+ 2); Thenoyltrifluoroacetone; Ticlopidine; Ticrynafen; Tiletamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  P[8G:Thiophanate D02.241.081.251.890; D02.886.904.601.900; D02.948.898.601.900; D05.723.288.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea; Phenylthiourea Organic Chemicals (Non MeSH); Urea; Thiourea; Phenylthiourea Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial 4,4'-Phenylenebis(ethyl-3-thioallophanate). Nematocide used in livestock; also has fungicidal properties. Synonyms: Cercobin; Enovit; Nemafax; Topsin. Carbamates (66-74); Phenylthiourea (66-74)  QX:r3Thiopental D03.383.742.698.253.800.810; D14.100.240.500.880; D15.050.035.075.900; D15.080.850; D15.210.100.175.075.900; D15.210.350.750.942; D15.325.850.942 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates; Thiobarbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A barbiturate that is administered intravenously for the induction of general anesthesia or for the production of complete anesthesia of short duration. It is also used for hypnosis and for the control of convulsive states. It has been used in neurosurgical patients to reduce increased intracranial pressure. It does not produce any excitation but has poor analgesic and muscle relaxant properties. Small doses have been shown to be anti-analgesic and lower the pain threshold. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.920).  U:#vThionucleotides D13.695.900 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Guanosine 5'-O-(3-Thiotriphosphate) Nucleotides in which the base moiety is substituted with one or more sulfur atoms. specific nucleotide (66-76); Nucleotides (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ [BP)d:DThionucleosides D13.570.900 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides Thioinosine (+ 1); Thiouridine Nucleosides in which the base moiety is substituted with one or more sulfur atoms. specific nucleoside (66-76); Nucleosides (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ ]BP'd:DThiones D02.886.753 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH)  _ 8FThiomalates D02.241.081.337.463.703; D02.886.489.891 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Malates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Gold Sodium Thiomalate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  `;.8:Thiolester Hydrolases D08.586.277.352.897 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Acetyl-CoA Hydrolase; Palmitoyl-CoA Hydrolase Esterases (66-72)  bF`5Thioinosine D13.570.583.616.900; D13.570.800.573.900; D13.570.900.800; D26.087.914 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Inosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Inosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Thionucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Methylthioinosine Methylthioinosine Methylthioinosine 9-beta-D-Ribofuranosyl-9H-purine-6-thiol. Sulfhydryl analog of inosine which inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. Inosine (73-74); Mercaptopurine (73-74)  cQP:<0Thiohydantoins D03.383.374.411.868 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Hydantoins Phenylthiohydantoin AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  f8d:Thioguanine D03.438.759.854; D22.204.144.915; D26.087.906 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 2-Amino-1,7-dihydro-6H-purine-6-thione. An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia.  h 5: Thioglycosides D09.203.408.903 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Thiogalactosides (+ 1); Thioglucosides (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  jj@Y7DThioglycolates D02.241.081.038.825; D02.886.489.828 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Organic esters of thioglycolic acid (HS-CH2COOH).  k*8<Thioglucosides D09.203.408.348.820; D09.203.408.903.703 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Thioglycosides Glucosinolates Glucosinolates  mf.@"Thiogalactosides D09.203.408.320.820; D09.203.408.903.600 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Galactosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Thioglycosides Isopropyl Thiogalactoside Isopropyl Thiogalactoside Galactosides in which the oxygen atom linking the sugar and aglycone is replaced by a sulfur atom. Galactose (74); Thioglycosides (74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ n.B:w,DThiocyanates D02.262.775; D02.886.728 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Cyanates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Organic derivatives of thiocyanic acid which contain the general formula R-SCN.  q8t^Thioctic Acid D08.176.906; D11.786.708.918 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex  r"DThiocholine D02.092.102.232.800; D02.675.276.232.800; D26.550.921 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Acetylthiocholine; Butyrylthiocholine Acetylthiocholine; Butyrylthiocholine (2-Mercaptoethyl)trimethylammonium. A reagent for the determination of cholinesterases; acts also as a highly selective nerve stain. Choline (66-74); Sulfhydryl Compounds (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ t5=.U7:Thiocarbamates D02.241.081.251.869; D02.886.706 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Dimethyldithiocarbamate (+ 2); Ditiocarb (+ 1); Ethylenebis(dithiocarbamates) (+ 2); Tolnaftate; Triallate Dimethyldithiocarbamate (+ 2); Ditiocarb (+ 1); Ethylenebis(dithiocarbamates) (+ 2); Tolnaftate; Triallate Carbamates in which the -CO- group has been replaced by a -CS- group. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  w5&8V:Thiobarbituric Acid Reactive Substances D02.047.700.700; D26.550.910 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Aldehydes; Malondialdehyde Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct.  z .",Thiobarbiturates D03.383.742.698.253.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Thiamylal; Thiopental Compounds in which one or more of the ketone groups on the pyrimidine ring of barbituric acid are replaced by thione groups. Barbiturates (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ |18x:Thiobacillus thiooxidans B03.440.400.450.800.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Chemolithotrophic Bacteria; Thiobacillus A strictly autotrophic bacterium that oxidizes sulfur and thiosulfate to sulfuric acid. Thiobacillus (66-71)  ~C"gThiobacillus B03.440.400.450.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Chemolithotrophic Bacteria Thiobacillus thiooxidans A genus of gram-negative, rod-shaped bacteria that derives energy from the oxidation of one or more reduced sulfur compounds. Its organisms are widely distributed in marine, freshwater, and soil environments, especially where oxidizable sulfur is abundant.  "y)Thioamides D02.065.900; D02.886.685 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Thioacetamide Thioacetamide Organic compounds containing the radical -CSNH2. Amides (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ 8r ::Thioacetamide D02.065.064.786; D02.065.900.890; D02.241.081.038.108.786; D02.886.685.800; D26.191.903 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amides; Acetamides Organic Chemicals (Non MeSH); Amides; Thioamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thioamides Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Ethanethioamide. Formerly used as a laboratory reagent; it is a potent hepatocarcinogen. Synonyms: Thioacetimidic Acid; Acetothioamide.  c.Thinness C23.888.220.853; G07.553.481.398.828 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Emaciation Body Weight; Weight Loss; Eating Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Weight Changes (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth; Body Weight   *N5Thinking F02.463.785 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes Autism; Concept Formation; Creativeness; Decision Making (+ 4); Esthetics (+ 1); Judgment; Problem Solving Mental activity, not predominantly perceptual, by which one apprehends some aspect of an object or situation based on past learning and experience. BLCFCICLCODEDHDIDTECEDEHENEPETGEHIIMMEMIMOMTNUPAPCPHPPPSPXRARERHRISUTHURUSVI  l  NPThimerosal D02.691.750.100.347.850; D20.187.812 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds; Ethylmercury Compounds Anti-Infective Agents; Anti-Infective Agents, Local ((o-Carboxyphenyl)thio)ethylmercury sodium salt. Topical antiseptic used on skin and mucous membranes; also used as a preservative in pharmaceuticals. Synonyms: ethylmercurithiosalicylate; Merfamin; Merthiolate; Mertorgan; Merzonin; thiomerosol. Benzoates (74); Ethylmercury Compounds (74); Sulfides (74)  *:HThigh A01.378.592.867 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Femur Body Regions (Non MeSH); Extremities; Leg  V ( 5Thiethylperazine D03.383.606.880; D03.494.741.780; D14.100.150.175.906; D15.095.915 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics A dopamine antagonist that is particularly useful in treating the nausea and vomiting associated with anesthesia, mildly emetic cancer chemotherapy agents, radiation therapy, and toxins. This piperazine phenothiazine does not prevent vertigo or motion sickness. (From AMA Drug Evaluations Annual, 1994, p.457).  L:wgThiepins D03.383.886 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Thiazepines   8GThienamycins D20.085.099.120.300 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Carbapenems Imipenem  Beta-lactam antibiotics that differ from penicillins in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors. Amides (66-73); Antibiotics (66-82); Lactams (74-82) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ b:P A<Thiazoles D03.383.871 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Chlormethiazole; Famotidine; FANFT; Levamisole; Niridazole; Nizatidine; Oxythiamine; Rhodanine; Sulfathiazoles; Tetramisole; Thiabendazole; Thiadiazoles (+ 3) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  e 8G:Thiazines D03.383.855 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Chlormezanone; Nifurtimox; Piroxicam; Thiadiazines; Xylazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   8GH:Thiazepines D03.383.066.785; D03.383.886.702 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiepins Azepines (66-72); Benzazepines (68-72); Dibenzazepines (68-72)  _&8KThiamylal D03.383.742.698.253.800.750; D15.050.035.075.875; D15.210.100.175.075.875; D15.210.350.750.913; D15.325.850.913 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates; Thiobarbiturates Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. (From Martindale, The Extra Pharmacopoeia, 30th ed, p. 919).   {:`Thiamphenicol D20.085.215.910; D22.569.910 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Chloramphenicol Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents 2,2-Dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4- (methylsulfonyl)phenyl)ethyl)acetamide. A methylsulfonyl analog of chloramphenicol. It is an antibiotic and immunosuppressive agent. Acetamides (73-74); Phenethylamines (68-74); Sulfones (66-74)  D":JThiamine Triphosphate D11.786.708.887.900 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Thiamine 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(4,6,8,8-tetrahydroxy-3,5,7-trioxa-4,6,8-triphosphaoct-1-yl)thiazolium hydroxide, inner salt, P,P',P''-trioxide. The triphosphate ester of thiamine. In Leigh's disease, this compound is present in decreased amounts in the brain due to a metabolic block in its formation. Organophosphorus Compounds (71-78); Thiamine (66-78)  Din>Thiamine Pyrophosphate D08.176.878; D11.786.708.887.702 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Thiamine The coenzyme form of vitamin B1, thiamine, present in many animal tissues. It is a required intermediate in the pyruvate decarboxylase, pyruvate dehydrogenase, and ketoglutarate dehydrogenase reactions.  1&DThiamine Pyrophosphatase D08.586.277.040.600.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Pyrophosphatases An enzyme that hydrolyzes thiamine pyrophosphate to thiamine monophosphate plus inorganic phosphate. EC 3.6.1.-. Pyrophosphatases (73-74); Thiamine Pyrophosphate (73-74)  qFBThiamine Monophosphate D11.786.708.887.600 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Thiamine Thiamine dihydrogen phosphate ester. The monophosphate ester of thiamine. Synonyms: monophosphothiamine; vitamin B1 monophosphate. Organophosphorus Compounds (71-78); Thiamine (66-78)  aDi>Thiamine Deficiency C18.654.223.133.699.827 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Beriberi Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency Beriberi; Wernicke's Encephalopathy A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. (From Cecil Textbook of Medicine, 19th ed, p. 1171).  <N *~Thiamine D11.786.708.887 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Thiamine Monophosphate; Thiamine Pyrophosphate; Thiamine Triphosphate 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2- hydroxyethyl)-4-methylthiazolium chloride. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  - B]PgDThiamin-Triphosphatase D08.586.277.040.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases An enzyme present in nerve tissue. It catalyzes reversibly the formation of thiamine diphosphate and orthophosphate from thiamine triphosphate. EC 3.6.1.28. Phosphatases (66-78); Phosphoric Acids (68-76); Thiamine (66-76); Thiamine Pyrophosphate (77-78)  FrsThiamin Pyrophosphokinase D08.586.913.696.175.825 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Diphosphotransferases An enzyme that catalyzes the formation of thiamine pyrophosphate from ATP and thiamine. EC 2.7.6.2. Phosphotransferases (66-73); Phosphotransferases, ATP (74-78); Thiamine (66-78)  KFw]Thiadiazoles D03.383.871.867 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Acetazolamide; Benzolamide; Methazolamide Heterocyclic Compounds (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  J8U1$:Thiadiazines D03.383.855.785 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazines Heterocyclic Compounds (66-70)  8U$Thiacetazone D02.845.746.703.702; D02.886.803.702; D20.338.903.702 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Semicarbazides; Semicarbazones; Thiosemicarbazones Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiosemicarbazones Anti-Infective Agents; Antitubercular Agents; Thiosemicarbazones  =:Thiabendazole D03.383.871.840; D03.438.103.850; D21.201.287.881 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents  R9:Theta Rhythm E01.236.257.401.940; E01.399.277.940 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH); Electroencephalography Diagnosis; Electrodiagnosis; Electroencephalography Waves in the electroencephalogram which have a frequency of 4-7 cycles per second.  *&cTheropithecus gelada B02.649.801.400.130.120.730.730 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Theropithecus The only species known of the genus THEROPITHECUS. Also known as gelada, it inhabits the rocky, mountainous areas of Ethiopia. Contrary to baboon troops, the gelada travels in herds containing many family units.  #(kTheropithecus B02.649.801.400.130.120.730 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae Theropithecus gelada A genus of Old World monkeys of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, that inhabits the mountainous regions of Ethiopia. The genus consists of only one species, THEROPITHECUS GELADA.  o(ZThermus thermophilus B03.440.400.425.875.875 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Thermus A species of gram-negative, aerobic, rod-shaped bacteria found in hot springs of neutral to alkaline pH, as well as in hot-water heaters. Bacteria (75); Gram-Negative Aerobic Bacteria (76-77); Thermus (78-91)  I"UThermus B03.440.400.425.875 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Thermus thermophilus Gram-negative aerobic rods found in warm water (40-79 degrees C) such as hot springs, hot water tanks, and thermally polluted rivers. Bacteria (66-75); Gram-Negative Aerobic Bacteria (76-77)  N "CThermoreceptors A08.800.550.700.840 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Body Temperature Regulation Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory Cellular receptors which mediate the sense of temperature. Thermoreceptors in vertebrates are mostly located under the skin. In mammals there are separate types of thermoreceptors for cold and for warmth and NOCICEPTORS which detect cold or heat extreme enough to cause pain. Receptors, Sensory (66-70); Temperature Sense (66-70)  ;8![C@Thermoplasma B03.107.800; B03.440.560.580.650 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales Apparently a true saprophyte which has been isolated from burning coal refuse piles and from acid hot springs. Bacteria (66-74); Mycoplasmatales (75)  &"e/Thermometers E07.900 AECLCTECHISDSNSTTDUTVE Temperature; Body Temperature Equipment and Supplies  ^ $Thermolysin D08.586.277.656.732.480.827 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Metalloproteinases Peptide Peptidohydrolases (66-70)  F'Thermoluminescent Dosimetry E05.799.638.785; G03.850.810.370.420; H01.671.768.765.588.852 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Radiometry; Radiation Monitoring Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Monitoring Physical Sciences (Non MeSH); Physics; Radiation; Radiometry; Radiation Monitoring Luminescence (66-70); Radiation Monitoring (66-70); Radiometry (66-70)  R E"2TThermogravimetry E05.196.904 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Technique whereby the weight of a sample can be followed over a period of time while its temperature is being changed (usually increased at a constant rate). Heat (66-76)  ʂ"EThermography E01.357.905 AECLCTECHIISMOMTNUPXSNSTTDUTVE Body Temperature Diagnosis; Diagnostic Imaging Measurement of the regional temperature of the body or an organ by infrared sensing devices, based on self-emanating infrared radiation.  "$Thermodynamics H01.671.912 Physical Sciences (Non MeSH); Physics Convection; Heat AEDUTU  B/ Thermodilution E01.145.643.940 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Indicator Dilution Techniques Measurement of blood flow based on induction at one point of the circulation of a known change in the intravascular heat content of flowing blood and detection of the resultant change in temperature at a point downstream. Cardiac Output (66-76); Indicator Dilution Techniques (67-76)  "\IThermal Conductivity H01.671.891 Physical Sciences (Non MeSH); Physics Heat (66-70); Physics (66-70)  /&Therapy, Computer-Assisted E02.950; L01.700.508.100.710 CLECEDHIISLJMAMTOGSNSTTD Therapeutics Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted Radiotherapy Planning, Computer-Assisted Drug Therapy, Computer-Assisted; Radiotherapy, Computer-Assisted (+ 1) Computer systems utilized as adjuncts in the treatment of disease.  Њ"}PTherapeutics E02 AECLCTECHIISMOMTNUPXSNSTTDUTVE Acupuncture (+ 6); Alternative Medicine (+ 35); Bed Rest; Biological Therapy (Non MeSH) (+ 30); Blood Component Removal (+ 6); Cardiac Pacing, Artificial; Catheterization (+ 21); Cautery (+ 2); Chiropractic; Combined Modality Therapy (+ 6); Contraception (+ 4); Cosmetic Techniques (Non MeSH) (+ 2); Diet Therapy (+ 5); Drainage (+ 1); Drug Therapy (+ 19); Electric Countershock; Emergency Treatment (Non MeSH) (+ 7); Enema; Feeding Methods (Non MeSH) (+ 7); General Patient Care (Non MeSH) (+ 26); Hemodilution; Hemostatic Techniques (+ 4); Hygiene (+ 2); Insemination, Artificial (+ 2); Insufflation; Intervertebral Disk Chemolysis; Lithotripsy (+ 1); Manipulation, Orthopedic; Moxibustion; Nutritional Support (+ 6); Orthoptics; Patient Isolation; Physical Therapy (+ 30); Prescriptions, Non-Drug; Punctures (+ 1); Radiotherapy (+ 16); Rehabilitation (+ 24); Rejuvenation; Remission Induction; Renal Replacement Therapy (+ 9); Respiratory Therapy (+ 11); Salvage Therapy; Self Care (+ 3); Sorption Detoxification (+ 10); Therapy, Computer-Assisted (+ 1); Tocolysis AECLCTDEECEDGEHIIMISLJMAMIMOMTNUOGPAPHPSPXRARERHRISDSNSTTDUSUTVEVI  g" FTherapeutic Processes (Non MeSH) F04.754.919 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Abreaction (+ 1); Acting Out; Association; Transference (Psychology) (+ 1)  'K[Therapeutic Equivalency G12.091.690.898 Chemical, Pharmacologic Phenomena (Non MeSH); Biopharmaceutics; Pharmacokinetics The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease. Drugs (66-69); Pharmacology (66-69)  ],Therapeutic Community F04.754.864.392.701 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy; Milieu Therapy Psychotherapeutic technique which emphasizes socioenvironmental and interpersonal influences in the resocialization and rehabilitation of the patient. The setting is usually a hospital unit or ward in which professional and nonprofessional staff interact with the patients. Psychotherapy (66); Psychotherapy, Group (66)  }97Theoretical Techniques (Non MeSH) F04.669.880 Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH) Decision Theory (+ 1); Game Theory (+ 1); Information Theory; Models, Psychological HI  (dgTheophylline D03.132.956.826; D03.438.759.758.824.751; D08.373.735.800; D16.050.110.872; D18.918.882 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Tea Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Cardiovascular Agents; Vasodilator Agents Aminophylline; Dimenhydrinate; Xanthinol Niacinate Aminophylline; Dimenhydrinate; Dyphylline; 1-Methyl-3-Isobutylxanthine; Xanthinol Niacinate Aminophylline; Dyphylline Aminophylline; Dyphylline Aminophylline; Dyphylline 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione. Alkaloid obtained from Thea sinensis (tea) and others. It stimulates the heart and central nervous system, dilates bronchi and blood vessels, and causes diuresis. The drug is used mainly in bronchial asthma and for myocardial stimulation. Among its more prominent cellular effects are inhibition of cyclic nucleotide phosphodiesterases and antagonism of adenosine receptors.  -c<Theobromine D03.132.956.701; D03.438.759.758.824.651; D16.050.110.865; D18.918.861 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Cardiovascular Agents; Vasodilator Agents Pentoxifylline Pentoxifylline Pentoxifylline 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1318-9).  PD;3UThenoyltrifluoroacetone D02.522.296.900; D03.383.903.820; D26.241.900 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ketones; Butanones Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents 4,4,4-Trifluoro-1-(2-thienyl)-1,3-butanedione. Chelating agent and inhibitor of cellular respiration. Butanones (71-74); Hydrocarbons, Fluorinated (74); Thiophenes (71-74)  5.tSThematic Apperception Test F04.711.647.622.851 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Projective Techniques A projective test in which a person is asked to make up stories about a series of pictures suggesting life situations. The themes expressed by the subject are viewed as those important in his own life or expressions of his personality needs.  a   Thelazioidea B01.500.294.700.750.700.722 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina Gnathostoma A superfamily of parasitic nematodes which includes three genera: Thelazia, Spirocerca, and GNATHOSTOMA. Only Thelazia and GNATHOSTOMA occasionally occur in man.  g*STheileriasis C03.701.688.735; C03.752.625.735; C03.752.750.823; C03.752.875.850; C22.196.831; C22.674.710.735 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Sporozoea Infections Parasitic Diseases; Protozoan Infections; Tick-Borne Diseases Animal Diseases; Cattle Diseases Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Infection of bovines with protozoa of the genus THEILERIA. This infection results in an acute or chronic febrile condition. Protozoan Infections (66-67)  nJ"Theileria parva B01.841.075.762.580.580.700.500 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Piroplasmia; Piroplasmida; Theileria A protozoan parasite that is the etiologic agent of East Coast fever (THEILERIASIS). Transmission is by ticks of the Physicephalus and Hyalomma genera. Sporozoea (66-91)  #&eTheileria annulata B01.841.075.762.580.580.700.100 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Piroplasmia; Piroplasmida; Theileria A protozoan parasite causing tropical theileriasis in cattle. It is transmitted by ticks of the Hyalomma genus. Sporozoea (66-91)  N#&eTheileria B01.841.075.762.580.580.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Piroplasmia; Piroplasmida Theileria annulata; Theileria parva A genus of tick-borne protozoa parasitic in the lymphocytes, erythrocytes, and endothelial cells of mammals. Its organisms multiply asexually and then invade erythrocytes, where they undergo no further reproduction until ingested by a transmitting tick. Sporozoea (66-91)   &X+%Theft I01.198.240.810; I01.880.735.191.410 CLECEHHILJPCPXSNTD Social Sciences; Criminology; Crime Social Sciences; Sociology; Social Problems; Crime Unlawful act of taking property.   *h)Thecoma C04.557.475.750.875 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue; Sex Cord-Stromal Tumor A sex cord-stromal tumor of the postmenopausal ovary that is yellow, large, and unilateral, composed of fascicles of lipid-rich spindle cells interspersed with collagen, reticulin fibers, and hyaline plaques. Thecomas and other estrogen-producing tumors (e.g., granulosa cell tumors) may induce adenomatous hyperplasia of the endometrium or well-differentiated endometrial carcinoma in 3%-20% of the cases. (Dictionary of Modern Medicine, 1992).   XyTheca Cells A05.360.319.114.630.535.400; A06.407.312.497.535.600; A11.329.850 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Graafian Follicle Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri; Ovary; Graafian Follicle Endocrine System (Non MeSH); Endocrine Glands; Gonads; Ovary; Graafian Follicle Cells; Connective Tissue Cells (Non MeSH) The connective tissue cells of the Graafian follicle.  "I*AThebaine D03.132.610.422.547.547.856; D03.549.686.575.547.851; D03.605.497.575.547.851; D15.210.600.840; D15.220.224.925 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives Central Nervous System Agents; Central Nervous System Depressants; Narcotics Central Nervous System Agents; Central Nervous System Stimulants; Convulsants A drug that is derived from opium, which contains from 0.3-1.5% thebaine depending on its origin. It produces strychnine-like convulsions rather than narcosis. It may be habit-forming and is a controlled substance (opiate) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.12 (1985). (From Merck Index, 11th ed).   {:Thanatophoric Dysplasia C05.116.099.343.914; C05.116.099.708.914; C05.660.585.984; C16.131.621.585.984; C16.614.890; C19.297.914 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dwarfism Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Endocrine Diseases; Dwarfism A severe form of neonatal dwarfism with very short limbs. All cases have died at birth or in the neonatal period. Dwarfism (66-84); Skull (66-84) vL\(Thanatology K01.752.827 HI Death Death Humanities; Philosophy The study of the theory, philosophy, and doctrine of death. Death (66-74) $  IThallium Radioisotopes D01.496.749.900 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of thallium that decay or disintegrate emitting radiation. Tl atoms with atomic weights 198-202, 204, and 206-210 are thallium radioisotopes. Radioisotopes (66-87); Thallium (66-87) 4C0Thallium D01.268.877; D01.552.858 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals E :`Thalidomide D02.241.223.805.810.800; D03.383.621.808.800; D20.661.866 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phthalic Acids; Phthalimides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Piperidones Anti-Infective Agents; Leprostatic Agents A sedative withdrawn from the market due to its association with fetal abnormalities. It currently has several investigational uses including the treatment of leprosy, recurrent aphthosis of nonviral and nonfungal origin in HIV patients, and graft vs. host disease and transplant rejection.  (A:RThalassotherapy E02.780.910 AECLCTECHIISMOMTNUPXSNSTTDUTVE Seawater Therapeutics; Physical Therapy The therapeutic use of seaside resorts; includes treatment by sea air, sea voyages, and sea bathing.  ;" %yThalassemia C15.378.071.141.150.875; C15.378.420.826 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies alpha-Thalassemia (+ 1); beta-Thalassemia alpha-Thalassemia (+ 1); beta-Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.  P.Lb0Thalamus A08.186.211.730.385.826 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon Thalamic Nuclei (+ 1) Paired bodies containing mostly gray substance and forming part of the lateral wall of the third ventricle of the brain. } 8ZThalamic Nuclei A08.186.211.730.385.826.701 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Thalamus Geniculate Bodies Several groups of nuclei in the thalamus that serve as the major relay centers for sensory impulses in the brain. Thalamus (66-70) ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $ 6f8Thalamic Diseases C10.228.140.915 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Brain Diseases (66-80); Thalamus (66-80) NV2Thailand Z01.252.145.841 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern  >Textiles J01.637.879 AEANCLECHIPORESDSNSTTOUT Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Cotton; Nylons; Wool ABAEAHANBSCHCLCSCTCYDEDUECEMENGDGEHIIMINIPIRMEMIPAPDPHPKPOPPPSRARERISDSESNSTTOTRULUSUTVI  O\Textile Industry J01.576.885 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry ATextbooks I02.903.847.508; L01.178.682.192.900; L01.178.820.900 HIST Reference Books Reference Books Education; Teaching; Teaching Materials Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books Information Science; Communications Media (Non MeSH); Teaching Materials Books used in the study of a subject that contain a systematic presentation of the principles and vocabulary of a subject. Books (66-80); Teaching Materials (74-80) $^ =3Texas Z01.107.567.875.100.858; Z01.107.567.875.600.822.858 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States  :Tetroses D09.203.546.805 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides ; >^Tetrodotoxin D24.185.926.580.910 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Fishes, Poisonous Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins Octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano- 10aH-(1,3)dioxocino(6,5-a)pyrimidine-4,7,10,11,12-pentol. An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order Tetradontiformes (pufferfish, globefish, toadfish), which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction. DhTetrazolium Salts D03.383.129.617.700; D26.550.900 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Tetrazoles Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Nitroblue Tetrazolium Nitroblue Tetrazolium AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU &,2.Tetrazoles D03.383.129.617 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles Tetrazolium Salts (+ 1) Azoles (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   i8R:Tetrathionic Acid D01.029.260.877.800.900; D01.875.800.800.900; D26.061.925; D26.550.894 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Sulfur Acids; Sulfuric Acids Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids Miscellaneous Drugs and Agents (Non MeSH); Antidotes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Tetrathionic acid (HOSO2SSSO3H). A sulfuric acid dimer, formed by disulfide linkage. This compound has been used to prolong coagulation time and as an antidote in cyanide poisoning. Thiosulfates (70-74) !P.qTetraphenylborate D02.203.087.050.750; D26.550.888 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Boron Compounds; Boranes; Borohydrides Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Tetraphenylborate(1-). An anionic compound that is used as a reagent for determination of potassium, ammonium, rubidium, and cesium ions. It also uncouples oxidative phosphorylation and forms complexes with biological materials, and is used in biological assays. Benzene Derivatives (73-74); Boron Compounds (73-74) $&.2?Tetranitromethane D02.455.326.146.571.850; D02.455.326.146.672.800; D02.640.720.800; D26.550.875 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Methane Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Nitroparaffins Organic Chemicals (Non MeSH); Nitro Compounds; Nitroparaffins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Corrosive oxidant, explosive; additive to diesel and rocket fuels; causes skin and lung irritation; proposed war gas. A useful reagent for studying the modification of specific amino acids, particularly tyrosine residues in proteins. Has also been used for studying carbanion formation and for detecting the presence of double bonds in organic compounds. Methane (72-74); Nitro Compounds (72-74) 'hX.2Tetramisole D03.383.374.884; D03.383.871.782 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles +z&:Tetramethylphenylenediamine D02.092.146.651.900; D02.092.782.258.651.900; D26.550.865 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Aniline Compounds; Phenylenediamines Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Phenylenediamines Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents N,N,N',N'-Tetramethyl-p-phenylenediamine. Used in the form of the hydrochloride as a reagent in analytical chemistry. Synonyms: Wurster's blue; Wurster's reagent. Dimethylamines (74); Phenylenediamines (74) ,A.4Tetralogy of Fallot C14.240.400.849; C14.280.400.849; C16.131.240.400.849 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital A combination of congenital cardiac defects consisting of pulmonary stenosis, interventricular septal defects, dextroposition of the aorta so that it overrides the interventricular septum and receives venous as well as arterial blood, and right ventricular hypertrophy. /X=LK5Tetraisopropylpyrophosphamide D02.705.900; D08.373.275.925; D14.100.120.300.925 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors N,N',N'',N'''-Tetraisopropylpyrophosphamide. A specific inhibitor of pseudocholinesterases. It is commonly used experimentally to determine whether pseudo- or acetylcholinesterases are involved in an enzymatic process. Amides (72-74); Organophosphorus Compounds (72-74) 2!9:N<Tetrahymenina B01.841.185.650.375.750 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida Tetrahymena (+ 2) A suborder of ciliate protozoa. Most organisms are free-living in fresh water and many species are used extensively for experimental studies. 5&STetrahymena thermophila B01.841.185.650.375.750.850.875 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida; Tetrahymenina; Tetrahymena A species of ciliate protozoa used in genetic and cytological research. Tetrahymena (78-91) 7c#&sVTetrahymena pyriformis B01.841.185.650.375.750.850.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida; Tetrahymenina; Tetrahymena A species of ciliate protozoa used extensively in genetic research. Tetrahymena (66-71) 8#&sQTetrahymena B01.841.185.650.375.750.850 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida; Tetrahymenina Tetrahymena pyriformis; Tetrahymena thermophila A genus of ciliate protozoa commonly used in genetic, cytological, and other research. :7&d7gTetrahydrouridine D13.570.685.852.800; D13.570.800.892.800; D26.087.898 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Uridine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 1-(beta-D-Ribofuranosyl)-4-hydroxy-3,4,5-tetrahydro-pyrimidin-2(1H)-one. An inhibitor of nucleotide metabolism. Uridine (71-74) ;=:&~Tetrahydropteroylglutamate Methyltransferase D08.586.913.517.810 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases An enzyme that catalyzes the formation of methionine by transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine. It requires a cobamide coenzyme. The enzyme can act on mono- or triglutamate derivatives. EC 2.1.1.13. Methionine (73-74); Methyltransferases (73-74); Tetrahydrofolates (73-74) >1FkVTetrahydropapaveroline D03.132.610.710.850; D03.438.531.667.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Papaverine Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines; Papaverine 1-(3,4-Dihydroxybenzyl)-1,2,3,4-tetrahydro-6,7-isoquinolinediol. A leukomaine (animal alkaloid) formed in brain and liver from dopamine and L-dopa; it may be implicated in psychiatric problems. Alcohols (66-73); Benzene Derivatives (68-73); Papaverine (66-77); Quinolines (66-73) @.:gTetrahydronaphthalenes D04.615.638.960 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes 8-Hydroxy-2-(di-n-propylamino)tetralin; Podophyllotoxin Partially saturated 1,2,3,4-tetrahydronaphthalene compounds. Naphthalenes (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $C88a?D@Tetrahydrofolates D03.438.733.631.400.800; D08.176.840; D11.786.708.328.850 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins; Folic Acid Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Folic Acid Formyltetrahydrofolates (+ 1) Formyltetrahydrofolates Formyltetrahydrofolates (+ 1) Coenzymes (66-71); Folic Acid (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  E AB]/DTetrahydrofolate Dehydrogenase D08.586.682.107.825 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (Dorland, 27th ed) EC 1.5.1.3. G#FrTetrahydrocortisone D04.808.745.558.783; D06.472.040.322.478.478.865 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnanediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 17-Hydroxycorticosteroids Cortisone (66-72) J6:Tetrahydrocortisol D04.808.745.887; D06.472.040.322.478.353.825; D06.472.040.322.478.478.782 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 17-Hydroxycorticosteroids Hydrocortisone (66-72) LMQ:Tetrahydrocannabinol D02.455.849.090.810; D15.095.900; D15.300.900; D15.700.372.900; D16.050.030.900 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Cannabinoids Central Nervous System Agents; Antiemetics Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics (6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol. The delta(1)-3,4-trans-isomer (also referred to as the delta(9)-isomer) is the major pharmacologically active constituent of Cannabis sativa L. (marihuana, hashish). Dronabinol, a synthetic form of tetrahydrocannabinol, is used to treat the wasting condition associated with AIDS and also cancer patients undergoing chemotherapy. Cannabis (66-70) N[<UTetragastrin D06.472.317.413.800; D12.644.456.830; D19.316.629.441.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones; Gastrins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones; Gastrins L-Tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide. The C-terminal tetrapeptide of gastrin. It is the smallest peptide fragment of gastrin which has the same physiological and pharmacological activity as gastrin. Gastrins (66-78); Oligopeptides (73-78); Peptides (66-72) RA::FTetraethylammonium Compounds D02.092.102.787; D02.675.276.787 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds U!&8Tetraethyl Lead D02.691.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds Tetraethylplumbane. A highly toxic compound used as a gasoline additive. It causes acute toxic psychosis or chronic poisoning if inhaled or absorbed through the skin. Lead (69-75); Organometallic Compounds (69-75) W :A8Tetradecanoylphorbol Acetate D02.455.849.291.500.510.850; D10.516.627.700.315.500.850; D26.191.208.744.742.903; J01.740.700.315.500.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Phorbols; Phorbol Esters Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils; Croton Oil; Phorbol Esters Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Croton Oil; Phorbols; Phorbol Esters Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils; Croton Oil; Phorbol Esters Tetradecanoic acid, (1aR-(1a alpha,1b beta,4a beta,7a alpha,7b alpha,8 alpha,9 beta,9a alpha))-9a (acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester. A phorbol ester with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Alcohols (66-74); Croton Oil (66-74); Diterpenes (74); Fatty Acids (66-74); Terpenes (66-73) X!t:sTetracyclines D20.085.868 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Chlortetracycline; Demeclocycline; Doxycycline; Lymecycline; Methacycline; Minocycline; Oxytetracycline; Rolitetracycline; Tetracycline Broad-spectrum natural and semisynthetic antibiotics with a naphthacene structure obtained from various Streptomyces species. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ]:)<Tetracycline Resistance G04.185.515.286.898; G05.386.310.898; G05.706.310.898; G12.392.269.898 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial Genetics; Genetics, Microbial; Drug Resistance, Microbial Genetics; Pharmacogenetics; Drug Resistance, Microbial Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial Nonsusceptibility of a microbe (usually a bacterium) to the action of tetracycline, which binds to the 30S ribosomal subunit and prevents the normal binding of aminoacyl-tRNA. Drug Resistance, Microbial (66-87); Tetracycline (66-87) _P CTetracycline D20.085.868.875 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5a alpha,6 beta,12a alpha))-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide. An antibiotic originally produced by Streptomyces viridifaciens, but used mostly in synthetic form. b<:+Tetrachlorvinphos D02.705.890; D05.723.491.574.890 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate 2-chloro-1-(2,4,5-trichlorophenyl)-vinyl dimethylphosphate. An organophosphate insecticide. Synonyms: Rabon; Ravap; Shell SD 8447. Organophosphorus Compounds (71) d&:%Tetrachloroethylene D02.455.526.439.880; D21.201.287.846 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Ethylene tetrachloride. Used as grease solvent in industry; defats skin and mucus membranes, causes CNS, liver, and kidney damage on chronic exposure; used as anthelmintic for hookworms. Synonyms: tetrachloroethene; Ankilostin; Didakene; Nema; Perclene; Tetracap; Tetropil. f*:BTetrachlorodibenzodioxin D03.383.231.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Dioxins 2,3,7,8-Tetrachlorodibenzo-p-dioxin. A contaminant of 2,4,5-T believed to have teratogenic effects. Synonym: TCDD. Chlorobenzenes (74); Dioxins (72-74) i:S-Tetracaine D02.241.223.106.061.075.900; D15.050.050.820; D15.210.100.200.820; D16.850.025.820 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; 4-Aminobenzoic Acid Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local The drug most widely used for spinal anesthesia. It is not recommended for infiltration or epidural blocks because of its slow onset of action and great systemic toxicity. The onset of action is slow (approximately five minutes) after injection, but the duration of anesthesia is more than twice as long as that of PROCAINE. (From AMA Drug Evaluations, 1992, p166). k+\:Tetrabenazine D03.438.834.850; D14.100.050.600.050.830; D14.100.600.050.830; D15.090.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolizines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Anti-Dyskinesia Agents A drug formerly used as an antipsychotic but now used primarily in the treatment of various movement disorders including tardive dyskinesia. Tetrabenazine blocks uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system. oiT: ETetany C10.772.900; C18.452.174.509.700; C19.642.482.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders; Hypocalcemia Endocrine Diseases; Parathyroid Diseases; Hypoparathyroidism Hyperexcitability of nerves and muscles due to decrease in concentration of extracellular ionized calcium, which may be associated with such conditions of parathyroid hypofunction, vitamin D deficiency, and alkalosis or result from ingestion of alkaline salts. It is characterized by carpopedal spasm, muscular twitching and cramps, laryngospasm with inspiratory stridor, hyperreflexia, and choreiform movements. (Dorland, 27th ed). sy 9NTetanus Toxoid D24.310.794.824 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Toxoids Diphtheria-Tetanus-Pertussis Vaccine w%BX)Tetanus Toxin D24.185.926.123.893 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Tetanus Antitoxin Clostridium tetani Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins The toxin elaborated by Clostridium tetani. It is a protein with a molecular weight of about 150,000, probably consisting of two fragments, tetanolysin being the hemolytic and tetanospasmin the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal convulsions.  x1:kTetanus Antitoxin D24.310.121.824; D24.611.125.272.849 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Tetanus Toxin Immunologic and Biologic Factors (Non MeSH); Biological Products; Antitoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antitoxins z*6Tetanus C01.252.410.090.217.864 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Trismus Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections; Clostridium Infections A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. |t P Testosterone 5-alpha-Reductase D08.586.682.910 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Oxidoreductases (72-74); Testosterone (72-74) #FX6Testosterone D04.808.054.079.429.824; D06.472.079.864; D06.472.866.154.864 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Androgens Epitestosterone; Hydroxytestosterones; Methenolone; Methyltestosterone Epitestosterone Epitestosterone EDrTestolactone D04.808.054.079.129.782; D04.808.496.699; D22.204.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstadienes Polycyclic Hydrocarbons; Steroids; Homosteroids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents #=:Testis A05.360.444.849; A05.360.576.782; A06.407.312.782 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Orchiectomy Urogenital System; Genitalia; Genitalia, Male Urogenital System; Genitalia; Gonads Endocrine System (Non MeSH); Endocrine Glands; Gonads Epididymis; Leydig Cells; Rete Testis; Seminiferous Tubules (+ 1); Sertoli Cells Leydig Cells Either of the paired male reproductive glands that produce the male germ cells and the male hormones. consider also terms at ORCHI-. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $ 9:s<Testicular Neoplasms C04.588.322.762; C04.588.945.440.915; C12.294.260.875; C12.294.829.782; C12.740.800.410.875; C19.344.762; C19.391.829.782 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Male Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Genital Neoplasms, Male Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Testicular Diseases Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Male Endocrine Diseases; Endocrine Gland Neoplasms Endocrine Diseases; Gonadal Disorders (Non MeSH); Testicular Diseases PXTesticular Hormones D06.472.866.900 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones Androgen-Binding Proteins Hormones produced in the testis. Sex Hormones (66-74) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $BS)FTesticular Feminization C12.740.700.842.749; C16.131.939.842.749; C19.391.301.699; C19.391.775.749 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Endocrine Diseases; Gonadal Disorders (Non MeSH); Feminization Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders A condition, due to lack of cellular receptors for testosterone and dihydrotestosterone, in which the subject is phenotypically female but lacks nuclear sex chromatin and is of XY chromosomal sex. The uterus and tubes are absent or rudimentary, and the gonads are typically testes and may be abdominal or inguinal in position. The incomplete form is marked by partial fusion of the labioscrotal folds and clitoromegaly, and at puberty, variable feminization and partial virilization may both take place. (Dorland, 27th ed). Sex Differentiation Disorders (66-67) TLd,Testicular Diseases C12.294.829; C19.391.829 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Endocrine Diseases; Gonadal Disorders (Non MeSH) Cryptorchidism; Orchitis; Testicular Neoplasms Cryptorchidism; Orchitis; Testicular Neoplasms BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI NlXTest Anxiety Scale F04.711.647.513.886 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Personality Inventory A self-reporting test consisting of items concerning fear and worry about taking tests and physiological activity, such as heart rate, sweating, etc., before, during, and after tests.  Territoriality F01.145.875.864 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Spatial Behavior Behavior in defense of an area against another individual or individuals primarily of the same species. Behavior, Animal (66-67) V{Terphenyl Compounds D02.455.426.559.389.805 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Polychloroterphenyl Compounds Compounds consisting of benzene rings linked to each other in either ortho, meta or para positions. Permitted are any substitutions, but ring fusion to any of the benzene rings is not allowed. Benzene Derivatives (73-74)  8"!Terpenes D02.455.849 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons Cannabinoids (+ 3); Carotenoids (+ 4); Diterpenes (+ 18); Eugenol; Gefarnate; Menthol; Norbornanes (+ 4); Polyisoprenyl Phosphates (+ 5); Pyrethrins (+ 1); Sesquiterpenes (+ 5); Thymol (+ 1); Triterpenes (+ 6) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR # 84HTerminator Regions (Genetics) G05.275.470.790.810; G05.331.599.110.689.810; G06.184.599.110.689.810 DEGEIMPHRE Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid DNA sequences which signal the termination of transcription. Gene Expression Regulation (81-84); Genes (66-67); Genes, Regulator (68-84); Transcription, Genetic (73-84) #MHTerminal Care E02.472.905; N02.421.589.886 CLECHILJMAMTOGPXSNSTTDUT Hospice Care; Life Support Care; Palliative Treatment Death Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Hospice Care Hospice Care Medical and nursing care of patients in the terminal stage of an illness. $"A  ZTerfenadine D02.455.426.559.389.115.800; D03.383.621.855; D14.100.375.425.400.835 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzhydryl Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug is used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria. Benzhydryl Compounds (75-91); Histamine H1 Receptor Blockaders (66-91); Piperidines (66-91)  M: lTerbutaline D02.033.329.291.905; D02.092.063.291.905; D06.347.930.825; D14.100.050.100.200.850; D16.050.110.850; D16.050.870.880; D26.930.825 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. :\Terbium D01.268.558.850; D01.552.550.852 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Terbium. An element of the rare earth family of metals. It has the atomic symbol Tb, atomic number 65, and atomic weight 158.92.  &:Teratoma C04.557.465.910 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal Struma Ovarii A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They may be solid or cystic and are classified histologically as mature, immature, and malignant. (From Dorland, 27th ed and DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed).  XhTeratology G01.100.529.500; G01.273.200.350.500 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Anatomy; Embryology Biological Sciences; Biology; Developmental Biology; Embryology That division of embryology which deals with abnormal development and congenital malformations. (From Dorland, 27th ed). *zTeratogens D05.569.864; D26.915 ANCHCLCSDUECHIIPMEPDPKRESDSTTO Abnormalities, Drug-Induced Abnormalities, Drug-Induced Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH) An agent that causes the production of physical defects in the developing embryo. Abnormalities, Drug-Induced (66-74) $c"  ~b)Teratocarcinoma C04.557.465.900 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed). Teratoma (67-93) %XhTeprotide D08.373.745.085.885; D12.644.456.810; D18.162.050.885 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors 2-L-Tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine bradykinin potentiator B. A synthetic nonapeptide with the sequence Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro, which is identical to that of the peptide from the venom of the snake, Bothrops jararaca. It acts as an inhibitor of kininase II and angiotensin I and has been proposed as an antihypertensive agent. Oligopeptides (73-74); Peptides (66-72); Snakes (66-72)  =:KDTepa D03.383.097.217.864; D05.723.141.749 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines; Aziridines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Chemosterilants Thiotepa Thiotepa Azirines (68-71); Chemosterilants (66-71) *:2Tenuazonic Acid D03.383.773.812.900; D20.085.075.930; D22.204.106.920 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic 3-Acetyl-5-sec-butyl-4-hydroxy-3-pyrrolin-2-one. A metabolite found in a strain of the fungus Alternaria tenuis Auct. which functions as an antibiotic with antiviral and antineoplastic properties, and may also act as a mycotoxin. Pyrrolidinones (71-74) =< Tensor Tympani A02.633.567.975; A09.246.397.749 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Sense Organs; Ear; Ear, Middle Tensor muscle of the tympanic membrane that draws the handle of the malleus medialward and tenses the tympanic membrane. (Stedman, 25th ed). y&:aTension Headache C10.597.617.485.500; C23.888.592.612.429.407 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Pain; Headache Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Headache A headache, usually bilateral, often with occipital-nuchal, temporal, or frontal predominance, or with diffuse extension over the top of the cranium. It is provoked by fatigue and nervous strain and is associated with depression, worry, and anxiety. While mainly in adults of both sexes, it is more frequent in women. Its incidence is probably as great as that of MIGRAINE but unlike it, infrequently begins in childhood or adolescence. (From Adams and Victor, Principles of Neurology, 5th ed, p155, p161). Headache (66-94) 2NSTensile Strength G07.900; G11.427.050.800; H01.671.100.131.800 DEPHRE Physiology, General (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Biomechanics Physical Sciences (Non MeSH); Physics; Biophysics; Biomechanics Resistance to rupture under tension. Biomechanics (68-76); Elasticity (67-76); Stress, Mechanical (73-76) 5 -RTenosynovitis C05.651.884 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Inflammation of a tendon sheath. Causes include trauma, tendon stress, bacterial disease (gonorrhea, tuberculosis), rheumatic disease, and gout. Common sites are the shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced. Friction rubs may be felt or heard (with a stethoscope) on movement. Calcium deposits may occur in the tendon ad its sheath, leading to opacities on radiographs of the affected area. (Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984). N3Tennis Elbow C05.906; C21.866.088.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Elbow Musculoskeletal Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries A condition characterized by pain in or near the lateral humeral epicondyle or in the forearm extensor muscle mass as a result of unusual strain. It occurs in tennis players as well as housewives, artisans, and violinists. Athletic Injuries (68-81); Elbow (66-81); Elbow Joint (66-81); Sports (66-75); Sports Medicine (66-67); Tendinitis (66-81); Tennis (76-81)  ŅN }Tennis I03.450.642.845.600.900 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports; Racquet Sports A game played by two or four players with rackets and an elastic ball on a level court divided by a low net. Sports (66-75) e eTennessee Z01.107.567.875.100.848; Z01.107.567.875.600.066.848 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Appalachian Region  :Teniposide D09.203.408.348.800; D22.204.179.612.696.898 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Podophyllin; Podophyllotoxin (5R-(5 alpha,5a beta,8a alpha,9 beta(R*)))-5,8,8a,9-Tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-9-((4,6-O-(2-thienylmethylene)-beta-D-glucopyranosyl)oxy)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one. A cytotoxic semisynthetic derivative of podophyllotoxin that may be effective in cancer chemotherapy. It prevents cells from entering the prophase of mitosis and inhibits DNA synthesis. Glucosides (75); Glycosides (73-74); Podophyllotoxin (73-74) K2:ITenebrio B01.131.617.155.304.615 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Coleoptera; Beetles A genus of beetles which infests grain products. Its larva is called mealworm. Beetles (66-71)  (C`Tendons, Para-Articular A02.633.837.781 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Tendons Rotator Cuff :1Tendons A02.633.837 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles Achilles Tendon; Tendons, Para-Articular (+ 1) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  8&8:Tendon Transfer E04.557.863 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Orthopedics Surgical procedure by which a tendon is incised at its insertion and placed at an anatomical site distant from the original insertion. The tendon remains attached at the point of origin and takes over the function of a muscle inactivated by trauma or disease. Tendons/SU (66-68) $&5Tendon Injuries C21.866.874 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Injuries to the fibrous cords of connective tissue which attach muscles to bones or other structures. NQyTendinitis C05.651.854 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Inflammation of tendons and of tendon-muscle attachments. (Dorland, 27th ed). <N3]Temporomandibular Joint Syndrome C05.500.607.221.897.897; C05.550.905.905; C05.651.243.897.897; C05.651.550.905; C07.320.610.291.897.897; C07.678.949 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Facial Pain Musculoskeletal Diseases; Jaw Diseases; Mandibular Diseases; Craniomandibular Disorders; Temporomandibular Joint Diseases Musculoskeletal Diseases; Joint Diseases; Temporomandibular Joint Diseases Musculoskeletal Diseases; Muscular Diseases; Craniomandibular Disorders; Temporomandibular Joint Diseases Musculoskeletal Diseases; Muscular Diseases; Myofascial Pain Syndromes Stomatognathic Diseases; Jaw Diseases; Mandibular Diseases; Craniomandibular Disorders; Temporomandibular Joint Diseases Stomatognathic Diseases; Temporomandibular Joint Diseases A symptom complex consisting of pain, muscle tenderness, clicking in the joint, and limitation or alteration of mandibular movement. The symptoms are subjective and manifested primarily in the masticatory muscles rather than the temporomandibular joint itself. Etiologic factors are uncertain but include occlusal dysharmony and psychophysiologic factors. Z&NmTemporomandibular Joint Diseases C05.500.607.221.897; C05.550.905; C05.651.243.897; C07.320.610.291.897; C07.678 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases; Mandibular Diseases; Craniomandibular Disorders Musculoskeletal Diseases; Joint Diseases Musculoskeletal Diseases; Muscular Diseases; Craniomandibular Disorders Stomatognathic Diseases; Jaw Diseases; Mandibular Diseases; Craniomandibular Disorders Stomatognathic Diseases Temporomandibular Joint Syndrome Temporomandibular Joint Syndrome Temporomandibular Joint Syndrome Temporomandibular Joint Syndrome Temporomandibular Joint Syndrome A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibilar diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed). Joint Diseases (66-81); Temporomandibular Joint (66-81)  ی&[N_BTemporomandibular Joint A02.835.583.861; A14.907 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Centric Relation Jaw; Mandible; Mandibular Condyle Musculoskeletal System; Skeleton; Joints Stomatognathic System 8*ITemporal Muscle A02.633.567.600.850; A14.530.940 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal; Masticatory Muscles Stomatognathic System; Masticatory Muscles A masticatory muscle whose action is closing the jaws; its posterior portion retracts the mandible. Facial Muscles (66-79); Masticatory Muscles (66-79); Muscles (66-79) &:wSTemporal Lobe A08.186.211.730.885.213.863 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex Auditory Cortex Lower lateral part of the cerebral hemisphere. 8o9Temporal Bone A02.835.232.781.885 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Labyrinth Musculoskeletal System; Skeleton; Bone and Bones; Skull Mastoid; Petrous Bone : DTemporal Arteritis C14.907.184.823; C14.907.940.090.905; C17.800.862.892 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Polymyalgia Rheumatica Polymyalgia Rheumatica Cardiovascular Diseases; Vascular Diseases; Arteritis Cardiovascular Diseases; Vascular Diseases; Vasculitis; Arteritis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular A systemic disease of people over 50 years old. It is characterized by a necrotizing panarteritis with granulomas and giant cells, which produce unilateral headache and tenderness in the scalp over the temporal or occipital arteries. Erythema and the affected artery become evident as a hard, pulsating, tender bulge under red or cyanotic skin. Scalp gangrene may also be present. (From Andrews' Diseases of the Skin, 8th ed).  =NTemporal Arteries A07.231.114.868 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Arteries arising from the external carotid or the maxillary artery and distributing to the temporal region. 88Templates G05.331.808 Genetics; Genetics, Biochemical Macromolecular moulds for the synthesis of complementary macromolecules, as in DNA replication, transcription of DNA to RNA, and translation of RNA into polypeptides. DNA (66-67); Genetics (66-67); RNA (66-67) , &7Temperature Sense F02.830.816.781; G11.561.796.781 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation The sensation of cold, heat, coolness, and warmth. &>Temperature G03.230.150.450; G03.230.300.100.725.710; H01.671.868 Body Temperature; Thermometers Environment and Public Health (Non MeSH); Environment; Environment, Controlled Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather Physical Sciences (Non MeSH); Physics  Cold; Heat Cold (+ 1); Heat AEDUTU =%( Temperance I03.828 CLECHILJPXSNTD Alcohol Drinking; Alcoholism Human Activities (Non MeSH) Abstinence from alcohol.  #"Temperament F01.752.898 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Personality Predisposition to react to one's environment in a certain way; usually refers to mood changes.  DrTemazepam D03.438.079.080.070.880; D14.100.240.500.860; D15.045.920; D15.075.050.825; D15.210.950.012.050.850; D15.700.872.015.050.845 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine 7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one. A benzodiazepinone that acts as a GABA modulator and anti-anxiety agent. Benzazepines (68-73); Benzodiazepine Tranquilizers (75-78); Benzodiazepinones (74-78)  :cTelophase G04.335.135.220.225.900; G05.148.165.220.225.900; G07.553.135.220.225.900 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Genetics; Cytogenetics; Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) The final phase of cell division, in which two daughter nuclei are formed, the cytoplasm divides, and the chromosomes lose their distinctness and are transformed into chromatin networks. Cell Division (66-77); Meiosis (68-77); Mitosis (68-77) g QETelomere A11.223.475.910 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cell Nucleus; Chromosomes A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Base Sequence (79-91); Chromosomes (76-91)  *)4Tellurium D01.268.185.950 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Chalcogens (Non MeSH) Tellurium. An element that is a member of the chalcogen family. It has the atomic symbol Te, atomic number 52, and atomic weight 127.60. It has been used as a coloring agent and in the manufacture of electrical equipment. Exposure may cause nausea, vomiting, and CNS depression. w :MMTelevision L01.178.147.898; L01.178.847.823 CLECHIISLJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids Information Science; Communications Media (Non MeSH); Telecommunications Videodisc Recording (+ 2); Videotape Recording CLECHIISLJMTSDSNSTTDUT &:Telephone L01.178.847.698 CLECHIISLJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Telecommunications Dataphone Communication (66-70)  U Telepathy F02.607.847 CLDEPHRE Parapsychology Psychologic Processes and Principles (Non MeSH); Parapsychology The knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes.   KTelencephalon A08.186.211.730.885 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon Basal Ganglia (+ 7); Cerebral Cortex (+ 11); Corpus Callosum; Olfactory Bulb Paired anteriolateral evaginations of the prosencephalon plus the lamina terminalis. The cerebral hemispheres are derived from it. 38J`Telemetry E01.621.697 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Monitoring, Physiologic  ")Telemedicine G02.403.840; L01.178.847.652; N04.590.374.800 CLECHIISLJMAMTOGSNSTTDUT Health Occupations; Medicine Information Science; Communications Media (Non MeSH); Telecommunications Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care Delivery of health services via remote telecommunications. This includes interactive consultative and diagnostic services. Telecommunications (76-92) 5Telefacsimile L01.178.847.606; L01.240.950 CLECHIISLJMAOGSDSNSTTDUT Information Science; Communications Media (Non MeSH); Telecommunications Information Science; Copying Processes A telecommunication system combining the transmission of a document scanned at a transmitter, its reconstruction at a receiving station, and its duplication there by a copier. Copying Processes (86-91); Telecommunications (86-91) "?Telecommunications L01.178.847 CLECHIISLJMAOGSDSNSTTDUT Information Science; Communications Media (Non MeSH) Radar; Radio; Satellite Communications; Telefacsimile; Telemedicine; Telephone (+ 1); Television Transmission of signs, signals, writing, images, sounds, or data of any nature by wire, radio, or other electromagnetic equipment. Communication (66-75); Radio (66-75); Telephone (71-75); Television (66-75) CLECHIISLJMAMTOGSDSNSTTDUT $>t\Telangiectasis C14.907.823 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Ataxia Telangiectasia; CREST Syndrome; Telangiectasia, Hereditary Hemorrhagic Permanent dilation of preexisting blood vessels (capillaries, arterioles, venules) creating small focal red lesions, usually in the skin or mucous membranes. The lesion may present as a coarse or fine red line or as a punctum with radiating limbs. (From Dorland, 27th ed).  N2YBTelangiectasia, Hereditary Hemorrhagic C14.907.823.780; C15.378.463.731 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Angiomatosis Cardiovascular Diseases; Vascular Diseases; Telangiectasis Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis An autosomal dominant vascular anomaly characterized by the presence of multiple small telangiectases of the skin, mucous membranes, gastrointestinal tract, and other organs, associated with recurrent episodes of bleeding from affected sites and gross or occult melena. (Dorland, 27th ed).  @,&NOTeicoplanin D20.085.116.095.850 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Antibiotics, Glycopeptide Teichomycin. Glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety. Glycopeptides (78-92)  <`Teichoic Acids D09.203.408.872; D09.203.698.718.825; D09.203.894.847; D24.611.216.161.616.797 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Polysaccharides, Bacterial Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial; Polysaccharides, Bacterial Bacterial polysaccharides that are rich in phosphodiester linkages. They are the major components of the cell walls and membranes of many bacteria. Glycosides (66-70); Phosphoric Acids (66-70) X@6Tegmentum Mesencephali A08.186.211.132.659.822 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon Periaqueductal Gray; Red Nucleus; Ventral Tegmental Area Mesencephalon (66-70) t8XDTegafur D03.383.742.698.875.404.850; D22.204.144.545.850; D26.087.387.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil; Fluorouracil Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic; Fluorouracil Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Fluorouracil 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-(1H,3H)- pyrimidinedione. Congener of fluorouracil with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. Fluorouracil (72-76); Furans (72-76)  I:X-Tedelparin D09.203.698.373.400.300.900; D19.461.119.380.300.900; D19.461.427.400.300.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Heparin; Heparin, Low-Molecular-Weight Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed). Heparin, Low-Molecular-Weight (88-93) U<+Tectorial Membrane A09.246.631.246.292.906 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea; Cochlear Duct A gelatinous membrane, attached to the bony spiral lamina, which overlies the hair cells within the cochlea of the inner ear. Cochlea (66-78) :BTectiviridae B04.123.900; B04.280.900 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses; DNA Viruses A family of lipid-containing bacteriophages with double capsids which infect both gram-negative and gram-positive bacteria. It has one genus, Tectivirus. E6Technology, Radiologic E05.920; G02.010.850; J01.897.891 CLECEDHIISLJMAMTOGSNSTTDVE Radiography Miscellaneous Techniques (Non MeSH) Health Occupations; Allied Health Occupations Technology, Industry, Agriculture (Non MeSH); Technology The application of scientific knowledge or technology to the field of radiology. The applications center mostly around x-ray or radioisotopes for diagnostic and therapeutic purposes but the technological applications of any radiation or radiologic procedure is within the scope of radiologic technology.  )^Technology, Pharmaceutical E05.916; G02.893; J01.897.836 CLECEDHIISLJMAMTOGSNSTTD Pharmacy; Drug Industry Miscellaneous Techniques (Non MeSH) Health Occupations Technology, Industry, Agriculture (Non MeSH); Technology Dosage Forms; Drug Compounding; Drug Incompatibility; Drug Labeling; Drug Packaging; Drug Stability; Drug Storage; Enzyme Stability; Materials Testing The application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures and in the treatment of patients. Chemistry, Pharmaceutical (66-67); Pharmacy (66-67) AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE (#1%=4Technology, Medical E05.909; G02.010.825; J01.897.780 CLECEDHIISLJMAMTOGSNSTTD Diagnosis, Laboratory Miscellaneous Techniques (Non MeSH) Health Occupations; Allied Health Occupations Technology, Industry, Agriculture (Non MeSH); Technology Cytological Techniques (+ 48); Histological Techniques (+ 31); Microbiological Techniques (+ 12); Tissue Culture (+ 2) The application of scientific knowledge or technology to the field of medicine. It includes a variety of medical diagnostic and determinative procedures as well as various therapeutic and surgical methods and techniques. Medical technology is also considered a specialty. AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE $'$)<4Technology, Industry, Agriculture (Non MeSH) J01 Agriculture (+ 8); Architecture (+ 8); Aviation (+ 5); Beverages (+ 9); Clothing (+ 4); Commerce (+ 1); Engineering (+ 9); Firearms; Food (+ 75); Food Services (+ 6); Food Supply; Food Technology (+ 8); Fossil Fuels (+ 6); Household Articles (+ 2); Household Products (+ 12); Industry (+ 25); Materials (Non MeSH) (+ 20); Military Science; Nuclear Reactors; Oils (+ 41); Power Plants; Product Labeling (+ 2); Technology (+ 11); Transportation (+ 7) AAABADAEAGAHAIANBIBLBSCFCHCICLCSCTCYDEDFDUECEDEMENETGDGEHIIMINIPIRISLJMAMEMIMTOGPAPDPHPKPOPPPSPXRARERISDSESNSTTDTOTRTUULURUSUTVEVI *j46Technology, High-Cost N03.880.502 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Technology Assessment, Biomedical Advanced technology that is costly, requires highly skilled personnel, and is unique in its particular application. Includes innovative, specialized medical/surgical procedures as well as advanced diagnostic and therapeutic equipment. -\ Technology, Dental E06.912; G02.010.800; J01.897.724 CLECEDHIISLJMAMTOGSNSTTD Dentistry Health Occupations; Allied Health Occupations Technology, Industry, Agriculture (Non MeSH); Technology Dental Casting Technique; Dental Impression Technique; Dental Soldering; Denture Design; Denture Identification Marking; Denture Rebasing; Denture Repair; Materials Testing; Orthodontic Appliance Design The field of dentistry involved in procedures for designing and constructing dental appliances. It includes also the application of any technology to the field of dentistry. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE  /K)*Technology Transfer J01.897.900; L01.143.320.800 Technology, Industry, Agriculture (Non MeSH); Technology Information Science; Communication; Diffusion of Innovation Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise. Technology (76-94); Technology, Medical (76-94) 27"09Technology Assessment, Biomedical N03.880; N05.715.360.825 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Technology, High-Cost Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. 5'Technology J01.897 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH) Automation (+ 1); Biotechnology (+ 1); Man-Machine Systems; Quality Control; Technology, Dental; Technology, Medical; Technology, Pharmaceutical; Technology, Radiologic; Technology Transfer The application of scientific knowledge to practical purposes in any field. It includes methods, techniques, and instrumentation. CLECEDHIISLJMAMTOGSNSTTDUTVE  7 4 Technetium Tc 99m Sulfur Colloid D01.875.900; D01.925.950 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Inorganic Chemicals (Non MeSH); Technetium Compounds A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen. Sulfur (66-84); Technetium (66-84) 9(:+Technetium Tc 99m Sestamibi D02.626.872; D02.691.825.937 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles Organic Chemicals (Non MeSH); Organometallic Compounds; Organotechnetium Compounds (OC-6-11)-Hexakis(1-isocyano-2-methoxy-2-methylpropane)technetium(1+)-99mTc. A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack. Organometallic Compounds (87-89); Organotechnetium Compounds (89-92); Technetium (87-89) ;"":gTechnetium Tc 99m Pyrophosphate D01.695.625.675.650.775.150.900; D01.925.925 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Polyphosphates; Diphosphates Inorganic Chemicals (Non MeSH); Technetium Compounds Technetium Tc 99m pyrophosphate. A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities. Pyrophosphates (66-91); Technetium (66-91) >&2:3Technetium Tc 99m Pentetate D02.092.782.275.800; D02.241.081.038.420.800; D02.691.825.875; D26.241.429.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; DTPA Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; DTPA Organic Chemicals (Non MeSH); Organometallic Compounds; Organotechnetium Compounds Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents; DTPA (N,N-Bis(2-bis(carboxymethyl)amino)ethyl)glycinato(5-))technetate(1-)99mTc. A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents. DTPA (66-90); Organometallic Compounds (68-89); Organotechnetium Compounds (90); Technetium (66-90) A"X:a;vTechnetium Tc 99m Mertiatide D02.691.825.775; D12.644.456.805 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organotechnetium Compounds Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides (SP-5-25)-(N-(N-(N-(mercaptoacetyl)glycyl)glycyl)glycinato(5-)-N,N',N'',S)-oxotechnetate(2-)-99mTc disodium. A technetium diagnostic aid used in renal function determination. Oligopeptides (86-92); Organometallic Compounds (86-89); Organotechnetium Compounds (90-92); Technetium (86-89) Ey#&:Technetium Tc 99m Medronate D02.691.825.750; D02.705.206.885 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organotechnetium Compounds Organic Chemicals (Non MeSH); Organophosphorus Compounds; Diphosphonates A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms. Diphosphonates (77-85); Technetium (66-85) H""&:3Technetium Tc 99m Aggregated Albumin D02.691.825.375; D12.776.034.900 AAADAEAGAIANBLCFCHCLCSCTDEDUECHIIMIPMEPDPKPORESDSTTOTUULUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organotechnetium Compounds Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation. Albumins (66-84); Serum Albumin (66-84); Technetium (66-84) J,&>ITechnetium Compounds D01.925 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Sodium Pertechnetate Tc 99m; Technetium Tc 99m Pyrophosphate; Technetium Tc 99m Sulfur Colloid Inorganic compounds that contain technetium as an integral part of the molecule. Technetium (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $L 8%p`:Technetium D01.268.271.870; D01.552.850 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organotechnetium Compounds Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Metals The first artificially produced element and a radioactive fission product of URANIUM. The stablest isotope has a mass number 99 and is used diagnostically as a radioactive imaging agent. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. N"4:Tears A12.838.882 CHCYDEENIMMEMIPHPSRARERISEUSVI Lacrimal Apparatus Fluids and Secretions (Non MeSH); Secretions (Non MeSH) consider also terms at DACRYO- and LACRIMAL. Q "D7Tear Gases D05.569.734.498.697; D26.897 AEANCHCLCSECHIIPMEPDPKPORESDSTTO Chemical Warfare Agents Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Riot Control Agents, Chemical; Irritants Miscellaneous Drugs and Agents (Non MeSH) o-Chlorobenzylidenemalonitrile; omega-Chloroacetophenone o-Chlorobenzylidenemalonitrile; omega-Chloroacetophenone Gases which irritate the eyes, throat, or skin. Severe lacrimation develops upon irritation of the eyes. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $R"$z}:Teaching Materials I02.903.847; L01.178.820 ECSDST Audio-Visual Aids Education; Teaching Information Science; Communications Media (Non MeSH) Audio-Visual Aids; Textbooks Textbooks Instructional materials used in teaching. CLECHILJSDSNSTTDUT $T U.2Teaching I02.903 CLECHILJMAMTOGSNSTTD Faculty Education Education Computer User Training; Models, Educational; Patient Simulation; Programmed Instruction (+ 1); Remedial Teaching; Teaching Materials (+ 2) The educational process of instructing. CLECHIISLJMAMTOGSDSNSTTDUT (U     0Tea B06.510.911; J01.125.873 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Theophylline Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Beverages Camellia sinensis, formerly Thea sinensis. An evergreen Asiatic shrub of the Theaceae family. The leaves and flowers contain CAFFEINE, THEOPHYLLINE, oils, and tannins. The infusion of leaves of this plant is used as a beverage. W[4] Tay-Sachs Disease C10.228.140.163.300.936; C10.496.253.930; C18.452.648.556.641.803.350.896; C18.452.648.595.803.350.896; F03.709.346.250.720 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI G(M2) Ganglioside Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic; Gangliosidoses Nervous System Diseases; Mental Retardation; Gangliosidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses; Gangliosidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses; Gangliosidoses Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation; Gangliosidoses Deficiency of hexosaminidase A inherited as an autosomal recessive trait, seen mainly in Ashkenazic Jews, leading to accumulation of G(M2) ganglioside in neurons. It manifests clinically as psychomotor retardation and deterioration, blindness, cherry red spot in the macula, and death in 3-4 years. Lipoidosis (66-78)  YUL[Taxes N03.219.900 CLECHILJSNTD Economics, Organizations, Control (Non MeSH); Economics Income Tax; Tax Equity and Fiscal Responsibility Act Governmental levies on property, inheritance, gifts, etc. CLECHILJOGSNSTTDUT  ^ B@DTax Equity and Fiscal Responsibility Act N03.219.900.880 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Taxes PL97-248. Title II of the Act specifies "provisions relating to savings in health and income security programs." This includes changes in payment for services, benefits and premiums of Medicare as well as changes in provisions under Medicaid and other specific programs covered by Social Security. Title II includes various revenue measures. _1KTaurolithocholic Acid D02.455.326.146.100.850.875.925; D02.886.645.600.055.850.800.925; D04.808.221.430.622.900; D04.808.221.430.873.940; D19.316.246.175.551.935; D19.316.246.225.905.925 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Taurine; Taurocholic Acid Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Taurine; Taurocholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Lithocholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Taurocholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Chenodeoxycholic Acid; Lithocholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids; Taurocholic Acid 2-(((3 alpha,5 beta)-3-hydroxy-24-oxocholan-24-yl)amino)ethanesulfonic acid. A bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. It is a cholagogue and choleretic. Bile Acids and Salts (66-72); Lithocholic Acid (73-77); Taurine (66-72); Taurocholic Acid (73-77) b(DFwTaurodeoxycholic Acid D02.455.326.146.100.850.875.900; D02.886.645.600.055.850.800.900; D04.808.221.430.342.900; D04.808.221.430.873.920; D19.316.246.225.272.925; D19.316.246.225.905.900 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Taurine; Taurocholic Acid Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Taurine; Taurocholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Taurocholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids; Deoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids; Taurocholic Acid Taurochenodeoxycholic Acid Taurochenodeoxycholic Acid Taurochenodeoxycholic Acid Taurochenodeoxycholic Acid Taurochenodeoxycholic Acid Taurochenodeoxycholic Acid 2-(((3 alpha, 5 beta,12 alpha)-3,12-Dihydro-24-oxocholan-24-yl)amino)ethanesulfonic acid. A bile salt formed in the liver by conjugation of deoxycholate with taurine, usually as the sodium salt. It is used as a cholagogue and choleretic, also industrially as a fat emulsifier. Bile Acids and Salts (66-72); Deoxycholic Acid (73-77); Taurine (66-72); Taurocholic Acid (73-77)  h;DDwTaurocholic Acid D02.455.326.146.100.850.875; D02.886.645.600.055.850.800; D04.808.221.430.873; D19.316.246.225.905 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Taurine Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Taurine Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids Taurodeoxycholic Acid (+ 1); Taurolithocholic Acid Taurodeoxycholic Acid (+ 1); Taurolithocholic Acid Taurodeoxycholic Acid (+ 1); Taurolithocholic Acid Taurodeoxycholic Acid (+ 1); Taurolithocholic Acid 2-(((3 alpha, 5 beta,7 alpha,12 alpha)-3,7,12-Trihydroxy-24-oxocholan-24-yl)amino)ethanesulfonic acid. The product of conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and cholerectic. Bile Acids and Salts (66-72); Taurine (66-72)  nlD9Taurochenodeoxycholic Acid D02.455.326.146.100.850.875.900.875; D02.886.645.600.055.850.800.900.875; D04.808.221.430.342.300.900; D04.808.221.430.342.900.910; D04.808.221.430.873.920.900; D19.316.246.175.895; D19.316.246.225.272.925.875; D19.316.246.225.905.900.875 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Taurine; Taurocholic Acid; Taurodeoxycholic Acid Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Taurine; Taurocholic Acid; Taurodeoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid; Chenodeoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid; Taurodeoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Taurocholic Acid; Taurodeoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Chenodeoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids; Deoxycholic Acid; Taurodeoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids; Taurocholic Acid; Taurodeoxycholic Acid 2-(((3 alpha, 5 beta, 7 alpha)-3,7-Dihydroxy-24-oxocholan-24-yl)amino)ethanesulfonic acid. A bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. It acts as detergent to solubilize fats in the small intestine and is itself absorbed. It is used as a cholagogue and choleretic. Bile Acids and Salts (66-72); Chenodeoxycholic Acid (73-77); Taurine (66-72); Taurocholic Acid (73-77) tD|Taurine D02.455.326.146.100.850; D02.886.645.600.055.850 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids Taurocholic Acid (+ 3) Taurocholic Acid (+ 3) 2-Aminoethanesulfonic acid. A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids. | 6F8tau Proteins D12.776.220.600.450.510; D12.776.641.560.510 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Alzheimer's Disease Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microtubule Proteins; Microtubule-Associated Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Microtubule-Associated Proteins One of the two major classes of microtubule-associated proteins isolated from the brain. The proteins have two domains: one that binds to microtubules and a second that binds to other cell components. By binding to several unpolymerized tubulin molecules simultaneously, tau proteins speed up the nucleation process in tubulin polymerization. Chemically modified tau proteins also appear to be involved in the formation and/or composition of the NEUROFIBRILLARY TANGLES found in ALZHEIMER'S DISEASE. Microtubules (76-85); Microtubule-Associated Proteins (86-91)  2FCGTattooing E02.218.780; E05.898 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Cosmetic Techniques (Non MeSH) Miscellaneous Techniques (Non MeSH) The insertion of permanent colors in the skin by introducing them through punctures. Tattooing of the cornea is the permanent coloring of the cornea chiefly to conceal leukomatous spots. (Dorland, 27th ed.).  "]TATA Box G05.275.470.790.675.850; G05.331.599.110.689.675.850; G06.184.599.110.689.675.850 DEGEIMPHRE Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid; Promoter Regions (Genetics) Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid; Promoter Regions (Genetics) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid; Promoter Regions (Genetics) A conserved A-T rich sequence which is contained in promoters for RNA polymerase II. The segment is seven base pairs long and the nucleotides most commonly found are TATAAAA. Base Sequence (81-90); Molecular Sequence Data (88-90)  YBTaste Threshold F02.463.593.710.790; G11.561.796.724.880 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Sensory Thresholds Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Taste The minimum concentration at which taste sensitivity to a particular substance or food can be perceived. Taste (66-75) ^. |Taste Disorders C10.597.751.861; C23.888.592.763.861 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Ageusia; Dysgeusia Ageusia; Dysgeusia Taste (66-70) Q*N.Taste Buds A08.800.550.700.120.800; A09.846; A14.549.885.779 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Chemoreceptors Sense Organs Stomatognathic System; Mouth; Tongue Small sensory organs which contain gustatory receptor cells, basal cells, and supporting cells. Taste buds in humans are found in the epithelia of the tongue, palate, and pharynx. They are innervated by the CHORDA TYMPANI NERVE (a branch of the facial nerve) and the GLOSSOPHARYNGEAL NERVE. $98VTaste F02.830.816.724; G11.561.796.724 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation  Taste Threshold The sensation or perception of certain qualities of substances put in the mouth, primarily sweet, sour, salt and bitter. CLDEGEIMPHRE   &Tasmania Z01.338.680 EHEP Geographicals (Non MeSH); Australia An island south of AUSTRALIA and a state of the Commonwealth of AUSTRALIA. Australia (66-87)  ,[Task Performance and Analysis F02.784.412.846; F02.784.692.746; F02.808.600; J01.293.556.779 Workload Systems Analysis Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Human Engineering Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial Psychologic Processes and Principles (Non MeSH); Psychomotor Performance Technology, Industry, Agriculture (Non MeSH); Engineering; Human Engineering Time and Motion Studies Time and Motion Studies Time and Motion Studies; Work Simplification The detailed examination of observable activity or behavior associated with the execution or completion of a required function or unit of work.  $H |oTartronates D02.241.081.337.902; D02.241.081.844.821; D02.241.511.902.821; D09.203.811.835 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids X8Tartrazine D02.172.950; D26.408.837; D26.471.355.869 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Miscellaneous Drugs and Agents (Non MeSH); Dyes Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Coloring Agents 4,5-Dihydro-5-oxo-1-(4-sulfophenyl)-4-((4-sulfophenyl)azo)-1H-pyrazole-3-carboxylic acid, trisodium salt. An anionic, hydrophilic azo dye with an orange-yellow color used in fabrics, foods and cosmetics, and as a biological stain. Azo Compounds (69-76); Benzenesulfonates (74-76); Pyrazoles (69-76) *1.QTartrates D02.241.081.337.864; D02.241.081.844.759; D02.241.511.902.759; D09.203.811.779 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids  X8Tarsus, Animal A13.473.821 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Hindlimb +:+Tarsus A01.378.592.350.510.800 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Tarsal Bones Body Regions (Non MeSH); Extremities; Leg; Foot; Heel The region of the articulation between the foot and the leg.  (EKTarsiidae B02.649.801.400.710 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini A family of the HAPLORHINI suborder of PRIMATES, consisting of one genus, Tarsius, that inhabits southern Sumatra, Borneo, Sulawesi, and the Philippines.  (4Tarsal Tunnel Syndrome C10.772.491.821; C23.304.351.821 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tibial Nerve Nervous System Diseases; Peripheral Nervous System Diseases; Nerve Compression Syndromes Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases Compression of the posterior tibial nerve caused by thickening of the laciniate ligament or by gouty or arthritic deposits around the ankle joint leading to symptoms of pain or paresthesia over the sole of the foot. <&NTarsal Joint A02.835.583.831 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints Subtalar Joint 81Tarsal Bones A02.835.232.262.710 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tarsus Musculoskeletal System; Skeleton; Bone and Bones; Foot Bones (Non MeSH) Calcaneus; Talus The seven bones which form the tarsus - namely, CALCANEUS, TALUS, cuboid, navicular, and first, second and third cuneiforms. The tarsus is a skeletal part of the foot. Ankle (66-71); Ankle Joint (66-71) $: W,Tars D26.884 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Coal Tar; Tar-Water ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  *2,Tar-Water D26.884.850 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Tars A cold infusion of tar in water, formerly regarded as a cure-all. (Webster, 3d ed). t ,;hTape Recording L01.178.147.846; L01.240.940 CLECHIISLJMTSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids Information Science; Copying Processes Videotape Recording Videotape Recording Recording of information on magnetic or punched paper tape. ".HTanzania Z01.058.290.120.840 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern  _Tantalum D01.268.854; D01.552.842 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals  :`Tannins D09.203.408.846 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Tannic Acid AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR { >Y@Tanning J01.576.852 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry  ATannic Acid D09.203.408.846.860; D23.100.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Tannins Dermatologic Agents; Astringents A lustrous powder, yellow to light-brown in color, that is found in tree bark (particularly oak), fruits, leaves, and tea. It is used medicinally as an astringent, commercially in tanning hides, and as a dye mordant. (Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984). It is also used as a histological fixative and stain. =&:Tangier Disease C18.452.648.556.485.894 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hypolipoproteinemia A familial lipoprotein deficiency caused by a decreased synthesis and increased catabolism of the apolipoprotein components A-L and A-II (apo A-I and apo A-II) of high-density lipoproteins (HDL) (LIPOPROTEINS, HDL). HDL is absent from plasma, and the other lipoproteins are abnormal. Cholesteryl esters accumulate in the reticuloendothelial cells. It is also called analphalipoproteinemia and familial high-density lipoprotein (HDL) deficiency. It was named after the Chesapeake Bay island where the first cases were identified. (Dorland, 27th ed; Magalini, Dictionary of Medical Syndromes, 3d ed). Blood Protein Disorders (66-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77); Lipoproteins, HDL (72-77) LTampons E07.858.826 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment  3Tamoxifen D02.455.426.559.389.150.700.900; D06.347.300.760; D22.204.865 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Toremifene Toremifene Toremifene (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine. A stilbene derivative with anti-estrogen and antifertility activities. It has been used in both the treatment and prevention of breast cancer. Dimethylamines (73-74); Phenyl Ethers (74); Stilbenes (66-74)   E:v&KTalus A02.835.232.262.710.780 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Heel Musculoskeletal System; Skeleton; Bone and Bones; Foot Bones (Non MeSH); Tarsal Bones The second largest of the tarsal bones and occupies the middle and upper part of the tarsus.  :iqTalin D12.776.220.985 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins A 235-kDa cytoplasmic protein that is also found in platelets. It has been localized to regions of cell-substrate adhesion. It binds to INTEGRINS, VINCULIN, and ACTINS and appears to participate in generating a transmembrane connection between the extracellular matrix and the cytoskeleton. Blood Proteins (84-86); Contractile Proteins (82-86); Cytoskeletal Proteins (85-91); Muscle Proteins (84-86)   H^RTalc D01.524.500.850; D01.578.725.500.800; D01.837.725.700.760.535.800; D26.394.225.672.779; J01.516.213.821 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Magnesium Compounds; Magnesium Silicates Inorganic Chemicals (Non MeSH); Minerals; Silicates; Magnesium Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Magnesium Silicates Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Powders Technology, Industry, Agriculture (Non MeSH); Household Products; Cosmetics Talc (Mg3H2(SiO3)4). Finely powdered native hydrous magnesium silicate. It is used as a dusting powder, either alone or with starch or boric acid, for medicinal and toilet preparations. It is also an excipient and filler for pills, tablets, and for dusting tablet molds. (From Merck Index, 11th ed). s,gTalampicillin D20.085.099.739.762.057.897 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Ampicillin 6-((Aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid 1,3-dihydro- 3-oxo-1-isobenzofuranyl ester. A form of ampicillin that has no antibacterial action itself, but is broken down in the intestinal mucosa to yield a high level of ampicillin to the blood without affecting intestinal flora. Ampicillin (66-77); Benzofurans (66-76) :o0Takayasu's Arteritis C14.907.109.239.650; C14.907.184.800; C14.907.940.090.800; C17.800.862.875 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aortic Diseases; Aortic Arch Syndromes Cardiovascular Diseases; Vascular Diseases; Arteritis Cardiovascular Diseases; Vascular Diseases; Vasculitis; Arteritis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular A thrombo-obliterative process of the great vessels stemming from the aortic arch, occurring generally in young women. Radial and carotid pulses are typically obliterated. Skin changes are due to the disturbed circulation. There may be loss of hair and atrophy of the skin and its appendages with underlying muscle atrophy. (Andrews' Diseases of the Skin, 8th ed). TNOTajikistan Z01.252.100.900; Z01.586.200.900; Z01.586.950.900 EHEP Geographicals (Non MeSH); Asia; Asia, Central Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR \9Taiwan Z01.252.474.872 EHEP Geographicals (Non MeSH); Asia; Far East  4Tail A13.895 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) specific animal (66-67) < :Taeniasis C03.335.190.902 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Cysticercosis Parasitic Diseases; Helminthiasis; Cestode Infections Cysticercosis Infection with tapeworms of the genus Taenia. Cestode Infections (66-67) $ P?8 Taenia B01.500.736.215.895 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda Cysticercus A genus of large tapeworms. ? *;$Tacrine D03.494.046.250.900; D08.373.275.915; D14.100.120.300.915; D15.590.860; D16.050.675.870 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Central Nervous System Agents; Nootropic Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Acridines (69-74); Amines (72-74)  c: *Tachyphylaxis G12.910 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH) @  4Tachykinins D12.644.320.900; D12.644.456.800; D12.776.641.650.800; D14.600.600.860; D17.350.050.375.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Tachykinin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins Eledoisin; Kassinin; Neurokinin A; Neurokinin K; Physalaemin; Substance P Eledoisin; Kassinin; Neurokinin A; Neurokinin K; Physalaemin; Substance P Eledoisin; Kassinin; Neurokinin A; Neurokinin K; Physalaemin; Substance P Eledoisin; Kassinin; Neurokinin A; Neurokinin K; Physalaemin; Substance P Eledoisin; Kassinin; Neurokinin A; Neurokinin K; Physalaemin; Substance P A family of biologically active peptides sharing a common conserved C-terminal sequence, -Phe-X-Gly-Leu-Met-NH2, where X is either an aromatic or a branched aliphatic amino acid. Members of this family have been found in mammals, amphibians, and mollusks. Tachykinins have diverse pharmacological actions in the central nervous system and the cardiovascular, genitourinary, respiratory, and gastrointestinal systems, as well as in glandular tissues. This diversity of activity is due to the existence of three or more subtypes of tachykinin receptors. Kinins (66-88); Neuropeptides (87-88); Nerve Tissue Proteins (66-88); Oligopeptides (66-88); Peptides (66-88) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (ϻgD|FTachycardia, Ventricular C14.280.067.845.940 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia An abnormally rapid ventricular rhythm with wide QRS complexes, usually in excess of 150 per minute. It is generated within the ventricle, below the BUNDLE OF HIS, and is most commonly associated with atrioventricular dissociation. Tachycardia (66-92) NLTachycardia, Supraventricular C14.280.067.845.880 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia Accelerated Idioventricular Rhythm; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Ectopic Atrial; Tachycardia, Ectopic Junctional; Tachycardia, Sinoatrial Nodal Reentry; Tachycardia, Sinus; Torsades de Pointes A generic expression for any tachycardia that originates above the BUNDLE OF HIS. Tachycardia (66-86); Tachycardia, Paroxysmal (66-86)  "NLb>Tachycardia, Sinus C14.280.067.845.880.845 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A simple tachycardia with origin in the sinus node with gradual onset and termination. Sinoatrial Node (78-86); Tachycardia (66-86) Nnh6Tachycardia, Sinoatrial Nodal Reentry C14.280.067.845.880.840 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A tachycardia arising from the sinus node region and characterized by rates between 115 and 140 beats per minute. It is paroxysmal rather than constant. Sinoatrial Node (78-86); Tachycardia (66-86) 2,Nn6Tachycardia, Paroxysmal C14.280.067.845.695 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia Condition marked by attacks of rapid action of the heart having sudden onset and cessation. HNLnTachycardia, Ectopic Junctional C14.280.067.845.880.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A tachycardia arising in the conduction tissues surrounding the atrioventricular node. It usually occurs during myocardial infarction, after heart surgery, or in digitalis intoxication. The rate may range from 140 to 250 beats per minute. Atrioventricular Node (75-86); Heart Conduction System (66-86); Tachycardia (66-86) %NncTachycardia, Ectopic Atrial C14.280.067.845.880.315 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A tachycardia originating in the atrial myocardium and characterized by rates between 135 and 175 beats per minute. Heart Atrium (66-86); Tachycardia (66-86) C!Nn3Tachycardia, Atrioventricular Nodal Reentry C14.280.067.845.880.095 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A tachycardia characterized by rates between 150 and 250 beats per minute and a QRS complex of supraventricular origin. Atrioventricular Node (75-86); Heart Conduction System (66-74); Tachycardia (66-86); Tachycardia, Paroxysmal (66-86) 2NnTachycardia C14.280.067.845 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Tachycardia, Paroxysmal; Tachycardia, Supraventricular (+ 7); Tachycardia, Ventricular Excessive rapidity in the action of the heart. It usually displays a heart rate above 100 beats per minute. eN=dTacaribe Complex Viruses B04.820.057.070.800; B04.909.777.080.070.800 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae; Arenavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae; Arenavirus Junin Virus; Pichinde Virus Junin Virus; Pichinde Virus One of two groups of viruses in the ARENAVIRUS genus and considered part of the New World complex. It includes JUNIN VIRUS, PICHINDE VIRUS, Amapari virus, and Machupo virus among others. They are the cause of human hemorrhagic fevers mostly in Central and South America. Arboviruses (66-74)   2DATaboo F01.829.918; I01.076.201.450.897.778 CLHIPX Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Social Sciences; Anthropology; Anthropology, Cultural; Culture; Superstitions That which is forbidden; the basis for prohibition is generally religious, magical, or superstitious.  * xTablets, Enteric-Coated D26.394.225.276.695; D26.394.225.901.695 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Delayed-Action Preparations Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Tablets h.,Tablets D26.394.225.901 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Tablets, Enteric-Coated  ,MTabes Dorsalis C01.252.400.840.744.456.778; C01.252.847.840.744.456.778; C10.228.228.674.778; C10.228.854.889 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections; Syphilis; Neurosyphilis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections; Syphilis; Neurosyphilis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Neurosyphilis Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Parenchymatous neurosyphilis in which there is slowly progressive degeneration of the posterior columns and posterior roots and ganglia of the spinal cord, occurring 15 to 20 years after the initial infection of syphilis, characterized by lancinating lightning pains, urinary incontinence, ataxia, impaired position and vibratory sense, optic atrophy, hypotonia, hyperreflexia, and trophic joint degeneration (Charcot's joints). It is also called Duchenne's disease, tabetic neurosyphilis, tabes, and tabes spinalis. (Dorland, 27th ed). hP+gT-2 Toxin D02.455.849.765.850.870; D24.185.926.587.933.870 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Sesquiterpenes; Trichothecenes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins; Trichothecenes (3 alpha,4 beta,8 alpha)-12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol 4,15-diacetate 8-(3-methylbutanoate). A potent mycotoxin produced in feedstuffs by several species of the genus FUSARIUM. It elicits a severe inflammatory reaction in animals and has teratogenic effects. Ethers (75); Sesquiterpenes (74); Trichothecenes (75-76) 6@8ET-Phages B04.123.205.891 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Coliphages Bacteriophage T3; Bacteriophage T4; Bacteriophage T7 A series of 7 virulent phages which infect E. coli. The T-even phages T2, T4 (BACTERIOPHAGE T4), and T6, and the phage T5 are called "autonomously virulent" because they cause cessation of all bacterial metabolism on infection. Phages T1, T3 (BACTERIOPHAGE T3), and T7 (BACTERIOPHAGE T7) are called "dependent virulent" because they depend on continued bacterial metabolism during the lytic cycle. The T-even phages contain 5-hydroxymethylcytosine in place of ordinary cytosine in their DNA. Coliphages (66-79)   +?>T-Lymphocytopenia, Idiopathic CD4-Positive C15.378.553.546.605.800; C20.673.627.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI CD4-Positive T-Lymphocytes Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Leukopenia; Lymphopenia Immunologic Diseases; Immunologic Deficiency Syndromes; Lymphopenia Reproducible depletion of CD4+ lymphocytes below 300 per cubic millimeter in the absence of HIV infection or other known causes of immunodeficiency. This is a rare, heterogeneous syndrome and does not appear to be caused by a transmissible agent. Immunologic Deficiency Syndromes (91-93); Lymphopenia (90-93)  =0.N"HT-Lymphocytes, Suppressor-Inducer A11.118.637.555.567.569.200.800; A15.145.229.637.555.567.569.200.800; A15.382.490.555.567.569.200.800; A15.382.520.520.604.200.800 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Subpopulation of CD4+ lymphocytes which induce CD8+ suppressor T-cells (T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR) to suppress antibody production by B-cells. They also stimulate other cellular immune responses. T-Lymphocytes (83-92); T-Lymphocytes, Helper-Inducer (83-92) v&*fFT-Lymphocytes, Suppressor-Effector A11.118.637.555.567.569.220.800; A15.145.229.637.555.567.569.220.800; A15.382.490.555.567.569.220.800; A15.382.520.520.604.220.800 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Subpopulation of CD8+ T-lymphocytes which suppress antibody production or inhibit cellular immune responses. Suppressor-effector cells execute the message received from suppressor-inducer cells (T-LYMPHOCYTES, SUPPRESSOR-INDUCER). Lymphocytes (66-79); T Lymphocytes (73-79) '*f4T-Lymphocytes, Helper-Inducer A11.118.637.555.567.569.200.400; A15.145.229.637.555.567.569.200.400; A15.382.490.555.567.569.200.400; A15.382.520.520.604.200.400 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Interleukin-2; Lymphocyte Cooperation Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes; CD4-Positive T-Lymphocytes Th1 Cells; Th2 Cells Th1 Cells; Th2 Cells Th1 Cells; Th2 Cells Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Antibody Formation (72-73); T-Lymphocytes (73-82) $"*,fQ;T-Lymphocytes, Cytotoxic A11.118.637.555.567.569.220.200; A15.145.229.637.555.567.569.220.200; A15.382.490.555.567.569.220.200; A15.382.520.520.604.220.200 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cytotoxicity, Immunologic Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes; CD8-Positive T-Lymphocytes Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These cells are distinct from natural killer cells (KILLER CELLS, NATURAL) and from KILLER CELLS mediating antibody-dependent cell cytotoxicity. Cytotoxicity, Immunologic (78-82); T Lymphocytes (73-82)  [*fCT-Lymphocytes A11.118.637.555.567.569; A15.145.229.637.555.567.569; A15.382.490.555.567.569; A15.382.520.520.604 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI CD4-CD8 Ratio; Immunity, Cellular; Lymphocyte Cooperation Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes CD4-Positive T-Lymphocytes (+ 4); CD8-Positive T-Lymphocytes (+ 2); T-Lymphocyte Subsets CD4-Positive T-Lymphocytes (+ 4); CD8-Positive T-Lymphocytes (+ 2); T-Lymphocyte Subsets CD4-Positive T-Lymphocytes (+ 4); CD8-Positive T-Lymphocytes (+ 2); T-Lymphocyte Subsets CD4-Positive T-Lymphocytes (+ 4); CD8-Positive T-Lymphocytes (+ 2); T-Lymphocyte Subsets Lymphoid cells concerned with cell-mediated immunity. They originate from lymphoid stem cells that migrate from the bone marrow to the thymus and differentiate under the influence of the thymic hormones. Various subpopulations have been described. (From Dorland, 27th ed). Lymphocytes (66-72) $l*D?T-Lymphocyte Subsets A11.118.637.555.567.550.500; A11.118.637.555.567.569.500; A15.145.229.637.555.567.550.500; A15.145.229.637.555.567.569.500; A15.382.490.555.567.550.500; A15.382.490.555.567.569.500; A15.382.520.520.430.500; A15.382.520.520.604.500 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI CD4-CD8 Ratio Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Lymphocyte Subsets Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Lymphocyte Subsets Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Lymphocyte Subsets Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; Lymphocyte Subsets Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Lymphocytes/classification (77-90)  T**Szondi Test F04.711.647.622.745 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Projective Techniques A projective test using pictures of several kinds of psychiatric patients, from which the subject selects two pictures he likes most and two he likes least from six sets of pictures. The distribution of selected cards is interpreted in terms of which type of patients the subject identifies with and which traits he rejects.   Systole G09.330.800.880 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Myocardial Contraction Period of contraction of the heart, especially of the ventricles. Heart (66-78); Heart Ventricle (66-78); Myocardial Contraction (75-78) # OUSystems Theory H01.770.808 Models, Theoretical; Systems Analysis Physical Sciences (Non MeSH); Science Principles, models, and laws that apply to complex interrelationships and interdependencies of sets of linked components which form a functioning whole, a system. Any system may be composed of components which are systems in their own right (sub-systems), such as several organs within an individual organism. Systems Analysis (66-79) $-/iSystems Integration H01.770.787; L01.906.787 Physical Sciences (Non MeSH); Science Information Science; Systems Analysis The procedures involved in combining separately developed modules, components, or subsystems so that they work together as a complete system. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). &ZSystems Analysis L01.906 Task Performance and Analysis Systems Theory; Research Information Science Operations Research (+ 3); Systems Integration The analysis of an activity, procedure, method, technique, or business to determine what must be accomplished and how the necessary operations may best be accomplished. CLECHILJSDSNSTTDUT $(U $9Syringomyelia C10.228.854.833 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases *N]Syringoma C04.557.470.035.175.800; C04.557.470.550.175.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Sweat Gland Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Adnexal and Skin Appendage (Non MeSH); Adenoma, Sweat Gland A benign tumor of the sweat glands which is usually multiple and results from malformation of sweat ducts. It is uncommon and more common in females than in males. It is most likely to appear at adolescence, and further lesions may develop during adult life. It does not appear to be hereditary. (Rook et al., Textbook of Dermatology, 4th ed). Adenoma (71-93); Adenoma, Sweat Gland (66-93); Sweat Gland Neoplasms (68-93) + 6VH]Syringes E07.877 AECLCTECHISDSNSTTDUTVE Equipment and Supplies /  Syria Z01.252.245.500.795; Z01.586.500.795 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East /n *Syphilis, Latent C01.252.400.840.744.871; C01.252.847.840.744.871 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections; Syphilis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections; Syphilis 0i6P&Syphilis, Cutaneous C01.252.400.840.744.800; C01.252.825.790; C01.252.847.840.744.800; C01.539.800.720.790; C17.800.838.765.790 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections; Syphilis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections; Syphilis Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Cutaneous lesions arising from infection with Treponema pallidum. In the primary stage, 18-21 days following infection, one or more chancres appear. If untreated, the subsequent stages of the disease appear as syphilids. These eruptions are superficial, nondestructive, exanthematic, transient, macular roseolas that may later be maculopapular or papular polymorphous or scaly, pustular, pigmented eruptions.(Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p409). 2IwP)Syphilis, Congenital C01.252.400.840.744.725; C01.252.847.840.744.725; C16.614.868 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections; Syphilis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections; Syphilis Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Syphilis acquired in utero and manifested by any of several characteristic tooth (Hutchinson's teeth) or bone malformations and by active mucocutaneous syphilis at birth or shortly thereafter. Ocular and neurologic changes may also occur. 8EN{Syphilis, Cardiovascular C01.252.400.840.744.657; C01.252.847.840.744.657; C14.728 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections; Syphilis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections; Syphilis Cardiovascular Diseases ;`AP@Syphilis Serodiagnosis E01.223.495.826.895 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Fluorescent Treponemal Antibody-Absorption Test; Treponema Immobilization Test; Wassermann Reaction Serologic tests for syphilis. =m"Nq%Syphilis C01.252.400.840.744; C01.252.810.859; C01.252.847.840.744; C01.539.780.281.859 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Sexually Transmitted Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Bacterial Chancre; Neurosyphilis (+ 1); Syphilis, Cardiovascular; Syphilis, Congenital; Syphilis, Cutaneous; Syphilis, Latent Chancre; Neurosyphilis (+ 1); Syphilis, Cardiovascular; Syphilis, Congenital; Syphilis, Cutaneous; Syphilis, Latent A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  > XNXPSynovitis, Pigmented Villonodular C05.550.870.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Synovitis Outgrowths of synovial membrane composed of villi and fibrous nodules characterized histologically by hemosiderin- and lipid-containing macrophages and multinucleated giant cells. It usually occurs in the knee. Synovitis (66-77) Cv'N=Synovitis C05.550.870 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Synovitis, Pigmented Villonodular Inflammation of a synovial membrane. It is usually painful, particularly on motion, and is characterized by a fluctuating swelling due to effusion within a synovial sac. (Dorland, 27th ed). Ej N0'Synovial Membrane A02.835.583.443.800 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Membranes Musculoskeletal System; Skeleton; Joints; Joint Capsule Synovial Fluid The inner of the two layers of the articular capsule of a synovial joint, composed of loose connective tissue and having a free smooth surface that lines the joint cavity. It secretes the SYNOVIAL FLUID. (Dorland, 27th ed).  G3: C Synovial Fluid A02.835.583.443.800.800; A12.207.849 CHCYDEENIMMEMIPHPSRARERISEUSVI Musculoskeletal System; Skeleton; Joints; Joint Capsule; Synovial Membrane Fluids and Secretions (Non MeSH); Body Fluids A transparent alkaline viscid fluid, resembling the white of an egg, secreted by the SYNOVIAL MEMBRANE and contained in joint cavities, bursae, and tendon sheaths. (Dorland, 27th ed). I4*"Synovial Cyst C04.182.867; C17.300.550.867 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses Popliteal Cyst A nodular, tumorlike lesion in or about a tendon sheath or joint capsule, especially of the hands, wrists, or feet. It is not a true cyst as it lacks an epithelial wall, and it does not communicate with the underlying synovial space. The lesion represents a focal accumulation of mucin in the dermis of the dorsal aspect of the distal phalanges or, less often, other portions of the extremities. K"VzSynostosis C05.116.099.370.894; C05.660.906; C16.131.621.906 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ossification, Heterotopic Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Craniosynostoses (+ 1); Syndactyly (+ 2) Craniosynostoses (+ 1); Syndactyly (+ 2) Craniosynostoses (+ 1); Syndactyly (+ 2) A union between adjacent bones or parts of a single bone formed by osseous material, such as ossified connecting cartilage or fibrous tissue. (Dorland, 27th ed).  N49LSynephrine D02.033.329.291.870; D02.092.063.291.870; D02.092.211.215.811.875; D14.100.050.100.100.840; D16.050.870.855; D18.222.863.882 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Tyramine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Sympathetic alpha-adrenergic with actions like PHENYLEPHRINE. It is used as a vasoconstrictor in circulatory failure, asthma, nasal congestion, and glaucoma. Q>]Synechocystis Group B03.440.200.725; B05.104.400.725 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Bacteria; Gram-Negative Bacteria; Cyanobacteria Algae and Fungi (Non MeSH); Algae; Cyanobacteria A provisional assemblage of unicellular cyanobacteria that divide by binary fission in two or three successive planes at right angles to one another. Typically, the cells occur singly or in pairs. These organisms are isolated from freshwater and seawater environments. By examining morphological, physiological, and chemical properties it has been possible to subdivide this group into four "strain clusters". These clusters are equivalent to genera but have not been formalized. Cyanobacteria (71-91) U&&s-Synechococcus Group B03.440.200.700; B05.104.400.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Bacteria; Gram-Negative Bacteria; Cyanobacteria Algae and Fungi (Non MeSH); Algae; Cyanobacteria A provisional assemblage of unicellular, coccoid-to-rod-shaped CYANOBACTERIA that divide by binary fission in a single plane. Its cells lack structured sheaths and range in diameter from 0.3 to 2.3 microns. These organisms are isolated from freshwater, marine, and hot spring environments. By examining morphological, physiological, and chemical properties it has been possible to subdivide this group into six "strain clusters". These clusters are equivalent to genera but have not been formalized. Algae (66); Cyanobacteria (71-91) X&&sB*Syndrome X C14.280.647.250.125.575; C14.907.553.470.250.125.575 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease; Angina Pectoris Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease; Angina Pectoris Angina pectoris or angina-like chest pain with a normal coronary arteriogram and positive exercise test. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski, 2d ed). Angina Pectoris (77-93) \@:NKSyndrome C23.280.900 Symptoms and General Pathology (Non MeSH); Disease A symptom complex characteristic of a particular abnormality. _S >ISyndactyly C05.116.099.370.894.819; C05.660.585.800; C05.660.906.819; C16.131.621.585.800; C16.131.621.906.819 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Synostosis Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Synostosis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Synostosis Acrocephalosyndactylia; Poland Syndrome Acrocephalosyndactylia; Poland Syndrome Acrocephalosyndactylia; Poland Syndrome Acrocephalosyndactylia; Poland Syndrome Acrocephalosyndactylia; Poland Syndrome The most common congenital anomaly of the hand or foot, marked by persistence of the webbing between adjacent fingers or toes, so they are more or less completely attached. It is called complicated syndactyly if the bones or nails of the involved digits are fused. (Dorland, 27th ed). Fingers/abnormalities (66)  `oLkS Syncope C10.597.917.777; C23.888.592.925.777 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Unconsciousness Nervous System Diseases; Neurologic Manifestations; Unconsciousness Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Unconsciousness A temporary suspension of consciousness due to generalized cerebral ischemia; a faint or swoon. (Dorland, 27th ed). e *NSynchrotrons H01.671.579.705.700 CLECHIISLJSDSNSTUT Physical Sciences (Non MeSH); Physics; Nuclear Physics; Particle Accelerators Devices for accelerating protons or electrons in closed orbits where the accelerating voltage and magnetic field strength varies (the accelerating voltage is held constant for electrons) in order to keep the orbit radius constant. Particle Accelerators (78-92) g] #Synaptosomes A11.904.859 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Synapses; Synaptic Membranes Cells; Subcellular Fractions Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates. Nerve Endings (66-71); Synaptic Vesicles (70-71)  i(##G;Synaptophysin D12.776.395.550.800; D12.776.543.550.800; D12.776.641.800; D24.185.101.840.800 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological A 38-kDa integral membrane glycoprotein of the presynaptic vesicles in neuron and neuroendocrine cells. It is expressed by a variety of normal and neoplastic neuroendocrine cells and is therefore used as an immunocytochemical marker for neuroendocrine differentiation in various tumors. In ALZHEIMER'S DISEASE and other dementing disorders there is an important synapse loss due in part to a decrease of synaptophysin in the presynaptic vesicles. Membrane Proteins (77-91); Nerve Tissue Proteins (66-91) l XHDSynaptonemal Complex G04.335.135.220.531.890; G05.148.165.220.531.890; G07.553.135.220.531.890 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division; Meiosis Genetics; Cytogenetics; Cell Cycle; Cell Division; Meiosis Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division; Meiosis The three-part structure of ribbon-like proteinaceous material that serves to align and join the paired homologous chromosomes during the pachytene stage of meiotic division. It is a prerequisite for crossing-over. Cell Division (66-67); Meiosis (68-85) pQ^0Synaptic Vesicles A08.850.840; A11.195.443.780.840 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Synapses Cells; Cell Membrane; Intercellular Junctions; Synapses Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents. Cytoplasmic Granules (66-69); Synapses (66-69) t&*`8Synaptic Transmission G11.561.920 DEGEIMPHRE Gap Junctions; Neurotransmitters; Synapses Synapses Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) The communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. In chemical synaptic transmission, the presynaptic neuron releases a neurotransmitter that diffuses across the synaptic cleft and binds to specific synaptic receptors. These activated receptors modulate ion channels and/or second-messenger systems to influence the postsynaptic cell. Electrical transmission is less common in the nervous system, and, as in other tissues, is mediated by gap junctions. Neural Conduction (66-67) $v3 hBSynaptic Membranes A08.850.800; A11.195.443.780.800; A11.195.844 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Synaptosomes Nervous System; Synapses Cells; Cell Membrane; Intercellular Junctions; Synapses Cells; Cell Membrane Cell membranes associated with synapses. Both presynaptic and postsynaptic membranes are included along with their integral or tightly associated specializations for the release or reception of transmitters. Cell Membrane (66-69); Synapses (66-69)  z35*y1Synapsins D12.776.641.750; D12.776.744.840 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Phosphoproteins A family of synaptic vesicle-associated proteins involved in the short-term regulation of neurotransmitter release. Synapsin I (Protein I), the predominant member of this family, links synaptic vesicles to actin filaments in the presynaptic nerve terminal. These interactions are modulated by the reversible phosphorylation of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and calcium-calmodulin-dependent protein kinases. It is believed that these functional properties are also shared by synapsin II (Protein III). Nerve Tissue Proteins (66-91); Neuropeptides (87-91); Phosphoproteins (70-91) |} &F\Synapses A08.850; A11.195.443.780 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Gap Junctions; Synaptic Transmission; Synaptosomes Synaptic Transmission Nervous System Cells; Cell Membrane; Intercellular Junctions Neuroeffector Junction (+ 2); Presynaptic Terminals; Synaptic Membranes; Synaptic Vesicles Neuroeffector Junction (+ 2); Presynaptic Terminals; Synaptic Membranes; Synaptic Vesicles Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate through direct electrical connections which are sometimes called electrical synapses; these are not included here but rather in GAP JUNCTIONS. ABAHBSCHCLCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI ( (<H<Symptoms and General Pathology (Non MeSH) C23 Adhesions; Ascites (+ 1); Bronchoalveolar Lavage Fluid; Calculi (+ 9); Cerebrospinal Otorrhea; Cerebrospinal Rhinorrhea; Cholesteatoma (+ 1); Choristoma; Death (+ 13); Disease (+ 16); Diseases of Body Regions (Non MeSH) (+ 19); Diverticulum (+ 6); Edema; Emphysema (+ 2); Extravasation of Diagnostic and Therapeutic Materials; Fibrosis; Fistula (+ 26); Granuloma (+ 20); Growth Disorders (+ 2); Hemorrhage (+ 32); Hemosiderosis; Hernia; Intraoperative Complications (+ 1); Multiple Organ Failure; Nasal Lavage Fluid; Pathologic Processes (Non MeSH) (+ 43); Periodic Disease; Postoperative Complications (+ 16); Prolapse (+ 7); Signs and Symptoms (Non MeSH) (+ 209); Yang Deficiency; Yin Deficiency BLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGEHIIMLJMEMIMONUPAPCPHPPPSPXRARERHRIRTSCSESNSUTHTMULURUSVEVI 2MfSymphysiotomy E04.910 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pubic Symphysis Surgery, Operative  $Sympathomimetics D16.050.870; D18.222.863 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic Agonists; Adrenergic Uptake Inhibitors; Monoamine Oxidase Inhibitors; Receptors, Adrenergic Sympathetic Nervous System; Adrenergic Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Cardiovascular Agents; Cardiotonic Agents Albuterol; Amphetamine (+ 1); Benzphetamine; Chlorphentermine; Clenbuterol; Dobutamine; Dopamine; Ephedrine; Epinephrine; Etilefrine; Fenoterol; Heptaminol; Hexoprenaline; Isoetharine; Isoproterenol; Isoxsuprine; Mephentermine; Metaraminol; Methamphetamine; Methoxamine; Methylphenidate; Midodrin; Norepinephrine; Nylidrin; Octopamine; Orciprenaline; Phenmetrazine; Phentermine; Phenylephrine; Phenylpropanolamine; Prenalterol; Procaterol; Ritodrine; Synephrine; Terbutaline; Tretoquinol; Tyramine; Xamoterol Dobutamine; Dopamine; Epinephrine; Heptaminol; p-Hydroxyamphetamine; Isoproterenol; Metaraminol; Norepinephrine; Octopamine; Phenylephrine; Prenalterol; Synephrine Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. Agents that potentiate sympathetic nervous system activity by inhibiting the uptake of adrenergic transmitters (ADRENERGIC UPTAKE INHIBITORS) or by inhibiting the breakdown of transmitters (MONOAMINE OXIDASE INHIBITORS) are not included here. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (F8v6y)DSympatholytics D16.050.850 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic Antagonists; Adrenergic Neuron Agents Sympathetic Nervous System; Miotics; Adrenergic Agents; Adrenergic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Acebutolol; Alprenolol (+ 1); Atenolol; Betaxolol; Bethanidine; Bisoprolol; Bretylium Tosylate; Bupranolol; Butoxamine; Carteolol; Celiprolol; Clonidine; Debrisoquin; Dibenamine; Doxazosin; Guanabenz; Guanethidine; Guanfacine; Labetalol; Levobunolol; Methyldopa; Metipranolol; Metoprolol; Moxisylyte; Nadolol; Oxidopamine; Oxprenolol; Penbutolol; Phenoxybenzamine; Phentolamine; Pindolol; Piperoxan; Practolol; Prazosin; Propranolol; Reserpine; Sotalol; Timolol; Tolazoline; Yohimbine Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (ADRENERGIC NEURON AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (}89\J::Sympathetic Nervous System A08.800.050.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Chromaffin System; Sympathectomy; Sympatholytics; Sympathomimetics Nervous System; Peripheral Nervous System; Autonomic Nervous System Ganglia, Sympathetic (+ 2); Splanchnic Nerves; Vasomotor System (+ 1) The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $q 6MPU8Sympathetic Fibers, Postganglionic A08.663.542.075.800; A08.663.542.100.800; A08.800.050.050.050.800; A08.800.800.060.050.800; A11.671.078.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Nerve Fibers; Adrenergic Fibers Nervous System; Neurons; Nerve Fibers; Autonomic Fibers, Postganglionic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways; Autonomic Fibers, Postganglionic Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways; Autonomic Fibers, Postganglionic Cells; Neurons; Autonomic Fibers, Postganglionic Nerve fibers which project from sympathetic ganglia to synapses on target organs. Sympathetic postganglionic fibers use norepinephrine as transmitter, except for those innervating eccrine sweat glands (and possibly some blood vessels) which use acetylcholine. They may also release peptide cotransmitters. Autonomic Fibers, Postganglionic (71-93); Ganglia, Autonomic (66-70) 3(w8_PSympathectomy, Chemical E04.530.324.084.800.800 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation; Sympathectomy Sympathectomy using chemicals (e.g., 6-hydroxydopamine or guanethidine) which selectively and reversibly destroy adrenergic nerve endings while leaving cholinergic nerve endings intact. specific sympathetic nervous system term (66-81); Dopamine (66-72); Guanethidine (66-81); Hydroxydopamines (73-81); Sympathectomy (66-81); Sympathetic Nervous System (66-81) $aSympathectomy E04.530.324.084.800 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sympathetic Nervous System Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation Ganglionectomy; Sympathectomy, Chemical The removal or interruption of some part of the sympathetic nervous system for therapeutic or research purposes.  ?$ P.Symbolism (Psychology) F04.628.693 Disciplines, Tests, Therapy, Services (Non MeSH); Psychoanalytic Interpretation The unconscious associational mental process whereby one object or idea represents another and carries in disguised form emotional feelings vested in the initial object or idea. \Symbiosis G04.185.848 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) The living together of organisms of different species. M kBSydnones D03.383.548.580.693 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Oxadiazoles Molsidomine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR G 8c:Switzerland Z01.542.883 EHEP Geographicals (Non MeSH); Europe u)Swine, Miniature B02.649.077.880.800 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Swine Genetically developed small pigs for use in biomedical research. There are several strains - Yucatan miniature, Sinclair miniature, and Minnesota miniature. Swine (66-82) (3Swine Vesicular Disease C02.782.687.359.855; C22.905.850 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Animal Diseases; Swine Diseases An enterovirus infection of swine clinically indistinguishable from foot-and-mouth disease, vesicular stomatitis, and vesicular exanthema. X&JSwine Erysipelas C01.252.410.334.776; C22.331.693; C22.905.832 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Erysipelothrix Infections Animal Diseases; Erysipelothrix Infections Animal Diseases; Swine Diseases An acute and chronic contagious disease of young pigs caused by Erysipelothrix insidiosa. >5JjSwine Diseases C22.905 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases African Swine Fever; Edema Disease of Swine; Encephalomyelitis, Enzootic Porcine; Epidermitis, Exudative, of Swine; Gastroenteritis, Transmissible, of Swine; Hog Cholera; Swine Erysipelas; Swine Vesicular Disease; Vesicular Exanthema of Swine Diseases of domestic swine and of the wild boar of the genus Sus. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  E HRJSwine B02.649.077.880 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla Swine, Miniature Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. consider also terms at HOG and PORCINE.  (*)Swimming Pools G03.850.860.410.500 CLECHILJSNST Environment and Public Health (Non MeSH); Public Health; Sanitation; Public Facilities (Non MeSH) suSwimming I03.450.642.845.869 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Diving A water sport in which the body is propelled through the water by specific movement of the arms and/or the legs. AECLECEDHIINLJPHPXSNSTTD  A R Sweetening Agents D09.818; D26.456.609; J01.341.390.609 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Flavoring Agents Technology, Industry, Agriculture (Non MeSH); Food; Flavoring Agents Aspartame; Cyclamates; Saccharin Aspartame; Cyclamates; Saccharin AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU -,O.Sweet's Syndrome C17.800.229.413.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema; Erythema Nodosum Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles erythema multiforme. Sweet's syndrome may herald the appearance of leukemia. Skin Diseases (66-91) NlSweden Z01.542.808.843 EHEP Geographicals (Non MeSH); Europe; Scandinavia c 8Sweating, Gustatory C10.772.848; C17.800.805.843.350.843 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases; Hyperhidrosis Excessive sweating of the forehead, upper lip, perioral region, or sternum subsequent to ingestion of hot or spicy foods. It may also be caused by tumors or other injuries to the parotid gland, as in auriculotemporal syndrome (Frey's disease). In this condition, thought to be due to some involvement of the auriculotemporal nerve, a red area and sweating on the cheek appear in connection with eating. *NSweating Sickness C23.888.189.344.803 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Temperature Changes (Non MeSH); Fever A disease characterized by fever and profuse sweating and associated with high mortality. It occurred in epidemic form five times in the fifteenth and sixteenth centuries in England, first in 1485 and last in 1551. The disease tended to occur during the summer and early autumn, attacking the relatively affluent adult male population. The etiology was unknown. (Hunter PR. The English sweating sickness, with particular reference to the 1551 outbreak in Chester. Rev Infect Dis 1991;13(2):303-6, from abstract). DN[Sweating G07.315.232.693; G10.795.869 DEGEIMPHRE Cystic Fibrosis; Hyperhidrosis; Hypohidrosis Apocrine Glands Physiology, General (Non MeSH); Body Temperature; Body Temperature Regulation Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH)  Water Loss, Insensible   "5Sweat Glands A01.835.858; A10.336.899 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Body Regions (Non MeSH); Skin Tissue Types (Non MeSH); Exocrine Glands Apocrine Glands; Eccrine Glands Apocrine Glands; Eccrine Glands H:XLSweat Gland Neoplasms C04.588.805.776; C17.800.805.843.743; C17.800.882.743 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Skin Neoplasms Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Neoplasms Skin Neoplasms (66-67); Sweat Glands (66-67) x=X!7Sweat Gland Diseases C17.800.805.843 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases Hidradenitis (+ 1); Hyperhidrosis (+ 1); Hypohidrosis; Miliaria (+ 1); Sweat Gland Neoplasms Diseases of the sweat glands. specific sweat gland disease (66-75); Sweat Glands (66-75); Sweating (66-75) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $ģNhs&]XSweat A12.838.849 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH)  "DSwaziland Z01.058.290.175.795 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern Ǡ `Swayback C10.228.337.886; C10.772.235.500; C18.654.223.857; C22.836.886 BLCFCICLCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Demyelinating Diseases Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases Animal Diseases; Sheep Diseases Congenital locomotor ataxia of lambs, thought to be associated with copper deficiency. It is characterized clinically by progressive incoordination of the hind limbs and pathologically by disruption of neuron and myelin development in the central nervous system. It is caused by a deficiency of metabolizable copper in the ewe during the last half of her pregnancy. (Dorland, 27th ed; Stedman, 25th ed). Deficiency Diseases/veterinary (66-67); Demyelinating Diseases (66-67); Sheep Diseases (66-67) K HHGoSwainsonine D03.132.830; D22.204.179.830 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic (1S-(1 alpha,2 alpha,8 beta,8a beta))-Octahydro-1,2,8-indolizinetriol. An indolizidine alkaloid from the plant Swainsona canescens that is a potent alpha-mannosidase inhibitor. Swainsonine also exhibits antimetastatic, antiproliferative, and immunomodulatory activity. Alkaloids (80-91) ̞":/Svalbard Z01.542.808.618.650 EHEP Geographicals (Non MeSH); Europe; Scandinavia; Norway  BSutures E07.858.784 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment Catgut Ϟ 3 Suture Techniques E04.901 AECLCTECHIISMONUPXRHSNSTTDUTVE Surgery, Operative Surgical Stapling AECLCTECHIISMOMTNUPXRHSNSTTDUTVE 2 "$Suspensions D26.394.225.220.860 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Colloids Colloids with liquid continuous phase and solid dispersed phase; the term is used loosely also for solid-in-gas (AEROSOL) and other colloidal systems; water-insoluble drugs may be given as suspensions. ,YSurvivors M01.643.836 CLHILJPXSN Named Groups (Non MeSH); Patients Persons who have experienced a prolonged survival after serious disease or who continue to live with a usually life-threatening condition. ҧ +Survival Rate E05.318.308.985.550.900; G03.850.505.400.975.550.900; G03.850.520.308.985.550.900; L01.280.975.550.900; N01.224.935.698.826 TD Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Information Science; Data Collection; Vital Statistics; Mortality Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Follow-Up Studies (66-89); specific disease/mortality (66-89) SFISurvival Analysis E05.318.740.998; G03.850.520.830.998; H01.548.832.975; N05.715.360.750.795 Proportional Hazards Models Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Disease-Free Survival Disease-Free Survival Disease-Free Survival Disease-Free Survival A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. iT!bSurvival I03.784 PHPX Human Activities (Non MeSH) Continuance of life or existence especially under adverse conditions; includes methods and philosophy of survival.   "Surrogate Mothers F01.829.263.500.320.892; I01.880.225.500.340.892; M01.620.892 EDLJPXSN Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family; Parents Social Sciences; Sociology; Family; Nuclear Family; Parents Named Groups (Non MeSH); Parents Women who allow themselves to be impregnated with the understanding that the offspring are to be given over to the parents who have commissioned the surrogate. Ethics, Medical (66-85); Insemination, Artificial (66-85); Insemination, Artificial, Heterologous (75-85) ݪE zSuriname Z01.107.757.833 EHEP Geographicals (Non MeSH); America; South America A country of northern South America bordered on the west by Guyana (British Guiana) and on the east by French Guiana. It was formerly called Netherlands Guiana or Dutch Guiana. Its capital is Paramaribo. Its chief mineral resources are bauxite and gold. R <.Surgicenters N02.278.035.652; N02.278.421.556.868 CLECHILJMAMTOGSDSNSTTDUT Ambulatory Surgery Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Facilities designed to serve patients who require surgical treatment exceeding the capabilities of usual physician's office yet not of such proportion as to require hospitalization. Hospitals, Special (68-71); Surgery, Minor (66-71)  *=Surgical Wound Infection C01.539.947.692; C23.814.892 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Wound Infection Symptoms and General Pathology (Non MeSH); Postoperative Complications Infection occurring at the site of a surgical incision. "PDSurgical Wound Dehiscence C23.814.842 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Postoperative Complications Separation of the layers of a surgical wound. It may be partial and superficial only, or complete, with disruption of all layers. (Dorland, 27th ed). "NSSurgical Stapling E04.901.800 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Suture Techniques A technique of closing incisions and wounds, or of joining and connecting tissues, in which staples are used as sutures. Surgical Staplers (66-93) $-Surgical Staplers E07.858.746 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment 3Surgical Sponges E07.858.740 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment Gauze material used to absorb body fluids during surgery. Referred to as gossypiboma if accidentally retained in the body following surgery. Foreign Bodies (66-89); Surgical Equipment (66-89); Surgical Instruments (74-89) 3`Surgical Nursing G02.478.676.898; N02.421.533.892 CLECEDHIISLJMAMTOGSNSTTD Operating Room Nursing Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care Nursing care of the surgical patient before, during and after surgery. Nursing Care (66-67); Operating Rooms (66-67); Surgery, Operative (66-67)  D&UYSurgical Mesh E07.858.708 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment $3Surgical Instruments E07.858.670 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment Obstetrical Forceps 3Surgical Flaps E04.860.887; E04.936.664.890 AECLCTECHIIMISMOMTNUPAPHPXRHSNSTTDUTVE Skin Transplantation Surgery, Operative; Surgery, Plastic Surgery, Operative; Transplantation; Transplantation, Autologous Tongues of tissue (skin and subcutaneous tissue, sometimes including muscle) cut away from the underlying parts but attached at one end. They retain their own blood supply during transfer to the new site. They are used in plastic surgery for filling a defect in a neighboring region. The concept includes pedicled flaps, rotation flaps, tube flaps, etc. Skin (66-79); Surgery, Plastic (66-79); Transplantation, Autologous (66-79)  a"*tZSurgical Equipment E07.858 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Artificial Organs (+ 11); Chest Tubes; Heart-Assist Devices; Nebulizers and Vaporizers; Orthopedic Equipment (+ 18); Pessaries; Prosthesis (+ 16); Stents; Surgical Instruments (+ 1); Surgical Mesh; Surgical Sponges; Surgical Staplers; Sutures (+ 1); Tampons; Tissue Adhesives; Tissue Expanders; Trusses AEANCHCLCSCTDUECHIIPISMEMIMOMTNUPDPKPOPSPXRERHSDSNSTTDTOTUUTVEVI u mDSurgery, Veterinary G02.956.692 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Veterinary Medicine /Surgery, Urologic, Male (Non MeSH) E04.887.774.692 Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH) Circumcision; Orchiectomy; Penile Prosthesis; Prostatectomy; Vasectomy; Vasovasostomy AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI 6*`d*Surgery, Urologic (Non MeSH) E04.887.774 Surgery, Operative; Surgery, Urogenital (Non MeSH) Cystectomy; Kidney Transplantation; Nephrectomy; Surgery, Urologic, Male (Non MeSH) (+ 6); Urinary Diversion (+ 4) AECLCTECHIIMISLJMIMOMTNUPAPHPSPXRARHRISNSTTDUSUTVEVI #<8Surgery, Urogenital (Non MeSH) E04.887 Surgery, Operative Castration (+ 2); Sterilization, Sexual (+ 4); Surgery, Gynecologic (Non MeSH) (+ 4); Surgery, Urologic (Non MeSH) (+ 15) AECLCTECHIIMISLJMIMOMTNUPAPHPSPXRARHRISNSTTDUSUTVEVI % 8Surgery, Plastic E04.860; G02.403.810.788 AECLECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE Surgery, Operative Health Occupations; Medicine; Specialties, Surgical Chemexfoliation; Dermabrasion; Lipectomy; Mammaplasty; Rhinoplasty; Rhytidoplasty; Scleroplasty; Surgical Flaps; Tissue Expansion The branch of surgery concerned with restoration, reconstruction, or improvement of defective, damaged, or missing structures. AECLCTECEDHIIMISLJMAMOMTNUOGPAPHPXRHSNSTTDUTVE   *R2Surgery, Otorhinolaryngologic (Non MeSH) E04.847 Surgery, Operative Adenoidectomy; Laryngectomy; Pharyngectomy; Pharyngostomy; Radical Neck Dissection; Rhinoplasty; Surgery, Ear (Non MeSH) (+ 9); Tonsillectomy; Tracheostomy; Tracheotomy AECLCTECHIISMIMOMTNUPSPXRHSDSNSTTDUTVEVI C/ ,Surgery, Oral, Preprosthetic E04.833.800; E06.892.800 AECLCTECHIISMAMOMTNUPXRHSNSTTDUTVE Prosthodontics; Mouth, Edentulous Surgery, Operative; Surgery, Oral Dentistry; Surgery, Oral Alveolar Ridge Augmentation; Alveolectomy; Alveoloplasty; Dental Implantation (+ 5); Vestibuloplasty Alveolar Ridge Augmentation; Alveolectomy; Alveoloplasty; Dental Implantation (+ 5); Vestibuloplasty Surgery necessary for a denture to rest on a firm base, free from marked osseous protuberances or undercuts, and devoid of interfering muscle attachments, excess mucoperiosteum, hyperplasias, and fibrous or papillary growths. Dental Prosthesis (66-79); Mouth/surgery (66-79); specific dental prosthesis (66-79); specific oral surgery heading (66-79); Surgery, Oral (66-79) AECLCTECHIISMAMIMOMTNUPSPXRHSDSNSTTDUTVEVI ("&(F.Surgery, Oral E04.833; E06.892; G02.163.876.886 CLCTECEDHIISLJMAMTNUOGPXRHSNSTTDUT Dentistry, Operative Mouth Surgery, Operative Dentistry Health Occupations; Dentistry; Specialties, Dental Apicoectomy; Gingivectomy; Gingivoplasty; Glossectomy; Mandibular Prosthesis; Maxillofacial Prosthesis; Surgery, Oral, Preprosthetic (+ 10); Tooth Extraction; Tooth Replantation Apicoectomy; Gingivectomy; Gingivoplasty; Glossectomy; Mandibular Prosthesis; Maxillofacial Prosthesis; Surgery, Oral, Preprosthetic (+ 10); Tooth Extraction (+ 1); Tooth Replantation A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region. AECLCTECEDHIISLJMAMIMOMTNUOGPSPXRHSDSNSTTDUTVEVI (|)& \4Surgery, Operative E04 AECLCTECMOMTNUPXRHSNSTTDUTVE Intraoperative Complications; Operating Rooms; Postoperative Complications; Reoperation Ambulatory Surgery; Anastomosis, Surgical (+ 22); Assisted Circulation (+ 3); Biopsy; Cryosurgery; Curettage (+ 2); Debridement; Diagnosis, Surgical; Dissection; Drainage (+ 1); Electrosurgery; Extracorporeal Circulation (+ 11); Hemostasis, Surgical; Intraoperative Care; Intraoperative Monitoring; Intraoperative Period; Laparotomy; Laser Surgery (+ 3); Ligation; Lymph Node Excision (+ 1); Mastectomy (+ 6); Microsurgery (+ 2); Neurosurgery (+ 29); Orthopedics (+ 22); Ostomy (+ 17); Pelvic Exenteration; Postoperative Care; Postoperative Period (+ 1); Preoperative Care (+ 1); Prosthesis (+ 18); Reoperation; Splenectomy; Surgery, Cardiovascular (Non MeSH) (+ 40); Surgery, Digestive System (Non MeSH) (+ 37); Surgery, Elective; Surgery, Endocrine (Non MeSH) (+ 9); Surgery, Eye (Non MeSH) (+ 20); Surgery, Laparoscopic (+ 1); Surgery, Minor; Surgery, Ob-Gyn (Non MeSH) (+ 26); Surgery, Oral (+ 19); Surgery, Otorhinolaryngologic (Non MeSH) (+ 19); Surgery, Plastic (+ 9); Surgery, Urogenital (Non MeSH) (+ 29); Suture Techniques (+ 1); Symphysiotomy; Thoracic Surgery (+ 30); Transplantation (+ 29) AEBSCLCTECEDHIIMIRISLJMAMIMOMTNUOGPAPHPPPSPXRARHRISDSNSTSUTDUSUTVEVI  d0HSurgery, Obstetrical (Non MeSH) E04.819.774 Surgery, Operative; Surgery, Ob-Gyn (Non MeSH) Abortion, Induced (+ 5); Delivery (+ 10) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE  U&84$Surgery, Ob-Gyn (Non MeSH) E04.819 Surgery, Operative Surgery, Gynecologic (Non MeSH) (+ 7); Surgery, Obstetrical (Non MeSH) (+ 17) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE  =! ^$Surgery, Minor E04.806 CLECEDHIISLJMAMTOGPXRHSNSTTD Surgery, Operative  %  Surgery, Lung (Non MeSH) E04.920.800 Surgery, Operative; Thoracic Surgery Collapse Therapy (+ 1); Lung Transplantation (+ 1); Pneumonectomy; Pneumonolysis AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE  ,b2Surgery, Laparoscopic E01.418.784; E04.799 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Diagnosis; Endoscopy Surgery, Operative Cholecystectomy, Laparoscopic Cholecystectomy, Laparoscopic Surgery performed with the use of a laparoscope. Endoscopy (66-92); Laparoscopy (73-92)   $/B</Surgery, Gynecologic (Non MeSH) E04.819.608; E04.887.690 Surgery, Operative; Surgery, Ob-Gyn (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH) Dilatation and Curettage (+ 1); Hysterectomy (+ 1); Ovariectomy; Salpingostomy; Sterilization, Tubal Hysterectomy; Ovariectomy; Salpingostomy; Sterilization, Tubal AECLCTECHIISMOMTNUPXRHSNSTTDUTVE  &r$Surgery, Eye (Non MeSH) E04.792 Surgery, Operative Cataract Extraction (+ 1); Corneal Transplantation (+ 2); Dacryocystorhinostomy; Eye, Artificial; Eye Enucleation; Eye Evisceration; Filtering Surgery (+ 2); Keratotomy, Radial; Lenses, Intraocular; Light Coagulation (+ 1); Orbit Evisceration; Scleral Buckling; Scleroplasty; Vitrectomy AECLCTECHIIMISLJMIMOMTNUPAPHPSPXRARHRISNSTTDUSUTVEVI  S8Surgery, Endocrine (Non MeSH) E04.779 Surgery, Operative Adrenalectomy; Castration (+ 2); Hypophysectomy (+ 1); Islets of Langerhans Transplantation; Parathyroidectomy; Thyroidectomy AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE $ 2Surgery, Elective E04.772 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Surgery which could be postponed or not done at all without danger to the patient. Elective surgery includes procedures to correct non-life-threatening medical problems as well as to alleviate conditions causing psychological stress or other potential risk to patients, e.g., cosmetic or contraceptive surgery. Surgery, Operative (66-93)  $g Surgery, Ear (Non MeSH) E04.847.774 Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) Cochlear Implant; Endolymphatic Shunt; Fenestration; Middle Ear Ventilation; Myringoplasty; Ossicular Replacement Prosthesis; Stapes Surgery (+ 1); Tympanoplasty AECLCTECHIISMIMOMTNUPSPXRHSDSNSTTDUTVEVI F,Surgery, Digestive System (Non MeSH) E04.765 Surgery, Operative Anastomosis, Roux-en-Y; Appendectomy; Biliary Tract Surgery (+ 8); Biliopancreatic Diversion; Colectomy (+ 1); Enterostomy (+ 5); Esophagectomy; Esophagoplasty; Esophagostomy; Fundoplication; Gastrectomy; Gastroenterostomy (+ 1); Gastroplasty; Gastrostomy; Hepatectomy; Jejunoileal Bypass; Liver Transplantation; Pancreas Transplantation; Pancreatectomy; Pancreaticoduodenectomy; Pancreaticojejunostomy; Peritoneovenous Shunt AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE l, 2Surgery, Cardiovascular (Non MeSH) E04.752 Surgery, Operative Heart Surgery (+ 16); Reperfusion (+ 1); Vascular Surgery (+ 20) AECLCTECEDHIIMISLJMAMIMOMTNUOGPAPHPSPXRARHRISDSNSTTDUSUTVEVI ) R@Surgery Department, Hospital N02.278.354.422.750; N04.452.442.422.750 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which administers all departmental functions and the provision of surgical, diagnostic, and therapeutic services. ". Surgery G02.403.810.762 EDHILJMAOGTD Health Occupations; Medicine; Specialties, Surgical A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities. + =Surface-Active Agents D26.866 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Pulmonary Surfactants Miscellaneous Drugs and Agents (Non MeSH) Antifoaming Agents; Detergents (+ 5); Dioctyl Sulfosuccinates; Immunosorbents; Polyethylene Glycols (+ 5); Sodium Dodecyl Sulfate; Sodium Tetradecyl Sulfate; Wetting Agents Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $B ,2:Surface Tension H01.181.529.875.816 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Surface Properties  -`Surface Properties H01.181.529.875 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Adhesiveness; Capillarity; Surface Tension; Wettability  IBSuramin D02.886.645.600.080.050.650.750; D04.615.638.555.750; D21.201.287.805; D21.370.884.741; D22.204.833 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Naphthalenesulfonates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Naphthalenesulfonates Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From Drug Evaluations Annual, 1992, p.1643) It has also been shown to have potent antineoplstic properties. ! o:xSural Nerve A08.800.800.720.450.760.820.820 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Lumbosacral Plexus; Sciatic Nerve; Tibial Nerve A branch of the tibial nerve which supplies sensory innervation to parts of the lower leg and foot. Leg/innervation (66-70); Spinal Nerves (66-70) &&#8y9Suprofen D02.241.223.701.700; D08.373.310.850; D16.850.015.050.880; D17.025.030.850; D17.050.030.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylpropionates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid. An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It inhibits prostaglandin synthesis and has been proposed as an anti-arthritic. Benzene Derivatives (68-73); Phenylpropionates (74-77); Propionates (66-73); Thiophenes (66-77) ' g:qSupratentorial Neoplasms C04.588.614.250.195.885; C10.228.140.211.885; C10.228.250.195.885; C10.551.250.195.885 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Neoplasms located above the tentorium cerebelli, a fold of dura mater separating the cerebellum from the cerebral cortex occipital and temporal lobes. Brain Neoplasms (66-88) ,`XSupraoptic Nucleus A08.186.211.730.385.357.342.650 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Anterior Hypothalamic nucleus overlying the beginning of the optic tract. 0#8MSupranuclear Palsy, Progressive C10.228.140.079.882; C10.228.140.380.220.882; F03.709.508.460.245.230.770; F03.709.680.610.392.360.882 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia; Dementia, Senile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Senile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Senile A progressive neurological disease usually of the fifth decade characterized by supranuclear ophthalmoplegia especially paralysis of downward gaze, pseudobulbar palsy, gait disturbance, dysathria, truncal dystonia, memory and personality deterioration, and dementia. Ophthalmoplegia (79-86); Paralysis (66-86); Paralysis, Bulbar (66-86) 2 %pFA-SSuprachiasmatic Nucleus A08.186.211.730.385.357.342.625 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Anterior An ovoid densely packed collection of small cells of the anterior hypothalamus lying close to the midline in a shallow impression of the optic chiasm. Hypothalamus (66-82) 6#8Suppuration C01.539.830; C23.739.487.856 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation Abscess (+ 11); Cellulitis; Empyema (+ 3) Abscess; Cellulitis; Empyema The formation of pus. (Dorland, 27th ed). 8"PX6Suppressor Factors, Immunologic D24.611.350.480.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Proteins, protein complexes, or glycoproteins secreted by suppressor T-cells that inhibit either subsequent T-cells, B-cells, or other immunologic phenomena. Some of these factors have both histocompatibility (I-J) and antigen-specific domains which may be linked by disulfide bridges. They can be elicited by haptens or other antigens and may be mass-produced by hybridomas or monoclones in the laboratory. Lymphokines (66-85); Suppressor Cells (79-85) :%Fw7Suppression, Genetic G05.632.890 DEGEIMPHRE Genes, Suppressor; Mutation Genetics; Mutation The restoration of the wild-type phenotype in an organism possessing a mutationally altered genotype. The effects of the mutation may be suppressed by a second "suppressor" mutation on a different gene, by a suppressor mutation on the same gene but located at a distance from the site of the primary mutation, or by the presence of a cytoplasmic suppressor due to a change in non-chromosomal DNA. Genes (66-67); Genes, Suppressor (68-79)  ="2Suppositories D26.394.225.821 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Administration, Rectal Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms @f,MSupine Position G11.427.818.625 PH Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Posture The posture of an individual lying face up. Posture (66-91); Supination (88-91) AA|7,Supination G11.427.614.780 PH Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement Applies to the movements of the forearm in turning the palm forward or upward and when applied to the foot, a combination of adduction and inversion of the foot. Movement (66-87); Posture (66-87) Bt}*Superstitions I01.076.201.450.897 HIPX Social Sciences; Anthropology; Anthropology, Cultural; Culture Magic (+ 1); Taboo A belief or practice which lacks adequate basis for proof; an embodiment of fear of the unknown, magic, and ignorance. CLHIPX  D+J Superoxides D01.248.497.158.685.750.850; D01.339.650; D01.650.550.750.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Respiratory Burst Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Oxides; Peroxides Inorganic Chemicals (Non MeSH); Free Radicals Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Peroxides Highly reactive compounds produced when oxygen is reduced by a single electron. In biological systems, they may be generated during the normal catalytic function of a number of enzymes and during the oxidation of hemoglobin to methemoglobin. In living organisms, SUPEROXIDE DISMUTASE protects the cell from the deleterious effects of superoxide. Anions (74); Oxygen (74)  EE8!Superoxide Dismutase D08.586.682.881 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An oxidoreductase that catalyzes the reaction between superoxide anions and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. EC l.l5.l.l. Oxidoreductases (66-72) HFXSuperovulation E05.820.150.890; G08.520.440.508.768 BLCFDEEHGEIMMEPHPXREUR Miscellaneous Techniques (Non MeSH); Reproduction Techniques; Breeding Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle; Ovulation Occurrence or induction of release of more ova than are normally released at the same time in a given species. The term applies to both animals and humans. J*Superior Vena Cava Syndrome C14.907.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vena Cava, Superior Cardiovascular Diseases; Vascular Diseases Obstruction of the superior vena cava caused by neoplasm, thrombosis, aneurysm, or external compression and causing suffusion and/or cyanosis of the face, neck, and upper arms. Thrombosis (66-85); Vascular Diseases (66-85); Vena Cava, Superior (66-85)  L"N2ZSuperior Mesenteric Artery Syndrome C06.405.469.275.395.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mesenteric Artery, Superior Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Duodenal Diseases; Duodenal Obstruction Duodenal obstruction caused by compression of the third part of the duodenum by the root of the intestinal mesentery which contains the superior mesenteric artery, vein, and nerve. Duodenal Obstruction (66-79); Mesenteric Arteries (66-79)  O *N!DSuperior Colliculus A08.186.211.132.659.237.816 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon; Corpora Quadrigemina Corpora Quadrigemina (66-70) Q8q"Superior Cervical Ganglion A08.340.315.350.850; A08.800.050.300.300.850; A08.800.050.800.300.850 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Autonomic; Ganglia, Sympathetic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Ganglia, Autonomic; Ganglia, Sympathetic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Sympathetic Nervous System; Ganglia, Sympathetic The largest and uppermost of the paravertebral sympathetic ganglia. Ganglia, Autonomic (66-79); Ganglia, Sympathetic (80-93) R M8SPCSuperinfection C01.539.597.880; C02.597.880; C03.684.880 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Drug Resistance, Microbial Bacterial and Fungal Diseases (Non MeSH); Infection; Opportunistic Infections Virus Diseases; Opportunistic Infections Parasitic Diseases; Opportunistic Infections A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies. Cell Line (69-88); Cells, Cultured (74-77,85-88); Drug Resistance, Microbial (66-88); Tissue Culture (67-80)  U]1P Superfetation G08.520.800.608 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple Y _Superego F01.752.747.859; F02.739.794.881 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory The component of the personality associated with ethics, standards, and self-criticism - the "conscience". It is derived mainly from identification with parents and parent substitutes. Y &Superantigens D24.611.216.820 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Apoptosis; Clonal Anergy; Receptors, Antigen, T-Cell, alpha-beta Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Minor Lymphocyte Stimulatory Antigens Microbial antigens that have in common an extremely potent activating effect on T-cells that bear a specific variable region. Superantigens cross-link the variable region with class II MHC proteins regardless of the peptide binding in the T-cell receptor's pocket. The result is a transient expansion and subsequent death and anergy of the T-cells with the appropriate variable regions. specific antigens (89-93) $[6Lg,Sunstroke C21.866.486.691 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sunburn Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Heat Exhaustion A condition produced by exposure to the sun, and marked by convulsions, coma, and a high temperature of the skin. It is distinguished from heatstroke (HEAT EXHAUSTION) which is caused by excessive heat, natural or artificial, and is marked by dry skin, vertigo, headache, thirst, nausea and muscular cramps. (From Dorland, 27th ed). _  N eSunscreening Agents D23.695; D26.313.855; D26.763.750; J01.516.213.690 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Sunburn Dermatologic Agents Miscellaneous Drugs and Agents (Non MeSH); Cosmetics Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents Technology, Industry, Agriculture (Non MeSH); Household Products; Cosmetics 4-Aminobenzoic Acid; Zinc Oxide 4-Aminobenzoic Acid; Zinc Oxide Chemical or physical agents that protect the skin from sunburn and erythema by absorbing or blocking ultraviolet radiation. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $a<, N:Sunlight G03.230.300.100.725.525 AE Heliotherapy Light Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather Infrared Rays; Ultraviolet Rays AECLDUHITU $dg  u'Sunburn C17.800.600.725; C21.866.200.855 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sunscreening Agents; Sunstroke Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Photosensitivity Disorders Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Burns An injury to the skin causing erythema, tenderness, and sometimes blistering and resulting from excessive exposure to the sun. The reaction is produced by the ultraviolet radiation in sunlight. e &L%Sumatriptan D02.065.884.750; D02.886.590.700.750; D03.438.473.880; D14.100.850.800.800; D18.793.865 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Cardiovascular Agents; Vasoconstrictor Agents A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraines. Indoles (88-93); Sulfonamides (88-93) gc:|.Sulpiride D02.065.277.866; D02.241.223.106.162.866; D14.100.150.175.875; D15.085.025.850; D15.150.850; D15.210.950.040.850; D15.700.122.050.850; D15.700.872.331.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed). k* :XSuloctidil D02.033.329.624.890; D02.092.063.624.890; D18.918.851 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Cardiovascular Agents; Vasodilator Agents (R*,S*)-4-((1-Methylethyl)thio)-alpha-(1-(octylamino)ethyl)benzenemethanol. A smooth muscle relaxant that also has anticoagulant properties and affects lipid metabolism. Amino Alcohols (66-73); Propanolamines (74-79) pS=:8Sulindac D04.615.486.875; D08.373.310.840; D16.850.015.050.870; D17.025.030.840; D17.050.030.840 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Indenes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal (Z)-5-Fluoro-2-methyl-1-((4 (methylsulfinyl)phenyl)methylene) 1H-indene-3-acetic acid. A sulfinylindene derivative whose sulfinyl moiety is converted in vivo to an active anti-inflammatory analgesic which undergoes enterohepatic circulation to maintain constant blood levels without causing gastrointestinal side effects. Benzene (66-67); Benzene Derivatives (68-74); Benzylidene Compounds (75-78); Indenes (66-78) r c:koSulfurtransferases D08.586.913.820 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Thiosulfate Sulfurtransferase Enzymes which transfer sulfur atoms to various acceptor molecules. EC 2.8.1. Transferases (66-71)  x8FU"\Sulfuric Acids D01.029.260.877.800; D01.875.800.800; D02.886.645.655 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Sulfur Acids Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Tetrathionic Acid Sulfates (+ 7); Tetrathionic Acid Sulfuric Acid Esters Inorganic and organic derivatives of sulfuric acid (H2SO4). The salts and esters of sulfuric acid are known as SULFATES and SULFURIC ACID ESTERS respectively. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  y=8W:Sulfuric Acid Esters D02.886.645.655.850 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids Organic esters of sulfuric acid. |8k)Sulfur-Reducing Bacteria B03.900 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Desulfovibrio (+ 1) A group of gram-negative, anaerobic bacteria that is able to oxidize acetate completely to carbon dioxide using elemental sulfur as the electron acceptor. } " Sulfur Radioisotopes D01.496.749.858; D01.496.868.690 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Sulfur Isotopes Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes. >&4Sulfur Oxides D01.650.550.850; D01.875.825 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Sulfur Dioxide Sulfur Dioxide Inorganic oxides of sulfur. Oxides (66-74); Sulfur (66-74)  "8$#'Sulfur Isotopes D01.496.868 Inorganic Chemicals (Non MeSH); Isotopes Sulfur Radioisotopes Stable sulfur atoms that have the same atomic number as the element sulfur, but differ in atomic weight. S-33, 34, and 36 are stable sulfur isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 24Sulfur Hexafluoride D01.303.350.300.900; D01.362.820; D01.875.812 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Fluorine Compounds; Hydrofluoric Acid; Fluorides Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Sulfur hexafluoride. An inert gas used mainly as a test gas in respiratory physiology. Other uses include its injection in vitreoretinal surgery to restore the vitreous chamber and as a tracer in monitoring the dispersion and deposition of air pollutants. Fluorides (66-79); Gases (66-79); Sulfur (66-79) !58-=Sulfur Dioxide D01.362.810; D01.650.550.850.925; D01.875.825.925; D05.284.101.143.815 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Sulfur Oxides Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Oxides Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants; Air Pollutants, Environmental Sulfur dioxide. A highly toxic, colorless, nonflammable gas. It is an environmental air pollutant.  P8tvSulfur Compounds (Non MeSH) D01.875; D02.886 Inorganic Chemicals (Non MeSH) Organic Chemicals (Non MeSH) Hydrogen Sulfide (+ 3); Sulfites (+ 1); Sulfur Acids (+ 13); Sulfur Hexafluoride; Sulfur Oxides (+ 1); Technetium Tc 99m Sulfur Colloid Isothiocyanates (+ 4); Sulfhydryl Compounds (+ 14); Sulfides (+ 2); Sulfones (+ 60); Sulfonium Compounds; Sulfoxides (+ 1); Sulfur Acids (+ 38); Thioamides (+ 1); Thiocarbamates (+ 10); Thiocyanates; Thiones; Thiosemicarbazones (+ 2); Thiourea (+ 11) Inorganic or organic compounds that contain sulfur as an integral part of the molecule. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR "FiFSulfur Acids D01.029.260.877; D01.875.800; D02.886.645 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Sulfinic Acids; Sulfonic Acids (+ 1); Sulfuric Acids (+ 1) Sulfinic Acids; Sulfonic Acids (+ 1); Sulfuric Acids (+ 9) Sulfenic Acids; Sulfinic Acids; Sulfonic Acids (+ 33); Sulfuric Acids (+ 1) Inorganic or organic acids that contain sulfur as an integral part of the molecule. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  18eFSulfur D01.268.185.900 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Chalcogens (Non MeSH) Sulfur. An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight 32.066. It is found in the amino acids cysteine and methionine.  :MSulfoxides D02.886.640 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Dimethyl Sulfoxide Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans (analogous to the ketones). (From Hackh's Chemical Dictionary, 4th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8F:Sulfotransferases D08.586.913.815 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Arylsulfotransferase Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2. Sulfurtransferases (66-88)  FUSulfonylurea Compounds D02.886.590.795; D02.948.828 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones Organic Chemicals (Non MeSH); Urea Acetohexamide; Carbutamide; Chlorpropamide; Gliclazide; Glipizide; Glyburide; Tolazamide; Tolbutamide Acetohexamide; Carbutamide; Chlorpropamide; Gliclazide; Glipizide; Glyburide; Tolazamide; Tolbutamide Hypoglycemic Agents (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  "8}!:Sulfonium Compounds D02.675.800; D02.886.620 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Onium Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Sulfur compounds in which the sulfur atom is attached to three organic radicals and an electronegative element or radical. Onium Compounds (68-74) 8|Sulfonic Acids D01.029.260.877.740; D01.875.800.740; D02.886.645.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Sulfur Acids Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Thiosulfonic Acids Thiosulfonic Acids Alkanesulfonic Acids (+ 13); Arylsulfonic Acids (+ 17); Thiosulfonic Acids Inorganic or organic oxy acids of sulfur which contain the RSO2(OH) radical. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  =8]FSulfones D02.886.590 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Dansyl Compounds; Dapsone (+ 1); Phenylmethylsulfonyl Fluoride; Sulfonamides (+ 38); Sulfonylurea Compounds (+ 8); Tosyl Compounds (+ 7) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8F:Sulfonamides D02.065.884; D02.886.590.700; D20.890 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones Anti-Infective Agents Benzolamide; Bumetanide; Chloramines; Chlorthalidone; Clopamide; Indapamide; Mafenide; Mefruside; Metolazone; Probenecid; Sulfanilamides (+ 24); Sulfasalazine; Sumatriptan; Xipamide Benzolamide; Bumetanide; Chloramines; Chlorthalidone; Clopamide; Indapamide; Mafenide; Mefruside; Metolazone; Probenecid; Sulfanilamides (+ 24); Sulfasalazine; Sumatriptan; Xipamide Mafenide; Sulfanilamides (+ 23); Sulfasalazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR R-8:Sulfolobus acidocaldarius B03.107.750.750.750.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Sulfolobales; Sulfolobaceae; Sulfolobus A species of aerobic, chemolithotrophic archaeobacteria consisting of coccoid cells that utilize sulfur as an energy source. The optimum temperature for growth is 70-75 degrees C. These bacteria are isolated from acidic fields. Bacteria (73-91) "N Sulfolobus B03.107.750.750.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Sulfolobales; Sulfolobaceae Sulfolobus acidocaldarius A genus of aerobic, chemolithotrophic, coccoid archaeobacteria whose organisms are thermoacidophilic. Its cells are highly irregular in shape, often lobed, but occasionally spherical. It has worldwide distribution with organisms isolated from hot acidic soils and water. Sulfur is used as an energy source. Bacteria (72-91)  "@dSulfolobales B03.107.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria Sulfolobaceae (+ 2) An order of aerobic or facultatively aerobic, chemolithotrophic, coccoid archaeobacteria whose organisms are extreme thermoacidophiles. These bacteria lack peptidoglycan in their cell walls. "Sulfolobaceae B03.107.750.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Sulfolobales Sulfolobus (+ 1) A family of aerobic or facultatively anaerobic, chemolithotrophic archaeobacteria. Most genera consist of coccoid cells that occur singly. These bacteria grow best at a pH of about 2. Q"/Sulfobromophthalein D26.408.646.600.773 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes; Phthalein Dyes; Phenolphthaleins .bSulfites D01.248.497.158.904; D01.875.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Dithionite Dithionite Inorganic salts of sulfurous acid.  &8+Sulfite Reductases D08.586.682.868 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Hydrogen sulfide:(acceptor) oxidoreductases. Enzymes which reversibly catalyze the oxidation of hydrogen sulfide in the presence of various acceptors to sulfite and a reduced acceptor. EC 1.8.1.2 utilizes NADP+ as the acceptor. EC 1.8.7.1 utilizes oxidized ferredoxin as acceptor and EC 1.8.99.1 will utilize a variety of acceptors. Oxidoreductases (66-78); Sulfites (66-78) FX2Sulfite Oxidases D08.586.682.864 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases A molybdohemoprotein which catalyzes the terminal reaction in the oxidative degradation of sulfur-containing amino acids with the formation of a sulfate. Cytochrome c, ferricyanide and molecular oxygen can act as acceptors. A deficiency is manifested by brain damage and mental deterioration. EC 1.8.2.1 utilizes ferricytochrome C as acceptor. EC 1.8.3.1 uses molecular oxygen. Oxidoreductases (66-78); Sulfites (66-78) FX2Sulfisoxazole D02.065.884.725.945; D02.886.590.700.725.945; D20.890.725.945 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide. One of the antibacterial sulfonamides generally used for treatment of infections. It is bacteriostatic against a wide range of gram- negative and gram-positive organisms, but acquired resistance is common. E:,Sulfisomidine D02.065.884.725.940; D02.886.590.700.725.940; D20.890.725.940 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides rE:Sulfinpyrazone D03.383.694.700.800; D17.050.337.900.725 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Phenylbutazone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants; Uricosuric Agents A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. .: Sulfinic Acids D01.029.260.877.700; D01.875.800.700; D02.886.645.585 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Sulfur Acids Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Any of the monobasic inorganic or organic acids of sulfur with the general formula RSO(OH). (From McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed). r=8Sulfides D01.248.497.158.874; D01.875.350.850; D02.886.520 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Hydrogen Sulfide Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Disulfides Disulfides (+ 1) Disulfides (+ 1) Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   986:Sulfhydryl Reagents D08.373.830; D26.550.844 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Arsenicals; 4-Chloromercuribenzenesulfonate; Chloromercurinitrophenols; Diamide; Dithiothreitol (+ 1); Ethylmaleimide; Iodoacetates (+ 1); Mercuribenzoates (+ 2) 4-Chloromercuribenzenesulfonate; Diamide; Nitroprusside Sulfhydryl Compounds/antagonists and inhibitors (68-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ,@:Sulfhydryl Compounds D02.886.489 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) Dimercaprol (+ 1); Ergothioneine; Mercaptoethanol; Mercaptoethylamines (+ 1); 3-Mercaptopropionic Acid; 6-Mercaptopurine; Mesna; Methimazole; Pantetheine; Succimer; Thioglycolates; Thiomalates Compounds containing the -SH radical. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  %:F.<Sulfhydrases D08.586.520.844 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases CFOSulfhemoglobinemia C15.378.896 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases A morbid condition due to the presence of sulfmethemoglobin in the blood. It is marked by persistent cyanosis, but the blood count does not reveal any special abnormality in the blood. It is thought to be caused by the action of hydrogen sulfide absorbed from the intestine. (Stedman, 25th ed). NJaSulfhemoglobin D12.776.124.400.877; D12.776.422.512.865 AAADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins [.BSulfenic Acids D02.886.645.575 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids Oxy acids of sulfur with the general formula RSOH, where R is an alkyl or aryl group such as CH3. They are often encountered as esters and halides. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). 8X Sulfatides D10.516.390.470.213.772; D10.516.808.530.288.772 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids; Cerebrosides Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids; Cerebrosides Cerebrosides (66-70) ǥ68Sulfathiazoles D02.065.884.725.935; D02.886.590.700.725.935; D03.383.871.725; D20.890.725.935 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Anti-Infective Agents; Sulfonamides; Sulfanilamides Sulfamethizole Sulfamethizole Sulfamethizole ?X8P3Sulfates D01.248.497.158.845; D01.875.800.800.850 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids Thiosulfates Alum Compounds; Ammonium Sulfate; Barium Sulfate; Calcium Sulfate; Magnesium Sulfate; Thiosulfates (+ 1) Inorganic salts of sulfuric acid. ˇ .8*Sulfate Adenylyltransferase D08.586.913.696.445.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases ATP:Sulfate adenylyltransferase. Catalyzes the activation of sulfate ions by ATP to form adenosine-5'-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4. Adenosine Triphosphate (66-78); Nucleotidyltransferases (66-78); Sulfates (66-78); Transferases (66-67) ͈ F%ySulfatases D08.586.277.352.827 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Arylsulfatases (+ 2); Chondroitinases (+ 1); Iduronate Sulfatase UF`OSulfasalazine D02.065.884.730; D02.886.590.700.730; D17.025.800; D17.050.875; D20.890.730 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Anti-Infective Agents; Sulfonamides A drug that is used in the management of inflammatory bowel diseases, its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (mesalazine) released in the colon. It is also used in the treatment of severe or progressive rheumatoid arthritis not responding to analgesics or anti-inflammatory drugs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.907). ђW:Sulfaquinoxaline D02.065.884.725.925; D02.886.590.700.725.925; D20.890.725.925 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides N(1)-(2-Quinoxalinyl)sulfanilamide. An antiprotozoal agent used to combat coccidial infections of swine, cattle, fowl and other veterinary animals. Also used in controlling outbreaks of fowl typhoid and fowl cholera and in treatment of infectious enteritis. Synonyms: Sulfa-Q 20; Sulquin. Quinoxalines (74); Sulfanilamides (74) E:Q/Sulfapyridine D02.065.884.725.900; D02.886.590.700.725.900; D20.890.725.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides N'-2-Pyridylsulfanilamide. Antibacterial, potentially toxic, used to treat certain skin diseases. Synonyms: Dagenan; Eubasin: Pyramid. Pyridines (74); Sulfanilamides (74)  E:,Sulfaphenazole D02.065.884.725.887; D02.886.590.700.725.887; D20.890.725.887 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides ۛE:Sulfanilic Acids D02.455.426.559.389.750; D02.886.645.600.080.850; D26.550.822 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Aminobenzenesulfonic acids. Organic acids that are used in the manufacture of dyes and organic chemicals and as reagents. Amines (74); Benzenesulfonates (74) HE8j,Sulfanilamides D02.065.884.725; D02.886.590.700.725; D20.890.725 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Anti-Infective Agents; Sulfonamides Furosemide; Sulfacetamide; Sulfachlorpyridazine; Sulfadiazine (+ 1); Sulfadimethoxine; Sulfadoxine; Sulfaguanidine; Sulfalene; Sulfamerazine; Sulfameter; Sulfamethazine; Sulfamethoxazole (+ 1); Sulfamethoxypyridazine; Sulfamonomethoxine; Sulfamoxole; Sulfaphenazole; Sulfapyridine; Sulfaquinoxaline; Sulfathiazoles (+ 1); Sulfisomidine; Sulfisoxazole Furosemide; Sulfacetamide; Sulfachlorpyridazine; Sulfadiazine (+ 1); Sulfadimethoxine; Sulfadoxine; Sulfaguanidine; Sulfalene; Sulfamerazine; Sulfameter; Sulfamethazine; Sulfamethoxazole (+ 1); Sulfamethoxypyridazine; Sulfamonomethoxine; Sulfamoxole; Sulfaphenazole; Sulfapyridine; Sulfaquinoxaline; Sulfathiazoles (+ 1); Sulfisomidine; Sulfisoxazole Sulfacetamide; Sulfachlorpyridazine; Sulfadiazine (+ 1); Sulfadimethoxine; Sulfadoxine; Sulfaguanidine; Sulfalene; Sulfamerazine; Sulfameter; Sulfamethazine; Sulfamethoxazole (+ 1); Sulfamethoxypyridazine; Sulfamonomethoxine; Sulfamoxole; Sulfaphenazole; Sulfapyridine; Sulfaquinoxaline; Sulfathiazoles (+ 1); Sulfisomidine; Sulfisoxazole AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR '98:Sulfamoxole D02.065.884.725.882; D02.886.590.700.725.882; D20.890.725.882 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides yE:Sulfamonomethoxine D02.065.884.725.877; D02.886.590.700.725.877; D20.890.725.877 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides N(1)-(-Methoxy-4-pyrimidinyl)sulfanilamide. Long acting sulfonamide. Synonyms: Daimeton; DJ 1550; Ro 4-3476. Pyrimidines (72-74); Sulfonamides (69-74) #E:2Sulfamethoxypyridazine D02.065.884.725.872; D02.886.590.700.725.872; D20.890.725.872 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides E:Sulfamethoxazole D02.065.884.725.867; D02.886.590.700.725.867; D20.890.725.867 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides Trimethoprim-Sulfamethoxazole Combination Trimethoprim-Sulfamethoxazole Combination Trimethoprim-Sulfamethoxazole Combination DE:Sulfamethizole D02.065.884.725.935.813; D02.886.590.700.725.935.813; D20.890.725.935.813 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides; Sulfathiazoles Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides; Sulfathiazoles Anti-Infective Agents; Sulfonamides; Sulfanilamides; Sulfathiazoles }Q83Sulfamethazine D02.065.884.725.862; D02.886.590.700.725.862; D20.890.725.862 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides jE:Sulfameter D02.065.884.725.857; D02.886.590.700.725.857; D20.890.725.857 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides N(1)-(5-Methoxy-2-pyrimidinyl)sulfanilamide. Long acting sulfonamide used in leprosy, urinary and respiratory tract infections. Synonyms: Bayrena; Dairena; Kinecid; Sulla; Ultrax. Pyrimidines (70-74); Sulfanilamides (73-74) E:4Sulfamerazine D02.065.884.725.853; D02.886.590.700.725.853; D20.890.725.853 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides E:Sulfalene D02.065.884.725.850; D02.886.590.700.725.850; D20.890.725.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides 4-Amino-N-(3-methoxypyrazinyl)benzenesulfonamide. Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria. Pyrazines (71-74); Sulfonamides (71-74) z E:0Sulfaguanidine D02.065.884.725.810; D02.078.370.853; D02.886.590.700.725.810; D20.890.725.810 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Amidines; Guanidines Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides X:9Sulfadoxine D02.065.884.725.765; D02.886.590.700.725.765; D20.890.725.765 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides N(1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide. Long acting sulfonamide, plasma bound, used for respiratory and urinary tract infections; may also be effective for malaria and leprosy. Synonyms: Fanasil; Ro 4-4393. Pyrimidines (71-74); Sulfonamides (71-74)  E:2Sulfadimethoxine D02.065.884.725.760; D02.886.590.700.725.760; D20.890.725.760 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides E:Sulfadiazine D02.065.884.725.755; D02.886.590.700.725.755; D20.890.725.755 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides Silver Sulfadiazine Silver Sulfadiazine Silver Sulfadiazine E:DSulfachlorpyridazine D02.065.884.725.700; D02.886.590.700.725.700; D20.237.875; D20.890.725.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Anti-Infective Agents, Urinary Anti-Infective Agents; Sulfonamides; Sulfanilamides 4-Amino-N-(6-chloro-3-pyridazinyl)benzenesulfonamide. A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine. Pyridazines (74); Sulfanilamides (74) T:9.Sulfacetamide D02.065.884.725.650; D02.886.590.700.725.650; D20.890.725.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Anti-Infective Agents; Sulfonamides; Sulfanilamides bE:Sulbenicillin D20.085.099.739.762.875 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G 3,3-Dimethyl-7-oxo-6-((phenylsulfoacetyl)amino)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid. Semisynthetic penicillin-type antibiotic. Penicillin G (73-74) /analogs and derivatives (75); Sulfonic Acids (73-75) :aYSulbactam D03.438.671.800; D08.373.820; D20.085.099.869 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Penicillanic Acid Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Anti-Infective Agents; Antibiotics; Antibiotics, Lactam 3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide. A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone. Beta Lactamases/antagonists and inhibitors (79-87); Enzyme Inhibitors (75-87); Enzymes/antagonists and inhibitors (66-74); Penicillanic Acids (71-87)  5:Suipoxvirus B04.280.650.160.800; B04.909.204.783.160.800 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, containing one species, swinepox virus.  62vSuicide, Attempted F03.126.918.600; I01.880.735.856.600 CLECEHHILJPCPXSNTD Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Suicide Social Sciences; Sociology; Social Problems; Suicide The unsuccessful attempt to kill oneself. Suicide (66-74)  *3Suicide, Assisted F03.126.918.300; I01.880.735.856.300; K01.316.333.366.175.750; K01.752.667.416.175.750; N05.350.340.500.345.750 CLECEHHILJPCPXSNTD Right to Die Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Suicide Social Sciences; Sociology; Social Problems; Suicide Humanities; Ethics; Ethics, Professional; Ethics, Medical; Euthanasia Humanities; Philosophy; Philosophy, Medical; Ethics, Medical; Euthanasia Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional; Ethics, Medical; Euthanasia Deliberate acceleration of death of a competent patient with an incurable disease or in the extremes of suffering. The patient seeking assistance in taking his own life may ask the help of a physician or other health professional, a family member, or a friend. The milieu may be a hospital, nursing home, or private residence. Assistance to the person in dire physical or psychological distress may take the form of lethal doses of medications or chemicals to be taken orally or by injection through human intervention or with a so-called suicide machine. Euthanasia (76-92); Suicide (76-92)  3{,Suicide F03.126.918; I01.880.735.856 CLECEHHILJPCPXSNTD Death Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Social Sciences; Sociology; Social Problems Suicide, Assisted; Suicide, Attempted Suicide, Assisted; Suicide, Attempted The act of killing oneself.   " X$Suggestion F04.754.424.771 Autogenic Training; Persuasive Communication Persuasive Communication Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Hypnosis Autosuggestion The uncritical acceptance of an idea or plan of action.   4WESugar Phosphates D09.203.894 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Dihydroxyacetone Phosphate; Glycerophosphates (+ 1); Hexosephosphates (+ 7); Inositol Phosphates (+ 2); Mannitol Phosphates; Pentosephosphates (+ 3); Polyisoprenyl Phosphate Sugars (+ 3); Teichoic Acids AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR UBKFSugar Alcohols D02.033.800; D09.203.853 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Dithioerythritol; Dithiothreitol; Dulcitol (+ 2); Erythritol; Glycerin (+ 3); Inositol (+ 3); Mannitol (+ 2); Ribitol; Sorbitol (+ 5); Xylitol Dithioerythritol; Dithiothreitol; Dulcitol (+ 2); Erythritol; Glycerin; Inositol (+ 3); Mannitol (+ 2); Ribitol; Sorbitol (+ 5); Xylitol Alcohols (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  d8y[DSugar Alcohol Dehydrogenases D08.586.682.047.150.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases Aldehyde Reductase; Glycerolphosphate Dehydrogenase; Iditol Dehydrogenase; Mannitol Dehydrogenase Reversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99. Alcohol Oxidoreductases (66-77)  %"Fo%Sugar Acids D02.241.081.844; D02.241.511.902; D09.203.811 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Ascorbic Acid (+ 1); 2,3-Diketogulonic Acid; Glucaric Acid; Gluconates (+ 2); Glyceric Acids (+ 1); Muramic Acids; Neuraminic Acids (+ 2); Tartrates; Tartronates; Uronic Acids (+ 3) Ascorbic Acid (+ 1); 2,3-Diketogulonic Acid; Glucaric Acid; Gluconates (+ 2); Glyceric Acids (+ 1); Muramic Acids; Neuraminic Acids (+ 2); Tartrates; Tartronates; Uronic Acids (+ 3) Ascorbic Acid (+ 1); 2,3-Diketogulonic Acid; Glucaric Acid; Gluconates (+ 2); Glyceric Acids (+ 1); Muramic Acids (+ 1); Neuraminic Acids (+ 2); Tartrates; Tartronates; Uronic Acids (+ 3) Carbohydrates (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  58FSufentanil D03.383.621.265.900; D15.040.150.850; D15.045.902; D15.050.035.075.806; D15.210.100.175.075.806; D15.210.600.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Fentanyl Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Narcotics N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide. An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent. Anilides (77-78); Fentanyl/analogs and derivatives (79-92); Piperidines (77-78) #~:4_Sudeck's Atrophy C05.116.198.579.688 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic; Osteoporosis Loss of bony substance following an injury where nerve damage was incurred. 'N][Sudden Infant Death C23.240.322.500 BLCFCLDIEHEPETGEIMPAPC Death, Sudden Symptoms and General Pathology (Non MeSH); Death; Death, Sudden The abrupt and unexplained death of an apparently healthy infant under one year of age, remaining unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. (Expert Panel of the National Institute of Child Health and Human Development in Pediatric Pathology, v.11, no.5, Sept-Oct 1991, p.681). Death, Sudden (66-74)  )GNSudan Z01.058.290.120.760 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern , _Suction E04.237.890 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Drainage The removal of secretions, gas or fluid from hollow or tubular organs or cavities by means of a tube and a device that acts on negative pressure. , $#Sucrose D09.203.698.629.305.770 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides Sucralfate - DSucrase-Isomaltase Complex D08.586.277.450.329.738.700; D08.586.277.450.770.800; D08.586.600.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Disaccharidases; Sucrase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Oligo-1,6-Glucosidase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes An enzyme complex found in the brush border membranes of the small intestine. It is believed to be an enzyme complex with different catalytic sites. Its absence is manifested by an inherited disease called sucrase-isomaltase deficiency. Glycoside Hydrolases (66-77); Multienzyme Complexes (73-77); Sucrase (72-77) .MFj[Sucrase D08.586.277.450.329.738 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Disaccharidases Sucrase-Isomaltase Complex 2 FSucralfate D02.691.925; D09.203.698.629.305.770.850; D19.316.203.880 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides; Sucrose Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents Hexadeca-omega-hydroxytetracosahydroxy-(mu(8)-(1,3,4,6-tetra-O-sulfo-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetrakis(hydrogen sulfato)(8-)))hexadecaaluminum. A basic aluminum complex of sulfated sucrose. It is advocated in the therapy of peptic, duodenal, and prepyloric ulcers, gastritis, reflux esophagitis, and other gastrointestinal irritations. It acts primarily at the ulcer site, where it has cytoprotective, pepsinostatic, antacid, and bile acid-binding properties. The drug is only slightly absorbed by the digestive mucosa, which explains the absence of systemic effects and toxicity. Aluminum (66-86); Sucrose/analogs and derivatives (77-81) 3A:4ESucking Behavior F01.145.916 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Any suction exerted by the mouth; response of the mammalian infant to draw milk from the breast. Includes sucking on inanimate objects. Not to be used for thumb sucking, which is indexed under fingersucking. 8 ASuccinylcholine D02.092.102.232.780; D02.241.081.337.817.725; D02.675.276.232.780; D16.700.710.550.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Depolarizing Agents 2,2'-((1,4-Dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethylethanaminium). A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. :7`:Succinyl Coenzyme A Synthetases D08.586.464.271.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Coenzyme A Synthetases Succinate:CoA ligase (GDP- or ADP-forming). Catalyze the first step leading to the oxidation of succinic acid by the reversible formation of succinyl-CoA from succinate and CoA with the concomitant cleavage of ATP to ADP (EC 6.2.1.5) or GTP to GDP (EC 6.2.1.4) and orthophosphate. Itaconate can act instead of succinate and ITP instead of GTP. Coenzyme A Synthetases (73); Succinates (73) >&Fl7Succinimides D02.241.081.337.817.687; D02.478.770; D03.383.773.812.852 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates Organic Chemicals (Non MeSH); Imides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Bromosuccinimide; Ethosuximide Bromosuccinimide; Ethosuximide Bromosuccinimide; Ethosuximide Pyrrolidines (66-71); Pyrrolidinones (66-71); Succinates (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  AA8hM:Succinic Anhydrides D02.113.700; D02.241.081.337.817.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Anhydrides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates Dihydro-2,5-furandiones. Succinic acid anhydrides. Can be substituted on any carbon atom. They modify and inhibit proteins and enzymes and are used in the acylation of amino- and hydroxyl groups. Anhydrides (66-78); Succinates (66-78) DJ*8/Succinates D02.241.081.337.817 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Argininosuccinic Acid; Dioctyl Sulfosuccinates; Succimer; Succinic Anhydrides; Succinimides (+ 2); Succinylcholine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR F8q:Succinate Dehydrogenase D08.586.682.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases HeFXSuccinate Cytochrome c Oxidoreductase D08.586.682.830 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases A portion of the electron transport chain, catalyzing the transfer of electrons from succinate to cytochrome c via FAD, ubiquinone, and cytochrome b. The first step is catalyzed by succinate dehydrogenase (EC 1.3.99.1), the other steps are not well characterized. EC 1.-. Cytochome C (73-74); Oxidoreductases (73-74); Succinates (73-74) IQ,FX?NSuccimer D02.241.081.337.817.575; D02.886.489.750; D26.061.850; D26.241.850 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Miscellaneous Drugs and Agents (Non MeSH); Antidotes Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents (R*,S*)-2,3-Dimercaptobutanedioic acid. A mercaptodicarboxylic acid used as an antidote to heavy metal poisoning because it forms strong chelates with them; its mercury chelate, labeled with technetium, is used in renal imaging. Succinates (66-78); Sulfhydryl Compounds (66-78) K L.a :Suburban Population N01.600.775 CLHISNTD Urban Population Population Characteristics (Non MeSH); Population The inhabitants of peripheral or adjacent areas of a city or town. Urban Population (68-79)  O4 ;RSubtraction Technique E01.357.880 AECLCTECHIISMOMTNUPXSNSTTDUTVE Image Enhancement Diagnosis; Diagnostic Imaging Angiography, Digital Subtraction; Radiography, Dual-Energy Scanned Projection Combination or superimposition of two images for demonstrating differences between them (e.g., radiograph with contrast vs. one without, radionuclide images using different radionuclides, radiograph vs. radionuclide image) and in the preparation of audio-visual materials (e.g., offsetting identical images, coloring of vessels in angiograms). AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $PR"$X&Subtilisins D08.586.277.656.732.760.787 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases A family of serine proteinases isolated from Bacillus subtilis. Peptide Peptidohydrolases (66-72) S FL'Subtalar Joint A02.835.583.831.780 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints; Tarsal Joint Formed by the articulation of the talus with the calcaneus. T8BISubstrate Specificity G06.184.880 DEGEIMPHRE Enzymes Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. U hSubstrate Cycling G06.535.335.835; G06.535.630.850 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) A set of opposing, nonequilibrium reactions catalyzed by different enzymes which act simultaneously, with at least one of the reactions driven by ATP hydrolysis. The results of the cycle are that ATP energy is depleted, heat is produced and no net substrate-to-product conversion is achieved. Examples of substrate cycling are cycling of gluconeogenesis and glycolysis pathways and cycling of the triglycerides and fatty acid pathways. Rates of substrate cycling may be increased many-fold in association with hypermetabolic states resulting from severe burns, cold exposure, hyperthyroidism, or acute exercise. Energy Metabolism (75-88); specific substance/metabolism (75-88) W6&LSubstantia Nigra A08.186.211.132.659.687 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon [8XSubstantia Innominata A08.186.211.730.885.105.880 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia Tissue in the base of the forebrain inferior to the anterior perforated substance, and anterior to the globus pallidus and ansa lenticularis. It contains the nucleus basalis of Meynert and may be implicated in Alzheimer's disease. Basal Ganglia (82-83); Brain (66-83); Globus Pallidus (66-83); Telencephalon (66-83) \k8mgSubstantia Gelatinosa A08.186.854.852 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Spinal Cord ^8?Substance Withdrawal Syndrome F03.709.508.490.310 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Substance-Induced Neonatal Abstinence Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  _#D"LSubstance Use Disorders F03.709.597.780 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Impulse Control Disorders; Behavior, Addictive Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders Substance Abuse (+ 3); Substance Dependence (+ 4); Tobacco Use Disorder Disorders manifested by maladaptive behavior associated with more or less regular use of substances. This concept should be distinguished from substance-induced organic mental disorders (ORGANIC MENTAL DISORDERS, SUBSTANCE-INDUCED) in which there are direct effects (acute or chronic) of these substances on the central nervous system. BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $btD7cYLSubstance P D12.644.320.900.866; D12.644.456.800.866; D12.776.641.650.800.750; D14.600.600.860.800; D17.350.050.375.850.890 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Neurokinin-1 Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins; Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Tachykinins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Tachykinins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins; Tachykinins An eleven-amino acid neurotransmitter that appears in both the central and peripheral nervous systems. It is involved in transmission of pain, causes rapid contractions of the gastrointestinal smooth muscle, and modulates inflammatory and immune responses. e{FR(Substance Dependence F03.709.597.780.660 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Co-Dependency (Psychology); Designer Drugs; Street Drugs Social Problems Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders Alcoholism; Narcotic Dependence (+ 2) Strong emotional and/or physiological dependence upon a drug or other substance which has progressed beyond voluntary control. BLCFCLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (jeDD.JSubstance Abuse, Intravenous F01.145.905.800; F03.709.597.780.610.800; I01.880.735.790.800 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Needle Sharing; Needle-Exchange Programs Behavior and Behavior Mechanisms (Non MeSH); Behavior; Substance Abuse Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Abuse Social Sciences; Sociology; Social Problems; Substance Abuse Abuse, overuse, or misuse of a substance by its injection into a vein. Injections, Intravenous (66-89); Substance Abuse (66-89)  l"EF0.WCSubstance Abuse Treatment Centers N02.278.035.128.800; N02.278.808.930 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities; Community Health Centers Facilities, Manpower and Services (Non MeSH); Health Facilities; Rehabilitation Centers Health facilities providing therapy and/or rehabilitation for substance-dependent individuals. Methadone distribution centers are included. o(*Substance Abuse Detection E05.885; G03.850.780.500.765 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Enzyme Multiplied Immunoassay Technique Mandatory Testing Miscellaneous Techniques (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection. Mass Screening (86-89); Street Drugs (77-89); Substance Abuse (68-89) $q"$.USubstance Abuse F01.145.905; F03.709.597.780.610; I01.880.735.790 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Designer Drugs; Drug and Narcotic Control; Street Drugs Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders Social Sciences; Sociology; Social Problems Substance Abuse, Intravenous Marijuana Abuse; Phencyclidine Abuse; Substance Abuse, Intravenous Substance Abuse, Intravenous Maladaptive behavior occurring as a result of the use of drugs. The degree of social or occupational impairment is less than the impairment of psychologic or physiologic dependence (SUBSTANCE DEPENDENCE). Distinguishing features of abuse are: a pattern of pathological use (e.g., intoxication throughout the day, inability to stop or cut down use, or a daily or constant need for the substance for adequate functioning) and impairment in social or occupational functioning over a period of time. Drug Therapy (66-67); Substance Dependence (66-67) BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI (te9DDB=FSubrenal Capsule Assay E05.337.300.250.200.700; E05.909.262.388.875 ECHIISMTSNSTUTVE Miscellaneous Techniques (Non MeSH); Evaluation Studies; Drug Approval; Drug Screening; Drug Screening Assays, Antitumor Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Drug Screening Assays, Antitumor In vivo method of screening investigative anticancer drugs and biologic response modifiers for individual cancer patients. Fresh tumor tissue is implanted under the kidney capsule of immunocompetent mice or rats; gross and histological assessments follow several days after tumor treatment in situ. Drug Screening (79-87); Neoplasm Transplantation (79-87); Transplantation, Heterologous (83-87); Tumor Stem Cell Assay (84-87) y2ZSubphrenic Abscess C01.539.830.025.020.810; C06.772.842 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess; Abdominal Abscess Digestive System Diseases; Peritoneal Diseases An abscess beneath the diaphragm. (Dorland, 27th ed). };*PCSubmucous Plexus A08.800.050.050.850; A08.800.050.150.750; A08.800.800.060.840 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Autonomic Nervous System; Enteric Nervous System Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways One of two ganglionated neural networks which together form the enteric nervous system. The submucous (Meissner's) plexus is in the connective tissue of the submucosa. Its neurons innervate the epithelium, blood vessels, endocrine cells, other submucosal ganglia, and myenteric ganglia, and play an important role in regulating ion and water transport. (From FASEB J 1989;3:127-38). ~E6.Submitochondrial Particles A11.368.702.564.882; A11.904.626.882 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles; Mitochondria Cells; Subcellular Fractions; Mitochondria The various filaments, granules, tubules or other inclusions within mitochondria. Mitochondria (66-78); specific mitochondria heading t**e_=Submarine Medicine G02.403.478.508 CLECEDHIISLJMAMTOGSNSTTD Ecological Systems, Closed Oceanography Health Occupations; Medicine; Naval Medicine The field of medicine concerned with conditions affecting the health of people in submarines or sealabs.   6|Submandibular Gland Neoplasms C04.588.443.591.824.885; C07.465.565.824.885; C07.465.815.718.885; C07.465.815.882.500 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Submandibular Gland Diseases Salivary Gland Neoplasms (66-80); Submandibular Gland (66-80) b#`XISubmandibular Gland Diseases C07.465.815.882 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Submandibular Gland Neoplasms Salivary Gland Diseases (66-80); Submandibular Gland (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  ^"NL#HXSubmandibular Gland A10.336.779.812; A14.549.760.812 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Exocrine Glands; Salivary Glands Stomatognathic System; Mouth; Salivary Glands &:|Sublingual Gland Neoplasms C04.588.443.591.824.882; C07.465.565.824.882; C07.465.815.718.870 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Salivary Gland Neoplasms Neoplasms of the sublingual glands. Salivary Gland Neoplasms (66-85) . IXI,'Sublingual Gland A10.336.779.687; A14.549.760.687 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Exocrine Glands; Salivary Glands Stomatognathic System; Mouth; Salivary Glands &:|Subliminal Stimulation F02.463.593.710.750 Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Sensory Thresholds Stimulation at an intensity below that where a differentiated response can be elicited. shSublimation F01.393.898; F03.407.898 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms A defense mechanism through which unacceptable impulses and instinctive urges are diverted into personally and socially acceptable channels; e.g., aggression may be diverted through sports activities. Psychoanalytic Theory (66-67) #Subject Headings L01.300.890 Unified Medical Language System Information Science; Documentation Terms or expressions which provide the major means of access by subject to the bibliographic unit. &)vSubgingival Curettage E06.721.874 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Periodontitis Dentistry; Periodontics Root Planing Removal of degenerated and necrotic epithelium and underlying connective tissue of a periodontal pocket in an effort to convert a chronic ulcerated wound to an acute surgical wound, thereby insuring wound healing and attachment or epithelial adhesion, and shrinkage of the marginal gingiva. The term is sometimes used in connection with smoothing of a root surface or ROOT PLANING. (Jablonski; Illustrated Dictionary of Dentistry, 1982).  $Subfornical Organ A08.713.840 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurosecretory Systems A structure, situated close to the intraventricular foramen, which induces drinking behavior after stimulation with angiotensin II. Neurosecretory Systems (70-76) 8.$Subdural Space A08.186.566.395.687 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Meninges; Dura Mater Meninges (66-71)  6JSubdural Effusion C10.228.228.507.825 BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis The leakage of cerebrospinal fluid into the subdural space. specific meningitis/complications (66-71); Meningitis/complications (66-71) RHWSubcutaneous Emphysema C23.390.880 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Emphysema Presence of air or gas in the subcutaneous tissues of the body. Emphysema (66-76) N@OSubcommissural Organ A08.713.810 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurosecretory Systems An ependymal derivative located at the junction of the third ventricle and the cerebral aqueduct, secreting somatostatin. Neurosecretory Systems (70-76) 8.$Subclavian Vein A07.231.908.877 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins The continuation of the axillary vein which follows the subclavian artery and then joins the internal jugular vein to form the brachiocephalic vein. e85Subclavian Steal Syndrome C10.228.140.300.459.832; C14.907.253.459.832 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Ischemia Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Ischemia Cerebral or brain stem ischemia resulting from diversion of blood flow from the basilar artery to the subclavian artery, in the presence of occlusive disease of the proximal portion of the subclavian artery. (Dorland, 27th ed). 2N Subclavian Artery A07.231.114.839 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Artery arising from the brachiocephalic trunk on the right side and from the arch of the aorta on the left side. It distributes to the neck, thoracic wall, spinal cord, brain, meninges, and upper limb. 88Subcellular Fractions A11.904 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cell Fractionation Cells Cell-Free System; Cytosol; Intracellular Membranes (+ 1); Microsomes (+ 1); Mitochondria (+ 4); Synaptosomes Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. (From Alberts, et al., Molecular Biology of the Cell, 2d ed, p163). Cytology (66-71); Microsomes (66-71) CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI (5 ( d-*Subarachnoid Space A08.186.566.166.686 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Meninges; Arachnoid Cisterna Magna 6HSubarachnoid Hemorrhage C10.228.140.300.420.811; C14.907.253.420.811; C23.542.115.811 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Hemorrhage Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Cerebral Hemorrhage Intracranial hemorrhage into the subarachnoid space. (Dorland, 27th ed). ENIWSubacute Sclerosing Panencephalitis C02.782.580.600.500.500.800; C02.839.862; C10.228.140.276.851; C10.228.140.437.851; C10.228.228.245.769 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections; Morbillivirus Infections; Measles Virus Diseases; Slow Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebral Sclerosis, Diffuse Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis A slowly progressive disease of the central nervous system that occurs almost exclusively in children and young adults. It is caused by the SSPE virus, which is a defective variant of measles virus (MORBILLIVIRUS). Cerebral Sclerosis, Diffuse (66-70) i)sP+*Styrenes D02.455.426.559.389.150.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polystyrenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds  8Stuttering C10.597.257.870.883; C23.888.592.257.870.883; F03.126.219.870.883 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders A spasmodic way of speaking in which there are involuntary halts, breaks, and repetitions, usually of psychogenic origin. IFSturge-Weber Syndrome C04.557.645.375.850; C04.700.850; C14.907.077.850; C16.466.700.850; F03.709.346.886 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue; Hemangioma Neoplasms; Neoplastic Syndromes, Hereditary Cardiovascular Diseases; Vascular Diseases; Angiomatosis Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A congenital syndrome consisting of nevus flammeus of the face, hemangiomas of the leptomeninges and choroid, and late glaucoma. It is often associated with intracranial calcification, mental retardation, contralateral hemiplegia, and epilepsy. _LStudy Design (Non MeSH) E05.318.780; G03.850.520.840; N05.715.360.780 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Cross-Over Studies; Double-Blind Method; Matched-Pair Analysis; Meta-Analysis; Random Allocation; Reproducibility of Results; Sample Size; Sensitivity and Specificity (+ 2); Seroepidemiologic Methods; Single-Blind Method Cross-Over Studies; Double-Blind Method; Matched-Pair Analysis; Meta-Analysis; Random Allocation; Reproducibility of Results; Sample Size; Sensitivity and Specificity (+ 2); Seroepidemiologic Methods; Single-Blind Method Cross-Over Studies; Double-Blind Method; Matched-Pair Analysis; Meta-Analysis; Random Allocation; Reproducibility of Results; Sample Size; Sensitivity and Specificity (+ 2); Seroepidemiologic Methods; Single-Blind Method 5!Study Characteristics (Non MeSH) E05.318.760; G03.850.520.835; N05.715.360.775 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Analytic Studies (Epidemiology) (Non MeSH) (+ 8); Clinical Protocols; Clinical Trials (+ 7); Feasibility Studies; Intervention Studies; Pilot Projects; Sampling Studies; Twin Studies Analytic Studies (Epidemiology) (Non MeSH) (+ 8); Clinical Protocols; Clinical Trials (+ 7); Feasibility Studies; Intervention Studies; Pilot Projects; Sampling Studies; Twin Studies Analytic Studies (Epidemiology) (Non MeSH) (+ 8); Clinical Protocols; Clinical Trials (+ 7); Feasibility Studies; Intervention Studies; Pilot Projects; Sampling Studies; Twin Studies AECLCTECHIISLJMOMTNUPXSDSNSTTDUTVE D'5!&Students, Premedical I02.851.686.851; M01.848.769.851 CLHILJPXSN Education; Students; Students, Health Occupations Named Groups (Non MeSH); Students; Students, Health Occupations Individuals enrolled in a preparatory course for medical school. &MStudents, Pharmacy I02.851.686.768; M01.848.769.768 CLHILJPXSN Education; Students; Students, Health Occupations Named Groups (Non MeSH); Students; Students, Health Occupations Individuals enrolled in a school of pharmacy or a formal educational program leading to a degree in pharmacy. Students (66-67) &Students, Nursing I02.851.686.685; M01.848.769.685 CLHILJPXSN Education; Students; Students, Health Occupations Named Groups (Non MeSH); Students; Students, Health Occupations Individuals enrolled in a school of nursing or a formal educational program leading to a degree in nursing. d&Students, Medical I02.851.686.602; M01.848.769.602 CLHILJPXSN Education; Students; Students, Health Occupations Named Groups (Non MeSH); Students; Students, Health Occupations Individuals enrolled in a school of medicine or a formal educational program in medicine. &kStudents, Health Occupations I02.851.686; M01.848.769 CLHILJPXSN Education; Students Named Groups (Non MeSH); Students Students, Dental; Students, Medical; Students, Nursing; Students, Pharmacy; Students, Premedical Students, Dental; Students, Medical; Students, Nursing; Students, Pharmacy; Students, Premedical Individuals enrolled in a school or formal educational program in the health occupations. Students (66-67)  6"BjStudents, Dental I02.851.686.519; M01.848.769.519 CLHILJPXSN Education; Students; Students, Health Occupations Named Groups (Non MeSH); Students; Students, Health Occupations Individuals enrolled a school of dentistry or a formal educational program in leading to a degree in dentistry. P&Students I02.233.748; I02.851; M01.848 CLHILJPXSN Education Education; Education, Nonprofessional (Non MeSH) Education Named Groups (Non MeSH) Student Dropouts Students, Health Occupations (+ 5) Student Dropouts; Students, Health Occupations (+ 5) Individuals enrolled in a school or formal educational program. CLEDHILJPXSN $ % `zLStudent Health Services N02.421.897 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services Health services for college and university students usually provided by the educational institution. xJuStudent Dropouts F02.784.629.796; I02.233.748.686; M01.848.602 CLEDHILJPXSN Social Problems Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Education; Education, Nonprofessional (Non MeSH); Students Named Groups (Non MeSH); Students Individuals who leave school, secondary or college, prior to completion of specified curriculum requirements. ɢ5Strychnine D03.132.820; D05.569.612.800; D14.100.300.800; D15.220.224.899 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Poisons Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Glycine Agents Central Nervous System Agents; Central Nervous System Stimulants; Convulsants An alkaloid found in the seeds of nux vomica. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison. ːH@VStruma Ovarii C04.557.465.910.850 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Thyroid Gland Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Teratoma A rare teratoid tumor of the ovary composed almost entirely of thyroid tissue, with large follicles containing abundant colloid. Occasionally there are symptoms of hyperthyroidism. 5-10% of struma ovarii become malignant, the only absolute criterion for which is the presence of metastasis. (Dorland, 27th ed; Dictionary of Modern Medicine, 1992). ξXtStructure-Activity Relationship G06.184.872; G12.869; H01.181.122.768; H01.181.466.685 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Chemical, Pharmacologic Phenomena (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Biochemistry Physical Sciences (Non MeSH); Chemistry; Chemistry, Pharmaceutical The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects. т$@&Strophanthins D04.808.155.160.861; D09.203.408.180.810; D18.222.175.810 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides Cymarine; Ouabain; Strophanthidin Cymarine; Ouabain Cymarine; Ouabain A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  ABSDStrophanthidin D04.808.155.160.861.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Strophanthins 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide. The aglycone cardioactive agent isolated from Strophanthus Kombe, S. gratus and other species; it is a very toxic material formerly used as digitalis. Synonyms: Apocymarin; Corchorin; Cynotoxin; Corchorgenin. Cardanolides (68-74) @:Y7Strontium Radioisotopes D01.496.749.815; D01.496.840.685 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Strontium Isotopes Unstable isotopes of strontium that decay or disintegrate spontaneously emitting radiation. Sr 80-83, 85, and 89-95 are radioactive strontium isotopes. w&4Strontium Isotopes D01.496.840 Inorganic Chemicals (Non MeSH); Isotopes Strontium Radioisotopes Stable strontium atoms that have the same atomic number as the element strontium, but differ in the atomic weight. Sr-84, 86, 87, and 88 are the stable strontium isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR J24Strontium D01.268.552.850; D01.552.539.861 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Alkaline Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Alkaline Earth Strontium. An element of the alkaline earth family of metals. It has the atomic symbol Sr, atomic number 38, and atomic weight 87.62.  &:Strongylus B01.500.294.700.775.710.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Strongyloidea A genus of intestinal parasitic nematodes occurring in animals and man. Strongyloidea (73-85) ߰*YVStrongyloidiasis C03.335.508.700.700.799 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Rhabditida Infections Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea. PuStrongyloides stercoralis B01.500.294.700.700.640.680.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida; Rhabdiasoidea; Strongyloides A species of parasitic nematode widely distributed in tropical and subtropical countries. The females and their larvae inhabit the mucosa of the intestinal tract, where they cause ulceration and diarrhea. Strongyloides (66-92) #*iStrongyloides ratti B01.500.294.700.700.640.680.600 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida; Rhabdiasoidea; Strongyloides A species of parasitic nematode found in rats. Strongyloides (68-92) #*i:Strongyloides B01.500.294.700.700.640.680 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida; Rhabdiasoidea Strongyloides ratti; Strongyloides stercoralis A genus of parasitic nematodes widely distributed as intestinal parasites of mammals. =*X6eStrongyloidea B01.500.294.700.775.710 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida Oesophagostomum; Strongylus A superfamily of strongyles or roundworms which are parasites in the intestinal tract of equines, pigs, rodents, and primates (including man). It includes the genera Cyasthostomum, Ransomus, Globocephalus, OESOPHAGOSTOMUM, and STRONGYLUS. Ancylostomatoidea (66); Nematoda (67-72)  *H!1Strongylida Infections C03.335.508.700.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections Hookworm Infections (+ 2); Oesophagostomiasis; Strongyle Infections, Equine; Trichostrongyloidiasis (+ 4) Infections with nematodes of the order STRONGYLIDA. P[{>Strongylida B01.500.294.700.775 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea Ancylostomatoidea (+ 3); Heligmosomatoidea (+ 3); Metastrongyloidea (+ 2); Strongyloidea (+ 2); Trichostrongyloidea (+ 4) An order of nematodes of the subclass SECERNENTEA. Characteristics include an H-shaped excretory system with two subventral glands. *9Strongyle Infections, Equine C03.335.349.840; C03.335.508.700.775.773; C03.701.377.840; C22.488.861; C22.674.377.840 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Horse Diseases Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Infection of horses with parasitic nematodes of the superfamily STRONGYLOIDEA. Characteristics include the development of hemorrhagic nodules on the abdominal peritoneum. Nematode Infections (66-67) y"cJ!Stromal Cells A11.329.830 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH) Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.  *3Stroke Volume E01.145.569.205.790; G09.330.612.280.882 DEGEIMPHRE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Cardiac Output Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Cardiac Output The amount of blood pumped out of the heart per beat not to be confused with cardiac output (volume/time). Cardiac Output (66-78) .Strikes, Employee N03.540.571.608; N04.452.677.842 CLECHILJMAMTOGSDSNSTTDUT Labor Unions Economics, Organizations, Control (Non MeSH); Organizations; Labor Unions Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Work-related situations in which the employees as a group refuse to work until certain conditions of employment are granted by the employer. Collective Bargaining (71-79); Labor Unions (66-70)  &>Stria Vascularis A09.246.631.246.292.876 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Sense Organs; Ear; Labyrinth; Cochlea; Cochlear Duct A layer of highly vascular pigmented granular cells on the outer wall of the cochlear duct. Cochlea (66-78); Organ of Corti (68-78) *Bo2Stress, Psychological F02.830.900; F03.126.903 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Crowding; Life Change Events Psychologic Processes and Principles (Non MeSH); Psychophysiology Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Burnout, Professional Burnout, Professional Psychosocial pressures or tension-producing factors in the environment to which the individual attempts to make a homeostatic adjustment.  <F$2Stress, Mechanical G11.427.050.700; H01.671.100.131.700 Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Biomechanics Physical Sciences (Non MeSH); Physics; Biophysics; Biomechanics A purely physical condition which exists within any material because of strain or deformation by external forces or by non-uniform thermal expansion; expressed quantitatively in units of force per unit area. Biomechanics (68-70); Physics (66-70) ~*.Stress Disorders, Post-Traumatic F03.709.438.180.680 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders Combat Disorders Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world. &FvgStress C23.280.853 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI General Adaptation Syndrome Symptoms and General Pathology (Non MeSH); Disease General Adaptation Syndrome The sum of the biological reactions to any adverse stimulus, physical, mental, or emotional, internal or external, that tends to disturb the organism's homeostasis. Should these compensating reactions be inadequate or inappropriate, they may lead to disorders. The term is also used to refer to the stimuli that elicit the reactions. (Dorland, 27th ed).  k N!>!Streptozocin D02.654.692.768; D02.948.594.768; D20.085.075.899; D22.204.106.903 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic 2-Deoxy-2-((methylnitrosoamino)carbonyl)amino)-D-glucose. Antineoplastic agent also used to induce diabetes in experimental animals. Antibiotics (66-71); Nitroso Compounds (66-71) L<M8Streptovaricin D20.085.075.870; D22.204.106.877 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic A complex of ansamycin antibiotics consisting of streptovaricins A, B, C, D, E, F, G, J, and K of which streptovaricin C is the major component. (From Merck Index, 11th ed). &<Streptothricins D20.085.116.775 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide A group of antibiotic substances produced by Streptomyces variants. They are composed of an aminosugar and different polypeptide chains and may have broad spectrum antimicrobial and some antiviral properties. Antibiotics (72-74); Peptides (72-74); Aminoglycosides (74) :BHStreptonigrin D03.066.707.768; D03.383.725.705.768; D20.085.075.841; D22.204.106.851 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Picolinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolinic Acids Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Complex cytotoxic antibiotic obtained from Streptomyces flocculus or S. rufochronmogenus. It is used in advanced carcinoma and causes leukopenia.  P<qStreptomycin D09.203.408.051.885; D20.085.060.790; D20.085.089.790; D20.338.135.810 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular Dihydrostreptomycin Dihydrostreptomycin Dihydrostreptomycin Dihydrostreptomycin O-2-Deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O-5- deoxy-3-C-formyl-alpha-L-lyxofuranosyl-(1-4)-N,N'-bis- (aminoiminomethyl)-D-streptamine. Antibiotic substance produced by the soil actinomycete Streptomyces griseus.  P<LVStreptomycetaceae B03.100.067.810; B03.300.390.400.810; B03.510.415.400.810; B03.510.460.410.810 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH) Streptomyces (+ 3) Streptomyces (+ 3) Streptomyces (+ 3) Streptomyces (+ 3) A family of soil bacteria. It also includes some parasitic forms. Bacteria (66-74)  SX"ZQStreptomyces griseus B03.100.067.810.768.375; B03.300.390.400.810.768.375; B03.510.415.400.810.768.375; B03.510.460.410.810.768.375 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Streptomycetaceae; Streptomyces Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces An actinomycete from which the antibiotics STREPTOMYCIN, grisein, and CANDICIDIN are obtained. Streptomyces (66-71) x"nStreptomyces aureofaciens B03.100.067.810.768.125; B03.300.390.400.810.768.125; B03.510.415.400.810.768.125; B03.510.460.410.810.768.125 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Streptomycetaceae; Streptomyces Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces An actinomycete from which the antibiotic CHLORTETRACYCLINE is obtained. Streptomyces (66-71) x"UStreptomyces antibioticus B03.100.067.810.768.100; B03.300.390.400.810.768.100; B03.510.415.400.810.768.100; B03.510.460.410.810.768.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Streptomycetaceae; Streptomyces Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae; Streptomyces An actinomycete from which the antibiotic ACTINOMYCIN is obtained. Streptomyces (66-71) yx"OStreptomyces B03.100.067.810.768; B03.300.390.400.810.768; B03.510.415.400.810.768; B03.510.460.410.810.768 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Streptomycetaceae Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Streptomycetaceae Streptomyces antibioticus; Streptomyces aureofaciens; Streptomyces griseus Streptomyces antibioticus; Streptomyces aureofaciens; Streptomyces griseus Streptomyces antibioticus; Streptomyces aureofaciens; Streptomyces griseus Streptomyces antibioticus; Streptomyces aureofaciens; Streptomyces griseus A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the antibiotics of practical value. Gh"GNStreptolysins D24.185.926.123.868; D24.185.926.235.440.868 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Antistreptolysin Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Cytotoxins; Hemolysins #2BStreptokinase D08.586.277.656.732.775; D19.461.427.684 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Streptodornase and Streptokinase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents Anistreplase; Streptodornase and Streptokinase Anistreplase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-.  %1.F&DDStreptodornase and Streptokinase D08.586.277.352.335.350.250.900; D08.586.277.656.732.775.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Streptokinase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; Deoxyribonuclease I Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Streptokinase A mixture of the enzymes (streptokinase and streptodornase) produced by hemolytic streptococci. It is used topically on surface lesions and by instillation in closed body cavities to remove clotted blood or fibrinous or purulent accumulations. It is also used as a skin test antigen in evaluating generalized cell-mediated immunodeficiency. (Dorland, 27th ed) EC 3.-. (&BF?Streptococcus suis B03.510.400.800.872.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A species of STREPTOCOCCUS isolated from pigs. It is a pathogen of swine but rarely occurs in humans. Streptococcus (66-91) ,Z"d|Streptococcus sobrinus B03.510.400.800.872.725 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A species of gram-positive, coccoid bacteria isolated from the human tooth surface. Strains have been shown to be cariogenic in experimental animals and may be associated with human dental caries. Streptococcus (86-91) -"dStreptococcus sanguis B03.510.400.800.872.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A gram-positive organism found in dental plaque, in blood, on heart valves in subacute endocarditis, and infrequently in saliva and throat specimens. L-forms are associated with recurrent aphthous stomatitis. Streptococcus (66-75) /"dStreptococcus pyogenes B03.510.400.800.872.575 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER. 1"dStreptococcus pneumoniae B03.510.400.800.872.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Pneumococcal Infections Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. 3"dStreptococcus Phages B04.123.850 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses whose host is Streptococcus. Bacteriophages (66-92) 5^-Streptococcus mutans B03.510.400.800.872.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque. Streptococcus (66-75) 60"ddStreptococcus equi B03.510.400.800.872.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A species of gram-positive, coccoid bacteria isolated from abscesses in submaxillary glands and mucopurulent discharges of the upper respiratory tract of horses. This organism belongs to Group C streptococci with regards to antigen response and is known to cause strangles. The subspecies S. zooepidemicus is also considered a pathogen of horses. Streptococcus (67-94) 7"dStreptococcus bovis B03.510.400.800.872.150 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A species of gram-positive, coccoid bacteria commonly found in the alimentary tract of cows, sheep, and other ruminants. It occasionally is encountered in cases of human endocarditis. This species is nonhemolytic. Streptococcus (66-91) :"dStreptococcus agalactiae B03.510.400.800.872.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Streptococcus A bacterium which causes mastitis in cattle and occasionally in man. Streptococcus (66-71) <"dSStreptococcus B03.510.400.800.872 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae Streptococcus agalactiae; Streptococcus bovis; Streptococcus equi; Streptococcus mutans; Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus sanguis; Streptococcus sobrinus; Streptococcus suis A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment. =a"SJStreptococcal Infections C01.252.410.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections Ecthyma; Endocarditis, Subacute Bacterial; Erysipelas; Impetigo; Pneumococcal Infections (+ 2); Rheumatic Fever (+ 1); Scarlet Fever Infections with bacteria of the genus STREPTOCOCCUS. @XPs?Streptococcaceae B03.510.400.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci Enterococcus (+ 2); Lactococcus (+ 1); Leuconostoc; Pediococcus; Streptococcus (+ 9) Gram-positive non-sporing bacteria including many parasitic, pathogenic, and saprophytic forms. Bacteria (66-74); Lactobacillaceae (75); Micrococcaceae (75)  BP"?hmIStreptobacillus B03.440.450.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that require serum, ascitic fluid, or blood for growth. Its organisms inhabit the throat and nasopharynx of wild and laboratory rats and cause one form of RAT-BITE FEVER in man. D!"X#Strepsirhini B02.649.801.700 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates Cheirogaleidae; Lemuridae (+ 1); Lorisidae (+ 1) A suborder of PRIMATES consisting of the following five families: CHEIROGALEIDAE, Daubentoniidae, Indriidae, LEMURIDAE, and LORISIDAE. Primates (66-74)  F(&=Street Drugs D26.394.878 AEAGANBLCFCHCLCSDUECHIIMIPLJMEPDPKPORESDSTTOUR Designer Drugs; Substance Dependence; Substance Abuse Miscellaneous Drugs and Agents (Non MeSH); Drugs Crack Cocaine Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity. Drug and Narcotic Control (68-76); Substance Abuse (68-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPLJMEPDPKPORESDSTTOTUUR (G2@<3G<Stramonium B06.560.868; B06.660.834 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic One of the very toxic Solanaceae, Datura stramonium, also called thornapple and jimsonweed. It contains the same alkaloids as in Belladonna and causes toxicity to cattle and other grazers. JX&:Strabismus C10.772.204.410.810; C11.590.810 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Orthoptics Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders Eye Diseases; Ocular Motility Disorders Esotropia; Exotropia Esotropia; Exotropia A condition in which the visual axes of each eye are not directed simultaneously to the same fixation point. This condition may be due to paralysis in which one or more muscles is weakened or to a nonparalytic form in which there is no primary muscle impairment.  K&N2;Stomatognathic System Abnormalities (Non MeSH) C07.650; C16.131.850 Stomatognathic Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Jaw Abnormalities (+ 5); Mouth Abnormalities (+ 7); Tooth Abnormalities (+ 9) Jaw Abnormalities (+ 5); Mouth Abnormalities (+ 7); Tooth Abnormalities (+ 9) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI N6cNStomatognathic System A14 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cheek; Dentition (+ 31); Facial Muscles; Jaw (+ 7); Masticatory Muscles (+ 3); Mouth (+ 16); Pharynx (+ 5); Temporomandibular Joint The mouth, teeth, jaws, pharynx, and related structures as they relate to mastication, deglutition, and speech. ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI P8jStomatognathic Diseases C07 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Jaw Diseases (+ 31); Mouth Diseases (+ 113); Pharyngeal Diseases (+ 13); Stomatognathic System Abnormalities (Non MeSH) (+ 24); Temporomandibular Joint Diseases (+ 1); Tooth Diseases (+ 50) General or unspecified diseases of the stomatognathic system, comprising the mouth, teeth, jaws, and pharynx. ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSCSESUTHTMTRULURUSVEVI RNnStomatitis, Herpetic C02.256.466.382.834; C07.465.864.840 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Herpes Labialis Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Simplex Stomatognathic Diseases; Mouth Diseases; Stomatitis Stomatitis caused by Herpesvirus hominis. It usually occurs as acute herpetic stomatitis (or gingivostomatitis), an oral manifestation of primary herpes simplex seen primarily in children and adolescents. Herpes Simplex (66-79); Herpesvirus Hominis (66-79); Herpesvirus Infections (66-79); Mouth Diseases (66-79); Stomatitis (66-79); Stomatitis, Aphthous (66-79)  U*PStomatitis, Denture C07.465.864.809 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Stomatitis Inflammation of the mouth due to denture irritation. Dental Prosthesis/AE (66-71); specific dental prosthesis/AE (66-71); Mouth Diseases (66-71); Stomatitis (66-71) X>N=@Stomatitis, Aphthous C07.465.864.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Stomatitis A disease of the oral mucosa of unknown etiology. It is characterized by recurrent small white ulcerative lesions. YN=Stomatitis C07.465.864 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Stevens-Johnson Syndrome; Stomatitis, Aphthous; Stomatitis, Denture; Stomatitis, Herpetic Inflammation of the oral mucosa, due to local or systemic factors, which may involve the buccal and labial mucosa, palate, tongue, floor of the mouth, and the gingivae. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  [DN/gPStomach, Ruminant A13.869 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Abomasum; Omasum; Reticulum; Rumen Stomach (66-67) ] :,Stomach, Avian A13.853 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Gizzard; Proventriculus Birds (66-67); Poultry (66-67); Stomach (66-67) ^ :<Stomach Volvulus C06.405.748.895 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Twisting of the stomach that may result in obstruction and impairment of the blood supply to the organ. It can occur in paraesophageal hernia and occasionally in eventration of the diaphragm. (Stedman, 25th ed). _wNRStomach Ulcer C06.405.613.860; C06.405.748.860 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases a^&NStomach Rupture C06.405.748.824; C21.866.017.809; C21.866.761.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Abdominal Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Rupture b9NStomach Neoplasms C04.588.274.476.767; C06.240.476.767; C06.405.282.767; C06.405.748.789 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases dmPXwStomach Diverticulum C06.405.748.753; C23.329.847 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Symptoms and General Pathology (Non MeSH); Diverticulum Saccular, outward protrusion of a portion of the mucous membrane of the stomach wall. f"NgStomach Diseases C06.405.748 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases Achlorhydria; Duodenogastric Reflux (+ 1); Gastric Fistula; Gastric Mucosa Prolapse; Gastric Outlet Obstruction (+ 1); Gastritis (+ 2); Gastroparesis; Stomach Dilatation; Stomach Diverticulum; Stomach Neoplasms; Stomach Rupture; Stomach Ulcer; Stomach Volvulus BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI hgN=5XStomach Dilatation C06.405.748.717 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Distention of the stomach with retained secretions, food, and/or gas due to obstruction, ileus, or denervation. (Dorland, 27th ed). jNRStomach A03.492.766 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Fundoplication; Gastrectomy; Gastroenterostomy; Gastroplasty; Gastroscopy; Gastrostomy Digestive System; Gastrointestinal System Cardia; Esophagogastric Junction; Gastric Fundus; Gastric Mucosa (+ 1); Gastric Stump; Pyloric Antrum; Pylorus The musculomembranous expansion of the alimentary canal between the esophagus and the duodenum. (Dorland, 27th ed). consider also terms at GASTR-. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $lT 8d1<Stochastic Processes E05.318.740.996; G03.850.520.830.996; H01.548.832.950; N05.715.360.750.770 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Markov Chains Markov Chains Markov Chains Markov Chains Processes that incorporate some element of randomness, used particularly to refer to a time series of random variables. nTBSTLV B04.820.650.400.851; B04.820.650.805.851; B04.909.574.807.400.851; B04.909.574.807.805.851; B04.909.777.731.400.851; B04.909.777.731.805.851 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; HTLV-BLV Viruses Viruses; RNA Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Simian A simian HTLV-BLV VIRUS species closely related to the human HTLV-I virus. The clinical, hematological, and histopathological characteristics of the disease in STLV-infected monkeys are very similar to those of human adult T-cell leukemia. Subgroups include the African green monkey subtype (STLV-I-AGM), for which the nucleotide sequence is 95% homologous with that of the HTLV-I virus, and the Asian rhesus macaque subtype (STLV-I-MM), for which the nucleotide sequence is 90% homologous with that of the HTLV-I virus. Monkey Diseases (78-88); Retroviridae (78-88) q"]7Stimulation, Chemical G12.836 Enzyme Induction Chemical, Pharmacologic Phenomena (Non MeSH) wa 4Stimulants (Historical) D26.851 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Agents or remedies that historically have produced stimulation or excited functional activity. (From Dorland, 27th ed). w ,2Still's Disease, Adult-Onset C05.550.114.154.870; C05.799.114.870; C17.300.775.099.870; C20.111.199.870 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Immunologic Diseases; Autoimmune Diseases; Arthritis, Rheumatoid Systemic-onset rheumatoid arthritis in adults. It differs from classical rheumatoid arthritis in that it is more often marked by acute febrile onset, and generalized lymphadenopathy and hepatosplenomegaly are more prominent. Arthritis, Juvenile Rheumatoid (66-91) y#"TNt-Stilbenes D02.455.426.559.389.150.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds Chlorotrianisene; Clomiphene; DIDS; Diethylstilbestrol (+ 1); SITS; Tamoxifen (+ 1) Organic compounds that contain 1,2-diphenylethylene as a functional group. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  | 8fW:Stilbamidines D02.078.766; D21.370.884.720 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents ~"8Stigmasterol D04.808.247.222.222.347.833; D04.808.247.808.756.808 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestadienes; Cholestadienols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Phytosterols Sterols (66-71) ::Stifle A13.473.683 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Animal Terms (Non MeSH); Hindlimb t 8+Stiff-Man Syndrome C05.651.504.900; C05.651.661.900; C10.228.900; C10.597.588.638.900; C10.668.900; C20.111.800; C23.888.592.588.638.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Muscle Rigidity Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Central Nervous System Diseases Nervous System Diseases; Neurologic Manifestations; Muscle Hypertonia; Muscle Rigidity Nervous System Diseases; Neuromuscular Diseases Immunologic Diseases; Autoimmune Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Muscle Hypertonia; Muscle Rigidity Rare central nervous system disorder of unknown etiology characterized by progressive rigidity and painful spasms of the axial and limb musculature. Diagnosis is based on the appropriate clinical signs, continuous motor activity on electromyography, and significant favorable response to diazepam. It has been suggested that the syndrome may result from an imbalance between the GABA-ergic and catecholaminergic pathways that control motor unit activity; the imbalance may be caused by autoantibodies against glutamic acid decarboxylase. Autoimmune Diseases (88-91); Central Nervous System Diseases (86-91); Fibromyalgia (66-76); Muscular Diseases (66-82); Neuromuscular Diseases (72-91) N;jStevens-Johnson Syndrome C07.465.864.558; C17.800.229.400.683; C17.800.865.475.683 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Stomatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema; Erythema Multiforme Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous; Erythema Multiforme A variant of bullous erythema multiforme. It ranges from mild skin and mucous membrane lesions to a severe, sometimes fatal systemic disorder. Ocular symptoms include ulcerative conjunctivitis, keratitis, iritis, uveitis, and sometimes blindness. The cause of the disease is unknown. uAN/JSterols D04.808.247.808; D10.516.851 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes Lipids and Antilipemic Agents (Non MeSH); Lipids Adosterol; Cholecalciferol (+ 5); Cholesterol (+ 8); Dihydrotachysterol; Ergocalciferols (+ 1); Fusidic Acid; Lanosterol; Phytosterols (+ 3); Solanine Cholecalciferol (+ 5); Cholesterol (+ 11); Dihydrotachysterol; Ergocalciferols (+ 1); Lanosterol AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  ":q*HSteroids, Heterocyclic D04.808.925 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Azasteroids (+ 1) Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with non-carbon atoms. specific steroid class compound (68-74); Steroids (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $.8(E:Steroids, Fluorinated D04.808.908 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Betamethasone (+ 2); Cronolone; Dexamethasone (+ 2); Fludrocortisone; Flumethasone; Fluocinolone Acetonide (+ 1); Fluocortolone (+ 1); Fluorometholone; Fluoxymesterone; Fluprednisolone; Flurandrenolone; Paramethasone; Triamcinolone (+ 1) Steroids which are substituted with one or more fluorine atoms in any position. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8(`:Steroids, Chlorinated D04.808.883 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Beclomethasone; Chlormadinone; Cyproterone (+ 1) Steroids which are substituted with one or more chlorine atoms in any position. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  x8(:`:Steroids, Brominated D04.808.875 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Steroids which are substituted with one or more bromine atoms in any position. Bromine (66-74); Steroids (66-74) 8(_*Steroids D04.808 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Receptors, Steroid Polycyclic Hydrocarbons Androstanes (+ 31); Bufanolides (+ 1); Cardanolides (+ 12); Catatoxic Steroids (+ 1); Cholanes (+ 21); Cholestanes (+ 59); Cyclosteroids; Estranes (+ 15); Gonanes; Homosteroids (+ 1); Hydroxysteroids; Ketosteroids (+ 9); Norsteroids (+ 22); Pregnanes (+ 73); Secosteroids (+ 9); Spirostans (+ 2); Steroids, Brominated; Steroids, Chlorinated (+ 4); Steroids, Fluorinated (+ 20); Steroids, Heterocyclic (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  8  <FSteroid 21-Hydroxylase D08.586.682.420.170.740; D08.586.682.420.783.760 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Steroid Hydroxylases Steroid,hydrogen-donor:oxygen oxidoreductase (21-hydroxylating). A steroid hydroxylase system found in adrenal cortex microsomes. It catalyzes the 21-hydroxylation of corticosteroids and shows a requirement for NADPH and molecular oxygen. Its deficiency is a cause of adrenogenital syndrome. EC 1.14.99.10. Steroid Hydroxylases (73-77) #6F`"Steroid 17-Hydroxylase D08.586.682.420.170.720; D08.586.682.420.783.745 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Steroid Hydroxylases Steroid, hydrogen-donor:oxygen oxidoreductase (17 alpha-hydroxylating). A steroid hydroxylase system found in the microsomal membrane of the steroid-hormone producing tissues. It catalyzes the 17-hydroxylation of steroids, such as progesterone or pregnenolone in the presence of NADPH and molecular oxygen. This is an important step in the biosynthesis of steroid hormones. EC 1.14.99.9. Steroid Hydroxylases (73-77) _6F"Steroid 12-Hydroxylase D08.586.682.420.170.710; D08.586.682.420.783.730 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Steroid Hydroxylases Steroid, hydrogen-donor:oxygen oxidoreductase (12-alpha-hydroxylating). A steroid hydroxylase found in liver microsomes. It catalyzes the 12-hydroxylation of steroids in the presence of NADPH, cytochrome P-450, and molecular oxygen. It is an important enzyme in the synthesis of cholic acid from cholesterol in the liver. EC 1.14.99.-. Steroid Hydroxylases (73-77) 6F"Steroid 11-Hydroxylase D08.586.682.420.170.700; D08.586.682.420.783.720 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Adrenal Hyperplasia, Congenital Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Steroid Hydroxylases A steroid hydroxylase system found in adrenal tissues. It catalyzes the 11-hydroxylation of steroids in the presence of molecular oxygen and consists of an NADPH-specific flavoprotein, a non-heme iron protein, and cytochrome P-450. Its deficiency is a cause of congenital adrenal hyperplasia (ADRENAL HYPERPLASIA, CONGENITAL). EC 1.14.15.4. Steroid Hydroxylases (73-77)  [6F%"Steroid Isomerases D08.586.399.860 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Catalyzes the transposition of double bond(s) in a steroid molecule. Isomerases (72-74); Ketosteroids (72-74) FSS1Steroid Hydroxylases D08.586.682.420.783 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases Cholesterol-7-Hydroxylase; 25-Hydroxycholecalciferol 1-Hydroxylase; Steroid 11-Hydroxylase; Steroid 12-Hydroxylase; Steroid 17-Hydroxylase; Steroid 21-Hydroxylase Hydroxylases (66-72) YFhSternum A02.835.232.904.766 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Thorax Manubrium; Xiphoid Bone , :ESternocostal Joints A02.835.583.790 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints 81Sternoclavicular Joint A02.835.583.781 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints 81Sterilization, Tubal E04.819.608.766; E04.887.599.683; E04.887.690.766 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sterilization Reversal Fallopian Tubes Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH); Sterilization, Sexual Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Gynecologic (Non MeSH) Fallopian Tubes (66-72); Sterilization, Sexual (66-72)  w9$ASterilization, Sexual E04.887.599 AECLCTECHIISLJMOMTNUPXRHSNSTTDUTVE Pest Control, Biological Population Control Surgery, Operative; Surgery, Urogenital (Non MeSH) Sterilization, Involuntary; Sterilization Reversal; Sterilization, Tubal; Vasectomy Procedures for the purpose of rendering individuals incapable of reproduction. $&<`\Sterilization, Involuntary E04.887.599.450 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Urogenital (Non MeSH); Sterilization, Sexual Sexual sterilization without consent of the patient. Sterilization, Sexual (66-77) H$W?#Sterilization Reversal E04.887.599.500 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sterilization, Tubal; Vasectomy Surgery, Operative; Surgery, Urogenital (Non MeSH); Sterilization, Sexual Reversal of sexual sterilization. Sterilization, Tubal (73-74); Vasectomy (73-74)  ~$&W)9Sterilization G03.850.780.200.450.850 CLECHIISLJMTOGSNSTTDUT Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Infection Control Disinfection The destroying of all forms of life, especially microorganisms, by heat, chemical, or other means. uSterigmatocystin D03.494.953.650; D24.185.926.587.850; D26.191.869 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 3a,12c-Dihydro-8-hydroxy-6-methoxy-7H-furo(3',2':4,5)furo (2,3-c)xanthen-7-one. A carcinogenic mycotoxin produced in high yields by strains of the common molds, Aspergillus versicolor, A. nidulans, and an unidentified species of Bipolaris. It causes necrosis of the liver and kidney and has an inhibitory effect on orotic acid incorporation into nuclear RNA. Furans (73-74); Xanthenes (69-74) r9<*Stereotyping F01.829.890 Social Perception Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social An oversimplified perception or conception especially of persons, social groups, etc. Stereotyped Behavior (73-80) Ld"Stereotyped Behavior F01.145.896; F03.126.892 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior (66-72); Behavior, Animal (66-72)   4Stereotaxic Techniques E04.530.832; E05.873 AECLCTECHIISMONUPXRHSNSTTDUTVE Brain Mapping Surgery, Operative; Neurosurgery Miscellaneous Techniques (Non MeSH) Radiosurgery Radiosurgery AECLCTECHIISMOMTNUPXRHSNSTTDUTVE  "O$Stereoisomers H01.181.404.705.682 Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic; Isomerism appropriate chemical heading U"Stereognosis F02.463.593.373.765; F02.463.593.885.682; G11.561.796.850.682 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Form Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Touch Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Touch Perception of shape and form of objects by touch. Form Perception (66-72); Touch (66-72) EP>0Stents E07.450.842; E07.858.650 AECLCTECHISDSNSTTDUTVE Splints Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting. Catheters, Indwelling (72-89); Implants, Artificial (72-89); Prosthesis (66-89); Splints (66-89)    fsStem Cells A11.872 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells Fibroblasts; Hematopoietic Stem Cells (+ 1); Tumor Stem Cells Relatively undifferentiated cells of the same lineage (family type) that retain the ability to divide and cycle throughout postnatal life to provide cells that can become specialized and take the place of those that die or are lost. Cell Differentiation (66-83); Cell Line (69-83); Cells, Cultured (72-83); Colony-Forming Units Assay (79-83)   * LStellate Ganglion A08.340.315.350.800; A08.800.050.300.300.800; A08.800.050.800.300.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Autonomic; Ganglia, Sympathetic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Ganglia, Autonomic; Ganglia, Sympathetic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Sympathetic Nervous System; Ganglia, Sympathetic A paravertebral sympathetic ganglion formed by the fusion of the inferior cervical and first thoracic ganglia. <M8SSteel D01.485.910; D01.552.033.847; D25.058.807 AEANCHCLDUECHIIPPDPKPORESDSTTO Inorganic Chemicals (Non MeSH); Iron Compounds Inorganic Chemicals (Non MeSH); Metals; Alloys Biomedical and Dental Materials (Non MeSH); Alloys Stainless Steel Stainless Steel Stainless Steel Steel. A tough, malleable, iron-based alloy containing up to, but no more than, two percent carbon and often other metals. It is used in medicine and dentistry in implants and instrumentation.  1"8Steatitis C18.654.223.133.841.682; C22.880 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin E Deficiency Animal Diseases A disease of cats and mink characterized by a marked inflammation of adipose tissue and the deposition of "ceroid" pigment in the interstices of the adipose cells. It is believed to be caused by feeding diets containing too much unsaturated fatty acid and too little vitamin E. (Merck Veterinary Manual, 5th ed; Stedman, 25th ed). Selenium (66-70); Swine Diseases (66-70); Vitamin E Deficiency/VE (66-70)  &JZStearoyl-CoA Desaturase D08.586.682.420.375.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Fatty Acid Desaturases An enzyme that catalyzes the formation of oleoyl-CoA, A, and water from stearoyl-CoA, AH2, and oxygen where AH2 is an unspecified hydrogen donor. EC 1.14.99.5. Coenzyme A (73-74); Hydroxylases (73-74); Stearic Acid (73-74) EFMStearic Acids D02.241.081.407.832; D10.516.251.882 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Stearates Stearates w*8Stearates D02.241.081.407.832.800; D10.516.251.882.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Stearic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Stearic Acids Salts and esters of the 18-carbon saturated, monocarboxylic acid--stearic acid. Stearic Acids (66-74)  28]Steam G03.230.700.435 AEAN Environment and Public Health (Non MeSH); Environment; Water  JStavudine D13.570.230.500.850; D13.570.230.855.875; D13.570.685.705.875; D20.388.330.850; D26.087.295.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Dideoxynucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Thymidine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Thymidine Anti-Infective Agents; Antiviral Agents; Dideoxynucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Dideoxynucleosides 2',3'-Didehydro-3'-deoxythymidine. A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. Dideoxynucleosides (89-93); Thymidine/analogs and derivatives (87-88) U k:QStatus Epilepticus C10.228.140.490.690 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy Epilepsia Partialis Continua A series of rapidly repeated seizures without regaining consciousness between them. Epilepsy (66-76)  Nb"bStatus Asthmaticus C08.127.108.880; C08.674.095.880; C20.543.480.680.095.880 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases; Asthma Respiratory Tract Diseases; Respiratory Hypersensitivity; Asthma Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity; Asthma A sudden intense and continuous aggravation of a state of asthma, marked by dyspnea to the point of exhaustion and collapse and not responding to the usual therapeutic efforts. Asthma (66-84) ANStatistics, Nonparametric E05.318.740.995; G03.850.520.830.995; H01.548.832.925; N05.715.360.750.760 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics A class of statistical methods applicable to a large set of probability distributions used to test for correlation, location, independence, etc. In most nonparametric statistical tests, the original scores or observations are replaced by another variable containing less information. An important class of nonparametric tests employs the ordinal properties of the data. Another class of tests uses information about whether an observation is above or below some fixed value such as the median, and a third class is based on the frequency of the occurrence of runs in the data. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1284; Corsini, Concise Encyclopedia of Psychology, 1987, p764-5). Statistics (66-94) rTAStatistics E05.318.740; G03.850.520.830; H01.548.832; N05.715.360.750 CLECEDHIISLJMAMTOGSTTD Bibliometrics; Biometry; Meta-Analysis; Models, Statistical; Psychometrics; Sociometric Techniques Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Physical Sciences (Non MeSH); Mathematics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Actuarial Analysis; Analysis of Variance (+ 1); Cluster Analysis (+ 2); Confidence Intervals; Data Interpretation, Statistical; Discriminant Analysis; Factor Analysis, Statistical; Matched-Pair Analysis; Models, Statistical (+ 6); Monte Carlo Method; Probability (+ 9); Regression Analysis (+ 4); Sensitivity and Specificity; Statistical Distributions (Non MeSH) (+ 4); Statistics, Nonparametric; Stochastic Processes (+ 1); Survival Analysis (+ 1) Actuarial Analysis; Analysis of Variance (+ 1); Cluster Analysis (+ 2); Confidence Intervals; Data Interpretation, Statistical; Discriminant Analysis; Factor Analysis, Statistical; Matched-Pair Analysis; Models, Statistical (+ 6); Monte Carlo Method; Probability (+ 9); Regression Analysis (+ 4); Sensitivity and Specificity; Statistical Distributions (Non MeSH) (+ 4); Statistics, Nonparametric; Stochastic Processes (+ 1); Survival Analysis (+ 1) Actuarial Analysis (+ 1); Analysis of Variance (+ 1); Biometry; Cluster Analysis (+ 2); Confidence Intervals; Data Interpretation, Statistical; Discriminant Analysis; Factor Analysis, Statistical; Matched-Pair Analysis; Monte Carlo Method; Probability (+ 10); Regression Analysis (+ 4); ROC Curve; Sensitivity and Specificity; Statistical Distributions (Non MeSH) (+ 4); Statistics, Nonparametric; Stochastic Processes (+ 1); Survival Analysis (+ 1) Actuarial Analysis; Analysis of Variance (+ 1); Cluster Analysis (+ 2); Confidence Intervals; Data Interpretation, Statistical; Discriminant Analysis; Factor Analysis, Statistical; Matched-Pair Analysis; Models, Statistical (+ 6); Monte Carlo Method; Probability (+ 9); Regression Analysis (+ 4); Sensitivity and Specificity; Statistical Distributions (Non MeSH) (+ 4); Statistics, Nonparametric; Stochastic Processes (+ 1); Survival Analysis (+ 1) The science and art of collecting, summarizing, and analyzing data that are subject to random variation. The term is also applied to the data themselves and to the summarization of the data. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $DrRE*Statistical Distributions (Non MeSH) E05.318.740.994; G03.850.520.830.994; H01.548.832.901; N05.715.360.750.750 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Binomial Distribution; Chi-Square Distribution; Normal Distribution; Poisson Distribution Binomial Distribution; Chi-Square Distribution; Normal Distribution; Poisson Distribution Binomial Distribution; Chi-Square Distribution; Normal Distribution; Poisson Distribution Binomial Distribution; Chi-Square Distribution; Normal Distribution; Poisson Distribution The complete summaries of the frequencies of the values or categories of a measurement made on a group of items, a population, or other collection of data. The distribution tells either how many or what proportion of the group was found to have each value (or each range of values) out of all the possible values that the quantitative measure can have. +TState Medicine N03.858 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH) A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.  4State Health Plans N03.349.650.480 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning State plans prepared by the State Health Planning and Development Agencies which are made up from plans submitted by the Health Systems Agencies and subject to review and revision by the Statewide Health Coordinating Council. NgState Health Planning and Development Agencies N03.540.452.508 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Health Planning Organizations Health Systems Agencies Agencies established under PL93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual State Health Plan and giving assistance to the Statewide Health Coordinating Council. Health Planning (68-79); Regional Health Planning (77-79)  !7i&EState Government I01.409.700 Social Sciences; Government The complex of political institutions, laws, and customs through which the function of governing the state is carried out (U.S. only). "State Dentistry N03.787 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH) Control, direction and financing of the total dental care of the population by a national government. State Medicine  4yStarvation C18.654.832 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hunger Food Deprivation; Fasting Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders N  OStartle Reaction E01.236.563.642.847; E01.706.592.642.847; F02.830.702.807; G11.561.730.869 DEGEIMPHRE Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Psychologic Processes and Principles (Non MeSH); Psychophysiology; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex A complex involuntary response to an unexpected strong stimulus usually auditory in nature. TilStarfish B01.408.765 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Echinodermata Echinoderms having bodies of usually five radially disposed arms coalescing at the center. Echinodermata (66-71) 9 ("kStarch (Bacterial Glycogen) Synthase D08.586.913.400.450.460.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases An enzyme that catalyzes the transfer of glucose from ADPglucose to glucose-containing polysaccharides in 1,4-alpha-linkages. It covers starch and glycogen synthases utilizing ADPglucose as a donor. EC 2.4.1.21. Adenosine Diphosphate (73-74); Glucosyltransferases (73-74); Nucleoside Diphosphate Sugars (73-74) J+FrStarch D09.203.698.365.855 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Amylopectin; Amylose; Dextrins (+ 1); Hydroxyethyl Starch  FiGStaphylococcus Phages B04.123.831 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses whose host is Staphylococcus. >.Staphylococcus epidermidis B03.510.400.500.846.343 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Micrococcaceae; Staphylococcus A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader. Staphylococcus (66-83) "cStaphylococcus aureus B03.510.400.500.846.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Micrococcaceae; Staphylococcus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and peritoneum of warm-blooded animals. They may cause a wide range of infections and intoxications. Staphylococcus (66-74) "cStaphylococcus B03.510.400.500.846 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Micrococcaceae Staphylococcus aureus; Staphylococcus epidermidis A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals. "Q9Staphylococcal Vaccines D24.310.894.135.744 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines \>pStaphylococcal Toxoid D24.310.794.681 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Toxoids \DXStaphylococcal Skin Infections C01.252.410.868.820; C01.252.825.770; C01.539.800.720.770; C17.800.838.765.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Furunculosis (+ 1); Impetigo; Staphylococcal Scalded Skin Syndrome Furunculosis (+ 1); Impetigo; Staphylococcal Scalded Skin Syndrome Furunculosis (+ 1); Impetigo; Staphylococcal Scalded Skin Syndrome Furunculosis (+ 1); Impetigo; Staphylococcal Scalded Skin Syndrome Infections to the skin caused by bacteria of the genus STAPHYLOCOCCUS. Skin Diseases, Infectious (68-85); Staphylococcal Infections (66-85)  D$XP:UPStaphylococcal Scalded Skin Syndrome C01.252.410.868.820.770; C01.252.825.770.770; C01.539.800.720.770.770; C17.800.838.765.770.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections; Staphylococcal Skin Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections A disease of infants due to group 2 phage type 17 staphylococci that produce an epidermolytic exotoxin. Superficial fine vesicles and bullae form and rupture easily, resulting in loss of large sheets of epidermis. Epidermal Necrolysis, Toxic (66-85); Staphylococcal Infections (66-85)  +hPRStaphylococcal Protein A D12.776.097.820; D24.611.216.161.821 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IgG. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function. Antigens, Bacterial (71-77); Bacterial Proteins (66-77); Staphylococcus (66-75); Staphylococcus aureus (76-77) *4Staphylococcal Infections C01.252.410.868 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Cross Infection Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections Pneumonia, Staphylococcal; Staphylococcal Food Poisoning; Staphylococcal Skin Infections (+ 4) Infections with bacteria of the genus STAPHYLOCOCCUS.  Psm@Staphylococcal Food Poisoning C01.252.410.868.806; C21.613.415.846 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Enterotoxins Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Food Poisoning Poisoning by staphylococcal toxins present in contaminated food. {#*NLStapes Surgery E04.847.774.731 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ear Ossicles Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Stapes Mobilization $eStapes Mobilization E04.847.774.731.681 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Otosclerosis Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH); Stapes Surgery $yStapes A09.246.397.247.806 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISETRULUSVI Sense Organs; Ear; Ear, Middle; Ear Ossicles ~ 89Stapedius A02.633.567.950; A09.246.397.727 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Sense Organs; Ear; Ear, Middle The stapedius muscle arises from the wall of the middle ear and is inserted into the neck of the stapes. Its action is to pull the head of the stapes backward. Ear, Middle (66-78); Ear Ossicles (66-78); Stapes (75-78) / &:aHStanozolol D04.808.054.040.881; D06.597.100.194.893 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids /.:Stanolone D04.808.054.040.831; D06.472.079.810 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Mesterolone  *:Stanford-Binet Test F04.711.141.493.225 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Aptitude Tests; Intelligence Tests An individual intelligence test designed primarily for school children to predict school performance and the ability to adjust to everyday demands. Intelligence Tests (66-74)   | Stains and Staining E05.909.262.620.670; E05.909.432.600.670 CLECHIISMTSNSTTDUTVE Dyes Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques Chromosome Banding; Negative Staining; Periodic Acid-Schiff Reaction; Prussian Blue Reaction; Shadowing (Histology); Silver Staining Chromosome Banding; Negative Staining; Periodic Acid-Schiff Reaction; Prussian Blue Reaction; Shadowing (Histology); Silver Staining The use of a dye, reagent, or other material for producing coloration in tissues or microorganisms for microscopic examination.  "f.4Stainless Steel D01.485.910.900; D01.552.033.847.681; D25.058.807.681 AEANCHCLDUECHIIPPDPKPORESDSTTO Inorganic Chemicals (Non MeSH); Iron Compounds; Steel Inorganic Chemicals (Non MeSH); Metals; Alloys; Steel Biomedical and Dental Materials (Non MeSH); Alloys; Steel Stainless steel. A steel containing Ni, Cr, or both. It does not tarnish on exposure and is used in corrosive environments. (Grant and Hack's Chemical Dictionary, 5th ed). %="Staff Development I02.574.700; N04.452.677.822 CLECHILJMAMTOGSDSNSTTDUT Education; Inservice Training Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The process by which the employer promotes staff performance and efficiency consistent with management goals and objectives. Education, Nursing, Continuing (66-85); Inservice Training (67-85); Nursing Staff, Hospital/education (68-85) ("Stachybotrys B05.354.381.546.840 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses. *""NSSPE Virus B04.265.700; B04.820.455.600.650.500.500.890; B04.909.777.455.600.650.500.500.890 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Morbillivirus; Measles Virus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Morbillivirus; Measles Virus A defective variant of measles virus (MORBILLIVIRUS genus) that has been isolated from the brain tissue of patients with subacute sclerosing panencephalitis. Subacute Sclerosing Panencephalitis (71-77) +wY02SRS-A D02.241.081.436.213.100.450.855; D10.516.251.355.255.100.450.855; D17.350.050.175.450.725 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Anaphylaxis Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Leukotrienes Leukotriene C4; Leukotriene D4; Leukotriene E4 Leukotriene C4; Leukotriene D4; Leukotriene E4 Leukotriene C4; Leukotriene D4; Leukotriene E4 A group of leukotrienes (LTC4, LTD4, and LTE4) that is the major mediator of bronchial constriction and other allergic reactions. Earlier studies had described a "slow-reacting substance of anaphylaxis" released from guinea pig and cat lung by cobra venom, and in guinea pig lung after anaphylactic shock. The relationship between SRS-A and members of the leukotriene family was established following publication of the UV spectrum of purified SRS-A, that showed the presence of the conjugated triene. (From Merck Index, 11th ed). Anaphylaxis (66); Muscle, Smooth/physiology (66) $.= aDk;Sri Lanka Z01.252.245.840 EHEP Geographicals (Non MeSH); Asia; Asia, Western 4g9Squid B01.644.857 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca A ten-armed cephalopod mollusk of the order Decapoda. It includes the squid as food. Mollusca (66-72) 4 (gSqualene Synthetase D08.586.682.820 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Catalyzes the rearrangement and reduction of the cyclopropane compound, presqualene pyrophosphate to form squalene, with NADPH as the coenzyme. Farnesol (72-74); Ligases (72-74); Pyrophosphoric Acids (72-74); Squalene (72-74) 5FXcSqualene D02.455.326.271.665.806; D02.455.849.919.681 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Triterpenes 7 2:SQ 18506 D02.640.600.900; D03.383.312.649.900; D03.383.548.580.650; D21.201.412.596.660; D21.370.884.660 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Oxadiazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents trans-5-Amino-3-[2-(5-nitro-2-furyl)vinyl]- 1,2,4-oxadiazole. A nitrovinyl furan used as schistosomicidal agent and proposed for trypanosomiasis, especially Chagas disease. Nitrofurans (72-74); Oxadiazoles (72-74); Vinyl Compounds (72-74) 98 k:OSputum A12.838.808 CHCYDEENIMMEMIPHPSRARERISEUSVI Drainage, Postural Fluids and Secretions (Non MeSH); Secretions (Non MeSH) < "DSpumavirus B04.820.650.850; B04.909.777.731.850 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Genus of non-oncogenic retroviruses which establish persistent infections in many animal species but are considered non-pathogenic. Its organisms have been isolated from primates (including man), cattle, cats, hamsters, and sea lions. Spumaviruses have a foamy or lace-like appearance and are often accompanied by syncytium formation. Human foamy virus is the type species. Foamy Virus (75-90); Retroviridae (77-90) =*y3Sprue, Tropical C06.405.469.637.850; C18.452.603.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Malabsorption Syndromes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Malabsorption Syndromes A malabsorption syndrome occurring in the tropics and subtropics. Protein malnutrition is usually precipitated by the malabsorption, and anemia due to folic acid deficiency is particularly common. Administration of antibiotics (especially tetracycline) and folic acid usually results in remission. (Dorland, 27th ed). @{*NoSpreading Cortical Depression G11.561.880 DEGEIMPHRE Cerebral Cortex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Cr#hSprains and Strains C21.866.844 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Repetition Strain Injury A collective term for muscle and ligament injuries without dislocation or fracture. A sprain is a joint injury in which some of the fibers of a supporting ligament are ruptured but the continuity of the ligament remains intact. A strain is an overstretching or overexertion of some part of the musculature. DQNQkSpouses F01.829.263.500.660; I01.880.225.500.670; M01.816 CLEDEHHILJPXSN Marriage Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family Social Sciences; Sociology; Family; Nuclear Family Named Groups (Non MeSH) Men or women joined in wedlock; married persons; husbands or wives. (From Webster, 3d ed). Marriage (66-94)  F 9 qSpouse Abuse F03.126.842.089.734.350.750; I01.198.240.856.350.750; I01.880.735.900.350.750 CLDIECEHHILJPCPXSNTD Battered Women Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence; Domestic Violence Social Sciences; Criminology; Crime; Violence; Domestic Violence Social Sciences; Sociology; Social Problems; Violence; Domestic Violence Deliberate severe and repeated physical injury to the wife or husband by the other marital partner. HUJwSports Medicine G02.403.830 CLECEDHIISLJMAMTOGSNSTTD Athletic Injuries; Protective Devices Health Occupations; Medicine The field of medicine concerned with physical fitness and the diagnosis and treatment of injuries sustained in sports activities. K-#Sports I03.450.642.845 CLECEDHILJPHPXSNSTTD Athletic Injuries; Doping in Sports Exertion Human Activities (Non MeSH); Leisure Activities; Recreation Baseball; Basketball; Bicycling; Boxing; Football; Golf; Gymnastics; Hockey; Martial Arts; Mountaineering; Racquet Sports (+ 1); Running (+ 1); Skating; Skiing; Soccer; Swimming (+ 1); Track and Field; Walking; Weight Lifting; Wrestling Activities or games, usually involving physical effort or skill. Reasons for engagement in sports include pleasure, competition, and/or financial reward. AECLECEDHIINLJPHPXSNSTTD (Lc , H$Sporozoea Infections C03.752.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections Babesiosis; Coccidiosis (+ 14); Theileriasis Infections with protozoa of the class SPOROZOEA. O>P07;Sporozoea B01.841.075.762 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa Coccidia (+ 21); Piroplasmia (+ 6) A class of homoxenous or heteroxenous parasitic protozoa exhibiting both sexual and asexual phases. Locomotion is by body flexion, gliding, or undulations of longitudinal ridges. Pseudopods, if present, are used only for feeding. It comprises three subclasses: Gregarinia, COCCIDIA, and PIROPLASMIA. P &,-[Sporotrichum B05.354.381.546.821 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes R"NSporotrichosis C01.539.800.200.675; C01.703.295.675; C17.800.838.208.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound. SVAP7Sporidesmins D03.438.473.840; D24.185.926.587.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins A group of related mycotoxins produced by the pasture fungus Pithomyces chartarum (formerly Sporidesmium bakeri); causes liver damage and facial eczema in cattle and sheep. Indoles (66-74); Pyrazines (66-74); Pyrroles (66-74) VE*8ASpores, Fungal B05.845.680 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Spores Reproductive bodies produced by fungi. Fungi (66-70); specific fungus; Spores (66-70) X"-/:Spores, Bacterial B03.867.680 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spores Heat and stain resistant, metabolically inactive bodies formed within the vegetative cells of bacteria of the genera Bacillus and Clostridium. Bacteria (66-70); specific bacterium; Spores (66-70) Y"@Spores B03.867; B05.845 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Algae and Fungi (Non MeSH) Spores, Bacterial Spores, Fungal The reproductive elements of lower organisms, such as protozoa, fungi, and cryptogamic plants. [  ",'oSporadotrichina B01.841.185.700.400.750 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Polymenophorea; Hypotrichida Euplotes; Oxytricha A suborder of ciliate protozoa having a body that is commonly oval to elliptical in shape. Most species are free-living in widely diverse habitats. \5&MSpontaneous Combustion G03.230.100.120.555; H01.181.529.860 HI Environment and Public Health (Non MeSH); Environment; Disasters; Fires Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical A circumstance where a substance or organism takes fire and burns without an exogenous source. Spontaneous human combustion differs from preternatural human combustibility in that in the latter, some spark or trivial flame sets the fire and the body tissues, which have a greatly enhanced inflammability, continue to undergo incineration without any external heat source or combustible materials. (Bergman NA. Spontaneous human combustion: its role in literature and science. Pharos 1988;Fall;51(4):18-21). ]*LSpondylolysis C05.116.900.877.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spondylolisthesis Dissolution of a vertebra, especially the pars interarticularis. aNXLSpondylolisthesis C05.116.900.877 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Spondylolysis Forward displacement of one vertebra over another. b[NC=Spondylitis, Ankylosing C05.116.900.853.750; C05.550.069.680; C05.550.114.154.856; C05.799.114.856; C17.300.775.099.856; C20.111.199.856 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spondylitis Musculoskeletal Diseases; Joint Diseases; Ankylosis Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Immunologic Diseases; Autoimmune Diseases; Arthritis, Rheumatoid The form of rheumatoid arthritis affecting the spine. It occurs predominantly in young males and produces pain and stiffness as a result of inflammation of the sacroiliac, intervertebral, and costovertebral joints. Etiology is unknown. c~NSpondylitis C05.116.165.762; C05.116.900.853 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH) Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Discitis Discitis; Spondylitis, Ankylosing g&N2Spodoptera B01.131.617.561.650.700 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lepidoptera; Moths A genus of owlet moths of the family Noctuidae. These insects are used in molecular biology studies during all stages of their life cycle. Insects (66-74); Lepidoptera (75-90); Moths (75-94) i(B@Splints E07.858.442.660.845 AECLCTECHISDSNSTTDUTVE Stents Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices j  mSpliceosomes A11.368.702.840 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI RNA Splicing RNA Splicing Cells; Cytoplasm; Organelles Organelles in which the splicing and excision reactions that remove introns from precursor messenger RNA molecules occur. One component of a spliceosome is five small nuclear RNA molecules (U1, U2, U4, U5, U6) that, working in conjunction with proteins, help to fold pieces of RNA into the right shapes and later splice them into the message. Ribonucleoproteins (86-92) $k*$Splenosis C15.604.744.742.500; C21.866.017.680.500; C21.866.761.555.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Splenic Diseases Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases; Splenic Rupture Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Abdominal Injuries; Splenic Rupture Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Rupture; Splenic Rupture The spontaneous transplantation of splenic tissue to unusual sites after open splenic trauma, e.g., after automobile accidents, gunshot or stab wounds. The splenic pulp implants appear as red-blue nodules on the peritoneum, omentum, and mesentery, morphologically similar to multifocal pelvic endometriosis. (Dictionary of Modern Medicine, 1992). Spleen (66-93); Splenic Diseases (66-93); Splenic Rupture (66-93)  n ENYPSplenorenal Shunt, Surgical E04.752.814.790.870; E04.035.760.835 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Portasystemic Shunt, Surgical Surgery, Operative; Anastomosis, Surgical; Portasystemic Shunt, Surgical Anastomosis of splenic vein to renal vein to relieve portal hypertension. Esophageal and Gastric Varices/surgery (66-80); Hypertension, Portal/surgery (66-80); Renal Veins/surgery (66-80); Splenic Vein/surgery (66-80) r!*$XSplenomegaly C15.604.744.805 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases tN]Splenic Vein A07.231.908.670.730 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins; Portal System Vein formed by the union (at the hilus of the spleen) of several small veins from the stomach, pancreas, spleen and mesentery. um8GSplenic Rupture C15.604.744.742; C21.866.017.680; C21.866.761.555 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Abdominal Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Rupture Splenosis Splenosis Splenosis v9N#Splenic Neoplasms C04.588.842; C15.604.744.680 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases x"XSplenic Infarction C15.604.744.617 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Infarction Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases Insufficiency of arterial or venous blood supply to the spleen due to emboli, thrombi, vascular torsion, or pressure that produces a macroscopic area of necrosis. (From Stedman, 25th ed). zN]Splenic Diseases C15.604.744 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Splenosis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Hypersplenism; Myeloid Metaplasia; Splenic Infarction; Splenic Neoplasms; Splenic Rupture (+ 1); Splenomegaly; Tuberculosis, Splenic BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  {N HZSplenic Artery A07.231.114.814 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The largest branch of the celiac trunk with distribution to the spleen, pancreas, stomach and greater omentum. }88Splenectomy E04.726 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Spleen Surgery, Operative  $ Spleen Focus-Forming Viruses B04.820.650.730.730.900.500.850; B04.909.574.807.730.730.900.500.850; B04.909.777.731.730.730.900.500.850 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Murine leukemia viruses that are replication-defective and rapidly transforming. The envelope gene plays an essential role in initiating erythroleukemia, manifested by splenic foci, splenomegaly, and polycythemia. Spleen focus-forming viruses are generated by recombination with other viral types including Friend P (polycythemia), Friend A (anemia), Rauscher, and Cas (from wild mice at Lake Casita, California). Friend Virus (66-85); Leukemia, Experimental (66-85); Mouse Leukemia Viruses (66-85) "qAeSpleen A15.382.520.604.713 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Splenectomy Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphoid Tissue  :hSplanchnic Nerves A08.800.050.050.800; A08.800.050.800.800; A08.800.800.060.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Autonomic Nervous System; Sympathetic Nervous System Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways The major nerves supplying sympathetic innervation to the abdomen. The greater, lesser, and lowest (or smallest) splanchnic nerves are formed by preganglionic fibers from the spinal cord which pass through the paravertebral ganglia and then to the celiac ganglia and plexuses. The lumbar splanchnic nerves carry fibers which pass through the lumbar paravertebral ganglia to the mesenteric and hypogastric ganglia. E82Splanchnic Circulation G09.330.163.881 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation Liver Circulation The circulation of blood through the vessels supplying the abdominal viscera. \Spiruroidea B01.500.294.700.750.700.680 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina A superfamily of parasitic nematodes which requires one or two intermediate arthropod hosts before finally being eaten by the final host. Its organisms occur rarely in man. *SSpirurina B01.500.294.700.750.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida Filarioidea (+ 15); Spiruroidea; Thelazioidea (+ 1) A suborder of nematodes characterized by larvae possessing cephalic hooks and multinucleated esophageal glands.  *F@Spirurida Infections C03.335.508.700.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections Dracunculiasis; Filariasis (+ 8) Infections with nematodes of the order SPIRURIDA. P[(<Spirurida B01.500.294.700.750 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea Camallanina (+ 2); Spirurina (+ 19) An order of nematodes of the subclass SECERNENTEA. Characteristics include ventral or caudoventral papillae and an esophagus divided into anterior muscular and posterior glandular parts.  *9.Spirostans D04.808.854 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Sapogenins (+ 1) Steroid derivatives containing a fused lactone ring at the 16,17-position and a spiroglycosidic linkage at C-22. The most common representatives in this group are the plant-derived SAPOGENINS. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  68(:Spiroplasmataceae B03.440.560.580.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales Spiroplasma A family of bacteria consisting of helical cells that require sterols for growth. "HbSpiroplasma B03.440.560.580.625.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Spiroplasmataceae Gram-negative organisms isolated from the leaves of citrus plants affected by "Stubborn" disease. Bacteria (66-74); Mycoplasmatales (75) <"]r/Spironolactone D02.540.679; D04.808.745.745.855; D06.347.050.735; D19.770.224.862 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Lactones Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Aldosterone Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics (7 alpha,17 alpha)-7-(Acetylthio)-17-hydroxy-3-oxopregn- 4-ene-21-carboxylic acid, gamma-lactone. L:9nSpirometry E01.302.796.733 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Bronchospirometry Measurement of volume of air inhaled or exhaled by the lung. "^KSpirometra B01.500.736.215.800 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda Sparganum A genus of tapeworms of the family Diphyllobothriidae, which are parasites of fish-eating cats, dogs, and birds. Infection in man is caused by eating undercooked fish. The larval form is called SPARGANUM. Cestoda (66-78); Sparganum (75-78)  7*; +Spirochaetales Infections C01.252.847 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Borrelia Infections (+ 3); Leptospirosis (+ 1); Treponemal Infections (+ 11) Infections with bacteria of the order SPIROCHAETALES. Spirochaeta (66-71)  PK^@Spirochaetales B03.851 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Leptospiraceae (+ 3); Spirochaetaceae (+ 7) An order of slender, flexuous, helically coiled bacteria, with one or more complete turns in the helix.  " 6|Spirochaetaceae B03.851.595 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales Borrelia (+ 1); Serpulina (+ 1); Spirochaeta; Treponema (+ 1) A family of spiral bacteria of the order SPIROCHAETALES. Bacteria (66-74)  "OESpirochaeta B03.851.595.679 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales; Spirochaetaceae A genus of flexible, spiral rods found in hydrogen sulfide-containing mud, sewage, and polluted water. None of the species properly referred to in this genus are pathogenic. "1Spiro Compounds D04.615.885 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Buspirone; Fluorescamine; Fluoresceins (+ 5); Fluspirilene; Leucogenenol; Prospidium; Spiperone A group of compounds consisting in part of two rings sharing one carbon atom in common. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ~8Prk:Spiritualism K01.844.799.679 HIPX Humanities; Religion; Religious Philosophies (Non MeSH) Religious philosophy expressing the fundamental belief that departed spirits may be contacted by the living through a medium. kBSpirillum B03.825.825 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spiral and Curved Bacteria (Non MeSH) A genus of gram-negative, curved and spiral-shaped bacteria found in stagnant, freshwater environments. These organisms are motile by bipolar tufts of flagella having a long wavelength and about one helical turn.  ":Spiramycin D20.085.115.362.700; D21.370.400.910 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Leucomycins Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats Spiramycin. A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii. Leucomycins (81-89) !*<Spiral Lamina A09.246.631.246.930 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea The bony plate which extends outwards from the modiolus. It is part of the structure which divides trhe cochlea into sections. Cochlea (66-78) :0Spiral Ganglion A08.340.390.800; A08.800.350.800; A08.800.800.120.090.120.800; A09.246.631.246.900 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Sensory Nervous System; Peripheral Nervous System; Ganglia, Sensory Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Acoustic Nerve; Cochlear Nerve Sense Organs; Ear; Labyrinth; Cochlea The sensory ganglion of the cochlear nerve. The cells of the spiral ganglion send fibers peripherally to the cochlear hair cells and centrally to the cochlear nuclei of the brain stem. Cochlea (66-78); Cochlear Nerve (66-78); Ganglia (66-78); Organ of Corti (68-78) \8%dSpiral and Curved Bacteria (Non MeSH) B03.825 Bacteria Azospirillum (+ 1); Bdellovibrio; Campylobacter (+ 3); Gastrospirillum (+ 1); Helicobacter (+ 1); Spirillum CHCLCYDEENGDGEIMIPMEPHPYREULVI ,.  "Spiperone D02.522.352.800; D04.615.885.800; D14.100.150.175.862; D15.150.015.750; D15.210.950.040.015.750; D15.700.872.331.015.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butyrophenones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of schizophrenia. Benzoates (66-74); Butyrophenones (66-74); Spiro Compounds (66-74) ; :PSpinothalamic Tracts A08.186.854.761; A08.612.220.735 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Spinal Cord Nervous System; Neural Pathways; Afferent Pathways Spinal Cord (66-70); Thalamus (66-70) &6z/Spinocerebellar Degeneration C10.228.140.252.253.871 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases; Cerebellar Ataxia Ataxia Telangiectasia; Cerebellar Dyssynergia; Friedreich's Ataxia; Machado-Joseph Disease; Olivopontocerebellar Atrophy Degeneration of the nervous system involving the cerebellum and its afferent and efferent pathways. Ataxia is a principal symptom and most of these conditions are hereditary. Cerebellar Ataxia (68-86); Cerebellar Diseases (66-86); Spinal Cord Diseases (66-86)  =!NeSpine A02.835.232.834 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUULUSVI Laminectomy Musculoskeletal System; Skeleton; Bone and Bones Cervical Vertebrae (+ 3); Coccyx; Intervertebral Disk; Lumbar Vertebrae; Sacrum; Spinal Canal (+ 1); Thoracic Vertebrae consider also terms at SPONDYL- and VERTEBRAL. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $1 6;9:Spinal Stenosis C05.116.900.805 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Narrowing of the spinal canal. Constriction, Pathologic (76-82); Lumbar Vertebrae (66-82); Spinal Canal (66-82); Spinal Diseases (66-82) NC'~Spinal Puncture E01.223.230.680; E01.223.894.632.804; E01.236.890 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Cytodiagnosis Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures Diagnosis; Diagnosis, Neurologic (Non MeSH) Tapping of the subarachnoid space in the lumbar region, usually between the third and fourth lumbar vertebrae. 9&Spinal Osteophytosis C05.116.900.802; C05.550.114.606.761; C05.799.613.678 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Musculoskeletal Diseases; Joint Diseases; Arthritis; Osteoarthritis Musculoskeletal Diseases; Rheumatic Diseases; Osteoarthritis Barre-Lieou Syndrome; Hyperostosis, Diffuse Idiopathic Skeletal Barre-Lieou Syndrome Barre-Lieou Syndrome Outgrowth of immature bony processes from the vertebrae, reflecting the presence of degenerative disease and calcification. It includes cervical and lumbar spondylosis. P=NwSpinal Nerves A08.800.800.720 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves Brachial Plexus (+ 4); Cervical Plexus (+ 1); Lumbosacral Plexus (+ 6); Spinal Nerve Roots (+ 2); Thoracic Nerves (+ 1) The 31 paired peripheral nerves formed by the union of the dorsal and ventral spinal roots from each spinal cord segment. The spinal nerve plexuses and the spinal roots are also included. )8HSpinal Nerve Roots A08.800.800.720.725 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Polyradiculitis; Radiculitis Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves Cauda Equina; Ganglia, Spinal The paired bundles of nerve fibers entering and leaving the spinal cord at each segment. The dorsal and ventral nerve roots join to form the mixed segmental spinal nerves. The dorsal roots are generally afferent, formed by the central projections of the spinal (dorsal root) ganglia sensory cells, and the ventral roots efferent, comprising the axons of spinal motor and autonomic preganglionic neurons. There are, however, some exceptions to this afferent/efferent rule. Spinal Nerves (66-69) ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI (l6"Z%'8Spinal Neoplasms C04.588.149.828; C05.116.231.828; C05.116.900.801 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms Musculoskeletal Diseases; Bone Diseases; Spinal Diseases 9XSpinal Injuries C21.866.831 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Spinal Fractures; Whiplash Injuries Injuries involving the vertebral column. ŪNQ+1Spinal Fusion E04.557.126.678 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Laminectomy Surgery, Operative; Orthopedics; Arthrodesis $5Spinal Fractures C21.866.405.795; C21.866.831.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Spinal Injuries Broken bones in the vertebral column. Fractures (66-90); Spinal Injuries (66-90) ǟ&N/4Spinal Dysraphism C10.500.680.800; C16.131.666.680.800 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Spina Bifida Cystica; Spina Bifida Occulta Spina Bifida Cystica; Spina Bifida Occulta Developmental abnormalities of the dorsal median region in the embryo, involving ectoderm, mesoderm, and neuroectoderm in varying degrees. Dysraphism signifies incomplete fusion or malformation of a seam or junction. Spinal dysraphism includes all forms of spina bifida. The open form is called SPINA BIFIDA CYSTICA and the closed form is SPINA BIFIDA OCCULTA. s*LfSpinal Diseases C05.116.900 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Intervertebral Disk Displacement; Ossification of Posterior Longitudinal Ligament; Platybasia; Scheuermann's Disease; Spinal Curvatures (Non MeSH) (+ 3); Spinal Neoplasms; Spinal Osteophytosis (+ 2); Spinal Stenosis; Spondylitis (+ 2); Spondylolisthesis (+ 1); Tuberculosis, Spinal BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI &N/KZSpinal Curvatures (Non MeSH) C05.116.900.800 Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Kyphosis; Lordosis; Scoliosis BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI ϒ#C%NSpinal Cord Neoplasms C04.588.614.250.803; C10.228.250.803; C10.228.854.780; C10.551.250.803 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms Epidural Neoplasms Epidural Neoplasms Epidural Neoplasms Epidural Neoplasms Neoplasms located in the spinal cord. They include neoplasms in the inner core or the outer layer of the cord, but not those in the protective membranes, or meninges ( = MENINGEAL NEOPLASMS). СPXVSpinal Cord Injuries C21.866.819 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Spinal Cord Compression Injuries to the spinal cord, that is, the part of the central nervous system that is situated within the vertebral column. `NQSpinal Cord Diseases C10.228.854 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Peripheral Nervous System Diseases Nervous System Diseases; Central Nervous System Diseases Amyotonia Congenita; Amyotrophic Lateral Sclerosis; Muscular Atrophy, Spinal (+ 1); Myelitis (+ 1); Poliomyelitis (+ 2); Spinal Cord Compression; Spinal Cord Neoplasms (+ 1); Syringomyelia; Tabes Dorsalis BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  N)CZSpinal Cord Compression C10.228.854.761; C21.866.819.678 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Spinal Cord Injuries A condition in which pressure is exerted on the spinal cord, as by a tumor, spinal fracture, etc. Its manifestations, which vary with location and degree of pressure, may include pain, paresthesias, and sensory and motor disturbances. (Dorland, 27th ed). ]&N-Spinal Cord A08.186.854 ABAHBSCHCYDEEMENGDIMMEMIPAPHPPPSRARERISESUTRULUSVI Cordotomy; Motor Neurons; Myelography Nervous System; Central Nervous System Extrapyramidal Tracts; Pyramidal Tracts; Spinothalamic Tracts; Substantia Gelatinosa consider also terms at MYEL-. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $6./b&8Spinal Canal A02.835.232.834.803 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine Epidural Space ܥ6DSpinach B06.510.956.700; J01.341.956.918 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables A widely cultivated plant, Spinacia oleracea, native to Asia, having succulent, edible leaves eaten as a vegetable. (From American Heritage Dictionary, 1982). Plants (66-94); Plants, Edible (66-94); Vegetables (66-94) } &4tHSpina Bifida Occulta C10.500.680.800.750; C16.131.666.680.800.750 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects; Spinal Dysraphism Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects; Spinal Dysraphism Congenital midline defect of the vertebrae where there is incomplete fusion of the spinal canal but without protrusion of the cord or meninges. Spinal Dysraphism (66-77) 2L"Spina Bifida Cystica C10.500.680.800.730; C16.131.666.680.800.730 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects; Spinal Dysraphism Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects; Spinal Dysraphism Congenital midline defect of the vertebrae where there is incomplete fusion of the spinal canal and protrusion through the defect of the meninges (meningocele), spinal cord (myelocele), or both (meningomyelocele). Meningomyelocele (78-90); Spinal Dysraphism (66-77) )2L"=Spin Labels D02.389.678 CS Electron Spin Resonance Spectroscopy Organic Chemicals (Non MeSH); Free Radicals Triacetoneamine-N-Oxyl AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  A+6:Spiders B01.131.166.803 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida Black Widow Spider Arthropods of the class ARACHNIDA, order Araneae. Except for mites and ticks, spiders constitute the largest order of arachnids, with approximately 37,000 species having been described. The majority of spiders are harmless, although some species can be regarded as moderately harmful since their bites can lead to quite severe local symptoms. (From Barnes, Invertebrate Zoology, 5th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973). F (,Spider Venoms D24.185.965.065.870 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Arthropod Venoms Venoms of arthropods of the order Araneida of the Arachnida. The venoms usually contain several protein fractions, including enzymes, hemolytic, neurolytic, and other toxins. Spiders (66-77); Venoms (66-77) <k(Spices J01.341.241.850 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Condiments Basil; Capsicum; Cinnamon The dried seeds, bark, root, stems, buds, leaves, or fruit of aromatic perennial plants used to season food. Condiments (66-92) AEAHANCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSNSTTOULUTVI $ "K!:Sphingosine D02.033.329.291.846; D02.033.618.843; D02.092.063.291.846 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Alcohols; Glycols Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Psychosine Psychosine Amino Alcohols (66-71); Glycols (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  A:1DSphingomyelins D10.516.695.850.878; D10.516.808.187.828 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Sphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Ceramides .BSphingomyelin Phosphodiesterase D08.586.277.352.640.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Niemann-Pick Disease Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases An enzyme that catalyzes the hydrolysis of sphingomyelin to ceramide (N-acylsphingosine) plus choline phosphate. A defect in this enzyme leads to NIEMANN-PICK DISEASE. EC 3.1.4.12. Phosphodiesterases (73-74); Sphingomyelins (73-74)  $F;Sphingolipids D10.516.695.850; D10.516.808 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids Lipids and Antilipemic Agents (Non MeSH); Lipids Sphingomyelins Ceramides (+ 1); Glycosphingolipids (+ 12) Lipids (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  p"BEHSphingolipidoses C18.452.648.556.641.803; C18.452.648.595.803 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases Adrenoleukodystrophy; Fabry's Disease; Gangliosidoses (+ 3); Gaucher's Disease; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic; Niemann-Pick Disease; Sea-Blue Histiocyte Syndrome Adrenoleukodystrophy; Fabry's Disease; Gangliosidoses (+ 3); Gaucher's Disease; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic; Niemann-Pick Disease; Sea-Blue Histiocyte Syndrome Lysosomal storage diseases characterized by failure to degrade sphingolipids and resulting in their abnormal storage. 72L,Sphincterotomy, Transhepatic E04.765.120.860 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Oddi's Sphincter; Vater's Ampulla Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Surgery of the smooth muscle sphincter of the hepatopancreatic ampulla to relieve blocked biliary or pancreatic ducts. Oddi's Sphincter/surgery (75-87); Vater's Ampulla/surgery (66-87)  Z!$)_NSphincterotomy, Endoscopic E01.184.340.350.850; E01.418.340.350.850; E04.765.120.850 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Oddi's Sphincter; Vater's Ampulla; Cholangiopancreatography, Endoscopic Retrograde Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System; Endoscopy, Gastrointestinal Diagnosis; Endoscopy; Endoscopy, Digestive System; Endoscopy, Gastrointestinal Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Incision of Oddi's sphincter or Vater's ampulla performed by inserting a sphincterotome through an endoscope (duodenoscope) often following retrograde cholangiography (CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE). Endoscopic treatment by sphincterotomy is the preferred method of treatment for patients with retained or recurrent bile duct stones post-cholecystectomy, and for poor-surgical-risk patients that have the gallbladder still present. Endoscopy (74-91); Oddi's Sphincter/surgery (74-91); Sphincterotomy, Transhepatic (86-91); Vater's Ampulla/surgery (74-91)  >A$^3Spheroplasts A11.868; B03.110.761 CHCLCYDEENGDGEIMIPMEPHPYREULVI Cells Bacteria; Atypical Bacterial Forms L Forms (66-71)  "1Spherocytosis, Hereditary C15.378.071.141.150.785 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anemia, Sideroblastic Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital A familial congenital hemolytic anemia characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions. LSpherocytes A11.118.413.330.802; A15.145.229.413.330.802 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes; Erythrocytes, Abnormal Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes; Erythrocytes, Abnormal 2*Sphenoid Sinusitis C08.460.692.752.827; C08.730.749.827; C09.603.692.752.827 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Respiratory Tract Diseases; Respiratory Tract Infections; Sinusitis Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Inflammation of the sphenoid sinus. This condition usually is accompanied by pansinusitis and may present itself in an acute or chronic form. Sinusitis (66-89) NANSphenoid Sinus A04.531.621.827 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Respiratory System; Nose; Paranasal Sinuses One of the paired paranasal sinuses, located in the body of the sphenoid bone and communicating with the highest meatus of the nasal cavity on the same side. 85Sphenoid Bone A02.835.232.781.802 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull Sella Turcica S:DSphaerotilus B03.440.400.425.800; B03.800.760 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Sheathed Bacteria (Non MeSH) A genus of gram-negative, rod-shaped bacteria whose organisms are usually arranged in single chains within sheaths of uniform width. The sheath is thin without encrustation by ferric and manganic oxides. Its normal habitat is slowly running freshwater heavily contaminated with sewage or wastewater from paper, potato, dairy, or other agricultural industries. /&"Sphaeriales B05.354.107.877 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes An order of ascomycetous fungi which includes many economically important plant parasites as well as saprophytes.  ";Spermine Synthase D08.586.913.805 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Catalyzes the transfer of the propylamine moiety from 5'-deoxy-5'-S-(3-methylthiopropylamine)sulfonium adenosine to spermidine in the biosynthesis of spermine. The enzyme has an acidic isoelectric point at pH 5.0. Propylamines (72-74); Spermine (72-74); Transferases (72-74)  "FUISpermine D02.092.211.415.701.801.821; D02.092.782.802 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Polyamines; Putrescine; Spermidine Organic Chemicals (Non MeSH); Amines; Polyamines N,N'-Bis(3-aminopropyl)-1,4-butanediamine. A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure. M 2>Spermidine D02.092.211.415.701.801; D02.092.782.677 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Polyamines; Putrescine Organic Chemicals (Non MeSH); Amines; Polyamines Spermine N-(3-Aminopropyl)-1,4-butanediamine. A polyamine formed from putrescine. It is found in almost all tissues in association with nucleic acids. It is found as a cation at all pH values, and is thought to help stabilize some membranes and nucleic acid structures. It is a precursor of spermine. Amines (66-70)  C.> \Spermatozoa A05.360.490.890; A11.497.760 ABCHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Antispermatogenic Agents; Oligospermia; Sperm Banks; Spermatocidal Agents Semen Urogenital System; Genitalia; Germ Cells Cells; Germ Cells Sperm Head (+ 1); Sperm Tail; Spermatids; Spermatocytes; Spermatogonia Sperm Head (+ 1); Sperm Tail; Spermatids; Spermatocytes; Spermatogonia Mature male germ cells, the specific output of the testes. The spermatozoon is the generative element of the semen and serves to fertilize the ovum. It consists of a head (or nucleus), a neck, a middle piece, and a tail with an end piece. Spermatzoa, formed in the seminiferous tubules, are derived from spermatogonia, which first develop into spermatocytes, which, in turn, undergo meiosis to produce spermatids; the spermatids then differentiate into spermatozoa. (Dorland, 27th ed). $".V H<Spermatogonia A05.360.490.890.900; A11.497.760.800 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Spermatozoa Cells; Germ Cells; Spermatozoa The primitive differentiated male gametes which give rise to spermatocytes. #*,fYSpermatogenesis-Blocking Agents D07.360.443.288.760 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Spermatogenesis Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Male; Antispermatogenic Agents Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa. Contraceptive Agents (67-74); Spermatogenesis/drug effects (71-74)  l$8NSpermatogenesis G08.520.310.760 DEGEIMPHRE Antispermatogenic Agents; Spermatogenesis-Blocking Agents Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Gametogenesis Sperm Maturation Process of formation and development of spermatozoa, including spermatocytogenesis and spermiogenesis. Spermatozoa (66-70) $AXuSpermatocytes A05.360.490.890.880; A11.497.760.700 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Sperm Maturation Urogenital System; Genitalia; Germ Cells; Spermatozoa Cells; Germ Cells; Spermatozoa Male germ cells derived from spermatogonia and developing into spermatids. Spermatozoa (66-74)  *,fXSpermatocidal Agents D07.360.276.827 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Spermatozoa Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Chemical substances with spermatocidal activity used as topically administered vaginal contraceptives. Contraceptive Agents (67-74); Spermatozoa/DE (66-74)  #8ju?Spermatocele C12.294.731 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male A cystic distention of the epididymis or the rete testis containing spermatozoa. (Dorland, 27th ed).  NTySpermatids A05.360.490.890.860; A11.497.760.600 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Spermatozoa Cells; Germ Cells; Spermatozoa Male germ cells derived from spermatocytes and developing into spermatozoa. Spermatozoa (66-74) "<*,fYSpermatic Cord Torsion C12.294.693 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Torsion of the spermatic cord caused usually by incomplete attachment of the epididymis to the testis or by inclusion of the cord within the tunica vaginalis. Faulty development of various anatomical components of the testes is also a cause. It occurs most frequently in childhood and adolescence. (From Current Medical Information and Terminology, 5th ed). #NTSpermatic Cord A05.360.444.777 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male &2:7Sperm-Ovum Interactions G08.520.277.800 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fertilization Interactive processes between the ovum and the spermatozoon. &XHSperm Transport G04.335.283.800; G08.520.277.820 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Movement Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fertilization Passive transport or active migration of spermatozoa from the testes through the male genital system as well as within the female genital system. Spermatozoa (66-74) '&Sperm Tail A05.360.490.890.840; A11.497.760.500 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Spermatozoa Cells; Germ Cells; Spermatozoa The posterior, filiform part of spermatozoa, which provides sperm motility. )*(fYSperm Motility G04.335.283.750; G08.520.277.780 DEGEIMPHRE Sperm Immobilizing Agents Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Movement Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fertilization Ability of the spermatozoon to move by flagellate swimming. Spermatozoa (66-74)  +-&HSperm Maturation G08.520.310.760.700 DEGEIMPHRE Antispermatogenic Agents Spermatocytes Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Gametogenesis; Spermatogenesis Posttesticular ripening of spermatozoa. Spermatozoa (66-74) $,k/Sperm Immobilizing Agents D07.360.276.727 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Sperm Motility Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Chemical substances with sperm immobilizing activity used as topically administered vaginal contraceptives. Contraceptive Agents (67-74); Spermatozoa/drug effects (66-74)  .68j{JSperm Head A05.360.490.890.820; A11.497.760.400 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Spermatozoa Cells; Germ Cells; Spermatozoa Acrosome Acrosome The anterior, usually ovoid, nucleus-containing part of spermatozoa. 0 *(fPSperm Count E01.223.920; G07.380.870 DEISMTREVE Oligospermia Cell Count Diagnosis; Diagnosis, Laboratory Physiology, General (Non MeSH); Cell Count A count of sperm in the ejaculum, expressed as number per milliliter. Cell Count (69-79); Oligospermia (75-79); Spermatozoa (66-79) $1aZUKSperm Capacitation G08.520.277.760 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fertilization The process by which spermatozoa become capable of fertilizing an ovum after it reaches the ampullary portion of the uterine tube. Spermatozoa (66-71) 2XSperm Banks N02.278.065.700 CLECHILJMAMTOGSDSNSTTDUT Insemination, Artificial; Semen; Semen Preservation; Spermatozoa Facilities, Manpower and Services (Non MeSH); Health Facilities; Biological Specimen Banks Centers for acquiring and storing semen. Insemination, Artificial (78-81); Semen Preservation (78-81); Spermatozoa (78-81); Tissue Banks (78-81)  4OLk2{Sperm Agglutination G04.610.143.100.700 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions; Agglutination Agglutination of spermatozoa by antibodies or autoantibodies. Spermatozoa 6HSpeech, Esophageal E02.831.727.541.677 ISMTPX Therapeutics; Rehabilitation; Rehabilitation, Speech and Language (Non MeSH); Speech, Alaryngeal 7Y qSpeech, Alaryngeal E02.831.727.541 ISMTPX Larynx, Artificial Larynx, Artificial; Laryngectomy Therapeutics; Rehabilitation; Rehabilitation, Speech and Language (Non MeSH) Speech, Esophageal Methods of enabling a patient without a larynx or with a non-functional larynx to produce voice or speech. The methods may be pneumatic or electronic. $8! 'YSpeech-Language Pathology G02.010.750 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Allied Health Occupations The study of speech or language disorders and their diagnosis and correction. Speech Therapy (66-79) 96]Speech Therapy E02.831.727.552 CLECEDHIISLJMAMTOGPXSNSTTD Voice Training Therapeutics; Rehabilitation; Rehabilitation, Speech and Language (Non MeSH) ;YSpeech Reception Threshold Test E01.276.299.375.297.105.902 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests; Audiometry; Audiometry, Speech A test to determine the lowest sound intensity level at which fifty percent or more of the spondaic test words (words of two syllables having equal stress) are repeated correctly. Syn: SRT. Audiometry (66-78); Auditory Threshold (68-78); Hearing (66-67); Speech (66-78) ;&"aSpeech Production Measurement E01.881 AECLCTECHIISMOMTNUPXSNSTTDUTVE Speech Intelligibility Diagnosis Speech Articulation Tests Measurement of parameters of the speech product such as vocal tone, loudness, pitch, voice quality, articulation, resonance, phonation, phonetic structure and prosody. Speech (66-78) $>@# " Speech Perception F02.463.593.800 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception The process whereby an utterance is decoded into a representation in terms of linguistic units (sequences of phonetic segments which combine to form lexical and grammatical morphemes). Auditory Perception (67-78); Hearing (66-67); Perception (66-67); Speech (66-78) ? \bSpeech Intelligibility F01.145.209.908.677.610; G11.561.854.686 CLDEPHRE Speech Production Measurement Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Verbal Behavior; Speech Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Speech Ability to make speech sounds that are recognizable. Auditory Perception (67-78); Speech (66-78)  A. #@5Speech Disorders C10.597.257.870; C23.888.592.257.870; F03.126.219.870 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Language Disorders Language Disorders; Verbal Behavior; Velopharyngeal Insufficiency Nervous System Diseases; Neurologic Manifestations; Communicative Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders Aphasia (+ 3); Articulation Disorders; Dysarthria; Echolalia; Mutism; Stuttering Aphasia (+ 3); Articulation Disorders; Dysarthria; Echolalia; Mutism; Stuttering Aphasia (+ 5); Articulation Disorders; Dysarthria; Echolalia; Mutism; Stuttering Any long-term disorder in speaking or in perception of speech (sometimes also of writing or of gestures) so grave as to interfere seriously with communication. $C=FL\"Speech Discrimination Tests E01.276.299.375.297.105.890 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests; Audiometry; Audiometry, Speech Tests of the ability to hear and understand speech as determined by scoring the number of words in a word list repeated correctly. Audiometry (66-78); Discrimination (Psychology) (66-78); Speech (66-78) H)!"USpeech Articulation Tests E01.881.929 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Speech Production Measurement Tests of accuracy in pronouncing speech sounds, e.g., Iowa Pressure Articulation Test, Deep Test of Articulation, Templin-Darley Tests of Articulation, Goldman-Fristoe Test of Articulation, Screening Speech Articulation Test, Arizona Articulation Proficiency Scale. J;"0-Speech Acoustics G11.561.854.650 Acoustics Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Speech The acoustic aspects of speech in terms of frequency, intensity, and time. Acoustics (66-79); Phonetics (66-79); Speech (66-79); Voice (66-79) L  sZTSpeech F01.145.209.908.677; G11.561.854; L01.143.506.423.676 CLDEPHRE Verbal Behavior Language Development Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Verbal Behavior Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Information Science; Communication; Language; Language Arts (Non MeSH) Speech Intelligibility Speech Acoustics; Speech Intelligibility Communication through a system of conventional vocal symbols. $M = JISpectrum Analysis, Raman E05.196.867.890; H01.671.768.831.860 HIISMTST Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Physical Sciences (Non MeSH); Physics; Radiation; Scattering, Radiation Analysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light. Scattering, Radiation (71-76); Spectrum Analysis (66-76) O* CSpectrum Analysis, Mass E05.196.867.877 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Mass Fragmentography; Spectrometry, Mass, Fast Atom Bombardment; Spectrometry, Mass, Secondary Ion Analysis of the mass of an object through means of determining the wave length(s) at which electromagnetic energy is absorbed by that object. Spectrum Analysis (66-70)  Q"[rSpectrum Analysis E05.196.867 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Circular Dichroism; Electron Spin Resonance Spectroscopy; Nuclear Magnetic Resonance; Optical Rotatory Dispersion; Pulse Radiolysis; Spectrometry, Fluorescence; Spectrometry, Gamma (+ 1); Spectrometry, X-Ray Emission (+ 1); Spectrophotometry (+ 5); Spectrum Analysis, Mass (+ 3); Spectrum Analysis, Raman The measurement of the amplitude of the components of a complex waveform throughout the frequency range of the waveform. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). AECLCTDUECHIISMOMTNUPXSNSTTDTUUTVE  S"Ee&Spectroscopy, Mossbauer E05.196.867.776.751 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrometry, Gamma A spectroscopic technique which uses the Mossbauer effect (inelastic scattering of gamma radiation resulting from interaction with heavy nuclei) to monitor the small variations in the interaction between an atomic nucleus and its environment. Such variations may be induced by changes in temperature, pressure, chemical state, molecular conformation, molecular interaction, or physical site. It is particularly useful for studies of structure-activity relationship in metalloproteins, mobility of heavy metals, and the state of whole tissue and cell membranes. Spectrometry, Gamma (73-88); Spectrum Analysis (66-88) W"sASpectroscopy, Fourier Transform Infrared E05.196.712.726.676.700; E05.196.867.826.676.700 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Spectrophotometry; Spectrophotometry, Infrared Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrophotometry; Spectrophotometry, Infrared A spectroscopic technique in which a range of wavelengths is presented simultaneously with an interferometer and the spectrum is mathematically derived from the pattern thus obtained. Spectrophotometry, Infrared (72-93) Z/6")Spectrophotometry, Ultraviolet E05.196.712.726.802; E05.196.867.826.802 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Spectrophotometry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrophotometry Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Spectrophotometry (66-72) ]#."(Spectrophotometry, Infrared E05.196.712.726.676; E05.196.867.826.676 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Spectrophotometry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrophotometry Spectroscopy, Fourier Transform Infrared Spectroscopy, Fourier Transform Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Spectrophotometry (66-72)  `@ ."\4Spectrophotometry, Atomic Absorption E05.196.712.726.551; E05.196.867.826.551 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Spectrophotometry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrophotometry A highly sensitive technique used to analyze various elements, especially metals, including aluminum, arsenic, beryllium, calcium, copper, iron, lead, and lithium, which are present in trace amounts. The atoms are excited above a ground state by flame vaporization, and the radiation emitted as the molecules return to a ground state is measured in unexcited non-ionized molecules. (Segen, Dictionary of Modern Medicine, 1992). Spectrophotometry (66-71) c_*."Spectrophotometry E05.196.712.726; E05.196.867.826 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Microspectrophotometry; Spectrophotometry, Atomic Absorption; Spectrophotometry, Infrared (+ 1); Spectrophotometry, Ultraviolet Microspectrophotometry; Spectrophotometry, Atomic Absorption; Spectrophotometry, Infrared (+ 1); Spectrophotometry, Ultraviolet The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum. f&"Spectrometry, X-Ray Emission E05.196.867.800; E05.799.830 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Miscellaneous Techniques (Non MeSH); Radiometry Electron Probe Microanalysis Electron Probe Microanalysis Identification and measurement of concentration of elements based on the fact that x-rays emitted by an excited element have a wavelength characteristic of that element and an intensity related to its concentration. It includes fluorescence, or secondary-emission, x-ray spectrometry, in which the specimen is irradiated by x-rays. Primary-emission x-ray spectrometry, in which the specimen is bombarded by electrons, is a specific type of x-ray emission spectrometry known as ELECTRON PROBE MICROANALYSIS. Fluorescence (66-77); Spectrometry, Fluorescence (72-77); Spectrum Analysis (66-77); X-Rays (75-77)  i"""BGvSpectrometry, Mass, Secondary Ion E05.196.867.877.760; E05.595.825 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrum Analysis, Mass Miscellaneous Techniques (Non MeSH); Microscopy A mass-spectrometric technique that is used for microscopic chemical analysis. A beam of primary ions with an energy of 5-20 kiloelectronvolts (keV) bombards a small spot on the surface of the sample under ultra-high vacuum conditions. Positive and negative secondary ions sputtered from the surface are analyzed in a mass spectrometer in regards to their mass-to-charge ratio. Spectrum Analysis, Mass (76-94) m(&"&Spectrometry, Mass, Fast Atom Bombardment E05.196.867.877.750 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrum Analysis, Mass A mass spectrometric technique that is used for the analysis of a wide range of biomolecules, such as glycoalkaloids, glycoproteins, polysaccharides, and peptides. Positive and negative fast atom bombardment spectra are recorded on a mass spectrometer fitted with an atom gun with xenon as the customary beam. The mass spectra obtained contain molecular weight recognition as well as sequence information. Spectrum Analysis, Mass (82-90) q1"x&Spectrometry, Gamma E05.196.867.776; E05.799.801; H01.671.768.765.826 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Miscellaneous Techniques (Non MeSH); Radiometry Physical Sciences (Non MeSH); Physics; Radiation; Radiometry Spectroscopy, Mossbauer Determination of the energy distribution of gamma rays emitted by nuclei. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Radiometry (66-68); Spectrum Analysis (66-68)  t9"7Spectrometry, Fluorescence E05.196.712.382.676; E05.196.867.726 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Fluorometry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Measurement of the intensity and quality of fluorescence. Fluorescence (66-71); Spectrum Analysis (66-71) v*"E9Spectrin D12.776.124.875; D12.776.220.980; D12.776.543.980 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins A high molecular weight (220-250 kDa) water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins, and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane. Blood Proteins (66-76); Cell Membrane (66-75); Erythrocytes (66-75) xM 9D RSpectinomycin D20.085.810 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics (2R-(2 alpha,4a beta,5a beta,6 beta,7 beta,8 beta,9 alpha,9a alpha,10a beta))-Decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-4H-pyrano(2,3-b)(1,4)benzodioxin-4-one. An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea. {<)bSpecimen Handling E01.223.894 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory Biopsy (+ 2); Punctures (+ 8); Vaginal Smears Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  }"'<&Specific Pathogen-Free Organisms G04.185.515.372.676 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Germ-Free Life Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free. &Specific Gravity H01.181.529.845 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Chemistry, Physical (66-67) tI!Species Specificity G04.610.106.759; G04.875 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antibody Specificity Biological Phenomena, Cell Physiology, Immunity (Non MeSH) Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species. 1tSpecialty Boards N03.706.110.120.580; N05.700.200.190.750 CLECHILJOGSNSTTDUT Certification Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Certification Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Certification Organizations which certify physicians and dentists as specialists in various fields of medical and dental practice. Certification (68-Jul 77); specific specialty (68-Jul 77)  .ESpecialties, Surgical G02.403.810 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine Colon and Rectal Surgery (Specialty); Gynecology; Neurosurgery; Obstetrics; Ophthalmology; Orthopedics; Otolaryngology; Surgery; Surgery, Plastic; Thoracic Surgery; Urology Various branches of surgical practice limited to specialized areas. Certification (68-77); Specialty Boards (77-79); Surgery (66-79) AECLECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE $#PN*Specialties, Other (Non MeSH) G02.403.790 Health Occupations; Medicine Anesthesiology; Emergency Medicine; Forensic Medicine; Neurology; Nuclear Medicine; Pathology (+ 2); Physical Medicine (+ 1); Preventive Medicine (+ 3); Psychiatry (+ 1); Radiology (+ 2) CLECEDHIISLJMAMTNUOGPXSNSTTD $# Specialties, Nursing G02.478.676 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing Emergency Nursing; Geriatric Nursing; Maternal-Child Nursing (+ 1); Midwifery; Military Nursing; Obstetrical Nursing; Occupational Health Nursing; Oncologic Nursing; Orthopedic Nursing; Pediatric Nursing (+ 1); Postanesthesia Nursing; Psychiatric Nursing; Public Health Nursing; School Nursing; Surgical Nursing; Transcultural Nursing Various branches of nursing practice limited to specialized areas. Nursing (66-70)  "OSpecialties, Medical G02.403.776 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine Allergy and Immunology; Dermatology; Family Practice; Internal Medicine (+ 9); Pediatrics (+ 2); Reproductive Medicine; Venereology Various branches of medical practice limited to specialized areas. Specialism (66-67)  #OSpecialties, Dental G02.163.876 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Dentistry Endodontics; Orthodontics; Pathology, Oral; Pediatric Dentistry; Periodontics; Prosthodontics; Public Health Dentistry (+ 1); Surgery, Oral Various branches of dental practice limited to specialized areas. Dentistry (66-67); Specialism (66-67) CLCTECEDHIISLJMAMTNUOGPXRHSNSTTDUT $$N.&Specialism G02.811 ECHILJSNSTTD Health Occupations The limitation of practice or study to a particular branch of medicine, dentistry, or other health profession. It is philosophically distinct from the generalist theory in which familiarity with a wide cross-section of the particular discipline is advocated.  -Spatial Behavior F01.145.875; I01.880.894 DEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Social Sciences; Sociology Crowding; Personal Space; Proxemics; Territoriality Proxemics Reactions of an individual or groups of individuals with relation to the immediate surrounding area including the animate or inanimate objects within that area. Adaptation, Psychological (66-67); Psychotherapy (66-67) DEPHPPPXRE $ `IBSpastic Paraplegia, Hereditary C10.500.686.800; C10.772.587.800; C16.131.666.686.800 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Motor and Sensory Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory An insidiously progressive inherited disorder (probably autosomal dominant) characterized by distal limb weakness. Stiffness of the legs in walking due to the spasticity marks the onset of the disorder. Peripheral sensory neurons may be affected in the later stages of the disease. Muscle Spasticity/genetics (75-88); Paraplegia/genetics (66-88) 4$=LIKSpasms, Infantile C10.228.140.490.300.760; F03.709.346.875 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Generalized Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Primary generalized epileptic seizures occurring in infants between birth and twelve months of age consisting of brief synchronous contractions of the neck, torso, and both arms. These seizures often occur in infants with underlying neurologic diseases. The prognosis for these infants is grave, with approximately ninety percent developing mental retardation in addition to their seizures. The EEG has a typical hypsarrhythmia pattern. The spasms and hypsarrhythmia have a tendency to disappear over the first three to five years of life, only to be replaced by other forms of generalized seizures. Infantile spasms sometimes respond to valproic acid or ACTH. Child, Preschool (66-76); Convulsions (66-76); Epilepsy (66-76); Epilepsy, Petit Mal (66-76); Infant (66-76); Infant, Newborn (66-76); Myoclonus (66-76) :.NSpasm C10.597.816; C23.888.592.826 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Muscle Cramp; Myotonia Muscle Spasticity Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Trismus Trismus A sudden, violent, involuntary contraction of a muscle or a group of muscles, attended by pain and interference with function, producing involuntary movement and distortion. It refers also to a sudden but transitory constriction of a passage, canal, or orifice. (Dorland, 27th ed). $ "NKSparteine D03.132.786; D18.097.876 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Cardiovascular Agents; Anti-Arrhythmia Agents (7S-(7 alpha,7a alpha,14 alpha,14a beta))-Dodecahydro-7,14-methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine. Alkaloid isolated from lupin beans, Lupinus luteus and Lupinus niger. It is used as an oxytocic. p <[Sparsomycin D20.085.075.825; D22.204.106.840 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic 1,2,3,4-Tetrahydro-N-(1-(hydroxymethyl)-2-(((methylthio) methyl)sulfinyl)ethyl)-6-methyl-2,4-dioxo-5-pyrimidine acrylamide. An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. Antibiotics (74); Antibiotics, Antineoplastic (74); Ribonucleosides (74) E&<VSparganum B01.500.736.215.228.831; B01.500.736.215.800.810; B01.583.382.831 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda; Diphyllobothrium Invertebrates; Helminths; Platyhelminths; Cestoda; Spirometra Invertebrates; Life Stages (Non MeSH); Larva The larval form of the diphyllobothriid tapeworms of the genus DIPHYLLOBOTHRIUM and SPIROMETRA. Fish-eating mammals and man are the final hosts. Cestoda (66-74); Diphyllobothrium (66-74)  I*2Sparganosis C03.335.190.304.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Diphyllobothriasis Diphyllobothriasis Parasitic Diseases; Helminthiasis; Cestode Infections; Diphyllobothriasis Infection of animals, including fish and man, with a developmental stage of Diphyllobothrium. This stage has recently been referred to as a plerocercoid but the name sparganum has persisted. Therefore, infection of fish or other animals with the plerocercoid larvae is sparganosis. Fish-eating mammals, including man, are the final hosts.  SPUSpain Z01.542.846 EHEP Geographicals (Non MeSH); Europe  )Spacecraft J01.095.850.900 CLECHIISLJSNST Space Flight Technology, Industry, Agriculture (Non MeSH); Aviation; Space Flight Devices, manned and unmanned, which are designed to be placed into an orbit about the Earth or into a trajectory to another celestial body. (NASA Thesaurus, 1988). Space Flight (66-94)  hRSpace-Time Clustering E05.318.740.250.700; G03.850.520.830.250.700; H01.548.832.266.750; N05.715.360.750.200.775 Disease Outbreaks Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Cluster Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Cluster Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Cluster Analysis Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Cluster Analysis A statistically significant excess of cases of a disease, occurring within a limited space-time continuum. Statistics (66-77) d}Space Simulation G03.230.150.440 AECLCTECHIISMOMTNUPXSNSTTDUTVE Weightlessness Simulation Environment and Public Health (Non MeSH); Environment; Environment, Controlled Weightlessness Simulation An environment simulating one or more parameters of the space environment, applied in testing space systems or components. Often, a closed chamber is used, capable of approximating the vacuum and normal environments of space. (From NASA Thesaurus, 1988).  5"]+Space Perception F02.463.593.778; F02.463.593.932.869 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception  Depth Perception (+ 2); Form Perception (+ 2); Size Perception The awareness of the spatial properties of objects; includes physical space. CLDEGEIMPHRE  n* P\Space Motion Sickness C09.218.568.900.498.800; C21.866.620.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases; Vestibular Diseases; Motion Sickness Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Motion Sickness Disorder characterized by nausea, vomiting, and dizziness, possibly in response to vestibular disorientation or fluid shifts associated with space flight. (From Webster's New World Dictionary). Motion Sickness (79-94); Space Flight (79-94) l.N8Space Maintenance E06.658.703.675 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Orthodontics; Orthodontics, Preventive $:Space Flight J01.095.850 CLECEDHIISLJMAMTOGSNSTTD Astronauts; Ecological Systems, Closed; Extraterrestrial Environment; Spacecraft; Weightlessness Aerospace Medicine Technology, Industry, Agriculture (Non MeSH); Aviation Extravehicular Activity; Spacecraft Travel beyond the earth's atmosphere. AECLECEDHIISLJMAMTOGPHSNSTTD (oA*. Soybeans B06.510.570.870; J01.341.956.570.870 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Legumes Technology, Industry, Agriculture (Non MeSH); Food; Vegetables; Legumes An annual legume or the seeds of this plant. p *4|9Soybean Oil D10.516.212.302.380.800; D10.516.212.507.800; D10.516.627.700.880; J01.740.250.750; J01.740.700.880 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils Oil from soybean or soybean plant. Oils (66-86) o@,Southwestern United States Z01.107.567.875.600.822 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Arizona; California (+ 2); Colorado; Nevada; New Mexico; Texas; Utah The geographic area of the southwestern region of the United States. The states usually included in this region are Arizona, California, Colorado, Nevada, New Mexico, Texas, and Utah.  yXSoutheastern United States Z01.107.567.875.600.820 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Alabama; Arkansas; Florida; Georgia; Louisiana; Mississippi; North Carolina; South Carolina; Virginia; West Virginia The geographic area of the southeastern region of the United States in general or when the specific state or states are not included. The states usually included in this region are Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, West Virginia and Virginia.  y_South Dakota Z01.107.567.875.100.816; Z01.107.567.875.600.516.816 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States x:South Carolina Z01.107.567.875.100.808; Z01.107.567.875.600.820.808 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States :South Australia Z01.338.600 EHEP Geographicals (Non MeSH); Australia A state in southern AUSTRALIA. Australia (66-87) Ĕ,'South America Z01.107.757 EHEP Geographicals (Non MeSH); America Argentina; Bolivia; Brazil; Chile; Colombia; Ecuador; French Guiana; Guyana; Paraguay; Peru; Suriname; Uruguay; Venezuela O*South Africa Z01.058.290.175.735 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern [`Sound Spectrography E05.855 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) The graphic registration of the frequency and intensity of sounds, such as speech, infant crying, and animal vocalizations.   "*Sound Localization F02.463.593.071.869 CLDEPHRE Echolocation Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception Ability to determine the specific location of a sound source. Auditory Perception (67-79); Hearing (66); Perception (66)  - tKHSound H01.671.031.675 AEDU Acoustic Stimulation; Noise Physical Sciences (Non MeSH); Physics; Acoustics Noise consider also terms at PHON-. AEDULJPC $ɩ "< & Sotalol D02.033.329.291.805; D02.092.063.291.805; D14.100.050.200.200.860; D16.050.850.840; D18.097.870 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias. Amino Alcohols (66-71); Sympatholytics (66-71) ʕ k:l8SOS Response (Genetics) G05.331.187.830; G05.386.690 DEGEIMPHRE Genetics; Genetics, Biochemical; DNA Repair Genetics; Genetics, Microbial An error-prone mechanism or set of functions for repairing damaged microbial DNA. SOS functions (a concept reputedly derived from the SOS of the international distress signal) are involved in DNA repair and mutagenesis, in cell division inhibition, in recovery of normal physiological conditions after DNA repair, and possibly in cell death when DNA damage is extensive. DNA, Bacterial (75-86); DNA Repair (75-86) "W5Sorption Detoxification E02.912 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Enterosorption; Hemodialysis (+ 2); Hemofiltration (+ 1); Hemoperfusion; Peritoneal Dialysis (+ 1); Plasmapheresis Elimination of toxic or biologically active substances from body fluids by interaction with a sorbent medium. The types of media include absorbents, adsorbents, ion-exchange materials, and complexing agents. Detoxification can be extracorporeal (hemodialysis, hemofiltration, hemoperfusion, plasmapheresis), or occur inside the body (enterosorption, peritoneal dialysis). Adsorption (77-82); Hemoperfusion (83-90) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE $Ы "2$Sorbose D09.203.546.359.862; D09.203.546.465.758 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Ketoses Ӻ .DSorbitol D02.033.800.813; D09.203.853.813; D19.770.224.453.758 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Osmotic Isosorbide (+ 1); Meglumine (+ 2) Isosorbide (+ 1); Meglumine (+ 2) Isosorbide & =:bSorbic Acid D02.241.081.436.820; D10.516.251.355.840; D26.471.385.840 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives 2,4-Hexadienoic acid. Mold and yeast inhibitor. Used as a fungistatic agent for foods, especially cheeses. Caproates (69-74); Fatty Acids, Unsaturated (74) EA.;;Sonication H01.671.031.849.675 AEDUIS Physical Sciences (Non MeSH); Physics; Acoustics; Ultrasonics  KSomnambulism C10.597.785.800; C23.888.592.796.800; F03.126.821.700 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sleep Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sleep Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Sleep Disorders A dissociated or fugue-like state in which the person can move about but otherwise seems asleep. Sleep Disorders (66-68) y=LDtSomatotypes G07.265.758 GEPHPX Phenotype Physiology, General (Non MeSH); Body Constitution A particular category of body build, determined on the basis of certain physical characteristics. The three basic body types are ectomorph (thin physique), endomorph (rounded physique), and mesomorph (athletic physique). The typology was devised by the American psychologist William Herbert Sheldon (1899-1977). Somatotypes have been related to personality in early studies.   <Somatotropin-Releasing Hormone D06.472.709.757; D12.776.641.650.740; D14.600.600.805 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Sermorelin Hypothalamic peptide that regulates the synthesis and secretion of SOMATOTROPIN in the anterior pituitary gland. Z#=F@Somatotropin D06.472.734.525.780; D12.776.641.650.730; D14.600.600.800 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Somatotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A small peptide hormone released by the anterior pituitary under hypothalamic control. Somatotropin, or growth hormone, stimulates mitosis, cell growth, and, for some cell types, differentiation in many tissues of the body. It has profound effects on many aspects of gene expression and metabolism. AFO\Somatostatinoma C04.557.465.625.650.240.285.825; C04.557.470.200.025.370.285.825; C04.557.580.625.650.240.285.825 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Islet Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Neuroendocrine; Carcinoma, Islet Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Islet Cell A rare somatostatin-secreting tumor of pancreatic delta cells associated with diabetes mellitus or abnormal glucose tolerance. It is also found in the intestine. Of the reported primary tumors, 60% were found in the pancreas and 40% in the duodenum or jejunum. Most patients were between 40 and 60 years of age with a 2:1 ratio of females to males. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed). Islet Cell Tumor (66-81) iX[Somatostatin D06.347.560.810; D06.472.610.780; D12.644.850; D12.776.641.650.720; D14.600.600.790 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Somatostatin Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Pituitary Hormone Release Inhibiting Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Octreotide Octreotide A polypeptide hormone produced in the hypothalamus that inhibits the release of SOMATOTROPIN. Somatostatin is also a neurotransmitter in the central and peripheral nervous systems and is released by the delta-cells of the pancreas. Somatotropin/antagonists and inhibitors (73-74); Somatotropin Releasing Hormone/antagonists and inhibitors (74) $_FSomatosensory Cortex A08.186.211.730.885.213.670.675 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex; Parietal Lobe Area of the parietal lobe concerned with receiving general sensations. It lies posterior to the central sulcus. Cerebral Cortex (66-70) w#8Somatomedins D12.776.124.862; D12.776.641.650.710; D14.600.600.780; D24.185.348.862 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Somatomedin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Nonsuppressible Insulin-Like Activity Insulin-Like Growth Factor I; Insulin-Like Growth Factor II Insulin-Like Growth Factor I; Insulin-Like Growth Factor II Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Nonsuppressible Insulin-Like Activity Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. Blood Proteins (66-70); Sulfates/metabolism (66-70) AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (5PDl6>FSomatoform Disorders F03.709.438.710 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders Conversion Disorder; Hypochondriasis Disorders characterized by physical symptoms suggesting a physical disorder for which there are no demonstrable organic findings and for which there is strong or positive evidence that they are linked to psychological factors. Unlike the factitious disorders, the symptom production is not under voluntary control. F`+lSomatic Therapies, Psychiatric (Non MeSH) F04.881 Disciplines, Tests, Therapy, Services (Non MeSH) Convulsive Therapy (+ 1); Orthomolecular Therapy; Psychopharmacology (+ 1); Psychosurgery AECLECEDHIISLJMAMOMTOGPXRHSNSTTD h1 9k$Soman D02.705.860; D08.373.275.872; D14.100.120.300.832; D15.220.224.857; D26.253.855 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Central Nervous System Agents; Central Nervous System Stimulants; Convulsants Miscellaneous Drugs and Agents (Non MeSH); Chemical Warfare Agents An organophosphorus compound that inhibits cholinesterase. It causes seizures and has been used as a chemical warfare agent. Cholinesterase Inhibitors (66-71); Organophosphorus Compounds (71)  [:MSomalia Z01.058.290.120.730 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern ) _Solvents D26.837 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH)   ,2Solutions D26.394.225.766 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Cardioplegic Solutions; Contact Lens Solutions; Dialysis Solutions (+ 1); Hypertonic Solutions (+ 2); Hypotonic Solutions; Isotonic Solutions; Ophthalmic Solutions; Rehydration Solutions; Sclerosing Solutions (+ 2) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU e ,M.Solubility H01.181.529.827 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical OISolitary Nucleus A08.186.211.132.810.406.750 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon; Medulla Oblongata Gray matter located in the dorsomedial part of the medulla oblongata associated with the solitary tract. The solitary nucleus receives inputs from most organ systems including the terminations of the facial, glossopharyngeal, and vagus nerves. It is a major coordinator of autonomic nervous system regulation of cardiovascular, respiratory, gustatory, gastrointestinal, and chemoreceptive aspects of homeostasis. The solitary nucleus is also notable for the large number of neurotransmitters which are found therein. Medulla Oblongata (66-93) 8pRSolar System H01.091.800 Extraterrestrial Environment Physical Sciences (Non MeSH); Astronomy Minor Planets; Planets (+ 10) The group of celestial bodies, including the EARTH, orbiting around and gravitationally bound by the sun. It includes nine planets, 34 natural satellites, more than 1,000 observed comets, and thousands of lesser bodies known as MINOR PLANETS (asteroids) and meteoroids. (From Academic American Encyclopedia, 1983). Astronomy (66-90); Extraterrestrial Environment (66-90)  T!1&nASolar Energy G03.230.132.708 ECLJSNSTUT Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources Energy transmitted from the sun in the form of electromagnetic radiation. Sunlight (66-81) aXSolanine D03.132.760.769; D04.808.247.808.874; D09.203.408.782.674 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Solanaceous Alkaloids Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Saponins  A:Solanaceous Alkaloids D03.132.760 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Parasympatholytics Heterocyclic Compounds; Alkaloids Belladonna Alkaloids (+ 2); Capsaicin; Nicotine; Solanine; Tomatine Alkaloids, mainly tropanes, elaborated by plants of the family Solanaceae, including Atropa, Hyoscyamus, Mandragora, Nicotiana, Solanum, etc. Some act as cholinergic antagonists; most are very toxic; many are used medicinally. Alkaloids (66-76); Solanum Alkaloids (77-78) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ( x>(S6@Soil Pollutants, Radioactive D05.284.638.756; D05.284.756.674 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Radioactive Pollutants Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Soil Pollutants Pollutants, present in soil, which exhibit radioactivity.  "&6DSoil Pollutants D05.284.756 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Acid Rain; Soil Pollutants, Radioactive Substances which pollute the soil. Use for soil pollutants in general or for which there is no specific heading. Environmental Pollution (71-74); Soil (66-74) ADAEAGAIANBLCFCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR $6U07<Soil Microbiology G01.273.540.274.555; G03.850.425.300 ST Biological Sciences; Biology; Microbiology; Environmental Microbiology Environment and Public Health (Non MeSH); Public Health; Environmental Microbiology The presence of bacteria, viruses, and fungi in the soil. This term is not restricted to pathogenic organisms. *Soil G03.230.600 ANPSST Environment and Public Health (Non MeSH); Environment The loose surface material of the earth in which plants grow. (Webster, 3d ed).  AcSoftware Validation L01.700.568.810.868 Information Science; Medical Informatics; Medical Informatics Computing; Software The act of testing the software for compliance with a standard. m_NSoftware Design L01.700.568.810.820 Information Science; Medical Informatics; Medical Informatics Computing; Software Specifications and instructions applied to the software. h_CSoftware L01.700.568.810 CLECHILJSDSNSTTD Information Science; Medical Informatics; Medical Informatics Computing Data Display (+ 2); Database Management Systems; Grateful Med; Programming Languages; Software Design; Software Validation; User-Computer Interface; Word Processing Sequential operating instructions for a particular problem or function to be run on a digital computer. Computers (66-82) AECLECEDHIISLJMAMTOGSDSNSTTDUT $T S{"Soft Tissue Neoplasms C04.588.839 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms, Connective Tissue Neoplasms; Neoplasms by Site (Non MeSH) Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc. ~X"1Soft Tissue Injuries C21.866.808 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Injuries of tissue other than bone. The concept is usually general and does not customarily refer to internal organs or viscera. It is meaningful with reference to regions or organs where soft tissue (muscle, fat, skin) should be differentiated from bones or bone tissue, as "soft tissue injuries of the hand". specific organ/injuries (66-93); specific region/injuries (66-93); specific tissue/injuries (66-93) NQovSoft Tissue Infections C01.539.820 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Skin Diseases, Infectious Bacterial and Fungal Diseases (Non MeSH); Infection Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the fecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites. (From Cecil Textbook of Medicine, 19th ed, p. 1688). `P?WSodium, Dietary D01.857.700; J01.341.241.800 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Sodium Compounds Technology, Industry, Agriculture (Non MeSH); Food; Condiments Sodium Chloride, Dietary Sodium Chloride, Dietary Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate. An excess of sodium in the diet may result in hypertension. Diet, Sodium-Restricted (66-87); Sodium (66-87); Sodium Chloride (66-87); Sodium Glutamate (75-87) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $"6:v8Sodium-Hydrogen Antiporter D12.776.157.070.775; D12.776.395.550.070.775; D12.776.543.550.070.775 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Antiporters Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Antiporters Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Antiporters A plasma membrane exchange glycoprotein transporter that functions in intracellular pH regulation, cell volume regulation, and cellular response to many different hormones and mitogens. Biological Transport, Active (76-82); Carrier Proteins (80-93) "MDgJSodium Tetradecyl Sulfate D02.033.555.900; D10.516.289.900; D26.394.225.766.826.824; D26.585.711.824; D26.866.875 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions; Sclerosing Solutions Miscellaneous Drugs and Agents (Non MeSH); Irritants; Sclerosing Solutions Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents 7-Ethyl-2-methyl-4-hendecanol sulfate sodium salt. An anionic surface-active agent used for its wetting properties in industry and used in medicine as an irritant and sclerosing agent for hemorrhoids and varicose veins. Sclerosing Solutions (66-74) &c."Sodium Selenite D01.810.950; D01.857.850 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Selenium Compounds Inorganic Chemicals (Non MeSH); Sodium Compounds Selenious acid, disodium salt. It is used therapeutically to supply the trace element selenium. Selenium (66-93) )8vrSodium Salicylate D02.241.223.106.505.700.710.850; D02.241.511.390.700.710.750; D02.755.410.700.710.750; D08.373.310.750; D16.850.015.050.830; D17.025.030.750; D17.050.030.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Salicylic Acids; Salicylates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Salicylic Acids; Salicylates Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Salicylic Acids; Salicylates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal A non-steroidal anti-inflammatory agent that is less effective than equal doses of ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding. (From AMA, Drug Evaluations Annual, 1992, p.120). +(:Sodium Radioisotopes D01.496.749.795; D01.496.807.800 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Sodium Isotopes Unstable isotopes of sodium that decay or disintegrate emitting radiation. Na atoms with atomic weights 20-22 and 24-26 are radioactive sodium isotopes. Radioisotopes (66-74); Sodium Isotopes (66-74) 2&48Sodium Pertechnetate Tc 99m D01.857.800; D01.925.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Sodium Compounds Inorganic Chemicals (Non MeSH); Technetium Compounds (T-4)-Technetate ((99)Tc)4(1-)), sodium. A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. Technetium (66-84) 4":x"Sodium Oxybate D02.241.081.161.627.700; D02.241.511.401.700; D15.050.035.075.737; D15.210.100.175.075.737 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates; Hydroxybutyrates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybutyrates Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Sodium 4-hydroxybutyrate. Anesthetic used for both induction and maintenance. It may cause bradycardia and dyskinesias. Sodium oxybate has been supplied illicitly as a drug of abuse promoted for body building, and weight loss. Hydroxybutyrates (69-74) 6fd: Sodium Nitrite D01.625.600.600.800; D01.857.775; D05.569.468.800; D26.471.385.810 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitrous Acid; Nitrites Inorganic Chemicals (Non MeSH); Sodium Compounds Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Mutagens Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives Nitrous acid sodium salt. Used in many industrial processes, in meat curing, coloring, and preserving, and as a reagent in analytical chemistry. The compound is toxic and mutagenic and will react in vivo with secondary or tertiary amines thereby producing highly carcinogenic nitrosamines. Nitrites (66-78); Sodium (66-78) :4L:GR)Sodium Morrhuate D02.241.081.407.800; D10.516.251.860; D26.394.225.766.826.524; D26.585.711.524 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions; Sclerosing Solutions Miscellaneous Drugs and Agents (Non MeSH); Irritants; Sclerosing Solutions The sodium salts of the fatty acids in cod liver oil; an irritant and sclerosing agent used to treat varicose veins and arthritic joints. Synonyms: Oleocid; Varicocid; Venotex. =X.|Sodium Isotopes D01.496.807 Inorganic Chemicals (Non MeSH); Isotopes Sodium Radioisotopes Stable sodium atoms that have the same atomic number as the element sodium, but differ in atomic weight. Na-23 is a stable sodium isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR @24Sodium Iodide D01.475.410.800; D01.857.760 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Iodine Compounds; Iodides Inorganic Chemicals (Non MeSH); Sodium Compounds Sodium iodide (NaI). A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive (I-131) form as an diagnostic aid, particularly for thyroid function determinants. Iodides (66-78); Sodium (66-78) B4"8(Sodium Hypochlorite D01.210.465.800; D01.650.550.400.800; D01.857.750; D20.187.222.700; D26.680.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hypochlorous Acid Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Hypochlorous Acid Inorganic Chemicals (Non MeSH); Sodium Compounds Anti-Infective Agents; Anti-Infective Agents, Local; Disinfectants Miscellaneous Drugs and Agents (Non MeSH); Oxidants Sodium hypochlorite (ClNaO). The sodium salt of hypochlorous acid. It is used as an oxidizing and bleaching agent and as a disinfectant. (From Grant and Hackh's Chemical Dictionary, 5th ed). Dt[8Sodium Hydroxide D01.045.250.750; D01.205.875; D01.455.824; D01.857.745; D05.569.185.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Alkalies; Hydroxides Inorganic Chemicals (Non MeSH); Caustics Inorganic Chemicals (Non MeSH); Hydroxides Inorganic Chemicals (Non MeSH); Sodium Compounds Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Caustics Sodium hydroxide Na(OH). A highly caustic substance that is used to neutralize acids and make sodium salts. (From Merck Index, 11th ed). GS84Sodium Glutamate D12.125.119.450.400.800; D26.471.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Glutamic Acid; Glutamates Miscellaneous Drugs and Agents (Non MeSH); Food Additives L-Glutamic acid, sodium salt. An additive used to impart meat flavor to foods, and to enhance other natural food flavors. Medically it has been used to reduce blood ammonia levels in ammoniacal azotemia, therapy of hepatic coma, in psychosis, and mental retardation. Glutamates (66-74) JN*::Sodium Fluoride D01.303.350.300.875; D01.857.725; D25.223.432.866 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Fluorine Compounds; Hydrofluoric Acid; Fluorides Inorganic Chemicals (Non MeSH); Sodium Compounds Biomedical and Dental Materials (Non MeSH); Cariostatic Agents; Fluorides, Topical Acidulated Phosphate Fluoride Acidulated Phosphate Fluoride Acidulated Phosphate Fluoride Sodium fluoride (NaF). A source of inorganic fluoride which has been used orally and topically to prevent dental caries. It is also effective as a pesticide and in the therapy of osteoporosis. Fluorides (66-76); Fluorides, Topical (66-76)  M 9,e7Sodium Dodecyl Sulfate D02.033.555.700.720; D10.516.289.700.710; D26.866.868 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols; Lauryl Alcohol Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols; Lauryl Alcohol Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents Sodium lauryl sulfate. An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry. Synonym: Irium. Surface-Active Agents (66-71) P*=.l#Sodium Cyanide D01.625.400.100.875; D01.857.660 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide; Cyanides Inorganic Chemicals (Non MeSH); Sodium Compounds Sodium cyanide (Na(CN)). A highly poisonous compound that is an inhibitor of many metabolic processes and is used as a test reagent for the function of chemoreceptors. It is also used in many industrial processes. Cyanides (66-78); Sodium (66-78) Sh&8)Sodium Compounds D01.857 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Gold Sodium Thiosulfate; Sodium Bicarbonate; Sodium Chloride (+ 1); Sodium Cyanide; Sodium, Dietary (+ 1); Sodium Fluoride (+ 1); Sodium Hydroxide; Sodium Hypochlorite; Sodium Iodide; Sodium Nitrite; Sodium Pertechnetate Tc 99m; Sodium Selenite Inorganic compounds that contain sodium as an integral part of the molecule. Sodium (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $U 8%&\:Sodium Chloride, Dietary D01.857.650.705; D01.857.700.705; J01.341.241.800.690 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Sodium Compounds; Sodium Chloride Inorganic Chemicals (Non MeSH); Sodium Compounds; Sodium, Dietary Technology, Industry, Agriculture (Non MeSH); Food; Condiments; Sodium, Dietary Sodium chloride used in foods or as a food. An excess of sodium chloride in the diet may result in hypertension. Sodium Chloride (66-93); Sodium, Dietary (88-93) X;=8;Sodium Chloride D01.210.450.150.875; D01.857.650 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Diet, Sodium-Restricted Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Inorganic Chemicals (Non MeSH); Sodium Compounds  Sodium Chloride, Dietary Sodium chloride (NaCl). A colorless, cubic crystal or white, crystalline powder, found widely distributed over the earth, in sea water, etc., which is a necessary constituent of the body and consequently of the diet. It makes up over 90 percent of the inorganic constituents of the blood serum and is the principal salt involved in maintaining osmotic tension of the blood and tissues. (From Dorland, 27th ed).  Z&8Sodium Channels D12.776.395.550.440.875; D12.776.543.550.425.875 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Na(+)-K(+)-Exchanging ATPase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Ion Channels Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Ion Channels Cell membrane glycoproteins selective for sodium ions. Fast sodium current is associated with the action potential in neural membranes. Ion Channels (79-88); Sodium (79-88)  ^6F%.Sodium Bicarbonate D01.200.275.150.100.800; D01.857.625 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH); Carbonic Acid; Carbonates; Bicarbonates Inorganic Chemicals (Non MeSH); Sodium Compounds Carbonic acid monosodium salt (CHNaO3). A white, crystalline powder that is used as an electrolyte replenisher and systemic alkalizer. It is applied topically in solution to wash the nose, mouth, or vagina, and as a cleansing enema. (From Dorland, 27th ed). Bicarbonates (80-93); Sodium (80-93) `*83-Sodium D01.268.549.750; D01.552.528.850 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Hypernatremia; Hyponatremia; Natriuresis Inorganic Chemicals (Non MeSH); Elements; Metals, Alkali Inorganic Chemicals (Non MeSH); Metals; Metals, Alkali Sodium. An element that is a member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. With a valence of 1, it has a strong affinity for oxygen and other nonmetallic elements. Sodium provides the chief cation of the extracellular body fluids. Its salts are the most widely used in medicine. (From Dorland, 27th ed) Physiologically the sodium ion plays a major role in blood pressure regulation, maintenance of fluid volume, and electrolyte balance. c &:0OSociometric Techniques I01.880.866 Statistics Social Sciences; Sociology Methods for quantitatively assessing and measuring interpersonal and group relationships. Psychology, Social (66-67); Sociology (66-67) g!g7Sociology, Medical F04.096.879.757.400; G02.790 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Social Sciences; Sociology Health Occupations The study of the social determinants and social effects of health and disease, and of the social structure of medical institutions or professions. Sociology (66-77) h<"Sociology F04.096.879.757; I01.880 CLECEDHIISLJMAMTOGSNSTTD Group Processes Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Social Sciences Social Sciences Sociology, Medical Culture (+ 18); Family (+ 17); Minority Groups; Social Change (+ 1); Social Class (+ 1); Social Conditions (+ 1); Social Control, Formal (+ 50); Social Control, Informal (+ 3); Social Environment (+ 1); Social Isolation (+ 2); Social Planning (+ 3); Social Problems (+ 33); Social Welfare (+ 15); Social Work (+ 1); Socialization; Socioeconomic Factors (+ 5); Sociometric Techniques; Spatial Behavior (+ 1) A social science dealing with group relationships, patterns of collective behavior, and social organization. AEBLCFCICLCNCODEDHDIDTECEDEHEMENEPETGEHIIMINISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERHRIRTSDSNSTSUTDTHURUSUTVEVI $j x~nSocioenvironmental Therapy F04.754.864 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Milieu Therapy (+ 1); Psychotherapy, Group (+ 5); Residential Treatment Therapy whose primary emphasis is on the physical and social structuring of the environment to promote interpersonal relationships which will be influential in reducing behavioral disturbances of patients. Psychotherapy (66-72)  mKXSocioeconomic Factors I01.880.840; N01.824 Economics Social Sciences; Sociology Population Characteristics (Non MeSH) Career Mobility; Poverty (+ 1); Social Class (+ 1) Career Mobility; Educational Status; Employment (+ 3); Family Characteristics (+ 6); Income (+ 6); Medical Indigency; Occupations (+ 1); Poverty (+ 1); Social Change; Social Class (+ 1); Social Conditions Social and economic factors that characterize the individual or group within the social structure. Social Conditions (66-67); Sociology (66-67) CLECEDEHHILJMAMTOGPCPXSNSTTDUT $p K<t6"Societies, Scientific N03.540.828.838 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Societies Societies whose membership is limited to scientists. rS?Societies, Pharmaceutical N03.540.828.755 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Societies Societies whose membership is limited to pharmacists. Pharmacy (66-67) sS@Societies, Nursing N03.540.828.672 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Societies American Nurses' Association; International Council of Nurses Societies whose membership is limited to nurses. tSH;Societies, Medical N03.540.828.589 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Societies American Medical Association Societies whose membership is limited to physicians. v,S"?Societies, Hospital N03.540.828.540 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Societies American Hospital Association Societies having institutional membership limited to hospitals and other health care institutions. Hospitals (66-Jul 77); Societies (66-Jul 77)  wGS#r7Societies, Dental N03.540.828.506 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Societies American Dental Association Societies whose membership is limited to dentists. xS!=Societies N03.540.828 CLECHILJOGSNSTTDUT Library Associations Organizations Economics, Organizations, Control (Non MeSH); Organizations American Speech-Language-Hearing Association; Societies, Dental (+ 1); Societies, Hospital (+ 1); Societies, Medical (+ 1); Societies, Nursing (+ 2); Societies, Pharmaceutical; Societies, Scientific Organizations composed of members with common interests and whose professions may be similar. $y FnSocialization I01.880.813 Personality Development Social Sciences; Sociology The training or molding of an individual through various relationships, educational agencies, and social controls, which enables him to become a member of a particular society. Child Rearing (66-67); Family (66-67); Parent-Child Relations (66-67) |!TSocialism I01.696.798 CLECHISNTD Social Sciences; Political Systems A system of government in which means of production and distribution of goods are controlled by the state. } *Social Work, Psychiatric F04.408.823; I01.880.792.410; N02.421.461.798; N02.421.849.673 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Mental Health Services Social Sciences; Sociology; Social Work Facilities, Manpower and Services (Non MeSH); Health Services; Mental Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Social Work Use of all social work processes in the treatment of patients in a psychiatric or mental health setting. ~HA~Social Work Department, Hospital N02.278.354.422.730; N04.452.442.422.730 CLECHILJMAOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for administering and providing social services to patients and their families. Hospital Departments (68-83); Social Work (78-83) '. <Social Work I01.880.792; N02.421.849 CLECEDHIISLJMAMTOGSNSTTD Community Health Services; Relief Work Social Sciences; Sociology Facilities, Manpower and Services (Non MeSH); Health Services Social Work, Psychiatric Social Work, Psychiatric The use of community resources, individual case work, or group work to promote the adaptive capacities of individuals in relation to their social and economic environments. It includes social service agencies.  o/i:Social Welfare I01.880.787 CLECEHHILJPXSNTD Public Assistance Social Sciences; Sociology Charities; Child Welfare (+ 10); Infant Welfare; Maternal Welfare; Relief Work Organized institutions which provide services to ameliorate conditions of need or social pathology in the community. BLCFCICLCNCODHDIDTECEDEHEMENEPETGEHIIMINLJMAMEMIMOMTNUOGPAPCPPPSPXRARHRIRTSDSNSTSUTDTHURUSUTVEVI $!adSocial Values F01.829.873 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Abstract standards or empirical variables in social life which are believed to be important and/or desirable. Judgment (66-68); Psychology, Social (66-68) L6Social Support I01.880.656.600 Self-Help Groups Social Sciences; Sociology; Social Environment Support systems that provide assistance and encouragement to individuals with physical or emotional disabilities in order that they may better cope. Informal social support is usually provided by friends, relatives, or peers, while formal assistance is provided by churches, groups, etc. Social Adjustment (69-82); Social Environment (73-82) 8M@Social Security N03.219.521.346.506.849; N03.219.521.576.823 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Aid to Families with Dependent Children Government sponsored social insurance programs.  218Social Sciences F04.096.879; I01 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Anthropology; Sociology (+ 1) Anthropology (+ 55); Cost of Illness; Criminology (+ 29); Demography (+ 16); Environment Design; Forecasting; Government (+ 3); Government Programs (Non MeSH) (+ 2); International Cooperation (+ 4); Political Systems (+ 4); Politics (+ 1); Private Sector; Public Sector; Quality of Life; Sociology (+ 170) Disciplines concerned with the interrelationships of individuals in a social environment including social organizations and institutions. Includes Sociology and Anthropology. AEBLCFCICLCNCOCTDEDHDIDTECEDEHEMENEPETGEHIIMINISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERHRIRTSDSNSTSUTDTHURUSUTVEVI  SpSocial Responsibility F01.829.500.680; K01.316.630.680; K01.752.256.547.680 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Morals Humanities; Ethics; Morals Humanities; Philosophy; Ethics; Morals The obligations and accountability assumed in carrying out actions or ideas in behalf of others. =sSocial Problems I01.880.735 CLECEHHILJPCPXSNTD Alcoholism; Substance Dependence; Student Dropouts Social Sciences; Sociology Civil Disorders (+ 1); Crime (+ 1); Divorce; Doping in Sports; Illegitimacy; Incest; Juvenile Delinquency; Needle Sharing; Poverty; Prostitution; Quackery; Race Relations; Substance Abuse (+ 1); Suicide (+ 2); Violence (+ 6); War (+ 6) Situations affecting a significant number of people, that are believed to be sources of difficulty or threaten the stability of the community, and that require programs of amelioration. Alcoholism (66-67); Antisocial Personality Disorder (66-67); Juvenile Delinquency (66-67); Prostitution (66-67) AEBLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMOMTNUPAPCPPPSPXRARHRISNSUTDTHURUSVI ( <!%PSocial Planning I01.880.709 Planning Techniques Social Sciences; Sociology City Planning; Environment Design; Urban Renewal Interactional process combining investigation, discussion, and agreement by a number of people in the preparation and carrying out of a program to ameliorate conditions of need or social pathology in the community. It usually involves the action of a formal political, legal, or recognized voluntary body. Housing (66-67); Social Conditions (66-67); Sociology (66-67) CLECEDHILJMAMTOGSDSNSTTDUT $!;dKSocial Perception F02.463.593.752 Stereotyping Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception The perceiving of attributes, characteristics, and behaviors of one's associates or social groups. Perception (66-68) 9\sSocial Mobility I01.880.552.673; I01.880.840.755.673; N01.824.782.673 ECHISNTD Social Sciences; Sociology; Social Class Social Sciences; Sociology; Socioeconomic Factors; Social Class Population Characteristics (Non MeSH); Socioeconomic Factors; Social Class The movement or shifting of membership between or within social classes by individuals or by groups. Sociology (66-67) = xSocial Medicine G02.403.720 CLECEDHIISLJMAMTOGSNSTTD Public Health Health Occupations; Medicine A branch of medicine concerned with the role of socio-environmental factors in the occurrence, prevention and treatment of disease. c#Social Justice I01.880.604.473.700; N03.706.437.700 CLECEDHIINLJPXSNSTTD Civil Rights; Human Rights Social Sciences; Sociology; Social Control, Formal; Human Rights Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights An interactive process whereby members of a community are concerned for the equality and rights of all. *"|Social Isolation F01.829.850; I01.880.683 PX Population Density Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Social Sciences; Sociology Loneliness; Social Alienation Loneliness; Social Alienation The separation of individuals or groups resulting in the lack of or minimizing of social contact and/or communication. This separation may be accomplished by physical separation, by social barriers and by psychological mechanisms. In the latter, there may be interaction but no real communication.  `kF\Social Identification F01.145.813.708; F01.829.759.708 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Behavior The process wherein the individual so strongly feels himself a member of a group that he adopts its ideas, beliefs, and habits. Social Behavior (69-77) &Social Facilitation F01.145.857; F01.829.827 Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Any enhancement of a motivated behavior in which individuals do the same thing with some degree of mutual stimulation and consequent coordination. Social Environment I01.880.656 Life Style Environment Social Sciences; Sociology Social Support The aggregate of social and cultural institutions, forms, patterns, and processes that influence the life of an individual or community. Adaptation, Psychological (66-68); Environment (66-71); Social Adjustment (69-71); Social Behavior (69-71); Social Conditions (66-71); Social Isolation (69-71); Social Planning (68-71); Socioeconomic Factors (68-71) $@!Social Dominance F01.145.843; F01.829.316.848 Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes Dominance-Subordination; Hierarchy, Social Superiority of relationship and rank of an individual in relation to his associates. "2eSocial Distance F01.829.316.777 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes The degree of closeness or acceptance an individual or group feels toward another individual or group. Interpersonal Relations (66-68); Psychology, Social (66-68) `zFSocial Desirability F01.829.805 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social A personality trait rendering the individual acceptable in social or interpersonal relations. It is related to social acceptance, social approval, popularity, social status, leadership qualities, or any quality making him a socially desirable companion. L$Social Control, Informal I01.880.630 CLHIMT Social Conformity; Power (Psychology) Social Sciences; Sociology Coercion; Public Opinion; Punishment Those forms of control which are exerted in less concrete and tangible ways, as through folkways, mores, conventions, and public sentiment. CLHIMTPX $6 -!- Social Control, Formal I01.880.604; N03.706 CLMT Social Sciences; Sociology Economics, Organizations, Control (Non MeSH) Animal Welfare (+ 1); Capital Punishment; Human Rights (+ 8); Jurisprudence (+ 21); Legislation, Drug (+ 2); Peer Review (+ 2); Police; Policies (Non MeSH) (+ 6); Prisons (+ 1) Credentialing (+ 10); Facility Regulation and Control; Human Rights (+ 8); Jurisprudence (+ 18); Legislation (+ 10); Peer Review (+ 2); Policies (Non MeSH) (+ 6); Policy Making Control which is exerted by the more stable organizations of society, such as established institutions and the law. They are ordinarily embodied in definite codes, usually written. Legislation (66-67); specific control (66-67); specific subject controlled (66-67) CLECEDEHHIINISLJMAMTOGPCPXSDSNSTTDUT $Sb(Social Conformity F01.145.828; F01.829.782 SOCIAL CONTROL, INFORMAL Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Behavioral or attitudinal compliance with recognized social patterns or standards. Attitude (66-67); Behavior (66-67); Interpersonal Relations (66-67) `QSocial Conditions I01.880.578; N01.824.827 CLECHILJSNTD Social Sciences; Sociology Population Characteristics (Non MeSH); Socioeconomic Factors Anomie The state of society as it exists or in flux. While it usually refers to society as a whole in a specified geographical or political region, it is applicable also to restricted strata of a society. Sf Social Class I01.880.552; I01.880.840.755; N01.824.782 Social Sciences; Sociology Social Sciences; Sociology; Socioeconomic Factors Population Characteristics (Non MeSH); Socioeconomic Factors Social Mobility Social Mobility Social Mobility A stratum of people with similar position and prestige; includes social stratification. Social class is measured by criteria such as education, occupation, and income. Social Conditions (66-67); Sociology (66-67) ECHISNTD  186 Social Change I01.880.526; N01.824.737 HI Group Processes Social Sciences; Sociology Population Characteristics (Non MeSH); Socioeconomic Factors Urbanization Social process whereby the values, attitudes, or institutions of society, such as education, family, religion, and industry become modified. It includes both the natural process and action programs initiated by members of the community. Social Conditions (66-67); Sociology (66-67) HILJTD (hf6 Social Breakdown Syndrome F03.126.842.848 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders The deterioration in social relationships of the individual as a result of his or her environment. It occurs in prisons, hospitals, institutions, etc. FySocial Behavior Disorders F03.126.842 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Antisocial Personality Disorder Anomie Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Aggression (+ 9); Juvenile Delinquency; Lying; Runaway Reaction; Social Alienation; Social Breakdown Syndrome Behaviors which are at variance with the expected social norm and which affect other individuals. Child Behavior Disorders (66-68) BLCFCICLCODEDHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPHPPPSPXRARERHRISNSUTDTHURUSVI ,uF% Yt'RSocial Behavior F01.145.813; F01.829.759 Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Altruism; Helping Behavior; Mass Behavior; Shyness; Social Identification Altruism; Helping Behavior; Mass Behavior; Shyness; Social Identification Any behavior caused by or affecting another individual, usually of the same species. Behavior (66-68); Psychology, Social (66-68) e6Social Alienation F01.829.056.672; F01.829.850.755; F03.126.842.777; I01.880.683.755 PX Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Anomie Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Isolation Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders Social Sciences; Sociology; Social Isolation The state of estrangement individuals feel in cultural settings that they view as foreign, unpredictable, or unacceptable. Interpersonal Relations (66-67); Psychology, Social (66-67); Social Conditions (66-67); Social Isolation (68-72); Sociology (66-67) EL`Social Adjustment F01.829.737 Adaptation, Psychological Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Those types of relationships which involve the accommodation of the individual to circumstances in his social environment for the satisfaction of his needs or motives. Adaptation, Psychological (66-68); Behavior (66-68) _L=Soccer I03.450.642.845.800 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A game in which a round inflated ball is advanced by kicking or propelling with any part of the body except the hands or arms. The object of the game is to place the ball in opposite goals. Sports (66-75)  RSoaps D26.866.265.861; J01.516.872 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Detergents Technology, Industry, Agriculture (Non MeSH); Household Products Sodium or potassium salts of long chain fatty acids. These detergent substances are obtained by boiling natural oils or fats with caustic alkali. Sodium soaps are harder and are used as topical anti-infectives and vehicles in pills and liniments; potassium soaps are soft, used as vehicles for ointments and also as topical antimicrobials.  ",Snow G03.230.300.100.725.480 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather suSnoring C23.888.852.779.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH); Respiratory Sounds Rough, noisy breathing during sleep, due to vibration of the uvula and soft palate. & NeSneezing G09.772.672 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH)  fSnakes B02.833.672 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Snake Bites; Snake Venoms Vertebrates; Reptiles Boidae; Colubridae; Elapidae (+ 2); Hydrophidae; Viperidae (+ 5) p &!QSnake Venoms D24.185.965.850 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Antivenins Snakes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms Elapid Venoms (+ 4); Hydrophid Venoms (+ 1); Viper Venoms (+ 4) Solutions or mixtures of toxic and nontoxic substances elaborated by snake (Ophidia) salivary glands for the purpose of killing prey or disabling predators and delivered by grooved or hollow fangs. They usually contain enzymes, toxins, and other factors. Venoms (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,c< VR)JSnake Bites C21.613.127.722 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antivenins Snakes Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Bites and Stings Bites by snakes. The condition of having been bitten by a venomous snake, characterized by stinging pain at the wound puncture. The venom injected at the site of the bite is capable of producing a deleterious effect on the blood or on the nervous system. (Webster's 3d ed; from Dorland, 27th ed, at snake, venomous).  @N [|Snails B01.644.776 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca Biomphalaria; Bulinus; Helix (Snails); Lymnaea Marine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man.  (:Smooth Muscle Tumor C04.557.450.590.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue A tumor composed of smooth muscle tissue, as opposed to leiomyoma, a tumor derived from smooth muscle. Leiomyoma (68-93); Leiomyosarcoma (66-93); Muscle, Smooth (69-93); Muscle, Smooth, Vascular (83-93); Neoplasms, Muscle Tissue (81-93) FX{Smoking Cessation F01.145.076.347.410.800; F01.145.466.753.800 ECEHMTPXSN Tobacco Use Disorder Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude to Health; Health Behavior Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits; Smoking Discontinuation of the habit of smoking, the inhaling and exhaling of tobacco smoke. Smoking/prevention and control (68-91); Smoking/therapy (72-91)  զ2eLSmoking F01.145.466.753 AEBLCFDTECEHEPGEHIIMLJMEMOPAPCPPPXTDTHUR Tobacco Use Disorder Tobacco Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits Marijuana Smoking; Smoking Cessation Inhaling and exhaling the smoke of tobacco or something similar to tobacco. AEBLCFDTECEHEPGEHIIMLJMEMOMTPAPCPPPXSNTDTHUR (׿ , K,[0Smoke Inhalation Injury C21.866.200.322.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fires Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Burns; Burns, Inhalation Pulmonary injury following the breathing in of toxic smoke from burning materials such as plastics, synthetics, building materials, etc. This injury is the most frequent cause of death in burn patients. Burns, Inhalation (66-88)  cN pSmoke G03.850.460.100.340 AEANPC Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution Tobacco Smoke Pollution Air Pollution (66-70) AEANECHILJPCSN  ۖ  rSmog G03.850.460.100.310 AEANPC Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution A mixture of smoke and fog polluting the atmosphere. (Dorland, 27th ed). Air Pollution (66-70) ܧ rZSmiling F01.145.209.530.385.671 PHPX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication; Facial Expression A facial expression which may denote feelings of pleasure, affection, amusement, etc.  eSmell F02.830.816.643; G11.561.796.643 DEGEIMPHRE Anosmia; Odors Odors Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation The sensation or perception of scents or odors.   & ;Smegma A12.838.769 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH)  "DSmear Layer E06.323.325.750 Dentistry; Dentistry, Operative; Dental Cavity Preparation Adherent debris produced when cutting the enamel or dentin in cavity preparation. It is about 1 micron thick and its composition reflects the underlying dentin, although different quantities and qualities of smear layer can be produced by the various instrumentation techniques. Its function is presumed to be protective, as it lowers dentin permeability. However, it masks the underlying dentin and interferes with attempts to bond dental material to the dentin. Dental Cavity Preparation (81-91); Dental Pulp Cavity (81-91); Dentin (81-91) DE^Smallpox Vaccine D24.310.894.899.859 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines I>lSmallpox C02.256.743.826 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Alastrim > PU Small-Area Analysis E05.318.740.250.675; G03.850.520.830.250.675; H01.548.832.266.675; N05.715.360.750.200.750 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Cluster Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Cluster Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Cluster Analysis Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Cluster Analysis A method of analyzing the variation in utilization of health care in small geographic or demographic areas. It often studies, for example, the usage rates for a given service or procedure in several small areas, documenting the variation among the areas. By comparing high- and low-use areas, the analysis attempts to determine whether there is a pattern to such use and to identify variables that are associated with and contribute to the variation. 1dSlow Virus Diseases C02.839 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Prion Diseases Prion Diseases Virus Diseases Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; AIDS-Related Complex; Aleutian Mink Disease; Equine Infectious Anemia; Feline Acquired Immunodeficiency Syndrome; Leukoencephalopathy, Progressive Multifocal; Pneumonia, Progressive Interstitial, of Sheep; Simian Acquired Immunodeficiency Syndrome; Subacute Sclerosing Panencephalitis; Visna Diseases of viral origin, characterized by incubation periods of months to years, insidious onset of clinical manifestations, and protracted clinical course. Though the disease process is protracted, viral multiplication may not be unusually slow. Conventional viruses produce slow virus diseases such as SUBACUTE SCLEROSING PANENCEPHALITIS, progressive multifocal leukoencephalopathy (LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL), and AIDS. Diseases produced by unconventional agents were originally considered part of this group. They are now called PRION DISEASES. Virus Diseases (66-67) ( PSlovenia Z01.542.248.820; Z01.586.980.820 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Yugoslavia Created 7 April 1992 as a result of the division of Yugoslavia. Yugoslavia (66-92)  &OSlovakia Z01.542.248.797; Z01.586.250.750 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Czechoslovakia Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia. Czechoslovakia (66-93) & &Sloths B02.649.314.800 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Edentata Slow-moving exclusively arboreal mammals that inhabit the tropical forests of South and Central America.  (&zSleep, REM F02.830.855.796.671; G11.561.826.754.671 DEGEIMPHRE Eye Movements Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sleep; Sleep Stages Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sleep; Sleep Stages A stage of sleep characterized by rapid movements of the eye and low voltage fast pattern EEG. It is usually associated with dreaming. Sleep (66-68)  .Sleep Stages F02.830.855.796; G11.561.826.754 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sleep Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sleep Sleep, REM Sleep, REM Periods of sleep manifested by changes in EEG activity and certain behavioral correlates; includes Stage 1: sleep onset, drowsy sleep; Stage 2: light sleep; Stages 3 and 4: delta sleep, light sleep, deep sleep, telencephalic sleep. Sleep (66-68)  &Sleep Disorders C10.597.785; C23.888.592.796; F03.126.821 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Hypersomnia (+ 1); Insomnia; Somnambulism Hypersomnia (+ 1); Insomnia; Somnambulism Hypersomnia (+ 1); Insomnia; Narcolepsy; Somnambulism Sleep disturbances due to physical or mental illness. [1NASleep Deprivation F02.830.855.671; G11.561.826.587 PH Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sleep Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sleep The condition of being deprived of sleep either under experimental or under unusual real life conditions, as distinguished from being unable to sleep. &Sleep Apnea Syndromes C08.618.085.852 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Apnea Pickwickian Syndrome Disorders involving apneic episodes during sleep. They may be due to cessation of diaphragmatic movement, obstruction of upper airway air flow, or a combination of these, and may be associated with hypersomnolence, insomnia, or obesity. Apnea (66-79); Hypoventilation (66-79); Sleep (66-79); Sleep Disorders (66-79)  NC`Sleep F02.830.855; G11.561.826 DEGEIMPHRE Polysomnography Psychologic Processes and Principles (Non MeSH); Psychophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Dreams; Sleep Deprivation; Sleep Stages (+ 1) Sleep Deprivation; Sleep Stages (+ 1) A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. CLDEGEIMPHPXRE $V fSkunks B02.649.147.875 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Omnivorous New World mammals showing typical warning coloration of patterned black and white and able to eject a malodorous secretion when the animal is startled or in danger.  ('Skull Neoplasms C04.588.149.721; C05.116.231.754 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms Jaw Neoplasms (+ 3); Nose Neoplasms; Orbital Neoplasms Jaw Neoplasms (+ 3); Nose Neoplasms; Orbital Neoplasms &XSkull Fractures C21.866.405.762; C21.866.460.836 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Jaw Fractures (+ 2); Orbital Fractures; Zygomatic Fractures Jaw Fractures (+ 2); Orbital Fractures; Zygomatic Fractures &NSkull A02.835.232.781 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cephalometry; Craniometry; Craniotomy; Intracranial Pressure; Trephining Head Musculoskeletal System; Skeleton; Bone and Bones Cranial Fossa, Posterior; Cranial Sutures; Ethmoid Bone; Facial Bones (+ 12); Frontal Bone; Occipital Bone (+ 1); Parietal Bone; Sphenoid Bone (+ 1); Temporal Bone (+ 2) The skeleton of the head including the bones of the face and the bones enclosing the brain. consider also terms at CRANI-. $ :U;Skinfold Thickness E01.706.886 Body Mass Index; Obesity Diagnosis; Physical Examination Obesity (66-67); Skin (66-67)  , &&Skin, Artificial E07.858.082.800 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Artificial Organs Synthetic material used for the treatment of burns and other conditions involving large-scale loss of skin. It often consists of an outer (epidermal) layer of silicone and an inner (dermal) layer of collagen and chondroitin 6-sulfate. The dermal layer elicits new growth and vascular invasion and the outer layer is later removed and replaced by a graft. Artificial Organs (66-93); Skin (66-93)  I1Skin Window Technique E05.478.877 Miscellaneous Techniques (Non MeSH); Immunologic Techniques Inflammation (66)  gFSkin Ulcer C17.800.893 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ulcer Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Decubitus Ulcer; Leg Ulcer (+ 3); Pyoderma Gangrenosum  N KDSkin Transplantation E04.936.580.700 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgical Flaps Surgery, Operative; Transplantation; Tissue Transplantation The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin. Skin/transplantation (66-89)  72E"Skin Tests E01.223.495.862; E01.862 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Diagnosis Intradermal Tests (+ 2); Passive Cutaneous Anaphylaxis; Patch Tests; Tuberculin Test Intradermal Tests (+ 2); Passive Cutaneous Anaphylaxis; Patch Tests; Tuberculin Test Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE  "H,Skin Test End-Point Titration E01.223.495.826.664.500; E01.223.495.862.345.770; E01.862.345.770; E05.196.922.875 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Neutralization Tests Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Skin Tests; Intradermal Tests Diagnosis; Skin Tests; Intradermal Tests Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Titrimetry A quantitative form of intradermal testing for the relative allergenicity of a substance. It is used to determine the amount of an allergen that will be tolerated in immunotherapy. Skin Tests (75-89) g$\"HSkin Temperature G07.315.753; G10.795.775 DEGEIMPHRE Physiology, General (Non MeSH); Body Temperature Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) Body Temperature (66-69); Skin (66-69) f0Skin Pigmentation E01.706.760.670; G04.185.672.890; G10.795.704 DEGEIMPHRE Pigmentation Diagnosis; Physical Examination; Pigmentation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Pigmentation Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) Coloration of the skin. Pigmentattion (66-74)  5Skin Physiology (Non MeSH) G10.795 Digestive, Oral, Skin Physiology (Non MeSH) Galvanic Skin Response; Hair Color; Piloerection; Skin Absorption; Skin Aging; Skin Pigmentation; Skin Temperature; Sweating (+ 1) DEGEIMPAPHRE Z! 4Skin Neoplasms C04.588.805; C17.800.882 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Lymphomatoid Papulosis; Sebaceous Gland Neoplasms; Sweat Gland Neoplasms Lymphomatoid Papulosis; Sebaceous Gland Neoplasms; Sweat Gland Neoplasms XzSkin Manifestations C17.800.871; C23.888.885 Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Dermatologic disorders attendant upon non-dermatologic disease or injury. XUSkin Diseases, Viral C02.825; C17.800.838.790 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious Erythema Infectiosum; Exanthema Subitum; Herpes Simplex (+ 2); Molluscum Contagiosum; Warts (+ 2) Erythema Infectiosum; Exanthema Subitum; Herpes Simplex (+ 2); Molluscum Contagiosum; Warts (+ 2) Skin diseases caused by viruses. P{)Skin Diseases, Vesiculobullous C17.800.865 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Acantholysis; Blister; Dermatitis Herpetiformis; Eczema, Dyshidrotic; Epidermolysis Bullosa (+ 4); Erythema Multiforme (+ 1); Herpes Gestationis; Hydroa Vacciniforme; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Pemphigus (+ 1) Skin diseases characterized by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Etiologies include immunologic and genetic factors. (From Scientific American Medicine, 1990). specific skin disease (66-75)  $NK$Skin Diseases, Vascular C17.800.862 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Angiomatosis, Bacillary; Behcet's Syndrome; Mucocutaneous Lymph Node Syndrome; Polyarteritis Nodosa; Pyoderma Gangrenosum; Takayasu's Arteritis; Temporal Arteritis; Urticaria (+ 1); Vasculitis, Allergic Cutaneous Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area. Skin Diseases (66-92) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $"NKPSkin Diseases, Parasitic C03.858; C17.800.838.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Ectoparasitic Infestations Parasitic Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious Larva Migrans; Leishmaniasis (+ 3); Pediculosis; Scabies Larva Migrans; Leishmaniasis (+ 3); Pediculosis; Scabies Skin diseases caused by arthropods, helminths, or protozoa. Parasitic Diseases (66-67); Skin Diseases (66-67) $%PG<Skin Diseases, Papulosquamous C17.800.859 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Dermatitis, Seborrheic; Lichenoid Eruptions (+ 6); Parapsoriasis (+ 2); Pityriasis (+ 4); Psoriasis (+ 1) A group of dermatoses with distinct morphologic features. The primary lesion is most commonly a papule, usually erythematous, with a variable degree of scaling on the surface. Plaques form through the coalescing of primary lesions. Skin Diseases (66-92)  (#NKSkin Diseases, Metabolic (Non MeSH) C17.800.849 Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Adiposis Dolorosa; Lipodystrophy (+ 1); Necrobiosis Lipoidica; Porphyria (+ 5); Xanthogranuloma, Juvenile; Xanthomatosis (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI *+KNSkin Diseases, Infectious C01.539.800; C17.800.838 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Soft Tissue Infections Bacterial and Fungal Diseases (Non MeSH); Infection Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Cellulitis; Dermatomycoses (+ 13); Skin Diseases, Bacterial (+ 22) Dermatomycoses (+ 13); Skin Diseases, Bacterial (+ 22); Skin Diseases, Parasitic (+ 7); Skin Diseases, Viral (+ 9) Skin diseases caused by bacteria, fungi, parasites, or viruses. specific skin disease (66-67) $,8PL$Skin Diseases, Genetic (Non MeSH) C17.800.827 Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Albinism (+ 3); Cutis Laxa; Dermatitis, Atopic; Keratosis Follicularis; Pemphigus, Benign Familial; Porokeratosis; Porphyria, Erythrohepatic; Porphyria, Erythropoietic; Porphyria, Hepatic (+ 2); Skin Abnormalities (Non MeSH) (+ 20) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI .)KXSkin Diseases, Eczematous C17.800.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Dermatitis, Atopic; Dermatitis, Contact (+ 7); Dermatitis, Exfoliative; Dermatitis, Seborrheic; Eczema (+ 1); Intertrigo; Neurodermatitis Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied. Eczema (66-92); Skin Diseases (66-92)  0NK/Skin Diseases, Bacterial C01.252.825; C01.539.800.720; C17.800.838.765 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious Actinomycosis, Cervicofacial; Angiomatosis, Bacillary; Ecthyma; Erysipelas; Erythema Chronicum Migrans; Erythrasma; Granuloma Inguinale; Hidradenitis Suppurativa; Maduromycosis; Paronychia; Pinta; Rhinoscleroma; Staphylococcal Skin Infections (+ 4); Syphilis, Cutaneous; Tuberculosis, Cutaneous (+ 2); Yaws Actinomycosis, Cervicofacial; Angiomatosis, Bacillary; Ecthyma; Erysipelas; Erythema Chronicum Migrans; Erythrasma; Granuloma Inguinale; Hidradenitis Suppurativa; Maduromycosis; Paronychia; Pinta; Rhinoscleroma; Staphylococcal Skin Infections (+ 4); Syphilis, Cutaneous; Tuberculosis, Cutaneous (+ 2); Yaws Actinomycosis, Cervicofacial; Angiomatosis, Bacillary; Ecthyma; Erysipelas; Erythema Chronicum Migrans; Erythrasma; Granuloma Inguinale; Hidradenitis Suppurativa; Maduromycosis; Paronychia; Pinta; Rhinoscleroma; Staphylococcal Skin Infections (+ 4); Syphilis, Cutaneous; Tuberculosis, Cutaneous (+ 2); Yaws Skin diseases caused by bacteria. 3J5P(*Skin Diseases C17.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dermatologic Agents Dermatology Skin and Connective Tissue Diseases (Non MeSH) Angiolymphoid Hyperplasia with Eosinophilia; Cicatrix (+ 3); Cutaneous Fistula; Cutis Laxa; Dermatitis (+ 22); Dermatomyositis; Erythema (+ 7); Exanthema (+ 1); Facial Dermatoses (+ 6); Foot Dermatoses (+ 1); Hand Dermatoses; Keratoacanthoma; Keratosis (+ 18); Leg Dermatoses; Lupus Erythematosus, Cutaneous (+ 2); Mastocytosis (+ 1); Necrobiotic Disorders (+ 2); Panniculitis (+ 3); Photosensitivity Disorders (+ 5); Pigmentation Disorders (+ 15); Prurigo; Pruritus (+ 2); Pyoderma (+ 2); Scalp Dermatoses (+ 2); Scleredema Adultorum; Sclerema Neonatorum; Scleroderma, Circumscribed; Scleroderma, Systemic (+ 1); Skin Appendage Diseases (+ 32); Skin Diseases, Eczematous (+ 15); Skin Diseases, Genetic (Non MeSH) (+ 35); Skin Diseases, Infectious (+ 55); Skin Diseases, Metabolic (Non MeSH) (+ 13); Skin Diseases, Papulosquamous (+ 18); Skin Diseases, Vascular (+ 10); Skin Diseases, Vesiculobullous (+ 17); Skin Manifestations; Skin Neoplasms (+ 3); Skin Ulcer (+ 6) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $9u N8ZSkin Care E02.547.800 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Hygiene Maintenance of the hygienic state of the skin under optimal conditions of cleanliness and comfort. Effective in skin care are proper washing, bathing, cleansing, and the use of soaps, detergents, oils, etc. In various disease states, therapeutic and protective solutions and ointments are useful. The care of the skin is particularly important in various occupations, in exposure to sunlight, in neonates, and in decubitus ulcer. ?Z"Skin Appendage Diseases C17.800.805 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Hair Diseases (+ 9); Nail Diseases (+ 5); Sebaceous Gland Diseases (Non MeSH) (+ 6); Sweat Gland Diseases (+ 8) specific skin appendage disease (66-67) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  ANK/ZSkin and Connective Tissue Diseases (Non MeSH) C17 Connective Tissue Diseases (+ 60); Skin Diseases (+ 336) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI C8FZSkin Aging G10.795.668 DEGEIMPAPHRE Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight. Aging (66-89); Skin (66-89); Sunlight (66-89) DV:Skin Absorption G10.795.633 DEGEIMPHRE Administration, Cutaneous Administration, Cutaneous Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) FVSkin Abnormalities (Non MeSH) C16.131.831; C17.800.827.800 Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH) Acrodermatitis; Ectodermal Dysplasia (+ 2); Ehlers-Danlos Syndrome; Epidermolysis Bullosa (+ 4); Ichthyosis (+ 6); Incontinentia Pigmenti; Poikiloderma Congenitale; Pseudoxanthoma Elasticum; Sclerema Neonatorum; Xeroderma Pigmentosum Acrodermatitis; Ectodermal Dysplasia (+ 2); Ehlers-Danlos Syndrome; Epidermolysis Bullosa (+ 4); Ichthyosiform Erythroderma, Congenital (+ 2); Ichthyosis Vulgaris; Ichthyosis, X-Linked; Incontinentia Pigmenti; Poikiloderma Congenitale; Pseudoxanthoma Elasticum; Sjogren-Larsson Syndrome; Xeroderma Pigmentosum BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI G$"rXSkin A01.835 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Dermatologic Agents; Keratinocytes Body Regions (Non MeSH) Hair (+ 2); Nails; Scalp; Sebaceous Glands; Sweat Glands (+ 2) consider also terms at CUTANEOUS, CUTIS, and DERMAT-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $K 8)QA:Skilled Nursing Facilities N02.278.825.610.770 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Residential Facilities; Nursing Homes Extended care facilities which provide skilled nursing care or rehabilitation services for inpatients on a daily basis. Hospitals (66-67) M) ySkiing I03.450.642.845.775 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A snow sport which uses skis to glide over the snow. It does not include water-skiing. N RkSkid Row Alcoholics M01.325.800 CLEDHILJPXSN Alcoholism Named Groups (Non MeSH); Homeless Persons Usually destitute, homeless persons who drink excessively and live in low socio-economic areas of the city known as Skid Row. Alcoholism (66-72)  O4Skeleton A02.835 Bone and Bones Musculoskeletal System Bone and Bones (+ 75); Joints (+ 35) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Q(  1:Skatole D03.438.473.808 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles R :SSkating I03.450.642.845.700 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Using ice skates, roller skates, or skateboards in racing or other competition or for recreation. Sports (66-75) R RtSkates (Fish) B02.493.378.682 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Electric Fish The common name for all members of the Rajidae family. Skates and rays are members of the same order. Skates have weak electric organs. Fishes (66-86) T&+SK and F-38393 D03.438.079.800; D14.100.150.151.885 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists A selective D1 dopamine receptor agonist used primarily as a research tool. Benzazepines (66-89); Dopaminergic Agents (89) U[*:[8Sjogren's Syndrome C05.550.114.154.774; C05.799.114.774; C07.465.815.929.669; C11.496.260.719; C17.300.775.099.774; C20.111.199.774 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Keratoconjunctivitis Sicca Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Xerostomia Eye Diseases; Lacrimal Apparatus Diseases; Dry Eye Syndromes Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Immunologic Diseases; Autoimmune Diseases; Arthritis, Rheumatoid Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Wy~NSjogren-Larsson Syndrome C16.131.831.512.723; C16.614.492.723; C17.800.428.333.723; C17.800.827.800.839; C18.452.648.556.641.723 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ichthyosis Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis Rare syndrome of autosomal recessive inheritance characterized by ichthyosis, mental retardation, and spastic pyramidal symptoms. It is associated with a defect in fatty alcohol metabolism. Ichthyosis (66-90) \sLySizofiran D09.203.698.365.800; D22.204.179.755; D24.611.062.750 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic Poly(3-(O-beta-D-glucopyranosyl-(1-3)-O-(beta-D-glucopyranosyl-(1-6))-O-beta-D-glucopyranosyl-(1-3)-O-beta-D-glucopyranosyl)-1). A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach. Mucopolysaccharides (73-75) a  =>Ra Size Perception F02.463.593.725; F02.463.593.932.869.794 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception; Space Perception The sensory interpretation of the dimensions of objects. d. DSIV B04.820.650.589.400.800; B04.820.650.805.700; B04.909.777.731.589.400.800; B04.909.777.731.805.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate Viruses; RNA Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Simian Species of LENTIVIRUS, subspecies primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV is 50% homologous in nucleotide sequence to HIV-1. SIV and HIV-2 exhibit close structural and immunologic properties and are 75% homologous. SIV does not cause immune deficiency in its natural host, the African green monkey, but does produce SAIDS in the rhesus macaque. Subgroups of SIV include SIV-1 and SIV-2. Monkey Diseases (78-88); Retroviridae (78-88) f#l7Situs Inversus C16.131.810 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Kartagener's Syndrome (+ 1); Levocardia Lateral transposition of the viscera of the thorax and abdomen. It has a familial pattern and consanguineous parents have been reported. (From Dorland, 27th ed). k*LI1SITS D02.455.426.559.389.150.700.850; D02.500.375.850; D02.886.250.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes Organic Chemicals (Non MeSH); Isocyanates; Isothiocyanates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Isothiocyanates 5-(Acetylamino)-2-(2-(-4-isothiocyanato-2-sulfophenyl)ethenyl)benzenesulfonic acid. A non-penetrating amino reagent which acts as an inhibitor of anion transport in erythrocytes and other cells. Stilbenes (66-79); Thiocyanates (66-75) lI:_0Sitosterols D04.808.247.222.857; D04.808.247.808.756.669 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Phytosterols A family of sterols commonly found in plants and plant oils. Alpha-, beta-, and gamma-isomers have been characterized. Estrogens (66-71); Sterols (66-71) p28+Sister Chromatid Exchange G05.148.301.840; G05.825.210.840 DEGEIMPHRE Chromatids Genetics; Cytogenetics; Crossing Over (Genetics) Genetics; Recombination, Genetic; Crossing Over (Genetics) An aberrant crossing-over event in which there is an exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. It can be induced by ultraviolet and ionizing radiation or by mutagenic agents and is observed by autoradiography. Chromatids (68-79); Chromosome Aberrations (68-79); Crossing Over (Genetics) (68-79); Cytogenetics (67); Genetics (66)  r &}Sisomicin D09.203.408.051.374.785; D20.085.060.350.700 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Gentamicins Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Gentamicins Netilmicin Netilmicin O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L- arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6- tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl- (1-4))-2-deoxy-D-streptamine. Antibiotic produced by Micromonospora inyoensis. Aminoglycosides (74); Antibiotics (66-74); Glycosides (66-73)  uF 2<JSiphoviridae B04.123.150.800; B04.280.090.800 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales Viruses; DNA Viruses; Caudovirales Bacteriophage lambda Bacteriophage lambda A family of bacteriophages which are characterized by long, non-contractile tails. Bacteriophages (84-93)  x&V0aSinusitis C08.460.692.752; C08.730.749; C09.603.692.752 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases Ethmoid Sinusitis; Frontal Sinusitis; Maxillary Sinusitis; Sphenoid Sinusitis Ethmoid Sinusitis; Frontal Sinusitis; Maxillary Sinusitis; Sphenoid Sinusitis Ethmoid Sinusitis; Frontal Sinusitis; Maxillary Sinusitis; Sphenoid Sinusitis An inflammatory process of the mucous membranes of the paranasal sinuses that occurs in three stages: acute, subacute, and chronic. Sinusitis results from any condition causing ostial obstruction or from pathophysiologic changes in the mucociliary transport mechanism. y 5N 6Sinus Thrombosis C10.228.140.300.378.669; C14.907.253.378.586; C14.907.355.350.850.213.669; C14.907.355.830.850.213.669 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism; Thromboembolism; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis; Thromboembolism; Cerebral Embolism and Thrombosis Formation of a clot in a cerebral venous sinus. }ipNT<Sinus of Valsalva A07.231.114.056.847 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cardiovascular System; Blood Vessels; Arteries; Aorta The dilatation of the aortic wall behind each of the cusps of the aortic valve. 6AbSinoatrial Node A07.541.409.819 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Conduction System The small mass of modified cardiac muscle fibers located at the junction of the superior vena cava and right atrium. Contraction impulses probably start in this node, spread over the atrium and are then transmitted by the atrioventricular bundle to the ventricle. 8@6Sinoatrial Block C14.280.067.558.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Heart Block Disturbance of heart conduction in which the atrial response is delayed or omitted because of partial or complete interference with the propagation of impulses from the sinoatrial node to the atria. NMSingle-Blind Method E05.318.780.850; G03.850.520.840.850; N05.715.360.780.730 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) A method in which either the observer(s) or the subject(s) is kept ignorant of the group to which the subjects are assigned. A|Single Person F01.829.263.315.500.725; I01.240.361.500.725; I01.880.225.423.500.725; M01.785; N01.224.361.500.725; N01.824.308.500.725 CLEDHILJPXSN Widowhood Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Characteristics; Marital Status Social Sciences; Demography; Family Characteristics; Marital Status Social Sciences; Sociology; Family; Family Characteristics; Marital Status Named Groups (Non MeSH) Population Characteristics (Non MeSH); Demography; Family Characteristics; Marital Status Population Characteristics (Non MeSH); Socioeconomic Factors; Family Characteristics; Marital Status Single Parent Single Parent Single Parent Single Parent Single Parent The unmarried man or woman. Illegitimacy (66-67); Marriage (66-67) $p S$/Single Parent F01.829.263.315.500.725.700; F01.829.263.500.320.785; I01.240.361.500.725.700; I01.880.225.423.500.725.700; I01.880.225.500.340.785; M01.620.785; N01.224.361.500.725.700; N01.824.308.500.725.700 CLEDHILJPXSN Parents Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Characteristics; Marital Status; Single Person Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family; Parents Social Sciences; Demography; Family Characteristics; Marital Status; Single Person Social Sciences; Sociology; Family; Family Characteristics; Marital Status; Single Person Social Sciences; Sociology; Family; Nuclear Family; Parents Named Groups (Non MeSH); Parents Population Characteristics (Non MeSH); Demography; Family Characteristics; Marital Status; Single Person Population Characteristics (Non MeSH); Socioeconomic Factors; Family Characteristics; Marital Status; Single Person An unmarried natural, adoptive, or substitute parent of a dependent child, whether living with or visiting the child. To be used also for single-parent families. The concept includes the never-married, as well as the divorced and widowed. Parents (69-88); Single Person (68-88)   >0Singapore Z01.252.145.774 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern  >Sindbis Virus B04.820.850.054.860; B04.909.777.923.054.860 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus The type species of ALPHAVIRUS normally transmitted to birds by Culex mosquitoes in Egypt, South Africa, India, Malaya, the Philippines, and Australia. It may be associated with fever in humans. Arboviruses (66-70) Q2Sincalide D06.472.317.152.700; D12.644.120.700; D19.316.325.850; D19.316.629.159.850 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones; Cholecystokinin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Cholecystokinin Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Caerulein Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones; Cholecystokinin 1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein. The eight-amino-acid carbon-terminal fragment and physiologically active portion of the cholecystokinin-pancreozymin molecule. It stimulates the GI tract, especially gallbladder and pancreas, and has many, often depressant, effects on the CNS. It is used to diagnose gallbladder disease and has also been proposed as an anorexic. Its amino acid sequence is: L-Asp-(O-sulfo)-L-Tyr-L-Met-L-Gly-L-Trp-L-Met-L-alpha-Asp-L-Phe-amide. Cholecystokinin (66-83); Oligopeptides (73-78); Peptide Fragments (79-83); Peptides (66-72) j TF,mSimuliidae B01.131.617.289.800 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera Several species of the genus Simulium (family Simuliidae) that act as intermediate hosts (vectors) for the parasitic disease ONCHOCERCIASIS. Diptera (66-83) y*5Simplexvirus B04.280.382.100.750; B04.909.204.382.100.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae Herpesvirus 1, Human; Herpesvirus 2, Bovine; Herpesvirus 2, Human Herpesvirus 1, Human; Herpesvirus 2, Bovine; Herpesvirus 2, Human A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. 2~Simian Acquired Immunodeficiency Syndrome C02.782.815.616.850; C02.839.850; C22.735.500.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections Virus Diseases; Slow Virus Diseases Animal Diseases; Primate Diseases; Monkey Diseases Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS (MPMV), or in monkeys infected with SIV. Monkey Diseases (83-90); Retrovirus Infections (86-90) #09PASimethicone D02.715.650.700.150.750; D19.316.890; D23.200.875; D25.720.900.850.150.750 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Organosilicon Compounds; Siloxanes; Silicones; Dimethylpolysiloxanes Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Dermatologic Agents; Emollients Biomedical and Dental Materials (Non MeSH); Polymers; Siloxanes; Silicones; Dimethylpolysiloxanes A mixture of dimethyl polysiloxanes and silica gel used as an antiflatulent. Without the addition of silica gel (dimethicone), it is used as an ointment base ingredient and skin protectant. Silicones (72-74) T.YSimbu Group Viruses B04.820.087.150.855; B04.909.777.147.150.855 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Bunyavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Bunyavirus A group of viruses in the BUNYAVIRUS genus of the BUNYAVIRIDAE family that are found in Asia, Africa, and the Americas. 2Simazine D03.383.931.819; D05.723.366.477.834 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Triazine Herbicides (66-71); Triazines (66-71)  *:.Silymarin D03.438.150.266.450.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones; Flavones 3,5,7-Trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)- 2-(hydroxymethyl)-1,4-benzodioxan-6-yl)-4-chromanone. A crystalline flavanolol from Silybum marianum. It is of possible use in liver therapy. Alcohols (71-74); Flavones (71-74) O :p+Silver Sulfadiazine D02.065.884.725.755.800; D02.886.590.700.725.755.800; D20.890.725.755.855 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides; Sulfadiazine Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides; Sulfadiazine Anti-Infective Agents; Sulfonamides; Sulfanilamides; Sulfadiazine N(1)-2-Pyrimidinylsulfanilanide, monosilver salt. Antibacterial used topically in burn therapy; may also have antiviral and antifungal activity. Synonym: Silvadene. Silver (66-76); Sulfadiazine (66-76) NQ:--Silver Staining E05.909.262.620.670.780; E05.909.432.600.670.780 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Stains and Staining Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Stains and Staining The use of silver, usually silver nitrate, as a reagent for producing contrast or coloration in tissue specimens. Stains and Staining (66-91) 16G"Silver Proteins D12.776.884; D20.187.776 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Anti-Infective Agents; Anti-Infective Agents, Local Compounds of silver and proteins used as topical anti-infective agents. 8~USilver Nitrate D01.625.525.550.850; D01.847.900; D20.187.769 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitric Acid; Nitrates Inorganic Chemicals (Non MeSH); Silver Compounds Anti-Infective Agents; Anti-Infective Agents, Local Nitric acid silver(1+) salt. A powerful germicide, used as an antiseptic, applied topically to the conjunctiva as a prophylactic against opthalmia neonatorum, and also used as an antiseptic in infections of the skin and mucous membrane. (From Dorland, 27th ed).  585Silver Compounds D01.847 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Silver Nitrate Inorganic compounds that contain silver as an integral part of the molecule. Silver (66-93)   8%\Silver D01.268.803; D01.552.804 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKRESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Silver. An element with the atomic symbol Ag, atomic number 47, and atomic weight 107.87. It is a soft metal that is used medically in surgical instruments, dental prostheses, and alloys. Long-continued use of silver salts can lead to a form of poisoning known as ARGYRIA.  8`ESiloxanes D01.837.800; D02.715.650; D25.720.900 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Silicon Compounds Organic Chemicals (Non MeSH); Organosilicon Compounds Biomedical and Dental Materials (Non MeSH); Polymers  Silicones (+ 3) Silicones (+ 3) Silicon polymers that contain alternate silicon and oxygen atoms in linear or cyclic molecular structures. Silicones (68-74) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $ -,)}.Silo Filler's Disease C08.381.846; C21.447.080.752 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Agricultural Workers' Diseases Pneumonia or bronchiolitis caused by inhalation of nitrogen dioxide released by silage. 7"LgSilkworms B01.131.617.561.650.669 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lepidoptera; Moths Moths of the family Bombycidae of the order LEPIDOPTERA, called silkworm moths. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree (on which it feeds). A native of Asia, it is sometimes reared in this country. It has long been raised for its silk and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental genetics. (From Borror, et al., An Introduction to the Study of Insects, 4th ed).  (BCSilicotuberculosis C01.252.410.040.552.846.899.669; C08.381.483.600.760.750; C08.381.922.669; C08.730.939.669; C21.447.800.834.752 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Pulmonary Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis; Silicosis Respiratory Tract Diseases; Lung Diseases; Tuberculosis, Pulmonary Respiratory Tract Diseases; Respiratory Tract Infections; Tuberculosis, Pulmonary Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis; Silicosis Tuberculosis of the silicotic lung. {Nb,Silicosis C08.381.483.600.760; C21.447.800.834 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Coal Mining Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis Anthracosilicosis; Silicotuberculosis Anthracosilicosis; Silicotuberculosis Pneumoconiosis due to the inhalation of dust of stone, sand, or flint containing silicon dioxide, with formation of generalized, nodular fibrotic changes in both lungs. (Dorland, 27th ed). BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $x *LTNSilicones D02.715.650.700; D25.720.900.850 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Organosilicon Compounds; Siloxanes Biomedical and Dental Materials (Non MeSH); Polymers; Siloxanes Dimethylpolysiloxanes (+ 1); Silicone Elastomers Dimethylpolysiloxanes (+ 1); Silicone Elastomers Any organosiloxane polymer in which the structural unit is usually -R2Si-O-, where R is a monovalent organic radical. Physical properties of silicones depend on the size and type of the radical (methyl, phenyl), the R:Si ratio, and the molecular configuration of the polymer (linear, cyclic, degree of crosslinking). (From Merck Index, 11th ed). AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU   &,r.Silicone Oils J01.740.750 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Technology, Industry, Agriculture (Non MeSH); Oils Organic siloxanes which are polymerized to the oily stage. The oils have low surface tension and density less than 1. They are used in industrial applications and in the treatment of retinal detachment, complicated by proliferative vitreoretinopathy. Silicones (66-86) B=%Silicone Elastomers D02.715.650.700.750; D25.720.840.849; D25.720.900.850.900 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Denture Liners; Dental Impression Materials Organic Chemicals (Non MeSH); Organosilicon Compounds; Siloxanes; Silicones Biomedical and Dental Materials (Non MeSH); Polymers; Rubber Biomedical and Dental Materials (Non MeSH); Polymers; Siloxanes; Silicones Polymers of silicone having properties similar to those of vulcanized natural rubber, namely the ability to be stretched to at least twice their original length and to retract very rapidly to approximately their original length when released. (From Hawley's Condensed Chemical Dictionary, 11th ed). A,4\Silicon Dioxide D01.578.750; D01.650.550.825; D01.837.725 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Minerals Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Inorganic Chemicals (Non MeSH); Silicon Compounds Kieselguhr; Quartz Kieselguhr; Quartz Kieselguhr; Quartz; Silicic Acid (+ 14) Silica. Transparent, tasteless crystals found in nature as agate, amethyst, chalcedony, cristobalite, flint, sand, QUARTZ, and tridymite. The compound is insoluble in water or acids except hydrofluoric acid. 18^Silicon Compounds D01.837 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Silanes; Silicon Dioxide (+ 17); Siloxanes Inorganic compounds that contain silicon as an integral part of the molecule. Silicon (66-93)   8%6]Silicon D01.268.912.850 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organosilicon Compounds Inorganic Chemicals (Non MeSH); Elements; Trace Elements Silicon. A trace element that constitutes about 27.6% of the earth's crust in the form of SILICON DIOXIDE. It does not occur free in nature. Silicon has the atomic symbol Si, atomic number 14, and atomic weight 28.09.  :ESilicic Acid D01.029.260.863; D01.837.725.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide  Silicates (+ 13) Silicic acid. Hydrated silicon dioxide that occurs in nature. It is insoluble in water or acids except hydrofluoric acid. (From Merck Index, 11th ed). &8Silicates D01.578.725; D01.837.725.700.760 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Minerals Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid Aluminum Silicates (+ 3); Asbestos (+ 4); Magnesium Silicates (+ 3) Aluminum Silicates (+ 3); Asbestos (+ 4); Magnesium Silicates (+ 3) The generic term for salts derived from silica or the silicic acids. They contain silicon, oxygen, and one or more metals, and may contain hydrogen. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th Ed). Silicic Acid (81-93)   &8Silicate Cement D25.339.291.618 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements ,\Silanes D01.837.700; D02.715.625 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Silicon Compounds Organic Chemicals (Non MeSH); Organosilicon Compounds Compounds similar to hydrocarbons in which a tetravalent silicon atom replaces the carbon atom. They are very reactive, ignite in air, and form useful derivatives. Silicon (66-74) ּ 8zSilage J01.341.052.793 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Animal Feed ؓ "MSikkim Z01.252.245.393.750 EHEP Geographicals (Non MeSH); Asia; Asia, Western; India > BSigns and Symptoms, Respiratory (Non MeSH) C23.888.852 Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Anoxia (+ 2); Apnea; Cheyne-Stokes Respiration; Cough; Dyspnea (+ 1); Hoarseness; Hypercapnia; Hyperoxia; Hyperventilation; Hypocapnia; Hypoventilation; Mouth Breathing; Respiratory Sounds (+ 1) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI 3XTSigns and Symptoms, Digestive (Non MeSH) C23.888.821 Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Aerophagy; Dyspepsia; Eructation; Flatulence; Gagging; Halitosis; Heartburn; Hiccup; Nausea; Vomiting (+ 1) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI 1XTSigns and Symptoms (Non MeSH) C23.888 Symptoms and General Pathology (Non MeSH) Asthenia; Body Temperature Changes (Non MeSH) (+ 5); Body Weight Changes (Non MeSH) (+ 4); Cyanosis; Eating Disorders (+ 2); Eye Manifestations; Fatigue (+ 1); Flushing; Jaundice (+ 12); Lameness, Animal; Neurologic Manifestations (+ 133); Oral Manifestations; Pallor; Retropneumoperitoneum; Shock (+ 6); Signs and Symptoms, Digestive (Non MeSH) (+ 11); Signs and Symptoms, Respiratory (Non MeSH) (+ 17); Skin Manifestations BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHTMURUSVEVI T% 2VSignal Transduction G06.535.898; G07.453.852; G11.561.450.852 DEGEIMPHRE Ion Channels; Second Messenger Systems Cell Communication; Receptor-CD3 Complex, Antigen, T-Cell Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Physiology, General (Non MeSH); Electrophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials Ion Channel Gating; Second Messenger Systems Ion Channel Gating Ion Channel Gating The intercellular or intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GABA-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Membrane Potentials (77-88); specific compounds/physiology (77-88) (01/CbNSignal Recognition Particle D12.776.664.800.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Ribonucleoproteins A cytosolic ribonucleoprotein complex that acts to induce elongation arrest of nascent presecretory proteins as the signal peptide protrudes from the large ribosomal subunit. It consists of a 7S RNA and six polypeptide subunits (relative molecular masses 9, 14, 19, 54, 68, and 72K). Ribonucleoproteins (85-93) !FlMSignal Processing, Computer-Assisted L01.700.568.110.800 IS Fetal Monitoring; Monitoring, Physiologic Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Computer-assisted processing of electric, ultrasonic, or electronic signals to interpret function and activity. **1|Signal Peptides D12.644.835 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Additional polypeptide sequence of 25 to 30 residues at the amino-terminal end of proteins. They direct the protein to its ultimate destination in the cell. These leaders are recognized by the signal recognition particle and bound by specific receptor sites on the outer surface of the endoplasmic reticulum. They are then transported into the cisterna of the endoplasmic reticulum and from there directed to their ultimate destination in the cell. In prokaryotes, the signal peptides attach to the plasma membrane. These signal sequences are ultimately removed by specific peptidases. Peptides (66-85) BDSignal Detection (Psychology) F02.463.593.257.800; F02.463.593.710.725; F04.096.753.814; H01.671.720.814 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Discrimination (Psychology) Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Sensory Thresholds Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychophysics Physical Sciences (Non MeSH); Physics; Psychophysics A theory of psychophysics which characterizes not only the acuity of an individual's discrimination but also the psychological factors that bias his judgment. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Attention (66-93); Auditory Perception (67-93); Auditory Threshold (67-93); Discrimination (Psychology) (68-93) U#T Sign Language E02.831.671.609.668; F01.145.209.530.702.668; L01.143.649.526.668 Language Therapeutics; Rehabilitation; Rehabilitation of Hearing Impaired (Non MeSH); Manual Communication Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication; Manual Communication Information Science; Communication; Nonverbal Communication; Manual Communication A system of hand gestures used for communication by the deaf or by people speaking different languages. I S|Sigmoidoscopy E01.184.340.350.230.890; E01.418.340.350.230.890 AECLCTECHIISMOMTNUPXSNSTTDUTVE Sigmoid Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System; Endoscopy, Gastrointestinal; Colonoscopy Diagnosis; Endoscopy; Endoscopy, Digestive System; Endoscopy, Gastrointestinal; Colonoscopy Endoscopic examination of the sigmoid flexure. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material, and to perform other surgical interventions. o6" Sigmoid Neoplasms C04.588.274.476.411.306.668; C06.240.476.411.306.668; C06.405.282.411.306.668; C06.405.469.158.355.668; C06.405.469.158.850.850; C06.405.469.505.306.668 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Sigmoid Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Colonic Neoplasms X1Sigmoid Diseases C06.405.469.158.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Proctocolitis; Sigmoid Neoplasms Colonic Diseases (66-79); specific colonic disease; Sigmoid (66-79); specific intestinal disease BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  @Nj'sXSigmoid A03.492.411.495.356.668 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sigmoidoscopy Digestive System; Gastrointestinal System; Intestines; Intestine, Large; Colon A :]Sigma Factor D12.776.930.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors A protein which is a subunit of RNA polymerase. It effects initiation of specific RNA chains from DNA. Bacterial Proteins (73-76); Proteins (66-76); Transcription, Genetic (73-76) 2F^}[Sierra Leone Z01.058.290.190.725 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western _Siderosis C08.381.483.600.750; C21.447.800.773 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemosiderosis Hemosiderin; Iron Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis The deposition of iron in a tissue. In the eye, the iron may be deposited in the stroma adjacent to the Descemet's membrane.   *LSiderophores D24.310.678; D26.241.688.700 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents; Iron Chelates Deferoxamine; Enterobactin; Ferrichrome Deferoxamine; Enterobactin; Ferrichrome Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. Catechols (72-75); Hydroxamic Acids (72-81); Iron Chelates (81-92); Peptides (72-78) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $"B\gDSickness Impact Profile E05.318.308.250.475.730; G03.850.520.308.250.475.730; N05.715.360.300.375.375.730 Activities of Daily Living; Quality of Life Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Health Status Indicators Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Health Status Indicators Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Health Status Indicators A quality-of-life scale developed in the United States in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviorally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behavior, social interaction, and the like. It measures the patient's perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups. (From Medical Care, vol.xix, no.8, August 1981, p.787-805). Activities of Daily Living (75-94); Attitude to Health (76-94); Health Status Indicators (76-94); Quality of Life (76-94) Y6Sickle Cell Trait C15.378.071.141.150.150.670; C15.378.420.155.668 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Anemia, Sickle Cell Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies; Anemia, Sickle Cell The condition of being heterozygous for hemoglobin S.  6L@Sick Sinus Syndrome C14.280.067.829 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Dysfunction of the sinoatrial node manifested by persistent sinus bradycardia, sinus arrest, sinoatrial exit block, chronic atrial fibrillation and inability of the heart to resume sinus rhythm following cardioversion for atrial fibrillation. Arrhythmia, Sinus (66-79) N=Sick Role F01.829.316.616.751 Attitude to Health Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes; Role Behavior patterns consistent with those expected of an individual functioning in a state of ill health. Role (69-70) h{Sick Leave N01.824.417.700.662; N04.452.677.800.662 CLECHILJSNTD Population Characteristics (Non MeSH); Socioeconomic Factors; Income; Salaries and Fringe Benefits Health Services Administration (Non MeSH); Organization and Administration; Personnel Management; Salaries and Fringe Benefits An absence from work permitted because of illness or the number of days per year for which an employer agrees to pay employees who are sick. (Webster's New Collegiate Dictionary, 1981). Absenteeism (66-94) .Sicily Z01.542.489.751 EHEP Geographicals (Non MeSH); Europe; Italy Italy (66-69) } 2Sibling Relations F01.829.263.370.450 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) Interactions and relationships between sisters and/or brothers. The concept also applies to animal studies. Child Psychology (66-67); Parent-Child Relations (66-67)  xCSiberia Z01.542.248.775.800; Z01.586.200.775.800; Z01.586.950.775.800 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Russia  ESialyltransferases D08.586.913.400.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases A group of enzymes with the general formula CMP-N-acetylneuraminate:acceptor N-acetylneuraminyl transferase. They catalyze the transfer of N-acetylneuraminic acid from CMP-N-acetylneuraminic acid to an acceptor, which is usually the terminal sugar residue of an oligosaccharide, a glycoprotein, or a glycolipid. They are classified within EC 2.4.99, transferring other glycosyl groups. Neuraminic Acids (72-74); Transferases (72-74) 0Fm8Sialorrhea C07.465.815.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Salivation Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Increased salivary flow. Salivary Gland Diseases (66-76); Salivation (66-76)  'NL>Sialometaplasia, Necrotizing C07.465.815.802 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases A benign, inflammatory, variably ulcerated, occasionally bilateral, self-healing lesion of the minor salivary glands that is often confused clinically and histologically with carcinoma. Metaplasia (66-82); Necrosis (66-82); Salivary Gland Diseases (66-82); Salivary Glands (66-82); Salivary Glands, Minor (79-82) x!NLSialography E01.184.791; E01.262.751; E01.357.818.845; E06.342.764.793 AECLCTECHIISMOMTNUPXSNSTTDUTVE Salivary Glands Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Diagnosis, Oral Diagnosis; Diagnostic Imaging; Radiography Dentistry; Diagnosis, Oral; Radiography, Dental Radiography of the salivary glands or ducts following injection of contrast medium. D"cSialoglycoproteins D12.644.233.800; D12.776.395.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Asialoglycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Glycopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Glycophorin Glycophorin Glycoproteins which contain sialic acid as one of their carbohydrates. They are often found on or in the cell or tissue membranes and participate in a variety of biological activities. Glycopeptides (73-76); Glycoproteins (66-76); Neuraminic Acids (66-74); Sialic Acids (75-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ( &FoHSialic Acids D09.203.067.687.668; D09.203.811.589.668; D02.241.081.844.562.668; D02.241.511.902.562.668 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Neuraminic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Neuraminic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Neuraminic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Neuraminic Acids Cytidine Monophosphate N-Acetylneuraminic Acid Cytidine Monophosphate N-Acetylneuraminic Acid Cytidine Monophosphate N-Acetylneuraminic Acid Cytidine Monophosphate N-Acetylneuraminic Acid A group of naturally occurring N-and O-acyl derivatives of the deoxyamino sugar neuraminic acid. They are ubiquitously distributed in many tissues. Neuraminic Acids (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $#dBDSialadenitis C07.465.815.793 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases (]NLShyness F01.145.813.617; F01.829.759.617 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Behavior Discomfort and partial inhibition of the usual forms of behavior when in the presence of others. )9 &tShy-Drager Syndrome C10.772.150.800; C14.907.514.482.853 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Autonomic Nervous System Diseases Cardiovascular Diseases; Vascular Diseases; Hypotension; Hypotension, Orthostatic A progressive degenerative disease of the central and autonomic nervous systems characterized by orthostatic hypotension, urinary and fecal incontinence, anhidrosis, external ophthalmoplegia, generalized weakness, muscle wasting, tremors, and impotence. Hypotension, Orthostatic (66-80); Nervous System Diseases (66-80) **NMShwartzman Phenomenon C15.378.463.134.793 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A two-stage reaction in which a first encounter with endotoxin produces intravascular fibrin thrombi whose clearance results in reticuloendothelial blockade which prevents the clearance of thrombi caused by a second encounter with endotoxin, resulting in tissue necrosis and/or hemorrhage. In pregnancy gram-negative septicemia during delivery or abortion may serve as the first or provocative encounter. The phenomenon is non-immunologic and is known to occur only in rabbits and man. -N1Shrimp B01.131.365.844 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Arthropods; Crustacea Various species of mostly marine crustaceans of the order Decapoda with ten legs and long abdomen. It includes shrimp as food. Crustacea (66-71)  0 ( ,Shrews B02.649.473.751 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Insectivora Insectivora (66-71) 2K ()Showdomycin D13.570.800.810; D20.085.075.800; D22.204.106.820 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic 3-beta-D-Ribofuranosylmaleimide. Antineoplastic antibiotic isolated from Streptomyces showdoensis. It is possibly active also as a sulfhydryl reagent. Antibiotics, Antineoplastic (71-74); Maleimides (74); Ribonucleosides (73-74) 29<[Shoulder-Hand Syndrome C05.550.808 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myocardial Infarction Musculoskeletal Diseases; Joint Diseases A syndrome characterized by pain and stiffness in the shoulder and hand with trophic changes in the latter. It is seen most commonly with myocardial infarction but is also associated with trauma, cervical vertebral disease, arm immobilization, etc. 5N0#Shoulder Joint A02.835.583.748 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints 781Shoulder Fractures C21.866.088.749; C21.866.405.727 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Fractures of the proximal humerus, including the head, anatomic and surgical necks, and tuberosities. 8x&NwShoulder Dislocation C21.866.088.666; C21.866.289.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Dislocations :[&NShoulder A01.378.209.749 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Arm ; (5Shorthand L01.143.506.423.906.539.750 Information Science; Communication; Language; Language Arts (Non MeSH); Writing; Handwriting ]$\LLShort Bowel Syndrome C06.405.469.637.832; C23.814.777 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Malabsorption Syndromes Symptoms and General Pathology (Non MeSH); Postoperative Complications A malabsorption syndrome resulting from extensive operative resection of small bowel. Malabsorption Syndromes (66-80); Postoperative Complications (66-80); Syndrome (72-80) Bz&NdeShoes J01.193.750 AECLECHILJSNST Technology, Industry, Agriculture (Non MeSH); Clothing D AShock, Traumatic C21.866.797; C23.888.789.843 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Shock Crush Syndrome Crush Syndrome Any shock produced by trauma. (Dorland, 27th ed). ED"N$?Shock, Surgical C23.814.767; C23.888.789.701 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Postoperative Complications Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Shock Shock that occurs during or after surgical operation. (Dorland, 27th ed). G"NZShock, Septic C01.539.757.720.800; C23.888.789.680 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Shock Shock due to circulatory insufficiency caused most commonly by gram-negative BACTEREMIA. It is less often the result of the persistent presence of other micro-organisms in the blood (FUNGEMIA, viremia); in rare instances, it is caused by gram-positive organisms, but with different symptomatology. H*PZShock, Hemorrhagic C23.542.857; C23.888.789.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Hemorrhage Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Shock Kx"NShock, Cardiogenic C14.280.647.500.750; C14.907.553.470.500.750; C23.888.789.488 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Myocardial Infarction Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Myocardial Infarction Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Shock Shock resulting from diminution of cardiac output in heart disease, as in myocardial infarction. Myocardial Infarction (66-70); Shock (66-70) LEN/r6Shock C23.888.789 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic; Shock, Surgical; Shock, Traumatic (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Og NXqPShivering G07.315.232.542 DEGEIMPHRE Cold Physiology, General (Non MeSH); Body Temperature; Body Temperature Regulation Q  \Ships J01.937.817 CLECHIISLJMAMTSNST Naval Medicine Technology, Industry, Agriculture (Non MeSH); Transportation Large vessels propelled by power or sail used for transportation on rivers, seas, oceans, or other navigable waters. Boats are smaller vessels propelled by oars, paddles, sail, or power; they may or may not have a deck. Q GShikimic Acid D02.241.223.268.792; D02.241.511.852 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Sw*:Shigella sonnei B03.440.450.425.850.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Shigella A lactose-fermenting bacterium causing dysentery. T"z:Shigella flexneri B03.440.450.425.850.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Shigella A bacterium which is one of the etiologic agents of bacillary dysentery (DYSENTERY, BACILLARY) and sometimes of infantile gastroenteritis. Shigella (66-71) U"zShigella dysenteriae B03.440.450.425.850.350 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Shigella A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is extremely pathogenic and causes severe dysentery. Infection with this organism often leads to ulceration of the intestinal epithelium. W"zShigella boydii B03.440.450.425.850.175 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Shigella One of the SHIGELLA species that produces bacillary dysentery (DYSENTERY, BACILLARY). Shigella (66-71) Y"zeShigella B03.440.450.425.850 CHCLCYDEENGDGEIMIPMEPHPYREULVI Dysentery, Bacillary Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Shigella boydii; Shigella dysenteriae; Shigella flexneri; Shigella sonnei A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).  Z "nW Sheltered Workshops N02.278.808.860 CLECHILJMAOGSDSNSTTDUT Employment, Supported Rehabilitation, Vocational Facilities, Manpower and Services (Non MeSH); Health Facilities; Rehabilitation Centers Protective places of employment for disabled persons which provide training and employment on a temporary or permanent basis.  ]WgShellfish J01.341.838.800 AEANCLECHIMIPOPSRESDSNSTTOUTVI Clams; Crabs; Crayfish; Lobsters; Mussels; Oysters; Shrimp Crustacea; Mollusca Technology, Industry, Agriculture (Non MeSH); Food; Seafood Aquatic invertebrates belonging to the crustacean or mollusk families and used as food.  ^ "JHhSheep Diseases C22.836 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Bluetongue; Border Disease; Ecthyma, Contagious; Louping Ill; Nairobi Sheep Disease; Pneumonia, Progressive Interstitial, of Sheep; Pulmonary Adenomatosis, Ovine; Scrapie; Swayback; Visna Diseases of domestic and mountain sheep of the genus Ovis. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  `z HHJSheep B02.649.077.380.791 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants b (7Sheathed Bacteria (Non MeSH) B03.800 Bacteria Leptothrix; Sphaerotilus CHCLCYDEENGDGEIMIPMEPHPYREULVI c+#  "Sharks B02.493.853 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Dogfish c & Shared Paranoid Disorder F03.709.680.700.810 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Paranoid Disorders A condition in which two closely related persons, usually in the same family, share the same delusions. Psychotic Disorders (66-67) dNFx|!Shame F01.470.483.666 Behavior and Behavior Mechanisms (Non MeSH); Emotions; Guilt An emotional attitude excited by realization of a shortcoming or impropriety. f J\Shadowing (Histology) E05.909.262.620.670.770; E05.909.432.600.670.770 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Stains and Staining Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Stains and Staining The technique of spraying a tissue specimen with a thin coat of a heavy metal such as platinum. The specimen is sprayed from an oblique angle, which results in the uneven deposition of the coating. The varying thicknesses create a shadow effect and give a three-dimensional appearance to the specimen. Microscopy, Electron (69-91); Stains and Staining (66-91) f6GeESezary Syndrome C04.557.386.480.750.800.775; C15.604.515.569.480.750.800.775; C15.604.515.841; C20.683.515.761.480.750.800.775; C20.683.515.920 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders A form of cutaneous T-cell lymphoma manifested by generalized exfoliative erythroderma, intense pruritus, peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear cells in the skin, lymph nodes, and peripheral blood (Sezary cells). (Dorland, 27th ed). Dermatitis Exfoliativa (66-78); Keratosis Palmaris et Plantaris (74-78); Reticuloendotheliosis (66-78) jfR.wSeychelles Z01.600.750 EHEP Geographicals (Non MeSH); Indian Ocean Islands p9Sexually Transmitted Diseases, Viral C02.800.801 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; AIDS-Related Complex; Condylomata Acuminata; Herpes Genitalis Viral diseases which are transmitted or propagated by sexual conduct. Sexually Transmitted Diseases (87-88); Venereal Diseases (66-86)  p~+P6SLSexually Transmitted Diseases, Bacterial C01.252.810; C01.539.780.281 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases Chancroid; Chlamydia Infections (+ 1); Gonorrhea; Granuloma Inguinale; Syphilis Chancroid; Chlamydia Infections (+ 1); Gonorrhea; Granuloma Inguinale; Syphilis Bacterial diseases transmitted or propagated by sexual conduct. Sexually Transmitted Diseases (87-88); Venereal Diseases (66-86)  r/"PKLSexually Transmitted Diseases C01.539.780; C02.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Venereology Bacterial and Fungal Diseases (Non MeSH); Infection Virus Diseases Sexually Transmitted Diseases, Bacterial (+ 6) Sexually Transmitted Diseases, Viral (+ 5) Diseases due to or propagated by sexual contact.  u_#PPh<Sexual Reproduction Periods (Non MeSH) G08.520.940 Reproduction, Urogenital Physiology (Non MeSH); Reproduction Climacteric (+ 4); Puberty (+ 1) BLCFDEEHGEIMMEPHPXREUR w.G+Sexual Partners M01.778 CLPX Sex Behavior Named Groups (Non MeSH) Married or single individuals who share sexual relations. Sex Behavior (66-87)  x ESexual Harassment F01.145.792.950 CLECEHHILJPCPXSN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior A form of discrimination in the workplace which violates the Civil Rights Act of 1964. Sexual harassment takes two forms: quid pro quo, where the employee must submit to sexual advances in exchange for job benefits or be penalized for refusing; or a hostile environment, where the atmosphere of the workplace is offensive and affects the employee's well-being. Offensive sexual conduct may include unwelcome advances, comments, touching, questions about marital status and sex practices, etc. Both men and women may be aggressors or victims. (Slee and Slee, Health Care Terms, 2d ed, p.404). While civil rights legislation deals with sexual harassment in the workplace, the behavior is not restricted to this; it may take place outside the work environment: in schools and colleges, athletics, and other social milieus and activities. Sex Behavior (79-92) xRSexual Abstinence F01.145.792.900 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Refraining from sexual intercourse. }R+Sex Reversal, Gonadal G08.520.920 Gonads Reproduction, Urogenital Physiology (Non MeSH); Reproduction Change from one sex to another with regard to gonadal development; may be induced or occurs naturally in some invertebrates. Sex Determination (66-72) ~K GSex Ratio G05.414.791; N01.224.935.780 Genetics; Genetics, Population Population Characteristics (Non MeSH); Demography; Vital Statistics The number of males per 100 females. Sex (66-67) "s/Sex Preselection E05.393.420.890 MTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Genetic Engineering Methods for control of genetic sex of offspring. Z<Sex Offenses I01.198.240.748 CLECEHHILJPCPXSNTD Paraphilias Social Sciences; Criminology; Crime Rape Any violation of established legal or moral codes in respect to sexual behavior. Criminology (66-67); Paraphilias (66-67) CLDIECEHHILJPCPXRHSNTD (,a1Sex Maturation G07.553.809 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Achievement of full sexual capacity. Applies to animals and humans. Puberty (66-74) ZRSex Manuals L01.178.682.192.609.666 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Manuals Books used for sex education and procedural instruction. qDSex Hormones D06.472.866 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Androgens (+ 6); Corpus Luteum Hormones (+ 2); Estrogens (+ 11); Inhibin; Testicular Hormones (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR BB}HSex Hormone-Binding Globulin D12.776.124.790.223.800; D12.776.157.762; D12.776.377.715.182.800 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Beta Globulins A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Changes in its concentration significantly affect the ratio of unbound (biologically active) testosterone to estradiol in plasma. Beta Globulins (74-76); Glycoproteins (74-75); Protein Binding (74-75); Sex Hormones (74-76); Carrier Proteins (71-91) "IFKSex Factors G03.850.490.875; N05.715.350.675 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. &Sex Education I02.233.332.749 CLECHILJMAMTOGSNSTTD Education; Education, Nonprofessional (Non MeSH); Health Education Education which increases the knowledge of the functional, structural, and behavioral aspects of human reproduction. OSex Distribution G03.850.505.400.850; I01.240.800; N01.224.803 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography Social Sciences; Demography Population Characteristics (Non MeSH); Demography The number of males and females in a given population. The distribution may refer to how many men or women or what proportion of either in the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine. Sex (66-67); Sex Factors (68-93) 5X*Sex Disorders C12.294.644; C13.371.665 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Impotence (+ 1) Dyspareunia; Frigidity Disturbances in normal sexual performance. L/3Sex Differentiation Disorders C12.740.700.842; C13.371.820.700.842; C16.131.939.842; C19.391.775 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Transsexualism Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Endocrine Diseases; Gonadal Disorders (Non MeSH) Gonadal Dysgenesis (+ 1); Hermaphroditism (+ 1); Kallmann Syndrome; Klinefelter's Syndrome; Testicular Feminization Gonadal Dysgenesis (+ 3); Hermaphroditism (+ 1); Kallmann Syndrome Gonadal Dysgenesis (+ 3); Hermaphroditism (+ 1); Kallmann Syndrome; Klinefelter's Syndrome; Testicular Feminization Gonadal Dysgenesis (+ 3); Hermaphroditism (+ 1); Kallmann Syndrome; Klinefelter's Syndrome; Testicular Feminization Disorders in the differentiation process of gonadal tissues and organs during embryogenesis. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $q#LLlNSex Differentiation G07.553.800; G08.520.288.520 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fetal Development Differentiation of male and female tissues and organs during embryogenesis. Do not confuse with sex determination. Gonads/embryology (66-74) "Sex Determination E01.223.855; E05.393.830; G05.883 MT Sex Chromatin Diagnosis; Diagnosis, Laboratory Miscellaneous Techniques (Non MeSH); Genetic Techniques Genetics Gonadal or genetic determination of sex. )q2Sex Counseling F02.784.176.700; F04.408.413.700; N02.421.461.363.700; N02.421.143.303.700 CLECEDHILJMAMTOGSDSNSTTDUT Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Counseling Disciplines, Tests, Therapy, Services (Non MeSH); Mental Health Services; Counseling Facilities, Manpower and Services (Non MeSH); Health Services; Mental Health Services; Counseling Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Counseling Advice and support given to individuals to help them understand and resolve their sexual adjustment problems. It excludes treatment for PSYCHOSEXUAL DISORDERS or PSYCHOSEXUAL DYSFUNCTION. Counseling (66-87); Psychotherapy (66-87) T2Sex Cord-Stromal Tumor C04.557.475.750 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue Thecoma A malignant neoplasm of the ovary or testis. These tumors differentiate toward sex cords (in embryonic gonads) in the form of female (i.e., granulosa and theca) cells, male (i.e., Sertoli and Leydig) cells, or indifferent elements. In the ovary, sex cord-stromal tumors comprise 5% of all ovarian neoplasms. In the testes, Leydig and Sertoli cell tumors comprise about 5% of all testicular neoplasms, 10% of which behave in a malignant fashion. (From Dictionary of Modern Medicine, 1992). Ovarian Neoplasms (80-93); Testicular Neoplasms (81-93)  #X] >BSex Chromosomes A11.223.475.865 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Cells; Cell Nucleus; Chromosomes X Chromosome; Y Chromosome The homologous chromosomes that are dissimilar in the heterogametic sex. There are the X CHROMOSOME, the Y CHROMOSOME, and the W, Z chromosomes (in animals in which the female is the heterogametic sex (the silkworm moth Bombyx mori, for example). In such cases the W chromosome is the female-determining and the male is ZZ. (From King and Stansfield, A Dictionary of Genetics, 4th ed). Chromosomes (66-67); Sex Chromatin (66-67)  ()"4Sex Chromosome Abnormalities C16.131.280.748 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities Bonnevie-Ullrich Syndrome; Ectodermal Dysplasia (+ 1); Fragile X Syndrome; Gonadal Dysgenesis, 46,XY; Gonadal Dysgenesis, Mixed; Kallmann Syndrome; Klinefelter's Syndrome; Oculocerebrorenal Syndrome; Orofaciodigital Syndromes; Turner's Syndrome; XYY Karyotype Chromosome Abnormalities (66-67); Sex (66-67) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  "Ff,7NSex Chromatin A11.223.349.748 CHCLDEENGEIMIPMEMIPAPHPSRARERISETRULUSVI Sex Determination Chromosome Abnormalities Cells; Cell Nucleus; Chromatin A condensed mass of chromatin representing an inactivated X chromosome. Each X CHROMOSOME in excess of one forms a sex chromatin body in the mammalian nucleus. (King and Stansfield, A Dictionary of Genetics, 4th ed).  =,'Sex Characteristics G08.520.905 Reproduction, Urogenital Physiology (Non MeSH); Reproduction Those characteristics that distinguish one sex from the other. The primary sex characteristics are the ovaries and testes and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction. G3Sex Behavior, Animal F01.145.113.252.748 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Consummatory Behavior Copulation; Pair Bond Sexual activities of animals. Behavior, Animal (66-67); Sex Behavior (66-67)   p%9Sex Behavior F01.145.792 CLDEEHHIPHPXRESN Sexual Partners Behavior and Behavior Mechanisms (Non MeSH); Behavior Bisexuality; Coitus (+ 1); Contraception Behavior; Courtship; Extramarital Relations; Homosexuality (+ 2); Masturbation; Orgasm; Prostitution; Sexual Abstinence; Sexual Harassment Normal sexual activities of humans. BLCFCICLCODEDHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPHPPPSPXRARERHRISNSUTDTHURUSVI $'A,RSex Attractants D24.185.641.800 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Pheromones Pheromones that elicit sexual attraction or mating behavior usually in members of the opposite sex in the same species. Behavior, Animal (66-67); Pheromones (68-74); Sex Behavior (66-67) 2BZQSex G08.520.900 Libido; Psychosexual Development; Religion and Sex Reproduction, Urogenital Physiology (Non MeSH); Reproduction Coitus; Copulation; Ejaculation; Orgasm; Penile Erection The totality of characteristics of structures and functions differentiating the male from the female organism. SEX includes sexology, the study of the differences and interactions between the sexes. It does not include various sexual factors in epidemiology and statistics or the role of the sexes or differences in behavior, psychology, and sociology. CLDEGEIMPHPXRE  =GESewage G03.850.460.710.600; G03.850.860.510.900.700 AEANLJSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management  Waste Disposal, Fluid Refuse liquid or waste matter carried off by sewers. (Webster's Third). AEANECHIISLJMTSNST   2 XSeverity of Illness Index N02.421.589.473.100.608 Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization; Diagnosis-Related Groups APACHE; Karnofsky Performance Status Levels of severity of illness within a diagnostic group which are established by various measurement criteria. HISNST  , Severe Combined Immunodeficiency C16.614.815; C20.673.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Immunologic Diseases; Immunologic Deficiency Syndromes Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. About half of the patients with autosomal recessive SCID are deficient in the enzyme adenosine deaminase. Immunologic Deficiency Syndromes (74-91) c&Nv/Setariasis C03.335.349.820; C03.335.508.700.750.361.852; C03.701.377.820; C22.674.377.820 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Infection with nematodes of the genus SETARIA. This condition is usually seen in cattle and equines and is of little pathogenic significance, although migration of the worm to the eye may lead to blindness. UXJSetaria B01.500.294.700.750.700.300.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea A genus of parasitic nematodes found in the peritoneal cavity of wild or domestic cattle or equines. Filarioidea (66-92)  #*bySet (Psychology) F02.463.425.838 Attitude Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Readiness to think or respond in a predetermined way when confronted with a problem or stimulus situation. / ZSesquiterpenes D02.455.849.765 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Farnesol; Santonin; Trichothecenes (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR _8@2@Sesamoid Bones A02.835.232.730 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones :;Sesame Oil D10.516.212.302.380.775; D10.516.212.507.775; D10.516.627.700.865; J01.740.250.730; J01.740.700.865 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils Oo@Seryl T RNA Synthetase D08.586.464.136.720 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates serine with its specific transfer RNA. EC 6.1.1.11. Amino Acyl T RNA Synthetases (73-74); Serine (73-74) Ft]ASerum Sickness C17.800.174.600.800; C20.543.206.380.800; C20.543.520.770; C21.613.276.505.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Drug Eruptions Immunologic Diseases; Hypersensitivity; Drug Hypersensitivity; Drug Eruptions Immunologic Diseases; Hypersensitivity; Immune Complex Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Drug Toxicity (Non MeSH); Drug Eruptions Immune complex disease caused by the administration of foreign serum or serum proteins and characterized by fever, lymphadenopathy, arthralgia, and urticaria. When they are complexed to protein carriers, some drugs can also cause serum sickness when they act as haptens inducing antibody responses. ƠXNZSerum Globulins D12.776.124.790; D12.776.377.715 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins Alpha Globulins (+ 12); Beta Globulins (+ 7); Gamma Globulins; Immunoglobulins (+ 33); Macroglobulins (+ 1); Transcobalamins Alpha Globulins (+ 12); Beta Globulins (+ 7); Fibronectins; Gamma Globulins; Immunoglobulins (+ 33); Macroglobulins (+ 1); Transcobalamins AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR X&D@HSerum Bactericidal Test E05.909.560.595.800 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques; Microbial Sensitivity Tests Method of measuring the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy. It is used to monitor the therapy in bacterial endocarditis, osteomyelitis and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test. Blood Bactericidal Activity (72-89); Microbial Sensitivity Tests (72-89) +"eUSerum Albumin, Radio-Iodinated D01.496.448.496.665; D01.496.749.474.665; D12.776.034.841.665; D12.776.124.727.665 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Iodoproteins Inorganic Chemicals (Non MeSH); Isotopes; Iodine Isotopes; Iodine Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes; Iodine Radioisotopes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins; Serum Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Albumin Normal human serum albumin mildly iodinated with radioactive iodine (131-I) which has a half-life of 8 days, and emits beta and gamma rays. It is used as a diagnostic aid in blood volume determination. (from Merck Index, 11th ed). $\8Serum Albumin, Bovine D12.776.034.841.540; D12.776.124.727.540 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins; Serum Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Albumin h.DSerum Albumin D12.776.034.841; D12.776.124.050.700; D12.776.124.727 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Methemalbumin; Prealbumin; Serum Albumin, Bovine; Serum Albumin, Radio-Iodinated Methemalbumin; Prealbumin; Serum Albumin, Bovine; Serum Albumin, Radio-Iodinated A major plasma protein that serves in maintaining the plasma colloidal osmotic pressure and transporting large organic anions. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $=DFSertoli-Leydig Cell Tumor C04.557.475.075.750 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue; Androblastoma An ovarian tumor usually of low-grade malignancy occurring most frequently in the third and fourth decades, with 75% seen in women under 40. It is rare, representing less than .02% of ovarian cancers. The tumor typically produces androgens with virilization being noted in 70-85% of the patients. (Holland et al., Cancer Medicine, 3d ed). Leydig Cell Tumor (68-93); Ovarian Neoplasms (68-93); Sertoli Cell Tumor (68-93) _VnbSertoli Cells A05.360.444.849.789; A11.436.829 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Genitalia, Male; Testis Cells; Epithelial Cells (Non MeSH) r&*jSertoli Cell Tumor C04.557.475.740 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue A rare benign tumor of the testis that histologically resembles the fetal testis. There are three varieties: diffuse stromal, mixed (stromal and epithelial), and tubular (epithelial). Sertoli cells in the epithelial elements may produce estrogen and cause feminization. (Dorland, 27th ed). ]X]TSerratia marcescens B03.440.450.425.814.664 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Serratia A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients. ޴"zSerratia Infections C01.252.400.310.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Infections with bacteria of the genus SERRATIA. Enterobacteriaceae Infections (70-91); Serratia (78-91); Serratia marcescens (72-91) P:cSerratia B03.440.450.425.814 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Serratia marcescens A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment (soil, water, and plant surfaces) or as an opportunistic human pathogen. \ "nSerpulina hyodysenteriae B03.851.595.670.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales; Spirochaetaceae; Serpulina A species of anaerobic, spiral bacteria that was formerly classified as Treponema hyodysenteriae (and for a short while, Serpula hyodysenteriae). This organism is the agent of swine dysentery. Treponema (74-92) !">Serpulina B03.851.595.670 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales; Spirochaetaceae Serpulina hyodysenteriae A genus of spiral bacteria of the family SPIROCHAETACEAE. This genus contains two species, SERPULINA HYODYSENTERIAE and Serpulina innocens, which were formerly classified as Treponema hyodysenteriae and Treponema innocens, respectively. When researchers determined that T. hyodysenteriae and T. innocens did not belong to the genus Treponema, the new genus was named Serpula. Within a short time, however, it was discovered that Serpula was already the name of a fungal genus and thus, Serpula was changed to Serpulina. Treponema (80-92)   "1[Serpins D08.373.745.800.810 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; Angiotensinogen; Antiplasmin; Antithrombins (+ 2); Complement 1 Inactivators; Ovalbumin; Plasminogen Inactivators (+ 3); Thyroxine-Binding Proteins A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. This family includes alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor, and barley Z protein. Enzyme Inhibitors (68-78); Protease Inhibitors (79-89) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ DAHSerous Membrane A10.615.789 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Membranes Pericardium; Peritoneum; Pleura :,'Serotyping E05.478.829; E05.909.560.150.125.890 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Immunologic Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques; Bacteriological Techniques; Bacterial Typing Techniques Antigens (66-67); Bacteriological Techniques (66-67) {*">Serotonin Uptake Inhibitors D14.100.600.850; D14.100.850.875.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic Uptake Inhibitors; Serotonin Antagonists Serotonin Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Amoxapine; Citalopram; Clomipramine; Fenfluramine (+ 1); Fluoxetine; Fluvoxamine; Paroxetine; Trazodone; Zimeldine Amoxapine; Citalopram; Clomipramine; Fenfluramine (+ 1); Fluoxetine; Fluvoxamine; Paroxetine; Trazodone; Zimeldine Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here. Serotonin Antagonists (78-92) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,!*8<=!#:Serotonin Neuron Agents (Non MeSH) D14.100.850.875 Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents p-Chloroamphetamine; 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Fenclonine; Fenfluramine (+ 1); 3,4-Methylenedioxyamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Serotonin Uptake Inhibitors (+ 10) Drugs that act on serotonergic systems but are not agonists or antagonists. Among these are drugs that affect serotonin synthesis, uptake, storage, and metabolism, and drugs that selectively destroy serotonergic neurons. Serotonin/pharmacology (66-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  *$:Serotonin Antagonists D14.100.850.850 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Serotonin Uptake Inhibitors Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents Bufotenin; Cinanserin; Cyproheptadine; N,N-Dimethyltryptamine; Granisetron; Ketanserin; Lysergic Acid Diethylamide; Methergoline; Methiothepin; Methysergide; Mianserin; Ondansetron; Pizotyline; Ritanserin Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonin agonists. Serotonin (66-67); Serotonin/antagonists and inhibitors (68-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,'4!!KDSerotonin Agonists D14.100.850.800 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents Buspirone; N,N-Dimethyltryptamine; DOM; 8-Hydroxy-2-(di-n-propylamino)tetralin; Lisuride; Lysergic Acid Diethylamide; Mescaline; Quipazine; Sumatriptan Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of migraine. Serotonin/physiology (66-92) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $4*"DSerotonin Agents D14.100.850 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Serotonin Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Serotonin Agonists (+ 9); Serotonin Antagonists (+ 14); Serotonin Neuron Agents (Non MeSH) (+ 19) Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons. Serotonin/pharmacology (66-94) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (4 kw$DSerotonin D02.092.211.215.801.852; D03.438.473.914.814; D14.600.100.800; D17.350.050.650 AAADAEANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Serotonin; Serotonin Agents Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Tryptamines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids 5-Methoxytryptamine Bufotenin (+ 1); 5-Methoxytryptamine 3-(2-Aminoethyl)-1H-indol-5-ol. A tryptamine formed from tryptophan and released from mast cells and blood platelets. It causes vasodilation, increased capillary permeability, smooth muscle contraction, and gastric secretion inhibition. It is also a precursor of melatonin and a central neurotransmitter. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ X@.D_DSerositis C23.739.487.746 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation Inflammation of a serous membrane. G Nj+Serology G02.781 CLECEDHIISLJMAMTOGSNSTTD Health Occupations The study of serum, especially of antigen-antibody reactions in vitro. m  TSeroepidemiologic Methods E05.318.780.825; G03.850.520.840.825; N05.715.360.780.710 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) Epidemiologic studies based on the detection through serological testing of characteristic change in the serum level of specific antibodies. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Epidemiologic Methods (77-89)  .A|!#Serodiagnosis E01.223.495.826 CLECEDHIISLJMAMTOGSNSTTD Immunologic Techniques Diagnosis; Diagnosis, Laboratory; Immunologic Tests Agglutination Tests; AIDS Serodiagnosis; Complement Fixation Tests (+ 2); Complement Hemolytic Activity Assay; Hemadsorption Inhibition Tests; Hemagglutination Inhibition Tests; Hemagglutination Tests (+ 1); Latex Fixation Tests; Neutralization Tests (+ 1); Precipitin Tests (+ 5); Radioallergosorbent Test; Radioimmunoprecipitation Assay; Syphilis Serodiagnosis (+ 3) Diagnostic procedures connected with immunology, involving serum reactions. Serologic tests are employed both for 1) identification of microorganisms or 2) demonstration of antibodies in the serum of the host. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $ p=*Sermorelin D06.472.709.757.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones; Somatotropin-Releasing Hormone Human growth hormone-releasing factor(1-29)amide. The biologically active fragment of SOMATOTROPIN-RELEASING HORMONE. It is used to stimulate growth in children with a growth hormone deficiency or insufficiency. Peptide Fragments (84-92); Somatotropin-Releasing Hormone/analogs and derivatives (84-92) :gSerine Proteinases D08.586.277.656.732.760 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Acrosin; Ancrod; Chymotrypsin; Complement Factor I; Enteropeptidase; Factor VIIa; Factor IXa; Factor Xa; Factor XIa; Factor XIIa; Kallikrein; Pancreatopeptidase; Plasmin; Plasminogen Activators (+ 1); Pronase; Properdin Factor B; Properdin Factor D; Prostate-Specific Antigen; Reptilase; Subtilisins; Thrombin; Trypsin; Urokinase Peptide hydrolases which have an active center histidine and serine involved in the catalytic process. This group of enzymes is inactivated by organic fluorophosphates such as diisopropylphosphofluoridate (DIPF). EC 3.4.21. Peptide Peptidohydrolases (66-87) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $rD'FSerine Proteinase Inhibitors D08.373.745.800 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Gabexate; Serpins (+ 14); Trypsin Inhibitors (+ 6) Exogenous or endogenous compounds which inhibit serine proteinases. Enzyme Inhibitors (68-78); Protease Inhibitors (79-89) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $"@h@OAHSerine Hydroxymethyltransferase D08.586.913.755 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases A pyridoxal phosphate enzyme that catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. It also catalyzes the reaction of glycine with acetaldehyde to form L-threonine. EC 2.1.2.1. Serine (73-74); Tetrahydrofolates (73-74); Transferases (73-74) $FULSerine Dehydratase D08.586.520.497.747 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases Hydro-Lyases (66) F_Serine D12.125.837 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids 3,4-Dihydroxyphenylserine; Enterobactin; Phosphoserine L-Serine. A nonessential amino acid occurring in natural form as the L-isomer.  FH>`Serial Publications (Non MeSH) L01.178.682.829 Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Newspapers; Periodicals CLECHILJSDSNSTTDUT q%\Serial Passage E05.909.560.837 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques Inoculation of a series of animals or in vitro tissue with an infectious bacterium or virus, as in VIRULENCE studies and the development of vaccines. Virulence (66-87); Virus Cultivation (66-87) ["b6Serial Learning F02.463.425.952.747 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Verbal Learning Learning to make a series of responses in exact order.   nDSerial Extraction E06.658.641.890; E06.892.834.664 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentition, Mixed Dentistry; Orthodontics; Orthodontics, Interceptive Dentistry; Surgery, Oral; Tooth Extraction Orthodontics, Corrective (66-70); Tooth Extraction (66-70) ! &$nESequence Tagged Sites G05.275.195.700; G05.331.599.110.410.700 Polymerase Chain Reaction Genetics; Genes; Gene Library Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Gene Library Short, tagged tracts of DNA sequence that are used as landmarks in genome mapping. In most instances, 200 to 500 base pairs of sequence define a Sequence Tagged Site (STS) that is operationally unique in the human genome (i.e., can be specifically detected by the polymerase chain reaction in the presence of all other genomic sequences). The overwhelming advantage of STSs over mapping landmarks defined in other ways is that the means of testing for the presence of a particular STS can be completely described as information in a database. "o.Sequence Homology, Nucleic Acid G05.331.599.110.791; G05.331.599.700.550; G06.184.599.110.791; G06.184.599.700.550 Sequence Alignment Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Genetics; Genetics, Biochemical; Molecular Sequence Data; Sequence Homology Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Sequence Homology The sequential correspondence of nucleotide triplets in a nucleic acid molecule which permits nucleic acid hybridization. Sequence homology is important in the study of mechanisms of oncogenesis and also as an indication of the evolutionary relatedness of different organisms. The concept includes viral homology. Base Sequence (71-85); Nucleic Acid Hybridization (71-85) &&\kESequence Homology, Amino Acid G05.331.599.056.750; G05.331.599.700.200; G06.184.599.056.750; G06.184.599.700.200 Genetics; Genetics, Biochemical; Molecular Sequence Data; Amino Acid Sequence Genetics; Genetics, Biochemical; Molecular Sequence Data; Sequence Homology Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Amino Acid Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Sequence Homology The degree of similarity between sequences of amino acids. This information is useful for the understanding of genetic relatedness of certain species. Amino Acid Sequence (67-92); Molecular Sequence Data (88-92) *O$\ISequence Homology G05.331.599.700; G06.184.599.700 Genetics; Genetics, Biochemical; Molecular Sequence Data Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid The degree of similarity between sequences. Studies of amino acid and nucleotide sequences provide useful information about the genetic relatedness of certain species. Amino Acid Sequence (67-92); Base Sequence (71-92); Molecular Sequence Data (88-92); Nucleic Acid Hybridization (71-85) -&Sequence Deletion G05.632.325.700 DEGEIMPHRE Genetics; Mutation; Gene Deletion Deletion of sequences of bases or amino acids from the genetic material of an individual. Evidence for these deletions may be obtained by cytological methods. Mutation (76-92) 0*Sequence Analysis, RNA E05.393.760.710 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Sequence Analysis A multistage process that includes RNA cloning, physical mapping, subcloning, sequencing, and information analysis. Amino Acid Sequence (66-92); Base Sequence (71-92); RNA (66-92) 2="XOSequence Analysis, DNA E05.393.760.700 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Sequence Analysis DNA Mutational Analysis A multistage process that includes DNA cloning, physical mapping, subcloning, sequencing, and information analysis. New technological advances have led to the automation of certain steps in this process and contribute to the potential for large-scale DNA sequencing efforts. Amino Acid Sequence (66-92); Base Sequence (71-92); DNA (66-92)  3"X=OSequence Analysis E05.393.760 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques Sequence Analysis, DNA (+ 1); Sequence Analysis, RNA A multistage process that includes the determination of a sequence (protein, carbohydrate, etc.), its fragmentation and analysis, and the interpretation of the resulting sequence information. This information is useful in that it: 1) reveals the similarities of homologous genes, thereby providing insight into the possible regulation and functions of these genes; and 2) leads to a better understanding of disease states related to genetic variation. New sequencing methodologies, fully automated instrumentation, and improvements in sequencing-related computational resources contribute to the potential for genome-size sequencing projects. Amino Acid Sequence (66-92); Base Sequence (71-92)  6^"BA>Sequence Alignment E05.393.751 AECLCTECHIISMOMTNUPXSNSTTDUTVE Molecular Sequence Data; Sequence Homology, Nucleic Acid Miscellaneous Techniques (Non MeSH); Genetic Techniques The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms. :p"CBSeptum Pellucidum A08.186.211.276.814; A08.186.211.577.851 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Cerebral Ventricles Nervous System; Central Nervous System; Brain; Limbic System  Septal Nuclei (+ 1) Cerebral Ventricles (66-72) =k.8!Septicemia C01.539.757.720 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis Bacteremia (+ 1); Fungemia; Parasitemia; Sepsis Syndrome; Shock, Septic; Viremia Systemic disease associated with the presence and persistence of pathogenic microorganisms or their toxins in the blood. (Dorland, 27th ed). >PIcSeptal Nuclei A08.186.211.577.851.664 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Limbic System; Septum Pellucidum Nucleus Accumbens Neural nuclei situated in the septal region of the diencephalon. Cerebral Ventricles (66-71); Hippocampus (66-71); Limbic System (66-71)  @6`NVSepsis Syndrome C01.539.757.720.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Respiratory Distress Syndrome, Adult Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia A systemic response to infection, defined as hypothermia or hyperthermia, tachycardia, tachypnea, a clinically evident focus of infection or positive blood cultures, one or more end organs with either dysfunction or inadequate perfusion, cerebral dysfunction, hypoxemia, increased plasma lactate or unexplained metabolic acidosis, and oliguria. It is one of the most common causes of adult respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, ADULT). (Segen, Dictionary of Modern Medicine, 1992). BtP+WESepsis C01.539.757 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Septicemia (+ 7) The presence of pathogenic microorganisms or their toxins in tissues or in the blood. Systemic disease caused by the spread of the microorganisms via the circulating blood is commonly called SEPTICEMIA. (From Stedman, 25th ed). specific infection (66-94); Septicemia (66-94)  E P? 8Sepharose D09.203.698.813 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides H  F^Sentinel Surveillance E05.318.308.250.700.650; E05.318.650; G03.850.520.308.250.700.650; G03.850.520.699; G03.850.780.675.650; N05.715.360.300.375.625.650 VE Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Population Surveillance Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Population Surveillance Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Population Surveillance Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Population Surveillance Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. to estimate trends in larger population. (From Last, Dictionary of Epidemiology, 1988). Population Surveillance (83-94) Hs%Sensory Thresholds F02.463.593.710 CLDEPHRE Pain Measurement Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Auditory Threshold; Differential Threshold; Pain Threshold; Signal Detection (Psychology); Subliminal Stimulation; Taste Threshold The minimum amount of stimulus energy necessary to elicit a sensory response. CLDEEHPHPXRE $Nq \]Sensory System Agents (Non MeSH) D16.850 Peripheral Nervous System Agents (Non MeSH) Analgesics, Non-Narcotic (+ 38); Anesthetics, Local (+ 15) Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. (From Smith and Reynard, Textbook of Pharmacology, 1991, p367). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR PL( 4GHSensory Deprivation F02.463.593.696 PH Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception The absence or restriction of the usual external sensory stimuli to which the individual responds. RF\uSensory Aids E07.814 AECLCTECHIPXSDSNSTTDUTVE Blindness Equipment and Supplies Hearing Aids (+ 1) Blindness/rehabilitation (66-72); Deafness/rehabilitation (66-72) AECLCTECHIMIPSPXSDSNSTTDUTVEVI $Sk  L"Sensitivity Training Groups F01.829.316.697; F04.754.864.581.813 CLECHILJOGSNSTTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy; Psychotherapy, Group Encounter Groups Encounter Groups A group of people who meet in an unstructured setting to learn about themselves, interpersonal relationships, and group processes and about larger social systems. Group Processes (66-68)  T!*(Sensitivity and Specificity E01.825; E05.318.740.872; E05.318.780.800; G03.850.520.830.872; G03.850.520.840.800; H01.548.832.852; N05.715.360.750.725; N05.715.360.780.700 Mass Screening Diagnosis Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH)  Predictive Value of Tests; ROC Curve Predictive Value of Tests; ROC Curve Predictive Value of Tests; ROC Curve Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person. (From Last, Dictionary of Epidemiology, 2d ed, 1988). V!bSense Organs A09 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Receptors, Sensory Ear (+ 39); Eye (+ 40); Nose (+ 2); Taste Buds Receptors, Sensory (66-71); Sensation (66-71) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  ]:B7<Sensation Disorders C10.597.751; C23.888.592.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Anosmia; Dizziness; Hallucinations; Hyperesthesia (+ 1); Hypesthesia; Illusions; Paresthesia (+ 1); Phantom Limb; Taste Disorders (+ 2); Vision Disorders (+ 7) Anosmia; Dizziness; Hallucinations; Hyperesthesia (+ 1); Hypesthesia; Illusions; Paresthesia (+ 1); Phantom Limb; Taste Disorders (+ 2); Vision Disorders (+ 7) Disorders in the physical response to external or internal stimuli to the senses. Nervous System Diseases (80-92); Sensation (69-92) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $_1"Nb=TSensation F02.830.816; G11.561.796 DEGEIMPHRE Perception Neurophysiology; Perception Psychologic Processes and Principles (Non MeSH); Psychophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Hearing; Pain (+ 1); Proprioception (+ 1); Smell; Taste; Temperature Sense; Touch; Vision (+ 2) Gravity Perception; Hearing (+ 3); Pain (+ 1); Proprioception (+ 2); Smell; Taste (+ 1); Temperature Sense; Touch (+ 1); Vision (+ 2) Transduction of physical or chemical changes in the external or internal environment into nerve impulses by specialized receptors, transmission of these impulses by afferent neurons to the effectors, either directly or through the CNS. BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI (c !$TSenna D19.316.396.875 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cassia Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Preparations of Cassia senna L. and C. angustifolia of the Leguminosae. They contain sennosides, which are anthraquinone type cathartics and are used in many different preparations as laxatives. f : aSenegal Z01.058.290.190.710 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western h _Senecio B06.660.826 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Pyrrolizidine Alkaloids Plants; Plants, Toxic A species of toxic plants of the Compositae. The poisonous compounds are alkaloids which cause cattle diseases, neoplasms, and liver damage and are used to produce cancers in experimental animals. iY &Semustine D02.654.692.440.700; D02.948.594.440.700; D22.204.493.835 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds; Lomustine Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds; Lomustine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Lomustine 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea. 4-Methyl derivative of lomustine (CCNU). An antineoplastic agent which functions as an alkylating agent. Synonyms: NSC-95441; MeCCNU; Me-CCNU. Cyclohexanes (66-74); Nitroso Compounds (66-72); Nitrosourea Compounds (73-74); Urea (66-72) j A: oSemliki Forest Virus B04.820.850.054.840; B04.909.777.923.054.840 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus A species of ALPHAVIRUS isolated in central, eastern, and southern Africa. m2YSeminoma C04.557.465.330.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Germinoma A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (Dorland, 27th ed). Dysgerminoma (66-93) oj XuSeminiferous Tubules A05.360.444.849.700 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male; Testis Seminiferous Epithelium The canals through which the testicular spermatozoa are conveyed to the rete testis. st:AeSeminiferous Epithelium A05.360.444.849.700.700; A10.272.700 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male; Testis; Seminiferous Tubules Tissue Types (Non MeSH); Epithelium Specialized epithelium lining the seminiferous tubules containing developing and mature spermatozoa and Sertoli cells. t*:Seminal Vesicles A05.360.444.713 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male vw:7Semilunar Bone A02.835.232.087.144.663 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH); Carpal Bones w/:hSemiconductors H01.288.745 AECLCTECHISDSNSTTDUTVE Physical Sciences (Non MeSH); Electronics Transistors Electricity (66); Electronics (66) x3+Semicircular Canals A09.246.631.663 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth Hair Cells, Vestibular Three long canals (anterior, posterior, and lateral) of the labyrinth. They are set at right angles to each other and are situated superior and posterior to the vestibule. x:%Semicarbazones D02.845.746 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Semicarbazides Thiosemicarbazones (+ 2) Hemostatics (66-71); Nitrofurazone (66-71); Semicarbazides (66-71); Thiosemicarbazones (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  z86o:Semicarbazides D02.845 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Diphenylcarbazide; Semicarbazones (+ 3) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR | 8#/:Semen Preservation E05.760.833.890 AECLCTECHIISMOMTNUPXSNSTTDUTVE Sperm Banks Insemination, Artificial Miscellaneous Techniques (Non MeSH); Preservation, Biological; Tissue Preservation Methods of preserving semen. Freezing (66-77); Semen (66-77) $}"`$(Semen A12.838.732 CHCYDEENIMMEMIPHPSRARERISEUSVI Sperm Banks; Spermatozoa Fluids and Secretions (Non MeSH); Secretions (Non MeSH) The thick, whitish secretion of the male reproductive organs. It is composed of spermatozoa in their nutrient plasma, secretions from the prostate, seminal vesicles, and various other glands, epithelial cells, and minor constituents. (Dorland, 27th ed). ~c "D(Semantics L01.143.506.598.745 Information Science; Communication; Language; Linguistics The relationships between symbols and their meanings. O D@Semantic Differential F02.694.663; F04.711.647.745 HISNST Psychologic Processes and Principles (Non MeSH); Psycholinguistics Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests Analysis of word concepts by the association of polar adjectives, e.g., good-bad, with the concept, father. The adjectives are usually scaled in 7 steps. The subject's placement of the concept on the adjectival scale indicates the connotative meaning of the concept. Psychological Tests (66-67); Semantics (66-67) " 98Sella Turcica A02.835.232.781.802.662 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Empty Sella Syndrome Musculoskeletal System; Skeleton; Bone and Bones; Skull; Sphenoid Bone (VSelf-Injurious Behavior F03.126.780 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Self Mutilation Behavior in which persons hurt or harm themselves without the motive of suicide or of sexual deviation. The most common expressions of this behavior are head-banging, biting, head-hitting, body-hitting, and scratching. The most frequently encountered injuries are excoriations, scars/callus formation, hematomas, and local infections. Self Mutilation (68-91)  FYSelf-Help Groups N03.540.782 CLECHILJOGSNSTTDUT Social Support Economics, Organizations, Control (Non MeSH); Organizations Alcoholics Anonymous Organizations which provide an environment encouraging social interactions through group activities or individual relationships especially for the purpose of rehabilitating or supporting patients, individuals with common health problems, or the elderly. They include therapeutic social clubs. Organizations (68-72) $7FMSelf-Help Devices E07.796 AECLCTECHIPXSDSNSTTDUTVE Disabled Equipment and Supplies Communication Aids for Disabled; Wheelchairs Devices, not affixed to the body, designed to help persons having musculoskeletal or neuromuscular disabilities to perform activities involving movement.  y  5Self-Examination E01.706.860 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Physical Examination Breast Self-Examination The inspection of one's own body, usually for signs of disease (e.g., BREAST SELF-EXAMINATION, testicular self-examination). Palpation (69-90)  "&Self-Evaluation Programs I02.399.780 CLECHILJMAMTOGSNSTTD Education; Educational Measurement Educational programs structured in such a manner that the participating professionals, physicians, or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires. Educational Measurement (74-78) H)%Self-Care Units N02.278.388.740 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units Rooms in health care facilities for patients who require a minimal level of care. _cSelf Tolerance G04.610.484.800 DEGEIMPHRE Autoimmune Diseases; Clonal Anergy; Clonal Deletion Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immune Tolerance The normal lack of the ability to produce an immunological response to autologous (self) antigens. A breakdown of self tolerance leads to autoimmune diseases. The ability to recognize the difference between self and non-self is the prime function of the immune system. Immune Tolerance (73-93)  ">f<Self Stimulation F01.145.775; F02.830.784 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Psychologic Processes and Principles (Non MeSH); Psychophysiology Central stimulation, usually electrical, of the brain, which is administered by the animal's pressing a bar or switch; the stimulation may result in negative or positive reinforcement.  Self Mutilation C21.866.780; F03.126.780.720 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Self-Injurious Behavior The act of injuring one's own body to the extent of cutting off or permanently destroying a limb or other essential part of a body. E"FSelf Medication E02.319.900; E02.900.900 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Drug Therapy Therapeutics; Self Care The self administration of medication not prescribed by a physician or in a manner not directed by a physician. I"=Self Disclosure F01.752.747.792.662 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Self Concept A willingness to reveal information about oneself to others. Self Concept (69-74) qISelf Concept F01.752.747.792 Body Image Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Self Assessment (Psychology); Self Disclosure A person's view of himself. `7$Self Care E02.900; N02.421.784.680 AECLCTECHIISMOMTPXSNSTTDUTVE Therapeutics Facilities, Manpower and Services (Non MeSH); Health Services; Rehabilitation Blood Glucose Self-Monitoring; Self Administration; Self Medication Performance of activities or tasks traditionally performed by professional health care providers. The concept includes care of oneself or one's family and friends. Activities of Daily Living (78-80); Consumer Participation (74-78); Health Education (66-80); Patient Education (66-80); Patient Participation (78) AECLCTECHIISMOMTNUPXSNSTTDUTVE $ jP"Self Assessment (Psychology) F01.752.747.792.537 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Self Concept Appraisal of one's own personal qualities or traits. Self Concept (69-74) "q@Self Administration E02.319.890; E02.900.890 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Drug Therapy Therapeutics; Self Care Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Self Medication (66-76); specific heading/administration and dosage (66-76) "=YSelenomethionine D02.712.700; D12.125.166.676.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organoselenium Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Methionine 2-Amino-4-(methylseleno)butanoic acid. Diagnostic aid in pancreas function determination. Methionine (71-74); Selenium (69-74) &:h-Selenocysteine D02.712.600; D12.125.166.230.700 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Organoselenium Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Cysteine 3-Selenyl-L-alanine. A naturally occurring amino acid in both eukaryotic and prokaryotic organisms. It is found in tRNAs and in the catalytic site of some enzymes. The genes for glutathione peroxidase and formate dehydrogenase contain the TGA codon, which codes for this amino acid. Cysteine/analogs and derivatives (77-92); Organoselenium Compounds (91-92); Selenium (77-91) ^&FMmSelenium Radioisotopes D01.496.749.780 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of selenium that decay or disintegrate emitting radiation. Se atoms with atomic weights 70-73, 75, 79, 81, and 83-85 are radioactive selenium isotopes. Radioisotopes (66-87); Selenium (66-87) i4C0Selenium Compounds D01.810 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Sodium Selenite Inorganic compounds that contain selenium as an integral part of the molecule. Selenium (66-93)  , 8%^Selenium D01.268.185.850; D01.268.912.825; D01.578.700 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Chalcogens (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Minerals Selenium. A nonmetallic trace element that is a member of the chalcogen family. It has the atomic symbol Se, atomic number 34, and atomic weight 78.96. It is an essential mineral, being a constituent of the enzyme glutathione peroxidase, and believed to be closely associated with vitamin E in its functions, but it occurs in toxic levels in several kinds of plants. Dietary deficiency, occurring where the soil has a low selenium content, results in cardiomyopathy. (From Dorland, 27th ed). ] 5:ESelegiline D02.092.471.683.915; D08.373.616.900; D15.090.050.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents (R)-N,alpha-Dimethyl-N-2-propynylbenzeneethanamine. A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p.385) The compound without isomeric designation is deprenyl. Monoamine Oxidase Inhibitors (66-78); Phenethylamines (66-78) =:HSelection Bias G03.850.490.500.500; N05.715.350.150.775 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Bias (Epidemiology) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Bias (Epidemiology) The introduction of error due to systematic differences in the characteristics between those selected and those not selected for a given study. In sampling bias, error is the result of failure to ensure that all members of the reference population have a known chance of selection in the sample. Epidemiologic Methods (66-89); Research Design (72-89)  .^ASelection (Genetics) G05.414.725 Genetics; Genetics, Population Differential and non-random reproduction of different genotypes, operating to alter the gene frequencies within a population. Genetics (66-67); Genetics, Population (66-67) %8Seizures C10.597.742; C23.888.592.742 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Convulsions (+ 1) Convulsions (+ 1) Attacks of cerebral origin consisting of sudden and transitory abnormal phenomena of a motor, sensory, autonomic or psychic nature resulting from transient dysfunction of the brain. Convulsions (66-78); Epilepsy (66-78); specific epilepsy heading  7 "N,NSEER Program E05.318.308.970.725; G03.850.520.308.970.725; L01.280.950.725; N04.452.859.819.725; N05.715.360.300.715.700.725 CLECHIISLJMAOGSDSNSTTDUT Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Registries Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Registries Information Science; Data Collection; Registries Health Services Administration (Non MeSH); Organization and Administration; Records; Registries Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Registries A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From a brochure of the National Cancer Institute, NIH Publication No. 91-3074, October 1990). {9-Seeds B06.413.775; J01.341.897 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Nuts Plants Plants; Plant Structures (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Food Cotyledon The encapsulated embryos of flowering plants. They are used as or for animal feed because of the high content of concentrated nutrients like starches, proteins, and fats. Rapeseed, cottonseed, and sunflower seed are produced for the oils (fats) they yield. $  & g.Sedatives, Nonbarbiturate D15.210.350.800; D15.325.875 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives Central Nervous System Agents; Hypnotics and Sedatives Alprazolam; Azaperone; Bromisovalum; Chloral Hydrate (+ 1); Chlordiazepoxide; Chlormethiazole; Diazepam; Diphenhydramine; Doxylamine; Estazolam; Ethchlorvynol; Etomidate; Flurazepam; Glutethimide; Hydroxyzine; Lorazepam; Medazepam; Meprobamate; Methapyrilene; Methaqualone; Midazolam; Nitrazepam; Oxazepam; Paraldehyde; Promethazine; Propofol; Triazolam; Zolazepam Alprazolam; Azaperone; Bromisovalum; Chloral Hydrate (+ 1); Chlordiazepoxide; Chlormethiazole; Diazepam; Diphenhydramine; Doxylamine; Estazolam; Ethchlorvynol; Etomidate; Flurazepam; Glutethimide; Hydroxyzine; Lorazepam; Medazepam; Meprobamate; Methapyrilene; Methaqualone; Midazolam; Nitrazepam; Oxazepam; Paraldehyde; Promethazine; Propofol; Triazolam; Zolazepam Compounds with diverse chemical and pharmacological properties that have in common the ability to allay excitement and anxiety and at higher concentrations induce sleep. Hypnotics and Sedatives (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $="8R&:Sedatives, Barbiturate D15.210.350.750; D15.325.850 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Barbiturates; GABA Modulators Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives Central Nervous System Agents; Hypnotics and Sedatives Amobarbital; Barbital; Hexobarbital; Mephobarbital; Pentobarbital; Phenobarbital; Secobarbital; Thiamylal; Thiopental Amobarbital; Barbital; Hexobarbital; Mephobarbital; Pentobarbital; Phenobarbital; Secobarbital; Thiamylal; Thiopental Those derivatives of barbituric or thiobarbituric acid that are used as hypnotics or sedatives. The structural class of all such derivatives, regardless of use, is BARBITURATES. Barbiturates (66-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ("8$:Security Measures N04.452.910 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Computer Security Regulations to assure protection of property and equipment. CLECHIISLJMAOGSNSTTDUT  ƬWGSecretory Rate G06.535.873 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism The amount of a substance secreted by cells or by a specific organ or organism over a given period of time; usually applies to those substances which are formed by glandular tissues and are released by them into biological fluids, e.g., secretory rate of corticosteroids by the adrenal cortex, secretory rate of gastric acid by the gastric mucosa. OSecretory Component D12.776.124.486.485.680.800; D12.776.124.790.651.596.800; D12.776.377.715.548.673.800; D24.611.125.600.662.833 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments A glycoprotein usually associated with secretory immunoglobulins (A and M). Its molecular weight is 60,000 to 75,000, depending on the species; it is linked to the heavy chains of the immunoglobulins by disulfide bonds and probably functions to protect the immunoglobulins from proteolysis in the secretions. Colostrum (73-75); IgA (73-75); Immunoglobulin Fragments (73-75) x6jiNSecretions (Non MeSH) A12.838 Fluids and Secretions (Non MeSH) Bile; Cerumen; Colostrum; Gastric Juice (+ 1); Intestinal Secretions; Milk, Human; Mucus (+ 1); Pancreatic Juice; Saliva; Sebum; Semen; Smegma; Sputum; Sweat; Tears; Venoms; Vernix Caseosa ADAEAGAIANBIBLCFCHCLCSCTCYDEDUECENGEHIIMIPMEMIPDPHPKPOPSRARERISETOTUURUSVI * (NSecretin D06.472.317.800; D12.644.820; D12.776.641.650.705; D14.600.600.760; D19.316.629.787 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones A hormone of the duodenal mucosa that activates pancreatic secretion and lowers the blood sugar level. (USAN and the USP Dictionary of Drug Names, 1994, p.597).  _FSecosteroids D04.808.812 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Cholecalciferol (+ 5); Dihydrotachysterol; Ergocalciferols (+ 1) Steroids in which fission of one or more ring structures and concomitant addition of a hydrogen atom at each terminal group has occurred. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  M8(MDSecond Messenger Systems G06.535.898.800 DEGEIMPHRE Cell Communication; Signal Transduction Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Signal Transduction Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system. ,/gSecobarbital D03.383.742.698.253.762; D14.100.240.500.840; D15.045.885; D15.210.350.750.885; D15.325.850.887 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity. 'k:ySecernentea Infections C03.335.508.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections Ascaridida Infections (+ 6); Oxyurida Infections (+ 2); Rhabditida Infections (+ 1); Spirurida Infections (+ 10); Strongylida Infections (+ 10) Infections with nematodes of the subclass SECERNENTEA. ܖP@ASecernentea B01.500.294.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda Ascaridida (+ 9); Oxyurida (+ 2); Rhabditida (+ 7); Spirurida (+ 23); Strongylida (+ 19); Tylenchida (+ 1) A subclass of nematodes characterized by numerous caudal papillae and an excretory system possessing lateral canals. j**Sebum A12.838.702 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH)  "DSebaceous Glands A01.835.744; A10.336.827 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Body Regions (Non MeSH); Skin Tissue Types (Non MeSH); Exocrine Glands  Meibomian Glands :XSebaceous Gland Neoplasms C04.588.805.578; C17.800.805.711.712; C17.800.882.712 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Skin Neoplasms Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sebaceous Gland Diseases (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Neoplasms Sebaceous Glands (66-67); Skin Neoplasms (66-67) =X2;Sebaceous Gland Diseases (Non MeSH) C17.800.805.711 Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases Acne Vulgaris; Dermatitis, Seborrheic; Favre-Racouchot Syndrome; Mucinosis, Follicular; Rhinophyma; Sebaceous Gland Neoplasms BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI +hXSeaweed B05.104.837 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Carrageenan Algae and Fungi (Non MeSH); Algae A marine alga (kelp, dulse, rockweed, sea lettuce) widely distributed in the ocean, occurring from the tide level to considerable depths, free-floating or anchored. Many are of economic importance as food, fertilizer, agar, potash, or source of iodine. (From Webster, 3d ed).  &,DSeawater G03.230.700.400 AEANCH Thalassotherapy Water Environment and Public Health (Non MeSH); Environment; Water Water (66-68)     JSeat Belts E07.712.831 AECLCTECHILJSDSNSTTDUTVE Air Bags Air Bags; Automobiles; Accidents, Traffic Equipment and Supplies; Protective Devices Restraining belts fastened to the frame of automobiles, aircraft, or other vehicles, and strapped around the person occupying the seat in the car or plane, intended to prevent the person from being thrown forward or out of the vehicle in case of sudden deceleration. Accident Prevention (66-69); Accidents, Traffic (66-69); Automobiles (66-69) $[ 33:[Seasons G03.230.560; H01.862.645.661 Environment and Public Health (Non MeSH); Environment Physical Sciences (Non MeSH); Time; Periodicity  "zSeasonal Affective Disorder F03.709.438.100.705 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Affective Disorders A syndrome characterized by depressions that recur annually at the same time each year, usually during the winter months. Other symptoms include anxiety, irritability, decreased energy, increased appetite (carbohydrate cravings), increased duration of sleep, and weight gain. SAD (seasonal affective disorder) can be treated by daily exposure to bright artificial lights (PHOTOTHERAPY), during the season of recurrence. Affective Disorders (85-91); Depressive Disorder (84-91); Seasons (84-91) !FxXSeals B02.649.754.578 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Pinnipedia  ((Seafood J01.341.838 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Fish Products (+ 2); Shellfish Marine fish and shellfish used as food or suitable for food. (Webster, 3d ed) SHELLFISH and FISH PRODUCTS are more specific types of SEAFOOD. ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEMIPDPKPOPSRESDSESNSTTOTUURUTVI  r "=(HSea-Blue Histiocyte Syndrome C15.604.667.400.410.800; C18.452.648.556.641.803.850; C18.452.648.595.803.850 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytosis, Non-Langerhans-Cell Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses Rare disorder consisting of splenomegaly, mild purpura secondary to thrombocytopenia, and occasionally, hepatic cirrhosis associated with the appearance of numerous histiocytes in the spleen and bone marrow which stain a sea-blue color. It is sometimes considered a variant of Niemann-Pick disease. Histiocytes (66-83) 0"ULXSea Urchins B01.408.578 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Echinodermata Somewhat flattened, globular echinoderms of the class Echinoidea, having thin, brittle shells of calcareous plates. Echinodermata (66-71) u("Sea Cucumbers B01.408.560 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Echinodermata A class of Echinodermata characterized by long, slender bodies. Echinodermata (66-77) ("LSea Anemones B01.308.700 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Cnidaria Numerous almost invariably solitary polyps of the order Actiniaria. (PScurvy C18.654.223.133.115.661 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ascorbic Acid Deficiency Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Ascorbic Acid Deficiency A condition due to deficiency of ASCORBIC ACID (vitamin C) in the diet and marked by weakness, anemia, spongy gums, a tendency to mucocutaneous hemorrhages and a brawny induration of the muscles of the calves and legs. (Dorland, 27th ed). u NSculpture K01.093.849 CLEDHIPXSNTD Humanities; Art  Scrub Typhus C01.252.400.810.700.810.800.855 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rickettsia Infections An acute infectious disease caused by RICKETTSIA TSUTSUGAMUSHI. It is limited to eastern and southeastern Asia, India, northern Australia, and the adjacent islands. Characteristics include the formation of a primary cutaneous lesion at the site of the bite of an infected mite, fever lasting about two weeks, and a maculopapular rash. >#PScrotum A05.360.444.661 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male n :7Screw Worm Infection C03.211.503.744 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations; Myiasis Infection with larvae of the blow fly Cochliomyia hominivorax (Callitroga americanum), a common cause of disease in livestock in the southern and southwestern U.S.A. PAScrapie C10.228.228.800.799; C10.228.337.799; C22.836.799 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Prions; PrPSc Proteins Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Prion Diseases Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Animal Diseases; Sheep Diseases A fatal disease of the nervous system in sheep and goats, characterized by pruritus, debility, and locomotor incoordination. It is caused by proteinaceous infectious particles called PRIONS.  9J Scotoma C10.597.751.941.811; C11.966.811; C23.888.592.763.941.811 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Eye Diseases; Vision Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders Localized area of defective vision surrounded by area of normal vision; occurs with variety of eye diseases such as glaucoma and optic neuritis. | AN.Scotland Z01.542.363.766 EHEP Geographicals (Non MeSH); Europe; Great Britain  ;Scorpions B01.131.166.661 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida Arthropods of the order Scorpiones, of which 1500 to 2000 species have been described. The most common live in tropical or subtropical areas. They are noctural and feed principally on insects and other arthropods. They are large arachnids but do not attack man spontaneously. They have a venomous sting. Their medical significance varies considerably and is dependent on their habits and venom potency rather than on their size. At most, the sting is equivalent to that of a hornet but certain species possess a highly toxic venom potentially fatal to humans. (From Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973; Barnes, Invertebrate Zoology, 5th ed).  (,*Scorpion Venoms D24.185.965.065.830 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Arthropod Venoms Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic. Scorpions (66-77); Venoms (66-77)  U<kS*Scopoletin D03.438.150.446.912.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; Umbelliferones 7-Hydroxy-6-methoxycoumarin. Plant growth factor derived from the root of Scopolia carniolica or Scopolia japonica. Coumarins (69-74); Bioflavonoids (72-74)  :v1Scopolamine Derivatives D03.132.889.848.661; D03.605.869.900.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Tropanes; Scopolamine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes; Scopolamine Butylscopolammonium Bromide Butylscopolammonium Bromide Analogs or derivatives of scopolamine. Scopolamine (66-74); Tropanes (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $.8>/.:Scopolamine D03.132.760.180.848; D03.132.889.848; D03.605.869.900; D14.100.120.200.500.840; D15.045.850; D15.095.810; D16.050.030.800; D16.050.500.870; D16.050.650.870 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Solanaceous Alkaloids; Belladonna Alkaloids Heterocyclic Compounds; Alkaloids; Tropanes Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics  Scopolamine Derivatives (+ 1) Scopolamine Derivatives (+ 1) An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. @MScoliosis C05.116.900.800.875 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spinal Curvatures (Non MeSH) An appreciable lateral deviation in the normally straight vertical line of the spine. (Dorland, 27th ed).  NfSclerotherapy E02.319.805 AECLCTECHIISMOMTNUPXSNSTTDUTVE Sclerosing Solutions Varicose Veins Therapeutics; Drug Therapy Treatment of varicose veins, hemorrhoids, gastric and esophageal varices, and peptic ulcer hemorrhage by injection or infusion of chemical agents which cause localized thrombosis and eventual fibrosis and obliteration of the vessels. Sclerosing Solutions (66-89) $]"! "Sclerostomy E04.579.895; E04.792.450.600 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sclera; Glaucoma Surgery, Operative; Ostomy Surgery, Operative; Surgery, Eye (Non MeSH); Filtering Surgery Surgical formation of an external opening in the sclera, primarily in the treatment of glaucoma. Sclera/surgery (71-87); Glaucoma/surgery (71-87)  J"$ks;Sclerosis C23.739.823 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) An induration or hardening, especially hardening of a part from inflammation and in diseases of the interstitial substance. (Dorland, 27th ed).  NYSclerosing Solutions D26.394.225.766.826; D26.585.711 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Varicose Veins; Sclerotherapy Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Miscellaneous Drugs and Agents (Non MeSH); Irritants Sodium Morrhuate; Sodium Tetradecyl Sulfate Sodium Morrhuate; Sodium Tetradecyl Sulfate AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  &,$f.Scleroproteins (Non MeSH) D12.776.860 Amino Acids, Peptides and Proteins (Non MeSH); Proteins Extracellular Matrix Proteins (+ 7); Fibroin; Gelatin; Keratin; Reticulin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR oDZHScleroplasty E04.792.892; E04.860.850 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sclera Surgery, Operative; Surgery, Eye (Non MeSH) Surgery, Operative; Surgery, Plastic Plastic surgery of the sclera. This procedure is used frequently to prevent blindness and poor vision in children with myopia. Myopia/surgery (72-91); Sclera/surgery (72-91)   $ _9Scleroderma, Systemic C17.300.799; C17.800.784 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases CREST Syndrome CREST Syndrome A chronic, progressive dermatosis characterized by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, esophagus, kidneys and heart. It may be accompanied by calcinosis, Raynaud's phenomenon, and telangiectasis (CREST syndrome). It includes acrosclerosis and sclerodactyly. "\N$vScleroderma, Circumscribed C17.300.790; C17.800.773 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A chronic, localized hardening and thickening of the skin. Lesions may be categorized as morphea (guttate, profunda, pansclerotic) or linear (with or without melorheostosis or hemiatrophy). It is twice as common in women as in men. The condition is characterized by skin ischemia, lymphocytic infiltrates, swollen collagen bundles, and thickening of the dermis with reduction of subcutaneous fat. Scleroderma, Systemic (66-70) %EN#Scleritis C11.790.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Scleral Diseases Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva. Inflammation (66-88); Sclera (66-88) ( N&|-Sclerema Neonatorum C16.131.831.812; C16.614.810; C17.800.762 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible. ,1L @Scleredema Adultorum C17.300.550.750; C17.800.751 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diabetes Mellitus Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. (From Dorland, 27th ed). /"NScleral Diseases C11.790 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Scleritis General disorders of the sclera or white of the eye. They may include anatomic, embryologic, degenerative, or pigmentation defects. Sclera (66-88); Eye Diseases (66-88)  3} N .Scleral Buckling E04.792.890 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Sclera; Retinal Detachment Surgery, Operative; Surgery, Eye (Non MeSH) An operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina. Retinal Detachment/SU (66-74); Sclera (66-74)  4$!58Sclera A09.371.784 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Limbus Corneae; Scleral Buckling; Scleroplasty; Sclerostomy Sense Organs; Eye 6 :GSciuridae B02.649.865.750 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia Marmota A family of the order Rodentia which contains 49 genera. Some of the more common genera are MARMOTA, which includes the marmot and woodchuck; Sciurus, the gray squirrel, S. carolinensis, and the fox squirrel, S. niger; Tamias, the eastern and western chipmunk; and Tamiasciurus, the red squirrel. The flying squirrels, except the scaly-tailed Anomaluridae, also belong to this family. Rodentia (66-67)  7p (& Scintillation Counting E05.799.700; H01.671.768.765.710 AECLCTECHIISMOMTNUPXSNSTTDUTVE Gamma Cameras Radionuclide Imaging Miscellaneous Techniques (Non MeSH); Radiometry Physical Sciences (Non MeSH); Physics; Radiation; Radiometry  Whole-Body Counting Detection and counting of scintillations produced in a fluorescent material by ionizing radiation. Radiometry (66-72) (9&"sScimitar Syndrome C08.381.844; C08.695.815; C14.240.700; C14.700; C14.907.780; C16.131.240.700; C16.131.740.815 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH) Cardiovascular Diseases Cardiovascular Diseases; Vascular Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) Anomalous venous drainage of the right lung into the inferior vena cava, with hypoplasia of the right lung. The scimitar-shaped radiographic shadow of the anomalous vein gives the syndrome its name. Lung/abnormalities (66-84); Pulmonary Artery/abnormalities (66-84); Pulmonary Veins/abnormalities (66-84) ;mL{Scientific Misconduct K01.316.815; K01.752.256.773 CLHILJPXSNTD Duplicate Publication; Plagiarism; Retraction of Publication; United States Office of Research Integrity Humanities; Ethics Humanities; Philosophy; Ethics Intentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact. Ethics (77-89); Fraud (74-89)  @1"z<&Science H01.770 CLECEDHIISLJMAMTOGSNSTTD Religion and Science Physical Sciences (Non MeSH) Algorithms; Methods; Models, Theoretical (+ 21); Research (+ 13); Research Support; Systems Integration; Systems Theory; Training Support (+ 1) B   #Sciatica C10.772.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Low Back Pain; Sciatic Nerve; Intervertebral Disk Displacement Nervous System Diseases; Peripheral Nervous System Diseases A syndrome characterized by pain radiating from the back into the buttock and into the lower extremity along its posterior or lateral aspect. It is most commonly caused by prolapse of the intervertebral disk. It refers also to pain anywhere along the course of the sciatic nerve. (Dorland, 27th ed). Cd NKFeSciatic Nerve A08.800.800.720.450.760 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Sciatica Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Lumbosacral Plexus Peroneal Nerve; Tibial Nerve (+ 1) A nerve which originates in the lumbar and sacral spinal cord (L4 to S3) and supplies motor and sensory innervation to the lower extremity. The sciatic nerve, which is the main continuation of the sacral plexus, is the largest nerve in the body. It has two major branches, the TIBIAL NERVE and the PERONEAL NERVE.  E8 q,vSchwann Cells A08.637.800; A08.800.800.690; A11.650.800 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neuroglia Nervous System; Peripheral Nervous System; Peripheral Nerves Cells; Neuroglia Myelin Sheath (+ 2) Myelin Sheath (+ 2) Myelin Sheath (+ 2) Neuroglial cells of the peripheral nervous system which form the insulating myelin sheaths of peripheral axons. CHCLCYDEENGEIMMEMIPAPHPSRARERISETRULUSVI  H1*zJ,Schools, Veterinary I02.783.660.836 CLECHILJMAOGSDSNSTTD Education; Schools; Schools, Health Occupations Educational institutions for individuals specializing in the field of veterinary medicine. J9iSchools, Public Health I02.783.660.765 CLECHILJMAOGSDSNSTTD Education; Schools; Schools, Health Occupations Educational institutions for individuals specializing in the field of public health. K9cSchools, Pharmacy I02.783.660.694 CLECHILJMAOGSDSNSTTD Education; Schools; Schools, Health Occupations Educational institutions for individuals specializing in the field of pharmacy. Education, Pharmacy (66-67) L9]!Schools, Nursing I02.783.660.623 CLECHILJMAOGSDSNSTTD Education; Schools; Schools, Health Occupations Educational institutions for individuals specializing in the field of nursing. M9\Schools, Nursery I02.233.659.660 CLECHILJMAOGSDSNSTTD Child Day Care Centers Education; Education, Nonprofessional (Non MeSH); Schools Schools for children usually under five years of age. NEBSchools, Medical I02.783.660.552; N02.278.020.578 CLECHILJMAOGSDSNSTTD Education; Schools; Schools, Health Occupations Facilities, Manpower and Services (Non MeSH); Health Facilities; Academic Medical Centers Educational institutions for individuals specializing in the field of medicine. O&]Schools, Health Occupations I02.783.660 CLECHILJMAOGSDSNSTTD Education; Schools Area Health Education Centers; Schools, Dental; Schools, Medical; Schools, Nursing; Schools, Pharmacy; Schools, Public Health; Schools, Veterinary Schools which offer training in the area of health. Health Occupations (66-67); Universities (66-67)  QH!@:Schools, Dental I02.783.660.481 CLECHILJMAOGSDSNSTTD Education; Schools; Schools, Health Occupations Educational institutions for individuals specializing in the field of dentistry. R9^Schools I02.233.659; I02.783 CLECHILJMAOGSDSNSTTD Education; Education, Nonprofessional (Non MeSH) Education Schools, Nursery Library Schools; Schools, Health Occupations (+ 7); Universities Educational institutions. CLECHILJMAOGSDSNSTTDUT  S DaSchool Nursing G02.478.676.824; N02.421.143.827.809.742; N02.421.726.809.742 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; School Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; School Health Services Health and nursing care given to primary and secondary school students by a registered nurse. Nursing (66); Public Health Nursing (66); School Health Services (66) U8EbpVSchool Health Services N02.421.143.827.809; N02.421.726.809 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services School Dentistry; School Nursing School Dentistry; School Nursing Preventive health services provided for students. It excludes college or university students. CLECEDHIISLJMAMTOGSDSNSTTDUT  W*Nn School Dentistry G02.163.809; N02.421.143.827.809.576; N02.421.726.809.576 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Dentistry Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; School Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; School Health Services Preventive dental services provided for students in primary and secondary schools. Dentistry (66-71); School Health Services (66-71) ZSAKa<School Admission Criteria I02.399.750 SNTD Education; Educational Measurement Requirements for the selection of students for admission to academic institutions. \)aSchizotypal Personality Disorder F03.709.597.730 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder in which there are oddities of thought (magical thinking, paranoid ideation, suspiciousness), perception (illusions, depersonalization), speech (digressive, vague, overelaborate), and behavior (inappropriate affect in social interactions, frequently social isolation) that are not severe enough to characterize schizophrenia. Schizophrenia (66-71) ]&FcSchizosaccharomyces B05.354.107.292.820; B05.354.930.720 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Algae and Fungi (Non MeSH); Fungi; Yeasts A genus of ascomycetous fungi of the family Saccharomycetaceae, order Endomycetales comprising the fission yeasts. `e*"Schizopyrenida B01.841.750.656.475.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea Naegleria (+ 1) An order of ameboid protozoa commonly having a monopodial cylindrically shaped body. Nuclear division is promitotic and most species have a temporary flagellate stage. a&JSchizophyllum B05.354.179.824 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes Fleshy shelf basidiomycetous fungi, family Schizophyllaceae, order Aphyllophorales, growing on woody substrata. c">Schizophrenic Psychology F04.824 Disciplines, Tests, Therapy, Services (Non MeSH) Study of mental processes and behavior of schizophrenics. d 9ESchizophrenic Language F03.126.769 Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) The artificial language of schizophrenic patients - neologisms (words of the patient's own making with new meanings). exYSchizophrenia, Paranoid F03.709.680.786.800 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Schizophrenia A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Paranoid Disorders (66-72); Schizophrenia (66-72) fFr;Schizophrenia, Disorganized F03.709.680.786.762 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Schizophrenia A form of schizophrenia characterized by disorganized thinking, shallow and inappropriate affect, inappropriate giggling, silly and regressive behavior, frequent hypochondriacal complaints, and usually bizarre delusions and hallucinations. Schizophrenia (66-71) h FrSchizophrenia, Childhood F03.709.680.500.110; F03.709.680.786.730 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Child Development Disorders, Pervasive Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Schizophrenia Schizophrenia occurring in childhood (after 1 year and up to 11 years). j.FXSchizophrenia, Catatonic F03.709.680.786.710 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Schizophrenia A form of schizophrenia characterized by abnormality of motor behavior which may involve particular forms of stupor, rigidity, excitement or inappropriate posture. Catatonia (66-74); Schizophrenia (66-74) lFr1Schizophrenia F03.709.680.786 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders Schizophrenia, Catatonic; Schizophrenia, Childhood; Schizophrenia, Disorganized; Schizophrenia, Paranoid A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, hallucinations, emotional disharmony, and regressive behavior. BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI  nDavFSchizoid Personality Disorder F03.709.597.680 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder manifested by a profound defect in the ability to form social relationships, no desire for social involvement, and an indifference to praise or criticism. Personality Disorders (68-71) qi#Fc#Schistosomicides D21.201.412.596 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Schistosoma; Schistosomiasis Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents Antimony Potassium Tartrate; Antimony Sodium Gluconate; Hycanthone; Lucanthone; Niridazole; Oxamniquine; SQ 18506 Agents that act systemically to kill adult schistosomes. Schistosomiasis/drug therapy (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (sb8"VD+:Schistosomiasis mansoni C03.335.865.859.576 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections; Schistosomiasis Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver. Schistosoma mansoni (72-85); Schistosomiasis (66-85) uPT>Schistosomiasis japonica C03.335.865.859.521 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections; Schistosomiasis Schistosomiasis caused by Schistosoma japonicum. It is endemic in the Far East and affects the bowel, liver, and spleen,. Schistosoma japonicum (79-85); Schistosomiasis (66-85) wPT@Schistosomiasis haematobia C01.539.895.775; C03.335.865.859.427; C12.777.892.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Urinary Tract Infections Parasitic Diseases; Helminthiasis; Trematode Infections; Schistosomiasis Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Tract Infections Schistosomiasis caused by SCHISTOSOMA HAEMATOBIUM. It is endemic in Africa and parts of the Middle East, and affects the urinary tract. Schistosoma haematobium (72-85); Schistosomiasis (66-85) yp=PBSchistosomiasis C03.335.865.859 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Schistosomicides Parasitic Diseases; Helminthiasis; Trematode Infections Schistosomiasis haematobia; Schistosomiasis japonica; Schistosomiasis mansoni Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States. (Merck Manual, 15th ed).  |?PAX8Schistosomatidae B01.500.736.715.770 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda Schistosoma (+ 3) A family of blood flukes of the class Trematoda which is found in animals and man. It Includes the genera Heterobilharzia, Schistosomatium, Schistosoma, Ornithobilharzia, Bilharziella, Trichobilharzia, Pseudobilharzia, and Austrobilharzia. Trematoda (66-81)  *=Schistosoma mansoni B01.500.736.715.770.680.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Schistosomatidae; Schistosoma A species of trematode blood flukes of the family Schistosomatidae. It is common in the Nile delta. The intermediate host is the planorbid snail. This parasite causes schistosomiasis mansoni and intestinal bilharziasis. Schistosoma (66-71) *`Schistosoma japonicum B01.500.736.715.770.680.570 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Schistosomatidae; Schistosoma A species of trematode blood flukes belonging to the family Schistosomatidae whose distribution is confined to areas of the Far East. The intermediate host is a snail. It occurs in man and other mammals. Schistosoma (66-78) *`Schistosoma haematobium B01.500.736.715.770.680.510 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Schistosomatidae; Schistosoma A species of trematode blood flukes of the family Schistosomatidae which occurs at different stages in development in veins of the pulmonary and hepatic system and finally the bladder lumen. This parasite causes urinary schistosomiasis. Schistosoma (66-71) *`Schistosoma B01.500.736.715.770.680 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Schistosomicides Invertebrates; Helminths; Platyhelminths; Trematoda; Schistosomatidae Schistosoma haematobium; Schistosoma japonicum; Schistosoma mansoni A genus of trematode flukes belonging to the family Schistosomatidae. There are over a dozen species. These parasites are found in man and other mammals. Snails are the intermediate hosts.  *QNSchilling Test E01.223.459.859; E01.289.846 AECLCTECHIISMOMTNUPXSNSTTDUTVE Vitamin B 12; Anemia, Pernicious Diagnosis; Diagnosis, Laboratory; Hematologic Tests Diagnosis; Diagnosis, Radioisotope For gastrointestinal absorption of vitamin B 12. A measured amount of radioactive vitamin B 12 is given orally, followed by a parenteral flushing dose of the radioactive vitamin. The percentage of radioactivity is determined in the urine excreted over a 24-hour period. (Dorland, 27th ed). "")dVSchiff Bases D02.491.784 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Imines Amines (66-70) C8.Scheuermann's Disease C05.116.791.835; C05.116.900.653 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Osteochondritis Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Osteochondrosis of the vertebral epiphyses in children. &NBSch-23390 D03.438.079.750; D14.100.150.175.850; D15.150.825; D15.210.950.040.825; D15.700.872.331.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents 8-Chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol. A dopamine D1 receptor antagonist that has no effect or only very limited effect on dopamine D2 receptors. The compound has tranquilizing effects, inhibits conditioned avoidance response, impairs memory acquisition, produces dose-dependent catalepsy, blocks central serotonin receptors, and reduces the lethal effects of cocaine. Benzazepines (68-90); Tranquilizing Agents, Major (75-90) u g:DScent Glands A13.820 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Exocrine glands in animals which secrete scents which either repel or attract other animals, e.g. perianal glands of skunks, anal glands of weasels, musk glands of foxes, ventral glands of wood rats, and dorsal glands of peccaries. ` :Scattering, Radiation H01.671.768.831 Nephelometry and Turbidimetry Physical Sciences (Non MeSH); Physics; Radiation Spectrum Analysis, Raman The process in which energy is removed from a beam of light or other electromagnetic radiation and emitted without appreciable change in wavelength. May be considered as the change in direction of a particle or photon owing to a collision with another particle or system. Radiation (66-70); specific radiation (66-70) HIISMTST $#<A7 Scarlet Fever C01.252.410.890.823 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Infection with group A streptococci that is characterized by tonsillitis and pharyngitis. An erythematous rash is commonly present. ePScapula A02.835.232.087.783 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH) Acromion + :V Scapegoating F01.145.299.500; F01.393.246.500; F01.393.693.500; F03.407.246.500; F03.407.693.500 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Displacement (Psychology) Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms; Displacement (Psychology) Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms; Projection Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms; Displacement (Psychology) Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms; Projection Process in which the mechanisms of projection or displacement are utilized in focusing feelings of aggression, hostility, frustration, etc., upon another individual or group; the amount of blame being unwarranted. Displacement (Psychology) (68-75); Schizophrenia (66-75)  _BScandium D01.268.558.800; D01.552.550.800 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Scandium. An element of the rare earth family of metals. It has the atomic symbol Sc, atomic number 21, and atomic weight 45.  &:Scandinavia Z01.542.808 EHEP Geographicals (Non MeSH); Europe Denmark; Norway (+ 1); Sweden n)(Scandentia B02.649.875 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Tupaiidae (+ 1) An order of the class MAMMALS that consists of one family, TUPAIIDAE (tree shrews), 5 genera (one of which is TUPAIA), and 16 species. Their recent distribution is from India to the Philippines, southern China to Java, Borneo, Sumatra, Bali, and other islands in those regions. (JScalp Dermatoses C17.800.738 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Tinea Capitis (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI NKPScalp A01.835.657 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Body Regions (Non MeSH); Skin ; 8'Scala Tympani A09.246.631.246.848 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea The lower tube of the cochlea, extending from the round window to the helicotrema and containing perilymph. Cochlea (66-78) :0Scabies C03.211.394.708; C03.858.800; C17.800.838.775.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations; Mite Infestations Parasitic Diseases; Skin Diseases, Parasitic Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic A contagious cutaneous inflammation caused by the bite of the mite SARCOPTES SCABIEI. It is characterized by pruritic papular eruptions and burrows and affects primarily the axillae, elbows, wrists, and genitalia, although it can spread to cover the entire body.  9P3SC-19220 D03.494.347.750; D26.744.825 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzoxazepines Miscellaneous Drugs and Agents (Non MeSH); Prostaglandin Antagonists 1-Acetyl-2-(8-chloro-10,11-dihydrodibenz(b,f)(1,4)oxazepine-10-carbonyl hydrazine. Inhibits the activity of prostaglandins. Dibenzoxazepines (72-74); Hydrazines (72-74)  ":5Saxitoxin D24.185.926.580.830 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Dinoflagellida Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins Poison found in certain edible mollusks at certain times; elaborated by Gonyaulax species (Dinoflagellate protozoans) and consumed by mollusks, fishes, etc. without ill effects; it is neurotoxic and causes respiratory paralysis and other effects in mammals, known as paralytic shellfish poisoning.  DhYSaudi Arabia Z01.252.245.500.750; Z01.586.500.750 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East j*Saturn H01.091.800.700.831 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The sixth planet in order from the sun. It is one of the five outer planets of the solar system. Its twelve natural satellites include Phoebe and Titan. Extraterrestrial Environment (66-90); Planets (91-94) m M?Satiety Response F02.830.749.658 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Satiation Behavioral response associated with the achieving of gratification.  ZOSatiation F02.830.749 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology Satiety Response Full gratification of a need or desire followed by a state of relative insensitivity to that particular need or desire.   MSatellite Viruses B04.265.658 CHCLDEENGDGEIMIPMEPHPYREUL Helper Viruses Helper Viruses Viruses; Defective Viruses Dependovirus Defective viruses which can multiply only by association with a helper virus which complements the defective gene. Defective Viruses (67-74); Viruses (66) (7!1Satellite Communications L01.178.847.550 CLECHIISLJMAOGSDSNSTTDUT Information Science; Communications Media (Non MeSH); Telecommunications Communications using an active or passive satellite to extend the range of radio, television, or other electronic transmission by returning signals to earth from an orbiting satellite. Communication (72-75); Telecommunications (76-92) U:Saskatchewan Z01.107.567.176.858 EHEP Geographicals (Non MeSH); America; North America; Canada FSarin D02.705.785 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Cholinesterase Inhibitors (66-71); Organophosphorus Compounds (71) ) :CMSarcosine D12.125.807 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Glycine (66-67) . DHSarcoptes scabiei B01.131.166.132.658 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida; Acari  (5Sarcoplasmic Reticulum A02.633.567.925; A10.690.350.800; A11.368.702.248.782 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Muscles Musculoskeletal System; Muscles; Muscle, Skeletal Tissue Types (Non MeSH); Muscles; Muscle, Skeletal Cells; Cytoplasm; Organelles; Endoplasmic Reticulum A special form of agranular reticulum found in the sarcoplasm of striated muscle and comprising a system of smooth-surfaced tubules forming a plexus around each myofibril. (Dorland, 27th ed). Endoplasmic Reticulum (66-71)  =* #Sarcomeres A02.633.565.850.700; A11.368.702.619.827 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Musculoskeletal System; Muscles; Muscle Fibers; Myofibrils Cells; Cytoplasm; Organelles; Myofibrils The repeating contractile units of the myofibril, delimited by Z bands along its length. Muscle Contraction (66-83); Muscles (66-83); Myofibrils (66-83) '.*vjMSarcomastigophora Infections C03.752.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections Mastigophora Infections (+ 15); Sarcodina Infections (+ 6) Infections with protozoa of the phylum SARCOMASTIGOPHORA. !P0GDSarcomastigophora B01.841.750 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa Mastigophora (+ 39); Sarcodina (+ 22) A phylum of protozoa with a single-type nucleus and locomotion by flagella, pseudopodia, or both types of locomotor organelles. It comprises the subphyla MASTIGOPHORA, Opalinata, and SARCODINA. C&0Sarcoma, Yoshida C04.557.450.795.830.850; C04.619.857.822 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Sarcoma, Experimental Neoplasms; Neoplasms, Experimental; Sarcoma, Experimental .RSarcoma, Synovial C04.557.450.565.835; C04.557.450.795.875 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). u.XSarcoma, Small Cell C04.557.450.565.825; C04.557.450.795.870 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A sarcoma characterized by the presence of small cells, cells measuring 9-14 micrometers with a faint or indistinct rim of cytoplasm and an oval-to-elongated nucleus with relatively dense chromatin. (From Dictionary of Modern Medicine, 1992). Sarcoma (72-93); Sarcoma, Ewing's (86-93) 3.X3Sarcoma, Mast-Cell C04.557.386.802.750; C15.604.667.750; C20.683.515.761.802.750 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Reticuloendotheliosis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Reticuloendotheliosis Mast Cells (66-67); Sarcoma (66-67) dEXB-Sarcoma, Kaposi's C04.557.450.795.850; C04.557.645.750 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed and Holland et al., Cancer Medicine, 3d ed). ʪ*XSarcoma, Experimental C04.557.450.795.830; C04.619.857 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Neoplasms; Neoplasms, Experimental Sarcoma 37; Sarcoma 180; Sarcoma, Avian; Sarcoma, Yoshida Sarcoma 37; Sarcoma 180; Sarcoma, Avian; Sarcoma, Yoshida 4&RSarcoma, Ewing's C04.557.450.565.575.650.800; C04.557.450.795.620.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue; Osteosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Osteosarcoma A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. There are conspicuous foci of necrosis in association with irregular masses of small, regular, rounded or ovoid cells with very scanty cytoplasm. The tumor occurs usually before the age of 20, about twice as frequently in males as in females. (From Dorland, 27th ed; Stedman, 25th ed).  :XYSarcoma, Endometrial Stromal C04.557.435.775; C04.557.450.795.820 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A highly malignant neoplasm of the endometrium, arising from the endometrial stroma. It represents one type of stromal tumor, the other being endolymphatic stromal myosis. They are differentiated on the basis of the number of mitoses per 10 high power fields: endometrial stromal sarcoma has 10 or more mitoses, endolymphatic stromal myosis fewer. Stroma sarcoma is seen most often between the ages of 45 and 50. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Sarcoma (67-93) !"*X;Sarcoma, Clear Cell C04.557.450.565.800; C04.557.450.795.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A sarcoma of young, often female, adults of the lower extremities and acral regions, intimately bound to tendons as circumscribed but unencapsulated melanin-bearing tumors of neuroectodermal origin. An ultrastructural finding simulates flattened and curved barrel staves, corresponding to the internal structures of premelanosomes. There is a 45-60% mortality in clear cell sarcoma. (Dictionary of Modern Medicine, 1992). Sarcoma (66-93) +.XSarcoma, Avian C02.782.815.800; C02.928.800; C04.557.450.795.830.800; C04.619.857.800; C04.619.935.800; C04.925.700; C22.131.800 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections Virus Diseases; Tumor Virus Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Sarcoma, Experimental Neoplasms; Neoplasms, Experimental; Sarcoma, Experimental Neoplasms; Neoplasms, Experimental; Tumor Virus Infections Neoplasms; Tumor Virus Infections Animal Diseases; Bird Diseases Connective tissue tumors, affecting primarily fowl, that are usually caused by avian sarcoma viruses. RwSarcoma, Alveolar Soft Part C04.557.450.590.775; C04.557.450.795.775 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A variety of sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck region of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (From Dorland, 27th ed and DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Sarcoma (66-93); Soft Tissue Neoplasms (76-93) w".X9Sarcoma 37 C04.557.450.795.830.760; C04.619.857.573 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Sarcoma, Experimental Neoplasms; Neoplasms, Experimental; Sarcoma, Experimental (.RSarcoma 180 C04.557.450.795.830.780; C04.619.857.656 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Sarcoma, Experimental Neoplasms; Neoplasms, Experimental; Sarcoma, Experimental .RSarcoma Viruses, Simian B04.820.650.730.730.820; B04.820.650.805.601; B04.909.574.807.730.730.820; B04.909.574.807.805.601; B04.909.777.731.730.730.820; B04.909.777.731.805.601 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; RNA Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Simian Species of mammalian type C retroviruses (RETROVIRUSES TYPE C, MAMMALIAN) producing tumors in primates. Originally isolated from a fibrosarcoma in a woolly monkey, SSV is a replication-defective v-onc virus which carries the sis oncogene. In order to propagate, SSV requires a replication-competent helper virus, simian sarcoma virus-associated virus (SSAV). C-Type Viruses (72-77); Oncogenic Viruses (66-77) C<Sarcoma Viruses, Murine B04.265.600; B04.820.650.730.730.900.750; B04.909.574.807.730.730.900.750; B04.909.777.731.730.730.900.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine Harvey Sarcoma Virus; Kirsten Sarcoma Virus; Moloney Sarcoma Virus Harvey Sarcoma Virus; Kirsten Sarcoma Virus; Moloney Sarcoma Virus Harvey Sarcoma Virus; Kirsten Sarcoma Virus; Moloney Sarcoma Virus Harvey Sarcoma Virus; Kirsten Sarcoma Virus; Moloney Sarcoma Virus Species of replication-defective mammalian type C retroviruses (RETROVIRUSES TYPE C, MAMMALIAN) which are capable of transforming cells, but which replicate and produce tumors only in the presence of murine leukemia viruses (LEUKEMIA VIRUSES, MURINE). Mouse Tumor Viruses (66-74)  t:""Sarcoma Viruses, Avian B04.820.650.700.775; B04.909.574.807.720.775; B04.909.777.731.720.775 CHCLDEENGDGEIMIPMEPHPYREUL Sarcoma Viruses; RNA Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, ALV-Related Species of ALV-related retroviruses (RETROVIRUSES, ALV-RELATED) producing sarcomata and other tumors in chickens and other fowl and also in pigeons, ducks, and rats. /M 'Sarcoma Virus, Feline B04.820.650.730.730.800; B04.909.574.807.730.730.800; B04.909.777.731.730.730.800 CHCLDEENGDGEIMIPMEPHPYREUL Leukemia Virus, Feline Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian A species of mammalian type C retroviruses (RETROVIRUSES TYPE C, MAMMALIAN) isolated from fibrosarcoma in cats. The virus is actually a recombinant feline leukemia virus (FeLV) where part of the genome has been replaced by cellular oncogenes. It is unique to individuals and not transmitted naturally to other cats. FeSV is replication defective and requires FeLV to reproduce. C-Type Viruses (74); Cats (69-74); Fibrosarcoma (69-74); Oncogenic Viruses (70-74); Retroviridae (70-74); Vertebrate Viruses, Unclassified (70-74)  YSarcoma C04.557.450.795 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Sarcoma Viruses, Avian Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH) Adenosarcoma; Carcinosarcoma (+ 1); Chondrosarcoma (+ 1); Fibrosarcoma (+ 2); Hemangiosarcoma; Leiomyosarcoma; Liposarcoma (+ 1); Lymphangiosarcoma; Mixed Tumor, Mesodermal; Myosarcoma (+ 3); Myxosarcoma; Osteosarcoma (+ 2); Phyllodes Tumor; Sarcoma, Alveolar Soft Part; Sarcoma, Clear Cell; Sarcoma, Endometrial Stromal; Sarcoma, Experimental (+ 4); Sarcoma, Kaposi's; Sarcoma, Small Cell; Sarcoma, Synovial A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.   Xx}Sarcolemma A11.195.707 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Muscles Cells; Cell Membrane The excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990). Cell Membrane (66); Muscles (66)  ?* *Sarcoidosis, Pulmonary C08.381.483.725; C15.604.515.827.725; C23.484.739.725 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Sarcoidosis Symptoms and General Pathology (Non MeSH); Granuloma; Sarcoidosis Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed). Lung Diseases (66-93); Sarcoidosis (66-93) =N-4Sarcoidosis C15.604.515.827; C23.484.739 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Kveim Test Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Symptoms and General Pathology (Non MeSH); Granuloma Sarcoidosis, Pulmonary; Uveoparotid Fever Sarcoidosis, Pulmonary; Uveoparotid Fever A chronic, progressive, systemic granulomatous reticulosis of unknown etiology, involving almost any organ or tissue, including the skin, lungs, lymph nodes, liver, spleen, eyes, and small bones of the hands and feet. It is characterized histologically by noncaseating epithelioid cell tubercles in all affected organs. Laboratory findings may show hypercalcemia and hypergammaglobulinemia, diminished or absent reactivity to tuberculin, and a positive Kveim reaction in most active cases. (Dorland, 27th ed).  "N`KSarcodina Infections C03.752.700.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections Amebiasis (+ 5) Infections with protozoa of the subphylum SARCODINA. PQ?Sarcodina B01.841.750.656 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora Eumycetozoea (+ 5); Lobosea (+ 15) A subphylum of protozoa characterized by the ability to alter their body shape. Its organisms acquire food by pseudopodia of various types, or by locomotive protoplasmic flow without the production of discrete pseudopodia. Flagella, when present, are usually restricted to developmental or other temporary stages.   &2-lSarcocystosis C03.752.750.259.634 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis Infection of the striated muscle of mammals by parasites of the genus SARCOCYSTIS. Disease symptoms such as vomiting, diarrhea, muscle weakness, and paralysis are produced by sarcocystin, a toxin produced by the organism.  VPXSarcocystis B01.841.075.762.167.275.250.600 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina A genus of protozoa found in reptiles, birds, and mammals, including humans. This heteroxenous parasite produces muscle cysts in intermediate hosts such as domestic herbivores (cattle, sheep, pigs) and rodents. Final hosts are predators such as dogs, cats, and man. L#&b7Sarcina B03.510.400.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci A genus of gram-positive, anaerobic bacteria whose organisms divide in three perpendicular planes and occur in packets of eight or more cells. It has been isolated from soil, grains, and clinical specimens. ` "?Saralasin D08.373.745.085.800; D12.644.456.073.041.800; D17.350.050.050.050.700; D18.162.050.800 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins; Angiotensin II Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Angiotensins; Angiotensin II Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors 1-(N-Methylglycine)-5-L-valine-8-L-alanineangiotensin II. An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II. Alanine (74); Angiotensin II (74); Sarcosine (74)  `F?Saponins D09.203.408.782 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ISCOMs Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Escin; Holothurin; Solanine Sapogenin glycosides. A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycon moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose. Sapogenins are poisonous towards the lower forms of life and are powerful hemolytics when injected into the blood stream able to dissolve red blood cells at even extreme dilutions. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $E > Y#DSapogenins D02.455.849.919.650; D04.808.854.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Triterpenes Polycyclic Hydrocarbons; Steroids; Spirostans Oleanolic Acid Diosgenin The aglucon moiety of a saponin molecule. It may be triterpenoid or steroid, usually spirostan, in nature. Spirostans (68-78); Terpenes (66-73); Triterpenes (74-78) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $*8F:Saphenous Vein A07.231.908.819 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins The vein which drains the foot and leg. 853Santonin D02.455.849.765.750; D21.201.287.770 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Sesquiterpenes Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents  *:Sanitation G02.229.782; G03.850.780.200.800; G03.850.860 CLECHIISLJMAMTSNSTTD Health Occupations; Environmental Health Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Environment and Public Health (Non MeSH); Public Health  Food Inspection; Sanitary Engineering (+ 5) Public Facilities (Non MeSH) (+ 4); Sanitary Engineering (+ 15) The development and establishment of environmental conditions favorable to the health of the public. AEANCLCTDEECEDHIISLJMAMOMTNUPXRESNSTTDUTVE  5v.Sanitary Engineering G02.229.656; G03.850.780.200.800.800; G03.850.860.510; J01.293.821 ECEDHIISLJMAMTSNSTTD Health Occupations; Environmental Health Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation Environment and Public Health (Non MeSH); Public Health; Sanitation Technology, Industry, Agriculture (Non MeSH); Engineering  Drainage, Sanitary; Refuse Disposal; Waste Disposal, Fluid; Waste Management (+ 1) Biodegradation; Toilet Facilities; Waste Management (+ 8); Water Softening; Water Supply (+ 2) A branch of engineering concerned with the design, construction, and maintenance of environmental facilities conducive to public health, such as water supply and waste disposal. AEANCLCTDEECEDHIISLJMAMOMTNUPXRESNSTTDUTVE   L^.Sandhoff Disease C10.228.140.163.300.853; C10.496.253.872; C18.452.648.556.641.803.350.827; C18.452.648.595.803.350.827; F03.709.346.250.650 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI G(M2) Ganglioside Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic; Gangliosidoses Nervous System Diseases; Mental Retardation; Gangliosidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses; Gangliosidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses; Gangliosidoses Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation; Gangliosidoses A variant of Tay-Sachs disease. It is caused by a deficiency of hexosaminidases A and B inherited as an autosomal recessive trait, leading to accumulation of G(M2) ganglioside and the sphingolipid globoside in neurons. The diseases manifests clinically as psychomotor retardation and deterioration, blindness, cherry red spot in the macula, hepatosplenomegaly, and death in 1-3 years. Lipoidosis (66-78); Gangliosides (66-78); Gangliosidosis (76-78); G(M2) Ganglioside (75-78); Hexosaminidases (71-78); Sphingolipidosis (74-78)  $~LSandfly Fever Group Viruses B04.820.087.710.800; B04.909.777.147.710.800 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Phlebovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Phlebovirus Rift Valley Fever Virus Rift Valley Fever Virus A group of viruses in the genus PHLEBOVIRUS of the family BUNYAVIRIDAE transmitted by the sandfly, Phlebotomus papatasii, and causing a short febrile illness in humans. The sandfly fever Sicilian virus, the type species of the PHLEBOVIRUS genus, is not part of this group. *"2:ASan Marino Z01.542.786 EHEP Geographicals (Non MeSH); Europe -l)San Francisco Z01.107.567.875.100.127.875; Z01.107.567.875.600.822.127.875; Z01.433.875 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH); California Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States; California Geographicals (Non MeSH); Cities (Non MeSH) -QmSampling Studies E05.318.760.875; G03.850.520.835.875; N05.715.360.775.700 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH) Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled. /ASample Size E05.318.780.762; G03.850.520.840.762; H01.770.644.728.902; N05.715.360.780.692 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Science; Research; Research Design Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) The number of units (persons, animals, patients, specified circumstances, etc.) in a population to be studied. The sample size should be big enough to have a high likelihood of detecting a true difference between two groups. (From Wassertheil-Smoller, Biostatistics and Epidemiology, 1990, p. 95). 2X]Samarium D01.268.558.775; D01.552.550.778 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Samarium. An element of the rare earth family of metals. It has the atomic symbol Sm, atomic number 62, and atomic weight 150.36. The oxide is used in the control rods of some nuclear reactors. 6_ &:Salvage Therapy E02.186.800; E02.895 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Combined Modality Therapy Therapeutics A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases. 8i"=Salts D01.786 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) :  8%Salt Gland A13.811 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) A compound tubular gland, located around the eyes and nasal passages in marine animals and birds, the physiology of which figures in water-electrolyte balance. The Pekin duck serves as a common research animal in salt gland studies. A rectal gland or rectal salt gland in the dogfish shark is attached at the junction of the intestine and cloaca and aids the kidneys in removing excess salts from the blood. (Storer, Usinger, Stebbins and Nybakken: General Zoology, 6th ed., p.658, 1979). : :@Salsoline Alkaloids D03.132.750; D03.438.531.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Tetrahydroisoquinolinol alkaloids in both dextro and levo forms, originally from Salsola richteri; may be hypotensive due to inhibition of certain brain enzymes; may be formed de novo in brain from dopamine during alcoholism. Alkaloids (66-78); Isoquinolines (69-78); Quinolines (66-68) ="8ISalpingostomy E04.035.832; E04.819.608.732; E04.887.690.750 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Fallopian Tubes Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Gynecologic (Non MeSH) Formation of an artificial opening in a fallopian tube. Fallopian Tube Diseases/surgery (66-87); Fallopian Tubes/surgery (66-87)  ?5$DVSalpingitis C13.371.056.114.781; C13.371.056.390.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Adnexitis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Fallopian Tube Diseases Inflammation of the uterine tube. (Dorland, 27th ed). B.N"CSalmoniformes B02.493.817 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Esocidae; Salmonidae (+ 6); Umbridae An order of fish comprising pikes, salmons, mudminnows, smelts, barreleyes, slickheads, trouts, and many other families - totalling 24 - with 145 genera and 508 species. They are both marine and freshwater fish, found in all oceans and are quite numerous in the Northern Hemisphere. (From Nelson: Fishes of the World). D.&/vSalmonidae B02.493.817.750 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes Oncorhynchus (+ 3); Trout (+ 1) A family of anadromous fish comprising the salmons, trouts, whitefishes, graylings, and chars. They are the most important food and game fishes. Their habitat is the northern Atlantic and Pacific, both marine and inland, and the Great Lakes. (Nelson: Fishes of the World, 1976). Fishes (66-67)  FY&**JSalmonella typhimurium B03.440.450.425.800.825 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that is the most frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. H|"|Salmonella typhi B03.440.450.425.800.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella The etiologic agent of typhoid fever. JA"|/Salmonella schottmuelleri B03.440.450.425.800.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella The etiologic agent of enteric fever in man. Salmonella (74); Salmonella paratyphi A (66-74) Ka"|8:Salmonella Phages B04.123.706 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Bacteriophage P22 Viruses whose host is Salmonella. A frequently encountered Salmonella phage is BACTERIOPHAGE P22. LsSalmonella paratyphi A B03.440.450.425.800.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella A bacterium that causes mild paratyphoid fever in humans. M"|FSalmonella Infections, Animal C01.252.400.310.821.706; C22.812 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Salmonella Infections Animal Diseases Infections in animals with bacteria of the genus SALMONELLA. O#&JISalmonella Infections C01.252.400.310.821 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Paratyphoid Fever; Salmonella Food Poisoning; Salmonella Infections, Animal; Typhoid Infections with bacteria of the genus SALMONELLA. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  PNc<PSalmonella hirschfeldii B03.440.450.425.800.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella An etiologic agent of PARATYPHOID FEVER in Asia, Africa, and southern Europe. Salmonella (74); Salmonella paratyphi A (66-74) S "|]:Salmonella Food Poisoning C01.252.400.310.821.606; C21.613.415.738 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Salmonella Infections Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Food Poisoning Poisoning caused by ingestion of food harboring species of SALMONELLA. Conditions of raising, shipping, slaughtering, and marketing of domestic animals contribute to the spread of this bacterium in the food supply. T.NSalmonella enteritidis B03.440.450.425.800.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella A bacterium which is an etiologic agent of gastroenteritis in man and other animals. Salmonella (66-71) W]"|fSalmonella arizonae B03.440.450.425.800.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Salmonella Gram-negative rods widely distributed in lizards, snakes, and warm-blooded animals, and implicated in enteric, bone, and joint infections in man. Enterobacteriaceae (66-77); Salmonella (66-77) X"|7Salmonella B03.440.450.425.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Salmonella arizonae; Salmonella enteritidis; Salmonella hirschfeldii; Salmonella paratyphi A; Salmonella schottmuelleri; Salmonella typhi; Salmonella typhimurium A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. This genus is separated into serotypes or species on the basis of antigenic characteristics. Z"nSalmon B02.493.817.750.600.750 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes; Salmonidae; Oncorhynchus Oncorhynchus keta; Oncorhynchus kisutch Fish of the genera ONCORHYNCHUS and Salmo in the family SALMONIDAE. They are anadromous game fish, frequenting the coastal waters of both the North Atlantic and Pacific. They are known for their gameness as a sport fish and for the quality of their flesh as a table fish. (Webster, 3d ed). Salmonidae (68-71)  ] &H/\Salmine D12.776.660.750.740; D12.776.664.750.739 AAADAEAGAIANBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins; Protamines Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Protamines `< .BSalivation G10.261.862; G10.549.595 DEGEIMPHRE Sialorrhea; Xerostomia Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) aSalivary Proteins D12.776.850 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Glue Proteins, Drosophila Proteins found in saliva and the salivary glands. These proteins show some enzymatic activity, but their composition varies in different individuals. Proteins (66-76); Saliva (66-76); Salivary Glands (66-76)  bFDGSalivary Glands, Minor A10.336.779.650; A14.549.760.650 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Exocrine Glands; Salivary Glands Stomatognathic System; Mouth; Salivary Glands Accessory salivary glands located in the lip, cheek, tongue, floor of mouth, palate and intramaxillary. Salivary Glands (66-78) d&:|zSalivary Glands A10.336.779; A14.549.760 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Sialography Tissue Types (Non MeSH); Exocrine Glands Stomatognathic System; Mouth Parotid Gland; Salivary Glands, Minor; Sublingual Gland; Submandibular Gland Parotid Gland; Salivary Glands, Minor; Sublingual Gland; Submandibular Gland consider also terms at SIAL-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $fu8T&:Salivary Gland Neoplasms C04.588.443.591.824; C07.465.565.824; C07.465.815.718 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Parotid Neoplasms; Sublingual Gland Neoplasms; Submandibular Gland Neoplasms Parotid Neoplasms; Sublingual Gland Neoplasms; Submandibular Gland Neoplasms Parotid Neoplasms; Sublingual Gland Neoplasms; Submandibular Gland Neoplasms h=XSalivary Gland Fistula C07.465.614.655; C07.465.815.655; C23.439.600.655 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Oral Fistula (Non MeSH) Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Symptoms and General Pathology (Non MeSH); Fistula; Oral Fistula (Non MeSH) An abnormal passage between a salivary duct or gland and the cutaneous surface, or into the oral cavity through other than a normal pathway. (Dorland, 27th ed). kQ9NSalivary Gland Diseases C07.465.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Mikulicz' Disease; Parotid Diseases (+ 3); Salivary Gland Calculi (+ 1); Salivary Gland Fistula; Salivary Gland Neoplasms (+ 3); Sialadenitis; Sialometaplasia, Necrotizing; Sialorrhea; Submandibular Gland Diseases (+ 1); Xerostomia (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI mN/ZSalivary Gland Calculi C07.465.815.594; C23.146.805 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Symptoms and General Pathology (Non MeSH); Calculi Salivary Duct Calculi Salivary Duct Calculi Calculi occurring in a salivary gland. Most salivary gland calculi occur in the submandibular gland, but can also occur in the parotid gland and in the sublingual and minor salivary glands. Calculi (66-88); Salivary Duct Calculi (66-88); Salivary Gland Diseases (66-88)  p"R4`Salivary Duct Calculi C07.465.815.594.807; C23.146.805.807 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Salivary Gland Calculi Symptoms and General Pathology (Non MeSH); Calculi; Salivary Gland Calculi Small calculi found in the terminal salivary ducts may be referred to as salivary sand. Larger calculi (stones) are found in the larger ducts, such as Stensen's duct and Wharton's duct. r*RSaliva, Artificial D25.583.820 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Mouthwashes A solution used for irrigating the mouth in xerostomia and as a substitute for saliva. Saliva (66-83) u,CiSaliva A12.838.666 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH) vV "DSaline Solution, Hypertonic D26.394.225.766.314.890 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions; Hypertonic Solutions Hypertonic sodium chloride solution. A solution having an osmotic pressure greater than that of physiologic salt solution (0.9 g NaCl in 100 ml purified water). Hypertonic Solutions (66-74); Sodium Chloride (66-74) v!,s@Salicylic Acids D02.241.223.106.505.700; D02.241.511.390.700; D02.755.410.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids Aminosalicylic Acids (+ 1); Aspirin; Diflunisal; Salicylates (+ 1) Aminosalicylic Acids (+ 1); Aspirin; Diflunisal; Salicylates (+ 1) Aminosalicylic Acids (+ 1); Aspirin; Diflunisal; Salicylates (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR xE8,:Salicylates D02.241.223.106.505.700.710; D02.241.511.390.700.710; D02.755.410.700.710 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Salicylic Acids Sodium Salicylate Sodium Salicylate Sodium Salicylate The salts, esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $|Q8Kh>:Salicylanilides D02.065.199.860; D02.065.793.650 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Organic Chemicals (Non MeSH); Amides; Salicylamides Niclosamide; Oxyclozanide; Rafoxanide Niclosamide; Oxyclozanide; Rafoxanide 2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes. Salicylamides (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $&8wX:Salicylamides D02.065.793 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Salicylanilides (+ 3) Amides of salicylic acid. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8.!:Salaries and Fringe Benefits N01.824.417.700; N04.452.677.800 CLECHILJSNTD Income Population Characteristics (Non MeSH); Socioeconomic Factors; Income Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Family Leave (+ 1); Health Benefit Plans, Employee; Sick Leave Family Leave (+ 1); Health Benefit Plans, Employee; Sick Leave The remuneration paid or benefits granted to an employee. Income (68-77) CLECHILJOGSNSTTDUT (#& FSalamandridae B02.090.608.700 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela Notophthalmus viridescens; Pleurodeles; Salamandra; Triturus A family of Urodela consisting of 15 living genera and about 42 species and occurring in North America, Europe, Asia, and North Africa. &&&GSalamandra B02.090.608.700.610 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Salamandridae A genus of European newts in the Salamandridae family. The two species of this genus are Salamandra salamandra (European "fire" salamander) and Salamandra atra (European alpine salamander). Urodela (66-71) &7Saints K01.844.188.715 HI Humanities; Religion; Christianity Persons officially recognized or acknowledged as pre-eminent for consecration, holiness, and piety, especially through canonization by a branch of the Christian church. (From Webster, 3d ed). Religion and Medicine (66-94) A *$Saimirinae B02.649.801.400.120.710 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae Saimiri A subfamily of CEBIDAE inhabiting the forests of Central and South America. This subfamily of New World monkeys consists of one genus, the SAIMIRI or squirrel monkeys. ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI  &? (Saimiri B02.649.801.400.120.710.710 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae; Saimirinae A genus of the family CEBIDAE consisting of four species: S. boliviensis, S. orstedii (red-backed squirrel monkey), S. sciureus (common squirrel monkey), and S. ustus. They inhabit tropical rain forests in Central and South America. S. sciureus is used extensively in research studies. k (MPSAIDS Vaccines D24.310.894.899.790 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines Vaccines or candidate vaccines designed to prevent SAIDS (SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME) and containing inactivated SIV or type D retroviruses or some of their component antigens. Simian Acquired Immunodeficiency Syndrome/prevention and control (90-94); Viral Vaccines/immunology (91-94) }>l|Saguinus B02.649.801.400.120.114.710 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae; Callitrichinae A genus of CALLITRICHINAE consisting of 22 species and found in Panama as well as South America. Species seen most frequently in the literature are S. oedipus (cotton-top marmoset), S. nigricollis, and S. fusicollis. Callithricidae (75-80)  (QSafrole D03.383.246.680; D26.191.825; D26.456.599 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Dioxoles Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Miscellaneous Drugs and Agents (Non MeSH); Flavoring Agents 4-Allyl-1,2-methylenedioxybenzene. Constituent of several essential oils, notably sassafras; it has been used as a topical antiseptic; it is carcinogenic to the liver and is no longer used as a flavoring agent in foods. Dioxoles (69-74); Allyl Compounds (72-74)  1.3Safflower Oil D10.516.212.302.380.750; D10.516.212.507.750; D10.516.627.700.840; J01.740.250.700; J01.740.700.840 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils Xo@Safety Management G03.850.110.060.075.800; N04.452.871.900; N04.452.884 CLECHILJMTOGSNSTTDUT Environment and Public Health (Non MeSH); Public Health; Accidents; Accident Prevention; Safety Health Services Administration (Non MeSH); Organization and Administration; Risk Management Health Services Administration (Non MeSH); Organization and Administration The development of systems to prevent accidents, injuries, and other adverse occurrences in an institutional setting. The concept includes prevention or reduction of adverse events or incidents involving employees, patients, or facilities. Examples include plans to reduce injuries from falls or plans for fire safety to promote a safe institutional environment. Risk Management (66-93); Safety (66-93) =11Safety G03.850.110.060.075 Environment and Public Health (Non MeSH); Public Health; Accidents; Accident Prevention Safety Management CLECHILJMTOGSNSTTDUT  iSadism F03.709.597.608.700.660 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias A condition in which there is a derivation of pleasure from inflicting pain, discomfort or humiliation on another person or persons. The sexual significance of sadistic wishes or behavior may be conscious or unconscious. k FSacrum A02.835.232.834.717 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine  :DSacroiliac Joint A02.835.583.707 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints G81Sacrococcygeal Region A01.176.780 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Back ('Saccule and Utricle A09.246.631.909.625 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule Acoustic Maculae (+ 2) Two membranous sacs within the vestibule of the inner ear. The smaller, the saccule, lies near the opening of the scala vestibuli. The larger, the utricle, is in the superoposterior part of the vestibule. Both receive filaments from the acoustic nerve. Labyrinth (66-74); Saccule (75-82); Utricle (75-82)  :2,@Saccharopolyspora B03.100.067.790; B03.300.390.400.790; B03.510.415.400.790; B03.510.460.410.790 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH) A genus of gram-positive bacteria whose spores are round to oval and covered by a sheath. Streptomyces (88-91) X"mSaccharopine Dehydrogenases D08.586.682.107.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases N-5-(1,3-Dicarboxypropyl)-L-lysine:NAD(P)+ oxidoreductase (L-lysine-forming). Catalyzes the oxidative cleavage of saccharopine to lysine plus ketoglutaric acid. EC 1.5.1.7 requires NAD; EC 1.5.1.8 requires NADP. Ketoglutaric Acids (72-74); Lysine (70-74); Oxidoreductases (70-74)   FrQSaccharomycopsis B05.354.107.292.815; B05.354.930.710 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Algae and Fungi (Non MeSH); Fungi; Yeasts Yeast-like ascomycetous fungi of the family Saccharomycetaceae, order Endomycetales isolated from the stomach of rabbits. f*"Saccharomyces cerevisiae B05.354.107.292.785.800; B05.354.930.705.655 CHCLCYDEENGDGEIMIPMEPHPYREULVI Yeast, Dried Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales; Saccharomyces Algae and Fungi (Non MeSH); Fungi; Yeasts; Saccharomyces A species of the genus Saccharomyces, family Saccharomycetaceae, order Endomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Saccharomyces (66-71)  2"Saccharomyces B05.354.107.292.785; B05.354.930.705 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Algae and Fungi (Non MeSH); Fungi; Yeasts Saccharomyces cerevisiae Saccharomyces cerevisiae A genus of the family Saccharomycetaceae, order Endomycetales, class Ascomycetes. )*"8_Saccharin D09.818.738; D26.456.609.738 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Sweetening Agents Miscellaneous Drugs and Agents (Non MeSH); Flavoring Agents; Sweetening Agents 1,2-Benzoisothiazol-3(2H)-one 1,1-dioxide. Flavoring agent and non-nutritive sweetener. Sweetening Agents (66-69)  ".eSaccades G11.697.384.500 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements An abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading. x rqS-Adenosylmethionine Decarboxylase D08.586.520.258.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases An enzyme that catalyzes the decarboxylation of S-adenosyl-L-methionine to yield 5'-deoxy-(5'-),3-aminopropyl-(1), methylsulfonium salt. It is one of the enzymes responsible for the synthesis of spermidine from putrescine. EC 4.1.1.50. S-Adenosylmethionine (72-74); Carboxy-Lyases (70-74) 'Fa=S-Adenosylmethionine D12.125.166.676.180; D13.570.583.138.264; D13.570.800.096.264 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Methionine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Adenosine 5'-((3-Amino-3-carboxypropyl)methylsulfonio)-5'-deoxyadenosine hydroxide, inner salt. Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed). Adenosine (66-70); Methionine (66-70) EHOt.S-Adenosylhomocysteine D12.125.166.498.050; D13.570.583.138.240; D13.570.800.096.240 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Homocysteine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Adenosine 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. Adenosine (72-74); Homocysteine (72-74) E:Q0S Phase G04.335.135.500.800; G05.148.165.500.800; G07.553.135.500.800 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Interphase Genetics; Cytogenetics; Cell Cycle; Interphase Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Interphase Phase of the cell cycle following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome. Cell Division (66-77); Interphase (78-90)  E13Rye B06.510.253.780; J01.341.182.780 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals A hardy cereal crop, Secale cereale, grown in northern climates. It is the most frequent host to ergot (CLAVICEPS), the toxic fungus. Its hybrid with wheat is triticale, another cereal grain. X&4nRyanodine D03.132.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Dodecahydro-4,6,7,8A,8B,9A-hexahydroxy-7-isopropyl-3,6A,9-trimethyl-6,9-methanobenzo(1,2)pentaleno(1,6-BC)furan-8-yl ester of pyrrole-2-carboxylic acid. Insecticidal alkaloid isolated from Ryania speciosa; proposed as a myocardial depressant. Synonyms: Ryanex; Ryania. Alkaloids (70-74) / :(+Rwanda Z01.058.290.120.680 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern  _Rutin D09.203.408.134.779; D11.786.170.804 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Bioflavonoids Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Bioflavonoids Hydroxyethylrutoside 3-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one. Found in many plants, including buckwheat, tobacco, forsythia, hydrangea, pansies, etc. It has been used therapeutically to decrease capillary fragility. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR   *@<DRuthenium Red D01.210.837; D01.625.800; D01.765.765; D26.408.800; D26.550.800 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH) Inorganic Chemicals (Non MeSH); Nitrogen Compounds Inorganic Chemicals (Non MeSH); Ruthenium Compounds Miscellaneous Drugs and Agents (Non MeSH); Dyes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Ruthenium chloride hydroxide heptaammoniate trihydrate. It is used in microscopy as a reagent and stain for pectin, gum, animal tissues and bacteria. Ruthenium (72-74) òK.HRuthenium Radioisotopes D01.496.749.745 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of ruthenium that decay or disintegrate emitting radiation. Ru atoms with atomic weights 93-95, 97, 103, and 105-108 are radioactive ruthenium isotopes. Radioisotopes (66-87); Ruthenium (66-87) r4C1Ruthenium Compounds D01.765 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Ruthenium Red Inorganic compounds that contain ruthenium as an integral part of the molecule. Ruthenium (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $7 8%_:Ruthenium D01.268.758; D01.552.767 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals ɧ :`Rutamycin D08.373.936.610.700; D20.085.062.840; D20.136.073.840 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Oligomycins Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal A macrolide antibiotic of the oligomycin group, obtained from Streptomyces rutgersensis. It is used in cytochemistry as a tool to inhibit various ATPases and to uncouple oxidative phosphorylation from electron transport and also clinically as an antifungal agent. Antibiotics, Antifungal (69-74) ʋ =<2%Russia (Pre-1917) Z01.586.800 EHEP Geographicals (Non MeSH); Historical Geographicals (Non MeSH) ͑IRussia Z01.542.248.775; Z01.586.200.775; Z01.586.950.775 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR Bashkiria; Dagestan; Moscow; Siberia Bashkiria; Dagestan; Moscow; Siberia Bashkiria; Dagestan; Moscow; Siberia & 9Russell's Viper B02.833.672.875.750 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes; Viperidae A genus of snakes of the family VIPERIDAE. It is distributed in West Pakistan, most of India, Burma, Ceylon, Thailand, southeast China, Taiwan, and a few islands of Indonesia. It hisses loudly when disturbed and strikes with great force and speed. Very prolific, it gives birth to 20-60 young. This viper is the leading cause of snakebite in India and Burma. (Moore: Poisonous Snakes of the World, 1980). Snakes (66-93) &2Rural Population N01.600.725 CLHISNTD Population Characteristics (Non MeSH); Population The inhabitants of rural areas or of small towns classified as rural. ҷ ;URural Health N01.407.540.750 CLHISNSTTD Agricultural Workers' Diseases Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health Use for articles dealing only with the problems of health in rural areas. Ӛ$]ZRupture, Spontaneous C23.739.789 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Tear or break of an organ, vessel or other soft part of the body, occurring in the absence of external force. NYRupture C21.866.761 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Aortic Rupture; Splenic Rupture (+ 1); Stomach Rupture; Uterine Rupture (+ 1) Forcible or traumatic tear or break of an organ or other soft part of the body. F NQ`cRunning I03.450.642.845.610 CLECEDHIINLJPHPXSNSTTD Track and Field Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Jogging A sport in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace. Sports (66-75) $ R Runaway Reaction F03.126.842.688; F03.234.193.560 Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders; Child Reactive Disorders A behavioral response manifested by leaving home in order to escape from threatening situations. Children or adolescents leaving home without permission is usually implied. Child Behavior Disorders (66-68) &'Ruminants B02.649.077.380 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla Antelopes; Bison; Buffaloes; Camelids, New World; Camels; Cattle; Deer (+ 2); Goats; Sheep A suborder of the order ARTIODACTYLA whose members have the distinguishing feature of a four-chambered stomach. Horns or antlers are usually present, at least in males. Artiodactyla (66-86)   (*sRumen A13.869.804 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Stomach, Ruminant  :5Rubredoxins D12.776.097.350.650; D12.776.157.435.319.654; D12.776.556.580.302.654 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins; Ferredoxins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Iron-Sulfur Proteins; Ferredoxins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins; Iron-Sulfur Proteins; Ferredoxins ޕMBfRubivirus Infections C02.782.930.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Togaviridae Infections Rubella (+ 1) Virus diseases caused by the RUBIVIRUS genus, of the family TOGAVIRIDAE. PVWRubivirus B04.820.850.700; B04.909.777.923.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae Rubella Virus Rubella Virus A genus of the family TOGAVIRIDAE containing only one recognized species, RUBELLA VIRUS. Transmission is primarily by aerosolization.  *w"Rubinstein-Taybi Syndrome C05.116.099.370.797; C10.496.830; C16.131.077.804; F03.709.346.854 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An autosomal recessive disorder usually occurring in males and characterized mainly by motor and mental retardation, broad thumbs, webbing of fingers and toes, facial and skeletal abnormalities. Abnormalities, Multiple (68-71); Mental Retardation (66-71) LLRFRubidium Radioisotopes D01.496.749.740 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of rubidium that decay or disintegrate emitting radiation. Rb atoms with atomic weights 79-84, and 86-95 are radioactive rubidium isotopes. Radioisotopes (66-87); Rubidium (66-87) "4C0Rubidium D01.268.549.650; D01.552.528.759 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Alkali Inorganic Chemicals (Non MeSH); Metals; Metals, Alkali Rubidium. An element that is an alkali metal. It has an atomic symbol Rb, atomic number 37, and atomic weight 85.47. It is used as a chemical reagent and in the manufacture of photoelectric cells.  &:Rubella Virus B04.820.850.700.700; B04.909.777.923.700.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Rubivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Rubivirus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. 2Rubella Vaccine D24.310.894.899.779 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines Rubella Virus (66-68); Viral Vaccines (66-68) >l8Rubella Syndrome, Congenital C02.782.930.700.700.700; C16.131.077.790 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Togaviridae Infections; Rubivirus Infections; Rubella Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Transplacental infection of the fetus with rubella usually in the first trimester of pregnancy, as a consequence of maternal infection, resulting in various developmental abnormalities in the newborn infant. They include cardiac and ocular lesions, deafness, microcephaly, mental retardation, and generalized growth retardation. (From Dorland, 27th ed). Rubella/congenital (66-86); Syndrome (72-86) ".N6Rubella C02.782.930.700.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Togaviridae Infections; Rubivirus Infections Rubella Syndrome, Congenital An acute, usually benign, infectious disease caused by the RUBELLA VIRUS and most often affecting children and nonimmune young adults, in which the virus enters the respiratory tract via droplet nuclei and spreads to the lymphatic system. (From Dorland, 27th edition). ~ Po";Rubber Dams E06.186.670; E07.222.670 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Dental Equipment Equipment and Supplies; Dental Equipment Sheets of latex rubber punched and placed over the teeth during dental procedures to isolate the field of operation from the rest of the oral cavity (Jablonski; Illustrated Dictionary of Dentistry, 1982). Rubber dams are useful in preventing the swallowing of instruments or restorations during dental work. Dental Materials (66-77); Dentistry, Operative/instrumentation (77-91) QiRRubber D25.720.840; J01.637.767 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Neoprene; Polystyrenes; Polyurethanes; Silicone Elastomers cis-1,4-Polyisoprene. A high-molecular-weight polymeric elastomer originally obtained from the milk juice (LATEX) of Hevea brasiliensis and other trees. Synthetic elastomers are made from synthetic latexes, not necessarily polyisoprene. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  ` ,F.rRNA Operon G05.275.201.800.575.817; G05.275.470.790.675.817; G05.275.769.817; G05.331.599.110.689.675.817; G06.184.599.110.689.675.817 DEGEIMPHRE Genetics; Genes; Genes, Bacterial; Regulon; Operon Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid; Promoter Regions (Genetics) Genetics; Genes; Operon Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid; Promoter Regions (Genetics) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid; Promoter Regions (Genetics) Genetic loci which direct transcription and translation of ribosomal RNA in bacterial operons. They are designated rrnB, rrnC, rrnD, etc. according to the structural position of the transcription unit in the DNA sequence. Operon (77-87); Promoter Regions (Genetics) (85-87); RNA, Ribosomal (77-87) K[Roxithromycin D20.085.115.250.630 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Erythromycin Erythromycin, 9-(O-((2-methoxyethoxy)methyl)oxime). Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections. Leucomycins (81-89) d:TvRoxarsone D02.691.088.700; D21.370.400.820 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 4-Hydroxy-3-nitrobenzenearsonic acid. An arsenic derivative which has anticoccidial and promotes growth in animals. Synonym: 3 Nitro. Arsenicals (70-74); Nitrophenols (72-74)  &:1Round Window A09.246.631.246.814 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea Fenestra of the cochlea; an opening in the medial wall of the middle ear leading into the cochlea. Cochlea (66-78) :0yRound Ligament A02.513.803; A05.360.319.114.803 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Ligaments Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri A fibromuscular band that attaches to the uterus and then passes along the broad ligament, out through the inguinal ring, and into the labium majus. &:pRotifera B01.500.770 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths A class of minute animals of the phylum Aschelminthes. Aschelminthes (75-76); Invertebrates (66-74)  *C5Rotenone D05.723.491.324.736 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Botanical  :rRotavirus Infections C02.782.791.814 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Reoviridae Infections Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice. Diarrhea (66-82); Reovirus Infections (68-82); Rotaviruses (81-82) PUPRotavirus B04.820.630.790; B04.909.777.714.790 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae A genus of REOVIRIDAE, causing acute gastroenteritis in birds and mammals, including humans. Transmission is horizontal and by environmental contamination. Reoviridae (66-77)  *uRotator Cuff A02.633.837.781.650 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Tendons; Tendons, Para-Articular The musculotendinous sheath formed by the supraspinatus, infraspinatus, subscapularis, and teres minor muscles. These help stabilize the head of the humerus in the glenoid fossa and allow for rotation of the shoulder joint about its longitudinal axis. Shoulder Joint (66-91); Tendons, Para-Articular (72-91)  r:M%BRotation H01.671.538.703 AE Centrifugation; Gravity, Altered Physical Sciences (Non MeSH); Physics; Motion Motion of a rigid body in which either one point is fixed, or all the points on a straight line are fixed. It is also the motion of a particle about a fixed point. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Acceleration (66-67); Aerospace Medicine (66-67)    '9:Ross River Virus B04.820.850.054.813; B04.909.777.923.054.813 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus A species of ALPHAVIRUS associated with epidemic exanthema and polyarthritis in Australia. 2jRosette Formation E05.478.810 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Immunologic Techniques The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immune Adherence Reaction (71-77) >"F0(Rosenzweig Picture-Frustration Study F04.711.647.622.550 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Projective Techniques A projective test depicting cartoon-like characters in frustrating situations. The scoring of the subject's responses indicates the direction of hostility or aggression, that is, whether he blames himself, the other person, or the set of circumstances. J* %Rose Bengal D03.494.953.275.700; D04.615.885.347.700; D26.408.348.514.775; D26.550.342.700 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Fluoresceins Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Fluoresceins 4,5,6,7-Tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one dipotassium salt. A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid. _X.Rosaniline Dyes D26.408.735 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes Gentian Violet; Methyl Green Any dye or mixture of dyes made from rosaniline, a red triphenylmethane aniline derivative; used to color fabrics, paper and as biological stain; also used as disinfectant and topical antifungal agent. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  ,;$.Rorschach Test F04.711.647.622.341.736 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Projective Techniques; Ink Blot Tests A projective test used to evaluate a broad range of personality variables including pathology of thought and perception. The subject's responses to inkblot prints are scored along with subjective interpretation by the test administrator.  Root Resorption C07.793.901.653; G10.549.917.653 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tooth Root Stomatognathic Diseases; Tooth Diseases; Tooth Resorption Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH); Tooth Resorption Resorption in which cementum or dentin is lost from the root of a tooth owing to cementoclastic or osteoclastic activity in conditions such as trauma of occlusion or neoplasms. (Dorland, 27th ed). &NRoot Planing E06.721.189.350.650; E06.721.874.650; E06.761.227.350.650 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Periodontics; Dental Prophylaxis; Dental Scaling Dentistry; Periodontics; Subgingival Curettage Dentistry; Preventive Dentistry; Dental Prophylaxis; Dental Scaling A procedure for smoothing of the roughened root surface or cementum of a tooth after subgingival curettage or scaling, as part of periodontal therapy. Tooth Root (66-91) A$Root Caries C07.793.720.210.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dental Caries Stomatognathic Diseases; Tooth Diseases; Tooth Demineralization; Dental Caries Dental caries involving the tooth root, cementum, or cervical area of the tooth. Dental Caries (66-92); Tooth Root (66-92)  !(N\a4Root Canal Therapy E06.397.778 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Endodontics Dental Pulp Devitalization; Root Canal Obturation (+ 1) "$CRoot Canal Obturation E06.397.778.778 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Endodontics; Root Canal Therapy Retrograde Obturation #$4Root Canal Irrigants D25.339.888 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials Chemicals used to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, EDTA, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. Irrigation (66-83); Root Canal Therapy (66-83) $[,I9Root Canal Filling Materials D25.339.859 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials Gutta-Percha Dental Materials (66-69) &I#*IRooming-in Care N02.421.088.120.240 CLECHILJMAMTOGPXSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Child Care; Infant Care Care of the newborn infant in a crib near the mother's bed, instead of in a nursery, during the hospital stay. 'CiRonidazole D02.640.672.730; D03.383.374.658.730; D21.370.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents 1-Methyl-5-nitroimidazole-2-methanol carbamate ester. Antiprotozoal and antimicrobial agent used mainly in veterinary practice. Synonyms: Dugo; Ridzol(e). Carbamates (74); Nitroimidazoles (74) (9:.Rome Z01.433.850; Z01.542.489.569 EHEP Geographicals (Non MeSH); Cities (Non MeSH) Geographicals (Non MeSH); Europe; Italy +"fRomania Z01.542.248.764 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern + =Roman World I01.076.201.450.226.600 HI Social Sciences; Anthropology; Anthropology, Cultural; Culture; Civilization A historical and cultural entity dispersed across a wide geographical area under the political domination and influence of ancient Rome, bringing to the conquered people the Roman civilization and culture from 753 B.C. to the beginning of the imperial rule under Augustus in 27 B.C. The early city built on seven hills grew to conquer Sicily, Sardinia, Carthage, Gaul, Spain, Britain, Greece, Asia Minor, etc., and extended ultimately from Mesopotamia to the Atlantic. Roman medicine was almost entirely in Greek hands, but Rome, with its superior water system, remains a model of sanitation and hygiene. (From A. Castiglioni, A History of Medicine, 2d ed; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed). ,PZYRolitetracycline D20.085.868.753 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines 4S-(4 alpha, 4a alpha,5a alpha,6 beta,12a alpha))-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide. A semisynthetic antibiotic prepared from tetracycline. It is usually administered as an injection. 0W::GRole Playing F04.754.864.581.679.653 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy; Psychotherapy, Group; Psychodrama The adopting or performing the role of another significant individual in order to gain insight into the behavior of that person. 2\Role F01.829.316.616 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes Physician's Role; Sick Role The expected and characteristic pattern of behavior exhibited by an individual as a member of a particular social group. Psychology, Social (66-68) 3`# Rods and Cones A08.663.694.530.650.700; A08.800.550.700.730.750; A09.371.729.778; A11.671.677.530.650.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Retinal Pigments Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Photoreceptors Sense Organs; Eye; Retina Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors Cones (Retina); Rods (Retina) (+ 1) Cones (Retina); Rods (Retina) (+ 1) Cones (Retina); Rods (Retina) (+ 1) Cones (Retina); Rods (Retina) (+ 1) The two photoreceptor cell types of the vertebrate retina. Rods have a rod-shaped outer segment containing stacks of pigmented disks which are separate from the outer cell membrane. They are specialized for vision in dim illumination. Cones have a cone-shaped outer segment with pigment contained in invaginations of the outer cell membrane. They mediate high-acuity vision. The rods and cones, as is the retina itself, are part of the central rather than the peripheral nervous system.  5Fd8I;Rods (Retina) A08.663.694.530.650.700.700; A08.800.550.700.730.750.750; A09.371.729.778.760; A11.671.677.530.650.700.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors; Rods and Cones Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Photoreceptors; Rods and Cones Sense Organs; Eye; Retina; Rods and Cones Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors; Rods and Cones Rod Outer Segments Rod Outer Segments Rod Outer Segments Rod Outer Segments One of the two photoreceptor cell types of the vertebrate retina. In rods the photopigment is in stacks of membranous disks separate from the outer cell membrane. Rods are more sensitive to light than cones, but rod mediated vision has less spatial and temporal resolution than cone vision. Photoreceptors (71-93); Rods and Cones (66-93)  :lt8ZX9Rodenticides D05.723.853 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Rodent Control Environmental Pollutants, Pesticides (Non MeSH); Pesticides Warfarin Substances used to destroy or inhibit the action of rats, mice, or other rodents. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $>8F c:Rodentia B02.649.865 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Chinchilla; Dipodomys; Guinea Pigs; Muridae (+ 52); Sciuridae (+ 1) A mammalian order which consists of 29 families and many genera. @a (UORodent Diseases C22.795 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Ectromelia, Infectious; Murine Acquired Immunodeficiency Syndrome Diseases of rodents of the order RODENTIA. This term includes diseases of Sciuridae (squirrels), Geomyidae (gophers), Heteromyidae (pouched mice), Castoridae (beavers), Cricetidae (rats and mice), Muridae (Old World rats and mice), Erethizontidae (porcupines), and Caviidae (guinea pigs). BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  A HKRJRodent Control G03.850.780.200.650.700 ECHIISLJMTOGSNSTTD Rodenticides Rats Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Pest Control The reduction or regulation of the population of noxious, destructive, or dangerous rodents through chemical, biological, or other means.  DRod Outer Segments A08.663.694.530.650.700.700.700; A08.800.550.700.730.750.750.700; A09.371.729.778.760.700; A11.671.677.530.650.700.700.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors; Rods and Cones; Rods (Retina) Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Photoreceptors; Rods and Cones; Rods (Retina) Sense Organs; Eye; Retina; Rods and Cones; Rods (Retina) Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors; Rods and Cones; Rods (Retina) The portion of the retinal rod cell between the inner segment and the pigment epithelium layer of the retina. Rods and Cones (66-80) E8Rocky Mountain Spotted Fever C01.252.400.810.700.810.800.830; C01.252.400.825.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rickettsia Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases An acute febrile illness caused by RICKETTSIA RICKETTSII. It is transmitted to humans by bites of infected ticks and occurs only in North and South America. Characteristics include a sudden onset with headache and chills and fever lasting about two to three weeks. A cutaneous rash commonly appears on the extremities and trunk about the fourth day of illness. I[#:PRochalimaea quintana B03.700.651.801.700.750.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Rochalimaea A species of gram-negative bacteria in which man is the primary host and the human body louse, Pediculus humanus, the principal vector. It is the etiological agent of TRENCH FEVER. Rickettsia (66-89); Rickettsiaceae (90-94) M`"|3Rochalimaea Infections C01.252.400.810.700.810.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections Angiomatosis, Bacillary; Cat-Scratch Disease; Trench Fever Infections by the genus ROCHALIMAEA. ROCHALIMAEA QUINTANA causes TRENCH FEVER, while ROCHALIMAEA HENSELAE is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY) and is also one of the causes of CAT-SCRATCH DISEASE in immunocompetent patients. Rickettsia Infections (66-89); Rickettsiaceae Infections (90-94)  OgPE.KRochalimaea henselae B03.700.651.801.700.750.350 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Rochalimaea A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY). This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients. Rickettsiaceae (92-94); Rickettsieae (92-94) R"|5Rochalimaea B03.440.400.425.750; B03.700.651.801.700.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae  Rochalimaea henselae; Rochalimaea quintana A genus of gram-negative, rod-shaped bacteria. These organisms are commonly found extracellularly in the arthropod host and are capable of growth in a cell-free medium. The species ROCHALIMAEA QUINTANA causes TRENCH FEVER, while ROCHALIMAEA HENSELAE is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY) and is also one of the causes of CAT-SCRATCH DISEASE in immunocompetent patients. Rickettsiaceae (78-94); Rickettsieae (92-94)  T2"35ROC Curve E05.318.780.800.750; G03.850.520.840.800.750; H01.548.832.803; N05.715.360.780.700.680 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH); Sensitivity and Specificity Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH); Sensitivity and Specificity Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH); Sensitivity and Specificity A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. X`! Robotics H01.288.643; J01.897.104.834; L01.700.568.110.065.630 CLECEDHIISLJMAMTOGSNSTTDUT Physical Sciences (Non MeSH); Electronics Technology, Industry, Agriculture (Non MeSH); Technology; Automation Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Artificial Intelligence The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses. Automation (66-86); Bionics (66-86) \S =L,Robenidine D02.078.370.810; D21.370.400.810 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 1,3-Bis[(p-chlorobenzylidene)amino]guanidine monohydrochloride. An anticoccidial agent mainly for poultry. Synonyms: Cytostat; Robenz. Chlorobenzenes (74); Guanidines (71-74) _r&:0Ro 4-1284 D03.438.834.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolizines 2-Hydroxy-2-ethyl-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11B-hexahydro-2H-benzo(A)quinolizine. Proposed catecholamine depletor. Quinolizines (70) a^:XRO 20-1724 D03.383.374.790 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone. Inhibitor of phosphodiesterases. Benzyl Compounds (72-74); Ethers (74); Imidazoles (72-74) b:V[GRNA, Viral D13.444.735.828 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, Viral Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Ribonucleic acid that makes up the genetic material of viruses. dPDZMRNA, Transfer, Val D13.444.735.757.700.900 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying valine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) eD<RNA, Transfer, Tyr D13.444.735.757.700.750 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying tyrosine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) gD<RNA, Transfer, Trp D13.444.735.757.700.740 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying tryptophan to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) iD<RNA, Transfer, Thr D13.444.735.757.700.725 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying threonine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) kD<RNA, Transfer, Ser D13.444.735.757.700.700 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying serine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) mD<RNA, Transfer, Pro D13.444.735.757.700.660 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying proline to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) oD<RNA, Transfer, Phe D13.444.735.757.700.650 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying phenylalanine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) q{D<RNA, Transfer, Methyltransferases D08.586.913.517.702 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases s|'FkRNA, Transfer, Met D13.444.735.757.700.525 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying methionine to sites on the ribosomes in preparation for protein elongation. Initiation of protein synthesis uses tRNA(f)Met in prokaryotic cells and tRNA(i)Met in eukaryotic cells. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) tD <RNA, Transfer, Lys D13.444.735.757.700.510 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying lysine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) wD<RNA, Transfer, Leu D13.444.735.757.700.500 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying leucine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) xD<RNA, Transfer, Ile D13.444.735.757.700.480 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying isoleucine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) zD<RNA, Transfer, His D13.444.735.757.700.450 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying histidine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) |D<RNA, Transfer, Gly D13.444.735.757.700.420 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) ~D<RNA, Transfer, Glu D13.444.735.757.700.410 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying glutamic acid to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) D<RNA, Transfer, Gln D13.444.735.757.700.400 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying glutamine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) D<RNA, Transfer, Cys D13.444.735.757.700.200 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying cysteine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) D<RNA, Transfer, Asp D13.444.735.757.700.090 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying aspartic acid to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) D<RNA, Transfer, Asn D13.444.735.757.700.085 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying asparagine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) D<RNA, Transfer, Arg D13.444.735.757.700.075 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying arginine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) D<RNA, Transfer, Amino Acyl D12.125.780; D13.444.735.757.715 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer Intermediates in protein biosynthesis. The compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase. They are key compounds in the genetic translation process. Amino Acids (66-77); RNA, Transfer (66-77)  &D5RNA, Transfer, Amino Acid-Specific D13.444.735.757.700 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer RNA, Transfer, Ala; RNA, Transfer, Arg; RNA, Transfer, Asn; RNA, Transfer, Asp; RNA, Transfer, Cys; RNA, Transfer, Gln; RNA, Transfer, Glu; RNA, Transfer, Gly; RNA, Transfer, His; RNA, Transfer, Ile; RNA, Transfer, Leu; RNA, Transfer, Lys; RNA, Transfer, Met; RNA, Transfer, Phe; RNA, Transfer, Pro; RNA, Transfer, Ser; RNA, Transfer, Thr; RNA, Transfer, Trp; RNA, Transfer, Tyr; RNA, Transfer, Val A group of transfer RNAs which are specific for carrying each one of the 20 amino acids to the ribosome in preparation for protein synthesis. Amino Acids (66-87); Amino Acyl T RNA (78-87); RNA, Transfer (72-87)  y)DlVRNA, Transfer, Ala D13.444.735.757.700.050 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer; RNA, Transfer, Amino Acid-Specific A transfer RNA which is specific for carrying alanine to sites on the ribosomes in preparation for protein synthesis. Amino Acyl T RNA (78-87); RNA, Transfer (66-87) tD<RNA, Transfer D13.444.735.757 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Anticodon; RNA, Transfer, Amino Acid-Specific (+ 20); RNA, Transfer, Amino Acyl oDZ`RNA, Small Nuclear D13.444.735.628.818 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Nuclear Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus. RNA (66-85); RNA, Messenger (66-85) Dk|-RNA, Ribosomal, 5S D13.444.735.686.650 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal Constituent of 50S subunit of prokaryotic ribosomes containing about 120 nucleotides and 34 proteins. 5S rRNA is involved in initiation of polypeptide synthesis. RNA, Ribosomal (71-87); RNA (66-70) cDm-RNA, Ribosomal, 5.8S D13.444.735.686.660 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal Constituent of the 60S subunit of eukaryotic ribosomes. 5.8S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes. RNA, Ribosomal (71-87); RNA (66-70) TDm-RNA, Ribosomal, 28S D13.444.735.686.690 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal Constituent of the 60S subunit of eukaryotic ribosomes. 28S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes. RNA, Ribosomal (71-87); RNA (66-70) *Dm-RNA, Ribosomal, 23S D13.444.735.686.680 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal Constituent of 50S subunit of prokaryotic ribosomes containing about 3200 nucleotides. 23S rRNA is involved in the initiation of polypeptide synthesis. RNA, Ribosomal (71-87); RNA (66-70) Dm-RNA, Ribosomal, 18S D13.444.735.686.675 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal Constituent of the 40S subunit of eukaryotic ribosomes. 18S rRNA is involved in the initiation of polypeptide synthesis in eukaryotes. RNA, Ribosomal (71-87); RNA (66-70) Dm-RNA, Ribosomal, 16S D13.444.735.686.670 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis. RNA, Ribosomal (71-87); RNA (66-70) Dm-RNA, Ribosomal D13.444.735.686 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ribosomes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA RNA, Catalytic; RNA, Ribosomal, 5S; RNA, Ribosomal, 5.8S; RNA, Ribosomal, 16S; RNA, Ribosomal, 18S; RNA, Ribosomal, 23S; RNA, Ribosomal, 28S Ribosomes (66-70); RNA (66-70)  D Z'RNA, Protozoan D13.444.735.650 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Ribonucleic acid in protozoa having regulatory and catalytic roles as well as involvement in protein synthesis. RNA (66-90); specific protozoa (66-90) mDZ0RNA, Plant D13.444.735.635 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA RNA, Chloroplast Ribonucleic acid in plants having regulatory and catalytic roles as well as involvement in protein synthesis. specific plant (66-94); Plants (66-94); RNA (66-94)   DZARNA, Nuclear D13.444.735.628 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA RNA, Heterogeneous Nuclear; RNA, Small Nuclear RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm. Cell Nucleus (66-88); Chromosomes (66-88); RNA (66-88)  DZ8nDRNA, Neoplasm D13.444.735.615 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Neoplasms Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA D ZRNA, Messenger D13.444.735.544 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Codon (+ 3); RNA Caps (+ 1) RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. DZ'RNA, Heterogeneous Nuclear D13.444.735.628.806 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Nuclear Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesized and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnRNA hybridizes with nuclear DNA rather than with mRNA. RNA (66-78) n DkTRNA, Helminth D13.444.735.520 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Ribonucleic acid in helminths having regulatory and catalytic roles as well as involvement in protein synthesis. RNA (66-94) DZRNA, Guide D13.444.735.510 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR RNA Editing Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Small kinetoplastid mitochondrial RNA that plays a major role in RNA EDITING. These molecules form perfect hybrids with edited mRNA sequences and possess nucleotide sequences at their 5'-ends that are complementary to the sequences of the mRNA's immediately downstream of the pre-edited regions. RNA (90-92)  ]DZWRNA, Fungal D13.444.735.500 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Ribonucleic acid in fungi having regulatory and catalytic roles as well as involvement in protein synthesis. RNA (66-79) DZRNA, Double-Stranded D13.444.735.490 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms. RNA (66-79) 7DZ{RNA, Complementary D13.444.600.723.480; D13.444.735.480; D26.651.600.723.480 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes; RNA Probes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes; RNA Probes Synthetic transcripts of a specific DNA molecule or fragment, made by an in vitro transcription system. This cRNA can be labeled with radioactive uracil and then used as a probe. (A Dictionary of Genetics, 4th ed). specific RNA (74-93); RNA (74-93) ADA+RNA, Chloroplast D13.444.735.476; D13.444.735.635.575 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Plant Ribonucleic acid in chloroplasts having regulatory and catalytic roles as well as involvement in protein synthesis. Chloroplasts (66-94); RNA (66-94) *D*RNA, Catalytic D08.586.913.696.445.735.700; D13.444.735.686.175 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Ribosomal RNA which contains an intron sequence that has an enzyme-like catalytic activity. This intron sequence has been shown to fold up to form a complex surface that can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein. RNA Splicing (86-90); RNA, Ribosomal (86-90) 6DY7RNA, Bacterial D13.444.735.473 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis. UDZRNA, Antisense D13.150.650; D13.444.735.150 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Antisense Elements (Genetics) Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA An RNA molecule which, by binding to a complementary sequence in either RNA or DNA, inhibits the function and/or completion of synthesis of the latter molecule. It is involved in various regulatory systems in vivo. Artificial antisense RNAs have been used to inhibit translation of specific mRNA molecules both in living cells (eukaryotic and bacterial) and in cell-free systems. RNA (85-90) Ŀ"DRNA-Binding Proteins D12.776.157.725 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Proteins which bind to RNA molecules. Certain structure motifs are common to several of the proteins, such as arginine (Arg)-rich tracts, typically consisting of alternating Arg-Asp, Arg-Ser, or Arg-Gly residues. These proteins also tend to have a common ribonucleotide sequence domain. Carrier Proteins (71-91); RNA (66-91) DYN/RNA Viruses B04.820; B04.909.777 CHCLDEENGDGEIMIPMEPHPYREUL Viruses Viruses; Vertebrate Viruses (Non MeSH) Arenaviridae (+ 7); Arterivirus (+ 3); Astroviruses; Birnaviridae (+ 3); Bunyaviridae (+ 15); Caliciviridae (+ 6); Carlavirus; Closterovirus; Coronaviridae (+ 11); Cystoviridae (+ 1); Flaviviridae (+ 14); Leviviridae (+ 2); Luteovirus; Mononegavirales (+ 32); Mosaic Viruses (+ 9); Nepovirus; Orthomyxoviridae (+ 7); Picobirnavirus; Picornaviridae (+ 23); Potexvirus; Reoviridae (+ 10); Retroviridae (+ 62); Togaviridae (+ 10); Tombusvirus Arenaviridae (+ 7); Arterivirus (+ 3); Astroviruses; Birnaviridae (+ 3); Bunyaviridae (+ 14); Caliciviridae (+ 6); Coronaviridae (+ 11); Delta Agent; Encephalitis Viruses (+ 11); Flaviviridae (+ 14); Mononegavirales (+ 32); Orthomyxoviridae (+ 7); Picobirnavirus; Picornaviridae (+ 24); Reoviridae (+ 10); Retroviridae (+ 62); Togaviridae (+ 10) Viruses whose genetic material is RNA. U80RNA Virus Infections (Non MeSH) C02.782 Virus Diseases Arenaviridae Infections (+ 3); Arterivirus Infections; Birnaviridae Infections; Bunyaviridae Infections (+ 8); Caliciviridae Infections (+ 2); Coronaviridae Infections (+ 5); Delta Infection; Encephalitis, Epidemic (+ 5); Flaviviridae Infections (+ 15); Hemorrhagic Fevers, Viral (+ 9); Mononegavirales Infections (+ 18); Orthomyxoviridae Infections (+ 2); Picornaviridae Infections (+ 17); Reoviridae Infections (+ 4); Retroviridae Infections (+ 24); Togaviridae Infections (+ 6) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI ' 9ZRNA Splicing G05.331.370.380.812.610 DEGEIMPHRE RNA Precursors; Spliceosomes Spliceosomes Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; RNA Processing, Post-Transcriptional Alternative Splicing The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm. Base Sequence (76-81); Nucleic Acid Precursors (76-81); RNA, Messenger (76-81); Transcription, Genetic (76-81) (#RNA Replicase D08.586.913.696.445.735.780 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases RNA Nucleotidyltransferases (69-74) IF)RNA Processing, Post-Transcriptional G05.331.370.380.812 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation RNA Editing; RNA Splicing (+ 1) Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein. Nucleic Acid Precursors (75-82); RNA, Messenger (66-82); Transcription, Genetic (73-82)  ճ*Z)%hRNA Probes D13.444.600.723; D26.651.600.723 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes RNA, Complementary RNA, Complementary RNA, usually prepared by transcription from cloned DNA, which complements a specific mRNA or DNA and is generally used for studies of virus genes, distribution of specific RNA in tissues and cells, integration of viral DNA into genomes, transcription, etc. Whereas DNA PROBES are preferred for use at a more macroscopic level for detection of the presence of DNA/RNA from specific species or subspecies, RNA probes are preferred for genetic studies. Conventional labels for the RNA probe include radioisotope labels 32P and 125I and the chemical label biotin. RNA probes may be further divided by category into plus-sense RNA probes, minus-sense RNA probes, and antisense RNA probes. Nucleic Acid Hybridization (72-88); RNA, Messenger (72-88)  =&D,FRNA Precursors D13.400.730; D13.444.735.640 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR RNA Splicing Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acid Precursors Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA RNA copies from DNA that exactly represent the genome sequence. This RNA cannot be used for producing protein until RNA splicing takes place. During this procedure the phosphodiester bonds at exon-intron boundaries are cleaved and the intron is excised. Consequently a new bond is formed between the ends of the exons. The resulting RNA is mature RNA which can be translated into protein. Nucleic Acid Precursors (75-87); Nucleic Acids (66-74)  <"DBRNA Polymerases D08.586.913.696.445.735.735 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases RNA Polymerase I; RNA Polymerase II; RNA Polymerase III A group of enzymes that catalyzes DNA template-directed extension of the 3'-end of an RNA strand one nucleotide at a time. It can initiate a chain de novo. In eukaryotes, three forms of the enzyme have been distinguished on the basis of sensitivity to alpha-amanitin, and the type of RNA synthesized. (From Enzyme Nomenclature, 1992) EC 2.7.7.6. RNA Nucleotidyltransferases (68-72)  FE)RNA Polymerase III D08.586.913.696.445.735.735.235 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases; RNA Polymerases A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II. EC 2.7.7.6. RNA Nucleotidyltransferases (68-72); RNA Polymerases (73-76) #FxGRNA Polymerase II D08.586.913.696.445.735.735.230 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases; RNA Polymerases A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. RNA Nucleotidyltransferases (68-72); RNA Polymerases (73-76) (#FJGRNA Polymerase I D08.586.913.696.445.735.735.225 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases; RNA Polymerases A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. The enzyme functions in the nucleolar structure and transcribes DNA into RNA. It has different requirements for cations and salts than RNA polymerase II and III and is not inhibited by alpha-amanitin. EC 2.7.7.6. RNA Nucleotidyltransferases (68-72); RNA Polymerases (73-76) #FVGRNA Phages B04.123.691 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Cystoviridae (+ 1); Leviviridae (+ 2) Bacteriophages whose genetic material is RNA, which is single-stranded in all except the Pseudomonas phage Phi6. All RNA phages infect their host bacteria via the host's surface pili. Some frequently encountered RNA phages are: QBeta, MS2, BF23, F2, R17, fr, Mu2, PhiCb5, PhiCb12r, PhiCb8r, PhiCb23r, 7s, Phi6, PP7. Bacteriophages (66-79); Coliphages (66-79)  0q3RNA Nucleotidyltransferases D08.586.913.696.445.735 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases Polynucleotide Phosphorylase; Q beta Replicase; RNA, Catalytic; RNA Polymerases (+ 3); RNA Replicase Nucleotidyltransferases (66-67) q Fy$RNA Editing G05.331.370.380.812.500 DEGEIMPHRE RNA, Guide Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; RNA Processing, Post-Transcriptional A process that changes the nucleotide sequence of mRNA from that of the DNA template encoding it. Some major classes of RNA editing are as follows: 1) the conversion of cytosine to uracil in mRNA; 2) the addition of variable number of guanines at pre-determined sites; and 3) the addition and deletion of uracils, templated by guide-RNAs (RNA, GUIDE). RNA Processing, Post-Transcriptional (88-92)  =3RNA Caps D13.444.735.544.700; D13.695.667.454.700; D13.695.827.426.700 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Messenger Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides RNA Cap Analogs RNA Cap Analogs RNA Cap Analogs Compounds with the general structure 7-methyl-5'-guanosine triphosphate-5'-X which modify the 5' end of eukaryotic cellular and viral messenger RNA and some heterogeneous nuclear RNAs. These compounds, which are positively charged, protect the above specified RNAs at their termini against attack by phosphatases and other nucleases and promote mRNA function at the level of initiation of translation. Analogs of the RNA caps (RNA CAP ANALOGS), which lack the positive charge, inhibit the initiation of protein synthesis. Guanine Nucleotides (66-71); Guanosine Triphosphate (72-74)/analogs and derivatives (75-79); Oligoribonucleotides (76-79); Ribonucleotides (71-75); RNA, Messenger (66-79)    EDc;[RNA Cap Analogs D13.444.735.544.700.710; D13.695.667.454.700.710; D13.695.827.426.700.710 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Messenger; RNA Caps Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; RNA Caps Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; RNA Caps Analogs of RNA cap compounds which do not have a positive charge. These compounds inhibit the initiation of translation of both capped and uncapped messenger RNA. Guanine Nucleotides (66-79); Oligoribonucleotides (76-79); Ribonucleotides (71-75); RNA, Messenger (66-79) QD}RNA D13.444.735 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nissl Bodies; Repetitive Sequences, Nucleic Acid Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids RNA, Antisense; RNA, Bacterial; RNA, Chloroplast; RNA, Complementary; RNA, Double-Stranded; RNA, Fungal; RNA, Guide; RNA, Helminth; RNA, Messenger (+ 6); RNA, Neoplasm; RNA, Nuclear (+ 2); RNA, Plant (+ 1); RNA Precursors; RNA, Protozoan; RNA, Ribosomal (+ 7); RNA, Transfer (+ 23); RNA, Viral A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and sugar units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger, et al., Glossary of Genetics:Classical and Molecular, 5th ed).  "D:SiRitodrine D02.033.329.624.870; D02.092.063.624.870; D02.092.471.683.870; D06.347.930.650; D14.100.050.100.200.730; D16.050.870.760; D26.930.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents Adrenergic beta-agonist used to control premature labor. Phenethylamines (71-74); Phenols (71-74); Propanolamines (74) j :CJRitanserin D03.383.621.840; D03.383.742.698.700; D14.100.850.850.760; D15.075.730; D15.210.950.012.730; D15.700.872.015.730 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure. Histamine H2 Receptor Blockaders (77-91); Piperidines (66-91) ~:v IRistocetin D20.085.116.095.750 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Antibiotics, Glycopeptide An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.  ]<`ZRisk-Taking F01.145.722 Behavior and Behavior Mechanisms (Non MeSH); Behavior Gambling Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her. Gambling (69-74) PX   A TRisk Management N03.219.463.800; N04.452.871 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Health Services Administration (Non MeSH); Organization and Administration  Risk Assessment; Safety Management The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimized. Effective risk management has its greatest benefits in application to insurance in order to avert or minimize financial liability. (From Slee and Slee: Health care terms, 2d ed). Insurance, Liability (66-79); Malpractice (66-79)  "+0;Risk Factors E05.318.740.600.800.725; G03.850.490.625.750; G03.850.520.830.600.800.725; H01.548.832.672.734.800; N05.715.350.200.700; N05.715.360.750.625.700.700 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability; Risk Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Causality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability; Risk Physical Sciences (Non MeSH); Mathematics; Statistics; Probability; Risk Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Causality Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability; Risk An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent. Risk (75-87) _Risk Assessment E05.318.740.600.800.715; G03.850.505.715; G03.850.520.830.600.800.715; H01.548.832.672.734.790; N04.452.871.715; N05.715.360.325.715; N05.715.360.750.625.700.690 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability; Risk Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability; Risk Physical Sciences (Non MeSH); Mathematics; Statistics; Probability; Risk Health Services Administration (Non MeSH); Organization and Administration; Risk Management Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability; Risk The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) The process by which new chemical substances are evaluated for their potential impact on human health, a process that entails determining the substance's toxicity and the number of people exposed to the substance. (Segen, Dictionary of Modern Medicine, 1990). Risk Factors (92-94) "k2Risk E05.318.740.600.800; G03.850.520.830.600.800; H01.548.832.672.734; N05.715.360.750.625.700 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability Logistic Models; Risk Assessment; Risk Factors Logistic Models; Risk Assessment; Risk Factors Logistic Models; Risk Assessment; Risk Factors Logistic Models; Risk Assessment; Risk Factors The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. dRiots I01.880.735.140.652 CLECEHHILJPCPXSNTD Violence Mass Behavior Social Sciences; Sociology; Social Problems; Civil Disorders A form of violent crowd behavior which expresses the emotional release of resentments and prejudices, usually relevant to grievances toward the social system. Emergency Service, Hospital (66-68); Race Relations (68); Social Conditions (66-68); Social Problems (68) $!  IRiot Control Agents, Chemical D05.569.734 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Irritants (+ 3) Chemical substances which are employed during a riot in order to control or disperse the rioting parties. Irritants (66-74); Tear Gases (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $#$8N~/:Rioprostil D02.241.081.436.687.700.450.750; D10.516.251.355.708.700.450.750; D17.350.700.660.750; D19.316.203.840 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents (11 alpha,13E)-1,11,16-Trihydroxy-16-methylprost-13-en-9-one. A synthetic methylprostaglandin E1 analog that reduces gastric acid secretion and enhances the gastric mucus-bicarbonate barrier. It is effective in the therapy of gastric ulcers and gives significant protection against NSAID-induced gastric mucosal damage. The drug also prevents cyclosporin A-induced damage to endocrine and exocrine pancreatic secretions. It shows a low order of acute toxicity and there is no evidence of embryotoxicity, fetotoxicity, teratogenicity, or mutagenicity in animal studies. Anti-Ulcer Agents (77-91); Prostaglandins E (75-91); Prostaglandins, Synthetic (77-91) %|p:fRing Chromosomes G05.148.266.751 Genetics; Cytogenetics; Chromosome Aberrations Aberrant chromosomes with no ends. Chromosome Aberrations (68-84); Chromosome Abnormalities (66-84) +7+KRinderpest Virus B04.820.455.600.650.500.675; B04.909.777.455.600.650.500.675 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Morbillivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Morbillivirus A species of MORBILLIVIRUS causing cattle plague, a disease with high mortality. Sheep, goats, pigs, and other animals of the order Artiodactyla can also be infected. ,BRinderpest C02.782.580.600.500.700; C22.780 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections; Morbillivirus Infections Animal Diseases A viral disease of cloven-hoofed animals caused by MORBILLIVIRUS. It may be acute, subacute, or chronic with the major lesions characterized by inflammation and ulceration of the entire digestive tract. /.&JRimantadine D02.219.075.700; D04.615.236.075.700; D20.388.815 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Bridged Compounds; Adamantane Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Bridged Compounds; Adamantane Anti-Infective Agents; Antiviral Agents alpha-Methyl-1-adamantanemethylamine. Antiviral agent proposed especially for prophylaxis of influenza A; inhibits viral RNA synthesis. Synonyms: EXP 126; JP 61; Meradan(e); remantadine. Adamantane/AA (75-79); Bridged Compounds (66-75); Ethylamines (66-75) 1d9:TRigor Mortis C23.240.224.617.839 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Death; Cadaver; Postmortem Changes Muscular rigidity which develops in the cadaver usually from 4 to 10 hours after death and lasts 3 or 4 days. Death (66-69) 4$N^Right to Die I01.880.604.473.600.805; N03.706.437.600.805 HILJ Suicide, Assisted Advance Directives; Living Wills Social Sciences; Sociology; Social Control, Formal; Human Rights; Patient Advocacy Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights; Patient Advocacy The right of the patient or the patient's representative to make decisions with regard to the patient's dying. Euthanasia, Passive (78-86); Patient Advocacy (76-86) $52(@Rift Valley Fever Virus B04.820.087.710.800.700; B04.909.777.147.710.800.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Phlebovirus; Sandfly Fever Group Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Phlebovirus; Sandfly Fever Group Viruses A mosquito-borne species of the PHLEBOVIRUS genus and member of the SANDFLY FEVER GROUP VIRUSES found in eastern, central, and southern Africa, producing massive hepatitis, abortion, and death in sheep, goats, cattle, and other animals. It also has caused disease in humans. 8 :ARift Valley Fever C02.407.810; C02.782.147.810; C02.782.417.762; C02.081.810; C06.552.380.315.430.812; C22.467.435.812 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Hepatitis, Viral, Animal Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral Virus Diseases; Arbovirus Infections Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Animal; Hepatitis, Viral, Animal Animal Diseases; Hepatitis, Animal; Hepatitis, Viral, Animal A febrile disease resembling dengue. It is caused by a mosquito-borne arbovirus. :rPaRifamycins D20.085.739 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Rifabutin; Rifampin A group of antibiotics characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known antibiotics. They have been isolated from fermentation broths of Streptomyces mediterranei. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  =:)<Rifampin D20.085.089.685; D20.085.739.651; D20.338.135.714; D20.661.733 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antibiotics; Rifamycins Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular Anti-Infective Agents; Leprostatic Agents 5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22- heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7- (epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan- 1,11(2H)-dione 21-acetate. Semisynthetic antibiotic used in treatment of tuberculosis. Rifamycins (66-72) ? H:Rifabutin D20.085.089.650; D20.085.739.625; D20.338.135.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antibiotics; Rifamycins Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular 1',4-Didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxorifamycin XIV. A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients. Rifamycins (81-93) B 9:Rickettsieae B03.700.651.801.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae Coxiella (+ 1); Rickettsia (+ 4); Rochalimaea (+ 2) A tribe of gram-negative bacteria of the family RICKETTSIACEAE whose organisms are found in arthropods and are pathogenic for man and certain other vertebrate hosts. Ea"]CRickettsias and Chlamydias (Non MeSH) B03.700 Bacteria Blood-Borne Pathogens; Chlamydiales (+ 5); Rickettsiales (+ 22) CHCLCYDEENGDGEIMIPMEPHPYREULVI G3-  M"Rickettsiales Infections C01.252.400.810.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH) Anaplasmataceae Infections (+ 2); Bartonellaceae Infections (+ 1); Rickettsiaceae Infections (+ 15) Infections with bacteria of the order RICKETTSIALES. H Pv?Rickettsiales B03.700.651 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH) Anaplasmataceae (+ 3); Bartonellaceae (+ 1); Rickettsiaceae (+ 15) An order of gram-negative bacteria including many that may cause disease in man or in other vertebrate or invertebrate hosts. J"9RRickettsial Vaccines D24.310.894.135.650 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines K>pRickettsial and Chlamydial Infections (Non MeSH) C01.252.400.810 Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Chlamydiaceae Infections (+ 5); Rickettsiales Infections (+ 21) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI L9sLPRickettsiaceae Infections C01.252.400.810.700.810 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections Ehrlichiosis; Heartwater Disease; Pneumonia, Rickettsial; Q Fever; Rickettsia Infections (+ 6); Rochalimaea Infections (+ 3) Infections with bacteria of the family RICKETTSIACEAE. Rickettsial Diseases (66-76)  NPA"Rickettsiaceae B03.700.651.801 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales Ehrlichieae (+ 3); Rickettsieae (+ 10) A family of small, gram-negative organisms often parasitic in man and other animals, causing diseases that may be transmitted by invertebrate vectors. Bacteria (66-74)  P"K1Rickettsia typhi B03.440.400.425.733.801; B03.700.651.801.700.733.801 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rickettsia Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Rickettsia The etiologic agent of murine typhus (see TYPHUS, ENDEMIC FLEA-BORNE). RA:" URickettsia tsutsugamushi B03.440.400.425.733.701; B03.700.651.801.700.733.701 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rickettsia Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Rickettsia A species of gram-negative, aerobic bacteria that is the etiologic agent of SCRUB TYPHUS. Strains of this species vary considerably in antigenic composition and in some cases in virulence and other biological properties. T6:" Rickettsia rickettsii B03.440.400.425.733.601; B03.700.651.801.700.733.601 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rickettsia Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Rickettsia A species of gram-negative, aerobic bacteria that is the etiologic agent of ROCKY MOUNTAIN SPOTTED FEVER. Its cells are slightly smaller and more uniform in size than those of RICKETTSIA PROWAZEKII. V:" Rickettsia prowazekii B03.440.400.425.733.501; B03.700.651.801.700.733.501 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rickettsia Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Rickettsia A species of gram-negative, aerobic bacteria that is the etiologic agent of epidemic typhus fever acquired through contact with lice (TYPHUS, EPIDEMIC LOUSE-BORNE) as well as BRILL'S DISEASE. Yo:" Rickettsia Infections C01.252.400.810.700.810.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections Boutonneuse Fever; Rocky Mountain Spotted Fever; Scrub Typhus; Typhus, Endemic Flea-Borne; Typhus, Epidemic Louse-Borne (+ 1) Infections by the genus RICKETTSIA. Rickettsial Infections (77-86)  [P,$Rickettsia B03.440.400.425.733; B03.700.651.801.700.733 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae Rickettsia prowazekii; Rickettsia rickettsii; Rickettsia tsutsugamushi; Rickettsia typhi Rickettsia prowazekii; Rickettsia rickettsii; Rickettsia tsutsugamushi; Rickettsia typhi A genus of gram-negative, aerobic, rod-shaped bacteria often surrounded by a protein microcapsular layer and slime layer. The natural cycle of its organisms generally involves a vertebrate and an invertebrate host. Species of the genus are the etiological agents of human diseases, such as typhus. ^s2"\Rickets C05.116.198.816; C18.452.174.845; C18.654.223.133.770.734 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vitamin D Deficiency Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin D Deficiency A condition caused by deficiency of VITAMIN D, especially in infancy and childhood, with disturbance of normal ossification. The disease is marked by bending and distortion of the bones under muscular action, by the formation of nodular enlargements on the ends and sides of the bones, by delayed closure of the fontanels, pain in the muscles, and sweating of the head. Vitamin D and sunlight together with an adequate diet are curative, provided that the parathyroid glands are functioning properly. (Dorland, 27th ed). b ANJcRicinus B06.660.751 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Castor Bean; Castor Oil; Ricin Plants; Plants, Toxic Castor Bean An euphorbiaceous plant with very toxic seeds. The CASTOR BEAN, CASTOR OIL, RICIN, and other lectins are its most important products.  f &(Ricinoleic Acids D02.241.081.436.275.600.780; D10.516.251.355.325.600.780 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated; Oleic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated; Oleic Acids g>8DRicin D12.776.034.756; D12.776.765.685; D24.185.526.545.756; D24.185.926.756; D24.310.545.756; D24.611.125.044.545.756 AAADAEAGAIANBIBLCFCHCLCSCTDEDFECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Ricinus Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens; Lectins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Immunologic and Biologic Factors (Non MeSH); Biological Products; Lectins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Lectins A protein phytotoxin from the seeds of Ricinus communis, the castor oil plant. It agglutinates cells, is proteolytic, and causes lethal inflammation and hemorrhage if taken internally. i ~D 1Rice B06.510.253.713; J01.341.182.713 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals Annual cereal grass, Oryza sativa, used by the majority of the human race as the major source of nutritive carbohydrates. m&4nRibulosephosphates D09.203.894.643.720 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Pentosephosphates Ribulose substituted by one or more phosphoric acid moieties. Ketoses (74); Pentosephosphates (73-74) ooBuJ0Ribulosebiphosphate Carboxylase D08.586.520.258.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases A copper protein that catalyzes the formation of 2 moles of 3-phosphoglycerate from ribulose 1,5-biphosphate in the presence of carbon dioxide. It utilizes oxygen instead of carbon dioxide to form 2-phosphoglycollate. EC 4.1.1.39. Carboxy-Lyases (73-74); Glyceric Acids (73-74); Organophosphorus Compounds (73-74); Pentosephosphates (73-74) p$Fa Ribs A02.835.232.904.567 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tietze's Syndrome Musculoskeletal System; Skeleton; Bone and Bones; Thorax s:ERibostamycin D09.203.408.051.623.800; D20.085.060.550.800 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Neomycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Neomycin O-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1,4)-O- (beta-D-ribofuranosyl-(1,5))-2-deoxy-D-streptamine. A broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus. Antibiotics (72-74); Aminoglycosides (74) ta2<2Ribosomes A11.368.702.248.651; A11.368.702.811 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI RNA, Ribosomal Cells; Cytoplasm; Organelles; Endoplasmic Reticulum Cells; Cytoplasm; Organelles Polyribosomes A class of multicomponent structures found in all cells, in mitochondria, and chloroplasts. They have roles both in the genetic translation of of transcripts and in the manufacture and secretion of the proteins. (From Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed).  v **`URibosomal Proteins D12.776.835 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Peptide Elongation Factors (+ 1); Peptide Initiation Factors (+ 2); Peptide Termination Factors Proteins found in ribosomes. They are believed to have a catalytic function in reconstituting biologically active ribosomal subunits. Proteins (66-74); Ribosomes (66-74)  y1FDs,Ribosemonophosphates D09.203.894.643.700 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Pentosephosphates Ribose substituted in the 1-, 3-, or 5-position by a phosphoric acid moiety. Pentosephosphates (68-74); Ribose (68-74) {GBu]2Ribose-Phosphate Pyrophosphokinase D08.586.913.696.175.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Diphosphotransferases ATP:ribose-5-phosphate pyrophosphotransferase. An enzyme that catalyzes the formation of phosphoribosyl pyrophosphate from ATP and ribose-5-phosphate. EC 2.7.6.1. Pentosephosphates (74); Phosphotransferases, ATP (74); Pyrophosphoric Acids (74) |'F_Ribose D09.203.546.627.651 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Pentoses A pentose active in biological systems usually in its D-form. / DjKRibonucleotides D13.695.827 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Adenine Nucleotides (+ 21); Cytosine Nucleotides (+ 7); FMN; Guanine Nucleotides (+ 14); Inosine Nucleotides (+ 4); Nicotinamide Mononucleotide; Nucleoside Diphosphate Sugars (+ 16); Uracil Nucleotides (+ 11) specific nucleotide (66-70); Nucleotides (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  lBP:HRibonucleotide Reductases D08.586.682.047.857 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases Ribonucleoside Diphosphate Reductase Ft*Ribonucleosides D13.570.800 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides Adenosine (+ 6); Cytidine (+ 1); Dichlororibofuranosylbenzimidazole; Formycins (+ 1); Guanosine (+ 1); Inosine (+ 4); Ribavirin; Showdomycin; Toyocamycin; Tubercidin; Uridine (+ 5) specific nucleoside (66-70); Nucleosides (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  BP:HRibonucleoside Diphosphate Reductase D08.586.682.047.857.567 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Ribonucleotide Reductases An enzyme of the oxidoreductase class that catalyzes the formation of 2'-deoxyribonucleotides from the corresponding ribonucleotides using NADPH as the ultimate electron donor. The deoxyribonucleoside diphosphates are used in DNA synthesis. (From Dorland, 27th ed) EC 1.17.4.1. B*F@Ribonucleoproteins, Small, U5 D12.776.664.800.700.620 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U5 snRNP along with U4-U6 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form mature SPLICEOSOMES. Ribonucleoproteins (82-92) #F"Ribonucleoproteins, Small, U4-U6 D12.776.664.800.700.615 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U4-U6 snRNP along with the U5 snRNP preassemble into a single 25S particle that binds to the U1 and U2 snRNPs and the substrate to form mature SPLICEOSOMES. There is also evidence for the existence of individual U4 or U6 snRNPs in addition to their organization as a U4-U6 snRNP. Ribonucleoproteins (82-92) A&FRibonucleoproteins, Small, U2 D12.776.664.800.700.605 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U2 snRNP along with other small ribonucleoproteins (U1, U4-U6, and U5) assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U2 snRNP base pairs with conserved sequence motifs at the branch point, which associates with a heat- and RNAase-sensitive factor in an early step of splicing. Ribonucleoproteins (75-92) Z#FRibonucleoproteins, Small, U1 D12.776.664.800.700.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear A nuclear RNA-protein complex that plays a role in RNA processing. In the nucleoplasm, the U1 snRNP along with other small ribonucleoproteins (U2, U4-U6, and U5) assemble into SPLICEOSOMES that remove introns from pre-mRNA by splicing. The U1 snRNP base pairs with conserved sequence motifs at the 5'-splice site and recognizes both the 5'- and 3'-splice sites and may have a fundamental role in aligning the two sites for the splicing reaction. Ribonucleoproteins (75-92) #F Ribonucleoproteins, Small Nuclear D12.776.664.800.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Ribonucleoproteins Ribonucleoproteins, Small, U1; Ribonucleoproteins, Small, U2; Ribonucleoproteins, Small, U4-U6; Ribonucleoproteins, Small, U5 Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The U3 snRNP is localized in the nucleolus, where it aligns into base pairs with the 28S rRNA precursor in a still unidentified region and functions in pre-rRNA processing. The U7 snRNP aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end. Ribonucleoproteins (81-92)  'FloRibonucleoproteins D12.776.664.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins Ribonucleoproteins, Small Nuclear (+ 4); Signal Recognition Particle Proteins conjugated with ribonucleic acids (RNA) or specific RNA. Many viruses are ribonucleoproteins. specific RNA(66-75); Nucleoproteins (66-75); RNA (66-75)  +FVQxFRibonucleases D08.586.277.352.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Endoribonucleases (+ 5); Exoribonucleases Enzymes that catalyze the hydrolysis of ester bonds within RNA. EC 3.1.-. *F`2ZRibonuclease, Pancreatic D08.586.277.352.355.350.715; D08.586.277.352.700.350.715 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endoribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases; Endoribonucleases An enzyme that catalyzes the endonucleolytic cleavage of pancreatic ribonucleic acids to 3'-phosphomono- and oligonucleotides ending in cytidylic or uridylic acids with 2',3'-cyclic phosphate intermediates. EC 3.1.27.5. Endonucleases (79-82); Endoribonucleases (82-83); Ribonucleases (79-82) >F TRibonuclease T1 D08.586.277.352.355.350.725; D08.586.277.352.700.350.725 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endoribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases; Endoribonucleases An enzyme catalyzing the endonucleolytic cleavage of RNA at the 3'-position of a guanylate residue. EC 3.1.27.3. Endonucleases (74); Guanine Nucleotides (74); Ribonucleases (74) >F NRibonuclease H, Calf Thymus D08.586.277.352.355.350.700; D08.586.277.352.700.350.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endoribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases; Endoribonucleases A ribonuclease that specifically cleaves the RNA moiety of RNA:DNA hybrids. It has been isolated from a wide variety of prokaryotic and eukaryotic organisms (particularly calf thymus) as well as retroviruses. EC 3.1.26.4. Endonucleases (73-82); Endoribonucleases (83-91); Ribonucleases (73-82) i">F TRiboflavin Synthase D08.586.913.730 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme that catalyzes the formation of riboflavin from two molecules of 6,7-dimethyl-8-ribityllumazine, utilizing a four-carbon fragment from one molecule which is transferred to the second molecule. EC 2.5.1.9. Pteridines (73-74); Transferases (73-74) FU1Riboflavin Deficiency C18.654.223.133.699.713 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency A dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-colored tongue that may show fissures, corneal vascularization, dyssebacia, and anemia. (Dorland, 27th ed). N/Riboflavin D11.557.405.650; D11.786.708.806 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Flavins Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FMN and FAD. &BNRibitol D02.033.800.780; D09.203.853.780 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols A sugar alcohol formed by the reduction of ribose. Sugar Alcohols (72-77)  &:?Ribavirin D13.570.800.790; D20.388.809; D26.087.890 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Anti-Infective Agents; Antiviral Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide. A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Amides (66-74); Nucleosides (66-72); Ribonucleosides (73-74); Triazoles (66-74) 3 1:`Rib Fractures C21.866.405.679; C21.866.891.733 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Thoracic Injuries &NRhytidoplasty E04.860.760 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Plastic Plastic surgery performed, usually by excision of skin, for the elimination of wrinkles from the skin. Surgery, Plastic (66-88) ;$,zRhythm Method E02.197.820 Therapeutics; Contraception A contraceptive method whereby abstinence is practiced a few days before and after the estimated day of ovulation. Contraception (66-74) j!Rhubarb B06.510.806; B06.560.771; J01.341.956.891 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Plants; Plants, Medicinal Technology, Industry, Agriculture (Non MeSH); Food; Vegetables Rheum officinale (Baill.), R. palmatum (L.), and other species of Polygonaceae that contain chrysophanic acid, rhein, EMODIN, and other anthraquinones. The roots were formerly used as purgatives. q 14Rhombencephalon A08.186.211.132.810 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem Medulla Oblongata (+ 2); Pons (+ 4); Raphe Nuclei That part of the brain stem constituting the MEDULLA OBLONGATA (myelencephalon) and PONS (metencephalon). Brain (66-86); Brain Stem (66-86)  m8GA|+Rhodotorula B05.354.381.546.750; B05.354.930.650 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Algae and Fungi (Non MeSH); Fungi; Yeasts Red yeast-like deuteromycetous fungal genus generally regarded as nonpathogenic, cultured from numerous sources in human patients. )*"Rhodospirillum rubrum B03.650.700.725.733.650 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales; Rhodospirillaceae; Rhodospirillum Vibrio- to spiral-shaped phototrophic bacteria found in stagnant water and mud exposed to light. Rhodospirillum (66-71) "arRhodospirillum B03.650.700.725.733 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales; Rhodospirillaceae Rhodospirillum rubrum A genus of gram-negative, spiral bacteria that possesses internal photosynthetic membranes. Its organisms divide by binary fission, are motile by means of polar flagella, and are found in aquatic environments. +"ORhodospirillales B03.650.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria Chromatiaceae (+ 1); Rhodospirillaceae (+ 6) An order of photosynthetic bacteria representing a physiological community of predominantly aquatic bacteria. Bacteria (66-74); Rhodospirillaceae (75)  "&7~1Rhodospirillaceae B03.650.700.725 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales Rhodobacter (+ 2); Rhodopseudomonas; Rhodospirillum (+ 1) Phototrophic bacteria isolated from stagnant water and mud. Bacteria (66-74)  v":FGRhodopsin D11.557.261.648.500.700; D12.776.306.500.700 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinal Pigments; Opsin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Eye Proteins; Opsin A photoreceptor protein found in retinal rods. It is a complex formed by the binding of retinal, the oxidized form of retinol, to the protein OPSIN and undergoes a series of complex reactions in response to visible light resulting in the transmission of nerve impulses to the brain.  2HORhodopseudomonas B03.650.700.725.720 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales; Rhodospirillaceae A genus of gram-negative, rod-shaped, phototrophic bacteria found in aquatic environments. Internal photosynthetic membranes are present as lamellae underlying the cytoplasmic membrane. "ORhodococcus equi B03.100.067.595.777.325; B03.510.595.777.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Rhodococcus Bacteria; Gram-Positive Bacteria; Nocardioform Group; Rhodococcus A species of RHODOCOCCUS found in soil, herbivore dung, and in the intestinal tract of cows, horses, sheep, and pigs. It causes bronchopneumonia in foals and can be responsible for infection in humans compromised by immunosuppressive drug therapy, lymphoma, or AIDS. Corynebacterium (66-86); Rhodococcus (87-91) "2"85Rhodococcus B03.100.067.595.777; B03.510.595.777 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group Bacteria; Gram-Positive Bacteria; Nocardioform Group Rhodococcus equi Rhodococcus equi A bacterial genus of the order ACTINOMYCETALES. Actinomycetales (67-86); Corynebacterium (66-86); Coryneform Group (76-86); Rhodospirillaceae (76-86)  *"(:wRhodobacter sphaeroides B03.650.700.725.700.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales; Rhodospirillaceae; Rhodobacter Spherical phototrophic bacteria found in mud and stagnant water exposed to light. Rhodopseudomonas (66-71) "^aRhodobacter capsulatus B03.650.700.725.700.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales; Rhodospirillaceae; Rhodobacter Non-pathogenic ovoid to rod-shaped bacteria that are widely distributed and found in fresh water as well as marine and hypersaline habitats. Rhodopseudomonas (68-90) L"^Rhodobacter B03.650.700.725.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Phototrophic Bacteria; Rhodospirillales; Rhodospirillaceae Rhodobacter capsulatus; Rhodobacter sphaeroides A genus of gram-negative bacteria widely distributed in fresh water as well as marine and hypersaline habitats. Rhodopseudomonas (66-91)  "O7Rhodnius B01.131.617.412.841.650 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hemiptera; Triatominae A genus of true bugs of the subfamily TRIATOMINAE (Reduviidae). Its species are vectors of TRYPANOSOMA CRUZI. ͅ (FRhodium D01.268.742; D01.552.752 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals  :`Rhode Island Z01.107.567.875.100.774; Z01.107.567.875.600.595.774 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); New England ϣ: Rhodanine D03.383.871.649 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles ! :URhodamines D03.494.953.600; D26.408.348.808; D26.550.795 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents A family of 3,6-di(substituted-amino)-9-benzoate derivatives of xanthene that are used as dyes and as indicators for various metals; also used as fluorescent tracers in histochemistry. Ammonium Compounds (69-74); Xanthenes (69-74); Benzoates (74) 5,KRho(D) Immune Globulin D12.776.124.486.485.567.700; D12.776.124.790.651.504.700; D12.776.377.715.548.546.700; D24.611.125.600.681.393.700 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; IgG Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; IgG Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; IgG Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes; IgG Immunizing agent containing IgG anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells. Antibodies, Anti-Idiotypic (80-83); Gamma Globulins (78-83); Immunoglobulins (73-93) ԙ|6.cRho Factor D12.776.930.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors A protein which effects termination of RNA synthesis during the genetic transcription process by dissociating the ternary transcription complex RNA-RNA POLYMERASE DNA at the termination of a gene. Bacterial Proteins (73-76); Proteins (66-76); Transcription, Genetic (73-76) F^[Rhizopus B05.354.730.944.550.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Zygomycotina; Mucorales A genus of zygomycetous fungi of the order Mucorales, a common saprophyte and facultative parasite of mature fruits and vegetables. It may cause cerebral mycoses in diabetes and cutaneous infection in severely burned patients.  "Y Rhizoctonia B05.354.381.546.740 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus, order Agonomycetales, that is an important plant pathogen affecting potatoes and other plants. "NRhizobium meliloti B03.440.400.425.700.775.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rhizobiaceae; Rhizobium A species of gram-negative, aerobic bacteria that causes formation of root nodules on some, but not all, types of sweet clover, alfalfa, and fenugreek. Rhizobium (66-91) "Rhizobium leguminosarum B03.440.400.425.700.775.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rhizobiaceae; Rhizobium A species of gram-negative, aerobic bacteria that causes formation of root nodules on some, but not all, types of field pea, lentil, kidney bean, and clover. Rhizobium (66-91) "Rhizobium B03.440.400.425.700.775 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rhizobiaceae Rhizobium leguminosarum; Rhizobium meliloti A genus of gram-negative, aerobic, rod-shaped bacteria that produce nodules on the roots of leguminous plants. Members of this genus are common soil inhabitants.  "3Rhizobiaceae B03.440.400.425.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Agrobacterium (+ 1); Rhizobium (+ 2) A family of gram-negative bacteria which are saprophytes, symbionts, or plant pathogens. Bacteria (66-74)  "/hRhinoviruses, Equine B04.820.565.780; B04.909.777.618.780 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae A group of viruses of the family PICORNAVIRIDAE, yet unclassified as to genus, though not a member of RHINOVIRUS. They cause a disease in horses characterized by rhinitis, pharyngitis, and fever. *}Rhinovirus B04.820.565.775; B04.909.777.618.775 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae A genus of PICORNAVIRIDAE inhabiting primarily the respiratory tract of mammalian hosts. It includes the human strains associated with common colds. t*}Rhinosporidium B05.354.107.292.731 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Ascomycetous fungi of the order Endomycetales which cause rhinosporidiosis. "LXRhinosporidiosis C01.703.829 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses *P=Rhinoscleroma C01.252.400.310.503.650; C01.252.825.705; C01.539.800.720.705; C08.460.850; C08.730.702; C09.603.850; C17.800.838.765.705; C23.484.500.850 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Klebsiella Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Respiratory Tract Diseases; Nose Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Nose Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Symptoms and General Pathology (Non MeSH); Granuloma; Granuloma, Respiratory Tract (Non MeSH) A granulomatous disease affecting the nose and nasopharynx, usually ascribed to KLEBSIELLA RHINOSCLEROMATIS. It occurs in Egypt, eastern Europe, and Central and South America. P%Rhinoplasty E04.847.677; E04.860.732 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Nose; Nasal Bone Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) Surgery, Operative; Surgery, Plastic  $pRhinophyma C17.800.271.125.150.650; C17.800.805.711.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Facial Dermatoses; Acneiform Eruptions (Non MeSH); Acne Rosacea Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sebaceous Gland Diseases (Non MeSH) A manifestation of severe ACNE ROSACEA resulting in significant enlargement of the nose and occurring primarily in men. It is caused by hypertrophy of the sebaceous glands and surrounding connective tissue. The nose is reddened and marked with numerous telangiectasias. 2N);Rhinitis, Vasomotor C08.460.799.910; C09.603.799.910 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Rhinitis Otorhinolaryngologic Diseases; Nose Diseases; Rhinitis A form of rhinitis brought about by changes in vascular tone and permeability. The etiology is obscure. Hay Fever (66-79); Rhinitis (66-79) &N|}-Rhinitis, Atrophic C08.460.799.649; C09.603.799.649 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Rhinitis Otorhinolaryngologic Diseases; Nose Diseases; Rhinitis A chronic form of rhinitis marked by wasting of the mucous membrane and the glands. It is usually associated with crusting and foul-smelling discharges. &N|Rhinitis, Allergic, Perennial C08.460.799.631; C08.674.810; C09.603.799.631; C20.543.480.680.791 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Rhinitis Respiratory Tract Diseases; Respiratory Hypersensitivity Otorhinolaryngologic Diseases; Nose Diseases; Rhinitis Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity Inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year. The causes are usually air-borne allergens, particularly dusts, feathers, molds, animal fur, etc. Hay Fever (66-79); Rhinitis (66-79) #LN'-Rhinitis C08.460.799; C08.730.674; C09.603.799 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Nose Diseases Hay Fever; Rhinitis, Allergic, Perennial; Rhinitis, Atrophic; Rhinitis, Vasomotor Hay Fever; Rhinitis, Allergic, Perennial; Rhinitis, Atrophic; Rhinitis, Vasomotor Inflammation of the mucous membrane of the nose.  -N<Rheumatology G02.403.776.409.730 CLECEDHIISLJMAMTOGSNSTTD Collagen Diseases; Rheumatic Diseases Health Occupations; Medicine; Specialties, Medical; Internal Medicine A subspecialty of internal medicine concerned with the study of inflammatory or degenerative processes and metabolic derangement of connective tissue structures which pertain to a variety of musculoskeletal disorders, such as arthritis. Rheumatism (66-79)  e-RRheumatoid Nodule C05.550.114.154.683; C05.799.114.683; C17.300.775.099.683 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Subcutaneous nodules seen in 20-30% of rheumatoid arthritis patients. They may arise anywhere on the body, but are most frequently found over the bony prominences. The nodules are characterized histologically by dense areas of fibrinoid necrosis with basophilic streaks and granules, surrounded by a palisade of cells, mainly fibroblasts and histiocytes. yAN+Rheumatoid Factor D24.611.125.308.732 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies 6{Rheumatic Nodule C05.550.114.843.566; C05.799.825.566 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Rheumatic Fever Musculoskeletal Diseases; Rheumatic Diseases; Rheumatic Fever A small round or oval, mostly subcutaneous nodule made up chiefly of a mass of Aschoff bodies and seen in cases of rheumatic fever. It is differentiated from the RHEUMATOID NODULE which appears in rheumatoid arthritis, most frequently over bony prominences. (From Dorland, 27th ed). *NNRheumatic Heart Disease C01.252.410.890.731.649; C14.280.874 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections; Rheumatic Fever Cardiovascular Diseases; Heart Diseases The most important manifestation of and sequel to rheumatic fever, i.e., any cardiac involvement in rheumatic fever. (Dorland, 27th ed). *PRheumatic Fever C01.252.410.890.731; C05.550.114.843; C05.799.825 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Musculoskeletal Diseases; Joint Diseases; Arthritis Musculoskeletal Diseases; Rheumatic Diseases Rheumatic Heart Disease Rheumatic Nodule; Wissler's Syndrome Rheumatic Nodule; Wissler's Syndrome A febrile disease occurring as a delayed sequela of infections with group A hemolytic streptococci and characterized by multiple focal inflammatory lesions of the connective tissue structures, especially of the heart, blood vessels, and joints (polyarthritis), and by the presence of Aschoff bodies in the myocardium and skin. (Dorland, 27th ed). 9PqRheumatic Diseases C05.799; C17.300.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Rheumatology Musculoskeletal Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Arthritis, Rheumatoid (+ 7); Fibromyalgia; Gout (+ 1); Hyperostosis, Sternocostoclavicular; Osteoarthritis (+ 3); Polymyalgia Rheumatica; Rheumatic Fever (+ 2) Arthritis, Rheumatoid (+ 7); Hyperostosis, Sternocostoclavicular; Polymyalgia Rheumatica Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $ Nt"PRheology E05.830; H01.671.799 CLDEECEDHIISLJMAMTOGRESNSTTD Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics Hemorheology; Laser-Doppler Flowmetry Fluid Shifts; Hemorheology; Laser-Doppler Flowmetry; Pulsatile Flow The study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY. AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE    Wz4Rhenium D01.268.735; D01.552.740 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals V :`Rhamnus B06.560.765; B06.660.650; B06.915.765 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic Plants; Trees A genus of poisonous and rhamnaceous trees and shrubs commonly called buckthorn. The bark and fruit of its many species are commonly used as purgatives. The most common species are Rhamnus cathartica (purging buckthorn), Rhamnus frangula (alder buckthorn, a cathartic), and Rhamnus purshiana, the bark of which is the source of CASCARA and EMODIN. Karwinskia humboldtiana of the family Rhamnaceae, known also as tollidora, causes buckthorn polyneuropathy, an ascending paralysis resulting from the ingestion of Karwinskia fruit. 8 -&KfRhamnose D09.203.254.799; D09.203.546.359.774 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Deoxy Sugars Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses j *DRhadinovirus B04.280.382.400.700; B04.909.204.210.400.700; B04.909.204.382.400.700; B04.909.574.204.500.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Gammaherpesvirinae Herpesvirus 2, Saimirine Herpesvirus 2, Saimirine Herpesvirus 2, Saimirine Herpesvirus 2, Saimirine A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, infecting New World primates. Herpesvirus 2, Ateline is the type species. hrRhabdoviridae Infections C02.782.580.830 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections Ephemeral Fever; Rabies Virus diseases caused by RHABDOVIRIDAE. Important infections include RABIES, EPHEMERAL FEVER, and vesicular stomatitis. PZRhabdoviridae B04.820.455.750; B04.909.777.455.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales Lyssavirus (+ 2); Vesiculovirus (+ 1) Lyssavirus (+ 2); Vesiculovirus (+ 1) A family of bullet-shaped viruses of the order MONONEGAVIRALES, infecting vertebrates, arthropods, protozoa, and plants. Genera include VESICULOVIRUS and LYSSAVIRUS. RNA Viruses (66-77)  *^Rhabdomyosarcoma, Embryonal C04.557.450.590.550.660.675; C04.557.450.795.550.660.675 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Myosarcoma; Rhabdomyosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Myosarcoma; Rhabdomyosarcoma A form of RHABDOMYOSARCOMA arising primarily in the head and neck, especially the orbit, of children below the age of 10. The cells are smaller than those of other rhabdomyosarcomas and are of two basic cell types: spindle cells and round cells. This cancer is highly sensitive to chemotherapy and has a high cure rate with multi-modality therapy. (From Holland et al., Cancer Medicine, 3d ed). Rhabdomyosarcoma (66-93)  >X]Rhabdomyosarcoma, Alveolar C04.557.450.590.550.660.665; C04.557.450.795.550.660.665 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Myosarcoma; Rhabdomyosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Myosarcoma; Rhabdomyosarcoma A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. "Alveolar" refers to its microscopic appearance simulating the cells of the respiratory alveolus. (Holland et al., Cancer Medicine, 3d ed). Rhabdomyosarcoma (68-93) #(>X]Rhabdomyosarcoma C04.557.450.590.550.660; C04.557.450.795.550.660 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Myosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Myosarcoma Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). 'Y6X5|Rhabdomyoma C04.557.450.590.540.700 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Myoma A benign tumor derived from striated muscle. It is extremely rare, generally occurring in the tongue, neck muscles, larynx, uvula, nasal cavity, axilla, vulva, and heart. These tumors are treated by simple excision. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). ,VjRhabdomyolysis C05.651.807 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Myoglobinuria Necrosis or disintegration of skeletal muscle often followed by myoglobinuria. Kidney Failure, Acute (67-83); Muscular Diseases (66-83); Myoglobinuria (66-83)  /N3\_Rhabdoid Tumor C04.557.435.710 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A rare but highly lethal childhood tumor found almost exclusively in infants. Histopathologically, it resembles RHABDOMYOSARCOMA but the tumor cells are not of myogenic origin. Although it arises primarily in the kidney, it may be found in other parts of the body. The rhabdoid cytomorphology is believed to be the expression of a very primitive malignant cell. (From Holland et al., Cancer Medicine, 3d ed). 10XnRhabditoidea B01.500.294.700.700.660 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida Caenorhabditis (+ 1) A superfamily of nematodes of the order RHABDITIDA. Characteristics include an open tube stoma and an excretory system with lateral canals. Nematoda (66-92)  4!*GRhabditida Infections C03.335.508.700.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections Strongyloidiasis Infections with nematodes of the order RHABDITIDA. 5P[=Rhabditida B01.500.294.700.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea Rhabdiasoidea (+ 3); Rhabditoidea (+ 2) An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by an annulated or smooth cuticle and the absence of caudal glands. 7*92Rhabdiasoidea B01.500.294.700.700.640 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida Strongyloides (+ 2) A superfamily of intestinal nematode parasites containing one genus, STRONGYLOIDES, and several species. It is transmitted through fecal material onto the skin and occurs in animals and humans. 8*GRh-Hr Blood-Group System D24.611.216.705.230.775; G04.610.241.775; G09.188.229.775 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Erythroblastosis, Fetal Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. :cA2PRh Isoimmunization C15.378.120.780; C20.188.780; G04.610.143.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Erythroblastosis, Fetal Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Group Incompatibility Immunologic Diseases; Blood Group Incompatibility Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother during delivery, causing her to produce IgG antibodies, which can cross the placenta and destroy the erythrocytes of Rh- fetuses in subsequent pregnancies. RH-HR Blood-Group System (66-84)  >5N'Reye's Syndrome C06.552.241.649; C10.228.140.869 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Fatty Liver Nervous System Diseases; Central Nervous System Diseases; Brain Diseases An acute disease in children characterized by vomiting, hepatic injury with fatty vacuolization, central nervous system damage, and hypoglycemia. Brain Diseases (66-72) AD&NRewarming E02.780.830 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hypothermia, Induced; Heat; Hypothermia Therapeutics; Physical Therapy Application of heat to correct hypothermia, accidental or induced. Body Temperature (67-93); Heat/therapeutic use (66-93)  CM "0%OBReward F02.463.425.770.836 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) Token Economy An object or a situation that can serve to reinforce a response, to satisfy a motive, or to afford pleasure. D yReview Literature L01.178.682.759 Meta-Analysis Meta-Analysis Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Consensus Development Conferences (+ 1) Published materials which provide an examination of recent or current literature. Review articles can cover a wide range of subject matter at various levels of completeness and comprehensiveness based on analyses of literature that may include research findings. The review may reflect the state of the art. It also includes reviews as a literary form.  E\/Reverse Transcriptase D08.586.913.696.445.308.649; D12.776.964.775.375.649; D12.776.964.970.850.375.649 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gene Products, pol Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; DNA Nucleotidyltransferases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, pol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins; Gene Products, pol An enzyme that synthesizes DNA on an RNA template. It is encoded by the pol gene of retroviruses and by certain retrovirus-like elements. EC 2.7.7.49. DNA Nucleotidyltransferases (68-71)  HYF)Reversal Learning F02.463.425.798 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Any situation where an animal or human is trained to respond differentially to two stimuli (e.g., approach and avoidance) under reward and punishment conditions and subsequently trained under reversed reward values (i.e., the approach which was previously rewarded is punished and vice versa). L; ZUReunion Z01.600.700 EHEP Geographicals (Non MeSH); Indian Ocean Islands Indian Ocean Islands (83-92) NB 9#Rett Syndrome C10.228.140.825; C10.496.825; F03.709.346.825 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Mental Retardation Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A progressive disorder affecting the cerebral cortex found exclusively in females and present from birth. It is characterized by ataxia, autistic behavior, loss of purposeful use of the hands, and seizures. Mental Retardation (83-89); Movement Disorders (86-89); Organic Mental Disorders (88-89) N5LiRetroviruses, Type D B04.820.650.815; B04.909.574.807.815; B04.909.777.731.815 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Retroviruses Type D, Simian (+ 1) Retroviruses Type D, Simian (+ 1) Retroviruses Type D, Simian (+ 1) A genus of the family RETROVIRIDAE consisting of oncogenic exogenous retroviruses that contain type D particles. They include the type species, MASON-PFIZER MONKEY VIRUS, isolated from mammary carcinoma and normal tissues in rhesus monkeys, and several other serotypes of simian type D retroviruses (RETROVIRUSES TYPE D, SIMIAN), all of which cause simian AIDS (SAIDS) and other malignancies. The permanent human fibroblast virus (PMFV) is also type D. The core of the type D viruses is the intracytoplasmic type A particle and its mechanism of budding from the cell membrane is similar to the type B oncoviruses. Oncogenic Viruses (72-76); Retroviridae (77-90)  QAz9Retroviruses, Simian B04.820.650.805; B04.909.574.807.805; B04.909.777.731.805 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Leukemia Virus, Gibbon Ape; Retroviruses Type D, Simian (+ 1); Sarcoma Viruses, Simian; SIV; STLV Leukemia Virus, Gibbon Ape; Retroviruses Type D, Simian (+ 1); Sarcoma Viruses, Simian; STLV Leukemia Virus, Gibbon Ape; Retroviruses Type D, Simian (+ 1); Sarcoma Viruses, Simian; SIV; STLV Classes of retroviruses for which monkeys or apes are hosts. Those isolated from the West African green monkey and the Asian rhesus macaque monkey are of particular interest because of their similarities to viruses causing cancer and acquired immunodeficiency syndrome (AIDS) in humans. Monkey Diseases (78-88); Retroviridae (78-88)  VA]N7Retroviruses, MLV-Related B04.820.650.730; B04.909.574.807.730; B04.909.777.731.730 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Reticuloendotheliosis Viruses (+ 1); Retroviruses Type C, Mammalian (+ 19) Reticuloendotheliosis Viruses (+ 1); Retroviruses Type C, Mammalian (+ 19) Reticuloendotheliosis Viruses (+ 1); Retroviruses Type C, Mammalian (+ 19) A genus of the family RETROVIRIDAE consisting of viruses with type C morphology that are related to murine leukemia virus. Three subgenera exist: RETICULOENDOTHELIOSIS VIRUSES, mammalian type C viruses (RETROVIRUSES TYPE C, MAMMALIAN), and reptilian type C viruses. MLV-related viruses are associated with a variety of diseases including malignancies, neurological disorders, and immunosuppressive diseases. [ ARetroviruses, ALV-Related B04.820.650.700; B04.909.574.807.720; B04.909.777.731.720 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Erythroblastosis Virus, Avian; Leukosis Virus, Avian; Myeloblastosis Virus, Avian; Sarcoma Viruses, Avian Erythroblastosis Virus, Avian; Leukosis Virus, Avian; Myeloblastosis Virus, Avian; Sarcoma Viruses, Avian Erythroblastosis Virus, Avian; Leukosis Virus, Avian; Myeloblastosis Virus, Avian; Sarcoma Viruses, Avian A genus of the family RETROVIRIDAE with type C morphology, that causes malignant and other diseases in wild birds and domestic fowl. _lAmRetroviruses Type D, Simian B04.820.650.805.590; B04.820.650.815.750; B04.909.574.807.805.590; B04.909.574.807.815.750; B04.909.777.731.805.590; B04.909.777.731.815.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, Simian Viruses; RNA Viruses; Retroviridae; Retroviruses, Type D Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Type D Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Type D Mason-Pfizer Monkey Virus Mason-Pfizer Monkey Virus Mason-Pfizer Monkey Virus Mason-Pfizer Monkey Virus Mason-Pfizer Monkey Virus Mason-Pfizer Monkey Virus Type D retroviruses that cause simian acquired immunodeficiency syndrome (SAIDS) and malignancies in monkeys. At least five serotypes of SRV are recognized: SRV-1, SRV-2 (Retrovirus-D/New England), SRV-3 (MASON-PFIZER MONKEY VIRUS), SRV-4, and SRV-5. Subcutaneous fibrosarcoma is associated with SRV-1 infection and retroperitoneal fibromatosis is associated with SRV-2 infection. Retroviridae (83-87); SIV (88-90)  b"1*Retroviruses Type C, Mammalian B04.820.650.730.730; B04.909.574.807.730.730; B04.909.777.731.730.730 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related Leukemia Virus, Feline; Leukemia Virus, Gibbon Ape; Sarcoma Virus, Feline; Sarcoma Viruses, Simian; Tumor Viruses, Murine (+ 14) Leukemia Virus, Feline; Leukemia Virus, Gibbon Ape; Sarcoma Virus, Feline; Sarcoma Viruses, Simian; Tumor Viruses, Murine (+ 14) Leukemia Virus, Feline; Leukemia Virus, Gibbon Ape; Sarcoma Virus, Feline; Sarcoma Viruses, Simian; Tumor Viruses, Murine (+ 14) A subgenus of MLV-related retroviruses (RETROVIRUSES, MLV-RELATED) comprising endogenous sequences in mammals that are related to the reticuloendotheliosis viruses of birds. Many species contain oncogenes and cause leukemias and sarcomas. h%M'Retroviridae Proteins, Oncogenic D12.776.677.520.750; D12.776.964.700.750; D12.776.964.775.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins Fusion Proteins, gag-onc (+ 1); Gene Products, rex; Gene Products, tax; Oncogene Protein gp140(v-fms); Oncogene Protein p21(ras); Oncogene Protein p55(v-myc); Oncogene Protein pp60(v-src); Oncogene Proteins v-abl; Oncogene Proteins v-erbA; Oncogene Proteins v-erbB; Oncogene Proteins v-fos; Oncogene Proteins v-mos Fusion Proteins, gag-onc (+ 1); Gene Products, rex; Gene Products, tax; Oncogene Protein gp140(v-fms); Oncogene Protein p21(ras); Oncogene Protein p55(v-myc); Oncogene Protein pp60(v-src); Oncogene Proteins v-abl; Oncogene Proteins v-erbA; Oncogene Proteins v-erbB; Oncogene Proteins v-fos; Oncogene Proteins v-mos Fusion Proteins, gag-onc (+ 1); Gene Products, rex; Gene Products, tax; Oncogene Protein gp140(v-fms); Oncogene Protein p21(ras); Oncogene Protein p55(v-myc); Oncogene Protein pp60(v-src); Oncogene Proteins v-abl; Oncogene Proteins v-erbA; Oncogene Proteins v-erbB; Oncogene Proteins v-fos; Oncogene Proteins v-mos Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic. Retroviridae Proteins (86-89); Viral Proteins (80-85)  mc&EFZa@Retroviridae Proteins D12.776.964.775 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins Gene Products, env (+ 2); Gene Products, gag (+ 4); Gene Products, pol (+ 3); Retroviridae Proteins, Oncogenic (+ 13) Proteins from the family Retroviridae. The most frequently encountered member of this family is the Rous sarcoma virus protein. Antigens, Viral, Tumor (84-85); Viral Proteins (66-85)  uFWBRetroviridae Infections C02.782.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Avian Leukosis; HTLV-BLV Infections (+ 6); Lentivirus Infections (+ 12); Leukemia, Feline; Murine Acquired Immunodeficiency Syndrome; Sarcoma, Avian Virus diseases caused by the RETROVIRIDAE. Retroviridae (66-77); Virus Diseases (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $whP:46ZRetroviridae B04.820.650; B04.909.574.807; B04.909.777.731 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses HTLV-BLV Viruses (+ 4); Lentivirus (+ 14); Oncoviruses Type B, Mammalian (+ 1); Proviruses; Retroviruses, ALV-Related (+ 4); Retroviruses, MLV-Related (+ 22); Retroviruses, Simian (+ 6); Retroviruses, Type D (+ 2); Spumavirus HTLV-BLV Viruses (+ 4); Oncoviruses Type B, Mammalian (+ 1); Proviruses; Retroviruses, ALV-Related (+ 4); Retroviruses, MLV-Related (+ 22); Retroviruses, Simian (+ 5); Retroviruses, Type D (+ 2) HTLV-BLV Viruses (+ 4); Lentivirus (+ 14); Oncoviruses Type B, Mammalian (+ 1); Proviruses; Retroviruses, ALV-Related (+ 4); Retroviruses, MLV-Related (+ 22); Retroviruses, Simian (+ 6); Retroviruses, Type D (+ 2); Spumavirus Family of RNA viruses that infects birds and mammals and encodes the enzyme reverse transcriptase. The family contains seven genera: HTLV-BLV VIRUSES; LENTIVIRUS; ONCOVIRUSES TYPE B, MAMMALIAN; RETROVIRUSES, ALV-RELATED; RETROVIRUSES, MLV-RELATED; RETROVIRUSES, TYPE D; and SPUMAVIRUS. A key feature of retrovirus biology is the synthesis of a DNA copy of the genome which is integrated into cellular DNA. After integration it is sometimes not expressed but maintained in a latent state (PROVIRUSES). y5JRetrotransposons D13.444.308.320.700; G05.275.180.700; G05.331.599.110.280.700 DEGEIMPHRE Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA Insertion Elements Genetics; Genes; DNA Insertion Elements Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; DNA Insertion Elements Transposable elements (transposons) that involve a retrovirus-like process of reverse transcription. The DNA element is transcribed into RNA, reverse-transcribed into DNA, and then inserted at a new site in the genome. (From Lewin, Genes IV, 1990, p. 817). DNA Insertion Elements (85-94) ?E-%Retrospective Studies E05.318.760.500.500.500; G03.850.520.835.500.500.500; N05.715.360.775.175.200.710 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Case-Control Studies Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Case-Control Studies Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Case-Control Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. 3Y~Retropneumoperitoneum C21.866.748; C23.888.748 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Pathological or accidental introduction of air into the retroperitoneal space. N\Retropharyngeal Abscess C01.539.830.025.780; C07.550.858; C09.775.754 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Stomatognathic Diseases; Pharyngeal Diseases Otorhinolaryngologic Diseases; Pharyngeal Diseases A soft tissue infection of the throat with entry usually by the pharynx but sometimes as an extension of a lateral neck infection resulting from a neck injury. The major risk is upper airway obstruction caused by pharyngeal swelling. (Daniel R. Masys, from a written communication). Abscess (77-92); Pharyngeal Diseases (77-92); Pharyngitis (79-90); Pharynx (84-92) 5POdRetroperitoneal Space A01.047.681 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Abdomen An area occupying the most posterior aspect of the abdominal cavity. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the diaphragm to the brim of the true pelvis, where it continues as the pelvic extraperitoneal space. (*4Retroperitoneal Neoplasms C04.588.033.731 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Abdominal Neoplasms XJRetroperitoneal Fibrosis C23.304.787 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH) A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis. Inflammation in chronic periaortitis is thought to be caused by immune reactivity to antigen produced in the atherosclerotic aorta. N_Retrograde Obturation E06.397.778.778.648 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Endodontics; Root Canal Therapy; Root Canal Obturation $ORetrograde Degeneration G11.561.491.648 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Nerve Degeneration The series of changes in the ganglion cell (central chromatolysis with displacement of the nucleus) following the severing of its axon. (Dorland, 27th ed.). Retrognathism C05.500.460.813; C05.500.607.813; C05.660.514.813; C07.320.440.813; C07.320.610.813; C07.650.460.813; C16.131.621.514.813; C16.131.850.460.813 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Malocclusion, Angle Class II; Malocclusion Musculoskeletal Diseases; Jaw Diseases; Jaw Abnormalities Musculoskeletal Diseases; Jaw Diseases; Mandibular Diseases Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Stomatognathic Diseases; Jaw Diseases; Jaw Abnormalities Stomatognathic Diseases; Jaw Diseases; Mandibular Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities Retrusion of the mandible. (Dorland, 27th ed). (L3;Retrocochlear Diseases (Non MeSH) C09.218.807 Otorhinolaryngologic Diseases; Ear Diseases Acoustic Nerve Diseases (+ 2); Auditory Diseases, Central (+ 2) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI (3NXRetraction of Publication L01.737.840 Scientific Misconduct Information Science; Publishing &Retirement I03.702 CLECHILJPXSNSTTD Aged Human Activities (Non MeSH) The state of being retired from one's position or occupation. o "KRetinopathy of Prematurity C11.768.836; C16.614.521.731 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Infant, Premature, Diseases A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed). 8 "LRetinol-Binding Proteins D12.776.124.790.106.750; D12.776.157.700; D12.776.377.715.085.750 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Proteins which bind with retinol. The retinol-binding protein found in plasma has an alpha-1 mobility on electrophoresis and a molecular weight of 21,000-22,000. The protein has one binding site for retinol and is responsible for the transport of Vitamin A. The retinol- protein complex (molecular weight 80,000 to 90,000) circulates in plasma in the form of a protein-protein complex with prealbumin. The retinol-binding protein found in tissue has a molecular weight of 14,000 and carries retinol as a non-covalently-bound ligand. Blood Proteins (72-75); Protein Binding (72-75); Proteins (72-75); Retinol (75); Vitamin A (72-74) IDMkzRetinoids D02.455.849.291.700; D11.557.261.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids Acitretin; Etretinate; Fenretinide; Isotretinoin; Retinaldehyde; Tretinoin; Vitamin A Acitretin; Etretinate; Fenretinide; Isotretinoin; Retinaldehyde; Tretinoin; Vitamin A Derivatives of vitamin A. Used clinically in the treatment of severe cystic acne, psoriasis, and other disorders of keratinization. Their possible use in the prophylaxis and treatment of cancer is being actively explored. Vitamin A (69-74); Vitamin A/analogs and derivatives (75-83) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ *8JDRetinoblastoma Protein D12.776.260.770; D12.776.660.770; D12.776.744.770 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Phosphoproteins Product of the retinoblastoma tumor suppressor gene. It is a nuclear phosphoprotein hypothesized to normally act as an inhibitor of cell proliferation. Rb protein is absent in retinoblastoma cell lines. It also has been shown to form complexes with the adenovirus E1A protein, the SV40 T antigen, and the human papilloma virus E7 protein. Phosphoproteins (90) 9F Retinoblastoma C04.557.465.625.600.725; C04.557.470.670.725; C04.557.580.625.600.725 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Genes, Retinoblastoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial A malignant tumor arising from the nuclear layer of the retina. It is the most common primary tumor of the eye in children. It may be multifocal, bilateral, congenital, inherited, or acquired. Patients with the inherited form also appear to be at increased risk for second, nonocular malignancies. It is usually diagnosed initially by a bright white or yellow pupillary reflex (leukokoria). (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1631; Dorland, 27th ed). MXJRetinitis Pigmentosa C11.270.684; C11.768.585.731; C16.131.410.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Diseases, Hereditary Eye Diseases; Retinal Diseases; Retinal Degeneration Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary  Kearns Syndrome Hereditary, progressive degeneration of the neuroepithelium of the retina characterized by night blindness and progressive contraction of the visual field. 5NRetinitis C11.768.773 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Chorioretinitis; Cytomegalovirus Retinitis; Retinal Necrosis Syndrome, Acute Inflammation of the retina. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the optic nerve (neuroretinitis). The disease may be confined to one eye, but since it is generally dependent on a constitutional factor, it is almost always bilateral. It may be acute in course, but as a rule it lasts many weeks or even several months. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI   N&XPRetinaldehyde D02.047.850; D02.455.849.291.700.690; D11.557.261.700.690 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids A carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in "dark" reactions to return to the native trans-configuration. %AD Retinal Vessels A07.231.611 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Fluorescein Angiography Cardiovascular System; Blood Vessels Retinal Artery; Retinal Vein The vessels which supply and drain the retina.  8,$:Retinal Vein Occlusion C11.768.760; C14.907.355.830.630; C14.907.760 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis Cardiovascular Diseases; Vascular Diseases Occlusion of the retinal vein. Those at high risk for this condition include patients with hypertension, diabetes mellitus, arteriosclerosis, and other cardiovascular diseases. Retinal Diseases (72-86); Retinal Vein (73-86) 5N9Retinal Vein A07.231.611.773; A07.231.908.783 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Retinal Vessels Cardiovascular System; Blood Vessels; Veins Central retinal vein and its tributaries. It runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus. Retinal Vessels (66-72) &8sRetinal Pigments D11.557.261.648 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Rods and Cones Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids Opsin (+ 1) Chemicals functioning in the visual cycle in retinal rod cells. Through excitation by visible light, a series of complex molecular changes occur that serve to trigger in the optical nerve endings an impulse transmitted to the brain, resulting in the perception of vision. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $zBU?HRetinal Perforations C11.768.740 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Perforations through the whole thickness of the retina including the macula as the result of inflammation, trauma, degeneration, etc. The concept includes retinal breaks, tears, dialyses, and holes. Retinal Detachment (66-83) N& Retinal Neovascularization C11.768.725; C23.739.589.500.725 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Metaplasia; Neovascularization New blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina. This process is characterized by a diseased retina with a disturbed vascular bed. Neovascularization is associated with a variety of conditions including vascular occlusion, sickle cell diseases, sarcoidosis. Neovascularization (66-89); Retinal Diseases (74-89); Retinal Vessels (69-89) &Nx\Retinal Necrosis Syndrome, Acute C11.768.773.674 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases; Retinitis Mild to fulminant necrotizing vaso-occlusive retinitis associated with a high incidence of retinal detachment and poor vision outcome. Necrosis (66-89); Retinal Detachment (70-89); Retinal Diseases (75-89); Retinitis (75-89) 'N3lRetinal Hemorrhage C11.290.807; C11.768.710; C23.542.290.807 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Hemorrhage Eye Diseases; Retinal Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage; Eye Hemorrhage 1NRetinal Ganglion Cells A08.663.694.530.700; A09.371.729.765; A11.671.677.530.700 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Sense Organs; Eye; Retina Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Cells of the innermost nuclear layer of the retina, the ganglion cell layer, which project axons through the optic nerve to the brain. They are quite variable in size and in the shapes of their dendritic arbors, which are generally confined to the inner plexiform layer. Retina (66-82) GA*ARetinal Dysplasia C11.250.666; C11.270.660; C11.768.660; C16.131.384.784; C16.131.410.660 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Eye Diseases; Eye Diseases, Hereditary Eye Diseases; Retinal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary Congenital, often bilateral, retinal abnormality characterized by the arrangement of outer nuclear retinal cells in a palisading or radiating pattern surrounding a central ocular space. This disorder is sometimes hereditary. Retina/abnormalities (66-89); Retinal Degeneration (70-89) SL:ERetinal Drusen C11.768.585.585 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases; Retinal Degeneration Colloid or hyaline bodies lying beneath the retinal pigment epithelium. They may occur either secondary to changes in the choroid that affect the pigment epithelium or as an autosomal dominant disorder of the retinal pigment epithelium. Hyalin Substance (66-89); Macular Degeneration (75-89); Pigment Epithelium of Eye (66-89) aN?kRetinal Diseases C11.768 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Angioid Streaks; Diabetic Retinopathy; Retinal Artery Occlusion; Retinal Degeneration (+ 5); Retinal Detachment; Retinal Dysplasia; Retinal Hemorrhage; Retinal Neovascularization; Retinal Perforations; Retinal Vein Occlusion; Retinitis (+ 3); Retinopathy of Prematurity; Vitreoretinopathy, Proliferative Retina (66-71) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  һ N`PRetinal Detachment C11.768.648 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Scleral Buckling Eye Diseases; Retinal Diseases Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed). (N&Retinal Degeneration C11.768.585 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Macular Degeneration (+ 1); Retinal Drusen; Retinitis Pigmentosa (+ 1) A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed). Eye Diseases (66-67); Retina (66-67)  N&VZ.Retinal Artery Occlusion C11.768.400; C14.907.137.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Occlusion or closure of the central retinal artery causing sudden, usually nearly complete, loss of vision in one eye. Occlusion of the branch retinal artery causes sudden visual loss in only a portion of the visual field. Arterial Occlusive Diseases (72-88); Retinal Artery (73-88); Retinal Diseases (72-88) ڏ"NwfRetinal Artery A07.231.114.765; A07.231.611.647 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Cardiovascular System; Blood Vessels; Retinal Vessels Central retinal artery and its branches. It arises from the ophthalmic artery, pierces the optic nerve and runs through its center, enters the eye through the porus opticus and branches to supply the retina. Retinal Vessels (66-72) )&8vRetina A09.371.729 ABAHCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Angioid Streaks; Electroretinography Sense Organs; Eye Fundus Oculi; Macula Lutea (+ 1); Optic Disk; Retinal Ganglion Cells; Rods and Cones (+ 3) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  J 6+r<Reticulum A13.869.697 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Stomach, Ruminant Stomach (66-67)  :5Reticuloendotheliosis Viruses B04.820.650.730.700; B04.909.574.807.730.700; B04.909.777.731.730.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related Reticuloendotheliosis Virus, Avian Reticuloendotheliosis Virus, Avian Reticuloendotheliosis Virus, Avian A subgenus of MLV-related retroviruses (RETROVIRUSES, MLV-RELATED) comprising a few isolates from birds, with no known corresponding endogenous relatives. w"M'tReticuloendotheliosis Virus, Avian B04.820.650.730.700.700; B04.909.574.807.730.700.700; B04.909.777.731.730.700.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Reticuloendotheliosis Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Reticuloendotheliosis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Reticuloendotheliosis Viruses A species of RETICULOENDOTHELIOSIS VIRUSES that causes a chronic neoplastic and a more acute immunosuppressive disease in fowl. w(YReticuloendotheliosis C04.557.386.802; C15.604.667; C20.683.515.761.802 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma Sarcoma, Mast-Cell Gaucher's Disease; Histiocytosis (+ 14); Sarcoma, Mast-Cell Sarcoma, Mast-Cell Hyperplasia of reticuloendothelial tissue, in any organ or tissue. A related concept is reticulosis which is an increase in reticuloendothelial elements. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  [9NrXReticuloendothelial System A15.382.812 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Histiocytes; Kupffer Cells; Macrophages; Phagocytes Hemic and Immune Systems (Non MeSH); Immune System Macrophages (+ 8); Monocytes (+ 1) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  8>?-<Reticulocytes A11.118.413.730; A15.145.229.413.730 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes **}Reticulocyte Count E01.223.459.107.330.725; G07.380.107.330.725 DEECISMTREVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count; Erythrocyte Count Physiology, General (Non MeSH); Cell Count; Blood Cell Count; Erythrocyte Count Determination of the number of reticulocytes in a measured volume of blood. Values for reticulocytes are expressed as a percentage of the erythrocyte count or in the form of a so-called "corrected" reticulocyte "index". An increase in circulating reticulocytes, often referred to as reticulocytosis, is among the simplest and most reliable signs of accelerated erythrocyte production. Reticulocytosis, or an increased reticulocyte count, occurs during active blood regeneration (stimulation of red bone marrow) and in certain anemias, particularly congenital hemolytic anemia. Blood Cell Count (68-88); Erythrocyte Count (66-93); Reticulocytes (66-93) 2ZReticulin D12.776.860.823 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH) K HcReticular Formation A08.186.211.132.772 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem Respiratory Center A region extending from the PONS and MEDULLA OBLONGATA through the MESENCEPHALON, characterized by a diversity of neurons of various sizes and shapes, arranged in different aggregations and enmeshed in a complicated fiber network. 58G Retention (Psychology) F02.463.425.540.772 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Memory The persistence to perform a learned behavior (facts or experiences) after an interval has elapsed in which there has been no performance or practice of the behavior. Memory (66-74) - dRete Testis A05.360.444.849.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Urogenital System; Genitalia; Genitalia, Male; Testis The network of canals at the termination of the straight seminiferous tubules in the mediastinum testis. 8A|Resuscitation Orders E02.365.647.740; I01.880.604.583.789; N03.706.535.704 LJPX Advance Directives; Euthanasia, Passive; Life Support Care; Medical Futility Therapeutics; Emergency Treatment (Non MeSH); Resuscitation Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Instructions issued by a physician pertaining to the institution, continuation, or withdrawal of life support measures. The concept includes policies, laws, statutes, decisions, guidelines, and discussions that may affect the issuance of such orders. Resuscitation (75-90)   =[!Resuscitation E02.365.647 AECLCTECEDHIISMOMTNUPXSNSTTDUTVE Drowning; Heart Arrest; Death, Sudden Therapeutics; Emergency Treatment (Non MeSH) Cardiopulmonary Resuscitation; Heart Massage; Respiration, Artificial; Resuscitation Orders The restoration to life or consciousness of one apparently dead. (Dorland, 27th ed). AECLCTECEDHIISLJMOMTNUPXSNSTTDUTVE $$/5ig&Restriction Mapping E05.393.183.815 DNA Restriction Enzymes Miscellaneous Techniques (Non MeSH); Genetic Techniques; Chromosome Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes or genes. The nucleotide sequence determined is often then translated into an amino acid sequence, providing a means for sequencing the protein for which the gene codes, or for which the mRNA is a messenger. Chromosome Mapping (66-88); DNA Restriction Enzymes (75-88); Endonucleases (71-75) YWbRestraint, Physical E05.823 AEISLJMTPXVE Immobilization; Protective Devices Miscellaneous Techniques (Non MeSH) Immobilization Use of a device for the purpose of preventing the individual from moving all or part of the body. The concept excludes splints and casts. Immobilization (66-76); Protective Devices (70-76); Stress (66-76) AEISLJMTPHPXVE (m )*PRestless Legs C10.597.751.670.647; C23.888.592.763.587.647 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Paresthesia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Paresthesia A paresthesia felt deep within the muscles of the leg, which begins when the individual is resting and forces him to keep moving the affected leg to obtain relief. Paresthesia (66-72) A2NRestaurants J01.364.772; J01.576.416.730 CLECHIISLJMASNST Technology, Industry, Agriculture (Non MeSH); Food Services Technology, Industry, Agriculture (Non MeSH); Industry; Food Handling "Rest I03.450.769.647 PHPX Bed Rest Human Activities (Non MeSH); Leisure Activities; Relaxation Freedom from activity.  HResponse Interference F03.126.185.900 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders The inability to suppress or screen out intruding associations, in order to make the appropriate response. It is primarily a schizophrenic trait. FrRespite Care N02.421.143.524.470.610; N02.421.533.320.610; N02.421.589.800 CLECHILJMAMTOGPXSDSNSTTDUT Hospice Care Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services; Home Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care; Home Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Patient care provided in the home or institution intermittently in order to provide temporary relief to the family home care giver. Home Care Services (67-84); Home Nursing (66-84)  @Es<Respiratory Transport G09.772.521.900 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration Pulmonary Gas Exchange (+ 3) The processes of gas exchange and various metabolic functions taking place in the lung, generally at the alveolar level. Respiration (66-89)   ;v$Respiratory Tract Physiology (Non MeSH) G09.772 Circulatory, Respiratory Physiology (Non MeSH) Respiration (+ 37); Sneezing; Voice (+ 2) CLDEDIETGEIMPHPPREVE  / 66Respiratory Tract Neoplasms C04.588.894.797; C08.785 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms Respiratory Tract Diseases Bronchial Neoplasms; Lung Neoplasms (+ 3); Pleural Neoplasms (+ 1); Tracheal Neoplasms Bronchial Neoplasms; Laryngeal Neoplasms; Lung Neoplasms (+ 3); Nose Neoplasms (+ 3); Pleural Neoplasms (+ 1); Tracheal Neoplasms BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  !XgZRespiratory Tract Infections C01.539.739; C08.730 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Respiratory Tract Diseases Empyema, Pleural (+ 1); Whooping Cough Bronchitis (+ 2); Common Cold; Empyema, Pleural (+ 1); Influenza; Laryngitis (+ 1); Legionellosis (+ 1); Lung Abscess; Lung Diseases, Fungal (+ 2); Lung Diseases, Parasitic (+ 1); Pharyngitis; Pleurisy (+ 1); Pneumonia (+ 11); Rhinitis; Rhinoscleroma; Sinusitis (+ 4); Tonsillitis (+ 1); Tracheitis; Tuberculosis, Laryngeal; Tuberculosis, Pleural (+ 1); Tuberculosis, Pulmonary (+ 1); Whooping Cough H"P]Respiratory Tract Fistula (Non MeSH) C08.702; C23.439.687 Respiratory Tract Diseases Symptoms and General Pathology (Non MeSH); Fistula Bronchial Fistula; Tracheoesophageal Fistula Bronchial Fistula; Tracheoesophageal Fistula BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI m,\fNRespiratory Tract Diseases C08 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bronchial Diseases (+ 16); Ciliary Motility Disorders (+ 1); Laryngeal Diseases (+ 13); Lung Diseases (+ 71); Nose Diseases (+ 24); Pleural Diseases (+ 16); Respiration Disorders (+ 25); Respiratory Hypersensitivity (+ 9); Respiratory System Abnormalities (Non MeSH) (+ 7); Respiratory Tract Fistula (Non MeSH) (+ 2); Respiratory Tract Infections (+ 48); Respiratory Tract Neoplasms (+ 13); Tracheal Diseases (+ 5) BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  N\Respiratory Therapy Department, Hospital N02.278.354.422.712; N04.452.442.422.712 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation. Hospital Departments (68-Jul 77); Respiratory Therapy (66-Jul 77) /. NRespiratory Therapy E02.880 AECLCTECEDHIISMOMTNUPXSNSTTDUTVE Administration, Inhalation Therapeutics Drainage, Postural; Extracorporeal Membrane Oxygenation; Oxygen Inhalation Therapy (+ 1); Respiration, Artificial (+ 6) Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. AECLCTECEDHIISMOMTNUPXRHSNSTTDUTVE $ $&Respiratory System Abnormalities (Non MeSH) C08.695; C16.131.740 Respiratory Tract Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Bronchogenic Cyst; Bronchopulmonary Sequestration; Choanal Atresia; Cystic Adenomatoid Malformation of Lung, Congenital; Kartagener's Syndrome; Scimitar Syndrome; Tracheobronchomegaly Bronchogenic Cyst; Bronchopulmonary Sequestration; Choanal Atresia; Cystic Adenomatoid Malformation of Lung, Congenital; Kartagener's Syndrome; Scimitar Syndrome; Tracheobronchomegaly BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI 3gVRespiratory System A04 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Bronchi; Larynx (+ 9); Lung (+ 3); Nose (+ 12); Pleura; Trachea The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. ABAHBSCHCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI 8V<Respiratory Syncytial Viruses B04.820.455.600.670.600.750; B04.909.777.455.600.670.600.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae; Pneumovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae; Pneumovirus Respiratory Syncytial Virus, Bovine; Respiratory Syncytial Virus, Human Respiratory Syncytial Virus, Bovine; Respiratory Syncytial Virus, Human A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.  \#BRespiratory Syncytial Virus, Human B04.820.455.600.670.600.750.730; B04.909.777.455.600.670.600.750.730 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae; Pneumovirus; Respiratory Syncytial Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae; Pneumovirus; Respiratory Syncytial Viruses The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor. Respiratory Syncytial Viruses (66-93) #o)J+$,Respiratory Syncytial Virus, Bovine B04.820.455.600.670.600.750.700; B04.909.777.455.600.670.600.750.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae; Pneumovirus; Respiratory Syncytial Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae; Pneumovirus; Respiratory Syncytial Viruses A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress. Respiratory Syncytial Viruses (68-93) &*J+,Respiratory Syncytial Virus Infections C02.782.580.600.620.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections; Pneumovirus Infections Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported. Paramyxoviridae Infections (77-93); Respiratory Tract Infections (66-93) )Y-PTRespiratory Sounds C23.888.852.779; E01.302.850; G09.772.521.700.701 CLDEDIETGEIMPHPPREVE Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Diagnosis; Diagnosis, Respiratory System (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Snoring Any sound emanating from any portion of the respiratory tract, especially those heard on auscultation; includes breath sounds. BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI  +9U TRespiratory Protective Devices E07.712.600 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices Respirators to protect individuals from breathing air contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or vapors. .$3Respiratory Paralysis C08.618.846.812; C10.597.622.812; C23.888.592.636.812 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Nervous System Diseases; Neurologic Manifestations; Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Paralysis (66-67); Respiratory Insufficiency (66-67) /=N >Respiratory Muscles A02.633.567.900 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Diaphragm; Intercostal Muscles These include the muscles of the DIAPHRAGM and the INTERCOSTAL MUSCLES. Diaphragm (66-86); Intercostal Muscles (66-86); Muscles (66-86); Respiration (66-86)  2:;%VfRespiratory Mechanics G09.772.521.700 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration Airway Resistance; Aspiration; Bronchoconstriction; Lung Compliance; Mucociliary Clearance; Respiratory Airflow (+ 7); Respiratory Dead Space; Respiratory Sounds; Total Lung Capacity (+ 9); Valsalva's Maneuver; Work of Breathing; Yawning The physical or mechanical action of the lungs, diaphragm, ribs, and chest wall during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc. Respiration (66-89) CLDEDIETGEIMPHPPREVE $3vRespiratory Insufficiency C08.618.846 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders Acidosis, Respiratory; Airway Obstruction (+ 1); Granuloma, Laryngeal; Hantavirus Pulmonary Syndrome; Hypoventilation; Positive-Pressure Respiration, Intrinsic; Respiratory Paralysis BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI 6N:PRespiratory Hypersensitivity C08.674; C20.543.480.680 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate Alveolitis, Extrinsic Allergic (+ 2); Aspergillosis, Allergic Bronchopulmonary; Asthma (+ 2); Hay Fever; Rhinitis, Allergic, Perennial Alveolitis, Extrinsic Allergic (+ 2); Aspergillosis, Allergic Bronchopulmonary; Asthma (+ 2); Hay Fever; Rhinitis, Allergic, Perennial A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and HAY FEVER. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  8!Nk<pPRespiratory Function Tests E01.302.796 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Respiratory System (Non MeSH) Airway Resistance; Blood Gas Analysis (+ 2); Bronchial Provocation Tests; Exercise Test; Lung Compliance; Lung Volume Measurements (+ 10); Plethysmography, Whole Body; Pulmonary Gas Exchange (+ 2); Respiratory Airflow (+ 7); Respiratory Dead Space; Spirometry (+ 1); Valsalva's Maneuver; Work of Breathing AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE ; "=o,Respiratory Distress Syndrome, Adult C08.381.840; C08.618.840 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sepsis Syndrome Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiration Disorders A syndrome of life-threatening progressive pulmonary insufficiency in the absence of known pulmonary disease, usually following a systemic insult such as surgery or major trauma. >1+NjRespiratory Distress Syndrome C08.381.801; C08.618.801; C16.614.521.563 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiration Disorders Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Infant, Premature, Diseases Hyaline Membrane Disease Hyaline Membrane Disease Hyaline Membrane Disease A condition of the newborn marked by dyspnea with cyanosis, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. (From Dorland, 27th ed). @<#1LVRespiratory Dead Space E01.302.796.662; G09.772.521.700.696 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Respiration (66-68) D *Respiratory Circulation G09.330.163.840; G09.772.521.500 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration Pulmonary Circulation Pulmonary Circulation (+ 1) The mechanisms of pulmonary circulation coordinated with the heart and systemic circulation. It involves the flow or interruption of the flow of blood to the lungs as it affects respiration. PULMONARY CIRCULATION, a circulatory concept, emphasizes the passage of blood from the right to the left heart through the lungs. RESPIRATORY CIRCULATION coordinates this with heart action, systemic circulation, and breathing. Respiration (66-89)  E&:Respiratory Center A08.186.211.132.772.646 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Reticular Formation Medulla Oblongata (66-67); Reticular Formation (66-67) I.8_ARespiratory Care Units N02.278.388.493.696 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units; Intensive Care Units The hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance. Intensive Care Units (66-70); Respiratory Tract Diseases (66-70) J[yMRespiratory Burst G06.535.723.620 DEGEIMPHRE Granulomatous Disease, Chronic Superoxides Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Oxygen Consumption A large increase in oxygen uptake by neutrophils and most types of tissue macrophages through activation of an NADPH-cytochrome b-dependent oxidase that reduces oxygen to a superoxide. Individuals with an inherited defect in which the oxidase that reduces oxygen to superoxide is decreased or absent (GRANULOMATOUS DISEASE, CHRONIC) often die as a result of recurrent bacterial infections. Oxygen Consumption (76-91) $L9$f Respiratory Airflow E01.302.796.624; G09.772.521.700.646 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Forced Expiratory Flow Rates (+ 4); Forced Expiratory Volume; Maximal Voluntary Ventilation Forced Expiratory Flow Rates (+ 4); Forced Expiratory Volume; Maximal Voluntary Ventilation Respiration (66-70) O*Respiration, Artificial E02.365.647.729; E02.880.820 AECLCTECHIISMOMTNUPXSNSTTDUTVE Ventilators, Mechanical Therapeutics; Emergency Treatment (Non MeSH); Resuscitation Therapeutics; Respiratory Therapy  High-Frequency Ventilation (+ 1); Positive-Pressure Respiration (+ 2); Ventilator Weaning Qn""mkRespiration Disorders C08.618 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases Apnea (+ 2); Cheyne-Stokes Respiration; Cough; Dyspnea (+ 1); Hoarseness; Hyperventilation (+ 1); Laryngismus; Meconium Aspiration; Mouth Breathing; Respiratory Distress Syndrome (+ 1); Respiratory Distress Syndrome, Adult; Respiratory Insufficiency (+ 8) Use for general material on diseases of the respiratory system or for specific diseases for which no main heading is provided. Respiration (66-76); Respiratory Insufficiency (66-76) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $R N 0@PRespiration G09.772.521 DEGEIMPHRE Apnea; Breath Tests; Breathing Exercises; Dyspnea; Mouth Breathing Lung Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH) Respiratory Circulation (+ 2); Respiratory Mechanics (+ 28); Respiratory Transport (+ 4) The act of breathing with the lungs, consisting of inspiration, or the taking into the lungs of the ambient air, and of expiration, or the expelling of the modified air which contains more carbon dioxide than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration (= OXYGEN CONSUMPTION). CLDEDIETGEIMPHPPREVE (VQfkResorcinols D02.755.852 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Hexylresorcinol; Zearalenone (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Y48/*@Resins, Synthetic D25.720.716.822 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers; Plastics Acrylic Resins (+ 3); Bone Cements; Composite Resins (+ 1); Epoxy Resins Polymers of high molecular weight which at some stage are capable of being molded and then harden to form useful components. Plastics (66-74) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $ZJ,L\.Resins D25.786 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH) Amber; Balsams; Propolis \N  ,3 Residual Volume E01.302.796.420.810.390.820; G09.772.521.700.810.390.820 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity; Functional Residual Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity; Functional Residual Capacity The volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is RV. ]>Residential Treatment F04.754.864.696 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy A specialized program for treating children with behavior disorders who live in residential centers. _jvResidential Mobility G03.850.505.400.800.700; N01.224.791.700 SNTD Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Residence Characteristics Population Characteristics (Non MeSH); Demography; Residence Characteristics Frequent change of residence, either in the same city or town, or between cities, states or communities. Emigration and Immigration (66-67); Population (66-67); Transients and Migrants (66-67) `.}hResidential Facilities N02.278.825 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Group Homes; Halfway Houses; Homes for the Aged; Nursing Homes (+ 2) Long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required. c"LVResidence Characteristics G03.850.505.400.800; N01.224.791 CLSN Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography Population Characteristics (Non MeSH); Demography Catchment Area (Health); Housing; Residential Mobility Catchment Area (Health); Housing (+ 2); Residential Mobility Elements of residence that characterize a population. They are applicable in determining need for and utilization of health services. Emigration and Immigration (66-67); Transients and Migrants (66-67) CLECHILJMAOGSDSNSTTDUT $d&PReserpine D03.132.973.641.696; D03.549.937.641.646; D14.100.050.600.050.710; D14.100.600.050.710; D16.050.850.805; D18.162.804.811 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Yohimbans; Rauwolfia Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Yohimbans; Rauwolfia Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents; Rauwolfia Alkaloids An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. g :Research Support H01.770.727; N03.219.483.645 CLECHILJMTOGSNSTTD Education Physical Sciences (Non MeSH); Science Economics, Organizations, Control (Non MeSH); Economics; Financial Support (Non MeSH) Financial support of research activities. m'" 2Research Personnel M01.526.839; M01.770 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Named Groups (Non MeSH)  Astronauts Those individuals engaged in research. Research (66-67)  nli/Research Design H01.770.644.728 LJSNSTTD Physical Sciences (Non MeSH); Science; Research Double-Blind Method; Meta-Analysis; Patient Selection; Random Allocation; Sample Size A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. o ;eResearch H01.770.644 CLECEDHIISLJMAMTOGSNSTTD Information Services; Nursing Research; Operations Research; Systems Analysis Physical Sciences (Non MeSH); Science Animal Testing Alternatives; Clinical Protocols; Feasibility Studies; Human Genome Project; Peer Review, Research; Pilot Projects; Reproducibility of Results; Research Design (+ 5) Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed).  qW [/Rescue Work G03.230.100.350 CLECHILJMAMTOGSNSTTDUT Relief Work Environment and Public Health (Non MeSH); Environment; Disasters Activities devoted to freeing persons or animals from danger to life or well-being in accidents, fires, bombings, floods, earthquakes, other disasters and life-threatening conditions. While usually performed by team efforts, rescue work is not restricted to organized services. Emergency Medical Services (68-94)  tN@)Reptiles B02.833 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates Alligators and Crocodiles; Lizards (+ 1); Snakes (+ 12); Turtles v  &RReptilase D08.586.277.656.732.760.745; D19.461.427.641; D24.185.965.850.960.200.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Viper Venoms; Crotalid Venoms A proteolytic enzyme obtained from the venom of fer de lance (Bothrops atrox). It is used as a plasma clotting agent for fibrinogen and for the detection of fibrinogen degradation products. The presence of heparin does not interfere with the clotting test. Peptide Hydrolases (69-74); Snakes (69-74); Venoms (69-74) w QF1HReproductive Medicine G02.403.776.675 CLECEDHIISLJMAMTOGSNSTTD Reproduction Techniques Gynecology Health Occupations; Medicine; Specialties, Medical A medical-surgical specialty concerned with the morphology, physiology, biochemistry, and pathology of reproduction in man and other animals, and on the biological, medical, and veterinary problems of fertility and lactation. It includes ovulation induction, diagnosis of infertility and recurrent pregnancy loss, and assisted reproductive technologies such as embryo transfer, in vitro fertilization, and intrafallopian transfer of zygotes. (From Infertility and Reproductive Medicine Clinics of North America, Foreword 1990; Journal of Reproduction and Fertility, Notice to Contributors, Jan 1979).  {m<Reproductive History E01.579.815; G03.850.490.812; N05.715.350.575 Diagnosis; Medical History Taking Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors An important aggregate factor in epidemiological studies of women's health. The concept usually includes the number and timing of pregnancies and their outcomes, the incidence of breast feeding, and may include age of menarche and menopause, regularity of menstruation, fertility, gynecological or obstetric problems, or contraceptive usage. ~5Reproductive Control Agents (Non MeSH) D07 Abortifacient Agents (+ 7); Contraceptive Agents (+ 48); Fertility Agents (+ 6); Luteolytic Agents (+ 1); Menstruation-Inducing Agents (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR .HReproduction, Urogenital Physiology (Non MeSH) G08 Blood-Testis Barrier; Reproduction (+ 99); Reproduction, Asexual; Urinary Tract Physiology (Non MeSH) (+ 6) AEBLCFCICLCNCOCTDEDHDIDTECEDEHEMENEPETGEHIIMISLJMEMIMOMTNUPAPCPHPPPSPXRARERHRIRTSNSTSUTDTHURUSUTVEVI 6hReproduction, Asexual G08.730 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH) Reproduction without fusion of sex cells. _ 63Reproduction Techniques E05.820 AECLCTECHIISLJMONUPXSNSTTDUTVE Reproductive Medicine Miscellaneous Techniques (Non MeSH) Breeding (+ 4); Embryo Transfer; Fallopian Tube Patency Tests; Fertilization in Vitro; Gamete Intrafallopian Transfer; Insemination, Artificial (+ 2); Oocyte Donation; Ovulation Detection; Ovulation Induction; Zygote Intrafallopian Transfer Methods pertaining to the generation of new individuals. AEBLCFCLCTDEECEHGEHIIMISLJMEMOMTNUPHPXRESNSTTDURUTVE $ "*D8Reproduction G08.520 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH) Fertility; Fertilization (+ 5); Fetal Development (+ 5); Gametogenesis (+ 4); Insemination (+ 1); Maternal Age (+ 2); Menstrual Cycle (+ 8); Oviposition; Ovum Implantation (+ 3); Parity; Parthenogenesis; Paternal Age; Placentation; Pregnancy (+ 14); Pregnancy, Animal (+ 7); Pregnancy, Multiple (+ 7); Pregnancy Trimesters (Non MeSH) (+ 3); Pregnancy, Unwanted; Prenatal Exposure Delayed Effects; Pseudopregnancy; Puerperium (+ 3); Sex (+ 5); Sex Characteristics; Sex Reversal, Gonadal; Sexual Reproduction Periods (Non MeSH) (+ 7) AEBLCFCICLCNCOCTDEDHDIDTECEDEHEMENEPETGEHIIMISLJMEMIMOMTNUPAPCPHPPPSPXRARERHRIRTSNSTSUTDTHURUSUTVEVI p 6hReproducibility of Results E05.318.780.725; E05.337.851; G03.850.520.840.725; H01.770.644.601; N05.715.360.780.685 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Miscellaneous Techniques (Non MeSH); Evaluation Studies Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Science; Research Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.  cRepressor Proteins D12.776.930.700 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Proteins which are normally bound to the operator locus of an operon, thereby preventing transcription of the structural genes. In enzyme induction, the substrate of the inducible enzyme binds to the repressor protein, causing its release from the operator and freeing the structural genes for transcription. In enzyme repression, the end product of the enzyme sequence binds to the free repressor protein, the resulting complex then binds to the operator and prevents transcription of the structural genes. Bacterial Proteins (66-78); Enzyme Repression (66-78); Genes, Regulator (68-78); Transcription, Genetic (73-78) `D^NRepression-Sensitization Scales F01.393.821.645.645; F03.407.821.645.645 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms; Repression; Repression-Sensitization Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms; Repression; Repression-Sensitization Scales used to identify two polar types of defensive reaction - approach and avoidance responses - to threatening stimuli. %$.Repression-Sensitization F01.393.821.645; F03.407.821.645 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms; Repression Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms; Repression Repression-Sensitization Scales Repression-Sensitization Scales Defense mechanisms involving approach and avoidance responses to threatening stimuli. The sensitizing process involves intellectualization in approaching or controlling the stimulus whereas repression involves unconscious denial in avoiding the stimulus. Repression (66-70) &F!Repression F01.393.821; F03.407.821 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Repression-Sensitization (+ 1) Repression-Sensitization (+ 1) The active mental process of keeping out and ejecting, banishing from consciousness, ideas or impulses that are unacceptable to it. FReplicon G05.331.599.110.720; G06.184.599.110.720 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence Replication Origin Replication Origin Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). DNA Replication (68-79); DNA/biosynthesis (66-67)  k .,9<Replication Origin G05.331.599.110.720.725; G06.184.599.110.720.725 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Replicon Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Replicon A unique DNA sequence of a replicon at which DNA replication is initiated and proceeds bidirectionally or unidirectionally. It contains the sites where the first separation of the complementary strands occurs, a primer RNA is synthesized, and the switch from primer RNA to DNA synthesis takes place. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed). DNA Replication (69-94) j6Replica Techniques E05.909.262.620.620; E05.909.432.600.620 CLECHIISSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques Corrosion Casting; Freeze Fracturing (+ 1) Corrosion Casting; Freeze Fracturing (+ 1) Methods of preparing tissue specimens for visualization using an electron microscope, usually a scanning electron microscope. The methods involve the creation of exact copies of the specimens by making a mold or cast (i.e., replica) of the specimen. Microscopy, Electron (73-91); Microscopy, Electron, Scanning (67-91) CLECHIISMTSNSTTDUTVE $.f$PReplantation E04.936.494 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Amputation, Traumatic Surgery, Operative; Transplantation Tooth Replantation Restoration of an organ or other structure to its original site. AECLCTECHIISMAMOMTNUPXRHSNSTTDUTVE $R$*O&Repetitive Sequences, Nucleic Acid G05.331.599.110.708; G06.184.599.110.708 DEGEIMPHRE Genes, Reiterated; DNA; RNA Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence HIV Long Terminal Repeat (+ 1); Immunoglobulin Switch Region; Variable Number of Tandem Repeats HIV Long Terminal Repeat (+ 1); Immunoglobulin Switch Region; Variable Number of Tandem Repeats Nucleotide sequences present in multiple copies in the genome. They include direct, inverted, tandem, and terminal repeat sequences and the Alu family repeat (named for the restriction endonuclease cleavage enzyme Alu I). Base Sequence (71-80); DNA (68-80) DEGEIMIPPHRE ().$,Repetition Strain Injury C21.866.844.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Sprains and Strains Harmful and painful condition caused by overuse or overexertion of some part of the musculoskeletal system. Occupational Diseases (66-87); Sprains and Strains (66-87) ^NjFReperfusion Injury C14.907.553.700; C23.814.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Ischemia Symptoms and General Pathology (Non MeSH); Postoperative Complications Myocardial Reperfusion Injury Myocardial Reperfusion Injury Functional, metabolic, or structural changes, including necrosis, in ischemic tissues thought to result from REPERFUSION to ischemic areas of the tissue. The most common instance is MYOCARDIAL REPERFUSION INJURY. Ischemia (71-88); Perfusion (71-88)  3"ND,Reperfusion E04.752.700; E05.680.730 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH) Miscellaneous Techniques (Non MeSH); Perfusion Myocardial Reperfusion Myocardial Reperfusion Restoration of blood supply to tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. It is primarily a procedure for treating infarction or other ischemia, by enabling viable ischemic tissue to recover, thus limiting further necrosis. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing REPERFUSION INJURY. Ischemia (69-88); Perfusion (68-88); specific organ/blood supply (76-88)  $v44XReovirus Type 3 B04.820.630.590.700; B04.909.777.714.590.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae; Orthoreovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae; Orthoreovirus A species of ORTHOREOVIRUS and the suspected cause of biliary atresia and neonatal hepatitis in human infants. 2Reoviridae Infections C02.782.791 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) African Horsesickness; Bluetongue; Colorado Tick Fever; Rotavirus Infections Infections produced by reoviruses, general or unspecified. Reoviridae (66-67); Virus Diseases (66-67)  .P:ZE4Reoviridae B04.820.630; B04.909.777.714 CHCLDEENGDGEIMIPMEPHPYREUL Arboviruses Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Coltivirus (+ 1); Orbivirus (+ 4); Orthoreovirus (+ 1); Rotavirus Coltivirus (+ 1); Orbivirus (+ 4); Orthoreovirus (+ 1); Rotavirus A family of unenveloped RNA viruses with cubic symmetry. The eight genera include ORTHOREOVIRUS, ORBIVIRUS, COLTIVIRUS, ROTAVIRUS, Aquareovirus, Cypovirus, Phytoreovirus, and Fijivirus.  "YReoperation E04.690 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Surgery, Operative A repeat operation for the same condition in the same patient. It includes reoperation for reexamination, reoperation for disease progression or recurrence, or reoperation following operative failure. : $Renin-Angiotensin System G06.535.805; G09.330.612.805 DEGEIMPHRE Angiotensin-Converting Enzyme Inhibitors Aldosterone; Angiotensins; Angiotensin II Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics A system consisting of renin, angiotensin-converting enzyme, and angiotensin II. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex. Angiotensin II (66-81); Renin (66-81) $".2C/Renin D08.586.277.656.732.066.780 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Juxtaglomerular Apparatus Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Aspartic Proteinases An enzyme which is secreted by the kidney and is formed from prorenin in plasma and kidney. The enzyme cleaves the Leu-Leu bond in angiotensinogen to generate angiotensin I. EC 3.4.23.15. (Formerly EC 3.4.99.19).  FRenal Veins A07.231.908.752 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins Short thick veins which return blood from the kidneys to the vena cava. 85XRenal Tubular Transport, Inborn Errors C12.777.419.815; C18.452.648.851 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Acidosis, Renal Tubular; Aminoaciduria, Renal (+ 2); Cystinosis (+ 1); Glycosuria, Renal; Hypophosphatemia, Familial; Oculocerebrorenal Syndrome; Pseudohypoaldosteronism Acidosis, Renal Tubular; Aminoaciduria, Renal (+ 2); Cystinosis (+ 1); Glycosuria, Renal; Hypophosphatemia, Familial; Oculocerebrorenal Syndrome; Pseudohypoaldosteronism Genetically determined disorders of the reabsorptive functions of the kidney with regard to specific nephron segments responsible for specific transport functions, classifiable by proximal nephron function, loop of Henle function, and distal nephron function. The transport defects can be selective or nonselective. (From Cecil Textbook of Medicine, 19th ed, p. 584; Harrison's Principles of Internal Medicine, 12th ed, p. 1140). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  '.&LNRenal Replacement Therapy E02.870 AECLCTECHIISMOMTNUPXSNSTTDUTVE Kidney; Kidney Diseases Therapeutics Hemodialysis (+ 2); Hemofiltration (+ 1); Kidney, Artificial; Kidney Transplantation; Peritoneal Dialysis (+ 1) Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys. AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISDSNSTTDUSUTVE $Ć "z4Renal Plasma Flow, Effective G09.330.163.812.750 DEGEIMPHRE Kidney Glomerulus Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation; Renal Circulation The amount of plasma flowing to the parts of the kidney that have a function in the production of constituents of urine. It is the amount of plasma perfusing the kidney tubules per unit time, generally measured by p-aminohippurate clearance. It should be differentiated from RENAL PLASMA FLOW which is approximately 10% greater than the effective renal plasma flow. (Stedman, 25th ed; Dorland, 27th ed). Kidney/blood supply (66-81); Regional Blood Flow (67-81); Renal Circulation (82-93)  c#eRenal Plasma Flow G09.330.163.812.740 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation; Renal Circulation The amount of plasma that perfuses the kidneys per unit time, approximately 10% greater than effective renal plasma flow (RENAL PLASMA FLOW, EFFECTIVE). It should be differentiated from the renal blood flow (RBF) which refers to the total volume of blood flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow (RPF). Kidney/blood supply (66-81); Regional Blood Flow (66-81); Renal Circulation (82-93) eRenal Osteodystrophy C12.777.419.795; C19.642.355.480.645 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Endocrine Diseases; Parathyroid Diseases; Hyperparathyroidism; Hyperparathyroidism, Secondary Decalcification of bone due to hyperparathyroidism secondary to chronic kidney disease. *NfRenal Circulation G09.330.163.812 DEGEIMPHRE Kidney Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation Renal Blood Flow, Effective; Renal Plasma Flow; Renal Plasma Flow, Effective The circulation of the blood through the vessels of the kidney. Kidney/blood supply (66-81); Regional Blood Flow (66-81) $δ \NERenal Blood Flow, Effective G09.330.163.812.700 DEGEIMPHRE Kidney Glomerulus Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation; Renal Circulation The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from RENAL PLASMA FLOW, EFFECTIVE which is based on the amount of plasma rather than on total renal blood. (Stedman, 25th ed; Dorland, 27th ed). Kidney/blood supply (70-81); Regional Blood Flow (70-81); Renal Circulation (82-93)  Д"eRenal Artery Obstruction C12.777.419.775; C14.907.137.727 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypertension, Renovascular Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Narrowing or occlusion of the renal arteries. It is due usually to atherosclerosis, fibromuscular dysplasia, thrombosis, embolism, or external pressure. It may result in renovascular hypertension. &NRenal Artery A07.231.114.745 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters. f88iRenal Agents (Non MeSH) D19.770 Hematologic, Gastric, Renal Agents (Non MeSH) Anti-Infective Agents, Urinary (+ 1); Diuretics (+ 37); Probenecid; Vasopressins (+ 5) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ׆ 6jFRemoxipride D02.065.277.796; D02.241.223.106.162.796; D14.100.150.175.827; D15.150.750; D15.210.950.040.750; D15.700.872.331.720 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents An antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. Benzamides (84-92) ظ:mRemission, Spontaneous C23.280.775 Symptoms and General Pathology (Non MeSH); Disease A spontaneous diminution or abatement of the symptoms of a disease. >RRemission Induction E02.860 MT Disease-Free Survival Therapeutics Therapeutic act or process that initiates a response to a complete or partial remission level. ݩ qReminder Systems L01.143.820; L01.700.508.300.790 CLECHIISLJSDSNSTTDUT Information Science; Communication Information Science; Medical Informatics; Medical Informatics Applications; Information Systems Systems used to prompt or aid the memory. The systems can be computerized reminders, color coding, telephone calls, or devices such as letters and postcards. ޔ&Remedial Teaching F02.784.629.709; I02.903.694 CLECHILJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Education; Teaching Specialized instruction for students deviating from the expected norm. Z"SReligious Philosophies (Non MeSH) K01.844.799 Humanities; Religion Mysticism; Spiritualism; Yoga HIPX (%Religion and Sex K01.844.754 Sex Humanities; Religion EReligion and Science K01.844.709 Science Humanities; Religion  Religion and Psychology F02.880; K01.844.664 Psychologic Processes and Principles (Non MeSH) Humanities; Religion Pastoral Care The interrelationship of psychology and religion. CLECEDHIISLJMAMTOGSNSTTD P;Religion and Medicine K01.844.619 Humanities; Religion /Religion K01.844 HI Humanities Buddhism; Christianity (+ 3); Hinduism; Islam; Judaism; Religion and Medicine; Religion and Psychology; Religion and Science; Religion and Sex; Religious Philosophies (Non MeSH) (+ 3) A set of beliefs concerning the nature, cause, and purpose of the universe, especially when considered as the creation of a superhuman agency. It usually involves devotional and ritual observances and often a moral code for the conduct of human affairs. (Random House Collegiate Dictionary, rev. ed.). HIPX    dRelief Work G03.230.100.300; I01.880.787.839 CLECHILJOGSNST Social Work; Disasters; Rescue Work; Natural Disasters Environment and Public Health (Non MeSH); Environment; Disasters Social Sciences; Sociology; Social Welfare Assistance, such as money, food, or shelter, given to the needy, aged, or victims of disaster. It is usually granted on a temporary basis. (From The American Heritage Dictionary, 2d college ed). -&CRelaxin D06.472.866.362.769 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Corpus Luteum Hormones H DoRelaxation Techniques E02.040.750; F04.754.137.750 CLECEDHIISLJMAOGSNSTTD Therapeutics; Alternative Medicine Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Behavior Therapy The use of muscular relaxation techniques in treatment. Relaxation (66-75) <"CRelaxation I03.450.769 PHPX Human Activities (Non MeSH); Leisure Activities Rest Activity which reduces feelings of tension. :5Relative Value Scales N03.219.521.710.305.500; N04.452.313.500 Rate Setting and Review; Fees, Medical Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms Health Services Administration (Non MeSH); Organization and Administration; Fee Schedules Coded listings of physician or other professional services using units that indicate the relative value of the various services they perform. They take into account time, skill, and overhead cost required for each service, but generally do not consider the relative cost-effectiveness. Appropriate conversion factors can be used to translate the abstract units of the relative value scales into dollar fees for each service based on work expended, practice costs, and training costs. Fee Schedules (88-89); Fees, Medical (86-89); Health Services Research (87-89); Reimbursement Mechanisms (86-89) ].02Relative Biological Effectiveness G03.850.810.250.275 Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Dosage The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays. Dose-Response Relationship, Radiation (73-76) '}4Relapsing Fever C01.252.400.155.644; C01.252.400.825.750; C01.252.847.193.644 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Borrelia Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Borrelia Infections An acute infection characterized by recurrent episodes of pyrexia alternating with asymptomatic intervals of apparent recovery. This condition has worldwide distribution and is caused by spirochetes of the genus BORRELIA. EPRejuvenation E02.040.730; E02.849 PHPX Therapeutics; Alternative Medicine Therapeutics 7Rejection (Psychology) F01.145.076.850 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection. Attitude (66-74) oMReiter's Disease C01.539.717; C05.550.114.782; C11.187.183.749; C12.777.767.851.644; C20.111.782 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Keratoderma Blennorrhagicum Arthritis, Reactive; Erythema Multiforme Bacterial and Fungal Diseases (Non MeSH); Infection Musculoskeletal Diseases; Joint Diseases; Arthritis Eye Diseases; Conjunctival Diseases; Conjunctivitis Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases; Urethritis Immunologic Diseases; Autoimmune Diseases A triad of nongonococcal urethritis followed by conjunctivitis and arthritis, of unknown etiology.  [P 0TsReinforcement, Verbal F02.463.425.770.769 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) Use of word stimulus to strengthen a response during learning. yLReinforcement, Social F02.463.425.770.706 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) The strengthening of a response with a social reward such as a nod of approval, a parent's love or attention. Interpersonal Relations (66-68); Reinforcement (Psychology) (66-68) yNReinforcement Schedule F02.463.425.770.644 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) A schedule prescribing when the subject is to be reinforced or rewarded in terms of temporal interval in psychological experiments. The schedule may be continuous or intermittent. pyReinforcement (Psychology) F02.463.425.770 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Extinction (Psychology); Knowledge of Results (Psychology); Punishment; Reinforcement Schedule; Reinforcement, Social; Reinforcement, Verbal; Reward (+ 1) The strengthening of a conditioned response. CLDEHIPHPXRE Z6Reindeer B02.649.077.380.373.644 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants; Deer A genus of deer, Rangifer, that inhabits the northern parts of Europe, Asia, and America. Caribou is the North American name; reindeer, the European. They are often domesticated and used, especially in Lapland, for drawing sleds and as a source of food. Rangifer is the only genus of the deer family in which both sexes are antlered. Most caribou inhabit arctic tundra and surrounding arboreal coniferous forests and most have seasonal shifts in migration. They are hunted extensively for their meat, skin, antlers, and other parts. (From Webster, 3d ed; Walker's Mammals of the World, 5th ed). Artiodactyla (66-67)   (?Reimbursement, Incentive N03.219.521.710.305.380 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms A scheme which provides reimbursement for the health services rendered, generally by an institution, and which provides added financial rewards if certain conditions are met. Such a scheme is intended to promote and reward increased efficiency and cost containment, with better care, or at least without adverse effect on the quality of the care rendered.  JReimbursement Mechanisms N03.219.521.710.305 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement Fee-for-Service Plans (+ 2); Physician Payment Review Commission; Prospective Payment System (+ 2); Reimbursement, Incentive; Relative Value Scales Processes or methods of reimbursement for services rendered or equipment. Financing, Organized (68-78)  W"Rehydration Solutions D26.394.225.766.741 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Water-Electrolyte Imbalance; Diarrhea; Fluid Therapy; Water-Electrolyte Balance; Dehydration Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Fluids restored to the body in order to maintain normal water-electrolyte balance. Fluid Therapy (79-89); Solutions (72-78)  ,kZb2Rehabilitation, Vocational E02.831.782; N02.421.784.644 CLCTECHIISMAMOMTPXSNSTTDUT Employment; Sheltered Workshops Therapeutics; Rehabilitation Facilities, Manpower and Services (Non MeSH); Health Services; Rehabilitation  Employment, Supported Training of the mentally or physically disabled in work skills so they may be returned to regular employment utilizing these skills. CLCTECHIISLJMAMOMTOGPXSNSTTDUT $ "&|"Rehabilitation, Speech and Language (Non MeSH) E02.831.727 Therapeutics; Rehabilitation Language Therapy; Speech, Alaryngeal (+ 1); Speech Therapy; Voice Training CLECEDHIISLJMAMTOGPXSNSTTD  7"[Rehabilitation of Hearing Impaired (Non MeSH) E02.831.671 Therapeutics; Rehabilitation Communication Methods, Total; Lipreading; Manual Communication (+ 1)  6"QRehabilitation Centers N02.278.808 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Sheltered Workshops; Substance Abuse Treatment Centers Facilities which provide programs for rehabilitating the mentally or physically disabled individuals. Hospitals (66-67); Rehabilitation (66-67) CLECHILJMAMTOGSDSNSTTDUT $ L@u2Rehabilitation E02.831; G02.403.790.508.610; N02.421.784 CLECEDHIISLJMAMTNUOGPXSNSTTD Disability Evaluation; Early Intervention (Education); Halfway Houses Disabled Therapeutics Health Occupations; Medicine; Specialties, Other (Non MeSH); Physical Medicine Facilities, Manpower and Services (Non MeSH); Health Services Activities of Daily Living; Art Therapy; Bibliotherapy; Dance Therapy; Early Ambulation; Music Therapy; Occupational Therapy; Physical Therapy (+ 4); Rehabilitation of Hearing Impaired (Non MeSH) (+ 4); Rehabilitation, Speech and Language (Non MeSH) (+ 5); Rehabilitation, Vocational Activities of Daily Living; Rehabilitation, Vocational (+ 1); Self Care Restoration to the maximum degree possible of a person or persons suffering from disease or injury. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE ( 1 R w*Regulon G05.275.201.800; G05.275.800 DEGEIMPHRE Genes, Regulator Genetics; Genes; Genes, Bacterial Genetics; Genes Operon (+ 2) In eukaryotes, a genetic unit consisting of a noncontiguous group of genes under the control of a single regulator gene. In bacteria, regulons are global regulatory systems involved in the interplay of pleiotropic regulatory domains. These regulatory systems consist of several operons. Base Sequence (84-93); Genes, Regulator (69-93) $  "=N:Regulatory Sequences, Nucleic Acid G05.275.470.790; G05.331.599.110.689; G06.184.599.110.689 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence Enhancer Elements (Genetics) (+ 1); Operator Regions (Genetics); Promoter Regions (Genetics) (+ 2); Terminator Regions (Genetics) Enhancer Elements (Genetics) (+ 1); Operator Regions (Genetics); Promoter Regions (Genetics) (+ 2); Terminator Regions (Genetics) Enhancer Elements (Genetics) (+ 1); Operator Regions (Genetics); Promoter Regions (Genetics) (+ 2); Terminator Regions (Genetics) DNA sequences involved in regulating the expression of other genes. Base Sequence (77-87); DNA or specific (77-87)  )AQ:Regression Analysis E05.318.740.750; G03.850.520.830.750; H01.548.832.793; N05.715.360.750.695 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Least-Squares Analysis; Linear Models; Logistic Models; Proportional Hazards Models Least-Squares Analysis; Linear Models; Logistic Models; Proportional Hazards Models Least-Squares Analysis; Linear Models; Logistic Models; Proportional Hazards Models Least-Squares Analysis; Linear Models; Logistic Models; Proportional Hazards Models Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In MULTIPLE REGRESSION the dependent variable is considered to depend on more than a single independent variable. Statistics (66-72)  TRegression (Psychology) F01.393.784; F03.407.784 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms The partial or symbolic return, under conditions of relaxation or stress, to an earlier stage of functioning.  !cRegistries E05.318.308.970; G03.850.520.308.970; L01.280.950; N04.452.859.819; N05.715.360.300.715.700 CLSNST Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Information Science; Data Collection Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records SEER Program SEER Program SEER Program SEER Program SEER Program The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Drugs/adverse effects (66-68); specific drug group/adverse effects (66-68); Information Systems (66-68); Medical Records (66-68); Records (66-68); Statistics (66-68); specific heading/epidemiology (66-68) CLECHIISLJMAOGSDSNSTTDUT $ "g MRegional Medical Programs N03.349.650.400 CLECHILJMAOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning Coordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under U.S. Public Law 89-239. Legislation, Medical (66); Public Health (66); United States Public Health Service (66)  'ggjRegional Health Planning N03.349.650 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning Catchment Area (Health); Certificate of Need; Community Health Planning; Health Facility Planning (+ 2); Health Systems Plans; Medically Underserved Area; Regional Medical Programs; State Health Plans Planning for health resources at a community or regional level. Health Planning (68-74) CLECHILJMAMTOGSNSTTDUT $ )IMRegional Blood Flow G09.330.612.793 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics  +{Regeneration G04.185.753 DEGEIMPHRE Wound Healing Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) Bone Remodeling (+ 2); Liver Regeneration; Nerve Regeneration; Wound Healing (+ 1)  ,keRefuse Disposal G03.850.780.200.800.800.700; G03.850.860.510.900.600 ECHIISLJMTSNST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation; Sanitary Engineering Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management  Garbage; Incineration; Medical Waste Disposal; Waste Disposal, Fluid The discarding or destroying of garbage, sewage, or other waste matter or its transformation into something useful or innocuous.  -:5SRefusal to Treat F01.145.076.147.500; F01.829.092.214.500; N04.590.233.727.605; N05.300.100.675 LJSN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude of Health Personnel Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Attitude; Attitude of Health Personnel Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Primary Health Care Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude of Health Personnel Refusal of the health professional to initiate or continue treatment of a patient or group of patients. The refusal can be based on any reason, but the risk of disease transmission, as in the case of AIDS, is a pressing motivation. The concept is differentiated from PATIENT REFUSAL OF TREATMENT see TREATMENT REFUSAL which originates with the patient and not the health professional. Attitude of Health Personnel (68-90); Continuity of Patient Care (75-90); Physician-Patient Relations (66-90)  0XRefugees M01.755 CLEDHILJPXSN Named Groups (Non MeSH) Persons fleeing to a place of safety, especially those who flee to a foreign country or power to escape danger or persecution in their own country or habitual residence because of race, religion, or political belief. (Webster, 3d ed).  5r  Refsum's Disease C10.500.686.708; C10.772.587.708; C16.131.666.686.708; C18.452.648.556.641.643 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Motor and Sensory Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis A chronic progressive peripheral neuropathy which is probably inherited in an autosomal recessive manner. Some of the manifestations of this disorder are atypical retinitis pigmentosa, cerebellar ataxia, and increased cerebrospinal protein levels. Excessive phytanic acid storage has been found in most cases. Onset of symptoms usually occurs in early childhood.  6XL=Refrigeration E05.760.643 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hypothermia, Induced Freezing; Cold Miscellaneous Techniques (Non MeSH); Preservation, Biological  ;"HRefractory Period, Psychological F02.830.650.400; F04.669.817.559 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Reaction Time Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Reaction Time A delayed response interval occurring when two stimuli are presented in close succession. Reaction Time (66-71)  <&& jRefractory Period, Neurologic G11.561.537.700 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Neural Conduction Neural Conduction (66-71)  >c#Refractometry E05.196.808; H01.671.606.811 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Physics; Optics Measurement of the index of refraction (the ratio of the velocity of light or other radiation in the first of two media to its velocity in the second as it passes from one into the other).  ?h"|Refractive Errors C11.744 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Visual Acuity Eye Diseases Aniseikonia; Anisometropia; Astigmatism; Hyperopia; Myopia; Presbyopia Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.  A7 NTRefraction, Ocular E01.210.935.768 Visual Acuity; Eye Diagnosis; Diagnosis, Eye (Non MeSH); Vision Tests Refraction of light effected by the media of the eye. It also includes the determination of the refractive state and refractive correction.  B?Reflexotherapy E02.040.720 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine Treatment of some morbid condition by producing a reflex action, as in the household treatment of nosebleed by a piece of ice applied to the cervical spine. (Stedman, 27th ed).  D ")Reflex, Vestibulo-Ocular G11.561.730.795 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex A reflex wherein impulses are conveyed from the cupulas of the SEMICIRCULAR CANALS and from the OTOLITHIC MEMBRANE of the SACCULE AND UTRICLE via the VESTIBULAR NUCLEI of the BRAIN STEM and the median longitudinal fasciculus to the OCULOMOTOR NERVE nuclei. It functions to maintain a stable retinal image during head rotation by generating appropriate compensatory EYE MOVEMENTS. Eye Movements (66-86); Nystagmus, Physiologic (83-86); Reflex (66-86); Vestibular Apparatus (66-86)  EswReflex, Stretch E01.236.563.642.725; E01.706.592.642.725; G11.561.730.768 DEGEIMPHRE Muscle Spindles Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Reflex contraction of a muscle in response to stretching, which stimulates muscle proprioceptors.  HArReflex, Pupillary E01.236.563.642.642; E01.706.592.642.642; G11.561.730.705 DEGEIMPHRE Adie's Syndrome Pupil Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Pupil (66-69); Reflex (66-69)  JA &Reflex, Oculocardiac G11.561.730.685 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Change of heartbeat induced by pressure on the eyeball, manipulation of extraocular muscles, or pressure upon the tissue remaining in the orbital apex after enucleation. Heart Rate (66-75); Reflex (66-75)  Ls,Reflex, Monosynaptic G11.561.730.643 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex H-Reflex Reflex (66-67)  N]s Reflex, Babinski E01.236.563.642.600; E01.706.592.642.600; G11.561.730.600 DEGEIMPHRE Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex An abnormal reflex consisting of dorsiflexion of the big toe on stimulation of the sole of the foot.  OPAzReflex, Acoustic E01.236.563.642.580; E01.706.592.642.580; G11.561.730.594 DEGEIMPHRE Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Intra-aural contraction of tensor tympani and stapedius in response to sound. Acoustic Stimulation (72-79); Reflex (66-79); Sound (66-71)  QeA\IReflex, Abnormal C10.597.704; C23.888.592.717; E01.236.563.642.558; E01.706.592.642.558; G11.561.730.587 DEGEIMPHRE Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Abnormal, involuntary response to a stimulus which includes hyperreflexia, hyporeflexia, and areflexia.  ScwReflex, Abdominal E01.236.563.642.475; E01.706.592.642.475; G11.561.730.580 DEGEIMPHRE Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination; Reflex Diagnosis; Physical Examination; Neurologic Examination; Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Abdominal Wall (66-69); Reflex (66-69)  VA0Reflex Sympathetic Dystrophy C10.772.150.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Autonomic Nervous System Diseases A disturbance of the sympathetic nervous system marked by pallor or rubor, pain, sweating, edema, or skin atrophy following sprain, fracture, or injury to nerves or blood vessels. (Dorland, 27th ed).  XW"NnReflex E01.236.563.642; E01.706.592.642; F02.830.702; G11.561.730 DEGEIMPHRE Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination Diagnosis; Physical Examination; Neurologic Examination Psychologic Processes and Principles (Non MeSH); Psychophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Reflex, Abdominal; Reflex, Abnormal; Reflex, Acoustic; Reflex, Babinski; Reflex, Pupillary; Reflex, Stretch; Startle Reaction Reflex, Abdominal; Reflex, Abnormal; Reflex, Acoustic; Reflex, Babinski; Reflex, Pupillary; Reflex, Stretch; Startle Reaction Galvanic Skin Response; Piloerection; Startle Reaction Baroreflex; Blinking; Gagging; Piloerection; Reflex, Abdominal; Reflex, Abnormal; Reflex, Acoustic; Reflex, Babinski; Reflex, Monosynaptic (+ 1); Reflex, Oculocardiac; Reflex, Pupillary; Reflex, Stretch; Reflex, Vestibulo-Ocular; Startle Reaction An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.  ZW D@Referral and Consultation N04.452.758.849 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Physician Self-Referral The practice of sending a patient to another program or practitioner for services or advice which the referring source is not prepared to provide. Interprofessional Relations (66-67)  _`q)Reference Values H01.939.810 Physical Sciences (Non MeSH); Weights and Measures The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.  a7>Reference Standards H01.939.808 Quality Control Physical Sciences (Non MeSH); Weights and Measures A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy.  b>Reference Books, Medical L01.178.682.192.836.842 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books Dictionaries, Medical Books in the field of medicine intended primarily for consultation.  dzQReference Books L01.178.682.192.836 ST Textbooks Textbooks Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books Almanacs; Atlases; Dictionaries (+ 6); Directories; Dispensatories; Encyclopedias; Formularies (+ 3); Pharmacopoeias (+ 1); Reference Books, Medical (+ 1) Books, e.g., dictionaries, encyclopedias, atlases, intended primarily for consultation. CLHIST ( eD  fd Reed-Sternberg Cells A11.828 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Hodgkin's Disease Cells Large cells of unknown origin, usually multinucleate, whose presence is the common histologic characteristic of HODGKIN'S DISEASE. Hodgkin's Disease/pathology (66-91)  gQ * *Red-Cell Aplasia, Pure C15.378.071.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. Anemia, Aplastic (66-84)  hNTqRed Nucleus A08.186.211.132.659.822.642 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon; Tegmentum Mesencephali  j16sRed Cross N03.540.514.642; N03.540.630.780.608 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; International Agencies Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit; Voluntary Health Agencies An international agency providing various humanitarian services.  k(* KRecurrent Laryngeal Nerve A08.800.050.050.925.450.700; A08.800.050.600.825.450.700; A08.800.800.060.920.450.700; A08.800.800.120.900.450.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways; Vagus Nerve; Laryngeal Nerves Nervous System; Peripheral Nervous System; Autonomic Nervous System; Parasympathetic Nervous System; Vagus Nerve; Laryngeal Nerves Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways; Vagus Nerve; Laryngeal Nerves Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Vagus Nerve; Laryngeal Nerves Branches of the vagus (tenth cranial) nerve. The recurrent (or inferior) laryngeal nerves originate more caudally than the superior laryngeal nerves and follow different paths on the right and left sides. They carry efferents to all muscles of the larynx except the cricothyroid and carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions.  l|8#Recurrence C23.280.734; N01.407.306.750 Symptoms and General Pathology (Non MeSH); Disease Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Disease The return of symptoms after a remission (diminution or abatement or lessening in severity) of a disease or after therapy. Relapse is often considered a synonym or in many texts as the return of manifestations of a disease after an interval of improvement. Recrudescence, also often a synonym for recurrence, differs from relapse in that a recrudescence occurs after days or weeks while a relapse occurs after weeks or months. The terms in the literature are not used as precisely as the dictionaries define them. (Dorland, 27th ed.; Stedman, 25th ed.).  q"Rectus Abdominis A02.633.567.050.800 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal; Abdominal Muscles A long flat muscle that extends along the whole length of both sides of the abdomen. It flexes the vertebral column, particularly the lumbar portion; it also tenses the anterior abdominal wall and assists in compressing the abdominal contents. It is frequently the site of hematomas. In reconstructive surgery it is often used for the creation of myocutaneous flaps. (From Gray's Anatomy, 30th American ed, p.491). Abdominal Muscles (66-93)  u:QRectum A03.492.411.495.767 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Intestines; Intestine, Large Anus consider also terms at PROCT-.  w :T'Rectovaginal Fistula C06.185.700.650.642; C06.405.469.478.650.642; C06.405.469.860.704.642; C13.371.894.763.558; C23.439.185.700.650.642; C23.439.775.642 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Fistula (Non MeSH); Intestinal Fistula; Rectal Fistula Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Fistula; Rectal Fistula Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Rectal Fistula Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases; Vaginal Fistula Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH); Intestinal Fistula; Rectal Fistula Symptoms and General Pathology (Non MeSH); Fistula; Vaginal Fistula Abnormal communication between the rectum and the vagina.  xNERectal Prolapse C06.405.469.860.800; C23.835.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Symptoms and General Pathology (Non MeSH); Prolapse Protrusion of the rectal mucous membrane through the anus. There are various degrees: incomplete with no displacement of the anal sphincter muscle; complete with displacement of the anal sphincter muscle; complete with no displacement of the anal sphincter muscle but with herniation of the bowel; and internal complete with rectosigmoid or upper rectum intussusception into the lower rectum.  },&NRectal Neoplasms C04.588.274.476.411.792; C06.240.476.411.792; C06.405.282.411.792; C06.405.469.505.792; C06.405.469.860.767 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Anus Neoplasms (+ 1) Anus Neoplasms (+ 1) Anus Neoplasms (+ 1) Anus Neoplasms (+ 1) Anus Neoplasms (+ 1)  GwXERectal Fistula C06.185.700.650; C06.405.469.478.650; C06.405.469.860.704; C23.439.185.700.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Fistula (Non MeSH); Intestinal Fistula Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Fistula Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH); Intestinal Fistula Rectovaginal Fistula Rectovaginal Fistula Rectovaginal Fistula Rectovaginal Fistula Abnormal passage communicating with the rectum.  XN^9Rectal Diseases C06.405.469.860 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Anus Diseases (+ 4); Fecal Incontinence; Hemorrhoids; Proctitis (+ 1); Rectal Fistula (+ 1); Rectal Neoplasms (+ 2); Rectal Prolapse BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  ;NUXRecruitment, Loudness C09.218.458.725; C10.597.257.443.807; C23.888.592.257.443.807 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Hearing Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Hearing Disorders An abnormally disproportionate increase in the sensation of loudness in response to a relatively slight increase in intensity of an acoustic signal. Loudness recruitment is also a special audiological procedure or test. Audiometry (66-78); Auditory Perception (67-78); Auditory Threshold (68-78); Hearing (66-67); Perception (66-67)  )EN[Recruitment Detection (Audiology) E01.276.299.375.570 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests Tests for measuring loudness recruitment. Audiometry (66-78); Auditory Threshold (68-78)  '"r28Recruitment (Neurology) G11.561.537.678 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Neural Conduction Neural Transmission (68-71)  B!Recreation I03.450.642 ECPHPX Human Activities (Non MeSH); Leisure Activities Camping; Dancing; Hobbies; Play and Playthings; Sports (+ 23) Activity engaged in for pleasure. AECLECEDHIINLJPHPXSNSTTD  B :M*Recovery Room N02.278.388.493.592 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units; Intensive Care Units Hospital unit providing continuous monitoring of the patient following anesthesia. Intensive Care Units (66-74)  ay`#Records E05.318.308.940; G03.850.520.308.940; L01.280.900; N04.452.859; N05.715.360.300.715 CLECLJSNSTVE Documentation Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Information Science; Data Collection Health Services Administration (Non MeSH); Organization and Administration Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection Birth Certificates; Death Certificates; Dental Records; Hospital Records; Medical Records (+ 6); Nursing Records Birth Certificates; Death Certificates; Dental Records; Hospital Records; Medical Records (+ 3); Nursing Records Birth Certificates; Death Certificates; Dental Records; Hospital Records; Medical Records (+ 7); Nursing Records Birth Certificates; Death Certificates; Dental Records; Diet Records; Hospital Records; Medical Records (+ 7); Nursing Records; Registries (+ 1) Birth Certificates; Death Certificates; Dental Records; Hospital Records; Medical Records (+ 7); Nursing Records; Registries (+ 1) The commitment in writing, as authentic evidence, of something having legal importance. The concept includes certificates of birth, death, etc., as well as hospital, medical, and other institutional records. Dental Records (67); Medical Records (66-67); Nursing Records (67) CLECHIISLJMAMTOGSDSNSTTDUTVE (  _R Recombination, Genetic G05.825 DEGEIMPHRE Reassortant Viruses Genetics Conjugation, Genetic; Crossing Over (Genetics) (+ 1); Gene Conversion; Transformation, Genetic (+ 4) Production of new arrangements of genes by various mechanisms such as assortment and segregation, crossing over, gene conversion, transformation, conjugation, transduction, F-duction, or mixed infection of viruses. Genetics (66-67) DEGEIMMTPHRE (   xRecombinant Proteins D12.776.828 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Biotechnology Amino Acids, Peptides and Proteins (Non MeSH); Proteins Interferon Alfa, Recombinant (+ 2); Interferon-gamma, Recombinant; Recombinant Fusion Proteins (+ 2); Vaccines, Synthetic (+ 2) Proteins prepared by recombinant DNA technology. DNA, Recombinant (77-85); Proteins or specific protein (66-85) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ( BD:KFRecombinant Fusion Proteins D12.776.828.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunotoxins Cloning, Molecular Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins CD4 Immunoadhesins; Chimeric Proteins Proteins that are the result of genetic engineering. A regulatory part or promoter of one or more genes is combined with a structural gene. The fusion protein is formed after transcription and translation of the fused gene. This type of fusion protein is used in the study of gene regulation or structure-activity relationships. They might also be used clinically as targeted toxins (IMMUNOTOXINS). $ !F]-Receptors, Virus D12.776.543.750.925 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Viruses Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Receptors, HIV (+ 1) Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response. Binding Sites (68-78) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR ( >$ w<Receptors, Very Late Antigen D12.776.543.750.705.408.460.850; D24.611.834.408.460.850 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Receptors, Cytoadhesin Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Receptors, Cytoadhesin Receptors, Fibronectin Receptors, Fibronectin Members of the integrin family appearing late after T-cell activation. They are a family of proteins initially identified at the surface of stimulated T-cells, but now identified on a variety of cell types. Five VLA antigens have been identified as heterodimeric adhesion receptors consisting of a single common beta-subunit and five distinct alpha-subunits. VLA-2 may be a receptor for collagen on platelets. Antigens, Differentiation (88-89); Antigens, Surface (78-89); Receptors, Endogenous Substances (73-89); Receptors, Immunologic (80-89)  #>$V4Receptors, Vasopressin D12.776.543.750.720.600.925; D12.776.543.750.750.555.925; D12.776.543.750.750.660.900 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone Specific molecular sites or structures on or in cells that vasopressins react or to which they bind in order to modify the function of the cells. Two types of vasopressin receptor exist, the V1 receptor and the V2 receptor. The V1 receptor can be subdivided into V1a and V1b (formerly V3) receptors. Receptors, Angiotensin (84-92); Receptors, Cell Surface (81-84)  y]$ eKReceptors, Vasoactive Intestinal Peptide D12.776.543.750.720.600.915; D12.776.543.750.750.360.900; D12.776.543.750.750.555.915 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Vasoactive Intestinal Peptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Gastrointestinal Hormone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind VASOACTIVE INTESTINAL PEPTIDE (VIP) with high affinity and trigger intracellular changes which influence the behavior of cells. Receptors, Cell Surface (80-86); Receptors, Gastrointestinal Hormone (87-93)  /]$#YReceptors, Tumor Necrosis Factor D12.776.543.750.705.852.760; D24.611.834.852.760 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine Cell surface receptors that bind tumor necrosis factor and trigger changes which influence the behavior of cells. The two recognized tumor necrosis factor receptors are designated alpha and beta receptors. Both receptors bind both alpha and beta tumor necrosis factors with high affinity, and both are members of the nerve growth factor receptor family. Receptors, Cell Surface (85-93)  )'6$6&Receptors, Transforming Growth Factor beta D12.776.543.750.705.852.720; D12.776.543.750.750.400.820; D24.611.834.852.720 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action. Transforming growth factor alpha binds to the same receptors as epidermal growth factor (see RECEPTORS, EPIDERMAL GROWTH FACTOR-UROGASTRONE). Receptors, Cell Surface (86-93)  2U$&Receptors, Transferrin D12.776.543.750.850 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Carrier Proteins Transferrin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released. Receptors, Endogenous Substances (73-86); Transferrin (66-86) $ $wHReceptors, Thyrotropin-Releasing Hormone D12.776.543.750.720.600.860; D12.776.543.750.750.555.860; D12.776.543.750.750.700.840 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Protirelin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone-Regulating Hormone Cell surface receptors that bind thyrotropin releasing hormone (TRH) with high affinity and trigger intracellular changes which influence the behavior of cells. Activated TRH receptors in the anterior pituitary stimulate the release of thyrotropin (thyroid stimulating hormone, TSH). TRH receptors on neurons mediate neurotransmission by TRH. Receptors, Cell Surface (81-86); Receptors, Neurotransmitter (87-93)  9.]$PReceptors, Thyrotropin D12.776.543.750.720.600.850; D12.776.543.750.750.555.850; D12.776.543.750.750.660.825 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Thyrotropin; Immunoglobulins, Thyroid-Stimulating Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone Cell surface proteins that bind thyrotropin and trigger intracellular changes influencing the behavior of cells. These receptors are present in the nervous system and on cells in the thyroid gland. Autoantibodies to these receptors are implicated in Graves', Hashimoto's, and other thyroid diseases. Receptors, Endogenous Substances (73-86); Thyrotropin (66-86)  ]$8 \HReceptors, Thyroid Hormone D12.776.818.830; D12.776.826.850; D12.776.930.691 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Thyroid Hormone Resistance Syndrome Diiodotyrosine; Triiodothyronine; Thyroxine; Long-Acting Thyroid Stimulator; Genes, erbA; Thyroid Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Proteins, usually found in the nucleus, that specifically bind thyroid hormones and regulate DNA transcription. These proteins, termed c-erbA, are activated by hormones and cause differentiation of erythroid progenitor cells which irreversibly lose proliferative potential. Thus c-erbA proteins act as growth suppressors. The c-erbA proteins are encoded by at least two genes, c-erbA alpha and c-erbA beta. Each of these has two isoforms. Mutations in the ligand-binding domain of the beta form causes THYROID HORMONE RESISTANCE SYNDROME. Receptors, Endogenous Substances (73-86); Thyroid Hormones (66-86); Thyroxine (66-86); Triiodothyronine (66-86) $  9$*|'pReceptors, Thromboxane D12.776.543.750.662.800 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Thromboxanes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Eicosanoid Cell surface proteins that bind thromboxanes with high affinity and trigger intracellular changes influencing the behavior of cells. At least a subset of thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems. Receptors, Prostaglandin (81-92)  1$#&Receptors, Thrombin D12.776.124.125.786.800; D12.776.395.550.625.800; D12.776.543.550.625.800; D12.776.543.750.705.408.450.800; D12.776.543.750.750.850; D24.611.834.408.450.800 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Platelet Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Platelet Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Platelet Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Platelet Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Platelet Membrane Glycoproteins Thrombomodulin Thrombomodulin Thrombomodulin Thrombomodulin Thrombomodulin Thrombomodulin Cell surface proteins that specifically bind thrombin and trigger changes in the behavior of blood cells. There are at least two types of thrombin receptors on platelets. The higher affinity receptors mediate the inhibition of stimulated adenylate cyclase, the secretion of acid hydrolases, and the activation of phospholipase A2. The lower affinity receptors are linked to phospholipase C and trigger platelet aggregation and exposure of fibrinogen binding sites. A human platelet thrombin receptor has been cloned and is a member of the family of peptide receptors. Receptors, Cell Surface (81-93)  ̠$b&Receptors, Tachykinin D12.776.543.750.720.600.830; D12.776.543.750.750.555.830 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3 Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3 Cell surface proteins that bind tachykinins with high affinity and trigger intracellular changes influencing the behavior of cells. Three classes of tachykinin receptors have been characterized, the NK-1, NK-2, and NK-3, which prefer, respectively, substance P, neurokinin A (substance K, neurokinin alpha, neuromedin L), and neurokinin B (neurokinin beta, neuromedin K). Receptors, Cell Surface (81-84); Receptors, Drug (68-82); Receptors, Neurotransmitter (85-93) $ Ԉ>$[nReceptors, Steroid D12.776.826.750; D12.776.930.682 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Steroids Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Receptors, Androgen; Receptors, Calcitriol; Receptors, Estrogen (+ 1); Receptors, Glucocorticoid; Receptors, Mineralocorticoid (+ 1); Receptors, Progesterone Receptors, Androgen; Receptors, Calcitriol; Receptors, Estrogen (+ 1); Receptors, Glucocorticoid; Receptors, Mineralocorticoid (+ 1); Receptors, Progesterone Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. Receptors, Cell Surface (73-76); Receptors, Drug (68-72); Steroids (66-76) $ ^&$ lZReceptors, Somatotropin D12.776.543.750.720.600.770; D12.776.543.750.750.555.770; D12.776.543.750.750.660.750 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Placental Lactogen; Somatotropin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone Cell surface proteins that bind somatotropin with high affinity and trigger intracellular changes influencing the behavior of cells. Activation of growth hormone receptors regulates amino acid transport through cell membranes, RNA translation to protein, DNA transcription, and protein and amino acid catabolism in many cell types. Many of these effects are mediated indirectly through stimulation of the release of somatomedins. Receptors, Endogenous Substances (73-86); Somatotropin (66-86)  ݛ]$' IReceptors, Somatostatin D12.776.543.750.720.600.760; D12.776.543.750.750.555.760; D12.776.543.750.750.580.720; D12.776.543.750.750.700.800 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Somatostatin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pancreatic Hormone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone-Regulating Hormone Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter. Receptors, Endogenous Substances (81-86); Receptors, Neurohumor (86-92)  |$2SReceptors, Somatomedin D12.776.543.750.750.400.780 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Somatomedins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Receptors, Insulin-Like-Growth Factor I; Receptors, Insulin-Like-Growth-Factor II Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes. Receptors, Endogenous Substances (80-92); Receptors, Insulin (80-89) $ $\PReceptors, sigma D12.776.543.750.720.600.610.775; D12.776.543.750.750.555.610.775 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Opioid A class of cell surface receptors recognized by its pharmacological profile. Sigma receptors were originally considered to be opioid receptors because they bind certain synthetic opioids. However they also interact with a variety of other psychoactive drugs, and their endogenous ligand is not known (although they can react to certain endogenous steroids). Sigma receptors are found in the immune, endocrine, and nervous systems, and in some peripheral tissues. Receptors, Endorphin (81-92)  F$"Receptors, Serotonin D12.776.543.750.600.800; D12.776.543.750.720.300.800 ANBICHCLDEDFGEHIIMIPMEPHREUL Tryptamines; Serotonin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine Cell-surface proteins that bind serotonin and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76); Serotonin (66-76)  Y: JdReceptors, Sensory A08.800.550.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Sense Organs; Neurons, Afferent Nervous System; Peripheral Nervous System; Nerve Endings Chemoreceptors (+ 6); Mechanoreceptors (+ 10); Nociceptors; Photoreceptors (+ 5); Thermoreceptors Specialized neurons or parts of neurons which transduce sensory information and relay it centrally. Included are receptors for stimuli outside the body (exteroceptors) as well as receptors for stimuli from within the body itself (interoceptors and proprioceptors). Sensory receptors may include accessory structures which condition (e.g., filter) the input received by the receptor neurons themselves. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $ 6'Dv8Receptors, Retinoic Acid D12.776.826.700; D12.776.930.675 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Tretinoin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Proteins in the nucleus or cytoplasm that specifically bind retinoic acid or retinol and trigger changes in the behavior of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognized. Carrier Proteins (79-93); Protein Binding (76-78); Proteins (76-78)  V&$ 0RReceptors, Purinergic P2 D12.776.543.750.720.700.720; D12.776.543.750.810.720 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Purinergic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Purinergic A class of cell surface receptors for purines that prefer ATP or ADP over adenosine. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. Subtypes have been proposed, usually designated P2 x, y, z, and t. P2x receptors may mediate fast synaptic transmission by ATP. The ADP-preferring P2t receptors in platelets stimulate aggregation. Receptors, Cell Surface (79-93); Receptors, Purinergic (87-93)  A:$@JReceptors, Purinergic P1 D12.776.543.750.720.700.700; D12.776.543.750.810.700 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Purinergic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Purinergic A class of cell surface receptors that prefers adenosine to other endogenous purines. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra). The methylxanthines, e.g., caffeine, bind to these receptors, but also have other unrelated effects. Receptors, Cell Surface (79-93); Receptors, Purinergic (87-93)  4:$@JReceptors, Purinergic D12.776.543.750.720.700; D12.776.543.750.810 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Receptors, Cyclic AMP; Receptors, Purinergic P1; Receptors, Purinergic P2 Receptors, Cyclic AMP; Receptors, Purinergic P1; Receptors, Purinergic P2 Cell surface proteins that bind purines with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer adenosine, and the P2 receptors, which prefer ATP or ADP. Adenosine (66-86); Purines (66-86); Receptors, Endogenous Substances (73-86)  !22$ S[Receptors, Prostaglandin E D12.776.543.750.662.700.600 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Eicosanoid; Receptors, Prostaglandin Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin E receptors prefer prostaglandin E2 to other endogenous prostaglandins. They are subdivided into EP1, EP2, and EP3 types based on their effects and their pharmacology. Receptors, Prostaglandin (81-93) !3 $x&Receptors, Prostaglandin D12.776.543.750.662.700 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Prostaglandins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Eicosanoid Receptors, Prostaglandin E Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Receptors, Drug (68-76); Prostaglandins (66-76) $! $ 9Receptors, Prolactin D12.776.543.750.720.600.710; D12.776.543.750.750.555.710; D12.776.543.750.750.660.350.725 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Prolactin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone; Receptors, Gonadotropin Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor. Prolactin (66-86); Receptors, Endogenous Substances (73-86)  ! a$ %FReceptors, Progesterone D12.776.826.750.765; D12.776.930.682.765 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Progesterone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76)  !.$gReceptors, Presynaptic D12.776.543.750.720.670 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter Autoreceptors Neurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed AUTORECEPTORS. !R$Receptors, Platelet-Derived Growth Factor D12.776.543.750.750.400.630 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Platelet-Derived Growth Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. PDGF binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain. Receptors, Endogenous Substances (82-92)  !]0$$/Receptors, Pituitary Hormone-Regulating Hormone D12.776.543.750.750.700 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Pituitary Hormone Release Inhibiting Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Receptors, Corticotropin-Releasing Hormone; Receptors, LHRH; Receptors, Somatostatin; Receptors, Thyrotropin-Releasing Hormone Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here.  ! 6$_Receptors, Pituitary Hormone D12.776.543.750.750.660 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Pituitary Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Receptors, Corticotropin; Receptors, Gonadotropin (+ 3); Receptors, Oxytocin; Receptors, Somatotropin; Receptors, Thyrotropin; Receptors, Vasopressin Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. Pituitary Hormones (72-86); Pituitary Hormones, Anterior (66-86); Pituitary Hormones, Posterior (66-86); Receptors, Endogenous Substances (73-86) $! "$=Receptors, Phencyclidine D12.776.827.550 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Phencyclidine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Drug Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for PCP. These are the PCP/sigma site, which binds both PCP and psychotomimetic opiates but not certain antipsychotics, and the PCP site, which selectively binds PCP analogs. Receptors, Drug (81-83); Receptors, Synaptic (83-92)  !$}$X?Receptors, Peptide D12.776.543.750.750 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Receptors, Albumin; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; Receptors, Calcitonin; Receptors, Endothelin; Receptors, Gastrointestinal Hormone (+ 3); Receptors, Growth Factor (+ 15); Receptors, Invertebrate Peptide; Receptors, Neuropeptide (+ 31); Receptors, Pancreatic Hormone (+ 3); Receptors, Parathyroid Hormone; Receptors, Pituitary Hormone (+ 9); Receptors, Pituitary Hormone-Regulating Hormone (+ 4); Receptors, Thrombin (+ 1) Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behavior of cells. Receptors, Cell Surface (73-93) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $!'$w&FReceptors, Parathyroid Hormone D12.776.543.750.750.600 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Cell surface proteins that bind parathyroid hormone with high affinity and trigger intracellular changes which influence the behavior of cells. Parathyroid hormone receptors on bone, kidney, and gastrointestinal cells mediate the hormone's role in calcium and phosphate homeostasis. Receptors, Cell Surface (80-93) !+$$E&Receptors, Pancreatic Hormone D12.776.543.750.750.580 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Pancreatic Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Receptors, Glucagon; Receptors, Insulin; Receptors, Somatostatin Cell surface proteins that bind pancreatic hormones with high affinity and trigger intracellular changes which influence the behavior of cells. These include receptors for glucagon (secreted by alpha cells), insulin (secreted by beta cells), somatostatin (secreted by delta cells), and pancreatic peptide (secreted by PP cells). Some of these hormones and receptors also support neurotransmission.  !.4#$KReceptors, Oxytocin D12.776.543.750.720.600.630; D12.776.543.750.750.555.630; D12.776.543.750.750.660.600 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Oxytocin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behavior of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter. Receptors, Angiotensin (85-93); Receptors, Cell Surface (81-84)  !1]$  KReceptors, Opioid, mu D12.776.543.750.720.600.610.550; D12.776.543.750.750.555.610.550 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Opioid A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Receptors, Endorphin (81-92) !6gF$("Receptors, Opioid, kappa D12.776.543.750.720.600.610.400; D12.776.543.750.750.555.610.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Dynorphins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Opioid A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins. Receptors, Endorphin (80-92)  !9F$"Receptors, Opioid, delta D12.776.543.750.720.600.610.200; D12.776.543.750.750.555.610.200 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Opioid A class of opioid receptors recognized by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins. Receptors, Endorphin (82-92) !=1F$"Receptors, Opioid D12.776.543.750.720.600.610; D12.776.543.750.750.555.610 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Narcotics; Endorphins; Enkephalins; Morphine; Opioid Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, sigma Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, sigma Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Narcotics (66-76); Receptors, Drug (66-76) $!@o>$J[4Receptors, Odorant D12.776.543.750.735 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Olfactory Receptor Neurons Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Proteins, usually projecting from the cilia of olfactory receptor neurons, that specifically bind odorant molecules and trigger responses in the neurons. The large number of different odorant receptors appears to arise from several gene families or subfamilies rather than from DNA rearrangement. Membrane Proteins (90-93)  !EF wWReceptors, Nicotinic D12.776.543.750.720.360.550 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Ganglionic Stimulants; Ganglionic Blockers Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Cholinergic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for nicotine over muscarine. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, molecular biology, and biophysical properties of the channels. Acetylcholine (66-76); Nicotine (74-76); Receptors, Cholinergic (71-76); Receptors, Drug (68-76)  !Hf$2usReceptors, Neurotransmitter D12.776.543.750.720 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neurotransmitters Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Receptors, Amino Acid (+ 9); Receptors, Biogenic Amine (+ 16); Receptors, Cholinergic (+ 2); Receptors, Neuropeptide (+ 31); Receptors, Presynaptic (+ 1); Receptors, Purinergic (+ 3) Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.  !K $weReceptors, Neurotensin D12.776.543.750.720.600.560; D12.776.543.750.750.555.560 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neurotensin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind neurotensin with high affinity and trigger intracellular changes which influence the behavior of cells. Neurotensin and neurotensin receptors are found in the central nervous system and in the periphery. Receptors, Cell Surface (80-84); Receptors, Neurotransmitter (85-93)  !P >$[PReceptors, Neuropeptide Y D12.776.543.750.720.600.540; D12.776.543.750.750.555.540 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neuropeptide Y Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells. Receptors, Endogenous Substances (85-86); Receptors, Neurohumor (86-92)  !S>$[SReceptors, Neuropeptide D12.776.543.750.720.600; D12.776.543.750.750.555 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neuropeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; Receptors, Bombesin; Receptors, Bradykinin; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Receptors, Cholecystokinin; Receptors, Corticotropin; Receptors, Corticotropin-Releasing Hormone; Receptors, FSH; Receptors, LH; Receptors, LHRH; Receptors, Neuropeptide Y; Receptors, Neurotensin; Receptors, Opioid (+ 4); Receptors, Oxytocin; Receptors, Prolactin; Receptors, Somatostatin; Receptors, Somatotropin; Receptors, Tachykinin (+ 3); Receptors, Thyrotropin; Receptors, Thyrotropin-Releasing Hormone; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasopressin Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; Receptors, Bombesin; Receptors, Bradykinin; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Receptors, Cholecystokinin; Receptors, Corticotropin; Receptors, Corticotropin-Releasing Hormone; Receptors, FSH; Receptors, LH; Receptors, LHRH; Receptors, Neuropeptide Y; Receptors, Neurotensin; Receptors, Opioid (+ 4); Receptors, Oxytocin; Receptors, Prolactin; Receptors, Somatostatin; Receptors, Somatotropin; Receptors, Tachykinin (+ 3); Receptors, Thyrotropin; Receptors, Thyrotropin-Releasing Hormone; Receptors, Vasoactive Intestinal Peptide; Receptors, Vasopressin Cell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behavior of cells. Many neuropeptides are also hormones outside of the nervous system. Neuropeptides (87-93); Receptors, Cell Surface (83-93); Receptors, Neurotransmitter (70-93) $!V6$#kReceptors, Neurokinin-3 D12.776.543.750.720.600.830.580; D12.776.543.750.750.555.830.580 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neurokinin K Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Tachykinin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Tachykinin A class of cell surface receptors for tachykinins that prefers neurokinin B (neurokinin beta, neuromedin K) over other tachykinins. Neurokinin-3 (NK-3) receptors have been cloned and are members of the G-protein coupled receptor superfamily. They have been found in the central nervous system and in peripheral tissues. Receptors, Neurotransmitter (87-93)  !_F$t)Receptors, Neurokinin-2 D12.776.543.750.720.600.830.540; D12.776.543.750.750.555.830.540 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neurokinin A Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Tachykinin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Tachykinin A class of cell surface receptors for tachykinins that prefers neurokinin A (NKA, substance K, neurokinin alpha, neuromedin L), neuropeptide K (NPK), or neuropeptide gamma over other tachykinins. Neurokinin-2 (NK-2) receptors have been cloned and are similar to other G-protein coupled receptors. Receptors, Neurotransmitter (85-93)  !cuF$Y)Receptors, Neurokinin-1 D12.776.543.750.720.600.830.500; D12.776.543.750.750.555.830.500 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Substance P Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide; Receptors, Tachykinin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide; Receptors, Tachykinin A class of cell surface receptors for tachykinins with a preference for substance P. Neurokinin-1 (NK-1) receptors have been cloned and are members of the G protein coupled receptor superfamily. They are found on many cell types including central and peripheral neurons, smooth muscle cells, acinar cells, endothelial cells, fibroblasts, and immune cells. Receptors, Cell Surface (81-84); Receptors, Drug (68-93); Receptors, Neurotransmitter (85-93)  !gHF$nReceptors, Nerve Growth Factor D12.776.543.750.750.400.550 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Nerve Growth Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Cell surface receptors that bind nerve growth factor (NGF) and trigger intracellular changes influencing the behavior of cells. Nerve growth factor receptors mediate the effects of nerve growth factor on the survival and growth of neurons. Receptors, Endogenous Substances (80-92)  !k%$/Receptors, N-Methyl-D-Aspartate D12.776.543.750.720.200.450.580 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL N-Methylaspartate Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid; Receptors, Glutamate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. Receptors, Cell Surface (73-84); Receptors, Neurotransmitter (85-90)  !nC$#$^PReceptors, Muscarinic D12.776.543.750.720.360.500 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Cholinergic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for muscarine over nicotine. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Acetylcholine (66-76); Parasympathomimetics (66-76); Receptors, Cholinergic (71-76); Receptors, Drug (68-76) !rg$NReceptors, Mitogen D12.776.543.750.705.880; D24.611.834.880 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Mitogens; Lectins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Receptors, Concanavalin A Receptors, Concanavalin A Glycoprotein molecules on the surface of B- and T-lymphocytes, that react with molecules of antilymphocyte sera, lectins, and other agents which induce blast transformation of lymphocytes. Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79); Mitogens (72-79) $!uj.$<fReceptors, Mineralocorticoid D12.776.826.750.530; D12.776.930.682.530 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid Receptors, Aldosterone Receptors, Aldosterone Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone. Receptors, Steroid (80-93)  !x!.$4 Receptors, Metabotropic Glutamate D12.776.543.750.720.200.450.500 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid; Receptors, Glutamate Cell surface proteins that bind glutamate and act through G-proteins to influence second messenger systems. Several types of metabotropic glutamate receptors have been cloned. They differ in pharmacology, distribution, and mechanisms of action. Receptors, Glutamate (93); Receptors, Neurotransmitter (88-92) !|'#$IReceptors, Macrophage Colony-Stimulating Factor D12.776.543.750.705.852.150.520; D12.776.543.750.750.400.200.560; D12.776.818.800; D24.611.834.852.150.520 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Genes, fms; Macrophage Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Glycoproteins of MW 165 kD which are encoded by the c-fms proto-oncogene. The binding of CSF-1 to its receptors activate an intrinsic tyrosine kinase activity resulting in autophosphorylation of the receptors on tyrosine, rapid receptor down-regulation, and phosphorylation of as yet unidentified physiologic substrates that initiate a mitogenic response. Proto-Oncogene Proteins (86-90); Receptors, Endogenous Substances (73-90)  !~6t$9UReceptors, Lymphocyte Homing D12.776.395.550.200.625; D12.776.543.550.200.625; D12.776.543.750.705.877; D24.185.101.100.110.850; D24.611.216.301.264.035.850; D24.611.216.301.350.625; D24.611.834.877 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Cell Adhesion Molecules Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Cell surface glycoproteins on lymphocytes and other leukocytes that mediate adhesion to specialized blood vessels called high endothelial venules. Several different classes of lymphocyte homing receptors have been identified, and they appear to target different surface molecules (addressins) on high endothelial venules in different tissues. The adhesion plays a crucial role in the trafficking of lymphocytes. Antigens, CD (90); Antigens, Differentiation (88-90); Cell Adhesion Molecules (90) !"$cReceptors, Lipoprotein D12.776.543.750.710 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Receptors, LDL Cell surface proteins that bind lipoproteins with high affinity. Lipoprotein receptors in the liver and peripheral tissues mediate the regulation of plasma and cellular cholesterol metabolism and concentration. The receptors generally recognize the apolipoproteins of the lipoprotein complex, and binding is often a trigger for endocytosis. Lipoproteins (81-93); Receptors, Cell Surface (81-93) $!$w@Receptors, LHRH D12.776.543.750.720.600.460; D12.776.543.750.750.555.460; D12.776.543.750.750.700.460 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Inhibin Gonadorelin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone-Regulating Hormone Receptors with a 6-kD protein on the surfaces of cells that secrete LH or FSH, usually in the adenohypophysis. LHRH binds to these receptors, is endocytosed with the receptor and, in the cell, triggers the release of LH or FSH by the cell. These receptors are also found in rat gonads. INHIBIN prevents the binding of GnRH to its receptors. LH-FSH Releasing Hormone (74-86); Receptors, Endogenous Substances (73-86) $!]$ WReceptors, LH D12.776.543.750.720.600.450; D12.776.543.750.750.555.450; D12.776.543.750.750.660.350.450 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL LH Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone; Receptors, Gonadotropin Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis. Gonadotropins, Chorionic (66-86); Receptors, Endogenous Substances (73-86)  !a$%xVReceptors, Leukotriene B4 D12.776.543.750.662.450.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Eicosanoid; Receptors, Leukotriene A class of cell surface leukotriene receptors with a preference for leukotriene B4. Leukotriene B4 receptor activation influences chemotaxis, chemokinesis, adherence, enzyme release, oxidative bursts, and degranulation in polymorphonuclear leukocytes. There are at least two subtypes of these receptors. Some actions are mediated through the inositol phosphate and diacylglycerol second messenger systems. Receptors, Cell Surface (82-84); Receptors, Immunologic (85-93) !$KReceptors, Leukotriene D12.776.543.750.662.450 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Leukotrienes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Eicosanoid Receptors, Leukotriene B4 Cell-surface receptors that bind leukotrienes with high affinity and trigger intracellular changes influencing the behavior of cells. The leukotriene receptor subtypes have been tentatively named according to their affinities for the endogenous leukotrienes LTB4, LTC4, LTD4, and LTE4. Receptors, Cell Surface (82-84); Receptors, Immunologic (90-93); Receptors, Prostaglandin (84-89) $!$HrReceptors, Leukocyte-Adhesion D12.776.543.750.705.408.460.475; D24.611.834.408.460.475 AGAIANBICHCLDEGEHIIMIPMEPHREUL Leukocyte Adhesion Deficiency Syndrome Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Receptors, Cytoadhesin Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Receptors, Cytoadhesin Antigen p150,95; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen Antigen p150,95; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen Family of proteins associated with the capacity of leukocytes, including lymphocytes, monocytes, and neutrophils, to adhere to each other and to certain substrata, e.g., the C3bi component of complement. Members of this family are the LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (LFA-1), the MACROPHAGE-1 ANTIGEN (Mac-1), and the ANTIGEN P150,95 or p150,95 leukocyte adhesion protein. They all share a common beta-subunit which is the CD18 antigen. All three of the above antigens are absent in inherited LEUKOCYTE ADHESION DEFICIENCY SYNDROME, which is characterized by recurrent bacterial infections, impaired pus formation, and wound healing as well as abnormalities in a wide spectrum of adherence-dependent functions of granulocytes, monocytes, and lymphoid cells. Antigens (66-87); Antigens, Differentiation (88-89); Receptors, Cell Surface (73-89); Receptors, Immunologic (80-89) ADAEAGAIANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR (!">"-Vr:Receptors, LDL D12.776.543.750.710.450 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Lipoproteins, LDL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Lipoprotein Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1) receptors do not bind to LDL; 2) there is reduced binding of LDL; and 3) there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. Lipoproteins, LDL (72-84); Receptors, Endogenous Substances (73-84)  !$jOReceptors, Laminin D12.776.543.750.705.876; D24.611.834.876 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Laminin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Glycoprotein molecules on the surface of cells that react with or bind to laminin whose function allows the binding of epithelial cells to the basement membrane. The molecular weight of this high-affinity receptor is 67 kD. Receptors, Endogenous Substances (83-84); Receptors, Immunologic (84-92)  !.$ TReceptors, Kainic Acid D12.776.543.750.720.200.450.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Kainic Acid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid; Receptors, Glutamate Cell surface proteins that bind glutamate and directly gate ion channels. Kainic acid receptors were originally discriminated from other glutamate receptors by their affinity for the agonist kainic acid. Activation of kainic acid receptors is generally excitatory to cells. Subtypes have been cloned, and for some the traditional distinction from AMPA receptors may not apply. Receptors, Cell Surface (81-84); Receptors, Glutamate (93); Receptors, Neurotransmitter (85-92)  !#$pReceptors, Invertebrate Peptide D12.776.543.750.750.460 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Cell surface receptors for invertebrate peptide hormones or neuropeptides. Receptors, Cell Surface (73-93) !q%$W&Receptors, Interleukin-3 D12.776.543.750.705.852.150.360; D12.776.543.750.705.852.420.340; D12.776.543.750.750.400.200.480; D24.611.834.852.150.360; D24.611.834.852.420.340 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Interleukin-3 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Interleukin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Colony-Stimulating Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Interleukin Phosphotyrosine-containing proteins, MW 140 kD. They form a stable complex with INTERLEUKIN-3 with an apparent mass of 170 kD. They are found on a variety of cells and activate INTERLEUKIN-3. Receptors, Immunologic (80-90)  !$$Receptors, Interleukin-2 D12.776.543.750.705.852.420.320; D24.185.101.100.110.700; D24.611.216.301.264.035.700; D24.611.834.852.420.320 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Interleukin-2 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Interleukin Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Interleukin Receptors present on activated T- and B-cells as a complex consisting of a 55 kD peptide, which reacts with the anti-Tac monoclonal antibody, and a 75 kD non-Tac interleukin-2-binding peptide. The receptor is present in two forms, one with a very high affinity and the other with low affinity for IL-2. The high-affinity form appears to mediate exclusively the growth-promoting response to IL-2. The receptor is present in large numbers on resting HTLV-I leukemia cells, but not on normal resting cells. Interleukin 2 (78-88); Receptors, Immunologic (80-88)  !x$O@Receptors, Interleukin-1 D12.776.543.750.705.852.420.300; D24.611.834.852.420.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Interleukin-1 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Interleukin Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Interleukin Specific molecular sites or structures on cells with which interleukin-1 reacts or to which it binds to modify the function of the cells. The IL-1 receptor on T-lymphocytes and fibroblasts is composed of a single polypeptide chain that binds both IL-1 alpha and IL-1 beta. The molecular weight of this high-affinity receptor is believed to be 80 kD. Receptors, Immunologic (85-92)  !>$l$Receptors, Interleukin D12.776.543.750.705.852.420; D24.611.834.852.420 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine Receptors, Interleukin-1; Receptors, Interleukin-2; Receptors, Interleukin-3 Receptors, Interleukin-1; Receptors, Interleukin-2; Receptors, Interleukin-3 Cell surface proteins that bind interleukins and trigger intracellular changes influencing the behavior of cells. Receptors, Immunologic (80-93)  !6$6$Receptors, Interferon D12.776.543.750.705.852.400; D24.611.834.852.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Interferons Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine Specific molecular sites or structures on or in cells with which interferons react or to which they bind in order to modify the function of the cells. Interferons exert their pleiotropic effects through two different receptors. alpha- and beta-interferon crossreact with common receptors, while gamma-interferon initiates its biological effects through its own specific receptor system. Receptors, Drug (80-81); Receptors, Endogenous Substances (80-84); Receptors, Immunologic (84-92)  !.6$6rReceptors, Insulin-Like-Growth-Factor II D12.776.543.750.750.400.780.410 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Insulin-Like Growth Factor II Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Somatomedin Specific proteins on or in cells to which insulin-like growth factor II and mannose-6-phosphate bind and thereby modify the function of the cells. These receptors have a MW of 250 kD and possess no tyrosine kinase activity. Receptors, Endogenous Substances (81-92)  !C.#$$ /Receptors, Insulin-Like-Growth Factor I D12.776.543.750.750.400.780.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Insulin-Like Growth Factor I Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Somatomedin Specific proteins on or in cells to which insulin-like growth factor I (somatomedin C) binds and thereby modifies the function of the cells. These receptors contain transmembrane and cytosolic domains, bind IGF-I preferentially, and have high-affinity sites for IGF-II. The alpha-subunit has a MW of 130 kD and the beta subunit possesses tyrosine kinase activity. Receptors, Endogenous Substances (86-92)  !.#$#/Receptors, Insulin D12.776.543.750.750.580.440 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Insulin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pancreatic Hormone Cell surface proteins that bind insulin and trigger intracellular changes which influence the behavior of cells. The best understood physiological consequence of insulin receptor activation is increased transport of glucose into most cells, which controls the rate of carbohydrate metabolism. The insulin receptor is a multifunctional protein complex that has intrinsic tyrosine kinase activity and is capable of autophosphorylation. Insulin (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76)  !g$ bReceptors, Immunologic D12.776.543.750.705; D24.611.834 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Integrins (+ 10); Receptors, Antigen (+ 6); Receptors, Complement (+ 3); Receptors, Cytokine (+ 13); Receptors, Fc (+ 2); Receptors, Laminin; Receptors, Lymphocyte Homing; Receptors, Mitogen (+ 1) Integrins (+ 10); Receptors, Antigen (+ 6); Receptors, Complement (+ 3); Receptors, Cytokine (+ 13); Receptors, Fc (+ 2); Receptors, Laminin; Receptors, Lymphocyte Homing; Receptors, Mitogen (+ 1) Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Binding Sites, Antibody (73-79); Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79); Macrophages (66-79) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $!&$=HReceptors, IgG D12.776.543.750.705.871.300; D24.185.101.100.110.695; D24.611.216.301.264.035.695; D24.611.834.871.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL IgG Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Fc Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Fc Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IgGs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor). Antigens, Differentiation (88-92); Receptors, Fc (81-92); Receptors, Immunologic (81-87)  !Pp$dhReceptors, IgE D12.776.543.750.705.871.280; D24.185.101.100.110.690; D24.611.216.301.264.035.690; D24.611.834.871.280 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL IgE Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Fc Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Fc Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RI) and high affinity receptors (Fc epsilon RII). Antigens, Differentiation, B-Lymphocyte (88-92); Receptors, Fc (81-92); Receptors, Immunologic (81-87)  !up$dwReceptors, HIV D12.776.543.750.925.700 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL HIV Envelope Protein gp120 HIV Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Virus Antigens, CD4 Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN gp120. Receptors, Virus (87-89) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR ,!$!<Receptors, Histamine H3 D12.776.543.750.600.450.500; D12.776.543.750.720.300.450.500 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Histamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Histamine A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. (From Biochem Soc Trans 1992 Feb;20(1):122-5). Receptors, Histamine (83-93) !B$|"Receptors, Histamine H2 D12.776.543.750.600.450.400; D12.776.543.750.720.300.450.400 ANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Histamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Histamine A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H2 receptors act via G-proteins to stimulate adenylate cylase. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. (From Biochem Soc Trans 1992 Feb;20(1):122-5). Histamine (66-76); Receptors, Drug (70-76) !B |4Receptors, Histamine H1 D12.776.543.750.600.450.300; D12.776.543.750.720.300.450.300 ANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Histamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Histamine A class of histamine receptors discriminated by their pharmacology and mode of action. Most histamine H1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis. (From Biochem Soc Trans 1992 Feb;20(1):122-5). Histamine (66-76); Receptors, Drug (70-76) !B |4Receptors, Histamine D12.776.543.750.600.450; D12.776.543.750.720.300.450 ANBICHCLDEDFGEHIIMIPMEPHREUL Histamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3 Receptors, Histamine H1; Receptors, Histamine H2; Receptors, Histamine H3 Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action. Histamine (70-76); Receptors, Drug (70-76); Receptors, Endogenous Substances (73-76) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL (!:  Jd$Receptors, Growth Factor D12.776.543.750.750.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Proto-Oncogene Proteins c-erbB-2; Receptors, Colony-Stimulating Factor (+ 5); Receptors, Epidermal Growth Factor-Urogastrone; Receptors, Fibroblast Growth Factor; Receptors, Nerve Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Somatomedin (+ 2); Receptors, Transforming Growth Factor beta Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells. Receptors, Cell Surface (80-93) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (!$c&FReceptors, Granulocyte-Macrophage Colony-Stimulating Factor D12.776.543.750.705.852.150.310; D12.776.543.750.750.400.200.420; D24.611.834.852.150.310 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Granulocyte-Macrophage Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Colony-Stimulating Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Receptors that bind and internalize the granulocyte-macrophage stimulating factor. Their MW is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor. Receptors, Endogenous Substances (73-90)  !wBa$6^N/Receptors, Granulocyte Colony-Stimulating Factor D12.776.543.750.705.852.150.280; D12.776.543.750.750.400.200.400; D24.611.834.852.150.280 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Granulocyte Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Colony-Stimulating Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Receptors that bind and internalize GRANULOCYTE COLONY-STIMULATING FACTOR. Their MW is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells. Receptors, Endogenous Substances (73-90)  !z7a$+^/Receptors, Gonadotropin D12.776.543.750.750.660.350 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Gonadotropins, Pituitary; Menotropins; Gonadotropins; Gonadotropins, Chorionic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone Receptors, FSH; Receptors, LH; Receptors, Prolactin Those protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hCG, LH, and FSH are the major specific gonadotropins. Gonadotropins, Chorionic (66-86); Gonadotropins, Pituitary (66-86); Receptors, Endogenous Substances (73-86) $"$Z>}Receptors, Glycine D12.776.543.750.720.200.470 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Glycine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid Cell surface receptors that bind glycine with high affinity and trigger intracellular changes which influence the behavior of cells. Glycine receptors in the central nervous system have an intrinsic chloride channel and are usually inhibitory. Receptors, Cell Surface (81-84); Receptors, Neurotransmitter (85-93)  "G$ PReceptors, Glutamate D12.776.543.750.720.200.450 ANBICHCLDEDFGEHIIMIPMEPHREUL Glutamic Acid; Excitatory Amino Acids; Glutamates Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid Receptors, AMPA; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases. Receptors, Drug (80-81); Receptors, Endogenous Substances (80-84); Receptors, Synaptic (80-92) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL (" <{No$Receptors, Glucocorticoid D12.776.826.750.430; D12.776.930.682.430 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Glucocorticoids; Adrenal Cortex Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Glucocorticoids (67-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76)  " .$0jReceptors, Glucagon D12.776.543.750.750.580.350 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Glucagon Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pancreatic Hormone Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behavior of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs. Glucagon (80-81); Receptors, Cell Surface (81-86); Receptors, Gastrointestinal Hormone (86-93)  "$ oReceptors, Gastrointestinal Hormone D12.776.543.750.750.360 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Receptors, Cholecystokinin; Receptors, Epidermal Growth Factor-Urogastrone; Receptors, Vasoactive Intestinal Peptide Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems. Gastrointestinal Hormones (66-86); Receptors, Endogenous Substances (73-86) $")$MWReceptors, GABA-B D12.776.543.750.720.200.300.320 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid; Receptors, GABA Cell surface proteins which bind GABA and influence cells via interactions with G-proteins. GABA-B receptors are pharmacologically characterized by their insensitivity to the blocker bicuculline and sensitivity to the agonist L-baclofen. They are found both presynaptically and postsynaptically, and act variously by inhibition of adenylate cyclase, activation of phospholipase A2, activation of potassium channels, and inactivation of voltage-activated calcium channels. GABA (80-93); Receptors, Cell Surface (81-84); Receptors, GABA-A (85-93) "c#$XReceptors, GABA-A D12.776.543.750.720.200.300.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Muscimol; Aminobutyric Acids; Diazepam; Benzodiazepines Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid; Receptors, GABA Cell surface proteins which bind GABA and control an integral membrane chloride channel. GABA-A receptors are the most prevalent inhibitory neurotransmitter receptors in the brain. Several isoforms have been cloned, and they belong to a superfamily which includes nicotinic receptors, glycine receptors, and 5HT-3 receptors. Most GABA-A receptors have separate modulatory sites sensitive to benzodiazepines and to barbiturates. Aminobutyric Acids (66-78); GABA (79-84); Receptors, Drug (68-84); Receptors, Endogenous Substances (73-84)  "#$BReceptors, GABA D12.776.543.750.720.200.300 ANBICHCLDEDFGEHIIMIPMEPHREUL GABA Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid Receptors, GABA-A; Receptors, GABA-B Cell-surface proteins that bind GABA with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen. GABA (79-84); Receptors, Cell Surface (73-84); Receptors, GABA-A (85-93) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL ("  ,X$Receptors, FSH D12.776.543.750.720.600.370; D12.776.543.750.750.555.370; D12.776.543.750.750.660.350.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL FSH Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone; Receptors, Gonadotropin Cell surface proteins that bind follicle-stimulating hormone (follitropin, FSH) with high affinity and trigger intracellular changes influencing the behavior of cells. FSH (66-86); Receptors, Endogenous Substances (73-86)  "$ a$%@Receptors, Fibronectin D12.776.543.750.705.408.460.850.400; D24.611.834.408.460.850.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Fibronectins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Very Late Antigen Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Very Late Antigen Specific sites or molecular structures on or in cells with which fibronectins react or to which they bind. Studies have shown that these receptors, also called VLA-5 receptors, function in certain types of adhesive contact as well as playing a major role in matrix assembly. Receptors, Endogenous Substances (81-84); Receptors, Immunologic (84-92)  "'F$DTReceptors, Fibroblast Growth Factor D12.776.543.750.750.400.370 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Fibroblast Growth Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Specific molecular sites or structures on cell membranes that react with fibroblast growth factors (both the basic and acidic forms), their analogs, or their antagonists to elicit or to inhibit the specific response of the cell to these factors. These receptors frequently possess tyrosine kinase activity. Receptors, Endogenous Substances (85-92)  "+*$f/Receptors, Fc D12.776.543.750.705.871; D24.611.834.871 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Immunoglobulins, Fc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Receptors, IgE; Receptors, IgG Receptors, IgE; Receptors, IgG Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Binding Sites, Antibody (73-79); Immunoglobulins, Fc (73-79); Lymphocytes (66-79); B Lymphocytes (73-79) $"..$J}Receptors, Estrogen D12.776.826.750.350; D12.776.930.682.350 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Estrogens Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid Receptors, Estradiol Receptors, Estradiol Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogens (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) $"2;.$ 0dReceptors, Estradiol D12.776.826.750.350.350; D12.776.930.682.350.350 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Estradiol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Receptors, Estrogen Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid; Receptors, Estrogen Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription. Estradiol (66-84); Pharmacology (66-67); Receptors, Drug (68-84); Receptors, Endogenous Substances (73-76); Receptors, Estrogen (77-84)  "5b6$ 'rReceptors, Erythropoietin D12.776.543.750.705.852.150.200; D12.776.543.750.750.400.200.340; D24.611.834.852.150.200 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Erythropoietin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor; Receptors, Colony-Stimulating Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine; Receptors, Colony-Stimulating Factor Cell surface proteins that bind erythropoietin with high affinity and trigger intracellular changes influencing the behavior of cells. Receptors, Endogenous Substances (85-92)  "8Fa$^/Receptors, Epidermal Growth Factor-Urogastrone D12.776.543.750.750.360.300; D12.776.543.750.750.400.340 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Epidermal Growth Factor-Urogastrone; Genes, erbB-1; Genes, erbB-2 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Gastrointestinal Hormone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Glycoproteins of about 170 kD that have protein kinase activity and span the plasma membranes of growing cells, including tumors. They are activated by the binding of EPIDERMAL GROWTH FACTOR-UROGASTRONE which then initiates DNA and protein synthesis. They are not found on mitotically quiescent cells except in the stomach where they control the synthesis and release of digestive enzymes and gastric acid. TRANSFORMING GROWTH FACTOR ALPHA also binds to and activates these receptors. Epidermal Growth Factor-Urogastrone (82-86); Epidermal Growth Factors (77-81); Receptors, Cell Surface (73-86); Urogastrone (66-81)  "$Ma4Receptors, Endothelin D12.776.543.750.750.320 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Endothelins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Cell surface proteins that bind endothelin with high affinity and trigger intracellular changes which influence the behavior of cells. Receptors, Endogenous Substances (88-92)  "A$/Receptors, Eicosanoid D12.776.543.750.662 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Eicosanoids Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Receptors, Leukotriene (+ 1); Receptors, Prostaglandin (+ 1); Receptors, Thromboxane Cell surface proteins that bind eicosanoids with high affinity and trigger intracellular changes influencing the behavior of cells. Among the eicosanoid receptors are receptors for the prostaglandins, thromboxanes, and leukotrienes. Receptors, Cell Surface (83-93); Receptors, Prostaglandin (77-93); Receptors, Thromboxane (93) $"Cz$we oReceptors, Drug D12.776.827 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Drugs Amino Acids, Peptides and Proteins (Non MeSH); Proteins Receptors, Phencyclidine Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Pharmacology (66-67) $"Fc$ D Receptors, Dopamine D2 D12.776.543.750.600.300.400.500; D12.776.543.750.720.300.300.400.500 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Dopamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Dopamine A class of dopamine receptors identified by their binding profiles for synthetic ligands, their molecular biology, and, perhaps, their mode of action. Receptors, Dopamine (82-92) "HfJ$!Receptors, Dopamine D1 D12.776.543.750.600.300.400.400; D12.776.543.750.720.300.300.400.400 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Dopamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Dopamine A class of dopamine receptors identified by their binding profiles for synthetic ligands, their molecular biology, and, perhaps, by their mode of action. Receptors, Dopamine (82-92) "KJ$!Receptors, Dopamine D12.776.543.750.600.300.400; D12.776.543.750.720.300.300.400 ANBICHCLDEDFGEHIIMIPMEPHREUL Dopamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine Receptors, Dopamine D1; Receptors, Dopamine D2 Receptors, Dopamine D1; Receptors, Dopamine D2 Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine (66-76); Receptors, Adrenergic (73-76); Receptors, Drug (68-76) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL ("NB  nW$Receptors, Cytoplasmic and Nuclear D12.776.826 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Transcription Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins Receptors, Aryl Hydrocarbon; Receptors, Retinoic Acid; Receptors, Steroid (+ 8); Receptors, Thyroid Hormone Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behavior of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands. Receptors, Cell Surface (83-93) $"R)$D&Receptors, Cytokine D12.776.543.750.705.852; D24.611.834.852 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Receptors, Colony-Stimulating Factor (+ 5); Receptors, Interferon; Receptors, Interleukin (+ 3); Receptors, Transforming Growth Factor beta; Receptors, Tumor Necrosis Factor Receptors, Colony-Stimulating Factor (+ 5); Receptors, Interferon; Receptors, Interleukin (+ 3); Receptors, Transforming Growth Factor beta; Receptors, Tumor Necrosis Factor Cell surface proteins that bind cytokines and trigger intracellular changes influencing the behavior of cells. Receptors, Immunologic (80-93)  "U.$$Receptors, Cytoadhesin D12.776.543.750.705.408.460; D24.611.834.408.460 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Extracellular Matrix Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins Receptors, Leukocyte-Adhesion (+ 3); Receptors, Very Late Antigen (+ 1) Receptors, Leukocyte-Adhesion (+ 3); Receptors, Very Late Antigen (+ 1) A group of glycoproteins that include the platelet outer membrane protein GPIIb-IIIa. They play a major role in cell adhesion and serve as receptors for fibronectin, von Willebrand factor, and vitronectin. These receptors all share a common beta-subunit and recognize sites that include the tripeptide Arg-Gly-Asp (RGD). Receptors, Cell Surface (73-89) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR ("Y6$# v&<Receptors, Cyclic AMP D12.776.543.750.720.700.150; D12.776.543.750.810.150 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Cyclic AMP Receptor Protein; Cyclic AMP-Dependent Protein Kinases Cyclic AMP Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Purinergic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Purinergic Cell surface proteins that bind cyclic AMP with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized cyclic AMP receptors are those of the slime mold Dictyostelium discoideum. The transcription regulator CYCLIC AMP RECEPTOR PROTEIN of prokaryotes is not included nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES. Adenine Nucleotides (66-67); Adenosine Cyclic Monophosphate (68-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76) $"^+:$M@Receptors, Corticotropin-Releasing Hormone D12.776.543.750.720.600.290; D12.776.543.750.750.555.290; D12.776.543.750.750.700.150 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Corticotropin-Releasing Hormone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone-Regulating Hormone Cell surface proteins that bind corticotropin-releasing hormone with high affinity and trigger intracellular changes which influence the behavior of cells. The corticotropin releasing-hormone receptors on anterior pituitary cells mediate the stimulation of corticotropin release by hypothalamic corticotropin releasing factor. The physiological consequence of activating corticotropin-releasing hormone receptors on central neurons is not well understood. Receptors, Cell Surface (83-86); Receptors, Neurohumor (86-93)  "c0]$$JReceptors, Corticotropin D12.776.543.750.720.600.285; D12.776.543.750.750.555.285; D12.776.543.750.750.660.285 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Corticotropin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Pituitary Hormone Cell surface receptors that bind CORTICOTROPIN (ACTH, adrenocorticotropic hormone) with high affinity and trigger intracellular changes. Pharmacology suggests there may be multiple ACTH receptors. An ACTH receptor has been cloned and belongs to a subfamily of G-protein-coupled receptors. In addition to the adrenal cortex, ACTH receptors are found in the brain and immune systems. Receptors, Cell Surface (81-86); Receptors, Pituitary Hormone (87-93)  "h]$ RReceptors, Concanavalin A D12.776.543.750.705.880.600; D24.611.834.880.600 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Concanavalin A Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Mitogen Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Mitogen Glycoprotein moieties on the surfaces of cell membranes that bind concanavalin A selectively; the number and location of the sites depends on the type and condition of the cell. Concanavalin A (71-76); Lectins (66-70); Receptors, Drug (68-76)  "mv6$4OReceptors, Complement 3d D12.776.543.750.705.833.610; D24.185.101.100.110.610; D24.611.216.301.264.035.610; D24.611.834.833.610 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Complement 3d Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Complement Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Complement Molecular sites on or in B-lymphocytes, follicular dendritic cells, lymphoid cells, and epithelial cells that recognize and combine with COMPLEMENT 3D. Human CR2 serves as a receptor for both C3dg and the gp350/220 glycoprotein of HERPESVIRUS 4, HUMAN, and binds the monoclonal antibody OKB7, which blocks binding of both ligands to the receptor. Antigens, Differentiation, B-Lymphocyte (88-92); Receptors, Complement (81-92)  "pp$tZReceptors, Complement 3b D12.776.543.750.705.833.600; D24.185.101.100.110.600; D24.611.216.301.264.035.600; D24.611.834.833.600 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Complement 3b Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Complement Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Complement Molecular sites on or in some B-lymphocytes and macrophages that recognize and combine with COMPLEMENT 3B. The primary structure of these receptors reveal that they contain transmembrane and cytoplasmic domains, with their extracellular portion composed entirely of thirty short consensus repeats each having 60 to 70 amino acids. Receptors, Complement (82-92)  "up$t#Receptors, Complement D12.776.543.750.705.833; D24.611.834.833 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Complement Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Macrophage-1 Antigen; Receptors, Complement 3b; Receptors, Complement 3d Macrophage-1 Antigen; Receptors, Complement 3b; Receptors, Complement 3d Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement (66-79); Lymphocytes (66-79); B Lymphocytes (73-79) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR ("z.$L<Receptors, Colony-Stimulating Factor D12.776.543.750.705.852.150; D12.776.543.750.750.400.200; D24.611.834.852.150 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Colony-Stimulating Factors; Hematopoietic Cell Growth Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Cytokine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Cytokine Receptors, Erythropoietin; Receptors, Granulocyte Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Receptors, Interleukin-3; Receptors, Macrophage Colony-Stimulating Factor Receptors, Erythropoietin; Receptors, Granulocyte Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Receptors, Interleukin-3; Receptors, Macrophage Colony-Stimulating Factor Receptors, Erythropoietin; Receptors, Granulocyte Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Receptors, Interleukin-3; Receptors, Macrophage Colony-Stimulating Factor Cell surface receptors for colony stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of hemopoietic cells. Receptors, Endogenous Substances (73-90) $"~l*U$G/Receptors, Cholinergic D12.776.543.750.720.360 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Neuromuscular Junction; Acetylcholine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter Receptors, Muscarinic; Receptors, Nicotinic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. Receptors, Drug (66-70); specific agonist, tissue, or organ affected (66-70) $"$,3[Receptors, Cholecystokinin D12.776.543.750.720.600.270; D12.776.543.750.750.360.200; D12.776.543.750.750.555.270 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Cholecystokinin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Gastrointestinal Hormone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind cholecystokinin (CCK) with high affinity and trigger intracellular changes influencing the behavior of cells. Cholecystokinin receptors are activated by gastrin as well as by CCK-4, CCK-8, and CCK-33. Activation of these receptors evokes secretion of amylase by pancreatic acinar cells, acid and pepsin by stomach mucosal cells, and contraction of the pylorus and gall bladder. The role of the widespread CCK receptors in the central nervous system is not well understood. Cholecystokinin (66-86); Receptors, Endogenous Substances (73-86)  "]$KLReceptors, Cell Surface D12.776.543.750 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Binding Sites; Hormones; Ligands Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins Autoreceptors; Receptors, Biogenic Amine (+ 16); Receptors, Eicosanoid (+ 5); Receptors, Immunologic (+ 43); Receptors, Lipoprotein (+ 1); Receptors, Neurotransmitter (+ 68); Receptors, Odorant; Receptors, Peptide (+ 80); Receptors, Purinergic (+ 3); Receptors, Transferrin; Receptors, Virus (+ 2) Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Molecular Biology of the Cell, 2nd ed). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Receptors, Drug (68-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ("/$)ZcHReceptors, Catecholamine D12.776.543.750.600.300; D12.776.543.750.720.300.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Catecholamines Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine Receptors, Adrenergic (+ 6); Receptors, Dopamine (+ 2) Receptors, Adrenergic (+ 6); Receptors, Dopamine (+ 2) Cell surface proteins that bind catecholamines with high affinity and trigger intracellular changes which influence the behavior of cells. The catecholamine messengers epinephrine, norepinephrine, and dopamine are synthesized from tyrosine by a common biosynthetic pathway. Receptors, Adrenergic (82-93) $":$J9#Receptors, Calcitriol D12.776.826.750.250; D12.776.930.682.250 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Vitamin D; Calcitriol; Cholecalciferol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid Proteins, usually found in the cytoplasm, that specifically bind calcitriol, migrate to the nucleus, and regulate transcription of specific segments of DNA. Vitamin D is converted in the liver and kidney to calcitriol and ultimately acts through these receptors. Receptors, Steroid (80-93)  "q.$/2 Receptors, Calcitonin Gene-Related Peptide D12.776.543.750.720.600.260; D12.776.543.750.750.555.260 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Calcitonin Gene-Related Peptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind calcitonin gene-related peptide (CGRP) with high affinity and trigger intracellular changes which influence the behavior of cells. CGRP receptors are present in both the central nervous system and the periphery and are not the same as calcitonin receptors. Receptors, Cell Surface (86-93)  "1>$%[P&Receptors, Calcitonin D12.776.543.750.720.600.250; D12.776.543.750.750.200; D12.776.543.750.750.555.250 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Calcitonin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind calcitonin and trigger intracellular changes which influence the behavior of cells. Calcitonin receptors outside the nervous system mediate the role of calcitonin in calcium homeostasis. The role of calcitonin receptors in the brain is not well understood. Receptors, Cell Surface (74-93)  "4Y$P&Receptors, Bradykinin D12.776.543.750.720.600.220; D12.776.543.750.750.555.220 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Bradykinin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface receptors that bind bradykinin and related kinins with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types (B-1 and B-2, or BK-1 and BK-2) recognize the endogenous kallidins, t-kinins, and certain bradykinin fragments as well as bradykinin itself. Receptors, Cell Surface (80-84); Receptors, Neurotransmitter (85-93)  "a>$[yPReceptors, Bombesin D12.776.543.750.720.600.200; D12.776.543.750.750.555.200 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Bombesin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind bombesin or closely related peptides with high affinity and trigger intracellular changes influencing the behavior of cells. Gastrin- releasing peptide (GRP), GRP 18-27 (neuromedin C), and neuromedin B are endogenous ligands of bombesin receptors in mammals. Receptors, Cell Surface (82-86); Receptors, Neurotransmitter (87-93)  ":>$ [RPReceptors, Biogenic Amine D12.776.543.750.600; D12.776.543.750.720.300 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Biogenic Amine Neurotransmitters; Biogenic Amines Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter Receptors, Catecholamine (+ 10); Receptors, Histamine (+ 3); Receptors, Serotonin Receptors, Catecholamine (+ 10); Receptors, Histamine (+ 3); Receptors, Serotonin Cell surface proteins that bind biogenic amines with high affinity and regulate intracellular signals which influence the behavior of cells. Biogenic amine is a chemically imprecise term which, by convention, includes the catecholamines epinephrine, norepinephrine, and dopamine, the indoleamine serotonin, the imidazolamine histamine, and compounds closely related to each of these.  "2$: Receptors, Atrial Natriuretic Factor D12.776.543.750.720.600.170; D12.776.543.750.750.160; D12.776.543.750.750.555.170 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Atrial Natriuretic Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind atrial natriuretic factor with high affinity and trigger intracellular changes influencing the behavior of cells. Muscle Proteins (84-85); Receptors, Endogenous Substances (84-92)  "G+Y$MReceptors, Aryl Hydrocarbon D12.776.826.480; D12.776.930.662 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Cytoplasmic proteins that bind certain aryl hydrocarbons, translocate to the nucleus, and activate transcription of particular DNA segments. AH receptors are identified by their high-affinity binding to several carcinogenic or teratogenic environmental chemicals including polycyclic aromatic hydrocarbons found in cigarette smoke and smog, heterocyclic amines found in cooked foods, and halogenated hydrocarbons including dioxins and polychlorinated biphenyls. No endogenous ligand has been identified, but an unknown natural messenger with a role in cell differentiation and development is suspected. Receptors, Drug (79-93) "!&$Receptors, Antigen, T-Cell, gamma-delta D12.776.543.750.705.816.824.830; D24.611.834.816.824.830 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see ANTIGENS, CD3). Receptors, Antigen, T-Cell (86-91)  "<.>$t)Receptors, Antigen, T-Cell, alpha-beta D12.776.543.750.705.816.824.825; D24.611.834.816.824.825 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor Superantigens Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility (MHC) molecules. Receptors, Antigen, T-Cell (80-91) $"->$tD)Receptors, Antigen, T-Cell D12.776.543.750.705.816.824; D24.611.834.816.824 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Antigens, CD3; Gene Rearrangement, T-Lymphocyte Antigens, CD3 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Antigen Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Antigen Antigens, CD28; Receptor-CD3 Complex, Antigen, T-Cell; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta Antigens, CD28; Receptor-CD3 Complex, Antigen, T-Cell; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (ANTIGENS, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Lymphocytes (66-79); T Lymphocytes (73-79) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR ," 6$84224<Receptors, Antigen, B-Cell D12.776.543.750.705.816.821; D24.611.834.816.821 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Antigen Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Antigen Immunoglobulin molecules on the surface of B-lymphocytes that recognize and bind antigen. Binding Sites, Antibody (73-79); Immunoglobulin Variable Region (77-79); Immunoglobulins, Fab (73-79); Lymphocytes (66-79); B Lymphocytes (73-79) "" 6$4iReceptors, Antigen D12.776.543.750.705.816; D24.611.834.816 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Antigens Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Receptors, Antigen, B-Cell; Receptors, Antigen, T-Cell (+ 4) Receptors, Antigen, B-Cell; Receptors, Antigen, T-Cell (+ 4) Molecules on the surface of B- and T-lymphocytes that recognize and combine with specific antigens. Binding Sites, Antibody (73-79); Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR (" .$ vw<Receptors, Angiotensin D12.776.543.750.720.600.150; D12.776.543.750.750.130; D12.776.543.750.750.555.150 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Angiotensins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Neuropeptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Neuropeptide Cell surface proteins that bind angiotensins and trigger intracellular changes influencing the behavior of cells. Angiotensin II (66-76); Receptors, Drug (68-76); Receptors, Endogenous Substances (73-76)  "qY$jReceptors, Androgen D12.776.826.750.150; D12.776.930.682.150 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Androgens Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid Proteins, generally found in the cytoplasm, that specifically bind androgens and mediate their cellular actions. The complex of the androgen and receptor migrates to the nucleus where it induces transcription of specific segments of DNA. Androgens (66-76); Receptors, Drug (68-72); Receptors, Endogenous Substances (73-76)  ".$ dReceptors, AMPA D12.776.543.750.720.200.450.200 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Amino Acid; Receptors, Glutamate Cell surface proteins that bind glutamate and directly gate ion channels in cell membranes. AMPA receptors were originally discriminated from other glutamate receptors by their affinity for the agonist AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid). They are probably the most common mediators of fast excitatory synaptic transmission in the central nervous system. Several subtypes have been cloned, and for some types the traditional distinction from kainate receptors may not apply. Receptors, Drug (81-89); Receptors, Glutamate (93); Receptors, Neurotransmitter (90-92)  "+#$=AgReceptors, Amino Acid D12.776.543.750.720.200 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids; Amino Acid Neurotransmitters Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter Receptors, GABA (+ 2); Receptors, Glutamate (+ 4); Receptors, Glycine Cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. Glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and GABA and glycine receptors are the most common receptors for fast inhibition. Receptors, Endogenous Substances (81-92) $"a$2Vr/Receptors, Aldosterone D12.776.826.750.530.150; D12.776.930.682.530.150 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Aldosterone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Receptors, Mineralocorticoid Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Receptors, Steroid; Receptors, Mineralocorticoid Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA. Receptors, Glucocorticoid (81-92)  "ت6$9'Receptors, Albumin D12.776.543.750.750.100 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Serum Albumin; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide Cell surface proteins that bind albumin with high affinity and trigger intracellular changes influencing the behavior of cells. Receptors, Endogenous Substances (81-92)  "۠$/Receptors, Adrenergic, beta-2 D12.776.543.750.600.300.300.340.725; D12.776.543.750.720.300.300.300.360 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic; Receptors, Adrenergic, beta Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). beta-2 Adrenergic receptors are more sensitive to epinephrine than to norepinephrine and have a high affinity for the agonist terbutaline. They are widespread, with clinically important roles in skeletal muscle, liver, and vascular, bronchial, gastrointestinal, and genitourinary smooth muscle. Receptors, Adrenergic, beta (77-93) "ݑ#N$*Receptors, Adrenergic, beta-1 D12.776.543.750.600.300.300.340.700; D12.776.543.750.720.300.300.300.350 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic; Receptors, Adrenergic, beta Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). beta-1 Adrenergic receptors are equally sensitive to epinephrine and norepinephrine and bind the agonist dobutamine and the antagonist metoprolol with high affinity. They are found in the heart, juxtaglomerular cells, and in the central and peripheral nervous systems. Receptors, Adrenergic, beta (77-93) "#N$*Receptors, Adrenergic, beta D12.776.543.750.600.300.300.340; D12.776.543.750.720.300.300.300.340 ANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 One of the two major pharmacologically defined classes of adrenergic receptors. The alpha-beta distinction was originally based on the cellular effects of receptor activation but now relies on the relative affinities for characteristic synthetic ligands. Beta adrenergic receptors are further subdivided based on information from endogenous and cloned receptors. Receptors, Adrenergic (73-76); Receptors, Drug (68-72) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL $":!J GA$Receptors, Adrenergic, alpha-2 D12.776.543.750.600.300.300.300.725; D12.776.543.750.720.300.300.300.335 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic; Receptors, Adrenergic, alpha Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic A subclass of alpha-adrenergic receptors (RECEPTORS, ADRENERGIC, ALPHA). alpha-2 Adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems. Receptors, Adrenergic, alpha (77-93) "$N$+Receptors, Adrenergic, alpha-1 D12.776.543.750.600.300.300.300.700; D12.776.543.750.720.300.300.300.325 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic; Receptors, Adrenergic, alpha Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic A subclass of alpha-adrenergic receptors (RECEPTORS, ADRENERGIC, ALPHA). alpha-1 Adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems. Receptors, Adrenergic, alpha (77-93) "$N$+Receptors, Adrenergic, alpha D12.776.543.750.600.300.300.300; D12.776.543.750.720.300.300.300.300 ANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine; Receptors, Adrenergic Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2 One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. alpha-Adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors. Receptors, Adrenergic (73-76); Receptors, Drug (68-76) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL $"$"J IA$Receptors, Adrenergic D12.776.543.750.600.300.300; D12.776.543.750.720.300.300.300 ANBICHCLDEDFGEHIIMIPMEPHREUL Epinephrine; Sympathomimetics; Norepinephrine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Biogenic Amine; Receptors, Catecholamine Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Biogenic Amine; Receptors, Catecholamine Receptors, Adrenergic, alpha (+ 2); Receptors, Adrenergic, beta (+ 2) Receptors, Adrenergic, alpha; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2 Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction. Receptors, Drug (68-70) AGAIANBICHCLDEDFGEHIIMIPMEPHREUL ("B 5#>$Receptor-CD3 Complex, Antigen, T-Cell D12.776.543.750.705.816.824.800; D24.185.101.100.110.095.800; D24.185.101.100.894.095.800; D24.611.216.301.264.035.095.800; D24.611.216.301.264.894.095.800; D24.611.834.816.824.800 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Signal Transduction Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD; Antigens, CD3 Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte; Antigens, CD3 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD; Antigens, CD3 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte; Antigens, CD3 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell Molecule composed of the non-covalent association of the T-cell antigen receptor (RECEPTORS, ANTIGEN, T-CELL) with the CD3 complex (ANTIGENS, CD3). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex. Antigens, CD (90-92); Antigens, Differentiation, T-Lymphocyte (87-92); Receptors, Antigen, T-Cell (87-92); Receptors, Antigen, T-Cell, alpha-beta (92); Receptors, Antigen, T-Cell, gamma-delta (92)  ",$hReceptor Protein-Tyrosine Kinase D08.586.913.696.620.682.725.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Tyrosine Kinase Epidermal Growth Factor Receptor Protein-Tyrosine Kinase; Insulin Receptor Protein-Tyrosine Kinase A catalytic PROTEIN-TYROSINE KINASE domain found on the cytoplasmic beta-portion of receptors. Many growth and differentiation factor receptors contain this domain. It is critical for the signal transduction pathways required for mitogenesis, transformation, and cell differentiation. (Neuron 1992;9:383) EC 2.7.1.-. specific receptors (83-93); Protein-Tyrosine Kinase (83-93)  #b&#FpkFReceptor Aggregation G04.335.857 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Immunologic Capping Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell. specific receptor (68-83)  # fRecall F02.463.425.540.641 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Memory The process whereby a representation of past experience is elicited. #   dRRec A Protein D08.586.277.656.850; D12.776.097.780 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Protein from E.coli rec gene. Catalyzes the ATP-driven exchange of DNA strands in genetic recombination. The product of the reaction consists of a duplex and a displaced single-stranded loop which has the shape of the letter D and is therefore called a D-loop structure. ATP is hydrolyzed to ADP during the reaction; also has proteolytic activity. Bacterial Proteins (66-83) # *B Reassortant Viruses B04.800 CHCLDEENGDGEIMIPMEPHPYREUL Recombination, Genetic Viruses Viruses containing two or more pieces of nucleic acid (segmented genome) from different parents. Such viruses are produced in cells coinfected with different strains of a given virus. Recombination, Genetic (81-91); specific virus/genetics (81-91)  #  KReality Therapy F04.754.804 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A form of therapy in which the patient learns to fulfill his needs of involvement and responsibility which are basic to facing and accepting reality. #lKReality Testing F01.752.747.189.508; F02.739.794.206.508 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Ego Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory; Ego The individual's objective evaluation of the external world and the ability to differentiate adequately between it and the internal world; considered to be a primary ego function. #.Reagins D24.611.125.890 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies # 6iReagent Strips D26.550.754.796; E07.754.820 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Reagent Kits, Diagnostic Equipment and Supplies; Reagent Kits, Diagnostic Indicators and Reagents (66-72) #",&Reagent Kits, Diagnostic D26.550.754; E07.754 CLECHISDSNSTTDUTVE Indicators and Reagents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Equipment and Supplies Reagent Strips Reagent Strips Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSNSTTDTOTUUTVE $#j$4Reading Frames G05.331.599.110.675; G06.184.599.110.675 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence Open Reading Frames Open Reading Frames The sequence of codons by which translation may occur. A segment of mRNA 5'AUCCGA3' could be translated in three reading frames, 5'AUC.. or 5'UCC.. or 5'CCG.., depending on the location of the start codon. Amino Acid Sequence (80-90); Base Sequence (80-90)  #o.0>Reading L01.143.506.423.557 Dyslexia, Acquired Information Science; Communication; Language; Language Arts (Non MeSH) #8 TReactive Oxygen Species D26.680.700 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Free Radicals Miscellaneous Drugs and Agents (Non MeSH); Oxidants Reactive intermediate oxygen species including both radicals and non-radicals. These substances are constantly formed in the human body and have been shown to kill bacteria and inactivate proteins, and have been implicated in a number of diseases. Scientific data exist that link the reactive oxygen species produced by inflammatory phagocytes to cancer development. #,?Reactive Inhibition F01.145.544.724; F02.463.425.475.724 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Inhibition (Psychology) Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Inhibition (Psychology) Tendency toward a lessened strength of response due to practice or activity. It is independent of the effect of reward and is a direct function of time interval since the last response and the number of preceding responses. # ]* Reaction Time F02.830.650; F04.669.817; G11.561.656 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Refractory Period, Psychological Refractory Period, Psychological The time from the onset of a stimulus until the organism responds. CLDEGEIMPHRE  #"-KRRazoxane D03.383.606.845; D22.204.802 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents (+-)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione. An antimitotic antineoplastic agent with immunosuppressive properties. Piperazines (66-74); Propane (73-74) #$ ":-Raynaud's Disease C14.907.744 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases CREST Syndrome An idiopathic vascular disorder characterized by bilateral attacks of RAYNAUD'S PHENOMENON. It affects females more often than males. (From Dorland, 27th ed). #&N2Rauwolfia Alkaloids D03.132.973.641; D03.549.937.641; D18.162.804 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Yohimbans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Yohimbans Cardiovascular Agents; Antihypertensive Agents Ajmaline (+ 1); Reserpine; Yohimbine Ajmaline (+ 1); Reserpine; Yohimbine Reserpine Alkaloids from Rauwolfia serpentina Benth and other species. The prototype is RESERPINE, which is a depleter of catecholamines and serotonin from the sympathetic postganglionic fibers and brain areas. They have been used in hypertension and psychoses despite their wide range of potentially adverse effects. Rauwolfia (69-74); Yohimbans (69-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $#(`5>ge-@Rauwolfia B06.560.755 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A large genus (family Apocynaceae) of tropical Asian trees and shrubs that contain alkaloids used to treat mental illness and hypertension; RESPERINE, RESCINNAMINE, deserpidine and their derivatives are the specific drugs obtained from Rauwolfia. #, & Rauscher Virus B04.820.650.730.730.900.500.770; B04.909.574.807.730.730.900.500.770; B04.909.777.731.730.730.900.500.770 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A murine leukemia virus associated with mouse tumors similar to those caused by the FRIEND VIRUS. #-qAuRats, Zucker B02.649.865.635.560.610.700 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Mutant Strains Two populations of Zucker rats have been cited in research--the "fatty" or obese and the lean. The "fatty" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene. Rats (66-80) #18(SRats, Wistar B02.649.865.635.560.835 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Rats (66-80); Rats, Inbred Strains (80-92) #3-(95Rats, Nude B02.649.865.635.560.610.508 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Mutant Strains A mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it. Rat, Mutant Strains (82-86) #4(S"Rats, Mutant Strains B02.649.865.635.560.610 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats Rats, Brattleboro; Rats, Gunn; Rats, Nude; Rats, Zucker Rats bearing mutant genes which are phenotypically expressed in the animals. Rats (77-81)  #6(9E[Rats, Inbred WKY B02.158.157.500.390; B02.649.865.635.560.500.390 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Inbred Strains (72-84) #86(~#Rats, Inbred WF B02.158.157.500.360; B02.649.865.635.560.500.360 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains Rats (66-71) #96(Rats, Inbred Strains B02.158.157.500; B02.649.865.635.560.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats Rats, Inbred ACI; Rats, Inbred BB; Rats, Inbred BN; Rats, Inbred BUF; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred SHR; Rats, Inbred WF; Rats, Inbred WKY Rats, Inbred ACI; Rats, Inbred BB; Rats, Inbred BN; Rats, Inbred BUF; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred SHR; Rats, Inbred WF; Rats, Inbred WKY Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. Rats (66-71)  #;,.(nGRats, Inbred SHR B02.158.157.500.300; B02.649.865.635.560.500.300 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Blood Pressure (66-84); Hypertension (66-84); Rats, Inbred Strains (72-84) #?6(ZRats, Inbred Lew B02.158.157.500.280; B02.649.865.635.560.500.280 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains Rats (66-71) #A06(Rats, Inbred F344 B02.158.157.500.200; B02.649.865.635.560.500.200 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains Rats (66-71) #Bz6(Rats, Inbred BUF B02.158.157.500.130; B02.649.865.635.560.500.130 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains Rats (66-71) #C6(Rats, Inbred BN B02.158.157.500.110; B02.649.865.635.560.500.110 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains Rats (66-71) #E6(Rats, Inbred BB B02.158.157.500.090; B02.649.865.635.560.500.090 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains A strain of Rattus norvegicus which is a model for spontaneous diabetes mellitus. Rats, Inbred Strains (72-85) #FX6(b#Rats, Inbred ACI B02.158.157.500.080; B02.649.865.635.560.500.080 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Rats, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Inbred Strains Rats (66-71) #H6(Rats, Gunn B02.649.865.635.560.610.308 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Mutant Strains Mutant strain of Rattus norvegicus which is used as a disease model of kernicterus. Rats (77-81) #Ic(SeRats, Brattleboro B02.649.865.635.560.610.110 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats; Rats, Mutant Strains A mutant strain of Rattus norvegicus used in research on renal function and hypertension and as a disease model for diabetes insipidus. Rats (66-82); Rats, Inbred Strains (72-82); Rats, Mutant Strains (82) #J(SVRats B02.649.865.635.560 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Rodent Control Vertebrates; Mammals; Rodentia; Muridae Rats, Inbred Strains (+ 9); Rats, Mutant Strains (+ 4); Rats, Sprague-Dawley; Rats, Wistar The common name for the species Rattus norvegicus.  #Lw(1p>Rationalization F01.393.746; F03.407.746 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms A defense mechanism operating unconsciously, in which the individual attempts to justify or make consciously tolerable, by plausible means, feelings, behavior, and motives that would otherwise be intolerable. #MRate Setting and Review N03.219.442.800; N03.219.463.060.800 CLHILJMTOGSNSTTDUT Relative Value Scales Fees and Charges Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges Economics, Organizations, Control (Non MeSH); Economics; Financial Management; Budgets A method of examining and setting levels of payments. Economics, Hospital (66-79); Fees and Charges (68-79) $#O*BARat-Bite Fever C01.252.400.771 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections A syndrome characterized by recurring fever, rash, and arthralgias occurring days to weeks after a rat bite. The causative agents are either Streptobacillus moniliformis or Spirillum minus. #QPsras Proteins D12.776.543.350.730 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, ras Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; G-Proteins Oncogene Protein p21(ras); Proto-Oncogene Protein p21(ras) G-proteins encoded by ras genes (GENES, RAS) that play a critical role in normal cellular growth, differentiation, and development, and have the potential for malignant transformation. Two of the major ras proteins include the normal cellular form, PROTO-ONCOGENE PROTEIN P21(RAS), and the malignant form, ONCOGENE PROTEIN P21(RAS).  #SFhGRare Books L01.178.682.192.779 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books #VqfRaphe Nuclei A08.186.211.132.659.632; A08.186.211.132.810.507 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon Collections of small neurons centrally scattered among many fibers from the level of the trochlear nucleus in the midbrain to the hypoglossal area in the medulla oblongata. Brain Stem (66-77); Mesencephalon (66-77); Reticular Formation (66-77) #W"66URape I01.198.240.748.640 DILJPCPXRHSN Social Sciences; Criminology; Crime; Sex Offenses Unlawful sexual intercourse without consent of the victim. #Y=FRanvier's Nodes A08.637.800.500.700; A08.663.542.512.560.700; A08.800.800.690.500.700; A10.755.503.700; A11.650.800.500.700; A11.671.514.553.640 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neuroglia; Schwann Cells; Myelin Sheath Nervous System; Neurons; Nerve Fibers; Nerve Fibers, Myelinated; Myelin Sheath Nervous System; Peripheral Nervous System; Peripheral Nerves; Schwann Cells; Myelin Sheath Tissue Types (Non MeSH); Nerve Tissue; Myelin Sheath Cells; Neuroglia; Schwann Cells; Myelin Sheath Cells; Neurons; Nerve Fibers, Myelinated; Myelin Sheath Regularly spaced gaps in the myelin sheaths of peripheral axons. Ranvier's nodes allow saltatory conduction, that is, jumping of impulses from node to node, which is faster and more energetically favorable than continuous conduction. #Zk*Ranula C04.182.766; C07.465.780 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Mucocele Neoplasms; Cysts Stomatognathic Diseases; Mouth Diseases A form of retention cyst of the floor of the mouth, usually due to obstruction of the ducts of the submaxillary or sublingual glands, presenting a slowly enlarging painless deep burrowing mucocele of one side of the mouth. It is also called sublingual cyst and sublingual ptyalocele. #^/ X CORanitidine D03.383.312.750; D14.100.375.425.425.750; D19.316.203.803 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. Furans (66-83) #`tA:pRanidae B02.090.180.708 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura Rana catesbeiana; Rana esculenta; Rana pipiens; Rana ridibunda; Rana temporaria The family of true frogs of the order Anura. The family occurs worldwide except in Antarctica. Anura (66-71)  #cQ &$`sRange of Motion, Articular G11.427.614.764 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement Range through which a joint can be extended and flexed. This is frequently assessed following surgery of the joint. Movement (66-90); specific joints (66-90) #d!}3Randomized Controlled Trials E05.318.760.535.750; E05.337.250.750; G03.850.520.835.535.750; N05.715.360.775.235.700 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Clinical Trials Miscellaneous Techniques (Non MeSH); Evaluation Studies; Clinical Trials Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Clinical Trials Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Clinical Trials Clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Treatment allocations using coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are not truly randomized and trials employing any of these techniques for patient assignment are designated simply CONTROLLED CLINICAL TRIALS. Clinical Trials (66-89) #fm"`$*Random Allocation E05.318.780.700; G03.850.520.840.700; H01.770.644.728.805; N05.715.360.780.675 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Science; Research; Research Design Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Research Design (73-77) #lAX)Ranavirus B04.280.410.700; B04.909.204.490.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Iridoviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Iridoviridae A genus of IRIDOVIRIDAE which infects amphibians. It is non-pathogenic for its natural host, Rana pipiens, but is lethal for tadpoles and Fowler toads. Frog Virus 3 is the type species. DNA Viruses (66-77); Iridoviridae (77-93) #o *y3Rana temporaria B02.090.180.708.420 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Ranidae A species of the family Ranidae occurring in a wide variety of habitats from within the Arctic Circle to South Africa, Australia, etc. Anura (66-71) #q&/Rana ridibunda B02.090.180.708.360 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Ranidae A species of the family Ranidae which occurs primarily in Europe and is used widely in biomedical research. Anura (66-80); Ranidae (72-80) #sA&/'Rana pipiens B02.090.180.708.310 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Ranidae A highly variable species of the family Ranidae in Canada, the United States and Central America. It is the most widely used Anuran in biomedical research. Anura (66-71) #t&/Rana esculenta B02.090.180.708.240 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Ranidae An edible species of the family Ranidae, occurring in Europe and used extensively in biomedical research. Commonly referred to as "edible frog". Anura (66-71) #u&/Rana catesbeiana B02.090.180.708.180 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Ranidae A species of the family Ranidae (true frogs). The only anuran properly referred to by the common name "bullfrog", it is the largest native anuran in North America. Anura (66-71) #wb&/Ramipril D02.219.308.750; D04.615.236.308.750; D08.373.745.085.750; D18.162.050.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Bridged Compounds; Bicyclo Compounds Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Bridged Compounds; Bicyclo Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors (2S-(1(R*(R*)),2 alpha,3a beta,6a beta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid. A long-acting angiotensin-converting enzyme inhibitor. It is a prodrug that is transformed in the liver to its active metabolite ramiprilat. Bicyclo Compounds (84-92) #x T:ORain G03.230.300.100.725.450 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather Acid Rain AEANECLJPCPOSNTO #|uRailroads J01.937.690 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Transportation Permanent roads having a line of rails fixed to ties and laid to gage, usually on a leveled or graded ballasted roadbed and providing a track for freight cars, passenger cars, and other rolling stock. Cars are designed to be drawn by locomotives or sometimes propelled by self-contained motors. (From Webster's 3d) The concept includes the organizational and administrative aspects of railroads as well. #} GRage F01.470.093.640 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Emotions; Anger Fury; violent, intense anger. ## J&Rafoxanide D02.065.199.860.600; D02.065.793.650.600; D21.201.287.743; D21.201.412.539 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Salicylanilides Organic Chemicals (Non MeSH); Amides; Salicylamides; Salicylanilides Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents 3'-Chloro-4'-(p-chlorophenoxy)-3,5-diiodosalicylanilide. Veterinary anthelmintic for grazing animals; used to treat fluke, hookworm and other infestations. Synonyms: Flukanide; Ranide. Iodines (72-74); Phenyl Ethers (74); Salicylamides (71-74) #T:@HRaffinose D09.203.698.629.802.700 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Trisaccharides O-alpha-D-Galactopyranosyl(1,6)-O-alpha-D-glucopyranosyl-(1,2)-beta-D-fructofuranoside. A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal. Oligosaccharides (70-74) # DRadon Daughters D01.268.271.800.800; D01.362.641.745.800; D05.569.162.600.800 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Radon Inorganic Chemicals (Non MeSH); Gases; Noble Gases; Radon Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Carcinogens, Environmental; Radon Short-lived radioactive decay products of radon that include 216-Po, 214-Pb, 214-Bi, and 214-Po. They have an effective half-life of about 30 minutes and are solids that can deposit on the bronchial airways during inhalation and exhalation. This results in exposure of the respiratory airways to alpha radiation and can lead to diseases of the respiratory system, including lung cancer. (From Casarett and Doull's Toxicology, 4th ed). Bismuth (81-92); Lead (81-92); Polonium (81-92); Radon (93) #E4LRadon D01.268.271.800; D01.268.613.700; D01.362.641.745; D05.569.162.600 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Air Pollutants, Radioactive Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Noble Gases Inorganic Chemicals (Non MeSH); Gases; Noble Gases Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Carcinogens, Environmental Radon Daughters Radon Daughters Radon Daughters Radon. A naturally radioactive element with atomic symbol Rn, atomic number 86, and atomic weight 222. It is a member of the noble gas family and released during the decay of radium and found in soil. There is a link between exposure to radon and lung cancer.  # L4!B99Radius Fractures C21.866.088.268.556; C21.866.405.638 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries; Forearm Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures  Colles' Fracture #*NRadius A02.835.232.087.702 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH) #A :VRadium D01.268.271.770; D01.268.552.775; D01.552.539.745 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Metals, Alkaline Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Alkaline Earth Radium. A radioactive element of the alkaline earth series of metals. It has the atomic symbol Ra, atomic number 88, and atomic weight 226. Radium is the product of the disintegration of uranium and is present in pitchblende and all ores containing uranium. It is used clinically as a source of beta and gamma-rays in radiotherapy, particularly BRACHYTHERAPY. # 94Radiotherapy, High-Energy E02.810.722 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Radiotherapy Neutron Capture Therapy (+ 1); Radioisotope Teletherapy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. #C" CRadiotherapy, Computer-Assisted E02.810.635; L01.700.508.100.710.600 CLECEDHIISLJMAMTOGSNSTTD Therapeutics; Radiotherapy Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted; Therapy, Computer-Assisted  Radiotherapy Planning, Computer-Assisted Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients. #$*/Radiotherapy, Adjuvant E02.186.775; E02.810.600 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Combined Modality Therapy Therapeutics; Radiotherapy Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. specific neoplasms/radiotherapy (66-94); Combined Modality Therapy (85-94) #"MWRadiotherapy Planning, Computer-Assisted E02.950.825; L01.700.508.100.710.600.608 CLECEDHIISLJMAMTOGSNSTTD Therapeutics; Therapy, Computer-Assisted Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted; Therapy, Computer-Assisted; Radiotherapy, Computer-Assisted Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy. Computer Programs (83-86); Computers (66-86); Radiotherapy Dosage (66-86) #..XRadiotherapy Dosage E02.810.639 STVE Dose-Response Relationship, Radiation Radiation Dosage Therapeutics; Radiotherapy #+ Radiotherapy E02.810 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Brachytherapy; Cranial Irradiation (+ 1); Hemibody Irradiation; Lymphatic Irradiation; Radioimmunotherapy; Radiosurgery; Radiotherapy, Adjuvant; Radiotherapy, Computer-Assisted; Radiotherapy Dosage; Radiotherapy, High-Energy (+ 3); Whole-Body Irradiation; X-Ray Therapy The use of ionizing radiation to treat malignant neoplasms and other benign conditions. The most common forms of ionizing radiation used as therapy are x-rays, gamma rays, and electrons. A special form of radiotherapy, targeted radiotherapy, links a cytotoxic radionuclide to a molecule that targets the tumor. When this molecule is an antibody or other immunologic molecule, the technique is called RADIOIMMUNOTHERAPY. AECLCTECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE  #H "6,Radiosurgery E02.810.530; E04.530.832.500; E05.873.500 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Particle Accelerators Therapeutics; Radiotherapy Surgery, Operative; Neurosurgery; Stereotaxic Techniques Miscellaneous Techniques (Non MeSH); Stereotaxic Techniques A stereotactic neurosurgery in which the usual rigid needles or probes are replaced with beams of ionizing radiation directed toward an intracranial target so as to achieve local tissue destruction. No skin incision or skull opening is required. It is performed with the "gamma knife", a self-contained unit with 201 cobalt-60 sources or with an isocentric linear accelerator (linac). (Goodman, M.L., Southern Medical Journal, vol. 83, May 1990, pp. 551-4). Stereotaxic Techniques (71-91)  # 1$$Radionuclide Ventriculography E01.145.077.805.902; E01.145.569.820; E01.289.806.800.902; E01.357.820.800.902 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography; Radionuclide Angiography Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging; Radionuclide Angiography Diagnosis; Diagnostic Imaging; Radionuclide Imaging; Radionuclide Angiography Gated Blood-Pool Imaging; Ventriculography, First-Pass Gated Blood-Pool Imaging; Ventriculography, First-Pass Gated Blood-Pool Imaging; Ventriculography, First-Pass Gated Blood-Pool Imaging; Ventriculography, First-Pass Imaging of a ventricle of the heart after the injection of a radioactive contrast medium. The technique is less invasive than cardiac catheterization and is used to assess ventricular function. Heart/radionuclide imaging (77-89); Heart Ventricle/radionuclide imaging (77-89)  #"X&k^Radionuclide Imaging E01.289.806; E01.357.820 AECLCTECHIISMOMTNUPXSNSTTDUTVE Gamma Cameras; Scintillation Counting Diagnosis; Diagnosis, Radioisotope Diagnosis; Diagnostic Imaging Absorptiometry, Photon; Radioimmunodetection; Radionuclide Angiography (+ 4); Tomography, Emission-Computed (+ 1) Absorptiometry, Photon; Radioimmunodetection; Radionuclide Angiography (+ 4); Tomography, Emission-Computed (+ 1) Process whereby a radionuclide is injected or measured (through tissue) from an external source, and a display is obtained from any one of several rectilinear scanner or gamma camera systems. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $#"-K&Radionuclide Generators H01.671.579.835 CLECHIISLJSDSNSTUT Physical Sciences (Non MeSH); Physics; Nuclear Physics Separation systems containing a relatively long-lived parent radionuclide which produces a short-lived daughter in its decay scheme. The daughter can be periodically extracted (milked) by means of an appropriate eluting agent. Radioisotopes (66-78) #CRadionuclide Angiography E01.145.077.805; E01.289.806.800; E01.357.820.800 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging Diagnosis; Diagnostic Imaging; Radionuclide Imaging Radionuclide Ventriculography (+ 2) Radioisotope Renography; Radionuclide Ventriculography (+ 2) Radioisotope Renography; Radionuclide Ventriculography (+ 2) The measurement of visualization by radiation of any organ after a radionuclide has been injected into its blood supply. It is used to diagnose heart, liver, lung, and other diseases and to measure the function of those organs, except renography, for which RADIOISOTOPE RENOGRAPHY is available. Angiocardiography (66-86); specific disease/radionuclide imaging (78-86); specific organ/radionuclide imaging (78-86)  #9&YRadiometry E05.799; H01.671.768.765 AECLCTECHIISMOMTNUPXSNSTTDUTVE Health Physics Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics; Radiation Radiation Dosage; Radiation Monitoring (+ 3); Scintillation Counting; Spectrometry, Gamma; Spectrometry, X-Ray Emission (+ 1); Whole-Body Counting Radiation Dosage (+ 1); Radiation Monitoring (+ 3); Scintillation Counting (+ 1); Spectrometry, Gamma The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING. AECLCTECHIISLJMOMTNUPXSNSTTDUTVE $#"d'$Radiology, Interventional G02.403.790.680.750 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH); Radiology Subspeciality of radiology that combines organ system radiography, catheter techniques and sectional imaging. Radiology (77-89) #cU~Radiology Information Systems L01.700.508.300.680.850; L01.700.508.300.780; N04.452.442.452.760; N04.452.515.360.750; N04.452.515.825 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Information Science; Medical Informatics; Medical Informatics Applications; Information Systems Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems; Hospital Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of radiology services and facilities. ##s,Radiology Department, Hospital N02.278.354.422.695; N04.452.442.422.695 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which is responsible for the administration and provision of x-ray diagnostic and therapeutic services. Hospital Departments (68-Jul 77); Radiology (66-Jul 77) #j$. CRadiology G02.403.790.680 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH) Radiation Oncology; Radiology, Interventional A specialty concerned with the use of x-ray and other forms of radiant energy in the diagnosis and treatment of disease. # G5Radiologic Health (Non MeSH) G03.850.810 Environment and Public Health (Non MeSH); Public Health Air Pollution, Radioactive; Food Contamination, Radioactive; Radiation Dosage (+ 2); Radiation Effects (+ 4); Radiation Monitoring (+ 2); Radiation Protection; Radioactive Fallout; Radioactive Waste; Water Pollution, Radioactive AEANBLCFCICLCNCOCTDHDIDTECEDEHEMENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPPPSPXRARHRIRTSNSTSUTDTHURUSUTVEVI #J#D hRadioligand Assay E01.197.744; E01.223.774; E01.289.764 AECLCTECHIISMOMTNUPXSNSTTDUTVE Protein Binding; Ligands Diagnosis; Diagnosis, Endocrine (Non MeSH) Diagnosis; Diagnosis, Laboratory Diagnosis; Diagnosis, Radioisotope Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Binding Sites (68-72); Protein Binding (66-72)  #X-"9Radioisotopes D01.496.749 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Isotope Labeling Nuclear Medicine; Elements Inorganic Chemicals (Non MeSH); Isotopes Barium Radioisotopes; Bromine Radioisotopes; Cadmium Radioisotopes; Calcium Radioisotopes; Carbon Radioisotopes; Cerium Radioisotopes; Cesium Radioisotopes; Chromium Radioisotopes; Cobalt Radioisotopes; Copper Radioisotopes; Fluorine Radioisotopes; Gallium Radioisotopes; Gold Radioisotopes (+ 1); Indium Radioisotopes; Iodine Radioisotopes (+ 1); Iridium Radioisotopes; Iron Radioisotopes; Krypton Radioisotopes; Lead Radioisotopes; Mercury Radioisotopes; Nitrogen Radioisotopes; Oxygen Radioisotopes; Phosphorus Radioisotopes; Potassium Radioisotopes; Radioactive Tracers; Rubidium Radioisotopes; Ruthenium Radioisotopes; Selenium Radioisotopes; Sodium Radioisotopes; Strontium Radioisotopes; Sulfur Radioisotopes; Thallium Radioisotopes; Tin Radioisotopes; Tritium; Xenon Radioisotopes; Yttrium Radioisotopes; Zinc Radioisotopes ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $#Ö4!28Radioisotope Teletherapy E02.810.722.820 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Radiotherapy; Radiotherapy, High-Energy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. #n">Radioisotope Renography E01.289.806.800.805; E01.341.453.764; E01.357.820.800.805 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging; Radionuclide Angiography Diagnosis; Diagnosis, Urologic (Non MeSH); Kidney Function Tests Diagnosis; Diagnostic Imaging; Radionuclide Imaging; Radionuclide Angiography Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys. #A&Radioisotope Dilution Technique E01.145.643.722; E01.289.577 AECLCTECHIISMONUPXSNSTTDUTVE Body Fluids Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Indicator Dilution Techniques Diagnosis; Diagnosis, Radioisotope #G%" Radioimmunotherapy E02.095.520.750; E02.186.750; E02.810.520 AECLCTECHIISMOMTNUPXSNSTTDUTVE Antibodies, Bispecific Therapeutics; Biological Therapy (Non MeSH); Immunotherapy Therapeutics; Combined Modality Therapy Therapeutics; Radiotherapy Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY). Antibodies, Monoclonal/therapeutic use (84-91); Immunotherapy (84-91); specific radioisotope/therapeutic use (81-91)  #d1"FRadioimmunosorbent Test E01.223.495.567.380.830; E01.223.495.567.639.830; E05.478.567.380.830; E05.478.567.639.830 AECLCTECHIISMOMTNUPXSNSTTDUTVE Radioallergosorbent Test Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunosorbent Techniques Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Radioimmunoassay Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunosorbent Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Radioimmunoassay Radioimmunoassay of proteins using antibody coupled to an immunosorbent. IgE (71-76); Iodine Radioisotopes (74-76); Radioimmunoassay (68-76)  #qd"UQRadioimmunoprecipitation Assay E01.223.495.567.380.825; E01.223.495.567.639.825; E01.223.495.826.840; E05.478.567.380.825; E05.478.567.639.825 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunosorbent Techniques Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Radioimmunoassay Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunosorbent Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Radioimmunoassay Sensitive assay using radiolabeled antigens to detect specific antibodies in serum. The antigens are allowed to react with the serum and then precipitated using a special reagent such as protein A sepharose beads. The bound radiolabeled immunoprecipitate is then commonly analyzed by gel electrophoresis. Radioimmunoprecipitation assay (RIPA) is often used as a confirmatory test for diagnosing the presence of HIV antibodies. Immunosorbent Techniques (72-77); Precipitation (66-82); Precipitin Tests (72-89); Radioimmunoassay (66-89) #ԟ#{"~Radioimmunodetection E01.289.806.780; E01.357.820.780; E05.478.780 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging Diagnosis; Diagnostic Imaging; Radionuclide Imaging Miscellaneous Techniques (Non MeSH); Immunologic Techniques Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera. Antibodies, Monoclonal/diagnostic use (80-91); Antibodies, Neoplasm (80-86); Radionuclide Imaging (80-91) #5"5{Radioimmunoassay E01.223.495.567.639; E01.289.514; E05.478.567.639 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay Diagnosis; Diagnosis, Radioisotope Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay Immunoradiometric Assay; Radioallergosorbent Test; Radioimmunoprecipitation Assay; Radioimmunosorbent Test Immunoradiometric Assay; Radioallergosorbent Test; Radioimmunoprecipitation Assay; Radioimmunosorbent Test Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma globulin or human serum albumin) capable of inducing antibody formation. Immunoassay (66-67)  #9"Radiography, Panoramic E01.262.556.722; E01.357.818.827.722; E06.342.764.639 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Oral; Radiography, Dental Diagnosis; Diagnostic Imaging; Radiography; Radiography, Dental Dentistry; Diagnosis, Oral; Radiography, Dental Extraoral body-section radiography depicting an entire maxilla, or both maxilla and mandible, on a single film. #F=$Radiography, Interventional E01.357.818.833; E02.148.694 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Therapeutics; Catheterization Diagnostic and therapeutic procedures that are invasive or surgical in nature, and require the expertise of a specially trained radiologist. In general, they are more invasive than diagnostic imaging but less invasive than major surgery. They often involve catheterization, fluoroscopy, or computed tomography. Some examples include percutaneous transhepatic cholangiography, percutaneous transthoracic biopsy, balloon angioplasty, and arterial embolization. Catheterization (72-89); Radiography (72-89); Radiology (77-89); Technology, Radiologic (72-89) #! ""T rRadiography, Dual-Energy Scanned Projection E01.357.710.500.802.450; E01.357.818.802.450; E01.357.880.500; H01.671.606.799.484.802.450; L01.700.568.110.308.380.800 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Photography; Image Enhancement; Radiographic Image Enhancement Diagnosis; Diagnostic Imaging; Radiography; Radiographic Image Enhancement Diagnosis; Diagnostic Imaging; Subtraction Technique Physical Sciences (Non MeSH); Physics; Optics; Photography; Image Enhancement; Radiographic Image Enhancement Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Image Processing, Computer-Assisted; Image Enhancement A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy x-rays. Radiographic Image Enhancement (83-89); Subtraction Technique (81-89) #|2"8QRadiography, Dental E01.262.556; E01.357.818.827; E06.342.764 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Oral Diagnosis; Diagnostic Imaging; Radiography Dentistry; Diagnosis, Oral Age Determination by Teeth; Radiography, Bitewing; Radiography, Panoramic Age Determination by Teeth; Radiography, Bitewing; Radiography, Panoramic Age Determination by Teeth; Radiography, Bitewing; Radiography, Panoramic; Sialography Radiographic techniques used in dentistry. #1$q 3Radiography, Bitewing E01.262.556.675; E01.357.818.827.675; E06.342.764.600 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Oral; Radiography, Dental Diagnosis; Diagnostic Imaging; Radiography; Radiography, Dental Dentistry; Diagnosis, Oral; Radiography, Dental Technique involving the passage of X-rays through oral structures to create a film record while a central tab or wing of dental X-ray film is being held between upper and lower teeth. Radiography, Dental (68-90) #=$!Radiography, Abdominal (Non MeSH) E01.357.818.820 Diagnosis; Diagnostic Imaging; Radiography Cholangiography (+ 1); Cholecystography; Portography AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE #1(3?&Radiography E01.357.818 AECLCTECHIISMOMTNUPXSNSTTDUTVE Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Technology, Radiologic Diagnosis; Diagnostic Imaging Age Determination by Skeleton; Angiography (+ 8); Arthrography; Cineradiography (+ 1); Densitometry, X-Ray; Electrokymography; Fluoroscopy (+ 1); Hysterosalpingography; Lymphography; Mammography (+ 1); Microradiography; Neuroradiography (+ 4); Pneumoradiography (+ 1); Radiographic Image Enhancement (+ 3); Radiographic Image Interpretation, Computer-Assisted; Radiographic Magnification; Radiography, Abdominal (Non MeSH) (+ 4); Radiography, Dental (+ 3); Radiography, Interventional; Sialography; Thoracic Radiography (+ 2); Tomography, X-Ray (+ 1); Urography; Xeroradiography (+ 1) Examination of any part of the body for diagnostic purposes by means of roentgen rays, recording the image on a sensitized surface (such as photographic film). AECLCTDEECEDHIISLJMAMOMTNUOGPXRESNSTTDUTVE $#'"l$.Radiographic Magnification E01.357.818.812 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Use of optic and geometric techniques to enhance radiographic image quality and interpretation. It includes use of microfocal X-ray tubes and intensifying fluoroscopic screens. Radiography (66-71); specific heading/radiography (66-71); specific radiography heading (66-71); Technology, Radiologic (66-71) #"3Radiographic Image Interpretation, Computer-Assisted E01.158.600.680; E01.357.505.806; E01.357.818.806; L01.700.508.100.158.600.680 ISMTSTUT Diagnosis; Diagnosis, Computer-Assisted; Image Interpretation, Computer-Assisted Diagnosis; Diagnostic Imaging; Image Interpretation, Computer-Assisted Diagnosis; Diagnostic Imaging; Radiography Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted; Diagnosis, Computer-Assisted; Image Interpretation, Computer-Assisted Computer systems or networks designed to provide radiographic interpretive information. #;X eRadiographic Image Enhancement E01.357.710.500.802; E01.357.818.802; H01.671.606.799.484.802; L01.700.568.110.308.380.600 ECISMTSTTD X-Ray Intensifying Screens Image Enhancement; Tomography Scanners, X-Ray Computed Diagnosis; Diagnostic Imaging; Photography; Image Enhancement Diagnosis; Diagnostic Imaging; Radiography Physical Sciences (Non MeSH); Physics; Optics; Photography; Image Enhancement Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Image Processing, Computer-Assisted; Image Enhancement Angiography, Digital Subtraction; Radiography, Dual-Energy Scanned Projection; Tomography, X-Ray Computed Angiography, Digital Subtraction; Radiography, Dual-Energy Scanned Projection; Tomography, X-Ray Computed Angiography, Digital Subtraction; Radiography, Dual-Energy Scanned Projection; Tomography, X-Ray Computed Improvement in the quality of an x-ray image by use of an intensifying screen, tube, or filter and by optimum exposure techniques. Digital processing methods are often employed. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE (#$d @e&Radiodermatitis C17.800.174.826; C21.866.733.804 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries A cutaneous inflammatory reaction occurring as a result of exposure to ionizing radiation. #&LkRadiochemistry H01.181.529.776 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical $IRadiobiology G01.273.789 CLECEDHIISLJMAMTOGSNSTTD Nuclear Medicine Biological Sciences; Biology Study of the scientific principles, mechanisms, and effects of the interaction of ionizing radiation with living matter. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). $-#Radioallergosorbent Test E01.223.495.567.380.810; E01.223.495.567.639.810; E01.223.495.826.830; E05.478.567.380.810; E05.478.567.639.810 AECLCTECHIISMOMTNUPXSNSTTDUTVE Radioimmunosorbent Test Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunosorbent Techniques Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Radioimmunoassay Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunosorbent Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Radioimmunoassay An in vitro allergen radioimmunoassay in which allergens are coupled to an immunosorbent. The coupled allergens bind the IgE in the sera of patients which in turn binds radioisotope-labeled anti-IgE antibodies. Allergens (66-76); IgE (71-76); Radioimmunoassay (68-76)  ${"ERadioactivity H01.671.579.826 Radiation Physical Sciences (Non MeSH); Physics; Nuclear Physics $ CRadioactive Waste D05.284.638.638; G03.850.460.710.380.638; G03.850.810.485 AEANCLECLJPCSN Nuclear Energy Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Radioactive Pollutants Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products; Hazardous Waste Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Liquid, solid, or gaseous waste resulting from mining of radioactive ore, production of reactor fuel materials, reactor operation, processing of irradiated reactor fuels, amd related operations, and from use of radioactive materials in research, industry, and medicine. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). $\AZRadioactive Tracers D01.496.749.731 Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes $ CRadioactive Pollutants D05.284.638 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Air Pollutants, Radioactive; Radioactive Fallout; Radioactive Waste; Soil Pollutants, Radioactive; Water Pollutants, Radioactive Radioactive substances which act as pollutants. They include chemicals whose radiation is released via radioactive waste, nuclear accidents, fallout from nuclear explosions, and the like. Environmental Pollution (71-74); Radioactivity (66-74) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR $$ g8U@>Radioactive Fallout D05.284.638.555; G03.850.810.460 AEANECHILJPCSN Nuclear Warfare Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Radioactive Pollutants Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) $8&Radio Waves H01.671.768.638.721 AECLDUHITU Radar Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Non-Ionizing That portion of the electromagnetic spectrum beyond the microwaves, with wavelengths as high as 30 KM. They are used in communications, including television. Short Wave or HF (high frequency), UHF (ultrahigh frequency) and VHF (very high frequency) waves are used in citizen's band communication. Ultrashort waves may also be called MICROWAVES. $ XRadio L01.178.147.739; L01.178.847.514 CLECHIISLJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids Information Science; Communications Media (Non MeSH); Telecommunications The transmission and reception of electric impulses or signals by means of electric waves without a connecting wire, or the use of these waves for the wireless transmission of electric impulses into which sound is converted. (From Webster's 3d). $ &"Radiesthesia E02.040.700 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine Therapeutic cult concerned with intangible energies surrounding the living body and based on the detection of these intrinsic radiations by dowsing, or divining, or the use of more elaborate instruments (radionics). $")Radiculitis C10.772.582.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Spinal Nerve Roots Nervous System Diseases; Peripheral Nervous System Diseases; Neuritis Polyradiculitis Polyradiculitis (66-70)  $NRRadicular Cyst C04.182.089.530.690.790.820; C05.500.470.690.790.820; C07.320.450.670.513.811; C07.465.690.820 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts; Odontogenic Cysts; Periodontal Cyst Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts; Periodontal Cyst Stomatognathic Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts; Periodontal Cyst Stomatognathic Diseases; Mouth Diseases; Periapical Diseases Slow-growing fluid-filled epithelial sac at the apex of a tooth with a nonvital pulp or defective root canal filling. $hVlRadical Neck Dissection E04.446.638; E04.847.610 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Lymph Nodes Surgery, Operative; Lymph Node Excision Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) $$tRadiation, Non-Ionizing H01.671.768.638 AE Physical Sciences (Non MeSH); Physics; Radiation Infrared Rays; Lasers; Light; Microwaves; Radio Waves; Ultraviolet Rays Electromagnetic radiation which does not produce ions in matter through which it passes. Its wavelengths are generally greater than those of far ultraviolet radiation and range through the longest radio waves. Radiation (66-75) AECLDUHISDSTTUUT $$<XRadiation, Ionizing H01.671.768.513 Physical Sciences (Non MeSH); Physics; Radiation Alpha Particles; Background Radiation; Beta Rays; Cosmic Radiation; Gamma Rays; X-Rays Electromagnetic or corpuscular radiation capable of producing ions, directly or indirectly, in its passage through matter. The wavelengths are equal to or smaller than those of short (far) ultraviolet radiation and include gamma and X-rays and high-energy elementary particles. Radiation (66-75) AECLDUHITU  $<iARadiation-Sensitizing Agents D26.776 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Radiation Tolerance Miscellaneous Drugs and Agents (Non MeSH) Cisplatin; Diamide; Etanidazole; Metronidazole; Misonidazole; Photosensitizing Agents (+ 4) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  $=! ,2l:Radiation-Protective Agents D26.763 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Radiation Tolerance Miscellaneous Drugs and Agents (Non MeSH) AET; Amifostine; Cystamine; Cystaphos; Cysteamine; Sunscreening Agents (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  $   ,2]:Radiation Tolerance G12.702 DEGEIMPH Radiation-Protective Agents; Radiation-Sensitizing Agents Chemical, Pharmacologic Phenomena (Non MeSH) The ability of some cells or tissues to withstand ionizing radiation without serious injury. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS. Radiation Dosage (72-76); Radiation Effects (66-76); Radiotherapy Dosage (66-76)  $"  A4`Radiation Protection G03.850.810.425 ECHIISLJMTSNST Health Physics; Nuclear Energy Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) $$]&gRadiation Pneumonitis C08.381.483.675; C21.866.733.762 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries Injurious effects of radiotherapy on the lungs. There are three phases in the reaction of the lungs to radiation injury: an acute phase occurring 1 to 2 months after exposure, a subacute phase 2 to 9 months after exposure, and a chronic or fibrotic phase more than 9 months after exposure. In the acute phase there is vascular damage, congestion, edema, and mononuclear cell infiltration; in the subacute phase the alveolar walls are infiltrated with mononuclear inflammatory cells and fibroblasts; in the chronic phase, alveolar fibrosis and capillary sclerosis take place. (Cecil Textbook of Medicine, 19th ed). Pneumonia (66-93); Radiation Injuries (66-93); Radiation Injuries, Experimental (66-93); Radiotherapy/adverse effects (67-93) $%K&NRadiation Oncology G02.403.776.409.515.500; G02.403.790.680.375 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Medical; Internal Medicine; Medical Oncology Health Occupations; Medicine; Specialties, Other (Non MeSH); Radiology A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer. Medical Oncology (79-94); Neoplasms/radiotherapy (75-94) $*2lCRadiation Monitoring E05.799.638; G03.850.780.375.700; G03.850.810.370; H01.671.768.765.588 ECHIISLJMTSNST Health Physics Miscellaneous Techniques (Non MeSH); Radiometry Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Environmental Monitoring Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Physical Sciences (Non MeSH); Physics; Radiation; Radiometry Body Burden; Film Dosimetry; Thermoluminescent Dosimetry Film Dosimetry; Thermoluminescent Dosimetry Body Burden; Film Dosimetry; Thermoluminescent Dosimetry The observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards. AECLCTECHIISLJMOMTNUPXSNSTTDUTVE $$,Pox$Radiation Leukemia Virus B04.820.650.730.730.900.500.750; B04.909.574.807.730.730.900.500.750; B04.909.777.731.730.730.900.500.750 CHCLDEENGDGEIMIPMEPHPYREUL Leukemia, Radiation-Induced Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A murine leukemia virus isolated from radiation-induced lymphomas in C57BL mice. It is leukemogenic, thymotrophic, can be transmitted vertically, and replicates only in vivo. Mouse Leukemia Viruses (66-91); Retroviridae (66-87)  $0q A?Radiation Injuries, Experimental C21.866.733.720; G03.850.810.300.360.285 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Effects; Radiation Injuries Harmful effects of exposure to ionizing or non-ionizing radiation produced experimentally in chordates. $4&.NxRadiation Injuries C21.866.733; G03.850.810.300.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Accidents, Radiation Accidents, Radiation Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Effects Abnormalities, Radiation-Induced; Leukemia, Radiation-Induced; Neoplasms, Radiation-Induced; Osteoradionecrosis; Radiation Injuries, Experimental; Radiation Pneumonitis; Radiodermatitis Abnormalities, Radiation-Induced; Radiation Injuries, Experimental Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in chordates. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI ($7 &NpXRadiation Genetics G03.850.810.300.310; G05.800 CLECEDHIISLJMAMTOGSNSTTD Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Effects Genetics  Radiation Chimera CLECEDGEHIIMISLJMAMTOGPHSNSTTD $:""Radiation Effects G03.850.810.300 Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Radiation Genetics; Radiation Injuries (+ 2) BLCFCICLCNCODHDIDTECEDEHEMENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPPPSPXRARHRIRTSNSTSUTDTHURUSVEVI $;g6`Radiation Dosage E05.799.513; G03.850.810.250; H01.671.768.765.488 Dose-Response Relationship, Radiation; Radiotherapy Dosage Miscellaneous Techniques (Non MeSH); Radiometry Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Physical Sciences (Non MeSH); Physics; Radiation; Radiometry  Dose-Response Relationship, Radiation; Relative Biological Effectiveness Dose-Response Relationship, Radiation Radiometry (66-71) $=-9C|Radiation Chimera G04.610.619.500; G05.148.630.763; G05.800.638 GEIMPH Mosaicism Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunocompromised Host Genetics; Cytogenetics; Mosaicism Genetics; Radiation Genetics An organism whose body contains cell populations of different genotypes as a result of the injection of foreign cells into it after it has received sufficient ionizing radiation to destroy the mature host cells which would otherwise reject the injected cells. $?^5  0Radiation H01.671.768 CL Nuclear Warfare; Radioactivity Physical Sciences (Non MeSH); Physics Electromagnetic Fields; Fluorescence; Photons; Radiation, Ionizing (+ 6); Radiation, Non-Ionizing (+ 6); Radiometry (+ 9); Scattering, Radiation (+ 1) Emission or propagation of electromagnetic energy (waves/rays), or the waves/rays themselves; a stream of electromagnetic particles (electrons, neutrons, protons, alpha particles) or a mixture of these. The most common source is the sun. AECLCTDUECHIISLJMOMTNUPXSDSNSTTDTUUTVE $$A %/*Radial Nerve A08.800.800.720.050.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Brachial Plexus A major nerve of the upper extremity. In humans the fibers of the radial nerve originate in the lower cervical and upper thoracic spinal cord (usually C5 to T1), travel via the posterior cord of the brachial plexus, and supply motor innervation to extensor muscles of the arm and cutaneous sensory fibers to extensor regions of the arm and hand. $Df8nRadial Artery A07.231.114.139.675 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Brachial Artery The direct continuation of the brachial trunk, originating at the bifurcation of the brachial artery opposite the neck of the radius. Its branches may be divided into three groups corresponding to the three regions in which the vessel is situated, the forearm, wrist, and hand. Arm/blood supply (66-92); Arteries (66-92); Forearm/blood supply (66-92); Hand/blood supply (66-92) $F8LGzRadar L01.178.847.500 HIISUT Radio Waves Information Science; Communications Media (Non MeSH); Telecommunications A system using beamed and reflected radio signals to and from an object in such a way that range, bearing, and other characteristics of the object may be determined. $I  URacquet Sports I03.450.642.845.600 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Tennis Games in which players use a racquet to hit a ball or similar type object. Sports (77-89); Tennis (78-89)  $KR ]'Racial Stocks I01.076.368.763 CLGEHI Social Sciences; Anthropology; Anthropology, Physical Australoid Race; Caucasoid Race; Mongoloid Race; Negroid Race Major living subspecies of man differentiated by genetic and physical characteristics. There are four racial groups: Australoid, Caucasoid, Mongoloid, and Negroid. Australoid Race (66-67); Blacks (66-67); Caucasoid Race (66-67); Ethnology (66-67); Mongoloid Race (66-67)  $LR ?KRacemases D08.586.399.788 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases $Nu FSRace Relations I01.880.735.768 HILJPXTD Civil Rights Psychology, Social Social Sciences; Sociology; Social Problems Cultural contacts between people of different races. Interpersonal Relations (66-67); Prejudice (66-67) $$OM 5?<Raccoons B02.649.147.802 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Carnivora (66-67) $P ('Rabies Virus B04.820.455.750.500.700; B04.909.777.455.750.500.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Rhabdoviridae; Lyssavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Rhabdoviridae; Lyssavirus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. $Q-:Rabies Vaccine D24.310.894.899.700 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines $Si>lRabies C02.782.580.830.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Rhabdoviridae Infections An acute infectious disease of the central nervous system affecting almost all mammals, including humans. It is caused by a rhabdovirus and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, vampire bat, mongoose, skunk, wolf, raccoon, and fox. (From Dorland, 27th ed). $T\ PwRabbits B02.649.521.637 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Lagomorpha $W  ((R Factors D13.444.308.212.500.600; D13.444.308.283.500.600 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Drug Resistance, Microbial Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation. Drug Resistance, Microbial (67-74)  $W6D x)Quisqualic Acid D03.383.548.580.600; D12.125.755; D14.100.190.200.640 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Oxadiazoles Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Agonists alpha-Amino-3,5-dioxo-1,2,4-oxadiazolidine-2-propanoic acid. An agonist at two subsets of excitatory amino acid receptors. The ionotropic receptors directly control membrane channels and the metabotropic receptors indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis. Convulsants (75-90); Neuromuscular Depolarizing Agents (70-90); Oxadiazoles (66-90) $Y=:[bQuipazine D03.383.606.827; D03.438.810.850; D06.472.583.833; D14.100.850.800.600; D15.085.025.700; D15.700.122.050.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Oxytocics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic. Quinolines (66-77) $] z:yQuinuclidinyl Benzilate D02.241.223.601.238.306.740; D02.241.511.085.740; D03.605.687.800; D14.100.120.200.500.770 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates; Diphenylacetic Acids; Benzilates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Benzilates Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Quinuclidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists A high-affinity muscarinic antagonist commonly used as a tool in animal and tissue studies. Benzilates (66-79); Quinuclidines (66-79) $b:d:m2Quinuclidines D03.605.687 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH) Quinidine; Quinine; Quinuclidinyl Benzilate AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $e8M4@Quintuplets G08.520.800.550; M01.438.587 CLEDGEHILJPXSN Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple Named Groups (Non MeSH); Multiple Birth Named Groups (Non MeSH) $f"Quinoxalines D03.438.857 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Carbadox; 6-Cyano-7-nitroquinoxaline-2,3-dione AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $h 8G4:Quinones D02.806 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Anthraquinones (+ 4); Benzoquinones (+ 5); Naphthoquinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  $i=  8#HFQuinone Reductases D08.586.682.608.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases NAD(P)H Dehydrogenase (Quinone) NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE)) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol. NADH, NADPH Oxidoreductases (73-74); Vitamin K (73-74)  $k Fy'BQuinolones D03.438.810.835 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents, Quinolone Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Ciprofloxacin (+ 1); Nalidixic Acid; Nedocromil; Norfloxacin; Oxolinic Acid; Pefloxacin Quinolines which are substituted in any position by one or more oxo groups. These compounds can have any degree of hydrogenation, any substituents, and fused ring systems. Quinolines (66-88) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ($oI8&Vj:Quinolizines D03.438.834 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Ro 4-1284; Tetrabenazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $q8G:Quinolinium Compounds D03.438.810.824 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Ammonium Compounds Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Dequalinium; Pyrvinium Compounds Ammonium Compounds (66-67); Quinolines (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $$r8V'8:Quinolinic Acids D03.383.725.822 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Quinolinic Acid ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $t8U:Quinolinic Acid D03.383.725.822.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Quinolinic Acids 2,3-Pyridinedicarboxylic acid. A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are significantly correlated with the severity of neuropsychological deficits in patients who have AIDS. Quinolinic Acids (81-92) $u:j%Quinolines D03.438.810 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Aminoquinolines (+ 4); Carbocyanines; Ethoxyquin; Hydroxyquinolines (+ 9); Mefloquine; Nitroquinolines (+ 2); Quinaldines; Quinidine; Quinine; Quinolinium Compounds (+ 2); Quinolones (+ 7); Quipazine AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $w8G@Quinine D03.132.206.719; D03.438.810.762; D03.605.687.762; D15.040.100.675; D16.700.600.750; D16.850.015.675; D21.370.286.737 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Cinchona Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Quinuclidines Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. $y @pQuinidine D03.132.206.636; D03.438.810.699; D03.605.687.637; D18.097.787 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Cinchona Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Quinuclidines Cardiovascular Agents; Anti-Arrhythmia Agents $c H:#Quinic Acid D02.241.223.106.777; D02.241.223.268.637; D02.241.511.764 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids $4A:0Quinestrol D04.808.668.651.568.291.750; D06.597.378.379.750; D07.360.276.210.443.332.291.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnatrienes; Ethinyl Estradiol Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Ethinyl Estradiol Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estrogens, Synthetic; Ethinyl Estradiol 3-(Cyclopentyloxy)-19-nor-17 alpha-pregna-1,3,5(10)-trien-20-yn-17-ol. The 3-cyclopentyl ether of ETHINYL ESTRADIOL. After gastrointestinal absorption, it is stored in adipose tissue, slowly released, and metabolized principally to the parent compound. It has been used in estrogen replacement therapy. (From AMA Drug Evaluations Annual, 1992). Contraceptives, Oral (66-71); Estrogens (66-71) $Y:9Quinazolines D03.438.786 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Ketanserin; Methaqualone; Metolazone; Prazosin (+ 1); Trimetrexate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $]8GQ:Quinaldines D03.438.810.637 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines $8VQuinacrine Mustard D02.455.526.728.650.760; D03.494.046.250.760.750; D26.408.348.760 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines; Quinacrine Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes 2-Methoxy-6-chloro-9-[4-bis(beta-chloroethyl)amino-1-methylbutylamino]acridine. Nitrogen mustard analog of quinacrine used primarily as a stain in the studies of chromosomes and chromatin. Fluoresces by reaction with nucleic acids in chromosomes. Mustard Compounds (73-74); Quinacrine (73-74) $|I.I7Quinacrine D03.494.046.250.760; D21.201.287.716; D21.201.412.100.686; D21.370.286.686; D22.204.777 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Anticestodal Agents Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Quinacrine Mustard N(4)-(6-Chloro-2-methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine. An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. $c:MQuestionnaires E05.318.308.750; G03.850.520.308.750; L01.280.800; N05.715.360.300.695 CLECSTUT Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Information Science; Data Collection Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection  Delphi Technique Predetermined sets of questions used to collect data - clinical data, social status, occupational group, etc. The term is often applied to a self-completed survey instrument. $P Quercetin D11.786.170.381.636; D03.438.150.266.450.600 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Bioflavonoids; Flavones Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones; Flavones 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4- one. Aglucon of quercetrin, rutin, and other glycosides. It is widely distributed in the plant kingdom, especially in rinds and barks, clover blossoms, and ragweed pollen. $ 2@ Queensland Z01.338.520 EHEP Geographicals (Non MeSH); Australia A state in northeastern AUSTRALIA. Australia (66-87) $@,+Quebec Z01.107.567.176.791 EHEP Geographicals (Non MeSH); America; North America; Canada $ FQuartz D01.578.750.600; D01.650.550.825.600; D01.837.725.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Minerals; Silicon Dioxide Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Silicon Dioxide Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide Quartz (SiO2). A glassy or crystalline form of silicon dioxide. Many colored varieties are semiprecious stones. (From Grant and Hackh's Chemical Dictionary, 5th ed). $ =8Quarantine G03.850.780.200.450.700 CLECHILJMTOGPXSNSTTDUTVE Patient Isolation Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Infection Control Confining or limiting the freedom of movement of susceptible persons or animals that have been exposed to a communicable or infectious disease, in order to prevent its spread. $Quantum Theory H01.671.579.800 HI Physical Sciences (Non MeSH); Physics; Nuclear Physics The theory that the radiation and absorption of energy take place in definite quantities called quanta (E) which vary in size and are defined by the equation E=hv in which h is Planck's constant and v is the frequency of the radiation. $CQuality, Access, Evaluation (Non MeSH) N05 Delivery of Health Care (+ 37); Ethics (+ 15); Health Services Research; Quality Assurance, Health Care (+ 25); Quality of Health Care (+ 162) AECLCTECEDEHHIISLJMAMOMTNUOGPCPXSDSNSTTDUTVE $.0Quality of Life I01.800; K01.752.770 Life Style; Sickness Impact Profile Life Style; Cost of Illness Social Sciences Humanities; Philosophy A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment. $,$.Quality of Health Care N04.761; N05.715 CLECHILJOGSNSTTDUT National Practitioner Data Bank; Professional Staff Committees Health Services Administration (Non MeSH) Quality, Access, Evaluation (Non MeSH) Clinical Competence; Medical Audit (+ 1); Nursing Audit; Outcome and Process Assessment (Health Care) (+ 5); Peer Review, Health Care; Professional Review Organizations; Program Evaluation; Quality Assurance, Health Care (+ 3); Utilization Review (+ 2) Epidemiologic Factors (+ 16); Evaluation Mechanisms, Health Care (Non MeSH) (+ 143); Peer Review, Health Care The levels of excellence which characterize the health service or health care provided based on accepted standards of quality. AECLCTECEDEHHIISLJMAMOMTNUOGPXSDSNSTTDUTVE $$AI].Quality Control J01.897.608 Reference Standards; Total Quality Management Total Quality Management Technology, Industry, Agriculture (Non MeSH); Technology $6CQuality Assurance, Health Care N04.761.700; N05.700 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH) Guidelines (+ 1); Total Quality Management Credentialing (+ 10); Facility Regulation and Control; Guidelines (+ 1); Medical Audit (+ 1); Nursing Audit; Professional Review Organizations; Professional Staff Committees (+ 2); Total Quality Management; Utilization Review (+ 2) Activities and programs intended to assure or improve the quality of care in either a defined medical setting or a program. The concept includes the assessment or evaluation of the quality of care; identification of problems or shortcomings in the delivery of care; designing activities to overcome these deficiencies; and follow-up monitoring to ensure effectiveness of corrective steps. Quality of Health Care (68-79) CLECHILJMAMTOGSNSTTDUT $$%{H&Quail B02.248.801 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds Colinus; Coturnix Birds (66-72); Poultry (66-72) $ &'Quadruplets G08.520.800.508; M01.438.486 CLEDGEHILJPXSN Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Multiple Named Groups (Non MeSH); Multiple Birth Named Groups (Non MeSH) $"Quadriplegia C10.597.622.760; C23.888.592.636.786 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Paralysis of all four limbs. $*N%Quackery I01.880.735.728 CLECEHHILJPCPXSNTD Nostrums Social Sciences; Sociology; Social Problems The fraudulent misrepresentation of the diagnosis and treatment of disease. $]  5YQatar Z01.252.245.500.690; Z01.586.500.690 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East $S *Q-Sort F04.513.636 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Personality Assessment A personality assessment technique in which the subject or observer indicates the degree to which a standardized set of descriptive statements actually describes the subject. The term reflects "sorting" procedures occasionally used with this technique. $N  U$Q Fever C01.252.400.810.700.810.795 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections An acute infectious disease caused by COXIELLA BURNETTI. It is characterized by a sudden onset of fever, headache, malaise, and weakness. In humans, it is commonly contracted by inhalation of infected dusts derived from infected domestic animals. $  P!Q beta Replicase D08.586.913.696.445.735.630 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases Catalyzes the replication of the RNA of coliphage Q beta. Coliphages (73-74); RNA Polymerases (73-74); Virus Replication (73-74) $FGUPyuria C01.539.895.719; C12.777.892.719 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Urine Bacterial and Fungal Diseases (Non MeSH); Infection; Urinary Tract Infections Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Tract Infections $ &P Pythium B05.354.730.576.625.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Mastigomycotina; Oomycetes A Mastigomycotina genus of destructive root-parasitic fungi including forms that cause damping-off of seedlings. $  "\Pyrvinium Compounds D03.438.810.824.700; D21.201.287.683 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolinium Compounds Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents $U*8Pyruvates D02.241.607.812 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids Phenylpyruvic Acids $ 8HPyruvate, Orthophosphate Dikinase D08.586.913.696.645.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Paired Acceptors) ATP:pyruvate, orthophosphate phosphotransferase. An enzyme that catalyzes the reaction of ATP, pyruvate, and orthophosphate to form AMP plus phosphoenolpyruvate plus pyrophosphate. EC 2.7.9.1. Phosphates (74); Phosphotransferases, ATP (74); Pyruvates (74) $'FLPyruvate Oxidase D08.586.682.472.636 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Ketone Oxidoreductases $FsPyruvate Metabolism, Inborn Errors C18.452.648.202.810 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Leigh Disease; Pyruvate Carboxylase Deficiency; Pyruvate Dehydrogenase Complex Deficiency Hereditary disorders of pyruvate metabolism. They are difficult to diagnose and describe because pyruvate is a key intermediate in glycolysis, gluconeogenesis, and the tricarboxylic acid cycle. Some inherited metabolic disorders may alter pyruvate metabolism indirectly. Disorders in pyruvate metabolism appear to lead to deficiencies in neurotransmitter synthesis and, consequently, to nervous system disorders. Carbohydrate Metabolism, Inborn Errors (66-88); Pyruvates (66-88)  $)LgMPyruvate Kinase D08.586.913.696.620.695 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Anemia, Hemolytic Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40. $F<Pyruvate Dehydrogenase Complex Deficiency C10.228.140.163.853; C18.452.648.202.810.766 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Pyruvate Metabolism, Inborn Errors An autosomal recessive pyruvate metabolism disorder resulting from deficient enzyme activity in one of several proteins of pyruvate dehydrogenase complex, resulting in deficiency of acetyl CoA. Deficiency in acetyl CoA product reduces the synthesis of acetylcholine, thereby causing neurological abnormalities. Clinical presentations include lactic acidosis, mental retardation, and ataxia. Pyruvate Dehydrogenase Complex/deficiency (74-88) $f02L69Pyruvate Dehydrogenase Complex D08.586.600.741 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Oxidoreductases (66-72); Pyruvate Oxidase (66-72); Pyruvates (66-72) $g$F_RPyruvate Dehydrogenase (Lipoamide)-Phosphatase D08.586.277.352.650.625.725 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases; Phosphoprotein Phosphatase (Pyruvate dehydrogenase (lipoamide))-phosphate phosphohydrolase. A mitochondrial enzyme that catalyzes the hydrolytic removal of a phosphate on a specific seryl hydroxyl group of pyruvate dehydrogenase, reactivating the enzyme complex. EC 3.1.3.43. Ketone Oxidoreductases (73-74); Phosphatases (72-74); Pyruvates (73-74) $ɸ5FUPyruvate Decarboxylase D08.586.520.258.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases Catalyzes the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde. Carboxy-Lyases (73-74); Pyruvates (73-74) $̏Fa=2Pyruvate Carboxylase Deficiency C10.228.140.163.843; C18.452.648.202.810.666 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Pyruvate Metabolism, Inborn Errors An autosomal recessive pyruvate metabolism disorder resulting from absent or deficient expression of pyruvate carboxylase activity. Decreased production of oxaloacetate leads to decreased gluconeogenesis, thereby causing fasting hypoglycemia, lactic acid acidosis, and decreased synthesis of amino acid neurotransmitters. Clinical presentations include acidosis, ataxia, mental retardation; sometimes co-occurs with LEIGH DISEASE. Pyruvate Carboxylase/deficiency (74-88) $%2L6.Pyruvate Carboxylase D08.586.464.830 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme of the ligase class that catalyzes the irreversible conversion of ATP, pyruvate, and HCO3 to ADP, orthophosphate, and oxaloacetate. The enzyme is a biotinyl protein requiring Mg2+ or Mn2+ and acetyl coenzyme A and occurs in the liver but not in muscle. The reaction is necessary for gluconeogenesis from lactate or amino acids forming pyruvate and also provides four carbon compounds for the tricarboxylic acid cycle. Deficiency of the enzyme, an autosomal recessive trait, causes severe psychomotor retardation and lactic acidosis in infants. (Dorland, 27th ed) EC 6.4.1.1. $FPPyruvaldehyde D02.047.644.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes; Glyoxal 2-Oxopropanal. An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals. Glyoxal (73-74) $֢:<bPyrrolnitrin D03.383.757.770; D20.085.062.800; D20.136.073.800 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrroles Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal 3-Chloro-4-(3-chloro-2-nitrophenyl)pyrrole. Antifungal antibiotic isolated from Pseudomonas pyrrocinia. It is effective mainly against Trichophyton, Microsporium, Epidermophyton, and Penicillium. Antibiotics, Antifungal (72-74); Pyrroles (69-74); Nitrobenzenes (72-74) $9<VPyrrolizidine Alkaloids D03.132.716; D26.191.795 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Senecio Heterocyclic Compounds; Alkaloids Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Monocrotaline Monocrotaline Alkaloids found in various species of Senecio and other plants; there are at least ten different chemicals, many of them hepatotoxic, teratogenic and carcinogenic; the plants may cause damage in grazing herds, but no longer have medical use. Alkaloids (66-70); Heterocyclic Compounds (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ($ۘ8 h ;<Pyrroline Carboxylate Reductases D08.586.682.107.695 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases L-Proline:NAD(P)+oxidoreductases. Catalyzes the reduction of 1-pyrroline carboxylate to proline in the presence of NAD(P)H. Includes both the 2-oxidoreductase (EC 1.5.1.1) and the 5-oxidoreductase (EC 1.5.1.2). The former also reduces 1-piperidine-2-carboxylate to pipecolate and the latter also reduces 1-pyrroline-3-hydroxy-5-carboxylate to hydroxyproline. Amine Oxidoreductases (75-76); Oxidoreductases (66-74) $d&Fr@Pyrrolidonecarboxylic Acid D03.383.773.812.718; D12.125.072.401.761 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Imino Acids Amino Acids (66-71); Pyrrolidinones (66-71) $Y.:5Pyrrolidinones D03.383.773.812 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Cotinine; Doxapram; Oxotremorine; Piracetam; Povidone (+ 1); Pyrrolidonecarboxylic Acid; Succinimides (+ 2); Tenuazonic Acid AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8X<Pyrrolidines D03.383.773 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Anisomycin; Bepridil; Clemastine; Clindamycin; Glycopyrrolate; Kainic Acid; Nafoxidine; Nitromifene; N-Nitrosopyrrolidine; Procyclidine; Pyrrolidinones (+ 11); Tremorine AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8G<Pyrroles D03.383.757 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Maleimides (+ 1); Porphobilinogen; Prodigiosin; Pyrrolnitrin; Tolmetin AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ 8GU<Pyrophosphatases D08.586.277.040.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases Thiamine Pyrophosphatase A group of enzymes within the class EC 3.6.1.- that catalyze the hydrolysis of diphosphate bonds, chiefly in nucleoside di- and triphosphates. They may liberate either a mono- or diphosphate. EC 3.6.1.-. $FrPyronine D03.494.953.570; D26.408.680 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes Miscellaneous Drugs and Agents (Non MeSH); Dyes [6-(Dimethylamino0-3H-xanthen-3ylidine]dimethylammonium chloride. Xanthene dye used as a bacterial and biological stain. Synonyms: Pyronin; Pyronine G; Pyronine Y. Use also for Pyronine B. which is diethyl-rather than dimethylamino-. Ammonium Compounds (69-74); Xanthenes (71-74) $ ". 7Pyrones D03.383.663.718 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrans $T 8RPyroglutamyl-Peptidase I D08.586.277.656.081.730 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases An enzyme that catalyzes the release of a N-terminal pyroglutamyl group from a polypeptide provided the next residue is not proline. It is inhibited by thiol-blocking reagents and occurs in mammalian tissues, microorganisms, and plants. (From Enzyme Nomenclature, 1992) EC 3.4.19.3. Aminopeptidases (70-74); Pyrrolidonecarboxylic Acid (72-74) $F}JEPyroglutamate Hydrolase D08.586.277.087.760 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases Hydrolyzes pyroglutamic acid in the presence of ATP to glutamate plus ADP and inorganic phosphate. Deficiency leads to pyroglutamic acidurea. Amidohydrolases (74); Pyrrolidonecarboxylic Acid (74) $Ff?Pyroglobulins D12.776.124.486.485.900.700; D12.776.124.790.651.900.700; D12.776.377.715.548.900.700 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Paraproteins Atypical gamma immunoglobulins characterized by their irreversible heat denaturation at 56-degrees C. Pyroprecipitation is inhibited at pH below 3 and above 9. The presence of pyroglobulins in the serum is the cause of pyroglobulinemia. They are frequently present in multiple myeloma and the pyroglobulin precipitate binds complement, reacts with rheumatoid factor, produces passive cutaneous anaphylaxis, generalized passive anaphylaxis and passive Arthus-type phenomena. Heat (72-75); Immunoglobulins (72-75); Precipitation (72-75) $]DIPyrogens D09.203.698.761; D24.185.733 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Fever Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Immunologic and Biologic Factors (Non MeSH); Biological Factors  Etiocholanolone Substances capable of increasing body temperature; they may be of microbial origin, often polysaccharides and may contaminate distilled water. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $$ "D FPyrogallol D02.755.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols $:/Pyrithioxin D03.383.725.812 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines 3,3'-(Dithiodimethylene)bis[5-hydroxy-6-methyl-4-pyridinemethanol. Neurotropic agent. Reduces permeability of blood-brain barrier to phosphate. Has no vitamin B6 activity. Synonyms: Bonifen; Encephabol. Disulfides (74); Pyridines (74) $:U(Pyrithiamine D03.383.725.762.760; D03.383.742.715; D26.087.783 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 1-[(4-Amino-2-methyl)-5-pyrimidylmethyl]-2-methyl-3-(beta-hydroxyethyl)pyridinium. Thiamine antagonist due to its inhibition of thiamine pyrophosphorylation; used to produce thiamine deficiency. Pyridinium Compounds (74-76); Pyrimidines (74-76) $9:;Pyrimidinones D03.383.742.698 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Alloxan; Barbiturates (+ 13); Cytosine (+ 1); Ritanserin; Uracil (+ 10) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $G8W[>Pyrimidines D03.383.742 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Buspirone; Dipyridamole; Epirizole; Fursultiamin; Hexetidine; Minoxidil; Mopidamol; Morantel; Nicarbazin; Oxypurinol; Pyrantel (+ 2); Pyrimethamine; Pyrimidinones (+ 29); Pyrithiamine; Trapidil; Trimethoprim (+ 1) A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE, THYMINE, and URACIL) and form the basic structure of the barbiturates. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  $:G>Pyrimidine Nucleotides D13.695.740 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Apurinic Acid; Cytosine Nucleotides (+ 10); Pyrimidine Dimers; Thymine Nucleotides (+ 1); Uracil Nucleotides (+ 13) Nucleotides (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  %BPDPyrimidine Nucleosides D13.570.685 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides Cytidine (+ 6); Formycins (+ 2); Thymidine (+ 3); Uridine (+ 10) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR %BPUDPyrimidine Dimers D13.695.578.424.600; D13.695.740.600 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR DNA Repair Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Oligonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides Dimers found in DNA chains damaged by ultraviolet irradiation. They consist of two adjacent pyrimidine nucleotides, usually thymine nucleotides, in which the pyrimidine residues are covalently joined by a cyclobutane ring. These dimers stop DNA replication. Pyrimidine Nucleotides (74-76); Thymine Nucleotides (72-76)  %*B+FPyrimethamine D03.383.742.675; D21.370.286.635 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials % &:Pyrilamine D03.383.725.050.805; D14.100.375.425.400.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Aminopyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies. Benzyl Compounds (72-74); Ethylenediamines (72-74); Pyridines (70-74) % S2:SPyridoxine Deficiency C18.654.223.133.699.635 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anemia, Sideroblastic Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency A nutritional condition produced by a deficiency of PYRIDOXINE in the diet, characterized by dermatitis, glossitis, cheilosis, and stomatitis. Marked deficiency causes irritability, weakness, depression, dizziness, peripheral neuropathy, and seizures. In infants and children typical manifestations are diarrhea, anemia, and seizures. Increasingly recognized as a cause is prolonged therapy with certain medications, among them isoniazid, cycloserine, and L-dopa. (From Cecil Textbook of Medicine, 19th ed, p. 1175). % hNPPyridoxine D11.786.708.762 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex % B]Pyridoxic Acid D03.066.349.600; D03.383.725.394.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Isonicotinic Acids 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinic acid. Chief metabolic product of pyridoxine, pyridoxal and pyridoxamine in urine. Alcohol, Methyl (74); Isonicotinic Acids (69-74) %*:;Pyridoxaminephosphate Oxidase D08.586.682.107.680 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases An enzyme catalyzing the deamination of pyridoxaminephosphate to pyridoxal phosphate. It is a flavoprotein that also oxidizes pyridoxine-5-phosphate and pyridoxine. EC 1.4.3.5. Oxidoreductases (73-74); Pyridoxamine (73-74) %"Fr6Pyridoxamine D03.383.725.676.760; D11.786.708.733 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolines Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Picolines (66-71); Pyridoxine (66-71) %6*:.Pyridoxal Phosphate D03.383.725.676.635.600; D08.176.740 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolines; Pyridoxal Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes 3-Hydroxy-2-methyl-5-((phosphonooxy)methyl)-4- pyridinecarboxaldehyde. An enzyme co-factor vitamin. %*DqPyridoxal Kinase D08.586.913.696.620.685 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes reversibly the phosphorylation of pyridoxal in the presence of ATP with the formation of pyridoxal 5-phosphate and ADP. Pyridoxine, pyridoxamine and various derivatives can also act as acceptors. EC 2.7.1.35. Phosphotransferases (66-73); Phosphotransferases, ATP (74-78); Pyridoxal (72-78) %F^Pyridoxal D03.383.725.676.635; D11.786.708.704 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolines Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Pyridoxal Phosphate 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4- pyridinecarboxaldehyde. Picolines (66-71); Pyridoxine (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $%1 *:G.DPyridostigmine Bromide D03.383.725.762.740; D08.373.275.829; D14.100.120.300.750; D16.050.675.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. %`T:Pyridones D03.383.725.791 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Bemegride; Iodopyridones (+ 2); Mimosine; Trazodone Pyridine derivatives with one or more keto groups on the ring. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  %! 8U@M:Pyridinolcarbamate D02.241.081.251.723; D10.162.718 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents %#}&:Pyridinium Compounds D03.383.725.762 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Ammonium Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Cetylpyridinium; Desmosine; Diquat; Isodesmosine; 1-Methyl-4-phenylpyridinium; Obidoxime Chloride; Paraquat; Pyridostigmine Bromide; Pyrithiamine; Trimedoxime; Viologens (+ 1) Ammonium Compounds (66-67); Pyridines (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $%$8U7:Pyridines D03.383.725 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Aminopyridines (+ 6); Betahistine; Carbolines; Chlorpheniramine; Clopidol; Dihydropyridines (+ 10); Dimethindene; 2,2'-Dipyridyl; Disopyramide; Doxylamine; Isonicotinic Acids (+ 6); 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Metyrapone; Naphthylvinylpyridine; Nicotine; Nicotinic Acids (+ 13); Nicotinyl Alcohol; Pheniramine (+ 2); Picolines (+ 4); Picolinic Acids (+ 3); Polyvinylpyridine N-Oxide; Pyridinium Compounds (+ 12); Pyridones (+ 6); Pyrithioxin; Quinolinic Acids (+ 1); Triprolidine; Tropicamide AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR %& 8G[DPyridazines D03.383.710 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Cilazapril; Luminol; Maleic Hydrazide; Phthalazines (+ 3) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR %*]8GF:Pyrethrum B06.781 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants Species cinerafolium vis. and coccineum Willd. of the genus Chrysanthemum (Compositae). The flowers contain PYRETHRINS, cinerolones, and chrysanthemines which are powerful contact insecticides. %+  & Pyrethrins D02.455.849.700; D05.723.491.324.550 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Botanical Allethrin Allethrin The active insecticidal constituent of pyrethrum flowers. Pyrethrin I is the pyretholone ester of chrysanthemummonocarboxylic acid and pyrethrin II is the pyretholone ester of chrysanthemumdicarboxylic acid monomethyl ester. Insecticides, Botanical (73-76); Pyrethrum (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $%,*8<:Pyrenes D04.615.799; D26.191.788 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Benzopyrenes (+ 3) Benzopyrenes AAADAEAIANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU %/ ,&0Pyrazoles D03.383.694 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Aminopyrine (+ 2); Antipyrine; Betazole; BW-755C; Epirizole; Indazoles (+ 2); Muzolimine; Oxypurinol; Phenylbutazone (+ 3) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR %1, 8G:Pyrazines D03.383.679 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Amiloride; Pyrazinamide AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR %2 8G:Pyrazinamide D03.383.679.750; D20.338.734 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazines Anti-Infective Agents; Antitubercular Agents %3":Pyrantel Tartrate D03.383.742.634.670; D03.383.903.634.670; D21.201.287.648.780 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrantel Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes; Pyrantel Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents; Pyrantel (E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine tartrate (1:1). Broad spectrum anthelmintic for livestock. Synonym: Banminth. Pyrantel (74); Tartrates (74) %4E:&Pyrantel Pamoate D03.383.742.634.600; D03.383.903.634.600; D21.201.287.648.775 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrantel Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes; Pyrantel Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents; Pyrantel (E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)-vinyl]pyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate](1:1). Broad spectrum antinematodal anthelmintic used also in veterinary medicine. Naphthalenes (74); Pyrantel (74) %7E:)Pyrantel D03.383.742.634; D03.383.903.634; D21.201.287.648 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Pyrantel Pamoate; Pyrantel Tartrate Pyrantel Pamoate; Pyrantel Tartrate Pyrantel Pamoate; Pyrantel Tartrate %:_ 9:}Pyrans D03.383.663 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Aurovertins; Glaucarubin; Patulin; Pyran Copolymer; Pyrones AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR %APutamen A08.186.211.730.885.105.487.550.784 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia; Corpus Striatum; Neostriatum The largest and most lateral of the basal ganglia lying between the lateral medullary lamina of the globus pallidus and the external capsule. It is part of the neostriatum and forms part of the lentiform nucleus along with the globus pallidus. Basal Ganglia (66-73); Corpus Striatum (74) %\ '8!6Pursuit, Smooth G11.697.384.453 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements Eye movements that are slow, continuous, and conjugate and occur when a fixed object is moved slowly. Eye Movements (66-83) %^rzPurpura, Thrombotic Thrombocytopenic C15.378.463.205.855.759; C15.378.463.597.716 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders; Thrombocytopenia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Purpura A disease characterized by thrombocytopenia, hemolytic anemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries. %_*2NPurpura, Thrombocytopenic, Idiopathic C15.378.463.205.855.700.600; C15.378.463.597.700.600; C20.111.759; C20.841.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders; Thrombocytopenia; Purpura, Thrombocytopenic Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Purpura; Purpura, Thrombocytopenic Immunologic Diseases; Autoimmune Diseases Immunologic Diseases; Purpura, Thrombocytopenic Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IgG autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms. Purpura, Thrombocytopenic (66-91) %b+XN'Purpura, Thrombocytopenic C15.378.463.205.855.700; C15.378.463.597.700; C20.841 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders; Thrombocytopenia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Purpura Immunologic Diseases Purpura, Thrombocytopenic, Idiopathic Purpura, Thrombocytopenic, Idiopathic Purpura, Thrombocytopenic, Idiopathic Any form of purpura in which the platelet count is decreased. Many forms are thought to be caused by immunological mechanisms. %f=N}Purpura, Schoenlein-Henoch C14.907.940.910.600; C15.378.463.597.580; C20.543.520.910.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Vasculitis; Vasculitis, Hypersensitivity Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Purpura Immunologic Diseases; Hypersensitivity; Immune Complex Diseases; Vasculitis, Hypersensitivity A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis (VASCULITIS, HYPERSENSITIVITY) associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement. Purpura (66-74) %iEN7*Purpura, Hyperglobulinemic C15.378.463.597.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Purpura Purpura associated with an increase in gamma globulins. The condition is no longer considered a specific entity since the clinical and laboratory findings are observed in a variety of hematologic conditions. (From Dorland, 25th ed). %mNoPurpura C15.378.463.597 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ecchymosis Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis Purpura, Hyperglobulinemic; Purpura, Schoenlein-Henoch; Purpura, Thrombocytopenic (+ 1); Purpura, Thrombotic Thrombocytopenic; Wiskott-Aldrich Syndrome A group of disorders characterized by purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues.  %oC NdPurple Membrane A11.195.648 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Bacteriorhodopsin Bacteriorhodopsin Cells; Cell Membrane Functionally and structurally differentiated, purple-pigmented regions of the cytoplasmic membrane of some strains of Halobacterium halobium. The membrane develops under anaerobic conditions and is made almost entirely of the purple pigment BACTERIORHODOPSIN. (From Dictionary of Microbiology and Molecular Biology, 2d ed). Bacteriorhodopsin (76-94); Cell Membrane (71-78) $%q(s:Puromycin Aminonucleoside D09.203.408.051.788.650; D13.570.230.229.650; D13.570.583.138.325.800; D20.085.075.740.779; D22.204.106.779; D22.204.144.779; D26.087.762.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Puromycin Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxyadenosines Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine; Deoxyadenosines Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Puromycin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Puromycin 3'-Amino-3'-deoxy-N,N-dimethyladenosine. Puromycin derivative which lacks the methoxyphenylalanyl group on the amine of the sugar ring. It is an antibiotic with antineoplastic properties and can cause nephrosis. Amino Sugars (74); Antibiotics, Antineoplastic (72-74); Deoxyadenosine (72-74) %t:]Puromycin D09.203.408.051.788; D20.085.075.740; D26.087.762 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Puromycin Aminonucleoside Puromycin Aminonucleoside Puromycin Aminonucleoside 3'-((2-Amino-3-(4-methoxyphenoxy)-1-oxopropyl)amino)-3'- deoxy-N,N-dimethyladenosine. An antibiotic from Streptomyces alboniger that inhibits protein synthesis by binding to RNA. It is a proposed antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis. %y 9<VXPurkinje Fibers A07.541.409.683 ABAHCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Conduction System Modified cardiac muscle fibers composing the terminal portion of the heart conduction system. %|6@nPurkinje Cells A08.186.211.212.212.633; A08.663.694.650; A11.671.677.650 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Central Nervous System; Brain; Cerebellum; Cerebellar Cortex Nervous System; Neurons; Neuron Types (Non MeSH) Cells; Neurons; Neuron Types (Non MeSH) The output neurons of the cerebellar cortex. %}A*7Purinones D03.438.759.758 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines Hypoxanthines (+ 4); Xanthines (+ 10) Ketones (66-67); Purines (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  % 8S0)DPurines D03.438.759 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Adenine (+ 1); Allopurinol; 6-Mercaptopurine (+ 1); Purinones (+ 16); Thioguanine; Zeatin A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  %  :Gp_DPurine-Pyrimidine Metabolism, Inborn Errors C18.452.648.798 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Gout (+ 1); Lesch-Nyhan Syndrome BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI %2Lm*NPurine-Nucleoside Phosphorylase D08.586.913.400.725.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Pentosyltransferases (73-74); Phosphates (73-74); Purine Nucleosides (73-74) %$FZPurine Nucleotides D13.695.667 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Adenine Nucleotides (+ 23); Guanine Nucleotides (+ 15); Inosine Nucleotides (+ 4) Nucleotides (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  %>PdHPurine Nucleosides D13.570.583 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides Adenosine (+ 11); Guanosine (+ 2); Inosine (+ 4); Tubercidin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR %Z>POHPurchasing, Hospital N02.278.354.422.679; N04.452.442.422.679 CLECHILJMAMTOGSNSTTDUT Equipment and Supplies, Hospital Group Purchasing; Economics, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Group Purchasing Group Purchasing Hospital department responsible for the purchasing of supplies and equipment. $%.'- ([Pupillary Functions, Abnormal C11.710 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Anisocoria (+ 2); Miosis; Mydriasis; Tonic Pupil (+ 2) Conditions in which the pupil does not react normally to dilation and constriction. Signs of pupillary abnormalities originate from the pupil's shape, position, and response to stimulation. Pupil (67-89); specific eye disease (69-89)  %># NF6Pupil A09.371.894.513.780 DEPHRE Miotics; Mydriatics; Reflex, Pupillary Sense Organs; Eye; Uvea; Iris The aperture in the iris through which light passes. %O  /(APupa B01.583.758 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Life Stages (Non MeSH) An inactive stage between the larval and adult stages in the life cycle of insects. Insects (66-69); specific insect; Metamorphosis, Biological (66-69) %8(.fPPunishment F02.463.425.770.571; I01.880.630.716 HIPX Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) Social Sciences; Sociology; Social Control, Informal The application of an unpleasant stimulus or penalty for the purpose of eliminating or correcting undesirable behavior. %*Punctures E01.223.894.632; E02.800 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Specimen Handling Therapeutics Amniocentesis; Biopsy, Needle; Blood Specimen Collection (+ 2); Bloodletting; Chorionic Villi Sampling; Spinal Puncture Bloodletting Incision of tissues for injection of medication or for other diagnostic or therapeutic procedures. Punctures of the skin, for example may be used for diagnostic drainage; of blood vessels for diagnostic imaging procedures; of lung as in pneumonocentesis and of pleural cavity as in thoracentesis. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  %' "K\&Punched-Card Systems L01.700.568.110.085.800 CLECHIISLJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Automatic Data Processing %Pulvinus B06.413.500.600.700 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH); Plant Shoots; Plant Leaves A group of cells at the base of a leaf in certain plants that, by rapidly losing water, brings about changes in the position of the leaves. (Concise Dictionary of Biology, 1990). Plants (66-94) % &OPulse Radiolysis E05.196.867.660 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Use of a pulse of X-rays or fast electrons to generate free radicals for spectroscopic examination. %"[wPulse E01.145.569.798; E01.706.817; G09.330.612.733 DEGEIMPHRE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Physical Examination Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics % 5Pulsatile Flow G09.330.612.725; H01.671.799.775 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Physical Sciences (Non MeSH); Physics; Rheology Rhythmic, intermittent propagation of a fluid through a vessel or piping system, in contrast to constant, smooth propagation, which produces laminar flow. The quality of blood flow, whether smooth (laminar) or pulsatile, is important to the integrity of the tissues being artificially perfused by various heart assist devices or in regional perfusion. Blood Flow Velocity (66-86); Models, Biological (66-79); Models, Cardiovascular (80-86); Rheology (66-86) %S&~Pulpotomy E06.397.695 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dental Pulp Dentistry; Endodontics % $Pulpitis C07.793.237.820 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Dental Pulp Diseases Inflammation of the dental pulp, usually due to bacterial infection in dental caries, tooth fracture, or other conditions causing exposure of the pulp to bacterial invasion. Chemical irritants, thermal factors, hyperemic changes, and other factors may also cause pulpitis. (Dorland, 27th ed). % NIUPulpectomy E06.397.633 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dental Pulp Dentistry; Endodontics %H$Pulmonary Wedge Pressure G09.330.612.114.695; G09.772.521.500.500.695 DEGEIMPHRE Heart Catheterization; Catheterization, Swan-Ganz Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Blood Pressure Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Circulation; Pulmonary Circulation The blood pressure as recorded after wedging a catheter in a small pulmonary artery; believed to reflect the pressure in the pulmonary capillaries. Blood Pressure (66-80); Pulmonary Circulation (66-80)  %298@Pulmonary Veno-Occlusive Disease C08.381.780; C14.907.690 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Cardiovascular Diseases; Vascular Diseases Obstruction of the small- and medium-sized pulmonary veins by fibrous proliferation of the intima and media or by thrombosis or a combination of both. Pulmonary Veins (66-86); Vascular Diseases (66-86) %&Nb=Pulmonary Veins A07.231.908.713 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins The veins that return the oxygenated blood from the lungs to the left atrium of the heart. %85oPulmonary Valve Stenosis C14.280.484.716 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases %NIPulmonary Valve Insufficiency C14.280.484.660 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Backflow of blood from the pulmonary artery into the right ventricle, owing to imperfect functioning of the pulmonary valve. Heart Diseases (66); Pulmonary Valve (66) %#NI4Pulmonary Valve A07.541.510.738 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Valves A valve situated at the entrance to the pulmonary trunk from the right ventricle. %84cPulmonary Surfactants D10.516.532.780; D10.516.695.300.700.870; D12.776.521.825; D24.185.701 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Surface-Active Agents Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins Immunologic and Biologic Factors (Non MeSH); Biological Factors  1,2-Dipalmitoylphosphatidylcholine Lipoproteins in which the lipid moiety is based mainly on lecithin and other phospholipids. They may also contain small amounts of prostaglandins and other compounds. Composition is species dependent. They are secreted by the mitochondria of type II alveolar cells. Surfactants regulate the surface tension of the mucoid layer lining the alveoli. Absence of the surfactants in premature infants results in HYALINE MEMBRANE DISEASE and in adults in ATELECTASIS. Synthetic pulmonary surfactants have also been prepared and are used therapeutically. Pulmonary Alveoli (66-70); Surface-Active Agents (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (%PF_)|CHPulmonary Subvalvular Stenosis C14.280.600.100.715 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases; Cardiomyopathy, Hypertrophic Stenosis of the conus arteriosus (infundibulum) with or without involvement of the pulmonary valve. It is usually associated with a defect in the interventricular septum. %8$NhPulmonary Stretch Receptors A08.800.550.700.500.780 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors Stretch receptors found in the bronchi and bronchioles. Pulmonary stretch receptors are sensors for a reflex which stops inspiration. In humans, the reflex is protective and is probably not activated during normal respiration. Lung/innervation (66-70) %!8o Pulmonary Heart Disease C14.280.832 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lung Diseases; Hypertension, Pulmonary Cardiovascular Diseases; Heart Diseases %EN./Pulmonary Gas Exchange E01.302.796.568; G09.772.521.900.602 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Transport Pulmonary Diffusing Capacity; Ventilation-Perfusion Ratio Blood-Air Barrier; Pulmonary Diffusing Capacity; Ventilation-Perfusion Ratio The exchange of oxygen and carbon dioxide between alveolar air and pulmonary capillary blood. %?*oPulmonary Fibrosis C08.381.483.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure. %NSPulmonary Eosinophilia C08.381.750; C15.378.553.231.549.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Eosinophilia; Hypereosinophilic Syndrome A disease characterized by pulmonary infiltrations of eosinophils and blood eosinophilia. Eosinophilia (66-81); Lung Diseases (66-81) %m*Nh5Pulmonary Emphysema C08.381.495.632 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Emphysema Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive Condition of the lungs characterized by increase beyond normal in the size of air spaces distal to the terminal bronchioles, either from dilatation of the alveoli or from destruction of their walls. %N RPulmonary Embolism C08.381.746; C14.907.355.350.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism Embolism in the pulmonary artery or one of its branches. %|&NFPulmonary Edema C08.381.742 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Respiratory Tract Diseases; Lung Diseases % N 2Pulmonary Disease (Specialty) G02.403.776.409.675 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Medical; Internal Medicine A subspecialty of internal medicine concerned with the study of the respiratory system. It is especially concerned with diagnosis and treatment of diseases and defects of the lungs and bronchial tree. Internal Medicine (66-88); Lung Diseases (66-88) %#R;Pulmonary Diffusing Capacity E01.302.796.568.572; G09.772.521.900.602.600 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Pulmonary Gas Exchange Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Transport; Pulmonary Gas Exchange Diffusion (68-70); Respiration (66-70); Respiratory Function Tests (66-70) %"2$YPulmonary Circulation G09.330.163.840.500; G09.772.521.500.500 DEGEIMPHRE Ventilation-Perfusion Ratio Lung Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation; Respiratory Circulation Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Circulation  Pulmonary Wedge Pressure The circulation of blood through the lungs. $%. -6Pulmonary Blastoma C04.557.435.675 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells (i.e., blast forms) with little or virtually no stroma. (From Stedman, 25th ed). Lung Neoplasms (66-93) %XnPulmonary Atresia C14.240.670; C14.280.484.640; C16.131.240.670 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH) Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH) Congenital absence of the normal valvular orifice into the pulmonary artery. This condition is characterized by cardiomegaly, reduced pulmonary vascularity, and right ventricular atrophy. (From Stedman, 25th ed; Dorland, 27th ed). Pulmonary Artery/abnormalities (66-94); Pulmonary Valve/abnormalities (66-94) %5L ZPulmonary Artery A07.231.114.715 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. %/88Pulmonary Alveoli A04.411.715 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Respiratory System; Lung Blood-Air Barrier Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place. ABAHBSCHCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUULUSVI  %|8:Pulmonary Alveolar Proteinosis C08.381.719 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases %i$N2Pulmonary Adenomatosis, Ovine C02.256.466.838; C22.836.715 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Animal Diseases; Sheep Diseases A pulmonary disease of sheep characterized by hyperplasia and hypertrophy of septal cells of the lung. Sheep Diseases (66-67) %;#"J}zPuerto Rico Z01.107.084.900.750 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies %OPuerperium G08.520.882 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction Lactation (+ 2) Period from delivery of the placenta until return of the reproductive organs to their normal nonpregnant morphologic state. In humans, the puerperium generally lasts for six to eight weeks. %ҡGPuerperal Infection C01.539.674.715; C13.703.700.715; C13.703.844.757 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Pregnancy Complications, Infectious Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Infectious Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Puerperal Disorders An infection occurring in the puerperium or postpartum period. %:9NqKPuerperal Disorders C13.703.844 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Lactation Disorders (+ 3); Postpartum Hemorrhage; Puerperal Infection Disorders or diseases associated with the six-to-eight-week period immediately following labor and delivery. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  %ָLfS}PPublishing L01.737 CLECHIISLJMAOGSDSNSTTDUT Book Industry; Duplicate Publication; Periodicals Book Industry Information Science Book Industry (+ 3); Copyright; Duplicate Publication; Journalism (+ 1); Peer Review, Research; Plagiarism; Printing; Publication Bias; Retraction of Publication "The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing. CLECHIISLJMAMTOGSDSNSTTDUT (% ;$Publications (Non MeSH) L01.178.682 Information Science; Communications Media (Non MeSH) Bibliography (+ 4); Book Reviews; Books (+ 31); Broadsides; Catalogs (+ 6); Dissertations, Academic; Government Publications; Manuscripts (+ 1); Pamphlets; Review Literature (+ 2); Serial Publications (Non MeSH) (+ 2); Translations CLECHILJSDSNSTTDUT %ۭ>Publication Bias L01.737.813 HILJSNTD Meta-Analysis Information Science; Publishing The influence of study results on the chances of publication and the tendency of investigators, reviewers, and editors to submit or accept manuscripts for publication based on the direction or strength of the study findings. Publication bias has an impact on the interpretation of clinical trials and meta-analyses. Bias can be minimized by insistence by editors on high-quality research, thorough literature reviews, acknowledgement of conflicts of interest, modification of peer review practices, etc. Publishing (86-93)  %j &FPublic Sector I01.795; N04.452.633.890 CLECHILJMAOGSNSTTDUT Social Sciences Health Services Administration (Non MeSH); Organization and Administration; Ownership The area of a nation's economy that is tax-supported and under government control. Government Agencies (79-92) %Yvc!Public Relations F01.829.674; N04.452.822 ECSNTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Health Services Administration (Non MeSH); Organization and Administration Community-Institutional Relations; Hospital-Patient Relations; Hospital-Physician Relations; Interdepartmental Relations; Interinstitutional Relations Anniversaries and Special Events; Community-Institutional Relations; Consumer Satisfaction (+ 1); Hospital-Patient Relations; Hospital-Physician Relations; Interdepartmental Relations; Interinstitutional Relations Relations of an individual, association, organization, hospital, or corporation with the publics which it must take into consideration in carrying out its functions. Publics may include consumers, patients, pressure groups, departments, etc. ECEHLJSNSTTD  % Public Policy I01.880.604.710.608; N03.706.710.608 Policy Making Social Sciences; Sociology; Social Control, Formal; Policies (Non MeSH) Economics, Organizations, Control (Non MeSH); Social Control, Formal; Policies (Non MeSH) Family Planning Policy; Health Policy (+ 2) Family Planning Policy; Health Policy (+ 2) A course or method of action selected, usually by a government, from among alternatives to guide and determine present and future decisions. CLECHILJMTOGSNSTTDUT  %*jPublic Opinion F01.829.651; I01.880.630.548 Attitude to Health Attitude Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Social Sciences; Sociology; Social Control, Informal The attitude of a significant portion of a population toward any given proposition, based upon a measurable amount of factual evidence, and involving some degree of reflection, analysis, and reasoning. Attitude (66-67)  %" Public Housing G03.230.150.360.650; N01.224.791.400.650 CLHISNSTTD Environment and Public Health (Non MeSH); Environment; Environment, Controlled; Housing Population Characteristics (Non MeSH); Demography; Residence Characteristics; Housing Housing subsidized by tax funds, usually intended for low income persons or families. Housing (66-67); Social Welfare (66-67) %.f1Public Health Practice (Non MeSH) G03.850.780 Environment and Public Health (Non MeSH); Public Health Communicable Disease Control (+ 29); Decontamination; Environmental Monitoring (+ 1); Mass Screening (+ 7); Population Surveillance (+ 1) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE %)D*Public Health Nursing G02.478.676.755 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing The field of nursing focusing on the health of the community through educational and preventive programs, as well as providing treatment and diagnostic services. %8;Public Health Dentistry G02.163.876.770; G03.890 CLECEDHIISLJMAMTOGSNSTTD Health Education, Dental Health Occupations; Dentistry; Specialties, Dental Environment and Public Health (Non MeSH) Community Dentistry Dental Health Surveys (+ 4); Fluoridation; Health Education, Dental A dental specialty concerned with the prevention of disease and the maintenance of oral health through promoting organized dental health programs at a community, state, or federal level. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $%kh*Public Health Administration N04.452.794 CLECEDHIISLJMAMTSNSTTD Community Health Services Health Services Administration (Non MeSH); Organization and Administration Management of public health organizations or agencies. %"WAPublic Health G02.403.790.548.560; G03.850; N01.407.540.740 CLECEDHIISLJMAMTSNSTTD Social Medicine; Zoonoses Health Occupations; Medicine; Specialties, Other (Non MeSH); Preventive Medicine Environment and Public Health (Non MeSH) Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health  Accidents (+ 12); Consumer Product Safety (+ 1); Disease Outbreaks; Disease Reservoirs; Disease Transmission (+ 4); Drug Contamination; Environmental Microbiology (+ 4); Environmental Pollution (+ 37); Epidemiologic Factors (+ 17); Epidemiologic Measurements (Non MeSH) (+ 36); Epidemiologic Methods (+ 139); Equipment Contamination; Equipment Reuse; Health Education; Hygiene (+ 1); Public Health Practice (Non MeSH) (+ 43); Radiologic Health (Non MeSH) (+ 17); Sanitation (+ 21) Branch of medicine concerned with the prevention and control of disease and disability, and the promotion of physical and mental health of the population on the international, national, state, or municipal level. AEAGAIANBLCFCHCICLCNCOCSCTDEDHDIDTDUECEDEHEMENEPETGEHIIMIPISLJMAMEMIMOMTNUOGPAPCPDPKPOPPPSPXRARERHRIRTSDSNSTSUTDTHTOURUSUTVEVI $%A5 BPublic Facilities (Non MeSH) G03.850.860.410 Environment and Public Health (Non MeSH); Public Health; Sanitation Bathing Beaches; Health Resorts; Swimming Pools; Toilet Facilities CLECHILJSNST %#RPPublic Assistance N03.219.521.346.506 CLECHILJOGSNSTTDUT Social Welfare Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government Medical Assistance (+ 4); Old Age Assistance; Social Security (+ 1) Financial assistance to impoverished persons for the essentials of living through federal, state or local government programs. Public Health (66-67); Social Welfare (66-67) $%uT8Pubic Symphysis A02.835.583.656 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Symphysiotomy Musculoskeletal System; Skeleton; Joints %81Pubic Bone A02.835.232.611.781 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Pelvic Bones %:LPuberty, Precocious C19.391.693 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Adrenal Hyperplasia, Congenital Endocrine Diseases; Gonadal Disorders (Non MeSH) Unusually early sexual maturity. %JJ%:(Puberty, Delayed C19.391.690 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Endocrine Diseases; Gonadal Disorders (Non MeSH) Unusually late sexual maturity. Puberty (66-80) %iJ:'Puberty G08.520.940.508 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sexual Reproduction Periods (Non MeSH) Menarche %s u Pterygoid Muscles A02.633.567.600.700; A14.530.790 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal; Masticatory Muscles Stomatognathic System; Masticatory Muscles Two of the masticatory muscles: the internal, or medial, pterygoid muscle and external, or lateral, pterygoid muscle. Action of the former is closing the jaws and that of the latter is opening the jaws, protruding the mandible, and moving the mandible from side to side. Facial Muscles (66-79); Masticatory Muscles (66-79); Muscles (66-79) %O&:@SPterygium C11.187.781 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Conjunctival Diseases An abnormal triangular fold of membrane in the interpalpebral fissure, extending from the conjunctiva to the cornea, being immovably united to the cornea at its apex, firmly attached to the sclera throughout its middle portion, and merged with the conjunctiva at its base. (Dorland, 27th ed). & N+XPteroylpolyglutamic Acids D03.438.733.631.400.600; D11.786.708.328.700 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins; Folic Acid Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Folic Acid Derivatives of folic acid (pteroylglutamic acid). In gamma-glutamyl linkage they are found in many tissues. They are converted to folic acid by the action of pteroylpolyglutamate hydrolase or synthesized from folic acid by the action of folate polyglutamate synthetase. Synthetic pteroylpolyglutamic acids, which are in alpha-glutamyl linkage, are active in bacterial growth assays. Folic Acid (66-78); Glutamates (66-78) &2B0Pteroyl Polyglutamate Hydrolase D08.586.277.656.732.215.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases Catalyzes the hydrolysis of pteroylpolyglutamic acids in gamma linkage to pterolylmonoglutamic acid and free glutamic acid. Carboxypeptidases (72-74); Folic Acid (72-74); Glutamates (72-74) &%FOPterins D03.438.733.631; D11.557.831 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Aminopterin (+ 1); Folic Acid (+ 4); Xanthopterin Xanthopterin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR &  "8NFPteridines D03.438.733 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Biopterin; Pterins (+ 8); Triamterene AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR & z8G0FPsyllium D19.316.396.777 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Plantago Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Dried, ripe seeds of Plantago psyllium, P. indica, and P. ovata (Plantaginaceae). Plantain seeds swell in water and are used as demulcents and bulk laxatives. &  : aPsychotropic Drugs D15.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Psychopharmacology Central Nervous System Agents Antidepressive Agents (+ 35); Hallucinogens (+ 12); Tranquilizing Agents (+ 67) A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $&] 8$aDPsychotic Disorders F03.709.680 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders Affective Disorders, Psychotic (+ 4); Capgras Syndrome; Child Development Disorders, Pervasive (+ 2); Organic Mental Disorders, Psychotic (+ 18); Paranoid Disorders (+ 1); Schizophrenia (+ 4) Disorders in which there is gross impairment in reality testing. The individual incorrectly evaluates his or her perception and thoughts and makes incorrect inferences about reality even in the face of contrary evidence. Delusions or hallucinations are present. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  &DI1PPsychotherapy, Rational-Emotive F04.754.785 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy The replacement of illogical and unrealistic ideas with more realistic and adaptive ones through direct intervention and confrontation by the therapist. Psychotherapy (66-76) &$KPsychotherapy, Multiple F04.754.766 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy The use of more than one therapist at one time in individual or group psychotherapy. Psychotherapy (66-72); Psychotherapy, Group (66-72) &Kg=Psychotherapy, Group F04.754.864.581 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy Family Therapy; Psychodrama (+ 1); Sensitivity Training Groups (+ 1) A form of therapy in which two or more patients participate under the guidance of one or more psychotherapists for the purpose of treating emotional disturbances, social maladjustments, and psychotic states. &jTPsychotherapy, Brief F04.754.738 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Any form of psychotherapy designed to produce therapeutic change within a minimal amount of time, generally not more than 20 sessions. Psychotherapy (66-72) &&KPsychotherapy F04.754 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH) Art Therapy; Autogenic Training; Behavior Therapy (+ 6); Bibliotherapy; Biofeedback (Psychology); Color Therapy; Crisis Intervention; Dance Therapy; Gestalt Therapy; Hypnosis (+ 2); Marital Therapy; Music Therapy; Nondirective Therapy; Play Therapy; Psychoanalytic Therapy (+ 3); Psychotherapy, Brief; Psychotherapy, Multiple; Psychotherapy, Rational-Emotive; Reality Therapy; Socioenvironmental Therapy (+ 9); Therapeutic Processes (Non MeSH) (+ 6) A generic term for the treatment of mental illness or emotional disturbances primarily by verbal or nonverbal communication. AECLCTDEECEDHIISLJMAMOMTNUOGPHPXRESNSTTDUTVE  & 90Psychosurgery E04.530.730; F04.881.630 AECLECEDHIISLJMAMOMTOGPXRHSNSTTD Surgery, Operative; Neurosurgery Disciplines, Tests, Therapy, Services (Non MeSH); Somatic Therapies, Psychiatric (Non MeSH) Treatment of chronic, severe and intractable psychiatric disorders by surgical removal or interruption of certain areas or pathways in the brain, especially in the prefrontal lobes. &$Psychosomatic Medicine F04.096.544.830 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry A system of medicine which aims at discovering the exact nature of the relationship between the emotions and bodily function, affirming the principle that the mind and body are one. &`Psychosocial Deprivation F01.829.628; I01.880.143.806 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Social Sciences; Sociology; Culture The absence of appropriate stimuli in the physical or social environment which are necessary for the emotional, social, and intellectual development of the individual. Cultural Deprivation (68) &!"vPsychosine D02.033.329.291.846.700; D02.092.063.291.846.700; D09.203.408.730 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines; Sphingosine Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines; Sphingosine Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides 2-Amino-3-hydroxy-4-octadecenyl-beta-D-galactopyranoside. An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside. Galactose (72-74); Glycosides (74); Sphingosine (72-74) &#;IDDPsychosexual Dysfunctions F03.709.597.608.780 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders Dyspareunia; Frigidity; Impotence (+ 1) Dysfunctions in which the essential feature is inhibition in the appetitive or psychophysiological changes that characterize the complete sexual response cycle. This cycle includes the following phases: appetitive, excitement, orgasm, and resolution (relaxation). BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  &&qF~1.LPsychosexual Disorders F03.709.597.608 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders Homosexuality, Ego-Dystonic; Paraphilias (+ 7); Psychosexual Dysfunctions (+ 4); Transsexualism Sexual disorders which are assumed to be due to psychological factors. They include transsexualism, the paraphilias, and the psychosexual dysfunctions--dyspareunia, frigidity, and impotence. BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  &)@FcqLPsychosexual Development F01.752.747.722; F02.739.794.793 CLDEPHRE Sex Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Anal Stage; Gender Identity; Latency Period (Psychology); Oral Stage; Phallic Stage Anal Stage; Gender Identity; Latency Period (Psychology); Oral Stage; Phallic Stage The stages of development of the psychological aspects of sexuality from birth to adulthood; i.e., oral, anal, genital, and latent periods. Child Psychology (66-67); Sex Behavior (66-67) $&+& 9Psychoses, Substance-Induced C21.613.809; F03.709.508.460.670; F03.709.680.610.580 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic  Psychoses, Alcoholic (+ 2) Psychoses, Alcoholic (+ 2) Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. &.!=D]APsychoses, Alcoholic C21.613.053.270.750; F03.709.508.460.670.675; F03.709.680.610.580.510 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Alcoholism Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Psychoses, Substance-Induced Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Psychoses, Substance-Induced Alcohol Amnestic Disorder; Alcohol Withdrawal Delirium Alcohol Amnestic Disorder; Alcohol Withdrawal Delirium Alcohol Amnestic Disorder; Alcohol Withdrawal Delirium A group of mental disorders associated with organic brain damage and caused by poisoning from alcohol. Included in this group are: delirium tremens, Korsakoff syndrome, and often alcoholic hallucinosis.  &1MDPsychophysiology F02.830; F04.096.795; G01.782.795 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH) Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Biological Sciences; Physiology Appetite; Arousal (+ 2); Biofeedback (Psychology); Blushing; Consciousness; Dominance, Cerebral (+ 1); Habituation (Psychophysiology); Lie Detection; Orientation (+ 2); Reaction Time (+ 1); Reflex (+ 3); Satiation (+ 1); Self Stimulation; Sensation (+ 12); Sleep (+ 4); Stress, Psychological (+ 1) Neuropsychology; Psychoneuroimmunology Neuropsychology; Psychoneuroimmunology The study of the physiological basis of human and animal behavior. BLCFCICLCNCODEDHDIDTECEDEHEMENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERHRIRTSNSTSUTDTHURUSVEVI  &6)QfPsychophysiologic Disorders F03.709.630 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders Serious disturbances of any organ system which are considered to be of psychogenic origin. Psychosomatic Medicine (66-67) &9 FIl$Psychophysics F04.096.753; H01.671.720 CLECEDHIISLJMAMTOGSNSTTD Differential Threshold Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Physical Sciences (Non MeSH); Physics Psychoacoustics; Signal Detection (Psychology) Psychoacoustics; Signal Detection (Psychology) The science dealing with the correlation of the physical characteristics of a stimulus, e.g., frequency or intensity, with the response to the stimulus, in order to assess the psychologic factors involved in the relationship. Perception (66-69) CLDEECEDHIISLJMAMTOGPHRESNSTTD (&;2j"Psychopharmacology F04.096.712; F04.881.505; G01.703.546; G02.628.546 CLECEDHIISLJMAMTOGSNSTTD Psychotropic Drugs Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Disciplines, Tests, Therapy, Services (Non MeSH); Somatic Therapies, Psychiatric (Non MeSH) Biological Sciences; Pharmacology Health Occupations; Pharmacology  Narcotherapy The study of the effects of drugs on mental and behavioral activity.  &=<TPsychopathology F04.096.670 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences The study of significant causes and processes in the development of mental illness. &@RdPsychoneuroimmunology F04.096.795.650; G01.782.795.180 CLECEDHIISLJMAMTOGSNSTTD Neuroimmunomodulation Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychophysiology Biological Sciences; Physiology; Psychophysiology The field concerned with the interrelationship between the brain, behavior and the immune system. Neuropsychologic, neuroanatomic and psychosocial studies have demonstrated their role in accentuating or diminishing immune/allergic responses. &A(&Psychomotor Performance F02.808 CLDEPHRE Psychologic Processes and Principles (Non MeSH) Motor Skills; Task Performance and Analysis The coordination of a sensory or ideational (cognitive) process and a motor activity. Motor Skills (66-82); Visual Perception (66-82)  &Cu  85f:Psychomotor Disorders F03.126.720 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Movement Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Apraxia; Automatism; Catalepsy; Cataplexy; Catatonia; Hyperkinesis; Mannosidosis; Psychomotor Agitation (+ 1); Tic (+ 1) Psychogenic disturbances in motor aspects of behavior. Movement Disorders (66-68); specific disorders BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (&DFYA8NPsychomotor Agitation F03.126.720.710 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders Akathisia, Drug-Induced Restlessness, a psychomotor expression of emotional tension. Motor Activity (68-77); Psychomotor Disorders (69-77) BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $&GKDtG@LPsychometrics F04.711.780 CLECEDHIISLJMAMTOGSNSTTD Statistics Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests Assessment of psychological variables by the application of mathematical procedures. &INRbPsychology, Social F01.829; F04.096.628.829 CLECEDHIISLJMAMTOGSNSTTD Race Relations Behavior and Behavior Mechanisms (Non MeSH) Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology Anomie (+ 1); Attitude (+ 4); Ethics (+ 1); Family (+ 27); Group Processes (+ 13); Internal-External Control; Interpersonal Relations (+ 8); Life Style (+ 1); Morale; Morals (+ 2); Prejudice; Psychosocial Deprivation; Public Opinion; Public Relations (+ 5); Social Adjustment; Social Behavior (+ 5); Social Conformity; Social Desirability; Social Facilitation; Social Isolation (+ 2); Social Values; Stereotyping; Taboo The branch of psychology concerned with the effects of group membership upon the behavior, attitudes, and beliefs of an individual. CLDEECEDEHHIISLJMAMTOGPCPHPXRESNSTTDUT $&Js*Psychology, Military F02.784.754 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH); Psychology, Applied The branch of applied psychology concerned with psychological aspects of selection, assignment, training, morale, etc., of Armed Forces personnel. &N`QPsychology, Medical F04.096.628.808; G02.720 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology Health Occupations A branch of psychology in which there is collaboration between psychologists and physicians in the management of medical problems. It differs from clinical psychology, which is concerned with the diagnosis and treatment of behavior disorders. &OuPsychology, Industrial F02.784.692; F04.096.628.779 CLECEDHIISLJMAMTOGSNSTTD Human Engineering Human Engineering Psychologic Processes and Principles (Non MeSH); Psychology, Applied Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology Absenteeism; Efficiency; Job Satisfaction; Task Performance and Analysis (+ 1); Time Management; Vocational Guidance Time Management The branch of applied psychology concerned with the application of psychologic principles and methods to industrial problems including selection and training of workers, working conditions, etc. CLDEECEDHIISLJMAMTOGPHPXRESNSTTD (&Q"$Psychology, Experimental F04.096.628.729 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology The branch of psychology which seeks to learn more about the fundamental causes of behavior by studying various psychologic phenomena in controlled experimental situations. &T`Psychology, Educational F02.784.629; F04.096.628.679 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH); Psychology, Applied Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology Achievement; Aptitude; Aspirations (Psychology); Child, Exceptional (+ 1); Child Guidance; Education of Mentally Retarded; Learning; Remedial Teaching; Student Dropouts; Underachievement; Vocational Guidance The branch of psychology concerned with psychological aspects of teaching and the formal learning process in school. CLDEECEDGEHIISLJMAMTOGPHPXRESNSTTD  &Vd"&Psychology, Comparative F04.096.628.629 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology The branch of psychology concerned with similarities or differences in the behavior of different animal species or of different races or peoples. &Y<`Psychology, Clinical F04.096.628.579 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology The branch of psychology concerned with psychological methods of recognizing and treating behavior disorders. &Z`Psychology, Applied F02.784 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH) Counseling (+ 2); Criminal Psychology (+ 1); Human Engineering (+ 5); Psychology, Educational (+ 12); Psychology, Industrial (+ 7); Psychology, Military The science which utilizes psychologic principles to derive more effective means in dealing with practical problems. AECLDEECEDGEHIISLJMAMTOGPHPXRESDSNSTTDUT  &[ 8,Psychology F04.096.628 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Adolescent Psychology; Child Psychology; Ethnopsychology; Psychology, Clinical; Psychology, Comparative; Psychology, Educational; Psychology, Experimental; Psychology, Industrial (+ 1); Psychology, Medical; Psychology, Social The science dealing with the study of mental processes and behavior in man and animals. CLECEDHIISLJMAMTOGPXSNSTTD  &^RjPsychological Warfare I01.880.735.944.711 HI Persuasive Communication; Propaganda Persuasive Communication Social Sciences; Sociology; Social Problems; War The manipulation of psychological influences, primarily concerned with morale, to strengthen the ability of one's own country and weaken the enemy.  &`P+<Psychological Theory F02.739 Psychologic Processes and Principles (Non MeSH) Behaviorism; Double Bind Theory; Existentialism; Gestalt Theory; Personal Construct Theory; Psychoanalytic Theory (+ 23) Principles applied to the analysis and explanation of psychological or behavioral phenomena. Psychology (66-68) CLDEHIPHPXRE  &a 8lPsychological Tests F04.711 HISNST Disciplines, Tests, Therapy, Services (Non MeSH) Aptitude Tests (+ 3); Language Tests; Neuropsychological Tests (+ 3); Personality Tests (+ 16); Psychometrics Standardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits. CLECEDHIISLJMAMTOGSNSTTD  &c  9Psychological Techniques (Non MeSH) F04.669 Disciplines, Tests, Therapy, Services (Non MeSH) Electroshock; Feedback; Galvanic Skin Response; Interview, Psychological; Reaction Time (+ 1); Theoretical Techniques (Non MeSH) (+ 6) AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE &e\* 9,Psychologic Processes and Principles (Non MeSH) F02 Mental Competency; Mental Health; Mental Processes (+ 123); Parapsychology (+ 1); Psycholinguistics (+ 1); Psychological Theory (+ 29); Psychology, Applied (+ 33); Psychomotor Performance (+ 2); Psychophysiology (+ 43); Religion and Psychology (+ 1) AEBLCFCICLCNCODEDHDIDTECEDEHEMENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERHRIRTSDSNSTSUTDTHURUSUTVEVI &f8.lPsycholinguistics F02.694; F04.096.586; L01.143.506.598.628 CLECEDHIISLJMAMTOGSNSTTD Language Development Psychologic Processes and Principles (Non MeSH) Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Information Science; Communication; Language; Linguistics Semantic Differential A discipline concerned with relations between messages and the characteristics of individuals who select and interpret them; it deals directly with the processes of encoding (phonetics) and decoding (psychoacoustics) as they relate states of messages to states of communicators. Language (66) $&h1BPsychodrama F04.754.864.581.679 CLECEDHIISLJMAMTOGSNSTTD Acting Out Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy; Psychotherapy, Group Role Playing Primarily a technique of group psychotherapy which involves a structure, directed, and dramatized acting out of the patient's personal and emotional problems.  &kPsychodidae B01.131.617.289.781 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera Phlebotomus Small, hairy, moth-like, blood-sucking flies which are of considerable public health importance as vectors of certain pathogenic organisms. Important disease-related genera are PHLEBOTOMUS, Lutzomyia, and Sergentomyia. Phlebotomus (66-72)  &m](5Psychoanalytic Therapy F04.754.709 CLECEDISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Existentialism; Free Association; Transactional Analysis A form of psychiatric treatment, based on Freudian principles, which seeks to eliminate or diminish the undesirable effects of unconscious conflicts by making the patient aware of their existence, origin, and inappropriate expression in current emotions and behavior. CLECEDHIISLJMAMTOGPXSNSTTD  &o+KB5Psychoanalytic Theory F02.739.794 Psychologic Processes and Principles (Non MeSH); Psychological Theory Ego (+ 1); Extraversion (Psychology); Freudian Theory; Id; Inhibition (Psychology); Introversion (Psychology); Jungian Theory; Libido; Narcissism; Object Attachment (+ 1); Oedipus Complex; Oral Character; Pleasure-Pain Principle; Psychosexual Development (+ 5); Superego; Unconscious (Psychology) Conceptual system developed by Freud and his followers in which unconscious motivations are considered to shape normal and abnormal personality development and behavior. CLDEHIPHRE &qzRaPsychoanalytic Interpretation F04.628 Disciplines, Tests, Therapy, Services (Non MeSH) Symbolism (Psychology) Utilization of Freudian theories to explain various psychologic aspects of art, literature, biographical material, etc. &tO" 9Psychoanalysis F04.096.544.779 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry A branch of science developed by Freud and his followers for the study of mental processes and behavior essentially utilizing free association to formulate the key concepts of unconscious motivation, conflict, and symbolism. &u}`Psychoacoustics F04.096.753.628; H01.671.031.503; H01.671.720.628 Acoustics Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychophysics Physical Sciences (Non MeSH); Physics; Acoustics Physical Sciences (Non MeSH); Physics; Psychophysics The science pertaining to the interrelationship of psychologic phenomena and the individual's response to the physical properties of sound. Acoustics (66-67); Auditory Perception (67) &wF9 5Psychiatry F04.096.544; G02.403.642; G02.403.790.600 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Health Occupations; Medicine Health Occupations; Medicine; Specialties, Other (Non MeSH) Adolescent Psychiatry; Biological Psychiatry; Child Psychiatry; Community Psychiatry (+ 2); Forensic Psychiatry (+ 4); Geriatric Psychiatry; Military Psychiatry; Orthopsychiatry; Psychiatric Nursing; Psychoanalysis; Psychosomatic Medicine Adolescent Psychiatry; Biological Psychiatry; Child Psychiatry; Community Psychiatry (+ 1); Forensic Psychiatry; Geriatric Psychiatry; Military Psychiatry Child Psychiatry The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders. CLECEDHIISLJMAMTOGPXSNSTTD  &yx1|Psychiatric Status Rating Scales F04.586 HISNST Disciplines, Tests, Therapy, Services (Non MeSH) Brief Psychiatric Rating Scale; Katz Adjustment Scales; Mental Status Schedule Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Psychological Tests (66-68)  &}*'  9]!Psychiatric Nursing F04.096.544.628; G02.478.676.710; N02.421.533.778 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care A specialty concerned with the application of psychiatric principles in caring for the mentally ill. It also includes the nursing care provided the mentally ill patient. &~9Psychiatric Department, Hospital N02.278.354.422.641; N04.452.442.422.641 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the organization and administration of psychiatric services. &=&. oPsychiatric Aides M01.526.485.067.652.628; N02.360.067.652.628 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Nurses' Aides Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Nurses' Aides Persons who assist in the routine care of psychiatric persons, usually under the supervision of the nursing department. Health Manpower (68-70); Psychiatry (68-70) &H2 5Psoriasis C17.800.859.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous Arthritis, Psoriatic A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. & Nn}Psoralens D03.438.150.446.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins Ficusin (+ 2) Coumarin derivatives found in many different plants, especially Psoralea corylifolia (Legume), used for skin diseases, especially vitiligo and as sunscreens; they interact with nucleic acids and are also used as research tools. Coumarins (66-78); Furans (66-78) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $&8 8d *:Psoas Muscles A02.633.567.825 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal A powerful flexor of the thigh at the hip joint (psoas major) and a weak flexor of the trunk and lumbar spinal column (psoas minor). Psoas is derived from the Greek "psoa", the plural meaning "muscles of the loin". It is a common site of infection manifesting as abscess (PSOAS ABSCESS). The psoas muscles and their fibers are also used frequently in experiments in muscle physiology. Muscles (68-91) &:;Psoas Abscess C01.539.830.025.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Abscess of the psoas muscle resulting usually from disease of the lumbar vertebrae, with the pus descending into the muscle sheath. The infection is most commonly tuberculous or staphylococcal. Abscess (68-91); Muscular Diseases (68-91) &GPY4Psittacines B02.248.710 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds Parakeets; Parrots Birds (66-67) &W&Psilocybine D03.438.473.914.700; D15.300.700; D15.700.372.828 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens The major of two hallucinogenic components of Teonanacatl, the sacred mushroom of Mexico, the other component being psilocin. (From Merck Index, 11th ed). &9DPseudoxanthoma Elasticum C16.131.831.766; C17.300.766; C17.800.827.800.766 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) A rare, progressive inherited disorder resulting from extensive basophilic degeneration of elastic tissue, usually presenting after puberty and involving the skin, eye, and cardiovascular system. Characteristic manifestations are small, circumscribed yellowish patches at sites of considerable movement of the skin, ANGIOID STREAKS in the retina, and a tendency towards hemorrhage and arterial insufficiency. &I9L[Pseudouridine D13.570.685.852.628; D13.570.800.892.628 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Uridine Uridine (66-71) &;.@Pseudotumor Cerebri C10.228.140.801 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Intracranial Pressure Nervous System Diseases; Central Nervous System Diseases; Brain Diseases A condition marked by raised intracranial pressure with headache, nausea, vomiting, and papilledema, but generally without neurological signs. There is no evidence of hydrocephalus or deformation of the ventricular system. Obesity is found in as many as 90% of the patients, predominantly women. While the incidence of pseudotumor cerebri in the general population is estimated at 1/100,000 persons, it is 19.3/100,000 in obese women between 20 and 44 years of age. &NV!Pseudorabies C02.256.466.793; C22.742 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Animal Diseases A highly contagious herpesvirus infection affecting the central nervous system of swine, cattle, dogs, cats, rats, and other animals. &JjPseudopseudohypoparathyroidism C05.116.198.709.628 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic; Pseudohypoparathyroidism An incomplete form of PSEUDOHYPOPARATHYROIDISM characterized by the same constitutional features (short stature, obesity, short metacarpals, and ectopic calcification) but by normal levels of calcium and phosphorus in the serum. (From Dorland, 27th ed). &"Ni%Pseudopregnancy C13.371.580; G08.520.870 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pregnancy Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Reproduction, Urogenital Physiology (Non MeSH); Reproduction False pregnancy. The term sometimes refers also to the premenstrual stage of the endometrium because it resembles the endometrium just before implantation of the blastocyst. (From Dorland, 27th ed). &L Pseudopodia A11.368.702.783 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Cilia; Flagella Temporary cytoplasmic extrusions in amebae or characteristically sarcodine protozoa which function in locomotion and/or in feeding by engulfing food. One or more may be formed at a time by a given cell. (From Dorland, 27th ed and Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Organoids (66-69)  &%*$pPseudomyxoma Peritonei C04.557.470.590.782 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Appendiceal Neoplasms; Ovarian Neoplasms Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Dictionary of Modern Medicine, 1992). Ascitic Fluid (68-86); Peritoneal Neoplasms (66-86)  &[N0>Pseudomonas putida B03.440.400.425.625.625.675 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae; Pseudomonas A species of gram-negative, aerobic bacteria isolated from soil and water as well as clinical specimens. Occasionally it is an opportunistic pathogen. Pseudomonas (66-91) &"Pseudomonas pseudomallei B03.440.400.425.625.625.650 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae; Pseudomonas A species of gram-negative, aerobic bacteria that causes MELIOIDOSIS. It has been isolated from soil and water in tropical regions, particularly Southeast Asia. Pseudomonas (67-91) &"Pseudomonas Phages B04.123.660 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Bacteriophage phi 6 Viruses whose host is Pseudomonas. A frequently encountered Pseudomonas phage is BACTERIOPHAGE PHI 6. Bacteriophages (66-92)  &xPseudomonas Infections C01.252.400.739 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Glanders; Melioidosis Infections with bacteria of the genus PSEUDOMONAS. &<Ps=Pseudomonas fluorescens B03.440.400.425.625.625.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae; Pseudomonas A species of nonpathogenic fluorescent bacteria found in feces, sewage, soil, and water, and which liquefy gelatin. Pseudomonas (66-71) &"Pseudomonas cepacia B03.440.400.425.625.625.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae; Pseudomonas A species of PSEUDOMONAS considered to be an opportunistic human pathogen. It has been associated with various types of infections of nosocomial origin. Pseudomonas (71-91) &x"Pseudomonas aeruginosa B03.440.400.425.625.625.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae; Pseudomonas A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. &l"*Pseudomonas B03.440.400.425.625.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Pseudomonadaceae Pseudomonas aeruginosa; Pseudomonas cepacia; Pseudomonas fluorescens; Pseudomonas pseudomallei; Pseudomonas putida A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants. &"Pseudomonadaceae B03.440.400.425.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Pseudomonas (+ 5); Xanthomonas (+ 1); Zoogloea A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens. Bacteria (66-74)  &"<Pseudohypoparathyroidism C05.116.198.709; C18.452.174.766; C18.452.648.618.815 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors Pseudopseudohypoparathyroidism A hereditary condition clinically resembling HYPOPARATHYROIDISM, but caused by failure of response to rather than deficiency of parathyroid hormones. It is characterized by hypocalcemia and hyperphosphatemia, and is commonly associated with short stature, obesity, short metacarpals, and ectopic calcification. (Dorland, 27th ed). &=NL${Pseudohypoaldosteronism C12.777.419.815.770; C18.452.648.851.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Aldosterone Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors A hereditary disorder characterized by salt wasting and growth retardation, presenting in infancy as high levels of urinary sodium despite hyponatremia, hyperkalemia, hyperreninemia, and elevated aldosterone levels. The mode of inheritance is probably autosomal dominant, affecting electrolyte secretion in the kidney tubule. Aldosterone (71-87); Hyperaldosteronism (75-80); Renal Tubular Transport, Inborn Errors (71-87)  &.N)tpPseudohermaphroditism C12.740.700.842.316.627; C13.371.820.700.842.316.627; C16.131.939.842.316.627; C19.391.775.316.627 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Hermaphroditism Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Hermaphroditism Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Hermaphroditism Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders; Hermaphroditism A condition in which the gonads are of one sex but one or more contradictions exist in the morphologic criteria of sex. Female pseudohermaphroditism is a form in which the affected individual is a genetic and gonadal female with partial masculinization. Male pseudohermaphroditism is a form in which the affected individual is a genetic and gonadal male with incomplete masculinization. (Dorland, 27th ed). Hermaphroditism (66-72) &slLPseudogenes G05.275.780 DEGEIMPHRE Genetics; Genes Genes bearing close resemblance to known genes at different loci, but rendered non-functional by additions or deletions in structure that prevent normal transcription or translation. When lacking introns and containing a poly-A segment near the downstream end (as a result of reverse copying from processed nuclear RNA into double-stranded DNA), they are called processed genes. Genes (75-87); Genes, Structural (75-87) & 2Pseudocowpox Virus B04.280.650.160.670.650; B04.909.204.783.160.670.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Parapoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Parapoxvirus A species of PARAPOXVIRUS causing a pox-like disease on udders of cows that may spread to milkers. &\:wPseudocholinesterase D08.586.277.352.100.170.710 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases; Cholinesterases An aspect of cholinesterases. &"D%Pseudarthrosis C21.866.405.341.627 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Fractures, Ununited A pathologic entity characterized by deossification of a weight-bearing long bone, followed by bending and pathologic fracture, with inability to form normal callus leading to existence of the "false joint" that gives the condition its name. (Dorland, 27th ed). &yNv2Pseudallescheria B05.354.107.780 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes Ascomycetous fungi, family Microascaceae, order Microascales, commonly found in the soil. They are causative agents of mycetoma, maduromycosis, and other infections in humans. Ascomycetes (66-85); Maduromycosis (66-85); Mycoses (66-85) &̻";HPrussian Blue Reaction E05.909.262.607.810; E05.909.262.620.670.660; E05.909.432.551.810; E05.909.432.600.670.660 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytochemistry Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Stains and Staining Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytochemistry Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Stains and Staining The reaction of potassium ferrocyanide with ferric iron to yield a dark blue precipitate at the sites of the ferric iron. Used to determine ferric iron in tissues, particularly in the diagnosis of disorders of iron metabolism. Dyes (66-78); Ferrocyanides (66-78) &yd, ,Pruritus Vulvae C13.371.944.626; C17.800.685.710 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vulvar Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pruritus Intense itching of the external female genitals. &Ҝ&N;Pruritus Ani C06.405.469.860.101.752; C17.800.685.544 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Anus Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pruritus Intense chronic itching in the anal area. &S.N4Pruritus C17.800.685 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antipruritics Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Pruritus Ani; Pruritus Vulvae An intense itching sensation that produces the urge to rub or scratch the skin to obtain relief.  & NK%uPrurigo C17.800.674 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A name applied to several itchy skin eruptions of unknown cause. The characteristic course is the formation of a dome-shaped papule with a small transient vesicle on top, followed by crusting over or lichenification. (From Dorland, 27th ed). &ב NKPrune Belly Syndrome C16.131.077.745 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple A syndrome characterized by abdominal wall musculature deficiency, cryptorchism, and urinary tract abnormalities. The syndrome derives its name from its characteristic distended abdomen with wrinkled skin. Abdominal Wall/AB (66-81); Abnormalities, Multiple (68-81); Cryptorchism (66-81); Urogenital System/AB (66-81) &مLePrPSc Proteins D12.776.785.700 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPOPYRESDSESTTOTUULUR Scrapie Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Prions PrP 27-30 Protein Abnormal isoform of prion proteins (PRIONS) resulting from a posttranslational modification of the cellular prion protein (PRPC PROTEINS). PrPSc are disease-specific proteins seen in certain human and animal neurodegenerative diseases (PRION DISEASES). Prions (92-94); Viral Proteins (89-91) $&D N#0PrPC Proteins D12.776.785.680 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPOPYRESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Prions Normal cellular isoform of prion proteins (PRIONS) encoded by a chromosomal gene and found in normal and scrapie-infected brain tissue, and other normal tissue. PrPC are protease-sensitive proteins whose function is unknown. Posttranslational modification of PrPC into PrPSC leads to infectivity. Prions (92-94) &VDNWPrP 27-30 Protein D12.776.785.700.700 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPOPYRESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Prions; PrPSc Proteins Protease-resistant core of PrPSC, the abnormal isoform of prion proteins (PRIONS). PrP 27-30 is produced by limited proteolysis of the N-terminus of PrPSc. Prions (92-94); Viral Proteins (85-91) &Da0Proxemics F01.145.875.709; I01.880.894.627 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Spatial Behavior Social Sciences; Sociology; Spatial Behavior Man's use of space as a specialized elaboration of culture. & &IProviruses B04.820.650.690; B04.909.574.807.690; B04.909.777.731.690 CHCLDEENGDGEIMIPMEPHPYREUL Mutagenesis, Insertional Virus Integration Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Duplex DNA sequences in a eukaryotic chromosome (corresponding to the genome of an RNA retrovirus) that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Oncogenic Viruses or specific (71-76); Retroviridae or specific (77-87) $&AbUProvidencia B03.440.450.425.670 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Gram-negative rods isolated from human urine and feces. &"nCProventriculus A13.853.710 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Stomach, Avian Birds (66-67); Poultry (66-67); Stomach (66-67) &:2<Protriptyline D04.615.181.384.650; D14.100.050.600.050.670; D14.100.600.050.670; D15.085.050.700; D15.700.122.055.792 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation. Dibenzocycloheptenes (69-74); Propylamines (69-74) &s:x;Protozoan Vaccines D24.310.894.582 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines Malaria Vaccines Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease. specific Protozoa (77-90); Vaccines (77-90)  &f>Y5Protozoan Proteins D12.776.820 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Proteins found in any species of protozoan. Proteins (66-89) &*DD6Protozoan Infections, Animal (Non MeSH) C03.701.688; C03.752.625; C22.674.710 Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections Animal Diseases; Parasitic Diseases, Animal (Non MeSH) Babesiosis; Cryptosporidiosis; Dourine; Theileriasis; Toxoplasmosis, Animal; Trypanosomiasis, Bovine Babesiosis; Cryptosporidiosis; Dourine; Theileriasis; Toxoplasmosis, Animal; Trypanosomiasis, Bovine Babesiosis; Cryptosporidiosis; Dourine; Theileriasis; Toxoplasmosis, Animal; Trypanosomiasis, Bovine BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI &J/-XJProtozoan Infections C03.752 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antiprotozoal Agents Parasitic Diseases Ciliophora Infections (+ 1); Microspora Infections (+ 1); Protozoan Infections, Animal (Non MeSH) (+ 6); Sarcomastigophora Infections (+ 23); Sporozoea Infections (+ 17); Tick-Borne Diseases (+ 2) Infections with unicellular organisms of the subkingdom PROTOZOA.  & PMProtozoa B01.841 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Antiprotozoal Agents Microbiology Invertebrates Apicomplexa (+ 30); Ciliophora (+ 18); Microspora (+ 6); Sarcomastigophora (+ 63) A subkingdom consisting of unicellular organisms that are the simplest in the animal kingdom. Most are free living. They range in size from submicroscopic to macroscopic. Protozoa are divided into seven phyla: SARCOMASTIGOPHORA, Labyrinthomorpha, APICOMPLEXA, MICROSPORA, Ascetospora, Myxozoa, and CILIOPHORA. $&$  &fdProtoveratrines D03.132.920.256.543; D03.549.256.543; D18.162.955.710 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Veratrum Alkaloids; Cevanes Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Cevanes Cardiovascular Agents; Antihypertensive Agents; Veratrum Alkaloids Mixtures of closely related hypotensive alkaloids from Veratrum album (Liliaceae). They are used as various salts in hypertension. &=:Prototheca B05.104.234.469.801 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae; Algae, Green; Chlorella An achlorophyllous mutant of the green alga Chlorella. It is found in decayed matter, water, sewage and soil and produces cutaneous and disseminated infections in various vertebrates including man. It infects the skin, lymph nodes, eye, myocardium, kidney, muscle, and bovine mammary gland. Algae (66-79); Algae, Green (70-79) &&JS-Protoporphyrins D11.557.727.725 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes. Porphyrins (68-74) & BTProtoplasts A11.789 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells & * Protons D01.248.497.300.459.700; D01.435.550; H01.671.579.404.765 AECLDUHITU Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Cations; Cations, Monovalent Inorganic Chemicals (Non MeSH); Hydrogen Physical Sciences (Non MeSH); Physics; Nuclear Physics; Elementary Particles Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion. &I AProton Pump D12.776.543.400.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR H(+)-Transporting ATP Synthase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Ion Pumps Integral membrane proteins that transport protons across a membrane against a concentration gradient. This transport is driven by hydrolysis of ATP by H(+)-transporting ATP synthase. H(+)-Transporting ATP Synthase (84-92)  'F&h/Protochlorophyllide D11.557.727.220.725; D11.557.727.640.220.725 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Chlorophyll Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Metalloporphyrins; Chlorophyll [3,4-Didehydro-9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoato(2)-N(23),N(24),N(25),N(26)]magnesium. A photo-active pigment localized in prolamellar bodies occurring within the proplastids of dark-grown bean leaves. In the process of photoconversion, the highly fluorescent protochlorophyllide is converted to chlorophyll. Chlorophyll (72-74); Porphyrins (72-74) '2D0Protocatechuate-3,4-Dioxygenase D08.586.682.690.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases An enzyme that catalyzes the oxidation of protocatechuate to 3-carboxy-cis-cis-muconate in the presence of molecular oxygen. It contains ferric ion. EC 1.13.11.3. Benzoates (72-74); Oxygenases (72-74) 'I#Ff.Proto-Oncogenes G05.275.740.791 DEGEIMPHRE Genetics; Genes; Oncogenes Genes, abl; Genes, erbA; Genes, erbB (+ 2); Genes, fms; Genes, fos; Genes, Intracisternal A-Particle; Genes, jun; Genes, mos; Genes, myc; Genes, ras; Genes, src Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Genes (66-77); Genes, Viral (78-82); Oncogenes (83-85)  'B"RDProto-Oncogene Proteins c-myc D12.776.260.760; D12.776.660.765; D12.776.818.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, myc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Cellular DNA-binding proteins encoded by the c-myc genes. They are normally involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Elevated and deregulated (constitutive) expression of c-myc proteins can cause tumorigenesis. Neoplasm Proteins (83-84); Phosphoproteins (85); Proto-Oncogene Proteins (86-90)  ' #9F1_Proto-Oncogene Proteins c-mos D12.776.818.649 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein-Serine-Threonine Kinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time. Proto-Oncogene Proteins (87-92)  '#F%`Y%Proto-Oncogene Proteins c-jun D12.776.260.755; D12.776.660.763; D12.776.818.647; D12.776.930.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription Factor AP-1 Genes, jun; Transcription Factor AP-1 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Cellular DNA-binding proteins encoded by the c-jun genes (GENES, JUN). They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization (with c-fos), DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun. DNA-Binding Proteins (87-91); Proto-Oncogene Proteins (87-91); Transcription Factors (87-91) $'H#LF.nwlProto-Oncogene Proteins c-fos D12.776.260.745; D12.776.660.760; D12.776.818.643; D12.776.930.640 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription Factor AP-1 Genes, fos; Transcription Factor AP-1 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes. Proto-Oncogene Proteins (85-91) $'#LF.n}%Proto-Oncogene Proteins c-erbB-2 D12.776.543.750.750.400.150; D12.776.818.642; D24.185.101.840.642 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, erbB-2 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Growth Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Cellular proteins in the epidermal growth factor receptor family encoded by the c-erbB genes. These proteins are overexpressed in a significant portion of adenocarcinomas found at various sites, especially in the breast. Gene amplification appears to be the predominant method leading to overexpression. Epidermal Growth Factor Receptor Protein-Tyrosine Kinase (94); Phosphoproteins (85); Proto-Oncogene Proteins (86-94)  ' &IF`Proto-Oncogene Proteins c-abl D12.776.818.640 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Fusion Proteins, bcr-abl Genes, abl Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Membrane proteins encoded by the c-abl genes. They exhibit tyrosine kinase activity and play a role in normal hematopoiesis especially of the myeloid lineage. Oncogenic transformation of c-abl arises when specific N-terminal amino acids are deleted, releasing the kinase from negative regulation. Proto-Oncogene Proteins (86-90); Neoplasm Proteins (83-85) $'n#F`XEProto-Oncogene Proteins D12.776.818 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Proto-Oncogene Protein p21(ras); Proto-Oncogene Protein pp60(c-src); Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-erbB-2; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-mos; Proto-Oncogene Proteins c-myc; Receptors, Macrophage Colony-Stimulating Factor; Receptors, Thyroid Hormone Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cell Differentiation (66-85); Gene Expression Regulation (81-85); Oncogenes (83-85); Proteins (66-85)  '!CFD|yProto-Oncogene Protein p21(ras) D12.776.543.350.730.750; D12.776.818.625 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, ras Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; G-Proteins; ras Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Cellular protein encoded by the c-ras genes. The protein has GTPase activity and is involved in transmembrane signal transduction as a guanine nucleotide binding protein. Elevated levels of p21 c-ras have been associated with neoplasia. Neoplasm Proteins (83-86); Proto-Oncogene Proteins (87-90)  '%&.FEProto-Oncogene Protein pp60(c-src) D12.776.818.630 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Proto-Oncogene Proteins Membrane-associated tyrosine-specific kinase encoded by the c-src genes. It has an important role in cellular growth control. Truncation of carboxy-terminal residues in pp60(c-src) leads to pp60(v-src) which has the ability to transform cells. Phosphoproteins (83-85); Proto-Oncogene Proteins (86-90) '( )F`BProtirelin D06.472.709.640; D12.644.456.745; D12.776.641.650.702; D14.600.600.650 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Thyrotropin-Releasing Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides 5-Oxo-L-prolyl-L-histidyl-L-prolinamide. A tripeptide hormone that originates in the hypothalamus and stimulates the secretion of thyrotropin from the pituitary gland. In humans, it also acts as a prolactin-releasing factor. It is also a neurotransmitter in the central nervous system. Hypothalamo-Hypophyseal System/physiology (66-67); Thyrotropin/biosynthesis (66-67); Thyrotropin/metabolism (66-67)  '*rPF.JProthrombin Time E01.223.459.153.627 VE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Coagulation Tests Measurement of clotting time of plasma recalcified in the presence of excess tissue thromboplastin. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X. It is used for monitoring anticoagulant therapy with coumarins. '.ZProthrombin D08.444.709; D12.776.124.125.800; D19.461.270.229.740; D19.461.270.792 AAADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. '0PD Prothionamide D03.066.349.570; D03.383.725.394.675; D20.338.722 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Isonicotinic Acids Anti-Infective Agents; Antitubercular Agents 2-Propylthioisonicotinamide. Antitubercular agent similar in action and side effects to ethionamide; used mostly in combination with other agents. Synonyms: Ektebin; Protiomide; Trevintix. Isonicotinic Acids (70-74); Sulfides (72-74) '4+9:6Proteus vulgaris B03.440.450.425.600.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Proteus A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis. Proteus (66-71) '6"yProteus Syndrome C04.651.750; C05.116.099.750; C05.660.585.620; C16.131.077.740; C16.131.445.620; C16.131.621.585.620 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms, Multiple Primary Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Hamartoma Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Hamartoneoplastic malformation syndrome of uncertain etiology characterized by partial gigantism of the hands and/or feet, asymmetry of the limbs, plantar hyperplasia, hemangiomas, lipomas, lymphangiomas, epidermal nevi, macrocephaly, cranial hyperostoses, and long-bone overgrowth. Joseph Merrick, the so-called "elephant man", apparently suffered from Proteus syndrome and not neurofibromatosis, a disorder with similar characteristics. Abnormalities, Multiple (79-91); Neoplasms, Multiple Primary (86-91); Neurofibromatosis 1 (79-90) '8rLTrProteus mirabilis B03.440.450.425.600.501 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Proteus A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract. Proteus (66-71) '>n"yProteus Infections C01.252.400.310.708 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Infections with bacteria of the genus PROTEUS. '@HP9Proteus B03.440.450.425.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Proteus mirabilis; Proteus vulgaris A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body. 'A "n+Proteolipids D10.516.730; D12.776.816 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipoproteins Lipoproteins Lipids and Antilipemic Agents (Non MeSH); Lipids Amino Acids, Peptides and Proteins (Non MeSH); Proteins Protein-lipid combinations abundant in brain tissue, but also present in a wide variety of animal and plant tissues. In contrast to lipoproteins, they are insoluble in water, but soluble in a chloroform-methanol mixture. The protein moiety has a high content of hydrophobic amino acids. The associated lipids consist of a mixture of phosphoglycerides, cerebrosides, and sulfatides, while lipoproteins contain phospholipids, cholesterol, and triglycerides. specific lipoprotein(66-76); Lipoproteins (66-76) $'DOD~ ;Proteoglycans D09.203.698.735; D12.776.395.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Platelet Factor 4; Proteochondroitin Sulfates Platelet Factor 4; Proteochondroitin Sulfates Glycoproteins which have a very high polysaccharide content. Mucopolysaccharides (66-74)  'G&FjH Proteochondroitin Sulfates D09.203.698.735.830; D12.776.395.650.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Proteoglycans Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Proteoglycans Proteoglycans found in cartilage. They consist of several chondroitin sulfate molecules linked to protein(s) by neutral sugar linkage regions. Chondroitin (73-74); Mucoproteins (73-74) 'J.F2Proteinuria C12.777.584 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Albuminuria 'LgN NProteins D12.776 ADAEAGAIANBICHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUL Amino Acid Sequence; Blood Proteins; Protein Conformation Amino Acids, Peptides and Proteins (Non MeSH) Albumins (+ 13); Apoproteins (+ 8); Bacterial Proteins (+ 20); Blood Proteins (+ 224); Carrier Proteins (+ 41); Cerebrospinal Fluid Proteins; Colipases; Contractile Proteins (+ 15); Cytoskeletal Proteins (+ 24); Dental Enamel Proteins; Dietary Proteins (+ 13); DNA-Binding Proteins (+ 28); Dynein ATPase; Egg Proteins (+ 7); Eye Proteins (+ 3); Fetal Proteins (+ 1); Flavoproteins (+ 1); Fungal Proteins; Globulins (+ 64); Glycoproteins (+ 66); Heat-Shock Proteins (+ 7); Helminth Proteins; Hemeproteins (+ 30); Immediate-Early Proteins (+ 3); Interferons (+ 8); Iodoproteins (+ 1); Lectins; Lipoproteins (+ 13); Luminescent Proteins (+ 2); Membrane Proteins (+ 274); Metalloproteins (+ 16); Molecular Chaperones (+ 7); Neoplasm Proteins (+ 3); Nerve Tissue Proteins (+ 78); Nuclear Proteins (+ 18); Nucleoproteins (+ 18); Oncogene Proteins (+ 27); Oxidative Phosphorylation Coupling Factors; Peptones; Phosphoproteins (+ 6); Plant Proteins (+ 18); Pregnancy Proteins (+ 7); Prions (+ 3); Protein Hydrolysates; Protein Precursors (+ 12); Protein Synthesis Inhibitors; Proteolipids; Proto-Oncogene Proteins (+ 10); Protozoan Proteins; Receptors, Cytoplasmic and Nuclear (+ 12); Receptors, Drug (+ 1); Recombinant Proteins (+ 10); Ribosomal Proteins (+ 6); Salivary Proteins (+ 1); Scleroproteins (Non MeSH) (+ 12); Silver Proteins; Thioredoxin; Thymosin; Transcription Factors (+ 29); Trypsin Inhibitors (+ 4); Viral Proteins (+ 86) Nitrogenous organic compounds, containing more than about 100 amino acid residues, molecular weight 8,000-200,000, in vegetable and animal matter. Proteins yield amino acids on hydrolysis and are foods assimilated as amino acids and reconstructed in the protoplasm. (Grant and Hackh's Chemical Dictionary, 5th ed). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEMIPAPDPHPKPOPSPYRARERISDSESTTOTRTUULURUSVI $'M`  >E7m\Protein-Tyrosine-Phosphatase D08.586.277.352.650.625.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases; Phosphoprotein Phosphatase An enzyme group that specifically dephosphorylates phosphotyrosyl residues in selected proteins. Together with PROTEIN-TYROSINE KINASE, it regulates tyrosine phosphorylation and dephosphorylation in cellular signal transduction and may play a role in cell growth control and carcinogenesis. EC 3.1.3.48. Phosphoprotein Phosphatases (85-91) 'V F[)Protein-Tyrosine Kinase D08.586.913.696.620.682.725 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Oncogene Protein pp60(v-src) Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases Receptor Protein-Tyrosine Kinase (+ 2) An enzyme that catalyzes the phosphorylation of tyrosine residues in proteins with ATP or other nucleotides as phosphate donors. EC 2.7.1.112. Phosphotransferases (66-72); Protein Kinases (73-85) $'YF#.>Protein-Serine-Threonine Kinases D08.586.913.696.620.682.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Proto-Oncogene Proteins c-mos Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases Calmodulin-Dependent Protein Kinases (+ 1); Cyclic Nucleotide-Regulated Protein Kinases (Non MeSH) (+ 3); Cyclin-Dependent Kinases (+ 3); Protein Kinase C A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. EC 2.7.10. Protein Kinases (83-92) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ('\d%F#HProtein-Lysine 6-Oxidase D08.586.682.135.848 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases An enzyme oxidizing peptidyl-lysyl-peptide in the presence of water and molecular oxygen to yield peptidyl-allysyl-peptide plus ammonia and hydrogen peroxide. EC 1.4.3.13. Amino Acid Oxidoreductases (72-74); Lysine (72-74) '_Fx=Protein-Losing Enteropathies C06.405.469.818; C18.452.805 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypoproteinemia Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Lymphangiectasis, Intestinal Lymphangiectasis, Intestinal A series of gastrointestinal disorders which share in common the excessive loss of protein, mainly albumin, across the gut wall. They occur in the stomach (Menetrier disease), as well as the small bowel (intestinal lymphangiectases, assorted inflammatory states). They are also occasionally associated with congestive heart failure (again a small bowel protein loss).  'a!"N@Protein-Glutamine gamma-Glutamyltransferase D08.586.913.050.825; D12.776.124.125.475.825; D19.461.270.229.379.825 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor XIII Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor XIII An enzyme that catalyzes the reaction of protein glutamine and an alkylamine to yield protein N(5)-alkylglutamine and ammonia. The gamma-carboxamide groups of peptide-bound glutamine residues act as acyl donors, and the 6-amino groups of protein- and peptide-bound lysine residues act as acceptors, to give intra- and inter-molecular N(6)-(5-glutamyl)lysine crosslinks. In the epidermis these cross-linked proteins are involved in the formation of the cornified envelope of the stratum corneum cells. In the plasma, the transglutaminase is called factor XIIIa, the activated form of factor XIII. The crosslinking results in the stabilization of the fibrin clot. EC 2.3.2.13. Acyltransferases (66-85) 'eK0MDProtein-Energy Malnutrition C18.654.223.708.626 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Protein Deficiency Kwashiorkor The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses. Infant Nutrition Disorders (66-71); Nutrition Disorders (66-71)  'j N~ KProtein-Bound Iodine Test E01.197.882.709; E01.223.174.229.802; E01.289.438 AECLCTECHIISMOMTNUPXSNSTTDUTVE Thyroxine-Binding Proteins Diagnosis; Diagnosis, Endocrine (Non MeSH); Thyroid Function Tests Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Diagnosis; Diagnosis, Radioisotope 'm9"Protein Synthesis Inhibitors D08.373.760; D12.776.814 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Peptide Chain Elongation; Peptide Chain Initiation Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins Compounds which inhibit the synthesis of proteins. They are usually antibiotics or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Proteins/biosynthesis (66-87)  'o"6<#Protein Structure, Tertiary G06.184.580.709.610; G06.184.815.610; H01.181.529.559.709.610; H01.181.529.570.575.610 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Conformation; Protein Conformation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Protein Structure (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Conformation; Protein Conformation Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Structure; Protein Structure (Non MeSH) The stage in the structural development of a protein in which combinations of alpha helices and beta sheets pack together to form compactly folded globular units named domains. Small proteins consist of only one domain but larger proteins contain a number of domains which are usually connected by open lengths of polypeptide chain. This stage is a combination of the second and third folding levels of protein building. Protein Conformation (72-92); Proteins (66-71) 'r=!`$8Protein Structure, Secondary G06.184.580.709.600; G06.184.815.600; H01.181.529.559.709.600; H01.181.529.570.575.600 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Conformation; Protein Conformation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Protein Structure (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Conformation; Protein Conformation Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Structure; Protein Structure (Non MeSH) The stage in the development of protein structure in which regular hydrogen-bond interactions within contiguous stretches of polypeptide chain give rise to alpha helices and beta sheets. This is the first folding level of protein building. Protein Conformation (72-92); Proteins (66-71) 'w7"`$8Protein Structure (Non MeSH) G06.184.815; H01.181.529.570.575 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Structure Amino Acid Sequence; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary Amino Acid Sequence; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary The amino acids and their manner of arrangement in constituting a protein. The four stages of protein structuring are primary (PROTEIN STRUCTURE, PRIMARY see AMINO ACID SEQUENCE), secondary (PROTEIN STRUCTURE, SECONDARY), tertiary (PROTEIN STRUCTURE, TERTIARY), and quaternary (PROTEIN STRUCTURE, QUATERNARY see PROTEIN CONFORMATION). DEGEIMPHRE '{\#&Protein S Deficiency C15.378.147.890 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders An autosomal dominant disorder showing decreased levels of plasma protein S antigen or activity, associated with venous thrombosis and pulmonary embolism. PROTEIN S is a vitamin K-dependent plasma protein that inhibits blood clotting by serving as a cofactor for activated PROTEIN C (also a vitamin K-dependent protein), and the clinical manifestations of its deficiency are virtually identical to those of protein C deficiency. Treatment with heparin for acute thrombotic processes is usually followed by maintenance administration of coumarin drugs for the prevention of recurrent thrombosis. (From Harrison's Principles of Internal Medicine, 12th ed, p. 1511; Wintrobe's Clinical Hematology, 9th ed, p. 1523). Glycoproteins/deficiency (84-92); Protein S/deficiency (93-94) ' Ng8JProtein S D12.776.124.670; D12.776.395.642; D19.461.119.800 AAADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants The vitamin K-dependent cofactor of activated PROTEIN C. Together with protein C, it inhibits the action of factors VIIIa and Va. A deficiency in protein S (PROTEIN S DEFICIENCY) can lead to recurrent venous and arterial thrombosis. Glycoproteins (80-92); Vitamin K (79-80) '9D2Protein p53 D12.776.260.720; D12.776.660.755; D12.776.744.740 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, p53 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Phosphoproteins Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control cell proliferation. A mutant or absent p53 protein has been found in leukemia, osteosarcoma, lung cancer, and colorectal cancer. Neoplasm Proteins (81-89); Oncogene Products (90); Phosphoproteins (81-90)  '9F YProtein p34cdc2 D08.586.913.696.620.682.700.200.675; D11.303.580.675; D12.776.260.150.200.580.675; D12.776.744.735; D24.185.348.580.675 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Cyclin-Dependent Kinases Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Maturation-Promoting Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases; Maturation-Promoting Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Phosphoproteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Maturation-Promoting Factor Phosphoprotein with protein kinase activity that functions in the G2/M phase transition of the cell cycle. It is the catalytic subunit of the MATURATION-PROMOTING FACTOR and complexes with both cyclin A and cyclin B in mammalian cells. The maximal activity of p34cdc2 is achieved when it is fully dephosphorylated. Protein p34cdc2, the product of the cdc2 gene in Schizosaccharomyces pombe, should not be confused with the unrelated product of the CDC2 gene in Saccharomyces cerevisiae that forms the large subunit of DNA polymerase III. Phosphoproteins (87-90) 'HuProtein Processing, Post-Translational G05.331.370.380.791 DEGEIMPHRE Glycosylation Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Protein Isoprenylation Any of various enzymically catalyzed post-translational modifications of peptides or proteins in the cell of origin. These modifications include carboxylation, hydroxylation, acetylation, phosphorylation, methylation, glycosylation, oxidation-reduction, degradation and lysis, peptide bond formation, and changes in molecular weight and electrophoretic motility. Translation, Genetic (73-82) $'U,Z"Protein Precursors D12.776.811 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzyme Precursors Amino Acids, Peptides and Proteins (Non MeSH); Proteins Amyloid beta-Protein Precursor; Angiotensinogen; Fibrinogen (+ 3); Kininogens; Procollagen; Proinsulin (+ 1); Pro-Opiomelanocortin; Tropoelastin specific protein (66-70); Proteins (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $'FD4HProtein O-Methyltransferase D08.586.913.517.610.640 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases; Protein Methyltransferases An enzyme that catalyzes the transfer of methyl groups from S-adenosylmethionine to free carboxyl groups of a protein molecule forming methyl esters. EC 2.1.1.24. Methyltransferases (71-76); Proteins (66-76); S-Adenosylmethionine (71-76) '/ FWProtein Methyltransferases D08.586.913.517.610 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases Histone-Lysine Methyltransferase; Protein Arginine Methyltransferase; Protein O-Methyltransferase Enzymes which catalyze the methylation of amino acids after their incorporation into a polypeptide chain. S-Adenosyl-L-methionine acts as the methylating agent. EC 2.1.1. S-Adenosylmethionine (71-76); Methyltransferases (71-76); Proteins (66-76); specific protein  'wFkmmProtein Kinases D08.586.913.696.620.682 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cell Cycle Proteins Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) Phosphorylase Kinase; Protein-Serine-Threonine Kinases (+ 11); Protein-Tyrosine Kinase (+ 3) A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. EC 2.7.1.37. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $'*FlHProtein Kinase C D08.586.913.696.620.682.700.725 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases An enzyme that phosphorylates proteins on serine or threonine residues in the presence of physiological concentrations of calcium and membrane phospholipids. The additional presence of diacylglycerols markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by phorbol esters and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. EC 2.7.1.-. Protein Kinases (73-85) '#F Protein Isoprenylation G05.331.370.380.791.600 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; Protein Processing, Post-Translational A post-translational modification of proteins by the attachment of an isoprenoid to the C-terminal cysteine residue. The isoprenoids used, farnesyl diphosphate or geranylgeranyl diphosphate, are derived from the same biochemical pathway that produces cholesterol. Protein Processing, Post-Translational (87-92) 'j.5Protein Hydrolysates D12.776.796 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Parenteral Nutrition, Total Amino Acids, Peptides and Proteins (Non MeSH); Proteins 'B!DProtein Hybridization G06.184.800 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) The formation of a protein consisting of two or more polypeptide chains from separate and different polypeptide chains. 'hProtein Folding G06.184.797 Protein Conformation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) A rapid biochemical reaction involved in the formation of proteins. It begins even before a protein has been completely synthesized and proceeds through discrete intermediates (primary, secondary, and tertiary structures) before the final structure (quaternary structure) is developed. Protein Conformation (71-92) 'hH"Protein Engineering E05.393.420.601 AECLCTECHIISMOMTNUPXSNSTTDUTVE Genetic Engineering Miscellaneous Techniques (Non MeSH); Genetic Techniques; Genetic Engineering Mutagenesis, Insertional; Mutagenesis, Site-Directed Procedures by which nonrandom single-site changes are introduced into structural genes (site-specific mutagenesis) in order to produce mutant genes which can be coupled to promoters that direct the synthesis of a specifically altered protein, which is then analyzed for structural and functional properties and then compared with the predicted and sought-after properties. The design of the protein may be assisted by computer graphic technology and other advanced molecular modeling techniques. Genes, Structural (83-88); Genetic Intervention (83-88); Mutation (83-88) AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE ('4"Z<:X,Protein Disulfide Reductase (Glutathione) D08.586.682.790 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme that catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. EC 1.8.4.2. Glutathione (72-74); Glutathione Reductase (74); Insulin (72-74); Oxidoreductases (72-74) ' 0FXkProtein Denaturation G06.184.794 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) 'XhProtein Deficiency C18.654.223.708 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dietary Proteins Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases Protein-Energy Malnutrition (+ 1) A nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization). (From Merck Manual, 16th ed, p. 957; Harrison's Principles of Internal Medicine, 12th ed, p. 406).  'Ng(<Protein Conformation G06.184.580.709; G06.184.815.550; H01.181.529.559.709; H01.181.529.570.575.550 DERE Protein Folding; Proteins Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Conformation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Protein Structure (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Conformation Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Structure; Protein Structure (Non MeSH) Protein Structure, Secondary; Protein Structure, Tertiary Protein Structure, Secondary; Protein Structure, Tertiary The characteristic 3-dimensional shape of a protein, imposed upon it by the secondary and tertiary structure of the peptide chain. This stage in the structure of a protein describes the highest level of organization in overall structure assumed by multimeric proteins (aggregates of more than one polypeptide chain). This is the fourth folding level of protein building. Proteins (66-71) $'X Protein C Inhibitor D08.373.745.800.810.737.625 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins; Plasminogen Inactivators A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and able to inhibit activated protein C, thrombin, kallikrein, and other serine proteinases. Blood Proteins (81-93); Plasminogen Inactivators (90-93) '@CProtein C D08.444.705; D12.776.124.650; D12.776.395.635; D19.461.119.780 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants A vitamin-K dependent zymogen present in the blood, which, upon activation by thrombin and thrombomodulin exerts anticoagulant properties by inactivating factors Va and VIIIa at the rate-limiting steps of thrombin formation. Its congenital deficiency is responsible for thrombotic diathesis. Acquired protein C deficiencies also have been found, e.g., low plasma levels of protein C have been found in certain liver and renal diseases. The deficiency of protein C can be treated by anticoagulants such as coumarin or heparin. Blood Proteins (66-86); Glycoproteins (66-86) 'HFdb7Protein Binding G06.184.775; G06.535.630.800 DEGEIMPHRE Binding Sites; Carrier Proteins; Metalloproteins; Radioligand Assay; Thyroxine-Binding Proteins Blood Proteins; Binding Sites Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.  '"o%Protein Arginine Methyltransferase D08.586.913.517.610.620 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases; Protein Methyltransferases An enzyme that catalyzes the methylation of arginine residues of proteins to yield N-mono- and N,N-dimethylarginine. This enzyme is found in many organs, primarily brain and spleen. EC 2.1.1.23. Arginine (66-76); Methyltransferases (71-76); Proteins (66-76); specific protein '(FaProteidae B02.090.608.630 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela Necturus (+ 1) The Proteidae family of permanently larval aquatic salamanders. It consists of two living genera - Necturus (mudpuppy) of the eastern United States and Proteus (the European olm). 'A &&Protective Devices E07.712 AECLCTECHISDSNSTTDUTVE Sports Medicine; Accident Prevention; Occupational Medicine; Restraint, Physical Equipment and Supplies Air Bags; Condoms; Ear Protective Devices; Eye Protective Devices; Head Protective Devices; Masks (+ 1); Mouth Protectors; Protective Clothing (+ 2); Respiratory Protective Devices; Seat Belts Devices designed to provide personal protection against injury to individuals exposed to hazards in industry, sports, aviation, or daily activities. Accident Prevention (66-69); Athletic Injuries (68-69); Aerospace Medicine (66-69); Clothing (66-69); Occupational Medicine (66-69) AECLCTECHILJSDSNSTTDUTVE ('Ż ^Protective Clothing E07.712.580; J01.193.542 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices Technology, Industry, Agriculture (Non MeSH); Clothing Gloves, Protective (+ 1) Gloves, Protective (+ 1) Clothing designed to protect the individual against known hazards to which he will be exposed. Clothing (66-69)  'r<qProtease Inhibitors D08.373.745 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Amino Acid Chloromethyl Ketones (+ 2); Angiotensin-Converting Enzyme Inhibitors (+ 10); Antipain; Cilastatin; Cysteine Proteinase Inhibitors (+ 2); Hirudin; HIV Protease Inhibitors; Isoflurophate; Leupeptins; Pepstatins; Phenylmethylsulfonyl Fluoride; Serine Proteinase Inhibitors (+ 23); Thiorphan Compounds which inhibit or antagonize biosynthesis or actions of proteases. Peptide Hydrolases/antagonists and inhibitors (68-78); Peptide Peptidohydrolases/antagonists and inhibitors (68-78) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $'ʟ6P^YHProtamines D12.776.660.750; D12.776.664.750; D19.461.270.546.500 ADAEAGAIANBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Heparin Antagonists Clupeine; Salmine Clupeine; Salmine AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR '=@--DProtamine Kinase D08.586.913.696.620.682.700.150.575 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Cyclic Nucleotide-Regulated Protein Kinases (Non MeSH) An aspect of protein kinase (EC 2.7.1.37) in which serine residues in protamines and histones are phosphorylated in the presence of ATP. EC 2.7.1.70. Histones (74); Protein Kinases (74) 'N'F-Protactinium D01.268.271.545.725; D01.552.517.778 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Protactinium. A radioactive element of the actinide group of metals. It has the atomic symbol Pa, atomic number 91, and atomic weight 231. It decays by alpha-emission. '*4Prostitution F01.145.792.790; I01.880.735.679 EHHILJPXSN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Social Sciences; Sociology; Social Problems The practice of indulging in promiscuous sexual relations for money. '&RProsthodontics E06.780; G02.163.876.708 CLECEDHIISLJMAMTOGSNSTTD Surgery, Oral, Preprosthetic Prosthesis Dentistry Health Occupations; Dentistry; Specialties, Dental Dental Casting Technique; Dental Implantation (+ 5); Dental Prosthesis (+ 28); Mandibular Prosthesis; Maxillofacial Prosthesis; Palatal Obturators; Tissue Conditioning (Dental) A dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing teeth and structures by artificial devices or prostheses. AECLCTECEDHIISLJMAMIMOMTNUOGPSPXRHSDSNSTTDUTVEVI ('8"G4Prosthesis-Related Infections C01.539.685; C23.814.761 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Biofilms Biofilms Bacterial and Fungal Diseases (Non MeSH); Infection Symptoms and General Pathology (Non MeSH); Postoperative Complications Infections resulting from the implantation of prosthetic devices. The infections may be acquired from intraoperative contamination (early) or hematogenously acquired from other sites (late). Infection (66-91); specific prosthesis/adverse effects (66-91) $'"P  JProsthesis Fitting E04.659.912 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Prosthesis The fitting and adjusting of artificial parts of the body. (From Stedman's, 25th ed). 'ۆ$%iProsthesis Failure C23.814.760; E05.325.771 ECVE Symptoms and General Pathology (Non MeSH); Postoperative Complications Miscellaneous Techniques (Non MeSH); Equipment Failure Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking. Postoperative Complications (66-85); Prosthesis Design (71-85) '܁tIProsthesis Design E04.659.825 AECLCTECHIMONUPXRHSNSTTDUTVE Denture Design Equipment Design Surgery, Operative; Prosthesis Prosthesis Coloring Prosthesis (66-70); specific prosthesis AECLCTECHIISMOMTNUPXRHSNSTTDUTVE ('4 %0$Prosthesis Coloring E04.659.825.600 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Prosthesis; Prosthesis Design Coloring, shading, or tinting of prosthetic components, devices, and materials. specific prosthesis (66-93); Color (66-93) 'e$;]4Prosthesis E04.659; E07.858.565 AECLCTECHIMIMONUPSPXRHSNSTTDUTVEVI Prosthodontics Surgery, Operative Equipment and Supplies; Surgical Equipment Artificial Limbs; Bioprosthesis; Blood Vessel Prosthesis; Cochlear Implant; Eye, Artificial; Heart Valve Prosthesis; Joint Prosthesis (+ 2); Larynx, Artificial; Lenses, Intraocular; Mandibular Prosthesis; Maxillofacial Prosthesis; Ossicular Replacement Prosthesis; Penile Prosthesis; Prosthesis Design (+ 1); Prosthesis Fitting Artificial Limbs; Bioprosthesis; Blood Vessel Prosthesis; Cochlear Implant; Eye, Artificial; Heart, Artificial; Heart Valve Prosthesis; Joint Prosthesis (+ 2); Larynx, Artificial; Lenses, Intraocular; Mandibular Prosthesis; Maxillofacial Prosthesis; Ossicular Replacement Prosthesis; Penile Prosthesis An artificial substitute for a missing body part, such as an arm or leg, eye or tooth, used for functional or cosmetic reasons, or both. (Dorland, 27th ed). AECLCTECHIISMIMOMTNUPSPXRHSDSNSTTDUTVEVI $'&H,Prostatitis C12.294.565.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Prostatic Diseases Inflammation of the prostate. (Dorland, 27th ed). 'BNk>Prostatic Neoplasms C04.588.945.440.770; C12.294.260.750; C12.294.565.625; C12.740.800.410.650 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Male Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Genital Neoplasms, Male Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Prostatic Diseases Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Male '~TXProstatic Hypertrophy C12.294.565.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Prostatic Diseases Enlargement or overgrowth of the prostate gland as a result of an increase in the size of its constituent cells. '%NkProstatic Diseases C12.294.565 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Prostatic Hypertrophy; Prostatic Neoplasms; Prostatitis BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI 'NTAXProstatectomy E04.887.774.692.625 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Prostate Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Surgery, Urologic, Male (Non MeSH) Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; transurethral - resection using a cystoscope passed through the urethra. '>$ Prostate-Specific Antigen D08.586.277.656.732.760.710; D24.185.101.840.625; D24.611.216.285.625 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm Kallikrein-like serine proteinase produced by epithelial cells of both benign and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Antigens, Neoplasm (82-92) 'M6 Prostate A05.360.444.575; A10.336.707 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Prostatectomy Urogenital System; Genitalia; Genitalia, Male Tissue Types (Non MeSH); Exocrine Glands A gland in the male which surrounds the neck of the bladder and the urethra. It consists of a median lobe and two lateral lobes, and is made up partly of glandular matter, the ducts from which empty into the prostatic portion of the urethra, and partly of muscular fibers which encircle the urethra. The prostate contributes to the seminal fluid a secretion containing acid phosphatase, citric acid, and proteolytic enzymes which account for the liquefaction of the coagulated semen. (From Dorland, 27th ed). ' ":hXProstanoic Acids D02.241.081.407.700; D10.516.251.740 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids 2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins. Cyclopentanes (71-74); Fatty Acids (71-74); Prostaglandins (71-74) '{*BPProstaglandins, Synthetic D02.241.081.436.687.700; D10.516.251.355.708.700; D17.350.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators Iloprost; Prostaglandin Endoperoxides, Synthetic; Prostaglandins A, Synthetic; Prostaglandins E, Synthetic (+ 5); Prostaglandins F, Synthetic (+ 2) Iloprost; Prostaglandin Endoperoxides, Synthetic; Prostaglandins A, Synthetic; Prostaglandins E, Synthetic (+ 5); Prostaglandins F, Synthetic (+ 2) Iloprost; Prostaglandin Endoperoxides, Synthetic; Prostaglandins A, Synthetic; Prostaglandins E, Synthetic (+ 5); Prostaglandins F, Synthetic (+ 2) Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity. Fatty Acids, Unsaturated (75-76); Prostaglandins (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $'E8C:Prostaglandins H D02.241.081.436.687.025.650; D10.516.251.355.708.025.650; D17.350.050.175.725.720.720 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandin Endoperoxides Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandin Endoperoxides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandin Endoperoxides A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2. Peroxides (66-77); Prostaglandins (66-77) '<]B 2Prostaglandins G D02.241.081.436.687.025.600; D10.516.251.355.708.025.600; D17.350.050.175.725.720.700 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandin Endoperoxides Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandin Endoperoxides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandin Endoperoxides A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2. Peroxides (66-77); Prostaglandins (66-77) (Q]B 2Prostaglandins F, Synthetic D02.241.081.436.687.700.500; D10.516.251.355.708.700.500; D17.350.700.670 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic Carboprost; Cloprostenol Carboprost; Cloprostenol Carboprost; Cloprostenol Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF. Prostaglandins F (75-77); Prostaglandins, Synthetic (77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $(a!Q8VC:Prostaglandins F D02.241.081.436.687.250; D10.516.251.355.708.400; D17.350.050.175.725.790 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins Dinoprost; 6-Ketoprostaglandin F1 alpha Dinoprost; 6-Ketoprostaglandin F1 alpha Dinoprost; 6-Ketoprostaglandin F1 alpha (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. Prostaglandins (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $( QBaDProstaglandins E, Synthetic D02.241.081.436.687.700.450; D10.516.251.355.708.700.450; D17.350.700.660 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic Arbaprostil; 16,16-Dimethylprostaglandin E2; Enprostil; Misoprostol; Rioprostil Arbaprostil; 16,16-Dimethylprostaglandin E2; Enprostil; Misoprostol; Rioprostil Arbaprostil; 16,16-Dimethylprostaglandin E2; Enprostil; Misoprostol; Rioprostil Analogs or derivatives of prostaglandins E that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGE. Prostaglandins E (75-77); Prostaglandins, Synthetic (77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $(q!Q8C:Prostaglandins E D02.241.081.436.687.150; D10.516.251.355.708.250; D17.350.050.175.725.780 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins Alprostadil; Dinoprostone Alprostadil; Dinoprostone Alprostadil; Dinoprostone (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. Prostaglandins (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $(nQBY|DProstaglandins D D02.241.081.436.687.100; D10.516.251.355.708.200; D17.350.050.175.725.770 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins Prostaglandin D2 Prostaglandin D2 Prostaglandin D2 Physiologically active prostaglandins found in many tissues and organs. They show pressor activity, are mediators of inflammation, and have potential antithrombotic effects. Prostaglandins (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $(&QB;DProstaglandins B D02.241.081.436.687.075; D10.516.251.355.708.150; D17.350.050.175.725.750 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins Physiologically active prostaglandins found in many tissues and organs. They are potent pressor substances and have many other physiological activities. Prostaglandins (66-77) ( QBProstaglandins A, Synthetic D02.241.081.436.687.700.350; D10.516.251.355.708.700.350; D17.350.700.645 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic Analogs or derivatives of prostaglandin A that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGA. Prostaglandins A (75-77); Prostaglandins, Synthetic (77) (!T!Q8CProstaglandins A D02.241.081.436.687.050; D10.516.251.355.708.100; D17.350.050.175.725.740 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins (13E,15S)-15-Hydroxy-9-oxoprosta-10,13-dien-1-oic acid (PGA(1)); (5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid (PGA(2)); (5Z,13E,15S,17Z)-15-hydroxy-9-oxoprosta-5,10,13,17-tetraen-1-oic acid (PGA(3)). A group of naturally occurring secondary prostaglandins derived from PGE. PGA(1) and PGA(2) as well as their 19-hydroxy derivatives are found in many organs and tissues. Prostaglandins (66-74) ($QBProstaglandins D02.241.081.436.213.100.650; D02.241.081.436.687; D10.516.251.355.255.100.650; D10.516.251.355.708; D17.350.050.175.725 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Prostaglandin Antagonists; Receptors, Prostaglandin Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids Epoprostenol Epoprostenol; Prostaglandin Endoperoxides (+ 2); Prostaglandins A; Prostaglandins B; Prostaglandins D (+ 1); Prostaglandins E (+ 2); Prostaglandins F (+ 2); Prostaglandins, Synthetic (+ 12) Epoprostenol Epoprostenol; Prostaglandin Endoperoxides (+ 2); Prostaglandins A; Prostaglandins B; Prostaglandins D (+ 1); Prostaglandins E (+ 2); Prostaglandins F (+ 2); Prostaglandins, Synthetic (+ 12) Epoprostenol; Prostaglandin Endoperoxides (+ 2); Prostaglandins A; Prostaglandins B; Prostaglandins D (+ 1); Prostaglandins E (+ 2); Prostaglandins F (+ 2) A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $()L@;DProstaglandin-Endoperoxide Synthase D08.586.600.720; D08.586.682.420.715 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases An enzyme complex that catalyzes the formation of prostaglandins from the appropriate unsaturated fatty acid, molecular oxygen, and a reduced acceptor. EC 1.14.99.1. Hydroxylases (74-77); Multienzyme Complexes (73-74); Oxygenases (71-73); Prostaglandins (71-74) (0(*DqProstaglandin Endoperoxides, Synthetic D02.241.081.436.687.700.250; D10.516.251.355.708.700.250; D17.350.700.630 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic Synthetic compounds that are analogs of the naturally occurring prostaglandin endoperoxides and that mimic their pharmacologic and physiologic activities. They are usually more stable than the naturally occurring compounds. Ethers, Cyclic (66-77); Peroxides (66-77); Prostaglandins (66-76); Prostaglandins, Synthetic (77) (3,Q8tProstaglandin Endoperoxides D02.241.081.436.687.025; D10.516.251.355.708.025; D17.350.050.175.725.720 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins Prostaglandins G; Prostaglandins H Prostaglandins G; Prostaglandins H Prostaglandins G; Prostaglandins H Precursors in the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. They are physiologically active compounds, having effect on vascular and airway smooth muscles, platelet aggregation, etc. Peroxides (66-77); Prostaglandins (66-77)  (7 QBz2Prostaglandin D2 D02.241.081.436.687.100.200; D10.516.251.355.708.200.200; D17.350.050.175.725.770.720 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins D Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins D Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandins D 9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid. The principal cyclooxygenase metabolite of arachidonic acid. It is released upon activation of mast cells and is also synthesized by alveolar macrophages. Among its many biological actions, the most important are its bronchoconstrictor, platelet-activating-factor-inhibitory, and cytotoxic effects. Prostaglandins (66-77); Prostaglandins D (78-88) (<]D:Prostaglandin Antagonists D26.744 ADAEANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Cyclooxygenase Inhibitors Prostaglandins Miscellaneous Drugs and Agents (Non MeSH) Polyphloretin Phosphate; SC-19220 Compounds that inhibit the action of prostaglandins. Prostaglandins/antagonists and inhibitors (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,(@ >2(?9DProspidium D03.383.606.810; D04.615.885.700; D22.204.738 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 3,12-Bis(3-chloro-2-hydroxypropyl)-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride. An antineoplastic dispiropiperazine derivative. Alcohol, Propyl (72-74); Piperazines (71-74); Spiro Compounds (71-74) (Bx5:TProspective Studies E05.318.760.500.750.500.650; G03.850.520.835.500.750.650; N05.715.360.775.175.250.630 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies; Longitudinal Studies Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. (E]Prospective Payment System N03.219.521.710.305.200 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms Diagnosis-Related Groups; Prospective Payment Assessment Commission A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims. (I  MProspective Payment Assessment Commission N03.219.521.710.305.200.605 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms; Prospective Payment System The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM. Prospective Payment System (86) (K0&Prosencephalon A08.186.211.730 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain Diencephalon (+ 21); Telencephalon (+ 22) The part of the brain developed from the most rostral of the three primary vesicles of the embryonic neural tube and consisting of the DIENCEPHALON and TELENCEPHALON. Brain (66-91); Diencephalon (66-91); Telencephalon (66-91) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $(M884G:Proscillaridin D04.808.122.580; D09.203.408.180.660; D18.222.175.701 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Bufanolides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides [(6-Deoxy-alpha-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide. Cardiotonic glycoside isolated from Scilla maritima var. alba (Squill). Synonyms: Talusin; Tradenal; Caradrin; Sandoscill. Bufanolides (70-74); Plants, Medicinal (70-74) (OV=:8Propylthiouracil D03.383.742.698.875.842.708; D06.347.789.625; D26.087.748 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil; Thiouracil Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Thyroid Antagonists Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites (RA:(Propyliodone D03.383.725.791.496.750; D26.298.801 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridones; Iodopyridones Miscellaneous Drugs and Agents (Non MeSH); Contrast Media Propyl 3,5-diiodo-4-oxo-1(4H)-pyridine acetate. Radiopaque medium usually in oil; used in bronchography. Synonyms: Dionosil; propiliodon; Propylix. (S*.Propylbenzilylcholine Mustard D02.092.102.232.720; D02.455.526.728.650.740; D02.675.276.232.720; D14.100.120.200.500.740; D26.550.020.754 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Affinity Labels An analog of benzilylcholine mustard. It is an alkylating nitrogen mustard analog that binds specifically and irreversibly to cholinergic muscarinic receptors and is used as an affinity label to isolate and study the receptors. Benzilates (74-75); Choline (74-76); Mustard Compounds (74-76) (U"w:H LPropylamines D02.092.831 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Citalopram; Clorgyline; Fluoxetine; Mexiletine; Promethazine; Tranylcypromine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (Ze8.[:Propylamine Transferase D08.586.913.710 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme that catalyzes the transfer of the propylamine moiety from 5'-deoxy-5'-S-(3-methylthiopropylamine)sulfonium adenosine to putrescine in the biosynthesis of spermidine. The enzyme has a molecular weight of approximately 73,000 kD and is composed of two subunits of equal size. EC 2.5.1.16. Propylamines (72-74); Spermidine (72-74); Transferases (72-74) ([FUZKPropyl Gallate D02.241.223.106.505.350.600; D02.241.511.390.350.600; D02.755.410.350.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Gallic Acid Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Gallic Acid Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Gallic Acid n-Propyl gallate. Antioxidant for foods, fats, oils, ethers, emulsions, waxes, transformer oils. Synonyms: Progallin P; Tenox PG. Alcohol, Propyl (74); Gallic Acid (73-74) (^<Q:\4Proprioception F02.830.816.541; G11.561.796.541 CLDEGEPHRE Mechanoreceptors Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation Kinesthesis Equilibrium; Kinesthesis The mechanism involved in the self-regulation of posture and movement through stimuli originating in the receptors imbedded in the joints, tendons, muscles, and labyrinth. Equilibrium (66-72); Kinesthesis (66-72) $(a*&+1Propranolol D02.033.329.624.836; D02.092.063.624.836; D14.100.050.200.200.720; D16.050.850.770; D18.097.675; D18.162.738; D18.918.792 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Vasodilator Agents A widely used non-cardioselective beta-adrenergic antagonist. Propranolol is used in the treatment or prevention of many disorders including acute myocardial infarction, arrhythmias, angina pectoris, hypertension, hypertensive emergencies, hyperthyroidism, migraine, pheochromocytoma, menopause, and anxiety. (c:QZPropoxyphene D02.241.081.751.725; D15.040.150.600; D15.153.700; D15.210.600.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Propionates Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Narcotics A narcotic analgesic structurally related to METHADONE. Only the dextro-isomer has an analgesic effect; the levo-isomer appears to exert an antitussive effect. (hDL:APropoxycaine D02.241.223.106.061.075.720; D15.050.050.770; D15.210.100.200.770; D16.850.025.770 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; 4-Aminobenzoic Acid Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A local anesthetic of the ester type that has a rapid onset of action and a longer duration of action than procaine hydrochloride. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1017). (j\:Proportional Hazards Models E05.318.740.500.700; E05.318.740.600.700; E05.318.740.750.725; G03.850.520.830.500.700; G03.850.520.830.600.700; G03.850.520.830.750.725; H01.548.832.672.617; H01.548.832.793.725; H01.770.461.835.900; N05.715.360.750.530.650; N05.715.360.750.625.650; N05.715.360.750.695.650 Survival Analysis Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Models, Statistical Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Regression Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Models, Statistical Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Regression Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Physical Sciences (Non MeSH); Mathematics; Statistics; Regression Analysis Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Regression Analysis Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Models, Theoretical (77-89) (nl!,!Propolis D25.786.762 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Bees Biomedical and Dental Materials (Non MeSH); Resins Resinous substance obtained from beehives; contains many different substances which may have antimicrobial or antimycotic activity topically; its extracts are called propolis resin or balsam. Synonyms: bee bread; hive dross; bee glue. Bees (66-78); Resins (66-78)  (v ,>%Propofol D02.755.773; D15.050.035.075.600; D15.210.100.175.075.600; D15.210.350.800.720; D15.325.875.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate 2,6-Bis(1-methylethyl)phenol. An intravenous anesthetic and a sedative for patients in the intensive care unit or under regional anesthesia. Induction of anesthesia is rapid and maintenance can be achieved by either continuous infusion or intermittent bolus injection. Recovery from propofol is rapid and the patient is clear-headed with almost no hangover effect or nausea following administration. Analgesics, Narcotic (75-89); Anesthetics (66-89); Phenols (66-89); Sedatives, Nonbarbiturate (75-89) (x k: xProplast D25.720.395.616.755 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers; Fluorocarbon Polymers; Polytetrafluoroethylene Polymer of polytetrafluoroethylene and carbon filaments; porous biocompatible material used in orofacial and middle ear reconstruction and as coating for metal implants. Carbon (66-79); Fluorocarbon Polymers (66-72); Polytetrafluoroethylene (73-79) (} .u\Propiophenones D02.522.818 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Bupropion; Chalcone; Hydroxypropiophenone (+ 2); Kynuramine; Oxyfedrine; Propafenone; Tolperisone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8/t:Propionic Acids D02.241.081.465.706.700; D02.241.081.751.700; D10.516.251.400.706.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Propionates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Propionates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Propionates  Flurbiprofen; 3-Mercaptopropionic Acid; Nafenopin 3-carbon saturated monocarboxylic acids. Propionates (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $(M8_<0:Propionibacterium acnes B03.100.600.625.100; B03.510.460.400.400.600.625.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Propionibacteriaceae; Propionibacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Propionibacteriaceae; Propionibacterium A bacteria isolated from normal skin, intestinal contents, wounds, blood, pus, and soft tissue abscesses. It is a common contaminant of clinical specimens, presumably from the skin of patients or attendants. Corynebacterium (66-74) (:">Propionibacterium B03.100.600.625; B03.510.460.400.400.600.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Propionibacteriaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Propionibacteriaceae Propionibacterium acnes Propionibacterium acnes A genus of gram-positive, rod-shaped bacteria whose cells occur singly, in pairs or short chains, in V or Y configurations, or in clumps resembling letters of the Chinese alphabet. Its organisms are found in cheese and dairy products as well as on human skin and can occasionally cause soft tissue infections. (2"6mPropionibacteriaceae B03.100.600; B03.510.460.400.400.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH) Eubacterium; Propionibacterium (+ 1) Eubacterium; Propionibacterium (+ 1) A family of gram-positive bacteria found in dairy products or in the intestinal tracts of animals. Bacteria (66-74)  (,*"VvPropionates D02.241.081.465.706; D02.241.081.751; D10.516.251.400.706 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile Propionic Acids Procetofen; Propionic Acids (+ 3); Propoxyphene Propionic Acids AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (~A81_:Propiolactone D02.540.600; D20.187.762; D26.191.766 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Lactones Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 2-Oxetanone. Disinfectant used in vapor form to sterilize vaccines, grafts, etc; the vapor is very irritating and the liquid form is carcinogenic. Synonym: Betaprone. Lactones (69-74); Propionates (72-74) (-:.Propidium D03.494.633.700; D26.550.690 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenanthridines Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 3,8-Diamino-5-(3-(diethymethyammonio) propyl)-6-phenylphenanthridium. Quaternary ammonium analog of ethidium; an intercalating dye with a specific affinity to certain forms of DNA and, used as diiodide, to separate them in density gradients; also forms fluorescent complexes with cholinesterase which it inhibits. Synonyms: propidium diiodide; propidium iodide. Ethidium (74-78); Phenanthridines (69-78) (3 ".2Prophase G04.335.135.220.225.750; G05.148.165.220.225.750; G07.553.135.220.225.750 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Genetics; Cytogenetics; Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) The first phase of cell division, in which the chromosomes become visible, the nucleus starts to lose its identity, the spindle appears, and the centrioles migrate toward opposite poles. Cell Division (66-77); Meiosis (68-77); Mitosis (68-77) (2 QEProperdin Factor D D08.586.277.300.650; D08.586.277.656.732.760.700; D12.776.124.486.274.860.650; D24.611.333.860.650 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Complement Activating Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Activating Enzymes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Activating Enzymes A serum protein which during the alternate pathway of complement activation converts the inactive properdin factor B to C3 convertase. Enzyme Precursors (66-77); Properdin (66-77); Serum Globulins (70-77) (lDCTProperdin Factor B D08.444.690; D08.586.277.656.732.760.695; D12.776.124.486.274.980; D24.611.333.980 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor B is converted by Factor D to C3 convertase. Complement 3 (75-77); Enzyme Precursors (66-77); Glycoproteins (66-77) (\DUProperdin D12.776.124.486.789; D12.776.124.790.223.624; D12.776.377.715.182.624; D24.611.779 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH) Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Beta Globulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) ( \FPropantheline D02.092.102.700; D02.675.276.700; D03.494.953.558; D14.100.120.200.500.730; D16.050.650.750; D19.316.203.783 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. (Az:bPropanolamines D02.033.134.624; D02.033.329.624; D02.092.063.624 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Propyl Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols Organic Chemicals (Non MeSH); Amines; Amino Alcohols Metipranolol Acebutolol; Alprenolol (+ 1); Atenolol; Betaxolol; Bisoprolol; Bupranolol; Butoxamine; Carteolol; Celiprolol; Ephedrine; Histidinol; Isoxsuprine; Levobunolol; Methoxamine; Metipranolol; Metoprolol; Nadolol; Nylidrin; Oxprenolol; Oxyfedrine; Penbutolol; Phenylpropanolamine (+ 2); Pindolol; Practolol; Prenalterol; Propranolol; Ritodrine; Suloctidil; Timolol; Xamoterol Acebutolol; Alprenolol (+ 1); Atenolol; Betaxolol; Bisoprolol; Bupranolol; Butoxamine; Carteolol; Celiprolol; Ephedrine; Histidinol; Isoxsuprine; Levobunolol; Methoxamine; Metipranolol; Metoprolol; Nadolol; Nylidrin; Oxprenolol; Oxyfedrine; Phenylpropanolamine (+ 2); Pindolol; Practolol; Prenalterol; Propranolol; Ritodrine; Suloctidil; Timolol; Xamoterol AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (p98f:Propanil D02.065.199.789; D05.723.366.780 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Anilides (66-71); Herbicides (66-71) (~ &:-Propanidid D02.241.223.601.774; D15.050.035.075.555; D15.210.100.175.075.555 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous An intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.918). Anesthetics (66-69) (I:gPropanediols D02.033.618.706 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols alpha-Chlorohydrin; Chloramphenicol; Chlorphenesin; Mephenesin; Pentaerythritol Tetranitrate; Tromethamine AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8;y<Propanediol Dehydratase D08.586.520.497.675 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the dehydration of 1,2-propanediol to propionaldehyde. EC 4.2.1.28. Hydro-Lyases (72-74); Propanediols (72-74) (PF_m3Propane D02.455.326.146.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Alkanes (66-72) ( :gPropaganda F01.145.209.729; L01.143.790 Persuasive Communication; Psychological Warfare Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Information Science; Communication The deliberate attempt to influence attitudes and beliefs for furthering one's cause or damaging an opponent's cause. ("7yPropafenone D02.522.818.830; D18.097.645 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones Cardiovascular Agents; Anti-Arrhythmia Agents 1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone. An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated. Propiophenones (66-86) (v":t Prone Position G11.427.818.525 PH Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Posture The posture of an individual lying face down. Posture (66-91); Pronation (88-91) (|9+Pronation G11.427.614.748 PH Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement Applies to movements of the forearm in turning the palm backward or downward or when applied to the foot, a combination of eversion and abduction movements in the tarsal and metatarsal joints, (turning the foot up and in toward the midline of the body). Movement (66-87); Posture (66-87) ( }.*Pronase D08.586.277.656.732.480.680; D08.586.277.656.732.760.680 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Metalloproteinases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Peptide Hydrolases (66-70) ( >F; Promoter Regions (Genetics) G05.275.470.790.675; G05.331.599.110.689.675; G06.184.599.110.689.675 DEGEIMPHRE Genes, Reporter Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid rRNA Operon; TATA Box rRNA Operon; TATA Box rRNA Operon; TATA Box DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. Gene Expression Regulation (81-84); Genes (66-67); Genes, Regulator (68-84); Operon (69-85); Transcription, Genetic (73-84) $(!MS-Prometryne D03.383.931.674; D05.723.366.477.623 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Triazine Herbicides (66-71); Triazines (66-71) (d*:.Promethium D01.268.271.720; D01.268.558.675; D01.552.550.715 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Promethium. A radioactive element of the rare earth family of metals. It has the atomic symbol Pm, atomic number 61, and atomic weight 147. It has been used in the construction of atomic batteries, in the preparation of self-luminous compounds, and as a beta-particle source for thickness gauges. (94_Promethazine D02.092.831.690; D03.494.741.670; D14.100.375.425.400.700; D15.095.720; D15.210.350.800.700; D15.325.875.625; D23.075.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Propylamines Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Dermatologic Agents; Antipruritics A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. (:Promegestone D04.808.668.651.443.680; D06.597.799.850 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic (17 beta)-17-Methyl-17-(1-oxopropyl)estra-4,9-dien-3-one. A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone. Norpregnadienes (75-78); Pregnanes (68-74); Progestational Hormones (66-74); Progestational Hormones, Synthetic (75-78) (+.:PPromedol D03.066.399.450.700; D03.383.621.349.450.700; D15.040.150.475.600; D15.210.600.487.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonipecotic Acids; Meperidine Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Isonipecotic Acids; Meperidine Central Nervous System Agents; Analgesics; Analgesics, Opioid; Meperidine Central Nervous System Agents; Central Nervous System Depressants; Narcotics; Meperidine 1,2,5-Trimethyl-4-phenyl-4-piperidinol propionate. A narcotic analgesic similar to MEPERIDINE; it exists in four stereoisomers, two of which, the beta (isopromedol) and the gamma (trimeperidine) are active. Meperidine (75-77); Piperidines (66-74); Propionates (66-77) (s `:IPromazine D03.494.741.661; D14.100.150.175.805; D15.095.710; D15.150.025.700; D15.210.950.040.025.700; D15.700.872.331.025.666 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. ( :Proline Oxidase D08.586.682.107.640 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases The first enzyme of the proline degradative pathway. It catalyzes the oxidation of proline to pyrroline-5-carboxylic acid in the presence of oxygen and water. The action is not reversible. The specific activity of proline oxidase increases with age. EC 1.5.3.-. Amine Oxidoreductases (75-79); Amino Acid Oxidoreductases (66-79); Oxidoreductases (66-79); Oxygenases (66-79) (ՑFr5Proline D12.125.072.401.623 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Imino Acids Captopril; Fosinopril; Hydroxyproline AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (R F-HProliferating Cell Nuclear Antigen D12.776.660.740; D24.185.101.840.600; D24.611.216.780 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types. Nuclear Proteins (88-94); Nucleoproteins (83-87) ()=6>|:Prolapse C23.835 Symptoms and General Pathology (Non MeSH) Gastric Mucosa Prolapse; Heart Valve Prolapse (+ 3); Rectal Prolapse; Uterine Prolapse The protrusion of an organ or part of an organ into a natural or artificial orifice. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (݌  2ihNProlactinoma C04.557.465.625.650.735; C04.557.470.035.625; C04.557.580.625.650.735 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Hyperprolactinemia Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors A pituitary adenoma which secretes prolactin, leading to increased serum levels of the hormone. Prolactinomas in women present with galactorrhea associated with amenorrhea. Prolactinomas are much less common in men, rarely produce galactorrhea, and later present as larger, space-occupying tumors. Adenoma (66-88); Pituitary Neoplasms (66-88); Prolactin (66-88)  (MVWMProlactin-Releasing Hormone D06.472.709.622; D12.776.641.650.700; D14.600.600.640 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland. Pituitary Hormone Releasing Hormones (68-74) (O =F@4Prolactin Release-Inhibiting Hormone D06.347.560.710; D12.776.641.650.680; D14.600.600.635 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Pituitary Hormone Release Inhibiting Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A polypeptide hormone produced in the hypothalamus that inhibits the release of PROLACTIN. Pituitary Hormone Releasing Hormones (68-74); Prolactin (68-74) (*=FWkKProlactin D06.472.351.576.773; D06.472.734.525.343.773; D12.776.641.650.670; D14.600.600.630 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hyperprolactinemia; Receptors, Prolactin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins; Gonadotropins, Pituitary Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Gonadotropins, Pituitary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Pituitary lactogenic hormone. A polypeptide hormone with a molecular weight of about 23,000. It is essential in the induction of lactation in mammals at parturition and is synergistic with estrogen. The hormone also brings about the release of progesterone from lutein cells, which renders the uterine mucosa suited for the embedding of the ovum should fertilization occur. ( \F/Prokaryotic Cells A11.760 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells Cells, such as those of bacteria and the blue green algae, which lack a nuclear membrane so that the nuclear material is either scattered in the cytoplasm or collected in a nucleoid region. appropriate cell, organism, subcellular fraction, or process ( * FProjective Techniques F04.711.647.622 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests Ink Blot Tests (+ 2); Rosenzweig Picture-Frustration Study; Szondi Test; Thematic Apperception Test Techniques whereby personality attributes are revealed through the subject's responses to relatively unstructured, ambiguous, or vague stimuli. These responses represent projections of the subject's own fears and needs. (6 hwProjection F01.393.693; F03.407.693 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Scapegoating Scapegoating A defense mechanism, operating unconsciously, whereby that which is emotionally unacceptable in the self is rejected and attributed (projected) to others. Defense Mechanisms (66-68) (o Proinsulin D06.472.610.575.788; D12.776.811.706 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Insulin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones; Insulin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors C-Peptide C-Peptide Insulin (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $(H*F HProgressive Patient Care N04.590.233.799 CLECHILJMAMTOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care Organization of medical and nursing care according to the degree of illness and care requirements in the hospital. The elements are intensive care, intermediate care, self-care, long-term care, and organized home care. (2|Programming, Linear L01.906.575.748 CLECHILJSDSNSTTDUT Information Science; Systems Analysis; Operations Research A technique of operations research for solving certain kinds of problems involving many variables where a best value or set of best values is to be found. It is most likely to be feasible when the quantity to be optimized, sometimes called the objective function, can be stated as a mathematical expression in terms of the various activities within the system, and when this expression is simply proportional to the measure of the activities, i.e., is linear, and when all the restrictions are also linear. It is different from computer programming, although problems using linear programming techniques may be programmed on a computer. (EProgramming Languages L01.700.568.810.780 Information Science; Medical Informatics; Medical Informatics Computing; Software Specific languages used to prepare computer programs. (_@Programmed Instruction I02.903.573 CLECHILJSDSNSTTDUT Education; Teaching Computer-Assisted Instruction A teaching method which employs self-instructional programs enabling the student to learn at his own pace. Teaching machines or programmed textbooks may be used. CLECHIISLJMTSDSNSTTDUT  ("Program Evaluation E05.337.820; N04.761.685; N05.715.360.650 ECMTSNSTTD Evaluation Studies Miscellaneous Techniques (Non MeSH); Evaluation Studies Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact. Evaluation Studies (71-88)  (1 Program Development N04.452.760 ECMTSNST Health Services Administration (Non MeSH); Organization and Administration The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development). ( WPrognosis E01.789 Disease Progression Diagnosis Disease-Free Survival; Karnofsky Performance Status; Medical Futility; Treatment Outcome (+ 2) A forecast as to the probable outcome of an attack of disease; the prospect as to recovery from a disease as indicated by the nature and symptoms of the case. (Dorland, 27th ed). HISNST  )   o Prognathism C05.500.460.655; C05.500.607.655; C05.660.514.705; C07.320.440.655; C07.320.610.655; C07.650.460.655; C16.131.621.514.705; C16.131.850.460.655 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Malocclusion, Angle Class III; Malocclusion Musculoskeletal Diseases; Jaw Diseases; Jaw Abnormalities Musculoskeletal Diseases; Jaw Diseases; Mandibular Diseases Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Stomatognathic Diseases; Jaw Diseases; Jaw Abnormalities Stomatognathic Diseases; Jaw Diseases; Mandibular Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities A condition marked by abnormal protrusion of the mandible. (Dorland, 27th ed). )L4`Proglumide D12.125.119.574.700; D19.316.203.764 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Glutamine Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 4-Benzamido-N,N-dipropylglutaramic acid. Exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. It is used clinically in the drug therapy of gastrointestinal ulcers. Frequently used synonym: Milid. Benzamides (74); Glutamine (72-74) )[*: +Progesterone-Binding Globulin D12.776.124.790.106.740; D12.776.377.715.085.740 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins A glycoprotein migrating as alpha 1 globulin. Molecular weight 70,000 to 120,000. The protein, which is present in increased amounts in the plasma during pregnancy, binds mainly progesterone, with other steroids including testosterone competing weakly. Alpha Globulins (74-76); Progesterone (74-76); Serum Globulins (74-76) ) "6F%UProgesterone Reductase D08.586.682.047.436.350.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases An enzyme that catalyzes the reduction of a 3 beta-hydroxy-delta(5)-steroid to 3-oxo-delta(4)-steroid in the presence of NAD. It converts pregnenolone to progesterone and dehydroepiandrosterone to androstenedione. EC 1.1.1.145. Hydroxysteroid Dehydrogenases (72-74) ) 8F +Progesterone D04.808.745.745.654.829; D06.472.798.773; D06.472.866.362.623 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Progesterone Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Progestational Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Corpus Luteum Hormones Algestone (+ 1); Dihydroprogesterone; Hydroxyprogesterones; Medroxyprogesterone (+ 1) Dihydroprogesterone; Hydroxyprogesterones Pregn-4-ene-3,20-dione. The principal progestational hormone of the body, secreted by the corpus luteum, adrenal cortex, and placenta. Its chief function is to prepare the uterus for the reception and development of the fertilized ovum. It acts as an antiovulatory agent when administered on days 5-25 of the menstrual cycle.  )ED}Progestational Hormones, Synthetic D06.597.799; D07.360.276.210.443.706 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic Algestone (+ 1); Allylestrenol; Chlormadinone; Cronolone; Desogestrel; Dimethisterone; Dydrogesterone; Ethisterone; Ethynodiol Diacetate; Gestonorone Caproate; Lynestrenol; Medrogestone; Medroxyprogesterone (+ 1); Megestrol; Melengestrol; Norethindrone; Norethynodrel; Norgestrel (+ 1); Norgestrienone; Promegestone Algestone (+ 1); Chlormadinone; Desogestrel; Dimethisterone; Ethynodiol Diacetate; Gestrinone; Lynestrenol; Medroxyprogesterone (+ 1); Megestrol; Norethindrone; Norethynodrel; Norgestrel (+ 1); Norgestrienone Compounds obtained by chemical synthesis that possess progestational activity, but differ in structure from naturally occurring progestational hormones. Progestational Hormones (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $)(*8d%:Progestational Hormones D06.472.798; D07.360.276.210.277.706 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal Pregnanediol; Pregnanetriol; Pregnenolone; Progesterone (+ 2) A class of sex hormones associated with certain changes in the uterus and vagina during the menstrual cycle. They are necessary for the development of mammary tissue and for the maintenance of pregnancy. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  )*BJDProgeria C05.116.099.343.773; C05.116.132.799; C19.753 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dwarfism Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Endocrine (Non MeSH) Endocrine Diseases  Werner's Syndrome A syndrome of uncertain genetic inheritance, characterized by precocious senility of striking degree, with death from coronary artery disease frequently occurring before 10 years of age. ) 5NProflavine D03.494.046.250.720; D20.187.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Anti-Infective Agents; Anti-Infective Agents, Local 3,6-Diaminoacridine. Topical antiseptic used mainly in wound dressings. Synonyms: Isoflav. Acridines (69-74); Diamines (74) )&:j)Professional-Patient Relations F01.829.401.650; N05.300.660 Truth Disclosure Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Dentist-Patient Relations; Nurse-Patient Relations; Physician-Patient Relations Dentist-Patient Relations; Nurse-Patient Relations; Physician-Patient Relations Interactions between health personnel and patients. Interpersonal Relations (66-67)  ) I#"=%Professional-Family Relations F01.829.401.550 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations The interactions between the professional person and the family. Family (66-75) )""hMProfessional Staff Committees N04.452.758.788; N05.700.685 CLECHILJOGSNSTTDUT Utilization Review Hospital Administration; Quality of Health Care Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Ethics Committees; Pharmacy and Therapeutics Committee Ethics Committees; Pharmacy and Therapeutics Committee Committees of professional personnel who have responsibility for determining policies, procedures, and controls related to professional matters in health facilities. Hospital Administration (66-67); Hospitals (66-67) ()##"9~<Professional Review Organizations N04.761.673; N05.700.675 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Organizations representing designated geographic areas which have contracts under the PRO program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by Medicare beneficiaries. Peer Review Improvement Act, PL 97-248, 1982. )&'4Professional Practice Location N04.452.758.772 ECLJSNSTTD Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Geographic area in which a professional person practices; includes primarily physicians and dentists. )) $qwProfessional Practice N04.452.758 CLECHILJOGSNSTTDUT Practice Management, Dental; Practice Management, Medical Health Services Administration (Non MeSH); Organization and Administration Group Practice (+ 4); Hospital-Physician Relations (+ 1); House Calls; Institutional Practice; Nursing (+ 3); Nursing Faculty Practice; Office Management (+ 3); Office Visits; Partnership Practice (+ 1); Private Practice (+ 2); Professional Autonomy; Professional Corporations; Professional Practice Location; Professional Staff Committees (+ 2); Referral and Consultation (+ 1) The use of one's knowledge in a particular profession. It includes, in the case of the field of biomedicine, professional activities related to health care and the actual performance of the duties related to the provision of health care. Office Management (66-67) CLECEDHIISLJMAMTOGPXSDSNSTTDUT ()*pCW"Professional Impairment I01.880.604.583.524.528; N03.706.535.606.528 CLECLJPXSN Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Malpractice Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Malpractice Physician Impairment Physician Impairment The inability of a health professional to provide proper professional care of patients due to his or her physical and/or mental disability. Alcoholism (66-85); Substance Dependence (81-85)  ).20:Professional Corporations N04.452.758.760 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Legally authorized corporations owned and managed by one or more professionals (medical, dental, legal) in which the income is ascribed primarily to the professional activities of the owners or stockholders. Practice Management, Dental (68-78); Practice Management, Medical (68-78); Professional Practice (68-78) )0qzProfessional Competence I02.399.630 ECLJSNST Education; Educational Measurement Clinical Competence The capability to perform the duties of one's profession generally, or to perform a particular professional task, with skill of an acceptable quality. )3F )Professional Autonomy N04.452.758.752 Health Services Administration (Non MeSH); Organization and Administration; Professional Practice The quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs. )4qProestrus G08.520.780.218.468 BLCFDEGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal; Estrus Phase of the estrous cycle preceding estrus during which the Graafian follicle undergoes maturation. Applies to animals. )62 gProduct Surveillance, Postmarketing E05.337.800 ECMTSNSTTD Miscellaneous Techniques (Non MeSH); Evaluation Studies Adverse Drug Reaction Reporting Systems; Clinical Trials, Phase IV Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale. Clinical Trials (66-82); Drug Therapy (66-82); specific drug/AE (66-82) AECLCTECHIISLJMAMOMTNUOGPXSDSNSTTDUTVE $)7)BOX*Product Line Management N02.278.354.700; N04.452.442.700; N04.590.374.600 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care Management control systems for structuring health care delivery strategies around case types, as in DRGs, or specific clinical services. )99RProduct Labeling E05.780; J01.790 CLECHIISLJMAMTSNSTTD Miscellaneous Techniques (Non MeSH) Technology, Industry, Agriculture (Non MeSH) Drug Labeling; Food Labeling Drug Labeling; Food Labeling Use of written, printed, or graphic materials upon or accompanying a product or its container or wrapper. It includes purpose, effect, description, directions, hazards, warnings, and other relevant information. )<-\FProdrugs D26.394.800 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Delayed-Action Preparations (66-87) )>- ,<)Prodigiozan D09.203.698.718.650; D20.085.698 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Polysaccharides, Bacterial Anti-Infective Agents; Antibiotics A bacterial polysaccharide isolated from Serratia marcescens and other bacteria. It is used in the treatment of a variety of bacterial and viral infections. Polysaccharides, Bacterial (66-78); Prodigiosin (66-78) )?&>AProdigiosin D03.383.757.748; D11.557.778; D20.085.690 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrroles Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Anti-Infective Agents; Antibiotics 4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)- 2,2'-bi-1H-pyrrole. A toxic, bright red tripyrrole pigment from Serratia marcescens and others. It has antibacterial, anticoccidial, antimalarial, and antifungal activities, but is used mainly as a biochemical tool. )A1<9Procyclidine D03.383.773.728; D14.100.120.200.500.720; D15.090.050.675; D15.525.700; D16.050.650.740; D16.700.600.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. )Dv:pProctoscopy E01.184.340.350.750; E01.418.340.350.750 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anus Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System; Endoscopy, Gastrointestinal Diagnosis; Endoscopy; Endoscopy, Digestive System; Endoscopy, Gastrointestinal Endoscopic examination of the rectum. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material and perform other surgical interventions, and for delivery of medication. )H."Proctocolitis C06.405.469.158.188.767; C06.405.469.158.850.790; C06.405.469.860.622.790 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colitis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Sigmoid Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Proctitis Inflammation of the rectum and colon. )JQNf/Proctocolectomy, Restorative E04.765.219.620 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Digestive System (Non MeSH); Colectomy A surgical procedure involving the excision of the colon and rectum and the formation of an ileoanal reservoir (pouch). In patients with intestinal diseases, such as ulcerative colitis, this procedure avoids the need for an ostomy by allowing for transanal defecation. Colectomy (81-91) )MV!$Q;Proctitis C06.405.469.860.622 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Proctocolitis )Ow NiProcollagen-Proline Dioxygenase D08.586.682.420.673 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases A mixed-function oxygenase that catalyzes the hydroxylation of a prolyl-glycyl-containing-peptide, usually in protocollagen, to a hydroxyprolylglycyl-containing-peptide. The enzyme utilizes molecular oxygen with a concomitant oxidative decarboxylation of 2-oxoglutarate to succinate. EC 1.14.11.2. Hydroxylases (66-71) )P$FhOProcollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase D08.586.682.420.660 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases A mixed-function oxygenase that catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4. Hydroxylases (66-76); Ketoglutaric Acids (66-76); Lysine (66-76) )R6Fh5NProcollagen Peptidase D08.586.277.656.732.660 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases An extracellular endopeptidase which excises a block of peptides at the amino terminal, nonhelical region of the procollagen molecule with the formation of collagen. Absence or deficiency of the enzyme causes accumulation of procollagen which results in the inherited connective tissue disorder--dermatosparaxis. EC 3.4.99.-. Collagen (66-76); Peptide Peptidohydrolases (66-76); Protein Precursors (73-76) )UFw^Procollagen D12.776.811.690; D12.776.860.300.250.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins; Collagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal ends of the three polypeptide chains. Protocollagen, a precursor of procollagen consists of procollagen peptide chains in which proline and lysine have not yet been hydroxylated. Collagen (66-76); Protein Precursors (73-76) )X.FD6Prochlorperazine D03.494.741.639; D14.100.150.175.780; D15.095.700; D15.150.025.690; D15.210.950.040.025.690; D15.700.872.331.025.642 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine antipsychotic used principally in the treatment of nausea, vomiting, and vertigo. It is more likely than CHLORPROMAZINE to cause extrapyramidal disorders. (From Martindale, The Extra Pharmacopoeia, 30 ed, p.612). )[: Procetofen D02.241.081.751.650; D10.162.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Propionates Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropionic acid-1-methylethyl ester. An antilipemic agent which reduces both cholesterol and triglycerides in the blood. Synonyms: LF 178; Lipantyl. Antilipemic Agents (66-79); Propionates (66-79) )`o&:9Process Assessment (Health Care) N04.761.559.650; N05.715.360.575.625 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care; Outcome and Process Assessment (Health Care) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Outcome and Process Assessment (Health Care) An evaluation procedure that focuses on how care is delivered, based on the premise that there are standards of performance for activities undertaken in delivering patient care, in which the specific actions taken, events occurring, and human interactions are compared with accepted standards. Outcome and Process Assessment (Health Care) (79-91) )b'*:T>Procaterol D02.033.329.291.630; D02.092.063.291.647; D03.438.810.350.700; D14.100.050.100.200.660; D16.050.110.700; D16.050.870.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. Amino Alcohols (78-80); Ethanolamines (81-92); Hydroxyquinolines (78-80) )f:VProcarbazine D02.065.277.727; D02.241.223.106.162.727; D22.204.727; D26.191.755 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH); Carcinogens N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide. An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. It is unrelated to other antineoplastic agents and may therefore be effective when other agents have failed. Antineoplastic Agents (66-70); Benzoates (66-70) )jL:A{:Procaine D02.241.223.106.061.075.700; D15.050.050.740; D15.210.100.200.740; D16.850.025.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; 4-Aminobenzoic Acid Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1016). )n> \:Procainamide D02.241.223.106.061.075.690; D18.097.622 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; 4-Aminobenzoic Acid Cardiovascular Agents; Anti-Arrhythmia Agents  Acetylprocainamide 4-Amino-N-[2-(diethylamino)ethyl]benzamide. Derivative of procaine with less CNS action; used in cardiac arrhythmias. Synonyms: Novocainamid(e); Novocamid(e); Procamid(e); Procardyl; Pronestyl; Supicain(e) Amid(e). )q.:Probucol D02.755.746; D10.162.202.747 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents Anticholesteremic Agents (66-72); Phenols (66-72) )tk ":;Problem-Based Learning F02.463.425.720; I02.158.660 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Education; Curriculum Instructional use of examples or cases to teach using problem-solving skills and critical thinking. Learning (75-94); Problem Solving (75-94); Teaching (75-94) )u" suIProblem Solving F02.463.425.725; F02.463.785.810 CLDEPHRE Decision Making Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking A learning situation involving more than one alternative from which a selection is made in order to attain a specific goal. )we& Probenecid D02.065.884.625; D02.886.590.700.625; D17.050.337.900.625; D19.770.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants; Uricosuric Agents Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH) The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment. )y,P:Probability Theory L01.906.575.622 Information Science; Systems Analysis; Operations Research )|gEProbability Learning F02.463.425.701 Models, Psychological Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Usually refers to the use of mathematical models in the prediction of learning to perform tasks based on the theory of probability applied to responses; it may also refer to the frequency of occurrence of the responses observed in the particular study. )|Z+Probability E05.318.740.600; G03.850.520.830.600; H01.548.832.672; N05.715.360.750.625 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Bayes Theorem; Likelihood Functions; Markov Chains; Odds Ratio; Proportional Hazards Models; Risk (+ 3) Bayes Theorem; Likelihood Functions; Markov Chains; Odds Ratio; Proportional Hazards Models; Risk (+ 3) Bayes Theorem; Likelihood Functions; Markov Chains; Odds Ratio; Predictive Value of Tests; Proportional Hazards Models; Risk (+ 3) Bayes Theorem; Likelihood Functions; Markov Chains; Odds Ratio; Proportional Hazards Models; Risk (+ 3) The study of chance processes or the relative frequency characterizing a chance process. )~TiProadifen D02.241.081.944.550; D26.734 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Valerates Miscellaneous Drugs and Agents (Non MeSH) alpha-Phenyl-alpha-propylbenzeneacetic acid, 2-(diethylamino)ethyl ester. )g ".SProactive Inhibition F01.145.544.538; F02.463.425.475.538 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Inhibition (Psychology) Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Inhibition (Psychology) The state or process hypothesized to account for poorer learning rate for elements later in a series as compared to the learning rate for elements coming earlier in a series. )*Pro-Opiomelanocortin D06.472.734.525.690; D12.776.811.730 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors Corticotropin (+ 2); Lipotropin; MSH (+ 1) A precursor protein, MW 30,000, synthesized mainly in the anterior pituitary gland but also found in the hypothalamus, brain, and several peripheral tissues. It incorporates the amino acid sequences of ACTH and beta-lipotropin. These two hormones, in turn, contain the biologically active peptides MSH, corticotropin-like intermediate lobe peptide, alpha-lipotropin, endorphins, and methionine enkephalin. Pituitary Hormones, Anterior (66-84); Protein Precursors (73-84)  )*H8LPrivatization N04.452.633.780 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Ownership Process of shifting publicly controlled services and/or facilities to the private sector. )djPrivate Sector I01.791; N04.452.633.390 CLECHILJMAOGSNSTTDUT Social Sciences Health Services Administration (Non MeSH); Organization and Administration; Ownership That distinct portion of the institutional, industrial, or economic structure of a country that is controlled or owned by non-governmental, private interests. Health Facilities, Proprietary (79-92) )v-Private Practice N04.452.758.745 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Fee-for-Service Plans; Independent Practice Associations Practice of a health profession by an individual, offering services on a person-to-person basis, as opposed to group or partnership practice. specific discipline (66-68); specific specialty (66-68); Medicine (66-68); Office Management (66-68); Professional Practice (68) CLECHILJMAOGSNSTTDUT $)qAPrisons I01.880.604.787 CLECEDHILJMAMTOGSDSNSTTDUT Social Sciences; Sociology; Social Control, Formal Concentration Camps Penal institutions, or places of confinement for war prisoners. ) =LPrisoners M01.729 CLEDHILJPXSN Named Groups (Non MeSH) Prisons (66-72) )!  Prions D12.776.785 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPOPYRESDSESTTOTUULUR Scrapie Amino Acids, Peptides and Proteins (Non MeSH); Proteins PrPC Proteins; PrPSc Proteins (+ 1) Small proteinaceous infectious particles which resist inactivation by procedures that modify nucleic acids and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME and GERSTMANN-STRAUSSLER SYNDROME. Scrapie Prion (66-85); Viral Proteins (66-85) $) D D-$8Prion Diseases C10.228.228.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Slow Virus Diseases Slow Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Creutzfeldt-Jakob Syndrome; Encephalopathy, Bovine Spongiform; Gerstmann-Straussler Syndrome; Kuru; Scrapie Transmissible and genetic neurodegenerative diseases of humans and animals caused by PRIONS. The diseases are usually characterized by vacuolation in the gray matter and result in ataxia, motor disturbances, dementia, and progression to a fatal outcome. They include CREUTZFELDT-JAKOB SYNDROME, GERSTMANN-STRAUSSLER SYNDROME, KURU, SCRAPIE, fatal familial insomnia, bovine spongiform encephalopathy (ENCEPHALOPATHY, BOVINE SPONGIFORM), transmissible mink encephalopathy, and chronic wasting disease of mule deer and elk. The literature has sometimes referred to these as unconventional slow virus diseases. Slow Virus Diseases (66-92) ()Px{"Printing L01.737.787 CLECHIISLJMAMTOGSDSNSTTDUT Engraving and Engravings Information Science; Publishing ) &Printers' Marks L01.178.682.192.122.622 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Book Imprints )ExPrince Edward Island Z01.107.567.176.732 EHEP Geographicals (Non MeSH); America; North America; Canada )FPrimidone D03.383.742.698.253.650.700; D15.080.585.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates; Phenobarbital Central Nervous System Agents; Anticonvulsants; Phenobarbital An antiepileptic agent related to the barbiturates; it is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with PHENOBARBITAL. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.309). ) 2:TPrimates B02.649.801 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Haplorhini (+ 39); Strepsirhini (+ 5) )n (0Primate Diseases C22.735 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Ape Diseases; Monkey Diseases (+ 2) Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  ) H-~PPrimary Prevention F04.096.544.215.508.428; G03.770.670 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry; Community Psychiatry; Preventive Psychiatry Environment and Public Health (Non MeSH); Preventive Medicine  Immunization (+ 1) Prevention of disease or mental disorders in susceptible individuals or populations through promotion of health, including mental health, and specific protection, as in immunization, as distinguished from the prevention of complications or after-effects of existing disease. specific disease/prevention and control (66-78); Preventive Health Services (68-78); Preventive Medicine (66-78) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $)*:*Primary Nursing Care N02.421.533.760 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The primary responsibility of one nurse for the planning, evaluation, and care of a patient throughout the course of illness, convalescence, and recovery. Nursing Care (74-76); Primary Health Care (74-76) )([=Primary Health Care N04.590.233.727 CLECHILJMAMTOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care Continuity of Patient Care; Patient-Centered Care; Refusal to Treat Care which provides basic health maintenance and therapeutic services, and coordination of all needed consultant and community services. Comprehensive Health Care (68-71)  )|Q(Primaquine D21.370.286.572 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials ):QPrilocaine D02.065.199.750; D15.050.050.730; D15.210.100.200.730; D16.850.025.730 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A local anesthetic that is similar pharmacologically to LIDOCAINE. Currently, it is used most often for infiltration anesthesia in dentistry. (From AMA Drug Evaluations Annual, 1992, p165). Anesthetics, Local (66) )P:fPriapism C12.294.494.786 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases Persistent abnormal erection of the penis, usually without sexual desire, and accompanied by pain and tenderness. It is seen in diseases and injuries of the spinal cord, and may be caused by vesical calculus and certain injuries to the penis. (Dorland, 27th ed). ) Nh8Prevotella melaninogenica B03.440.425.410.194.640.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae; Prevotella A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium has been isolated from the mouth, urine, feces, and infections of the mouth, soft tissue, respiratory tract, urogenital tract, and intestinal tract. It is pathogenic, but usually in association with other kinds of organisms. Bacteroides (66-75) )"Prevotella intermedia B03.440.425.410.194.640.375 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae; Prevotella A species of gram-negative, anaerobic, rod-shaped bacteria originally classified within the BACTEROIDES genus. This bacterium is a common commensal in the gingival crevice and is often isolated from cases of gingivitis and other purulent lesions related to the mouth. Bacteroides (79-94) )"7Prevotella B03.440.425.410.194.640 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae Prevotella intermedia; Prevotella melaninogenica A genus of gram-negative, anaerobic, nonsporeforming, nonmotile rods. Organisms of this genus had originally been classified as members of the BACTEROIDES genus but overwhelming biochemical and chemical findings in 1990 indicated the need to separate them from other Bacteroides species, and hence, this new genus was established. Bacteroides (90-94)  )"8~Preventive Psychiatry F04.096.544.215.508; G02.403.642.150.580 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry; Community Psychiatry Health Occupations; Medicine; Psychiatry; Community Psychiatry Primary Prevention A discipline concerned with the prevention of mental illness and the promotion of mental health. )|.sPreventive Medicine G02.403.790.548; G03.770 CLECEDHIISLJMAMTOGSNSTTD Health Promotion Health Occupations; Medicine; Specialties, Other (Non MeSH) Environment and Public Health (Non MeSH) Aerospace Medicine; Occupational Medicine; Public Health Primary Prevention (+ 2) A medical specialty primarily concerned with prevention of disease and the promotion and preservation of health in the individual. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $)Sv`*Preventive Health Services N02.421.143.827; N02.421.726 CLECHILJMAMTOGSDSNSTTDUT Health Promotion; Immunization Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Facilities, Manpower and Services (Non MeSH); Health Services Diagnostic Services (+ 6); Early Intervention (Education); Health Education (+ 3); Immunization Programs; Needle-Exchange Programs; School Health Services (+ 2) Diagnostic Services (+ 4); Early Intervention (Education); Health Education (+ 3); Immunization Programs; Needle-Exchange Programs; School Health Services (+ 2) Services designed for promotion of health and prevention of disease. specific disease/PC (66-67) AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE () "%|R",Preventive Dentistry E06.761; G02.163.721; G03.700 CLECEDHIISLJMAMTOGSNSTTD Dental Clinics; Health Education, Dental Dentistry Health Occupations; Dentistry Environment and Public Health (Non MeSH) Dental Prophylaxis (+ 2); Fluoridation; Mouth Protectors; Oral Hygiene (+ 2) The branch of dentistry concerned with the prevention of disease and the maintenance and promotion of oral health. AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE $)%1^`,Prevalence E05.318.308.985.525.750; G03.850.505.400.975.525.750; G03.850.520.308.985.525.750; L01.280.975.525.750; N01.224.935.597.750 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Morbidity Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Morbidity Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Morbidity Information Science; Data Collection; Vital Statistics; Morbidity Population Characteristics (Non MeSH); Demography; Vital Statistics; Morbidity The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Prevalence Studies (89) )1SPresynaptic Terminals A08.663.542.145.750; A08.850.700; A11.195.443.780.700; A11.671.137.750 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Nerve Endings Nervous System; Neurons; Nerve Fibers; Axons Nervous System; Synapses Cells; Cell Membrane; Intercellular Junctions; Synapses Cells; Neurons; Axons The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included. Nerve Endings (66-93); Synapses (66-93)  )OP(^1Pressure H01.671.691 AE Atmospheric Pressure; Blood Pressure; Manometry Physical Sciences (Non MeSH); Physics Decompression; Hydrostatic Pressure; Osmotic Pressure; Partial Pressure; Vacuum AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  )^ 9/^&Pressoreceptors A08.800.050.800.900.700; A08.800.550.700.500.750 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Baroreflex Carotid Sinus Nervous System; Peripheral Nervous System; Autonomic Nervous System; Sympathetic Nervous System; Vasomotor System Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls.  )Ȗ66Preservatives, Pharmaceutical D26.698.771 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include antibiotics and antioxidants. Pharmaceutic Aids (68-74); Pharmacy (66-67) )",I5Preservation, Biological E05.760 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cryoprotective Agents; Fixatives Miscellaneous Techniques (Non MeSH) Cryopreservation (+ 2); Refrigeration; Tissue Preservation (+ 3) )̗ "'*NPrescriptions, Non-Drug E02.790 CLECHISNSTVE Therapeutics Written directions for the preparation, administration, or application of a non-drug remedy. This includes prescriptions for corrective lenses, self-help and orthopedic devices, and physical therapy and rehabilitation measures. Eyeglasses (66-77); Orthopedic Equipment (66-77); Orthotic Devices (72-74); Prescriptions (66-77) )ͧ tPrescriptions, Drug E02.319.720 CLECHISNSTVE Pharmacy Therapeutics; Drug Therapy Directions written for the preparation and adminstration of a drug. )ύ !QPrescription Fees N03.219.442.551.621; N03.219.442.675 CLHILJSNSTTD Economics, Pharmaceutical Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges; Fees, Pharmaceutical Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges The charge levied on the consumer for drugs or therapy prescribed under written order of a physician or other health professional. )i*Presbyopia C11.744.786 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Refractive Errors Hyperopia and impairment of vision due to advancing years or to old age. It is dependent on diminution of the power of accommodation from loss of elasticity of the crystalline lens, causing the near point of distinct vision to be removed farther from the eye. (Dorland, 27th ed). )`N'NPresbycusis C09.218.458.500.481.772 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial; Hearing Loss, Sensorineural Progressive bilateral loss of hearing that occurs in the aged. Syn: senile deafness. Deafness (66-71) )cNfPrephenate Dehydrogenase D08.586.399.700; D08.586.682.770 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme that catalyzes the conversion of phenate to p-hydroxyphenylpyruvate in the presence of NAD. In the enteric bacteria, this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of tyrosine. EC 1.3.1.12. Cyclohexanes (72-74); Oxidoreductases (72-74); Pyruvates (72-74) )&F7MPrephenate Dehydratase D08.586.399.685; D08.586.520.497.655 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the conversion of prephenate to phenylpyruvate with the elimination of water and carbon dioxide. In the enteric bacteria this enzyme also possesses chorismate mutase activity, thereby catalyzing the first two steps in the biosynthesis of phenylalanine. EC 4.2.1.51. Cyclohexanes (70-74); Hydro-Lyases (70-74); Pyruvates (70-74) )*FRJPrepaid Health Plans N03.219.521.576.343.925 CLECHILJOGSNSTTDUT Group Practice, Prepaid Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Health Maintenance Organizations Contracts between an insurer and a subscriber or a group of subscribers whereby a specified set of health benefits is provided in return for a periodic premium. Health Maintenance Organizations (72-91); Insurance, Health (66-91) CLECHILJMAOGSNSTTDUT ()~&OPreoptic Area A08.186.211.730.385.357.342.450 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Anterior Region of hypothalamus between the anterior commissure and optic chiasm. )B#6VPreoperative Care E02.472.795; E04.641; N02.421.589.775 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; General Patient Care (Non MeSH) Surgery, Operative Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH)  Preanesthetic Medication Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed). )߫-$uPrenylamine D02.092.471.683.825; D18.192.786; D18.918.173.780 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers )9:Prenazone D03.383.694.700.670; D16.850.015.050.720; D17.025.030.620; D17.050.030.620 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Phenylbutazone Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 4-(3-Methyl-2-butenyl)-1,2-diphenyl-3,5-pyrazolidinedione. A pyrazole that has analgesic, anti-inflammatory, and antipyretic properties. It has been used in mild to moderate pain, fever, and inflammation associated with musculoskeletal and joint disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.15). Alkenes (74); Pyrazoles (72-74); Terpenes (72-74) ) T:]i>Prenatal Exposure Delayed Effects G08.520.860 Maternal Exposure; Paternal Exposure Reproduction, Urogenital Physiology (Non MeSH); Reproduction Delayed effects on offspring of maternal or fetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc. )(,GPrenatal Diagnosis E01.249.746 AECLCTECHIISMOMTNUPXSNSTTDUTVE Genetic Counseling Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Amniocentesis; Amnioscopy; Chorionic Villi Sampling; Fetoscopy; Ultrasonography, Prenatal Amniocentesis (71-72); specific disease or abnormality/diagnosis (66-72)  )H"0hUPrenatal Care E02.472.786; N02.421.143.620.704 CLECHILJMAMTOGSNSTTDUT Preconception Care; Pregnancy Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Maternal Health Services Care provided the pregnant woman in order to prevent complications, and decrease the incidence of maternal and prenatal mortality. )&$Prenalterol D02.033.329.624.800; D02.092.063.624.800; D14.100.050.100.200.640; D16.050.870.730; D18.222.863.758 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the Shy-Drager syndrome. Practolol/analogs and derivatives (75-86); Propylamines (66-74) )o:8KPremenstrual Syndrome C13.371.491.771 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Menstruation Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Menstruation Disorders A syndrome occurring most often during the last week of the menstrual cycle and ending soon after the onset of menses. Some of the symptoms are emotional instability, insomnia, headache, nausea, vomiting, abdominal distension, and painful breasts. ) N!Premenopause G08.520.940.110.654 BLCFDEEHGEIMMEPHPXREUR Menopause Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sexual Reproduction Periods (Non MeSH); Climacteric The physiological period preceding the climacteric, during which occurs the regression of ovarian function, up to the menopause, the permanent cessation of the menstrual life. Since in the United States the age of the menopause ranges between 48 and 55 years, the premenopause refers in general to middle-aged women. (Best and Taylor's Physiological Basis of Medical Practice, 12th ed). Climacteric (69-93); Menopause (69-93); Menstruation (66-93)  )c IPremedication E02.319.703 AECLCTECHIISMOMTNUPXSNSTTDUTVE PREANESTHETIC MEDICATION Therapeutics; Drug Therapy specific drug/TU (66-68) )n"!Premarital Examinations E01.774 AECLCTECHIISMOMTNUPXSNSTTDUTVE Marriage Diagnosis )4 "  Preleukemia C04.834.770; C15.378.800 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Precancerous Conditions Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria. )XqAPrekallikrein D08.444.675; D12.776.124.125.550.800; D19.461.270.229.533.731 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Kallikrein Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Kallikrein A plasma protein which is the precursor of kallikrein. Plasma that is deficient in prekallikrein has been found to be abnormal in thromboplastin formation, kinin generation, evolution of a permeability globulin, and plasmin formation. The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease. Blood Coagulation Factors (73-75); Enzyme Precursors (73-75); Kallikrein (73-75) )EDg`Prejudice F01.829.595 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social A preconceived judgment made without adequate evidence and not easily alterable by presentation of contrary evidence. ) LPreimplantation Phase G08.520.500.690 DEGEIMPHRE Blastocyst Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Ovum Implantation The time period between fertilization and implantation. specific mammal/embryology (66-74); Blastocyst (74); Embryo (66-74); Mammals/embryology (66-74); Ovum (66-74); Ovum Implantation (66-74)  *-]BPregnenolone Carbonitrile D02.626.745; D04.808.183.620; D04.808.745.745.725.703; D06.597.225.620 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles Polycyclic Hydrocarbons; Steroids; Catatoxic Steroids Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Catatoxic Steroids (3 beta,16 alpha)-3-Hydroxy-20-oxopregn-5-ene-16-carbonitrile. A catatoxic steroid and microsomal enzyme inducer having significant effects on the induction of cytochrome P450. It has also demonstrated the potential for protective capability against acetaminophen-induced liver damage. *P: DPregnenolone D04.808.745.745.725; D06.472.040.322.478.745; D06.472.798.670 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Progestational Hormones Hydroxypregnenolone; Pregnenolone Carbonitrile *ED(7Pregnenes D04.808.745.745 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Cortisone; Dimethisterone; Ethisterone; Pregnenediones (+ 20); Pregnenolone (+ 2); Spironolactone Unsaturated derivatives of PREGNANES. Pregnanes (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $*/ 85u-DPregnenediones D04.808.745.745.654 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes Aldosterone; Corticosterone (+ 1); Cortodoxone; Cronolone; Desoxycorticosterone (+ 1); Fludrocortisone; Flurandrenolone; Gestonorone Caproate; Halcinonide; Hydrocortisone (+ 1); Progesterone (+ 6) Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  *8BoDPregnatrienes D04.808.745.683 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Pregnane derivatives containing three double bonds in the ring structures. Pregnanes (66-72) * P85XPregnanolone D04.808.745.640 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes 3 alpha-Hydroxy-5 beta-pregnan-20-one. A pregnane found in urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties. Hydroxysteroids (72-74); Ketosteroids (72-74); Pregnanes (69-74) * vB5MPregnanetriol D04.808.745.620; D06.472.798.570 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Progestational Hormones *0&:Pregnanes D04.808.745 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Pregnadienes (+ 35); Pregnanediol; Pregnanediones (+ 2); Pregnanetriol; Pregnanolone; Pregnatrienes; Pregnenes (+ 28); Tetrahydrocortisol Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  *Q 8(DPregnanediones D04.808.745.558 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Althesin; Tetrahydrocortisone Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton (or a combination thereof) have been oxidized to keto groups. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  *85#:Pregnanediol D04.808.745.495; D06.472.798.470 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Progestational Hormones *&DPregnancy, Unwanted G08.520.850 EHPHPXSN Reproduction, Urogenital Physiology (Non MeSH); Reproduction Pregnancy, usually accidental or unplanned, that is not desired by the parent or parents. Pregnancy (66-72) * GkPregnancy, Tubal C13.703.733.703 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy, Ectopic Ectopic pregnancy within an oviduct. (Dorland, 27th ed). *L}FPregnancy, Prolonged G08.520.769.689 BLCFDEEHGEIMMEPHPXREUR Pregnancy Complications Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Pregnancy continuing beyond the normal duration; in humans, usually beyond 294 days after the beginning of the last menses. (From Dorland, 27th ed). *0TPregnancy, Multiple G08.520.800 BLCFDEEHGEIMMEPHPXRESNUR Pregnancy Reduction, Multifetal Reproduction, Urogenital Physiology (Non MeSH); Reproduction Quadruplets; Quintuplets; Superfetation; Triplets; Twins (+ 2) The condition of bearing two or more fetuses simultaneously. (Stedman, 25th ed). BLCFCLDEEDEHGEHIIMLJMEPHPXRESNUR $*%GLb$Pregnancy, High-Risk G08.520.769.525 BLCFDEEHGEIMMEPHPXREUR Pregnancy Complications Maternal Age 35 and over Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Pregnancy in which the mother and/or fetus are at greater than normal risk of morbidity or mortality. Causes include lack of adequate prenatal care, previous obstetrical history, pre-existing maternal disease or pregnancy-induced disease, and multiple gestation, as well as advanced maternal age. Pregnancy Complications (66-94) $*o TX%Pregnancy, Ectopic C13.703.733 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Pregnancy, Abdominal; Pregnancy, Tubal Development of the fertilized ovum outside of the uterine cavity. (Dorland, 27th ed). *Lf.hPregnancy, Animal G08.520.780 BLCFDEGEIMMEPHPXREUR Animals, Newborn Reproduction, Urogenital Physiology (Non MeSH); Reproduction Estrus (+ 5); Litter Size *G#Pregnancy, Abdominal C13.703.733.536 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy, Ectopic Ectopic pregnancy with development of the fetus in the abdominal cavity. (Dorland, 27th ed). *iL}pPregnancy-Specific beta 1-Glycoprotein D06.472.759.730; D06.472.785.730; D12.776.780.730 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Placental Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins A glycoprotein with the electrophoretic mobility of a beta-1 globulin. It is produced by the placental trophoblast and secreted into the maternal bloodstream during pregnancy. It can be detected 18 days after ovulation and its concentration in plasma rises steadily until, at the end of gestation, it reaches 200 mg/ml. It has been proposed as a measure of placental function for fertility control and is a candidate for an early pregnancy test. Beta Globulins (66-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79); Serum Globulins (66-79) * ,9D  Pregnancy-Associated beta Plasma Protein D06.472.785.710; D12.776.780.710 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins A beta globulin now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation. Beta Globulins (66-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79); Serum Globulins (66-79) *%`/&DPregnancy-Associated alpha Plasma Protein D06.472.785.700; D12.776.780.700 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation. Alpha Globulins (66-79); Alpha Macroglobulins (76-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79) *(0&DPregnancy Zone Proteins D06.472.785.760; D12.776.780.760 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins Glycoproteins with the electrophoretic mobility of an alpha 2-globulin. They are found in small amounts in normal human plasma but in much larger volume in the plasma of pregnant women. These proteins have also been found in increased amounts in individuals undergoing estrogen therapy and are sometimes produced ectopically by tumors of non-placental origin. Pregnancy zone proteins are believed to be of maternal rather than placental origin. Alpha Globulins (66-79); Alpha Macroglobulins (76-79); Blood Proteins (66-79); Glycoproteins (66-79); Pregnancy (66-79) *+&DPregnancy Trimesters (Non MeSH) G08.520.840 Reproduction, Urogenital Physiology (Non MeSH); Reproduction Pregnancy Trimester, First; Pregnancy Trimester, Second; Pregnancy Trimester, Third BLCFDEEHGEIMMEPHPXREUR */&GaPregnancy Trimester, Third G08.520.840.520 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Trimesters (Non MeSH) Period of pregnancy from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Gestational Age (68-74); Pregnancy (66-74); Time Factors (67-74) *0 mOPregnancy Trimester, Second G08.520.840.490 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Trimesters (Non MeSH) Period of pregnancy from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Gestational Age (68-74); Pregnancy (66-74); Time Factors (67-74) *1!mOPregnancy Trimester, First G08.520.840.408 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Trimesters (Non MeSH) Period of pregnancy from the first day of the last normal menstrual period through the completion of 14 weeks (98 days) of gestation. Gestational Age (68-74); Pregnancy (66-74); Time Factors (67-74) *3 mOPregnancy Toxemias C13.703.799 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Toxemia Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Eclampsia (+ 3); Gestosis, EPH; Hyperemesis Gravidarum Pregnancy-induced hypertensive states, including EPH gestosis when edema and proteinuria accompany hypertension. Other hypertensive disorders that develop during pregnancy or the puerperium are pre-eclampsia and eclampsia, either of which may be superimposed upon chronic hypertensive vascular or renal disease.  *5cL fCcPregnancy Tests, Immunologic E01.223.495.785; E01.223.700.620; E01.249.682.620 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunologic Techniques Diagnosis; Diagnosis, Laboratory; Immunologic Tests Diagnosis; Diagnosis, Laboratory; Pregnancy Tests Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Pregnancy Tests Pregnancy Tests (66-72) *8"9"Pregnancy Tests E01.223.700; E01.249.682 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Pregnancy Tests, Immunologic Pregnancy Tests, Immunologic Tests to determine whether or not an individual is pregnant. *9"UBJPregnancy Reduction, Multifetal E04.819.774.173.340.700; E04.819.774.173.700 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pregnancy, Multiple Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Abortion, Induced; Abortion, Therapeutic Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Abortion, Induced Selective abortion of one or more embryos or fetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or fetuses. Abortion, Induced (84-94); Pregnancy, Multiple (84-94)  *;%2$APregnancy Proteins D06.472.785; D12.776.780 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins Gonadotropins, Chorionic; Gonadotropins, Equine; Placental Lactogen; Pregnancy-Associated alpha Plasma Protein; Pregnancy-Associated beta Plasma Protein; Pregnancy-Specific beta 1-Glycoprotein; Pregnancy Zone Proteins Gonadotropins, Chorionic; Gonadotropins, Equine; Placental Lactogen; Pregnancy-Associated alpha Plasma Protein; Pregnancy-Associated beta Plasma Protein; Pregnancy-Specific beta 1-Glycoprotein; Pregnancy Zone Proteins Proteins produced by organs of the mother or the placenta during pregnancy. They may be either pregnancy specific (present only during pregnancy) or pregnancy associated (always present during pregnancy, but may also be present in individuals undergoing estrogen therapy, taking oral contraceptives or in patients with certain malignancies.). Placenta (66-79); Placental Hormones (66-79); Pregnancy (66-79); Proteins (66-79); specific protein AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $*=FyHPregnancy Outcome C13.703.778 ECEHEPGEPXVE Epidemiologic Methods Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Possible sequelae to conception and subsequent pregnancy. The concept usually refers to, but is not limited to the consequences of an abnormal pregnancy, e.g., fetal death, fetal disease, and spontaneous abortion. Pregnancy Complications (66-87); Pregnancy (66-87)  *C7f<Pregnancy Maintenance G08.520.769.640 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Physiological mechanisms that sustain the state of pregnancy. *ELTIPregnancy in Diabetes C13.703.766; C18.452.297.820; C19.246.820 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diabetes, Gestational Diabetes, Gestational Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Diabetes, Gestational; Fetal Macrosomia Diabetes, Gestational; Fetal Macrosomia Diabetes, Gestational; Fetal Macrosomia  *FG1LPregnancy in Adolescence G08.520.420.770 BLCFDEEHGEIMMEPHPXRESNUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Maternal Age Pregnancy in girls under 19. Adolescence (66-78); Pregnancy (66-78) *HX%/Pregnancy Complications, Parasitic C03.718; C13.703.700.680 BLCFCICLDHDIDTECEHENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Parasitic Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Infectious Parasitic diseases occurring during the course of pregnancy, or pregnancy during the course of a parasitic disease. Some of the more commonly co-occurring infections are amebiasis, malaria and toxoplasmosis. Pregnancy Complications, Infectious (66-92) *I(D2Pregnancy Complications, Neoplastic C04.850; C13.703.720 BLCFCICLDHDIDTECEHENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Trophoblastic Neoplasms (+ 4) Trophoblastic Neoplasms (+ 4) Neoplasms occurring during the course of pregnancy, or pregnancy during the course of a neoplastic disease. specific neoplasms (66-82); Pregnancy Complications (66-82) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $*LR)DqFFXPregnancy Complications, Infectious C01.539.674; C13.703.700 BLCFCICLDHDIDTECEHENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Abortion, Septic; Puerperal Infection Abortion, Septic; Pregnancy Complications, Parasitic; Puerperal Infection Infections occurring during the course of pregnancy, or pregnancy during the course of an infectious disease. BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  *N)DNPregnancy Complications, Hematologic C13.703.667; C15.378.785 BLCFCICLDHDIDTECEHENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases The co-occurrence of pregnancy and a blood disease. The hematologic disorder may be of the cells or coagulation elements of the blood but does not refer to deficiencies or excesses of various substances in the blood, such as hypercalcemia or hypocalcemia. It may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus. *Q*DPregnancy Complications, Cardiovascular C13.703.634; C14.583 BLCFCICLDHDIDTECEHENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Cardiovascular Diseases Embolism, Amniotic Fluid Embolism, Amniotic Fluid The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus. BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  *T-D:LPregnancy Complications C13.703 BLCFCICLDHDIDTECEHENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pregnancy, Prolonged Obstetrics; Pregnancy, High-Risk; Perinatology Female Genital Diseases and Pregnancy Complications (Non MeSH) Abortion (+ 7); Fetal Death (+ 2); Fetal Diseases (+ 9); Herpes Gestationis; Labor Complications (+ 9); Labor, Premature; Oligohydramnios; Phenylketonuria, Maternal; Placenta Diseases (+ 6); Polyhydramnios; Pregnancy Complications, Cardiovascular (+ 1); Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious (+ 3); Pregnancy Complications, Neoplastic (+ 5); Pregnancy, Ectopic (+ 2); Pregnancy in Diabetes (+ 2); Pregnancy Outcome; Pregnancy Toxemias (+ 6); Puerperal Disorders (+ 6) The co-occurrence of pregnancy and a disease. The disease may precede or follow conception and it may or may not have a deleterious effect on the pregnant woman or fetus. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI (*W2 D7IWZPregnancy G08.520.769 BLCFDEEHGEIMMEPHPXRESNUR Prenatal Care; Pseudopregnancy Reproduction, Urogenital Physiology (Non MeSH); Reproduction Corpus Luteum Maintenance; Labor (+ 6); Labor Presentation (+ 1); Maternal-Fetal Exchange; Pregnancy, High-Risk; Pregnancy Maintenance; Pregnancy, Prolonged The condition of having a developing embryo or fetus in the body, after union of an ovum and spermatozoon. (Dorland, 27th ed).  *[ %GPregnadienetriols D04.808.745.432.769 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Beclomethasone; Betamethasone (+ 1); Desonide; Dexamethasone (+ 1); Flumethasone; Paramethasone; Prednisolone (+ 5) Doubly unsaturated pregnane derivatives substituted with three hydroxy groups anywhere within the ring structure or side chains. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  *^ 8E:Pregnadienes D04.808.745.432 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes Canrenoate Potassium (+ 1); Chlormadinone; Cyproterone (+ 1); Danazol; Dydrogesterone; Fluocinolone Acetonide (+ 1); Medrogestone; Megestrol; Melengestrol; Pregnadienediols (+ 5); Pregnadienetriols (+ 14); Triamcinolone (+ 1) Pregnane derivatives containing two double bonds anywhere within the ring structures. Pregnanes (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $*`785d:Pregnadienediols D04.808.745.432.719 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Desoximetasone; Fluocortolone (+ 1); Fluorometholone; Prednisone Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  *b8EM:Prefrontal Cortex A08.186.211.730.885.213.270.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex; Frontal Lobe The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the mediodorsal nucleus of the thalamus. The prefrontal cortex receives afferent fibers from numerous structures of the diencephalon, mesencephalon, and limbic system as well as cortical afferents of visual, auditory, and somatic origin. Cerebral Cortex (66-92); Frontal Lobe (66-92) *d#88Preferred Provider Organizations N03.219.521.576.343.800.750; N04.590.374.410.750 CLECHILJMAOGSNSTTDUT Competitive Medical Plans Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Managed Care Programs Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care; Managed Care Programs Arrangements negotiated between a third-party payer (often a self-insured company or union trust fund) and a group of health-care providers (hospitals and physicians) who furnish services at lower than usual fees, and, in return, receive prompt payment and an expectation of an increased volume of patients. Insurance, Health (66-84)  *g&6-ePrednisone D04.808.745.432.719.702; D06.597.481.561.478.758; D17.025.050.650; D17.050.040.670; D22.204.717 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienediols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione. A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to PREDNISOLONE in the liver. *jk:Prednisolone, Topical D04.808.745.432.769.795.744; D06.597.481.364.807; D17.025.050.625.750; D17.025.080.200.750; D23.037.200.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols; Prednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Prednisolone that is applied topically as an anti-inflammatory agent. *oPw:RPrednisolone D04.808.745.432.769.795; D06.597.481.561.353.744; D06.597.481.561.478.702; D17.025.050.625; D17.050.040.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal Fluprednisolone; Methylprednisolone (+ 1); Prednimustine; Prednisolone, Topical Fluprednisolone; Methylprednisolone (+ 1) Fluprednisolone; Methylprednisolone (+ 1) Fluprednisolone; Methylprednisolone (+ 1); Prednisolone, Topical Fluprednisolone; Methylprednisolone (+ 1) A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. *sSw:4Prednimustine D02.455.526.728.650.156.700; D04.808.745.432.769.795.700; D22.204.585.186.742 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds; Chlorambucil Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols; Prednisolone Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds; Chlorambucil 11-beta,17,21-Trihydroxypregna-1,4-diene- 3,20-dione 21-[4[p(bis(2- chloroethyl)amino)phenyl]butyrate]. Ester of chlorambucil and prednisolone; combination alkylating agent and synthetic steroid used in various leukemias and other neoplasms; causes gastrointestinal and bone marrow toxicity. Synonyms: EORTC 1502; Leo 1031; NSC 134087; Stereocyt. Chlorambucil (66-74) /AA (75-79); Prednisolone (66-74) /AA (75-79) *yyU:~OPredictive Value of Tests E05.318.780.800.650; G03.850.520.840.800.650; H01.548.832.672.500; N05.715.360.780.700.640 False Negative Reactions; False Positive Reactions Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH); Sensitivity and Specificity Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH); Sensitivity and Specificity Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH); Sensitivity and Specificity In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. *} d<0Prediabetic State C18.452.297.774; C19.246.774 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diabetes Mellitus Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus *"NPredatory Behavior F01.145.113.111.600; F01.145.113.252.520 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Appetitive Behavior Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Consummatory Behavior Instinctual behavior pattern in which food is obtained by killing and consuming other species. *. pPreconception Care E02.472.775; N02.421.143.620.620; N02.421.589.745; N02.421.920.660 CLECHILJMAMTOGSNSTTDUT Prenatal Care Genetic Counseling Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Maternal Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Women's Health Services An organized and comprehensive program of health care that identifies and reduces a woman's reproductive risks before conception through risk assessment, health promotion, and interventions. Preconception care programs may be designed to include the male partner in providing counseling and educational information in preparation for fatherhood, such as genetic counseling and testing, financial and family planning, etc. This concept is different from PRENATAL CARE, which occurs during pregnancy. Pregnancy (81-91) $*L<Precipitins D24.611.125.837 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies which elicit precipitation when combined with antigen. *Q6iMPrecipitin Tests E01.223.495.826.769 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Flocculation Tests; Immunodiffusion (+ 3) Serologic tests in which a positive reaction manifested by visible precipitation occurs when a soluble antigen reacts with its antibody. *"N2Precipitation H01.181.529.741 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Flocculation; Fractional Precipitation *I-Precipitating Factors G03.850.490.625.500; N05.715.350.200.650 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Causality Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Causality Factors associated with the definitive onset of a disease, illness, accident, behavioral response, or course of action. Usually one factor is more important or more obviously recognizable than others, if several are involved, and one may often be regarded as "necessary". Examples include exposure to specific disease; amount or level of an infectious organism, drug, or noxious agent, etc. Risk (66-89); specific disease/epidemiology (66-89); specific disease/etiology (66-89) *.gPreceptorship I02.600 CLECHILJMAMTOGSNSTTD Education An educational program designed to give the professionally trained student experience outside the academic environment working in the specialty area of his choice with a physician, dentist or other advisory supervisors. Education, Dental (66-74); Education, Medical (66-74) *F  @Precancerous Conditions C04.834 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Hyperplasia; Neoplasms Neoplasms Cervix Dysplasia; Erythroplasia; Leukoplakia (+ 2); Lymphomatoid Granulomatosis; Lymphomatoid Papulosis; Preleukemia; Xeroderma Pigmentosum Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed).  * X kPreanesthetic Medication E03.806; E04.641.619 AECLCTECHIISMOMTNUPXSNSTTDUTVE Premedication Anesthesia and Analgesia (Non MeSH) Surgery, Operative; Preoperative Care *"VPrealbumin D12.776.034.841.450; D12.776.124.727.450 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins; Serum Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Albumin A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease. Protein Precursors (73-74); Serum Albumin (72-74)  *.D C<Pre-Excitation, Mahaim-Type C14.280.067.780.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Pre-Excitation Syndromes A form of pre-excitation characterized by a normal PR interval and a long QRS interval with a delta wave. * NZPre-Excitation Syndromes C14.280.067.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Lown-Ganong-Levine Syndrome; Pre-Excitation, Mahaim-Type; Wolff-Parkinson-White Syndrome Conditions characterized by activation of the whole or some part of the ventricle by the atrial impulse earlier than would be expected if the impulse reached the ventricle by way of the normal specific conduction system only. Arrhythmia (66-85); Heart Conduction System (66-85); Tachycardia (66-85)  *0N=c WPre-Eclampsia C13.703.799.314.619 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eclampsia Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Toxemias; Eclampsia HELLP Syndrome Development of hypertension with proteinuria, edema, or both, due to pregnancy or the influence of a recent pregnancy. It occurs after the 20th week of gestation, but it may develop before this time in the presence of trophoblastic disease. Pregnancy Toxemias (66-74) $*L  Prazosin D03.438.786.750; D14.100.050.200.100.690; D16.050.850.760; D18.162.730 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinazolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents Doxazosin Doxazosin A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention. Piperazines (74-76); Quinazolines (74-76)  *c P:2Praziquantel D03.438.531.690; D21.201.412.534 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents 2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one. An anthelmintic used in most schistosome and many cestode infestations. It may be given orally, parenterally or by nasal spray. Isoquinolines (69-79); Pyrazines (66-79); Quinolines (66-68) *&:IPrazepam D03.438.079.080.070.784; D14.100.240.500.730; D15.075.050.650; D15.210.950.012.050.700; D15.700.872.015.050.795 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine A benzodiazepine that is used in the treatment of anxiety disorders. Benzazepines (68-71); Muscle Relaxants, Central (70-71) *] {:SBPravastatin D04.615.638.930; D08.373.740; D10.162.202.700 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents (1S-(1 alpha(beta S*,delta S*),2 alpha,6 alpha,8 beta(R*),8a alpha))-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic acid. An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES). *5@Prasterone D04.808.054.079.429.625; D04.808.578.502.620; D06.472.040.502.620; D06.472.079.750; D06.472.866.154.750 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Androgens (3 beta)-3-Hydroxyandrost-5-en-17-one. A naturally occurring androgen isolated from urine. *sDiPraseodymium D01.268.558.650; D01.552.550.679 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Praseodymium. An element of the rare earth family of metals. It has the atomic symbol Pr, atomic number 59, and atomic weight 140.91. *&:Pralidoxime Compounds D02.092.570.665.535 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Oximes Various salts of a quaternary ammonium oxime that reconstitute inactivated acetylcholinesterase, especially at the neuromuscular junction, and may cause neuromuscular blockade. They are used as antidotes to organophosphorus poisoning as chlorides, iodides, methanesulfonates (mesylates), or other salts. *8JZPrajmaline D03.132.973.641.119.650; D03.549.937.641.144.650; D18.097.069.612 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Yohimbans; Rauwolfia Alkaloids; Ajmaline Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Yohimbans; Rauwolfia Alkaloids; Ajmaline Cardiovascular Agents; Anti-Arrhythmia Agents; Ajmaline 17R,21 alpha-Dihydroxy-4-propylajmalinium. A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage. Ajmaline (71-74) /analogs and derivatives (75-79); Rauwolfia (66-71) *I<QPrader-Willi Syndrome C10.496.770; C16.131.077.730; C16.131.280.600; C18.654.621.740; F03.709.346.790 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Obesity Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A congenital disorder of unknown etiology characterized by mental retardation, muscular hypotonia, obesity, short stature, hypogonadism, and frequently developing insulin-resistant diabetes. Abnormalities, Multiple (68-76); Carbohydrate Metabolism, Inborn Errors (69-76); Hypogonadism (66-76); Mental Retardation (66-76); Obesity (66-76) *[LPractolol D02.033.329.624.795; D02.092.063.624.795; D14.100.050.200.200.710; D16.050.850.750; D18.097.614 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents A beta-adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias. * k:tPractice Management, Medical N04.452.758.572.702 CLECHILJOGSNSTTDUT Professional Practice Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Office Management The organization and operation of the business aspects of a physician's practice. Office Management (66-67)  *"aPractice Management, Dental N04.452.758.572.535 CLECHILJOGSNSTTDUT Professional Practice Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Office Management The organization and operation of the business aspects of a dental practice. Dentistry (66-67); Office Management (66-67)  *!\6Practice Guidelines N04.761.700.350.650; N05.700.350.650 ST Health Services Administration (Non MeSH); Quality of Health Care; Quality Assurance, Health Care; Guidelines Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Guidelines Directions or principles presenting current or future rules of policy for the health care practitioner to assist him in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery. *@*Practice (Psychology) F02.463.425.674 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Performance of an act one or more times, with a view to its fixation or improvement; any performance of an act or behavior that leads to learning. *ĤZPoxviridae Infections C02.256.743 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Cowpox; Ecthyma, Contagious; Ectromelia, Infectious; Fowlpox; Lumpy Skin Disease; Milker's Nodes; Molluscum Contagiosum; Myxomatosis, Infectious; Smallpox (+ 1); Vaccinia Virus diseases caused by the POXVIRIDAE. *P:2Poxviridae B04.280.650; B04.909.204.783 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Chordopoxvirinae (+ 21); Entomopoxvirinae Chordopoxvirinae (+ 21) A family of double-stranded DNA viruses infecting mammals (including humans), birds and insects. There are two subfamilies: CHORDOPOXVIRINAE, poxviruses of vertebrates, and ENTOMOPOXVIRINAE, poxviruses of insects. *"YMPower Sources E07.690 AECLCTECHISDSNSTTDUTVE Bioelectric Energy Sources Energy-Generating Resources Equipment and Supplies Bioelectric Energy Sources Devices that supply energy. $*    #Power Plants H01.671.252.780; J01.780 CLECEDHIISLJMAMTOGSNSTTD Energy-Generating Resources Physical Sciences (Non MeSH); Physics; Electricity Technology, Industry, Agriculture (Non MeSH) Units that convert some form of energy into electrical energy, such as hydroelectric or steam-generating stations, diesel-electric engines in locomotives, or nuclear power plants. Air Pollution (66-76); Nuclear Energy (66-76); Electricity (66-76); Nuclear Reactors (66-76); Occupational Medicine (66-76)  * pPower (Psychology) F01.145.698; F01.658.780 Social Control, Informal Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Motivation The exertion of a strong influence or control over others in a variety of settings--administrative, social, academic, etc. *PPowders D26.394.225.672 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Kaolin; Talc * ,MPovidone-Iodine D02.455.326.271.884.533.710; D03.383.773.812.615.630; D20.187.524.600; D25.720.716.721.838.745; D26.561.600 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Vinyl Compounds; Polyvinyls Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones; Povidone Anti-Infective Agents; Anti-Infective Agents, Local; Iodophors Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Polyvinyls; Povidone Miscellaneous Drugs and Agents (Non MeSH); Iodophors 1-Ethenyl-2-pyrrolidone homopolymer complexed with iodine. An iodinated polyvinyl polymer used as topical antiseptic in surgery and for skin and mucous membrane infections, also as aerosol. The iodine may be radiolabeled for research purposes. *Ϥw,Povidone D02.455.326.271.884.533.699; D03.383.773.812.615; D19.461.140.500.968; D25.720.716.721.838; D26.698.716 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Vinyl Compounds; Polyvinyls Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Blood Substitutes; Plasma Substitutes Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Polyvinyls Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids  Povidone-Iodine Povidone-Iodine 1-Ethenyl-2-pyrrolidinone homopolymer. A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. Synonyms: Kollidon; Periston; Plasdone; Plasmosan; PVP; 143-RP. *} s.'2Poverty Areas I01.880.840.535.550; N01.824.600.550 Social Sciences; Sociology; Socioeconomic Factors; Poverty Population Characteristics (Non MeSH); Socioeconomic Factors; Poverty City, urban, rural, or suburban areas which are characterized by severe economic deprivation and by accompanying physical and social decay. Poverty (68-79) **Poverty I01.880.735.634; I01.880.840.535; N01.824.600 CLECEHHILJPCPXSNTD Cultural Deprivation Social Sciences; Sociology; Social Problems Social Sciences; Sociology; Socioeconomic Factors Population Characteristics (Non MeSH); Socioeconomic Factors  Poverty Areas Poverty Areas A situation in which the level of living of an individual, family, or group is below the standard of the community. It is often related to a specific income level.  *m 5#Poultry Products J01.341.805 AEANCLECHIMIPOPSRESDSNSTTOUTVI Eggs Technology, Industry, Agriculture (Non MeSH); Food Food products manufactured from poultry (e.g., liver pate). Poultry (66-67)  *ۣ"=HPoultry Diseases C22.131.728 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Bird Diseases Diseases of birds which are raised as a source of meat or eggs for human consumption and are usually found in barnyards, hatcheries, etc. The concept is differentiated from BIRD DISEASES which is for diseases of birds not considered poultry and usually found in zoos, parks, and the wild. *ܵH&VPoultry B02.248.617 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds Chickens; Ducks; Geese; Turkeys * &)Potyvirus B04.715.464.600; B04.820.464.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses Plum Pox Virus Plum Pox Virus A large group of plant viruses which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. Some possible members of the group are transmitted by whiteflies, mites, or fungi. Mosaic Viruses (73-93); Plant Viruses (67-93)  *d &\&8Potexvirus B04.715.620; B04.820.580 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses A group of plant viruses that cause mosaic and ringspot symptoms. Transmission occurs mechanically. Mosaic Viruses (83-93); Plant Viruses (88-93) *6v8Potentiometry E05.196.922.750; H01.181.529.307.794 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Titrimetry Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry Solution titration in which the end point is read from the electrode-potential variations with the concentrations of potential determining ions. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). **"Potatoes B06.510.956.600; J01.341.956.782 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables Solanum tuberosum, one of the annual, herbaceous, poisonous Solanaceae or its non-poisonous tubers which are highly nutritious as food crops of the temperate regions. The plant yields starch and other nutrients, a number of enzymes, alkaloids, and lectins; the berries are very toxic. Plants (66-85); Plants, Edible (66-85); Vegetables (66-85) *" &4tMHPotassium, Dietary D01.745.660 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Potassium Compounds Potassium or potassium compounds used in foods or as foods. Potassium (66-92) *6>IPotassium Radioisotopes D01.496.705.700; D01.496.749.690 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Potassium Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of potassium that decay or disintegrate emitting radiation. K atoms with atomic weights 37, 38, 40, and 42-45 are radioactive potassium isotopes. Potassium Isotopes (66-74); Radioisotopes (66-74) *&4;Potassium Permanganate D01.530.700; D01.745.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Manganese Compounds Inorganic Chemicals (Non MeSH); Potassium Compounds Permanganic acid (HMnO4), potassium salt. A highly oxidative, water-soluble compound with purple crystals, and a sweet taste. (From McGraw-Hill Dictionary of Scientific and Technical Information, 4th ed). *8zPotassium Magnesium Aspartate D12.125.119.170.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Aspartic Acid An intra-extracellular electrolyte exchange agent with a variety of effects. Beneficial in cardiac insufficiency, potentiates the effect of cardiac glycosides by reducing their toxicity, has hypocholesteremic effects and potentiates the effects of calcium in disturbed calcium metabolism. Synonyms: Panangin; Tromcardin. Asparagine (72-73); Aspartic Acid (74-76); Magnesium (72-75); Potassium (72-75) *#:yoaPotassium Isotopes D01.496.705 Inorganic Chemicals (Non MeSH); Isotopes Potassium Radioisotopes Stable potassium atoms that have the same atomic number as the element potassium, but differ in atomic weight. K-41 is a stable potassium isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR *24Potassium Iodide D01.475.410.700; D01.745.680 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Iodine Compounds; Iodides Inorganic Chemicals (Non MeSH); Potassium Compounds Potassium iodide (KI). An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed). *Y"8Potassium Dichromate D01.205.750; D01.220.150.650; D01.745.650; D05.569.185.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Caustics Inorganic Chemicals (Non MeSH); Chromium Compounds; Chromates Inorganic Chemicals (Non MeSH); Potassium Compounds Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Caustics Chromic acid (H2Cr2O7), dipotassium salt. A compound having bright orange-red crystals and used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically it has been used externally as an astringent, antiseptic, and caustic. When taken internally, it is a corrosive poison. Chromates (69-74) *QD8rPotassium Deficiency C18.654.223.617 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypokalemia Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing polyuria and decreased maximal urinary concentrating ability with secondary polydipsia. (Merck Manual, 16th ed, p. 999-1000). *NgPotassium Cyanide D01.625.400.100.750; D01.745.635 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide; Cyanides Inorganic Chemicals (Non MeSH); Potassium Compounds Potassium cyanide (K(CN)). A highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes. Cyanides (66-78); Potassium (66-78) *&8,Potassium Compounds D01.745 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Potassium Chloride; Potassium Cyanide; Potassium Dichromate; Potassium, Dietary; Potassium Iodide; Potassium Permanganate Inorganic compounds that contain potassium as an integral part of the molecule. Potassium (66-93)  *8 8%_Potassium Chloride D01.210.450.150.750; D01.745.625 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Inorganic Chemicals (Non MeSH); Potassium Compounds Potassium chloride. A white crystal or crystalline powder used as an electrolyte replenisher, in the treatment of hypokalemia, in buffer solutions, and in fertilizers and explosives. *&8Potassium Channels D12.776.395.550.440.750; D12.776.543.550.425.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Na(+)-K(+)-Exchanging ATPase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Ion Channels Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Ion Channels Cell membrane glycoproteins selective for potassium ions. Ion Channels (79-88); Potassium (79-88)  +6F%D1Potassium D01.268.549.550; D01.552.528.652 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Hyperkalemia; Hypokalemia Inorganic Chemicals (Non MeSH); Elements; Metals, Alkali Inorganic Chemicals (Non MeSH); Metals; Metals, Alkali Potassium. An element that is in the alkali group of metals. It has an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte and it plays a significant role in the regulation of fluid volume and maintenance of the water-electrolyte balance. +Y &:Posture G11.427.818 PH Hypotension, Orthostatic; Kinesics Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Head-Down Tilt; Prone Position; Supine Position The position of the limbs or the carriage of the body as a whole. (Stedman, 25th ed.). AEPH $+A )p:mPostpoliomyelitis Syndrome C02.782.687.359.764.650; C05.651.518.650; C05.651.661.468.650; C10.228.228.769.650; C10.228.854.641.650; C10.668.468.650 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Poliomyelitis Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections; Poliomyelitis Musculoskeletal Diseases; Muscular Diseases; Muscular Atrophy Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases; Muscular Atrophy Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Poliomyelitis Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases; Poliomyelitis Nervous System Diseases; Neuromuscular Diseases; Muscular Atrophy A "postpolio" syndrome characterized by new neuromuscular symptoms, including muscle weakness, that develops years after recovery from poliomyelitis. The symptoms may vary from simple nonprogressive deterioration of function, with joint pain, fatigue, and subsequent stabilization, to atypical forms of spinal muscular dystrophy. The new, slowly progressive muscle weakness may occur in muscles that were previously affected by polio and recovered or in muscles that were clinically unaffected by the acute disease. Poliomyelitis/complications (83-90)  +JkP)Postphlebitic Syndrome C14.907.681.760; C14.907.952.760 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Phlebitis Cardiovascular Diseases; Vascular Diseases; Venous Insufficiency Post-thrombotic complications, including destruction of the valves of the deep veins and communication veins of the leg, and obliteration of the thrombosed veins rather than recanalization, resulting in chronic venous insufficiency, marked by edema, stasis dermatitis, and ulceration of the leg. Phlebitis (66-86); Thrombophlebitis (66-86); Varicose Ulcer (66-86); Venous Insufficiency (73-86) + &NTtPostpericardiotomy Syndrome C14.280.793; C23.814.668 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Symptoms and General Pathology (Non MeSH); Postoperative Complications A febrile illness associated with pericardial and sometimes pleuropulmonary reaction that often follows extensive pericardiotomy. + NPostpartum Hemorrhage C13.703.420.725; C13.703.844.700; C23.542.946.700 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Puerperal Disorders Symptoms and General Pathology (Non MeSH); Hemorrhage; Uterine Hemorrhage Hemorrhage occurring soon after labor or childbirth. (Dorland, 27th ed). +9LPXPostoperative Period E04.630 Surgery, Operative Anesthesia Recovery Period The period following a surgical operation. +  4Postoperative Complications C23.814 BLCFCICLDHDIDTECENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Surgery, Operative Symptoms and General Pathology (Non MeSH) Afferent Loop Syndrome; Graft Occlusion, Vascular; Malignant Hyperthermia; Pain, Postoperative; Postcholecystectomy Syndrome; Postgastrectomy Syndromes (+ 1); Postpericardiotomy Syndrome; Prosthesis Failure; Prosthesis-Related Infections; Reperfusion Injury (+ 1); Shock, Surgical; Short Bowel Syndrome; Surgical Wound Dehiscence; Surgical Wound Infection Disorders affecting patients after surgery. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $+  B2PPostoperative Care E02.472.750; E04.624; N02.421.589.725 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; General Patient Care (Non MeSH) Surgery, Operative Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed). +t-$Postnatal Care E02.472.741; N02.421.143.620.534 CLECHILJMAMTOGPXSNSTTDUT Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Maternal Health Services The care provided a woman following the birth of a child. Puerperium (66-70) +&HPostmortem Changes C23.240.224.617 Symptoms and General Pathology (Non MeSH); Death; Cadaver Autolysis; Rigor Mortis Changes that occur in bodies after death. Death (66-69) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  +YG4NPostmenopause G08.520.940.110.308.750 BLCFDEEHGEIMMEPHPXREUR Menopause Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sexual Reproduction Periods (Non MeSH); Climacteric; Menopause The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life. Since in the United States the age of the menopause ranges between 48 and 55 years, generally conceived as middle age, the postmenopause often refers to women considerably older. Climacteric (69-93); Menopause (69-93); Menstruation (66-93)  + BIPostimplantation Phase G08.520.500.670 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Ovum Implantation The time period between implantation and placentation. specific mammal/embryology (66-74); Embryo (66-74); Mammals/embryology (66-74); Ovum Implantation (66-74) +!B]A~Postgastrectomy Syndromes C06.405.650; C23.814.617 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gastrectomy Digestive System Diseases; Gastrointestinal Diseases Symptoms and General Pathology (Non MeSH); Postoperative Complications Dumping Syndrome Dumping Syndrome Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (dumping syndrome and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $+"L(NPosterior Cruciate Ligament A02.513.514.600; A02.835.583.512.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Anterior Cruciate Ligament; Medial Collateral Ligament, Knee Anterior Cruciate Ligament; Patellar Ligament Musculoskeletal System; Ligaments; Ligaments, Articular Musculoskeletal System; Skeleton; Joints; Ligaments, Articular A strong ligament of the knee that originates from the anterolateral surface of the medial condyle of the femur, passes posteriorly and inferiorly between the condyles, and attaches to the posterior intercondylar area of the tibia. Knee Joint (73-90); Ligaments, Articular (73-90) $+%!*:G6;Postcholecystectomy Syndrome C06.130.825; C23.814.575 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cholecystectomy Digestive System Diseases; Biliary Tract Diseases Symptoms and General Pathology (Non MeSH); Postoperative Complications Abdominal sequelae of cholecystectomy as a result of various biliary tract disorders. Often the same symptoms that are present before the operation recur or postoperative symptoms such as colicky pain, bloating, nausea, and vomiting occur. There is pain on palpation of the right upper quadrant and sometimes jaundice. (Magalini, Dictionary of Medical Syndromes, 3d ed). Cholecystectomy (66-93); Postoperative Complications (66-93)  +(!LFPostanesthesia Nursing G02.478.676.670; N02.421.533.725 CLECEDHIISLJMAMTOGSNSTTD Anesthesia Recovery Period Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The specialty or practice of nursing in the care of patients in the recovery room following surgery and/or anesthesia. Recovery Room (75-91); Surgical Nursing (75-91)  ++& :Postal Service I01.451.617 CLECEDHILJMAMTOGSDSNSTTDUT Social Sciences; Government Programs (Non MeSH) The functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express. +-9Post and Core Technique E06.780.345.250.500 AECLCTECHIISMAMONUPXSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Crowns Use of a metal casting, usually with a post in the pulp or root canal, designed to support and retain an artificial crown. +/8"?Positive-Pressure Respiration, Intrinsic C08.618.846.688 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Non-therapeutic positive end-expiratory pressure occurring frequently in patients with severe airway obstruction. It can appear with or without the administration of external positive end-expiratory pressure (POSITIVE-PRESSURE RESPIRATION). It presents an important load on the inspiratory muscles which are operating at a mechanical disadvantage due to hyperinflation. Auto-PEEP may cause profound hypotension that should be treated by intravascular volume expansion, increasing the time for expiration, and/or changing from assist mode to intermittent mandatory ventilation mode. (From Harrison's Principles of Internal Medicine, 12th ed, p. 1127). Positive-Pressure Respiration (82-94) +0.NX+Positive-Pressure Respiration E02.880.820.790 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy; Respiration, Artificial Intermittent Positive-Pressure Breathing; Intermittent Positive-Pressure Ventilation A method of mechanical ventilation in which pressure is maintained to increase the volume of gas remaining in the lungs at the end of expiration, thus reducing the shunting of blood through the lungs and improving gas exchange. +4""D^ Portugal Z01.542.727 EHEP Geographicals (Non MeSH); Europe +6 )Portraits K01.093.742 CLEDHIPXSNTD Humanities; Art +7@ Portography E01.145.077.756; E01.184.697; E01.357.818.084.730.756; E01.357.818.820.770 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Portal System; Portal Vein Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography; Angiography; Phlebography Diagnosis; Diagnostic Imaging; Radiography; Radiography, Abdominal (Non MeSH) Examination of the portal circulation by the use of X-ray films after injection of radiopaque material. +7T&"*{Portoenterostomy, Hepatic E04.035.775; E04.765.120.775 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Bile Ducts Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Operation for biliary atresia by anastomosis of the bile ducts into the jejunum or duodenum. Bile Ducts/surgery (71-87); Biliary Atresia/surgery (87); Duodenum/surgery (71-87); Liver/surgery (71-87); Jejunum/surgery (71-87)  +:"$oPortasystemic Shunt, Surgical E04.752.814.790; E04.035.760 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Hypertension, Portal Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Surgery, Operative; Anastomosis, Surgical Portacaval Shunt, Surgical; Splenorenal Shunt, Surgical Portacaval Shunt, Surgical; Splenorenal Shunt, Surgical Surgical venous shunt between the portal and systemic circulation to effect decompression of the portal circulation. It is performed primarily in the treatment of bleeding esophageal varices resulting from portal hypertension. Types of shunt include portacaval, splenorenal, mesocaval, splenocaval, left gastric-caval (coronary-caval), portarenal, umbilicorenal, and umbilicocaval. Esophageal and Gastric Varices/surgery (66-80); Hypertension, Portal/surgery (66-80); Portacaval Shunt, Surgical (66-80); Portal System/surgery (66-80); specific portal system vein/surgery (66-80) $+clDPolyribonucleotide Synthetase D08.586.464.754.720 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Polynucleotide Synthetases An enzyme that catalyzes the conversion of linear RNA to a circular form by the transfer of the 5'-phosphate to the 3'-hydroxyl terminus. It also catalyzes the covalent joining of two polyribonucleotides in phosphodiester linkage. EC 6.5.1.3. Polynucleotide Synthetases (74-77) + "Fo(Polyradiculoneuritis C10.772.582.629 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Neuritis Inflammation of many nerve roots and peripheral nerves. Guillain-Barre Syndrome is the commonest form. Polyradiculitis (66-78) +fNRyPolyradiculitis C10.772.582.763.616 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Spinal Nerve Roots Nervous System Diseases; Peripheral Nervous System Diseases; Neuritis; Radiculitis +NaPolyps C04.799 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms Intestinal Polyps (+ 4); Nasal Polyps A general descriptive term used with reference to any mass of tissue that bulges or projects outward or upward from the normal surface level, thereby being macroscopically visible as a hemispheroidal, spheroidal, or irregular moundlike structure growing from a relatively broad base or a slender stalk. Classically applied to a growth on the mucous membrane of the nose, the term is now applied to such protrusions from any mucous membrane. (From Stedman, 25th ed; Dorland, 27th ed). +  X 08Polypropylenes D02.455.326.271.665.590; D25.720.716.550 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Biomedical and Dental Materials (Non MeSH); Polymers; Plastics Propylene or propene polymers. Thermoplastics that can be extruded into fibers, films or solid forms; used as copolymer in plastics, especially polyethylene; the fibers are used for fabrics, filters, surgical sutures, etc. Synonyms: Herculon; Hostalen; Moplen; Noblen; Polypro; Prolene. Alkenes (72-74); Polymers (72-74) + .,R*Polyporaceae B05.354.179.760 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes A class of basidiomycetous fungi, order Aphyllophorales, living in decaying plant matter and timber. +">vPolyploidy G05.148.777.740 Genetics; Cytogenetics; Ploidies The chromosomal constitution of a cell containing multiples of the normal number of chromosomes; includes triploidy (symbol: 3N), tetraploidy (symbol: 4N), etc. Chromosome Abnormalities (66-67); Chromosomes (66-67) +(?Polyphosphates D01.248.497.158.730.650; D01.695.625.675.650.775 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Phosphates Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates Diphosphates Diphosphates (+ 2); Tin Polyphosphates Linear polymers in which orthophosphate residues are linked with energy-rich phosphoanhydride bonds. They are found in plants, animals, and microorganisms. Phosphates (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $+Z68>:Polyphloretin Phosphate D02.522.818.561.602.615; D02.755.684.602.615; D25.720.795; D26.744.750 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ketones; Propiophenones; Hydroxypropiophenone; Phloretin Organic Chemicals (Non MeSH); Phenols; Phloroglucinol; Phloretin Biomedical and Dental Materials (Non MeSH); Polymers Miscellaneous Drugs and Agents (Non MeSH); Prostaglandin Antagonists A polymeric mixture of polyesters of phosphoric acid and phloretin. It blocks some cellular responses to prostaglandins. Organophosphorus Compounds (72-74); Phloretin (73-74); Polymers (66-74) +%P,?UPolyomavirus macacae B04.280.570.615.700; B04.909.204.210.711.615.700; B04.909.204.585.615.700; B04.909.574.204.711.615.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae; Polyomavirus A species of POLYOMAVIRUS isolated from Rhesus monkey kidney tissue, which produces malignancy in human and newborn hamster kidney cell cultures and tumors on inoculation into newborn hamsters. +pPolyomavirus hominis 2 B04.280.570.615.610; B04.909.204.210.711.615.610; B04.909.204.585.615.610; B04.909.574.204.711.615.610 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae; Polyomavirus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Papovaviridae (71-82); Polyomaviruses (71-82) +?p6Polyomavirus hominis 1 B04.280.570.615.600; B04.909.204.210.711.615.600; B04.909.204.585.615.600; B04.909.574.204.711.615.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae; Polyomavirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae; Polyomavirus A species of POLYOMAVIRUS apparently infecting over 90% of children but not clearly associated with any clinical illness in childhood. The virus remains latent in the body throughout life and can be reactivated under certain circumstances. +RpPolyomavirus B04.280.570.615; B04.909.204.210.711.615; B04.909.204.585.615; B04.909.574.204.711.615 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae Polyomavirus hominis 1; Polyomavirus hominis 2; Polyomavirus macacae Polyomavirus hominis 1; Polyomavirus hominis 2; Polyomavirus macacae Polyomavirus hominis 1; Polyomavirus hominis 2; Polyomavirus macacae Polyomavirus hominis 1; Polyomavirus hominis 2; Polyomavirus macacae A genus of the family PAPOVAVIRIDAE consisting of potentially oncogenic viruses normally present in the host as a latent infection. The virus is oncogenic in hosts different from the species of origin. +`M>Polynucleotides D13.695.578 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Oligonucleotides (+ 5); Polydeoxyribonucleotides (+ 3); Polyribonucleotides (+ 11) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR +>PbDPolynucleotide Synthetases D08.586.464.754 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases Polydeoxyribonucleotide Synthetases; Polyribonucleotide Synthetase Catalyze the joining of preformed ribonucleotides or deoxyribonucleotides in phosphodiester linkage during genetic processes. Ligases (66-73)  +oFPJPolynucleotide Phosphorylase D08.586.913.696.445.735.532 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; RNA Nucleotidyltransferases An enzyme of the transferase class that catalyzes the reaction RNA(n+1) and orthophosphate to yield RNA(n) and a nucleoside diphosphate, or the reverse reaction. ADP, IDP, GDP, UDP, and CDP can act as donors in the latter case. This bacterial enzyme was used in research elucidating the genetic code. (From Dorland, 27th ed) EC 2.7.7.8. Nucleotidyltransferases (66-71); RNA Nucleotidyltransferases (68-71) +O!FNPolynucleotide Hydroxylkinase D08.586.913.696.620.680 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes the transfer of a phosphate group to the 5'-terminal hydroxyl groups of DNA and RNA. EC 2.7.1.78. Phosphotransferases, ATP (74); Polynucleotides (74) +"F=Polyneuritis C10.772.582.615 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Neuritis Inflammation of many nerves at once; multiple or disseminated neuritis. (Dorland, 27th ed). +NRoPolynesia Z01.782.815 EHEP Geographicals (Non MeSH); Pacific Islands Hawaii; Pitcairn Island; Tonga; Western Samoa + 39Polymyxin B D20.085.116.700.750 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Polymyxin A mixture of polymyxins B1 and B2, obtained from Bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin B is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic. +<ORPolymyxin D20.085.116.700 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Colistin; Polymyxin B Basic polypeptide antibiotic group obtained from Bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. At least eleven different members of the polymyxin group have been identified, each designated by a letter. + <B>Polymyositis C05.651.594.819 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Myositis A chronic, progressive inflammatory disease of skeletal muscle. It is characterized by symmetrical weakness of the limb girdles, neck, and pharynx, and usually associated with pain and tenderness. It may be accompanied by characteristic skin lesions, DERMATOMYOSITIS. (Dorland, 27th ed). Myositis (66-92) +N?PPolymyalgia Rheumatica C05.651.742; C05.799.720; C17.300.775.720 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Temporal Arteritis Temporal Arteritis Musculoskeletal Diseases; Muscular Diseases Musculoskeletal Diseases; Rheumatic Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with TEMPORAL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.  +%1NAPolymorphism, Single-Stranded Conformational G05.414.615.600 Nucleic Acid Conformation; DNA Mutational Analysis Genetics; Genetics, Population; Polymorphism (Genetics) Variation occurring within a species in the conformation of denatured DNA fragments. These single-stranded DNA fragments are allowed to partially renature in a way that prevents the formation of double-stranded DNA. The fragments are run on polyacrylamide gels under various conditions to detect subtle changes in migration due to altered secondary structure. The resulting bands will align themselves if the fragments are the same, but will misalign if any point mutations are present. SSCPs have been used in detecting mutations in various genes, such as oncogenes, tumor suppressor genes, and genes responsible for genetic diseases. Polymorphism (Genetics) (90-94) +,2<A%Polymorphism, Restriction Fragment Length G05.414.615.595 DNA Restriction Enzymes; Chromosome Mapping Genetics; Genetics, Population; Polymorphism (Genetics) Variation occurring within a species in the length of DNA fragments generated by a specific endonuclease. Such variations are generated by mutations that create or abolish recognition sites for these enzymes. Chromosome Mapping (71-86); DNA (66-71); DNA Restriction Enzymes (79-86); Endonucleases (75-77); Genes, Structural (77-86); Polymorphism (Genetics) (80-86) +04APolymorphism (Genetics) G05.414.615 DEGEIMPHRE Genetics; Genetics, Population Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes chromosome polymorphism. Genetics (66-67); Genetics, Population (66-67)  +%b8Polymethacrylic Acids D02.241.081.069.800; D25.720.716.822.111.650 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Methacrylates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic; Acrylic Resins Methylmethacrylates; Polyhydroxyethyl Methacrylate Methylmethacrylates; Polyhydroxyethyl Methacrylate Poly-2-methylpropenoic acids. Used in the manufacture of methacrylate resins and plastics in the form of pellets and granules, as absorbent for biological materials and as filters; also as biological membranes and as hydrogens. Synonyms: methylacrylate polymer; poly(methylacrylate); acrylic acid methyl ester polymer. Acrylates (66-74); Polymers (66-74) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU (+2,ps,.Polymers D25.720 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Macromolecular Systems Macromolecular Systems Biomedical and Dental Materials (Non MeSH) Cellulose (+ 2); Colestipol; Cyanoacrylates (+ 2); Fluorocarbon Polymers (+ 2); Glass; Hexadimethrine; Latex; Lignin; Plastics (+ 21); Polyanetholesulfonate; Polyesters (+ 4); Polyethylene Glycols (+ 5); Polygeline; Polyphloretin Phosphate; Pyran Copolymer; Rubber (+ 4); Siloxanes (+ 4) Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., polypeptides, proteins, plastics). AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (,Z  ,3^DPolymerase Chain Reaction E05.393.330.500 CLCTDEECHIISMOMTRESNSTTDUTVE Sequence Tagged Sites Miscellaneous Techniques (Non MeSH); Genetic Techniques; Gene Amplification In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Gene Amplification (88-89)  , Y Polymenophorea B01.841.185.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora Hypotrichida (+ 3) A class of ciliate protozoa characterized by a well-developed, conspicuous adoral zone of numerous buccal or peristomial organelles, often extending out onto the body surface. , &+Polylysine D12.125.095.647.750; D12.644.760 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Lysine Amino Acids, Peptides and Proteins (Non MeSH); Peptides A peptide which is a homopolymer of lysine. Lysine (69-74); Peptides (73-74) , 8&D7)Polyisoprenyl Phosphates D02.455.849.690; D02.705.690 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Organic Chemicals (Non MeSH); Organophosphorus Compounds Dolichol Phosphates; Polyisoprenyl Phosphate Sugars (+ 3) Dolichol Phosphates Phosphoric or pyrophosphoric acid esters of polyisoprenoids. Organophosphorus Compounds (71-77); Terpenes (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $, ":ZG>DPolyisoprenyl Phosphate Sugars D02.455.849.690.700; D09.203.894.680; D10.516.390.700 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Polyisoprenyl Phosphates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids Polyisoprenyl Phosphate Monosaccharides (+ 1); Polyisoprenyl Phosphate Oligosaccharides Polyisoprenyl Phosphate Monosaccharides (+ 1); Polyisoprenyl Phosphate Oligosaccharides Polyisoprenyl Phosphate Monosaccharides (+ 1); Polyisoprenyl Phosphate Oligosaccharides Compounds functioning as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. They include the polyisoprenyl pyrophosphates. specific carbohydrate (66-77); specific terpene groups or specific terpene (66-77); Carbohydrates (66-77); Sugar Phosphates (74-77); Terpenes (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $,1$=<(>Polyisoprenyl Phosphate Oligosaccharides D02.455.849.690.700.710; D09.203.894.680.710; D10.516.390.700.710 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Polyisoprenyl Phosphates; Polyisoprenyl Phosphate Sugars Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Polyisoprenyl Phosphate Sugars Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Polyisoprenyl Phosphate Sugars These compounds function as activated glycosyl carriers in the biosynthesis of glycoproteins and glycophospholipids. Include the pyrophosphates. Sugar Phosphates (74-77); Terpenes (66-77); specific terpene or terpene group (66-77) ,.I8pgPolyisoprenyl Phosphate Monosaccharides D02.455.849.690.700.700; D09.203.894.680.700; D10.516.390.700.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Polyisoprenyl Phosphates; Polyisoprenyl Phosphate Sugars Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Polyisoprenyl Phosphate Sugars Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Polyisoprenyl Phosphate Sugars Dolichol Monophosphate Mannose Dolichol Monophosphate Mannose Dolichol Monophosphate Mannose These compounds function as activated monosaccharide carriers in the biosynthesis of glycoproteins and oligosaccharide phospholipids. Obtained from a nucleoside diphosphate sugar and a polyisoprenyl phosphate. Sugar Phosphates (74-77); specific sugar phosphate(74-77); Terpenes (66-77); specific terpene or terpene group AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $,"-I8ph:Polyhydroxyethyl Methacrylate D02.033.618.690.675; D02.241.081.069.800.700; D25.720.716.822.111.650.750 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Polyethylene Glycols Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates; Polymethacrylic Acids Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic; Acrylic Resins; Polymethacrylic Acids Poly(2-hydroxyethyl methacrylate). A biocompatible, hydrophilic, inert gel that is permeable to tissue fluids. It is used as an embedding medium for microscopy, as a coating for implants and prostheses, for contact lenses, as microspheres in adsorption research, etc. Acrylates (66-74); Polyethylene Glycols (75-77); Polymers (66-74); Polymethacrylic Acids (75-77) ,"Q.`9sPolyhydramnios C13.703.610 BLCFCICLCODHDIDTECEHENEPETHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Amniotic Fluid Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Excess of amniotic fluid greater than 2,000 ml. It is a common obstetrical complication whose major causes include maternal diabetes, chromosomal disorders, isoimmunological disease, congenital abnormalities, and multiple gestations. ,YHf Polyglycolic Acid D25.720.728.780 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Glycolates Biomedical and Dental Materials (Non MeSH); Polymers; Polyesters Poly(oxy(1-oxo-1,2-ethanediyl)). A biocompatible polymer used as a surgical suture material. Glycolates (66-72)  ,!m.NnPolyglutamic Acid D12.125.119.450.400.700; D12.644.748 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Glutamates Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Glutamic Acid; Glutamates Amino Acids, Peptides and Proteins (Non MeSH); Peptides A peptide that is a homopolymer of glutamic acid. Glutamates (66-78); Peptides (66-78)  ,"*F>-Polyglactin 910 D25.720.728.772 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers; Polyesters 2-Hydroxy-propanoic acid polymer with polymerized hydroxyacetic acid, which forms 3,6-dimethyl-1,4-dioxane-dione polymer with 1,4-dioxane-2,5-dione copolymer with molecular weight about 80,000 daltons. Synthetic, absorbable surgical suture material and mesh fabric; used especially in ophthalmic surgery. Polymers (66-78) ,$.NWPolygeline D12.644.740; D19.461.140.500.937; D25.720.780 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Amino Acids, Peptides and Proteins (Non MeSH); Peptides Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Blood Substitutes; Plasma Substitutes Biomedical and Dental Materials (Non MeSH); Polymers A 3.5 per cent colloidal solution containing urea- cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander. Peptides (72-74); Polymers (72-74) ,&5. +Polygalacturonase D08.586.277.450.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases A cell wall-degrading enzyme found in microorganisms and higher plants. It catalyzes the random hydrolysis of 1,4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. EC 3.2.1.15. Glycoside Hydrolases (66-76); Pectins (66-76); Uronic Acids (66-76) ,)FlRPolyethylenes D02.455.326.271.665.550; D25.720.716.507 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Ethylenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Biomedical and Dental Materials (Non MeSH); Polymers; Plastics Polyethyleneimine Polyethyleneimine Ethylene homopolymers. Synthetic thermoplastics that are tough, flexible, inert, and resistant to chemicals and electrical current. They are often used as biocompatible materials for prostheses and implants. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $,,., (.Polyethyleneimine D02.455.326.271.665.550.600; D02.491.650; D25.720.716.507.600 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes; Polyethylenes Organic Chemicals (Non MeSH); Imines Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Polyethylenes Strongly cationic polymer that binds to certain proteins; used as a marker in immunology, to precipitate and purify enzymes and lipids. Synonyms: aziridine polymer; Epamine; Epomine; ethylenimine polymer; Montrek; PEI; Polymin(e). Imines (73-74); Polyethylenes (73-74) ,.E. .Polyethylene Terephthalates D25.720.728.764 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers; Polyesters Polyester polymers formed from terephthalic acid or its esters and ethylene glycol. They can be formed into tapes, films or pulled into fibers that are pressed into meshes or woven into fabrics. Polymers (66-72) ,1 ,NPolyethylene Glycols D02.033.618.690; D25.720.741; D26.866.762 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols Biomedical and Dental Materials (Non MeSH); Polymers Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents Cetomacrogol; Nonoxynol; Octoxynol; Poloxalene; Polyhydroxyethyl Methacrylate; Polysorbates Cetomacrogol; Nonoxynol; Octoxynol; Poloxalene; Polysorbates Cetomacrogol; Nonoxynol; Octoxynol; Poloxalene; Polysorbates alpha-Hydro-omega-hydroxypoly(oxy-1,2-ethanediyls). Additional polymers of ethylene oxide and water and their ethers. They vary in consistency from liquid to solid, depending on the molecular weight, indicated by a number following the name. Used as surfactants in industry, including foods, cosmetics and pharmaceutics; in biomedicine, as dispersing agents, solvents, ointment and suppository bases, vehicles, tablet excipients. Some specific groups are lauromagrogols, nonoxynols, octoxinols and poloxamers. Synonyms: Carbowax; Nycoline; Solbase; Triton. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  ,31,.Polyesters D25.720.728 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers Polydioxanone; Polyethylene Terephthalates; Polyglactin 910; Polyglycolic Acid Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. Polymers (66-76) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $,8,@[.Polyenes D02.455.326.271.665 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes Alkadienes (+ 2); Diphenylhexatriene; Filipin; Mepartricin; Neoprene; Polyethylenes (+ 1); Polypropylenes; Polyvinyls; Squalene AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,: 8g<Polyendocrinopathies, Autoimmune C19.750; C20.111.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases Immunologic Diseases; Autoimmune Diseases Autoimmune disease affecting multiple endocrine organs. Type I is characterized by childhood onset and mucocutaneous candidiasis, while type II exhibits any combination of adrenal insufficiency (ADDISON'S DISEASE), lymphocytic thyroiditis, hypoparathyroidism, and gonadal failure. In both types organ-specific antibodies against a variety of endocrine glands have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present. Autoimmune Diseases (68-91); Endocrine Diseases (78-91) ,<%NFmBPolydnaviridae B04.280.630; B04.525.630 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Insect Viruses A family of insect viruses isolated from endoparasitic hymenopteran insects belonging to the families Ichneumonidae and Braconidae. The two genera are Ichnovirus and Bracovirus. Insect Viruses (84-93) ,@?7Polydioxanone D25.130.650; D25.720.728.700 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Biocompatible Materials Biomedical and Dental Materials (Non MeSH); Polymers; Polyesters Poly(oxy(1-oxo-1,2-ethanediyl)oxy-1,2-ethanediyl). An absorbable suture material used also as ligating clips, as pins for internal fixation of broken bones, and as ligament reinforcement for surgically managed ligament injuries. Its promising characteristics are elasticity, complete biodegradability, and lack of side effects such as infections. Polyesters (77-91); Sutures (66-91) ,A".,Polydeoxyribonucleotides D13.695.578.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides Apurinic Acid; Poly dA-dT; Poly T A group of 13 or more deoxyribonucleotides in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Polynucleotides (66-75) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $,D>c,DPolydeoxyribonucleotide Synthetases D08.586.464.754.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Polynucleotide Synthetases Poly(deoxyribonucleotide):poly(deoxyribonucleotide)ligases. Enzymes that catalyze the joining of preformed deoxyribonucleotides in phosphodiester linkage during genetic processes during repair of a single-stranded break in duplex DNA. The class includes both EC 6.5.1.1 (ATP) and EC 6.5.1.2 (NAD). Polynucleotide Synthetases (74-77) ,G(FoW(Polydactyly C05.660.585.600; C16.131.621.585.600 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Short Rib-Polydactyly Syndrome Short Rib-Polydactyly Syndrome A developmental anomaly characterized by the presence of more than five fingers on the hand or more than five toes on the foot in primates. In non-primate vertebrates, it refers to the presence of more than the normal number of toes on the forelimb or hindlimb. (Dorland, 27th ed; Stedman, 25th ed). Fingers/abnormalities (66-93); Toes/abnormalities (66-93)  ,I*L"FgDPolycythemia Vera C15.378.190.636.753 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. ,MlNPolycythemia C15.378.738 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases An increase in the total red cell mass of the blood. (Dorland, 27th ed). ,PBNJ\Polycystic Ovary Syndrome C04.182.612.765; C13.371.056.630.580.765; C19.391.630.580.765 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Hyperandrogenism Neoplasms; Cysts; Ovarian Cysts Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases; Ovarian Cysts Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases; Ovarian Cysts Clinical symptom complex characterized by oligomenorrhea or amenorrhea, anovulation, and regularly associated with bilateral polycystic ovaries. ,QxEX*Polycyclic Hydrocarbons, Aromatic (Non MeSH) D04.615 Polycyclic Hydrocarbons Acenaphthenes; Anthracenes (+ 10); Benzocycloheptenes (+ 8); Bridged Compounds (+ 6); Fluorenes (+ 4); Indenes (+ 5); Naphthacenes; Naphthalenes (+ 22); Phenanthrenes (+ 1); Pyrenes (+ 4); Spiro Compounds (+ 12) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ,T=4 @Polycyclic Hydrocarbons D04 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Compounds; Polycyclic Hydrocarbons, Aromatic (Non MeSH) (+ 83); Steroids (+ 302) Hydrocarbons consisting of two or more fused ring structures. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,V8mJFPolycyclic Compounds D04.490 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons Compounds consisting of two or more fused ring structures. ,W 8GPolychondritis, Relapsing C05.182.531; C17.300.182.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Cartilage Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Cartilage Diseases An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and can result in deformities such as floppy ear and saddle nose. Loss of cartilage in the respiratory tract can lead to respiratory obstruction. ,Xc"NVPolychloroterphenyl Compounds D02.455.426.559.389.805.700; D02.455.526.439.785 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Terphenyl Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated  Aroclors Compounds consisting of three benzene rings linked to each other in either ortho, meta or para positions and substituted with chlorine atoms. Chlorobenzenes (74); Hydrocarbons, Chlorinated (74); Polycyclic Compounds (74)  ,[ "68" ]Polychlorinated Biphenyls D02.455.426.559.389.185.698; D02.455.526.439.773 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated  Aroclors Biphenyl compounds which are extensively chlorinated. Many of these compounds are toxic environmental pollutants. Biphenyl Compounds (66-70)  ,]68!  Polychaeta B01.091.700 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Annelida A class of marine annelids including sandworms, tube worms, clamworms, and fire worms. It includes also the genus Myxicola infundibulum. Annelida (66-74) ,`(Polycarboxylate Cement D25.339.291.464 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements Water-soluble low-molecular-weight polymers of acrylic or methacrylic acid that form solid, insoluble products when mixed with specially prepared ZnO powder. The resulting cement adheres to dental enamel and is also used as a luting agent. Acrylates (66-71); Dental Cements (71); Zinc (66-71) ,a*\BPolybrominated Biphenyls D02.455.426.559.389.185.680; D02.455.526.368.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Brominated Biphenyl compounds which are extensively brominated. Many of these compounds are toxic environmental pollutants. Biphenyl Compounds (66-76); Hydrocarbons, Brominated (74-75) ,c68 GPolyarteritis Nodosa C14.907.184.595; C14.907.940.090.720; C17.800.862.625 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Arteritis Cardiovascular Diseases; Vascular Diseases; Vasculitis; Arteritis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular A form of necrotizing vasculitis involving small- and medium-sized arteries. The signs and symptoms result from infarction and scarring of the affected organ system. ,f=NPolyanetholesulfonate D02.455.426.559.389.097.675; D02.886.645.600.080.050.100.600; D25.720.722 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzenesulfonates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Benzenesulfonates Biomedical and Dental Materials (Non MeSH); Polymers (E)-1-Methoxy-4-(1-propenyl)benzene homopolymer, sulfonated, sodium salt. A compound originally developed as an anticoagulant, but possessing anticomplement action and lowering the bactericidal action of blood. It is used in vitro to inhibit blood coagulation and as a diagnostic reagent to encourage the growth of pathogens in the blood. It is also used to stabilize colloidal solutions such as milk and gelatin. (From Merck Index, 11th ed). Benzenesulfonates (74-76); Polymers (66-76); Sulfonic Acids (66-73) ,i Q.QPolyamines D02.092.782 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Colestipol; Diamines (+ 11); DTPA (+ 1); Hexadimethrine; Methenamine; Spermidine; Spermine Amines (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  ,m8.p>Poly U D13.695.578.550.750 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides Poly A-U ,o& >z Poly T D13.695.578.500.600 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polydeoxyribonucleotides A group of thymine nucleotides in which the phosphate residues of each thymine nucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Polynucleotides (66-75) ,p0 >Poly I-C D13.695.578.550.560.600; D13.695.578.550.650.600; D20.388.630.725 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides; Poly C Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides; Poly I Anti-Infective Agents; Antiviral Agents; Interferon Inducers Interferon inducer consisting of a synthetic, mismatched double-stranded RNA. The polymer is made of one strand each of polyinosinic acid and polycytidylic acid. Interferons/biosynthesis (66-70); Polynucleotides (66-70) ,r I>MCPoly I D13.695.578.550.650 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides Poly I-C A group of inosine ribonucleotides in which the phosphate residues of each inosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Polynucleotides (66-75)  ,u >z Poly G D13.695.578.550.600 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides A group of guanine ribonucleotides in which the phosphate residues of each guanine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Polynucleotides (66-75) ,w >zPoly dA-dT D13.695.578.500.300 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polydeoxyribonucleotides Polydeoxyribonucleotides made up of deoxyadenine nucleotides and thymine nucleotides. Present in DNA preparations isolated from crab species. Synthetic preparations have been used extensively in the study of DNA. Adenine Nucleotides (66-76); Polynucleotides (66-76); Thymine Nucleotides (72-76) ,x>`Poly C D13.695.578.550.560 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides Poly I-C A group of cytosine ribonucleotides in which the phosphate residues of each cytosine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Polynucleotides (66-75)  ,{T >z Poly Adenosine Diphosphate Ribose D09.203.408.620.569.070.600; D13.695.578.550.500.525; D13.695.827.708.070.600 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides; Poly A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Adenosine Diphosphate Sugars A polynucleotide formed from NAD in the presence of NAD+ NUCLEOSIDASE. Adenosine Diphosphate (73-74); Nucleoside Diphosphate Sugars (73-74); Polynucleotides (73-74) ,}J(UDUmPoly A-U D13.695.578.550.500.510; D13.695.578.550.750.510; D20.388.630.700 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides; Poly A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides; Poly U Anti-Infective Agents; Antiviral Agents; Interferon Inducers A double-stranded polyribonucleotide comprising polyadenylic and polyuridylic acids and believed to be a stimulant of the immune system through induction of interferon. Interferon Inducers (66-71); Polynucleotides (66-71) , I>M>Poly A Polymerase D08.586.913.696.445.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases An enzyme that catalyzes the synthesis of polyadenylic acid from ATP. May be due to the action of RNA polymerase (EC 2.7.7.6) or polynucleotide adenylyltransferase (EC 2.7.7.19). EC 2.7.7.19. Adenosine Triphosphate (72-74); Nucleotidyltransferases (72-74) ,FIPoly A D13.695.578.550.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides Poly A-U; Poly Adenosine Diphosphate Ribose 5'-Adenylic acid, homopolymer. An adenylic acid polymer in which the phosphate residues of each adenine ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Polynucleotides (66-75) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $,$ >z5DPoloxalene D02.033.618.690.650; D25.720.741.650; D26.866.762.750 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Polyethylene Glycols Biomedical and Dental Materials (Non MeSH); Polymers; Polyethylene Glycols Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Polyethylene Glycols Methyloxirane polymer with oxirane. A copolymer of polyethylene and polypropylene ether glycol. It is a non-ionic polyol surface-active agent used medically as a fecal softener and in cattle for prevention of bloat. Polyethylene Glycols (74) ,=.Polonium D01.268.185.600; D01.268.271.680 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Chalcogens (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Polonium. A radioactive element that is a member of the chalcogen family. It has the atomic symbol Po, atomic number 84, and the atomic weight of the isotope with the longest half-life (209Po) is 208.98. It decays by alpha-emission. ,k &4Pollen B06.714 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Allergens; Hay Fever Grasses; Plants Plants The male fertilizing element of flowering plants analogous to sperm in animals. It is released from the anthers as yellow dust, to be carried by insect or other vectors, including wind, to the ovary (stigma) of other flowers to produce the embryo enclosed by the seed. The pollens of many plants are allergenic.  ,  & rPolitics I01.738 Social Sciences Lobbying Activities concerned with governmental policies, functions, etc. ,   KPolitical Systems I01.696 CLHI Social Sciences Colonialism; Communism; Democracy; Socialism The units based on political theory and chosen by countries under which their governmental power is organized and administered to their citizens. Politics (66-79) CLECHISNTD $,e 6Polioviruses, Murine B04.820.565.284.779.670; B04.909.777.618.284.779.670 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus; Polioviruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus; Polioviruses A murine ENTEROVIRUS which causes poliomyelitis in rats. Also called THEILER'S MURINE ENCEPHALOMYELITIS VIRUS, it should not be confused with the Cardiovirus ENCEPHALOMYELITIS VIRUS, MURINE. Encephalomyelitis Virus, Murine (75-93); Enterovirus (75-93) ,:GPolioviruses, Human 1-3 B04.820.565.284.779.650; B04.909.777.618.284.779.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus; Polioviruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus; Polioviruses Species of ENTEROVIRUS which are the causal agents of poliomyelitis in humans. Three serotypes (strains) exist: Brunhilde (type 1), Lansing (type 2), and Leon (type 3). Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Both inactivated and live attenuated vaccines have proven effective in combatting the infection. Polioviruses (66-93) ,K:Polioviruses B04.820.565.284.779; B04.909.777.618.284.779 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus Polioviruses, Human 1-3; Polioviruses, Murine Polioviruses, Human 1-3; Polioviruses, Murine Species of ENTEROVIRUS causing acute infection in humans and leading to nervous system damage in a minority of cases. Humans are the only natural host, but infection can also occur in non-human primates and experimentally in rodents. ,`2jPoliovirus Vaccine, Oral D24.310.894.899.614.614 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines; Poliovirus Vaccine ,>Poliovirus Vaccine D24.310.894.899.614 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines Poliovirus Vaccine, Oral ,>lPoliomyelitis, Bulbar C02.782.687.359.764.614; C10.228.140.763; C10.228.228.769.614; C10.228.854.641.614 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections; Poliomyelitis Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Poliomyelitis Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases; Poliomyelitis A serious form of poliomyelitis in which the medulla oblongata is affected, and in which there may be dysfunction of the swallowing mechanism, and respiratory and circulatory distress. (Dorland, 27th ed). ,1\PPoliomyelitis C02.782.687.359.764; C10.228.228.769; C10.228.854.641 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Postpoliomyelitis Syndrome Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Poliomyelitis, Bulbar; Postpoliomyelitis Syndrome Poliomyelitis, Bulbar; Postpoliomyelitis Syndrome Poliomyelitis, Bulbar; Postpoliomyelitis Syndrome An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUSES, HUMAN 1-3). Infection affects the gastrointestinal tract and nasopharynx, but frequently is asymptomatic. The CNS is affected in exceptional cases, leading to paralysis.  ,=PE[Policy Making N03.706.742 Health Policy; Public Policy Decision Making, Organizational; Decision Making Economics, Organizations, Control (Non MeSH); Social Control, Formal The decision process by which individuals, groups or institutions establish policies pertaining to plans, programs or procedures. ,$9QPolicies (Non MeSH) I01.880.604.710; N03.706.710 Social Sciences; Sociology; Social Control, Formal Economics, Organizations, Control (Non MeSH); Social Control, Formal Organizational Policy; Public Policy (+ 4) Organizational Policy; Public Policy (+ 4) CLECHILJMTOGSNSTTDUT ,"fPolice I01.880.604.646; M01.526.760 CLECEDHILJMAOGSDSNSTTDUT Social Sciences; Sociology; Social Control, Formal Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Agents of the law charged with the responsibility of maintaining law and order among the citizenry. Social Control, Formal (71-91) , "w%Polarography E05.196.749; H01.181.529.307.719 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry An electrochemical technique for identifying and estimating the concentration of reducible elements by means of the dual measurement of the current flowing through an electrochemical cell (which contains the test solution) and the electrical potential between the two electrodes as the potential is increased at a constant rate by an external voltage source. As the voltage reaches the standard electrode potential of the test substance, there is a sharp increase in current flow. The indicator electrode is usually a dropping mercury electrode. (Dorland, 27th ed). ,&"Polarity of Translation G05.331.370.725.770 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Translation, Genetic Decrease in the synthesis of proteins specified by genes distal to the operator and to the site of a nonsense, frameshift, deletion or insertion mutation in an operon. A mutation which produces polarity is called a polar mutation or a polarity mutation. Mutation (66-79); Operon (69-79); Transcription, Genetic (73-79); Translation, Genetic (73-79) ,;S,qPolarcardiography E01.145.569.359.731.614; E01.399.214.731.614 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Electrocardiography; Vectorcardiography Diagnosis; Electrodiagnosis; Electrocardiography; Vectorcardiography A vectorcardiographic technique using an analog computer that provides the spherical polar coordinates of the heart vector from signals obtained from a suitable vectorcardiographic lead system. (Moore AD, Harding P, Dower GE. The polarcardiograph. Am Heart J 1962 Sep;64(3):382-91). ,2&KPoland Syndrome C05.116.099.370.894.819.756; C05.660.585.800.756; C05.660.906.819.756; C16.131.621.585.800.756; C16.131.621.906.819.756 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Synostosis; Syndactyly Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH); Syndactyly Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Synostosis; Syndactyly Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH); Syndactyly Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Synostosis; Syndactyly A syndrome which is characterized by symbrachydactyly and aplasia of the sternal head of pectoralis major. Hand (66-84); Pectoralis Muscles (66-84); Syndactylia (67-84) ,;L~KPoland Z01.542.248.679 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern , =Pokeweed Mitogens D12.776.765.682; D24.185.526.545.742; D24.310.545.742; D24.611.125.044.545.742 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens; Lectins Immunologic and Biologic Factors (Non MeSH); Biological Products; Lectins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Lectins Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells. Lectins (66-78); Mitogens (66-72) ,BXD*Poisson Distribution E05.318.740.994.750; G03.850.520.830.994.750; H01.548.832.901.750; N05.715.360.750.750.620 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics; Statistical Distributions (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Statistical Distributions (Non MeSH) A distribution function used to describe the occurrence of rare events or to describe the sampling distribution of isolated counts in a continuum of time or space. ,d7Poisons D05.569.612 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Toxicology Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Strychnine Substances which, when ingested, inhaled, or absorbed, or when applied to, injected into, or developed within the body in relatively small amounts may, by their chemical action, cause damage to structure or disturbance of function. (From Dorland, 27th ed). AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $,S 6N-@Poisoning C21.613 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antidotes Injury, Occupational Dis, Poisoning (Non MeSH) Alcoholic Intoxication (+ 10); Argyria; Bites and Stings (+ 5); Cadmium Poisoning; Carbon Tetrachloride Poisoning; Drug Toxicity (Non MeSH) (+ 7); Ergotism; Fluoride Poisoning; Food Poisoning (+ 5); Gas Poisoning (+ 2); Hepatitis, Toxic; Lead Poisoning; Mercury Poisoning; Mycotoxicosis (+ 2); Overdose; Plant Poisoning (+ 4); Psychoses, Substance-Induced Morbid condition produced by a poison. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $,  L 70PPoison Control Centers N02.278.726; N02.421.297.695 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services Facilities which provide information concerning poisons and treatment of poisoning in emergencies. ,­"rPoint Mutation G05.632.675 DEGEIMPHRE Genetics; Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation (66-92) ,NPoikiloderma Congenitale C16.131.831.649; C16.614.739; C17.800.827.800.649 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) An autosomal recessive syndrome occurring principally in females, characterized by the presence of reticulated, atrophic, hyperpigmented, telangiectatic cutaneous plaques, often accompanied by juvenile cataracts, saddle nose, congenital bone defects, disturbances in the growth of hair, nails, and teeth, and hypogonadism. ,|9LYnPoetry K01.517.781 HI Humanities; Literature , POEMS Syndrome C10.772.670; C15.378.147.780.750; C20.683.780.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias A chronic, progressive multisystem disorder of obscure etiology characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes. ,b9N Poecilia B02.493.280.680 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cyprinodontiformes A genus of livebearing cyprinodont fish comprising the guppy and molly. Some species are virtually all female and depend on sperm from other species to stimulate egg development. Poecilia is used in carcinogenicity studies as well as neurologic and physiologic research. Fishes (66-86) , &/=Podoviridae B04.123.150.700; B04.280.090.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales Viruses; DNA Viruses; Caudovirales Bacteriophage P22; Bacteriophage T3; Bacteriophage T7 Bacteriophage P22; Bacteriophage T3; Bacteriophage T7 A family of bacteriophages which are characterized by short, non-contractile tails. Bacteriophages (83-93)  ,&V~bPodophyllum B06.560.706; B06.660.620 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic A genus of poisonous American herbs, family Berberidaceae. The roots yield PODOPHYLLOTOXINS and other pharmacologically important agents. The plant was formerly used as a cholagogue and cathartic. It is different from the European mandrake, MANDRAGORA. ,ϡ&:&Podophyllotoxin D04.615.638.960.675; D22.204.179.612.696; D23.400.550.666; D24.310.674.675.675; D26.714.675.675 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Tetrahydronaphthalenes Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Podophyllin Dermatologic Agents; Keratolytic Agents; Podophyllin Immunologic and Biologic Factors (Non MeSH); Biological Products; Plant Extracts; Podophyllin Miscellaneous Drugs and Agents (Non MeSH); Plant Extracts; Podophyllin  Etoposide; Teniposide (5R-(5 alpha,5a beta,8a alpha,9 alpha))-5,8,8a,9-Tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one. The main active constituent of the resin from the roots of may apple or mandrake (Podophyllum peltatum and P. emodi). It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. Alkaloids (66-72); Antineoplastic Agents (66-72)  ,wk@:Podophyllin D22.204.179.612; D23.400.550; D24.310.674.675; D26.714.675 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Dermatologic Agents; Keratolytic Agents Immunologic and Biologic Factors (Non MeSH); Biological Products; Plant Extracts Miscellaneous Drugs and Agents (Non MeSH); Plant Extracts Podophyllotoxin (+ 2) Podophyllotoxin Podophyllotoxin Podophyllotoxin Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses. ,ED@FNxPodiatry G02.696 CLECEDHIISLJMAMTOGSNSTTD Foot Diseases Health Occupations A specialty concerned with the diagnosis and treatment of foot disorders and injuries and anatomic defects of the foot. ,   Pneumovirus Infections C02.782.580.600.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections Respiratory Syncytial Virus Infections Infections with viruses of the genus PNEUMOVIRUS, family PARAMYXOVIRIDAE. This includes RESPIRATORY SYNCYTIAL VIRUS INFECTIONS, an important cause of respiratory disease in humans. ,Py-Pneumovirus B04.820.455.600.670.600; B04.909.777.455.600.670.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Pneumovirinae Respiratory Syncytial Viruses (+ 2) Respiratory Syncytial Viruses (+ 2) A genus of the family PARAMYXOVIRIDAE (subfamily PNEUMOVIRINAE) where the human and bovine virions have neither hemagglutinin nor neuraminidase activity. Pneumonia virus of mice has hemagglutinin activity. RESPIRATORY SYNCYTIAL VIRUS, HUMAN is the type species. Paramyxoviridae (85-93)  ,;:T.Pneumovirinae B04.820.455.600.670; B04.909.777.455.600.670 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae Pneumovirus (+ 3) Pneumovirus (+ 3) A subfamily of PARAMYXOVIRIDAE containing one genus: PNEUMOVIRUS. ,22,MPneumothorax, Artificial E04.920.800.250.790 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Thoracic Surgery; Surgery, Lung (Non MeSH); Collapse Therapy ,$aPneumothorax C08.528.778 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemopneumothorax; Hydropneumothorax Respiratory Tract Diseases; Pleural Diseases An accumulation of air or gas in the pleural space, which may occur spontaneously or as a result of trauma or a pathological process, or be introduced deliberately ( = PNEUMOTHORAX, ARTIFICIAL). (Dorland, 27th ed). ,N)5Pneumoradiography E01.357.818.760 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Pneumoencephalography Radiography using air, oxygen, or some other gas as a contrast medium. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  ,"3V&Pneumoperitoneum, Artificial E01.753 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Deliberate introduction of air into the peritoneal cavity. ,! " FPneumoperitoneum C06.772.723 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Peritoneal Diseases The presence of gas or air in the peritoneal cavity. It may occur spontaneously or be deliberately introduced as an aid to radiologic examination (PNEUMOPERITONEUM, ARTIFICIAL). (From Dorland, 27th ed). ,N7Pneumopericardium C14.280.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases ,]N/Pneumonolysis E04.920.800.810 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pleura Surgery, Operative; Thoracic Surgery; Surgery, Lung (Non MeSH) ,$ KPneumonia, Viral C02.705; C08.381.677.807; C08.730.610.763 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Respiratory Tract Diseases; Lung Diseases; Pneumonia Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia ,1PPneumonia, Staphylococcal C01.252.410.868.675; C01.252.620.620; C08.381.677.540.620; C08.730.610.540.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Pneumonia, Bacterial Respiratory Tract Diseases; Lung Diseases; Pneumonia; Pneumonia, Bacterial Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia; Pneumonia, Bacterial Pneumonia caused by STAPHYLOCOCCUS AUREUS. This condition is a frequent complication of viral influenza. Pneumonia (66-67); Staphylococcal Infections (66-67) ,/XP{>Pneumonia, Rickettsial C01.252.400.810.700.810.750; C01.252.620.600; C08.381.677.540.600; C08.730.610.540.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Pneumonia, Bacterial Respiratory Tract Diseases; Lung Diseases; Pneumonia; Pneumonia, Bacterial Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia; Pneumonia, Bacterial Pneumonia caused by infection with bacteria of the family RICKETTSIACEAE. ,`PWPneumonia, Progressive Interstitial, of Sheep C02.782.815.616.660; C02.839.660; C22.836.660 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections Virus Diseases; Slow Virus Diseases Animal Diseases; Sheep Diseases Chronic respiratory disease caused by the VISNA-MAEDI VIRUS. It was formerly believed to be identical with jaagsiekte (PULMONARY ADENOMATOSIS, OVINE) but is now recognized as a separate entity. Pulmonary Adenomatosis, Ovine (68-75) ,55J,Pneumonia, Pneumocystis carinii C01.703.534.700; C01.703.770.700; C08.381.472.700; C08.381.677.675; C08.730.435.700; C08.730.610.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses; Lung Diseases, Fungal Bacterial and Fungal Diseases (Non MeSH); Mycoses; Pneumocystis carinii Infections Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Fungal Respiratory Tract Diseases; Lung Diseases; Pneumonia Respiratory Tract Diseases; Respiratory Tract Infections; Lung Diseases, Fungal Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia A pulmonary disease occurring in immunodeficient or malnourished patients or infants, characterized by dyspnea, tachypnea, and hypoxemia. Pneumocystis carinii pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus Pneumocystis carinii. ,x%rP9Pneumonia, Mycoplasma C01.252.400.610.610.760; C01.252.620.500; C08.381.677.540.500; C08.730.610.540.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Mycoplasmatales Infections; Mycoplasma Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Pneumonia, Bacterial Respiratory Tract Diseases; Lung Diseases; Pneumonia; Pneumonia, Bacterial Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia; Pneumonia, Bacterial Interstitial pneumonia caused by extensive infection of the lungs and bronchi, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE. It may be distinguished from viral pneumonia by the presence of cold agglutinins. Mycoplasma (66-67); Mycoplasma Infections (68-79); Pneumonia (66-79) ,\P RPneumonia, Lobar C01.252.410.890.670.750; C01.252.620.480; C08.381.677.540.480; C08.730.610.540.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections; Pneumococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Pneumonia, Bacterial Respiratory Tract Diseases; Lung Diseases; Pneumonia; Pneumonia, Bacterial Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia; Pneumonia, Bacterial A febrile disease caused by STREPTOCOCCUS PNEUMONIAE. This condition is characterized by inflammation of one or more lobes of the lungs and symptoms include chills, fever, rapid breathing, and cough. ,\PPneumonia, Lipid C08.381.677.529.612; C08.730.610.529.612 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Pneumonia; Pneumonia, Aspiration Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia; Pneumonia, Aspiration Pneumonia due to aspiration or inhalation of various oily or fatty substances. -P.N^Pneumonia, Bacterial C01.252.620; C08.381.677.540; C08.730.610.540 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Respiratory Tract Diseases; Lung Diseases; Pneumonia Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia Pneumonia, Lobar; Pneumonia, Mycoplasma; Pneumonia, Rickettsial; Pneumonia, Staphylococcal Pneumonia, Lobar; Pneumonia, Mycoplasma; Pneumonia, Rickettsial; Pneumonia, Staphylococcal Pneumonia, Lobar; Pneumonia, Mycoplasma; Pneumonia, Rickettsial; Pneumonia, Staphylococcal Pneumonia caused by various species of bacteria. Bacterial pneumonia commonly results from bronchogenic spread of infection following microaspiration of secretions. The largest category of this disease arises from community-acquired pneumonias. -"5P4Pneumonia, Atypical Interstitial, of Cattle C22.196.690 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Cattle Diseases A cattle disease of uncertain cause, probably an allergic reaction. -3J(QPneumonia, Aspiration C08.381.677.529; C08.730.610.529 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Pneumonia Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia Pneumonia, Lipid Pneumonia, Lipid A type of pneumonia resulting from the aspiration of food, liquid, or gastric contents into the upper respiratory tract. -0&N(Pneumonia C08.381.677; C08.730.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory Tract Infections Bronchopneumonia; Pleuropneumonia; Pneumonia, Aspiration (+ 1); Pneumonia, Bacterial (+ 4); Pneumonia, Pneumocystis carinii; Pneumonia, Viral Bronchopneumonia; Pleuropneumonia; Pneumonia, Aspiration (+ 1); Pneumonia, Bacterial (+ 4); Pneumonia, Pneumocystis carinii; Pneumonia, Viral BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI - ( NrJPPneumonectomy E04.920.800.780 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Tuberculosis, Pulmonary; Lung Surgery, Operative; Thoracic Surgery; Surgery, Lung (Non MeSH) - $$KPneumomediastinum, Diagnostic E01.739 AECLCTECHIISMOMTNUPXSNSTTDUTVE Mediastinum Diagnosis Deliberate introduction of air or gas into the mediastinum as an aid to examination and diagnosis. - " " vPneumoencephalography E01.236.257.694; E01.236.688.662; E01.357.818.638.760; E01.357.818.760.730 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH) Diagnosis; Diagnosis, Neurologic (Non MeSH); Neuroradiography Diagnosis; Diagnostic Imaging; Radiography; Neuroradiography Diagnosis; Diagnostic Imaging; Radiography; Pneumoradiography Radiographic visualization of the cerebral ventricles by injection of air or other gas. Ventriculography, Cerebral (66-68) -T&)h(Pneumocystis carinii Infections C01.703.770 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Pneumonia, Pneumocystis carinii Infection with Pneumocystis carinii, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS CARINII) and other infections in humans. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally. Mycoses (89-91); Pneumonia, Pneumocystis carinii (66-91); Protozoan Infections (85-88)  -)%P=%efPneumocystis carinii B05.354.750 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi A species of fungi causing interstitial plasma cell pneumonia and other infections in man, as well as infections in other animals. -",Pneumoconiosis C08.381.483.600; C21.447.800 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Coal Mining; Dust Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases Asbestosis; Berylliosis; Byssinosis; Caplan's Syndrome; Siderosis; Silicosis (+ 2) Asbestosis; Berylliosis; Byssinosis; Caplan's Syndrome; Siderosis; Silicosis (+ 2) Condition characterized by permanent deposition of substantial amounts of particulate matter in the lungs, usually of occupational or environmental origin, and by the tissue reaction to its presence. BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $-9"LNPneumococcal Infections C01.252.410.890.670 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Streptococcus pneumoniae Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Meningitis, Pneumococcal; Pneumonia, Lobar Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.  -P2MPneumocephalus C21.866.460.694 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Presence of air within the skull due to fistulous tract formation, penetrating wounds, fractures, erosions from tumors or infections, surgery, or may occur spontaneously. -vNcPneumatosis Cystoides Intestinalis C06.405.469.778 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases A condition characterized by the presence of thin-walled, gas-containing cysts in the wall of the intestines. The lesions may be subserosal or submucosal. (Dorland, 27th ed). -5(NUPlutonium D01.268.271.545.700; D01.552.517.734 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Plutonium. A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, atomic number 94, and atomic weight 242. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons. - *4mPluto H01.091.800.700.813 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The ninth planet in order from the sun. It is one of the five outer planets of the solar system. Its only natural satellite is Charon. Extraterrestrial Environment (66-90); Planets (91-94) -  M?Plummer-Vinson Syndrome C06.306.418.408.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Motility Disorders; Deglutition Disorders Syndrome of dysphagia with iron deficiency anemia and mucosal lesions of the mouth, pharynx, and esophagus. -"'NtPlum Pox Virus B04.715.464.600.600; B04.820.464.600.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses; Potyvirus Viruses; RNA Viruses; Mosaic Viruses; Potyvirus A member of the Potyvirus group that affects many species of Prunus. It is transmitted by aphids and by infected rootstocks. Plant Viruses (69-93) -#.vPloidies G05.148.777 Genetics; Cytogenetics Diploidy; Haploidy; Polyploidy The degree of replication of the chromosome set in the karyotype. specific ploidies heading -%l &PPlicamycin D20.085.075.302.600; D22.204.106.307.600; D26.408.348.199.700 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Chromomycins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Chromomycins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Chromomycins Mithramycin. A tricyclic pentaglycosidic antibiotic from Streptomyces strains that inhibits RNA and protein synthesis by adhering to DNA. It is used as a fluorescent dye and as an antineoplastic agent, especially in bone and testicular tumors. Plicamycin is also used to reduce hypercalcemia, especially that due to malignancies. Antibiotics, Antineoplastic (67-70) -&_E<5)Pliability H01.671.649 DERE Physical Sciences (Non MeSH); Physics The quality or state of being able to be bent or creased repeatedly. (From Webster, 3d ed). -)/rPleuropneumonia, Contagious C01.252.400.610.610.717; C22.717 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Mycoplasmatales Infections; Mycoplasma Infections Animal Diseases A pleuropneumonia of cattle and goats caused by species of MYCOPLASMA. -* &JUPleuropneumonia C08.381.677.473; C08.528.735.473; C08.730.582.473; C08.730.610.473 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Pneumonia Respiratory Tract Diseases; Pleural Diseases; Pleurisy Respiratory Tract Diseases; Respiratory Tract Infections; Pleurisy Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia Pleurisy complicated with pneumonia. (Dorland, 27th ed). -,LNEPleurodynia, Epidemic C02.782.687.359.213.737 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections; Coxsackievirus Infections An acute, febrile, infectious disease generally occurring in epidemics, most often seen in persons under the age of 20. It is usually caused by COXSACKIEVIRUSES B and sometimes by COXSACKIEVIRUSES A, ECHOVIRUSES, and other enteroviruses. (Dorland, 27th ed). -.P.Pleurodesis E02.319.694 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Drug Therapy The production of adhesions between the parietal and visceral pleura. The procedure is used in the treatment of bronchopleural fistulas, malignant pleural effusions, and pneumothorax and often involves instillation of chemicals or other agents into the pleural space causing, in effect, a pleuritis that seals the air leak. (From Fishman, Pulmonary Diseases, 2d ed, p2233 and Dorland, 27th ed). Pleura (76-94) -16"!Pleurodeles B02.090.608.700.540 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Salamandridae A genus of aquatic newts belonging to the family Salamandridae and sometimes referred to as "spiny" tritons. There are two species P. waltlii and P. poireti. P. waltlii is commonly used in the laboratory. Since this genus adapts to aquarium living, it is easy to maintain in laboratories. Amphibia (66-80); Salamandridae (75-80); Urodela (66-74) -3&7WEPleurisy C08.528.735; C08.730.582 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Pleural Diseases Respiratory Tract Diseases; Respiratory Tract Infections Pleuropneumonia Pleuropneumonia -5 Nu$Pleural Neoplasms C04.588.894.797.640; C08.528.694; C08.785.640 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms Respiratory Tract Diseases; Pleural Diseases Respiratory Tract Diseases; Respiratory Tract Neoplasms Pleural Effusion, Malignant Pleural Effusion, Malignant Pleural Effusion, Malignant Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms. BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  -75X_ZPleural Effusion, Malignant C04.588.894.797.640.700; C08.528.652.700; C08.528.694.700; C08.785.640.700 BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms; Pleural Neoplasms Respiratory Tract Diseases; Pleural Diseases; Pleural Effusion Respiratory Tract Diseases; Pleural Diseases; Pleural Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms; Pleural Neoplasms Presence of fluid in the pleural cavity as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells. Pleural Effusion (66-90); specific neoplasm (66-90)  -:!TR f>Pleural Effusion C08.528.652 BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Exudates and Transudates Respiratory Tract Diseases; Pleural Diseases Pleural Effusion, Malignant Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.  -=R5!Pleural Diseases C08.528 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases Chylothorax; Empyema, Pleural (+ 1); Hemopneumothorax; Hemothorax; Hydropneumothorax; Hydrothorax; Pleural Effusion (+ 1); Pleural Neoplasms (+ 1); Pleurisy (+ 1); Pneumothorax; Tuberculosis, Pleural (+ 1) BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI -? N \Pleura A04.716; A10.615.789.736 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Pneumonolysis Respiratory System Tissue Types (Non MeSH); Membranes; Serous Membrane The thin serous membrane enveloping the lungs and lining the thoracic cavity. -A :U]Plethysmography, Whole Body E01.302.796.513; E01.725.694 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Diagnosis; Plethysmography Measurement of the volume of gas in the lungs, including that which is trapped in poorly communicating air spaces. It is of particular use in chronic obstructive pulmonary disease and emphysema. (Segen, Dictionary of Modern Medicine, 1992). Plethysmography (66-70); Respiratory Function Tests (66-70) -C!""|FPlethysmography, Impedance E01.145.811.611; E01.399.799; E01.725.528 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Plethysmography Diagnosis; Electrodiagnosis Diagnosis; Plethysmography Cardiography, Impedance Cardiography, Impedance -E1&7Plethysmography E01.145.811; E01.725 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Blood Circulation Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Diagnosis Photoplethysmography; Plethysmography, Impedance (+ 1) Photoplethysmography; Plethysmography, Impedance (+ 1); Plethysmography, Whole Body Recording of change in the size of a part as modified by the circulation in it.  -F&CcPlesiomonas B03.440.450.900.620 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in fish and other aquatic animals and in a variety of mammals, including man. Its organisms probably do not belong to the normal intestinal flora of man and can cause diarrhea. Vibrionaceae (78-91) -H"h1Plectrovirus B04.123.370.600; B04.280.400.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Inoviridae Viruses; DNA Viruses; Inoviridae A genus of bacteriophages of the family INOVIRIDAE. Organisms of this genus infect Acholeplasma and Spiroplasma. -J&RPleasure-Pain Principle F02.739.794.746 Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory The psychoanalytic concept that man instinctively seeks to avoid pain and discomfort and strives for gratification and pleasure. -L$lPlay Therapy F04.754.664 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A treatment technique utilizing play as a medium for expression and communication between patient and therapist. Acting Out (68); Play (66-68); Projective Techniques (66-67); Psychotherapy, Group (66-68) -MtKnPlay and Playthings I03.450.642.693 Human Activities (Non MeSH); Leisure Activities; Recreation Spontaneous or voluntary recreational activities pursued for enjoyment and accessories or equipment used in the activities; includes games, toys, etc. -OHPlatypus B02.649.627.600 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Monotremata A small aquatic oviparous mammal of the order Monotremata found in Australia and Tasmania. -PV ()lPlatyhelminths B01.500.736 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths Cestoda (+ 9); Trematoda (+ 19); Turbellaria (+ 1) A phylum of acoelomate, bilaterally symmetrical flatworms, without a definite anus. It includes three classes: Cestoda, Turbellaria, and Trematoda. -QU*BPlatybasia C05.116.099.742; C05.116.900.540; C05.660.724; C16.131.621.724 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Arnold-Chiari Deformity Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) A developmental deformity of the occipital bone and upper end of the cervical spine, in which the latter appears to have pushed the floor of the occipital bone upward. (Dorland, 27th ed). Occipital Bone/abnormalities (66)  -RHLR(Platinum Compounds D01.710 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Cisplatin Inorganic compounds which contain platinum as the central atom. Platinum (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $-V 8% L:Platinum D01.268.679; D01.552.691 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organoplatinum Compounds Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals A silvery gray, malleable metal used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae". -Wl :`Plateletpheresis E02.095.160.790; E02.110.285.790; E05.909.262.363.285.790 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Platelets Therapeutics; Biological Therapy (Non MeSH); Cytapheresis Therapeutics; Blood Component Removal; Cytapheresis Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Cell Separation; Cytapheresis The preparation of platelet concentrates with the return of red cells and platelet-poor plasma to the donor. Blood Platelets (66-78); Blood Transfusion (66-78); Cell Separation (72-78); Plasmapheresis (78)  -YA"tPlatelet-Derived Growth Factor D11.303.780; D12.644.725; D12.776.124.625; D24.185.348.740 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Platelet-Derived Growth Factor Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Blood Proteins (77-83); Growth Substances (77-83); Peptides (77-83)  -\<$DF0GRPlatelet Transfusion E02.095.135.140.650 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Blood Platelets Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion; Blood Component Transfusion The transfer of blood platelets from a donor to a recipient or reinfusion to the donor. Blood Component Transfusion (92-93); Blood Platelets (66-93); Blood Platelets/transplantation (72-93); Blood Transfusion (66-91)  -_$lkPlatelet Storage Pool Deficiency C15.378.463.205.735 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders A group of disorders characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored. Blood Platelet Disorders (67-85) -a'N'Platelet Membrane Glycoproteins D12.776.124.125.786; D12.776.395.550.625; D12.776.543.550.625; D12.776.543.750.705.408.450; D24.611.834.408.450 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Platelet Adhesiveness; Platelet Aggregation Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins Receptors, Thrombin (+ 1) Receptors, Thrombin (+ 1) Receptors, Thrombin (+ 1) Receptors, Thrombin (+ 1) Receptors, Thrombin (+ 1) Platelet membrane glycoproteins have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. The platelet membrane glycoproteins, IIb and IIIa, form a calcium ion-dependent heterodimer complex that functions as the fibrinogen receptor in activated platelets to mediate platelet aggregation. A deficiency of this glycoprotein results in Glanzmann's thrombasthenia. Glycoprotein Ib has been identified as the platelet-binding site mediating the factor VIII/von Willebrand-factor-dependent adhesion of platelets to vascular endothelium. A deficiency of this glycoprotein results in Bernard-Soulier disease. Glycoproteins (66-86); Membrane Proteins (66-86) $-d%{H3u:Platelet Function Tests E01.223.459.770 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Platelets Diagnosis; Diagnosis, Laboratory; Hematologic Tests Bleeding Time; Clot Retraction; Platelet Count Blood Platelets (66-79); Platelet Adhesiveness (69-79); Platelet Aggregation (75-79) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $-ks"=9d&Platelet Factor 4 D09.203.698.735.800; D12.776.124.125.780; D12.776.395.650.700; D19.461.270.229.700 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Proteoglycans Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Proteoglycans Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors A high-molecular-weight proteoglycan-platelet factor complex which is released from blood platelets by thrombin. It acts as a mediator in the heparin-neutralizing capacity of the blood and plays a role in platelet aggregation. At high ionic strength (I=0.75), the complex dissociates into the active component (molecular weight 29,000) and the proteoglycan carrier (chondroitin 4-sulfate, molecular weight 350,000). The molecule exists in the form of a dimer consisting of 8 moles of platelet factor 4 and 2 moles of proteoglycan. Blood Coagulation Factors (73-75); Blood Platelets (74-75); Glycoproteins (74-75) -m\DiaPlatelet Factor 3 D10.516.532.760; D12.776.124.125.760; D12.776.521.800; D19.461.270.229.698 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors A lipoprotein with pronounced electronegative surface charge found in association with platelet membrane and platelet granules. In the sequence of blood coagulation reactions, it is required for activation of factor VIII and for the conversion of prothrombin to thrombin. Blood Coagulation Factors (74); Blood Platelets (74); Lipoproteins (74) -r~TD;WPlatelet Count E01.223.459.107.700; E01.223.459.770.790; G07.380.107.740 DEISMTREVE Blood Platelets Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Platelet Function Tests Physiology, General (Non MeSH); Cell Count; Blood Cell Count Blood Cell Count (66-79); Blood Platelets (66-79) -vA=Platelet Aggregation Inhibitors D19.461.780 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Blood Platelets Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Aspirin; Dipyridamole; Epoprostenol; Iloprost; Ketanserin; Ticlopidine Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Blood Platelets (66-87); Platelet Adhesiveness (72-87); Platelet Aggregation (76-87) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (-xM%6[T(dDPlatelet Aggregation G09.188.560.600.640 DEGEIMPHRE Platelet Membrane Glycoproteins Blood Platelets Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hemostasis; Platelet Activation The attachment of platelets to one another. This clumping together can be induced by a number of agents (e.g., thrombin, collagen) and is part of the mechanism leading to the formation of a thrombus. Blood Platelets (66-74); Platelet Adhesiveness (69-74) $-{}%APlatelet Adhesiveness G09.188.560.600.500 DEGEIMPHRE Platelet Membrane Glycoproteins Adhesiveness; Blood Platelets Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hemostasis; Platelet Activation The process whereby platelets adhere to something other than platelets, e.g., collagen, basement membranes, microfibrils, or other "foreign" surfaces. Blood Platelets (66-68) $-}%$Platelet Activation G09.188.560.600 DEGEIMPHRE Blood Platelets Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hemostasis Platelet Adhesiveness; Platelet Aggregation A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. Blood Platelets (72-89); Platelet Aggregation (77-89) $-h3T@Platelet Activating Factor D10.516.695.300.725.725; D12.776.124.125.730; D17.350.050.600; D19.461.270.229.695 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phospholipid Ethers Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors 1-O-Alkyl-2-acetyl-sn-glycero-3-phosphocholine. A phospholipid derivative formed by platelets, basophils, neutrophils, monocytes, and macrophages. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including hypotension, thrombocytopenia, neutropenia, and bronchoconstriction. Lysophosphatidylcholines (66-82) -~ \F_%Plastoquinone D02.806.250.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Benzoquinones 2,3-Dimethyl-5-(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-2,5-cyclohexadiene-1,4-dione. Polyunsaturated side-chain quinone derivative which is an important link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds. Plant Proteins (72-74); Quinones (72-74) -:A2Plastocyanin D12.776.556.760; D12.776.765.680 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins A copper-containing plant protein that is a fundamental link in the electron transport chain of green plants during the photosynthetic conversion of light energy by photophosphorylation into the potential energy of chemical bonds. Copper (70-74); Plant Proteins (70-74) -}&H 0Plastids A11.368.702.700 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Chloroplasts Self-replicating cytoplasmic organelles of plant and algal cells that contain pigments and may synthesize and accumulate various substances. Plastids are used in phylogenetic studies. Base Sequence (87-93); Chloroplasts (66-93)  -  *$5Plastics D25.720.716 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers Nylons; Polyethylenes (+ 1); Polypropylenes; Polystyrenes (+ 1); Polyurethanes; Polyvinyls (+ 4); Resins, Synthetic (+ 8) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU - *@.Plasticizers D25.700 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH) Dibutyl Phthalate; Diethylhexyl Phthalate Materials incorporated mechanically in plastics (usually PVC) to increase flexibility, workability or distensibility; due to the non-chemical inclusion, plasticizers leach out from the plastic and are found in body fluids and the general environment. Phthalic Acids (70-76) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $-) ,31!.Plastic Embedding E05.909.262.620.720.640; E05.909.432.600.720.640 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Tissue Embedding Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Tissue Embedding The infiltrating of histological specimens with plastics, including acrylic resins, epoxy resins and polyethylene glycol, for support of the tissues in preparation for sectioning with a microtome. Plastics (66-91) -n6?Plasmodium yoelii B01.841.075.762.167.275.400.611.780 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A species of PLASMODIUM causing malaria in rodents. Plasmodium (66-87) -0'&s?Plasmodium vivax B01.841.075.762.167.275.400.611.761 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite that causes vivax malaria (MALARIA, VIVAX). This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions. -'&sPlasmodium malariae B01.841.075.762.167.275.400.611.661 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite that occurs primarily in subtropical and temperate areas. It is the causal agent of quartan malaria. As the parasite grows it exhibits little ameboid activity. -g'&sPlasmodium knowlesi B01.841.075.762.167.275.400.611.610 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite from Southeast Asia that causes monkey malaria. It is naturally acquired by man in Malaysia and can also be transmitted experimentally to humans. Plasmodium (66-91) -8'&sPlasmodium gallinaceum B01.841.075.762.167.275.400.611.576 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite that causes avian malaria (MALARIA, AVIAN), primarily in chickens, and is transmitted by the Aedes mosquito. Plasmodium (66-85) -'&sPlasmodium falciparum B01.841.075.762.167.275.400.611.561 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. -'&sPlasmodium cynomolgi B01.841.075.762.167.275.400.611.505 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite that occurs naturally in the macaque. It is similar to PLASMODIUM VIVAX and produces a type of malaria similar to vivax malaria (MALARIA, VIVAX). This species has been found to give rise to both natural and experimental human infections. Plasmodium (66-91) -n'&s3Plasmodium chabaudi B01.841.075.762.167.275.400.611.490 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite of rodents transmitted by the mosquito Anopheles stephensi. Plasmodium (66-91) -'&s_Plasmodium berghei B01.841.075.762.167.275.400.611.461 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina; Plasmodium A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni. Plasmodium (66-72) --'&s\Plasmodium B01.841.075.762.167.275.400.611 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Antimalarials Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Haemosporina Plasmodium berghei; Plasmodium chabaudi; Plasmodium cynomolgi; Plasmodium falciparum; Plasmodium gallinaceum; Plasmodium knowlesi; Plasmodium malariae; Plasmodium vivax; Plasmodium yoelii A genus of coccidian protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM, PLASMODIUM MALARIAE, P. ovale, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI, PLASMODIUM CHABAUDI, P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI, and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens.  -#&eYPlasminogen Inactivators D08.373.745.800.810.737 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Protein C Inhibitor Important modulators of the activity of plasminogen activators. Four inhibitors, all belonging to the serpin family of proteins, have been implicated in plasminogen activation inhibition. They are PAI-1, PAI-2, protease-nexin, and PROTEIN C INHIBITOR (PAI-3). All inhibit both the tissue-type and urokinase-type plasminogen activators. Glycoproteins (66-89); Plasminogen Activators/antagonists and inhibitors (76-89) AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $-@i]BPlasminogen Activators D08.586.277.656.732.635; D08.586.277.656.732.760.635; D19.461.427.600.620 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Plasminogen Alteplase; Anistreplase Alteplase Alteplase; Anistreplase; Urokinase A heterogeneous group of proteolytic enzymes that convert plasminogen to plasmin. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Enzyme Activation (74-75); Peptide Hydrolases (75); Plasminogen (74-75)  -QFPVPlasminogen Activator Inhibitor 2 D08.373.745.800.810.737.610 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins; Plasminogen Inactivators Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators. Plasminogen Inactivators (90-92) -(B&Plasminogen Activator Inhibitor 1 D08.373.745.800.810.737.600 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins; Plasminogen Inactivators A member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators. Plasminogen Inactivators (90-92) -(B&Plasminogen D08.444.610; D19.461.427.600 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents  Plasminogen Activators (+ 3) Precursor of fibrinolysin (plasmin). It is a single-chain beta globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  -"D$FPlasmin D08.586.277.656.732.760.625; D19.461.427.595 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents A product of the lysis of plasminogen (profibrinolysin) by plasminogen activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. EC 3.4.21.7. - 2DPlasmids D13.444.308.212.500; D13.444.308.283.500; D13.444.308.300.500; D13.444.308.435.500 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Extrachromosomal Inheritance DNA Insertion Elements Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Fungal Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Plant Colicin Factors; Cosmids; F Factor; Genetic Vectors; Hemolysin Factors; Lactose Factors; R Factors Colicin Factors; Cosmids; F Factor; Genetic Vectors; Hemolysin Factors; Lactose Factors; R Factors Any extrachromosomal hereditary determinant. Plasmids are self-replicating circular molecules of DNA that are found in a variety of bacterial, fungal, algal, and plant species. Extrachromosomal Inheritance (68-74); Genetics (66-67) (- \D!@Plasmapheresis E02.110.770; E02.912.715 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cell Separation Therapeutics; Blood Component Removal Therapeutics; Sorption Detoxification Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. -"WPlasmalogens D10.516.695.300.725.700 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phospholipid Ethers -r@zPlasmacytoma C04.557.386.720; C20.683.515.761.720 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Interleukin-6 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma Multiple Myeloma Multiple Myeloma Any discrete, presumably solitary, mass of neoplastic plasma cells either in bone marrow or various extramedullary sites.  -v*X(Plasma Volume G09.188.313.610; G09.330.612.214.610 DEGEIMPHREVE Fluid Shifts Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Volume Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Blood Volume Volume of plasma in the circulation. It is usually measured by indicator dilution techniques. -ë*pPlasma Substitutes D19.461.140.500 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Blood Substitutes Blood Substitutes Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Blood Substitutes Dextrans (+ 1); Hydroxyethyl Starch; Pectins; Polygeline; Povidone Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR (-Ŕ,rR>BPlasma Exchange E02.095.135.750 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Blood Transfusion (68-80); Exchange Transfusion, Whole Blood (68-80); Plasmapheresis (68-80) -ȍ"KJmPlasma Cells A11.063.693; A11.329.810; A15.382.520.118.693 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Antibody-Producing Cells Cells; Connective Tissue Cells (Non MeSH) Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Antibody-Producing Cells -5*Plasma A12.207.152.693; A15.145.693 CHCYDEENIMMEMIPHPSRARERIUSVI Fluids and Secretions (Non MeSH); Body Fluids; Blood Hemic and Immune Systems (Non MeSH); Blood -T " vPlaque Assay E05.909.560.970.790 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cytopathogenic Effect, Viral Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques; Virus Cultivation Method for measuring viral infectivity and multiplication in cultured cells. Clear lysed areas or plaques develop as the viral particles are released from the infected cells during incubation. With some viruses, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain viral antigens which can be measured by immunofluorescence. Virus Cultivation (66-72)  -5""xPlants, Transgenic B06.680 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Genetic Engineering Plants Plants into which cloned genetic material has been experimentally transferred. The technique most frequently applied makes use of a natural plant-directed gene vector, the gram-negative soil bacterium Agrobacterium tumefaciens. A second system more analogous to those used for transforming mammalian cell lines is the direct transfer of DNA into plant protoplasts, for example by electroporation or polyethylene glycol treatment. This technology has widespread applications in the world of biotechnology; for example, plants have been transformed to carry herbicide and pest resistance by the introduction of foreign genes, often of bacterial origin. Plants/genetics (86-91); specific plant/genetics (86-91)  -q & DPlants, Toxic B06.660 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plant Poisoning Plants Belladonna; Digitalis; Ferula; Hemlock; Mandragora; Podophyllum; Rhamnus; Ricinus (+ 1); Senecio; Stramonium; Tobacco; Toxicodendron; Veratrum Plants or plant parts which are harmful to man or other animals. Plants (66-75) $-7 & PPlants, Medicinal B06.560 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Alkaloids; Pharmacognosy; Medicine, Herbal Drugs Plants Aloe; Areca; Arnica; Belladonna; Cannabis; Capsicum; Cinchona; Coca; Colchicum; Digitalis; Erythrina; Eucalyptus; Ferula; Garlic; Ginseng; Legumes (+ 3); Mustard; Papaver; Plantago; Podophyllum; Rauwolfia; Rhamnus; Rhubarb; Stramonium; Valerian; Veratrum; Viscum Plants whose roots, leaves, seeds, bark, or other constituent possess therapeutic, tonic, purgative, or other pharmacologic activity when administered to higher animals. AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI (- &3  A4Plants, Edible B06.510 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Legumes; Food Plants Allium (+ 1); Basil; Brassica (+ 1); Cacao; Capsicum; Cassava; Cereals (+ 7); Chicory; Coffee; Crops, Agricultural; Fruit (+ 1); Helianthus; Legumes (+ 4); Nuts (+ 2); Rhubarb; Tea; Vegetables (+ 7) An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI $- & ?4Plants B06 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Herbicides; Pollen; Seeds Botany Arabidopsis; Cotton; Grasses (+ 1); Herbs (+ 1); Plant Structures (Non MeSH) (+ 12); Plants, Edible (+ 40); Plants, Medicinal (+ 30); Plants, Toxic (+ 14); Plants, Transgenic; Pollen; Pyrethrum; Trees (+ 5) AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI  - &! 4Plantago B06.560.690 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Psyllium Plants; Plants, Medicinal Three different species of Plantago or plantain, P. psyllium, P. ovata and P. indica. The seeds swell in water and are used as laxatives. Psyllium (66-77)  -ޕ &  Plant Viruses B04.715 CHCLDEENGDGEIMIPMEPHPYREUL Viruses Carlavirus; Closterovirus; Geminivirus; Luteovirus; Mosaic Viruses (+ 10); Nepovirus; Phycodnaviridae; Potexvirus; Tombusvirus; Tospovirus Viruses parasitic on plants higher than bacteria. -  <Plant Tumors C04.619.765 CHCICLETMIPSSEUL Neoplasms; Neoplasms, Experimental A localized proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumors or galls are usually form in response to the action of a pathogen or a pest. (Holliday, P., A Dictionary of Plant Pathology, 1989, p. 330). -5)mPlant Transpiration G04.742.750 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH) The loss of water vapor by plants to the atmosphere. It occurs mainly from the leaves through pores (stomata) whose primary function is gas exchange. The water is replaced by a continuous column of water moving upwards from the roots within the xylem vessels. (Concise Dictionary of Biology, 1990). -"gcPlant Structures (Non MeSH) B06.413 Plants Plant Roots (+ 2); Plant Shoots (+ 3); Plant Stems (+ 2); Seeds (+ 1) AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI -D"  ]&Plant Stems B06.413.525 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH) Hypocotyl; Meristem Parts of plants that usually grow vertically upwards towards the light and support the leaves, buds, and reproductive structures. (From Concise Dictionary of Biology, 1990). Plants (66-94)  -!&,Plant Shoots B06.413.500 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH) Plant Leaves (+ 2) The aerial portions of a plant, including stem, branches, and leaves and also, new immature growth on a plant. (McGraw-Hill Dictionary of Science and Technology, 4th ed). Plants (66-94)  -&,Plant Roots B06.413.400 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH) Meristem (+ 1) The usually underground portions of a plant that serve as support, store food, and through which water and mineral nutrients enter the plant. (From American Heritage Dictionary, 1982; Concise Dictionary of Biology, 1990). Plants (66-94)  -I&,Plant Root Cap B06.413.400.500.600 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH); Plant Roots; Meristem A cone-shaped structure in plants made up of a mass of meristematic cells that covers and protects the tip of a growing root. It is the putative site of gravity sensing in plant roots. Plants (66-94) -&IPlant Proteins D12.776.765 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Abrin; Concanavalin A; Ferredoxins; Gluten (+ 1); Leghemoglobin; Photosynthetic Reaction Center, Plant; Phycocyanin; Phycoerythrin; Phytochrome; Phytohemagglutinins; Plastocyanin; Pokeweed Mitogens; Ricin; Trichosanthin; Vegetable Proteins; Wheat Germ Agglutinins; Zein Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which VEGETABLE PROTEINS is available. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  -DD<HPlant Poisoning C21.613.756 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Plants, Toxic Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Ergotism; Favism; Lathyrism; Milk Sickness Poisoning by the ingestion of plants or its leaves, berries, roots or stalks. The manifestations in both humans and animals vary in severity from mild to life threatening. In animals, especially domestic animals, it is usually the result of ingesting moldy or fermented forage. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $-LE5GNPlant Physiology (Non MeSH) G04.742 Biological Phenomena, Cell Physiology, Immunity (Non MeSH) Germination; Gravity Perception; Photosynthesis; Plant Transpiration; Tropism (+ 2) CLDEGEIMPHRE -" DcPlant Oils D10.516.627.700; J01.740.700 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils Technology, Industry, Agriculture (Non MeSH); Oils Castor Oil; Corn Oil; Cottonseed Oil; Croton Oil (+ 3); Iodized Oil (+ 1); Linseed Oil; Safflower Oil; Sesame Oil; Soybean Oil Castor Oil; Corn Oil; Cottonseed Oil; Croton Oil (+ 3); Eugenol; Iodized Oil (+ 1); Linseed Oil; Safflower Oil; Sesame Oil; Soybean Oil Oils derived from plants or plant products. Oils (66-86) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $-",K6@Plant Leaves B06.413.500.600 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH); Plant Shoots Cotyledon; Pulvinus Expanded structures, usually green, of vascular plants, characteristically consisting of a bladelike expansion attached to a stem, and functioning as the principal organ of photosynthesis and transpiration. (American Heritage Dictionary, 2d ed). Plants (66-94)  -&>Plant Growth Regulators D11.303.760 AGAIANBICHCLCSDUECGEHIIMIPMEPDPHPKPORESDSESTTO Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Abscisic Acid; Auxins; Chlormequat; Cytokinins (+ 3); Gibberellins; Indoleacetic Acids (+ 1); Triiodobenzoic Acids Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  -|2PBPlant Extracts D24.310.674; D26.714 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products Miscellaneous Drugs and Agents (Non MeSH) Cascara; Curare; Drugs, Chinese Herbal; Ipecac (Syrup); Podophyllin (+ 1) Cascara; Curare; Drugs, Chinese Herbal; Ipecac (Syrup); Podophyllin (+ 1) Plants (66) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  -B}DPlant Diseases J01.040.735 CICLECETGEHILJMIPSSN Technology, Industry, Agriculture (Non MeSH); Agriculture Plants (66-67) - DPlanning Techniques N04.452.718 Health Planning; Social Planning Health Services Administration (Non MeSH); Organization and Administration Procedures, strategies, and theories of planning. -(W;Plankton B01.766; B05.692 CHCLCYDEENGDGEIMIPMEPHPYREULVI Diatoms; Eutrophication Marine Biology Invertebrates Algae and Fungi (Non MeSH) Zooplankton Phytoplankton A collective name for the minute free-floating organisms, plant and animal, which live in practically all natural waters. (Dorland, 27th ed). $- "1Planets H01.091.800.700 Extraterrestrial Environment Extraterrestrial Environment Physical Sciences (Non MeSH); Astronomy; Solar System Earth (Planet) (+ 1); Jupiter; Mars; Mercury (Planet); Neptune; Pluto; Saturn; Uranus; Venus Heavenly bodies with their own motion among the stars, revolving, in the case of the solar system, around the sun, along the plane of the ecliptic. They are grouped into inner planets and outer planets, based on distance from the sun and common characteristics. Astronomy (66-90); Extraterrestrial Environment (66-90) $.^ !!Bv6APlanarians B01.500.736.847.610 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Turbellaria Nonparasitic free-living flatworms of the class Turbellaria. The most common genera are Dugesia, formerly Planaria, which lives in water, and Bipalium, which lives on land. Geoplana occurs in South America and California. .*?Plague Vaccine D24.310.894.135.609 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines A suspension of killed Yersinia pestis used for immunizing people in enzootic plague areas. .>pmPlague C01.252.400.310.980.745 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Yersinia Infections An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form. .8 P3Plagiarism L01.737.684 Scientific Misconduct Information Science; Publishing Passing off as one's own the work of another without credit. Fraud (77-89) .&KPlacentation G08.520.720 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction Development of a site of fetomaternal union for physiologic exchange, a placenta or placenta-like organ. Placenta (66-74) . G{Placental Lactogen D06.472.759.692; D06.472.785.650; D12.776.780.650 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Somatotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Placental Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins Placental Hormones (66-67) . 9H  Placental Insufficiency C13.703.590.800 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Placenta Diseases Failure of the placenta to deliver an adequate supply of nutrients and oxygen to the fetus. . L|oPlacental Hormones D06.472.759 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Gonadotropins, Chorionic; Gonadotropins, Equine; Placental Lactogen; Pregnancy-Specific beta 1-Glycoprotein AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR .IBBzHPlacental Function Tests E01.249.636 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Methods used for the assessment of placental function. Fetal Diseases/diagnosis (66-74); Placenta (66-74); Placenta Diseases (69-74) ."0B]Placental Extracts D24.185.893.608 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts Extracts prepared from placental tissue; they may contain specific but uncharacterized factors or proteins with specific activities. .!B`Placenta, Retained C13.703.590.767 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Placenta Diseases A placenta which is either adherent or incarcerated by irregular uterine contractions, and which in consequence fails to be expelled after birth. (Dorland, 27th ed). Placenta (66-94); Placenta Diseases (70-94) .L|5Placenta Praevia C13.703.420.714; C13.703.590.734 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Placenta Diseases A placenta which develops in the lower uterine segment, in the zone of dilatation, so that it covers or adjoins the internal os. Painless hemorrhage in the last trimester, particularly during the eighth month, is the most common symptom. (Dorland, 27th ed). .&L2Placenta Diseases C13.703.590 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Abruptio Placentae; Chorioamnionitis; Placenta Accreta; Placenta Praevia; Placenta, Retained; Placental Insufficiency Placenta (66-68); Pregnancy Complications (66-68) .Nf;Placenta Accreta C13.703.420.643; C13.703.590.609 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Placenta Diseases Abnormal adherence of part or all of the placenta to the uterine wall, with partial or complete absence of the decidua basalis, especially of the spongiosum layer. (Dorland, 27th ed). .S&LPlacenta A16.759 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Maternal-Fetal Exchange; Uteroplacental Circulation Embryonic Structures (Non MeSH) Chorionic Villi; Decidua; Trophoblast ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  .  :;&.<Placebos D26.394.774 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. . ,<Placebo Effect G03.850.490.734.875; N05.715.350.350.625 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Effect Modifiers (Epidemiology) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Effect Modifiers (Epidemiology) An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion. Placebos (66-89) .h. Pizotyline D03.383.903.580; D14.100.850.850.700; D15.040.100.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic Serotonin antagonist used against migraine and vascular headaches. Benzocycloheptenes (73-74); Piperidines (72-74); Thiophenes (70-74) .!=:<NPPivampicillin D20.085.099.739.762.057.774 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Ampicillin 6-((Aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid (2,2-dimethyl- 1-oxopropoxy)methyl ester. Pivalate ester analog of ampicillin. Ampicillin (72-74); Valerates (73-74) .$H:o.Pityriasis Rubra Pilaris C17.800.859.600.685 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Pityriasis A chronic skin disease characterized by small follicular papules, disseminated reddish-brown scaly patches, and often, palmoplantar hyperkeratosis. The papules are about the size of a pin and topped by a horny plug. Dermatitis Exfoliative (66) .&?N|!Pityriasis Rosea C17.800.859.600.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Pityriasis A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting. Pityriasis (66-92) .(N|Pityriasis Lichenoides C17.800.859.475.650; C17.800.859.575.650; C17.800.859.600.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Lichenoid Eruptions Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Parapsoriasis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Pityriasis Lymphomatoid Papulosis Lymphomatoid Papulosis Lymphomatoid Papulosis A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis. An important variant of the chronic form is LYMPHOMATOID PAPULOSIS. Parapsoriasis (66-85); Pityriasis (77-92)  .+[EN}M2Pityriasis C17.800.859.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous Pityriasis Lichenoides (+ 1); Pityriasis Rosea; Pityriasis Rubra Pilaris A name originally applied to a group of skin diseases characterized by the formation of fine, branny scales, but now used only with a modifier. (Dorland, 27th ed). .0+NnWPituitrin D06.472.734.692.559 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior .2K D|Pituitary-Adrenal System A06.407.691 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Endocrine System (Non MeSH); Endocrine Glands The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. .3N88Pituitary-Adrenal Function Tests E01.197.571 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Endocrine (Non MeSH) Pituitary Function Tests (66-67) .5&"3'Pituitary Neoplasms C04.588.322.609; C19.344.609; C19.700.734 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms Endocrine Diseases; Pituitary Diseases Nelson Syndrome Nelson Syndrome Nelson Syndrome .51X8Pituitary Irradiation E02.810.190.600 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hypophysectomy; Cranial Irradiation Therapeutics; Radiotherapy; Cranial Irradiation .7"*8Pituitary Hormones, Posterior D06.472.734.692 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Neurophysins Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones Oxytocin; Pituitrin; Vasopressins (+ 5); Vasotocin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  .8e#BY?FPituitary Hormones, Anterior D06.472.734.525 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones Glycoprotein Hormones, Alpha Subunit; Gonadotropins, Pituitary (+ 4); Pro-Opiomelanocortin (+ 6); Somatotropin; Thyrotropin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR .9"BYHPituitary Hormones D06.472.734 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hypopituitarism; Receptors, Pituitary Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones Pituitary Hormones, Anterior (+ 15); Pituitary Hormones, Posterior (+ 9) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  .;B5BWHPituitary Hormone-Releasing Hormones D06.472.709; D12.644.722; D12.776.641.650.645 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Pituitary Hormone-Regulating Hormone Hypothalamo-Hypophyseal System; Neurosecretion Hormones, Substitutes, Antagonists (Non MeSH); Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Corticotropin-Releasing Hormone; Gonadorelin (+ 5); MSH-Releasing Hormone; Prolactin-Releasing Hormone; Protirelin; Somatotropin-Releasing Hormone (+ 1) Hormones released by one structure (e.g., the hypothalamus or the thyroid gland) that effect the secretion of hormones from the pituitary gland. Hypothalamo-Hypophyseal System/physiology (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,.=o*5D658FPituitary Hormone Release Inhibiting Hormones D06.347.560; D12.644.720; D12.776.641.650.640 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Pituitary Hormone-Regulating Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides MSH Release-Inhibiting Hormone; Prolactin Release-Inhibiting Hormone; Somatostatin (+ 1) Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. Used for PHRIH in general or for which there is no specific heading. Pituitary Hormone Releasing Hormones (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (.A55D6h4FPituitary Gland, Posterior A06.407.747.734 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands; Pituitary Gland The neural or post-neural lobe of the pituitary gland. .E< :LCPituitary Gland, Anterior A06.407.747.608 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands; Pituitary Gland The glandular or anterior lobe of the pituitary gland. Pituitary Gland (66-74) .F[:LCPituitary Gland A06.407.747 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Hypophysectomy Endocrine System (Non MeSH); Endocrine Glands Hypothalamo-Hypophyseal System; Pituitary Gland, Anterior; Pituitary Gland, Posterior A small, unpaired gland situated in the sella turcica tissue. It is connected to the hypothalamus by a short stalk. consider also terms at HYPOPHYS-.  .G:8bPituitary Function Tests E01.197.642 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Endocrine (Non MeSH) .I"3Pituitary Diseases C19.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases Empty Sella Syndrome; Hyperpituitarism (+ 2); Hypopituitarism (+ 4); Inappropriate ADH Syndrome; Pituitary Apoplexy; Pituitary Neoplasms (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI .J# NXPituitary Apoplexy C19.700.725 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Pituitary Diseases Sudden hemorrhage into or ischemic necrosis of a normal or adenomatous pituitary gland. Pituitary Diseases (66-86); Pituitary Neoplasms (66-86) .KN.hBPitch Perception F02.463.593.071.700 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception Pitch Discrimination A dimension of auditory sensation varying with cycles per second of the sound stimulus. Auditory Perception (67-79); Perception (66); Pitch Discrimination (66-79)  .MF tiYPitch Discrimination F02.463.593.071.700.408 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception; Pitch Perception The ability to differentiate tones. .N ,Pitcairn Island Z01.782.815.700 EHEP Geographicals (Non MeSH); Pacific Islands; Polynesia .P@Pit and Fissure Sealants D25.339.773 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials Agents used to occlude dental enamel pits and fissures in the prevention of dental caries. Dental Materials (66-71) .P*ImPiroxicam D03.383.855.500; D08.373.310.600; D16.850.015.050.710; D17.025.030.600; D17.050.030.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide. A non-steroidal anti-inflammatory agent that is well established in the treatment of rheumatoid arthritis and osteoarthritis. Its usefulness has also been demonstrated in the treatment of musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. The drug has also been shown to be effective if administered rectally. Gastrointestinal complaints are the most frequently reported side effects. Thiazines (66-86) .Q c:dPiroplasmida B01.841.075.762.580.580 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Piroplasmia Babesia (+ 1); Theileria (+ 2) An order of protozoa comprising heteroxenous tick-borne blood parasites. Representative genera include BABESIA, Dactylosoma, and THEILERIA. .W&H)Piroplasmia B01.841.075.762.580 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea Piroplasmida (+ 5) A subclass of heteroxenous parasitic protozoa usually transmitted by ticks. Its organisms are rod-shaped or amoeboid with conoid, oocysts, spores, and pseudocysts absent. Locomotion is by body flexion, gliding, or, in sexual stages, by large axopodium-like organelles. .Y|&97Piromidic Acid D03.066.515.650; D03.383.725.547.650; D20.237.765 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Anti-Infective Agents; Anti-Infective Agents, Urinary  Pipemidic Acid 8-Ethyl-5,8-dihydro-5-oxo-2-(1-pyrrolidinyl)pyrido (2,3-d)pyrimidine-6-carboxylic acid. Antibacterial against mainly gram negative organisms; proposed for urinary tract infections. Synonyms: Panacid; PD 93. Nicotinic Acids (76-78); Picolinic Acids (68-75); Pyrimidines (66-75); Pyrrolidines (66-78)  .[w9:nPirinitramide D03.066.399.650; D03.383.621.349.700; D15.040.150.590; D15.210.600.717 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonipecotic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Isonipecotic Acids Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics 1'-(3-Cyano-3,3-diphenylpropyl)-(1,4'-bipiperidine)-4'-carboxamide. A diphenylpropylamine with intense narcotic analgesic activity of long duration. It is a derivative of MEPERIDINE with similar activity and usage. Isonipecotic Acids (69-76); Nitriles (71-76); Piperidines (71-75) .^P:cOPiribedil D03.383.606.790; D14.100.150.151.770; D15.090.050.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist. Dioxoles (71-74); Piperazines (71-74); Pyrimidines (71-74) .a =:AGPirenzepine D03.438.079.080.070.750; D14.100.120.200.500.680; D16.050.650.730; D19.316.203.727 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one. An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Azepines (66-73); Benzodiazepinones (74-86) .e\:4Piracetam D02.065.064.650; D02.241.081.038.108.650; D03.383.773.812.555; D15.575.700; D15.590.720 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Acetamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Central Nervous System Agents; Neuroprotective Agents Central Nervous System Agents; Nootropic Agents A compound suggested to be both a nootropic and a neuroprotective agent. Its efficacy and mechanisms of action are not clear. Acetamides (73-74); Pyrrolidinones (71-74) .j c:3Pipobroman D03.383.606.773; D22.204.678 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Antineoplastic Agents (66); Bromine (66); Piperazines (66); Propionates (66) .m":^Pipidae B02.090.180.610 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura Xenopus (+ 1) A family of the order Anura, distinguished by the lack of a tongue. It includes four living genera of aquatic "toads". Two of the most familiar pipids are the popularly called Surinam "toad" (Pipa pipa) and XENOPUS LAEVIS. .of &$ Piperoxan D03.383.621.815; D14.100.050.200.100.670; D16.050.850.730; D18.162.727 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents A benzodioxane alpha-adrenergic blocking agent with considerable stimulatory action. It has been used to diagnose pheochromocytoma and as an antihypertensive agent. Dioxanes (75); Dioxins (73-74); Piperidines (70-76); Sympatholytics (66-74) .q P:\Piperonyl Butoxide D03.383.246.558; D05.723.748.483 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Dioxoles Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Pesticide Synergists Dioxoles (68-71); Insecticides (66-71); Pesticides (66-71) .t&:GPiperidones D03.383.621.808 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Cycloheximide; Dexetimide; Glutethimide (+ 1); Thalidomide; Triacetoneamine-N-Oxyl Piperidines (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  .v8Wa<Piperidines D03.383.621 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Alphaprodine; Anabasine; Biperiden; Cyproheptadine (+ 1); 1-Deoxynojirimycin; Dipyridamole; Domperidone; Fentanyl (+ 2); Flecainide; Fluspirilene; Indoramin; Isonipecotic Acids (+ 5); Ketanserin; Ketotifen; Lobeline; Loperamide; Mepivacaine; Methylphenidate; Minoxidil; Nipecotic Acids; Paroxetine; Pempidine; Penfluridol; Perhexiline; Phencyclidine; Pipecolic Acids (+ 1); Piperidones (+ 6); Piperoxan; Ritanserin; Terfenadine; Trihexyphenidyl A family of hexahydropyridines. Piperidine itself is found in the pepper plant as the alkaloid piperine. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  .w8G}@Piperazines D03.383.606 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Almitrine; Cinnarizine; Cyclizine; Diethylcarbamazine; DMPP; Flunarizine; Flupenthixol; HEPES; Hydroxyzine (+ 1); Itraconazole; Ketoconazole; Lidoflazine; Meclizine; Ofloxacin; Pipecuronium; Pipemidic Acid; Pipobroman; Piribedil; Prospidium; Quipazine; Razoxane; Thiethylperazine; Trazodone; Trimetazidine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR .{A8Gg:Piperacillin D20.085.099.739.762.057.746 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Ampicillin 6-(((((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl) amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid. Semisynthetic, broad-spectrum, ampicillin-derived ureidopenicillin antibiotic proposed for Pseudomonas infections. It is also used in combination with other antibiotics. Penicillins (66-83) .}:o`Pipemidic Acid D03.066.515.635; D03.383.606.765; D03.383.725.547.635; D20.237.765.745 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Anti-Infective Agents; Anti-Infective Agents, Urinary; Piromidic Acid 8-Ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido (2,3-d)pyrimidine-6-carboxylic acid. Antimicrobial against Gram negative and some Gram positive bacteria; protein bound and concentrated in bile and urine; used for gastrointestinal, biliary and urinary infections. Nalidixic Acid (66-75); Nicotinic Acids (76-78); Piperazines (66-70) .P:`-SPipecuronium D03.383.606.760; D04.808.054.040.080.600; D06.472.079.080.600; D14.100.120.200.600.770; D16.700.710.575.775 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols; 5-Androstane-3,17-diol Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens; 5-Androstane-3,17-diol Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents 4,4'-((2 beta,3 alpha,5 alpha,16 beta,17 beta)-(3,17-Bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethylpiperazinium). A non-depolarizing neuromuscular blocking agent used during halothane anesthesia and obstetric and gynecologic surgery. Piperazines (80-92); Steroids (79-80); 5-Androstane-3,17-diol/analogs and derivatives (80-92) .w:mmPipecolic Acids D03.066.758; D03.383.621.758 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines  Bupivacaine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ."8:Pinta C01.252.400.840.558; C01.252.825.630; C01.252.847.840.558; C01.539.800.720.630; C17.800.838.765.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial An infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact. . oPu[Pinocytosis G04.335.487.370 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Endocytosis The engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles. .vPinnipedia B02.649.754 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Seals; Walrus Carnivora (66-67) . (Pinealoma C04.557.465.625.600.640; C04.557.470.670.640; C04.557.580.625.600.640 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial A tumor of the pineal body composed of neoplastic nests of large cells. Tumors in this region are rare, accounting for less than 1% of intracranial tumors, although in children they constitute 3%-8% of intracranial tumors. Its symptoms include hydrocephalus, conjugate paralysis of upward gaze, disturbances of gait, and precocious puberty, the last due to suppression of pineal secretion of melatonin. Because pinealomas are near the center of the brain, they are among the most difficult of brain tumors to remove. A variety of surgical approaches has been described. Radiotherapy and chemotherapy are also used. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1597-9; Dorland, 27th ed). . MXMPineal Body A06.407.635; A06.688.733; A08.186.211.730.385.608; A08.713.733 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands Endocrine System (Non MeSH); Neurosecretory Systems Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon Nervous System; Neurosecretory Systems A small conical midline body attached to the posterior part of the third ventricle and lying between the superior colliculi, below the splenium of the corpus callosum. .H:Pindolol D02.033.329.624.748; D02.092.063.624.748; D14.100.050.200.200.680; D16.050.850.725; D18.097.606; D18.162.725 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents A beta-adrenergic antagonist with some agonist activity. Pindolol is used in the treatment of angina pectoris, arrhythmias, glaucoma, and hypertension. Sympatholytics (66-72) . z:"Pimozide D03.438.103.732; D14.100.150.175.720; D15.090.700; D15.150.675; D15.210.950.040.675; D15.700.872.331.690 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA, Drug Evaluations Annual, 1994, p.403). Benzimidazoles (66-72); Tranquilizing Agents (66-72) . v:Q>Pimelic Acids D02.241.081.337.699 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Diaminopimelic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR .8q:Pilot Projects E05.318.760.750; G03.850.520.835.720; H01.770.644.524; N05.715.360.775.625 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH) Physical Sciences (Non MeSH); Science; Research Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH) Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Research (66-70) .KTPilonidal Cyst C04.182.710 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts A hair-containing cyst or sinus, occurring chiefly in the coccygeal region. .kVZPilomatrixoma C04.557.470.565.625 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Basal Cell A tumor composed of cells resembling those of the hair matrix, which undergo 'mummification' and may calcify. It is a relatively uncommon tumor, which may occur at any age from infancy. The majority of patients are under 20, and females are affected more than males. The lesion is usually a solitary deep dermal or subcutaneous tumor 3-30 mm in diameter, situated in the head, neck, or upper extremity. (From Rook et al., Textbook of Dermatology, 4th ed, p. 240l). Skin Neoplasms (66-93) .vX(Piloerection F02.830.702.607; G10.795.499; G11.561.730.482 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Reflex Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Involuntary erection or bristling of hairs. Hair (66-71); Reflex (66-71) .55%Pilocarpine D03.132.672; D14.100.120.140.500.700; D16.050.495.720 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. .=@-Pigments D11.557 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH) Adrenochrome; Anthocyanins; Bile Pigments (+ 4); Carotenoids (+ 15); Ceroid; Flavins (+ 1); Gossypol; Hemocyanin; Lipofuscin; Melanins; Phycocyanin; Phycoerythrin; Phytochrome; Porphyrins (+ 24); Prodigiosin; Pterins (+ 1); Pyocyanine Any normal or abnormal coloring matter in plants, animals, or micro-organisms. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  .M  B9]HPigmentation Disorders C17.800.621 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Argyria; Hyperpigmentation (+ 4); Hypopigmentation (+ 5); Incontinentia Pigmenti; Urticaria Pigmentosa; Xeroderma Pigmentosum BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI .NKXPigmentation E01.706.760; G04.185.672 DEGEIMPHRE Skin Pigmentation Chromatophores Diagnosis; Physical Examination Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) Skin Pigmentation Eye Color; Hair Color; Skin Pigmentation Coloration or discoloration of a part by a pigment. $.G@Pigment Epithelium of Eye A09.371.670; A10.272.640 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye Tissue Types (Non MeSH); Epithelium Epithelium in the retina, ciliary body, and iris containing pigment granules. Ciliary Body (66-75); Iris (66-75); Retina (66-75); Retinal Degeneration (68-75); Retinal Diseases (72-75) .L :C\Pigeons B02.248.523 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds Birds (66-67); Poultry (66-67) .  &'Pierre Robin Syndrome C05.500.460.606; C05.660.514.606; C07.320.440.606; C07.650.460.606; C16.131.621.514.606; C16.131.850.460.606 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases; Jaw Abnormalities Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Stomatognathic Diseases; Jaw Diseases; Jaw Abnormalities Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities An autosomal recessive disorder characterized by brachygnathia and cleft palate, often associated with glossoptosis, backward and upward displacement of the larynx, and angulation of the manubrium sterni. Cleft palate makes sucking and swallowing difficult, permitting easy access of fluids into the larynx. It may appear in several syndromes or as an isolated hypoplasia. (Dorland, 27th ed). .zLnPiedra C01.703.753 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Either of two diseases resulting from fungal infection of the hair shafts. Black piedra occurs mainly in and on the hairs of the scalp and is caused by Piedraia hortae; white piedra occurs in and on the hairs of the scalp, beard, moustache and genital areas and is caused by Trichosporon beigelii. . P=cPiebaldism C16.131.410.040.600; C17.800.621.440.102.600; C17.800.827.130.600; C18.452.648.066.102.600 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Waardenburg's Syndrome Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary; Albinism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hypopigmentation; Albinism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Albinism Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Albinism Autosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. The most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. The underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). Piebaldism may be closely related to Waardenburg's syndrome. Albinism (66-71); Pigmentation Disorders (66-90)  .dL:Picryl Chloride D02.455.526.439.750; D02.640.529.880.607; D24.611.216.119.480.820 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Organic Chemicals (Non MeSH); Nitro Compounds; Nitrobenzenes; Trinitrobenzenes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Haptens 2-Chloro-1,3,5-trinitrobenzene. A hapten that generates suppressor cells capable of down-regulating the efferent phase of trinitrophenol-specific contact hypersensitivity. (Arthritis Rheum 1991 Feb;34(2):180). .^I:VPicrotoxin D09.203.408.348.700; D14.100.240.300.700; D15.220.224.798; D15.220.740; D26.061.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Antagonists Central Nervous System Agents; Central Nervous System Stimulants; Convulsants Central Nervous System Agents; Central Nervous System Stimulants Miscellaneous Drugs and Agents (Non MeSH); Antidotes A noncompetitive antagonist at GABA-A receptors and thus a convulsant. Picrotoxin blocks the GABA-activated chloride ionophore. Although it is most often used as a research tool, it has been used as a CNS stimulant and an antidote in poisoning by CNS depressants, especially the barbiturates. .]_:WPicrates D02.640.743.690; D02.755.566.690 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrophenols Organic Chemicals (Non MeSH); Phenols; Nitrophenols .U &8Picornaviridae Infections C02.782.687 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Cardiovirus Infections; Common Cold; Enterovirus Infections (+ 13); Foot-and-Mouth Disease Virus diseases caused by the PICORNAVIRIDAE. Picornaviridae (66-79); Virus Diseases (66-79)  .cP:k68Picornaviridae B04.820.565; B04.909.777.618 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Aphthovirus; Cardiovirus (+ 5); Enterovirus (+ 11); Hepatovirus (+ 1); Rhinovirus; Rhinoviruses, Equine Aphthovirus; Cardiovirus (+ 5); Enterovirus (+ 12); Hepatovirus (+ 1); Rhinovirus; Rhinoviruses, Equine A family of small RNA viruses comprising some important pathogens of humans and animals. Transmission usually occurs mechanically. There are five genera: APHTHOVIRUS, CARDIOVIRUS, ENTEROVIRUS, HEPATOVIRUS, and RHINOVIRUS. ."YPicolinic Acids D03.066.707; D03.383.725.705 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Fusaric Acid; Picloram; Streptonigrin Fusaric Acid; Picloram; Streptonigrin AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ."8Z@Picolines D03.383.725.676 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Amprolium; Pyridoxal (+ 1); Pyridoxamine AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR .ҭ 8U3DPicobirnavirus B04.820.562; B04.909.777.610; B04.970.610 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Viruses; Viruses, Unclassified Unclassified, bisegmented, double-stranded RNA virus isolated from the feces of humans and other animals. Some reports associate it with gastroenteritis in humans. RNA Viruses (88-94) .1|Picloram D03.066.707.523; D03.383.725.705.523; D05.723.366.734 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Picolinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolinic Acids Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Herbicides (66-70); Picolinic Acids (68-70) . =:5Pickwickian Syndrome C08.618.085.852.741; C18.654.621.690 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Apnea; Sleep Apnea Syndromes Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Obesity Extreme obesity with polycythemia, somnolence, hypoventilation, arterial unsaturation and hypercapnia, and pulmonary hypertension. .׼*NPicibanil D22.204.670; D24.310.670 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Immunologic and Biologic Factors (Non MeSH); Biological Products A lyophilized preparation of a low-virulence strain (SU) of Streptococcus pyogenes (S. hemolyticus), inactivated by heating with penicillin G. It has been proposed as a noncytotoxic antineoplastic agent because of its immune system-stimulating activity. Streptococcus (66-77) .ٹ :$Pichinde Virus B04.820.057.070.800.650; B04.909.777.080.070.800.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae; Arenavirus; Tacaribe Complex Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae; Arenavirus; Tacaribe Complex Viruses A species of ARENAVIRUS, one of the TACARIBE COMPLEX VIRUSES, causing a fatal infection in the cricetine rodent Oryzomys albigularis. Asymptomatic laboratory infection in humans has been reported. Arenaviridae (79-93); RNA Viruses (71-75); Tacaribe Complex Viruses (79-93) .:[Pichia B05.354.107.292.700; B05.354.930.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Algae and Fungi (Non MeSH); Fungi; Yeasts Yeast-like ascomycetous fungi of the family Saccharomycetaceae, order Endomycetales isolated from exuded tree sap. . *"Pica C23.888.298.500; F03.126.298.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Eating Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Eating Disorders A craving for substances unsuitable as food. Appetite Disorders (66-67) .>&N7 Pia Mater A08.186.566.731 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Meninges .8;Phytosterols D04.808.247.808.756 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Ergosterol; Sitosterols; Stigmasterol Cholestanes (68-72); Sterols (68-72) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  .:B--@Phytoplankton B05.692.606 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Plankton Minute plant organisms which live in practically all natural waters. Plankton (66-70) .."/RPhytophthora B05.354.730.576.625.725 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Mastigomycotina; Oomycetes A Mastigomycotina genus of destructive parasitic fungi affecting numerous fruit, vegetable, and other crops. .-"\~Phytonadione D11.786.875.689; D19.461.270.546.861.689 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin K Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Heparin Antagonists; Vitamin K 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione. A fat-soluble vitamin occurring naturally as the trans-isomer. It is used in the treatment of prothrombinemias. .w.DPhytomastigophorea B01.841.750.443.575 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora Dinoflagellida; Euglenida (+ 2); Volvocida (+ 2) A class of protozoa consisting of plantlike flagellates. Its organisms are free-living and have one or two flagella. .&B=Phytol D02.455.849.291.523 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes .Q :NPhytohemagglutinins D12.776.395.560.825; D12.776.765.677; D24.185.526.545.711; D24.310.545.711; D24.611.125.044.545.711 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens; Lectins Immunologic and Biologic Factors (Non MeSH); Biological Products; Lectins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Lectins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Lectins (66-78) .oD-Phytochrome D11.557.712; D12.776.765.675 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins A blue-green biliprotein widely distributed in the plant kingdom. Bile Pigments (73-74); Plant Proteins (72-74) .="DN8Phytic Acid D02.033.800.519.400.700; D09.203.853.519.400.700; D09.203.894.480.700 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Inositol; Inositol Phosphates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Inositol; Inositol Phosphates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Inositol Phosphates myo-Inositol hexakis(dihydrogen phosphate). Complexing agent for removal of traces of heavy metal ions. It acts also as a hypocalcemic agent. Inositol (66-77) .M<]Phytanic Acid D02.241.081.407.300.700; D02.455.849.291.515; D10.516.251.220.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Eicosanoic Acids Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Eicosanoic Acids 3,7,11,15-Tetramethylhexadecanoic acid. A 20-carbon branched chain fatty acid. In phytanic acid storage disease (Refsum's disease) this lipid may comprise as much as 30% of the total fatty acids of the plasma. This is due to a phytanic acid alpha-hydroxylase deficiency. Diterpenes (74); Fatty Acids (70-74) .I:*=.Physostigmine D02.241.081.251.642; D03.132.656; D08.373.275.745; D14.100.120.300.720; D16.050.495.710; D16.050.675.670 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Heterocyclic Compounds; Alkaloids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. .&v:LEPhysiology, General (Non MeSH) G07 Adaptation, Physiological (+ 3); Aging (+ 1); Body Constitution (+ 2); Body Temperature (+ 6); Cell Count (+ 9); Chronobiology (+ 4); Electrophysiology (+ 14); Fluid Shifts; Growth and Embryonic Development (Non MeSH) (+ 42); Homeostasis (+ 6); Tensile Strength; Tropism (+ 2) AEBLCFCICLCNCODEDHDIDTDUECEDEHEMENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERHRIRTSNSTSUTDTHTUURUSVEVI .%VlPhysiology, Comparative G01.782.688 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Physiology .&Physiology G01.782 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences Electrophysiology; Endocrinology (+ 1); Neurophysiology; Physiology, Comparative; Psychophysiology (+ 2) The science which treats of the functions of the living organism and its parts, and of the physical and chemical factors and processes involved. (Dorland, 27th ed). .4 zPhysiognomy E05.734 Facial Expression Miscellaneous Techniques (Non MeSH) . *Physics H01.671 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH) Acoustics (+ 6); Biophysics (+ 14); Doppler Effect; Elasticity (+ 1); Electricity (+ 7); Friction; Gravitation (+ 4); Hardness (+ 1); Health Physics; Kinetics; Lubrication; Magnetics (+ 2); Motion (+ 4); Nuclear Physics (+ 21); Optics (+ 25); Oscillometry; Pliability; Porosity; Pressure (+ 5); Psychophysics (+ 2); Radiation (+ 29); Rheology (+ 4); Temperature (+ 3); Thermal Conductivity; Thermodynamics (+ 2); Vibration AECLCTDEDUECEDGEHIIMISLJMAMOMTNUOGPCPHPXRERHSDSNSTTDTUUTVE /`  #>Physicians' Offices N02.278.692 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities The room or rooms in which the physician and his staff provide patient health care. The offices include all rooms in the physician's office suite. /*LPhysicians, Women M01.526.485.810.820; M01.975.790; N02.360.810.820 CLECHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Physicians Named Groups (Non MeSH); Women Facilities, Manpower and Services (Non MeSH); Health Personnel; Physicians Women licensed to practice medicine. /9-Physicians, Family M01.526.485.810.770; N02.360.810.770 CLECEDHILJOGPXSDSNSTTDUT Family Practice Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Physicians Facilities, Manpower and Services (Non MeSH); Health Personnel; Physicians Those physicians who have completed the education requirements specified by the American Academy of Family Physicians. Family Practice (66-71); Physicians (66-71)  /1*5Physicians M01.526.485.810; N02.360.810 CLECHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Foreign Medical Graduates; Physicians, Family; Physicians, Women Foreign Medical Graduates; Physicians, Family; Physicians, Women Individuals licensed to practice medicine. CLECEDHILJOGPXSDSNSTTDUT  /T"3Physician's Role F01.829.316.616.500; N05.300.100.600 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes; Role Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude of Health Personnel The expected and characteristic behavior of a physician as a member of the medical profession. Role (69-77) / Z*qPhysician's Practice Patterns N04.590.748; N05.300.625 CLECHILJOGSNSTTDUT Insurance, Health Health Services Administration (Non MeSH); Patient Care Management (Non MeSH) Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided. Costs and Cost Analysis (66-86); Health Services Misuse (77-86); Professional Practice (68-86)  / #qPhysician-Patient Relations F01.829.401.650.675; N05.300.660.625 Truth Disclosure Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations; Professional-Patient Relations Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Professional-Patient Relations The interactions between physician and patient. /Z *9Physician Self-Referral K01.316.130.500; K01.752.256.095.500; N02.278.354.550.380.500; N04.452.442.550.380.500; N04.452.758.849.500; N05.350.225.500 LJSNTD Humanities; Ethics; Conflict of Interest Humanities; Philosophy; Ethics; Conflict of Interest Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Restructuring; Hospital-Physician Joint Ventures Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Restructuring; Hospital-Physician Joint Ventures Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Referral and Consultation Quality, Access, Evaluation (Non MeSH); Ethics; Conflict of Interest Referral by physicians to testing or treatment facilities in which they have financial interest. The practice is regulated by the Ethics in Patient Referrals Act of 1989. Referral and Consultation (83-94) / (Physician Payment Review Commission N03.219.521.710.305.180 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms A commission created by the Consolidated Omnibus Reconciliation Act of 1985, enacted in 1986, and given the mandate to advise Congress on Medicare-physician payment. The commission members are appointed by the U.S. Office of Technology Assessment. /*!Physician Incentive Plans N04.452.677.740 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Compensatory plans designed to motivate physicians in relation to patient referral, physician recruitment, and efficient use of the health facility. Employee Incentive Plans (79-87); Personnel Management (66-87) /pJPhysician Impairment I01.880.604.583.524.528.500; N03.706.535.606.528.500 CLECLJPXSN Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Malpractice; Professional Impairment Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Malpractice; Professional Impairment The physician's inability to practice medicine with reasonable skill and safety to the patient due to the physician's disability. Common causes include alcohol and drug abuse, mental illness, physical disability, and senility. Clinical Competence (75-80); Mental Disorders (66-80); specific mental disorder; Physicians (66-80) /:vPhysician Assistants M01.526.485.067.740; N02.360.067.740 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Ophthalmic Assistants; Pediatric Assistants Ophthalmic Assistants; Pediatric Assistants Persons academically trained, licensed, or credentialed to provide medical care under the supervision of a physician. The concept does not include nurses, but does include orthopedic assistants, surgeon's assistants, and assistants to other specialists. Health Manpower (68-70); Physicians (68-70)  /*d$5Physical Therapy Department, Hospital N02.278.354.422.615; N04.452.442.422.615 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which is responsible for the administration and provision of diagnostic and medical rehabilitation services to restore or improve the functional capacity of the patient. Hospital Departments (68-Jul 77); Physical Therapy (66-Jul 77) /,. KPhysical Therapy E02.780; E02.831.578; G02.010.575 AECLCTECEDHIISLJMAMTNUOGPXSNSTTDUT Naturopathy Therapeutics Therapeutics; Rehabilitation Health Occupations; Allied Health Occupations Balneology (+ 4); Cryotherapy (+ 1); Drainage, Postural; Electric Stimulation Therapy (+ 2); Exercise Therapy (+ 1); Hydrotherapy; Hyperthermia, Induced (+ 4); Massage; Photochemotherapy (+ 3); Phototherapy (+ 3); Rewarming; Thalassotherapy Drainage, Postural; Exercise Therapy (+ 2) The restoration of function and the prevention of disability following disease or injury with the use of light, heat, cold, water, electricity, ultrasound, and exercise. AECLCTECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE $/!)&dW,Physical Stimulation E05.723 AEISMT Miscellaneous Techniques (Non MeSH) Acoustic Stimulation; Electric Stimulation (+ 1); Photic Stimulation AECLCTECHIISMOMTNUPXSNSTTDUTVE /$  *R"Physical Sciences (Non MeSH) H01 Astronomy (+ 13); Chemistry (+ 126); Electronics (+ 8); Geography (+ 1); Geology; Mathematics (+ 55); Physics (+ 156); Science (+ 43); Time (+ 6); Weights and Measures (+ 5) ADAEAGAIANBLCFCHCLCSCTDEDUECEDGEHIIMIPISLJMAMEMOMTNUOGPCPDPHPKPOPXRERHSDSNSTTDTOTUURUTVE /%#\Physical Medicine G02.403.790.508 CLECEDHIISLJMAMTOGSNSTTD Biomechanics Health Occupations; Medicine; Specialties, Other (Non MeSH) Rehabilitation A medical specialty concerned with the use of physical agents, mechanical apparatus, and manipulation in rehabilitating physically diseased or injured patients. CLECEDHIISLJMAMTNUOGPXSNSTTD $/'[G Physical Fitness I03.621; N01.407.540.730 PHPX Exercise Exercise Human Activities (Non MeSH) Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health A state of well-being in which performance is optimal, often as a result of physical conditioning which may be prescribed for disease therapy.  /)  }Physical Examination E01.706 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Apgar Score; Auscultation (+ 1); Blood Pressure Determination; Body Constitution (+ 3); Body Temperature; Cephalometry (+ 1); Facial Expression; Gait; Hand Strength; Neurologic Examination (+ 8); Palpation; Pelvimetry; Percussion; Pigmentation (+ 1); Pulse; Self-Examination (+ 1); Skinfold Thickness Systematic and thorough inspection of the patient for physical signs of disease or abnormality. AECLCTDEECEHGEHIIMISMOMTNUPHPXRESNSTTDUTVE  /* " kq.Physical Endurance G11.427.394.625 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Exertion Exercise Tolerance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Exertion (66-76); Fatigue (66-76)  /-=}*Physical Education and Training I02.233.543 CLECHILJMAMTOGSNSTTD Education; Education, Nonprofessional (Non MeSH) Gymnastics Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is EXERCISE THERAPY. CLECEDHIINLJMAMTOGPHPXSNSTTD  /.&9 Physical Conditioning, Animal E05.718 AECLCTECHIISMOMTNUPHPXSNSTTDUT Miscellaneous Techniques (Non MeSH) Physical conditioning of domestic, laboratory, and zoo animals. Includes exercising of animals. /0# "*pPhysarum polycephalum B01.841.750.656.300.600.700.550; B05.354.618.700.550 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Eumycetozoea; Physarida; Physarum Algae and Fungi (Non MeSH); Fungi; Myxomycota; Physarum An organism considered both a fungus and a protozoon (Dictionary of Microbiology and Molecular Biology, 2d ed). Characteristics include sporangia that are stalked and multilobed. It is widely used in biomedical research. Physarum (66-91) /1:&Physarum B01.841.750.656.300.600.700; B05.354.618.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Eumycetozoea; Physarida Algae and Fungi (Non MeSH); Fungi; Myxomycota Physarum polycephalum Physarum polycephalum An organism considered both a fungus and a protozoon (Dictionary of Microbiology and Molecular Biology, 2d ed). Characteristics include the presence of violet to brown spores. Myxomycetes (66-74)  /3 2&2Physarida B01.841.750.656.300.600 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Eumycetozoea Physarum (+ 1) An order of protozoa characterized by a peridium and capillitium that are calcareous and a spore mass that is usually dark-colored. /61 &OPhysalaemin D12.644.320.900.800; D12.644.456.800.745; D12.776.641.650.800.625; D14.600.600.860.700; D17.350.050.375.850.780; D24.185.965.033.728 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins; Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Tachykinins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Tachykinins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins; Tachykinins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Amphibian Venoms An oligopeptide isolated from the skin of Physalaemus fuscumaculatus, a South American frog. It is a typical kinin, resembling SUBSTANCE P in structure and action and has been proposed as a sialagogue, antihypertensive, and vasodilator. Peptides (69-76) /7DPhylogeny G04.185.349.605 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Evolution The relationships of groups of organisms as reflected by their evolutionary history. Evolution (66-74) /< ydPhyllodes Tumor C04.557.450.565.590.595.350.650; C04.557.450.795.650; C04.557.470.625.350.650 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Neoplasms, Fibroepithelial; Fibroadenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Fibroepithelial; Fibroadenoma A variant of mammary fibroadenoma, usually of large size, with an unusually cellular, sarcoma-like stroma. It is partially epithelial and partially nonepithelial. It is both common and usually benign, although it has been known to metastasize. It may achieve great size and sometimes invades adjacent breast tissue. A phyllodes tumor is best handled by local excision with a rim of breast tissue. (From Dorland, 25th ed; Holland et al., Cancer Medicine, 3d ed). /=UX!Phycomycetes B05.354.730 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Mastigomycotina (+ 4); Zygomycotina (+ 5) A large group of lower fungi, including the common water, leaf, and bread molds; formerly considered a class, but now split into two subdivisions, Mastigomycotina and Zygomycotina. /B",4Phycomyces B05.354.730.944.550.740 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Zygomycotina; Mucorales A genus of zygomycetous fungi, order Mucorales, forming mycelia having a metallic sheen. It has been used for research on phototropism. /Dl"YPhycoerythrin D11.557.705; D12.776.765.665 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins The metal-free red phycobilin pigment in a conjugated chromoprotein of red algae. It functions as a light-absorbing substance together with chlorophylls. Bile Pigments (72-74); Pigments (74); Plant Proteins (72-74) /E"DKPhycodnaviridae B04.280.600; B04.715.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Plant Viruses A family of DNA plant viruses that infect eukaryotic algae. /H 6IPhycocyanin D11.557.690; D12.776.765.650 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins The metal-free blue phycobilin pigment in a conjugated chromoprotein of blue-green algae. It functions as light-absorbing substance together with chlorophylls. Bile Pigments (71-74); Pigments (74); Plant Proteins (71-74) /H"DKPhthalimides D02.241.223.805.810; D02.478.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phthalic Acids Organic Chemicals (Non MeSH); Imides Thalidomide The imide of phthalic acids. Imides (66-74); Phthalic Acids (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $/K6&8%0:Phthalic Anhydrides D02.113.600; D02.241.223.805.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Anhydrides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phthalic Acids Phthalic acid anhydrides. Can be substituted on any carbon atom. Used extensively in industry and as a reagent in the acylation of amino- and hydroxyl groups. Anhydrides (66-78); Phthalic Acids (66-78) /M&84Phthalic Acids D02.241.223.805 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Dibutyl Phthalate; Diethylhexyl Phthalate; o-Phthalaldehyde; Phthalic Anhydrides; Phthalimides (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR /O?8]u:Phthalein Dyes D26.408.646 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes Phenolphthaleins (+ 3) Colored condensation products of phenols with phthalic anhydride; some are used in dye dilution methods to determine kidney or liver function; others are used as pH indicators in chemistry; phenolphthalein is an effective mild cathartic. Dyes (66-74) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $/P,;.Phthalazines D03.383.710.605 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines Hydralazine (+ 1); Todralazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR /R8W':Phrenology K01.419.799 HIIS Humanities; History The study of the conformation of the skull as indicative of mental faculties and traits of character, especially according to the hypothesis of F. J. Gall (1758-1828). (Webster 3d ed). /T4Phrenic Nerve A08.800.800.720.150.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Cervical Plexus The motor nerve of the diaphragm. The phrenic nerve fibers originate in the cervical spinal column (mostly C4) and travel through the cervical plexus to the diaphragm. /Ur8nPhototropism G04.742.800.700; G07.950.700 DEGEIMPHRE Light Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH); Tropism Physiology, General (Non MeSH); Tropism The directional growth of organisms in response to light. In plants, aerial shoots usually grow towards light. The phototropic response is thought to be controlled by auxin (= AUXINS), a plant growth substance. (From Concise Dictionary of Biology, 1990). Plants (66-94)  /W/" .Phototrophic Bacteria B03.650 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Rhodospirillales (+ 9) A physiological community of gram-negative bacteria whose members can perform photosynthesis under anaerobic conditions. Bacteria (66-77)  /Y " Phototherapy E02.780.750 AECLCTECHIISMOMTNUPXSNSTTDUTVE Light Therapeutics; Physical Therapy Color Therapy; Heliotherapy; Ultraviolet Therapy Treatment of disease, especially neonatal jaundice and certain neoplasms, with visible light, including LASERS. Jaundice, Neonatal/TH (66-80); Light/TU (67-80) $/Z" %:;Photosynthetic Reaction Center, Plant D12.776.765.575 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins A system consisting of proteins and cofactors which facilitates light energy and electron transfer in plants. Chlorophyll (66-90); Plant Proteins (66-90) /\S,BW5Photosynthetic Reaction Center, Bacterial D12.776.097.705 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins A system consisting of proteins and cofactors which acts as a light-driven electron pump across the photosynthetic membrane of photosynthetic bacteria. Bacterial Proteins (66-90) /^0B[ Photosynthesis G04.742.600; G06.535.335.755; H01.181.529.711.730 DEGEIMPHRE Chlorophyll; Chloroplasts; Light; Photobiology Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Photochemistry  Photophosphorylation The formation of carbohydrates, with release of molecular oxygen, from carbon dioxide and water in the chlorophyll tissue of plants and blue-green algae under the influence of light. In bacteria, photosynthesis uses hydrogen sulfide, molecular hydrogen, and other reduced compounds in place of water, so that molecular oxygen is not released. (Dorland, 27th ed.).  /_98#Photosensitizing Agents D23.600; D26.776.819 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematoporphyrin Photoradiation; Photochemotherapy; PUVA Therapy Dermatologic Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents Hematoporphyrin Derivative (+ 1); Methoxsalen; Trioxsalen Hematoporphyrin Derivative (+ 1); Methoxsalen; Trioxsalen Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $/c8Ij:Photosensitivity Disorders C17.800.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Light Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Dermatitis, Photoallergic; Dermatitis, Phototoxic; Hydroa Vacciniforme; Sunburn; Xeroderma Pigmentosum Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $/g$N Kv^XPhotoreceptors, Invertebrate A08.663.694.530.650.650; A08.800.550.700.730.700; A11.671.677.530.650.650 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Photoreceptors Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors Cells in invertebrates which are specialized to detect and transduce light and darkness and relay that information centrally in the nervous system. Photoreceptors (66-93) /kO!Q8)Photoreceptors A08.663.694.530.650; A08.800.550.700.730; A11.671.677.530.650 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Photoreceptors, Invertebrate; Rods and Cones (+ 3) Photoreceptors, Invertebrate; Rods and Cones (+ 3) Photoreceptors, Invertebrate; Rods and Cones (+ 3) Cells specialized to detect and transduce light and darkness. In vertebrates, photoreceptors in the retina are designated RODS AND CONES. Receptors, Sensory (66-70)  /nE8 Photoplethysmography E01.145.811.305; E01.725.264 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Plethysmography Diagnosis; Plethysmography Plethysmographic determination in which the intensity of light reflected from the skin surface and the red cells below is measured to determine the blood volume of the respective area. There are two types, transmission and reflectance. Plethysmography (66-92) /q3"&jPhotophosphorylation G06.535.335.755.605; G06.535.630.780.680; H01.181.529.711.605 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism; Photosynthesis Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH); Phosphorylation Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Photochemistry The formation of ATP in chloroplasts during photosynthesis. It is analogous to oxidative phosphorylation. (Dorland, 27th ed.). Photosynthesis (66-71) /sTEVPhotopheresis E02.780.740.770.500; E04.292.762 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Photochemotherapy; PUVA Therapy Surgery, Operative; Extracorporeal Circulation A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases. Methoxsalen (86-93); Photochemotherapy (84-93); PUVA Therapy (84-93) /u&"RPhotoperiod H01.862.675 Circadian Rhythm Physical Sciences (Non MeSH); Time The time period of daily exposure that an organism receives from daylight or artificial light. It is believed that photoperiodic responses may affect the control of energy balance and thermoregulation. Light (66-92); Periodicity (66-92) /x,+Photons H01.671.579.404.705; H01.671.768.441 AECLDUHITU Physical Sciences (Non MeSH); Physics; Nuclear Physics; Elementary Particles Physical Sciences (Non MeSH); Physics; Radiation Discrete concentrations of energy, apparently massless elementary particles, that move at the speed of light. They are the unit or quantum of electromagnetic radiation. Photons are emitted when electrons move from one energy state to another. (From Hawley's Condensed Chemical Dictionary, 11th ed). /z] *]Photomicrography E01.357.710.715; E05.595.799; H01.671.606.799.730 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Photography Miscellaneous Techniques (Non MeSH); Microscopy Physical Sciences (Non MeSH); Physics; Optics; Photography Photography of objects viewed under a microscope using ordinary photographic methods. /|9"dPhotometry E05.196.712 AECLCTECHIISMOMTNUPXSNSTTDUTVE Light Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Densitometry (+ 2); Fluorometry (+ 6); Nephelometry and Turbidimetry; Spectrophotometry (+ 5) /~\" EqPhotolysis H01.181.529.711.480 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Photochemistry Light (66-70); Ultraviolet Rays (66-70) /[1Photography E01.357.710; E05.712; H01.671.606.799 CLECEDHIISLJMAMTOGSNSTTDVE Microfilming; Motion Pictures Diagnosis; Diagnostic Imaging Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics; Optics Holography; Image Enhancement (+ 6); Photofluorography; Photogrammetry (+ 1); Photomicrography Holography; Image Enhancement (+ 5); Photofluorography; Photogrammetry (+ 1); Photomicrography Method of making images on a sensitized surface by exposure to light or other radiant energy. AECLCTDEECEDHIISLJMAMOMTNUOGPXRESNSTTDUTVE $/]-$q.Photogrammetry E01.357.710.708; H01.671.606.799.715 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Photography Physical Sciences (Non MeSH); Physics; Optics; Photography Moire Topography Moire Topography Making measurements by the use of stereoscopic photographs. / *"y(GPhotofluorography E01.357.710.705; E01.357.818.375.700; H01.671.606.799.700 CLECEDHIISLJMAMTOGSNSTTDVE Diagnosis; Diagnostic Imaging; Photography Diagnosis; Diagnostic Imaging; Radiography; Fluoroscopy Physical Sciences (Non MeSH); Physics; Optics; Photography The photography of images produced on a fluorescent screen by X-rays. /zATPhotochemotherapy E02.186.500; E02.319.685; E02.780.740 AECLCTECHIISMOMTNUPXSNSTTDUTVE Ultraviolet Therapy; Photosensitizing Agents; Light Therapeutics; Combined Modality Therapy Therapeutics; Drug Therapy Therapeutics; Physical Therapy  Hematoporphyrin Photoradiation; PUVA Therapy (+ 1) Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Light (66-77); Ultraviolet Therapy (66-77) $/-"=q>h4Photochemistry H01.181.529.711 CLECEDHIISLJMAMTOGSNSTTD Light; Photobiology Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Photolysis; Photophosphorylation; Photosynthesis Light (66-70) CLDEECEDGEHIIMISLJMAMTOGPHRESNSTTD $/9I8&Photobiology G01.273.738 CLECEDHIISLJMAMTOGSNSTTD Light; Photochemistry; Photosynthesis Light Biological Sciences; Biology The branch of biology which deals with the effect of light on living organisms. (Dorland, 27th ed). Light (66-94) $/{- #zPhotobacterium B03.440.450.900.604 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are common in the marine environment and on the surfaces and in the intestinal contents of marine animals. Some species are bioluminescent and are found as symbionts in specialized luminous organs of fish. /"hHPhotic Stimulation E05.723.729 AEISMT Light Miscellaneous Techniques (Non MeSH); Physical Stimulation Light (66-71) /  DPhosvitin D12.776.256.317.700; D12.776.290.700; D12.776.744.700 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Egg Proteins, Dietary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Phosphoproteins An egg yolk phosphoglycoprotein which contains about 90% of the yolk protein phosphorus. It is synthesized in the liver of the hen and transferred to the developing oocyte, where it is bound to lipoproteins within the yolk granules. Egg Proteins (73-74); Phosphoproteins (73-74) / =H7Phosvel D02.719.800; D05.723.491.657.825 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate O-(4-Bromo-2,5-dichlorophenyl)-O-methylphenyl phosphonothioate. An organothiophosphate insecticide. Synonyms: VCS-506; Leptophos. Benzene Derivatives (74); Insecticides, Organothiophosphate (73-74) / &:NPhosphotungstic Acid D01.029.260.700.675.750; D01.695.625.675.750; D01.940.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Phosphorus Acids; Phosphoric Acids Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids Inorganic Chemicals (Non MeSH); Tungsten Compounds Tungsten hydroxide oxide phosphate. A white or slightly yellowish-green, slightly efflorescent crystal or crystalline powder. It is used as a reagent for alkaloids and many other nitrogen bases, for phenols, albumin, peptone, amino acids, uric acid, urea, blood, and carbohydrates. (From Merck Index, 11th ed). /A80kPhosphotransferases (Phosphomutases) D08.586.399.665 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Bisphosphoglycerate Mutase; Phosphoglucomutase; Phosphoglycerate Mutase A group of enzymes that catalyze an intramolecular transfer of a phosphate group. It has been shown in some cases that the enzyme has a functional phosphate group, which can act as the donor. These were previously listed under PHOSPHOTRANSFERASES (EC 2.7.-). (From Enzyme Nomenclature, 1992) EC 5.4.2. Isomerases (84-93); Phosphotransferases (66-93)  /@)FSQe8Phosphotransferases (Phosphate Group Acceptor) D08.586.913.696.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases Adenylate Kinase; Nucleoside-Diphosphate Kinase; Nucleoside-Phosphate Kinase A group of enzymes that catalyzes the transfer of a phosphate group onto a phosphate group acceptor. EC 2.7.4. Phosphotransferases (66-93)  /.5FlW Phosphotransferases (Paired Acceptors) D08.586.913.696.645 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases Pyruvate, Orthophosphate Dikinase A group of enzymes that transfers two phosphate groups from a donor such as ATP to two different acceptors. (From Enzyme Nomenclature, 1992, p.262) EC 2.7.9. Phosphotransferases (66-93)  /T,Fl' Phosphotransferases (Nitrogenous Group Acceptor) D08.586.913.696.640 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases Arginine Kinase; Creatine Kinase A group of enzymes that catalyzes the transfer of a phosphate group onto a nitrogenous group acceptor. EC 2.7.3. Phosphotransferases (66-93)  /w7Fl( Phosphotransferases (Carboxyl Group Acceptor) D08.586.913.696.630 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases Acetate Kinase; Aspartate Kinase (+ 1); Phosphoglycerate Kinase A class of enzymes that transfers phosphate groups and has a carboxyl group as an acceptor. EC 2.7.2. Phosphotransferases (66-93)  /r4FlM| Phosphotransferases (Alcohol Group Acceptor) D08.586.913.696.620 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases Adenosine Kinase; Choline Kinase; Deoxycytidine Kinase; Fructokinases (+ 1); Galactokinase; Glucokinase; Glycerol Kinase; Hexokinase; Phosphoenolpyruvate Sugar Phosphotransferase System; Polynucleotide Hydroxylkinase; Protein Kinases (+ 17); Pyridoxal Kinase; Pyruvate Kinase; Thymidine Kinase; Uridine Kinase A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1. Phosphotransferases (66-93) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $/3Flhr HPhosphotransferases D08.586.913.696 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Diphosphotransferases (+ 3); Nucleotidyltransferases (+ 25); Phosphotransferases (Alcohol Group Acceptor) (+ 33); Phosphotransferases (Carboxyl Group Acceptor) (+ 4); Phosphotransferases (Nitrogenous Group Acceptor) (+ 2); Phosphotransferases (Paired Acceptors) (+ 1); Phosphotransferases (Phosphate Group Acceptor) (+ 3); Transferases (Other Substituted Phosphate Groups) (+ 3) A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992, p.262) EC 2.7. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  /FU#HPhosphothreonine D02.705.683; D12.125.901.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Threonine L-Threonine, dihydrogen phosphate. The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins and enzymes. Organophosphorus Compounds (71-78); Phosphoric Acid Esters (79); Phosphoric Acids (68-70); Threonine (66-74) /AA (75-79) /":Phosphoserine D02.705.679; D12.125.837.800 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Serine DL-Serine, dihydrogen phosphate. The phosphoric acid ester of serine. Used as an identifier in the analysis of peptides, proteins and enzymes. Organophosphorus Compounds (71-78); Phosphoric Acid Esters (79); Phosphoric Acids (68-70); Serine (66-74) /AA (75-79) /j":Phosphorylcholine D02.092.102.232.700; D02.675.276.232.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline (2-Hydroxyethyl)trimethylammonium chloride phosphate. Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction. Choline (69-74); Organophosphorus Compounds (73-74) /.:=Phosphorylation G06.535.630.780; H01.181.404.780 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Oxidative Phosphorylation; Photophosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. DEGEIMPHRE  /&7Phosphorylase Phosphatase D08.586.277.352.650.625.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases; Phosphoprotein Phosphatase An enzyme that deactivates glycogen phosphorylase a by releasing inorganic phosphate and phosphorylase b, the inactive form. EC 3.1.3.17. Glycogen Phosphorylase (73-74); Phosphatases (73-74) /F>Phosphorylase Kinase D08.586.913.696.620.682.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases An enzyme that catalyzes the conversion of ATP and phosphorylase b to ADP and phosphorylase a. EC 2.7.1.38. /#FPhosphorylase b D08.586.913.400.450.460.400.775 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases; Glycogen Phosphorylase The relatively inactive form of GLYCOGEN PHOSPHORYLASE (EC 2.4.1.1) that is reactivated to form PHOSPHORYLASE A by PHOSPHORYLASE KINASE, which catalyzes the enzymatic phosphorylation of the serine residues at the expense of ATP. Glucosyltransferases (66-70); Glycogen Phosphorylase (71-78) /#F FPhosphorylase a D08.586.913.400.450.460.400.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases; Glycogen Phosphorylase  The phosphorylated and more active form of GLYCOGEN PHOSPHORYLASE (EC 2.4.1.1) that functions as a regulatory enzyme during glycogen breakdown. The phosphate groups are hydrolytically removed by phosphorylase phosphatase to form PHOSPHORYLASE B and orthophosphate. Glucosyltransferases (66-70); Glycogen Phosphorylase (71-78) /#F1FPhosphorus, Dietary D01.695.635 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH) Phosphorus used in foods or obtained from food. This element is a major intracellular component which plays an important role in many biochemical pathways relating to normal physiological functions. High concentrations of dietary phosphorus can cause nephrocalcinosis which is associated with impaired kidney function. Low concentrations of dietary phosphorus cause an increase in calcitriol in the blood and osteoporosis. Phosphorus (66-90) /u6LPhosphorus Radioisotopes D01.496.669.604; D01.496.749.658 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Phosphorus Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. /D&4Phosphorus Metabolism Disorders C18.452.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Hypophosphatemia /#%NNPhosphorus Isotopes D01.496.669 Inorganic Chemicals (Non MeSH); Isotopes Phosphorus Radioisotopes Stable phosphorus atoms that have the same atomic number as the element phosphorus, but differ in atomic weight. P-31 is a stable phosphorus isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR /*24Phosphorus Compounds (Non MeSH) D01.695 Inorganic Chemicals (Non MeSH) Phosphines; Phosphoranes; Phosphorus Acids (+ 18); Phosphorus, Dietary Inorganic compounds that contain phosphorus as an integral part of the molecule. Phosphorus (66-93) AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  /­& %U`>Phosphorus Acids D01.029.260.700; D01.695.625 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH) Phosphinic Acids; Phosphonic Acids; Phosphoric Acids (+ 1); Phosphorous Acids Phosphinic Acids; Phosphonic Acids; Phosphoric Acids (+ 13); Phosphorous Acids (+ 1) Inorganic acids that contain phosphorus as an integral part of the molecule. Phosphorus (66-93) AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $/8"8\>Phosphorus D01.268.666 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organophosphorus Compounds; Organothiophosphorus Compounds Inorganic Chemicals (Non MeSH); Elements Phosphorus. An element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element in the diet, a major component of the mineral phase of bone, and is abundant in all tissues, being involved in some form in almost all metabolic processes. (From Dorland, 27th ed). /:B2iPhosphorous Acids D01.029.260.700.700; D01.695.625.700; D02.705.676 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Phosphorus Acids Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids Organic Chemicals (Non MeSH); Organophosphorus Compounds  Phosphites Phosphites Inorganic or organic derivatives of phosphorous acid (P(OH)3). Inorganic salts are known as PHOSPHITES. The tautomeric form of this compound (HPO(OH)2) = PHOSPHONIC ACIDS. /D98 Phosphoric Monoester Hydrolases D08.586.277.352.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Acid Phosphatase; Alkaline Phosphatase; Fructose-Bisphosphatase; Glucose-6-Phosphatase; Histidinol-Phosphatase; 4-Nitrophenylphosphatase; Nucleotidases (+ 1); Phosphatidate Phosphatase; Phosphoprotein Phosphatase (+ 4); 6-Phytase A group of hydrolases which catalyze the hydrolysis of monophosphoric esters with the production of one mole of orthophosphate. EC 3.1.3. Phosphatases (66-74)  /%F`Phosphoric Diester Hydrolases D08.586.277.352.640 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Annexin III; 3',5'-Cyclic-GMP Phosphodiesterase; 3',5'-Cyclic-Nucleotide Phosphodiesterase; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Phospholipases (+ 2); Sphingomyelin Phosphodiesterase A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphatases (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $/ε#D`HPhosphoric Acids D01.029.260.700.675; D01.695.625.675 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Phosphorus Acids Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids Phosphotungstic Acid Phosphates (+ 11); Phosphotungstic Acid Inorganic derivatives of phosphoric acid (H3PO4). Inorganic salts are known as PHOSPHATES and organic esters are PHOSPHORIC ACID ESTERS. AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  /х*8H>Phosphoric Acid Esters D02.705.673 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Phosphates Organic Chemicals (Non MeSH); Organophosphorus Compounds Organic esters of phosphoric acid. /8C+Phosphoribosyl Pyrophosphate D09.203.894.643.650 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Pentosephosphates 5-(Dihydrogen phosphate) 1-(trihydrogen diphosphate) D-ribofuranose. The key substance in the biosynthesis of histidine, tryptophan and purine and pyrimidine nucleotides. Organophosphorus Compounds (72-74); Pentosephosphates (72-74); Pyrophosphoric Acids (72-74) /!DujPhosphoranes D01.695.550; D02.705.671 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH) Organic Chemicals (Non MeSH); Organophosphorus Compounds Inorganic or organic compounds that contain pentavalent phosphorus and the general formula R5P. /e8pPhosphoramide Mustards D02.455.526.728.650.730; D02.705.670; D22.204.585.748 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Organic Chemicals (Non MeSH); Organophosphorus Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds Cyclophosphamide; Ifosfamide Cyclophosphamide (+ 1) Cyclophosphamide (+ 1) A group of nitrogen mustard compounds which are substituted with a phosphoramide group or its derivatives; they are usually cytotoxic and used as antineoplastic agents. Cyclophosphamide (75-78); Nitrogen Mustard Compounds (66-74); Organophosphorus Compounds (72-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $/=87Vp:Phosphopyruvate Hydratase D08.586.520.497.631 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases /ܧF_Phosphoproteins D12.776.744 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Phosvitin; Protein p34cdc2; Protein p53; Retinoblastoma Protein; Synapsins; Vitellogenin Phosphoric Acids (68-70); Proteins (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  /ݠFDi4HPhosphoprotein Phosphatase D08.586.277.352.650.625 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cell Cycle Proteins Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases Glycogen-Synthase-D Phosphatase; Phosphorylase Phosphatase; Protein-Tyrosine-Phosphatase; Pyruvate Dehydrogenase (Lipoamide)-Phosphatase A class of enzymes that catalyze the dephosphorylation of phosphoproteins with the formation of a protein and orthophosphate. EC 3.1.3.16. Phosphomonoesterases (75-77); Phosphoproteins (71-77) $/\F>Phosphopeptides D12.644.717 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides /!DDPhosphonoacetic Acid D02.241.081.038.725; D02.705.644; D20.388.760 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Organic Chemicals (Non MeSH); Organophosphorus Compounds Anti-Infective Agents; Antiviral Agents Foscarnet Foscarnet Foscarnet (Carboxymethyl)phosphonic acid. Simple organophosphorus compound that inhibits DNA polymerase, especially in viruses; used as antiviral agent. Organophosphorus Compounds (72-77)  /5:#(Phosphonic Acids D01.029.260.700.650; D01.695.625.650; D02.705.639 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Phosphorus Acids Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids Organic Chemicals (Non MeSH); Organophosphorus Compounds Inorganic or organic derivatives of phosphonic acid with the general formula ROP(OH)2. This includes phosphonates and phosphonic acid esters. The tautomeric form of this compound (P(OH)3) = PHOSPHOROUS ACIDS. /f98 Phospholipids D10.516.695 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Antibodies, Antiphospholipid; Antiphospholipid Syndrome Lipids and Antilipemic Agents (Non MeSH); Lipids Glycerophosphates (+ 18); Liposomes; Sphingolipids (+ 1) Lipids containing one or more phosphate groups, particularly those derived from either glycerol (PHOSPHOGLYCERIDES see GLYCEROPHOSPHATES) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $/B?<EHPhospholipid Ethers D02.033.800.421.400.750; D02.355.460.750; D10.516.695.300.725 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Glycerin; Glyceryl Ethers Organic Chemicals (Non MeSH); Ethers; Glyceryl Ethers Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates  Plasmalogens; Platelet Activating Factor Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues. Ethers (66-87); Phosphatidic Acids or derivatives (75-87); Phospholipids (66-87) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $/UE82x`HPhospholipases A D08.586.277.352.100.680.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases; Phospholipases Phosphatide acylhydrolases. Catalyze the hydrolysis of one of the acyl groups of phosphoglycerides or glycerophosphatidates. Phospholipase A1 hydrolyzes the acyl group attached to the 1-position (EC 3.1.1.32) and phospholipase A2 hydrolyzes the acyl group attached to the 2-position (EC 3.1.1.4). Phospholipases (66-79) /nFWPhospholipases D08.586.277.352.100.680; D08.586.277.352.640.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases Lysophospholipase; Phospholipases A Phospholipase C; Phospholipase D A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-. /6FP{Phospholipase D D08.586.277.352.640.700.710 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases; Phospholipases An enzyme found mostly in plant tissue. It hydrolyzes glycerophosphatidates with the formation of a phosphatidic acid and a nitrogenous base such as choline. This enzyme also catalyzes transphosphatidylation reactions. EC 3.1.4.4. Phospholipases (66-79) /F Phospholipase C D08.586.277.352.640.700.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases; Phospholipases An enzyme found in the alpha-toxin of Clostridium welchii and other strains of clostridia and bacilli. It hydrolyzes glycerophosphatidates with the formation of 1,2-diacylglycerol and a phosphorylated nitrogenous base such as choline. EC 3.1.4.3. Phospholipases (66-79) /FPhosphoglycerate Mutase D08.586.399.665.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Phosphotransferases (Phosphomutases) An enzyme that catalyzes the conversion of 2-phospho-D-glycerate to 3-phospho-D-glycerate. EC 5.4.2.1. Diphosphoglyceric Acids (73-74); Phosphotransferases (73-74) /aF|wFPhosphoglycerate Kinase D08.586.913.696.630.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Carboxyl Group Acceptor) An enzyme catalyzing the transfer of a phosphate group from 3-phospho-D-glycerate in the presence of ATP to yield 3-phospho-D-glyceroyl phosphate and ADP. EC 2.7.2.3. /:FPhosphogluconate Dehydrogenase D08.586.682.047.150.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases An enzyme of the oxidoreductase class that catalyzes the reaction 6-phospho-D-gluconate and NADP+ to yield D-ribulose 5-phosphate, carbon dioxide, and NADPH. The reaction is a step in the pentose phosphate pathway of glucose metabolism. (From Dorland, 27th ed) EC 1.1.1.43. /=#F?Phosphoglucomutase D08.586.399.665.675 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Phosphotransferases (Phosphomutases) An enzyme that catalyzes the conversion of alpha D-glucose 1-phosphate to alpha D-glucose 6-phosphate. EC 5.4.2.2. /F|Phosphoenolpyruvate Sugar Phosphotransferase System D08.586.600.700; D08.586.913.696.620.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) The bacterial sugar phosphotransferase system (PTS) that catalyzes the transfer of the phosphoryl group from phosphoenolpyruvate to its sugar substrates (the PTS sugars) concomitant with the translocation of these sugars across the bacterial membrane. The phosphorylation of a given sugar requires four proteins, two general proteins, Enzyme I and HPr and a pair of sugar-specific proteins designated as the Enzyme II complex. The PTS has also been implicated in the induction of synthesis of some catabolic enzyme systems required for the utilization of sugars that are not substrates of the PTS as well as the regulation of the activity of adenylate cyclase. EC 2.7.1.-. Phosphoenolpyruvate (72-79); Phosphoric Acids (68-71); Phosphotransferases (66-79) 0P:.F`Phosphoenolpyruvate Carboxylase D08.586.520.258.610 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases An enzyme with high affinity for carbon dioxide. It catalyzes irreversibly the formation of oxaloacetate from phosphoenolpyruvate and carbon dioxide. This fixation of carbon dioxide in several bacteria and some plants is the first step in the biosynthesis of glucose. EC 4.1.1.31. Carboxy-Lyases (66-78); Phosphoenolpyruvate (72-78) 0$FaI<Phosphoenolpyruvate Carboxykinases D08.586.520.258.603 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases An enzyme of the lyase class that catalyzes the conversion of GTP and oxaloacetate to GDP, phosphoenolpyruvate, and carbon dioxide. This reaction is part of gluconeogenesis in the liver. The enzyme occurs in both the mitochondria and cytosol of mammalian liver. (From Dorland, 27th ed) EC 4.1.1.32. Carboxy-Lyases (66-72) 0 'Fa`Phosphoenolpyruvate D02.241.511.701 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Phosphoric Acids (68-71); Pyruvates (66-71) 0 :K5Phosphodiesterase Inhibitors D08.373.735 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Caffeine; Enoximone; Etazolate; 1-Methyl-3-Isobutylxanthine; Papaverine; Theophylline (+ 2) Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterases/antagonists and inhibitors (72-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $0 !6Pkg=DPhosphocreatine D12.125.373.603 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Creatine 0FTPhosphoadenosine Phosphosulfate D13.695.667.138.850; D13.695.827.068.850 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides 3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms. Adenosine Monophosphate (73-78); Sulfuric Acids (73-74); Organophosphorus Compounds (73-74) 0$.DkPhospho-2-keto-3-deoxyheptonate Aldolase D08.586.520.110.715 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Aldehyde-Lyases An enzyme that catalyzes the formation of 7-phospho-2-keto-3-deoxy-D-arabinoheptonate from phosphoenolpyruvate and D-erythrose-4-phosphate. It is one of the first enzymes in the biosynthesis of tyrosine and phenylalanine. EC 4.1.12.15. Aldehyde-Lyases (72-74); Heptoses (72-74); Tetroses (72-74); Phosphoenolpyruvate (73-74) 0-Fb iPhosphites D01.248.497.158.750; D01.695.625.700.675; D02.705.676.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphorous Acids Organic Chemicals (Non MeSH); Organophosphorus Compounds; Phosphorous Acids Inorganic salts or organic esters of phosphorous acid that contain the (3-)PO3 radical. (From Grant and Hackh's Chemical Dictionary, 5th ed). Organophosphorus Compounds (73-93); Phosphorous Acids (68-93) 0A8HPhosphinic Acids D01.029.260.700.600; D01.695.625.600; D02.705.629 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH); Phosphorus Acids Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids Organic Chemicals (Non MeSH); Organophosphorus Compounds Hypophosphorous acids. Inorganic or organic derivatives of phosphinic acid, H2PO(OH). They include phosphinates and phosphinic acid esters. 098 Phosphines D01.695.525; D02.705.621 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH) Organic Chemicals (Non MeSH); Organophosphorus Compounds Inorganic or organic compounds derived from phosphine (PH3) by the replacement of H atoms. (From Grant and Hackh's Chemical Dictionary, 5th ed). 0+8Phosphenes F02.830.816.929.300; G11.561.796.929.300; G11.697.911.500 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation; Vision Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Vision Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision Visual sensations arising from mechanical or electrical stimulation of the eyeball. 0AJbPhosphatidylserines D10.516.695.300.700.830 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a serine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and serine and 2 moles of fatty acids. Synonyms: serine phosphoglycerides. Phosphatidylethanolamines (66-74) 0By"&Phosphatidylinositols D10.516.695.300.700.800 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids Glycosylphosphatidylinositols; Phosphatidylinositol Phosphates Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids. Phosphoinositides (66-74)  0!sByEPhosphatidylinositol Phosphates D10.516.695.300.700.800.750 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids; Phosphatidylinositols Phosphatidylinositols in which one or more alcohol group of the inositol has been substituted with a phosphate group. Phosphatidylinositols (77-93); Polymers (78-82) 0$$B8Phosphatidylglycerols D10.516.695.300.700.780 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids Cardiolipins A nitrogen-free class of lipids present in animal and particularly plant tissues and composed of one mole of glycerol and 1 or 2 moles of phosphatidic acid. Members of this group differ from one another in the nature of the fatty acids released on hydrolysis. Glycerophosphates (72-74); Phospholipids (66-74) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $0&By59FPhosphatidylethanolamines D10.516.695.300.700.750 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Synonyms: cephalins; ethanolamine phosphoglycerides. 0(ByBPhosphatidylcholines D10.516.695.300.700.710 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids Dimyristoylphosphatidylcholine; 1,2-Dipalmitoylphosphatidylcholine Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to a choline moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and choline and 2 moles of fatty acids. Synonyms: lecithins; choline phosphoglycerides. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  0+?ByH2DPhosphatidic Acids D10.516.695.300.700 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates Phosphatidylcholines (+ 2); Phosphatidylethanolamines; Phosphatidylglycerols (+ 1); Phosphatidylinositols (+ 2); Phosphatidylserines; Pulmonary Surfactants Fatty acid derivatives of glycerophosphates. They are composed of glycerol bound in ester linkage with 1 mole of phosphoric acid at the terminal 3-hydroxyl group and with 2 moles of fatty acids at the other two hydroxyl groups. Phospholipids (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $0.BbHPhosphatidate Phosphatase D08.586.277.352.650.620 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases A phosphomonoesterase involved in the synthesis of triacylglycerols. It catalyzes the hydrolysis of phosphatidates with the formation of diacylglycerols and orthophosphate. EC 3.1.3.4. Phosphatases (66-74); Phosphatidic Acids (75-78); Phospholipids (66-74); Phosphomonoesterases (75-78) 01:FwPhosphates D01.248.497.158.730; D01.695.625.675.650 ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Hypophosphatemia; Phosphoric Acid Esters Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids Polyphosphates (+ 1) Acidulated Phosphate Fluoride; Calcium Phosphates (+ 4); Polyphosphates (+ 4) Inorganic salts of phosphoric acid. AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $03.<0u,>Phosphate Acetyltransferase D08.586.913.050.134.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Acetyltransferases An enzyme that catalyzes the synthesis of acetylphosphate from acetyl-CoA and inorganic phosphate. Acetylphosphate serves as a high-energy phosphate compound. EC 2.3.1.8. Acetyltransferases (73-74); Phosphates (73-74); Acetyl Coenzyme A (73-74) 06$ FXPhosphamidon D02.705.614; D05.723.491.574.741 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate Insecticides (66-71) 08i&:Phosmet D02.719.790; D05.723.491.657.818 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate S-((1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl)phosphorodithioic acid O,O-dimethyl ester. An organothiophosphorus insecticide that has been used to control pig mange. Indoles (74); Insecticides, Organothiophosphate (74) 09 &:>Phosgene D02.522.741; D26.253.710 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ketones Miscellaneous Drugs and Agents (Non MeSH); Chemical Warfare Agents 0< .}Phorbols D02.455.849.291.500; D26.191.208.744 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Croton Oil Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Croton Oil Phorbol Esters (+ 2) Phorbol Esters (+ 2) The parent alcohol of the tumor promoting compounds from croton oil (Croton tiglium). Alcohols (66-74); Croton Oil (66-74); Diterpenes (74); Terpenes (66-73) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (0= *,4gY:Phorbol 12,13-Dibutyrate D02.455.849.291.500.510.700; D10.516.627.700.315.500.700; D26.191.208.744.742.700; J01.740.700.315.500.700 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Phorbols; Phorbol Esters Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils; Croton Oil; Phorbol Esters Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Croton Oil; Phorbols; Phorbol Esters Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils; Croton Oil; Phorbol Esters 1,1a,1b,4,4a,7a,7b,8,9,9a-Decahydro 4a,7b,9,9a-tetrahydroxy-3-(hydroxymethyl) 1,1,6,8-tetramethyl-5H-cyclopropa(3,4)benz(1,2-e)azulen-5-one butanoic acid diester. A phorbol ester which, in addition to being a potent skin tumor promotor, is also an effective activator of calcium-activated, phospholipid-dependent protein kinase (protein kinase C). Due to its activation of this enzyme, phorbol 12,13-dibutyrate profoundly affects many different biological systems. Phorbol Esters (79-88) 0?t. Phorbol Esters D02.455.849.291.500.510; D10.516.627.700.315.500; D26.191.208.744.742; J01.740.700.315.500 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Phorbols Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils; Croton Oil Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Croton Oil; Phorbols Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils; Croton Oil Phorbol 12,13-Dibutyrate; Tetradecanoylphorbol Acetate Phorbol 12,13-Dibutyrate; Tetradecanoylphorbol Acetate Phorbol 12,13-Dibutyrate; Tetradecanoylphorbol Acetate Phorbol 12,13-Dibutyrate; Tetradecanoylphorbol Acetate Tumor-promoting compounds obtained from croton oil (Croton tiglium). Croton Oil (66-74); Diterpenes (74); Esters (74); Terpenes (66-73) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $0DId,nQT:Phorate D02.719.783; D05.723.491.657.803 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71) 0HZ &:Phonophoresis E05.300.720; H01.671.031.849.550 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes Physical Sciences (Non MeSH); Physics; Acoustics; Ultrasonics Use of ultrasound to increase the percutaneous adsorption of drugs. Ultrasonics (66-89) 0I&"QPhonocardiography E01.145.569.499.685 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Heart Auscultation; Heart Sounds; Heart Murmurs Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Heart Auscultation Graphic registration of the heart sounds picked up as vibrations and transformed by a piezoelectric crystal microphone into a varying electrical output according to the stresses imposed by the sound waves. The electrical output is amplified by a stethograph amplifier and recorded by a device incorporated into the electrocardiograph or by a multichannel recording machine. 0K?&:jPhonetics L01.143.506.598.518 Information Science; Communication; Language; Linguistics 0N  DPhonation G09.772.862.793 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Voice The process of producing vocal sounds by means of vocal cords vibrating in an expiratory blast of air. Speech (66-78); Vocal Cords (66-78); Voice (66-78) 0N p|@Phodopus B02.649.865.635.325.630 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Hamsters A genus of hamsters characterized by small size, very short tail, and short, broad feet with hairy soles. Hamsters (70-92) 0P (=Phobic Disorders F03.709.438.180.508 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Fear Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders Agoraphobia; Dental Anxiety Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.  0QXFv"Phloroglucinol D02.755.684; D26.550.667 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Phloretin (+ 1) 1,3,5-Benzenetriol. A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent. 0S:}Phlorhizin D09.203.408.702 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides 0UaDYPhloretin D02.522.818.561.602; D02.755.684.602 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones; Hydroxypropiophenone Organic Chemicals (Non MeSH); Phenols; Phloroglucinol Polyphloretin Phosphate Polyphloretin Phosphate 0V> *:6Phleomycins D20.085.075.236.758; D20.085.116.095.236.750; D22.204.106.244.758 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Bleomycins Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Antibiotics, Glycopeptide; Bleomycins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Bleomycins Water-soluble, copper-containing low molecular weight polypeptides obtained from the culture medium of Streptomyces verticillus. They are specific inhibitors of DNA synthesis in bacteria and have been found to act as antitumor agents. They have also been used against rust fungi of plants. Antibiotics, Antineoplastic (71-74); Antibiotics (71-74); Peptides (71-74) 0WI:?QXPhlebovirus B04.820.087.710; B04.909.777.147.710 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae Sandfly Fever Group Viruses (+ 1); Uukuniemi Group Viruses Sandfly Fever Group Viruses (+ 1); Uukuniemi Group Viruses A genus of the family BUNYAVIRIDAE comprising many viruses, most of which are transmitted by Phlebotomus flies and cause PHLEBOTOMUS FEVER. The type species is Sandfly Fever Sicilian Virus, which is not part of the antigenic complex SANDFLY FEVER GROUP VIRUSES. Bunyaviridae (83-91)  0[A*y3Phlebotomus Fever C02.782.147.700; C02.081.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections Virus Diseases; Arbovirus Infections Influenza-like febrile viral disease caused by several members of the BUNYAVIRIDAE family and transmitted mostly by the bloodsucking sandfly Phlebotomus papatasii. 0^"PPhlebotomus B01.131.617.289.781.602 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Psychodidae A genus of PSYCHODIDAE which functions as the vector of a number of pathogenic organisms, including LEISHMANIA DONOVANI, LEISHMANIA TROPICA, Bartonella bacilliformis, and the Pappataci fever virus (SANDFLY FEVER GROUP VIRUSES). 0_(DPhlebography E01.145.077.707; E01.357.818.084.730 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Veins Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnostic Imaging; Radiography; Angiography  Portography Radiographic visualization or recording of a vein after the injection of contrast medium.  0a*& jPhlebitis C14.907.681; C14.907.940.740 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Cardiovascular Diseases; Vascular Diseases; Vasculitis Postphlebitic Syndrome; Thrombophlebitis Thrombophlebitis Inflammation of a vein. 0cT "NpAPhimosis C12.294.494.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases Paraphimosis Constriction of the preputial orifice so that the prepuce cannot be retracted back over the glans. (Dorland, 27th ed). 0d NhPhilosophy, Nursing K01.752.712 HI Humanities; Philosophy Ethics, Nursing Nursing (66-68); Philosophy (66-68) EDHI  0fc,Philosophy, Medical K01.752.667 HI Humanities; Philosophy Ethics, Medical (+ 6); Holistic Health CLECEDEHHILJPCPXSNTDVE 0g1Philosophy, Dental K01.752.622 HI Humanities; Philosophy Ethics, Dental Philosophy (66-70); appropriate dental heading EDHI  0g8Philosophy K01.752 HI Humanities Esthetics (+ 1); Ethics (+ 8); Existentialism; Logic (+ 1); Metaphysics; Philosophy, Dental (+ 1); Philosophy, Medical (+ 8); Philosophy, Nursing (+ 1); Quality of Life; Thanatology; Utopias; Vitalism; Yin-Yang CLECEDEHHILJPCPXSNTDVE 0h Philology, Romance K01.517.732.727 HI Humanities; Literature; Philology The study of literature written in the Romance languages (French, Spanish, Italian, and others descended from Latin), including grammar, etymology, criticism, literary history, and language and linguistic history. 0j)Philology, Oriental K01.517.732.602 HI Humanities; Literature; Philology The study of literature written in languages of Asia and the Far East, including grammar, etymology, criticism, literary history, and language and linguistic history. 0k)Philology, Classical K01.517.732.477 HI Humanities; Literature; Philology The study of ancient Greek and Roman literature, including grammar, etymology, criticism, literary history, and language and linguistic history. 0l)Philology K01.517.732 HI Humanities; Literature Philology, Classical; Philology, Oriental; Philology, Romance The study of literature in its widest sense, including grammar, etymology, criticism, literary history, language history, linguistic history, systems of writing, and anything else that is relevant to literature or language viewed as literature. Philology as a discipline has both philosophical and scientific overtones. 0m HpPhilippines Z01.252.145.671 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern 0p>Philately K01.093.660 CLECEDHIISLJMAMTOGSNSTTD Humanities; Art Study of stamps or postal markings. It usually refers to the design and commemorative aspects of the stamp. 0p Philadelphia Chromosome G05.148.266.764.680 Oncogene Proteins, Fusion Leukemia, Myeloid, Philadelphia-Negative; Leukemia, Myeloid, Philadelphia-Positive; Fusion Proteins, bcr-abl; Chromosomes, Human, Pair 22 Genetics; Cytogenetics; Chromosome Aberrations; Translocation (Genetics) An aberrant form of human chromosome 22 characterized by translocation of genetic material from chromosome 22, usually to the long arms of chromosome 9. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia. Chromosome Abnormalities (66-67); Chromosomes (66-67); Chromosomes, Human, 21-22 (68-85); Leukemia, Myelocytic/FG (66-85)  0qT3Philadelphia Z01.107.567.875.100.708.820; Z01.107.567.875.600.066.708.820; Z01.107.567.875.600.313.708.820; Z01.107.567.875.600.513.708.820; Z01.433.820 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH); Pennsylvania Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Appalachian Region; Pennsylvania Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region; Pennsylvania Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Mid-Atlantic Region; Pennsylvania Geographicals (Non MeSH); Cities (Non MeSH) 0tPhialophora B05.354.381.546.706 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes 0x$"NPheromones D24.185.641 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Chemotactic Factors; Animal Communication Immunologic and Biologic Factors (Non MeSH); Biological Factors Sex Attractants Chemical substances which, when secreted by an individual into the environment, cause specific reactions in other individuals, usually of the same species. The substances relate only to multicellular organisms. This includes kairomones. Allomones are repellent pheromones. Behavior, Animal (66-67); Sex Behavior (66-67) $0xB1L;9Pheophytins D11.557.727.220.700 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Chlorophyll Chlorophylls from which the magnesium has been removed by treatment with weak acid. Porphyrins (71-74) 0{lBcdPheochromocytoma C04.557.465.625.650.700.725; C04.557.580.625.650.700.725 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent. During severe attacks, there may be headache, sweating, palpitation, apprehension, tremor, pallor or flushing of the face, nausea and vomiting, pain in the chest and abdomen, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). 0|>XXMAPhenytoin D03.383.374.411.730; D15.080.600; D16.700.600.670; D18.097.591 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Hydantoins Central Nervous System Agents; Anticonvulsants Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central Cardiovascular Agents; Anti-Arrhythmia Agents An anticonvulsant that is used in a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. 0 H:7Phenylurea Compounds D02.948.684 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea Carbanilides (+ 2); Diflubenzuron; Linuron AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 0(8,5:Phenylthiourea D02.886.904.601; D02.948.898.601 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Phenylthiazolylthiourea; Thiophanate Phenylthiazolylthiourea; Thiophanate 0J&:RPhenylthiohydantoin D03.383.374.411.868.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Hydantoins; Thiohydantoins 3-Phenyl-2-thiohydantoin. Thiohydantoin benzene derivative. Hydantoins (71-72); Thiohydantoins (73-74) 0:vD3Phenylthiazolylthiourea D02.886.904.601.600; D02.948.898.601.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea; Phenylthiourea Organic Chemicals (Non MeSH); Urea; Thiourea; Phenylthiourea 1-Phenyl-3-(2-thiazolyl)-2-thiourea. A dopamine-beta-hydroxylase inhibitor. Synonym: U-14,624. Phenylthiourea (72-74); Thiazoles (72-74) 0:.:l2Phenylpyruvic Acids D02.241.223.751; D02.241.607.812.601 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids; Pyruvates 0/*8Phenylpropionates D02.241.223.701 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Fenoprofen; Ibuprofen; Indoprofen; Ketoprofen; Suprofen AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 0x8]C:Phenylpropanolamine D02.033.329.624.706; D02.092.063.624.706; D14.100.050.100.100.680; D14.100.050.600.720; D15.155.710; D16.050.870.710; D18.793.952.746 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Central Nervous System Agents; Appetite Depressants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents; Vasoconstrictor Agents, Nasal p-Hydroxynorephedrine; Metaraminol p-Hydroxynorephedrine; Metaraminol A sympathomimetic that acts mainly by causing release of norepinephrine but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. 0:SPhenylmethylsulfonyl Fluoride D02.886.590.625; D08.373.745.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors alpha-Toluenesulfonyl fluoride. An enzyme inhibitor which inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex. Benzyl Compounds (73-74); Fluorine (74); Sulfones (73-74) 0 "&:GPhenylmercury Compounds D02.691.750.740; D05.723.288.700 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Chloromercurinitrophenols; 4-Chloromercuribenzenesulfonate; Mercuribenzoates (+ 2); Phenylmercuric Acetate Phenylmercuric Acetate Organic mercury compounds in which the mercury is attached to a phenyl group. Often used as fungicides and seed treatment agents. Mercury (68-76); Organometallic Compounds (68-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $0d&8;:Phenylmercuric Acetate D02.691.750.740.760; D05.723.288.700.760 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Phenylmercury Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial; Phenylmercury Compounds A phenyl mercury compound used mainly as a fungicide. Has also been used as a herbicide, slimicide and bacteriocide. Mercury (68-76); Organometallic Compounds (68-76) 0j.:;Phenylketonuria, Maternal C10.228.140.163.766.675; C10.496.742.675; C13.703.575; C18.452.648.066.766.675; F03.709.346.779.675 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic; Phenylketonuria Nervous System Diseases; Mental Retardation; Phenylketonuria Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Phenylketonuria Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation; Phenylketonuria Phenylketonuria in a pregnant woman. The maternal disease puts the fetus at great risk of mental retardation and other congenital diseases. Phenylketonuria (66-91) 0oLLPhenylketonuria C10.228.140.163.766; C10.496.742; C18.452.648.066.766; F03.709.346.779 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Mental Retardation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Phenylketonuria, Maternal Phenylketonuria, Maternal Phenylketonuria, Maternal Phenylketonuria, Maternal An inborn error of metabolism transmitted as a simple recessive autosomal Mendelian trait and characterized by an inability to convert phenylalanine to tyrosine resulting in hyperphenylalaninemia. The majority of patients are severely retarded. Attainment of normal or near normal intelligence is possible if dietary treatment is instituted in early infancy.  0PL rPhenylisopropyladenosine D13.570.583.138.630; D13.570.800.096.630 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Adenosine N-Isopropyl-N-phenyl-adenosine. Antilipemic agent. Synonym: TH 162. Adenosine (72-74); Propylamines (72-74) 0k.:O0Phenylhydrazines D02.442.726 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Dithizone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 0w82 :Phenylglyoxal D02.047.644.620; D08.373.725; D26.550.642 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Aldehydes; Glyoxal Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents alpha-Oxo-benzeneacetaldehyde. A reagent which is highly selective for the modification of arginyl residues. It is used to selectively inhibit various enzymes and acts as an energy transfer inhibitor in photophosphorylation. Aldehydes (66-72); Glyoxal (73-74) /AA (75-79) 0r1.9Phenylethylmalonamide D02.241.081.337.540.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Malonates 2-Ethyl-2-phenylmalonamide. A metabolite of primidone. Amides (72-74); Malonates (72-74) 0:~@*Phenylephrine D02.033.329.291.617; D02.092.063.291.617; D14.100.050.100.100.640; D16.050.500.700; D16.050.870.700; D18.222.863.700; D18.793.777; D18.793.952.705 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents Cardiovascular Agents; Vasoconstrictor Agents; Vasoconstrictor Agents, Nasal Etilefrine Etilefrine An alpha-adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. 0: kPhenylenediamines D02.092.146.651; D02.092.782.258.651 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines Tetramethylphenylenediamine Tetramethylphenylenediamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 0*8<:Phenylbutyrates D02.241.223.651 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) 08]Phenylbutazone D03.383.694.700; D16.850.015.050.700; D17.025.030.590; D17.050.030.590 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Oxyphenbutazone; Prenazone; Sulfinpyrazone Oxyphenbutazone Oxyphenbutazone Oxyphenbutazone A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA, Drug Evaluations Annual, 1994, p.1822). 0P:KePhenylalanyl T RNA Synthetase D08.586.464.136.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates phenylalanine with its specific transfer RNA. EC 6.1.1.20. Amino Acyl T RNA Synthetases (73-74); Phenylalanine (73-74) 0$FtdHPhenylalanine Hydroxylase D08.586.682.420.601 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases An enzyme of the oxidoreductase class that catalyzes the reaction L-phenylalanine, tetrahydrobiopterin, and oxygen to yield L-tyrosine, dihydrobiopterin, and water, the reaction synthesizing tyrosine from phenylalanine. (Dorland, 27th ed) EC 1.14.16.1. Hydroxylases (66-70) 0Fh Phenylalanine Ammonia-Lyase D08.586.520.161.700; D22.204.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ammonia-Lyases Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents An enzyme that catalyzes the deamination of L-phenylalanine to form trans-cinnamate and ammonia. It may also act on L-tyrosine. Since the enzyme deprives neoplastic tissue of phenylalanine, it has been used experimentally in the treatment of acute lymphoblastic leukemia. The enzyme is obtained from many plants. EC 4.3.1.5. Ammonia-Lyases (73-74); Phenylalanine (73-74) 0 &F|6Phenylalanine D12.125.072.573; D12.125.142.666 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Dopa (+ 3); Fenclonine; p-Fluorophenylalanine 0&F9Phenylacetates D02.241.223.601 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Cyclopentolate; Diclofenac; 3,4-Dihydroxyphenylacetic Acid; Diphenylacetic Acids (+ 3); Guanfacine; Homogentisic Acid; Homovanillic Acid; Methylphenidate; Propanidid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 08]:Phenyl Ethers D02.355.726 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers Anisoles (+ 2); Guaiacol (+ 1); Phenetidine; Triclosan AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 0Þ8.F:Phentolamine D03.383.374.754; D14.100.050.200.100.660; D16.050.850.720; D18.162.721 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of Raynaud's disease and frostbite, clonidine withdrawal sydrome, impotence, and peripheral vascular disease. 0P:"Phentermine D02.092.471.683.152.766; D14.100.050.600.050.635; D14.100.050.600.700; D14.100.150.600.220.700; D14.100.150.600.700; D14.100.600.050.635; D14.100.600.220.700; D15.155.700; D15.220.730; D16.050.870.690 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Chlorphentermine; Mephentermine A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity. 0K:t.Phenprocoumon D03.438.150.446.520.750; D19.461.119.196.475.722 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; 4-Hydroxycoumarins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Coumarins; 4-Hydroxycoumarins 3-(1-Phenylpropyl)-4-hydroxycoumarin. Long acting oral anticoagulant; may cause diarrhea. Synonyms: Liquamar; Marcoumar; Marcumar. Benzene (66-67); Benzene Derivatives (68-71); Benzyl Compounds (72-76); Coumarins (66-74) 0 6: lPhenoxybenzamine D02.092.471.739; D14.100.050.200.100.650; D16.050.850.710; D18.162.712; D18.918.754 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Vasodilator Agents N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl) benzenemethanamine. An alpha-adrenergic anatagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator. 0_:Phenoxyacetates D02.241.511.316.682 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates Ticrynafen 0.8YPhenotype G05.735 Somatotypes Gene Expression Genetics Dosage Compensation (Genetics); Epistasis, Genetic; Genetic Markers The outward appearance of the individual. It is the product of interactions between genes and between the genotype and the environment. This includes the killer phenotype, characteristic of YEASTS. Genetics (66-67) DEGEIMPHRE (0   PPhenothiazines D03.494.741 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antipsychotic Agents, Phenothiazine Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Acepromazine; Azure Stains; Chlorpromazine; Fluphenazine; Mesoridazine; Methotrimeprazine; Methylene Blue; Moricizine; Nonachlazine; Perazine; Perphenazine; Prochlorperazine; Promazine; Promethazine; Thiethylperazine; Thioridazine; Tolonium Chloride; Trifluoperazine; Triflupromazine; Trimeprazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  08)GV:Phenoperidine D03.066.399.600; D03.383.621.349.683; D15.040.150.585; D15.210.600.714 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonipecotic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Isonipecotic Acids Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics 1-(3-Hydroxy-3-phenylpropyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester. A narcotic analgesic partly metabolized to meperidine in the liver. It is similar to morphine in action and used for neuroleptanalgesia, usually with droperidol. 0sP:cPhenolsulfonphthalein D26.408.646.600.517 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes; Phthalein Dyes; Phenolphthaleins 4,4'-(3H-2,1-Benzoxathiol-3-ylidene)bisphenol S,S-dioxide. Red dye, pH indicator and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems. Phenolphthaleins (66-74) 0ި.bPhenols D02.755 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Aminophenols; Anisoles (+ 5); Bisphenol A-Glycidyl Methacrylate; Bithionol; Bromphenol Blue; Catechols (+ 8); Chlorophenols (+ 2); Cresols (+ 10); Dienestrol; Hydroquinones; Hydroxybenzoic Acids (+ 13); Indophenol (+ 1); Nitrophenols (+ 6); Phloroglucinol (+ 2); Probucol; Propofol; Pyrogallol; Resorcinols (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 0  8#|HPhenolphthaleins D26.408.646.600; D26.550.620 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes; Phthalein Dyes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Phenolsulfonphthalein; Sulfobromophthalein; Thymolphthalein Thymolphthalein AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU 0",T.Phenobarbital D03.383.742.698.253.650; D14.100.240.500.680; D15.080.585; D15.210.350.750.775; D15.325.850.775 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate Primidone Primidone A barbiturate used as a sedative and an anticonvulsant. It was used as an anti-anxiety agent but has been supplanted by benzodiazepines for that purpose. It may also be useful in the treatment of neonatal hyperbilirubinemia and in the symptomatic treatment of opiate withdrawal in mothers and infants. 0k:cPhenmetrazine D03.383.533.640.650; D14.100.050.600.050.617; D14.100.050.600.690; D14.100.150.600.220.690; D14.100.150.600.690; D14.100.600.050.617; D14.100.600.220.690; D15.155.685; D15.220.720; D16.050.870.655 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines; Morpholines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE. 0:wPheniramine D03.383.725.620; D14.100.375.425.400.670; D23.075.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Dermatologic Agents; Antipruritics Brompheniramine (+ 1) Histamine H1 antagonist with little sedative action. It is used in hay fever, rhinitis, allergic dermatoses, and pruritus. 0e=:3Phenindione D19.461.119.765 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants 0:nPhenformin D02.078.370.141.700; D09.482.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines; Biguanides Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents 0&:Phenetidine D02.092.146.100.700; D02.355.417.650; D02.355.726.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds; Aminophenols Organic Chemicals (Non MeSH); Ethers; Ethyl Ethers Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers p-Aminophenyl ethyl ether. Used in the manufacture of acetophenetidin. Aniline Compounds (69-74); Ethyl Ethers (74) 0=:T7Phenethylamines D02.092.471.683 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Albuterol; Amphetamines (+ 12); Dimethoxyphenylethylamine; Dobutamine; Fendiline; Fenfluramine (+ 1); Hexoprenaline; 2-Hydroxyphenethylamine; Mescaline; Methoxamine; Octopamine; Prenylamine; Ritodrine; Selegiline; Verapamil (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 0 8= DPhenethyl Alcohol D02.033.057.650; D20.187.675 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Ethyl Anti-Infective Agents; Anti-Infective Agents, Local 2-Phenylethanol. Antimicrobial, antiseptic and disinfectant; used also as aromatic essence and preservative in pharmaceutics and perfumery. Synonyms: phenethanol; phenethylol. Alcohol, Ethyl (69-74); Benzene Derivatives (72-74) 0":}>Phenethanolamine N-Methyltransferase D08.586.913.517.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases A methyltransferase that catalyzes the reaction of S-adenosyl-L-methionine and phenylethanolamine to yield S-adenosyl-L-homocysteine and N-methylphenylethanolamine. It can act on various phenylethanolamines and converts norepinephrine into epinephrine. (From Enzyme Nomenclature, 1992) EC 2.1.1.28. Methyltransferases (71); Transferases (66-71) 0=)FkP6Phenelzine D02.442.700; D08.373.616.700; D15.085.700; D15.700.122.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents A drug that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. Some patients refractory to the tricyclic drugs respond to phenelzine, especially those with atypical depression or severe anxiety. It has improved eating behavior in some patients with bulimia; however, its definitive role in this disorder awaits the results of controlled clinical trials. Phenelzine is also effective in panic and phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p.311). 0D:1PPhencyclidine Abuse F03.709.597.780.610.560 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Phencyclidine Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Abuse The misuse of phencyclidine with associated psychological symptoms and impairment in social or occupational functioning. Phencyclidine (66-80); Substance Abuse (68-80)  1 D8Phencyclidine D03.383.621.699; D14.100.190.300.700; D15.300.675; D15.700.372.754 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Phencyclidine Abuse; Receptors, Phencyclidine Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens 1-(1-Phenylcyclohexyl)piperidine. A hallucinogen formerly used as a veterinary anesthetic and briefly as a general anesthetic in man. The range of subjective effects reported for this drug is particularly broad. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). It probably also interacts with sigma receptors, and may inhibit uptake of catecholamines, but the mechanisms of its psychological effects is not well understood. As a drug of abuse, it is also known as PCP and Angel Dust. Anesthetics (66-72); Piperidines (68-72)  1L:51Phenazopyridine D03.383.725.050.610; D15.050.050.700; D15.210.100.200.700; D16.850.025.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Aminopyridines Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity. 1 zT:Phenazocine D03.132.610.422.106.715; D15.040.150.580; D15.210.600.708 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Benzomorphans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics An opioid analgesic with actions and uses similar to MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1095). 1 A:Phenazines D03.494.704 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Clofazimine; Methylphenazonium Methosulfate; Neutral Red; Pyocyanine AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR 18GP@Phenanthrolines D03.494.669 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) 18GPhenanthridines D03.494.633 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Ethidium; Propidium AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 18G:Phenanthrenes D04.615.723 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Chrysenes 18P Phenacetin D02.065.199.092.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides A non-prostaglandin synthase inhibitor. It was utilized extensively in a wide variety of analgesic mixtures, but its causal role in analgesic-abuse nephropathy led to its withdrawal from the market. (From Smith and Reynard, Textbook of Pharmacology, 1991, p.431). 1:J4Pharynx A14.724 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Pharyngectomy; Pharyngostomy Stomatognathic System Hypopharynx; Nasopharynx; Oropharynx (+ 1); Pharyngeal Muscles ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  1  8"L:Pharyngostomy E04.579.740; E04.847.540 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pharynx Surgery, Operative; Ostomy Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) External surgical fistulization of the pharynx for feeding. Enteral Feeding (66-87); Pharynx/surgery (66-87)  1$ eG;Pharyngitis C07.550.781; C08.730.541; C09.775.649 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Pharyngeal Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Pharyngeal Diseases Inflammation of the throat. 1w-N#Pharyngectomy E04.847.515 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pharynx Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) 1$ FPharyngeal Neoplasms C04.588.443.665.710; C07.550.745; C09.647.710; C09.775.549 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms Stomatognathic Diseases; Pharyngeal Diseases Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms Otorhinolaryngologic Diseases; Pharyngeal Diseases Hypopharyngeal Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms (+ 1) Hypopharyngeal Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms (+ 1) Hypopharyngeal Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms (+ 1) Hypopharyngeal Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms (+ 1) 1DX rPharyngeal Muscles A02.633.567.800; A14.724.617 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Stomatognathic System; Pharynx The muscles of the pharynx are the inferior, middle and superior constrictors, salpingopharyngeus, and stylopharyngeus. Muscles (66-78); Pharynx (66-78) 1":^)Pharyngeal Diseases C07.550; C09.775 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases Stomatognathic Diseases Otorhinolaryngologic Diseases Nasopharyngeal Diseases (+ 2); Peritonsillar Abscess; Pharyngeal Neoplasms (+ 4); Pharyngitis; Retropharyngeal Abscess; Tonsillitis; Velopharyngeal Insufficiency Nasopharyngeal Diseases (+ 2); Peritonsillar Abscess; Pharyngeal Neoplasms (+ 4); Pharyngitis; Retropharyngeal Abscess; Tonsillitis; Velopharyngeal Insufficiency General or unspecified diseases of the pharynx. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $1N"<v:ZPharmacy Service, Hospital N02.278.354.422.603; N02.421.668.556; N04.452.442.422.603 CLECHILJMAMTOGSDSNSTTDUT Pharmacy Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Health Services; Pharmaceutical Services Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the receiving, storing, and distribution of pharmaceutical supplies. 1! A oxPharmacy and Therapeutics Committee N04.452.758.788.682; N05.700.685.625 CLECHILJOGSNSTTDUT Formularies, Hospital Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Professional Staff Committees Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Professional Staff Committees An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department. Pharmacy Service, Hospital (66-67)  1$j** )Pharmacy Administration N04.452.706 CLECEDHIISLJMAMTSNSTTD Fees, Pharmaceutical; Insurance, Pharmaceutical Services Health Services Administration (Non MeSH); Organization and Administration Drug and Narcotic Control; Drug Utilization (+ 1) The business and managerial aspects of pharmacy in its broadest sense. Drug Industry (66-67); Pharmacy (66-67) CLECEDHIISLJMAMTOGSNSTTDUT (1'AW=U1Pharmacy G02.646 CLECHIISMAMTOGSNSTTD Community Pharmacy Services; Education, Pharmacy; Legislation, Pharmacy; Pharmacy Service, Hospital; Prescriptions, Drug; Technology, Pharmaceutical Health Occupations The practice of compounding and dispensing medicinal preparations. 1)  NPharmacopoeias, Homeopathic L01.178.682.192.836.749.599 HIST Homeopathy Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Pharmacopoeias 1*g Pharmacopoeias L01.178.682.192.836.749 CLHIST Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books Pharmacopoeias, Homeopathic 1+k z Pharmacology, Clinical G01.703.152 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Pharmacology The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans. Pharmacology (66-79) 1,_(xPharmacology G01.703; G02.628 CLECEDHIISLJMAMTOGSNSTTD Drugs Biological Sciences Health Occupations Neuropharmacology; Pharmacoepidemiology; Pharmacognosy; Pharmacology, Clinical; Psychopharmacology; Toxicology Neuropharmacology; Pharmacoepidemiology; Psychopharmacology; Toxicology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.  1- -}Pharmacokinetics G06.535.780; G12.091.690 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Chemical, Pharmacologic Phenomena (Non MeSH); Biopharmaceutics Biotransformation (+ 1); Tissue Distribution Biological Availability; Biotransformation (+ 2); Therapeutic Equivalency Dynamic and kinetic mechanisms of exogenous chemical and drug absorption, biotransformation, distribution, release, transport, uptake, and elimination as a function of dosage, and extent and rate of metabolic processes. specific Category D heading/metabolism (66-87); Kinetics (66-87) DEGEIMPHRE  1/qMPharmacognosy G01.273.118.598; G01.703.060 CLECEDHIISLJMAMTOGSNSTTD Plants, Medicinal Biological Sciences; Biology; Botany Biological Sciences; Pharmacology 12E"SPharmacogenetics G05.706 CLECEDHIISLJMAMTOGSNSTTD Genetics Drug Resistance, Microbial (+ 9); Insecticide Resistance A branch of genetics which deals with the genetic components of variability in individual responses to drugs. CLECEDGEHIIMISLJMAMTOGPHRESNSTTD  13   D$Pharmacoepidemiology G01.703.045; G02.403.290.650; G02.628.413 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Pharmacology Health Occupations; Medicine; Epidemiology Health Occupations; Pharmacology The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1)). Epidemiologic Methods (85-93); Epidemiology (84-93); Pharmacology (84-93) 14|1~WPharmacists' Aides M01.526.485.067.735; N02.360.067.730 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Persons who perform certain functions under the supervision of the pharmacist. Health Manpower (68-70); Pharmacy (68-70) 18*]3Pharmacists M01.526.485.780; N02.360.780 CLECHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Those persons legally qualified by education and training to engage in the practice of pharmacy. Pharmacy (66-67) 1:"sPharmacies N02.278.678 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Facilities for the preparation and dispensing of drugs. 1 :sBPeru Z01.107.757.702 EHEP Geographicals (Non MeSH); America; South America 1{<Pertussis Vaccine D24.310.894.135.535 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Whooping Cough; Bordetella pertussis Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines Diphtheria-Tetanus-Pertussis Vaccine 1|>,p)Pertussis Toxins D24.185.926.123.720 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Bordetella pertussis Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins Any of various biologically active proteins or toxins elaborated by Bordetella pertussis that cause the symptoms of whooping cough. Some activate pancreatic islets, others inhibit the adenylate cyclase cascade and some cause lymphocytosis. Bacterial Proteins (66-85); Bacterial Toxins (77-85); Bordetella Pertussis (66-85); Toxins (66-76)  1}Z:kvPersuasive Communication F01.145.209.631; L01.143.762 Propaganda; Psychological Warfare; Suggestion Suggestion; Psychological Warfare Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Information Science; Communication Coercion A mode of communication concerned with inducing or urging the adoption of certain beliefs, theories, or lines of action by others. Suggestion (66-68) $1"6(y Personnel, Hospital M01.526.485.740; N02.360.740 CLECEDHILJPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Dental Staff, Hospital; Hospital Administrators (+ 1); Hospital Volunteers (+ 1); Medical Staff, Hospital; Nursing Staff, Hospital Dental Staff, Hospital; Hospital Administrators (+ 1); Hospital Volunteers (+ 2); Medical Staff, Hospital; Nursing Staff, Hospital The individuals employed by the hospital. Personnel Administration, Hospital (66-67) CLECEDHILJOGPXSDSNSTTDUT $1"631Personnel Turnover N04.452.677.680 ECLJSNTD Health Services Administration (Non MeSH); Organization and Administration; Personnel Management A change or shift in personnel due to reorganization, resignation, or discharge. 1 p`Personnel Staffing and Scheduling Information Systems L01.700.508.300.680.800; N04.452.515.800 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems Computer-based systems for use in personnel management in a facility, e.g., distribution of caregivers with relation to patient needs. 1 >. Personnel Staffing and Scheduling N04.452.677.650 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The selection, appointing, and scheduling of personnel. 1_(pBPersonnel Selection N04.452.677.500 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The process of choosing employees for specific types of employment. The concept includes recruitment. 1pxPersonnel Management N04.452.677 CLECLJMAMTSNSTTD Personnel Administration, Hospital Health Services Administration (Non MeSH); Organization and Administration Career Mobility; Collective Bargaining; Employee Discipline; Employee Grievances; Employee Incentive Plans; Employee Performance Appraisal; Job Application; Job Description; Management Quality Circles; Negotiating; Personnel Administration, Hospital; Personnel Loyalty; Personnel Selection; Personnel Staffing and Scheduling; Personnel Turnover; Physician Incentive Plans; Salaries and Fringe Benefits (+ 4); Staff Development; Strikes, Employee; Workload; Workplace Planning, organizing, and administering all activities related to personnel. CLECEDHIISLJMAMTOGPXSDSNSTTDUT $1(WY"Personnel Loyalty N04.452.677.460 Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Dedication or commitment shown by employees to organizations or institutions where they work. 1TpnPersonnel Administration, Hospital N02.278.354.422.565; N04.452.442.422.565; N04.452.677.440 CLECEDHIISLJMAMTSNSTTD Personnel Management Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Management activities concerned with hospital employees. 1z(AyBPersonality Tests F04.711.647 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests Bender-Gestalt Test; Personality Inventory (+ 5); Projective Techniques (+ 6); Semantic Differential; Word Association Tests Standardized objective tests designed to facilitate the evaluation of personality. 1 R`Personality Inventory F04.711.647.513 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests Cattell Personality Factor Questionnaire; Edwards Personal Preference Schedule; Manifest Anxiety Scale; MMPI; Test Anxiety Scale Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. 1 hPersonality Disorders F03.709.597 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Anomie Behavioral and Mental Disorders (Non MeSH); Mental Disorders Antisocial Personality Disorder; Borderline Personality Disorder; Compulsive Personality Disorder; Dependent Personality Disorder; Histrionic Personality Disorder; Impulse Control Disorders (+ 3); Paranoid Personality Disorder; Passive-Aggressive Personality Disorder; Psychosexual Disorders (+ 15); Schizoid Personality Disorder; Schizotypal Personality Disorder; Substance Use Disorders (+ 10) A major deviation from normal patterns of behavior. Mental Disorders (66-67); Personality (66-67) BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (1F I?7LPersonality Development F01.752.747 Socialization Child Development; Growth Behavior and Behavior Mechanisms (Non MeSH); Personality Ego (+ 1); Extraversion (Psychology); Id; Identification (Psychology) (+ 1); Identity Crisis; Individuation; Introversion (Psychology); Psychosexual Development (+ 5); Self Concept (+ 2); Superego; Type A Personality; Unconscious (Psychology) Growth of habitual patterns of behavior in childhood and adolescence. Personality (66-67) CLDEPHRE (1 D#S Personality Assessment F04.513 HISNST Disciplines, Tests, Therapy, Services (Non MeSH) Q-Sort The determination and evaluation of personality attributes by interviews, observations, tests, or scales. Articles concerning personality measurement are considered to be within scope of this term. 1  9 Personality F01.752 CLDEGEPHRE Behavior and Behavior Mechanisms (Non MeSH) Authoritarianism; Character; Co-Dependency (Psychology); Creativeness; Dependency (Psychology); Empathy; Individuality; Intelligence; Leadership; Machiavellianism; Personality Development (+ 21); Temperament Behavior-response patterns that characterize the individual. 1 4FPersonal Space F01.145.875.596 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Spatial Behavior Invisible boundaries surrounding the individual's body which are maintained in relation to others. 1VsPersonal Satisfaction F01.145.076.747 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude Job Satisfaction A subjective evaluation, judgment, or attitude expressed by an individual with respect to the attainment of certain goals or needs based on his level of aspiration or expectation. Attitude (66-69) 1MPersonal Health Services N02.421.631 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services Health care provided to individuals. specific service (66-67); Community Health Services (66-67) 1mJ-GPersonal Construct Theory F02.739.660 Psychologic Processes and Principles (Non MeSH); Psychological Theory A psychological theory based on dimensions or categories used by a given person in describing or explaining the personality and behavior of others or of himself. The basic idea is that different people will use consistently different categories. The theory was formulated in the fifties by George Kelly. Two tests devised by him are the role construct repertory test and the repertory grid test. (From Stuart Sutherland, The International Dictionary of Psychology, 1989). 1R)Persistent Vegetative State C10.597.917.525; C23.888.592.925.525 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Coma Nervous System Diseases; Neurologic Manifestations; Unconsciousness Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Unconsciousness A persistent loss of upper cortical function that may follow acute (e.g., infections, toxins, trauma or vascular) events or chronic (e.g., degenerative) events. The patient is bedridden and nutritional support is completely passive, either parenteral or via nasogastric tube. The patient does not require respiratory support or circulatory assistance for survival and is in a state of chronic wakefulness without awareness which may be accompanied by spontaneous eye opening, grunts or screams, brief smiles, sporadic movement of facial muscles and limbs. While the eyes blink upon stimulation, they do not do so in response to visual threats. Some patients chew or clamp their teeth. Urinary and fecal incontinence is universal. (From Segen, Dictionary of Modern Medicine, 1992). Coma (72-94)  1c!*NPersistent Fetal Circulation Syndrome C14.907.489.531.694; C16.614.694 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ductus Arteriosus, Patent Cardiovascular Diseases; Vascular Diseases; Hypertension; Hypertension, Pulmonary Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterized by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale. Ductus Arteriosus, Patent (66-79); Hypertension, Pulmonary (66-79); Pulmonary Circulation (66-79)  1,&LrPerphenazine D03.494.741.593; D14.100.150.175.710; D15.150.025.675; D15.210.950.040.025.675; D15.700.872.331.025.594 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine 4-(3-(2-Chloro-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol. An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE. 1rs:Peroxides D01.248.497.158.685.750; D01.650.550.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Benzoyl Peroxide; Lipid Peroxides Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Oxides Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Superoxides Hydrogen Peroxide; Superoxides A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed).  1 .8)2Peroxidases D08.586.682.732 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Catalase; Chloride Peroxidase; Cytochrome-c Peroxidase; Glutathione Peroxidase; Horseradish Peroxidase; Iodide Peroxidase; Lactoperoxidase; Peroxidase 1VFXPeroxidase D08.586.682.732.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Peroxidases (70-74) 1FgPeroneal Nerve A08.800.800.720.450.760.640 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Lumbosacral Plexus; Sciatic Nerve The lateral of the two terminal branches of the sciatic nerve. The peroneal (or fibular) nerve provides motor and sensory innervation to parts of the leg and foot. Leg/innervation (66-70); Spinal Nerves (66-70) 189Peromyscus B02.649.865.635.350.510 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Hesperomyinae A genus of the subfamily Hesperomyinae consisting of 49 species. Two of these are widely used in medical research. They are P. leucopus, or the white-footed mouse, and P. maniculatus, or the deer mouse. Mice (66-77) 1(BPermissiveness F01.145.076.675 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude The attitude that grants freedom of expression and activity to another individual, but not necessarily with sanction or approval. 1MPermeases D08.586.747 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Biological Transport Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes ABC Transporters 1 FEPermeability H01.181.529.687 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Osmosis; Osmotic Pressure Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. DEPHRE  1I  Peritonsillar Abscess C01.539.830.025.675; C07.550.700; C08.730.817.700; C09.775.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Stomatognathic Diseases; Pharyngeal Diseases Respiratory Tract Diseases; Respiratory Tract Infections; Tonsillitis Otorhinolaryngologic Diseases; Pharyngeal Diseases An abscess in the peritonsillar tissue extending into the tonsil capsule, resulting from suppuration of the tonsil. (Dorland, 27th ed). 1KHPPeritonitis C06.772.661 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Peritoneal Diseases 1N7Peritoneum A01.047.596; A10.615.789.596 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ascitic Fluid; Laparoscopy Body Regions (Non MeSH); Abdomen Tissue Types (Non MeSH); Membranes; Serous Membrane Douglas' Pouch; Mesentery (+ 1); Omentum; Peritoneal Cavity Endothelial lining of the abdominal cavity, the parietal peritoneum covering the inside of the abdominal wall and the visceral peritoneum covering the bowel, the mesentery, and certain of the organs. The portion that covers the bowel becomes the serosal layer of the bowel wall.  1ĕ":!hKGPeritoneovenous Shunt E04.752.814.750; E04.765.790; E04.035.735 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgery, Operative; Anastomosis, Surgical An operation for the continuous emptying of ascitic fluid into the venous system. Fluid removal is based on intraperitoneal and intrathoracic superior vena cava pressure differentials and is performed via a pressure-sensitive one-way valve connected to a tube traversing the subcutaneous tissue of the chest wall to the neck where it enters the internal jugular vein and terminates in the superior vena cava. It is used in the treatment of intractable ascites. Ascites (75-80); Jugular Veins (75-80); Peritoneal Cavity (75-80); Peritoneum (75-80); Vena Cava, Superior (75-80) 1E1$Peritoneal Neoplasms C04.588.033.513; C04.588.274.780; C06.240.780; C06.772.616 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Abdominal Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms Digestive System Diseases; Digestive System Neoplasms Digestive System Diseases; Peritoneal Diseases 1FDX Peritoneal Lavage E05.510.705 AECLCTECHIISMOMTNUPXSNSTTDUTVE Ascitic Fluid Miscellaneous Techniques (Non MeSH); Irrigation Washing out of the peritoneal cavity. The procedure is a diagnostic as well as a therapeutic technique following abdominal trauma or inflammation. Irrigation (66-87); Peritoneal Cavity (66-87)  1&"97Peritoneal Diseases C06.772 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases Chyloperitoneum; Hemoperitoneum; Mesenteric Cyst; Mesenteric Lymphadenitis; Mesenteric Vascular Occlusion; Panniculitis, Peritoneal; Peritoneal Neoplasms; Peritonitis; Pneumoperitoneum; Subphrenic Abscess; Tuberculosis, Peritoneal Conditions or disorders affecting the PERITONEUM. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  1 N;ZPeritoneal Dialysis, Continuous Ambulatory E02.472.106.790; E02.870.700.500; E02.912.650.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; General Patient Care (Non MeSH); Ambulatory Care Therapeutics; Renal Replacement Therapy; Peritoneal Dialysis Therapeutics; Sorption Detoxification; Peritoneal Dialysis Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. Ambulatory Care (78-81); Peritoneal Dialysis (78-81) 119"?Peritoneal Dialysis E02.870.700; E02.912.650 AECLCTECHIISMOMTNUPXSNSTTDUTVE Dialysis Solutions; Kidney, Artificial Therapeutics; Renal Replacement Therapy Therapeutics; Sorption Detoxification Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, Continuous Ambulatory Dialysis through the peritoneum, the dialysis being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure (Dorland, 27th edition).  1".Y`Peritoneal Cavity A01.047.596.678 ABAHBSCYEMGDINIRMIPAPHPPPSRARERISUUSVI Ascitic Fluid; Laparoscopy Body Regions (Non MeSH); Abdomen; Peritoneum The space enclosed by the peritoneum. It is divided into two portions, the greater sac and the lesser sac or omental bursa, which lies behind the stomach. The two sacs are connected by the foramen of Winslow, or epiploic foramen. 1*!8Peristalsis G10.261.482.596 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH); Gastrointestinal Motility 1Perissodactyla B02.649.709 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Equidae (+ 1) An order of ungulates having an odd number of toes, including the horse, tapir, and rhinoceros. (Dorland, 27th ed). 1(Periplaneta B01.131.617.678.108.580 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Orthoptera; Cockroaches A genus of Blattidae containing several species with the most common being P. americana, the American cockroach. 1(GPeripheral Vascular Diseases C14.907.617 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases General or unspecified diseases of the blood vessels outside the heart. It is for diseases of the peripheral as opposed to the cardiac circulation. Vascular Diseases (66-91) 1>"N2Peripheral Nervous System Diseases C10.772 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neuromuscular Diseases; Spinal Cord Diseases Nervous System Diseases Acrodynia; Amyloid Neuropathies; Autonomic Nervous System Diseases (+ 6); Cranial Nerve Diseases (+ 33); Demyelinating Diseases (+ 2); Diabetic Neuropathies (+ 1); Nerve Compression Syndromes (+ 5); Neuralgia (+ 4); Neuritis (+ 6); Neuropathies, Hereditary Motor and Sensory (+ 5); Neuropathies, Hereditary Sensory and Autonomic (+ 2); Peripheral Nerve Neoplasms (+ 3); POEMS Syndrome; Sciatica; Sweating, Gustatory; Tetany Diseases of the peripheral nervous system, including disorders of the peripheral autonomic system, the cranial nerves, and the spinal nerves and roots, but not including neuromuscular and spinal cord diseases. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $1) N5ZPeripheral Nervous System Agents (Non MeSH) D16 Autonomic Agents (+ 192); Neuromuscular Agents (+ 32); Sensory System Agents (Non MeSH) (+ 55) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 124tHPeripheral Nervous System A08.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Neural Pathways Nervous System Autonomic Nervous System (+ 36); Ganglia, Sensory (+ 5); Nerve Endings (+ 30); Peripheral Nerves (+ 66) The nervous system outside of the brain and spinal cord. The peripheral nervous system has autonomic and somatic divisions. The autonomic nervous system includes the enteric, parasympathetic, and sympathetic subdivisions. The somatic nervous system includes the cranial and spinal nerves and their ganglia and the peripheral sensory receptors. Peripheral Nerves (66-93) ABAHBSCHCLCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI (1H 6<Peripheral Nerves A08.800.800 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nerve Fibers Nervous System; Peripheral Nervous System Autonomic Pathways (+ 13); Cranial Nerves (+ 27); Schwann Cells (+ 3); Spinal Nerves (+ 19) The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. ABAHBSCHCLCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI $1l82tj<Peripheral Nerve Neoplasms C04.588.614.596; C10.551.625; C10.772.643 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms Nervous System Diseases; Nervous System Neoplasms Nervous System Diseases; Peripheral Nervous System Diseases Cranial Nerve Neoplasms (+ 2) Cranial Nerve Neoplasms (+ 2) Cranial Nerve Neoplasms (+ 2) 1U 1XkPeriostitis C05.116.165.595 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH) Inflammation of the periosteum. The condition is generally chronic, and is marked by tenderness and swelling of the bone and an aching pain. Acute periostitis is due to infection, is characterized by diffuse suppuration, severe pain, and constitutional symptoms, and usually results in necrosis. (Dorland, 27th ed). 1YN[rPeriosteum A10.165.265.746 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Connective Tissue; Bone and Bones 1:IPeriodontosis C07.465.714.533.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Periodontitis Severe loss of attachment and destruction of bone adjacent to teeth in children, adolescents, or young adults. Periodontal Diseases (66-83) 1|NY"Periodontium A14.254.646 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition Alveolar Process; Dental Cementum; Epithelial Attachment; Gingiva; Periapical Tissue; Periodontal Ligament 1:'}Periodontitis C07.465.714.533 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Subgingival Curettage Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Periodontal Abscess; Periodontal Pocket; Periodontosis Inflammatory reaction of the tissues surrounding a tooth (periodontium), usually resulting from the extension of gingival inflammation (gingivitis) into the periodontium. (From Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $17NH@PPeriodontics E06.721; G02.163.876.623 CLECEDHIISLJMAMTOGSNSTTD Dentistry Health Occupations; Dentistry; Specialties, Dental Dental Prophylaxis (+ 2); Gingivectomy; Gingivoplasty; Guided Tissue Regeneration; Periodontal Dressings; Periodontal Index; Periodontal Prosthesis (+ 1); Subgingival Curettage (+ 1) A dental specialty concerned with the histology, physiology, and pathology of the tissues that support, attach, and surround the teeth, and of the treatment and prevention of disease affecting these tissues. AEANCHCLCSCTDUECEDHIIPISLJMAMEMIMOMTNUOGPDPKPOPSPXRESDSNSTTDTOTUUTVEVI  1GJPeriodontal Splints E06.721.721.680 AECLCTECHISDSNSTTDUTVE Dentistry; Periodontics; Periodontal Prosthesis 1}8Periodontal Prosthesis E06.721.721 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Dentistry; Periodontics Periodontal Splints Any restorative and replacement device that is used as a therapeutic aid in the treatment of periodontal disease. It is an adjunct to other forms of periodontal therapy and does not cure periodontal disease by itself. (Boucher's Clinical Dental Terminology, 3d ed). AECLCTECHIISMAMIMOMTNUPSPXSDSNSTTDUTVEVI  1*:,Periodontal Pocket C07.465.714.533.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gingival Pocket Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Periodontitis An abnormal extension of a gingival sulcus accompanied by the apical migration of the epithelial attachment and bone resorption. Gingival Pocket (75-78); Periodontal Diseases (72-78); Periodontitis (66-78)  13NY[Periodontal Ligament A14.254.646.771 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Periodontal Attachment Loss Stomatognathic System; Dentition; Periodontium Fibrous connective tissue surrounding the root of a tooth that separates it from and attaches it to the alveolar bone. Its principal function is to hold the tooth in its socket. Periodontium (66-71)  19:!7Periodontal Index E05.318.308.250.300.725; E06.208.720; E06.721.658; G03.850.520.308.250.300.725; G03.890.160.215; N05.715.360.300.375.300.690 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Dentistry; Dental Health Surveys Dentistry; Periodontics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health Dentistry; Dental Health Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Dental Health Surveys A numerical rating scale for classifying the periodontal status of a person or population with a single figure which takes into consideration prevalence as well as severity of the condition. It is based upon probe measurement of periodontal pockets and on gingival tissue status. 1HPeriodontal Dressings D25.339.719; E06.721.595 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials Dentistry; Periodontics Dental Materials (66-70) 2*dPeriodontal Diseases C07.465.714 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Alveolar Bone Loss; Furcation Defects; Gingival Diseases (+ 12); Periodontal Attachment Loss; Periodontal Cyst; Periodontitis (+ 3); Tooth Exfoliation; Tooth Loss; Tooth Migration (+ 1); Tooth Mobility BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI 2N/\Periodontal Cyst C04.182.089.530.690.790; C05.500.470.690.790; C07.320.450.670.513; C07.465.714.470 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts; Odontogenic Cysts Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Stomatognathic Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Radicular Cyst Radicular Cyst Radicular Cyst An epithelium-lined sac containing fluid; usually found at the apex of a pulp-involved tooth. The lateral type occurs less frequently along the side of the root. 2\V.6Periodontal Attachment Loss C07.465.714.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Periodontal Ligament Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Loss or destruction of periodontal tissue caused by periodontitis or other destructive periodontal diseases or by injury during instrumentation. Attachment refers to the periodontal ligament which attaches to the alveolar bone. It has been hypothesized that treatment of the underlying periodontal disease and the seeding of periodontal ligament cells enable the creating of new attachment. Periodontal Diseases (76-93); Periodontitis (76-93)  2!NH=Periodontal Abscess C01.539.830.025.665; C07.465.714.533.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Periodontitis Localized circumscribed purulent area of inflammation in the periodontal tissue. It is a derivative of marginal periodontitis and commonly associated with suprabony and infrabony pockets and interradicular involvements, in contrast to periapical abscess which is attributable to pulp necrosis. 2 .PQPeriodicity G07.450.730; H01.862.645 Biological Clocks; Circadian Rhythm Physiology, General (Non MeSH); Chronobiology Physical Sciences (Non MeSH); Time Circadian Rhythm (+ 1) Seasons The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian). DEGEIMPHRE  2 +a& Periodicals L01.178.682.829.678 CLECHILJSDSNSTTDUT Publishing Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Serial Publications (Non MeSH) A publication issued at stated, more or less regular, intervals. 2NPeriodic Disease C23.768 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) A condition characterized by regularly recurring and intermittent episodes of fever, edema, arthralgia, and gastric pain and vomiting, continuing for years without further development in otherwise healthy individuals. It is also called familial Mediterranean fever. It does not refer to conditions in which episodes recur at regular intervals. (From Dorland, 27th ed). 2  N2Periodic Acid-Schiff Reaction E05.909.262.607.790; E05.909.262.620.670.620; E05.909.432.551.790; E05.909.432.600.670.620 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytochemistry Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Stains and Staining Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytochemistry Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Stains and Staining A histochemical technique based on periodic acid oxidation of a substance containing the 1,2-glycol grouping. The resulting dialdehyde reacts with Schiff reagent to form a colored product. Substances that can be demonstrated include carbohydrates, mucins, cartilage matrix, collagen, reticulum, basement membranes, fibrin, thyroid colloid, amyloid, glomerular hyaline deposits, and a number of other secretions or tissue constituents. Histocytochemistry (66-76); Periodic Acids (66-76); Stains and Staining (66-76) 2z#d,_Periodic Acid D01.029.260.675; D01.475.705 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Iodine Compounds Periodic acid (H5IO6). A strong oxidizing agent. 2"8=Perineum A01.719 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH) 2  (Perinephritis C12.777.419.685 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Inflammation of the perinephrium. It is marked by fever, local pain, and tenderness on pressure. (Dorland, 27th ed). 2NbPerinatology G02.403.776.671.500 CLECEDHIISLJMAMTOGSNSTTD Fetal Diseases; Infant, Newborn, Diseases; Maternal-Child Nursing; Perinatal Care; Pregnancy Complications Health Occupations; Medicine; Specialties, Medical; Pediatrics The branch of medicine dealing with the fetus and infant during the perinatal period. The perinatal period begins with the twenty-eighth week of gestation and ends twenty-eight days after birth. (From Dorland, 27th ed). Obstetrics (66-76); Pediatrics (66-76)  2|J/Perinatal Care E02.472.703; N02.421.088.120.180 CLECHILJMAMTOGSNSTTDUT Perinatology Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Child Care; Infant Care The care and management of the fetus and newborn infant in the perinatal period before, during, and after delivery. (From Dorland, 27th ed). 2}&Perimetry E01.210.935.595 AECLCTECHIISMOMTNUPXSNSTTDUTVE Visual Fields Diagnosis; Diagnosis, Eye (Non MeSH); Vision Tests Determination of the extent of the visual field for various types and intensities of stimuli. 2N "?pPerilymph A12.207.571.678 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Body Fluids; Labyrinthine Fluids 2 x "QPericoronitis C07.465.714.258.771 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gingivitis Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases Inflammation of the gingiva surrounding the crown of a tooth. 2!*N^KPericardium A07.541.795; A10.615.789.470 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Pericardiectomy Cardiovascular System; Heart Tissue Types (Non MeSH); Membranes; Serous Membrane The fibroserous sac surrounding the heart and the roots of the great vessels. 2"~"8a^Pericarditis, Tuberculous C01.252.410.040.552.846.561.595; C14.280.720.801; C14.826.595 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Cardiovascular Cardiovascular Diseases; Heart Diseases; Pericarditis Cardiovascular Diseases; Tuberculosis, Cardiovascular Infection of the pericardium with tubercle bacilli. This condition arises by contiguous extension of tuberculous lesions of the hilar or mediastinal lymph nodes or by pleuropulmonary tuberculosis. 2#EPXPericarditis, Constrictive C14.280.720.595 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Pericarditis 2&N?Pericarditis C14.280.720 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Pericarditis, Constrictive; Pericarditis, Tuberculous Inflammation of the pericardium. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  2'N/=APPericardiectomy E04.752.376.735; E04.920.490.720 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pericardium Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Surgical excision (total or partial) of a portion of the pericardium. Pericardiotomy refers to incision of the pericardium. Pericardium/surgery (66-87)  2)e&$!Pericardial Window Techniques E04.035.720; E04.752.376.730; E04.920.490.705 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Surgical construction of an opening or window in the pericardium. It is often called subxiphoid pericardial window technique. Cardiac Tamponade/surgery (66-87); Pericardial Effusion/surgery (66-87); Pericarditis/surgery (66-87); Pericardium/surgery (66-87) 2+>#5$Pericardial Effusion C14.280.695 BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiac Tamponade Exudates and Transudates Cardiovascular Diseases; Heart Diseases Presence of fluid within the pericardium.  2-R/3Periarthritis C05.550.114.678; C05.550.251.595 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis Musculoskeletal Diseases; Joint Diseases; Bursitis Inflammation of the tissues around a joint. (Dorland, 27th ed). 2/&NwOPeriaqueductal Gray A08.186.211.132.659.822.595 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon; Tegmentum Mesencephali Central gray matter surrounding the cerebral aqueduct in the mesencephalon. Physiologically it is probably involved in rage reactions, the lordosis reflex, feeding responses, bladder tonus, and pain. Brain (66-82); Cerebral Aqueduct (71-82); Mesencephalon (66-82) 20u8sMPeriapical Tissue A14.254.646.700 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Periodontium Tissue surrounding the apex of a tooth, including the apical portion of the periodontal membrane and alveolar bone. Periodontium (66-71) 22:7Periapical Periodontitis C07.465.690.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periapical Diseases Periapical Abscess; Periapical Granuloma Inflammation of the periapical tissue. It includes general, unspecified, or acute nonsuppurative inflammation. Chronic nonsuppurative inflammation is PERIAPICAL GRANULOMA. Suppurative inflammation is PERIAPICAL ABSCESS. Periodontal Diseases (66-79); Periodontitis (66-79) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $24NG0=PPeriapical Granuloma C07.465.690.700.740; C23.484.694 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periapical Diseases; Periapical Periodontitis Symptoms and General Pathology (Non MeSH); Granuloma Chronic nonsuppurative inflammation of periapical tissue resulting from irritation following pulp disease or endodontic treatment. 26&NPeriapical Diseases C07.465.690 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Periapical Periodontitis (+ 2); Radicular Cyst Diseases of the periapical tissue. Periapical Tissue (72-79); Periodontal Diseases (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHTMULURUSVEVI $28N/9+BXPeriapical Abscess C01.539.830.025.650; C07.465.690.700.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Stomatognathic Diseases; Mouth Diseases; Periapical Diseases; Periapical Periodontitis Acute or chronic inflammation of tissues surrounding the apical portion of a tooth, associated with the collection of pus, resulting from infection following pulp infection through a carious lesion or as a result of an injury causing pulp necrosis. (Dorland, 27th ed). 2:y.P<Perianal Glands A13.734 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Anus (66-67) 2=( :Perhexiline D03.383.621.644; D18.192.754; D18.918.173.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort; may cause neuropathy and hepatitis. Synonyms: perhexilline; Pexid. Piperidines (66-74) 2=5:Pergolide D03.132.327.287.800; D03.549.439.800; D14.100.150.151.750; D15.090.050.620 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents 8-((Methylthio)methyl)-6-propylergoline. A long-acting dopamine agonist which is effective in the treatment of Parkinson's disease and hyperprolactinemia. It has also been observed to have antihypertensive effects. Ergolines (69-86); Ergot Alkaloids (66-86) 2@' T:4Perfusion, Regional E04.292.550; E05.300.690 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Antineoplastic Agents Surgery, Operative; Extracorporeal Circulation Miscellaneous Techniques (Non MeSH); Drug Administration Routes Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. 2C$Perfusion E05.680 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Reperfusion (+ 1) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE 2E  "*$Perfume D26.313.676; J01.516.694 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Cosmetics Technology, Industry, Agriculture (Non MeSH); Household Products 2F ,Percussion E01.706.716 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Physical Examination Act of striking a part with short, sharp blows as an aid in diagnosing the condition beneath the sound obtained. 2G"&Perciformes B02.493.602 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Bass; Perch; Tilapia The most diversified of all fish orders and the largest vertebrate order. It includes many of the commonly known fish such as porgies, croakers, mullets, dolphin fish, etc. Fishes (66-86)  2H&Perchloric Acid D01.029.260.650; D01.210.675 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH) Perchloric acid (HClO4). An oxidizing agent that is used in analytical chemistry for separation of potassium from sodium. (From Merck Index, 11th ed). 2J"8Perch B02.493.602.600 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Perciformes A common name for fish belonging to the order Perciformes with many genera and species. Fishes (66-86) 2K &(jPerceptual Masking F02.463.593.071.594; F02.463.593.932.733 PH Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception The interference of one perceptual stimulus with another causing a decrease or lessening in perceptual effectiveness. Auditory Perception (67-71); Auditory Threshold (68-71); Visual Perception (66-71) 2M.bPerceptual Distortion F02.463.593.603 CLDEPHRE Perceptual Disorders Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Lack of correspondence between the way a stimulus is commonly perceived and the way an individual perceives it under given conditions. Perception (66)  2OG \Perceptual Disorders F03.126.185.794 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Perceptual Distortion Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders Agnosia (+ 1); Auditory Perceptual Disorders; Hallucinations; Illusions; Phantom Limb Disturbances in recognizing and interpreting sensory stimuli dependent upon one's previous experience. Agnosia (66-68); Hallucinations (66-68); Illusions (66-68); Perception (66-68); Phantom Limb (66-68) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI (2PFrgvzTPerceptual Defense F01.393.628; F03.407.628 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Selective perceiving such that the individual protects himself from becoming aware of something unpleasant or threatening, e.g., obscene words are not heard correctly, or violent acts are not seen accurately. 2SPerceptual Closure F02.463.593.932.677 PH Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception The tendency to perceive an incomplete pattern or object as complete or whole. This includes the Gestalt Law of Closure. Form Perception (66-68); Visual Perception (66-68) 2Ur=Perception F02.463.593 CLDEPHRE Sensation Sensation Psychologic Processes and Principles (Non MeSH); Mental Processes Auditory Perception (+ 7); Body Image; Depth Perception (+ 1); Differential Threshold; Discrimination (Psychology) (+ 1); Eidetic Imagery; Field Dependence-Independence; Form Perception (+ 1); Gravity Perception; Illusions (+ 2); Perceptual Distortion; Sensory Deprivation; Sensory Thresholds (+ 6); Size Perception; Social Perception; Space Perception; Speech Perception; Time Perception; Touch (+ 1); Visual Perception (+ 16); Weight Perception The process by which the nature and meaning of sensory stimuli are recognized and interpreted. CLDEEHETGEHIIMPHPXRE (2W%   NqPerazine D03.494.741.575; D14.100.150.175.700; D15.150.025.650; D15.210.950.040.025.650; D15.700.872.331.025.553 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine antipsychotic with actions and uses similar to those of CHLORPROMAZINE. Extrapyramidal symptoms may be more common than other side effects. Phenothiazine Tranquilizers (73-75); Piperazines (72-75) 2Z s:BPeracetic Acid D02.241.081.038.700; D20.187.222.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Anti-Infective Agents; Anti-Infective Agents, Local; Disinfectants Ethaneperoxoic acid. A liquid that functions as a strong oxidizing agent. It has an acrid odor and is used as a disinfectant. Acetic Acids (69-74); Peroxides (69-74) 2^*:1Peptostreptococcus B03.510.400.700.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Peptococcaceae A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of humans. Its organisms are opportunistic pathogens causing bacteremias and soft tissue infections. 2a "QPeptones D12.776.719 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins 2b FDPeptococcus B03.510.400.700.593 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Peptococcaceae A genus of gram-positive, anaerobic, coccoid bacteria that is part of the normal flora of the mouth, upper respiratory tract, and large intestine in humans. Its organisms cause infections of soft tissues and bacteremias. 2cn"QPeptococcaceae B03.510.400.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci Peptococcus; Peptostreptococcus A family of bacteria found in the mouth and intestinal and respiratory tracts of man and other animals as well as in the human female urogenital tract. Its organisms are also found in soil and on cereal grains. Bacteria (66-77); Lactobacillaceae (75); Micrococcaceae (75)  2e-"?%IPeptidyl-Dipeptidase A D08.586.277.656.732.600 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, -Xaa-*-Xbb-Xcc, when neither Xaa nor Xbb is Pro. Thus, conversion of angiotensin I to angiotensin II. It is a Cl(-)-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. Only single dipeptides are released from angiotensin I and bradykinin because of the lack of activity on bonds involving proline. It may also have endopeptidase activity on some substrates. (From Enzyme Nomenclature, 1992) EC 3.4.15.1. Peptide Peptidohydrolases (66-72) 2gIDZ'Peptidyl Transferases D08.586.913.050.800 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases A part of the 50 S ribosomal subunit in protein synthesis. It transfers aminoacyl-tRNA to formyl-methionine-tRNA or peptidyl-tRNA during peptide chain elongation. EC 2.3.2.12. Acyltransferases (72-74); Peptides (72-74); Peptide Elongation Factors (73-74) 2jFi]Peptidoglycan D09.203.400.420.700; D09.203.698.718.594; D12.644.233.594; D12.776.395.560.800; D24.611.216.161.616.594 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPORETOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates; Glycopeptides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Polysaccharides, Bacterial Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Glycopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial; Polysaccharides, Bacterial Mucopolysaccharides (66-70); Polysaccharides, Bacterial (66-70) 2m$s4<IPeptides, Cyclic D12.644.641 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amanitins; Cyclosporins (+ 1); Ferrichrome; Octreotide; Phalloidine Peptides (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  2pDDRFPeptides D12.644 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acid Sequence Amino Acids, Peptides and Proteins (Non MeSH) Atrial Natriuretic Factor; Bombesin; C-Peptide; Calcitonin; Cholecystokinin (+ 1); Corticotropin; Corticotropin-Releasing Hormone; Endothelins; Enteroglucagon; Epidermal Growth Factor-Urogastrone; Fibrinopeptides A; Fibrinopeptides B; Fibroblast Growth Factor (+ 2); Gastric Inhibitory Polypeptide; Gastrins; Glucagon; Glycopeptides (+ 4); Kinins (+ 10); Motilin; MSH (+ 1); MSH Release-Inhibiting Hormone; MSH-Releasing Hormone; Myocardial Depressant Factor; Neuropeptide Y; Neurotensin; Oligopeptides (+ 51); Opioid Peptides (+ 10); Pancreatic Polypeptide; Peptichemio; Peptide Fragments; Peptide PHI; Peptides, Cyclic (+ 6); Phosphopeptides; Pituitary Hormone Release Inhibiting Hormones; Pituitary Hormone-Releasing Hormones; Platelet-Derived Growth Factor; Polygeline; Polyglutamic Acid; Polylysine; Secretin; Signal Peptides; Somatostatin (+ 1); Transforming Growth Factors (+ 2); Urotensins; Vasoactive Intestinal Peptide Any member of a class of compounds of low molecular weight which yield two or more amino acids on hydrolysis. Formed by loss of water from the NH2 and COOH groups of adjacent amino acids, they are known as di-, tri-, tetra- (etc.) peptides, depending on the number of amino acids in the molecule. Peptides form the constituent parts of proteins. (Dorland, 27th ed). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $2r  D7>HPeptide Termination Factors D12.776.835.862 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Peptide Chain Termination Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Ribosomal Proteins Proteins that are exclusively involved in the termination reactions of protein synthesis on the ribosome. Bacterial Proteins (66-72); Peptides (66-72); Proteins (66-72)  2y!F[|LPeptide T D12.644.456.729 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR HIV Envelope Protein gp120 Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides N-(N-(N(2)-(N-(N-(N-(N-D-Alanyl L-seryl)-L-threonyl)-L-threonyl) L-threonyl)-L-asparaginyl)-L-tyrosyl) L-threonine. Octapeptide sharing sequence homology with HIV envelope protein gp120. It is potentially useful as antiviral agent in AIDS therapy. The core pentapeptide sequence, TTNYT, consisting of amino acids 4-8 in peptide T, is the HIV envelope sequence required for attachment to the CD4 receptor. Oligopeptides (87-89); Peptide Fragments (87-89)  2{F!U:Peptide Synthetases D08.586.464.677 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases gamma-Glutamyl-Cysteine Synthetase; Glutathione Synthetase Ligases (66-72) 2~FPBPeptide Synthesis (Non MeSH) G06.535.770 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Amino Acid Activation; Peptide Chain Elongation; Peptide Chain Initiation; Peptide Chain Termination DEGEIMPHRE 2[#OvPeptide PHI D12.644.570; D12.776.641.650.610; D14.600.600.620 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A 27-amino acid peptide with histidine at the N-terminal and isoleucine amide at the C-terminal. The exact amino acid composition of the peptide is species dependent. The peptide is secreted in the intestine, but is found in the nervous system, many organs, and in the majority of peripheral tissues. It has a wide range of biological actions, affecting the cardiovascular, gastrointestinal, respiratory, and central nervous systems. Gastrointestinal Hormones (66-86); Peptides (66-86) 29F=Peptide Peptidohydrolases D08.586.277.656.732 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases Aspartic Proteinases (+ 5); Cathepsins (+ 1); Cysteine Proteinases (+ 7); Dipeptidyl Peptidases (+ 1); Gelatinases; Metalloproteinases (+ 5); Peptidyl-Dipeptidase A; Plasminogen Activators (+ 2); Procollagen Peptidase; Serine Proteinases (+ 24); Streptokinase (+ 2) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 2Dj?FPeptide Mapping E05.196.181.400.454.720; E05.196.401.319.720; E05.196.700 AECLCTECHIISMOMTNUPXSNSTTDUTVE Peptide Fragments Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Liquid; Chromatography, Paper Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Paper Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Blotting, Western Blotting, Western Blotting, Western Two-dimensional separation and analysis of peptides. Chromatography, Paper (66-86); Electrophoresis, Paper (73-86) $2A"@>>HPeptide Initiation Factors D12.776.835.725 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Peptide Chain Initiation Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Ribosomal Proteins eIF-1; eIF-2 Protein factors uniquely required during the initiation phase of protein synthesis. Bacterial Proteins (66-72); Peptides (66-72); Proteins (66-72) $2 F[bLPeptide Hydrolases D08.586.277.656 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gene Products, pol Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Aminopeptidases (+ 7); Brinolase; Carboxypeptidases (+ 2); Dipeptidases; Insulinase; Lysostaphin; Peptide Peptidohydrolases (+ 58); Rec A Protein AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  2DSHPeptide Fragments D12.644.541 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Peptide Mapping Amino Acids, Peptides and Proteins (Non MeSH); Peptides 2DDPeptide Elongation Factors D12.776.835.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Peptide Chain Elongation Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Ribosomal Proteins Peptide Elongation Factor Tu Protein factors uniquely required during the elongation phase of protein synthesis. Bacterial Proteins (66-72); Peptides (66-72); Proteins (66-72) $2 F[#bLPeptide Elongation Factor Tu D12.776.835.700.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Ribosomal Proteins; Peptide Elongation Factors A protein found in bacteria and eukaryotic cells which delivers aminoacyl-tRNA's to the A site of the ribosome. The aminoacyl-tRNA is first bound to a complex of elongation factor Tu containing a molecule of bound GTP. The resulting complex is then bound to the 70S initiation complex. Simultaneously the GTP is hydrolyzed and a Tu-GDP complex is released from the 70S ribosome. The Tu-GTP complex is regenerated from the Tu-GDP complex by the Ts elongation factor and GTP. Bacterial Proteins (66-72); Peptide Elongation Factors (73-85); Peptides (66-72); Proteins (66-72) 2#F{/vPeptide Chain Termination G05.331.370.725.743; G06.535.770.743 DEGEIMPHRE Peptide Termination Factors Codon, Terminator Genetics; Genetics, Biochemical; Gene Expression; Translation, Genetic Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Peptide Synthesis (Non MeSH) The process whereby the last amino acid is added to a polypeptide. This termination is signaled by one of three termination triplets in the mRNA, immediately following the last amino acid codon. Peptides/biosynthesis (66-70) $2P*!#Peptide Chain Initiation G05.331.370.725.643; G06.535.770.643 DEGEIMPHRE Peptide Initiation Factors; Protein Synthesis Inhibitors Codon, Initiator Genetics; Genetics, Biochemical; Gene Expression; Translation, Genetic Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Peptide Synthesis (Non MeSH) The process whereby the formation of a peptide chain is started. This process requires (1) the 30s subunit, (2) the mRNA coding for the polypeptide to be made, (3) Met-tRNAi, (4) initiation factors, and (5) GTP. Peptides/biosynthesis (66-70) $2*B#Peptide Chain Elongation G05.331.370.725.543; G06.535.770.543 DEGEIMPHRE Peptide Elongation Factors; Protein Synthesis Inhibitors Genetics; Genetics, Biochemical; Gene Expression; Translation, Genetic Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Peptide Synthesis (Non MeSH) The process whereby an amino acid is joined through a substituted amide linkage to a chain of peptides. Peptides/biosynthesis (66-70)  2*B}#Peptichemio D02.455.526.728.650.594.690; D12.644.490; D22.204.585.613.698 AAADAEAGAIANBLCFCHCLCSCTDEDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds; Melphalan Amino Acids, Peptides and Proteins (Non MeSH); Peptides Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds; Melphalan A mixture of six peptides of melphalan; used as a broad-spectrum antineoplastic due to its alkylating and antimetabolic actions; toxic to bone marrow, gastrointestinal system and vasculature. Nitrogen Mustard Compounds (74); Peptides (74) 2E<R9Peptic Ulcer Perforation C06.405.613.698 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer Penetration of a peptic ulcer through the stomach wall. May be free, i.e., at a point where the stomach wall faces a real or potential space,, or confined, i.e., at a point where the stomach wall is defended by contiguous or adjacent structures, such as the pancreas. 2NN?Peptic Ulcer Hemorrhage C06.405.270.718; C06.405.613.627; C23.542.305.718 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Hemorrhage Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer Symptoms and General Pathology (Non MeSH); Hemorrhage; Gastrointestinal Hemorrhage 29NPeptic Ulcer C06.405.613 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anti-Ulcer Agents; Gastrectomy; Zollinger-Ellison Syndrome Ulcer Digestive System Diseases; Gastrointestinal Diseases Duodenal Ulcer (+ 1); Esophagitis, Peptic; Marginal Ulcer; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Stomach Ulcer; Zollinger-Ellison Syndrome Ulcer that occurs in those portions of the alimentary tract which come into contact with gastric juice containing pepsin and acid. It occurs when the amount of acid and pepsin is sufficient to overcome the gastric mucosal barrier. $2ND =Pepstatins D08.373.745.725; D12.644.456.724 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides N-acylated oligopeptides isolated from culture filtrates of Actinomycetes, which act specifically to inhibit acid proteases such as pepsin and renin. Oligopeptides (73-74) 2&DPepsinogen D08.444.509 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gastric Juice Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Enzyme Precursors (66-71); Pepsin (66-71) 2FP3Pepsin A D08.586.277.656.732.066.700; D19.316.720 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gastric Juice Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Aspartic Proteinases Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Formed from pig pepsinogen by cleavage of one peptide bond. The enzyme is a single polypeptide chain and is inhibited by methyl 2-diaazoacetamidohexanoate. It cleaves peptides preferentially at the carbonyl linkages of phenylalanine or leucine and acts as the principal digestive enzyme of gastric juice. (Formerly EC 3.4.4.1). 2 .FPeplomycin D20.085.075.236.725; D20.085.116.095.236.725; D22.204.106.244.725 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Bleomycins Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Antibiotics, Glycopeptide; Bleomycins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Bleomycins (S)-N(1)-(3-((1-Phenylethyl)amino)propyl)bleomycinamide. An antineoplastic agent derived from bleomycin and claimed to produce a lower incidence of pulmonary toxicity. The sulfate has been used in the treatment of malignant neoplasms of the prostate and lung. (Martindale, The Extra Pharmacopoeia, 29th ed). Bleomycins (79-93) 20I<?iPentylenetetrazole D03.383.066.600; D15.220.224.765 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines Central Nervous System Agents; Central Nervous System Stimulants; Convulsants 6,7,8,9-Tetrahydro-5H-tetrazolo(1,5-a)azepine. A convulsant used primarily in animal experiments. It was formerly used as a central nervous system stimulant. 2&:Pentoxyl D03.383.742.698.875.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil 5-Hydroxymethyl-6-methyl- 2,4-(1H,3H)-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil. Uracil (66-74) /AA (75-79) 2 :r !Pentoxifylline D03.132.956.701.700; D03.438.759.758.824.651.700; D18.918.861.739 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids; Theobromine Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines; Theobromine Cardiovascular Agents; Vasodilator Agents; Theobromine 3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione. Theobromine-derived vasodilator agent that also inhibits phosphodiesterases. It is used mostly in peripheral vascular disturbances. Xanthines (72-76) 2I:Pentosyltransferases D08.586.913.400.725 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases Adenine Phosphoribosyltransferase; Amidophosphoribosyltransferase; Anthranilate Phosphoribosyltransferase; ATP Phosphoribosyltransferase; Hypoxanthine Phosphoribosyltransferase; NAD+ ADP-Ribosyltransferase; NAD(P)(+)-Arginine ADP-Ribosyltransferase; Orotate Phosphoribosyltransferase; Purine-Nucleoside Phosphorylase; Thymidine Phosphorylase; Uridine Phosphorylase Transferases (66-71) 2|FmPentostatin D08.373.300.700; D13.570.230.677; D13.570.685.350.200.700; D20.085.075.480.200.700; D22.204.106.450.154.500; D22.569.450.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Coformycin Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Formycins; Coformycin Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Formycins; Coformycin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Formycins; Coformycin Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents; Coformycin 3-(2-Deoxy-beta-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol. A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity. Azepines (66-78); Coformycin/analogs and derivatives (79-89); Deoxyribonucleosides (71-78) 2/<jPentoses D09.203.546.627 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides Arabinose; Ribose; Xylose; Xylulose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 2 B^-DPentosephosphates D09.203.894.643 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Phosphoribosyl Pyrophosphate; Ribosemonophosphates; Ribulosephosphates AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 2B`ODPentosephosphate Pathway G06.535.760 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate. Hexosephosphates (66-84); Pentosephosphates (66-84) 2O<Pentosan Sulfuric Polyester D09.203.698.682; D19.461.119.655 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants A sulfated pentosyl polysaccharide with heparin-like properties used in treatment of thromboses, inflammation and as an enzyme inhibitor. Synonyms: Fibrase; Hemoclar; Tavan; CB 8061; SP 54. Polysaccharides (70-74); Sulfuric Acids (72-74) 2I!&F9Pentolinium Tartrate D14.100.120.200.600.750; D16.050.340.740; D18.162.703 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Blockers Cardiovascular Agents; Antihypertensive Agents A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension. 2=:MkPentobarbital D03.383.742.698.253.593; D14.100.240.500.660; D15.045.770; D15.210.350.750.750; D15.325.850.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p.236). 2Kk:Pentazocine D03.132.610.422.106.700; D15.040.150.575; D15.045.750; D15.210.600.696; D15.550.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Benzomorphans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Central Nervous System Depressants; Narcotics Central Nervous System Agents; Narcotic Antagonists The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA, Drug Evaluations Annual, 1991, p97). 2_:ePentanones D02.522.720 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones 5-carbon straight-chain or branched-chain ketones. Ketones (66-74) 28/;Pentanoic Acids D02.241.081.465.895.593; D02.241.081.944.509; D10.516.251.400.895.593 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Valerates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Valerates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Valerates Gemfibrozil; Valproic Acid Gemfibrozil; Valproic Acid Gemfibrozil; Valproic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 2M8Y_:Pentanes D02.455.326.146.770 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Five-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Alkanes (66-77); Hydrocarbons (66-77) 2 8gp.Pentamidine D02.078.100.700; D21.370.750; D21.370.884.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Benzamidines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents 4,4'-(Pentamethylenedioxy)dibenzamidine. Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of Pneumocystis carinii pneumonia in HIV-infected patients. May cause diabetes mellitus, central nervous system damage and other toxic effects. Amidines (72-74); Phenyl Ethers (74) 2L5:Q.Pentagastrin D06.472.317.413.593; D12.644.456.716; D19.316.629.441.593 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones; Gastrins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones; Gastrins Gastrointestinal Hormones (66-71); Peptides (66-71) 2DA::=Pentaerythritol Tetranitrate D02.033.618.706.690; D18.918.716 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Propanediols Cardiovascular Agents; Vasodilator Agents 2i!&:zPentachlorophenol D02.755.190.633; D05.723.366.690; D08.373.936.642 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Chlorophenols Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents Herbicides (66-70); Phenols (66-70) 2ۃ9:,Pensions N01.824.417.510 CLHISN Aged Population Characteristics (Non MeSH); Socioeconomic Factors; Income Fixed sums paid regularly to individuals. 2P  Q3Pennsylvania Z01.107.567.875.100.708; Z01.107.567.875.600.066.708; Z01.107.567.875.600.313.708; Z01.107.567.875.600.513.708 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Appalachian Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Mid-Atlantic Region Philadelphia Philadelphia Philadelphia Philadelphia 2,x3:Penis A05.360.444.492 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Circumcision Urogenital System; Genitalia; Genitalia, Male Urethra 2L :7 Penile Prosthesis E04.659.762; E04.887.774.692.621; E07.450.763; E07.858.565.873 AECLCTECHIISMIMONUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Surgery, Urologic, Male (Non MeSH) Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis Rigid, semi-rigid, or inflatable cylindric hydraulic devices, with either combined or separate reservoir and pumping systems, implanted for the surgical treatment of organic impotence. Impotence (66-89); Penis/surgery (66-89); Prosthesis (66-89) 2H( JPenile Neoplasms C04.588.945.440.715; C12.294.260.500; C12.294.494.591; C12.740.800.410.600 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Male Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Genital Neoplasms, Male Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Male Cancers or tumors of the penis or of its component tissues. 2TXJPenile Induration C12.294.494.508; C17.300.715 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases A disease of unknown etiology in which there are plaques or strands of dense fibrous tissue causing induration of the corpora cavernosa of the penis. The condition produces a painful deformity and is sometimes seen in cases of DUPUYTREN'S CONTRACTURE. 2"N(Penile Erection G08.520.900.460 DEGEIMPHPXRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sex The state of the penis when the erectile tissue becomes filled with blood and causes the penis to become rigid and elevated. Penis (66-85) 2NPenile Diseases C12.294.494 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Balanitis; Hypospadias; Penile Induration; Penile Neoplasms; Phimosis (+ 1); Priapism BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI 2NThXPeniculina B01.841.185.650.375.550 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida Paramecium (+ 1) A suborder of protozoa characterized by peniculi, which are often situated deep in the buccal cavity, and by fusiform trichocysts. 2&SPenicillium chrysogenum B05.354.381.546.662.592 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Penicillium A deuteromycetous fungal species used in the production of penicillin. Penicillium (66-71) 2"]TPenicillium B05.354.381.546.662 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Penicillium chrysogenum 2G"NPenicillins D20.085.099.739 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Penicillanic Acid Anti-Infective Agents; Antibiotics; Antibiotics, Lactam Amdinocillin (+ 1); Cyclacillin; Methicillin; Nafcillin; Oxacillin (+ 3); Penicillin G (+ 12); Penicillin V; Ticarcillin A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. A change in the nucleus will lead to a decrease in anti-bacterial activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p.1065). AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $2:A <Penicillinase D08.586.277.087.180.697 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases; beta-Lactamases 2FyPenicillin V D20.085.099.739.773 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins (2S-(2 alpha,5 alpha,6 beta)-3,3-Dimethyl-7-oxo-6-((phenoxyacetyl)amino)-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid. A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms. 2:P-Penicillin Resistance G04.185.515.286.100.600; G05.386.310.100.600; G05.706.310.100.600; G12.392.269.100.600 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial; beta-Lactam Resistance Genetics; Genetics, Microbial; Drug Resistance, Microbial; beta-Lactam Resistance Genetics; Pharmacogenetics; Drug Resistance, Microbial; beta-Lactam Resistance Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial; beta-Lactam Resistance Ampicillin Resistance; Methicillin Resistance Ampicillin Resistance; Methicillin Resistance Ampicillin Resistance; Methicillin Resistance Ampicillin Resistance; Methicillin Resistance Nonsusceptibility of an organism to the action of penicillins. 2`  KPenicillin G, Procaine D20.085.099.739.762.693 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G (2S-(2 alpha,5 alpha,6 beta))-3,3-Dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid compound with 2-(diethylamino)ethyl) 4-aminobenzoate (1:1) monohydrate. Semisynthetic antibiotic prepared by combining penicillin G with procaine. 2:a1Penicillin G, Benzathine D20.085.099.739.762.683 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G (2S)-(2 alpha,5 alpha,6 beta))-3,3-Dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid compound with N,N'-bis(phenylmethyl)-1,2-ethanediamine. Semisynthetic antibiotic prepared by combining the sodium salt of penicillin G with N,N'-dibenzylethylenediamine. 2:aJPenicillin G D20.085.099.739.762 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins Ampicillin (+ 6); Carbenicillin (+ 1); Penicillin G, Benzathine; Penicillin G, Procaine; Sulbenicillin (2S-(2 alpha,5 alpha,6 beta))-3,3-Dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. 3:P|Penicillin Amidase D08.586.277.087.690 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases An enzyme catalyzing the hydrolysis of penicillin to penicin and a carboxylic acid anion. EC 3.5.1.11. Amidohydrolases (70-74); Penicillins (70-74) 3Ff{5Penicillic Acid D02.241.081.193.467.700; D24.185.926.587.735; D26.191.712 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Caproates; Hexanoic Acids Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 3-Methoxy-5-methyl-4-oxo-2,5-hexadienoic acid (in tautomeric equilibrium with its lactone). A mycotoxin with antibiotic and carcinogenic activity produced by various strains of Penicillium, by Aspergillus ochraceus and Aspergillus melleus. Has been found in tobacco, sausages and corn. Caproates (69-74); Keto Acids (72-74); Lactones (73-74) 3A:GEPenicillanic Acid D03.438.671 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Penicillins Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Sulbactam 3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.1)heptane-2-carboxylic acid. A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed). Penicillins (66-70); Thiazoles (66-70) $3:G /Penicillamine D12.125.166.786; D17.050.750; D26.241.768 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. 3 1: Penfluridol D03.383.621.620; D14.100.150.175.680; D15.150.650; D15.210.950.040.650; D15.700.872.331.615 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A long-acting antipsychotic used for maintenance or long-term therapy of schizophrenia and other psychoses. Hydrocarbons, Halogenated (71-74); Piperidines (71-74); Toluene (73-74) 3 yg:}UPenbutolol D02.033.329.624.690; D14.100.050.200.200.655; D16.050.850.670; D18.097.582; D18.162.691 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents A nonselective beta-blocker used as an antihypertensive and an antianginal agent. Amino Alcohols (66-73); Propanolamines (74-78) 33c:`8Pempidine D03.383.621.610; D14.100.120.200.600.725; D16.050.340.730; D18.162.679 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Blockers Cardiovascular Agents; Antihypertensive Agents A nicotinic antagonist most commonly used as an experimental tool. It has been used as a ganglionic blocker in the treatment of hypertension but has largely been supplanted for that purpose by more specific drugs. 3n P:Pemphigus, Benign Familial C17.800.827.700; C17.800.865.716.700; C20.111.736.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous; Pemphigus Immunologic Diseases; Autoimmune Diseases; Pemphigus Rare hereditary disease characterized by recurrent eruptions of vesicles and bullae mainly on the neck, axillae, and groin. It exhibits autosomal dominant inheritance and is unrelated to pemphigus vulgaris though it closely resembles that disease. Pemphigus (66-91) 3 =N*Pemphigus C17.800.865.716; C20.111.736 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Immunologic Diseases; Autoimmune Diseases Pemphigus, Benign Familial Pemphigus, Benign Familial Group of chronic blistering diseases characterized histologically by acantholysis and blister formation within the epidermis. 3 "N>Pemphigoid, Bullous C17.800.865.690; C20.111.730 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Immunologic Diseases; Autoimmune Diseases A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis. Skin Diseases (66-75); Skin Diseases, Bullous (76-80) 3"NAPemphigoid, Benign Mucous Membrane C17.800.865.670 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous A chronic blistering disease with predilection for mucous membranes and less frequently the skin, and with a tendency to scarring. It is sometimes called ocular pemphigoid because of conjunctival mucous membrane involvement. Skin Diseases (66-75); Skin Diseases, Bullous (76-80) 3*)NoAPemoline D03.383.548.673; D15.220.710 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Central Nervous System Agents; Central Nervous System Stimulants 2-Imino-5-phenyl-4-oxazolidinone. A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children. 3  ":Pelvis A01.673 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Adnexitis Body Regions (Non MeSH) Pelvic Floor 3"l  ( Pelvimetry E01.249.591; E01.706.682; E05.118.785 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Physical Examination Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Measurement of the dimensions and capacity of the pelvis. It includes cephalopelvimetry (measurement of fetal head size in relation to maternal pelvic capacity), a prognostic guide to the management of labor associated with disproportion. 3# -"Pelvic Pain C23.888.592.612.813 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pain in the pelvic region of genital and non-genital origin and of organic or psychogenic etiology. Frequent causes of pain are distension or contraction of hollow viscera, rapid stretching of the capsule of a solid organ, chemical irritation, tissue ischemia, and neuritis secondary to inflammatory, neoplastic, or fibrotic processes in adjacent organs. (Kase, Weingold and Gershenson: Principles and Practice of Clinical Gynecology, 2d ed). Pain (66-93); Pelvis (66-93) 3%LN%Pelvic Neoplasms C04.588.699 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) 3(X1Pelvic Floor A01.673.600 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Pelvis Soft floor composed mainly of two muscles. These are the levators of the anus and a pair of sacrosciatic ligaments. (Black's Medical Dictionary, 36th ed). Pelvis (66-93) 3)Y()Pelvic Exenteration E04.584 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative 3* $Pelvic Bones A02.835.232.611 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones Acetabulum; Ilium; Ischium; Pubic Bone 3+;:;1Pellagra C18.654.223.133.699.529 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vitamin B Deficiency Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency 3,( NPeliosis Hepatis C06.552.802 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases A condition in which microscopic pools of blood are present throughout the liver parenchyma, which may lead to congestion and necrosis. Liver Diseases (66-80) 3-kN2Pelger-Huet Anomaly C15.378.553.696 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH) An inherited defect interfering with normal nuclear lobulation of neutrophils and eosinophils. The nuclei appear rodlike, spherical, or dumbbell-shaped and their structure is coarse and lumpy. (From Dorland, 27th ed). 3.NoPefloxacin D03.438.810.835.530; D20.220.050.700; D20.237.050.050.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones Anti-Infective Agents; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone 1-Ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo 3-quinolinecarboxylic acid. An orally administered broad spectrum quinolone antibacterial agent active against most gram-negative and gram-positive bacteria. It is effective against urinary tract infections as well as against many other systemic infections. The drug is well tolerated in adults, but should not be given to children and pregnant women. Anti-Infective Agents (81-88); Anti-Infective Agents, Urinary (81-88); Norfloxacin/analogs and derivatives (84-88); Quinolines (81-83) 30A:\Peer Review, Research F01.829.316.549.700; H01.770.644.487; I01.880.604.640.700; L01.737.640; N03.706.700.700 LJMTSTTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes; Peer Review Physical Sciences (Non MeSH); Science; Research Social Sciences; Sociology; Social Control, Formal; Peer Review Information Science; Publishing Economics, Organizations, Control (Non MeSH); Social Control, Formal; Peer Review The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions. Peer Review (71-93) 35|c w|Peer Review, Health Care F01.829.316.549.690; I01.880.604.640.690; N03.706.700.690; N04.761.616; N05.715.680 LJMTSTTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes; Peer Review Social Sciences; Sociology; Social Control, Formal; Peer Review Economics, Organizations, Control (Non MeSH); Social Control, Formal; Peer Review Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality of Health Care The concurrent or retrospective review by practicing physicians or other health professionals of the quality and efficiency of patient care practices or services ordered or performed by other physicians or other health professionals (From The Facts On File Dictionary of Health Care Management, 1988). Peer Review (71-93) 399_ ^Peer Review F01.829.316.549; I01.880.604.640; N03.706.700 LJMTSTTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes Social Sciences; Sociology; Social Control, Formal Economics, Organizations, Control (Non MeSH); Social Control, Formal Peer Review, Health Care; Peer Review, Research Peer Review, Health Care; Peer Review, Research Peer Review, Health Care; Peer Review, Research An organized procedure carried out by a select committee of professionals in evaluating the performance of other professionals in meeting the standards of their specialty. Review by peers is used by editors in the evaluation of articles and other papers submitted for publication. Peer review is used also in the evaluation of grant applications. It is applied also in evaluating the quality of health care provided to patients. Medical Assistance (68-70); Quality of Health Care (68-70)  3=5 GPeer Group F01.829.316.483 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes Group composed of associates of same species, approximately the same age, and usually of similar rank or social status. Group Processes (66-67) 3A``Pedophilia F03.709.597.608.700.580 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias A psychosexual disorder involving sexual activity with prepubertal children as the objects. It may involve fantasy or any form of heterosexual or homosexual intercourse. 3BFPediococcus B03.510.400.800.653 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. No endospores are produced. Its organisms are found in fermenting plant products and are nonpathogenic to plants and animals, including humans. 3D"S@Pedigree E05.393.673 Miscellaneous Techniques (Non MeSH); Genetic Techniques Genetics (66-67); Genetics, Medical (66-67) 3F B5Pediculus B01.131.617.564.159.716 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lice; Anoplura Lice of the genus Pediculus. Lice (66-74) 3GD (>%Pediculosis C03.211.641; C03.858.700; C17.800.838.775.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Lice Parasitic Diseases; Ectoparasitic Infestations Parasitic Diseases; Skin Diseases, Parasitic Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic Infestation with lice of the family Pediculidae, especially infestation with Pediculus humanus. The infestation may be present on various parts of the body, including the eyelashes and pubis. The hair of the head is a frequent site. (Dorland, 27th ed; Stedman, 25th ed). 3H/5PBPediatrics G02.403.776.671 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Medical Neonatology; Perinatology A medical specialty concerned with maintaining health and providing medical care to children from birth to adolescence. 3K#<Pediatric Nursing G02.478.676.631; N02.421.533.691 CLECEDHIISLJMAMTOGSNSTTD Maternal-Child Nursing Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care Neonatal Nursing Neonatal Nursing The nursing care of children from birth to adolescence. It includes the clinical and psychological aspects of nursing care. Nursing (66); Nursing Care (66); Pediatrics (66) $3Ln&(>Pediatric Dentistry E06.700; G02.163.700; G02.163.876.600 CLECEDHIISLJMAMTOGSNSTTD Dentistry Health Occupations; Dentistry Health Occupations; Dentistry; Specialties, Dental The practice of dentistry concerned with children. The specialty includes restoring and maintaining the primary, mixed, and permanent dentitions in children; prevention of caries and periodontal diseases in children; and dental health education for children. 3N-i,Pediatric Assistants M01.526.485.067.740.750; N02.360.067.740.750 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Physician Assistants Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Physician Assistants Persons academically trained to provide medical care, under the supervision of a physician, to infants and children. 3P2Pectoralis Muscles A02.633.567.775 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal These are musculus pectoralis major and musculus pectoralis minor. (Dorland, 27th ed). 3R:;hPectins D09.203.698.670; D19.316.161.674; D19.461.140.500.875 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Antidiarrheals Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Blood Substitutes; Plasma Substitutes 3T  =@HPeas B06.510.570.795; B06.510.956.500; J01.341.956.570.795; J01.341.956.729 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Legumes Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables; Legumes Technology, Industry, Agriculture (Non MeSH); Food; Vegetables A variable annual leguminous vine (Pisum sativum) that is cultivated for its rounded smooth or wrinkled edible protein-rich seeds, the seed of the pea, and the immature pods with their included seeds. (From Webster's New Collegiate Dictionary, 1973). Legumes (78-94) 3UP4&Peanuts B06.510.570.721; B06.510.645.721; J01.341.739.673; J01.341.956.570.721 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Legumes Plants; Plants, Edible; Nuts Technology, Industry, Agriculture (Non MeSH); Food; Nuts Technology, Industry, Agriculture (Non MeSH); Food; Vegetables; Legumes A leguminous annual herb, Arachis hypogaea, that yields edible seeds containing high quality proteins, several lectins, and oils. 3X P4Peak Expiratory Flow Rate E01.302.796.624.390.790; G09.772.521.700.646.390.790 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow; Forced Expiratory Flow Rates Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow; Forced Expiratory Flow Rates Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are PEFR and PFR. 3[ :bPC12 Cells A11.251.210.750; A11.251.353.750; A11.251.928.750 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Cells; Cells, Cultured; Clone Cells Cells; Cells, Cultured; Tumor Cells, Cultured A cell line derived from a pheochromocytoma of the rat adrenal medulla. PC12 cells stop dividing and undergo terminal differentiation when treated with nerve growth factor, making the line a useful model system for neuronal differentiation. Cell Line (76-91); Clone Cells (77-87); Tumor Cells, Cultured (87-91) 3]9*VPatulin D03.383.663.670; D24.185.926.587.725; D26.191.708 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrans Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 4-Hydroxy-4H-furo(3,2-c)pyran-2(6H)-one. A mycotoxin produced by several species of Aspergillus and Penicillium. It is found in unfermented apple and grape juice and field crops. It has antibiotic properties and has been shown to be carcinogenic and mutagenic and causes chromosome damage in biological systems. Furans (66-74); Pyrans (66-74) 3`" 9@m'Pattern Recognition, Visual F02.463.593.932.869.435.673 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception; Space Perception; Form Perception Visually perceived characters, shapes, displays, or designs. 3cU! GPattern Recognition L01.725 Information Science Neural Networks (Computer) 3d  Patients' Rooms N02.278.220.640 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facility Environment Rooms occupied by one or more individuals during a stay in a health facility. The concept includes aspects of environment, design, care, or economics. Hospital Units (74-79) 3e mPatients M01.643 CLHILJPXSN Inpatients; Outpatients Named Groups (Non MeSH) Adolescent, Hospitalized; Child, Hospitalized; Inpatients; Outpatients; Patient Dropouts; Survivors CLEDHILJPXSN  3f  tPatient-Centered Care N04.590.233.675; N04.590.233.727.407; N04.590.720 CLECHILJMAMTOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Primary Health Care Health Services Administration (Non MeSH); Patient Care Management (Non MeSH) Design of patient care wherein institutional resources and personnel are organized around patients rather than around specialized departments. (From Hospitals 1993 Feb 5;67(3):14). 3g9iPatient Transfer N02.421.589.473.800 CLECHILJMAMTOGSDSNSTTDUT Transfer Agreement Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization Interfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as type of care provided. 3jPatient Simulation I02.903.525 Education; Teaching The use of persons coached to feign symptoms or conditions of real diseases in a life-like manner in order to teach or evaluate medical personnel. 3lPatient Selection H01.770.644.728.653; N04.590.731 Health Care Rationing; Clinical Protocols Physical Sciences (Non MeSH); Science; Research; Research Design Health Services Administration (Non MeSH); Patient Care Management (Non MeSH) Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols. 3m&22Patient Satisfaction F01.145.076.347.570.630; N04.452.822.360.600; N05.300.150.600.630; N05.715.360.600 ECEHLJSN Patient Acceptance of Health Care Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude to Health; Patient Acceptance of Health Care Health Services Administration (Non MeSH); Organization and Administration; Public Relations; Consumer Satisfaction Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health; Patient Acceptance of Health Care Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) The degree to which the individual regards the health care service or product or the manner in which it is delivered by the provider as useful, effective, or beneficial. Consumer Satisfaction (66-91)  3p%\ )#Patient Readmission N02.421.589.473.750 ECLJSNSTTD Patient Admission Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization Subsequent admissions of a patient to a hospital or other health care institution for treatment. Hospitalization (66-69)  3tsPatient Participation N02.421.143.262.300; N03.540.245.360.300; N05.300.150.600.620 ECHILJMTPXSNTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Consumer Participation Economics, Organizations, Control (Non MeSH); Organizations; Consumer Organizations; Consumer Participation Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health; Patient Acceptance of Health Care Patient involvement in the decision-making process in matters pertaining to health. 3uEbPatient Isolators E07.325.755 AECLCTECHISDSNSTTDUTVE Cross Infection; Environment, Controlled Equipment and Supplies; Equipment and Supplies, Hospital Equipment used to prevent contamination of and by patients, especially those with bacterial infections. This includes plastic surgical isolators and isolators used to protect immunocompromised patients. Cross Infection/prevention and control (66-67); Equipment and Supplies, Hospital (66-67); Germ-Free Life (66-67)  3x!0CPatient Isolation E02.770; G03.850.780.200.450.650 CLECHIISLJMTOGPXSNSTTDUT Cross Infection; Quarantine Therapeutics Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Infection Control The segregation of patients with communicable or other diseases for a specified time. Isolation may be strict, in which movement and social contacts are limited; modified, where an effort to control specified aspects of care is made in order to prevent cross infection; or reverse, where the patient is secluded in a controlled or germ-free environment in order to protect him or her from cross infection. Bacterial Infections/prevention and control (72-76); Cross Infection (66-76); Patient Isolators (66-76)  3zl&"zPatient Identification Systems N04.452.653 CLECHILJMAMTOGSDSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Organized procedures for establishing patient identity, including use of bracelets, etc. 3~$WgPatient Escort Service N02.360.740.400.650 CLECEDHILJOGPXSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital; Hospital Volunteers A special service provided by volunteers to accompany patients who need help in moving about the health facility. 3M{Patient Education I02.233.332.500; N02.421.143.827.407.680; N02.421.726.407.680 CLECHILJMAMTOGSNSTTD Education; Education, Nonprofessional (Non MeSH); Health Education Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Health Education Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Health Education The teaching or training of patients concerning their own health needs. 3EhVPatient Dropouts M01.643.673 CLEDHILJPXSN Attitude to Health; Patient Compliance; Treatment Refusal Named Groups (Non MeSH); Patients 3E+Patient Discharge N02.421.589.473.690 ECLJSNSTTD Hospitalization Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization The administrative process of discharging the patient, live or dead, from hospitals or other health facilities. Hospitalization (66-77)  3Patient Credit and Collection N03.219.463.030.320 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management; Accounting Accounting procedures for determining credit status and methods of obtaining payment. 3$idPatient Compliance F01.145.076.347.570.600; N05.300.150.600.600 PX Patient Dropouts; Treatment Refusal Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude to Health; Patient Acceptance of Health Care Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health; Patient Acceptance of Health Care Voluntary cooperation of the patient in following a prescribed regimen. Cooperative Behavior (71-74)  32+U"Patient Care Team N04.590.715 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH) Nursing, Team Care of patients by a multidisciplinary team usually organized under the leadership of a physician; each member of the team has specific responsibilities and the whole team contributes to the care of the patient. Nursing, Team (66-67); Progressive Patient Care (66-67) CLECHILJMTOGSNSTTDUT $3\CPatient Care Planning N04.590.233.624 CLECHILJOGSNSTTDUT Aftercare; Consumer Participation Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care Usually a written medical and nursing care program designed for a particular patient. 3)(|fPatient Care Management (Non MeSH) N04.590 Health Services Administration (Non MeSH) Comprehensive Health Care (+ 17); Delivery of Health Care (+ 10); Patient Care Team (+ 1); Patient-Centered Care; Patient Selection; Physician's Practice Patterns CLECEDHIISLJMAMTOGSDSNSTTDUT 3* 1 Patient Care Characteristics (Non MeSH) N02.421.589 Facilities, Manpower and Services (Non MeSH); Health Services Aftercare; Ambulatory Care; Critical Care (+ 2); Custodial Care; Day Care; Episode of Care; Hospitalization (+ 10); Institutionalization (+ 1); Intraoperative Care; Long-Term Care (+ 1); Night Care; Postoperative Care; Preconception Care; Preoperative Care; Respite Care; Terminal Care (+ 1) AECLCTECHIISLJMAMOMTNUOGPXRHSDSNSTTDUTVE 3 /Ja,Patient Advocacy I01.880.604.473.600; N03.706.437.600 CLECEDHILJPXSNSTTD Commitment of Mentally Ill Social Sciences; Sociology; Social Control, Formal; Human Rights Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights Right to Die Right to Die Promotion and protection of the rights of patients, frequently through a legal process. Human Rights (73-75) $3C*!"hPatient Admission N02.421.589.473.650 ECLJSNSTTD Patient Readmission Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution. Hospitalization (66-77)  3:Patient Acceptance of Health Care F01.145.076.347.570; N05.300.150.600 EHPXSN Patient Satisfaction Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude to Health Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health Patient Compliance; Patient Satisfaction; Treatment Refusal Patient Compliance; Patient Participation; Patient Satisfaction; Treatment Refusal The seeking and acceptance by patients of health service. Attitude to Health (68-74) ECEHHILJMTPXSNTDUT (3)* F!Pathology, Veterinary G02.956.465 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Veterinary Medicine The field of veterinary medicine concerned with the causes of and changes produced in the body by disease. 3/Pathology, Surgical G02.403.790.480.600 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH); Pathology A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment. 3UPathology, Oral E06.685; G02.163.876.506 CLECEDHIISLJMAMTOGSNSTTD Dentistry Health Occupations; Dentistry; Specialties, Dental A dental specialty concerned with pathology of the oral cavity. Pathology (66-69) 3GMPathology, Clinical G02.403.790.480.522 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH); Pathology A subspecialty of pathology which deals with the laboratory analysis of specimens of human blood and other fluids. Pathology (66-79) 3-UPathology Department, Hospital N02.278.354.422.535; N04.452.442.422.535 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which administers and provides pathology services. 3$. RPathology G02.403.790.480 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH) Pathology, Clinical; Pathology, Surgical A specialty concerned with the nature and cause of disease as expressed by changes in cellular or tissue structure and function caused by the disease process. 3~ G0Pathologic Processes (Non MeSH) C23.739 Symptoms and General Pathology (Non MeSH) Acantholysis; Anaplasia; Atrophy; Autolysis; Cocarcinogenesis; Constriction, Pathologic; Dilatation, Pathologic; Gliosis; Hyperostosis (+ 2); Hyperplasia (+ 1); Hypertrophy; Inflammation (+ 10); Lipomatosis; Malacoplakia; Metaplasia (+ 3); Necrosis (+ 5); Ossification, Heterotopic (+ 1); Rupture, Spontaneous; Sclerosis; Torsion; Ulcer BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI 3& 2ZPaternity I01.198.560.766 Blood Groups; DNA Fingerprinting Social Sciences; Criminology; Forensic Medicine Establishing the father relationship of a man and a child. 3 (9HPaternal Exposure G03.850.460.350.700 AECLECHILJPCSNST Maternal Exposure Maternal Exposure; Prenatal Exposure Delayed Effects Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Environmental Exposure Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. Environmental Exposure (67-94) $3r>{.$Paternal Deprivation F01.829.263.370.380 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) Prolonged separation of the offspring from the father. 3xBPaternal Behavior F01.145.688; F01.829.263.370.330 EH Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) The behavior patterns associated with or characteristic of a father. Child Psychology (66-68); Parent-Child Relations (66-68) 3&RCPaternal Age G08.520.700 Reproduction, Urogenital Physiology (Non MeSH); Reproduction Age of the father. 3GPatents I01.880.604.583.652 HILJSN Social Sciences; Sociology; Social Control, Formal; Jurisprudence Exclusive legal rights or privileges applied to inventions, plants, etc. 3k  NVPatellar Ligament A02.513.514.475; A02.835.583.512.475 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Anterior Cruciate Ligament; Medial Collateral Ligament, Knee; Posterior Cruciate Ligament Musculoskeletal System; Ligaments; Ligaments, Articular Musculoskeletal System; Skeleton; Joints; Ligaments, Articular The continuation of the central portion of the tendon of the quadriceps femoris muscle distal to the patella. It extends from the patella to the tuberosity of the tibia. (Dorland, 27th ed). Ligaments (68-93); Ligaments, Articular (68-93)  3^*:h9Patella A02.835.232.484.624 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Leg Bones (Non MeSH) 3 :VPatch-Clamp Techniques E05.909.262.800 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques A family of electrophysiologic techniques for studying cells, cell membranes, and occasionally isolated organelles. Patch clamping can resolve the behavior of single ion channels. All patch-clamp methods rely on a very high resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used. Electrophysiology (75-94); Ion Channels (78-94); Membrane Potentials (75-94) 3"^[Patch Tests E01.223.495.862.640; E01.862.640 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Skin Tests Diagnosis; Skin Tests Skin tests in which the sensitizer is applied to a patch of cotton cloth or gauze held in place for approximately 48-72 hours. It is used for the elicitation of a contact hypersensitivity reaction. 3!&"fPastoral Care F02.784.176.560; F02.880.410 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Counseling Psychologic Processes and Principles (Non MeSH); Religion and Psychology Counseling or comfort given by ministers, priests, rabbis, etc., to those in need of help with emotional problems or stressful situations. 3"Pasteurellosis, Pneumonic C01.252.400.700.662.648; C22.196.648 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections; Pasteurella Infections Animal Diseases; Cattle Diseases Bovine respiratory disease found in animals that have been shipped or exposed to cattle recently transported. It is thought to be caused by infection with the bovine paramyxovirus para-influenza 3 (or one of several other respiratory viruses), followed by infection with either PASTEURELLA MULTOCIDA or PASTEURELLA HAEMOLYTICA. 3*J|Pasteurellaceae Infections C01.252.400.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Actinobacillus Infections (+ 1); Haemophilus Infections (+ 2); Pasteurella Infections (+ 2) Infections with bacteria of the family PASTEURELLACEAE. 3PsnBPasteurellaceae B03.440.450.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods Actinobacillus (+ 2); Haemophilus (+ 2); Pasteurella (+ 2) A family of coccoid to rod-shaped nonsporeforming, gram-negative, nonmotile, facultatively anaerobic bacteria that consists of three genera - ACTINOBACILLUS, HAEMOPHILUS, and PASTEURELLA. Pasteurella (74-89)  3"XJPasteurella multocida B03.440.450.600.600.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae; Pasteurella A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally found in the flora of the mouth and respiratory tract of animals and birds. It causes shipping fever (see PASTEURELLOSIS, PNEUMONIC), HEMORRHAGIC BACTEREMIA, and intestinal disease in animals. In humans, disease usually arises from a wound infection following a bite or scratch from domesticated animals. Pasteurella (66-91) 3"zPasteurella Infections C01.252.400.700.662 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections Hemorrhagic Bacteremia; Pasteurellosis, Pneumonic Infections with bacteria of the genus PASTEURELLA. 3WP9=Pasteurella haemolytica B03.440.450.600.600.380 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae; Pasteurella A species of gram-negative, facultatively anaerobic, rod-shaped bacteria normally found in the flora of cattle and sheep. It causes mastitis in sheep and shipping fever (see PASTEURELLOSIS, PNEUMONIC) in cattle. Pasteurella (66-91) 3"zPasteurella B03.440.450.600.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae Pasteurella haemolytica; Pasteurella multocida The oldest recognized genus of the family PASTEURELLACEAE. It consists of several species. Its organisms occur most frequently as coccobacillus or rod-shaped and are gram-negative, nonmotile, facultative anaerobes. Species of this genus are found in both animals and humans. 3"k6@Passive-Aggressive Personality Disorder F03.709.597.562 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder characterized by aggressive behavior manifested in passive ways, such as pouting, procrastination, and stubbornness. These behaviors are the indirect expression of resistance to demands for adequate performance in both occupational and social functioning. 3`-Fc?Passive Cutaneous Anaphylaxis E01.223.495.862.539; E01.862.539; G04.610.143.754 DEGEIMPHRE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Skin Tests Diagnosis; Skin Tests Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. 3ƫ#9!Parvovirus, Feline B04.280.580.600.670; B04.909.204.671.600.670 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Parvoviridae; Parvovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae; Parvovirus Parvovirus, Canine Parvovirus, Canine A species of PARVOVIRUS chiefly affecting young cats in endemic areas, but all felines are susceptible, even lions and tigers. It also affects mink and raccoons. 3-2,Parvovirus, Canine B04.280.580.600.670.600; B04.909.204.671.600.670.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Parvoviridae; Parvovirus; Parvovirus, Feline Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae; Parvovirus; Parvovirus, Feline A species host range variant (subspecies) of feline parvovirus (PARVOVIRUS, FELINE) of the genus PARVOVIRUS. It causes a highly infectious fulminating enteritis in dogs producing high mortality. It is distinct from minute virus of canines, another parvovirus which is sometimes also called canine parvovirus. Parvoviridae (79-93) 3<:fParvovirus B19, Human B04.280.580.600.650; B04.909.204.671.600.650 CHCLDEENGDGEIMIPMEPHPYREUL Erythema Infectiosum Viruses; DNA Viruses; Parvoviridae; Parvovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae; Parvovirus A species of PARVOVIRUS and the etiological agent of ERYTHEMA INFECTIOSUM, a disease most commonly seen in school-age children. Parvoviridae (81-91)  32Parvovirus B04.280.580.600; B04.909.204.671.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Parvoviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae Aleutian Mink Disease Parvovirus; Minute Virus of Mice; Parvovirus B19, Human; Parvovirus, Feline (+ 1) Aleutian Mink Disease Parvovirus; Minute Virus of Mice; Parvovirus B19, Human; Parvovirus, Feline (+ 1) A genus of PARVOVIRIDAE infecting a variety of vertebrates including humans. Parvoviruses are responsible for a number of important diseases but also can be non-pathogenic in certain hosts. DNA Viruses (66-73); Parvoviridae (74-93)  3*y3Parvoviridae Infections C02.256.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Aleutian Mink Disease; Erythema Infectiosum; Feline Infectious Enteritis Virus infections caused by the PARVOVIRIDAE. Dog Diseases (66-83); Parvoviridae (81-83); Virus Diseases (66-83)  3P:U6QParvoviridae B04.280.580; B04.909.204.671 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Densovirus; Dependovirus; Parvovirus (+ 5) Dependovirus; Parvovirus (+ 5) A family of very small DNA viruses containing a single linear molecule of single-stranded DNA and consisting of three genera: DENSOVIRUS, DEPENDOVIRUS, and PARVOVIRUS. They infect both vertebrates and invertebrates. 3"YXParvalbumins D12.776.034.700; D12.776.210.500.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Low molecular weight, calcium binding muscle proteins. Their physiological function is possibly related to the contractile process. Muscle Proteins (73-76) 3*FParturient Paresis C22.695 BLCFCICLCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases A disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease, which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes. Hypocalcemia/veterinary (66-74) 3 H!%Partnership Practice, Dental N04.452.758.671.589 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Partnership Practice A voluntary contract between two or more dentists who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses. Dentistry (66-71); specific dentistry specialty; Partnership Practice (68-71) 3"[Partnership Practice N04.452.758.671 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Partnership Practice, Dental A voluntary contract between two or more doctors who may or may not share responsibility for the care of patients, with proportional sharing of profits and losses. Group Practice (66-67); Group Practice, Dental (67)  3 q"?Particle Size H01.181.529.665 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical 3 IParticle Accelerators H01.671.579.705 CLECHIISLJSDSNSTUT Radiosurgery Physical Sciences (Non MeSH); Physics; Nuclear Physics Cyclotrons; Synchrotrons Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. Fast Neutrons (71-77); Neutrons (66-77); Nuclear Medicine (67-77) $3CPPartial Thromboplastin Time E01.223.459.153.580 VE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Coagulation Tests Test of the intrinsic (factors VIII, IX, XI, and XII) and common (fibrinogen, prothrombin, factors V and X) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. It is used as a screening test and to monitor heparin therapy. Blood Coagulation Tests (66-79); Thromboplastin (66-79) 3!ZBPartial Pressure H01.671.691.714 Physical Sciences (Non MeSH); Physics; Pressure 3@;Parthenogenesis G08.520.689 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction 3GPars Planitis C11.941.160.478.700; C11.941.879.780.900.300.659; C11.941.879.900.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Choroid Diseases; Choroiditis Eye Diseases; Uveal Diseases; Uveitis; Panuveitis; Uveitis, Posterior; Choroiditis Eye Diseases; Uveal Diseases; Uveitis; Uveitis, Intermediate Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata. Uveitis (71-89) 3TMNParrots B02.248.710.672 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Psittacines Birds widely distributed in tropical regions and having a distinctive stout curved cered hooked bill whose upper mandible is movably hinged to the skull. Parrots are often crested and highly variegated and are excellent mimics. They often readily learn to simulate laughter and crying and to enunciate words and phrases. (Webster, 3d ed). 3% &'Paroxetine D03.383.621.600; D14.100.600.850.700; D14.100.850.875.800.700; D15.085.025.650; D15.700.122.050.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation trans-(-)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine. A serotonin uptake inhibitor that is effective in the treatment of depression. Dioxolanes (78-82); Piperidines (82-92) 3Bo:0Parovarian Cyst C04.182.668; C13.371.056.739 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases A cyst of the epoophoron or parovarium, a vestigial structure associated with the ovary, consisting of a more cranial group of mesonephric tubules and a corresponding portion of the mesonephric duct. (From Dorland, 27th ed). 3"V Parotitis C07.465.815.470.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Parotid Diseases Mumps Inflammation of the parotid gland. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  3  Na +PParotin D06.472.664 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Hormones (66-71) 3 DBParotid Neoplasms C04.588.443.591.824.695; C07.465.565.824.695; C07.465.815.470.770; C07.465.815.718.589 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms; Salivary Gland Neoplasms Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Parotid Diseases Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Salivary Gland Neoplasms 3e`XParotid Gland A10.336.779.464; A14.549.760.464 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Exocrine Glands; Salivary Glands Stomatognathic System; Mouth; Salivary Glands 3&:|Parotid Diseases C07.465.815.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases Parotid Neoplasms; Parotitis (+ 1) Parotid Gland (66-79); Salivary Gland Diseases (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  3NL+BZParonychia C01.252.825.610; C01.539.624; C01.539.800.720.610; C17.800.805.506.639; C17.800.838.765.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Nail Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Inflammation involving the folds of tissue surrounding the nail. (Dorland, 27th ed). 3gPfParomomycin D09.203.408.051.623.635; D20.085.060.550.635; D21.370.107.635 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Neomycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Neomycin Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides O-2-Amino-2-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-D-streptamine. An oligosaccharide antibiotic produced by various Streptomyces. 3'E<Parkinson Disease, Symptomatic C10.228.140.079.804.832 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases; Parkinson Disease Parkinson Disease, Postencephalitic Symptoms of PARKINSON DISEASE induced by drugs, or following cerebral arteriosclerosis, brain tumor, or other central nervous system disorders except encephalitis, which is PARKINSON DISEASE, POSTENCEPHALITIC. Parkinson Disease (66-72)  4$N)Parkinson Disease, Postencephalitic C10.228.140.079.804.832.751; C10.228.140.437.739; C10.228.228.245.739 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Encephalitis, Epidemic Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases; Parkinson Disease; Parkinson Disease, Symptomatic Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis A form of PARKINSON DISEASE due to degeneration of the corpus striatum or substantia nigra, frequently occurring as a sequel of lethargic encephalitis. The early age of onset, the rapid progression of symptoms and signs of stabilization, and the presence of a variety of other neurological disorders (sociopathic behavior, tics, spasms, oculogyric crises and other restricted motor disorders, breathing arrhythmias, hyperphagia, and bizarre movements, postures, and gaits) distinguish this disease from the one described by Parkinson. (From Adams and Victor, Principles of Neurology, 5th ed, p. 978). Parkinson Disease (66)  4T)MNParkinson Disease C10.228.140.079.804 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antiparkinson Agents; Lewy Bodies Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Parkinson Disease, Symptomatic (+ 1) Progressive, degenerative disease of unknown etiology characterized by rhythmic tremor of the limbs, stooped posture, slowness of voluntary movements, and masklike facial expression. Pathologically there is nerve cell loss in the melanin-containing cells in the brainstem and a corresponding reduction in dopamine levels in the corpus striatum. Lewy bodies are present in the substantia nigra and locus coeruleus. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $4L)r,NParking Facilities J01.086.339.490 ECLJSNST Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction Indoor or outdoor areas designated for the parking of vehicles. 4 a lMParity G08.520.615 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction A female's status with respect to the number of live offspring she has borne. It is contrasted with gravidity, which refers to the number of pregnancies, regardless of outcome. 4 s GParis Z01.542.286.588; Z01.433.800 EHEP Geographicals (Non MeSH); Europe; France Geographicals (Non MeSH); Cities (Non MeSH) 4 "gParietal Lobe A08.186.211.730.885.213.670 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex Somatosensory Cortex Upper central part of the cerebral hemisphere. 48o9Parietal Cells, Gastric A03.492.766.440.708; A11.436.708 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Gastric Acid; Intrinsic Factor Digestive System; Gastrointestinal System; Stomach; Gastric Mucosa Cells; Epithelial Cells (Non MeSH) Cells of the gastric glands which secrete hydrochloric acid and intrinsic factor. Gastric Acid (81-83); Gastric Juice (66-83); Gastric Mucosa (66-83); Stomach (66-83)  4&*&xahParietal Bone A02.835.232.781.651 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull 4:DPargyline D02.092.200.650; D02.455.426.559.389.140.210.650; D08.373.616.638; D18.162.653 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Benzylamines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzyl Compounds; Benzylamines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Cardiovascular Agents; Antihypertensive Agents A monoamine oxidase inhibitor with antihypertensive properties. 4 X:JParesthesia C10.597.751.670; C23.888.592.763.587 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Restless Legs Restless Legs A condition in which abnormal sensations, such as prickling, burning, tingling, etc., are experienced. 4R*N"xParesis C10.597.636; C23.888.592.643 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations A slight loss of motor function, as contrasted with PARALYSIS which is a severe loss. In older literature paresis often referred specifically to paretic neurosyphilis (see NEUROSYPHILIS) and "general paresis" and "general paralysis" may still carry that connotation. 4z "P5Parents F01.829.263.500.320; I01.880.225.500.340; M01.620 EDPX Child of Impaired Parents; Single Parent Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family Social Sciences; Sociology; Family; Nuclear Family Named Groups (Non MeSH) Fathers; Mothers; Single Parent; Surrogate Mothers Fathers; Mothers; Single Parent; Surrogate Mothers Fathers; Mothers; Single Parent; Surrogate Mothers Persons functioning as natural, adoptive, or substitute parents. The heading includes the concept of parenthood as well as preparation for becoming a parent. Family (66) CLEDHILJPXSN (4 92Parenting F01.829.263.370.310 EHHIPXTD Child Rearing Child Rearing Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) Performing the role of a parent by care-giving, nurturance, and protection of the child by a natural or substitute parent. The parent supports the child by exercising authority and through consistent, empathic, appropriate behavior in response to the child's needs. PARENTING differs from CHILD REARING in that in child rearing the emphasis is on the act of training or bringing up the children and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent. Child Rearing (70-91); Parent-Child Relations (70-91) $4  xw@Parenteral Nutrition, Total E02.421.505.575; E02.707.505.750 AECLCTECHIISMOMTNUPXSNSTTDUTVE Protein Hydrolysates Therapeutics; Feeding Methods (Non MeSH); Parenteral Nutrition Therapeutics; Nutritional Support; Parenteral Nutrition Parenteral Nutrition, Home Total Parenteral Nutrition, Home Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins.  4!!&"LParenteral Nutrition, Home Total E02.421.505.550.565; E02.421.505.575.565; E02.707.505.550.565; E02.707.505.750.565; N02.421.143.524.650.565 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Feeding Methods (Non MeSH); Parenteral Nutrition; Parenteral Nutrition, Home Therapeutics; Feeding Methods (Non MeSH); Parenteral Nutrition; Parenteral Nutrition, Total Therapeutics; Nutritional Support; Parenteral Nutrition; Parenteral Nutrition, Home Therapeutics; Nutritional Support; Parenteral Nutrition; Parenteral Nutrition, Total Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services; Parenteral Nutrition, Home The at-home administering of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously or by some other non-alimentary route. Home Care Services (74-91); Home Nursing (77-91); Parenteral Nutrition (74-91); Parenteral Nutrition, Total (75-91) 4%3'w"3Parenteral Nutrition, Home E02.421.505.550; E02.707.505.550; N02.421.143.524.650 AECLCTECHIISMOMTNUPXSNSTTDUTVE Home Infusion Therapy Therapeutics; Feeding Methods (Non MeSH); Parenteral Nutrition Therapeutics; Nutritional Support; Parenteral Nutrition Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services Parenteral Nutrition, Home Total Parenteral Nutrition, Home Total Parenteral Nutrition, Home Total The at-home administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered via a route other than the alimentary canal (e.g., intravenously, subcutaneously). Parenteral Feeding (74-90) $4) =" q, Parenteral Nutrition E02.421.505; E02.707.505 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fat Emulsions, Intravenous Therapeutics; Feeding Methods (Non MeSH) Therapeutics; Nutritional Support Parenteral Nutrition, Home (+ 1); Parenteral Nutrition, Total (+ 1) Parenteral Nutrition, Home (+ 1); Parenteral Nutrition, Total (+ 1) The administering of nutrients for assimilation and utilization by a patient who cannot maintain adequate nutrition by enteral feeding alone. Nutrients are administered by a route other than the alimentary canal (e.g., intravenously, subcutaneously).  4-]" W"Parental Leave N01.824.417.700.162.500; N04.452.677.800.162.500 CLECHILJSNSTTDUT Population Characteristics (Non MeSH); Socioeconomic Factors; Income; Salaries and Fringe Benefits; Family Leave Health Services Administration (Non MeSH); Organization and Administration; Personnel Management; Salaries and Fringe Benefits; Family Leave The authorized absence from work of either parent prior to and after the birth of their child. It includes also absence because of the illness of a child or at the time of the adoption of a child. It does not include leave for care of siblings, parents, or other family members: for this FAMILY LEAVE is available. Pregnancy (78-90); Salaries and Fringe Benefits (81-90) 406'zCParent-Child Relations F01.829.263.370.290 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) Father-Child Relations; Mother-Child Relations The interactions between parent and child. 43x64Paraventricular Hypothalamic Nucleus A08.186.211.730.385.357.342.400 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Anterior Nucleus in the anterior part of the hypothalamus. 44*#8=Paratyphoid Fever C01.252.400.310.821.438 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections; Salmonella Infections A prolonged febrile illness commonly caused by serotypes of Salmonella paratyphi. It is similar to typhoid fever but less severe. 46/PParatuberculosis C01.252.410.040.552.588; C22.688 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections Animal Diseases An infectious disease caused by MYCOBACTERIUM PARATUBERCULOSIS. Characteristics include chronic debilitation and weight loss. 48&JParathyroidectomy E04.779.694 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Parathyroid Glands Surgery, Operative; Surgery, Endocrine (Non MeSH) Excision of one or both of the parathyroid glands. Parathyroid Glands/surgery (66-90)  4:$;?)Parathyroid Neoplasms C04.588.322.525; C19.344.525; C19.642.713 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms Endocrine Diseases; Parathyroid Diseases 4;A1XParathyroid Hormones D06.472.638 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hypoparathyroidism Hormones, Substitutes, Antagonists (Non MeSH); Hormones 4<BBParathyroid Glands A06.407.560 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Parathyroidectomy Endocrine System (Non MeSH); Endocrine Glands Two small paired endocrine glands in the region of the thyroid gland. They secrete parathyroid hormone and are concerned with the metabolism of calcium and phosphorus. 4=:8Parathyroid Diseases C19.642 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases Hyperparathyroidism (+ 2); Hypoparathyroidism (+ 1); Parathyroid Neoplasms BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI 4?5 NYXParathion D02.719.746; D05.723.491.657.763 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Methyl Parathion Methyl Parathion 4@ &:(Parasystole C14.280.067.672 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia A cardiac arrhythmia caused by the interaction of two foci independently initiating cardiac impulses at different rates. Generally one of the foci is the sinoatrial node (the normal pacemaker) and the ectopic focus is usually in the ventricle, but can occur in the sinus and AV nodes, atrium and ventricle, and AV junction. Each focus - and thus each rhythm - is protected from the influence of the other. Arrhythmia (66-93) 4BN=Parasympathomimetics D16.050.675 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cholinesterase Inhibitors; Muscarinic Agonists Parasympathetic Nervous System; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Acetylcholine; Ambenonium Chloride; Arecoline; Bethanechol; Carbachol; Echothiophate Iodide; Edrophonium; Galanthamine; Isoflurophate; Methacholine Chloride; Muscarine; Neostigmine; Physostigmine; Pyridostigmine Bromide; Tacrine Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (4D86/JDParasympatholytics D16.050.650 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Ulcer Agents; Antiparkinson Agents; Muscarinic Antagonists Parasympathetic Nervous System; Muscarinic Antagonists; Solanaceous Alkaloids Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Atropine; Benactyzine; Benztropine; Biperiden; Butylscopolammonium Bromide; Cyclopentolate; Dexetimide; Dicyclomine; Emepronium; Flavoxate; Glycopyrrolate; Ipratropium; Orphenadrine; Oxyphenonium; Papaverine; Pirenzepine; Procyclidine; Propantheline; Scopolamine; Trihexyphenidyl; Tropicamide Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (4I)8JYJQ@Parasympathetic Nervous System A08.800.050.600 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Parasympathectomy; Parasympatholytics; Parasympathomimetics Nervous System; Peripheral Nervous System; Autonomic Nervous System Ganglia, Parasympathetic; Parasympathetic Fibers, Postganglionic; Vagus Nerve (+ 3) The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $4L$6CPa8Parasympathetic Fibers, Postganglionic A08.663.542.100.700; A08.663.542.234.700; A08.800.050.050.050.700; A08.800.050.600.650; A08.800.800.060.050.700; A11.671.078.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Nerve Fibers; Autonomic Fibers, Postganglionic Nervous System; Neurons; Nerve Fibers; Cholinergic Fibers Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways; Autonomic Fibers, Postganglionic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Parasympathetic Nervous System Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways; Autonomic Fibers, Postganglionic Cells; Neurons; Autonomic Fibers, Postganglionic Nerve fibers which project from parasympathetic ganglia to synapses on target organs. Parasympathetic postganglionic fibers use acetylcholine as transmitter. They may also release peptide cotransmitters. Autonomic Fibers, Postganglionic (71-93); Ganglia, Autonomic (66-70) 4P,8QPParasympathectomy E04.530.324.084.700 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Parasympathetic Nervous System Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation Vagotomy (+ 2) The removal or interruption of some part of the parasympathetic nervous system for therapeutic or research purposes.  4UM$$PParasitology G01.273.688 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology Food Parasitology Parasites (66); Parasitic Diseases (66) 4V#1Parasitic Diseases, Animal (Non MeSH) C03.701; C22.674 Parasitic Diseases Animal Diseases Babesiosis; Helminthiasis, Animal (Non MeSH) (+ 7); Protozoan Infections, Animal (Non MeSH) (+ 6) Helminthiasis, Animal (Non MeSH) (+ 7); Protozoan Infections, Animal (Non MeSH) (+ 6) BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI 4W-)JParasitic Diseases C03 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Ectoparasitic Infestations (+ 8); Eye Infections, Parasitic (+ 3); Helminthiasis (+ 72); Intestinal Diseases, Parasitic (+ 7); Liver Diseases, Parasitic (+ 3); Lung Diseases, Parasitic (+ 1); Opportunistic Infections (+ 2); Parasitemia; Parasitic Diseases, Animal (Non MeSH) (+ 16); Pregnancy Complications, Parasitic; Protozoan Infections (+ 56); Skin Diseases, Parasitic (+ 7); Zoonoses Infections or infestations with parasitic organisms. They are often contracted through contact with an intermediate vector, but may occur as the result of direct exposure. 4YXPParasites B01.714 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Anthelmintics; Anti-Infective Agents; Antiprotozoal Agents; Food Parasitology; Host-Parasite Relations Invertebrates 4\  *vParasitemia C01.539.757.720.595; C03.695 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia Parasitic Diseases The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed). specific organism (66-94); specific parasitic disease/blood (66-94) 4]o"PlnPParasite Egg Count E01.223.640 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory Ovum (66-70); Parasites (66-70); specific parasite; specific specimen 4_A"'UParaquat D03.383.725.762.621; D05.723.366.656 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Herbicides (66-70); Pyridinium Compounds (68-70) 4`) *::Parapsychology F02.607; F04.096.462 CLECEDHIISLJMAMTOGSNSTTD Telepathy Psychologic Processes and Principles (Non MeSH) Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Telepathy Branch of psychology that deals with paranormal behavior and events such as telepathy, precognition, and clairvoyance, which are not explicable by present day "natural laws". CLDEECEDHIISLJMAMTOGPHRESNSTTD $4a "Parapsoriasis C17.800.859.575 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous Pityriasis Lichenoides (+ 1) The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis). 4cNn#Paraproteins D12.776.124.486.485.900; D12.776.124.790.651.900; D12.776.377.715.548.900 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Bence Jones Protein; Cryoglobulins; Myeloma Proteins; Pyroglobulins Bence Jones Protein; Cryoglobulins; Myeloma Proteins; Pyroglobulins Bence Jones Protein; Cryoglobulins; Myeloma Proteins; Pyroglobulins Abnormal immunoglobulins synthesized by atypical cells of the reticuloendothelial system. Paraproteins containing only light chains lead to Bence Jones paraproteinemia, while the presence of only atypical heavy chains leads to heavy chain disease. Most of the paraproteins show themselves as an M-component (monoclonal gammopathy) in electrophoresis. Diclonal and polyclonal paraproteins are much less frequently encountered. specific immunoglobulin (66-75); Blood Protein Disorders (66-75); Immunoglobulins (70-75) AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $4gQD|iFParaproteinemias C15.378.147.780; C20.683.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunoglobulins Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders Immunologic Diseases; Immunoproliferative Disorders Amyloidosis (+ 2); Cryoglobulinemia; Heavy Chain Disease (+ 1); Multiple Myeloma; POEMS Syndrome; Waldenstrom's Macroglobulinemia Amyloidosis (+ 2); Cryoglobulinemia; Heavy Chain Disease (+ 1); Monoclonal Gammopathies, Benign; Multiple Myeloma; POEMS Syndrome; Waldenstrom's Macroglobulinemia A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. specific immunoglobulin (71-75); Blood Protein Disorders (66-75); Immunoglobulins (70-75) $4l"NW=iParapoxvirus B04.280.650.160.670; B04.909.204.783.160.670 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Orf Virus; Pseudocowpox Virus Orf Virus; Pseudocowpox Virus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, which infect ungulates and may infect humans. ORF VIRUS is the type species. Poxviridae (78-93)  4q82HParaplegia C10.597.622.669; C23.888.592.636.637 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Brown-Sequard Syndrome Brown-Sequard Syndrome Paralysis of the legs and lower part of the body. (Dorland, 27th ed). 4sc*N4XParaphimosis C12.294.494.684.587 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases; Phimosis Retraction of phimotic foreskin, causing a painful swelling of the glans that, if severe, may cause dry gangrene unless corrected. (Dorland, 27th ed). 4ufNtParaphilias F03.709.597.608.700 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Sex Offenses Impulse Control Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders Exhibitionism; Fetishism (Psychiatric); Masochism; Pedophilia; Sadism; Transvestism; Voyeurism Abnormal sexual behavior manifested by unusual or bizarre imagery or acts that are necessary for sexual excitement. They tend to be involuntarily repetitive. $4w%F~pParaparesis, Tropical Spastic C02.782.815.483.470.710; C05.651.661.788; C10.597.622.602; C10.668.802 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; HTLV-BLV Infections; HTLV-I Infections Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neurologic Manifestations; Paralysis Nervous System Diseases; Neuromuscular Diseases Subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by type I human lymphotropic retrovirus (HTLV-I). Toxic nutritional factors have largely been ruled out as the cause of this syndrome, the primary clinical feature of which is progressive weakness of the legs and lower body. HTLV Infections (87-88); Human T-Cell Leukemia Virus (85-88); Paralysis (84-88); Paraplegia (83-88); Retrovirus Infections (85-86) 4y#PPMParaoxon D02.705.569; D05.723.491.574.670 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate Insecticides (66-71) 4~Z &:Paranoid Personality Disorder F03.709.597.508 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder characterized by the avoidance of accepting deserved blame and an unwarranted view of others as malevolent. The latter is expressed as suspiciousness, hypersensitivity, and mistrust. 4#FcParanoid Disorders F03.709.680.700 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders Shared Paranoid Disorder Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state. 4FabParanoid Behavior F01.145.672; F03.126.680 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Behavior exhibited by individuals who are overly suspicious. They do not have the constellation of symptoms characteristic of a paranoid personality disorder or a paranoid psychosis. Paranoid Disorders (66-78); Paranoid Personality Disorder (69-78) 4#FMParaneoplastic Syndromes C04.730 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms Neoplastic Endocrine-Like Syndromes (+ 2) In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. 4~ N 1Paranasal Sinuses A04.531.621 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Respiratory System; Nose Ethmoid Sinus; Frontal Sinus; Maxillary Sinus; Sphenoid Sinus Air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones. They vary in size and form in different individuals and are lined by the ciliated mucous membranes of the nasal cavity. 4#8K(Paranasal Sinus Neoplasms C04.588.443.665.650.693; C08.460.669.693; C08.460.692.503; C08.785.600.693; C09.603.669.693; C09.603.692.503; C09.647.685.693 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Nose Neoplasms Respiratory Tract Diseases; Nose Diseases; Nose Neoplasms Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases Respiratory Tract Diseases; Respiratory Tract Neoplasms; Nose Neoplasms Otorhinolaryngologic Diseases; Nose Diseases; Nose Neoplasms Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Nose Neoplasms Maxillary Sinus Neoplasms Maxillary Sinus Neoplasms Maxillary Sinus Neoplasms Maxillary Sinus Neoplasms Maxillary Sinus Neoplasms Maxillary Sinus Neoplasms Maxillary Sinus Neoplasms Neoplasms or tumors of the paranasal sinuses. Malignant neoplasms are rare, comprising 3% of all head and neck neoplasms. The majority arise in the maxillary sinus with malignancies of the ethmoid sinus constituting virtually all the remaining tumors. 49XT'Paranasal Sinus Diseases C08.460.692; C09.603.692 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Otorhinolaryngologic Diseases; Nose Diseases Paranasal Sinus Neoplasms (+ 1); Sinusitis (+ 4) Paranasal Sinus Neoplasms (+ 1); Sinusitis (+ 4) Diseases affecting or involving the PARANASAL SINUSES and generally manifesting as inflammation, abscesses, cysts, or tumors. Paranasal Sinuses (66-76) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $4NdxXParamyxoviruses, Avian B04.820.455.600.650.700.720; B04.909.777.455.600.650.700.720 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus Newcastle Disease Virus Newcastle Disease Virus A group of viruses in the genus PARAMYXOVIRUS causing disease in domestic fowl. There are many serotypes, the most well-known being avian paramyxovirus type 1 (NEWCASTLE DISEASE VIRUS), the type species of Paramyxovirus. Paramyxoviridae (75-93)  4IB8Paramyxovirus Infections C02.782.580.600.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections Mumps; Newcastle Disease; Parainfluenza Infections with viruses of the genus PARAMYXOVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via hemagglutinin, to the cell surface. Orthomyxovirus Infections (66-76)  43Py0'Paramyxovirus B04.820.455.600.650.700; B04.909.777.455.600.650.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae Mumps Virus; Parainfluenza Viruses (+ 3); Paramyxoviruses, Avian (+ 1) Mumps Virus; Parainfluenza Viruses (+ 3); Paramyxoviruses, Avian (+ 1) A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the virions have both hemagglutinin and neuraminidase activities. NEWCASTLE DISEASE VIRUS is the type species. Paramyxoviridae (67-93)  4i:Paramyxovirinae B04.820.455.600.650; B04.909.777.455.600.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae Morbillivirus (+ 6); Paramyxovirus (+ 7) Morbillivirus (+ 6); Paramyxovirus (+ 7) A subfamily of PARAMYXOVIRIDAE containing two genera: PARAMYXOVIRUS and MORBILLIVIRUS. 4f2ddParamyxoviridae Infections C02.782.580.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections Morbillivirus Infections (+ 4); Paramyxovirus Infections (+ 3); Pneumovirus Infections (+ 1) Infections with viruses of the family PARAMYXOVIRIDAE. This includes MORBILLIVIRUS INFECTIONS, PARAMYXOVIRUS INFECTIONS, and PNEUMOVIRUS INFECTIONS. Paramyxovirus Infections (77-93)  4]PZo&Paramyxoviridae B04.820.455.600; B04.909.777.455.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales Paramyxovirinae (+ 15); Pneumovirinae (+ 4) Paramyxovirinae (+ 15); Pneumovirinae (+ 4) A family of spherical viruses, of the order MONONEGAVIRALES, somewhat larger than the orthomyxoviruses, and containing single-stranded RNA. Subfamilies include PARAMYXOVIRINAE and PNEUMOVIRINAE. Orthomyxoviridae (66-70)  4*jParamyoclonus Multiplex C05.651.536.587; C10.668.797 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Myoclonus Nervous System Diseases; Neuromuscular Diseases A condition occurring more often in males than in females, characterized by sudden shocklike contractions affecting first the proximal muscles of the arms and the shoulder girdle, with any muscles of the limbs and trunk being involved later, and finally involving the face and bulbar muscles. (Dorland, 27th ed). 4 "NvoParamphistomatidae B01.500.736.715.600 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda A family of flukes of the class Trematoda found in the intestinal tract and liver of animals and man. Some of the genera are Homalagaster, Gastrodiscus, Paramphistomum, Watsonius, Nilocotyle, Gigantocotyle, Gastrothylax, Macropotrema, Ceylonocotyle, Zygocotyle, Cotylophoron, and Calicophoron. Trematoda (66-81) 4*=OParametritis C13.371.056.114.587 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Adnexitis Inflammation of the parametrium, the extension of the subserous coat of the supracervical portion of the uterus laterally between the layers of the broad ligament. (From Dorland, 27th ed). 4NParamethasone D04.808.745.432.769.692; D04.808.908.727; D06.597.481.561.353.649; D06.597.481.561.478.614; D17.025.050.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.737). 4w:Paramecium tetraurelia B01.841.185.650.375.550.637.700 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida; Peniculina; Paramecium A species of ciliate protozoa. It is used in biomedical research. Paramecium (76-91) 4#&oQParamecium B01.841.185.650.375.550.637 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea; Hymenostomatida; Peniculina Paramecium tetraurelia A genus of ciliate protozoa that is often large enough to be seen by the naked eye. Paramecia are commonly used in genetic, cytological, and other research. 4&aParalysis, Obstetric C16.614.131.587; C21.866.141.587 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Birth Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Birth Injuries Paralysis of an infant resulting from injury received at birth. (From Dorland, 27th ed). 42&LlParalysis, Familial Periodic C05.651.661.780; C10.668.780; C18.452.648.618.711 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors An autosomal dominant trait marked by recurring attacks of rapidly progressive flaccid paralysis. There are three types: I, associated with a fall in serum potassium levels (hypokalemic periodic paralysis); II, associated with a rise therein (hyperkalemic periodic paralysis, called also adynamia episodica hereditaria); and III, with normal levels (normokalemic periodic paralysis). (Dorland, 27th ed). 4"9NParalysis, Bulbar C10.597.622.502; C23.888.592.636.502 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis A paralysis resulting from changes in the motor centers of the medulla oblongata. It is chronic, usually fatal, and most commonly occurring in persons over 50 years old. 4*NParalysis C10.597.622; C23.888.592.636 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Facial Paralysis (+ 1); Gastroparesis; Hemiplegia; Ophthalmoplegia (+ 5); Paralysis, Bulbar; Paraparesis, Tropical Spastic; Paraplegia (+ 1); Quadriplegia; Respiratory Paralysis; Vocal Cord Paralysis Facial Paralysis (+ 1); Gastroparesis; Hemiplegia; Ophthalmoplegia (+ 5); Paralysis, Bulbar; Paraplegia (+ 1); Quadriplegia; Respiratory Paralysis; Vocal Cord Paralysis Loss or impairment of motor function in a part due to a lesion of the neural or muscular mechanism. (From Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  4 "NPParaldehyde D02.047.064.586; D15.080.580; D15.210.350.800.675; D15.325.875.612 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes; Acetaldehyde Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate A hypnotic and sedative with anticonvulsant effects. However, because of the hazards associated with its administration, its tendency to react with plastic, and the risks associated with its deterioration, it has largely been superseded by other agents. It is still occasionally used to control status epilepticus resistant to conventional treatment. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.608-9). 4 L:YParakeratosis C17.800.428.736 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Persistence of the nuclei of the keratinocytes into the stratum corneum of the skin. This is a normal state only in the epithelium of true mucous membranes in the mouth and vagina. (Dorland, 27th ed). 4NXParakeets B02.248.710.503 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Psittacines 4 &'Parainfluenza Viruses B04.820.455.600.650.700.700; B04.909.777.455.600.650.700.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus Parainfluenza Virus Type 1; Parainfluenza Virus Type 2; Parainfluenza Virus Type 3 Parainfluenza Virus Type 1; Parainfluenza Virus Type 2; Parainfluenza Virus Type 3 A group of viruses in the genus PARAMYXOVIRUS causing mainly respiratory tract diseases in a variety of vertebrates including humans. 4cBParainfluenza Virus Type 3 B04.820.455.600.650.700.700.735; B04.909.777.455.600.650.700.700.735 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus; Parainfluenza Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus; Parainfluenza Viruses A species of PARAMYXOVIRUS frequently isolated from small children with pharyngitis, bronchitis, and pneumonia, as well as from domestic animals. It has been associated with SHIPPING FEVER in cattle. 4R!J!Parainfluenza Virus Type 2 B04.820.455.600.650.700.700.725; B04.909.777.455.600.650.700.700.725 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus; Parainfluenza Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus; Parainfluenza Viruses A species of PARAMYXOVIRUS associated particularly with acute laryngotracheitis (croup) in children aged 6 months to 3 years. 4!J!Parainfluenza Virus Type 1 B04.820.455.600.650.700.700.715; B04.909.777.455.600.650.700.700.715 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus; Parainfluenza Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus; Parainfluenza Viruses A species of PARAMYXOVIRUS that includes the Sendai strain, which causes pneumonia in mice and pigs, and the hemadsorption virus 2 (HA2), which causes laryngotracheitis in man, especially children. 4h!J!Parainfluenza C02.782.580.600.600.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections; Paramyxovirus Infections A group of respiratory infections caused by four serologically distinct strains of PARAMYXOVIRUS. Only type 4 is known to infect humans. 4PParaguay Z01.107.757.656 EHEP Geographicals (Non MeSH); America; South America 4 <Paragonimus B01.500.736.715.800.610 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Troglotrematidae (Non MeSH) A genus of lung flukes of the family Troglotrematidae. This genus consists of several species one of which is P. westermani, a common lung fluke in man. Members of this and other species also occur in other mammals. 4u*^Paragonimiasis C03.335.865.741 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections Infection with trematodes of the genus PARAGONIMUS. (Dorland, 27th ed). 4MPAWParaganglioma, Extra-Adrenal C04.557.465.625.650.700.705; C04.557.580.625.650.700.705 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma Carotid Body Tumor; Glomus Jugulare Tumor; Glomus Tumor Carotid Body Tumor; Glomus Jugulare Tumor; Glomus Tumor A relatively rare, usually benign neoplasm originating in the chemoreceptor tissue of the carotid body, glomus jugulare, and aortic bodies. It consists histologically of rounded or ovoid hyperchromatic cells that tend to be grouped in an alveolus-like pattern within a scant to moderate amount of fibrous stroma and a few large thin-walled vascular channels. They are uncommon before the age of 20, with a female predominance in some series. (Stedman, 25th ed; from DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). 4}!>XMvParaganglioma C04.557.465.625.650.700; C04.557.580.625.650.700 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors Paraganglioma, Extra-Adrenal (+ 3); Pheochromocytoma Paraganglioma, Extra-Adrenal (+ 3); Pheochromocytoma A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Dictionary of Modern Medicine, 1992). 4פ6X+zeParaganglia, Nonchromaffin A08.800.550.700.120.600 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Chemoreceptors Aortic Bodies; Carotid Body; Glomus Jugulare Several clusters of chemoreceptive and supporting cells associated with blood vessels and nerves (especially the glossopharyngeal and vagus). The nonchromaffin paraganglia sense pH, carbon dioxide, and oxygen concentrations in the blood and participate in respiratory, and perhaps circulatory, control. They include the carotid and aortic bodies, the glomus jugulare, and the glomus tympanicum. 4t8m7Paraganglia, Chromaffin A06.224.736 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Endocrine System (Non MeSH); Chromaffin System Small bodies containing chromaffin cells occurring outside of the adrenal medulla, most commonly near the sympathetic ganglia and in organs such as the kidney, liver, heart and gonads. 4w*9Paraffin Embedding E05.909.262.620.720.610; E05.909.432.600.720.610 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Tissue Embedding Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Tissue Embedding The infiltrating of tissue specimens with paraffin, as a supporting substance, to prepare for sectioning with a microtome. Paraffin (66-91) 46?Paraffin D26.698.636; J01.637.680.636 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH); Petroleum A mixture of solid hydrocarbons obtained from petroleum; used as stiffening agent in ointments, as lubricant and topical anti-inflammatory. Synonyms: Cosmolloids; Gloken. 4p ".Paracoccus denitrificans B03.440.400.425.600.380 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Paracoccus A species of bacteria isolated from soil. Micrococcus (66-71) 4Z"4Paracoccus B03.440.400.425.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Paracoccus denitrificans Gram-negative non-motile bacteria found in soil or brines. Micrococcus (66-75)  4"FParacoccidioidomycosis C01.539.800.200.600; C01.703.295.600; C01.703.700; C17.800.838.208.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses A mycosis affecting the skin, mucous membranes, lymph nodes, and internal organs. It is caused by Paracoccidioides brasiliensis. It is also called paracoccidioidal granuloma. Blastomycosis (66-74) 4+PPrParacoccidioides B05.354.381.546.648 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus. P. brasiliensis is the etiologic agent of PARACOCCIDIOIDOMYCOSIS. Phycomycetes (66-71) 4d"NrParabiosis E05.660 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Cross Circulation The experimental joining of two individuals for the purpose of studying the effects of one on the other. 4 "*~Parabens D02.241.223.106.505.600; D02.241.511.390.600; D02.755.410.600; D26.698.586 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Benzoates (66-70) 4 T,sPara-Aortic Bodies A06.224.636 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Endocrine System (Non MeSH); Chromaffin System Small masses of chromaffin cells found near the sympathetic ganglia along the abdominal aorta. They serve as chemoreceptors responsive to oxygen, carbon dioxide, and hydrogen ion concentration, and help to control respiration. 4 *9Papua New Guinea Z01.782.590.715 EHEP Geographicals (Non MeSH); Pacific Islands; Melanesia A country consisting of the eastern half of the island of New Guinea and adjacent islands, including New Britain, New Ireland, the Admiralty Islands, and New Hanover in the Bismarck Archipelago; Bougainville and Buka in the northern Solomon Islands; the D'Entrecasteaux and Trobriand Islands; Woodlark (Murua) Island; and the Louisiade Archipelago. It became independent on September 16, 1975. Formerly, the southern part was the Australian Territory of Papua, and the northern part was the UN Trust Territory of New Guinea, administered by Australia. They were administratively merged in 1949 and named Papua and New Guinea, and renamed Papua New Guinea in 1971. New Guinea (66-81) 4@Papovaviridae Infections C02.256.690 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Warts (+ 2) Virus diseases caused by the PAPOVAVIRIDAE. This includes both papillomavirus infections and polyomavirus infections. Tumor Virus Infections (66-93)  4tP:%Papovaviridae B04.280.570; B04.909.204.210.711; B04.909.204.585; B04.909.574.204.711 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses Papillomavirus (+ 3); Polyomavirus (+ 3) Papillomavirus (+ 3); Polyomavirus (+ 3) Papillomavirus (+ 3); Polyomavirus (+ 3) Papillomavirus (+ 3); Polyomavirus (+ 3) A family of small, non-enveloped DNA viruses affecting mostly mammals. Most members can induce tumors in hosts. There are two genera: PAPILLOMAVIRUS and POLYOMAVIRUS. 4P Papio B02.649.801.400.130.120.610 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of seven named species: P. ursinus (chacma baboon), P. cynocephalus (yellow baboon), P. papio (western or Guinea baboon), P. anubis (anubis or olive baboon), P. hamadryas (hamadryas or sacred baboon), P. sphinx (mandrill), and P. leucophaeus (drill). Some authors have recognized a separate genus for the drill and mandrill: Mandrillus. The Papio genus is geographically distributed throughout east and west Africa, Arabia, Egypt, and the Sudan. 4L (ZbPapillon-Lefevre Disease C17.800.428.435.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Keratoderma, Palmoplantar Rare, autosomal recessive disorder occurring between the first and fifth years of life. It is characterized by palmoplantar keratoderma with periodontosis followed by the premature shedding of both deciduous and permanent teeth. 4{Nv Papillomavirus, Human B04.280.570.460.690; B04.909.204.210.711.460.690; B04.909.204.585.460.690; B04.909.574.204.711.460.690 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae; Papillomavirus A species of PAPILLOMAVIRUS causing warts in humans. These benign, squamous epithelial tumors can sometimes progress to malignancy. Papillomavirus (75-93) 4pPapillomavirus, Bovine B04.280.570.460.650; B04.909.204.210.711.460.650; B04.909.204.585.460.650; B04.909.574.204.711.460.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae; Papillomavirus A species of PAPILLOMAVIRUS producing large numbers of warts on calves. Connective tissue proliferation is an important component of the warts. 5pPapillomavirus sylvilagi B04.280.570.460.750; B04.909.204.210.711.460.750; B04.909.204.585.460.750; B04.909.574.204.711.460.750 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae; Papillomavirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae; Papillomavirus The type species of PAPILLOMAVIRUS. It is reported to occur naturally in cottontail rabbits in North America. 5pPapillomavirus B04.280.570.460; B04.909.204.210.711.460; B04.909.204.585.460; B04.909.574.204.711.460 CHCLDEENGDGEIMIPMEPHPYREUL Condylomata Acuminata Viruses; DNA Viruses; Papovaviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Papovaviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Papovaviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Papovaviridae Papillomavirus, Bovine; Papillomavirus, Human; Papillomavirus sylvilagi Papillomavirus, Bovine; Papillomavirus, Human; Papillomavirus sylvilagi Papillomavirus, Bovine; Papillomavirus, Human; Papillomavirus sylvilagi Papillomavirus, Bovine; Papillomavirus, Human; Papillomavirus sylvilagi A genus of PAPOVAVIRIDAE causing proliferation of the epithelium, which may lead to malignancy. A wide range of animals are infected including humans, chimpanzees, cattle, rabbits, dogs, and horses.  5`MBPapilloma, Inverted C04.557.470.700.600.610 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell; Papilloma A mucosal tumor of the urinary bladder or nasal cavity in which proliferating epithelium is invaginated beneath the surface and is more smoothly rounded than in other papillomas. (Stedman, 25th ed). Papilloma (66-93) 5 VPapilloma, Intraductal C04.557.470.615.670 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) A small, often impalpable benign papilloma arising in a lactiferous duct and frequently causing bleeding from the nipple. (Stedman, 25th ed). Breast Neoplasms (66-93); Papilloma (66-93) 58X5Papilloma C04.557.470.700.600 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Warts Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell Papilloma, Inverted A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed).  5l V Papilledema C10.772.204.607.710; C11.640.710 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ophthalmoscopy Intracranial Pressure; Edema Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Optic Nerve Diseases Eye Diseases; Optic Nerve Diseases Edema of the optic disk (papilla), most commonly due to increased intracranial pressure, malignant hypertension, or thrombosis of the central retinal vein. (Dorland, 27th ed).  5&N#Papillary Muscles A07.541.510.619 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Chordae Tendineae Cardiovascular System; Heart; Heart Valves Conical muscular projections from the walls of the cardiac ventricles, attached to the cusps of the atrioventricular valves by the chordae tendineae. 5,84Paper J01.637.632 HIST Cellulose Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) 5  OPapaverine D03.132.610.710; D03.438.531.667; D08.373.735.700; D16.050.650.700; D18.918.698 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Opium Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Cardiovascular Agents; Vasodilator Agents Tetrahydropapaveroline Tetrahydropapaveroline An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phophodiesterases and it may have direct actions on calcium channels. 5L[@5Papaver B06.560.671 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Opium Plants; Plants, Medicinal A genus of Eurasian herbaceous plants, the poppies (family Papaveraceae), that yield OPIUM from the latex of the unripe seed pods. Opium contains a great number of medically important alkaloids. Poppy seeds (nontoxic) are used in cookery and for poppy seed oils. 5 &  7Papain D08.586.277.656.732.215.585 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases 5 FPanuveitis C11.941.879.780 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Uveitis Ophthalmia, Sympathetic; Uveitis, Anterior (+ 3); Uveitis, Posterior (+ 3) Inflammation in which both the anterior and posterior segments of the uvea are involved and a specific focus is not apparent. It is often severe and extensive and a serious threat to vision. Causes include systemic diseases such as tuberculosis, sarcoidosis, and syphilis, as well as malignancies. The intermediate segment of the eye is not involved. Uveitis (77-89)  5N/ZPantothenic Acid D11.786.708.625 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex 5!D]Pantetheine D02.886.489.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds 2,4-Dihydroxy-N-[2-[(2-merceptoethyl)carbamoyl]ethyl]-3,3-dimethylbutyramide. An intermediate in the pathway of coenzyme A formation in mammalian liver and some microorganisms. Pantothenic Acid (72-74); Sulfhydryl Compounds (72-74) 5"u:`APanstrongylus B01.131.617.412.841.460 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hemiptera; Triatominae A genus of cone-nosed bugs of the subfamily TRIATOMINAE (Reduviidae). Its species are vectors of TRYPANOSOMA CRUZI. 5$`(FPanophthalmitis C01.539.375.725.675; C11.294.900.675; C11.941.879.960.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Endophthalmitis Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Uveitis, Suppurative Eye Diseases; Eye Infections; Uveitis, Suppurative Eye Diseases; Uveal Diseases; Uveitis; Uveitis, Suppurative Acute suppurative inflammation of the inner eye with necrosis of the sclera (and sometimes the cornea) and extension of the inflammation into the orbit. Pain may be severe and the globe may rupture. In endophthalmitis the globe does not rupture. 5%AP#Panniculitis, Peritoneal C06.772.600; C17.300.710.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Peritoneal Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Panniculitis Condition of the peritoneum, most commonly of the mesentery, but also of the omentum, characterized by tissue thickening, alteration of fat cells, infiltration of lipid-laden macrophages, and fibrosis. Mesentery (66-88); Panniculitis, Nodular Nonsuppurative (66-88); Peritoneal Diseases (66-88) 5("NlPanniculitis, Nodular Nonsuppurative C17.300.710.500; C17.800.566.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Panniculitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Panniculitis A form of panniculitis characterized by recurrent episodes of fever accompanied by the eruption of single or multiple erythematous subcutaneous nodules on the lower extremities. They normally resolve, but tend to leave depressions in the skin. The condition is most often seen in women, alone or in association with other disorders. 5+;*&NPanniculitis, Lupus Erythematosus C17.300.475.479.400; C17.300.710.400; C17.800.480.479.400; C17.800.566.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lupus Erythematosus, Discoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Panniculitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Panniculitis A type of lupus erythematosus characterized by deep dermal or subcutaneous nodules, most often on the head, face, or upper arms. It is generally chronic and occurs most often in women between the ages of 20 and 45. Lupus Erythematosus, Discoid (66-88); Lupus Erythematosus, Systemic (66-88); Panniculitis, Nodular Nonsuppurative (66-88)  5.C'TN"Panniculitis C17.300.710; C17.800.566 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Erythema Induratum; Panniculitis, Lupus Erythematosus; Panniculitis, Nodular Nonsuppurative; Panniculitis, Peritoneal Erythema Induratum; Panniculitis, Lupus Erythematosus; Panniculitis, Nodular Nonsuppurative General term for inflammation of adipose tissue, usually of the skin, characterized by reddened subcutaneous nodules. Adipose Tissue (66-88); Panniculitis, Nodular Nonsuppurative (66-88) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $52NPPPanic Disorder F03.709.438.180.501 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait. Anxiety Disorders (78-91); Fear (78-91); Panic (78-91) 565FvyDPanic F01.470.361.585 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Emotions; Fear A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function. 5:  IPangamic Acid D26.690 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Controversial mixture of compounds erroneously labeled as vitamin B15. There is no clear chemical identity for this substance and products sold as pangamic acid in the U.S. vary considerably in their composition. (From Merck Index, 11th ed.). 5< ,2Pancytopenia C15.378.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. 5=NJlPancuronium D04.808.054.040.685; D14.100.120.200.600.700; D16.700.710.575.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Androstanes (68-71); Curare-Like Agents (70-71) 5? I:9Pancreatopeptidase D08.586.277.656.732.760.560 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, albumin, etc. 5BFPancreatitis C06.689.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Pancreatic Diseases 5DN7Pancreatin D08.586.277.610; D24.185.893.500.720; D19.316.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts; Pancreatic Extracts Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Pancreatic extract, dried, containing trypsin amylase and a lipase in specified activities. It is used as a digestant in pancreatic malfunction. 5E9FPancreaticojejunostomy E04.035.703; E04.765.762 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pancreatectomy; Pancreas Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgical anastomosis of the pancreatic duct, or the divided end of the transected pancreas, with the jejunum. (Dorland, 27th ed). Jejunum/surgery (66-87); Pancreas/surgery (66-87); Pancreatic ducts/surgery (66-87); Pancreatitis/surgery (66-87)  5H,$rPancreaticoduodenectomy E04.765.760 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Digestive System (Non MeSH) The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected. Duodenum (66-91); Pancreatectomy (66-91) 5Je$C1Pancreatic Pseudocyst C04.182.640.692; C06.689.500.692 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Cysts; Pancreatic Cyst Digestive System Diseases; Pancreatic Diseases; Pancreatic Cyst Cyst-like space not lined by epithelium and contained within the pancreas. Pancreatic Cyst (66-80) 5K&XsYPancreatic Polypeptide D06.472.610.700; D12.644.480; D12.776.641.650.600; D14.600.600.610 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A 36-amino acid polypeptide with physiological regulatory functions. It is secreted by pancreatic tissue. Plasma pancreatic polypeptide increases after ingestion of food, with age, and in disease states. A lack of pancreatic polypeptide in the islets of Langerhans has been associated with the obese syndrome in rats and mice. Hormones (66-73); Pancreatic Hormones (74-78); Peptides (66-78) 5MxLFp~MPancreatic Neoplasms C04.588.274.761; C06.240.761; C06.689.667 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms Digestive System Diseases; Digestive System Neoplasms Digestive System Diseases; Pancreatic Diseases 5Q1XPancreatic Juice A12.838.567 CHCYDEENIMMEMIPHPSRARERISEUSVI Chymotrypsin; Chymotrypsinogen; Trypsin; Trypsinogen Fluids and Secretions (Non MeSH); Secretions (Non MeSH) 5S ">DPancreatic Insufficiency C06.689.612 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Pancreatic Diseases Absence of or reduced pancreatic exocrine secretion into the duodenum and resultant poor digestion of lipids, vitamins, nitrogen, and carbohydrates. Pancreatic Diseases (66-80); Pancreatitis (66-80) 5SN7;Pancreatic Hormones D06.472.610 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Pancreatic Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones Glucagon; Insulin (+ 5); Pancreatic Polypeptide; Somatostatin Peptide hormones secreted into the blood by cells in the ISLETS OF LANGERHANS of the pancreas. The alpha cells secrete glucagon; the beta cells secrete insulin; the delta cells secrete somatostatin; and the PP cells secrete pancreatic polypeptide. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $5UB#BK%HPancreatic Function Tests E01.184.670 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Digestive System (Non MeSH) Tests based on the biochemistry and physiology of the exocrine pancreas and involving analysis of blood, duodenal contents, feces, or urine for products of pancreatic secretion. Pancreas (66-79); Pancreatic Diseases (66-79); specific pancreatic disease 5Xk";YPancreatic Fistula C06.185.800; C06.689.583; C23.439.185.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Fistula (Non MeSH) Digestive System Diseases; Pancreatic Diseases Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH) Abnormal passage communicating with the pancreas. 5ZE1N;Pancreatic Extracts D24.185.893.500 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts Pancreatin Extracts prepared from pancreatic tissue that may contain the pancreatic enzymes or other specific uncharacterized factors or proteins with specific activities. PANCREATIN is a specific extract containing digestive enzymes and used to treat pancreatic insufficiency. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  5\B`2FPancreatic Ducts A03.734.667 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Pancreas 5^:!Pancreatic Diseases C06.689 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hyperinsulinism Digestive System Diseases Cystic Fibrosis; Pancreatic Cyst (+ 1); Pancreatic Fistula; Pancreatic Insufficiency; Pancreatic Neoplasms; Pancreatitis BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  5_; NXPancreatic Cyst C04.182.640; C06.689.500 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Digestive System Diseases; Pancreatic Diseases Pancreatic Pseudocyst Pancreatic Pseudocyst A true cyst of the pancreas to be distinguished from the much more common PANCREATIC PSEUDOCYST by possessing a mucous epithelial lining. Pancreatic cysts are categorized as congenital, retention, neoplastic, parasitic, enterogenous, or dermoid. Congenital cysts occur more frequently as solitary cysts but may be multiple. Retention cysts are gross enlargements of pancreatic ducts secondary to ductal obstruction. (From Bockus Gastroenterology, 4th ed, p. 4145). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  5`VK2XPancreatectomy E04.765.752 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pancreaticojejunostomy Pancreas Surgery, Operative; Surgery, Digestive System (Non MeSH) 5d$ CPancreas Transplantation E04.765.725; E04.936.450.650 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgery, Operative; Transplantation; Organ Transplantation The transference of a pancreas from one human or animal to another. Pancreas/transplantation (66-89) 5ef"2S&Pancreas A03.734; A10.336.583 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Pancreatectomy; Pancreaticojejunostomy Digestive System Tissue Types (Non MeSH); Exocrine Glands Islets of Langerhans; Pancreatic Ducts ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  5f 8,F0:Pancoast's Syndrome C04.588.894.797.520.734; C08.381.540.734; C08.785.520.734 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms; Lung Neoplasms Respiratory Tract Diseases; Lung Diseases; Lung Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms; Lung Neoplasms Destructive lesions of the thoracic inlet with involvement of the brachial and sympathetic plexus or carcinoma of the lung apex. It is characterized by pain in the shoulder region radiating toward the axilla and scapula, sensory and motor disorders and wasting of the muscles of the hand, the Bernard-Horner syndrome, and compression of the blood vessels with edema. (Jablonski's Dictionary of Syndromes and Eponymic Diseases, 2d ed). 5haAXPanama Canal Zone Z01.107.169.772.584 EHEP Geographicals (Non MeSH); America; Central America; Panama 5lCHPanama Z01.107.169.772 EHEP Geographicals (Non MeSH); America; Central America Panama Canal Zone 5l >Pan American Health Organization N03.540.514.718.800.628 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; International Agencies; United Nations; World Health Organization WHO regional office for the Americas acting as a coordinating agency for the improvement of health conditions in the hemisphere. The four main functions are: control or eradication of communicable diseases, strengthening of national and local health services, education and training, and research. International Agencies (66-72); World Health Organization (66-72) 5m}' YMPamphlets L01.178.682.707 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Printed publications usually having a format with no binding and no cover and having fewer than some set number of pages. They are often devoted to a single subject. 5p) \Palpation E01.706.644 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Physical Examination Application of fingers with light pressure to the surface of the body to determine consistence of parts beneath in physical diagnosis; includes palpation for determining the outlines of organs. 5q "&Palmitoylcarnitine D02.241.081.407.634.600.700; D11.786.708.168.700 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Palmitic Acids; Palmitates Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Carnitine 3-Carboxy-N,N,N-trimethyl-2-((1-oxohexadecyl)oxy)-1- propanaminium hydroxide, inner salt. A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids. Carnitine (66-77); Palmitic Acids (66-77) 5r6D)3Palmitoyl-CoA Hydrolase D08.586.277.352.897.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Thiolester Hydrolases Enzyme catalyzing reversibly the hydrolysis of palmitoyl-CoA or other long-chain acyl coenzyme A compounds to yield CoA and palmitate or other acyl esters. The enzyme is involved in the esterification of fatty acids to form triglycerides. EC 3.1.2.2. Thiolester Hydrolases (73-77) 5vFz&#Palmitoyl Coenzyme A D08.176.211.300.700; D13.695.667.138.382.300.700; D13.695.827.068.382.300.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes; Coenzyme A; Acyl Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Coenzyme A; Acyl Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Coenzyme A; Acyl Coenzyme A S-Palmitoyl coenzyme A. A fatty acid coenzyme derivative which plays a key role in fatty acid oxidation and biosynthesis. Coenzyme A (66-77); Palmitates (75-77); Palmitic Acids (66-77) 5xlUFMPalmitic Acids D02.241.081.407.634; D10.516.251.694 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Palmitates (+ 1) Palmitates AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 5{*8"DPalmitates D02.241.081.407.634.600; D10.516.251.694.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Palmitic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Palmitic Acids Palmitoylcarnitine Salts and esters of the 16-carbon saturated monocarboxylic acid--palmitic acid. Fatty Acids (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $5}28]DPallor C23.888.656 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) 5 NXPalliative Treatment E02.472.666 AECLCTECHIISMOMTNUPXSNSTTDUTVE Pain, Intractable; Terminal Care; Pain Therapeutics; General Patient Care (Non MeSH) 5"07Palladium D01.268.640; D01.552.653 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals A chemical element having an atomic weight of 106.4, atomic number of 46, and the symbol Pd. It is a white, ductile metal resembling platinum, and following it in abundance and importance of applications. It is used in dentistry in the form of gold, silver, and copper alloys. 5 :`JPaleopathology I01.076.368.584.709 CLECEDHIISLJMAMTOGSNSTTD Social Sciences; Anthropology; Anthropology, Physical; Paleontology The study of disease in prehistoric times as revealed in bones, mummies, and archaeologic artifacts. 5OwPaleontology I01.076.368.584 CLECEDHIISLJMAMTOGSNSTTD Mummies Social Sciences; Anthropology; Anthropology, Physical Fossils; Mummies; Paleodontology; Paleopathology The study of early forms of life through fossil remains. CLECEDHIISLJMAMTOGPARARISNSTTDUS $5 ?:F$Paleography L01.143.506.423.906.539.500 HIIS Archaeology Information Science; Communication; Language; Language Arts (Non MeSH); Writing; Handwriting The study of ancient inscriptions and modes of writing. It includes the deciphering of manuscripts and other forms to determine their date, provenance, etc. (Webster's 1st ed). 5DoPaleodontology I01.076.368.584.583 CLECEDHIISLJMAMTOGSNSTTD Tooth Social Sciences; Anthropology; Anthropology, Physical; Paleontology The study of the teeth of early forms of life through fossil remains. 5 OVPalate, Soft A14.549.617.780 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Mouth; Palate Uvula A movable fold suspended from the posterior border of the hard palate. The uvula hangs from the middle of the lower border. Palate (66-78)  5 :- Palate A02.835.232.781.324.502.658; A14.521.658; A14.549.617 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw Stomatognathic System; Jaw Stomatognathic System; Mouth  Palatal Muscles; Palate, Soft (+ 1) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI 5s =8/:Palatal Obturators E06.780.745 AECLCTECHIMIPSPXSDSNSTTDUTVEVI Dentistry; Prosthodontics Appliances that close a cleft or fissure of the palate. 5"EPalatal Neoplasms C04.588.149.721.450.692; C04.588.443.591.692; C05.116.231.754.450.692; C05.500.499.692; C07.320.515.692; C07.465.565.692 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms; Skull Neoplasms; Jaw Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms; Skull Neoplasms; Jaw Neoplasms Musculoskeletal Diseases; Jaw Diseases; Jaw Neoplasms Stomatognathic Diseases; Jaw Diseases; Jaw Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms 5XPalatal Muscles A02.633.567.750; A14.549.617.623 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Stomatognathic System; Mouth; Palate The muscles of the palate are the glossopalatine, palatoglossus, levator palati(ni), musculus uvulae, palatopharyngeus, and tensor palati(ni). Muscles (66-78); Palate (66-78) 5&:f(Palatal Expansion Technique E06.658.578.458 AECLCTECHIISMAMONUPXSNSTTDUTVE Dentistry; Orthodontics; Orthodontics, Corrective Orthodontics, Corrective (66-72); Palate (66-72) 5!"::Pakistan Z01.252.245.723 EHEP Geographicals (Non MeSH); Asia; Asia, Western 5 9Paired-Associate Learning F02.463.425.952.500 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Verbal Learning Learning in which the subject must respond with one word or syllable when presented with another word or syllable. 5+ nPair Bond F01.145.113.252.748.400 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Consummatory Behavior; Sex Behavior, Animal In animals, the social relationship established between a male and female for reproduction. It may include raising of young. 5Paintings K01.093.646 CLEDHIPXSNTD Humanities; Art 5 Paint J01.637.597 AEANCLECHIPORESDSNSTTOUT Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Lacquer 5L O Pain, Postoperative C23.814.533; C23.888.592.612.722 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Postoperative Complications Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pain during the period after surgery. 5&N/Pain, Intractable C10.597.617.791; C23.888.592.612.666 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Palliative Treatment Nervous System Diseases; Neurologic Manifestations; Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pain which is difficult to control. 5*N-Pain Threshold F02.463.593.710.560; F02.830.816.444.700; G11.561.796.444.700 CLDEEHPHPXRE Pain Measurement Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Sensory Thresholds Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation; Pain Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Pain Amount of stimulation required before the sensation of pain is experienced. Pain (66-92); Sensory Thresholds (79-92)  5fEOZ2Pain Measurement E01.236.563.540 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Pain Threshold; Sensory Thresholds Diagnosis; Diagnosis, Neurologic (Non MeSH); Neurologic Examination Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Pain (66-86)  5&*PPain Clinics N02.278.035.380.600; N02.278.035.516; N02.278.354.422.527.600; N04.452.442.422.527.600 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities; Outpatient Clinics, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments; Outpatient Clinics, Hospital Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments; Outpatient Clinics, Hospital Facilities providing diagnostic, therapeutic, and palliative services for patients with severe chronic pain. These may be free-standing clinics or hospital-based and serve ambulatory or inpatient populations. The approach is usually multidisciplinary. These clinics are often referred to as "acute pain services". (From Br Med Bull 1991 Jul;47(3):762-85). Pain (66-94) 5`EPain C10.597.617; C23.888.592.612; F02.830.816.444; G11.561.796.444 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Analgesia; Analgesia, Congenital; Analgesics; Hyperalgesia; Palliative Treatment Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation Arthralgia; Back Pain (+ 1); Facial Pain; Headache (+ 1); Neuralgia; Pain, Intractable Abdominal Pain (+ 2); Back Pain (+ 1); Chest Pain; Colic; Earache; Facial Pain; Glossalgia; Headache (+ 4); Neuralgia; Pain, Intractable; Pain, Postoperative; Pelvic Pain; Toothache Pain Threshold Pain Threshold A more or less localized sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings. It serves as a protective mechanism insofar as it induces the sufferer to remove or withdraw from the source. (Dorland, 27th ed). BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $5gHN^|n4TPaget's Disease, Mammary C04.557.470.200.025.275.625; C04.557.470.615.275.625 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Intraductal, Noninfiltrating Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH); Carcinoma, Intraductal, Noninfiltrating An intraductal carcinoma of the breast extending to involve the nipple and areola, characterized clinically by eczema-like inflammatory skin changes and histologically by infiltration of the dermis by malignant cells (Paget's cells). (Dorland, 27th ed). 5:X'Paget's Disease, Extramammary C04.557.470.200.025.660; C04.557.470.615.660 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) A rare cutaneous neoplasm that occurs in the elderly. It develops more frequently in women and predominantly involves apocrine gland-bearing areas, especially the vulva, scrotum, and perianal areas. The lesions develop as erythematous scaly patches that progress to crusted, pruritic, erythematous plaques. The clinical differential diagnosis includes squamous cell carcinoma in situ and superficial fungal infection. It is generally thought to be an adenocarcinoma of the epidermis, from which it extends into the contiguous epithelium of hair follicles and eccrine sweat ducts. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1478). 5#2X+Paecilomyces B05.354.381.546.640 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus occasionally causing human diseases such as pulmonary infections, mycotic keratitis, endocarditis, and opportunistic infections. Hyphomycetes (66-85) 5}"NPactamycin D20.085.075.680; D22.204.106.700 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic 3-((3-acetylphenyl)amino)-4-amino-5-(((dimethylamino) carbonyl)amino)-1,2-dihydroxy-5-(1-hydroxyethyl)-2- (methylcyclopentyl)methyl 2-hydroxy-6-methylbenzoate. Antibiotic produced by Streptomyces pactum used as an antineoplastic agent. It is also used as a tool in biochemistry because it inhibits certain steps in protein synthesis. Antibiotics, Antineoplastic (72-74) 5 &<{)Paclitaxel D03.132.640; D22.204.179.600 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Antineoplastic agent isolated from the bark of the Pacific yew tree, Taxus brevifolia. Paclitaxel stabilizes microtubules in their polymerized form and thus mimics the action of the PROTO-ONCOGENE PROTEINS C-MOS. Alkaloids (82-92); Terpenes (77-81) 5"<,Pacinian Corpuscles A08.800.550.700.500.700 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors Rapidly adapting mechanoreceptors found in subcutaneous tissue beneath both hairy and glabrous skin. Pacinian corpuscles contain an afferent nerve fiber surrounded by a capsule with multiple concentric layers. They have large receptive fields and are most sensitive to high-frequency stimuli, such as vibration. 5N8ohPacific Ocean Z01.756.700 Geographicals (Non MeSH); Oceans and Seas 54Pacific Islands Z01.782 EHEP Geographicals (Non MeSH) Melanesia (+ 4); Micronesia (+ 1); Polynesia (+ 4) 5# BPacemaker, Artificial E07.858.082.748 AECLCTECHIPXSDSNSTTDUTVE Cardiac Pacing, Artificial Equipment and Supplies; Surgical Equipment; Artificial Organs A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external). 5 Ip-Hydroxynorephedrine D02.033.329.624.706.400; D02.092.063.624.706.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines; Phenylpropanolamine Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines; Phenylpropanolamine alpha-(1-Aminoethyl)-p-hydroxybenzyl alcohol. Parahydroxy analog of phenylpropanolamine with properties as a sympathomimetic. Phenols (72-74); Phenylpropanolamine (72-74) 5h6:5p-Hydroxyamphetamine D02.092.471.683.152.500; D16.050.500.320; D18.222.863.480 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Amphetamine metabolite with sympathomimetic effects. Amphetamine (73-74); Phenols (68-74) 5A:=-P-Glycoprotein D12.776.157.610; D12.776.395.550.610; D12.776.543.550.610 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Drug Resistance, Multiple Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Family of integral plasma membrane proteins which, when overexpressed, function as adenosine triphosphate-dependent efflux pumps, causing multidrug resistance (DRUG RESISTANCE, MULTIPLE). Mammalian P-glycoproteins are encoded by small mdr gene families. There are several isotypes in multiple species. Glycoproteins (80-87); Membrane Glycoproteins (89-94); Membrane Proteins (80-88)  5AF:Y_p-Fluorophenylalanine D12.125.072.573.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Phenylalanine 3-(p-Fluorophenyl)-alanine. Phenylalanine (72-74); Fluorine (72-74) 5Ţ:"0p-Dimethylaminoazobenzene D02.092.146.325; D26.191.282; D26.408.262 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Aniline Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Miscellaneous Drugs and Agents (Non MeSH); Dyes  Methyldimethylaminoazobenzene N,N-Dimethyl-4-(phenylazo)benzenamine. Reagent used primarily for the induction of experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound "may reasonably be anticipated to be a carcinogen." (Merck, 11th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  51.#M:p-Chloroamphetamine D02.092.471.683.152.200; D14.100.850.875.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Chlorinated analog of amphetamine. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool. Amphetamine (66-74); Chlorine (66-74) 52: .p-Azobenzenearsonate D02.172.045; D02.691.088.060; D24.611.216.119.480.097 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Organic Chemicals (Non MeSH); Azo Compounds Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Haptens 4,4'-Azodibenzenearsonic acid. A hapten capable of eliciting both antibody formation and delayed hypersensitivity when bound to aromatic amino acids, polypeptides or proteins. It is used as an immunologic research tool. Arsenicals (72-75); Azo Compounds (72-75) 5̫=63p-Aminosalicylic Acid D02.241.223.106.505.700.050.060; D02.241.511.390.700.050.060; D02.755.410.700.050.060; D20.338.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Salicylic Acids; Aminosalicylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Salicylic Acids; Aminosalicylic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Salicylic Acids; Aminosalicylic Acids Anti-Infective Agents; Antitubercular Agents 4-Amino-2-hydroxybenzoic acid. An antitubercular agent often administered in association with isoniazid. The sodium salt of the drug is better tolerated than the free acid. Aminosalicylic Acids (66-76) 5ϝl:"p-Aminohippuric Acid D02.065.277.431.192.100; D02.241.223.106.162.431.151.192; D02.241.607.360.192.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides; Hippurates; Aminohippuric Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides; Hippurates; Aminohippuric Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids; Hippurates; Aminohippuric Acids N-(4-Aminobenzoyl)glycine. A diagnostic aid used as the sodium salt in renal function tests. Aminohippuric Acids (66-76) 5UY:kp!p-Aminoazobenzene D02.172.032; D26.408.065 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Miscellaneous Drugs and Agents (Non MeSH); Dyes p-(Phenylazo)aniline. Used in the form of its salts as a dye; also as an intermediate in manufacture of Acid Yellow, diazo dyes, and indulines. Synonym: C.I. 11000. Aniline Compounds (73-75); Azo Compounds (69-75) 5$.o;P Blood-Group System D24.611.216.705.230.691; G04.610.241.691; G09.188.229.691 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups A blood group related to the ABO, Lewis and I systems. At least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group. Blood Groups (66-75) 5A2POzone D01.268.185.550.600; D01.362.670.600; D05.284.101.143.631.500; D26.680.580.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Chalcogens (Non MeSH); Oxygen Inorganic Chemicals (Non MeSH); Gases; Oxygen Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants; Air Pollutants, Environmental; Oxidants, Photochemical Miscellaneous Drugs and Agents (Non MeSH); Oxidants; Oxidants, Photochemical Ozone. An unstable form of oxygen that exists as a blue gas. It is found in the atmosphere in varying proportions since it is produced continuously in the outer layers of the atmosphere by the action of solar UV-radiation on the oxygen of the air. (From Merck Index, 11th ed) It is the major oxidant of photochemical smog and can cause lung irritation which sometimes leads to death from pulmonary edema. 51 X8Oysters B01.644.617 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Mollusca Marine bivalve mollusks of several genera (Ostrea, Crassostrea, Pinctada, Meleagrina) with a rough irregular shell closed by a single adductor muscle. It includes oysters as food. Mollusca (66-71)  5\ ( Oxyuroidea B01.500.294.700.500.500 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Oxyurida Enterobius A superfamily of parasitic nematodes consisting of several genera. ENTEROBIUS, which occurs in humans, and Oxyuris, which occurs in horses, are two of the most common. Other genera are: Skrjabinema, Passalurus, Dermatoxys, and Probstmayria. 5*EOxyurida Infections C03.335.508.700.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections Oxyuriasis (+ 1) Infections with nematodes of the order OXYURIDA. 5P[;Oxyurida B01.500.294.700.500 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea Oxyuroidea (+ 1) An order of nematodes of the subclass SECERNENTEA. Its organisms are characterized by a single, ventral excretory gland and a relatively stout, short body. 5 *9Oxyuriasis C03.335.508.700.550.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Oxyurida Infections Enterobiasis Infection with nematodes of the superfamily OXYUROIDEA. 5PsBOxytricha B01.841.185.700.400.750.600 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Polymenophorea; Hypotrichida; Sporadotrichina A genus of ciliate protozoa having a unique cursorial type of locomotion. Ciliophora (73-91) 5 &`YOxytocinase D08.586.277.656.081.708 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases 5:F}Oxytocin D06.472.583.666; D06.472.734.692.433; D12.644.456.925.730; D12.776.641.650.900.700; D14.600.600.920.600 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Oxytocin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Oxytocics Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Vasopressins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Vasopressins Oxytocin. A nonapeptide posterior pituitary hormone that causes uterine contractions and stimulates lactation. 5F sF Oxytocics D06.472.583 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Labor, Induced; Labor; Uterine Contraction Hormones, Substitutes, Antagonists (Non MeSH); Hormones Dinoprost; Dinoprostone; Ergonovine; Oxytocin; Quipazine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  5 84BDFOxythiamine D03.383.871.540; D26.087.683 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 5-(2-Hydroxyethyl)-3-[(4-hydroxy-2-methyl-5-pyrimidinyl)methyl]-4-methylthiazolium chloride. Thiamine antagonist, antimetabolite. Pyrimidines (74); Thiazoles (70-74) 5i":,Oxytetracycline D20.085.868.633 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5a alpha,6 beta,12a alpha))-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide. An antibiotic substance isolated from the actinomycete Streptomyces rimosus and used in a wide variety of clinical conditions. 5O<:LOxyquinoline D03.438.810.350.625 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines Chloroquinolinols (+ 1); Clioquinol; Iodoquinol 8-Quinolinol. An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics. Quinolines (71-74)  5Z:k:mOxypurinol D03.383.694.650; D03.383.742.550; D08.373.710 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol. A xanthine oxidase inhibitor. Pyrazoles (73-74); Pyrimidines (73-74) 55:N/Oxyphenonium D02.092.102.648; D02.675.276.648; D14.100.120.200.500.620; D16.050.500.580; D16.050.650.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect. Oxyphenonium Bromide (66-91) 5(g:P"Oxyphenisatin Acetate D03.438.473.725; D19.316.396.725 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics 3,3-Bis(p-hydroxyphenyl)-2-indolinone acetate. Laxative that undergoes enterohepatic circulation; may cause jaundice. Synonyms: Isalax; Isocrin; Lavema; Prulet. Indoles (69-74); Phenols (72-74) 5p&:)Oxyphenbutazone D03.383.694.700.640; D16.850.015.050.700.500; D17.025.030.590.500; D17.025.080.600; D17.050.030.590.550; D23.037.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Phenylbutazone Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Phenylbutazone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Phenylbutazone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Phenylbutazone Dermatologic Agents; Anti-Inflammatory Agents, Topical A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflamation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p.2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.27). 5:tYOxymorphone D03.132.610.422.547.547.692; D03.549.686.575.547.437.707; D03.605.497.575.547.437.707; D15.040.150.550; D15.045.637; D15.210.600.684 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives; Dihydromorphinone Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives; Dihydromorphinone Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Central Nervous System Depressants; Narcotics An opioid analgesic with actions and uses similar to those of MORPHINE, apart from an absence of cough suppressant activity. It is used in the treatment of moderate to severe pain, including pain in obstetrics. It may also be used as an adjunct to anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1092). 6f:l|Oxymetholone D04.808.054.040.632; D06.597.100.194.723 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids (5 alpha,17 beta)-17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one. A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed). 6 L.:Oxymetazoline D03.383.374.704; D18.793.952.664 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Cardiovascular Agents; Vasoconstrictor Agents; Vasoconstrictor Agents, Nasal 6 :&:Oxyhemoglobins D12.776.124.400.707; D12.776.422.512.687 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins A compound formed by the combination of hemoglobin and oxygen. It is a complex in which the oxygen is bound directly to the iron without causing a change from the ferrous to the ferric state. Hemoglobins (66-72) 6 v.DOxygenators, Membrane E07.652.582 AECLCTECHISDSNSTTDUTVE Extracorporeal Membrane Oxygenation Equipment and Supplies; Oxygenators Heart, Mechanical (66-71); Membranes, Artificial (66-71) 6)+COxygenators E07.652 AECLCTECHISDSNSTTDUTVE Heart, Mechanical Equipment and Supplies Oxygenators, Membrane Heart, Mechanical (66-71)  6 Oxygenases D08.586.682.690 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases 7-Alkoxycoumarin O-Dealkylase; 4-Hydroxyphenylpyruvate Dioxygenase; Lipoxygenase (+ 4); Mixed Function Oxidases; Protocatechuate-3,4-Dioxygenase; Tryptophan Oxygenase 6FXOxygen Radioisotopes D01.496.625.600; D01.496.749.635 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Oxygen Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of oxygen that decay or disintegrate emitting radiation. O atoms with atomic weights 13, 14, 15, 19, and 20 are radioactive oxygen isotopes. Oxygen Isotopes (66-74); Radioisotopes (66-74) 6P&48Oxygen Isotopes D01.496.625 Inorganic Chemicals (Non MeSH); Isotopes Oxygen Radioisotopes Stable oxygen atoms that have the same atomic number as the element oxygen, but differ in atomic weight. O-17 and 18 are stable oxygen isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 6e24Oxygen Inhalation Therapy E02.880.690 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy Hyperbaric Oxygenation 6"(Oxygen Consumption G06.535.723 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Anaerobic Threshold; Respiratory Burst 6O.Oxygen Compounds (Non MeSH) D01.650 Inorganic Chemicals (Non MeSH) Oxides (+ 27) Inorganic compounds that contain oxygen as an integral part of the molecule. Oxygen (66-93) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPOPSRESDSTTOTUUR  6f" %\@Oxygen D01.268.185.550; D01.362.670 ADAEAGAIANBLCFCHCLCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Anoxemia; Anoxia; Hyperoxia Inorganic Chemicals (Non MeSH); Elements; Chalcogens (Non MeSH) Inorganic Chemicals (Non MeSH); Gases Ozone Ozone Oxygen. An element with atomic symbol O, atomic number 8, and atomic weight 16. It is the most abundant element on earth and essential for respiration. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $6 "8#z:Oxyfedrine D02.033.329.624.675; D02.092.063.624.675; D02.522.818.800; D18.918.680 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Ketones; Propiophenones Cardiovascular Agents; Vasodilator Agents L-3[(beta-Hydroxy-alpha-methylphenethyl)amino]-3'-methoxypropiophenone. Vasodilator agent; myocardial depressant. Synonyms: Ildamen; Modacor. Propanolamines (74); Propiophenones (71-74) 6P:4Oxycodone D03.132.610.422.547.547.149.575; D03.549.686.575.547.204.650; D03.605.497.575.547.204.650; D15.040.150.537; D15.153.640; D15.210.600.678 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives; Codeine Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives; Codeine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives; Codeine Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Narcotics (5 alpha)-4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan- 6-one. Semisynthetic derivative of CODEINE that acts as a narcotic analgesic more potent and addicting than codeine. Ethers, Cyclic (74-75); Morphinans (69-75) 6| :a4Oxyclozanide D02.065.199.860.500; D02.065.793.650.500; D21.201.412.529 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Salicylanilides Organic Chemicals (Non MeSH); Amides; Salicylamides; Salicylanilides Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents 3,3',5,5',6-Pentachloro-2'-hydroxysalicylanilide. Anthelmintic used in grazing animals for fasciola and cestode infestations. Synonyms: Diplin; Zanil; Zanilox. Chlorobenzenes (74); Salicylamides (71-74) 6"A:3Oxprenolol D02.033.329.624.651; D02.092.063.624.651; D14.100.050.200.200.630; D16.050.850.590; D18.097.577 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Amino Alcohols (66-71); Sympatholytics (66-71) 6%kk:8Oxotremorine D03.383.773.812.498; D14.100.120.140.500.660 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists A non-hydrolyzed muscarinic agonist used as a research tool. Tremorine (66-71) 6(2:IOxonic Acid D03.383.931.640 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines 2,4-Dihydroxy-6-carboxy-1,3,5-triazine. Antagonist of urate oxidase. Triazines (71-74) 6+ :UNOxolinic Acid D03.438.810.835.519; D20.220.680; D20.237.050.680 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones Anti-Infective Agents; Anti-Infective Agents, Quinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone 5-Ethyl-5,8-dihydro-8-oxo-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid. Synthetic antimicrobial related to nalidixic acid and used in urinary tract infections. Anti-Infective Agents, Urinary (66-71); Quinolines (66-71) 6,F9:EOximetry E01.145.569.685; E01.223.174.229.134.582; E01.302.796.139.582 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis; Blood Gas Analysis Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Blood Gas Analysis Blood Gas Monitoring, Transcutaneous Blood Gas Monitoring, Transcutaneous Blood Gas Monitoring, Transcutaneous The determination of oxygen-hemoglobin saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold. It includes non-invasive oxygen monitoring by pulse oximetry. 6. E"9}fOximes D02.092.570.665 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines Fluvoxamine; Obidoxime Chloride; Pralidoxime Compounds; Trimedoxime Compounds (cis or trans) that contain the radical, =C:N.OH; a condensation product of aldehydes or ketones (From Grant and Hackh's Chemical Dictionary, 5th ed). Members of this group frequently function as cholinesterase reactivators. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  62 8@O:Oxidoreductases, O-Demethylating D08.586.682.670 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Nitroanisole O-Demethylase Drug metabolizing enzymes which oxidize methyl ethers. Usually found in liver microsomes. Oxidoreductases (68-74)  65%FXjOxidoreductases, N-Demethylating D08.586.682.107.582 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases Aminopyrine N-Demethylase; Ethylmorphine-N-Demethylase Oxidoreductases (66-72) 66%Fr=Oxidoreductases D08.586.682 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Alcohol Oxidoreductases (+ 37); Aldehyde Oxidoreductases (+ 4); Amine Oxidoreductases (+ 8); Amino Acid Oxidoreductases (+ 7); Aromatase; Ascorbate Oxidase; Ceruloplasmin; Cholesterol Desmolase; Coproporphyrinogen Oxidase; Cytochrome-c Oxidase; Dihydroorotate Oxidase; Hydrogenase; Hydroxylases (+ 31); Ketone Oxidoreductases (+ 4); Luciferase; Methylenetetrahydrofolate Dehydrogenase; NADH, NADPH Oxidoreductases (+ 16); Nitrogenase (+ 2); Nitroreductases; Oxidoreductases, O-Demethylating (+ 1); 15-Oxoprostaglandin 13-Reductase; Oxygenases (+ 10); Peroxidases (+ 8); Prephenate Dehydrogenase; Protein Disulfide Reductase (Glutathione); Squalene Synthetase; Succinate Cytochrome c Oxidoreductase; Succinate Dehydrogenase; Sulfite Oxidases; Sulfite Reductases; Superoxide Dismutase; Testosterone 5-alpha-Reductase; Ubiquinol-Cytochrome-c Reductase; Urate Oxidase AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 68FEHOxidopamine D02.092.311.342.478.650; D14.100.050.600.600; D16.050.850.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Dopamine; Hydroxydopamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics 5-(2-Aminoethyl)-1,2,4-benzenetriol. A catecholamine, vasoactive neurotoxic compound which depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. The compound has been used clinically for purging of neuroblastoma cells prior to autologous bone marrow transplantation. When used by subconjunctival injection it produces reversible chemical sympathectomy in glaucoma. Hydroxydopamines (73-91) 6=E:XOxides D01.248.497.158.685; D01.650.550 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cyclic N-Oxides; Cyclic P-Oxides; Cyclic S-Oxides Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH) Peroxides (+ 1) Aluminum Oxide (+ 4); Carbon Dioxide (+ 1); Carbon Monoxide; Hypochlorous Acid (+ 1); Magnesium Oxide; Nitrogen Oxides (+ 3); Osmium Tetroxide; Peroxides (+ 2); Silicon Dioxide (+ 2); Sulfur Oxides (+ 1); Thorium Dioxide; Water; Zinc Oxide Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPOPSRESDSTTOTUUR $6A" &8<>@Oxidative Stress G06.535.710 DEGEIMPHRE Antioxidants Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, p. xv-xvi). 6DO3Oxidative Phosphorylation Coupling Factors D12.776.691 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Oxidative Phosphorylation (66-71) 6F1FD'Oxidative Phosphorylation G06.535.335.631; G06.535.630.780.631 DERE Uncoupling Agents Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH); Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. 6G*Oxidation-Reduction G06.535.335.531; H01.181.529.641 DERE Antioxidants; Oxidants Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Electron Transport; Lipid Peroxidation A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). DEGEIMPHRE $6I&/Oxidants, Photochemical D05.284.101.143.631; D26.680.580 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants; Air Pollutants, Environmental Miscellaneous Drugs and Agents (Non MeSH); Oxidants Nitrogen Dioxide; Ozone Nitrogen Dioxide; Ozone Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light. Oxidation-Reduction (66-74); Photochemistry (71-74) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $6L&,:<8Oxidants D26.680 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Antioxidants Oxidation-Reduction Miscellaneous Drugs and Agents (Non MeSH) Oxidants, Photochemical (+ 2); Reactive Oxygen Species; Sodium Hypochlorite Oxidizing agents or electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). In vivo, it appears that phagocyte-generated oxidants function as tumor promoters or cocarcinogens rather than as complete carcinogens perhaps because of the high levels of endogenous antioxidant defenses. It is also thought that oxidative damage in joints may trigger the autoimmune response that characterizes the persistence of the rheumatoid disease process. Oxidation-Reduction (66-91) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,6O  ,2ZU 8Oxepins D03.383.564 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) 6S 8GOxazolone D03.383.548.620; D24.611.062.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic 2-Phenyl-4-ethoxymethylene-5-oxazolone. Immunologic adjuvant and sensitizing agent. Ethyl Ethers (74); Oxazoles (74) 6Te &:^*Oxazoles D03.383.548 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Aminorex; Dimethadione; Fura-2; Ibotenic Acid; Isoxazoles (+ 2); Muscimol; Oxadiazoles (+ 5); Oxazolone; Pemoline; Trimethadione Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  6VI 8G<Oxazocines D03.383.113.767 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azocines Nefopam One ring heterocyclic compounds defined by C6H7NO. Permitted are any degree of hydrogenation, any substituents and any ortho-fused or ortho-peri-fused ring systems. Azocines (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $6Xn8T :Oxazines D03.383.533 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Ifosfamide; Maytansine; Morpholines (+ 4) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 6Zc 8G3:Oxazepines D03.383.066.498 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines 6[8TOxazepam D03.438.079.080.070.663; D14.100.240.500.600; D15.075.050.600; D15.210.350.800.650; D15.210.950.012.050.630; D15.325.875.600; D15.700.872.015.050.686 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine A benzodiazepine used in the treatment of anxiety, alchohol withdrawal, and insomnia. 6\] :eOxathiins D03.383.517 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Carboxin Heterocyclic Compounds (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  6a\ 8G $:Oxandrolone D04.808.054.040.581; D06.597.100.194.686 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids (5 alpha,17 beta)-17-Hydroxy-17-methyl-2-oxaandrostan-3-one. A synthetic hormone with anabolic and androgenic properties. 6b.:Oxamniquine D03.438.810.350.600; D03.438.810.470.600; D21.201.412.596.560 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Nitroquinolines Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides 6-Hydroxymethyl-2-isopropylaminomethyl-7-nitro-1,2,3,4-tetrahydroquinoline. Proposed as anthelmintic or schistosomicide. Synonyms: UK 4271; 4261. Nitro Compounds (73-74); Propylamines (73-74); Quinolines (73-74) 6drE::OOxamic Acid D02.241.152.367.600; D12.125.730 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Aldehydic (Non MeSH); Glyoxylates Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Amino-substituted glyoxylic acid derivative. Amino Acids (72-74); Glyoxylates (72-74) 6gR&:42Oxaloacetates D02.241.081.337.635.581; D02.241.607.686 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Oxalates Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids 6i.8Oxalates D02.241.081.337.635 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hyperoxaluria; Hyperoxaluria, Primary Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Calcium Oxalate; Oxaloacetates Ethanedioic acids. Salts of oxalic acid. The acid occurs in many plants and vegetables and is produced in the body by metabolism of glyoxylic acid or ascorbic acid. Ingestion of a diet rich in oxalates or the existence of primary hyperoxaluria (a genetic disorder of glycine metabolism) may lead to the formation of calcium oxalate kidney calculi. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $6jY 8,q%:Oxadiazoles D03.383.548.580 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles NBD Chloride; Quisqualic Acid; SQ 18506; Sydnones (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 6mz8TF:Oxacillin D20.085.099.739.681 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins Cloxacillin (+ 2) (((5-Methyl-3-phenyl-4-isoxazolyl)carbonyl)amino)-3,3- dimethyl-6-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2- carboxylic acid. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  6n :P<Ownership N04.452.633 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Private Sector; Privatization; Public Sector The ownership of any object, property, or facility, including proprietary, public, non-profit, secular, physician-owned, etc. Hospital Administration (66-67) CLECHILJMAOGSNSTTDUT $6p W6%Ovum Transport G04.335.283.700; G08.520.277.360 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Movement Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fertilization Transport of the ovum or zygote from the site of ovulation to the site of implantation. Ovum (66-74) 6r>&kOvum Implantation, Delayed G08.520.500.100 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Ovum Implantation Delay of embryonal development whereby the blastocyst remains in the uterine cavity for a variable period of time before attaching to the endometrium and continuing its development. 6s ]Ovum Implantation G08.520.500 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction Ovum Implantation, Delayed; Postimplantation Phase; Preimplantation Phase Endometrial implantation of the blastocyst. 6uGU4Ovum A05.360.490.690; A11.497.497; A16.631 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Graafian Follicle Graafian Follicle Urogenital System; Genitalia; Germ Cells Cells; Germ Cells Embryonic Structures (Non MeSH) Oocytes; Oogonia; Zona Pellucida; Zygote Oocytes; Oogonia; Zona Pellucida; Zygote Egg Yolk; Vitelline Membrane; Zona Pellucida consider also terms at OO-. ABAEAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPOPPPSRARERISESUTOTRULUSVI (6v-,l$BOvulation Induction E05.820.740 AECLCTECHIISMOMTNUPXSNSTTDUTVE Ovarian Hyperstimulation Syndrome Miscellaneous Techniques (Non MeSH); Reproduction Techniques Techniques for the artifical induction of ovulation. Anovulation (75-77); Ovulation (66-77)  6x"'G?/Ovulation Detection E01.249.530.690; E05.820.690 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Ovarian Function Tests Miscellaneous Techniques (Non MeSH); Reproduction Techniques Methods for recognition of the occurrence of ovulation. Ovulation (66-74) 6z1""COvulation G08.520.440.508 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle Anovulation; Corpus Luteum Regression; Superovulation The discharge of a secondary oocyte from a ruptured graafian follicle. BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI  6{ [?UTOvomucin D08.373.745.800.900.700; D12.776.256.317.675; D12.776.290.675; D12.776.395.560.760 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Trypsin Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Egg Proteins, Dietary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins A heterogeneous mixture of glycoproteins responsible for the gel structure of egg white. It has trypsin-inhibiting activity. Egg Proteins (73-74) 6}G \DOviposition G08.520.480 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction 6GOviducts A13.706 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) 6!  :Overlearning F02.463.425.612 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Learning in which practice proceeds beyond the point where the act can just be performed with the required degree of excellence. 6 ZOverinclusion F03.126.185.690 Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders A cognitive disorder in which conceptual boundaries are not preserved, and irrelevant or distantly associated elements become part of the concept, making thought more abstract and disconnected. Cognition Disorders (69-71) 6r!Overdose C21.613.730 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning An accidental or deliberate dose of a medication or street drug that is in excess of what is normally used. Poisoning (66-89) 6 HEOvary A05.360.319.114.630; A05.360.576.497; A06.407.312.497 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ovariectomy Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri Urogenital System; Genitalia; Gonads Endocrine System (Non MeSH); Endocrine Glands; Gonads Corpus Luteum (+ 1); Graafian Follicle (+ 3) Corpus Luteum (+ 1); Graafian Follicle (+ 3) Either of the paired glands in the female that produce the female germ cells and secrete some of the female sex hormones. consider also terms at OOPHOR- and THEC-. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $6 =:q<Ovariectomy E04.779.282.685; E04.819.608.685; E04.887.165.685; E04.887.690.680 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ovary Surgery, Operative; Surgery, Endocrine (Non MeSH); Castration Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH); Castration Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Gynecologic (Non MeSH) The surgical removal of one or both ovaries. Castration (66-85)  6L$ Q8Ovarian Neoplasms C04.588.322.455; C04.588.945.418.685; C13.371.056.630.705; C13.371.270.750; C13.371.820.800.418.685; C19.344.455; C19.391.630.705 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Krukenberg Tumor; Pseudomyxoma Peritonei Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female Endocrine Diseases; Endocrine Gland Neoplasms Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases Meigs' Syndrome Meigs' Syndrome Meigs' Syndrome Meigs' Syndrome Meigs' Syndrome Meigs' Syndrome Meigs' Syndrome 6NX0Ovarian Hyperstimulation Syndrome C13.371.056.630.642; C19.391.630.642 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ovulation Induction; Ovarian Cysts; Fertilization in Vitro Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases Syndrome composed of a combination of ovarian enlargement and an acute fluid shift out of the intravascular space. The enlargement is caused by ovarian cyst formation and the fluid shift may result in ascites, hydrothorax, or generalized edema. The syndrome is most usually seen as a complication of ovulation induction, a treatment for infertility. Ovarian Diseases (66-91); Ovulation Induction/adverse effects (78-91)  6*'*NFROvarian Function Tests E01.197.530; E01.249.530 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Endocrine (Non MeSH) Diagnosis; Diagnosis, Ob-Gyn (Non MeSH)  Ovulation Detection Methods used for assessment of ovarian function. Ovarian Diseases (66-74); Ovary (66-74)  6"a;1Ovarian Failure, Premature C13.371.056.630.611; C19.391.630.611 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases Premature failure of ovulation associated with hypergonadotropinism and hypoestrogenism in women under the age of 40. The etiology appears to be multifactorial and many cases are idiopathic. When follicles are present but the ovaries are unable to respond to gonadotropins, resistant ovary syndrome results and this may be associated with autoimmune disease. Even when there is a loss of ovarian follicles, it is not always complete. Permanent and irreversible loss of follicles is termed premature menopause (MENOPAUSE, PREMATURE). Menopause, Premature (75-91); Ovarian Diseases (66-91) 6r *NkAOvarian Diseases C13.371.056.630; C19.391.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH) Anovulation; Oophoritis; Ovarian Cysts (+ 1); Ovarian Failure, Premature; Ovarian Hyperstimulation Syndrome; Ovarian Neoplasms (+ 1) Anovulation; Oophoritis; Ovarian Cysts (+ 1); Ovarian Failure, Premature; Ovarian Hyperstimulation Syndrome; Ovarian Neoplasms (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI 6"N8XOvarian Cysts C04.182.612; C13.371.056.630.580; C19.391.630.580 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Ovarian Hyperstimulation Syndrome Neoplasms; Cysts Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases Polycystic Ovary Syndrome Polycystic Ovary Syndrome Polycystic Ovary Syndrome General term for cysts and cystic diseases of the ovary. Cysts (66-67); Ovarian Diseases (66-67) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI (69V'YF1XOvalbumin D08.373.745.800.810.650; D12.776.034.614; D12.776.256.317.663; D12.776.290.663 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Egg White Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Egg Proteins, Dietary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins  Avidin Avidin Avidin An albumin obtained from the white of eggs. It is a member of the serpin superfamily.  6 XFjOval Window A09.246.631.909.551 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule Fenestra of the vestibule; an oval opening in the medial wall of the middle ear leading into the vestibule. Normally it is covered by the base of the stapes. Ear, Middle (66-78) 6:2Outpatients M01.643.630 CLEDHILJPXSN Patients Named Groups (Non MeSH); Patients Persons who receive ambulatory care at an outpatient department or clinic without room and board being provided. Ambulatory Care (66-79)  6i +Outpatient Clinics, Hospital N02.278.035.380; N02.278.354.422.527; N04.452.442.422.527 CLECHILJMAOGSDSNSTTDUT Ambulatory Care Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Pain Clinics Pain Clinics Pain Clinics Organized services in a hospital which provide medical care on an outpatient basis.  6"Au/dOutliers, DRG N02.421.589.473.100.456 ECSN Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization; Diagnosis-Related Groups In health care reimbursement, especially in the prospective payment system, those patients who require an unusually long hospital stay or whose stay generates unusually high costs. Costs and Cost Analysis (86-90); Diagnosis-Related Groups (86-90) 6_NOutcome Assessment (Health Care) N04.761.559.590; N05.715.360.575.575 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care; Outcome and Process Assessment (Health Care) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Outcome and Process Assessment (Health Care) Treatment Outcome (+ 2) Treatment Outcome (+ 2) Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). Outcome and Process Assessment (Health Care) (79-91)  6'*::Y>Outcome and Process Assessment (Health Care) N04.761.559; N05.715.360.575 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Outcome Assessment (Health Care) (+ 3); Process Assessment (Health Care) Outcome Assessment (Health Care) (+ 3); Process Assessment (Health Care) Evaluation procedures that focus on both the outcome or status (OUTCOME ASSESSMENT) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (PROCESS ASSESSMENT) - what is done for the patient diagnostically and therapeutically. Quality of Health Care (68-78)  6"5"W&Ouabain D04.808.155.160.861.600; D09.203.408.180.810.600; D18.222.175.810.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Strophanthins Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Strophanthins Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Strophanthins 1 beta,3 beta,5,11 alpha,14,19-Hexahydroxy-5 beta-card-20(22)-enolide-3-L-rhamnoside. A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like digitalis. Synonyms: Gratibain; Astrobain; Purostrophan; Strophoperm. 6 M:/gOtters B02.649.147.725 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Fish-eating mammals. 6 ('Otosclerosis C09.218.768 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fenestration; Stapes Mobilization Otorhinolaryngologic Diseases; Ear Diseases A pathological condition of the bony labyrinth of the ear, in which there is formation of spongy bone (otospongiosis), especially in front of and posterior to the footplate of the stapes. It may cause bony ankylosis of the stapes, resulting in conductive hearing loss. Cochlear otosclerosis may also develop, resulting in sensorineural hearing loss. (Dorland, 27th ed). 6N(3Otorhinolaryngologic Neoplasms C04.588.443.665; C09.647 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms Otorhinolaryngologic Diseases Ear Neoplasms; Laryngeal Neoplasms; Nose Neoplasms (+ 3); Pharyngeal Neoplasms (+ 4) Ear Neoplasms; Laryngeal Neoplasms; Neuroma, Acoustic (+ 1); Nose Neoplasms (+ 3); Pharyngeal Neoplasms (+ 4) The general concept of ORL neoplasms or those for which no specific heading exists. Neoplasms (66-83); Otorhinolaryngological Diseases (66-83)  6H#XpeDOtorhinolaryngologic Diseases C09 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ear Diseases; Laryngeal Diseases; Nose Diseases; Pharyngeal Diseases Otolaryngology Ciliary Motility Disorders (+ 1); Ear Diseases (+ 43); Laryngeal Diseases (+ 13); Nose Diseases (+ 24); Otorhinolaryngologic Neoplasms (+ 13); Pharyngeal Diseases (+ 13) General or unspecified diseases of the ear, nose, and throat. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $6"NRKZOtolithic Membrane A09.246.631.909.625.125.680 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule; Saccule and Utricle; Acoustic Maculae A gelatinous membrane surmounting the acoustic maculae of the saccule and utricle and containing minute calciferous granules, known as otoconia, otoliths, or statoconia. Labyrinth (66-82); Maculae, Acoustic (79-82); Saccule and Utricle (75-82) 6:`YOtolaryngology G02.403.810.526 CLECEDHIISLJMAMTOGSNSTTD Otorhinolaryngologic Diseases Health Occupations; Medicine; Specialties, Surgical A surgical specialty concerned with the study and treatment of disorders of the ear, nose, and throat. 6"={Otoacoustic Emissions, Spontaneous G11.561.796.263.570 DEGEIMPHRE Cochlea Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Hearing Sinusoidal tones originating in the cochlea. These faint sounds, with levels between 10-30 decibels, are usually not recognized by the persons having them. However, the emissions can be recorded using sensitive microphones placed in the ear canals. The clinical significance of having or not having spontaneous otoacoustic emissions is unclear; however, some association between tinnitus and the spontaneous emissions has been reported. Acoustic Stimulation (84-92); Acoustics (84-92); Cochlea (83-92)  6( NOtitis Media, Suppurative C09.218.705.663.694 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Otitis; Otitis Media Inflammation of the middle ear with purulent discharge. Otitis Media (66-78) 60NNCOtitis Media with Effusion C09.218.705.663.683 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Otitis; Otitis Media Inflammation of the middle ear with a clear pale yellow-colored transudate. Otitis Media (66-78) 6ņ!NNZOtitis Media C09.218.705.663 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Otitis Mastoiditis; Otitis Media with Effusion; Otitis Media, Suppurative Inflammation of the middle ear. 6N=O(Otitis Externa C09.218.705.496 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Otitis Inflammation of the external auditory canal. (Dorland, 27th ed). 6BN=OOtitis C09.218.705 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Otitis Externa; Otitis Media (+ 3) Inflammation of the ear, which may be marked by pain, fever, abnormalities of hearing, hearing loss, tinnitus, and vertigo. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS. (From Dorland, 27th ed). 6e N3,=Ostomy E04.579 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Cystostomy; Dacryocystorhinostomy; Enterostomy (+ 5); Esophagostomy; Gastrostomy; Middle Ear Ventilation; Nephrostomy, Percutaneous; Pharyngostomy; Sclerostomy; Thoracostomy; Tracheostomy; Ureterostomy Surgical construction of an artificial opening (stoma) for external fistulization of a duct or vessel by insertion of a tube with or without a supportive stent. Colostomy (66-87); Ileostomy (66-87); Urinary Diversion (73-87)  6ˏ  $MOstertagiasis C03.335.508.700.775.825.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections; Trichostrongyloidiasis A disease of herbivorous mammals, particularly cattle and sheep, caused by stomach worms of the genus OSTERTAGIA. 6POstertagia B01.500.294.700.775.746.432 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Trichostrongyloidea A genus of parasitic nematodes occurring in the stomach of ruminants. Trichostrongyloidea (66-85) 6Ϸ*_T Osteotomy E04.557.703 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Bone and Bones Surgery, Operative; Orthopedics 6 $&Osteosclerosis C05.116.099.708.702 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Melorheostosis; Osteopetrosis; Osteopoikilosis The hardening or abnormal density of bone, as in eburnation and condensing osteitis. (Dorland, 27th ed). 6ѥNk6~Osteosarcoma, Juxtacortical C04.557.450.565.575.650.655; C04.557.450.795.620.655 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue; Osteosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Osteosarcoma A form of osteogenic sarcoma of relatively low malignancy, probably arising from the periosteum and initially involving cortical bone and adjacent connective tissue. It occurs in middle-aged as well as young adults and most commonly affects the lower part of the femoral shaft. (Stedman, 25th ed). Osteosarcoma (66-93) 6b :XY^Osteosarcoma C04.557.450.565.575.650; C04.557.450.795.620 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Osteosarcoma, Juxtacortical; Sarcoma, Ewing's Osteosarcoma, Juxtacortical; Sarcoma, Ewing's A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed). 6 2X9h Osteoradionecrosis C21.866.733.579 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries Necrosis of bone following radiation injury. 6wNh6Osteoporosis, Postmenopausal C05.116.198.579.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Menopause Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic; Osteoporosis Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. Menopause (66-89); Osteoporosis (66-89)  6ۯ!N ]0Osteoporosis C05.116.198.579 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bone Demineralization, Pathologic Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic Osteoporosis, Postmenopausal; Sudeck's Atrophy Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.  6N'M6Osteopoikilosis C05.116.099.708.702.685; C17.300.705 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Osteosclerosis Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases An asymptomatic, autosomal dominant trait in which pea-sized sclerotic spots, prominent in the metaphyseal area, are accompanied by unique cutaneous lesions. These are yellowish papules or plaques with increased elastin content. (From Cecil Textbook of Medicine, 19th ed). 6l*N=Osteopetrosis C05.116.099.708.702.678 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Osteosclerosis Excessive formation of dense trabecular bone leading to pathological fractures, osteitis, splenomegaly with infarct, anemia, and extramedullary hemopoiesis. 6+N}Osteopathic Medicine G02.403.500 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine A system of therapy and medicine based on the theory that the normal body is a vital mechanical organism whose structural and functional states are of equal importance and is capable of making its own remedies against infections and toxic conditions when there are favorable environmental circumstances and adequate nutrition. 6#|Osteonectin D12.776.157.125.715; D12.776.395.600 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Non-collagenous, calcium-binding glycoprotein of developing bone. It links collagen to mineral in the bone matrix. In the synonym SPARC glycoprotein, the acronym stands for Secreted Protein, Acidic and Rich in Cysteine. Calcium-Binding Proteins (86-89); Carrier Proteins (80-89) 6*HEOsteonecrosis C05.116.852; C23.739.638.732 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Necrosis Femur Head Necrosis (+ 1) Femur Head Necrosis Death of a bone or part of a bone either atraumatic or posttraumatic. Bone Diseases (66-76); Necrosis (66-76)  6"N8V1Osteomyelitis C05.116.165.495 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH) 6N[Osteomalacia C05.116.198.495; C18.452.174.662; C18.654.223.133.770.496 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin D Deficiency A condition marked by softening of the bones (due to impaired mineralization, with excess accumulation of osteoid), with pain, tenderness, muscular weakness, anorexia, and loss of weight, resulting from deficiency of vitamin D and calcium. (Dorland, 27th ed). 6ANJ0Osteoma, Osteoid C04.557.450.565.575.625.625 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue; Osteoma Benign circumscribed tumor of spongy bone occurring especially in the bones of the extremities and vertebrae, most often in young persons. (Dorland, 27th ed). 6VOsteoma C04.557.450.565.575.625 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue Osteoma, Osteoid A benign tumor composed of bone tissue or a hard tumor of bonelike structure developing on a bone (homoplastic osteoma) or on other structures (heteroplastic osteoma). (From Dorland, 27th ed). 6 VOsteolysis, Essential C05.116.099.736; C05.116.264.579.704 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Musculoskeletal Diseases; Bone Diseases; Bone Resorption; Osteolysis Syndromes of bone destruction where the cause is not obvious such as neoplasia, infection, or trauma. The destruction follows various patterns: massive (Gorham disease), multicentric (Hajdu-Cheney syndrome, Winchester syndrome), or carpal/tarsal. 6X*NOsteolysis C05.116.264.579; G11.427.150.150.570 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Resorption Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Remodeling; Bone Resorption Osteolysis, Essential Dissolution of bone that particularly involves the removal or loss of calcium. 6*N^Osteogenesis Imperfecta C05.116.099.708.685; C17.300.200.540 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dentinogenesis Imperfecta Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases A collagen disorder resulting from defective biosynthesis of type I collagen and characterized by brittle, osteoporotic, and easily fractured bones. It may also present with blue sclerae, loose joints, and imperfect dentin formation. There are four major types, I-IV. 6*N8Osteogenesis G07.553.121.729; G11.427.111.729 DEGEIMPHRE Bone and Bones; Calcification, Physiologic Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Bone Development Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Development The histogenesis of bone including ossification. It occurs continuously but particularly in the embryo and child and during fracture repair. 6&3Osteocytes A11.329.729 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH) 6*3Osteoclasts A11.329.679 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH) A large multinuclear cell associated with the absorption and removal of bone. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in cementum resorption. 6*3Osteochondromatosis C04.557.450.565.575.610.615; C05.116.099.708.670.615 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue; Osteochondroma Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Osteochondroma Exostoses, Multiple Hereditary Exostoses, Multiple Hereditary A condition marked by the presence of multiple osteochondromas. (Dorland, 27th ed). Chondroma (66-74); Chondromatosis, Synovial (89-90); Exostoses, Multiple Hereditary (85-93); Synovial Membrane (66-71)  7:NDFeOsteochondroma C04.557.450.565.575.610; C05.116.099.708.670 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Osteochondromatosis (+ 1) Osteochondromatosis (+ 1) A cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors. Chondroma (66-89)  7X2V <pOsteochondrodysplasias C05.116.099.708 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Achondroplasia; Chondrodysplasia Punctata; Cleidocranial Dysplasia; Diaphyseal Dysplasia, Progressive; Ellis-Van Creveld Syndrome; Enchondromatosis; Fibrous Dysplasia of Bone (+ 3); Hyperostosis, Cortical, Congenital; Hyperostosis Frontalis Interna; Langer-Giedion Syndrome; Osteochondroma (+ 2); Osteogenesis Imperfecta; Osteosclerosis (+ 3); Short Rib-Polydactyly Syndrome; Thanatophoric Dysplasia Abnormal development of cartilage and bone. Bone Diseases (66-69); Bone Diseases, Developmental (70-84) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI $7NQ5GVOsteochondritis Dissecans C05.116.791.668 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Osteochondritis A type of osteochondritis in which articular cartilage and associated bone becomes partially or totally detached to form joint loose bodies. Affects mainly the knee, ankle, and elbow joints. Osteochondritis (66-84) 7 NBOsteochondritis C05.116.791 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cartilage Diseases Musculoskeletal Diseases; Bone Diseases Osteochondritis Dissecans; Scheuermann's Disease 7 zN/8Osteocalcin D12.776.157.125.700 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins Vitamin K-dependent calcium-binding protein synthesized by osteoblasts and found primarily in bone. Serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. The protein contains three residues of the amino acid gamma-carboxyglutamic acid (Gla), which, in the presence of calcium, promotes binding to hydroxyapatite and subsequent accumulation in bone matrix. Two CAS Registry Numbers exist: one for mouse-reduced osteocalcin and one for rat-reduced osteocalcin. The registry number given in this record is for mouse-reduced osteocalcin. Binding Proteins (78-80); Calcium (78-80); Calcium-Binding Proteins (80-89); 1-Carboxyglutamic Acid (78-81); Proteins (80-81) 7 HvOsteoblasts A11.329.629 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH) Cells that arise from fibroblasts and which, as they mature, are associated with the production of bone. (From Dorland, 27th ed). 7*3Osteoblastoma C04.557.450.565.575.600 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue A benign, painful, tumor of bone characterized by the formation of osteoid tissue, primitive bone and calcified tissue. It occurs frequently in the spine of young persons. (From Dorland, 27th ed; Stedman, 25th ed). Osteoma, Osteoid (66-93) 7VOsteoarthropathy, Secondary Hypertrophic C05.116.758; C05.550.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Musculoskeletal Diseases; Joint Diseases Symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by dorsal kyphosis and joint involvement. It is often secondary to chronic conditions of the lungs and heart. (Dorland, 27th ed). 7t.N]Osteoarthropathy, Primary Hypertrophic C05.116.725; C05.550.648 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Musculoskeletal Diseases; Joint Diseases A conditioned chiefly characterized by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, seborrhea, hyperhidrosis, periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. It is believed to be inherited as an autosomal dominant trait. (From Dorland, 27th ed). 7<,N]!Osteoarthritis, Hip C05.550.114.606.508; C05.799.613.508 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Osteoarthritis Musculoskeletal Diseases; Rheumatic Diseases; Osteoarthritis Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion. Hip (66-88); Hip Joint (66-88); Osteoarthritis (66-88) 7u*NJDOsteoarthritis C05.550.114.606; C05.799.613 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis Musculoskeletal Diseases; Rheumatic Diseases Osteoarthritis, Hip; Spinal Osteophytosis (+ 1) Osteoarthritis, Hip; Spinal Osteophytosis (+ 1) A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. 7M"NopxOsteitis Fibrosa Cystica C05.116.132.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hyperparathyroidism Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Endocrine (Non MeSH) Rarefying osteitis with fibrous degeneration and formation of cysts, and with the presence of fibrous nodules on the affected bones. It is due to marked osteoclastic activity secondary to hyperfunction of the parathyroid glands. (Dorland, 27th ed). 7!MNZ$Osteitis Deformans C05.116.692 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry. 7#N/tOsteitis C05.116.165.412 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH) 7% N[Ossification, Heterotopic C23.739.686 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Synostosis Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Ossification of Posterior Longitudinal Ligament The development of bony substance in normally soft structures.  7&NY7KOssification of Posterior Longitudinal Ligament C05.116.900.480; C23.739.686.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Longitudinal Ligaments Musculoskeletal Diseases; Bone Diseases; Spinal Diseases Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Ossification, Heterotopic Ossification or calcification of the posterior longitudinal ligament of the spinal column. The main symptoms arise from myelopathy of various degrees of severity, usually spinal cord compression caused by stenosis of the spinal canal. It is very common in the Japanese but relatively less common in Caucasians. It is frequently, but not exclusively, located at the level of the cervical spine. It is often associated with anterior ankylosing hyperostosis. Calcinosis (69-93); Ossification, Heterotopic (67-93)  7(87&N?Ossicular Replacement Prosthesis E04.659.700; E04.847.774.684; E07.450.684; E07.858.565.747 AECLCTECHIISMIMONUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis An implant used to replace one or more of the ear ossicles. They are usually made of plastic (Plasti-Pore, Teflon), Gelfoam, ceramic, or stainless steel. Ear Ossicles (66-86); Prosthesis (66-86); Tympanoplasty (66-86) 7,5&D(MOsseointegration G04.185.753.150.150.570; G11.427.150.140.570 DEGEIMPHRE Arthroplasty; Bone Substitutes; Dental Implantation, Endosseous; Hip Prosthesis Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration; Bone Remodeling; Bone Regeneration Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Remodeling; Bone Regeneration The growth action of bone tissue, as it assimilates surgically implanted devices or prostheses to be used as either replacement parts (e.g., hip) or as anchors (e.g., endosseous dental implants). 7.2]?Osmotic Pressure H01.181.529.687.661; H01.671.691.578 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Permeability Physical Sciences (Non MeSH); Physics; Pressure Osmosis (66-67) 71*Osmotic Fragility E01.223.459.733; G09.188.702 DEGEIMPHRE Hemolysis; Cell Membrane Diagnosis; Diagnosis, Laboratory; Hematologic Tests Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) 72"Osmosis G06.184.708; H01.181.529.687.495 DEPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Permeability Tendency of fluids (e.g., water) to move from the less concentrated to the more concentrated side of a semipermeable membrane. 74 & Osmolar Concentration H01.181.529.623 Diuresis; Water-Electrolyte Balance Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Osmosis (66-67); Water-Electrolyte Balance (66-67) 75*I<Osmium Tetroxide D01.640.500; D01.650.550.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Osmium Compounds Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides (T-4)-Osmium oxide (OsO4). A highly toxic and volatile oxide of osmium used in industry as an oxidizing agent. It is also used as a histological fixative and stain and as a synovectomy agent in arthritic joints. Its vapor can cause eye, skin, and lung damage. Osmium (66-78); Oxides (66-78) 77"89'Osmium Compounds D01.640 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Osmium Tetroxide Inorganic compounds that contain osmium as an integral part of the molecule. Osmium (66-93)  7:> 8%\Osmium D01.268.622; D01.552.636 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals 7;j :`Oscillometry E05.654; H01.671.628 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics 7zL "Orthoreovirus B04.820.630.590; B04.909.777.714.590 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae Reovirus Type 3 Reovirus Type 3 A genus of the family REOVIRIDAE infecting vertebrates only. Serotypes 1, 2, and 3 infect mammals. Reovirus type 1 is the type species. 7?*u(Orthoptics E02.730; G02.573 CLECEDHIISLJMAMTOGSNSTTD Strabismus; Ophthalmology Therapeutics Health Occupations The study and treatment of defects in binocular vision resulting from defects in the optic musculature or of faulty visual habits. It involves a technique of eye exercises designed to correct the visual axes of eyes not properly coordinated for binocular vision. 7A%5Orthoptera B01.131.617.678 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Cockroaches (+ 1); Grasshoppers; Gryllidae An order of insects consisting of several families and genera. The most commonly occurring families are: Acrididae (GRASSHOPPERS), Blattidae and Blatellidae (Oriental, American, and German COCKROACHES), and GRYLLIDAE (crickets). Insects (66-74)  7C(*5 Orthopsychiatry F04.096.544.528 CLECEDHIISLJMAMTOGSNSTTD Mental Health Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry The study and treatment of human behavior problems utilizing principles derived from the behavioral, medical, and social science with emphasis on promotion of mental health. 7E`Orthopoxvirus B04.280.650.160.650; B04.909.204.783.160.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Cowpox Virus; Ectromelia Virus; Monkeypoxvirus; Vaccinia Virus; Variola Virus Cowpox Virus; Ectromelia Virus; Monkeypoxvirus; Vaccinia Virus; Variola Virus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRNINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS. Poxviridae (77-93)  7G'2Orthopedics E04.557; G02.403.810.494 CLECEDHILJMAMTOGSNSTTDVE Surgery, Operative Health Occupations; Medicine; Specialties, Surgical Amputation (+ 3); Arthrodesis (+ 1); Arthroplasty (+ 3); Artificial Limbs; Bone Lengthening; Bone Transplantation; Diskectomy (+ 1); Fracture Fixation (+ 2); Manipulation, Orthopedic; Osteotomy; Tendon Transfer; Traction A surgical specialty which utilizes medical, surgical, and physical methods to treat and correct deformities, diseases, and injuries to the skeletal system, its articulations, and associated structures. AEBSCLCTECEDHIIMIRISLJMAMIMOMTNUOGPAPHPPPSPXRARHRISNSTSUTDUSUTVEVI  7JR FOrthopedic Nursing G02.478.676.615; N02.421.533.635 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The specialty or practice of nursing in the care of the orthopedic patient. Orthopedics/nursing (70-91); Specialties, Nursing (72-91) 7M &\DOrthopedic Fixation Devices E07.858.442.660 AECLCTECHISDSNSTTDUTVE Fracture Fixation Equipment and Supplies; Surgical Equipment; Orthopedic Equipment Bone Nails; Bone Plates; Bone Screws; Bone Wires; Casts, Surgical; External Fixators; Internal Fixators; Splints Devices which are used in the treatment of orthopedic injuries and diseases. Fracture Fixation/instrumentation (66-70); Fracture Fixation, Intramedullary/instrumentation (70); Orthopedic Equipment (66-70) $7N!L\Orthopedic Equipment E07.858.442 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment Artificial Limbs; Canes; Crutches; Joint Prosthesis (+ 2); Orthopedic Fixation Devices (+ 8); Orthotic Devices (+ 1); Walkers AECLCTECHIISMIMOMTNUPSPXRHSDSNSTTDUTVEVI 7Q*3,Orthomyxoviruses Type D B04.820.545.740; B04.909.777.545.740 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae Viruses of the family ORTHOMYXOVIRIDAE comprising tick-borne viruses occasionally infecting humans. Dhori and Thogoto viruses were formerly thought to be members of Bunyaviridae. Arboviruses (70-87); Bunyaviridae (85-89); Orthomyxoviridae (87-93) 7R*POrthomyxoviruses Type C B04.820.545.720; B04.909.777.545.720 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae A genus of the family ORTHOMYXOVIRIDAE comprising viruses similar to Types A and B but less common, more stable, and more homogeneous. They have not been associated with epidemics but may cause mild influenza. Orthomyxoviridae (81-85) 7T*Orthomyxoviruses Type B B04.820.545.690; B04.909.777.545.690 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae Viruses of the family ORTHOMYXOVIRIDAE that cause influenza and other diseases in humans only. Antigenic variation is less extensive than in type A viruses (ORTHOMYXOVIRUSES TYPE A) and consequently there is no basis for distinct subtypes or variants. Epidemics are less likely than with type A and there have been no pandemics. Orthomyxoviridae (81-84) 7V*Orthomyxoviruses Type A B04.820.545.650; B04.909.777.545.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae Orthomyxovirus Type A, Avian; Orthomyxovirus Type A, Human; Orthomyxovirus Type A, Porcine Orthomyxovirus Type A, Avian; Orthomyxovirus Type A, Human; Orthomyxovirus Type A, Porcine Viruses of the family ORTHOMYXOVIRIDAE that cause influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Orthomyxoviridae (68-76)  7Y*Orthomyxovirus Type A, Porcine B04.820.545.650.680; B04.909.777.545.650.680 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae; Orthomyxoviruses Type A Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae; Orthomyxoviruses Type A Strains of ORTHOMYXOVIRUSES TYPE A causing influenza and pneumonia in domestic pigs. 7\x%2dOrthomyxovirus Type A, Human B04.820.545.650.660; B04.909.777.545.650.660 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae; Orthomyxoviruses Type A Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae; Orthomyxoviruses Type A Strains of ORTHOMYXOVIRUSES TYPE A causing influenza and sometimes pneumonia in humans. Orthomyxoviridae (68-74) 7^/#2gOrthomyxovirus Type A, Avian B04.820.545.650.640; B04.909.777.545.650.640 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Orthomyxoviridae; Orthomyxoviruses Type A Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Orthomyxoviridae; Orthomyxoviruses Type A Strains of ORTHOMYXOVIRUSES TYPE A causing influenza in birds. Transmission is caused by close contact. 7`#2{Orthomyxoviridae Infections C02.782.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Fowl Plague; Influenza Virus diseases caused by the ORTHOMYXOVIRIDAE. 7a P:8Orthomyxoviridae B04.820.545; B04.909.777.545 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Orthomyxoviruses Type A (+ 3); Orthomyxoviruses Type B; Orthomyxoviruses Type C; Orthomyxoviruses Type D Orthomyxoviruses Type A (+ 3); Orthomyxoviruses Type B; Orthomyxoviruses Type C; Orthomyxoviruses Type D A family of RNA viruses causing influenza and other diseases. There are two recognized genera but they do not have official names as yet (1993). They have been called Influenzavirus A and B, and Influenzavirus C. 7c "YOrthomolecular Therapy E02.319.630; F04.881.400 AECLECEDHIISLJMAMTOGSNSTTD Therapeutics; Drug Therapy Disciplines, Tests, Therapy, Services (Non MeSH); Somatic Therapies, Psychiatric (Non MeSH) The use of very large doses of vitamins or other naturally occurring substances normally present in the body, frequently for the treatment of mental disorders. Ascorbic Acid (74-76); Vitamins (74-76) 7e1Orthohepadnavirus B04.280.375.650; B04.450.390.650; B04.909.204.340.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Hepadnaviridae Viruses; Hepatitis Viruses; Hepadnaviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Hepadnaviridae Hepatitis B Virus; Hepatitis Virus, Woodchuck Hepatitis B Virus; Hepatitis Virus, Woodchuck Hepatitis B Virus; Hepatitis Virus, Woodchuck A genus of HEPADNAVIRIDAE causing hepatitis in humans, woodchucks, and ground squirrels. It is also associated with human hepatocellular carcinoma. 7g=Orthodontics, Preventive E06.658.703 AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE Dentistry; Orthodontics Space Maintenance 7jZ*Orthodontics, Interceptive E06.658.641 AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE Dentistry; Orthodontics Serial Extraction Recognition and elimination of potential irregularities and malpositions in the developing dentofacial complex. Orthodontics, Preventive (66-74)  7k*&Orthodontics, Corrective E06.658.578 AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE Crown Lengthening Malocclusion Dentistry; Orthodontics Palatal Expansion Technique; Tooth Movement, Minor The phase of orthodontics concerned with the correction of malocclusion with proper appliances and prevention of its sequelae (Jablonski's Illus. Dictionary of Dentistry). $7lb*<Orthodontics E06.658; G02.163.876.439 CLECEDHIISLJMAMTOGSNSTTD Dentistry Health Occupations; Dentistry; Specialties, Dental Orthodontic Appliance Design; Orthodontic Appliances (+ 9); Orthodontics, Corrective (+ 2); Orthodontics, Interceptive (+ 1); Orthodontics, Preventive (+ 1) A dental specialty concerned with the prevention and correction of dental and oral anomalies (malocclusion). AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE  7n.G,Orthodontic Wires E06.658.453.684 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances Wires of various dimensions and grades made of stainless steel or precious metal. They are used in orthodontic treatment. Orthodontic Appliances (66-81) 7pP8$Orthodontic Retainers E06.658.453.637 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances Orthodontic appliances, fixed or removable, used to maintain teeth in corrected positions during the period of functional adaptation following corrective treatment. These appliances are also used to maintain the positions of the teeth and jaws gained by orthodontic procedures. (From Zwemer, Boucher's Clinical Dental Terminology, 4th ed, p263). Orthodontic Appliances (66-94) 7q8$Orthodontic Brackets E06.658.453.590 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances Small metal or ceramic attachments used to fasten an arch wire. These attachments are soldered or welded to an orthodontic band or cemented directly onto the teeth. Bowles brackets, edgewise brackets, multiphase brackets, ribbon arch brackets, twin-wire brackets, and universal brackets are all types of orthodontic brackets. Orthodontic Appliances (67-91) 7t8z$Orthodontic Appliances, Removable E06.658.453.578 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances Activator Appliances; Extraoral Traction Appliances Orthodontic Appliances (66-70) 7vD'8<$Orthodontic Appliances, Functional E06.658.453.560 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances Activator Appliances Loose, usually removable intra-oral devices which alter the muscle forces against the teeth and craniofacial skeleton. These are dynamic appliances which depend on altered neuromuscular action to effect bony growth and occlusal development. They are usually used in mixed dentition to treat pediatric malocclusions. (ADA, 1992). Activator Appliances (75-92)  7wW(8~"Orthodontic Appliances E06.658.453 AECLCTECHISDSNSTTDUTVE Dental Bonding Dentistry; Orthodontics Occlusal Splints; Orthodontic Appliances, Functional (+ 1); Orthodontic Appliances, Removable (+ 2); Orthodontic Brackets; Orthodontic Retainers; Orthodontic Wires 7yOrthodontic Appliance Design E06.658.450; E06.912.675 AECLCTECHIISMTNUPXSNSTTDVE Dentistry; Orthodontics Dentistry; Technology, Dental The planning, calculation, and creation of an apparatus for the purpose of correcting the placement or straightening of teeth. Orthodontic Appliances (72-91) 7{""?$Orphenadrine D02.092.471.600; D02.455.426.559.389.115.600; D14.100.120.200.500.600; D15.090.050.600; D15.525.590; D16.050.650.560; D16.700.600.590 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzhydryl Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. 7|:yOrphan Drug Production J01.576.318.600 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Industry; Drug Industry Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others. Drug Industry (66-84); Drugs (66-84); Legislation, Drug (68-84); Legislation, Medical (66-67) 7"SqOrotidine-5'-Phosphate Decarboxylase D08.586.520.258.540 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases Orotidine-5'-phosphate carboxy-lyase. Catalyzes the decarboxylation of orotidylic acid to yield uridylic acid in the final step of the pyrimidine nucleotide biosynthesis pathway. EC 4.1.1.23. Carboxy-Lyases (66-76); Pyrimidine Nucleotides (73-74); Ribonucleotides (73-74); Uracil Nucleotides (75-76) 7)Fa~Orotic Acid D03.066.627; D03.383.742.698.875.660 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil 7b*:Orotate Phosphoribosyltransferase D08.586.913.400.725.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases The enzyme catalyzing the formation of orotidine-5'-phosphoric acid (orotidylic acid) from orotic acid and 5-phosphoribosyl-1-pyrophosphate in the course of pyrimidine nucleotide biosynthesis. EC 2.4.2.10. Pentosyltransferases (72-76); Pyrimidine Nucleotides (72-74); Ribonucleotides (72-74); Uracil Nucleotides (75-76) 7&FOrosomucoid D12.776.124.050.600; D12.776.124.790.106.640; D12.776.377.715.085.640; D12.776.395.560.742 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins 7FdFOropharynx A14.724.603 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Stomatognathic System; Pharynx Tonsil Oral part of the pharynx. Pharynx (66-78) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $78% ":Oropharyngeal Neoplasms C04.588.443.665.710.684; C07.550.745.671; C09.647.710.685; C09.775.549.685 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms Stomatognathic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms Otorhinolaryngologic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms Tonsillar Neoplasms Tonsillar Neoplasms Tonsillar Neoplasms Tonsillar Neoplasms Oropharynx (79-84); Pharyngeal Neoplasms (66-84) 7 TXZ:Orofaciodigital Syndromes C05.116.099.370.652; C16.131.077.677; C16.131.280.748.590 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Two syndromes of oral, facial, and digital malformations. Type I (Papillon-Leage and Psaume syndrome, Gorlin-Psaume syndrome) is inherited as an X-linked dominant trait and is found only in females and XXY males. Type II (Mohr syndrome) is inherited as an autosomal recessive trait. 7ALHKOroantral Fistula C07.465.614.421; C23.439.600.421 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Oral Fistula (Non MeSH) Symptoms and General Pathology (Non MeSH); Fistula; Oral Fistula (Non MeSH) A fistula between the maxillary sinus and the oral cavity, sometimes through the tooth socket. (Jablonski, Illustrated Dictionary of Dentistry). Fistula (66) 7q&NOrnithosis C01.252.400.810.200.195.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Chlamydiaceae Infections; Chlamydia Infections Infection with CHLAMYDIA PSITTACI, transmitted to man by inhalation of dust-borne contaminated nasal secretions or excreta of infected birds. This infection results in a febrile illness characterized by pneumonitis and systemic manifestations. 7POrnithine Decarboxylase D08.586.520.258.520 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. EC 4.1.1.17. Carboxy-Lyases (72-74); Ornithine (72-74) 7FaO2Ornithine Carbamoyltransferase D08.586.913.593 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme of the transferase class that catalyzes the reaction of carbamoyl phosphate and L-ornithine to yield orthophosphate and L-citrulline. The enzyme occurs in the liver. The reaction is a part of the urea cycle. Genetic deficiency of the enzyme, an X-linked trait, impairs urea formation and produces hyperammonemia. (From Dorland, 27th ed) EC 2.1.3.3. 7#FUOrnithine Aminotransferase D08.586.913.140.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Aminotransferases A pyridoxal phosphate enzyme that catalyzes the formation of glutamate gamma-semialdehyde and an L-amino acid from L-ornithine and a 2-keto-acid. EC 2.6.1.13. Aminotransferases (69-74); Ornithine (69-74) 7:Fj5Ornithine D12.125.095.765 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino Eflornithine Ornithine. An amino acid produced in the urea cycle by the splitting off of urea from arginine. 75 FbuOrnipressin D06.472.734.692.781.700; D12.644.456.925.700; D18.793.670; D19.770.896.670 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Cardiovascular Agents; Vasoconstrictor Agents Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Vasopressins 8-L-Ornithine vasopressin. Synthetic analog of vasopressin with ornithine in position 8 of the cyclic octapeptide chain; used as local vasoconstrictor and hemostatic. Synonyms: Haesandon; POR 8. Ornithine (66-78); Vasopressins (66-78) 7T:0Ornidazole D02.640.672.700; D03.383.374.658.700; D21.370.107.600; D21.370.370.695 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antitrichomonal Agents alpha-(Chloromethyl)-2-methyl-5-nitro-1H-imidazole-1-ethanol. A nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action. Alcohol, Propyl (66-74); Imidazoles (66-73); Nitroimidazoles (74) 7P:WOOrientation F01.058.577; F02.830.606 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Adaptation, Psychological Psychologic Processes and Principles (Non MeSH); Psychophysiology  Echolocation; Kinesis Awareness of oneself in relation to time, place and person. 7\ IOrgasm F01.145.792.659; G08.520.900.400 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sex The crisis of sexual excitement in either humans or animals. 7 & JOrganotin Compounds D02.691.850 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Tin Organic Chemicals (Non MeSH); Organometallic Compounds Trialkyltin Compounds (+ 2) Organic compounds which contain tin in the molecule. Used widely in industry and agriculture. Organometallic Compounds (74); Tin (74) $78A"p1Organothiophosphorus Compounds D02.719 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cholinesterase Inhibitors; Cholinesterase Reactivators; Insecticides, Organothiophosphate Phosphorus Organic Chemicals (Non MeSH) Abate; Amifostine; Azinphosmethyl; Coumaphos; Cystaphos; Diazinon; Dimethoate; Disulfoton; Dursban; Dyfonate; Echothiophate Iodide; EPN; Fenchlorphos; Fenitrothion; Fenthion; Malathion; Parathion (+ 1); Phorate; Phosmet; Phosvel; Thiophosphoric Acid Esters; Thiotepa Compounds containing carbon-phosphorus bonds in which the phosphorus component is also bonded to one or more sulfur atoms. Many of these compounds function as pesticides (e.g., INSECTICIDES, ORGANOTHIOPHOSPHATE). Phosphates (66-70); Phosphonic Acids (66-70); Phosphoric Acids (68-70); Phosphorous Acids (68-70); Phosphorus (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,7# 8d#>:Organotherapy E02.095.682 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH) 7"4Organotechnetium Compounds D02.691.825 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Technetium Organic Chemicals (Non MeSH); Organometallic Compounds Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Medronate; Technetium Tc 99m Mertiatide; Technetium Tc 99m Pentetate; Technetium Tc 99m Sestamibi Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents. Organometallic Compounds (66-89); Technetium (66-89) AAADAEAGAIANBLCFCHCLCSCTDEDUECHIIMIPMEPDPKPORESDSTTOTUULUR (7a8A>>Organosilicon Compounds D02.715 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Silicon Organic Chemicals (Non MeSH) Silanes; Siloxanes (+ 4); Trimethylsilyl Compounds Organic compounds that contain silicon as an integral part of the molecule. Silicon (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (7" 8 #>[:Organoselenium Compounds D02.712 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Selenocysteine; Selenomethionine Organic compounds which contain selenium as an integral part of the molecule. Selenium (66-91) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $7 8#&]FOrganoplatinum Compounds D02.691.800 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Platinum Organic Chemicals (Non MeSH); Organometallic Compounds Carboplatin Organic compounds which contain platinum as an integral part of the molecule. Organometallic Compounds (68-77); Platinum (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (7Y8 A]<:Organophosphorus Compounds D02.705 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cholinesterase Inhibitors; Cholinesterase Reactivators; Insecticides, Organophosphate Phosphorus Organic Chemicals (Non MeSH) Aminoethylphosphonic Acid; Armin; Carbamyl Phosphate; Chlorfenvinphos; Dichlorvos; Diphosphoglyceric Acids; Diphosphonates (+ 3); Fosfomycin; Fosinopril; Hempa; Isoflurophate; Mevinphos; Monocrotophos; Naled; Paraoxon; Phosphamidon; Phosphines; Phosphinic Acids; Phosphonic Acids; Phosphonoacetic Acid (+ 1); Phosphoramide Mustards (+ 2); Phosphoranes; Phosphoric Acid Esters; Phosphorous Acids (+ 1); Phosphoserine; Phosphothreonine; Polyisoprenyl Phosphates (+ 1); Sarin; Soman; Tetrachlorvinphos; Tetraisopropylpyrophosphamide; Trichlorfon; Tritolyl Phosphates Organic compounds that contain phosphorus as an integral part of the molecule. Phosphates (66-70); Phosphonic Acids (66-70); Phosphoric Acids (68-70); Phosphorous Acids (68-70); Phosphorus (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,7 8`#^DOrganometallic Compounds D02.691 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Diuretics, Mercurial Metals Organic Chemicals (Non MeSH) Antimony Potassium Tartrate; Antimony Sodium Gluconate; Arsenicals (+ 8); Aurothioglucose (+ 1); Ferric Compounds (+ 1); Ferrous Compounds; Gold Sodium Thiomalate; Maneb; Organomercury Compounds (+ 16); Organoplatinum Compounds (+ 1); Organotechnetium Compounds (+ 5); Organotin Compounds (+ 3); Sucralfate; Tetraethyl Lead; Zineb AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR $7  8 #DOrganomercury Compounds D02.691.750 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Mercury Organic Chemicals (Non MeSH); Organometallic Compounds Alkylmercury Compounds (+ 7); Merbromine; Phenylmercury Compounds (+ 6) Organic compounds which contain mercury as an integral part of the molecule. Mercury (68-76); Organometallic Compounds (68-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (78 AV\;:Organoids A11.700 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells An organization of cells of different tissue types generated in culture to simulate an organ. The term can also refer to certain neoplasms that contain cytologic and histologic elements arranged in a pattern that closely resembles or is virtually identical to a normal organ. 7  ( DOrganizations, Nonprofit N03.540.630 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations Foundations; Voluntary Health Agencies (+ 5) Organizations which are not operated for a profit and may be supported by endowments or private contributions. CLECHILJMAOGSDSNSTTDUT  7hF6Organizations N03.540 CLECHILJOGSNSTTDUT Societies Economics, Organizations, Control (Non MeSH) Academies and Institutes; Congresses (+ 2); Consumer Organizations (+ 2); Government Agencies (+ 25); Health Planning Organizations (+ 4); Home Care Agencies; International Agencies (+ 4); Labor Unions (+ 2); National Academy of Sciences (U.S.) (+ 1); Organizations, Nonprofit (+ 7); Self-Help Groups (+ 1); Societies (+ 12) Administration and functional structures for the purpose of collectively systematizing activities for a particular goal. specific organization (66-67) CLECHILJMAMTOGPXSDSNSTTDUT (7  4#Organizational Policy I01.880.604.710.550; N03.706.710.550 Social Sciences; Sociology; Social Control, Formal; Policies (Non MeSH) Economics, Organizations, Control (Non MeSH); Social Control, Formal; Policies (Non MeSH) A course or method of action selected, usually by an organization, institution, university, society, etc., from among alternatives to guide and determine present and future decisions and positions on public matters. It does not include internal policy relating to the organization and administration within the corporate body, for which ORGANIZATION AND ADMINISTRATION is available. Public Policy (78-90) 7*Organizational Objectives N04.452.615 EC Health Services Administration (Non MeSH); Organization and Administration The purposes, missions, and goals of an individual organization or its units, established through administrative processes. It includes an organization's long-range plans and administrative philosophy. 7WOrganizational Innovation N04.452.610 EC Health Services Administration (Non MeSH); Organization and Administration Entrepreneurship Introduction of changes which are new to the organization and are created by management. CLECHILJOGSNSTTDUT  7yWjOrganizational Culture N04.452.606 Health Services Administration (Non MeSH); Organization and Administration Beliefs and values shared by all members of the organization. These shared values are reflected in the day to day operations of the organization. Culture (66-88); Organization and Administration (68-88) 7WCOrganizational Affiliation N04.452.602 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Transfer Agreement Formal relationships established between otherwise independent organizations. These include affiliation agreements, interlocking boards, common controls, hospital medical school affiliations, etc. specific organization (66-67)  7WW#Organization and Administration N04.452 ECSNST Health Services Administration (Non MeSH) Annual Reports; Appointments and Schedules (+ 1); Constitution and Bylaws; Decision Making, Organizational; Efficiency, Organizational; Eligibility Determination; Fee Schedules (+ 1); Formularies (+ 1); Governing Board (+ 1); Hospital Administration (+ 57); Institutional Management Teams; Management Audit; Management Information Systems (+ 15); Medication Systems (+ 1); Models, Organizational; Multi-Institutional Systems (+ 1); Organizational Affiliation (+ 1); Organizational Culture; Organizational Innovation (+ 1); Organizational Objectives; Ownership (+ 3); Patient Identification Systems; Personnel Management (+ 25); Pharmacy Administration (+ 3); Planning Techniques; Professional Practice (+ 32); Program Development; Public Health Administration; Public Relations (+ 8); Records (+ 16); Risk Management (+ 2); Safety Management; Security Measures (+ 1); Time Management; Total Quality Management The planning and managing of programs, services, and resources. CLECEDEHHIISLJMAMTOGPXSDSNSTTDUTVE  74%  13L&Organic Mental Disorders, Substance-Induced F03.709.508.490 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders Alcoholic Intoxication; Substance Withdrawal Syndrome (+ 1) Organic brain syndromes caused by the direct effects on the nervous system of various substances. These are distinguished from the substance use disorders that refer to the behavior associated with taking substances that affect the central nervous system. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  7o2DgF*NOrganic Mental Disorders, Psychotic F03.709.508.460; F03.709.680.610 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Brain Diseases Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders Alcohol Amnestic Disorder; Delirium; Delusions (+ 1); Dementia (+ 9); Psychoses, Substance-Induced (+ 3) Alcohol Amnestic Disorder; Delirium; Delusions (+ 1); Dementia (+ 9); Psychoses, Substance-Induced (+ 3) Psychotic manifestations associated with or resulting from a demonstrable physical disturbance of brain function such as tremor, infection, or injury. Psychotic Disorders (66-68) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI (7H*&F!POrganic Mental Disorders F03.709.508 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders Organic Mental Disorders, Psychotic (+ 18); Organic Mental Disorders, Substance-Induced (+ 3) Mental disorders associated with or caused by disturbance in the physiologic functioning of brain tissue without evidence of psychosis. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  7DInPOrganic Chemicals (Non MeSH) D02 Alcohols (+ 148); Aldehydes (+ 17); Amides (+ 98); Amidines (+ 27); Amines (+ 260); Anhydrides (+ 5); Aza Compounds (+ 3); Azides; Azo Compounds (+ 17); Boron Compounds (+ 7); Bridged Compounds (+ 6); Carboxylic Acids (+ 480); Cyanates (+ 1); Ethers (+ 33); Free Radicals (+ 2); Glycosylation End Products, Advanced; Hydrazines (+ 14); Hydrocarbons (+ 297); Imides (+ 9); Imines (+ 8); Isocyanates (+ 6); Ketones (+ 39); Lactones (+ 8); Nitrates; Nitriles (+ 11); Nitrites (+ 1); Nitro Compounds (+ 40); Nitroso Compounds (+ 16); Onium Compounds (+ 45); Organometallic Compounds (+ 50); Organophosphorus Compounds (+ 41); Organoselenium Compounds (+ 2); Organosilicon Compounds (+ 7); Organothiophosphorus Compounds (+ 23); Phenols (+ 68); Quinones (+ 12); Semicarbazides (+ 5); Sulfur Compounds (Non MeSH) (+ 156); Triazenes (+ 2); Urea (+ 42) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 7F# HOrganelles A11.368.702 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm Centrosome (+ 1); Coated Vesicles (+ 1); Endoplasmic Reticulum (+ 4); Fimbriae, Bacterial; Golgi Apparatus; Lysosomes; Microbodies; Mitochondria (+ 4); Mitotic Spindle Apparatus; Myofibrils (+ 1); Neurofibrils (+ 1); Phagosomes; Pili, Sex; Plastids (+ 1); Pseudopodia (+ 2); Ribosomes; Spliceosomes; Vacuoles Specific, usually subcellular, particles of membrane-bound organized living substances present in practically all eukaryotic cells, including mitochondria, the Golgi complex, endoplasmic reticulum, lysosomes, centrioles and the cell center, as well as the plastids of plant cells. Includes also the minute organs of protozoa concerned with such functions as locomotion and metabolism. Organoids (66-88)  7*yOrgan Weight E05.118.715; G07.553.481.690 DEGEIMPHRE Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth 7"Organ Transplantation E04.936.450 AECLCTECHIISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Transplantation Immunology Transplantation Surgery, Operative; Transplantation Bone Transplantation; Heart Transplantation (+ 1); Kidney Transplantation; Liver Transplantation; Lung Transplantation (+ 1); Pancreas Transplantation Transference of an organ between individuals of the same species or between individuals of different species. specific organ/transplantation (66-90); Transplantation (66-90) AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE ,70*J2Organ Specificity G04.610.106.493 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antibody Specificity Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology. 7zj7Organ Procurement N02.421.559 CLECHILJMAMTOGSNSTTDUT Tissue Donors Facilities, Manpower and Services (Non MeSH); Health Services The obtaining of organs for transplantation, which includes methods of obtaining through programs, systems, or organizations. It includes also the transporting of donor organs, after surgical removal, to the hospital for processing and transplant. Tissue Donors (66-86)  7uJOrgan Preservation E05.760.833.660 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Preservation, Biological; Tissue Preservation 7t"`Organ of Corti A09.246.631.246.577 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea Hair Cells (+ 2); Labyrinth Supporting Cells The organ that contains the special sensory receptors for hearing. It is composed of a series of epithelial structures placed upon the inner part of the basilar membrane. ABAHBSCHCLCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI  7?808:Organ Culture E05.909.813.576 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cells, Cultured; Tissue Culture Miscellaneous Techniques (Non MeSH); Technology, Medical; Tissue Culture Tissue Culture (66-68) 7:"'VOrf Virus B04.280.650.160.670.600; B04.909.204.783.160.670.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Parapoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Parapoxvirus The type species of PARAPOXVIRUS which causes a skin infection in natural hosts, usually young sheep. Humans may contract local skin lesions by contact. The virus apparently persists in soil. 7A:Oregon Z01.107.567.875.100.683; Z01.107.567.875.600.656.683 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Northwestern United States 7j :Orciprenaline D02.033.329.291.550; D02.092.063.291.550; D02.092.211.215.311.600; D02.092.311.660; D14.100.050.100.200.590; D16.050.110.590; D16.050.870.620 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines Organic Chemicals (Non MeSH); Amines; Catecholamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Fenoterol Fenoterol Fenoterol Fenoterol A beta-adrenergic agonist used in the treatment of asthma and bronchospasms. 7:1[Orchitis C12.294.829.493; C19.391.829.493 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Testicular Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Testicular Diseases Inflammation of a testis. The disease is marked by pain, swelling, and a feeling of weight. It may occur idiopathically, or it may be associated with conditions such as mumps, gonorrhea, filarial disease, syphilis, or tuberculosis. (Dorland, 27th ed). 7K &N*Orchiectomy E04.779.282.679; E04.887.165.679; E04.887.774.692.618 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Testis Surgery, Operative; Surgery, Endocrine (Non MeSH); Castration Surgery, Operative; Surgery, Urogenital (Non MeSH); Castration Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Surgery, Urologic, Male (Non MeSH) The surgical removal of one or both testicles. Castration (66-85)  7=$ :Orbivirus B04.820.630.550; B04.909.777.714.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae African Horsesickness Virus; Bluetongue Virus; Hemorrhagic Disease Virus, Epizootic; Kemerovo Virus African Horsesickness Virus; Bluetongue Virus; Hemorrhagic Disease Virus, Epizootic; Kemerovo Virus A genus of REOVIRIDAE infecting a wide range of arthropods and vertebrates including humans. It comprises at least twelve serological subgroups. Transmission is by vectors such as midges, mosquitoes, sandflies, and ticks. Reoviridae (76-93); RNA Viruses (75-77)  7 *u1Orbital Neoplasms C04.588.149.721.656; C04.588.364.659; C05.116.231.754.659; C11.319.457; C11.675.659 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Eye Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms; Skull Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Eye Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms; Skull Neoplasms Eye Diseases; Eye Neoplasms Eye Diseases; Orbital Diseases Neoplasms of the bony orbit and contents except the eyeball. 8_X4JOrbital Fractures C21.866.405.762.684; C21.866.460.836.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Skull Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Skull Fractures Fractures of the bones in the orbit, which include parts of the frontal, ethmoidal, lacrimal, and sphenoid bones and the maxilla and zygoma. Fractures (66-82); Orbit (66-82); Skull Fractures (66-82) 8z.NGOrbital Diseases C11.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Enophthalmos; Exophthalmos (+ 1); Granuloma, Plasma Cell, Orbital; Orbital Neoplasms Diseases of the bony orbit and contents except the eyeball. Eye Diseases (66-80); Orbit (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $8 NeI-XOrbit Evisceration E04.792.760 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Eye Evisceration Eye Evisceration Surgery, Operative; Surgery, Eye (Non MeSH) The surgical removal of the contents of the orbit. This includes the eyeball, blood vessels, muscles, fat, nerve supply, and periosteum. It should be differentiated from EYE EVISCERATION which removes the inner contents of the eye, leaving the sclera intact. Orbit/surgery (66-92) $8 $50Orbit A02.835.232.781.324.690 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones 8  :UOral Submucous Fibrosis C07.465.654 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Mouth Diseases (66-67) 8 N/Oral Stage F01.752.747.722.626; F02.739.794.793.626 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Psychosexual Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory; Psychosexual Development The earliest of the stages of infantile psychosexual development, lasting from birth to 12 months or longer. 8 .Oral Manifestations C07.465.634; C23.888.636 Mouth Stomatognathic Diseases; Mouth Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Disorders of the mouth attendant upon non-oral disease or injury. 8 OOral Hygiene Index E05.318.308.250.300.675; E06.208.576; G03.850.520.308.250.300.675; G03.890.160.168; N05.715.360.300.375.300.670 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Dentistry; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health Dentistry; Dental Health Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Dental Health Surveys A combination of the debris index and the dental calculus index to determine the status of oral hygiene. 8{v~Oral Hygiene E02.547.600; E06.761.726 AECLCTECEDHIISMAMOMTNUPXSNSTTDUTVE Dental Devices, Home Care; Toothbrushing Therapeutics; Hygiene Dentistry; Preventive Dentistry  Dental Devices, Home Care; Toothbrushing The practice of personal hygiene of the mouth. It includes the maintenance of oral cleanliness, tissue tone, and general preservation of oral health. Oral Health (66-72) AECLCTECEDHIISMAMOMTNUPXSDSNSTTDUTVE (8&1?2(Oral Hemorrhage C07.465.625; C23.542.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Gingival Hemorrhage Gingival Hemorrhage Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums; the term should not be used for the escape of blood from the mouth due to internal injuries. Hemorrhage (66); specific disease or procedure  8Nn.'9Oral Health N01.407.540.576 ST Dental Clinics; Dental Health Surveys; Diagnosis, Oral; Mouth Diseases; Mouth Rehabilitation Mouth Diseases Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health The optimal state of the mouth and normal functioning of the organs of the mouth without evidence of disease.  8Fn]Oral Fistula (Non MeSH) C07.465.614; C23.439.600 Stomatognathic Diseases; Mouth Diseases Symptoms and General Pathology (Non MeSH); Fistula Dental Fistula; Oroantral Fistula; Salivary Gland Fistula Dental Fistula; Oroantral Fistula; Salivary Gland Fistula BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI 8kNOral Character F02.739.794.684 Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory A pattern of personal traits determined by drives originating in the oral stage of psychosexual development. 8lOptometry G02.553 CLECEDHIISLJMAMTOGSNSTTD Health Occupations The professional practice of primary eye and vision care that includes the measurement of visual refractive power and the correction of visual defects with lenses or glasses. 8  Optics H01.671.606 CLHIIS Lenses; Vision Physical Sciences (Non MeSH); Physics Anisotropy; Birefringence; Color; Darkness; Fiber Optics; Light (+ 4); Microscopy; Optical Rotation; Photography (+ 11); Refractometry AECLCTDEDUECEDHIISLJMAMOMTNUOGPXRESDSNSTTDTUUTVE  8  /4Optical Storage Devices L01.178.147.668; L01.700.568.080.260.115.475.600 CLECHILJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers; Computer Peripherals; Computer Storage Devices Videodisc Recording (+ 2) CD-ROM; Compact Disks A computer disk read by a laser beam, containing data prerecorded by a vendor. The buyer cannot enter or modify data in any way but the advantages lie in the speed of accessibility, relative immunity to damage, and relatively low cost of purchase. CLECHIISLJMTSDSNSTTDUT  8 q6:'Optical Rotatory Dispersion E05.196.867.576 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis The method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule. Spectrum Analysis (66-67) 8#!"[Optical Rotation H01.671.606.714 Physical Sciences (Non MeSH); Physics; Optics Chemistry, Physical (66-70) 8%W9!Optical Illusions F02.463.593.446.659 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Illusions An illusion of vision usually affecting spatial relations. 8% iFOptic Neuritis C10.772.204.607.600; C10.772.582.451; C11.640.576 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Optic Nerve Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Neuritis Eye Diseases; Optic Nerve Diseases Neuromyelitis Optica Neuromyelitis Optica Inflammation of the optic nerve. It may affect the part of the nerve within the eyeball (neuropapillitis) or the portion behind the eyeball (retrobulbar neuritis). (Dorland, 27th ed). 8'9N1Optic Nerve Diseases C10.772.204.607; C11.640 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Eye Diseases Optic Atrophy (+ 1); Optic Disk Drusen; Optic Neuritis (+ 1); Papilledema Optic Atrophy (+ 1); Optic Disk Drusen; Optic Neuritis (+ 1); Papilledema Diseases of the optic nerve. Optic Nerve (66-75)  8)Nq%Optic Nerve A08.800.800.120.680 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves Optic Chiasm; Optic Disk The 2nd cranial nerve. The optic nerve conveys visual information from the retina to the brain. The nerve carries the axons of the retinal ganglion cells which sort at the optic chiasm and continue via the optic tracts to the brain. The largest projection is to the lateral geniculate nuclei; other important targets include the superior colliculi and the suprachiasmatic nuclei. The optic nerve is part of the central rather than the peripheral nervous system but is grouped here with the other cranial nerves. 8+8[ \Optic Lobe A13.686 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) 8/: 8Optic Disk Drusen C10.772.204.607.530; C11.640.513 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Optic Nerve Diseases Eye Diseases; Optic Nerve Diseases Hyaline bodies occurring in the intra-ocular portion of the optic nerve. They are distinguished from RETINAL DRUSEN, which lie beneath the retinal pigment epithelium. This disorder is differentiated also from PAPILLEDEMA by the absence of dilated retinal vessels. Optic Disk (75-89); Optic Nerve (68-85); Optic Nerve Diseases (75-89) 8/&N3VOptic Disk A08.800.800.120.680.660; A09.371.729.690 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Optic Nerve Sense Organs; Eye; Retina The portion of the optic nerve seen in the fundus with the ophthalmoscope. It is formed by the meeting of all the retinal ganglion cell axons as they enter the optic nerve. Because the retina at the optic disk has no photoreceptors there is a corresponding blind spot in the visual field. 82.6ZOptic Chiasm A08.800.800.120.680.600 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Optic Nerve The X-shaped structure formed by the meeting of the two optic nerves. At the optic chiasm the fibers from the medial part of each retina cross to project to the other side of the brain while the lateral retinal fibers continue on the same side. As a result each half of the brain receives information about the contralateral visual field from both eyes. 85$6kOptic Atrophy, Hereditary C10.500.686.580; C10.772.204.607.500.500; C10.772.587.580; C11.270.564; C11.640.451.451; C16.131.410.564; C16.131.666.686.580 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Optic Nerve Diseases; Optic Atrophy Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Motor and Sensory Eye Diseases; Eye Diseases, Hereditary Eye Diseases; Optic Nerve Diseases; Optic Atrophy Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory An inherited disorder in which optic atrophy is associated with muscle weakness, peroneal muscular atrophy and, in some patients, lancinating pains. In these patients the peripheral sensory neurons are probably affected. Optic Atrophy/genetics (66-88) 87L%Optic Atrophy C10.772.204.607.500; C11.640.451 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Optic Nerve Diseases Eye Diseases; Optic Nerve Diseases Optic Atrophy, Hereditary Optic Atrophy, Hereditary Atrophy of the optic disk resulting from degeneration of the nerve fibers of the optic nerve and optic tract. (Dorland, 27th ed). 8<&N<Opsonins D12.776.124.486.657; D24.611.125.767 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Phagocytosis Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH) Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies 8?  *6Opsin D11.557.261.648.500; D12.776.306.500 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinal Pigments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Eye Proteins Rhodopsin Rhodopsin A visual pigment protein found in the retinal rods. It combines with retinaldehyde to form RHODOPSIN. Eye Proteins (73-92) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $8@ *DzHOpportunistic Infections C01.539.597; C02.597; C03.684 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Virus Diseases Parasitic Diseases AIDS-Related Opportunistic Infections; Superinfection AIDS-Related Opportunistic Infections; Superinfection AIDS-Related Opportunistic Infections; Superinfection An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Acquired Immunodeficiency Syndrome (83-86); Bacterial Infections (72-86); Infection (66-86); specific infection (66-86)  8B%PeOpossums B02.649.573.575 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Marsupialia Marsupials of the family Didelphidae. Opossums are common, omnivorous, largely nocturnal and arboreal mammals, grow to about three feet in length, including the scaly prehensile tail, have coarse grayish fur mingled with whitish hairs, and have an abdominal pouch in which the young are carried at birth. (Webster, 3d ed). Marsupialia (66-67) 8E (){Opium D03.132.610; D15.040.150.525; D15.210.600.672; D19.316.161.613 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Papaver Heterocyclic Compounds; Alkaloids Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Antidiarrheals Morphinans (+ 26); Noscapine; Papaverine (+ 1) The air-dried exudate from the unripe seed capsule of the opium poppy, Papaver somniferum, or its variant, P. album. It contains a number of alkaloids, but only a few - MORPHINE, CODEINE, and PAPAVERINE - have clinical significance. Opium has been used as an analgesic, antitussive, antidiarrheal, and antispasmodic. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $8H H: *>q@Opisthorchis B01.500.736.715.520.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Opisthorchidae A genus of trematode liver flukes of the family Opisthorchidae. It consists of the following species: O. felineus, O. noverca (Amphimerus noverca), and O. viverrini. The intermediate hosts are snails, fish, and amphibia. 8K*OOpisthorchidae B01.500.736.715.520 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda Clonorchis sinensis; Opisthorchis A family of lanceolate liver flukes of the class Trematoda which occurs in animals and man. There are several genera including Amphimerus, Cyclorchis, Delphinicola, Metorchis, Parametorchis, Phocitrema, Clonorchis, and Opisthorchis. Trematoda (66-81)  8M*=( Opisthorchiasis C03.335.865.685 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections Infection with flukes of the genus Opisthorchis. Trematode Infections (66-67) 8OPA;"Opipramol D03.494.240.625; D14.100.050.600.050.600; D14.100.600.050.600; D15.085.050.600; D15.700.122.055.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic A tricyclic antidepressant with actions similar to AMITRIPTYLINE. 8P o:MOpioid Peptides D12.644.468; D12.776.641.650.575; D14.600.600.577 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Dynorphins; Endorphins (+ 3); Enkephalins (+ 4) Dynorphins; Endorphins (+ 3); Enkephalins (+ 2) Dynorphins; Endorphins (+ 3); Enkephalins (+ 2) The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and pro-opiomelanocortin, respectively. There are also at least three classes of opioid receptors, but the peptide families do not map to the receptors in a simple way. Endorphins (78-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (8T9DFOphthalmoscopy E01.210.675 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fundus Oculi; Papilledema Diagnosis; Diagnosis, Eye (Non MeSH) Examination of the interior of the eye with an ophthalmoscope. 8Y" -LOphthalmoplegia, Chronic Progressive External C05.651.460.620.650; C10.597.622.447.750; C10.772.204.410.472.750; C11.590.472.750; C18.452.648.556.650.620.650; C23.888.592.636.447.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies Nervous System Diseases; Neurologic Manifestations; Paralysis; Ophthalmoplegia Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders; Ophthalmoplegia Eye Diseases; Ocular Motility Disorders; Ophthalmoplegia Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Ophthalmoplegia Kearns Syndrome Kearns Syndrome Kearns Syndrome Kearns Syndrome Kearns Syndrome Kearns Syndrome One of the MITOCHONDRIAL ENCEPHALOMYOPATHIES characterized by slowly progressive paralysis of the extraocular muscles. Muscle biopsies disclose the characteristic ragged red fibers and large numbers of mitochondria with deleted DNA. DNA, Mitochondrial (88-92); Mitochondria, Muscle (72-92); Ophthalmoplegia (66-92)  8Z4N n `Ophthalmoplegia C10.597.622.447; C10.772.204.410.472; C11.590.472; C23.888.592.636.447 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders Eye Diseases; Ocular Motility Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Diplopia; Duane's Syndrome; Horner's Syndrome; Ophthalmoplegia, Chronic Progressive External (+ 1) Duane's Syndrome; Horner's Syndrome; Ophthalmoplegia, Chronic Progressive External (+ 1) Duane's Syndrome; Horner's Syndrome; Ophthalmoplegia, Chronic Progressive External (+ 1) Diplopia; Duane's Syndrome; Horner's Syndrome; Ophthalmoplegia, Chronic Progressive External (+ 1) Paralysis of the ocular muscles, innervated by the oculomotor, trochlear, and abducens nerves. 8`PNwoOphthalmology G02.403.810.468 CLECEDHIISLJMAMTOGSNSTTD Eye Diseases; Orthoptics; Vision Health Occupations; Medicine; Specialties, Surgical A surgical specialty concerned with the structure and function of the eye and the medical and surgical treatment of its defects and diseases. 8e*)=Ophthalmodynamometry E01.210.625 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Eye (Non MeSH) 8f"-Ophthalmic Solutions D26.394.225.766.657 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Sterile solutions, essentially free from foreign particles and suitably compounded and dispensed, for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. (From Dorland, 27th ed). 8g4,ZOphthalmic Nerve A08.800.800.120.760.650 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Trigeminal Nerve A sensory branch of the trigeminal (5th cranial) nerve. The ophthalmic nerve carries general afferents from the superficial division of the face including the eyeball, conjunctiva, upper eyelid, upper nose, nasal mucosa, and scalp. 8i8pOphthalmic Assistants M01.526.485.067.740.690; N02.360.067.740.690 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Physician Assistants Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Physician Assistants Persons academically trained to care for patients with eye diseases or structural defects of the eye, under the supervision of an ophthalmologist. 8k(2Ophthalmic Artery A07.231.114.622 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures. 8mw88Ophthalmia, Sympathetic C11.941.879.780.500; C20.111.709 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Uveitis; Panuveitis Immunologic Diseases; Autoimmune Diseases Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye. 8n&NlOphthalmia Neonatorum C01.252.354.225.625; C01.252.400.625.391.658; C01.539.375.354.220.625; C11.187.183.220.538; C11.294.354.220.625; C16.614.677 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Neisseriaceae Infections; Gonorrhea Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Eye Diseases; Conjunctival Diseases; Conjunctivitis; Conjunctivitis, Bacterial Eye Diseases; Eye Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is NEISSERIA GONORRHOEAE. The baby's eyes are contaminated during passage through the birth canal. 8pNOperon G05.275.201.800.575; G05.275.769 DEGEIMPHRE Genetics; Genes; Genes, Bacterial; Regulon Genetics; Genes Lac Operon; rRNA Operon Genes, araC; Lac Operon; rRNA Operon The genetic unit consisting of a feedback system under the control of an operator gene, in which a structural gene transcribes its message in the form of mRNA upon blockade of a repressor produced by a regulator gene. Included here is the attenuator site of bacterial operons where transcription termination is regulated. Genetics, Biochemical (68)  8u &HLz Operator Regions (Genetics) G05.275.470.790.650; G05.331.599.110.689.650; G06.184.599.110.689.650 DEGEIMPHRE Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid DNA sequences which signal the initiation of transcription when derepressed. Genes, Regulator (68-85); Operon (69-85) 8x>!MZ2Operations Research L01.906.575 Game Theory; Information Theory; Decision Theory Research Information Science; Systems Analysis Monte Carlo Method; Probability Theory; Programming, Linear A group of techniques developed to apply scientific methods and tools to solve the problems of decision making in complex organizations and systems. Operations research searches for optimal solutions in situations of conflicting goals and makes use of mathematical models from which solutions for actual problems may be derived. (From Psychiatric Dictionary, 6th ed, 1989). CLECHILJSDSNSTTDUT $8z; -GOperating Rooms N02.278.388.700 CLECHILJMAMTOGSDSNSTTDUT Gas Scavengers Surgery, Operative Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units Facilities equipped for performing surgery.  8}_4Operating Room Technicians M01.526.485.067.700; N02.360.067.700 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Specially trained personnel to assist in routine technical procedures in the operating room. Operating Rooms/manpower (68-70) 8 *m'Operating Room Nursing N02.421.533.625 CLECEDHILJMAMTOGSDSNSTTDUT Surgical Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The functions of the professional nurse in the operating room. 8[LOperating Room Information Systems L01.700.508.300.680.360.500; N04.452.442.452.600; N04.452.515.360.555 CLECHILJOGSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems; Hospital Information Systems Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems; Hospital Information Systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of operating room services and facilities. 87)M2Open Reading Frames G05.331.599.110.675.500; G06.184.599.110.675.500 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Reading Frames Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Reading Frames Reading frames where successive nucleotide triplets can be read as codons specifying amino acids and where the sequence of these triplets is not interrupted by stop codons. Amino Acid Sequence (81-90); Base Sequence (77-90) 86>Oophoritis C13.371.056.114.450; C13.371.056.630.450; C19.391.630.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Adnexitis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases Inflammation of an ovary. 8ANh!Oomycetes B05.354.730.576.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Mastigomycotina Phytophthora; Pythium A class of Mastigomycotina fungi infecting higher plants and also producing oomycoses in various animals including fish, horses and mules. 8 "OOogonia A05.360.490.690.700; A11.497.497.650 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Ovum Cells; Germ Cells; Ovum The primitive differentiated female gametes which give rise to oocytes. 8Z *,XUOogenesis G08.520.310.500 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Gametogenesis Vitellogenesis The formation, development, and maturation of the female germ cell. Ovum (66-74)  8 XQOocytes A05.360.490.690.680; A11.497.497.600 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Ovum Cells; Germ Cells; Ovum Female germ cells in stages between the prophase of the first maturation division and the completion of the second maturation division. Ovum (66-74) 8 *,XOocyte Donation E05.820.605 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Reproduction Techniques Transfer of egg cell from donor to host mother. Oocytes are captured by laparoscopy, fertilized in vitro, and transferred to the recipient. Patient candidates include women with premature ovarian failure or severe genetic disorders, women who respond poorly to human menopausal gonadotropin, and women older than 40 years who do not conceive with use of other therapies. (From Lancet 1982 May 8;1(8280):1031-3). Oocytes (80-94); Tissue Donors (83-94) 8A$G0Onychomycosis C01.539.800.200.720.550; C01.703.295.872.458; C17.800.805.506.550; C17.800.838.208.883.458 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses; Tinea Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses; Tinea Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Nail Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses; Tinea A fungal infection of the nail plate, usually caused by a species of Epidermophyton, Microsporum, or Trichophyton, and producing opaque, white, thickened, friable, and brittle nails. (Dorland, 27th ed). 8 dPOntario Z01.107.567.176.639 EHEP Geographicals (Non MeSH); America; North America; Canada 8 FOnly Child F01.829.263.500.280; I01.880.225.500.280; M01.471.392.750 CLEDHILJPXSN Child Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family Social Sciences; Sociology; Family; Nuclear Family Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child Child who has no siblings. 87A #Online Systems L01.700.508.300.742 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems MEDLINE Computers (66-70) 8n Onium Compounds D02.675 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Ammonium Compounds (+ 43); Sulfonium Compounds AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 8 8#9BOndansetron D03.383.374.690; D03.494.148.500; D14.100.850.850.650; D15.075.600; D15.095.625; D15.150.575; D15.210.950.012.600; D15.210.950.040.575; D15.700.872.015.600; D15.700.872.331.570; D16.050.030.625 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Carbazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and it has reported anxiolytic and neuroleptic properties. Imidazoles (87-92) 8:bOncoviruses Type B, Mammalian B04.820.650.650; B04.909.574.807.650; B04.909.777.731.650 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Mammary Tumor Viruses, Mouse Mammary Tumor Viruses, Mouse Mammary Tumor Viruses, Mouse A genus of the family RETROVIRIDAE consisting of a few exogenous, vertically transmitted and endogenous viruses of mice. It is associated with mammary carcinoma and T-cell lymphoma. 8$AeOncorhynchus mykiss B02.493.817.750.825.620 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes; Salmonidae; Trout A large stout-bodied, sometimes anadromous, TROUT found in still and flowing waters of the Pacific coast from southern California to Alaska. It has a greenish back, a whitish belly, and pink, red, or lavender stripes on the sides, with usually a sprinkling of black dots. It is highly regarded as a sport and food fish. Its former name was Salmo gairdneri. The sea-run rainbow trouts are often called steelheads. Redband trouts refer to interior populations of rainbows. Fishes (66-67); Salmonidae (68-74); Trout (75-93) 8v&A,>Oncorhynchus kisutch B02.493.817.750.600.750.615 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes; Salmonidae; Oncorhynchus; Salmon An anadromous species of SALMON ranging from the Arctic and Pacific Oceans to Monterey Bay, California and inhabiting ocean and coastal streams. It is familiarly known as the coho or silver salmon. It is relatively small but its light-colored flesh is of good flavor. Fishes (66-67); Salmon (72-93); Salmonidae (68-71) 8&R=?Oncorhynchus keta B02.493.817.750.600.750.610 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes; Salmonidae; Oncorhynchus; Salmon An anadromous species of SALMON found in the streams of the Pacific coast from Sacramento north, and also common in Japan. It is used frequently in genetic and other medical research. It is called dog salmon and chum salmon, the latter name possibly from Chinook jargon for spots or writing, with reference to its body markings. Fishes (66-67); Salmon (72-93); Salmonidae (68-71) 8&R?Oncorhynchus B02.493.817.750.600 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes; Salmonidae Salmon (+ 2) A genus of the family SALMONIDAE (salmons and trouts). They are named for their hooked (onco) nose (rhynchus). They are usually anadromous and occasionally inhabit freshwater. They can be found in North Pacific coastal areas from Japan to California and adjacent parts of the Arctic Ocean. Salmon and trout are popular game and food fish. Various species figure heavily in genetic, metabolism, and hormone research. Fishes (66-67); Salmon (73-93); Salmonidae (68-72)  8&8?Oncology Service, Hospital N02.278.354.422.513; N04.452.442.422.513 CLECHILJMAOGSNSTTDUT Cancer Care Facilities Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cancer patient. 8y . Oncologic Nursing G02.478.676.605; N02.421.533.600 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care Nursing care provided cancer patients. It includes aspects of family functioning through education of both patient and family. The specialty of oncologic nursing focuses on cancer as a major health care problem. Neoplasms/nursing (75-84); Specialties, Nursing (71-84) 8&BOncogenic Viruses B04.909.574 CHCLDEENGDGEIMIPMEPHPYREUL Tumor Virus Infections Carcinogens; Neoplasms Viruses; Vertebrate Viruses (Non MeSH) DNA Tumor Viruses (+ 21); Retroviridae (+ 45) Viruses that produce tumors. $8/:$Oncogenes G05.275.740 DEGEIMPHRE Genetics; Genes Proto-Oncogenes (+ 13) Genes which can potentially induce neoplastic transformation. They include genes for growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. When these genes are constitutively expressed after structural and/or regulatory changes, uncontrolled cell proliferation may result. Viral oncogenes have names of the form v-onc; cellular oncogenes (PROTO-ONCOGENES) are designated c-onc. Genes (66-77); Genes, Viral (78-82)  8O -Oncogene Proteins, Viral D12.776.677.520; D12.776.964.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins Adenovirus Early Proteins (+ 6); Antigens, Polyomavirus Transforming; Retroviridae Proteins, Oncogenic (+ 13) Adenovirus Early Proteins (+ 6); Antigens, Polyomavirus Transforming; Retroviridae Proteins, Oncogenic (+ 13) Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Antigens, Viral, Tumor (84-85); Viral Proteins (66-85)  8&FBOncogene Proteins, Fusion D12.776.677.500; D12.776.964.690 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Philadelphia Chromosome Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins Fusion Proteins, bcr-abl; Fusion Proteins, gag-onc (+ 1) Fusion Proteins, gag-onc (+ 1) The translation products of the fusion between an oncogene and another gene. The latter may be of viral or cellular origin. Retroviridae Proteins (86-89); Viral Proteins (80-85) $8E&Fh@Oncogene Proteins v-mos D12.776.677.520.750.900; D12.776.964.700.750.900; D12.776.964.775.750.900 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming proteins coded by mos oncogenes. The v-mos proteins were originally isolated from the Moloney murine sarcoma virus (Mo-MSV). Retroviridae Proteins (87-89); Retroviridae Proteins, Oncogenic (90-92) 8QFSOncogene Proteins v-fos D12.776.677.520.750.887; D12.776.964.700.750.887; D12.776.964.775.750.887 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, fos Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming proteins coded by fos oncogenes. These proteins have been found in the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses which induce osteogenic sarcomas in mice. The FBJ-MSV v-fos gene encodes a p55 kD protein and the FBR-MSV v-fos gene encodes a p75 kD fusion protein. Oncogene Proteins, Viral (89-91); Retroviridae Proteins (87-88)  8QFxKOncogene Proteins v-erbB D12.776.677.520.750.883; D12.776.964.700.750.883; D12.776.964.775.750.883 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, erbB-1; Genes, erbB-2 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming proteins encoded by erbB oncogenes from the avian erythroblastosis virus. The protein is a truncated form of the EGF receptor (RECEPTORS, EPIDERMAL GROWTH FACTOR-UROGASTRONE) whose kinase domain is constitutively activated by deletion of the ligand-binding domain. Oncogene Proteins, Viral (88-94)  8 QF$?'Oncogene Proteins v-erbA D12.776.677.520.750.882; D12.776.964.700.750.882; D12.776.964.775.750.882 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, erbA Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming proteins encoded by erbA oncogenes from the avian erythroblastosis virus. They are truncated versions of c-erbA, the thyroid hormone receptor (RECEPTORS, THYROID HORMONE) that have retained both the DNA-binding and hormone-binding domains. Mutations in the hormone-binding domains abolish the transcriptional activation function. v-erbA acts as a dominant repressor of c-erbA, inducing transformation by disinhibiting proliferation. Retroviridae Proteins (87-89); Retroviridae Proteins, Oncogenic (90-94)  8VQFSOncogene Proteins v-abl D12.776.677.520.750.875; D12.776.964.700.750.875; D12.776.964.775.750.875 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, abl Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids. Retroviridae Proteins (87-90); Viral Proteins (84-86)  8aQF@Oncogene Proteins D12.776.677 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Oncogene Proteins, Fusion (+ 3); Oncogene Proteins, Viral (+ 22) Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION). Neoplasm Proteins (83-89); Viral Proteins (83-89)  87FDO<Oncogene Protein p65(gag-jun) D12.776.677.500.320.700; D12.776.677.520.750.320.700; D12.776.964.690.320.700; D12.776.964.700.750.320.700; D12.776.964.775.350.320.700; D12.776.964.775.750.320.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, jun Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Fusion; Fusion Proteins, gag-onc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic; Fusion Proteins, gag-onc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Fusion; Fusion Proteins, gag-onc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic; Fusion Proteins, gag-onc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, gag; Fusion Proteins, gag-onc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic; Fusion Proteins, gag-onc Transforming protein coded by jun oncogenes (GENES, JUN). This is a gag-onc fusion protein of about 65 kD derived from avian sarcoma virus. v-jun lacks a negative regulatory domain that regulates transcription in c-jun. Retroviridae Proteins (87-89); Retroviridae Proteins, Oncogenic (90-91)  8?$FSOncogene Protein p55(v-myc) D12.776.260.700; D12.776.660.700; D12.776.677.520.750.750; D12.776.964.700.750.750; D12.776.964.775.750.750 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, myc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming protein coded by myc oncogenes. The v-myc protein has been found in several replication-defective avian retrovirus isolates which induce a broad spectrum of malignancies. Retroviridae Proteins (87-89); Retroviridae Proteins, Oncogenic (90)  8"wF~POncogene Protein p21(ras) D12.776.543.350.730.710; D12.776.677.520.750.710; D12.776.964.700.750.710; D12.776.964.775.750.710 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, ras Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; G-Proteins; ras Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene (c-ras) can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21(ras) has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20% of all human tumors. Neoplasm Proteins (80-86); Oncogene Proteins, Viral (86-89)  8 lFCkGOncogene Protein pp60(v-src) D12.776.677.520.750.760; D12.776.964.700.750.760; D12.776.964.775.750.760 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein-Tyrosine Kinase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Tyrosine-specific protein kinase encoded by the v-src oncogene of Rous sarcoma virus. The transforming activity of pp60(v-src) depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60(v-src) to the plasma membrane which is accomplished by myristylation of its N-terminal glycine. Retroviridae Proteins (86-89); Viral Proteins (81-85)  8#QF@Oncogene Protein gp140(v-fms) D12.776.677.520.750.650; D12.776.964.700.750.650; D12.776.964.775.750.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, fms Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Transforming glycoprotein coded by the fms oncogene from the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The oncogene protein v-fms lacks sequences, which, in the highly homologous proto-oncogene protein c-fms (CSF-1 receptor), normally serve to regulate its tyrosine kinase activity. The missing sequences in v-fms mimic the effect of ligand and lead to constitutive cell growth. The protein gp120(v-fms) is post-translationally modified to generate gp140(v-fms). Oncogene Proteins, Viral (85-89); Retroviridae Proteins (87-89); Retroviridae Proteins, Oncogenic (90)  8A$QF,xOnchocerciasis, Ocular C03.300.562; C03.335.508.700.750.361.699.500; C11.294.725.562 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Eye Infections, Parasitic Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis; Onchocerciasis Eye Diseases; Eye Infections; Eye Infections, Parasitic Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20% are blind. The incidence of eye lesions has been reported to be as high as 30% in Central America and parts of Africa. Microfilaria (67-89); Onchocerca (66-89); Onchocerciasis (66-89); Eye Diseases or specifics (66-89) 8EP wOnchocerciasis C03.335.508.700.750.361.699 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis Onchocerciasis, Ocular Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, pruritus, and ocular lesions. 8POnchocerca volvulus B01.500.294.700.750.700.300.510.850 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea; Onchocerca A species of parasitic nematodes widely distributed throughout central Africa and also found in northern South America, southern Mexico, and Guatemala. Its intermediate host and vector is the blackfly or buffalo gnat. Onchocerca (66-92) 8'*pOnchocerca B01.500.294.700.750.700.300.510 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea Onchocerca volvulus A genus of parasitic nematodes whose organisms live and breed in skin and subcutaneous tissues. Onchocercal microfilariae may also be found in the urine, blood, or sputum. 8 #*bOmeprazole D03.438.103.675; D19.316.203.661 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl) methyl)sulfinyl)benzimidazole. A highly effective inhibitor of gastric acid secretion used in the therapy of gastric ulcers and Zollinger-Ellison syndrome. The drug inhibits the H+,K+-ATPase in a pH-dependent manner. This ATPase is considered the proton pump in the secretory membrane of the parietal cell. Benzimidazoles (66-86) 8&:Omentum A01.047.596.573 ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Abdomen; Peritoneum 8 *8omega-Chloroacetophenone D02.522.120.575; D05.569.734.498.697.575; D26.897.575 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ketones; Acetophenones Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Riot Control Agents, Chemical; Irritants; Tear Gases Miscellaneous Drugs and Agents (Non MeSH); Tear Gases 2-Chloro-1-phenylethanone. A potent eye, throat, and skin irritant. One of its uses is as a riot control agent. 8}=. Omasum A13.869.524 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Stomach, Ruminant Stomach (66-67) 8 :5Oman Z01.252.245.500.600; Z01.586.500.600 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East 9z*Olivopontocerebellar Atrophy C10.228.140.252.253.871.679 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases; Cerebellar Ataxia; Spinocerebellar Degeneration A collection of diseases with atrophy of the cerebellum, pons, and inferior olives described in 1900 by Dejerine and Thomas. Signs and symptoms include ataxia of trunk and limbs, dysarthria, intention tremor, followed by generalized rigidity and dementia. Atrophy (66-86); Brain Diseases (66-86); Cerebellar Ataxia (68-86); Cerebellar Diseases (66-86); Olivary Nucleus (66-86); Pons (66-86) 9t!N*Olivomycins D20.085.075.302.574; D22.204.106.307.574; D26.408.348.199.671 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Chromomycins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Chromomycins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Chromomycins A mixture of several closely related glycosidic antibiotics obtained from Actinomyces (or Streptomyces) olivoreticuli. They are used as fluorescent dyes that bind to DNA and prevent both RNA and protein synthesis and are also used as antineoplastic agents. 9E:5+Olivary Nucleus A08.186.211.132.810.406.574 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon; Medulla Oblongata 96pOliguria C12.777.419.078.574 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Anuria Secretion of a diminished amount of urine in relation to the fluid intake. (Dorland, 27th ed). 9 NltOligospermia C12.294.365.700.508 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sperm Count; Spermatozoa Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Infertility; Infertility, Male Deficiency in the number of spermatozoa in semen. (Dorland, 27th ed). Spermatozoa (66-74)  9 LyVOligosaccharides D09.203.698.629 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Disaccharides (+ 10); Trisaccharides (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR 9 @^5FOligoribonucleotides D13.695.578.424.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Oligonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties. Oligonucleotides (74-75) 9 #>wOligopeptides D12.644.456 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amanitins; Angiotensins (+ 7); Antipain; Bradykinin (+ 1); Caerulein; Delta Sleep-Inducing Peptide; Dipeptides (+ 7); N-Formylmethionine Leucyl-Phenylalanine; Glutathione; Gonadorelin; Leupeptins; Pentagastrin; Pepstatins; Peptide T; Phalloidine; Protirelin; Tachykinins (+ 6); Technetium Tc 99m Mertiatide; Teprotide; Tetragastrin; Thymic Factor, Circulating; Tuftsin; Vasopressins (+ 7) Peptides (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  9 BDHOligonucleotides, Antisense D13.150.480; D13.695.578.424.480 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Antisense Elements (Genetics) Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Oligonucleotides Short fragments (usually between 2 and 12 nucleotides) of DNA or RNA that are used to hinder or block the translation or processing of mRNA. Oligonucleotides (87-90) 9 &>Oligonucleotides D13.695.578.424 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides Oligodeoxyribonucleotides (+ 1); Oligonucleotides, Antisense; Oligoribonucleotides; Pyrimidine Dimers ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 9P>ctBOligonucleotide Probes D13.444.600.601; D26.651.600.601 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acid Hybridization Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin. Nucleic Acid Hybridization (72-88); Oligonucleotides (72-88)  9&D _GOligomycins D08.373.936.610 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents Rutamycin A closely related group of toxic substances elaborated by various strains of Streptomyces. They are 26-membered macrolides with lactone moieties and double bonds and inhibit various ATPases, causing uncoupling of phosphorylation from mitochondrial respiration. Used as tools in cytochemistry. Some specific oligomycins are RUTAMYCIN, peliomycin, and botrycidin (formerly venturicidin X). AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  96:f <Oligomenorrhea C13.371.491.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Menstruation Disorders Abnormally infrequent menstruation. Do not use for scanty menstrual flow (hypomenorrhea). 9)NjOligohymenophorea B01.841.185.650 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora Hymenostomatida (+ 7) A class of ciliate protozoa. Characteristics include the presence of a well developed oral apparatus and oral cilia being clearly distinct from somatic cilia. 9&+Oligohydramnios C13.703.560 BLCFCICLCODHDIDTECEHENEPETHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Amniotic Fluid Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Presence of less than 300 ml of amniotic fluid at term. Principal causes include malformations of fetal urinary tracts, intra-uterine growth retardation, high maternal blood pressure, nicotine poisoning, and prolonged pregnancy. Polyhydramnios (66-90)  9 "HfOligodeoxyribonucleotides D13.695.578.424.450 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Oligonucleotides DNA Primers A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligonucleotides (74-75)  9"S>wOligodendroglioma C04.557.465.625.600.380.590; C04.557.470.670.380.590; C04.557.580.625.600.380.590 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma A relatively rare, moderately well differentiated, relatively slow-growing glioma that occurs most frequently in the cerebrum of adults. It is grossly homogeneous, fairly well circumscribed, moderately firm, and somewhat gritty in consistency with interstitial calcification sufficiently dense as to be detected by x-ray imaging of the skull. The peak occurrence of oligodendrogliomas is in persons aged 30 to 49. (From Stedman, 25th ed and DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1587). 9$eYX^Oligodendroglia A08.637.600; A11.650.600 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neuroglia Cells; Neuroglia Myelin Sheath Myelin Sheath A class of neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal satellite cells according to their location. The most important recognized function of these cells is the formation of the insulating myelin sheaths of axons in the central nervous system. CHCLCYDEENGEIMMEMIPAPHPSRARERISETRULUSVI  9)*4",Oligochaeta B01.091.657 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Annelida A class of annelid worms with few setae per segment. It includes the earthworms such as Lumbricus and Eisenia. Annelida (66-74) 9,(Oligo-1,6-Glucosidase D08.586.277.450.770 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases Sucrase-Isomaltase Complex An enzyme that catalyzes the endohydrolysis of 1,6-alpha-glucosidic linkages in isomaltose and dextrins produced from starch and glycogen by alpha-amylase. EC 3.2.1.10. Glycoside Hydrolases (66-77)  9-8Fl"Olfactory Receptor Neurons A04.531.520.573.580; A08.663.694.530.540; A08.800.550.700.120.540; A09.531.623.580; A10.615.550.707.573.580; A11.671.677.530.540 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Receptors, Odorant Respiratory System; Nose; Nasal Mucosa; Olfactory Mucosa Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Chemoreceptors Sense Organs; Nose; Olfactory Mucosa Tissue Types (Non MeSH); Membranes; Mucous Membrane; Nasal Mucosa; Olfactory Mucosa Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Neurons in the olfactory epithelium with proteins (RECEPTORS, ODORANT) that bind, and thus detect, odorants. Olfactory receptor neurons are bipolar. They send to the surface of the epithelium apical dendrites with non-motile cilia from which project odorant receptor molecules. Their unmyelinated axons synapse in the olfactory bulb of the brain. Unlike other neurons, they can be generated from precursor cells in adults. Nasal Mucosa (66-71); Olfactory Mucosa (72-93); Receptors, Sensory (66-93)  9/I 6ZOlfactory Pathways A08.186.211.577.699; A08.612.220.640 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Limbic System Nervous System; Neural Pathways; Afferent Pathways Olfactory Bulb Set of nerve fibers conducting impulses from olfactory receptors to the cerebral cortex. It includes the OLFACTORY NERVE, OLFACTORY BULB, olfactory tract, olfactory tubercle, anterior perforated substance, and olfactory cortex. Central Nervous System (66-71); Smell (66-71); specific brain site ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $94*6R8Olfactory Nerve A08.800.800.120.640 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 1st cranial nerve. The olfactory nerve conveys the sense of smell. It is formed by the axons of OLFACTORY RECEPTOR NEURONS which project from the olfactory epithelium (in the nasal epithelium) to the OLFACTORY BULB. 97]8[Olfactory Mucosa A04.531.520.573; A09.531.623; A10.615.550.707.573 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Respiratory System; Nose; Nasal Mucosa Sense Organs; Nose Tissue Types (Non MeSH); Membranes; Mucous Membrane; Nasal Mucosa Olfactory Receptor Neurons Olfactory Receptor Neurons Olfactory Receptor Neurons That portion of the nasal mucosa containing the sensory endings for olfaction; the organ of smell. Nasal Mucosa (66-71)  99C9:\wOlfactory Bulb A08.186.211.577.699.573; A08.186.211.730.885.573 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Limbic System; Olfactory Pathways Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon Ovoid body resting on the cribriform plate of the ethmoid bone where the olfactory nerve terminates. The olfactory bulb contains several types of nerve cells including the mitral cells, on whose dendrites the olfactory nerve synapses, forming the olfactory glomeruli. Limbic System (66-71) 9;y688Oleic Acids D02.241.081.436.275.600; D10.516.251.355.325.600 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Ricinoleic Acids Ricinoleic Acids 9>.6B$(Oleanolic Acid D02.455.849.919.650.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Triterpenes; Sapogenins 3 beta-Hydroxyolean-12-en-28-oic acid. Occurs in leaves of Olea europaea, Viscum album L., and other higher plants. It is also the aglycone component of many saponins. Carboxylic Acids (74); Triterpenes (74) 9@%:]1Oleandomycin D20.085.115.662 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Troleandomycin Antibiotic substance produced by Streptomyces antibioticus. 9B<DEOld Age Assistance N03.219.521.346.506.678 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance Financial assistance for the impoverished elderly through public funding of programs, services, and individual income supplements. 9C)Oklahoma Z01.107.567.875.100.672; Z01.107.567.875.600.516.672 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States 9D :Ointments D26.394.225.589 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medicaments; ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Synonyms: salves; unctions; unguents. 9F= ,M@Ointment Bases D26.698.523 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Lanolin; Mineral Oil; Petrolatum Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  9H9,I)Q.Oils, Volatile D10.516.627.675; J01.740.675 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils Technology, Industry, Agriculture (Non MeSH); Oils 9J",Oils D10.516.627; J01.740 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids Technology, Industry, Agriculture (Non MeSH) Fish Oils (+ 4); Oils, Volatile; Plant Oils (+ 13) Dietary Fats, Unsaturated (+ 10); Fish Oils (+ 4); Industrial Oils (+ 7); Oils, Volatile; Plant Oils (+ 14); Silicone Oils AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESNSTTOTUURUTVI 9K,nNOhio Z01.107.567.875.100.663; Z01.107.567.875.600.313.663; Z01.107.567.875.600.516.663 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States 9MYOfloxacin D03.383.606.725; D03.494.600; D20.220.050.655; D20.237.050.050.655 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Anti-Infective Agents; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid. An orally administered broad-spectrum quinolone antibacterial drug active against most gram-negative and gram-positive bacteria. Clinical efficacy has been confirmed in a variety of systemic infections as well as in acute and chronic urinary tract infections. Anti-Infective Agents (81-88); Anti-Infective Agents, Urinary (81-88); Oxazines (81-88) 9O L:gOffice Visits N04.452.758.635 ECSNTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Visits made by patients to health service providers' offices for diagnosis, treatment, and follow-up. 9TE qwOffice Nursing N04.452.758.377.875 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Nursing Nursing practice limited to assisting a physician in his private office. 9U|WOffice Management N04.452.758.572 CLECHILJOGSNSTTDUT Economics, Medical; Economics, Dental Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Forms and Records Control; Practice Management, Dental; Practice Management, Medical Planning, organizing, and administering activities in an office. CLECHILJMTOGSNSTTDUT $9V-qcLOffice Automation L01.700.508.300.680.708; N04.452.515.708 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems Word Processing Word Processing Use of computers or computer systems for doing routine clerical work, e.g., billing, records pertaining to the administration of the office, etc. CLECEDHIISLJMTSDSNSTTDUT  9X. &Off-Road Motor Vehicles J01.937.647 CLECHILJSDSNST Motorcycles Technology, Industry, Agriculture (Non MeSH); Transportation Motorized, recreational vehicles used on non-public roads. They include all-terrain vehicles, dirt-bikes, minibikes, motorbikes, trailbikes, and snowmobiles. Excludes MOTORCYCLES, which are considered public road vehicles. Automobiles (66-89); Motorcycles (66-89)  9[G1Oesophagostomum B01.500.294.700.775.710.600 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Strongyloidea A genus of nematodes of the superfamily STRONGYLOIDEA, parasitic in the intestines of animals. The adults are usually free in the intestinal lumen; the larvae encyst in the wall. Ancylostomatoidea (66) 9\*YOesophagostomiasis C03.335.508.700.775.583 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections Infection of the intestinal tract with worms of the genus OESOPHAGOSTOMUM. This condition occurs mainly in animals other than man. Hookworm Infections (66) 9^PvOedipus Complex F02.739.794.653 Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Attachment of the child to the parent of the opposite sex, accompanied by envious and aggressive feelings toward the parent of the same sex. 9`lOdors G03.230.480 ANLJPC Smell Smell Environment and Public Health (Non MeSH); Environment 9a    AOdontometry E05.118.656; E06.623 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Dentistry Cephalometry (66-72); Dentition (66-72); Tooth (66-72); specific tooth heading 9b"c`Odontoma C04.557.695.610 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Odontogenic Tumors A mixed tumor of odontogenic origin, in which both the epithelial and mesenchymal cells exhibit complete differentiation, resulting in the formation of tooth structures. (Jablonski, Illustrated Dictionary of Dentistry, 1982). Odontogenic Tumors (66-74) 9c VU Odontoid Process A02.835.232.834.151.383.668 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine; Cervical Vertebrae; Axis The toothlike process on the upper surface of the axis, which articulates with the atlas above. Axis (66-84) 9e:csOdontogenic Tumors C04.557.695 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Ameloblastoma; Cementoma; Odontogenic Cyst, Calcifying; Odontoma Neoplasms produced from tooth-forming tissues. 9gQX=L7Odontogenic Cysts C04.182.089.530.690; C05.500.470.690; C07.320.450.670 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts Stomatognathic Diseases; Jaw Diseases; Jaw Cysts Basal Cell Nevus Syndrome; Dentigerous Cyst; Odontogenic Cyst, Calcifying; Periodontal Cyst (+ 1) Basal Cell Nevus Syndrome; Dentigerous Cyst; Odontogenic Cyst, Calcifying; Periodontal Cyst (+ 1) Basal Cell Nevus Syndrome; Dentigerous Cyst; Odontogenic Cyst, Calcifying; Periodontal Cyst (+ 1) Cysts found in the jaws and arising from epithelium involved in tooth formation. They include follicular cysts (e.g., primordial cyst, dentigerous cyst, multilocular cyst), lateral periodontal cysts, and radicular cysts. They may become keratinized (odontogenic keratocysts). Follicular cysts may give rise to ameloblastomas and, in rare cases, undergo malignant transformation. 9h=VXOdontogenic Cyst, Calcifying C04.182.089.530.690.605; C04.557.695.605; C05.500.470.690.605; C07.320.450.670.495 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts; Odontogenic Cysts Neoplasms; Neoplasms by Histologic Type (Non MeSH); Odontogenic Tumors Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Stomatognathic Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts A mixed radiolucent-radiopaque lesion of the jaws with features of both a cyst and a solid neoplasm. It is characterized microscopically by an epithelial lining showing a palisaded layer of columnar basal cells, presence of ghost cell keratinization, dentinoid, and calcification. (Stedman, 25th ed). Odontogenic Cysts (67-93); Odontogenic Tumors (66-93) 9m9"\V;_@Odontogenesis G07.553.767 DEGEIMPHRE Tooth Germ; Tooth Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Amelogenesis; Dentinogenesis 9qZ"Odontodysplasia C07.650.800.600; C07.793.700.600; C16.131.850.800.600 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities A localized arrested tooth development which appears to involve most commonly the anterior teeth, usually on one side of the midline, most often the maxillary central and lateral incisors. Roentgenographically, the teeth have a ghostlike appearance. Calcification and bits of prismatic enamel may be found in the pulp and the enamel is thin and absent in part. (Jablonski, Illustrated Dictionary of Dentistry, 1982). 9q=LFOdontoblasts A11.329.522 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Dentin Cells; Connective Tissue Cells (Non MeSH) 9u* 3Odds Ratio E05.318.740.600.600; G03.850.520.830.600.600; H01.548.832.672.471; N05.715.360.750.625.590 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Probability (77-89); Risk (77-89) 9vd*Oddi's Sphincter A03.159.183.079.300.900.600; A03.492.411.620.270.731.572 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cholangiopancreatography, Endoscopic Retrograde; Sphincterotomy, Endoscopic; Sphincterotomy, Transhepatic Digestive System; Biliary Tract; Bile Ducts; Bile Ducts, Extrahepatic; Common Bile Duct; Vater's Ampulla Digestive System; Gastrointestinal System; Intestines; Intestine, Small; Duodenum; Vater's Ampulla An annular sheath of muscle that invests the bile duct within the wall of the duodenum. (Dorland, 27th ed). 9{/>:uOculomotor Nerve Paralysis C10.772.204.410.436; C10.772.204.508; C11.590.436 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Eye Diseases; Ocular Motility Disorders Partial or complete paralysis of the eye muscles due to third cranial, or oculomotor, nerve lesion. The lesion may result from injury, ischemia (cerebral hemorrhage), tumors, or other brain pathology. Oculomotor Nerve (69-89); Ophthalmoplegia (66-89) 9} 9N;Oculomotor Nerve A08.800.800.120.600 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 3d cranial nerve. The oculomotor nerve sends motor fibers to the levator muscles of the eyelid and to the superior rectus, inferior rectus, and inferior oblique muscles of the eye. It also sends parasympathetic efferents (via the ciliary ganglion) to the muscles controlling pupillary constriction and accommodation. The motor fibers originate in the oculomotor nuclei of the midbrain. 98[Oculomotor Muscles A02.633.567.700; A09.371.613 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Sense Organs; Eye Muscles of the eye that include musculi bulbi (extraocular), musculus orbicularis oculi (eyelids), and musculus orbitalis. These control the eye and surrounding structures. (From Dorland, 27th ed; Stedman, 25th ed). 9y":QOculocerebrorenal Syndrome C10.496.670; C12.777.419.815.720; C16.131.077.661; C16.131.280.748.580; C18.452.648.851.750; F03.709.346.710 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Autosomal recessive syndrome in which ocular signs include cataracts and glaucoma. The central nervous system defects are manifested by mental retardation and hypotonia, and the renal abnormalities consist of tubular and later, glomerular insufficiency. Abnormalities, Multiple (68-76); Eye Diseases (66-76); Kidney Diseases (66-76) 9_zL$^Ocular Physiology (Non MeSH) G11.697 Musculoskeletal, Neural, Eye Physiology (Non MeSH) Accommodation, Ocular; Adaptation, Ocular (+ 1); Blinking; Blood-Retinal Barrier; Evoked Potentials, Visual; Eye Color; Eye Movements (+ 7); Intraocular Pressure; Vision (+ 18) CLDEGEIMPHRE 9# ;Ocular Motility Disorders C10.772.204.410; C11.590 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Eye Diseases Amblyopia; Nystagmus; Oculomotor Nerve Paralysis; Ophthalmoplegia (+ 4); Strabismus (+ 2) Amblyopia; Nystagmus; Oculomotor Nerve Paralysis; Ophthalmoplegia (+ 4); Strabismus (+ 2) Disorders of eye movement resulting from malfunction of the sensory-motor mechanism of the eye which leads to faulty alignment of the eyes and/or visual impairment. Ophthalmoplegia (66-89); specific eye disease (66-89)  9Nq@Ocular Hypotension C11.540 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Intraocular Pressure Eye Diseases Abnormally low intraocular pressure often related to chronic inflammation (uveitis). Intraocular Pressure (66-89)  9 Nc"Ocular Hypertension C11.525 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Intraocular Pressure Eye Diseases Glaucoma (+ 4) A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma. Glaucoma (66-82); Intraocular Pressure (66-82) $9H N{8Octreotide D06.347.560.810.650; D12.644.641.650; D12.644.850.650; D22.204.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Pituitary Hormone Release Inhibiting Hormones; Somatostatin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Peptides, Cyclic Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Somatostatin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide. A potent, long-acting somatostatin octapeptide analog which has a wide range of physiological actions. It inhibits growth hormone secretion, is effective in the treatment of hormone-secreting tumors from various organs, and has beneficial effects in the management of many pathological states including diabetes mellitus, orthostatic hypertension, hyperinsulinism, hypergastrinemia, and small bowel fistula. Antineoplastic Agents (82-88); Somatostatin/analogs and derivatives (82-88) 9L:pXOctoxynol D02.033.618.690.610; D25.720.741.610; D26.866.762.610 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Polyethylene Glycols Biomedical and Dental Materials (Non MeSH); Polymers; Polyethylene Glycols Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Polyethylene Glycols alpha-(Octylphenyl)-omega-hydroxypoly(oxy-1,2-ethanediyl). Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Octoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide. Phenyl Ethers (75-76); Polyethylene Glycols (74-93) 9 =,j>Octopus B01.644.535 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca An eight-armed cephalopod mollusk belonging to the order Octopoda. It includes the octopus as food. Mollusca (66-72) 9: (wOctopamine D02.033.329.291.525; D02.092.063.291.525; D02.092.211.215.811.651; D02.092.471.683.725; D14.100.050.100.100.600; D14.600.100.600; D16.050.870.590; D18.222.863.651 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Tyramine Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics An alpha-adrenergic sympathomimetic amine, biosynthesized from tyramine in the CNS and platelets and also in invertebrate nervous systems. It is used to treat hypotension and as a cardiotonic. The natural D(-) form is more potent than the L(+) form in producing cardiovascular adrenergic responses. It is also a neurotransmitter in some invertebrates. 9LD&Octanoic Acids D02.241.081.222.572; D02.241.081.407.177.572; D10.516.251.122.572 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Caprylates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Caprylates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Caprylates 96I86Octanes D02.455.326.146.720 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Eight-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Alkanes (66-77); Hydrocarbons (66-77) 9 8gq.Ochronosis C18.452.648.066.187.572 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Alkaptonuria Deposition of polymerized homogentisic acid as a brown-black pigment in the connective tissue. It occurs in alkaptonuria, but has also been observed in connection with exposure to certain chemicals (e.g., phenol, trinitrophenol, benzene derivatives). 9L"Ochratoxins D03.438.150.446.677; D24.185.926.587.697 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Toxins produced by Aspergillus ochraceus. Occurring widely, ochratoxins have been found as natural contaminants on storage grains, corn, peanuts, cottonseed, and decaying vegetation. They are produced by several other species of Aspergillus as well as by Penicillium viridicatum. Coumarins (66-70); Mycotoxins (67-70) 9 .:C.Oceans and Seas Z01.756 Geographicals (Non MeSH) Atlantic Ocean (+ 1); Mediterranean Sea; Pacific Ocean 9 DOceanography H01.374.572 CLECEDHIISLJMAMTOGSNSTTD Marine Biology; Submarine Medicine Physical Sciences (Non MeSH); Geography The science that deals with the ocean and its phenomena. (Webster, 3d ed). Marine Biology (66-67); Submarine Medicine (66-67)  9*1]=Occupations N01.824.547 CLECHILJMASNSTTD Health Occupations; Workplace Population Characteristics (Non MeSH); Socioeconomic Factors Career Mobility Crafts, trades, professions, or other means of earning a living.  9$GNOccupational Therapy Department, Hospital N02.278.354.422.500; N04.452.442.422.500 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the administration and provision of any occupational or work activity for remedial purposes. Hospital Departments (68-Jul 77); Occupational Therapy (66-Jul 77) 90. OOccupational Therapy E02.831.489; G02.010.500 CLECEDHIISLJMAMTNUOGPXSNSTTDUT Therapeutics; Rehabilitation Health Occupations; Allied Health Occupations The field concerned with utilizing craft or work activities in the rehabilitation of patients. Occupational therapy can also refer to the activities themselves. 9"VOccupational Medicine G02.403.790.548.510 CLECEDHIISLJMAMTOGSNSTTD Occupational Diseases; Occupational Health Services; Protective Devices Industry Health Occupations; Medicine; Specialties, Other (Non MeSH); Preventive Medicine Medical specialty concerned with the promotion and maintenance of the physical and mental health of employees in occupational settings.  9 S `Occupational Health Services N02.421.143.740 CLECHILJMAMTOGSDSNSTTDUT Occupational Medicine Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Health services for employees, usually provided by the employer at the place of work. Occupational Medicine (66-67)  9"ig#Occupational Health Nursing G02.478.676.590; N02.421.533.585 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The practice of nursing in the work environment. 9~!&<Occupational Health N01.407.540.500 HILJSN Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health The promotion and maintenance of physical and mental health in the work environment. Occupational Health Nursing (66-90); Occupational Health Services (68-90); Occupational Medicine (66-90) 9 ]ezOccupational Exposure G03.850.460.350.600 AEANCLECHILJPCSNST Air Pollutants, Occupational; Multiple Chemical Sensitivity Environmental Exposure Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation. Environmental Exposure (67-90); Occupational Diseases (66-89) $9lE{HOccupational Diseases C21.447 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Accidents, Occupational Occupational Medicine; Industry Injury, Occupational Dis, Poisoning (Non MeSH) Agricultural Workers' Diseases (+ 2); Bird Fancier's Lung; Dermatitis, Occupational; High Pressure Nervous Syndrome; Inert Gas Narcosis; Laboratory Infection; Pneumoconiosis (+ 8) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $9 N&7POccupational Dentistry G02.163.640 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Dentistry The branch of dentistry concerned with maintaining oral health of employees in occupational environments. 9${Occultism K01.672 HIPX Humanities Astrology 9   Occult Blood E01.223.597 Melena Blood Diagnosis; Diagnosis, Laboratory Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood. 98  'eOcclusive Dressings E07.101.572 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Bandages 9(Occlusal Splints E06.186.585; E06.658.453.510; E07.222.585 AECLCTECHISDSNSTTDUTVE Dentistry; Dental Equipment Dentistry; Orthodontics; Orthodontic Appliances Equipment and Supplies; Dental Equipment Rigid or flexible appliances that overlay the occlusal surfaces of the teeth. They are used to maintain the position of displaced or movable teeth, to treat clenching and bruxism and their sequelae, and to provide temporary relief from muscle or temporomandibular joint pain. Orthodontic Appliances (69-92) 91C$Occipital Lobe A08.186.211.730.885.213.571 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex Visual Cortex Posterior part of the cerebral hemisphere. 98o4Occipital Bone A02.835.232.781.572 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull Foramen Magnum 9a:DObturator Nerve A08.800.800.720.450.600 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Lumbosacral Plexus A nerve originating in the lumbar spinal cord (L2 to L4) and traveling through the lumbar plexus to the lower extremity. The obturator nerve provides motor innervation to the adductor muscles of the thigh and cutaneous sensory innervation of the inner thigh. 9?8q1Obstetrics and Gynecology Department, Hospital N02.278.354.422.495; N04.452.442.422.495 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the administration and management of services provided for obstetric and gynecologic patients. Gynecology (66-Jul 77); Hospital Departments (68-Jul 77); Obstetrics (66-Jul 77) 9k6. aObstetrics G02.403.810.450 CLECEDHIISLJMAMTOGSNSTTD Pregnancy Complications Health Occupations; Medicine; Specialties, Surgical A medical-surgical specialty concerned with management and care of women during pregnancy, parturition, and the puerperium. 9=Obstetrical Nursing G02.478.676.570; N02.421.533.571 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care Nursing care given to the pregnant patient before, after, or during childbirth. Nursing (66); Nursing Care (66); Obstetrics (66) 9^&_>Obstetrical Forceps E07.858.670.571 AECLCTECHISDSNSTTDUTVE Extraction, Obstetrical Equipment and Supplies; Surgical Equipment; Surgical Instruments Surgical instrument designed to extract the newborn by the head from the maternal passages without injury to it or the mother. 9LObsessive-Compulsive Disorder F03.709.438.180.490 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Compulsive Behavior Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders Trichotillomania An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.  9{"FvObsessive Behavior F01.145.527.508; F03.126.517.508 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Behavior; Impulsive Behavior Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Impulsive Behavior Persistent, unwanted idea or impulse which is considered normal when it does not markedly interfere with mental processes or emotional adjustment. An example may be a song which is constantly running through your mind. 9ϝ&FObserver Variation E01.354.753; G03.850.490.500.250; G03.850.490.750; N05.715.350.150.675 Diagnosis; Diagnostic Errors Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Bias (Epidemiology) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Bias (Epidemiology) The failure by the observer to measure or identify a phenomenon accurately, which results in an error. Sources for this may be due to the observer's missing an abnormality, or to faulty technique resulting in incorrect test measurement, or to misinterpretation of the data. Two varieties are inter-observer variation (the amount observers vary from one another when reporting on the same material) and intra-observer variation (the amount one observer varies between observations when reporting more than once on the same material). 9 PolObject Attachment F02.739.794.624 Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Bonding, Human-Pet Emotional attachment to someone or something in the environment. Parent-Child Relations (66-68); Psychoanalytic Theory (66-68) 9llMHObidoxime Chloride D02.092.570.665.500; D03.383.725.762.600; D08.515.347.600; D14.100.120.400.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Oximes Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Reactivators; Cholinesterase Reactivators Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Reactivators 1,1'-(Oxybis(methylene))bis(4-(hydroxyimino)methyl)pyridinium dichloride. Cholinesterase reactivator occurring in two interchangeable isomeric forms, syn and anti. Cholinesterase Reactivators (71); Oximes (71) 9X:7Obesity, Morbid C18.654.621.495 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Biliopancreatic Diversion; Gastric Bubble; Gastric Bypass; Gastroplasty; Jejunoileal Bypass Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Obesity The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. Obesity (66-86)  9^NkZObesity in Diabetes C18.452.297.681; C18.654.621.488; C19.246.681 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Obesity Endocrine Diseases; Diabetes Mellitus 9ݍ5NObesity C18.654.621; C23.888.220.621; G07.553.481.398.571 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Appetite Depressants; Diet, Reducing; Lipectomy; Skinfold Thickness Body Weight; Weight Gain; Eating Disorders; Hyperphagia Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Weight Changes (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth; Body Weight Obesity in Diabetes; Obesity, Morbid; Pickwickian Syndrome; Prader-Willi Syndrome Increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. More than two times the ideal weight is considered OBESITY, MORBID. $9/ 9NPD?bOats B06.510.253.596; J01.341.182.596 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals A grass of the genus Avena, especially A. sativa, widely cultivated for its edible seeds and also the seeds of the oat, used as food and fodder. (From American Heritage Dictionary, 1982). Cereals (66-94) 9#&4no-Phthalaldehyde D02.047.750; D02.241.223.805.780; D26.550.675 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Aldehydes Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phthalic Acids Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 1,2-Benzenedicarboxaldehyde. A reagent that forms fluorescent conjugation products with primary amines. It is used for the detection of many biogenic amines, peptides, and proteins in nanogram quantities in body fluids. Aldehydes (66-76); Phthalic Acids (66-76) 95.3o-Chlorobenzylidenemalonitrile D02.626.310; D05.569.734.498.697.355; D26.897.355 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Riot Control Agents, Chemical; Irritants; Tear Gases Miscellaneous Drugs and Agents (Non MeSH); Tear Gases ((2-Chlorophenyl)methylene)propanedinitrile. A riot control agent which causes temporary irritation of the eyes and the mucosal surface of the respiratory tract. It is a more potent irritant than OMEGA-CHLOROACETOPHENONE, but less incapacitating. Benzyl Compounds (72-74); Nitriles (70-74) 9"9:4o-Aminoazotoluene D02.172.037; D26.191.048; D26.408.078 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Miscellaneous Drugs and Agents (Non MeSH); Dyes 4-(o-Tolylazo)-o-toluidine. An azo dye with carcinogenic properties. Synonym: C.I. 11160B. Azo Compounds (68-75); Toluidines (72-75) 9-.m3Nystatin D20.085.062.654; D20.085.115.550; D20.136.073.654 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Polyene antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. 9 9<Nystagmus, Physiologic G11.697.384.378 DEGEIMPHRE Electronystagmography Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements Nystagmus, Optokinetic Involuntary rhythmical movements of the eyes in the normal person. These can be naturally occurring as in end-position (end-point, end-stage, or deviational) nystagmus or induced by the optokinetic drum (NYSTAGMUS, OPTOKINETIC), caloric test, or a rotating chair. Eye Movements (66-82) $9r2Nystagmus, Optokinetic G11.697.384.378.500 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements; Nystagmus, Physiologic The normal or physiological nystagmus induced by the attempt to fixate objects moving rapidly across the field of vision. It occurs, for example, when viewing objects from a moving railroad car or automobile. It is also called railroad nystagmus. (Dictionary of Visual Science, 3d ed and Dorland, 27th ed). Eye Movements (66-82); Nystagmus, Physiologic (83-92) 9qk@Nystagmus C10.772.204.410.400; C11.590.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Electronystagmography Eye Movements Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders Eye Diseases; Ocular Motility Disorders An involuntary, rapid, rhythmic movement of the eyeball, which may be horizontal, vertical, rotatory, or mixed. (Dorland, 27th ed).  9 &NNymph B01.583.571 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Life Stages (Non MeSH) The immature stage in the life cycle of those orders of insects characterized by gradual metamorphosis, in which the young resemble the imago in general form of body, including compound eyes and external wings; also the 8-legged stage of mites and ticks that follows the first moult. specific arachnid; specific insect 92 (.O*Nylons D25.720.716.392; J01.637.879.571 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Biomedical and Dental Materials (Non MeSH); Polymers; Plastics Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH); Textiles Polymers where the main polymer chain comprises recurring amide groups. These compounds are generally formed from combinations of diamines, diacids, and amino acids and yield fibers, sheeting, or extruded forms used in textiles, gels, filters, sutures, contact lenses, and other biomaterials. 9@ &(RNylidrin D02.033.329.624.605; D02.092.063.624.605; D06.347.930.602; D14.100.050.100.200.560; D16.050.870.570; D18.918.671; D26.930.602 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasodilator Agents Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor. Amino Alcohols (66-71); Sympathomimetics (66-71) 9 ::Nuts B06.510.645; J01.341.739 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Seeds Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food Coconut; Peanuts Coconut; Peanuts Dry fruit consisting of an edible kernel or meat enclosed in a woody or leathery shell.  9z4 X*kNutritive Value G06.696.741 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition An indication of the contribution of a food to the nutrient content of the diet. This value depends on the quantity of a food which is digested and absorbed and the amounts of the essential nutrients (protein, fat, carbohydrate, minerals, vitamins) which it contains. This value can be affected by soil and growing conditions, handling and storage, and processing. Nutrition (66-78) :NNutritional Support E02.707 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Enteral Nutrition; Parenteral Nutrition (+ 4) The administration of nutrients for assimilation and utilization by a patient by means other than normal eating. It does not include FLUID THERAPY which normalizes body fluids to restore WATER-ELECTROLYTE BALANCE. Enteral Nutrition (69-94); Parenteral Nutrition (66-94)  :L "7BNutritional Status G06.696.738; N01.224.425.525 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition Population Characteristics (Non MeSH); Demography; Health Status State of the body in relation to the consumption and utilization of nutrients. :>"_Nutritional Requirements G06.696.736 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition specific nutrient :NNutritional and Metabolic Diseases (Non MeSH) C18 Metabolic Diseases (+ 230); Nutrition Disorders (+ 36) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI :O6CPNutrition Surveys E05.318.308.250.600; E05.318.308.585.550; G03.850.520.308.250.600; G03.850.520.308.585.550; N05.715.360.300.375.560; N05.715.360.300.560.565 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Nutrition Assessment Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Nutrition Assessment Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Nutrition Assessment Diet Surveys Diet Surveys Diet Surveys Diet Surveys Diet Surveys Diet Surveys A systematic collection of factual data pertaining to the nutritional status of a human population within a given geographic area. Data from these surveys are used in preparing NUTRITION ASSESSMENTs. :>>\Nutrition Policy I01.880.604.710.608.400.650; N03.706.710.608.428.650 ECHILJTD Social Sciences; Sociology; Social Control, Formal; Policies (Non MeSH); Public Policy; Health Policy Economics, Organizations, Control (Non MeSH); Social Control, Formal; Policies (Non MeSH); Public Policy; Health Policy Governmental guidelines and objectives pertaining to public food supply and nutrition including recommendations for healthy diet and changes in food habits to ensure healthy diet. Health Policy (80-94) : : Nutrition Disorders C18.654 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH) Child Nutrition Disorders (+ 1); Deficiency Diseases (+ 27); Obesity (+ 4); Starvation BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI :  N6lPNutrition Assessment E05.318.308.585; G03.850.520.308.585; N05.715.360.300.560 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection Nutrition Surveys (+ 1) Nutrition Surveys (+ 1) Nutrition Surveys (+ 1) Evaluation and measurement of nutritional variables in order to assess the level of nutrition or the nutritional status of the individual. Nutrition surveys may be used in making the assessment. Nutrition Disorders (66-89); Nutrition Surveys (66-89); Nutritional Status (87-89) :A^VbNutrition G02.513; G06.696 EDPH Diet; Food Health Occupations Biochemical Phenomena, Metabolism, Nutrition (Non MeSH)  Animal Nutrition; Child Nutrition (+ 4); Diet (+ 3); Nutritional Requirements; Nutritional Status; Nutritive Value The science of food, the nutrients and other substances contained therein, their action, interaction, and balance in relation to health and disease. AECLCTDEECEDEHGEHIIMISMOMTNUPHPXRESNSTTDUTVE $: U0Nursing, Team N04.590.715.571 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Patient Care Team Coordination of nursing services by various nursing care personnel under the leadership of a professional nurse. The team may consist of a professional nurse, nurses' aides, and the practical nurse. :9tNursing, Supervisory N04.452.758.377.750 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Nursing Administration of nursing services for one or more clinical units. :|PNursing, Private Duty N04.452.758.377.500 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Nursing The practice of nursing by a registered or licensed nurse to care for a specific patient in a health facility or in the home. Nursing (66) :+|Nursing, Practical G02.495; N02.421.533.520 CLECEDHIISLJMAMTOGSNSTTD Health Occupations Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The practice of nursing by licensed, non-registered persons qualified to provide routine care to the sick. :p~Nursing Theory G02.478.408 Models, Nursing Health Occupations; Nursing Concepts, definitions, and propositions applied to the study of various phenomena which pertain to nursing and nursing research. Models, Theoretical (68-85); Philosophy, Nursing (69-85) :""CNursing Staff, Hospital M01.526.485.680.490; M01.526.485.740.523; N02.360.680.490; N02.360.740.523 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nursing Staff Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital Facilities, Manpower and Services (Non MeSH); Health Personnel; Nursing Staff Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital Personnel who provide nursing service to patients in a hospital. Nursing Service, Hospital (66-67) :zTN(Nursing Staff M01.526.485.680; N02.360.680 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Nursing Staff, Hospital Nursing Staff, Hospital Personnel who provide nursing service to patients in an organized facility, institution, or agency. :!N"8uNursing Services N02.421.539 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services Nursing Service, Hospital A general concept referring to the organization and administration of nursing activities. :#JiNursing Service, Hospital N02.278.354.422.489; N02.421.539.180; N04.452.442.422.489 CLECHILJMAOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Services Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments The hospital department which is responsible for the organization and administration of nursing activities. :$UAh}Nursing Research G02.478.395; N04.590.233.508.613 CLECEDHIISLJMAMTOGSNSTTD Research Health Occupations; Nursing Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process Clinical Nursing Research; Nursing Administration Research; Nursing Education Research; Nursing Evaluation Research; Nursing Methodology Research Clinical Nursing Research; Nursing Administration Research; Nursing Education Research; Nursing Evaluation Research; Nursing Methodology Research Research carried out by nurses, generally in clinical settings, in the areas of clinical practice, evaluation, nursing education, nursing administration, and methodology. Nursing or specific nursing (66-88); Research (66-88) $:&& LANursing Records E05.318.308.940.984; G03.850.520.308.940.984; L01.280.900.984; N04.452.859.675; N05.715.360.300.715.550 CLECLJSNST Forms and Records Control Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records Information Science; Data Collection; Records Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records Data recorded by nurses concerning the nursing care given to the patient, including judgment of the patient's progress. Medical Records (66)  :*hs Nursing Process N04.590.233.508 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care Nursing Assessment (+ 1); Nursing Research (+ 5) The sum total of nursing activities which includes assessment (identifying needs), intervention (ministering to needs), and evaluation (validating the effectiveness of the help given). Nursing Care (66-79); Patient Care Planning (68-79) CLECEDHIISLJMAMTOGSNSTTDUT $:.|=?Nursing Methodology Research G02.478.395.634; N04.590.233.508.613.634 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Nursing Research Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process; Nursing Research Research carried out by nurses concerning techniques and methods to implement projects and to document information, including methods of interviewing patients, collecting data, and forming inferences. The concept includes exploration of methodological issues such as human subjectivity and human experience. Nursing or specific nursing (66-88); Research (66-88) :0\".`ANursing Homes N02.278.825.610 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Residential Facilities Intermediate Care Facilities; Skilled Nursing Facilities Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization. CLECHILJMAMTOGSDSNSTTDUT  :3jgBNursing Faculty Practice N04.452.758.388 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Clinical practice by members of the nursing faculty in order to maintain a balance in their nursing activities--clinical, education, and research. Faculty, Nursing (66-87) :5!qNursing Evaluation Research G02.478.395.432; N04.590.233.508.613.432 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Nursing Research Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process; Nursing Research Research carried out by nurses that uses interviews, data collection, observation, surveys, etc., to evaluate nursing, health, clinical, and nursing education programs and curricula, and which also demonstrates the value of such evaluation. Nursing or specific nursing (66-88); Research (66-88) :6!.ANursing Education Research G02.478.395.413; I02.358.462.612; N04.590.233.508.613.413 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Nursing Research Education; Education, Professional (Non MeSH); Education, Nursing Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process; Nursing Research Investigations into the problems of integrating research findings into nursing curricula, developing problem solving skills, finding approaches to clinical teaching, determining the level of practice by graduates from different basic preparations, etc. Nursing or specific nursing (66-88); Research (66-88) :9 A& ANursing Diagnosis N04.590.233.508.480.110 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process; Nursing Assessment Conclusions derived from the nursing assessment that establish a health status profile for the patient and from which nursing interventions may be ordered. Nursing Assessment (80-86) :< Nursing Care E02.472.611; N02.421.533 CLLJMAMTOGPXSNSTTDUT Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services Home Nursing Emergency Nursing; Geriatric Nursing; Home Nursing (+ 1); Maternal-Child Nursing (+ 1); Nursing, Practical; Obstetrical Nursing; Occupational Health Nursing; Oncologic Nursing; Operating Room Nursing; Orthopedic Nursing; Pediatric Nursing (+ 1); Postanesthesia Nursing; Primary Nursing Care; Psychiatric Nursing; Surgical Nursing Care given to patients by nursing service personnel. CLECEDHIISLJMAMTOGPXSDSNSTTDUT  :>@"Nursing Audit N04.761.520; N05.700.520 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of nursing care. Nursing Service, Hospital (66-67) :A(Nursing Assessment N04.590.233.508.480 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process Nursing Diagnosis Evaluation of the nature and extent of nursing problems presented by a patient for the purpose of patient care planning. :CaNursing Administration Research G02.478.395.385; N04.590.233.508.613.385 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Nursing Research Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Nursing Process; Nursing Research Research concerned with establishing costs of nursing care, examining the relationships between nursing services and quality patient care, and viewing problems of nursing service delivery within the broader context of policy analysis and delivery of health services (from a national study, presented at the 1985 Council on Graduate Education for Administration in Nursing (CGEAN) meeting). Nursing or specific nursing (66-88); Research (66-88) :E%.ANursing G02.478; N04.452.758.377 CLISMAMTOGSNSTTD Economics, Nursing; Education, Nursing; History of Nursing; Legislation, Nursing Health Occupations Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Nursing Research (+ 5); Nursing Theory; Specialties, Nursing (+ 18) Nursing, Private Duty; Nursing, Supervisory; Office Nursing The field of nursing care concerned with the promotion, maintenance, and restoration of health. CLECEDHIISLJMAMTOGSNSTTDUT $:Hv _qNurses' Aides M01.526.485.067.652; N02.360.067.652 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Psychiatric Aides Psychiatric Aides Allied health personnel who assist the professional nurse in routine duties. :J**[Nurses, Male M01.390.660; M01.526.485.650.670; N02.360.650.670 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Men Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nurses Facilities, Manpower and Services (Non MeSH); Health Personnel; Nurses Nurses of the male sex. Nursing (66) :L9 Nurses M01.526.485.650; N02.360.650 CLECLJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Nurse Administrators; Nurse Anesthetists; Nurse Clinicians; Nurse Midwives; Nurse Practitioners; Nurses, Male Nurse Administrators; Nurse Anesthetists; Nurse Clinicians; Nurse Midwives; Nurse Practitioners; Nurses, Male Professionals qualified by education at an accredited school of nursing and licensed by state law to practice nursing. They provide services to patients requiring assistance in recovering or maintaining their physical or mental health. CLECEDHILJOGPXSDSNSTTDUT  :Nz "Nurseries, Hospital N02.278.388.540; N02.278.617.473 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units Facilities, Manpower and Services (Non MeSH); Health Facilities; Nurseries Hospital facilities which provide care for newborn infants. Cross Infection (66-71); Infant, Newborn, Diseases (66-71) :Q&GFNurseries N02.278.617 CLECHILJMAOGSDSNSTTDUT Child Day Care Centers Child Day Care Centers Facilities, Manpower and Services (Non MeSH); Health Facilities Nurseries, Hospital Facilities which provide care for infants. $:S L4Nurse-Patient Relations F01.829.401.650.600; N05.300.660.560 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations; Professional-Patient Relations Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Professional-Patient Relations Interaction between the patient and nurse. :T*4Nurse Practitioners M01.526.485.650.640; N02.360.650.640 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nurses Facilities, Manpower and Services (Non MeSH); Health Personnel; Nurses Nurses who are specially trained to assume an expanded role in providing medical care under the supervision of a physician. :VN*Nurse Midwives M01.526.485.650.620; N02.360.650.620 CLECEDHILJOGPXSDSNSTTDUT Midwifery Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nurses Facilities, Manpower and Services (Non MeSH); Health Personnel; Nurses Professional nurses who have received postgraduate training in midwifery. :X"* VNurse Clinicians M01.526.485.650.610; N02.360.650.610 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nurses Facilities, Manpower and Services (Non MeSH); Health Personnel; Nurses Registered nurses who hold Master's degrees in nursing with an emphasis in clinical nursing and who function independently in coordinating plans for patient care. Nurse Practitioners (73-77) :Y*!Nurse Anesthetists M01.526.485.650.600; N02.360.650.600 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nurses Facilities, Manpower and Services (Non MeSH); Health Personnel; Nurses Professional nurses who have completed postgraduate training in the administration of anesthetics and who function under the responsibility of the operating surgeon. :[*Nurse Administrators M01.526.070.670; M01.526.485.650.580; N02.360.650.580 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Administrative Personnel Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Nurses Facilities, Manpower and Services (Non MeSH); Health Personnel; Nurses Nurses professionally qualified in administration. Administrative Personnel (68-81); Nursing Service, Hospital (68-77)/organization and administration (78-81) :]=);{Numismatics K01.093.560 CLECEDHIISLJMAMTOGSNSTTD Humanities; Art Study of coins, tokens, medals, etc. However, it usually refers to medals pertaining to the history of medicine. :`]Numerical Analysis, Computer-Assisted L01.700.568.110.680.700 IS Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Mathematical Computing Computer-assisted study of methods for obtaining useful quantitative solutions to problems that have been expressed mathematically. :aV+Nudism I03.548 CLECHILJPXSNTD Human Activities (Non MeSH) :b  "Nucleus Accumbens A08.186.211.577.851.664.568 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Limbic System; Septum Pellucidum; Septal Nuclei The largest neuronal nucleus in the septal region of the diencephalon. Cerebral Ventricles (66-77); Septal Nuclei (72-77) :c\6rU=Nucleotidyltransferases D08.586.913.696.445 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases Acylneuraminate Cytidylyltransferase; Adenine Nucleotide Translocase; DNA Nucleotidyltransferases (+ 6); Galactosephosphate Uridylyltransferase; Glucosephosphate Uridylyltransferase; Hexosephosphate Uridylyltransferase; NMN Adenylyltransferase; 2',5'-Oligoadenylate Synthetase; Poly A Polymerase; RNA Nucleotidyltransferases (+ 8); Sulfate Adenylyltransferase A class of enzymes that transfers nucleotidyl residues. EC 2.7.7. :dFlPNucleotides, Cyclic D13.695.462 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Cyclic AMP (+ 2); Cyclic CMP; Cyclic GMP (+ 1); Cyclic IMP AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR :gBPNDNucleotides D09.203.408.620; D13.695 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Base Sequence Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH) Nucleoside Diphosphate Sugars (+ 16) Arabinonucleotides (+ 2); Deoxyribonucleotides (+ 9); Dinucleoside Phosphates; Nucleotides, Cyclic (+ 7); Polynucleotides (+ 22); Purine Nucleotides (+ 45); Pyrimidine Nucleotides (+ 29); Ribonucleotides (+ 81); Thionucleotides (+ 1) The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From A Dictionary of Genetics, 4th ed, 1990). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $:iQBBHNucleotide Mapping E05.196.181.400.454.655; E05.196.401.319.670; E05.196.680 ISMT Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Liquid; Chromatography, Paper Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Paper Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Blotting, Northern; Blotting, Southern Blotting, Northern; Blotting, Southern Blotting, Northern; Blotting, Southern Two-dimensional separation and analysis of nucleotides. Chromatography, Paper (66-86); Electrophoresis, Paper (73-86) AECLCTECHIISMOMTNUPXSNSTTDUTVE $:mA@AH"Nucleotide Deaminases D08.586.277.151.653 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases AMP Deaminase; Deoxycytidylate Deaminase Catalyze the hydrolysis of nucleotides with the elimination of ammonia. Aminohydrolases (66-74)  :pFf0UNucleotidases D08.586.277.352.650.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases 5'-Nucleotidase A class of enzymes that catalyze the conversion of a nucleotide and water to a nucleoside and orthophosphate. EC 3.1.3.-. :qFNucleosomes A11.223.349.625; D12.776.660.224.550; D12.776.664.224.550 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cell Nucleus; Chromatin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins; Chromatin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Chromatin The repeating structural units of chromatin, each consisting of approximately 200 base pairs of DNA wound around a protein core. This core is composed of the histones H2A, H2B, H3, and H4. Cell Nucleus (66-79); Chromatin (72-79) :s~A*1Nucleosides D09.203.408.595; D13.570 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH)  Arabinonucleosides (+ 4); Deoxyribonucleosides (+ 23); Purine Nucleosides (+ 21); Pyrimidine Nucleosides (+ 25); Ribonucleosides (+ 29); Thionucleosides (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR :vBHNucleoside-Phosphate Kinase D08.586.913.696.650.575 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Phosphate Group Acceptor) An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4. Nucleotides (66-76); Phosphotransferases (66-73); Phosphotransferases, ATP (74-76) :xR FO`Nucleoside-Diphosphate Kinase D08.586.913.696.650.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Phosphate Group Acceptor) An enzyme that is found in mitochondria and in the soluble cytoplasm of cells. It catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside diphosphate, e.g., UDP, to form ADP and UTP. Many nucleoside diphosphates can act as acceptor, while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.6. Nucleotides (66-76); Phosphotransferases (66-73); Phosphotransferases, ATP (74-76) :{J"F`Nucleoside Q D13.570.583.454.500; D13.570.800.453.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Guanosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Guanosine (1S-(1 alpha,4 beta,5 beta))-2-Amino-5-(((4,5-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-1,7-dihydro-7-beta-D-ribofuranosyl-4H-pyrrolo(2,3-d)pyrimidin-4-one. A modified nucleoside which is present in the first position of the anticodon of tRNA-tyrosine, tRNA-histidine, tRNA-asparagine and tRNA-aspartic acid of many organisms. It is believed to play a role in the regulatory function of tRNA. Nucleoside Q can be further modified to nucleoside Q*, which has a mannose or galactose moiety linked to position 4 of its cyclopentenediol moiety. Guanosine (72-74)/analogs and derivatives (75-79); Nucleosides (66-71) :~.DlSNucleoside Diphosphate Sugars D09.203.408.620.569; D13.695.201.486; D13.695.827.708 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Adenosine Diphosphate Sugars (+ 3); Cytidine Diphosphate Diglycerides; Guanosine Diphosphate Sugars (+ 2); Uridine Diphosphate Sugars (+ 7) Adenosine Diphosphate Sugars (+ 3); Cytidine Diphosphate Diglycerides; Guanosine Diphosphate Sugars (+ 2); Uridine Diphosphate Sugars (+ 7) specific carbohydrate (66-72); specific nucleotide (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  :#=>/IEDNucleoside Deaminases D08.586.277.151.486 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases Adenosine Deaminase; Cytidine Deaminase Catalyze the hydrolysis of nucleosides with the elimination of ammonia. Aminohydrolases (66-74)  :Ff/UNucleosidases D08.586.277.450.737 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases NAD+ Nucleosidase :NFlNucleoproteins D12.776.664 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Chromatin (+ 2); Chromosomal Proteins, Non-Histone (+ 2); Deoxyribonucleoproteins; Histones; Protamines (+ 2); Ribonucleoproteins (+ 6) Proteins conjugated with nucleic acids. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEMIPAPDPHPKPOPSRARERISDSESTTOTRTUULURUSVI  :aFD0ZNucleolus Organizer Region A11.223.475.658; G05.275.658 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Cell Nucleolus Cells; Cell Nucleus; Chromosomes Genetics; Genes The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Cell Nucleolus (66-79); Chromosomes (66-79); Chromosomes, Human (78-79); specific human chromosome (68-79)  :c "(<Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH) D13 Antisense Elements (Genetics) (+ 3); Nucleic Acid Precursors (+ 1); Nucleic Acids (+ 111); Nucleosides (+ 111); Nucleotides (+ 205) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR :O@HNucleic Acids D13.444 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genetics, Biochemical Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH) DNA (+ 42); Nucleic Acid Heteroduplexes; Nucleic Acid Probes (+ 9); RNA (+ 56) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  : D@dFNucleic Acid Renaturation G06.184.680 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) The reformation of all, or part of, the native conformation of a nucleic acid molecule after the molecule has undergone denaturation. DNA (66-70); Nucleic Acids (66-70); RNA (66-70) :/h=Nucleic Acid Probes D13.444.600; D26.651.600 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acid Hybridization Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes Antisense Elements (Genetics); DNA Probes (+ 4); Oligonucleotide Probes; RNA Probes (+ 1) Antisense Elements (Genetics); DNA Probes (+ 4); Oligonucleotide Probes; RNA Probes (+ 1) Nucleic acid which complements a specific mRNA or DNA molecule, or fragment thereof; used for hybridization studies in order to identify microorganisms and for genetic studies. Nucleic Acids or specific nucleic acid (72-88); Nucleic Acid Hybridization (72-88) $:D bNucleic Acid Precursors D13.400 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH) RNA Precursors Use for nucleic acid precursors in general or for which there is no specific heading. Nucleic Acids (68-74)  :C D@hNucleic Acid Hybridization E05.393.661; G06.184.661 DEGEIMPHRE Blotting, Southern Nucleic Acid Probes; Oligonucleotide Probes; DNA Miscellaneous Techniques (Non MeSH); Genetic Techniques Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) In Situ Hybridization (+ 1) Formation of base pairs by hydrogen bonds and hydrophobic linkage between two single strands of nucleic acids to produce a double-stranded molecule. This may be between two strands of DNA or between DNA and RNA. It generally results in the formation of helical structures. DNA (66-70); RNA (66-70) AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE ,: ;$B!,Nucleic Acid Heteroduplexes D13.444.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids Double-stranded nucleic acid molecules (DNA-DNA or DNA-RNA) which contain regions of nucleotide mismatches (non-complementary). In vivo, these heteroduplexes can result from mutation or genetic recombination; in vitro, they are formed by nucleic acid hybridization. Electron microscopic analysis of the resulting heteroduplexes facilitates the mapping of regions of base sequence homology of nucleic acids. Base Sequence (71-79); DNA (66-79); specific DNA (66-79); Mutation (66-79); Nucleic Acid Hybridization (71-79); Recombination, Genetic (68-79); RNA (66-79); specific RNA (66-79) :!FSNucleic Acid Denaturation G06.184.642 DEGEIMPHRE DNA Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Disorganization of secondary structures of nucleic acids through cleavage of hydrogen bonds and hydrophobic linkages. Denatured DNA appears to be a single-stranded flexible structure. The effects of denaturation on RNA are similar though less pronounced and largely reversible. :{hANucleic Acid Conformation G06.184.580.486; H01.181.529.559.486 DERE Polymorphism, Single-Stranded Conformational Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Conformation Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Conformation The characteristic 3-dimensional shape of a nucleic acid or polynucleotide. Its secondary structure is due to the formation of hydrogen bonds between nucleotides, resulting in base pairing and areas with alpha helix structure. Nucleic Acids (66-71)  :*2Nuclear Warfare I01.880.735.944.600 HI Radioactive Fallout Radiation Social Sciences; Sociology; Social Problems; War Warfare involving the use of nuclear weapons.  :E <8Nuclear Reactors H01.671.579.694; J01.724 CLECHIISLJSDSNSTUT Accidents, Radiation Physical Sciences (Non MeSH); Physics; Nuclear Physics Technology, Industry, Agriculture (Non MeSH) Devices containing fissionable material in sufficient quantity and so arranged as to be capable of maintaining a controlled, self-sustaining nuclear fission chain reaction. They are also known as atomic piles, atomic reactors, fission reactors, and nuclear piles, although such names are deprecated. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). ::uNuclear Proteins D12.776.660 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Chromatin (+ 2); Chromosomal Proteins, Non-Histone (+ 2); Histones; NF-kappa B; Oncogene Protein p55(v-myc); Proliferating Cell Nuclear Antigen; Protamines (+ 2); Protein p53; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Retinoblastoma Protein Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleoproteins (66-87); Proteins (66-87) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEMIPAPDPHPKPOPSRARERISDSESTTOTRTUULURUSVI $:FDX1ZNuclear Polyhedrosis Virus B04.280.065.500; B04.525.100.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Baculoviridae Viruses; Insect Viruses; Baculoviridae A genus of the family BACULOVIRIDAE, subfamily Eubaculovirinae, characterized by the formation of crystalline, polyhedral occlusion bodies in the host cell nucleus. Baculoviridae (73-93) :p &YNuclear Physics H01.671.579 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Physics Alpha Particles; Beta Rays; Electron Spin Resonance Spectroscopy; Elementary Particles (+ 6); Nuclear Energy (+ 2); Nuclear Magnetic Resonance; Nuclear Reactors; Particle Accelerators (+ 2); Quantum Theory; Radioactivity; Radionuclide Generators AECLCTDUECEDHIISLJMAMOMTNUOGPXSDSNSTTDTUUTVE :,/#0Nuclear Membrane A11.223.650; A11.904.514.700 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Membranes; Cell Membrane Cells; Cell Nucleus Cells; Subcellular Fractions; Intracellular Membranes An intracellular structure, consisting of two concentric membranes, enclosing the nucleoplasm and separating it from the cytoplasm. The areas where these two membranes fuse are called nuclear pore complexes. Cell Membrane (66-76); Cell Nucleus (66-76); Membranes (68-76)  :"*WMNuclear Medicine Department, Hospital N02.278.354.422.472; N04.452.442.422.472 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the administration and management of nuclear medicine services. Hospital Departments (68-81); Nuclear Medicine (67-81) :T,. sANuclear Medicine G02.403.790.470 CLECEDHIISLJMAMTOGSNSTTD Radioisotopes Radiobiology Health Occupations; Medicine; Specialties, Other (Non MeSH) A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form. Nuclear Energy (66); Nuclear Warfare (66); Radiation Injuries (66); Radioisotopes (66) $:GjNuclear Matrix A11.223.630 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Cells; Cell Nucleus The fibrogranular network of residual structural elements within which are immersed both chromatin and ribonucleoproteins. It extends throughout the nuclear interior from the nucleolus to the nuclear pore complexes along the nuclear periphery. Cell Nucleus (72-89) :(Nuclear Magnetic Resonance E05.196.867.519; H01.671.579.631 AECLDUHIISMTTU Magnetic Resonance Imaging Magnetic Resonance Imaging Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Physical Sciences (Non MeSH); Physics; Nuclear Physics Spectroscopic method of measuring the magnetic moment of atomic nuclei in a covalent bond. Clinical application is in biochemical, metabolic, and physiologic studies of living tissue. It includes proton and electron spin-echo and spin-relaxation times.  :Y &  %Nuclear Fusion G03.230.132.580.520; H01.671.579.580.652 Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Nuclear Energy Physical Sciences (Non MeSH); Physics; Nuclear Physics; Nuclear Energy Thermonuclear reaction in which the nuclei of an element of low atomic weight unite under extremely high temperature and pressure to form a nucleus of a heavier atom. Nuclear Energy (66-70) :.Nuclear Fission G03.230.132.580.500; H01.671.579.580.485 Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Nuclear Energy Physical Sciences (Non MeSH); Physics; Nuclear Physics; Nuclear Energy Nuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon. Nuclear Energy (66-70) :.Nuclear Family F01.829.263.500; I01.880.225.500 EHPX Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family Social Sciences; Sociology; Family Only Child; Parents (+ 4); Spouses Only Child; Parents (+ 4); Spouses A family composed of husband and wife with their children. CLEDEHHILJPXSN  :&ZHNuclear Energy G03.230.132.580; H01.671.579.580 ECHILJSN Radiation Protection; Radioactive Waste Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources Physical Sciences (Non MeSH); Physics; Nuclear Physics Nuclear Fission; Nuclear Fusion Nuclear Fission; Nuclear Fusion Energy released by nuclear fission or nuclear fusion.  :& /LANoxythiolin D02.886.904.500; D02.948.898.500; D20.187.651 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Anti-Infective Agents; Anti-Infective Agents, Local 1-(Hydroxymethyl)-3-methyl-2-thiourea. Local antibacterial that probably acts by releasing formaldehyde in aqueous solutions; it is used for irrigation of infected body cavities - bladder, peritoneum, etc. and as a spray for burns. Synonyms: Gynaflex, Noxyflex. Alcohol, Methyl (74) /AA (75); Thiourea (74) /AA (75) :k5:0CNoxae (Non MeSH) D05.569 Environmental Pollutants, Pesticides (Non MeSH) Carcinogens, Environmental (+ 2); Caustics (+ 3); Mutagens (+ 6); Poisons (+ 1); Riot Control Agents, Chemical (+ 4); Teratogens; Xenobiotics AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR :F 7@Novobiocin D20.085.565 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics N-(7-((3-O-(Aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl- beta-L-lyxopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1- benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)benzamide. Antibiotic substance produced by Streptomyces spheroides. :ñ<)Nova Scotia Z01.107.567.176.589 EHEP Geographicals (Non MeSH); America; North America; Canada :UFNotophthalmus viridescens B02.090.608.700.480 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Salamandridae A genus of the Salamandridae family in which the larvae transform into terrestrial eft (newt) stage and later into an aquatic adult. They occur from Canada to southern United States. Salamandridae (75-80); Urodela (66-74) :&7/Notochord A16.254.610 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo The rod-shaped body, composed of cells derived from the mesoblast and defining the primitive axis of the embryo. In lower vertebrates, it persists throughout life as the main axial support of the body, but in higher vertebrates it is replaced by the vertebral column. Chick Embryo (66-78); Embryo (66-78) :Ǫ :1<.Nostrums D26.394.651 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Quackery Miscellaneous Drugs and Agents (Non MeSH); Drugs : , <Nosema B01.841.500.500.500.100.400 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Microspora; Microsporea; Microsporida; Apansporoblastina A genus of parasitic protozoa. Some species are pathogenic for invertebrates of economic importance while others are being researched for possible roles in controlling pest insects. Protozoa (68-91); Sporozoea (66-91) :t &_,Nose Neoplasms C04.588.149.721.600; C04.588.443.665.650; C05.116.231.754.600; C08.460.669; C08.785.600; C09.603.669; C09.647.685 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms; Skull Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms; Skull Neoplasms Respiratory Tract Diseases; Nose Diseases Respiratory Tract Diseases; Respiratory Tract Neoplasms Otorhinolaryngologic Diseases; Nose Diseases Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms  Nasal Polyps; Paranasal Sinus Neoplasms (+ 1) Nasal Polyps; Paranasal Sinus Neoplasms (+ 1) Nasal Polyps; Paranasal Sinus Neoplasms (+ 1) Nasal Polyps; Paranasal Sinus Neoplasms (+ 1) Nasal Polyps; Paranasal Sinus Neoplasms (+ 1) :IXNose Diseases C08.460; C09.603 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases Respiratory Tract Diseases Otorhinolaryngologic Diseases Choanal Atresia; Epistaxis; Granuloma, Lethal Midline; Nasal Obstruction; Nasal Polyps; Nose Deformities, Acquired; Nose Neoplasms (+ 3); Paranasal Sinus Diseases (+ 7); Rhinitis (+ 4); Rhinoscleroma Choanal Atresia; Epistaxis; Granuloma, Lethal Midline; Nasal Obstruction; Nasal Polyps; Nose Deformities, Acquired; Nose Neoplasms (+ 3); Paranasal Sinus Diseases (+ 7); Rhinitis (+ 4); Rhinoscleroma Disorders of the nose, general or unspecified. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $:lN"@9ZNose Deformities, Acquired C08.460.619; C09.603.619 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Otorhinolaryngologic Diseases; Nose Diseases Deformities of the nose acquired after birth from injury or disease. : LdSNose A01.456.505.733; A04.531; A09.531 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Rhinoplasty Body Regions (Non MeSH); Head; Face Respiratory System Sense Organs  Nasal Bone; Nasal Cavity; Nasal Mucosa (+ 2); Nasal Septum; Paranasal Sinuses (+ 4); Turbinates Olfactory Mucosa (+ 1) A specialized structure that serves as an organ of the sense of smell as well as part of the respiratory system; the term includes both the external nose and the nasal cavity. consider also terms at NAS- and RHIN-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $:H)8S:Noscapine D03.132.610.568; D03.438.531.567; D15.153.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Central Nervous System Agents; Antitussive Agents A naturally occurring opium alkaloid that is a centrally acting antitussive agent. : 5:bNorway Z01.542.808.618 EHEP Geographicals (Non MeSH); Europe; Scandinavia Svalbard : 8 Norwalk Virus B04.820.095.600; B04.909.777.162.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Caliciviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Caliciviridae An RNA virus of the family CALICIVIRIDAE isolated from the stools of school children in Norwalk, Ohio, who were suffering from gastroenteritis in 1968. The virions are non-enveloped spherical particles containing a single protein. Gastroenteritis (66-81) :a*{ Nortropanes D03.605.869.744 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes :܆8ZNortriptyline D04.615.181.384.535; D14.100.050.600.050.550; D14.100.600.050.550; D15.085.050.550; D15.700.122.055.664 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic A metabolite of AMITRYPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions. :Ys:Northwestern United States Z01.107.567.875.600.656 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Idaho; Montana; Oregon; Washington; Wyoming The geographic area of the northwestern region of the United States. The states usually included in this region are Idaho, Montana, Oregon, Washington, and Wyoming. : y7Northwest Territories Z01.107.567.176.564 EHEP Geographicals (Non MeSH); America; North America; Canada Canada (66-89) :FNorthern Territory Z01.338.500 EHEP Geographicals (Non MeSH); Australia A state in north central Australia. Australia (69-89) :O,-Northern Ireland Z01.542.363.602 EHEP Geographicals (Non MeSH); Europe; Great Britain :;North Sea Z01.756.092.650 Geographicals (Non MeSH); Oceans and Seas; Atlantic Ocean :GNorth Dakota Z01.107.567.875.100.650; Z01.107.567.875.600.516.650 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States : :North Carolina Z01.107.567.875.100.641; Z01.107.567.875.600.820.641 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States ::North America Z01.107.567 EHEP Geographicals (Non MeSH); America Canada (+ 12); Greenland; Mexico; United States (+ 139) :<*GNorsteroids D04.808.668 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Norandrostanes; Norpregnanes (+ 20) Steroids which have undergone contraction in ring size or reduction in side chains. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  :8(+d:Norprogesterones D04.808.668.651.693.820 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Progesterones which have undergone ring contraction or which are lacking carbon 18 or 19. Norpregnanes (74); Progesterone (74) :k8Wk-Norpregnenes D04.808.668.651.693 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes Desogestrel; Ethylestrenol; Ethynodiol Diacetate; Gestonorone Caproate; Lynestrenol; Norethandrolone; Norethindrone; Norethynodrel; Norgestrel (+ 1); Norprogesterones Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19.. Norpregnanes (74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $:8G:Norpregnatrienes D04.808.668.651.568 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes Ethinyl Estradiol (+ 2); Norgestrienone (+ 1) Pregnatrienes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Norpregnanes (74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $:u8G9k:Norpregnanes D04.808.668.651 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids Norpregnadienes (+ 1); Norpregnatrienes (+ 5); Norpregnenes (+ 11) Pregnanes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Unsaturation in the steroid ring system is not included. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  :B87R:Norpregnadienes D04.808.668.651.443 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes Promegestone Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19. Norpregnanes (74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $:58Gj:Normetanephrine D02.092.211.215.311.560.651; D02.092.311.461.651 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines; Norepinephrine Organic Chemicals (Non MeSH); Amines; Catecholamines; Epinephrine :6>Normal Distribution E05.318.740.994.500; G03.850.520.830.994.500; H01.548.832.901.500; N05.715.360.750.750.565 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics; Statistical Distributions (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Statistical Distributions (Non MeSH) Continuous frequency distribution of infinite range. Its properties are as follows: 1) continuous, symmetrical distribution with both tails extending to infinity; 2) arithmetic mean, mode, and median identical; and 3) shape completely determined by the mean and standard deviation. :Hd7GNorleucine D12.125.213.568 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Aminocaproic Acids Aminocaproic Acids (66-71) :aF_ Norgestrienone D04.808.668.651.568.620; D06.597.799.742; D07.360.276.210.443.706.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnatrienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic Gestrinone 17-Hydroxy-19-nor-17 alpha-pregna-4,9,11-trien-20-yn-3-one. A synthetic steroid with progestational and contraceptive activities. Hydroxysteroids (73-74); Ketosteroids (73-74); Pregnatrienes (73-74); Norpregnanes (74)  :jM:hNorgestrel D04.808.668.651.693.762; D06.597.799.734; D07.360.276.210.443.706.723 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic Levonorgestrel Levonorgestrel Levonorgestrel (+-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one. A progestational agent with actions similar to those of progesterone. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive and ovulation inhibitor and for the control of menstrual disorders and endometriosis. Contraceptives, Oral (66-71); Ketones (66-71); Pregnanes (68-71); Progestational Hormones (66-71)  :M:2tNorfloxacin D03.438.810.835.475; D20.220.050.610; D20.237.050.050.610 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones Anti-Infective Agents; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid. Quinoline-derived synthetic antibacterial agent with a very broad spectrum of action. Oral administration yields highly bactericidal plasma, tissue, and urine levels. Norfloxacin inhibits bacterial DNA-gyrase and is used in gastrointestinal, eye, and urinary infections. Anti-Infective Agents (66-85); Anti-Infective Agents, Urinary (66-85); Nalidixic Acid (66-85) ;\A:\nNorfenfluramine D02.092.471.683.467.500; D14.100.600.850.260.550; D14.100.850.875.260.550; D14.100.850.875.800.260.550; D15.155.200.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Fenfluramine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors; Fenfluramine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Fenfluramine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors; Fenfluramine Central Nervous System Agents; Appetite Depressants; Fenfluramine A FENFLURAMINE analog that acts as a serotonin neuron agent and a serotonin uptake inhibitor. It is used as an appetite depressant. Hydrocarbons, Fluorinated (74); Phenethylamines (73-74) ;c:ANorethynodrel D04.808.668.651.693.706; D06.597.799.708; D07.360.276.210.443.706.678 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (17 alpha)-17-Hydroxy-19-norpregn-5(10)-en-20-yn-3-one. A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL. ; <M:lNorethindrone D04.808.668.651.693.651; D06.597.799.682; D07.360.276.210.443.706.633 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (l7 alpha)-17 Hydroxy-19-norpregn-4-en-20-yn-3-one. A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception. ;M:Norethandrolone D04.808.668.651.693.595; D06.597.100.194.637 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids 17-Hydroxy-19-norpregn-4-en-3-one. A synthetic hormone with anabolic and androgenic properties and moderate progestational activity. ;2:Norepinephrine D02.092.211.215.311.560; D02.092.311.461.484; D14.100.050.100.100.560; D14.600.100.550; D16.050.870.560; D18.222.863.630 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Adrenergic Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines Organic Chemicals (Non MeSH); Amines; Catecholamines; Epinephrine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Normetanephrine Nordefrin Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.  ;D"Nordihydroguaiaretic Acid D02.755.166.550; D08.373.310.550; D08.373.390.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Catechols Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Lipoxygenase Inhibitors 4,4'-(2,3-Dimethyl-1,4-butanediyl)bis(1,2-benzenediol). A potent lipoxygenase inhibitor that interferes with arachidonic acid metabolism. The compound also inhibits formyltetrahydrofolate synthetase, carboxylesterase, and cyclooxygenase to a lesser extent. It also serves as an antioxidant in fats and oils. Catechols (66-86) ;p9:`Nordefrin D02.092.311.461.484.400; D18.793.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Epinephrine; Norepinephrine Cardiovascular Agents; Vasoconstrictor Agents 4-(2-Amino-1-hydroxypropyl)-1,2-benzenediol. A norepinephrine derivative used as a vasoconstrictor agent. ; *:yNordazepam D03.438.079.080.070.216.500; D14.100.240.500.200.600; D15.075.050.150.500; D15.210.950.012.050.153.500; D15.700.872.015.050.275.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones; Diazepam Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators; Diazepam Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine; Diazepam Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine; Diazepam Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine; Diazepam An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam. Dealkylation (73-75); Diazepam (73-76) ; Q:/Norbornanes D02.455.849.618 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Bornanes (+ 1); Mecamylamine; Toxaphene Bridged Compounds (66-70); Camphor (66-70); Heterocyclic Compounds (66-70); Polycyclic Compounds (66-70); Terpenes (70-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ;$8@2:Norandrostanes D04.808.668.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids Androstanes in which ring contractions have occurred or which are lacking carbon-18. Compounds with any degree of unsaturation are included. Androstanes which are lacking carbon-19 are ESTRANES. Androstanes (68-74); Norsteroids (68-74) ;&871Nootropic Agents D15.590 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents Acetylcarnitine; Cytidine Diphosphate Choline; Dihydroergotoxine; Ergoloid Mesylates; Meclofenoxate; Nicergoline; Piracetam; Tacrine Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated. Psychotropic Drugs (89-94) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $;(x 8$P DNoonan Syndrome C05.660.650; C16.131.621.650; C17.300.690 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases A multifaceted disorder due to a basic defect of connective tissue. It is characterized by short stature, webbed neck, ptosis, skeletal malformations, hypertelorism, hormonal imbalance, cryptorchidism, multiple cardiac abnormalities (most commonly including pulmonary valve stenosis), and some degree of mental retardation. The phenotype resembles that of Turner's syndrome; however, Noonan syndrome occurs in both males and females, and no chromosomal abnormality has been found. Nevertheless, familial studies suggest that the trait is inherited as an autosomal dominant. Turner's Syndrome (66-78) ;+p1LNonverbal Communication F01.145.209.530; L01.143.649 PHPX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Information Science; Communication Blushing; Crying; Facial Expression (+ 1); Kinesics (+ 1); Laughter; Manual Communication (+ 1) Manual Communication (+ 1) Transmission of emotions, ideas, and attitudes between individuals in ways other than the spoken language. Communication (66-69); Verbal Behavior (66-69) CLDEPHPXRE $;/"y}8Nonsuppressible Insulin-Like Activity D12.776.124.862.575; D24.185.348.862.655 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Insulin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Somatomedins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Somatomedins A blood protein (NSILA) which mimics the biological activity of insulin in serum, but is not suppressed by insulin antibodies. During acid-ethanol extraction of Cohn fraction III, 10% of the activity is found in the supernatant (NSILA-S) and the remaining activity in the precipitate (NSILA-P). The latter is a large molecular compound, much less stable than the soluble fraction. NSILA-S is a more potent growth factor than insulin and exhibits sulfation activity. Blood Proteins (66-76); Insulin (66-76)  ;2:+.D !1Nonoxynol D02.033.618.690.575; D25.720.741.575; D26.866.762.575 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Polyethylene Glycols Biomedical and Dental Materials (Non MeSH); Polymers; Polyethylene Glycols Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Polyethylene Glycols alpha-(4-Nonylphenyl)-omega-hydroxypoly(oxy-1,2-ethanediyl). Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams. Polyethylene Glycols (75-92) ;66 =,"Nonodontogenic Cysts C04.182.089.530.660; C05.500.470.660; C07.320.450.640 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts Stomatognathic Diseases; Jaw Diseases; Jaw Cysts Cysts formed from epithelial inclusions in the lines of fusion of the embryonic processes which form the jaws. They include nasopalatine or incisive canal cyst, incisive papilla cyst, globulomaxillary cyst, median palatal cyst, median alveolar cyst, median mandibular cyst, and nasoalveolar cyst. ;9=VWNonlinear Dynamics H01.548.675; H01.770.461.850 HI Fractals Fractals Physical Sciences (Non MeSH); Mathematics Physical Sciences (Non MeSH); Science; Models, Theoretical The study of systems which respond disproportionately (nonlinearly) to initial conditions or perturbing stimuli. Nonlinear systems may exhibit "chaos" which is classically characterized as sensitive dependence on initial conditions. Chaotic systems, while distinguished from more ordered periodic systems, are not random. When their behavior over time is appropriately displayed (in "phase space"), constraints are evident which are described by "strange attractors". Phase space representations of chaotic systems, or strange attractors, usually reveal fractal (FRACTALS) self-similarity across time scales. Natural, including biological, systems often display nonlinear dynamics and chaos. Mathematics (74-93); Models, Biological (70-93) $;<"  x9Nondisjunction, Genetic G05.148.266.645 Genetics; Cytogenetics; Chromosome Aberrations The failure of homologous chromosomes or chromatids to segregate during mitotic or meiotic cell division with the result that one daughter cell has two chromosomes or two chromatids and the other has none. Cell Division (66-67); Chromosome Aberrations (68-81); Chromosomes (66-67); Meiosis (68-81) ;@7nNondirective Therapy F04.754.592 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A procedure in which the therapist refrains from directing the client, but instead reflects back to the client what the latter has said, sometimes restating the client's remark. ;BKNonachlazine D03.494.741.550; D18.918.662 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Cardiovascular Agents; Vasodilator Agents 2-Chloro-10-(3-(hexahydropyrrolo(1,2-a) pyrazin-2-(1H)-oxopropyl-10H-phenothiazine. Coronary vasodilator with a novel mechanism of action; proposed as antianginal agent. Phenothiazines (66-78); Piperazines (66-78) ;D?":4Nomifensine D03.438.531.535; D14.100.150.600.220.550; D14.100.600.220.560 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors 8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline. An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.266). Isoquinolines (69-77); Quinolines (66-68) ;FQE:2Nomenclature L01.143.506.598.400 Unified Medical Language System Information Science; Communication; Language; Linguistics Names (+ 3) A system or set of names, designations, or symbols used in a particular science, discipline, or art and formally adopted or sanctioned by the usage of its practitioners. (Webster's Third New International Dictionary). ;J&DNoma C07.465.604 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases A severe gangrenous process occurring predominantly in debilitated and malnourished children, especially in underdeveloped countries. It typically begins as a small vesicle or ulcer on the gingiva that rapidly becomes necrotic and spreads to produce extensive destruction of the buccal and labial mucosa and tissues of the face, which may result in severe disfigurement and even death. Various bacteria have been implicated in the etiology. (Dorland, 27th ed). ;LN/Noise, Transportation G03.850.460.610.680 AEECLJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Noise Noise associated with transportation, particularly aircraft and automobiles. Aircraft (66-78); Noise (66-78) ;OiX(Noise, Occupational G03.850.460.610.526 AEECLJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Noise Noise present in occupational, industrial, and factory situations. Noise (66-78); Occupational Medicine (66-78) ;PiN6Noise G03.230.400; G03.850.460.610; H01.671.031.675.567 AELJPC Acoustic Stimulation; Hearing Loss, Noise-Induced Sound Environment and Public Health (Non MeSH); Environment Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Physical Sciences (Non MeSH); Physics; Acoustics; Sound  Noise, Occupational; Noise, Transportation AEECLJPCSN $;R6 9 : 4Nogalamycin D20.085.075.105.200.500; D22.204.106.125.200.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin Menogaril Menogaril (2R-(2 alpha,3 beta,4 alpha,5 beta,6 alpha,11 beta,13 alpha,14 alpha))-11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-2,6-epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylic acid methyl ester. An antineoplastic agent from a Streptomyces nogalater variant. It is a cytolytic antibiotic that inhibits DNA-dependent RNA synthesis by binding to DNA and has some antibacterial action. Antibiotics (66); Antibiotics, Antineoplastic (67-75); Glycosides (66-75); Naphthacenes (66-75)  ;T6<,qNodose Ganglion A08.340.390.550; A08.800.050.050.925.550; A08.800.050.600.825.550; A08.800.350.550; A08.800.800.060.920.550; A08.800.800.120.900.550 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Sensory Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways; Vagus Nerve Nervous System; Peripheral Nervous System; Autonomic Nervous System; Parasympathetic Nervous System; Vagus Nerve Nervous System; Peripheral Nervous System; Ganglia, Sensory Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways; Vagus Nerve Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Vagus Nerve The inferior (caudal) ganglion of the vagus (10th cranial) nerve. The unipolar nodose ganglion cells are sensory cells with central projections to the medulla and peripheral processes traveling in various branches of the vagus nerve. ;X8ENocodazole D03.438.103.637; D22.204.592 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents (5-(2-Thienylcarbonyl) 1H-benzimidazol-2-yl)carbamic acid methyl ester. Nocodazole is an antineoplastic agent which exerts its effect by depolymerizing microtubules. Antineoplastic Agents (66-89); Benzimidazoles (66-89) ;\":?Nociceptors A08.800.550.700.650 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory Peripheral receptors for pain. Nociceptors include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli. All nociceptors are free nerve endings. Neurons, Afferent (69-77); Pain (66-77) ;_8[1Nocardioform Group B03.100.067.595; B03.510.595 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales Bacteria; Gram-Positive Bacteria Corynebacterium (+ 3); Mycobacteriaceae (+ 14); Nocardiaceae (+ 2); Rhodococcus (+ 1) Corynebacterium (+ 3); Mycobacteriaceae (+ 14); Nocardiaceae (+ 2); Rhodococcus (+ 1) A group of actinomycetes that forms mycelia that break up into rod-shaped or coccoid elements. Certain genera in this group are pathogenic to man. ;a""|Nocardiaceae B03.100.067.595.600; B03.510.595.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group Bacteria; Gram-Positive Bacteria; Nocardioform Group Nocardia (+ 1) Nocardia (+ 1) A family of gram-positive, aerobic actinomycetes found in soil and animal tissue. Some species are the cause of infection in man and animals. Actinomycetaceae (75); Actinomycetales (66-74)  ;c*"&7Nocardia Infections C01.252.410.040.692 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections Maduromycosis Infections with bacteria of the genus NOCARDIA. ;eP:Nocardia asteroides B03.100.067.595.600.600.100; B03.510.595.600.600.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Nocardiaceae; Nocardia Bacteria; Gram-Positive Bacteria; Nocardioform Group; Nocardiaceae; Nocardia A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man. Nocardia (66-71) ;gI:"jNocardia B03.100.067.595.600.600; B03.510.595.600.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Nocardiaceae Bacteria; Gram-Positive Bacteria; Nocardioform Group; Nocardiaceae Nocardia asteroides Nocardia asteroides A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for man and animals. ;iE 2".Noble Gases D01.268.613; D01.362.641 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Gases Argon; Helium; Krypton; Neon; Radon; Xenon Argon; Helium; Krypton; Neon; Radon (+ 1); Xenon Gases which are members of the zero group of the periodic system. These gases generally do not react chemically. Gases (66-75) ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $;k8_w<Nobelium D01.268.271.545.575; D01.552.517.659 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Nobelium. A man-made radioactive element of the actinide metal series. It has the atomic symbol No, atomic number 102, and atomic weight 259. ;m *4Nobel Prize K01.150.567 Humanities; Awards and Prizes ;o%NMN Adenylyltransferase D08.586.913.696.445.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases An enzyme that catalyzes reversibly the transfer of the adenylyl moiety of ATP to the phosphoryl group of NMN to form NAD+ and pyrophosphate. The enzyme is found predominantly in the nuclei and catalyzes the final reaction in the major pathway for the biosynthesis of NAD in mammals. EC 2.7.7.1. Adenosine Triphosphate (66-78); Nicotinamide Mononucleotide (73-78); Nucleotidyltransferases (66-78); Transferases (66-67) ;pF_Nizatidine D03.383.871.500; D14.100.375.425.425.550; D19.316.203.634 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. Thiazoles (66-91) ;s)A:sNitroxinil D02.640.743.620; D02.755.566.620; D21.201.412.482 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrophenols Organic Chemicals (Non MeSH); Phenols; Nitrophenols Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents 4-Hydroxy-3-iodo-5-nitrobenzonitrile. Proposed anthelmintic for fasciola and liver fluke infestations. Synonym: Trodax. Nitriles (72-74); Nitrophenols (72-74) ;v9:/Nitrovin D02.640.600.750; D03.383.312.649.750 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans [(3-(5-nitro-2-furyl)-1-(2-(5-nitro-2-furyl)vinyl)allylidene)amino]guanidine monohydrochloride. Amidines (71-74); Hydrazones (72-74); Nitrofurans (71-74) ;xG *:mFNitrous Oxide D01.362.635.625; D01.625.550.550; D01.650.550.587.650; D15.040.100.610; D15.050.035.060.525; D15.210.100.175.060.525 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gases; Nitrogen Oxides Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitrogen Oxides Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Nitrogen Oxides Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream. ;z7896Nitrous Acid D01.029.260.575; D01.625.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Nitrogen Compounds  Nitrites (+ 1) Nitrous acid (HNO2). A weak acid that exists only in solution. It can form water-soluble nitrites and stable esters. (From Merck Index, 11th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ;~"8:Nitrosourea Compounds D02.654.692; D02.948.594 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds Organic Chemicals (Non MeSH); Urea Carmustine; Ethylnitrosourea; Lomustine (+ 1); Methylnitrosourea; Nimustine; Streptozocin Carmustine; Ethylnitrosourea; Lomustine (+ 1); Methylnitrosourea; Nimustine; Streptozocin Nitroso Compounds (66-70); Urea (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ;8d1<Nitrosomonas B03.440.400.450.504.520 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Chemolithotrophic Bacteria; Nitrobacteraceae A genus of gram-negative, ellipsoidal or rod-shaped bacteria whose major source of energy and reducing power is from the oxidation of ammonia to nitrite. Its species occur in soils, oceans, lakes, rivers, and sewage disposal systems. ;"Nitrosomethylurethane D02.241.081.251.944.500; D02.654.585; D26.191.646.658 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Urethane Organic Chemicals (Non MeSH); Nitroso Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Nitrosamines N-Methyl-N-nitrosourethane. An alkylating carcinogen that produces gastrointestinal and probably lung and nervous system tumors. Nitroso Compounds (72-74); Urethane (72-74) ; =,5Nitrosoguanidines D02.078.370.649; D02.654.567 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Organic Chemicals (Non MeSH); Nitroso Compounds Methylnitronitrosoguanidine Methylnitronitrosoguanidine Carcinogens (66-70); Guanidines (66-70); Nitroso Compounds (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ;v"8v<P:Nitroso Compounds D02.654 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Nitrosamines (+ 4); Nitrosoguanidines (+ 1); Nitrosomethylurethane; Nitrosourea Compounds (+ 7) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ;L 8#r<Nitrosation G06.184.627; G06.535.630.742; H01.181.404.742 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Conversion into nitroso compounds. An example is the reaction of nitrites with amino compounds to form carcinogenic N-nitrosamines. Nitrates (66-89); Nitrites (66-89); Nitrosamines (66-89); Nitroso Compounds (66-89) ;5 eNitrosamines D02.654.442; D26.191.646 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Butylhydroxybutylnitrosamine; Diethylnitrosamine; Dimethylnitrosamine; N-Nitrosopyrrolidine Butylhydroxybutylnitrosamine; Diethylnitrosamine; Dimethylnitrosamine; Nitrosomethylurethane; N-Nitrosopyrrolidine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ;/8z:Nitroreductases D08.586.682.655 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Enzymes which reduce nitro groups. A variety of compounds can act as acceptors. If NADH or NADPH are the acceptors, the enzymes are classified as EC 1.6.6.- . Oxidoreductases (66-86) ;QFXNitroquinolines D02.640.820; D03.438.810.470 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines 4-Nitroquinoline-1-oxide 4-Nitroquinoline-1-oxide; Oxamniquine Quinolines substituted in any position by one or more nitro groups. Quinolines (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $;"8ER:Nitroprusside D01.248.497.158.291.350.550; D01.485.250.300.550; D01.625.400.100.325.550; D18.162.650; D18.918.644; D26.550.844.550 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Cyanides; Ferricyanides Inorganic Chemicals (Non MeSH); Iron Compounds; Ferric Compounds; Ferricyanides Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide; Cyanides; Ferricyanides Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Vasodilator Agents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Sulfhydryl Reagents (OC-6-22)-Pentakis(cyano-C)nitrosoferrate(2-). A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Ferricyanides (66-74); Nitric Oxide (66-74) ;(.5Nitrophenylgalactosides D09.203.408.320.550 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Galactosides Includes ortho-, meta-, and para-nitrophenylgalactosides. Galactose (70-74); Glycosides (70-74); Nitrophenols (73-74) ;4>iBHNitrophenols D02.640.743; D02.755.566 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds Organic Chemicals (Non MeSH); Phenols Dinitrophenols; 2-Hydroxy-5-nitrobenzyl Bromide; Niclofolan; Nitrohydroxyiodophenylacetate; Nitroxinil; Picrates Dinitrophenols; 2-Hydroxy-5-nitrobenzyl Bromide; Niclofolan; Nitrohydroxyiodophenylacetate; Nitroxinil; Picrates AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR ;8eDNitroparaffins D02.455.326.146.672; D02.640.720 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Organic Chemicals (Non MeSH); Nitro Compounds Tetranitromethane Tetranitromethane AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ;&8(:Nitromifene D03.383.773.610; D06.347.300.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists 1-(2-(4-(1-(4-Methoxyphenyl)-2-nitro-2-phenylethenyl)phenoxy)ethyl)pyrrolidine. A non-steroidal estrogen antagonist (as the 1:1 citrate) with anti-fertility activity. Anisoles (72-74); Pyrrolidines (72-74); Styrenes (72-74) ;&:ENitroimidazoles D02.640.672; D03.383.374.658 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Dimetridazole; Etanidazole; Ipronidazole; Metronidazole; Misonidazole; Nimorazole; Ornidazole; Ronidazole; Tinidazole Dimetridazole; Etanidazole; Ipronidazole; Metronidazole; Misonidazole; Nimorazole; Ornidazole; Ronidazole; Tinidazole AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ;"8:Nitrohydroxyiodophenylacetate D02.640.743.610; D02.755.566.610; D24.611.216.119.480.641 AAADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrophenols Organic Chemicals (Non MeSH); Phenols; Nitrophenols Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Haptens 3-Nitro-4-hydroxy-5-iodophenylacetate. Also called 4-hydroxy-3-iodo-5-nitrophenylacetate. A haptenic determinant that can be radiolabeled and used as salts and derivatives for investigations of immunogenic specificity studies. Iodine (72-75); Nitrophenols (72-75); Phenylacetates (74-75) ;G!A8INitroglycerin D02.033.800.421.560; D18.918.637 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Glycerin Cardiovascular Agents; Vasodilator Agents 1,2,3-Propanetriol trinitrate. A highly volatile organic nitrate that acts as a dilator of arterial and venous smooth muscle and is used in the treatment of angina. It provides relief through improvement of the balance between myocardial oxygen supply and demand. Although total coronary blood flow is not increased, there is redistribution of blood flow in the heart when partial occlusion of coronary circulation is effected. ;`&:~Nitrogenase D08.586.682.647 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Dinitrogenase Reductase; Molybdoferredoxin An enzyme system that catalyzes the fixing of nitrogen in soil bacteria and blue-green algae (CYANOBACTERIA). EC 1.18.6.1. ;eFX1Nitrogen Radioisotopes D01.496.586.520; D01.496.749.615 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Nitrogen Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of nitrogen that decay or disintegrate emitting radiation. N atoms with atomic weights 12, 13, 16, 17, and 18 are radioactive nitrogen isotopes. Nitrogen Isotopes (71-74); Radioisotopes (71-74) ;&4:Nitrogen Oxides D01.362.635; D01.625.550; D01.650.550.587 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Nitrogen Compounds Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Nitrogen Dioxide; Nitrous Oxide Nitric Oxide; Nitrogen Dioxide; Nitrous Oxide Nitric Oxide; Nitrogen Dioxide; Nitrous Oxide Inorganic oxides that contain nitrogen. Nitrogen (66-70); Oxides (66-70); Peroxides (66-70) ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $;.180@<Nitrogen Mustard Compounds D02.455.526.728.650; D22.204.585 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Alkylating Agents Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Aniline Mustard; Chlorambucil (+ 1); Estramustine; ICR 170; Mannomustine; Mechlorethamine; Melphalan (+ 1); Phosphoramide Mustards (+ 2); Propylbenzilylcholine Mustard; Quinacrine Mustard; Uracil Mustard Aniline Mustard; Chlorambucil (+ 1); Estramustine; ICR 170; Mannomustine; Mechlorethamine; Melphalan (+ 1); Phosphoramide Mustards (+ 2); Uracil Mustard A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. AAADAEAGAIANBLCFCHCLCSCTDEDUECHIIMIPMEPDPKPORESDSTTOTUUR $; &8E<Nitrogen Isotopes D01.496.586 Inorganic Chemicals (Non MeSH); Isotopes Nitrogen Radioisotopes Stable nitrogen atoms that have the same atomic number as the element nitrogen, but differ in atomic weight. N-15 is a stable nitrogen isotope. Nitrogen (66-70) ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ;w24Nitrogen Fixation G04.185.515.120.600; G04.185.515.671; G06.184.620; G06.535.630.730 DEGEIMPHRE Genes, Nitrogen Fixation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Bacterial Phenomena (Non MeSH) Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Ability of certain bacteria, fungi, and blue-green algae to convert free atmospheric nitrogen to biologically usable forms (ammonia, nitrates, amino groups, etc.). ; L&Nitrogen Dioxide D01.362.635.600; D01.625.550.525; D01.650.550.587.625; D05.284.101.143.631.475; D26.680.580.475 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gases; Nitrogen Oxides Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitrogen Oxides Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Nitrogen Oxides Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants; Air Pollutants, Environmental; Oxidants, Photochemical Miscellaneous Drugs and Agents (Non MeSH); Oxidants; Oxidants, Photochemical Nitrogen oxide (NO2). A highly poisonous gas. Exposure produces inflammation of lungs that may only cause slight pain or pass unnoticed, but resulting edema several days later may cause death. (From Merck, 11th ed) It is a major atmospheric pollutant that is able to absorb UV light that does not reach the earth's surface. ;k8Nitrogen Compounds D01.625 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Ammonia; Ammonium Compounds (+ 2); Cisplatin; Cyanogen Bromide; Hydrogen Cyanide (+ 7); Nitric Acid (+ 3); Nitrogen Oxides (+ 3); Nitrous Acid (+ 2); Ruthenium Red Inorganic compounds that contain nitrogen as an integral part of the molecule. Nitrogen (66-93) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $; 8%^>Nitrogen D01.268.604; D01.362.625 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Gases Nitrogen. An element with the atomic symbol N, atomic number 7, and atomic weight 14. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells. ; :_:Nitrofurazone D02.640.600.691; D03.383.312.649.691; D20.187.619; D20.237.649.691 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Anti-Infective Agents; Anti-Infective Agents, Local Anti-Infective Agents; Anti-Infective Agents, Urinary; Nitrofurans 2-((5-Nitro-2-furanyl)methylene)hydrazinecarboxamide. A topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial wounds, burns, ulcers, and skin infections. Nitrofurazone has also been administered orally in the treatment of trypanosomiasis. ;?L:+WNitrofurantoin D02.640.600.566; D03.383.312.649.566; D19.770.056.560; D20.237.649.566 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Anti-Infective Agents, Urinary Anti-Infective Agents; Anti-Infective Agents, Urinary; Nitrofurans 1-(((5-Nitro-2-furanyl)methylene)amino)-2,4-imidazolidinedione. A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. ;{P:i{Nitrofurans D02.640.600; D03.383.312.649; D20.237.649 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans Anti-Infective Agents; Anti-Infective Agents, Urinary FANFT; Furagin; Furazolidone; Furylfuramide; Nifuratel; Nifurtimox; Nitrofurantoin; Nitrofurazone; Nitrovin; SQ 18506 FANFT; Furagin; Furazolidone; Furylfuramide; Nifuratel; Nifurtimox; Nitrofurantoin; Nitrofurazone; Nitrovin; SQ 18506 Furazolidone; Nitrofurantoin; Nitrofurazone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ;18G:Nitroblue Tetrazolium D03.383.129.617.700.500; D26.550.900.750 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Tetrazoles; Tetrazolium Salts Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Tetrazolium Salts 3,3'-(3,3'-Dimethoxy-4,4'-biphenylene)bis (2-(p-nitrophenyl)-5-phenyl-2H-tetrazolium. Colorless to yellow dye that is reducible to blue or black formazan crystals by certain cells; formerly used to distinguish between nonbacterial and bacterial diseases, the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease. Synonyms: NBT; nitrotetrazolium blue; tetrazolium nitroblue. Nitro Compounds (73-74); Tetrazolium Salts (72-74) ;..=Nitrobenzoates D02.241.223.106.650 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Dithionitrobenzoic Acid Benzoic acid or benzoic acid esters substituted with one or more nitro groups. Benzoates (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $;͞8k_:Nitrobenzenes D02.455.426.559.389.565; D02.640.529 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Organic Chemicals (Non MeSH); Nitro Compounds Dinitrobenzenes; Dinitrochlorobenzene; Dinitrofluorobenzene; Trinitrobenzenes (+ 1) Dinitrobenzenes (+ 2); Trinitrobenzenes (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR ;d*8DNitrobacteraceae B03.440.400.450.504 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Chemolithotrophic Bacteria Nitrobacter; Nitrosomonas A family of gram-negative bacteria which derive energy from the oxidation of ammonia to nitrite or nitrite to nitrate. Its organisms are commonly found in soil and fresh water. Bacteria (66-74)  ;ѩ"yNitrobacter B03.440.400.450.504.504 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Chemolithotrophic Bacteria; Nitrobacteraceae A genus of gram-negative, rod-shaped bacteria that oxidizes nitrites to nitrates. Its organisms occur in aerobic environments where organic matter is being mineralized. ;Ӡ"Nitroanisole O-Demethylase D08.586.682.670.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxidoreductases, O-Demethylating Oxidative enzyme which transforms p-nitroanisole into p-nitrophenol. Anisoles (74); Nitro Compounds (74); Oxidoreductases (74) ;`F}OGNitro Compounds D02.640 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Dinitrocresols; Nitrobenzenes (+ 6); Nitrofurans (+ 10); Nitroimidazoles (+ 9); Nitroparaffins (+ 1); Nitrophenols (+ 6); Nitroquinolines (+ 1) specific compound containing nitro group (71-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR  ; 8#9DNitrites D01.248.497.158.635; D01.625.600.600; D02.633 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitrous Acid Organic Chemicals (Non MeSH)  Sodium Nitrite Amyl Nitrite Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant and Hackh's Chemical Dictionary, 5th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ; 58#m:Nitrite Reductases D08.586.682.608.671 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases Oxidoreductases (66-72) ; FyNitrilotriacetic Acid D02.241.081.038.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids ;7:kNitriles D02.626 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cyanides Cyanides Organic Chemicals (Non MeSH) Acetonitriles (+ 1); Acrylonitrile; Aminopropionitrile; Amygdalin; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; o-Chlorobenzylidenemalonitrile; Fadrozole; Pregnenolone Carbonitrile; Technetium Tc 99m Sestamibi Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Cyanides (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ,;,  8  #%@Nitric Oxide D01.625.550.500; D01.650.550.587.600; D14.600.640 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Endothelium-Derived Relaxing Factor Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitrogen Oxides Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Nitrogen Oxides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters Nitrogen oxide (NO). An inorganic compound that may act as a neurotransmitter in both the central and peripheral nervous systems and as an immune defense molecule that is produced by, and acts on, most cells. There is a controversy as to whether nitric oxide is identical to ENDOTHELIUM-DERIVED RELAXING FACTOR. ; 9<) pNitric Acid D01.029.260.550; D01.625.525 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Nitrogen Compounds  Nitrates (+ 2) Nitric acid (HNO3). A colorless liquid that is used in the manufacture of inorganic and organic nitrates and nitro compounds for fertilizers, dye intermediates, explosives, and many different organic chemicals. Continued exposure to vapor may cause chronic bronchitis; chemical pneumonitis may occur. (From Merck Index, 11th ed). Acids (74-79); Nitrates (80-93) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $;\"8(:Nitrendipine D03.383.725.203.590; D18.162.648; D18.192.648; D18.918.173.648 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers Ethyl methyl 2,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl)-3,5-pyridinedicarboxylate. A slow-channel calcium blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. Nifedipine/analogs and derivatives (82-86); Pyridines (66-81) ;~H: INitrazepam D03.438.079.080.070.565; D14.100.240.500.550; D15.075.050.550; D15.080.575; D15.210.350.800.600; D15.210.950.012.050.560; D15.325.875.575; D15.700.872.015.050.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine 1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one. A benzodiazepine derivative used as an anticonvulsant and hypnotic. Benzazepines (68-71); Hypnotics and Sedatives (66-71); Tranquilizing Agents (66-71) ;,:cNitrates D01.248.497.158.606; D01.625.525.550; D02.583 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Nitric Acid Organic Chemicals (Non MeSH)  Silver Nitrate; Uranyl Nitrate Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. ; 5:(sNitrate Reductases D08.586.682.608.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases Oxidoreductases (66-72) ;FyNitracrine D03.494.046.250.650; D22.204.575 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 4-(Methylsulfonyl)-2,6-dinitro-N,N-dipropylbenzenamine. Acridine antineoplastic agent used in mammary and ovarian tumors. It inhibits RNA synthesis. Acridines (71-74); Nitro Compounds (72-74); Dimethylamines (73-74) ;&:PNissl Degeneration G11.561.491.441 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Nerve Degeneration ;_Nissl Bodies A08.663.712; A11.368.702.248.441; A11.671.693 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI RNA Nervous System; Neurons Cells; Cytoplasm; Organelles; Endoplasmic Reticulum Cells; Neurons Large granular basophilic bodies found in the cytoplasm of neurons, composed of rough endoplasmic reticulum and free polyribosomes. (Dorland, 27th ed). ;65*lNisoldipine D03.383.725.203.580; D18.162.646; D18.192.645; D18.918.173.646 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 1,4-Dihydro-2,6-dimethyl-4 (2-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-methylpropyl ester. Nisoldipine is a dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina. Nifedipine/analogs and derivatives (81-89); Pyridines (66-80) ;H: UINisin D20.085.116.600; D26.471.385.550 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives Nisin. A 34-amino acid polypeptide antibiotic produced by Streptococcus lactis. It has been used as a food preservative in canned fruits and vegetables, and cheese. Antibiotics (66-72) ;h &BNiridazole D03.383.374.626; D03.383.871.482; D21.201.412.596.441 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides Amebicides (66-71); Anthelmintics (66-71); Imidazoles (66-71); Thiazoles (66-71) ;x=:aNippostrongylus B01.500.294.700.775.400.575 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Heligmosomatoidea A genus of intestinal nematode parasites belonging to the superfamily HELIGMOSOMATOIDEA, which commonly occurs in rats but has been experimentally transmitted to other rodents and rabbits. Infection is usually through the skin. Ancylostomatoidea (66-74) <*]Nipples A01.236.500; A10.336.153.500 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Body Regions (Non MeSH); Breast Tissue Types (Non MeSH); Exocrine Glands; Breast The conic organs which usually give outlet to milk from the mammary glands. < ":d\Nipecotic Acids D03.066.566; D03.383.621.566 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines <"8Niobium D01.268.598; D01.552.613 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals < :`Ninhydrin D04.615.486.487.500; D26.550.541 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Indenes; Indans Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 2,2-Dihydroxy-1H-indene-1,3-(2H)-dione. Reagent toxic to skin and mucus membranes; used in chemical assay for peptide bonds, i.e., protein determinations; has radiosensitizing properties. Synonyms: 1,2,3-indantrione monohydrate; triketohydrindene monohydrate. < &.(Nimustine D02.654.692.550; D02.948.594.550; D22.204.570 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents N'-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-N-(2-chloroethyl)-N-nitrosourea. Antineoplastic agent especially effective against malignant brain tumors. The resistance which brain tumor cells acquire to the initial effectiveness of this drug can be partially overcome by the simultaneous use of membrane-modifying agents such as reserpine, calcium antagonists such as nicardipine or verapamil, or the calmodulin inhibitor, trifluoperazine. The drug has also been used in combination with other antineoplastic agents or with radiotherapy for the treatment of various neoplasms. Antineoplastic Agents (75-88); Nitrosourea Compounds (75-88) <F 5:GNimorazole D02.640.672.580; D03.383.374.658.580; D21.370.370.690 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antitrichomonal Agents 1-[2-(5-Nitroimidazole-1-yl)ethyl]morpholine. An antitrichomonal agent which is effective either topically or orally and whose urinary metabolites are also trichomonicidal. Synonym: Naxogin. Morpholines (71-74); Nitroimidazoles (74) < =: 2Nimodipine D03.383.725.203.570; D03.383.725.547.570; D18.162.644; D18.192.643; D18.918.173.643 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl)-3,5-pyridinedicarboxylate. A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects, lowers blood pressure, and is effective in the therapy and/or prevention of cerebral vasospasm caused by stroke, cerebral hemorrhage, aneurysm, severe head injury, or cerebral ischemia. Nicotinic Acids (66-86) <i_:Nikethamide D03.066.515.530.500; D03.383.725.547.530.500; D15.220.637 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids; Niacinamide Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids; Niacinamide Central Nervous System Agents; Central Nervous System Stimulants A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1229). <A:$Night Care E02.472.564; N02.421.589.690 CLECHILJMAMTOGPXSNSTTDUT Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Institutional night care of patients. <".Night Blindness C11.966.671 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Choroideremia; Vitamin A Deficiency Eye Diseases; Vision Disorders Failure or imperfection of vision at night or in dim light, with good vision only on bright days. (Dorland, 27th ed). <N+&Nigericin D20.085.545 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Spiromacrolide antibiotic. Antibiotics (69-74); Carboxylic Acids (73-74) <R <) 7Nigeria Z01.058.290.190.565 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western <Q _Niger Z01.058.290.190.560 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western < _Nifurtimox D02.640.600.480; D03.383.312.649.480; D03.383.855.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazines 4-(5-Nitrofurfurylidenamino)-3-methylthiomorpholine-1,1-dioxide. Possibly effective against parasites. Synonyms: Lampit; Bayer 2502. Cyclic S-Oxides (73-74); Nitrofurans (71-74); Thiazines (73-74) <=:MNifuratel D02.640.600.410; D03.383.312.649.410; D20.136.642; D21.370.370.684 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Anti-Infective Agents; Antifungal Agents Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antitrichomonal Agents 5-[(Methylthio)methyl]-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone. Local antiprotozoal and antifungal agent that may also be given orally; used for vaginal candidiasis and trichomoniasis. Synonyms: Macmiror; Magmilor; Polmiror; Thiodinone; Tydantil. Nitrofurans (68-75); Oxazoles (68-75); Sulfides (72-75) <' L:-%DNiflumic Acid D03.066.515.550; D03.383.725.547.550; D08.373.310.525; D16.850.015.050.610; D17.025.030.560; D17.050.030.560 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 2-(3-Trifluoromethylanilino)nicotinic acid. An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. Aniline Compounds (72-74); Nicotinic Acids (68-74) c T@ 9Nicotinamide Mononucleotide D13.695.827.648 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides 3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. Nicotinamide (66-72); Ribonucleotides (66-72) Nialamide D03.066.349.490; D03.383.725.394.628; D08.373.616.565; D15.085.575; D15.700.122.575 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Isonicotinic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents An MAO inhibitor that is used as an antidepressive agent. $=Neutron Activation Analysis E05.196.039.564 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Activation Analysis Activation analysis in which the specimen is bombarded with neutrons. Identification is made by measuring the resulting radioisotopes. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). < !"]Neutralization Tests E01.223.495.826.664; E05.196.922.625 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Titrimetry Skin Test End-Point Titration Titration of an antiserum by testing a series of dilutions of virus or immune serum to a given end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). <*"%Neutral Red D03.494.704.600; D26.408.588; D26.550.500 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenazines Miscellaneous Drugs and Agents (Non MeSH); Dyes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 3-Amino-7-dimethylamino-2-methylphenazine hydrochloride. A vital dye used as an indicator and biological stain. Various adverse effects have been observed in biological systems. Dimethylamines (73-74); Phenazines (69-74) <1.3Neurotransmitters and Neurotransmitter Agents (Non MeSH) D14 Neurotransmitter Agents (Non MeSH) (+ 469); Neurotransmitters (+ 81) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR <.ARHNeurotransmitters D14.600 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Autacoids; Neuroimmunomodulation; Receptors, Neurotransmitter Autacoids; Synaptic Transmission Neurotransmitters and Neurotransmitter Agents (Non MeSH) Acetylcholine; Adenosine; Adenosine Triphosphate; Amino Acid Neurotransmitters (+ 5); Biogenic Amine Neurotransmitters (+ 7); Neuropeptides (+ 62); Nitric Oxide Endogenous signaling molecules that alter the behavior of neurons or effector cells. Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. Included are neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not acting at synapses. Nerve Endings/physiology (66-67); Neurosecretion (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,Neurilemma A08.561.600; A08.637.800.500.550; A08.663.542.512.560.550; A08.800.800.690.500.550; A10.755.503.550; A10.755.612; A11.650.800.500.550; A11.671.514.553.550 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Membranes Nervous System; Nerve Tissue Nervous System; Neuroglia; Schwann Cells; Myelin Sheath Nervous System; Neurons; Nerve Fibers; Nerve Fibers, Myelinated; Myelin Sheath Nervous System; Peripheral Nervous System; Peripheral Nerves; Schwann Cells; Myelin Sheath Tissue Types (Non MeSH); Nerve Tissue; Myelin Sheath Tissue Types (Non MeSH); Nerve Tissue Cells; Neuroglia; Schwann Cells; Myelin Sheath Cells; Neurons; Nerve Fibers, Myelinated; Myelin Sheath The outermost part of the ectodermal sheath of myelinated nerve fibers, including the sheath cell nucleus and its cytoplasm but not the concentric myelin-containing lamellae. Multiple nonmyelinated fibers may be contained within a single neurolemma sheath. (Lockard, Desk Reference for Neuroscience, 2d ed). =* eNeurasthenia F03.709.438.100.410.500 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Fatigue Syndrome, Chronic Asthenia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Affective Disorders; Depressive Disorder A neurosis characterized by chronic fatigue and concomitant physiologic symptoms.  =\F _Neuraminidase D08.586.277.450.692 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992, p.348) EC 3.2.1.18. =Fl]Neuraminic Acids D02.241.081.844.562; D02.241.511.902.562; D09.203.067.687; D09.203.811.589 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids Sialic Acids (+ 1) Sialic Acids (+ 1) Sialic Acids (+ 1) Sialic Acids (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR =lT8v^DNeuralgia C10.597.617.640; C10.772.537; C23.888.592.612.589 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Pain Nervous System Diseases; Peripheral Nervous System Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain  Causalgia; Cervico-Brachial Neuralgia; Facial Neuralgia; Trigeminal Neuralgia Paroxysmal pain which extends along the course of one or more nerves. Many varieties of neuralgia are distinguished according to the part affected or to the cause, as brachial, facial, etc., or anemic, diabetic, gouty, etc. (From Dorland, 27th ed). =L 9N\'Neural Tube Defects C10.500.680; C16.131.666.680 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH) Anencephaly (+ 1); Arnold-Chiari Deformity; Encephalocele; Meningocele; Meningomyelocele; Spinal Dysraphism (+ 2) Anencephaly (+ 1); Arnold-Chiari Deformity; Encephalocele; Meningocele; Meningomyelocele; Spinal Dysraphism (+ 2) Congenital malformations of the nervous system due to closure failures of the neural tube. Anencephaly (66-78); Central Nervous System (66-78); Spina Bifida (66-78)  ="L lYNeural Pathways A08.612 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Peripheral Nervous System Nervous System Afferent Pathways (+ 5); Efferent Pathways (+ 2); Medial Forebrain Bundle Neural tracts connecting one part of the nervous system with another.  = 6[TNeural Networks (Computer) H01.548.635.310.500; L01.700.568.110.065.605; L01.700.568.110.680.310.600; L01.725.500 Artificial Intelligence Physical Sciences (Non MeSH); Mathematics; Mathematical Computing; Decision Support Techniques Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Artificial Intelligence Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Mathematical Computing; Decision Support Techniques Information Science; Pattern Recognition A computer architecture, implementable in either hardware or software, modeled after biological neural networks. Like the biological system in which the processing capability is a result of the interconnection strengths between arrays of nonlinear processing nodes, computerized neural networks, often called perceptrons or multilayer connectionist models, consist of neuron-like units. A homogeneous group of units makes up a layer. These networks are good at pattern recognition. They are adaptive, performing tasks by example, and thus are better for decision-making than are linear learning machines or cluster analysis. They do not require explicit programming. Artificial Intelligence (87-91); Computer Simulation (87-91); Image Processing, Computer-Assisted (90-91) =2 `zNeural Inhibition G11.561.559 DEGEIMPHRE Neural Conduction Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Neural Transmission (66-71); specific neuroanatomic site (66-71) =ZhLNeural Crest A16.254.600 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo A strip of specialized ectoderm flanking each side of the embryonal neural plate, which after the closure of the neural tube, forms a column of isolated cells along the dorsal aspect of the neural tube. Most of the cranial and all of the spinal sensory ganglion cells arise by differentiation of neural crest cells. Nervous System/EM (66-78) =~81v Neural Conduction G11.561.537 DEGEIMPHRE Neural Inhibition Neurons Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Recruitment (Neurology); Refractory Period, Neurologic; Wedensky Inhibition  = hXNeural Analyzers A08.186.667 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System =6/Netropsin D20.085.116.585; D20.388.730 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Anti-Infective Agents; Antiviral Agents 4-((((Aminoiminomethyl)amino)acetyl)amino)-N-(5-(((3-amino-3-iminopropyl)amino)carbonyl)-1-methyl-1H-pyrrol-3-yl)-1-methyl-1H-pyrrole-3-carboxamide. A basic polypeptide isolated from Streptomyces netropsis. It has antibacterial and antiviral properties, and is used as a tool in the study of nucleic acids due to its strong, specific binding to the A-T areas of DNA. Guanidines (66-76); Pyrroles (66-76) =ѫ "<o-Netilmicin D09.203.408.051.374.785.525; D20.085.060.350.700.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Gentamicins; Sisomicin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Gentamicins; Sisomicin O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L- arabinopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy- alpha-D-glycero-hex-4-enopyranosyl-(1-4)-2-deoxy-N(1)- ethyl-D-streptamine. Semisynthetic 1-N-ethyl derivative of sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. Gentamicins (66-74); Sisomicin (75-78) =~::i/Netherlands Antilles Z01.107.084.900.645 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies =תONetherlands Z01.542.651 EHEP Geographicals (Non MeSH); Europe =P)Nesting Behavior F01.145.113.252.478 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Consummatory Behavior Animal behavior associated with the nest; includes construction, effects of size and material; behavior of the adult during the nesting period and the effect of the nest on the behavior of the young. Behavior, Animal (66) =ؾ pNervous System Physiology (Non MeSH) G11.561 Musculoskeletal, Neural, Eye Physiology (Non MeSH) Arousal (+ 1); Blood-Brain Barrier; Cerebrospinal Fluid Pressure (+ 1); Chronaxy; Contingent Negative Variation; Dominance, Cerebral (+ 1); Habituation (Psychophysiology); Higher Nervous Activity; Kindling (Neurology); Membrane Potentials (+ 10); Nerve Degeneration (+ 3); Nerve Regeneration; Neural Conduction (+ 3); Neural Inhibition; Neuroimmunomodulation; Neuronal Plasticity (+ 1); Neurosecretion; Reaction Time; Reflex (+ 15); Sensation (+ 19); Sleep (+ 3); Speech (+ 2); Spreading Cortical Depression; Synaptic Transmission BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI =ږ, ;{TNervous System Neoplasms C04.588.614; C10.551 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Nervous System Diseases Central Nervous System Neoplasms (+ 10); Peripheral Nerve Neoplasms (+ 3) Central Nervous System Neoplasms (+ 10); Peripheral Nerve Neoplasms (+ 3) Brain Neoplasms (66-79); Neoplasms (66-79); Neoplasms, Experimental (66-79); Nervous System Diseases (66-79) =XLNervous System Diseases C10 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neurology Central Nervous System Diseases (+ 267); Mental Retardation (+ 24); Nervous System Abnormalities (Non MeSH) (+ 20); Nervous System Neoplasms (+ 15); Neurologic Manifestations (+ 123); Neuromuscular Diseases (+ 18); Peripheral Nervous System Diseases (+ 83) BLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSCSESUTHTMULURUSVEVI =.N 3bNervous System Abnormalities (Non MeSH) C10.500; C16.131.666 Nervous System Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Holoprosencephaly; Neural Tube Defects (+ 9); Neuropathies, Hereditary Motor and Sensory (+ 5); Neuropathies, Hereditary Sensory and Autonomic (+ 2) Holoprosencephaly; Neural Tube Defects (+ 9); Neuropathies, Hereditary Motor and Sensory (+ 5); Neuropathies, Hereditary Sensory and Autonomic (+ 2) BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI =i/d^LNervous System A08 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Central Nervous System (+ 109); Ganglia (+ 12); Nerve Net; Nerve Tissue (+ 2); Neural Pathways (+ 10); Neuroglia (+ 8); Neurons (+ 44); Neurosecretory Systems (+ 5); Peripheral Nervous System (+ 141); Synapses (+ 6) consider also terms at NERVE and NEUR-. ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI =62>Nerve Transfer E04.530.670 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Nerve Regeneration Surgery, Operative; Neurosurgery Surgical reinnervation of a denervated peripheral target using a healthy donor nerve and/or its proximal stump. The direct connection is usually made to a healthy postlesional distal portion of a non-functioning nerve or implanted directly into denervated muscle or insensitive skin. Nerve sprouts will grow from the transferred nerve into the denervated elements and establish contact between them and the neurons that formerly controlled another area. specific nerve/surgery (70-90); specific nerve/transplantation (72-90)  =$'SNerve Tissue Proteins D12.776.641 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Agrin; Chromogranins; Microtubule-Associated Proteins (+ 2); Myelin Proteins (+ 1); Nerve Growth Factors; Nerve Tissue Protein S 100; Neurofilament Proteins; Neuropeptides (+ 64); Synapsins; Synaptophysin; Tubulin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR =FDHNerve Tissue Protein S 100 D12.776.157.125.600; D12.776.641.611 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins Highly acidic calcium-binding protein found in large concentration in the brain and believed to be glial in origin; also found in other organs in the body. Nerve Tissue Proteins (66-72) = "*H$Nerve Tissue A08.561; A10.755 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System Tissue Types (Non MeSH) Ependyma; Neurilemma Ependyma; Myelin Sheath (+ 2); Neurilemma ABAHBSCHCLCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI =w8/M<Nerve Sheath Tumors C04.557.580.600 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue Neurofibroma (+ 4); Neurofibrosarcoma; Neuroma (+ 2); Neurothekeoma Tumors arising in the sheath surrounding the axon of some nerve cells and formed by the plasma membrane of Schwann cells in the peripheral nervous sytem and by oligodendrocytes in the central nervous system. Neurofibromas and neurilemmomas are the most commonly occurring tumors of this type. =X[SWNerve Regeneration G04.185.753.611; G11.561.513 DEGEIMPHRE Nerve Transfer Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Renewal or physiological repair of damaged nerve tissue. =e"DNerve Net A08.511 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System A meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction. =  6sNerve Growth Factors D11.303.611; D12.776.641.600; D24.185.348.686 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Nerve Growth Factor Neurites Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.  =5F%  gNerve Fibers, Myelinated A08.663.542.512; A11.671.514 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Nerve Fibers Cells; Neurons Myelin Sheath (+ 2) Myelin Sheath (+ 2) Grayish white nerve fibers whose axons are encased in a myelin sheath which may in turn be enclosed by a neurilemma (a thin membrane spirally enwrapping the myelin layers). (From Dorland, 27th ed). Neurons (66-71) CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI $=i"(A2*Nerve Fibers A08.663.542 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Peripheral Nerves Nervous System; Neurons Adrenergic Fibers (+ 1); Autonomic Fibers, Postganglionic (+ 2); Autonomic Fibers, Preganglionic; Axons (+ 2); Cholinergic Fibers (+ 2); Nerve Fibers, Myelinated (+ 3) Slender processes of neurons, especially the prolonged axons that conduct nerve impulses. Nerve Fibers, Myelinated (69-76); Neurons (66-76) ABAHBSCHCLCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI (=(i<<Nerve Endings A08.800.550 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Presynaptic Terminals Nervous System; Peripheral Nervous System Neuroeffector Junction (+ 2); Receptors, Sensory (+ 26) Specialized terminations of peripheral neurons. Nerve endings include NEUROEFFECTOR JUNCTION(s) by which neurons activate target organs and sensory receptors (see RECEPTORS, SENSORY) which transduce information from the various sensory modalities and send it centrally in the nervous system. Presynaptic nerve endings are PRESYNAPTIC TERMINALS. ABAHBSCHCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI $=62D:Nerve Degeneration G11.561.491 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Nissl Degeneration; Retrograde Degeneration; Wallerian Degeneration =hNNerve Crush E04.530.324.595 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery; Denervation >$6Nerve Compression Syndromes C10.772.491 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Compartment Syndromes Nervous System Diseases; Peripheral Nervous System Diseases Carpal Tunnel Syndrome; Tarsal Tunnel Syndrome; Thoracic Outlet Syndrome (+ 1); Ulnar Nerve Compression Syndrome Repeated or prolonged pressure on a nerve root or peripheral nerve leading to ischemia, the response to which is edema above and below the source of pressure. If the pressure is not relieved, fibrosis tends to develop. Types of nerve compression syndromes are the neuropathy caused by intervertebral disk herniation, compression of the median nerve in the carpal tunnel, compression of the ulnar nerve in the elbow, and compression of the lateral cutaneous nerve of the thigh in meralgia paresthetica. This is also called pressure neuropathy. (From Brain and Bannister's Clinical Neurology, 7th ed., p.422-3). Peripheral Nerve Diseases (66-69) $>}!NF(Nerve Block E03.155.086.711; E04.530.324.524 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Conduction Surgery, Operative; Neurosurgery; Denervation Autonomic Nerve Block >&"Neptunium D01.268.271.545.550; D01.552.517.621 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Neptunium. A radioactive element of the actinide metals family. It has the atomic symbol Np, atomic number 93, and atomic weight 237. >! *4Neptune H01.091.800.700.796 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The eighth planet in order from the sun. It is one of the five outer planets of the solar system. Its two natural satellites are Nereid and Triton. Extraterrestrial Environment (66-90); Planets (91-94) >  M?Nepovirus B04.715.500; B04.820.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses A group of polyhedral plant viruses causing spotting on leaves or sometimes symptomless infection. Transmission occurs by seeds, soil nematodes, or experimentally by mechanical inoculation. Plant Viruses (85-93) >  6Nephrotic Syndrome C12.777.419.630.643 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephrosis Clinical association of heavy proteinuria, hypoalbuminemia, and generalized edema. > $No_Nephrostomy, Percutaneous E01.341.642; E04.579.642; E04.887.774.852.642 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Urologic (Non MeSH) Surgery, Operative; Ostomy Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Urinary Diversion The insertion of a catheter through the skin and body wall into the kidney pelvis, mainly to provide urine drainage where the ureter is not functional. It is used also to remove or dissolve renal calculi and to diagnose ureteral obstruction. Urinary Catheterization (66-85); Urinary Diversion (66-85) > 5"ENephrosis, Lipoid C12.777.419.630.477 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephrosis Glomerular disease causing heavy proteinuria characterized by absence of obvious histologic glomerular changes on light microscopy. It is also called minimal change glomerular disease and minimal lesion glomerulonephritis. >WNoNephrosis C12.777.419.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Nephrosis, Lipoid; Nephrotic Syndrome Descriptive histopathologic term for renal disease without an inflammatory component. >c Nb-cNephrosclerosis C12.777.419.610; C14.907.489.631.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Cardiovascular Diseases; Vascular Diseases; Hypertension; Hypertension, Renal Hardening of the kidney due to overgrowth and contraction of interstitial connective tissue. It is due to renovascular disease. (Dorland, 27th ed; Stedman, 25th ed). >*NNephrons A05.810.453.736 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney Kidney Glomerulus (+ 2); Kidney Tubules (+ 4) The functional units of the kidney, consisting of the glomerulus and the attached tubule. Kidney (66-72)  > :2:kNephroma, Mesoblastic C04.557.435.600 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A malignant tumor of the kidney characterized by spindled myofibroblastic cells arranged in sheets or bundles with a tendency to infiltrate into the adjoining normal kidney and through the capsule into the perirenal tissues. While it appears on gross examination to be circumscribed, partial excision is usually unsuccessful and total removal is recommended. (From Holland et al., Cancer Medicine, 3d ed). Nephroblastoma (73-93) >XnNephrology G02.403.776.409.580 CLECEDHIISLJMAMTOGSNSTTD Kidney Diseases Health Occupations; Medicine; Specialties, Medical; Internal Medicine A subspecialty of internal medicine concerned with the anatomy, physiology, and pathology of the kidney. Kidney Diseases (66-79)  >R{Nephrocalcinosis C12.777.419.590; C18.452.174.130.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders; Calcinosis A condition characterized by precipitation of calcium phosphate in the tubules of the kidney, with resultant renal insufficiency. (Dorland, 27th ed). >*NNephroblastoma C04.557.435.595 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Genes, Wilms' Tumor Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) WAGR Syndrome A malignant kidney tumor made up of three cell types: blastemal, stromal, and epithelial, but not all present in every case. One child in 10,000 will develop this tumor and 350 new cases are diagnosed yearly in the United States. The median age at diagnosis is 39 months for unilateral and 26 months for bilateral tumors. (From Holland et al., Cancer Medicine, 3d ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed).  >;Xn Nephritis, Interstitial C12.777.419.570.643 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis Balkan Nephropathy; Pyelonephritis (+ 1) Primary or secondary disease of the renal interstitial tissue resulting from arterial, arteriolar, glomerular, or tubular disease which destroys individual nephrons, or from toxic involvement of interstitital cells and tubules due to systemic diseases such as gout, to drug exposure, or to mercury poisoning. Clinically it may be manifested primarily by loss of concentrating capacity, mineral wasting, proteinuria, and abnormal urine sediment. It may be seen in an acute form, particularly after specific bacterial infection, and may result in acute papillary necrosis. More commonly, the process is a chronic one with progressive renal atrophy and diminution of renal function. (Dorland, 27th ed). >!No1*Nephritis, Hereditary C12.740.700.742; C12.777.419.570.620; C13.371.820.700.742; C16.131.939.742 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Hereditary disease characterized initially by hematuria and slowly progressing to renal insufficiency. It is sometimes associated with perceptual deafness and/or congenital ocular defects. >%TLNephritis C12.777.419.570 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Glomerulonephritis (+ 6); Nephritis, Hereditary; Nephritis, Interstitial (+ 3) Inflammation of the kidney. It is a focal or diffuse proliferative or destructive process which may involve the glomerulus, tubule, or interstitial renal tissue. (Dorland, 27th ed). >) Nb]Nephrectomy E04.887.774.435 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Kidney Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH) >+$ `Nephelometry and Turbidimetry E05.196.712.650 AECLCTECHIISMOMTNUPXSNSTTDUTVE Scattering, Radiation Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam. >,#"SNepal Z01.252.245.674 EHEP Geographicals (Non MeSH); Asia; Asia, Western >/ 9Neovascularization C23.739.589.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Collateral Circulation Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Metaplasia Corneal Neovascularization; Retinal Neovascularization Formation of new blood vessels, especially capillaries, in ocular and neoplastic tissue, etc.  >0&Nh>nNeostriatum A08.186.211.730.885.105.487.550 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia; Corpus Striatum Caudate Nucleus; Putamen The phylogenetically newer part of the CORPUS STRIATUM consisting of the CAUDATE NUCLEUS and PUTAMEN. It is often called simply the striatum. Basal Ganglia (66-73); Corpus Striatum (74-92)  >1#89Neostigmine D02.092.102.602; D02.675.276.602; D08.373.275.643; D14.100.120.300.550; D16.050.675.570 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. >4 c:Neospora B01.841.075.762.167.275.250.560 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina A genus of protozoan parasites of the subclass COCCIDIA. Its species are parasitic in dogs, cattle, goats, and sheep, among others. N. caninum, a species that mainly infects dogs, is intracellular in neural and other cells of the body, multiplies by endodyogeny, has no parasitophorous vacuole, and has numerous rhoptries. It is known to cause lesions in many tissues, especially the brain and spinal cord as well as abortion in the expectant mother. Apicomplexa (92-94); Protozoa (89-91) >7 #&b.Neoprene D02.455.326.271.665.480; D25.720.840.645 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Biomedical and Dental Materials (Non MeSH); Polymers; Rubber Poly(2-chloro-1,3-butadiene). An oil-resistant synthetic rubber made by polymerization of chloroprene which is toxic to most body systems and may be carcinogenic. Synonym: Duprene. Butadienes (71-74); Polymers (71-74); Hydrocarbons, Chlorinated (74) >: ..RNeoplastic Syndromes, Hereditary C04.700; C16.466.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases Adenomatous Polyposis Coli; Colorectal Neoplasms, Hereditary Nonpolyposis; Dysplastic Nevus Syndrome; Gardner Syndrome; Hamartoma Syndrome, Multiple; Li-Fraumeni Syndrome; Multiple Endocrine Neoplasia (+ 3); Neurofibromatosis (+ 2); Peutz-Jeghers Syndrome; Sturge-Weber Syndrome Adenomatous Polyposis Coli; Colorectal Neoplasms, Hereditary Nonpolyposis; Dysplastic Nevus Syndrome; Gardner Syndrome; Hamartoma Syndrome, Multiple; Li-Fraumeni Syndrome; Multiple Endocrine Neoplasia (+ 3); Neurofibromatosis (+ 2); Peutz-Jeghers Syndrome; Sturge-Weber Syndrome The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  >=n&N[OXNeoplastic Processes (Non MeSH) C04.697 Neoplasms Anaplasia; Cell Transformation, Neoplastic (+ 1); Cocarcinogenesis; Neoplasm Invasiveness (+ 1); Neoplasm Metastasis (+ 4); Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Neoplasm, Residual BLBSCFCHCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARERHRIRTSCSESUTHULURUSVEVI >C&  \Neoplastic Endocrine-Like Syndromes C04.588.322.443; C04.730.713; C19.344.443; C19.576 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI ACTH Syndrome, Ectopic Hormones, Ectopic Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Neoplasms; Paraneoplastic Syndromes Endocrine Diseases; Endocrine Gland Neoplasms Endocrine Diseases ACTH Syndrome, Ectopic; Zollinger-Ellison Syndrome ACTH Syndrome, Ectopic; Zollinger-Ellison Syndrome ACTH Syndrome, Ectopic; Zollinger-Ellison Syndrome ACTH Syndrome, Ectopic; Zollinger-Ellison Syndrome Endocrine syndromes due to hormone production by neoplasms of non-endocrine tissue, or by other than the usual endocrine tissues. They are often the first indication of a previously undetected neoplasm. Hormones, Ectopic (68-72) (>EV)<NNeoplasms, Vascular Tissue C04.557.645 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Angiofibroma; Angiokeratoma; Glomus Tumor; Hemangioma (+ 6); Hemangiopericytoma; Hemangiosarcoma; Meningioma; Sarcoma, Kaposi's Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels. >I" X=~Neoplasms, Unknown Primary C04.697.650.895 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplastic Processes (Non MeSH); Neoplasm Metastasis Metastases in which the tissue of origin is unknown. >K! VLANeoplasms, Squamous Cell C04.557.470.700 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Carcinoma, Papillary; Carcinoma, Squamous Cell (+ 1); Carcinoma, Verrucous; Papilloma (+ 1) Neoplasms composed of squamous cells of the epithelium. The concept does not refer to neoplasms located in tissue composed of squamous elements. Carcinoma, Squamous Cell (73-93)  >LZXhn'Neoplasms, Second Primary C04.692 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms, Multiple Primary Leukemia, Radiation-Induced; Neoplasms, Radiation-Induced; Neoplasms, Multiple Primary Neoplasms Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause. Neoplasms, Multiple Primary (66-91) $>N X!b 1*Neoplasms, Radiation-Induced C04.682; C21.866.733.476 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Leukemia, Radiation-Induced; Neoplasms, Second Primary Neoplasms Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries Leukemia, Radiation-Induced >RR!X?s!Neoplasms, Post-Traumatic C04.666 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms Cancers, tumors, or other neoplasms caused by or resulting from trauma or other non-radiation injuries. >S V zNeoplasms, Neuroepithelial C04.557.465.625.600; C04.557.470.670; C04.557.580.625.600 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors Ganglioneuroma; Glioma (+ 9); Neurocytoma; Neuroectodermal Tumor, Peripheral (+ 6); Pinealoma; Retinoblastoma Ganglioneuroma; Glioma (+ 9); Neurocytoma; Neuroectodermal Tumor, Peripheral (+ 6); Pinealoma; Retinoblastoma Ganglioneuroma; Glioma (+ 9); Neurocytoma; Neuroectodermal Tumor, Peripheral (+ 6); Pinealoma; Retinoblastoma Neoplasms composed of epithelial cells of the nervous system. This concept does not refer to neoplasms located in the nervous system, nerves, or neural tissue. >U AX]Neoplasms, Nerve Tissue C04.557.580 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Meningioma; Nerve Sheath Tumors (+ 10); Neuroectodermal Tumors (+ 52) Neoplasms composed of nerve tissue. This concept does not refer to neoplasms located in the nervous system or its component nerves. >YX=UNeoplasms, Muscle Tissue C04.557.450.590 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH) Granular Cell Tumor; Leiomyoma (+ 3); Leiomyosarcoma; Myoma (+ 1); Myosarcoma (+ 3); Sarcoma, Alveolar Soft Part; Smooth Muscle Tumor Neoplasms composed of muscle tissue: skeletal, cardiac, or smooth. The concept does not refer to neoplasms located in muscles. >[dXxNeoplasms, Multiple Primary C04.651 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms, Second Primary Neoplasms, Second Primary Neoplasms Hamartoma Syndrome, Multiple; Lipomatosis, Multiple Symmetrical; Multiple Endocrine Neoplasia (+ 3); Proteus Syndrome Two or more abnormal growths of tissue occurring simultaneously. The neoplasms are histologically different and may be found in the same or different sites. $>]! X Neoplasms, Mesothelial C04.557.470.660 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Adenomatoid Tumor; Mesothelioma (+ 1) Neoplasms composed of tissue of the mesothelium, the layer of flat cells, derived from the mesoderm, which lines the body cavity of the embryo. In the adult it forms the simple squamous epithelium which covers all true serous membranes (peritoneum, pericardium, pleura). The concept does not refer to neoplasms located in these organs. (From Dorland, 27th ed). >`Xh.Neoplasms, Hormone-Dependent C04.626 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms Certain tumors that 1) arise in organs that are normally dependent on specific hormones and 2) are stimulated or caused to regress by manipulation of the endocrine environment. >b! X Neoplasms, Gonadal Tissue C04.557.475 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Adrenal Rest Tumor; Androblastoma (+ 1); Granulosa Cell Tumor; Gynandroblastoma; Leydig Cell Tumor; Luteoma; Sertoli Cell Tumor; Sex Cord-Stromal Tumor (+ 1) Neoplasms composed of ovarian or testicular tissue. This concept does not refer to neoplasms located in the ovaries or testes. >dxX=Neoplasms, Glandular and Epithelial C04.557.470 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Adenoma (+ 30); Carcinoma (+ 60); Neoplasms, Adnexal and Skin Appendage (Non MeSH) (+ 6); Neoplasms, Basal Cell (+ 4); Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) (+ 14); Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) (+ 7); Neoplasms, Fibroepithelial (+ 4); Neoplasms, Mesothelial (+ 3); Neoplasms, Neuroepithelial (+ 21); Neoplasms, Squamous Cell (+ 6) Neoplasms composed of glandular tissue, an aggregation of epithelial cells that elaborate secretions, and of any type of epithelium itself. The concept does not refer to neoplasms located in the various glands or in epithelial tissue. >f*X=Neoplasms, Germ Cell and Embryonal C04.557.465 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Carcinoma, Embryonal; Chordoma; Dermoid Cyst; Germinoma (+ 3); Mesonephroma (+ 1); Neuroectodermal Tumors (+ 52); Teratocarcinoma; Teratoma (+ 1); Trophoblastic Neoplasms (+ 4) Neoplasms composed of primordial germ cells of embryonic gonads or of elements of the germ layers of the embryo. The concept does not refer to neoplasms located in the gonads or present in an embryo or fetus. >jz*X=Neoplasms, Fibrous Tissue C04.557.450.565.590 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Dermatofibroma (+ 1); Fibroma (+ 4); Fibrosarcoma (+ 2); Myofibromatosis; Neoplasms, Fibroepithelial (+ 4) Neoplasms composed of fibrous tissue, the ordinary connective tissue of the body, made up largely of yellow or white fibers. The concept does not refer to neoplasms located in fibrous tissue. >m?XNeoplasms, Fibroepithelial C04.557.450.565.590.595; C04.557.470.625 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Adenofibroma; Brenner Tumor; Fibroadenoma (+ 1) Adenofibroma; Brenner Tumor; Fibroadenoma (+ 1) Neoplasms composed of fibrous and epithelial tissue. The concept does not refer to neoplasms located in fibrous tissue or epithelium. >o.X rNeoplasms, Experimental C04.619 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasm Transplantation; Tumor Virus Infections Neoplasms Carcinoma 256, Walker; Carcinoma, Brown-Pearce; Carcinoma, Ehrlich Tumor; Carcinoma, Krebs 2; Carcinoma, Lewis Lung; Leukemia, Experimental (+ 4); Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Melanoma, Experimental; Plant Tumors; Sarcoma, Experimental (+ 4); Tumor Virus Infections (+ 3) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  >r R9 gZNeoplasms, Ductal, Lobular, and Medullary (Non MeSH) C04.557.470.615 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Carcinoma, Infiltrating Duct; Carcinoma, Intraductal, Noninfiltrating (+ 1); Carcinoma, Lobular; Carcinoma, Medullary; Paget's Disease, Extramammary; Papilloma, Intraductal BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI >u>hXNeoplasms, Cystic, Mucinous, and Serous (Non MeSH) C04.557.470.590 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Adenocarcinoma, Mucinous; Carcinoma, Mucoepidermoid; Carcinoma, Signet Ring Cell (+ 1); Cystadenocarcinoma (+ 3); Cystadenoma (+ 3); Mucoepidermoid Tumor; Pseudomyxoma Peritonei BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI >w<hXNeoplasms, Connective Tissue C04.557.450.565; C17.300.680 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Soft Tissue Neoplasms Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Chondroblastoma; Chondroma (+ 1); Chondrosarcoma (+ 1); Giant Cell Tumors (+ 1); Myxoma (+ 1); Myxosarcoma; Neoplasms, Bone Tissue (+ 11); Neoplasms, Fibrous Tissue (+ 16); Sarcoma, Clear Cell; Sarcoma, Small Cell; Sarcoma, Synovial Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.  >y""XNeoplasms, Connective and Soft Tissue (Non MeSH) C04.557.450 Neoplasms; Neoplasms by Histologic Type (Non MeSH) Neoplasms, Adipose Tissue (+ 6); Neoplasms, Connective Tissue (+ 42); Neoplasms, Muscle Tissue (+ 14); Sarcoma (+ 34) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI >};:=XNeoplasms, Complex and Mixed (Non MeSH) C04.557.435 Neoplasms; Neoplasms by Histologic Type (Non MeSH) Adenolymphoma; Adenoma, Pleomorphic; Adenomyoma; Adenosarcoma; Carcinoma, Adenosquamous; Carcinosarcoma (+ 1); Hepatoblastoma; Mesenchymoma; Mixed Tumor, Malignant; Mixed Tumor, Mesodermal; Mixed Tumor, Mullerian; Myoepithelioma; Nephroblastoma (+ 1); Nephroma, Mesoblastic; Pulmonary Blastoma; Rhabdoid Tumor; Sarcoma, Endometrial Stromal; Thymoma BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI >~0=XNeoplasms, Bone Tissue C04.557.450.565.575 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Fibroma, Ossifying; Giant Cell Tumor of Bone; Osteoblastoma; Osteochondroma (+ 2); Osteoma (+ 1); Osteosarcoma (+ 2) Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones. Bone Neoplasms (66-93)  >XXNeoplasms, Basal Cell C04.557.470.565 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Carcinoma, Basal Cell (+ 1); Carcinoma, Basosquamous; Pilomatrixoma Neoplasms composed of cells from the deepest layer of the epidermis. The concept does not refer to neoplasms located in the stratum basale. > XhQNeoplasms, Adnexal and Skin Appendage (Non MeSH) C04.557.470.550 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Adenocarcinoma, Sebaceous; Adenoma, Sweat Gland (+ 3); Carcinoma, Skin Appendage BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI >:h`XNeoplasms, Adipose Tissue C04.557.450.550 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH) Angiolipoma; Angiomyolipoma; Lipoma; Liposarcoma (+ 1); Myelolipoma Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue. Adipose Tissue (67-93); Soft Tissue Neoplasms (78-93)  >XxRANeoplasms by Site (Non MeSH) C04.588 Neoplasms Abdominal Neoplasms (+ 2); Anal Gland Neoplasms; Bone Neoplasms (+ 9); Breast Neoplasms (+ 3); Digestive System Neoplasms (+ 31); Endocrine Gland Neoplasms (+ 18); Eye Neoplasms (+ 6); Head and Neck Neoplasms (+ 28); Nervous System Neoplasms (+ 15); Pelvic Neoplasms; Skin Neoplasms (+ 3); Soft Tissue Neoplasms; Splenic Neoplasms; Thoracic Neoplasms (+ 11); Urogenital Neoplasms (+ 19) BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI >=$  ZNeoplasms by Histologic Type (Non MeSH) C04.557 Neoplasms Histiocytic Disorders, Malignant (+ 4); Leukemia (+ 60); Lymphatic Vessel Tumors (+ 5); Lymphoma (+ 66); Neoplasms, Complex and Mixed (Non MeSH) (+ 20); Neoplasms, Connective and Soft Tissue (Non MeSH) (+ 100); Neoplasms, Germ Cell and Embryonal (+ 70); Neoplasms, Glandular and Epithelial (+ 165); Neoplasms, Gonadal Tissue (+ 10); Neoplasms, Nerve Tissue (+ 65); Neoplasms, Vascular Tissue (+ 14); Nevi and Melanomas (Non MeSH) (+ 12); Odontogenic Tumors (+ 4) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI >0  1ZNeoplasms C04 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Antibodies, Neoplasm; Anticarcinogenic Agents; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Genes, Suppressor, Tumor; Oncogenic Viruses; Pleural Effusion, Malignant; Precancerous Conditions; RNA, Neoplasm Medical Oncology Cysts (+ 41); Neoplasms by Histologic Type (Non MeSH) (+ 608); Neoplasms by Site (Non MeSH) (+ 160); Neoplasms, Experimental (+ 23); Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary (+ 7); Neoplasms, Post-Traumatic; Neoplasms, Radiation-Induced (+ 1); Neoplasms, Second Primary; Neoplastic Processes (Non MeSH) (+ 14); Neoplastic Syndromes, Hereditary (+ 15); Paraneoplastic Syndromes (+ 3); Polyps (+ 6); Precancerous Conditions (+ 9); Pregnancy Complications, Neoplastic (+ 5); Tumor Virus Infections (+ 5) New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. consider also terms at CANCER, CARCINO-, ONCO-, and TUMOR. BLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARERHRIRTSCSESUTHTMULURUSVEVI $> V i `Neoplasm, Residual C04.697.700 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplastic Processes (Non MeSH) Remnant of a tumor or cancer after primary, potentially curative therapy. (Dr. Daniel Masys, written communication). Neoplasm Recurrence, Local (68-94) >OX3)Neoplasm Transplantation E05.624 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Neoplasms, Experimental; Transplantation Miscellaneous Techniques (Non MeSH) Experimental transplantation of neoplasms in laboratory animals for research purposes. > 2/*dNeoplasm Staging E01.670 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. > " sNeoplasm Seeding C04.697.650.830 Neoplasms; Neoplastic Processes (Non MeSH); Neoplasm Metastasis The local implantation of tumor cells by contamination of instruments and surgical equipment during and after surgical resection, resulting in local growth of the cells and tumor formation. >LNeoplasm Regression, Spontaneous C04.697.670 GEIMPAPP Neoplasms; Neoplastic Processes (Non MeSH) Disappearance of a neoplasm or neoplastic state without the intervention of therapy. >n& 3dNeoplasm Recurrence, Local C04.697.655 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplastic Processes (Non MeSH) The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. >i X3Neoplasm Proteins D12.776.624 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Autocrine Motility Factor; Fusion Proteins, bcr-abl; Myeloma Proteins AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR >@FDRHNeoplasm Metastasis C04.697.650 DIGEIMPAPCPPRARIULUS Neoplasms; Neoplastic Processes (Non MeSH) Lymphatic Metastasis; Neoplasm Circulating Cells; Neoplasm Seeding; Neoplasms, Unknown Primary The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. The ability to metastasize is characteristic of all malignant neoplasms. BLBSCFCHCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARERHRIRTSESUTHULURUSVEVI  >3nZNeoplasm Invasiveness C04.697.645 DIGEIMPAPCPPRARIULUS Leukemic Infiltration Neoplasms; Neoplastic Processes (Non MeSH) Leukemic Infiltration Ability of neoplasms to infiltrate and actively destroy surrounding tissue. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI $>3YPNeoplasm Circulating Cells C04.697.650.645 CHCLDEIMMEPARESEUL Neoplasms; Neoplastic Processes (Non MeSH); Neoplasm Metastasis Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. >g LmNeonatology G02.403.776.671.400 CLECEDHIISLJMAMTOGSNSTTD Infant, Newborn Health Occupations; Medicine; Specialties, Medical; Pediatrics A subspecialty of Pediatrics concerned with the newborn infant. Pediatrics (66-76)  >JLNeonatal Screening E01.223.563; E01.563.816; E05.318.308.250.580.580; G03.850.520.308.250.580.580; G03.850.780.500.580; N02.421.143.827.233.443.816; N05.715.360.300.375.500.575 AECLCTECHIISLJMOMTNUOGPXSTTDUTVE Diagnosis; Diagnosis, Laboratory Diagnosis; Mass Screening Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Diagnostic Services; Mass Screening Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Mass Screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. Infant, Newborn (66-89); Mass Screening (66-89) >$D:Neonatal Nursing G02.478.676.390.600; G02.478.676.631.600; N02.421.533.460.600; N02.421.533.691.600 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing; Maternal-Child Nursing Health Occupations; Nursing; Specialties, Nursing; Pediatric Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care; Maternal-Child Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care; Pediatric Nursing The nursing specialty that deals with the care of newborn infants during the first four weeks after birth. Maternal-Child Nursing (91-92) >\$Neonatal Diseases and Abnormalities (Non MeSH) C16 Abnormalities (+ 263); Fetal Diseases (+ 9); Hereditary Diseases (+ 16); Infant, Newborn, Diseases (+ 39) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI >7ZNeonatal Abstinence Syndrome C16.614.610; F03.709.508.490.310.400 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Substance-Induced; Substance Withdrawal Syndrome Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances. Infant, Newborn (66-87); Substance Withdrawal Syndrome (66-87) >"*J=JNeon D01.268.613.600; D01.362.641.592 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Noble Gases Inorganic Chemicals (Non MeSH); Gases; Noble Gases Neon. A noble gas with the atomic symbol Ne, atomic number 10, and atomic weight 20.18. It is found in the earth's crust and atmosphere as an inert, odorless gas and is used in vacuum tubes and incandescent lamps. >P&:Neomycin D09.203.408.051.623; D20.085.060.550 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside Paromomycin; Ribostamycin Framycetin; Paromomycin; Ribostamycin Antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C. >\ *<JpNeodymium D01.268.558.525; D01.552.550.587 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Neodymium. An element of the rare earth family of metals. It has the atomic symbol Nd, atomic number 60, and atomic weight 144.24, and is used in industrial applications. >b &:Nematospiroides dubius B01.500.294.700.775.400.550.275 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Heligmosomatoidea; Nematospiroides A species of intestinal nematode parasites which occur most commonly in mice. Infection is by ingesting larvae. This particular species is used extensively in immunological research. Nematoda (66-85); Trichostrongyloidea (66-85) >O#*p6Nematospiroides B01.500.294.700.775.400.550 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Heligmosomatoidea Nematospiroides dubius A genus of nematodes found mainly in mice. Its organisms are used in biomedical research. Heligmosomatoidea (86-92); Nematoda (66-85)  >Z*]m4Nematode Infections C03.335.508 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antinematodal Agents Parasitic Diseases; Helminthiasis Adenophorea Infections (+ 3); Larva Migrans (+ 1); Secernentea Infections (+ 34) Infections by nematodes, general or unspecified.  >P(c:Nematoda B01.500.294 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Antinematodal Agents Invertebrates; Helminths Adenophorea (+ 8); Secernentea (+ 67) A class of unsegmented helminths with fundamental bilateral symmetry and secondary triradiate symmetry of the oral and esophageal structures. Many species are parasites.  >z *0Nemaline Myopathy C05.651.661.736; C10.668.736 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibers. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (Greek nema, thread) rods or myofibrils (Latin fibrilla, a little fiber or threadlike structure). Muscle Hypotonia (67-93); Muscular Diseases (66-93); Neuromuscular Diseases (71-93) >"LcNelson Syndrome C04.588.322.609.585; C19.344.609.585; C19.700.734.585 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Pituitary Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms; Pituitary Neoplasms Endocrine Diseases; Pituitary Diseases; Pituitary Neoplasms A syndrome characterized by deep pigmentation and the presence of an ACTH-MSH secreting adenoma of the pituitary gland developing after adrenalectomy for CUSHING'S SYNDROME. At present it is not known whether the adenoma occurs de novo or represents enlargement of a previously undetected tumor. Adenoma (66-77); Pigmentation Disorders (66-77); Pituitary Neoplasms (66-77) >9=NX[Neisseriaceae Infections C01.252.400.625 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Acinetobacter Infections; Gonorrhea (+ 1); Meningococcal Infections (+ 2) Infections with bacteria of the family NEISSERIACEAE. >ūPsX@Neisseriaceae B03.440.400.425.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Acinetobacter (+ 1); Kingella (+ 1); Moraxella (+ 2); Neisseria (+ 2) A family of gram-negative, parasitic bacteria including several important pathogens of man. Bacteria (66-74)  >]"ZkNeisseria meningitidis B03.440.400.425.550.550.641 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae; Neisseria A species of gram-negative, aerobic bacteria found in cerebrospinal fluid as the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL) as well as in venereal discharges and blood. >0"Neisseria gonorrhoeae B03.440.400.425.550.550.474 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae; Neisseria A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA. >6"Neisseria B03.440.400.425.550.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae Neisseria gonorrhoeae; Neisseria meningitidis A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans. > "5Negroid Race I01.076.368.763.708 CLGEHI Blacks Blacks Social Sciences; Anthropology; Anthropology, Physical; Racial Stocks A major racial group distinguished by classification according to physical features. This group is found largely as African Negroes in the western, central, and southern parts of Africa; as Melanesians and Papuans in New Guinea; as Negrillos in the African Congo; and as Negritos in the African Congo, Malay peninsula, New Guinea, and Andaman Islands. (Winick: Dictionary of Anthropology, 1972). Blacks (66-67) $>   QNegotiating F01.145.209.520; F01.829.401.520; F02.463.785.373.520; L01.143.620; N04.452.677.430 MTPX Collective Bargaining Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking; Decision Making Information Science; Communication Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The process of bargaining in order to arrive at an agreement or compromise on a matter of importance to the parties involved. It also applies to the hearing and determination of a case by a third party chosen by the parties in controversy, as well as the interposing of a third party to reconcile the parties in controversy. >_Negativism F01.393.556; F03.407.556 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Opposition and resistance to suggestions or advice. Seen normally in late infancy. A common symptom of catatonic schizophrenia. >շNegative Staining E05.909.262.620.670.520; E05.909.432.600.670.520 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Stains and Staining Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Stains and Staining The technique of washing tissue specimens with a concentrated solution of a heavy metal salt and letting it dry. The specimen will be covered with a very thin layer of the metal salt, being excluded in areas where an adsorbed macromolecule is present. The macromolecules allow electrons from the beam of an electron microscope to pass much more readily than the heavy metal; thus, a reversed or negative image of the molecule is created. Stains and Staining (66-91) >.6G"Nefopam D03.383.113.767.500; D15.040.100.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azocines; Oxazocines Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic 3,4,5,6-Tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine hydrochloride. Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.26). Azocines (72-74); Benzene Derivatives (72-74) >( *:A7Needlestick Injuries C21.866.986.950.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Wounds, Penetrating; Wounds, Stab Penetrating stab wounds caused by needles. They are of special concern to health care workers since such injuries put them at risk for developing infectious disease. Needles (78-91) >NzNeedles E07.612 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Sharp instruments used for puncturing or suturing. appropriate heading/instrumentation (66-70) >  =2Needle-Exchange Programs N02.421.143.827.708; N02.421.726.708 CLECHILJMAMTOGSDSNSTTDUT Needle Sharing; Substance Abuse, Intravenous Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services Organized services for exchange of sterile needles and syringes used for injections as a potential means of reducing the transmission of infectious diseases. Needles (85-94); Substance Abuse, Intravenous (90-94); Syringes (85-94)  >*5VNeedle Sharing I01.880.735.580 AEECHILJPXSNTD Needle-Exchange Programs Substance Abuse, Intravenous Social Sciences; Sociology; Social Problems Usage of a single needle among two or more people for injecting drugs. Needle sharing is a high-risk behavior for contracting infectious disease. Needles (85-91); Substance Abuse (85-91); Syringes (85-91) $>"5HNedocromil D03.438.810.835.465; D17.025.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents A pyranoquinolone derivative that prevents asthma attacks. It affects the function and inhibits the release of inflammatory mediators from tissue mast cells, inhibits recruitment of other inflammatory cells (such as eosinophils and neutrophils) into the airway epithelium, inhibits both immediate and late bronchoconstriction, and decreases bronchial hyperresponsiveness. It is not a bronchodilator and is not useful in the treatment of acute asthma. (From AMA Drug Evaluations Annual, 1994, p508, p537). Quinolines (84-88); Quinolones (89-93) >P&:F/Necturus maculosus B02.090.608.630.510.508 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Proteidae; Necturus A neotenic aquatic species of mudpuppy (Necturus) occurring from Manitoba to Louisiana and Texas. Urodela (66-80) >;&?sNecturus B02.090.608.630.510 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Proteidae Necturus maculosus A genus of the Proteidae family with five recognized species, which inhabit the Atlantic and Gulf drainages. Urodela (66-80)  > &3Necrosis C23.739.638 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tumor Necrosis Factor Cell Death; Apoptosis Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Fat Necrosis; Gangrene; Infarction; Osteonecrosis (+ 1) One of the two mechanisms by which CELL DEATH occurs (the other being the physiological process of APOPTOSIS). Necrosis is caused by the progressive degradative action of enzymes and is generally associated with severe cellular trauma. It is characterized by mitochondrial swelling, nuclear flocculation, and uncontrolled cell lysis. $> NYDNecrobiotic Disorders C17.300.200.495; C17.800.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Granuloma Annulare; Necrobiosis Lipoidica Granuloma Annulare; Necrobiosis Lipoidica A group of disorders characterized by swelling, basophilia, and distortion of collagen bundles in the dermis. >"N`Necrobiosis Lipoidica C17.300.200.495.545; C17.800.550.545; C17.800.849.495 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases; Necrobiotic Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Necrobiotic Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH) A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes. > =N`2Neck Muscles A02.633.567.650 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal The neck muscles consist of the platysma, splenius cervicis, sternocleidomastoid(eus), longus colli, the anterior, medius, and posterior scalenes, digastric(us), stylohyoid(eus), mylohyoid(eus), geniohyoid(eus), sternohyoid(eus), omohyoid(eus), sternothyroid(eus), and thyrohyoid(eus). Muscles (66-78); Neck (66-78) >g:;N&Neck A01.598 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Cervical Vertebrae Body Regions (Non MeSH) consider also terms at CERVICAL and CERVICO-. > (8Necatoriasis C03.335.508.700.775.455.683 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections; Hookworm Infections Infection of humans or animals with hookworms of the genus NECATOR. The resulting anemia from this condition is less severe than that from ANCYLOSTOMIASIS. Hookworm Infections (66-78) >jP!Necator americanus B01.500.294.700.775.100.550.100 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Ancylostomatoidea; Necator A common parasite of humans in the moist tropics and subtropics. These organisms attach to villi in the small intestine and suck blood causing diarrhea, anorexia, and anemia. Necator (66-92) >w#*hNecator B01.500.294.700.775.100.550 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Ancylostomatoidea Necator americanus A genus of intestinal parasite worms which includes one of the most important hookworms of man, NECATOR AMERICANUS. The only other known species, N. suillus, has been recovered from pigs. >M *]Nebulizers and Vaporizers E07.605; E07.858.400 CLECHISDSNSTTDUTVE Aerosols Administration, Intranasal Equipment and Supplies Equipment and Supplies; Surgical Equipment Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Aerosols (66-86); Anesthesia, Inhalation (66-86); Volatilization (71-86) $> MVNebraska Z01.107.567.875.100.571; Z01.107.567.875.600.516.571 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States >\ :Nebramycin D09.203.408.051.476.600; D20.085.060.425.600 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Kanamycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Kanamycin Tobramycin Tobramycin A complex of antibiotic substances produced by Streptomyces tenebrarius. Antibiotics (71-74); Aminoglycosides (74)  ?2<U2Near Drowning C21.866.304.500; G03.850.110.500.500 BLCFCLCODIECENEPETHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Drowning Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Drowning Environment and Public Health (Non MeSH); Public Health; Accidents; Drowning Non-fatal immersion or submersion in water. The subject is resuscitable. Drowning (66-89)  ?*@ WNBD Chloride D03.383.548.580.400; D26.550.494 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Oxadiazoles Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 4-Chloro-7-nitrobenzofuran. A benzofuran derivative used as a protein reagent since the terminal N-NBD-protein conjugate possesses interesting fluorescence and spectral properties. It has also been used as a covalent inhibitor of both beef heart mitochondrial ATPase and bacterial ATPase. Nitro Compounds (74-75); Oxadiazole (72-75) ?&:L5Naval Medicine G02.403.478 CLECEDHIISLJMAMTOGSNSTTD Diving; Ships Health Occupations; Medicine Submarine Medicine The practice of medicine concerned with conditions affecting the health of individuals associated with the marine environment.  ?#Nausea C23.888.821.712 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antiemetics; Emetics Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) An unpleasant sensation, vaguely referred to the epigastrium and abdomen, and often culminating in VOMITING. (Dorland, 27th ed). ? NNaturopathy E02.040.600 AECLCTECHIISMOMTNUPXSNSTTDUTVE Physical Therapy Therapeutics; Alternative Medicine A drugless system of therapy, making use of physical forces such as air, light, water, heat, massage, etc. (Dorland, 27th ed). ? ")Natural Language Processing L01.700.568.110.065.580 Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Artificial Intelligence Computer processing of a language with rules that reflect and describe current usage rather than prescribed usage. ? !Natural Disasters G03.230.100.200 CLECHISN Relief Work Environment and Public Health (Non MeSH); Environment; Disasters Volcanic Eruption Sudden calamitous events producing great material damage, loss, and distress. They are the result of natural phenomena such as earthquakes, floods, etc. Disasters (66-71) AEANCLECHILJSN (? i NNatural Childbirth E04.819.774.457.696 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Labor Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery Psychophysical relaxation techniques that are used to facilitate childbirth. ? $ lYNatriuretic Hormone D06.472.540 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones A low-molecular weight substance, possibly from the hypothalamus, which is released due to plasma volume expansion. It causes natriuresis in part by inhibiting sodium potassium ATPase. The development of hypertension may be the consequence of an abnormality in volume regulation induced by a defect in the renal response to the natriuretic effect of the natriuretic hormone. Do not confuse with ATRIAL NATRIURETIC FACTOR or cardionatrin which is a different, well characterized hormone. Biological Products (66-80); Blood Proteins (66-85); Natriuresis (66-85); Proteins (66-85) ?gDB5mNatriuresis G08.852.241.557 DEGEIMPHRE Sodium Reproduction, Urogenital Physiology (Non MeSH); Urinary Tract Physiology (Non MeSH); Diuresis ? oNational Practitioner Data Bank L01.700.508.300.333.500 ECHILJSNUT Quality of Health Care Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Databases, Factual A databank established by the Health Care Quality Improvement Act of 1986 authorizing the Department of Health and Human Services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like. Information Systems (89-91); Malpractice (89-91)  ?&:National Library of Medicine (U.S.) L01.346.596.563.725; N03.540.427.300.650.450.475 CLECHILJOGSNSTTDUT Grateful Med; MEDLARS; Unified Medical Language System Information Science; Information Centers; Libraries; Libraries, Medical Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service; National Institutes of Health (U.S.) An agency of the NATIONAL INSTITUTES OF HEALTH concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine. ?+6BBNational Institutes of Health (U.S.) N03.540.427.300.650.450 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service National Library of Medicine (U.S.) An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research. ?,+National Institute of Mental Health (U.S.) N03.540.427.300.650.920.525 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service; United States Substance Abuse and Mental Health Services Administration A component of the UNITED STATES SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION concerned with research, overall planning, promoting, and administering mental health programs and research. ?'3National Institute for Occupational Safety and Health N03.540.427.300.650.225.520 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service; Centers for Disease Control and Prevention (U.S.) An institute of the CENTERS FOR DISEASE CONTROL AND PREVENTION which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals. ??!National Health Programs N03.349.550 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning National Health Insurance, United States Components of a national health care system which administer specific services, e.g., national health insurance. ?"eI0National Health Planning Information Center N03.540.427.300.650.790.525 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service; United States Health Resources and Services Administration A center in the HEALTH RESOURCES ADMINISTRATION Division of Planning Methods and Technology which provides access to current information on health planning and resources development. ?#3National Health Planning and Resources Development Act of 1974 N03.349.510 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning Legislation establishing a coordinated program in health planning and resource development with a federal agency overseeing the programs as developed by the states and health systems agencies. The resource development portion of the act grants funds for a variety of programs, including funds for facilities and services. Health Planning (79-81) ?&1JIuNational Health Insurance, United States N03.219.521.576.343.900; N03.349.550.610 ECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Economics, Organizations, Control (Non MeSH); Health Planning; National Health Programs National Health Programs (75-77) ?(0.'National Center for Health Statistics (U.S.) N03.540.427.300.650.425 ECHILJOG Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service A center in the PUBLIC HEALTH SERVICE which is primarily concerned with the collection, analysis, and dissemination of health statistics on vital events and health activities to reflect the health status of people, health needs, and health resources. ?*?5 $National Center for Health Care Technology N03.540.427.300.650.400 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service A center in the PUBLIC HEALTH SERVICE which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology. ?,3National Academy of Sciences (U.S.) N03.540.608 HIOG Economics, Organizations, Control (Non MeSH); Organizations Institute of Medicine (U.S.) A United States organization of distinguished scientists and engineers established for the purpose of investigating and reporting upon any subject of art or science as requested by any department of government. The National Research Council organized by NAS serves as the principal operating agency to stimulate and support research. ?.+F#Natamycin D20.085.062.617; D20.085.115.475; D20.136.073.617 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. ?1& 9<Natal Teeth A14.254.860.815.557 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Tooth, Deciduous Predeciduous teeth present at birth. They may be well formed and normal or may represent hornified epithelial structures without roots. They are found on the gingivae over the crest of the ridge and arise from accessory buds of the dental lamina ahead of the deciduous buds or from buds of the accessory dental lamina. (From Illustrated Dictionary of Dentistry, 1982). ?3U:ENasopharynx A14.724.557 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Stomatognathic System; Pharynx The nasal part of the pharynx, lying above the level of the soft palate. ?58%ZNasopharyngitis C07.550.350.700; C09.775.350.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Pharyngeal Diseases; Nasopharyngeal Diseases Otorhinolaryngologic Diseases; Pharyngeal Diseases; Nasopharyngeal Diseases Inflammation of the nasopharynx. ?6&N(Nasopharyngeal Neoplasms C04.588.443.665.710.650; C07.550.350.650; C07.550.745.650; C09.647.710.650; C09.775.350.650; C09.775.549.650 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms Stomatognathic Diseases; Pharyngeal Diseases; Nasopharyngeal Diseases Stomatognathic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms Otorhinolaryngologic Diseases; Pharyngeal Diseases; Nasopharyngeal Diseases Otorhinolaryngologic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms ?8@zX&Nasopharyngeal Diseases C07.550.350; C09.775.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Pharyngeal Diseases Otorhinolaryngologic Diseases; Pharyngeal Diseases Nasopharyngeal Neoplasms; Nasopharyngitis Nasopharyngeal Neoplasms; Nasopharyngitis General or unspecified diseases of the nasopharynx. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  ?;tNl^>XNasolacrimal Duct A09.371.463.640 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Lacrimal Apparatus ?=:/Nasal Septum A02.165.639; A04.531.591 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage Respiratory System; Nose The partition separating the two nasal cavities in the midplane, composed of cartilaginous, membranous and bony parts. ?>8:ENasal Provocation Tests E01.276.660 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH) Application of allergens to the nasal mucosa. Interpretation includes observation of nasal symptoms, rhinoscopy, and rhinomanometry. Nasal provocaton tests are used in the diagnosis of nasal hypersensitivity, including hay fever. Allergens (66-79); Hay Fever (66-79); Nasal Mucosa (66-79) ??"> INasal Polyps C04.588.443.665.650.557; C04.799.557; C08.460.557; C08.460.669.557; C08.785.600.557; C09.603.557; C09.603.669.557; C09.647.685.557 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Nose Neoplasms Neoplasms; Polyps Respiratory Tract Diseases; Nose Diseases Respiratory Tract Diseases; Nose Diseases; Nose Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms; Nose Neoplasms Otorhinolaryngologic Diseases; Nose Diseases Otorhinolaryngologic Diseases; Nose Diseases; Nose Neoplasms Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Nose Neoplasms Focal accumulations of edema fluid in the nasal mucosa accompanied by hyperplasia of the associated submucosal connective tissue. Polyps may be neoplasms, foci of inflammation, degenerative lesions, or malformations. ?AX-Nasal Obstruction C08.460.525; C08.618.846.185.525; C09.603.525 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency; Airway Obstruction Otorhinolaryngologic Diseases; Nose Diseases Any hindrance to the passage of air into and out of the nose. The obstruction may be in the nasal vestibule, fossae, or other areas of the nasal cavity. Airway Obstruction (72-89); Airway Resistance (80-89); Nose Diseases (66-89) ?E5N\Nasal Mucosa A04.531.520; A10.615.550.707 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Respiratory System; Nose Tissue Types (Non MeSH); Membranes; Mucous Membrane Olfactory Mucosa (+ 1) Olfactory Mucosa (+ 1) The mucous membrane lining the nasal cavity. ?H":]87Nasal Lavage Fluid C23.682 CHCYIMMIPS Symptoms and General Pathology (Non MeSH) Fluid obtained by irrigation or washout of the nasal cavity and nasal mucosa. The resulting fluid is used in cytologic and immunologic assays of the nasal mucosa such as with the NASAL PROVOCATION TEST in the diagnosis of nasal hypersensitivity. Irrigation (71-93) ?I 2"Nasal Cavity A04.531.449 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUULUSVI Respiratory System; Nose The proximal portion of the respiratory passages on either side of the nasal septum, lined with ciliated mucosa, extending from the nares to the pharynx. Nose (66-74) ?K6Nasal Bone A02.835.232.781.324.665; A04.531.378 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Rhinoplasty Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones Respiratory System; Nose Either of two small elongated rectangular bones that together form the bridge of the nose. Nose (66-74)  ?M *:rmNarcotics D15.210.600 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Analgesics, Opioid; Cocaine; Narcotic Dependence; Receptors, Opioid Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants Alphaprodine; Buprenorphine; Butorphanol; Cocaine; Codeine; Dextromoramide; Diacetylmorphine; Dihydromorphine; Dihydromorphinone; Diphenoxylate; Ethylmorphine; Etorphine; Fentanyl (+ 1); Hydrocodone; Levorphanol; Meperidine (+ 1); Meptazinol; Methadone (+ 1); Methadyl Acetate; Morphine; Nalbuphine; Opium; Oxycodone; Oxymorphone; Pentazocine; Phenazocine; Phenoperidine; Pirinitramide; Propoxyphene; Sufentanil; Thebaine; Tilidine; Tramadol Originally, agents that caused somnolence or induced sleep; now, any derivative, natural or synthetic, of opium or morphine or any substance that has their effects. Narcotics have potent analgesic effects associated with significant changes in mood and behavior, and with the potential for dependence and tolerance following repeated administration. (Stedman, 25th ed). AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (?N 6PM@Narcotic Dependence F03.709.597.780.660.400 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Narcotics Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Dependence Heroin Dependence; Morphine Dependence Strong dependence, both physiological and emotional, upon any derivative, synthetic or natural, of opium, or any substance that has the same pharmacologic effects. Narcotics (66-79); Opium (66-79); Substance Dependence (66-79) $?SD .LNarcotic Antagonists D15.550 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Drug Antagonism Central Nervous System Agents Buprenorphine; Butorphanol; Cyclazocine; Diprenorphine; Levallorphan; Meptazinol; Nalbuphine; Nalorphine; Naloxone; Naltrexone; Pentazocine Agents inhibiting the effect of narcotics on the central nervous system. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $?V[ 4$W:Narcotherapy F04.881.505.557 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Somatic Therapies, Psychiatric (Non MeSH); Psychopharmacology Intravenous injections of sodium amytal or sodium pentothal to induce a state in which the patient is more relaxed and communicative. Narcosuggestion, narcosynthesis, and narcoanalysis are therapeutic processes using these drug adjuncts. ?XNNarcolepsy C10.228.140.725; F03.126.821.640 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cataplexy Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Sleep Disorders Cataplexy Sleep disorder consisting of attacks of imperative drowsiness and sleep.  ?ZD&L VNarcissism F02.739.794.582 Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory A psychoanalytic term meaning self-love. ?\"l1Naproxen D04.615.638.472.450; D08.373.310.500; D16.850.015.050.590; D17.025.030.550; D17.050.030.550; D17.050.337.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Naphthaleneacetic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants 2-(6-Methoxy-2-naphthyl)propionic acid. An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Methyl Ethers (73-74); Naphthalenes (72-74); Propionates (72-74) ?\ z:n<NNaphthyridines D03.438.612 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Enoxacin; Nalidixic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ?b8G:Naphthylvinylpyridine D03.383.725.495; D04.615.638.900 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes 4(1-Naphthylvinyl)pyridine hydrochloride. Cholinesterase inhibitor. Synonym: YuB 25. Naphthalenes (71-74); Pyridines (71-74); Vinyl Compounds (71-74) ?c&:cNNaphthoquinones D02.806.550; D04.615.638.721 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. ?f"8Naphthols D04.615.638.638 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Naphthalene derivatives carrying one or more hydroxyl (-OH) groups at any ring position. They are often used in dyes and pigments, as antioxidants for rubber, fats, and oils, as insecticides, in pharmaceuticals, and in numerous other applications. Naphthalenes (66-71) ?g 8a!Naphthol AS D Esterase D08.586.277.352.100.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases Hydrolytic enzyme activity used as a histocytochemical test for the presence of esterases in tissue. Substrate used is 3-hydroxy-4'-nitro-2-naphthanilide chloroacetate (naphthol AS-D). Esterases (71-74); Naphthols (72-74) ?iF-Naphthalenesulfonates D02.886.645.600.080.050.650; D04.615.638.555 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Amaranth; Amido Black; Anilino Naphthalenesulfonates; Evans Blue; Suramin Amaranth; Amido Black; Anilino Naphthalenesulfonates; Evans Blue; Suramin A class of organic compounds that contains a naphthalene moiety linked to a sulfonic acid salt or ester. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ?l28~:Naphthalenes D04.615.638 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Bunaftine; Dansyl Compounds; Lovastatin; Naphthaleneacetic Acids (+ 1); Naphthalenesulfonates (+ 5); Naphthols; Naphthoquinones; 1-Naphthylamine; 2-Naphthylamine; 1-Naphthylisothiocyanate; Naphthylvinylpyridine; Pravastatin; Tetrahydronaphthalenes (+ 2); Tolnaftate Two-ring crystalline hydrocarbons isolated from coal tar. They are used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, preservatives, and, formerly, as topical antiseptics. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  ?o8P2@Naphthaleneacetic Acids D04.615.638.472 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Naproxen Naphthalene derivatives containing the -CH2CCO2H radical at the 1-position, the 2-position, or both. Compounds are used as plant growth regulators to delay sprouting, exert weed control, thin fruit, etc. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ?rD8a :Naphthacenes D04.615.597 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Polycyclic four-ring hydrocarbons isolated from coal tar and found as contaminants in commercial anthracene preparations. ?tj8PNaphazoline D03.383.374.585; D18.793.952.633 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Cardiovascular Agents; Vasoconstrictor Agents; Vasoconstrictor Agents, Nasal 4,5-Dihydro-2-(1-naphthalenylmethyl)-1H-imidazole. An adrenergic vasoconstrictor agent used as a decongestant. ?u&:~Nandrolone D04.808.365.415.638; D06.597.100.194.590 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids ?w|.:Namibia Z01.058.290.175.580 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern The former German colony of South West Africa, mandated to South Africa 1920-1966, and made a direct dependent of the United Nations October 1966. Its name was changed from South West Africa to Namibia in 1968. Africa, Southern (66-77); South Africa (66-74) ?x `9Names L01.143.506.598.400.556 Information Science; Communication; Language; Linguistics; Nomenclature Abbreviations; Anonyms and Pseudonyms; Eponyms Personal names, given or surname, as cultural characteristics, as ethnological or religious patterns, as indications of the geographic distribution of families and inbreeding, etc. Analysis of isonymy, the quality of having the same or similar names, is useful in the study of population genetics. NAMES is used also for the history of names or name changes of corporate bodies, such as medical societies, universities, hospitals, government agencies, etc. ?z T8Named Groups by Occupation (Non MeSH) M01.526 Named Groups (Non MeSH) Administrative Personnel (+ 6); Clergy; Faculty (+ 3); Foreign Professional Personnel (+ 1); Health Personnel (+ 60); Librarians; Military Personnel; Missions and Missionaries; Police; Research Personnel CLECEDHILJMAMTOGPXSDSNSTTDUT ?}.  Named Groups by Age (Non MeSH) M01.471 Named Groups (Non MeSH) Adult (+ 4); Child (+ 20) BLCFCLEDEHGDGEHIIMLJMEMIPHPSPXSNURVI ?%' $(Named Groups (Non MeSH) M01 Abortion Applicants; Caregivers; Consultants; Disabled (+ 1); Ethnic Groups (+ 12); Famous Persons; Homebound Persons; Homeless Persons (+ 2); Legal Guardians; Medically Uninsured; Men (+ 1); Mentors; Minority Groups; Multiple Birth Named Groups (Non MeSH) (+ 6); Named Groups by Age (Non MeSH) (+ 26); Named Groups by Occupation (Non MeSH) (+ 80); Parents (+ 4); Patients (+ 6); Prisoners; Refugees; Research Personnel (+ 1); Sexual Partners; Single Person; Spouses; Students (+ 7); Tissue Donors (+ 1); Transients and Migrants; Veterans; Visitors to Patients; Voluntary Workers (+ 2); Women (+ 4) BLCFCLECEDEHGDGEHIIMLJMAMEMIMTOGPHPSPXRHSDSNSTTDURUTVI ?:Naltrexone D03.132.610.422.706.550; D03.549.686.750.550; D03.605.497.750.550; D15.550.595 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Naloxone Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Naloxone Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Naloxone Central Nervous System Agents; Narcotic Antagonists 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one. Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. Cyclopropanes (73-75); Morphinans (73-74); Naloxone/analogs and derivatives (75) ?AX:X``Naloxone D03.132.610.422.706; D03.549.686.750; D03.605.497.750; D15.550.585 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Narcotic Antagonists Naltrexone Naltrexone Naltrexone (5 alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one. A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. Morphinans (69-71); Narcotic Antagonists (66-71)  ?  L:4':Nalorphine D03.132.610.422.656; D03.549.686.694; D03.605.497.694; D15.550.575 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Narcotic Antagonists (5 alpha,6 alpha)-7,8-Didehydro-4,5-epoxy-17-(2-propenyl)morphinan-3,6-diol. A narcotic antagonist with some agonist properties. It is an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. Given alone it produces a broad spectrum of unpleasant effects and it is considered to be clinically obsolete. ?XL:4yNalidixic Acid D03.438.612.500; D03.438.810.835.450; D20.220.500; D20.237.050.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Naphthyridines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones Anti-Infective Agents; Anti-Infective Agents, Quinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone 1-Ethyl-1-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid. Synthetic antimicrobial agent used in urinary tract infections. It is active against Gram-negative bacteria but has little activity against Gram-positive organisms or Pseudomonas. ?L:\Naled D02.705.509; D05.723.491.574.583 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate Insecticides (66-71) ? &:Nalbuphine D03.132.610.422.606; D03.549.686.639; D03.605.497.639; D15.040.150.510; D15.210.600.625; D15.550.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Central Nervous System Agents; Narcotic Antagonists A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. Morphinans (66-71); Narcotic Antagonists (66-71) ?Nr::Nairovirus B04.820.087.565; B04.909.777.147.565 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae Hemorrhagic Fever Virus, Crimean-Congo; Nairobi Sheep Disease Viruses Hemorrhagic Fever Virus, Crimean-Congo; Nairobi Sheep Disease Viruses A genus of the family BUNYAVIRIDAE named after NAIROBI SHEEP DISEASE, an acute, hemorrhagic, tick-borne, gastroenteritis affecting sheep and goats. Some viruses in this genus are capable of causing severe and fatal disease in humans. Bunyaviridae (80-91)  ?*yNairobi Sheep Disease Viruses B04.820.087.565.600; B04.909.777.147.565.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Nairovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Nairovirus A group of viruses of the genus NAIROVIRUS, transmitted by the ixodid ticks and producing a lethal gastroenteritis in sheep and goats, especially in Africa. Though major veterinary pathogens, their effect on humans has not been firmly established. Arboviruses (66-80); Bunyaviridae (81-90); Nairovirus (91-93) ?$2"JNairobi Sheep Disease C02.081.885.550; C02.782.147.633; C22.836.583 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections Animal Diseases; Sheep Diseases An arbovirus infection of sheep and goats transmitted by ticks. It is characterized by high fever and hemorrhagic gastroenteritis. Arbovirus Infections (66-69); Sheep Diseases (66-69) ?T5J?Nails, Malformed C17.800.805.506.506 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Nail Diseases Deformities in nail structure or appearance, including hypertrophy, splitting, clubbing, furrowing, etc. ?NzxNails, Ingrown C17.800.805.506.406 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Nail Diseases Excessive lateral nail growth into the nail fold. Because the lateral margin of the nail acts as a foreign body, inflammation and granulation may result. It is caused by improperly fitting shoes and by improper trimming of the nail. ?;NzNails A01.835.472 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Body Regions (Non MeSH); Skin consider also terms at ONYCHO-. ?e 8'(Nail-Patella Syndrome C16.131.077.606; C17.800.805.506.400 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Nail Diseases A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the patella and congenital nail dystrophy. It is a genetically determined autosomal dominant trait. ?'*LNail Diseases C17.800.805.506 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases Nail-Patella Syndrome; Nails, Ingrown; Nails, Malformed; Onychomycosis; Paronychia Diseases of the nail plate and tissues surrounding it. The concept is limited to primates. Nails (66-78) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $?NhanPNail Biting F01.145.466.554; F03.234.193.308.600 AEPXTH Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders; Child Reactive Disorders; Habits Common form of habitual body manipulation which is an expression of tension. ?* \Nafronyl D03.383.312.620; D18.918.615 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans Cardiovascular Agents; Vasodilator Agents 2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate oxalate. Possible vasodilator. Synonyms: Dusodril; Praxilene. Diethylamines (74); Furans (71-74); Naphthalenes (71-74); Propionates (71-74) ?M ":^Nafoxidine D03.383.773.589; D06.347.300.472 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists 1-(2-(4-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)pyrrolidine. An estrogen antagonist that has been used in the treatment of breast cancer. ?W&:Nafenopin D02.241.081.751.700.600; D10.162.202.618 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Propionates; Propionic Acids Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents Anticholesteremic Agents (66-72); Antilipemic Agents (66-72); Propionates (66-72) ?X .:`Nafcillin D20.085.099.739.637 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins ?1 :PNafarelin D06.472.709.429.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones; Gonadorelin 6-(3-(2-Naphthalenyl)-D-alanine)luteinizing hormone-releasing factor (pig). A GONADORELIN analog agonist. It has been used in the treatment of central precocious puberty and endometriosis. Gonadorelin/analogs and derivatives (81-92) ? :{3Naegleria fowleri B01.841.750.656.475.700.710.375 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Schizopyrenida; Naegleria A species of parasitic protozoa having both an ameboid and flagellate stage in its life cycle. Infection with this pathogen produces primary amebic meningoencephalitis. Amoeba (74-87); Naegleria (88-91) ? #&i*Naegleria B01.841.750.656.475.700.710 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Schizopyrenida Naegleria fowleri A free-living soil amoeba pathogenic to humans and animals. It occurs also in water and sewage. The most commonly found species in man is NAEGLERI FOWLERI which is the pathogen for primary amebic meningoencephalitis in primates. Amoeba (66-87)  ? &\Nadroparin D09.203.698.373.400.300.600; D19.461.119.380.300.600; D19.461.427.400.300.600 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Heparin; Heparin, Low-Molecular-Weight Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. (From Merck Index, 11th ed). Heparin/analogs and derivatives (87); Heparin, Low-Molecular-Weight (88-93) ?UFXNADPH-Ferrihemoprotein Reductase D08.586.682.608.191.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases; Cytochrome Reductases A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. Its physiological acceptor is probably cytochrome P-450. EC 1.6.2.4. Cytochrome C (73-74); Cytochrome Reductases (73-74); Cytochromes (66-72); Oxidoreductases (66-74) ?%FtNADPH Dehydrogenase D08.586.682.608.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1. ?pFymNADP Transhydrogenase D08.586.682.608.540 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy (ATP) it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1. NADH, NADPH Oxidoreductases (73-78); Oxidoreductases (66-72) ?FyGNADP D08.176.625; D13.695.667.138.749; D13.695.827.068.749 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed). ?=H=vNadolol D02.033.329.624.580; D02.092.063.624.580; D14.100.050.200.200.580; D16.050.850.560; D18.097.573; D18.162.630 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents 5(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthaenediol. A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for migraine and for tremor. Adrenergic Beta Receptor Blockaders (69-86); Propanolamines (74-86) ?{ z:"KONADH, NADPH Oxidoreductases D08.586.682.608 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Cytochrome Reductases (+ 2); Dihydropteridine Reductase; Ferredoxin-NADP Reductase; Glutathione Reductase; Lipoamide Dehydrogenase; Methemoglobin Reductase; NADH Tetrazolium Reductase; NADP Transhydrogenase; NADPH Dehydrogenase; Nitrate Reductases; Nitrite Reductases; Quinone Reductases (+ 1); Thioredoxin Reductase (NADPH) Oxidoreductases (66-72) ?!FXuNADH Tetrazolium Reductase D08.586.682.608.530 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases Catalyzes the reduction of tetrazolium compounds in the presence of NADH. Oxidoreductases (73); NADH, NADPH Oxidoreductases (74); Tetrazolium Salts (73-74) ?ʧ FyXaNADH Dehydrogenase D08.586.682.608.191.475 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases; Cytochrome Reductases A flavoprotein containing iron. Cytochrome c may act as receptor. The enzyme catalyzes the oxidation of NADH to NAD and reduced acceptor. EC 1.6.99.3. Cytochrome Reductases (73-79); Cytochrome c (73-79); NADH, NADPH Oxidoreductases (73-79); Oxidoreductases (66-72) ?}FNAD+ Nucleosidase D08.586.277.450.737.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Nucleosidases An enzyme that catalyzes the hydrolysis of NAD to nicotinamide and ADPribose. EC 3.2.2.5. Nucleosidases (73-74); NAD (73-74) ?F}l+NAD+ ADP-Ribosyltransferase D08.586.913.400.725.525 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme isolated from the nuclei of a variety of cells. It catalyzes the incorporation of ADP-ribose groups of NAD+ into a homopolymer of repeating ADP-ribose units. EC 2.4.2.30. NAD Nucleosidase (75-76); Nucleosidases (66-74) ?М F9NAD(P)H Dehydrogenase (Quinone) D08.586.682.608.800.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases; Quinone Reductases A flavoprotein that reversibly catalyzes the oxidation of NADH or NADPH by various quinones and oxidation-reduction dyes. Since the enzyme is a part of the mitochondrial respiratory chain, defects or deficiencies of this enzyme are an important cause of neurological diseases such as Parkinsonism. It may have a protective effect against cancer caused by quinones or their metabolic precursors. The enzyme is inhibited by dicoumarol, capsaicin, and caffeine. EC 1.6.99.2. NADH, NADPH Oxidoreductases (75-79); Oxidoreductases (66-74) ?'F%GNAD(P)(+)-Arginine ADP-Ribosyltransferase D08.586.913.400.725.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme that catalyzes the transfer of the ADP-ribose moiety from NAD to specific protein substrates with agmatine, arginine-type compounds, or guanidine as acceptors. This reaction can be catalyzed by prokaryotic and eukaryotic enzyme systems. Mono-ADP-ribosylation is a mechanism of action common to several bacterial toxins. It effects profound changes in cellular metabolism, such as activation of adenylate cyclase, regulation of protein synthesis at the level of elongation factor 2, and ion transport across biological membranes. EC 2.4.2.31. Pentosyltransferases (76-88) ?ք1F}!NAD D08.176.589; D13.695.667.138.694; D13.695.827.068.694 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides Adenosine 5'-(trihydrogen diphosphate) 5'-5'-ester with 3- (aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, hydroxide, inner salt. A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed). ?`=H=Na(+)-K(+)-Exchanging ATPase D08.586.277.040.025.600; D12.776.543.400.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Potassium Channels; Sodium Channels Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Ion Pumps An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. EC 3.6.1.37. Adenosine Triphosphatase (66-78); Potassium (66-78); Sodium (66-78)  ?K%2F+wQN,N-Dimethyltryptamine D02.092.211.215.801.451; D03.438.473.914.237; D14.100.850.800.180; D14.100.850.850.200; D15.300.185; D15.700.372.317 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Tryptamines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens Methoxydimethyltryptamines Bufotenin (+ 1) 3-(2-(Dimethylamino)ethyl)indole. An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others. ?Du5jN-Nitrosopyrrolidine D02.654.442.550; D03.383.773.630; D26.191.646.661 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosamines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Nitrosamines 1-Nitrosopyrrolidine. Carcinogenic nitrosamine that may be formed from preservatives in meats during their preparation or in the liver during metabolism. Nitrosamines (66-78) ?9.N-Methylaspartate D12.125.119.170.400; D14.100.190.200.560 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, N-Methyl-D-Aspartate Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Aspartic Acid Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Agonists An amino acid that is the defining agonist for the NMDA receptor subtype of glutamate receptors (RECEPTORS, NMDA). Aspartic Acid (66-90); Convulsants (75-90)  ?u.F$+4N-Methyl-3,4-methylenedioxyamphetamine D02.092.471.683.152.670; D14.100.050.600.050.525.500; D14.100.600.050.525.500; D14.100.850.875.515; D15.300.625; D15.700.372.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors; Methamphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors; Methamphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. 3,4-Methylenedioxyamphetamine/analogs and derivatives (84-94) ?5*: EN-Formylmethionine Leucyl-Phenylalanine D12.125.166.676.450.440; D12.644.456.400; D24.185.125.320.685; D24.185.125.685 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Methionine; N-Formylmethionine Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Immunologic and Biologic Factors (Non MeSH); Biological Factors; Chemotactic Factors; Chemotactic Factors, Eosinophil Immunologic and Biologic Factors (Non MeSH); Biological Factors; Chemotactic Factors N-Formylmethionyl-leucyl-phenylalanine. A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. Chemotactic Factors (80-83); Chemotaxis (70-79); Chemotaxis, Leucocyte (77-83); Cytology (66-69); N-Formylmethionine (75-83); Methionine (66-74); Oligopeptides (73-83); Peptides (66-72) ?r,X:N-Formylmethionine D12.125.166.676.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Methionine N-Formylmethionine Leucyl-Phenylalanine Effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells. Formic Acids (74); Methionine (74)  ?:o,,N-Acetylmuramoyl-L-alanine Amidase D08.586.277.087.030 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases An autolytic enzyme bound to the surface of bacterial cell walls. It catalyzes the hydrolysis of the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell wall glycopeptides, particularly peptidoglycan. EC 3.5.1.28. Alanine (66-78); Amidohydrolases (66-78); Muramic Acids (73-78) ?'FfMN-Acetyllactosamine Synthase D08.586.913.400.450.400.500.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Galactosyltransferases; Lactose Synthase The A protein of the lactose synthase complex. In the presence of the B protein (LACTALBUMIN) specificity is changed from N-acetylglucosamine to glucose. EC 2.4.1.90. Glucosamine (73-74); Lactose Synthase (73-74) ?!#F7N-Acetylhexosaminyltransferases D08.586.913.400.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases N-Acetylgalactosaminyltransferases (+ 1); N-Acetylglucosaminyltransferases Enzymes that catalyze the transfer of N-acetylhexosaminyl groups to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1. Hexosyltransferases (72-92)  ?\#FmS N-Acetylglucosaminyltransferases D08.586.913.400.100.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; N-Acetylhexosaminyltransferases Enzymes that catalyze the transfer of N-acetylglucosamine from a nucleoside diphosphate N-acetylglucosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-. Glucosyltransferases (66-92) ?$F!N-Acetylgalactosaminyltransferases D08.586.913.400.100.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; N-Acetylhexosaminyltransferases Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase Enzymes that catalyze the transfer of N-acetylgalactosamine from a nucleoside diphosphate N-acetylgalactosamine to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-. Galactosyltransferases (76-92)  @&F?#Myxosarcoma C04.557.450.565.560; C04.557.450.795.560 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A sarcoma, usually a liposarcoma or malignant fibrous histiocytoma, with an abundant component of myxoid tissue resembling primitive mesenchyme containing connective tissue mucin. (Stedman, 25th ed). @:.XMyxomycota B05.354.618 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Dictyostelium; Physarum (+ 1) A division of organisms that exist vegetatively as complex mobile plasmodia, reproduce by means of spores, and have complex life cycles. They are usually classed as fungi, but some authorities, following de Bary, 1859, regard them as protozoans. CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI  @",% &Myxomatosis, Infectious C02.256.743.665; C22.627 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Animal Diseases @JgMyxoma Virus B04.280.650.160.500.550; B04.909.204.210.600.550; B04.909.204.783.160.500.550; B04.909.574.204.600.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Leporipoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Leporipoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Leporipoxvirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Leporipoxvirus The type species of LEPORIPOXVIRUS causing infectious myxomatosis, a severe generalized disease, in rabbits. Tumors are not always present. @ pMyxoma C04.557.450.565.550 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Neurothekeoma A benign neoplasm derived from connective tissue, consisting chiefly of polyhedral and stellate cells that are loosely embedded in a soft mucoid matrix, thereby resembling primitive mesenchymal tissue. It occurs frequently intramuscularly where it may be mistaken for a sarcoma. It appears also in the jaws and the skin. (From Stedman, 25th ed). @  VMyxococcus xanthus B03.350.638.500.500.900 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Myxococcales; Myxococcaceae; Myxococcus A species of gliding bacteria found on soil as well as in surface fresh water and coastal seawater. Bacteria (66-73); Myxococcales (74-91) @"^y/Myxococcus B03.350.638.500.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Myxococcales; Myxococcaceae Myxococcus xanthus A genus of gliding bacteria that are common inhabitants on tree bark and decomposing vegetation. The cells are slender rods with tapering ends. Bacteria (66-73); Myxococcales (74-91)  @\"P/Myxococcales B03.350.638 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH) Myxococcaceae (+ 2) An order of rod-shaped, gram-negative gliding bacteria found in soil, water, and decomposing matter. @".vMyxococcaceae B03.350.638.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Myxococcales Myxococcus (+ 1) A family of MYXOCOCCALES found in soils. The cells are slender rods that are straight to slightly tapered. Bacteria (66-73); Myxococcales (74-91)  @4"?/Myxedema C17.300.550.590; C19.874.482.638 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cretinism Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses Endocrine Diseases; Thyroid Diseases; Hypothyroidism A condition characterized by a dry, waxy type of swelling with abnormal deposits of mucin in the skin and other tissues. It is produced by a functional insufficiency of the thyroid gland, resulting in deficiency of thyroid hormone. The skin becomes puffy around the eyes and on the cheeks and the face is dull and expressionless with thickened nose and lips. The congenital form of the disease is CRETINISM. @ &L Mythology K01.517.647 PX Humanities; Literature A body of stories, the origins of which may be unknown or forgotten, that serve to explain practices, beliefs, institutions or natural phenomena. Mythology includes legends and folk tales. It may refer to classical mythology or to a body of modern thought and modern life. (From Webster's 1st ed). @ bMysticism K01.844.799.430 HIPX Humanities; Religion; Religious Philosophies (Non MeSH) A philosophy based upon spiritual intuition that is believed to transcend ordinary sensory experiences or understanding. @ BMyristic Acids D02.241.081.407.535; D10.516.251.640 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Myristates Myristates 14-carbon saturated monocarboxylic acids. Fatty Acids (66-74)  @*81Myristates D02.241.081.407.535.510; D10.516.251.640.610 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Myristic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Myristic Acids Salts and esters of the 14-carbon saturated monocarboxylic acid--myristic acid. Fatty Acids (66-74) @u28]Myringoplasty E04.847.774.505 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Tympanoplasty Tympanic Membrane; Tympanoplasty Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Surgical restoration of a perforated tympanic membrane by grafting. (Dorland, 27th ed.).  @d$'ejMyoviridae B04.123.150.500; B04.280.090.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales Viruses; DNA Viruses; Caudovirales Bacteriophage mu; Bacteriophage P1; Bacteriophage P2; Bacteriophage T4 Bacteriophage mu; Bacteriophage P1; Bacteriophage P2; Bacteriophage T4 A family of bacteriophages which are characterized by complex contractile tails. Bacteriophages (83-93)  @ &V_Myotonia Congenita C05.651.624.638; C05.651.661.693; C10.668.693 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Myotonia Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases A congenital genetic disease characterized by tonic spasm and rigidity of certain muscles when an attempt is made to move them after a period of rest or when mechanically stimulated. The stiffness disappears as the muscles are moved. (Dorland, 27th ed). @"5L.Myotonia Atrophica C05.651.624.471; C05.651.661.638; C10.668.638 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Myotonia Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases A rare, slowly progressive, hereditary disease transmitted as an autosomal dominant trait and characterized by myotonia followed by atrophy of the muscles, cataracts, hypogonadism, balding, and cardiac abnormalities. (From Dorland, 27th ed). @%{5NMyotonia C05.651.624 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Spasm Musculoskeletal Diseases; Muscular Diseases Myotonia Atrophica; Myotonia Congenita Increased muscular irritability and contractility with decreased power of relaxation; toxic spasm of muscle. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $@( L 3.NMyositis Ossificans C05.651.594.638 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Myositis A disease characterized by bony deposits or the ossification of muscle tissue. @)N?^Myositis C05.651.594 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Dermatomyositis; Myositis Ossificans; Polymyositis An inflammation of voluntary muscle. @+/ N3;-Myosin-Light-Chain Kinase D08.586.913.696.620.682.700.125.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Calmodulin-Dependent Protein Kinases An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and calmodulin. The 20-kD light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction. EC 2.7.1.117. Phosphotransferases, ATP (66-72); Protein Kinases (73-86) @,Z'FDMyosin Subfragments D12.776.210.500.600.500; D12.776.220.525.475.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Myosin ATPase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins; Myosin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins; Myosin Parts of the myosin molecule resulting from cleavage by proteolytic enzymes (papain, trypsin, or chymotrypsin) at well-localized regions. Study of these isolated fragments helps to delineate the functional roles of different parts of myosin. Two of the most common subfragments are myosin S-1 and myosin S-2. S-1 contains the heads of the heavy chains plus the light chains and S-2 contains part of the double-stranded, alpha-helical, heavy chain tail (myosin rod). Muscle Proteins (66-70); Myosin (66-89); Peptide Fragments (74-89)  @0.6F QMyosin ATPase D08.586.277.040.025.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Myosin Subfragments Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase An enzyme that catalyzes the hydrolysis of myosin ATP in the presence of actin to form myosin ADP and orthophosphate. This reaction is the immediate source of free energy that drives muscle contraction. In the absence of actin, myosin ATPase activity is low and requires calcium ions. EC 3.6.1.32. Adenosine Triphosphatase (66-88); Myosin (71-88)  @4lFa:Myosin D12.776.210.500.600; D12.776.220.525.475 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins Myosin Subfragments Myosin Subfragments Chief protein in muscle and the main constituent of the thick filaments of muscle fibers. In conjunction with actin, it is responsible for the contraction and relaxation of muscles. Adenosine Triphosphatase (66-68); Muscle Proteins (66-70)  @7J .H.DMyosarcoma C04.557.450.590.550; C04.557.450.795.550 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Rhabdomyosarcoma (+ 2) Rhabdomyosarcoma (+ 2) A general term for a malignant neoplasm derived from muscular tissue. (Stedman, 25th ed). @:&.X6mMyopia C11.744.636 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Refractive Errors A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus in front of the retina, as a result of the eyeball being too long from front to back. It is also called nearsightedness because the near point is less distant than it is in emmetropia with an equal amplitude of accommodation. (Dorland, 27th ed). @< N'Myometrium A02.633.570.500; A05.360.319.679.690; A10.690.467.500 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Smooth Urogenital System; Genitalia; Genitalia, Female; Uterus Tissue Types (Non MeSH); Muscles; Muscle, Smooth The smooth muscle coat of the uterus, which forms the main mass of the organ. Uterus (66-74) @>=:`Myoma C04.557.450.590.540 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue Rhabdomyoma A benign neoplasm of muscular tissue. (Stedman, 25th ed). @@ VHMyography E01.642 AECLCTECHIISMOMTNUPXSNSTTDUTVE Muscles Diagnosis Electromyography The recording of muscular movements. The apparatus is called a myograph, the record or tracing, a myogram. (From Stedman, 25th ed). AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $@BW  "  &Myoglobinuria C05.651.807.628 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Rhabdomyolysis @CNEMyoglobin D12.776.422.704; D12.776.210.500.588 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins A conjugated protein which is the oxygen-transporting pigment of muscle. It is made up of one globin polypeptide chain and one heme group. @D *FMyogenin D12.776.210.500.570.600; D12.776.260.570.600; D12.776.930.570.600 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins; Myogenic Regulatory Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Myogenic Regulatory Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Myogenic Regulatory Factors A myogenic regulatory factor that controls myogenesis. Myogenin is induced during differentiation of every skeletal muscle cell line that has been investigated, in contrast to the other myogenic regulatory factors that only appear in certain cell types. Muscle Proteins (89-93) @F ID'Myogenic Regulatory Factors D12.776.210.500.570; D12.776.260.570; D12.776.930.570 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors MyoD Protein; Myogenin MyoD Protein; Myogenin MyoD Protein; Myogenin A family of muscle-specific transcription factors which bind to DNA in control regions and thus regulate myogenesis. All members of this family contain a conserved helix-loop-helix motif which is homologous to the myc family proteins. These factors are only found in skeletal muscle. Members include the myoD protein (MYOD PROTEIN), MYOGENIN, myf-5, and myf-6 (also called MRF4 or herculin). Muscle Proteins (89-93)  @J!=D(SMyofibromatosis C04.557.450.565.590.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue A condition characterized by multiple formations of myofibromas (LEIOMYOMA). Fibroma (81-93); Leiomyoma (84-93) @NONZ+Myofibrils A02.633.565.850; A11.368.702.619; A11.640.850 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Muscle Contraction Musculoskeletal System; Muscles; Muscle Fibers Cells; Cytoplasm; Organelles Cells; Muscle Fibers Sarcomeres Sarcomeres Slender threads which can be rendered visible in a muscle fiber by maceration in certain acids. They run parallel with the long axis of the fiber, and are composed of numerous myofilaments ( = MICROFILAMENTS). (Dorland, 27th ed).  @P15*sMyofascial Pain Syndromes C05.651.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Temporomandibular Joint Syndrome Muscular pain in numerous body regions that can be reproduced by pressure on trigger points, localized hardenings in skeletal muscle tissue. Pain is referred to a location distant from the trigger points. A prime example is the TEMPOROMANDIBULAR JOINT SYNDROME. @RN3&3Myoepithelioma C04.557.435.585 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A benign tumor composed predominantly of myoepithelial cells. A pure myoepithelial neoplasm is rare. (Dorland, 27th ed). @TVnMyoelectric Complex, Migrating G07.453.697.100.570; G10.261.482.570; G11.561.450.100.570 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH); Gastrointestinal Motility Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials Bursts of depolarization that move from the stomach to the ileocecal valve at regular frequency during the interdigestive period. The complex and its accompanying motor activity periodically cleanse the bowel of interdigestive secretion and debris in preparation for the next meal. Gastrointestinal Motility (77-90) @VK$A~G'MyoD Protein D12.776.210.500.570.590; D12.776.260.570.590; D12.776.930.570.590 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins; Myogenic Regulatory Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Myogenic Regulatory Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Myogenic Regulatory Factors A myogenic regulatory factor that controls myogenesis. Though it is not clear how its function differs from the other myogenic regulatory factors, MyoD appears to be related to fusion and terminal differentiation of the muscle cell. Muscle Proteins (89-93) @YIDMyoclonus C05.651.536; C10.597.559.645; C23.888.592.574.608 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders Paramyoclonus Multiplex Shocklike contractions of a portion of a muscle, an entire muscle, or a group of muscles, restricted to one area of the body or appearing synchronously or asynchronously in several areas. (Dorland, 27th ed). @]O 9NMyocardium A02.633.580; A07.541.704; A10.690.637 CHCYENIMMEPAUL Heart Musculoskeletal System; Muscles Cardiovascular System; Heart Tissue Types (Non MeSH); Muscles The middle and thickest layer of the heart wall consisting of cardiac muscle. consider also terms at CARDIAC and HEART. @`.- oMyocarditis C14.280.600.625 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Inflammation of the muscular walls of the heart. (Stedman, 25th ed). @aNGUMyocardial Stunning C14.280.647.500.375; C14.280.647.750; C14.907.553.470.500.375; C14.907.553.470.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myocardial Contraction; Myocardial Reperfusion; Myocardial Reperfusion Injury Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Myocardial Infarction Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Myocardial Infarction Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue. (Braunwald, Heart Disease, v.2, p.1176). Myocardial Contraction (84-93); Myocardial Reperfusion (89-93); Myocardial Reperfusion Injury (89-93)  @b\NYhvMyocardial Revascularization E04.752.376.719; E04.920.490.630 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Myocardial Ischemia; Coronary Disease Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Angioplasty, Transluminal, Percutaneous Coronary; Atherectomy, Coronary; Coronary Artery Bypass (+ 1) Angioplasty, Transluminal, Percutaneous Coronary; Atherectomy, Coronary; Coronary Artery Bypass (+ 1) Coronary Disease/SU (66-71); Coronary Vessels/SU (66-71); Myocardial Infarct/SU (66-71)  @g!&$-jMyocardial Reperfusion Injury C14.280.600.615; C14.907.553.700.600; C23.814.763.530 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myocardial Stunning Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Cardiovascular Diseases; Vascular Diseases; Ischemia; Reperfusion Injury Symptoms and General Pathology (Non MeSH); Postoperative Complications; Reperfusion Injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from REPERFUSION to the ischemic areas. Changes can be fatal to muscle cells and may include edema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include hemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion. Coronary Circulation (75-88); Coronary Disease (71-88); Ischemia (71-88); Myocardial Infarction (73-88); Perfusion (71-88)  @j#=NMyocardial Reperfusion E04.752.700.600; E05.680.730.600 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Myocardial Stunning Myocardial Ischemia Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Reperfusion Miscellaneous Techniques (Non MeSH); Perfusion; Reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY. Coronary Circulation (73-88); Coronary Disease (73-88); Ischemia (69-88); Myocardial Infarction (72-88); Myocardium/metabolism (74-88); Perfusion (68-88) $@p&$Myocardial Ischemia C14.280.647; C14.907.553.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myocardial Infarction; Myocardial Reperfusion; Myocardial Revascularization Cardiovascular Diseases; Heart Diseases Cardiovascular Diseases; Vascular Diseases; Ischemia Coronary Disease (+ 9); Myocardial Infarction (+ 2); Myocardial Stunning Coronary Disease (+ 9); Myocardial Infarction (+ 2); Myocardial Stunning A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERIOSCLEROSIS), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). Coronary Disease (66-92) $@t"NVk2Myocardial Infarction C14.280.647.500; C14.907.553.470.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Heart Rupture, Post-Infarction; Shoulder-Hand Syndrome Myocardial Ischemia; Infarction Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia Myocardial Stunning; Shock, Cardiogenic Myocardial Stunning; Shock, Cardiogenic Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area. (Dorland, 27th ed). $@y.*N?&\Myocardial Diseases C14.280.600 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Cardiomyopathy, Alcoholic; Cardiomyopathy, Congestive; Cardiomyopathy, Hypertrophic (+ 2); Cardiomyopathy, Restrictive; Chagas Cardiomyopathy; Endocardial Fibroelastosis; Endomyocardial Fibrosis; Kearns Syndrome; Myocardial Reperfusion Injury; Myocarditis Diseases of the myocardium. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  @{L/"#PMyocardial Depressant Factor D12.644.370 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental hemorrhagic pancreatitis, severe ischemia, and postoligemic shock. Peptides (73-74) @~9"FDMyocardial Contraction G09.330.800 DEGEIMPHRE Cardiotonic Agents; Myocardial Stunning Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Diastole; Systole Contractile activity of the heart. Heart (66-74) $@ /j+Myiasis C03.211.503 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations Hypodermyiasis; Screw Worm Infection The invasion of living tissues of man and other mammals by dipterous larvae. @t P6,]Myenteric Plexus A08.800.050.050.500; A08.800.050.150.500; A08.800.800.060.500 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Autonomic Nervous System; Enteric Nervous System Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways One of two ganglionated neural networks which together form the ENTERIC NERVOUS SYSTEM. The myenteric (Auerbach's) plexus is located between the longitudinal and circular muscle layers of the gut. Its neurons project to the circular muscle, to other myenteric ganglia, to submucosal ganglia, or directly to the epithelium, and play an important role in regulating and patterning gut motility. (From FASEB J 1989;3:127-38). @E6.Myeloproliferative Disorders C15.378.190.636 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Leukemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases Anemia, Myelophthisic; Leukemia, Erythroblastic, Acute; Leukemoid Reaction; Myelofibrosis; Myeloid Metaplasia; Polycythemia Vera; Thrombocythemia, Hemorrhagic; Thrombocytosis Disorders in which one or more stimuli cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential.  @!N dMyeloma Proteins D12.776.124.486.485.900.500; D12.776.124.790.651.900.500; D12.776.377.715.548.900.500; D12.776.624.553 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Multiple Myeloma Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Neoplasm Proteins Multiple Myeloma (66-71); Neoplasm Proteins (66-71); Serum Globulins (66-71) @"p@\Myelolipoma C04.557.450.550.710 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Adipose Tissue A rare benign tumor of the adrenal gland, several centimeters in diameter, composed in varying proportions of adipose tissue, lymphocytes, and primitive myeloid cells, probably a developmental abnormality. (Dorland, 27th ed). Adrenal Gland Neoplasms (66-93); Lipoma (71-93); Myeloid Metaplasia (71-79) @V[Myeloid Metaplasia C15.378.190.636.636; C15.604.744.428 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Metaplasia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases The occurrence of myeloid tissue in extramedullary sites. Specifically it is a syndrome characterized by splenomegaly, anemia, the presence of nucleated erythrocytes and immature granulocytes in the circulating blood, and extramedullary hemoatopoiesis in the liver and spleen. The primary form is also known as agnogenic myeloid metaplasia, myelosclerosis, and myelofibrosis. The secondary or symptomatic form may be associated with various diseases, including carcinomatosis, tuberculosis, leukemia, and polycythemia vera. (Dorland, 27th ed). @*NoMyelography E01.236.688.503; E01.357.818.638.620 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Spinal Cord Diagnosis; Diagnosis, Neurologic (Non MeSH); Neuroradiography Diagnosis; Diagnostic Imaging; Radiography; Neuroradiography X-ray visualization of the spinal cord following injection of contrast medium into the spinal arachnoid space. @2*&Myelofibrosis C15.378.190.636.581 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders Replacement of the bone marrow by fibrous tissue, occurring in association with a myeloproliferative disorder or secondary to another, unrelated condition. (Dorland, 27th ed). @NMyelodysplastic Syndromes C15.378.190.625 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases Anemia, Refractory (+ 1); Anemia, Sideroblastic; Hemoglobinuria, Paroxysmal; Leukemia, Myeloid Conditions in which the bone marrow shows qualitative and quantitative changes suggestive of a preleukemic process, but having a chronic course that does not necessarily terminate as acute leukemia. Anemia, Aplastic (66-85); Bone Marrow Diseases (66-85); Leukemia, Myelocytic (66-85); Myeloproliferative Disorders (66-85); Preleukemia (77-85)  @NdoMyeloblastosis Virus, Avian B04.820.650.700.550; B04.909.574.807.720.550; B04.909.777.731.720.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, ALV-Related A species of ALV-related retroviruses (RETROVIRUSES, ALV-RELATED) causing anemia in fowl. @!M'hMyelitis, Transverse C10.228.228.618.553; C10.228.337.636; C10.228.854.525.553 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Myelitis Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases; Myelitis Inflammation involving the entire thickness of the spinal cord, but of limited longitudinal extent. (Stedman, 25th ed). Demyelinating Diseases (66-70); Myelitis (66-70) @ANH:Myelitis C10.228.228.618; C10.228.854.525 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Myelitis, Transverse Myelitis, Transverse @ &N0Myelinolysis, Central Pontine C10.228.140.163.647; C10.228.337.607 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases A form of massive demyelination of the pons occurring in malnutrition and alcoholism. The remarkable unsystematic dissolution of the sheaths of medullated fibers is its most certain feature. The lesion varies from only a few millimeters in diameter to almost the entire pons. The basic pathology is the destruction of the medullated sheaths throughout the lesions with relative sparing of the axis cylinders and intactness of the nerve cells of the pontine nuclei. Pathologically it is easily differentiated from infarction and the inflammatory demyelinations of multiple sclerosis and postinfectious encephalomyelitis. There does not appear to be a genetic, sex, or age factor. It is often, however, associated with some other serious disease, particularly chronic alcoholism. (Adams and Victor, Principles of Neurology, 2d ed, p.720). Demyelinating Diseases (66-93); Pons (66-93) @#*N6Myelin Sheath A08.637.600.500; A08.637.800.500; A08.663.542.512.560; A08.800.800.690.500; A10.755.503; A11.650.600.500; A11.650.800.500; A11.671.514.553 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Demyelinating Diseases; Myelin Proteins Nervous System; Neuroglia; Oligodendroglia Nervous System; Neuroglia; Schwann Cells Nervous System; Neurons; Nerve Fibers; Nerve Fibers, Myelinated Nervous System; Peripheral Nervous System; Peripheral Nerves; Schwann Cells Tissue Types (Non MeSH); Nerve Tissue Cells; Neuroglia; Oligodendroglia Cells; Neuroglia; Schwann Cells Cells; Neurons; Nerve Fibers, Myelinated  Neurilemma; Ranvier's Nodes Neurilemma; Ranvier's Nodes Neurilemma; Ranvier's Nodes Neurilemma; Ranvier's Nodes Neurilemma; Ranvier's Nodes Neurilemma; Ranvier's Nodes The lipid-rich sheath investing many axons in both the central and peripheral nervous systems. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem.  @(*/Myelin Proteins D12.776.641.580 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Myelin Sheath Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins Encephalitogenic Basic Proteins Proteins found in the myelin sheath. They consist of three major proteins: The Folch-Pi-Lees proteolipid, the Wolfgram proteolipid, and the encephalitogenic basic proteins or Al basic proteins. Myelin Sheath (66-76); Nerve Tissue Proteins (66-76) $@F_%@Mydriatics D16.050.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Mydriasis; Pupil Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Atropine; Cyclopentolate; Epinephrine; p-Hydroxyamphetamine; Oxyphenonium; Phenylephrine; Scopolamine; Tropicamide; Yohimbine Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. The latter cause cycloplegia or paralysis of accommodation at high doses and may precipitate glaucoma. Mydriatics are used in eye diseases and to facilitate eye examination. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $@&8J3DMydriasis C11.710.570 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mydriatics Eye Diseases; Pupillary Functions, Abnormal Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in Adie's syndrome. Pupil (67-89)  @ N45Mycotoxins D24.185.926.587 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Ergotism Mushroom Poisoning Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Aflatoxins (+ 2); Amanitins; Cytochalasins (+ 2); Gliotoxins; Ibotenic Acid; Muscimol; Ochratoxins; Patulin; Penicillic Acid; Phalloidine; Sporidesmins; Sterigmatocystin; Trichothecenes (+ 2); Zearalenone Carcinogens (66); Fungi (66); Toxins (66) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (@0: V6BMycotoxicosis C21.613.680 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Ergotism; Mushroom Poisoning Poisoning caused by the ingestion of mycotoxins (toxins of fungal origin). Mushroom Poisoning (85-89); Mycotoxins (67-89); Toxins (66)  @LE#ZIMycosis Fungoides C04.557.386.480.750.800.550; C15.604.515.569.480.750.800.550; C20.683.515.761.480.750.800.550 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous A chronic malignant T-cell lymphoma of the skin. In the late stages the lymph nodes and viscera are affected. @FeRMycoses C01.703 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antifungal Agents Bacterial and Fungal Diseases (Non MeSH) Aspergillosis (+ 1); Blastomycosis; Candidiasis (+ 4); Coccidioidomycosis; Cryptococcosis (+ 1); Dermatomycoses (+ 13); Eye Infections, Fungal; Fungemia; Geotrichosis; Histoplasmosis; Lung Diseases, Fungal (+ 2); Meningitis, Fungal (+ 1); Mucormycosis; Paracoccidioidomycosis; Piedra; Pneumocystis carinii Infections (+ 1); Rhinosporidiosis @  P1Mycoplasmatales Infections C01.252.400.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Mycoplasma Infections (+ 2); Ureaplasma Infections Infections with bacteria of the order MYCOPLASMATALES. Bacterial Infections (70-76)  @>Ps=A"Mycoplasmatales B03.440.560.580 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes Acholeplasmataceae (+ 2); Mycoplasmataceae (+ 7); Spiroplasmataceae (+ 1); Thermoplasma An order of highly pleomorphic, gram-negative bacteria including both pathogenic and saprophytic species. Bacteria (66-74)  @"5jzMycoplasmataceae B03.440.560.580.553 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales Mycoplasma (+ 4); Ureaplasma (+ 1) A family of gram-negative, non-motile bacteria from human and animal sources. One saprophytic species is known. Bacteria (66-74)  @"H-Mycoplasma pneumoniae B03.440.560.580.553.553.650 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Mycoplasma Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man. Mycoplasma (66-79) @%"jMycoplasma penetrans B03.440.560.580.553.553.645 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Mycoplasma A species of gram-negative, facultatively anaerobic bacteria. This organism shows remarkable pathobiologic properties: it adheres to cell surfaces, deeply penetrates into the cell, and strongly adsorbs human red blood cells and human CD4+ lymphocytes and monocytes. M. penetrans was first isolated from the urogenital tract of patients with AIDS and high frequencies of antibodies to it are seen in HIV-infected patients. Mycoplasma (92-94) @"jMycoplasma mycoides B03.440.560.580.553.553.634 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Mycoplasma The etiological agent of contagious pleuropneumonia (PLEUROPNEUMONIA, CONTAGIOUS) of cattle and goats. Mycoplasma (66-71) @"jvMycoplasma Infections C01.252.400.610.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Mycoplasmatales Infections Pleuropneumonia, Contagious; Pneumonia, Mycoplasma Infections with species of the genus MYCOPLASMA. Mycoplasma (66-67)  @qP:;Mycoplasma fermentans B03.440.560.580.553.553.315 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae; Mycoplasma A species of the genus MYCOPLASMA, originally isolated infrequently from the lower genital tract of humans, and possessing uncertain pathogenicity. The incognitus strain of M. fermentans has been identified in necrotizing lesions of multiple organs from AIDS and non-AIDS patients dying of an acute influenza-like disease. Mycoplasma (70-91) @;"juMycoplasma B03.440.560.580.553.553 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Mycoplasmataceae Mycoplasma fermentans; Mycoplasma mycoides; Mycoplasma penetrans; Mycoplasma pneumoniae A genus of gram-negative, facultatively anaerobic bacteria bounded by a plasma membrane only. Its organisms are parasites and pathogens, found on the mucous membranes of humans, animals, and birds. @̳"\eMycophenolic Acid D02.241.081.193.678; D10.516.251.618; D20.085.075.622; D22.204.106.641 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Caproates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Antibiotics, Antineoplastic (67-71); Caproates (67-71) @P<f@Mycology G01.273.540.553 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology; Microbiology Fungi (66-71); Mycoses (66-71) @8 3'Mycological Typing Techniques E05.909.560.610 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques Procedures for identifying types and strains of fungi. specific fungus/classification (78-91) @# bB-Mycolic Acids D02.241.081.407.502; D02.241.511.621; D10.516.251.572 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Fatty Acids (66-72) @>=8Mycobacterium, Atypical B03.100.067.595.552.552.250; B03.510.460.400.410.552.552.250; B03.510.595.552.552.250 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium scrofulaceum Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium scrofulaceum Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium scrofulaceum So-called atypical species of the genus MYCOBACTERIUM. They are also called tuberculoid bacilli, i.e.: M. buruli, M. CHELONAE, M. duvali, M. flavescens, M. fortuitum (minetti, giae), M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX), M. kansasii (Kansas), M. marinum, M. obuense, M. SCROFULACEUM, M. szulgai, M. terrae, M. ulcerans, M. xenopi (littorale). Mycobacterium (66-76)  @]" Mycobacterium tuberculosis B03.100.067.595.552.552.702; B03.510.460.400.410.552.552.702; B03.510.595.552.552.702 CHCLCYDEENGDGEIMIPMEPHPYREULVI Antitubercular Agents Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium A species of gram-positive, aerobic bacteria that produces tuberculosis in man, other primates, dogs, and some animals which have contact with man. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. @^]""Mycobacterium scrofulaceum B03.100.067.595.552.552.250.625; B03.510.460.400.410.552.552.250.625; B03.510.595.552.552.250.625 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical A non-tuberculous mycobacterium causing cervical lymphadenitis in children. It very rarely causes pulmonary disease, and is believed to be non-pathogenic in animals. Mycobacterium (66-88); Mycobacterium, Atypical (66-88) @i" @Mycobacterium phlei B03.100.067.595.552.552.640; B03.510.460.400.410.552.552.640; B03.510.595.552.552.640 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium A saprophytic bacterium widely distributed in soil and dust and on plants. @]"ZMycobacterium paratuberculosis B03.100.067.595.552.552.630; B03.510.460.400.410.552.552.630; B03.510.595.552.552.630 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium A species of gram-positive, aerobic bacteria non-pathogenic for humans. It is the etiologic agent of Johne's disease (see PARATUBERCULOSIS). Mycobacterium (66-91) @#]"Mycobacterium lepraemurium B03.100.067.595.552.552.602; B03.510.460.400.410.552.552.602; B03.510.595.552.552.602 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium The etiologic agent of rat leprosy, also known as murine leprosy. Mycobacterium (66-72) @]"PMycobacterium leprae B03.100.067.595.552.552.502; B03.510.460.400.410.552.552.502; B03.510.595.552.552.502 CHCLCYDEENGDGEIMIPMEPHPYREULVI Leprostatic Agents Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side. @]"Mycobacterium Infections, Atypical C01.252.410.040.552.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections Mycobacterium avium-intracellulare Infection Infections with so called atypical mycobacteria (tuberculoid bacilli): M. kansasii (Kansas), M. marinum, M. SCROFULACEUM, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. CHELONAE. Mycobacterium Infections (66-76)  @>(P2&Mycobacterium Infections C01.252.410.040.552 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections Leprosy (+ 3); Mycobacterium Infections, Atypical (+ 1); Paratuberculosis; Tuberculosis (+ 32) Infections with bacteria of the genus MYCOBACTERIUM. @Pr?Mycobacterium haemophilum B03.100.067.595.552.552.480; B03.510.460.400.410.552.552.480; B03.510.595.552.552.480 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium A species of gram-positive, aerobic bacteria that causes granulomatous or ulcerating skin lesions in immunosuppressed persons. This organism owes its name to its requirement for growth of high levels of iron, conveniently supplied as blood, heme, or ferric ammonium citrate. Mycobacterium (79-94) @]"?Mycobacterium chelonae B03.100.067.595.552.552.250.225; B03.510.460.400.410.552.552.250.225; B03.510.595.552.552.250.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical A species of gram-positive, aerobic bacteria commonly found in soil and occasionally isolated from sputum. It causes postoperative wound infections as well as gluteal abscesses. Mycobacterium, Atypical (86-91) @[i" %Mycobacterium bovis B03.100.067.595.552.552.402; B03.510.460.400.410.552.552.402; B03.510.595.552.552.402 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. @']"zMycobacterium avium-intracellulare Infection C01.252.410.040.552.475.495 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Mycobacterium Infections, Atypical Nontuberculous infection occurring in humans. This condition is frequently associated with pulmonary disease and recently recognized as an opportunistic infection in AIDS patients. Mycobacterium avium ((75)87-88); Mycobacterium Infections (66-88) @2PMMycobacterium avium Complex B03.100.067.595.552.552.250.100; B03.100.067.595.552.552.300.100; B03.510.460.400.410.552.552.250.100; B03.510.460.400.410.552.552.300.100; B03.510.595.552.552.250.100; B03.510.595.552.552.300.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium avium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium; Mycobacterium avium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium, Atypical Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium; Mycobacterium avium A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS. Distinguish from M. avium which is for animals. Mycobacterium avium ((75)-88) A!"$Mycobacterium avium B03.100.067.595.552.552.300; B03.510.460.400.410.552.552.300; B03.510.595.552.552.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae; Mycobacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae; Mycobacterium Mycobacterium avium Complex Mycobacterium avium Complex Mycobacterium avium Complex A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans. A]"_BMycobacterium B03.100.067.595.552.552; B03.510.460.400.410.552.552; B03.510.595.552.552 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Mycobacteriaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Mycobacteriaceae Bacteria; Gram-Positive Bacteria; Nocardioform Group; Mycobacteriaceae Mycobacterium, Atypical (+ 3); Mycobacterium avium (+ 1); Mycobacterium bovis; Mycobacterium haemophilum; Mycobacterium leprae; Mycobacterium lepraemurium; Mycobacterium paratuberculosis; Mycobacterium phlei; Mycobacterium tuberculosis Mycobacterium, Atypical (+ 3); Mycobacterium avium (+ 1); Mycobacterium bovis; Mycobacterium haemophilum; Mycobacterium leprae; Mycobacterium lepraemurium; Mycobacterium paratuberculosis; Mycobacterium phlei; Mycobacterium tuberculosis Mycobacterium, Atypical (+ 3); Mycobacterium avium (+ 1); Mycobacterium bovis; Mycobacterium haemophilum; Mycobacterium leprae; Mycobacterium lepraemurium; Mycobacterium paratuberculosis; Mycobacterium phlei; Mycobacterium tuberculosis A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. A ,Q"&Mycobacteriophages B04.123.502 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses whose host is one or more Mycobacterium species. They include both temperate and virulent types. AI}Mycobacteriaceae B03.100.067.595.552; B03.510.460.400.410.552; B03.510.595.552 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH) Bacteria; Gram-Positive Bacteria; Nocardioform Group Mycobacterium (+ 13) Mycobacterium (+ 13) Mycobacterium (+ 13) A family of gram-positive bacteria found in soil and dairy products and as parasites on animals and man. Several are important pathogens. Bacteria (66-74)  AIE"GJMycobacillin D20.085.062.580; D20.085.116.550; D20.136.073.580 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal A cyclic polypeptide antibiotic isolated from culture filtrates of Bacillus subtilis that acts as an antifungal agent. Antibiotics, Antifungal (71-74); Peptides, Cyclic (73-74) A99<DMyasthenia Gravis C05.651.661.580; C10.668.580; C20.111.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases Immunologic Diseases; Autoimmune Diseases A disorder of neuromuscular function due to the presence of antibodies to acetylcholine receptors at the neuromuscular junction. Clinically there is fatigue and exhaustion of the muscular system with a tendency to fluctuate in severity and without sensory disturbance or atrophy. The disorder may be restricted to a muscle group or become generalized with severe weakness and, in some cases, ventilatory insufficiency. (Dorland, 27th ed). A1NMyanmar Z01.252.145.570 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern A >Muzolimine D03.383.694.550; D19.770.224.680 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics 3-Amino-1-(3,4-dichloro-alpha-methylbenzyl)- 2-pyrazolin-5-one. Pyrazole diuretic with long duration and high capacity of action; proposed for kidney failure and hypertension. Pyrazoles (66-79) Ap&:Mutism C10.597.257.870.638; C23.888.592.257.870.638; F03.126.219.870.638 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders An inhibition, voluntary or involuntary, of speech. A IF>Mutation G05.632 DEGEIMPHRE Antimutagenic Agents; Mutagenesis; Mutagens; Suppression, Genetic Genetics DNA Damage; Frameshift Mutation; Gene Deletion (+ 1); Germ-Line Mutation; Mutagenesis (+ 1); Point Mutation; Suppression, Genetic Any detectable and heritable change in the genetic material not caused by genetic segregation or recombination, which is transmitted to daughter cells and to succeeding generations, providing it is not a dominant lethal factor. DEECGEHIIMISMTPHRESNSTUT $A!.  M  Mutagens D05.569.468 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU DNA Adducts; Mutagenesis Mutagenesis; Mutation Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Benzo(a)pyrene; Ethyl Methanesulfonate; 4-Hydroxyaminoquinoline-1-oxide; Methyl Methanesulfonate; 4-Nitroquinoline-1-oxide; Sodium Nitrite Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (A# ,N:Mutagenicity Tests E05.393.560; E05.940.560 AECLCTECHIISMOMTNUPXSNSTTDUTVE Carcinogenicity Tests Carcinogenicity Tests Miscellaneous Techniques (Non MeSH); Genetic Techniques Miscellaneous Techniques (Non MeSH); Toxicity Tests Micronucleus Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Mutagens (66-80); Mutation (66-80) (A&I"~+Mutagenesis, Site-Directed E05.393.420.601.575 DEGEIMPHRE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Genetic Engineering; Protein Engineering Mutagenesis where the mutation is caused by in vitro induction directed at a specific site in a DNA molecule. The most common method involves use of a chemically synthesized oligonucleotide mutant which can hybridize with the DNA target molecule. The resulting mismatch-carrying DNA duplex may then be transfected into a bacterial cell line and the mutant strands recovered. Mutation (72-90) A(rrMutagenesis, Insertional E05.393.420.601.550; G05.331.370.380.700; G05.632.625.550 DEECGEHIIMISMTPHRESNSTUT DNA Insertion Elements; Proviruses Miscellaneous Techniques (Non MeSH); Genetic Techniques; Genetic Engineering; Protein Engineering Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Genetics; Mutation; Mutagenesis Mutagenesis where the mutation is caused by the introduction of foreign DNA sequences into a gene. This may occur spontaneously in vivo or be experimentally induced in vivo or in vitro. Proviral DNA can be inserted into or adjacent to a cellular proto-oncogene. Insertion of the provirus can cause mutations by interrupting coding sequences or regulatory elements, or cause unregulated expression of the proto-oncogene resulting in tumor formation. DNA Insertion Elements (83-90); Mutation (82-90)  A+A* ;Mutagenesis G05.632.625 DEGEIMPHRE Antimutagenic Agents; Mutagens Mutation; Mutagens Genetics; Mutation Mutagenesis, Insertional Process of generating genetic mutations. It may occur spontaneously or be induced by mutagens. Mutation (66-90) DEECGEHIIMISMTPHRESNSTUT ,A/%qMustard Gas D02.455.526.728.468; D26.253.605 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds Miscellaneous Drugs and Agents (Non MeSH); Chemical Warfare Agents 1,1'-Thiobis(2-chloroethane). Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP-85-002, 1985) (Merck, 11th ed). A0&.Mustard Compounds D02.455.526.728 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated Mustard Gas; Nitrogen Mustard Compounds (+ 15) Strong alkylating and immunosuppressive agents whose biological activity is based on the presence of bis(2-chloroethyl)- groups. Although otherwise structurally diverse, the compounds have in common the capacity to contribute alkyl groups to DNA. They are generally highly toxic but include among their number many widely used and effective antineoplastic agents. AAADAEAGAIANBLCFCHCLCSCTDEDUECHIIMIPMEPDPKPORESDSTTOTUUR  A38R9<Mustard B06.510.092.625; B06.560.610; J01.341.241.579 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Brassica Plants; Plants, Medicinal Technology, Industry, Agriculture (Non MeSH); Food; Condiments Any of several Brassica species of the Crucifer family. Brassica alba is white mustard, B. nigra is black, brown, or red mustard. The plant is grown both for mustard seed from which oil is extracted and for foliage or animal feed. It was formerly used as an emetic, counter-irritant, and carminative. A6~ 54fMussels B01.644.444 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Mollusca Marine bivalve mollusks especially of the genus Mytilus or freshwater bivalve mollusks, especially the genera Unio and Anodonta. The edible mussel is Mytilus edulis. Mollusca (66-71)  A9  ( Music Therapy E02.040.580; E02.831.440; F04.754.549 CLECEDHIISLJMAMTOGSNSTTD Therapeutics; Alternative Medicine Therapeutics; Rehabilitation Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy The use of music as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders. A:y-Music K01.602 HIPX Humanities A<   Mushroom Poisoning C21.613.415.551; C21.613.680.551 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mycotoxins Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Food Poisoning Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Mycotoxicosis Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties. Food Poisoning (66-67); Mushrooms (66-67)  Ac %Musculoskeletal, Neural, Eye Physiology (Non MeSH) G11 Musculoskeletal System Physiology (Non MeSH) (+ 42); Nervous System Physiology (Non MeSH) (+ 83); Ocular Physiology (Non MeSH) (+ 35) AEBLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI A>;VMusculoskeletal System Physiology (Non MeSH) G11.427 Musculoskeletal, Neural, Eye Physiology (Non MeSH) Biomechanics (+ 4); Bone Density; Bone Development (+ 3); Bone Remodeling (+ 5); Equilibrium; Exertion (+ 4); Hand Strength; Immobilization; Movement (+ 7); Muscle Contraction (+ 3); Muscle Fatigue; Muscle Tonus; Posture (+ 3) AEBLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI A@"4 ;VMusculoskeletal System A02 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cartilage (+ 10); Fascia (+ 1); Ligaments (+ 11); Muscles (+ 35); Skeleton (+ 112) ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI AB.8l>Musculoskeletal Diseases C05 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bone Diseases (+ 137); Cartilage Diseases (+ 2); Fasciitis; Foot Deformities (+ 6); Hand Deformities (+ 2); Jaw Diseases (+ 31); Joint Diseases (+ 48); Muscular Diseases (+ 63); Musculoskeletal Abnormalities (Non MeSH) (+ 36); Rheumatic Diseases (+ 20); Tennis Elbow Diseases of the muscles and their associated ligaments and other connective tissue and of the bones and cartilage viewed collectively. Bone Diseases (67-91); Muscular Diseases (67-91); Musculoskeletal System (66) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  ACUNI]ZMusculoskeletal Abnormalities (Non MeSH) C05.660; C16.131.621 Musculoskeletal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Arthrogryposis; Cleidocranial Dysplasia; Craniofacial Dysostosis (+ 4); Funnel Chest; Hip Dislocation, Congenital; Jaw Abnormalities (+ 5); Klippel-Feil Syndrome; Limb Deformities, Congenital (Non MeSH) (+ 10); Microcephaly; Noonan Syndrome; Platybasia; Synostosis (+ 5) Arthrogryposis; Cleidocranial Dysplasia; Craniofacial Dysostosis (+ 4); Funnel Chest; Hip Dislocation, Congenital; Jaw Abnormalities (+ 5); Klippel-Feil Syndrome; Limb Deformities, Congenital (Non MeSH) (+ 10); Microcephaly; Noonan Syndrome; Platybasia; Synostosis (+ 5) BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI AF/d|LMusculocutaneous Nerve A08.800.800.720.050.540 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Brachial Plexus A major nerve of the upper extremity. The fibers of the musculocutaneous nerve originate in the lower cervical spinal cord (usually C5 to C7), travel via the lateral cord of the brachial plexus, and supply sensory and motor innervation to the upper arm, elbow, and forearm. AJ(8nEMuscular Dystrophy, Animal C22.595 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases White Muscle Disease Muscular Dystrophy (66-69) ALl  J Muscular Dystrophy C05.651.661.523; C10.668.523 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Mice, Inbred mdx Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases A group of genetic degenerative myopathies characterized by weakness and muscle atrophy without nervous system involvement. The three main types are pseudohypertrophic (Duchenne, Becker), limb-girdle, and facioscapulohumeral. AMV"LMuscular Diseases C05.651 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Arthrogryposis; Compartment Syndromes (+ 1); Contracture (+ 2); Craniomandibular Disorders (+ 2); Eosinophilia-Myalgia Syndrome; Fatigue Syndrome, Chronic; Fibromyalgia; Mitochondrial Myopathies (+ 5); Muscle Cramp; Muscle Hypotonia; Muscle Rigidity (+ 1); Muscle Spasticity; Muscular Atrophy (+ 4); Myoclonus (+ 1); Myofascial Pain Syndromes (+ 1); Myositis (+ 3); Myotonia (+ 2); Neuromuscular Diseases (+ 17); Polymyalgia Rheumatica; Rhabdomyolysis (+ 1); Tendinitis; Tenosynovitis; Torticollis BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI AO NTPMuscular Atrophy, Spinal C05.651.518.620; C05.651.661.468.620; C10.228.854.468; C10.668.468.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Muscular Atrophy Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases; Muscular Atrophy Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Nervous System Diseases; Neuromuscular Diseases; Muscular Atrophy Charcot-Marie Disease; Werdnig-Hoffmann Disease Charcot-Marie Disease; Werdnig-Hoffmann Disease Werdnig-Hoffmann Disease Charcot-Marie Disease; Werdnig-Hoffmann Disease Progressive degenerative disorder of motor neurons in the spinal cord, brain stem, and motor cortex, manifested clinically by muscular weakness, atrophy, and corticospinal tract signs in varying combinations. Muscular Atrophy (66-87); Spinal Cord Diseases (66-87)  ARPNOBMuscular Atrophy C05.651.518; C05.651.661.468; C10.668.468 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases Muscular Atrophy, Spinal (+ 2); Postpoliomyelitis Syndrome Muscular Atrophy, Spinal (+ 2); Postpoliomyelitis Syndrome Muscular Atrophy, Spinal (+ 2); Postpoliomyelitis Syndrome Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation. AW1NMuscles A02.633; A10.690 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Myography; Sarcolemma; Sarcoplasmic Reticulum Musculoskeletal System Tissue Types (Non MeSH) Muscle Fibers (+ 4); Muscle, Skeletal (+ 20); Muscle, Smooth (+ 3); Myocardium; Tendons (+ 3) Muscle, Skeletal (+ 1); Muscle, Smooth (+ 3); Myocardium consider also terms at MYO-. ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $AZ: :67%>Muscle, Smooth, Vascular A02.633.570.491; A07.231.491; A10.690.467.491 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Vasomotor System Musculoskeletal System; Muscles; Muscle, Smooth Cardiovascular System; Blood Vessels Tissue Types (Non MeSH); Muscles; Muscle, Smooth Tunica Media Tunica Media Tunica Media The nonstriated, involuntary muscle tissue of blood vessels. Muscle, Smooth (66-79) $A\Q5:/HMuscle, Smooth A02.633.570; A10.690.467 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles Tissue Types (Non MeSH); Muscles Muscle, Smooth, Vascular (+ 1); Myometrium Muscle, Smooth, Vascular (+ 1); Myometrium Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed). A^S:NhMuscle, Skeletal A02.633.567; A10.690.350 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles Tissue Types (Non MeSH); Muscles Abdominal Muscles (+ 1); Facial Muscles; Laryngeal Muscles; Masticatory Muscles (+ 3); Neck Muscles; Oculomotor Muscles; Palatal Muscles; Pectoralis Muscles; Pharyngeal Muscles; Psoas Muscles; Respiratory Muscles (+ 2); Sarcoplasmic Reticulum; Stapedius; Tensor Tympani Sarcoplasmic Reticulum Striated muscles having fibers connected at either or both extremities with the bony framework of the body. These are found in appendicular and axial muscles. (From Stedman, 25th ed). Muscles (66-94) ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $AaA:NZ>Muscle Tonus G11.427.706 DEGEIMPHRE Dystonia; Muscle Hypertonia; Muscle Hypotonia Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Muscle Contraction (66-69) Ad7p Muscle Spindles A08.800.550.700.500.500 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Reflex, Stretch Motor Neurons, Gamma Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors Mechanoreceptors found between skeletal muscle fibers. Muscle spindles are arranged in parallel with muscle fibers and respond to the passive stretch of the muscle, but cease to discharge if the muscle contracts isotonically, thus signaling muscle length. The muscle spindles are the receptors responsible for the stretch or myotactic reflex (REFLEX, STRETCH).  Ae8oMuscle Spasticity C05.651.512; C10.597.588.652; C23.888.592.588.652 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Spasm Musculoskeletal Diseases; Muscular Diseases Nervous System Diseases; Neurologic Manifestations; Muscle Hypertonia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Muscle Hypertonia A combination of the symptoms of increased resistance to lengthening, hyperactive tendon reflexes, and clonus. Muscle spasticity occurs in hemiplegia. Spasm (66-76)  Ah9N  Muscle Rigidity C05.651.504; C10.597.588.638; C23.888.592.588.638 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases Nervous System Diseases; Neurologic Manifestations; Muscle Hypertonia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Muscle Hypertonia Stiff-Man Syndrome Stiff-Man Syndrome Stiff-Man Syndrome Continuous tonic contraction of skeletal muscle. Muscular Diseases (66-71)  Ak?9N A:Muscle Relaxation G11.427.661.554 DEGEIMPHRE Muscle Contraction Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Muscle Contraction That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Contraction (66-76)  Ame Muscle Relaxants, Central D15.525; D16.700.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents Baclofen; Carisoprodol; Chlormezanone; Chlorphenesin; Chlorzoxazone; Diazepam; Estazolam; Medazepam; Mephenesin; Meprobamate; Methocarbamol; Orphenadrine; Procyclidine; Tolperisone; Zoxazolamine Baclofen; Carisoprodol; Chlormezanone; Chlorphenesin; Chlorzoxazone; Dantrolene; Diazepam; Estazolam; Medazepam; Mephenesin; Meprobamate; Methocarbamol; Orphenadrine; Phenytoin; Procyclidine; Quinine; Tolperisone; Zoxazolamine A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. (From Smith and Reynard, Texbook of Pharmacology, 1991, p.358). Muscles (66-69) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $Ao28p@Muscle Proteins D12.776.210.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins Actinin; Actins; Actomyosin; Calsequestrin; Dystrophin; Myogenic Regulatory Factors (+ 2); Myoglobin; Myosin (+ 1); Parvalbumins; Tropomyosin; Troponin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Au>F]HMuscle Hypotonia C05.651.484; C10.597.559.596; C23.888.592.574.558 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Muscle Tonus Musculoskeletal Diseases; Muscular Diseases Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders A diminution of the skeletal muscle tone with a diminished resistance to passive stretching. Muscular Diseases (66-76)  Aw.9NnMuscle Hypertonia C10.597.588; C23.888.592.588 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Muscle Tonus Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Muscle Rigidity (+ 1); Muscle Spasticity Muscle Rigidity (+ 1); Muscle Spasticity Abnormal increase in muscle tone. Muscle Spasticity (77-78); Muscle Tonus (70-78); Spasm (66-76) $Ay"Nd*MMuscle Fibers, Slow-Twitch A02.633.565.700; A11.640.700 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle Fibers Cells; Muscle Fibers Skeletal muscle fibers having low myofibrillar ATPase activity, low glycogen content, and high myoglobin content, high mitochondrial oxidative enzyme activities, and an intermediate mitochondrial content which produce a slow twitch and are fatigue-resistant. (From Best, Physiological Basis of Medical Practice, 12th ed, p. 101). A{ ":Q{Muscle Fibers, Fast-Twitch A02.633.565.600; A11.640.400 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle Fibers Cells; Muscle Fibers Skeletal muscle fibers having high myofibrillar ATPase activity, high glycolytic enzyme activities, and an intermediate glycogen content which produce a fast twitch. There are two types. Fast fatigable fibers, also called white fibers, have a low myoglobin content, and a small mitochondrial content, and fatigue rapidly due to their limited glycogen content and low capacity for oxidative metabolism. Fast fatigue-resistant fibers, also called red fibers, have a large mitochondrial content and a high myoglobin content, related to their resistance to fatigue. (From Best, Physiological Basis of Medical Practice, 12th ed, p. 100). A~^ ":QMuscle Fibers A02.633.565; A11.640 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Musculoskeletal System; Muscles Cells Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Myofibrils (+ 1) Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Myofibrils Any of the cells of skeletal or cardiac muscle tissue. Skeletal muscle fibers are cylindrical multinucleate cells containing contracting MYOFIBRILS, across which run transverse striations, enclosed in a SARCOLEMMA. Cardiac muscle fibers contain one or sometimes two nuclei and myofibrils and are separated from one another by an intercalated disk; although striated, cardiac fibers branch to form an interlacing network. (Dorland, 27th ed). Muscles (66-94) ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $A+*->Muscle Fatigue G11.427.670 DEGEIMPHRE Muscle Contraction Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) A state arrived at through prolonged and strong contraction of a muscle. Studies in athletes during prolonged submaximal exercise have shown that muscle fatigue increases in almost direct proportion to the rate of muscle glycogen depletion. Muscle fatigue in short-term maximal exercise is associated with oxygen lack and an increased level of blood and muscle lactic acid, and an accompanying increase in hydrogen-ion concentration in the exercised muscle. specific muscle (66-94); Fatigue (66-94); Muscles (66-94)  ApGMuscle Denervation E04.530.324.443 AEISMTVE Surgery, Operative; Neurosurgery; Denervation A  6Muscle Cramp C05.651.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Spasm Musculoskeletal Diseases; Muscular Diseases AN 3Muscle Contraction G11.427.661 DEGEIMPHRE Muscle Fatigue; Muscle Relaxation Myofibrils Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Isometric Contraction; Isotonic Contraction; Muscle Relaxation A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. $Ae)pIMuscimol D03.383.548.470; D14.100.240.200.500; D24.185.926.587.586 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, GABA-A Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Agonists Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins 5-(Aminomethyl)-3-isoxazolol. Neurotoxic isoxazole isolated from Amanita muscaria and A. phalloides and also obtained by decarboxylation of IBOTENIC ACID. It is a potent agonist at GABA-A receptors and is used mainly as an experimental tool in animal and tissue studies. Mycotoxins (67-78); Oxazoles (66-78); Toxins (66)  A A:B=>Muscidae B01.131.617.289.642 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera Houseflies A family of the order Diptera with over 700 species. The genera are Musca domesticus (HOUSEFLIES), Musca autumnalis (face fly), Stomoxys (stable fly), Haematobia (horn fly), Glossina spp. (TSETSE FLIES), and Fannia. Both sexes of the stable fly, horn fly and tsetse fly bite. Diptera (66-87); Houseflies (66-87)  A* (5K,Muscarinic Antagonists D14.100.120.200.500 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Parasympatholytics Parasympatholytics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists Atropine; Benactyzine; Benztropine; Biperiden; Butylscopolammonium Bromide; Cyclopentolate; Dexetimide; Dicyclomine; Emepronium; Glycopyrrolate; Ipratropium; Orphenadrine; Oxyphenonium; Pirenzepine; Procyclidine; Propantheline; Propylbenzilylcholine Mustard; Quinuclidinyl Benzilate; Scopolamine; Trihexyphenidyl; Tropicamide Drugs that bind to but do not activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC), thereby blocking the actions of endogenous acetycholine or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. Antagonists that discriminate among the various muscarinic receptor subtypes and might allow better control of peripheral and central actions are under development. Parasympatholytics (66-94) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ,AZ4t@Muscarinic Agonists D14.100.120.140.500 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Miotics; Parasympathomimetics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists Acetylcholine; Arecoline; Bethanechol; Carbachol; McN A 343; Methacholine Chloride; Muscarine; Oxotremorine; Pilocarpine Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $AW4#RDMuscarine D02.092.102.580; D02.675.276.580; D03.132.545; D14.100.120.140.500.540; D16.050.675.550 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Heterocyclic Compounds; Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics 2-Methyl-3-hydroxy-5-(aminomethyl)tetrahydrofuran, trimethylammonium salt. A toxic alkaloid found in Amanita muscaria (fly fungus) and other fungi of the Inocybe species. It is the first parasympathomimetic substance ever studied and causes profound parasympathetic activation that may end in convulsions and death. The specific antidote is atropine. Alkaloids (68-76); Ammonium Compounds (70-76); Furans (72-76); Mycotoxins (75-76); Parasympathomimetics (66-76) A c@Muromonab-CD3 D12.776.124.486.485.567.570; D12.776.124.790.651.504.570; D12.776.377.715.548.546.570; D22.569.825; D24.611.125.200.570; D24.611.125.600.681.393.570 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPKPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; IgG Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; IgG Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; IgG Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Monoclonal Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes; IgG Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti). This biochemically purified IgG immunoglobulin is obtained through the fusion of mouse myeloma cells to lymphocytes from immunized animals to produce hybridomas that secrete specific antibodies to the T3 (CD3) antigens of human T-lymphocytes. It is often used as an immunosuppressive agent in transplantation. Antibodies, Monoclonal (81-91) A8 $Muromegalovirus B04.280.382.150.500; B04.909.204.382.150.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Betaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Betaherpesvirinae A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, causing infection involving several organs in mice and other animals. Murid (beta) Herpesvirus 1 is the type species. Possible other species affected include the pig, horse, rat, and guinea pig. Cytomegalovirus (66-93) A20Murine Acquired Immunodeficiency Syndrome C02.782.815.650; C02.928.650; C22.795.650 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections Virus Diseases; Tumor Virus Infections Animal Diseases; Rodent Diseases Acquired defect of cellular immunity that occurs in mice infected with mouse leukemia viruses (MuLV). The syndrome shows striking similarities with human AIDS and is characterized by lymphadenopathy, profound immunosuppression, enhanced susceptibility to opportunistic infections, and B-cell lymphomas. Retrovirus Infections (87-90) AX01JZ#Muridae B02.649.865.635 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia Gerbillinae; Hamsters (+ 3); Hesperomyinae (+ 1); Mice (+ 25); Microtinae; Rats (+ 17) A family of the order Rodentia containing 250 genera including the two genera Mus and Rattus, from which the laboratory inbred strains are developed. The fifteen subfamilies are HESPEROMYINAE (New World mice and rats), Cricetinae, Spalacinae, Myospalacinae, Lophiomyinae, Platacanthomyinae, Nesomyinae, Otomyinae, Rhizomyinae, MICROTINAE (Arvicolinae), GERBILLINAE, Dendromurinae, Cricetomyinae, Murinae (Old World mice and rats), and Hydromyinae. Mice (66-81); Rats (66-81); Rodentia (66-81)  AQ (&o9Murexide D03.383.742.698.253.500; D26.550.488 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 5,5'-Nitrilodibarbituric acid ammonium derivative. Used as an indicator for complexometric titrations. Barbiturates (69-74) A *.vMuramidase D08.586.277.450.642; D20.664 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases Anti-Infective Agents A basic enzyme which is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. An"FMuramic Acids D02.241.081.844.520; D02.241.511.902.522; D09.203.067.550; D09.203.811.522 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids  Acetylmuramyl-Alanyl-Isoglutamine Acetylmuramyl-Alanyl-Isoglutamine Amino Sugars (66-70); Disaccharides (71-72); Glucosamine (66-72); Hexoseamines (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  AT8vJhBMupirocin D20.085.516 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics (2S-(2 alpha(E),3 beta,4 beta,5 alpha(2R*,3R*(1R*,2R*))))-9-((3-Methyl-1-oxo-4-(tetrahydro-3,4-dihydroxy-5-((3-(2-hydroxy-1-methylpropyl)oxiranyl)methyl)-2H-pyran-2-yl)-2-butenyl)oxy)nonanoic acid. A topically used antibiotic from a strain of Pseudomonas fluorescens. It has shown excellent activity against gram-positive staphylococci and streptococci. The antibiotic is used primarily for the treatment of primary and secondary skin disorders, nasal infections, and wound healing. Antibiotics (66-91); Fatty Acids (66-91) AB <)&2Muntjacs B02.649.077.380.373.322 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants; Deer A genus, Muntiacus, of the deer family (Cervidae) comprising six species living in China, Tibet, Nepal, India, the Malay Peninsula, and neighboring island countries. They are usually found in forests and areas of dense vegetation, usually not far from water. They emit a deep barklike sound which gives them the name "barking deer." If they sense a predator they will "bark" for an hour or more. They are hunted for their meat and skins; they thrive in captivity and are found in many zoos. The Indian muntjac is believed to have the lowest chromosome number in mammals and cell lines derived from them figure widely in chromosome and DNA studies. (From Walker's Mammals of the World, 5th ed.). Deer (70-94) AB (?7Municipal Government I01.409.550 Social Sciences; Government Urban governmental functions. A?"$Munchausen Syndrome by Proxy F03.126.842.089.734.350.250.525; F03.709.438.500.620.570; I01.198.240.856.350.250.525; I01.880.735.900.350.250.525; I01.880.787.293.292.525 BLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence; Domestic Violence; Child Abuse Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Factitious Disorders; Munchausen Syndrome Social Sciences; Criminology; Crime; Violence; Domestic Violence; Child Abuse Social Sciences; Sociology; Social Problems; Violence; Domestic Violence; Child Abuse Social Sciences; Sociology; Social Welfare; Child Welfare; Child Abuse A phenomenon in which symptoms of a disease are fabricated by an individual other than the patient causing unnecessary, and often painful, physical examinations and treatments. This syndrome is considered a form of CHILD ABUSE, since another individual, usually a parent, is the source of the fabrication of symptoms and presents the child for medical care. Munchausen Syndrome (77-91) A#H]!Munchausen Syndrome F03.709.438.500.620 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Factitious Disorders Munchausen Syndrome by Proxy A factitious disorder characterized by habitual presentation for hospital treatment of an apparent acute illness, the patient giving a plausible and dramatic history, all of which is false. BLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI  AFy#HMumps Virus B04.820.455.600.650.700.625; B04.909.777.455.600.650.700.625 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Paramyxovirus A species of PARAMYXOVIRUS that causes an acute infectious disease in humans, affecting mainly children. Transmission occurs by droplet infection. AvBMumps Vaccine D24.310.894.899.488 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines Mumps Virus (66-68); Viral Vaccines (66-68) Aȡ>l6Mumps C02.782.580.600.600.500; C07.465.815.470.800.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections; Paramyxovirus Infections Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases; Parotid Diseases; Parotitis An acute infectious disease caused by PARAMYXOVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (Dorland, 27th ed). A 6P@Mummies I01.076.368.584.500 HIPARARIUS Embalming; Paleontology Social Sciences; Anthropology; Anthropology, Physical; Paleontology Bodies preserved either by the ancient Egyptian technique or due to chance under favorable climatic conditions. A OMultivariate Analysis E05.318.740.150.500; G03.850.520.830.150.500; H01.548.832.128.500; N05.715.360.750.125.500 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Analysis of Variance Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Analysis of Variance Physical Sciences (Non MeSH); Mathematics; Statistics; Analysis of Variance Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Analysis of Variance A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables. Analysis of Variance (68-89); Statistics (66-89) Ad;Multiple-Personality Disorder F03.709.438.416.520 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Dissociative Disorders A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden. A"F{,Multiple Trauma C21.866.640 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Physical insults or injuries occurring simultaneously in several parts of the body. Wounds and Injuries (66-87) A3NQc"Multiple Sclerosis C10.228.337.578; C20.111.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Immunologic Diseases; Autoimmune Diseases Aա"NMultiple Organ Failure C23.625 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) A progressive condition usually characterized by combined failure of the lungs, liver, kidney, and clotting mechanisms, usually postinjury or postoperative. A N2Multiple Myeloma C04.557.386.720.550; C15.378.147.780.650; C20.683.515.761.720.550; C20.683.780.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myeloma Proteins Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Plasmacytoma Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Plasmacytoma Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias A malignant tumor of plasma cells usually arising in the bone marrow; characterized by diffuse involvement of the skeletal system, hyperglobulinemia, Bence-Jones proteinuria, and anemia. AR\NMultiple Endocrine Neoplasia Type 2b C04.588.322.400.510; C04.651.600.510; C04.700.630.510; C16.466.700.630.510; C19.344.400.510 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Medullary; Pheochromocytoma Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia Neoplasms; Neoplasms, Multiple Primary; Multiple Endocrine Neoplasia Neoplasms; Neoplastic Syndromes, Hereditary; Multiple Endocrine Neoplasia Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary; Multiple Endocrine Neoplasia Endocrine Diseases; Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterized by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from MEN 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas. Multiple Endocrine Neoplasia (75-94)  Aۼ,gX-+Multiple Endocrine Neoplasia Type 2a C04.588.322.400.505; C04.651.600.505; C04.700.630.505; C16.466.700.630.505; C19.344.400.505 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Medullary; Pheochromocytoma Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia Neoplasms; Neoplasms, Multiple Primary; Multiple Endocrine Neoplasia Neoplasms; Neoplastic Syndromes, Hereditary; Multiple Endocrine Neoplasia Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary; Multiple Endocrine Neoplasia Endocrine Diseases; Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia A type of multiple endocrine neoplasia characterized by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands. (From Holland, et al., Cancer Medicine, 3d ed, pp1172-75). Multiple Endocrine Neoplasia (66-94)  AE,gX-L+Multiple Endocrine Neoplasia Type 1 C04.588.322.400.500; C04.651.600.500; C04.700.630.500; C16.466.700.630.500; C19.344.400.500 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Zollinger-Ellison Syndrome; Hyperparathyroidism; Gastrinoma Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia Neoplasms; Neoplasms, Multiple Primary; Multiple Endocrine Neoplasia Neoplasms; Neoplastic Syndromes, Hereditary; Multiple Endocrine Neoplasia Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary; Multiple Endocrine Neoplasia Endocrine Diseases; Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia A rare syndrome characterized by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to Zollinger-Ellison Syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generallly dependent on the genetic expression in individual patients. (From Holland, et al., Cancer Medicine, 3d ed, pp1169-72). Multiple Endocrine Neoplasia (72-94)  A+gXD(+Multiple Endocrine Neoplasia C04.588.322.400; C04.651.600; C04.700.630; C16.466.700.630; C19.344.400 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Apudoma Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Neoplasms; Neoplasms, Multiple Primary Neoplasms; Neoplastic Syndromes, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary Endocrine Diseases; Endocrine Gland Neoplasms Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b A group of autosomal dominant, often overlapping diseases characterized by hyperplasia or neoplasia of more than one endocrine gland, many of which are made up of APUD cells. (From Segen, Dictionary of Modern Medicine, 1992).  A"SX V Multiple Chemical Sensitivity C20.543.620 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Occupational Exposure; Hypersensitivity; Environmental Exposure Immunologic Diseases; Hypersensitivity An acquired disorder characterized by recurrent symptoms, referable to multiple organ systems, occurring in response to demonstrable exposure to many chemically unrelated compounds at doses far below those established in the general population to cause harmful effects. No single widely accepted test of physiologic function can be shown to correlate with symptoms. (Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med 1987;2(4):655-61). Environmental Exposure (87-94); Hypersensitivity (87-94); Occupational Diseases (87-94)  A#LI- fMultiple Carboxylase Deficiency C18.452.648.066.620; C18.452.648.202.720 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Abnormalities in carbohydrate and branched-chain amino acid catabolism that are responsive to biotin therapy. It may be due to deficiency of propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, biotinidase, or propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and pyruvate carboxylase. specific enzyme/deficiency (75-86); specific enzyme (66-74) A:%.L1SGMultiple Birth Named Groups (Non MeSH) M01.438 Named Groups (Non MeSH) Quadruplets; Quintuplets; Triplets; Twins (+ 2) CLEDGEHILJPXSN A/ ;Multiphasic Screening E01.563.633; E05.318.308.250.580.560; G03.850.520.308.250.580.560; G03.850.780.500.560; N02.421.143.827.233.443.633; N02.421.726.233.443.633; N05.715.360.300.375.500.540 AECLCTECHIISLJMOMTNUOGPXSTTDUTVE Diagnosis; Mass Screening Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Diagnostic Services; Mass Screening Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Diagnostic Services; Mass Screening Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Mass Screening The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people. Diagnosis (66-67); Mass Screening (66-67); Physical Examination (66-67) A$VMultienzyme Complexes D08.586.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Anthranilate Phosphoribosyltransferase; Anthranilate Synthase; Aspartate Carbamoyltransferase; Aspartokinase Homoserine Dehydrogenase; Cholesterol Desmolase; Fatty Acid Synthetase Complex; Ketoglutarate Dehydrogenase Complex; Lactose Synthase; Phosphoenolpyruvate Sugar Phosphotransferase System; Prostaglandin-Endoperoxide Synthase; Pyruvate Dehydrogenase Complex; Sucrase-Isomaltase Complex; Tryptophan Synthase; Ubiquinol-Cytochrome-c Reductase Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates; may involve simply a transfer of water molecules of hydrogen atoms or be associated with large supramolecular structures such as mitochondria or ribosomes. specific enzymes or enzyme groups (66-73)  BaFEC2Multicenter Studies E05.318.760.535.500; E05.337.250.500; G03.850.520.835.535.500; N05.715.360.775.235.545 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Clinical Trials, Phase III; Clinical Trials, Phase IV Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Clinical Trials Miscellaneous Techniques (Non MeSH); Evaluation Studies; Clinical Trials Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Clinical Trials Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Clinical Trials Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. B`$A* Multi-Institutional Systems N04.452.540 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Hospital Shared Services Institutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures. Hospital Administration (66-79); Hospital Shared Services (68-79) CLECHILJMAMTOGSDSNSTTDUT $B  WMMullerian Ducts A16.254.570 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo Two ducts of the embryo which empty into the cloaca, and which in the female develop into vagina, uterus and oviducts; in the male they disappear except for the vestigial vagina masculina and the appendix testis. B :1Mud Therapy E02.780.108.610 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Balneology B"3Mucus A12.838.503 CHCYDEENIMMEMIPHPSRARERISEUSVI Drainage, Postural Fluids and Secretions (Non MeSH); Secretions (Non MeSH) Cervix Mucus BS "DMucous Membrane A10.615.550 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Membranes Gastric Mucosa; Intestinal Mucosa; Laryngeal Mucosa; Mouth Mucosa; Nasal Mucosa (+ 2) B :,hMucormycosis C01.703.663 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Infection in humans and animals caused by any fungus in the orders Mucorales (e.g., Absidia, Mucor, Rhizopus) or Entomophtorales (e.g., Basidiobolus, Conidiobolus, Entomophthora). There are many clinical types associated with infection of the central nervous system, lung, gastrointestinal tract, skin, orbit and paranasal sinuses. Predisposing factors include diabetes mellitus, leukemia, lymphoma and chemo- and radiotherapy. B4P=Mucorales B05.354.730.944.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Zygomycotina Mucor; Phycomyces; Rhizopus An order of zygomycetous fungi, usually saprophytic, causing damage to food in storage, but which may cause respiratory infection or MUCORMYCOSIS in persons suffering from other debilitating diseases. Phycomycetes (66-74)  B "L#Mucor B05.354.730.944.550.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Zygomycotina; Mucorales A genus of zygomycetous fungi of the order Mucorales, primarily saprophytic, but may cause MUCORMYCOSIS in man from spores germinating in the lungs. B "YMucoproteins D12.776.395.560 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Cell Wall Skeleton; Haptoglobins; Intrinsic Factor; Mucins (+ 1); Orosomucoid; Ovomucin; Peptidoglycan; Phytohemagglutinins Conjugated proteins in which mucopolysaccharides are combined with proteins. The mucopolysaccharide moiety is the predominant group with the protein making up only a small percentage of the total weight. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  B>FUHMucopolysaccharidosis VII C17.300.550.575.675; C18.452.648.202.715.675; C18.452.648.595.715.675 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucopolysaccharidoses Mucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and Hurler-like features. It is caused by a deficiency of beta-glucuronidase. Mucopolysaccharidoses (74-91) BML"Mucopolysaccharidosis VI C17.300.550.575.670; C18.452.648.202.715.670; C18.452.648.595.715.670 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucopolysaccharidoses Mucopolysaccharidosis with excessive chondroitin sulfate B in urine, characterized by dwarfism and deafness. It is caused by a deficiency of N-acetylgalactosamine-4-sulfatase (arylsulfatase B). Carbohydrate Metabolism, Inborn Errors (66-74); Chondroitin (66-74); Mucopolysaccharides/metabolism (66-74); Mucopolysaccharidosis (74) BMLMucopolysaccharidosis IV C17.300.550.575.655; C18.452.648.202.715.655; C18.452.648.595.715.655 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucopolysaccharidoses Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme. B!ML<Mucopolysaccharidosis III C17.300.550.575.650; C18.452.648.202.715.650; C18.452.648.595.715.650 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucopolysaccharidoses Mucopolysaccharidosis characterized by heparitin sulfate in the urine, progressive mental retardation, mild dwarfism, and other skeletal disorders. There are four clinically indistinguishable but biochemically distinct forms, each due to a deficiency of a different enzyme. Carbohydrate Metabolism, Inborn Errors (66-76); Mental Retardation (66-76); Mucopolysaccharides/metabolism (66-74); Mucopolysaccharidosis (74) B%ML9Mucopolysaccharidosis II C17.300.550.575.645; C18.452.648.202.715.645; C18.452.648.595.715.645 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucopolysaccharidoses Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15. Mucopolysaccharidosis I (66-91) B**ML%Mucopolysaccharidosis I C17.300.200.470; C17.300.550.575.640; C18.452.648.202.715.640; C18.452.648.595.715.640 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Iduronidase Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Mucopolysaccharidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucopolysaccharidoses Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase and characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler's syndrome, Hurler-Scheie syndrome and Scheie's syndrome (formerly mucopolysaccharidosis V). Symptoms may include dwarfism, hepatosplenomegaly, gargoyle-like facies, corneal clouding, cardiac complications, and noisy breathing. B.`LAbMucopolysaccharidoses C17.300.550.575; C18.452.648.202.715; C18.452.648.595.715 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Mucopolysaccharidosis VII Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Mucopolysaccharidosis VII Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis III; Mucopolysaccharidosis IV; Mucopolysaccharidosis VI; Mucopolysaccharidosis VII Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency. B4tAL >Mucolipidosis C10.496.600; C18.452.648.595.635; C18.452.648.625; F03.709.346.625 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Fucosidosis Fucosidosis Fucosidosis A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. Mental retardation and skeletal changes are common. Lipid Metabolism, Inborn Errors (66-76); Lipochondrodystrophy (66-76); Lipoidosis (66-76); Mucopolysaccharidosis (74-76)  B:LL*tMucoepidermoid Tumor C04.557.470.590.580 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) A malignant epithelial tumor of glandular tissue, especially the salivary glands, characterized by acini with mucus-producing cells and by the presence of malignant squamous elements. Most mucoepidermoid tumors are low-grade lesions readily cured by adequate excision. They may appear in any age group. They grow slowly. If high-grade, they behave aggressively, widely infiltrating the salivary gland and producing lymph node and distant metastases. (Dorland, 27th ed; from DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 575). Carcinoma (67-93); Myoepithelioma (66-74) B>X2Mucocutaneous Lymph Node Syndrome C14.907.940.560; C15.604.560; C17.800.862.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Vasculitis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. BB(5NfMucociliary Clearance E01.302.615; G09.772.521.700.500 DEGEIMPHRE Biological Transport Diagnosis; Diagnosis, Respiratory System (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Rate of ciliary and secretory activity of the respiratory submucosal glands. It is a non-specific host defense mechanism, measurable in vivo by mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. Biological Transport (75-87); Cilia (66-87); Mucus (66-87); specific respiratory organ/tissue (66-87)  BE&zMucocele C04.182.511 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Ranula Neoplasms; Cysts Dilatation of a cavity with accumulated mucous secretion. (Dorland, 27th ed). BH X ^Mucins D12.776.395.560.631 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins Gastric Mucin A secretion containing mucopolysaccharides and protein that is the chief constituent of mucus. BI FeoMucinosis, Follicular C17.300.550.550; C17.800.805.305.122.550; C17.800.805.711.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Mucinoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases; Alopecia Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sebaceous Gland Diseases (Non MeSH) A disease of the pilosebaceous unit, presenting clinically as grouped follicular papules or plaques with associated hair loss. It is caused by mucinous infiltration of tissues, and usually involving the scalp, face, and neck. It may be primary (idiopathic) or secondary to mycosis fungoides or reticulosis. BK%EN{fMucinoses C17.300.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Mucinosis, Follicular; Mucopolysaccharidoses (+ 6); Myxedema; Scleredema Adultorum; Synovial Cyst Mucoid states characterized by the elevated deposition and accumulation of mucin (mucopolysaccharides) in dermal tissue. The fibroblasts are responsible for the production of acid mucopolysaccharides (GLYCOSAMINOGLYCANS) in the ground substance of the connective tissue system. When fibroblasts produce abnormally large quantities of mucopolysaccharides as hyaluronic acid, chondroitin sulfate, or heparin, they accumulate in large amounts in the dermis. Mucins (66-92); Skin Diseases (66-92) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI $BN NYs/VMSH-Releasing Hormone D06.472.709.500; D12.644.365; D12.776.641.650.470; D14.600.600.490 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A polypeptide hormone which originates in the hypothalamus and stimulates secretion of melanocyte-stimulating hormones in the pituitary gland. MSH/antagonists and inhibitors (68-74); Pituitary Hormone Releasing Hormones (68-74) BRLFcMSH Release-Inhibiting Hormone D06.347.560.500; D12.644.363; D12.776.641.650.465; D14.600.600.485 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Pituitary Hormone Release Inhibiting Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides An oligopeptide hormone produced in the hypothalamus that inhibits the release of melanocyte-stimulating hormone (MSH). Hypothalamo-Hypophyseal System (66-74); Hypothalamus (66-74); Pituitary Hormone Releasing Hormone (71-74); MSH (66-74); Oligopeptides (73-74); Peptides (71-73) BV"$LFMSH D06.472.734.525.690.583; D12.644.360; D12.776.641.650.460; D14.600.600.480 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pro-Opiomelanocortin Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides alpha-MSH alpha-MSH alpha-MSH alpha-MSH Peptide hormones secreted by the intermediate lobe of the pituitary that stimulate melanin release and dispersal. Melanocyte-stimulating hormones are also found in the brain where they are presumed to play a signaling role. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  BYTD.FMozambique Z01.058.290.175.545 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern B]`Moyamoya Disease C10.228.140.300.123.620; C14.907.137.615; C14.907.253.123.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Carotid Artery Diseases Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Carotid Artery Diseases Bilateral internal carotid artery occlusion with extensive intracranial collateral circulation. Carotid Artery Diseases (66-77); Cerebral Artery Diseases (66-77); Cerebrovascular Disorders (66-77) B^wENMmvMoxisylyte D02.092.668.387.500; D14.100.050.200.100.520; D16.050.495.540; D16.050.850.500; D18.918.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Methylamines; Dimethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Vasodilator Agents (2-(4-Acetoxy-2-isopropyl-5-methylphenoxy)ethyl)dimethylamine. An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacolpoeia, 30th ed, p.1312). Carvacrol (66-71); Sympatholytics (66-71) Bavg:i2Moxibustion E02.040.555; E02.684 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine Therapeutics Be"7Moxalactam D20.085.099.603 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam 7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3- (((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-oxa-1- azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. Broad- spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain cephalosporins. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. Antibiotics (66-80); Cefamandole/AA (78-83); Cephalosporins (66-74); Cephamycins (75-77); Lactams (72-80) Bfp:AMovement Disorders C10.597.559; C23.888.592.574 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Psychomotor Disorders Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Angelman Syndrome; Ataxia; Athetosis; Chorea; Dystonia; Hypokinesia; Muscle Hypotonia; Myoclonus; Tic; Torticollis; Tremor Angelman Syndrome; Ataxia; Athetosis; Chorea; Dystonia; Hypokinesia; Muscle Hypotonia; Myoclonus; Tic; Torticollis; Tremor BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  Bi"L&NMovement G11.427.614 DEPHRE Immobilization; Motion Motion Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Flight, Animal; Gait; Locomotion; Motor Activity; Pronation; Range of Motion, Articular; Supination DEGEIMPHRE $Bl   pxMouthwashes D25.583; D26.313.548; J01.516.599 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Dentifrices Dentifrices Biomedical and Dental Materials (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Cosmetics Technology, Industry, Agriculture (Non MeSH); Household Products Saliva, Artificial  Bn,),Mouth, Edentulous C07.465.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Denture, Complete; Surgery, Oral, Preprosthetic Stomatognathic Diseases; Mouth Diseases Jaw, Edentulous (+ 1) Having teeth in neither the mandible nor the maxilla.  BoN8/BMouth Rehabilitation E06.584 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Tooth Diseases; Mouth Diseases; Oral Health Dentistry Bq $6 Mouth Protectors E06.761.599; E07.712.549 AECLCTECHISDSNSTTDUTVE Dentistry; Preventive Dentistry Equipment and Supplies; Protective Devices BqWMouth Physiology (Non MeSH) G10.549 Digestive, Oral, Skin Physiology (Non MeSH) Dental Caries Susceptibility; Dental Enamel Solubility; Dental Occlusion; Dentin Solubility; Mastication; Salivation; Tooth Calcification; Tooth Eruption; Tooth Exfoliation; Tooth Migration (+ 1); Tooth Mobility; Tooth Permeability (+ 2); Tooth Resorption (+ 1) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI Br" 46TMouth Neoplasms C04.588.443.591; C07.465.565 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms Stomatognathic Diseases; Mouth Diseases Gingival Neoplasms; Leukoplakia, Oral (+ 1); Lip Neoplasms; Palatal Neoplasms; Salivary Gland Neoplasms (+ 3); Tongue Neoplasms Gingival Neoplasms; Leukoplakia, Oral (+ 1); Lip Neoplasms; Palatal Neoplasms; Salivary Gland Neoplasms (+ 3); Tongue Neoplasms Bt"X}2Mouth Mucosa A10.615.550.599; A14.549.512 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Membranes; Mucous Membrane Stomatognathic System; Mouth Bv":aMouth Floor A14.549.441 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Stomatognathic System; Mouth Bw8#Mouth Diseases C07.465 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diagnosis, Oral; Halitosis; Mouth Rehabilitation; Oral Health Oral Health Stomatognathic Diseases Behcet's Syndrome; Burning Mouth Syndrome; Candidiasis, Oral; Dry Socket; Facial Pain; Focal Epithelial Hyperplasia; Leukoedema, Oral; Lichen Planus, Oral; Lip Diseases (+ 4); Ludwig's Angina; Melkersson-Rosenthal Syndrome; Mouth Abnormalities (+ 7); Mouth, Edentulous (+ 2); Mouth Neoplasms (+ 10); Noma; Oral Fistula (Non MeSH) (+ 3); Oral Hemorrhage (+ 1); Oral Manifestations; Oral Submucous Fibrosis; Periapical Diseases (+ 4); Periodontal Diseases (+ 26); Ranula; Salivary Gland Diseases (+ 19); Stomatitis (+ 4); Tongue Diseases (+ 7); Tuberculosis, Oral BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $Bxu NJ\Mouth Breathing C08.618.659; C23.888.852.749 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiration Respiratory Tract Diseases; Respiration Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Abnormal breathing through the mouth, usually associated with obstructive disorders of the nasal passages. Respiration (66-67)  B|"N|Mouth Abnormalities C07.465.525; C07.650.525; C16.131.850.525 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH) Cleft Lip; Cleft Palate; Fibromatosis Gingivae; Macroglossia; Macrostomia; Microstomia; Velopharyngeal Insufficiency Cleft Lip; Cleft Palate; Fibromatosis Gingivae; Macroglossia; Macrostomia; Microstomia; Velopharyngeal Insufficiency Cleft Lip; Cleft Palate; Fibromatosis Gingivae; Macroglossia; Macrostomia; Microstomia; Velopharyngeal Insufficiency Congenital absence of or defects in structures of the mouth. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  B~1LJNMouth A01.456.505.631; A14.549 AHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Oral Manifestations; Surgery, Oral Body Regions (Non MeSH); Head; Face Stomatognathic System Lip Lip (+ 1); Mouth Floor; Mouth Mucosa; Palate (+ 3); Salivary Glands (+ 4); Tongue (+ 2) consider also terms at ORAL, ORO-, and STOMAT-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $B 6*Gx;:Mountaineering I03.450.642.845.582 CLECEDHIINLJPHPXSNSTTD Altitude Altitude Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A sport involving mountain climbing techniques.  Bp  R9Mottled Enamel C07.793.540 BLCFCLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases BJ/Motorcycles J01.937.605 CLECHILJSDSNST Off-Road Motor Vehicles Technology, Industry, Agriculture (Non MeSH); Transportation Two-wheeled, engine-driven vehicles. Transportation (76-86)  B;G+Motor Skills F02.808.260 CLDEPHRE Child Development Psychologic Processes and Principles (Non MeSH); Psychomotor Performance Performance of complex motor acts. B@ U+Motor Neurons, Gamma A08.663.694.560.500.525; A11.671.677.560.500.525 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Muscle Spindles Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Efferent; Motor Neurons Cells; Neurons; Neuron Types (Non MeSH); Neurons, Efferent; Motor Neurons Motor neurons which activate the contractile regions of intrafusal muscle fibers, thus adjusting the sensitivity of the muscle spindles to stretch. Gamma motor neurons may be "static" or "dynamic" according to which aspect of responsiveness (or which fiber types) they regulate. The alpha and gamma motor neurons are often activated together (alpha gamma coactivation) which allows the spindles to contribute to the control of movement trajectories despite changes in muscle length. B)6*/Motor Neurons A08.663.694.560.500; A11.671.677.560.500 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Neuromuscular Junction Spinal Cord Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Efferent Cells; Neurons; Neuron Types (Non MeSH); Neurons, Efferent Anterior Horn Cells; Motor Neurons, Gamma Anterior Horn Cells; Motor Neurons, Gamma Neurons which activate muscle cells. $B.*d-Motor Neuron Disease C05.651.661.460; C10.668.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases Selective degeneration of the motor neurons primarily involving the anterior horn cells of the spinal cord, motor nuclei of the medulla, and corticospinal tracts. The main clinical forms are AMYOTROPHIC LATERAL SCLEROSIS, progressive muscular atrophy (MUSCULAR ATROPHY, SPINAL), progressive bulbar palsy (PARALYSIS, BULBAR), and PRIMARY LATERAL SCLEROSIS. Motor Neurons (66-91); Neuromuscular Diseases (72-91) B"N@Motor Endplate A08.800.550.550.550.500; A08.850.550.550.500; A11.195.443.780.550.550.500 ABAHBSCHCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Neuroeffector Junction; Neuromuscular Junction Nervous System; Synapses; Neuroeffector Junction; Neuromuscular Junction Cells; Cell Membrane; Intercellular Junctions; Synapses; Neuroeffector Junction; Neuromuscular Junction The specialized postsynaptic region of a muscle cell. The motor endplate is immediately across the synaptic cleft from the presynaptic axon terminal. Among its anatomical specializations are junctional folds which harbor a high density of cholinergic receptors. BQ8D0Motor Cortex A08.186.211.730.885.213.270.548 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex; Frontal Lobe Area of the frontal lobe concerned with primary motor control. It lies anterior to the central sulcus. Cerebral Cortex (66-70) B#8|Motor Activity F01.145.632; G11.427.614.698 DEGEIMPHRE Hyperkinesis Behavior and Behavior Mechanisms (Non MeSH); Behavior Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement Hyperkinesis The physical activity of an organism as a behavioral phenomenon. Behavior (66-67); Behavior, Animal (66-67) BLCFCICLCODEDHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRISUTHURUSVI (B"N4LMotivation F01.658 Cognitive Dissonance; Libido Drive Behavior and Behavior Mechanisms (Non MeSH) Achievement; Aspirations (Psychology); Conflict (Psychology); Drive (+ 2); Exploratory Behavior; Food Deprivation; Goals; Handling (Psychology); Instinct; Power (Psychology); Water Deprivation Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli. CLDEPHRE $B # 4 Motion Therapy, Continuous Passive E02.780.351.500; E02.831.578.391.660 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Exercise Therapy Therapeutics; Rehabilitation; Physical Therapy; Exercise Therapy Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization. Exercise Therapy (72-89); Manipulation, Orthopedic (66-77); Movement (66-89); Physical Therapy (66-89) B/)*"zMotion Sickness C09.218.568.900.498; C21.866.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases; Vestibular Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Space Motion Sickness Space Motion Sickness Sickness caused by motion, as sea sickness, train sickness, car sickness, and air sickness. B&N4mMotion Pictures L01.178.147.598 CLECHIISLJSDSNSTTDUT Cineangiography; Cineradiography Photography Information Science; Communications Media (Non MeSH); Audio-Visual Aids B&UMotion Perception F02.463.593.932.567; G11.697.911.860.811 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception The real or apparent movement of objects through the visual field. B. QMotion H01.671.538 Movement Movement Physical Sciences (Non MeSH); Physics Acceleration (+ 1); Coriolis Force; Rotation Physical motion, i.e., a change in position of a body or subject as a result of an external force. It is distinguished from MOVEMENT, a process resulting from biological activity. Acceleration (66-67); Kinetics (66-67); Movement (66-67) AE (B   /8EMotilin D06.472.317.525; D12.644.355; D12.776.641.650.450; D14.600.600.460; D19.316.629.601 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones A 22-amino acid polypeptide (molecular weight 2700) isolated from the duodenum. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect. Gastrointestinal Hormones (72-76); Peptides (72-76) Bl _F=Moths B01.131.617.561.650 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lepidoptera Manduca; Silkworms; Spodoptera Insects of the suborder Heterocera of the order LEPIDOPTERA. B3 (9&IMothers F01.829.263.500.320.200; I01.880.225.500.340.270; M01.620.630 CLEDHILJPXSN Maternal Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family; Parents Social Sciences; Sociology; Family; Nuclear Family; Parents Named Groups (Non MeSH); Parents Female parents, human or animal. Female (66-77); Maternal Behavior (68-77); Mother-Child Relations (68-77)  BJ E)XMother-Child Relations F01.829.263.370.290.170 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH); Parent-Child Relations Interaction between the mother and the child. Parent-Child Relations (66-67) BO8$Mosquito Control G03.850.780.200.650.425.500 ECHIISLJMTOGSNSTTD Chemosterilants; Insecticide Resistance; Pest Control, Biological Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Pest Control; Insect Control The reduction or regulation of the population of mosquitoes through chemical, biological, or other means. BL|Moscow Z01.433.653; Z01.542.248.775.510; Z01.586.200.775.510; Z01.586.950.775.510 EHEP Geographicals (Non MeSH); Cities (Non MeSH) Geographicals (Non MeSH); Europe; Europe, Eastern; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Russia B TPMosaicism G05.148.630 DIGEIMPAPP Freemartinism; Mice, Transgenic; Radiation Chimera Genetics; Cytogenetics Chimera (+ 1); Freemartinism; Radiation Chimera The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single zygote. BLCFCICLCNCODEDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERIRTSUTHTMURUSVI $Bd <;PMosaic Viruses B04.715.464; B04.820.464 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses Alfalfa Mosaic Virus; Bromovirus; Caulimovirus; Comovirus; Cucumovirus; Potyvirus (+ 1); Tobamovirus (+ 1); Tymovirus Alfalfa Mosaic Virus; Bromovirus; Comovirus; Cucumovirus; Potyvirus (+ 1); Tobamovirus (+ 1); Tymovirus Viruses which produce a mottled appearance of the leaves of plants. Plant Viruses (66-72)  B=6 RMorula A16.254.270.550 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo; Cleavage Stage, Ovum The early embryo at the developmental stage in which the blastomeres, resulting from repeated mitotic divisions of the fertilized ovum, form a compact mass. Bf *KMortuary Practice G02.438 CLECEDHIISLJMAMTOGSNSTTD Death Health Occupations Burial; Embalming Activities associated with the physical burial of the dead. It excludes cultural practices such as funeral rites.  B  Mortality E05.318.308.985.550; G03.850.505.400.975.550; G03.850.520.308.985.550; L01.280.975.550; N01.224.935.698 TD Fatal Outcome Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics Information Science; Data Collection; Vital Statistics Population Characteristics (Non MeSH); Demography; Vital Statistics Cause of Death; Fatal Outcome; Hospital Mortality; Infant Mortality; Maternal Mortality; Survival Rate Cause of Death; Fatal Outcome; Hospital Mortality; Infant Mortality; Maternal Mortality; Survival Rate Cause of Death; Fatal Outcome; Hospital Mortality; Infant Mortality; Maternal Mortality; Survival Rate Cause of Death; Fatal Outcome; Hospital Mortality; Infant Mortality; Maternal Mortality; Survival Rate Cause of Death; Fatal Outcome; Fetal Death; Hospital Mortality; Infant Mortality; Maternal Mortality; Survival Rate All deaths reported in a given population. BLCFCICLCODIECEHEMENEPETGEHIIMMEMIPAPCPPPSRARISUTDTHURUSVEVI $B so5@Morpholines D03.383.533.640 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines Dextromoramide; Moricizine; Phenmetrazine; Viloxazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR B8T?:Morphogenesis G07.553.686 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Growth (66-67) BZMorphine Derivatives D03.132.610.422.547.547; D03.549.686.575.547; D03.605.497.575.547 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine Codeine (+ 2); Diacetylmorphine; Dihydromorphine; Dihydromorphinone; Ethylmorphine; Oxymorphone; Thebaine Codeine (+ 2); Diacetylmorphine; Dihydromorphine; Dihydromorphinone (+ 1); Ethylmorphine; Thebaine Codeine (+ 2); Diacetylmorphine; Dihydromorphine; Dihydromorphinone (+ 1); Ethylmorphine; Thebaine Analogs or derivatives of morphine. Morphine (66-74); Morphinans (69-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $BI8d,-:Morphine Dependence F03.709.597.780.660.400.560 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Dependence; Narcotic Dependence Strong dependence, both physiological and emotional, upon morphine. BDOMorphine D03.132.610.422.547; D03.549.686.575; D03.605.497.575; D15.040.150.490; D15.210.600.530 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, Opioid Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Morphine Derivatives (+ 9) Morphine Derivatives (+ 9) Morphine Derivatives (+ 9) The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $B= c8a:Morphinans D03.132.610.422; D03.549.686; D03.605.497 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH) Benzomorphans (+ 2); Buprenorphine; Butorphanol; Dextrorphan; Diprenorphine; Etorphine; Levallorphan; Levorphanol (+ 1); Morphine (+ 10); Nalbuphine; Nalorphine; Naloxone (+ 1) Buprenorphine; Butorphanol; Dextrorphan; Diprenorphine; Etorphine; Levallorphan; Levorphanol (+ 1); Morphine (+ 10); Nalbuphine; Nalorphine; Naloxone (+ 1) Buprenorphine; Butorphanol; Dextrorphan; Diprenorphine; Etorphine; Levallorphan; Levorphanol (+ 1); Morphine (+ 10); Nalbuphine; Nalorphine; Naloxone (+ 1) Codeine (66-68); Diacetylmorphine (66-68); Dihydromorphinone (66-68); Morphine (66-68); Opium (66-68); Thebaine (66-68) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  B18G:Morocco Z01.058.266.629 EHEP Geographicals (Non MeSH); Africa; Africa, Northern B˞ >Moricizine D03.383.533.640.475; D03.494.741.533; D18.097.555 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines; Morpholines Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Cardiovascular Agents; Anti-Arrhythmia Agents (10-(3-(4-Morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)carbamic acid ethyl ester. An effective, well-tolerated antiarrhythmia agent. The drug is used primarily for ventricular rhythm disturbances, but has been shown to be effective also for automatic atrial ectopic tachycardia and for ventricular arrhythmias associated with mitral valve prolapse syndrome. Anti-Arrhythmia Agents (66-90); Morpholines (66-90); Phenothiazines (66-90) B!9:YMorbillivirus Infections C02.782.580.600.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections Distemper; Measles (+ 1); Rinderpest Infections with viruses of the genus MORBILLIVIRUS, family PARAMYXOVIRIDAE. Infections mainly cause acute disease in their hosts, although in some cases infection is persistent and leads to degenerative conditions. BϬPy/Morbillivirus B04.820.455.600.650.500; B04.909.777.455.600.650.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae Distemper Virus, Canine; Distemper Virus, Phocine; Measles Virus (+ 1); Peste-des-Petits-Ruminants Virus; Rinderpest Virus Distemper Virus, Canine; Distemper Virus, Phocine; Measles Virus (+ 1); Peste-des-Petits-Ruminants Virus; Rinderpest Virus A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the virions have hemagglutinin but not neuraminidase activity. All members produce both cytoplasmic and intranuclear inclusion bodies. MEASLES VIRUS is the type species. specific Morbillivirus (79-93); Paramyxoviridae (83-93)  B:AMorbidity E05.318.308.985.525; G03.850.505.400.975.525; G03.850.520.308.985.525; L01.280.975.525; N01.224.935.597 TD Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics Information Science; Data Collection; Vital Statistics Population Characteristics (Non MeSH); Demography; Vital Statistics Incidence; Prevalence Incidence; Prevalence Incidence; Prevalence Incidence; Prevalence Incidence; Prevalence The proportion of patients with a particular disease during a given year per given unit of population. B s{Moraxella (Moraxella) bovis B03.440.400.425.550.500.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae; Moraxella A species of gram-negative, aerobic bacteria that is most frequently isolated from bovine eyes in cases of infectious keratoconjunctivitis (KERATOCONJUNCTIVITIS, INFECTIOUS), but also occurs in unaffected eyes and the nasal cavity of cattle. Moraxella (66-91) Bي!"Moraxella (Branhamella) catarrhalis B03.440.400.425.550.500.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae; Moraxella Gram-negative aerobic cocci that are frequently isolated from the nasal cavity of man. They rarely cause disease but may play a role as an extranasal invader in the respiratory tract. Moraxella (83-87); Neisseria (75-87); Neisseriaceae (75-87) B)"HMoraxella B03.440.400.425.550.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae Moraxella (Branhamella) catarrhalis; Moraxella (Moraxella) bovis A genus of gram-negative, aerobic bacteria occurring as rods (subgenus Moraxella) or cocci (subgenus Branhamella). Its organisms are parasitic on the mucous membranes of man and other warm-blooded animals. B9 "JMorantel D03.383.742.440; D03.383.903.440; D21.201.287.505 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents (E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(3-methyl-2-thienyl)vinyl]pyrimidine tartrate (1:1). Antinematodal agent used mainly for livestock. Pyrimidines (72-74); Thiophenes (72-74) Bz 9:0Morals F01.829.500; K01.316.630; K01.752.256.547 Conflict of Interest Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Humanities; Ethics Humanities; Philosophy; Ethics Conscience; Social Responsibility Conscience; Social Responsibility Conscience; Social Responsibility Standards of conduct as right or wrong. B 1t2Morale F01.829.477 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social The prevailing temper or spirit of an individual or group in relation to the tasks or functions which are expected. B LMopidamol D03.383.742.430; D22.204.565 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 2,2',2'',2'''-((4-(1-Piperidinyl)pyrimido(5,4-d)pyrimidine- 2,6-diyl)dinitrilo)tetrakisethanol. Proposed antineoplastic agent that may have antiplatelet properties. Ethanolamines (73-74); Piperidines (71-74); Pyrimidines (71-74) B ":LMoon H01.091.800.700.200.500 Extraterrestrial Environment Physical Sciences (Non MeSH); Astronomy; Solar System; Planets; Earth (Planet) The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil. Astronomy (66-90); Extraterrestrial Environment (66-90); Meteorological Factors (77-90); Periodicity (66-90); Space Flight (66-90) B!`Monteggia's Fracture C21.866.405.908.547 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Ulna Fractures Fracture in the proximal half of the shaft of the ulna, with dislocation of the head of the radius. BNqzMonte Carlo Method E05.318.740.525; G03.850.520.830.525; H01.548.832.522; L01.906.575.422; N05.715.360.750.540 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Information Science; Systems Analysis; Operations Research Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics BlgMontana Z01.107.567.875.100.552; Z01.107.567.875.600.656.552 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Northwestern United States B :Monsters C16.131.581 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Anencephaly (+ 1); Twins, Conjoined A fetus or infant with such pronounced developmental anomalies as to be grotesque and usually nonviable. (Dorland, 27th ed). B\ LI-Monotremata B02.649.627 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Echidna; Platypus Mammals (66-72) B(Monosomy G05.148.266.131.500 DIGEIMPAPP Genetics; Cytogenetics; Chromosome Aberrations; Aneuploidy The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1. Aneuploidy (68-84); Chromosome Aberrations (68-84); Chromosome Abnormalities (66-84); Chromosome Deletion (75-84) B EMonosaccharides D09.203.546 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Heptoses (+ 1); Hexoses (+ 8); Ketoses (+ 5); Pentoses (+ 4); Tetroses; Trioses (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Bb>KqDMonosaccharide Transport Proteins D12.776.157.590 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Membrane transport proteins which bind glucose and sodium ions and enter the cell together. The sodium ions are then pumped out of the cell by a sodium potassium ATPase. The rate and extent of the sugar transport depends on the sodium ion concentration. Inhibitors of the monosaccharide transport system are phlorizin, cytochalasin B, and inhibitors of the sodium potassium ATPase system. Insulin increases the rate of monosaccharide transport across the membrane into the cell. Carrier Proteins (73-85); Galactose (66-85); Glucose (66-85); Monosaccharides (66-85) B'FY0gMonophenol Monooxygenase D08.586.682.420.125.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Albinism Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Catechol Oxidase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Diphenol Oxidases (68-76); Tyrosine Decarboxylase (66-67)  BF }>DMononegavirales Infections C02.782.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Filoviridae Infections (+ 2); Paramyxoviridae Infections (+ 11); Rhabdoviridae Infections (+ 2) Infections with viruses of the order MONONEGAVIRALES. The concept includes FILOVIRIDAE INFECTIONS, PARAMYXOVIRIDAE INFECTIONS, and RHABDOVIRIDAE INFECTIONS. B4P:rMononegavirales B04.820.455; B04.909.777.455 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Filoviridae (+ 3); Paramyxoviridae (+ 21); Rhabdoviridae (+ 5) Filoviridae (+ 3); Paramyxoviridae (+ 21); Rhabdoviridae (+ 5) An order comprising three families of eukaryotic viruses possessing linear, non-segmented, negative-strand RNA genomes. The families are FILOVIRIDAE, PARAMYXOVIRIDAE, and RHABDOVIRIDAE. B7"YMonomethylhydrazine D02.442.600.601 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines; Methylhydrazines Hydrazine substituted by one methyl group. Bw:F4Monokines D24.611.350.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines Interleukin-1; Tumor Necrosis Factor Soluble mediators of the immune response that are neither antibodies nor complement. They are produced largely, but not exclusively, by monocytes and macrophages. Biological Factors (88-89); Biological Products (87-88); Proteins (81-87) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $Cx Fh,XHMonocytes, Activated Killer A11.118.637.555.652.500; A11.733.547.500; A15.145.229.637.555.652.500; A15.382.490.555.652.500; A15.382.680.547.500; A15.382.812.547.500 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Immunotherapy, Adoptive Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Monocytes Cells; Phagocytes; Monocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Monocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Monocytes Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Monocytes Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Monocytes Monocytes made cytotoxic by ex vivo incubation with cytokines, especially interferon-gamma. AKM cells are used for adoptive immunotherapy in cancer patients. Monocytes (88-90)  C!*"Monocytes A11.118.637.555.652; A11.733.547; A15.145.229.637.555.652; A15.382.490.555.652; A15.382.680.547; A15.382.812.547 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear Cells; Phagocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System Monocytes, Activated Killer Monocytes, Activated Killer Monocytes, Activated Killer Monocytes, Activated Killer Monocytes, Activated Killer Monocytes, Activated Killer Large, phagocytic mononuclear leukocytes produced in the vertebrate bone marrow and released into the blood; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. C ~*Monocrotophos D02.705.471; D05.723.491.574.519 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate Insecticides (66-71) C &:Monocrotaline D03.132.716.500; D26.191.795.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Pyrrolizidine Alkaloids Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Pyrrolizidine Alkaloids (13 alpha,14 alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione. A pyrrolizidine alkaloid and a toxic plant constituent that poisons livestock and humans through the ingestion of contaminated grains and other foods. The alkaloid causes pulmonary artery hypertension, right ventricular hypertrophy, and pathological changes in the pulmonary vasculature. Significant attenuation of the cardiopulmonary changes are noted after oral magnesium treatment. Pyrrolizidine Alkaloids (71-73) C &< %Monoclonal Gammopathies, Benign C15.378.147.542.640; C20.683.460.640; C20.683.780.640 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Hypergammaglobulinemia Immunologic Diseases; Immunoproliferative Disorders; Hypergammaglobulinemia Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias Conditions characterized by the presence of a monoclonal serum (or urine) protein without clinical manifestations of plasma cell dyscrasia. Blood Protein Disorders (66-68); Hypergammaglobulinemia (69-85) CR%=N!JMonobactams D20.085.099.598 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam Aztreonam Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized. Addition of therapeutically proven penicillin and cephalosporin side chains to the monobactam nucleus will yield other beta-lactamase-resistant and more efficaceous antibiotics. Antibiotics (66-82); Antibiotics, Lactam (83-85) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $C6:A :<Monoamine Oxidase Inhibitors D08.373.616 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antidepressive Agents Adrenergic Neuron Agents; Sympathomimetics; Antidepressive Agents Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Clorgyline; Harmine; Iproniazid; Isocarboxazid; Nialamide; Pargyline; Phenelzine; Selegiline; Tranylcypromine A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. Although MAO inhibitors are probably as effective as tricyclic antidepressants in the treatment of major depression, the complex, sometimes severe, and often unpredictable interactions between MAO inhibitors and many other drugs and food-derived amines make their medical use difficult and potentially hazardous. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (C$"6LP}DMonoamine Oxidase D08.586.682.135.697 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases Benzylamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p.415) EC 1.4.3.4. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  CDxFMonoacylglycerol Lipases D08.586.277.352.100.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases An enzyme that catalyzes the hydrolysis of glycerol monoesters of long-chain fatty acids EC 3.1.1.23. Esterases (70-74); Glycerides (70-74) CFx.Monkeypoxvirus B04.280.650.160.650.500; B04.909.204.783.160.650.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus A species of ORTHOPOXVIRUS causing an epidemic disease among captive primates. C :]Monkey Diseases C22.735.500 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Primate Diseases Marburg Virus Disease; Simian Acquired Immunodeficiency Syndrome Diseases of Old World and New World monkeys. This term includes diseases of baboons but not of chimpanzees or gorillas (= APE DISEASES). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  C"H)KPMonitoring, Physiologic E01.621 AECLCTECHIISMOMTNUPXSNSTTDUTVE Signal Processing, Computer-Assisted Diagnosis Blood Glucose Self-Monitoring; Drug Monitoring; Fetal Monitoring (+ 1); Intraoperative Monitoring; Monitoring, Ambulatory (+ 2); Monitoring, Immunologic; Polysomnography; Telemetry; Uterine Monitoring The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $C$ "* L&Monitoring, Immunologic E01.223.495.670; E01.621.590; E05.478.700 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Diagnosis; Monitoring, Physiologic Miscellaneous Techniques (Non MeSH); Immunologic Techniques Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumor antigen and other markers (often by RADIOIMMUNOASSAY), studies of cellular or humoral immunity in cancer etiology, IMMUNOTHERAPY trials, etc. Immunosuppression (77-88); Immunotherapy (74-88); Monitoring, Physiologic (76-88) C'1"_Monitoring, Ambulatory E01.621.555 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Monitoring, Physiologic Blood Pressure Monitoring, Ambulatory; Electrocardiography, Ambulatory The use of electronic equipment to observe or record physiologic processes while the patient undergoes normal daily activities. Monitoring, Physiologic (66-94) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $C+ ")P%&Moniliformis B01.500.132.546 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Acanthocephala A genus of roundworms of the phylum Acanthocephala, parasitic in rats, mice, hamsters, dogs and cats. Occasional infection in man produces inflammation and ulceration of the intestinal mucosa. C,*0Monieziasis C03.335.190.628; C03.335.349.656; C03.701.377.656; C22.674.377.656 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Cestode Infections Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Infection of ruminants with tapeworms of the genus Moniezia. Cestode Infections (66-67) C.uLJ]I Mongoose B02.649.147.650 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora An agile, keen-sighted mammal of Asia and Africa that feeds on rodents and snakes. C1 ('dMongoloid Race I01.076.368.763.596 CLGEHI Social Sciences; Anthropology; Anthropology, Physical; Racial Stocks A major racial group distinguished by classification according to physical features. This group centers around the Pacific Ocean and includes the Malayan, Northern and Southern Chinese, Mongolian, Siberian, Eskimo, and American Indian. C1 QMongolia Z01.252.474.651 EHEP Geographicals (Non MeSH); Asia; Far East C3 4Monensin D03.383.312.600; D08.373.936.500.450; D21.370.400.630 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Ionophores Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 2-[5-Ethyltetrahydro-5-[tetrahydro-3-methyl-5-[tetrahydro-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl-2H-pyran-2-yl]-2-furyl]-9-hydroxy-beta-methoxy-alpha,gamma,2,8-tetramethyl-1,6-dioxaspiro[4.5]decane-7-butyric acid. An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. Does not interfere with hosts' development of acquired immunity to the majority of coccidial species. Synonym: Coban. Antibiotics (72-74); Furans (74); Pyrans (74) C4. =<W:Monaco Z01.542.616 EHEP Geographicals (Non MeSH); Europe C8~ )Molybdoferredoxin D08.586.682.647.550; D12.776.097.350.450; D12.776.157.435.319.450; D12.776.556.580.302.450 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Nitrogenase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins; Ferredoxins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Iron-Sulfur Proteins; Ferredoxins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins; Iron-Sulfur Proteins; Ferredoxins A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE, which is active in nitrogen fixation, and consists of two subunits with molecular weights of 59.5 kD and 50.7 kD, respectively. Ferredoxins (66-76); Molybdenum (66-76) C8dB&0Molybdenum D01.268.912.555; D01.552.571 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Molybdenum. A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.94. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. (From Dorland, 27th ed). C<":s*Molteno Implants E07.450.672 AECLCTECHIMIPSSDSNSTTDUTVEVI Filtering Surgery Equipment and Supplies; Implants, Artificial Devices implanted to control intraocular pressure by allowing aqueous fluid to drain from the anterior chamber. The implant was named for Dr. Anthony Molteno, a South African ophthalmologist, now of New Zealand. (Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989; telephone conversation with Dr. Donald Abrams, Krieger Eye Institute, Baltimore). Glaucoma/surgery (80-94); Implants, Artificial (80-94)  C? 5AMolsidomine D03.383.548.580.693.450; D18.918.585 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Oxadiazoles; Sydnones Cardiovascular Agents; Vasodilator Agents 3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(morpholinylmethyl)- 4H-indol-4-one. An effective, safe antianginal agent with beneficial hemodynamic effects in patients with heart failure complicating acute myocardial infarction. Morpholines (66-82); Oxadiazoles (66-74); Sydnones (75-86) CA*:GMoloney Sarcoma Virus B04.265.600.600; B04.820.650.730.730.900.750.600; B04.909.574.807.730.730.900.750.600; B04.909.777.731.730.730.900.750.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses; Sarcoma Viruses, Murine Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine A replication-defective murine sarcoma virus (SARCOMA VIRUSES, MURINE) isolated from a rhabdomyosarcoma by Moloney in 1966. Mouse Sarcoma Viruses (80-84) CD#z$Moloney Leukemia Virus B04.820.650.730.730.900.500.596; B04.909.574.807.730.730.900.500.596; B04.909.777.731.730.730.900.500.596 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A murine virus arising during the propagation of S37 mouse sarcoma, and causing lymphoid leukemia in mice. It also infects rats and newborn hamsters and is apparently transmitted vertically to embryos in utero and through mother's milk. CH4qAMollusk Venoms D24.185.926.580.590; D24.185.965.590 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms Eledoisin Eledoisin Venoms from mollusks, including the Conus and Octopus species. The venoms contain proteins, enzymes, choline derivatives, slow-reacting substances, and several characterized polypeptide toxins that affect the nervous system. Mollusk venoms include cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, and murexine. Mollusca (66-77); Venoms (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $CLY*<p)HMolluscum Contagiosum Virus B04.280.650.160.550.500; B04.909.204.783.160.550.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Molluscipoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Molluscipoxvirus A species of MOLLUSCIPOXVIRUS causing skin lesions in humans. It is transmitted by direct contact or from non-living reservoirs (fomites), such as books or clothing. CO!:Molluscum Contagiosum C02.256.743.611; C02.825.550; C17.800.838.790.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Virus Diseases; Skin Diseases, Viral Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral A common, benign, usually self-limited viral infection of the skin and occasionally the conjunctivae by a poxvirus (MOLLUSCUM CONTAGIOSUM VIRUS). (Dorland, 27th ed). CQ9PMolluscipoxvirus B04.280.650.160.550; B04.909.204.783.160.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Molluscum Contagiosum Virus Molluscum Contagiosum Virus A genus of POXVIRIDAE, subfamily CHORDOPOXVIRIDAE, infecting humans. Transmission is by direct contact among children, by sexual contact among young adults, or by fomites. MOLLUSCUM CONTAGIOSUM VIRUS is the type species. CTf2@Molluscacides D05.723.596 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides Methiocarb Agents destructive to snails and other mollusks. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  CV8F;:Mollusca B01.644 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates Aplysia; Clams; Mussels; Octopus; Oysters; Snails (+ 4); Squid A phylum of animals containing SNAILS, slugs, MUSSELS, OYSTERS, CLAMS, OCTOPUS, nautiluses, SQUID, cuttlefish, etc. The name mollusk is derived from the Latin mollis, soft, with reference to their soft unsegmented bodies. (Dorland, 27th ed; Webster, 3d ed).  CX  ( Q/Mollicutes B03.440.560 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Mycoplasmatales (+ 14) A class of gram-negative bacteria consisting of cells bounded by a plasma membrane. Its organisms differ from other bacteria in that they are devoid of cell walls. It contains a single order, MYCOPLASMATALES. CZ#"'Molindone D03.438.473.629; D15.150.500; D15.210.950.040.500; D15.700.872.331.526 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents An indole derivative effective in schizophrenia and other psychoses and possibly useful in the treatment of the aggressive type of undersocialized conduct disorder. Molindone has much lower affinity for D2 receptors than most antipsychotic agents and has a relatively low affinity for D1 receptors. It has only low to moderate affinity for cholinergic and alpha-adrenergic receptors. Some electrophysiologic data from animals indicate that molindone has certain characteristics that resemble those of CLOZAPINE. (From AMA, Drug Evaluations Annual, 1994, p.283). Antidepressive Agents (66-71); Indoles (66-71) C[ P:v8Moles B02.649.473.450 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Insectivora Any of numerous burrowing mammals found in temperate regions and having minute eyes often covered with skin. C` ()Molecular Weight H01.181.529.574 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical CaIMolecular Structure H01.181.529.570 Models, Molecular Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Protein Structure (Non MeSH) (+ 4) The location of the atoms, groups or ions relative to one another in a molecule, as well as the number and location of chemical bonds. Chemistry (66-88); Models, Molecular (75-88) DEGEIMPHRE $CbUI+6Molecular Sequence Data G05.331.599; G06.184.599 Sequence Alignment Genetics; Genetics, Biochemical Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Amino Acid Sequence (+ 6); Base Sequence (+ 26); Carbohydrate Sequence; Conserved Sequence; Sequence Homology (+ 2) Amino Acid Sequence (+ 6); Base Sequence (+ 21); Carbohydrate Sequence; Conserved Sequence; Sequence Homology (+ 2) Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GenBank, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Amino Acid Sequence (66-87); Base Sequence (71-87); Cloning, Molecular (80-87); Information Systems (83-87) DEGEIMIPPHRE $Cd mMolecular Probes D26.651 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Biological Markers Miscellaneous Drugs and Agents (Non MeSH) Nucleic Acid Probes (+ 9) A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures.  ChC F2!Molecular Probe Techniques E05.393.525; E05.601 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques Miscellaneous Techniques (Non MeSH) Blotting, Northern; Blotting, Southern Biosensors; Blotting, Northern; Blotting, Southern The use of devices which use detector molecules to detect, investigate, or analyze other molecules, macromolecules, molecular aggregates, or organisms. AECLCTECHIISMOMTNUPXSDSNSTTDUTVE  Ci  jh$Molecular Mimicry G05.331.553; G05.511.625; G06.184.589 DEGEIMPHRE Antigenic Determinants; Antibodies, Anti-Idiotypic Genetics; Genetics, Biochemical Genetics; Immunogenetics Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) The process in which structural properties of an introduced molecule imitate or simulate molecules of the host. Direct mimicry of a molecule enables a viral protein to bind directly to a normal substrate as a substitute for the homologous normal ligand. Immunologic molecular mimicry generally refers to what can be described as antigenic mimicry and is defined by the properties of antibodies raised against various facets of epitopes on the viral protein. (From Immunology Letters 1991 May;28(2):91-9). Amino Acid Sequence (80-94)  Cl-:O"Molecular Conformation G06.184.580; H01.181.529.559 RE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Carbohydrate Conformation; Nucleic Acid Conformation; Protein Conformation (+ 2) Carbohydrate Conformation; Nucleic Acid Conformation; Protein Conformation (+ 2) The characteristic three-dimensional shape of a molecule. DERE  Co"DMolecular Chaperones D12.776.580 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Heat-Shock Proteins Heat-Shock Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins Chaperonins (+ 4); Heat-Shock Proteins 70; Heat-Shock Proteins 90 A family of cellular proteins that mediate the correct assembly or disassembly of other polypeptides, and in some cases their assembly into oligomeric structures, but which are not components of those final structures. It is believed that chaperone proteins assist polypeptides to self-assemble by inhibiting alternative assembly pathways that produce nonfunctional structures. Some classes of molecular chaperones are the nucleoplasmins, the CHAPERONINS, the HEAT-SHOCK PROTEINS 70, and the HEAT-SHOCK PROTEINS 90. Heat-Shock Proteins (87-94); Proteins (87-94) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,Cr DDPP7FMolecular Biology G01.273.595 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology Epidemiology, Molecular; Genetics, Biochemical Biology (66-67) CLDEECEDHIISLJMAMTOGRESNSTTD  CvA#6 Moldova Z01.542.248.540; Z01.586.200.540; Z01.586.950.540 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR Cw: 9Molasses J01.341.694 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Cx "=Molar, Third A14.254.860.615.612 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Molar The aftermost permanent tooth on each side in the maxilla and mandible. Molar (66-81) Cy<:9WMolar A14.254.860.615 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth Molar, Third Czg :0Moire Topography E01.357.710.708.500; E05.490.815; H01.671.606.799.715.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Photography; Photogrammetry Miscellaneous Techniques (Non MeSH); Interferometry Physical Sciences (Non MeSH); Physics; Optics; Photography; Photogrammetry A method of three-dimensional morphometry in which contour maps are produced from the overlapping interference fringes created when an object is illuminated by beams of coherent light issuing from two different point sources. Interferometry (77-89); Photogrammetry (74-89) C{!A"7Mohs Surgery E04.494.575 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Microsurgery A surgical technique used primarily in the treatment of skin neoplasms, especially basal cell or squamous cell carcinoma of the skin. This procedure is a microscopically controlled excision of cutaneous tumors either after fixation in vivo or after freezing the tissue. Serial examinations of fresh tissue specimens are most frequently done. Microsurgery (75-90); Skin Neoplasms/surgery (75-90) C}$'?Models, Theoretical H01.770.461 Computer Simulation; Systems Theory Physical Sciences (Non MeSH); Science Fractals; Fuzzy Logic; Models, Biological (+ 4); Models, Chemical; Models, Educational; Models, Molecular; Models, Nursing; Models, Organizational; Models, Psychological; Models, Statistical (+ 6); Nonlinear Dynamics Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. HI  C4+/Models, Structural L01.178.147.545 Information Science; Communications Media (Non MeSH); Audio-Visual Aids Models, Anatomic (+ 1) CUModels, Statistical E05.318.740.500; G03.850.520.830.500; H01.770.461.835; N05.715.360.750.530 Meta-Analysis Statistics Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Science; Models, Theoretical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Likelihood Functions; Linear Models; Logistic Models; Models, Economic (+ 1); Proportional Hazards Models Likelihood Functions; Linear Models; Logistic Models; Models, Economic (+ 1); Proportional Hazards Models Likelihood Functions; Linear Models; Logistic Models; Models, Economic (+ 1); Proportional Hazards Models Likelihood Functions; Linear Models; Logistic Models; Models, Economic (+ 1); Proportional Hazards Models Statistical formulations or analyses which, when applied to data and found to fit the data, are then used to verify the assumptions and parameters used in the analysis. Examples of statistical models are the linear model, binomial model, polynomial model, two-parameter model, etc. Models, Biological (66-88); Models, Theoretical (66-88); Statistics (66-88) $CTIZModels, Psychological F04.669.880.580; H01.770.461.695 Probability Learning Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Theoretical Techniques (Non MeSH) Physical Sciences (Non MeSH); Science; Models, Theoretical Theoretical representations that simulate psychological processes and/or social processes. These include the use of mathematical equations, computers, and other electronic equipment. Models, Theoretical (66-67) Ca&!Models, Organizational H01.770.461.670; N04.452.534 Physical Sciences (Non MeSH); Science; Models, Theoretical Health Services Administration (Non MeSH); Organization and Administration Theoretical representations and constructs that describe or explain the structure and hierarchy of relationships and interactions within or between formal organizational entities or informal social groups. Models, Theoretical (68-92) C"!Models, Nursing H01.770.461.645 Nursing Theory Physical Sciences (Non MeSH); Science; Models, Theoretical Theoretical models simulating behavior or activities in nursing, including nursing care, management and economics, theory, assessment, research, and education. Some examples of these models include Orem Self-Care Model, Roy Adaptation Model, and Rogers Life Process Model. Models, Theoretical (77-90) CG9!Models, Neurological H01.770.461.395.642 Kindling (Neurology) Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Biological Theoretical representations that simulate the behavior or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Models, Theoretical (66-67) C^!Models, Molecular H01.770.461.595 Molecular Structure Physical Sciences (Non MeSH); Science; Models, Theoretical Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. CGModels, Immunological H01.770.461.395.500 Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Biological Theoretical representations that simulate the behavior or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment. Models, Biological (67-94) C^ Models, Genetic G05.621; H01.770.461.395.397 Genetics Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Biological Theoretical representations that simulate the behavior or activity of genetic processes or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Models, Biological (68-79) C"h Models, Educational H01.770.461.545; I02.903.302 Physical Sciences (Non MeSH); Science; Models, Theoretical Education; Teaching Theoretical models which propose methods of learning or teaching as a basis or adjunct to changes in attitude or behavior. These educational interventions are usually applied in the fields of health and patient education but are not restricted to patient care. Models, Theoretical (68-92); Teaching (66-92) C"^27Models, Economic E05.318.740.500.600; G03.850.520.830.500.600; H01.770.461.835.890; N05.715.360.750.530.500 Economics Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Models, Statistical Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Models, Statistical Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Models, Statistical Models, Econometric Models, Econometric Models, Econometric Models, Econometric Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available. Economics (94)  Cd Z"Models, Econometric E05.318.740.500.600.500; G03.850.520.830.500.600.500; H01.770.461.835.890.500; N05.715.360.750.530.500.500 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Models, Statistical; Models, Economic Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Models, Statistical; Models, Economic Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Statistical; Models, Economic Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Models, Statistical; Models, Economic The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems. CtEModels, Chemical H01.770.461.495 Physical Sciences (Non MeSH); Science; Models, Theoretical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Models, Theoretical (66-67) CG!Models, Cardiovascular H01.770.461.395.161 Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Biological Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment. Models, Biological (68-79) C^ Models, Biological H01.770.461.395 Bionics; Disease Models, Animal Physical Sciences (Non MeSH); Science; Models, Theoretical Models, Cardiovascular; Models, Genetic; Models, Immunological; Models, Neurological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Models, Theoretical (66-67)  C'GbE!Models, Anatomic L01.178.147.545.129 Manikins Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Models, Structural Manikins Three-dimensional representation to show anatomic structures. C` l GMobiluncus B03.440.425.410.194.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are found in the human vagina, particularly in association with Gardnerella vaginalis in cases of bacterial vaginosis. Bacteria, Anaerobic (84-93) C~"!Mobile Health Units N02.421.143.827.233.628; N02.421.726.233.628 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Diagnostic Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Diagnostic Services Movable facilities in which diagnostic and therapeutic services are provided to the community. Health Facilities (68-69) C2!oMNSs Blood-Group System D24.611.216.705.230.606; G04.610.241.606; G09.188.229.606 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups A system of universal human blood group isoantigens with many associated subgroups. The M and N traits are codominant and the S and s traits are probably very closely linked alleles, including the U antigen. This system is most frequently used in paternity studies. Blood Groups (66-75) CA2P;MMPI F04.711.647.513.607 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Personality Inventory A personality inventory consisting of statements to be asserted or denied by the individual. The patterns of response are characteristic of certain personality attributes. C6 MM Virus B04.820.565.170.520; B04.909.777.618.170.520 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Cardiovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Cardiovirus A species of CARDIOVIRUS causing neurological disease in the mouse. Encephalomyocarditis Virus (66-93) C 2Q(Mixed Tumor, Mullerian C04.557.435.540 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p. 1703). Neoplasms, Germ Cell and Embryonal (68-93) CdXnB3Mixed Tumor, Mesodermal C04.557.435.530; C04.557.450.795.530 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed). Neoplasms, Germ Cell and Embryonal (68-93) C*XT3Mixed Tumor, Malignant C04.557.435.525 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A malignant tumor composed of more than one type of neoplastic tissue. (Dorland, 27th ed). Adenoma, Pleomorphic (66-93); Neoplasms, Germ Cell and Embryonal (66-93) C2XnoVMixed Function Oxidases D08.586.682.690.570 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases Catalyse the insertion of one oxygen atom of molecular oxygen into the organ substrate. Require a second substrate to donate electrons for the reduction of the second atom in the oxygen molecule to water. CFfMixed Connective Tissue Disease C17.300.540 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. Collagen Diseases (72-78); Lupus Erythematosus, Systemic (72-78); Scleroderma, Systemic (72-78) C &NYqMitral Valve Stenosis C14.280.484.517 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases CNIMitral Valve Prolapse C14.280.484.400.500; C23.835.400.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases; Heart Valve Prolapse Symptoms and General Pathology (Non MeSH); Prolapse; Heart Valve Prolapse Abnormal protrusion of one or both of the leaflets of the mitral valve into the left atrium during systole. This may be accompanied by mitral regurgitation, systolic murmur, nonejection click, or cardiac arrhythmia. Heart Valve Diseases (67-78); Mitral Valve (66-78); Mitral Valve Insufficiency (66-78); Prolapse (77-78) C*N~Mitral Valve Insufficiency C14.280.484.461 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Backflow of blood from the left ventricle into the left atrium, owing to imperfect functioning of the mitral valve. C NIMitral Valve A07.541.510.507 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Valves The valve between the left atrium and left ventricle of the heart. Cb84RMitoxantrone D02.806.100.500; D04.615.117.159.500; D22.204.555 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Anthraquinones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes; Anthraquinones Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9,10-anthracenedione. An anthracenedione antineoplastic agent. It is particularly effective against advanced breast cancer, acute leukemia, and malignant lymphoma. It has mild side effects, especially with respect to nausea, vomiting, hair loss, and cardiotoxicity. Anthraquinones (66-86) Cg9:tMitotic Spindle Apparatus A11.368.702.581 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Centromere; Centrosome; Kinetochores; Microtubules Cells; Cytoplasm; Organelles An organelle consisting of three components: 1) the astral microtubules, which form around each centrosome and extend to the periphery; 2) the polar microtubules which extend from one spindle pole to the equator; and 3) the kinetochore microtubules, which connect the centromeres of the various chromosomes to either centrosome. Cell Division (66-67); Mitosis (68-83)  CȠ*<$0Mitotic Index E05.909.262.730; G04.335.135.220.669.600; G05.148.165.220.669.600; G07.553.135.220.669.600 DEGEIMPHRE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division; Mitosis Genetics; Cytogenetics; Cell Cycle; Cell Division; Mitosis Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division; Mitosis An expression of the number of mitoses found in a stated number of cells. C6d[Mitotane D02.455.526.439.681; D05.723.491.491.723; D22.204.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1-Chloro-2-(2,2-dichloro)-1-(4-Chlorophenyl)ethylbenzene. A derivative of the insecticide DDD that specifically inhibits cells of the adrenal cortex and their production of hormones; used to treat adrenocortical tumors; causes CNS damage, but no bone marrow depression. Synonyms: CB 313; Lysoderm; NSC 38721. DDD/PD (66-72) C =:3iMitosis G04.335.135.220.669; G05.148.165.220.669; G07.553.135.220.669 DEGEIMPHRE Maturation-Promoting Factor; Mitogens Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division Genetics; Cytogenetics; Cell Cycle; Cell Division Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division Mitotic Index Mitotic Index Mitotic Index A method of indirect cell division by means of which the two daughter nuclei normally receive identical complements of the number of chromosomes of the somatic cells of the species. Cell Division (66-67) $CL E,=2Mitomycins D03.383.097.500; D20.085.075.584; D22.204.106.584 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Mitomycin C; Porfiromycin Mitomycin C; Porfiromycin Mitomycin C; Porfiromycin A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as antineoplastic agents in some solid tumors. PORFIROMYCIN and MITOMYCIN C are the most useful members of the group. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  Cf9: \<Mitomycin C D03.383.097.500.350; D20.085.075.584.375; D22.204.106.584.375 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines; Mitomycins Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Mitomycins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Mitomycins (1aS(1a alpha,8 beta,8a alpha,8b alpha))-6-Amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino(2,3':3,4)pyrrolo(1,2-a)indole-4,7-dione. A member of the group of antitumor antibiotics produced by Streptomyces caespitosus. It has antineoplastic action against a variety of tumors, particularly liver, gastrointestinal, and bladder neoplasms. It is used extensively in chemotherapy protocols. Mitomycins (66-91) CE<3Mitolactol D02.033.800.256.500; D09.203.853.256.500; D22.204.545 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Dulcitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Dulcitol Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,6-Dibromo-1,6-dideoxygalactitol. Alkylating antineoplastic toxic to bone marrow; used in breast cancer, also in combination with other drugs. Synonyms: DBD; Dibromgalactitol; Elobromol; NSC 104800. Antineoplastic Agents (66-73); Bromine (66-73) C۱=:8Mitoguazone D02.078.370.600; D22.204.540 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,1-[(Methylethanediylidene)dinitrilo]diguanidine. Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase. Synonyms: NSC-32946; MGGH. Amidines (73-74); Hydrazones (73-74); Glyoxal (73-74) Cނ": BMitogens D24.185.526 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Mitogen Mitosis Immunologic and Biologic Factors (Non MeSH); Biological Factors Angiogenesis Factor; Lectins (+ 6); Lipopolysaccharides Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with lectins, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed). Mitosis/drug effects (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,C B LC6#HMitochondrial Swelling G04.335.723 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Increase in volume of mitochondria due to an influx of fluid; it occurs in hypotonic solutions due to osmotic pressure and in isotonic solutions as a result of altered permeability of the membranes of respiring mitochondria. Mitochondria (66-68); Mitochondria, Liver (68); Mitochondria, Muscle (68) Cf XMitochondrial Myopathies C05.651.460; C18.452.648.556.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mitochondria, Muscle Musculoskeletal Diseases; Muscular Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors Mitochondrial Encephalomyopathies (+ 4) Mitochondrial Encephalomyopathies (+ 4) Diseases of the muscles characterized by morphologic changes in mitochondria and often associated with excessive lipid accumulation. Muscle biopsies reveal "the presence of overly abundant and large mitochondria (often containing abnormal inclusions and cristae) in many muscle fibers. The terms mitochondrial and lipid storage have been used interchangeably to designate these myopathies, since the enzymes essential for intramuscular lipid metabolism are contained in the mitochondria, and a defect in the latter results in an abnormal accumulation of lipid bodies in muscle fibers." Often defects in various oxidative enzymes figure. One type of mitochondrial myopathy is called pleoconial with reference to "a remarkably large number (pleo-) of enlarged mitochondria in the biopsied muscle", another is "called megaconial with reference to giant (mega-) mitochondria in the muscle." (Adams and Victor: Principles of Neurology, 2d ed, p.980-1). Mitochondria, Muscle (68-92); Muscular Diseases (68-92) $C&NZABMitochondrial Encephalomyopathies C05.651.460.620; C10.228.140.163.634; C18.452.648.556.650.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mitochondria, Muscle Musculoskeletal Diseases; Muscular Diseases; Mitochondrial Myopathies Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies MELAS Syndrome; MERRF Syndrome; Ophthalmoplegia, Chronic Progressive External (+ 1) MELAS Syndrome; MERRF Syndrome MELAS Syndrome; MERRF Syndrome; Ophthalmoplegia, Chronic Progressive External (+ 1) Brain diseases associated with disease of the muscles, accompanied by morphological changes in the muscle mitochondria and their metabolism. The mitochondrial encephalopathies are often multisystemic and vary considerably in age at onset, distribution of weakness, severity, and course. Mitochondrial cytochrome c oxidase deficiency appears to be implicated and often several mitochondrial enzymes are affected in the same patient. The brain lesions can be said to be clinical and morphological expressions of a mitochondrial defect. Brain Diseases, Metabolic (77-92); Mitochondria, Muscle (77-92); Neuromuscular Diseases (77-92) $Cr&ENqfpMitochondrial Contraction G04.335.690 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) The reversal of mitochondrial swelling by active contraction; it can be induced by ATP and is probably brought about by a specific contractile protein with ATPase activity. Mitochondria (66-68); Mitochondria, Liver (68); Mitochondria, Muscle (68) CfXMitochondria, Muscle A11.368.702.564.627; A11.904.626.627 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Mitochondrial Encephalomyopathies; Mitochondrial Myopathies Cells; Cytoplasm; Organelles; Mitochondria Cells; Subcellular Fractions; Mitochondria Mitochondria, Heart Mitochondria, Heart Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available. Mitochondria (66-67); Muscle Contraction (66-67); Muscles (66-67); Myocardium (66-67) $C**Ce.gMitochondria, Liver A11.368.702.564.461; A11.904.626.461 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles; Mitochondria Cells; Subcellular Fractions; Mitochondria Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts, et al., Molecular Biology of the Cell, 2d ed, p343-4). Mitochondria (66-67) C**eMitochondria, Heart A11.368.702.564.627.603; A11.904.626.627.603 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles; Mitochondria; Mitochondria, Muscle Cells; Subcellular Fractions; Mitochondria; Mitochondria, Muscle The mitochondria of the myocardium. Heart (66-77); Mitochondria (66-77); Mitochondria, Muscle (68-77); Myocardium (66-77) C2*,gMitochondria A11.368.702.564; A11.904.626 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Cells; Subcellular Fractions Mitochondria, Liver; Mitochondria, Muscle (+ 1); Submitochondrial Particles Mitochondria, Liver; Mitochondria, Muscle (+ 1); Submitochondrial Particles Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER), AMINO ACYL T RNA SYNTHETASES, and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King and Stansfield, A Dictionary of Genetics, 4th ed). C"*EMitobronitol D02.033.800.609.500; D09.203.853.609.500; D22.204.535 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Mannitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Mannitol Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,6-Dibromo-1,6-dideoxy-D-mannitol. Brominated analog of mannitol which is an antineoplastic agent appearing to act as an alkylating agent. Synonyms: Myelobromol; DBM; NSC-94,100. Bromine (71-74); Mannitol (71-74) D=:*Mites B01.131.166.132.419 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida; Acari Trombiculid Mites Any arthropod of the order Acarina except the ticks. They are minute animals related to the spiders, usually having transparent or semitransparent bodies. They may be parasitic on man and domestic animals, producing various irritations of the skin (acariasis or MITE INFESTATIONS). Many mite species are important to human and veterinary medicine as both parasite and vector. (From Dorland, 27th ed). D (5Mite Infestations C03.211.394 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations Scabies; Trombiculiasis Infestations with arthropods of the order Acarina other than the suborder Ixodides. D7P6cMissouri Z01.107.567.875.100.540; Z01.107.567.875.600.516.540 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States D :Mississippi Z01.107.567.875.100.532; Z01.107.567.875.600.820.523 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States D :Missions and Missionaries M01.526.682; N02.720 CLECHILJMAMTOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Facilities, Manpower and Services (Non MeSH) To be used for articles pertaining to medical activities carried out by personnel in institutions which are administered by a religious organization. D Misoprostol D02.241.081.436.687.700.450.500; D07.131.100.505; D10.516.251.355.708.700.450.500; D17.350.700.660.500; D19.316.203.608 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Reproductive Control Agents (Non MeSH); Abortifacient Agents; Abortifacient Agents, Non-Steroidal Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents (11 alpha,13E-(+-))- 11,6-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester. A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. Abortifacient Agents, Non-Steroidal (75-91); Alprostadil/analogs and derivatives (75-91); Anti-Ulcer Agents (77-91) D E:uMisonidazole D02.640.672.530; D03.383.374.658.530; D22.204.530; D26.776.530 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol. A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Imidazoles (66-73); Nitroimidazoles (74-78) DEH:R 4Miscellaneous Techniques (Non MeSH) E05 Animal Identification Systems; Artifacts; Autoanalysis; Autopsy; Biological Assay (+ 1); Body Weights and Measures (Non MeSH) (+ 11); Brain Mapping; Calibration; Calorimetry (+ 1); Catheterization; Cementation; Centrifugation (+ 4); Chemistry, Analytical (+ 121); Constriction; Containment of Biohazards; Decompression (+ 1); Dermatoglyphics; Diet (+ 5); Dilatation; Drug Administration Routes (+ 37); Drug Administration Schedule; Epidemiologic Methods (+ 142); Equipment Design; Equipment Failure (+ 1); Equipment Reuse; Equipment Safety; Ergometry (+ 1); Evaluation Studies (+ 21); Food Analysis; Genetic Techniques (+ 37); Hardness Tests; Human Experimentation; Immersion; Immunologic Techniques (+ 48); Interferometry (+ 3); Intubation (+ 3); Irrigation (+ 2); Isotope Labeling; Manometry; Methods; Microscopy (+ 16); Molecular Probe Techniques (+ 3); Neoplasm Transplantation; Oscillometry; Parabiosis (+ 1); Perfusion (+ 2); Photography; Physical Conditioning, Animal; Physical Stimulation (+ 4); Physiognomy; Preservation, Biological (+ 8); Product Labeling (+ 2); Radiometry (+ 10); Reproduction Techniques (+ 16); Restraint, Physical (+ 1); Rheology (+ 2); Sound Spectrography; Stereotaxic Techniques (+ 1); Substance Abuse Detection; Tattooing; Technology, Medical (+ 97); Technology, Pharmaceutical (+ 9); Technology, Radiologic; Toxicity Tests (+ 3); Trauma Severity Indices (+ 3); Vivisection; Weightlessness Countermeasures; Weightlessness Simulation; Whole-Body Irradiation AEBLCFCLCTDEDUECEDEHGEHIIMISLJMAMEMOMTNUOGPAPHPPPXRARERHRISDSNSTTDTUURUSUTVE D*PMiscellaneous Drugs and Agents (Non MeSH) D26 Adhesives (+ 5); Agrochemicals (+ 1); Alcohol Deterrents (+ 1); Anticarcinogenic Agents (+ 1); Antidotes (+ 6); Antimetabolites (+ 52); Antimutagenic Agents; Antioxidants (+ 1); Aphrodisiacs (+ 1); Buffers (+ 3); Carcinogens (+ 71); Charcoal; Chelating Agents (+ 20); Chemical Warfare Agents (+ 3); Compound 48-80; Contrast Media (+ 24); Cosmetics (+ 8); Cryoprotective Agents (+ 2); Culture Media (+ 3); DNA Primers; Drugs (+ 50); Dyes (+ 53); Expectorants (+ 8); Fixatives; Flame Retardants; Flavoring Agents (+ 6); Food Additives (+ 13); Free Radical Scavengers; Humic Acids; Indicators and Reagents (+ 70); Iodophors (+ 1); Ion Exchange Resins (+ 4); Irritants (+ 4); Ligands; Molecular Probes (+ 10); Oxidants (+ 5); Pangamic Acid; Pharmaceutic Aids (+ 16); Plant Extracts (+ 6); Proadifen; Prostaglandin Antagonists (+ 2); Radiation-Protective Agents (+ 8); Radiation-Sensitizing Agents (+ 10); Solvents; Stimulants (Historical); Surface-Active Agents (+ 18); Tars (+ 2); Tear Gases (+ 2); Teratogens; Tobacco, Smokeless; Tocolytic Agents (+ 10); Turpentine; Xenobiotics AAADAEAGAHAIANBIBLCFCHCLCSCTCYDEDFDUECEMENGDGEHIIMIPLJMEMIPDPHPKPOPSRESDSESNSTTDTOTUULURUTVEVI D$2.bMirex D02.455.526.439.659; D05.723.491.491.690 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Insecticides (66-72) D#  .:Miotics D16.050.495 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic Antagonists; Cholinesterase Inhibitors; Muscarinic Agonists; Parasympathomimetics; Sympatholytics Pupil Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Acetylcholine; Carbachol; Echothiophate Iodide; Isoflurophate; Methacholine Chloride; Moxisylyte; Physostigmine; Pilocarpine Agents causing contraction of the pupil of the eye. Because the size of the pupil is under the antagonistic control of the sympathetic and parasympathetic systems, drugs affecting either system can cause miosis. Drugs that mimic or potentiate the parasympathetic input to the circular constrictor muscle and drugs that inhibit sympathetic input to the radial dilator muscle tend to contract the pupils. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (D$ 8{ JdDMiosis C11.710.528 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Pupillary Functions, Abnormal Constriction of the pupil to less than 2 mm and failure of pupil to dilate in darkness. There are several causes of this condition including congenital absence of the dilatator pupillary muscle, paretic lesion of the sympathetic nervous system, and irritation of the conjunctiva or cornea. Pupils (66-89) D)) N4TMiocamycin D20.085.115.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Leucomycin V, 3(B),9-diacetate 3,4(B)-dipropionate. A macrolide antibiotic which has a wide antimicrobial spectrum and is particularly effective in respiratory and genital infections. Leucomycins (81-89) D+R:DMinute Virus of Mice B04.280.580.600.550; B04.909.204.671.600.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Parvoviridae; Parvovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae; Parvovirus The type species of PARVOVIRUS prevalent in mouse colonies and found as a contaminant of many transplanted tumors or leukemias. The common abbreviation is MVM. D-2Minoxidil D03.383.621.493; D03.383.742.418; D18.162.586 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Cardiovascular Agents; Antihypertensive Agents Antihypertensive Agents (66-71); Piperidines (66-71); Pyrimidines (66-71) D. 5:WMinority Groups I01.880.371; M01.403 CLEDHILJPXSN Social Sciences; Sociology Named Groups (Non MeSH) A subgroup having special characteristics within a larger group, often bound together by special ties which distinguish it from the larger group. Attitude (66-67); Blacks (66-67); Jews (66-67); Prejudice (66-67) D0=RMinor Planets H01.091.800.600 Physical Sciences (Non MeSH); Astronomy; Solar System Small solar system planetary bodies including asteroids. Most asteroids are found within the gap lying between the orbits of Mars and Jupiter. Extraterrestrial Environment (66-90); Solar System (91-94) D2[BEMinor Lymphocyte Stimulatory Loci G04.610.626.600; G05.511.600 DEGEIMPHRE Minor Lymphocyte Stimulatory Antigens Mammary Tumor Viruses, Mouse Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Immunogenetics Genetic loci responsible for the encoding of minor lymphocyte stimulatory antigens. There are at least two unlinked loci (in the mouse) and they appear to be separate from the major histocompatibility complex and minor histocompatibility loci. The mouse mammary tumor virus (see MAMMARY TUMOR VIRUSES, MOUSE) has the ability to integrate into these loci. The antigens induce strong T-cell proliferative responses in mixed lymphocyte reactions.  D3(",#Minor Lymphocyte Stimulatory Antigens D24.611.216.301.625; D24.611.216.820.625 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Mammary Tumor Viruses, Mouse; Minor Lymphocyte Stimulatory Loci Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Superantigens Endogenous superantigens responsible for inducing strong proliferative responses in T-cells in mixed lymphocyte reactions (see LYMPHOCYTE CULTURE TEST, MIXED). They are encoded by mouse mammary tumor viruses that have integrated into the germ line as DNA proviruses (MINOR LYMPHOCYTE STIMULATORY LOCI). D7',.6K^Minor Histocompatibility Loci G04.610.626.590; G05.511.590 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Immunogenetics Genetic loci responsible for the encoding of histocompatibility antigens other than those encoded by the major histocompatibility complex. The antigens encoded by these genes are often responsible for graft rejection in cases where histocompatibility has been established by standard tests. The location of some of these loci on the X and Y chromosomes explains why grafts from males to females may be rejected while grafts from females to males are accepted. In the mouse roughly 30 minor histocompatibility loci have been recognized, comprising more than 500 genes. H-2 Antigens (78-82); Histocompatibility Antigens (73-82); T Lymphocytes (73-82) D:z#"`Minor Histocompatibility Antigens D24.611.216.301.500.600; D24.611.216.705.552.600 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens H-Y Antigen H-Y Antigen Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen. Histocompatibility Antigens (72-89)  D>h'661y)Minocycline D20.085.868.543 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5a alpha,12a alpha))-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacene carboxamide. A semisynthetic antibiotic effective against tetracycline-resistant staphylococcus infections. Tetracycline (66-72) DB::Minnesota Z01.107.567.875.100.523; Z01.107.567.875.600.313.565; Z01.107.567.875.600.516.523 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States DD YMink Cell Focus-Inducing Viruses B04.820.650.730.730.900.500.580; B04.909.574.807.730.730.900.500.580; B04.909.777.731.730.730.900.500.580 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Murine leukemia viruses discovered in 1976 by Hartley, Wolford, Old, and Rowe and so named because the viruses originally isolated had the capacity to transform cell foci in mink cell cultures. MCF viruses are generated in a multi-step process by recombination with other viral types including AKR, Friend, Moloney, and Rauscher. Friend Virus (66-85); Leukemia, Experimental (66-85); Mouse Leukemia Viruses (66-85) DF9'qAeMink B02.649.147.625 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Carnivora (66-67) DK=('Mining J01.576.670 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry Coal Mining DK AMinicomputers L01.700.568.080.260.580 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers Small computers that lack the speed, memory capacity, and instructional capability of the full-size computer but usually retain its programmable flexibility. They are larger, faster, and more flexible, powerful, and expensive than microcomputers. Computers (66-79) DLuMiniaturization H01.288.542 ISMTSNST Physical Sciences (Non MeSH); Electronics DN 3Minerals D01.578 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Apatites (+ 2); Calcium Carbonate; Calcium Sulfate; Graphite; Selenium; Silicates (+ 13); Silicon Dioxide (+ 2) ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR DO  8%<Mineralocorticoids, Synthetic D06.597.648 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic Fludrocortisone Synthetic steroids that mimic the activity of the mineralocorticoids obtained from the adrenal cortex, but differ in structure from the naturally occurring mineralocorticoids. Mineralocorticoids (67-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $DPz"8N:Mineralocorticoids D06.472.040.668 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones Hydroxycorticosteroids (+ 6) A group of corticosteroids primarily associated with the regulation of water and electrolyte balance. This is accomplished through the effect on ion transport in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is itself regulated by plasma volume, serum potassium, and angiotensin II. Adrenal Cortex Hormones (66) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $DRB_"#DMineral Waters J01.125.648 ADAEANCLECHIMIPOPSRESDSNSTTOTUUTVI Balneology; Water Technology, Industry, Agriculture (Non MeSH); Beverages DU&BMineral Oil D19.316.396.656; D23.200.525; D26.698.523.626; J01.740.400.700.500 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Dermatologic Agents; Emollients Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids; Ointment Bases Technology, Industry, Agriculture (Non MeSH); Oils; Industrial Oils; Petroleum A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient. DVaL,;Mimosine D03.383.725.791.550; D12.125.042.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Alanine 3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca. Alanine (72-74); Pyridones (69-74) DX *:+Millet B06.510.253.480; J01.341.182.480 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals A genus of small cereal grasses, Panicum, used for forage. Its grain is used for food. DZ &4nkMilker's Nodes C02.256.743.563 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections A pox-like disease occurring on the udders of cows from which it may be spread to the hands of milkers; it is often confused with cowpox. D\<PUMilk, Human A12.838.467 CHCYDEENIMMEMIPHPSRARERISEUSVI Breast Feeding; Lactation; Milk Banks Infant Nutrition; Lactation Fluids and Secretions (Non MeSH); Secretions (Non MeSH) D]"/"DMilk Sickness C21.613.756.600 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Plant Poisoning An acute, often fatal disease caused by the ingestion of milk, milk products, or the flesh of cattle or sheep which have a disease known as trembles. It is marked by weakness, anorexia, vomiting, constipation, and sometimes muscular tremors. It is caused by poisoning by white snakeroot (Eupatorium rugosum) and the rayless goldenrod (Haplopappus heterophyllus). (From Dorland, 27th ed). Plant Poisoning (66-94) D^LYMilk Proteins D12.776.256.626 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins Caseins; Lactalbumin; Lactoglobulins (+ 1) Albumins (66-72); Caseins (66-72); Lactoglobulins (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  DaBY4FHMilk Hypersensitivity C20.543.480.370.500 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lactose Intolerance Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Food Hypersensitivity Allergic reaction to milk (usually cow's milk) or milk products. In infants the hypersensitivity is manifested by colic, vomiting, diarrhea, rhinitis, wheezing, etc. MILK HYPERSENSITIVITY should be differentiated from LACTOSE INTOLERANCE, an intolerance to milk as a result of congenital deficiency of lactase. Food Hypersensitivity (66-90); Milk/adverse effects (66-90)  DcQLggGMilk Ejection G08.520.882.608.460 DEPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Puerperium; Lactation Reflex in which tactile stimulation of nipples causes release of oxytocin which causes myoepithelial cells surrounding mammary alveoli to contract and expel the milk. Applies to humans and animals. Df& bMilk Banks N02.278.065.600 CLECHILJMAOGSDSNSTTDUT Milk, Human Facilities, Manpower and Services (Non MeSH); Health Facilities; Biological Specimen Banks Centers for acquiring, storing, and distributing human milk. DgkHMilk A13.622; J01.125.576; J01.341.273.692 AECHCLCYDEECENHIIMMEMIPHPOPSRARERISDSESNSTTOUSUTVI Lactation Infant Nutrition; Lactation Animal Terms (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Beverages Technology, Industry, Agriculture (Non MeSH); Food; Dairy Products Dh-6 "Military Science J01.675 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH) DjX 4Military Psychiatry F04.096.544.480; G02.403.642.508 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry Branch of psychiatry concerned with problems related to the prevention, diagnosis, etiology, and treatment of mental or emotional disorders of Armed Forces personnel. Dj&Military Personnel M01.526.625 CLEDHILJPXSN Veterans Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Dl MMilitary Nursing G02.478.676.458 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing The practice of nursing in military environments. Dm`;<Military Medicine G02.403.458 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine The practice of medicine as applied to special circumstances associated with military operations. Dn>#rMilitary Hygiene G03.850.670.300 CLECEDHIISLJMAMTOGSNSTTD Environment and Public Health (Non MeSH); Public Health; Hygiene Do7OMilitary Dentistry G02.163.592 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Dentistry The practice of dentistry as applied to special circumstances associated with military operations. Do$sMilieu Therapy F04.754.864.392 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy Therapeutic Community A treatment program based on manipulation of the patient's environment by the medical staff. The patient does not participate in planning the treatment regimen. Psychotherapy (66)  DpjMiliaria C17.800.805.843.492 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases Fox-Fordyce Disease A syndrome of cutaneous changes associated with sweat retention and extravasation of sweat at different levels in the skin. Miliaria rubra, or prickly heat, results from apocrine duct obstruction. The sweat then seeps into the epidermis, producing pruritic erythematous papulovesicles. (From Dorland, 27th ed). Dr NjMikulicz' Disease C07.465.815.355 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Salivary Gland Diseases A chronic, benign, and usually painless inflammatory swelling of the lacrimal and salivary glands. It is considered by some to include the glandular enlargement associated with other diseases, such as Sjogren's syndrome, sarcoidosis, lupus erythematosus, etc. DuFNL,Migraine C10.228.140.300.937.542; C14.907.253.937.542; C23.888.592.612.429.814.458 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Vascular Headache Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Vascular Headache Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Headache; Vascular Headache A periodic vascular headache, usually temporal and unilateral in onset, commonly associated with irritability, nausea, vomiting, constipation or diarrhea, and often photophobia. DwX QNMifepristone D04.808.365.415.580; D06.347.505; D07.131.200.500; D07.360.276.210.443.519; D07.360.276.500.500; D07.650.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Reproductive Control Agents (Non MeSH); Abortifacient Agents; Abortifacient Agents, Steroidal Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Menstruation-Inducing Agents Reproductive Control Agents (Non MeSH); Menstruation-Inducing Agents 11-((4-Dimethylamino)phenyl)-17-hydroxy-17- (1-propynyl)estra-4,9-dien-3-one. A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary Cushing's syndrome. Abortifacient Agents, Steroidal (75-89); Contraceptives, Oral, Synthetic (75-89); Estrenes (75-89); Glucocorticoids/antagonists and inhibitors (67-89) Dz~z:tMidwifery G02.478.676.416 CLECEDHIISLJMAMTOGSNSTTD Home Childbirth; Nurse Midwives Health Occupations; Nursing; Specialties, Nursing The practice of assisting women in childbirth. D ';9Midwestern United States Z01.107.567.875.600.516 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Illinois (+ 1); Indiana; Iowa; Kansas; Kentucky; Michigan; Minnesota; Missouri; Nebraska; North Dakota; Ohio; Oklahoma; South Dakota; Wisconsin The geographic area of the midwestern region of the United States in general or when the specific state or states are not indicated. The states usually included in this region are Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Missouri, Nebraska, Ohio, Oklahoma, North Dakota, South Dakota and Wisconsin. D~yvMidodrin D02.033.329.291.480; D02.092.063.291.480; D14.100.050.100.100.520; D16.050.870.520 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension. Ethanolamines (73-74); Glycine (73-74); Hydroquinones (73-74) D \:JMiddle Lobe Syndrome C08.381.069.542 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Atelectasis Atelectasis of the right middle pulmonary lobe, with chronic pneumonitis. (Dorland, 27th ed). DNApMiddle East Z01.252.245.500; Z01.586.500 EHEP Geographicals (Non MeSH); Asia; Asia, Western Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Afghanistan; Bahrain; Iran; Iraq; Israel; Jordan; Kuwait; Lebanon; Oman; Qatar; Saudi Arabia; Syria; Turkey; United Arab Emirates; Yemen Afghanistan; Bahrain; Egypt; Iran; Iraq; Israel; Jordan; Kuwait; Lebanon; Libya; Oman; Qatar; Saudi Arabia; Syria; Turkey; United Arab Emirates; Yemen The countries of southwest Asia and northern Africa usually considered as extending from Libya on the west to Afghanistan on the east. specific Middle East country (66-81); Asia, Western (66-81)  D?"fHMiddle Ear Ventilation E04.847.774.472; E04.579.592 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Surgery, Operative; Ostomy Ventilation of the middle ear in the treatment of secretory (serous) otitis media, usually by placement of tubes or grommets which pierce the tympanic membrane. Intubation (66-82); Otitis Media (66-82); Tympanic Membrane (66-82) Dr"$RMiddle Age M01.471.116.630 PHPX Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Adult DPMidazolam D03.438.079.080.575; D14.100.240.500.525; D15.045.525; D15.050.035.075.510; D15.075.050.515; D15.210.100.175.075.510; D15.210.350.800.515; D15.210.950.012.050.490; D15.325.875.562; D15.700.872.015.050.575 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine A short-acting compound, water-soluble at pH less than 4 and lipid-soluble at physiological pH. It is a hypnotic-sedative drug with anxiolytic and amnestic properties. It is used for sedation in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. Because of its short duration and cardiorespiratory stability, it is particularly useful in poor-risk, elderly, and cardiac patients. Azepines (66-74); Benzodiazepines (75-86) D' :2Mid-Atlantic Region Z01.107.567.875.600.513 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Delaware; District of Columbia; Maryland (+ 1); New Jersey; New York (+ 1); Pennsylvania (+ 1) The geographic area of the Mid-Atlantic Region in general or when the specific state or states are not indicated. The states usually included in this region are Delaware, Maryland, New York, New Jersey, and Pennsylvania. DWyxMicrowaves H01.671.768.638.605 AECLDUHITU Diathermy Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Non-Ionizing That portion of the electromagnetic spectrum lying between UHF (ultrahigh frequency) radio waves and heat (infrared) waves. Microwaves are used to generate heat, especially in some types of diathermy. They may cause heat damage to tissues. D XMicrovirus B04.123.470.500; B04.280.470.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Microviridae Viruses; DNA Viruses; Microviridae Bacteriophage phi X 174 Bacteriophage phi X 174 A genus of bacteriophages of the family MICROVIRIDAE. The genome consists of isometric single-stranded DNA. D&V:Microviridae B04.123.470; B04.280.470 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses; DNA Viruses Microvirus (+ 1) Microvirus (+ 1) A large family of lytic bacteriophages infecting enterobacteria. It contains two genera: MICROVIRUS and spiromicrovirus. Bacteriophages (83-93)  D6*Microvilli A11.195.590 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cell Membrane Minute projections of cell membranes which greatly increase the surface area of the cell. Cell Membrane (66-77); Intestinal Mucosa (66-77); Kidney Cortex (73-77); Kidney Tubules, Proximal (73-77) D*kMicrotubules A11.368.250.602 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Mitotic Spindle Apparatus Cells; Cytoplasm; Cytoskeleton The largest of the cytoskeletal filaments. Composed primarily of subunits of the protein tubulin, they are involved in the maintenance of cell shape, and they form the mitotic spindle. Organoids (66-69)  D*&Microtubule-Associated Proteins D12.776.220.600.450; D12.776.641.560 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microtubule Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins Kinesin; tau Proteins Kinesin; tau Proteins High molecular weight proteins found in the microtubules of the cytoskeletal system. Under certain conditions they are required for tubulin assembly into the microtubules and stabilize the assembled microtubules. Nerve Tissue Proteins (66-84); Proteins (66-84)  D$*F6:Microtubule Proteins D12.776.220.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins Dynein ATPase; Microtubule-Associated Proteins (+ 2); Tubulin Proteins found in the microtubules. Cytoplasm (77-79); Cytoskeleton (80-84); Proteins (66-84); Tubulin (75-84) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $DF^J,[HMicrotomy E05.909.262.620.530; E05.909.432.600.530 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques Cryoultramicrotomy (+ 1) Cryoultramicrotomy (+ 1) The technique of using a microtome to cut thin or ultrathin sections of tissues embedded in a supporting substance. The microtome is an instrument that hold a steel, glass or diamond knife in clamps at an angle to the blocks of prepared tissues, which it cuts in sections of equal thickness. D .:[Microtinae B02.649.865.635.510 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae A subfamily of the Muridae consisting of 20 genera. Voles, lemmings, and muskrats are included in this subfamily. They occur nearly world-wide. Rats (66-81); Rodentia (66-81) D(1'Microsurgery E04.494 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Cerebral Revascularization; Mohs Surgery Microscopy (66-68); Surgery, Operative (66-68) DX $08Microstomia C07.465.525.520; C07.650.525.520; C16.131.850.525.520 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Mouth Abnormalities Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities A congenital defect in which the mouth is unusually small. (Dorland, 27th ed). Mouth Abnormalities (66-70); Mouth Diseases (66-70) D==LFa>Microsporum B05.354.318.542; B05.354.381.546.560 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Dermatophytes Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes D*"Microsporida B01.841.500.500.500 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Microspora; Microsporea Apansporoblastina (+ 3) An order of parasitic protozoa found mostly in arthropods and fish and in some lower vertebrates. It comprises two suborders: Pansporoblastina and APANSPOROBLASTINA. Protozoa (69-91); Sporozoea (69-91)  D&:,Microsporea B01.841.500.500 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Microspora Microsporida (+ 4) A class of parasitic protozoa. Characteristics include spores that are spherical, oval, or tubular in shape and sporoplasm which is uninuclear or binuclear. D&+Microspora Infections C03.752.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections Encephalitozoonosis Infections with protozoa of the phylum MICROSPORA. D P0=Microspora B01.841.500 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa Microsporea (+ 5) A phylum of protozoa comprising minute intracellular parasites with spores of unicellular origin. It has two classes: Rudimicrosporea and MICROSPOREA. D.&Microspheres E07.579 Enzymes, Immobilized Equipment and Supplies D{ Microspectrophotometry E05.196.712.726.300; E05.196.867.826.300 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Spectrophotometry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrophotometry Analytical technique for studying substances present at enzyme concentrations in single cells, in situ, by measuring light absorption. Light from a tungsten strip lamp or xenon arc dispersed by a grating monochromator illuminates the optical system of a microscope. The absorbance of light is measured (in nanometers) by comparing the difference between the image of the sample and a reference image. Spectrophotometry (66-89) D."Microsomes, Liver A11.904.540.541 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Subcellular Fractions; Microsomes Microsomes isolated from hepatocytes. Liver (66-69); Microsomes (66-69) DE(1-*Microsomes A11.904.540 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Subcellular Fractions Microsomes, Liver Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (Glick, Glossary of Biochemistry and Molecular Biology, 1990; from Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed). DE(#Microscopy, Video E05.595.690 HIISMT Miscellaneous Techniques (Non MeSH); Microscopy Microscopy in which television cameras are used to brighten magnified images that are otherwise too dark to be seen with the naked eye. Microscopy (74-94) D 9Microscopy, Ultraviolet E05.595.680 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Microscopy Microscopy in which the image is formed by ultraviolet radiation and is displayed and recorded by means of photographic film. Microscopy (66-72); Ultraviolet Rays (66-72) D-"96Microscopy, Scanning Tunneling E01.357.585.590.500; E05.595.402.541.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Microscopy, Atomic Force Microscopy, Atomic Force Diagnosis; Diagnostic Imaging; Microscopy, Electron; Microscopy, Electron, Scanning Miscellaneous Techniques (Non MeSH); Microscopy; Microscopy, Electron; Microscopy, Electron, Scanning Electron microscopy in which a very sharp conducting needle is swept just a few angstroms above the surface of a sample. The tiny tunneling current that flows between the sample and the needle tip is measured and from this are produced three-dimensional topographs, with a lateral resolution often as good as 1-2 angstroms and a vertical resolution of less than 1 angstrom. Due to their composition, biological samples are usually coated with a conductive layer, e.g., by depositing a thin metal or carbon film on top of the sample, to enhance their conductivity. Microscopy, Electron, Scanning (87-90) $D$."-Microscopy, Polarization E05.595.624 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Microscopy Microscopy using polarized light in which phenomena due to the preferential orientation of optical properties with respect to the vibration plane of the polarized light are made visible and correlated parameters are made measurable. D"9Microscopy, Phase-Contrast E05.490.630.569; E05.595.513.569 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Interferometry; Microscopy, Interference Miscellaneous Techniques (Non MeSH); Microscopy; Microscopy, Interference A form of interference microscopy in which variations of the refracting index in the object are converted into variations of intensity in the image. This is achieved by the action of a phase plate. D&"Microscopy, Interference E05.490.630; E05.595.513 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Interferometry Miscellaneous Techniques (Non MeSH); Microscopy Microscopy, Phase-Contrast Microscopy, Phase-Contrast Microscopy in which physiological and photometric contrast in the image is influenced or produced by the action of optical components which regulate interference. D"t<Microscopy, Immunoelectron E01.357.585.625; E05.595.402.625 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Microscopy, Electron Miscellaneous Techniques (Non MeSH); Microscopy; Microscopy, Electron Microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. Immunoelectron microscopy is used extensively in diagnostic virology as part of very sensitive immunoassays. Microscopy, Electron (73-90) D&""Microscopy, Fluorescence E05.595.458 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Microscopy Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. D,"9=Microscopy, Electron, Scanning Transmission E01.357.585.590.250; E05.595.402.541.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Microscopy, Electron; Microscopy, Electron, Scanning Miscellaneous Techniques (Non MeSH); Microscopy; Microscopy, Electron; Microscopy, Electron, Scanning A type of electron microscopy which scans with an extremely narrow beam that is transmitted through the sample. The detection apparatus produces an image whose brightness depends on the atomic number of the sample. It should not be confused with MICROSCOPY, ELECTRON SCANNING nor with MICROSCOPY, ELECTRON, TRANSMISSION (see MICROSCOPY, ELECTRON). (McGraw-Hill Dictionary of Scientific and Technical Terms, 3d ed). Microscopy, Electron, Scanning (69-92) D2."-Microscopy, Electron, Scanning E01.357.585.590; E05.595.402.541 AECLCTECHIISMOMTNUPXSNSTTDUTVE Corrosion Casting Diagnosis; Diagnostic Imaging; Microscopy, Electron Miscellaneous Techniques (Non MeSH); Microscopy; Microscopy, Electron Microscopy, Electron, Scanning Transmission; Microscopy, Scanning Tunneling Microscopy, Electron, Scanning Transmission; Microscopy, Scanning Tunneling Microscopy in which the object is examined directly by an electron beam scanning the specimen point-by-point, giving the surface image a three-dimensional quality. Microscopy, Electron (66-68) $Dѡ$&""Microscopy, Electron E01.357.585; E05.595.402 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging Miscellaneous Techniques (Non MeSH); Microscopy Microscopy, Electron, Scanning (+ 2); Microscopy, Immunoelectron Microscopy, Electron, Scanning (+ 2); Microscopy, Immunoelectron Visual and photographic microscopy in which electron beams with wavelengths thousands of times shorter than visible light are used in place of light, thereby allowing much greater magnification. Di"[Microscopy, Confocal E05.595.395 HIISMT Miscellaneous Techniques (Non MeSH); Microscopy A light microscopic technique in which only a small spot is illuminated and observed at a time. An image is constructed through point-by-point scanning of the field in this manner. Light sources may be conventional or laser, and fluorescence or transmitted observations are possible. Microscopy (85-94); Microscopy, Fluorescence (85-94) Dּ 9M>Microscopy, Atomic Force E05.595.380 HIISMT Microscopy, Scanning Tunneling Microscopy, Scanning Tunneling Miscellaneous Techniques (Non MeSH); Microscopy Microscopy in which a probe systematically rides across the surface of a sample being scanned in a raster pattern. The vertical position is recorded as a spring attached to the probe rises and falls in response to peaks and valleys on the surface. A microcomputer keeps track of the vertical excursions as a function of the position of the probe in the horizontal plane and presents the sample's image. Microscopy (88-94); Microscopy, Scanning Tunneling (88-94) $D $$9EMicroscopy E05.595; H01.671.606.624 HIISMT Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics; Optics Micromanipulation; Microscopy, Atomic Force; Microscopy, Confocal; Microscopy, Electron (+ 4); Microscopy, Fluorescence; Microscopy, Interference (+ 1); Microscopy, Polarization; Microscopy, Ultraviolet; Microscopy, Video; Photomicrography; Spectrometry, Mass, Secondary Ion The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye. AECLCTECHIISMOMTNUPXSNSTTDUTVE  D a="Microradiography E01.357.818.590 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Production of a radiographic image of a small or very thin object on fine-grained photographic film under conditions which permit subsequent microscopic examination or enlargement of the radiograph at linear magnifications of up to several hundred and with a resolution approaching the resolving power of the photographic emulsion (about 1000 lines per millimeter). Dސ"3Micropore Filters E07.560; H01.181.529.365.541 AECLCTECHISDSNSTTDUTVE Ultrafiltration Equipment and Supplies Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Filtration Filtration (66-71) D"qMicrophthalmos C11.250.566; C16.131.384.666 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Congenital or developmental anomaly in which the eyeballs are abnormally small. D"L^Micronucleus Tests E05.393.560.598 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Mutagenicity Tests Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei in cells which have been exposed to genotoxic agents or ionizing radiation. Cell Nucleus (71-88); Genetic Techniques (72-80); Mutagenicity Tests (81-88) Do"Y\Micronuclei A11.630 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Chromosome Aberrations Cells Nuclei, separate from and additional to the main nucleus of a cell, produced during the telophase of mitosis or meiosis by lagging chromosomes or chromosome fragments derived from spontaneous or experimentally induced chromosomal structural changes. Cell Nucleus (66-89); Chromosome Aberrations (72-89); Mutagenicity Tests (81-89)  Dd *  `Micronesia Z01.782.680 EHEP Geographicals (Non MeSH); Pacific Islands Guam The collective name for islands of the Pacific Ocean east of the Philippines, including the Mariana, Palau, Caroline, Marshall, and Kiribati Islands. Micronesia (from the Greek micro, small + nesos, island) is inhabited by a mixed race of Melanesians, Polynesians, and some Malaysians. Dw3MMicromonosporaceae B03.100.067.500; B03.300.390.400.500; B03.510.415.400.500; B03.510.460.410.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH) Micromonospora Micromonospora Micromonospora Micromonospora A family of gram-positive, saprophytic bacteria occurring in soil and aquatic environments. Bacteria (66-74); Streptomycetaceae (75)  DKX"Bk1Micromonospora B03.100.067.500.457; B03.300.390.400.500.457; B03.510.415.400.500.457; B03.510.460.410.500.457 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Micromonosporaceae Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Micromonosporaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Micromonosporaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Micromonosporaceae A genus of gram-positive bacteria that forms a branched mycelium. It commonly occurs as a saprophytic form in soil and aquatic environments. Dh"KMicromanipulation E05.595.346 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Microscopy The performance of dissections, injections, surgery, etc., by the use of micromanipulators (attachments to a microscope that manipulate tiny instruments). D"9Microinjections E05.300.530.690 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Injections (66-72) D"YMicrognathism C05.500.460.457; C05.660.514.457; C07.320.440.457; C07.650.460.457; C16.131.621.514.457; C16.131.850.460.457 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases; Jaw Abnormalities Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Stomatognathic Diseases; Jaw Diseases; Jaw Abnormalities Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Jaw Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Jaw Abnormalities Unusual or undue smallness of the jaws. (Dorland, 27th ed). DzLnKMicroglia A08.637.400; A11.650.400 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neuroglia Cells; Neuroglia The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling. Neuroglia (66-93) Dh *4Microfilming L01.240.630 CLECHIISLJMTSDSNSTTDUT Photography Information Science; Copying Processes D!.Microfilaria B01.500.294.700.750.700.300.470; B01.583.382.470 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea Invertebrates; Life Stages (Non MeSH); Larva The prelarval stage of Filarioidea in the blood and other tissues of mammals and birds. They are removed from these hosts by blood-sucking insects in which they metamorphose into mature larvae. D6*Microfilaments A11.368.250.510 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Cytoskeleton The smallest of the cytoskeletal filaments. They are composed chiefly of actin and/or myosin. Cytoplasm (66-76); Cytoskeleton (77-85) D*&q0Microfilament Proteins D12.776.220.525 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins Actinin; Actins; Gelsolin; Myosin (+ 1); Tropomyosin; Troponin Filaments which are composed primarily of actin and found in the cytoplasmic matrix of almost all cells. They are often associated with microtubules and may play a role in cytoskeletal function and/or mediate movement of the cell or the organelles within the cell. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  DF^O9HMicroelectrodes E07.296.623 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Electrodes Electrodes (68-70) E*Microdialysis E05.196.353.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Dialysis A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane. Dialysis (66-93) Et"Q!Microcomputers L01.700.568.080.260.550 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers Small computers using LSI (large-scale integration) microprocessor chips as the CPU (central processing unit) and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. "Microprocessor" may refer to just the CPU or the entire microcomputer. Computers (66-79) EhuMicrococcus luteus B03.100.067.100.500.400; B03.510.400.500.500.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group; Micrococcus Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Micrococcaceae; Micrococcus A species of gram-positive, spherical bacteria whose organisms occur in tetrads and in irregular clusters of tetrads. The primary habitat is mammalian skin. Micrococcus (68-91) EO6"Micrococcus B03.100.067.100.500; B03.510.400.500.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Micrococcaceae Micrococcus luteus Micrococcus luteus A genus of gram-positive, spherical bacteria found in soils and fresh water, and frequently on the skin of man and other animals. E.",Micrococcal Nuclease D08.586.277.352.335.350.500; D08.586.277.352.355.325.500; D08.586.277.352.355.350.500; D08.586.277.352.700.350.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endoribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases; Endoribonucleases An enzyme that catalyzes the endonucleolytic cleavage to 3'-phosphomononucleotide and 3'-phospholigonucleotide end-products. It can cause hydrolysis of double- or single-stranded DNA or RNA. (From Enzyme Nomenclature, 1992) EC 3.1.31.1. E |F!Micrococcaceae B03.510.400.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci Micrococcus (+ 1); Staphylococcus (+ 2) A family of bacteria ranging from free living and saprophytic to parasitic and pathogenic forms. Bacteria (66-74)  E"?2sMicroclimate G03.230.300.100.250.450 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Climate The climate of a very small area. E7u,Microcirculation A07.231.432; G09.330.163.645 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cardiovascular System; Blood Vessels Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation Arterioles; Arteriovenous Anastomosis; Capillaries; Venules The vascular network lying between the arterioles and venules; includes capillaries, metarterioles and arteriovenous anastomoses. Also, the flow of blood through this network. Blood Circulation (66-69); Capillaries (66-69) ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $E""6G88Microchemistry E05.196.620; H01.181.278.590 CLECEDHIISLJMAMTOGSNSTTD Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Analytical The study of chemical reactions, using small quantities of materials, frequently less than 1 milligram or 1 milliliter, and often requiring special small apparatus and microscopical observation. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). E"0Microcephaly C05.660.620; C16.131.621.620 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Abnormal smallness of the head, usually associated with mental retardation. (Dorland, 27th ed). E"LrMicrobodies A11.368.702.515 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Membrane-bound cytoplasmic particles containing enzymes and other substances. Organoids (66-72) E*$YMicrobiology G01.273.540 CLECEDHIISLJMAOGSNSTTD Bacteria; Fungi; Protozoa; Viruses Biological Sciences; Biology Bacteriology; Environmental Microbiology (+ 4); Industrial Microbiology; Mycology; Virology CLECEDHIISLJMAMTOGSNSTTD  E,#lMicrobiological Techniques E05.909.560 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical Bacteriological Techniques (+ 4); Colony Count, Microbial; Microbial Sensitivity Tests (+ 1); Mycological Typing Techniques; Serial Passage; Virus Cultivation (+ 1) Techniques used in microbiology. Microbiology (66-77); Mycology (66-77); Parasitology (66-77) AECLCTECHIISMOMTNUPXSNSTTDUTVE $E3 C(I"Microbiologic Phenomena (Non MeSH) G04.185.515 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) Antibiosis; Bacterial Phenomena (Non MeSH) (+ 4); Drug Resistance, Microbial (+ 9); Germ-Free Life (+ 1); Hemadsorption; Nitrogen Fixation; Transfection; Viral Phenomena (Non MeSH) (+ 12); Virulence CHCLDEENGEIMMEMIMTPAPHPSRARERISETRULUSVI EI)k,Microbial Sensitivity Tests E05.909.560.595 AECLCTECHIISMOMTNUPXSNSTTDUTVE Drug Resistance, Microbial Drug Resistance, Microbial Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques Serum Bactericidal Test Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Antibiotics (66-69); Drug Resistance, Microbial (66-69) (E+!"  bBMicrobial Collagenase D08.586.277.656.732.480.205.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Metalloproteinases; Collagenases A metalloproteinase which degrades helical regions of native collagen to small fragments. Preferred cleavage is -Gly in the sequence -Pro-Xaa-Gly-Pro-. Six forms (or 2 classes) have been isolated from Clostridium histolyticum that are immunologically cross-reactive but possess different sequences and different specificities. Other variants have been isolated from Bacillus cereus, Empedobacter collagenolyticum, Pseudomonas marinoglutinosa, and species of Vibrio and Streptomyces. EC 3.4.24.3. E c#F5Miconazole D03.383.374.550; D20.136.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Anti-Infective Agents; Antifungal Agents 1-(2-(2,4-Dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)imidazole. An antifungal agent. Benzyl Compounds (72-74); Ethers (71-74); Imidazoles (71-74) E#":nJMichigan Z01.107.567.875.100.502; Z01.107.567.875.600.313.502; Z01.107.567.875.600.516.502 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States E% YMicelles H01.181.529.183.500 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Colloids Electrically charged colloidal particles or ions consisting of oriented molecules; aggregates of a number of molecules held loosely together by secondary bonds. Colloids (68-74) E' UMice, Transgenic B02.158.199.085.600; B02.158.296.600; B02.649.865.635.500.600 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Mosaicism; Genetic Engineering Vertebrates; Animals; Animals, Laboratory; Animals, Transgenic Vertebrates; Animals; Animals, Transgenic Vertebrates; Mammals; Rodentia; Muridae; Mice Laboratory mice that have been produced from a genetically manipulated egg or embryo. The technique involves microinjection of foreign DNA fragments into the nucleus of the fertilized egg and transferring it into the uterus of a foster mother mouse. The inserted gene becomes integrated into every cell and tissue of the developing mouse, including its germ line cells. E)ZE&%Mice, SCID B02.649.865.635.500.440.780 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. Mice, Mutant Strains (83-91) E,(Sy#Mice, Quaking B02.649.865.635.500.440.560 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Mice homozygous for the mutant autosomal recessive gene, quaking (qk), associated with disorder in myelin formation and manifested by axial tremors. Mice (66-77); Mutation (66-77) E/(S'Mice, Obese B02.649.865.635.500.440.530 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Mice (66-74) E1(SMice, Nude B02.649.865.635.500.440.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Mice (66-74) E3d(SMice, Neurologic Mutants B02.649.865.635.500.440.480 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Mice which carry mutant genes for neurologic defects or abnormalities. Mice, Inbred Strains (72-78) E4(ST#Mice, Mutant Strains B02.649.865.635.500.440 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice Mice, Jimpy; Mice, Knockout (+ 1); Mice, Neurologic Mutants; Mice, Nude; Mice, Obese; Mice, Quaking; Mice, SCID Mice bearing mutant genes which are phenotypically expressed in the animals. E6O(9[Mice, Knockout B02.649.865.635.500.440.450 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Genetic Engineering Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Mice, Inbred mdx Mice whose genome contains a gene whose function has been disrupted, or "knocked-out". A common method of producing disabled genes using recombinant DNA technology is by inserting an antibiotic resistance gene into the normal DNA sequence of a clone of the gene being studied. This disrupts the gene's action, thereby preventing it from making an active protein product. Cells in which this transfer is successful are then injected into mouse embryos, producing chimeric mice. These mice are bred to yield a strain in which all the cells contain the knocked-out gene. Knockout mice are used as animal models for various diseases, such as cystic fibrosis, and are helping to clarify the functions of the genes studied within the fields of immunology, cancer genetics, and developmental biology. Mice (92-93) $E7(SMice, Jimpy B02.649.865.635.500.440.430 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains Myelin-deficient mutants which are from the inbred Tabby-Jimpy strain. Mice, Inbred Strains (72-78) E<(SS#Mice, Inbred Strains B02.158.157.250; B02.649.865.635.500.380 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice Mice, Inbred A; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL (+ 1); Mice, Inbred CBA; Mice, Inbred CFTR; Mice, Inbred DBA; Mice, Inbred HRS; Mice, Inbred ICR; Mice, Inbred NOD; Mice, Inbred NZB; Mice, Inbred SENCAR Mice, Inbred A; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL (+ 1); Mice, Inbred CBA; Mice, Inbred CFTR; Mice, Inbred DBA; Mice, Inbred HRS; Mice, Inbred ICR; Mice, Inbred NOD; Mice, Inbred NZB; Mice, Inbred SENCAR Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Mice (66-71)  E=.(n\cMice, Inbred SENCAR B02.158.157.250.600; B02.649.865.635.500.380.600 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice selectively bred for hypersusceptibility to two-stage chemical skin carcinogenesis. They are also hypersusceptible to UV radiation tumorigenesis with single high-dose, but not chronic low-dose, exposures. SENCAR (SENsitive to CARcinogenesis) mice are used in research as an animal model for tumor production. Mice (81-94) EB6(iMice, Inbred NZB B02.158.157.250.580; B02.649.865.635.500.380.580 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) EE6(Mice, Inbred NOD B02.158.157.250.565; B02.649.865.635.500.380.565 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Diabetes Mellitus, Experimental; Diabetes Mellitus, Insulin-Dependent Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Diabetes Mellitus, Experimental (80-91); Mice (80-91)  EF6(O@@Mice, Inbred mdx B02.158.157.250.420.500; B02.649.865.635.500.380.420.500; B02.649.865.635.500.440.450.410 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Muscular Dystrophy; Dystrophin Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains; Mice, Inbred C57BL Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains; Mice, Inbred C57BL Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Mutant Strains; Mice, Knockout A strain of mice arising from a spontaneous mutation (mdx) in inbred C57BL mice. This mutation is X chromosome-linked and produces viable homozygous animals that lack the muscle protein dystrophin, have high serum levels of muscle enzymes, and possess histological lesions similar to human muscular dystrophy. The histological features, linkage, and map position of mdx make these mice a worthy animal model of Duchenne muscular dystrophy. Mice, Inbred C57BL (84-93); Mice, Mutant Strains (84-93)  EIa(%6EMice, Inbred ICR B02.158.157.250.510; B02.649.865.635.500.380.510 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) ENI6(Mice, Inbred HRS B02.158.157.250.480; B02.649.865.635.500.380.480 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Homozygous, permanently near-hairless mice which lose their hair at about 10 days of age. EO6(kMice, Inbred DBA B02.158.157.250.460; B02.649.865.635.500.380.460 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) EQ76(Mice, Inbred C57BL B02.158.157.250.420; B02.649.865.635.500.380.420 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Carcinoma, Lewis Lung Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice, Inbred mdx Mice, Inbred mdx Mice (66-71)  ER6(*Mice, Inbred C3H B02.158.157.250.388; B02.649.865.635.500.380.388 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) ET6(Mice, Inbred CFTR B02.158.157.250.445; B02.649.865.635.500.380.445 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Cystic Fibrosis Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains A strain of mice widely studied as a model for cystic fibrosis. These mice are generated from embryonic stem cells in which the CFTR (cystic fibrosis transmembrane conductance regulator) gene is inactivated by gene targeting. As a result, all mice have one copy of this altered gene in all their tissues. Mice homozygous for the disrupted gene exhibit many features common to young cystic fibrosis patients, including failure to thrive, meconium ileus, and alteration of mucous and serous glands. Mice (92-93)  EUd6(FMice, Inbred CBA B02.158.157.250.440; B02.649.865.635.500.380.440 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) EY6(Mice, Inbred BALB C B02.158.157.250.338; B02.649.865.635.500.380.338 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) EZ[6(Mice, Inbred AKR B02.158.157.250.318; B02.649.865.635.500.380.318 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) E[6(Mice, Inbred A B02.158.157.250.300; B02.649.865.635.500.380.300 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals; Animals, Inbred Strains; Mice, Inbred Strains Vertebrates; Mammals; Rodentia; Muridae; Mice; Mice, Inbred Strains Mice (66-71) E\6(Mice B02.649.865.635.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae Mice, Inbred Strains (+ 14); Mice, Mutant Strains (+ 8); Mice, Transgenic The common name for the species Mus musculus. E^;(1\9Mianserin D03.494.240.550; D14.100.050.200.100.485; D14.100.850.850.530; D15.085.025.530; D15.700.122.050.530 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic and some types of serotonin receptors. Dibenzazepines (72-74); Pyrazines (72-74) E_o o: 2Mezlocillin D20.085.099.739.762.057.585 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Ampicillin 3,3-Dimethyl-6-(((((3-(methylsulfonyl)-2-oxo-1- imidazolidinyl)carbonyl)amino)phenylacetyl)amino)- 7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections. Penicillins (66-83) Ed8:ouMexiletine D02.092.831.500; D18.097.520 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Propylamines Cardiovascular Agents; Anti-Arrhythmia Agents 1-(2,6-Dimethylphenoxy)-2-propanamine. Antiarrhythmic agent pharmacologically similar to lidocaine. It may have some anticonvulsant properties. Phenyl Ethers (74); Propylamines (72-74) Ef":q2Mexico Z01.107.567.589 EHEP Geographicals (Non MeSH); America; North America Eh <Mexican Americans I01.076.201.450.416.350.500; I01.880.143.522.350.500; M01.194.285.500 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups; Hispanic Americans Social Sciences; Sociology; Culture; Ethnic Groups; Hispanic Americans Named Groups (Non MeSH); Ethnic Groups; Hispanic Americans Persons living in the United States of Mexican descent. Hispanic Americans (77-91); Mexico/ethnology (78-91) EiM D?Mevinphos D02.705.434; D05.723.491.574.456 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate EkF &:Mevalonic Acid D02.241.511.579 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids El:KMetyrapone D03.383.725.463 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines EmU:UMetrorrhagia C13.371.852.691.622; C23.542.946.664 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Uterine Hemorrhage Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Uterine Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Uterine Hemorrhage Uterine bleeding, usually of normal amount, occurring at completely irregular intervals, the period of flow sometimes being prolonged. (Dorland, 27th ed). En$*NMetronidazole D02.640.672.500; D03.383.374.658.500; D21.370.370.664; D26.776.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antitrichomonal Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents 2-Methyl-5-nitroimidazole-1-ethanol. Antiprotozoal used in amebiasis, trichomoniasis, giardiasis, and as treponemacide in livestock. It has also been proposed as a radiation sensitizer for hypoxic cells. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985, p. 133), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed). EpL:]Metrizoate D02.241.223.106.530.718.480; D26.298.695 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 3-Acetamido-2,4,6-triiodo-5-(N-methylacetamido)benzoate. Usually the sodium salt. Contrast medium suitable for angiography. Synonyms: Isopaque; NSC 107431; Ronpacon [a mixture of the calcium, sodium, and magnesium salts]; Triosil. Diatrizoate (72-74); Salts (72-74) EtI.. +Metrizamide D02.241.223.106.530.718.470; D09.203.408.051.545; D26.298.686 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 2-((3-(Acetylamino)-5-(acetylmethylamino)-2,4,6- triiodobenzoyl)amino)-2-deoxy-D-glucose. Solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also being used as a resorbable, non-ionic contrast medium. Acetamides (71-77); Benzamides (73-77); Glucosamine (66-77); Iodobenzoates (72-77) EvE.CFcMetric System H01.939.539 HIISST Physical Sciences (Non MeSH); Weights and Measures Ez~ >Metribolone D04.808.365.415.550; D06.597.100.650 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic 17 beta-Hydroxy-17-methylestra-4,9,11-trien-3-one. A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors. Androgens, Synthetic (75-89); Estranes (68-72); Estrenes (73-89) E{*:4NMetrial Gland A13.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Collection of granular epithelial cells in the uterine muscle beneath the placenta that develop during pregnancy in certain species of animals. Uterus (66-74) E} :Metoprolol D02.033.329.624.550; D02.092.063.624.550; D14.100.050.200.200.500; D16.050.850.470 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics 1-(4-(2-Methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol. Adrenergic beta-1-blocking agent with no stimulatory action. It is less bound to plasma albumin than alprenolol and may be useful in angina pectoris, hypertension, or cardiac arrhythmias. Phenyl Ethers (75); Propanolamines (74-76); Propylamines (74-76) E\:'NMetolazone D02.065.884.600; D02.886.590.700.600; D03.438.786.560; D19.770.224.516.630 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinazolines Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl 7-Chloro-1,2,3,4-tetrahydro-2-methyl-4-oxo-3-o-tolyl-6-quinazoline sulfonamide. A potent, long acting diuretic useful in chronic renal disease; also tends to lower blood pressure and increase potassium loss. Synonyms: SR 720-22; Zaroxolyn. Diuretics, Sulfamyl (74); Quinazolines (71-74) ET:n8Metoclopramide D02.065.277.573; D02.241.223.106.162.573; D14.100.150.175.500; D15.095.587; D16.050.030.587 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics A dopamine D2 antagonist that is used as an antiemetic. Eg:EMetmyoglobin D12.776.422.690 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins Myoglobin which is in the oxidized ferric or hemin form. The oxidation causes a change in color from red to brown. Ferric Compounds (75-78); Hemeproteins (73-78); Myoglobin (66-78) EHTOMetipranolol D02.033.134.624.500; D02.033.329.624.545; D02.092.063.624.545; D14.100.050.200.200.490; D16.050.850.465; D18.097.510; D18.162.570 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Propyl; Propanolamines Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent. Amino Alcohols (66-73); Propanolamines (74-78) EA:v8Metiamide D02.886.904.455; D02.948.898.455; D14.100.375.425.425.500; D19.316.203.591 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents A histamine H2 receptor antagonist that is used as an anti-ulcer agent. Imidazoles (74); Sulfides (74); Thiourea (74) E T:W:Methysergide D03.132.327.287.689; D03.549.439.689; D14.100.850.850.520 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists An ergot derivative that is a congener of LSD. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. EA:AMethylurea Compounds D02.948.511 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea Diuron; Linuron Urea compounds which are substituted with one or more methyl groups. Urea (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $E 8,S:Methyltyrosines D12.125.072.917.664 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Tyrosine EyD{Methyltransferases D08.586.913.517 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Acetylserotonin Methyltransferase; Catechol Methyltransferase; DNA (Cytosine-5-)-Methyltransferase; DNA Modification Methylases (+ 2); Histamine Methyltransferase; Phenethanolamine N-Methyltransferase; Protein Methyltransferases (+ 3); RNA, Transfer, Methyltransferases; Tetrahydropteroylglutamate Methyltransferase; Thymidylate Synthetase Transferases (66-70) EFU|Methylthiouracil D03.383.742.698.875.842.455; D06.347.789.476 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil; Thiouracil Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Thyroid Antagonists E2:Methylthioinosine D13.570.583.616.900.500; D13.570.800.573.900.500; D13.570.900.800.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Inosine; Thioinosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Inosine; Thioinosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Thionucleosides; Thioinosine 6-(Methylthio)-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position. Inosine (72-74); Sulfides (72-74) EM:l*Methyltestosterone D04.808.054.079.429.824.664; D06.597.100.622 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Testosterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic 17 beta-Hydroxy-17-methylandrost-4-en-3-one. E}2:2Methylprednisolone Hemisuccinate D04.808.745.432.769.795.539.500; D06.597.481.364.600.500; D06.597.481.561.353.744.622.500; D06.597.481.561.478.702.622.500; D15.095.568.500; D16.050.030.568.500; D17.025.050.625.500.500; D17.025.080.200.500.500; D17.050.040.650.500.500; D23.037.200.500.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols; Prednisolone; Methylprednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical; Methylprednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Prednisolone; Methylprednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic; Prednisolone; Methylprednisolone Central Nervous System Agents; Antiemetics; Methylprednisolone Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics; Methylprednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone; Methylprednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Methylprednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone; Methylprednisolone Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Methylprednisolone (6 alpha,11 beta)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione. A water-soluble ester of METHYLPREDNISOLONE used for cardiac, allergic, and hypoxic emergencies. Methylprednisolone (66-74)/analogs and derivatives (75-79); Succinates (66-79) E%:m[Methylprednisolone D04.808.745.432.769.795.539; D06.597.481.364.600; D06.597.481.561.353.744.622; D06.597.481.561.478.702.622; D15.095.568; D16.050.030.568; D17.025.050.625.500; D17.025.080.200.500; D17.050.040.650.500; D23.037.200.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols; Prednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Prednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic; Prednisolone Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate Methylprednisolone Hemisuccinate (6 alpha,11 beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,2-dione. A prednisolone derivative which has pharmacological actions similar to prednisolone. E]:`Methylphenidate D02.241.223.601.600; D03.383.621.460; D14.100.050.600.050.545; D14.100.050.600.560; D14.100.150.600.220.537; D14.100.150.600.522; D14.100.600.050.545; D14.100.600.220.542; D15.220.564; D16.050.870.510 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. Ed:Methylphenazonium Methosulfate D03.494.704.550 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenazines 5-Methylphenazinium methosulfate. Used as an electron carrier in place of the flavine enzyme of Warburg in the hexosemonophosphate system and also in the preparation of succinic dehydrogenase. Phenazines (70-74); Sulfuric Acids (72-74) E:#.V4Methylococcaceae B03.440.400.425.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) A family of gram-negative, aerobic bacteria utilizing only one-carbon organic compounds. Bacteria (66-74) E/"gMethylnitrosourea D02.654.692.480; D02.948.594.490; D26.191.612 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 1-Methyl-1-nitrosourea. A nitrosourea compound with alkylating, carcinogenic and mutagenic properties. Methane (73-74); Nitrosourea Compounds (73-74) E5.u8Methylnitronitrosoguanidine D02.078.370.649.400; D02.654.567.400; D26.191.598 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amidines; Guanidines; Nitrosoguanidines Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosoguanidines Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 1-Methyl-3-nitro-1-nitrosoguanidine. A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. Nitro Compounds (73-74); Nitrosoguanidines (73-74) E9.<Methylmethacrylates D02.241.081.069.800.550; D25.720.716.822.111.650.605 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates; Polymethacrylic Acids Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic; Acrylic Resins; Polymethacrylic Acids Methyl 2-methyl-2-propenoate and polymer. The methyl ester of methacrylic acid that polymerizes easily and is used as a tissue cement, dental material, absorbent for biological substances, and as copolymer in plastics. Acrylic Resins (66-71) E:,Methylmercury Compounds D02.691.750.100.738; D05.723.288.050.601 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial; Alkylmercury Compounds Antifungal Agents (66-71); Mercury (66-71); Mercury Poisoning (66-71); Organometallic Compounds (68-71) E.8{Methylmannosides D09.203.408.490.500; D09.203.408.514.700 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Mannosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Methylglycosides Mannosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with methyl alcohol. They include both alpha- and beta-methylmannosides. Methylglycosides (74); Mannose (74) E.>,Methylmalonyl-CoA Mutase D08.586.399.565 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases An enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA. It requires a cobamide coenzyme. A block in this enzymatic conversion leads to the metabolic disease, methylmalonic aciduria. EC 5.4.99.2. Isomerases (69-74); Malonates (69-74) E\FS.Methylmalonic Acid D02.241.081.337.540.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Malonates Methylpropanedioic acid. A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. Malonates (74) Ew:~kMethylhydrazines D02.442.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Dimethylhydrazines; Monomethylhydrazine Hydrazines substituted by one or more methyl groups in any position. Hydrazines (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $E82-S:Methylhistidines D12.125.072.329.539 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Histidine Histidine substituted in any position with one or more methyl groups. Histidine (66-71) EГ8|TMethylhistamines D02.092.211.215.501.621; D02.092.471.440.500; D03.383.374.373.500 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Histamine Organic Chemicals (Non MeSH); Amines; Ethylamines; Histamine Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Histamine Histamine substituted in any position with one or more methyl groups. Many of these are agonists for the H1, H2, or both histamine receptors. Histamine (70-76) EI<Methylguanidine D02.078.370.570 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines A product of putrefaction. Poisonous. Guanidines (69-74) Eԓ:>/Methylglycosides D09.203.408.514 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Methylgalactosides; Methylglucosides; Methylmannosides E՞>Y>Methylglycine D12.125.481.622 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine EֽDSMethylglucosides D09.203.408.514.622; D09.203.408.348.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Methylglycosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Eח.>Methylgalactosides D09.203.408.514.455; D09.203.408.320.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Methylglycosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Galactosides E.>Methylergonovine D03.132.327.287.262.455; D03.549.439.262.538 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines; Ergonovine Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines; Ergonovine E}2:Methylenetetrahydrofolate Dehydrogenase D08.586.682.545 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Catalyzes the oxidation of methylenetetrahydrofolate to 5,10-methenyltetrahydrofolate. Includes EC 1.5.1.15 which uses NAD+. EC 1.5.1.5. Oxidoreductases (73-74); Tetrahydrofolates (73-74) E,FX;Methylenebis(chloroaniline) D02.092.146.500; D02.455.426.559.389.115.500; D26.191.588 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Aniline Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzhydryl Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 4,4'-Methylene-bis(2-chloroaniline). Aromatic diamine used in the plastics industry as curing agent for epoxy resins and urethane rubbers; it causes bladder, liver, lung and other neoplasms. Synonyms: CLMDA; Quodorole; MOCA. Aniline Compounds (74-76); Benzhydryl Compounds (75-76); Hydrocarbons, Chlorinated (74) Eݼ A.7gMethylene Chloride D02.455.526.439.642 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Dichloromethane. A chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations. Its primary use is as a solvent in manufacturing and food technology. Hydrocarbons, Chlorinated (74); Methane (74) E:p6Methylene Blue D03.494.741.517; D20.237.510; D26.408.537 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Anti-Infective Agents; Anti-Infective Agents, Urinary Miscellaneous Drugs and Agents (Non MeSH); Dyes EA1.Methyldopa D02.092.311.242.538; D12.125.072.573.400.600; D14.100.050.100.100.510; D16.050.850.460; D18.162.558 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Dopa Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Phenylalanine; Dopa Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents Carbidopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Before its alpha-adrenergic actions became clear, methyldopa was thought to act by inhibiting decarboxylation of DOPA leading to depletion of norepinephrine or by conversion to and release as the false transmitter alpha-methylnorepinephrine. Eo:Methyldimethylaminoazobenzene D26.191.282.588 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; p-Dimethylaminoazobenzene N,N-Dimethyl-p-(m-tolylazo)aniline. Very potent liver carcinogen. Synonyms: MDAB; MeDAB; 3-methyl-DAB; 3'-methyl-4-dimethylaminoazobenzene. Dimethylaminoazobenzene (72-74); Methane (73-74) Ed!:_9Methylcholanthrene D26.191.579 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Carcinogens E1.BMethylcellulose D09.203.698.365.180.663; D19.316.396.618 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Cellulose Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Carboxymethylcellulose Carboxymethylcellulose Methylester of cellulose. Used as suspending agent in cosmetics, pharmaceutics and the chemical industry; therapeutically as bulk laxative. Synonyms: Cellumeth; Cologel; Hydrolose; Nicel; Tearisol. E..2Methylazoxymethanol Acetate D02.172.080.600; D26.191.090.600 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds; Azoxymethane Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Azoxymethane (Methyl-ONN-azoxy)methanol acetate. The aglycone of cycasin. It acts as a potent carcinogen and neurotoxin and inhibits hepatic DNA, RNA, and protein synthesis. Alcohol, Methyl (73-74); Azo Compounds (73-74) Ej &.9Methylation G06.535.630.146.538; H01.181.404.146.538 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH); Alkylation Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic; Alkylation E.Methylamines D02.092.668 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Dimethylamines (+ 1) Amines (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  E8.:Methyl Parathion D02.719.746.500; D05.723.491.657.763.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds; Parathion Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate; Parathion Phosphorothioic acid, O,O-dimethyl O-(4-nitrophenyl) ester. The methyl homolog of parathion. An effective, but highly toxic, organothiophosphate insecticide and cholinesterase inhibitor. Parathion (73-74) E.:Methyl N-Butyl Ketone D02.522.520.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Hexanones 2-Hexanone. An industrial solvent which causes nervous system degeneration. Synonym: MBK. Hexanones (75-76); Ketones (66-76) EM:<j+Methyl Methanesulfonate D02.455.326.146.100.050.500.500; D02.886.645.600.055.050.510.500; D05.569.468.575; D22.204.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Alkanesulfonates; Mesylates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Alkanesulfonates; Mesylates Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Mutagens Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Methanesulfonic acid, methyl ester. An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA. Alkanes (66-73); Methane (66-73); Methanesulfonates (74); Sulfonic Acids (66-73) Eh:bMethyl Green D26.408.735.600 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes; Rosaniline Dyes (4-(para(Dimethylamino)-alpha-(para(dimethylamino)phenyl) benzylidene)-2,5-cyclohexadien-1-ylidene)dimethylammonium chloride ethobromide. Used as a biological stain and for the dyeing and printing of textiles. Usually compounded with zinc chloride. Rosaniline Dyes (72-74) E.OMethyl Ethers D02.355.601 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers Anisoles (+ 2); Bis(Chloromethyl) Ether; Enflurane; Guaiacol (+ 2); Isoflurane; Methoxyflurane Ethers (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  E8.t:Methyl Chloride D02.455.526.439.632 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated E:pMethyclothiazide D03.438.174.620; D18.162.276.572; D19.770.224.578.572 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide E=:"Methoxyhydroxyphenylglycol D02.033.618.454 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols 1-(4-Hydroxy-3-methoxyphenyl)-1,2-ethanediol. Synthesized by animals from endogenous epinephrine and norepinephrine. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover. Glycols (66-74) F:; Methoxyflurane D02.355.417.600; D02.355.601.620; D15.050.035.060.500; D15.210.100.175.060.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Ethyl Ethers Organic Chemicals (Non MeSH); Ethers; Methyl Ethers Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p.180). FX:rMethoxydimethyltryptamines D02.092.211.215.801.451.601; D03.438.473.914.237.150.500; D03.438.473.914.814.150.500 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Tryptamines; N,N-Dimethyltryptamine Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; N,N-Dimethyltryptamine; Bufotenin Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; Serotonin; Bufotenin Compounds that contain the biogenic monoamine tryptamine and are substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia. Bufotenin (66-74) /analogs and derivatives (75-79); Dimethyltryptamine (73-79); Serotonin (66-74) /analogs and derivatives (75-79); Tryptamines (66-73) F]<Methoxychlor D02.455.526.439.610; D05.723.491.491.651 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Insecticides (66-72) F B.:Methoxsalen D03.438.150.446.750.480.500; D23.600.500; D26.776.819.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; Psoralens; Ficusin Dermatologic Agents; Photosensitizing Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents; Photosensitizing Agents A furocoumarin obtained from several different plants, especially Psoralea corylifolia. It is used to increase skin pigmentation with sunlight in the treatment of depigmentation conditions such as vitiligo and may cause skin burns and liver damage. F A:!Methoxamine D02.033.329.624.536; D02.092.063.624.536; D02.092.471.683.661; D14.100.050.100.100.500; D16.050.870.500; D18.793.572 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents An alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system. F:9Methotrimeprazine D03.494.741.513; D14.100.150.175.496; D15.150.025.515; D15.210.950.040.025.515; D15.700.872.331.025.513 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine with pharmacological activity similar to that of both CHLORPROMAZINE and PROMETHAZINE. It has the histamine-antagonist properties of the antihistamines together with central nervous system effects resembling those of chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.604). Fs:bMethotrexate D03.438.733.631.192.500; D17.050.550; D22.204.144.579.192.500; D26.087.393.052.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins; Aminopterin Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic; Folic Acid Antagonists; Aminopterin Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Folic Acid Antagonists; Aminopterin N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamic acid. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of difolate reductase and prevents the formation of tetrahydrofolate, necessary for DNA formation. It has also been used in the treatment of psoriasis. Fk\:lMethoprene D02.241.081.436.490; D06.472.445.573.666.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Invertebrate Hormones; Insect Hormones; Juvenile Hormones Isopropyl-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate. Juvenile hormone analog and insect growth regulator used to control insects by disrupting metamorphosis. Has been effective in controlling mosquito larvae. Synonyms: ZR-515; Altosid. Fatty Acids, Unsaturated (73-74); Juvenile Hormones (73-75); Methyl Ethers (74) F2:`Methonium Compounds D02.092.102.558; D02.675.276.558 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Decamethonium Compounds; Hexamethonium Compounds (+ 1) Decamethonium Compounds; Hexamethonium Compounds (+ 1) Compounds containing polymethylene bis-trimethylammonium cations. Members of this group frequently act as ganglionic blockers and neuromuscular depolarizing agents. F&8~Methomyl D05.723.491.408.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Carbamate S-Methyl N-[methylcarbamoyl)oxy]thioacetimidate. Insecticide. Synonym: Lannate. Carbamates (71-74); Imines (71-74); Sulfides (71-74) F"  :r[AMethohexital D03.383.742.698.253.488; D15.050.035.075.500; D15.210.100.175.075.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous An intravenous anesthetic with a short duration of action that may be used for induction of anesthesia. F#M:o|Methods E05.581; H01.770.370 Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Science F&B WMethocarbamol D02.241.081.251.515; D02.355.601.536.400.500; D02.755.075.536.400.500; D15.525.480; D16.700.600.480 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Organic Chemicals (Non MeSH); Ethers; Methyl Ethers; Guaiacol; Guaiacol Glyceryl Ether Organic Chemicals (Non MeSH); Phenols; Anisoles; Guaiacol; Guaiacol Glyceryl Ether Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A centrally acting muscle relaxant whose mode of action has not been established. It is usd as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1206). F&o:5Methisazone D02.845.746.703.450; D02.886.803.450; D03.438.473.615; D20.388.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Semicarbazides; Semicarbazones; Thiosemicarbazones Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiosemicarbazones Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Anti-Infective Agents; Antiviral Agents 1-Methylindole-2,3-dione 3-(thiosemicarbazone). An antiviral agent effective against pox viruses. Synonym: Marboran. Indoles (69-74); Thiosemicarbazones (71-74) F*L:74Methiothepin D03.494.311.520; D14.100.850.850.500; D15.150.485; D15.210.950.040.485; D15.700.872.331.521 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzothiepins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents 8-Methylthio-10-(4-methyl-1-piperazinyl)-10,11-dihydrodibenzo-(b,f)thiepin. A serotonin receptor antagonist in the central nervous system used as an antipsychotic. Dibenzothiepins (68-75); Piperazines (73-75); Sulfides (73-75) F-vg:KMethionyl T RNA Synthetase D08.586.464.136.530 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates methionine with its specific transfer RNA. EC 6.1.1.10. Amino Acyl T RNA Synthetases (72-74); Methionine (72-74) F1j!FtaEMethionine Sulfoximine D12.125.166.676.620 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Methionine F3):oMethionine Adenosyltransferase D08.586.913.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme that catalyzes the synthesis of S-adenosylmethionine from methionine and ATP. EC 2.5.1.6. Adenosine Triphosphate (72-74); S-Adenosylmethionine (73-74); Methionine (72); Transferases (72-74) F4##FUvuMethionine D10.642.687; D12.125.142.557; D12.125.166.676 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipotropic Factors Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur  S-Adenosylmethionine; N-Formylmethionine (+ 1); Methionine Sulfoximine; Selenomethionine; Vitamin U AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR F65F vHMethiocarb D05.723.491.408.585; D05.723.596.585 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Carbamate Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Molluscacides 4-(Methylthio)-3,5-xylyl-N-methylcarbamate. Insecticide, molluscacide, acaricide. Synonym: Mesurol. Carbamates (69-74); Xylenes (73-74) F8~*:q,Methimazole D02.886.489.600; D03.383.374.535; D06.347.789.412 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Thyroid Antagonists 1,3-Dihydro-1-methyl-2H-imidazole-2-thione. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Imidazoles (66-67); Thyroid Antagonists (66-67) F:{9:9Methicillin Resistance G04.185.515.286.100.600.525; G05.386.310.100.600.525; G05.706.310.100.600.525; G12.392.269.100.600.525 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Genetics; Genetics, Microbial; Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Genetics; Pharmacogenetics; Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative. Drug Resistance, Microbial (86-90); Methicillin (66-90); Penicillin Resistance (66-90) F=p qvfMethicillin D20.085.099.739.606 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins 6-((2,6-Dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptene-2-carboxylic acid. FB:PtMethergoline D03.132.327.287.630; D03.549.439.630; D14.100.150.151.512; D14.100.850.850.490 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for migraine therapy. Ergolines (71-74) FCNX:Methenolone D04.808.054.079.429.824.537; D06.597.100.194.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Testosterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids FF6:Methenamine D02.092.782.500; D20.237.454 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines Anti-Infective Agents; Anti-Infective Agents, Urinary FH)":xMethemoglobinemia C15.378.619 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed). FI+NJ4Methemoglobin Reductase D08.586.682.608.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases An erythrocyte enzyme which catalyzes the reduction of methemoglobin (ferrihemoglobin) to hemoglobin (ferrohemoglobin). Deficiency produces the inherited disease familial methemoglobinemia. In the absence of methemoglobin, the enzyme can also reduce methylene blue. Lipoamide Dehydrogenase (72-73); Methemoglobin (74); NADH, NADPH Oxidoreductases (74) FL>Fy0eMethemoglobin D12.776.124.400.599; D12.776.422.512.571 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins FN.FMethemalbumin D12.776.034.841.350; D12.776.124.727.350; D12.776.422.680 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins; Serum Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins A 1:1 molar complex of heme or hematin and albumin formed after the dissociation of methemoglobin into heme or hematin and globin in plasma. This complex, which imparts a coffee-brown color to plasma, occurs in hemolytic and hemorrhagic disorders. Its presence in plasma is used as a test to differentiate between hemorrhagic and edematous pancreatitis. Heme (66-76); Hemeproteins (73-76); Serum Albumin (66-76) FPWADGMethazolamide D03.383.871.867.537; D08.373.220.687; D19.770.224.266.687 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles; Thiadiazoles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Carbonic Anhydrase Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Carbonic Anhydrase Inhibitors FTA:ZMethaqualone D03.438.786.535; D15.210.350.800.500; D15.325.875.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinazolines Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.604). Hypnotics and Sedatives (66-67); Tranquilizing Agents (66-67) FV=:;IMethapyrilene D02.092.782.258.368.500; D03.383.725.050.440; D14.100.375.425.400.500; D15.210.350.800.496; D15.325.875.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Ethylenediamines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Aminopyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Histamine H1 antagonist with sedative action used as a hypnotic and in allergies. FYDw:[bMethanosarcinaceae B03.107.585.550.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanomicrobiales Methanosarcina (+ 1) A family of gram-variable, anaerobic methanogens whose cells are mesophilic or thermophilic and appear as irregular spheroid bodies or sheathed rods. These bacteria are found in any anaerobic environment. F\"DMethanosarcina barkeri B03.107.585.550.550.550.200; B03.510.400.475 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanomicrobiales; Methanosarcinaceae; Methanosarcina Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci A species of gram-positive, anaerobic, coccoid methanogens whose organisms are nonmotile. The energy-yielding metabolism of these bacteria involves methane production. Habitats include freshwater and marine mud, animal-waste lagoons, and the rumens of ungulates. Methanogens (79-91); Sarcina (66-68) F^2"--Methanosarcina B03.107.585.550.550.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanomicrobiales; Methanosarcinaceae Methanosarcina barkeri A genus of gram-variable, anaerobic, methane-producing methanogens whose organisms are nonmotile. Endospores are not formed. These bacteria derive energy via formation of methane from acetate, methanol, mono-, di-, and trimethylamine, and possibly, carbon monoxide. Organisms are isolated from freshwater and marine environments. Bacteria (73-78); Methanogens (79-91); Sarcina (66-74)  FaA"ZzCMethanomicrobiales B03.107.585.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens Methanosarcinaceae (+ 2) An order of gram-variable, anaerobic methanogens. Its organisms are nonmotile or motile with cells occurring as coccoid bodies, pseudosarcina, or rods. These bacteria are widely distributed in nature. Fc".Methanogens B03.107.585 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria Methanobacteriales (+ 2); Methanococcales (+ 2); Methanomicrobiales (+ 3) Organisms requiring completely anaerobic conditions for growth and producing methane gas. They are considered by some authorities to be distinct from true bacteria. Methanogens are found in the bovine stomach, swamp mud, and other environments in which oxygen is not present. Bacteria (66-78); Methane (66-78)  Fe"YB*Methanococcus B03.107.585.525.525.525 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanococcales; Methanococcaceae A genus of anaerobic, methane-producing, coccoid methanogens whose organisms are motile by means of polar tufts of flagella. Its cells lose integrity during gram staining. These bacteria are found in salt marshes, marine and estuarine sediments, and the intestinal tract of animals. Bacteria (77-78); Methanogens (79-91) Fg"UJ.Methanococcales B03.107.585.525 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens Methanococcaceae (+ 1) An order of anaerobic, methane-producing, coccoid methanogens. The cell wall of these bacteria is composed of protein. It consists of one family, METHANOCOCCACEAE. Fj&".Methanococcaceae B03.107.585.525.525 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanococcales Methanococcus A family of anaerobic, methane-producing methanogens whose organisms are motile by means of flagella. These bacteria use carbon dioxide as an electron acceptor. Fk"AMethanobacterium B03.107.585.500.500.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanobacteriales; Methanobacteriaceae A genus of anaerobic, rod-shaped methanogens that produces methane. Its organisms are nonmotile, use ammonia as the sole source of nitrogen, and are generally gram-positive. These bacteria are found in aquatic sediments, soil, sewage, and the gastrointestinal tract of animals. Bacteria (68-78); Methanogens (79-91) Fm!"[C.Methanobacteriales B03.107.585.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens Methanobacteriaceae (+ 1) An order of anaerobic, coccoid to rod-shaped methanogens whose organisms are typically gram-positive. These bacteria are non-motile, do not catabolize carbohydrates, proteinaceous material, or organic compounds other than formate or carbon monoxide, and are widely distributed in nature. Foe".JMethanobacteriaceae B03.107.585.500.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Methanogens; Methanobacteriales Methanobacterium A family of anaerobic, coccoid-to-rod-shaped methanogens. Cells are typically gram-positive with membranes composed mainly of polyisoprenoid hydrocarbons ether-linked to glycerol. Its organisms are found in anaerobic habitats throughout nature. Fqn"DMethane D02.455.326.146.571 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Tetranitromethane FsT :gMethandrostenolone D04.808.054.079.129.453; D06.597.100.194.464 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids FtO2:Methandriol D06.597.100.194.429; D04.808.054.079.429.154.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Androstenediols Fu6:Methamphetamine D02.092.471.683.152.619; D14.100.050.600.050.525; D14.100.050.600.520; D14.100.150.600.220.525; D14.100.150.600.520; D14.100.600.050.525; D14.100.600.220.525; D15.155.520; D15.220.552; D16.050.870.490 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Benzphetamine N-Methyl-3,4-methylenedioxyamphetamine N-Methyl-3,4-methylenedioxyamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. FwE:thMethallibure D02.886.904.425; D02.948.898.425; D06.347.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists 1-Methyl-6-(1-methylallyl)-2,5-dithiobiurea. A dithiobiurea compound with anti-gonadotropic activity. Allyl Compounds (73-74); Thiourea (73-74) Fm5:s3Methadyl Acetate D02.522.675.500; D15.040.150.486.500; D15.210.600.496.500; D15.210.600.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Methadone Central Nervous System Agents; Analgesics; Analgesics, Opioid; Methadone Central Nervous System Agents; Central Nervous System Depressants; Narcotics; Methadone Central Nervous System Agents; Central Nervous System Depressants; Narcotics 6-(Dimethylamino)-4,4-diphenyl-3-heptanol acetate (ester). A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. Acetic Acids (73-74); Methadone (73-74) FT:M1Methadone D02.522.675; D15.040.150.486; D15.153.500; D15.210.600.496 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Narcotics Methadyl Acetate Methadyl Acetate Methadyl Acetate A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1082-3). F D:<fMethacycline D20.085.868.486 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5 alpha,5a alpha,12a alpha))-4-Dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide. A broad-spectrum semisynthetic antibiotic related to tetracycline but excreted more slowly and maintaining effective blood levels for a more extended period. F::mMethacrylates D02.241.081.069.600 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polymethacrylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates Bisphenol A-Glycidyl Methacrylate Acrylic acids or acrylates which are substituted in the C-2 position with a methyl group. Acrylates (68-74) $F-,g'lMethacholine Compounds D02.092.102.534; D02.675.276.534 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Methacholine Chloride Methacholine Chloride AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR F&82:Methacholine Chloride D02.092.102.534.500; D02.675.276.534.500; D14.100.120.140.500.500; D16.050.100.500; D16.050.495.520; D16.050.675.520 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Methacholine Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Methacholine Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchoconstrictor Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A slowly hydrolyzed muscarinic agonist. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. It has also been used in the treatment of glaucoma and in the treatment of Raynaud's syndrome and other vasospastic conditions. Methacholine Compounds (66-90) Fx:B$Metformin D02.078.370.141.450; D09.482.586 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines; Biguanides Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents Fn &:Metestrus G08.520.780.218.320 BLCFDEGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal; Estrus Short period following estrus during which the phenomena of estrus subside in those animals in which pseudopregnancy does not occur. Does not apply to humans. F gMeteorological Factors G03.230.300 Environment and Public Health (Non MeSH); Environment Atmosphere (+ 27) The atmospheric phenomena which pertain to climate and weather. Weather (66-74) AEANCLDEDUECHILJPCPOPSRESNSTTOTU  FAL$Metatarsus A01.378.592.350.300.480 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Metatarsal Bones Body Regions (Non MeSH); Extremities; Leg; Foot; Forefoot, Human FI(QMetatarsophalangeal Joint A02.835.583.899.536 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints; Toe Joint The articulation between a metatarsal bone and a phalanx. Metatarsus (66-74); Toe Joint (66-74) F#8?F/Metatarsal Bones A02.835.232.262.492 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Metatarsus Musculoskeletal System; Skeleton; Bone and Bones; Foot Bones (Non MeSH) The five long bones of the METATARSUS articulating with the tarsus proximally and the TOES (phalanges) distally. Fk:WMetastrongyloidea B01.500.294.700.775.588 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida Angiostrongylus (+ 1) A superfamily of nematodes of the order STRONGYLIDA. Characteristics include a fluid-filled outer layer of cuticle and a reduced mouth and bursa. F*HMetaraminol D02.033.329.624.706.500; D02.092.063.624.706.500; D14.100.050.100.100.480; D14.100.050.600.510; D16.050.870.480; D18.222.863.585; D18.793.499 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines; Phenylpropanolamine Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines; Phenylpropanolamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol. An adrenergic agonist that acts predominantly at alpha adrenergic receptors and also stimulates the release of norepinephrine. It has been used primarily as a vasoconstrictor in the treatment of hypotension. Fr:%Metaplasia C23.739.589 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myeloid Metaplasia Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Neovascularization (+ 2) A condition in which there is a change of one adult cell type to another similar adult cell type.  FNYxMetaphysics K01.752.511 HI Humanities; Philosophy F6Metaphase G04.335.135.220.225.580; G05.148.165.220.225.580; G07.553.135.220.225.580 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Genetics; Cytogenetics; Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) The second phase of cell division, in which the chromosomes line up across the equatorial plane of the spindle prior to separation. Cell Division (66-74); Mitosis (68-77) F Q0Metanephrine D02.092.211.215.311.461.400; D02.092.311.461.400 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines; Epinephrine Organic Chemicals (Non MeSH); Amines; Catecholamines; Epinephrine alpha-(Methylaminomethyl)vanillyl alcohol. Product of epinephrine O-methylation. It is a commonly occurring, pharmacologically and physiologically inactive metabolite of epinephrine. Epinephrine (74); Methyl Ethers (74) F6>.Metamorphosis, Biological G07.553.619 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) FZMetals, Rare Earth D01.268.558; D01.552.550 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Cerium; Dysprosium; Erbium; Europium; Gadolinium; Holmium; Lanthanum; Lutetium; Neodymium; Praseodymium; Promethium; Samarium; Scandium; Terbium; Thulium; Ytterbium; Yttrium Cerium; Dysprosium; Erbium; Europium; Gadolinium; Holmium; Lanthanum; Lutetium; Neodymium; Praseodymium; Promethium; Samarium; Scandium; Terbium; Thulium; Ytterbium; Yttrium Elements of group IIIb of the periodic table from lanthanum, atomic number 57, to and including lutetium, atomic number 71. Metals (66-75) ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $F8`<Metals, Alkaline Earth D01.268.552; D01.552.539 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Barium; Calcium; Radium; Strontium Barium; Calcium; Radium; Strontium Metals that constitute the group IIa in the periodic table. Metals (66-75) ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $FK8`VI<Metals, Alkali D01.268.549; D01.552.528 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Cesium; Francium; Lithium; Potassium; Rubidium; Sodium Cesium; Francium; Lithium; Potassium; Rubidium; Sodium Metals that constitute group Ia in the periodic table. They are the most strongly electropositive of the metals. Metals (66-75) ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $F:8`<Metals, Actinoid D01.268.271.545; D01.552.517 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Metals Actinium; Americium; Berkelium; Californium; Curium; Einsteinium; Fermium; Lawrencium; Mendelevium; Neptunium; Nobelium; Plutonium; Protactinium; Thorium; Uranium Actinium; Americium; Berkelium; Californium; Curium; Einsteinium; Fermium; Lawrencium; Mendelevium; Neptunium; Nobelium; Plutonium; Protactinium; Thorium; Uranium A series of radioactive elements from actinium, atomic number 89, to and including lawrencium, atomic number 103. They are the theoretical analogs of the rare earth metal series. Metals (66-75)  F"8Metals D01.552; J01.637.517 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organometallic Compounds Inorganic Chemicals (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Alloys (+ 6); Aluminum; Antimony; Beryllium; Bismuth; Cadmium; Chromium; Cobalt; Copper; Gallium; Germanium; Gold; Hafnium; Indium; Iridium; Iron; Lead; Magnesium; Manganese; Mercury; Metals, Actinoid (+ 15); Metals, Alkali (+ 6); Metals, Alkaline Earth (+ 4); Metals, Rare Earth (+ 17); Molybdenum; Nickel; Niobium; Osmium; Palladium; Platinum; Rhenium; Rhodium; Ruthenium; Silver; Tantalum; Technetium; Thallium; Tin; Titanium; Tungsten; Vanadium; Zinc; Zirconium ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  F 8r?<Metallurgy J01.576.634 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry FAMetallothionein D12.776.556.670 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins A low-molecular-weight (approx. 10,000 kD) protein occurring in the cytoplasm of kidney cortex and liver. It is rich in cysteinyl residues and contains no aromatic amino acids. Metallothionein shows high affinity for bivalent heavy metals. Metalloproteins (73-74) FAHWMetalloproteins D12.776.556 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein Binding Amino Acids, Peptides and Proteins (Non MeSH); Proteins Azurin; Ceruloplasmin; Ferritin (+ 1); Hemerythrin; Hemocyanin; Hemosiderin; Iron-Sulfur Proteins (+ 4); Lactoferrin; Metallothionein; Plastocyanin; Transferrin specific metal (66-72); Proteins (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $FbFD2HMetalloproteinases D08.586.277.656.732.480 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Collagenases (+ 1); Membrane Metallo-Endopeptidase; Pronase; Thermolysin Peptide hydrolases which use a metal in the catalytic mechanism. This group of enzymes is inactivated by metal chelators. EC 3.4.24. Peptide Peptidohydrolases (66-87)  FFV'Metalloporphyrins D11.557.727.640 ADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Chlorophyll (+ 3); Heme (+ 1) Porphyrins which are combined with a metal ion. The metal is bound equally to all four nitrogen atoms of the pyrrole rings. They possess characteristic absorption spectra which can be utilized for identification or quantitative estimation of porphyrins and porphyrin-bound compounds. specific porphyrin (66-76); Organometallic Compounds (68-76); Porphyrins (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $F>T(J_DMetal Metabolism, Inborn Errors C18.452.648.618 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Hemochromatosis; Hepatolenticular Degeneration; Hypophosphatasia; Hypophosphatemia, Familial; Kinky Hair Syndrome; Paralysis, Familial Periodic; Pseudohypoparathyroidism BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI F&LmNMetal Ceramic Alloys D01.552.033.690; D25.058.520; D25.339.208.720 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Metals; Alloys Biomedical and Dental Materials (Non MeSH); Alloys Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Alloys The fusion of ceramics (porcelain) to an alloy of two or more metals for use in restorative and prosthodontic dentistry. Examples of metal alloys employed include cobalt-chromium, gold-palladium, gold-platinum-palladium, and nickel-based alloys. Dental Alloys (71-91) F5*Metacarpus A02.835.232.087.535 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH) Fǘ:VMetacarpophalangeal Joint A02.835.583.345.512 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints; Finger Joint The articulation between a metacarpal bone and a phalanx. Finger Joint (66-76); Metacarpus (66-76) Fl8BF2Metabolism, Inborn Errors C18.452.648 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anemia, Hemolytic, Congenital; Mental Retardation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Amino Acid Metabolism, Inborn Errors (+ 14); Amyloidosis (+ 2); Carbohydrate Metabolism, Inborn Errors (+ 30); Glucosephosphate Dehydrogenase Deficiency; Hyperbilirubinemia, Hereditary (+ 2); Jaundice, Chronic Idiopathic; Lipid Metabolism, Inborn Errors (+ 39); Lysosomal Storage Diseases (+ 24); Metal Metabolism, Inborn Errors (+ 7); Mucolipidosis (+ 1); Porphyria (+ 5); Purine-Pyrimidine Metabolism, Inborn Errors (+ 3); Renal Tubular Transport, Inborn Errors (+ 10) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  FɺL:N-NMetabolism G06.535 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH) Biological Transport (+ 9); Citric Acid Cycle; Energy Metabolism (+ 8); Enterohepatic Circulation; Kallikrein-Kinin System; Metabolic Processes (Non MeSH) (+ 32); Oxidative Stress; Oxygen Consumption (+ 2); Pentosephosphate Pathway; Peptide Synthesis (Non MeSH) (+ 4); Pharmacokinetics (+ 3); Renin-Angiotensin System; Secretory Rate; Signal Transduction (+ 2) Fb @Metabolic Processes (Non MeSH) G06.535.630 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Absorption; Acylation (+ 1); Aerobiosis; Alkylation (+ 1); Amination; Anaerobiosis; Biological Transport, Active; Cyclization; Dealkylation; Deamination; Decarboxylation; Enzyme Activation; Esterification; Fermentation; Gluconeogenesis; Glycolysis; Glycosylation; Hydrogenation; Hydrolysis; Hydroxylation; Ion Transport; Lipid Mobilization; Lipolysis; Nitrogen Fixation; Nitrosation; Phosphorylation (+ 2); Protein Binding; Substrate Cycling DEGEIMPHRE FϘ%OMetabolic Diseases C18.452 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH) Achlorhydria; Acid-Base Imbalance (+ 8); Calcium Metabolism Disorders (+ 11); Diabetes Insipidus (+ 2); Diabetes Mellitus (+ 19); Glucose Intolerance; Glycosuria (+ 1); Hyperglycemia; Hyperlipidemia (+ 3); Hyperprolactinemia; Hypervitaminosis A; Hypoglycemia (+ 1); Malabsorption Syndromes (+ 5); Metabolism, Inborn Errors (+ 150); Phosphorus Metabolism Disorders (+ 1); Protein-Losing Enteropathies (+ 1); Water-Electrolyte Imbalance (+ 9); Xanthomatosis (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI FP L6'PMetabolic Detoxication, Drug G12.091.690.140.600 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH); Biopharmaceutics; Pharmacokinetics; Biotransformation Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. FՒ" rMetabolic Clearance Rate E01.597; G06.535.780.202.640; G12.091.690.140.595 DEGEIMPHRE Diagnosis Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Pharmacokinetics; Biotransformation Chemical, Pharmacologic Phenomena (Non MeSH); Biopharmaceutics; Pharmacokinetics; Biotransformation Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. specific heading/metabolism (66-67) Fׇ9*Meta-Analysis E05.318.780.500; G03.850.520.840.500; H01.770.644.728.501; N05.715.360.780.515 Publication Bias; Review Literature Review Literature; Statistics; Clinical Trials; Models, Statistical Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Science; Research; Research Design Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) A quantitative method of combining the results of independent studies (usually drawn from the published literature) and synthesizing summaries and conclusions which may be used to evaluate therapeutic effectiveness, plan new studies, etc., with application chiefly in the areas of research and medicine. Outcome and Process Assessment (77-79); Follow-Up Studies (77-79); Research (80-82); Research Design (80-88); Statistics (80-88)  F5X+P^Mesylates D02.455.326.146.100.050.500; D02.886.645.600.055.050.510 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Alkanesulfonates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Alkanesulfonates Busulfan; Ethyl Methanesulfonate; Methyl Methanesulfonate Busulfan; Ethyl Methanesulfonate; Methyl Methanesulfonate Organic salts or esters of methanesulfonic acid. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  F >8*;:Mestranol D04.808.668.651.568.291.500; D06.597.378.379.500; D07.360.276.210.443.332.291.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnatrienes; Ethinyl Estradiol Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Ethinyl Estradiol Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estrogens, Synthetic; Ethinyl Estradiol (17 alpha)-3-Methoxy-19-norpregna-1,3,5(10)-trien-20-yn-17-ol. The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated before it becomes biologically active. It is used as the estrogen component of many combination oral contraceptives. (From AMA Drug Evaluations Annual, 1992). F Y:MMesterolone D04.808.054.040.831.450; D06.597.100.194.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols; Stanolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids 17 beta-Hydroxy-1 alpha-methyl-5 alpha-androstan-3-one. A synthetic steroid with anabolic and androgenic activities. Methane (73-74); Stanolone (72-74) F2:+Mesothelioma, Cystic C04.557.470.035.510.515; C04.557.470.660.510.515 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Mesothelioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Mesothelial; Mesothelioma A peritoneal mesothelioma affecting mainly young females and producing cysts of variable size and number lined by a single layer of benign mesothelial cells. The disease follows a benign course and is compatible with a normal life expectancy, requiring occasionally partial excision or decompression for relief of pain or other symptoms. Malignant potential is exceptional. (From Holland et al., Cancer Medicine, 3d ed). Mesothelioma (79-93) F6XMesothelioma C04.557.470.035.510; C04.557.470.660.510 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Mesothelial Mesothelioma, Cystic Mesothelioma, Cystic A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed). F.X0eMesoridazine D03.494.741.470; D14.100.150.175.493; D15.150.025.500; D15.210.950.040.025.500; D15.700.872.331.025.488 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine antipsychotic with effects similar to CHLORPROMAZINE. Phenothiazines (66-71); Tranquilizing Agents (66-71) Fs:Q>Mesoporphyrins D11.557.727.620 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Porphyrins with four methyl, two ethyl, and two propionic acid side chains attached to the pyrrole rings. Porphyrins (68-74) FBT~Mesons H01.671.579.404.600 AECLDUHITU Physical Sciences (Non MeSH); Physics; Nuclear Physics; Elementary Particles Short-lived elementary particles found in cosmic radiation or produced from nuclear disintegration. Their mass is between that of protons and electrons and they can be negative, positive, or neutral. pi-Mesons (pions) are heavier than mu-mesons (muons) and are proposed for cancer radiotherapy because their capture and disintegration by matter produces powerful, but short-lived, secondary radiation. Elementary Particles (75-84); Nuclear Physics (66-74) Fm \@Mesonephros A16.254.500 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo The excretory organ of the embryo, collective Wolffian tubules, which forms the urogenital fold from which the reproductive organs develop. The mesonephros is the permanent kidney in fish and amphibians, but atrophies in reptiles, birds, and mammals. Kidney (66-74) F-:1$Mesonephroma C04.557.465.510 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal Endodermal Sinus Tumor A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed). FXh@Mesoderm A16.254.425.660 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo; Germ Layers The middle germ layer of the embryo. Fz *A/Mesocricetus B02.649.865.635.325.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Hamsters A genus of the family Muridae having three species. The present domesticated strains were developed from individuals brought from Syria. They are widely used in biomedical research. FV(=Mesocolon A01.047.596.451.535 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Abdomen; Peritoneum; Mesentery The fold of peritoneum by which the colon is attached to the posterior abdominal wall. F (EiMesocestoides B01.500.736.215.520 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda A genus of tapeworm, containing several species, found as adults in birds and mammals. The larvae or cysticercoid stage develop in invertebrates. Human infection has been reported and is probably acquired from eating inadequately cooked meat of animals infected with the second larval stage known as the tetrahythridium. Cestoda (66-85) F*;vMesna D02.455.326.146.100.050.490; D02.886.489.590; D02.886.645.600.055.050.500; D26.415.480 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Alkanesulfonates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Alkanesulfonates Miscellaneous Drugs and Agents (Non MeSH); Expectorants 2-Mercaptoethanesulfonic acid sodium salt. An inhalation expectorant that breaks disulfide bonds in the mucopolysaccharides of mucus. It is used to treat chronic bronchitis and other respiratory diseases. Coenzyme M (2-mercaptoethanesulfonic acid) is involved in the methanogenesis pathway. Alkyl Sulfonates (74-75); Mercaptoethanol (74-76) G: `:N;Mesial Movement of Teeth C07.465.714.836.535; G10.549.803.535 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Tooth Migration Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH); Tooth Migration GV*NMesentery A01.047.596.451 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Body Regions (Non MeSH); Abdomen; Peritoneum Mesocolon G :8 Mesenteric Veins A07.231.908.670.385 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins; Portal System Veins which return blood from the intestines; the inferior mesenteric vein empties into the splenic vein, the superior mesenteric vein joins the splenic vein to form the portal vein. G8GMesenteric Vascular Occlusion C06.405.469.675; C06.772.510; C14.907.137.534 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Digestive System Diseases; Peritoneal Diseases Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Obstruction of the flow in the mesenteric circulation by atherosclerosis, emboli or thrombi, stenosis, trauma, and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as periarteritis nodosa and thromboangiitis obliterans. (From Juergens, et al., Peripheral Vascular Diseases, 5th ed). G :#5NMesenteric Lymphadenitis C06.772.465; C15.604.315.618 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Peritoneal Diseases Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphadenitis A condition clinically resembling acute appendicitis, in which there is inflammation of the mesenteric lymph nodes receiving lymph from the intestine. A septal form, which is frequently fatal, and a milder form, which is self-limited, are caused by YERSINIA (Pasteurella) PSEUDOTUBERCULOSIS. (Dorland, 27th ed). G "NjMesenteric Cyst C04.182.473; C06.772.420 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Digestive System Diseases; Peritoneal Diseases A congenital thin-walled cyst of the abdomen between the leaves of the mesentery, which may be of wolffian or lymphatic duct origin. As it enlarges it may cause colicky pain and intestinal obstruction. (Dorlamd, 27th ed). G:VKMesenteric Artery, Superior A07.231.114.565.755 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Superior Mesenteric Artery Syndrome Cardiovascular System; Blood Vessels; Arteries; Mesenteric Arteries A large vessel supplying the whole length of the small intestine except the superior part of the duodenum. It also supplies the cecum and the ascending part of the colon and about half the transverse part of the colon. It arises from the anterior surface of the aorta below the celiac artery at the level of the first lumbar vertebra. Mesenteric Arteries (66-92)  G8!8*P!Mesenteric Artery, Inferior A07.231.114.565.510 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Mesenteric Arteries The artery supplying nearly all the left half of the transverse colon, the whole of the descending colon, the sigmoid colon, and the greater part of the rectum. It is smaller than the superior mesenteric artery (MESENTERIC ARTERY, SUPERIOR) and arises from the aorta above its bifurcation into the common iliac arteries. Mesenteric Arteries (66-92) G!8Py!Mesenteric Arteries A07.231.114.565 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Mesenteric Artery, Inferior; Mesenteric Artery, Superior Arteries which arise from the abdominal aorta and distribute to most of the intestines. G88BiMesenchymoma C04.557.435.500 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A mixed mesenchymal tumor composed of two or more mesodermal cellular elements not commonly associated, not counting fibrous tissue as one of the elements. Mesenchymomas are widely distributed in the body and about 75% are malignant. (Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed). GXn[Mesencephalon A08.186.211.132.659 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem Corpora Quadrigemina (+ 2); Locus Coeruleus; Raphe Nuclei; Substantia Nigra; Tegmentum Mesencephali (+ 3) GS8GMescaline D02.092.471.683.635; D03.132.524; D14.100.850.800.500; D15.300.500; D15.700.372.599 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Heterocyclic Compounds; Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens 3,4,5-Trimethoxyphenethylamine. Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church. G _@Mersalyl D02.691.750.100.710; D19.770.224.391.710 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Mercurial (3-((2-(Carboxylatomethoxy)benzoyl)amino)-2-methoxypropyl)hydroxymercurate(1-) sodium. A toxic thiol mercury salt formerly used as a diuretic. It inhibits various biochemical functions, especially in mitochondria, and is used to study those functions. G  .:#MERRF Syndrome C05.651.460.620.530; C10.228.140.163.634.530; C10.228.140.490.300.280.530; C18.452.648.556.650.620.530 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic; Mitochondrial Encephalomyopathies Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Generalized; Epilepsy, Myoclonic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies One of the MITOCHONDRIAL ENCEPHALOMYOPATHIES characterized by myoclonic epilepsy and ragged red fibers of muscle tissue. Red muscle tends to be rich in mitochondria. Biochemical tests disclose changes in the enzymes of the respiratory chain. Epilepsy, Myoclonic (80-92); Mitochondria, Muscle (80-92) G#pNuDMermithoidea B01.500.294.100.275.570 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida A superfamily of nematodes of the order ENOPLIDA. Characteristics include a reduced alimentary tract and the presence of a trophosome. Its organisms can be present in the human intestine through ingestion of unwashed or contaminated raw vegetables. G(b*E#Meristem B06.413.400.500; B06.413.525.500 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH); Plant Roots Plants; Plant Structures (Non MeSH); Plant Stems Plant Root Cap A group of plant cells that are capable of dividing infinitely and whose main function is the production of new growth at the growing tip of a root or stem. (From Concise Dictionary of Biology, 1990). Plants (66-94)  G*B &&xMeridians E02.030.510; E02.040.025.510 CL Therapeutics; Acupuncture Therapeutics; Alternative Medicine; Acupuncture Acupuncture Points Acupuncture Points Classical loci in acupuncture. They are main and collateral channels, regarded as a network of passages, through which vital energy circulates and along which acupoints (ACUPUNCTURE POINTS) are distributed. The meridians are a series of 14 lines upon which more than 400 acupoints are located on the body. (The Pinyin Chinese-English Dictionary, p. 359; Dr. Wu Lancheng, Academy of Traditional Chinese Medicine, Beijing). Acupuncture (68-91)  G,W "U,Mercury Radioisotopes D01.496.532.500; D01.496.749.590 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Mercury Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of mercury that decay or disintegrate emitting radiation. Hg atoms with atomic weights 185-195, 197, 203, 205, and 206 are radioactive mercury isotopes. Mercury Isotopes (68-74); Radioisotopes (68-74) G/>&49Mercury Poisoning C21.613.647 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning G1bLEMercury Isotopes D01.496.532 Inorganic Chemicals (Non MeSH); Isotopes Mercury Radioisotopes Stable mercury atoms that have the same atomic number as the element mercury, but differ in atomic weight. Hg-196, 198-201, and 204 are stable mercury isotopes. Chlormerodrin (66); Diuretics, Mercurial (66); Mercury (66) ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  G272I4Mercury Compounds D01.538 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Mercuric Chloride Inorganic compounds that contain mercury as an integral part of the molecule. Mercury (66-93)  G4 8%]Mercury (Planet) H01.091.800.700.762 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The first planet in order from the sun. It has no known natural satellites. It is one of the four inner or terrestrial planets of the solar system. Extraterrestrial Environment (66-90); Planets (91-94) G5>M?Mercury D01.268.536; D01.552.504 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKRESDSTTOTUUR Organomercury Compounds Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Mercury. A silver metallic element that exists as a liquid at room temperature. It has the atomic symbol Hg (from hydrargyrum, liquid silver), atomic number 80, and atomic weight 200.59. Mercury is used in many industrial applications and its salts have been employed therapeutically as purgatives, antisyphilitics, disinfectants, and astringents. It can be absorbed through the skin and mucous membranes which leads to MERCURY POISONING. Because of its toxicity, the clinical use of mercury and mercurials is diminishing. G6 8`bMercuric Chloride D01.210.450.150.525; D01.538.500; D20.187.222.500; D20.187.570 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Inorganic Chemicals (Non MeSH); Mercury Compounds Anti-Infective Agents; Anti-Infective Agents, Local; Disinfectants Anti-Infective Agents; Anti-Infective Agents, Local Mercury chloride (HgCl2). A highly toxic compound that volatizes slightly at ordinary temperature and appreciably at 100 degrees C. It is corrosive to mucous membranes and used as a topical antiseptic and disinfectant. Mercury (66-84) G:4H8-Mercuribenzoates D02.241.223.106.604; D02.691.750.740.644; D08.373.830.699 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Phenylmercury Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Chloromercuribenzoates Chloromercuribenzoates; Hydroxymercuribenzoates Chloromercuribenzoates; Hydroxymercuribenzoates Benzoates (66-71); Chloromercuribenzoates (66-71); Mercury (66-71); Organometallic Compounds (68-71) G=3A8HvMercaptopropionylglycine D12.125.166.650; D12.125.481.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine Thiorphan Thiorphan Sulfhydryl acylated derivative of glycine used in treatment of liver diseases, as a detoxicant and in therapy of myopia. Amino Acids, Sulfur (74); Glycine (74)  G@%&:1Mercaptoethylamines D02.092.471.562; D02.886.489.472 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Cysteamine Cysteamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR GBV&8:Mercaptoethanol D02.033.057.534; D02.886.489.409 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Ethyl Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds GC&:Merbromine D02.691.750.575; D20.187.560 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds Anti-Infective Agents; Anti-Infective Agents, Local A popular topical antiseptic with weak antibacterial action. It is incompatible with local anesthetics. Fluoresceins (69-74); Mercury (72-74) GE":z.Meptazinol D03.383.066.400; D15.040.150.480; D15.210.600.491; D15.550.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Central Nervous System Agents; Narcotic Antagonists A narcotic antagonist with analgesic properties. It is used for the control of moderate to severe pain. Azepines (66-79); Phenols (66-76) GFH:.}*Meprobamate D02.241.081.251.510; D15.075.500; D15.080.562; D15.210.350.800.485; D15.210.950.012.500; D15.325.875.515; D15.525.475; D15.700.872.015.525; D16.700.600.475 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Muscle Relaxants, Central Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of anxiety disorders, and also for the short-term management of insomnia but has largely been susperseded by the benzodiazepines. (From Martindale, The Extra Pharmacopoeia, 1993, p.603). GIp:LMepivacaine D03.383.621.450; D15.050.050.490; D15.210.100.200.490; D16.850.025.490 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p.168). GPcP:xMephobarbital D03.383.742.698.253.434; D14.100.240.500.500; D15.080.550; D15.210.350.750.500; D15.325.850.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A barbiturate that is metabolized to PHENOBARBITAL. It has been used for similar purposes, especially in epilepsy, but there is no evidence mephobarbital offers any advantage over PHENOBARBITAL. GTk:Mephenytoin D03.383.374.411.620; D15.080.537 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Hydantoins Central Nervous System Agents; Anticonvulsants 5-Ethyl-3-methyl-5-phenylhydantoin. An anticonvulsant effective in grand mal epilepsy. It may cause blood dyscrasias. Hydantoins (69-74) GW&:Mephentermine D02.092.471.683.152.766.617; D14.100.050.600.500; D16.050.870.470; D18.793.480 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines; Phentermine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents A sympathomimetic agent with mainly indirect effects on adrenergic receptors. It is used to maintain blood pressure in hypotensive states, for example, following spinal anesthesia. Although the central stimulant effects of mephentermine are much less than those of amphetamine, its use may lead to amphetamine-type dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1248). GYX:Mephenesin D02.033.618.706.517; D15.525.470; D16.700.600.470 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Propanediols Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A centrally acting muscle relaxant with a short duration of action. G]9:RMeperidine D03.066.399.450; D03.383.621.349.450; D15.040.150.475; D15.045.500; D15.210.600.487 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonipecotic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Isonipecotic Acids Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Central Nervous System Depressants; Narcotics Promedol Promedol Promedol Promedol 1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester. A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration. G__:+Mepartricin D02.455.326.271.665.400; D20.085.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Anti-Infective Agents; Antibiotics Polyene antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is proposed as an antifungal and/or an antiprotozoal agent. Polyenes (74-75) Gc*<Menu Planning J01.364.510; N02.421.242.472.310 ECMTSTTD Technology, Industry, Agriculture (Non MeSH); Food Services Facilities, Manpower and Services (Non MeSH); Health Services; Dietary Services; Food Service, Hospital Food Service, Hospital (66-Jul 77); Food Services (Jan-Jul 77) Gf& LMentors I02.588; M01.395 CLEDHILJPXSN Education Named Groups (Non MeSH) Senior professionals who provide guidance, direction and support to those persons desirous of improvement in academic positions, administrative positions or other career development situations. Ggs )Menthol D02.033.460.500; D02.455.426.392.368.367.318.500; D02.455.849.533; D23.075.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Cyclohexanols Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes; Cyclohexanols Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Dermatologic Agents; Antipruritics An alcohol obtained from diverse mint oils or prepared synthetically. It is used as a topical antipruritic, and in inhalers for treatment of upper respiratory disorders or added to water for inhalation in acute bronchitis. (From Dorland, 27th ed). Gh X:\%Mental Status Schedule F04.586.574 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychiatric Status Rating Scales Standardized clinical interview used to assess current psychopathology by scaling patient responses to the questions. Gl aMental Retardation, Psychosocial F03.709.346.598 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Cultural Deprivation Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Marginal or mild subnormal intellectual functioning due to cultural or environmental deprivation. It is usually associated with mental retardation of one or both parents and often with severe sensory deprivation in infancy and childhood. Mental Retardation (66-68)  GmO&F` Mental Retardation C10.496; F03.709.346 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cretinism; Education of Mentally Retarded Metabolism, Inborn Errors; Chromosome Abnormalities Nervous System Diseases Behavioral and Mental Disorders (Non MeSH); Mental Disorders Angelman Syndrome; Cri-du-Chat Syndrome; De Lange's Syndrome; Down Syndrome; Gangliosidoses (+ 3); Hartnup Disease; Homocystinuria; Laurence-Moon-Biedl Syndrome; Lesch-Nyhan Syndrome; Maple Syrup Urine Disease; Mucolipidosis (+ 1); Neuronal Ceroid-Lipofuscinosis; Oculocerebrorenal Syndrome; Phenylketonuria (+ 1); Prader-Willi Syndrome; Rett Syndrome; Rubinstein-Taybi Syndrome; Tuberous Sclerosis; WAGR Syndrome Angelman Syndrome; Cockayne Syndrome; Cri-du-Chat Syndrome; De Lange's Syndrome; Down Syndrome; Fragile X Syndrome; Gangliosidoses (+ 3); Gaucher's Disease; Hallervorden-Spatz Syndrome; Hartnup Disease; Homocystinuria; Kernicterus; Kinky Hair Syndrome; Laurence-Moon-Biedl Syndrome; Lesch-Nyhan Syndrome; Maple Syrup Urine Disease; Mental Retardation, Psychosocial; Mucolipidosis; Neuronal Ceroid-Lipofuscinosis; Niemann-Pick Disease; Oculocerebrorenal Syndrome; Phenylketonuria (+ 1); Prader-Willi Syndrome; Rett Syndrome; Rubinstein-Taybi Syndrome; Spasms, Infantile; Sturge-Weber Syndrome; Tuberous Sclerosis; WAGR Syndrome Subnormal intellectual functioning which originates during the developmental period and is associated with impairment of one or more of the following: (1) maturation, (2) learning, (3) social adjustment. For the last, MENTAL RETARDATION, PSYCHOSOCIAL is available. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (GoL2<d1NMental Processes F02.463 CLDEPHRE Psychologic Processes and Principles (Non MeSH) Cognition (+ 6); Learning (+ 44); Perception (+ 56); Thinking (+ 12); Volition Conceptual functions or thinking in all its forms. BLCFCICLCODEDHDIDTECEDEHENEPETGEHIIMMEMIMOMTNUPAPCPHPPPSPXRARERHRISUTHURUSVI  GwW  8f>PMental Health Services F04.408; N02.421.461 CLECHILJMAOGSDSNSTTDUT Disciplines, Tests, Therapy, Services (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services Child Guidance; Community Mental Health Services; Counseling (+ 1); Emergency Services, Psychiatric; Social Work, Psychiatric Community Mental Health Services; Counseling (+ 1); Social Work, Psychiatric Organized services to provide mental health care. CLECEDHIISLJMAMTOGSDSNSTTDUT  Gx< Mental Health Associations N03.540.630.780.500 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit; Voluntary Health Agencies Voluntary organizations which support educational programs and research in psychiatry with the objective of the promotion of mental health. An early association in the United States was founded as the National Committee for Mental Hygiene in 1909, became the Mental Health Association in 1976 and later the National Mental Health Association in 1980. State and local mental health associations in this country are chartered by the national organization and affiliated with it. Community Mental Health Services (67-74); Mental Disorders (66-74); Mental Health (66-74); Voluntary Health Agencies (66-74) G{   *Mental Health F02.418; F04.366; N01.407.540.408 Orthopsychiatry Psychologic Processes and Principles (Non MeSH) Disciplines, Tests, Therapy, Services (Non MeSH) Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health The state wherein the person is well adjusted. G~):Mental Healing E02.040.530 HIPX Therapeutics; Alternative Medicine The use of suggestion or faith to cure disease, particularly physical illness. G=)^Mental Fatigue F03.126.610 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Fatigue arising in consequence of mental effort. GFY;Mental Disorders F03.709 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH) Adjustment Disorders; Mental Retardation (+ 33); Neurotic Disorders (+ 28); Organic Mental Disorders (+ 23); Personality Disorders (+ 40); Psychophysiologic Disorders; Psychotic Disorders (+ 35) Psychiatric illness as manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  G0 F3RMental Competency F01.590; F02.410; I01.880.604.583.530; N03.706.535.625 CLLJPXSN Behavior and Behavior Mechanisms (Non MeSH) Psychologic Processes and Principles (Non MeSH) Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Ability to perform or accomplish an action or task that another person of similar background and training, or any human being, could reasonably be expected to perform. The term almost always refers to mental capacity. Incompetency refers to primarily defects in intellectual functioning such that comprehension of the nature of a transaction is interfered with or otherwise inadequate. It takes no note of temperament, emotions, or the like, even though these may interfere with a person's capacity to function. (Campbell, Psychiatric Dictionary, 6th ed, pp. 139 and 363). Forensic Psychiatry (66-91); Mental Disorders (66-91); Mental Retardation (66-9l) G@ aMenstruation-Inducing Agents D07.650; D07.360.276.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Menstruation Reproductive Control Agents (Non MeSH) Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Mifepristone Mifepristone Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed). Menstruation/drug effects (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (G!8(:Menstruation Disorders C13.371.491 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Amenorrhea; Dysmenorrhea; Menorrhagia; Oligomenorrhea; Premenstrual Syndrome GNhYMenstruation G08.520.440.428 BLCFDEEHGEIMMEPHPXREUR Menstruation-Inducing Agents; Premenstrual Syndrome Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle The normal physiologic discharge through the vagina of blood and mucosal tissues from the nonpregnant uterus. G;[Menstrual Cycle G08.520.440 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction Follicular Phase (+ 1); Luteal Phase; Menstruation; Ovulation (+ 3) The period of the regularly recurring physiologic changes in the endometrium occurring during the reproductive period in human females and some primates and culminating in partial sloughing of the endometrium (MENSTRUATION). Menstruation (66-84) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $G_GTTMenotropins D06.472.351.576.583; D06.472.734.525.343.583; D07.552.344.400.500 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Gonadotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins; Gonadotropins, Pituitary Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Gonadotropins, Pituitary Reproductive Control Agents (Non MeSH); Fertility Agents; Fertility Agents, Female; Gonadotropins, Pituitary An extract of postmenopausal urine containing FSH and LH activity. It is used to treat female sterility. (Merck Index, 11th ed). Gonadotropins, Pituitary (66-72)  GIB&Menorrhagia C13.371.491.583; C13.371.852.691.449; C23.542.946.533 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Uterine Hemorrhage Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Menstruation Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Uterine Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Uterine Hemorrhage Excessive menstrual flow. G=Nk Menopause, Premature G08.520.940.110.308.500 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sexual Reproduction Periods (Non MeSH); Climacteric; Menopause Premature failure of ovulation associated with the permanent disappearance of oocytes and follicles from the ovary in women under the age of 40. If failure occurs while follicles are still present, the condition is called premature ovarian failure (OVARIAN FAILURE, PREMATURE). G`DMenopause G08.520.940.110.308 BLCFDEEHGEIMMEPHPXREUR Estrogen Replacement Therapy; Osteoporosis, Postmenopausal; Postmenopause; Premenopause Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sexual Reproduction Periods (Non MeSH); Climacteric Menopause, Premature; Postmenopause G d*Menogaril D20.085.075.105.200.500.500; D22.204.106.125.200.500.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin; Nogalamycin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin; Nogalamycin (2R-(2 alpha,3 beta,4 alpha,5 beta,6 alpha,11 alpha,13 alpha))-4-(Dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-2,6-epoxy-2H-naphthaceno(1,2-b)oxocin-9,16-dione. A semisynthetic anthracycline antibiotic with the amino sugar on the D ring. It displays broad-spectrum antineoplastic activity against a variety of tumors. Nogalamycin/analogs and derivatives (79-92) G ><33Menisci, Tibial A02.165.590; A02.835.583.475.590 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage Musculoskeletal System; Skeleton; Joints; Knee Joint G&:fMeningomyelocele C10.500.680.610; C16.131.666.680.610 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Hernial protrusion of part of the meninges and substance of the spinal cord through a defect in the vertebral column. It is commonly seen in spina bifida cystica. Spina Bifida (66-74) G*LMeningoencephalitis C10.228.140.437.615; C10.228.228.245.615; C10.228.228.553 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Uveomeningoencephalitic Syndrome Uveomeningoencephalitic Syndrome Uveomeningoencephalitic Syndrome Inflammation of both the brain and meninges. (Dorland, 27th ed). GIANckPMeningococcal Infections C01.252.400.625.549 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Neisseriaceae Infections Meningitis, Meningococcal (+ 1) Infections with bacteria of the species NEISSERIA MENINGITIDIS. G4P&KMeningocele C10.500.680.598; C16.131.666.680.598 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Hernial protrusion of the meninges through a defect in the skull or vertebral column. G*LgMeningitis, Viral C02.587; C10.228.228.507.248.587 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Aseptic Lymphocytic Choriomeningitis Lymphocytic Choriomeningitis Meningitis of viral origin usually due to picornaviruses, togaviruses, herpesviruses, paramyxoviruses, or arenaviruses. Symptoms include headache, malaise, nausea, fever, and neck stiffness. G&P@Meningitis, Pneumococcal C01.252.410.890.670.595; C01.252.580.560; C10.228.228.507.280.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections; Pneumococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Meningitis, Bacterial Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Bacterial Meningitis caused by bacteria of the species STREPTOCOCCUS PNEUMONIAE. This condition can develop as a complication of pneumococcal pneumonia; by extension from otitis, mastoiditis, or sinusitis; following a skull injury; or without preceding sign of infection elsewhere. GaIP<Meningitis, Meningococcal C01.252.400.625.549.449; C01.252.580.505; C10.228.228.507.280.505 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Neisseriaceae Infections; Meningococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Meningitis, Bacterial Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Bacterial Waterhouse-Friderichsen Syndrome Waterhouse-Friderichsen Syndrome Waterhouse-Friderichsen Syndrome Inflammation in response to infection with NEISSERIA MENINGITIDIS of the pia-arachnoid and the fluid residing in the space which it encloses as well as the fluid in the ventricles of the brain. This condition occurs most often in children and adolescents. G$IPk-Meningitis, Listeria C01.252.410.514.533; C01.252.580.449; C10.228.228.507.280.449 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Listeria Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Meningitis, Bacterial Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Bacterial Meningitis caused by bacteria of the genus LISTERIA. GIEP@Meningitis, Haemophilus C01.252.400.700.433.615; C01.252.580.393; C10.228.228.507.280.393 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections; Haemophilus Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Meningitis, Bacterial Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Bacterial A type of meningitis caused by Haemophilus influenzae type b. It develops insidiously over several days and is commonly associated with an upper respiratory infection. GIPMeningitis, Fungal C01.703.580; C10.228.228.507.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis Meningitis, Cryptococcal Meningitis, Cryptococcal Meningitis caused by species of fungi. Meningitis (66-91); specific mycosis (66-91)  G2&P806Meningitis, Cryptococcal C01.703.248.290; C01.703.580.290; C10.228.228.507.400.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses; Cryptococcosis Bacterial and Fungal Diseases (Non MeSH); Mycoses; Meningitis, Fungal Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Fungal A type of meningitis caused by CRYPTOCOCCUS NEOFORMANS. This condition is a commonly encountered opportunistic infection of AIDS patients. Cryptococcosis (67-91); Meningitis (67-91) GJAP=3Meningitis, Bacterial C01.252.580; C10.228.228.507.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis Meningitis, Haemophilus; Meningitis, Listeria; Meningitis, Meningococcal (+ 1); Meningitis, Pneumococcal; Tuberculosis, Meningeal Meningitis, Haemophilus; Meningitis, Listeria; Meningitis, Meningococcal (+ 1); Meningitis, Pneumococcal; Tuberculosis, Meningeal Meningitis caused by species of BACTERIA. Meningitis (66-91); specific bacterial meningitis (66-91); specific bacterium (66-91)  G1&P(3eMeningitis, Aseptic C10.228.228.507.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis Meningitis, Viral (+ 1) A meningeal reaction in the cerebrospinal fluid sometimes occurring in the absence of an infecting organism. It can be due to a virus, foreign substance, diagnostic or therapeutic procedure, or to a tumor or a septic focus within the skull or spinal canal. Meningitis (66-76) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $G|N0PMeningitis C10.228.228.507 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Arachnoiditis; Meningitis, Aseptic (+ 2); Meningitis, Bacterial (+ 6); Meningitis, Fungal (+ 1); Subdural Effusion BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI GdNxTMeningism C10.228.637; C10.597.544; C23.888.592.544 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations The symptoms and signs of meningeal irritation associated with acute febrile illness or dehydration without actual infection of the meninges. (Dorland, 27th ed). GQ 1NMeningioma C04.557.580.520; C04.557.645.520 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue An encapsulated neoplasm of arachnoidal origin, most frequently consisting of elongated, fusiform cells in whorls and pseudolobules with psammoma bodies frequently present. It tends to occur along the superior sagittal sinus, along the sphenoid ridge or in the vicinity of the optic chiasm. Meningiomas account for 13%-17% of brain tumors, occurring most often during the fourth through sixth decades of life with a peak occurrence in patients about 45 years old. About 65% occur in women. 2%-10% of meningiomas are malignant. (From Stedman, 25th ed; from Holland et al., Cancer Medicine, 3d ed, p. 1111). Gȯ&XMeninges A08.186.566 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System Arachnoid (+ 2); Dura Mater (+ 1); Pia Mater G 8/<Meningeal Neoplasms C04.588.614.250.580; C10.228.250.580; C10.551.250.580 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms Neoplasms located in any of the meninges, the dura mater, pia mater, or arachnoid. Brain Neoplasms (66-77); Meninges (66-77); Neoplasms (66-77) Gͽ=X?dJMeningeal Arteries A07.231.114.545 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Arteries which supply the dura mater. G~88/Meniere's Disease C09.218.568.217.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endolymphatic Hydrops Endolymphatic Hydrops Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases; Endolymphatic Hydrops A disease of the inner ear characterized by vertigo, tinnitus, and fluctuating hearing loss often accompanied by fullness in the affected ear. ENDOLYMPHATIC HYDROPS (swelling of the endolymph-containing structures) is the main pathologic finding.  GjNdMengovirus B04.820.565.170.500; B04.909.777.618.170.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Cardiovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Cardiovirus A species of CARDIOVIRUS isolated from rodents and lagomorphs and occasionally causing febrile illness in man. Encephalomyocarditis Viruses (66-72) G2*Mendelevium D01.268.271.545.525; D01.552.517.561 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Mendelevium. A man-made radioactive element of the actinide family with atomic symbol Md, atomic number 101, and atomic weight 258. GՑ*4Menarche G08.520.940.508.410 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sexual Reproduction Periods (Non MeSH); Puberty Menstruation (66-68); Puberty (66-68) Go .Men M01.390 EDPX Named Groups (Non MeSH) Nurses, Male Human adult males as cultural, psychological, sociological, political, and economic entities. Male (66-79) CLECEDHILJOGPXSDSNSTTDUT $G~ lMemory, Short-Term F02.463.425.540.407 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Memory Temporary storage of information for a few seconds to hours, as opposed to long-term memory which refers to material stored for days, years, or a lifetime. Memory (66-68) Gُ dMemory Disorders F03.126.185.597 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders Amnesia (+ 1); Deja Vu Disturbances in registering an impression, in the retention of an acquired impression or in the recall of an impression. Amnesia (66-68); Deja Vu (68); Memory (66-68)  G Fr ;Memory F02.463.425.540 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Memory, Short-Term; Recall; Retention (Psychology) Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory. G  Z<Membranes, Artificial H01.181.529.530 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Lipid Bilayers; Liposomes Artificially produced membranes, such as semipermeable membranes used in artificial kidney dialysis, monomolecular and bimolecular membranes used as models to simulate biological membranes. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR GI 8Membranes A10.615 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cell Membrane; Cell Wall; Intracellular Membranes; Membrane Lipids; Membrane Proteins; Neurilemma; Nuclear Membrane; Synovial Membrane Tissue Types (Non MeSH) Basement Membrane (+ 1); Mucous Membrane (+ 7); Serous Membrane (+ 3) Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.  G  :XMembrane Proteins D12.776.543 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Membranes; Cell Membrane Amino Acids, Peptides and Proteins (Non MeSH); Proteins Ankyrins; Bacterial Outer Membrane Proteins (+ 3); Clathrin; Connexins (+ 1); Dystrophin; G-Proteins (+ 4); Ion Pumps (+ 3); Membrane Glycoproteins (+ 24); Receptors, Cell Surface (+ 229); Spectrin Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membranes (66-76); Membranes (68-76); Proteins (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (GFD;IHMembrane Potentials G06.535.166.310.657; G07.453.697; G11.561.450; H01.671.100.708 DEGEIMPHRE Cell Membrane Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport; Biological Transport, Active Physiology, General (Non MeSH); Electrophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Physical Sciences (Non MeSH); Physics; Biophysics  Action Potentials (+ 7) Action Potentials (+ 7); Signal Transduction (+ 1) Ratio of inside versus outside concentration of potassium, sodium, chloride and other ions in diffusible tissues or cells. Also called transmembrane and resting potentials, they are measured by recording electrophysiologic responses in voltage-dependent ionic channels of (e.g.) nerve, muscle and blood cells as well as artificial membranes. Electrophysiology (66) $GHd]Membrane Metallo-Endopeptidase D08.586.277.656.732.480.400; D24.185.101.100.110.400; D24.185.101.840.500; D24.611.216.285.500; D24.611.216.301.264.035.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Leukemia, CALLA-Positive Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Metalloproteinases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Membrane metallo-endopeptidase is identical to common acute lymphoblastic leukemia antigen (CALLA), an important marker in the diagnosis of human acute lymphocytic leukemia. EC 3.4.24.11. Metalloproteinases (87-88); Peptide Peptidohydrolases (66-87)  G#FGMembrane Lipids D10.516.570 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Membranes; Cell Membrane Lipids and Antilipemic Agents (Non MeSH); Lipids Lipid Bilayers Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation. Cell Membrane (66-76); Lipids (66-76); Membranes (68-76); Phospholipids (66-76) $GB<aMembrane Glycoproteins D12.776.395.550; D12.776.543.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins ABC Transporters; Antigens, Thy-1; Antiporters (+ 2); Cell Adhesion Molecules (+ 5); Fibronectins; Ion Channels (+ 4); Laminin; P-Glycoprotein; Platelet Membrane Glycoproteins (+ 2); Synaptophysin; Variant Surface Glycoproteins, Trypanosoma ABC Transporters; Antigens, Thy-1; Antiporters (+ 2); Cell Adhesion Molecules (+ 5); Fibronectins; Ion Channels (+ 4); Laminin; P-Glycoprotein; Platelet Membrane Glycoproteins (+ 2); Synaptophysin; Variant Surface Glycoproteins, Trypanosoma Glycoproteins found on the membrane or surface of cells. Glycoproteins (66-87); Membrane Proteins (77-87) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $G&F:E:HMembrane Fusion G04.335.670 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) The adherence of cell membranes, intracellular membranes, or artifical membrane models of either to each other or to viruses, parasites, or interstitial particles through a variety of chemical and physical processes. Cell Fusion (71-81); Cell Membrane (66-81) GGf5Membrane Fluidity G06.184.568 DEGEIMPHRE Cell Membrane Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) The motion of phospholipid molecules within the lipid bilayer, dependent on the classes of phospholipids present, their fatty acid composition and degree of unsaturation of the acyl chains, the cholesterol concentration, and temperature. Cell Membrane (66-78); Lipids (66-76); Membrane Lipids (77-78); Membranes (66-76); Phospholipids (66-76)  G5hMemantine D02.219.075.080.600; D02.455.426.392.368.075.080.500; D04.615.236.075.080.600; D14.100.150.600.515; D15.090.050.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Bridged Compounds; Adamantane; Amantadine Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Adamantane; Amantadine Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Bridged Compounds; Adamantane; Amantadine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents 3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine. Amantadine derivative that has some dopaminergic effects. It has been proposed as an antiparkinson agent. Amantadine (74)/analogs and derivatives (75) G :5Melphalan D02.455.526.728.650.594; D22.204.585.613 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds Peptichemio Peptichemio 4-(Bis(2-chloroethyl)amino)phenylalanine. An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Synonyms: Alkeran; CB 3007; CB 3025; CB 3026; DL-PAM; D-PAM; L-PAM; medfalan; melfalan; merfalan; NSC 14210; NSC 35051; NSC 8806; Sarcoclorin. AAADAEAGAIANBLCFCHCLCSCTDEDUECHIIMIPMEPDPKPORESDSTTOTUUR  H .:<Melorheostosis C05.116.099.708.702.593 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Osteosclerosis A form of osteosclerosis or hyperostosis extending in a linear track through one of the long bones of an extremity, and consisting of proliferated ivory-like new bone. "Melo-" is from the Greek, limb and "-rheostosis" refers to streaks (rheo- from the Greek, flow), in the bones. (Dorland, 27th ed). HN}dMelkersson-Rosenthal Syndrome C07.465.466; C10.772.204.266.297.593 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tongue, Fissured Stomatognathic Diseases; Mouth Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Facial Nerve Diseases; Facial Paralysis A syndrome often beginning in childhood or adolescence, characterized by chronic facial edema, recurrent peripheral facial paralysis, sometimes fissured tongue, and ophthalmological involvement. It is also called granulomatous cheilitis or cheilitis granulomatosa. Hj"*N-Melitten D24.185.965.065.115.580 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Arthropod Venoms; Bee Venoms Basic polypeptide from the venom of the honey bee (Apis mellifera); it contains 62 amino acids, has cytolytic properties, causes contracture of muscle, releases histamine and disrupts surface tension, probably due to lysis of cell and mitochondrial membranes. Synonyms: melittin; melliten. Bees (73-74); Peptides (73-74); Venoms (73-74) H , DzS;Melioidosis C01.252.400.739.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pseudomonas Infections A disease of humans and animals that resembles GLANDERS. It is caused by PSEUDOMONAS PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, pneumonia, and bacteremia. H PMelibiose D09.203.698.629.305.540 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides 6-0-alpha-D-Galactopyranosyl-D-glucose. A disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage. Disaccharides (66-78) H DMelengestrol D04.808.745.432.581; D06.597.799.619 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic 17 alpha-Hydroxy-6-methyl-16-methylenepregna-4,6-diene-3,20-dione. A progestational hormone with reported glucocorticoid and antineoplastic activity. Pregnadienes (66-72); Progestational Hormones (66-72) H*:?Melena C06.405.270.531; C23.542.305.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Occult Blood; Feces Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Gastrointestinal Hemorrhage Black, tarry stools containing digested blood. H &N8Melatonin D03.438.473.914.481; D06.472.506 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines Hormones, Substitutes, Antagonists (Non MeSH); Hormones H &DMELAS Syndrome C05.651.460.620.520; C10.228.140.163.634.520; C18.452.648.556.650.620.520 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic; Mitochondrial Encephalomyopathies Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies A major subgroup of the MITOCHONDRIAL ENCEPHALOMYOPATHIES characterized by mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. It has been diagnosed in all age groups. Acidosis (85-86); Acidosis, Lactic (87-92); Brain Diseases (85-87); Brain Diseases, Metabolic (87-92); Cerebrovascular Disorders (87-92); Lactates (85-86); Mitochondria, Muscle (84-92); Neuromuscular Diseases (87-92) HQNMelarsoprol D02.691.088.500; D21.370.884.420 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents p-[(4,6-diamino-s-triazin-2y1)amino]dithiobenzenearsonous acid-3-hydroxypropylene ester. Arsenical used in trypanosomiases; may cause fatal encephalopathy and other undesirable side effects. Synonyms: Arsobal; Mel-B. Arsenicals (68-74); Triazines (68-74) H}&:.Melanosis C17.800.621.430.530 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hyperpigmentation Acanthosis Nigricans; Lentigo (+ 1) Disorders of increased melanin pigmentation that develop without preceding inflammatory disease. H N{,oMelanophores A11.436.265.531 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Epithelial Cells (Non MeSH); Chromatophores Pigment cells containing melanin. Chromatophores (66-74) H*>)Melanoma, Experimental C04.557.465.625.650.510.525; C04.557.580.625.650.510.525; C04.557.665.510.525; C04.619.600 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Melanoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Melanoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Nevi and Melanomas (Non MeSH); Melanoma Neoplasms; Neoplasms, Experimental Melanoma (66-86) H dRMelanoma, Amelanotic C04.557.465.625.650.510.515; C04.557.580.625.650.510.515; C04.557.665.510.515 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Melanoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Melanoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Nevi and Melanomas (Non MeSH); Melanoma An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. (Dorland, 27th ed; Stedman, 25th ed). Melanoma (66-93) H#aUXMelanoma C04.557.465.625.650.510; C04.557.580.625.650.510; C04.557.665.510 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Nevi and Melanomas (Non MeSH) Hutchinson's Melanotic Freckle; Melanoma, Amelanotic; Melanoma, Experimental Hutchinson's Melanotic Freckle; Melanoma, Amelanotic; Melanoma, Experimental Hutchinson's Melanotic Freckle; Melanoma, Amelanotic; Melanoma, Experimental A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p. 2445). H& IXMelanocytes A11.436.613 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Epithelial Cells (Non MeSH) Chromatophores (66-68) H-&*+Melanins D11.557.596 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Pigments causing darkness in skin, hair, feathers, etc. They are irregular polymeric structures and are divided into three groups: allomelanins in the plant kingdom and eumelanins and phaeomelanins in the animal kingdom. H- BFMelanesia Z01.782.590 EHEP Geographicals (Non MeSH); Pacific Islands Fiji; New Caledonia; Papua New Guinea; Vanuatu The collective name for the islands of the Pacific Ocean northeast of Australia, including NEW CALEDONIA, New Hebrides, Solomon Islands, Admiralty Islands, Bismarck Archipelago, FIJI, etc. Melanesia (from the Greek melas, black + nesos, island) is so called from the black color of the natives who are generally considered to be descended originally from the Negroid Papuans and the Polynesians or Malays. H/ 3;Mekong Valley Z01.252.145.530 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern The geographic area of the Mekong Valley in general or when the specific country or countries are not indicated. Usually includes Cambodia, Indochina, and Laos. H2/>Meiosis G04.335.135.220.531; G05.148.165.220.531; G07.553.135.220.531 DEGEIMPHRE Maturation-Promoting Factor Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division Genetics; Cytogenetics; Cell Cycle; Cell Division Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division Synaptonemal Complex Synaptonemal Complex Synaptonemal Complex A special method of cell division, occurring in maturation of the germ cells, by means of which each daughter nucleus receives half the number of chromosomes characteristic of the somatic cells of the species. Cell Division (66-67) $H3{ E =GMeigs' Syndrome C04.588.322.455.531; C04.588.945.418.685.595; C13.371.056.630.705.531; C13.371.270.750.500; C13.371.820.800.418.685.531; C19.344.455.531; C19.391.630.705.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Ovarian Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female; Ovarian Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases; Ovarian Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female; Ovarian Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female; Ovarian Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms; Ovarian Neoplasms Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases; Ovarian Neoplasms Ascites and hydrothorax associated with ovarian fibroma or other pelvic tumors. H6N^Meige Syndrome C10.228.140.079.590 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases A syndrome characterized by blepharospasm and involuntary facial movements, in the absence of neuroleptic drug therapy. Blepharospasm (75-84); Dystonia (82-84); Facial Muscles (66-84) H;NrMMeibomian Glands A09.371.337.614; A10.336.827.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Chalazion Sense Organs; Eye; Eyelids Tissue Types (Non MeSH); Exocrine Glands; Sebaceous Glands Sebaceous glands between the tarsi and the conjunctiva of the eyelids. (Dorland, 27th ed). H=&: inMeglumine D02.033.800.813.550; D09.203.067.342.600; D09.203.853.813.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Sorbitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Sorbitol Diatrizoate Meglumine; Iothalamate Meglumine Diatrizoate Meglumine; Iothalamate Meglumine Diatrizoate Meglumine; Iothalamate Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Amino Sugars (71-76); Sorbitol (69-76)  H?W E: 0Megestrol D04.808.745.432.531; D06.597.799.593; D07.360.276.210.443.706.551 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic 17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer. HB I:NMegaloblasts A11.118.413.330.531; A15.145.229.413.330.531 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes; Erythrocytes, Abnormal Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes; Erythrocytes, Abnormal HF}2*Megakaryocytes A11.148.614; A15.378.316.614 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Bone Marrow Cells (Non MeSH) Hemic and Immune Systems (Non MeSH); Hematopoietic System; Bone Marrow Cells (Non MeSH) Very large bone marrow cells which release mature blood platelets. HG"*PMegacolon, Toxic C06.405.469.158.188.231.531; C06.405.469.158.701.591 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colitis; Colitis, Ulcerative Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Megacolon Acute dilatation of the colon associated with amebic or ulcerative colitis. The dilatation may precede perforation of the colon. (Dorland, 27th ed). HI!:NMegacolon C06.405.469.158.701 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Hirschsprung Disease; Megacolon, Toxic Pathological enlargement of the colon. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  HK Lj./NMegacins D20.085.133.531; D24.310.125.531 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Bacteriocins Immunologic and Biologic Factors (Non MeSH); Biological Products; Bacteriocins Bacteriocins elaborated by mutant strains of Bacillus megaterium. They are protein or protein-lipopolysaccharide complexes lethal to other strains of the same species. Antibiotics (66-67); Bacteriocins (68-74); Megacin (75-78) HMD &:GMefruside D02.065.884.575; D02.886.590.700.575; D19.770.224.516.592 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl 4-Chloro-N(1)-methyl-N(1)-(tetrahydro-2-methylfurfuryl)-m-benzenedisulfonamide. A diuretic that affects the concentrating ability of the kidney, increases sodium chloride excretion, but may not spare potassium. It inhibits carbonic anhydrases and may increase the blood uric acid level. Diuretics, Sulfamyl (74-75); Furans (72-75) HOt A:I5Mefloquine D03.438.810.410; D21.370.286.423 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials alpha-2-Piperidinyl-2,8-bis (trifluoromethyl)-4-quinolinemethanol. A phospholipid-interacting antimalarial drug. It is very effective against Plasmodium falciparum with very few side effects. Antimalarials (66-89); Quinolines (66-89) HR&:2Mefenamic Acid D02.241.223.106.061.105.510; D08.373.310.475; D16.850.015.050.530; D17.025.030.500; D17.050.030.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; Anthranilic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal A non-steroidal anti-inflammatory agent used in painful and inflammatory conditions, and in menstrual disorders. It has analgesic, anti-inflammatory, and antipyretic properties; it is an inhibitor of cyclooxygenase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.23). HTo:=Medulloblastoma C04.557.465.625.600.380.515; C04.557.465.625.600.600.515; C04.557.470.670.380.515; C04.557.470.670.600.515; C04.557.580.625.600.380.515; C04.557.580.625.600.600.515 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral A glioma consisting of neoplastic cells that resemble the undifferentiated cells of the primitive medullary tube. The neoplastic cells are compactly arranged, round or ovoid, with hyperchromatic nuclei in relatively scant cytoplasm, and lie in small and poorly defined groups or, occasionally, in a pseudorosette pattern. Medulloblastomas comprise approximately 3% of all intracranial neoplasms and occur approximately twice as frequently in boys as in girls. (From Stedman, 25th ed). HZX1Medulla Oblongata A08.186.211.132.810.406 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon Olivary Nucleus; Solitary Nucleus Ha8Z)Medroxyprogesterone 17-Acetate D04.808.745.745.654.829.614.500; D06.597.799.567.500; D07.360.276.210.443.706.506.500; D07.360.276.475; D07.360.443.600; D22.204.498 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Progesterone; Medroxyprogesterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic; Medroxyprogesterone Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic; Medroxyprogesterone Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Male Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents (6 alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione. A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms. Hydroxyprogesterones (76-78); Medroxyprogesterone (73-75); Medroxyprogesterone/analogs and derivatives (78-92) Hb#:G~Medroxyprogesterone D04.808.745.745.654.829.614; D06.597.799.567; D07.360.276.210.443.706.506 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Progesterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic Medroxyprogesterone 17-Acetate Medroxyprogesterone 17-Acetate Medroxyprogesterone 17-Acetate (6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator. Hh|Q:eMedrogestone D04.808.745.432.481; D06.597.799.541 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic 6,17-Dimethylpregna-4,6-diene-3,20-dione. A synthetic progestational hormone with actions similar to those of progesterone. It is used in the treatment of menstrual irregularities and has also been employed in the treatment of prostatic hypertrophy and endometrial carcinoma. Pregnadienes (66-71); Progestational Hormones (66-71) Hk*:<?MEDLINE L01.700.508.280.710.500; L01.700.508.300.259.500; L01.700.508.300.710.500; L01.700.508.300.742.500 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Storage and Retrieval; MEDLARS Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Databases, Bibliographic Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; MEDLARS Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Online Systems An online database of MEDLARS, the computerized bibliographic Medical Literature Analysis and Retrieval System of the National Library of Medicine. Information Systems (66-77); MEDLARS (78-90); National Library of Medicine (U.S.) (66-77) Hn lkMEDLARS L01.700.508.280.710; L01.700.508.300.710 CLECHIISLJMAOGSDSNSTTDUT National Library of Medicine (U.S.) Information Science; Medical Informatics; Medical Informatics Applications; Information Storage and Retrieval Information Science; Medical Informatics; Medical Informatics Applications; Information Systems MEDLINE MEDLINE A computerized biomedical bibliographic storage and retrieval system operated by the National Library of Medicine. From it a monthly and cumulated Index Medicus is generated and through it the online system, MEDLINE, as well as many other databases, is operated. Information Systems (66-77); National Library of Medicine (U.S.) (66-77) $Hr .+3VMediterranean Sea Z01.756.592 Geographicals (Non MeSH); Oceans and Seas Hu4Mediterranean Islands Z01.542.581 EHEP Geographicals (Non MeSH); Europe Cyprus; Malta Hv@)Medigoxin D04.808.155.160.349.500; D09.203.408.180.261.436.500; D18.222.175.324.595 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Digoxin Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides; Digoxin Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides (3 beta,5 beta,12 beta)-3-((O-2,6-Dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-card-20(22)-enolide. A semisynthetic digitalis glycoside with the general properties of digoxin but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to digoxin in the liver. It has been used in the treatment of congestive heart failure. Digoxin (66-78) Hv Q:DMedicine, Traditional E02.040.515; I01.076.201.450.654 HI Health Services, Indigenous Materia Medica Therapeutics; Alternative Medicine Social Sciences; Anthropology; Anthropology, Cultural; Culture Medicine, African Traditional; Medicine, Arabic; Medicine, Ayurvedic; Medicine, Herbal; Medicine, Oriental Traditional (+ 2) Medicine, African Traditional; Medicine, Arabic; Medicine, Ayurvedic; Medicine, Herbal; Medicine, Oriental Traditional (+ 2) Systems of medicine based on cultural beliefs and practices handed down from generation to generation. The concept includes mystical and magical rituals, herbal therapy, and other treatments which may not be explained by modern medicine. $Hz&!q Medicine, Oriental Traditional E02.040.515.660; I01.076.201.450.654.660 HI Therapeutics; Alternative Medicine; Medicine, Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional Medicine, Chinese Traditional (+ 1) Medicine, Chinese Traditional (+ 1) A system of traditional medicine which is based on the customs, beliefs and practices of the Oriental people. H~7$.TMedicine, Herbal E02.040.515.540; I01.076.201.450.654.540 HI Drugs, Chinese Herbal Plants, Medicinal; Herbs Therapeutics; Alternative Medicine; Medicine, Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional Use of plants or herbs to treat diseases or to alleviate pain.  H2.NMedicine, Chinese Traditional E02.040.515.660.520; I01.076.201.450.654.660.520 HI Drugs, Chinese Herbal; Yang Deficiency; Yin Deficiency; Yin-Yang Therapeutics; Alternative Medicine; Medicine, Traditional; Medicine, Oriental Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional; Medicine, Oriental Traditional Yin-Yang Yin-Yang A system of traditional medicine which is based on the beliefs and practices of the Chinese culture.  H#6NyMedicine, Ayurvedic E02.040.515.515; I01.076.201.450.654.515 HI Hinduism Therapeutics; Alternative Medicine; Medicine, Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional The traditional Hindu system of medicine which is based on customs, beliefs, and practices of the Hindu culture. H'. Medicine, Arabic E02.040.515.510; I01.076.201.450.654.510; K01.419.552.643 HI Therapeutics; Alternative Medicine; Medicine, Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional Humanities; History; History of Medicine HAMedicine, African Traditional E02.040.515.505; I01.076.201.450.654.505 HI Therapeutics; Alternative Medicine; Medicine, Traditional Social Sciences; Anthropology; Anthropology, Cultural; Culture; Medicine, Traditional A system of traditional medicine which is based on the beliefs and practices of the African peoples. It includes treatment by medicinal plants and other materia medica as well as by the ministrations of diviners, medicine men, witch doctors, and sorcerers. Medicine, Traditional (66-91) H!#..#Medicine in Literature K01.517.584 Literature Humanities; Literature HMedicine in Art K01.093.530 Art Humanities; Art H Medicine G02.403 Economics, Medical; Education, Medical; Health Manpower; History of Medicine; Legislation, Medical Health Occupations Adolescent Medicine; Behavioral Medicine; Clinical Medicine; Community Medicine; Epidemiology (+ 2); Genetics, Medical (+ 1); Geriatrics; Military Medicine; Naval Medicine (+ 1); Osteopathic Medicine; Psychiatry (+ 8); Social Medicine; Specialties, Medical (+ 18); Specialties, Other (Non MeSH) (+ 19); Specialties, Surgical (+ 11); Sports Medicine; Telemedicine; Traumatology; Tropical Medicine The art and science of preventing, diagnosing, and treating disease, as well as the maintenance of health. AECLECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE  Hh  t*Medication Systems, Hospital N02.278.354.675; N04.452.442.675; N04.452.528.473 CLECHILJOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Medication Systems Overall systems, traditional or automated, to provide medication to patients in hospitals. Elements of the system are: handling the physician's order, transcription of the order by nurse and/or pharmacist, filling the medication order, transfer to the nursing unit, and administration to the patient. Pharmacy Service, Hospital (66-67) H"9E])Medication Systems N04.452.528 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Medication Systems, Hospital Overall systems, traditional or automated, to provide medication to patients. HW"[Medication Errors E02.319.529 CLECPXSNVE Drug Therapy Therapeutics; Drug Therapy HP!Medicare Part B N03.219.521.346.506.564.663.515; N03.219.521.576.343.840.754 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance; Medical Assistance; Medicare Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Medicare The voluntary portion of Medicare, known as the Supplementary Medical Insurance (SMI) Program, that includes physician's services, home health care, medical services, outpatient hospital services, and laboratory, pathology, and radiology services. All persons entitled to Medicare Part A may enroll in Medicare Part B on a monthly premium basis. Fees, Medical (72-77); Medicare (79-90) HB61Medicare Part A N03.219.521.346.506.564.663.500; N03.219.521.576.343.840.725 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance; Medical Assistance; Medicare Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Medicare The compulsory portion of Medicare that is known as the Hospital Insurance Program. All persons 65 years and older who are entitled to benefits under the Old Age, Survivors, Disability and Health Insurance Program or railroad retirement, persons under the age of 65 who have been eligible for disability for more than two years, and insured workers (and their dependents) requiring renal dialysis or kidney transplantation are automatically enrolled in Medicare Part A. Hospitalization (79-90); Medicare (66-90) HbB6"2Medicare Assignment N03.219.521.576.343.616.508; N03.219.521.576.343.840.508 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Insurance, Physician Services Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Medicare Concept referring to the standardized fees for services rendered by health care providers, e.g., laboratories and physicians, and reimbursement for those services under Medicare Part B. It includes acceptance by the physician. Health Insurance for Aged and Disabled, Title 18 (72-88); Insurance, Physician Services (81-88) H>)qMedicare N03.219.521.346.506.564.663; N03.219.521.576.343.840 CLECHILJOGSNSTTDUT Insurance, Medigap Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance; Medical Assistance Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Medicare Part A; Medicare Part B Medicare Assignment; Medicare Part A; Medicare Part B Federal program, created by Public Law 89-97, Title XVIII-Health Insurance for the Aged, a 1965 amendment to the Social Security Act, that provides health insurance benefits to persons over the age of 65 and others eligible for Social Security benefits. It consists of two separate but coordinated programs: hospital insurance (MEDICARE PART A) and supplementary medical insurance (MEDICARE PART B). (Hospital Administration Terminology, AHA, 2nd ed. and A Discursive Dictionary of Health Care, US House of Representatives).  H :jbMedically Uninsured M01.385 CLEHHILJPXSN Uncompensated Care Uncompensated Care; Medical Indigency; Insurance, Health Named Groups (Non MeSH) Individuals or groups with no or inadequate health insurance coverage. Those falling into this category usually comprise three primary groups: the medically indigent (MEDICAL INDIGENCY); those whose clinical condition makes them medically uninsurable; and the working uninsured.  H; CCMedically Underserved Area N03.349.650.340; N05.300.450.520 Health Services Accessibility Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Services Needs and Demand A geographic location which has insufficient health resources (manpower and/or facilities) to meet the medical needs of the resident population. HT &#Medical Waste Disposal G03.850.460.710.460.300; G03.850.860.510.900.600.600 ECHIISLJMTSNST Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products; Medical Waste Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management; Refuse Disposal Management, removal, and elimination of biologic, infectious, pathologic, and dental waste. The concept includes blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special control and handling. Disposal may take place where the waste is generated or elsewhere. Medical Waste (91-93); Refuse Disposal (66-93); Waste Products (78-90) Hc:pVMedical Waste G03.850.460.710.460 AEANCLECHILJPCSN Blood-Borne Pathogens Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products Dental Waste; Medical Waste Disposal Blood, mucus, tissue removed at surgery or autopsy, soiled surgical dressings, and other materials requiring special disposal procedures. Refuse Disposal (66-77) AEANCLECHIISLJMTPCSNST (Hs-Medical Staff, Hospital M01.526.485.630.490; M01.526.485.740.422; N02.360.630.490; N02.360.740.422 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Medical Staff Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital Facilities, Manpower and Services (Non MeSH); Health Personnel; Medical Staff Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital Professional medical personnel approved to provide care to patients in a hospital. HTbMedical Staff Privileges N02.278.354.458.500; N04.452.442.530.500; N04.452.758.275.500 CLECEDHILJOGPXSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital-Physician Relations Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital-Physician Relations Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Hospital-Physician Relations Those rights or activities which are specific to members of the institution's medical staff, including the right to admit private patients. Hospital Administration (66-Jul 77); Medical Staff, Hospital (66-Jul 77) HEVMedical Staff M01.526.485.630; N02.360.630 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Medical Staff, Hospital Medical Staff, Hospital Professional medical personnel who provide care to patients in an organized facility, institution or agency. H"8Medical Secretaries M01.526.485.067.600; N02.360.067.600 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Medical Receptionists Medical Receptionists Individuals responsible for various duties pertaining to the medical office routine. H*2cMedical Records, Problem-Oriented E05.318.308.940.968.750; G03.850.520.308.940.968.750; L01.280.900.968.750; N04.452.859.564.600; N05.715.360.300.715.500.520 SNSTUT Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records; Medical Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records; Medical Records Information Science; Data Collection; Records; Medical Records Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records The structuring of a patient's record according to a complete listing of his medical problems accompanied by progress notes for each problem. H' xMedical Records Systems, Computerized L01.280.900.968.775; L01.700.508.300.695; N04.452.859.564.650; N05.715.360.300.715.500.530 CLECHIISLJMAOGSDSNSTTDUT Forms and Records Control Information Science; Data Collection; Records; Medical Records Information Science; Medical Informatics; Medical Informatics Applications; Information Systems Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records Computer-based systems for input, storage, display, retrieval, and printing of information contained in a patient's medical record. H,d Medical Records Department, Hospital N02.278.354.422.465; N04.452.442.422.465 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the creating, care, storage and retrieval of medical records. It also provides statistical information for the medical and administrative staff. H+. Medical Records E05.318.308.940.968; G03.850.520.308.940.968; L01.280.900.968; N04.452.859.564; N05.715.360.300.715.500 CLECLJSNST Forms and Records Control; Medical History Taking Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records Information Science; Data Collection; Records Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records Medical Record Linkage; Medical Records, Problem-Oriented; Trauma Severity Indices (+ 3) Medical Record Linkage; Medical Records, Problem-Oriented; Trauma Severity Indices Medical Record Linkage; Medical Records, Problem-Oriented; Medical Records Systems, Computerized; Trauma Severity Indices (+ 3) Medical Record Linkage; Medical Records, Problem-Oriented; Medical Records Systems, Computerized; Trauma Severity Indices (+ 3) Medical Record Linkage; Medical Records, Problem-Oriented; Medical Records Systems, Computerized; Trauma Severity Indices (+ 3) Recording of pertinent information concerning patient's illness or illnesses. CLECHIISLJMAMTOGSDSNSTTDUT $Hs<|ZMedical Record Linkage E05.318.308.940.968.500; G03.850.520.308.940.968.500; L01.280.900.968.500; N04.452.859.564.550; N05.715.360.300.715.500.500 ISMTST Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records; Medical Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records; Medical Records Information Science; Data Collection; Records; Medical Records Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records The creation and maintenance of medical and vital records in multiple institutions in a manner that will facilitate the combined use of the records of identified individuals. Medical Records (66-89) HŎ xMedical Record Administrators M01.526.485.067.550; N02.360.067.550 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Individuals professionally qualified in the management of patients' records. Duties may include planning, designing, and managing systems for patient administrative and clinical data, as well as patient medical records. The concept includes medical record technicians. H#*5Medical Receptionists M01.526.485.067.600.630; N02.360.067.600.630 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Medical Secretaries Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Medical Secretaries Individuals who receive patients in a medical office. Hk2AMedical Oncology G02.403.776.409.515 CLECEDHIISLJMAMTOGSNSTTD Neoplasms Health Occupations; Medicine; Specialties, Medical; Internal Medicine Radiation Oncology A subspecialty of internal medicine concerned with the study of neoplasms. Internal Medicine (66-78); Specialties, Medical (68-78) $HM RYBMedical Office Buildings N02.278.562 CLECHILJOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Office and laboratory facilities constructed for the use of physicians and other health personnel. Health Facilities (68-79) HLtMedical Missions, Official I01.534.655 CLECHILJMAOGSDSNSTTDUT Social Sciences; International Cooperation Travel by a group of physicians to a foreign country for the purpose of making a special study or of undertaking a special project of a short-term duration; not to be confused with MISSIONS AND MISSIONARIES which covers permanent medical establishments and personnel maintained by religious organizations. H  2eMedical Informatics Computing L01.700.568 CLECHILJSDSNSTTDUT Information Science; Medical Informatics Computer Systems (+ 15); Computing Methodologies (Non MeSH) (+ 24); Computing Milieu (Non MeSH) (+ 3); Software (+ 10) Precise procedural mathematical and logical operations utilized in the study of medical information pertaining to health care. AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE  H##0,Medical Informatics Applications L01.700.508 Biomedical Engineering Information Science; Medical Informatics Decision Making, Computer-Assisted (+ 7); Information Storage and Retrieval (+ 3); Information Systems (+ 27) Automated systems applied to the patient care process including diagnosis, therapy, and systems of communicating medical data within the health care setting. AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE  H&0,Medical Informatics L01.700 CLECEDHIISLJMAMTOGSNSTTD Information Science Medical Informatics Applications (+ 40); Medical Informatics Computing (+ 56) The field of information science concerned with the analysis and dissemination of medical data through the application of computers to various aspects of health care and medicine. Information Systems (82-86) AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE $H( \!,Medical Indigency N01.824.460; N03.219.780 ECEHHILJPXSNTD Medically Uninsured; Uncompensated Care Population Characteristics (Non MeSH); Socioeconomic Factors Economics, Organizations, Control (Non MeSH); Economics The condition in which an individual is unable to provide himself and his dependents with adequate medical care without depriving himself and his dependents of food, clothing, shelter, and other essentials of living. H)/Medical Illustration G02.385; L01.178.147.480; K01.093.410 EDHI Art Health Occupations Information Science; Communications Media (Non MeSH); Audio-Visual Aids Humanities; Art  Anatomy, Artistic The field which deals with illustrative clarification of biomedical concepts, as in the use of diagrams and drawings. The illustration may be produced by hand, photography, computer, or other electronic or mechanical methods. CLECEDHIISLJMAMTOGSNSTTD $HI-}Medical History Taking E01.579 MTSNSTVE Data Collection Medical Records Diagnosis Cornell Medical Index; Reproductive History Diagnosis (66) $H݅   4Medical Futility E01.789.600; E01.789.800.500; F02.463.785.373.433; K01.316.333.366.775; K01.752.667.416.775; N04.761.559.590.800.500; N05.350.340.500.712; N05.715.360.575.575.800.500 Resuscitation Orders Diagnosis; Prognosis Diagnosis; Prognosis; Treatment Outcome Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking; Decision Making Humanities; Ethics; Ethics, Professional; Ethics, Medical Humanities; Philosophy; Philosophy, Medical; Ethics, Medical Health Services Administration (Non MeSH); Quality of Health Care; Outcome and Process Assessment (Health Care); Outcome Assessment (Health Care); Treatment Outcome Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional; Ethics, Medical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Outcome and Process Assessment (Health Care); Outcome Assessment (Health Care); Treatment Outcome The absence of a useful purpose or useful result in a diagnostic procedure or therapeutic intervention. The situation of a patient whose condition will not be improved by treatment or instances in which treatment preserves permanent unconsciousness or cannot end dependence on intensive medical care. (From Ann Intern Med 1990 Jun 15;112(12):949). Decision Making (85-94); Ethics, Medical (90-94); Resuscitation (89) HcWSMedical Directors M01.526.070.630; M01.526.485.600; N02.360.600 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Administrative Personnel Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Physicians employed by a medical facility who serve in a medical and administrative capacity as head of the organized medical staff and who also may serve as liaison for the medical staff with the administration and governing board. H5Medical Audit N04.761.380; N05.700.500 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Commission on Professional and Hospital Activities Commission on Professional and Hospital Activities A detailed review and evaluation of selected clinical records by qualified professional personnel for evaluating quality of medical care. Hospital Administration (66-67)  Hct%Medical Assistance N03.219.521.346.506.564 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance Medicaid; Medicare (+ 2) Financing of medical care provided to public assistance recipients. Public Health (66-67); Social Welfare (66-67)  H P8Medicaid N03.219.521.346.506.564.655 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance; Medical Assistance Federal program, created by Public Law 89-97, Title XIX, a 1965 amendment to the Social Security Act, administered by the states, that provides health care benefits to indigent and medically indigent persons. Medical Assistance (68-70) HV  Mediastinum A01.911.529 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Mediastinoscopy; Pneumomediastinum, Diagnostic Body Regions (Non MeSH); Thorax Ht(5)Mediastinoscopy E01.418.659 AECLCTECHIISMOMTNUPXSNSTTDUTVE Mediastinum Diagnosis; Endoscopy H;"Mediastinitis C23.304.612.679 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Mediastinal Diseases Inflammation of the mediastinum. (Dorland, 27th ed). HNyAMediastinal Neoplasms C04.588.894.479; C23.304.612.579 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Mediastinal Diseases H&XMediastinal Emphysema C23.304.612.479; C23.390.529 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Mediastinal Diseases Symptoms and General Pathology (Non MeSH); Emphysema Presence of air in the mediastinal tissues due to leakage of air from the tracheobronchial tree, usually as a result of trauma. H"NMediastinal Diseases C23.304.612 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH) Mediastinal Cyst; Mediastinal Emphysema; Mediastinal Neoplasms; Mediastinitis Disorders of the mediastinum, general or unspecified. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  HN_Z@XMediastinal Cyst C04.182.444; C23.304.612.379 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Mediastinal Diseases Cysts of one of the parts of the mediastinum: the superior part, containing the trachea, esophagus, thoracic duct and thymus organs; the inferior middle part, containing the pericardium; the inferior anterior part containing some lymph nodes; and the inferior posterior part, containing the thoracic duct and esophagus. H"VuMedian Nerve A08.800.800.720.050.500 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Carpal Tunnel Syndrome Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Brachial Plexus A major nerve of the upper extremity. In humans, the fibers of the median nerve originate in the lower cervical and upper thoracic spinal cord (usually C6 to T1), travel via the brachial plexus, and supply sensory and motor innervation to parts of the forearm and hand. H28nBMedian Eminence A08.186.211.730.385.357.579 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus Raised area on the infundibular hypothalamus at the floor of the third ventricle of the brain which contains the primary capillary network of the hypophyseal portal system. H6jMedial Forebrain Bundle A08.612.492 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Neural Pathways A complex group of fibers arising from the basal olfactory regions, the periamygdaloid region, and the septal nuclei, and passing to the lateral hypothalamus. Some fibers continue into the tegmentum. Hypothalamus (66-76); Limbic System (66-76); Neural Pathways (74-76) HJ6'SMedial Collateral Ligament, Knee A02.513.514.162.600; A02.835.583.512.162.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Anterior Cruciate Ligament; Posterior Cruciate Ligament; Patellar Ligament Musculoskeletal System; Ligaments; Ligaments, Articular; Collateral Ligaments Musculoskeletal System; Skeleton; Joints; Ligaments, Articular; Collateral Ligaments A broad, flat, longitudinal band on the medial side of the knee joint. It is attached superiorly to the medial epicondyle of the femur, inferiorly to the medial surface of the body of the tibia, and in between to the medial meniscus. It is a frequent site of injury, particularly rupture and tear. (Dorland, 27th ed). Ligaments (66-93); Ligaments, Articular (68-93)  H7'2:W}9Medazepam D03.438.079.080.550; D14.100.240.500.470; D15.075.050.500; D15.080.525; D15.210.350.800.457; D15.210.950.012.050.480; D15.325.875.500; D15.525.460; D15.700.872.015.050.550; D16.700.600.460 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Muscle Relaxants, Central Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central 7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine monohydrochloride. A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM. Benzazepines (70-74) I :XHMeconium Aspiration C08.381.580; C08.618.580; C13.703.277.785; C16.300.580; C16.614.580 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiration Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Syndrome caused by sucking of thick meconium into the lungs, usually by term or post-term infants (often small for gestational age) either in utero or with first breath. The resultant small airway obstruction may produce respiratory distress, tachypnea, cyanosis, pneumothorax, and/or pneumomediastinum. Asphyxia Neonatorum (77-87); Aspiration (75-87); Infant, Newborn, Diseases (71-83); Meconium (66-87); Pneumonia, Aspiration (66-87); Respiratory Distress Syndrome (71-87) IOL_Meconium A12.459.529; A16.378.529 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Feces Embryonic Structures (Non MeSH); Fetus I 7 "`Meclofenoxate D02.241.511.316.510; D15.575.500; D15.590.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates Central Nervous System Agents; Neuroprotective Agents Central Nervous System Agents; Nootropic Agents (4-Chlorophenoxy)acetic acid 2-(dimethylamino)ethyl ester. A drug proposed to be a nootropic and neuroprotective agent. I5:Meclofenamic Acid D02.241.223.106.061.105.500; D08.373.310.465; D16.850.015.050.520; D17.025.030.475; D17.050.030.475 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; Anthranilic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis. Anthranilic Acids (69-74); Toluene (72-74) Io:4Meclizine D02.455.426.559.389.115.475; D03.383.606.650; D14.100.375.425.400.485; D15.095.550; D16.050.030.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzhydryl Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness. I o:IMeckel's Diverticulum A03.492.411.620.484.612; C06.175.556; C16.131.314.556 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System; Gastrointestinal System; Intestines; Intestine, Small; Ileum Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) An occasional sacculation or appendage of the ileum, derived from an unobliterated yolk stalk. (Dorland, 27th ed). Id=L#Mechlorethamine D02.455.526.728.650.529; D22.204.585.602 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds 2-Chloro-N-(2-chloroethyl)-N-methylethanamine. A vesicant and necrotizing irritant destructive to mucous membranes. It was formerly used as a war gas. The hydrochloride is used as an antineoplastic in Hodgkin's disease and lymphomas. It causes severe gastrointestinal and bone marrow damage. I.:SMechanoreceptors A08.800.550.700.500 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Proprioception Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory Golgi-Mazzoni Corpuscles; Hair Cells (+ 3); Muscle Spindles; Neurotendinous Spindles; Pacinian Corpuscles; Pressoreceptors; Pulmonary Stretch Receptors Cells specialized to transduce mechanical stimuli and relay that information centrally in the nervous system. Mechanoreceptors include HAIR CELLS, which mediate hearing and balance, and the various somatosensory receptors, often with non-neural accessory structures. Nerve Endings (66-70); Receptors, Sensory (66-70) $I8[1<Mecamylamine D02.455.849.618.500; D14.100.120.200.600.500; D16.050.340.510; D18.162.526 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Norbornanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Blockers Cardiovascular Agents; Antihypertensive Agents A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool. I T:;Mebendazole D03.438.103.600; D21.201.287.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Methyl-5-benzoyl-2-benzimidazolecarbamate. A nematocide in humans and animals. It acts by interfering with the carbohydrate metabolism and associated energy production of the parasite. Benzimidazoles (71-74); Benzoates (71-74); Carbamates (71-74) I$p&:JMeat-Packing Industry J01.576.598 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry Abattoirs I&A Meat Products J01.341.659.600 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Meat Articles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food (e.g., head cheese, sausage, scrapple). I'"EMeat J01.341.659 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Meat Products The edible portions of any animal used for food including domestic mammals (the major ones being cattle, swine, and sheep) along with poultry, fish, shellfish, and game. I("=Measles Virus B04.820.455.600.650.500.500; B04.909.777.455.600.650.500.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Morbillivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Paramyxoviridae; Paramyxovirinae; Morbillivirus SSPE Virus SSPE Virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease measles, which affects mostly children. I*iBMeasles Vaccine D24.310.894.899.404 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines I,>lMeasles C02.782.580.600.500.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Paramyxoviridae Infections; Morbillivirus Infections Subacute Sclerosing Panencephalitis A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the reticuloendothelial system. (From Dorland, 27th ed). I- P)mMCPA D02.241.511.316.500; D05.723.366.580 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides 4-Chloro-2-methylphenoxyacetic acid. A powerful herbicide used as a selective weed killer. Glycolates (69-74); Toluene (74) I0]*:j)McN A 343 D02.092.102.515; D02.675.276.515; D14.100.120.140.500.480; D14.100.120.140.700.520; D16.050.400.520 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Nicotinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Stimulants A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes. Ammonium Compounds (68-74); Carbamates (68-74); Alkynes (72-74) I2.o:WMMazindol D03.438.473.600; D14.100.050.600.050.512; D14.100.150.600.220.500; D14.100.600.050.512; D14.100.600.220.500; D15.155.500; D15.220.528 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. Indoles (72-74); Imidazoles (72-74) I6 :,Maze Learning F02.463.425.507 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Learning the correct route through a maze to obtain reinforcement. It is used for human or animal populations. (Thesaurus of Psychological Index Terms, 6th ed). Discrimination Learning (66-94); Learning (66-94) I< Z;Maytansine D03.383.533.580; D22.204.179.578 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic An ansa macrolide isolated from the East African shrubs Maytenus serrata and M. buchananii; has antineoplastic activity, probably due to its inhibition of DNA synthesis. Morpholines (66-75); Oxazines (76) I>B&:+Maximum Permissible Exposure Level G03.850.460.350.210 Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Environmental Exposure appropriate environment heading (66-68); Environmental Health (66-68); specific agent (66-68) I@){nMaximal Voluntary Ventilation E01.302.796.624.630; G09.772.521.700.646.630 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow Measure of the maximum amount of air that can be breathed in and blown out over a sustained interval such as 15 or 20 seconds. Common abbreviations are MVV and MBC. IA#2Maximal Midexpiratory Flow Rate E01.302.796.624.390.670; G09.772.521.700.646.390.670 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow; Forced Expiratory Flow Rates Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow; Forced Expiratory Flow Rates Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are MMFR and FEF 25%-75%. IDD&:bMaximal Expiratory Flow-Volume Curves E01.302.796.624.390.630; G09.772.521.700.646.390.630 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow; Forced Expiratory Flow Rates Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow; Forced Expiratory Flow Rates Curves depicting maximal expiratory flow in liters/second at each point of lung inflation (expressed in liters or percentage of forced vital capacity) during a forced vital capacity determination. Common abbreviation is MEFV. IG,:bMaximal Expiratory Flow Rate E01.302.796.624.390.590; G09.772.521.700.646.390.590 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow; Forced Expiratory Flow Rates Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow; Forced Expiratory Flow Rates Measurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and FEF 0.2-1.2. IJ#:bMaxillofacial Prosthesis E04.659.678; E04.833.610; E06.780.653; E06.892.610; E07.450.660; E07.858.565.728 AECLCTECHIMIMONUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Oral Dentistry; Prosthodontics Dentistry; Surgery, Oral Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis A prosthetic appliance for the replacement of areas of the maxilla, mandible, and face, missing as a result of deformity, disease, injury, or surgery. When the prosthesis replaces portions of the mandible only, it is referred to as MANDIBULAR PROSTHESIS. IM^&,Maxillofacial Injuries C21.866.460.589 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Facial Injuries (+ 10); Maxillary Fractures General or unspecified injuries involving the face and jaw (either upper, lower, or both). IONc6mMaxillofacial Development G07.553.121.478; G11.427.111.478 DEGEIMPHRE Cephalometry Maxilla Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Bone Development Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Development IQ& Maxillary Sinusitis C08.460.692.752.578; C08.730.749.578; C09.603.692.752.578 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Respiratory Tract Diseases; Respiratory Tract Infections; Sinusitis Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Inflammation of the maxillary sinus. In most cases it is the result of infection by the bacteria HAEMOPHILUS INFLUENZAE, STREPTOCOCCUS PNEUMONIAE, and STAPHYLOCOCCUS AUREUS. This condition may be acute or chronic. Sinusitis (66-89) IS ANMaxillary Sinus Neoplasms C04.588.443.665.650.693.575; C08.460.669.693.575; C08.460.692.503.503; C08.785.600.693.575; C09.603.669.693.575; C09.603.692.503.503; C09.647.685.693.575 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Nose Neoplasms; Paranasal Sinus Neoplasms Respiratory Tract Diseases; Nose Diseases; Nose Neoplasms; Paranasal Sinus Neoplasms Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms; Nose Neoplasms; Paranasal Sinus Neoplasms Otorhinolaryngologic Diseases; Nose Diseases; Nose Neoplasms; Paranasal Sinus Neoplasms Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Nose Neoplasms; Paranasal Sinus Neoplasms Neoplasms or tumors of the maxillary sinus. The majority of paranasal sinus neoplasms arise here. They develop silently when confined to the sinus and produce symptoms on extension through the walls. Paranasal Sinus Neoplasms (66-83) IVX-(Maxillary Sinus A04.531.621.578 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Respiratory System; Nose; Paranasal Sinuses One of the paired paranasal sinuses, located in the body of the maxilla, communicating with the middle meatus of the nasal cavity. I[85Maxillary Nerve A08.800.800.120.760.550 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Trigeminal Nerve The intermediate sensory division of the trigeminal (5th cranial) nerve. The maxillary nerve carries general afferents from the intermediate region of the face including the lower eyelid, nose and upper lip, the maxillary teeth, and parts of the dura. I\8p'Maxillary Neoplasms C04.588.149.721.450.601; C05.116.231.754.450.601; C05.500.499.601; C05.500.693.528; C07.320.515.601; C07.320.660.601 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms; Skull Neoplasms; Jaw Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms; Skull Neoplasms; Jaw Neoplasms Musculoskeletal Diseases; Jaw Diseases; Jaw Neoplasms Musculoskeletal Diseases; Jaw Diseases; Maxillary Diseases Stomatognathic Diseases; Jaw Diseases; Jaw Neoplasms Stomatognathic Diseases; Jaw Diseases; Maxillary Diseases Cancer or tumors of the maxilla or upper jaw. I_X:Maxillary Fractures C21.866.405.762.467.611; C21.866.460.589.338.500.611; C21.866.460.589.445; C21.866.460.836.500.611 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Skull Fractures; Jaw Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries; Jaw Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Skull Fractures; Jaw Fractures Ib!lN)Maxillary Diseases C05.500.693; C07.320.660 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases Maxillary Neoplasms Maxillary Neoplasms Bone Diseases (66); Maxilla (66) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  Ie;NY.*XMaxillary Artery A07.231.114.523 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries A branch of the external carotid artery which distributes to the deep structures of the face (internal maxillary) and to the side of the face and nose (external maxillary). If88Maxilla A02.835.232.781.324.502.645; A14.521.645 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Maxillofacial Development Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw Stomatognathic System; Jaw Ih{ .:{Mauritius Z01.600.520 EHEP Geographicals (Non MeSH); Indian Ocean Islands Ii 9Mauritania Z01.058.290.190.520 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western Ij&_Maturation-Promoting Factor D08.586.913.696.620.682.700.200.580; D11.303.580; D12.776.260.150.200.580; D24.185.348.580 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Cyclins Mitosis; Meiosis; Cyclins Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Cyclin-Dependent Kinases Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances  Protein p34cdc2 Protein p34cdc2 Protein p34cdc2 Protein kinase that drives both the mitotic and meiotic cycles in all eukaryotic organisms. In meiosis it induces immature oocytes to undergo meiotic maturation. In mitosis it has a role in the G2/M phase transition. Once activated by CYCLINS, MPF directly phosphorylates some of the proteins involved in nuclear envelope breakdown, chromosome condensation, spindle assembly, and the degradation of cyclins. The catalytic subunit of MPF is PROTEIN P34CDC2. Growth Substances (79-90) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,Ij dD !59HMatrix Bands E06.186.501.630; E07.222.501.630 AECLCTECHISDSNSTTDUTVE Dentistry; Dental Equipment; Dental Instruments Equipment and Supplies; Dental Equipment; Dental Instruments Devices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity. Ip&tMathematics H01.548 HI Physical Sciences (Non MeSH) Algorithms; Fourier Analysis; Fractals; Game Theory (+ 1); Mathematical Computing (+ 5); Nonlinear Dynamics; Statistics (+ 42) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE IrM #*Mathematical Computing H01.548.635; L01.700.568.110.680 Physical Sciences (Non MeSH); Mathematics Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Decision Support Techniques (+ 4) Decision Support Techniques (+ 4); Numerical Analysis, Computer-Assisted Computer-assisted interpretation and analysis of various mathematical functions related to a particular problem. IS Is{&|Maternal-Fetal Exchange G08.520.769.455 DEGEIMPHRE Abnormalities, Drug-Induced Biological Transport; Placenta; Fetus; Maternal Exposure Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Exchange of substances between the maternal blood and the fetal blood through the placental barrier. It excludes microbial or viral transmission.  Iu DTMaternal-Child Nursing G02.478.676.390; N02.421.533.460 CLECEDHIISLJMAMTOGSNSTTD Pediatric Nursing; Perinatology Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care Neonatal Nursing Neonatal Nursing The nursing specialty that deals with the care of women throughout their pregnancy and childbirth and the care of their newborn children.  Iw^&&(Maternal-Child Health Centers N02.278.035.310 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities Facilities which administer the delivery of health care services to mothers and children. Child Health Services (68-78); Maternal Health Services (68-78) Iyk#ljLMaternal Welfare I01.880.787.678 CLECEHHILJPXSNTD Maternal Health Services Social Sciences; Sociology; Social Welfare Organized efforts by communities or organizations to improve the health and well-being of the mother. I{4xMaternal Mortality E05.318.308.985.550.500; G03.850.505.400.975.550.500; G03.850.520.308.985.550.500; L01.280.975.550.500; N01.224.935.698.653 TD Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Information Science; Data Collection; Vital Statistics; Mortality Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality Maternal deaths resulting from complications of pregnancy and childbirth in a given population. I|1SpMaternal Health Services N02.421.143.620 CLECHILJMAMTOGSDSNSTTDUT Maternal Welfare Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Postnatal Care; Preconception Care; Prenatal Care Organized services to provide health care to expectant and nursing mothers. Maternal Welfare (66-67); Prenatal Care (66-67) CLECHILJMAMTOGPXSDSNSTTDUT (Ii<Z:Maternal Exposure G03.850.460.350.145 AECLECHILJPCSNST Maternal-Fetal Exchange; Paternal Exposure Paternal Exposure; Prenatal Exposure Delayed Effects Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Environmental Exposure Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure. Environmental Exposure (67-94) $I2>{d$Maternal Deprivation F01.829.263.370.240 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) Prolonged separation of the offspring from the mother. IxBMaternal Behavior F01.145.597; F01.829.263.370.215 DEEHPHPXRE Mothers Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) The behavior patterns associated with or characteristic of a mother. Behavior, Animal (66-67); Parent-Child Relations (66-67)  I& RCMaternal Age 35 and over G08.520.420.630 Pregnancy, High-Risk Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Maternal Age Pregnancy in women 35 or more years of age. It is used for normal pregnancies and for problems of pregnancy occurring in a woman's late reproductive years. These include effects on the mother's physical and mental health as well as risks of perinatal mortality and fetal abnormality. Maternal Age (66-80) Ii XPMaternal Age G08.520.420 Reproduction, Urogenital Physiology (Non MeSH); Reproduction Maternal Age 35 and over; Pregnancy in Adolescence BLCFDEEHGEIMMEPHPXRESNUR IG>Materials Testing E05.916.600; E06.912.600 ECISMTSNSTVE Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical Dentistry; Technology, Dental The testing of materials and devices, especially those used for implants, prostheses, sutures, adhesives, etc., for hardness, strength, durability, safety, and efficacy. Biocompatible Materials (72-86); Stress, Mechanical (71-86) IlFMaterials Management, Hospital N02.278.354.650; N04.452.442.650 CLECHILJMAMTOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Inventories, Hospital Inventories, Hospital The management of all procurement, distribution, and storage of equipment and supplies, as well as logistics management including laundry, processing of reusables, etc. Ib$&2Materials (Non MeSH) J01.637 Technology, Industry, Agriculture (Non MeSH) Adhesives; Cellophane; Ceramics; Charcoal; Construction Materials; Glass; Ink; Metals; Paint (+ 1); Paper; Petroleum (+ 2); Rubber; Textiles (+ 3); Wood AAABADAEAGAHAIANBLBSCFCHCLCSCTCYDEDUECEMENGDGEHIIMINIPIRMEMIPAPDPHPKPOPPPSRARERISDSESNSTTOTRTUULURUSUTVI I 4lMateria Medica D26.394.600 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Medicine, Traditional Miscellaneous Drugs and Agents (Non MeSH); Drugs Materials or substances used in the composition of medical remedies. Restrict the use of this term to historical articles or those concerned with folk medicine. Examples are powdered tiger bones and antler horns, oil of ants, steel tonics, extracts of viper flesh, live frogs and worms. Drugs (66-87); Folklore (68-87); Medicine, Arabic (66-87); Medicine, Ayurvedic (66-87); Medicine, Chinese Traditional (75-87); Medicine, Herbal (66-87); Medicine, Oriental Traditional (66-87); Medicine, Traditional (66-87)  Ic,<RMatched-Pair Analysis E05.318.740.475; E05.318.780.485; G03.850.520.830.475; G03.850.520.840.485; H01.548.832.475; N05.715.360.750.500; N05.715.360.780.500 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) A type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects (e.g., age-matched controls). IMasturbation F01.145.792.526; F03.709.597.460.600 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Impulse Control Disorders Sexual stimulation or gratification of the self. Ir*F;Mastoiditis C09.218.705.663.652 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Otitis; Otitis Media Inflammation of the mastoid antrum and cells of the mastoid process of the temporal bone. (Dorland, 27th ed). I"NNMastoid A02.835.232.781.885.444 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull; Temporal Bone I :VMastocytosis C17.800.508 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Urticaria Pigmentosa A group of diseases resulting from proliferation of mast cells. Urticaria Pigmentosa (66-86)  IaNKM"Mastitis, Bovine C19.146.677.527; C22.196.581 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Endocrine Diseases; Breast Diseases; Mastitis Animal Diseases; Cattle Diseases I"J]Mastitis C13.703.844.506.677; C19.146.677 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Puerperal Disorders; Lactation Disorders Endocrine Diseases; Breast Diseases  Mastitis, Bovine Inflammatory disease of the breast, or mammary gland. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  I &NAPMastigophora Infections C03.752.700.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections Dientamoebiasis; Giardiasis; Leishmaniasis (+ 4); Trichomonas Infections (+ 1); Trypanosomiasis (+ 5) Infections with protozoa of the subphylum MASTIGOPHORA. IPQzBMastigophora B01.841.750.443 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora Phytomastigophorea (+ 7); Zoomastigophora (+ 30) A subphylum of flagellate protozoa. It contains two classes: PHYTOMASTIGOPHORA and ZOOMASTIGOPHORA. I&2;tMastigomycotina B05.354.730.576 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes Blastocladiella; Oomycetes (+ 2) A subdivision of the fungi, formerly included in the Phycomycetes. Phycomycetes (66-85)  I"<(PMasticatory Muscles A02.633.567.600; A14.530 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Stomatognathic System Masseter Muscle; Pterygoid Muscles; Temporal Muscle Masseter Muscle; Pterygoid Muscles; Temporal Muscle Muscles arising in the zygomatic arch that close the jaw. Their nerve supply is masseteric from the mandibular division of the trigeminal nerve. (From Stedman, 25th ed). I:SzMastication G10.261.692; G10.549.429 DEGEIMPHRE Tooth Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) IM Mastectomy, Subcutaneous E04.466.823 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Mastectomy Excision of breast tissue with preservation of overlying skin, nipple, and areola so that breast form may be reconstructed. Breast/surgery (66-88); Breast Neoplasms/surgery (66-88); Mastectomy (66-88) Il$%\Mastectomy, Simple E04.466.754 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Mastectomy Removal of only the breast tissue and nipple and a small portion of the overlying skin. Breast/surgery (66-88); Breast Neoplasms/surgery (66-88); Mastectomy (66-88) I$%k\Mastectomy, Segmental E04.466.701 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Mastectomy Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor. Breast/surgery (66-88); Breast Neoplasms/surgery (66-88); Mastectomy (66-88) IS$%\Mastectomy, Radical E04.466.678 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Mastectomy Mastectomy, Extended Radical; Mastectomy, Modified Radical Removal of the breast, pectoral muscles, axillary lymph nodes, and associated skin and subcutaneous tissue. Breast/surgery (66-88); Breast Neoplasms/surgery (66-88); Mastectomy (66-88)  I$%D~\Mastectomy, Modified Radical E04.466.678.476 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Mastectomy; Mastectomy, Radical Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles. Breast/surgery (66-88); Breast Neoplasms/surgery (66-88); Mastectomy (66-88) I"$=o\Mastectomy, Extended Radical E04.466.678.354 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Mastectomy; Mastectomy, Radical Radical mastectomy with removal of the ipsilateral half of the sternum and a portion of ribs two through five with the underlying pleura and the internal mammary lymph nodes. Breast/surgery (66-88); Breast Neoplasms/surgery (66-88); Mastectomy (66-88) I"$=\Mastectomy E04.466 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Breast Surgery, Operative Mastectomy, Radical (+ 2); Mastectomy, Segmental; Mastectomy, Simple; Mastectomy, Subcutaneous I $ oMastadenovirus B04.280.030.500; B04.909.204.097.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Adenoviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Adenoviridae Adenoviruses, Canine; Adenoviruses, Human; Adenoviruses, Simian Adenoviruses, Canine; Adenoviruses, Human; Adenoviruses, Simian A genus of ADENOVIRIDAE that infects mammals including humans and causes a wide range of diseases. Adenoviridae (83-93); Adenoviruses, Human (83-93)  I*yv;Mast Cells A11.329.427; A15.382.652 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH) Hemic and Immune Systems (Non MeSH); Immune System I2*pMasseter Muscle A02.633.567.600.500; A14.530.630 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal; Masticatory Muscles Stomatognathic System; Masticatory Muscles A masticatory muscle whose action is closing the jaws. Masticatory Muscles (66-79); Muscles (66-79) I&:C6Massage E02.040.500; E02.780.580 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine Therapeutics; Physical Therapy Group of systematic and scientific manipulations of body tissues best performed with the hands for the purpose of affecting the nervous and muscular systems and the general circulation. I "LMassachusetts Z01.107.567.875.100.481; Z01.107.567.875.600.595.481 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); New England Boston Boston IB: Mass Screening E01.563; E05.318.308.250.580; G03.850.520.308.250.580; G03.850.780.500; N02.421.143.827.233.443; N02.421.726.233.443; N05.715.360.300.375.500 AECLCTECHIISLJMOMTNUOGPXSNSTTDUTVE Sensitivity and Specificity Diagnosis Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Diagnostic Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Diagnostic Services Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys Genetic Screening; Mass Chest X-Ray; Multiphasic Screening; Neonatal Screening Genetic Screening; Mass Chest X-Ray; Multiphasic Screening; Neonatal Screening; Vision Screening Genetic Screening; Mass Chest X-Ray; Multiphasic Screening; Neonatal Screening; Vision Screening Genetic Screening; Mandatory Testing; Mass Chest X-Ray; Multiphasic Screening; Neonatal Screening; Substance Abuse Detection; Vision Screening Genetic Screening; Mass Chest X-Ray; Multiphasic Screening; Neonatal Screening Mass Chest X-Ray; Multiphasic Screening Genetic Screening; Mass Chest X-Ray; Multiphasic Screening; Neonatal Screening; Vision Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease.  I&!,zMass Media L01.178.590 CLECHILJSDSNSTTDUT Information Science; Communications Media (Non MeSH) Instruments or technological means of communication that reach large numbers of people with a common message: press, radio, television, etc. Communication (66-79); Newspapers (66-79); Periodicals (66-79); Radio (66-79); Television (66-79) Iy>vMass Fragmentography E05.196.181.349.500; E05.196.867.877.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Gas Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrum Analysis, Mass A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas (66-76); Spectrum Analysis, Mass (71-76) I,."HMass Chest X-Ray E01.302.577; E01.357.818.910.580; E01.563.443; E05.318.308.250.580.510; G03.850.520.308.250.580.510; G03.850.780.500.500; N02.421.143.827.233.443.443; N02.421.726.233.443.443; N05.715.360.300.375.500.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Tuberculosis, Pulmonary; Thorax Diagnosis; Diagnosis, Respiratory System (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography; Thoracic Radiography Diagnosis; Mass Screening Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Diagnostic Services; Mass Screening Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Diagnostic Services; Mass Screening Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Mass Screening X-ray screening of large groups of persons for diseases of the lung and heart by means of radiography of the chest. IƗ"&7Mass Behavior F01.145.813.527; F01.829.759.527 Civil Disorders; Riots Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Behavior Collective behavior of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation. I̾&Mason-Pfizer Monkey Virus B04.820.650.805.590.505; B04.820.650.815.750.505; B04.909.574.807.805.590.505; B04.909.574.807.815.750.505; B04.909.777.731.805.590.505; B04.909.777.731.815.750.505 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, Simian; Retroviruses Type D, Simian Viruses; RNA Viruses; Retroviridae; Retroviruses, Type D; Retroviruses Type D, Simian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Simian; Retroviruses Type D, Simian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Type D; Retroviruses Type D, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Simian; Retroviruses Type D, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Type D; Retroviruses Type D, Simian The type species of type D retroviruses (RETROVIRUSES, TYPE D) isolated from mammary carcinoma and normal tissues in rhesus monkeys. It appears to have evolved from a recombination between a murine B oncovirus and a primate C oncovirus related to the baboon endogenous virus. MPMV induces simian AIDS (SAIDS). Oncogenic Viruses (72-76); Retroviridae (77-90); Vertebrate Viruses, Unclassified (66-71) IumiMasochism F03.709.597.608.700.490 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias Pleasure derived from being subjected to physical or psychological pain whether inflicted by oneself or by others. Masochism includes sexual masochism. I^ FMasks E07.712.402 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices Laryngeal Masks I- 3Maryland Z01.107.567.875.100.472; Z01.107.567.875.600.513.472 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Mid-Atlantic Region Baltimore Baltimore I :Martinique Z01.107.084.900.600 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies IfOMartial Arts I03.450.642.845.560 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Activities in which participants learn self-defense mainly through the use of hand-to-hand combat. Judo involves throwing an opponent to the ground while karate (which includes kung fu and tae kwon do) involves kicking and punching an opponent. Sports (68-90) IRMarsupialia B02.649.573 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Kangaroos; Opossums I(Mars H01.091.800.700.625 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The fourth planet in order from the sun. Its two natural satellites are Deimos and Phobos. It is one of the four inner or terrestrial planets of the solar system. Extraterrestrial Environment (66-90); Planets (91-94) IۉM?Marriage F01.829.263.315.500.500; I01.240.361.500.500; I01.880.225.423.500.500; N01.224.361.500.500; N01.824.308.500.500 EHHILJPXSNTD Premarital Examinations; Spouses Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Characteristics; Marital Status Social Sciences; Demography; Family Characteristics; Marital Status Social Sciences; Sociology; Family; Family Characteristics; Marital Status Population Characteristics (Non MeSH); Demography; Family Characteristics; Marital Status Population Characteristics (Non MeSH); Socioeconomic Factors; Family Characteristics; Marital Status The social institution involving legal and/or religious sanction whereby men and women are joined together for the purpose of founding a family unit. I {'Marmota B02.649.865.750.460 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Sciuridae A genus of Sciuridae consisting of 14 species. They are shortlegged, burrowing rodents which hibernate in winter. I (3Markov Chains E05.318.740.600.500; E05.318.740.996.500; G03.850.520.830.600.500; G03.850.520.830.996.500; H01.548.832.672.442; H01.548.832.950.500; N05.715.360.750.625.500; N05.715.360.750.770.500 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Stochastic Processes Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Stochastic Processes Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Physical Sciences (Non MeSH); Mathematics; Statistics; Stochastic Processes Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Stochastic Processes A stochastic process such that the conditional probability distribution for a state at any future instant, given the present state, is unaffected by any additional knowledge of the past history of the system. IMarketing of Health Services N03.219.463.548; N05.300.430.500 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Services Accessibility Application of marketing principles and techniques to maximize the use of health care resources. I#&rMarital Therapy F04.754.500 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A form of psychotherapy involving the husband and wife and directed to improving the marital relationship. Marriage (66-72) I>K~Marital Status F01.829.263.315.500; I01.240.361.500; I01.880.225.423.500; N01.224.361.500; N01.824.308.500 EHSN Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Characteristics Social Sciences; Demography; Family Characteristics Social Sciences; Sociology; Family; Family Characteristics Population Characteristics (Non MeSH); Demography; Family Characteristics Population Characteristics (Non MeSH); Socioeconomic Factors; Family Characteristics Divorce; Marriage; Single Person (+ 1); Widowhood Divorce; Marriage; Single Person (+ 1); Widowhood Divorce; Marriage; Single Person (+ 1); Widowhood Divorce; Marriage; Single Person (+ 1); Widowhood Divorce; Marriage; Single Person (+ 1); Widowhood A demographic parameter indicating a person's status with respect to marriage, divorce, widowhood, singleness, etc. Marriage (66-92) CLECEDEHHILJPCPXSNTD $Ig3Marine Toxins D24.185.926.580 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Ciguatoxin; Cnidarian Venoms; Fish Venoms; Holothurin; Lyngbya Toxins; Mollusk Venoms (+ 1); Saxitoxin; Tetrodotoxin Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous fishes. Clupeotoxin, pahutoxin, prymnesin, scombrotoxin go here. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  I<V3HMarine Biology G01.273.476 CLECEDHIISLJMAMTOGSNSTTD Plankton Oceanography Biological Sciences; Biology I #Marijuana Smoking F01.145.466.753.488 AEBLCFDTECEHEPGEHIIMLJMEMOPAPCPPPXTDTHUR Cannabis Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits; Smoking Inhaling and exhaling the smoke from CANNABIS. Cannabis (66-87)  IK, V9Marijuana Abuse F03.709.597.780.610.200 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Cannabis Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Abuse The excessive use of marijuana with associated psychological symptoms and impairment in social or occupational functioning. Cannabis (66-80); Substance Abuse (68-80)  ID 3Marginal Ulcer C06.405.613.489 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer Peptic ulcer at the esophagogastric mucosal junction. INN@Marginal Adaptation (Dentistry) E06.323.428.550 CLST Dentistry; Dentistry, Operative; Dental Restoration, Permanent The degree of proximity and interlocking of filling material to the wall of the cavity of a tooth. The term has come to be used synonymously with adaptation at the cavosurface margin. (Jablonski, Illustrated Dictionary of Dentistry, 1982; J Dent 1993;21:265-73). Dental Cavity Preparation (67-94); Dental Restoration, Permanent (67-94) I%I7UMargarine D10.516.212.302.651; J01.341.637 AEANCLECHIMIPOPSRESDSNSTTOUTVI Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats Technology, Industry, Agriculture (Non MeSH); Food I &"Marfan Syndrome C05.116.099.674; C16.131.077.550; C17.300.500 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases A hereditary disorder of connective tissue characterized by tall stature, elongated extremities, subluxation of the lens, dilatation of the ascending aorta, and "pigeon breast." It is inherited as an autosomal dominant trait. I5L Marek's Disease C02.256.466.650; C02.928.489; C04.619.935.489; C04.925.489; C15.604.515.700; C20.683.515.840; C22.131.546 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Virus Diseases; Tumor Virus Infections Neoplasms; Neoplasms, Experimental; Tumor Virus Infections Neoplasms; Tumor Virus Infections Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Animal Diseases; Bird Diseases A lymphoproliferative disease of fowl caused by a herpesvirus. Lymphoid cell infiltrations are most common in the peripheral nerves and gonads, but widespread infiltrations may also be found in any of the visceral organs, skin, muscle, and the iris of the eye. The location of the lesions dictates the clinical signs, such as paralysis, general depression, and blindness. (Dorland, 27th ed). Avian Leukosis (66-71); Herpesvirus Infections (66-71); Poultry Diseases (66-71) IyJ`Marburg Virus Disease C02.782.417.560; C02.782.580.250.250.500; C22.735.500.500 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Filoviridae Infections; Filovirus Infections Animal Diseases; Primate Diseases; Monkey Diseases An RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man. Virus Diseases (66-74) JAJ!eMarburg Virus B04.820.455.300.300.500; B04.909.777.455.300.300.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Filoviridae; Filovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Filoviridae; Filovirus The type species of FILOVIRUS associated with severe illness in workers handling tissues of African green monkeys. RNA Viruses (66-74) J:Maps L01.178.147.426 Geography Information Science; Communications Media (Non MeSH); Audio-Visual Aids J UMaprotiline D04.615.117.600; D14.100.050.600.050.500; D14.100.600.050.500; D15.085.025.500; D15.085.050.500; D15.700.122.050.500; D15.700.122.055.573 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic A bridged-ring tetracyclic antidepressant usually classified with the tricyclic antidepressants. Its effects and mechanism appear similar to AMITRIPYLINE. Anthracenes (72-74); Propylamines (72-74) J:2Maple Syrup Urine Disease C10.228.140.163.608; C10.496.560; C18.452.648.066.608; F03.709.346.569 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Mental Retardation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Familial cerebral degenerative disease caused by a defect in branched-chain amino acid metabolism and characterized by severe mental and motor retardation and urine with a maple syrup-like odor. J % PL Manuscripts, Medical L01.178.682.608.526 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Manuscripts JlManuscripts L01.178.682.608 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Manuscripts, Medical Compositions written by hand, as one written before the invention or adoption of printing. A manuscript may also refer to a handwritten copy of an ancient author. A manuscript may be handwritten or typewritten as distinguished from a printed copy, especially the copy of a writer's work from which printed copies are made. (Webster, 3d ed). JP\Manure J01.040.427.500 ANCLMIPSREVI Feces Technology, Industry, Agriculture (Non MeSH); Agriculture; Fertilizers Accumulations of solid or liquid animal excreta usually from stables and barnyards with or without litter material. Its chief application is as a fertilizer. (From Webster's 3d ed). Feces (66-78)  J  SManubrium A02.835.232.904.766.442 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Thorax; Sternum JF :PManuals L01.178.682.192.609 ST Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books Sex Manuals Books (66-68) J fManual Communication E02.831.671.609; F01.145.209.530.702; L01.143.649.526 Therapeutics; Rehabilitation; Rehabilitation of Hearing Impaired (Non MeSH) Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication Information Science; Communication; Nonverbal Communication Sign Language Sign Language Sign Language Method of nonverbal communication utilizing hand movements as speech equivalents. Nonverbal Communication (70-71) J=2_%Mansonelliasis C03.335.508.700.750.361.588 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis Infection with nematodes of the genus MANSONELLA. Symptoms include pruritus, headache, and articular swelling. J(PMansonella ozzardi B01.500.294.700.750.700.300.438.410 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea; Mansonella A filarial nematode parasite found in the mesentery and visceral fat of man, usually in Central and South America. J'*pMansonella B01.500.294.700.750.700.300.438 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea Mansonella ozzardi A genus of parasitic nematodes whose organisms are distributed in Central and South America. Characteristics include a smooth cuticle and an enlarged anterior end. JS#*bManometry E05.559 AECLCTECHIISMOMTNUPXSNSTTDUTVE Pressure Miscellaneous Techniques (Non MeSH) J  " *Mannosyltransferases D08.586.913.400.450.560 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases Enzymes that catalyze the transfer of mannose from a nucleoside diphosphate mannose to an acceptor molecule which is frequently another carbohydrate. The group includes EC 2.4.1.32, EC 2.4.1.48, EC 2.4.1.54, and EC 2.4.1.57. Hexosyltransferases (73-74); Mannose (73-74) JF5Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase D08.586.277.450.483.531.080.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Hexosaminidases; Glucosaminidase; Acetylglucosaminidase A group of related enzymes responsible for the endohydrolysis of the di-N-acetylchitobiosyl unit in high-mannose-content glycopeptides and glycoproteins. EC 3.2.1.96. Acetylglucosaminidase (86-91); Glycoside Hydrolases (79-85) J <#FEMannosidosis C18.452.648.202.625; C18.452.648.595.625; F03.126.720.650 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders Inborn error of metabolism marked by a defect in alpha-mannosidase activity that results in lysosomal accumulation of mannose-rich substrates. Virtually all patients have psychomotor retardation, facial coarsening, and some degree of dysostosis multiplex. It is thought to be an autosomal recessive disorder. Carbohydrate Metabolism, Inborn Errors (66-84); Mannose (66-84); Mannosidases (75-84); Metabolism, Inborn Errors (66-84) J"{ALdMannosides D09.203.408.490 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Methylmannosides Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of mannose with an alcohol to form an acetal. They include both alpha- and beta-mannosides. Glycosides (66-74); Mannose (66-74)  J&>Y,Mannosidases D08.586.277.450.625 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases alpha or beta-Mannoside mannohydrolases. Catalyzes the hydrolysis of terminal, non-reducing alpha or beta-D-mannose residues in mannosides. Deficiency of the alpha form can cause mannosidosis. Glycoside Hydrolases (66-74); Mannose (66-74) J(Fl7Mannosephosphates D09.203.894.417.650 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates Phosphoric acid esters of mannose. Hexosephosphates (66-77); Mannose (66-77) J*>t+2Mannosephosphate Isomerase D08.586.399.278.560 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Carbohydrate Isomerases An enzyme that catalyzes the reversible isomerization of D-mannose-6-phosphate to form D-fructose-6-phosphate, an important step in glycolysis process. EC 5.3.1.8. Carbohydrate Isomerases (73-77) J,3Fo%Mannose D09.203.546.359.588 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses J.& DiMannomustine D02.455.526.728.650.463; D22.204.585.581 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds 1,6-Bis(2-chloroethylamino)-1,6-dideoxy-D-mannitol. Nitrogen mustard derivative alkylating agent used as antineoplastic; causes severe bone marrow depression and is a powerful vesicant. Synonyms: BCM; Degranol; Mannitlost; NSC 9698; Zitofenton. J/.:Mannoheptulose D09.203.546.286.500; D09.203.546.465.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Heptoses Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Ketoses Manno-heptulose. A 7-carbon keto sugar having the mannose configuration. Heptoses (72-74); Ketoses (74) J1.DV'Mannitol Phosphates D02.033.800.609.450; D09.203.853.609.450; D09.203.894.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Mannitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Mannitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Phosphoric acid esters of mannitol. Mannitol (66-77); Sugar Phosphates (74-77) J3A8,4Mannitol Dehydrogenase D08.586.682.047.150.700.649 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases; Sugar Alcohol Dehydrogenases J5FMannitol D02.033.800.609; D09.203.853.609; D19.770.224.453.442 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Osmotic Mannitol Phosphates; Mitobronitol Mannitol Phosphates; Mitobronitol D-Mannitol. A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. J7; =:OMannich Bases D02.092.650; D02.522.650 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Organic Chemicals (Non MeSH); Ketones Ketonic amines prepared from the condensation of a ketone with formaldehyde and ammonia or a primary or secondary amine. A Mannich base can act as the equivalent of an alpha,beta unsaturated ketone in synthesis or can be reduced to form physiologically active amino alcohols. Amines (66-76) J:8[DMannans D09.203.698.550 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Polysaccharides consisting of mannose units. Mannose (71-74); Polysaccharides (71-74) J=@ @^51Manitoba Z01.107.567.176.410 EHEP Geographicals (Non MeSH); America; North America; Canada J> FManipulation, Orthopedic E02.643; E04.557.607 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Surgery, Operative; Orthopedics J?"4Manikins L01.178.147.545.129.400 Models, Anatomic Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Models, Structural; Models, Anatomic J? Manifest Anxiety Scale F04.711.647.513.463 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Personality Inventory True-false questionnaire made up of items believed to indicate anxiety, in which the subject answers verbally the statement that describes him. J@ Manic Disorder F03.709.680.080.408 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Affective Disorders, Psychotic An affective psychotic disorder in which the predominant mood is either elevated, expansive, or irritable. Associated symptoms include hyperactivity, flight of ideas, inflated self-esteem, etc. JB+FManganese Compounds D01.530 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Potassium Permanganate Inorganic chemicals that contain manganese as an integral part of the molecule. Manganese (66-93)  JD" 8%_Manganese D01.268.912.540; D01.552.484 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Manganese. A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p.2035). JE] ":s Maneb D02.241.081.251.869.265.441; D02.691.600; D02.886.706.250.500; D05.723.288.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates; Ethylenebis(dithiocarbamates) Organic Chemicals (Non MeSH); Organometallic Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates; Ethylenebis(dithiocarbamates) Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial ((1,2-Ethanediylbis(carbamodithioato))(2-))manganese. Manganese derivative of ethylenebisdithiocarbamate. It is used in agriculture as a fungicide and has been shown to cause irritation to the eyes, nose, skin, and throat. Antifungal Agents (66-71); Manganese (66-71); Pesticides (66-71); Thiocarbamates (66-71) JHi X:jManduca B01.131.617.561.650.525 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lepidoptera; Moths A genus of sphinx or hawk moths of the family Sphingidae. These insects are used in molecular biology studies during all stages of their life cycle. Insects (67-74); Lepidoptera (75-94); Moths (75-94) JLJ (B@Mandragora B06.660.569 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Toxic A genus of Eurasian solanaceous herbs, mandrake, that yields belladonna-like alkaloids. It should not be confused with "mandrake root", which is an American plant, PODOPHYLLUM. JM&Mandibulofacial Dysostosis C05.116.099.370.231.576; C05.660.246.650; C16.131.621.246.650 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Craniofacial Dysostosis Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis Goldenhar Syndrome Goldenhar Syndrome Goldenhar Syndrome A hereditary disorder occurring in two forms: the complete form (Franceschetti's syndrome) is characterized by antimongoloid slant of the palpebral fissures, coloboma of the lower lid, micrognathia and hypoplasia of the zygomatic arches, and microtia. It is transmitted as an autosomal trait. The incomplete form (Treacher Collins syndrome) is characterized by the same anomalies in less pronounced degree. It occurs sporadically, but an autosomal dominant mode of transmission is suspected. (Dorland, 27th ed). JODELuAQMandibular Prosthesis E04.659.625; E04.833.566; E06.780.588; E06.892.566; E07.450.630; E07.858.565.675 AECLCTECHIMIMONUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Oral Dentistry; Prosthodontics Dentistry; Surgery, Oral Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis A prosthetic appliance for the replacement of areas of the mandible missing or defective as a result of deformity, disease, injury, or surgery. Prosthesis (66) JT"^&Mandibular Nerve A08.800.800.120.760.500 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Trigeminal Nerve Lingual Nerve A branch of the trigeminal (5th cranial) nerve. The mandibular nerve carries motor fibers to the muscles of mastication and sensory fibers to the teeth and gingivae, the face in the region of the mandible, and parts of the dura. JV8pMandibular Neoplasms C04.588.149.721.450.583; C05.116.231.754.450.583; C05.500.499.583; C05.500.607.442; C07.320.515.583; C07.320.610.583 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms; Skull Neoplasms; Jaw Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms; Skull Neoplasms; Jaw Neoplasms Musculoskeletal Diseases; Jaw Diseases; Jaw Neoplasms Musculoskeletal Diseases; Jaw Diseases; Mandibular Diseases Stomatognathic Diseases; Jaw Diseases; Jaw Neoplasms Stomatognathic Diseases; Jaw Diseases; Mandibular Diseases JXXMandibular Injuries C21.866.460.589.338.608 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries Mandibular Fractures Injuries to the lower jaw bone. J[N)Mandibular Fractures C21.866.405.762.467.441; C21.866.460.589.338.500.441; C21.866.460.589.338.608.441; C21.866.460.836.500.441 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Skull Fractures; Jaw Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries; Jaw Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries; Mandibular Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Skull Fractures; Jaw Fractures Fractures of the lower jaw. J] tNU$Mandibular Diseases C05.500.607; C07.320.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases Craniomandibular Disorders (+ 2); Mandibular Neoplasms; Prognathism; Retrognathism Craniomandibular Disorders (+ 2); Mandibular Neoplasms; Prognathism; Retrognathism Bone Diseases (66); Mandible (66) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  J`NY+XMandibular Condyle A02.835.232.781.324.502.632.600; A14.521.632.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Temporomandibular Joint Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw; Mandible Stomatognathic System; Jaw; Mandible The posterior process on the ramus of the mandible composed of two parts: a superior part, the articular portion, and an inferior part, the condylar neck. Jb6:Mandible A02.835.232.781.324.502.632; A14.521.632 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUTRULUSVI Chin; Temporomandibular Joint Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw Stomatognathic System; Jaw Chin; Mandibular Condyle Chin; Mandibular Condyle ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  Jd .8${<:Mandelic Acids D02.241.223.475; D02.241.511.536; D20.237.386 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Anti-Infective Agents; Anti-Infective Agents, Urinary Cyclandelate; Vanilmandelic Acid Cyclandelate; Vanilmandelic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Jf58M:Mandatory Testing G03.850.780.200.550; G03.850.780.500.412 ECHIISLJMTOGSNSTTD Substance Abuse Detection Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Testing or screening required by federal, state, or local law or other agencies for the diagnosis of specified conditions. It is usually limited to specific populations such as categories of health care providers, members of the military, and prisoners or to specific situations such as premarital examinations or donor screening. specific infectious disease/diagnosis (89-94); specific infectious disease/prevention and control (89-94)  Jh.zManagement Quality Circles N04.452.677.420 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Participation of employees with management as a labor-management team, in decisions pertaining to the operational activities of the organization or industry. Personnel Management (66-84); Quality Assurance, Health Care (80-84) Jlg pQManagement Information Systems L01.700.508.300.680; N04.452.515 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems Health Services Administration (Non MeSH); Organization and Administration Ambulatory Care Information Systems; Clinical Laboratory Information Systems; Clinical Pharmacy Information Systems; Database Management Systems; Decision Support Systems, Management; Hospital Information Systems (+ 1); Office Automation (+ 1); Personnel Staffing and Scheduling Information Systems; Radiology Information Systems Ambulatory Care Information Systems; Clinical Laboratory Information Systems; Clinical Pharmacy Information Systems; Database Management Systems; Decision Support Systems, Management; Hospital Information Systems (+ 5); Office Automation (+ 1); Personnel Staffing and Scheduling Information Systems; Radiology Information Systems Systems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc. Information Systems (66-82); Organization and Administration (68-82) CLECEDHIISLJMAMTOGSDSNSTTDUT $JnN$&P Management Audit N04.452.500 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Management review designed to evaluate efficiency and to identify areas in need of management improvement within the institution in order to ensure effectiveness in meeting organizational goals. JsWManaged Care Programs N03.219.521.576.343.800; N04.590.374.410 CLECHILJMAOGSNSTTDUT Cost Sharing Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care Competitive Medical Plans; Health Maintenance Organizations; Independent Practice Associations; Preferred Provider Organizations Competitive Medical Plans; Health Maintenance Organizations; Independent Practice Associations; Preferred Provider Organizations Health insurance plans intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as HEALTH MAINTENANCE ORGANIZATIONS and PREFERRED PROVIDER ORGANIZATIONS.  Juu."Man-Machine Systems F02.784.412.575; J01.293.556.441; J01.897.441 Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Human Engineering Technology, Industry, Agriculture (Non MeSH); Engineering; Human Engineering Technology, Industry, Agriculture (Non MeSH); Technology A system in which the functions of the man and the machine are interrelated and necessary for the operation of the system. J{15Mammography E01.357.818.578 AECLCTECHIISMOMTNUPXSNSTTDUTVE Breast Diagnosis; Diagnostic Imaging; Radiography Xeromammography Radiographic examination of the breast.  J}1" 30Mammary Tumor Viruses, Mouse B04.820.650.650.500; B04.909.574.807.650.500; B04.909.777.731.650.500 CHCLDEENGDGEIMIPMEPHPYREUL Minor Lymphocyte Stimulatory Antigens; Minor Lymphocyte Stimulatory Loci Viruses; RNA Viruses; Retroviridae; Oncoviruses Type B, Mammalian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Oncoviruses Type B, Mammalian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Oncoviruses Type B, Mammalian A species of Type B oncovirus (ONCOVIRUSES TYPE B, MAMMALIAN) commonly latent in mice. It causes mammary adenocarcinoma when in a genetically susceptible strain of mice and when the appropriate hormonal influences operate. J~ #MT9Mammary Neoplasms, Experimental C04.588.180.525; C04.619.590 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Site (Non MeSH); Breast Neoplasms Neoplasms; Neoplasms, Experimental Jf%"RnMammary Neoplasms C04.588.180.520; C22.520 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Site (Non MeSH); Breast Neoplasms Animal Diseases Tumors of the mammary gland. Their occurrence is uncommon with the exception of the female dog, in which they account for 25% of all neoplasms. Mammae (68-89); Neoplasms/veterinary (67-89) JRY6Mammary Arteries A07.231.114.891.525 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Thoracic Arteries Arteries originating from the subclavian or axillary arteries and distributing to the anterior thoracic wall, mediastinal structures, diaphragm, pectoral muscles and mammary gland. Ju8NMammaplasty E04.860.600 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Breast Surgery, Operative; Surgery, Plastic Surgical reconstruction of the breast including both augmentation and reduction. Breast/surgery (66-91); Surgery, Plastic (66-91)  J$ ,^;Mammals B02.649 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates Artiodactyla (+ 14); Carnivora (+ 12); Cetacea (+ 2); Chiroptera; Edentata (+ 2); Elephants; Hyraxes; Insectivora (+ 3); Lagomorpha (+ 1); Marsupialia (+ 2); Monotremata (+ 2); Perissodactyla (+ 2); Pinnipedia (+ 2); Primates (+ 46); Rodentia (+ 58); Scandentia (+ 2) JU  (SMammae A10.336.482; A13.589 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Breast Tissue Types (Non MeSH); Exocrine Glands Animal Terms (Non MeSH) J : OMamillary Bodies A08.186.211.730.385.357.362.500 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Posterior A pair of nuclei and associated gray matter in the interpeduncular space rostral to the posterior perforated substance in the posterior hypothalamus. Hypothalamus (66-70) J#8Maltose D09.203.698.365.450; D09.203.698.629.305.523 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides J 2DMalta Z01.542.581.600 EHEP Geographicals (Non MeSH); Europe; Mediterranean Islands Ja CMalpractice I01.880.604.583.524; N03.706.535.606 CLECHILJSNTD Insurance, Liability Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Defensive Medicine; Professional Impairment (+ 1) Defensive Medicine; Professional Impairment (+ 1) Improper, injurious, or faulty care rendered by a health professional. CLECEDHIISLJMAMTOGPXSNSTTD $J*tTMalpighian Tubules A13.574 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) J  :Malonyl Coenzyme A D08.176.211.300.500; D13.695.667.138.382.300.500; D13.695.827.068.382.300.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes; Coenzyme A; Acyl Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Coenzyme A; Acyl Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Coenzyme A; Acyl Coenzyme A S-Malonyl coenzyme A. A coenzyme A derivative which plays a key role in the fatty acid synthesis in the cytoplasmic and microsomal systems. Coenzyme A (66-77); Malonates (66-77) JUF/Malondialdehyde D02.047.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Thiobarbituric Acid Reactive Substances The dialdehyde of malonic acid. Aldehydes (71-74); Malonates (71-74)  J:1.(-Malonates D02.241.081.337.540 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Methylmalonic Acid; Phenylethylmalonamide AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR J8 8q0:Malocclusion, Angle Class III C07.793.494.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Prognathism Stomatognathic Diseases; Tooth Diseases; Malocclusion Malocclusion in which the mandible is anterior to the maxilla as reflected by the first relationship of the first permanent molar (mesioclusion). Malocclusion (66-78)  J$N?Malocclusion, Angle Class II C07.793.494.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Retrognathism Stomatognathic Diseases; Tooth Diseases; Malocclusion Malocclusion in which the mandible is posterior to the maxilla as reflected by the relationship of the first permanent molar (distoclusion). Malocclusion (66-78)  JY#N?Malocclusion, Angle Class I C07.793.494.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Malocclusion Malocclusion in which the mandible and maxilla are anteroposteriorly normal as reflected by the relationship of the first permanent molar (i.e., in neutroclusion), but in which individual teeth are abnormally related to each other. Malocclusion (66-78) J"N?Malocclusion C07.793.494 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Orthodontics, Corrective; Prognathism; Retrognathism Dental Occlusion; Tooth Stomatognathic Diseases; Tooth Diseases Dental Occlusion, Traumatic; Diastema; Malocclusion, Angle Class I; Malocclusion, Angle Class II; Malocclusion, Angle Class III Such malposition and contact of the maxillary and mandibular teeth as to interfere with the highest efficiency during the excursive movements of the jaw that are essential for mastication. (Jablonski, Illustrated Dictionary of Dentistry, 1982). $J'N=/Mallory-Weiss Syndrome C06.306.468.524 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Perforation Mucosal tears usually linear and confined to the esophagogastric junction but may be located in the fundus of the stomach or in the distal esophagus. Upper gastrointestinal bleeding from these lacerations is often precipitated by retching or vomiting. JNR&Mallophaga B01.131.617.564.524 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lice A suborder of insects comprising the chewing lice, many of which are parasitic on wild birds and domestic fowl and on wild and domestic mammals. Lice (66-71) J(2Malleus A09.246.397.247.524 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Ear, Middle; Ear Ossicles J{ :9Malingering F03.126.594 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Simulation of symptoms of illness or injury with intent to deceive in order to obtain a goal, e.g., a claim of physical illness to avoid jury duty. J/FYMalignant Hyperthermia C23.814.424; C23.888.189.344.607 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Postoperative Complications Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Temperature Changes (Non MeSH); Fever Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia. Anesthesia, General (66-72); Fever (66-72) J&Lw4Malignant Catarrh C02.256.466.606; C22.196.540 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Animal Diseases; Cattle Diseases A herpesvirus infection of cattle characterized by catarrhal inflammation of the upper respiratory and alimentary epithelia, keratoconjunctivitis, encephalitis and lymph node enlargement. Syn: bovine epitheliosis, snotsiekte. Cattle Diseases (66-70); Herpesvirus Infections/VE (66-70) J"J~FMalignant Carcinoid Syndrome C04.557.465.625.650.200.500; C04.557.470.200.025.200.500; C04.557.580.625.650.200.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoid Tumor Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoid Tumor Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoid Tumor Carcinoid Heart Disease Carcinoid Heart Disease Carcinoid Heart Disease A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed). Jl"]NSUMali Z01.058.290.190.500 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western J_Maleimides D02.241.081.337.502.524; D02.478.440; D03.383.757.399 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Maleates Organic Chemicals (Non MeSH); Imides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrroles Ethylmaleimide Ethylmaleimide Ethylmaleimide Imides (66-71); Maleates (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  J=82):Maleic Hydrazide D03.383.710.400; D05.723.366.560 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides 1,2-Dihydro-3,6-pyridazinedione. A herbicide and plant growth regulator; also used to control suckering of tobacco. Its residue in food and tobacco is highly toxic, causing CNS disturbances and liver damage. Hydrazines (66-76); Maleates (66-76); Pyridazines (66-76) J&:FMaleic Anhydrides D02.113.450; D03.383.312.520 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Anhydrides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans cis-Butenedioic anhydride. Used in copolymerization reactions, in the Diels-Alder(diene)synthesis, in the preparation of resins, pharmaceuticals and agricultural chemicals. It is a powerful irritant and causes burns. Anhydrides (66-76); Furans (66-76); Maleates (66-76) JU"8AMaleates D02.241.081.337.502 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Maleimides (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR J 8q:Malaysia Z01.252.145.487 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern J >Malawi Z01.058.290.175.500 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern Jp `Malathion D02.719.639; D05.723.491.657.648 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Phosphates (66-71); Phosphoric Acids (68-71); Thiomalates (66-71) J &:OMalates D02.241.081.337.463; D02.241.511.505 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Thiomalates (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR J *8:Malate Synthase D08.586.520.567.620 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases An important enzyme in the glyoxylic acid cycle which reversibly catalyzes the synthesis of L-malate from acetyl-CoA and glyoxylate. EC 4.1.3.2. Ketoacid-Lyases (73-76); Malates (73-76) JXFb1Malate Dehydrogenase D08.586.682.047.605 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme that catalyzes the conversion of (S)-malate and NAD+ to oxaloacetate and NADH. EC 1.1.1.37. J-Ft{Malassezia B05.354.381.546.522; B05.354.930.574 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Algae and Fungi (Non MeSH); Fungi; Yeasts a hypomycete. J*"Malaria, Vivax C03.752.750.259.552.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Malaria Malaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day. Malaria (66-91) JPcMalaria, Falciparum C03.752.750.259.552.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Malaria Blackwater Fever; Malaria, Cerebral Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Malaria (66-91)  JPc+jMalaria, Cerebral C03.752.750.259.552.620; C03.752.750.259.552.650.675; C10.228.140.675; C10.228.228.399 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Malaria Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Malaria; Malaria, Falciparum Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) A condition that is most commonly seen as a severe complication of MALARIA, FALCIPARUM mainly involving the brain. It has also been reported to occur as a result of infection with other Plasmodium species. This disease is often fatal and presents as disturbances in consciousness ranging from somnolence to coma, major motor seizures, and organic psychosis. The onset may be gradual or sudden following a convulsion. Brain Diseases (66-91); Malaria (66-91) JŌ`P1Malaria, Avian C03.752.750.259.552.606; C22.131.498 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Malaria Animal Diseases; Bird Diseases Any of a group of infections of fowl caused by protozoa of the genera PLASMODIUM, Leucocytozoon, and Haemoproteus. The life cycles of these parasites and the disease produced bears strong resemblance to those observed in human malaria. J9*JMalaria Vaccines D12.776.828.868.500; D24.310.894.582.500; D24.310.894.865.500; D24.611.216.865.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins; Vaccines, Synthetic Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Protozoan Vaccines Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Vaccines, Synthetic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Vaccines, Synthetic Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents. Malaria (72-93); Protozoan Vaccines (91-93); Vaccines (72-93) J\>KMalaria C03.752.750.259.552 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Antimalarials Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis Malaria, Avian; Malaria, Cerebral; Malaria, Falciparum (+ 2); Malaria, Vivax A protozoan disease caused by four species of the genus PLASMODIUM (P. falciparum (MALARIA, FALCIPARUM), P. vivax (MALARIA, VIVAX), P. ovale, and P. malariae) and transmitted by the bite of an infected female mosquito of the genus Anopheles. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high fever, sweating, shaking chills, and anemia.  J/ PX]*Malacoplakia C23.739.548 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) The formation of soft patches on the mucous membrane of a hollow organ, such as the urogenital tract or digestive tract. JӼNYMalabsorption Syndromes C06.405.469.637; C18.452.603 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Intestinal Absorption Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Blind Loop Syndrome; Celiac Disease; Lactose Intolerance; Lipodystrophy, Intestinal; Short Bowel Syndrome; Sprue, Tropical Blind Loop Syndrome; Celiac Disease; Lactose Intolerance; Lipodystrophy, Intestinal; Sprue, Tropical General term for syndromes of malnutrition due to failure of normal intestinal absorption of nutrients.  J6"NzMajor Histocompatibility Complex G04.610.626.580; G05.511.580 DEGEIMPHRE Genes, MHC Class I Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Immunogenetics Genes, MHC Class I; Genes, MHC Class II Genes, MHC Class I; Genes, MHC Class II The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) transplantation antigens, genes which control the structure of the immune response-associated (Ia) antigens, the immune response (Ir) genes which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement. Histocompatibility Antigens (73-78); HLA Antigens (75-78) $J&&"dDMaintenance and Engineering, Hospital N02.278.354.422.450; N02.628.472; N04.452.442.422.450 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Maintenance Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department whose primary function is the upkeep and supervision of the buildings and grounds and the maintenance of hospital physical plant and equipment which requires engineering expertise. J,=NMaintenance N02.628 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH) Maintenance and Engineering, Hospital The upkeep of property or equipment. J 5,.Mainstreaming (Education) I02.158.600; I02.233.213.600 CLECHILJMAMTOGSNSTTD Child, Exceptional; Disabled Education; Curriculum Education; Education, Nonprofessional (Non MeSH); Education, Special Most frequently refers to the integration of a physically or mentally disabled child into the regular class of normal peers and provision of the appropriately determined educational program. Education, Special/trends (68-86)  J"#j(Maine Z01.107.567.875.100.460; Z01.107.567.875.600.595.460 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); New England J : Maillard Reaction H01.181.216.652; H01.181.529.520 DERE Food Handling; Food Preservation Physical Sciences (Non MeSH); Chemistry; Chemistry, Agricultural Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical One of a group of nonenzymatic reactions in which aldehydes, ketones, or reducing sugars react with amino acids, peptides, or proteins. Food browning reactions, such as those that occur with cooking of meats, and also food deterioration reactions, resulting in decreased nutritional value and color changes, are attributed to this reaction type. The Maillard reaction is studied by scientists in the agriculture, food, nutrition, and carbohydrate chemistry fields. Chemistry (66-88)  J]&(Magnetoencephalography E01.236.257.601 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH) The measurement of magnetic fields over the head generated by electric currents in the brain. As in any electrical conductor, electric fields in the brain are accompanied by orthogonal magnetic fields. The measurement of these fields provides information about the localization of brain activity which is complementary to that provided by electroencephalography. Magnetoencephalography may be used alone or together with electroencephalography, for measurement of spontaneous or evoked activity, and for research or clinical purposes. Brain (83-88); Magnetics (83-88) J&Wg)Magnetics H01.671.493 AECLDUHITU Physical Sciences (Non MeSH); Physics Electromagnetics (+ 1) AECLDUECHIISLJMTSNSTTDTU J /Magnetic Resonance Imaging E01.357.578; E01.357.927.578 AECLCTECHIISMOMTNUPXSNSTTDUTVE Nuclear Magnetic Resonance Nuclear Magnetic Resonance Diagnosis; Diagnostic Imaging Diagnosis; Diagnostic Imaging; Tomography Echo-Planar Imaging; Magnetic Resonance Angiography Echo-Planar Imaging; Magnetic Resonance Angiography Non-invasive method of demonstrating internal anatomy based on the principle that certain nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Nuclear Magnetic Resonance (66-87) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE ,J ""  Tv[)&Magnetic Resonance Angiography E01.145.077.563; E01.357.578.625; E01.357.927.578.625 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnostic Imaging; Magnetic Resonance Imaging Diagnosis; Diagnostic Imaging; Tomography; Magnetic Resonance Imaging Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures. Angiography (83-94); Magnetic Resonance Imaging (88-94); Nuclear Magnetic Resonance (83-87) J $=&lMagnesium Sulfate D01.524.550; D01.875.800.800.850.500; D06.347.930.525; D15.080.487; D26.930.525 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Magnesium Compounds Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Central Nervous System Agents; Anticonvulsants Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents Sulfuric acid magnesium salt (1:1). A small colorless crystal used as an anticonvulsant and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potential in the myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083). J2[8Magnesium Silicates D01.524.500; D01.578.725.500; D01.837.725.700.760.535 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Magnesium Compounds Inorganic Chemicals (Non MeSH); Minerals; Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates Asbestos, Amosite; Asbestos, Serpentine; Talc Asbestos, Amosite; Asbestos, Serpentine; Talc Asbestos, Amosite; Asbestos, Serpentine; Talc A generic term for a variety of compounds that contain silicon, oxygen, and magnesium, and may contain hydrogen. Examples include TALC and some kinds of ASBESTOS. Magnesium (66-93); Silicic Acid (66-93)  J\=81Magnesium Oxide D01.524.490; D01.650.550.575; D19.316.203.059.581; D19.316.396.566 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Magnesium Compounds Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents; Antacids Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Magnesium oxide (MgO). An inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. It is used as an antacid and mild laxative and has many nonmedicinal uses. JL8a Magnesium Hydroxide D01.455.550; D01.524.485; D19.316.203.059.578; D19.316.396.562 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Hydroxides Inorganic Chemicals (Non MeSH); Magnesium Compounds Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents; Antacids Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Magnesium hydroxide (Mg(OH)2). An inorganic compound that occurs in nature as the mineral brucite. It acts as an antacid with cathartic effects. Hydroxides (66-76); Magnesium (66-76) JH8B.Magnesium Deficiency C18.654.223.439 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p. 1936). JNggMagnesium Compounds D01.524 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Magnesium Chloride; Magnesium Hydroxide; Magnesium Oxide; Magnesium Silicates (+ 3); Magnesium Sulfate Inorganic compounds that contain magnesium as an integral part of the molecule. Magnesium (66-93)  K 8%z_Magnesium Chloride D01.210.450.150.500; D01.524.475 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Inorganic Chemicals (Non MeSH); Magnesium Compounds Magnesium chloride. An inorganic compound consisting of one magnesium and two chloride ions. The compound is used in medicine as a source of magnesium ions, which are essential for many cellular activities. It has also been used as a cathartic and in alloys. Magnesium (66-89) K&84Magnesium D01.268.508; D01.552.474 ADAEAGAIANBLCFCHCLCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Magnesium. A light, silvery, metallic element. It has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. Its salts are essential in nutrition, being required for the activity of many enzymes, especially those concerned with oxidative phosphorylation. It is a component of both intra- and extracellular fluids and is excreted in the urine and feces. Deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. (From Dorland, 27th ed). K= 8`eMagic I01.076.201.450.897.439 HIPX Social Sciences; Anthropology; Anthropology, Cultural; Culture; Superstitions Witchcraft Beliefs and practices concerned with producing desired results through supernatural forces or agents as with the manipulation of fetishes or rituals. K  [Mafenide D02.065.884.570; D02.886.590.700.570; D20.890.210 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Anti-Infective Agents; Sulfonamides 4-(Aminomethyl)benzenesulfonamide. Toxic sulfonamide used as topical anti-infective, especially in burn therapy. Synonyms: Ambamide; Benzamsulfonamide; Emilene; Mefamide; Mesudrin; Paramenyl; Septicid; Sulfomyl. Sulfonamides (70-74); Tosyl Compounds (73-74) K  9:7Maduromycosis C01.252.410.040.692.606; C01.252.825.557; C01.539.800.200.500; C01.539.800.720.557; C01.703.295.522; C17.800.838.208.557; C17.800.838.765.557 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Nocardia Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial A disease caused by various fungi (Madurella mycetomi) or actinomycetes (Nocardia brasiliensis). It usually affects the foot, hand, and legs with tissues becoming necrosed and swollen after infection. K PFMadagascar Z01.600.500 EHEP Geographicals (Non MeSH); Indian Ocean Islands K9Macular Edema, Cystoid C04.182.437; C11.768.585.439.245 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Neoplasms; Cysts Eye Diseases; Retinal Diseases; Retinal Degeneration; Macular Degeneration Macular degeneration characterized by edema and cystic spaces which may lead to a macular depression or hole. Edema (66-83); Macula Lutea (66-83)  KZ&N l-Macular Degeneration C11.768.585.439 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases; Retinal Degeneration Macular Edema, Cystoid Degenerative changes in the macula lutea of the retina. Retinal Degeneration (70-78)  K9N?D"Macula Lutea A09.371.729.522 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Retina Fovea Centralis K:"Macrostomia C07.465.525.480; C07.650.525.480; C16.131.850.525.480 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Mouth Abnormalities Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Greatly exaggerated width of the mouth, resulting from failure of union of the maxillary and mandibular processes, with extension of the oral orifice toward the ear. The defect may be unilateral or bilateral. (Dorland, 27th ed). KV=LFMacrophages, Peritoneal A11.329.372.630; A11.733.397.630; A15.382.680.397.630; A15.382.812.522.630 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum. Macrophages (66-93); Peritoneal Cavity (67-93); Peritoneum (66-71) KfT*,jPMacrophages, Alveolar A11.329.372.600; A11.733.397.600; A15.382.680.397.600; A15.382.812.522.600 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Round, granular, mononuclear phagocytes found in the alveoli of the lungs. They ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. Macrophages (66-91); Pulmonary Alveoli (66-91) K T*,8Macrophages A11.329.372; A11.733.397; A15.382.680.397; A15.382.812.522 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Phagocytosis Reticuloendothelial System Cells; Connective Tissue Cells (Non MeSH) Cells; Phagocytes Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System Epithelioid Cells; Foam Cells; Giant Cells, Foreign-Body; Giant Cells, Langhans; Histiocytes; Kupffer Cells; Macrophages, Alveolar; Macrophages, Peritoneal Epithelioid Cells; Foam Cells; Giant Cells, Foreign-Body; Giant Cells, Langhans; Histiocytes; Kupffer Cells; Macrophages, Alveolar; Macrophages, Peritoneal Epithelioid Cells; Foam Cells; Giant Cells, Foreign-Body; Giant Cells, Langhans; Histiocytes; Kupffer Cells; Macrophages, Alveolar; Macrophages, Peritoneal Epithelioid Cells; Foam Cells; Giant Cells, Foreign-Body; Giant Cells, Langhans; Histiocytes; Kupffer Cells; Macrophages, Alveolar; Macrophages, Peritoneal  K D*Macrophage-1 Antigen D12.776.543.750.705.408.460.475.500; D12.776.543.750.705.833.500; D24.185.101.100.110.111.500; D24.611.216.301.264.035.111.500; D24.611.834.408.460.475.500; D24.611.834.833.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigens, CD18 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Leukocyte-Adhesion Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Complement Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD; Antigens, CD11 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD; Antigens, CD11 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Leukocyte-Adhesion Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Complement An adhesion-promoting leukocyte surface membrane heterodimer. The alpha subunit consists of the CD11b antigen and the beta subunit of the CD18 antigen (ANTIGENS, CD18). The antigen functions both as a receptor for complement 3 and in cell-cell and cell-substrate adhesive interactions. Antigens, Differentiation (88-90); Receptors, Leukocyte-Adhesion (89-90)  K$62MSMacrophage-Activating Factors D24.611.350.480.615 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Interferon Type II Factors secreted by stimulated lymphocytes that prime macrophages to become nonspecifically cytotoxic to tumors. They also modulate the expression of macrophage cell surface Ia antigens. One MAF is interferon-gamma (INTERFERON TYPE II). Other factors antigenically distinct from IFN-gamma have also been identified. Lymphokines (76-90)  K+"FwmMacrophage Migration-Inhibitory Factors D24.611.350.480.625 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Cell Migration Inhibition Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Proteins released by sensitized lymphocytes and possibly other cells that inhibit the migration of macrophages away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Cell Migration Inhibition (72-73); Cell Movement (70-71)  K.-BwDMacrophage Colony-Stimulating Factor D12.776.395.240.500; D24.185.348.453.240.500; D24.611.350.400.442.240.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Macrophage Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors A mononuclear phagocyte colony-stimulating factor synthesized by mesenchymal cells. The compound stimulates the survival, proliferation, and differentiation of hematopoietic cells of the monocyte-macrophage series. M-CSF is a disulfide-bonded glycoprotein dimer with a MW of 70 kDa. It binds to a single class of high affinity receptor which is identical to the product of the c-fms proto-oncogene. Colony-Stimulating Factors (76-90)  K1*QF6(Macrophage Activation G04.610.270.500 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Cytotoxicity, Immunologic The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Macrophages (66-81) K6oMacromolecular Systems D12.472 Polymers Polymers Amino Acids, Peptides and Proteins (Non MeSH) Biopolymers AEAGAIANBIBLCFCHCLDFDUECGEHIIMIPMEPDPHPKPORESETOTUUR  K8   78Macroglossia C07.465.525.460; C07.465.910.460; C07.650.525.460; C16.131.850.525.460 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Beckwith-Wiedemann Syndrome Stomatognathic Diseases; Mouth Diseases; Mouth Abnormalities Stomatognathic Diseases; Mouth Diseases; Tongue Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Excessive size of the tongue. (Dorland, 27th ed). Tongue/abnormalities (69-74)  K9hPL ?"Macroglobulins D12.776.124.790.720; D12.776.377.715.647 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins alpha Macroglobulins alpha Macroglobulins KNJMacedonia (Republic) Z01.542.248.517; Z01.586.980.557 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Yugoslavia Formerly a constituent republic of Yugoslavia, comprising the Yugoslav section of the region of Macedonia. It was made a constituent republic in the 1946 constitution. It became independent on 8 February 1994 and was recognized as The Former Yugoslav Republic of Macedonia by the United States Board on Geographic Names 16 February 1994. KDE&Macao Z01.252.474.580 EHEP Geographicals (Non MeSH); Asia; Far East A Portuguese colony on the island of Macao and adjacent islands off the southeast coast of China. Portugal (66-77) KF 4vMacaca radiata B02.649.801.400.130.120.510.570 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Macaca A species of macaque monkey that mainly inhabits the forest of southern India. They are also called bonnet macaques or bonnet monkeys. KG#(dMacaca nemestrina B02.649.801.400.130.120.510.560 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Macaca A species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted. Macaca (71-80) KI^#(dMacaca mulatta B02.649.801.400.130.120.510.550 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Macaca A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. KK#(dMacaca fascicularis B02.649.801.400.130.120.510.520 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Macaca A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. KL#(dMacaca B02.649.801.400.130.120.510 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae Macaca fascicularis; Macaca mulatta; Macaca nemestrina; Macaca radiata A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes. Anthropoidea (66-70)  KNt (ZTLysyl T RNA Synthetase D08.586.464.136.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates lysine with its specific transfer RNA. EC 6.1.1.6. Amino Acyl T RNA Synthetases (72-74); Lysine (72-74) KPFt\ALyssavirus B04.820.455.750.500; B04.909.777.455.750.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Rhabdoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Rhabdoviridae Ephemeral Fever Virus, Bovine; Rabies Virus Ephemeral Fever Virus, Bovine; Rabies Virus A genus of the family RHABDOVIRIDAE that includes RABIES VIRUS and other rabies-like viruses. Rhabdoviridae (78-93)  KR92hoLysostaphin D08.586.277.656.550; D20.085.116.500; D20.187.540 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Bacteriolysis Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Anti-Infective Agents; Anti-Infective Agents, Local A mixture of three different proteolytic enzymes, two of which lyse bacterial walls. It is obtained from Staphylococcus staphylolyticus (S. epidermidis). Lysostaphin is very antigenic, but has been used in animals and topically in man against certain infections. KTT9<3Lysosomes A11.368.702.452 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured. Such rupture is supposed to be under metabolic (hormonal) control. (From Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed). KW' *$Lysosomal Storage Diseases C18.452.648.595 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Cholesterol Ester Storage Disease; Mannosidosis; Mucolipidosis (+ 1); Mucopolysaccharidoses (+ 6); Sphingolipidoses (+ 11); Wolman Disease Inborn errors of metabolism characterized by defects in specific lysosomal hydrolases and resulting in intracellular accumulation of unmetabolized substrates. Metabolism, Inborn Errors (72-91)  KZ Lm(Lysophospholipids D10.516.695.300.450 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates Lysophosphatidylcholines Derivatives of phosphoglycerols which have only one of the alcohol groups of the glycerol backbone ester-linked with a fatty acid. Phosphatidic Acids or derivatives (75-87); Phospholipids (66-87)  K]bBbLLysophospholipase D08.586.277.352.100.680.510 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases; Phospholipases An enzyme that catalyzes the hydrolysis of a single fatty acid ester bond in lysoglycerophosphatidates with the formation of glyceryl phosphatidates and a fatty acid. EC 3.1.1.5. Phospholipases (66-79) K__FLysophosphatidylcholines D10.516.695.300.450.400 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Lysophospholipids Derivatives of phosphatidylcholines obtained by their partial hydrolysis which removes one of the fatty acid moieties. Synonym: lysolecithins. Ka>wLysolecithin Acyltransferase D08.586.913.050.650 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme localized predominantly within the plasma membrane of lymphocytes. It catalyzes the transfer of long-chain fatty acids, preferentially unsaturated fatty acids, to lysophosphatides with the formation of 1,2-diacylglycero-3-phosphocholine and CoA. EC 2.3.1.23. Acyltransferases (72-75); Coenzyme A (73-75); Lysophosphatidylcholines (72-75) Kc4!Fi3\Lysogeny G04.185.515.880.930.500; G05.386.930.500 DEGEIMPHRE Bacteriophages Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH); Virus Integration Genetics; Genetics, Microbial; Virus Integration Attachment Sites (Microbiology) Attachment Sites (Microbiology) The phenomenon by which a temperate phage incorporates itself into the DNA of a bacterial host, establishing a kind of symbiotic relation between prophage and bacterium which results in the perpetuation of the prophage in all the descendants of the bacterium until induction by various agents, such as ultraviolet radiation, releases the phage, which then becomes virulent and lyses the bacterium. Bacteria (66-67); Bacteriophages (66-67); Bacteriolysis (66-67); specific bacteriophage (66-67); specific bacterium (66-67) $Ke .HLysinoalanine D12.125.042.475; D12.125.095.647.575 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Alanine Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Lysine N(6)-(2-Amino-2-carboxyethyl)-L-lysine. An unusual amino acid, not a dipeptide, which has been found in proteins of cooked foods. It is formed in food that is heated or treated with alkali. Has been implicated in nephrocytomegalia in rats. Alanine (66-78); Dipeptides (66-78); Lysine (66-78) Kj*:@Lysine D12.125.095.647; D12.125.142.497 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Hydroxylysine; Lysinoalanine; Polylysine L-Lysine. An essential amino acid. It is used for food enrichment and results in improved growth and tissue synthesis. Kl &F1Lysergic Acid Diethylamide D03.132.327.287.572.522; D03.549.439.572.522; D14.100.850.800.475; D14.100.850.850.480; D15.300.475; D15.700.372.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines; Lysergic Acid Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines; Lysergic Acid Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood. Kn :xLysergic Acid D03.132.327.287.572; D03.549.439.572 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Lysergic Acid Diethylamide Lysergic Acid Diethylamide Kt *:>Lypressin D06.472.734.692.781.400; D12.644.456.925.480; D12.776.641.650.900.400; D14.600.600.920.440; D19.770.896.540 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Vasopressins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Vasopressins Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Vasopressins Felypressin Felypressin 8-Lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically. A cyclic nonapeptide with lysine in position 8 of the chain; it is used to treat diabetes insipidus and as hemostatic because of its vasoconstrictor action. Lysine (66-74); Vasopressins (66-74)  Ku wFG-Lyngbya Toxins D24.185.926.580.565 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins Toxins isolated from any species of the seaweed Lyngbya or similar chemicals from other sources, including mollusks and micro-organisms. These have been found to be potent tumor promoters. Alkaloids (66-84); Carcinogens (66-84); Indoles (66-84); Lactones (66-84); Marine Toxins (74-84); Toxins (66-84) Kz0:hLynestrenol D04.808.668.651.693.494; D06.597.799.506; D07.360.276.210.443.706.452 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (17 alpha)-19-Norpregn-4-en-20-yn-17-ol. A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive. K|M:Lymphotoxin D24.185.926.235.565; D24.611.350.480.438 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Cytotoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Soluble substance released by lymphocytes activated by antigens or T-cell mitogens, that is cytotoxic to other cells. It is involved in allergies and chronic inflammatory diseases. Lymphotoxin is antigenically distinct from tumor necrosis factor-alpha (TUMOR NECROSIS FACTOR), though they both share a common receptor, biological activities, and significant amino acid sequences. K}.@Lymphoproliferative Disorders C15.604.515; C20.683.515 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Immunologic Diseases; Immunoproliferative Disorders Agammaglobulinemia; Amyloidosis (+ 2); Giant Lymph Node Hyperplasia; Heavy Chain Disease (+ 1); Immunoblastic Lymphadenopathy; Infectious Mononucleosis; Leukemia, Hairy Cell; Leukemia, Lymphocytic; Leukemia, Myeloid (+ 2); Lymphangiomyoma (+ 1); Lymphoma (+ 59); Lymphomatoid Granulomatosis; Marek's Disease; Sarcoidosis (+ 2); Sezary Syndrome; Tumor Lysis Syndrome; Waldenstrom's Macroglobulinemia Giant Lymph Node Hyperplasia; Immunoblastic Lymphadenopathy; Immunoproliferative Small Intestinal Disease; Infectious Mononucleosis; Leukemia, Hairy Cell; Leukemia, Lymphocytic; Leukemia, Myeloid (+ 2); Leukemia, Plasmacytic; Lymphangiomyoma (+ 1); Lymphoma (+ 63); Marek's Disease; Sezary Syndrome; Tumor Lysis Syndrome Disorders characterized by proliferation of lymphoid tissue, general or unspecified. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  K"NIbZLymphopenia C15.378.553.546.605; C20.673.627 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lymphocyte Depletion Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Leukopenia Immunologic Diseases; Immunologic Deficiency Syndromes T-Lymphocytopenia, Idiopathic CD4-Positive T-Lymphocytopenia, Idiopathic CD4-Positive Reduction in the number of lymphocytes. Leukopenia (66-69); Lymphocytes (66-69) $K&N^10Lymphomatoid Papulosis C04.588.805.400; C04.834.580; C17.800.859.475.650.580; C17.800.859.575.650.580; C17.800.859.600.650.580; C17.800.882.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Skin Neoplasms Neoplasms; Precancerous Conditions Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Lichenoid Eruptions; Pityriasis Lichenoides Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Parapsoriasis; Pityriasis Lichenoides Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Pityriasis; Pityriasis Lichenoides Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Neoplasms Clinically benign, histologically malignant, recurrent cutaneous eruption characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble Reed-Sternberg cells of Hodgkin's disease or the malignant cells of cutaneous T-cell lymphoma. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including mycosis fungoides, Hodgkin's disease, cutaneous T-cell lymphoma, or Ki-1 lymphoma. Skin Diseases (68-93); Skin Neoplasms (68-93) K/N8Lymphomatoid Granulomatosis C04.834.567; C15.604.515.571; C23.484.567 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Precancerous Conditions Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Symptoms and General Pathology (Non MeSH); Granuloma An angiocentric and angiodestructive lymphoreticular proliferative disorder primarily involving the lungs. Histologically it simulates malignant lymphoma and in some cases may progress to lymphoma. Granuloma (66-79); Lung Diseases (66-79); Lymphoma (66-79) K 1NHLymphoma, Undifferentiated C04.557.386.480.875; C15.604.515.569.480.875; C20.683.515.761.480.875 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Large-Cell, Diffuse; Lymphoma, Small Noncleaved-Cell (+ 1) Lymphoma, Large-Cell, Diffuse; Lymphoma, Small Noncleaved-Cell (+ 1) Lymphoma, Large-Cell, Diffuse; Lymphoma, Small Noncleaved-Cell (+ 1) A form of lymphoma in which relatively large stem cells with large nuclei, pale, scanty cytoplasm, and indistinct borders are predominant. The cells are undifferentiated, i.e., show no morphologic evidence of maturation toward lymphocytes or histiocytes. Lymphoma (66-86)  KMRy'Lymphoma, T-Cell, Peripheral C04.557.386.480.750.825; C15.604.515.569.480.750.825; C20.683.515.761.480.750.825 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Lymphoma, Large-Cell, Immunoblastic Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment. Lymphoma, Non-Hodgkin's (77-90); T-Lymphocytes (77-90)  K`"YR)@Lymphoma, T-Cell, Cutaneous C04.557.386.480.750.800; C15.604.515.569.480.750.800; C20.683.515.761.480.750.800 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Lymphoma, Large-Cell, Ki-1; Mycosis Fungoides; Sezary Syndrome Lymphoma, Large-Cell, Ki-1; Mycosis Fungoides; Sezary Syndrome Lymphoma, Large-Cell, Ki-1; Mycosis Fungoides; Sezary Syndrome A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES and SEZARY SYNDROME are the best characterized of these disorders. K|!YR&Lymphoma, T-Cell C04.557.386.480.750; C15.604.515.569.480.750; C20.683.515.761.480.750 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Lymphoblastic; Lymphoma, T-Cell, Cutaneous (+ 3); Lymphoma, T-Cell, Peripheral Lymphoma, Lymphoblastic; Lymphoma, T-Cell, Cutaneous (+ 3); Lymphoma, T-Cell, Peripheral Lymphoma, Lymphoblastic; Lymphoma, T-Cell, Cutaneous (+ 3); Lymphoma, T-Cell, Peripheral A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. Lymphoma, Non-Hodgkin's (80-90); T-Lymphocytes (80-90)  K'MRy4p@Lymphoma, Small-Cell C04.557.386.480.150.700; C04.557.386.480.700; C15.604.515.569.480.150.700; C15.604.515.569.480.700; C20.683.515.761.480.150.700; C20.683.515.761.480.700 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's  Lymphoma, Small Cleaved-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Small Lymphocytic; Lymphoma, Small Noncleaved-Cell Lymphoma, Small Cleaved-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Small Lymphocytic; Lymphoma, Small Noncleaved-Cell Lymphoma, Small Cleaved-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Small Lymphocytic; Lymphoma, Small Noncleaved-Cell A B-cell lymphoma presumably representing a tumor of interfollicular B-lymphocytes that may be functional. Those that are secrete identical immunoglobulin molecules. Lymphoma (66-86); Lymphoma, Non-Hodgkin's (66-86)  KcR/;Lymphoma, Small Noncleaved-Cell C04.557.386.480.175.425.775; C04.557.386.480.300.775; C04.557.386.480.700.775; C04.557.386.480.875.775; C15.604.515.569.480.300.775; C15.604.515.569.480.425.775; C15.604.515.569.480.700.775; C15.604.515.569.480.875.775; C20.683.515.761.480.300.775; C20.683.515.761.480.425.775; C20.683.515.761.480.700.775; C20.683.515.761.480.875.775 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, High-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated Burkitt's Lymphoma Burkitt's Lymphoma Burkitt's Lymphoma Burkitt's Lymphoma Burkitt's Lymphoma Burkitt's Lymphoma A high-grade malignant lymphoma that includes both Burkitt's tumor (BURKITT'S LYMPHOMA) and other lymphomas previously designated undifferentiated non-Burkitt's type. Nuclei in Burkitt's tumor are round to ovoid and uniform in size. The non-Burkitt's type exhibits greater nuclear variation and less evidence of cellular maturation with a correspondingly lesser degree of differentiation. K%hR8Lymphoma, Small Lymphocytic C04.557.386.480.175.500.770; C04.557.386.480.300.750; C04.557.386.480.700.750; C15.604.515.569.480.300.750; C15.604.515.569.480.500.770; C15.604.515.569.480.700.750; C20.683.515.761.480.300.750; C20.683.515.761.480.500.770; C20.683.515.761.480.700.750 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Leukemia, Lymphocytic, Chronic Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Low-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell A low-grade malignant lymphoma that may, in some cases, be considered histologically identical to chronic lymphocytic leukemia (CLL; LEUKEMIA, LYMPHOCYTIC, CHRONIC). It is diffuse in pattern, representing the neoplastic proliferation of well-differentiated B-lymphocytes. In patients with immunoglobulin gammopathies, the lymphocytes may exhibit plasmacytoid characteristics. K+!R$aLymphoma, Small Cleaved-Cell, Follicular C04.557.386.480.175.500.750; C04.557.386.480.350.750; C04.557.386.480.700.730; C15.604.515.569.480.350.750; C15.604.515.569.480.500.750; C15.604.515.569.480.700.730; C20.683.515.761.480.350.750; C20.683.515.761.480.500.750; C20.683.515.761.480.700.730 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Low-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell A low-grade malignant lymphoma of predominantly follicular pattern. Follicles are of relatively uniform size and shape and the cells are usually somewhat larger than normal lymphocytes. Nuclei are irregular with prominent indentations and cytoplasm can rarely be identified. Cells exhibiting these characteristics are often called centrocytes. K/RjLymphoma, Small Cleaved-Cell, Diffuse C04.557.386.480.175.450.725; C04.557.386.480.300.725; C04.557.386.480.700.725; C15.604.515.569.480.300.725; C15.604.515.569.480.450.725; C15.604.515.569.480.700.725; C20.683.515.761.480.300.725; C20.683.515.761.480.450.725; C20.683.515.761.480.700.725 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Intermediate-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Small-Cell An intermediate-grade malignant lymphoma in which the neoplastic cells (B-lymphocytes) exhibit variability in size, configuration, and degree of differentiation. The cells have distinctive nuclei, irregular in shape, with marked indentations and angularity. (From Dorland, 27th ed). Kɭ,R|ELymphoma, Non-Hodgkin's C04.557.386.480; C15.604.515.569.480; C20.683.515.761.480 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma Lymphoma, B-Cell (+ 4); Lymphoma by Grade (Non MeSH) (+ 15); Lymphoma, Diffuse (+ 7); Lymphoma, Follicular (+ 3); Lymphoma, Large-Cell (+ 5); Lymphoma, Mixed-Cell (+ 2); Lymphoma, Small-Cell (+ 4); Lymphoma, T-Cell (+ 6); Lymphoma, Undifferentiated (+ 3) Lymphoma, B-Cell (+ 4); Lymphoma, Diffuse (+ 7); Lymphoma, Follicular (+ 3); Lymphoma, High-Grade (+ 4); Lymphoma, Intermediate-Grade (+ 4); Lymphoma, Large-Cell (+ 5); Lymphoma, Low-Grade (+ 4); Lymphoma, Mixed-Cell (+ 2); Lymphoma, Small-Cell (+ 4); Lymphoma, T-Cell (+ 6); Lymphoma, Undifferentiated (+ 3) Lymphoma, B-Cell (+ 4); Lymphoma, Diffuse (+ 7); Lymphoma, Follicular (+ 3); Lymphoma, High-Grade (+ 4); Lymphoma, Intermediate-Grade (+ 4); Lymphoma, Large-Cell (+ 5); Lymphoma, Low-Grade (+ 4); Lymphoma, Mixed-Cell (+ 2); Lymphoma, Small-Cell (+ 4); Lymphoma, T-Cell (+ 6); Lymphoma, Undifferentiated (+ 3) Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN'S DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. Lymphoma (66-86)  KAR%"xLymphoma, Mucosa-Associated Lymphoid Tissue C04.557.386.480.150.570; C04.557.386.480.175.500.570; C15.604.515.569.480.150.570; C15.604.515.569.480.500.570; C20.683.515.761.480.150.570; C20.683.515.761.480.500.570 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Low-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire MALT tissue as a result of an immunologically mediated disorder. Lymphoid Tissue (89-94); Lymphoma (89-94); Lymphoma, B-Cell (90-94); Lymphoma, Non-Hodgkin's (91-94) K2RmxLymphoma, Mixed-Cell, Follicular C04.557.386.480.175.500.525; C04.557.386.480.350.525; C04.557.386.480.550.525; C15.604.515.569.480.350.525; C15.604.515.569.480.500.525; C15.604.515.569.480.550.525; C20.683.515.761.480.350.525; C20.683.515.761.480.500.525; C20.683.515.761.480.550.525 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Low-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Mixed-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Mixed-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Low-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Mixed-Cell A low-grade malignant lymphoma of follicular pattern in which there is no clear preponderance of one cell type (small or large) over another. The large cells, cleaved or noncleaved, are often 2-3 times larger in diameter than normal lymphocytes. K&Rj!Lymphoma, Mixed-Cell, Diffuse C04.557.386.480.175.450.500; C04.557.386.480.300.500; C04.557.386.480.550.500; C15.604.515.569.480.300.500; C15.604.515.569.480.450.500; C15.604.515.569.480.550.500; C20.683.515.761.480.300.500; C20.683.515.761.480.450.500; C20.683.515.761.480.550.500 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Intermediate-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Mixed-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Mixed-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Mixed-Cell A heterogeneous group of intermediate-grade lymphomas of mixed cellular composition. Although they have not been extensively studied, it appears that they are predominantly B-cell diseases. K#R|Lymphoma, Mixed-Cell C04.557.386.480.550; C15.604.515.569.480.550; C20.683.515.761.480.550 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Mixed-Cell, Follicular Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Mixed-Cell, Follicular Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Mixed-Cell, Follicular Malignant lymphoma characterized by the presence of a mixed population of cells, with the smaller cells resembling lymphocytes and the larger ones histiocytes. It usually presents in a nodular (follicular) pattern, but may evolve into a diffuse pattern. (Dorland, 27th ed). Lymphoma (66-86); Lymphoma, Giant Follicular (66-86)  KMRyA?Lymphoma, Lymphoblastic C04.557.386.480.175.425.475; C04.557.386.480.300.475; C04.557.386.480.475.475; C04.557.386.480.750.475; C15.604.515.569.480.300.475; C15.604.515.569.480.425.475; C15.604.515.569.480.475.475; C15.604.515.569.480.750.475; C20.683.515.761.480.300.475; C20.683.515.761.480.425.475; C20.683.515.761.480.475.475; C20.683.515.761.480.750.475 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Leukemia, T-Cell, Acute Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, High-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell A high-grade malignant lymphoma composed of a diffuse, relatively uniform proliferation of cells with round or convoluted nuclei and scanty cytoplasm. The cells are cytologically similar to the lymphoblasts seen in acute lymphocytic leukemia, and in some cases, the disease may evolve into a leukemic phase morphologically indistinguishable from acute T-lymphocytic leukemia (LEUKEMIA, T-CELL, ACUTE). Lymphoblastic lymphoma represents approximately one-third of the cases of non-Hodgkin's lymphomas in children and 5% of the cases in adults. It is more prevalent in males. Lymphoma (77-86); Lymphoma, Non-Hodgkin's (87-90)  KhR;Lymphoma, Low-Grade C04.557.386.480.175.500; C15.604.515.569.480.500; C20.683.515.761.480.500 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Mixed-Cell, Follicular; Lymphoma, Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular; Lymphoma, Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular; Lymphoma, Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Cleaved-Cell, Follicular; Lymphoma, Small Lymphocytic One of the three major prognostic groupings for non-Hodgkin's lymphomas as proposed in the Working Formulation of the Non-Hodgkin's Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute (1981). Lymphomas falling within this group have a relatively favorable survival potential. LQRdLymphoma, Large-Cell, Ki-1 C04.557.227.510.465; C04.557.386.480.475.465; C04.557.386.480.750.800.465; C15.604.515.569.480.475.465; C15.604.515.569.480.750.800.465; C15.604.667.400.390.550.465; C20.683.515.761.480.475.465; C20.683.515.761.480.750.800.465 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Antigens, CD30 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Histiocytic Disorders, Malignant; Lymphoma, Large-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytic Disorders, Malignant; Lymphoma, Large-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous A large-cell, non-Hodgkin's, malignant lymphoma with pleomorphic appearance and reactivity with the monoclonal antibody Ki-1. The lymphoma is most often found in the skin and lymph nodes and expresses the Ki-1 (CD30) antigen (ANTIGENS, CD30) on its surface. It is often mistaken for metastatic carcinoma and malignant histiocytosis. Lymphoma (87-93); Lymphoma, Large-Cell (87-93); Lymphoma, Non-Hodgkin's (87-93)  Lt R^Lymphoma, Large-Cell, Immunoblastic C04.557.386.480.175.425.450; C04.557.386.480.300.450; C04.557.386.480.475.450; C15.604.515.569.480.300.450; C15.604.515.569.480.425.450; C15.604.515.569.480.475.450; C20.683.515.761.480.300.450; C20.683.515.761.480.425.450; C20.683.515.761.480.475.450 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Lymphoma, T-Cell, Peripheral Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, High-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Malignant lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, one or more prominent nucleoli, and abundant cytoplasm. This class may be subdivided into plasmacytoid and clear-cell types based on cytoplasmic characteristics. A third category, pleomorphous, may be analogous to some of the peripheral T-cell lymphomas (LYMPHOMA, T-CELL, PERIPHERAL) recorded in both the United States and Japan. L)R"dLymphoma, Large-Cell, Follicular C04.557.386.480.175.450.350; C04.557.386.480.350.350; C04.557.386.480.475.350; C15.604.515.569.480.350.350; C15.604.515.569.480.450.350; C15.604.515.569.480.475.350; C20.683.515.761.480.350.350; C20.683.515.761.480.450.350; C20.683.515.761.480.475.350 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Intermediate-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Follicular Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Malignant lymphoma in which the majority of neoplastic cells within the follicles are large cleaved or noncleaved cells. The degree to which the follicular center cells retain their ability to form follicles varies with the state of B-cell transformation. L'&R+Lymphoma, Large-Cell, Diffuse C04.557.386.480.175.450.300; C04.557.386.480.300.300; C04.557.386.480.475.300; C04.557.386.480.875.300; C15.604.515.569.480.300.300; C15.604.515.569.480.450.300; C15.604.515.569.480.475.300; C15.604.515.569.480.875.300; C20.683.515.761.480.300.300; C20.683.515.761.480.450.300; C20.683.515.761.480.475.300; C20.683.515.761.480.875.300 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, Intermediate-Grade Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Diffuse Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Intermediate-Grade Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Large-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated Malignant lymphoma composed of large cells which may be both cleaved and noncleaved. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. L!#hRPLymphoma, Large-Cell C04.557.227.510; C04.557.386.480.475; C15.604.515.569.480.475; C15.604.667.400.390.550; C20.683.515.761.480.475 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Histiocytic Disorders, Malignant Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytic Disorders, Malignant Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Large-Cell, Ki-1 Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Follicular; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Large-Cell, Ki-1; Lymphoma, Lymphoblastic Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Follicular; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Large-Cell, Ki-1; Lymphoma, Lymphoblastic Lymphoma, Large-Cell, Ki-1 Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Follicular; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Large-Cell, Ki-1; Lymphoma, Lymphoblastic A form of malignant lymphoma in which the malignant cells resemble histiocytes morphologically but are presently considered to be derived from lymphoid elements. These cells are irregular in shape with relatively abundant, frequently acidophilic cytoplasm. Large-cell lymphoma can occur in both nodular (follicular) and diffuse forms, with the latter being more frequently seen. (Dorland, 27th ed). Lymphoma (66-86)  L+{RqBLymphoma, Intermediate-Grade C04.557.386.480.175.450; C15.604.515.569.480.450; C20.683.515.761.480.450 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Follicular; Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Diffuse Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Follicular; Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Diffuse Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Follicular; Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Diffuse One of the three major prognostic groupings for non-Hodgkin's lymphomas as proposed in the Working Formulation of the Non-Hodgkin's Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute (1981). Lymphomas falling within this group have an intermediate survival potential. L3!QR\Lymphoma, High-Grade C04.557.386.480.175.425; C15.604.515.569.480.425; C20.683.515.761.480.425 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Lymphoblastic; Lymphoma, Small Noncleaved-Cell (+ 1) Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Lymphoblastic; Lymphoma, Small Noncleaved-Cell (+ 1) Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Lymphoblastic; Lymphoma, Small Noncleaved-Cell (+ 1) One of the three major prognostic groupings for non-Hodgkin's lymphomas as proposed in the Working Formulation of the Non-Hodgkin's Lymphoma Pathologic Classification Project sponsored by the National Cancer Institute (1981). Lymphomas falling within this group have a relatively unfavorable survival potential. L9?QRRfLymphoma, Follicular C04.557.386.480.350; C15.604.515.569.480.350; C20.683.515.761.480.350 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Large-Cell, Follicular; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular Lymphoma, Large-Cell, Follicular; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular Lymphoma, Large-Cell, Follicular; Lymphoma, Mixed-Cell, Follicular; Lymphoma, Small Cleaved-Cell, Follicular Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the lymph nodes. The nodules resemble to some extent the germinal centers of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-lymphocytes. This class of lymphoma usually occurs in older persons, is commonly multinodal, and possibly extranodal. Patients whose lymphomas present a follicular or nodular pattern generally have a more indolent course than those presenting with a diffuse pattern. L>wMRymLymphoma, Diffuse C04.557.386.480.300; C15.604.515.569.480.300; C20.683.515.761.480.300 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Lymphoblastic; Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Diffuse; Lymphoma, Small Lymphocytic; Lymphoma, Small Noncleaved-Cell Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Lymphoblastic; Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Diffuse; Lymphoma, Small Lymphocytic; Lymphoma, Small Noncleaved-Cell Lymphoma, Large-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Lymphoblastic; Lymphoma, Mixed-Cell, Diffuse; Lymphoma, Small Cleaved-Cell, Diffuse; Lymphoma, Small Lymphocytic; Lymphoma, Small Noncleaved-Cell Malignant lymphoma in which neoplastic cells diffusely infiltrate the entire lymph node without any definite organized pattern. Patients whose lymphomas present a diffuse pattern generally have a more unfavorable survival outlook than those presenting with a follicular or nodular pattern. Lymphoma, Non-Hodgkin's (86-90)  LDMRyN%Lymphoma, B-Cell C04.557.386.480.150; C15.604.515.569.480.150; C20.683.515.761.480.150 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's Burkitt's Lymphoma; Lymphoma, AIDS-Related; Lymphoma, Mucosa-Associated Lymphoid Tissue; Lymphoma, Small-Cell Burkitt's Lymphoma; Lymphoma, AIDS-Related; Lymphoma, Mucosa-Associated Lymphoid Tissue; Lymphoma, Small-Cell Burkitt's Lymphoma; Lymphoma, AIDS-Related; Lymphoma, Mucosa-Associated Lymphoid Tissue; Lymphoma, Small-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Lymphocytes (77-90); Lymphoma, Non-Hodgkin's (87-90)  LK{MRys@Lymphoma, AIDS-Related C04.557.386.480.150.450; C15.604.515.569.480.150.450; C20.683.515.761.480.150.450 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI HIV Infections; Acquired Immunodeficiency Syndrome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including Burkitt's lymphoma, immunoblastic large-cell lymphoma, small non-cleaved-cell lymphoma and diffuse large-cell lymphoma. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation. Lymphoma (86-91)  LP2YR;~Lymphoma by Grade (Non MeSH) C04.557.386.480.175 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's Lymphoma, High-Grade (+ 4); Lymphoma, Intermediate-Grade (+ 4); Lymphoma, Low-Grade (+ 4) BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI LU$flRLymphoma C04.557.386; C15.604.515.569; C20.683.515.761 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Lymphatic Diseases Neoplasms; Neoplasms by Histologic Type (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Histiocytosis, Malignant; Hodgkin's Disease; Immunoproliferative Small Intestinal Disease; Lymphoma, Non-Hodgkin's (+ 58); Plasmacytoma (+ 1); Reticuloendotheliosis (+ 1) Hodgkin's Disease; Lymphoma, Non-Hodgkin's (+ 57) Hodgkin's Disease; Lymphoma, Non-Hodgkin's (+ 57); Plasmacytoma (+ 1); Reticuloendotheliosis (+ 1) A general term for various neoplastic diseases of the lymphoid tissue. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $LW+ 5RsUXLymphokines D24.611.350.480 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunity, Cellular Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines Interferon Type II; Interleukin-2; Leukocyte Migration-Inhibitory Factors; Lymphotoxin; Macrophage-Activating Factors (+ 1); Macrophage Migration-Inhibitory Factors; Neuroleukin; Suppressor Factors, Immunologic; Transfer Factor Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $L[$FhHLymphoid Tissue A10.549; A15.382.520.604 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH) Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System Peyer's Patches Adenoids; Bursa of Fabricius; Lymph Nodes; Peyer's Patches; Spleen; Thymus Gland; Tonsil L^:pLymphography E01.357.818.565 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Lymph Nodes; Lymphatic System Diagnosis; Diagnostic Imaging; Radiography Radiographic study of the lymphatic system following injection of dye or contrast medium. L_&%3jLymphogranuloma Venereum C01.252.400.810.200.195.501; C01.252.810.301.501; C01.539.780.281.301.501 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Chlamydiaceae Infections; Chlamydia Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Sexually Transmitted Diseases, Bacterial; Chlamydia Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Bacterial; Chlamydia Infections Subacute inflammation of the inguinal lymph glands caused by certain immunotypes of CHLAMYDIA TRACHOMATIS. It is a sexually transmitted disease in the U.S. but is more widespread in developing countries. It is distinguished from granuloma venereum (see GRANULOMA INGUINALE), which is caused by Calymmatobacterium granulomatis. L`QP{Lymphocytosis C15.378.553.475.604 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Leukocytosis Excess of normal lymphocytes in the blood or in any effusion. LeENLLymphocytic Choriomeningitis Virus B04.820.057.070.500.550; B04.909.777.080.070.500.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae; Arenavirus; LCM-Lassa Complex Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae; Arenavirus; LCM-Lassa Complex Viruses The type species of ARENAVIRUS, part of the LCM-LASSA COMPLEX VIRUSES, producing an inapparent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host. Lf(:Lymphocytic Choriomeningitis C02.587.580; C02.782.082.580; C10.228.228.507.248.587.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Meningitis, Viral Virus Diseases; RNA Virus Infections (Non MeSH); Arenaviridae Infections Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis; Meningitis, Aseptic; Meningitis, Viral A form of viral meningitis caused by the LYMPHOCYTIC CHORIOMENINGITIS VIRUS. In humans it may be inapparent or present with symptoms of a flu-like disease, aseptic meningitis, encephalitis, or myelitis. Lj!AP1Lymphocytes, Tumor-Infiltrating A11.118.637.555.567.650; A15.145.229.637.555.567.650; A15.382.490.555.567.650; A15.382.520.520.650 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Immunotherapy, Adoptive Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. Lymphocytes (76-90); T-Lymphocytes (77-90); T-Lymphocytes, Cytotoxic (84-90)  Lm$l*ZLymphocytes, Null A11.118.637.555.567.622; A15.145.229.637.555.567.584; A15.382.490.555.567.622; A15.382.520.520.615 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes A class of lymphocytes characterized by the lack of surface markers specific for either T or B lymphocytes. Lymphocytes (73-81); B Lymphocytes (73-81); T Lymphocytes (73-81) Lpl*PLymphocytes A11.118.637.555.567; A15.145.229.637.555.567; A15.382.490.555.567; A15.382.520.520 CHCLCYDEENIMMEMIPAPHPSRARERISEULUSVI Antilymphocyte Serum Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System Killer Cells; Killer Cells, Natural (+ 1); Lymphocyte Subsets (+ 2); B-Lymphocytes (+ 1); T-Lymphocytes (+ 9); Lymphocytes, Null; Lymphocytes, Tumor-Infiltrating Killer Cells; Killer Cells, Natural (+ 1); Lymphocyte Subsets (+ 2); B-Lymphocytes (+ 1); T-Lymphocytes (+ 9); Lymphocytes, Null; Lymphocytes, Tumor-Infiltrating Killer Cells; Killer Cells, Natural (+ 1); Lymphocyte Subsets (+ 2); B-Lymphocytes (+ 1); T-Lymphocytes (+ 9); Lymphocytes, Null; Lymphocytes, Tumor-Infiltrating Killer Cells; Killer Cells, Natural (+ 1); Lymphocyte Subsets (+ 2); B-Lymphocytes (+ 1); T-Lymphocytes (+ 9); Lymphocytes, Null; Lymphocytes, Tumor-Infiltrating White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each); those with characteristics of neither major class are called null cells. CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI $LtB\(j*Lymphocyte Transfusion E02.095.135.140.425.445 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Leukocyte Transfusion Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion; Blood Component Transfusion; Leukocyte Transfusion The transfer of lymphocytes from a donor to a recipient or reinfusion to the donor. Blood Component Transfusion (92-93); Blood Transfusion (69-93); Lymphocytes (69-77); Lymphocytes/transplantation (69-93)  L{c$fLymphocyte Transformation E05.478.680; G04.610.555.545 DEGEIMPHRE Antigen-Presenting Cells Miscellaneous Techniques (Non MeSH); Immunologic Techniques Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular Morphologic alteration of small lymphocytes in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by interleukins, mitogens such as phytohemagglutinins, and by specific antigens. It may also occur in vivo, as in graft rejection and chronic myelogenous leukemia. Lymphocytes/immunology (66-68)  L}{"t$Lymphocyte Subsets A11.118.637.555.567.550; A15.145.229.637.555.567.550; A15.382.490.555.567.550; A15.382.520.520.430 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Immunophenotyping Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes B-Lymphocyte Subsets; T-Lymphocyte Subsets B-Lymphocyte Subsets; T-Lymphocyte Subsets B-Lymphocyte Subsets; T-Lymphocyte Subsets B-Lymphocyte Subsets; T-Lymphocyte Subsets A classification of lymphocytes based on structurally or functionally different populations of cells. Lymphocytes/classification (77-90) $LUl*v(Lymphocyte Function-Associated Antigen-1 D12.776.543.750.705.408.460.475.400; D24.185.101.100.110.111.400; D24.611.216.301.264.035.111.400; D24.611.834.408.460.475.400 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigens, CD18 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Leukocyte-Adhesion Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD; Antigens, CD11 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD; Antigens, CD11 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Leukocyte-Adhesion A heterodimer molecule widely expressed on cells of hematopoietic origin. CD11a antigen comprises the alpha chain and the CD18 antigen (ANTIGENS, CD18) the beta chain. LFA-1 is a major receptor of T-cells, B-cells, and granulocytes. It mediates the leukocyte adhesion reactions underlying cytolytic conjugate formation, helper T-cell interactions, and antibody-dependent killing by natural killer cells and granulocytes. Intracellular adhesion molecule-1 (ICAM-1) has been defined as a ligand for LFA-1. Antigens, Differentiation (88-90); Receptors, Leukocyte-Adhesion (89-90)  LL.6DSLymphocyte Depletion E02.095.520.450.521; E05.478.610.570 AECTECISMOMTSNSTUTVE Lymphopenia Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunosuppression Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunosuppression Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Immunosuppression (71)  L*FLymphocyte Culture Test, Mixed E01.223.495.468.429; E05.478.468.429 AECLCTECHIISMOMTSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Histocompatibility Testing Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Histocompatibility Testing Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine update) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with mitomycin C or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Histocompatibility Testing (68-72); Leukocytes (66-72) L%*@Lymphocyte Count E01.223.459.107.595.500; G07.380.107.595.500 DEECISMTREVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count; Leukocyte Count Physiology, General (Non MeSH); Cell Count; Blood Cell Count; Leukocyte Count CD4 Lymphocyte Count (+ 1) CD4 Lymphocyte Count (+ 1) A count of the number of lymphocytes in the blood. Leukocyte Count (68-94)  L2B@Lymphocyte Cooperation G04.335.650; G04.610.749 DEGEIMPHRE B-Lymphocytes; T-Lymphocytes, Helper-Inducer; T-Lymphocytes Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity T-cell enhancement of the B-cell response to thymic-dependent antigens. Lymphocytes (66-72); B-Lymphocytes (73-77); T-Lymphocytes (73-77)  LDTNLymphocryptovirus B04.280.382.400.500; B04.909.204.210.400.500; B04.909.204.382.400.500; B04.909.574.204.500.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Gammaherpesvirinae Herpesvirus 4, Human Herpesvirus 4, Human Herpesvirus 4, Human Herpesvirus 4, Human A genus of the family HERPESVIRIDAE, subfamily GAMMAHERPESVIRINAE, consisting of viruses similar to the type species human herpesvirus 4 (HERPESVIRUS 4, HUMAN), better known as the Epstein-Barr virus. LhbLymphocele C04.182.430; C15.604.510 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Cystic mass containing lymph from diseased lymphatic channels or following surgical trauma or other injury. Lymph (66-80); Lymphangioma (75-83); Lymphatic Diseases (66-87) LV\~MLymphedema C15.604.496 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Elephantiasis (+ 1) Edema due to obstruction of lymph vessels or disorders of the lymph nodes. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $LWN H[PLymphatic Vessel Tumors C04.557.375 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Lymphangioma (+ 1); Lymphangiomyoma (+ 1); Lymphangiosarcoma Neoplasms composed of lymphoid tissue, a lattice work of reticular tissue the interspaces of which contain lymphocytes. The concept does not refer to neoplasms located in lymphatic vessels. Lymphatic Metastasis (80-89); Lymphoma (70-93)  LX=J8Lymphatic System A15.382.520 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUULUSVI Lymphography Hemic and Immune Systems (Non MeSH); Immune System Antibody-Producing Cells (+ 3); Endothelium, Lymphatic; Lymph (+ 1); Lymphocytes (+ 20); Lymphoid Tissue (+ 7); Thoracic Duct ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  LR6?<Lymphatic Metastasis C04.697.650.560 DIGEIMPAPCPPRARIRTULUS Neoplasms; Neoplastic Processes (Non MeSH); Neoplasm Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. LLLymphatic Irradiation E02.810.350 AECLCTECHIISMOMTNUPXSNSTTDUTVE Whole-Body Irradiation Therapeutics; Radiotherapy External or interstitial irradiation to treat lymphomas (e.g., Hodgkin's and non-Hodgkin's lymphomas) and lymph node metastases and also some autoimmune diseases, such as rheumatoid arthritis. Radiotherapy (66-88); Radiotherapy Dosage (66-88); Radiotherapy, High Energy (66-88)  LI" dLymphatic Diseases C15.604 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chylothorax; Leukemia, Lymphocytic; Lymphoma Hemic and Lymphatic Diseases (Non MeSH) Lymphadenitis (+ 2); Lymphangiectasis; Lymphangitis; Lymphedema (+ 2); Lymphocele; Lymphoproliferative Disorders (+ 84); Mucocutaneous Lymph Node Syndrome; Reticuloendotheliosis (+ 17); Splenic Diseases (+ 8); Thymus Hyperplasia; Thymus Neoplasms; Tuberculosis, Lymph Node (+ 1) Lymphatic System (66-67) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $L; N50JZLymphangitis C15.604.406 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases LNHLymphangiosarcoma C04.557.375.480; C04.557.450.795.480 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphatic Vessel Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed). L*XLymphangiomyomatosis C04.557.375.460.465; C15.604.515.562.465; C20.683.515.710.465 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphatic Vessel Tumors; Lymphangiomyoma Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphangiomyoma Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphangiomyoma A progressive disorder of women of child-bearing age, marked by nodular and diffuse interstitial proliferation of smooth muscle in the lungs, lymph nodes, and thoracic duct. (Dorland, 27th ed). Lymphangioma (68-93) LENWLymphangiomyoma C04.557.375.460; C15.604.515.562; C20.683.515.710 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphatic Vessel Tumors Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Lymphangiomyomatosis Lymphangiomyomatosis Lymphangiomyomatosis A tumorlike condition characterized by smooth muscle and endothelium proliferation of lymphatic vessels and lymph nodes in the mediastinum and retroperitoneum, also in the lung. It may be manifested by chylous pleural effusion and ascites. Lymphangioma (66-79); Lymphatic Diseases (68-79)  L89VD:Lymphangioma, Cystic C04.557.375.450.450 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphatic Vessel Tumors; Lymphangioma A lymphangioma, often very large, usually occurring in the neck area, and composed of large, multilocular thin-walled cysts. It is also called hygroma or cystic hygroma. (Dorland, 27th ed). Lymphangioma (66-93) LVkLymphangioma C04.557.375.450 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphatic Vessel Tumors Lymphangioma, Cystic A benign tumor representing a congenital malformation of the lymphatic system and made up of newly formed lymph-containing vascular spaces and channels. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component. (From Dorland, 27th ed). LV[HLymphangiectasis, Intestinal C06.405.469.818.521; C18.452.805.521 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Protein-Losing Enteropathies Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Protein-Losing Enteropathies Dilatation of the intestinal lymphatic system, particularly in the lacteals in the intestinal villi, characterized by protein-losing enteropathy, steatorrhea, and lymphopenia. It may be congenital, due to abnormality of the lymphatic system (as in Milroy's disease) or acquired, due to involvement of the major intestinal lymphatic ducts by inflammatory processes or neoplasm, or to increased lymphatic pressure, as in valvular heart disease and constrictive pericarditis. (Dorland, 27th ed). L&!*N7Lymphangiectasis C15.604.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Dilatation of the lymphatic vessels. (Dorland, 27th ed). LNHFLymphadenitis C15.604.315 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases Cat-Scratch Disease; Mesenteric Lymphadenitis BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI LNH5PLymph Nodes A15.382.520.604.412 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Lymphography; Radical Neck Dissection Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphoid Tissue L:-hLymph Node Excision E04.446 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Radical Neck Dissection L $Lymph A12.207.630; A15.382.520.436 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Body Fluids Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System Chyle Chyle L8 ""Lymnaea B01.644.776.645 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca; Snails A genus of dextrally coiled freshwater snails that includes some species of importance as intermediate hosts of parasitic flukes. Snails (66-71) LC ('Lymecycline D20.085.868.389 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5a alpha,6 beta,12a alpha-N(6)-((((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenyl)carbonyl)amino)methyl)-L-lysine. A semisynthetic antibiotic related to tetracycline. It is more readily absorbed than tetracycline and can therefore be given in lower doses; it is also reported to have fewer gastrointestinal side effects. L::Lyme Disease C01.252.400.155.569; C01.252.400.825.480; C01.252.847.193.569 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Borrelia burgdorferi Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Borrelia Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Borrelia Infections Erythema Chronicum Migrans Erythema Chronicum Migrans Erythema Chronicum Migrans An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini and pacificus ticks in the United States and Ixodes ricinis in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut. Arthritis, Infectious (79-84); Spirochaetales Infections (82-84) $LEP\KLying F03.126.842.483 Lie Detection Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders Communication to others of what one knows to be untrue or contrary to fact; an attempt to deceive. L% yyLye D01.045.250.400; D01.205.500; D01.455.450; D05.569.185.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Alkalies; Hydroxides Inorganic Chemicals (Non MeSH); Caustics Inorganic Chemicals (Non MeSH); Hydroxides Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Caustics A caustic solution of sodium or potassium hydroxide. LhD8@Lyases D08.586.520 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Adenyl Cyclase; Adenylosuccinate Lyase; Aldehyde-Lyases (+ 2); Ammonia-Lyases (+ 5); Argininosuccinate Lyase; Carboxy-Lyases (+ 14); Cystathionine gamma-Lyase; Cysteine Synthase; DNA Photolyase; Ferrochelatase; Guanylate Cyclase; Hydro-Lyases (+ 14); Ketoacid-Lyases (+ 8); Lactoyl Glutathione Lyase; Polysaccharide-Lyases (+ 3); Sulfhydrases; Tryptophanase; Tyrosine Phenol-Lyase LI FELuxembourg Z01.542.550 EHEP Geographicals (Non MeSH); Europe L)Lutheran Blood-Group System D24.611.216.705.230.552; G04.610.241.552; G09.188.229.552 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups A complex blood group system having pairs of alternate antigens and amorphic genes, but also subject to a dominant independently segregating repressor. Blood Groups (66-75) L;!A2PLutetium D01.268.558.500; D01.552.550.518 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Lutetium. An element of the rare earth family of metals. It has the atomic symbol Lu, atomic number 71, and atomic weight 175. L &:Luteovirus B04.715.430; B04.820.430 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses A group of plant viruses that infects both monocotyledonous and dicotyledonous plants. Its organisms are persistently transmitted by aphids, and weeds may provide reservoirs of infection. Plant Viruses (86-93) L6Luteoma C04.557.475.480 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue A benign ovarian tumor of granulosa or theca-lutein cell origin, producing progesterone effects on the uterine mucosa. (Stedman, 25th ed). Ovarian Neoplasms (67-93); Thecoma (66-93) Lg V]4Luteolytic Agents D07.610; D07.360.276.450 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Corpus Luteum Reproductive Control Agents (Non MeSH) Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Triptorelin Chemical compounds causing corpus luteum regression or degeneration. Corpus Luteum/drug effects (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (L78P*:Lutembacher's Syndrome C14.240.400.560.375.518; C14.280.400.560.375.518; C16.131.240.400.560.375.518 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Atrial A combination of atrial septal defect and mitral stenosis. LBULGLutein Cells A05.360.319.114.630.278.400; A06.407.312.497.278.400; A11.600 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri; Ovary; Corpus Luteum Endocrine System (Non MeSH); Endocrine Glands; Gonads; Ovary; Corpus Luteum Cells The cells of the corpus luteum which are derived from the granulosa cells and the theca cells of the Graafian follicle. LjE*Luteal Phase G08.520.440.410 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle The period of the menstrual cycle that begins with ovulation and ends with menstruation. Ld[jLuria-Nebraska Neuropsychological Battery F04.711.513.300 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Neuropsychological Tests A series of tests designed to assess neuropsychological function. The battery is used to diagnose specific cerebral dysfunction and also to determine lateralization. Psychological Tests (66-84) Lފ/ o!Lupus Nephritis C12.777.419.570.363.680; C17.300.480.680; C20.111.590.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Glomerulonephritis Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Lupus Erythematosus, Systemic Immunologic Diseases; Autoimmune Diseases; Lupus Erythematosus, Systemic Glomerulonephritis associated with systemic lupus erythematosus. It is classified into four histologic types: mesangial, focal, diffuse, and membranous. Glomerulonephritis (66-86); Lupus Erythematosus, Systemic (66-86); Nephritis (66-86) LNANQcLupus Erythematosus, Systemic C17.300.480; C20.111.590 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antiphospholipid Syndrome; Lupus Coagulation Inhibitor; LE Cells Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Immunologic Diseases; Autoimmune Diseases Lupus Nephritis Lupus Nephritis A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.  L{#NL&+Lupus Erythematosus, Discoid C17.300.475.479; C17.800.480.479 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Panniculitis, Lupus Erythematosus Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Lupus Erythematosus, Cutaneous Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Lupus Erythematosus, Cutaneous Panniculitis, Lupus Erythematosus Panniculitis, Lupus Erythematosus A chronic form of cutaneous lupus erythematosus (LUPUS ERYTHEMATOSUS, CUTANEOUS) in which the skin lesions mimic those of the systemic form but in which systemic signs are rare. It is characterized by the presence of discoid skin plaques showing varying degrees of edema, erythema, scaliness, follicular plugging, and skin atrophy. Lesions are surrounded by an elevated erythematous border. The condition typically involves the face and scalp, but widespread dissemination may occur.  LZ"&N'L1Lupus Erythematosus, Cutaneous C17.300.475; C17.800.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Lupus Erythematosus, Discoid (+ 1) Lupus Erythematosus, Discoid (+ 1) A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID). Lupus Erythematosus, Discoid (66-86); Lupus Erythematosus, Systemic (66-86)  L$NRmXLupus Coagulation Inhibitor D12.776.124.125.600; D19.461.270.229.600; D24.611.125.308.210.600 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antiphospholipid Syndrome Lupus Erythematosus, Systemic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies; Antibodies, Antiphospholipid An antiphospholipid antibody found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC), ANTIPHOSPHOLIPID SYNDROME, and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications. Autoantibodies (66-91); Blood Coagulation Factors (66-91) $L!I6#DLupus C01.252.410.040.552.846.583.470; C01.252.825.820.470; C01.539.800.720.820.470; C17.800.838.765.820.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Cutaneous Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial; Tuberculosis, Cutaneous Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial; Tuberculosis, Cutaneous Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial; Tuberculosis, Cutaneous A form of cutaneous tuberculosis. It is seen predominantly in women and typically involves the nasal, buccal, and conjunctival mucosa. L pPLung Volume Measurements E01.302.796.420 ISMTVE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Total Lung Capacity (+ 9) Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle. Lung (66-74); Respiration (66-74); Respiratory Function Tests (66-74) DEGEIMISMTPHREVE $L ^!}TLung Transplantation E04.920.800.495; E04.936.450.495 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Heart-Lung Transplantation Surgery, Operative; Thoracic Surgery; Surgery, Lung (Non MeSH) Surgery, Operative; Transplantation; Organ Transplantation Heart-Lung Transplantation Heart-Lung Transplantation The transference of either one or both of the lungs from one human or animal to another. Lung/transplantation (66-89) $L&2<m"Lung Neoplasms C04.588.894.797.520; C08.381.540; C08.785.520 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory Tract Neoplasms Carcinoma, Bronchogenic; Coin Lesion, Pulmonary; Pancoast's Syndrome Carcinoma, Bronchogenic; Coin Lesion, Pulmonary; Pancoast's Syndrome Carcinoma, Bronchogenic; Coin Lesion, Pulmonary; Pancoast's Syndrome L5X?Lung Diseases, Parasitic C03.582; C08.381.517; C08.730.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory Tract Infections Echinococcosis, Pulmonary Echinococcosis, Pulmonary Echinococcosis, Pulmonary Infections of the lungs with a parasite. They are caused most commonly by nematodes (roundworms). L)PVvLung Diseases, Obstructive C08.381.495 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Airway Obstruction Respiratory Tract Diseases; Lung Diseases Asthma; Bronchitis (+ 4); Pulmonary Emphysema Any disorder marked by persistent obstruction of bronchial air flow. Lung Diseases (66-70) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI (M N29RPLung Diseases, Interstitial C08.381.483 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Alveolitis, Extrinsic Allergic (+ 2); Bronchiolitis Obliterans (+ 1); Goodpasture's Syndrome; Histiocytosis, Langerhans-Cell; Pneumoconiosis (+ 8); Pulmonary Fibrosis; Radiation Pneumonitis; Sarcoidosis, Pulmonary; Wegener's Granulomatosis A heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma. "Interstitial" refers to the fact that the interstitium of the alveolar walls is thickened, usually by fibrosis. This group of diseases is usually inflammatory. (Dorland, 27th ed; Cecil, Textbook of Medicine, 19th ed). Pulmonary Fibrosis (66-93) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $M!N2  PLung Diseases, Fungal C01.703.534; C08.381.472; C08.730.435 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory Tract Infections Aspergillosis, Allergic Bronchopulmonary; Pneumonia, Pneumocystis carinii Aspergillosis, Allergic Bronchopulmonary; Pneumonia, Pneumocystis carinii Aspergillosis, Allergic Bronchopulmonary; Pneumonia, Pneumocystis carinii M-PLung Diseases C08.381 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pulmonary Heart Disease Respiratory Tract Diseases Atelectasis (+ 1); Bronchopulmonary Dysplasia; Cystic Adenomatoid Malformation of Lung, Congenital; Cystic Fibrosis; Granuloma, Plasma Cell, Pulmonary; Hemoptysis; Lung Abscess; Lung Diseases, Fungal (+ 2); Lung Diseases, Interstitial (+ 20); Lung Diseases, Obstructive (+ 7); Lung Diseases, Parasitic (+ 1); Lung Neoplasms (+ 3); Meconium Aspiration; Pneumonia (+ 11); Pulmonary Alveolar Proteinosis; Pulmonary Edema; Pulmonary Embolism; Pulmonary Eosinophilia; Pulmonary Veno-Occlusive Disease; Respiratory Distress Syndrome (+ 1); Respiratory Distress Syndrome, Adult; Scimitar Syndrome; Silo Filler's Disease; Tuberculosis, Pulmonary (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  M \ N ZLung Compliance E01.302.796.384; G09.772.521.700.420 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Elasticity (66-67); Lung/physiology (66-67) M}*5Lung Abscess C01.539.830.025.490; C08.381.449; C08.730.407 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory Tract Infections A complication of a localized area of pneumonia or when a neoplasm becomes necrotic and contains purulent material that cannot drain easily from the area because of partial or complete bronchial obstruction. (Harrison's Principles of Internal Medicine, 12th ed, p1068). M 5P;Lung A04.411 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Air Sacs; Pneumonectomy; Pulmonary Circulation; Respiration Respiratory System Extravascular Lung Water; Pulmonary Alveoli (+ 1) Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. consider also terms at PNEUMO- and PULMON-. ABAHBSCHCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUULUSVI $M 8G<:Lumpy Skin Disease Virus B04.280.650.160.150.500; B04.909.204.783.160.150.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Capripoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Capripoxvirus A species of CAPRIPOXVIRUS causing a cattle disease occurring in Africa. M:WLumpy Skin Disease C02.256.743.494; C22.196.497 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Animal Diseases; Cattle Diseases A poxvirus infection of cattle characterized by the appearance of nodules on all parts of the skin. Cattle Diseases (66-69); Virus Diseases (66-69) My"J{x:Luminol D03.383.710.350; D26.550.440 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations. Pyridazines (68-74) MQ ".Luminescent Proteins D12.776.532 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Aequorin; Luciferin Proteins which are involved in the phenomenon of light emission in living systems. Included are the "enzymatic" and "non-enzymatic" types of system with or without the presence of oxygen or co-factors. Luminescence (66-78); Proteins (66-78) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $MDD/HLuminescence, Bacterial G04.185.515.120.525; H01.671.606.552.565.750 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Bacterial Phenomena (Non MeSH) Physical Sciences (Non MeSH); Physics; Optics; Light; Luminescence The emission of light by bacteria. It is applied to studies on bacterial viability, metabolism, genetics, adhesiveness, and other physiological properties. Luminescence (66-92) Mx2 Luminescence H01.671.606.552.565 Chemiluminescence Physical Sciences (Non MeSH); Physics; Optics; Light Chemiluminescence; Luminescence, Bacterial The property of giving off light without emitting a corresponding degree of heat. It includes the luminescence of inorganic matter or the bioluminescence of human matter, invertebrates and other living organisms. For the luminescence of bacteria, LUMINESCENCE, BACTERIAL is available. MB1JLumicolchicines D03.132.225.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Colchicine N-(5,6,7,7b,8,10a-Hexahydro-1,2,3,9-Tetramethoxy- 8-oxobenzo(A) cyclopenta(3,4)cyclobuta(1,2-c)cyclopenten- 7-ylacetamide. Three, alpha, beta, and gamma isomers of ultraviolet degradation products of colchicine that lack many of the physiological actions of the parent; used as experimental control for colchicine actions. Colchicine (66-74) /AA (75-79) M 86o%Lumbosacral Region A01.176.519 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Low Back Pain Body Regions (Non MeSH); Back M#1('Lumbosacral Plexus A08.800.800.720.450 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves Femoral Nerve; Obturator Nerve; Sciatic Nerve (+ 3) The lumbar and sacral plexuses taken together. The fibers of the lumbosacral plexus originate in the lumbar and upper sacral spinal cord (L1 to S3) and innervate the lower extremities. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI  M#6Z@8Lumbar Vertebrae A02.835.232.834.519 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine M&:DLudwig's Angina C01.539.535; C07.465.433 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Stomatognathic Diseases; Mouth Diseases Severe cellulitis of the submaxillary space with secondary involvement of the sublingual and submental space. It usually results from infection in the lower molar area or from a penetrating injury to the mouth floor. (From Dorland, 27th ed). M&PlLuciferin D12.776.532.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Luminescent Proteins A heterocyclic phenol that exists in many forms and is present in certain animals capable of bioluminescence. When acted upon by luciferase it is oxidized and emits energy in the form of light. M) D]Luciferase D08.586.682.517 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Any one of several enzymes that catalyze the bioluminescent reaction in certain marine crustaceans, fish, bacteria, and insects. The enzyme is a flavoprotein; it oxidizes luciferin to an electronically excited compound that emits energy in the form of light. The color of light emitted varies with the organism. The firefly enzyme is a valuable reagent for measurement of ATP concentration. (Dorland, 27th ed) EC 1.13.12.-. M*FXLucensomycin D20.085.062.540; D20.085.115.400; D20.136.073.540 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Lucensomycin. Antifungal antibiotic isolated from cultures of Streptomyces lucensis. Antibiotics, Antifungal (71-74); Glycosides (72-74) M-9<b=Lucanthone D03.494.953.704.500; D21.201.412.596.331 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Thioxanthenes Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides M/.:Lubrication H01.671.469 Physical Sciences (Non MeSH); Physics M1-/Loxapine D03.494.347.500; D14.100.150.175.421; D15.150.450; D15.210.950.040.450; D15.700.872.331.516 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzoxazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents Amoxapine An antipsychotic agent used in schizophrenia. Dibenzoxazepines (71-74); Piperazines (71-74)  M1 g:76Lown-Ganong-Levine Syndrome C14.280.067.780.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Pre-Excitation Syndromes A form of pre-excitation characterized by a short PR interval associated with a normal QRS complex. Arrhythmia (66-85); Tachycardia (66-85); Tachycardia, Paroxysmal (66-85) M5 NZwVLower Body Negative Pressure E05.245.570 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fluid Shifts Miscellaneous Techniques (Non MeSH); Decompression External decompression applied to the lower body. It is used to study orthostatic intolerance, produce simulated hemorrhage in physiologic research, assess cardiovascular function, and reduce abdominal stress during childbirth. Atmospheric Pressure (66-79); Pressure (66-79)  M6#"<8Low Back Pain C10.597.617.152.500; C23.888.592.612.107.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sciatica Lumbosacral Region; Back Pain Nervous System Diseases; Neurologic Manifestations; Pain; Back Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Back Pain A continuous pain in the lower back or lumbar region. Back Pain (66-92) $M82N %CLove F01.470.734 Behavior and Behavior Mechanisms (Non MeSH); Emotions Affection; in psychiatry commonly refers to pleasure, particularly as it applies to gratifying experiences between members of the opposite sex. M;ALovastatin D04.615.638.400; D08.373.400; D10.162.202.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents (1S-(1 alpha(R*),3 alpha,7 beta,8 beta(2S*,4S*),8a beta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester. A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Several studies have shown that because of its enzyme inhibitory activity it acts as an antineoplastic agent for certain tumors. Anticholesteremic Agents (66-87); Hydroxymethylglutaryl CoA Reductases/antagonists and inhibitors (77-87); Naphthalenes (66-87) M<%5@ Louping Ill C02.782.350.250.650; C22.836.435 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Animal Diseases; Sheep Diseases An acute tick-borne arbovirus infection causing meningoencephalomyelitis of sheep. Encephalitis, Tick-Borne/veterinary (66-70); Sheep Diseases (66-70) MA&J_OLouisiana Z01.107.567.875.100.447; Z01.107.567.875.600.820.447 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States MCj :Loudness Perception F02.463.593.071.576 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception The perceived attribute of a sound which corresponds to the physical attribute of intensity. Auditory Perception (67-78); Auditory Threshold (68-78) MD tnBLos Angeles Z01.107.567.875.100.127.565; Z01.107.567.875.600.822.127.565; Z01.433.565 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH); California Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States; California Geographicals (Non MeSH); Cities (Non MeSH) MFzQmLorisidae B02.649.801.700.572 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Strepsirhini Galago A family of Primates of the suborder Strepsirhini containing six genera. The family is distributed in parts of Africa, India, Asia, and the Philippines. The six genera are: Arctocebus (golden potto), GALAGO (bush babies), Loris (slender loris), Nycticebus (slow loris), and Perodicticus (potto). Lorises and pottos are relatively common except for Arctocebus, the golden potto. All are arboreal and nocturnal. Prosimii (75-80)  MHo (6 Lordosis C05.116.900.800.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spinal Curvatures (Non MeSH) The anterior concavity in the curvature of the lumbar and cervical spine as viewed from the side. The term usually refers to abnormally increased curvature (hollow back, saddle back, swayback). It does not include lordosis as normal mating posture in certain animals ( = POSTURE + SEX BEHAVIOR, ANIMAL). MK NfgLorazepam D03.438.079.080.070.450; D14.100.240.500.400; D15.075.050.475; D15.080.450; D15.095.460; D15.210.350.800.430; D15.210.950.012.050.450; D15.325.875.425; D15.700.872.015.050.508; D16.050.030.425 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Antiemetics Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one. An anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Benzodiazepinones (74); Chlorobenzenes (74) MM~ :I4Loratadine D03.383.621.160.500; D04.615.181.384.340.500; D14.100.375.425.400.470; D23.075.485 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Cyproheptadine Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes; Cyproheptadine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Dermatologic Agents; Antipruritics A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines it lacks central nervous system depressing effects such as drowsiness. Cyproheptadine/analogs and derivatives (87-92); Piperidines (84-86) MTU\:OLoperamide D03.383.621.440; D19.316.161.552 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Antidiarrheals 4-(p-Chlorophenyl)-4-hydroxy-N.N-dimethyl-alpha,alpha-diphenyl-1-piperidine butyramide hydrochloride. Synthetic anti-diarrheal agent with a long duration of action; it is not significantly absorbed from the gut, has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. Synonym: R 18533. Amides (74-75); Chlorobenzenes (74-75); Piperidines (74-75) MXA&:HLoop of Henle A05.810.453.736.560.610 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Nephrons; Kidney Tubules Kidney Tubules (66-72) M[:QLongitudinal Studies E05.318.760.500.750.500; G03.850.520.835.500.750.500; N05.715.360.775.175.250.450 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Follow-Up Studies; Prospective Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Epidemiologic Methods (66-74) M\{Yl0#Longitudinal Ligaments A02.513.514.350; A02.835.583.512.350 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ossification of Posterior Longitudinal Ligament Musculoskeletal System; Ligaments; Ligaments, Articular Musculoskeletal System; Skeleton; Joints; Ligaments, Articular Two extensive fibrous bands running the length of the vertebral column. The anterior longitudinal ligament (ligamentum longitudinale anterius; lacertus medius) interconnects the anterior surfaces of the vertebral bodies; the posterior longitudinal ligament (ligamentum longitudinale posterius) interconnects the posterior surfaces. The commonest clinical consideration is OSSIFICATION OF POSTERIOR LONGITUDINAL LIGAMENT. (From Stedman, 25th ed). Ligaments (67-93); Ligaments, Articular (68-93)  M`Z*:79Longevity G07.168.519 DEGEIMPHRE Aged; Aged, 80 and over; Life Expectancy Life Expectancy Physiology, General (Non MeSH); Aging Mc 4/Long-Term Potentiation G11.561.594.350 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Neuronal Plasticity A persistent increase in synaptic efficacy, usually induced by appropriate activation of the same synapses. The phenomenological properties of long-term potentiation suggest that it may be a cellular mechanism of learning and memory. Synapses/physiology (77-93) Md!Long-Term Care E02.472.476; N02.421.589.581 CLECHILJMAMTOGPXSNSTTDUT Insurance, Long-Term Care Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH)  Life Support Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Chronic Disease (66-67) CLECHIISLJMAMTOGPXSNSTTDUT (Mf"Long-Acting Thyroid Stimulator D24.611.125.308.550; D24.611.125.600.681.393.550 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Receptors, Thyroid Hormone Hyperthyroidism Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes; IgG Thyroid stimulator, long-acting. An immunoglobulin G, often found in the blood of hyperthyroid individuals. It stimulates the thyroid for a longer duration than does thyrotoxin and may cause hyperthyroidism in newborns due to placental transmission.  Mi$66 "Long QT Syndrome C14.280.067.565 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Syndrome characterized by history of syncopal episodes and a long QT interval, sometimes leading to sudden death due to paroxysmal ventricular arrhythmia. When associated with autosomal recessive inheritance and congenital deafness, it is called the Jervell-Lange Nielsen syndrome. When associated with autosomal dominant inheritance and no deafness is present, it is called the Romano-Ward syndrome. Arrhythmia (66-85); Tachycardia (66-85) Ml9N=0Loneliness F01.829.850.435; I01.880.683.435 PX Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Isolation Social Sciences; Sociology; Social Isolation The state of feeling sad or dejected as a result of lack of companionship or being separated from others. Mo&London Z01.433.553; Z01.542.363.300.553 EHEP Geographicals (Non MeSH); Cities (Non MeSH) Geographicals (Non MeSH); Europe; Great Britain; England Mp &zLomustine D02.654.692.440; D02.948.594.440; D22.204.493 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Semustine Semustine Semustine 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea. An alkylating agent of value against both hematologic malignancies and solid tumors. Synonyms: Belustine; CeeNU; NSC 79037. Cyclohexanes (72-74); Nitrosourea Compounds (72-74)  MqT 5:#=Lolium B06.252.561 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Grasses Common member of the Graminea family used as cattle fodder. It harbors several fungi and other parasites toxic to livestock and people and produces allergenic compounds, especially in its pollen. The most commonly seen varieties are L. perenne, L. multiflorum, and L. rigidum. Grasses (66-85); Rye (66-85) Mt &F%Loiasis C03.335.508.700.750.361.518 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis A parasitic infection caused by the nematode Loa loa. The vector in the transmission of this infection is the horsefly (Tabanus) or the deerfly or mango fly (Chrysops). The larvae may be seen just beneath the skin or passing through the conjunctiva. Eye lesions are not uncommon. The disease is generally mild and painless. Mu PLogistic Models E05.318.740.500.525; E05.318.740.600.800.450; E05.318.740.750.450; G03.850.520.830.500.525; G03.850.520.830.600.800.450; G03.850.520.830.750.450; H01.548.832.672.734.400; H01.548.832.793.450; H01.770.461.835.875; N05.715.360.750.530.480; N05.715.360.750.625.700.450; N05.715.360.750.695.470 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Models, Statistical Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability; Risk Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Regression Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Models, Statistical Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability; Risk Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Regression Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Probability; Risk Physical Sciences (Non MeSH); Mathematics; Statistics; Regression Analysis Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability; Risk Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Regression Analysis Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor. Models, Theoretical (72-89); Regression Analysis (80-93); Statistics (74-79) Mx<[Logic K01.752.448 Humanities; Philosophy Fuzzy Logic M Lofepramine D03.494.240.520; D15.085.050.475; D15.700.122.055.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic 1-(4-Chlorophenyl)-2-((3-(10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl)methylamino)ethanone. A psychotropic IMIPRAMINE derivative that acts as a tricyclic antidepressant and possesses few anticholinergic properties. It is metabolized to DESIPRAMINE. Dibenzazepines (69-78) M)=:5Lod Score G05.568.562 Genetics; Linkage (Genetics) The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds.". Genetics (70-72); Linkage (Genetics) (70-80) ME#6Locus Coeruleus A08.186.211.132.659.473; A08.186.211.132.810.450.352 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon; Pons Bluish region in the superior angle of the fourth ventricle floor, corresponding to melanin-like pigmented nerve cells which lie lateral to the ponto-mesencephalic central gray (griseum centrale). It is also known as nucleus pigmentosus pontis, locus cinereus, and locus ferrugineus. Cerebral Ventricles (66-77); Mesencephalon (66-77); Pons (66-77) M:8INLocomotion G11.427.614.568 DEGEIMPHRE Gait Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement M}Location Directories and Signs J01.086.339.400 CLSNST Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction Directory signs or listings of designated areas within or without a facility. Mr% l]Local Area Networks L01.700.568.080.110.600 CLECHIISLJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computer Communication Networks Communications networks connecting various hardware devices together within or between buildings by means of a continuous cable or voice data telephone system. MLobsters B01.131.365.623 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Arthropods; Crustacea Large marine decapod crustaceans of the family Homaridae, commonly used for food. Crustacea (66-71)  MU ( ,aLobosea B01.841.750.656.475 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina Amoebida (+ 11); Schizopyrenida (+ 2) A class of ameboid protozoa that forms either filiform subpseudopodia or lobopodia. Characteristics include the absence of sorocarps, sporangia, or similar fruiting bodies. Mw &?0Lobeline D03.132.478; D03.383.621.418; D14.100.120.140.700.480; D15.220.516; D16.050.400.420 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Nicotinic Agonists Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Stimulants An alkaloid that has actions similar to NICOTINE on nicotinic cholinergic receptors but is less potent. It has been proposed for a variety of therapeutic uses including in respiratory disorders, peripheral vascular disorders, insomnia, and smoking cessation. M _@,Lobbying I01.738.610 Social Sciences; Politics A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization. Politics (68-81) M  Loa B01.500.294.700.750.700.300.410 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea A genus of parasitic nematodes found throughout the rain-forest areas of the Sudan and the basin of the Congo. L. loa inhabits the subcutaneous tissues, which it traverses freely. M-#*bLLC-PK1 Cells A11.251.210.520 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Renal epithelial cell line originally derived from porcine kidneys. It is used for pharmacologic and metabolic studies. Cell Line (79-94); Cells, Cultured (80-93) M*+5Lizards B02.833.393 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles Iguanas Reptiles (66-67) M> & Living Wills I01.880.604.583.020.500; I01.880.604.583.927.500; N03.706.535.020.500 CLECEHHILJPCPXSNTD Right to Die Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Advance Directives Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Wills Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Advance Directives Written, witnessed declarations in which persons request that if they become disabled beyond reasonable expectation of recovery, they be allowed to die rather than be kept alive by extraordinary means. (Bioethics Thesaurus). Right to Die (87-90); Wills (77-86)  MM1.Liver Transplantation E04.765.650; E04.936.450.490; E04.936.580.490 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgery, Operative; Transplantation; Organ Transplantation Surgery, Operative; Transplantation; Tissue Transplantation The transference of a part of or an entire liver from one human or animal to another. Liver/transplantation(66-89) M52j"Liver Regeneration G04.185.753.468; G10.261.642 DEGEIMPHRE Hepatectomy Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) Repair or renewal of hepatic tissue. M".Liver Neoplasms, Experimental C04.588.274.623.460; C04.619.540 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Liver Neoplasms Neoplasms; Neoplasms, Experimental Experimentally induced tumors of the liver. Hepatoma (66-78); Liver Neoplasms (66-78); Neoplasms, Experimental (66-78) Mz#&R5YLiver Neoplasms C04.588.274.623; C06.552.697 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms Digestive System Diseases; Liver Diseases Liver Neoplasms, Experimental MW"X$Liver Glycogen D09.203.698.365.388.518 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Glycogen MFuLiver Function Tests E01.184.558 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Digestive System (Non MeSH) M";Liver Failure, Acute C06.552.680.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Liver Failure A form of liver failure with rapid onset. It is often induced by the toxic effect of drugs and various toxic substances in experimental studies in animals and in clinical states in humans. If coma ensues, the constellation of neurological symptoms is referred to as HEPATIC ENCEPHALOPATHY. Hepatic Encephalopathy (67-92); Hepatitis, Toxic (69-92); Liver Diseases (66-92) M[NDV`Liver Failure C06.552.680 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Hepatic Encephalopathy; Liver Failure, Acute Severe inability of the liver to carry out its normal functions or the demands made upon it, as evidenced by such clinical phenomena as severe jaundice and abnormal levels of ammonia, bilirubin, alkaline phosphatase, glutamic oxaloacetic transaminase, lactic dehydrogenase, and reversal of the albumin/globulin ratio. For the presence of disturbed mental functioning, usually coma, HEPATIC ENCEPHALOPATHY is available. (Blakiston's Gould Medical Dictionary, 4th ed). Hepatic Encephalopathy (67-92); Liver Diseases (66-92)  MN25ALiver Extracts D19.461.543.600; D24.185.893.351 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia. MS&8Liver Diseases, Parasitic C03.518; C06.552.664 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases Digestive System Diseases; Liver Diseases Echinococcosis, Hepatic; Fascioliasis; Liver Abscess, Amebic Echinococcosis, Hepatic; Fascioliasis; Liver Abscess, Amebic Infections of the liver with a parasite. They are caused most commonly by trematodes (flukes). MPGsLiver Diseases, Alcoholic C06.552.645; C21.613.053.270.645 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Liver Cirrhosis, Alcoholic Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Liver Cirrhosis, Alcoholic Liver diseases associated with alcoholism. It usually refers to the coexistence of two or more subentities, i.e., alcoholic fatty liver, alcoholic hepatitis, and alcoholic liver cirrhosis, but may be the general entity when subentities are not specified. Alcoholism (66-78); Liver Diseases (66-78); specific liver disease  M&L(QLiver Diseases C06.552 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases Acute Yellow Atrophy; Cholestasis, Intrahepatic (+ 2); Fatty Liver (+ 2); Hepatic Vein Thrombosis; Hepatic Veno-Occlusive Disease; Hepatitis (+ 13); Hepatolenticular Degeneration; Hepatomegaly; Hepatorenal Syndrome; Hypertension, Portal (+ 2); Liver Abscess (+ 1); Liver Cirrhosis (+ 3); Liver Diseases, Alcoholic (+ 3); Liver Diseases, Parasitic (+ 3); Liver Failure (+ 2); Liver Neoplasms; Peliosis Hepatis; Porphyria, Erythrohepatic; Porphyria, Hepatic (+ 2); Tuberculosis, Hepatic; Zellweger Syndrome BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI M NZZLiver Cirrhosis, Experimental C06.552.630.467 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Liver Cirrhosis Me#NFLiver Cirrhosis, Biliary C06.130.450.250.250; C06.552.150.250; C06.552.630.400; C23.888.498.250.250.612 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Cholestasis; Cholestasis, Intrahepatic Digestive System Diseases; Liver Diseases; Cholestasis, Intrahepatic Digestive System Diseases; Liver Diseases; Liver Cirrhosis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Cholestasis; Cholestasis, Intrahepatic Liver cirrhosis in which there is interference with intrahepatic bile flow. It includes primary biliary cirrhosis, an intrahepatic disturbance of bile secretion affecting predominantly middle-aged women and with segmental destruction and, later, absence of septal bile ducts (cirrhosis is the end stage); and secondary biliary cirrhosis, which is produced by prolonged mechanical obstruction of large intrahepatic or extrahepatic bile ducts. MNXNLiver Cirrhosis, Alcoholic C06.552.630.380; C06.552.645.590; C21.613.053.270.645.550 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Liver Cirrhosis Digestive System Diseases; Liver Diseases; Liver Diseases, Alcoholic Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism; Liver Diseases, Alcoholic Liver cirrhosis in alcoholics. Alcoholism (66-77); Liver Cirrhosis (66-77) M AL &5Liver Cirrhosis C06.552.630 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. M N2aLiver Circulation G09.330.163.881.552 DEGEIMPHRE Enterohepatic Circulation; Portal System Hepatic Artery; Hepatic Veins; Portal System Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation; Splanchnic Circulation The circulation of blood through the vessels of the liver.  M<07HLiver Abscess, Amebic C01.539.830.025.020.455.460; C03.518.600; C03.752.700.700.055.407.570; C06.552.597.517; C06.552.664.642 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess; Abdominal Abscess; Liver Abscess Parasitic Diseases; Liver Diseases, Parasitic Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Sarcodina Infections; Amebiasis; Entamoebiasis Digestive System Diseases; Liver Diseases; Liver Abscess Digestive System Diseases; Liver Diseases; Liver Diseases, Parasitic Liver abscess caused by ENTAMOEBA HISTOLYTICA. MsP8Liver Abscess C01.539.830.025.020.455; C06.552.597 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess; Abdominal Abscess Digestive System Diseases; Liver Diseases Liver Abscess, Amebic Liver Abscess, Amebic Solitary or multiple collections of pus within the liver. It is usually associated with systemic manifestations of toxemia and clinical signs of disease in the right upper quadrant of the abdomen. It was known in ancient times to Hippocrates and Celsus. (Bockus Gastroenterology, 4th ed, p3288-9). M*P4_Liver A03.620 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Hepatectomy Digestive System Bile Ducts, Intrahepatic (+ 1) consider also terms at HEPAT-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $M  8&':Litter Size G08.520.780.300 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal The number of offspring produced at one birth by an animal. Animals, Newborn (66-74) M]JLithuania Z01.542.248.136.580; Z01.586.950.140.580 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern; Baltic States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Baltic States M .Lithotripsy, Laser E02.600.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Lithotripsy Fragmentation of calculi, notably urinary or biliary, by laser. It is usually performed with an endoscopically guided pulsed tunable dye laser, a combination of a pulsed laser and a dye laser usually referred to as a pulsed dye laser. It is both safe and effective when extracorporeal shockwave lithotripsy is infeasible or unsuccessful. Lasers/therapeutic use (84-93); Lithotripsy (86-93) M-">Lithotripsy E02.600 AECLCTECHIISMOMTNUPXSNSTTDUTVE Calculi Therapeutics Lithotripsy, Laser The destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER. Electrotherapy (66-85); Physical Therapy (66-85); Ultrasonic Therapy (66-85) $M̅ " [Lithocholic Acid D04.808.221.430.622; D19.316.246.175.551 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Chenodeoxycholic Acid Taurolithocholic Acid Taurolithocholic Acid 3 alpha-Hydroxy-5 beta-cholanic Acid. Bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic. M..D26Lithium Compounds D01.510 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Lithium Carbonate; Lithium Chloride Inorganic compounds that contain lithium as an integral part of the molecule. Lithium (66-93)  M 8%+]Lithium Chloride D01.210.450.150.450; D01.510.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Inorganic Chemicals (Non MeSH); Lithium Compounds Lithium chloride (LiCl). A salt of lithium that has been used experimentally as an immunomodulator. Chlorides (77-93); Lithium (77-93) MT&8x+Lithium Carbonate D01.045.125.500; D01.200.275.150.550; D01.510.475; D15.130.475; D15.210.950.025.475; D15.700.872.025.475 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Alkalies; Carbonates Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH); Carbonic Acid; Carbonates Inorganic Chemicals (Non MeSH); Lithium Compounds Central Nervous System Agents; Antimanic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antimanic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antimanic Agents Dilithium carbonate. An orally administered white granular powder used in the treatment of acute manic states and for prophylaxis of recurrent affective disorders, including those manifested by depression or mania only, or those in which both mania and depression occur. It is also used in the treatment of cluster headaches. Lithium (66-91); Tranquilizing Agents (66-91) M9v8}7Lithium D01.268.549.450; D01.552.528.480 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Alkali Inorganic Chemicals (Non MeSH); Metals; Metals, Alkali Lithium. An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight 6.94. Salts of lithium are used in treating manic-depressive disorders. M &:Literature, Modern K01.517.533 HI Humanities; Literature MLiterature, Medieval K01.517.495 HI Humanities; Literature M4Literature K01.517 HI Medicine in Literature Humanities Anecdotes; Aphorisms and Proverbs; Bible; Biography (+ 2); Drama; Literature, Medieval; Literature, Modern; Medicine in Literature; Mythology; Philology (+ 3); Poetry; Wit and Humor HIPX  Mܝ Lisuride D03.132.327.287.560; D03.549.439.560; D14.100.150.151.475; D14.100.850.800.450; D15.090.050.505 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents An ergot derivative that acts as an agonist at dopamine D2 receptors, may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors. It has been used in parkinsonism but it may be hepatotoxic. It is commonly used as a research tool. Ergolines (69-78); Ergot Alkaloids (66-68) M k:(G4Listeria monocytogenes B03.510.460.400.410.485.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Listeria A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion. Mq"0Listeria Infections C01.252.410.514 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections Meningitis, Listeria Infections with bacteria of the genus LISTERIA. MPs:Listeria B03.510.460.400.410.485 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH) Listeria monocytogenes A genus of bacteria which may be found in the feces of animals and man, on vegetation, and in silage. Its species are parasitic on cold-blooded and warm-blooded animals, including man. Bacteria (66-74); Corynebacteriaceae (75)  M4 "2Lissamine Green Dyes D02.092.102.475; D02.675.276.475; D02.886.645.600.080.050.550; D26.408.492 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates Miscellaneous Drugs and Agents (Non MeSH); Dyes Green dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously. They have mostly been used in the study of kidney physiology. Ammonium Compounds (69-75) MpT,] Lisinopril D08.373.745.085.550; D12.644.456.345.600; D18.162.050.550; D18.222.556 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents; Cardiotonic Agents (S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline dihydrate. An orally active angiotensin-converting enzyme inhibitor that has been used in the treatment of hypertension and congestive heart failure. Dipeptides (81-85,93); Enalapril/analogs and derivatives (86-92) MP:LLipreading E02.831.671.432; L01.143.506.423.348 Deafness Therapeutics; Rehabilitation; Rehabilitation of Hearing Impaired (Non MeSH) Information Science; Communication; Language; Language Arts (Non MeSH) The process by which an observer comprehends speech by watching the movements of the speaker's lips without hearing the speaker's voice. M* Lipoxygenase Inhibitors D08.373.390 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors BW-755C; Diethylcarbamazine; Nordihydroguaiaretic Acid Compounds or agents that combine with lipoxygenase and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of the eicosanoid products hydroxyeicosatetraenoic acid and various leukotrienes. Lipoxygenase/antagonists and inhibitors (78-91) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $M6P?7:Lipoxygenase D08.586.348.600; D08.586.682.690.433 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isoenzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases  Arachidonate Lipoxygenases (+ 3) An enzyme of the oxidoreductase class that catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives. Related enzymes in this class include the ARACHIDONATE LIPOXYGENASES, ARACHIDONATE 5-LIPOXYGENASE, ARACHIDONATE 12-LIPOXYGENASE, and ARACHIDONATE 15-LIPOXYGENASE. EC 1.13.11.12. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  MR*D(}FLipotropin D06.472.734.525.690.480 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pro-Opiomelanocortin MDLipotropic Factors D10.642 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lipids and Antilipemic Agents (Non MeSH) Betaine; Choline; Inositol; Methionine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR M 810FLiposomes D10.516.695.492; H01.181.529.530.517 ADAEANCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Membranes, Artificial Membranes, Artificial (66-72) M *.#Liposarcoma, Myxoid C04.557.450.550.420.425; C04.557.450.795.465.425 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Adipose Tissue; Liposarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Liposarcoma A liposarcoma containing myxomatous tissue. (Dorland, 27th ed). Liposarcoma (68-93) M=6X8MLiposarcoma C04.557.450.550.420; C04.557.450.795.465 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Adipose Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Liposarcoma, Myxoid Liposarcoma, Myxoid A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed). M.X.Lipoproteins, VLDL Cholesterol D10.516.532.599.700; D10.516.851.208.900; D12.776.521.622.700 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins; Lipoproteins, VLDL Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins; Lipoproteins, VLDL Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High concentrations of VLDL cholesterol are found in Type IIB and Type V hyperlipoproteinemia. The end product of VLDL cholesterol catabolism is LDL (low density lipoproteins). Cholesterol (72-88); Lipoproteins, VLDL (72-88) N$EF 39Lipoproteins, VLDL D10.516.532.599; D12.776.521.622 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins Lipoproteins, VLDL Cholesterol Lipoproteins, VLDL Cholesterol Lipoproteins (66-71) N&FFLipoproteins, LDL Cholesterol D10.516.532.515.500; D10.516.851.208.700; D12.776.521.550.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hypercholesterolemia; Hypercholesterolemia, Familial Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins; Lipoproteins, LDL Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins; Lipoproteins, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL). LDL transport cholesterol to peripheral tissues and regulate de novo cholesterol synthesis at these sites. Atherosclerosis is caused by the deposit of cholesterol on the walls of blood vessels, because of high concentrations of LDL cholesterol in plasma. Cholesterol (66-84); Lipoproteins, LDL (72-84)  N#EF;8Lipoproteins, LDL D10.516.532.515; D12.776.521.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, LDL Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins Lipoproteins, LDL Cholesterol Lipoproteins, LDL Cholesterol Lipoproteins (66-71)  N &FDLipoproteins, HDL Cholesterol D10.516.532.432.400; D10.516.851.208.680; D12.776.521.479.470 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hypercholesterolemia; Hypercholesterolemia, Familial Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins; Lipoproteins, HDL Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins; Lipoproteins, HDL Cholesterol which is contained in or bound to high density lipoproteins (HDL). High density lipoproteins transport cholesterol from peripheral tissues to the liver thereby acting as a scavenger to prevent excess accumulation and deposition of cholesterol in blood vessels. Cholesterol (66-84); Lipoproteins, HDL (72-84)  N B#EF;=8Lipoproteins, HDL D10.516.532.432; D12.776.521.479 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins Lipoproteins, HDL Cholesterol Lipoproteins, HDL Cholesterol Lipoproteins (66-71) N&FDLipoproteins D10.516.532; D12.776.521 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Apolipoproteins; Hyperlipoproteinemia; Hypolipoproteinemia; Lipoidproteinosis; Proteolipids; Receptors, Lipoprotein Proteolipids Lipids and Antilipemic Agents (Non MeSH); Lipids Amino Acids, Peptides and Proteins (Non MeSH); Proteins Chylomicrons; Lipoprotein(a); Lipoprotein-X; Lipoproteins, HDL (+ 1); Lipoproteins, LDL (+ 1); Lipoproteins, VLDL (+ 1); Platelet Factor 3; Pulmonary Surfactants; Vitellogenin Chromogranins; Chylomicrons; Lipoprotein(a); Lipoprotein-X; Lipoproteins, HDL (+ 1); Lipoproteins, LDL (+ 1); Lipoproteins, VLDL (+ 1); Platelet Factor 3; Pulmonary Surfactants; Vitellogenin Any of the lipid-protein complexes in which lipids are transported in the blood. Lipoprotein particles consist of a spherical hydrophobic core of triglycerides or cholesteryl esters surrounded by an amphipathic monolayer of phospholipids, cholesterol, and apolipoproteins. (From Dorland, 27th ed). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (NF~XHLipoprotein-X D10.516.532.400; D12.776.521.450 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins An abnormal lipoprotein which is present in large amounts in individuals suffering from obstructive liver diseases. It exists as a bilayer vesicle of equimolar phospholipids and unesterified cholesterol containing small amounts of plasma proteins (mainly albumin) in its internal aqueous compartment together with some apolipoproteins adsorbed on its surface. Separates with LDL by ultracentrifugation. Lipoproteins (66-79); Lipoproteins, LDL (72-79) N&H9Lipoprotein(a) D10.516.532.350; D12.776.521.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins A family of lipoprotein particles varying in density and size depending on the protein-lipid ratio and the protein composition. These particles consist of apolipoprotein B-100 covalently linked to apolipoprotein-a by one or two disulfide bonds. There is a correlation between high plasma levels of this lipoprotein and increased risk for atherosclerotic cardiovascular disease. Lipoproteins (77-92) N&HLipoprotein Lipase Deficiency, Familial C18.452.648.556.481.552 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia A rare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins. It is due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood. Hyperlipidemia/familial and genetic (66-79) N.L^3Lipoprotein Lipase D08.586.277.352.100.430 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. NF"Lipopolysaccharides D09.203.400.500; D09.203.698.718.450; D10.516.494; D24.185.526.600; D24.611.216.161.616.525 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Polysaccharides, Bacterial Lipids and Antilipemic Agents (Non MeSH); Lipids Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial; Polysaccharides, Bacterial  Lipid A Lipid A Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  N"/g<pFLipomatosis, Multiple Symmetrical C04.651.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms, Multiple Primary Multiple circumscribed or encapsulated lipomas which may be distributed symmetrically or haphazardly or which may form a collar around the neck. Lipoma (66-86); Lipomatosis (66-86) N&'N.,Lipomatosis C23.739.517 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) A condition characterized by abnormal localized, or tumor-like, accumulations of fat in the tissues. (Dorland, 27th ed). N(NYLipoma C04.557.450.550.400 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Adipose Tissue A benign tumor usually composed of mature fat cells. At times the tumor may be composed partly or entirely of fetal fat cells (hibernoma). (Dorland, 27th ed). N*  VLipolysis G06.535.630.710 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) The hydrolysis of lipids. Lipid Mobilization (70-79); Lipids/metabolism (66-79) N, t!@Lipoidproteinosis C18.452.648.556.641.391 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lipoproteins Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis A familial disease occurring in the course of latent diabetes, marked by yellowish nodules on the skin and mucosae, keratotic lesions on the extremities, and hoarseness due to faulty lipid metabolism. (Dorland, 27th ed). N-*LLipoidosis C18.452.648.556.641 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors Cholesterol Ester Storage Disease; Lipoidproteinosis; Neuronal Ceroid-Lipofuscinosis; Refsum's Disease; Sjogren-Larsson Syndrome; Sphingolipidoses (+ 11); Wolman Disease A disturbance of lipid metabolism with abnormal deposit of lipids in the cells. (Dorland, 27th ed). N/LyLipofuscin D10.516.460; D11.557.550 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments A naturally occurring lipid pigment with histochemical characteristics similar to ceroid. It accumulates in various normal tissues and apparently increases in quantity with age. Lipids (72-74); Pigments (72-74) N1D)Lipodystrophy, Intestinal C06.405.469.637.598; C18.452.603.598 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Malabsorption Syndromes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Malabsorption Syndromes A disease marked by diarrhea with fatty stools, arthritis, emaciation, and loss of strength, and attended with deposits of fat in the intestinal lymphatic tissue. (Dorland, 27th ed). N3*NLipodystrophy C17.800.849.391 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH) Diabetes Mellitus, Lipoatrophic A collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat. They include total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy. N6aNv%Lipoamide Dehydrogenase D08.586.682.608.479 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases A flavoprotein that catalyzes the reduction of lipoamide by NADH to yield dihydrolipoamide and NAD+. The enzyme is a component of the multienzyme pyruvate dehydrogenase complex and 2-oxoglutarate dehydrogenase complex. EC 1.8.1.4. N8Fy Lipids and Antilipemic Agents (Non MeSH) D10 Antilipemic Agents (+ 21); Lipids (+ 291); Lipotropic Factors (+ 4) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESNSTTOTUULURUTVI N:1URLipids D10.516 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Fats Lipids and Antilipemic Agents (Non MeSH) Ceroid; Fats (+ 27); Fatty Acids (+ 116); Fatty Alcohols (+ 13); Glycerides (+ 4); Glycolipids (+ 19); Lipid Peroxides; Lipofuscin; Lipopolysaccharides (+ 1); Lipoproteins (+ 12); Membrane Lipids (+ 1); Oils (+ 20); Phospholipids (+ 22); Proteolipids; Sphingolipids (+ 15); Sterols (+ 22); Waxes (+ 2) A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, sterols, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant and Hackh's Chemical Dictionary, 5th ed). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESNSTTOTUULURUTVI $N;  B1{RLipid Peroxides D10.516.440 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Peroxides Lipids and Antilipemic Agents (Non MeSH); Lipids Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Lipids (66-79); Peroxides (66-79)  N?B <l*Lipid Peroxidation G06.535.335.531.587 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism; Oxidation-Reduction Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxides/metabolism (80-88); Lipids/metabolism (66-88) NC9|iILipid Mobilization G06.535.630.700 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) The breakdown of stored triglyceride in adipose tissue with the release of free fatty acids and glycerol. Depot fat hydrolysis is catalyzed by a lipase in response to pituitary lipid mobilization factors (LMF), various hormones, serotonin, or hepatotoxins such as carbon tetrachloride. Lipids/metabolism (66-69) NDtMLipid Metabolism, Inborn Errors C18.452.648.556 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Hyperlipoproteinemia (+ 8); Hypolipoproteinemia (+ 4); Lipoidosis (+ 18); Mitochondrial Myopathies (+ 5) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI NG &Lm~NLipid Bilayers D10.516.570.510; H01.181.529.530.510 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Membrane Lipids Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Membranes, Artificial Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Membranes, Artificial (66-79) NH*8#Lipid A D09.203.698.718.450.500; D10.516.494.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Polysaccharides, Bacterial; Lipopolysaccharides Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipopolysaccharides Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties. Lipids (72-76); Lipopolysaccharides (72-76) NJ .D4Lipectomy E04.860.552 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Adipose Tissue; Obesity Surgery, Operative; Surgery, Plastic Removal of localized subcutaneous fat deposits by suction curettage or blunt cannulization in the cosmetic correction of obesity and other esthetic contour defects. Adipose Tissue/surgery (67-88); Suction (82-88); Surgery, Plastic (67-88)  NMY $,YLipase D08.586.277.352.100.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. NO& FJLip Neoplasms C04.588.443.591.550; C07.465.409.640; C07.465.565.550 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Lip Diseases Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms NQ=XLip Diseases C07.465.409 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Cheilitis; Cleft Lip; Herpes Labialis; Lip Neoplasms Lip (66-71); Mouth Diseases (66-71) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  NS(N/A-ZLip A01.456.505.631.515; A14.549.336 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Body Regions (Non MeSH); Head; Face; Mouth Stomatognathic System; Mouth  Labial Frenum Either of the two fleshy, full-blooded margins of the mouth. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  NT&8YJ:Lions B02.649.147.600 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Large chiefly nocturnal mammals of the cat family found in Africa and southern Asia. NV8 ('fLinuron D02.948.511.515; D02.948.684.515; D05.723.366.506.515 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea; Methylurea Compounds Organic Chemicals (Non MeSH); Urea; Phenylurea Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Urea Herbicides (66-71); Urea (66-71) NW, =:)Linseed Oil D10.516.212.507.550; D10.516.627.700.615; J01.740.400.425; J01.740.700.615 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Technology, Industry, Agriculture (Non MeSH); Oils; Industrial Oils Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils NXT,DLinolenic Acids D02.241.081.436.410; D10.516.251.355.310.640; D10.516.251.355.450 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Essential Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated alpha-Linolenic Acid; gamma-Linolenic Acid alpha-Linolenic Acid; gamma-Linolenic Acid alpha-Linolenic Acid; gamma-Linolenic Acid Eighteen-carbon essential fatty acids that contain three double bonds. Fatty Acids, Essential (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $NZIBdS%DLinoleic Acids D02.241.081.436.390; D10.516.251.355.310.515; D10.516.251.355.432 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Essential Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated N^\IBdLinkage Disequilibrium G05.568.500 GEIMPH Genetics; Linkage (Genetics) Nonrandom association of linked genes. This is the tendency of the alleles of two separate but already linked loci to be found together more frequently than would be expected by chance alone. Linkage (66-89) N`} #Linkage (Genetics) G05.568 DEGEIMPHRE Genetics Linkage Disequilibrium; Lod Score The association in inheritance of two or more non-allelic genes due to their being located more or less closely on the same chromosome. Genetics (66-69)  Na  )Linitis Plastica C04.557.470.200.025.095.410 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Adenocarcinoma, Scirrhous Diffuse fibrous proliferation of the submucous connective tissue of the stomach, resulting in thickening and fibrosis so that the stomach is constricted, inelastic, and rigid (like a leather bottle). It is almost always a manifestation of adenocarcinoma but is also seen in benign conditions such as gastric syphilis. (Dorland, 27th ed). Nc:XLiniments D26.394.225.493 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Nf ,MLinguistics L01.143.506.598 CLECEDHIISLJMAMTOGSNSTTD Information Science; Communication; Language Nomenclature (+ 4); Phonetics; Psycholinguistics; Semantics; Vocabulary Nf5VLingual Nerve A08.800.800.120.760.500.450 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Trigeminal Nerve; Mandibular Nerve A sensory branch of the MANDIBULAR NERVE, which is part of the trigeminal (5th cranial) nerve. The lingual nerve carries general afferent fibers from the anterior two-thirds of the tongue, the floor of the mouth, and the mandibular gingivae. Mandibular Nerve (66-70) Ng8Lingual Frenum A14.549.885.431 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Mouth; Tongue Nj:-Linear Models E05.318.740.500.500; E05.318.740.750.425; G03.850.520.830.500.500; G03.850.520.830.750.425; H01.548.832.793.425; H01.770.461.835.750; N05.715.360.750.530.460; N05.715.360.750.695.460 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Models, Statistical Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Regression Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Models, Statistical Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Regression Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Regression Analysis Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Regression Analysis Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Models, Theoretical (66-89); Regression Analysis (66-93) NjCLinear Energy Transfer G06.184.348.400; H01.181.529.328.400; H01.671.100.442.400 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Energy Transfer Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Energy Transfer Physical Sciences (Non MeSH); Physics; Biophysics; Energy Transfer Rate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue (keV/micrometer T). Energy Transfer (68-94) NpA'Lincomycin D09.203.408.465; D20.085.466 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Anti-Infective Agents; Antibiotics  Clindamycin (2S-trans)-Methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside. An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal and Bacteroides fragilis infections. Nsj"<WLimulus Test E01.223.530; E05.091.570; E05.909.560.150.570 AECLCTECHIISMOMTNUPXSNSTTDUTVE Endotoxins; Horseshoe Crabs Diagnosis; Diagnosis, Laboratory Miscellaneous Techniques (Non MeSH); Biological Assay Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques; Bacteriological Techniques Sensitive method for detection of bacterial endotoxins and endotoxin-like substances that depends on the in vitro gelation of Limulus amebocyte lysate (LAL), prepared from the circulating blood (amebocytes) of the horseshoe crab, by the endotoxin or related compound. Used for detection of endotoxin in body fluids and parenteral pharmaceuticals. Endotoxins (66-77)  Nu5""Limbus Corneae A09.371.060.217.659 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Sclera Sense Organs; Eye; Anterior Eye Segment; Cornea An annular transitional zone, approximately 1 mm wide, between the cornea and the bulbar conjunctiva and sclera. It is highly vascular and is involved in the metabolism of the cornea. It is ophthalmologically significant in that it appears on the outer surface of the eyeball as a slight furrow, marking the line between the clear cornea and the sclera. (Dictionary of Visual Science, 3d ed). Cornea (66-91)  Ny%8 <Limbic System A08.186.211.577 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain Amygdaloid Body; Entorhinal Cortex; Gyrus Cinguli; Hippocampus (+ 1); Hypothalamus; Olfactory Pathways (+ 1); Septum Pellucidum (+ 2) ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI N{688Limb Deformities, Congenital (Non MeSH) C05.660.585; C16.131.621.585 Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Ectromelia; Foot Deformities, Congenital; Hand Deformities, Congenital; Polydactyly (+ 1); Proteus Syndrome; Syndactyly (+ 2); Thanatophoric Dysplasia Ectromelia; Foot Deformities, Congenital; Hand Deformities, Congenital; Polydactyly (+ 1); Proteus Syndrome; Syndactyly (+ 2); Thanatophoric Dysplasia BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI N}p/"bLLikelihood Functions E05.318.740.500.475; E05.318.740.600.400; G03.850.520.830.500.475; G03.850.520.830.600.400; H01.548.832.672.289; H01.770.461.835.500; N05.715.360.750.530.450; N05.715.360.750.625.450 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Models, Statistical Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Models, Statistical Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Physical Sciences (Non MeSH); Science; Models, Theoretical; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Models, Statistical Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability Functions constructed from a statistical model and a set of observed data which give the probability of that data for various values of the unknown model parameters. Those parameter values that maximize the probability are the maximum likelihood estimates of the parameters. Probability (66-89) NTALignin D09.203.698.365.180.515; D25.720.549 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Cellulose Biomedical and Dental Materials (Non MeSH); Polymers Lignin. The most abundant natural aromatic organic polymer found in all vascular plants. Lignin together with cellulose and hemicellulose are the major cell wall components of the fibers of all wood and grass species. Lignin is composed of coniferyl, p-coumaryl, and sinapyl alcohols in varying ratios in different plant species. (From Merck Index, 11th ed). Ng *DLignans D02.455.426.559.389.140.450 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzyl Compounds A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Dictionary of Microbiology and Molecular Biology, 2d ed). Lignin (90-93); Plant Extracts (81-89) N\ :j0Lightning Injuries C21.866.324.550 BLCFCICLCNCODHDIDTECEHEMENEPGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Electric Injuries Accidental injuries caused by brief high-voltage electrical discharges during thunderstorms. Cardiopulmonary arrest, coma and other neurologic symptoms, myocardial necrosis, and dermal burns are common. Prompt treatment of the acute sequelae, including cardiopulmonary resuscitation, is indicated for survival. Burns, Electric (66-88); Electric Injuries (66-88); Lightning (66-88) N2LgaTLightning G03.230.300.100.725.375 Electricity Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather N uLighting G03.230.150.410 AECLECHILJMTSNSTTD Light Environment and Public Health (Non MeSH); Environment; Environment, Controlled N  ]Light Coagulation E04.792.630 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Eye (Non MeSH) Laser Coagulation The coagulation of tissue by an intense beam of light, including laser (LASER COAGULATION). In the eye it is used in the treatment of retinal detachments, retinal holes, aneurysms, hemorrhages, and malignant and benign neoplasms. (Dictionary of Visual Science, 3d ed). Nt$5=Light H01.671.606.552; H01.671.768.638.552 AEDU Lighting; Photic Stimulation; Photobiology; Photochemistry; Photochemotherapy; Photometry; Photosensitivity Disorders; Photosynthesis; Phototherapy; Phototropism; Sunlight; Ultraviolet Therapy Photobiology Physical Sciences (Non MeSH); Physics; Optics Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Non-Ionizing Lasers; Luminescence (+ 2) That portion of the electromagnetic spectrum to which the human eye is sensitive. Light is about 400 to 800 nanometers in wavelength, i.e., between the ultraviolet and infrared spectra. consider also terms at PHOTIC and PHOTO-. AECLDUHISDSTTUUT (Nl *# Ligation E04.426 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Application of a ligature to tie a vessel or strangulate a part. Surgery, Operative (66-70); specific heading/surgery (66-70) N  $PHLigases D08.586.464 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Acetyl-CoA Carboxylase; Adenylosuccinate Synthetase; Amino Acyl T RNA Synthetases (+ 16); Argininosuccinate Synthetase; Aspartate-Ammonia Ligase; Carbamyl Phosphate Synthase (Ammonia); Carbamyl Phosphate Synthase (Glutamine); Coenzyme A Synthetases (+ 2); Fatty Acid Synthetase Complex; Formyltetrahydrofolate Synthetase; Glutamate-Ammonia Ligase; Peptide Synthetases (+ 2); Polynucleotide Synthetases (+ 2); Pyruvate Carboxylase N FELigands D26.640 Radioligand Assay; Receptors, Cell Surface Miscellaneous Drugs and Agents (Non MeSH) A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed). Metals (66-72); Organometallic Compounds (68-72) Nd  32,:Ligamentum Flavum A02.513.514.287; A02.835.583.512.287 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Ligaments; Ligaments, Articular Musculoskeletal System; Skeleton; Joints; Ligaments, Articular One of a series of bands of yellow (Latin flavum) elastic tissue attached to and extending between the ventral portions of the laminae of two adjacent vertebrae, from the junction of the axis and the third cervical vertebra to the junction of the fifth lumbar vertebra and the sacrum. They assist in maintaining or regaining the erect position and serve to close in the spaces between the arches. (Dorland, 27th ed). Ligaments (66-93) Nl*:Ligaments, Articular A02.513.514; A02.835.583.512 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Ligaments Musculoskeletal System; Skeleton; Joints Anterior Cruciate Ligament; Collateral Ligaments (+ 2); Ligamentum Flavum; Longitudinal Ligaments; Patellar Ligament; Posterior Cruciate Ligament Anterior Cruciate Ligament; Collateral Ligaments (+ 2); Ligamentum Flavum; Longitudinal Ligaments; Patellar Ligament; Posterior Cruciate Ligament N":WRLigaments A02.513 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System Broad Ligament; Ligaments, Articular (+ 8); Round Ligament N  :HLifting G11.427.050.400; H01.671.100.131.342 AE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Biomechanics Physical Sciences (Non MeSH); Physics; Biophysics; Biomechanics Moving or bringing something from a lower level to a higher one. The concept encompasses biomechanic stresses resulting from work done in transferring objects from one plane to another as well as the effects of varying techniques of patient handling and transfer. N *6Life Tables E05.318.308.985.475; G03.850.505.400.975.475; G03.850.520.308.985.475; H01.548.832.067.500; L01.280.975.475; N01.224.935.530 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics Physical Sciences (Non MeSH); Mathematics; Statistics; Actuarial Analysis Information Science; Data Collection; Vital Statistics Population Characteristics (Non MeSH); Demography; Vital Statistics Summarizing techniques used to describe the pattern of mortality and survival in populations. These methods can be applied to the study not only of death, but also of any defined endpoint such as the onset of disease or the occurrence of disease complications. Actuarial Analysis (79-89); Life Expectancy (66-78) Nh4>Life Support Systems G03.230.150.391 CLECHIISLJSNSTUT Environment and Public Health (Non MeSH); Environment; Environment, Controlled Systems that provide all or most of the items necessary for maintaining life and health. Provisions are made for the supplying of oxygen, food, water, temperature and pressure control, disposition of carbon dioxide and body waste. The milieu may be a spacecraft, a submarine, or the surface of the moon. In medical care, usually under hospital conditions, LIFE SUPPORT CARE is available. (From Webster's New Collegiate Dictionary). N]Life Support Care E02.472.440; N02.421.589.581.325 CLECHIISLJMAMTOGPXSNSTTDUT Resuscitation Orders Terminal Care Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Long-Term Care Extracorporeal Membrane Oxygenation Care provided patients requiring extraordinary therapeutic measures in order to sustain and prolong life. Ethics, Medical (66-77); Life Expectancy (66-77); Longevity (66-77) AECLCTECHIISLJMAMOMTNUOGPXRHSNSTTDUTVE ,Nf&*{R*Life Style F01.829.458 EH Health Behavior; Quality of Life Social Environment; Quality of Life Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Life Change Events The individual's active adaptation to the social milieu, which develops as a unique, personal product of his need for integration into that social milieu and for differentiation from it. Personality Development (68-69) (N),L%Life Stages (Non MeSH) B01.583 Invertebrates Larva (+ 3); Nymph; Pupa AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI N #*Life Expectancy E05.318.308.985.450; G03.850.505.400.975.450; G03.850.520.308.985.450; L01.280.975.450; N01.224.935.464 EHTD Longevity Longevity Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics Information Science; Data Collection; Vital Statistics Population Characteristics (Non MeSH); Demography; Vital Statistics A figure representing the number of years, based on known statistics, to which any person of a given age may reasonably expect to live.  Ns  Life Change Events F01.829.458.410 Stress, Psychological Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Life Style Those occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual's pattern of living. Life Style (72-76); Stress, Psychological (69-76) NH[<Liechtenstein Z01.542.524 EHEP Geographicals (Non MeSH); Europe N)Lie Detection F02.784.240.514; F02.830.512; I01.198.560.619 PX Lying Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Criminal Psychology Psychologic Processes and Principles (Non MeSH); Psychophysiology Social Sciences; Criminology; Forensic Medicine Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph. No5 Lidoflazine D03.383.606.596; D18.918.575 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Cardiovascular Agents; Vasodilator Agents 4-[4,4-Bis(p-fluorophenyl)butyl]-1-piperazine aceto-2',6'-xylidine. Coronary vasodilator with some antiarrhythmic action. Synonyms: Clinium; Corflazine; Klinium; McN-JR-7904; R 7904. Acetic Acids (66-72); Amides (66-72); Piperazines (66-72); Xylenes (66-72) N":\Lidocaine D02.065.199.092.500; D15.050.050.420; D15.210.100.200.410; D16.850.025.420; D18.097.464 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local Cardiovascular Agents; Anti-Arrhythmia Agents 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide. A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of procaine but its duration of action is shorter than that of bupivacaine or prilocaine. N c:NLichens B05.513 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH) Thallophytic plants formed by mutualistic combination of an alga and a fungus, the algal component being a green or blue-green alga, and the fungal usually an ascomycete. (Dorland, 27th ed). N  ""Lichenoid Eruptions C17.800.859.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous Lichen Nitidus; Lichen Planus (+ 1); Lichen Sclerosus et Atrophicus; Pityriasis Lichenoides (+ 1) Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. (From Textbook of Dermatology, 4th ed, Rook et al., eds.). NNnv}Lichen Sclerosus et Atrophicus C17.800.859.475.605 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Lichenoid Eruptions A chronic, atrophic skin disease characterized by white, angular, flat, well-defined, indurated papules with an erythematous halo and follicular, black, keratotic plugs. It is the most common cause of kraurosis vulvae in females and balanitis xerotica obliterans in males. It is called also white spot disease and Csillag's disease. (Dorland, 27th ed). Lichenoid Eruptions (93-94); Skin Diseases (66-92) N%N=Lichen Planus, Oral C07.465.397; C17.800.859.475.560.397 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Lichenoid Eruptions; Lichen Planus Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected (in a descending order of frequency). Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks (Wickham's striae). (Jablonski, Illustrated Dictionary of Dentistry). Lichen Planus (66-93); Mouth Diseases (66-93) N*N&8Lichen Planus C17.800.859.475.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Lichenoid Eruptions Lichen Planus, Oral An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a "saw-tooth" pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown. NNqLichen Nitidus C17.800.859.475.545 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Lichenoid Eruptions A chronic inflammatory disease characterized by shiny, flat-topped, usually flesh-colored micropapules no larger than the head of a pin. Lesions are localized in the early stages, found chiefly on the lower abdomen, penis, and inner surface of the thighs. Distribution may become generalized as the disease progresses. N΁NsLicensure, Pharmacy N03.706.110.510.560; N05.700.200.450.625 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Licensure Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Licensure The granting of a license to practice pharmacy. Pharmacy (66-67) N.;Licensure, Nursing N03.706.110.510.490; N05.700.200.450.550 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Licensure Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Licensure The granting of a license to practice the profession of nursing. N.OLicensure, Medical N03.706.110.510.410; N05.700.200.450.500 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Licensure Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Licensure The granting of a license to practice medicine. No.;Licensure, Hospital N03.706.110.510.290; N05.700.200.450.380 CLECHIOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Licensure Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Licensure The granting of a license to a hospital. N.4Licensure, Dental N03.706.110.510.180; N05.700.200.450.300 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Licensure Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Licensure The granting of a license to practice dentistry. Nו.<Licensure N03.706.110.510; N05.700.200.450 CLECHILJSNSTTDUT Accreditation; Certification Accreditation; Certification; Legislation Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing Licensure, Dental; Licensure, Hospital; Licensure, Medical; Licensure, Nursing; Licensure, Pharmacy Licensure, Dental; Licensure, Hospital; Licensure, Medical; Licensure, Nursing; Licensure, Pharmacy The legal authority or formal permission from authorities to carry on certain activities which by law or regulation require such permission. It may be applied to licensure of institutions as well as individuals. CLECHILJOGSNSTTDUT (N+ &"1Lice B01.131.617.564 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Pediculosis Invertebrates; Arthropods; Insects Anoplura (+ 1); Mallophaga Small, wingless, parasitic insects of the order Phthiraptera, composed of the suborders ANOPLURA (sucking lice), MALLOPHAGA (biting lice), and Rhynchophthirina (elephant-lice).  Nܲ(*#Libya Z01.058.266.513; Z01.586.500.460 EHEP Geographicals (Non MeSH); Africa; Africa, Northern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East NH &Library Technical Services L01.453.819; L01.583.782 CLECHILJMAOGSDSNSTTDUT Information Science; Information Services Information Science; Library Science Acquisition, organization, and preparation of library materials for use, including selection, weeding, cataloging, classification, and preservation. specific library or library science heading(66-75) N4 [<Library Surveys L01.583.564 CLECHILJMTSDSNSTTDUT Information Science; Library Science Collection and analysis of data pertaining to operations of a particular library, library system, or group of independent libraries, with recommendations for improvement and/or ordered plans for further development. N,Library Services L01.453.639; L01.583.464 CLECHILJMAOGSDSNSTTDUT Information Science; Information Services Information Science; Library Science Interlibrary Loans Interlibrary Loans Services offered to the library user. They include reference and circulation. specific library or library science heading(66-75) CLECHIISLJMAMTOGSDSNSTTDUT $Nu[,]<Library Science L01.583 CLECEDHILJMAMTOGSNSTTD Information Science Library Administration; Library Associations; Library Automation; Library Collection Development; Library Schools; Library Services (+ 1); Library Surveys; Library Technical Services Study of the principles and practices of library administration and services. CLECEDHIISLJMAMTOGSDSNSTTDUT  N/ \ Library Schools I02.783.388; L01.583.430 CLECHILJMAOGSDSNSTTDUT Education; Schools Information Science; Library Science Educational institutions for individuals specializing in the field of library science or information. NBvLibrary Collection Development L01.583.410 CLECHILJSDSNSTTDUT Information Science; Library Science Development of a library collection, including the determination and coordination of selection policy, assessment of needs of users and potential users, collection use studies, collection evaluation, identification of collection needs, selection of materials, planning for resource sharing, collection maintenance and weeding, and budgeting. Book Selection (66-90) N#$,Library Automation L01.583.400 CLECHILJSDSNSTTDUT Information Science; Library Science The use of automatic machines or processing devices in libraries. The automation may be applied to library administrative activities, office procedures, and delivery of library services to users. Automatic Data Processing (66-90); Automation (66-90); Libraries (66-90) N_,WLibrary Associations L01.583.390 CLECHILJMAOGSDSNSTTDUT Societies Information Science; Library Science N* ,Library Administration L01.583.363 CLECEDHIISLJMAMTSNSTTD Information Science; Library Science Planning, organizing, staffing, direction, and control of libraries. N,PLibraries, Nursing L01.346.596.663 CLECHILJMAOGSDSNSTTDUT Information Science; Information Centers; Libraries N=Libraries, Medical L01.346.596.563 CLECHILJMAOGSDSNSTTDUT Information Science; Information Centers; Libraries National Library of Medicine (U.S.) NK=+Libraries, Hospital L01.346.596.463; N02.278.354.600; N04.452.442.600 CLECHILJMAOGSDSNSTTDUT Information Science; Information Centers; Libraries Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Information centers primarily serving the needs of hospital medical staff and sometimes also providing patient education and other services. N9Libraries, Dental L01.346.596.363 CLECHILJMAOGSDSNSTTDUT Information Science; Information Centers; Libraries N_=Libraries L01.346.596 CLECHILJMAOGSDSNSTTDUT Information Services Information Science; Information Centers Libraries, Dental; Libraries, Hospital; Libraries, Medical (+ 1); Libraries, Nursing Collections of organized information for study and reference.  N 0eILibrarians M01.526.555 CLHILJPXSN Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Specialists in the management of a library or the services rendered by a library, bringing professional skills to administration, organization of material and personnel, interpretation of bibliothecal rules, the development and maintenance of the library's collection, and the provision of information services. Libraries (66-90) NVMeLibido F02.739.794.511 CLDEPHRE Instinct; Motivation; Sex Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory The psychic drive or energy associated with sexual instinct in the broad sense (pleasure and love-object seeking). It may also connote the psychic energy associated with instincts in general that motivate behavior. Np  !lLiberia Z01.058.290.190.425 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western NI _Liability, Legal I01.880.604.583.490; N03.706.535.547 ECHI Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Accountability and responsibility to another, enforceable by civil or criminal sanctions. Jurisprudence (66-90); Malpractice (68-90); Malpractice/legislation and jurisprudence (81-90) N*hmLi-Fraumeni Syndrome C04.700.600; C16.466.700.600 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Genes, p53 Neoplasms; Neoplastic Syndromes, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary Rare autosomal dominant syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites. A point mutation of the p53 tumor suppressor gene apparently predisposes family members who inherit it to develop certain cancers. Neoplasms (82-86); Neoplastic Syndromes, Hereditary (87-91); Syndrome (82-86)  N"L\LH D06.472.351.576.463; D06.472.734.525.343.463; D12.776.641.650.400; D14.600.600.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, LH Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins; Gonadotropins, Pituitary Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Gonadotropins, Pituitary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A small glycoprotein hormone secreted by the anterior pituitary. LH plays an important role in controlling ovulation and in controlling secretion of hormones by the ovaries and testes. N\FLeydig Cells A05.360.444.849.513; A06.407.312.782.513; A11.593 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Genitalia, Male; Testis Endocrine System (Non MeSH); Endocrine Glands; Gonads; Testis Cells Cells in the interstitial tissue of the testis that are believed to furnish the internal secretion of that gland. NL9*Leydig Cell Tumor C04.557.475.440 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue The most common nongerminal tumor of the testis, derived from the Leydig cells. It is rarely malignant. This tumor appears among 1-3% of testicular tumors and although they may be seen in children, the median age of appearance is 60 years. They are sometimes seen in women as ovarian tumors. Clinically, symptoms are usually related to the endocrine abnormalities induced by this tumor. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed). OX]Lewy Bodies A08.663.460; A11.368.600; A11.515.460; A11.671.460 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Parkinson Disease Nervous System; Neurons Cells; Cytoplasm Cells; Inclusion Bodies Cells; Neurons Intracytoplasmic, eosinophilic, round to elongated inclusions found in vacuoles of injured or fragmented neurons. The presence of Lewy bodies is the histological marker of the degenerative changes in Parkinson disease but they may be seen in other neurological conditions. They are typically found in the substantia nigra and locus coeruleus but they are also seen in the basal forebrain, hypothalamic nuclei, and neocortex. Cellular Inclusions (72-91); Cytoplasmic Granules (66-91)  O<*`DLewis Blood-Group System D24.611.216.705.230.544; G04.610.241.544; G09.188.229.544 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups CA-19-9 Antigen A group of dominantly and independently inherited antigens associated with the ABO blood factors. They are glycolipids present in plasma and secretions that may adhere to the erythrocytes. The phenotype Le(b) is the result of the interaction of the Le gene Le(a) with the genes for the ABO blood groups. ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR  O_A2Pi6Levulinic Acids D02.241.607.547 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids Aminolevulinic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR O 8H:Levothyroxine D06.472.931.812.370; D12.125.072.734.370 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones; Thyroxine Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Thyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine. Levo isomer of the thyroid hormone THYROXINE. It is used for replacement therapy in reduced or absent thyroid function. Thyroxine (66-90) O @.:Levorphanol D03.132.610.422.463; D03.549.686.485; D03.605.497.485; D15.040.150.450; D15.210.600.475 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Dextromethorphan Dextromethorphan Dextromethorphan A narcotic analgesic that may be habit-forming. It is nearly as effective orally as by injection. Oc::vLevonorgestrel D04.808.668.651.693.762.450; D06.597.799.734.450; D07.360.276.210.443.706.723.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes; Norgestrel Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic; Norgestrel Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic; Norgestrel (17 alpha)-(-)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one. A progestational hormone with actions similar to those of progesterone and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. Norgestrel (80-91) OY:]Levodopa D02.092.311.242.480; D12.125.072.573.400.500; D14.100.150.600.200.400; D15.090.050.495 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Dopa Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Phenylalanine; Dopa Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopa Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents The naturally occurring form of DOPA and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of parkinsonism and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Dopa (66-74) O `DLevocardia C14.240.400.701; C14.280.400.701; C16.131.240.400.701; C16.131.810.700 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Situs Inversus Location of heart in left hemithorax with apex pointing to the left, but with situs inversus of other viscera and defects of the heart, or corrected transposition of great vessels. OEPLLevobunolol D02.033.329.624.500; D02.092.063.624.500; D14.100.050.200.200.470; D16.050.850.440 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics (S)-5-(3-((1,1-Dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone. A nonselective beta-adrenoceptor antagonist used in the treatment of glaucoma. Amino Alcohols (66-71); Sympatholytics (66-71) O\:8Levivirus B04.123.205.600.500; B04.123.450.500; B04.123.691.600.500; B04.820.410.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Coliphages; Leviviridae Viruses; Bacteriophages; Leviviridae Viruses; Bacteriophages; RNA Phages; Leviviridae Viruses; RNA Viruses; Leviviridae A bacteriophage genus of the family LEVIVIRIDAE, whose infectivity is UV-resistant. O!  TbLeviviridae B04.123.205.600; B04.123.450; B04.123.691.600; B04.820.410 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Coliphages Viruses; Bacteriophages Viruses; Bacteriophages; RNA Phages Viruses; RNA Viruses Allolevivirus; Levivirus Allolevivirus; Levivirus Allolevivirus; Levivirus Allolevivirus; Levivirus A family of bacteriophages that infects enterobacteria, Caulobacter, and Pseudomonas. The genome consists of linear, positive-sense single-stranded RNA. O"DrLevamisole D03.383.374.480; D03.383.871.346; D17.050.515; D21.201.287.461; D24.611.062.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p.435-36). O%[:Levallorphan D03.132.610.422.413; D03.549.686.429; D03.605.497.429; D15.550.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Narcotic Antagonists An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, p683). O)L:4Leuprolide D06.472.709.429.480; D22.204.480 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones; Gonadorelin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 6-D-Leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamideluteinizing hormone-releasing factor (pig). A synthetic nonapeptide agonist analog of GONADORELIN. It is used in the treatment of advanced prostatic cancer, fibrocystic disease of the breast, and leiomyoma of the uterus. Antineoplastic Agents (84-91); Gonadorelin/analogs and derivatives (80-91) O-v&::WLeupeptins D08.373.745.535; D12.644.456.580 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides A group of acylated oligopeptides produced by Actinomycetes that function as protease inhibitors. They have been known to inhibit to varying degrees trypsin, plasmin, kallikrein, papain and the cathepsins. Oligopeptides (73-74) O0e&:Leukotrienes D02.241.081.436.213.100.450; D10.516.251.355.255.100.450; D17.350.050.175.450 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Leukotriene Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids Leukotriene A4; Leukotriene B4; SRS-A (+ 3) Leukotriene A4; Leukotriene B4; SRS-A (+ 3) Leukotriene A4; Leukotriene B4; SRS-A (+ 3) A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. Arachidonic Acids (79-88); Leukotrienes B (83-88); SRS-A (79-88) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (O2UBODLeukotriene E4 D02.241.081.436.213.100.450.855.470; D10.516.251.355.255.100.450.855.470; D17.350.050.175.450.725.425 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes; SRS-A Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes; SRS-A Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Leukotrienes; SRS-A (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid. A biologically active principle of SRS-A that is formed from LEUKOTRIENE D4 via a peptidase reaction that removes the glycine residue. The biological actions of LTE4 are similar to LTC4 and LTD4. (From Dictionary of Prostaglandins and Related Compounds, 1990). Arachidonic Acids (80-82); SRS-A/analogs and derivatives (83-93) O8mD MLeukotriene D4 D02.241.081.436.213.100.450.855.461; D10.516.251.355.255.100.450.855.461; D17.350.050.175.450.725.415 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes; SRS-A Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes; SRS-A Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Leukotrienes; SRS-A (R-(R*,S*-(E,E,Z,Z)))-N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-L-cysteinyl)glycine. One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990). SRS-A (82-93) O=mD #Leukotriene C4 D02.241.081.436.213.100.450.855.455; D10.516.251.355.255.100.450.855.455; D17.350.050.175.450.725.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes; SRS-A Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes; SRS-A Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Leukotrienes; SRS-A (R-(R*,S*-(E,E,Z,Z))))-N-(S-(1-(4-Carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-N-L-gamma-glutamyl-L-cysteinyl)glycine. The conjugation product of LEUKOTRIENE A4 and glutathione. It is the major arachidonic acid metabolite in macrophages and human mast cells as well as in antigen-sensitized lung tissue. It stimulates mucus secretion in the lung, and produces contractions of nonvascular and some vascular smooth muscle. (From Dictionary of Prostaglandins and Related Compounds, 1990). SRS-A (81-93) OBmD 4Leukotriene B4 D02.241.081.436.213.100.450.411; D10.516.251.355.255.100.450.411; D17.350.050.175.450.415 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Leukotrienes (S-(R*,S*-(E,Z,E,Z)))-5,12-Dihydroxy-6,8,10,14-eicosatetraenoic acid. The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990). Arachidonic Acids (67-82) OHaDLeukotriene A4 D02.241.081.436.213.100.450.405; D10.516.251.355.255.100.450.405; D17.350.050.175.450.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Leukotrienes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Leukotrienes (2S-(2 alpha,3 beta(1E,3E,5Z,8Z)))-3-(1,3,5,8-Tetradecatetraenyl)oxiranebutanoic acid. An unstable allylic epoxide, formed from the immediate precursor 5-HPETE via the stereospecific removal of a proton at C-10 and dehydration. Its biological actions are determined primarily by its metabolites, i.e., LEUKOTRIENE B4 and cysteinyl-leukotrienes. Alternatively, leukotriene A4 is converted into LEUKOTRIENE C4 by glutathione-S-transferase or into 5,6-di-HETE by the epoxide-hydrolase. (From Dictionary of Prostaglandins and Related Compounds, 1990). Arachidonic Acids (80-88); Leukotrienes (89-93) OL~aDp9Leukosis Virus, Avian B04.820.650.700.500; B04.909.574.807.720.500; B04.909.777.731.720.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, ALV-Related The type species of ALV-related retroviruses (RETROVIRUSES, ALV-RELATED) producing latent or manifest lymphoid leukosis in fowl. OQM'Leukosarcoma C04.557.337.801 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Lymphosarcoma accompanied by leukemia. OT[NJ.Leukorrhea C13.371.894.405 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases A whitish, viscid discharge from the vagina and uterine cavity. (Dorland, 27th ed). OUgN}fLeukoplakia, Oral C04.588.443.591.545; C04.834.512.513; C07.465.565.545 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms Neoplasms; Precancerous Conditions; Leukoplakia Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms Leukoplakia, Hairy Leukoplakia, Hairy Leukoplakia, Hairy A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY). Leukoplakia (66-69); Mouth Neoplasms (66-69)  OV=XA6Leukoplakia, Hairy C04.588.443.591.545.500; C04.834.512.513.500; C07.465.565.545.500 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Tongue, Hairy Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms; Leukoplakia, Oral Neoplasms; Precancerous Conditions; Leukoplakia; Leukoplakia, Oral Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms; Leukoplakia, Oral Epithelial hyperplasia of the oral mucosa associated with Epstein-Barr virus and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy. Leukoplakia, Oral (85-93)  OZ IXLeukoplakia C04.834.512 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Precancerous Conditions Leukoplakia, Oral (+ 1) A white patch on a mucous membrane that will not rub off. (Dorland, 27th ed). O]0X)bLeukopenia C15.378.553.546 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH) Agranulocytosis (+ 1); Lymphopenia (+ 1) O^vNo3Leukomalacia, Periventricular C10.228.140.300.550; C10.228.140.461.550; C14.907.253.612; C16.614.521.450 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalomalacia Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Infant, Premature, Diseases A disease of premature or newborn infants hypoxic and ischemic in nature and leading to infarction of brain white matter and cerebral ventricle enlargement. Cerebral Hemorrhage (66-86); Cerebral Ventricles (66-86); Encephalomalacia (66-86); Infant, Newborn (66-86); Infant, Premature, Diseases (66-86) O_"TLLeukoencephalopathy, Progressive Multifocal C02.839.550; C10.228.337.484 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Virus Diseases; Slow Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Rare demyelinating disease of the central nervous system which develops in immunocompromised patients secondary to lymphoproliferative disease, immunosuppressive therapy, autoimmune disorders, or AIDS. It is caused by the JC virus, a polyomavirus. Demyelinating Diseases (66-70) Oc1"N$Leukoedema, Oral C07.465.385 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases A disorder of the buccal mucosa resembling early leukoplakia, characterized by the presence of filmy opalescence of the mucosa in the early stages to a whitish gray cast with a coarsely wrinkled surface in the later stages, associated with intracellular edema of the spinous or malpighian layer. (Dorland, 27th ed). Mouth Diseases (66-71) Of%N/sLeukodystrophy, Metachromatic C10.228.140.276.511; C10.228.337.144.637; C18.452.648.556.641.803.594; C18.452.648.595.803.594 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cerebroside-Sulfatase Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebral Sclerosis, Diffuse Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases; Cerebral Sclerosis, Diffuse Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses A sphingolipidosis where there is defective desulfation of galactosyl-3-sulfate ceramide due to a defective enzyme cerebroside sulfatase (arylsulfatase A). The result is an accumulation of sulfatide in neural and non-neural tissues which manifests as mental deterioration and severe disturbances of the central nervous system. Oh|"hLFxLeukodystrophy, Globoid Cell C10.228.140.276.428; C10.228.337.144.512; C18.452.648.556.641.803.585; C18.452.648.595.803.585 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebral Sclerosis, Diffuse Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases; Cerebral Sclerosis, Diffuse Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses An inherited metabolic disorder of the nervous system, particularly the white matter. It is characterized histologically by a paucity of myelin and oligodendroglia, severe astrocytic gliosis, and massive infiltration with unique multinucleated globoid cells which are enriched in galactosylceramide. The primary genetic defect is a deficiency of galactosylceramide beta-galactosidase (galactosylceramidase). OmP"hLFLeukocytosis C15.378.553.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH) Leukemoid Reaction; Lymphocytosis Or_No(Leukocytes, Mononuclear A11.118.637.555; A15.145.229.637.555; A15.382.490.555 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes Lymphocytes (+ 20); Monocytes (+ 1) Lymphocytes (+ 20); Monocytes (+ 1) Lymphocytes (+ 20); Monocytes (+ 1) Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Leukocytes (66-87); Lymphocytes (66-87); Macrophages (66-87); Monocytes (66-87)  Os=*+`Leukocytes A11.118.637; A15.145.229.637; A15.382.490 CHCLCYDEENIMMEMIPAPHPSRARERISEULUSVI Phagocytosis Cells; Blood Cells Hemic and Immune Systems (Non MeSH); Blood; Blood Cells Hemic and Immune Systems (Non MeSH); Immune System Granulocytes (+ 3); Leukocytes, Mononuclear (+ 23) Granulocytes (+ 3); Leukocytes, Mononuclear (+ 23) Granulocytes (+ 3); Leukocytes, Mononuclear (+ 23) White blood cells. These include granular leukocytes (BASOPHILS, EOSINOPHILS, and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI $Ow 1(*Leukocyte Transfusion E02.095.135.140.425 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Lymphocyte Transfusion Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion; Blood Component Transfusion Lymphocyte Transfusion The transfer of leukocytes from a donor to a recipient or reinfusion to the donor. Blood Component Transfusion (92-93); Blood Transfusion (66-92); Leukocytes (66-76); Leukocytes/transplantation (73-92) $Oy$leLeukocyte Migration-Inhibitory Factors D24.611.350.480.428 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Protein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of leukocytes, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the leukocyte migration capillary tube technique (LMCT) and the leukocyte migration agarose technique (LMAT). Cell Migration Inhibition (71-73); Cell Movement (70-71); Lymphokines (74-79); Macrophage Migration Inhibitory Factor (74-79) O{,BwLeukocyte Disorders (Non MeSH) C15.378.553 Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Eosinophilia (+ 5); Infectious Mononucleosis; Leukocytosis (+ 2); Leukopenia (+ 4); Pelger-Huet Anomaly; Phagocyte Bactericidal Dysfunction (+ 3) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI O{%JPLeukocyte Count E01.223.459.107.595; G07.380.107.595 DEECISMTREVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count Physiology, General (Non MeSH); Cell Count; Blood Cell Count Lymphocyte Count (+ 2) Lymphocyte Count (+ 2) A count of the number of white blood cells per unit volume in venous blood. A differential leukocyte count measures the relative numbers of the different types of white cells. O*8Leukocyte Adhesion Deficiency Syndrome C20.673.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Receptors, Leukocyte-Adhesion; Antigens, CD18 Immunologic Diseases; Immunologic Deficiency Syndromes Rare, autosomal recessive disorder caused by deficiency of the beta 2 integrin receptors (RECEPTORS, LEUKOCYTE-ADHESION) comprising the CD11/CD18 family of glycoproteins. The syndrome is characterized by abnormal adhesion-dependent functions, especially defective tissue emigration of neutrophils, leading to recurrent infection. Immunologic Deficiency Syndromes (88-94); Receptors, Leukocyte-Adhesion/deficiency (88-90)  O5-N5?vgLeukocyte Adherence Inhibition Test E01.223.495.640; E05.478.640 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor. Immunity, Cellular (70-76); Leukocytes (66-76) O;*""8Leukocidins D24.185.926.123.545; D24.185.926.235.545 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Cytotoxins O.BLeukemoid Reaction C15.378.190.636.484; C15.378.553.475.428 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Leukocytosis A peripheral blood picture resembling that of leukemia or indistinguishable from it on the basis of morphologic appearance alone. (Dorland, 27th ed). O.NLeukemic Infiltration C04.697.645.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Leukemia; Neoplasm Invasiveness Neoplasms; Neoplastic Processes (Non MeSH); Neoplasm Invasiveness A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site. specific leukemia (66-92); specific neoplasm (66-92)  OfN&N?Leukemia, T-Cell, HTLV-II-Associated C02.782.815.483.480.350; C04.557.337.150.800.350; C04.557.337.415.700; C20.673.483.480.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; HTLV-BLV Infections; HTLV-II Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, T-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Hairy Cell Immunologic Diseases; Immunologic Deficiency Syndromes; HTLV-BLV Infections; HTLV-II Infections HTLV Infections (87-88); Leukemia (84-88); Leukemia, Hairy Cell (84-88); T Lymphocytes (84-88) O*dPsLeukemia, T-Cell, Chronic C04.557.337.150.800.250; C04.557.337.428.550.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, T-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Chronic Leukemia, Lymphocytic (77-88); T Lymphocytes (77-88) O6N?Leukemia, T-Cell, Acute C04.557.337.150.800.100; C04.557.337.428.511.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lymphoma, Lymphoblastic Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, T-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated HTLV Infections (87-88); Leukemia, Lymphoblastic (75-88); Leukemia, Lymphocytic (75-88); T Lymphocytes (75-88) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $O46NrPLeukemia, T-Cell C04.557.337.150.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH) Leukemia, T-Cell, Acute (+ 1); Leukemia, T-Cell, Chronic; Leukemia, T-Cell, HTLV-II-Associated HTLV Infections (87-88); Leukemia, Lymphocytic (75-88); T Lymphocytes (75-88) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  O{N|o]PLeukemia, Subleukemic C04.557.337.706 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Leukemia (66) ONJLeukemia, Radiation-Induced C04.557.337.650; C04.682.512; C21.866.733.345 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms, Second Primary; Radiation Leukemia Virus Neoplasms, Radiation-Induced Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Neoplasms; Neoplasms, Radiation-Induced Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries O 5N=!Leukemia, Promyelocytic, Acute C04.557.337.539.550.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Leukemia, Myelocytic (66-88); Leukemia, Myeloid (66-88) O$NBLeukemia, Prolymphocytic C04.557.337.428.550.675 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Chronic Leukemia, Lymphoblastic (67-88); Leukemia, Lymphocytic (66-88) O-NILeukemia, Pre-B-Cell C04.557.337.150.125.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, B-Cell Leukemia, Lymphoblastic (77-88); Leukemia, Lymphocytic (77-88); B Lymphocytes (77-88) ONeLeukemia, Plasmacytic C04.557.337.595; C20.683.515.695 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Leukemia (66) OC&NLeukemia, Null-Cell C04.557.337.150.550; C04.557.337.428.511.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic (77-88); Leukemia, Lymphocytic (77-88) O2NILeukemia, Nonlymphocytic, Acute C04.557.337.539.550; C15.604.515.561.550; C20.683.515.639.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Leukemia, Myeloid Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Leukemia, Myeloid Leukemia, Basophilic, Acute; Leukemia, Eosinophilic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Mast-Cell; Leukemia, Megakaryocytic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myelocytic, Acute; Leukemia, Promyelocytic, Acute Leukemia, Myelocytic, Acute Leukemia, Myelocytic, Acute Acute leukemia distinguished from acute lymphocytic leukemia (ALL) by the morphology of the marrow and blood leukemic cells. Cytoplasmic granules are usually present and the nucleus is usually large and irregular. ANLL is more common in adults than ALL and occurs at any age. Leukemia (66-88); Leukemia, Myeloblastic (66-88)  O%ENOIE:Leukemia, Neutrophilic, Chronic C04.557.337.539.250.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Chronic Leukemia, Myelocytic (66-88); Leukemia, Myeloid (66-88); Neutrophils (66-88) O%N[Leukemia, Myelomonocytic, Chronic C04.557.337.539.250.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Chronic Leukemia, Myelocytic (80-88); Leukemia, Myeloid (80-88) O5'NBLeukemia, Myelomonocytic, Acute C04.557.337.539.520 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid Leukemia (66-88); Leukemia, Myelocytic (81-88) O%N`8Leukemia, Myeloid, Philadelphia-Positive C04.557.337.539.510 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Philadelphia Chromosome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid Leukemia, Myelocytic (66-88); Leukemia, Myeloid (66-88); Philadelphia Chromosome (86-88) O.N`hLeukemia, Myeloid, Philadelphia-Negative C04.557.337.539.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Philadelphia Chromosome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid Leukemia, Myelocytic (66-88); Leukemia, Myeloid (66-88); Philadelphia Chromosome (86-88) O.N`hLeukemia, Myeloid, Chronic-Phase C04.557.337.539.250.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Chronic Leukemia, Myelocytic (72-88); Leukemia, Myeloid (72-88) O+&NBLeukemia, Myeloid, Chronic C04.557.337.539.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid Blast Crisis; Leukemia, Monocytic, Chronic; Leukemia, Myeloid, Aggressive-Phase; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myelomonocytic, Chronic; Leukemia, Neutrophilic, Chronic Leukemia, Myelocytic (66-88); Leukemia, Myeloid (66-88) O N`BLeukemia, Myeloid, Aggressive-Phase C04.557.337.539.250.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Chronic Leukemia, Myelocytic (72-88); Leukemia, Myeloid (72-88) O)NBLeukemia, Myeloid C04.557.337.539; C15.378.190.625.543; C15.604.515.561; C20.683.515.639 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myelodysplastic Syndromes Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Leukemia, Myeloid, Chronic (+ 6); Leukemia, Myeloid, Philadelphia-Negative; Leukemia, Myeloid, Philadelphia-Positive; Leukemia, Myelomonocytic, Acute; Leukemia, Nonlymphocytic, Acute (+ 8) Leukemia, Nonlymphocytic, Acute (+ 1) Leukemia, Nonlymphocytic, Acute (+ 1) Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors in the bone marrow and other sites. Leukemia, Myelocytic (66-88)  O2PN."Leukemia, Myelocytic, Acute C04.557.337.539.550.512; C15.604.515.561.550.512; C20.683.515.639.550.512 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Progressive, malignant disease of the myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate. Leukemia, Myelocytic (66) O!QNLeukemia, Monocytic, Chronic C04.557.337.539.250.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Chronic Leukemia, Monocytic (74-88) O"N!Leukemia, Monocytic, Acute C04.557.227.500; C04.557.337.539.550.484; C15.604.667.400.390.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Histiocytic Disorders, Malignant Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytic Disorders, Malignant Leukemia, Monocytic (66) OI IN}Leukemia, Mixed-Cell C04.557.337.150.500; C04.557.337.428.511.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic (77-88); Leukemia, Lymphocytic (77-88); B Lymphocytes (77-88); T Lymphocytes (77-88) Oľ2NLeukemia, Megakaryocytic, Acute C04.557.337.539.550.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Nonlymphocytic leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common. Hemorrhagic Thrombocythemia (66-86); Thrombocythemia, Hemorrhagic (86) O%NQLeukemia, Mast-Cell C04.557.337.440; C04.557.337.539.550.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute A disorder characterized by the presence of large numbers of tissue mast cells in the peripheral blood. Leukemia (66-86); Mast Cells (66-86) OR.N|.Leukemia, Lymphocytic, Chronic C04.557.337.428.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lymphoma, Small Lymphocytic Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic Leukemia, B-Cell, Chronic; Leukemia, Prolymphocytic; Leukemia, T-Cell, Chronic Leukemia, Lymphocytic (66-88)  O˄$N!d[#Leukemia, Lymphocytic, Acute, L2 C04.557.337.428.511.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic (75-88); Leukemia, Lymphocytic (75-88) O;'NILeukemia, Lymphocytic, Acute, L1 C04.557.337.428.511.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic (75-88); Leukemia, Lymphocytic (75-88) Oν'NILeukemia, Lymphocytic, Acute C04.557.337.428.511 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic Leukemia, B-Cell, Acute; Leukemia, CALLA-Positive; Leukemia, Lymphocytic, Acute, L1; Leukemia, Lymphocytic, Acute, L2; Leukemia, Mixed-Cell; Leukemia, Null-Cell; Leukemia, T-Cell, Acute (+ 1) Leukemia, Lymphoblastic (67-88); Leukemia, Lymphocytic (66-88) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  O?"NdIPLeukemia, Lymphocytic C04.557.337.428; C15.604.515.560; C20.683.515.528 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lymphatic Diseases Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Leukemia, Lymphocytic, Acute (+ 8); Leukemia, Lymphocytic, Chronic (+ 3) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  O9N YPLeukemia, Hairy Cell C04.557.337.415; C15.604.515.553; C20.683.515.517 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Leukemia, T-Cell, HTLV-II-Associated A neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of "hairy" or "flagellated" cells in the blood and bone marrow. Leukemia (66-77); Reticuloendotheliosis (66-77); Spleen/pathology (66-77); Splenomegaly (66-77) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $Oe9N ,tqPLeukemia, Feline C02.782.815.622; C04.557.337.385; C22.180.500 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Animal Diseases; Cat Diseases A neoplastic disease of cats frequently associated with feline leukemia virus infection. Cat Diseases (66-91); Leukemia/veterinary (66-91) O٣5Jh<Leukemia, Experimental C04.557.337.372; C04.619.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Neoplasms; Neoplasms, Experimental Avian Leukosis; Leukemia L1210; Leukemia L5178; Leukemia P388 Avian Leukosis; Leukemia L1210; Leukemia L5178; Leukemia P388 Leukemia induced experimentally by administration of various leukemogenic agents, viruses, radiation or transplantation. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVI  O"LqNLeukemia, Erythroblastic, Acute C04.557.337.539.550.325; C15.378.190.636.276 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. Erythremic Myelosis (66-67) OT%2N!Leukemia, Eosinophilic, Acute C04.557.337.539.550.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Eosinophils (66-88); Leukemia (66-88); Leukemia, Myeloblastic (66-88) O#NSLeukemia, CALLA-Positive C04.557.337.428.511.225 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Membrane Metallo-Endopeptidase Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Acute leukemia in which lymphocytes are positive for the common acute lymphoblastic leukemia antigen (CALLA). Antigens, Neoplasm (77-88); Leukemia, Lymphoblastic/immunology (77-88); Leukemia, Lymphocytic/immunology (77-88)  ON#Leukemia, Basophilic, Acute C04.557.337.539.550.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Nonlymphocytic, Acute Basophils (66-88); Leukemia (66-88); Leukemia, Myeloblastic (66-88) O!NQLeukemia, B-Cell, Chronic C04.557.337.150.125.250; C04.557.337.428.550.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, B-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Chronic Leukemia, Lymphoblastic (77-88); Leukemia, Lymphocytic (77-88); B Lymphocytes (77-88) O6NeLeukemia, B-Cell, Acute C04.557.337.150.125.100; C04.557.337.428.511.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, B-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute Leukemia, Lymphoblastic (77-88); Leukemia, Lymphocytic (77-88); B Lymphocytes (77-88) O6NeLeukemia, B-Cell C04.557.337.150.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH) Leukemia, B-Cell, Acute; Leukemia, B-Cell, Chronic; Leukemia, Pre-B-Cell Leukemia, Lymphocytic (66-88); B Lymphocytes (73-88) ON|U?Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated C02.782.815.483.470.300; C04.557.337.150.800.100.300; C04.557.337.428.511.800.300; C20.673.483.470.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; HTLV-BLV Infections; HTLV-I Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia by Immunologic Marker (Non MeSH); Leukemia, T-Cell; Leukemia, T-Cell, Acute Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Lymphocytic; Leukemia, Lymphocytic, Acute; Leukemia, T-Cell, Acute Immunologic Diseases; Immunologic Deficiency Syndromes; HTLV-BLV Infections; HTLV-I Infections HTLV Infections (87-88); Leukemia, Lymphoblastic (83-88); Leukemia, Lymphocytic (83-88); T Lymphocytes (83-88) O:pP>Leukemia Viruses, Murine B04.820.650.730.730.900.500; B04.909.574.807.730.730.900.500; B04.909.777.731.730.730.900.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine Abelson Leukemia Virus; AKR Virus; Friend Virus; Gross Virus; Mink Cell Focus-Inducing Viruses; Moloney Leukemia Virus; Radiation Leukemia Virus; Rauscher Virus; Spleen Focus-Forming Viruses Abelson Leukemia Virus; AKR Virus; Friend Virus; Gross Virus; Mink Cell Focus-Inducing Viruses; Moloney Leukemia Virus; Radiation Leukemia Virus; Rauscher Virus; Spleen Focus-Forming Viruses Abelson Leukemia Virus; AKR Virus; Friend Virus; Gross Virus; Mink Cell Focus-Inducing Viruses; Moloney Leukemia Virus; Radiation Leukemia Virus; Rauscher Virus; Spleen Focus-Forming Viruses Species of mammalian type C retroviruses (RETROVIRUSES TYPE C, MAMMALIAN) producing leukemia in mice. It is commonly induced by injecting filtrates of propagable tumors into newborn mice. The Gross strain (GROSS VIRUS) occurs spontaneously in inbred mice, but none of the other strains occurs naturally. OebLeukemia Virus, Gibbon Ape B04.820.650.730.730.510; B04.820.650.805.510; B04.909.574.807.730.730.510; B04.909.574.807.805.510; B04.909.777.731.730.730.510; B04.909.777.731.805.510 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; RNA Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, Simian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, Simian A species of mammalian type C retrovirus (RETROVIRUSES TYPE C, MAMMALIAN) causing leukemia in the gibbon ape. Natural transmission is by contact. OB!Leukemia Virus, Feline B04.820.650.730.730.500; B04.909.574.807.730.730.500; B04.909.777.731.730.730.500 CHCLDEENGDGEIMIPMEPHPYREUL Sarcoma Virus, Feline Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian A species of mammalian type C retrovirus (RETROVIRUSES TYPE C, MAMMALIAN) causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. Several cellular oncogenes confer on FeLV the ability to induce sarcomas (see also SARCOMA VIRUS, FELINE). Retroviridae (66-72)  OY<Leukemia Virus, Bovine B04.820.650.400.600; B04.909.574.807.400.600; B04.909.777.731.400.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; HTLV-BLV Viruses A species of HTLV-BLV VIRUSES that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis. OfM Leukemia P388 C04.557.337.372.782; C04.619.531.782 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Experimental Neoplasms; Neoplasms, Experimental; Leukemia, Experimental An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. Leukemia, Experimental (66-79); Neoplasms, Experimental (66-79) P*L|JLeukemia L5178 C04.557.337.372.602; C04.619.531.602 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Experimental Neoplasms; Neoplasms, Experimental; Leukemia, Experimental An experimental lymphocytic leukemia of mice. Leukemia, Experimental (66-79); Lymphoma (66-79) P*L7:Leukemia L1210 C04.557.337.372.594; C04.619.531.594 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Experimental Neoplasms; Neoplasms, Experimental; Leukemia, Experimental P*LLeukemia by Immunologic Marker (Non MeSH) C04.557.337.150 Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Leukemia, B-Cell (+ 3); Leukemia, Mixed-Cell; Leukemia, Null-Cell; Leukemia, T-Cell (+ 4) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI P2JlPLeukemia C04.557.337 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Leukemic Infiltration Myeloproliferative Disorders Neoplasms; Neoplasms by Histologic Type (Non MeSH) Enzootic Bovine Leukosis; Leukemia by Immunologic Marker (Non MeSH) (+ 11); Leukemia, Experimental (+ 4); Leukemia, Feline; Leukemia, Hairy Cell (+ 1); Leukemia, Lymphocytic (+ 13); Leukemia, Mast-Cell; Leukemia, Myeloid (+ 19); Leukemia, Plasmacytic; Leukemia, Radiation-Induced; Leukemia, Subleukemic; Leukosarcoma BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $PS N!=vPLeukapheresis E02.095.160.570; E02.110.285.570; E05.909.262.363.285.570 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Cytapheresis Therapeutics; Blood Component Removal; Cytapheresis Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Cell Separation; Cytapheresis The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor. Blood Transfusion (66-78); Cell Separation (72-78); Leukocytes (66-78) P )A"ULeucyl-beta-Naphthylamidase D08.586.277.656.081.150.400; D08.586.277.656.081.511.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases; Amino Acid Naphthylamidases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases; Leucine Aminopeptidase Frequently used to test for leucine aminopeptidase (EC 3.4.11.1) activity; hydrolyzes naphthylamides of leucine. Leucine Aminopeptidase (74) P >F4!Leucyl T RNA Synthetase D08.586.464.136.480 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates leucine with its specific transfer RNA. EC 6.1.1.4. Amino Acyl T RNA Synthetases (72-74); Leucine (72-74) P>Ft]BLeucovorin D03.438.733.631.400.800.350.450; D11.786.708.328.850.350.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins; Folic Acid; Tetrahydrofolates; Formyltetrahydrofolates Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Folic Acid; Tetrahydrofolates; Formyltetrahydrofolates N-(4-(((2-Amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl methyl)amino)benzoyl)glutamic acid. The active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. PBD:MLeuconostoc B03.510.400.800.511 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae A genus of gram-positive, facultatively anaerobic bacteria whose growth is dependent on the presence of a fermentable carbohydrate. It is nonpathogenic to plants and animals, including humans. P1"SLeucomycins D20.085.115.362 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Josamycin; Kitasamycin; Spiramycin; Tylosin An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities. Aminoglycosides (74-75); Antibiotics (70-75); Lactones (73-75) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $P:D5 K<Leucogenenol D04.615.885.511 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Alcohols (71-72); Cyclohexanes (71-72); Penicillium (66-72); Spiro Compounds (71-72) Pf:efLeucine Zippers G05.331.599.056.490; G06.184.599.056.490 DEGEIMPHRE DNA-Binding Proteins Genetics; Genetics, Biochemical; Molecular Sequence Data; Amino Acid Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Amino Acid Sequence Domains in DNA-binding proteins that contain amino acid sequences that show periodic arrays of leucine residues. These residues exist in an alpha-helical conformation, with the leucine side chains extending from one alpha helix interdigitating with those displayed from a similar alpha helix of a second polypeptide, facilitating dimerization. Amino Acid Sequence (89-90); DNA-Binding Proteins (89-90); Molecular Sequence Data (89-90)  P.lLeucine Aminopeptidase D08.586.277.656.081.511 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases Leucyl-beta-Naphthylamidase P6F}Leucine D12.125.142.441; D12.125.070.637 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Branched-Chain Pq &FLettuce B06.510.956.400; J01.341.956.676 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables Any of the various plants of the genus Lactuca, especially L. sativa, cultivated for its edible leaves. (From American Heritage Dictionary, 2d ed). Plants, Edible (66-94) P  &4tLetterer-Siwe Disease C15.604.667.400.400.570 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytosis, Langerhans-Cell Acute, disseminated, rapidly progressive form of Langerhans-cell histiocytosis. P"N[Lethal Dose 50 G12.602 Chemical, Pharmacologic Phenomena (Non MeSH) specific drug/toxicity (66-70) P$4 4%Lesotho Z01.058.290.175.400 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern P$ `Lesch-Nyhan Syndrome C10.228.140.163.551; C10.496.509; C18.452.648.798.594; F03.709.346.508 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypoxanthine Phosphoribosyltransferase Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Mental Retardation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Purine-Pyrimidine Metabolism, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An x-linked disease caused by a deficiency of an enzyme of purine metabolism, hypoxanthine phosphoribosyltransferase, and characterized by physical and mental retardation, hyperuricemia, self-mutilation, and choreoathetosis. Athetosis (66-70); Mental Retardation (66-70); Purine-Pyrimidine Metabolism, Inborn Errors (66-70); Self Mutilation (66-70)  P%tPL+Leriche's Syndrome C14.907.109.661; C14.907.137.427 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aortic Diseases Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases A syndrome caused by obstruction of the terminal aorta. It usually occurs in males and is characterized by fatigue in the hips, thighs, or calves on exercising, absence of pulsation in the femoral arteries, impotence, and often pallor and coldness of the lower limbs. (From Dorland, 27th ed). P)&N[Leptothrix B03.440.400.425.485; B03.800.427 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Sheathed Bacteria (Non MeSH) A genus of gram-negative, rod-shaped bacteria found in fresh or polluted waters. Its organisms commonly occur in chains within a sheath. The sheath has a tendency to become covered with ferric or manganic oxides. P,P&"Leptospirosis C01.252.400.511; C01.252.847.511 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections Weil's Disease Weil's Disease Infections with bacteria of the genus LEPTOSPIRA. P.v&P$<Leptospiraceae B03.440.400.425.475; B03.851.475 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Spirochaetales Leptospira (+ 2) Leptospira (+ 2) A family of bacteria consisting of flexible helical cells exhibiting a right-handed conformation. It consists of a single genus, LEPTOSPIRA. P0^&"*Leptospira interrogans B03.440.400.425.475.475.400; B03.851.475.475.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Leptospiraceae; Leptospira Bacteria; Spirochaetales; Leptospiraceae; Leptospira A genus of question mark-shaped aerobic spirochetes, which includes two formerly recognized genera: the parasitic L. icterohemorrhagiae and the saprophytic L. biflexa. P2N6"Leptospira canicola B03.440.400.425.475.475.280; B03.851.475.475.280 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Leptospiraceae; Leptospira Bacteria; Spirochaetales; Leptospiraceae; Leptospira A serological group of LEPTOSPIRA found in dogs. P46"<Leptospira B03.440.400.425.475.475; B03.851.475.475 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Leptospiraceae Bacteria; Spirochaetales; Leptospiraceae Leptospira canicola; Leptospira interrogans Leptospira canicola; Leptospira interrogans A genus of aerobic, helical spirochetes, some species of which are pathogenic, others free-living or saprophytic. P66."dLeprosy, Tuberculoid C01.252.410.040.552.386.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Leprosy A principal or polar form of LEPROSY in which the skin lesions are few and are sharply demarcated. Peripheral nerve involvement is pronounced and may be severe. Unlike lepromatous leprosy (LEPROSY, LEPROMATOUS), the lepromin test is positive. Tuberculoid leprosy is rarely a source of infection to others. Leprosy (66-88) P8iPhLeprosy, Lepromatous C01.252.410.040.552.386.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Leprosy A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage. Leprosy (66-88) P;NPtLeprosy, Borderline C01.252.410.040.552.386.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Leprosy A form of LEPROSY in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms. Leprosy (66-88) P>?PLeprosy C01.252.410.040.552.386 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Leprostatic Agents Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections Leprosy, Borderline; Leprosy, Lepromatous; Leprosy, Tuberculoid A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.  P@ PJ Leprostatic Agents D20.661 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Mycobacterium leprae; Leprosy Anti-Infective Agents Clofazimine; Dapsone (+ 1); Rifampin; Thalidomide Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions. Anti-Infective Agents (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (PCW 8$>#:Lepromin D24.611.216.161.386 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial PEv 6Leporipoxvirus B04.280.650.160.500; B04.909.204.210.600; B04.909.204.783.160.500; B04.909.574.204.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses Fibroma Virus, Rabbit; Myxoma Virus Fibroma Virus, Rabbit; Myxoma Virus Fibroma Virus, Rabbit; Myxoma Virus Fibroma Virus, Rabbit; Myxoma Virus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, consisting of ether-sensitive viruses of leporids and squirrels. They commonly cause tumors and are usually transmitted mechanically by arthropods. MYXOMA VIRUS is the type species. Poxviridae (89-93)  PFm`MLepidoptera B01.131.617.561 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Butterflies; Moths (+ 3) A large order of insects comprising the butterflies and moths. Insects (66-74)  PJP(* LLeper Colonies N02.278.524 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Residential treatment centers for individuals with leprosy. PKoLFLentiviruses, Ovine-Caprine B04.820.650.589.600; B04.909.777.731.589.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus Arthritis-Encephalitis Virus, Caprine; Visna-Maedi Virus Arthritis-Encephalitis Virus, Caprine; Visna-Maedi Virus A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in sheep and goats. PL` 2Lentiviruses, Feline B04.820.650.589.530; B04.909.777.731.589.530 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus Immunodeficiency Virus, Feline Immunodeficiency Virus, Feline A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cats. PN2FLentiviruses, Equine B04.820.650.589.520; B04.909.777.731.589.520 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus Infectious Anemia Virus, Equine Infectious Anemia Virus, Equine A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in horses. PP2JLentiviruses, Bovine B04.820.650.589.500; B04.909.777.731.589.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus Immunodeficiency Virus, Bovine Immunodeficiency Virus, Bovine A subgenus of LENTIVIRUS comprising viruses that produce multi-organ disease with long incubation periods in cattle. PR2FLentivirus Infections C02.782.815.616 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections Equine Infectious Anemia; Feline Acquired Immunodeficiency Syndrome; HIV Infections (+ 6); Pneumonia, Progressive Interstitial, of Sheep; Simian Acquired Immunodeficiency Syndrome; Visna Virus diseases caused by the Lentivirus genus. They are multi-organ diseases characterized by long incubation periods and persistent infection. Retrovirus Infections (81-90)  PTzPW#Lentivirus B04.820.650.589; B04.909.777.731.589 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae Immunodeficiency Viruses, Primate (+ 4); Lentiviruses, Bovine (+ 1); Lentiviruses, Equine (+ 1); Lentiviruses, Feline (+ 1); Lentiviruses, Ovine-Caprine (+ 2) Immunodeficiency Viruses, Primate (+ 4); Lentiviruses, Bovine (+ 1); Lentiviruses, Equine (+ 1); Lentiviruses, Feline (+ 1); Lentiviruses, Ovine-Caprine (+ 2) A genus of the family RETROVIRIDAE consisting of non-oncogenic retroviruses that produce multi-organ diseases characterized by long incubation periods and persistent infection. Lentiviruses are unique in that they contain open reading frames (ORFs) between the pol and env genes and in the 3' env region. Visna Virus (79-90)  PW*yzbLentinan D09.203.698.490 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Polysaccharide isolated from the edible mushroom Lentinus edodes, of which the exact composition unknown. It has been proposed as an antineoplastic agent. Polysaccharides (72-74) P[  F^Lentigo C17.800.621.430.530.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hyperpigmentation; Melanosis Peutz-Jeghers Syndrome Small circumscribed melanoses resembling, but differing histologically from, freckles. The concept includes senile lentigo ('liver spots') and nevoid lentigo (nevus spilus, lentigo simplex) and may also occur in association with multiple congenital defects or congenital syndromes (e.g., Peutz-Jeghers syndrome). P\ NeLenses, Intraocular E04.659.600; E04.792.600; E07.450.570; E07.532.570; E07.858.565.650 AECLCTECHIISMIMONUPSPXRHSNSTTDUTVEVI Cataract Extraction Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Eye (Non MeSH) Equipment and Supplies; Implants, Artificial Equipment and Supplies; Lenses Equipment and Supplies; Surgical Equipment; Prosthesis Artificial implanted lenses, their insertion, or fixation. Cataract Extraction (66-78); Lenses (66-78); Prosthesis (66-78)  P_hO(EMLenses E07.532 AECLCTECHISDSNSTTDUTVE Optics Equipment and Supplies Contact Lenses (+ 2); Eyeglasses; Lenses, Intraocular Pieces of glass or other transparent materials used for magnification or increased visual acuity. AECLCTECHIISMIMONUPSPXRHSDSNSTTDUTVEVI $Pa   Bs*Lens, Crystalline A09.371.509 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Aphakia Sense Organs; Eye Lens Capsule, Crystalline; Lens Cortex, Crystalline; Lens Nucleus, Crystalline Pc: \Lens Subluxation C11.510.598 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Lens Diseases Ectopia Lentis Incomplete rupture of the zonule with the displaced lens remaining behind the pupil. In dislocation, or complete rupture, the lens is displaced forward into the anterior chamber or backward into the vitreous body. When congenital, this condition is known as ECTOPIA LENTIS. Eye Diseases (66-77); Eye Injuries (66-77); Lens, Crystalline (66-77)  Pd"L#AULens Nucleus, Crystalline A09.371.509.670 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Lens, Crystalline The core of the crystalline lens, surrounded by the cortex. Lens, Crystalline (66-82) Pf:.ILens Diseases C11.510 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Aphakia (+ 1); Cataract; Lens Subluxation (+ 1) Eye Diseases (66-77); Lens, Crystalline (66-77) Pg N=:Lens Cortex, Crystalline A09.371.509.225 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Lens, Crystalline The portion of the crystalline lens surrounding the nucleus and bound anteriorly by the epithelium and posteriorly by the capsule. It contains lens fibers and amorphous, intercellular substance. Lens, Crystalline (66-82) Ph:.Lens Capsule, Crystalline A09.371.509.155 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Lens, Crystalline The noncellular outer covering of the crystalline lens, secreted by the embryonic anterior and posterior epithelium. The embryonic posterior epithelium later disappears. Lens, Crystalline (66-82) Pj:.Length of Stay N02.421.589.473.593 ECLJSNTD Hospitalization Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization The period of confinement of a patient to a hospital or other health facility. Hospitalization (66-68)  Pl2 `Lemuridae B02.649.801.700.508 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Strepsirhini Lemur A family of the order PRIMATES, suborder Strepsirhini (PROSIMII), containing four genera which inhabit Madagascar and the Comoro Island. Most of the lemurs prefer wooded areas. The four genera are Hapalemur, LEMUR, Lepilemur, and Varecia. Pm (6 Lemur B02.649.801.700.508.490 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Strepsirhini; Lemuridae A genus of the family Lemuridae consisting of five species: L. catta (ring-tailed lemur), L. fulvus, L. macaco (acoumba or black lemur), L. mongoz (mongoose lemur), and L. variegatus (white lemur). Most members of this genus occur in forested areas on Madagascar and the Comoro Islands. Poz (CULeisure Activities I03.450 CLECPX Human Activities (Non MeSH) Holidays; Recreation (+ 28); Relaxation (+ 1) Voluntary use of free time for activities outside the daily routine. Hobbies (66-69); Recreation (66-69) AECLECEDHIINLJPHPXSNSTTD $Pq  ":S,Leishmaniasis, Visceral C03.752.700.500.508.510 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Leishmaniasis A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. PrP~Leishmaniasis, Mucocutaneous C03.752.700.500.508.400.385; C03.858.560.400.385; C17.800.838.775.560.400.385 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Leishmaniasis; Leishmaniasis, Cutaneous Parasitic Diseases; Skin Diseases, Parasitic; Leishmaniasis; Leishmaniasis, Cutaneous Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic; Leishmaniasis; Leishmaniasis, Cutaneous A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms. Pu!UPLeishmaniasis, Diffuse Cutaneous C03.752.700.500.508.400.350; C03.858.560.400.350; C17.800.838.775.560.400.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Leishmaniasis; Leishmaniasis, Cutaneous Parasitic Diseases; Skin Diseases, Parasitic; Leishmaniasis; Leishmaniasis, Cutaneous Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic; Leishmaniasis; Leishmaniasis, Cutaneous A form of LEISHMANIASIS, CUTANEOUS caused by Leishmania aethiopica in Ethiopia and Kenya, L. pifanoi in Venezuela, L. braziliensis in South America, and L. mexicana in Central America. This disease is characterized by massive dissemination of skin lesions without visceral involvement. Leishmaniasis (66-91) Pz&UPKLeishmaniasis, Cutaneous C03.752.700.500.508.400; C03.858.560.400; C17.800.838.775.560.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Leishmaniasis Parasitic Diseases; Skin Diseases, Parasitic; Leishmaniasis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic; Leishmaniasis Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Mucocutaneous Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Mucocutaneous Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Mucocutaneous An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes. Leishmaniasis (66-91)  P~IPYLeishmaniasis C03.752.700.500.508; C03.858.560; C17.800.838.775.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections Parasitic Diseases; Skin Diseases, Parasitic Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic Leishmaniasis, Cutaneous (+ 2); Leishmaniasis, Visceral Leishmaniasis, Cutaneous (+ 2) Leishmaniasis, Cutaneous (+ 2) A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). P =P&Leishmania tropica B01.841.750.443.950.450.868.488.680 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and rodents. This taxonomic complex includes species which cause a disease called Oriental sore which is a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Leishmania (66-85) P'&4Leishmania mexicana B01.841.750.443.950.450.868.488.410 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals including rodents. The Leishmania mexicana complex causes both cutaneous (LEISHMANIASIS, CUTANEOUS) and diffuse cutaneous leishmaniasis (LEISHMANIASIS, DIFFUSE CUTANEOUS) and includes the subspecies amazonensis, garnhami, mexicana, pifanoi, and venezuelensis. L. m. mexicana causes chiclero ulcer, a form of cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) in the New World. The sandfly, Lutzomyia, appears to be the vector. Leishmania (66-85) Pa'&QLeishmania major B01.841.750.443.950.450.868.488.405 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Transmission is by Phlebotomus sandflies. Leishmania (66-85); Leishmania tropica (86-93) P'&8Leishmania infantum B01.841.750.443.950.450.868.488.325 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). Human infections are confined almost entirely to children. This parasite is commonly seen in dogs, other Canidae, and porcupines with humans considered only an accidental host. Transmission is by Phlebotomus sandflies. Leishmania (80-85); Leishmania donovani (86-93) P'&9Leishmania guyanensis B01.841.750.443.950.450.868.488.285 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals and causes mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS). Transmission is by Lutzomyia sandflies. Leishmania (76-85); Leishmania braziliensis (86-93) P'&=Leishmania enriettii B01.841.750.443.950.450.868.488.240 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania leishmania that has been found as a natural infection of the Brazilian guinea pig. Its host-tissue relationship is, in general, comparable to that of L. braziliensis. Leishmania (78-85); Leishmania mexicana (86-93) PT'&9Leishmania donovani B01.841.750.443.950.450.868.488.230 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (66-85) P'&Leishmania braziliensis B01.841.750.443.950.450.868.488.080 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Leishmania A parasitic hemoflagellate of the subgenus Leishmania viannia that infects man and animals. It causes cutaneous (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), and mucocutaneous leishmaniasis (LEISHMANIASIS, MUCOCUTANEOUS) depending on the subspecies of this organism. The sandfly, Lutzomyia, is the vector. The Leishmania braziliensis complex includes the subspecies braziliensis and peruviana. Uta, a form of cutaneous leishmaniasis in the New World, is caused by the subspecies peruviana. Leishmania (66-85) P'&ZLeishmania B01.841.750.443.950.450.868.488 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina Leishmania braziliensis; Leishmania donovani; Leishmania enriettii; Leishmania guyanensis; Leishmania infantum; Leishmania major; Leishmania mexicana; Leishmania tropica A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi. PR#&zLeiomyosarcoma C04.557.450.590.455; C04.557.450.795.455 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed). P.XLeiomyomatosis C04.557.450.590.450.465 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Leiomyoma The state of having multiple leiomyomas throughout the body. (Stedman, 25th ed). Leiomyoma (66-93) PTNbLeiomyoma, Epithelioid C04.557.450.590.450.455 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Leiomyoma A relatively rare smooth muscle tumor found most frequently in the wall of the gastrointestinal tract, especially in the stomach. It is similar to other smooth muscle tumors but may become very large and hemorrhage and exhibit small cystic areas. Simple excision is almost always curative. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Leiomyoma (66-93) PVLeiomyoma C04.557.450.590.450 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue Angiomyoma; Leiomyoma, Epithelioid; Leiomyomatosis A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the uterus and the gastrointestinal tract. They can occur in the skin and subcutaneous tissues and probably arise from the smooth muscle of small blood vessels in these tissues. They are treated by simple excision. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed.). PF V;Leigh Disease C10.228.140.163.535; C18.452.648.202.810.444 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Pyruvate Metabolism, Inborn Errors A disease of pyruvate metabolism manifesting in infancy with psychomotor retardation, dysphagia, hypotonia, ataxia, weakness, external ophthalmoplegia, vision loss, hearing loss, and convulsions. It was described by Leigh in 1951 and is now thought to be an inherited enzyme defect. Brain Diseases (66-84); Encephalomalacia (66-84); Pyruvate Carboxylase/deficiency (75-84) P2L6GiLegumes B06.510.570; B06.560.546; J01.341.956.570 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants, Edible Plants; Plants, Edible Plants; Plants, Medicinal Technology, Industry, Agriculture (Non MeSH); Food; Vegetables Alfalfa; Peanuts; Peas; Soybeans Acacia; Cassia; Glycyrrhiza Peanuts; Peas; Soybeans The large family of plants, Leguminosae, including many with edible parts. Most species harbor nitrogen-fixing bacteria on their roots. Several species, like the vetches, cause LATHYRISM, FAVISM, and other forms of poisoning of cattle or people. Other species yield useful materials like gums from ACACIA and various lectins like PHYTOHEMAGGLUTININ from Phaseolus.  P. 14hLegislation, Veterinary N03.706.615.686 CLECHIOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations, pertaining to the field of veterinary medicine, proposed for enactment or enacted by a legislative body. Po`Legislation, Pharmacy N03.706.615.615 CLECHIOGSNSTTDUT Pharmacy Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations, pertaining to the field of pharmacy, proposed for enactment or enacted by a legislative body. Pharmacy (66-67)  P `Legislation, Nursing N03.706.615.544 CLECHIOGSNSTTDUT Nursing Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations, pertaining to the field of nursing, proposed for enactment by a legislative body. P@ `{Legislation, Medical N03.706.615.473 CLECHIOGSNSTTDUT Medicine Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations, pertaining to the field of medicine, proposed for enactment or enacted by a legislative body. P `Legislation, Hospital N03.706.615.420 CLECHIOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations concerning hospitals, which are proposed for enactment or enacted by a legislative body. P`Legislation, Food N03.706.615.412 CLECHIOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations concerned with industrial processing and marketing of foods. Legislation, Drug (75-78) P.``Legislation, Drug I01.880.604.605; N03.706.615.402 CLECHIOGSNSTTDUT Social Sciences; Sociology; Social Control, Formal Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Drug and Narcotic Control (+ 1) Drug and Narcotic Control Laws concerned with manufacturing, dispensing, and marketing of drugs. Legislation, Medical (66-67) CLECHILJMAMTOGSNSTTDUT $Pq&FS"Legislation, Dental N03.706.615.331 CLECHIOGSNSTTDUT Dentistry Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Laws and regulations pertaining to the field of dentistry, proposed for enactment or recently enacted by a legislative body. P` `Legislation N03.706.615 CLECHIOGSNSTTDUT Licensure Economics, Organizations, Control (Non MeSH); Social Control, Formal Antitrust Laws; Legislation, Dental; Legislation, Drug (+ 1); Legislation, Food; Legislation, Hospital; Legislation, Medical; Legislation, Nursing; Legislation, Pharmacy; Legislation, Veterinary The enactment of laws and ordinances and their regulation by official organs of a nation, state, or other legislative organization. It refers also to health-related laws and regulations in general or for which there is no specific heading. CLECHILJMAMTOGSNSTTDUT $P QLegionnaires' Disease C01.252.400.500.501; C08.730.382.380 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Legionellosis Respiratory Tract Diseases; Respiratory Tract Infections; Legionellosis An acute, sometimes fatal, pneumonia-like bacterial infection characterized by high fever, malaise, muscle aches, respiratory disorders and headache. It is named for an outbreak at the 1976 Philadelphia convention of the American Legion. Bacterial Infections (76-78); Disease Outbreaks (76-78) P›*PBLegionellosis C01.252.400.500; C08.730.382 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Respiratory Tract Diseases; Respiratory Tract Infections Legionnaires' Disease Legionnaires' Disease Infections with bacteria of the genus LEGIONELLA. Bacterial Infections (72-86); Legionella (81-86); Legionnaires' Disease (78-86); Pneumonia (66-86)  Pŀ"P2<uLegionellaceae B03.440.400.425.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Legionella (+ 1) A family of gram-negative, aerobic bacteria that do not form endospores or microcysts. It contains one genus, LEGIONELLA. P"Legionella pneumophila B03.440.400.425.450.450.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Legionellaceae; Legionella A species of gram-negative, aerobic bacteria that is the causative agent of LEGIONNAIRES' DISEASE. It has been isolated from numerous environmental sites as well as from human lung tissue, respiratory secretions, and blood. Bacteria (78-80); Legionella (81-91) P`"-Legionella B03.440.400.425.450.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Legionellaceae Legionella pneumophila Gram-negative aerobic rods, isolated from surface water, mud, or thermally polluted lakes or streams. It is pathogenic for man and it has no known soil or animal sources. Bacteria (78-80); Legionnaires' Disease (78-80)  P˺"9Leghemoglobin D12.776.422.600; D12.776.765.500 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins A hemoglobin-like oxygen-binding hemeprotein present in the nitrogen-fixing root nodules of leguminous plants. The red pigment has a molecular weight approximately 1/4 that of hemoglobin and has been suggested to act as an oxido-reduction catalyst in symbiotic nitrogen fixation. Hemeproteins (73-74); Plant Proteins (72-74) P&DD6Legg-Perthes Disease C05.116.852.175.570 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Osteonecrosis; Femur Head Necrosis A particular type of FEMUR HEAD NECROSIS occurring in children, mainly male, with a course of four years or so. Femur Head (66-72); Femur Head Necrosis (73-74); Necrosis (66-72); Osteochondritis (66-74) PЫNYnLegal Guardians M01.380 CLEDHILJPXSN Named Groups (Non MeSH) Individuals who are legally designated to care for persons who are considered legally incapable of acting in behalf of themselves, e.g., minors and mental incompetents. PҞ Leg Ulcer C17.800.893.592 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Ulcer Foot Ulcer (+ 1); Varicose Ulcer Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes. PNZ+Leg Length Inequality C05.116.099.655; C23.304.537 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bone Lengthening Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH) A condition in which one of a pair of legs fails to grow as long as the other. P"NdLeg Injuries C21.866.558 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Ankle Injuries; Femoral Fractures (+ 2); Foot Injuries; Hip Dislocation; Knee Injuries; Tibial Fractures General or unspecified injuries involving the leg. P׾NQ=Leg Dermatoses C17.800.446 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed). P`NKLeg Bones (Non MeSH) A02.835.232.484 Musculoskeletal System; Skeleton; Bone and Bones Femur (+ 2); Fibula; Patella; Tibia ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI P;0:Leg A01.378.592 ABAHBSEMGDIRMIPAPHPPPSRARERISUTRUSVI Hindlimb Body Regions (Non MeSH); Extremities Ankle; Foot (+ 6); Hip; Knee; Thigh ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI  P( .2*Leeches B01.091.426 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Annelida Annelids of the class Hirudinea, especially Hirudo medicinalis. Some species, the bloodsuckers, may become temporarily parasitic upon animals, including man. Leeches were formerly used extensively for drawing blood. (Dorland, 27th ed). P (Lectins D12.776.503; D24.185.526.545; D24.310.545; D24.611.125.044.545 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Mitogen Amino Acids, Peptides and Proteins (Non MeSH); Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens Immunologic and Biologic Factors (Non MeSH); Biological Products Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins  Abrin; Concanavalin A; Phytohemagglutinins; Pokeweed Mitogens; Ricin; Wheat Germ Agglutinins Abrin; Concanavalin A; Phytohemagglutinins; Pokeweed Mitogens; Ricin; Wheat Germ Agglutinins Abrin; Concanavalin A; Phytohemagglutinins; Pokeweed Mitogens; Ricin; Wheat Germ Agglutinins Protein or glycoprotein substances, usually of plant origin, that bind to sugar moieties in cell walls or membranes and thereby change the physiology of the membrane to cause agglutination, mitosis, or other biochemical changes in the cell. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $Po HF[GHLecithin Acyltransferase Deficiency C18.452.648.556.485.448 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hypolipoproteinemia A disease characterized by deficiency or low levels of plasma lecithin cholesterol acyl transferase. Clinical manifestations include corneal opacity, anemia, and proteinuria. Acyltransferases (66-77); Lecithin Acyltransferase/DF (75-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77) PQ)LLecithin Acyltransferase D08.586.913.050.625 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme secreted from the liver into the plasma of many mammalian species. It catalyzes the esterification of the hydroxyl group of lipoprotein cholesterol by the transfer of a fatty acid from the C-2 position of lecithin. In familial lecithin:cholesterol acyltransferase deficiency disease, the absence of the enzyme results in an excess of unesterified cholesterol in plasma. EC 2.3.1.43. Acyltransferases (66-74); Cholesterol (66-74); Phosphatidylcholines (66-74) P DiXLebanon Z01.252.245.500.450; Z01.586.500.450 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East P7 *Least-Squares Analysis E05.318.740.750.400; G03.850.520.830.750.400; H01.548.832.793.400; N05.715.360.750.695.440 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Regression Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Regression Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Regression Analysis Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Regression Analysis A principle of estimation in which the estimates of a set of parameters in a statistical model are those quantities minimizing the sum of squared differences between the observed values of a dependent variable and the values predicted by the model. Regression Analysis (73-89) P4d%!Leasing, Property N03.219.463.500 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Contractual arrangement between the lessor (owner) and the lessee in which the use of equipment or facilities is granted to the lessee for a period of time and at a specified rate. P[Learning Disorders F03.126.185.529 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Dyslexia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders Impairment of learning ability due to emotional, environmental or physiological factors. PF rgLearning F02.463.425; F02.784.629.529 CLDEPHRE Education Psychologic Processes and Principles (Non MeSH); Mental Processes Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Association (+ 1); Avoidance Learning; Conditioning (Psychology) (+ 4); Critical Period (Psychology); Cues; Discrimination Learning; Generalization (Psychology) (+ 2); Habituation (Psychophysiology); Imprinting (Psychology); Inhibition (Psychology) (+ 2); Maze Learning; Memory (+ 3); Overlearning; Practice (Psychology); Probability Learning; Problem-Based Learning; Problem Solving; Reinforcement (Psychology) (+ 8); Reversal Learning; Set (Psychology); Transfer (Psychology); Verbal Learning (+ 2) Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge. BLCFCICLCODEDHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRISUTHURUSVI $P "  PLLeadership F01.752.609 Behavior and Behavior Mechanisms (Non MeSH); Personality The function of directing or controlling the actions or attitudes of an individual or group with more or less willing acquiescence of the followers. PDLead Radioisotopes D01.496.749.560 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of lead that decay or disintegrate emitting radiation. Pb atoms with atomic weights 194-203, 205, and 209-214 are radioactive lead isotopes. Lead (66-87); Radioisotopes (66-87) P4C,Lead Poisoning C21.613.589 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning PhLELead D01.268.481; D01.552.435 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKRESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals P:8`LE Cells E01.223.459.619 Antibodies, Antinuclear; Lupus Erythematosus, Systemic Diagnosis; Diagnosis, Laboratory; Hematologic Tests P ?=LCM-Lassa Complex Viruses B04.820.057.070.500; B04.909.777.080.070.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae; Arenavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae; Arenavirus Lassa Virus; Lymphocytic Choriomeningitis Virus Lassa Virus; Lymphocytic Choriomeningitis Virus One of two groups of viruses in the ARENAVIRUS genus and considered part of the Old World complex. It includes LASSA VIRUS and LYMPHOCYTIC CHORIOMENINGITIS VIRUS, although the latter has worldwide distribution now. P2nLawrencium D01.268.271.545.500; D01.552.517.507 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Lawrencium. A radioactive actinide discovered in 1961. It has the atomic symbol Lr, atomic number 103, and atomic weight of 257. There are two isotopes with mass number 257 or 258, and mass number 256. Elements (66-74) Pg*4Lauryl Alcohol D02.033.555.700; D10.516.289.700 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols Sodium Dodecyl Sulfate Sodium Dodecyl Sulfate n-Dodecyl alcohol. A saturated 12-carbon fatty alcohol. Fatty Alcohols (72-74)  P&:6CLauric Acids D02.241.081.407.460; D10.516.251.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Laurates Laurates 12-Carbon saturated monocarboxylic acids. Fatty Acids (66-74)  Qw*81Laurence-Moon-Biedl Syndrome C10.496.472; C16.131.077.509; F03.709.346.484 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A hereditary syndrome of childhood, transmitted as an autosomal recessive trait, with obesity, retinitis pigmentosa, mental retardation, polydactyly, and hypogonadism as the main features. Q)!5LLaurates D02.241.081.407.460.410; D10.516.251.500.410 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Lauric Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Lauric Acids Salts and esters of the 12-carbon saturated monocarboxylic acid--lauric acid. Fatty Acids (66-74) Q 28[Laundry Service, Hospital N02.278.354.422.428; N04.452.442.422.428 CLECHILJMAOGSNSTTDUT Bedding and Linens Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which administers all activities pertaining to the hospital laundry service. Laundering (66-79)  Q. pLaundering J01.576.549 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry Q ALaughter F01.145.209.530.614; F01.470.693 PHPX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication Behavior and Behavior Mechanisms (Non MeSH); Emotions An involuntary expression of merriment and pleasure; it includes the patterned motor responses as well as the inarticulate vocalization. Q u &Latvia Z01.542.248.136.560; Z01.586.950.140.560 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern; Baltic States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Baltic States Q  .Latin America Z01.107.424 EHEP Geographicals (Non MeSH); America The geographic area of Latin America in general and when the specific country or countries are not indicated. It usually includes Central America, South America, Mexico, and the islands of the Caribbean. Q /*Lathyrism C21.613.756.558 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Aminopropionitrile Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Plant Poisoning A morbid condition resulting from ingestion of the seeds of leguminous plants of the genus Lathyrus, which includes many kinds of peas. The toxic ingredient is beta-aminopropionitrile, which inhibits the enzyme lysyl oxidase. The disease is characterized by spastic paraplegia, pain, hyperesthesia, and paresthesia. (Dorland, 27th ed). Q NYLatex Fixation Tests E01.223.495.826.558 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Q"NLatex D25.720.540 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers White, milky exudate from certain plants, now also synthetic; any aqueous colloid with particles of polymers in suspension; can be vulcanized to form elastomers (rubber); thin rubber sheeting is often called latex rubber. Synonyms: balata; chicle; guayule. Rubber (66-80) Q ,@0Laterality F02.830.297.425; G11.561.232.508 CLDEGEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Dominance, Cerebral Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Dominance, Cerebral Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot. Q&Lateral Ligament, Ankle A02.513.514.162.500; A02.835.583.512.162.500 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Ligaments; Ligaments, Articular; Collateral Ligaments Musculoskeletal System; Skeleton; Joints; Ligaments, Articular; Collateral Ligaments Three ligamentous fasciculi present on the lateral side of the ankle joint considered collectively: pars tibiocalcanea (the calcaneotibial ligament), pars tibiotalaris anterior (the anterior talotibial ligament), pars tibiotalaris posterior (the posterior talotibial ligament). It is a common site of injury. (From Dorland, 27th ed). Ligaments (66-93); Ligaments, Articular (66-93) Q2:9Latency Period (Psychology) F01.752.747.722.458; F02.739.794.793.458 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Psychosexual Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory; Psychosexual Development The period from about 5 to 7 years to adolescence when there is an apparent cessation of psychosexual development. Q-!.Lassa Virus B04.820.057.070.500.500; B04.909.777.080.070.500.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae; Arenavirus; LCM-Lassa Complex Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae; Arenavirus; LCM-Lassa Complex Viruses A species of ARENAVIRUS, part of the LCM-LASSA COMPLEX VIRUSES, and the etiologic agent of LASSA FEVER. Lassa virus is a common infective agent in humans in West Africa. Its natural host is the multimammate mouse Mastomys natalensis. RNA Viruses (66-71) Q(:Lassa Fever C02.782.417.505; C02.782.082.545 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral Virus Diseases; RNA Virus Infections (Non MeSH); Arenaviridae Infections An acute febrile human disease caused by the Lassa virus. Hemorrhagic Fevers, Viral (66-76) Q&PG(Lasers H01.671.606.552.548; H01.671.768.638.548 AECLDUHISDSTTUUT Holography Physical Sciences (Non MeSH); Physics; Optics; Light Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Non-Ionizing Light Amplification by Stimulated Emission of Radiation. Coherent amplification of electromagnetic waves by stimulated emission of radiation that operate in the visible, infrared, or ultraviolet regions of the spectrum. They are capable of producing immense heat and power when focused at close range and are used in surgical procedures, in diagnosis, and in physiologic studies. Q .Laser-Doppler Flowmetry E01.145.727; E05.830.500; H01.671.799.387 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Miscellaneous Techniques (Non MeSH); Rheology Physical Sciences (Non MeSH); Physics; Rheology A method of non-invasive, continuous measurement of microcirculation. The technique is based on the values of the Doppler effect of low-power laser light scattered randomly by static structures and moving tissue particulates. Doppler Effect (75-92); Lasers (66-92) Q"T1"0Laser Surgery E04.416 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Angioplasty, Laser (+ 1); Laser Coagulation The use of a laser either to vaporize surface lesions or to make bloodless cuts in tissue. It does not include the coagulation of tissue by laser (LASER COAGULATION). Lasers/therapeutic use (66-86)  Q$ $6%Laser Coagulation E04.416.410; E04.792.630.410 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Laser Surgery Surgery, Operative; Surgery, Eye (Non MeSH); Light Coagulation The coagulation of tissues using lasers. These lasers produce light in the visible green wavelength that is selectively absorbed by hemoglobin, and thus it is possible to seal bleeding blood vessels. Light Coagulation (66-92) Q&m"$sLasalocid D08.373.936.500.400; D20.085.456; D21.370.400.547 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Ionophores Anti-Infective Agents; Antibiotics Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 6-(7R-(5S-Ethyl-5-(5R-ethyltetrahydro-5-hydroxy-6S-methyl- 2H-pyran-2R-yl)tetrahydro-3S-methyl-2S-furanyl)-4S-hydroxy- 3R,5S-dimethyl-6-oxononyl)-2-hydroxy-3-methylbenzoic acid. Cationic ionophore antibiotic obtained from Streptomyces lasaliensis that, among other effects, dissociates the calcium fluxes in muscle fibers. It is used as a coccidiostat, especially in poultry, and proposed as an anti-arrhythmic and positive inotropic agent for the heart. Antibiotics (73-74); Benzoates (73-74) Q(m 9</Larynx, Artificial E04.659.581; E07.858.082.601; E07.858.565.639 AECLCTECHIISMIMONUPSPXRHSNSTTDUTVEVI Speech, Alaryngeal Speech, Alaryngeal; Laryngectomy Surgery, Operative; Prosthesis Equipment and Supplies; Surgical Equipment; Artificial Organs Equipment and Supplies; Surgical Equipment; Prosthesis A device, activated electronically or by expired pulmonary air, which simulates laryngeal activity and enables a laryngectomized person to speak. Examples of the pneumatic mechanical device are the Tokyo and Van Hunen artificial larynges. Electronic devices include the Western Electric electrolarynx, Tait oral vibrator, Cooper-Rand electrolarynx and the Ticchioni pipe. Larynx (66-79); Prosthesis (66-79); Speech, Alaryngeal (68-79) $Q,,5('LLarynx A04.329 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Laryngectomy; Laryngoscopy Respiratory System Glottis (+ 1); Laryngeal Cartilages (+ 4); Laryngeal Mucosa; Laryngeal Muscles An irregularly shaped, musculocartilaginous tubular structure, lined with mucous membrane, located at the top of the trachea and below the root of the tongue and the hyoid bone. It is the essential sphincter guarding the entrance into the trachea and functioning secondarily as the organ of voice. consider also terms at VOCAL and VOICE. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $Q/  8 a:Laryngostenosis C08.360.591; C09.400.591 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Otorhinolaryngologic Diseases; Laryngeal Diseases Stricture or narrowing of the larynx. This condition may be developmental or acquired; with progressive respiratory difficulty as a symptom. Q2NnLaryngoscopy E01.276.591; E01.418.600 AECLCTECHIISMOMTNUPXSNSTTDUTVE Larynx Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH) Diagnosis; Endoscopy Q4@" VLaryngitis C08.360.535; C08.730.368; C09.400.535 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Respiratory Tract Diseases; Respiratory Tract Infections Otorhinolaryngologic Diseases; Laryngeal Diseases Croup Epiglottitis Croup Inflammation of the larynx. This condition presents itself with dryness and soreness of the throat, difficulty in swallowing, cough, and hoarseness. Q5-NLaryngismus C08.360.480; C08.618.573; C09.400.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Respiratory Tract Diseases; Respiration Disorders Otorhinolaryngologic Diseases; Laryngeal Diseases Spasm of the larynx. Q7=-NLaryngectomy E04.847.369 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Larynx, Artificial; Speech, Alaryngeal Larynx Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) Total or partial excision of the larynx.  Q8$. F3Laryngeal Perichondritis C08.360.424; C09.400.424 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Otorhinolaryngologic Diseases; Laryngeal Diseases Inflammation of the perichondrium of the laryngeal cartilages. (Dorland, 27th ed). Q9NncLaryngeal Nerves A08.800.050.050.925.450; A08.800.050.600.825.450; A08.800.800.060.920.450; A08.800.800.120.900.450 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways; Vagus Nerve Nervous System; Peripheral Nervous System; Autonomic Nervous System; Parasympathetic Nervous System; Vagus Nerve Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways; Vagus Nerve Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Vagus Nerve Recurrent Laryngeal Nerve Recurrent Laryngeal Nerve Recurrent Laryngeal Nerve Recurrent Laryngeal Nerve Branches of the VAGUS NERVE (the tenth cranial nerve). The superior laryngeal nerves originate near the nodose ganglion and separate into external branches, which supply motor fibers to the cricothyroid muscles, and internal branches, which carry sensory fibers. The RECURRENT (inferior) LARYNGEAL NERVE originates more caudally and carries efferents to all muscles of the larynx except the cricothyroid. The laryngeal nerves and their various branches also carry sensory and autonomic fibers to the laryngeal, pharyngeal, tracheal, and cardiac regions. Q;Hl8vLaryngeal Neoplasms C04.588.443.665.481; C08.360.369; C08.785.481; C09.400.369; C09.647.481 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms Respiratory Tract Diseases; Laryngeal Diseases Respiratory Tract Diseases; Respiratory Tract Neoplasms Otorhinolaryngologic Diseases; Laryngeal Diseases Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms Cancers or tumors of the larynx or any of its parts: the glottis, epiglottis, laryngeal cartilages, laryngeal muscles, and vocal cords. Q@SXaLaryngeal Muscles A02.633.567.500; A04.329.604 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Respiratory System; Larynx The intrinsic muscles of the larynx are the aryepiglottic(us), arytenoid(eus), cricoarytenoid(eus), cricothyroid(eus), thyroarytenoid(eus), thyroepiglottic(us) and vocal(is). Larynx (66-78); Muscles (66-78) QC":Z(Laryngeal Mucosa A04.329.597; A10.615.550.543 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Respiratory System; Larynx Tissue Types (Non MeSH); Membranes; Mucous Membrane The mucous lining of the larynx; mainly stratified squamous epithelium in the upper part and ciliated columnar in the lower part of the larynx. Larynx (66-78); Mucous Membrane (66-78) QE":_1Laryngeal Masks E05.497.578.475; E07.712.402.475 AECLCTECHISDSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Intubation; Intubation, Intratracheal Equipment and Supplies; Protective Devices; Masks A type of oropharyngeal airway that provides an alternative to endotracheal intubation and standard mask anesthesia in certain patients. It is introduced into the hypopharynx to form a seal around the larynx thus permitting spontaneous or positive pressure ventilation without penetration of the larynx or esophagus. It is used in place of a facemask in routine anesthesia. The advantages over standard mask anesthesia are better airway control, minimal anesthetic gas leakage, a secure airway during patient transport to the recovery area, and minimal postoperative problems. Intubation (85-92); Intubation, Intratracheal (85-92); Masks (89-92) QG&RLaryngeal Edema C08.360.313; C09.400.313 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Respiratory Tract Diseases; Laryngeal Diseases Otorhinolaryngologic Diseases; Laryngeal Diseases Edema of any region of the larynx from a variety of causes. In the earliest stages it may be difficult to differentiate from infection, although mucosal injection and erythema are found more often in the latter. Allergic edema may result as a response from provocation induced by foods, inhalants, and drugs. The entire respiratory tract or only an isolated portion of the larynx may be affected. Laryngeal edema may also be hereditary. Other possible causes of laryngeal edema include increased capillary pressure due to superior vena cava syndrome, internal jugular vein ligation, lowered plasma osmotic failure induced by renal failure, impaired lymphatic flow, and increased capillary permeability to proteins. (From Paparella, et al., Otolaryngology, 3d ed, p. 2253). QKN nLaryngeal Diseases C08.360; C09.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases Respiratory Tract Diseases Otorhinolaryngologic Diseases Granuloma, Laryngeal; Laryngeal Edema; Laryngeal Neoplasms; Laryngeal Perichondritis; Laryngismus; Laryngitis (+ 1); Laryngostenosis; Tuberculosis, Laryngeal; Vocal Cord Paralysis; Voice Disorders (+ 2) Granuloma, Laryngeal; Laryngeal Edema; Laryngeal Neoplasms; Laryngeal Perichondritis; Laryngismus; Laryngitis (+ 1); Laryngostenosis; Tuberculosis, Laryngeal; Vocal Cord Paralysis; Voice Disorders (+ 2) Disorders of the larynx, general or unspecified. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $QP/N"@;ZLaryngeal Cartilages A02.165.507; A04.329.591 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cartilage Musculoskeletal System; Cartilage Respiratory System; Larynx Arytenoid Cartilage; Cricoid Cartilage; Epiglottis; Thyroid Cartilage Arytenoid Cartilage; Cricoid Cartilage; Epiglottis; Thyroid Cartilage The nine cartilages of the larynx, including the cricoid, thyroid and epiglottic, and two each of arytenoid, corniculate and cuneiform.  QS: GLarva Migrans, Visceral C03.335.508.523.780; C03.335.508.700.100.868.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Larva Migrans Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Ascaridida Infections; Toxocariasis A condition produced in man by the prolonged migration of animal nematode larvae in extraintestinal tissues other than skin; characterized by persistent hypereosinophilia, hepatomegaly, and frequently pneumonitis, commonly caused by Toxocara canis and Toxocara cati. Larva Migrans (66-67) QU6P2Larva Migrans C03.335.508.523; C03.858.424; C17.800.838.775.424 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections Parasitic Diseases; Skin Diseases, Parasitic Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Parasitic Larva Migrans, Visceral Infections caused by nematode larvae which never develop into the adult stage and migrate through various body tissues. They commonly infect the skin, eyes, and viscera in man. Ancylostoma brasiliensis causes cutaneous larva migrans. Toxocara causes visceral larva migrans. QX9P?Larva B01.583.382 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Life Stages (Non MeSH) Cysticercus; Microfilaria; Sparganum Wormlike or grublike stage, following the egg in the life cycle of insects, worms, and other metamorphosing animals. Insects (66-69); specific organism; Metamorphosis, Biological (66-69) AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI $Q[ (.,R*Laparotomy E04.406 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Q] $Laparoscopy E01.418.590 AECLCTECHIISMOMTNUPXSNSTTDUTVE Peritoneal Cavity; Peritoneum Diagnosis; Endoscopy Examination of the abdomen's interior by means of a laparoscope. Q^ "$NLaos Z01.252.145.435 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern Q_>Lanthanum D01.268.558.475; D01.552.550.474 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Lanthanum. The prototypical element in the rare earth family of metals. It has the atomic symbol La, atomic number 57, and atomic weight 138.91. Lanthanide ion is used in experimental biology as a calcium antagonist; lanthanum oxide improves the optical properties of glass. Q_ &:ELanosterol D04.808.247.222.222.347.557; D04.808.247.808.607; D10.516.851.590 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestadienes; Cholestadienols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols Sterols (66-71) QaI<Lanolin D10.516.945.507; D23.200.500; D26.698.523.424 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Waxes Dermatologic Agents; Emollients Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids; Ointment Bases A yellow fat obtained from sheep's wool. It is used as an emollient, cosmetic, and pharmaceutic aid. Qc 5.zLanguage Therapy E02.831.727.344 CLECEDHIISLJMAMTOGPXSNSTTD Therapeutics; Rehabilitation; Rehabilitation, Speech and Language (Non MeSH) Rehabilitation of persons with language disorders or training of children with language development disorders. Language Disorders (67-79); Speech Therapy (66-79) QeY=Language Tests F04.711.400 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests Tests designed to assess language behavior and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, and Assessment of Children's Language Comprehension. Language (66-78); Language Development (68-78) Qg R~8Language Disorders C10.597.257.543; C23.888.592.257.543; F03.126.219.543 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Speech Disorders Speech Disorders; Verbal Behavior; Verbal Learning Nervous System Diseases; Neurologic Manifestations; Communicative Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders Aphasia (+ 4); Dyslexia (+ 1); Language Development Disorders Aphasia (+ 4); Dyslexia (+ 1); Language Development Disorders Aphasia (+ 6); Dyslexia (+ 1); Language Development Disorders Disabilities related to both the sensory and motor aspects of language; includes impairments in understanding of written and spoken language, and impairments in speaking and writing language. Language (66) (Qj^=F=\Language Development Disorders C10.597.257.543.562; C23.888.592.257.543.562; F03.126.219.543.562; F03.305.410 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders Behavioral and Mental Disorders (Non MeSH); Child Development Disorders Failure to understand or speak the language at the expected age. Causal factors include slow maturation, hearing loss, brain injury, mental retardation and emotional disorders. Language Development (68-79); Language Disorders (67-79) Qn$XFCLanguage Development F01.525.200.310 Speech Psycholinguistics Behavior and Behavior Mechanisms (Non MeSH); Human Development; Child Development Child Language; Crying The gradual expansion in complexity and meaning of symbols and sounds as perceived and interpreted by the individual through a maturational and learning process. Stages in development include babbling, cooing, word imitation with cognition, and use of short sentences. Child Psychology (66-67); Language (66-67); Learning (66-67); Speech (66-67) PHPX (Qr a8^Language Arts (Non MeSH) L01.143.506.423 Information Science; Communication; Language Lipreading; Reading; Speech; Translating; Writing (+ 5) CLDEHIISPHREST Qu55ELanguage F01.145.209.399; L01.143.506 Sign Language Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Information Science; Communication  Language Arts (Non MeSH) (+ 10); Linguistics (+ 9) A verbal or nonverbal means of communicating ideas or feelings. CLDEECEDHIISLJMAMTOGPHRESNSTTD  Qv "yAM"Langerhans Cells A11.066.270.500; A11.436.270.545; A15.382.066.270.500 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Antigen-Presenting Cells; Dendritic Cells Cells; Epithelial Cells (Non MeSH); Dendritic Cells Hemic and Immune Systems (Non MeSH); Immune System; Antigen-Presenting Cells; Dendritic Cells Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the epidermis and are rich in Class II major histocompatibility complex molecules. Cytoplasmic Granules (66-68); Epithelium (66-68); Skin (66-68) Qw=*%LLanger-Giedion Syndrome C05.116.099.708.582 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Autosomal dominant disorder characterized by cone-shaped epiphyses in the hands and multiple cartilaginous exostoses. Mental retardation and abnormalities of chromosome 8 are often present. The exostoses in this syndrome appear identical to those of hereditary multiple exostoses (EXOSTOSES, HEREDITARY MULTIPLE). Exostoses, Multiple (72-89) QzNkh!Lanatosides D09.203.408.180.261.657; D18.222.175.324.542 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides Deslanoside Deslanoside AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Q}@2>DLampreys B02.493.181.590 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cyclostomes Q. &(Laminin D12.776.395.550.530; D12.776.543.550.500; D12.776.860.300.675 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Laminin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Glycoproteins (66-83); Membrane Proteins (77-83); Neoplasm Proteins (66-83)  Q EHh"ZLaminectomy E04.530.557 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Spinal Fusion; Spine Surgery, Operative; Neurosurgery Qx$'Laminaria B05.104.163.450 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae; Algae, Brown A genus of Laminariaceae. Dried pencil-like pieces may be inserted in the cervix where they swell as they absorb moisture, and thus dilate the cervix. Seaweed (66-79) Q &=Lameness, Animal C22.510; C23.888.530 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) A departure from the normal gait in animals. It is also called claudication. Gait (66-75) QJj^Lambert-Eaton Myasthenic Syndrome C05.651.661.440; C10.668.440; C20.111.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Neuromuscular Diseases Immunologic Diseases; Autoimmune Diseases An acquired autoimmune disease characterized by weakness and fatigability of proximal muscles, particularly of the pelvic girdle and thighs, with relative sparing of extraocular and bulbar muscles. It is often associated with small cell carcinoma of the lung. The neuromuscular defect in this disease is believed to be due to a deficient release of acetylcholine. Muscular Diseases (67-88); Myasthenia Gravis (80-89); Neuromuscular Diseases (80-89); Neuromuscular Junction (80-86) Q '1NLagomorpha B02.649.521 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Rabbits An order comprising two families, Ochotonidae and Leporidae, 13 genera, and 69 species. It has a natural range covering most of the world's major land masses. Head and body length ranges from about 125 mm to 750 mm. Hares and rabbits have a short tail, and the pikas lack a tail. The fur is long, soft, and fine in pikas and usually thick and soft in rabbits and hares. All are vegetarians. (From Nowak, Walker's Mammals of the World, 5th ed, p539-41). Q( !Lactulose D09.203.698.629.305.423; D19.316.396.521 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Qm .DLactoyl Glutathione Lyase D08.586.520.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that catalyzes the interconversion of methylglyoxal and lactate, with glutathione serving as a coenzyme. EC 4.4.1.5. Glutathione (73-74); Glyoxal (74); Lyases (73-74) QFO>Lactosylceramides D10.516.390.470.530; D10.516.808.530.530 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids Glycosphingolipids which contain as their polar head group a lactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in lactosylceramide beta-galactosidase, is the cause of lactosylceramidosis. Ceramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) Q.B/PLactose Tolerance Test E01.184.506; E01.223.174.229.612 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Q&"Lactose Synthase D08.586.600.541; D08.586.913.400.450.400.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Galactosyltransferases  N-Acetyllactosamine Synthase Glucosyltransferases (66-71); Lactation (66-71); Ligases (66-71); Transferases (66-71) Q2F"gLactose Intolerance C06.405.469.637.506; C18.452.603.506; C18.452.648.202.589 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Milk Hypersensitivity Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Malabsorption Syndromes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Malabsorption Syndromes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors The disease state resulting from the absence of lactase enzyme in the musocal cells of the gastrointestinal tract, and therefore an inability to break down the disaccharide lactose in milk for absorption from the gastrointestinal tract. It is manifested by indigestion of a mild nature to severe diarrhea. It may be due to inborn defect genetically conditioned or may be acquired. QALqLactose Factors D13.444.308.212.500.500; D13.444.308.283.500.500 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids Plasmids which determine the ability of a bacterium to ferment lactose. Lactose (66-77); Plasmids (75-77) Q6DV*Lactose D09.203.698.629.305.340 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides Q% DLactoperoxidase D08.586.682.732.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases An enzyme derived from cow's milk. It catalyzes the radioiodination of tyrosine and its derivatives and of peptides containing tyrosine. Peroxidases (69-74) Q1FgLactones D02.540 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) 4-Butyrolactone; Dehydroascorbic Acid; Ivermectin; Propiolactone; Spironolactone; Venturicidins; Zearalenone (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Q  8#DLactoglobulins D12.776.256.626.632; D12.776.377.457 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Milk Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins Lactoferrin Lactoferrin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR QJ*FHLactoferrin D12.776.157.470; D12.776.256.626.632.507; D12.776.377.457.507; D12.776.395.507; D12.776.556.632 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Milk Proteins; Lactoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Lactoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins QkHLactococcus lactis B03.510.400.800.500.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Lactococcus A non-pathogenic lactococcus found in dairy products and responsible for the souring of milk. Streptococcus (66-71) Q"boLactococcus B03.510.400.800.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae Lactococcus lactis A genus of gram-positive, coccoid bacteria mainly isolated from milk and milk products. These bacteria are also found in plants and nonsterile frozen and dry foods. Previously thought to be a member of the genus STREPTOCOCCUS (group N), it is now recognized as a separate genus. Gram-Positive Bacteria (88); Streptococcus (88-91)  Q5"SK<Lactobacillus casei B03.510.460.400.410.475.475.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Lactobacillaceae; Lactobacillus A rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. Lactobacillus (66-71) Q#"Lactobacillus acidophilus B03.510.460.400.410.475.475.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Lactobacillaceae; Lactobacillus A species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals and the human mouth and vagina. This organism produces the fermented product, acidophilus milk. Q#"Lactobacillus B03.510.460.400.410.475.475 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH); Lactobacillaceae Lactobacillus acidophilus; Lactobacillus casei A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare. Q"6/Lactobacillaceae B03.510.460.400.410.475 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH) Lactobacillus (+ 2) A family of gram-positive bacteria found regularly in the mouth and intestinal tract of man and other animals, in food and dairy products, and in fermenting vegetable juices. A few species are highly pathogenic. Bacteria (66-74)  Q"Lactation, Prolonged G08.520.882.608.410 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Puerperium; Lactation Prolongation of the usual period of lactation. It should be differentiated from LACTATION DISORDERS such as hypogalactia (a deficiency of milk secretion) and galactorrhea (excessive or spontaneous flow). QbLactation Disorders C13.703.844.506; C19.146.556 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Galactorrhea Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Puerperal Disorders Endocrine Diseases; Breast Diseases Chiari-Frommel Syndrome; Galactorrhea; Mastitis Chiari-Frommel Syndrome; Galactorrhea Disturbances of milk secretion in either sex, not necessarily related to pregnancy. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $Q"LbcNLactation G08.520.882.608 BLCFDEEHGEIMMEPHPXREUR Breast Feeding; Colostrum; Milk; Milk, Human Milk; Breast; Milk, Human Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Puerperium Lactation, Prolonged; Milk Ejection  Q* 8"U+Lactates D02.241.511.459 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Qi :KLactate Dehydrogenase Virus B04.820.060.500; B04.909.777.090.500; B04.970.060.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arterivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arterivirus Viruses; Viruses, Unclassified; Arterivirus A species of RNA virus, probably an ARTERIVIRUS, occurring in a number of transplantable mouse tumors. Infected mice have permanently elevated serum levels of lactate dehydrogenase. RNA Viruses (66-74) Q,!=Lactate Dehydrogenase Isoenzymes D08.586.348.423; D08.586.682.047.547.506 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isoenzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Lactate Dehydrogenase Lactate Dehydrogenase (66) Qe&.F Lactate Dehydrogenase D08.586.682.047.547 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases Lactate Dehydrogenase Isoenzymes Q!Ft&Lactams D02.065.589; D03.383.411 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Caprolactam Caprolactam Amides (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  QU 8s:Lactalbumin D12.776.034.398; D12.776.256.626.506 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Milk Proteins Albumins (66-72) Q*DLacrimal Duct Obstruction C11.496.456 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Lacrimal Apparatus Diseases Interference with the secretion of tears by the lacrimal glands. Obstruction of the lacrimal sac or nasolacrimal duct causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p. 250). Q+N21Lacrimal Apparatus Diseases C11.496 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Dacryocystitis; Dry Eye Syndromes (+ 3); Lacrimal Duct Obstruction Diseases of the lacrimal apparatus. Lacrimal Apparatus (66-75); specific lacrimal apparatus disease heading  Q-! NQ,TLacrimal Apparatus A09.371.463; A10.336.422 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Dacryocystorhinostomy; Tears Sense Organs; Eye Tissue Types (Non MeSH); Exocrine Glands Nasolacrimal Duct The tear-forming and tear-conducting system which includes the lacrimal glands, eyelid margins, conjunctival sac, and the tear drainage system.  QŴ:"ILacquer J01.637.597.422 AEANCLECHIPORESDSNSTTOUT Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH); Paint Qv YLac Operon G05.275.201.800.575.545; G05.275.769.545 DEGEIMPHRE Genetics; Genes; Genes, Bacterial; Regulon; Operon Genetics; Genes; Operon The genetic unit consisting of three structural genes, an operator and a regulatory gene, which controls the synthesis of beta-galactosidase, beta-galactoside permease, and beta-thiogalactoside acetyltransferase. It includes the structural gene lac Z (lacZ) of ESCHERICHIA COLI. Lactose (66-78); Operon (69-78) Q(.\?(Labyrinthitis C09.218.568.315 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases Inflammation of the inner ear. Q]NJ'Labyrinthine Fluids A12.207.571 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Body Fluids Endolymph; Perilymph Qc"9Labyrinth Supporting Cells A09.246.631.246.577.543; A11.436.495 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Sense Organs; Ear; Labyrinth; Cochlea; Organ of Corti Cells; Epithelial Cells (Non MeSH) Cells forming a framework supporting the organ of Corti. Specific cells are those of Claudius, Deiters and Hensen. Cochlea (66); Organ of Corti (67-78) Q" **m/Labyrinth Diseases C09.218.568 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Cochlear Diseases; Endolymphatic Hydrops (+ 1); Labyrinthitis; Vestibular Diseases (+ 3) QN3jLabyrinth A09.246.631 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Temporal Bone Sense Organs; Ear Cochlea (+ 14); Semicircular Canals (+ 1); Vestibule (+ 8) The internal ear; the essential part of the organ of hearing. It consists of an osseous and a membranous portion. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $Q :K<Laboratory Personnel M01.526.485.510; N02.360.510 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Those health care professionals, technicians, and assistants staffing a research or health care facility where specimens are grown, tested, or evaluated and the results of such measures are recorded. Q"Laboratory Infection C01.539.503; C21.447.506 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases Accidentally acquired infection in laboratory workers. QP@Laboratory Animal Science G01.273.368 CLECEDHIISLJMAMTOGSNSTTD Animals, Laboratory; Veterinary Medicine Biological Sciences; Biology The science and technology dealing with the procurement, breeding, care, health, and selection of animals used in biomedical research and testing. Animals, Laboratory (66-86)  Q^0#!Laboratories, Hospital N02.278.354.422.420; N02.278.487.410; N04.452.442.422.420 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Health Facilities; Laboratories Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital facilities equipped to carry out investigative procedures. Laboratories (66-87) QAeOLaboratories, Dental N02.278.192.631 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Dental Facilities Facilities in which the dentist or his auxiliaries perform services related to treatment not done directly in the patient's mouth. Q\bLaboratories N02.278.487 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Laboratories, Hospital Facilities equipped to carry out investigative procedures. QLELabor, Premature C13.703.453 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Infant, Premature; Tocolytic Agents Uterine Contraction Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Onset of labor before term but after the fetus has become viable, usually sometime during the 29th through 38th week of gestation.  QN+fLabor, Induced E04.819.774.457.533 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Oxytocics Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery Labor that is brought about by artificial means. Qܯ$ l<Labor Unions N03.540.571 CLECHILJOGSNSTTDUT Collective Bargaining; Strikes, Employee Economics, Organizations, Control (Non MeSH); Organizations Collective Bargaining; Strikes, Employee Organizations comprising wage and salary workers in health-related fields for the purpose of improving their status and conditions. The concept includes labor union activities toward providing health services to members. CLECHILJMAMTOGSDSNSTTDUT $Q0F0Labor Stage, Third G08.520.769.326.200.110 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor; Labor Onset Period of labor from birth of the fetus through expulsion or extraction of the placenta and membranes. Qm{Labor Stage, Second G08.520.769.326.200.090 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor; Labor Onset Period of labor from complete dilatation of the cervix through birth of the fetus. QWmdLabor Stage, First G08.520.769.326.200.080 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor; Labor Onset Period from the onset of labor through complete dilatation of the cervix. QmYLabor Presentation G08.520.769.362 Delivery Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Breech Presentation The part of the fetal body that is in advance in the birth canal. Q TSLabor Onset G08.520.769.326.200 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor Labor Stage, First; Labor Stage, Second; Labor Stage, Third The establishment of regular uterine contractions together with beginning dilatation of the cervix. Q]ItLabor Complications C13.703.420 BLCFCICLDHDIDTECEHENEPETHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Abruptio Placentae; Dystocia (+ 1); Fetal Membranes, Premature Rupture (+ 1); Placenta Accreta; Placenta Praevia; Postpartum Hemorrhage; Uterine Rupture Medical problems associated with labor including cephalopelvic disproportion, hemorrhage, FETAL DISTRESS, or other disorders. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  QmFfNLabor G08.520.769.326 BLCFDEEHGEIMMEPHPXREUR Fetal Monitoring; Natural Childbirth; Oxytocics; Trial of Labor Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Labor Onset (+ 3); Trial of Labor; Uterine Contraction The function in the female by which the product of conception is expelled from the uterus through the vagina to the outside world.  Q MTELabial Frenum A14.549.336.505 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Diastema Stomatognathic System; Mouth; Lip Q: *Labetalol D02.033.329.291.460; D02.092.063.291.460; D14.100.050.200.100.450; D14.100.050.200.200.450; D16.050.850.430; D18.162.510 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents 2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino) ethyl)benzamide. Blocker of both alpha- and beta-adrenergic receptors that is used as an antihypertensive. Butylamines (74); Ethanolamines (74); Salicylamides (74) Q :ELa Crosse Virus B04.820.087.150.160.500; B04.909.777.147.150.160.500; B04.909.777.270.100.500 CHCLDEENGDGEIMIPMEPHPYREUL Encephalitis, California Viruses; RNA Viruses; Bunyaviridae; Bunyavirus; California Group Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Bunyavirus; California Group Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses; California Group Viruses A species of the genus BUNYAVIRUS and member of the CALIFORNIA GROUP VIRUSES causing human meningoencephalitis. This is the agent most responsible for California encephalitis, the most prevalent mosquito-borne disease recognized in the United States. California Group Viruses (75-93); Encephalitis Viruses (72-74)  Q8UF"JL Forms B03.110.422 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Atypical Bacterial Forms Bacterial variants, unable to form a complete cell wall, which are formed in cultures by various bacteria; granules (L bodies) appear, unite, and grow into amorphous bodies which multiply and give rise to bacterial cells morphologically indistinguishable from the parent strain. Q "*DL Cells A11.251.210.505; A11.329.228.505 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Cells; Connective Tissue Cells (Non MeSH); Fibroblasts Q &*lKyrgyzstan Z01.252.100.450; Z01.586.200.450; Z01.586.950.450 EHEP Geographicals (Non MeSH); Asia; Asia, Central Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR Qo9Kyphosis C05.116.900.800.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spinal Curvatures (Non MeSH) Abnormally increased convexity in the curvature of the thoracic spine as viewed from the side. (Dorland, 27th ed). Q NfKynurenine D12.125.608 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Q[FHKynurenic Acid D03.066.942.505; D03.438.810.350.400; D14.100.190.300.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Xanthurenates Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists A broad-spectrum excitatory amino acid antagonist used as a research tool. Q%A:pYKynuramine D02.522.818.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones 3-Amino-1-(2-aminophenyl)-1-propanone. Amines (72-74); Propiophenones (72-74) Q:A-/Kymography E01.528 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Electrokymography The recording of variations or undulations, arterial or other, using an instrument called the kymograph. The tracing or other graphic record is called a kymogram. (From Dorland, 27th ed). AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  Q " &Kyasanur Forest Disease C02.081.885.475; C02.782.350.250.635; C02.782.417.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral Tick-borne flavivirus infection occurring in the Kyasanur Forest in India. Arbovirus Infections (66-77); Hemorrhagic Fevers, Viral (66-74) QK=P XKKwashiorkor C18.654.223.708.626.505 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Protein Deficiency; Protein-Energy Malnutrition A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in Gold Coast, Africa, meaning "displaced child". Although first reported from Africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus. (From Dorland, 27th ed). RN8Kveim Test E01.223.495.862.345.540; E01.862.345.540 AECLCTECHIISMOMTNUPXSNSTTDUTVE Sarcoidosis Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Skin Tests; Intradermal Tests Diagnosis; Skin Tests; Intradermal Tests Intradermal injection of a heated (pasteurized) saline suspension of sarcoid tissue obtained from a sarcoid spleen or lymph node. In patients with active sarcoidosis a dusky red nodule develops slowly over the next few weeks at the injection site. Histologic examination, an essential part of the complete test, reveals sarcoid tissue. R;."Kuwait Z01.252.245.500.425; Z01.586.500.425 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East R *Kuru C10.228.228.800.435 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Prion Diseases A chronic, progressive, uniformly fatal nervous system disorder characterized by a long incubation period and transmissible to subhuman primates. It is found among the Fore and neighboring peoples of New Guinea. It is thought to be associated with cannibalism. Pathologically, the brain shows the changes of the spongiform encephalopathies: neuronal loss, astrogliosis, and status spongiosus; amyloid plaques are also present in about two thirds of the cases. (Dorland, 27th ed). RP/Kupffer Cells A11.329.372.588; A11.733.397.588; A15.382.680.397.588; A15.382.812.522.588 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Reticuloendothelial System Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Macrophages (66-72) R 3T*,Krypton Radioisotopes D01.496.749.540 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of krypton that decay or disintegrate emitting radiation. Kr atoms with atomic weights 74-77, 79, 81, 85, and 87-94 are radioactive krypton isotopes. Krypton (66-87); Radioisotopes (66-87) RM4C/Krypton D01.268.613.425; D01.362.641.468 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Noble Gases Inorganic Chemicals (Non MeSH); Gases; Noble Gases Krypton. A noble gas that is found in the atmosphere. It has the atomic symbol Kr, atomic number 36, atomic weight 83.80, and has been used in electric bulbs. R  &:Krukenberg Tumor C04.557.470.200.025.415.410; C04.557.470.590.415.410 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Ovarian Neoplasms Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Signet Ring Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Carcinoma, Signet Ring Cell Mucocellular carcinoma of the ovary, usually metastatic from the gastrointestinal tract, characterized by areas of mucoid degeneration and the presence of signet-ring-like cells. It accounts for 30%-40% of metastatic cancers to the ovaries and possibly 1%-2% of all malignant ovarian tumors. The lesions may not be discovered until the primary disease is advanced, and most patients die of their disease within a year. In some cases, a primary tumor is not found. (From Dorland, 27th ed and Holland et al., Cancer Medicine, 3d ed). Ovarian Neoplasms (66-74)  R:XnpKringles G05.331.599.056.450; G06.184.599.056.450 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Amino Acid Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Amino Acid Sequence Triple-looped protein domains linked by disulfide bonds. These common structural motifs, so-named for their resemblance to Danish pastries known as kringlers, play a role in binding membranes, proteins, and phospholipids as well as in regulating proteolysis. Kringles are also present in coagulation-related and fibrinolytic proteins and other plasma proteinases. Amino Acid Sequence (81-93); Peptide Fragments (80-93) R .BKraurosis Vulvae C13.371.944.338 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vulvar Diseases An atrophic disease affecting the female external genitalia, most often of older women, resulting in drying and shriveling of the parts, and marked by leukoplakic patches on the mucosa, itching, dyspareunia, dysuria, and soreness. It occurs most commonly as a result of lichen sclerosus et atrophicus of the vulva, but may be associated with other types of genital atrophy. (Dorland, 27th ed). R N|Koro F03.126.056.296.450; F03.126.185.304.450; F03.709.438.180.080.450; F03.709.438.416.408.450; F03.709.508.460.225.450; F03.709.680.610.360.450 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Affective Symptoms; Depersonalization Disorder Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Delusions Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders; Anxiety, Castration Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Dissociative Disorders; Depersonalization Disorder Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Delusions Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Delusions A culture-specific acute delusional syndrome occurring mostly in the Malay people and Southern Chinese. The syndrome is characterized by the individual's sudden experience of depersonalization depicted by the belief that his penis is shrinking into his abdomen and that he will die when this occurs. Although generally classified as a culture-specific syndrome, koro may be no more than a variant of castration anxiety (ANXIETY, CASTRATION) as it has been described in non-Asian patients. Anxiety, Castration (76-91); Delusions (83-91); Depersonalization Disorder (69-91) RFc7aKorea Z01.252.474.538 EHEP Geographicals (Non MeSH); Asia; Far East R# 4Knowledge, Attitudes, Practice F01.145.076.511; F01.829.092.690; N02.421.143.401.625; N05.300.150.410 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Attitude Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Family Planning Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health Knowledge, attitudes, and associated behaviors which pertain to health-related events such as procedures, diseases, or family planning. R$o$PKnowledge of Results (Psychology) F02.463.425.770.379 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) The hypothesis that learning is facilitated when the learner is informed at each step about the progress he is making in his learning. It hypothesizes also that learning is facilitated when the learner is promptly informed whether a particular response is correct, and if incorrect, of the direction of error. The two usages refer to distinguishable situations and probably to different psychological processes. R'(yKnee Prosthesis E04.557.168.530.540; E04.659.550.540; E07.450.530.550; E07.858.442.499.540; E07.858.565.600.540 AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI Surgery, Operative; Orthopedics; Arthroplasty; Joint Prosthesis Surgery, Operative; Prosthesis; Joint Prosthesis Equipment and Supplies; Implants, Artificial; Joint Prosthesis Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Joint Prosthesis Equipment and Supplies; Surgical Equipment; Prosthesis; Joint Prosthesis Partial or total replacement of the knee joint. Arthroplasty (66-79); Joint Prosthesis (71-79); Knee (66-79); Knee Joint (66-79); Prosthesis (66-70) R)k*~;{Knee Joint A02.835.583.475 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints Menisci, Tibial ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI R,61:Knee Injuries C21.866.558.554 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries Injuries to the knee or the knee joint. R-Nb3Knee A01.378.592.586 ABAHBSEMGDIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Leg R/&5Kluyveromyces B05.354.107.292.536; B05.354.930.536 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Algae and Fungi (Non MeSH); Fungi; Yeasts An ascomycetous yeast of the fungal family Saccharomycetaceae, order Endomycetales. This genus is used in the study of genetic transformation and transcription. Ascomycetes (66-85); Endomycetales (75-85) R/*"3Klippel-Trenaunay-Weber Syndrome C14.907.077.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Angiomatosis A rare condition usually affecting one extremity, characterized by hypertrophy of the bone and related soft tissues, large cutaneous hemangiomas, persistent nevus flammeus, and skin varices. (Dorland, 27th ed). R1%NBKlippel-Feil Syndrome C05.116.099.370.535; C05.660.551; C16.131.621.551 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) A condition characterized by shortness of the neck resulting from reduction in the number of vertebrae or the fusion of multiple hemivertebrae into one osseous mass. The hairline is low and the motion of the neck is limited. (Dorland, 27th ed). R3j9L$Klinefelter's Syndrome C12.740.700.842.454; C16.131.280.748.421; C16.131.939.842.454; C19.391.482.629; C19.391.775.454 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Endocrine Diseases; Gonadal Disorders (Non MeSH); Hypogonadism Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders A condition characterized by small testes with hyalinization of the seminiferous tubules, variable degrees of masculinization, azoospermia and infertility, and increased urinary excretion of gonadotropin. Patients tend to be tall, with long legs, and about half have gybecomastia. It is associated typically with an XXY chromosome complement, although variants include XXYY, XXXY, XXXXY, and several mosaic patterns (XY/XXY, XXY, XXXY, etc.). (Dorland, 27th ed). R6okL^Kleine-Levin Syndrome C10.597.785.200.400; C23.888.592.796.200.400; F03.126.298.208.400; F03.126.821.320.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sleep Disorders; Hypersomnia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sleep Disorders; Hypersomnia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Eating Disorders; Hyperphagia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Sleep Disorders; Hypersomnia A rare form of periodic hypersomnia associated with hyperphagia occurring in males 10 to 25 years old, characterized by periods of ravenous appetite alternating with prolonged sleep (as long as 18 hours), along with behavioral disturbances, impaired thought processes, and hallucinations. Acute illness or fatigue may precede an episode which may occur as often as several times a year. (Stedman, 25th ed). Eating Disorders (66-76); Hunger (66-71); Hyperphagia (81-93); Hypersomnia (75-93); Sleep Disorders (66-79) R;`NKlebsiella rhinoscleromatis B03.440.450.425.425.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Klebsiella A gram-negative, facultatively anaerobic, rod-shaped bacterium found consistently and exclusively in patients with RHINOSCLEROMA and their contacts. Klebsiella (66-71) RA "|Klebsiella pneumoniae B03.440.450.425.425.600 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Klebsiella Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in man. Klebsiella (66-71) RB"|Klebsiella Infections C01.252.400.310.503 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Rhinoscleroma Infections with bacteria of the genus KLEBSIELLA. Klebsiella (66-67)  RDP<Klebsiella B03.440.450.425.425 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Klebsiella pneumoniae; Klebsiella rhinoscleromatis A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection. RF/"n:rKlatskin's Tumor C04.557.470.200.025.540 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Adenocarcinoma of the common hepatic duct bifurcation. These tumors are generally small, sharply localized, and seldom metastasizing. G. Klatskin's original review of 13 cases was published in 1965. Once thought to be relatively uncommon, tumors of the bifurcation of the bile duct now appear to comprise more than one-half of all bile duct cancers. (From Holland et al., Cancer Medicine, 3d ed, p. 1457). Adenocarcinoma (86-93); Adenoma, Bile Duct (81-93); Bile Duct Neoplasms (81-93) RHX`Kitasamycin D20.085.115.362.400 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Leucomycins A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens. Antibiotics (70-75); Kitasamycins (76-80); Leucomycins (81-89) RL+<SKKirsten Sarcoma Virus B04.265.600.500; B04.820.650.730.730.900.750.500; B04.909.574.807.730.730.900.750.500; B04.909.777.731.730.730.900.750.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses; Sarcoma Viruses, Murine Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine A replication-defective murine sarcoma virus (SARCOMA VIRUSES, MURINE) capable of transforming mouse lymphoid cells and producing erythroid leukemia after superinfection with murine leukemia viruses. It has also been found to transform cultured human fibroblasts, rat liver epithelial cells, and rat adrenocortical cells. Mouse Sarcoma Viruses (75-79); Mouse Tumor Viruses (66-74) RMzpGKinky Hair Syndrome C10.228.140.163.520; C17.800.805.305.550; C18.452.648.618.590; F03.709.346.465 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An x-linked inherited disease with disturbance of intestinal absorption of copper, causing growth retardation, pili torti, progressive cerebral degeneration, mental retardation, and other abnormalities. Brain Diseases (66-76) RSXLKinins D12.644.320; D17.350.050.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids Bradykinin (+ 1); Kininogens; Tachykinins (+ 6) Bradykinin (+ 1); Kininogens; Tachykinins (+ 6); Urotensins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p.588). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  RV "DBFKininogens D08.373.745.325.250.400; D12.644.320.654; D12.776.811.420; D17.350.050.375.425 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Cysteine Proteinase Inhibitors; Cystatins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins Inert endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. High-molecular-weight kininogen (HMWK) is split by plasma kallikrein to produce BRADYKININ. Low-molecular-weight kininogen (LMWK) is split by tissue kallikrein to produce KALLIDIN. Kinins (66-71); Proteins (66-71) R[<XD)Kingella kingae B03.440.400.425.550.400.375 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae; Kingella A species of gram-negative, aerobic, rod-shaped bacteria. The most commonly diagnosed infections due to this organism are endocarditis and septic arthritis. There have also been, however, isolated reports of bacteremia, discitis, abscesses, meningitis, and oropharyngeal infections. Moraxella (69-88); Neisseriaceae (83-93) R_"D1Kingella B03.440.400.425.550.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae Kingella kingae A genus of gram-negative, aerobic, rod-shaped bacteria whose organisms are part of the normal flora of the mucous membranes of the upper respiratory tract. Some species are pathogenic for man. Moraxella (69-88); Neisseriaceae (83-93)  Rbm "1King's Evil C01.252.410.040.552.846.719.500; C15.604.921.500 HI Tuberculosis, Lymph Node Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Lymph Node Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Tuberculosis, Lymph Node The historic designation for scrofula (TUBERCULOSIS, LYMPH NODE). The disease is so called from the belief that it could be healed by the touch of a king. This term is used only for historical articles using the name "king's evil", and is to be differentiated from scrofula as lymph node tuberculosis in modern clinical medicine. (From Webster, 3d ed). Tuberculosis, Lymph Node (66-94)  Rd6A'Kinetoplastida B01.841.750.443.950.450 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora Trypanosomatina (+ 19) An order of flagellate protozoa. Characteristics include the presence of one or two flagella arising from a depression in the cell body and a single mitochondrion that extends the length of the body. Rh@&UKinetofragminophorea B01.841.185.375 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora Trichostomatida (+ 2) A class of ciliate protozoa. Prominent cytopharyngeal apparatus is characteristic of this class as is only a slight distinction between oral and somatic cilia. Rj&+Kinetochores A11.223.475.135.500 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Mitotic Spindle Apparatus Cells; Cell Nucleus; Chromosomes; Centromere Large multiprotein complexes that bind the centromeres of the chromosomes to the microtubules of the mitotic spindle during metaphase in the cell cycle. Chromosomes (66-94)  Rk(7Kinetocardiography E01.145.569.627 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests The technique of graphically recording the slow vibrations of the anterior chest wall in the region of the heart, the vibrations representing the absolute motion of the heart at a given point on the chest. (Dorland, 27th ed). Rm-&S Kinetins D11.303.760.265.400 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators; Cytokinins Zeatin Cell division factors found in various plant parts and in yeast and used as plant growth regulators. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  Rn @{ yBKinetics H01.671.434 Physical Sciences (Non MeSH); Physics Rp /Kinesthesis F02.830.816.541.504; G11.561.796.541.587 CLDEGEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation; Proprioception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Proprioception The sense by which muscular motion, weight, position, etc., are perceived. Rq2.YKinesis F02.830.606.587 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Orientation Locomotor behavior not involving a steering reaction, but in which there may be a turning random in direction. It includes orthokinesis, the rate of movement and klinokinesis, the amount of turning, which are related to the intensity of stimulation. Rr  \%Kinesin D08.586.277.040.025.450; D12.776.220.600.450.450; D12.776.641.560.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microtubule Proteins; Microtubule-Associated Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Microtubule-Associated Proteins A microtubule-associated mechanical adenosine triphosphatase, that uses the energy of ATP hydrolysis to move organelles along microtubules toward the plus end of the microtubule. The protein is found in squid axoplasm, optic lobes, and in bovine brain. Bovine kinesin is a heterotetramer composed of two heavy (120 kDa) and two light (62 kDa) chains. EC 3.6.1.-. Adenosine Triphosphatase (66-91); Microtubule Proteins (85-91); Nerve Tissue Proteins (66-91) Rt MFnKinesics F01.145.209.530.538 Posture Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication Gestures Systematic study of the body and the use of its static and dynamic position as a means of communication. Behavior, Animal (66-67); Communication (66-67)  Ry<  n 9Kindling (Neurology) G11.561.426 DEGEIMMEPAPHRE Convulsions; Epilepsy; Models, Neurological Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) A phenomenon in which there is a relatively profound alteration in brain function resulting from repeated electrical or chemical stimulation and culminating in the appearance of electrographic and behavioral convulsions whenever the stimulus is re-applied. It is used as an experimental model for epilepsy. Amygdaloid Body (66-81); Convulsions (66-81); Electric Stimulation (66-81)  Rz4hcYKillifish B02.493.280.428 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cyprinodontiformes Small oviparous fishes usually striped or barred black. They are much used in mosquito control. R} &/sKiller Cells, Natural A11.118.637.555.567.537; A15.145.229.637.555.567.537; A15.382.490.555.567.537; A15.382.520.520.425 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cytotoxicity, Immunologic Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes Killer Cells, Lymphokine-Activated Killer Cells, Lymphokine-Activated Killer Cells, Lymphokine-Activated Killer Cells, Lymphokine-Activated Cells responsible for spontaneous cytotoxicity of a variety of tumor cells without prior immunization. These natural killer cells are found in non-immune humans and experimental animals and are distinct from killer cells (K cells) which mediate antibody-dependent cell cytotoxicity. Cytotoxicity, Immunologic (78-82); Immunity, Cellular (76-82); Killer Cells (78-82) $R~l*FcKiller Cells, Lymphokine-Activated A11.118.637.555.567.537.500; A15.145.229.637.555.567.537.500; A15.382.490.555.567.537.500; A15.382.520.520.425.500 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Immunotherapy, Adoptive; Interleukin-2 Cytotoxicity, Immunologic Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Killer Cells, Natural Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Killer Cells, Natural Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Killer Cells, Natural Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; Killer Cells, Natural Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are interleukin-2-activated NK cells that have no MHC (major histocompatibility complex) restriction or need for antigen stimulation. LAK cells are used for adoptive immunotherapy in cancer patients. Killer Cells, Natural (82-89) $Rv(|*-h$Killer Cells A11.118.637.555.567.532; A15.145.229.637.555.567.532; A15.382.490.555.567.532; A15.382.520.520.420 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Antibody-Dependent Cell Cytotoxicity Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their Fc receptors. Lymphocytes (66-77); T Lymphocytes (73-77)  R\l**4Kieselguhr D01.578.750.300; D01.650.550.825.400; D01.837.725.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Minerals; Silicon Dioxide Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Silicon Dioxide Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide Kieselguhr. A soft, bulky, solid material (88% silica) composed of skeletons of small prehistoric aquatic plants related to algae (diatoms). It can absorb 1.5-4 times its weight in water. (From Hawley's Condensed Chemical Dictionary, 11th ed). R=8 Kidney, Sponge C04.182.394.586; C12.777.419.413.586 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Cysts; Kidney, Cystic Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney, Cystic Cystic disease of the medullary portion of the renal pyramids; asymptomatic unless complicated by infection, calculi, or obstruction; should be distinguished from congenital polycystic disease of the kidneys. R*XKidney, Polycystic, Autosomal Recessive C04.182.394.420.510; C12.740.700.608.510; C12.777.419.413.420.510; C13.371.820.700.608.510; C16.131.939.608.510 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Kidney, Cystic; Kidney, Polycystic Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Kidney, Polycystic Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney, Cystic; Kidney, Polycystic Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Kidney, Polycystic Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Kidney, Polycystic Rare genetic disorder with autosomal recessive inheritance characterized by multiple cysts in both kidneys and associated hepatic lesions. Serious manifestations are usually present at birth and there is high perinatal mortality. Kidney, Polycystic (66-91) R.{V  Kidney, Polycystic, Autosomal Dominant C04.182.394.420.500; C12.740.700.608.500; C12.777.419.413.420.500; C13.371.820.700.608.500; C16.131.939.608.500 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Kidney, Cystic; Kidney, Polycystic Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Kidney, Polycystic Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney, Cystic; Kidney, Polycystic Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Kidney, Polycystic Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Kidney, Polycystic A genetic disorder with autosomal dominant inheritance characterized by multiple cysts in both kidneys and progressive deterioration of renal function. It is usually caused by a mutant gene at the PKD1 locus on the short arm of chromosome 16, though mutations elsewhere in the genome can also cause the disease. The age of onset of symptoms varies widely. Kidney, Polycystic (74-91) R-{V Kidney, Polycystic C04.182.394.420; C12.740.700.608; C12.777.419.413.420; C13.371.820.700.608; C16.131.939.608 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Kidney, Cystic Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney, Cystic Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Kidney, Polycystic, Autosomal Dominant; Kidney, Polycystic, Autosomal Recessive Kidney, Polycystic, Autosomal Dominant; Kidney, Polycystic, Autosomal Recessive Kidney, Polycystic, Autosomal Dominant; Kidney, Polycystic, Autosomal Recessive Kidney, Polycystic, Autosomal Dominant; Kidney, Polycystic, Autosomal Recessive Kidney, Polycystic, Autosomal Dominant; Kidney, Polycystic, Autosomal Recessive Kidney whose tissue is displaced by a large number of tightly packed cysts so that cystic volume predominates over the solid parts to a considerable degree. RogV-Kidney, Cystic C04.182.394; C12.777.419.413 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Kidney, Polycystic (+ 2); Kidney, Sponge Kidney, Polycystic (+ 2); Kidney, Sponge A kidney containing one or more cysts, including polycystic disease (KIDNEY, POLYCYSTIC), solitary cyst, multiple simple cysts, and retention cysts (associated with parenchymal scarring). (Stedman, 25th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  R"VvdXKidney, Artificial E02.870.450; E07.858.082.585 AECLCTECHIPXSDSNSTTDUTVE Hemodialysis; Peritoneal Dialysis Therapeutics; Renal Replacement Therapy Equipment and Supplies; Surgical Equipment; Artificial Organs Device(s) which can substitute for normally functioning kidneys in cleansing the blood. R"(vhKidney Tubules, Proximal A05.810.453.736.560.570 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Nephrons; Kidney Tubules Kidney Tubules (66-72) Rl:QKidney Tubules, Distal A05.810.453.736.560.540 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Nephrons; Kidney Tubules Kidney Tubules (66-72) Ro:QKidney Tubules, Collecting A05.810.453.736.560.510 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Nephrons; Kidney Tubules Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla. Kidney (66-78); Kidney Medulla (73-78); Kidney Tubules (66-78); Kidney Tubules, Distal (73-78) Rp :QNsKidney Tubules A05.810.453.736.560 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Nephrons Kidney Tubules, Collecting; Kidney Tubules, Distal; Kidney Tubules, Proximal; Loop of Henle R:>mKidney Tubular Necrosis, Acute C12.777.419.430.205.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney Failure; Kidney Failure, Acute Acute kidney failure resulting from destruction of tubular epithelial cells. It is commonly attributed to exposure to toxic agents or renal ischemia following severe trauma. RP%NKidney Transplantation E02.870.500; E04.887.774.175; E04.936.450.485 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Therapeutics; Renal Replacement Therapy Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH) Surgery, Operative; Transplantation; Organ Transplantation The transference of a kidney from one human or animal to another. Kidney/transplantation (66-89) R\52Q$Kidney Pelvis A05.810.453.537 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney Kidney Calices consider also terms at PYEL-. RI:2&Kidney Papillary Necrosis C12.777.419.493 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases A form of acute kidney disease characterized by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual etiologic agents. R:NbKidney Neoplasms C04.588.945.947.535; C12.740.800.820.750; C12.777.419.473; C13.371.820.800.820.535 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Neoplasms or tumors of the kidney. Renal cell carcinoma is the most common neoplastic lesion of the kidney, accounting for approximately 85% of all kidney neoplasms. The vast majority of these tumors are adenocarcinoma. R\XKidney Medulla A05.810.453.466 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. Kidney (66-72) R:2Kidney Glomerulus A05.810.453.736.520 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Glomerular Filtration Rate; Renal Blood Flow, Effective; Renal Plasma Flow, Effective Urogenital System; Urinary Tract; Kidney; Nephrons Glomerular Mesangium; Juxtaglomerular Apparatus Globular tufts of capillaries, one projecting into the expanded end or capsule of each of the uriniferous tubules, which together with its surrounding capsule (glomerular capsule) constitute the renal corpuscle. (Dorland, 27th ed).  R:e>7Kidney Function Tests E01.341.453 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Urologic (Non MeSH) Blood Urea Nitrogen; Glomerular Filtration Rate; Radioisotope Renography AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE R0"2U,Kidney Failure, Chronic C12.777.419.430.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemodialysis; Uremia Glomerulonephritis; Pyelonephritis Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney Failure An irreversible and usually progressive reduction in renal function in which both kidneys have been damaged by a variety of diseases to the extent that they are unable to adequately remove the metabolic products from the blood and regulate the body's electrolyte composition and acid-base balance. Chronic kidney failure requires HEMODIALYSIS or surgery, usually KIDNEY TRANSPLANTATION.  RVN(uKidney Failure, Acute C12.777.419.430.205 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anuria; Hemodialysis Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney Failure Kidney Tubular Necrosis, Acute A clinical syndrome characterized by a sudden decrease in glomerular filtration rate, often to values of less than 1 to 2 ml per minute. It is usually associated with oliguria (urine volumes of less than 400 ml per day) and is always associated with biochemical consequences of the reduction in glomerular filtration rate such as a rise in blood urea nitrogen (BUN) and serum creatinine concentrations.  RyNu%Kidney Failure C12.777.419.430 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Diabetes Insipidus, Nephrogenic; Kidney Failure, Acute (+ 1); Kidney Failure, Chronic The inability of a kidney to excrete metabolites at normal plasma levels under conditions of normal loading, or the inability to retain electrolytes under conditions of normal intake. In the acute form (KIDNEY FAILURE, ACUTE), it is marked by uremia and usually by oliguria or anuria, with hyperkalemia and pulmonary edema. The chronic form (KIDNEY FAILURE, CHRONIC) is irreversible and requires hemodialysis. Kidney Diseases (66-92); Kidney Failure, Acute (66-92); Kidney Failure, Chronic (66-92)  R±NbfiKidney Diseases C12.777.419 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Renal Replacement Therapy; Nephrology Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases AIDS-Associated Nephropathy; Anuria (+ 1); Diabetic Nephropathies; Fanconi Syndrome; Hepatorenal Syndrome; Hydronephrosis; Hyperoxaluria, Primary; Hypertension, Renal (+ 1); Kidney Calculi; Kidney Cortex Necrosis; Kidney, Cystic (+ 4); Kidney Failure (+ 4); Kidney Neoplasms; Kidney Papillary Necrosis; Nephritis (+ 12); Nephrocalcinosis; Nephrosclerosis; Nephrosis (+ 2); Perinephritis; Pyelitis (+ 3); Renal Artery Obstruction; Renal Osteodystrophy; Renal Tubular Transport, Inborn Errors (+ 10); Tuberculosis, Renal; Uremia (+ 1); Wegener's Granulomatosis; Zellweger Syndrome BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  R_N-NZKidney Cortex Necrosis C12.777.419.393 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases The death of all the functioning renal cells of the kidney cortex with continued viability of the majority of the medullary units. It is due usually to the arterial distribution peculiar to the kidney which makes the renal cortex more susceptible to diminished blood flow. R}NbBKidney Cortex A05.810.453.324 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney Kidney (66-72) R:2Kidney Concentrating Ability G08.852.553 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Urinary Tract Physiology (Non MeSH) Kidney/physiology (66) R͈"bKidney Calices A05.810.453.537.503 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Kidney Pelvis Rh:DKidney Calculi C12.777.419.373; C12.777.809.503; C23.146.935.542 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Calculi Symptoms and General Pathology (Non MeSH); Calculi; Urinary Calculi Calculi occurring in the kidney. Calculi too large to pass spontaneously range in size from 1 cm to the staghorn stones that occupy the renal pelvis and calyces. Bilateral renal calculi cause additional problems, with infection a common occurrence. R/9R%Kidney A05.810.453 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Diuresis; Nephrectomy; Renal Circulation Renal Replacement Therapy Urogenital System; Urinary Tract Kidney Cortex; Kidney Medulla; Kidney Pelvis (+ 1); Nephrons (+ 8) consider also terms at GLOMERUL-, NEPHR-, PYEL-, and RENAL. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI (R' 81(TH:Kidd Blood-Group System D24.611.216.705.230.538; G04.610.241.538; G09.188.229.538 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups A group of antigens consisting principally of Jk(a) and Jk(b), determined by allelic genes. Amorphs are encountered. Antibodies of these substances are usually weak and quite labile, stimulated by erythrocytes. Blood Groups (66-75) RA2PKhellin D18.918.543 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cardiovascular Agents; Vasodilator Agents R :1Ketotifen D03.383.621.370; D03.383.903.370; D14.100.375.425.400.440; D23.075.446 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Dermatologic Agents; Antipruritics A cycloheptathiophene that interferes with the release of inflammatory mediators and blocks histamine H1 receptors. It has been proposed as an anti-asthmatic and for rhinitis, skin allergies, and anaphylaxis. Piperidines (66-81); Thiophenes (66-81) R׷ P:0Ketosteroids D04.808.578 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids 17-Ketosteroids (+ 8) Steroid derivatives formed by oxidation of a methyl group on the side chain or a methylene group in the ring skeleton to form a ketone. appropriate steroid class (71-73) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $R 8((DKetosis C18.452.076.176.652 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance; Acidosis A condition characterized by an abnormally elevated concentration of ketone bodies in the body tissues and fluids. It is a complication of diabetes mellitus and starvation. (Dorland, 27th ed). R NrKetoses D09.203.546.465 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides Dihydroxyacetone; Fructose; Mannoheptulose; Sorbose; Xylulose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR R >^IDKetoprofen D02.241.223.701.480; D08.373.310.425; D16.850.015.050.480; D17.025.030.425; D17.050.030.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylpropionates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 3-Benzoyl-alpha-methylbenzeneacetic acid. An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzophenones (68-74); Ketones (66-67); Propionates (66-67) RPg:HKetones D02.522 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Acetone; Acetophenones (+ 2); Benzophenones; Butanones (+ 3); Butyrophenones (+ 6); Camphor; Cyclohexanones (+ 1); Hexanones (+ 1); Ketone Bodies (+ 2); Mannich Bases; Methadone (+ 1); Pentanones; Phosgene; Propiophenones (+ 9) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR R   8#<Ketone Oxidoreductases D08.586.682.472 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Ketoglutarate Dehydrogenase Complex; Pyruvate Oxidase; Xanthine Dehydrogenase; Xanthine Oxidase Oxidoreductases (66-72) RFXnKetone Bodies D02.522.585 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Acetoacetates; Acetone AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Rw:/<Ketoglutaric Acids D02.241.081.337.351.502; D02.241.607.465 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Glutarates Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids R.8Ketoglutarate Dehydrogenase Complex D08.586.600.465; D08.586.682.472.377 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Ketone Oxidoreductases R)*FKetoconazole D03.383.606.560; D20.136.533 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Anti-Infective Agents; Antifungal Agents 1-Acetyl-4-[4-[(2-(2,4-dichlorophenyl)-2- (1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy] -phenyl]-cis-piperazine. Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Imidazoles (66-83); Piperazines (66-83) Ri":0Ketocholesterols D04.808.247.222.265.450; D04.808.247.222.284.600; D04.808.247.808.197.600; D10.516.851.208.650 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestenones Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholesterol Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Cholesterol substituted in any position by a keto moiety. The 7-keto isomer inhibits 3-hydroxy-3-methylglutaryl-CoA reductase activity and inhibits cholesterol uptake in the coronary arteries and aorta in vitro. Cholesterol (66-74) /analogs and derivatives (75-79) RhBM=Ketoacid-Lyases D08.586.520.567 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases Acetolactate Synthase; Anthranilate Synthase; ATP Citrate Lyase; Citrate Synthase; Hydroxymethylglutaryl-CoA Synthase; Isocitrate Lyase; 2-Isopropylmalate Synthase; Malate Synthase Lyases (66-72) RFOKeto Acids D02.241.607 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids Acetoacetates; Hippurates (+ 3); Ketoglutaric Acids; Levulinic Acids (+ 1); Oxaloacetates; Pyruvates (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR R89:Ketanserin D03.383.621.365; D03.438.786.430; D14.100.850.850.425; D18.162.505; D19.461.780.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinazolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Cardiovascular Agents; Antihypertensive Agents Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Platelet Aggregation Inhibitors A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. Piperidines (66-86) RJ_:BKetamine D02.455.426.392.368.367.652; D14.100.190.300.380; D15.050.035.075.035.350; D15.210.100.175.075.035.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Anesthetics, Dissociative Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Anesthetics, Dissociative (+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone. Cyclohexanone derivative used as an intravenous anesthetic. Ketamine produces a dissociative anesthesia in which the patient is not asleep but does not respond appropriately to environmental stimuli, including pain, and does not remember what occurred under the influence of the drug. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. Analgesics (66-71); Anesthetics (72); Cyclohexanes (68-72) Rk p:>GKerosine G03.230.132.258.630.600; J01.435.723.627; J01.740.400.700.450 AEANCLECHIMIPOPSRESDSNSTTOUTVI Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Fossil Fuels; Petroleum Technology, Industry, Agriculture (Non MeSH); Fossil Fuels; Petroleum Technology, Industry, Agriculture (Non MeSH); Oils; Industrial Oils; Petroleum A refined petroleum fraction used as a fuel as well as a solvent. R\ E",RKernicterus C10.228.140.163.501; C15.378.120.413.502; C16.614.304.502; C20.188.413.502; C23.888.498.329.585; F03.709.346.455 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Group Incompatibility; Erythroblastosis, Fetal Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Erythroblastosis, Fetal Immunologic Diseases; Blood Group Incompatibility; Erythroblastosis, Fetal Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Hyperbilirubinemia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A condition characterized by high levels of nonconjugated bilirubin in the blood with biliary pigmentation of certain nuclei in the brain and spinal cord and frequently resulting in cerebral palsy, mental retardation, and hearing deficit. It is commonly a sequel to icterus gravis neonatorum. Sp~LUKeratotomy, Radial E04.792.535 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cornea Surgery, Operative; Surgery, Eye (Non MeSH) A procedure to treat myopia by cutting radial slits into the cornea to flatten it and thereby change its refractive properties. Cornea (66-86); Myopia (66-86)  SW$ 5'Keratosis, Seborrheic C17.800.428.580 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Benign eccrine poromas that present as multiple oval, brown-to-black plaques, located mostly on the chest and back. The age of onset is usually in the fourth or fifth decade. Dermatitis, Seborrheic (66-92); Keratosis (66-92) SNX;Keratosis Follicularis C17.800.428.452; C17.800.827.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH) A slowly progressive autosomal dominant disorder of keratinization characterized by pinkish-to-tan papules that coalesce to form plaques. These lesions become darker over time and commonly fuse, forming papillomatous and warty malodorous growths. S &NKeratosis C17.800.428 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Callosities; Cholesteatoma (+ 1); Ichthyosis (+ 6); Keratoderma Blennorrhagicum; Keratoderma, Palmoplantar (+ 2); Keratosis Follicularis; Keratosis, Seborrheic; Parakeratosis; Porokeratosis Any horny growth such as a wart or callus. S f NK7Keratoplasty, Penetrating E04.792.225.350; E04.936.580.225.350 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Surgery, Eye (Non MeSH); Corneal Transplantation Surgery, Operative; Transplantation; Tissue Transplantation; Corneal Transplantation Partial or total replacement of all layers of a central portion of the cornea. Cornea/transplantation (66-89) SW*2`$Keratolytic Agents D23.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Dermatologic Agents Acitretin; Benzoyl Peroxide; Coal Tar; Etretinate; Isotretinoin; Podophyllin (+ 1); Tretinoin Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. Dermatologic Agents (67-74); Skin Diseases (66) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $S- 8r:@Keratoderma, Palmoplantar, Diffuse C17.800.428.435.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Keratoderma, Palmoplantar An autosomal dominant disorder characterized by a widely distributed, well-demarcated hyperkeratosis of the palms and soles. There is more than one genotypically distinct form, each of which is clinically similar but histologically distinguishable. Diffuse palmoplantar keratoderma is distinct from palmoplantar keratoderma (KERATODERMA, PALMOPLANTAR), as the former exhibits autosomal dominant inheritance and hyperhidrosis is frequently present. Keratosis (66-73); Keratosis, Palmaris et Plantaris (74-89) S(NvGKeratoderma, Palmoplantar C17.800.428.435 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Keratoderma, Palmoplantar, Diffuse; Papillon-Lefevre Disease Group of mostly hereditary disorders characterized by thickening of the palms and soles as a result of excessive keratin formation leading to hypertrophy of the stratum corneum (hyperkeratosis). S&NXEKeratoderma Blennorrhagicum C17.800.428.418 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Reiter's Disease Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis A cutaneous manifestation of REITER'S DISEASE, most often involving the palms, soles, toes, and penis, and characterized by the presence of erythematous macules that vesiculate, become purulent, and develop thick keratotic coverings. (Dorland, 27th ed). SL NX&Keratoconus C11.204.627 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases A noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. (From Dorland, 27th ed). SN&rKeratoconjunctivitis, Infectious C01.252.354.450; C01.539.375.354.450; C11.187.183.394.520; C11.204.564.585.500; C11.294.354.450; C22.500 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial Eye Diseases; Conjunctival Diseases; Conjunctivitis; Keratoconjunctivitis Eye Diseases; Corneal Diseases; Keratitis; Keratoconjunctivitis Eye Diseases; Eye Infections; Eye Infections, Bacterial Animal Diseases Infectious diseases of cattle, sheep, and goats, characterized by blepharospasm, lacrimation, conjunctivitis, and varying degrees of corneal opacity and ulceration. In cattle the causative agent is MORAXELLA (MORAXELLA) BOVIS; in sheep, MYCOPLASMA, RICKETTSIA, CHLAMYDIA, or ACHOLEPLASMA; in goats, RICKETTSIA. Bacterial Infections (72-85); Cattle Diseases (66-85); Keratoconjunctivitis (66-85); Moraxella (66-85) S%vJdyKeratoconjunctivitis Sicca C11.187.183.394.550; C11.204.564.585.630; C11.496.260.394 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sjogren's Syndrome Eye Diseases; Conjunctival Diseases; Conjunctivitis; Keratoconjunctivitis Eye Diseases; Corneal Diseases; Keratitis; Keratoconjunctivitis Eye Diseases; Lacrimal Apparatus Diseases; Dry Eye Syndromes Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME. Keratoconjunctivitis (66-85)  S!_AN!Keratoconjunctivitis C11.187.183.394; C11.204.564.585 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Conjunctival Diseases; Conjunctivitis Eye Diseases; Corneal Diseases; Keratitis Keratoconjunctivitis, Infectious; Keratoconjunctivitis Sicca Keratoconjunctivitis, Infectious; Keratoconjunctivitis Sicca Simultaneous inflammation of the cornea and conjunctiva. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  S$,&NnCPKeratoacanthoma C17.800.417 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption. S&jNKKeratitis, Herpetic C02.256.466.382.465; C02.325.465; C11.204.564.425; C11.294.800.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Simplex Virus Diseases; Eye Infections, Viral Eye Diseases; Corneal Diseases; Keratitis Eye Diseases; Eye Infections; Eye Infections, Viral Keratitis, Dendritic Keratitis, Dendritic Keratitis, Dendritic Keratitis, Dendritic A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers (KERATITIS, DENDRITIC). (Dictionary of Visual Science, 3d ed, p324). Keratitis, Dendritic (66-91)  S)/LP^ "Keratitis, Dendritic C02.256.466.382.465.450; C02.325.465.450; C11.204.564.425.450; C11.294.800.475.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Simplex; Keratitis, Herpetic Virus Diseases; Eye Infections, Viral; Keratitis, Herpetic Eye Diseases; Corneal Diseases; Keratitis; Keratitis, Herpetic Eye Diseases; Eye Infections; Eye Infections, Viral; Keratitis, Herpetic A form of herpetic keratitis characterized by the formation of small vesicles which break down and coalesce to form recurring dendritic ulcers, characteristically irregular, linear, branching, and ending in knoblike extremities. (Dictionary of Visual Science, 3d ed, p323). S,\Pe=Keratitis C11.204.564 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases Acanthamoeba Keratitis; Corneal Ulcer; Keratitis, Herpetic (+ 1); Keratoconjunctivitis (+ 2) Inflammation of the cornea. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  S0= N&n#PKeratinocytes A11.436.397 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Skin Cells; Epithelial Cells (Non MeSH) Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Epidermis/cytology (75-89); Keratin (68-89); Skin/cytology (68-89)  S1*+QKeratin D12.776.220.475.450; D12.776.860.607 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Intermediate Filament Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH) A class of fibrous proteins or scleroproteins important both as structural proteins and as keys to the study of protein conformation. The family represents the principal constituent of epidermis, hair, nails, horny tissues, and the organic matrix of tooth enamel. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms an alpha-helix, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. S4R *HKeratan Sulfate D09.203.698.373.550 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans A sulfated mucopolysaccharide initially isolated from bovine cornea. At least two types are known. Type I, found mostly in the cornea, contains D-galactose and D-glucosamine-6-O-sulfate as the repeating unit; type II, found in skeletal tissues, contains D-galactose and D-galactosamine-6-O-sulfate as the repeating unit. Mucopolysaccharides (70-74); Galactosamine (72-74) S7Ftr;Kepone D02.455.526.439.550; D05.723.491.491.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Decachlorooctahydro-1,3,4-metheno-2H-cyclobuta[CD]pentalen-2-one. A highly chlorinated polycyclic hydrocarbon insecticide whose large number of chlorine atoms makes it resistant to degradation. It has been shown to be toxic to mammals and causes abnormal cellular changes in laboratory animals. Synonym: GC-1,189. Bridged Compounds (69-76); Insecticides, Organochlorine (73-76) S: .:eJKenya Z01.058.290.120.400 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern S= _Kentucky Z01.107.567.875.100.422; Z01.107.567.875.600.066.422; Z01.107.567.875.600.516.422 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Appalachian Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States S>p YKemerovo Virus B04.820.630.550.500; B04.909.777.714.550.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae; Orbivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae; Orbivirus A species of antigenically related tick-borne viruses found in Eastern Europe, Egypt, and Sudan. S@2rKeloid C17.300.200.425; C17.800.120.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cicatrix, Hypertrophic Cicatrix; Cicatrix, Hypertrophic Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Cicatrix Acne Keloid Acne Keloid A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar (CICATRIX, HYPERTROPHIC) in that the former does not spread to surrounding tissues. $SB, &N'^Kell Blood-Group System D24.611.216.705.230.533; G04.610.241.533; G09.188.229.533 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups Multiple erythrocytic antigens that comprise at least three pairs of alternates and amorphs, determined by one complex gene or possibly several genes at closely linked loci. The system is important in transfusion reactions. Its expression involves the X-chromosome. Blood Groups (66-75) SE[A2P5Kearns Syndrome C05.651.460.620.650.410; C10.597.622.447.750.410; C10.772.204.410.472.750.410; C11.590.472.750.410; C11.768.585.731.627; C14.280.600.510; C18.452.648.556.650.620.650.410; C23.888.592.636.447.750.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies; Ophthalmoplegia, Chronic Progressive External Nervous System Diseases; Neurologic Manifestations; Paralysis; Ophthalmoplegia; Ophthalmoplegia, Chronic Progressive External Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders; Ophthalmoplegia; Ophthalmoplegia, Chronic Progressive External Eye Diseases; Ocular Motility Disorders; Ophthalmoplegia; Ophthalmoplegia, Chronic Progressive External Eye Diseases; Retinal Diseases; Retinal Degeneration; Retinitis Pigmentosa Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Mitochondrial Myopathies; Mitochondrial Encephalomyopathies; Ophthalmoplegia, Chronic Progressive External Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Ophthalmoplegia; Ophthalmoplegia, Chronic Progressive External A triad of progressive external ophthalmoplegia, cardiomyopathy, and retinitis pigmentosa. Heart Block (66-82); Ophthalmoplegia (66-82); Retinitis Pigmentosa (66-82) SHNhYKB Cells A11.251.210.501; A11.251.353.501; A11.251.928.501 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Cells; Cells, Cultured; Clone Cells Cells; Cells, Cultured; Tumor Cells, Cultured A cell line derived from a human carcinoma of the nasopharynx, used as an assay for antineoplastic agents. Cell Line (69-84); Tissue Culture (66-71) SO 9*4Kazakhstan Z01.252.100.420; Z01.586.200.440; Z01.586.950.440 EHEP Geographicals (Non MeSH); Asia; Asia, Central Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR SQ9Katz Adjustment Scales F04.586.334 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychiatric Status Rating Scales Rating scales designed to measure adjustment and social behavior of psychiatric patients in the community prior to release or during post-hospitalization period. SR aKassinin D12.644.320.900.475; D12.644.456.800.475; D12.776.641.650.800.475; D14.600.600.860.400; D17.350.050.375.850.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins; Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Tachykinins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Tachykinins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Tachykinins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins; Tachykinins Dodecapeptide tachykinin found in the central nervous system of the amphibian Kassina senegalensis. It is similar in structure and action to other tachykinins, but is especially effective in contracting smooth muscle tissue and stimulating the micturition reflex. Kinins (77-88); Oligopeptides (77-88) STd {FR1.Karyotyping E05.393.500 ISMTVE Cytogenetics; Chromosome Abnormalities; Chromosomes Miscellaneous Techniques (Non MeSH); Genetic Techniques SY  <BKaryometry E05.909.262.695 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cell Nucleus Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques SY"^Kartagener's Syndrome C08.200.531; C08.695.501; C09.150.531; C16.131.740.501; C16.131.810.501 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Ciliary Motility Disorders Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Otorhinolaryngologic Diseases; Ciliary Motility Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Situs Inversus  Dextrocardia An inherited disorder involving a combination of situs inversus, bronchiectasis, and sinusitis. SZSLoKarnofsky Performance Status E01.789.400; N02.421.589.473.100.608.400 HISNST Diagnosis; Prognosis Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization; Diagnosis-Related Groups; Severity of Illness Index A performance measure for rating a person's usual activities, and evaluating a patient's progress after a therapeutic procedure. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy. S]". Karaya Gum D09.203.698.450; D19.316.396.510; D26.698.931.419.510 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids; Vehicles; Excipients Polysaccharide gum from Sterculia urens, an Indian tree; it is used as suspending or stabilizing agent in foods, cosmetics and pharmaceuticals; also as bulk-forming laxative, surgical lubricant and adhesive and in the treatment of skin ulcers. Synonyms: Kadaya; Kadillo; Kullo; Mucara; Sterculia. Polysaccharides (66-77); Resins (66-77) S`=@]0Kaposi's Varicelliform Eruption C02.256.466.382.410; C02.825.320.410; C17.800.838.790.320.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Simplex Virus Diseases; Skin Diseases, Viral; Herpes Simplex Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral; Herpes Simplex A generalized vesiculopustular eruption of viral origin, superimposed upon a preexisting atopic dermatitis. It may be caused by herpes simplex virus (HERPESVIRUS HOMINIS) (eczema herpeticum) or VACCINIA VIRUS (eczema vaccinatum). (Dorland, 27th ed). Sd%EP>"Kaolin D01.056.050.075.350; D01.578.725.025.350; D01.650.550.050.075.350; D01.837.725.700.760.050.400; D19.316.161.418; D26.394.225.672.418 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Aluminum Compounds; Aluminum Oxide; Aluminum Silicates Inorganic Chemicals (Non MeSH); Minerals; Silicates; Aluminum Silicates Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Aluminum Oxide; Aluminum Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Aluminum Silicates Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Antidiarrheals Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Powders Kaolin. The most common mineral of a group of hydrated aluminum silicates, approximately H2Al2Si2O8-H2O. It is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (From Merck Index, 11th ed) The name is derived from Kao-ling (Chinese: "high ridge"), the original site. (From Grant and Hackh's Chemical Dictionary, 5th ed). SgL ,rKansas Z01.107.567.875.100.413; Z01.107.567.875.600.516.413 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States SlY :Kangaroos B02.649.573.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Marsupialia Herbivorous leaping mammals of Australia, New Guinea, and adjacent islands. Sm ()YKanamycin Resistance G04.185.515.286.493; G05.386.310.493; G05.706.310.493; G12.392.269.493 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial Genetics; Genetics, Microbial; Drug Resistance, Microbial Genetics; Pharmacogenetics; Drug Resistance, Microbial Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial Nonsusceptibility of bacteria to the antibiotic KANAMYCIN, which can bind to their 70S ribosomes and cause misreading of messenger RNA. Drug Resistance, Microbial (66-87); Kanamycin (66-87) SnP @Kanamycin D09.203.408.051.476; D20.085.060.425; D20.085.089.464; D20.338.135.501 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular Amikacin; Dibekacin; Nebramycin (+ 1) Amikacin; Dibekacin; Nebramycin (+ 1) Dibekacin Dibekacin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Sq P<LrKallmann Syndrome C12.740.700.842.425; C13.371.820.700.842.425; C16.131.280.748.400; C16.131.939.842.425; C19.391.482.600; C19.391.775.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Endocrine Diseases; Gonadal Disorders (Non MeSH); Hypogonadism Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders Congenital and familial disorder characterized by hypogonadotropic hypogonadism, eunuchoidal features, and anosmia or hyposmia. It is caused by a defect in the synthesis and/or release of LHRH (luteinizing hormone-releasing hormone; GONADORELIN) from the hypothalamus as a result of faulty embryonic neuronal migration. The gene responsible for this is found in the region Xp22.3 on the short arm of the X chromosome. There is a homolog on the Y chromosome. The syndrome is more prevalent in males by a ratio of three to one. Hypogonadism (66-92) Su4N*jKallikrein-Kinin System G06.184.963.500; G06.535.516; G07.621.888.500; G09.330.612.530 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Water-Electrolyte Balance Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Physiology, General (Non MeSH); Homeostasis; Water-Electrolyte Balance Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics A system produced in the distal nephron of the kidney. Its components are kallikrein, kinins, kininase I and II, and enkephalinase. It is involved in mediation and modulation of the renin-angiotensin-aldosterone system, prostaglandins, vasopressins, and in the regulation of sodium-water balance, renal hemodynamics, and particularly blood pressure. The system participates in the control of renal functions and the physiopathology of renal diseases. Kallikrein (66-90); Kinins (66-90) S{H+Kallikrein D08.586.277.656.732.760.426; D12.776.124.125.550; D19.461.270.229.533 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors  Prekallikrein Prekallikrein Peptidohydrolytic enzyme found in normal blood and urine. It is involved in blood coagulation and is formed from prekallikrein, probably by clotting factor XII. Kallikrein is a potent vasodilator and hypotensive, increases vascular permeability and affects smooth muscle. It is thereby intimately involved in inflammation and allergic reactions. Two forms are recognized, plasma kallikrein (EC 3.4.21.34) and tissue kallikrein (EC 3.4.21.35). S[MD!Kallidin D12.644.320.169.400; D12.644.456.193.400; D17.350.050.375.110.400; D18.918.520 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins; Bradykinin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Bradykinin Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins; Bradykinin Cardiovascular Agents; Vasodilator Agents N(2)-L-Lysylbradykinin. A decapeptide bradykinin homolog produced by the action of tissue and glandular kallikreins on low-molecular-weight kininogen. It is a smooth-muscle stimulant and hypotensive agent that functions through vasodilatation. S XFKainic Acid D03.383.773.400; D14.100.190.200.420; D21.201.287.435 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, Kainic Acid Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Agonists Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. Pyrrolidines (66-77)  SM=:YJuxtaglomerular Apparatus A05.810.453.736.520.520 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Bartter's Disease; Renin Urogenital System; Urinary Tract; Kidney; Nephrons; Kidney Glomerulus A collective term for the juxtaglomerular cells in a nephron. These are specialized cells containing secretory granules, located in the tunica media of the afferent glomerular arterioles. They are receptors thought to stimulate secretion of the adrenal hormone aldosterone and to play a major role in renal autoregulation. (Dorland, 27th ed). Sh:TJuvenile Hormones D06.472.445.573.666 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Invertebrate Hormones; Insect Hormones Diflubenzuron; Methoprene Compounds, either natural or synthetic, which block development of the growing insect. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  SBpfDJuvenile Delinquency F03.126.842.393; F03.234.451; I01.880.735.479 CLECEHHILJPCPXRHSNTD Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders Social Sciences; Sociology; Social Problems The antisocial acts of children or persons under age which are illegal or lawfully interpreted as constituting delinquency. S5Jurisprudence I01.880.604.583; N03.706.535 HI Forensic Dentistry; Forensic Medicine Social Sciences; Sociology; Social Control, Formal Economics, Organizations, Control (Non MeSH); Social Control, Formal Advance Directives (+ 1); Confidentiality (+ 1); Criminal Law; Expert Testimony; Forensic Psychiatry (+ 1); Informed Consent (+ 1); Liability, Legal; Malpractice (+ 3); Mental Competency; Patents; Resuscitation Orders; Wills (+ 1); Wrongful Life Advance Directives (+ 1); Confidentiality (+ 1); Expert Testimony; Forensic Psychiatry (+ 2); Informed Consent (+ 1); Liability, Legal; Malpractice (+ 3); Mental Competency; Resuscitation Orders; Wrongful Life The application of the principles of law and justice to health and medicine. CLECEDEHHIISLJMAMTOGPCPXSNSTTDUT $S"-(]$Jupiter H01.091.800.700.412 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets The fifth planet in order from the sun. It is one of the five outer planets of the solar system. Its sixteen natural satellites include Callisto, Europa, Ganymede, and Io. Extraterrestrial Environment (66-90); Planets (91-94) S M?Juniper B06.915.554 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Trees Any of the trees or shrubs of the genus Juniperus. The dried ripe fruit of Juniperus communis or common juniper tree was formerly used as a diuretic. The fruit is also used for flavoring certain alcoholic beverages (e.g., gin). The fruit is referred to as juniper berries. (From Dorland, 27th ed). Trees (69-94) SY &fJunin Virus B04.820.057.070.800.450; B04.909.777.080.070.800.450 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae; Arenavirus; Tacaribe Complex Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae; Arenavirus; Tacaribe Complex Viruses A species of ARENAVIRUS, part of the TACARIBE COMPLEX VIRUSES, causing Argentinian hemorrhagic fever. The disease is characterized by congestion, edema, generalized lymphadenopathy and hemorrhagic necrosis, leading to death in up to 30% of the cases. Tacaribe Complex Viruses (76-93) SK:#'Jungian Theory F02.739.794.471 HI Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory A theoretical psychoanalytical system centered around symbols of the unconscious with the unconscious material derived from two sources - the personal unconscious (repressed or forgotten experiences, thoughts and feelings) and the collective or objective unconscious (the universal inherited qualities which dispose the individual to behave as his ancestors). SlJugular Veins A07.231.908.498 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins Veins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins. SK85zJudgment F02.463.785.626 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking The process of discovering or asserting an objective or intrinsic relation between two objects or concepts; a faculty or power that enables a person to make judgments; the process of bringing to light and asserting the implicit meaning of a concept; a critical evaluation of a person or situation. Sz  ZaJudaism K01.844.385 HIPX Jews Jews Humanities; Religion The religion of the Jews characterized by belief in one God and in the mission of the Jews to teach the Fatherhood of God as revealed in the Hebrew Scriptures. (Webster, 3d ed).  S Journalism, Dental L01.737.526.500 HIST Information Science; Publishing; Journalism Content, management, editing, policies, and printing of dental periodicals such as journals, newsletters, tabloids, and bulletins. S4Journalism L01.737.526 HIST Information Science; Publishing Journalism, Dental The collection, writing, and editing of material of current interest for presentation through the media of newspapers, magazines, radio, or television. It is published in electronic or print forms. It includes also journalistic writing designed for publication in popular, scientific, or professional presses. (From Webster, 3d ed). Periodicals (66-93); Publishing (66-93)  S&0Josamycin D20.085.115.362.350 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Leucomycins Leucomycin V, 3-acetate, 4 beta-(3-methylbutanoate). A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens. Antibiotics (66-80); Leucomycins (81-89) S1 <S1Jordan Z01.252.245.500.400; Z01.586.500.400 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East S *Joints A02.835.583 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Arthrography; Arthroplasty; Arthroscopy Musculoskeletal System; Skeleton Acromioclavicular Joint; Ankle Joint; Atlanto-Axial Joint; Atlanto-Occipital Joint; Bursa, Synovial; Cartilage, Articular; Elbow Joint; Finger Joint (+ 1); Hip Joint; Joint Capsule (+ 2); Knee Joint (+ 1); Ligaments, Articular (+ 8); Pubic Symphysis; Sacroiliac Joint; Shoulder Joint; Sternoclavicular Joint; Sternocostal Joints; Tarsal Joint (+ 1); Temporomandibular Joint; Toe Joint (+ 1); Wrist Joint consider also terms at ARTHR-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $S  8/'':Joint Prosthesis E04.557.168.530; E04.659.550; E07.450.530; E07.858.442.499; E07.858.565.600 AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI Surgery, Operative; Orthopedics; Arthroplasty Surgery, Operative; Prosthesis Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Orthopedic Equipment Equipment and Supplies; Surgical Equipment; Prosthesis Hip Prosthesis; Knee Prosthesis Hip Prosthesis; Knee Prosthesis Hip Prosthesis; Knee Prosthesis Hip Prosthesis; Knee Prosthesis Hip Prosthesis; Knee Prosthesis Partial or total replacement of a joint. specific joint (66-70); Prosthesis (66-70)  S)W*34Joint Loose Bodies C05.550.535 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Fibrous, bony, cartilaginous and osteocartilaginous fragments in a synovial joint. Major causes are osteochondritis dissecans, synovial chondromatosis, osteophytes, fractured articular surfaces and damaged menisci. Joint Diseases (66-82); Knee Joint (66-82); Osteochondritis (66-82); Synovial Membrane (66-82) S!N0rJoint Instability C05.550.521 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Lack of stability of a joint or joint prosthesis. Factors involved are intra-articular disease and integrity of extra-articular structures such as joint capsule, ligaments, and muscles. Joint Diseases (66-82); Ligaments, Articular (66-82) SRN0?Joint Diseases C05.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Ankylosis (+ 1); Arthralgia; Arthritis (+ 24); Arthrogryposis; Arthropathy, Neurogenic; Bursitis (+ 1); Chondromatosis, Synovial; Contracture (+ 1); Hemarthrosis; Hip Dislocation, Congenital; Hydrarthrosis; Joint Deformities, Acquired; Joint Instability; Joint Loose Bodies; Osteoarthropathy, Primary Hypertrophic; Osteoarthropathy, Secondary Hypertrophic; Shoulder-Hand Syndrome; Synovitis (+ 1); Temporomandibular Joint Diseases (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI S3 NPJoint Deformities, Acquired C05.550.515 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Deformities acquired after birth as the result of injury or disease. The joint deformity is often associated with rheumatoid arthritis and leprosy. S0!L0Joint Commission on Accreditation of Healthcare Organizations N03.706.110.070.410; N05.700.200.100.420 ECHILJOG Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing; Accreditation Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing; Accreditation A private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation. SG. Joint Capsule A02.835.583.443 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Joints Synovial Membrane (+ 1) The sac-like envelope which encloses the cavity of a synovial joint by attaching to the circumference of the articular end of each involved bone. It consists of two layers. The fibrous membrane of the articular capsule (membrana fibrosa capsulae articularis) is the outer layer and is composed of dense white fibrous tissue. The SYNOVIAL MEMBRANE (membrana synovialis capsulae articularis) is the inner layer composed of loose connective tissue and possessing a smooth surface lining the joint cavity. (From Dorland, 27th ed). Joints (66-93)  S:1hJogging I03.450.642.845.610.320 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports; Running Running at a low rate of speed as a means of conditioning for other sports or for general health and well being. Physical Fitness (66-75) SS ]Job's Syndrome C15.378.553.774.600; C20.673.774.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Phagocyte Bactericidal Dysfunction Immunologic Diseases; Immunologic Deficiency Syndromes; Phagocyte Bactericidal Dysfunction A disorder of neutrophils characterized by the presence of abnormal or absent chemotactic responses and hyperimmunoglobulinemia E. It is transmitted as an autosomal recessive trait and most cases reported have been in girls. S*NJob Satisfaction F01.145.076.747.150; F02.784.692.425 Employment Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Personal Satisfaction Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial Personal satisfaction relative to the work situation. Personal Satisfaction (72-75) So*@#Job Description N04.452.677.410 ST Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Statement of the position requirements, qualifications for the position, wage range, and any special conditions expected of the employee. SpJob Application N04.452.677.400 Employment Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Process of applying for employment. It includes written application for employment or personal appearance. Employment (70-82); Personnel Management (66-82) Swp}:Jews I01.076.201.450.416.582; I01.880.143.522.582; M01.194.582 CLEDGEHILJPXSN Judaism Judaism Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group with certain cultural and religious traditions.  SA  LJellyfish B01.308.495 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Cnidaria Free swimming marine cnidarians. Most of the large jellyfish are in the class Scyphozoa; the small jellyfish are in the class Hydrozoa. Coelenterata (66-74) Sȩ (Jejunum A03.492.411.620.625 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Jejunostomy Digestive System; Gastrointestinal System; Intestines; Intestine, Small S :TJejunostomy E04.579.338.523; E04.765.338.523 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Jejunum Surgery, Operative; Ostomy; Enterostomy Surgery, Operative; Surgery, Digestive System (Non MeSH); Enterostomy Surgical formation of an opening through the abdominal wall into the jejunum, usually for enteral hyperalimentation. Jejunum/surgery (66-87)  S&$ Jejunoileal Bypass E04.035.415; E04.765.626 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Obesity, Morbid Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Digestive System (Non MeSH) A surgical procedure consisting of the anastomosis of the proximal part of the jejunum to the distal portion of the ileum, so as to bypass the nutrient-absorptive segment of the small intestine, to treat morbid obesity. Ileum (66-85); Jejunum (66-85); Obesity (66-85)  S̄$r<Jejunal Neoplasms C04.588.274.476.411.523; C06.240.476.411.523; C06.405.282.411.523; C06.405.469.505.523; C06.405.469.600.523 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Jejunal Diseases Intestinal Neoplasms (66-79); Jejunum (66-79) SwXF7Jejunal Diseases C06.405.469.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Jejunal Neoplasms Intestinal Diseases (66-79); specific intestinal disease; Jejunum (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  SRNUWXJealousy F01.470.653 Behavior and Behavior Mechanisms (Non MeSH); Emotions An irrational reaction compounded of grief, loss of self-esteem, enmity against the rival and self criticism. S  AJaw, Edentulous, Partially C05.500.480.450; C07.320.480.450; C07.465.550.425.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases; Jaw, Edentulous Stomatognathic Diseases; Jaw Diseases; Jaw, Edentulous Stomatognathic Diseases; Mouth Diseases; Mouth, Edentulous; Jaw, Edentulous Absence of teeth from a portion of the mandible and/or maxilla. Mouth, Edentulous (66-79) S  =NOJaw, Edentulous C05.500.480; C07.320.480; C07.465.550.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases Stomatognathic Diseases; Mouth Diseases; Mouth, Edentulous Jaw, Edentulous, Partially Jaw, Edentulous, Partially Jaw, Edentulous, Partially The total absence of teeth from either the mandible or the maxilla, but not both. Total absence of teeth from both is MOUTH, EDENTULOUS. Partial absence of teeth in either is JAW, EDENTULOUS, PARTIALLY. Mouth, Edentulous (66-79)  S!1N\Jaw Relation Record E06.520 ISMT Dental Occlusion Dentistry Centric Relation A registration of any positional relationship of the mandible in reference to the maxillae. These records may be any of the many vertical, horizontal, or orientation relations. (Jablonski, Illustrated Dictionary of Dentistry). Dental Occlusion (66-69) $S   Jaw Neoplasms C04.588.149.721.450; C05.116.231.754.450; C05.500.499; C07.320.515 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms; Skull Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms; Skull Neoplasms Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases Mandibular Neoplasms; Maxillary Neoplasms; Palatal Neoplasms Mandibular Neoplasms; Maxillary Neoplasms; Palatal Neoplasms Mandibular Neoplasms; Maxillary Neoplasms; Palatal Neoplasms Mandibular Neoplasms; Maxillary Neoplasms; Palatal Neoplasms Cancers or tumors of the maxilla or mandible unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available. Jaw (66); Mandibular Neoplasms (66); Maxillary Neoplasms (66)  SۡLXLJaw Fractures C21.866.405.762.467; C21.866.460.589.338.500; C21.866.460.836.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Skull Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Skull Fractures Mandibular Fractures; Maxillary Fractures Mandibular Fractures; Maxillary Fractures Mandibular Fractures; Maxillary Fractures Fractures of the upper or lower jaw. S߷INw/Jaw Diseases C05.500; C07.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Stomatognathic Diseases Cherubism; Granuloma, Giant Cell; Jaw Abnormalities (+ 5); Jaw Cysts (+ 7); Jaw, Edentulous (+ 1); Jaw Neoplasms (+ 3); Mandibular Diseases (+ 6); Maxillary Diseases (+ 1) Cherubism; Granuloma, Giant Cell; Jaw Abnormalities (+ 5); Jaw Cysts (+ 7); Jaw, Edentulous (+ 1); Jaw Neoplasms (+ 3); Mandibular Diseases (+ 6); Maxillary Diseases (+ 1) Bone Diseases (66); Jaw (66); Mandible (66); Maxilla (66) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  SN7KXJaw Cysts C04.182.089.530; C05.500.470; C07.320.450 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases Nonodontogenic Cysts; Odontogenic Cysts (+ 5) Nonodontogenic Cysts; Odontogenic Cysts (+ 5) Nonodontogenic Cysts; Odontogenic Cysts (+ 5) Saccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts (pseudocysts) as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic. Bone Cysts (66-79); Cysts (66-79); Jaw Diseases (67-79); specific jaw disease; Jaw Neoplasms (67-79); specific jaw neoplasm  S1V|jJaw Abnormalities C05.500.460; C05.660.514; C07.320.440; C07.650.460; C16.131.621.514; C16.131.850.460 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Stomatognathic Diseases; Jaw Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH) Cleft Palate; Micrognathism; Pierre Robin Syndrome; Prognathism; Retrognathism Cleft Palate; Micrognathism; Pierre Robin Syndrome; Prognathism; Retrognathism Cleft Palate; Micrognathism; Pierre Robin Syndrome; Prognathism; Retrognathism Cleft Palate; Micrognathism; Pierre Robin Syndrome; Prognathism; Retrognathism Cleft Palate; Micrognathism; Pierre Robin Syndrome; Prognathism; Retrognathism Cleft Palate; Micrognathism; Pierre Robin Syndrome; Prognathism; Retrognathism Congenital absence of or defects in structures of the jaw. SbL$HJaw A02.835.232.781.324.502; A14.521 AHBSCHCYDEEMENIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Dental Arch; Temporomandibular Joint Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones Stomatognathic System Alveolar Process; Dental Arch; Mandible (+ 2); Maxilla; Palate Alveolar Process; Dental Arch; Mandible (+ 2); Maxilla; Palate ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  S&6,m:Jaundice, Neonatal C16.614.555; C23.888.498.550 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Erythroblastosis, Fetal Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice The jaundice sometimes seen in newborn infants. It is also called icterus neonatorum. (Dorland, 27th ed). S"LJaundice, Chronic Idiopathic C18.452.648.499; C23.888.498.450 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice A familial chronic form of nonhemolytic jaundice thought to be due to a defect in the excretion of conjugated bilirubin and certain other organic anions (e.g., sulfobromophthalein) by the liver. It is characterized by the presence of a brown, coarsely granular pigment in the hepatic cells, which is pathognomonic of the condition. (Dorland, 27th ed). S"&LJaundice C23.888.498 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Cholestasis (+ 4); Hyperbilirubinemia (+ 4); Jaundice, Chronic Idiopathic; Jaundice, Neonatal A syndrome characterized by hyperbilirubinemia and deposition of bile pigment in the skin, mucous membranes, and sclera with resulting yellow appearance of the patient. (Dorland, 27th ed). S NXpJapan Z01.252.474.463 EHEP Geographicals (Non MeSH); Asia; Far East Tokyo ST 4 Jamaica Z01.107.084.900.525 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies S OIvermectin D02.540.400; D05.723.491.700; D09.203.698.629.305.328; D21.201.287.278.460; D21.201.287.425; D21.201.412.425; D21.201.425; D21.370.625 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Lactones Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents; Filaricides Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents Antiparasitic Agents (Non MeSH); Anthelmintics Antiparasitic Agents (Non MeSH); Antiprotozoal Agents A mixture of ivermectin component B1a (RN 71827-03-7) and B1b (RN 70209-81-3), which is a semisynthetic product from Streptomyces avermitilis. A potent macrocyclic lactone disaccharide antiparasitic agent used to prevent and treat parasite infestations in animals. The compound has activity against internal and external parasites and has been found effective against arthropods, insects, nematodes, filarioidea, platyhelminths, and protozoa. Anthelmintics (66-86); Antinematodal Agents (74-86); Antiprotozoal Agents (66-86); Filaricides (73-86); Insecticides (66-86); Lactones (66-86) Sp:zItraconazole D03.383.129.799.550; D03.383.606.530; D03.383.946.550; D20.136.470 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Triazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazoles Anti-Infective Agents; Antifungal Agents 4-(4-(4-(4-((2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one. An antifungal agent that has been used in the treatment of histoplasmosis, blastomycosis, cryptococcal meningitis, and aspergillosis. Ketoconazole/analogs and derivatives (84-93) SL:5\4Italy Z01.542.489 EHEP Geographicals (Non MeSH); Europe Rome; Sicily T )Israel Z01.252.245.500.375; Z01.586.500.375 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East T *Isradipine D03.383.725.203.310; D18.162.500; D18.192.400; D18.918.173.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 4-(4-Benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methyl ethyl ester. A potent calcium channel antagonist that is highly selective for vascular smooth muscle. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure. Dihydropyridines (91-92); Oxadiazoles (83-91); Pyridines (87-91) TH: ^MIsoxsuprine D02.033.329.624.427; D02.092.063.624.427; D06.347.930.400; D14.100.050.100.200.470; D16.050.870.360; D18.918.509; D26.930.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasodilator Agents Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor. Amino Alcohols (66-71); Sympathomimetics (66-71) T:O:Isoxazoles D03.383.548.332 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Isocarboxazid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR T &8TN:Isotretinoin D02.455.849.291.700.325; D11.557.261.700.325; D23.400.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids Dermatologic Agents; Keratolytic Agents 13-cis-Retinoic acid. A topical dermatologic agent that is used in the treatment of acne vulgaris and several other skin diseases. The drug has teratogenic and other adverse effects. Dermatologic Agents (75-88); Keratolytic Agents (75-88); Tretinoin (75-88) TA:YIsotopes D01.496 Elements Inorganic Chemicals (Non MeSH) Calcium Isotopes (+ 1); Carbon Isotopes (+ 1); Cerium Isotopes (+ 1); Cesium Isotopes (+ 1); Chromium Isotopes (+ 1); Cobalt Isotopes (+ 1); Deuterium; Gallium Isotopes (+ 1); Gold Isotopes (+ 2); Iodine Isotopes (+ 2); Iron Isotopes (+ 1); Mercury Isotopes (+ 1); Nitrogen Isotopes (+ 1); Oxygen Isotopes (+ 1); Phosphorus Isotopes (+ 1); Potassium Isotopes (+ 1); Radioisotopes (+ 39); Sodium Isotopes (+ 1); Strontium Isotopes (+ 1); Sulfur Isotopes (+ 1); Xenon Isotopes (+ 1); Yttrium Isotopes (+ 1); Zinc Isotopes (+ 1) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR TM   %8Isotope Labeling E05.522 AECLCTECHIISMOMTNUPXSNSTTDUTVE Radioisotopes Miscellaneous Techniques (Non MeSH) Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. specific isotope (66-71)  T "*>Isotonic Solutions D26.394.225.766.498 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions T,ZIsotonic Contraction G11.427.661.493 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Muscle Contraction Muscle contraction with negligible change in the force of contraction but shortening of the distance between the origin and insertion. Muscle Contraction (66-83); Muscles (66-83) T^5Isothiuronium D02.886.904.390; D02.948.898.390; D17.025.080.300; D23.037.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical Proposed topical anti-inflammatory agent that may release histamine if given intradermally. Thiourea (73-74) /analogs and derivatives (75); Undecyclenic Acids (73-75) TH:jjXIsothiocyanates D02.500.375; D02.886.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Isocyanates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH) DIDS; Fluorescein-5-isothiocyanate; 1-Naphthylisothiocyanate; SITS DIDS; Fluorescein-5-isothiocyanate; 1-Naphthylisothiocyanate; SITS Organic compounds with the general formula R-NCS. Thiocyanates (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $T8w<:Isospora B01.841.075.762.167.275.250.467 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina A genus of protozoan parasites found in the intestines of birds, amphibians, reptiles, and mammals, including man. The oocysts produce two sporocysts, each with four sporozoites. Many species are parasitic in wild and domestic animals. T4 #&bIsosorbide Dinitrate D02.033.800.813.480.500; D09.203.853.813.480.500; D18.918.498 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Sorbitol; Isosorbide Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Sorbitol; Isosorbide Cardiovascular Agents; Vasodilator Agents T "E:Isosorbide D02.033.800.813.480; D09.203.853.813.480; D19.770.224.453.758.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Sorbitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Sorbitol Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Osmotic; Sorbitol Isosorbide Dinitrate Isosorbide Dinitrate 1,4:3,6-Dianhydro D-glucitol. Chemically inert osmotic diuretic used mainly to treat hydrocephalus; also used in glaucoma. Ethers, Cyclic (74); Sorbitol (74)  T!I:;1,Isoquinolines D03.438.531 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Atracurium; Bicuculline; Debrisoquin; Emetine; Nomifensine; Noscapine; Papaverine (+ 1); Praziquantel; Salsoline Alkaloids; Tretoquinol Quinolines (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  T$8G@Isoproterenol D02.033.329.291.439; D02.092.063.291.439; D02.092.311.649; D14.100.050.100.200.450; D16.050.110.350; D16.050.870.350; D18.222.863.516 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Catecholamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. T&:Isopropyl Thiogalactoside D09.203.408.320.820.500; D09.203.408.903.600.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Galactosides; Thiogalactosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Thioglycosides; Thiogalactosides 1-Methylethyl 1-thio-beta-D-galactopyranoside. Galactose (74); Thioglycosides (74) T*6D4,Isoprinosine D02.065.199.092.450; D13.570.583.616.450; D13.570.800.573.450; D20.388.651 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Inosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Inosine Anti-Infective Agents; Antiviral Agents Hypoxanthene riboside complexed with p-acetamidobenzoic acid-(2-dimethylamino-1-methylethyl)-ester. An Alkylamino-alcohol complex of inosine that may have some antiviral activity, probably due to its inhibition of viral protein synthesis and facilitation of the host's mRNA synthesis. Synonyms: NP 113; NPT 10381; Viruxan. Acetanilides (74) /AA (75); Dimethylamines (74-75); Inosine (74) /AA (75) T- T:SsZIsopentenyladenosine D11.303.760.265.350; D13.570.583.138.500; D13.570.800.096.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators; Cytokinins Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Adenosine N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is a member of the cytokinin family of plant growth regulators. Adenosine (72-74); Alkenes (72-74) T0E@[+Isonipecotic Acids D03.066.399; D03.383.621.349 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Diphenoxylate; Meperidine (+ 1); Phenoperidine; Pirinitramide Diphenoxylate; Meperidine (+ 1); Phenoperidine; Pirinitramide AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR T3"8:Isonicotinic Acids D03.066.349; D03.383.725.394 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Ethionamide; Iproniazid; Isoniazid; Nialamide; Prothionamide; Pyridoxic Acid Ethionamide; Iproniazid; Isoniazid; Nialamide; Prothionamide; Pyridoxic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR T5"8:Isoniazid D02.442.436; D03.066.349.410; D03.383.725.394.582; D20.338.499 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Isonicotinic Acids Anti-Infective Agents; Antitubercular Agents  Iproniazid 4-Pyridinecarboxylic acid hydrazide. Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. T7 H:$Isometric Contraction G11.427.661.472 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Muscle Contraction Muscular contractions characterized by increase in tension without change in length. Exertion (66-76) T:cIsomerism H01.181.404.705 Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Stereoisomers Chemistry, Organic (66-70) T; H Isomerases D08.586.399 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes 2-Acetolactate Mutase; Amino Acid Isomerases (+ 1); Carbohydrate Isomerases (+ 6); Chorismate Mutase; DNA Helicases; DNA Topoisomerase; DNA Topoisomerase (ATP-Hydrolysing); Epimerases (+ 1); Methylmalonyl-CoA Mutase; Phosphotransferases (Phosphomutases) (+ 3); Prephenate Dehydratase; Prephenate Dehydrogenase; Racemases; Steroid Isomerases; Thromboxane Synthetase T<FEIsomaltose D09.203.698.365.410; D09.203.698.629.305.320 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides 6-0-alpha-Glucopyranosyl-D-glucose. A disaccharide consisting of two glucose units in an alpha (1-6) glycosidic linkage. Disaccharides (66-78) T?2DIsoleucyl T RNA Synthetase D08.586.464.136.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates isoleucine with its specific transfer RNA. EC 6.1.1.5. Amino Acyl T RNA Synthetases (72-74); Isoleucine (72-74) TAT!Ft`EIsoleucine D12.125.142.383; D12.125.070.577 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Branched-Chain TC&FIsoflurophate D02.705.364; D08.373.275.581; D08.373.745.500; D14.100.120.300.380; D16.050.495.390; D16.050.675.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics Phosphorofluoridic acid bis(l-methylethyl) ester. An irreversible cholinesterase inhibitor with actions similar to those of echothiophate. It is a powerful miotic used mainly in the treatment of glaucoma. Its vapor is highly toxic and it is recommended that only solutions in arachis oil be used therapeutically. (From Martindale, The Extra Pharmacopoeia, 29th ed, p.1330). TDvr:gIsoflurane D02.355.601.570; D15.050.035.060.375; D15.210.100.175.060.375 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Methyl Ethers Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation 1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether. A stable, non-explosive inhalation anesthetic, relatively free from significant side effects. Ethers (71-74); Hydrocarbons, Fluorinated (74) TIqE:58Isoflavones D03.438.150.266.450.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones; Flavones 3-Phenylchromones. Isomeric form of flavones in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position. Flavones (66-74) TL68pIsoetharine D02.033.329.400; D02.092.063.400; D14.100.050.100.200.430; D16.050.110.340; D16.050.870.340 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols Organic Chemicals (Non MeSH); Amines; Amino Alcohols Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Adrenergic beta-2 agonist used as bronchodilator for emphysema, bronchitis and asthma. Amino Alcohols (69-74); Catechols (69-74); Propylamines (72-74) TMg:eMIsoenzymes D08.586.348 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes beta-N-Acetylhexosaminidase; Creatine Kinase Isoenzymes; Lactate Dehydrogenase Isoenzymes; Lipoxygenase One of various structurally related forms of an enzyme, each having the same mechanism but with differing chemical, physical, or immunologically characteristics. (Dorland, 27th ed). TQwFEuIsoelectric Point H01.181.529.428.500 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Hydrogen-Ion Concentration The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. TShwIsoelectric Focusing E05.196.401.663; H01.181.529.307.437.663 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrophoresis (66-69) TT."Isodesmosine D03.383.725.762.500; D12.125.072.415 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) 2-(4-Amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring. Amino Acids (72-74); Pyridinium Compounds (70-74) TW*:<Isocyanates D02.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Isothiocyanates (+ 4); Toluene 2,4-Diisocyanate Organic compounds that contain the -NCO radical. Cyanates (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $TY 8#9;:Isocitrates D02.241.081.901.434.498 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Tricarboxylic Acids; Citrates Tricarboxylic Acids (66-70) T[ 8~!Isocitrate Lyase D08.586.520.567.525 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases A key enzyme in the glyoxylate cycle. It catalyzes the conversion of isocitrate to succinate and glyoxylate. EC 4.1.3.1. Isocitrates (73-76); Ketoacid-Lyases (73-76) T\0Fb5Isocitrate Dehydrogenase D08.586.682.047.497 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid (tricarboxylic) cycle. (From Dorland, 27th ed) (The NADP+ enzyme is EC 1.1.1.42.) EC 1.1.1.41. T]FtIsochromosomes G05.148.266.460 DEGEIMPHRE Genetics; Cytogenetics; Chromosome Aberrations Metacentric chromosomes produced during meiosis or mitosis when the centromere splits transversely instead of longitudinally. The chromosomes produced by this abnormal division are one chromosome having the two long arms of the original chromosome, but no short arms, and the other chromosome consisting of the two short arms and no long arms. Each of these isochromosomes constitutes a simultaneous duplication and deletion. specific chromosome (66-94); Chromosome Aberrations (66-94) Ta7FIsocarboxazid D03.383.548.332.300; D08.373.616.398; D15.085.315; D15.700.122.315 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Isoxazoles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p.311). TcL:a#Isoantigens D24.611.216.705 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Blood Groups Blood Groups Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Antigens, Human Platelet; Blood Groups (+ 11); Histocompatibility Antigens (+ 48)  Tg6gbIsoantibodies D24.611.125.664 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Blood Groups Blood Groups Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Th6iIsoamylase D08.586.277.450.585 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases An enzyme that hydrolyzes 1,6-alpha-glucosidic branch linkages in glycogen, amylopectin, and their beta-limit dextrins. It is distinguished from pullulanase (EC 3.2.1.41) by its inability to attack pullulan and by the feeble action of alpha-limit dextrins. It is distinguished from amylopectin 6-glucanohydrolase (EC 3.2.1.69) by its action on glycogen. With EC 3.2.1.69, it produces the activity called "debranching enzyme". EC 3.2.1.68. Glycoside Hydrolases (74); Polysaccharides (74) TiFl9Islets of Langerhans Transplantation E04.779.550; E04.936.225.375 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Surgery, Endocrine (Non MeSH) Surgery, Operative; Transplantation; Cell Transplantation The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species. Islets of Langerhans/transplantation (66-90) Tl+"2|4Islets of Langerhans A03.734.414; A06.407.414; A11.525 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Digestive System; Pancreas Endocrine System (Non MeSH); Endocrine Glands Cells Irregular microscopic structures, varying from a few to hundreds of cells, scattered throughout the pancreas and comprising its endocrine portion. There are three cell types: alpha, secreting glucagon; beta, secreting insulin; and delta, secreting somatostatin. Tn)8^/Islam K01.844.275 HIPX Humanities; Religion A monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity. Tp eIsethionic Acid D02.455.326.146.100.300; D02.886.645.600.055.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids 2-Hydroxyethanesulfonic acid. A colorless, syrupy, strongly acidic liquid that can form detergents with oleic acid. Alkyl Sulfonates (73-74); Alcohol, Ethyl (73-74) Tq6:;ISCOMs D12.776.828.868.400; D24.310.894.865.400; D24.611.216.865.400 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPORETOTUULUR Saponins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins; Vaccines, Synthetic Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Vaccines, Synthetic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Vaccines, Synthetic Synthetic vaccines consisting of an assembly of antigens in a multimeric form on a matrix with built-in adjuvant (saponin), forming submicroscopic particles. This produces a highly immunogenic form of subunit vaccine. Adjuvants, Immunologic (85-91); Viral Vaccines (85-91)  Tt E4 aAIschium A02.835.232.611.548 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Pelvic Bones Twr :LIschemia C14.907.553 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Circulation Cardiovascular Diseases; Vascular Diseases Cerebral Ischemia; Colitis, Ischemic; Compartment Syndromes (+ 1); Myocardial Ischemia (+ 14); Reperfusion Injury (+ 1) Deficiency of blood in a part, due to functional constriction or actual obstruction of a blood vessel. (Dorland, 27th ed).  Tx9 N2Isatin D03.438.473.525 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Tz9 :SIrritants D05.569.734.498; D26.585 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Riot Control Agents, Chemical Miscellaneous Drugs and Agents (Non MeSH) Tear Gases (+ 2) Cantharidin; Sclerosing Solutions (+ 2) Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  T{ ,Eh:Irritable Mood F01.470.047.110 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Emotions; Affect Abnormal or excessive excitability with easily triggered anger, annoyance, or impatience. T~ KhIrrigation E05.510 AECLCTECHIISMOMTNUPXSNSTTDUTVE Bronchoalveolar Lavage Fluid Miscellaneous Techniques (Non MeSH) Gastric Lavage; Peritoneal Lavage The washing of a body cavity or surface by flowing solution which is inserted and then removed. Any drug in the irrigation solution may be absorbed.  T ""*)Iron-Sulfur Proteins D12.776.157.435; D12.776.556.580 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins Adrenodoxin; Ferredoxins (+ 2) Adrenodoxin; Ferredoxins (+ 2) A group of proteins possessing only the iron-sulfur complex as the prosthetic group. These proteins participate in all major pathways of electron transport: photosynthesis, respiration, hydroxylation and bacterial hydrogen and nitrogen fixation. Iron (73-76); Metalloproteins (73-76); Sulfur (73-76)  T&FJBIron-Dextran Complex D02.691.340.350; D09.203.698.365.272.400; D19.461.543.525 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Ferric Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Dextrans Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics Iron dextran. A complex of ferric oxyhydroxide with dextrans of 5000 to 7000 daltons in a viscous solution containing 50 mg/ml of iron. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p.1292). TA81XIron Radioisotopes D01.496.473.498; D01.496.749.514 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Iron Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of iron that decay or disintegrate emitting radiation. Fe atoms with atomic weights 52, 53, 55, and 59-61 are radioactive iron isotopes. T&4Iron Isotopes D01.496.473 Inorganic Chemicals (Non MeSH); Isotopes Iron Radioisotopes Stable iron atoms that have the same atomic number as the element iron, but differ in atomic weight. Fe-54, 57, and 58 are stable iron isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR T24Iron Compounds D01.485 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Ferric Compounds (+ 2); Ferrous Compounds (+ 1); Steel (+ 1) Inorganic compounds that contain iron as an integral part of the molecule. Iron (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $T* 8%NZ:Iron Chelates D26.241.688 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Chelating Agents Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Siderophores (+ 3) Organic chemicals that form two or more coordination links with an iron ion. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $T,H]DIron D01.268.912.420; D01.552.412 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Ferric Compounds; Ferritin; Ferrous Compounds; Hemosiderin; Siderosis; Transferrin Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Iron. A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It has the atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia. (From Dorland, 27th ed). TY":bskIritis C11.941.375.385; C11.941.879.780.880.448 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Iris Diseases Eye Diseases; Uveal Diseases; Uveitis; Panuveitis; Uveitis, Anterior Inflammation of the iris characterized by circumcorneal injection, aqueous flare, keratotic precipitates, and constricted and sluggish pupil along with discoloration of the iris. T$ .NIris Neoplasms C04.588.364.978.400; C11.319.494.400; C11.941.375.375; C11.941.855.400 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Eye Neoplasms; Uveal Neoplasms Eye Diseases; Eye Neoplasms; Uveal Neoplasms Eye Diseases; Uveal Diseases; Iris Diseases Eye Diseases; Uveal Diseases; Uveal Neoplasms Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi. Iris (68-89); Eye Neoplasms (68-89); Melanoma (68-89) T!PXUCIris Diseases C11.941.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases Aniridia (+ 1); Exfoliation Syndrome; Iridocyclitis; Iris Neoplasms; Iritis Diseases, dysfunctions, or disorders of or located in the iris. Iris (66-80); Uveal Diseases (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $TN$\M.XIris A09.371.894.513 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Uvea Pupil The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium. T:  GIridovirus B04.280.410.400; B04.525.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Iridoviridae Viruses; Insect Viruses A genus of IRIDOVIRIDAE comprising small iridescent insect viruses. The infected larvae and purified virus pellets exhibit a blue to purple iridescence. DNA Viruses (75-77); Iridoviridae (79-93) To"G3Iridoviridae B04.280.410; B04.909.204.490 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Iridovirus; Ranavirus Ranavirus A family of large icosahedral DNA viruses infecting insects and poikilothermic vertebrates. Genera include IRIDOVIRUS, RANAVIRUS, Chloriridovirus, Lymphocystivirus, and goldfish virus. DNA Viruses (66-77); Insect Viruses (66-77)  T"Y&6Iridocyclitis C11.941.375.360; C11.941.879.780.880.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases; Iris Diseases Eye Diseases; Uveal Diseases; Uveitis; Panuveitis; Uveitis, Anterior Acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil. Symptoms include radiating pain, photophobia, lacrimation, and interference with vision. Uveitis, Anterior (66-89) T.N,Iridium Radioisotopes D01.496.749.500 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of iridium that decay or disintegrate emitting radiation. Ir atoms with atomic weights 182-190, 192, and 194-198 are radioactive iridium isotopes. Iridium (66-87); Radioisotopes (66-87) T4C/Iridium D01.268.445; D01.552.401 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals TS :`Ireland Z01.542.467 EHEP Geographicals (Non MeSH); Europe T5 )Iraq Z01.252.245.500.360; Z01.586.500.360 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East T*Iran Z01.252.245.500.350; Z01.586.500.350 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East T*Ipronidazole D02.640.672.400; D03.383.374.658.400; D21.370.527 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents 2-Isopropyl-1-methyl-5-nitroimidazole. An antihistomonal agent with low toxicity. It also promotes growth and feed utilization in poultry. Synonyms: Ipropran; NSC 109212; RO 7-1554. Imidazoles (66-73); Nitroimidazoles (74) T9:1Iproniazid D02.442.372; D03.066.349.390; D03.383.725.394.414; D08.373.616.347; D15.085.300; D15.700.122.300; D20.338.499.372 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Isonicotinic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents Anti-Infective Agents; Antitubercular Agents; Isoniazid An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. T2:0zIprindole D03.438.473.469; D14.100.050.600.050.420; D14.100.600.050.420; D15.085.050.360; D15.700.122.055.528 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic A tricyclic antidepressant that has actions and uses similar to those of AMITRIPTYLINE, but has only weak antimuscarinic and sedative effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p257). Antidepressive Agents (66-71); Indoles (66-71) T o:8Ipratropium D03.132.889.180.297.297.400; D03.605.869.189.297.400; D14.100.120.200.500.420; D16.050.110.320; D16.050.650.330; D18.097.419 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Tropanes; Belladonna Alkaloids; Atropine; Atropine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes; Atropine; Atropine Derivatives Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. Atropine (73-74); Propane (73-74) Tk:*Ipodate D02.455.426.559.389.454.450; D02.455.526.581.496.450; D26.298.602 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Iodobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Iodinated; Iodobenzenes Miscellaneous Drugs and Agents (Non MeSH); Contrast Media T I.lIpecac (Syrup) D03.132.442; D15.270.400; D16.050.225.400; D24.310.674.450; D26.415.390; D26.714.450 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Emetine Heterocyclic Compounds; Alkaloids Central Nervous System Agents; Emetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Emetics Immunologic and Biologic Factors (Non MeSH); Biological Products; Plant Extracts Miscellaneous Drugs and Agents (Non MeSH); Expectorants Miscellaneous Drugs and Agents (Non MeSH); Plant Extracts A syrup made from the dried rhizomes of two different species, C. ipecacuanha and C. acuminata of Cephaelis (or Uragoga) of the Rubiaciae; they contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone. It may also be used as an expecorant. T&b8 Ioxaglic Acid D02.241.223.106.530.718.425; D26.298.575 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 3-((((3-(Acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodobenzoic acid. An effective, low-osmolar, ionic contrast medium used in various radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Benzoates (66-71); Triiodobenzoic Acids (72-86) TO..9Iowa Z01.107.567.875.100.400; Z01.107.567.875.600.516.400 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States Tv:Iothalamic Acid D02.241.223.106.530.718.415; D26.298.566 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media  Iopamidol; Iothalamate Meglumine 3-(Acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoic acid. A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts. T..(Iothalamate Meglumine D02.033.800.813.550.600; D02.241.223.106.530.718.412; D09.203.067.342.600.600; D09.203.853.813.550.600; D26.298.566.470 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Sorbitol; Meglumine Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines; Meglumine Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Sorbitol; Meglumine Miscellaneous Drugs and Agents (Non MeSH); Contrast Media; Iothalamic Acid 3-(Acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl) benzoic acid salt with 1-deoxy-1-(methylamino)-D-glucitol. Radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins. Adipic Acids (66-77); Iothalamic Acid (66-77); Sorbitol (66-77) T«.2NIophendylate D02.455.426.559.389.454.400; D02.455.526.581.496.400; D26.298.545 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Iodobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Iodinated; Iodobenzenes Miscellaneous Drugs and Agents (Non MeSH); Contrast Media Ethyl-10(p-iodophenyl)undecylate. A mixture of isomers used as contrast medium, mainly for brain and spinal cord visualization. Synonyms: Ethiodan; Mulsopaque; Myelodil; Myodil; Neurotrast; Pantopaque. Benzene (66-67); Benzene Derivatives (68-72); Fatty Acids (66-74); Iodobenzenes (73-74) T6I.ljIopanoic Acid D02.455.426.559.389.454.385; D02.455.526.581.496.385; D26.298.531 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Iodobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Iodinated; Iodobenzenes Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 3-Amino-alpha-ethyl-2,4,6-triiodobenzenepropanoic acid. Radiopaque medium used as diagnostic aid. TʧI.lnIopamidol D02.241.223.106.530.718.410; D26.298.566.450 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media; Iothalamic Acid (S)-N,N'-Bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-1,3,5-benzenedicarboxamide. An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. Its non-ionic, water-soluble properties result in optimal imaging and reduced toxicity. Iothalamic Acid (68-74); Iothalamic Acid/analogs and derivatives (75-86) T- 2.VIontophoresis E05.300.650; H01.181.529.307.437.575 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Therapeutic introduction of ions of soluble salts into tissues by means of electric current. In medical literature it is commonly used to indicate the process of increasing the penetration of drugs into surface tissues by the application of electric current. It has nothing to do with ION EXCHANGE, AIR IONIZATION nor PHONOPHORESIS, none of which requires current. TЧ*"Ions D01.248.497 Inorganic Chemicals (Non MeSH); Electrolytes Anions (+ 35); Cations (+ 3) Atoms or radicals having a charge of positive (cation) or negative (anion) electricity owing to the loss (positive) or gain (negative) of one or more electrons. (Dorland, 27th ed). AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR TӍ6'>Ionophores D08.373.936.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents Alamethicin; Calcimycin; Ionomycin; Lasalocid; Monensin; Valinomycin Substances, usually antibiotics, which have the ability to carry mono- or divalent cations across lipid barriers including artificial and biological membranes. They act as uncoupling agents by preventing oxidative phosphorylation but without inhibiting respiration. Antibiotics (66-75); Biological Transport (66-75); Uncoupling Agents (72-75) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $T=8fR0[<Ionomycin D02.241.081.436.350; D08.373.936.500.320; D10.516.251.355.391 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Ionophores Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated A divalent calcium ionophore which mimics intracellular messengers involved in cell activation. Ethers (66-89); Ionophores (76-89) TD E:Ro+Ion-Selective Electrodes E07.296.471 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Electrodes Electrodes which can be used to measure the concentration of particular ions in cells, tissues, or solutions. Electrodes (66-93) T*Ion Transport G06.184.480; G06.535.166.500; G06.535.630.655 DEGEIMPHRE Antiporters; Ion Pumps Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) The movement of ions across energy-transducing cell membranes. Transport can be active or passive. Passive ion transport (facilitated diffusion) derives its energy from the concentration gradient of the ion itself and allows the transport of a single solute in one direction (uniport). Active ion transport is usually coupled to an energy-yielding chemical or photochemical reaction such as ATP hydrolysis. This form of primary active transport is called an ION PUMP. Secondary active transport utilizes the voltage and ion gradients produced by the primary transport to drive the cotransport of other ions or molecules. These may be transported in the same (symport) or opposite (antiport) direction. Ion Exchange (66-92)  T5@1Ion Pumps D12.776.543.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ion Transport; Biological Transport, Active; Ion Channels Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins Ca(2+)-Transporting ATPase; Na(+)-K(+)-Exchanging ATPase; Proton Pump Integral membrane proteins that transport ions across a membrane against an electrochemical gradient. Biological Transport, Active (67-91); specific ion/metabolism (67-91) $T;FEZVvRIon Exchange Resins D26.572 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Chromatography, Ion Exchange Miscellaneous Drugs and Agents (Non MeSH) Anion Exchange Resins (+ 2); Cation Exchange Resins High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ION EXCHANGE) with either cations or anions. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $T ,"2@.Ion Exchange H01.181.529.479 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Reversible chemical reaction between a solid, often an ION EXCHANGE RESIN, and a fluid whereby ions may be exchanged from one substance to another. This technique is used in water purification, in research, and in industry. TIIon Channels D12.776.395.550.440; D12.776.543.550.425 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ion Channel Gating; Ion Pumps Signal Transduction Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Calcium Channels; Chloride Channels; Potassium Channels; Sodium Channels Calcium Channels; Chloride Channels; Potassium Channels; Sodium Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for channel gating can be a membrane potential, drug, transmitter, cytoplasmic messenger, or a mechanical deformation. Ion channels which are integral parts of ionotropic neurotransmitter receptors are not included. Cell Membrane (66-78); Electric Conductivity (68-78); Membrane Potentials (67-78) (T'.F&KaIon Channel Gating G04.335.591; G06.535.898.400; G07.453.852.400; G11.561.450.852.400 DEGEIMPHRE Ion Channels Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Signal Transduction Physiology, General (Non MeSH); Electrophysiology; Signal Transduction Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Signal Transduction The opening and closing of ion channels due to a stimulus. The stimulus can be a change in membrane potential (voltage-gated), drugs or chemical transmitters (ligand-gated), or a mechanical deformation. Gating is thought to involve conformational changes of the ion channel which alters selective permeability. Electric Conductivity (66-89); Electrophysiology (66-89); Ion Channels (79-89); Membrane Potentials (66-89)  TVLlIohexol D02.241.223.106.530.718.403; D26.298.525 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 5-(Acetyl(2,3-dihydroxypropyl)amino)-N,N'-bis(2,3- dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide. An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Triiodobenzoic Acids (72-86) T .."Ioglycamic Acid D02.241.223.106.530.718.400; D26.298.510 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 3,3'-[Oxybis((1-oxo-2,1-ethanediyl)imino)]bis(2,4,6-triiodo-benzoic acid). Radiopaque medium; a mixture of its meglumine and sodium salts is used to visualize the biliary tract. Synonyms: BE 419; Biligram; Bilivistan; SH 419. Amides (66-74); Benzoates (66-73); Glycolates (66-74); Iodobenzoates (74) T.. ZIodotyrosine D06.472.931.388; D12.125.072.917.496 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Tyrosine Thyroid Hormones (66-67); Tyrosine (66-67) T*H4Iodoquinol D03.438.810.350.625.420; D21.370.107.445 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines; Oxyquinoline Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides 5,7-Diiodo-8-quinolinol. One of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. It is also used topically in other infections and may cause CNS and eye damage. It is known by very many similar trade names world-wide. TA.:CIodopyridones D03.383.725.791.496; D26.298.495 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridones Miscellaneous Drugs and Agents (Non MeSH); Contrast Media Iodopyracet; Propyliodone Iodopyracet Contrast Media (66-67) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  T&,,.Iodopyracet D03.383.725.791.496.371; D26.298.495.371 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridones; Iodopyridones Miscellaneous Drugs and Agents (Non MeSH); Contrast Media; Iodopyridones T..Iodoproteins D12.776.486 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Serum Albumin, Radio-Iodinated Amino Acids, Peptides and Proteins (Non MeSH); Proteins Thyroglobulin Iodine (66-67); Proteins (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $TD$D)HIodophors D20.187.524; D26.561 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH) Povidone-Iodine Povidone-Iodine Complexes of iodine and non-ionic surface-active agent acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. (From Merck Index, 11th ed). Iodine (71-74)  T\ ,l$YIodohippuric Acid D02.065.277.431.579; D02.241.223.106.162.431.496; D02.241.607.360.579; D26.298.459 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amides; Benzamides; Hippurates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides; Hippurates Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids; Hippurates Miscellaneous Drugs and Agents (Non MeSH); Contrast Media U\.gIodobenzoates D02.241.223.106.530 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Triiodobenzoic Acids (+ 11) Benzoates (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  U8k":Iodobenzenes D02.455.426.559.389.454; D02.455.526.581.496 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Iodinated Iopanoic Acid; Iophendylate; Ipodate; Tyropanoate Iopanoic Acid; Iophendylate; Ipodate; Tyropanoate Benzene Derivatives (68-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  Ud28v!:Iodoacetates D02.241.081.038.209.495; D08.373.830.578 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Iodoacetamide Iodoacetamide AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR U.8 :Iodoacetamide D02.065.064.400; D02.241.081.038.108.400; D02.241.081.038.209.495.400; D08.373.830.578.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Acetamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetates; Iodoacetates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents; Iodoacetates 2-Iodoacetamide. A sulfhydryl reagent. Its actions are similar to those of iodoacetate. Amides (72-74); Iodoacetates (69-74) Ud:i-Iodized Oil D10.516.627.700.550; D26.298.423; J01.740.700.550 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Miscellaneous Drugs and Agents (Non MeSH); Contrast Media Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils Ethiodized Oil Ethiodized Oil Ethiodized Oil Iodinated vegetable oil. The mixture contains 38-42% organically combined iodine that is used as a diagnostic aid (radiopaque medium). (From Merck Index, 11th ed). U 9,5Iodipamide D26.298.388 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Contrast Media UE.FIodine Radioisotopes D01.496.448.496; D01.496.749.474 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Iodine Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Serum Albumin, Radio-Iodinated Serum Albumin, Radio-Iodinated Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  U&4F8Iodine Isotopes D01.496.448 Inorganic Chemicals (Non MeSH); Isotopes Iodine Radioisotopes (+ 1) Stable iodine atoms that have the same atomic number as the element iodine, but differ in atomic weight. I-127 is the only naturally occurring stable iodine isotope. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR UR2!8Iodine Compounds D01.475 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Iodates; Iodides (+ 2); Periodic Acid Inorganic compounds that contain iodine as an integral part of the molecule. Iodine (66-93)  U 8%1\Iodine D01.268.380.400; D01.268.912.400; D20.187.516 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Halogens Inorganic Chemicals (Non MeSH); Elements; Trace Elements Anti-Infective Agents; Anti-Infective Agents, Local Iodine. A nonmetallic halogen with the atomic symbol I, atomic number 53, and atomic weight 127. It is essential in nutrition, being especially necessary for the synthesis of thyroid hormones (thyroxine and triiodothyronine), which regulate the metabolic rate in all cells. It is used in solution as a topical anti-infective agent. (From Dorland, 27th ed). U4 5:Iodides D01.248.497.158.490; D01.475.410 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Iodine Compounds  Potassium Iodide; Sodium Iodide Inorganic binary compounds of iodine or the I- ion. U0 &8(@Iodide Peroxidase D08.586.682.732.525 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8. Iodides (73-75); Iodotyrosine (73-75); Peroxidases (73-75) UFgGIodates D01.248.497.158.480; D01.475.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Iodine Compounds Inorganic salts of iodic acid (HIO3). Iodine (66-70) U &80Iodamide D02.241.223.106.530.718.380; D26.298.350 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media 3-Acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid. Contrast media. Acetamides (74); Iodobenzoates (74) U  ..U,Investments N03.219.702 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics Use for articles on the investing of funds for income or profit. UBPInvestigational New Drug Application E05.337.300.400 ECHILJMAMTOGSN Drugs, Investigational Miscellaneous Techniques (Non MeSH); Evaluation Studies; Drug Approval An application that must be submitted to a regulatory agency (the FDA in the United States) before a drug can be studied in humans. This application includes results of previous experiments; how, where, and by whom the new studies will be conducted; the chemical structure of the compound; how it is thought to work in the body; any toxic effects found in animal studies; and how the compound is manufactured. (From the "New Medicines in Development" Series produced by the Pharmaceutical Manufacturers Association and published irregularly.). Drugs, Investigational (90-92)  U+T$Invertebrates B01 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Animals, Laboratory; Annelida (+ 3); Arthropods (+ 68); Bryozoa; Chordata (+ 2); Cnidaria (+ 3); Disease Vectors (+ 3); Echinodermata (+ 3); Helminths (+ 114); Life Stages (Non MeSH) (+ 6); Mollusca (+ 11); Parasites; Plankton (+ 1); Porifera; Protozoa (+ 121) Animals that have no spinal column. ABAHBLCFCHCLCYDEEMENGDGEIMINIPMEMIPHPSPXPYRESUULURVI U"k(I-8Invertebrate Hormones D06.472.445 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Insect Hormones (+ 5) Hormones (66); Insects (66) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  U$BB$DInversion (Genetics) G05.148.266.445 Genetics; Cytogenetics; Chromosome Aberrations An aberration in which a chromosomal segment is deleted and reinserted in the same place but turned 180 degrees from its original orientation, so that the gene sequence for the segment is reversed with respect to that of the rest of the chromosome. Chromosome Aberrations (68-74); Chromosome Abnormalities (66-67) U%7'KInventories, Hospital N02.278.354.650.300; N04.452.442.650.300 CLECHILJMAMTOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Materials Management, Hospital Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Materials Management, Hospital Materials and equipment in stock; includes drugs in pharmacies, blood in blood banks, etc. U'.!mInulin D09.203.698.350.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Fructans A vegetable starch, (C6H10O5)4, an indigestible polysaccharide occurring in the rhizome of certain plants (Compositae). It is a polymer of fructofuranose, yields fructose on hydrolysis, and is used in a test for determining renal function. (Dorland, 27th ed). U) Fj2Intussusception C06.405.469.531.577 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Obstruction The prolapse of one part of the intestine into the lumen of an immediately adjoining part. There are four varieties: colic, involving segments of the large intestine; enteric, involving only the small intestine; ileocecal, in which the ileocecal valve prolapses into the cecum, drawing the ileum along with it; and ileocolic, in which the ileum prolapses through the ileocecal valve into the colon. (Dorland, 27th ed). U, NpIntubation, Intratracheal E05.497.578 AECLCTECHIISMOMTNUPXSNSTTDUTVE Trachea Miscellaneous Techniques (Non MeSH); Intubation Laryngeal Masks AECLCTECHIISMOMTNUPXSDSNSTTDUTVE  U/" 9$Intubation, Gastrointestinal E05.497.412 AECLCTECHIISMOMTNUPXSNSTTDUTVE Enteral Nutrition Miscellaneous Techniques (Non MeSH); Intubation The insertion of a tube into the stomach, intestines, or other portion of the gastrointestinal tract to allow for the passage of food products, etc. U/!"9Intubation E05.497 AECLCTECHIISMOMTNUPXSNSTTDUTVE Chest Tubes Miscellaneous Techniques (Non MeSH) Intubation, Gastrointestinal; Intubation, Intratracheal (+ 1) Introduction of a tube into a hollow organ to restore or maintain patency if obstructed. It is differentiated from CATHETERIZATION in that the insertion of a catheter is usually performed for the introducing or withdrawing of fluids from the body. AECLCTECHIISMOMTNUPXSDSNSTTDUTVE $U1u "*G$$Introversion (Psychology) F01.752.747.511; F02.739.794.438 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory A state in which attention is largely directed inward upon one's self. Personality (66-67) U3&VIntrons G05.331.599.110.505; G06.184.599.110.505 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence Non-coding, intervening sequences of DNA that are transcribed, but are removed from within the primary gene transcript and rapidly degraded during maturation of messenger RNA. Most genes in the nuclei of eukaryotes contain introns, as do mitochondrial and chloroplast genes. Base Sequence (77-86); Genes (77-80); Genes, Structural (77-86) U5G .?NIntrinsic Factor D12.776.395.560.494; D19.461.543.494 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Parietal Cells, Gastric Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics U8-*FIntrauterine Devices, Medicated E07.190.250.520.520 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Contraceptive Devices; Contraceptive Devices, Female; Intrauterine Devices Intrauterine Devices, Copper Intrauterine devices that release contraceptive agents. Intrauterine Devices (67-74)  U9%r"A"Intrauterine Devices, Copper E07.190.250.520.520.520 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Contraceptive Devices; Contraceptive Devices, Female; Intrauterine Devices; Intrauterine Devices, Medicated Intrauterine contraceptive devices that depend on the release of metallic copper. Intrauterine Devices (67-77); Intrauterine Devices, Medicated (75-77) U;7"`QIntrauterine Devices E07.190.250.520 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Contraceptive Devices; Contraceptive Devices, Female Intrauterine Devices, Medicated (+ 1) Contraceptive Devices (66) U<Y- Intrauterine Device Expulsion E02.197.520 AE Therapeutics; Contraception Spontaneous loss of intrauterine devices from the uterus. Intrauterine Devices (67-74) U>#!E"Intraoperative Period E04.375 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative The period during a surgical operation. U> $1Intraoperative Monitoring E01.621.520; E04.370 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Monitoring, Physiologic Surgery, Operative The constant checking on the state or condition of a patient during the course of a surgical operation (e.g., checking of vital signs). Monitoring, Physiologic (78-90) U?">%Intraoperative Complications C23.612 BLCFCICLDHDIDTECENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Surgery, Operative Symptoms and General Pathology (Non MeSH) Blood Loss, Surgical Disorders affecting patients during surgery. They may or may not be related to the disease for which the surgery is done. They may or may not be direct results of the surgery. BLCFCICLDHDIDTECENEPETIMMEMIMONUPAPCPPPSPXRARHRIRTSNSUTHURUSVEVI $UA2! B2DIntraoperative Care E02.472.420; E04.365; N02.421.589.530 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; General Patient Care (Non MeSH) Surgery, Operative Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Patient care procedures performed during the operation that are ancillary to the actual surgery. It includes monitoring, fluid therapy, medication, transfusion, anesthesia, radiography, and laboratory tests. UCK-$Intraocular Pressure G11.697.600 DEGEIMPHRE Glaucoma; Ocular Hypertension; Ocular Hypotension; Tonometry Eye Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) UEH_Intradermal Tests E01.223.495.862.345; E01.862.345 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Skin Tests Diagnosis; Skin Tests Kveim Test; Skin Test End-Point Titration Kveim Test; Skin Test End-Point Titration Skin tests in which the sensitizer is injected. UF&"fd;Intracranial Pressure G11.561.131.505 DEGEIMPHRE Papilledema; Pseudotumor Cerebri Skull; Cerebrospinal Fluid Pressure Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Cerebrospinal Fluid Pressure Cerebrospinal fluid (CSF) pressure within the cranial cavity. It is influenced by brain mass, the circulatory system, CSF dynamics, and skull rigidity. Abnormally high intracerebral pressure occurs in pseudotumor cerebri, hydrocephalus, and cerebral hemorrhage.  UH'+-Intracellular Membranes A11.904.514 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Membranes; Cell Membrane Cells; Subcellular Fractions Nuclear Membrane Membranes of subcellular structures. Membranes (66-78) CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI (UJ(#,*Intracellular Fluid A12.207.515 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Body Fluids UK"9Intra-Aortic Balloon Pumping E04.050.215.400 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Assisted Circulation; Counterpulsation Counterpulsation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion. Assisted Circulation (67-76) ULw"$D"Intestines A03.492.411 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Enterostomy Digestive System; Gastrointestinal System Intestinal Mucosa; Intestine, Large (+ 6); Intestine, Small (+ 8) consider also terms at ENTER-. ABAHBLBSCFCHCICLCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI $UOd81Q'hIntestine, Small A03.492.411.620 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Intestines Duodenum (+ 3); Ileum (+ 2); Jejunum ABAHBLBSCFCHCICLCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI UQ:?2hIntestine, Large A03.492.411.495 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Intestines Cecum (+ 1); Colon (+ 1); Rectum (+ 1) URj:?6Intestinal Secretions A12.838.390 CHCYDEENIMMEMIPHPSRARERISEUSVI GASTROINTESTINAL HORMONES Intestinal Mucosa Fluids and Secretions (Non MeSH); Secretions (Non MeSH) USd"DIntestinal Pseudo-Obstruction C06.405.469.531.560 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Obstruction Colonic Pseudo-Obstruction Obstruction of the intestines that is functional, not mechanical. Intestinal Obstruction (66-80)  UTN"NpN$Intestinal Polyps C04.588.274.476.411.510; C04.799.411; C06.240.476.411.510; C06.405.282.411.510; C06.405.469.505.510; C06.405.469.583 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Neoplasms; Polyps Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Colonic Polyps (+ 1); Gardner Syndrome; Peutz-Jeghers Syndrome Colonic Polyps (+ 1); Gardner Syndrome; Peutz-Jeghers Syndrome Colonic Polyps (+ 1); Gardner Syndrome; Peutz-Jeghers Syndrome Colonic Polyps (+ 1); Gardner Syndrome; Peutz-Jeghers Syndrome Colonic Polyps (+ 1); Gardner Syndrome; Peutz-Jeghers Syndrome Colonic Polyps (+ 1); Gardner Syndrome; Peutz-Jeghers Syndrome Pedunculated or sessile growths arising from the intestinal mucosa and extending into the lumen. Includes intestinal polyposis. Intestinal Diseases (66-67); Polyps (66-67)  UVXF5Intestinal Perforation C06.405.469.557 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases U[NUIntestinal Obstruction C06.405.469.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Afferent Loop Syndrome; Duodenal Obstruction; Feces, Impacted; Intestinal Pseudo-Obstruction (+ 1); Intussusception Any impairment, arrest, or reversal of the normal flow of intestinal contents toward the anus. U\NUqIntestinal Neoplasms C04.588.274.476.411; C06.240.476.411; C06.405.282.411; C06.405.469.505 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Cecal Neoplasms (+ 1); Colonic Neoplasms (+ 5); Duodenal Neoplasms; Ileal Neoplasms; Intestinal Polyps (+ 4); Jejunal Neoplasms; Rectal Neoplasms (+ 2) Cecal Neoplasms (+ 1); Colonic Neoplasms (+ 5); Duodenal Neoplasms; Ileal Neoplasms; Intestinal Polyps (+ 4); Jejunal Neoplasms; Rectal Neoplasms (+ 2) Cecal Neoplasms (+ 1); Colonic Neoplasms (+ 5); Duodenal Neoplasms; Ileal Neoplasms; Intestinal Polyps (+ 4); Jejunal Neoplasms; Rectal Neoplasms (+ 2) Cecal Neoplasms (+ 1); Colonic Neoplasms (+ 5); Duodenal Neoplasms; Ileal Neoplasms; Intestinal Polyps (+ 4); Jejunal Neoplasms; Rectal Neoplasms (+ 2) U^PXzIntestinal Mucosa A03.492.411.369; A10.615.550.444 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Intestinal Secretions Digestive System; Gastrointestinal System; Intestines Tissue Types (Non MeSH); Membranes; Mucous Membrane Ud&:}Intestinal Fistula C06.185.700; C06.405.469.478; C23.439.185.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Fistula (Non MeSH) Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH) Rectal Fistula (+ 1) Rectal Fistula (+ 1) Rectal Fistula (+ 1) Abnormal passage communicating with the intestines. Ue65NM=Intestinal Diseases, Parasitic C03.432; C06.405.469.452 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Anisakiasis; Balantidiasis; Blastocystis Infections; Cryptosporidiosis; Dientamoebiasis; Dysentery, Amebic; Giardiasis Anisakiasis; Balantidiasis; Blastocystis Infections; Cryptosporidiosis; Dientamoebiasis; Dysentery, Amebic; Giardiasis Infections of the intestines with a parasite. They are caused most commonly by intestinal nematodes (roundworms) and cestodes (tapeworms). (From Merck Manual, 15th ed and Dorland, 27th ed). Ug$PjIntestinal Diseases C06.405.469 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases Cecal Diseases (+ 3); Colonic Diseases (+ 23); Constipation; Crohn Disease; Diarrhea (+ 4); Duodenal Diseases (+ 6); Enteritis (+ 2); Ileal Diseases (+ 2); Immunoproliferative Small Intestinal Disease; Inflammatory Bowel Diseases (+ 2); Intestinal Atresia; Intestinal Diseases, Parasitic (+ 7); Intestinal Fistula (+ 2); Intestinal Neoplasms (+ 19); Intestinal Obstruction (+ 6); Intestinal Perforation; Intestinal Polyps (+ 4); Jejunal Diseases (+ 1); Malabsorption Syndromes (+ 6); Mesenteric Vascular Occlusion; Pneumatosis Cystoides Intestinalis; Protein-Losing Enteropathies (+ 1); Rectal Diseases (+ 15) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI UjN=ZIntestinal Atresia C06.175.466; C06.405.469.445; C16.131.314.466 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Congenital obliteration of the lumen of the intestine, with the ileum involved in 50% of the cases and the jejunum and duodenum following in frequency. It is the most frequent cause of intestinal obstruction in the newborn infant. Its etiology may be related to failure of recanalization during early development or to some impairment of blood supply during intrauterine life. (From Stedman, 25th ed). Un5LIntestinal Absorption G10.261.576 DEGEIMPHRE Malabsorption Syndromes Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) UrScInterviews E05.318.308.420; G03.850.520.308.420; L01.280.520; N05.715.360.300.400 MTSTUT Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Information Science; Data Collection Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection Focus Groups Focus Groups Focus Groups Focus Groups Conversations with an individual or individuals held in order to obtain information about their background and other personal biographical data, their attitudes and opinions, etc. It includes school admission or job interviews. Us,P >Interview, Psychological F04.669.599 MTST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH) A directed conversation aimed at eliciting information for psychiatric diagnosis, evaluation, treatment planning, etc. The interview may be conducted by a social worker or psychologist. UvdIntervertebral Disk Displacement C05.116.900.307 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Intervertebral Disk Chemolysis; Sciatica Musculoskeletal Diseases; Bone Diseases; Spinal Diseases An intervertebral disk in which the nucleus pulposus has protruded through surrounding fibrocartilage. This occurs most frequently in the lower lumbar region. Ux&N0CIntervertebral Disk Chemolysis E02.590 AECLCTECHIISMOMTNUPXSNSTTDUTVE Chymopapain Intervertebral Disk Displacement Therapeutics The dissolving of the nucleus pulposus of a displaced intervertebral disk, usually by the direct injection of a proteolytic enzyme, especially chymopapain, into the diseased disk. Chymopapain (75-86); Intervertebral Disk Displacement (66-86) $Uy$ "&HIntervertebral Disk A02.165.410; A02.835.232.834.432 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Diskectomy Musculoskeletal System; Cartilage Musculoskeletal System; Skeleton; Bone and Bones; Spine U{&:jIntervention Studies E05.318.760.565; G03.850.520.835.565; N05.715.360.775.390 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH) Epidemiologic investigations designed to test a hypothesized cause-effect relation by modifying the supposed causal factor(s) in the study population. U|AIntertrigo C17.800.174.640; C17.800.815.650 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous A superficial dermatitis occurring on skin surfaces in contact with each other, such as the axillae, neck creases, intergluteal fold, between the toes, etc. Obesity is a predisposing factor. The condition is caused by moisture and friction and is characterized by erythema, maceration, burning, and exudation. U&NiInterrenal Gland A13.530 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Structures in fishes homologous to the cortical tissue of the mammalian adrenal gland; they are in close proximity to or imbedded in the kidney. Us :Interprofessional Relations F01.829.401.205 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations The reciprocal interaction of two or more professional individuals. U hPInterphase G04.335.135.500; G05.148.165.500; G07.553.135.500 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle Genetics; Cytogenetics; Cell Cycle Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle G0 Phase; G1 Phase; G2 Phase; S Phase G0 Phase; G1 Phase; G2 Phase; S Phase G0 Phase; G1 Phase; G2 Phase; S Phase The interval between two successive cell divisions during which the chromosomes are not individually distinguishable and DNA replication occurs. Cell Division (66-77); Mitosis (68-77)  U90Interpersonal Relations F01.829.401 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Intergenerational Relations; Interprofessional Relations; Negotiating; Professional-Family Relations; Professional-Patient Relations (+ 3) The reciprocal interaction of two or more persons. EHMTPX UL> Internship, Nonmedical I02.358.750 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH) Advanced programs of training to meet certain professional requirements in fields other than medicine or dentistry, e.g., pharmacology, nutrition, nursing, etc. U:6Internship and Residency I02.358.399.644 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Medical Programs of training in medicine and medical specialties offered by hospitals for graduates of medicine to meet the requirements established by accrediting authorities. UNInterneurons A08.663.694.300; A11.671.677.300 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH) Cells; Neurons; Neuron Types (Non MeSH) Most generally any neurons which are not motor or sensory. Interneurons may also refer to neurons whose axons remain within a particular brain region as contrasted with projection neurons which have axons projecting to other brain regions. Neurons (66-67) U &*lInternational System of Units H01.939.507 CLHIISST Physical Sciences (Non MeSH); Weights and Measures A system of physical units in which the fundamental quantities are length, time, mass, electric current, temperature, luminous intensity, and amount of substance, and the corresponding units are the meter, second, kilogram, ampere, kelvin, candela, and mole. The system has been given official status and recommended for universal use by the General Conference on Weights and Measures. Metric System (74-78); Weights and Measures (66-78) U+$ >?International Educational Exchange I01.534.494 ECHISNTD Foreign Medical Graduates Social Sciences; International Cooperation The exchange of students or professional personnel between countries done under the auspices of an organization for the purpose of further education. International Cooperation (66-67)  U( 2'International Council of Nurses N03.540.828.672.463 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Societies; Societies, Nursing An international professional organization composed of one association per country for the purpose of improving and developing nursing's contribution to the promotion of health and care of the sick. International Cooperation (66-79); Societies, Nursing (66-79) Ub& jHInternational Cooperation I01.534 HI Congresses Social Sciences Developing Countries; European Economic Community; International Educational Exchange; Medical Missions, Official The interaction of persons or groups of persons representing various nations in the pursuit of a common goal or interest. CLECHILJMAOGSDSNSTTDUT $Ui International Agencies N03.540.514 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations Red Cross; United Nations (+ 2) International organizations which provide health-related or other cooperative services. UF)dInternal-External Control F01.829.379 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social A general principle that man's attempts to control his personal environment are influenced by internal or external factors. Perception (66-71); Self Concept (69-71); Social Control, Informal (68-71) UPLZInternal Medicine G02.403.776.409 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Medical Cardiology; Endocrinology; Gastroenterology; Hematology; Medical Oncology (+ 1); Nephrology; Pulmonary Disease (Specialty); Rheumatology A medical specialty concerned with the diagnosis and treatment of diseases of the internal organ systems of adults. U<Internal Mammary-Coronary Artery Anastomosis E04.752.376.719.332.400; E04.920.490.630.280.400 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery; Myocardial Revascularization; Coronary Artery Bypass Surgery, Operative; Thoracic Surgery; Heart Surgery; Myocardial Revascularization; Coronary Artery Bypass Direct myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. The internal mammary artery is the most frequent choice, especially for a single graft, for coronary artery bypass surgery. U36$ [Internal Fixators E07.450.515; E07.858.442.660.515 AECLCTECHISDSNSTTDUTVE Fracture Fixation, Internal; Fracture Fixation, Intramedullary Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices Internal devices used in osteosynthesis to hold the position of the fracture in proper alignment. By applying the principles of biomedical engineering, the surgeon uses metal plates, nails, rods, etc., for the correction of skeletal defects. Fracture Fixation, Internal (86-90); Orthopedic Fixation Devices (86-90)  U&HUIntermittent Positive-Pressure Ventilation E02.880.820.790.550 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy; Respiration, Artificial; Positive-Pressure Respiration Application of positive pressure to the inspiratory phase when the patient has an artificial airway in place and is connected to a ventilator. Intermittent Positive Pressure Breathing (75-78); Positive Pressure Respiration (66-78) U0"feIntermittent Positive-Pressure Breathing E02.880.820.790.520 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy; Respiration, Artificial; Positive-Pressure Respiration Application of positive pressure to the inspiratory phase of spontaneous respiration. U."fdIntermittent Claudication C14.907.137.126.669 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases; Arteriosclerosis A symptom complex characterized by leg pain and weakness brought on by walking, with the disappearance of the symptoms following a brief rest. UNgIntermediate Filaments A11.368.250.410 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Cytoskeleton Cytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus. Cytoplasm (75-76); Cytoskeleton (77-85) U*&0Intermediate Filament Proteins D12.776.220.475 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins Desmin; Glial Fibrillary Acidic Protein; Keratin; Neurofilament Proteins; Vimentin Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Muscle Proteins (66-82); Nerve Tissue Proteins (66-82); Peptides (66-82); Proteins (66-82) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $U{$F^bnHIntermediate Care Facilities N02.278.825.610.480 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Residential Facilities; Nursing Homes Institutions which provide health-related care and services to individuals who do not require the degree of care which hospitals or skilled nursing facilities provide, but because of their physical or mental condition require care and services above the level of room and board. Nursing Homes (66-78) U"yEInterlibrary Loans L01.453.639.493; L01.583.464.493 CLECHIISLJMAMTOGSDSNSTTDUT Information Science; Information Services; Library Services Information Science; Library Science; Library Services U&Interleukins D24.185.348.505; D24.611.350.400.505 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances Interleukin-1; Interleukin-2; Interleukin-3; Interleukin-4; Interleukin-5; Interleukin-6; Interleukin-7; Interleukin-8; Interleukin-9; Interleukin-10; Interleukin-11; Interleukin-12; Interleukin-13 Interleukin-1; Interleukin-2; Interleukin-3; Interleukin-4; Interleukin-5; Interleukin-6; Interleukin-7; Interleukin-8; Interleukin-9; Interleukin-10; Interleukin-11; Interleukin-12; Interleukin-13 Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  U*B3DInterleukin-9 D24.185.348.505.509; D24.611.350.400.505.509 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Factor that is thought to be a regulator of hematopoiesis. It has been shown to enhance the growth of human mast cells and megakaryoblastic leukemic cells as well as murine helper t-cell clones. IL-9 is a glycoprotein with a molecular weight of 32-39 that is derived from T-cells, and maps to human chromosome 5. Growth Substances (89-90); Interleukins (90-91) U2Bu9Interleukin-8 D24.185.348.505.508; D24.611.350.400.505.508 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Neutrophil Activation Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Factor that activates neutrophils and attracts neutrophils and T-lymphocytes. It is released by several cell types including monocytes, macrophages, T-lymphocytes, fibroblasts, endothelial cells, and keratinocytes by an inflammatory stimulus. IL-8 is a member of the beta-thromboglobulin superfamily and structurally related to platelet factor 4. Interleukins (88-90)  U2DInterleukin-7 D24.185.348.505.507; D24.611.350.400.505.507 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Hematopoietic growth factor that promotes growth of B-cell precursors and also is co-mitogenic with Interleukin-2 for mature T-cell activation. It is produced by bone marrow stromal cells. Interleukins (88-89) U2DInterleukin-6 D24.185.348.505.506; D24.611.350.400.505.506 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hybridomas; Plasmacytoma Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Factor that stimulates the growth and differentiation of human B-cells and is also a growth factor for hybridomas and plasmacytomas. It is produced by many different cells including T-cells, monocytes, and fibroblasts. Interleukins (88-89); Lymphokines (87)  U'2D/Interleukin-5 D24.185.348.505.505; D24.611.350.400.505.505 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Factor promoting eosinophil differentiation and activation in hematopoiesis. It also triggers activated B-cells for a terminal differentiation into Ig-secreting cells. Interleukins (88-89); Lymphokines (77-87) U#2D2Interleukin-4 D24.185.348.505.504; D24.611.350.400.505.504 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Histocompatibility Antigens Class II Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Soluble factor produced by activated T-lymphocytes that causes proliferation and differentiation of B-cells. Interleukin-4 induces the expression of class II major histocompatibility complex and Fc receptors on B-cells. It also acts on T-lymphocytes, mast cell lines, and several other hematopoietic lineage cells including granulocyte, megakaryocyte, and erythroid precursors, as well as macrophages. Interleukins (88-89); Lymphokines (74-87)  U2D+2Interleukin-3 D12.776.395.240.400; D24.185.348.453.240.400; D24.185.348.505.503; D24.611.350.400.442.240.400; D24.611.350.400.505.503 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Interleukin-3 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins A multilineage cell growth factor secreted by lymphocytes, epithelial cells, and astrocytes which stimulates clonal proliferation and differentiation of various types of blood and tissue cells. Also called multi-CSF, it is considered one of the hematopoietic colony stimulating factors. Colony-Stimulating Factor (79-86); Glycoproteins (76-78); Lymphokines (74-86)  UřDJ[Interleukin-2 D24.185.348.505.502; D24.611.350.400.505.502; D24.611.350.480.372 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Interleukin-2 Killer Cells, Lymphokine-Activated; T-Lymphocytes, Helper-Inducer Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Soluble substances elaborated by antigen- or mitogen-stimulated T-lymphocytes which induce DNA synthesis in naive lymphocytes. Mitogens (73-77) $U8IDJsInterleukin-13 D24.185.348.505.513; D24.611.350.400.505.513 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins T-lymphocyte-derived cytokine that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-lymphocytes. It appears to play a role in regulating inflammatory and immune responses. Interleukins (93-94) U΅2DInterleukin-12 D24.185.348.505.512; D24.611.350.400.505.512 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunity, Cellular Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Heterodimeric cytokine that stimulates the production of interferon gamma from T-cells and natural killer cells and also induces differentiation of TH1 cells. Consequently, it is the initiator of cell-mediated immunity. Interleukins (91-94)  UJ2BInterleukin-11 D24.185.348.505.511; D24.611.350.400.505.511 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Lymphohematopoietic cytokine that has the ability to modulate antigen-specific antibody responses, potentiate megakaryocytes, and regulate bone marrow adipogenesis. Interleukins (90-92) U'2BInterleukin-10 D24.185.348.505.510; D24.611.350.400.505.510 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Factor that is a coregulator of mast cell growth. It is produced by T-cells and B-cells and shows extensive homology with the Epstein-Barr virus BCRFI gene. Interleukins (90-91) U֥2BInterleukin-1 D24.185.348.505.501; D24.611.350.400.505.501; D24.611.350.500.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Interleukin-1 Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Interleukins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Monokines Soluble factor produced by monocytes, macrophages, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Its biological effects include the ability to replace macrophage requirements for T-cell activation. The factor is distinct from INTERLEUKIN-2. Lymphocyte Transformation (72-82); Lymphocytes (66-71); Lymphokines (74-82); Macrophages (66-82); Toxins (66-73)  U$IDqUInterior Design and Furnishings J01.086.339.290 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction The planning of the furnishings and decorations of an architectural interior. UV&l\Interinstitutional Relations F01.829.674.400; N04.452.822.400 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Public Relations Health Services Administration (Non MeSH); Organization and Administration; Public Relations The interactions between representatives of institutions, agencies, or organizations. Uސ!&bIntergenerational Relations F01.829.263.370.110; F01.829.401.190 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH) Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations The interactions between individuals of different generations. These interactions include communication, caring, accountability, loyalty, and even conflict between related or non-related individuals. U# *Interferons D12.776.468; D20.388.643; D22.204.460; D24.611.350.440 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Interferon Viral Interference Amino Acids, Peptides and Proteins (Non MeSH); Proteins Anti-Infective Agents; Antiviral Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines Interferon Type I (+ 5); Interferon Type II (+ 1) Interferon Type I (+ 5); Interferon Type II (+ 1) Interferon Type I (+ 5); Interferon Type II (+ 1) Interferon Type I (+ 5); Interferon Type II (+ 1) Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. $UV@F%Interferon-gamma, Recombinant D12.776.468.550.510; D12.776.828.210; D20.388.643.893.510; D22.204.460.510.550; D24.611.350.440.893.510 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons; Interferon Type II Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins Anti-Infective Agents; Antiviral Agents; Interferons; Interferon Type II Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons; Interferon Type II Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons; Interferon Type II A type II interferon produced by recombinant DNA technology. It is similar to the interferon secreted by lymphocytes and has antiviral and antineoplastic activity. Interferon Type II (83-88); Recombinant Proteins (86-88) U"sBDInterferon-beta D12.776.468.500.275; D20.388.643.890.275; D22.204.460.500.275; D24.611.350.440.890.275 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons; Interferon Type I Anti-Infective Agents; Antiviral Agents; Interferons; Interferon Type I Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons; Interferon Type I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons; Interferon Type I One of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA. It is a cytokine with antiviral, antiproliferative, and immunomodulating activity. Interferon Type I (84-91) U5`F Interferon-alpha D12.776.468.500.250; D20.388.643.890.250; D22.204.460.500.250; D24.611.350.440.890.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons; Interferon Type I Anti-Infective Agents; Antiviral Agents; Interferons; Interferon Type I Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons; Interferon Type I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons; Interferon Type I Interferon Alfa, Recombinant (+ 2) Interferon Alfa, Recombinant (+ 2) Interferon Alfa, Recombinant (+ 2) Interferon Alfa, Recombinant (+ 2) One of the type I interferons (INTERFERON TYPE I) produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products. It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukemia. Interferon Type I (83-91)  U`F Interferon Type II D12.776.468.550; D20.388.643.893; D22.204.460.510; D24.611.350.440.893; D24.611.350.480.350; D24.611.350.480.615.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons Anti-Infective Agents; Antiviral Agents; Interferons Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Lymphokines; Macrophage-Activating Factors Interferon-gamma, Recombinant Interferon-gamma, Recombinant Interferon-gamma, Recombinant Interferon-gamma, Recombinant The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (INTERFERON TYPE I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease. Interferons (66-82)  UCFmInterferon Type I D12.776.468.500; D20.388.643.890; D22.204.460.500; D24.611.350.440.890 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons Anti-Infective Agents; Antiviral Agents; Interferons Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons Interferon-alpha (+ 3); Interferon-beta Interferon-alpha (+ 3); Interferon-beta Interferon-alpha (+ 3); Interferon-beta Interferon-alpha (+ 3); Interferon-beta Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons (66-82)  UPFaInterferon Inducers D20.388.630 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antiviral Agents Poly A-U; Poly I-C; Tilorone Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Interferons/biosynthesis (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $U8/&&@Interferon Alfa, Recombinant D12.776.468.500.250.210; D12.776.828.200; D20.388.643.890.250.210; D22.204.460.500.250.210; D24.611.350.440.890.250.210 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons; Interferon Type I; Interferon-alpha Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins Anti-Infective Agents; Antiviral Agents; Interferons; Interferon Type I; Interferon-alpha Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons; Interferon Type I; Interferon-alpha Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons; Interferon Type I; Interferon-alpha Interferon Alfa-2a; Interferon Alfa-2b Interferon Alfa-2a; Interferon Alfa-2b Interferon Alfa-2a; Interferon Alfa-2b Interferon Alfa-2a; Interferon Alfa-2b Interferon Alfa-2a; Interferon Alfa-2b A type I interferon with antiviral and antineoplastic activity produced by recombinant DNA technology. It can be a mixture of the kind of interferon secreted by leukocytes or lymphoblasts. Interferon Type I (83-88); Recombinant Proteins (86-88)  Vk"BhCInterferon Alfa-2b D12.776.468.500.250.210.210; D12.776.828.200.210; D20.388.643.890.250.210.210; D22.204.460.500.250.210.210; D24.611.350.440.890.250.210.210 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins; Interferon Alfa, Recombinant Anti-Infective Agents; Antiviral Agents; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Interferon alpha 2b (human leukocyte clone Hif-SN 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. Interferon Type I (83-88); Recombinant Proteins (86-88) VBCInterferon Alfa-2a D12.776.468.500.250.210.200; D12.776.828.200.200; D20.388.643.890.250.210.200; D22.204.460.500.250.210.200; D24.611.350.440.890.250.210.200 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins; Interferon Alfa, Recombinant Anti-Infective Agents; Antiviral Agents; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Interferons; Interferon Type I; Interferon-alpha; Interferon Alfa, Recombinant Interferon A (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. Interferon Type I (83-88); Recombinant Proteins (86-88) V BjCInterferometry E05.490 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Microscopy, Interference (+ 1); Moire Topography Measurement of distances or movements by means of the phenomena caused by the interference of two rays of light (optical interferometry) or of sound (acoustic interferometry). Lasers (66-76); Optics (66-76)  V "*;'Interdepartmental Relations F01.829.674.388; N04.452.822.388 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Public Relations Health Services Administration (Non MeSH); Organization and Administration; Public Relations The interactions between representatives of institutional departments. Interprofessional Relations (66-88) Vr &Q)Intercostal Nerves A08.800.800.720.800.350 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Thoracic Nerves The ventral rami of the thoracic nerves from segments T1 through T11. The intercostal nerves supply motor and sensory innervation to the thorax and abdomen. The skin and muscles supplied by a given pair are called, respectively, a dermatome and a myotome. V 8n/Intercostal Muscles A02.633.567.900.500 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal; Respiratory Muscles Respiratory muscles that arise from the lower border of one rib and insert into the upper border of the adjoining rib, and contract during inspiration or respiration. (From Stedman, 25th ed). VJ:SIntercellular Junctions A11.195.443 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Cell Communication Cells; Cell Membrane Blood-Air Barrier; Blood-Brain Barrier; Blood-Retinal Barrier; Blood-Testis Barrier; Desmosomes; Gap Junctions; Synapses (+ 6) Direct contact of a cell with a neighboring cell. Most such junctions are too small be to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. (From Alberts, et al., Molecular Biology of the Cell, 2d ed, p792). Cell Membrane (66-69) ABAHBSCHCLCYDEEMENGDGEIMINMEMIPAPHPPPSRARERISESUTRULUSVI (V (<Intercellular Adhesion Molecule-1 D12.776.395.550.200.450; D12.776.543.550.200.450; D24.185.101.100.110.300; D24.611.216.301.264.035.300; D24.611.216.301.350.450 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Cell Adhesion Molecules Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Cell Adhesion Molecules A cell-surface ligand with a role in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Cell Adhesion Molecules (89-94) V'6&Intercalating Agents D26.550.435 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning; used in the study of DNA. Synonyms: intercalators; intercalative compounds; intercalating ligands. specific DNA(66-79); DNA (66-79); Nucleic Acid Conformation (72-79) V!,PHSIntensive Care, Neonatal E02.472.190.400.405; N02.421.088.120.120; N02.421.589.230.400.405 CLECHILJMAMTOGPXSNSTTDUT Infant Care Therapeutics; General Patient Care (Non MeSH); Critical Care; Intensive Care Facilities, Manpower and Services (Non MeSH); Health Services; Child Care; Infant Care Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Critical Care; Intensive Care Continuous care and monitoring of newborn infants with life-threatening conditions, in any setting. Infant Care (66-89); Infant, Newborn (66-89); Intensive Care Units (66-81); Intensive Care Units, Neonatal (82-89)  V$IatIntensive Care Units, Pediatric N02.278.388.493.390 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units; Intensive Care Units Intensive Care Units, Neonatal Hospital units providing continuous surveillance and care to acutely ill infants and children. Neonates are excluded since INTENSIVE CARE UNITS, NEONATAL is available. Child (66-88); Infant (66-88); Intensive Care Units (66-88)  V'9&y%JIntensive Care Units, Neonatal N02.278.388.493.390.380 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units; Intensive Care Units; Intensive Care Units, Pediatric Hospital units providing continuing surveillance and care to acutely ill newborn infants. Infant, Newborn (66-81); Intensive Care Units (66-81) V)f%iAIntensive Care Units N02.278.388.493 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units Burn Units; Coronary Care Units; Intensive Care Units, Pediatric (+ 1); Recovery Room; Respiratory Care Units Hospital units providing continuous surveillance and care to acutely ill patients. CLECHILJMAMTOGSDSNSTTDUT  V+0_aIntensive Care E02.472.190.400; N02.421.589.230.400 CLECHILJMAMTOGPXSNSTTDUT Critical Care Critical Care Therapeutics; General Patient Care (Non MeSH); Critical Care Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Critical Care Intensive Care, Neonatal Intensive Care, Neonatal Advanced and highly specialized care provided to medical or surgical patients whose conditions are life-threatening and require comprehensive care and constant monitoring. It is usually administered in specially equipped units of a health care facility. $V-*:%Intelligence Tests F04.711.141.493 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Aptitude Tests Stanford-Binet Test; Wechsler Scales Standardized tests that measure the present general ability or aptitude for intellectual performance. V/ e,vIntelligence F01.752.543 CLDEGEPHRE Behavior and Behavior Mechanisms (Non MeSH); Personality The ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions. V1DDIntegrins D12.776.543.750.705.408; D24.611.834.408 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic Platelet Membrane Glycoproteins (+ 2); Receptors, Cytoadhesin (+ 6) Platelet Membrane Glycoproteins (+ 2); Receptors, Cytoadhesin (+ 6) A family of transmembrane glycoproteins consisting of noncovalent heterodimers. They interact with a wide variety of ligands including extracellular matrix glycoproteins, complement, and other cells, while their intracellular domains interact with the cytoskeleton. The integrins consist of at least three identified families: the cytoadhesin receptors, the leukocyte adhesion receptors, and the very-late-antigen receptors. Each family contains a common beta-subunit combined with one or more distinct alpha-subunits. These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development, hemostasis, thrombosis, wound healing, immune and nonimmune defense mechanisms, and oncogenic transformation. Glycoproteins (66-87); Membrane Glycoproteins (88-89); Receptors, Endogenous Substances (73-89); Receptors, Immunologic (80-89) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $V2] .$nHIntegrated Advanced Information Management Systems L01.700.508.300.420 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems A concept, developed in 1983 under the aegis of and supported by the National Library of Medicine under the name of Integrated Academic Information Management Systems, to provide professionals in academic health sciences centers and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In August 1992 the name was changed from Integrated Academic Information Management Systems to Integrated Advanced Information Management Systems to reflect use beyond the academic milieu. Information Systems (86-91); National Library of Medicine (U.S.) (86-88) V8:nVInsurance, Surgical N03.219.521.576.343.700 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health A specific type of health insurance which provides surgeons' fees for specified amounts according to the type of surgery listed in the policy. V>~Insurance, Psychiatric N03.219.521.576.343.658 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Insurance providing benefits to cover part or all of the psychiatric care. Insurance, Health (66-67) V?~ZInsurance, Physician Services N03.219.521.576.343.616 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Blue Shield; Medicare Assignment Insurance providing benefits for the costs of care by a physician which can be comprehensive or limited to surgical expenses or for care provided only in the hospital. It is frequently called "regular medical expense" or "surgical expense". Insurance, Health (66-67) CLECHILJOGSNSTTDUT $VA#~(Insurance, Pharmaceutical Services N03.219.521.576.343.575 CLECHILJSNSTTDUT Pharmacy Administration Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products. Pharmacy (66-67); Prescriptions (66-67)  VC(~0Insurance, Nursing Services N03.219.521.576.343.545 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Insurance providing benefits for the costs of care provided by nurses, especially nurse practitioners and nurse clinicians. VE!~Insurance, Medigap N03.219.521.576.343.539 CLECHILJSNSTTDUT Medicare Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health A supplemental health insurance policy sold by private insurance companies and designed to pay for health care costs and services that are not paid for either by Medicare alone or by a combination of Medicare and existing private health insurance benefits. (From Facts on File Dictionary of Health Care Management, 1988). Insurance, Health (77-91); Medicare (77-91)  VG ~z5Insurance, Major Medical N03.219.521.576.343.533 CLECHILJSNSTTDUT Catastrophic Illness Catastrophic Illness Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Insurance providing a broad range of medical services and supplies, when prescribed by a physician, whether or not the patient is hospitalized. It frequently is an extension of a basic policy and benefits will not begin until the basic policy is exhausted. Insurance, Health (66-67) $VI~/Insurance, Long-Term Care N03.219.521.576.343.508 CLECHILJSNSTTDUT Long-Term Care Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Health insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home. Insurance, Health (66-86); Long-Term Care (68-86)  VL%~<Insurance, Life N03.219.521.576.543 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Insurance providing for payment of a stipulated sum to a designated beneficiary upon death of the insured. VN9hInsurance, Liability N03.219.521.576.443 CLECHILJSNSTTDUT Malpractice Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Insurance against loss resulting from liability for injury or damage to the persons or property of others. VOhInsurance, Hospitalization N03.219.521.576.343.492 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Blue Cross Health insurance providing benefits to cover or partly cover hospital expenses. CLECHILJOGSNSTTDUT  VP~^Insurance, Health, Reimbursement N03.219.521.576.343.480; N03.219.521.710 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized  Reimbursement Mechanisms (+ 9) Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. (From Facts on File Dictionary of Health Care Management, 1988). CLECHILJOGSNSTTDUT  VR]&.&Insurance, Health N03.219.521.576.343 CLECHILJSNSTTDUT Medically Uninsured; Physician's Practice Patterns Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Health Benefit Plans, Employee; Insurance, Accident; Insurance, Dental; Insurance, Health, Reimbursement; Insurance, Hospitalization (+ 1); Insurance, Long-Term Care; Insurance, Major Medical; Insurance, Medigap; Insurance, Nursing Services; Insurance, Pharmaceutical Services; Insurance, Physician Services (+ 2); Insurance, Psychiatric; Insurance, Surgical; Managed Care Programs (+ 4); Medicare (+ 3); National Health Insurance, United States; Prepaid Health Plans (+ 1) Insurance providing coverage of medical, surgical, or hospital care in general or for which there is no specific heading. CLECHILJMAOGSNSTTDUT $VU;h(Insurance, Dental N03.219.521.576.343.450 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Insurance providing coverage for dental care. VY~7Insurance, Accident N03.219.521.576.343.409 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Insurance providing coverage for physical injury suffered as a result of unavoidable circumstances. VZ~tInsurance Selection Bias N03.219.521.576.585 Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Adverse of favorable selection bias exhibited by insurers or enrollees resulting in disproportionate enrollment of certain groups of people. Consumer Participation/economics (74-88); Insurance, Health/utilization (76-88) V[{h\Insurance Pools N03.219.521.576.570 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance An organization of insurers or reinsurers through which particular types of risk are shared or pooled. The risk of high loss by a particular insurance company is transferred to the group as a whole (the insurance pool) with premiums, losses, and expenses shared in agreed amounts. Insurance, Health (71-88); Insurance, Liability (71-88) V]:hKBInsurance Claim Review N03.219.521.576.215 CLECHILJOGSNSTTDUT Utilization Review Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality. Insurance, Health/utilization (66-85); Insurance, Hospitalization/utilization (66-85); Utilization Review (68-85)  V_hInsurance Claim Reporting N03.219.521.576.210 CLECHILJSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance The design, completion, and filing of forms with the insurer. VbhKInsurance Carriers N03.219.521.576.160 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Organizations which assume the financial responsibility for the risks of policyholders. VchfInsurance Benefits N03.219.521.576.130 CLECHILJMTSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Payments or services provided under stated circumstances under the terms of an insurance policy. In prepayment programs, benefits are the services the programs will provide at defined locations and to the extent needed. Insurance (66-77) Ve*hInsurance N03.219.521.576 CLECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized Cost Sharing (+ 1); Insurance Benefits; Insurance Carriers; Insurance Claim Reporting; Insurance Claim Review; Insurance, Health (+ 28); Insurance, Liability; Insurance, Life; Insurance Pools; Insurance Selection Bias; Social Security Coverage by contract whereby one part indemnifies or guarantees another against loss by a specified contingency. CLECHILJMAMTOGSNSTTDUT  Vg [Insulinoma C04.557.470.035.100.410 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Islet Cell A tumor of the beta cells of the islets of Langerhans. Although usually benign, such tumors are among the most important causes of hypoglycemia. Insulinomas usually occur in patients between the ages of 20 and 75 years, the average age being 44-46. Women are 60% of the patients in most series. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Islet Cell Tumor (66-81) ViXInsulinase D08.586.277.656.520 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases VlFjInsulin, Protamine Zinc D06.472.610.575.574; D09.482.500.642 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones; Insulin Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents; Insulin Vm*:Insulin, Lente D06.472.610.575.491; D09.482.500.542 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones; Insulin Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents; Insulin Vn*:Insulin, Isophane D06.472.610.575.408; D09.482.500.442 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones; Insulin Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents; Insulin VpI*:Insulin-Like Growth Factor II D12.776.124.862.425; D12.776.641.650.710.420; D14.600.600.780.440; D24.185.348.862.508 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Insulin-Like-Growth-Factor II Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Somatomedins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Somatomedins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Somatomedins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Somatomedins A well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. Blood Proteins (66-85); Growth Substances (66-85); Insulin (66-85); Peptides (66-85); Somatomedins (73-85); Sulfation Factor (71-72)  Vq$`F.Insulin-Like Growth Factor I D12.776.124.862.400; D12.776.641.650.710.400; D14.600.600.780.400; D24.185.348.862.505 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Insulin-Like-Growth Factor I Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Somatomedins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Somatomedins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Somatomedins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Somatomedins A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. Growth Substances (66-85); Insulin (66-85); Peptides (66-85); Somatomedins (73-85); Sulfation Factor (71-72)  Vv#`F.Insulin Resistance G12.392.617 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance Diminished effectiveness of insulin in lowering blood sugar levels; arbitrarily defined as requiring 200 units or more of insulin per day to prevent hyperglycemia or ketosis. It is usually due to insulin binding by antibodies, but abnormalities in insulin receptors on cell surfaces also occur. It is associated with obesity, ketoacidosis, infection, and certain rare conditions. (Stedman, 25th ed). V| IInsulin Receptor Protein-Tyrosine Kinase D08.586.913.696.620.682.725.700.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Tyrosine Kinase; Receptor Protein-Tyrosine Kinase A catalytic PROTEIN-TYROSINE KINASE domain found on the cytoplasmic beta-portion of the insulin receptor. EC 2.7.1.-. Protein Kinases (83-85); Protein-Tyrosine Kinase (86-93) V~/'FCInsulin Infusion Systems E02.319.300.508; E07.505.508; E07.858.082.505.508 AECLCTECHIMIPSPXSDSNSTTDUTVEVI Therapeutics; Drug Therapy; Drug Delivery Systems Equipment and Supplies; Infusion Pumps Equipment and Supplies; Surgical Equipment; Artificial Organs; Infusion Pumps Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. Artificial Organs (73-81); Infusions, Parenteral (73-81); Insulin (73-81); Islands of Langerhans (73-81); Pancreas (73-81) V9"Insulin Coma C18.452.528.492 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Hypoglycemia VL^Insulin Antibodies D24.611.125.632 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies V6iInsulin Antagonists D06.347.420 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Compounds which inhibit or antagonize the biosynthesis or action of insulin. Insulin (66-77) V6N[Insulin D06.472.610.575; D09.482.500 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nonsuppressible Insulin-Like Activity; Proinsulin; Receptors, Insulin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents Insulin, Isophane; Insulin, Lente; Insulin, Protamine Zinc; Proinsulin (+ 1) Insulin, Isophane; Insulin, Lente; Insulin, Protamine Zinc AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  V "BPHInsufflation E01.484; E02.583 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Therapeutics The act of blowing a powder, vapor, or gas into any body cavity for experimental, diagnostic, or therapeutic purposes. V?"Institutionalization N02.421.589.508 CLECHILJMAMTOGSDSNSTTDUT Child, Institutionalized; Deinstitutionalization; Hospitalization Hospitalization Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Deinstitutionalization The caring for individuals in institutions and their adaptation to routines characteristic of the institutional environment, and/or their loss of adaptation to life outside the institution. $VRJyInstitutional Practice N04.452.758.367 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Professional practice as an employee or contractee of a health care institution. Medical Staff, Hospital (66-67) Vq`&Institutional Management Teams N04.452.460 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Administrator-selected management groups who are responsible for making decisions pertaining to the provision of integrated direction for various institutional functions. V$WInstitute of Medicine (U.S.) N03.540.608.500 HIOG Economics, Organizations, Control (Non MeSH); Organizations; National Academy of Sciences (U.S.) Identifies, for study and analysis, important issues and problems that relate to health and medicine. The Institute initiates and conducts studies of national policy and planning for health care and health-related education and research; it also responds to requests from the federal government and other agencies for studies and advice. Academies and Institutes (70-89); National Academy of Sciences (86-89); Organizations (86-89) V{#qoInstinct F01.658.642 Libido Drive Behavior and Behavior Mechanisms (Non MeSH); Motivation Stereotyped patterns of response, characteristic of a given species, that have been phylogenetically adapted to a specific type of situation. VI   CInstillation, Drug E05.300.640 Miscellaneous Techniques (Non MeSH); Drug Administration Routes The administration of therapeutic agents drop by drop, as eye drops, ear drops, or nose drops. It is also administered into a body space or cavity through a catheter. It differs from irrigation in that the irrigate is removed within minutes, but the instillate is left in place. VKLInspiratory Reserve Volume E01.302.796.420.810.970.500.375; G09.772.521.700.810.970.500.375 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity; Vital Capacity; Inspiratory Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity; Vital Capacity; Inspiratory Capacity The extra volume of air that can be inspired with maximal effort after reaching the end of a normal, quiet inspiration. Common abbreviation is IRV. Vb FInspiratory Capacity E01.302.796.420.810.970.500; G09.772.521.700.810.970.500 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity; Vital Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity; Vital Capacity Inspiratory Reserve Volume; Tidal Volume Inspiratory Reserve Volume; Tidal Volume The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the tidal volume and the inspiratory reserve volume. Common abbreviation is IC. V>>b`Insomnia C10.597.785.367; C23.888.592.796.367; F03.126.821.408 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Wakefulness Nervous System Diseases; Neurologic Manifestations; Sleep Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sleep Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Sleep Disorders Inability to sleep. Vz =NDInservice Training I02.574 CLECHILJMAMTOGSNSTTD Education Staff Development On the job training programs for personnel carried out within an institution or agency. It includes orientation programs. Education, Continuing (66) CLECHILJMAMTOGSDSNSTTDUT $V   Insemination, Artificial, Homologous E05.820.520.525; E02.574.525 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Reproduction Techniques; Insemination, Artificial Therapeutics; Insemination, Artificial Human artificial insemination in which the husband's semen is used. V*""QInsemination, Artificial, Heterologous E05.820.520.515; E02.574.515 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Reproduction Techniques; Insemination, Artificial Therapeutics; Insemination, Artificial Human artificial insemination in which the semen used is that of a man other than the woman's husband. Vn,""|Insemination, Artificial E02.574; G08.520.392.492; E05.820.520 AECLCTECGEHIIMISMOMTNUPHPXSNSTTDUTVE Fertilization in Vitro; Semen Preservation; Sperm Banks Therapeutics Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Insemination Miscellaneous Techniques (Non MeSH); Reproduction Techniques Insemination, Artificial, Heterologous; Insemination, Artificial, Homologous Insemination, Artificial, Heterologous; Insemination, Artificial, Homologous Artificial introduction of semen into the vagina for the purpose of inducing conception.  V -(CiInsemination G08.520.392 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction Insemination, Artificial AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE VG,Insects B01.131.617 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods Coleoptera (+ 3); Diptera (+ 16); Fleas; Hemiptera (+ 6); Hymenoptera (+ 3); Lepidoptera (+ 5); Lice (+ 3); Orthoptera (+ 4) Insects are a class, Insecta, of Arthropoda whose members are characterized by division into three parts: head, thorax, and abdomen. They are the dominant group of animals on earth, several hundred thousand different kinds having been described. They have lived on earth for about 350 million years, as compared with less than 2 million for man. While insects are often commercially valuable and useful as scavengers, many species are harmful, causing enormous losses in agriculture and storage. Three orders, HEMIPTERA, DIPTERA, and Siphonaptera, are of medical interest in that they cause disease in man and animal. (From Dorland, 27th ed; Borror, et al., An Introduction to the Study of Insects, 4th ed). AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI  V (>*Insectivora B02.649.473 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Hedgehogs; Moles; Shrews V$( Insecticides, Organothiophosphate D05.723.491.657 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organothiophosphorus Compounds; Cholinesterase Inhibitors Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides Abate; Azinphosmethyl; Coumaphos; Diazinon; Dimethoate; Disulfoton; Dursban; Dyfonate; EPN; Fenchlorphos; Fenitrothion; Fenthion; Malathion; Parathion (+ 1); Phorate; Phosmet; Phosvel Insecticides (66-72); Organothiophosphorus Compounds (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $V&8AVF:Insecticides, Organophosphate D05.723.491.574 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organophosphorus Compounds; Cholinesterase Inhibitors Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides Chlorfenvinphos; Dichlorvos; Mevinphos; Monocrotophos; Naled; Paraoxon; Phosphamidon; Tetrachlorvinphos; Trichlorfon Insecticides (66-72); Organophosphorus Compounds (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $V\"6=VB:Insecticides, Organochlorine D05.723.491.491 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides Aldrin; Benzene Hexachloride; Chlordan; DDD; DDE; DDT; Dicofol; Dieldrin; Endosulfan; Endrin; Heptachlor (+ 1); Kepone; Methoxychlor; Mirex; Mitotane; Toxaphene Insecticides (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  V!8V:Insecticides, Carbamate D05.723.491.408 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides Aldicarb; Aprocarb; Carbaryl; Carbofuran; Methiocarb; Methomyl Insecticides, which owe their activity to the carbamate moiety in the molecule. Carbamates (66-74); Insecticides (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $V8VL_1:Insecticides, Botanical D05.723.491.324 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides Anabasine; Pyrethrins (+ 1); Rotenone Insecticides (66-72); Pyrethrum (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  V8V00:Insecticides D05.723.491 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cholinesterase Inhibitors Environmental Pollutants, Pesticides (Non MeSH); Pesticides Chlorphenamidine; Ethylene Dibromide; Insecticides, Botanical (+ 4); Insecticides, Carbamate (+ 6); Insecticides, Organochlorine (+ 17); Insecticides, Organophosphate (+ 9); Insecticides, Organothiophosphate (+ 18); Ivermectin Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $V8F :Insecticide Resistance G05.706.574; G12.392.491 GEIMPHRE Insect Control; Mosquito Control Genetics; Pharmacogenetics Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance The development by insects of resistance to insecticides. VE (gEInsect Viruses B04.525 CHCLDEENGDGEIMIPMEPHPYREUL Viruses Baculoviridae (+ 1); Densovirus; Entomopoxvirinae; Iridovirus; Polydnaviridae Viruses infecting insects, the largest family being BACULOVIRIDAE. V  \NInsect Vectors B01.371.294.574 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Disease Vectors; Arthropod Vectors V(;Insect Repellents D05.723.441 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides Deet Substances causing insects to turn away from them or reject them as food. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  VE8FZ:Insect Hormones D06.472.445.573 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Invertebrate Hormones Ecdysone; Ecdysterone; Juvenile Hormones (+ 2) Hormones secreted by insects. They influence their growth and development. Also synthetic substances that act like insect hormones. Invertebrate Hormones (67-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $VB\9#DInsect Control G03.850.780.200.650.425 ECHIISLJMTOGSNSTTD Chemosterilants; Insecticide Resistance; Pest Control, Biological Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Pest Control Mosquito Control The reduction or regulation of the population of noxious, destructive, or dangerous insects through chemical, biological, or other means.  VLInsect Bites and Stings C21.613.127.441 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Bites and Stings VN[Insanity Defense F04.096.544.335.528; I01.198.560.469.528; I01.880.604.583.310.528; N03.706.535.351.528 CLHISN Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry; Forensic Psychiatry Social Sciences; Criminology; Forensic Medicine; Forensic Psychiatry Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Forensic Psychiatry Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Forensic Psychiatry A legal concept that a person cannot be convicted of a crime if he lacked criminal responsibility by reason of insanity, which term is defined as a matter of law. V` Inpatients M01.643.470 CLEDHILJPXSN Patients Named Groups (Non MeSH); Patients Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment. Hospitalization (66-79); Patients (66-79)  V +2Inovirus B04.123.370.400; B04.280.400.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Inoviridae Viruses; DNA Viruses; Inoviridae Bacteriophage M13 Bacteriophage M13 A genus of filamentous bacteriophages of the family INOVIRIDAE. Organisms of this genus infect enterobacteria, Pseudomonas, Vibrio, and Xanthomonas. Bacteriophages (84-93)  VJ &R*Inoviridae B04.123.370; B04.280.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses; DNA Viruses Inovirus (+ 1); Plectrovirus Inovirus (+ 1); Plectrovirus A family of rod-shaped or filamentous bacteriophages consisting of single-stranded DNA. There are two genera: INOVIRUS and PLECTROVIRUS. Bacteriophages (84-93)  V6HInositol-1-Phosphate Synthase D08.586.399.278.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Carbohydrate Isomerases An enzyme that catalyzes the formation of myo-inositol-1-phosphate from glucose-6-phosphate in the presence of NAD. EC 5.5.1.4. Carbohydrate Isomerases (73-74); Inositol (73-74); Glucosephosphates (73-74) Vʵ"FoZInositol 1,4,5-Trisphosphate D02.033.800.519.400.350; D09.203.853.519.400.350; D09.203.894.480.350 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Inositol; Inositol Phosphates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Inositol; Inositol Phosphates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Inositol Phosphates Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. Inositol Phosphates (78-89); Sugar Phosphates (74-77) V̹!MB]@Inositol Phosphates D02.033.800.519.400; D09.203.853.519.400; D09.203.894.480 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Inositol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Inositol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Inositol 1,4,5-Trisphosphate; Phytic Acid Inositol 1,4,5-Trisphosphate; Phytic Acid Inositol 1,4,5-Trisphosphate; Phytic Acid Phosphoric acid esters of inositol. They include mono- and polyphosphoric acid esters, with the exception of inositol hexaphosphate which is PHYTIC ACID. Inositol (66-77); Sugar Phosphates (74-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $VAB4DInositol D09.203.853.519; D10.642.441; D11.786.708.415; D02.033.800.519 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipotropic Factors Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols Inositol Phosphates (+ 2) Inositol Phosphates (+ 2) Vԍ HDA@Inosine Triphosphate D13.695.667.616.800; D13.695.827.519.800 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Inosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Inosine Nucleotides Inosine 5'-(tetrahydrogen triphosphate). An inosine nucleotide containing three phosphate groups esterified to the sugar moiety. Synonym: IRPPP. Inosine Nucleotides (71-77) V.D!Inosine Nucleotides D13.695.667.616; D13.695.827.519 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Cyclic IMP; Inosine Diphosphate; Inosine Monophosphate; Inosine Triphosphate Cyclic IMP; Inosine Diphosphate; Inosine Monophosphate; Inosine Triphosphate Nucleotides (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  V=&BDInosine Monophosphate D13.695.667.616.500; D13.695.827.519.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Inosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Inosine Nucleotides Inosine 5'-Monophosphate. A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety. Synonyms: IMP. Inosine Nucleotides (71-74) V۾.D!Inosine Diphosphate D13.695.667.616.400; D13.695.827.519.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Inosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Inosine Nucleotides Inosine 5'-(trihydrogen diphosphate). An inosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: IRPP; inosine pyrophosphate. Inosine Nucleotides (71-77) V?.D!Inosine D13.570.583.616; D13.570.800.573 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Didanosine; Isoprinosine; Thioinosine (+ 1) Didanosine; Isoprinosine; Thioinosine (+ 1) Nucleosides (66-70) V &DhInorganic Chemicals (Non MeSH) D01 Acids (+ 28); Alkalies (+ 6); Aluminum Compounds (+ 7); Arsenic Compounds (+ 2); Barium Compounds (+ 1); Boron Compounds (+ 6); Bromine Compounds (+ 4); Calcium Compounds (+ 12); Carbon Compounds, Inorganic (Non MeSH) (+ 10); Caustics (+ 3); Chlorine Compounds (Non MeSH) (+ 15); Chromium Compounds (+ 4); Electrolytes (+ 41); Elements (+ 127); Fluorine Compounds (+ 7); Free Radicals (+ 2); Gases (+ 22); Gold Compounds (+ 4); Hydrogen (+ 4); Hydroxides (+ 8); Iodine Compounds (+ 5); Iron Compounds (+ 7); Isotopes (+ 85); Lithium Compounds (+ 2); Magnesium Compounds (+ 8); Manganese Compounds (+ 1); Mercury Compounds (+ 1); Metals (+ 91); Minerals (+ 24); Nitrogen Compounds (+ 26); Osmium Compounds (+ 1); Oxygen Compounds (Non MeSH) (+ 28); Phosphorus Compounds (Non MeSH) (+ 22); Platinum Compounds (+ 1); Potassium Compounds (+ 6); Ruthenium Compounds (+ 1); Salts; Selenium Compounds (+ 1); Silicon Compounds (+ 20); Silver Compounds (+ 1); Sodium Compounds (+ 15); Sulfur Compounds (Non MeSH) (+ 24); Technetium Compounds (+ 3); Thorium Compounds (+ 1); Tin Compounds (+ 2); Tungsten Compounds (+ 1); Uranium Compounds (+ 1); Vanadium Compounds (+ 1); Zinc Compounds (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPOPSRESDSTTOTUUR V%BInlays E06.323.428.491 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dental Materials Dentistry; Dentistry, Operative; Dental Restoration, Permanent Restorations of metal, porcelain, or plastic made to fit a cavity preparation, then cemented into the tooth. Onlays are restorations which fit into cavity preparations and overlay the occlusal surface of a tooth or teeth. Onlays are retained by frictional or mechanical factors. V $IGInlay Casting Wax D25.339.334.574 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Waxes Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Impression Materials V, jInk Blot Tests F04.711.647.622.341 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Projective Techniques Holtzman Inkblot Test; Rorschach Test Projective tests utilizing ink blots to which a subject responds. They are used in personality diagnosis. V .~Ink J01.637.439 Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) V}OInjury, Occupational Dis, Poisoning (Non MeSH) C21 Occupational Diseases (+ 17); Poisoning (+ 52); Wounds and Injuries (+ 165) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI V7^ZInjury Severity Score E05.318.308.940.968.875.500; E05.944.600; L01.280.900.968.875.500; N04.452.859.564.800.500; N05.715.360.300.715.500.800.400 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records; Medical Records; Trauma Severity Indices Miscellaneous Techniques (Non MeSH); Trauma Severity Indices Information Science; Data Collection; Records; Medical Records; Trauma Severity Indices Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records; Trauma Severity Indices Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records; Trauma Severity Indices An anatomic severity scale based on the Abbreviated Injury Scale (AIS) and developed specifically to score multiple traumatic injuries. It has been used as a predictor of mortality. Severity of Illness Index (85-89); Wounds and Injuries (74-89) VLInjections, Subcutaneous E05.300.530.620 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Injections, Intradermal; Injections, Jet Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. V"Y0Injections, Spinal E05.300.530.580 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia, Spinal; Anesthesia, Epidural Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Injections, Epidural (+ 1) V5"0Y!Injections, Jet E05.300.530.620.570 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections; Injections, Subcutaneous The injection of solutions into the skin by compressed air devices so that only the solution pierces the skin. Injections (66-71) VR"vInjections, Intraventricular E05.300.530.550 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cerebral Ventricles Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Injections into the cerebral ventricles. Cerebral Ventricles (66-75); Injections (66-75)  V!"Y19Injections, Intravenous E05.300.530.540 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Injections made into a vein for therapeutic or experimental purposes. V4"YSInjections, Intraperitoneal E05.300.530.490 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. VT "YInjections, Intramuscular E05.300.530.460 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. V"YInjections, Intralymphatic E05.300.530.440 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections V["YInjections, Intralesional E05.300.530.430 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections Injections introduced directly into localized lesions. Injections (66-89) V'"Y@Injections, Intradermal E05.300.530.620.410 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections; Injections, Subcutaneous The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. VQ"vInjections, Intra-Articular E05.300.530.380 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections W "YInjections, Intra-Arterial E05.300.530.370 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections W"YInjections, Epidural E05.300.530.580.300 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia, Epidural Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections; Injections, Spinal Blood Patch, Epidural The injection of drugs, most often analgesics, into the spinal canal without puncturing the dura mater. Epidural Space (79-86); Injections (66-86) $Wo"p{4Injections E05.300.530 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes Injections, Intra-Arterial; Injections, Intra-Articular; Injections, Intralesional; Injections, Intralymphatic; Injections, Intramuscular; Injections, Intraperitoneal; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal (+ 2); Injections, Subcutaneous (+ 2); Microinjections WC"KPInhibition (Psychology) F01.145.544; F02.463.425.475; F02.739.794.405 Behavior and Behavior Mechanisms (Non MeSH); Behavior Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Proactive Inhibition; Reactive Inhibition Proactive Inhibition; Reactive Inhibition The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. Conditioning (Psychology) (66-70); Learning (66-70); Psychoanalytic Theory (66-70) W@5aaInhibin D06.472.866.640; D12.776.395.450 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, LHRH Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Glyceroprotein hormone produced in the seminiferous tubules by the Sertoli cells in the male and by the granulosa cells in the female follicles. The hormone inhibits FSH and LH synthesis and secretion by the pituitary cells thereby affecting sexual maturation and fertility. Proteins (66-82); Testicular Hormones (75-82)  W e &HA7Inguinal Canal A01.047.412 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Abdomen W ;(*Infusions, Parenteral E05.300.510 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fluid Therapy; Home Infusion Therapy Miscellaneous Techniques (Non MeSH); Drug Administration Routes Infusions, Intra-Arterial; Infusions, Intraosseous; Infusions, Intravenous The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping.  W "-KUInfusions, Intravenous E05.300.510.590 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunoglobulins, Intravenous Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Infusions, Parenteral The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Infusions, Parenteral (66-86)  W"!e#Infusions, Intraosseous E05.300.510.560 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Infusions, Parenteral The adminstration of medication or fluid through a needle directly into the bone marrow. The technique is especially useful in the management of pediatric emergencies when intravenous access to the systemic circulation is difficult. Infusions, Parenteral (76-92) W"e#Infusions, Intra-Arterial E05.300.510.520 AECLCTECHIISMOMTNUPXSNSTTDUTVE Antineoplastic Agents Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Infusions, Parenteral Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Parenteral (66-77); Injections, Intra-Arterial (66-77); Isolation Perfusion (66-77)  W"enInfusion Pumps, Implantable E07.505.254; E07.858.082.505.254 AECLCTECHIMIPSPXSDSNSTTDUTVEVI Catheters, Indwelling Equipment and Supplies; Infusion Pumps Equipment and Supplies; Surgical Equipment; Artificial Organs; Infusion Pumps Implanted fluid propulsion systems with self-contained power source for providing long-term controlled-rate delivery of drugs such as chemotherapeutic agents or analgesics. Delivery rate may be externally controlled or osmotically or peristaltically controlled with the aid of transcutaneous monitoring. Drug Implants (77-89); Infusion Pumps (87-89); Infusions, Parenteral (75-86)  WW!&"Z\Infusion Pumps E07.505; E07.858.082.505 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies Equipment and Supplies; Surgical Equipment; Artificial Organs Infusion Pumps, Implantable; Insulin Infusion Systems Infusion Pumps, Implantable; Insulin Infusion Systems Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus (INSULIN INFUSION SYSTEMS is also available), and other disorders. Infusions, Intra-Arterial (78-86); Infusions, Parenteral (66-86); Perfusion, Regional (78-86) AECLCTECHIMIPSPXSDSNSTTDUTVEVI $WDc|m"Infratentorial Neoplasms C04.588.614.250.195.254.501; C10.228.140.211.254.501; C10.228.140.252.420.501; C10.228.250.195.254.501; C10.551.250.195.254.501 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms; Cerebellar Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Neoplasms; Cerebellar Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases; Cerebellar Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Brain Neoplasms; Cerebellar Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms; Cerebellar Neoplasms Intracranial tumors originating in the infratentorial region and occurring in both children and adults. Histological diagnoses include teratoma, medulloblastoma, glioblastoma, astrocytoma, ependymoma, craniopharyngioma, choroid plexus papilloma, and undetermined types. Therapeutic treatments include tumor resection, ventriculoperitoneal shunt, subdural peritoneal shunt, ventricular drainage, radiotherapy, and chemotherapy. Brain Neoplasms (66-88); Cerebellar Neoplasms (71-88) WX@Infrared Rays G03.230.300.100.725.525.400; H01.671.768.638.508 AECLDUHITU Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather; Sunlight Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Non-Ionizing That portion of the electromagnetic spectrum usually sensed as heat. Infrared wavelengths are longer than those of visible light, extending into the microwave frequencies. They are used therapeutically as heat, and also to warm food in restaurants. W"6#Informed Consent I01.880.604.583.427; N03.706.535.489 HILJSN Human Experimentation; Truth Disclosure Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Duty to Warn Duty to Warn Voluntary authorization, given to the physician by the patient, with full comprehension of the risks involved, for diagnostic or investigative procedures and medical and surgical treatment. Jurisprudence (66-70); Physician-Patient Relations (66-70) HILJPXSN (W$* /"D Information Theory F04.669.880.483; L01.488 HI Operations Research Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Theoretical Techniques (Non MeSH) Information Science An interdisciplinary study dealing with the transmission of messages or signals, or the communication of information. Information theory does not directly deal with meaning or content, but with physical representations that have meaning or content. It overlaps considerably with communication theory and CYBERNETICS. W')mInformation Systems L01.700.508.300 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications Clinical Laboratory Information Systems; Databases, Bibliographic (+ 1); Databases, Factual (+ 1); Hospital Information Systems; Integrated Advanced Information Management Systems; Management Information Systems (+ 11); Medical Records Systems, Computerized; MEDLARS (+ 1); Online Systems (+ 1); Radiology Information Systems; Reminder Systems; Unified Medical Language System Integrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information. CLECEDHIISLJMAMTOGSDSNSTTDUT  W)V Information Storage and Retrieval L01.700.508.280 CLECHILJSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications Grateful Med; MEDLARS (+ 1) A branch of computer or library science relating to the storage, locating, searching, and selecting, upon demand, relevant data on a given subject. Information Systems (66-90) CLECHIISLJMAOGSDSNSTTDUT $W,(V$!Information Services L01.453 CLECHIISLJMAOGSDSNSTTDUT Libraries Research Information Science Bibliography (+ 5); Book Selection; Drug Information Services (+ 2); Human Genome Project; Library Services (+ 1); Library Technical Services CLECHIISLJMAMTOGSDSNSTTDUT $W.   Information Science L01 CLECEDHIISLJMAMTOGSNSTTD Book Collecting; Chronology; Classification; Communication (+ 36); Communications Media (Non MeSH) (+ 93); Computer Security; Copying Processes (+ 9); Data Collection (+ 35); Documentation (+ 5); Information Centers (+ 7); Information Services (+ 14); Information Theory; Library Science (+ 9); Medical Informatics (+ 98); Pattern Recognition (+ 1); Publishing (+ 13); Systems Analysis (+ 5) The field of knowledge, theory, and technology dealing with the collection of facts and figures, and the processes and methods involved in their manipulation, storage, dissemination, publication, and retrieval. It includes the fields of COMMUNICATION, PUBLISHING, LIBRARY SCIENCE and informatics. Information Services (66-92); Information Systems (66-92) AECLCTDEECEDEHHIISLJMAMOMTNUOGPHPXRESDSNSTTDUTVE  W0"UD4Information Centers L01.346 CLECHILJOGSDSNSTTDUT Information Science Archives; Libraries (+ 5) Facilities for collecting and organizing information. They may be specialized by subject field, type of source material, persons served, location, or type of services. Information Services (66-75) CLECHILJMAOGSDSNSTTDUT $W41 !"Influenza Vaccine D24.310.894.899.302 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines W5>lInfluenza C02.782.620.505; C08.730.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Orthomyxoviridae Infections Respiratory Tract Diseases; Respiratory Tract Infections An acute viral infection involving the respiratory tract. It is marked by inflammation of the nasal mucosa, the pharynx, and conjunctiva, and by headache and severe, often generalized, myalgia. W6 "PInflation, Economic N03.219.680 CLHILJSNTD Economics, Organizations, Control (Non MeSH); Economics An increase in the volume of money and credit relative to available goods resulting in a substantial and continuing rise in the general price level. W8BInflammatory Bowel Diseases C06.405.469.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Colitis, Ulcerative; Crohn Disease Chronic, non-specific disorders of unknown etiology. Includes Crohn disease and ulcerative colitis. Extracolonic manifestations are often associated with Inflammatory Bowel Disease (IBD) and involve the liver, joints and skin. Colitis, Ulcerative (66-88); Crohn Disease (80-88)  W:5!NU*=Inflammation Mediators D17.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH) Autacoids (+ 48); Prostaglandins, Synthetic (+ 12) The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  W< 8a>HInflammation C23.739.487 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Acute-Phase Reaction; Anti-Inflammatory Agents Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Acute-Phase Reaction; Foreign-Body Reaction (+ 1); Granuloma (+ 1); Serositis; Suppuration (+ 3) A localized protective response elicited by injury or destruction of tissues, which srves to destroy, dilute, or wall off both the injurious agent and the injured tissue. It is characterized in the acute form by the classical signs of pain, heat, redness, swelling, and loss of function. Histologically it involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the inflammatory focus. (From Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $W>N6YvPInfertility, Male C12.294.365.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Infertility Oligospermia Inability of the male to effect conception. WCYNc6Infertility, Female C13.371.365.700 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Infertility Inability of a woman to achieve conception. WDNw6Infertility C12.294.365; C13.371.365 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fertility Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Infertility, Male (+ 1) Infertility, Female The inability to conceive or produce offspring.  WEN 4:Inferior Colliculus A08.186.211.132.659.237.364 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon; Corpora Quadrigemina Corpora Quadrigemina (66-70) WG8q"Infectious Peritonitis Virus, Feline B04.820.155.150.520; B04.909.777.199.150.520 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS infecting cats of all ages and commonly found in catteries and zoos. Cats are often found carrying the virus but only a small proportion develop disease. Coronaviridae (77-91) WH+2Infectious Pancreatic Necrosis Virus B04.820.075.100.430; B04.909.777.123.100.430 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Birnaviridae; Birnavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Birnaviridae; Birnavirus The type species of BIRNAVIRUS, causing infectious pancreatic necrosis in salmonid fish and other freshwater and marine animals including mollusks. Reoviridae (69-93); RNA Viruses (69-93) WK+21Infectious Mononucleosis C02.256.466.530; C15.378.553.381; C15.604.515.516; C20.683.515.515 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders A common, acute, usually self-limited infectious disease caused by the Epstein-Barr virus, characterized by fever, membranous pharyngitis, lymph node and splenic enlargement, lymphocyte proliferation, and the presence of atypical lymphocytes, and giving rise to various immune reactions, including the development of a transient heterophile and a persistent Epstein-Barr virus antibody response. Potential complications include hepatitis and encephalomeningitis. It affects primarily adolescents and young adults, being spread by saliva transfer and possibly other modes; in children the infection is largely subclinical. (Dorland, 27th ed). WM&LPInfectious Bursal Disease Virus B04.820.075.100.400; B04.909.777.123.100.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Birnaviridae; Birnavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Birnaviridae; Birnavirus A species of BIRNAVIRUS causing severe inflammation of the bursa of Fabricius in chickens and other fowl. Transmission is thought to be through contaminated feed or water. Vaccines have been used with varying degrees of success. WRg&2Infectious Bronchitis Virus, Avian B04.820.155.150.500; B04.909.777.199.150.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS causing infections in chickens and possibly pheasants. Chicks up to 4 weeks old are the most severely affected. WT)2Infectious Bovine Rhinotracheitis C02.256.466.488; C22.196.429 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Animal Diseases; Cattle Diseases A herpesvirus infection of cattle characterized by inflammation and necrosis of the mucous membranes of the upper respiratory tract. Cattle Diseases (66-72); Infectious Bovine Rhinotracheitis Virus (66-72) WV{'"J~UInfectious Anemia Virus, Equine B04.820.650.589.520.400; B04.909.777.731.589.520.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Equine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Equine A species of LENTIVIRUS, subgenus equine lentiviruses (LENTIVIRUSES, EQUINE), causing acute and chronic infection in horses. It is transmitted mechanically by biting flies, mosquitoes, and midges, and iatrogenically through unsterilized equipment. Chronic infection often consists of acute episodes with remissions. WX&:jInfection Control Practitioners M01.526.485.490; N02.360.490 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Physicians or other qualified individuals responsible for implementing and overseeing the policies and procedures followed by a health care facility to reduce the risk of infection to patients and staff. W[u%"Infection Control G03.850.780.200.450 ECHIISLJMTOGSNSTTD Communicable Disease Control; Cross Infection Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Antisepsis (+ 1); Patient Isolation; Quarantine; Sterilization (+ 1) Programs of disease surveillance, generally within health care facilities, designed to investigate, prevent, and control the spread of infections and their causative microorganisms. Communicable Disease Control (66-91); Cross Infection/prevention and control (66-91); Infection/prevention and control (66-91) CLECHIISLJMTOGPXSNSTTDUTVE (W]6TInfection C01.539 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPPPSPXRARHRIRTSUTHTMURUSVEVI Anti-Infective Agents Bacterial and Fungal Diseases (Non MeSH) Aneurysm, Infected; Arthritis, Infectious (+ 1); Carrier State; Communicable Diseases; Community-Acquired Infections; Cross Infection; Eye Infections (+ 13); Focal Infection (+ 1); Gingivitis, Necrotizing Ulcerative; Laboratory Infection; Ludwig's Angina; Opportunistic Infections (+ 2); Paronychia; Pregnancy Complications, Infectious (+ 2); Prosthesis-Related Infections; Reiter's Disease; Respiratory Tract Infections (+ 3); Sepsis (+ 8); Sexually Transmitted Diseases (+ 7); Skin Diseases, Infectious (+ 38); Soft Tissue Infections; Suppuration (+ 17); Thyroiditis, Suppurative; Toxemia; Urinary Tract Infections (+ 3); Wound Infection (+ 1) Invasion and multiplication of microorganisms in body tissues, which may be clinically inapparent or result in local cellular injury. A local infection may persist and spread by extension to become an acute, subacute, or chronic clinical infection or disease state. It may also become systemic when the microorganisms gain access to the lymphatic or vascular system. (From Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $W`  N1PInfarction C23.739.638.489 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myocardial Infarction; Splenic Infarction Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Necrosis The formation of an infarct, an area of coagulation necrosis in a tissue due to a local ischemia resulting from obstruction of circulation to the area, most commonly by a thrombus or embolus. (From Dorland, 27th ed). WfN1fInfanticide I01.198.240.470.572 CLECEHHILJPCPXSNTD Death Social Sciences; Criminology; Crime; Homicide The killing of infants at birth or soon after. Wh 8;Infant, Small for Gestational Age M01.471.392.520.520.460.560 BLCFGDIMMEMIPHPSPXURVI Fetal Growth Retardation Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Infant; Infant, Newborn; Infant, Low Birth Weight Infant having a birth weight lower than expected for its gestational age. Birth Weight (66-76); Infant, Low Birth Weight (77); Infant, Newborn (66-76); Infant, Premature (66-76)  Wi)Y~Infant, Premature, Diseases C16.614.521 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Bronchopulmonary Dysplasia; Leukomalacia, Periventricular; Respiratory Distress Syndrome (+ 1); Retinopathy of Prematurity BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Wk!JWLInfant, Premature M01.471.392.520.520.520 BLCFGDIMMEMIPHPSPXURVI Gestational Age; Labor, Premature Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Infant; Infant, Newborn Infant born before 38 weeks of gestation. Wm)n4Infant, Postmature M01.471.392.520.520.500 BLCFGDIMMEMIPHPSPXURVI Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Infant; Infant, Newborn Infant born at or after 42 weeks of gestation. Wnn;Infant, Newborn, Diseases C16.614 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Perinatology Neonatal Diseases and Abnormalities (Non MeSH) Amniotic Band Syndrome; Anemia, Neonatal (+ 2); Asphyxia Neonatorum; Birth Injuries (+ 1); Cystic Fibrosis; Erythroblastosis, Fetal (+ 1); Hemorrhagic Disease of Newborn; Hernia, Umbilical; Hydrocephalus; Hydrophthalmos; Hyperostosis, Cortical, Congenital; Ichthyosis (+ 5); Infant, Premature, Diseases (+ 5); Jaundice, Neonatal; Meconium Aspiration; Neonatal Abstinence Syndrome; Ophthalmia Neonatorum; Persistent Fetal Circulation Syndrome; Poikiloderma Congenitale; Sclerema Neonatorum; Severe Combined Immunodeficiency; Syphilis, Congenital; Thanatophoric Dysplasia; Toxoplasmosis, Congenital; Wolman Disease Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $Wo J7PInfant, Newborn M01.471.392.520.520 BLCFGDIMMEMIPHPSPXURVI Animals, Newborn Neonatology Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Infant Infant, Low Birth Weight (+ 1); Infant, Postmature; Infant, Premature  WutZUInfant, Low Birth Weight M01.471.392.520.520.460 BLCFGDIMMEMIPHPSPXURVI Birth Weight Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Infant; Infant, Newborn Infant, Small for Gestational Age Infant having a birth weight of 2500 gm. (5 lb., 8 oz.) or less. Birth Weight (66-76); Infant, Newborn (66-76); Infant, Premature (66-76) $Wvn)TXInfant Welfare I01.880.787.539 CLECEHHILJPCPXSNTD Social Sciences; Sociology; Social Welfare Organized efforts by communities or organizations to improve the health and well-being of the infant. Wx4xInfant Nutrition Disorders C18.654.180.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Child Nutrition Disorders Child Nutrition Disorders Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Child Nutrition Disorders Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.  Wy Nn-Infant Nutrition G06.696.259.750 EDPH Child Nutrition; Milk; Milk, Human Child Nutrition Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Child Nutrition Breast Feeding; Weaning Nutrition of children from birth to 2 years of age. EDEHPHPXSN (W|,bAInfant Mortality E05.318.308.985.550.475; G03.850.505.400.975.550.475; G03.850.520.308.985.550.475; L01.280.975.550.475; N01.224.935.698.489 TD Fetal Death Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Information Science; Data Collection; Vital Statistics; Mortality Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality Perinatal, neonatal, and infant deaths in a given population. W}SJInfant Food J01.341.580 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Food (66-69); Infant Nutrition (66-69) W"=0Infant Equipment E07.490 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Equipment and furniture used by infants and babies in the home, car, and play area. Equipment and Supplies (66-88) W f%Infant Care N02.421.088.120 CLECHIISLJMAMTOGPXSDSNSTTDUT Child Care; Incubators, Infant; Intensive Care, Neonatal Child Care Facilities, Manpower and Services (Non MeSH); Health Services; Child Care Intensive Care, Neonatal; Perinatal Care; Rooming-in Care Care of infants in the home or institution. $W DYE7Infant Behavior F01.145.179.500 CLDEEHPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Child Behavior Any observable response or action of a neonate or infant up through the age of 23 months. specific infant heading (67-94); Child Behavior (67-94) WyTnCInfant M01.471.392.520 Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child Infant, Newborn (+ 4) BLCFGDIMMEMIPHPSPXURVI W PInert Gas Narcosis C21.447.426; C21.613.455.571 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diving Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Gas Poisoning Progressive mental disturbances and unconsciousness due to breathing mixtures of oxygen and inert gases (argon, helium, xenon, krypton, and atmospheric nitrogen) at high pressure. specific gas (66-67)  W"L Industry J01.576 CLECEDHIISLJMAMTOGSNSTTD Commerce; Occupational Diseases; Occupational Medicine; Workplace Commerce Technology, Industry, Agriculture (Non MeSH) Barbering; Beauty Culture; Book Industry; Chemical Industry; Dairying; Drug Industry (+ 3); Fisheries; Food Handling (+ 4); Forestry; Laundering; Meat-Packing Industry (+ 1); Metallurgy; Mining (+ 1); Tanning; Textile Industry; Welding CLECEDHIISLJMAMTOGSDSNSTTDUT $W  M 4  Industrial Waste D05.284.404; G03.850.460.710.420 AEANECLJPCSN Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products W&Industrial Oils J01.740.400 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Oils Castor Oil; Linseed Oil; Petroleum (+ 4) Oils which are used in industrial or commercial applications. Oils (66-86) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEMIPDPKPOPSRESDSESNSTTOTUURUTVI $WL"=4JJIndustrial Microbiology G01.273.540.460; J01.897.120.460 CLECEDHIISLJMAMTOGSNSTTD Genetic Engineering Biological Sciences; Biology; Microbiology Technology, Industry, Agriculture (Non MeSH); Technology; Biotechnology The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms. W&Indoramin D02.065.277.480; D02.241.223.106.162.480; D03.383.621.320; D03.438.473.432; D18.162.495 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Cardiovascular Agents; Antihypertensive Agents N-[1-(2-Indol-3-ylethyl)-4-piperidyl]benzamide. Hypotensive agent with some anti-arrhythmic effects, used to treat essential hypertension. Benzamides (73-74); Indoles (71-74); Piperidines (71-74) W c:EIndoprofen D02.241.223.701.450; D08.373.310.365; D26.191.495 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylpropionates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Miscellaneous Drugs and Agents (Non MeSH); Carcinogens A drug that has analgesic and anti-inflammatory properties. Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.21). Phenylpropionates (74-78); Propionates (66-73) W9:*7Indophenol D02.755.446 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols 2,6-Dichloroindophenol W<:/Indonesia Z01.252.145.380 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern A republic stretching from the Indian Ocean east to New Guinea, comprising six main islands: Java, Sumatra, Bali, Kalimantan (the Indonesian portion of the island of Borneo), Sulawesi (formerly known as the Celebes) and Irian Jaya (the western part of New Guinea). The ethnic groups living there are largely Chinese, Arab, Eurasian, Indian, and Pakistani; 85% of the peoples are of the Islamic faith. W >Indomethacin D03.438.473.420; D06.347.930.390; D08.373.310.350; D16.850.015.050.420; D17.025.030.360; D17.050.030.360; D17.050.337.350; D26.930.390 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid. A non-steroidal anti-inflammatory agent that is used in the treatment of osteoarthritis, acute gouty arthritis, rheumatoid arthritis, and ankylosing spondylitis. Due to its action as a prostaglandin synthase inhibitor, indomethacin has also been used to delay premature labor. W`:Indolizines D03.438.496 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) W8GIndoles D03.438.473 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Adrenochrome; Alcian Blue; Captan; Carbolines; Cytochalasins (+ 2); Gliotoxins; Hydroxytryptophol; Ibogaine; Indican; Indigo Carmine; Indoleacetic Acids (+ 2); Indomethacin; Indoramin; Iprindole; Isatin; Mazindol; Methisazone; Molindone; Oxyphenisatin Acetate; Skatole; Sporidesmins; Sumatriptan; Tryptamines (+ 12) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR W 8GwDIndoleacetic Acids D03.066.288; D03.438.473.404; D11.303.760.522 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators Etodolac; Hydroxyindoleacetic Acid Etodolac; Hydroxyindoleacetic Acid Etodolac AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR W 58Z:Indole-3-Glycerol-Phosphate Synthase D08.586.520.258.420 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases An enzyme in the tryptophan biosynthetic pathway. EC 4.1.1.48. Carboxy-Lyases (70-74); Glycerophosphates (70-74); Indoles (70-74); Pentosephosphates (70-74) WF)FaLnIndocyanine Green D26.408.445 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes W.;Individuation F01.752.747.466 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development A process of differentiation having for its goal the development of the individual personality. W`qIndividuality F01.752.488 Behavior and Behavior Mechanisms (Non MeSH); Personality Those psychological characteristics which differentiate individuals from one another. Personality (66-74) WDbIndium Radioisotopes D01.496.749.460 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes. Indium (66-87); Radioisotopes (66-87) W4C.Indium D01.268.424; D01.552.381 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals W :`Indigo Carmine D03.438.473.396; D26.408.420 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Miscellaneous Drugs and Agents (Non MeSH); Dyes 3,3'-Dioxo-(delta-2,2'-biindoline)-5,5'-disulfonic acid disodium salt. Used as a dye in renal function testing and as a reagent for the detection of nitrates and chlorates and in the testing of milk. Synonyms: C.I. Acid Blue 74; C.I. Food Blue 1; C.I. 73015; FD and C Blue 2. Indoles (69-74); Sulfonic Acids (69-74) Wn".N1Indicators and Reagents D26.550 ADAEANCHCLCSCTECHIIPMEPDPKPORESDSTTOTU Reagent Kits, Diagnostic Miscellaneous Drugs and Agents (Non MeSH) Affinity Labels (+ 1); Alkylating Agents; Ampyrone; Arsenazo III; Aurovertins; Benzoin; Biuret; Bromcresol Green; Bromcresol Purple; Bromphenol Blue; Bromthymol Blue; Carbocyanines; Chromogenic Compounds (+ 1); Cross-Linking Reagents; Dansyl Compounds; 2,6-Dichloroindophenol; Digitonin; Dimyristoylphosphatidylcholine; Dinitrochlorobenzene; Diphenylcarbazide; 2,2'-Dipyridyl; Dithionitrobenzoic Acid; Dithizone; Ferrozine; Fluorescamine; Fluoresceins (+ 5); Formazans; Guaiac; 2-Hydroxy-5-nitrobenzyl Bromide; Hymecromone; Imidoesters (+ 2); Intercalating Agents; Luminol; Murexide; NBD Chloride; Neutral Red; Ninhydrin; Phenolphthaleins (+ 1); Phenylglyoxal; Phloroglucinol; o-Phthalaldehyde; Propidium; Reagent Kits, Diagnostic (+ 1); Rhodamines; Ruthenium Red; Sulfanilic Acids; Sulfhydryl Reagents (+ 3); Tetramethylphenylenediamine; Tetranitromethane; Tetraphenylborate; Tetrathionic Acid; Tetrazolium Salts (+ 1); Thiobarbituric Acid Reactive Substances; Thiocholine; Tiron AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESNSTTDTOTUULURUTVE  W *2uNIndicator Dilution Techniques E01.145.643 AECLCTECHIISMONUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Dye Dilution Technique; Radioisotope Dilution Technique; Thermodilution Dye Dilution Technique (66) AECLCTECHIISMOMTNUPXSNSTTDUTVE  W# 8S""Indican D03.438.473.393 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hartnup Disease Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles 1H-Indol-3-ol hydrogen sulfate ester. A substance occurring in the urine of mammals and also in blood plasma as the normal metabolite of tryptophan. An increased urinary excretion of indican is seen in Hartnup disease from the bacterial degradation of unabsorbed tryptophan. W DSAIndians, South American I01.076.201.450.416.486; I01.880.143.522.486; M01.194.486 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group belonging to the Mongoloid racial stock in South America. WAYIndians, North American I01.076.201.450.416.403; I01.880.143.522.403; M01.194.403 CLEDGEHILJPXSN United States Indian Health Service Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group belonging to the Mongoloid racial stock in North America. WA+YIndians, Central American I01.076.201.450.416.385; I01.880.143.522.387; M01.194.370 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group belonging to the Mongoloid racial stock in Central America. This does not include Mexican Indians. Indians, South American (66-77) WA&Indiana Z01.107.567.875.100.382; Z01.107.567.875.600.313.436; Z01.107.567.875.600.516.382 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States W YIndian Ocean Islands Z01.600 EHEP Geographicals (Non MeSH) Comoros; Madagascar; Mauritius; Reunion; Seychelles W ?India Z01.252.245.393 EHEP Geographicals (Non MeSH); Asia; Asia, Western Sikkim W 9 Independent Practice Associations N03.219.521.576.343.800.450; N04.452.758.244.450; N04.452.758.745.450; N04.590.374.410.450 CLECHILJMAOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Managed Care Programs Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Group Practice Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Private Practice Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care; Managed Care Programs A partnership, corporation, association, or other legal entity that enters into an arrangement for the provision of services with persons who are licensed to practice medicine, osteopathy, and dentistry, and with other care personnel. Under an IPA arrangement, licensed professional persons provide services through the entity in accordance with a mutually accepted compensation arrangement, while retaining their private practices. Services under the IPA are marketed through a prepaid health plan. (From Facts on File Dictionary of Health Care Management, 1988). W 'd3Indenes D04.615.486 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Dimethindene; Indans (+ 2); Sulindac A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  Wƥ 8P/:Indazoles D03.383.694.487; D03.438.449 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Benzydamine; Granisetron Benzydamine; Granisetron Pyrazoles (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  WȦ "8::Indapamide D02.065.884.540; D02.886.590.700.540; D19.770.224.516.550 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide. A sulfamyl diuretic with about 16x the effect of furosemide. Has also been shown to be an effective antihypertensive agent in the clinic. Synonyms: SE 1520; S 1520. Benzamides (74); Diuretics, Sulfamyl (74); Indoles (74) W\A:EIndans D04.615.486.487 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Indenes Aprindine; Ninhydrin AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Wl 8\:Incus A09.246.397.247.362 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Ear, Middle; Ear Ossicles WΘ :9Incunabula L01.178.682.192.515 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books WJfIncubators, Infant E07.325.569; E07.461.487 AECLCTECHISDSNSTTDUTVE Infant Care Equipment and Supplies; Equipment and Supplies, Hospital Equipment and Supplies; Incubators An apparatus for maintaining a premature infant in an environment of proper temperature and humidity. (Dorland, 27th ed). WkIncubators E07.461 AECLCTECHISDSNSTTDUTVE Environment, Controlled Equipment and Supplies Incubators, Infant Wr Incontinentia Pigmenti C16.131.077.445; C16.131.831.580; C17.800.621.497; C17.800.827.800.580 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) A genodermatosis occurring mostly in females and characterized by skin changes in three phases - vesiculobullous, verrucous papillomatous, and macular melanodermic. Hyperpigmentation is bizarre and irregular. Sixty percent of patients have abnormalities of eyes, teeth, central nervous system, and skin appendages. Pigmentation Disorders (66-86) WPLh$Incontinence Pads E07.455 AECLCTECHIPXSDSNSTTDUTVE Urinary Incontinence Equipment and Supplies Absorbent pads made of various materials used for personal hygiene usually in urinary incontinence and usually in the elderly. They may be worn as underpants or as pants liners. They are made of absorbent materials such as fluff wood pulp and hydrogel absorbent with viscose rayon, polyester, polypropylene, or polyethylene coverstock. Clothing (83-91); Disposable Equipment (86-91)  WP 8Income Tax N03.219.900.250 CLECHILJSNTD Economics, Organizations, Control (Non MeSH); Economics; Taxes Tax on the net income of an individual, organization, or business. WحKQIncome N01.824.417 CLHISNTD Salaries and Fringe Benefits Financial Management Population Characteristics (Non MeSH); Socioeconomic Factors Pensions; Salaries and Fringe Benefits (+ 4) Revenues or receipts accruing from business enterprise, labor, or invested capital. Social Conditions (66-67) CLECHILJOGSNSTTDUT ,Wٞ  #G7bInclusion Bodies, Viral A11.515.410; G04.185.515.880.450 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Viruses Cells; Inclusion Bodies Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) An area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent "virus factories" in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. One example, Negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies. WK&* Inclusion Bodies A11.515 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells Cytoplasmic Granules; Inclusion Bodies, Viral; Lewy Bodies A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or Mallory bodies), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed). Cytoplasmic Granules (66-69)  W} * F"Incisor A14.254.860.521 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth W :0Incineration G03.850.860.510.900.600.500 ECHIISLJMTSNST Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management; Refuse Disposal High temperature destruction of waste by burning with subsequent reduction to ashes or conversion to an inert mass. Refuse Disposal (66-93) WIncidence E05.318.308.985.525.375; G03.850.505.400.975.525.375; G03.850.520.308.985.525.375; L01.280.975.525.375; N01.224.935.597.500 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Morbidity Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Morbidity Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Morbidity Information Science; Data Collection; Vital Statistics; Morbidity Population Characteristics (Non MeSH); Demography; Vital Statistics; Morbidity The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time. Incidence Studies (89) W? SVIncest I01.880.735.442 CLECEHHILJPCPXSNTD Social Sciences; Sociology; Social Problems Sexual intercourse between persons so closely related that they are forbidden by law to marry. Paraphilias (66) W 5qInbreeding G05.414.133.403; E05.820.150.520 Animals, Inbred Strains; Consanguinity Genetics; Genetics, Population; Breeding Miscellaneous Techniques (Non MeSH); Reproduction Techniques; Breeding The mating of plants or non-human animals which are closely related genetically. It includes self-fertilization, sib mating, half-sib mating, and backcrossing. Inbreeding of humans is CONSANGUINITY. Genetics (66-67); Genetics, Population (66-67) W&.8Inappropriate ADH Syndrome C18.452.950.626; C19.700.490 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vasopressins Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Endocrine Diseases; Pituitary Diseases Hyponatremia and renal salt loss attributed to overexpansion of body fluids resulting from sustained release of antidiuretic hormone despite the absence of appropriate stimuli. Hyponatremia (66-78); Vasopressins (66-78)  W "N3In Situ Hybridization, Fluorescence E05.393.661.475.350 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Nucleic Acid Hybridization; In Situ Hybridization A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. Microscopy, Fluorescence (77-92); Nucleic Acid Hybridization (77-92) W]*"}^PIn Situ Hybridization E05.393.661.475 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Nucleic Acid Hybridization In Situ Hybridization, Fluorescence A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes. Nucleic Acid Hybridization (71-92)  W"b*)Impulsive Behavior F01.145.527; F03.126.517 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Compulsive Behavior (+ 1); Obsessive Behavior Compulsive Behavior (+ 1); Obsessive Behavior An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus. Behavior (66-67)  WFnImpulse Control Disorders F03.709.597.460 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Paraphilias; Substance Use Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders Firesetting Behavior; Gambling; Masturbation A disorder whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.  WSF,c5uImpromidine D02.078.370.500; D03.383.374.445; D14.100.375.400.380 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Agonists N-(3-(1H-Imidazol-4-yl)propyl)-N'-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine. A highly potent and specific histamine H2 receptor agonist. It has been used diagnostically as a gastric secretion indicator. Guanidines (79-82,89-92); Imidazoles (79-92) W/=:(5Imprinting (Psychology) F02.463.425.448 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning A particular kind of learning characterized by occurrence in very early life, rapidity of acquisition, and relative insusceptibility to forgetting or extinction. Imprinted behavior includes most (or all) behavior commonly called instinctive, but imprinting is used purely descriptively. W9 ZIImpotence, Vasculogenic C12.294.644.486.500; F03.126.496.500; F03.709.597.608.780.580.500 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Sex Disorders; Impotence Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Impotence Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Psychosexual Dysfunctions; Impotence Impotence caused by a diminution of blood flow to the penis. Arteries involved can be the terminal aorta, hypogastric, pudendal, penile, and cavernous arteries. Ectopic drainage of the corpora cavernosa via large superficial dorsal veins or abnormally large cavernous and crural veins can cause venogenic impotence. (From Walsh, et al., Campbell's Urology, 6th ed, p720). The expression "venous leakage" is seen often in international literature. Leakage refers to the failure of the blood to reach the penile erectile tissues. Impotence (85-94); Penis/blood supply (85-94) W:ILh8Impotence C12.294.644.486; F03.126.496; F03.709.597.608.780.580 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Sex Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Psychosexual Dysfunctions Impotence, Vasculogenic Impotence, Vasculogenic Impotence, Vasculogenic The inability of the male to perform sexual intercourse. X1 =LWPEImplosive Therapy F04.754.137.506.325 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Behavior Therapy; Desensitization, Psychologic A method for extinguishing anxiety by a saturation exposure to the feared stimulus situation or its substitute. XImplants, Artificial E07.450 AECLCTECHIMIPSSDSNSTTDUTVEVI Biocompatible Materials; Biofilms Equipment and Supplies Bioprosthesis; Blood Vessel Prosthesis; Bone Nails; Bone Plates; Bone Screws; Breast Implants; Cochlear Implant; Defibrillators, Implantable; Dental Implants; Heart, Artificial; Heart Valve Prosthesis; Internal Fixators; Joint Prosthesis (+ 2); Lenses, Intraocular; Mandibular Prosthesis; Maxillofacial Prosthesis; Molteno Implants; Ossicular Replacement Prosthesis; Penile Prosthesis; Stents; Tissue Expanders; Urinary Sphincter, Artificial; Vena Cava Filters Materials inserted into tissue for prosthetic, cosmetic, or therapeutic purposes. AECLCTECHIISMIMOMTNUPSPXRHSDSNSTTDUTVEVI $XK  (_,Impetigo C01.252.410.868.820.504; C01.252.410.890.485; C01.252.825.770.360; C01.539.800.720.770.360; C17.800.838.765.770.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections; Staphylococcal Skin Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose. X PwIMP Dehydrogenase D08.586.682.047.485 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme that catalyzes the dehydrogenation of inosine 5'-phosphate to xanthosine 5'-phosphate in the presence of NAD. EC 1.1.1.205. Inosine Nucleotides (74); Ketone Oxidoreductases (74) X1Ft@Immunotoxins D24.185.926.450; D24.611.125.580.450 ADAEANBLCFCHCLCTDEDUECGEHIIMIPMEPDPKPORETOTUULUR Recombinant Fusion Proteins; Antibodies, Bispecific Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoconjugates Semisynthetic conjugates of various toxic molecules, including radioactive isotopes and bacterial or plant toxins, with specific immune substances such as immunoglobulins, monoclonal antibodies, and antigens. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect. Antibodies, Monoclonal (82-86); Antigens, Surface (79-86); Antitoxins (66-86); Cytotoxicity, Immunologic (78-86); Ricin (78-85)  X*4<Immunotherapy, Adoptive E02.095.520.400.330.400; E05.478.550.520.400 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Cytapheresis; Monocytes, Activated Killer; Killer Cells, Lymphokine-Activated; Lymphocytes, Tumor-Infiltrating Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunization; Immunization, Passive Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunization; Immunization, Passive Form of passive immunization where sensitized lymphoid cells are passively infused in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells, tumor-infiltrating lymphocytes (TIL), and activated killer monocytes (AKM). Immunization, Passive (83-90)  X2$}<#Immunotherapy, Active E02.095.520.400.530 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunization Vaccination Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system. Immunotherapy (67-90)  X=$VImmunotherapy E02.095.520 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Immunity, Active; Immunologic Techniques Therapeutics; Biological Therapy (Non MeSH) Immunization (+ 6); Immunosuppression (+ 3); Radioimmunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. specific disease/therapy (66-72) $X$04M'Immunosuppressive Agents D22.569 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antilymphocyte Serum Biological Response Modifiers; Antirheumatic Agents Antineoplastics, Immunosuppressives (Non MeSH) Antilymphocyte Serum; Azaserine; Azathioprine; Busulfan; Cladribine; Coformycin (+ 1); Cyclophosphamide (+ 1); Cyclosporins (+ 1); Ellipticines; FK-506; Muromonab-CD3; Thiamphenicol Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of suppressor T-cell populations or by inhibiting the activation of helper cells. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of interleukins and other cytokines are emerging. AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (X 8<5*FImmunosuppression E02.095.520.450; E05.478.610 AECLCTECHIISMOMTNUPXSNSTTDUTVE Antilymphocyte Serum; Immune Tolerance; Immunocompromised Host Immune Tolerance; Transplantation Immunology Therapeutics; Biological Therapy (Non MeSH); Immunotherapy Miscellaneous Techniques (Non MeSH); Immunologic Techniques Desensitization, Immunologic; Graft Enhancement, Immunologic; Lymphocyte Depletion Desensitization, Immunologic; Graft Enhancement, Immunologic; Lymphocyte Depletion Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antilymphocyte Serum (68-70); Immune Tolerance (66-70); Immunity (66-70); Immunosuppressive Agents (66-70) (X T""I4a~Immunosorbents D24.611.171.501; D26.866.501 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzyme-Linked Immunosorbent Assay Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigen-Antibody Complex Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents An insoluble support for an antigen or antibody used to adsorb the homologous antibody or antigen from a mixture; the adsorbed entity may then be eluted in pure form for assay or analysis; many different substances are used, among them sepharose, glutaraldehyde, copolymers of anhydrides, polyacrylamides, etc. Absorption (66-76); Adsorption (66-76); Antigen-Antibody Complex (70-76); Antigen-Antibody Reactions (66-76)  X$"8'kImmunosorbent Techniques E01.223.495.567.380; E05.478.567.380 AECLCTECHIISMONUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay Enzyme-Linked Immunosorbent Assay; Radioallergosorbent Test; Radioimmunoprecipitation Assay; Radioimmunosorbent Test Enzyme-Linked Immunosorbent Assay; Radioallergosorbent Test; Radioimmunoprecipitation Assay; Radioimmunosorbent Test Techniques for removal by adsorption and subsequent elution of a specific antibody or antigen using an immunosorbent containing the homologous antigen or antibody. Adsorption (66-76); specific antibody/isolation and purification (69-76); specific antigen/isolation and purification (69-76) AECLCTECHIISMOMTNUPXSNSTTDUTVE $X'* "Immunoradiometric Assay E01.223.495.567.639.405; E05.478.567.639.405 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Radioimmunoassay Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Radioimmunoassay Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured. Immunoassay (66-89); Radioimmunoassay (66-89) X+2"6Immunoproteins (Non MeSH) D12.776.124.486 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins C-Reactive Protein; Complement (+ 33); Immunoglobulins (+ 34); Opsonins; Properdin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR X-WeHImmunoproliferative Small Intestinal Disease C04.557.386.390; C06.405.469.436; C15.378.147.780.490.512; C15.604.515.435.512; C20.683.515.512; C20.683.780.490.512 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias; Heavy Chain Disease Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Heavy Chain Disease Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias; Heavy Chain Disease A spectrum of conditions ranging from a benign plasma cell hyperplasia to a highly malignant lymphoma of the small intestine. Heavy Chain Disease (66-86); Intestinal Neoplasms (66-86); Lymphoma (66-86) X/3Nq[Immunoproliferative Disorders C20.683 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases Hypergammaglobulinemia (+ 1); Lymphoproliferative Disorders (+ 79); Paraproteinemias (+ 10) Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  X3" NlZImmunophenotyping E05.478.600 AECLCTECHIISMOMTNUPXSNSTTDUTVE Lymphocyte Subsets Miscellaneous Techniques (Non MeSH); Immunologic Techniques Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Phenotype (79-90)  X5"FImmunomagnetic Separation E02.110.142.400; E05.909.262.363.400 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Blood Component Removal; Bone Marrow Purging Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Cell Separation A cell-separation technique where magnetizable microspheres or beads are first coated with monoclonal antibody, allowed to search and bind to target cells, and are then selectively removed when passed through a magnetic field. Among other applications, the technique is commonly used to remove tumor cells from the marrow of patients who are to undergo autologous bone marrow transplantation. Cell Separation (83-93) X7*"Immunologic Tests E01.223.495 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunologic Techniques Diagnosis; Diagnosis, Laboratory Basophil Degranulation Test; Cell Migration Inhibition; Cytotoxicity Tests, Immunologic (+ 1); Fluorescent Antibody Technique (+ 3); Hemolytic Plaque Technique; Histocompatibility Testing (+ 2); Immune Adherence Reaction; Immunoassay (+ 15); Leukocyte Adherence Inhibition Test; Monitoring, Immunologic; Pregnancy Tests, Immunologic; Serodiagnosis (+ 25); Skin Tests (+ 6) Diagnostic techniques involving the demonstration or measurement of an immune response, including antibody production or assay, antigen-antibody reactions, serologic cross-reactivity, delayed hypersensitivity reactions, or heterogenetic responses. Immunologic Techniques (73-86); Serodiagnosis (66-86); specific technique or test (73-86) AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE (X:"'j4Immunologic Techniques E05.478 AECLCTECHIISMONUPXSNSTTDUTVE Blood Grouping and Crossmatching; Immunologic Tests; Immunotherapy; Pregnancy Tests, Immunologic; Serodiagnosis Immunity; Immunochemistry Miscellaneous Techniques (Non MeSH) Cell Migration Inhibition; Cytotoxicity Tests, Immunologic (+ 1); Epitope Mapping; Hemolytic Plaque Technique; Histocompatibility Testing (+ 1); Immune Adherence Reaction; Immunization (+ 3); Immunoassay (+ 15); Immunohistochemistry (+ 7); Immunophenotyping; Immunosuppression (+ 3); Leukocyte Adherence Inhibition Test; Lymphocyte Transformation; Monitoring, Immunologic; Radioimmunodetection; Rosette Formation; Serotyping; Skin Window Technique AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE $X>  * 4Immunologic Surveillance G04.610.555.412 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells. specific cell, organ, neoplasm/TR XB{h)Immunologic Memory G04.610.662 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Antibody Formation (66-70) XD8Q Immunologic Factors (Non MeSH) D24.611 Immunologic and Biologic Factors (Non MeSH) Adjuvants, Immunologic (+ 8); Antibodies (+ 93); Antigen-Antibody Complex (+ 1); Antigens (+ 246); Biological Response Modifiers (+ 2); Complement (+ 33); Cytokines (+ 47); Properdin; Receptors, Immunologic (+ 43); Tuftsin; Virus Inhibitors AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR XF% 4&HImmunologic Diseases C20 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Protein Disorders Autoimmune Diseases (+ 31); Blood Group Incompatibility (+ 4); Glomerulonephritis, Membranoproliferative; Graft vs Host Disease; Hypersensitivity (+ 35); Immunologic Deficiency Syndromes (+ 30); Immunoproliferative Disorders (+ 93); Purpura, Thrombocytopenic (+ 1) Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated or both. Allergy and Immunology (66-70) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $XGN6w%ZImmunologic Deficiency Syndromes C20.673 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunocompromised Host Immunologic Diseases Agammaglobulinemia; Ataxia Telangiectasia; Common Variable Immunodeficiency; Digeorge Syndrome; Dysgammaglobulinemia (+ 2); HIV Infections (+ 6); HTLV-BLV Infections (+ 5); Leukocyte Adhesion Deficiency Syndrome; Lymphopenia (+ 1); Phagocyte Bactericidal Dysfunction (+ 4); Severe Combined Immunodeficiency; Wiskott-Aldrich Syndrome Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Immunity (66-67) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI (XJ& NPImmunologic Capping G04.335.857.612; G04.610.143.612 DEGEIMPHRE Immunoglobulins, Surface Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Receptor Aggregation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions The process by which lymphoid cell surface immunoglobulin receptors, when exposed to bivalent anti-Ig antibodies, collect in patches and form a cap at one pole of the cell. The caps may then be endocytosed or shed into the environment in the form of antigen-antibody complexes. Capping has also been induced by lectins and antigens. Cell Membrane (66-77); Lymphocytes (66-77)  XN4&4Immunologic and Biologic Factors (Non MeSH) D24 Biological Factors (+ 233); Biological Products (+ 76); Immunologic Factors (Non MeSH) (+ 484) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR XQr4sJImmunohistochemistry E05.478.588; E05.909.262.607.512; E05.909.432.551.512; G01.201.344.512; G01.201.486.512 CLECEDHIISLJMAMTOGSNSTTD Miscellaneous Techniques (Non MeSH); Immunologic Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytochemistry Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytochemistry Biological Sciences; Biochemistry; Histocytochemistry Biological Sciences; Biochemistry; Immunochemistry Fluorescent Antibody Technique (+ 3); Immunoenzyme Techniques (+ 2) Fluorescent Antibody Technique Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Antibodies, Monoclonal (82-87); Fluorescent Antibody Technique (66-87); Immunoenzyme Techniques (77-87) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $XRcvkx*Immunoglobulins, Thyroid-Stimulating D12.776.124.486.485.760; D12.776.124.790.651.760; D12.776.377.715.548.760; D24.611.125.308.480; D24.611.125.600.760 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Graves' Disease; Receptors, Thyrotropin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins Autoantibodies that bind to the thyroid-stimulating hormone (TSH) receptor (RECEPTORS, THYROTROPIN) on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES' DISEASE. Autoantibodies (69-94)  XVr)6/oImmunoglobulins, Surface D12.776.124.486.485.750; D24.611.125.600.700 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic Capping Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins Immunoglobulins bound to the surface of lymphocytes. Immunoglobulins (70-74)  X[M26?Immunoglobulins, mu-Chain D12.776.124.486.485.680.680.500; D12.776.124.790.651.596.680.500; D12.776.377.715.548.673.680.500; D24.611.125.600.662.680.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Heavy chains found in the Fab and Fc fragments of IgM and having a molecular weight of approximately 72 kD. They contain about 57 amino acid residues arranged in five domains and have more oligosaccharide branches and a higher carbohydrate content than the heavy chains of IgG. IgM (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) X]t6I`Immunoglobulins, Light-Chain D12.776.124.486.485.680.720; D12.776.124.790.651.596.720; D12.776.377.715.548.673.720; D24.611.125.600.662.720 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments Immunoglobulins, kappa-Chain; Immunoglobulins, lambda-Chain Immunoglobulins, kappa-Chain; Immunoglobulins, lambda-Chain Immunoglobulins, kappa-Chain; Immunoglobulins, lambda-Chain Immunoglobulins, kappa-Chain; Immunoglobulins, lambda-Chain Polypeptide chains, consisting of 211 to 217 amino acid residues, isolated from immunoglobulins and having a molecular weight of approximately 22 kD. There are two major types of light chains, kappa and lambda. In man they are found in a ratio of 60% to 40%, respectively. Both chains consist of linear repeating, similar, but not identical, segments of about 110 amino acid residues. In each segment a disulfide bond establishes a tightly folded approximately 60-membered loop or domain. Adjacent domains are linked by less tightly folded regions. Both light chains contain two such domains. Two light and two heavy chains make one immunoglobulin molecule, but both light chains in one Ig are of the same type. Immunoglobulin Fragments (73-75)  Xc!x6jF&Immunoglobulins, lambda-Chain D12.776.124.486.485.680.720.550; D12.776.124.790.651.596.720.550; D12.776.377.715.548.673.720.550; D24.611.125.600.662.720.550 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain One of the light chains of the immunoglobulins with a molecular weight of approximately 22 kD. They constitute about 40% of all light chains and can be recognized serologically as well as by their specific amino acid sequence. Gamma Globulins (66-71); Immunoglobulin Fragments (73-74); Immunoglobulins (72) Xj"6 ^Immunoglobulins, kappa-Chain D12.776.124.486.485.680.720.530; D12.776.124.790.651.596.720.530; D12.776.377.715.548.673.720.530; D24.611.125.600.662.720.530 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Light-Chain One of the light chains of the immunoglobulins with a molecular weight of approximately 22 kD. They constitute about 60% of all light chains and can be recognized serologically as well as by their specific amino acid sequence. Gamma Globulins (66-71); Immunoglobulin Fragments (73-74); Immunoglobulins (72) XpD!6 ^Immunoglobulins, J-Chain D12.776.124.486.485.680.700; D12.776.124.790.651.596.700; D12.776.377.715.548.673.700; D24.611.125.600.662.700 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments The immunoglobulin fragments found in the light chain fractions of secretory IgA and polymeric IgM in a ratio of one J chain per one IgA dimer or one IgM pentamer. It is a polypeptide with a molecular weight of about 17 kD and probably serves either to bind the components of the globulins together or to transfer the globulins across membranes. Xux6jImmunoglobulins, Intravenous D12.776.124.486.485.730; D12.776.124.790.651.730; D12.776.377.715.548.730; D24.611.125.600.690 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPKPORESTTOTUULUR Infusions, Intravenous Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins Immunoglobulin preparations used in intravenous infusion, containing primarily IgG. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS, primary hypergammaglobulinemia, SCID, cytomegalovirus infections in transplant recipients, chronic lymphocytic leukemia, Kawasaki syndrome, infection in neonates, and idiopathic thrombocytopenic purpura. IgG (70-91); Immunoglobulins (70-91)  Xz!h:-Immunoglobulins, Heavy-Chain D12.776.124.486.485.680.680; D12.776.124.790.651.596.680; D12.776.377.715.548.673.680; D24.611.125.600.662.680 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Heavy Chain Disease Heavy Chain Disease Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments Immunoglobulins, alpha-Chain; Immunoglobulins, delta-Chain; Immunoglobulins, epsilon-Chain; Immunoglobulins, gamma-Chain; Immunoglobulins, mu-Chain Immunoglobulins, alpha-Chain; Immunoglobulins, delta-Chain; Immunoglobulins, epsilon-Chain; Immunoglobulins, gamma-Chain; Immunoglobulins, mu-Chain Immunoglobulins, alpha-Chain; Immunoglobulins, delta-Chain; Immunoglobulins, epsilon-Chain; Immunoglobulins, gamma-Chain; Immunoglobulins, mu-Chain Immunoglobulins, alpha-Chain; Immunoglobulins, delta-Chain; Immunoglobulins, epsilon-Chain; Immunoglobulins, gamma-Chain; Immunoglobulins, mu-Chain Major components of immunoglobulin molecules. They are the larger of the two types of polypeptide chains responsible for the biological and immunological properties of the different immunoglobulins. They differ according to the class of Ig from which they were isolated, contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kD. One Ig molecule comprises two heavy and two light chains. Immunoglobulin Fragments (73-74) (X!x6j&Immunoglobulins, gamma-Chain D12.776.124.486.485.680.680.380; D12.776.124.790.651.596.680.380; D12.776.377.715.548.673.680.380; D24.611.125.600.662.680.380 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Heavy chains found in the Fab and Fc fragments of IgG and having a molecular weight of approximately 51 kD. They contain about 450 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment. The gamma chains of the four IgG subgroups are not identical, but resemble each other more closely than the heavy chains of a different immunoglobulin. IgG (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) X!6`Immunoglobulins, Fc D12.776.124.486.485.680.660; D12.776.124.790.651.596.660; D12.776.377.715.548.673.660; D24.611.125.600.662.660 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Receptors, Fc Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments Crystallizable fragments composed of the carboxy-terminal halves of both heavy chains linked to each other by disulfide bonds. Fc fragments are responsible for the effector functions of antibodies (complement fixation, binding to cell membranes, and placental transport). Immunoglobulins (70-72)  Xx6j:Immunoglobulins, Fab D12.776.124.486.485.680.650; D12.776.124.790.651.596.650; D12.776.377.715.548.673.650; D24.611.125.600.662.650 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments Antigen-binding fragments composed of one entire light chain and about half of one of the heavy chains, linked to each other by disulfide bonds. Fab contains the antigen binding site which is part of the variable region of the immunoglobulin molecule. Immunoglobulins (70-72) Xx6j)Immunoglobulins, epsilon-Chain D12.776.124.486.485.680.680.370; D12.776.124.790.651.596.680.370; D12.776.377.715.548.673.680.370; D24.611.125.600.662.680.370 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Heavy chains found in the Fab and Fc fragments of IgE and having a molecular weight of approximately 72 kD. They contain about 550 amino acid residues arranged in five domains and about three times more carbohydrate than the heavy chains of IgA, IgD, and IgG. IgE (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) X\#66`Immunoglobulins, delta-Chain D12.776.124.486.485.680.680.360; D12.776.124.790.651.596.680.360; D12.776.377.715.548.673.680.360; D24.611.125.600.662.680.360 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Heavy chains found in the Fab and Fc fragments of IgD and having a molecular weight of approximately 64 kD. They contain about 500 amino acid residues arranged in four domains and an oligosaccharide component covalently bound to the Fc fragment. IgD (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) X!6#`Immunoglobulins, alpha-Chain D12.776.124.486.485.680.680.350; D12.776.124.790.651.596.680.350; D12.776.377.715.548.673.680.350; D24.611.125.600.662.680.350 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments; Immunoglobulins, Heavy-Chain Heavy chains found in the Fab and Fc fragments of IgA and having a molecular weight of approximately 58 kD. They contain about 470 amino acid residues arranged in four domains and an oligosaccharide component bound covalently to the Fc fragment. IgA (73-75); Immunoglobulin Fragments (73-75); Immunoglobulins, Heavy Chain (75) X_!6#`Immunoglobulins D12.776.124.486.485; D12.776.124.790.651; D12.776.377.715.548; D24.611.125.600 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Paraproteinemias Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH) Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies CD4 Immunoadhesins; IgA (+ 1); IgD; IgE; IgG (+ 2); IgM; Immunoglobulin Fragments (+ 16); Immunoglobulins, Intravenous; Immunoglobulins, Surface; Immunoglobulins, Thyroid-Stimulating; Paraproteins (+ 4) CD4 Immunoadhesins; IgA (+ 1); IgD; IgE; IgG (+ 2); IgM; Immunoglobulin Fragments (+ 16); Immunoglobulins, Intravenous; Immunoglobulins, Thyroid-Stimulating; Paraproteins (+ 4) CD4 Immunoadhesins; IgA (+ 1); IgD; IgE; IgG (+ 2); IgM; Immunoglobulin Fragments (+ 16); Immunoglobulins, Intravenous; Immunoglobulins, Thyroid-Stimulating; Paraproteins (+ 4) CD4 Immunoadhesins; Immunoglobulin Fragments (+ 16); Immunoglobulin Isotypes (+ 11); Immunoglobulins, Intravenous; Immunoglobulins, Surface; Immunoglobulins, Thyroid-Stimulating Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity. (Dorland, 27th ed). Gamma Globulins (66-69) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (XX6aHImmunoglobulin Variable Region D12.776.124.486.485.680.600; D12.776.124.790.651.596.600; D12.776.377.715.548.673.600; D24.611.125.600.662.600 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Binding Sites, Antibody Gene Rearrangement Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments That region of the immunoglobulin (antibody) molecule that varies in its amino acid sequence and composition, confers the antigenic specificity, and is thought to comprise the binding site for the antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable and framework regions, VH family subgroups, and the complementarity-determining region. Antigenic Determinants (72-76); Binding Sites, Antibody (73-76); Immunoglobulin Fragments (73-76); Immunoglobulins, Fab (73-76) $X"$x6jImmunoglobulin Switch Region G05.275.351.328; G05.331.599.110.708.328; G06.184.599.110.708.328 DEGEIMIPPHRE Genetics; Genes; Genes, Immunoglobulin Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid Site on a segment of a B-cell immunoglobulin heavy-chain gene where recombination or rearrangement can occur, expressed as isotype or allotype switching, maturation of immune response, or recombination of DNA molecules. It is found on genes encoding all five immunoglobulin heavy chains. Genes, Structural (77-87); Immunoglobulins, Constant Region (79-87); Immunoglobulins, Variable Region (77-87) X"IjNImmunoglobulin Joining Region D12.776.124.486.485.680.300; D12.776.124.790.651.596.300; D12.776.377.715.548.673.300; D24.611.125.600.662.300 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Genes, Immunoglobulin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments Segment of light and heavy chains of mouse and human immunoglobulins where the genes for the variable region upstream join those of the constant region downstream (an important part of the ANTIBODY DIVERSITY mechanism). In the joining region of the light chain are the genes coding for amino acids 96 to 107. Amino Acid Sequence (71-87); Immunoglobulin Constant Region (79-87); Immunoglobulin Variable Region (77-87); Immunoglobulins, Heavy Chain (77-87)  X#x6jnImmunoglobulin Isotypes D24.611.125.600.681 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins IgA (+ 1); IgD; IgE; IgG (+ 5); IgM The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties. Immunoglobulins(72-86) ADAEANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPKPORETOTUULUR $X6|5M:Immunoglobulin Inv Allotypes D24.611.125.584.587; D24.611.125.600.681.393.500; G04.610.626.500.507; G05.275.077.500.505; G05.511.500.505 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulin Allotypes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes; IgG Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Immunoglobulin Allotypes Genetics; Genes; Alleles; Immunoglobulin Allotypes Genetics; Immunogenetics; Immunoglobulin Allotypes Hereditary allotypic markers associated with the light chain of IgG. X{"w6RImmunoglobulin Idiotypes D24.611.125.588; G04.610.626.510; G05.511.510 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antibodies, Anti-Idiotypic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Immunogenetics Unique, genetically controlled determinants present on antibodies whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the variable regions of both immunoglobin polypeptide chains. Anti-Antibodies (66-69); Antibody Specificity (70-78); Antigenic Determinants (70-78); Binding Sites, Antibody (73-78)  X56 Immunoglobulin Gm Allotypes D24.611.125.584.586; D24.611.125.600.681.393.495; G04.610.626.500.504; G05.275.077.500.495; G05.511.500.495 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulin Allotypes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes; IgG Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Immunoglobulin Allotypes Genetics; Genes; Alleles; Immunoglobulin Allotypes Genetics; Immunogenetics; Immunoglobulin Allotypes Hereditary allotypic markers associated with the heavy chain of IgG. Alleles (68-74); IgG (71-86); Immunoglobulin Allotypes (75-86) X !w6RLImmunoglobulin Fragments D12.776.124.486.485.680; D12.776.124.790.651.596; D12.776.377.715.548.673; D24.611.125.600.662 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Genes, Immunoglobulin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins Immunoglobulin Constant Region; Immunoglobulin Joining Region; Immunoglobulin Variable Region; Immunoglobulins, Fab; Immunoglobulins, Fc; Immunoglobulins, Heavy-Chain (+ 5); Immunoglobulins, J-Chain; Immunoglobulins, Light-Chain (+ 2); Secretory Component Immunoglobulin Constant Region; Immunoglobulin Joining Region; Immunoglobulin Variable Region; Immunoglobulins, Fab; Immunoglobulins, Fc; Immunoglobulins, Heavy-Chain (+ 5); Immunoglobulins, J-Chain; Immunoglobulins, Light-Chain (+ 2); Secretory Component Immunoglobulin Constant Region; Immunoglobulin Joining Region; Immunoglobulin Variable Region; Immunoglobulins, Fab; Immunoglobulins, Fc; Immunoglobulins, Heavy-Chain (+ 5); Immunoglobulins, J-Chain; Immunoglobulins, Light-Chain (+ 2); Secretory Component Immunoglobulin Constant Region; Immunoglobulin Joining Region; Immunoglobulin Variable Region; Immunoglobulins, Fab; Immunoglobulins, Fc; Immunoglobulins, Heavy-Chain (+ 5); Immunoglobulins, J-Chain; Immunoglobulins, Light-Chain (+ 2); Secretory Component Immunoglobulins (70-72)  Xh6Immunoglobulin Constant Region D12.776.124.486.485.680.110; D12.776.124.790.651.596.110; D12.776.377.715.548.673.110; D24.611.125.600.662.110 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Immunoglobulin Fragments Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Fragments That region of the immunoglobulin (antibody) molecule that is invariable in its amino acid sequence within any class of immunoglobulins. It confers the biological specificity to the Ig and is grossly species specific. It comprises the C-terminus half of the light chains and three quarters or more of the heavy chains, all of the Fc fragment, and the C-terminus half of the Fab fragment. Gamma Globulins (66-71); Immunoglobulin Allotypes (75-78); Immunoglobulins (72-78); Immunoglobulins, Fc (73); specific immunoglobulin fragment (73-78) Xh$x6jImmunoglobulin Class Switching G04.610.626.321.900; G05.331.390.900; G05.511.321.900 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement Genetics; Genetics, Biochemical; Gene Rearrangement Genetics; Immunogenetics; Gene Rearrangement Gene rearrangement of the B-lymphocyte which results in a substitution in the type of heavy-chain constant region that is expressed. This allows the effector response to change while the antigen binding specificity (variable region) remains the same. The majority of class switching occurs by a DNA recombination event but it also can take place at the level of RNA processing. Immunoglobulin Isotypes/biosynthesis (88-93); Immunoglobulins, Heavy-Chain/genetics (80-93) XD$=hImmunoglobulin Allotypes D24.611.125.584; G04.610.626.500; G05.275.077.500; G05.511.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Genes; Alleles Genetics; Immunogenetics Immunoglobulin Gm Allotypes; Immunoglobulin Inv Allotypes Immunoglobulin Gm Allotypes; Immunoglobulin Inv Allotypes Immunoglobulin Gm Allotypes; Immunoglobulin Inv Allotypes Immunoglobulin Gm Allotypes; Immunoglobulin Inv Allotypes Hereditary serologic types based on antigenic differences in the light and heavy chains of immunoglobulins due to allelic genes in the gene loci coding the chains. The Inv system applies to the kappa light chains, the Gm system applies to the heavy chains of IgG. Alleles (68-74); Antibody Specificity (70-74); Antigenic Determinants (70-74); Immunoglobulins (70-74); Isoantibodies (66-74)  XH69Immunogenetics G04.610.626; G05.511 CLECEDHIISLJMAMTOGSNSTTD Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Genetics Antibody Diversity; Antigenic Variation; Gene Rearrangement (+ 9); Genes, Immunoglobulin; Immunoglobulin Allotypes (+ 2); Immunoglobulin Idiotypes; Major Histocompatibility Complex (+ 2); Minor Histocompatibility Loci; Minor Lymphocyte Stimulatory Loci Antibody Diversity; Antigenic Variation; Gene Rearrangement (+ 9); Genes, Immunoglobulin; Immunoglobulin Allotypes (+ 2); Immunoglobulin Idiotypes; Major Histocompatibility Complex (+ 2); Minor Histocompatibility Loci; Minor Lymphocyte Stimulatory Loci; Molecular Mimicry A branch of genetics which deals with the genetic basis of the immune response. Allergy and Immunology (66-70); Genetics (66-70) ADAEANBIBLCFCHCLCTDEDUECEDGEHIIMIPISLJMAMEMTOGPDPHPORESNSTTDTOTUULUR $X[`a;HImmunoenzyme Techniques E01.223.495.567.350; E05.478.567.350; E05.478.588.400 AECLCTECHIISMONUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry Enzyme-Linked Immunosorbent Assay; Enzyme Multiplied Immunoassay Technique Enzyme-Linked Immunosorbent Assay; Enzyme Multiplied Immunoassay Technique Enzyme-Linked Immunosorbent Assay; Enzyme Multiplied Immunoassay Technique Immunologic techniques based on the use of: 1) enzyme-antibody conjugates; 2) enzyme-antigen conjugates; 3) antienzyme antibody followed by its homologous enzyme; or 4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Enzymes (66-76); Immunologic Techniques (73-76); Peroxidases (66-76) AECLCTECHIISMOMTNUPXSNSTTDUTVE $X= <R"Immunoelectrophoresis, Two-Dimensional E01.223.495.826.769.442.400.520; E05.196.401.568.520; H01.181.529.307.437.568.520 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Precipitin Tests; Immunodiffusion; Immunoelectrophoresis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Immunoelectrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis; Immunoelectrophoresis Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis. Immunoelectrophoresis (66-75) X+Y""Immunoelectrophoresis E01.223.495.826.769.442.400; E05.196.401.568; H01.181.529.307.437.568 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Protein Electrophoresis Blood Protein Electrophoresis; Electrophoresis Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Precipitin Tests; Immunodiffusion Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Counterimmunoelectrophoresis; Immunoelectrophoresis, Two-Dimensional Counterimmunoelectrophoresis; Immunoelectrophoresis, Two-Dimensional Counterimmunoelectrophoresis; Immunoelectrophoresis, Two-Dimensional A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera. $XRM"#6:nImmunodominant Epitopes D24.611.216.119.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody. Antigenic Determinants (66-90) X6$Immunodiffusion E01.223.495.826.769.442 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Precipitin Tests Immunoelectrophoresis (+ 2) Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. X"c!Immunodeficiency Viruses, Primate B04.820.650.589.400; B04.909.777.731.589.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus HIV (+ 2); SIV HIV (+ 2); SIV A subgenus of LENTIVIRUS comprising viruses that produce immunodeficiencies in primates, including humans. X'2,{Immunodeficiency Virus, Feline B04.820.650.589.530.400; B04.909.777.731.589.530.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Feline Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Feline A species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells. Retroviridae (87-90) Xc$:)Immunodeficiency Virus, Bovine B04.820.650.589.500.400; B04.909.777.731.589.500.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Bovine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Bovine A species of LENTIVIRUS, subgenus bovine lentiviruses (LENTIVIRUSES, BOVINE), found in cattle and causing lymphadenopathy, lymphocytosis, central nervous system lesions, progressive weakness, and emaciation. It has immunological cross-reactivity with other lentiviruses including HIV. Retroviridae (87-90) X$:CImmunoconjugates D24.611.125.580 ADAEANBLCFCHCLCTDEDUECGEHIIMIPMEPDPKPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Immunotoxins Combinations of diagnostic or therapeutic substances linked with specific immune substances such as immunoglobulins, monoclonal antibodies or antigens. Often the diagnostic or therapeutic substance is a radionuclide. These conjugates are useful tools for specific targeting of drugs and radioisotopes in the chemotherapy and radioimmunotherapy of certain cancers. Immunotoxins (87-94)  X4iImmunocompromised Host G04.610.619 DEGEIMPHRE Immunosuppression; Immune Tolerance; Immunologic Deficiency Syndromes Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Radiation Chimera A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immune Tolerance (80-91); Immunologic Deficiency Syndromes (77-91); Immunosuppression (76-91) $YPQmImmunocompetence G04.610.612 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. Antibody Formation (66-79); Immunity (66-72); Immunity, Cellular (70-79); Lymphocytes (66-79); B Lymphocytes (73-79); T Lymphocytes (73-79) YQ}Immunochemistry E05.196.512; G01.201.486; H01.181.278.550 CLECEDHIISLJMAMTOGSNSTTD Immunoblotting; Immunologic Techniques Immunoblotting Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Biological Sciences; Biochemistry Physical Sciences (Non MeSH); Chemistry; Chemistry, Analytical  Immunohistochemistry Field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues. It includes physicochemical interactions between antigens and antibodies. $Y1-Immunoblotting E01.223.495.567.320; E05.478.567.320 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunochemistry Immunochemistry Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay Blotting, Western Blotting, Western Immunologic methods for isolating and quantitatively measuring immunoreactive substances. When used with immune reagents such as monoclonal antibodies, the process is known generically as western blot analysis (BLOTTING, WESTERN). Electrophoresis, Polyacrylamide Gel (82-88); Immunochemistry (83-88); Immunoelectrophoresis (84-88); Immunoenzyme Techniques (83-88); Isoelectric Focusing (84-88) (Y[*"* Immunoblastic Lymphadenopathy C15.604.515.509; C20.683.515.501 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly. Y "&N;Immunoassay E01.223.495.567; E05.478.567 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques Immunoblotting (+ 1); Immunoenzyme Techniques (+ 2); Immunosorbent Techniques (+ 4); Radioimmunoassay (+ 4) Immunoblotting (+ 1); Immunoenzyme Techniques (+ 2); Immunosorbent Techniques (+ 4); Radioimmunoassay (+ 4) Immunochemical assay or detection of a substance by serologic or immunologic methods. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Y X""Immunization, Secondary E02.095.520.400.485; E05.478.550.550 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunization Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunization Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization (66-70) YX*"Immunization, Passive E02.095.520.400.330; E05.478.550.520 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immune Sera; Immunity, Maternally-Acquired Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunization Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunization Immunotherapy, Adoptive Immunotherapy, Adoptive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, immune RNA, or transplantation of lymphocytes (IMMUNOTHERAPY, ADOPTIVE). Immunity, Maternally-Acquired (66-69) AECLCTECHIISLJMOMTNUPXSNSTTDUTVE (Y1*"26+$Immunization Schedule E02.095.520.400.360 Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunization Schedule giving optimum times usually for primary and/or secondary immunization. YV_Immunization Programs N02.421.143.827.608; N02.421.726.608 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services Organized services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international. Immunization (66-93); Immunization Schedule (67-93); Vaccination (66-93) Y*VImmunization E02.095.520.400; E05.478.550; G03.770.670.310; G03.850.780.200.425 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Preventive Health Services Therapeutics; Biological Therapy (Non MeSH); Immunotherapy Miscellaneous Techniques (Non MeSH); Immunologic Techniques Environment and Public Health (Non MeSH); Preventive Medicine; Primary Prevention Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Immunization, Passive (+ 1); Immunization Schedule; Immunization, Secondary; Immunotherapy, Active (+ 1) Immunization, Passive (+ 1); Immunization, Secondary Vaccination Vaccination Deliberate stimulation of the host's immune response. Active immunization involves administration of antigens or immunologic adjuvants. Passive immunization involves administration of immune sera or lymphocytes or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).  YL$ wImmunity, Natural G04.610.575 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Blood Bactericidal Activity; Phagocytosis The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from non-specific mechanisms such as genetic endowment, naturally occurring antiviral and bactericidal substances, phagocytosis, and constitutional factors such as body temperature, oxygen tension, and age. specific term/immunology (66-77); Immunity (66-77)  Y#Q1b=Immunity, Maternally-Acquired G04.610.570 DEGEIMPHRE Immunization, Passive Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Resistance to a disease-causing agent induced by the introduction of maternal immunity into the fetus by transplacental transfer or into the neonate through colostrum and milk. Y "QImmunity, Cellular G04.610.555 DEGEIMPHRE Hypersensitivity, Delayed Lymphokines; T-Lymphocytes; Interleukin-12 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Antigen Presentation; Immunologic Surveillance; Lymphocyte Transformation; Transplantation Immunology (+ 5) Those manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Immunity (66-69) BLCFCICLCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI ,Y"A2Q{RImmunity, Active G04.610.519 DEGEIMPHRE Immunotherapy Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. Y%CQImmunity G04.610 DEGEIMPHRE Immunologic Techniques Biological Phenomena, Cell Physiology, Immunity (Non MeSH) Antibody Diversity; Antibody Formation; Antibody Specificity (+ 2); Antigen-Antibody Reactions (+ 11); Autoimmunity; Blood Groups (+ 10); CD4-CD8 Ratio; Complement Activation (+ 2); Cytotoxicity, Immunologic (+ 2); Dose-Response Relationship, Immunologic; Histamine Liberation; HIV Seronegativity; Immune Tolerance (+ 3); Immunity, Active; Immunity, Cellular (+ 9); Immunity, Maternally-Acquired; Immunity, Natural (+ 2); Immunocompetence; Immunocompromised Host (+ 1); Immunogenetics (+ 22); Immunologic Memory; Lymphocyte Cooperation; Neuroimmunomodulation; Neutrophil Activation Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. ADAEANBIBLCFCHCICLCNCOCTDEDHDIDTDUECEDEHEMENEPETGEHIIMIPISLJMAMEMIMOMTNUOGPAPCPDPHPOPPPSPXRARERHRIRTSNSTSUTDTHTOTUULURUSVEVI $Y&  DImmune Tolerance G04.610.484 DEGEIMPHRE Graft vs Host Disease; Immunocompromised Host; Immunosuppression Immunosuppression Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Clonal Anergy; Clonal Deletion; Self Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. $Y+(LQ9Immune System A15.382 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Hemic and Immune Systems (Non MeSH) Antigen-Presenting Cells (+ 2); Bone Marrow; Enterochromaffin Cells; Leukocytes (+ 28); Lymphatic System (+ 37); Mast Cells; Phagocytes (+ 12); Reticuloendothelial System (+ 11) Cellular and molecular components having the primary function of distinguishing self from non-self and defense against foreign organisms or substances. The primary cellular components are lymphocytes and macrophages, and the primary molecular components are antibodies and lymphokines. (From Dorland, 27th ed). Antibody Formation (66-84); Immunity (66-84); Immunity, Cellular (70-84); Lymphocyte Transformation (69-84); Lymphocytes (66-84); B Lymphocytes (73-84); T Lymphocytes (73-84) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $Y. 8,f<Immune Sera D24.310.401; D24.611.125.573 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOULUR Immunization, Passive Immunologic and Biologic Factors (Non MeSH); Biological Products Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antilymphocyte Serum; Antireticular Cytotoxic Serum Antilymphocyte Serum; Antireticular Cytotoxic Serum Serum that contains antibodies. It is obtained from an animal that has been immunized either by antigen injection or infection with microorganisms containing the antigen. ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR $Y2"4v6Immune Complex Diseases C20.543.520 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antigen-Antibody Complex Immunologic Diseases; Hypersensitivity Arthus Reaction; Serum Sickness; Vasculitis, Hypersensitivity (+ 2) Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other systemic immunologic diseases including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA. Immunologic Diseases (71) $Y4N-PImmune Adherence Reaction E01.223.495.525; E05.478.525 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Antigen-Antibody Reactions (66-70) Y8""l(Immobilization E05.823.400; G11.427.505 AEPH Hypokinesia Movement; Restraint, Physical Miscellaneous Techniques (Non MeSH); Restraint, Physical Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) The act of rendering whole or part of the body immobile, whether accidental or deliberate. This also refers to the state of immobility.  Y:$Immersion Foot C23.304.351.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cold Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed). Y<NrImmersion E05.466 AEPP Diving; Drowning Miscellaneous Techniques (Non MeSH) The placing of a body or a part thereof into a liquid. Diving (66)  Y@.  *FImmediate-Early Proteins D12.776.260.900.610; D12.776.460; D12.776.964.950.610 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, Immediate-Early Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins  Adenovirus E1 Proteins (+ 2) Proteins that are coded by immediate-early genes, in the absence of de novo protein synthesis. The term was originally used exclusively for viral regulatory proteins that were synthesized just after viral integration into the host cell. It is also used to describe cellular proteins which are synthesized immediately after the resting cell is stimulated by extracellular signals. Viral Proteins (74-93) $YA=H2&Imitative Behavior F01.145.510 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior The mimicking of the behavior of one individual by another. Behavior (66-67); Behavior, Animal (66-67) YE) AI4Imipramine D03.494.240.485; D14.100.050.600.050.400; D14.100.600.050.400; D15.085.050.350; D15.700.122.055.511 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. YF@o:$Imipenem D20.085.099.120.300.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Carbapenems; Thienamycins 6-(1-Hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7- oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid. Semisynthetic thienamycin which has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Antibiotics (80-82); Thienamycins (83-88) YJ :`{2Imino Acids D02.241.081.583; D02.491.485; D12.125.072.401 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Organic Chemicals (Non MeSH); Imines Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) Azetidinecarboxylic Acid Azetidinecarboxylic Acid Azetidinecarboxylic Acid; Proline (+ 3); Pyrrolidonecarboxylic Acid AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR YN|58HImines D02.491 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Carbodiimides (+ 3); Imino Acids (+ 1); Polyethyleneimine; Schiff Bases AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR YP  8#Y:Imidoesters D02.478.400; D26.550.430 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Imides Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Dimethyl Adipimidate; Dimethyl Suberimidate Dimethyl Adipimidate; Dimethyl Suberimidate Esters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents. Imides (66-79) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $YR ,|d.Imidocarb D02.065.199.326.400; D02.948.684.202.400; D21.370.522 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Carbanilides Organic Chemicals (Non MeSH); Urea; Phenylurea Compounds; Carbanilides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents N,N'-bis(3-(4,5-Dihydro-1H-imidazol-2-yl)phenyl)urea. Antiprotozoal agent used in veterinary medicine against blood parasites, especially babesia in livestock; causes kidney damage. Synonyms: 4 A 65; Imizol. Carbanilides (74); Imidazoles (66-74); Urea (66-73) YT =:@Imides D02.478 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Imidoesters (+ 2); Maleimides (+ 1); Phthalimides; Succinimides (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR YW:  8#W:Imidazoles D03.383.374 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Aminoimidazole Carboxamide; Antazoline; Carbimazole; Cimetidine; Clonidine; Clotrimazole; Creatinine; Dacarbazine; Econazole; Enoximone; Ethylenethiourea; Etimizol; Etomidate; Fadrozole; FLA 63; Fluspirilene; Histamine (+ 1); Histidinol; Hydantoins (+ 6); Impromidine; Levamisole; Methimazole; Miconazole; Naphazoline; Niridazole; Nitroimidazoles (+ 9); Ondansetron; Oxymetazoline; Phentolamine; RO 20-1724; Tetramisole; Tolazoline; Trimethaphan; Urocanic Acid AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR YXb8GDImagination F02.463.188.634 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Cognition Dreams; Fantasy A new pattern of perceptual or ideational material derived from past experience. CLDEPHPXRE  Y[ [`Image Processing, Computer-Assisted L01.700.568.110.308 CLECHIISLJMTSDSNSTTDUT Diagnostic Imaging Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Image Enhancement (+ 2) A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. AECLCTECHIISLJMOMTNUPXSDSNSTTDUTVE $Y\)|&Image Interpretation, Computer-Assisted E01.158.600; E01.357.505; L01.700.508.100.158.600 ISMTSTUT Diagnosis; Diagnosis, Computer-Assisted Diagnosis; Diagnostic Imaging Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted; Diagnosis, Computer-Assisted Radiographic Image Interpretation, Computer-Assisted Radiographic Image Interpretation, Computer-Assisted; Tomography, Emission-Computed (+ 1); Tomography, X-Ray Computed Radiographic Image Interpretation, Computer-Assisted Computer systems developed to aid in the interpretation of ultrasound, radiographic images, etc. AECLCTECHIISMOMTNUPXSNSTTDUTVE  Y^-9 q"Image Enhancement E01.357.710.500; H01.671.606.799.484; L01.700.568.110.308.380 ISMTST Radiographic Image Enhancement; Subtraction Technique Diagnosis; Diagnostic Imaging; Photography Physical Sciences (Non MeSH); Physics; Optics; Photography Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Image Processing, Computer-Assisted Radiographic Image Enhancement (+ 3); Tomography, Emission-Computed (+ 1) Radiographic Image Enhancement (+ 3); Tomography, Emission-Computed Radiographic Image Enhancement; Radiography, Dual-Energy Scanned Projection Improvement of the quality of a picture by various techniques, including computer processing, digital filtering, echocardiographic techniques, light and ultrastructural microscopy, fluorescence spectrometry and microscopy, scintigraphy, and in vitro image processing at the molecular level. Photography (66-70); Technology, Radiologic (66-70) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE (YaE >I=&Iloprost D02.241.081.436.687.700.125; D10.516.251.355.708.700.125; D17.350.700.275; D18.918.456; D19.461.780.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic Cardiovascular Agents; Vasodilator Agents Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Platelet Aggregation Inhibitors (E)-(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-delta(2(1H),gamma-pentalenevaleric acid). A stable synthetic analog of EPOPROSTENOL but with a longer half-life than the parent compound. The drug has vasodilator and antiplatelet activities and improves the fibrinolytic activity in patients with atherosclerotic disease, thereby providing them with further antithrombotic protection. It is also used in the treatment of Raynaud's disease and provides dose-dependent protection of the heart against some of the deleterious effects of ischemia and reperfusion. Cardiovascular Agents (79-90); Epoprostenol (78-90); Vasodilator Agents (66-90) Yf s:^Illusions C10.597.751.525; F02.463.593.446; F03.126.185.794.534; C23.888.592.763.525 CLDEETGEHIPHPXRE Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Perceptual Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders  Autokinetic Effect; Optical Illusions The misinterpretation of a real external, sensory experience. Yl T0IIllinois Z01.107.567.875.100.370; Z01.107.567.875.600.313.370; Z01.107.567.875.600.516.370 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States Chicago Chicago Chicago Yo YIllegitimacy I01.880.225.465; I01.880.735.424 CLECEHHILJPCPXSNTD Social Sciences; Sociology; Family Social Sciences; Sociology; Social Problems The state of birth outside of wedlock. It may refer to the offspring or the parents. Yr-&^iIlium A02.835.232.611.434 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Pelvic Bones Ysc :LIliac Vein A07.231.908.427 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins A vein on either side of the body which is formed by the union of the external and internal iliac veins and passes upward to join with its fellow of the opposite side to form the inferior vena cava. Yt(85Iliac Artery A07.231.114.444 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Either of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs. Yu88Iliac Aneurysm C14.907.055.625 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm An aneurysm of the common, internal, or external iliac arteries. Aneurysm (66-92); Iliac Artery (66-92) YwN>N0Ileum A03.492.411.620.484 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ileostomy Digestive System; Gastrointestinal System; Intestines; Intestine, Small Ileocecal Valve; Meckel's Diverticulum ABAHBLBSCFCHCICLCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI  Yxn : T.hIleostomy E04.579.338.508; E04.765.338.508 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ileum Surgery, Operative; Ostomy; Enterostomy Surgery, Operative; Surgery, Digestive System (Non MeSH); Enterostomy Surgical creation of an external opening into the ileum for fecal diversion or drainage. Loop or tube procedures are most often employed. Yy &$ Ileocecal Valve A03.492.411.620.484.400 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Intestines; Intestine, Small; Ileum Y{:]Ileitis C06.405.469.420.520 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Enteritis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Ileal Diseases Y|{ N hIleal Neoplasms C04.588.274.476.411.501; C06.240.476.411.501; C06.405.282.411.501; C06.405.469.420.501; C06.405.469.505.501 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Ileal Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms Neoplasms of the ileum including the ileocecal valve. Ileum (66-79); Intestinal Neoplasms (66-79) Y}wXDA5Ileal Diseases C06.405.469.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Ileal Neoplasms; Ileitis Diseases of the ileum including the ileocecal valve. Ileum (66-79); Intestinal Diseases (66-79); specific intestinal disease BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $YGNU@VXIguanas B02.833.393.500 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Lizards Large herbivorous tropical American lizards. YL &&5IgM D12.776.124.486.485.622; D12.776.124.790.651.549; D12.776.377.715.548.609; D24.611.125.600.681.574 ADAEANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes Immunoglobulins (70) Yl8IgG Deficiency C15.378.147.333.750; C20.673.430.750 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Dysgammaglobulinemia Immunologic Diseases; Immunologic Deficiency Syndromes; Dysgammaglobulinemia A dysgammaglobulinemia characterized by a deficiency of IgG. IgG (71-72); IgG/deficiency (73-92) Y*NH-IgG D12.776.124.486.485.567; D12.776.124.790.651.504; D12.776.377.715.548.546; D24.611.125.600.681.393 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Receptors, IgG Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes Muromonab-CD3; Rho(D) Immune Globulin Muromonab-CD3; Rho(D) Immune Globulin Muromonab-CD3; Rho(D) Immune Globulin Immunoglobulin Gm Allotypes; Immunoglobulin Inv Allotypes; Long-Acting Thyroid Stimulator; Muromonab-CD3; Rho(D) Immune Globulin Immunoglobulins (70) ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPKPORETOTUULUR $Yl68IgE D12.776.124.486.485.511; D12.776.124.790.651.459; D12.776.377.715.548.484; D24.611.125.600.681.312 ADAEANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR Receptors, IgE Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes Immunoglobulins (70) Yil8IgD D12.776.124.486.485.456; D12.776.124.790.651.414; D12.776.377.715.548.421; D24.611.125.600.681.251 ADAEANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes Immunoglobulins (70) Yyl8IgA, Secretory D12.776.124.486.485.400.350; D12.776.124.790.651.369.350; D12.776.377.715.548.359.350; D24.611.125.600.681.026.030 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; IgA Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; IgA Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; IgA Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes; IgA The principle Ig found in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. It is composed of two to four molecules of 7S IgA and one molecule each of J Chain and secretory component (SC), also called secretory piece. Molecular weight appr. 400,000. Colostrum (73-75); IgA (73-75); Immunoglobulin Fragments (73-75) Yr|6.TNIgA Deficiency C15.378.147.333.500; C20.673.430.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Dysgammaglobulinemia Immunologic Diseases; Immunologic Deficiency Syndromes; Dysgammaglobulinemia A dysgammaglobulinemia characterized by a deficiency of IgA. Dysgammaglobulinemia (75-92); IgA/deficiency (71-92) Y.*NH>IgA D12.776.124.486.485.400; D12.776.124.790.651.369; D12.776.377.715.548.359; D24.611.125.600.681.026 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins; Immunoglobulin Isotypes IgA, Secretory IgA, Secretory IgA, Secretory IgA, Secretory Immunoglobulins (70) Y:l6FIfosfamide D02.455.526.728.650.730.500; D02.705.670.243.500; D03.383.533.500; D22.204.585.748.243.511; D22.569.518.511 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds; Phosphoramide Mustards Organic Chemicals (Non MeSH); Organophosphorus Compounds; Phosphoramide Mustards; Cyclophosphamide Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds; Phosphoramide Mustards; Cyclophosphamide Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents; Cyclophosphamide 3-(2-Chloroethyl)-2-(2-chloroethylamino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide. Positional isomer of cyclophosphamide which is active as an alkylating agent and an immunosuppressive agent. Synonyms: Asta A 4942; NSC-109724. Cyclic P-Oxides (72-74); Ethylamines (72-74); Oxazines (72-74) Y{w:gLIduronidase D08.586.277.450.560 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Mucopolysaccharidosis I Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases An enzyme that hydrolyzes iduronosidic linkages in desulfated dermatan. Deficiency of this enzyme produces Hurler's syndrome. EC 3.2.1.76. Glycoside Hydrolases (72-74); Hexoses (72-74); Uronic Acids (72-74)  YFlRIduronic Acid D02.241.081.844.915.400.500; D02.241.152.811.400.500; D02.241.511.902.915.400.500; D09.203.811.922.400.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Uronic Acids; Hexuronic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Aldehydic (Non MeSH); Uronic Acids; Hexuronic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Uronic Acids; Hexuronic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Uronic Acids; Hexuronic Acids Component of dermatan sulfate. Differs in configuration from glucuronic acid only at the C-5 position. Uronic Acids (71-74) Y-t: zIduronate Sulfatase D08.586.277.352.827.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Sulfatases An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 3.1.6.13. Iduronic Acid (75); Sulfatases (72-75); Uronic Acids (72-75) YFnKIdoxuridine D13.570.230.430.609; D13.570.685.852.300.400; D20.388.534; D26.087.274.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxyuridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine; Deoxyuridine Anti-Infective Agents; Antiviral Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Deoxyuridine 2'-Deoxy-5-iodouridine. An analog of DEOXYURIDINE that inhibits viral DNA synthesis. The drug is used as an antiviral agent, particularly in the treatment of herpes simplex keratitis. Antimetabolites (66-91); Antiviral Agents (66-91); Deoxyuridine (66-91) YT:}UIditol Dehydrogenase D08.586.682.047.150.700.475 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases; Sugar Alcohol Dehydrogenases An alcohol oxidoreductase which catalyzes the oxidation of L- or D-iditol to L- or D-sorbose in the presence of NAD. Acts also on glucitol to form fructose and on other closely related sugar alcohols. EC 1.1.1.14 and EC 1.1.1.15. Alcohol Oxidoreductases (66-76); specific polyol Y{F:Identity Crisis F01.752.747.423 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Chaotic concept of self wherein one's role in life appears to be an insoluble dilemma often expressed by isolation, withdrawal, rebellion and extremism. Defense Mechanisms (66-67); Identification (Psychology) (68-70); Self Concept (66-70) Y"`eIdentification (Psychology) F01.393.446; F01.752.747.385; F03.407.446 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Gender Identity Gender Identity Gender Identity A defense mechanism by which an individual unconsciously endeavors to pattern himself after another. This mechanism is also important in the development of the personality, particularly the superego or conscience, which is modeled largely on parental behavior. Defense Mechanisms (66-67); Personality (66-67) Y 18.9Idarubicin D20.085.075.105.200.400; D22.204.106.125.200.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin 3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy- 6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy- alpha-L-lyxo-hexapyranoside. An orally administered anthracycline antibiotic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with potential for reduced cardiac toxicity. Antibiotics, Antineoplastic (67-88); Daunorubicin/analogs and derivatives (75-88) Y6:X^Idaho Z01.107.567.875.100.361; Z01.107.567.875.600.656.361 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Northwestern United States Y^ :Id F01.752.747.347; F02.739.794.371 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory The part of the personality structure which harbors the unconscious instinctive desires and strivings of the individual. Personality (66-67); Psychoanalytic Theory (66-67) Y&<Ictaluridae B02.493.080.148 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Catfish A family of North American freshwater catfishes. It consists of five genera with several species two of which are eyeless. Fishes (66-86) Y&$ICR 170 D02.455.526.728.650.400; D03.494.046.250.530; D22.204.585.498 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds 6-Chloro-9-[[3-[(2-chloroethyl)ethylamino]propyl]amino]-2-methoxyacridine dihydrochloride. A monofunctional quinacrine mustard compound which acts both as an alkylating agent and as a mutagen. Acridines (71-74); Nitrogen Mustard Compounds (71-74) Y E:[@Ichthyosis, X-Linked C16.131.831.512.420; C16.614.492.420; C17.800.428.333.420; C17.800.827.800.570 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ichthyosis Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Chronic form of ichthyosis that is inherited as a sex-linked recessive trait carried on the X-chromosome and transmitted to the male offspring. It is characterized by severe scaling, especially on the extremities, and is associated with steroid sulfatase deficiency. Ichthyosis (66-90) Y%XL6Ichthyosis, Lamellar C16.131.831.512.400.410; C16.614.492.400.410; C17.800.428.333.250.410; C17.800.827.800.550.410 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ichthyosis; Ichthyosiform Erythroderma, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Ichthyosis; Ichthyosiform Erythroderma, Congenital Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Ichthyosis; Ichthyosiform Erythroderma, Congenital Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Ichthyosiform Erythroderma, Congenital A chronic, congenital ichthyosis inherited as an autosomal recessive trait. Infants are usually born encased in a collodion membrane which sheds within a few weeks. Scaling is generalized and marked with grayish-brown quadrilateral scales, adherent at their centers and free at the edges. In some cases, scales are so thick that they resemble armored plate. Ichthyosiform Erythroderma, Congenital (91-92); Ichthyosis (66-92) Y0hLMIchthyosis Vulgaris C16.131.831.512.410; C17.800.428.333.410; C17.800.827.800.560 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Most common form of ichthyosis characterized by prominent scaling especially on the exterior surfaces of the extremities. It is inherited as an autosomal dominant trait. Ichthyosis (66-90) YɟELwIchthyosis C16.131.831.512; C16.614.492; C17.800.428.333 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Ichthyosiform Erythroderma, Congenital (+ 2); Ichthyosis Vulgaris; Ichthyosis, X-Linked; Sjogren-Larsson Syndrome Ichthyosiform Erythroderma, Congenital (+ 2); Ichthyosis, X-Linked; Sjogren-Larsson Syndrome Ichthyosiform Erythroderma, Congenital (+ 2); Ichthyosis Vulgaris; Ichthyosis, X-Linked; Sjogren-Larsson Syndrome Any of several generalized skin disorders characterized by dryness, roughness, and scaliness, due to hypertrophy of the stratum corneum epidermis. Most are genetic, but some are acquired, developing in association with other systemic disease or genetic syndrome. Y5Lm0Ichthyosiform Erythroderma, Congenital C16.131.831.512.400; C16.614.492.400; C17.800.428.333.250; C17.800.827.800.550 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ichthyosis Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Ichthyosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Hyperkeratosis, Epidermolytic; Ichthyosis, Lamellar Hyperkeratosis, Epidermolytic; Ichthyosis, Lamellar Hyperkeratosis, Epidermolytic; Ichthyosis, Lamellar Hyperkeratosis, Epidermolytic; Ichthyosis, Lamellar Designation for several severe forms of ichthyosis, present at birth, that are characterized by hyperkeratotic scaling. Infants may be born encased in a collodion membrane which begins shedding within 24 hours. This is followed in about two weeks by persistent generalized scaling. The forms include bullous (HYPERKERATOSIS, EPIDERMOLYTIC), non-bullous (ICHTHYOSIS, LAMELLAR), wet type, and dry type. Ichthyosis (66-90)  Y/,XLIceland Z01.542.433 EHEP Geographicals (Non MeSH); Europe Y )Ice Cream J01.341.273.533 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Dairy Products Y<"PIce G03.230.700.300 AEANST Dry Ice Freezing Environment and Public Health (Non MeSH); Environment; Water Y   JIbuprofen D02.241.223.701.430; D08.373.310.330; D16.850.015.050.400; D17.025.030.350; D17.050.030.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylpropionates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal A nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis. Propionates (72-74) Y؛ g:Ibotenic Acid D03.383.548.320; D14.100.190.200.360; D24.185.926.587.475 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Agonists Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins alpha-Amino-3-hydroxy-5-isoxazoleacetic acid. Neurotoxic isoxazole substance found in Amanita muscaria and A. pantherina. It causes motor depression, ataxia, and changes in mood, perceptions and feelings, and is a potent excitatory amino acid agonist. Ammonium Compounds (73-75); Mushrooms (73-75); Oxazoles (73-75) YA<h!MIbogaine D03.132.430; D03.438.473.390; D15.300.375; D15.700.372.492 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens One of several indole alkaloids extracted from Tabernanthe iboga, Baill. It is a hallucinogen and is being investigated for treatment of drug addiction, especially cocaine addiction. The mechanisms of action are not clear, but ibogaine probably interacts with opioid receptors and may be a neurotoxin. Alkaloids (69-75); Azepines (75); Benzazepines (69-74); Indoles (72-75) Ym DD`XIatrogenic Disease C23.280.537 EPPCVE Disease Transmission, Professional-to-Patient Symptoms and General Pathology (Non MeSH); Disease Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by the patient during the course of treatment. Y 3>I Blood-Group System D24.611.216.705.230.501; G04.610.241.501; G09.188.229.501 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups A blood group related both to the ABO and P systems that includes several different antigens found in most people on erythrocytes, in milk, and in saliva. The antibodies react only at low temperatures. Blood Groups (66-75) YA2PHysteroscopy E01.249.430; E01.418.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hysterosalpingography Uterus Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Endoscopy Endoscopy of the interior of the uterus. The technique is indicated in the diagnosis and treatment of intrauterine lesions, infertility, abnormal uterine bleeding, hysterographic abnormalities, and intrauterine foreign bodies. Hysteroscopy is considered a more accurate diagnostic technique than hysterosalpingography. Endoscopy (66-89) $Y" HkHysterosalpingography E01.249.420; E01.357.818.480 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Genitalia, Female; Hysteroscopy; Uterus; Fallopian Tubes Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography Radiography of the uterus and fallopian tubes after the injection of a contrast medium. Y"&DaiHysteria F03.126.473 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) A chronic, but fluctuating, disorder beginning in early life and characterized by recurrent and multiple somatic complaints for which medical attention is sought, but which are not apparently due to physical illness. Y FYHysterectomy, Vaginal E04.819.608.399.490 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH); Hysterectomy Removal of the uterus through the vagina. Yu$p4Hysterectomy E04.819.608.399; E04.887.690.399 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Uterus Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Gynecologic (Non MeSH) Hysterectomy, Vaginal Excision of the uterus.  Y&$ Hyraxes B02.649.400 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Any of certain small mammals of the order Hyracoidea. Y (BHypoxanthines D03.438.759.758.399 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones Guanine (+ 3) Purine bases related to hypoxanthine, an intermediate product of uric acid synthesis and a breakdown product of adenine catabolism. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  Y:`>Hypoxanthine Phosphoribosyltransferase D08.586.913.400.725.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lesch-Nyhan Syndrome Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or 6-mercaptopurine to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8. Pentosephosphates (72-74); Pentosyltransferases (72-74)  Y+F@Hypoventilation C08.618.846.565; C23.888.852.638 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) A condition in which the amount of air entering the pulmonary alveoli is reduced. Y2&NcHypotrichosis C17.800.805.305.122.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases; Alopecia Presence of less than the normal amount of hair. (Dorland, 27th ed). Y!NVHypotrichida B01.841.185.700.400 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Polymenophorea Sporadotrichina (+ 2) An order of ciliate protozoa. Characteristics include a dorsoventrally flattened, highly mobile body with a unique cursorial type of locomotion. Ciliophora (66-91)  Y&=Hypotonic Solutions D26.394.225.766.399 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Y*,ZHypothyroidism C19.874.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Thyroid Hormones Endocrine Diseases; Thyroid Diseases Cretinism; Myxedema YN,Hypothermia, Induced E03.607 AECLCTECHIISMOMTNUPXSNSTTDUTVE Rewarming Refrigeration; Cryotherapy; Cold Anesthesia and Analgesia (Non MeSH) Abnormally low body temperature intentionally induced in warm-blooded animals by artificial means.  Y " (+rHypothermia C23.888.189.565 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Rewarming Cold Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Temperature Changes (Non MeSH) Lower than normal body temperature, especially in warm-blooded animals; in man usually accidental or unintentional.  Y1N Hypothalamus, Posterior A08.186.211.730.385.357.362 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus Mamillary Bodies The posterior portion of the hypothalamus, consisting of the lateral and medial nuclei of the mamillary body and the posterior hypothalamic nucleus. (Dorland, 27th ed., 1988). Z8jHypothalamus, Middle A08.186.211.730.385.357.352 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus Arcuate Nucleus; Dorsomedial Hypothalamic Nucleus; Hypothalamic Area, Lateral; Ventromedial Hypothalamic Nucleus That middle portion of the hypothalamus containing the arcuate, dorsomedial, and ventromedial nuclei, and the lateral hypothalamic area. Z8jHypothalamus, Anterior A08.186.211.730.385.357.342 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus Hypothalamic Area, Anterior; Paraventricular Hypothalamic Nucleus; Preoptic Area; Suprachiasmatic Nucleus; Supraoptic Nucleus The anterior portion of the hypothalamus containing the lateral and medial preoptic nuclei, the supraoptic and paraventricular nucleus, and the anterior hypothalamic nucleus. (Dorland, 27th ed., 1988). Z8jHypothalamus A08.186.211.577.482; A08.186.211.730.385.357 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Limbic System Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon  Hypothalamo-Hypophyseal System; Hypothalamus, Anterior (+ 5); Hypothalamus, Middle (+ 4); Hypothalamus, Posterior (+ 1); Median Eminence; Tuber Cinereum Ventral part of the diencephalon extending from the region of the optic chiasm to the caudal border of the mammillary bodies and forming the inferior and lateral walls of the third ventricle. Zq28Hypothalamo-Hypophyseal System A06.407.747.357; A06.688.357; A08.186.211.730.385.357.332; A08.713.357 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Pituitary Hormone-Releasing Hormones Endocrine System (Non MeSH); Endocrine Glands; Pituitary Gland Endocrine System (Non MeSH); Neurosecretory Systems Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus Nervous System; Neurosecretory Systems A neuroendocrine system of neurons, fiber tracts, endocrine tissue, and blood vessels which produces and releases pituitary hormones into the systemic circulation. Z M#P8*Hypothalamic Neoplasms C04.588.614.250.195.486; C10.228.140.211.485; C10.228.140.617.477; C10.228.250.195.486; C10.551.250.195.486 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Hypothalamic Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Neoplasms located in the hypothalamus including the anterior, medial, and posterior portions. Brain Neoplasms (66-80); Hypothalamus (66-80) Z "wXQm7Hypothalamic Hormones D06.472.420 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones Hormones isolated from the hypothalamus which exercise control over other organs, primarily the pituitary gland. Well-known members include certain pituitary hormone-releasing hormones and pituitary hormone release inhibiting hormones. Vasopressin and oxytocin which are found in the posterior pituitary may also be secreted by the hypothalamus. Hormones (66-78); Hypothalamus (66-78); Pituitary Hormones (72-78); specific hormone (66-78) Z(BBoHypothalamic Diseases C10.228.140.617 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Hypothalamic Neoplasms Brain Diseases (66-80); Hypothalamus (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  ZNV6XHypothalamic Area, Lateral A08.186.211.730.385.357.352.543 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Middle An area in the middle hypothalamus continuous rostrally with the lateral preoptic area and caudally with the tegmentum mesencephali. It contains the tuberomammillary and lateral tuberal nuclei. Hypothalamus (66-82) Z #6Hypothalamic Area, Anterior A08.186.211.730.385.357.342.063 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Anterior Loose heterogeneous collection of cells in the anterior hypothalamus, continuous rostrally with the medial and lateral preoptic areas and caudally with the tuber cinereum. Hypothalamus (66-82); Hypothalamus, Anterior (75-82) Z!#6>Hypotension, Orthostatic C14.907.514.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Posture Cardiovascular Diseases; Vascular Diseases; Hypotension Shy-Drager Syndrome A fall in blood pressure associated with dizziness, syncope, and blurred vision occurring upon standing or when standing motionless in a fixed position. It can be acquired or idiopathic, or occurring alone or secondary to a central nervous system disorder. (Dorland, 27th ed.).  ZN AGHypotension, Controlled E03.545 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH) Z8 "+Hypotension C14.907.514 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Pressure Cardiovascular Diseases; Vascular Diseases Hypotension, Orthostatic (+ 1) ZN2%Hypospadias C12.294.494.400; C12.740.700.516; C16.131.939.516 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) A developmental anomaly in the male in which the urethra opens on the underside of the penis or on the perineum. Z9LQHypoprothrombinemias C15.378.463.134.676 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders Factor V Deficiency; Factor X Deficiency Z YN2Hypoproteinemia C15.378.147.607 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Protein-Losing Enteropathies Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders Z!N!gHypoplastic Left Heart Syndrome C14.240.400.625; C14.280.400.625; C16.131.240.400.625 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital A condition characterized by underdevelopment of the left cardiac chambers, atresia or stenosis of the aorta or mitral valve or both, and hypoplasia of the aorta. These anomalies are a common cause of heart failure in early infancy. Heart Defects, Congenital (66-94) Z"&=LK(Hypopituitarism C19.700.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pituitary Hormones Endocrine Diseases; Pituitary Diseases Diabetes Insipidus (+ 2); Dwarfism, Pituitary Diminution or cessation of the pituitary function resulting from surgical or radiation ablation, from nonsecretory pituitary tumors, from metastatic tumors, from infarction, and from a number of infiltrative or granulomatous processes.  Z&+N.8Hypopigmentation C17.800.621.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders Albinism (+ 3); Vitiligo A condition caused by a deficiency in melanin formation or a loss of pre-existing melanin or melanocytes. It can be complete or partial and may result from trauma, inflammation, and certain infections. Pigmentation Disorders (66-92)  Z(QNf!$Hypophysectomy, Chemical E04.779.532.490 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Endocrine (Non MeSH); Hypophysectomy Total or subtotal destruction of the pituitary gland by chemical injection. It is usually achieved by injection of ethyl alcohol via trans-sphenoidal cannulation under stereotaxic control. It is usually performed for the treatment of intractable pain. Alcohol, Ethyl (77-81); Hypophysectomy (77-81); Pain, Intractable (77-81); Pituitary Gland/drug effects (77-81) Z*$N%Hypophysectomy E04.530.482; E04.779.532 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Pituitary Irradiation Pituitary Gland Surgery, Operative; Neurosurgery Surgery, Operative; Surgery, Endocrine (Non MeSH)  Hypophysectomy, Chemical  Z,$`Hypophosphatemia, Familial C12.777.419.815.647; C18.452.648.618.544; C18.452.648.851.647 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors Familial disorder characterized by hypophosphatemia associated with decreased renal tubular reabsorption of inorganic phosphorus. It is sometimes associated with osteomalacia or rickets which do not respond to the usual doses of vitamin D. Z.(ELHypophosphatemia C18.452.750.400 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Phosphates Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Phosphorus Metabolism Disorders An abnormally decreased level of phosphates in the blood. The manifestations include hemolysis, lassitude, weakness, and convulsions. It may be found in hyperparathyroidism, rickets, osteomalacia, and several renal tubular abnormalities. (Dorland, 27th ed). Phosphates/blood (66-93)  Z1Ls*Hypophosphatasia C18.452.648.618.482 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Alkaline Phosphatase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed). Z40L9Hypopharynx A14.724.490 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Stomatognathic System; Pharynx Laryngeal part of the pharynx. Pharynx (66-78) Z78%'Hypopharyngeal Neoplasms C04.588.443.665.710.485; C07.550.745.436; C09.647.710.485; C09.775.549.485 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms Stomatognathic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms; Pharyngeal Neoplasms Otorhinolaryngologic Diseases; Pharyngeal Diseases; Pharyngeal Neoplasms Hypopharynx (79-84); Pharyngeal Neoplasms (66-84) Z8TX;Hypoparathyroidism C19.642.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Parathyroid Hormones Endocrine Diseases; Parathyroid Diseases Tetany Z;;N0 Hyponatremia C18.452.950.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sodium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed). Z<(N nXHypolipoproteinemia C18.452.648.556.485 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lipoproteins Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors Abetalipoproteinemia; Hypobetalipoproteinemia; Lecithin Acyltransferase Deficiency; Tangier Disease The presence of abnormally low levels of lipoproteins in the serum. Blood Protein Disorders (66-77); Hypoproteinemia (66-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77); Lipoproteins, HDL (72-77) $Z=LpRHypokinesia C10.597.559.452; C23.888.592.574.433 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immobilization Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders Abnormally decreased mobility, decreased motor function, or diminished activity. It also includes diminished or slow movement. It can result from IMMOBILIZATION or other inactivity. (Dorland, 27th ed; Stedman, 25th ed). Immobilization (67-94)  Z@K*NHypokalemia C18.452.950.565 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Potassium; Potassium Deficiency Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed). ZC N&nHypohidrosis C17.800.805.843.370 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sweating Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases Abnormally diminished or absent perspiration. Both generalized and segmented (reduced or absent sweating in circumscribed locations) forms of the disease are usually associated with other underlying conditions. Ectodermal Dysplasia (66-74); Sweating (66-74)  ZF*N 8Hypogravity H01.671.323.369.400 AE Weightlessness Physical Sciences (Non MeSH); Physics; Gravitation; Gravity, Altered Weightlessness Condition wherein the force of gravity is less than or is decreased below that on the surface of the earth. This is expressed as being between 0 and 1 g. Gravitation (66-94) $ZHSHypogonadism C19.391.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Gonadal Disorders (Non MeSH) Eunuchism; Kallmann Syndrome; Klinefelter's Syndrome Condition resulting from or characterized by abnormally decreased functional activity of the gonads, with retardation of growth and sexual development. ZJ'N:>Hypoglycins D02.455.426.392.368.533.450; D24.185.926.412 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclopropanes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Methylene cyclopropyl alanine and congeners isolated from the unripe edible fruit of the akee plant (Blighia sapida); hypoglycin B is the gamma-glutamyl congener of hypoglycin A; they are very toxic and teratogenic, causing a fall in blood glucose due to the interference of fatty acid and leucine metabolism which leads to vomiting, liver damage, convulsions and death; the syndrome is called Jamaican Vomiting Sickness. Alanine (73-76); Cyclopropanes (70-76) ZK28/Hypoglycemic Agents D09.482 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH) Acetohexamide; Buformin; Carbutamide; Chlorpropamide; Gliclazide; Glipizide; Glyburide; Insulin (+ 3); Metformin; Phenformin; Tolazamide; Tolbutamide Agents which lower the blood glucose level. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  ZO 896DHypoglycemia C18.452.528 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glucose; Blood Glucose Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Insulin Coma An abnormally diminished concentration of glucose in the blood, which may lead to tremulousness, cold sweat, piloerection, hypothermia, and headache, accompanied by irritability, confusion, hallucinations, bizarre behavior, and ultimately, convulsions and coma. (Dorland, 27th ed).  ZQNNBHypoglossal Nerve A08.800.800.120.330 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 12th cranial nerve. The hypoglossal nerve originates in the hypoglossal nucleus of the medulla and supplies motor innervation to all of the muscles of the tongue except the palatoglossus (which is supplied by the vagus). This nerve also contains proprioceptive afferents from the tongue muscles. ZS8[`Hypogastric Plexus A08.800.050.050.400; A08.800.800.060.400 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways A complex network of nerve fibers in the pelvic region. The hypogastric plexus distributes sympathetic fibers from the lumbar paravertebral ganglia and the aortic plexus, parasympathetic fibers from the pelvic nerve, and visceral afferents. The bilateral pelvic plexus is in its lateral extent. ZV.6WHypodermyiasis C03.211.503.398 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Ectoparasitic Infestations; Myiasis Infestation with larvae of the genus Hypoderma, the warble fly. Myiasis (66-67) ZXPAMHypocreales B05.354.107.501 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes Gibberella An order of Ascomycetes including a number of species which are parasitic on higher plants, insects or fungi; other species are saprophytic. Ascomycetes (66-74)  ZZ";Hypocotyl B06.413.525.400 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH); Plant Stems The region of the stem beneath the stalks of the seed leaves (cotyledons) and directly above the young root of the embryo plant. It grows rapidly in seedlings showing epigeal germination and lifts the cotyledons above the soil surface. In this region (the transition zone) the arrangement of vascular bundles in the root changes to that of the stem. (From Concise Dictionary of Biology, 1990). Plants (66-94) Z[ &=Hypochondriasis F03.126.451; F03.709.438.710.560 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Somatoform Disorders Persistent overconcern with the state of physical or emotional health accompanied by various bodily complaints without demonstrable organic pathology. Z^&FHypochlorous Acid D01.029.260.365; D01.210.465; D01.650.550.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH) Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides  Sodium Hypochlorite Sodium Hypochlorite Hypochlorous acid (HClO). An oxyacid of chlorine containing monovalent chlorine that acts as an oxidizing or reducing agent. Sodium Hypochlorite (66-74)  Z`:58/!Hypocapnia C23.888.852.614 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Alkalosis, Respiratory Hyperventilation; Carbon Dioxide Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Deficiency of carbon dioxide in the blood, resulting from hyperventilation and eventually leading to alkalosis. (Dorland, 27th ed). Carbon Dioxide/blood (66-91) $ZbN'#Hypocalcemia C18.452.174.509; C18.452.950.509 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Calcium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Tetany Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed).  Zd&N  Hypobetalipoproteinemia C18.452.648.556.485.440 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hypolipoproteinemia A disease in which the low density lipoprotein (beta-lipoprotein) concentrations are far below normal. Blood Protein Disorders (66-77); Lipid Metabolism, Inborn Errors (66-77); Lipoproteins (66-77); Lipoproteins, LDL (72-77) ZgbLxHypoaldosteronism C19.053.264.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Aldosterone Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Hypofunction A syndrome presenting as aldosterone deficiency with renal salt wasting, metabolic acidosis, and low plasma renin activity (hence the term hyporeninemic hypoaldosteronism). Adrenal Gland Hypofunction (66-87); Aldosterone (66-87)  ZiNSBHypnotics and Sedatives D15.210.350; D15.325 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Histamine H1 Antagonists; Tranquilizing Agents Tranquilizing Agents Central Nervous System Agents; Central Nervous System Depressants Central Nervous System Agents Sedatives, Barbiturate (+ 9); Sedatives, Nonbarbiturate (+ 29) Sedatives, Barbiturate (+ 9); Sedatives, Nonbarbiturate (+ 29) Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (Zk87ol:Hypnosis, Dental E03.155.141.481; E03.155.675.481; E06.045.481 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Dental Anesthesia and Analgesia (Non MeSH); Anesthesia; Hypnosis, Anesthetic Dentistry; Anesthesia, Dental Znd5"Hypnosis, Anesthetic E03.155.675 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia Hypnosis, Dental Zo":Hypnosis F04.754.424 HIISMTSN Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Suggestion (+ 1) A state of increased receptivity to suggestion and direction, initially induced by the influence of another person. Zpo  KHyphomycetes B05.354.381.546 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes Acremonium; Alternaria; Aspergillus (+ 6); Candida (+ 1); Chrysosporium; Cladosporium; Coccidioides; Cryptococcus (+ 1); Epidermophyton; Exophiala; Fusarium; Geotrichum; Helminthosporium; Histoplasma; Malassezia; Microsporum; Paecilomyces; Paracoccidioides; Penicillium (+ 1); Phialophora; Rhizoctonia; Rhodotorula; Sporotrichum; Stachybotrys; Trichoderma; Trichophyton; Trichosporon One of two classes of the fungi Deuteromycetes. Most are anamorphs (i.e., asexual forms) of Ascomycetes. Zq">}Hyphema C11.290.484; C23.542.290.484 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Eye Hemorrhage Hemorrhage within the anterior chamber of the eye. (Dorland, 27th ed). Zt "NvWHypesthesia C10.597.751.480; C23.888.592.763.397 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Diminished sensitivity to stimulation. (Stedman, 25th ed). Zu*NGHypervitaminosis A C18.452.512 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases A symptom complex resulting from ingestion of excessive amounts of vitamin A. Vitamin A (66-86) ZwNN\Hyperventilation C08.618.501; C23.888.852.591 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypocapnia Respiratory Tract Diseases; Respiration Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Alkalosis, Respiratory Increased alveolar ventilation relative to metabolic carbon dioxide production, so that alveolar carbon dioxide pressure tends to fall below normal.  Zy("NHypertrophy, Right Ventricular C14.280.445.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Hypertrophy Enlargement of the right ventricle of the heart. This increase in ventricular mass is often attributed to pulmonary hypertension and is a contributor to cardiovascular morbidity and mortality. Heart Hypertrophy (66-92) Z{q$NEHypertrophy, Left Ventricular C14.280.445.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Hypertrophy Enlargement of the left ventricle of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality. Heart Hypertrophy (66-92) Z}b#NEHypertrophy C23.739.451 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) General increase in bulk of a part or organ, not due to tumor formation, nor to an increase in the number of cells, which is HYPERPLASIA. ZcNYHypertriglyceridemia C18.452.494.851 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Hyperlipidemia Condition of elevated triglyceride concentration in the blood; an inherited form occurs in familial hyperlipoproteinemia IIb and HYPERLIPOPROTEINEMIA TYPE IV. It has been linked to higher risk of heart disease and arteriosclerosis. Hyperlipidemia (66-88); Triglycerides (66-88) ZN` 6Hypertrichosis C17.800.805.305.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hirsutism Hirsutism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases Localized or generalized excess hair. The concept does not include HIRSUTISM, which is excess hair in females and children with an adult male pattern of distribution.  Z5N  zHypertonic Solutions D26.394.225.766.314 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Glucose Solution, Hypertonic; Saline Solution, Hypertonic Z0,ZCHyperthyroxinemia C19.874.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Thyroxine Endocrine Diseases; Thyroid Diseases Excess of thyroxine in the blood. Thyroxine/blood (66-86)  ZLN ,+Hyperthyroidism C19.874.397 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Long-Acting Thyroid Stimulator Thyroid Hormones Endocrine Diseases; Thyroid Diseases Graves' Disease Excessive functional activity of the thyroid gland. $ZjN$,>Hyperthermia, Induced E02.780.480 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fever; Heat Therapeutics; Physical Therapy Ammotherapy; Diathermy (+ 2) Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.  Z"%$Hypertension, Renovascular C12.777.419.331.490; C14.907.489.631.485 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Renal Artery Obstruction Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Hypertension, Renal Cardiovascular Diseases; Vascular Diseases; Hypertension; Hypertension, Renal Hypertension due to compression or obstruction of the renal artery or its branches. Hypertension, Renal (66-78)  Z`.Nd!Hypertension, Renal C12.777.419.331; C14.907.489.631 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Cardiovascular Diseases; Vascular Diseases; Hypertension Hypertension, Renovascular Hypertension, Renovascular; Nephrosclerosis Hypertension due to renal diseases, especially chronic parenchymal disease. Hypertension as a result of compression or obstruction of the renal artery or its branches is HYPERTENSION, RENOVASCULAR. Z&NOHypertension, Pulmonary C14.907.489.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pulmonary Heart Disease Cardiovascular Diseases; Vascular Diseases; Hypertension Persistent Fetal Circulation Syndrome Increased pressure within the pulmonary circulation, usually secondary to cardiac or pulmonary disease.  Z$NB,xHypertension, Portal C06.552.494; C14.907.489.430 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Portasystemic Shunt, Surgical Digestive System Diseases; Liver Diseases Cardiovascular Diseases; Vascular Diseases; Hypertension Cruveilhier-Baumgarten Syndrome; Esophageal and Gastric Varices Esophageal and Gastric Varices Abnormally increased pressure in the portal venous system; frequently seen in cirrhosis of the liver and in other conditions which cause obstruction of the portal vein.  Z"N#rlHypertension, Malignant C14.907.489.330 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Hypertension Severe hypertension characterized by papilledema and necrosis of small arteries and arterioles. The diastolic pressure is generally greater than 130 mm Hg. ZKNBHypertension C14.907.489 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antihypertensive Agents; Vascular Resistance Blood Pressure Cardiovascular Diseases; Vascular Diseases Hypertension, Malignant; Hypertension, Portal (+ 1); Hypertension, Pulmonary (+ 1); Hypertension, Renal (+ 2) Persistently high arterial blood pressure. Currently accepted threshold levels are 140 mm Hg systolic and 90 mm Hg diastolic pressure. $ZN42Hypertelorism C05.116.099.370.231.480; C05.660.246.480; C16.131.621.246.480 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Craniofacial Dysostosis Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis Abnormal increase in the interorbital distance due to overdevelopment of the lesser wings of the sphenoid. ZELu~Hypersplenism C15.604.744.293 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Splenic Diseases Condition characterized by splenomegaly, some reduction in the number of circulating blood cells in the presence of a normal or hyperactive bone marrow, and the potential for reversal by splenectomy. ZN]Hypersomnia C10.597.785.200; C23.888.592.796.200; F03.126.821.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sleep Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sleep Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Sleep Disorders Kleine-Levin Syndrome Kleine-Levin Syndrome Kleine-Levin Syndrome Excessive need to sleep. Z=NDJ Hypersensitivity, Immediate C20.543.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antigen-Antibody Reactions; Histamine; Histamine H1 Antagonists Immunologic Diseases; Hypersensitivity Anaphylaxis; Conjunctivitis, Allergic; Dermatitis, Atopic; Food Hypersensitivity (+ 1); Respiratory Hypersensitivity (+ 9); Urticaria (+ 1) Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $Z NJ-PHypersensitivity, Delayed C20.543.418 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cell Migration Inhibition; Encephalomyelitis, Acute Disseminated Immunity, Cellular Immunologic Diseases; Hypersensitivity Dermatitis, Allergic Contact (+ 2) An increased reactivity to specific antigens mediated not by antibodies but by cells. $ZENJ-*fHypersensitivity C20.543 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Desensitization, Immunologic; Multiple Chemical Sensitivity Immunologic Diseases Drug Hypersensitivity (+ 4); Hypersensitivity, Delayed (+ 3); Hypersensitivity, Immediate (+ 17); Immune Complex Diseases (+ 5); Multiple Chemical Sensitivity; Wissler's Syndrome Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $Z  LDPHyperprolactinemia C18.452.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Prolactinoma; Prolactin Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Increased levels of prolactin in the blood. Prolactin/blood (66-85)  ZNN6Hyperplasia C23.739.423 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Precancerous Conditions Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Giant Lymph Node Hyperplasia An increase in the number of cells in a tissue or organ, not due to tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.  ZNY#Hyperpituitarism C19.700.355 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Pituitary Diseases Acromegaly; Gigantism A state of increased activity of the pituitary gland. Z*N.BHyperpigmentation C17.800.621.430 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders Melanosis (+ 3) Excessive pigmentation of the skin, usually as a result of increased melanization of the epidermis rather than as a result of an increased number of melanocytes. Etiology is varied and the condition may arise from exposure to light, chemicals or other substances, or from a primary metabolic imbalance. Pigmentation Disorders (66-92)  ZMNfc$Hyperphagia F03.126.298.208 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Obesity Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Eating Disorders Bulimia; Kleine-Levin Syndrome Ingestion of a greater than optimal quantity of food. Appetite Disorders (66-80); Eating (66-80); Feeding Behavior (69-80) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (ZF o%BSNHyperparathyroidism, Secondary C19.642.355.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Parathyroid Diseases; Hyperparathyroidism Renal Osteodystrophy Hyperparathyroidism (66-69) Z #NG Hyperparathyroidism C19.642.355 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Multiple Endocrine Neoplasia Type 1; Osteitis Fibrosa Cystica Endocrine Diseases; Parathyroid Diseases Hyperparathyroidism, Secondary (+ 1) Abnormally increased activity of the parathyroid glands, which may be primary or secondary (HYPERPARATHYRODISM, SECONDARY). Primary hyperparathyroidism is associated with neoplasia or hyperplasia. The excess of parathyroid hormone leads to alteration in function of bone, renal tubules, and gastrointestinal mucosa. (Dorland, 27th ed).  Z8NI0+Hyperoxia C23.888.852.567 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Oxygen Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) An excess of oxygen in the system, resulting from exposure to high oxygen concentrations, especially to hyperbaric pressures of oxygen. (Dorland, 27th ed). Oxygen/toxicity (66-94)  Z N Hyperoxaluria, Primary C12.777.419.320; C18.452.648.202.490.490 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Oxalates Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Hyperoxaluria Either of two genetic disorders characterized by urinary excretion of large amounts of oxalate, with nephrolithiasis, nephrocalcinosis, early onset of renal failure, and often a generalized deposit of calcium oxalate, resulting from a defect in glyoxalate metabolism. Z.L  4Hyperoxaluria C18.452.648.202.490 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Oxalates Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Hyperoxaluria, Primary Excretion of an excessive amount of oxalate in the urine. Oxalates/urine (66-86) $Z L GHyperostosis, Sternocostoclavicular C05.116.540.600; C05.799.440; C17.300.775.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Hyperostosis Musculoskeletal Diseases; Rheumatic Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases A rare, benign rheumatologic disorder or syndrome characterized by hyperostosis and soft tissue ossification between the clavicles and the anterior part of the upper ribs. It is often associated with the dermatologic disorder palmoplantar pustulosis, particularly in Japan. Careful diagnosis is required to distinguish it from psoriatic arthritis, OSTEITIS DEFORMANS, and other diseases. Spondylitis of pustulosis palmaris et plantaris is one of the possible causes; also, evidence suggests one origin may be bone infection. Bone imaging is especially useful for diagnosis. It was originally described by Sonozaki in 1974. Bone Diseases (75-88); Clavicle (75-88); Sternum (75-88) Z(5NFHyperostosis, Diffuse Idiopathic Skeletal C05.116.540.410; C05.116.900.802.651 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Hyperostosis Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spinal Osteophytosis A disease of elderly men characterized by large osteophytes that bridge vertebrae and ossification of ligaments and tendon insertions. Spinal Diseases (66-84); Spinal Osteophytosis (66-84); Spondylitis, Ankylosing (66-84) Z0*NfHyperostosis, Cortical, Congenital C05.116.099.708.479; C05.116.540.400; C16.614.465 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Musculoskeletal Diseases; Bone Diseases; Hyperostosis Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases A disease of young infants characterized by soft tissue swellings over the affected bones, fever, and irritability, and marked by periods of remission and exacerbation. (Dorland, 27th ed.). Z(9LHyperostosis Frontalis Interna C05.116.099.708.486; C05.116.540.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Musculoskeletal Diseases; Bone Diseases; Hyperostosis Thickening of the inner table of the frontal bone, which may be associated with hypertrichosis and obesity. It most commonly affects women near menopause. Zï$*NHyperostosis C05.116.540; C23.739.415 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Exostoses (+ 1); Hyperostosis, Cortical, Congenital; Hyperostosis, Diffuse Idiopathic Skeletal; Hyperostosis Frontalis Interna; Hyperostosis, Sternocostoclavicular Exostoses (+ 1) Increase in the mass of bone per unit volume. Bone and Bones (66-89); Bone Diseases (66-89); Bone Diseases, Developmental (70-89); Exostoses (66-89); Exostoses, Multiple (66-89); Hypertrophy (66-89); Osteochondrodysplasias (85-89); Spondylitis, Ankylosing (66-89)  ZN:Hyperopia C11.744.479 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Refractive Errors A refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus behind the retina, as a result of the eyeball being too short from front to back. It is also called farsightedness because the near point is more distant than it is in emmetropia with an equal amplitude of accommodation. (Dorland, 27th ed). Z N'Hypernatremia C18.452.950.452 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sodium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Excessive amount of sodium in the blood. (Dorland, 27th ed). ZYN nLHyperlipoproteinemia Type V C18.452.648.556.481.495 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia A severe familial adult-onset hypertriglyceridemia different from that due to lipoprotein lipase deficiency. Hyperlipidemia (66-79) Z̶!L}Hyperlipoproteinemia Type IV C18.452.648.556.481.480.395; C18.452.648.556.481.490 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia; Hyperlipidemia, Familial Combined Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia A familial disorder characterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in VLDL. It is considered to be an autosomal dominant trait. Hyperlipidemia (66-79) ZΨ":L{Hyperlipoproteinemia Type III C18.452.648.556.481.485 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia A rather uncommon form of familial hyperlipemia characterized by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-VLDL and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal VLDL. Hyperlipidemia/familial and genetic (66-79) Z#LR3Hyperlipoproteinemia C18.452.494.481; C18.452.648.556.481 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lipoproteins Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Hyperlipidemia Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors  Hypercholesterolemia, Familial; Hyperlipidemia, Familial Combined (+ 2); Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoprotein Lipase Deficiency, Familial Metabolic disease characterized by elevated plasma cholesterol and/or triglyceride levels. The inherited form is attributed to a single gene mechanism. Hyperlipidemia (66-79) $Z*NHyperlipidemia, Familial Combined C18.452.648.556.481.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia Hypercholesterolemia, Familial; Hyperlipoproteinemia Type IV A disorder genetically distinct from the other inherited hyperlipidemias characterized by the type II or type IV lipoprotein pattern (the pattern may change from time to time and the lipid level may be normal at one time and abnormal at another time). Z?'NE*Hyperlipidemia C18.452.494 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antilipemic Agents Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Hypercholesterolemia; Hyperlipoproteinemia; Hypertriglyceridemia An excess of lipids in the blood.  ZNNH,Hyperkinesis F01.145.632.480; F03.126.720.605 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Motor Activity Behavior and Behavior Mechanisms (Non MeSH); Behavior; Motor Activity Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders Excessive motor activity. Movement Disorders (66-67)  Z܃&F  Hyperkeratosis, Epidermolytic C16.131.831.512.400.375; C16.614.492.400.375; C17.800.428.333.250.375; C17.800.827.800.550.375 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ichthyosis; Ichthyosiform Erythroderma, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Ichthyosis; Ichthyosiform Erythroderma, Congenital Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Ichthyosis; Ichthyosiform Erythroderma, Congenital Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Ichthyosiform Erythroderma, Congenital A form of congenital ichthyosis inherited as an autosomal dominant trait and characterized by erythroderma and severe hyperkeratosis. It is manifested at birth by blisters followed by the appearance of thickened, horny, verruciform scales over the entire body, but accentuated in flexural areas. Ichthyosiform Erythroderma, Congenital (91-92); Ichthyosis (66-92); Keratosis (72-92); Skin Diseases, Vesiculobullous (72-92) ZC"hLWHyperkalemia C18.452.950.396 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Potassium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed). ZN nyHyperinsulinism C19.458 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pancreatic Diseases Endocrine Diseases Excessive secretion of INSULIN by the pancreas, resulting in hypoglycemia. (Dorland, 27th ed.). Z@ NrHyperhidrosis C17.800.805.843.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sweating Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases Sweating, Gustatory Excessive sweating. In the localized type, the most frequent sites are the palms, soles, axillae, inguinal folds, and the perineal area. Its chief cause is thought to be emotional. Generalized hyperhidrosis may be induced by a hot, humid environment, by fever, or by vigorous exercise. Sweating (66-75) $ZtN QHypergravity H01.671.323.369.300 AE Centrifugation Physical Sciences (Non MeSH); Physics; Gravitation; Gravity, Altered Condition wherein the force of gravity is greater than or is increased above that on the surface of the earth. This is expressed as being greater than 1 g. Gravitation (66-94)  Z%SHyperglycemic Hyperosmolar Nonketotic Coma C18.452.297.357.490; C19.246.357.490 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Diabetic Coma Endocrine Diseases; Diabetes Mellitus; Diabetic Coma A syndrome consisting of extreme hyperglycemia, serum hyperosmolarity and dehydration in the absence of ketosis and acidosis. Diabetic Coma (66-76); Hyperglycemia (66-76); Osmolar Concentration (70-76) Z1*NZHyperglycemia C18.452.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glucose; Blood Glucose Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Abnormally increased content of sugar in the blood. (Dorland, 27th ed). Z%NNXHypergammaglobulinemia C15.378.147.542; C20.683.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders Immunologic Diseases; Immunoproliferative Disorders Monoclonal Gammopathies, Benign Monoclonal Gammopathies, Benign An excess of GAMMA GLOBULINS in the blood. It is seen frequently in chronic infectious diseases. (Dorland, 27th ed). Blood Protein Disorders (66-68)  Z}"NH&Hyperesthesia C10.597.751.437; C23.888.592.763.312 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Hyperalgesia Hyperalgesia Abnormal acuteness of sensitivity to touch or other sensory stimulation. (From Stedman, 25th ed). Z*NuHypereosinophilic Syndrome C15.378.553.231.549 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Eosinophilia Pulmonary Eosinophilia A heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. There is a massive increase in the number of eosinophils in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs. It is often referred to as idiopathic. Eosinophilia (66-93)  ZNHyperemia C14.371 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Circulation Cardiovascular Diseases The presence of an increased amount of blood in a part or organ. (Stedman, 25th ed). ZF  NjHyperemesis Gravidarum C06.405.937.562; C13.703.799.562 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Vomiting Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Toxemias Pernicious vomiting of pregnancy. (Dorland, 27th ed). Zo&LBHypercholesterolemia, Familial C18.452.648.556.481.475; C18.452.648.556.481.480.390 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cholesterol, Dietary; Lipoproteins, LDL Cholesterol; Lipoproteins, HDL Cholesterol Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hyperlipoproteinemia; Hyperlipidemia, Familial Combined A familial disorder characterized by increased plasma concentration of cholesterol carried in low density lipoproteins (LDL) and by a deficiency in a cell surface receptor which regulates LDL degradation and cholesterol synthesis. It is frequently associated with ARCUS SENILIS and premature atherosclerosis. Hypercholesterolemia (66-79); Hyperlipidemia/familial and genetic (66-79)  Z%#:L_{cUHypercholesterolemia C18.452.494.396 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cholesterol, Dietary; Lipoproteins, LDL Cholesterol; Lipoproteins, HDL Cholesterol; Cholesterol Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Hyperlipidemia Abnormally high levels of cholesterol in the blood. ZNn`?Hypercementosis C07.793.422 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases A regressive change of teeth characterized by excessive development of secondary cementum on the tooth surface. It may occur on any part of the root, but the apical two-thirds are most commonly affected. (Dorland, 27th ed). [8N/ Hypercapnia C23.888.852.544 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Carbon Dioxide Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Abnormal increase in the amount of carbon dioxide in the blood to the point where the partial pressure of carbon dioxide in the arterial blood exceeds 50 mm of mercury. [NHypercalcemia C18.452.174.451; C18.452.950.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Alkalies; Calcium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance Abnormally high level of calcium in the blood. [&N:Hyperbilirubinemia, Hereditary C18.452.648.437; C23.888.498.329.396 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Hyperbilirubinemia Crigler-Najjar Syndrome; Gilbert's Disease Crigler-Najjar Syndrome; Gilbert's Disease Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood. [#*LbHyperbilirubinemia C23.888.498.329 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bilirubin Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice Hyperbilirubinemia, Hereditary (+ 2); Kernicterus [L e;Hyperbaric Oxygenation E02.880.690.490 AECLCTECHIISMOMTNUPXSNSTTDUTVE Atmospheric Pressure Therapeutics; Respiratory Therapy; Oxygen Inhalation Therapy [ *"GHyperandrogenism C19.391.442 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hirsutism; Virilism Polycystic Ovary Syndrome; Adrenal Gland Hyperfunction Endocrine Diseases; Gonadal Disorders (Non MeSH) A state characterized or caused by an excessive secretion of androgens by the adrenal cortex, ovaries, or testes. The clinical significance in males is negligible, so the term is used most commonly with reference to the female. The common manifestations in women are hirsutism and virilism. It is often caused by ovarian disease (particularly the POLYCYSTIC OVARY SYNDROME) and by adrenal diseases (particularly ADRENAL GLAND HYPERFUNCTION). Androgens (66-93) $[ N@:Hyperalgesia C10.597.751.437.479; C23.888.592.763.312.518 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pain Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Hyperesthesia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Hyperesthesia The sensation of pain enhanced in response to subsequent stimuli when peripheral tissues are damaged. The phenomenon may involve a lowering of threshold of the nociceptors or an increase in the magnitude of pain evoked by suprathreshold stimuli. Hyperalgesia can occur both at the site of tissue damage (primary hyperalgesia) and in the surrounding undamaged areas (secondary hyperalgesia). (Kandel, Schwartz, Jessell, Principles of Neural Science, 3d ed). [I2NHyperaldosteronism C19.053.181.604 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Aldosterone Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Hyperfunction Bartter's Disease An abnormality of electrolyte function caused by excessive secretion of aldosterone by the adrenal cortex. (Dorland, 27th ed).  [NTHyoid Bone A02.835.232.409 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones [:;Hymenostomatida B01.841.185.650.375 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Oligohymenophorea Peniculina (+ 2); Tetrahymenina (+ 3) An order of ciliate protozoa. Characteristics include a ventral oral area and a well-defined buccal cavity. It comprises three suborders: TETRAHYMENINA, Ophryoglenina, and PENICULINA. [&@0Hymenoptera B01.131.617.479 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Ants; Bees; Wasps An extensive order of highly specialized insects including bees, wasps, and ants. Insects (66-74); specific insect  [A(*a)Hymenolepis B01.500.736.215.454 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda A genus of small tapeworms of birds and mammals. Cestoda (66-74) [*;=Hymenolepiasis C03.335.190.519 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Cestode Infections Infection with tapeworms of the genus Hymenolepis. Cestode Infections (66-67) [P?= Hymen A05.360.319.779.479 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Female; Vagina [ :CHymecromone D03.438.150.446.912.530; D19.316.508.485; D26.550.420 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; Umbelliferones Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cholagogues and Choleretics Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 7-Hydroxy-4-methylcoumarin. A coumarin derivative possessing properties as a spasmolytic, choleretic and light-protective agent. It is also used in analytical chemistry for the determination of nitric acid. Coumarins (69-74) [z=:6Hylobatidae B02.649.801.400.390 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini Hylobates A family of the suborder HAPLORHINI comprising only one genus, HYLOBATES (also called Nomascus or Symphalangus). Pongidae (67-91)  [a(4 Hylobates B02.649.801.400.390.390 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Hylobatidae A genus of the family HYLOBATIDAE consisting of six species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees. Some authors refer to Symphalangus and Nomascus as Hylobates. The six genera include: H. concolor (crested or black gibbon), H. hoolock (Hoolock gibbon), H. klossii (Kloss's gibbon; dwarf siamang), H. lar (common gibbon), H. pileatus (pileated gibbon), and H. syndactylus (siamang). H. lar is also known as H. agilis (lar gibbon), H. moloch (agile gibbon), and H. muelleri (silvery gibbon). [ (CHygromycin B D09.203.408.051.420; D20.085.060.400; D21.201.287.410 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents O-6-Amino-6-deoxy-L-glycero-D-galacto-heptopyranosylidene- (1-2-3)-O-beta-D-talopyranosyl-(1-5)-2-deoxy-N(3)-methyl-D- streptamine. Antibiotic substance produced by Streptomyces hygroscopicus. It is used as an anthelmintic against swine infections by large roundworms, nodular worms, and whipworms. Antibiotics (70-74); Aminoglycosides (74) ["=<N2Hygiene E02.547; G03.850.670 ECHILJST Therapeutics Environment and Public Health (Non MeSH); Public Health Oral Hygiene; Skin Care Military Hygiene AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE [&&  R2*Hydroxyzine D03.383.606.515; D14.100.375.425.400.390; D15.075.390; D15.095.370; D15.210.350.800.290; D15.210.950.012.390; D15.325.875.350; D15.700.872.015.390; D16.050.030.300; D23.075.367 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Antiemetics Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics Dermatologic Agents; Antipruritics Cetirizine A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative. [',:YHydroxyurea D02.948.395; D22.204.442 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Antineoplastic Agents (66); Urea (66) [-:z/Hydroxytryptophol D03.438.473.385 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles 5-Hydroxy-indole-3-ethanol. Alcohol, Ethyl (72-74); Indoles (70-74) [.:S 1Hydroxytestosterones D04.808.054.079.429.824.375 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Testosterone 17 beta-Hydroxy-4-androsten-3-ones. Testosterone derivatives formed by the substitution of one or more hydroxyl groups in any position. Hydroxysteroids (72-75); Testosterone (72-76) [/8f6Hydroxysteroids D04.808.528 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hydroxycorticosteroids Polycyclic Hydrocarbons; Steroids Steroids in which one or more hydroxy groups have been substituted for hydrogen atoms either within the ring skeleton or on any of the side chains. [18(Hydroxysteroid Dehydrogenases D08.586.682.047.436 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases 3-Hydroxysteroid Dehydrogenases (+ 2); 17-Hydroxysteroid Dehydrogenases (+ 1); 20-Hydroxysteroid Dehydrogenases (+ 1) [35"FtHydroxyquinolines D03.438.810.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Decoquinate; Kynurenic Acid; Oxamniquine; Oxyquinoline (+ 4); Procaterol The 8-hydroxy derivatives inhibit various enzymes and their halogenated derivatives, though neurotoxic, are used as topical anti-infective agents, among other uses. Quinolines (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $[48VX:Hydroxyprostaglandin Dehydrogenases D08.586.682.047.428 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases Catalyzes reversibly the oxidation of hydroxyl groups of prostaglandins. Alcohol Oxidoreductases (66-77); Prostaglandins (66-74) [7(FtUAHydroxypropiophenone D02.522.818.561 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones Phloretin (+ 1) [8:AHydroxyproline D12.125.072.401.623.478 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Imino Acids; Proline [9HHydroxyprogesterones D04.808.745.745.654.829.395; D06.472.798.773.478 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Progesterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Progestational Hormones; Progesterone [:68Hydroxypregnenolone D04.808.745.745.725.395; D06.472.040.322.478.478.477 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 17-Hydroxycorticosteroids [@cDHydroxycholesterols D04.808.247.222.284.478; D04.808.247.808.197.561; D10.516.851.208.603 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholesterol Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Cholesterol which is substituted by a hydroxy group in any position. Cholesterol (66-77) [g!M8SHydroxycholecalciferols D04.808.247.222.159.478; D04.808.247.808.146.478; D04.808.812.221.478; D10.516.851.152.478; D11.786.763.196.478 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholecalciferol Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholecalciferol Polycyclic Hydrocarbons; Steroids; Secosteroids; Cholecalciferol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholecalciferol Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D; Cholecalciferol Calcifediol; Calcitriol; Dihydroxycholecalciferols (+ 1) Calcifediol; Calcitriol; Dihydroxycholecalciferols (+ 1) Calcifediol; Dihydroxycholecalciferols (+ 2) Calcifediol; Dihydroxycholecalciferols (+ 2) Calcifediol; Dihydroxycholecalciferols (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR [iG{BDHydroxychloroquine D03.438.810.050.180.350; D17.050.125.350; D21.370.286.245.477 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Aminoquinolines; Chloroquine Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Chloroquine Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials; Chloroquine A drug used in the treatment of systemic and discoid lupus erythematosus and rheumatoid arthritis. It is sometimes used as an alternative to CHLOROQUINE when oral therapy with chloroquine is indicated for the prophylaxis or treatment of malaria. It has similar adverse effects to chloroquine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.401). [mTE:^Hydroxybutyrates D02.241.081.161.627; D02.241.511.401 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Sodium Oxybate Sodium Oxybate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR [q*8$:Hydroxybutyrate Dehydrogenase D08.586.682.047.393 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases [r"FtHydroxybenzoic Acids D02.241.223.106.505; D02.241.511.390; D02.755.410 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Organic Chemicals (Non MeSH); Phenols Gallic Acid (+ 1); Gentisates; Hydroxymercuribenzoates; Parabens; Salicylic Acids (+ 6); Vanillic Acid Gallic Acid (+ 1); Gentisates; Hydroxymercuribenzoates; Parabens; Salicylic Acids (+ 6); Vanillic Acid Gallic Acid (+ 1); Gentisates; Hydroxymercuribenzoates; Parabens; Salicylic Acids (+ 6); Vanillic Acid Benzoic acid substituted by one or more hydroxy groups in any position on the benzene ring. Benzoates (66-74); Phenols (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $[s98so+:Hydroxyapatites D01.146.360.050.300; D01.578.122.477; D01.695.625.675.650.075.025.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds; Calcium Phosphates; Apatites Inorganic Chemicals (Non MeSH); Minerals; Apatites Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Calcium Phosphates; Apatites Durapatite Durapatite Durapatite A group of compounds with the general formula M10(PO4)6(OH)2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. (Grant and Hackh's Chemical Dictionary, 5th ed). [wM8A&Hydroxyacetylaminofluorene D02.065.064.150.400; D02.241.081.038.108.080.400; D04.615.389.050.400; D26.191.372.016.478 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amides; Acetamides; 2-Acetylaminofluorene Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides; 2-Acetylaminofluorene Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Fluorenes; 2-Acetylaminofluorene Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Fluorenes; 2-Acetylaminofluorene N-Fluoren-2-yl-acetohydroxamic acid. A fluorene derivative with carcinogenic action. Synonyms: N-Hydroxy-2-acetylaminofluorene; N-Hydroxy-2-fluorenylacetamide. Fluorenes (66-74); Hydroxamic Acids (66-74) [{Md.5Hydroxy Acids D02.241.511 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids Benzilates (+ 2); Glycolates (+ 7); Hydroxamic Acids (+ 3); Hydroxybenzoic Acids (+ 13); Hydroxybutyrates (+ 1); Lactates; Malates; Mandelic Acids (+ 2); Mevalonic Acid; Mycolic Acids; Phosphoenolpyruvate; Quinic Acid; Shikimic Acid; Sugar Acids (+ 19) Organic compounds containing both the hydroxyl and carboxyl radicals. Carboxylic Acids (71-74); Fatty Acids (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $[~896R8DHydroxocobalamin D11.786.708.950.560; D19.461.543.901.477 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Vitamin B 12 Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics; Vitamin B 12 [.DHydroxides D01.045.250; D01.248.497.158.459; D01.455 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Alkalies Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH) Aluminum Hydroxide; Lye; Sodium Hydroxide Hydroxyl Radical Aluminum Hydroxide; Calcium Hydroxide; Hydroxyl Radical; Lye; Magnesium Hydroxide; Sodium Hydroxide; Water (+ 1) Inorganic compounds that contain the OH- group. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPOPSRESDSTTOTUUR  [18:<Hydroxamic Acids D02.092.570.394; D02.241.511.372 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Bufexamac; Deferoxamine; Ferrichrome Bufexamac; Deferoxamine; Ferrichrome AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR [&8V:Hydrothorax C08.528.476 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Pleural Diseases A collection of watery fluid in the pleural cavity. (Dorland, 27th ed). [NN5YHydrotherapy E02.780.450 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy External application of water for therapeutic purposes. [k"%BHydrostatic Pressure H01.671.691.352 AE Physical Sciences (Non MeSH); Physics; Pressure Pressure (66-72) [6;Hydroquinones D02.755.393 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols [8/Hydrops Fetalis C13.703.277.060.480; C15.378.071.141.150.875.100.350; C15.378.120.413.480; C15.378.420.826.100.350; C16.300.060.480; C20.188.413.480 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases; Erythroblastosis, Fetal Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Thalassemia; alpha-Thalassemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Group Incompatibility; Erythroblastosis, Fetal Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies; Thalassemia; alpha-Thalassemia Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases; Erythroblastosis, Fetal Immunologic Diseases; Blood Group Incompatibility; Erythroblastosis, Fetal Edema of the entire body due to abnormal accumulation of serous fluid in the tissues, associated with severe anemia and occurring in ERYTHROBLASTOSIS, FETAL. Edema (66-88); Fetal Diseases (66-88)  [L /Hydroponics J01.040.581 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Agriculture A technique for growing plants in culture solutions rather than in soil. The roots are immersed in an aerated solution containing the correct proportions of essential mineral salts. (From Concise Dictionary of Biology, 1990). Plants (66-94) [D Hydropneumothorax C08.528.434 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pneumothorax Respiratory Tract Diseases; Pleural Diseases A collection of fluid and gas within the pleural cavity. (Dorland, 27th ed). [UN5_Hydrophthalmos C11.250.480; C11.525.381.407.480; C16.131.384.480; C16.614.438 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Eye Diseases; Ocular Hypertension; Glaucoma; Glaucoma, Open-Angle Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Congenital open-angle glaucoma that results from dysgenesis of the angle structures accompanied by increased intraocular pressure and enlargement of the eye. Treatment is both medical and surgical. [HL%Hydrophidae B02.833.672.400 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Hydrophid Venoms Vertebrates; Reptiles; Snakes A family of sea snakes comprising about 50 species with flattened oar-like tails used as sculls. They are found mostly in the coastal waters of south Asia and Australia. The largest reach a length of almost 9 feet but most species are only about a third as long. They are all venomous. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980). Snakes (66-93)  [e&%Hydrophid Venoms D24.185.965.850.480 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Hydrophidae Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms Erabutoxins Venoms of sea snakes, Hydrophiinae, found around Pacific islands. The venoms contain fewer enzymes and more neuro- or myotoxins than land snakes. The neurotoxic proteins are similar to elapid small, short, or type I neurotoxins, some of which have been characterized. Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) ADAEAGAIANBIBLCFCHCLCSCTDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ([<g:BDHydronephrosis C12.777.419.307 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases A distention of the pelvis and calices of the kidney with urine, as a result of obstruction of the ureter, with accompanying atrophy of the parenchyma of the organ. (Dorland, 27th ed). [NbHydrolysis G06.535.630.610; H01.181.529.444 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical The splitting of a compound into fragments by the addition of water, the hydroxyl group being incorporated in one fragment, and the hydrogen atom in the other (Dorland, 27th ed). Chemistry, Physical (66-70) [&!Hydrolases D08.586.277 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Acid Anhydride Hydrolases (+ 14); Amidohydrolases (+ 15); Aminohydrolases (+ 8); Complement Activating Enzymes (+ 4); Epoxide Hydrolases; Esterases (+ 92); Glycoside Hydrolases (+ 43); Pancreatin; Peptide Hydrolases (+ 75); Ureohydrolases (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR [FE(HHydrogenation G06.535.630.600; H01.181.404.600 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Chemistry, Organic (66-70); Hydrogen (66-70) [&6Hydrogenase D08.586.682.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme found in bacteria. It catalyzes the reduction of ferredoxin and other substances in the presence of molecular hydrogen and is involved in the electron transport of bacterial photosynthesis. EC 1.18.99.1. Oxidoreductases (66-84) [RFXHydrogen-Ion Concentration H01.181.529.428 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Acid-Base Equilibrium; Buffers; Isoelectric Point DEGEIMPHRE [PI;Hydrogen Sulfide D01.029.260.340; D01.362.350; D01.875.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH)  Sulfides (+ 2) Hydrogen sulfide (H2S). A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed). Hydrogen (66-70); Sulfides (66-70)  [C18+Hydrogen Peroxide D01.650.550.750.400; D20.187.495 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Peroxides Anti-Infective Agents; Anti-Infective Agents, Local A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. [&8 Hydrogen Cyanide D01.029.260.330; D01.625.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Nitrogen Compounds  Cyanides (+ 6) Hydrogen cyanide (HCN). A toxic liquid or colorless gas. It is found in the smoke of various tobacco products and released by combustion of nitrogen-containing organic materials. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  [D"8:Hydrogen Bonding H01.181.529.400 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. [IHydrogen D01.268.406; D01.362.340; D01.435 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH)  Deuterium (+ 1); Protons; Tritium Hydrogen. The first chemical element in the periodic table. It has the atomic symbol H, atomic number 1, and atomic weight 1. It exists, under normal conditions, as a colorless, odorless, tasteless, diatomic gas. Hydrogen ions are PROTONS. Besides the common H1 isotope, hydrogen exists as the stable isotope DEUTERIUM and the unstable, radioactive isotope TRITIUM. ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  [ ):.<Hydrofluoric Acid D01.029.260.328; D01.303.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Fluorine Compounds  Fluorides (+ 5) Hydrofluoric acid. A solution of hydrogen fluoride in water. It is a colorless fuming liquid which can cause painful burns. Acids (66-71); Fluorides (66-71)  ["8)Hydroflumethiazide D03.438.174.475; D18.162.276.439; D19.770.224.578.439 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide [=:"Hydrocortisone, Topical D04.808.745.745.654.600.476; D06.597.481.364.539; D17.025.050.275.350; D17.025.080.200.250; D23.037.200.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Hydrocortisone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Hydrocortisone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Hydrocortisone that is applied topically as an anti-inflammatory agent. [w8THydrocortisone D04.808.745.745.654.600; D06.472.040.322.478.353.476; D06.472.040.322.478.478.392; D17.025.050.275 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 17-Hydroxycorticosteroids Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Hydrocortisone, Topical Hydrocortisone, Topical (11 beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione. The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. [lDH8hHydrocodone D03.132.610.422.547.547.149.287; D03.549.686.575.547.204.540; D03.605.497.575.547.204.540; D15.040.150.300; D15.153.375; D15.210.600.415 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives; Codeine Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives; Codeine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives; Codeine Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Narcotics Narcotic analgesic related to CODEINE, but more potent and more addicting by weight. It is used also as cough suppressant. Codeine/analogs and derivatives (75); Ethers, Cyclic (73-74); Morphinans (70-74) [:aaHydrochlorothiazide D03.438.174.261.476; D18.162.276.237.476; D19.770.224.578.237.476 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines; Chlorothiazide Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide; Chlorothiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide; Chlorothiazide Trichlormethiazide Trichlormethiazide Trichlormethiazide [I:X>Hydrochloric Acid D01.029.260.326; D01.210.450 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Gastric Acid Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH)  Chlorides (+ 7) Hydrochloric acid. Solutions of hydrogen chloride gas in water. It is a highly corrosive, strong mineral acid commonly used as a laboratory reagent. It is present endogenously as the acid component of GASTRIC JUICE (HYDROCHLORIC ACID, GASTRIC see GASTRIC ACID). (From Dorland, 27th ed). ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $[m"8T:Hydrocephalus, Normal Pressure C10.228.140.602.559 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Hydrocephalus Hydrocephalus (66-70) [^$NgHydrocephalus C10.228.140.602; C16.614.414 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Dandy-Walker Syndrome; Hydrocephalus, Normal Pressure A condition marked by dilatation of the cerebral ventricles, most often occurring secondarily to obstruction of the cerebrospinal fluid pathways and accompanied by an accumulation of cerebrospinal fluid within the skull. The fluid is usually under increased pressure, but occasionally may be normal or nearly so. It is typically characterized by enlargement of the head, prominence of the forehead, brain atrophy, mental deterioration, and convulsions. It may be congenital or acquired; it may be of sudden onset (acute hydrocephalus) or be slowly progressive (chronic or primary hydrocephalus). (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  [ȋ"L?NHydrocele C12.294.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male A circumscribed collection of fluid, especially a collection of fluid in the tunica vaginalis of the testicle or along the spermatic cord. (Dorland, 27th ed). [9 NTHydrocarbons, Iodinated D02.455.526.581 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated Iodobenzenes (+ 4) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR [8R:Hydrocarbons, Halogenated D02.455.526 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons Halothane; Hydrocarbons, Brominated (+ 4); Hydrocarbons, Chlorinated (+ 37); Hydrocarbons, Fluorinated (+ 4); Hydrocarbons, Iodinated (+ 5); Mustard Compounds (+ 17) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR [ 84DHydrocarbons, Fluorinated D02.455.526.510 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Fluorocarbon Polymers Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated Chlorofluorocarbons (+ 1); Fluorobenzenes; Fluorocarbons [8RCHydrocarbons, Cyclic (Non MeSH) D02.455.426 Organic Chemicals (Non MeSH); Hydrocarbons Hydrocarbons, Alicyclic (Non MeSH) (+ 24); Hydrocarbons, Aromatic (Non MeSH) (+ 78) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR [&4dDHydrocarbons, Chlorinated D02.455.526.439 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated Aldrin; Benzene Hexachloride; Carbon Tetrachloride; Chlordan; Chlorobenzenes (+ 2); Chlorofluorocarbons (+ 1); Chloroform (+ 1); DDD; DDE; DDT; Dichloroethylenes; Dieldrin; Endrin; Ethyl Chloride; Ethylene Dichlorides; Heptachlor; Kepone; Methoxychlor; Methyl Chloride; Methylene Chloride; Mirex; Mitotane; Picryl Chloride; Polychlorinated Biphenyls (+ 1); Polychloroterphenyl Compounds (+ 1); Tetrachloroethylene; Toxaphene; Trichloroepoxypropane; Trichloroethanes; Trichloroethylene; Vinyl Chloride AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR [F8RMDHydrocarbons, Brominated D02.455.526.368 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated Bromobenzenes; Bromotrichloromethane; Ethylene Dibromide; Polybrominated Biphenyls AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR [׹8R^:Hydrocarbons, Aromatic (Non MeSH) D02.455.426.559 Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH) Benzene; Benzene Derivatives (+ 76) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR [2(Z,DHydrocarbons, Alicyclic (Non MeSH) D02.455.426.392 Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH) Cycloparaffins (+ 23) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR [Z)Z:Hydrocarbons, Acyclic (Non MeSH) D02.455.326 Organic Chemicals (Non MeSH); Hydrocarbons Alkanes (+ 26); Alkenes (+ 27); Alkynes (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR [h'4=FHydrocarbons D02.455 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Hydrocarbons, Acyclic (Non MeSH) (+ 57); Hydrocarbons, Cyclic (Non MeSH) (+ 104); Hydrocarbons, Halogenated (+ 73); Terpenes (+ 59) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR [x 8#HHydrobromic Acid D01.029.260.300; D01.139.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Bromine Compounds  Bromides (+ 1) Hydrobromic acid (HBr). A solution of hydrogen bromide gas in water. Acids (83-93); Bromides (74-82)  ["8U(Hydroa Vacciniforme C17.800.600.425; C17.800.865.575 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Photosensitivity Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous A vesicular and bullous eruption having a tendency to recur in summer during childhood and commonly appearing on sun-exposed skin. The lesions are surrounded by an erythematous zone and resemble a vaccination. (From Dorland, 27th ed). [߷&NHydro-Lyases D08.586.520.497 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases Aconitate Hydratase; Aminolevulinic Acid Dehydratase; Carbonate Dehydratase; Cystathionine beta-Synthase; Enoyl CoA Hydratases; Fumarate Hydratase; Phosphopyruvate Hydratase; Prephenate Dehydratase; Propanediol Dehydratase; Serine Dehydratase; Threonine Dehydratase; Tryptophan Synthase; Urocanate Hydratase; Uroporphyrinogen III Synthase [RFOHydrazones D02.442.288 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone specific hydrazine (66-71); Hydrazines (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  [82h8:Hydrazines D02.442 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Benserazide; Carbidopa; Hydrazones (+ 2); Iproniazid; Isoniazid; Methylhydrazines (+ 2); Phenelzine; Phenylhydrazines (+ 1); Todralazine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR [: 8#:Hydrarthrosis C05.550.509 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Accumulation of watery fluid in the cavity of a joint. (Dorland, 27th ed). [N0]Hydranencephaly C10.500.680.196.475; C16.131.581.197.475; C16.131.666.680.196.475 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects; Anencephaly Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Monsters; Anencephaly Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects; Anencephaly Complete or almost complete absence of the cerebral hemispheres, the space they normally occupy being filled with cerebrospinal fluid. (Dorland, 27th ed). [ILvHydralazine D03.383.710.605.500; D18.162.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines; Phthalazines Cardiovascular Agents; Antihypertensive Agents Dihydralazine Dihydralazine [&: Hydra B01.308.475 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Cnidaria A genus of freshwater cnidarians, of interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals. Coelenterata (66-71) [ (Hydatidiform Mole, Invasive C04.557.465.955.485.490; C04.850.908.485.490; C13.703.720.949.485.490 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Trophoblastic Neoplasms; Hydatidiform Mole Neoplasms; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Hydatidiform Mole Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Hydatidiform Mole A tumor or tumor-like process invading the myometrium, and characterized by trophoblastic hyperplasia and persistence of placental villous structures. It commonly results from complete hydatidiform mole but may do so from partial hydatidiform mole. Invasive mole may metastasize but it does not exhibit the progression of a true cancer, and it may regress spontaneously. (Holland et al., Cancer Medicine, 3d ed). [!MXHydatidiform Mole C04.557.465.955.485; C04.850.908.485; C13.703.720.949.485 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Trophoblastic Neoplasms Neoplasms; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms Hydatidiform Mole, Invasive Hydatidiform Mole, Invasive Hydatidiform Mole, Invasive A trophoblastic disease characterized by hydrops of the mesenchymal portion of the villus. Its karyotype is paternal and usually homozygotic. The tumor is indistinguishable from chorioadenoma destruens or invasive mole ( = HYDATIDIFORM MOLE, INVASIVE) except by karyotype. There is no apparent relation by karyotype to CHORIOCARCINOMA. Hydatidiform refers to the presence of the hydropic state of some or all of the villi (Greek hydatis, a drop of water). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  [AV}_XHydantoins D03.383.374.411 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Allantoin; Dantrolene; Mephenytoin; Phenytoin; Thiohydantoins (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR [(8VQDHycanthone D03.494.953.704.450; D21.201.412.596.320 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Thioxanthenes Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides 1-[[2-(diethylamino)ethyl]amino]-4-(hydroxymethyl)thioxanthen-9-one. Potentially toxic, but effective antischistosomal agent; metabolite of lucanthone. Synonyms: Etrenol. Ethylenediamines (74); Thioxanthenes (74) [.:2Hybridomas A11.251.353.485; A11.251.600.485 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Antibodies, Monoclonal Antibodies, Monoclonal; Interleukin-6 Cells; Cells, Cultured; Clone Cells Cells; Cells, Cultured; Hybrid Cells Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure or "monoclonal" antibodies or T-cell products, identical to those produced by the immunologically competent parent, and continually grow and divide as the neoplastic parent. Cell Fusion (75-81); Cell Line (75-81); Clone Cells (75-81); Hybrid Cells (75-81) $[&*,YjfHybridization G05.414.413 DEGEIMPHRE Crosses, Genetic Genetics; Genetics, Population Hybrid Vigor In genetics, the act or process of producing a hybrid, an animal or plant whose parents are different varieties of the same species or belong to different but closely allied species. In molecular genetics, for the creation of DNA and RNA hybrids, NUCLEIC ACID HYBRIDIZATION is available. In protein chemistry, PROTEIN HYBRIDIZATION is available. (Dorland, 27th ed; Stedman, 25th ed).  [%Hybrid Vigor G05.414.413.475 DEGEIMPHRE Genetics; Genetics, Population; Hybridization The adaptive superiority of heterozygous genotypes with respect to one or more characters in comparison with the corresponding homozygotes. Hybridization (66-67) \V6Hybrid Cells A11.251.600 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cell Fusion Cells; Cells, Cultured Hybridomas Hybridization (66-71); Tissue Culture (66-71)  \*7Hyaluronidase D08.586.277.450.529; D08.586.520.726.475 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Polysaccharide-Lyases \.FHyaluronic Acid D09.203.698.373.475 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans Hyaluronic acid. A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the umbilical cord, in vitreous humor, in synovial fluid, in pathologic joints, in group A and C hemolytic streptococci, and in Wharton's jelly. (Merck, 11th ed). \FtqHyaline Membrane Disease C08.381.801.475; C08.618.801.475; C16.614.521.563.475 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Respiratory Distress Syndrome Respiratory Tract Diseases; Respiration Disorders; Respiratory Distress Syndrome Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Infant, Premature, Diseases; Respiratory Distress Syndrome A disorder affecting newborn infants (usually premature) characterized pathologically by the development of a hyaline-like membrane lining the terminal respiratory passages. Extensive atelectasis is attributed to the lack of surfactant. (Dorland, 27th ed). \w=LI(Hyalin Substance A12.580 CHCYDEENIMMEMIPHPSRARERISEULUSVI Fluids and Secretions (Non MeSH) \  $(Hutchinson's Melanotic Freckle C04.557.465.625.650.510.385; C04.557.580.625.650.510.385; C04.557.665.510.385 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Melanoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Melanoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Nevi and Melanomas (Non MeSH); Melanoma A cutaneous malignant melanoma found most often on the sun-exposed areas of the skin, especially the face, which begins as a circumscribed, macular patch of mottled pigmentation, showing shades of dark brown, tan, or black, and enlarges by lateral growth before dermal invasion occurs. This type is the slowest growing, has the least tendency to metastasize, and seems to be the least aggressive form of malignant melanoma. Patients are commonly in their sixth or seventh decade. (Dorland, 27th ed; from Rook et al., Textbook of Dermatology, 4th ed, p. 2450). \ =$UXHuntington's Disease C10.228.140.079.255.492 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases; Chorea An autosomal dominant disease characterized by chronic progressive chorea and mental deterioration terminating in dementia. The age of onset is variable but usually occurs in the fourth decade of life. Death usually follows within 15 years. (Dorland, 27th ed). \tL|3Hunger F01.658.293.391; G10.261.530 CLDEPHRE Starvation; Food Deprivation; Fasting Behavior and Behavior Mechanisms (Non MeSH); Motivation; Drive Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) The desire for food generated by a sensation arising from the lack of food in the stomach. \ " .oHungary Z01.542.248.495 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern \o =Humidity G03.230.150.372; G03.230.300.100.725.310 AEPCST Environment and Public Health (Non MeSH); Environment; Environment, Controlled Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather \ . Humic Acids D26.525 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Humic Acids. Allomelanins found in soils, coals, and peat, resulting from the decomposition of organic matter, particularly dead plants. They are a mixture of complex macromolecules having polymeric phenolic structures with the ability to chelate metals, especially iron. (Merck Index, 11th ed). \$ ,2YHumerus A02.835.232.087.412 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH) \ :VHumeral Fractures C21.866.088.390; C21.866.405.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures \&NHumanities K01 CLEDHIPXSNTD Art (+ 12); Awards and Prizes (+ 1); Ethics (+ 23); History (+ 22); Literature (+ 17); Music; Occultism (+ 1); Philosophy (+ 33); Religion (+ 16) CLECEDEHHIISLJMAMTOGPCPXSNSTTDVE \Q$Humanism K01.316.400; K01.752.256.120 HI Humanities; Ethics Humanities; Philosophy; Ethics An ethical system which emphasizes human values and the personal worth of each individual, as well as concern for the dignity and freedom of humankind. Ethics (66-77); Ethics, Medical (66-77); Philosophy (66-77); Philosophy, Medical (66-77) \{ "<kHuman Rights I01.880.604.473; N03.706.437 CLECEDHIINLJPXSNSTTD Civil Rights; Women's Rights Social Justice; Ethics Social Sciences; Sociology; Social Control, Formal Economics, Organizations, Control (Non MeSH); Social Control, Formal Child Advocacy; Civil Rights; Consumer Advocacy; Freedom; Patient Advocacy (+ 1); Social Justice; Women's Rights Child Advocacy; Civil Rights; Consumer Advocacy; Freedom; Patient Advocacy (+ 1); Social Justice; Women's Rights The rights of the individual to cultural, social, economic, and educational opportunities as provided by society, e.g., right to work, right to education, and right to social security. Civil Rights (68-72) CLECEDHIINLJMAMTOGPXSDSNSTTDUT ,\1"$"Human Genome Project G02.403.388.450; H01.770.644.450; L01.453.450 ECHILJOG Genomic Library Health Occupations; Medicine; Genetics, Medical Physical Sciences (Non MeSH); Science; Research Information Science; Information Services A coordinated effort of researchers to map and sequence the human genome. Base Sequence (87-89); Chromosomes, Human (87-89)  \ 5 Y<Human Experimentation E05.445 HI Ethics, Medical; Informed Consent Miscellaneous Techniques (Non MeSH) \"t )*Human Engineering F02.784.412; J01.293.556 CLECHIISLJMAMTPXSNST Psychology, Industrial Psychology, Industrial Psychologic Processes and Principles (Non MeSH); Psychology, Applied Technology, Industry, Agriculture (Non MeSH); Engineering Data Display; Man-Machine Systems; Task Performance and Analysis (+ 1); Time Management Man-Machine Systems; Task Performance and Analysis (+ 2); Time Management The science of designing, building or equipping mechanical devices or artificial environments to the anthropometric, physiological, or psychological requirements of the people who will use them. AECLECHIISLJMAMTOGPXSDSNSTTDUT (\#"Human Development F01.525 Behavior and Behavior Mechanisms (Non MeSH) Child Development (+ 3) Continuous sequential changes which occur in the physiological and psychological functions during the individual's life. CLDEPHPXRE \&  4Human Body I01.076.201.450.560; K01.093.378 Social Sciences; Anthropology; Anthropology, Cultural; Culture Humanities; Art The human being as a non-anatomical and non-zoological entity. The emphasis is on the philosophical or artistic treatment of the human being, and includes lay and social attitudes toward the body in history. (From J. Cassedy, NLM History of Medicine Division). \'S&]4Human Activities (Non MeSH) I03 Activities of Daily Living; Automobile Driving (+ 1); Diet Fads; Exercise; Leisure Activities (+ 32); Nudism; Physical Fitness; Retirement; Survival; Temperance; Travel (+ 1); Work (+ 1) AECLECEDHIINLJPHPXSNSTTD \)8"HTLV-II Infections C02.782.815.483.480; C20.673.483.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; HTLV-BLV Infections Immunologic Diseases; Immunologic Deficiency Syndromes; HTLV-BLV Infections Leukemia, T-Cell, HTLV-II-Associated Leukemia, T-Cell, HTLV-II-Associated HTLV Infections (87-88); Leukemia, Hairy Cell (86-88) \**PRAHTLV-II Antigens D24.611.216.327.570.510 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; HTLV-BLV Antigens Antigens associated with the HTLV-II VIRUS. Antigens, Viral (83-88); Human T-Cell Leukemia Virus/immunology (84-88) \,65UHTLV-II Antibodies D24.611.125.243.460.510 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Viral; HTLV-BLV Antibodies Antibodies reactive with the HTLV-II ANTIGENS. Antibodies, Viral (82-88); Human T-Cell Leukemia Virus/immunology (84-88) \.968WHTLV-II B04.820.650.400.510; B04.909.574.807.400.510; B04.909.777.731.400.510 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; HTLV-BLV Viruses A species of HTLV-BLV VIRUSES that can transform normal T-lymphocytes and can replicate in both T- and B-cell lines. The virus is related to but distinct from HTLV-I. It is associated with T-cell hairy cell leukemia, a relatively benign disease. Human T-Cell Leukemia Virus (84-88); Retroviridae (81-83) \/ M #EHTLV-I Infections C02.782.815.483.470; C20.673.483.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; HTLV-BLV Infections Immunologic Diseases; Immunologic Deficiency Syndromes; HTLV-BLV Infections Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated; Paraparesis, Tropical Spastic Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated HTLV Infections (87-88); Human T-Cell Leukemia Virus (85-87); Retrovirus Infections (85-86) \2*PmHTLV-I Antigens D24.611.216.327.570.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; HTLV-BLV Antigens Antigens associated with the HTLV-I VIRUS. Antigens, Viral (83-88); Human T-Cell Leukemia Virus/immunology (84-88) \5|64UHTLV-I Antibodies D24.611.125.243.460.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Viral; HTLV-BLV Antibodies Antibodies reactive with the HTLV-I ANTIGENS. Antibodies, Viral (82-88); Human T-Cell Leukemia Virus/immunology (84-88) \7"67WHTLV-I B04.820.650.400.500; B04.909.574.807.400.500; B04.909.777.731.400.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; HTLV-BLV Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; HTLV-BLV Viruses A species of HTLV-BLV VIRUSES isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (ATL), T-cell lymphoma, and is involved in mycosis fungoides, Sezary syndrome and tropical spastic paraparesis. Human T-Cell Leukemia Virus (84-88); Retroviridae (81-83) \8 M )EHTLV-BLV Viruses B04.820.650.400; B04.909.574.807.400; B04.909.777.731.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae HTLV-I; HTLV-II; Leukemia Virus, Bovine; STLV HTLV-I; HTLV-II; Leukemia Virus, Bovine; STLV HTLV-I; HTLV-II; Leukemia Virus, Bovine; STLV Genus of the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B or adult T-cell leukemia/lymphoma, and bovine leukemia. \;A HTLV-BLV Infections C02.782.815.483; C20.673.483 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections Immunologic Diseases; Immunologic Deficiency Syndromes Enzootic Bovine Leukosis; HTLV-I Infections (+ 2); HTLV-II Infections (+ 1) Enzootic Bovine Leukosis; HTLV-I Infections (+ 1); HTLV-II Infections (+ 1) Infections caused by the HTLV or BLV retroviruses. They include human T-cell leukemia-lymphoma and adult T-cell leukemia. Human T-Cell Leukemia Virus (84-86); Retrovirus Infections (81-86)  \?"POHTLV-BLV Antigens D24.611.216.327.570 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral HTLV-I Antigens; HTLV-II Antigens Antigens associated with the HTLV-BLV VIRUSES. HTLV-I ANTIGENS and HTLV-II ANTIGENS belong to this group. Antigens, Viral (83-88); HIV/immunology (88); HTLV-III/immunology (87); Human T-Cell Leukemia Virus/immunology (84-87)  \A6{)}HTLV-BLV Antibodies D24.611.125.243.460 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Viral HIV Antibodies; HTLV-I Antibodies; HTLV-II Antibodies Antibodies reactive with various types of human T-cell leukemia/lymphoma antigens or bovine leukemia virus antigens. Antibodies, Monoclonal (82-88); Antibodies, Viral (82-88); HIV/immunology (88); HTLV-III (87); Human T-Cell Leukemia Virus/immunology (84-88)  \D 6@Housing, Animal G03.230.150.360.250 CLECHILJSNSTTD Environment and Public Health (Non MeSH); Environment; Environment, Controlled; Housing Hospitals, Animal Animals, Laboratory (66-71); Housing (66-71) \Fh6Housing for the Elderly G03.230.150.360.260; N01.224.791.400.410 CLECHILJMAOGSDSNSTTDUT Homes for the Aged Aged; Homes for the Aged Environment and Public Health (Non MeSH); Environment; Environment, Controlled; Housing Population Characteristics (Non MeSH); Demography; Residence Characteristics; Housing Housing arrangements for the elderly or aged, intended to foster independent living. The housing may take the form of group homes or small apartments. It is available to the economically self-supporting but the concept includes housing for the elderly with some physical limitations. The concept should be differentiated from HOMES FOR THE AGED which is restricted to long-term geriatric facilities providing supervised medical and nursing services. Housing (67-91) $\G.! Housing G03.230.150.360; G03.850.505.400.800.400; N01.224.791.400 CLECHILJSNSTTD Urban Renewal Environment and Public Health (Non MeSH); Environment; Environment, Controlled Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Residence Characteristics Population Characteristics (Non MeSH); Demography; Residence Characteristics Housing, Animal (+ 1); Housing for the Elderly; Public Housing Housing for the Elderly; Public Housing Living facilities for humans. CLECHILJMAOGSDSNSTTDUT $\Ko AO~%Housekeeping, Hospital N02.278.354.422.412; N02.508.472; N04.452.442.422.412 CLECHILJMAMTOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Housekeeping Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which manages and provides the required housekeeping functions in all areas of the hospital. \N=OHousekeeping N02.508 CLECHILJMAMTOGSNSTTDUT Facilities, Manpower and Services (Non MeSH) Housekeeping, Hospital The care and management of property. \P 5.Household Products J01.516 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH) Cosmetics (+ 4); Dentifrices (+ 1); Deodorants; Detergents; Mouthwashes; Perfume; Soaps Substances or materials used in the course of housekeeping or personal routine. ADAEANCHCLCSCTDUECHIIPMEMIPDPKPOPSRESDSNSTTOTUUTVI  \Q\ "4m_6Household Articles J01.494 CLECHIISLJSNST Technology, Industry, Agriculture (Non MeSH) Bedding and Linens; Cooking and Eating Utensils Various material objects and items in the home. It includes temporary or permanent machinery and appliances. It does not include furniture or interior furnishings (FURNITURE see INTERIOR DESIGN AND FURNISHINGS; INTERIOR FURNISHINGS see INTERIOR DESIGN AND FURNISHINGS). AECLCTECHIISLJSDSNSTTDUTVE  \S 4::Houseflies B01.131.617.289.642.470 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Muscidae Flies of the species Musca domestica (family MUSCIDAE), which infest human habitations throughout the world and often act as carriers of pathogenic organisms. \U&(AHouse Calls N04.452.758.307 ECSNTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Visits to the patient's home by professional personnel for the purpose of diagnosis and/or treatment. \V qyHotlines L01.143.380 CLECHIISLJMAOGSDSNSTTDUT Crisis Intervention; Emergency Services, Psychiatric; Emergencies Information Science; Communication A direct communication system, usually telephone, established for instant contact. It is designed to provide special information and assistance through trained personnel and is used for counseling, referrals, and emergencies such as poisonings and threatened suicides. \W L)5Hostility F01.470.596 Behavior and Behavior Mechanisms (Non MeSH); Emotions Tendency to feel anger toward and to seek to inflict harm upon a person or group. Hate (66-67) \Y AeHost-Parasite Relations G04.185.410 DEGEIMPHRE Parasites Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) The interactions between two organisms, one of which lives at the expense of the other. specific host, organ, disease/parasitology (75-79)  \Z kj;Host vs Graft Reaction G04.610.555.714.545 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular; Transplantation Immunology Graft Rejection; Graft Survival The immune responses of a host to a graft. A specific response is GRAFT REJECTION. Graft Rejection (71-76); Transplantation Immunology (66-72) BLCFCICLCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $\\P'fFRHospitals, Voluntary N02.278.421.481.800 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Private Private, not-for-profit hospitals that are autonomous, self-established, and self-supported. \^mpiHospitals, Veterans N02.278.421.510.180.400 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public; Hospitals, Federal Hospitals providing medical care to veterans of wars. \_AHospitals, Urban N02.278.421.660 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospitals, Municipal Hospitals located in metropolitan areas. Hospitals (66-85); Urban Health (79-85); Urban Population (68-85)  \`Y1PHospitals, University N02.278.020.300.310; N02.278.421.639.725 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Academic Medical Centers; Hospitals, Teaching Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Teaching Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research. \bJ.Hospitals, Teaching N02.278.020.300; N02.278.421.639 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Academic Medical Centers Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospitals, University Hospitals, University Hospitals engaged in educational and research programs, as well as providing medical care to the patients. Hospitals (66-67)  \dV&2~Hospitals, State N02.278.421.510.300 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public Hospitals controlled by agencies and departments of the state government. \fboWHospitals, Special N02.278.421.556 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Cancer Care Facilities; Cardiac Care Facilities; Hospices; Hospitals, Chronic Disease; Hospitals, Convalescent; Hospitals, Maternity; Hospitals, Osteopathic; Hospitals, Pediatric; Hospitals, Psychiatric; Surgicenters Hospitals which provide care for a single category of illness with facilities and staff directed toward a specific service. Hospitals (66-67)  \gYHospitals, Satellite N02.278.421.530 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Those hospitals which are extensions of a main hospital and are wholly or partly administered by that hospital. \iYHospitals, Rural N02.278.421.518 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospitals located in a rural area. Hospitals (66-85); Rural Health (66-85); Rural Population (68-85) \kEY,PHospitals, Religious N02.278.421.481.600 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Private Private hospitals that are owned or sponsored by religious organizations. Hospitals, Private (91); Hospitals, Voluntary (85-90) \lpW@Hospitals, Public N02.278.421.510 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospitals, County; Hospitals, District; Hospitals, Federal (+ 2); Hospitals, Municipal; Hospitals, State Hospitals controlled by various types of government, i.e., city, county, district, state or federal. \mY|vHospitals, Psychiatric N02.278.421.556.508 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Special hospitals which provide care to the mentally ill patient. \opOHospitals, Proprietary N02.278.215.110; N02.278.421.481.500 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facilities, Proprietary Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Private Hospitals owned and operated by a corporation or an individual that operate on a for-profit basis, also referred to as investor-owned hospitals. \p*Hospitals, Private N02.278.421.481 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospitals, Proprietary; Hospitals, Religious; Hospitals, Voluntary A class of hospitals that includes profit or not-for-profit hospitals that are controlled by a legal entity other than a government agency. (Hospital Administration Terminology, AHA, 2d ed). Hospitals, Proprietary (75-90)  \rYM$Hospitals, Pediatric N02.278.421.556.437 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Special hospitals which provide care for ill children. \upBHospitals, Packaged E07.325.473; N02.278.421.473 CLECHILJMAOGSDSNSTTDUT Equipment and Supplies; Equipment and Supplies, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospital equipment and supplies, packaged for long-term storage, sufficient to set up a general hospital in an emergency situation. They are also called Packaged Disaster Hospitals and formerly Civil Defense Emergency Hospitals. Hospitals (66) \v"" Hospitals, Osteopathic N02.278.421.556.386 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Hospitals providing care utilizing the generally accepted medical and surgical methods but with emphasis on the osteopathic system of therapy. Hospitals, Special (68-81); Osteopathic Medicine (66-81) \xSpCHospitals, Municipal N02.278.421.510.210; N02.278.421.660.400 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Urban Hospitals controlled by the city government. \z.6Hospitals, Military N02.278.421.510.180.250 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public; Hospitals, Federal Hospitals which provide care for the military personnel and usually for their dependents. \{jHospitals, Maternity N02.278.421.556.366 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Special hospitals which provide care to women during pregnancy and parturition. \}p^Hospitals, Group Practice N02.278.421.395 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Hospitals organized and controlled by a group of physicians who practice together and provide each other with mutual support. Group Practice (66-Jul 77); Hospitals (66-Jul 77) \~OY=Hospitals, General N02.278.421.389 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Large hospitals with a resident medical staff which provides continuous care to maternity, surgical and medical patients. Hospitals (66-67) \YHospitals, Federal N02.278.421.510.180 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public Hospitals, Military; Hospitals, Veterans Hospitals controlled by agencies and departments of the U.S. federal government. \Vo0`Hospitals, District N02.278.421.510.140 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public Government-controlled hospitals which represent the major health facility for a designated geographic area. \o|Hospitals, County N02.278.421.510.100 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Public Hospitals controlled by the county government. \o8Hospitals, Convalescent N02.278.421.556.294 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Hospitals which provide care to the patient for the period following an acute illness until health is restored. \.pHospitals, Community N02.278.421.306 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals Institutions with permanent facilities and organized medical staff which provide the full range of hospital services primarily to a neighborhood area. Community Health Services (66-72); Hospitals (66-72) \Y?Hospitals, Chronic Disease N02.278.421.556.200 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Hospitals which provide care to patients with long-term illnesses. Hospitals, Special (68-77) \K pO Hospitals, Animal G03.230.150.360.250.200 CLECHILJSNSTTD Environment and Public Health (Non MeSH); Environment; Environment, Controlled; Housing; Housing, Animal \|Hospitals N02.278.421 CLHIMASDSNSTTDUT Economics, Hospital; Equipment and Supplies, Hospital; Hospital Administration Facilities, Manpower and Services (Non MeSH); Health Facilities Hospitals, Community; Hospitals, General; Hospitals, Group Practice; Hospitals, Packaged; Hospitals, Private (+ 3); Hospitals, Public (+ 7); Hospitals, Rural; Hospitals, Satellite; Hospitals, Special (+ 10); Hospitals, Teaching (+ 1); Hospitals, Urban (+ 1) Institutions with an organized medical staff which provide medical care to patients. CLECHILJMAMTOGSDSNSTTDUT $\ [L3dHospitalization N02.421.589.473 ECLJSNTD Child, Hospitalized; Institutionalization; Length of Stay; Patient Discharge Institutionalization Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Diagnosis-Related Groups (+ 4); Length of Stay; Patient Admission; Patient Discharge; Patient Readmission; Patient Transfer The confinement of a patient in a hospital. CLECHILJMAMTOGSDSNSTTDUT (\9 Zy7Hospital-Physician Relations F01.829.674.379; N02.278.354.458; N04.452.442.530; N04.452.758.275; N04.452.822.379 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Public Relations Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Health Services Administration (Non MeSH); Organization and Administration; Public Relations  Medical Staff Privileges Medical Staff Privileges Medical Staff Privileges Includes relationships between hospitals, their governing boards, and administrators in regard to physicians, whether or not the physicians are members of the medical staff or have medical staff privileges. Physicians (66-94) CLECEDHILJOGPXSDSNSTTDUT  \o!_XHospital-Physician Joint Ventures N02.278.354.550.380; N04.452.442.550.380 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Restructuring Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Restructuring Physician Self-Referral Physician Self-Referral A formal financial agreement made between one or more physicians and a hospital to provide ambulatory alternative services to those patients who do not require hospitalization. Hospital Restructuring (84-85); Medical Staff, Hospital (78-85)  \'.6KHospital-Patient Relations F01.829.674.370; N02.278.354.455; N04.452.442.510; N04.452.822.370 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Public Relations Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Public Relations Interactions between hospital staff or administrators and patients. Includes guest relations programs designed to improve the image of the hospital and attract patients. Consumer Satisfaction (83-88) \L#Hospital Volunteers M01.526.485.740.400; M01.955.473; N02.360.740.400 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital Named Groups (Non MeSH); Voluntary Workers Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital Hospital Auxiliaries Hospital Auxiliaries Hospital Auxiliaries; Patient Escort Service Individuals who donate their services to the hospital. \9cBHospital Units N02.278.388 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Delivery Rooms; Hemodialysis Units, Hospital; Intensive Care Units (+ 6); Nurseries, Hospital; Operating Rooms; Self-Care Units Those areas of the hospital organization not considered departments which provide specialized patient care. They include various hospital special care wards. CLECHILJMAMTOGSDSNSTTDUT  \LHospital Shops N02.278.354.580; N04.452.442.585 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Stores located in hospitals selling merchandise or services for the convenience of patients, staff, and visitors. \&Hospital Shared Services N02.278.354.565; N04.452.442.565; N04.452.540.308 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Multi-Institutional Systems Cooperation among hospitals for the purpose of sharing various departmental services, e.g., pharmacy, laundry, data processing, etc. Hospital Administration (66-67); specific department \9N>Hospital Restructuring N02.278.354.550; N04.452.442.550 CLECHILJMAMTOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Hospital-Physician Joint Ventures (+ 1) Hospital-Physician Joint Ventures (+ 1) Reorganization of the hospital corporate structure. Financial Management (78-83); Hospital Administration (66-83) CLECHILJMAMTOGSDSNSTTDUT $\&\=HHospital Records E05.318.308.940.425; G03.850.520.308.940.425; L01.280.900.425; N04.452.859.380; N05.715.360.300.715.380 CLECLJSNST Forms and Records Control Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records Information Science; Data Collection; Records Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records Compilations of data on hospital activities and programs; excludes patient medical records. \s lHospital Planning N03.349.650.250.200 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning; Health Facility Planning Areawide planning for hospitals or planning of a particular hospital unit on the basis of projected consumer need. This does not include hospital design and construction or architectural plans. Hospital Design and Construction (66-67) \o0Hospital Mortality E05.318.308.985.550.400; G03.850.505.400.975.550.400; G03.850.520.308.985.550.400; L01.280.975.550.400; N01.224.935.698.400 TD Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Information Science; Data Collection; Vital Statistics; Mortality Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality A vital statistic measuring or recording the rate of death from any cause in hospitalized populations. Mortality (66-91) \sSzHospital Information Systems L01.700.508.300.408; L01.700.508.300.680.360; N04.452.442.452; N04.452.515.360 CLECHILJOGSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems  Operating Room Information Systems Clinical Pharmacy Information Systems; Operating Room Information Systems; Radiology Information Systems Ambulatory Care Information Systems; Clinical Laboratory Information Systems; Clinical Pharmacy Information Systems; Operating Room Information Systems; Radiology Information Systems Integrated, computer-assisted systems designed to store, manipulate, and retrieve information concerned with the administrative and clinical aspects of providing medical services within the hospital. CLECHIISLJMAOGSDSNSTTDUT  \!"XnHospital Distribution Systems N02.278.354.446; N04.452.442.450 CLECHILJOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Systems for delivering hospital supplies, food, laundry, etc., to patient care areas. \1#&eHospital Design and Construction J01.086.339.250; N02.278.200.403 CLECHIISLJMAMTSNSTTD Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction Facilities, Manpower and Services (Non MeSH); Health Facilities; Facility Design and Construction The architecture, functional design, and construction of hospitals. \'&OHospital Departments N02.278.354.422; N04.452.442.422 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Admitting Department, Hospital; Anesthesia Department, Hospital; Cardiology Service, Hospital; Central Supply, Hospital; Chaplaincy Service, Hospital; Dental Service, Hospital; Education Department, Hospital; Emergency Service, Hospital (+ 1); Food Service, Hospital; Housekeeping, Hospital; Laboratories, Hospital; Laundry Service, Hospital; Maintenance and Engineering, Hospital; Medical Records Department, Hospital; Nuclear Medicine Department, Hospital; Nursing Service, Hospital; Obstetrics and Gynecology Department, Hospital; Occupational Therapy Department, Hospital; Oncology Service, Hospital; Outpatient Clinics, Hospital (+ 1); Pathology Department, Hospital; Personnel Administration, Hospital; Pharmacy Service, Hospital; Physical Therapy Department, Hospital; Psychiatric Department, Hospital; Purchasing, Hospital (+ 1); Radiology Department, Hospital; Respiratory Therapy Department, Hospital; Social Work Department, Hospital; Surgery Department, Hospital; Urology Department, Hospital Admitting Department, Hospital; Anesthesia Department, Hospital; Cardiology Service, Hospital; Central Supply, Hospital; Chaplaincy Service, Hospital; Dental Service, Hospital; Education Department, Hospital; Emergency Service, Hospital (+ 1); Food Service, Hospital; Housekeeping, Hospital; Laboratories, Hospital; Laundry Service, Hospital; Maintenance and Engineering, Hospital; Medical Records Department, Hospital; Nuclear Medicine Department, Hospital; Nursing Service, Hospital; Obstetrics and Gynecology Department, Hospital; Occupational Therapy Department, Hospital; Oncology Service, Hospital; Outpatient Clinics, Hospital (+ 1); Pathology Department, Hospital; Personnel Administration, Hospital; Pharmacy Service, Hospital; Physical Therapy Department, Hospital; Psychiatric Department, Hospital; Purchasing, Hospital (+ 1); Radiology Department, Hospital; Respiratory Therapy Department, Hospital; Social Work Department, Hospital; Surgery Department, Hospital; Urology Department, Hospital Major administrative divisions of the hospital. Hospital Administration (66-67) CLECEDHIISLJMAMTOGSDSNSTTDUT $\&9% Hospital Costs N03.219.151.400.687; N03.219.262.500; N05.300.375.500 CLHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Health Care Costs Economics, Organizations, Control (Non MeSH); Economics; Economics, Hospital Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Care Costs The expenses incurred by a hospital in providing care. The hospital costs attributed to a particular patient care episode include the direct costs plus an appropriate proportion of the overhead for administration, personnel, building maintenance, equipment, etc. Hospital costs are one of the factors which determine HOSPITAL CHARGES (the price the hospital sets for its services). Costs and Cost Analysis (66-93); Economics, Hospital (66-93) \v=1IHospital Communication Systems N02.278.354.322; N04.452.442.322 CLECHILJOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration The transmission of messages to staff and patients within a hospital. \7$&THospital Charges N03.219.262.300; N03.219.442.613 CLHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Economics, Hospital Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges The prices a hospital sets for its services. HOSPITAL COSTS (the direct and indirect expenses incurred by the hospital in providing the services) are one factor in the determination of hospital charges. Other factors may include, for example, profits, competition, and the necessity of recouping the costs of uncompensated care. Economics, Hospital (67-93); Fees and Charges (67-93) \&AHospital Bed Capacity, 500 and over N02.278.306.472.300 ECSNST Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facility Size; Hospital Bed Capacity Hospital Bed Capacity (75-77) \, $Hospital Bed Capacity, 300 to 499 N02.278.306.472.180 ECSNST Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facility Size; Hospital Bed Capacity Hospital Bed Capacity (75-77) \* $Hospital Bed Capacity, 100 to 299 N02.278.306.472.120 ECSNST Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facility Size; Hospital Bed Capacity Hospital Bed Capacity (75-77) \* $Hospital Bed Capacity, under 100 N02.278.306.472.080 ECSNST Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facility Size; Hospital Bed Capacity Hospital Bed Capacity (75-77); Hospital Bed Capacity, 100 to 299 (78-79) \ ( XHospital Bed Capacity N02.278.306.472 ECSNST Bed Occupancy Bed Occupancy Facilities, Manpower and Services (Non MeSH); Health Facilities; Health Facility Size Hospital Bed Capacity, under 100; Hospital Bed Capacity, 100 to 299; Hospital Bed Capacity, 300 to 499; Hospital Bed Capacity, 500 and over The number of beds which a hospital has been designed and constructed to contain. It may also refer to the number of beds set up and staffed for use. Health Facility Size (68-74) (\N f#Hospital Auxiliaries M01.526.485.740.400.375; M01.955.473.375; N02.360.740.400.375 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital; Hospital Volunteers Named Groups (Non MeSH); Voluntary Workers; Hospital Volunteers Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital; Hospital Volunteers Volunteer organizations whose members perform work for the hospital without compensation. \EWhHospital Administrators M01.526.070.490.490; M01.526.485.430.490; M01.526.485.740.380; N02.360.430.490; N02.360.740.380 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Administrative Personnel; Health Facility Administrators Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Health Facility Administrators Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital Facilities, Manpower and Services (Non MeSH); Health Personnel; Health Facility Administrators Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital Chief Executive Officers, Hospital Chief Executive Officers, Hospital Chief Executive Officers, Hospital Chief Executive Officers, Hospital Chief Executive Officers, Hospital Managerial personnel responsible for implementing policy and directing the activities of hospitals. Hospital Administration (66-77)  \!k[s%Hospital Administration G02.309; N02.278.354; N04.452.442 CLECEDHIISLJMAMTSNSTTD Professional Staff Committees Hospitals Health Occupations Facilities, Manpower and Services (Non MeSH); Health Facilities Health Services Administration (Non MeSH); Organization and Administration  Ancillary Services, Hospital; Centralized Hospital Services; Financial Management, Hospital; Hospital Communication Systems; Hospital Departments (+ 34); Hospital Distribution Systems; Hospital-Patient Relations; Hospital-Physician Relations (+ 1); Hospital Restructuring (+ 2); Hospital Shared Services; Hospital Shops; Libraries, Hospital; Materials Management, Hospital (+ 1); Medication Systems, Hospital; Product Line Management Ancillary Services, Hospital; Centralized Hospital Services; Financial Management, Hospital; Hospital Communication Systems; Hospital Departments (+ 34); Hospital Distribution Systems; Hospital Information Systems (+ 3); Hospital-Patient Relations; Hospital-Physician Relations (+ 1); Hospital Restructuring (+ 2); Hospital Shared Services; Hospital Shops; Libraries, Hospital; Materials Management, Hospital (+ 1); Medication Systems, Hospital; Product Line Management Management of the internal organization of the hospital. CLECEDHIISLJMAMTOGPXSDSNSTTDUT (\ק)# D"Hospices N02.278.421.556.185; N02.421.143.550 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Facilities or services which are especially devoted to providing palliative and supportive care to the patient with a terminal illness and to the patient's family. Hospitals, Special (68-Jul 77) \ݙ *%Hospice Care E02.472.905.400; N02.421.589.886.400 CLECHILJMAMTOGPXSNSTTDUT Respite Care Terminal Care Therapeutics; General Patient Care (Non MeSH); Terminal Care Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Terminal Care Specialized health care, supportive in nature, provided to a dying person. A holistic approach is often taken, providing the patient and his or her family with legal, financial, emotional, or spiritual counseling in addition to meeting the patient's immediate physical needs. Care may be provided in the home, in the hospital, in specialized facilities (HOSPICES), or in specially designated areas of long-term care facilities. The concept also includes bereavement care for the family. (From Dictionary of Health Services Management, 2d ed). Hospices (77-91) $\*yHorseshoe Crabs B01.131.450 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Limulus Test Invertebrates; Arthropods An arthropod subclass (Xiphosura) comprising the North American (Limulus) and Asiatic (Tachypleus) genera of horseshoe crabs. Arachnida (66-76); Arthropods (66-76); Crustacea (66-76)  \(EHorses B02.649.709.235.472 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Perissodactyla; Equidae Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. consider also terms at EQUINE. \U (7AHorseradish Peroxidase D08.586.682.732.512 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases An enzyme isolated from horseradish which is able to act as an antigen. It is frequently used as a histochemical tracer for light and electron microscopy. Its antigenicity has permitted its use as a combined antigen and marker in experimental immunology. Peroxidases (72-75); Plants (72-75) \9Fg-,Horse Diseases C22.488 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases African Horsesickness; Equine Infectious Anemia; Glanders; Strongyle Infections, Equine Diseases of domestic and wild horses of the species Equus caballus. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  \ HfRJHorns A13.507 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Antlers specific animal (66-67) \?  : Horner's Syndrome C10.597.622.447.686; C10.772.150.300; C10.772.204.410.472.400; C11.590.472.400; C11.710.800.300; C23.888.592.636.447.686 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis; Ophthalmoplegia Nervous System Diseases; Peripheral Nervous System Diseases; Autonomic Nervous System Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders; Ophthalmoplegia Eye Diseases; Ocular Motility Disorders; Ophthalmoplegia Eye Diseases; Pupillary Functions, Abnormal; Tonic Pupil Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Ophthalmoplegia Interruption of the sympathetic pathways anywhere from the hypothalamus to the orbit. This is usually caused by mediastinal tumors, Hodgkin's disease, or metastatic tumors. \NqHormones, Synthetic D06.597 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH) Androgens, Synthetic (+ 17); Catatoxic Steroids (+ 1); Estrogens, Synthetic (+ 10); Glucocorticoids, Synthetic (+ 61); Mineralocorticoids, Synthetic (+ 1); Progestational Hormones, Synthetic (+ 23) Synthetic chemical compounds that mimic the activity of hormones produced in the body, but differ in structure from naturally occurring hormones. Hormones (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $\A 85HHormones, Substitutes, Antagonists (Non MeSH) D06 Hormone Antagonists (+ 45); Hormones (+ 206); Hormones, Synthetic (+ 119) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR \5[HHormones, Ectopic D06.472.397 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Neoplastic Endocrine-Like Syndromes Hormones, Substitutes, Antagonists (Non MeSH); Hormones \@)BHormones D06.472 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormone Antagonists; Receptors, Cell Surface Endocrine Glands Hormones, Substitutes, Antagonists (Non MeSH) Adrenal Cortex Hormones (+ 29); Androgens (+ 9); Calcitonin; Estrogens (+ 12); Gastrointestinal Hormones (+ 11); Gonadotropins (+ 7); Hormones, Ectopic; Hypothalamic Hormones; Invertebrate Hormones (+ 6); Melatonin; Natriuretic Hormone; Oxytocics (+ 5); Pancreatic Hormones (+ 9); Parathyroid Hormones; Parotin; Pituitary Hormone-Releasing Hormones (+ 12); Pituitary Hormones (+ 26); Placental Hormones (+ 4); Pregnancy Proteins (+ 7); Progestational Hormones (+ 6); Sex Hormones (+ 25); Thymus Hormones (+ 4); Thyroid Hormones (+ 10); Tretinoin Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (\  @55HHormone Antagonists D06.347 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones Hormones, Substitutes, Antagonists (Non MeSH) Aldosterone Antagonists (+ 3); Androgen Antagonists (+ 3); Bromocriptine; Estrogen Antagonists (+ 9); Insulin Antagonists; Methallibure; Mifepristone; Pituitary Hormone Release Inhibiting Hormones (+ 4); Thyroid Antagonists (+ 6); Tocolytic Agents (+ 10) Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. Hormones/antagonists and inhibitors (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (\| 6 5/3FHordeolum C01.252.354.400; C01.539.375.354.400; C11.294.354.400; C11.338.648 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial Eye Diseases; Eye Infections; Eye Infections, Bacterial Eye Diseases; Eyelid Diseases Purulent infection of one of the sebaceous glands of Zeis along the eyelid margin (external) or of the meibomian gland on the conjunctival side of the eyelid (internal). \ LP=Hookworm Infections C03.335.508.700.775.455 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections Ancylostomiasis; Necatoriasis Infection of humans or animals with hookworms other than those caused by the genus Ancylostoma or Necator, for which the specific terms ANCYLOSTOMIASIS and NECATORIASIS are available. ]Pv#Hoof and Claw A13.491 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Foot (66-67); specific animal ] :&Hong Kong Z01.252.474.363 EHEP Geographicals (Non MeSH); Asia; Far East ]b4Honey J01.341.544 AEANCLECHIMIPOPSRESDSNSTTOUTVI Bees Technology, Industry, Agriculture (Non MeSH); Food ] "=Honduras Z01.107.169.534 EHEP Geographicals (Non MeSH); America; Central America ] >Homozygote G05.441.554 Genetics; Genotype An individual in which both alleles at a given locus are identical. Genes (66-67); Genetics (66-67) ]S(Homovanillic Acid D02.241.223.601.521 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates ]:pHomosteroids D04.808.496 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Testolactone Steroids whose structure has been expanded by the addition of one or more carbon atoms to the ring skeleton in any of the four rings. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ]8(:Homosexuality, Male F01.145.792.320.390 EHGEHIPXSN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior; Homosexuality Sexual attraction or relationship between males. Homosexuality (66-94) ]cc:Homosexuality, Female F01.145.792.320.250 EHGEHIPXSN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior; Homosexuality Sexual attraction or relationship between females. Homosexuality (66-94) ] ~c<Homosexuality, Ego-Dystonic F03.709.597.608.480 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders Homosexuality characterized by the individual's desire to acquire or increase heterosexual arousal so that heterosexual relationships can be initiated and maintained. There is also a sustained pattern of homosexual arousal that the individual explicitly states has been unwanted and a persistent source of distress. Homosexuality (66-80) ]  F~lHomosexuality F01.145.792.320 EHGEHIPXSN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Homosexuality, Female; Homosexuality, Male Sexual attraction or relationship between members of the same sex. ] ER2PHomoserine Dehydrogenase D08.586.682.047.370 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases Aspartokinase Homoserine Dehydrogenase An enzyme that catalyzes the reduction of aspartic beta-semialdehyde to homoserine, which is the branch point in biosynthesis of methionine, lysine, threonine and leucine from aspartic acid. EC 1.1.1.3. Alcohol Oxidoreductases (73-74); Homoserine (73-74)  ]rFt,=Homoserine D12.125.526 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Amino Acids (66-70); Hydroxybutyrates (66-70) ]FH7Homogentisic Acid D02.241.223.601.421 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Phenylacetates (66-70) ]:pHomocystinuria C10.228.140.163.428; C10.496.363; C17.300.428; C18.452.648.066.470; F03.709.346.378 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cystathionine beta-Synthase Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Mental Retardation Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An inborn error of methionine metabolism characterized by elevated levels of homocystine in the plasma and urine and systemic abnormalities of the connective tissue. The predominant clinical feature is mental retardation. A deficiency in cystathionine synthase exists in the most common form of the disease. Amino Acid Metabolism, Inborn Errors (66); Mental Retardation (66)  ]_L fPHomocystine D12.125.095.533; D12.125.119.658; D12.125.166.554 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTU Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Aminobutyric Acids (66) ]9D&Homocysteine D12.125.166.498 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur S-Adenosylhomocysteine ]FaHomoarginine D12.125.095.104.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Arginine N-6-(Aminoiminomethyl)-lysine. Aminocaproic Acids (72-74); Guanidines (72-74) ]Fn%8Hominidae B02.649.801.400.350 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Anthropology Vertebrates; Mammals; Primates; Haplorhini Family of the suborder HAPLORHINI (Anthropoidea). It includes Homo sapiens (modern man), the only human species still in existence. Anthropoidea (81-88); Primates (68-88)  ] (4/Homicide I01.198.240.470 CLECEHHILJPCPXSNTD Death Social Sciences; Criminology; Crime Infanticide The killing of one person by another.  ]  ,0Homes for the Aged N02.278.825.462 CLECHILJMAOGSDSNSTTDUT Housing for the Elderly Aged; Housing for the Elderly Facilities, Manpower and Services (Non MeSH); Health Facilities; Residential Facilities Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.  ]^&gHomeostasis G07.621 DEGEIMPHRE Neuroimmunomodulation Physiology, General (Non MeSH) Acid-Base Equilibrium (+ 1); Body Temperature Regulation; Feedback; Water-Electrolyte Balance (+ 1) ] . %vHomeopathy E02.040.380 CLECEDHIISLJMAMTOGSNSTTD Formularies, Homeopathic; Pharmacopoeias, Homeopathic Therapeutics; Alternative Medicine A system of therapeutics founded by Samuel Hahnemann (1755-1843), in which diseases are treated by drugs which are capable of producing in healthy persons symptoms like those of the disease to be treated, the drug being administered in minute doses. (Dorland, 27th ed). ]!1=)?Homeodomain Proteins D12.776.260.400 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, Homeobox Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL). DNA-Binding Proteins (88-94)  ]#6D]S"Homemaker Services N02.421.143.524.595 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services Non-medical support services, such as food preparation and bathing, given by trained personnel to disabled, sick or convalescent individuals in their home. Home Care Services (66-72) ]%!Homeless Youth M01.325.400; M01.471.392.050.575; M01.471.392.492 CLEDEHHILJPXSN Named Groups (Non MeSH); Homeless Persons Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Adolescence Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child Runaway and homeless children and adolescents living on the streets of cities and having no fixed place of residence. Homeless Persons (87-94) ]'9Homeless Persons M01.325 CLEDHILJPXSN Transients and Migrants Named Groups (Non MeSH) Homeless Youth; Skid Row Alcoholics Persons who have no permanent residence. The concept excludes nomadic peoples. Transients and Migrants (66-85) CLEDEHHILJPXSN (]) ,^&Homebound Persons M01.276 CLEDHILJPXRHSN Frail Elderly Named Groups (Non MeSH) Those unable to leave home without exceptional effort and support; patients (in this condition) who are provided with or are eligible for home health services, including medical treatment and personal care. Persons are considered homebound even if they may be infrequently and briefly absent from home if these absences do not indicate an ability to receive health care in a professional's office or health care facility. (From Facts on File Dictionary of Health Care Management, 1988, p. 309). Disabled (83-94)  ]* DHome Range F01.145.113.646 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal Refers to the area about the animal's home which is traversed by the animal in its normal activities for food gathering, mating, and caring for young. Behavior, Animal (66-67) ]-VHome Nursing E02.472.611.470; N02.421.143.524.470; N02.421.533.320 CLECEDHILJMAMTOGPXSNSTTDUT Therapeutics; General Patient Care (Non MeSH); Nursing Care Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care  Respite Care Respite Care Nursing care given to an individual in the home. The care may be provided by a family member or a friend. Home nursing as care by a non-professional is differentiated from HOME CARE SERVICES provided by professionals: visiting nurse, home health agencies, hospital, or other organized community group. CLECEDHILJMAMTOGPXSDSNSTTDUT  ]/A=!!d Home Infusion Therapy E02.319.444; N02.421.143.524.436 AECLCTECHIISMOMTNUPXSNSTTDUTVE Parenteral Nutrition, Home Infusions, Parenteral Therapeutics; Drug Therapy Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services Use of any infusion therapy on an ambulatory, outpatient, or other non-institutionalized basis.  ]2&" pHome Health Aides M01.526.485.067.350; N02.360.067.350 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Persons who assist ill, elderly, or disabled persons in the home, carrying out personal care and housekeeping tasks. (From Slee and Slee, Health Care Terms. 2d ed, p. 202). Home Care Services (67-94); Nurses' Aides (66-94) ]4v*=Home Childbirth E04.819.774.457.450 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Midwifery Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery Childbirth taking place in the home. Delivery (66-82)  ]6$ l.Home Care Services, Hospital-Based N02.421.143.524.403 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services Hospital-sponsored provision of health services, such as nursing, therapy, and health-related homemaker or social services, in the patient's home. (Hospital Administration Terminology, 2d ed). Home Care Services (67-94) ]8#)!Home Care Services N02.421.143.524 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Hemodialysis, Home; Home Care Services, Hospital-Based; Home Infusion Therapy; Home Nursing (+ 1); Homemaker Services; Parenteral Nutrition, Home (+ 1) Community health and nursing services providing coordinated multiple service home care to the patient in his home. It includes services provided by a visiting nurse, home health agencies, hospitals, or other organized community groups. It differs from HOME NURSING in that it is given by professionals while HOME NURSING is provided by non-professionals. AECLCTECEDHIISLJMAMOMTNUOGPXRHSDSNSTTDUTVE  ]:$i.Home Care Agencies N03.540.483 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations Public or private organizations that provide, either directly or through arrangements with other organizations, home health services in the patient's home. (Hospital Administration Terminology, 2d ed). Home Care Services (78-94) ]=|F!Holtzman Inkblot Test F04.711.647.622.341.387 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Projective Techniques; Ink Blot Tests Personality evaluation based on the scoring of several variables as a result of the subject's responses in perceiving 47 inkblot plates. Ink Blot Tests (66-70) ]?0 Holothurin D09.203.408.782.350; D24.185.926.580.450 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Saponins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins A highly toxic saponin occurring in the tropical sea cucumber, Holothuriodeae, phylum Echinodermata. This marine toxin is an anionic surfactant, hemolyzing red blood corpuscles. It acts irreversibly to destroy the excitability at cholinergic neuromuscular junctions. Echinodermata (70-74); Saponins (70-74); Steroids (72-74); Toxins (70-74) ]@.D3ZHoloprosencephaly C10.500.410; C16.131.077.410; C16.131.280.400; C16.131.666.410 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH) Spectrum of craniofacial malformations resulting from the failure of the embryonic prosencephalon to undergo segmentation and cleavage. There are three types of malformations based on the degree of failure of separation of the prosencephalon: alobar, semilobar, and lobar. Concurrent facial anomalies can include cyclopia, cleft lip, cleft palate, and hypotelorism. Holoprosencephaly is thought to be a developmental field defect and is associated with chromosomal abnormalities. Abnormalities, Multiple (66-90); Brain/abnormalities (66-90) ]CHL'GHolography E01.357.710.450; H01.671.606.799.345 CLECEDHIISLJMAMTOGSNSTTDVE Lasers Diagnosis; Diagnostic Imaging; Photography Physical Sciences (Non MeSH); Physics; Optics; Photography The recording of images in three-dimensional form on a photographic film by exposing it to a laser beam reflected from the object under study. Lasers (66-68); Photography (66-68)  ]H* y,Holocaust I01.198.240.903.300; I01.880.735.944.903.300 CLECEHHILJPCPXSNTD Concentration Camps Social Sciences; Criminology; Crime; War Crimes Social Sciences; Sociology; Social Problems; War; War Crimes A massive slaughter, especially the systematic mass extermination of European Jews in Nazi concentration camps prior to and during World War II. ]J 2Holmium D01.268.558.250; D01.552.550.406 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Holmium. An element of the rare earth family of metals. It has the atomic symbol Ho, atomic number 67, and atomic weight 164.93. ]LM &:Holistic Health K01.752.667.710; N01.407.540.375 HI Humanities; Philosophy; Philosophy, Medical Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health Health as viewed from the perspective that man and other organisms function as complete, integrated units rather than as aggregates of separate parts. ]N&Holidays I03.450.345 CLHIPXSN Human Activities (Non MeSH); Leisure Activities Days commemorating events. Holidays also include vacation periods. ]O  :OHog Cholera Virus B04.820.250.700.400; B04.909.777.310.700.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Pestivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Pestivirus A species of the PESTIVIRUS genus causing exceedingly contagious and fatal hemorrhagic disease of swine. Hog Cholera (66-78); RNA Viruses (66-78) ]P~2{3Hog Cholera C02.782.350.675.553; C22.905.553 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Pestivirus Infections Animal Diseases; Swine Diseases An acute, highly contagious disease affecting swine of all ages and caused by the HOG CHOLERA VIRUS. It has a sudden onset with high morbidity and mortality. ]RO&JHoe 33258 D03.438.103.500; D21.201.287.278.455; D26.408.348.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents; Filaricides Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes 2-[2-(4-Hydroxyphenyl)-6-benzimidazolyl]-6-(1-methyl-4-piperazyl)-benzimidazole trihydrochloride. A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis. Benzimidazoles (71-76); Phenols (72-75); Piperazines (71-75) ]TE=:HIHodgkin's Disease C04.557.386.355; C15.604.515.569.355; C20.683.515.761.355 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Reed-Sternberg Cells Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue, and the presence of large, usually multinucleate, cells (REED-STERNBERG CELLS) of unknown origin. ]WAN%Hockey I03.450.642.845.475 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A game in which two parties of players provided with curved or hooked sticks seek to drive a ball or puck through opposite goals. This applies to either ice hockey or field hockey. Sports (66-75) ]Z RHock A13.473.345 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Hindlimb ]\+:+Hobbies I03.450.642.469 CLECHIPXSNTD Human Activities (Non MeSH); Leisure Activities; Recreation Leisure activities engaged in for pleasure. ]\ H5Hoarseness C08.360.940.490; C08.618.490; C09.400.940.490; C10.597.257.960.490; C23.888.592.257.960.490; C23.888.852.490 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases; Voice Disorders Respiratory Tract Diseases; Respiration Disorders Otorhinolaryngologic Diseases; Laryngeal Diseases; Voice Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Voice Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Voice Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) An unnaturally deep or rough quality of voice. ]]zNf:HN Protein D12.776.964.970.880.350; D24.611.216.327.461.350 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Hemagglutinins, Viral Glycoprotein from Sendai, para-influenza, Newcastle Disease, and other viruses that participates in binding the virus to cell-surface receptors. The HN protein possesses both hemagglutinin and neuraminidase activity. Hemagglutinins, Viral (72-89); Viral Envelope Proteins (86-89); Viral Proteins (72-85) ]a-66&gHLA-DR7 Antigen D24.611.216.301.500.410.400.440.475; D24.611.216.301.500.450.400.440.475; D24.611.216.705.552.410.400.440.475; D24.611.216.705.552.450.400.440.475 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is strongly associated with celiac disease and psoriasis vulgaris. Histocompatibility Antigens Class II (81-86); HLA Antigens (81-86); HLA-DR Antigens (86-89) ]dT6tmHLA-DR6 Antigen D24.611.216.301.500.410.400.440.470; D24.611.216.301.500.450.400.440.470; D24.611.216.705.552.410.400.440.470; D24.611.216.705.552.450.400.440.470 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. Histocompatibility Antigens Class II (81-86); HLA Antigens (78-86); HLA-DR Antigens (86-89) ]j6tmHLA-DR5 Antigen D24.611.216.301.500.410.400.440.465; D24.611.216.301.500.450.400.440.465; D24.611.216.705.552.410.400.440.465; D24.611.216.705.552.450.400.440.465 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D-locus on chromosome 6 and found on lymphoid cells. It is associated with Kaposi's sarcoma in AIDS and juvenile rheumatoid arthritis. Histocompatibility Antigens Class II (80-86); HLA Antigens (83-86); HLA-DR Antigens (86-89) ]o6tmHLA-DR4 Antigen D24.611.216.301.500.410.400.440.460; D24.611.216.301.500.450.400.440.460; D24.611.216.705.552.410.400.440.460; D24.611.216.705.552.450.400.440.460 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is strongly associated with rheumatoid arthritis and juvenile diabetes. Histocompatibility Antigens Class II (81-86); HLA Antigens (81-86); HLA-DR Antigens (86-89) ]uP6tmHLA-DR3 Antigen D24.611.216.301.500.410.400.440.455; D24.611.216.301.500.450.400.440.455; D24.611.216.705.552.410.400.440.455; D24.611.216.705.552.450.400.440.455 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is in linkage disequilibrium with HLA-A1 and HLA-B8. The HLA-DR3 antigen is strongly associated with celiac disease, Grave's disease, dermatitis herpetiformis, early-age onset myasthenia gravis, systemic lupus erythematosus, juvenile diabetes, and opportunistic infections in AIDS. Histocompatibility Antigens Class II (80-86); HLA Antigens (80-86); HLA-DR Antigens (86-89) ]{6tmHLA-DR2 Antigen D24.611.216.301.500.410.400.440.450; D24.611.216.301.500.450.400.440.450; D24.611.216.705.552.410.400.440.450; D24.611.216.705.552.450.400.440.450 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. It is in linkage disequilibrium with HLA-A3 and HLA-B7 and is strongly associated with Goodpasture's syndrome, multiple sclerosis, and narcolepsy. Histocompatibility Antigens Class II (80-86); HLA Antigens (80-86); HLA-DR Antigens (86-89) ]6t)mHLA-DR1 Antigen D24.611.216.301.500.410.400.440.445; D24.611.216.301.500.450.400.440.445; D24.611.216.705.552.410.400.440.445; D24.611.216.705.552.450.400.440.445 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens; HLA-DR Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens; HLA-DR Antigens Human immune-response, D-related antigen encoded by the D locus on chromosome 6 and found on lymphoid cells. Histocompatibility Antigens Class II (81-86); HLA-DR Antigens (86-89) ]6tRHLA-DR Antigens D24.611.216.301.500.410.400.440; D24.611.216.301.500.450.400.440; D24.611.216.705.552.410.400.440; D24.611.216.705.552.450.400.440 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens HLA-DR1 Antigen; HLA-DR2 Antigen; HLA-DR3 Antigen; HLA-DR4 Antigen; HLA-DR5 Antigen; HLA-DR6 Antigen; HLA-DR7 Antigen HLA-DR1 Antigen; HLA-DR2 Antigen; HLA-DR3 Antigen; HLA-DR4 Antigen; HLA-DR5 Antigen; HLA-DR6 Antigen; HLA-DR7 Antigen HLA-DR1 Antigen; HLA-DR2 Antigen; HLA-DR3 Antigen; HLA-DR4 Antigen; HLA-DR5 Antigen; HLA-DR6 Antigen; HLA-DR7 Antigen HLA-DR1 Antigen; HLA-DR2 Antigen; HLA-DR3 Antigen; HLA-DR4 Antigen; HLA-DR5 Antigen; HLA-DR6 Antigen; HLA-DR7 Antigen A group of D-related human leukocyte antigens that are polymorphic glycoproteins found on lymphoid cells. They consist of alpha and beta chains and their inheritance differs from that of the DQ and DP antigens; their presence seems to be associated with certain skin diseases like pemphigus vulgaris, dermatitis herpetiformis, and type I diabetes. Antigens, Immune Response (81-86)  ]26$*(HLA-DQ Antigens D24.611.216.301.500.410.400.430; D24.611.216.301.500.450.400.430; D24.611.216.705.552.410.400.430; D24.611.216.705.552.450.400.430 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens A group of the D-related HLA antigens found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. Antigens, Immune Response (81-86) ]?6$G(HLA-DP Antigens D24.611.216.301.500.410.400.420; D24.611.216.301.500.450.400.420; D24.611.216.705.552.410.400.420; D24.611.216.705.552.450.400.420 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II; HLA-D Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-D Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. Antigens, Immune Response (81-86) ]6$P(HLA-D Antigens D24.611.216.301.500.410.400; D24.611.216.301.500.450.400; D24.611.216.705.552.410.400; D24.611.216.705.552.450.400 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class II Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class II Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens HLA-DP Antigens; HLA-DQ Antigens; HLA-DR Antigens (+ 7) HLA-DP Antigens; HLA-DQ Antigens; HLA-DR Antigens (+ 7) HLA-DP Antigens; HLA-DQ Antigens; HLA-DR Antigens (+ 7) HLA-DP Antigens; HLA-DQ Antigens; HLA-DR Antigens (+ 7) Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, Immune Response (81-86)  ]h|6 (HLA-C Antigens D24.611.216.301.500.400.390; D24.611.216.301.500.450.390; D24.611.216.705.552.400.390; D24.611.216.705.552.450.390 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens Class I human histocompatibility (HLA) antigens encoded by a small cluster of structural genes at the C locus on chromosome 6. They have significantly lower immunogenicity than the HLA-A and -B determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations (e.g., spondylarthritis, psoriasis, multiple myeloma). HLA Antigens (77-88) ]a|6HLA-B8 Antigen D24.611.216.301.500.400.380.385; D24.611.216.301.500.450.380.385; D24.611.216.705.552.400.380.385; D24.611.216.705.552.450.380.385 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Human histocompatibility (HLA) surface antigen encoded by the B locus on chromosome 6. It is in linkage disequilibrium with HLA-A1 and HLA-DR3. This explains the fact that though HLA-B8 was originally associated with several diseases, including celiac disease, dermatitis herpetiformis, and myasthenia gravis, their association with HLA-DR3 is now considered more significant. HLA Antigens (75-88); HLA-B Antigens (89) ]!6"4HLA-B7 Antigen D24.611.216.301.500.400.380.383; D24.611.216.301.500.450.380.383; D24.611.216.705.552.400.380.383; D24.611.216.705.552.450.380.383 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Human histocompatibility (HLA) surface antigen encoded by the B locus on chromosome 6. There is a weak association between the presence of the HLA-B7 antigen and the diseases of narcolepsy and idiopathic hemochromatosis. HLA-B7 is in linkage disequilibrium with HLA-A3 and HLA-DR2. HLA Antigens (72-88); HLA-B Antigens (89) ]%6"I4HLA-B35 Antigen D24.611.216.301.500.400.380.388; D24.611.216.301.500.450.380.388; D24.611.216.705.552.400.380.388; D24.611.216.705.552.450.380.388 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Human histocompatibility (HLA) surface antigen encoded by the B locus on chromosome 6. It is weakly associated with a number of diseases. HLA Antigens (76-88); HLA-B Antigens (89) ]6"4HLA-B27 Antigen D24.611.216.301.500.400.380.387; D24.611.216.301.500.450.380.387; D24.611.216.705.552.400.380.387; D24.611.216.705.552.450.380.387 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-B Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-B Antigens Human histocompatibility (HLA) surface antigen encoded by the B locus on chromosome 6. It is strongly associated with acute anterior uveitis, ankylosing spondylitis, and Reiter's disease. HLA Antigens (75-88); HLA-B Antigens (89) ]6"4HLA-B Antigens D24.611.216.301.500.400.380; D24.611.216.301.500.450.380; D24.611.216.705.552.400.380; D24.611.216.705.552.450.380 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens HLA-B7 Antigen; HLA-B8 Antigen; HLA-B27 Antigen; HLA-B35 Antigen HLA-B7 Antigen; HLA-B8 Antigen; HLA-B27 Antigen; HLA-B35 Antigen HLA-B7 Antigen; HLA-B8 Antigen; HLA-B27 Antigen; HLA-B35 Antigen HLA-B7 Antigen; HLA-B8 Antigen; HLA-B27 Antigen; HLA-B35 Antigen Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Histocompatibility Antigens (75-81); HLA Antigens (75-88)  ]|62DHLA-A3 Antigen D24.611.216.301.500.400.370.376; D24.611.216.301.500.450.370.376; D24.611.216.705.552.400.370.376; D24.611.216.705.552.450.370.376 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-A Antigens Human histocompatibility (HLA) surface antigen encoded by the A locus on chromosome 6. The allele occurs with increased frequency in individuals with idiopathic hemochromatosis. HLA-A3 is in linkage disequilibrium with HLA-B7 and HLA-DR2. HLA Antigens (76-88); HLA-A Antigens (89) ]6"4HLA-A2 Antigen D24.611.216.301.500.400.370.374; D24.611.216.301.500.450.370.374; D24.611.216.705.552.400.370.374; D24.611.216.705.552.450.370.374 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-A Antigens Human histocompatibility (HLA) surface antigen encoded by the A locus on chromosome 6. The HLA-A2 antigen is associated with recognition of the influenza A virus. HLA Antigens (76-88); HLA-A Antigens (89) ]φ6"4HLA-A1 Antigen D24.611.216.301.500.400.370.372; D24.611.216.301.500.450.370.372; D24.611.216.705.552.400.370.372; D24.611.216.705.552.450.370.372 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I; HLA-A Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens; HLA-A Antigens Human histocompatibility (HLA) surface antigen encoded by the A locus on chromosome 6. Individuals bearing this allele are more susceptible to Hodgkin's disease. HLA-A1 is in linkage disequilibrium with HLA-B8 and HLA-DR3. HLA Antigens (77-88); HLA-A Antigens (89) ]Ԙ6"4HLA-A Antigens D24.611.216.301.500.400.370; D24.611.216.301.500.450.370; D24.611.216.705.552.400.370; D24.611.216.705.552.450.370 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; HLA Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; HLA Antigens HLA-A1 Antigen; HLA-A2 Antigen; HLA-A3 Antigen HLA-A1 Antigen; HLA-A2 Antigen; HLA-A3 Antigen HLA-A1 Antigen; HLA-A2 Antigen; HLA-A3 Antigen HLA-A1 Antigen; HLA-A2 Antigen; HLA-A3 Antigen Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Histocompatibility Antigens (75-80); HLA Antigens (75-88)  ]|6DHLA Antigens D24.611.216.301.500.450; D24.611.216.705.552.450 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens HLA-A Antigens (+ 3); HLA-B Antigens (+ 4); HLA-C Antigens; HLA-D Antigens (+ 10) HLA-A Antigens (+ 3); HLA-B Antigens (+ 4); HLA-C Antigens; HLA-D Antigens (+ 10) Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Histocompatibility (70-72); Histocompatibility Antigens (73-74)  ]f661>IHIV-2 B04.820.650.589.400.350.410; B04.909.777.731.589.400.350.410 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate; HIV Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate; HIV An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIV and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HIV (87-88) ] B=HIV-1 B04.820.650.589.400.350.400; B04.909.777.731.589.400.350.400 CHCLDEENGDGEIMIPMEPHPYREUL Acquired Immunodeficiency Syndrome Viruses; RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate; HIV Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate; HIV An HIV species widely recognized as the etiologic agent of acquired immunodeficiency syndrome (AIDS). It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. HIV (87-88)  ]` B(HIV Seroprevalence E05.318.760.500.875.250; G03.850.520.835.500.875.250; N05.715.360.775.175.275.375 TD HIV Seropositivity; Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cross-Sectional Studies Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cross-Sectional Studies Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cross-Sectional Studies Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY). Antibodies, Viral (83-87); HIV Seropositivity/epidemiology (88-89)  ]YV$NHIV Seropositivity C02.782.815.616.400.500; C20.673.480.500 BLCFCLCNCODIDTECEHENEPGEHIIMMEMIMONUPAPPPSPXRARHRITHTMURUSVEVI HIV Seronegativity; HIV Seroprevalence HIV Seronegativity; Acquired Immunodeficiency Syndrome Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections; HIV Infections Immunologic Diseases; Immunologic Deficiency Syndromes; HIV Infections Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). Acquired Immunodeficiency Syndrome (84-87); Antibodies, Viral (83-87); HTLV-III (87); Human T-Cell Leukemia Virus (84-86) $].B.?HIV Seronegativity G04.610.440 DEGEIMPHRE HIV Seropositivity HIV Seropositivity Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Immune status consisting of non-production of HIV antibodies, as determined by various serological tests. HIV Seropositivity (88-93) $]Q{ HIV Protease Inhibitors D08.373.745.420; D20.388.460 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Anti-Infective Agents; Antiviral Agents Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. Antiviral Agents (90-92); HIV Protease/antagonists and inhibitors (90-92) ]"8wWHIV Protease D08.586.277.656.732.066.340; D12.776.964.775.375.340; D12.776.964.970.850.375.340 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Aspartic Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, pol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins; Gene Products, pol Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. EC 3.4.23.-. Gene Products, pol (90); Peptide Peptidohydrolases (87-90) ]YDJFHIV Long Terminal Repeat G05.331.599.110.708.300; G06.184.599.110.708.300 DEGEIMPHRE Gene Products, nef; Gene Products, tat; Transcription Factor, Sp1 Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid HIV Enhancer HIV Enhancer Regulatory sequences important for viral replication that are located on each end of the HIV genome. The LTR includes the HIV ENHANCER, promoter, and other sequences. Specific regions in the LTR include the negative regulatory element (NRE), NF-kappa B binding sites , Sp1 binding sites, TATA BOX, and trans-acting responsive element (TAR). The binding of both cellular and viral proteins to these regions regulates HIV transcription. Repetitive Sequences, Nucleic Acid (86-90) $]6O= 2HIV Infections C02.782.815.616.400; C20.673.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Lymphoma, AIDS-Related Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections Immunologic Diseases; Immunologic Deficiency Syndromes Acquired Immunodeficiency Syndrome; AIDS-Associated Nephropathy; AIDS Dementia Complex; AIDS-Related Complex; AIDS-Related Opportunistic Infections; HIV Seropositivity Acquired Immunodeficiency Syndrome; AIDS-Associated Nephropathy; AIDS Dementia Complex; AIDS-Related Complex; AIDS-Related Opportunistic Infections; HIV Seropositivity Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). Acquired Immunodeficiency Syndrome (83-89); HIV Seropositivity (88-89) $]!&PzRHIV Envelope Protein gp41 D12.776.964.775.325.330; D12.776.964.970.880.325.330; D12.776.964.970.880.910.330; D24.611.216.327.520.330 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, env Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins; Gene Products, env Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins; Viral Fusion Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; HIV Antigens Transmembrane envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in cell fusion with the CD4 antigens of T4 lymphocytes, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by immunoblotting. Retroviridae Proteins (86-89); Viral Envelope Proteins (83-89) ^F t6hJHIV Envelope Protein gp120 D12.776.964.775.325.350; D12.776.964.970.880.325.350; D24.611.216.327.520.350 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Peptide T Receptors, HIV; Antigens, CD4 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, env Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins; Gene Products, env Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; HIV Antigens External envelope protein of the human immunodeficiency virus which is encoded by the HIV env gene. It has a molecular weight of 120,000 kD and contains numerous glycosylation sites. Gp120 binds to cells expressing CD4 cell-surface antigens, most notably T4-lymphocytes and monocytes/macrophages. Gp120 has been shown to interfere with the normal function of CD4 and is at least partly responsible for the cytopathic effect of HIV. Retroviridae Proteins (86-89); Viral Envelope Proteins (83-89) $^!U6%JHIV Enhancer G05.275.470.790.330.400; G05.331.599.110.689.330.400; G05.331.599.110.708.300.400; G06.184.599.110.689.330.400; G06.184.599.110.708.300.400 DEGEIMPHRE NF-kappa B Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid; Enhancer Elements (Genetics) Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid; Enhancer Elements (Genetics) Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid; HIV Long Terminal Repeat Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid; Enhancer Elements (Genetics) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Repetitive Sequences, Nucleic Acid; HIV Long Terminal Repeat Cis-acting regulatory sequences in the HIV long terminal repeat (LTR) which play a major role in induction or augmentation of HIV gene expression in response to environmental stimuli such as mitogens, phorbol esters, or other viruses. The HIV enhancer is the binding site for many cellular transcription factors including the nuclear factor NF-kappa B. Enhancer Elements (Genetics) (86-90)  ^ m+HIV Core Protein p24 D12.776.964.775.350.400; D12.776.964.970.850.350.400; D24.611.216.327.520.300 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, gag Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins; Gene Products, gag Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; HIV Antigens A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines. Antigens, Viral (85-91); Gene Products, gag (89-91); HIV Antigens (88-91); Retroviridae Proteins (85-91); Viral Core Proteins (85-91) ^U6HIV Antigens D24.611.216.327.520 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral HIV Core Protein p24; HIV Envelope Protein gp41; HIV Envelope Protein gp120 Antigens associated with specific proteins of the human adult T-cell immunodeficiency virus (HIV); also called HTLV-III-associated and lymphadenopathy-associated virus (LAV) antigens. Antigens, Viral (83-88); HIV/immunology (88); HTLV-III (87); Human T-Cell Leukemia Virus/immunology (84-87)  ^6{\HIV Antibodies D24.611.125.243.460.440 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR AIDS Serodiagnosis Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Viral; HTLV-BLV Antibodies Antibodies reactive with human immunodeficiency virus (HIV, previously called HTLV-III/LAV) antigens of AIDS. This includes HIV-1 antibodies and HIV-2 antibodies. Antibodies, Viral (86-88); HIV/immunology (88); HTLV-III/immunology (87); Human T-Cell Leukemia Virus/immunology (86-87)  ^P6HIV B04.820.650.589.400.350; B04.909.777.731.589.400.350 CHCLDEENGDGEIMIPMEPHPYREUL Receptors, HIV Viruses; RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Immunodeficiency Viruses, Primate HIV-1; HIV-2 HIV-1; HIV-2 Human immunodeficiency virus. The type species of LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME. Human T-Cell Leukemia Virus (84-86) $^:"+Histrionic Personality Disorder F03.709.597.357 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder characterized by overly reactive and intensely expressed or overly dramatic behavior, proneness to exaggeration, emotional excitability, and disturbances in interpersonal relationships. Hysteria (66-68) ^ %FcHistory of Nursing K01.419.608 Nursing Humanities; History ^" History of Medicine, 20th Cent. K01.419.552.550.484 Humanities; History; History of Medicine; History of Medicine, Modern ^# 'THistory of Medicine, 19th Cent. K01.419.552.550.451 Humanities; History; History of Medicine; History of Medicine, Modern ^#'THistory of Medicine, 18th Cent. K01.419.552.550.418 Humanities; History; History of Medicine; History of Medicine, Modern ^$c'THistory of Medicine, 17th Cent. K01.419.552.550.385 Humanities; History; History of Medicine; History of Medicine, Modern ^%'THistory of Medicine, 16th Cent. K01.419.552.291.750 Humanities; History; History of Medicine; History of Medicine, Early Modern ^%'[History of Medicine, 15th Cent. K01.419.552.291.500 Humanities; History; History of Medicine; History of Medicine, Early Modern ^&q'[History of Medicine, Modern K01.419.552.550 Humanities; History; History of Medicine History of Medicine, 17th Cent.; History of Medicine, 18th Cent.; History of Medicine, 19th Cent.; History of Medicine, 20th Cent. The period of the history of medicine from 1601 A.D. to the present. ^'%"2VHistory of Medicine, Medieval K01.419.552.287 Humanities; History; History of Medicine The period of the history of medicine from 500 through 1450 A.D. ^($2PHistory of Medicine, Early Modern K01.419.552.291 Humanities; History; History of Medicine History of Medicine, 15th Cent.; History of Medicine, 16th Cent. The period of the history of medicine from 1451 through 1600 A.D. HISTORY OF MEDICINE, 15TH CENT. and HISTORY OF MEDICINE, 16TH CENT. are also available. History of Medicine, Modern (66-94) ^)y)2N+History of Medicine, Ancient K01.419.552.285 Humanities; History; History of Medicine The period of the history of medicine before 500 A.D. ^+A#2CHistory of Medicine K01.419.552 Medicine Humanities; History History of Medicine, Ancient; History of Medicine, Medieval; History of Medicine, Early Modern (+ 2); History of Medicine, Modern (+ 4); Medicine, Arabic HI ^,  History of Dentistry K01.419.497 Dentistry Humanities; History ^-> History K01.419 Humanities Alchemy; Anniversaries and Special Events; Archives (+ 1); Emblems and Insignia; Genealogy and Heraldry; Historiography; History of Dentistry; History of Medicine (+ 11); History of Nursing; Phrenology CLHIIS ^-   Historiography K01.419.441 Humanities; History The writing of history; the principles, theory, and history of historical writing; the product of historical writing. (Webster, 3d ed). ^.Historical Geographicals (Non MeSH) Z01.586 Geographicals (Non MeSH) Ancient Lands (Non MeSH) (+ 5); Commonwealth of Independent States (+ 16); Czechoslovakia (+ 2); European Economic Community; Germany (+ 2); Middle East (+ 17); New Guinea; Russia (Pre-1917); USSR (+ 20); Yugoslavia (+ 4) ECEHEPHIOGSN ^/* Histoplasmosis C01.703.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Infecton resulting from inhalation or ingestion of spores of the fungus of the genus HISTOPLASMA, species H. capsulatum. It is worldwide in distribution and particularly common in the midwestern United States. (From Dorland, 27th ed). ^1P=Histoplasmin D24.611.216.202.386 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Fungal ^3i6|Histoplasma B05.354.381.546.440 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes ^4a"NHistones D12.776.660.470; D12.776.664.469 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. ^5 &FPHistone-Lysine Methyltransferase D08.586.913.517.610.395 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases; Protein Methyltransferases An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine. This enzyme is present in many organs, however, histones are a major substrate. It is localized exclusively in the nuclei. EC 2.1.1.43. Lysine (66-76); Methyltransferases (71-76); Proteins (66-76); specific protein (66-76) ^7%FOhHistone Deacetylase D08.586.277.087.520 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases Hydrolyzes N-acetyl groups on histones. Acetic Acids (71-74); Amidohydrolases (71-74); Histones (71-74) ^:Ff0MHistology, Comparative G01.100.656.469 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Anatomy; Histology ^<0Histology G01.100.656 CLECEDHIISLJMAOGSNSTTD Biological Sciences; Anatomy Histology, Comparative CLECEDHIISLJMAMTOGSNSTTD ^< #Histological Techniques E05.909.432 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical Autoradiography; Bone Demineralization Technique; Decalcification Technique; Histocytochemistry (+ 4); Histocytological Preparation Techniques (+ 22) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE ^=k C*Histocytological Preparation Techniques E05.909.262.620; E05.909.432.600 CLECHIISSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques Microtomy (+ 2); Replica Techniques (+ 3); Stains and Staining (+ 6); Tissue Embedding (+ 2); Tissue Preservation (+ 4) Microtomy (+ 2); Replica Techniques (+ 3); Stains and Staining (+ 6); Tissue Embedding (+ 2); Tissue Preservation (+ 4) Methods of preparing cells or tissues for examination and study of their origin, structure, function, or pathology. The methods include preservation, fixation, sectioning, staining, replica, or other technique to allow for viewing using a microscope. AECLCTECHIISMOMTNUPXSNSTTDUTVE  ^>-&*""Histocytochemistry E05.909.262.607; E05.909.432.551; G01.201.344 CLECEDHIISLJMAMTOGSNSTTD Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques Biological Sciences; Biochemistry Immunohistochemistry; Periodic Acid-Schiff Reaction; Prussian Blue Reaction Immunohistochemistry (+ 1); Periodic Acid-Schiff Reaction; Prussian Blue Reaction Immunohistochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE  ^B5*Histocompatibility Testing E01.223.495.468; E05.478.468 AECLCTECHIISMOMTNUPXSNSTTDUTVE Transplantation Immunology; Genetics; Transplantation Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques Blood Grouping and Crossmatching; Lymphocyte Culture Test, Mixed Lymphocyte Culture Test, Mixed Identification of the major histocompatibility antigens of transplant donors and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for histocompatibility antigens in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed). Transplantation Immunology (66-67) $^F "">o(Histocompatibility Antigens Class II D24.611.216.301.500.410; D24.611.216.705.552.410 ADANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigen-Presenting Cells; Interleukin-4 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens HLA-D Antigens (+ 10) HLA-D Antigens (+ 10) Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Histocompatibility Antigens (73-80); HLA Antigens (75-80); Isoantigens (73-80) ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR (^I+64.167]6Histocompatibility Antigens Class I D24.611.216.301.500.400; D24.611.216.705.552.400 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens H-2 Antigens; HLA-A Antigens (+ 3); HLA-B Antigens (+ 4); HLA-C Antigens H-2 Antigens; HLA-A Antigens (+ 3); HLA-B Antigens (+ 4); HLA-C Antigens Large transmembrane, polymorphic glycoproteins noncovalently associated with nonpolymorphic beta 2-microglobulin. In humans, three structural genes on chromosome 6 code for the HLA-A, HLA-B and HLA-C antigens. In mice, three genes named K, D, and L on chromosome 17 code for the H-2 antigens. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during graft rejection and restrict cell-mediated lysis of virus-infected cells. They are primarily associated with rheumatologic diseases and certain malignant disorders. Histocompatibility Antigens (73-88); HLA Antigens (78-88)  ^O*661DHistocompatibility Antigens D24.611.216.301.500; D24.611.216.705.552 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens Histocompatibility Antigens Class I (+ 11); Histocompatibility Antigens Class II (+ 11); HLA Antigens (+ 21); Minor Histocompatibility Antigens (+ 1) Histocompatibility Antigens Class I (+ 11); Histocompatibility Antigens Class II (+ 11); HLA Antigens (+ 21); Minor Histocompatibility Antigens (+ 1) A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Histocompatibility (70-72); Immunology (66-72); Transplantation (66-72); Transplantation Immunology (66-69)  ^U .6d}Histocompatibility G04.610.555.714.519 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular; Transplantation Immunology The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. Transplantation Immunology (66-67) ^Z(Histiocytosis, Sinus C15.604.667.400.410.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytosis, Non-Langerhans-Cell Benign, non-Langerhans-cell, histiocytic proliferative disorder that primarily affects the lymph nodes. It is often referred to as sinus histiocytosis with massive lymphadenopathy. Lymphatic Diseases (66-89); Reticuloendotheliosis (66-89) ^\BNCHistiocytosis, Non-Langerhans-Cell C15.604.667.400.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis Histiocytosis, Sinus; Niemann-Pick Disease; Sea-Blue Histiocyte Syndrome; Xanthogranuloma, Juvenile Group of disorders which feature accumulations of active histiocytes and lymphocytes, but where the histiocytes are not Langerhans cells. The group includes hemophagocytic lymphohistiocytosis, infection-associated hemophagocytic syndrome, sinus histiocytosis, xanthogranuloma, reticulohistiocytoma, juvenile xanthoma, xanthoma disseminatum, as well as the lipid storage diseases (sea-blue histiocyte syndrome and Niemann-Pick disease). Reticuloendotheliosis (66-89)  ^^'Nrr"Histiocytosis, Malignant C04.557.227.400; C04.557.386.345; C15.604.667.400.390.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Histiocytic Disorders, Malignant Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytic Disorders, Malignant A rare, usually rapidly progressive disorder, characterized by abrupt onset, fever, weight loss, hepato-splenomegaly, pancytopenia, and lymphadenopathy. Reticuloendotheliosis (66-86) ^b=ANB"Histiocytosis, Langerhans-Cell C08.381.483.375; C15.604.667.400.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis  Eosinophilic Granuloma; Hand-Schueller-Christian Syndrome; Letterer-Siwe Disease Group of disorders of histiocyte proliferation which includes LETTERER-SIWE DISEASE, HAND-SCHUELLER-CHRISTIAN SYNDROME, and EOSINOPHILIC GRANULOMA. Langerhans cells are components of the lesions. Reticuloendotheliosis (66-74)  ^e!#*N\"Histiocytosis C15.604.667.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis Histiocytic Disorders, Malignant (+ 4); Histiocytosis, Langerhans-Cell (+ 3); Histiocytosis, Non-Langerhans-Cell (+ 4) General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS CELL; and HISTIOCYTIC DISORDERS, MALIGNANT. BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI  ^hNaxRHistiocytoma, Fibrous C04.557.450.565.590.300.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Dermatofibroma A tumor composed, wholly or in part, of cells with the morphologic characteristics of histiocytes and with various fibroblastic components. There are many variants and many names. Superficially located histiocytic lesions behave benignly but deep, benign histiocytomas may invade locally into surrounding tissue. Fibrous histiocytomas can occur anywhere in the body. Superficial lesions are always cured by simple excision; a wider margin of tissue should be obtained for deep, benign types. Local recurrence is uncommon. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Dermatofibroma (68-93) ^kXXHistiocytic Disorders, Malignant C04.557.227; C15.604.667.400.390 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH) Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis Histiocytosis, Malignant; Leukemia, Monocytic, Acute; Lymphoma, Large-Cell (+ 1) Histiocytosis, Malignant; Leukemia, Monocytic, Acute; Lymphoma, Large-Cell (+ 1) Distinctive neoplastic disorders of histiocytes. Included are acute monocytic leukemias, malignant histiocytosis (HISTIOCYTOSIS, MALIGNANT), and true histiocytic lymphomas. BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI  ^o&&NRHistiocytes A11.329.372.385; A11.733.397.385; A15.382.680.397.385; A15.382.812.522.385 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Reticuloendothelial System Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages ^rT*,Histidyl T RNA Synthetase D08.586.464.136.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates histidine with its specific transfer RNA. EC 6.1.1.21. Amino Acyl T RNA Synthetases (72-74); Histidine (72-74) ^t Ft`DHistidinol-Phosphatase D08.586.277.352.650.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the hydrolysis of histidinol-phosphate to histidinol. One of the regulatory enzymes in histidine biosynthesis. EC 3.1.3.15. Amino Alcohols (72-74); Imidazoles (72-74); Phosphatases (73-74) ^vFNHistidinol D02.033.329.624.380; D02.092.063.624.380; D03.383.374.385 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles beta-Amino-1H-imidazole-4-propanol. The penultimate step in the pathway of histidine biosynthesis. Oxidation of the alcohol group on the side chain gives the acid group forming histidine. Histidinol has also been used as an inhibitor of protein synthesis. Amino Alcohols (72-74); Imidazoles (72-74) ^xA:*4Histidine Decarboxylase D08.586.520.258.390 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22. Carboxy-Lyases (73-74); Histidine (73-74) ^{Fa2Histidine D12.125.072.329; D12.125.142.308 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Methylhistidines ^} &FHistidase D08.586.520.161.468 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ammonia-Lyases An enzyme of the lyase class that catalyzes the reaction of L-histidine to form urocanate and ammonia. The reaction is the initial step of histidine catabolism. Genetic deficiency of the enzyme, transmitted as an autosomal recessive trait, causes histidinemia. (From Dorland, 27th ed) EC 4.3.1.3. ^^ Fa\Histamine Methyltransferase D08.586.913.517.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to histamine, forming N-methylhistamine, the major metabolite of histamine in man. EC 2.1.1.8. Histamine (73-74); Methyltransferases (73-74) ^ Fk6Histamine Liberation G04.610.431 DEGEIMPHRE Compound 48-80 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity ^QHistamine H2 Antagonists D14.100.375.425.425 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Ulcer Agents Anti-Ulcer Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists Burimamide; Cimetidine; Famotidine; Metiamide; Nizatidine; Ranitidine Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (^x4S:Histamine H1 Antagonists D14.100.375.425.400 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hypersensitivity, Immediate; Bronchodilator Agents Hypnotics and Sedatives Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists Antazoline; Astemizole; Brompheniramine; Cetirizine; Chlorpheniramine; Cinnarizine; Clemastine; Cyclizine; Cyproheptadine; Dimenhydrinate; Dimethindene; Diphenhydramine; Doxylamine; Hydroxyzine; Ketotifen; Loratadine; Meclizine; Methapyrilene; Pheniramine; Promethazine; Pyrilamine; Terfenadine; Tripelennamine; Triprolidine Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (^44:vt:Histamine Antagonists D14.100.375.425 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents Histamine H1 Antagonists (+ 24); Histamine H2 Antagonists (+ 6) Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Histamine H1 Receptor Blockaders (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $^4N0:Histamine Agonists D14.100.375.400 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents Betahistine; Betazole; Dimaprit; Impromidine; Tolazoline Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically. Receptors, Histamine/drug effects (75-92) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $^4D1:Histamine Agents D14.100.375 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Histamine Agonists (+ 5); Histamine Antagonists (+ 32) Drugs used for their actions on histaminergic systems. Included are drugs that act at histamine receptors, affect the life cycle of histamine, or affect the state of histaminergic cells. Histamine/pharmacology (66-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $^B4kC$:Histamine D02.092.211.215.501; D02.092.471.440; D03.383.374.373; D14.600.100.400; D17.350.050.300 AAADAEANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSTTOTUUR Hypersensitivity, Immediate; Receptors, Histamine Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines Organic Chemicals (Non MeSH); Amines; Ethylamines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids Methylhistamines Methylhistamines Methylhistamines 1H-Imidazole-4-ethanamine. A depressor amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSTTOTUUR $^ c<9:@Hispanic Americans I01.076.201.450.416.350; I01.880.143.522.350; M01.194.285 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups Mexican Americans Mexican Americans Mexican Americans Persons living in the United States of Mexican (MEXICAN AMERICANS), Puerto Rican, Cuban, Central or South American, or other Spanish culture or origin. The concept does not include Brazilian Americans or Portuguese Americans. Ethnic Groups (68-77); Mexico (66-77); Puerto Rico (66-77); United States (66-77); specific state (66-77)  ^HA>Hirudin D08.373.745.412; D19.461.119.071.510; D19.461.427.410; D24.310.300 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Antithrombins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents Immunologic and Biologic Factors (Non MeSH); Biological Products The active principle in the buccal gland secretion of leeches. It acts as an antithrombin and as an antithrombotic agent. ^l L@Hirsutism C17.800.805.305.470; C19.391.922.468 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypertrichosis Hypertrichosis; Hyperandrogenism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Virilism Excess hair in females and children with an adult male pattern of distribution. The concept does not include HYPERTRICHOSIS, which is localized or generalized excess hair.  ^Z *N&Hirschsprung Disease C06.175.439; C06.405.469.158.701.439; C16.131.314.439 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Megacolon Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Congenital megacolon due to absence of myenteric ganglion cells in a distal segment of the large intestine. Megacolon (66-82) ^=L=Hippurates D02.065.277.431; D02.241.223.106.162.431; D02.241.607.360 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids Aminohippuric Acids (+ 1); Iodohippuric Acid Aminohippuric Acids (+ 1); Iodohippuric Acid Aminohippuric Acids (+ 1); Iodohippuric Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ^gA8:Hippocratic Oath K01.316.333.366.551; K01.752.667.416.551; N05.350.340.500.425 Humanities; Ethics; Ethics, Professional; Ethics, Medical Humanities; Philosophy; Philosophy, Medical; Ethics, Medical Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional; Ethics, Medical ^EHippocampus A08.186.211.577.405 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Limbic System Pyramidal Cells ^M8JHippel-Lindau Disease C14.907.077.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Angiomatosis ^,NBHip Prosthesis E04.557.168.530.490; E04.659.550.490; E07.450.530.530; E07.858.442.499.490; E07.858.565.600.490 AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI Osseointegration Surgery, Operative; Orthopedics; Arthroplasty; Joint Prosthesis Surgery, Operative; Prosthesis; Joint Prosthesis Equipment and Supplies; Implants, Artificial; Joint Prosthesis Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Joint Prosthesis Equipment and Supplies; Surgical Equipment; Prosthesis; Joint Prosthesis Partial or total replacement of the hip joint. Arthroplasty (66-79); Hip (66-79); Hip Joint (66-79); Joint Prosthesis (71-79); Prosthesis (66-70)  ^k*~:yHip Joint A02.835.583.411 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints ^ 81Hip Fractures C21.866.405.207.425; C21.866.558.276.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Femoral Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries; Femoral Fractures Femoral Neck Fractures Femoral Neck Fractures Fractures of the femur head, the femur neck, the trochanters, or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region. For the fractures of the femur neck the specific term FEMORAL NECK FRACTURES is available. Femoral Fractures (66-77); Fractures (66-77)  ^.N6_6Hip Dysplasia, Canine C22.268.485 BLCFCICLCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Dog Diseases A hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age. Hip Dislocation, Congenital/veterinary (66-75) ^7H%6Hip Dislocation, Congenital C05.550.485; C05.660.449; C16.131.621.449 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Congenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males. ^!1LMHip Dislocation C21.866.289.384; C21.866.558.418 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Dislocations Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries ^&LHip Contracture C05.550.323.468; C05.651.197.468 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Contracture Musculoskeletal Diseases; Muscular Diseases; Contracture Permanent fixation of the hip in primary positions, with limited passive or active motion at the hip joint. Locomotion is difficult and pain is sometimes present when the hip is in motion. It may be caused by trauma, infection, or poliomyelitis. (From Current Medical Information and Technology, 5th ed). ^&NiHip A01.378.592.467 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Leg consider also terms at COX-. ^(5%Hinduism K01.844.231 HIPX Medicine, Ayurvedic Humanities; Religion A complex body of social, cultural, and religious beliefs and practices evolved in and largely confined to the Indian subcontinent and marked by a caste system, an outlook tending to view all forms and theories as aspects of one eternal being and truth, and the practice of the way of works, the way of knowledge, or the way of devotion as a means of release from the round of rebirths. (From Webster, 3d ed). Religion (66-94)  ^o Hindlimb A13.473 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Leg Animal Terms (Non MeSH) Hock; Stifle; Tarsus, Animal Extremities (66-67); Leg (66-67)  ^  :%)Higher Nervous Activity G11.561.353 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) ^hHigh-Frequency Ventilation E02.880.820.508 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy; Respiration, Artificial High-Frequency Jet Ventilation Ventilatory support system using frequencies from 60-900 cycles/min or more. Three types of systems have been distinguished on the basis of rates, volumes, and the system used. They are high frequency positive-pressure ventilation (HFPPV), HIGH-FREQUENCY JET VENTILATION (HFJV), and high-frequency oscillation (HFO). Respiration, Artificial (66-87)  ^"D$p%High-Frequency Jet Ventilation E02.880.820.508.510 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Respiratory Therapy; Respiration, Artificial; High-Frequency Ventilation Respiratory support system used primarily with rates of about 100 to 200/min with volumes of from about one to three times predicted anatomic dead space. Used to treat respiratory failure and maintain ventilation under severe circumstances. Respiration, Artificial (66-87) ^$"c%High Pressure Nervous Syndrome C10.228.470; C21.447.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases A syndrome of tremors, nausea, dizziness, and decreased motor and mental performance which develops in those who dive deeply (c. 1000 ft) usually breathing a mixture of oxygen and helium. Nitrogen is not a factor as it is in INERT GAS NARCOSIS. Atmospheric Pressure (66-85); Central Nervous System Diseases (66-85); Diving (66-85); Pressure (66-85); Syndrome (72-85) ^?%N#High Mobility Group Proteins D12.776.660.235.400; D12.776.664.235.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins; Chromosomal Proteins, Non-Histone Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Chromosomal Proteins, Non-Histone Ubiquitin Ubiquitin A group of non-histone proteins found in chromatin. Their role has not been definitely established, but they are believed to have a role in matrix stabilization, protection of single-stranded DNA, and are required for transcription. Chromosomal Proteins, Non-Histone (77-84); Nucleoproteins (66-81) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $^?#.FLHHierarchy, Social F01.145.843.551 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Dominance Social rank-order established by certain behavioral patterns. ^ʼVHHidrocystoma C04.557.470.035.175.375; C04.557.470.550.175.375 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Sweat Gland Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Adnexal and Skin Appendage (Non MeSH); Adenoma, Sweat Gland A cystic form of sweat gland adenoma (ADENOMA, SWEAT GLAND). It is produced by the cystic proliferation of apocrine secretory glands. It is not uncommon, occurring in adult life in no particular age group, with males and females equally affected. The commonest site is around the eye, particularly lateral to the outer canthus. It is cured by surgical removal. (Stedman, 25th ed; Rook et al., Textbook of Dermatology, 4th ed). Adenoma, Sweat Gland (73-89); Cystadenoma (71-93); Sweat Gland Neoplasms (71-93) ^ˢ6VHaHidradenitis Suppurativa C01.252.825.420; C01.539.800.720.420; C17.800.805.843.315.320; C17.800.838.765.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases; Hidradenitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident. Hormonal mechanisms are expected in its pathogenesis. Hidradenitis (92); Sweat Gland Diseases (76-91); Sweat Glands (66-75) ^ \NUHidradenitis C17.800.805.843.315 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases Hidradenitis Suppurativa The inflammation of a sweat gland (usually of the apocrine type). The condition can be idiopathic or occur as a result of or in association with another underlying condition. Neutrophilic eccrine hidradenitis is a relatively rare variant that has been reported in patients undergoing chemotherapy, usually for non-Hodgkin lymphomas or leukemic conditions. Sweat Glands (66-91); Sweat Gland Diseases (76-91)  ^\N>Hiccup C23.888.821.578 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) ^w NHibernation G07.062.592; G07.315.232.450 DEGEIMPHRE Physiology, General (Non MeSH); Adaptation, Physiological Physiology, General (Non MeSH); Body Temperature; Body Temperature Regulation The dormant state in which some animal species pass the winter. It is characterized by narcosis and by sharp reduction in body temperature and metabolic activity and by a depression of vital signs. It is a natural physiological process in many warm-blooded animals. ^ً":Hexylresorcinol D02.755.852.467; D21.201.287.382; D21.201.412.382; D20.187.482 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Resorcinols Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents Anti-Infective Agents; Anti-Infective Agents, Local ^H:Hexuronic Acids D02.241.081.844.915.400; D02.241.152.811.400; D02.241.511.902.915.400; D09.203.811.922.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Uronic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Aldehydic (Non MeSH); Uronic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Uronic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Uronic Acids Glucuronates; Iduronic Acid Glucuronates; Iduronic Acid Glucuronates; Iduronic Acid Glucuronates; Iduronic Acid Term used to designate tetrahydroxy aldehydic acids obtained by oxidation of hexose sugars, i.e. glucuronic acid, galacturonic acid, etc. Historically, the name hexuronic acid was originally given to ascorbic acid. Uronic Acids (71-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $^ݔd8:Hexosyltransferases D08.586.913.400.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases Fucosyltransferases; Galactosyltransferases (+ 3); Glucosyltransferases (+ 8); Glucuronosyltransferase; Mannosyltransferases Transferases (66-71) ^FmHexoses D09.203.546.359 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides Fructose; Fucose; Galactose; Glucose (+ 1); Mannose; Rhamnose; Sorbose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ^ B^YDHexosephosphates D09.203.894.417 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Fructosephosphates (+ 1); Galactosephosphates; Glucosephosphates; Hexosediphosphates (+ 1); Mannosephosphates ^.B`Hexosephosphate Uridylyltransferase D08.586.913.696.445.480 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases An enzyme that catalyzes the transfer of UMP from UDPglucose to galactose 1-phosphate, forming UDPgalactose and glucose 1-phosphate. Deficiency in this enzyme is the major cause of GALACTOSEMIA. EC 2.7.7.12. Galactose (70-74); Hexosephosphates (70-74); Nucleotidyltransferases (70-74); Uridine Diphosphate Sugars (70-74) ^(FHexosediphosphates D09.203.894.417.592 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates Fructosediphosphates Hexosephosphates (66-72) ^FBtHexosaminidases D08.586.277.450.483 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gangliosidoses Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases beta-N-Acetylhexosaminidase; Galactosaminidase; Glucosaminidase (+ 2) Enzymes that catalyze the hydrolysis of N-acylhexosamine residues in N-acylhexosamides. Hexosaminidases also act on glucosides, galactosides, and several oligosaccharides. Glycoside Hydrolases (66-70) $^FlO"Hexosamines D09.203.067.342 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars Galactosamine (+ 1); Glucosamine (+ 1); Meglumine (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ^B\GDHexoprenaline D02.092.471.683.530; D06.347.930.380; D14.100.050.100.200.400; D16.050.110.300; D16.050.870.300; D26.930.380 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents N,N'-Hexamethylenebis(2-amino-1-(3,4-dihydroxy-phenyl)ethanol). Stimulant of adrenergic beta 2 receptors. It is used as a bronchodilator, antiasthmatic agent, and tocolytic agent. Catechol (73-74); Ethanolamines (73-74); Phenethylamines (72-74) ^Hz:jMHexokinase D08.586.913.696.620.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes the conversion of ATP and a D-hexose to ADP and a D-hexose 6-phosphate. D-Glucose, D-mannose, D-fructose, sorbitol, and D-glucosamine can act as acceptors; ITP and dATP can act as donors. The liver isoenzyme has sometimes been called glucokinase. (From Enzyme Nomenclature, 1992) EC 2.7.1.1. ^FtHexobendine D02.241.223.106.490; D18.918.415 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Cardiovascular Agents; Vasodilator Agents N,N'-Dimethyl-N,N'-bis[3-(3,4,5-trimethoxybenzoyloxy) propyl]ethylenediamine. A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries. Without any effects on heart rate, blood pressure or cardiac output. Synonyms: Andiamine; Corimon; Ustinom. Benzoates (69-74); Ethylenediamines (71-74) ^_&:T4Hexobarbital D03.383.742.698.253.317; D14.100.240.500.350; D15.210.350.750.280; D15.325.850.280 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A barbiturate that is effective as a hypnotic and sedative. ^\:IHexetidine D03.383.742.279; D20.136.407; D20.187.464 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Anti-Infective Agents; Antifungal Agents Anti-Infective Agents; Anti-Infective Agents, Local ^ 1:Hexestrol D02.455.426.559.389.150.700.175.450; D06.597.378.359.275.450; D22.204.439 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes; Diethylstilbestrol Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Estrogens, Non-Steroidal; Diethylstilbestrol Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 4,4'-(1,2-Diethyl-1,2-ethanediyl)bis-phenol. A synthetic estrogen that has been used as a hormonal antineoplastic agent. ^c Q:Hexanones D02.522.520 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Methyl N-Butyl Ketone 6-carbon straight-chain or branched ketones. Ketones (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $^i 8/5:Hexanoic Acids D02.241.081.193.467; D02.241.081.465.326.467; D10.516.251.400.326.467 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Caproates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Caproates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Caproates Penicillic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR _M8Y:Hexanes D02.455.326.146.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Six-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Various polyneuropathies are caused by hexane poisoning. Alkanes (66-77); Hydrocarbons (66-77) _! 8g.Hexamethonium Compounds D02.092.102.558.592; D02.675.276.558.592; D18.162.419 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Methonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Methonium Compounds Cardiovascular Agents; Antihypertensive Agents Hexamethonium Hexamethonium Compounds containing the hexamethylenebis(trimethylammonium) cation. Members of this group frequently act as antihypertensive agents and selective ganglionic blocking agents. _=8!Hexamethonium D02.092.102.558.592.400; D02.675.276.558.592.500; D14.100.120.200.600.330; D16.050.340.380 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Methonium Compounds; Hexamethonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Methonium Compounds; Hexamethonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Blockers A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool. Hexamethonium Compounds (80-94) _}d8%Hexadimethrine D02.092.782.420; D19.461.270.546.350; D25.720.470 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Polyamines Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Heparin Antagonists Biomedical and Dental Materials (Non MeSH); Polymers N,N,N',N'-tetramethyl-1,6-hexanediamine polymer with 1,3-dibromopropane. Synthetic polymer which agglutinates red blood cells; used as a heparin antagonist. Synonym: Polybrene. Hydrocarbons, Brominated (74); Polyamines (72-74); Polymers (72-74) _ m9.QHexachlorophene D20.187.409 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Anti-Infective Agents, Local _!:<Hexachlorobenzene D05.723.288.440; D02.455.426.559.389.261.400; D02.455.526.439.202.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Chlorobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated; Chlorobenzenes An agricultural fungicide and seed treatment agent. Chlorobenzenes (74) _M:>Heterozygote Detection E05.393.450 ISMT Genetic Screening Miscellaneous Techniques (Non MeSH); Genetic Techniques Identification of genetic carriers for a given trait. Heterozygote (68-78)  _~BAHeterozygote G05.441.383 Genetics; Genotype An individual having different alleles at one or more loci in homologous chromosome segments. Genes (66-67); Genetics (66-67) _o(Heterophyidae B01.500.736.715.465 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda A family of intestinal flukes of the class Trematoda which occurs in animals and man. Some of the genera are Heterophyes, Metagonimus, Cryptocotyle, Stellantchasmus, and Euryhelmis. Trematoda (66-81) _~*=Heterocyclic Oxides D03.661 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds Cyclic N-Oxides (+ 3); Cyclic P-Oxides; Cyclic S-Oxides Oxides of a ring compound having atoms other than carbon in its ring. Heterocyclic Compounds (66-74); Oxides (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $_ 8EV8:Heterocyclic Cpds, 4 or More Rings (Non MeSH) D03.549 Heterocyclic Compounds Aporphines (+ 1); Berbines (+ 1); Cevanes (+ 4); Dihydro-beta-Erythroidine; Ergolines (+ 13); Morphinans (+ 23); Yohimbans (+ 5) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR _8 @Heterocyclic Cpds, 3-Ring (Non MeSH) D03.494 Heterocyclic Compounds Acridines (+ 13); Carbazoles (+ 1); Cinoxacin; Dibenzazepines (+ 9); Dibenzothiazepines; Dibenzothiepins (+ 2); Dibenzoxazepines (+ 3); Dibenzoxepins (+ 1); FK-506; Harmaline; Harmine; Ofloxacin; Phenanthridines (+ 2); Phenanthrolines; Phenazines (+ 4); Phenothiazines (+ 20); Xanthenes (+ 17) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR _2, fDHeterocyclic Cpds, 2-Ring (Non MeSH) D03.438 Heterocyclic Compounds Benzazepines (+ 27); Benzimidazoles (+ 13); Benzofurans (+ 3); Benzopyrans (+ 33); Benzothiadiazines (+ 8); Benzothiepins (+ 1); Benzoxazoles (+ 3); Benzoxepins; Indazoles (+ 2); Indoles (+ 39); Indolizines; Isoquinolines (+ 11); Naphthyridines (+ 2); Penicillanic Acid (+ 1); Pteridines (+ 11); Purines (+ 24); Quinazolines (+ 6); Quinolines (+ 36); Quinolizines (+ 2); Quinoxalines (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR _Q, FHeterocyclic Cpds, 1-Ring (Non MeSH) D03.383 Heterocyclic Compounds Azepines (+ 7); Azetines (+ 2); Azirines (+ 9); Azocines (+ 4); Azoles (+ 9); Dioxins (+ 2); Dioxoles (+ 3); Furans (+ 18); Imidazoles (+ 50); Lactams (+ 1); Oxathiins (+ 1); Oxazines (+ 7); Oxazoles (+ 17); Oxepins; Piperazines (+ 25); Piperidines (+ 46); Pyrans (+ 5); Pyrazines (+ 2); Pyrazoles (+ 16); Pyridazines (+ 7); Pyridines (+ 90); Pyrimidines (+ 48); Pyrroles (+ 6); Pyrrolidines (+ 23); Thiazines (+ 5); Thiazoles (+ 15); Thiepins (+ 1); Thiophenes (+ 11); Triazines (+ 8); Triazoles (+ 5) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR _, DHeterocyclic Cpds, Bridged-Ring (Non MeSH) D03.605 Heterocyclic Compounds Cyclazocine (+ 1); Morphinans (+ 23); Quinuclidines (+ 3); Tropanes (+ 10) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR _!42 _@Heterocyclic Compounds D03 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Acids, Heterocyclic (Non MeSH) (+ 38); Alkaloids (+ 135); Heterocyclic Cpds, 1-Ring (Non MeSH) (+ 473); Heterocyclic Cpds, 2-Ring (Non MeSH) (+ 244); Heterocyclic Cpds, 3-Ring (Non MeSH) (+ 89); Heterocyclic Cpds, 4 or More Rings (Non MeSH) (+ 54); Heterocyclic Cpds, Bridged-Ring (Non MeSH) (+ 41); Heterocyclic Oxides (+ 6) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR _"N8FHeterochromatin A11.223.349.383; D12.776.660.224.460; D12.776.664.224.466 CHCLDEENGEIMIPMEMIPAPHPSRARERISETRULUSVI Cells; Cell Nucleus; Chromatin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins; Chromatin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Chromatin That state of chromatin in which it is dark-staining and tightly coiled, forming irregular clumps (karyosomes) or Barr bodies in the nuclei of cells in interphase, or stains densely in certain areas of mitotic chromosomes. (Dorland, 27th ed). Chromosomes (66-67) _$A,Hesperomyinae B02.649.865.635.350 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae Peromyscus A subfamily of the Muridae consisting of 69 genera. New World mice and rats are included in this subfamily. Microtinae (82-90); Rats (66-81); Rodentia (66-81)  _'c(1?Hesperidin D09.203.408.134.466; D11.786.170.516 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Bioflavonoids Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Bioflavonoids 7-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D- glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4- methoxyphenyl)-4H-1-benzopyran-4-one. Predominant flavonoid in lemons and sweet oranges. _(*DHerpesvirus 7, Human B04.280.382.515; B04.909.204.382.515 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae A species of the family HERPESVIRIDAE isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human. Herpesviridae (90) _+*{Herpesvirus 6, Human B04.280.382.509; B04.909.204.382.509 CHCLDEENGDGEIMIPMEPHPYREUL Exanthema Subitum Viruses; DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae A species of the family HERPESVIRIDAE isolated from patients with AIDS and other lymphoproliferative disorders. It infects and replicates in fresh and established lines of hematopoietic cells and cells of neural origin. It also appears to alter NK cell activity. HHV-6 (HBLV) antibodies are elevated in patients with AIDS, Sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. HHV-6 is the cause of EXANTHEMA SUBITUM. Herpesviridae (86-89)  _,*{ Herpesvirus 4, Human B04.280.382.400.500.450; B04.909.204.210.400.500.400; B04.909.204.382.400.500.400; B04.909.574.204.500.500.400 CHCLDEENGDGEIMIPMEPHPYREUL Fatigue Syndrome, Chronic Viruses; DNA Viruses; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Gammaherpesvirinae; Lymphocryptovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Gammaherpesvirinae; Lymphocryptovirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Gammaherpesvirinae; Lymphocryptovirus A species of LYMPHOCRYPTOVIRUS cultivated from cultures of BURKITT'S LYMPHOMA. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS. specific disease/microbiology (66-68); Herpesviridae (66-68)  _0 xGHerpesvirus 3, Human B04.280.382.100.900.445; B04.909.204.382.100.900.445 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. _3:{Herpesvirus 3, Equid B04.280.382.100.900.440; B04.909.204.382.100.900.440 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS causing coital exanthema in horses. _5:LHerpesvirus 2, Saimirine B04.280.382.400.700.400; B04.909.204.210.400.700.400; B04.909.204.382.400.700.400; B04.909.574.204.500.700.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Gammaherpesvirinae; Rhadinovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Gammaherpesvirinae; Rhadinovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Gammaherpesvirinae; Rhadinovirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Gammaherpesvirinae; Rhadinovirus A species of RHADINOVIRUS isolated from squirrel monkeys. It produces malignant lymphomas in inoculated marmosets or owl monkeys. Herpesviridae (66-74) _7WxHerpesvirus 2, Human B04.280.382.100.750.440; B04.909.204.382.100.750.440 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Simplexvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Simplexvirus A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. Simplexvirus (66-93) _::Herpesvirus 2, Gallid B04.280.382.400.400; B04.909.204.210.400.400; B04.909.204.382.400.400; B04.909.574.204.500.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Gammaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Gammaherpesvirinae A species of an as yet unnamed genus in the subfamily GAMMAHERPESVIRINAE. It is the etiologic agent of a disease of domestic fowl and wild birds. Herpesviridae (66-74) _<hHerpesvirus 2, Bovine B04.280.382.100.750.400; B04.909.204.382.100.750.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Simplexvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Simplexvirus A species of SIMPLEXVIRUS causing mammillitis in cattle in Great Britain and South Africa. _?:lHerpesvirus 1, Suid B04.280.382.100.900.435; B04.909.204.382.100.900.435 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS producing a respiratory infection in swine, its natural host. It also produces an usually fatal encephalomyelitis in cattle, sheep, dogs, cats, foxes, and mink. Herpesviridae (66-74) _A:Herpesvirus 1, Ranid B04.280.382.500; B04.909.204.210.430; B04.909.204.382.500; B04.909.574.204.550 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses A species of the family HERPESVIRIDAE, whose genus is so far unnamed. It is probably the causative agent of adenoma or adenocarcinoma in the kidneys of certain frogs. _DX+Herpesvirus 1, Human B04.280.382.100.750.390; B04.909.204.382.100.750.390 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Simplexvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Simplexvirus The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions. Simplexvirus (66-93) _F:bHerpesvirus 1, Gallid B04.280.382.100.900.425; B04.909.204.382.100.900.425 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS found on every continent and affecting mainly chickens and occasionally pheasants. _I:Herpesvirus 1, Equid B04.280.382.100.900.420; B04.909.204.382.100.900.420 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS and the etiologic agent of a disease in horses causing abortion. It may also cause respiratory catarrh in young horses. _Kh:Herpesvirus 1, Cercopithecine B04.280.382.100.900.410; B04.909.204.382.100.900.410 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS that causes vesicular lesions of the mouth in monkeys. When the virus is transmitted to man it causes an acute encephalitis or encephalomyelitis, which is nearly always fatal. Herpesviridae (66-70) _Mx#:Herpesvirus 1, Canid B04.280.382.100.900.406; B04.909.204.382.100.900.406 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS virus that causes a disease in newborn puppies. _O:[Herpesvirus 1, Bovine B04.280.382.100.900.400; B04.909.204.382.100.900.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Alphaherpesvirinae; Varicellovirus A species of VARICELLOVIRUS that causes rhinotracheitis in cattle. _Q:OHerpesviridae Infections C02.256.466 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Burkitt's Lymphoma; Chickenpox; Cytomegalovirus Infections (+ 1); Exanthema Subitum; Herpes Simplex (+ 6); Herpes Zoster (+ 2); Infectious Bovine Rhinotracheitis; Infectious Mononucleosis; Malignant Catarrh; Marek's Disease; Pseudorabies; Pulmonary Adenomatosis, Ovine Virus diseases caused by the HERPESVIRIDAE. BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMULURUSVEVI  _SZP:;5THerpesviridae B04.280.382; B04.909.204.382 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Alphaherpesvirinae (+ 13); Betaherpesvirinae (+ 2); Gammaherpesvirinae (+ 5); Herpesvirus 1, Ranid; Herpesvirus 6, Human; Herpesvirus 7, Human Alphaherpesvirinae (+ 13); Betaherpesvirinae (+ 2); Gammaherpesvirinae (+ 5); Herpesvirus 1, Ranid; Herpesvirus 6, Human; Herpesvirus 7, Human A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. There are three subfamilies based on biological characteristics: ALPHAHERPESVIRINAE, BETAHERPESVIRINAE, and GAMMAHERPESVIRINAE. _U"YTHerpes Zoster Oticus C02.256.466.423.733; C09.218.513; C10.597.622.214.500; C10.772.204.266.297.296; C23.888.592.636.214.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Zoster Otorhinolaryngologic Diseases; Ear Diseases Nervous System Diseases; Neurologic Manifestations; Paralysis; Facial Paralysis Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Facial Nerve Diseases; Facial Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Facial Paralysis Herpes zoster involving the facial and auditory nerves associated with ipsilateral facial paralysis, usually transitory, and herpetic vesicles of the external ear or tympanic membrane, which also may or may not be associated with tinnitus, vertigo, and hearing disorders. (Dorland, 27th ed., p. 1642). Facial Paralysis (66-91); Herpes Zoster (66-91) _Y"sP_:Herpes Zoster Ophthalmicus C02.256.466.423.466; C02.325.450; C11.294.800.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Zoster Virus Diseases; Eye Infections, Viral Eye Diseases; Eye Infections; Eye Infections, Viral Virus infection of the Gasserian ganglion and its nerve branches characterized by pain and vesicular eruptions with much swelling. Ocular involvement is usually heralded by a vesicle on the tip of the nose. This area is innervated by the nasociliary nerve. _] 9P/Herpes Zoster C02.256.466.423 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Herpes Zoster Ophthalmicus; Herpes Zoster Oticus An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of chickenpox. It involves the sensory ganglia and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed). _`PX:Herpes Simplex Virus Protein Vmw65 D12.776.260.900.800.400; D12.776.930.900.400; D12.776.964.950.800.445 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins; Trans-Activators Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors; Trans-Activators Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins; Trans-Activators Trans-acting protein that combines with host factors to induce immediate early gene transcription in herpes simplex virus. Trans-Activators (91-92); Viral Proteins (84-90) _c*MH:Herpes Simplex C02.256.466.382; C02.825.320; C17.800.838.790.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Virus Diseases; Skin Diseases, Viral Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral Herpes Genitalis; Herpes Labialis; Kaposi's Varicelliform Eruption; Keratitis, Herpetic (+ 1); Stomatitis, Herpetic Herpes Labialis; Kaposi's Varicelliform Eruption Herpes Labialis; Kaposi's Varicelliform Eruption A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.). _g9PHerpes Labialis C02.256.466.382.316; C02.825.320.320; C07.465.409.466; C17.800.838.790.320.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Stomatitis, Herpetic Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Simplex Virus Diseases; Skin Diseases, Viral; Herpes Simplex Stomatognathic Diseases; Mouth Diseases; Lip Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral; Herpes Simplex Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares. (Dorland, 27th ed.). _kiXP|QHerpes Gestationis C13.703.320; C17.800.865.540 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous An itching polymorphous bullous eruption which occurs in pregnancy or the puerperium and which recurs in successive pregnancies. Dermatitis Herpetiformis (66-75) _o2"N&Herpes Genitalis C02.256.466.382.290; C02.800.801.500; C12.294.300; C13.371.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Herpes Simplex Virus Diseases; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Herpes simplex of the genitals. Genital Diseases, Female (66-81); Genital Diseases, Male (66-81); Herpes Simplex (66-81) _qoHP(jHerpangina C02.782.687.359.213.466 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections; Coxsackievirus Infections _tWPHeroin Dependence F03.709.597.780.660.400.110 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Dependence; Narcotic Dependence Strong dependence, both physiological and emotional, upon heroin. Diacetylmorphine (66-72); Morphine Dependence (66-72); Substance Dependence (66-72) _uDMbHernia, Ventral C06.405.396.897 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Hernia _wNGHernia, Umbilical C06.405.396.806; C16.614.390 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Beckwith-Wiedemann Syndrome Digestive System Diseases; Gastrointestinal Diseases; Hernia Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases The protrusion of part of the intestine at the umbilicus (Dorland, 27th ed). _x\"L ^Hernia, Obturator C06.405.396.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Hernia Hernia through the obturator foramen. _z!NG.Hernia, Inguinal C06.405.396.489 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Hernia _{0NGHernia, Hiatal C06.306.700.490; C06.405.396.216.467 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Hernia, Diaphragmatic Digestive System Diseases; Gastrointestinal Diseases; Hernia; Hernia, Diaphragmatic Herniation of the lower esophagus and/or portion of the stomach through the esophageal hiatus. _| *NqHernia, Femoral C06.405.396.342 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Hernia _}NGHernia, Diaphragmatic, Traumatic C06.306.700.245; C06.405.396.216.233; C21.866.017.258 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Hernia, Diaphragmatic Digestive System Diseases; Gastrointestinal Diseases; Hernia; Hernia, Diaphragmatic Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Abdominal Injuries Protrusion of some part of the abdominal or retroperitoneal structures through the diaphragm into the thorax, occurring as a result of injury, usually to the abdomen. (From Dorland, 27th ed). _~&=NHernia, Diaphragmatic C06.306.700; C06.405.396.216 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases Digestive System Diseases; Gastrointestinal Diseases; Hernia Hernia, Diaphragmatic, Traumatic; Hernia, Hiatal Hernia, Diaphragmatic, Traumatic; Hernia, Hiatal Protrusion of some part of the abdominal or retroperitoneal structures through the diaphragm into the thorax. (Dorland, 27th ed). _"N|pHernia C06.405.396; C23.592 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Trusses Digestive System Diseases; Gastrointestinal Diseases Symptoms and General Pathology (Non MeSH) Hernia, Diaphragmatic (+ 2); Hernia, Femoral; Hernia, Inguinal; Hernia, Obturator; Hernia, Umbilical; Hernia, Ventral Protrusion of a loop or knuckle of an organ or tissue through an abnormal opening.  _ N meHermaphroditism C12.740.700.842.316; C13.371.820.700.842.316; C16.131.939.842.316; C19.391.775.316 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders Pseudohermaphroditism Pseudohermaphroditism Pseudohermaphroditism Pseudohermaphroditism Originally, a state characterized by the presence of both male and female sex organs. In humans, true hermaphroditism is caused by anomalous differentiation of the gonads, with the presence of both ovarian and testicular tissue and of ambiguous morphologic criteria of sex. If only testicular tissue is present, but there are some female morphological criteria of sex, it is known as male PSEUDOHERMAPHRODITISM. If only ovarian tissue is present, but there are some male morphological criteria of sex, it is known as female PSEUDOHERMAPHRODITISM. (Dorland, 27th ed). _\L[^Hereditary Diseases C16.466 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Genetics, Medical Neonatal Diseases and Abnormalities (Non MeSH) Neoplastic Syndromes, Hereditary (+ 15) Genetics, Medical (66-67) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $_ J7/XHerbs B06.316; J01.341.241.310 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Medicine, Herbal Plants Technology, Industry, Agriculture (Non MeSH); Food; Condiments Chicory Chicory Any plant designated as herb by any source. Formerly the term designated those angiosperms that have little or no woody tissue and die at the end of the growing season, especially in the temperate zones where winter cold suspends plant growth. It includes also plants used for their aromatic, savory, or medicinal properties.  _ 4SHerbicides, Urea D05.723.366.506 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Diuron; Linuron Herbicides which owe their activity to the urea moiety in the molecule. Herbicides (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $_8TW:Herbicides, Triazine D05.723.366.477 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Atrazine; Prometryne; Simazine Herbicides which owe their activity to the triazine moiety in the molecule. Herbicides (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $_8T&[:Herbicides, Carbamate D05.723.366.448 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Chlorpropham; Triallate Herbicides which owe their activity to the carbamate moiety in the molecule. Herbicides (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $_\8T\:Herbicides D05.723.366 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Plants Environmental Pollutants, Pesticides (Non MeSH); Pesticides Amitrole; Cacodylic Acid; Defoliants, Chemical; Dicamba; 2,4-Dichlorophenoxyacetic Acid; Diquat; Herbicides, Carbamate (+ 2); Herbicides, Triazine (+ 3); Herbicides, Urea (+ 2); Maleic Hydrazide; MCPA; 1-Methyl-4-phenylpyridinium; Paraquat; Pentachlorophenol; Picloram; Propanil; 2,4,5-Trichlorophenoxyacetic Acid; Trifluralin Pesticides used to destroy unwanted vegetation, especially various types of weeds, grasses, and woody plants. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $_8 F}:Heptoses D09.203.546.286 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides Mannoheptulose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR _ B^DHeptanoic Acids D02.241.081.407.380; D10.516.251.450 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Heptanoates Heptanoates 7-carbon saturated monocarboxylic acids. Fatty Acids (66-74)  _U*80Heptanoates D02.241.081.407.380.350; D10.516.251.450.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Heptanoic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Heptanoic Acids Salts and esters of the 7-carbon saturated monocarboxylic acid heptanoic acid. Fatty Acids (69-74) _28]Heptanes D02.455.326.146.485 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Seven-carbon saturated hydrocarbon group of the methane series. Include isomers and derivatives. Alkanes (66-77); Hydrocarbons (66-77) _ 8gq.Heptaminol D02.033.329.350; D02.092.063.350; D16.050.870.270; D18.222.863.433 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols Organic Chemicals (Non MeSH); Amines; Amino Alcohols Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism. Alcohols, Octyl (73-75); Amino Alcohols (69-75) _L:!~:Heptachlor Epoxide D05.723.491.491.545.465 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine; Heptachlor _:Heptachlor D02.455.526.439.516; D05.723.491.491.545 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine  Heptachlor Epoxide Insecticides (66-70) _-.:HEPES D02.455.326.146.100.250; D02.886.645.600.055.250; D03.383.606.500; D26.172.400 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Miscellaneous Drugs and Agents (Non MeSH); Buffers 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid. A dipolar ionic buffer. Alcohol, Ethyl (71-74); Alkyl Sulfonates (74); Piperazines (70-74) _ X.XQHepatovirus B04.450.420; B04.820.565.400; B04.909.777.618.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Hepatitis Viruses Viruses; RNA Viruses; Picornaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae Hepatitis A Virus, Human Hepatitis A Virus, Human Hepatitis A Virus, Human A genus of PICORNAVIRIDAE causing infectious hepatitis naturally in humans and experimentally in other primates. It is transmitted through fecal contamination of food or water. _9YHepatorenal Syndrome C06.552.465; C12.777.419.291 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Renal failure in those with liver disease, usually liver cirrhosis or obstructive jaundice. Historically called Heyd disease, urohepatic syndrome, or bile nephrosis. Kidney Diseases (66-86); Kidney Failure, Acute (67-86); Kidney Failure, Chronic (66-86); Liver Cirrhosis (66-86); Liver Diseases (66-86); Syndrome (72-86) _""NHepatomegaly C06.552.446 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Enlargement of the liver. _N2!Hepatolenticular Degeneration C06.552.413; C10.228.140.079.501; C10.228.140.163.381; C18.452.648.618.403 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors Autosomal recessive inborn error of metabolism involving the transport and storage of copper in the body. _"TL}Hepatocyte Growth Factor D11.303.475; D24.185.348.475 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Multifunctional growth factor which regulates both cell growth and cell motility. It exerts a strong mitogenic effect on hepatocytes and primary epithelial cells. Its receptor is the proto-oncogene protein c-met. Blood Proteins (84-91); Growth Substances (92) _"D9Hepatoblastoma C04.557.435.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed). Carcinoma, Hepatocellular (66-93) _UXn'Hepatitis, Viral, Human C02.440; C06.552.380.705 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Digestive System Diseases; Liver Diseases; Hepatitis Delta Infection; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis, Chronic Active; Hepatitis E Delta Infection; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis, Chronic Active; Hepatitis E Viral hepatitis in man. Hepatitis A (66-76)  _PPHepatitis, Viral, Animal C02.407; C06.552.380.315.430; C22.467.435 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Animal Animal Diseases; Hepatitis, Animal Hepatitis, Infectious Canine; Rift Valley Fever Hepatitis, Infectious Canine; Rift Valley Fever Hepatitis, Infectious Canine; Rift Valley Fever Viral hepatitis in animals. Hepatitis, Animal (66-76) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $_1J#PHepatitis, Toxic C06.552.380.615; C21.613.512 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Hepatitis Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Hepatitis caused by true hepatotoxins and drugs which induce a hypersensitivity reaction. _1"LiHepatitis, Infectious Canine C02.256.076.381; C02.407.432; C06.552.380.315.430.440; C22.268.465; C22.467.435.442 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Adenoviridae Infections Virus Diseases; Hepatitis, Viral, Animal Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Animal; Hepatitis, Viral, Animal Animal Diseases; Dog Diseases Animal Diseases; Hepatitis, Animal; Hepatitis, Viral, Animal An adenovirus infection causing fever, edema, vomiting, and diarrhea in dogs, especially puppies. In foxes it causes acute encephalitis with convulsions, paralysis, coma, and death. Hepatitis, Animal (66-70) _"_J`Hepatitis, Chronic Active C02.440.460; C06.552.380.705.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Virus Diseases; Hepatitis, Viral, Human Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Viral, Human A continuing inflammatory lesion of the liver with a potential to progress to a more severe disease, including cirrhosis, to continue unchanged or to subside (spontaneously or with treatment). Most patients have a history of viral hepatitis. Hepatitis (66-82); Hepatitis B (66-82) _&N0Hepatitis, Animal C06.552.380.315; C22.467 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Digestive System Diseases; Liver Diseases; Hepatitis Animal Diseases Hepatitis, Viral, Animal (+ 2) Hepatitis, Viral, Animal (+ 2) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI _JQJPHepatitis, Alcoholic C06.552.380.290; C06.552.645.490; C21.613.053.270.645.490 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Hepatitis Digestive System Diseases; Liver Diseases; Liver Diseases, Alcoholic Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism; Liver Diseases, Alcoholic An acute or chronic degenerative and inflammatory lesion of the liver in the alcoholic which is potentially progressive or reversible; it does not necessarily include steatosis, fibrosis, or cirrhosis of alcoholics, although it is frequently associated with these conditions. Alcoholism (66-77); Hepatitis (66-77); Hepatitis, Toxic (66-77) _&AL?MHepatitis Viruses B04.450 CHCLDEENGDGEIMIPMEPHPYREUL Viruses Adenoviruses, Canine; Delta Agent; Gastroenteritis Virus, Murine; Hepadnaviridae (+ 5); Hepatitis C Viruses; Hepatitis E Virus; Hepatovirus (+ 1) Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals. _Ƙ  Hepatitis Virus, Woodchuck B04.280.375.650.460; B04.450.390.650.460; B04.909.204.340.650.460 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Hepadnaviridae; Orthohepadnavirus Viruses; Hepatitis Viruses; Hepadnaviridae; Orthohepadnavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Hepadnaviridae; Orthohepadnavirus An ORTHOHEPADNAVIRUS causing chronic liver disease and hepatocellular carcinoma in woodchucks. It closely resembles the human hepatitis B virus. Hepatitis Viruses (79-93) _[ IHepatitis Virus, Duck B04.909.777.618.284.660 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus An enterovirus with high mortality that attacks ducklings 3 days to 3 weeks old. _ʾabHepatitis E Virus B04.450.412; B04.820.095.500; B04.909.777.162.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Hepatitis Viruses Viruses; RNA Viruses; Caliciviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Caliciviridae A positive-stranded RNA virus causing enterically-transmitted non-A, non-B hepatitis (HEPATITIS E). The morphological and physiochemical properties suggest that it is a member of the calicivirus family (CALICIVIRIDAE). Hepatitis Viruses (90-91) _9Hepatitis E C02.440.470; C02.782.160.470; C06.552.380.705.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Hepatitis, Viral, Human Virus Diseases; RNA Virus Infections (Non MeSH); Caliciviridae Infections Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Viral, Human An acute form of hepatitis caused by a virus serologically distinct from the agents of hepatitis A, B, and C. Hepatitis E is associated with fecally-contaminated water, is enterically transmitted, and is commonly found in tropical or subtropical countries. Hepatitis, Viral, Human (90-91) _B9P+&Hepatitis C Viruses B04.450.410; B04.820.250.475; B04.909.777.310.475 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Hepatitis Viruses Viruses; RNA Viruses; Flaviviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae A genus of FLAVIVIRIDAE causing parenterally-transmitted non-A, non-B hepatitis (HEPATITIS C) which is associated with transfusions and drug abuse. Hepatitis Viruses (88-90) _39Hepatitis C C02.440.440; C02.782.350.350; C06.552.380.705.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Hepatitis, Viral, Human Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Viral, Human A form of hepatitis, similar to type B post-transfusion hepatitis, but caused by a virus which is serologically distinct from the agents of hepatitis A, B, and E, and which may persist in the blood of chronic asymptomatic carriers. Hepatitis C is parenterally transmitted and associated with transfusions and drug abuse. Hepatitis (72-79); Hepatitis, Viral, Human (77-79) _+9Px=Hepatitis B Virus, Duck B04.280.375.100.450; B04.450.390.100.450; B04.909.204.340.100.450 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Hepadnaviridae; Avihepadnavirus Viruses; Hepatitis Viruses; Hepadnaviridae; Avihepadnavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Hepadnaviridae; Avihepadnavirus A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks. Hepatitis B Virus (81-89) _I Hepatitis B Virus B04.280.375.650.425; B04.450.390.650.425; B04.909.204.340.650.425 CHCLDEENGDGEIMIPMEPHPYREUL Hepatitis B Surface Antigens Viruses; DNA Viruses; Hepadnaviridae; Orthohepadnavirus Viruses; Hepatitis Viruses; Hepadnaviridae; Orthohepadnavirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Hepadnaviridae; Orthohepadnavirus The type species of the genus ORTHOHEPADNAVIRUS which causes human hepatitis B and is also apparently a causal agent in human hepatocellular carcinoma. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. _عI#cHepatitis B Vaccines D24.310.894.899.955.400 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines; Viral Hepatitis Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Viral Hepatitis Vaccines (85-92); Viral Vaccines (82-84) _>DHepatitis B Surface Antigens D24.611.216.327.500.475 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Hepatitis B Virus Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Hepatitis B Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles; several subspecificities of the surface antigen are known; formerly called the Australia antigen. Hepatitis B Antigens (73-77); Hepatitis B Virus (70-72)  _ #6DHepatitis B e Antigens D24.611.216.327.500.469 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Hepatitis B Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. Hepatitis B Antigens (73-80); Hepatitis B Virus (66-72) _64DHepatitis B Core Antigens D24.611.216.327.500.450 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Hepatitis B Antigens The hepatitis B antigen within the core of the Dane particle. Hepatitis B Antigens (73-76); Hepatitis B Virus (70-72) _= 6LDHepatitis B Antigens D24.611.216.327.500 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens Antigens of the virion of Hepatitis B or the Dane particle, its surface, core and other associated antigens, like the "e" antigen. Hepatitis B Virus (66-72)  _6{` Hepatitis B Antibodies D24.611.125.243.450.504 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Viral; Hepatitis Antibodies Antibodies to the hepatitis B antigens, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Hepatitis B (66); Hepatitis B Virus (67-72); Immune Sera (66-72) _#6QHepatitis B C02.256.430.400; C02.440.435; C06.552.380.705.437 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Hepadnaviridae Infections Virus Diseases; Hepatitis, Viral, Human Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Viral, Human Hepatitis caused by hepatitis B virus. It may be transmitted by transfusion of contaminated blood or blood products. _P9PHepatitis Antibodies D24.611.125.243.450 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Viral Hepatitis B Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Viral (73-84)  _x6Hepatitis A Virus, Human B04.450.420.400; B04.820.565.400.400; B04.909.777.618.400.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Hepatitis Viruses; Hepatovirus Viruses; RNA Viruses; Picornaviridae; Hepatovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Hepatovirus The type species of HEPATOVIRUS which causes human hepatitis A. The virus replicates in hepatocytes and is presumed to reach the intestine via the bile duct. Transmission occurs by the fecal-oral route. Hepatovirus (66-93) _aEHepatitis A C02.440.420; C02.782.687.359.500; C06.552.380.705.422 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Hepatitis, Viral, Human Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Viral, Human Hepatitis caused by HEPATOVIRUS. It can be transmitted through fecal contamination of food or water. _=PxHepatitis C06.552.380 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Digestive System Diseases; Liver Diseases Hepatitis, Alcoholic; Hepatitis, Animal (+ 3); Hepatitis, Toxic; Hepatitis, Viral, Human (+ 6) Inflammation of the liver and liver disease involving degenerative or necrotic alterations of hepatocytes. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  _ J2r|PHepatic Veno-Occlusive Disease C06.552.360; C14.907.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hepatic Vein Thrombosis Digestive System Diseases; Liver Diseases Cardiovascular Diseases; Vascular Diseases Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis. Hepatic Vein Thrombosis (66-86); Hepatic Veins (66-86); Liver/blood supply (66-86)  _$NbdHepatic Veins A07.231.908.380 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Liver Circulation Cardiovascular System; Blood Vessels; Veins Veins which drain the liver. _A85%Hepatic Vein Thrombosis C06.552.347; C14.907.355.830.381 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hepatic Veno-Occlusive Disease Digestive System Diseases; Liver Diseases Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis Occlusion of the hepatic veins caused by thrombi or fibrous obliteration of the veins. _5&N$hHepatic Encephalopathy C06.552.680.356; C10.228.140.163.356 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Liver Failure Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic All stages in the onset and development of coma (prodrome, impending coma, stupor, and coma) occurring in advanced liver disease. _*NHepatic Duct, Common A03.159.183.079.600 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Biliary Tract; Bile Ducts; Bile Ducts, Extrahepatic Predominantly extrahepatic bile duct which is formed by the junction of the right and left hepatic ducts, which are predominantly intrahepatic, and, in turn, joins the cystic duct to form the common bile duct. _:THepatic Artery A07.231.114.407 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Liver Circulation Cardiovascular System; Blood Vessels; Arteries A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. _88Hepatectomy E04.765.556 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Liver Regeneration Liver Surgery, Operative; Surgery, Digestive System (Non MeSH) _W$ CHeparitin Sulfate D09.203.698.373.425 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans Heparitin, sulfate. A glycosaminoglycan occurring in the liver, aorta, and lung. It has a structure similar to heparin, but there are more N-acetyl groups and fewer O- and N-sulfate groups. It is an accumulation product in several mucopolysaccharidoses. (Dorland, 27th ed). Mucopolysaccharides (66-71) _#FtC Heparinoid D19.461.119.463 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants `:nHeparin, Low-Molecular-Weight D09.203.698.373.400.300; D19.461.119.380.300; D19.461.427.400.300 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans; Heparin Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Heparin Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Heparin Enoxaparin; Nadroparin; Tedelparin Enoxaparin; Nadroparin; Tedelparin Enoxaparin; Nadroparin; Tedelparin Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Heparin (66-87)  `|"IFszHeparin Cofactor II D08.373.745.800.810.230.400; D12.776.124.790.106.450; D12.776.377.715.085.450; D19.461.119.071.500 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins; Antithrombins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Antithrombins A sulfated plasma protein with the MW of approximately 66kDa. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Antithrombins (66-89); Glycoproteins (66-89) `-lD5Heparin Antagonists D19.461.270.546 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants Hexadimethrine; Protamines; Tolonium Chloride; Vitamin K (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ` _6jLHHeparin D09.203.698.373.400; D19.461.119.380; D19.461.427.400 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents Heparin, Low-Molecular-Weight (+ 3) Heparin, Low-Molecular-Weight (+ 3) Heparin, Low-Molecular-Weight (+ 3) Heparinic acid. A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  `  =DRzFHepadnaviridae Infections C02.256.430 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Hepatitis B Virus diseases caused by the HEPADNAVIRIDAE. `P:6Hepadnaviridae B04.280.375; B04.450.390; B04.909.204.340 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Hepatitis Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Avihepadnavirus (+ 1); Orthohepadnavirus (+ 2) Avihepadnavirus (+ 1); Orthohepadnavirus (+ 2) Avihepadnavirus (+ 1); Orthohepadnavirus (+ 2) A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus (HEPATITIS VIRUS, WOODCHUCK). Hepatitis B Virus (82-89)  `1x Hempa D02.705.320; D05.723.141.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Chemosterilants Hexamethylphosphoric triamide. Chemosterilant. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck, 11th ed). Dimethylamines (72-74); Organophosphorus Compounds(72-74) `G ":CHemothorax C08.528.380; C23.542.572 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Pleural Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage  Hemopneumothorax A collection of blood in the pleural cavity. (Dorland, 27th ed). `NtQHemostatics D19.461.270.463 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Blood Coagulation Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants Antifibrinolytic Agents (+ 3); Calcium Dobesilate; Cellulose, Oxidized; Ethamsylate; Fibrin (+ 2); Fibrinogen (+ 1); Gelatin Sponge, Absorbable; Thrombin; Thromboplastin Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $`8jHHemostatic Techniques E02.520 AECLCTECHIISMONUPXSNSTTDUTVE Therapeutics Embolization, Therapeutic (+ 1); Hemostasis, Endoscopic; Hemostasis, Surgical Techniques for controlling bleeding. Hemostasis (66-75) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE $`  [,$Hemostasis, Surgical E02.520.490; E04.350 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Blood Loss, Surgical Therapeutics; Hemostatic Techniques Surgery, Operative Control of bleeding during or after surgery. Hemostasis (66-75)  `D$?7Hemostasis, Endoscopic E02.520.425 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Gastrointestinal Hemorrhage Therapeutics; Hemostatic Techniques Control of bleeding performed through the channel of the endoscope. Techniques include use of lasers, heater probes, bipolar electrocoagulation, and local injection. Endoscopic hemostasis is commonly used to treat bleeding esophageal and gastrointestinal varices and ulcers. Gastrointestinal Hemorrhage/surgery (76-91); Hemostasis, Surgical (85-91); Hemostatic Techniques (76-91)  ` m$ *<yHemostasis G09.188.560 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Blood Coagulation (+ 1); Platelet Activation (+ 2) The process which spontaneously arrests the flow of blood from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements, and the process of blood or plasma coagulation. `"Y?%Hemosiderosis C23.566 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Siderosis Symptoms and General Pathology (Non MeSH) Conditions in which there is a generalized increase in the iron stores of body tissues, particularly of liver and the reticuloendothelial system, without demonstrable tissue damage. `$ N 2Hemosiderin D12.776.556.526 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Siderosis Iron Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins `&F WHemorrhoids C06.405.469.860.401; C14.907.449 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Cardiovascular Diseases; Vascular Diseases Varicosities of the hemorrhoidal venous plexuses. `'&N;Hemorrhagic Fevers, Viral C02.782.417 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Dengue; Hemorrhagic Fever, American; Hemorrhagic Fever, Crimean; Hemorrhagic Fever, Omsk; Hemorrhagic Fever with Renal Syndrome; Kyasanur Forest Disease; Lassa Fever; Marburg Virus Disease; Rift Valley Fever A group of viral diseases of diverse etiology but having many similar clinical characteristics; increased capillary permeability, leukopenia, and thrombocytopenia are common to all. Hemorrhagic fevers are characterized by sudden onset, fever, headache, generalized myalgia, backache, conjunctivitis, and severe prostration, followed by various hemorrhagic symptoms. Hemorrhagic fever with kidney involvement is HEMORRHAGIC FEVER WITH RENAL SYNDROME. specific hemorrhagic fever (77)  `) P:&Hemorrhagic Fever, Omsk C02.081.885.440; C02.782.350.250.560; C02.782.417.435 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral Infection with the Omsk hemorrhagic fever virus, a Flavivirus. Hemorrhagic Fevers, Viral (66-76) `- =P K(Hemorrhagic Fever, Crimean C02.081.885.430; C02.782.147.444; C02.782.417.412 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral A severe, often fatal disease in humans caused by the Crimean-Congo hemorrhagic fever virus (HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO). Hemorrhagic Fevers, Viral (66-76) `/X 9P(Hemorrhagic Fever, American C02.782.417.400; C02.782.082.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral Virus Diseases; RNA Virus Infections (Non MeSH); Arenaviridae Infections Diseases caused by American hemorrhagic fever viruses (TACARIBE COMPLEX VIRUSES). Hemorrhagic Fevers, Viral (66-76) `1!&P`(Hemorrhagic Fever with Renal Syndrome C02.782.147.420.400; C02.782.417.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections; Hantavirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral An acute febrile disease occurring predominately in Asia. It is characterized by fever, prostration, vomiting, hemorrhagic phenonema, shock, and renal failure. It is caused by any one of several closely related species of the genus Hantavirus. The most severe form is caused by HANTAAN VIRUS whose natural host is the rodent Apodemus agrarius. A milder form is caused by Seoul virus and related species and transmitted by the rodents Rattus rattus and R. norvegicus. Hemorrhagic Fevers, Viral (66-76) `3-*P$(Hemorrhagic Fever Virus, Crimean-Congo B04.820.087.565.400; B04.909.777.147.565.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Nairovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Nairovirus The type species of NAIROVIRUS of the family BUNYAVIRIDAE isolated from febrile patients in Africa. It is primarily transmitted by ticks and causes a severe, often fatal disease in humans. `7-2Hemorrhagic Disease Virus, Rabbit B04.820.095.450; B04.909.777.162.450 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Caliciviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Caliciviridae A virus in the family CALICIVIRIDAE which causes hemorrhagic disease, including hemorrhagic septicemia, in rabbits. Caliciviridae (91-93) `9(*{Hemorrhagic Disease Virus, Epizootic B04.820.630.550.400; B04.909.777.714.550.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae; Orbivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae; Orbivirus A species of ORBIVIRUS causing a fatal disease in deer. It is transmitted by flies of the genus Culicoides. Reoviridae (70-93) `;{+2Hemorrhagic Disease of Newborn C15.378.463.841.464; C16.614.378 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Vitamin K Deficiency Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases A self-limited hemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin K-dependent blood coagulation factors II, VII, IX, and X. (Dorland, 27th ed). `=F%&LHemorrhagic Diathesis C15.378.463 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Disease Susceptibility Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Blood Coagulation Disorders (+ 12); Blood Platelet Disorders (+ 10); Purpura (+ 6); Telangiectasia, Hereditary Hemorrhagic; Vitamin K Deficiency (+ 1); von Willebrand's Disease Any tendency to spontaneous bleeding or bleeding from trivial trauma caused by a defect in clotting or a flaw in the structure of blood vessels. (Stedman, 25th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $`?LJNHemorrhagic Bacteremia C01.252.100.375; C01.252.400.700.662.297; C01.539.757.720.100.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Bacteremia Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections; Pasteurella Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia; Bacteremia Any of several diseases usually caused by PASTEURELLA MULTOCIDA, marked by the presence of hemorrhagic areas in the subcutaneous tissues, serous membranes, muscles, lymph glands, and throughout the internal organs. `BIPgHemorrhage C23.542 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) Blood Loss, Surgical; Cerebral Hemorrhage (+ 3); Ecchymosis; Epistaxis; Eye Hemorrhage (+ 4); Gastrointestinal Hemorrhage (+ 3); Hemarthrosis; Hematocele; Hematoma; Hematuria; Hemobilia; Hemoperitoneum; Hemoptysis; Hemothorax (+ 1); Oral Hemorrhage (+ 1); Shock, Hemorrhagic; Uterine Hemorrhage (+ 3) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSNSUTHURUSVEVI `E N2iPHemorheology E05.830.250; G09.330.612.522; H01.671.799.193 CLDEECEDHIISLJMAMTOGRESNSTTD Erythrocyte Deformability; Blood Viscosity Miscellaneous Techniques (Non MeSH); Rheology Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Physical Sciences (Non MeSH); Physics; Rheology The scientific study of the deformation and flow properties of cellular and plasmatic components of blood in macroscopic, microscopic, and submicroscopic dimensions, and the rheological properties of vessel structure with which the blood comes in direct contact. (Dorland, 27th ed). Blood Viscosity (66-93); Erythrocyte Deformability (85-93); Rheology (66-93)  `HG5 2H[Hemoptysis C08.381.348; C23.542.488 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Expectoration of blood or blood-stained sputum. (Dorland, 27th ed). `KNqRHemopneumothorax C08.528.338; C23.542.572.463 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pneumothorax Respiratory Tract Diseases; Pleural Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage; Hemothorax Accumulation of air and blood in the pleural cavity. (Stedman, 25th ed). `L"NZHemophilia C15.378.463.134.546 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemarthrosis Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders An inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhages, spontaneous or traumatic, due to a defect in the blood coagulating system. Hemophilia may refer to a HEMORRHAGIC DIATHESIS wherein the coagulation factor is not specified or it may refer to a deficiency of FACTOR VIII, the classic hemophilia, the most common hereditary coagulation disorder. It does not include hemophilia B (CHRISTMAS DISEASE) nor hemophilia C (FACTOR XI DEFICIENCY). (From Stedman, 25th ed and Lee, et al., Wintrobe's Clinical Hematology, 9th ed, p. 1424). `NLHemopexin D12.776.124.050.350; D12.776.124.790.223.338; D12.776.377.715.182.338; D12.776.395.401 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Beta Globulins (66-70); Heme (66-70) `RU `F.Hemoperitoneum C06.772.303; C23.542.461 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Peritoneal Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage An effusion of blood in the peritoneal cavity. (Dorland, 27th ed). `UNvSHemoperfusion E02.912.430; E04.292.510 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; Sorption Detoxification Surgery, Operative; Extracorporeal Circulation Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemodialysis (67-77); Kidney, Artificial (66-77); Perfusion (66-77) `Vy$`QHemolytic-Uremic Syndrome C12.777.419.936.463; C15.378.071.141.610; C15.378.463.205.313 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Uremia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Platelet Disorders Syndrome of hemolytic anemia, thrombocytopenia, and acute renal failure, with pathological finding of thrombotic microangiopathy in kidney and renal cortical necrosis. Anemia, Hemolytic (66-71); Uremia (66-71) `YhENT3Hemolytic Plaque Technique E01.223.495.421; E05.478.421 AECLCTECHIISMONUPXSNSTTDUTVE Antibody-Producing Cells Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques Antibody Formation (66-68) `\ "  Hemolysis G04.610.143.545 DEGEIMPHRE Anemia, Hemolytic; Osmotic Fragility Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions `] ,pHemolysins D24.185.926.235.440; D24.611.125.525 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Cytotoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Streptolysins Substances, usually of biological origin, that destroy blood cells; they may be antibodies or other immunologic factors, toxins, enzymes, etc.; hemotoxins are toxic to blood in general, including the clotting mechanism; hematotoxins may refer to the hematopoietic system. ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  `^*6<FHemolysin Factors D13.444.308.212.500.430; D13.444.308.283.500.430 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids Plasmids controlling the synthesis of hemolysin by bacteria. Hemolysins (66-77); Plasmids (66-77) `a6DH-Hemolymph A13.453 CHCYDEENIMMEMIPHPSRARERISEUSVI Animal Terms (Non MeSH) `c  "Hemoglobinuria, Paroxysmal C15.378.071.141.510.460; C15.378.190.625.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Hemoglobinuria Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myelodysplastic Syndromes Disorder characterized by intravascular hemolysis and hemoglobinuria. Some cases occur on exposure to cold and are due to the presence of an autohemolysin in the serum. Other cases are more marked during or immediately after sleep and are considered to be due to an acquired intracorpuscular defect. `dE2N`Hemoglobinuria C12.777.337; C15.378.071.141.510 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic  Hemoglobinuria, Paroxysmal The presence of free hemoglobin in the urine.  `gc&N  9Hemoglobins, Abnormal D12.776.124.400.463; D12.776.422.512.426 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins Hemoglobin C; Hemoglobin E; Hemoglobin H; Hemoglobin J; Hemoglobin M; Hemoglobin, Sickle Hemoglobin C; Hemoglobin E; Hemoglobin H; Hemoglobin J; Hemoglobin M; Hemoglobin, Sickle AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR `i,.DFHemoglobins D12.776.124.400; D12.776.422.512 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins Carboxyhemoglobin; Erythrocruorins; Fetal Hemoglobin; Globin; Hemoglobin A (+ 2); Hemoglobins, Abnormal (+ 6); Methemoglobin; Oxyhemoglobins; Sulfhemoglobin Carboxyhemoglobin; Erythrocruorins; Fetal Hemoglobin; Hemoglobin A (+ 2); Hemoglobins, Abnormal (+ 6); Methemoglobin; Oxyhemoglobins; Sulfhemoglobin AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR `k&BfFHemoglobinopathies C15.378.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Anemia, Sickle Cell (+ 2); Hemoglobin C Disease; Thalassemia (+ 3) `nNJSHemoglobinometry E01.223.459.528 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests Measurement of hemoglobin concentration in blood. `o"=;Hemoglobin, Sickle D12.776.124.400.463.588; D12.776.422.512.426.588 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobins, Abnormal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobins, Abnormal An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia. Hemoglobins, Abnormal (66-72) `p6F #Hemoglobin SC Disease C15.378.071.141.150.150.440; C15.378.420.155.440 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Anemia, Sickle Cell Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies; Anemia, Sickle Cell One of the sickle cell disorders characterized by the presence of both hemoglobin S and hemoglobin C. It is similar to, but less severe than sickle cell anemia. Anemia, Sickle Cell (66-83); Hemoglobin C Disease (66-83) `s6LFHemoglobin M D12.776.124.400.463.510; D12.776.422.512.426.510 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobins, Abnormal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobins, Abnormal A group of abnormal hemoglobins in which amino acid substitutions take place in either the alpha or beta chains but near the heme iron. This results in facilitated oxidation of the hemoglobin to yield excess methemoglobin which leads to cyanosis. Hemoglobins, Abnormal (66-76) `v6F##Hemoglobin J D12.776.124.400.463.480; D12.776.422.512.426.480 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobins, Abnormal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobins, Abnormal A group of abnormal hemoglobins with similar electrophoretic characteristics. They have faster electrophoretic mobility and different amino acid substitutions in either the alpha or beta chains than normal adult hemoglobin. Some of the variants produce hematologic abnormalities, others result in no clinical disorders. Hemoglobins, Abnormal (66-76) `y6Fp#Hemoglobin H D12.776.124.400.463.463; D12.776.422.512.426.463 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobins, Abnormal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobins, Abnormal `|6FHemoglobin E D12.776.124.400.463.375; D12.776.422.512.426.375 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobins, Abnormal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobins, Abnormal An abnormal hemoglobin resulting from the substitution of lysine for glutamic acid at position 26 of the beta chain of the globin moiety. Occurs most frequently in Southeast Asia and is associated with microcythemia, target cell formation and mild hemolytic anemia. Hemoglobins, Abnormal (66-76) `~v6F7#Hemoglobin C Disease C15.378.420.463; C15.378.071.141.150.490 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital A disease characterized by compensated hemolysis with a normal hemoglobin level or a mild to moderate anemia. There may be intermittent abdominal discomfort, splenomegaly, and slight jaundice. `.LHemoglobin C D12.776.124.400.463.338; D12.776.422.512.426.338 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobins, Abnormal Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobins, Abnormal `6FHemoglobin A2 D12.776.124.400.405.450; D12.776.422.512.380.450 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobin A Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobin A An adult hemoglobin component normally present in hemolysates from human erythrocytes in concentrations of about 3%. The hemoglobin is composed of two alpha chains and two delta chains. The percentage of HbA2 varies in some hematologic disorders, but is about double in beta-thalassemia. Hemoglobins (66-76); Hemoglobin A (77-78) `6FP3Hemoglobin A, Glycosylated D09.203.408.375; D12.776.124.400.405.440; D12.776.422.512.380.440 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Blood Glucose Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins; Hemoglobin A Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins; Hemoglobin A Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time. Hemoglobin A (77-81); Hemoglobins (66-76)  ` IF@3Hemoglobin A D12.776.124.400.405; D12.776.422.512.380 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins Hemoglobin A, Glycosylated; Hemoglobin A2 Hemoglobin A, Glycosylated; Hemoglobin A2 Normal adult human hemoglobin. The globin moiety consists of two alpha and two beta chains. Hemoglobins (66-76)  `C.FboHemofiltration E02.870.350; E02.912.400; E04.292.471; E04.292.975.300; E05.196.454.807.300; H01.181.529.365.807.300; H01.671.100.534.807.300 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ultrafiltration Therapeutics; Renal Replacement Therapy Therapeutics; Sorption Detoxification Surgery, Operative; Extracorporeal Circulation Surgery, Operative; Extracorporeal Circulation; Ultrafiltration Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Filtration; Ultrafiltration Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Filtration; Ultrafiltration Physical Sciences (Non MeSH); Physics; Biophysics; Filtration; Ultrafiltration Hemodiafiltration Hemodiafiltration Hemodiafiltration Hemodiafiltration Hemodiafiltration Hemodiafiltration Hemodiafiltration Extracorporeal ultrafiltration technique without hemodialysis for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Blood (66-87); Extracorporeal Circulation (66-87); Filtration (66-87); Ultrafiltration (73-87) $`$pHemodynamics G09.330.612 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Blood Flow Velocity; Blood Pressure (+ 4); Blood Viscosity; Blood Volume (+ 2); Cardiac Output (+ 1); Cardiac Volume; Heart Rate (+ 1); Heart Sounds; Hemorheology; Kallikrein-Kinin System; Pulsatile Flow; Pulse; Regional Blood Flow; Renin-Angiotensin System; Valsalva's Maneuver; Vascular Resistance (+ 1); Vasoconstriction; Vasodilation; Ventricular Pressure The movements of the blood and the forces involved in systemic or regional blood circulation. CLDEECEDGEHIIMISLJMAMTOGPHRESNSTTDVE  `]jp(Hemodilution E02.514 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Reduction of blood viscosity usually by the addition of cell free solutions. Used clinically l) in states of impaired microcirculation, 2) for replacement of intraoperative blood loss without homologous blood transfusion, and 3) in cardiopulmonary bypass and hypothermia. Blood Viscosity (66-78); Blood Volume (66-78); Cardiopulmonary Bypass (72-78); Extracorporeal Circulation (67-78); Plasma Substitutes (66-78) `f ":Hemodialysis, Home E02.870.300.300; E02.912.390.300; N02.421.143.524.337 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; Renal Replacement Therapy; Hemodialysis Therapeutics; Sorption Detoxification; Hemodialysis Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Home Care Services Long-term maintenance hemodialysis in the home. Hemodialysis (66-72); Home Care Services (66-72); Home Nursing (66-72); Kidney, Artificial (66-72); Peritoneal Dialysis (66-72) `=$9Hemodialysis Units, Hospital N02.278.388.200 CLECHILJMAOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units Hospital units in which care is provided the hemodialysis patient. This includes hemodialysis centers in hospitals. Hemodialysis (74-81); Hospital Units (74-81) `$"_6Hemodialysis Solutions D26.394.225.766.220.651 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions; Dialysis Solutions Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers (e.g., acetate or carbonate), the addition of cations (Na+, K+, Ca2+), and addition of carbohydrates (glucose). Hemodialysis (67-88) `,qHemodialysis E02.870.300; E02.912.390 AECLCTECHIISMOMTNUPXSNSTTDUTVE Kidney, Artificial Kidney Failure, Acute; Kidney Failure, Chronic Therapeutics; Renal Replacement Therapy Therapeutics; Sorption Detoxification Hemodiafiltration; Hemodialysis, Home Hemodiafiltration; Hemodialysis, Home Removal of certain elements from the blood based on the difference in their rates of diffusion through a semipermeable membrane. Dialysis (66); Kidney, Artificial (66) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE ,`"8YV0$Hemodiafiltration E02.870.300.200; E02.870.350.300; E02.912.390.200; E02.912.400.300; E04.292.471.350; E04.292.975.300.300; E05.196.454.807.300.300; H01.181.529.365.807.300.300; H01.671.100.534.807.300.300 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Renal Replacement Therapy; Hemodialysis Therapeutics; Renal Replacement Therapy; Hemofiltration Therapeutics; Sorption Detoxification; Hemodialysis Therapeutics; Sorption Detoxification; Hemofiltration Surgery, Operative; Extracorporeal Circulation; Hemofiltration Surgery, Operative; Extracorporeal Circulation; Ultrafiltration; Hemofiltration Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Filtration; Ultrafiltration; Hemofiltration Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Filtration; Ultrafiltration; Hemofiltration Physical Sciences (Non MeSH); Physics; Biophysics; Filtration; Ultrafiltration; Hemofiltration The combination of hemodialysis and hemofiltration either simultaneously or sequentially. Convective transport (hemofiltration) may be better for removal of larger molecular weight substances and diffusive transport (hemodialysis) for smaller molecular weight solutes. Hemodialysis (75-93); Hemofiltration (87-93); Ultrafiltration (75-93) `"1RHemocytes A11.118.480; A15.145.229.480 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells Hemic and Immune Systems (Non MeSH); Blood; Blood Cells Any blood or formed element especially in invertebrates. Blood Cells (66-76); Hemolymph (66-76) ` "*]D0Hemocyanin D11.557.482; D12.776.124.337; D12.776.422.412; D12.776.556.462 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins `HFBHemochromatosis C18.452.648.618.337 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors A disorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary. Full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron. Acquired hemochromatosis may be the result of blood transfusions, excessive dietary iron, or secondary to other disease. Idiopathic or genetic hemochromatosis is an autosomal recessive disorder of metabolism associated with a gene tightly linked to the A locus of the HLA complex on chromosome 6. (From Dorland, 27th ed). `LHemobilia C06.130.650; C23.542.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Hemorrhage in or through the biliary tract. The blood may drain into the intestine or form clots within the biliary tract. The causes include trauma, inflammation, cholelithiasis, vascular disease, or neoplasms. Biliary Tract Diseases (66-79); Hemorrhage (66-79); Hemorrhage, Gastrointestinal (66-79); Hepatic Artery (66-79); Liver/IN (66-79) ` NzHemlock B06.660.463 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Toxic Any of several poisonous herbs commonly called the poison hemlock (Conium maculatum and Cicuta major) and the water hemlock (Cicuta virosa). Conium maculatum is a large toxic umbelliferous herb, which contains the poisonous alkaloid coniine. The dried, fully grown, unripe fruit has sedative, anodyne, and antispasmodic effects. Cicuta virosa is also toxic but is too dangerous to be employed internally, except in homeopathic doses. The hemlock tree, unrelated, referred to as the hemlock fir or hemlock spruce, belongs to the genus Tsuga. (From Webster, 3d ed; from Dorland, 27th ed; from Steinmetz, Codex Vegetabilis, 1958). Plant Poisoning (66-94) `q &Hemiptera B01.131.617.412 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Aphids; Bedbugs; Triatominae (+ 3) A large order of insects comprising the true bug, as BEDBUGS and cinch bugs, and closely related insects, including APHIDS. Insects (66-74)  ` (*,Hemiplegia C10.597.622.295; C23.888.592.636.312 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Paralysis of one side of the body. (Dorland, 27th ed). ``*NFHemipelvectomy E04.557.069.600 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Orthopedics; Amputation Amputation of a lower limb through the sacroiliac joint. `$4EHemin D11.557.727.640.587.462 AAADAEAGAIANBICFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Metalloporphyrins; Heme Chloro(7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N(21),N(22),N(23),N(24)) ferrate(2-) dihydrogen. ` BqHemicholinium 3 D02.092.102.435; D02.675.276.435; D14.100.600.390 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors A potent inhibitor of the high affinity uptake system for CHOLINE. It has less effect on the low affinity uptake system. Since choline is one of the components of ACETYLCHOLINE, treatment with hemicholinium can deplete acetylcholine from cholinergic terminals. Hemicholinium 3 is commonly used as a research tool in animal and in vitro experiments. Morpholines (66-71) `9:$Hemic and Lymphatic Diseases (Non MeSH) C15 Hematologic Diseases (+ 152); Lymphatic Diseases (+ 126) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI `0EZHemic and Immune Systems (Non MeSH) A15 Blood (+ 45); Hematopoietic System (+ 5); Immune System (+ 98) ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI `,P>Hemibody Irradiation E02.810.270 AECLCTECHIISMOMTNUPXSNSTTDUTVE Whole-Body Irradiation Whole-Body Irradiation Therapeutics; Radiotherapy Irradiation of one half or both halves of the body in the treatment of disseminated cancer or widespread metastases. It is used to treat diffuse metastases in one session as opposed to multiple fields over an extended period. The more frequent treatment modalities are upper hemibody irradiation (UHBI) or lower hemibody irradiation (LHBI). Less common is mid-body irradiation (MBI). In the treatment of both halves of the body sequentially, hemibody irradiation permits radiotherapy of the whole body with larger doses of radiation than could be accomplished with WHOLE-BODY IRRADIATION. It is sometimes called "systemic" hemibody irradiation with reference to its use in widespread cancer or metastases. (P. Rubin et al. Cancer, Vol 55, p.2210, 1985). Radiotherapy (80-93); Radiotherapy Dosage (80-93); Whole-Body Irradiation (81-93) $`" r`Hemianopsia C10.597.751.941.512; C11.966.075.500; C23.888.592.763.941.512 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Eye Diseases; Vision Disorders; Blindness Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders Defect in the visual field characterized by vision in only half of the visual field of one or both eyes. `ņEN;Hemerythrin D12.776.157.400; D12.776.556.440 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins A non-heme iron protein consisting of eight apparently identical subunits each containing 2 iron atoms. It binds one molecule of oxygen per pair of iron atoms and functions as a respiratory protein. Carrier Proteins (73-74); Iron (73-74); Metalloproteins (73-74) `&HMHemeproteins D12.776.422 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Cytochromes (+ 7); Hemocyanin; Hemoglobins (+ 16); Leghemoglobin; Methemalbumin; Metmyoglobin; Myoglobin Blood Proteins (66-72); Heme (66-72); Proteins (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  `ʐDD~DHHeme Oxygenase D08.586.682.420.410 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3. Heme (66-79); Hydroxylases (66-79); Oxygenases (66-79) `lFh=CHeme D11.557.727.640.587 AAADAEAGAIANBICFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Metalloporphyrins Hemin (7,12-Diethenyl-3,18,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N(21),N(22),N(23),N(24)) ferrate(2-) dihydrogen. The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. `Bi Hematuria C12.777.295; C23.542.404 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Blood in the urine. (Dorland, 27th ed). ` N 4Hematoxylin D03.438.150.600; D26.408.401 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans Miscellaneous Drugs and Agents (Non MeSH); Dyes 7,11b-Dihydrobenz(b)indeno(1,2-d)pyran-3,4,6a,9,10(6H)-pentol. A dye obtained from the heartwood of logwood (Haematoxylon campechianum Linn., Leguminosae) used as a stain im microscopy and in the manufacture of ink. Synonyms: Black 1; CI Natural Black 1; C.I. 75290; Haematoxylin; Haematoxylum; Logwood extract; Steam Black. Benzopyrans (69-74); Indenes (73-74) `m".-Hematoporphyrins D11.557.727.462 ADAEAGAIANCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Hematoporphyrin Derivative (+ 1) Iron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. AAADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  `/<T'@Hematoporphyrin Photoradiation E02.780.740.435 AECLCTECHIISMOMTNUPXSNSTTDUTVE Dihematoporphyrin Ether; Photosensitizing Agents; Hematoporphyrin Derivative Therapeutics; Physical Therapy; Photochemotherapy Photochemotherapy using visible light, usually red, topically or delivered locally by fiberoptic probe to tissues sensitized with hematoporphyrins. Hematoporphyrins (80-85); Photochemotherapy (78-85); Phototherapy (81-85)  `#"W:VHematoporphyrin Derivative D11.557.727.462.400; D22.204.436; D23.600.300; D26.776.819.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematoporphyrin Photoradiation Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Hematoporphyrins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Dermatologic Agents; Photosensitizing Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents; Photosensitizing Agents Dihematoporphyrin Ether Dihematoporphyrin Ether Dihematoporphyrin Ether Dihematoporphyrin Ether A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER. Hematoporphyrins (80-92) $`(H:#VjHematopoietic System A15.378 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Hemic and Immune Systems (Non MeSH) Bone Marrow Cells (Non MeSH) (+ 4) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI ` 8,,<Hematopoietic Stem Cells A11.148.378; A11.872.378; A15.378.316.378 CHCLCYDEENIMMEMIPAPHPSRARERISEULUSVI Colony-Forming Units Assay Cells; Bone Marrow Cells (Non MeSH) Cells; Stem Cells Hemic and Immune Systems (Non MeSH); Hematopoietic System; Bone Marrow Cells (Non MeSH) Erythroid Progenitor Cells (+ 1) Erythroid Progenitor Cells Erythroid Progenitor Cells (+ 1) Progenitor cells from which all blood cells derive. Bone Marrow/cytology (66-70) CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI (`1( l?#*Hematopoietic Stem Cell Transplantation E04.936.225.350 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Bone Marrow Transplantation Surgery, Operative; Transplantation; Cell Transplantation The transference of stem cells from one animal or human to another (allogeneic), or within the same individual (autologous). The source for the stem cells may be the bone marrow or peripheral blood. Stem cell transplantation has been used as an alternative to autologous bone marrow transplantation in the treatment of a variety of neoplasms. Bone Marrow/transplantation (66-70); Hematopoietic Stem Cells/transplantation (71-94)  `m.$!CcHematopoietic Cell Growth Factors D24.185.348.453; D24.611.350.400.442 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Colony-Stimulating Factor Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances Colony-Stimulating Factors (+ 5) Colony-Stimulating Factors (+ 5) These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes. Growth Substances (66-90) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (`Y(*D*LHHematopoiesis, Extramedullary G09.188.544.463 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hematopoiesis The formation and development of blood cells outside the bone marrow, as in the spleen, liver, or lymph nodes. Hematopoiesis (66-86); Hematopoietic Stem Cells (71-86) `"kBHematopoiesis G09.188.544 DEGEIMPHRE Blood Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Erythropoiesis; Hematopoiesis, Extramedullary `s Y4Hematometra C13.371.320.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Gynatresia (Non MeSH) Collection of blood in the uterine cavity. Uterine Diseases (66-74) `^N5Hematoma, Subdural C10.228.140.300.420.462; C14.907.253.420.462; C23.542.115.462 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Hemorrhage Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Cerebral Hemorrhage Accumulation of blood in the subdural space. There are acute and chronic forms. They are usually the result of trauma. (From Dorland, 27th ed). `ENIHematoma, Epidural C10.228.140.300.420.336; C14.907.253.420.336; C23.542.115.336 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Hemorrhage Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Hemorrhage Symptoms and General Pathology (Non MeSH); Hemorrhage; Cerebral Hemorrhage Accumulation of blood in the epidural space, due to damage to the middle meningeal artery and producing compression of the dura mater and thus compression of the brain. Unless evacuated, it may result in herniation through the tentorium, and death. (Dorland, 27th ed). `ENI>Hematoma C23.542.376 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Hemorrhage A localized collection of blood, usually clotted, in an organ, space, or tissue, due to a break in the wall of a blood vessel. (Dorland, 27th ed). ` NAHematology G02.403.776.409.445 CLECEDHIISLJMAMTOGSNSTTD Hematologic Diseases Health Occupations; Medicine; Specialties, Medical; Internal Medicine A subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues. `dRHematologic, Gastric, Renal Agents (Non MeSH) D19 Gastrointestinal Agents (+ 91); Hematologic Agents (Non MeSH) (+ 121); Renal Agents (Non MeSH) (+ 47) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR `6|HHematologic Tests E01.223.459 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory Blood Cell Count (+ 7); Blood Coagulation Tests (+ 5); Blood Grouping and Crossmatching; Blood Sedimentation; Bone Marrow Examination; Erythrocyte Aggregation; Erythrocyte Indices; FIGLU Test; Hematocrit; Hemoglobinometry; LE Cells; Osmotic Fragility; Platelet Function Tests (+ 3); Schilling Test Tests used in the diagnosis of diseases of the blood. Hematology (66-77) AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE $`"'bC,Hematologic Diseases C15.378 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hematology Hemic and Lymphatic Diseases (Non MeSH) Anemia (+ 36); Blood Group Incompatibility (+ 4); Blood Protein Disorders (+ 19); Bone Marrow Diseases (+ 16); Erythrocyte Aggregation, Intravascular; Hemoglobinopathies (+ 8); Hemorrhagic Diathesis (+ 35); Leukocyte Disorders (Non MeSH) (+ 20); Methemoglobinemia; Pancytopenia; Polycythemia; Pregnancy Complications, Hematologic; Preleukemia; Sulfhemoglobinemia BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  `q N0ZHematologic Agents (Non MeSH) D19.461 Hematologic, Gastric, Renal Agents (Non MeSH) Anticoagulants (+ 26); Antisickling Agents; Blood Substitutes (+ 7); Coagulants (+ 52); Fibrinolytic Agents (+ 16); Hematinics (+ 7); Platelet Aggregation Inhibitors (+ 6) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR `Q$ 6HHematocrit E01.223.459.481 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests `"=Hematocolpos C13.371.320.480; C13.371.894.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Gynatresia (Non MeSH) Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases Collection of blood usually menstrual in the vagina. Vagina/AB (66-78); Vaginal Diseases (66-78) `&N@6Hematocele C12.294.287; C23.542.349 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Symptoms and General Pathology (Non MeSH); Hemorrhage An effusion of blood into a cavity, especially into the tunica vaginalis testis. (Dorland, 27th ed). `NzHematinics D19.461.543 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Ferric Compounds; Folic Acid; Intrinsic Factor; Iron-Dextran Complex; Liver Extracts; Vitamin B 12 (+ 1) Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. Anemia/drug therapy (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $aZ8["HHematemesis C06.405.270.336; C06.405.937.378; C23.542.305.336 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Hemorrhage Digestive System Diseases; Gastrointestinal Diseases; Vomiting Symptoms and General Pathology (Non MeSH); Hemorrhage; Gastrointestinal Hemorrhage Vomiting of blood. a9NHemarthrosis C05.550.459; C23.542.321 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemophilia Musculoskeletal Diseases; Joint Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Bleeding into the joints which arises either from trauma or spontaneously in patients with hemophilia. aNoyHemangiosarcoma C04.557.450.795.390; C04.557.645.390 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed). aG*XHemangiopericytoma C04.557.645.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1364). a X^Hemangioma, Cavernous C04.557.645.375.385 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue; Hemangioma A vascular tumor preponderantly composed of large dilated blood vessels, often containing large amounts of blood, occurring in the skin, subcutaneously, or both, and also in many viscera, particularly the liver, spleen, pancreas, and sometimes the brain. The typical superficial lesions are bright to dark red in color; deep lesions have a blue color. A cavernous hemangioma in the skin extends more deeply than a capillary hemangioma and is less likely to regress spontaneously. (Dorland, 27th ed; from Stedman, 25th ed). a VleHemangioma, Capillary C04.557.645.375.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue; Hemangioma Hemangioblastoma A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed). Hemangioma (66-93) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $aLVlXHemangioma C04.557.645.375 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Arteriovenous Malformations Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue Hemangioendothelioma (+ 1); Hemangioma, Capillary (+ 1); Hemangioma, Cavernous; Sturge-Weber Syndrome An extremely common benign tumor, occurring most commonly in infancy and childhood, made up of newly formed blood vessels, and resulting from malformation of angioblastic tissue of fetal life. It can occur anywhere in the body but is most frequently noticed in the skin and subcutaneous tissues. About 75% are present at birth, and about 60% occur in the head and neck area. The majority in infancy will regress spontaneously. Some hemangiomas grow rapidly during the early months of life and may be a source of some concern, although virtually all disappear by about 5 years of age. They do not metastasize and simple excision will often be curative. (Dorland, 27th ed; from Stedman, 25th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1355). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $aV ^xXHemangioendothelioma, Epithelioid C04.557.645.375.370.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue; Hemangioma; Hemangioendothelioma A tumor of medium-to-large veins, composed of plump-to-spindled endothelial cells that bulge into vascular spaces in a tombstone-like fashion. These tumors are thought to have "borderline" aggression, where one-third develop local recurrences, but only rarely metastasize. It is unclear whether the epithelioid hemangioendothelioma is truly neoplastic or an exuberant tissue reaction, nor is it clear if this is equivalent to Kimura's disease (see ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA). (Dictionary of Modern Medicine, 1992). Hemangioendothelioma (82-93) aH&Xe!Hemangioendothelioma C04.557.645.375.370 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue; Hemangioma Hemangioendothelioma, Epithelioid A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p. 1866). aXl&'Hemangioblastoma C04.557.645.375.380.370 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue; Hemangioma; Hemangioma, Capillary A capillary hemangioma of the brain consisting of proliferated blood vessel cells or angioblasts. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, and supratentorial compartment. Cerebellar hemangioblastomas are usually recognized in the third decade. Clinical progression is slow, as these tumors enlarge very slowly. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 2605). Hemangiosarcoma (66-93) a yXHemagglutinins, Viral D24.611.216.327.461; D24.611.125.044.377.416 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Hemagglutinins HN Protein Antigens (66) a$x26Hemagglutinins D24.611.125.044.377 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins Hemagglutinins, Viral Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Antibodies (66-74)  a&F6xHemagglutination, Viral G04.185.515.880.420 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) Agglutination of erythrocytes by a virus. Hemagglutination (66-69) a(L3Hemagglutination Tests E01.223.495.826.461 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Coombs' Test a)"NHemagglutination Inhibition Tests E01.223.495.826.411 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. a*'"NHemagglutination G04.610.143.100.200 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions; Agglutination a,}Hemadsorption Inhibition Tests E01.223.495.826.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis a-V$"NHemadsorption G04.185.515.423 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) A phenomenon manifested by an agent or substance adhering to or being adsorbed on the surface of a red blood cell, as tuberculin can be adsorbed on red blood cells under certain conditions. (Stedman, 25th ed). Hemagglutination (66-69) a. Helsinki Declaration K01.316.333.366.377; K01.752.667.416.377; N05.350.340.500.400 HI Humanities; Ethics; Ethics, Professional; Ethics, Medical Humanities; Philosophy; Philosophy, Medical; Ethics, Medical Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional; Ethics, Medical a0&EHelplessness, Learned F03.126.430 Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) A psychological response to adverse situations from which there appears to be no escape or to tasks and problems which appear to have no solution. a1YHelping Behavior F01.145.813.225; F01.829.759.225 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Behavior Behaviors associated with the giving of assistance or aid to individuals. Interpersonal Relations (69-74); Social Behavior (69-74); specific interpersonal relations heading a2&XsHelper Viruses B04.423 CHCLDEENGDGEIMIPMEPHPYREUL Satellite Viruses Satellite Viruses Viruses Viruses which enable defective viruses to replicate or to form a protein coat by complementing the missing gene function of the defective (satellite) virus. Helper and satellite may be of the same or different genus. specific virus (66) $a4  Helminths B01.500 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates Acanthocephala (+ 1); Nematoda (+ 77); Platyhelminths (+ 32); Rotifera a6  *YHelminthosporium B05.354.381.546.420 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus including both saprophytes and plant parasites. a7N"N\Helminthiasis, Animal (Non MeSH) C03.335.349; C03.701.377; C22.674.377 Parasitic Diseases; Helminthiasis Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH) Dictyocaulus Infections; Dirofilariasis; Fascioloidiasis; Monieziasis; Setariasis; Strongyle Infections, Equine; Toxocariasis Dictyocaulus Infections; Dirofilariasis; Fascioloidiasis; Monieziasis; Setariasis; Strongyle Infections, Equine; Toxocariasis Dictyocaulus Infections; Dirofilariasis; Fascioloidiasis; Monieziasis; Setariasis; Strongyle Infections, Equine; Toxocariasis BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI a8h'-JHelminthiasis C03.335 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Anthelmintics Parasitic Diseases Cestode Infections (+ 9); Helminthiasis, Animal (Non MeSH) (+ 7); Nematode Infections (+ 41); Trematode Infections (+ 11) Infestation with parasitic worms of the helminth class.  a;~ PCHelminth Proteins D12.776.419 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Proteins found in any species of helminth. Proteins (66-89); specific helminth (66-89) a=DD55HELLP Syndrome C13.703.799.314.309; C13.703.799.314.619.500 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Toxemias; Eclampsia Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Toxemias; Eclampsia; Pre-Eclampsia Hemolysis-elevated liver enzymes-low platelet count syndrome. A pre-eclamptic or eclamptic disorder with the findings shown in the clinical description from which the acronym is created. Severe hypertension may be present. Abnormal SGOT and SGPT levels also appear. (Jablonski, 2d ed). Eclampsia (85-92); Hemolysis (82-92); Liver/enzymology (82-92); Pre-Eclampsia (82-92); Thrombocytopenia (82-92) a>R2L#NHelix-Loop-Helix Motifs G05.331.599.056.400; G06.184.599.056.400 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Amino Acid Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Amino Acid Sequence A group of 20-residue peptides characterized by two alpha helices separated by a non-helical segment. These recurring supersecondary structural patterns are found in many sequence-specific DNA-binding proteins. Amino Acid Sequence (89-93) aB."Helix (Snails) B01.644.776.450 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca; Snails A genus of chiefly Eurasian and African land snails including the principal edible snails as well as several pests of cultivated plants. Snails (66-74) aD('Helium D01.268.613.350; D01.362.641.352 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Noble Gases Inorganic Chemicals (Non MeSH); Gases; Noble Gases Helium. A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics. (Dorland, 27th ed). aE &:1Heliotherapy E02.780.750.430 AECLCTECHIISMOMTNUPXSNSTTDUTVE Sunlight Therapeutics; Physical Therapy; Phototherapy aI" 5Heligmosomatoidea B01.500.294.700.775.400 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida Nematospiroides (+ 1); Nippostrongylus A superfamily of parasitic nematodes which were formerly considered a part of TRICHOSTRONGYLOIDEA. It includes the following genera: Heligmosomum, NEMATOSPIROIDES, and NIPPOSTRONGYLUS. The hosts are rodents. aI*H/Helicobacter pylori B03.440.500.550; B03.825.400.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Helicobacter Bacteria; Spiral and Curved Bacteria (Non MeSH); Helicobacter A newly classified spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the new genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter (84-90) aK&"Helicobacter Infections C01.252.400.466 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. aOPsrHelicobacter B03.440.500; B03.825.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Bacteria; Spiral and Curved Bacteria (Non MeSH) Helicobacter pylori Helicobacter pylori A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the intestinal tract of mammals, including humans. Campylobacter (84-90)  aR%"_.Helianthus B06.510.500 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Edible A genus of tall, erect American herbs of the Compositae. The seeds yield oil and are used as food and animal feed; the roots of Helianthus tuberosum (Jerusalem artichoke) are edible. aS&Hela Cells A11.251.210.460; A11.251.353.460; A11.251.928.460 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Cells; Cells, Cultured; Clone Cells Cells; Cells, Cultured; Tumor Cells, Cultured The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks (one of several pseudonyms); used for VIRUS CULTIVATION and antitumor drug screening assays. aUO9*Heinz Bodies A11.118.413.330.340.335; A15.145.229.413.330.340.335 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes; Erythrocytes, Abnormal; Erythrocyte Inclusions Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes; Erythrocytes, Abnormal; Erythrocyte Inclusions aWa:(Heel A01.378.592.350.510 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Achilles Tendon; Calcaneus; Talus Body Regions (Non MeSH); Extremities; Leg; Foot Tarsus aX(*= Hedgehogs B02.649.473.376 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Insectivora Insectivora (66-71) aY ()Hebrides Z01.542.363.423 EHEP Geographicals (Non MeSH); Europe; Great Britain aZg ;Heavy Chain Disease C15.378.147.780.490; C15.604.515.435; C20.683.780.490 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunoglobulins, Heavy-Chain Immunoglobulins, Heavy-Chain Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias Immunoproliferative Small Intestinal Disease Immunoproliferative Small Intestinal Disease Immunoproliferative Small Intestinal Disease A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the N- (amino-) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable (V) and constant (C) region genes. $aZ=N!!0-Heating G03.230.150.300 AEECHIISLJMTSNSTTD Environment and Public Health (Non MeSH); Environment; Environment, Controlled a_ ]Heat-Shock Proteins 90 D12.776.410.380; D12.776.580.380 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones A class of MOLECULAR CHAPERONES whose members act in the mechanism of signal transduction by steroid receptors. Heat-Shock Proteins (86-94) a`&F!Heat-Shock Proteins 70 D12.776.410.375; D12.776.580.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones A class of MOLECULAR CHAPERONES found in both prokaryotes and in several compartments of eukaryotic cells. There is evidence that these proteins can interact with polypeptides during a variety of assembly processes in such a way as to prevent the formation of nonfunctional structures. Heat-Shock Proteins (84-94); Proteins (82-83) ab&FN7Heat-Shock Proteins D12.776.410 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Molecular Chaperones Fever; Molecular Chaperones Amino Acids, Peptides and Proteins (Non MeSH); Proteins Chaperonins (+ 4); Heat-Shock Proteins 70; Heat-Shock Proteins 90 Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Heat (66-83); Proteins (66-83) (aeF"DP'Heat Exhaustion C21.866.486 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Sunstroke An effect of excessive exposure to heat occurring commonly among workers in furnace rooms, foundries, etc., although it may occur from exposure to the sun's heat. It is marked by subnormal temperature, with dizziness, headache, nausea, and sometimes delirium and/or collapse. It is distinguished from heat stroke, in which the body temperature may be dangerously elevated. Heat exhaustion is also called heat prostration. (Dorland, 27th ed). ah9NQ Heat G03.230.300.100.725.710.380; H01.671.868.543; H01.671.912.460 AEDUTU Calorimetry; Desert Climate; Hyperthermia, Induced; Rewarming; Tropical Climate; Water Pollution, Thermal Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather; Temperature Physical Sciences (Non MeSH); Physics; Temperature Physical Sciences (Non MeSH); Physics; Thermodynamics consider also terms at THERM-. ak4E |'Heartwater Disease C01.252.400.810.700.810.434; C01.252.400.825.430; C22.434 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases Animal Diseases A tick-borne septicemic disease of ruminants caused by Cowdria ruminantium. Cattle Diseases (66-69); Rickettsial Infections (66-69) amTAJYBHeartburn C23.888.821.525 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus. ap; NHeart, Mechanical E07.858.082.458 AECLCTECHIPXSDSNSTTDUTVE Oxygenators Cardiopulmonary Bypass Equipment and Supplies; Surgical Equipment; Artificial Organs aqIHeart, Artificial E04.752.376.400; E04.920.490.465; E07.450.470; E07.858.082.374; E07.858.565.458 AECLCTECHIPXSDSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Artificial Organs Equipment and Supplies; Surgical Equipment; Prosthesis A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 27th ed). Artificial Organs (66); Heart, Mechanical (66) ar[H,9Heart-Lung Transplantation E04.752.376.475.450; E04.920.490.505.450; E04.920.800.495.450; E04.936.450.475.450; E04.936.450.495.450 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Lung Transplantation Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery; Heart Transplantation Surgery, Operative; Thoracic Surgery; Heart Surgery; Heart Transplantation Surgery, Operative; Thoracic Surgery; Surgery, Lung (Non MeSH); Lung Transplantation Surgery, Operative; Transplantation; Organ Transplantation; Heart Transplantation Surgery, Operative; Transplantation; Organ Transplantation; Lung Transplantation The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another. Heart/transplantation (66-89); Lung/transplantation (66-89)  avs2FHeart-Assist Devices E04.050.430; E07.858.336 AECLCTECHISDSNSTTDUTVE Counterpulsation; Assisted Circulation Surgery, Operative; Assisted Circulation Equipment and Supplies; Surgical Equipment Small pumps, often implantable, designed for temporarily assisting the heart, usually the left ventricle, to pump blood; they consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors; the devices are used after myocardial infarction or to wean the repaired heart from the heart-lung machine after open-heart surgery. Assisted Circulation (67-85); Heart, Artificial (67-85); Pacemaker, Artificial (66-85)  ay-afHeart Ventricle A07.541.560 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ventricular Function; Ventricular Pressure Cardiovascular System; Heart The lower right and left chambers of the heart. The right pumps venous blood into the lungs and the left pumps oxygenated blood into the systemic arterial circulation. a} 82#Heart Valves A07.541.510 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart Aortic Valve; Chordae Tendineae; Mitral Valve; Papillary Muscles; Pulmonary Valve; Tricuspid Valve Flaps of tissue that prevent regurgitation of blood from the ventricles to the atria or from the pulmonary arteries or aorta to the ventricles. a~8#vHeart Valve Prosthesis E04.659.459; E04.752.376.597; E04.920.490.520; E07.450.500; E07.858.565.509 AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis An artificial substitute for a heart valve. It may be mechanical or composed of tissue. (Dorland, 27th ed). anW*$Heart Valve Prolapse C14.280.484.400; C23.835.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Symptoms and General Pathology (Non MeSH); Prolapse Aortic Valve Prolapse; Mitral Valve Prolapse; Tricuspid Valve Prolapse Aortic Valve Prolapse; Mitral Valve Prolapse; Tricuspid Valve Prolapse Displacement of the valves of the heart. Heart Valve Diseases (67-90)  a"N3#Heart Valve Diseases C14.280.484 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Aortic Valve Insufficiency; Aortic Valve Stenosis; Heart Murmurs; Heart Valve Prolapse (+ 3); Mitral Valve Insufficiency; Mitral Valve Stenosis; Pulmonary Atresia; Pulmonary Valve Insufficiency; Pulmonary Valve Stenosis; Tricuspid Atresia; Tricuspid Valve Insufficiency; Tricuspid Valve Stenosis Heart Diseases (66); specific heart valve disease a N/Y=Heart Transplantation E04.752.376.475; E04.920.490.505; E04.936.450.475 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Surgery, Operative; Transplantation; Organ Transplantation Heart-Lung Transplantation Heart-Lung Transplantation Heart-Lung Transplantation The transference of a heart from one human or animal to another. Heart/transplantation (66-89)  ap92YP#Heart Surgery E04.752.376; E04.920.490 AECLECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH) Surgery, Operative; Thoracic Surgery Cardiomyoplasty; Heart Arrest, Induced; Heart, Artificial; Heart Bypass, Right (+ 1); Heart Massage; Heart Transplantation (+ 1); Heart Valve Prosthesis; Myocardial Revascularization (+ 4); Pericardial Window Techniques; Pericardiectomy Cardiomyoplasty; Heart Arrest, Induced; Heart, Artificial; Heart Bypass, Right (+ 1); Heart Massage; Heart Transplantation (+ 1); Heart Valve Prosthesis; Myocardial Revascularization (+ 4); Pericardial Window Techniques; Pericardiectomy Use for general articles concerning surgical procedures on the heart. AECLCTECEDHIIMISLJMAMIMOMTNUOGPAPHPSPXRARHRISDSNSTTDUSUTVEVI  a*j,S@Heart Sounds G09.330.612.515 DEGEIMPHRE Heart Auscultation; Heart Murmurs; Phonocardiography Heart Murmurs Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics The sounds heard over the cardiac region produced by the functioning of the heart. There are four distinct sounds: the first occurs at the beginning of systole and is heard as a "lubb" sound; the second is produced by the closing of the aortic and pulmonary valves and is heard as a "dupp" sound; the third is produced by vibrations of the ventricular walls when suddenly distended by the rush of blood from the atria; and the fourth is produced by atrial contraction and ventricular filling but is rarely audible in the normal heart. The physiological concept of HEART SOUNDS is differentiated from the pathological HEART MURMURS.  ak>{Heart Septum A07.541.459 AHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart The thin membranous structure between the two heart atria or the thick muscular structure between the two heart ventricles. a~6#Heart Septal Defects, Ventricular C14.240.400.560.540; C14.280.400.560.540; C16.131.240.400.560.540 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Heart Septal Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects Congenital defects in the septum between the cardiac ventricles, most often due to failure of the bulbar septum to completely close the interventricular foramen. a(ILHeart Septal Defects, Atrial C14.240.400.560.375; C14.280.400.560.375; C16.131.240.400.560.375 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Heart Septal Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects Lutembacher's Syndrome; Trilogy of Fallot Lutembacher's Syndrome; Trilogy of Fallot Lutembacher's Syndrome; Trilogy of Fallot Defects in the septum between the atria of the heart, due to failure of fusion between either the septum secundum or the septum primum and the endocardial cushions. a#ILHeart Septal Defects C14.240.400.560; C14.280.400.560; C16.131.240.400.560 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Aortopulmonary Septal Defect; Endocardial Cushion Defects; Heart Septal Defects, Atrial (+ 2); Heart Septal Defects, Ventricular Aortopulmonary Septal Defect; Endocardial Cushion Defects; Heart Septal Defects, Atrial (+ 2); Heart Septal Defects, Ventricular Aortopulmonary Septal Defect; Endocardial Cushion Defects; Heart Septal Defects, Atrial (+ 2); Heart Septal Defects, Ventricular Defects in the cardiac septa, resulting in abnormal communications between the opposite chambers of the heart. a=LKHeart Rupture, Post-Infarction C14.280.470.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myocardial Infarction Cardiovascular Diseases; Heart Diseases; Heart Rupture Ventricular Septal Rupture Rupture of the heart after myocardial infarction. Heart Rupture (78-86); Myocardial Infarction (79-86) $a$NA <?Heart Rupture C14.280.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Heart Rupture, Post-Infarction (+ 1) Laceration or tearing of the walls of the heart, of the interatrial or interventricular septum, of the papillary muscles or chordae tendineae, or of any of the valves of the heart. Rupture may be due to a variety of pathological entities, however, the majority are secondary to myocardial infarction (HEART RUPTURE, POST-INFARCTION). Heart Diseases (66-77); Myocardial Infarction (66-77); Rupture, Spontaneous (66-77)  aN/,cHeart Rate, Fetal G09.330.612.509.430 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Heart Rate The heart rate of the fetus. The normal range at term is between 120 and 160 beats per minute. Fetal Heart (66-86); Heart Rate (66-86) av2Heart Rate G09.330.612.509 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Heart Rate, Fetal a&{Heart Neoplasms C04.588.894.309; C14.280.459 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms Cardiovascular Diseases; Heart Diseases a "XvHeart Murmurs C14.280.484.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Heart Auscultation; Heart Sounds; Phonocardiography Heart Sounds Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases A sound generated by disturbed blood flow through the heart manifested as "turbulence". Turbulence is an irregular condition of motion caused by local vibrations of the wall of a vessel or heart chamber. Heart murmurs are usually detectable in VENTRICULAR OUTFLOW OBSTRUCTION and in various types of heart valve disease and are differentiated from HEART SOUNDS, a physiological concept.  a.N=IHeart Massage E02.365.647.375; E04.752.376.458; E04.920.490.490 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Emergency Treatment (Non MeSH); Resuscitation Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery a&9"Heart Injuries C21.866.891.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Thoracic Injuries General or unspecified injuries to the heart. aNg8Heart Hypertrophy C14.280.445 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Cardiomyopathy, Congestive; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular aN/fHeart Function Tests E01.145.569 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Ventricular Function Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Angiocardiography; Ballistocardiography; Cardiac Output (+ 1); Cardiography, Impedance; Cardiotocography; Coronary Angiography; Echocardiography (+ 4); Electrocardiography (+ 5); Exercise Test; Heart Auscultation (+ 1); Heart Catheterization (+ 2); Kinetocardiography; Oximetry (+ 1); Pulse; Radionuclide Ventriculography (+ 2); Valsalva's Maneuver AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE  a&8,Heart Failure, Congestive C14.280.434 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Cardiomyopathy, Congestive; Dyspnea, Paroxysmal; Edema, Cardiac ayN/JHeart Diseases C14.280 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neurocirculatory Asthenia Cardiology Cardiovascular Diseases Arrhythmia (+ 28); Carcinoid Heart Disease; Cardiac Output, High; Cardiac Output, Low; Cardiac Tamponade; Endocarditis (+ 2); Heart Aneurysm; Heart Arrest (+ 1); Heart Defects, Congenital (+ 22); Heart Failure, Congestive (+ 3); Heart Hypertrophy (+ 3); Heart Neoplasms; Heart Rupture (+ 2); Heart Valve Diseases (+ 15); Myocardial Diseases (+ 12); Myocardial Ischemia (+ 14); Pericardial Effusion; Pericarditis (+ 2); Pneumopericardium; Postpericardiotomy Syndrome; Pulmonary Heart Disease; Rheumatic Heart Disease; Ventricular Dysfunction (+ 2); Ventricular Outflow Obstruction BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $a L\Heart Defects, Congenital C14.240.400; C14.280.400; C16.131.240.400 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH) Cardiovascular Diseases; Heart Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH) Aortic Coarctation; Cor Triatriatum; Coronary Vessel Anomalies; Crisscross Heart; Dextrocardia; Ductus Arteriosus, Patent; Ebstein's Anomaly; Eisenmenger Complex; Heart Septal Defects (+ 6); Hypoplastic Left Heart Syndrome; Levocardia; Tetralogy of Fallot; Transposition of Great Vessels (+ 1); Tricuspid Atresia; Truncus Arteriosus, Persistent Aortic Coarctation; Cor Triatriatum; Coronary Vessel Anomalies; Crisscross Heart; Dextrocardia; Ductus Arteriosus, Patent; Ebstein's Anomaly; Eisenmenger Complex; Heart Septal Defects (+ 6); Hypoplastic Left Heart Syndrome; Levocardia; Tetralogy of Fallot; Transposition of Great Vessels (+ 1); Tricuspid Atresia; Truncus Arteriosus, Persistent Aortic Coarctation; Cor Triatriatum; Coronary Vessel Anomalies; Crisscross Heart; Dextrocardia; Ductus Arteriosus, Patent; Ebstein's Anomaly; Eisenmenger Complex; Heart Septal Defects (+ 6); Hypoplastic Left Heart Syndrome; Levocardia; Tetralogy of Fallot; Transposition of Great Vessels (+ 1); Tricuspid Atresia; Truncus Arteriosus, Persistent Imperfections or malformations of the heart, existing at birth. a1LLHeart Conduction System A07.541.409 ABAHCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Arrhythmia Cardiovascular System; Heart Atrioventricular Node; Bundle of His; Purkinje Fibers; Sinoatrial Node An impulse-conducting system composed of modified cardiac muscle and having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $a76#U8Heart Catheterization E01.145.569.540; E02.148.442 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Pulmonary Wedge Pressure Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Therapeutics; Catheterization Catheter Ablation; Catheterization, Swan-Ganz Catheter Ablation; Catheterization, Swan-Ganz Procedure which includes placement of catheter, recording of intracardiac and intravascular pressure, obtaining blood samples for chemical analysis, and cardiac output measurement, etc. Specific angiographic injection techniques are also involved.  aU"&thHeart Bypass, Right E04.035.410; E04.752.376.410; E04.920.490.475 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery Fontan Procedure Fontan Procedure Fontan Procedure Diversion of the flow of blood from the entrance to the right atrium directly to the pulmonary arteries, avoiding the right atrium and right ventricle (Dorland, 27th ed). This a permanent procedure often performed to bypass a congenitally deformed right atrium or right ventricle. a5$;JHeart Bypass, Left E04.292.465 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cardiopulmonary Bypass Surgery, Operative; Extracorporeal Circulation Diversion of the flow of blood from the pulmonary veins directly to the aorta, avoiding the left atrium and the left ventricle (Dorland, 27th ed). This is a temporary procedure usually performed to assist other surgical procedures. a$6Heart Block C14.280.067.558 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Adams-Stokes Syndrome; Bundle-Branch Block; Sinoatrial Block Impairment of conduction in heart excitation. It is often applied specifically to atrioventricular heart block. (Dorland, 27th ed). aħN=GHeart Auscultation E01.145.569.499; E01.706.110.458 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Phonocardiography Auscultation; Heart Sounds; Heart Murmurs Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Physical Examination; Auscultation Phonocardiography Act of listening for sounds within the heart. $a_&&39Heart Atrium A07.541.358 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Atrial Function Cardiovascular System; Heart The upper right and left chambers of the heart. a8#<Heart Arrest, Induced E04.752.376.374; E04.920.490.460 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cardioplegic Solutions Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery a&$Heart Arrest C14.280.383 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Resuscitation Cardiovascular Diseases; Heart Diseases Death, Sudden, Cardiac Sudden and usually momentary cessation of cardiac function. This sudden cessation may, but not usually, lead to DEATH, SUDDEN, CARDIAC.  a3N/Heart Aneurysm C14.280.358; C14.907.055.608 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Cardiovascular Diseases; Vascular Diseases; Aneurysm a"NkHeart A07.541 AHDEEMGDIRMIPHPPPSRARERIVI Angiocardiography; Anti-Arrhythmia Agents; Ballistocardiography; Cardiotonic Agents; Electrocardiography; Myocardium Cardiovascular System Endocardium; Fetal Heart (+ 2); Heart Atrium; Heart Conduction System (+ 4); Heart Septum; Heart Valves (+ 6); Heart Ventricle; Myocardium; Pericardium The hollow, muscular organ that maintains the circulation of the blood. consider also terms at CARDI- and MYOCARDI-. ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $a  8Hearing Tests E01.276.299.375 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH) Acoustic Impedance Tests; Audiometry (+ 5); Dichotic Listening Tests; Recruitment Detection (Audiology) aR"_zHearing Loss, Sensorineural C09.218.458.500.481 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial Hearing Loss, Central; Hearing Loss, Noise-Induced; Presbycusis Hearing loss resulting from damage to the sensory mechanism internal from the oval and round windows. Deafness (66-78)  aЕ!NdKyHearing Loss, Partial C09.218.458.500; C10.597.257.443.439; C23.888.592.257.443.439 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Hearing Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Hearing Disorders Hearing Loss, Bilateral; Hearing Loss, Conductive; Hearing Loss, Functional; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural (+ 3) A condition in which the sense of hearing, although defective, is functional with or without a hearing aid. The hearing level for speech is approximately 40-70 decibels I.S.O. (International Organization for Standardization) or 30-60 db A.S.A. (American Standards Association). Deafness (66-78); Hearing Disorders (66-78)  a҃EN[D5Hearing Loss, Noise-Induced C09.218.458.500.481.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Noise Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial; Hearing Loss, Sensorineural Hearing loss from exposure to noise. The loss is often in the frequency range 4000-6000 hertz. Acoustic Trauma (66-78); Deafness (66-78); Noise (66-78)  a!N sFHearing Loss, High-Frequency C09.218.458.500.448 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial Hearing loss in frequencies above 1000 hertz. Deafness (66-78) a"Nd8Hearing Loss, Functional C09.218.458.500.442; F03.126.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Hearing loss without a physical basis. It is often the result of malingering or hysteria. Deafness (66-78) a1&NmHearing Loss, Conductive C09.218.458.500.437 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial Hearing loss due to interference with the acoustic transmission of sound to the cochlea. The interference is in the outer or middle ear. Deafness (66-78) a'NdHearing Loss, Central C09.218.458.500.481.432; C09.218.807.186.432; C10.228.140.068.432 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial; Hearing Loss, Sensorineural Otorhinolaryngologic Diseases; Ear Diseases; Retrocochlear Diseases (Non MeSH); Auditory Diseases, Central Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Auditory Diseases, Central Hearing loss due to central nervous system disease, anywhere in the auditory pathways from the cochlear nucleus of the pons to the auditory cortex. Deafness (66-78) aINsHearing Loss, Bilateral C09.218.458.500.403 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Hearing Loss, Partial Partial hearing loss in both ears. Deafness (66-78) aNd,Hearing Disorders C09.218.458; C10.597.257.443; C23.888.592.257.443 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Nervous System Diseases; Neurologic Manifestations; Communicative Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders Deafness (+ 1); Hearing Loss, Partial (+ 8); Recruitment, Loudness; Tinnitus Deafness; Hearing Loss, Partial; Recruitment, Loudness; Tinnitus Deafness; Hearing Loss, Partial; Recruitment, Loudness; Tinnitus aL9NHearing Aids E07.814.458 AECLCTECHIPXSDSNSTTDUTVE Deafness Equipment and Supplies; Sensory Aids Cochlear Implant AECLCTECHIMIPSPXSDSNSTTDUTVEVI  a -"Hearing F02.830.816.263; G11.561.796.263 DEGEIMPHRE Acoustic Stimulation; Auditory Perception; Bone Conduction Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sensation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation  Auditory Perception; Bone Conduction; Otoacoustic Emissions, Spontaneous The sensation of sound. consider also terms at ACOUSTIC and AUDIO-. CLDEGEIMPHRE $a &EUSHealthy Worker Effect G03.850.490.734.750; N05.715.350.350.375 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Effect Modifiers (Epidemiology) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Effect Modifiers (Epidemiology) Phenomenon of workers' usually exhibiting overall death rates lower than those of the general population due to the fact that the severely ill and disabled are ordinarily excluded from employment. a*. Health Systems Plans N03.349.650.270 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning Statements of goals for the delivery of health services pertaining to the Health Systems Agency service area, established under PL 93-641, and consistent with national guidelines for health planning. agHealth Systems Agencies N03.540.452.508.440 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Health Planning Organizations; State Health Planning and Development Agencies Health planning and resources development agencies which function in each health service area of the United States (PL 93-641). Health Planning (68-77) a9Health Surveys E05.318.308.250; G03.850.520.308.250; N05.715.360.300.375 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection Dental Health Surveys (+ 4); Health Status Indicators (+ 1); Mass Screening (+ 5); Nutrition Surveys (+ 1); Population Surveillance (+ 1) Dental Health Surveys (+ 4); Health Status Indicators (+ 1); Mass Screening (+ 5); Nutrition Surveys (+ 1); Population Surveillance (+ 1) Dental Health Surveys (+ 4); Health Status Indicators (+ 1); Mass Screening (+ 5); Nutrition Surveys (+ 1); Population Surveillance (+ 1) A systematic collection of factual data pertaining to health and disease in a human population within a given geographic area. AECLCTECHIISLJMOMTNUOGPXSNSTTDUTVE aA^&Health Status Indicators E05.318.308.250.475; G03.850.520.308.250.475; N05.715.360.300.375.375 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys Sickness Impact Profile Sickness Impact Profile Sickness Impact Profile The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources. aMSHealth Status G03.850.505.400.425; I01.240.425; N01.224.425 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography Social Sciences; Demography Population Characteristics (Non MeSH); Demography  Nutritional Status The level of health of the individual, group, or population as subjectively assessed by the individual or by more objective measures. Health (66-79); Health Status Indicators (75-79); Health Surveys (66-79) DEGEIMPHRE  a5XHealth Services, Indigenous N02.421.330 CLECHILJMAOGSDSNSTTDUT Medicine, Traditional Facilities, Manpower and Services (Non MeSH); Health Services Health care provided to specific cultural or tribal peoples which incorporates local customs, beliefs, and taboos. a!JHealth Services Research N03.349.380; N05.425 CLECHILJMAMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning Quality, Access, Evaluation (Non MeSH) Health Services Needs and Demand The integration of epidemiologic, sociological, economic, and other analytic sciences in the study of health services. Health services research is usually concerned with relationships between need, demand, supply, use, and outcome of health services. The aim of the research is evaluation, particularly in terms of structure, process, output, and outcome. (From Last, Dictionary of Epidemiology, 2d ed). Health Services (74-79); Research (66-79)  axu)3Health Services Needs and Demand N03.349.380.420; N05.300.450 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Health Services Research Quality, Access, Evaluation (Non MeSH); Delivery of Health Care  Medically Underserved Area Health services required by a population or community as well as the health services that the population or community is able and willing to pay for. It includes the identification and assessment of the needs as measured by objective criteria and standards. a("!0Health Services Misuse N02.421.380; N05.300.150.395 ECLJSNTD Facilities, Manpower and Services (Non MeSH); Health Services Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health Excessive or unnecessary utilization of health services by patients or physicians. a$" aHealth Services for the Aged N02.421.320 CLECHILJMAOGSDSNSTTDUT Aged; Frail Elderly Facilities, Manpower and Services (Non MeSH); Health Services Services for the diagnosis and treatment of diseases in the aged and the maintenance of health in the elderly. Aged (66-79); Health Services (74-79); specific health service (66-79)  b$JVHealth Services Administration (Non MeSH) N04 Organization and Administration (+ 205); Patient Care Management (Non MeSH) (+ 34); Quality of Health Care (+ 20) CLECEDEHHIISLJMAMTOGPXSDSNSTTDUTVE bV1&Health Services Accessibility N04.590.374.350; N05.300.430 CLECHILJOGSNSTTD Medically Underserved Area Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care Quality, Access, Evaluation (Non MeSH); Delivery of Health Care  Health Care Rationing; Health Facility Closure; Health Facility Environment; Health Facility Size; Marketing of Health Services The degree to which individuals are inhibited or facilitated in their ability to gain entry to and to receive care and services from the health care system. Factors influencing this ability include geographic, architectural, transportational, and financial considerations, among others. Delivery of Health Care (71-77); Health Services (74-77) CLECHILJMAMTOGSDSNSTTDUT (b]#" KEHealth Services N02.421 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH) Adolescent Health Services; Child Care (+ 4); Community Health Services (+ 47); Dental Health Services (+ 5); Dietary Services (+ 2); Emergency Medical Services (+ 9); Health Services for the Aged; Health Services, Indigenous; Health Services Misuse; Mental Health Services (+ 4); Nursing Care (+ 18); Nursing Services (+ 1); Organ Procurement; Patient Care Characteristics (Non MeSH) (+ 31); Personal Health Services; Pharmaceutical Services (+ 5); Preventive Health Services (+ 15); Rehabilitation (+ 4); Social Work (+ 1); Student Health Services; Women's Health Services (+ 1) Services for the diagnosis and treatment of disease and the maintenance of health. AECLCTECEDHIISLJMAMOMTNUOGPXRHSDSNSTTDUTVE  b 5c.Health Resources N03.349.340; N05.300.420 CLECHILJOGSDSNSTTDUT Health Care Rationing Economics, Organizations, Control (Non MeSH); Health Planning Quality, Access, Evaluation (Non MeSH); Delivery of Health Care  Health Manpower Available manpower, facilities, revenue, equipment, and supplies to produce requisite health care and services.  b Health Resorts G03.850.860.410.250 CLECHILJSNST Balneology Environment and Public Health (Non MeSH); Public Health; Sanitation; Public Facilities (Non MeSH) b uHealth Promotion N02.370 CLECHILJMAMTOGSDSNSTTDUT Health Behavior Health Education; Preventive Health Services; Preventive Medicine Facilities, Manpower and Services (Non MeSH) Encouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care.  b  M5Health Priorities N03.349.330; N05.300.400 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Preferentially rated health-related activities or functions to be used in establishing health planning goals. This may refer specifically to PL93-641. b]Health Policy I01.880.604.710.608.400; N03.706.710.608.428 ECHILJTD Policy Making Social Sciences; Sociology; Social Control, Formal; Policies (Non MeSH); Public Policy Economics, Organizations, Control (Non MeSH); Social Control, Formal; Policies (Non MeSH); Public Policy Health Care Reform; Nutrition Policy Health Care Reform; Nutrition Policy Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system. National Health Programs (77-79); Public Policy (78-79) CLECHILJMTOGSNSTTDUT (b 2 XCHealth Planning Technical Assistance N03.349.325 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning The provision of expert assistance in developing health planning programs, plans as technical materials, etc., as requested by Health Systems Agencies or other health planning organizations. b+IHealth Planning Support N03.219.483.408 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Support (Non MeSH) Financial resources provided for activities related to health planning and development. Financing, Government (68-79); Health Planning (68-79) bsefAHealth Planning Organizations N03.540.452 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations Health Care Coalitions; Health Planning Councils; State Health Planning and Development Agencies (+ 1) Organizations involved in all aspects of health planning activities. b#FyQHealth Planning Guidelines N03.349.315 Economics, Organizations, Control (Non MeSH); Health Planning Recommendations for directing health planning functions and policies. These may be mandated by PL93-641 and issued by the Department of Health and Human Services for use by state and local planning agencies. Health Planning (68-79) bk IHealth Planning Councils N03.540.452.210 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Health Planning Organizations Organized groups serving in advisory capacities related to health planning activities. Health Planning (68-79) bieHealth Planning N03.349 CLECHILJMTOGSNSTTDUT Planning Techniques Economics, Organizations, Control (Non MeSH) Health Care Rationing; Health Care Reform; Health Plan Implementation; Health Planning Guidelines; Health Planning Technical Assistance; Health Priorities; Health Resources; Health Services Research (+ 1); National Health Planning and Resources Development Act of 1974; National Health Programs (+ 1); Regional Health Planning (+ 10) Planning for needed health and/or welfare services and facilities. Social Medicine (66-67); Social Welfare (66-67) CLECHILJMAMTOGSDSNSTTDUT (bp 4P:Health Plan Implementation N03.349.300 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning Those actions designed to carry out recommendations pertaining to health plans or programs. Health Planning (68-79) bT IlHealth Physics G02.229.333; H01.671.368 CLECEDHIISLJMAMTOGSNSTTD Radiation Monitoring; Radiation Protection; Radiometry Health Occupations; Environmental Health Physical Sciences (Non MeSH); Physics The science concerned with problems of radiation protection relevant to reducing or preventing radiation exposure, and the effects of ionizing radiation on humans and their environment. Radiation Protection (66)  b@]Health Personnel M01.526.485; N02.360 CLECEDHILJOGPXSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Facilities, Manpower and Services (Non MeSH) Allied Health Personnel (+ 19); Caregivers; Coroners and Medical Examiners; Dental Staff (+ 1); Dentists (+ 1); Faculty, Dental; Faculty, Medical; Faculty, Nursing; Health Facility Administrators (+ 2); Infection Control Practitioners; Laboratory Personnel; Medical Directors; Medical Staff (+ 1); Nurses (+ 6); Nursing Staff (+ 1); Personnel, Hospital (+ 7); Pharmacists; Physicians (+ 3); Veterinarians Allied Health Personnel (+ 19); Caregivers; Coroners and Medical Examiners; Dental Staff (+ 1); Dentists (+ 1); Faculty, Dental; Faculty, Medical; Faculty, Nursing; Health Facility Administrators (+ 2); Infection Control Practitioners; Laboratory Personnel; Medical Directors; Medical Staff (+ 1); Nurses (+ 6); Nursing Staff (+ 1); Personnel, Hospital (+ 8); Pharmacists; Physicians (+ 3); Veterinarians Men and women working in the provision of health services, whether as individual practitioners or employees of health institutions and programs, whether or not professionally trained, and whether or not subject to public regulation. (From A Discursive Dictionary of Health Care, 1976). Health Manpower (66-91) CLECEDHILJOGPXSDSNSTTDUT $b!MHealth Occupations G02 CLECEDHILJSNSTTD Occupations Allied Health Occupations (+ 7); Biomedical Engineering; Chiropractic; Dentistry (+ 19); Dietetics; Environmental Health (+ 3); Hospital Administration; Medical Illustration; Medicine (+ 79); Mortuary Practice (+ 2); Nursing (+ 26); Nursing, Practical; Nutrition; Optometry; Orthoptics; Pharmacology (+ 4); Pharmacy; Podiatry; Psychology, Medical; Serology; Sociology, Medical; Specialism; Technology, Pharmaceutical; Veterinary Medicine (+ 3) Professions or other business activities directed to the cure and prevention of disease. For occupations of medical personnel who are not physicians but who are working in the fields of medical technology, physical therapy, etc., ALLIED HEALTH OCCUPATIONS is available. AECLCTECEDHIISLJMAMOMTNUOGPHPXRHSNSTTDUTVE  b':.Health Manpower N02.350; N05.300.420.400 CLECHILJOGSNSTTDUT Medicine Facilities, Manpower and Services (Non MeSH) Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Resources The availability of HEALTH PERSONNEL. It includes the demand and recruitment of both professional and allied health personnel, their present and future supply and distribution, and their assignment and utilization. Health Occupations (66-67)  b+  Health Maintenance Organizations N03.219.521.576.343.800.400; N03.219.521.576.343.925.400; N04.452.758.244.425; N04.590.374.410.400 CLECHILJMAOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Managed Care Programs Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Prepaid Health Plans Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Group Practice Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care; Managed Care Programs Organized systems for providing comprehensive prepaid health care that have five basic attributes: 1) provide care in a defined geographic area; 2) provide or ensure delivery of an agreed-upon set of basic and supplemental health maintenance and treatment services; 3) provide care to a voluntarily enrolled group of persons; 4) require their enrollees to use the services of designated providers; and 5) receive reimbursement through a predetermined, fixed, periodic prepayment made by the enrollee without regard to the degree of services provided. (From Facts on File Dictionary of Health Care Management, 1988). Group Practice (66-70); Insurance, Health (66-70) b-&lE<Health Fairs I02.233.332.390; N02.421.143.827.407.478; N02.421.726.407.478 CLECHILJMAMTOGSDSNSTTDUT Education; Education, Nonprofessional (Non MeSH); Health Education Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Health Education Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Health Education Community health education events focused on prevention of disease and promotion of health through audiovisual exhibits. Exhibits (66-82); Health Education (66-82) b4Eh4Health Facility Size N02.278.306; N05.300.430.410 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Services Accessibility Hospital Bed Capacity (+ 4) The physical space or dimensions of a facility. Size may be indicated by bed capacity. Hospitals (66-67)  b6"$jHealth Facility Planning N03.349.650.250 ECHILJOGSNSTTD Facility Design and Construction Architecture Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning Bed Conversion; Hospital Planning Areawide planning for health care institutions on the basis of projected consumer need. Hospital Design and Construction (66-67) CLECHILJMTOGSNSTTDUT ,b8'g)h0Health Facility Moving N02.278.255 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities The relocation of health care institutions or units thereof. The concept includes equipment relocation. b:LzHealth Facility Merger N02.278.235 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities The combining of administrative and organizational resources of two or more health care facilities. b;LuHealth Facility Environment N02.278.220; N05.300.430.400 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Services Accessibility Patients' Rooms Physical surroundings or conditions of a hospital or other health facility and influence of these factors on patients and staff. b= !"Health Facility Closure N02.278.218; N05.300.430.390 ECHILJMTSNSTTD Facilities, Manpower and Services (Non MeSH); Health Facilities Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Services Accessibility The closing of any health facility, e.g., health centers, residential facilities, and hospitals. Hospital Administration (66-Jul 77) b>"q*Health Facility Administrators M01.526.070.490; M01.526.485.430; N02.360.430 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Administrative Personnel Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Hospital Administrators (+ 1) Hospital Administrators (+ 1) Hospital Administrators (+ 1) Managerial personnel responsible for implementing policy and directing the activities of health care facilities such as nursing homes. b@$5hHealth Facilities, Proprietary N02.278.215 CLECHILJOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Hospitals, Proprietary Health care institutions operated by private groups or corporations for a profit. CLECHILJMAOGSDSNSTTDUT  bCx$LaHealth Facilities N02.278 CLECHILJOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH) Academic Medical Centers (+ 3); Ambulatory Care Facilities (+ 9); Bed Occupancy; Biological Specimen Banks (+ 6); Birthing Centers; Dental Facilities (+ 3); Facility Design and Construction (+ 2); Health Facilities, Proprietary (+ 1); Health Facility Closure; Health Facility Environment (+ 1); Health Facility Merger; Health Facility Moving; Health Facility Size (+ 5); Hospital Administration (+ 53); Hospital Units (+ 12); Hospitals (+ 33); Laboratories (+ 1); Leper Colonies; Medical Office Buildings; Nurseries (+ 1); Pharmacies; Physicians' Offices; Poison Control Centers; Rehabilitation Centers (+ 2); Residential Facilities (+ 6) Institutions which provide medical or health-related services. specific facility (1966-67) CLECEDHIISLJMAMTOGPXSDSNSTTDUT $bD 5I!"Health Expenditures N03.219.151.450; N05.300.385 CLHILJSNSTTD Health Care Costs Health Care Costs Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Capital Expenditures The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs (HEALTH CARE COSTS) and may or may not be shared among the patient, insurers, and/or employers. Economics (66-67); Economics, Medical (66-67) (bH"`7Health Education, Dental G03.890.410; I02.233.332.374; N02.421.143.827.407.457; N02.421.726.407.457 CLECHILJMAMTOGSNSTTDUT Public Health Dentistry; Preventive Dentistry Environment and Public Health (Non MeSH); Public Health Dentistry Education; Education, Nonprofessional (Non MeSH); Health Education Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Health Education Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services; Health Education Education which increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of dental health on a personal or community basis. bLT6Health Education G03.850.630; I02.233.332; N02.421.143.827.407; N02.421.726.407 CLECHILJMAMTOGSNSTTDUT Health Promotion Environment and Public Health (Non MeSH); Public Health Education; Education, Nonprofessional (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services  Health Education, Dental; Health Fairs; Patient Education; Sex Education Health Education, Dental; Health Fairs; Patient Education Health Education, Dental; Health Fairs; Patient Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. CLECHILJMAMTOGSDSNSTTDUT $bOfHjHealth Care Reform I01.880.604.710.608.400.285; N03.349.285; N03.706.710.608.428.285; N04.590.374.285; N05.300.380 CLECHILJMTOGSNSTTDUT Social Sciences; Sociology; Social Control, Formal; Policies (Non MeSH); Public Policy; Health Policy Economics, Organizations, Control (Non MeSH); Health Planning Economics, Organizations, Control (Non MeSH); Social Control, Formal; Policies (Non MeSH); Public Policy; Health Policy Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Innovation and improvement of the health care system by reappraisal, amendment of services, and removal of faults and abuses in providing and distributing health services to patients. It includes a re-alignment of health services and health insurance to maximum demographic elements (the unemployed, indigent, uninsured, elderly, inner cities, rural areas) with reference to coverage, hospitalization, pricing and cost containment, insurers' and employers' costs, pre-existing medical conditions, prescribed drugs, equipment, and services. Delivery of Health Care (70-93); Health Planning (68-92); Health Policy (81-93); Health Services (77-93) bSDkgHealth Care Rationing N03.349.270; N05.300.430.375 CLECHILJOGSNSTTDUT Patient Selection Health Resources Economics, Organizations, Control (Non MeSH); Health Planning Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Services Accessibility Planning for the equitable allocation, apportionment, or distribution of available health resources. Health Resources/supply and distribution (78-88); Health Services/supply and distribution (74-88) $bX"trHealth Care Costs N03.219.151.400; N05.300.375 CLHILJSNSTTD Health Expenditures Health Expenditures Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Direct Service Costs; Drug Costs; Employer Health Costs; Hospital Costs Direct Service Costs; Drug Costs; Employer Health Costs; Hospital Costs The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost. Costs and Cost Analysis (66-91); Health Expenditures (68-91) CLHILJOGSNSTTDUT ,b[I"uIHealth Care Coalitions N03.540.452.188 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Health Planning Organizations Voluntary groups of people representing diverse interests in the community such as hospitals, businesses, physicians, and insurers, with the principal objective to improve health care cost effectiveness. Health Planning Organizations (80-85) b_"i,Health Benefit Plans, Employee N01.824.417.700.325; N03.219.521.576.343.290; N04.452.677.800.325 CLECHILJOGSNSTTDUT Cost Sharing Population Characteristics (Non MeSH); Socioeconomic Factors; Income; Salaries and Fringe Benefits Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health Health Services Administration (Non MeSH); Organization and Administration; Personnel Management; Salaries and Fringe Benefits Health insurance plans for employees, and generally including their dependents, usually on a cost-sharing basis with the employer paying a percentage of the premium. ba %IHealth Behavior F01.145.076.347.410; N05.300.150.375 EH Life Style; Health Promotion Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude; Attitude to Health Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Attitude to Health Smoking Cessation Behaviors expressed by individuals to protect, maintain or promote their health status. For example, proper diet, and appropriate exercise are activities perceived to influence health status. Life style is closely associated with health behavior and factors influencing life style are socioeconomic, educational, and cultural. Attitude to Health (69-88) ECEHMTPXSN (bd *$x!Health and Disease (Non MeSH) N01.407 Population Characteristics (Non MeSH) Disease (+ 6); Health (+ 11) CLDTECEDEHEPETHIISLJMAMOMTNUPHPXRHSNSTTDTH bg,% ,'.Health N01.407.540 Population Characteristics (Non MeSH); Health and Disease (Non MeSH) Family Health; Holistic Health; Mental Health; Occupational Health; Oral Health; Physical Fitness; Public Health; Rural Health; Urban Health; Women's Health; World Health The state of the organism when it functions optimally without evidence of disease. CLECEDEHHIISLJMAMTPHPXSNSTTD bh Rc Headache C10.597.617.485; C23.888.592.612.429 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Tension Headache Tension Headache; Vascular Headache (+ 2) bi *NFHead-Down Tilt G11.427.818.300 AEPH Tilt-Table Test Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Posture Posture while lying with the head lower than the rest of the body. Extended time in this position is associated with temporary physiologic disturbances. Posture (66-94)  bk|Head Protective Devices E07.712.350 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices Personal devices for protection of heads from impact, penetration from falling and flying objects, and from limited electric shock and burn. bmA3Head Injuries, Closed C21.866.460.382; C21.866.974.382 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Brain Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Wounds, Nonpenetrating Organic or functional damage resulting from trauma to the head where continuity of the scalp and mucous membranes is maintained. When brain injury results from closed head injuries, the primary cause is mechanical stretching and shearing of nerve fibers. Also common are focal intracranial lesions including hematomas and contusions. Head Injuries (66-91)  bn&NHead Injuries C21.866.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Brain Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Brain Injuries (+ 1); Cerebrospinal Otorrhea; Cerebrospinal Rhinorrhea; Head Injuries, Closed; Maxillofacial Injuries (+ 12); Pneumocephalus; Skull Fractures (+ 5) General or unspecified injuries involving the head.  bqNQ>Head and Neck Neoplasms C04.588.443 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Esophageal Neoplasms; Facial Neoplasms; Mouth Neoplasms (+ 10); Otorhinolaryngologic Neoplasms (+ 11); Thyroid Neoplasms (+ 1); Tracheal Neoplasms Neoplasms of the head and neck. bsX1)Head A01.456 ABAHBSEMGDIRMIPAPHPPPSRARERISUUSVI Facial Bones; Skull Body Regions (Non MeSH) Ear; Face (+ 10) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  bun &:Hazardous Waste G03.850.460.710.380 AEANCLECHILJPCSN Hazardous Substances Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products Radioactive Waste Waste products which, upon release into the atmosphere, water or soil, cause health risks to humans or animals through skin contact, inhalation or ingestion. Hazardous waste sites which contain hazardous waste substances go here. Environmental Pollutants (75-87); Environmental Pollution (71-87); Industrial Waste (66-87); Refuse Disposal (66-87); Waste Products (76-87) $bv\s Hazardous Substances D05.284.360 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hazardous Waste Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Substances which, upon release into the atmosphere, water, or soil, or which, in direct contact with the skin, eyes, or mucous membranes, or as additives to food, cause health risks to humans or animals through absorption, inhalation, or ingestion. The concept includes safe handling, transportation, and storage of these substances. Environmental Exposure (67-88); Environmental Pollutants (75-88); Environmental Pollution (71-88)  by6UqHay Fever C08.460.799.407; C08.674.425; C09.603.799.407; C20.543.480.680.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pollen Respiratory Tract Diseases; Nose Diseases; Rhinitis Respiratory Tract Diseases; Respiratory Hypersensitivity Otorhinolaryngologic Diseases; Nose Diseases; Rhinitis Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity A seasonal variety of allergic rhinitis, marked by acute conjunctivitis with lacrimation and itching, regarded as an allergic condition triggered by specific allergens. b|LN 'Hawaii Z01.107.567.875.100.326; Z01.782.815.482 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); Pacific Islands; Polynesia b~ .Haversian System A10.165.265.507 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Connective Tissue; Bone and Bones b:IHate F01.470.548 Behavior and Behavior Mechanisms (Non MeSH); Emotions An enduring attitude or sentiment toward persons or objects manifested by anger, aversion and desire for the misfortune of others. bAHarvey Sarcoma Virus B04.265.600.400; B04.820.650.730.730.900.750.400; B04.909.574.807.730.730.900.750.400; B04.909.777.731.730.730.900.750.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses; Sarcoma Viruses, Murine Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Sarcoma Viruses, Murine A replication-defective mouse sarcoma virus (SARCOMA VIRUSES, MURINE) first described by J.J. Harvey in 1964. Mouse Sarcoma Viruses (80-83); Mouse Tumor Viruses (66-79) bzGHartnup Disease C10.228.140.163.331; C10.496.313; C12.777.419.815.191.457; C18.452.648.066.210.490; C18.452.648.851.191.457; F03.709.346.342 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Indican Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Mental Retardation Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors; Aminoaciduria, Renal Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Aminoaciduria, Renal Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors; Aminoaciduria, Renal Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Familial syndrome characterized clinically by a pellagrous rash, cerebellar ataxia, and mental retardation and biochemically by the loss of renal tubular and intestinal transport of neutral amino acids. bL Hartmannella B01.841.750.656.475.100.700.430 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Tubulina A genus of free-living amoebae found in fresh water. The cysts usually pass harmlessly through the intestinal tract of man and may thus be found in feces. Occasionally, these organisms cause respiratory tract infections or generalized fatal meningoencephalitis. Amoeba (66-71); Sarcodina (66-71) b#&b1*Harringtonines D03.132.420; D22.204.179.424 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Substances isolated from the seeds of Cephalotaxus harringtonia, var. drupacea. They are esters of the alkaloid cephalotaxine and may be effective as antineoplastic agents. Alkaloids (72-76); Dioxoles (72-76) b:">,Harmine D03.132.415; D03.494.515; D08.373.616.300; D15.300.337; D15.700.372.454 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens Alkaloid isolated from seeds of Peganum harmala L., Zygophyllaceae. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic Parkinson disease in the 1920's. Alkaloids (69-74); Indoles (69-74); Pyridines (69-74) bf SDZBHarmaline D03.132.410; D03.494.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) 4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido[3,4-b]indole. Alkaloid isolated from seeds of Peganum harmala L., Zygophyllaceae. A CNS stimulant acting as a monoamine oxidase inhibitor. Alkaloids (70-74); Indoles (70-74); Pyridines (72-74) b :mBHardness Tests E05.417; H01.671.347.457 ISMTST Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics; Hardness b cHardness H01.671.347 DERE Physical Sciences (Non MeSH); Physics Hardness Tests DEISMTREST bH /Harderian Gland A13.445 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) A sebaceous gland that, in some animals, acts as an accessory to the lacrimal gland. The harderian gland excretes fluid that facilitates movement of the third eyelid. b :Haptoglobins D12.776.124.050.300; D12.776.124.790.106.394; D12.776.377.715.085.394; D12.776.395.560.373 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins Plasma glycoproteins that form a stable complex with hemoglobin to aid the recycling of heme iron. They are encoded in man by a gene on the short arm of chromosome 16. bBdDHaptens D24.611.216.119.480 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants p-Azobenzenearsonate; Cardiolipins; Dinitrochlorobenzene; Nitrohydroxyiodophenylacetate; Picryl Chloride Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response. AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR  b 6uDHappiness F01.470.516 Behavior and Behavior Mechanisms (Non MeSH); Emotions Highly pleasant emotion characterized by outward manifestations of gratification; joy. Emotions (66-69) bC AeHaplotypes G05.470 DEGEIMPHRE Genetics The genetic constitution of individuals with respect to one member of a pair of allelic genes; sets of single alleles or closely linked genes that tend to be inherited together, such as those of the major histocompatibility complex; portions of phenotypes determined by genes located on one of a pair of chromosomes. Genotype (68-86); Haploidy (68-86); specific histocompatibility antigen (75-86) b=  v^Haplorhini B02.649.801.400 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates Cebidae (+ 12); Cercopithecidae (+ 17); Hominidae; Hylobatidae (+ 1); Pongidae (+ 3); Tarsiidae A suborder of PRIMATES consisting of six families: CEBIDAE (New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), PONGIDAE (great apes), TARSIIDAE (tarsiers), and HOMINIDAE (humans). bk(&yHaploidy G05.148.777.456 Genetics; Cytogenetics; Ploidies The number of chromosomes in the gametes, which is half the number normally found in somatic cells. Symbol: N. Chromosomes (66-67) b} (Hantavirus Pulmonary Syndrome C02.782.147.420.380; C08.618.846.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections; Hantavirus Infections Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Acute respiratory illness in humans caused by the Muerto Canyon virus whose primary rodent reservoir is the deer mouse Peromyscus maniculatus. First identified in the southwestern United States, this syndrome is characterized most commonly by fever, myalgias, headache, cough, and rapid respiratory failure. Bunyaviridae Infections (93-94) b#*Pc%Hantavirus Infections C02.782.147.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections Hantavirus Pulmonary Syndrome; Hemorrhagic Fever with Renal Syndrome Infections with viruses of the genus HANTAVIRUS. This is associated with at least four clinical syndromes: HEMORRHAGIC FEVER WITH RENAL SYNDROME caused by viruses of the Hantaan group; a milder form of HFRS caused by Seoul and related viruses; nephropathia epidemica caused by Puumala and related viruses; and HANTAVIRUS PULMONARY SYNDROME caused by Muerto Canyon virus. Bunyaviridae Infections (84-94)  bPWP%Hantavirus B04.820.087.440; B04.909.777.147.440 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae Hantaan Virus Hantaan Virus A genus of the family BUNYAVIRIDAE causing HANTAVIRUS INFECTIONS, first identified during the Korean war. Infection is found primarily in rodents and humans. Transmission does not appear to involve arthropods. The genus has one recognized group (Hantaan group) consisting of several species including Leaky virus, Seoul virus, Prospect Hill virus, Puumala virus, Thottapalayam virus, and HANTAAN VIRUS, the type species. b*y"Hantaan Virus B04.820.087.440.400; B04.909.777.147.440.400 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Hantavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Hantavirus The type species of the genus HANTAVIRUS infecting the rodent Apodemus agrarius and humans who come in contact with it. It causes syndromes of hemorrhagic fever associated with vascular and especially renal pathology. b2Hansenula B05.354.107.292.420; B05.354.930.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Endomycetales Algae and Fungi (Non MeSH); Fungi; Yeasts Yeast-like fungi, of the family Saccharomycetaceae, order Endomycetales isolated from trees, bark beetles, fruit, and soil. b *"Handwriting L01.143.506.423.906.539 Agraphia Information Science; Communication; Language; Language Arts (Non MeSH); Writing Paleography; Shorthand HIIS b` `Handwashing G03.850.780.200.400 MTST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control The act of cleansing the hands with water or other liquid, with or without the inclusion of soap or other detergent, for the purpose of removing soil or microorganisms. Cross Infection/prevention and control (66-81); Disinfection (75-81); Sterilization (66-74) bAlHandling (Psychology) F01.658.556 Behavior and Behavior Mechanisms (Non MeSH); Motivation Physical manipulation of animals and humans to induce a behavioral or other psychological reaction. In experimental psychology, the animal is handled to induce a stress situation or to study the effects of "gentling" or "mothering". b[CHand, Foot and Mouth Disease C02.782.687.359.213.331 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections; Coxsackievirus Infections A mild, highly infectious viral disease of children, characterized by vesicular lesions in the mouth and on the hands and feet. It is caused by COXSACKIEVIRUSES A. b$PHand-Schueller-Christian Syndrome C15.604.667.400.400.490 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytosis, Langerhans-Cell Disseminated, chronic form of Langerhans-cell histiocytosis. It may exhibit the classic triad of exophthalmos, diabetes insipidus, and bone destruction. b&NHand Strength E01.706.475; G11.427.449 PH Diagnosis; Physical Examination Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Force exerted when gripping or grasping. Hand/physiology (66-94) b2Hand Injuries C21.866.448 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Wrist Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Finger Injuries General or unspecified injuries to the hand.  b3NQ7Hand Dermatoses C17.800.338 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases b|NKHand Deformities, Congenital C05.390.408; C05.660.585.425; C16.131.621.585.425 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Hand Deformities Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Alterations or deviations from normal shape or size which result in a disfigurement of the hand occurring at or before birth. bW"9LRHand Deformities, Acquired C05.390.110 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Hand Deformities Deformities of the hand, or a part of the hand, acquired after birth as the result of injury or disease. b  L2Hand Deformities C05.390 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Hand Deformities, Acquired; Hand Deformities, Congenital Alterations or deviations from normal shape or size which result in a disfigurement of the hand. bY LBtHand A01.378.209.455 AHBSEMGDIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Extremities; Arm Fingers (+ 1) ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI b¿&5*Hamsters B02.649.865.635.325 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae Cricetulus; Mesocricetus; Phodopus A common name used to describe a subfamily of the Muridae. Four of the more common genera are Cricetus, CRICETULUS, MESOCRICETUS, and PHODOPUS. bÙ (1*Hamartoma Syndrome, Multiple C04.651.435; C04.700.435; C16.131.445.435; C16.466.700.435 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms, Multiple Primary Neoplasms; Neoplastic Syndromes, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Hamartoma Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary A hereditary disease characterized by multiple ectodermal, mesodermal, and endodermal nevoid and neoplastic anomalies. Papules of the face and oral mucosa are the most characteristic lesion. Other changes occur in the skin, in the thyroid, the breast, the gastrointestinal system, and the nervous system. Hamartoma (66-86); Neoplasms, Multiple Primary (66-86) b"DN'bAHamartoma C16.131.445 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Hamartoma Syndrome, Multiple; Proteus Syndrome; Tuberous Sclerosis A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  bȶ LINNHalothane D02.455.526.340; D15.050.035.060.350; D15.210.100.175.060.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p.178). b E:GHaloperidol D02.522.352.506; D14.100.150.175.350; D15.090.300; D15.095.300; D15.150.015.350; D15.210.950.040.015.350; D15.700.872.331.015.506 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butyrophenones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone A drug that is used primarily to treat schizophrenia and other psychoses. It is also used in schizoaffective disorder, delusional disorder, ballism, and Tourette's syndrome (a drug of choice) and occasionally as adjunctive therapy in mental retardation and the chorea of Huntington's disease. It is a potent antiemetic and is effective in the treatment of intractable hiccups. (From AMA, Drug Evaluations Annual, 1994, p. 279). bt:Halogens D01.268.380 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Astatine; Bromine; Chlorine; Fluorine; Iodine A family of nonmetallic, generally electronegative, elements of group VIIb of the periodic table. They are all multivalent and have oxidation numbers of -1 (the most common), 1, 3, 5, and 7. ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  bI 829<Halofenate D02.241.511.316.455; D10.162.202.456 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Glycolates Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents Anticholesteremic Agents (66-72); Antilipemic Agents (66-72); Glycolates (66-72) bR*:_Halobacterium halobium B03.107.390.410.410.410; B03.440.400.425.410.410.410 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Halobacteriales; Halobacteriaceae; Halobacterium Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Halobacteriaceae; Halobacterium A species of halophilic archaeobacteria found in heavily salted protein materials and salt lakes. Halobacterium (67-91) b:"sHalobacterium B03.107.390.410.410; B03.440.400.425.410.410 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Halobacteriales; Halobacteriaceae Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Halobacteriaceae Halobacterium halobium Halobacterium halobium A genus of HALOBACTERIACEAE whose growth requires a high concentration of salt. Its organisms are gram-negative and divide by constriction. b-2"4Halobacteriales B03.107.390 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria Halobacteriaceae (+ 2) An order of ARCHAEOBACTERIA consisting of extremely halophilic members. bn"THalobacteriaceae B03.107.390.410; B03.440.400.425.410 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Archaeobacteria; Halobacteriales Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Halobacterium (+ 1) Halobacterium (+ 1) A family of halophilic archaeobacteria found in environments with high salt concentrations, such as some salt lakes or proteinaceous materials preserved with salt. Bacteria (66-74); Pseudomonadaceae (75)  bh*"00Hallux Valgus C05.330.610 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Foot Deformities Lateral displacement of the great toe, producing deformity of the first metatarsophalangeal joint with callous, bursa, or bunion formation over the bony prominence. bN2Hallux A01.378.592.350.300.792.380 ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Extremities; Leg; Foot; Forefoot, Human; Toes bH *YHallucinogens D15.300; D15.700.372 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hallucinations; Cannabinoids Central Nervous System Agents Central Nervous System Agents; Psychotropic Drugs Bufotenin; N,N-Dimethyltryptamine; DOM; Harmine; Ibogaine; Lysergic Acid Diethylamide; Mescaline; 3,4-Methylenedioxyamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybine; Tetrahydrocannabinol Bufotenin; N,N-Dimethyltryptamine; DOM; Harmine; Ibogaine; Lysergic Acid Diethylamide; Mescaline; 3,4-Methylenedioxyamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybine; Tetrahydrocannabinol Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $b8"]DHallucinations C10.597.439; C10.597.751.330; C23.888.592.763.307; F03.126.185.794.405 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Hallucinogens Nervous System Diseases; Neurologic Manifestations Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Perceptual Disorders Subjectively experienced sensation in the absence of an actual appropriate stimulus, but which is regarded by the individual as real. bPFHallervorden-Spatz Syndrome C10.228.140.558; C10.228.140.079.493; F03.709.346.318 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Progressive hereditary disorder with marked reduction in the number of myelin sheaths of the globus pallidus and substantia nigra with accumulation of iron pigment. Manifestations include dysarthria, progressive mental deterioration, and corticospinal and extrapyramidal motor signs. b =N$DHallermann's Syndrome C05.116.099.370.231.427; C05.660.246.330; C16.131.621.246.330 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Craniofacial Dysostosis Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis An oculomandibulofacial syndrome principally characterized by dyscephaly (usually brachycephaly), parrot nose, mandibular hypoplasia, proportionate nanism, hypotrichosis, bilateral congenital cataracts, and microphthalmia. (Dorland, 27th ed). b%ELuHalitosis C23.888.821.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mouth Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) by NHalfway Houses N02.278.825.408 CLECHILJMAMTOGSDSNSTTDUT Aftercare; Rehabilitation Facilities, Manpower and Services (Non MeSH); Health Facilities; Residential Facilities Specialized residences for persons who do not require full hospitalization, and are not well enough to function completely within the community without professional supervision, protection and support. bgHalf-Life H01.862.405 Physical Sciences (Non MeSH); Time The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Time (66-70); specific radioisotope, substance, or cell b~ ,CHalcinonide D04.808.745.745.654.570; D17.025.050.250; D17.025.080.200.225; D23.037.200.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical 21-Chloro-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy)pregn-4-ene-3,20-dione. A topical glucocorticoid used in the treatment of dermatitis, eczema, or psoriasis. It may cause skin irritation. Pregnanes (68-73); Pregnenediones (74-78) bX:2Haiti Z01.107.084.900.425 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies b OHair Removal E02.218.372 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Cosmetic Techniques (Non MeSH) b`"5Hair Preparations D26.313.300; J01.516.213.450 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Miscellaneous Drugs and Agents (Non MeSH); Cosmetics Technology, Industry, Agriculture (Non MeSH); Household Products; Cosmetics Hair Dyes Hair Dyes Hair grooming and cleansing aids or other products meant for topical application to hair, usually human. They include sprays, bleaches, conditioners, rinses, shampoos, nutrient lotions, etc. Cosmetics (66-79); Hair (66-79)  b"((Hair Dyes D26.313.300.299; D26.408.355; J01.516.213.450.426 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Miscellaneous Drugs and Agents (Non MeSH); Cosmetics; Hair Preparations Miscellaneous Drugs and Agents (Non MeSH); Dyes Technology, Industry, Agriculture (Non MeSH); Household Products; Cosmetics; Hair Preparations Dyes used as cosmetics to change hair color either permanently or temporarily. Cosmetics (66-78); Dyes (66-78); Hair (66-78); Hair Color (76-78) b79(^SHair Diseases C17.800.805.305 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases Alopecia (+ 3); Folliculitis (+ 1); Hirsutism; Hypertrichosis; Kinky Hair Syndrome Diseases affecting the orderly growth and persistence of hair. Hair (66-79); Skin Appendage Diseases (68-79)  bzNhfK8Hair Color G04.185.672.490; G10.795.280 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Pigmentation Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) Color of hair or fur. Hair (66-75); Color (66-75); Pigmentation (66-75); Pigments (66-75) ci"THair Cells, Vestibular A08.663.694.530.250.380; A08.800.550.700.500.350.380; A09.246.631.663.350; A09.246.631.909.625.125.340; A11.671.677.530.250.380 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Hair Cells Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors; Hair Cells Sense Organs; Ear; Labyrinth; Semicircular Canals Sense Organs; Ear; Labyrinth; Vestibule; Saccule and Utricle; Acoustic Maculae Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Hair Cells Mechanoreceptors located in the acoustic maculae and the semicircular canals that mediate the sense of balance, movement, and head position. The vestibular hair cells are connected to accessory structures in such a way that movements of the head displace their stereocilia. This influences the membrane potential of the cells which relay information about movements via the vestibular part of the acoustic nerve to the brain stem. Hair Cells (80-93); Mechanoreceptors (77-79) c86Hair Cells, Outer A08.663.694.530.250.315; A08.800.550.700.500.350.365; A09.246.631.246.577.325.380; A11.671.677.530.250.315 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Hair Cells Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors; Hair Cells Sense Organs; Ear; Labyrinth; Cochlea; Organ of Corti; Hair Cells Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Hair Cells Mechanoreceptors in the organ of Corti. In mammals the outer hair cells are arranged in three rows which are further from the modiolus than the single row of inner hair cells. The motile properties of the outer hair cells may contribute actively to tuning the sensitivity and frequency selectivity of the cochlea. Hair Cells (80-93); Mechanoreceptors (77-79); Organ of Corti (66-76) ct8sTHair Cells, Inner A08.663.694.530.250.250; A08.800.550.700.500.350.350; A09.246.631.246.577.325.315; A11.671.677.530.250.250 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Hair Cells Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors; Hair Cells Sense Organs; Ear; Labyrinth; Cochlea; Organ of Corti; Hair Cells Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Hair Cells Bulbous cells that are medially placed in one row in the organ of Corti. In contrast to the outer hair cells, the inner hair cells are fewer in number, have fewer sensory hairs, and are less differentiated. Hair Cells (77-79); Mechanoreceptors (77-79); Organ of Corti (66-76) c Ft8THair Cells A08.663.694.530.250; A08.800.550.700.500.350; A09.246.631.246.577.325; A11.671.677.530.250 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors Sense Organs; Ear; Labyrinth; Cochlea; Organ of Corti Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent Hair Cells, Inner; Hair Cells, Outer; Hair Cells, Vestibular Hair Cells, Inner; Hair Cells, Outer; Hair Cells, Vestibular Hair Cells, Inner; Hair Cells, Outer Hair Cells, Inner; Hair Cells, Outer; Hair Cells, Vestibular Mechanoreceptors located in the organ of Corti that are sensitive to auditory stimuli and in the vestibular apparatus that are sensitive to movement of the head. In each case the accessory sensory structures are arranged so that appropriate stimuli cause movement of the hair-like projections (stereocilia and kinocilia) which relay the information centrally in the nervous system. Organ of Corti (66-76)  cd8IHair A01.835.288 ABAHCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERITRULUSVI Body Regions (Non MeSH); Skin Eyebrows; Eyelashes Keratinous filaments projecting from the skin, composed of a cylindrical shaft and a root. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI  c2'l8Hagfish B02.493.181.371 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cyclostomes cV &(Hafnium D01.268.367; D01.552.337 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals c :`Haemosporina B01.841.075.762.167.275.400 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida Plasmodium (+ 9) A suborder of heteroxenous protozoa in which the macrogamete and microgamont develop independently. A conoid is usually absent. c&UHaemophilus Vaccines D24.310.894.135.450 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines Vaccines or candidate vaccines containing antigenic polysaccharides from Haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine. Bacterial Vaccines (75-93) c@>px Haemophilus influenzae B03.440.450.600.400.425 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae; Haemophilus Once thought to be the causative agent for epidemic influenza. Nonencapsulated strains of biotypes II or III are normal in the healthy human nasopharynx. Encapsulated strains of biotype I are the most common cause of bacterial meningitis in children. c"z'Haemophilus Infections C01.252.400.700.433 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections Chancroid; Meningitis, Haemophilus Infections with bacteria of the genus HAEMOPHILUS. Haemophilus (66-67)  cP)=Haemophilus ducreyi B03.440.450.600.400.350 CHCLCYDEENGDGEIMIPMEPHPYREULVI Chancroid Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae; Haemophilus A species of HAEMOPHILUS that appears to be the pathogen or causative agent of the sexually transmitted disease, CHANCROID. c" zHaemophilus B03.440.450.600.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae Haemophilus ducreyi; Haemophilus influenzae A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile. c K"k3Haemonchus B01.500.294.700.775.746.410 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Trichostrongyloidea A genus of parasitic nematode worms which infest the duodenum and stomach of domestic and wild herbivores, which ingest it with the grasses they eat. Infestation of man is accidental. c"H*_Haemonchiasis C03.335.508.700.775.825.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections; Trichostrongyloidiasis Infection with nematodes of the genus HAEMONCHUS, characterized by digestive abnormalities and anemia similar to that from hookworm infestation. c#PHaemobartonella B03.700.651.129.501 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Anaplasmataceae A genus of the family ANAPLASMATACEAE, parasitic on or within the erythrocytes of many vertebrate species. Anaplasmataceae (75-79); Anaplasmataceae Infections (77-79) c%"^~EHabituation (Psychophysiology) F02.463.425.393; F02.830.422; G11.561.317 CLDEGEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Psychologic Processes and Principles (Non MeSH); Psychophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) The disappearance of responsiveness to accustomed stimulation. It does not include drug habituation. Learning (66-67) c'i#1 vHabits F01.145.466; F03.234.193.308 Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders; Child Reactive Disorders Fingersucking; Food Habits; Nail Biting; Smoking (+ 2); Tongue Habits Fingersucking; Nail Biting; Tongue Habits Acquired or learned responses which are regularly manifested. AEBLCFCLDEDTECEHEPGEHIIMLJMEMOMTPAPCPHPPPXRESNTDTHUR c) "I8H-2 Antigens D24.611.216.301.500.400.350; D24.611.216.705.552.400.350 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Histocompatibility Antigens Class I Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Histocompatibility Antigens Class I The major group of transplantation antigens in the mouse. Histocompatibility (70-72); Histocompatibility Antigens (73-77); Transplantation Immunology (66-69) c+>6FrH-Y Antigen D24.611.216.301.500.600.400; D24.611.216.705.552.600.400 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Histocompatibility Antigens; Minor Histocompatibility Antigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Histocompatibility Antigens; Minor Histocompatibility Antigens A sex-specific cell surface antigen produced by the sex-determining gene of the Y chromosome in mammals. It causes syngeneic grafts from males to females to be rejected and interacts with somatic elements of the embryologic undifferentiated gonad to produce testicular organogenesis. Histocompatibility (68-72); Histocompatibility Antigens (73-78) c.|>6IIH-Reflex G11.561.730.643.474 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex; Reflex, Monosynaptic A monosynaptic reflex elicited by stimulating a nerve, particularly the tibial nerve, with an electric shock. c28 H(+)-Transporting ATP Synthase D08.586.277.040.025.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Proton Pump Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase A group of enzymes which are involved in the reversible synthesis of ATP and that transport protons from the cytoplasmic to the matrix side of the mitochondrial membrane. The flow of protons through the F(0) channel results in ATP synthesis by F1. EC 3.6.1.34. Adenosine Triphosphatase (66-82)  c3&F7&H(+)-K(+)-Exchanging ATPase D08.586.277.040.025.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase An enzyme isolated from the gastric mucosa that catalyzes the hydrolysis of ATP coupled with the exchange of hydrogen and potassium ions across the cell wall. EC 3.6.1.36. Adenosinetriphosphatase (80-92) c6E$F$G2 Phase G04.335.135.500.340; G05.148.165.500.340; G07.553.135.500.340 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Interphase Genetics; Cytogenetics; Cell Cycle; Interphase Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Interphase Phase of the cell cycle following DNA synthesis and preceding mitosis. The chromosomes are tetraploid in this phase. Cell Division (66-77); Interphase (78-90) c8n E13G1 Phase G04.335.135.500.320; G05.148.165.500.320; G07.553.135.500.320 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Interphase Genetics; Cytogenetics; Cell Cycle; Interphase Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Interphase Phase of the cell cycle preceding protein systhesis. The subphases of G1 include competence, entry (G1a), progression (G1b), and assembly (G1c), based on the effects of limiting growth factors, nutrients, or inhibitors. Cell Division (66-77); Interphase (78-90) c: E13G0 Phase G04.335.135.500.300; G05.148.165.500.300; G07.553.135.500.300 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Interphase Genetics; Cytogenetics; Cell Cycle; Interphase Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Interphase Phase of the cell cycle where cells exist in a quiescent state. These cells have unduplicated DNA, degraded RNA and protein, and low enzyme activity. The ability to switch between G0 and G1 (and vice versa) determines the post-embryonic cell proliferation rate and is defectively controlled in neoplastic cells. Cell Division (68-77); Interphase (78-90) c= E1n3Gyrus Cinguli A08.186.211.577.330 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Limbic System One of the convolutions on the medial surface of the cerebral hemisphere. It surrounds the rostral part of the brain and interhemispheric commissure and forms part of the limbic system. cA+8JGyrate Atrophy C11.270.468; C11.941.160.578; C16.131.410.468 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Diseases, Hereditary Eye Diseases; Uveal Diseases; Choroid Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary Progressive, autosomal recessive, diffuse atrophy of the choroid, pigment epithelium, and sensory retina that begins in childhood. Atrophy (70-89); Choroid (70-89); Retinal Degeneration (70-89) cB5NLGypsies I01.076.201.450.416.280; I01.880.143.522.282; M01.194.265 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups Ethnic group coming originally from India and entering Europe in the 14th or 15th century. Many still maintain somewhat their itinerant life and tribal organization. Caucasoid Race (66-78); Ethnic Groups (68-78); Ethnology (66-67) cE@ AOGynecomastia C19.146.404 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Breast Diseases Excessive development of the male mammary glands, even to the functional state. (Dorland, 27th ed). cGN+xGynecology G02.403.810.310 CLECEDHIISLJMAMTOGSNSTTD Genital Diseases, Female; Reproductive Medicine Health Occupations; Medicine; Specialties, Surgical A medical-surgical specialty concerned with the physiology and disorders primarily of the female genital tract, as well as female endocrinology and reproductive physiology. cH8=Gynatresia (Non MeSH) C13.371.320 Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Hematocolpos; Hematometra BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI cJqhNGynandroblastoma C04.557.475.335 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue A rare ovarian tumor containing histological features of both androblastoma and granulosa cell tumor. It produces simultaneous androgenic and estrogenic effects. (From Dorland, 27th ed; Stedman, 25th ed). cKX]Gymnastics I02.233.543.454; I03.450.642.845.417 CLECEDHIINLJPHPXSNSTTD Education; Education, Nonprofessional (Non MeSH); Physical Education and Training Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Systematic physical exercise. This includes calisthenics, a system of light gymnastics for promoting strength and grace of carriage. cM*Guyana Z01.107.757.488 EHEP Geographicals (Non MeSH); America; South America cOB <Gutta-Percha D25.339.859.495 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Root Canal Filling Materials trans-Polyisoprene. Coagulated exudate isolated from several species of the tropical tree Palaquium (Sapotaceae). It is the trans-isomer of natural rubber and is used as a filling and impression material in dentistry and orthopedics and as an insulator in electronics. It has also been used as a rubber substitute. cO*lrGum Arabic D09.203.698.380; D26.698.931.419.399 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids; Vehicles; Excipients Powdered exudate from various Acacia species, especially A. senegal (Leguminosae); forms mucilage or syrup in water; used as suspending agent, excipient, emulsifier in foods and pharmaceuticals. Synonyms: Acacia syrup; Arabic gum; Australian gum; Gum ovaline; Gum Senegal; Indian gum. Acacia (66-79); Polysaccharides (66-79) cR*,P0Guinea-Bissau Z01.058.290.190.380 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western In western Africa, originally discovered by the Portuguese in 1446 and founded as a Portuguese colony. Its boundaries were established by convention with France in 1886. It gained its independence in 1974. Its capital is Bissau, its religions are traditional, Moslem, and Catholic. cT_KGuinea Pigs B02.649.865.550 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia A common name used for the family Caviidae. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. cV(&Guinea Z01.058.290.190.375 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western In western Africa, once a part of Senegal. It was established as a colony called French Guinea in 1893, but gained its independence in 1958. Its capital is Conakry, its religion, largely Moslem. Africa, Western (66-91) cX. _Guilt F01.470.483 Behavior and Behavior Mechanisms (Non MeSH); Emotions Shame Subjective feeling of having committed an error, offense or sin; unpleasant feeling of self-criticism. These result from acts, impulses, or thoughts contrary to one's personal conscience. cY A Guidelines N04.761.700.350; N05.700.350 ST Health Services Administration (Non MeSH); Quality of Health Care; Quality Assurance, Health Care Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Practice Guidelines Practice Guidelines Directions or principles presenting current or future rules of policy. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The text may be cursive or in outline form but is generally a comprehensive guide to problems and approaches in any field of activity. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES is available. c[C".Guided Tissue Regeneration E06.721.485 Dentistry; Periodontics The repopulating of the periodontium, after treatment for periodontal disease. Repopulation is achieved by guiding the periodontal ligament progenitor cells to reproduce in the desired location by blocking contact of epithelial and gingival connective tissues with the root during healing. This blocking is accomplished by using synthetic membranes or collagen membranes. Periodontal Diseases (86-91); Periodontal Ligament (86-91); Periodontitis (86-91); Periodontium (87-91); Regeneration (86-91) c^ Guatemala Z01.107.169.454 EHEP Geographicals (Non MeSH); America; Central America caa >Guanylyl Imidodiphosphate D13.695.667.454.504.400; D13.695.827.426.504.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; Guanosine Triphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; Guanosine Triphosphate 5'-Guanylic acid, monoanhydride with imidophosphoric acid. An analog of GTP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. The nucleotide is a potent stimulator of adenylate cyclase. Synonyms: GMP-P(NH)P; GPP(NH)P. Guanine Nucleotides (66-77); Guanosine Triphosphate (72-77) ca6D.=FGuanylthiourea D02.886.904.365; D02.948.898.365 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea 1-Amidino-2-thiourea. May protect against hypoxic damage; proposed for treatment of shock due to trauma or blood loss; also stimulates paretic gastrointestinal system. Synonyms: guthimine; guthymine. Thiourea (66-78) ceV&:Guanylate Cyclase D08.586.520.429 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that catalyzes the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. It also acts on ITP and dGTP. (From Enzyme Nomenclature, 1992) EC 4.6.1.2. Nucleotidyltransferases (66-72) cgvFO$Guanosine 5'-O-(3-Thiotriphosphate) D13.695.667.454.504.380; D13.695.827.426.504.380; D13.695.900.380 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; Guanosine Triphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; Guanosine Triphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Thionucleotides Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes. Guanosine Triphosphate (72-90); Thionucleotides (77-90) ci?)ID\AGuanosine Triphosphate D13.695.667.454.504; D13.695.827.426.504 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides Guanosine 5'-O-(3-Thiotriphosphate); Guanylyl Imidodiphosphate Guanosine 5'-O-(3-Thiotriphosphate); Guanylyl Imidodiphosphate Guanosine 5'-(tetrahydrogen triphosphate). A guanine nucleotide containing three phosphate groups esterified to the sugar moiety. Guanine Nucleotides (66-71)  cmH.D!Guanosine Tetraphosphate D13.695.667.454.480; D13.695.827.426.480 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides Guanosine 5'-diphosphate 2'(3')-diphosphate. A guanine nucleotide containing four phosphate groups. Two phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot I. Guanine Nucleotides (66-77) cp>.D!Guanosine Pentaphosphate D13.695.667.454.440; D13.695.827.426.440 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides Guanosine 5'-triphosphate 2'(3')-diphosphate. A guanine nucleotide containing five phosphate groups. Three phosphate groups are esterified to the sugar moiety in the 5' position and the other two in the 2' or 3' position. This nucleotide serves as a messenger to turn off the synthesis of ribosomal RNA when amino acids are not available for protein synthesis. Synonym: magic spot II. Guanine Nucleotides (66-77) cs.D!Guanosine Diphosphate Sugars D09.203.408.620.569.400; D13.695.667.454.340.350; D13.695.827.426.340.350; D13.695.827.708.400 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; Guanosine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; Guanosine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose Esters formed between the aldehydic carbon of sugars and the terminal phosphate of guanosine diphosphate. Guanine Nucleotides (73-74); Nucleoside Diphosphate Sugars (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $cwc"hB9|NDGuanosine Diphosphate Mannose D09.203.408.620.569.400.500; D13.695.667.454.340.350.500; D13.695.827.426.340.350.500; D13.695.827.708.400.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Guanosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Guanosine Diphosphate Sugars A nucleoside diphosphate sugar which can be converted to the deoxy sugar GDPfucose, which provides fucose for lipopolysaccharides of bacterial cell walls. Also acts as mannose donor for glycolipid synthesis. Guanine Nucleotides (73-74); Mannose (73-74); Nucleoside Diphosphate Sugars (73-74) c|#xDcGuanosine Diphosphate Fucose D09.203.408.620.569.400.410; D13.695.667.454.340.350.400; D13.695.827.426.340.350.400; D13.695.827.708.400.410 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Guanosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; Guanosine Diphosphate; Guanosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Guanosine Diphosphate Sugars A nucleoside diphosphate sugar formed from GDPmannose, which provides fucose for lipopolysaccharides of bacterial cell walls, and for blood group substances and other glycoproteins. Fucose (73-74); Guanine Nucleotides (73-74); Nucleoside Diphosphate Sugars (73-74) c"xDbGuanosine Diphosphate D13.695.667.454.340; D13.695.827.426.340 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides Guanosine Diphosphate Sugars (+ 2) Guanosine Diphosphate Sugars (+ 2) Guanosine 5'-(trihydrogen diphosphate). A guanine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: GRPP; guanosine pyrophosphate. Guanine Nucleotides (66-77)  c.DR!Guanosine D13.570.583.454; D13.570.800.453 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Deoxyguanosine; Nucleoside Q Nucleoside Q Nucleosides (66-71) c &D2Guanine Nucleotides D13.695.667.454; D13.695.827.426 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Cyclic GMP (+ 1); Deoxyguanine Nucleotides; Guanosine Diphosphate (+ 3); Guanosine Pentaphosphate; Guanosine Tetraphosphate; Guanosine Triphosphate (+ 2); 5'-Guanylic Acid; RNA Caps (+ 1) Cyclic GMP (+ 1); Guanosine Diphosphate (+ 3); Guanosine Pentaphosphate; Guanosine Tetraphosphate; Guanosine Triphosphate (+ 2); 5'-Guanylic Acid; RNA Caps (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR c[&BHGuanine Deaminase D08.586.277.151.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases An enzyme that catalyzes the deamination of guanine to form xanthine. EC 3.5.4.3. Aminohydrolases (73-74); Guanine (73-74) cFfc1Guanine D03.438.759.758.399.454 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Hypoxanthines Acyclovir (+ 1); Azaguanine cG >q$Guanidines D02.078.370 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines Agmatine; Bethanidine; Biguanides (+ 5); Cimetidine; Creatine; Gabexate; Guanabenz; Guanethidine; Guanfacine; Impromidine; Methylguanidine; Mitoguazone; Nitrosoguanidines (+ 1); Robenidine; Sulfaguanidine A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  cc80FGuanfacine D02.078.370.465; D02.241.223.601.329; D14.100.050.100.100.320; D16.050.850.318; D18.162.388 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents A centrally acting antihypertensive agent. The drug lowers both systolic and diastolic blood pressure by activating the central nervous system alpha-2 adrenoreceptors, which results in reduced sympathetic outflow leading to reduced vascular tone. Its adverse reactions include dry mouth, sedation, and constipation. Adrenergic alpha Agonists (69-90); Antihypertensive Agents (66-90); Guanidines (66-90); Phenylacetates (66-90) c>g:kGuanethidine D02.078.370.460; D14.100.050.600.340; D16.050.850.315; D18.162.384 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. cL:jbGuanazole D03.383.129.799.500; D03.383.946.500; D22.204.430 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Triazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazoles Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 3,5-Diamino-1,2,4-triazole. A cytostatic triazole derivative which is not to be confused with guanazolo, the generic name for 8-azaguanine. Diamines (72-74); Triazoles (72-74) cv 9:,Guanabenz D02.078.370.435; D14.100.050.100.100.310; D16.050.850.305; D18.162.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents An alpha-2 selective adenergic agonist used as an antihypertensive agent. Guanidines (73-74); Imines (73-74) c P:W+Guam Z01.782.680.435 EHEP Geographicals (Non MeSH); Pacific Islands; Micronesia cAGuaiacol Glyceryl Ether D02.355.601.536.400; D02.355.726.453.400; D02.755.075.536.400; D02.755.166.453.400; D26.415.300.300 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ethers; Methyl Ethers; Guaiacol Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers; Guaiacol Organic Chemicals (Non MeSH); Phenols; Anisoles; Guaiacol Organic Chemicals (Non MeSH); Phenols; Catechols; Guaiacol Miscellaneous Drugs and Agents (Non MeSH); Expectorants; Guaiacol Methocarbamol Methocarbamol 3-(2-Methoxyphenoxy)-1,2-propanediol. An expectorant that also has some muscle relaxing action. It is used in many cough preparations. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  c0o.n#:Guaiacol D02.355.601.536; D02.355.726.453; D02.755.075.536; D02.755.166.453; D20.187.222.250; D26.415.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Methyl Ethers Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers Organic Chemicals (Non MeSH); Phenols; Anisoles Organic Chemicals (Non MeSH); Phenols; Catechols Anti-Infective Agents; Anti-Infective Agents, Local; Disinfectants Miscellaneous Drugs and Agents (Non MeSH); Expectorants Guaiacol Glyceryl Ether (+ 1) Guaiacol Glyceryl Ether Guaiacol Glyceryl Ether (+ 1) Guaiacol Glyceryl Ether Guaiacol Glyceryl Ether An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747). c n:}Guaiac D26.550.383 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents c .PGTP Pyrophosphokinase D08.586.913.696.175.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Diphosphotransferases An enzyme that catalyzes reversibly the transfer of a pyrophosphate group from ATP to the 3'-OH group of GDP or GTP with the formation of guanosine 3'-diphosphate 5'-diphosphate or guanosine 3'-diphosphate 5'-triphosphate and AMP. The enzyme, also called stringent factor, is located in the relA gene in stringent strains of bacteria. The above synthesis is induced by mRNA and uncharged tRNA which is bound to the aminoacyl-t-RNA binding site of the ribosome by a codon-specific association. EC 2.7.6.5. Adenosine Triphosphate (66-79); Bacterial Proteins (66-79); Guanine Nucleotides (66-79); Phosphotransferases (66-73); Phosphotransferases, ATP (74-79); Pyrophosphates (66-79); Ribosomal Proteins (75-79) cFMGTP Phosphohydrolase D08.586.277.040.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases An enzyme that hydrolyzes GTP to GDP and provides energy for peptide chain elongation. EC 3.6.1.-. Guanosine Triphosphate (69-74); Phosphatases (69-74) c(Frw>GTP Cyclohydrolase D08.586.277.151.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases (GTP cyclohydrolase I) or GTP 7,8-8,9-dihydrolase (pyrophosphate-forming) (GTP cyclohydrolase II). An enzyme group that hydrolyzes the imidazole ring of GTP, releasing carbon-8 as formate. Two C-N bonds are hydrolyzed and the pentase unit is isomerized. This is the first step in the synthesis of folic acid from GTP. EC 3.5.4.16 (GTP cyclohydrolase I) and EC 3.5.4.25 (GTP cyclohydrolase II). Aminohydrolases (74); Guanosine Triphosphate (74) cFf;Gryllidae B01.131.617.678.410 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Orthoptera The family Gryllidae consists of the common house cricket, Acheta domesticus, which is used in neurological and physiological studies. Other genera include Gryllotalpa (mole cricket); Gryllus (field cricket); and Oecanthus (tree cricket). Orthoptera (75-85) c (8Growth Substances, Pigments, Vitamins (Non MeSH) D11 Growth Substances (+ 29); Pigments (+ 62); Vitamins (+ 54); Yeast, Dried AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR c9]HGrowth Substances D11.303; D24.185.348; D24.611.350.400 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Growth Factor Growth Substances, Pigments, Vitamins (Non MeSH) Immunologic and Biologic Factors (Non MeSH); Biological Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines Angiogenesis Factor; Biopterin; Cyclins; Endothelial Growth Factors; Fibroblast Growth Factor (+ 2); Growth Inhibitors; Hepatocyte Growth Factor; Maturation-Promoting Factor (+ 1); Nerve Growth Factors; Neuroleukin; Plant Growth Regulators (+ 11); Platelet-Derived Growth Factor; Transforming Growth Factors (+ 2) Angiogenesis Factor; Cyclins; Endothelial Growth Factors; Epidermal Growth Factor-Urogastrone; Fibroblast Growth Factor (+ 2); Growth Inhibitors; Hematopoietic Cell Growth Factors (+ 6); Hepatocyte Growth Factor; Interleukins (+ 13); Maturation-Promoting Factor (+ 1); Nerve Growth Factors; Neuroleukin; Platelet-Derived Growth Factor; Somatomedins (+ 3); Transforming Growth Factors (+ 2) Hematopoietic Cell Growth Factors (+ 6); Interleukins (+ 13); Transforming Growth Factor beta Signal molecules that are involved in the control of cell growth and differentiation. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $c-@fHGrowth Plate A02.835.232.251.352 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Bone Development Musculoskeletal System; Skeleton; Bone and Bones; Epiphyses The area between the epiphysis and the diaphysis within which bone growth occurs. Cartilage (66-83); Epiphyses (66-83)  c:Hb-Growth Inhibitors D11.303.450; D24.185.348.402 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS). c\"BGrowth Disorders C23.509 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bone Diseases, Developmental; Dwarfism; Gigantism Symptoms and General Pathology (Non MeSH) Failure to Thrive; Fetal Growth Retardation Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth. Growth (66-68) $c N;25Growth and Embryonic Development (Non MeSH) G07.553 Physiology, General (Non MeSH) Bone Development (+ 3); Cell Cycle (+ 15); Cell Differentiation (+ 1); Ectogenesis; Fetal Viability (+ 1); Gestational Age; Growth (+ 8); Metamorphosis, Biological; Morphogenesis; Odontogenesis (+ 2); Sex Differentiation; Sex Maturation BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI c4 % TGrowth G07.553.481 DEGEIMPHRE Child Development; Personality Development Child Development Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Body Height; Body Weight (+ 5); Organ Weight BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $c 2Z:TGroup Structure F01.829.316.274 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes The informal or formal organization of a group of people based on a network of personal relationships which is influenced by the size and composition, etc., of the group. Group Processes (66-67) c{`Group Purchasing N02.278.354.422.679.375; N03.219.463.430; N04.452.442.422.679.375 CLECHILJMTOGSNSTTDUT Purchasing, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments; Purchasing, Hospital Economics, Organizations, Control (Non MeSH); Economics; Financial Management Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments; Purchasing, Hospital A shared service which combines the purchasing power of individual organizations or facilities in order to obtain lower prices for equipment and supplies. (From Health Care Terms, 2nd ed). Hospital Shared Services (72-93); Purchasing, Hospital (78-93)  c IJGroup Processes F01.829.316 Social Change Sociology Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Focus Groups; Group Structure; Peer Group; Peer Review (+ 2); Role (+ 2); Sensitivity Training Groups (+ 1); Social Distance; Social Dominance The procedures through which a group approaches, attacks, and solves a common problem. CLECHILJMTOGSNSTTDUT $cʆ LgGroup Practice, Prepaid N04.452.758.244.400 CLECHILJOGSNSTTDUT Prepaid Health Plans Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Group Practice An organized group of three or more full-time physicians rendering services for a fixed prepayment. Group Practice (66-79); Insurance, Health (66-79)  csv<Group Practice, Dental N04.452.758.244.369 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Group Practice Any group of three or more full-time dentists, organized in a legally recognized entity for the provision of dental care, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income. Dentistry (66); Group Practice (66) c8Q-Group Practice N04.452.758.244 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice Group Practice, Dental; Group Practice, Prepaid; Health Maintenance Organizations; Independent Practice Associations Any group of three or more full-time physicians organized in a legally recognized entity for the provision of health care services, sharing space, equipment, personnel and records for both patient care and business management, and who have a predetermined arrangement for the distribution of income. CLECHILJMAOGSNSTTDUT  cЪq\Group Homes N02.278.825.375 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Residential Facilities Housing for groups of patients, children, or others who need or desire emotional or physical support. They are usually established as planned, single housekeeping units in residential dwellings that provide care and supervision for small groups of residents, who, although unrelated, live together as a family. Halfway Houses (70-90); Residential Facilities (70-90) c|giAGross Virus B04.820.650.730.730.900.500.300; B04.909.574.807.730.730.900.500.300; B04.909.777.731.730.730.900.500.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A murine leukemia obtained from inbred mice with a high incidence of spontaneous lymphoid leukemia. Infection is passed by vertical transmission from one generation to another through the ovum. cqAGrooming F01.145.113.111.453 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Appetitive Behavior An animal's cleaning and caring for the body surface. This includes preening, the cleaning and oiling of feathers with the bill or of hair with the tongue. Behavior, Animal (66-67) c  nGroin A01.047.365 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Abdomen The external junctural region between the lower part of the abdomen and the thigh. Inguinal Canal (66-80) cv (*dGroES Protein D12.776.097.450; D12.776.410.210.175.325; D12.776.580.210.175.325 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins; Chaperonins; Chaperonin 10 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones; Chaperonins; Chaperonin 10 A chaperonin 10 heat-shock protein isolated from Escherichia coli. Bacterial Proteins (89-94); Heat-Shock Proteins (89-94) c܇IDROBGroEL Protein D12.776.097.445; D12.776.410.210.180.325; D12.776.580.210.180.325 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins; Chaperonins; Chaperonin 60 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones; Chaperonins; Chaperonin 60 A chaperonin 60 heat-shock protein isolated from Escherichia coli. Bacterial Proteins (89-94); Heat-Shock Proteins (89-94) c0IDROBGriseofulvin D20.085.062.480; D20.136.073.480 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal c&<Grief F01.470.142.110 Bereavement Behavior and Behavior Mechanisms (Non MeSH); Emotions; Bereavement Normal, appropriate sorrowful response to an immediate cause. It is self-limiting and gradually subsides within a reasonable time. c PGreenland Z01.107.567.403 EHEP Geographicals (Non MeSH); America; North America c0 <Greenhouse Effect G03.230.265; G03.230.300.100.250.387 Environment and Public Health (Non MeSH); Environment Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Climate The effect of global warming and the resulting increase in world temperatures. The predicted health effects of such long-term climatic change include increased incidence of respiratory, water-borne, and vector-borne diseases. Climate (66-93) c*Greek World I01.076.201.450.226.400 HI Social Sciences; Anthropology; Anthropology, Cultural; Culture; Civilization A historical and cultural entity dispersed across a wide geographical area under the influence of Greek civilization, culture, and science. The Greek Empire extended from the Greek mainland and the Aegean islands from the 16th century B.C., to the Indus Valley in the 4th century under Alexander the Great, and to southern Italy and Sicily. Greek medicine began with Homeric and Aesculapian medicine and continued unbroken to Hippocrates (480-355 B.C.). The classic period of Greek medicine was 460-136 B.C. and the Graeco-Roman period, 156 B.C.-576 A.D. (From A. Castiglioni, A History of Medicine, 2d ed; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed). cZ Greece Z01.542.383; Z01.586.035.450 EHEP Geographicals (Non MeSH); Europe Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Ancient Lands (Non MeSH) c "Great Lakes Region Z01.107.567.875.600.313 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Illinois (+ 1); Indiana; Michigan; Minnesota; New York (+ 1); Ohio; Pennsylvania (+ 1); Wisconsin The geographic area of the Great Lakes in general and when the specific state or states are not indicated. It usually includes Illinois, Indiana, Michigan, Minnesota, New York, Ohio, Pennsylvania, and Wisconsin. cy}Great Britain Z01.542.363 EHEP Geographicals (Non MeSH); Europe Channel Islands; England (+ 1); Hebrides; Northern Ireland; Scotland; Wales c)^Gravity, Altered H01.671.323.369 AE Centrifugation; Rotation Physical Sciences (Non MeSH); Physics; Gravitation Hypergravity; Hypogravity (+ 1) A change in, or manipulation of, gravitational force. This may be a natural or artificial effect. Gravitation (66-94) $c>'vGravity Perception F02.463.593.409; G04.742.450; G11.561.796.255 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation Process whereby a bodily structure or organism (animal or plant) receives or detects a gravity stimulus. The sensing may be direct or indirect and may or may not initiate a reaction to the stimulus. Gravitation (66-94) c$5 5Gravitropism G04.742.800.400; G07.950.400 DEGEIMPHRE Gravitation; Auxins Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH); Tropism Physiology, General (Non MeSH); Tropism The directional growth of organisms in response to gravity. In plants, the main root is positively gravitropic (growing downwards) and a main stem is negatively gravitropic (growing upwards), irrespective of the positions in which they are placed. Plant gravitropism is thought to be controlled by auxin (AUXINS), a plant growth substance. (From Concise Dictionary of Biology, 1990). c"Gravitation H01.671.323 Gravitropism Physical Sciences (Non MeSH); Physics Gravity, Altered (+ 3) Acceleration produced by the mutual attraction of two masses, and of magnitude inversely proportional to the square of the distance between the two centers of mass. It is also the force imparted by the earth, moon, or a planet to an object near its surface. (From NASA Thesaurus, 1988). AE  c/VGraves' Disease C11.675.349.500; C19.874.283.605; C19.874.397.370; C20.111.555 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunoglobulins, Thyroid-Stimulating Eye Diseases; Orbital Diseases; Exophthalmos Endocrine Diseases; Thyroid Diseases; Goiter Endocrine Diseases; Thyroid Diseases; Hyperthyroidism Immunologic Diseases; Autoimmune Diseases Hyperthyroidism associated with a diffuse hyperplastic goiter resulting from production of an antibody directed against the thyroid-stimulating hormone (TSH) receptor, which acts as an agonist of TSH. (Braverman, The Thyroid, 6th ed, p. 648). cHN)Grateful Med L01.700.508.280.400; L01.700.568.810.400 CLECHIISLJMAOGSDSNSTTDUT National Library of Medicine (U.S.) Information Science; Medical Informatics; Medical Informatics Applications; Information Storage and Retrieval Information Science; Medical Informatics; Medical Informatics Computing; Software A microcomputer-based software package providing a user-friendly interface to the MEDLARS system of the National Library of Medicine. MEDLARS (86-90)  c.+Grasshoppers B01.131.617.678.369 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Orthoptera Plant-eating orthopterans having hindlegs adapted for jumping. There are several families and many genera. Some of the more common genera are: Melanoplus, the most common grasshopper; Conocephalus, the eastern meadow grasshopper; and Pterophylla, the true katydid. Insects (66-71) c(84Grasses B06.252 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Pollen Plants Lolium A large family, Graminea, of narrow-leaved herbaceous monocots. Many grasses produce highly allergenic pollens and are hosts to cattle parasites and toxic fungi.  c  &   Graphite D01.268.150.300; D01.578.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Carbon Inorganic Chemicals (Non MeSH); Minerals Graphite. An allotropic form of carbon that is used in pencils, as a lubricant, and in matches and explosives. It is obtained by mining and its dust can cause lung irritation. d "8lGranulosa Cells A05.360.319.114.630.535.200; A06.407.312.497.535.300; A11.436.300 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Graafian Follicle Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri; Ovary; Graafian Follicle Endocrine System (Non MeSH); Endocrine Glands; Gonads; Ovary; Graafian Follicle Cells; Epithelial Cells (Non MeSH) Cells of the membrana granulosa lining the vesicular ovarian follicle which become luteal cells after ovulation. dI*Granulosa Cell Tumor C04.557.475.325 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue An ovarian tumor originating in the cells of the primordial membrana granulosa of the graafian follicle. It may be associated with excessive production of estrin, inducing endometrial hyperplasia with menorrhagia. It can be benign or malignant. It is soft, solid, white or yellow, and consists of small round cells sometimes enclosing Call-Exner bodies. Larger lipid-containing cells may be present. Granulosa cell tumors are seen in women of all ages. Treatment depends on the age of the patient and the extent of the disease. (From Dorland, 27th ed; Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p. 1683-4). d!X]Granulomatous Disease, Chronic C15.378.553.774.535; C20.673.774.535 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Burst Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Phagocyte Bactericidal Dysfunction Immunologic Diseases; Immunologic Deficiency Syndromes; Phagocyte Bactericidal Dysfunction A recessive X-linked defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. Granuloma (66-71); Immunologic Deficiency Syndromes (68-71); Phagocyte Bactericidal Dysfunction (72-77); Phagocytosis (66-71)  d$*NGranuloma, Respiratory Tract (Non MeSH) C23.484.500 Symptoms and General Pathology (Non MeSH); Granuloma Granuloma, Laryngeal; Granuloma, Lethal Midline; Rhinoscleroma; Wegener's Granulomatosis BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI d B/@fPGranuloma, Pyogenic C23.484.490; C23.739.487.451.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Granuloma Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation; Granuloma A usually solitary polypoid capillary hemangioma of the skin and gingival or oral mucosa, often associated with trauma or local irritation, representing a vasoproliferative inflammatory response. It presents as a small erythematous papule that enlarges and may become pedunculated and may become infected and ulcerate with accompanying purulent exudate. The hemangioma without suppuration is called angiogranuloma. Pyogenic granuloma is not a granuloma: the name refers to the mass of inflamed, highly vascular granulation tissue. (From Dorland, 27th ed; Stedman, 25th ed). Granuloma (67-93); Hemangioma (69-93) d &N.Granuloma, Plasma Cell, Pulmonary C08.381.331; C23.484.480.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Symptoms and General Pathology (Non MeSH); Granuloma; Granuloma, Plasma Cell A pseudotumor of the lung composed of inflammatory cells and showing complete maturity of fibroblastic components with a striking lack of mitosis. It is also called postinflammatory pseudotumor and pseudoneoplastic pneumonitis. (Berardi, R.S. et al. Inflammatory pseudotumors of the lung. Surg Gynecol Obstet 156:89-96, Jan 83). Lung Diseases (66-91) d("NGranuloma, Plasma Cell, Orbital C11.675.504; C23.484.480.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Orbital Diseases Symptoms and General Pathology (Non MeSH); Granuloma; Granuloma, Plasma Cell A distinctive, chronic inflammatory reaction in the orbital tissues of the eye, of unknown etiology, that may closely resemble a neoplasm and often becomes bilateral. Symptoms include exophthalmos and congestion of the lids with edema. When limitation of ocular motility also occurs, it is sometimes called orbital myositis. (Dorland, 27th ed.). Granuloma (66-91); Orbit (66-80); Orbital Diseases (81-91) d&"NHGranuloma, Plasma Cell C23.484.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Granuloma Granuloma, Plasma Cell, Orbital; Granuloma, Plasma Cell, Pulmonary A slow-growing benign pseudotumor in which plasma cells greatly outnumber the inflammatory cells. Granuloma (66-83); Plasma Cells (66-83)  dN@Nr1Granuloma, Lethal Midline C08.460.352; C09.603.352; C23.484.500.352 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Otorhinolaryngologic Diseases; Nose Diseases Symptoms and General Pathology (Non MeSH); Granuloma; Granuloma, Respiratory Tract (Non MeSH) A non-neoplastic disease of unknown etiology beginning with inflammation, ulceration, and perforation of nose and palate and progressing to gradual destruction of midline facial structures. d1NGranuloma, Laryngeal C08.360.232; C08.618.846.414; C09.400.232; C23.484.500.232 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Otorhinolaryngologic Diseases; Laryngeal Diseases Symptoms and General Pathology (Non MeSH); Granuloma; Granuloma, Respiratory Tract (Non MeSH) A polypoid granulomatous projection into the lumen of the larynx. dDN1OGranuloma, Giant Cell C05.500.368; C07.320.391; C07.465.714.258.557; C23.484.368 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases Symptoms and General Pathology (Non MeSH); Granuloma A non-neoplastic inflammatory lesion, usually of the jaw or gingiva, containing large, multinucleated cells. It includes reparative giant cell granuloma. Peripheral giant cell granuloma refers to the gingiva (giant cell epulis); central refers to the jaw. dUDN+Granuloma, Foreign-Body C21.866.392.560.325; C23.484.350; C23.739.487.351.325 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Foreign Bodies; Foreign-Body Reaction Symptoms and General Pathology (Non MeSH); Granuloma Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation; Foreign-Body Reaction Histiocytic, inflammatory response to a foreign body. It consists of modified macrophages with multinucleated giant cells, in this case foreign-body giant cells (GIANT CELLS, FOREIGN-B0DY), usually surrounded by lymphocytes. Foreign Bodies (66-89); Foreign Body Reaction (72-89); Granuloma (66-89) d C=N>XGranuloma Inguinale C01.252.400.411; C01.252.810.451; C01.252.825.360; C01.539.780.281.451; C01.539.800.720.360; C17.800.838.765.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Sexually Transmitted Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Anogenital ulcers caused by Calymmatobacterium granulomatis as distinguished from lymphogranuloma inguinale (see LYMPHOGRANULOMA VENEREUM) caused by CHLAMYDIA TRACHOMATIS. Diagnosis is made by demonstration of typical intracellular Donovan bodies in crushed-tissue smears. d#~P4Granuloma Annulare C17.300.200.495.380; C17.800.550.380; C23.484.321 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases; Necrobiotic Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Necrobiotic Disorders Symptoms and General Pathology (Non MeSH); Granuloma Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures. Granuloma (66-91); Skin Diseases (66-91) d(9N* 2Granuloma C23.484; C23.739.487.451 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tuberculoma Symptoms and General Pathology (Non MeSH) Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation Angiolymphoid Hyperplasia with Eosinophilia; Churg-Strauss Syndrome; Eosinophilic Granuloma; Granuloma Annulare; Granuloma, Foreign-Body; Granuloma, Giant Cell; Granuloma, Plasma Cell (+ 2); Granuloma, Pyogenic; Granuloma, Respiratory Tract (Non MeSH) (+ 4); Lymphomatoid Granulomatosis; Periapical Granuloma; Sarcoidosis (+ 2) Granuloma, Pyogenic An imprecise term applied to (1) any small nodular delimited aggregation of mononuclear inflammatory cells, or (2) such a collection of modified macrophages resembling epithelial cells, usually surrounded by a rim of lymphocytes, often with multinucleated giant cells. Some granulomas contain eosinophils and plasma cells, and fibrosis is commonly seen around the lesion. Granuloma formation represents a chronic inflammatory response initiated by various infectious and noninfectious agents. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $d+ NNPGranulocytes A11.118.637.415; A15.145.229.637.415; A15.382.490.315 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes Basophils; Eosinophils; Neutrophils Basophils; Eosinophils; Neutrophils Basophils; Eosinophils; Neutrophils Leukocytes with abundant granules in the cytoplasm. They are divided into three groups: NEUTROPHILS, EOSINOPHILS, and BASOPHILS. Leukocytes (66-74)  d1v=*}Granulocyte-Macrophage Colony-Stimulating Factor D12.776.395.240.300; D24.185.348.453.240.375; D24.611.350.400.442.240.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Granulocyte-Macrophage Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors An acidic glycoprotein of MW 23 kDa with internal disulfide bonds. The protein is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation. GM-CSF is able to stimulate the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from fetal liver progenitor cells. GM-CSF can also stimulate some functional activities in mature granulocytes and macrophages. Colony-Stimulating Factors (76-90); Growth Substances (66-90); Interleukin-3 (81-87)  d46QFBcGranulocyte Colony-Stimulating Factor D12.776.395.240.200; D24.185.348.453.240.350; D24.611.350.400.442.240.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Granulocyte Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factors (76-90)  d:+QF7(Granulation Tissue A10.424 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Wound Healing Tissue Types (Non MeSH) Cicatrix ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI  d? : jGranular Cell Tumor C04.557.450.590.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue Unusual tumor affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma. Myoblastoma (66-91) d@3XGranisetron D03.383.694.487.350; D03.438.449.350; D14.100.850.850.350; D15.095.225; D16.050.030.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Indazoles Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients. Indazoles (88-93) dCc:Gramicidins D20.085.116.875.375; D20.187.925.412 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Tyrothricin Anti-Infective Agents; Anti-Infective Agents, Local; Tyrothricin Antibiotic mixture that is one of the two principle components of tyrothricin from Bacillus brevis. Gramicidin C or S is a cyclic, ten-amino acid polypeptide and gramicidins A, B, D, etc., seem to be linear polypeptides. The mixture is used topically for gram-positive organisms. It is toxic to blood, liver, kidneys, meninges, and the olfactory apparatus. dF*:Gram-Positive Rods B03.510.460 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria Gram-Positive Asporogenous Rods (+ 39); Gram-Positive Endospore-Forming Rods (Non MeSH) (+ 21) A large group of rod-shaped bacteria that retains the crystal violet stain when treated by Gram's method. dI"'o~Gram-Positive Endospore-Forming Rods (Non MeSH) B03.300.390.400; B03.510.415.400; B03.510.460.410 Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria Bacteria; Gram-Positive Bacteria; Gram-Positive Rods Bacillaceae (+ 12); Micromonosporaceae (+ 1); Saccharopolyspora; Streptomycetaceae (+ 4) Bacillaceae (+ 12); Micromonosporaceae (+ 1); Saccharopolyspora; Streptomycetaceae (+ 4) Bacillaceae (+ 12); Micromonosporaceae (+ 1); Saccharopolyspora; Streptomycetaceae (+ 4) Rod-shaped bacteria that form endospores and are gram-positive. Representative genera include BACILLUS and CLOSTRIDIUM. CHCLCYDEENGDGEIMIPMEPHPYREULVI dK&79:"Gram-Positive Endospore-Forming Bacteria B03.300.390; B03.510.415 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH) Bacteria; Gram-Positive Bacteria Gram-Positive Endospore-Forming Rods (Non MeSH) (+ 21) Gram-Positive Endospore-Forming Rods (Non MeSH) (+ 21) Bacteria that form endospores and are gram-positive. Representative genera include BACILLUS, CLOSTRIDIUM, MICROMONOSPORA, SACCHAROPOLYSPORA, and STREPTOMYCES. dN."]~Gram-Positive Cocci B03.510.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria Methanosarcina barkeri; Micrococcaceae (+ 5); Peptococcaceae (+ 2); Sarcina; Streptococcaceae (+ 17) Coccus-shaped bacteria that retain the crystal violet stain when treated by Gram's method. Bacteria (66-72,76-83); Gram-Positive Bacteria (73-75,84-91)  dP"'ykFGram-Positive Bacterial Infections C01.252.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Actinomycetales Infections (+ 48); Bacillaceae Infections (+ 7); Erysipelothrix Infections (+ 2); Listeria Infections (+ 1); Staphylococcal Infections (+ 7); Streptococcal Infections (+ 10) Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections (72-91); Gram-Positive Bacteria (84-91); specific bacteria (72-83); specific bacterial infection (66-71)  dR(PKGram-Positive Bacteria B03.510 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Gram-Positive Cocci (+ 29); Gram-Positive Endospore-Forming Bacteria (+ 22); Gram-Positive Rods (+ 62); Nocardioform Group (+ 24) Bacteria which retain the crystal violet stain when treated by Gram's method. Bacteria (66-83)  dU " ]Gram-Positive Asporogenous Rods, Regular (Non MeSH) B03.510.460.400.410 Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods Erysipelothrix; Lactobacillaceae (+ 3); Listeria (+ 1); Mycobacteriaceae (+ 14) A group of regular rod-shaped bacteria that stain gram-positive and do not produce endospores. CHCLCYDEENGDGEIMIPMEPHPYREULVI dW <cap"Gram-Positive Asporogenous Rods, Irregular (Non MeSH) B03.510.460.400.400 Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods Actinobacteria Group (+ 6); Corynebacterium (+ 3); Propionibacteriaceae (+ 3) A group of irregular rod-shaped bacteria that stain gram-positive and do not produce endospores. CHCLCYDEENGDGEIMIPMEPHPYREULVI dX>c^r"Gram-Positive Asporogenous Rods B03.510.460.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods Gram-Positive Asporogenous Rods, Irregular (Non MeSH) (+ 15); Gram-Positive Asporogenous Rods, Regular (Non MeSH) (+ 22) A gram-positive, non-spore-forming group of bacteria comprising organisms that have morphological and physiological characteristics in common. dZ%">Gram-Negative Facultatively Anaerobic Rods B03.440.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Calymmatobacterium; Capnocytophaga; Chromobacterium; Eikenella (+ 1); Enterobacteriaceae (+ 36); Pasteurellaceae (+ 9); Streptobacillus; Vibrionaceae (+ 7); Zymomonas A large group of facultatively anaerobic, rod-shaped bacteria that show up as pink (negative) when treated by the gram-staining method. Bacteria (66-72); Gram-Negative Anaerobic Bacteria (76-91); Gram-Negative Bacteria (73-75)  d\1"'jGram-Negative Chemolithotrophic Bacteria B03.440.400.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria Nitrobacteraceae (+ 2); Thiobacillus (+ 1) A large group of bacteria including those which oxidize ammonia or nitrite, metabolize sulfur and sulfur compounds, or deposit iron and/or manganese oxides. Bacteria (66-72); Schizomycetes (73-74)  d_."K50Gram-Negative Bacterial Infections C01.252.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Bacteroidaceae Infections (+ 2); Bordetella Infections (+ 1); Borrelia Infections (+ 3); Brucellosis (+ 1); Campylobacter Infections; Cat-Scratch Disease; Enterobacteriaceae Infections (+ 14); Granuloma Inguinale; Helicobacter Infections; Legionellosis (+ 1); Leptospirosis (+ 1); Mycoplasmatales Infections (+ 4); Neisseriaceae Infections (+ 6); Pasteurellaceae Infections (+ 8); Pseudomonas Infections (+ 2); Rat-Bite Fever; Rickettsial and Chlamydial Infections (Non MeSH) (+ 28); Tick-Borne Diseases (+ 9); Treponemal Infections (+ 11); Tularemia; Vibrio Infections (+ 1) Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method. Bacterial Infections (72-91); Gram-Negative Bacteria (84-91); specific bacteria (72-83); specific bacterial infection (66-71)  da(PK{Gram-Negative Bacteria B03.440 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Campylobacter (+ 3); Cyanobacteria (+ 3); Gastrospirillum (+ 1); Gram-Negative Aerobic Bacteria (+ 81); Gram-Negative Anaerobic Bacteria (+ 19); Gram-Negative Facultatively Anaerobic Rods (+ 62); Helicobacter (+ 1); Mollicutes (+ 15) Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Bacteria (66-83) CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI $de " o&Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH) B03.440.425.410 Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria Bacteroidaceae (+ 12); Desulfovibrio (+ 1) A group of anaerobic, rod-shaped bacteria which show up as pink (negative) when treated by the gram-staining method. CHCLCYDEENGDGEIMIPMEPHPYREULVI dhQM5"Gram-Negative Anaerobic Cocci B03.440.425.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria Veillonellaceae (+ 1) A group of anaerobic coccoid bacteria that show up as pink (negative) when treated by the gram-staining method. Bacteria (66-75); Gram-Negative Anaerobic Bacteria (76-91)  di#"MEGram-Negative Anaerobic Bacteria B03.440.425 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Gram-Negative Anaerobic Cocci (+ 2); Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH) (+ 15) A large group of anaerobic bacteria which show up as pink (negative) when treated by the gram-staining method. Bacteria (66-75)  dk~&"'Gram-Negative Aerobic Rods and Cocci (Non MeSH) B03.440.400.425 Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria Acetobacteraceae (+ 1); Alcaligenes; Azospirillum (+ 1); Azotobacteraceae (+ 2); Bdellovibrio; Bordetella (+ 2); Brucella (+ 2); Flavobacterium; Francisella (+ 1); Halobacteriaceae (+ 2); Legionellaceae (+ 2); Leptospiraceae (+ 3); Leptothrix; Methylococcaceae; Neisseriaceae (+ 10); Paracoccus (+ 1); Pseudomonadaceae (+ 9); Rhizobiaceae (+ 5); Rickettsia (+ 4); Rochalimaea; Sphaerotilus; Thermus (+ 1) A group of gram-negative bacteria consisting of rod- and coccus-shaped cells. CHCLCYDEENGDGEIMIPMEPHPYREULVI dmF9K\"Gram-Negative Aerobic Bacteria B03.440.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Achromatiaceae (+ 1); Beggiatoales (+ 1); Caulobacter (+ 1); Gram-Negative Aerobic Rods and Cocci (Non MeSH) (+ 68); Gram-Negative Chemolithotrophic Bacteria (+ 5) A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method. Bacteria (66-75)  dpp$"'Graft vs Host Reaction G04.610.555.714.402 DEGEIMPHRE Graft vs Host Disease Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular; Transplantation Immunology An immunological attack mounted by a graft against the host because of tissue incompatibility when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. Graft vs Host Disease (66-69); Transplantation Immunology (66-69)  drs%NGraft vs Host Disease C20.452 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Graft vs Host Reaction; Immune Tolerance Immunologic Diseases The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. dt N2Graft Survival G04.610.555.714.545.340 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular; Transplantation Immunology; Host vs Graft Reaction The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Rejection (71-76); Transplantation Immunology (66-72) dvFGraft Rejection G04.610.555.714.545.328 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular; Transplantation Immunology; Host vs Graft Reaction An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplantation Immunology (66-70) dxL(Graft Occlusion, Vascular C23.814.395 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Vascular Patency Symptoms and General Pathology (Non MeSH); Postoperative Complications Obstruction of flow in biological or prosthetic vascular grafts. dzNSMGraft Enhancement, Immunologic E02.095.520.450.440; E05.478.610.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunosuppression Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunosuppression The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. Graft Survival (77-79); Transplantation, Homologous (66-79); Transplantation Immunology (66-79) d|?$*"}oGraafian Follicle A05.360.319.114.630.535; A06.407.312.497.535 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Granulosa Cells; Ovum; Theca Cells Ovum Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri; Ovary Endocrine System (Non MeSH); Endocrine Glands; Gonads; Ovary Follicular Fluid; Granulosa Cells; Theca Cells Follicular Fluid; Granulosa Cells; Theca Cells An ovarian follicle in which the oocyte attains its full size and is surrounded by a thickened oolemma (zona pellucida) at the periphery of the fluid-filled antrum. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI (dv2:,p<Government Publications L01.178.682.492 Information Science; Communications Media (Non MeSH); Publications (Non MeSH) dj\Government Programs (Non MeSH) I01.451 Social Sciences Civil Defense; Postal Service CLECEDHIISLJMAMTOGSDSNSTTDUT d% % Government Agencies I01.409.275; N03.540.427 CLECHILJOGSNSTTDUT Social Sciences; Government Economics, Organizations, Control (Non MeSH); Organizations  United States Department of Agriculture; United States Department of Veterans Affairs; United States Dept. of Health and Human Services (+ 16); United States Environmental Protection Agency; United States Federal Trade Commission; United States National Aeronautics and Space Administration; United States Occupational Safety and Health Administration; United States Office of Economic Opportunity; United States Office of Technology Assessment Administrative units of government responsible for policy making and management of governmental activities in the U.S. and abroad. Government (66-67)  dfGovernment I01.409 Social Sciences Government Agencies; Municipal Government; State Government The complex of political institutions, laws, and customs through which the function of governing is carried out in a specific political unit. CLECHILJOGSNSTTDUT dK FGoverning Board N04.452.394 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration Trustees The group in which legal authority is vested for the control of health-related institutions and organizations. Hospital Administration (66-67); Organization and Administration (66-67); Public Health Administration (66-67) CLECHILJOGPXSDSNSTTDUT $dW Gout Suppressants D17.050.337 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Gout Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Allopurinol; Colchicine; Indomethacin; Naproxen; Uricosuric Agents (+ 5) Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout. Uricosuric Agents (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (d8{W:Gout C05.550.114.423; C05.799.414; C18.452.648.798.368 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gout Suppressants Musculoskeletal Diseases; Joint Diseases; Arthritis Musculoskeletal Diseases; Rheumatic Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Purine-Pyrimidine Metabolism, Inborn Errors Arthritis, Gouty Arthritis, Gouty Arthritis, Gouty Hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi.  d-9N ;Gossypol D02.455.849.919.330; D11.557.450 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cottonseed Oil Cottonseed Oil Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Triterpenes Growth Substances, Pigments, Vitamins (Non MeSH); Pigments 1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)(2,2'-binaphthalene)-8,8'-dicarboxaldehyde. Poisonous pigment found in cottonseed and potentially irritating to gastrointestinal tract.  d! &<Goserelin D06.472.709.429.315; D22.204.425 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones; Gonadorelin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 6-(O-(1,1-Dimethylethyl)-D-serine)-10-deglycinamideluteinizing hormone-releasing factor (pig) 2-(aminocarbonyl)hydrazide. A long-acting GONADORELIN agonist. It is used in the treatment of malignant neoplasms of the prostate, uterine fibromas, and metastatic breast cancer. Buserelin/analogs and derivatives (84-92); Gonadorelin/analogs and derivatives (79-84) dN &:7eGorilla gorilla B02.649.801.400.650.350 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Pongidae This single species of Gorilla, which is a member of the PONGIDAE family, is the largest and most powerful of the Primates. It is distributed in isolated scattered populations throughout forests of equatorial Africa. Pongidae (66-74) dG(@Goodpasture's Syndrome C08.381.483.250; C12.777.419.570.363.651; C20.111.550 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Glomerulonephritis Immunologic Diseases; Autoimmune Diseases A combination of pulmonary hemorrhage and glomerulonephritis. It is known also as the lung purpura glomerulonephritis complex. It is considered by some to be a form of hypersensitivity reaction. d=NGonorrhea C01.252.400.625.391; C01.252.810.401; C01.539.780.281.401 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Neisseriaceae Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Sexually Transmitted Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Bacterial Ophthalmia Neonatorum Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879. d APGonioscopy E01.210.451 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Eye (Non MeSH) d"-Gonanes D04.808.451 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Steroids containing the fundamental tetracyclic unit with no methyl groups at C-10 and C-13 and with no side chain at C-17. The concept includes both saturated and unsaturated derivatives. d 8(Gonads A05.360.576; A06.407.312 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Castration; Sex Reversal, Gonadal Urogenital System; Genitalia Endocrine System (Non MeSH); Endocrine Glands Ovary; Testis Ovary (+ 6); Testis (+ 1) The gamete-producing glands, OVARY or TESTIS. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $d :)Y57<Gonadotropins, Pituitary D06.472.351.576; D06.472.734.525.343; D07.552.344.400 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Gonadotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior Reproductive Control Agents (Non MeSH); Fertility Agents; Fertility Agents, Female FSH; LH; Menotropins; Prolactin FSH; LH; Menotropins; Prolactin Menotropins Hormones secreted by the anterior lobe of the pituitary gland that stimulate the normal functioning of the gonads and the secretion of sex hormones in both men and women. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $d=B,]FGonadotropins, Equine D06.472.351.451; D06.472.759.451; D06.472.785.451; D12.776.780.451 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Placental Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins Polypeptide hormones secreted in pregnant mares at the junction of the placenta and endometrial cups. Preparations of this taken from the blood serum of pregnant mares have been used in the treatment of infertility, pituitary dwarfism, cryptorchidism, and other conditions in both human males and females. dALBZdGonadotropins, Chorionic D06.472.351.326; D06.472.759.367; D06.472.785.400; D12.776.780.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Gonadotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Placental Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pregnancy Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Pregnancy Proteins dLFZGonadotropins D06.472.351 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Gonadotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones Gonadotropins, Chorionic; Gonadotropins, Equine; Gonadotropins, Pituitary (+ 4) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  dBB\HGonadorelin D06.472.709.429; D12.644.456.460; D12.776.641.650.350; D14.600.600.342 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, LHRH Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Buserelin; Goserelin; Leuprolide; Nafarelin; Triptorelin Luteinizing hormone-releasing factor. A decapeptide hormone released by the hypothalamus that stimulates the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland.  dPFGGonadoblastoma C04.557.465.330.300.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Germinoma; Dysgerminoma A DYSGERMINOMA that contains all gonadal elements - germ cells, sex cord derivatives, and stromal derivatives. It occurs almost exclusively in abnormal gonads, most often associated with some form of gonadal dysgenesis, frequently associated with abnormal chromosomal karyotype. It is rare and occurs almost exclusively during the first two decades of life. Almost 33% are associated with germinomas. Gonadoblastomas consist of large germ cells surrounded by smaller round, darkly staining Sertoli cells, forming microfollicles consisting of hyaline bodies and calcium deposits. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Dysgerminoma (66-93) dQXGonadal Dysgenesis, 46,XY C13.371.820.700.842.309.388; C16.131.280.748.388; C16.131.939.842.309.388; C19.391.775.309.388 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis A syndrome characterized by "streak gonads" in a phenotypic female with a 46,XY karyotype. It is due to a mutation which inhibits the function of the Y-borne determinant that would normally cause the indifferent embryonic gonad to differentiate into a testis. The streak gonad is incapable of ovulation or estrogen secretion. The syndrome is sometimes called "pure gonadal dysgenesis," but this designation may also refer to the presence of streak gonads with a 46,XX karyotype. Sex Differentiation Disorders (66-79); Turner's Syndrome (67-79) dhL0LGonadal Dysgenesis, Mixed C12.740.700.842.309.391; C13.371.820.700.842.309.391; C16.131.280.748.391; C16.131.939.842.309.391; C19.391.775.309.391 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders; Gonadal Dysgenesis A syndrome of gonadal dysgenesis in which there is a testis on one side and a "streak gonad" on the other. The phenotype is generally male, but may be female since the individual is a mosaic. Various karyotypes have been identified, including 45,XO/47,XYY; 45,XO/46,XY; and 45,XO/46,XYo. Sex Differentiation Disorders (66-79); Turner's Syndrome (67-79) dL=XLGonadal Dysgenesis C12.740.700.842.309; C13.371.820.700.842.309; C16.131.939.842.309; C19.391.775.309 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH); Sex Differentiation Disorders Endocrine Diseases; Gonadal Disorders (Non MeSH); Sex Differentiation Disorders Gonadal Dysgenesis, Mixed Gonadal Dysgenesis, 46,XY; Gonadal Dysgenesis, Mixed; Turner's Syndrome Gonadal Dysgenesis, 46,XY; Gonadal Dysgenesis, Mixed; Turner's Syndrome Gonadal Dysgenesis, 46,XY; Gonadal Dysgenesis, Mixed; Turner's Syndrome Any of several developmental anomalies involving the total or partial failure of the indifferent embryonic gonad to differentiate into ovary or testis. This concept includes gonadal agenesis. Sex Differentiation Disorders (66-79); Turner's Syndrome (67-79)  d\L[LGonadal Disorders (Non MeSH) C19.391 Endocrine Diseases Adrenal Hyperplasia, Congenital; Feminization (+ 1); Hyperandrogenism; Hypogonadism (+ 3); Ovarian Diseases (+ 8); Puberty, Delayed; Puberty, Precocious; Sex Differentiation Disorders (+ 9); Testicular Diseases (+ 3); Virilism (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI d# XGolgi-Mazzoni Corpuscles A08.800.550.700.500.300 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Mechanoreceptors Tactile corpuscles found in the subcutaneous tissue of the fingertips, resembling PACINIAN CORPUSCLES, but possessing fewer lamellae and a relatively larger cone, and having the contained fibers more extensively branched (Dorland, 27th ed). d8oGolgi Apparatus A11.368.702.336 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles A stack of flattened vesicles that functions in posttranslational processing and sorting of proteins, receiving them from the rough ENDOPLASMIC RETICULUM and directing them to secretory vesicles, LYSOSOMES, or the CELL MEMBRANE. The movement of proteins takes place by transfer vesicles that bud off from the rough endoplasmic reticulum or Golgi apparatus and fuse with the Golgi, lysosomes or cell membrane. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990). d *$)Golf I03.450.642.845.400 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A game whose object is to sink a ball into each of 9 or 18 successive holes on a golf course using as few strokes as possible. Sports (66-75) dRGoldfish B02.493.200.244.248.480 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cypriniformes; Cyprinidae; Carp d. &@Goldenhar Syndrome C05.116.099.370.231.576.410; C05.660.246.650.307; C16.131.621.246.650.307 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Craniofacial Dysostosis; Mandibulofacial Dysostosis Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis; Mandibulofacial Dysostosis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Craniofacial Dysostosis; Mandibulofacial Dysostosis Mandibulofacial dysostosis with congenital eyelid dermoids. Abnormalities, Multiple (68-78); Mandibulofacial Dysostosis (66-78) dQLENGold Sodium Thiosulfate D01.379.425; D01.857.300; D01.875.800.800.850.900.250; D17.050.050.260 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gold Compounds Inorganic Chemicals (Non MeSH); Sodium Compounds Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates; Thiosulfates Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Antirheumatic Agents, Gold An antirheumatic agent with the same actions and uses as GOLD SODIUM THIOMALATE. dP8aGold Sodium Thiomalate D02.241.081.337.463.703.451; D02.691.426; D17.050.050.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Malates; Thiomalates Organic Chemicals (Non MeSH); Organometallic Compounds Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Antirheumatic Agents, Gold A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis. Gold (66-72) dA:cGold Radioisotopes D01.496.381.550; D01.496.749.410 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Gold Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Gold Colloid, Radioactive Gold Colloid, Radioactive Unstable isotopes of gold that decay or disintegrate emitting radiation. Au 185-196, 198-201, and 203 are radioactive gold isotopes. Gold Isotopes (66-74); Radioisotopes (66-74)  dؗ&4<6Gold Isotopes D01.496.381 Inorganic Chemicals (Non MeSH); Isotopes Gold Radioisotopes (+ 1) Stable gold atoms that have the same atomic number as the element gold, but differ in atomic weight. Au-197 is a stable isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR d24Gold Compounds D01.379 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Gold Alloys; Gold Colloid (+ 1); Gold Sodium Thiosulfate Inorganic compounds that contain gold as an integral part of the molecule. Gold (66-93)  d/ 8%GZGold Colloid, Radioactive D01.379.400.350; D01.496.381.550.400; D01.496.749.410.400; D22.204.423 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gold Compounds; Gold Colloid Inorganic Chemicals (Non MeSH); Isotopes; Gold Isotopes; Gold Radioisotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes; Gold Radioisotopes Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents A radioactive suspension of minute particles of metallic gold, made by exposure to neutrons. It is used in the pleural cavity to treat lung cancer. (From Dorland, 27th ed). d݇P4IGold Colloid D01.379.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gold Compounds Gold Colloid, Radioactive A purplish suspension of minute particles of metallic gold, made by reducing a solution of bromauric acid or other acid or salt of gold. (From Dorland, 27th ed) It is used as a probe in immunochemistry. Gold (86-93)  df89Gold Alloys D01.379.375; D01.552.033.533; D25.058.451; D25.339.208.534 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Gold Compounds Inorganic Chemicals (Non MeSH); Metals; Alloys Biomedical and Dental Materials (Non MeSH); Alloys Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Alloys Alloys that contain a high percentage of gold. They are used in restorative or prosthetic dentistry. dED,yGold D01.268.357; D01.552.322 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Antirheumatic Agents, Gold Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications are in the form of its salts. dg: `*Goiter, Substernal C19.874.283.601 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases; Goiter An enlarged thyroid gland where the enlarged gland is situated beneath the sternum. (Dorland, 27th ed). dN6}Goiter, Nodular C19.874.283.501 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Thyroid Nodule Endocrine Diseases; Thyroid Diseases; Goiter An enlarged thyroid gland containing circumscribed nodules within its substance. (Dorland, 27th ed). Goiter (66-71)  dN6wGoiter, Endemic C19.874.283.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases; Goiter Enlargement of the thyroid gland in a significantly large fraction of a population group, generally considered to be due to insufficient iodine in the diet. Goiter (66-68) dYN6Goiter C19.874.283 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Thyroid Diseases Goiter, Endemic; Goiter, Nodular; Goiter, Substernal; Graves' Disease Enlargement of the thyroid gland. d N,S*Goats B02.649.077.380.513 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Any of numerous agile, hollow-horned ruminants of the genus Capra, closely related to the sheep. d. (7sGoat Diseases C22.405 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Diseases of the domestic or wild goat of the genus Capra. Goats (66-89) dC HHGoals F01.658.500 Behavior and Behavior Mechanisms (Non MeSH); Motivation The end-result or objective, which may be specified or required in advance. Motivation (66-74) d= C[Gnathostoma B01.500.294.700.750.700.722.375 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Thelazioidea A genus of parasitic nematodes that occurs in mammals including man. Infection in humans is either by larvae penetrating the skin or by ingestion of uncooked fish. d-#*cGlyoxylates D02.241.152.367 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Aldehydic (Non MeSH) Oxamic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR d8[:Glyoxal D02.047.644 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Phenylglyoxal; Pyruvaldehyde d :1"Glycyrrhiza B06.560.546.445 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal; Legumes A genus of leguminous herbs or shrubs whose roots yield GLYCYRRHETINIC ACID and its derivatives, CARBENOXOLONE for example. Licorice toxicity is manifested as hypokalemia, low blood potassium. Licorice is used as flavoring and aromatic in pharmaceuticals and as candy. d&+9Glycyrrhetinic Acid D02.455.849.919.300; D17.025.080.225; D23.037.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Triterpenes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical Carbenoxolone 3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid. A product from Glycyrrhiza glabra L. Leguminosae with some antiallergic, antibacterial, and antiviral properties; it is used topically for allergic or infectious skin inflammation and orally for its aldosterone effects in electrolyte regulation. Glycyrrhiza (66-76); Triterpenes (74-76)  d9:0L1Glycylglycine D12.644.456.345.575 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides N-Glycylglycine. The simplest of all peptides. It functions as a gamma-glutamyl acceptor. dFckGlycyl T RNA Synthetase D08.586.464.136.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates glycine with its specific transfer RNA. EC 6.1.1.14. Amino Acyl T RNA Synthetases (72-74); Glycine (72-74) dfFt^BGlycosyltransferases D08.586.913.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases N-Acetylhexosaminyltransferases (+ 3); Hexosyltransferases (+ 16); Pentosyltransferases (+ 11); Sialyltransferases Enzymes that catalyze the transfer of glycosyl groups to an acceptor. Most often another carbohydrate molecule acts as an acceptor, but inorganic phosphate can also act as an acceptor, such as in the case of phosphorylases. Some of the enzymes in this group also catalyze hydrolysis, which can be regarded as transfer of a glycosyl group from the donor to water. Subclasses include the HEXOSYLTRANSFERASES, PENTOSYLTRANSFERASES, SIALYLTRANSFERASES, and those transferring other glycosyl groups. EC 2.4. Transferases (66-91)  dFUIGlycosylphosphatidylinositols D09.203.400.410.475; D10.516.390.475; D10.516.695.300.700.800.250 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates; Glycolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids; Phosphatidylinositols Compounds containing carbohydrate or glycosyl groups linked to phosphatidylinositols. They act to anchor proteins or polysaccharides to cell membranes. Glycolipids (88-92); Phosphatidylinositols (88-92) d!IBF;Glycosylceramidase D08.586.277.450.420.475 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Glucosidases Glucosylceramidase The enzyme hydrolyzing glycosyl-N-acylsphingosine to a sugar and N-acylsphingosine. It also catalyzes the hydrolysis of phlorizin to phloretin and glucose. It is found in the intestinal brush border membrane often in conjunction with lactase. EC 3.2.1.62. Glucosidases (66-77)  eF|*Glycosylation End Products, Advanced D02.415 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Glycosylation; Diabetes Mellitus Organic Chemicals (Non MeSH) Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus. Glycosylation (88-92)  en+ B'#Glycosylation G06.535.630.550; H01.181.404.495 DERE Glycosylation End Products, Advanced; Protein Processing, Post-Translational Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic The chemical or biochemical addition of carbohydrate or glycosyl groups to other chemicals, especially peptides or proteins. Glycosyl transferases are used in this biochemical reaction. Glycoproteins (66-86); Protein Processing, Post-Translational (83-86)  e-&WPGlycosuria, Renal C12.777.419.815.532; C18.452.398.450; C18.452.648.851.532 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Glycosuria Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors Glycosuria occurring when there is only the normal amount of sugar in the blood, due to inherited inability of the renal tubules to reabsorb glucose completely. (Dorland, 27th ed). e ALGlycosuria C18.452.398 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glucose; Urine Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Glycosuria, Renal The presence of glucose in the urine, especially the excretion of an abnormally large amount of sugar (glucose) in the urine. (Dorland, 27th ed).  e NNGlycosphingolipids D09.203.400.410.420; D10.516.390.470; D10.516.808.530 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates; Glycolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids Antigens, CD15 Antigens, CD15; Cerebrosides (+ 3); Gangliosides (+ 3); Globosides; Lactosylceramides; Trihexosylceramides Antigens, CD15; Cerebrosides (+ 3); Gangliosides (+ 3); Globosides; Lactosylceramides; Trihexosylceramides Ceramides which contain one or more sugar moieties. Glycolipids (66-74); Sphingolipids (72-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $e=B ?3HGlycosides D09.203.408 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Aminoglycosides (+ 19); Anthocyanins; Atractyloside; Bioflavonoids (+ 4); Cardiac Glycosides (+ 13); Galactosides (+ 4); Glucosides (+ 10); Hemoglobin A, Glycosylated; Lincomycin; Mannosides (+ 1); Methylglycosides (+ 3); Nucleosides; Nucleotides (+ 17); Phlorhizin; Psychosine; Saponins (+ 3); Tannins (+ 1); Teichoic Acids; Thioglycosides (+ 4); Tomatine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR e8BKHGlycoside Hydrolases D08.586.277.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Amylases (+ 2); Cellulase; Chitinase; Dextranase; Disaccharidases (+ 3); Endo-1,3-beta-Glucanase; Fucosidase; Galactosidases (+ 4); Glucosidases (+ 6); Glucuronidase; Hexosaminidases (+ 5); Hyaluronidase; Iduronidase; Isoamylase; Mannosidases; Muramidase; Neuraminidase; Nucleosidases (+ 1); Oligo-1,6-Glucosidase (+ 1); Polygalacturonase; Xylosidases eFSGlycosaminoglycans D09.203.698.373 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Chondroitin (+ 2); Heparin (+ 4); Heparitin Sulfate; Hyaluronic Acid; Keratan Sulfate Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine or N-acetylgalactosamine. Mucopolysaccharides (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $eD^j* FGlycopyrrolate D02.092.102.425; D02.675.276.425; D03.383.773.342; D14.100.120.200.500.340; D15.045.275; D16.050.650.290 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anesthesia Adjuvants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. ev:9Glycoproteins D09.203.400.430; D12.776.395 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates Amino Acids, Peptides and Proteins (Non MeSH); Proteins  Amyloid (+ 5); Asialoglycoproteins; Avidin; Colony-Stimulating Factors (+ 5); Hemopexin; Inhibin; Lactoferrin; Membrane Glycoproteins (+ 24); Mucoproteins (+ 9); Osteonectin; Protein C; Protein S; Proteoglycans (+ 2); Sialoglycoproteins (+ 1); Thrombopoietin; Thyroglobulin; Thyroxine-Binding Proteins; Transcortin; Tumor Necrosis Factor; Uteroglobin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR eI"FHGlycoprotein 4-beta-Galactosyltransferase D08.586.913.400.450.400.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Galactosyltransferases An enzyme that catalyzes the transfer of galactose from UDP-galactose to a specific glycoprotein receptor, 2-acetamido-2-deoxy-D-glucosyl-glycopeptide, during glycopeptide synthesis. EC 2.4.1.38. Galactose (73-75); Glycoproteins (73-75); Hexosyltransferases (73-75) e!s.FRGlycoprotein Hormones, Alpha Subunit D06.472.734.525.300 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior A non-covalently bound subunit of the glycoprotein hormones TSH, FSH, LH and HCG which originates in the anterior pituitary gland and placenta. This subunit is virtually identical in structure and indistinguishable by radioimmunoassay in all of the above glycoproteins. It is present in both men and women, but is elevated in postmenopausal women and in patients with hypothyroidism, uremia and malignant tumors. The alpha subunit may be involved directly in recognition of certain receptors. FSH (72-88); Gonadotropins, Chorionic (72-88); Gonadotropins, Pituitary (72-88); LH (72-88); Menotropins (73-88); Pituitary Hormones, Anterior (72-88); Thyrotropin (72-88) e#+B{=Glycophorin D12.644.233.800.350; D12.776.124.300; D12.776.395.700.350 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Glycopeptides; Sialoglycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Sialoglycoproteins The major sialoglycoprotein of the human erythrocyte membrane. It consists of at least two sialoglycopeptides and is composed of 60% carbohydrate including sialic acid and 40% protein. It is involved in a number of different biological activities including the binding of MN blood groups, influenza viruses, kidney bean phytohemagglutinin, and wheat germ agglutinin. Erythrocytes (66-76); Glycopeptides (73-76); Glycoproteins (66-76); Neuraminic Acids (66-76); Sialic Acids (75-76) e()AF)Glycopeptides D09.203.400.420; D12.644.233 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates Amino Acids, Peptides and Proteins (Non MeSH); Peptides Peptidoglycan Acetylmuramyl-Alanyl-Isoglutamine; Peptidoglycan; Sialoglycoproteins (+ 1) Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. specific polysaccharide (66-70); Peptides (66-70); Polysaccharides (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $e,A"DcXHGlycolysis G06.535.630.535 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) e/tGlycols D02.033.618 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Butanediols (+ 1); Ethylene Glycols (+ 3); Methoxyhydroxyphenylglycol; Polyethylene Glycols (+ 6); Propanediols (+ 6); Sphingosine AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR e0A 80<Glycolipids D09.203.400.410; D10.516.390 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates Lipids and Antilipemic Agents (Non MeSH); Lipids Glycosphingolipids (+ 1); Glycosylphosphatidylinositols Cord Factors; Glycosphingolipids (+ 12); Glycosylphosphatidylinositols; Polyisoprenyl Phosphate Sugars (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR e1"BHGlycolates D02.241.511.316 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polyglycolic Acid Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids 2,4-Dichlorophenoxyacetic Acid; Halofenate; MCPA; Meclofenoxate; Phenoxyacetates (+ 1); 2,4,5-Trichlorophenoxyacetic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  e38K:Glycogen-Synthase-D Phosphatase D08.586.277.352.650.625.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases; Phosphoprotein Phosphatase An enzyme that catalyzes the conversion of phosphorylated, inactive glycogen synthase D to active dephosphoglycogen synthase I. EC 3.1.3.42. Glycogen Synthetase (73-74) e5$F!Glycogen Synthase D08.586.913.400.450.460.425 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases An enzyme of the transferase class that catalyzes the reaction of UDPglucose and (1,4-alpha-D-glucosyl)n to yield UDP and 1,4-alpha-D-glucosyl)n+1. The reaction is highly regulated by allosteric effectors, by phosphorylation reactions, and by insulin. Insulin secretion causes an increase in enzyme activity. (From Dorland, 27th ed) EC 2.4.1.11. Glucosyltransferases (66-71) e7F!Glycogen Storage Disease Type VIII C18.452.648.202.449.620 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glycogen Phosphorylase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon. Glycogenosis (66-74)  e:*LPGlycogen Storage Disease Type VII C18.452.648.202.449.600 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI 6-Phosphofructokinase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease An autosomal recessive muscle glycogen storage disease in which there is deficient expression of muscle phosphofructokinase activity, resulting in increased concentrations of glucose-6-phosphate and fructose-6-phosphate and low concentrations of fructose-1,6-diphosphate in muscle tissue. Glycogen storage in muscle is increased, perhaps due to activation of glycogen synthase by accumulated glucose-6-phosphate. It has been proposed that shunting of glucose-6-phosphate and fructose-6-phosphate into the pentose phosphate pathway may result in increased synthesis of purines and pyrimidines, causing hyperuricemia and gout. Erythrocytes from patients may show decreased phosphofructokinase activity and 2,3-diphosphoglycerate deficiency. Exercise intolerance is present and severe congenital muscular dystrophy has been reported. Glycogenosis (66-74)  e=)LGlycogen Storage Disease Type VI C18.452.648.202.449.580 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glycogen Phosphorylase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis. Glucosyltransferases/metabolism (66-74); Glycogenosis (66-74); Liver Diseases (66-74)  eB(L6dGlycogen Storage Disease Type V C18.452.648.202.449.560 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glycogen Phosphorylase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise. Glucosyltransferases/metabolism (66-74); Glycogenosis (66-74); Muscular Diseases (66-74)  eF'LgGlycogen Storage Disease Type IV C18.452.648.202.449.540 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease An autosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2. Glucosyltransferases/metabolism (66-74); Glycogenosis (66-74); Liver Diseases (66-74) eH(LxdGlycogen Storage Disease Type III C18.452.648.202.449.520 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glycogen Debranching Enzyme System Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent. Glucosidases/metabolism (66-74); Glycogenosis (66-74); Liver Diseases (66-74)  eK)L)\Glycogen Storage Disease Type II C18.452.648.202.449.500 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glucan 1,4-alpha-Glucosidase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease Glycogenosis due to alpha-1,4-glucosidase (acid maltase) deficiency. It affects muscle, heart, and other organs. Glucosidases/metabolism (66-74); Glycogenosis (66-74); Heart Diseases (66-74)  ePV(L!\Glycogen Storage Disease Type I C18.452.648.202.449.448 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Glycogen Storage Disease An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood. eR'LGlycogen Storage Disease C18.452.648.202.449 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Glycogen Storage Disease Type I; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Glycogen Storage Disease Type V; Glycogen Storage Disease Type VI; Glycogen Storage Disease Type VII; Glycogen Storage Disease Type VIII A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement. eULBGGlycogen Phosphorylase D08.586.913.400.450.460.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Glycogen Storage Disease Type V; Glycogen Storage Disease Type VI; Glycogen Storage Disease Type VIII Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases Phosphorylase a; Phosphorylase b Glucosyltransferases (66-70)  eYFy(!Glycogen Debranching Enzyme System D08.586.277.450.420.450; D08.586.913.400.450.460.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Glycogen Storage Disease Type III Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Glucosidases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases 1,4-alpha-D-Glucan-1,4-alpha-D-glucan 4-alpha-D-glucosyltransferase/dextrin 6 alpha-D-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (EC 2.4.1.25) and amylo-1,6-glucosidase (EC 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-D-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-D-glucan. As a glucosidase it catalyzes the endohydrolysis of 1,6-alpha-D-glucoside linkages at points of branching in chains of 1,4-linked alpha-D-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III. Glucosidase (73-75); Glucosyltransferase (73-75); Glycogen (73-75)  e[):F)OGlycogen D09.203.698.365.388 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Liver Glycogen e` FiGlycodeoxycholic Acid D04.808.221.430.342.400; D04.808.221.430.484.430; D12.125.481.366.420; D19.316.246.225.272.411 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Glycocholic Acid Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine; Glycocholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids; Deoxycholic Acid Glycochenodeoxycholic Acid Glycochenodeoxycholic Acid Glycochenodeoxycholic Acid N-(3 alpha,12 alpha-Dihydroxy-5 beta-cholan-24-oyl)glycine. A bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic. Bile Acids and Salts (66-72); Deoxycholic Acid (73-77); Glycine (66-77); Glycocholic Acid (73-77)  eahFZUwGlycoconjugates D09.203.400 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Glycolipids (+ 3); Glycopeptides (+ 1); Glycoproteins; Lipopolysaccharides Carbohydrates which are covalently linked with other types of chemical constituents. The major groups are glycoproteins, glycopeptides, peptidoglycans, glycolipids, and lipopolysaccharides. Glycolipids (66-87); Glycopeptides (71-87); Glycoproteins (66-87); Lipopolysaccharides (66-87); Peptidoglycans (71-87) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ef@KZFGlycocholic Acid D04.808.221.430.484; D12.125.481.366; D19.316.246.225.399 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids Glycodeoxycholic Acid (+ 1) Glycodeoxycholic Acid (+ 1) N-Cholylglycine. Bile salt, conjugate of cholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic. eiAFCGlycochenodeoxycholic Acid D04.808.221.430.342.300.400; D04.808.221.430.342.400.450; D04.808.221.430.484.430.420; D12.125.481.366.420.400; D19.316.246.175.393 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid; Chenodeoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid; Glycodeoxycholic Acid Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Glycocholic Acid; Glycodeoxycholic Acid Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine; Glycocholic Acid; Glycodeoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Chenodeoxycholic Acid N-(3 alpha,7 alpha-Dihydroxy-5 beta-cholan-24-oyl)glycine. A bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. Bile Acids and Salts (66-72); Chenodeoxycholic Acid (73-77); Glycine (66-72); Glycocholic Acid (73-77) elF^?|Glycine Agents D14.100.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Strychnine Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. Glycine/pharmacology (68-94) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $eq8k"@Glycine D12.125.481; D14.600.050.390 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Glycine Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Amino Acid Neurotransmitters Allylglycine; Glycocholic Acid (+ 2); Mercaptopropionylglycine (+ 1); Methylglycine A nonessential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.  et) "FeGlycerylphosphorylcholine D09.203.894.299.449; D10.516.695.300.310 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Glycerophosphates Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates ev.DGlyceryl Ethers D02.033.800.421.400; D02.355.460 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Glycerin Organic Chemicals (Non MeSH); Ethers Phospholipid Ethers Phospholipid Ethers Compounds in which one or more of the three hydroxyl groups of glycerol are in ethereal linkage with a saturated or unsaturated aliphatic alcohol; one or two of the hydroxyl groups of glycerol may be esterified. These compounds have been found in various animal tissue. Ethers (66-87); Glycerin/analogs and derivatives (75-87); Glycerin (66-74); Glycerides (66-87)  exH&8{.@rGlycerophosphates D09.203.894.299; D10.516.695.300 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids Glycerylphosphorylcholine Glycerylphosphorylcholine; Lysophospholipids (+ 1); Phosphatidic Acids (+ 11); Phospholipid Ethers (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR e{@&BHGlycerolphosphate Dehydrogenase D08.586.682.047.150.700.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases; Sugar Alcohol Dehydrogenases e}n$FGlycerolphosphate Acyltransferase D08.586.913.050.600 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme that transfers acyl groups from acyl-CoA to glycerol-3-phosphate to form monoglyceride phosphates. It acts only with CoA derivatives of fatty acids of chain length above C-10. Also forms diglyceride phosphates. EC 2.3.1.15. Acyltransferases (72-74); Glycerophosphates (72-74); Coenzyme A (72-74) e~&FiUGlycerol Kinase D08.586.913.696.620.275 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes the formation of glycerol 3-phosphate from ATP and glycerol. Dihydroxyacetone and L-glyceraldehyde can also act as acceptors; UTP and, in the case of the yeast enzyme, ITP and GTP can act as donors. It provides a way for glycerol derived from fats or glycerides to enter the glycolytic pathway. EC 2.7.1.30. Glycerin (73-74); Phosphotransferases (73-74); Phosphotransferases, ATP (74) eFFZGlycerin D02.033.800.421; D09.203.853.421; D26.328.532 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Miscellaneous Drugs and Agents (Non MeSH); Cryoprotective Agents Glyceryl Ethers (+ 1); Nitroglycerin ef 5:0Glycerides D10.516.351 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids Diglycerides; Triglycerides (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR eB<)DGlyceric Acids D02.241.081.844.387; D02.241.511.902.387; D09.203.811.366 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids Diphosphoglyceric Acids Diphosphoglyceric Acids Diphosphoglyceric Acids eMA8PGlyceraldehydephosphate Dehydrogenase D08.586.682.075.532 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Aldehyde Oxidoreductases eh*FuGlyceraldehyde 3-Phosphate D02.047.587.450; D09.203.546.894.449.450 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Aldehydes; Glyceraldehyde Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Trioses; Glyceraldehyde 2-Hydroxy-3-(phosphonooxy)propanal. An aldotriose which is an important intermediate in glycolysis and in tryptophan biosynthesis. Glyceraldehyde (66-74) /AA (75-79) e.D)Glyceraldehyde D02.047.587; D09.203.546.894.449 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Trioses Glyceraldehyde 3-Phosphate Glyceraldehyde 3-Phosphate AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR e&:<DGlyburide D02.886.590.795.575; D02.948.828.575; D09.482.440 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents 5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methyoxybenzamide. An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide. Hypoglycemic Agents (66-70) eh 9:!Glutethimide D03.383.621.808.425; D15.210.350.800.275; D15.325.875.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Piperidones Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Aminoglutethimide A hypnotic and sedative. Its use has been largely superseded by other drugs. eA:I^Gluten D12.776.765.412 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Gliadin eu DW Glutathione Transferases D08.586.913.380 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Transferases that catalyze the addition of aliphatic, aromatic, or heterocyclic radicals as well as epoxides and arene oxides to glutathione. Addition takes place at the sulfur atom. They also catalyze the reduction of polyol nitrate by glutathione to polyol and nitrite. EC 2.5.1.18. Glutathione (70-76); Transferases (70-76) e[FUN2Glutathione Synthetase D08.586.464.677.530 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Peptide Synthetases One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamyl-cysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3. Glutathione (73-76); Peptide Synthetases (73-76) eFh:Glutathione Reductase D08.586.682.608.341 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases eFyGlutathione Peroxidase D08.586.682.732.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases An enzyme catalyzing the oxidation of 2 moles of glutathione in the presence of hydrogen peroxide to yield oxidized glutathione and water. EC 1.11.1.9. Glutathione (68-74); Peroxidases (68-74) eFg1Glutathione D12.644.456.448 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides e FUGlutarates D02.241.081.337.351 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids Formiminoglutamic Acid; 3-Hydroxy-3-Methylglutaric Acid; Ketoglutaric Acids AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR e8qV:Glutaral D02.047.532 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Pentanedial. A disinfectant used for sterilization of equipment that cannot be heat-sterilized and as a laboratory reagent, especially as a fixative. ej :1Glutamyl T RNA Synthetase D08.586.464.136.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates glutamic acid with its specific transfer RNA. EC 6.1.1.17. Amino Acyl T RNA Synthetases (72-74); Glutamates (72-74) e FteEGlutamine D12.125.119.574 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Proglumide e FgGlutaminase D08.586.277.087.483 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases eFfGlutamic Acid D12.125.119.450; D14.600.050.200.300 AAADAEANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Glutamate Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Amino Acid Neurotransmitters; Excitatory Amino Acids 1-Carboxyglutamic Acid; Glutamates (+ 2) An amino acid naturally occurring in the L-form. Glutamic acid (glutamate) is the most common excitatory neurotransmitter in the central nervous system. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $es*B2FGlutamates D12.125.119.450.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polyglutamic Acid; Receptors, Glutamate Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic; Glutamic Acid Polyglutamic Acid; Sodium Glutamate Salts and esters of glutamic acid. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $e^D/y+,FGlutamate-Ammonia Ligase D08.586.464.460 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. (From Enzyme Nomenclature, 1992) EC 6.3.1.2. Ligases (66-71) e;FPGlutamate Synthase D08.586.913.140.520 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Aminotransferases An enzyme that catalyzes the formation of 2 molecules of glutamate from glutamine plus alpha-ketoglutarate in the presence of NADPH. EC 1.4.1.13. Aminotransferases (72-74); Glutamine (72-74); Ketoglutaric Acid (72-74); NADP (74) e.FjdGlutamate Dehydrogenase (NADP+) D08.586.682.135.410 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases An enzyme that catalyzes the conversion of L-glutamate, H2O, and NADP+ to 2-oxoglutarate, NH3, and NADPH. (From Enzyme Nomenclature, 1992) EC 1.4.1.4. Glutamate Dehydrogenase (82-93) eC%Fx%Glutamate Dehydrogenase D08.586.682.135.398 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases An enzyme that catalyzes the conversion of L-glutamate and water to 2-oxoglutarate and NH3 in the presence of NAD+. (From Enzyme Nomenclature, 1992) EC 1.4.1.2. e:FxGlutamate Decarboxylase D08.586.520.258.360 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GABA levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15. Carboxy-Lyases (73-74); Glutamates (73-74) e Fa3Glue Proteins, Drosophila D12.776.850.400 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Drosophila Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Salivary Proteins Glycosylated proteins which are part of the salivary glue that Drosophila larvae secrete as a means of fixing themselves to an external substrate for the duration of the pre-pupal and pupal period. The proteins which consist of at least eight polypeptides are encoded in the third larval instar by the Sgs-3, Sgs-4, Sgs-7 and Sgs-8 genes. Proteins (66-76); Salivary Proteins (77-87)  eDZ5Glucuronosyltransferase D08.586.913.400.450.480 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the glucuronic acid conjugation of a variety of endogenous and exogenous compounds. EC 2.4.1.17. Hexosyltransferases (72-73); Transferases (66-71) eF5:Glucuronidase D08.586.277.450.426 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases ewFlGlucuronates D02.241.081.844.915.400.448; D02.241.152.811.400.448; D02.241.511.902.915.400.448; D09.203.811.922.400.448 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Uronic Acids; Hexuronic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Aldehydic (Non MeSH); Uronic Acids; Hexuronic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Uronic Acids; Hexuronic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Uronic Acids; Hexuronic Acids ept8 Glucosyltransferases D08.586.913.400.450.460 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases 1,4-alpha-Glucan Branching Enzyme; Chitin Synthase; Glycogen Debranching Enzyme System; Glycogen Phosphorylase (+ 2); Glycogen Synthase; Starch (Bacterial Glycogen) Synthase Enzymes that catalyze the transfer of glucose from a nucleoside diphosphate glucose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-. eUFGlucosylceramides D10.516.390.470.213.490; D10.516.808.530.288.490 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids; Cerebrosides Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids; Cerebrosides Cerebrosides which contain as their polar head group a glucose moiety bound in glycosidic linkage to the hydroxyl group of ceramides. Their accumulation in tissue, due to a defect in beta-glucosidase, is the cause of Gaucher's disease. Ceramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) e6BPGlucosylceramidase D08.586.277.450.420.475.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Glucosidases; Glycosylceramidase A glycosidase that hydrolyzes a glucosylceramide to yield free ceramide plus glucose. Deficiency of this enzyme leads to abnormally high concentrations of glucosylceramide in the brain in Gaucher's disease. EC 3.2.1.45. Cerebrosides (70-74); Glucose (70-74); Glycoside Hydrolases (70-74) eFQGlucosinolates D09.203.408.348.820.350; D09.203.408.903.703.350 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides; Thioglucosides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Thioglycosides; Thioglucosides Substituted thioglucosides. They are found in rapeseed (Brassica campestris) products and related cruciferae. They are metabolized to a variety of toxic products which are most likely the cause of hepatocytic necrosis in animals and humans. Glycosides (66-73); Thioglucosides (75-78); Thioglycosides (74) e6>LGlucosides D09.203.408.348 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Amygdalin; Arbutin; Chloralose; Esculin; Etoposide; Methylglucosides; Picrotoxin; Teniposide; Thioglucosides (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR eDž>YDGlucosidases D08.586.277.450.420 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases alpha-Glucosidases; beta-Glucosidase; Glucan 1,4-alpha-Glucosidase; Glycogen Debranching Enzyme System; Glycosylceramidase (+ 1) e0FlGlucosephosphates D09.203.894.417.448 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates Glucose (66-70); Hexosephosphates (66-71) eʾBt2Glucosephosphate Uridylyltransferase D08.586.913.696.445.440 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases UTP:alpha-D-glucose-1-phosphate uridylyltransferase. Catalyzes the formation of UDPglucose from UTP plus glucose 1-phosphate. EC 2.7.7.9. Glucosephosphates (72-74); Nucleotidyltransferases (72-74); Uridine Diphosphate Sugars (73-74) e)FmGlucosephosphate Isomerase D08.586.399.278.448 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Carbohydrate Isomerases e7FoGlucosephosphate Dehydrogenase Deficiency C15.378.071.141.150.480; C18.452.648.390 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Favism A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of enzyme activity in erythrocytes, leading to hemolytic anemia. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  eA/.L NGlucosephosphate Dehydrogenase D08.586.682.047.150.300 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases e"#DGlucose-6-Phosphatase D08.586.277.352.650.225 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the conversion of D-glucose 6-phosphate and water to D-glucose and orthophosphate. EC 3.1.3.9. eWDGlucose Tolerance Test E01.197.340; E01.223.174.229.482 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Glucose; Glucose Intolerance Diagnosis; Diagnosis, Endocrine (Non MeSH) Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Determination of whole blood or plasma sugar in a fasting state before and at prescribed intervals (usually 1/2 hr, 1 hr, 3 hr, 4 hr) after taking a specified amount (usually 100 gm orally) of glucose. e&"*Glucose Solution, Hypertonic D09.203.546.359.448.400; D26.394.225.766.314.420 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses; Glucose Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions; Hypertonic Solutions Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent. Glucose (69-74); Hypertonic Solutions (69-74) e8"6,7Glucose Oxidase D08.586.682.047.239 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme of the oxidoreductase class that catalyzes the conversion of beta-D-glucose and oxygen to D-glucono-1,5-lactone and peroxide. It is a flavoprotein, highly specific for beta-D-glucose. The enzyme is produced by Penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. It is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (From Enzyme Nomenclature, 1992) EC 1.1.3.4. eكFtiGlucose Intolerance C18.452.390; C18.452.648.202.435 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diabetes Mellitus; Glucose Tolerance Test Diabetes Mellitus Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors A pathological state in which the fasting plasma glucose level is less than 140 mg per deciliter and the 30-, 60-, or 90-minute plasma glucose concentration following a glucose tolerance test exceeds 200 mg per deciliter. This condition is seen frequently in DIABETES MELLITUS but also occurs with other diseases. Blood Glucose (66-93) $e&L2pGlucose Dehydrogenases D08.586.682.047.150.270 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases D-Glucose:1-oxidoreductases. Catalyzes the oxidation of D-glucose to D-glucono-gamma-lactone and reduced acceptor. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.47; EC 1.1.1.118; EC 1.1.1.119 and EC 1.1.99.10. Alcohol Oxidoreductases (66-77) efF %Glucose Clamp Technique E01.223.174.229.452; E05.196.500 AECLCTECHIMONUPXSNSTTDUTVE Blood Glucose Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration. Blood Glucose/metabolism (75-88)  e&'Glucose D09.203.546.359.448 AAADAEAGAIANBICFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTU Blood Glucose; Glycosuria; Hyperglycemia; Hypoglycemia Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses Glucose Solution, Hypertonic D-Glucose. A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.  e: @Ai"Glucosaminidase D08.586.277.450.483.531 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Hexosaminidases Acetylglucosaminidase (+ 1) Glycoside Hydrolases (66-70) eF!"Glucosaminephosphate Isomerase (Glutamine-Forming) D08.586.399.278.430 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Carbohydrate Isomerases An enzyme that catalyzes the synthesis of fructose-6-phosphate plus glutamine from glutamate plus glucosamine-6-phosphate. EC 2.6.1.16. Aminotransferases (70-74); Carbohydrate Isomerases (74); Fructosephosphates (72-74); Glucosamine (74); Glutamine (70-74) e8FoGlucosamine D09.203.067.342.531 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines Acetylglucosamine eGDkGluconeogenesis G06.535.630.520 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) eTtGluconates D02.241.081.844.322; D02.241.511.902.322; D09.203.811.308 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids Antimony Sodium Gluconate; Calcium Gluconate Antimony Sodium Gluconate; Calcium Gluconate Antimony Sodium Gluconate; Calcium Gluconate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR eA8:Glucokinase D08.586.913.696.620.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) A group of enzymes that catalyzes the conversion of ATP and D-glucose to ADP and D-glucose 6-phosphate. They are found in invertebrates and microorganisms, and are highly specific for glucose. (Enzyme Nomenclature, 1992) EC 2.7.1.2. eFGlucocorticoids, Topical D06.597.481.364; D17.025.080.200; D23.037.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical Beclomethasone; Desonide; Dexamethasone (+ 1); Fluocinolone Acetonide (+ 1); Fluocortolone (+ 1); Fluorometholone; Flurandrenolone; Hydrocortisone, Topical; Methylprednisolone (+ 1); Prednisolone, Topical Beclomethasone; Betamethasone (+ 2); Desonide; Dexamethasone (+ 2); Fluocinolone Acetonide (+ 1); Fluocortolone (+ 1); Fluorometholone; Flurandrenolone; Halcinonide; Hydrocortisone, Topical; Methylprednisolone (+ 1); Prednisolone, Topical; Triamcinolone (+ 1) Betamethasone (+ 2); Desonide; Dexamethasone (+ 2); Fluocinolone Acetonide (+ 1); Fluocortolone (+ 1); Fluorometholone; Flurandrenolone; Halcinonide; Hydrocortisone, Topical; Methylprednisolone (+ 1); Prednisolone, Topical; Triamcinolone (+ 1) A class of corticosteroids that produces suppression of inflammatory diseases when applied as ointments, lotions, or other topical dosage forms. Penetration of the preparations may be increased by means of occlusive dressings. Glucocorticoids (67-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $e58NA:Glucocorticoids, Synthetic D06.597.481 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Anti-Inflammatory Agents, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic Glucocorticoids, Topical (+ 14); Hydroxycorticosteroids, Synthetic (+ 45) Synthetic chemical compounds which increase gluconeogenesis, raising the concentration of liver glycogen and blood sugar, but differ in structure from naturally occurring glucocorticoids. Glucocorticoids (67-74); Glucocorticoids, Topical (73-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (e8mNVC:Glucocorticoids D06.472.040.322 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Glucocorticoid Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones Hydroxycorticosteroids (+ 13) A group of corticosteroids that affect carbohydrate metabolism (gluconeogenesis, liver glycogen deposition, elevation of blood sugar), inhibit corticotropin secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Adrenal Cortex Hormones (66) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (eB_##DGlucaric Acid D02.241.081.844.300; D02.241.511.902.300; D09.203.811.295 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids D-Glucaric acid. A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups. Adipic Acids (70-75); Sugar Acids (74) eVA:1Glucans D09.203.698.365 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Cellulose (+ 6); Dextrans (+ 3); Glycogen (+ 1); Isomaltose; Maltose; Sizofiran; Starch (+ 5); Trehalose Polysaccharides composed of repeating glucose units. They can consist of branched or unbranched chains in any linkages. Glucose (66-78); Polysaccharides (66-78) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $f5 @^1FGlucan 1,4-alpha-Glucosidase D08.586.277.450.420.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Glycogen Storage Disease Type II Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Glucosidases An enzyme that catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4. EC 3.2.1.3. Glucosidases (66-77)  f!F(|PGlucagonoma C04.557.470.035.100.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Islet Cell Glucagon-secreting tumor of the pancreatic alpha cells characterized by a distinctive rash, weight loss, stomatitis, glossitis, diabetes, hypoaminoacidemia, and normochromic normocytic anemia. Islet Cell Tumor (66-81) fdXGlucagon D06.472.610.364; D12.644.227; D12.776.641.650.330; D14.600.600.335; D19.316.629.451 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Glucagon Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones A blood glucose regulatory hormone secreted by the alpha cells of the pancreas. It is a 29-amino acid straight chain polypeptide (MW 3550 kD) that increases blood glucose and has other physiological effects. It is also present in the brain. f  _FGloves, Surgical E07.712.580.375.375; J01.193.542.375.375 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices; Protective Clothing; Gloves, Protective Technology, Industry, Agriculture (Non MeSH); Clothing; Protective Clothing; Gloves, Protective Gloves, usually rubber, worn by surgeons, examining physicians, dentists, and other health personnel for the mutual protection of personnel and patient. f .Gloves, Protective E07.712.580.375; J01.193.542.375 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices; Protective Clothing Technology, Industry, Agriculture (Non MeSH); Clothing; Protective Clothing Gloves, Surgical Gloves, Surgical Coverings for the hands, usually with separations for the fingers, made of various materials, for protection against infections, toxic substances, extremes of hot and cold, radiations, water immersion, etc. The gloves may be worn by patients, care givers, housewives, laboratory and industrial workers, police, etc. Clothing (67-90); Protective Clothing (70-93)  f&(m7Glottis A04.329.364 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Respiratory System; Larynx Vocal Cords The vocal apparatus of the larynx, consisting of the true vocal cords (plica vocalis) and the opening between them (rima glottidis). fp :!Glossopharyngeal Nerve A08.800.800.120.290 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 9th cranial nerve. The glossopharyngeal nerve is a mixed motor and sensory nerve; it conveys somatic and autonomic efferents as well as general, special, and visceral afferents. Among the connections are motor fibers to the stylopharyngeus muscle, parasympathetic fibers to the parotid glands, general and taste afferents from the posterior third of the tongue, the nasopharynx, and the palate, and afferents from baroreceptors and chemoreceptors of the carotid sinus. f8[%Glossitis, Benign Migratory C07.465.910.363.447 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Tongue Diseases; Glossitis An inflammatory disease of the tongue of unknown etiology, characterized by multiple annular areas of desquamation of the filiform papillae on the dorsal surface of the tongue, usually presenting pinkish-red central lesions outlined by thin, yellowish lines or bands that change patterns and shift from one area to another every few days. (Dorland, 27th ed). f!NPGlossitis C07.465.910.363 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Tongue Diseases Glossitis, Benign Migratory Inflammation of the tongue. fc NC!#Glossinidae B01.131.617.289.400 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera Tsetse Flies A family of the order DIPTERA that includes the TSETSE FLIES. These flies occur only in Africa. f(5uGlossectomy E04.833.446; E06.892.446 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Tongue Surgery, Operative; Surgery, Oral Dentistry; Surgery, Oral f$ FGlossalgia C07.465.910.280; C23.888.592.612.363 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Tongue Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pain or burning sensations in the tongue. fs*N4Glomus Tumor C04.557.465.625.650.700.705.350; C04.557.580.625.650.700.705.350; C04.557.645.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma; Paraganglioma, Extra-Adrenal Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma; Paraganglioma, Extra-Adrenal Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue A blue-red, extremely painful paraganglioma involving a glomeriform arteriovenous anastomosis (glomus body), which may be found anywhere in the skin, most often in the distal portion of the fingers and toes, especially beneath the nail. They may also occur in the stomach and nasal cavity. It is composed of specialized pericytes (sometimes termed glomus cells), usually in single encapsulated nodular masses which may be several millimeters in diameter. When located in the usual subungual site, the abundant innervation makes the tumor exquisitely painful; when located elsewhere, the glomus tumor is painless. (From Dorland, 27th ed; Stedman, 25th ed; Dictionary of Modern Medicine, 1992). fYV)Glomus Jugulare Tumor C04.557.465.625.650.700.705.340; C04.557.580.625.650.700.705.340 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma; Paraganglioma, Extra-Adrenal Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma; Paraganglioma, Extra-Adrenal A paraganglioma involving the glomus jugulare, a microscopic collection of chemoreceptor tissue in the adventitia of the bulb of the jugular vein. It may cause paralysis of the vocal cords, attacks of dizziness, blackouts, and nystagmus. It is not resectable but radiation therapy is effective. It regresses slowly, but permanent control is regularly achieved. (From Dorland, 27th ed; Stedman, 25th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). f$FX-Glomus Jugulare A08.800.550.700.120.600.350 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Chemoreceptors; Paraganglia, Nonchromaffin A nonchromaffin paraganglion located in the wall of the jugular bulb. The most common tumors of the middle ear arise from this tissue. (Lockard, Desk Reference for Neuroscience, 1992, p.114). f(8Glomerulosclerosis, Focal C12.777.419.570.363.640 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Glomerulonephritis Glomerular disease characterized by focal and segmental areas of glomerular sclerosis, usually commencing in the juxtamedullary glomeruli and gradually spreading to involve other parts of the kidney, with eventual kidney failure. Kidney Glomerulus (66-76) f*NGlomerulonephritis, Membranous C12.777.419.570.363.625; C20.111.535 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Glomerulonephritis Immunologic Diseases; Autoimmune Diseases A disease of the glomerulus manifested clinically by proteinuria, and sometimes by other features of the nephrotic syndrome. It is histologically characterized by deposits in the glomerular capillary wall between the epithelial cell and the basement membrane and a thickening of the membrane. Also characteristic are outward projections of the membrane between the epithelial deposits in the form of "spikes". There is some agreement that the deposits are antigen-antibody complexes. Glomerulonephritis (66-88) f,#*N0Glomerulonephritis, Membranoproliferative C12.777.419.570.363.615; C20.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Glomerulonephritis Immunologic Diseases Chronic glomerulonephritis characterized histologically by proliferation of mesangial cells, increase in the mesangial matrix, and a thickening of the glomerular capillary walls. The wall thickening is sometimes said to be a result of the interposition of mesangial cytoplasm or matrix between the basement membrane and the endothelium of the capillary wall. It is often divided into types I and II, and sometimes III. Pathogenesis is not well understood, but some types are thought to involve the immune system, with the complement system, in particular, being implicated. Glomerulonephritis (69-88) f0.&NGlomerulonephritis, IGA C12.777.419.570.363.608; C20.111.525 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Glomerulonephritis Immunologic Diseases; Autoimmune Diseases Chronic form of glomerulonephritis characterized by recurring hematuria with only slight proteinuria and by deposits of IGA immunoglobulin in the mesangial areas of the renal glomeruli. It usually occurs in young males. Glomerulonephritis/immunology (66-84); IGA/immunology (73-84) f4*NHGlomerulonephritis C12.777.419.570.363 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Kidney Failure, Chronic Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal; Goodpasture's Syndrome; Lupus Nephritis Glomerular disease characterized by an inflammatory reaction, with leukocyte infiltration and cellular proliferation of the glomeruli, or that appears to be the result of immune glomerular injury.  f7NoGlomerular Mesangium A05.810.453.736.520.380 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Urinary Tract; Kidney; Nephrons; Kidney Glomerulus The thin membrane which helps to support the capillary loops in a renal glomerulus. Kidney Glomerulus (66-83) f:`:TeGlomerular Filtration Rate E01.341.453.447; G08.852.397 DEGEIMPHREVE Kidney Glomerulus Diagnosis; Diagnosis, Urologic (Non MeSH); Kidney Function Tests Reproduction, Urogenital Physiology (Non MeSH); Urinary Tract Physiology (Non MeSH) f; "Globus Pallidus A08.186.211.730.885.105.487.397 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia; Corpus Striatum The representation of the phylogenetically oldest part of the corpus striatum called the paleostriatum. It forms the smaller, more medial part of the lentiform nucleus. f=#8Globulins D12.776.377 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Lactoglobulins (+ 1); Serum Globulins (+ 60); Thyroglobulin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR f> BDJHGlobosides D10.516.390.470.479; D10.516.808.530.510 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids Glycosphingolipids containing N-acetylglucosamine (paragloboside) or N-acetylgalactosamine (globoside). Globoside is the P antigen on erythrocytes and paragloboside is an intermediate in the biosynthesis of erythrocyte blood group ABH and P 1 glycosphingolipid antigens. The accumulation of globoside in tissue, due to a defect in hexosaminidases A and B, is the cause of Sandhoff disease. Cerebrosides (72-78); Glycolipids (66-78); Glycosphingolipids (75-78) f@:.BRGlobin D12.776.124.400.384 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins fC FfGlipizide D02.886.590.795.500; D02.948.828.500; D09.482.415 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents N-[4-[beta-(5-Methylpyrazine-2-carboxamido)ethyl]-phenylsulfonyl]-N'-cyclohexylurea. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. Cyclohexanes (71-74); Pyrazines (71-74); Sulfonylurea Compounds (71-74) fD 9:UGliotoxins D03.438.473.360; D20.388.401; D24.185.926.587.401 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Anti-Infective Agents; Antiviral Agents Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins 2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione. Antibiotic substance produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. Gliotoxin inhibits viral reverse transcriptase and is proposed as an antiviral agent. Alkaloids (69-74); Indoles (69-74); Piperazines (72-74); Disulfides (73-74) fGW9:h\Gliosis C23.739.362 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion. Neuroglia (66-68); appropriate heading/PA (66-68) fJ NY<Gliosarcoma C04.557.465.625.600.380.400; C04.557.470.670.380.400; C04.557.580.625.600.380.400 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma A glioma consisting of immature, undifferentiated, pleomorphic, spindle-shaped cells with relatively large, hyperchromatic, frequently bizarre nuclei and poorly formed fibrillary processes. It is sometimes used as a term for a malignant neoplasm derived from connective tissue (e.g., that associated with blood vessels in the brain) in which there are proliferating glial cells. (Stedman, 25th ed). Glioma (67-93) fLYXGlioma, Subependymal C04.557.465.625.600.380.290.390; C04.557.470.670.380.290.390; C04.557.580.625.600.380.290.390 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma; Ependymoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma; Ependymoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma; Ependymoma An ependymoma in which there is a diffuse proliferation of subependymal fibrillary astrocytes among the ependymal tumor cells. Discrete lobulated ependymal nodules in the walls of the anterior third or posterior fourth ventricle are commonly found at autopsy. (Dorland, 27th ed; Stedman, 25th ed). fQeX]Glioma C04.557.465.625.600.380; C04.557.470.670.380; C04.557.580.625.600.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial Astrocytoma (+ 1); Ependymoma (+ 1); Esthesioneuroblastoma; Ganglioglioma; Gliosarcoma; Medulloblastoma; Oligodendroglioma Astrocytoma (+ 1); Ependymoma (+ 1); Esthesioneuroblastoma; Ganglioglioma; Gliosarcoma; Medulloblastoma; Oligodendroglioma Astrocytoma (+ 1); Ependymoma (+ 1); Esthesioneuroblastoma; Ganglioglioma; Gliosarcoma; Medulloblastoma; Oligodendroglioma A malignant tumor composed of tissue which represents neuroglia in any one of its stages of development. The term is sometimes extended to include all the primary intrinsic neoplasms of the brain and spinal cord, including astrocytomas, ependymomas, neurocytomas, etc. Gliomas are the most common primary tumors of the brain. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1560). fUw MXGlioblastoma C04.557.465.625.600.380.080.335; C04.557.470.670.380.080.335; C04.557.580.625.600.380.080.335 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma; Astrocytoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma; Astrocytoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma; Astrocytoma A glioma consisting chiefly of undifferentiated anaplastic cells that are precursors of astrocytes and that vary greatly in size, shape, and staining reactions. Grades III and IV are referred to as glioblastoma multiforme. For glioblastoma more than for other glial neoplasms the incidence increases with increasing age, suggesting a different mechanism of oncogenesis. (From Stedman, 25th ed; Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p. 1080-1). f[eXGliding Bacteria (Non MeSH) B03.350 Bacteria Achromatiaceae (+ 1); Beggiatoales (+ 1); Cytophagales (+ 3); Myxococcales (+ 3) CHCLCYDEENGDGEIMIPMEPHPYREULVI f`"  e"Gliclazide D02.886.590.795.475; D02.948.828.475; D09.482.405 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents N-(((Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)- 4-methylbenzenesulfonamide. An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Cyclopentanes (72-74); Pyrroles (72-74); Sulfonylurea Compounds (72-74) fa9:UGlial Fibrillary Acidic Protein D12.776.220.475.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Intermediate Filament Proteins An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. Intermediate Filament Proteins (83-84); Nerve Tissue Proteins (66-84) fdW&HtRGliadin D12.776.765.412.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins; Gluten Simple protein, one of the prolamines, derived from the gluten of wheat, rye, etc. May be separated into 4 discrete electrophoretic fractions. It is the toxic factor associated with celiac disease. Plant Proteins (73-74) ffK DaGlaucoma, Open-Angle C11.525.381.407 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Exfoliation Syndrome Eye Diseases; Ocular Hypertension; Glaucoma Hydrophthalmos Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris. Glaucoma (66-81) $fh?N5Glaucoma, Neovascular C11.525.381.348 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Ocular Hypertension; Glaucoma A form of secondary glaucoma which develops as a consequence of another ocular disease and is attributed to the forming of new vessels in the angle of the anterior chamber. Glaucoma (66-88); Neovascularization (79-88) fiN55Glaucoma, Angle-Closure C11.525.381.056 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Ocular Hypertension; Glaucoma A form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber. Glaucoma (66-89) fkN5Glaucoma C11.525.381 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Filtering Surgery; Sclerostomy; Trabeculectomy Intraocular Pressure Eye Diseases; Ocular Hypertension Glaucoma, Angle-Closure; Glaucoma, Neovascular; Glaucoma, Open-Angle (+ 1) An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed). $fm N7)WGlaucarubin D03.383.663.363; D21.370.107.410 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrans Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides (1 beta,2 alpha,11 beta,12 alpha,15 beta(S))-11,20-Epoxy-1,2,11,12-tetrahydroxy-15-(2-hydroxy-2-methyl-1-oxobutoxy)picras-3-en-16-one. A quassinoid (Simaroubolide) from Simaruba glauca, a tropical shrub. It has been used as an antiamebic agent and is found to be cytotoxic. It may be of use in cancer chemotherapy. fq&:jGlass Ionomer Cements D25.339.291.402 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements Cermet Cements A polymer obtained by reacting polyacrylic acid with a special anion-leachable glass (alumino-silicate); the resulting cement is more durable and tougher than others in that the materials comprising the polymer backbone do not leach out. Synonym: Alumino-Silicate Polyacrylic Acid cement. Cementation (66-71); Dental Cements (72-79) ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $ft[*\O5,Glass D25.720.400; J01.637.361 ANCHHIREST Biomedical and Dental Materials (Non MeSH); Polymers Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Hard, amorphous, brittle, inorganic, usually transparent, polymerous silicate of basic oxides, usually potassium or sodium. It is used in the form of hard sheets, vessels, tubing, fibers, ceramics, beads, etc. fw Glasgow Coma Scale E05.318.308.940.968.875.250; E05.944.500; L01.280.900.968.875.250; N04.452.859.564.800.250; N05.715.360.300.715.500.800.325 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records; Medical Records; Trauma Severity Indices Miscellaneous Techniques (Non MeSH); Trauma Severity Indices Information Science; Data Collection; Records; Medical Records; Trauma Severity Indices Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records; Trauma Severity Indices Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records; Trauma Severity Indices A scale that assesses the degree of coma in patients with craniocerebral injuries; also assesses brain function, brain damage, and patient progress. Brain Injuries (76-89); Coma (76-89); Head Injuries (76-89); Severity of Illness Index (86-89) fxtGlanders C01.252.400.739.355; C22.488.409 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pseudomonas Infections Animal Diseases; Horse Diseases A contagious disease of horses that can be transmitted to humans. It is caused by Pseudomonas mallei and characterized by ulceration of the respiratory mucosa and an eruption of nodules on the skin. f}b &JGlafenine D02.241.223.106.061.105.445; D15.040.100.357; D16.850.015.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; Anthranilic Acids Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic An anthranilic acid derivative with analgesic properties used for the relief of all types of pain. Anthranilic Acids (70-74); Quinolines (72-74); Glycols (72-74) f E:^vLGizzard A13.853.363 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Stomach, Avian Birds (66-67); Poultry (66-67); Stomach (66-67) fs :2<Ginseng B06.560.434 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal An araliaceous genus of plants that contains a number of pharmacologically active agents used as stimulants, sedatives, and tonics, especially in traditional medicine. fX & Gingivoplasty E04.833.410; E06.721.384; E06.892.410 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Gingiva Surgery, Operative; Surgery, Oral Dentistry; Periodontics Dentistry; Surgery, Oral f-$ aGingivitis, Necrotizing Ulcerative C01.539.424; C07.465.714.258.480.446 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases; Gingivitis An acute or chronic gingival infection characterized by redness and swelling, necrosis extending from the interdental papillae along the gingival margins, pain, hemorrhage, necrotic odor, and often a pseudomembrane. The condition may extend to the oral mucosa, tongue, palate, or pharynx. f(*NNGingivitis C07.465.714.258.480 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pericoronitis Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases Gingival Crevicular Fluid; Gingival Pocket; Gingivitis, Necrotizing Ulcerative BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  fHN^[RGingivectomy E04.833.400; E06.721.321; E06.892.400 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Gingiva Surgery, Operative; Surgery, Oral Dentistry; Periodontics Dentistry; Surgery, Oral f-$ aGingival Recession C07.465.714.258.447 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases The exposure of root surface by an apical shift in the position of the gingiva. Gingival Diseases (66-84) fN^bGingival Pocket C07.465.714.258.480.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Periodontal Pocket Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases; Gingivitis An abnormal extension of a gingival sulcus not accompanied by the apical migration of the epithelial attachment. Periodontitis (68-74)  ftNlGingival Neoplasms C04.588.443.591.402; C07.465.565.402; C07.465.714.258.409 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Mouth Neoplasms Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases Gingival Diseases (66-70); Mouth Neoplasms (66-70) f>AX=Gingival Hypertrophy C07.465.714.258.338 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases fON^Gingival Hyperplasia C07.465.714.258.267 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases fJN^Gingival Hemorrhage C07.465.625.446; C07.465.714.258.250; C23.542.750.446 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Oral Hemorrhage Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage; Oral Hemorrhage The flowing of blood from the marginal gingival area, particularly the sulcus, seen in such conditions as gingivitis, marginal periodontitis, injury, and ascorbic acid deficiency. fE=NGingival Diseases C07.465.714.258 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Fibromatosis Gingivae; Gingival Hemorrhage; Gingival Hyperplasia; Gingival Hypertrophy; Gingival Neoplasms; Gingival Recession; Gingivitis (+ 3); Granuloma, Giant Cell; Pericoronitis BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI fNHZGingival Crevicular Fluid C07.465.714.258.480.300 CHCYENIMMEMIPS Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases; Gingivitis Gingival fluid that contains cells or cellular debris (exudate) which has escaped from blood vessels and has deposited in the shallow trough surrounding the anatomical crown of the tooth (gingival crevice) as a result of inflammation of the gingivae (GINGIVITIS). Gingiva (66-72) fl4Gingiva A14.254.646.480 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Gingivectomy; Gingivoplasty Stomatognathic System; Dentition; Periodontium f  :!7Gills A13.421 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Branchial Region (66-67); Fishes (66-67) f  :2Gilbert's Disease C18.452.648.437.528; C23.888.498.329.396.528 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Hyperbilirubinemia, Hereditary Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Hyperbilirubinemia; Hyperbilirubinemia, Hereditary A benign familial disorder, transmitted as an autosomal dominant trait. It is characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level. f2L,Gigantism C05.116.099.492; C05.116.132.479; C19.700.355.528 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Beckwith-Wiedemann Syndrome Growth Disorders; Adenoma, Acidophil Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Endocrine (Non MeSH) Endocrine Diseases; Pituitary Diseases; Hyperpituitarism The condition of abnormal overgrowth or excessive size of the whole body or any of its parts.  f^ 9N ,rGibraltar Z01.542.335 EHEP Geographicals (Non MeSH); Europe f )Gibberellins D11.303.760.408 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators A class of plant growth hormone isolated from cultures of Gibberella fujikuroi, a fungus causing Bakanae disease in rice. There are many different members of the family as well as mixtures of multiple members; all are diterpenoid acids based on the gibberellane skeleton. f0>m@Gibberella B05.354.107.501.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes; Hypocreales A genus of ascomycetous fungi of the family Hypocreaceae, order Hypocreales including several pathogens of grains and cereals; also the source of plant growth regulators such as gibberellin and gibberellic acid. fa"JGiardiasis C03.432.481; C03.752.700.500.381; C06.405.469.452.481 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Intestinal Diseases, Parasitic Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic An infection of the small intestine caused by the flagellated protozoan GIARDIA LAMBLIA. It is spread via contaminated food and water and by direct person-to-person contact. f =PGiardia lamblia B01.841.750.443.950.250.385.400 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Diplomonadida; Giardia A species of parasitic protozoa that attaches itself to the intestinal mucosa and feeds on mucous secretions. The organism is roughly pear-shaped and motility is somewhat erratic, with a slow oscillation about the long axis. Considered for many years to be non-pathogenic and often found in completely asymptomatic individuals, there is presently strong evidence for its pathogenic potential. Giardia (67-91) f#&qGiardia B01.841.750.443.950.250.385 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Diplomonadida Giardia lamblia A genus of flagellate intestinal protozoa parasitic in various vertebrates, including humans. Characteristics include the presence of four pairs of flagella arising from a complicated system of axonemes and cysts that are ellipsoidal to ovoidal in shape. f &f(Giant Lymph Node Hyperplasia C15.604.515.245; C20.683.515.250; C23.739.423.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Hyperplasia Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IgA. Hyperplasia (66-86); Lymph Nodes (66-86) f#9N,K2Giant Cells, Langhans A11.329.372.380; A11.502.380; A11.733.397.380; A15.382.680.397.380; A15.382.812.522.380 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Giant Cells Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Multinucleated cells (fused macrophages) seen in granulomatous inflammations such as tuberculosis, syphilis, sarcoidosis, and deep fungal infections. They resemble foreign-body giant cells (GIANT CELLS, FOREIGN BODY) but Langhans giant cells contain less chromatin and their nuclei are arranged peripherally in a horseshoe-shaped pattern. Langhans giant cells occur frequently in delayed hypersensitivity. Granuloma, Giant Cell (77-89); Macrophages (66-89) fc*C=Giant Cells, Foreign-Body A11.329.372.376; A11.502.376; A11.733.397.376; A15.382.680.397.376; A15.382.812.522.376 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Giant Cells Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Multinucleated cells (fused macrophages), characteristic of granulomatous inflammation, which form around exogenous material in the skin. They are similar in appearance to Langhans giant cells (GIANT CELLS, LANGHANS), but foreign-body giant cells have more abundant chromatin and their nuclei are scattered in an irregular pattern in the cytoplasm. Foreign Body Reaction (72-89); Macrophages (66-89) f4c*C=Giant Cells A11.502 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Epithelioid Cells Cells Giant Cells, Foreign-Body; Giant Cells, Langhans Multinucleated masses produced by the fusion of many cells; often associated with viral infections. In AIDS, they are induced when the envelope glycoprotein of the HIV virus binds to the CD4 antigen of uninfected neighboring T4 cells. The resulting syncytium leads to cell death and thus may account for the cytopathic effect of the virus. Cell Fusion (72-89) $f * :Giant Cell Tumors C04.557.450.565.380 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Giant Cell Tumor of Bone Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE. fX Giant Cell Tumor of Bone C04.557.450.565.380.380; C04.557.450.565.575.420 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Giant Cell Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue A bone tumor composed of cellular spindle-cell stroma containing scattered multinucleated giant cells resembling osteoclasts. The tumors range from benign to frankly malignant lesions. The tumor occurs most frequently in an end of a long tubular bone in young adults. (From Dorland, 27th ed; Stedman, 25th ed). Bone Neoplasms (66-93); Giant Cell Tumors (66-93) f 6Xgn=Ghana Z01.058.290.190.320 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western f _Gestures F01.145.209.530.538.445 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication; Kinesics Movement of a part of the body for the purpose of communication. fe zPGestrinone D04.808.668.651.568.620.400; D07.360.276.210.443.706.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnatrienes; Norgestrienone Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (17 alpha)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one. A non-estrogenic contraceptive which is a weak progestin with strong anti-progesterone properties. It is effective if used once a week orally or can also be used in intravaginal devices. Gonanes (68-74); Norgestrienone/analogs and derivatives (75-78) fu>:;,KGestosis, EPH C13.703.799.399 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Toxemias Hypertensive state associated with edema and proteinuria which develops during pregnancy up to the 20th week of gestation, after which it is classified as pre-eclampsia. Edema (68-88); Hypertension (68-88); Pregnancy Complications (75-83); Pregnancy Toxemias (68-88); Proteinuria (68-88) fL}Gestonorone Caproate D04.808.668.651.693.362; D04.808.745.745.654.527; D06.597.799.403 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Pregnanes (71) f;I:Gestational Age G07.553.417; G08.520.288.380 Crown-Rump Length; Infant, Premature Embryo; Fetus Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fetal Development Age of the conceptus. In humans, this may be assessed by medical history, physical examination, early immunologic pregnancy tests, radiography, ultrasonography, and amniotic fluid analysis. Embryo (66-67); Fetus (66-67); Infant, Premature (66-67)  f*",FGestalt Therapy F04.754.360 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A form of psychotherapy with emphasis on the interplay of organism and environment. Basic to this therapy is the development of awareness and maturity, as well as self-confidence. fˠKGestalt Theory F02.739.527 HI Psychologic Processes and Principles (Non MeSH); Psychological Theory A system which emphasizes that experience and behavior contain basic patterns and relationships which cannot be reduced to simpler components; that is, the whole is greater than the sum of its parts. f!RGerstmann's Syndrome C10.597.044.445; C23.888.592.043.445; F03.126.185.794.118.445 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Agnosia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Agnosia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Perceptual Disorders; Agnosia Tetrad of finger agnosia, dysgraphia, dyscalculia, and right-left disorientation. The syndrome can occur in brain-damaged and apparently normal children as well as in adults who have had vascular accidents. fΪENZGerstmann-Straussler Syndrome C10.228.228.800.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Prion Diseases Familially occurring neurodegenerative condition that has morphological similarities to CREUTZFELDT-JAKOB SYNDROME. In Gerstmann-Straussler syndrome there is slower progression, signs of spinocerebellar ataxia, and the spongiosis is less pronounced. Prion proteins and amyloid plaques are found in the brain of patients with the syndrome. A germline mutation of the prion protein has been demonstrated. Slow Virus Diseases (88-90) f"P"Germinoma C04.557.465.330 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal Dysgerminoma (+ 1); Seminoma A malignant neoplasm of the germinal tissue of the gonads, mediastinum, or pineal region. The degree of differentiation to form adult cell types varies. The germ cell tumors of infants and children reflect the transformation of primordial cells that have failed to migrate to their predestined location. Germinomas are uniform in appearance, consisting of large, round cells with vesicular nuclei and clear or finely granular eosinophilic-staining cytoplasm. Germinomas comprise about 3% of childhood neoplasms; almost 67% arise in extragonadal sites. They account for 10% of ovarian tumors in children and 15% of all germ cell tumors. (Stedman, 25th ed; from DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Dysgerminoma (66-93); Neoplasms, Germ Cell and Embryonal (72-93); Pinealoma (66-93); Teratoma (66-93)  f Xh%WzGermine Acetates D03.132.920.256.310; D03.549.256.310 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Veratrum Alkaloids; Cevanes Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Cevanes Germine derivatives acetylated on any one or more of the hydroxy groups. These compounds are present in many polyester alkaloids which occur in Veratrum and Zygadenus species. They are used as antihypertensive agents, and in some cases, exhibit curare-like activity. Veratrum (72-74) f*88Germination G04.742.300 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Plant Physiology (Non MeSH) The initial stages of the growth of a seed into a seedling. The embryonic shoot (plumule) and embryonic root (radicle) emerge and grow upwards and downwards respectively. Food reserves for germination come from endosperm tissue within the seed and/or from the seed leaves (cotyledons). (Concise Dictionary of Biology, 1990). Plants (66-94) f܂gGermany, West Z01.542.315.440; Z01.586.315.440 EHEP Geographicals (Non MeSH); Europe; Germany Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Germany f&Germany, East Z01.542.315.315; Z01.586.315.315 EHEP Geographicals (Non MeSH); Europe; Germany Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Germany fߴ&Germany Z01.542.315; Z01.586.315 EHEP Geographicals (Non MeSH); Europe Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Berlin; Germany, East; Germany, West Germany, East; Germany, West f pPGermanium D01.268.345; D01.552.305 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals f :`Germ-Line Mutation G05.632.350 DEGEIMPHRE Genetics; Mutation Any detectable and heritable alteration in the lineage of germ cells. Mutations in these cells (i.e., "generative" cells ancestral to the gametes) are transmitted to progeny while those in somatic cells are not. Mutation (80-93) fGerm-Free Life G04.185.515.372 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) Specific Pathogen-Free Organisms Animals not contaminated by or associated with any foreign organisms. f&SGerm Layers A16.254.425 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo Ectoderm; Endoderm; Mesoderm The three layers of cells comprising the early embryo. f|*1$CGerm Cells A05.360.490; A11.497 CHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia Cells Ovum (+ 4); Spermatozoa (+ 6) Ovum (+ 4); Spermatozoa (+ 6) Cells from which gametes are derived. In relation to species the cells of the germ line (unlike somatic cells) bridge the gaps between generations. ABCHCLCYDEENGDIMMEMIPAPHPSRARERISETRULUSVI  f,*N.Geriatrics G02.403.398 CLECEDHIISLJMAMTOGSNSTTD Aged Health Occupations; Medicine The branch of medicine concerned with the physiological and pathological aspects of the aged, including the clinical problems of senescence and senility. fZ#Geriatric Psychiatry F04.096.544.380; G02.403.642.260 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry A subspecialty of psychiatry concerned with the mental health of the aged. Psychiatry (66-74) f&ZGeriatric Nursing G02.478.676.236; N02.421.533.245 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care Nursing care of the aged patient given in the home, the hospital, or special institutions such as nursing homes, psychiatric institutions, etc. Geriatrics (66); Nursing (66); Nursing Care (66) f&>Geriatric Dentistry G02.163.394 CLECEDHIISLJMAMTOGSNSTTD Dental Care for Aged Health Occupations; Dentistry The branch of dentistry concerned with the dental problems of older people. f$[Geriatric Assessment E05.318.308.225; G03.850.520.308.225; L01.280.360; N05.715.360.300.360 CLHISN Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection Information Science; Data Collection Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection Evaluation of the level of physical, physiological, or mental functioning in the older population group. Aged (66-89); Health Services for the Aged (80-89); Health Status (80-89) fP {[Gerbillinae B02.649.865.635.300 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae A subfamily of the Muridae consisting of several genera including Gerbillus, Rhombomys, Tatera, Meriones, and Psammomys. Rodentia (66-67) f(1Geotrichum B05.354.381.546.380 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus, various species of which have been isolated from pulmonary lesions. fW"NuGeotrichosis C01.703.392 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Infection due to the fungus Geotrichum. fP=1Georgia (Republic) Z01.542.900.420; Z01.586.200.420; Z01.586.950.420 EHEP Geographicals (Non MeSH); Europe; Transcaucasia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR f9Georgia Z01.107.567.875.100.296; Z01.107.567.875.600.820.296 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States f :Geology H01.419 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH) f~  #Geography H01.374 CLECEDHIISLJMAMTOGSNSTTD Maps Physical Sciences (Non MeSH) Oceanography The science that deals with the earth and its life, especially the description of land, sea, and air and the distribution of plant and animal life, including man and his industries with reference to the mutual relations of these elements. (Webster, 3d ed).  f  #1Geographicals (Non MeSH) Z01 Africa (+ 52); America (+ 194); Antarctic Regions; Arctic Regions; Asia (+ 53); Atlantic Islands (+ 2); Australia (+ 7); Cities (Non MeSH) (+ 14); Europe (+ 71); Historical Geographicals (Non MeSH) (+ 76); Indian Ocean Islands (+ 5); New Zealand; Oceans and Seas (+ 4); Pacific Islands (+ 12) ECEHEPHIOGSN fpGentisates D02.241.223.106.505.375; D02.241.511.390.375; D02.755.410.375 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids fE8,Gentian Violet D20.187.331; D21.201.287.326; D26.408.735.527 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Anti-Infective Agents; Anti-Infective Agents, Local Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Miscellaneous Drugs and Agents (Non MeSH); Dyes; Rosaniline Dyes fW5.Gentamicins D09.203.408.051.374; D20.085.060.350 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside Sisomicin (+ 1) Sisomicin (+ 1) A complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2, and C1(subA), obtained from Micromonospora purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  f*:(<Genotype G05.441 Genetics Gene Dosage; Heterozygote; Homozygote The genetic constitution of the individual; the characterization of the genes. Genes (66-67); Genetics (66-67) g   .^(Genomic Library G05.275.195.425; G05.331.599.110.410.425; G05.430.425 Chromosomes, Yeast Artificial; DNA, Recombinant; Human Genome Project Genes Genetics; Genes; Gene Library Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Gene Library Genetics; Genome A collection of recombinant DNA molecules representative of the genome of an individual organism. It contrasts with a cDNA library which contains DNA coding sequences lacking introns. Base Sequence (80-89); Cloning, Molecular (80-89); Molecular Sequence Data (88-89); Nucleic Acid Hybridization (80-89)  g=R Genomic Imprinting G05.331.370.400 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression The variable phenotypic expression of a gene depending on whether it is of paternal or maternal origin, which is a function of the methylation pattern. Imprinted regions are observed to be more methylated and less transcriptionally active. (Segen, Dictionary of Modern Medicine, 1992). gc:OGenome, Viral G05.275.605.950; G05.430.400 Genetics; Genes; Genes, Viral Genetics; Genome The complete gene complement contained in a DNA or RNA molecule in a virus. DNA, Viral (66-77); Genes, Viral (78-91); RNA, Viral (66-77) gG":]LGenome, Protozoan G05.275.395.900; G05.430.375 Genetics; Genes; Genes, Protozoan Genetics; Genome The complete gene complement contained in a set of chromosomes in a protozoan. specific protozoa (66-90); DNA (66-90); DNA, Protozoan (91-94); Genes (66-92); Genes, Protozoan (93-94) g">_Genome, Plant G05.275.393.900; G05.430.365 Genetics; Genes; Genes, Plant Genetics; Genome The complete gene complement contained in a set of chromosomes in a plant. specific plant (73-94); Base Sequence (73-91); DNA (73-84); Genome (92-94); Plants (73-94) g ":[qGenome, Human G05.430.350 Genetics; Genome The complete gene complement contained in a set of chromosomes in a human, either haploid (the set derived from one parent) or diploid (the double set, derived from both parents). The haploid set contains 50,000 to 100,000 genes and about 3 billion base pairs. Base Sequence (72-89); Chromosome Mapping (72-89); DNA (72-87); Genes (72-89) g U6`Genome, Fungal G05.275.320.325; G05.430.325 Genetics; Genes; Genes, Fungal Genetics; Genome The complete gene complement contained in a set of chromosomes in a fungus. Base Sequence (71-91); DNA, Fungal (80-91); Genes, Fungal (84-91) g E";\QGenome, Bacterial G05.275.201.300; G05.430.300 Genetics; Genes; Genes, Bacterial Genetics; Genome The complete gene complement contained in a single chromosome in a bacterium. Base Sequence (71-91); DNA, Bacterial (66-91) g">]8Genome G05.430 Genetics Genome, Bacterial; Genome, Fungal; Genome, Human; Genome, Plant; Genome, Protozoan; Genome, Viral; Genomic Library The complete gene complement of an organism. It is contained in a set of chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA or RNA molecule in viruses. Base Sequence (71-91); Genetic Code (66-70); Genomic Library (90-91) g   TGenitalia, Male A05.360.444 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Urogenital System; Genitalia Bulbourethral Glands; Ejaculatory Ducts; Penis (+ 1); Prostate; Scrotum; Seminal Vesicles; Spermatic Cord; Testis (+ 6); Vas Deferens The male reproductive organs. They are divided into the external organs (penis, scrotum, and urethra) and the internal organs (testis, epididymis, ductus deferens, seminal vesicle, ejaculatory duct, prostate, and bulbourethral gland. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  g8# <Genitalia, Female A05.360.319 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Hysterosalpingography Urogenital System; Genitalia Adnexa Uteri (+ 10); Uterus (+ 4); Vagina (+ 1); Vulva (+ 2) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  g:8#R<Genitalia A05.360 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Urogenital System Genitalia, Female (+ 21); Genitalia, Male (+ 16); Germ Cells (+ 12); Gonads (+ 2) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI g  8i<Genital Neoplasms, Male C04.588.945.440; C12.294.260; C12.740.800.410 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms Penile Neoplasms; Prostatic Neoplasms; Testicular Neoplasms Penile Neoplasms; Prostatic Neoplasms; Testicular Neoplasms Penile Neoplasms; Prostatic Neoplasms; Testicular Neoplasms Neoplasms of the male genitalia. Urogenital Neoplasms (66-77)  g5X)"Genital Neoplasms, Female C04.588.945.418; C13.371.270; C13.371.820.800.418 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms Fallopian Tube Neoplasms; Ovarian Neoplasms (+ 1); Uterine Neoplasms (+ 2); Vaginal Neoplasms; Vulvar Neoplasms Fallopian Tube Neoplasms; Ovarian Neoplasms (+ 1); Uterine Neoplasms (+ 2); Vaginal Neoplasms; Vulvar Neoplasms Fallopian Tube Neoplasms; Ovarian Neoplasms (+ 1); Uterine Neoplasms (+ 2); Vaginal Neoplasms; Vulvar Neoplasms g9XHGenital Diseases, Male C12.294 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH) Epididymitis; Genital Neoplasms, Male (+ 3); Hematocele; Herpes Genitalis; Hydrocele; Infertility (+ 2); Penile Diseases (+ 7); Prostatic Diseases (+ 3); Sex Disorders (+ 2); Spermatic Cord Torsion; Spermatocele; Testicular Diseases (+ 3); Tuberculosis, Male Genital; Varicocele BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI g\ N7QZGenital Diseases, Female C13.371 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gynecology Female Genital Diseases and Pregnancy Complications (Non MeSH) Adnexal Diseases (+ 17); Endometriosis; Genital Neoplasms, Female (+ 8); Gynatresia (Non MeSH) (+ 2); Herpes Genitalis; Infertility (+ 1); Menstruation Disorders (+ 5); Pseudopregnancy; Sex Disorders (+ 2); Tuberculosis, Urogenital (+ 1); Urogenital Diseases (+ 31); Uterine Diseases (+ 17); Vaginal Diseases (+ 12); Vulvar Diseases (+ 6) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  g NIZGeniculate Ganglion A08.340.390.380; A08.800.350.380; A08.800.800.120.250.280 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Sensory Nervous System; Peripheral Nervous System; Ganglia, Sensory Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Facial Nerve The sensory ganglion of the facial (7th cranial) nerve. The geniculate ganglion cells send central processes to the brain stem and peripheral processes to the taste buds in the anterior tongue, the soft palate, and the skin of the external auditory meatus and the mastoid process. g"A8KGeniculate Bodies A08.186.211.730.385.826.701.444 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Thalamus; Thalamic Nuclei Part of the diencephalon inferior to the caudal end of the dorsal thalamus. Includes the lateral geniculate body which relays visual impulses from the optic tract to the calcarine cortex, and the medial geniculate body which relays auditory impulses from the lateral lemniscus to the auditory cortex. g%#8z`Genetics, Population G05.414 DEHIRE Genetics Breeding (+ 1); Founder Effect; Gene Frequency; Gene Pool; Genetic Heterogeneity; Hybridization (+ 1); Polymorphism (Genetics) (+ 2); Selection (Genetics); Sex Ratio; Variation (Genetics) (+ 1) The study of the genetic composition of populations and of the effects of factors such as selection, population size, mutation, migration, and genetic drift on the frequencies of various genotypes and phenotypes. DEECGEHIIMLJMTPHRESNST  g(   Genetics, Microbial G05.386 CLDEECEDHIIMISLJMAMTOGRESNSTTD Chromosomes, Bacterial; Chromosomes, Fungal Genetics Antigenic Variation; Cell Transformation, Viral; Conjugation, Genetic; Drug Resistance, Microbial (+ 9); SOS Response (Genetics); Transduction, Genetic; Transfection; Transformation, Bacterial; Virus Integration (+ 2) A branch of genetics which deals with the genetic mechanisms and processes of microorganisms. Genetics (66-67) CLDEECEDGEHIIMISLJMAMTOGPHRESNSTTD (g*{ "3 o&Genetics, Medical G02.403.388; G05.358 CLECEDHIISLJMAMTOGSNSTTD Chromosome Abnormalities; Diseases in Twins; Eugenics; Hereditary Diseases Anthropology, Physical Health Occupations; Medicine Genetics Human Genome Project Consanguinity; Eugenics; Genetic Counseling A field of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of any two parents or potential parents. CLECEDHIISLJMAMTOGPXSDSNSTTDUT (g,X-L"Genetics, Biochemical G01.273.595.331; G05.331 CLDEECEDHIISLJMAMTOGRESNSTTD Nucleic Acids Biological Sciences; Biology; Molecular Biology Genetics  Cloning, Molecular; DNA Damage; DNA Repair (+ 1); DNA Replication; Gene Expression (+ 31); Gene Rearrangement (+ 9); Genetic Code; Molecular Mimicry; Molecular Sequence Data (+ 39); Templates; Trans-Activation (Genetics) A branch of genetics which deals with the chemical structure of the genes and with the mechanisms by which the genes control and regulate the structure and synthesis of proteins. Biochemistry (66-67); Genetics (66-67) CLDEECEDGEHIIMIPISLJMAMTOGPHRESNSTTDUT (g/@ C /*Genetics, Behavioral F04.096.276; G05.303 CLDEECEDHIISLJMAMTOGRESNSTTD Behavior Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Genetics The experimental study of the relationship between the genotype of an organism and its behavior. The scope includes the effects of genes on simple sensory processes to complex organization of the nervous system. Behavior (66-67); Behavior, Animal (66-67); Genetics (66-67)  g2Y  \JGenetics G01.273.343; G05 CLECEDHIISLJMAOGSNSTTD Histocompatibility Testing Biological Sciences; Biology  Cytogenetics (+ 39); Extrachromosomal Inheritance; Genes (+ 132); Genetics, Behavioral; Genetics, Biochemical (+ 91); Genetics, Medical (+ 3); Genetics, Microbial (+ 20); Genetics, Population (+ 15); Genome (+ 7); Genotype (+ 3); Haplotypes; Immunogenetics (+ 23); Linkage (Genetics) (+ 2); Models, Genetic; Mutation (+ 9); Pharmacogenetics (+ 11); Phenotype (+ 3); Radiation Genetics (+ 1); Recombination, Genetic (+ 9); Sex Determination ADAEANBIBLCFCHCICLCNCOCTDEDHDIDTDUECEDEMENEPETGEHIIMIPISLJMAMEMIMOMTNUOGPAPCPDPHPOPPPSPXRARERIRTSDSESNSTSUTDTHTMTOTUULURUSUTVI  g4 $Genetic Vectors B04.401; D13.444.308.212.500.401; D13.444.308.283.500.401 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR DNA, Recombinant DNA, Recombinant Viruses Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids Plasmids, bacteriophages, or viruses used during recombinant DNA techniques that transport foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain a genetic marker to facilitate their selective recognition. Bacteriophages (66-79); Coliphages (66-79); DNA, Recombinant (77-79); Plasmids (75-79) $g7AD!hGenetic Techniques E05.393 AECLCTECHIISMONUPXSNSTTDUTVE Chromosomes, Yeast Artificial Genetic Counseling Miscellaneous Techniques (Non MeSH) Chromosome Banding; Chromosome Mapping (+ 2); Cloning, Molecular; Crosses, Genetic (+ 1); DNA Fingerprinting; Epidemiology, Molecular; Gene Amplification (+ 1); Gene Targeting; Gene Transfer (+ 1); Genetic Engineering (+ 5); Heterozygote Detection; Karyotyping; Molecular Probe Techniques (+ 2); Mutagenicity Tests (+ 1); Nucleic Acid Hybridization (+ 2); Pedigree; Sequence Alignment; Sequence Analysis (+ 3); Sex Determination Chromosomal, biochemical, intracellular, and other methods used in the study of genetics. AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE (g;;  #*i4Genetic Screening E01.563.390; E05.318.308.250.580.350; G03.850.520.308.250.580.350; G03.850.780.500.325; N02.421.143.827.233.443.125; N05.715.360.300.375.500.350 AECLCTECHIISLJMOMTNUOGPXSTTDUTVE Heterozygote Detection Diagnosis; Mass Screening Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Mass Screening Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Mass Screening Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services; Diagnostic Services; Mass Screening Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Mass Screening Searching a population for persons possessing certain genotypes or karyotypes that: (1) are already associated with disease or predispose to disease; (2) may lead to disease in their descendants; or (3) produce other variations not known to be associated with disease. Genetic screening may be directed toward identifying phenotypic expression of genetic traits. It includes prenatal genetic screening. Genetic Counseling (73-77); Genetics, Population (66-77); Hereditary Diseases (68-77); Mass Screening (68-77)  g>$Genetic Markers D24.185.101.387; G05.735.450 DEGEIMPHRE Chromosome Mapping Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers Genetics; Phenotype A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Mapping (66-79); Linkage (Genetics) (70-79); Phenotype (68-79); Recombination, Genetic (68-79)  gEF"z}Genetic Heterogeneity G05.414.360 DEHIRE Genetics; Genetics, Population The presence of apparently similar characters for which the genetic evidence indicates that different genes or different genetic mechanisms are involved in different pedigrees. In clinical settings genetic heterogeneity refers to the presence of a variety of genetic defects which cause the same disease, often due to mutations at different loci on the same gene, a finding common to many human diseases including Alzheimer's disease, cystic fibrosis, lipoprotein lipase and polycystic kidney disease. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed; Segen, Dictionary of Modern Medicine, 1992). gGa %Genetic Engineering E05.393.420 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Animals, Transgenic; DNA, Recombinant; Mice, Knockout; Mice, Transgenic; Plants, Transgenic; Protein Engineering Cloning, Molecular; DNA, Recombinant; Biotechnology; Industrial Microbiology Miscellaneous Techniques (Non MeSH); Genetic Techniques Gene Therapy; Protein Engineering (+ 2); Sex Preselection Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Eugenics (66-72); Genetics, Medical (66-72) AECLCTDEECGEHIIMISLJMOMTNUPHPXRESNSTTDUTVE ,gJ$YBG5.Genetic Counseling G05.358.493; N02.421.143.401.526 CLECHILJMAMTOGPXSDSNSTTDUT Genetic Techniques; Preconception Care Prenatal Diagnosis; Eugenics Genetics; Genetics, Medical Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Family Planning Advising families of the risks involved pertaining to birth defects, in order that they may make an informed decision on current or future pregnancies. Counseling (66-72); Eugenics (66-72) $gM&.#-Genetic Complementation Test E05.393.281.526 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques; Crosses, Genetic A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell. Genetics (66-67) gPH""WGenetic Code G05.331.508 DEGEIMPHRE DNA Genetics; Genetics, Biochemical The precise protocol stored in the nucleic acid of the gene, according to which an exact sequence of nucleotide base pairs is transcribed into a molecule of messenger RNA to be translated into the amino acid sequence of a peptide. gRM&Genes, Wilms' Tumor G05.275.415.400.420; G05.275.540.400.420 DEGEIMPHRE Nephroblastoma Genetics; Genes; Genes, Recessive; Genes, Suppressor, Tumor Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located in the 11p13 region on the short arm of human chromosome 11. The absence of these genes is associated with the formation of Wilms' tumor. gS.Genes, vpu G05.275.470.580; G05.275.605.900 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for the HIV-1 regulatory protein vpu (viral protein U) that greatly increases the export of virus particles from infected cells. The vpu genes are not present in HIV-2 or SIV. Genes, Viral (88-90) gU&NGenes, vpr G05.275.470.578; G05.275.605.897 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for a trans-activator protein that specifies rapid growth in human immunodeficiency virus (HIV). vpr is short for viral protein R, where R is undefined. Genes, Viral (89-90) gW&NGenes, Viral G05.275.605 DEGEIMPHRE DNA, Viral; RNA, Viral; Viral Proteins Genetics; Genes Genes, Immediate-Early; Genes, nef; Genes, pX; Genes, rev; Genes, Structural, Viral (+ 3); Genes, tat; Genes, vif; Genes, vpr; Genes, vpu; Genome, Viral The hereditary material of viruses, consisting in all DNA and some RNA viruses of a single molecule of nucleic acid, and in some RNA viruses of several separate pieces of RNA. DNA, Viral (66-77); RNA, Viral (66-77) $gYV11Genes, vif G05.275.470.575; G05.275.605.890 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for the vif (virion infectivity factor) protein that is important for the generation of infectious virions in human immunodeficiency virus (HIV). The former name of this gene was sor (short open reading frame). Genes, Viral (86-90) g[&N+Genes, tat G05.275.470.560; G05.275.605.850 DEGEIMPHRE Transcription, Genetic Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for the protein responsible for trans-activation of transcription (tat) in human immunodeficiency virus (HIV). Genes, Viral (88-89)  g]&NGenes, Synthetic G05.275.582 DEGEIMPHRE Genetics; Genes Biologically functional sequences of DNA chemically synthesized in vitro. Deoxyribonucleotides (73-79); DNA (70-79); DNA, Recombinant (77-79); Genes, Structural (70-79); Oligodeoxyribonucleotides/chemical synthesis (76-79) g_XVGenes, Switch G05.275.470.420 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genes that cause the epigenotype (i.e., the interrelated developmental pathways through which the adult organism is realized) to switch to an alternate cell lineage-related pathway. Switch complexes control the expression of normal functional development as well as oncogenic transformation. Genes, Structural (77-87) g`*OGenes, Suppressor, Tumor G05.275.415.400; G05.275.540.400 DEGEIMPHRE Neoplasms Genetics; Genes; Genes, Recessive Genetics; Genes; Genes, Suppressor Genes, APC; Genes, MCC; Genes, Neurofibromatosis 1; Genes, Neurofibromatosis 2; Genes, Retinoblastoma; Genes, Wilms' Tumor Genes, APC; Genes, DCC; Genes, MCC; Genes, Neurofibromatosis 1; Genes, Neurofibromatosis 2; Genes, p53; Genes, Retinoblastoma; Genes, Wilms' Tumor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and deregulated growth is possible. Suppression, Genetic (86-90) $gb& S>-"Genes, Suppressor G05.275.540 DEGEIMPHRE Suppression, Genetic Genetics; Genes Genes, Suppressor, Tumor (+ 8) Genes that inhibit expression of a previous mutation. They allow the wild-type phenotype to be wholly or partially restored. Genes, Suppressor (68-79); Suppression, Genetic (80-90) $gf)&BGenes, Structural, Viral G05.275.526.850; G05.275.605.800 DEGEIMPHRE Genetics; Genes; Genes, Structural Genetics; Genes; Genes, Viral Genes, env; Genes, gag; Genes, pol Genes, env; Genes, gag; Genes, pol DNA or RNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of viral cells. Genes (66-67); Genes, Structural (68-89); specific virus (66-89)  gg&OXOGenes, Structural, Protozoan G05.275.395.830; G05.275.526.830 DEGEIMPHRE Genetics; Genes; Genes, Protozoan Genetics; Genes; Genes, Structural DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of protozoan cells. specific protozoa (74-92); Genes, Structural (74-92) gi"&S?Genes, Structural, Plant G05.275.393.825; G05.275.526.825 DEGEIMPHRE Genetics; Genes; Genes, Plant Genetics; Genes; Genes, Structural DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of plant cells. Genes (66-67); Genes, Structural (68-89); Plants (66-89); specific plants (66-89) gkb&OdGenes, Structural, Neoplasm G05.275.526.800 DEGEIMPHRE Genetics; Genes; Genes, Structural DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of neoplastic cells. Genes (66-67); Genes, Structural (68-89); specific neoplasms (66-89) gm!+SGenes, Structural, Insect G05.275.353.790; G05.275.526.790 DEGEIMPHRE Genetics; Genes; Genes, Insect Genetics; Genes; Genes, Structural DNA sequences that code for RNA and for proteins required for the enzymatic and structural function of insect cells. specific insect (66-92); Genes (66-67); Genes, Structural (68-92) gn&PPGenes, Structural, Helminth G05.275.328.785; G05.275.526.785 DEGEIMPHRE Genetics; Genes; Genes, Helminth Genetics; Genes; Genes, Structural DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of helminthic cells. specific helminth (77-92); Genes, Structural (77-92) gp=!&R?Genes, Structural, Fungal G05.275.320.200; G05.275.526.775 DEGEIMPHRE Genetics; Genes; Genes, Fungal Genetics; Genes; Genes, Structural  Genes, Nitrogen Fixation DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of fungal cells. Genes (66-67); Genes, Structural (68-89); specific fungi (66-89)  gq&POGenes, Structural, Bacterial G05.275.201.200; G05.275.526.750 DEGEIMPHRE Genetics; Genes; Genes, Bacterial Genetics; Genes; Genes, Structural  Genes, Nitrogen Fixation DNA sequences that code for RNA and for the proteins required for the enzymatic and structural function of bacterial cells. Genes (66-67); Genes, Structural (68-89); specific bacteria (66-89)  gs"&SRGenes, Structural G05.275.526 DEGEIMPHRE Genetics; Genes Genes, Structural, Bacterial (+ 1); Genes, Structural, Fungal (+ 1); Genes, Structural, Helminth; Genes, Structural, Insect; Genes, Structural, Neoplasm; Genes, Structural, Plant; Genes, Structural, Protozoan; Genes, Structural, Viral (+ 3) Genes that code for proteins required for the enzymatic and structural functions of cells. They include developmental and differentiated genes. Genes (66-67)  guGenes, src G05.275.740.791.570 DEGEIMPHRE Genetics; Genes; Oncogenes; Proto-Oncogenes Retrovirus-associated DNA sequences (src) originally isolated from the Rous sarcoma virus (RSV). The proto-oncogene src (c-src) codes for a protein that is a member of the tyrosine kinase family and was the first proto-oncogene identified in the human genome. The human c-src gene is located at 20q12-13 on the long arm of chromosome 20. Genes, Structural (80-90); Genes, Viral (77-90); Oncogenes (83-90) gw5QGenes, rev G05.275.470.418; G05.275.605.775 DEGEIMPHRE Transcription, Genetic Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus (HIV). rev is short for regulator of virion. Genes, Viral (86-89)  gz8&NGenes, Retinoblastoma G05.275.415.400.400; G05.275.540.400.400 DEGEIMPHRE Retinoblastoma Genetics; Genes; Genes, Recessive; Genes, Suppressor, Tumor Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located on human chromosome 13 in the region 13q14 and coding for a family of phosphoproteins with molecular weights ranging from 104 kDa to 115 kDa. One copy of the wild-type Rb gene is necessary for normal retinal development. Loss or inactivation of both alleles at this locus results in retinoblastoma. Retinoblastoma/genetics (72-90)  g|".%Genes, Reporter G05.275.495 DEGEIMPHRE Promoter Regions (Genetics) Genetics; Genes Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest. Promoter Regions (Genetics) (87-93)  g~!*Genes, Reiterated G05.275.483 DEGEIMPHRE Repetitive Sequences, Nucleic Acid Genetics; Genes Reiterated genes present in multiple copies either clustered on the same chromosome or dispersed on different chromosomes. They are descended by duplication and variation from an ancestral gene. Examples include genes encoding histones, hemoglobins, immunoglobulins, actins, heat shock proteins, and phaseolins, as well as ribosomal RNA and transfer RNA genes. Genes (66-70); Genes, Bacterial (82-86); Genes, Structural (71-86); Genes, Viral (78-86)  g)lGenes, Regulator G05.275.470 DEGEIMPHRE Regulon; Trans-Activation (Genetics) Genetics; Genes Genes, araC; Genes, nef; Genes, Nitrogen Fixation; Genes, pX; Genes, rev; Genes, Switch; Genes, tat; Genes, vif; Genes, vpr; Genes, vpu; Regulatory Sequences, Nucleic Acid (+ 7) Genes which regulate or circumscribe the activity of other genes; specifically, genes which code for proteins (repressors or activators) which regulate the genetic transcription of the structural genes and/or regulatory genes. Genes (66-67) $gV+Genes, Recessive G05.275.415 DEGEIMPHRE Genetics; Genes Genes, Suppressor, Tumor (+ 6) Genes that are reflected in the phenotype only in the homozygous state. Genes (66-67)  g&WGenes, ras G05.275.740.791.550 DEGEIMPHRE ras Proteins; Oncogene Protein p21(ras); Proto-Oncogene Protein p21(ras) Genetics; Genes; Oncogenes; Proto-Oncogenes Family of retrovirus-associated DNA sequences (ras) originally isolated from Harvey (H-ras, Ha-ras, rasH) and Kirsten (K-ras, Ki-ras, rasK) murine sarcoma viruses. Ras genes are widely conserved among animal species and sequences corresponding to both H-ras and K-ras genes have been detected in human, avian, murine, and non-vertebrate genomes. The closely related N-ras gene has been detected in human neuroblastoma and sarcoma cell lines. All genes of the family have a similar exon-intron structure and each encodes a p21 protein. Genes, Viral (78-87); Oncogenes (83-87)  gX5l1Genes, RAG-1 G05.275.400 DEGEIMPHRE Genetics; Genes Genes involved in activating the enzyme VDJ recombinase. RAG-1 is located on chromosome 11 in humans (chromosome 2 in mice) and is expressed exclusively in maturing lymphocytes. gsGenes, p53 G05.275.540.400.350 DEGEIMPHRE Protein p53 Li-Fraumeni Syndrome Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, Structural (86-90) $gIGenes, pX G05.275.470.416; G05.275.605.735 DEGEIMPHRE Transcription, Genetic Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for at least three proteins which regulate the expression of HTLV-I and HTLV-II. The proteins are p21(x), p27(rex), and p40(tax). The tax (trans-activator x) and rex (regulator x) genes are part of pX but are in overlapping reading frames. X was the original designation for the sequences or region (at that time of unknown function) in the long open reading frame (lor) which is now called pX. Genes, Regulator (84-90); Genes, Viral (84-90)  g!&N 9Genes, Protozoan G05.275.395 DEGEIMPHRE Genetics; Genes Genes, Structural, Protozoan; Genome, Protozoan The genetic material of protozoa. specific protozoa (66-92); Genes (66-92)  g;8*2Genes, pol G05.275.526.850.700; G05.275.605.800.700 DEGEIMPHRE Genetics; Genes; Genes, Structural; Genes, Structural, Viral Genetics; Genes; Genes, Viral; Genes, Structural, Viral DNA sequences that form the coding region for retroviral enzymes including reverse transcriptase, protease, and endonuclease/integrase. "pol" is short for polymerase, the enzyme class of reverse transcriptase. Genes, Structural (83-89); Genes, Viral (77-89) gA.:Genes, Plant G05.275.393 DEGEIMPHRE Genetics; Genes Genes, Structural, Plant; Genome, Plant The hereditary material of plants. specific plant (66-92); Genes (66-92)  gj0+/Genes, Overlapping G05.275.391 DEGEIMPHRE Genetics; Genes Genes whose nucleotide sequences overlap to some degree. The overlapped sequences may involve structural or regulatory genes of eukaryotic or prokaryotic cells. Base Sequence (75-87); Genes, Structural(75-87); specific microbial gene heading (78-87) gbjGenes, Nitrogen Fixation G05.275.201.180; G05.275.320.180; G05.275.470.415; G05.275.526.750.180; G05.275.526.775.180 DEGEIMPHRE Nitrogen Fixation Genetics; Genes; Genes, Bacterial Genetics; Genes; Genes, Fungal Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Structural; Genes, Structural, Bacterial Genetics; Genes; Genes, Structural; Genes, Structural, Fungal Regulatory and structural genes present in certain bacteria, algae and fungi that control the conversion of atmospheric nitrogen into biologically usable compounds; include nif structural genes (e.g., nifD, nifH) for nitrogenase and nitrate reductase as well as regulator genes nifA, nifB, ntrA, ntrB, ntrC. Some are responsible for regulating transcription of genes involved in the assimilation of poor nitrogen sources in enteric bacteria. Genes, Bacterial (82-87); Genes, Regulator (66-87); Genes, Structural (75-87); Nitrogen Fixation (71-87)  gg }Genes, Neurofibromatosis 2 G05.275.415.400.345; G05.275.540.400.345 DEGEIMPHRE Neurofibromatosis 2 Genetics; Genes; Genes, Recessive; Genes, Suppressor, Tumor Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes neurofibromatosis 2. Neurofibromatosis 1/genetics (88-91); Neuroma, Acoustic/genetics (88-91)  gP .UGenes, Neurofibromatosis 1 G05.275.415.400.340; G05.275.540.400.340 DEGEIMPHRE Neurofibromatosis 1 Genetics; Genes; Genes, Recessive; Genes, Suppressor, Tumor Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located on the long arm of human chromosome 17 in the region 17q11.2. Mutation of these genes is thought to cause neurofibromatosis 1. Neurofibromatosis 1/genetics (87-91)  go .+Genes, nef G05.275.470.413; G05.275.605.600 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genetics; Genes; Genes, Viral DNA sequences that form the coding region for a protein that down-regulates the expression of human immunodeficiency virus (HIV). nef is short for negative factor. Genes, Viral (87-89) g&NGenes, myc G05.275.740.791.420 DEGEIMPHRE Oncogene Protein p55(v-myc); Proto-Oncogene Proteins c-myc Genetics; Genes; Oncogenes; Proto-Oncogenes Family of retrovirus-associated DNA sequences (myc) originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc (c-myc) codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8. Genes, Viral (82); Oncogenes (83-90)  gF5 .Genes, mos G05.275.740.791.400 DEGEIMPHRE Genes, Intracisternal A-Particle Genetics; Genes; Oncogenes; Proto-Oncogenes Retrovirus-associated DNA sequences (mos) originally isolated from the Moloney murine sarcoma virus (Mo-MSV). The proto-oncogene mos (c-mos) codes for a protein which is a member of the serine kinase family. There is no evidence as yet that human c-mos can become transformed or has a role in human cancer. However, in mice, activation can occur when the retrovirus-like intracisternal A-particle inserts itself near the c-mos sequence. The human c-mos gene is located at 8q22 on the long arm of chromosome 8. Genes, Viral (82); Oncogenes (83-85); Proto-Oncogenes (86-90)  g,&5WKGenes, MHC Class II G04.610.626.580.600; G05.275.370; G05.511.580.600 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Major Histocompatibility Complex Genetics; Genes Genetics; Immunogenetics; Major Histocompatibility Complex Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and in the I region in mice. Genes (66-77); Genes, Structural (68-77) g92Genes, MHC Class I G04.610.626.580.595; G05.275.364; G05.511.580.595 DEGEIMPHRE Major Histocompatibility Complex Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Major Histocompatibility Complex Genetics; Genes Genetics; Immunogenetics; Major Histocompatibility Complex Genetic loci in the vertebrate major histocompatibility complex which encode polymorphic characteristics not related to immune responsiveness or complement activity, e.g., B loci (chicken), DLA (dog), GPLA (guinea pig), H-2 (mouse), RT-1 (rat), HLA-A, -B, and -C class I genes of man. H-2 Antigens/genetics (80-87); HLA Antigens/genetics (81-87); Major Histocompatibility Complex (80-87)  g19&PyGenes, MCC G05.275.415.400.320; G05.275.540.400.320 DEGEIMPHRE Genes, DCC Colorectal Neoplasms; Genes, DCC Genetics; Genes; Genes, Recessive; Genes, Suppressor, Tumor Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located in the 5q21 region on the long arm of human chromosome 5. The mutation of these genes is associated with the formation of colorectal cancer (MCC stands for mutated in colorectal cancer). Genes, Suppressor, Tumor (91-92) $g.('Genes, Lethal G05.275.359 DEGEIMPHRE Genetics; Genes Genes which result in the premature death of the organism; dominant lethal genes kill heterozygotes, whereas recessive lethal genes kill only homozygotes. Genes (66-67) gGenes, jun G05.275.740.791.365 DEGEIMPHRE Oncogene Protein p65(gag-jun); Proto-Oncogene Proteins c-jun Genetics; Genes; Oncogenes; Proto-Oncogenes Retrovirus-associated DNA sequences (jun) originally isolated from the avian sarcoma virus 17 (ASV 17). The proto-oncogene jun (c-jun) codes for a nuclear protein which is involved in growth-related transcriptional control. Insertion of c-jun into ASV-17 or the constitutive expression of the c-jun protein produces tumorgenicity. The human c-jun gene is located at 1p31-32 on the short arm of chromosome 1. Genes, Viral (87-91); Oncogenes (87-91); Proto-Oncogenes (87-91)  g%H5NGenes, Intracisternal A-Particle G05.275.740.791.360 DEGEIMPHRE Genes, mos Genetics; Genes; Oncogenes; Proto-Oncogenes A family of retrovirus-like genetic elements coding for virus-like particles found regularly in early rodent embryos (2-cell to blastocyst stage), but which, under certain circumstances such as DNA hypomethylation, are transcribed in a wide variety of neoplasms, including plasmacytomas, neuroblastomas, rhabdomyosarcomas, teratocarcinomas, and colon carcinomas. Base Sequence (80-85); Genes, Viral (80-85); Oncogenes (83-85); Repetitive Sequences, Nucleic Acid (81-85); Retroviridae (80-85)  g*&5Genes, Insect G05.275.353 DEGEIMPHRE Genetics; Genes Genes, Structural, Insect The hereditary material of insects. specific insect (66-92); Genes (66-92)  g,0Genes, Immunoglobulin G04.610.626.398; G05.275.351; G05.511.398 DEGEIMPHRE Immunoglobulin Fragments Gene Rearrangement; Immunoglobulin Joining Region Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Genes Genetics; Immunogenetics  Immunoglobulin Switch Region Genes encoding the light and heavy chain segments of immunoglobulins. Light chain gene segments are symbolized L-V (variable), J (joining) and C (constant); Ig heavy chain segments have, in addition, a diversity (D) gene. Each segment codes for certain amino acids, and each has a different nucleotide sequence; the genes are assembled by a remarkable shuffling of the segments during B lymphocyte maturation. Genes, Structural (72-87); Immunoglobulins (72-87); specific immunoglobulin chain or region (75-87) DEGEIMIPPHRE ,g1:$uGenes, Immediate-Early G05.275.345; G05.275.605.345 DEGEIMPHRE Immediate-Early Proteins Genetics; Genes Genetics; Genes; Genes, Viral Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters. specific genes (72-93); Genes, Viral (80-93)  g"97Genes, Homeobox G05.275.330 DEGEIMPHRE Homeodomain Proteins Genetics; Genes Highly conserved DNA sequences which have been identified in specific gene transcripts ranging from those of Drosophila melanogaster to mouse and human. Homeobox genes function, in part, to generate DNA-binding proteins with an evolutionary conserved approximately 60-residue sequence (HOMEODOMAIN PROTEINS). Alleles (68-75); Drosophila Melanogaster (72-86); Genes, Structural (83-86); Morphogenesis (83-86)  gbuGenes, Helminth G05.275.328 DEGEIMPHRE Genetics; Genes Genes, Structural, Helminth The hereditary material of helminths. specific helminths (74-92); Genes (74-92)  gf!.3Genes, gag G05.275.526.850.300; G05.275.605.800.300 DEGEIMPHRE Genetics; Genes; Genes, Structural; Genes, Structural, Viral Genetics; Genes; Genes, Viral; Genes, Structural, Viral DNA sequences that form the coding region for proteins associated with the viral core in retroviruses. gag is short for group-specific antigen. Genes, Structural (72-89); Genes, Viral (77-89) gY.:Genes, Fungal G05.275.320 DEGEIMPHRE Genetics; Genes Genes, Nitrogen Fixation; Genes, Structural, Fungal; Genome, Fungal The genetic material of fungi. It includes mating type genes of SACCHAROMYCES CEREVISIAE. DNA, Fungal (80-83); Genes (66-77); specific fungus/genetics (78-79)  g:PkTGenes, fos G05.275.740.791.330 DEGEIMPHRE Oncogene Proteins v-fos; Proto-Oncogene Proteins c-fos Genetics; Genes; Oncogenes; Proto-Oncogenes Retrovirus-associated DNA sequences (fos) originally isolated from the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses. The proto-oncogene protein c-fos codes for a nuclear protein which is involved in growth-related transcriptional control. The insertion of c-fos into FBJ-MSV or FBR-MSV induces osteogenic sarcomas in mice. The human c-fos gene is located at 14q21-31 on the long arm of chromosome 14. Oncogenes (83-91); Proto-Oncogenes (85-91)  gĸ@53Genes, fms G05.275.740.791.325 DEGEIMPHRE Oncogene Protein gp140(v-fms); Receptors, Macrophage Colony-Stimulating Factor Genetics; Genes; Oncogenes; Proto-Oncogenes Family of retrovirus-associated DNA sequences (fms) originally isolated from the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The proto-oncogene fms (c-fms) codes for a protein (CSF-1) that is a member of the transmembrane tyrosine kinase growth factor receptor family. The human c-fms gene is located at 5q33.3 on the long arm of chromosome 5. Oncogenes (83-90); Proto-Oncogenes (86-90)  gǿ[53Genes, erbB-2 G05.275.740.791.295.305 DEGEIMPHRE Oncogene Proteins v-erbB; Proto-Oncogene Proteins c-erbB-2; Receptors, Epidermal Growth Factor-Urogastrone Genetics; Genes; Oncogenes; Proto-Oncogenes; Genes, erbB Retrovirus-associated DNA sequences (erbB) related to the c-erbB-1 gene and identified by probes from c-erbB-1 or its avian viral homologue v-erbB. The proto-oncogene erbB-2 (c-erbB-2) codes for a protein that has structural features indicative of a growth factor receptor with close similarity to the epidermal growth factor (EGF) receptor. Overexpression and amplification of the gene is associated with adenocarcinomas and with poor prognosis in breast carcinomas. The human c-erbB-2 gene is located at 17p12-21 on the short arm of chromosome 17. Oncogenes (86-94); Proto-Oncogenes (86-94)  gʄyE}3Genes, erbB-1 G05.275.740.791.295.300 DEGEIMPHRE Oncogene Proteins v-erbB; Receptors, Epidermal Growth Factor-Urogastrone Genetics; Genes; Oncogenes; Proto-Oncogenes; Genes, erbB Retrovirus-associated DNA sequences (erbB) originally isolated from the avian erythroblastosis virus (AEV). The oncogene v-erbB arose by insertion of viral DNA into the c-erbB-1 proto-oncogene resulting in expression of a protein lacking the amino-terminal ligand-binding domain. v-erbB is the primary transforming gene of AEV and abrogates the requirements for other mitogens. The proto-oncogene c-erbB-1 codes for the protein epidermal growth factor receptor (EPIDERMAL GROWTH FACTOR RECEPTOR-UROGASTRONE). Overexpression of the gene occurs in a wide range of tumors, commonly squamous carcinomas of various sites and less commonly adenocarcinomas. The human c-erbB-1 gene is located at 7p12-13 on the short arm of chromosome 7. Oncogenes (86-94); Proto-Oncogenes (85-94)  gXSEK3Genes, erbB G05.275.740.791.295 DEGEIMPHRE Genetics; Genes; Oncogenes; Proto-Oncogenes Genes, erbB-1; Genes, erbB-2 Retrovirus-associated DNA sequences (erbB) originally isolated from, or related to, the avian erythroblastosis virus (AEV). These genes code for the epidermal growth factor receptor (EGFR) family of receptors which is important in the control of normal cell proliferation and in the pathogenesis of human cancer. The genes include erbB-1 (GENES, ERBB-1), erbB-2 (GENES, ERBB-2), and erbB-3, all of which show abnormalities of expression in various human neoplasms. Proto-Oncogenes (92-94)  g5$Genes, erbA G05.275.740.791.290 DEGEIMPHRE Oncogene Proteins v-erbA; Receptors, Thyroid Hormone Genetics; Genes; Oncogenes; Proto-Oncogenes Retrovirus-associated DNA sequences (ERYTHROBLASTOSIS VIRUS, AVIAN, hence erbA) originally isolated from the avian erythroblastosis virus. The c-erbA proto-oncogene encodes the thyroid hormone receptors (RECEPTORS, THYROID HORMONE). Two distinct c-erbA proto-oncogenes have been identified, erbA-alpha and erbA-beta, each giving rise to at least two proteins. erbA-alpha is located at 17q21 on the long arm of chromosome 17. erbA-beta is located at 3p24 on the short arm of chromosome 3. The v-erbA oncogene potentiates cell transformation through inhibition of spontaneous differentiation of cells already transformed by the v-erbB gene and eliminates growth requirements of transformed erythroblasts. Oncogenes (84-94); Proto-Oncogenes (87-94)  g>5&3Genes, env G05.275.526.850.200; G05.275.605.800.200 DEGEIMPHRE Genetics; Genes; Genes, Structural; Genes, Structural, Viral Genetics; Genes; Genes, Viral; Genes, Structural, Viral DNA sequences that form the coding region for the viral envelope (env) proteins in retroviruses. The env genes contain a cis-acting RNA target sequence for the rev protein (= GENE PRODUCTS, REV), termed the rev-responsive element (RRE). Genes, Structural (83-89); Genes, Viral (77-89) g.:Genes, Dominant G05.275.304 DEGEIMPHRE Genetics; Genes Genes that are reflected in the phenotype both in the homozygous and the heterozygous state. Genes (66-67) g@oGenes, DCC G05.275.540.400.300 DEGEIMPHRE Genes, MCC Genes, MCC; Colorectal Neoplasms Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located in the 18q21-qter region of human chromosome 18. The absence of these genes is associated with the formation of colorectal cancer (DCC stands for deleted in colorectal cancer). The products of these genes show significant homology to neural cell adhesion molecules and other related cell surface glycoproteins.  g.(IGenes, cdc G05.275.250 DEGEIMPHRE Cell Cycle Proteins Cell Division Genetics; Genes Genes that code for proteins that regulate the cell division cycle. These genes form a regulatory network that culminates in the onset of mitosis by activating the p34cdc2 protein (PROTEIN P34CDC2).  gߜGenes, Bacterial G05.275.201 DEGEIMPHRE Genetics; Genes Genes, Nitrogen Fixation; Genes, Structural, Bacterial; Genome, Bacterial; Regulon (+ 3) Genes (66-81); specific bacterium/GE (78-81) gi7Genes, araC G05.275.470.412; G05.275.769.418 DEGEIMPHRE Genetics; Genes; Genes, Regulator Genetics; Genes; Operon Regulatory genes which encode a cyclic AMP receptor protein required for L-arabinose utilization in E. coli. It is an example of positive control or regulation of gene expression in the bacterial operon. Arabinose (71-87); Genes, Regulator (71-87); Operon (71-87) g,&GIGenes, APC G05.275.415.400.050; G05.275.540.400.050 DEGEIMPHRE Adenomatous Polyposis Coli Genetics; Genes; Genes, Recessive; Genes, Suppressor, Tumor Genetics; Genes; Genes, Suppressor; Genes, Suppressor, Tumor Tumor suppressor genes located in the 5q21 region on the long arm of chromosome 5. The mutation of these genes is associated with familial adenomatous polyposis (APC stands for adenomatous polyposis coli) and Gardner's syndrome, as well as some sporadic colorectal cancers. Genes, Suppressor, Tumor (91-92); Polyposis Syndrome, Familial/genetics (89-92)  g. @]Genes, abl G05.275.740.791.100 DEGEIMPHRE Fusion Proteins, bcr-abl; Oncogene Proteins v-abl; Proto-Oncogene Proteins c-abl Genetics; Genes; Oncogenes; Proto-Oncogenes Retrovirus-associated DNA sequences (abl) originally isolated from the Abelson murine leukemia virus (Ab-MuLV). The proto-oncogene abl (c-abl) codes for a protein that is a member of the tyrosine kinase family. The human c-abl gene is located at 9q34.1 on the long arm of chromosome 9. It is activated by translocation to bcr on chromosome 22 in chronic myelogenous leukemia. Oncogenes (82-90)  g^5Genes G05.275 DEGEIMPHRE Base Sequence; Genomic Library Genetics Alleles (+ 3); DNA Insertion Elements (+ 1); Gene Library (+ 2); Genes, Bacterial (+ 7); Genes, cdc; Genes, Dominant; Genes, Fungal (+ 3); Genes, Helminth (+ 1); Genes, Homeobox; Genes, Immediate-Early; Genes, Immunoglobulin (+ 1); Genes, Insect (+ 1); Genes, Lethal; Genes, MHC Class I; Genes, MHC Class II; Genes, Overlapping; Genes, Plant (+ 2); Genes, Protozoan (+ 2); Genes, RAG-1; Genes, Recessive (+ 7); Genes, Regulator (+ 18); Genes, Reiterated; Genes, Reporter; Genes, Structural (+ 13); Genes, Suppressor (+ 9); Genes, Synthetic; Genes, Viral (+ 13); Nucleolus Organizer Region; Oncogenes (+ 14); Operon (+ 3); Pseudogenes; Regulon Specific sequences of nucleotides along a molecule of DNA (or, in the case of some viruses, RNA) which represent the functional units of heredity. The majority of eukaryotic genes contain coding regions (codons) that are interrupted by non-coding regions (introns) and are therefore labeled split genes. ADAEANBIBLCFCHCLCTDEDUECENGEHIIMIPMEMIPAPDPHPOPSRARERISETOTUULURUSVI $g  & bHGeneralization, Stimulus F02.463.425.357.526 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Generalization (Psychology) The tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus. g zGeneralization, Response F02.463.425.357.359 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Generalization (Psychology) The principle that after an organism learns to respond in a particular manner to a stimulus, that stimulus is effective in eliciting similar responses. gU zGeneralization (Psychology) F02.463.425.357 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Generalization, Response; Generalization, Stimulus The phenomenon of an organism's responding to all situations similar to one in which it has been conditioned. g  Z:General Practice, Dental G02.163.342 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Dentistry Nonspecialized dental practice which is concerned with providing primary and continuing dental care. Dentistry (66); Family Practice (66) gb$u.General Patient Care (Non MeSH) E02.472 Therapeutics Aftercare; Ambulatory Care (+ 1); Critical Care (+ 2); Custodial Care; Day Care; Episode of Care; Foster Home Care; Intraoperative Care; Life Support Care (+ 1); Long-Term Care; Night Care; Nursing Care (+ 1); Palliative Treatment; Perinatal Care; Postnatal Care; Postoperative Care; Preconception Care; Prenatal Care; Preoperative Care; Terminal Care (+ 1) AECLCTECEDHIISLJMAMOMTNUOGPXRHSNSTTDUTVE g' ,General Adaptation Syndrome C23.280.853.442 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stress Symptoms and General Pathology (Non MeSH); Disease; Stress The sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress. g!L H|Genealogy and Heraldry K01.419.359 Emblems and Insignia Emblems and Insignia Humanities; History gRGene Transfer E05.393.350 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques Transfection The introduction of functional (usually cloned) genes into cells and organisms. A variety of techniques can be used for gene transfer: (1) cell hybridization; (2) microcell-mediated gene transfer; (3) chromosome-mediated gene transfer; (4) DNA-mediated gene transfer. Gene transfer results in genetically transformed cells and individuals and is a step in recombinant DNA technology when cloned genes are being used for transfer. (Glossary of Genetics: Classical and Molecular, 5th ed). Transfection (88-93) AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE $g B7,Gene Therapy E02.095.301; E05.393.420.301 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH) Miscellaneous Techniques (Non MeSH); Genetic Techniques; Genetic Engineering The introduction of new genes into cells for the purpose of treating disease by restoring or adding gene expression. Techniques include insertion of retroviral vectors, transfection, homologous recombination, and injection of new genes into the nuclei of single cell embryos. The entire gene therapy process may consist of multiple steps. The new genes may be introduced into proliferating cells in vivo (e.g., bone marrow) or in vitro (e.g., fibroblast cultures) and the modified cells transferred to the site where the gene expression is required. Gene therapy may be particularly useful for treating enzyme deficiency diseases, hemoglobinopathies, and leukemias and may also prove useful in restoring drug sensitivity, particularly for leukemia. Genetic Intervention (73-88) g+"$b"Gene Targeting E05.393.335 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Genetic Techniques The integration of exogenous DNA into the genome of an organism at sites where its expression can be suitably controlled. This integration occurs as a result of homologous recombination. h"BGene Rearrangement, T-Lymphocyte G04.610.626.321.801; G05.331.390.801; G05.511.321.801 DEGEIMPHRE Receptors, Antigen, T-Cell Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement Genetics; Genetics, Biochemical; Gene Rearrangement Genetics; Immunogenetics; Gene Rearrangement Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor Ordered rearrangement of T-cell variable gene regions coding for the antigen receptors. DNA/genetics (77-88); Genes or specific gene (77-88); T Lymphocytes/immunology (77-88); Receptors, Antigen, T-Cell/genetics (77-88) $h>&= gGene Rearrangement, gamma-Chain T-Cell Antigen Receptor G04.610.626.321.801.311; G05.331.390.801.311; G05.511.321.801.311 DEGEIMPHRE Receptors, Antigen, T-Cell, gamma-delta Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Genetics, Biochemical; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors. DNA/genetics (77-88); Genes or specific gene (77-88); T Lymphocytes/immunology (77-88); Receptors, Antigen, T-Cell/genetics (77-88)  h@I.ZxGene Rearrangement, delta-Chain T-Cell Antigen Receptor G04.610.626.321.801.261; G05.331.390.801.261; G05.511.321.801.261 DEGEIMPHRE Receptors, Antigen, T-Cell, gamma-delta Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Genetics, Biochemical; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors. Gene Rearrangement, T-Lymphocyte (89-91); Receptors, Antigen, T-Cell/genetics (87-88)  h B@I.ZxcGene Rearrangement, beta-Chain T-Cell Antigen Receptor G04.610.626.321.801.211; G05.331.390.801.211; G05.511.321.801.211 DEGEIMPHRE Receptors, Antigen, T-Cell, alpha-beta Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Genetics, Biochemical; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors. DNA/genetics (77-88); Genes or specific gene (77-88); T Lymphocytes/immunology (77-88); Receptors, Antigen, T-Cell/genetics (77-88)  hg?I-ZwGene Rearrangement, B-Lymphocyte, Light Chain G04.610.626.321.401.601; G05.331.390.401.601; G05.511.321.401.601 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement; Gene Rearrangement, B-Lymphocyte Genetics; Genetics, Biochemical; Gene Rearrangement; Gene Rearrangement, B-Lymphocyte Genetics; Immunogenetics; Gene Rearrangement; Gene Rearrangement, B-Lymphocyte Ordered rearrangement of B-lymphocyte variable gene regions coding for the kappa or lambda light chains, thereby contributing to antibody diversity. It occurs during the second stage of differentiation of the immature B-lymphocyte. DNA/genetics (77-88); Genes, Immunoglobulin (77-88); Immunoglobulins, Light Chain/genetics (77-88); B Lymphocytes/immunology (77-88) h5IZ Gene Rearrangement, B-Lymphocyte, Heavy Chain G04.610.626.321.401.501; G05.331.390.401.501; G05.511.321.401.501 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement; Gene Rearrangement, B-Lymphocyte Genetics; Genetics, Biochemical; Gene Rearrangement; Gene Rearrangement, B-Lymphocyte Genetics; Immunogenetics; Gene Rearrangement; Gene Rearrangement, B-Lymphocyte Ordered rearrangement of B-lymphocyte variable gene regions thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the immature B-lymphocyte. B Lymphocytes/immunology (77-88); DNA/genetics (77-88); Genes, Immunoglobulin (77-88); Immunoglobulins, Heavy Chain/genetics (77-88) hx5IZGene Rearrangement, B-Lymphocyte G04.610.626.321.401; G05.331.390.401; G05.511.321.401 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement Genetics; Genetics, Biochemical; Gene Rearrangement Genetics; Immunogenetics; Gene Rearrangement Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain Ordered rearrangement of B-lymphocyte variable gene regions coding for the immunoglobulin chains, thereby contributing to antibody diversity. It occurs during the differentiation of the immature B-lymphocyte. DNA/genetics (77-88); Genes, Immunoglobulin (77-88); B-Lymphocytes/immunology (77-88)  h&=:eGene Rearrangement, alpha-Chain T-Cell Antigen Receptor G04.610.626.321.801.111; G05.331.390.801.111; G05.511.321.801.111 DEGEIMPHRE Receptors, Antigen, T-Cell, alpha-beta Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Genetics, Biochemical; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Genetics; Immunogenetics; Gene Rearrangement; Gene Rearrangement, T-Lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors. DNA/genetics (77-88); Genes or specific gene (77-88); T Lymphocytes/immunology (77-88); Receptors, Antigen, T-Cell/genetics (77-88)  h @I-ZxGene Rearrangement G04.610.626.321; G05.331.390; G05.511.321 DEGEIMPHRE Antibody Diversity; Genes, Immunoglobulin; Immunoglobulin Variable Region Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Genetics, Biochemical Genetics; Immunogenetics Gene Rearrangement, B-Lymphocyte (+ 2); Gene Rearrangement, T-Lymphocyte (+ 4); Immunoglobulin Class Switching Gene Rearrangement, B-Lymphocyte (+ 2); Gene Rearrangement, T-Lymphocyte (+ 4); Immunoglobulin Class Switching Gene Rearrangement, B-Lymphocyte (+ 2); Gene Rearrangement, T-Lymphocyte (+ 4); Immunoglobulin Class Switching Ordered rearrangement of variable gene regions; especially, the rearrangement of antibody genes during the differentiation of B-lymphocytes and the rearrangement of T-cell antigen receptor genes. DNA/genetics (77-88); Genes or specific gene (77-88) $h g1UAGene Products, vpu D12.776.260.900.580; D12.776.964.950.580; D12.776.964.970.880.940.580 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins; Viral Matrix Proteins Non-glycosylated, membrane-associated, 16 kDa proteins which are expressed in large amounts in cells infected with HIV-1. The proteins are required for efficient virion maturation and release. They are not present in HIV-2 nor in SIV. vpu is short for viral protein U, with U undefined. Retroviridae Proteins (88-90) h$MFR#Gene Products, vpr D12.776.964.950.800.430 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins; Trans-Activators Trans-acting proteins which accelerate virus replication in HIV. The vpr proteins act in trans to increase the levels of HIV specified proteins. vpr is short for viral protein R, where R is undefined. Retroviridae Proteins (90) h(kF Gene Products, vif D12.776.260.900.575; D12.776.964.950.575 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins A 23 kDa regulatory protein important for virion infectivity in HIV. The protein is found in the cytoplasm of HIV-infected cells and is not absolutely required for virion formation. Retroviridae Proteins (86); Viral Proteins (87-90) h*.F=Gene Products, tax D12.776.677.520.750.480; D12.776.964.700.750.480; D12.776.964.775.750.480; D12.776.964.950.800.410 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription, Genetic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins; Trans-Activators Transcriptional trans-acting proteins of the promoter elements found in the long terminal repeats (LTR) of HTLV-I and HTLV-II. The tax (trans-activator x; x is undefined) proteins act by binding to enhancer elements in the LTR. Trans-Activators (90); Transcription Factors (86-89)  h-[lFT >Gene Products, tat D12.776.964.950.800.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR HIV Long Terminal Repeat; Transcription, Genetic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins; Trans-Activators Trans-acting transcription factors. Nuclear proteins whose expression is required for HIV viral replication. The tat protein stimulates HIV-LTR-driven RNA synthesis for both viral regulatory and viral structural proteins. tat stands for trans-activation of transcription. Transcription Factors (88-89)  h2 F:8#Gene Products, rex D12.776.260.900.470; D12.776.677.520.750.470; D12.776.964.700.750.470; D12.776.964.775.750.470; D12.776.964.950.470 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HTLV-I and HTLV-II. The rex (regulator x; x is undefined) products act by binding to elements in the LTR. Viral Regulatory Proteins (90) h4F%Gene Products, rev D12.776.964.950.800.385 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription, Genetic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins; Trans-Activators Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (CAR) in env, also known as the rev-responsive element (RRE), is responsive to the rev gene product. rev is short for regulator of virion. Retroviral Proteins (86-89); Viral Proteins (86-89)  h9FM>Gene Products, pol D12.776.964.775.375; D12.776.964.970.850.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Endonucleases; Peptide Hydrolases; Reverse Transcriptase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins Fusion Proteins, gag-pol; HIV Protease; Reverse Transcriptase Fusion Proteins, gag-pol; HIV Protease; Reverse Transcriptase Retroviral proteins coded by the pol gene. Often synthesized as a gag-pol fusion protein (FUSION PROTEINS, GAG-POL) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. pol is short for polymerase, the enzyme class of reverse transcriptase. Retroviridae Proteins (83-89); Reverse Transcriptase (77-89); Viral Proteins (77-89) $h=2FBbdGene Products, nef D12.776.260.900.365; D12.776.964.950.365 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR HIV Long Terminal Repeat Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Viral Regulatory Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Regulatory Proteins Products of the HIV nef gene (formerly 3'-orf gene). The products trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor. Retroviridae Proteins (87-89); Viral Proteins (87-88)  hA.F@Gene Products, gag D12.776.964.775.350; D12.776.964.970.850.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins Fusion Proteins, gag-onc (+ 1); Fusion Proteins, gag-pol; HIV Core Protein p24 Fusion Proteins, gag-pol; HIV Core Protein p24 Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or polyproteins, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. Antigens, Viral (83-89); Retroviridae Proteins (86-89); Viral Core Proteins (86-89); Viral Proteins (72-89)  hD2FsGene Products, env D12.776.964.775.325; D12.776.964.970.880.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Envelope Proteins HIV Envelope Protein gp41; HIV Envelope Protein gp120 HIV Envelope Protein gp41; HIV Envelope Protein gp120 Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (polyproteins) and later cleaved into the final products by a viral protease. Antigens, Surface (79-89); Antigens, Viral (77-89); Retroviridae Proteins (86-89); Viral Envelope Proteins (84-89); Viral Proteins (77-85)  hI 2FGene Pool G05.414.350 Founder Effect Genetics; Genetics, Population The total genetic information possessed by the reproductive members of a population of sexually reproducing organisms. Gene Frequency (68-77); Genetics, Population (66-77) hL%?Gene Library G05.275.195; G05.331.599.110.410 DNA, Recombinant Genetics; Genes Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Genomic Library; Sequence Tagged Sites Genomic Library; Sequence Tagged Sites A collection of cloned genes, frequently consisting of most or all of the genes of a particular species. It may contain complete genomic sequences (GENOMIC LIBRARY) or complementary DNA sequences, the latter being formed from messenger RNA and lacking intron sequences. Base Sequence (78-89); Cloning, Molecular (80-89); Plasmids (78-85)  hN &h\;RGene Frequency G05.414.317 DEGEIMPHRE Genetics; Genetics, Population The proportion of one particular allelotype to the total of all alleles at this genetic locus in a breeding population. Genes (66-67); Genetics (66-67); Genetics, Population (66-67) hP%KGene Expression Regulation, Viral G05.331.370.380.530 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Gene Expression Regulation (81-89); Genes, Regulator (73-80); specific viruses (73-89) hR>(ZgGene Expression Regulation, Plant G05.331.370.380.500 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in plants. specific plant (73-94); Gene Expression Regulation (81-94); Genes, Regulator (73-80) hS(ZeGene Expression Regulation, Neoplastic G05.331.370.380.480 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Gene Expression Regulation, Leukemic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Gene Expression Regulation (81-89); Genes (72-89); specific neoplasm (72-89)  hU-Z+\Gene Expression Regulation, Leukemic G05.331.370.380.480.400 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in leukemia. Gene Expression Regulation (81-89); Genes (73-80); specific leukemia (73-89) hW+\Gene Expression Regulation, Fungal G05.331.370.380.450 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in fungi. Gene Expression Regulation (81-89); Genes, Regulator (72-80); specific fungi (72-89) hY)ZeGene Expression Regulation, Enzymologic G05.331.370.380.435 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Enzyme Induction; Enzyme Repression Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymes (72-89); Gene Expression Regulation (81-89); Genes, Regulator (72-80)  h[.Z+]Gene Expression Regulation, Developmental G05.331.370.380.425 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action during the developmental stages of an organism. Gene Expression Regulation (81-94); Genes, Regulator (73-80) h]0ZHGene Expression Regulation, Bacterial G05.331.370.380.400 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Gene Expression Regulation (81-89); Genes, Regulator (73-80); specific bacteria (73-89) h_,ZhGene Expression Regulation G05.331.370.380 DEGEIMPHRE Cell Differentiation; Chromosomal Proteins, Non-Histone; Trans-Activators; Transcription Factors Genetics; Genetics, Biochemical; Gene Expression Dosage Compensation (Genetics); Down-Regulation (Physiology); Gene Amplification; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Developmental; Gene Expression Regulation, Enzymologic (+ 2); Gene Expression Regulation, Fungal; Gene Expression Regulation, Neoplastic (+ 1); Gene Expression Regulation, Plant; Gene Expression Regulation, Viral; Mutagenesis, Insertional; Protein Processing, Post-Translational (+ 1); RNA Processing, Post-Transcriptional (+ 3); Trans-Activation (Genetics); Up-Regulation (Physiology) Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action at the level of transcription or translation. These processes include gene activation and genetic induction. Genes (66-80); Genes, Regulator (73-80); Transcription, Genetic (73-80); Translation, Genetic (73-80) DEECGEHIIMISMTPHRESNSTUT (har n:eyGene Expression G05.331.370 DEGEIMPHRE Phenotype Genetics; Genetics, Biochemical Gene Expression Regulation (+ 22); Genomic Imprinting; Transcription, Genetic; Translation, Genetic (+ 5) The phenotypic manifestation of a gene or genes by the processes of gene action. Gene Expression Regulation (81-89); Genes (66-80); Phenotype (69-89) DEECGEHIIMISMTPHRESNSTUT (hf &}bSGene Dosage G05.441.350 Gene Amplification Genetics; Genotype The number of copies of a given gene present in a cell or nucleus. An increase in gene dosage can result in the formation of higher levels of gene product, provided that the gene is not subject to autogenous regulation. hh~Gene Deletion G05.632.325 Chromosome Deletion Genetics; Mutation Sequence Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Chromosome Deletion (76-92); Mutation (72-75) DEGEIMPHRE $hiJ7Gene Conversion G05.825.380 DEGEIMPHRE Genetics; Recombination, Genetic The asymmetrical segregation of genes during replication which leads to the production of non-reciprocal recombinant strands and the apparent conversion of one allele into another. Thus, e.g., the meiotic products of an Aa individual may be AAAa or aaaA instead of AAaa, i.e., the A allele has been converted into the a allele or vice versa. Mutation (66-79); Recombination, Genetic (68-79) hl':Gene Amplification E05.393.330; G05.331.370.380.330 DEGEIMMTPHRE Gene Dosage Miscellaneous Techniques (Non MeSH); Genetic Techniques Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Polymerase Chain Reaction A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Genes (66-67); Genes, Structural (68-79); Nucleic Acid Hybridization (71-79); Plasmids (75-79) CLCTDEECGEHIIMISMOMTPHRESNSTTDUTVE (hng& 0r&Gender Identity F01.393.446.250; F01.752.747.385.200; F01.752.747.722.200; F02.739.794.793.200; F03.407.446.200 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms; Identification (Psychology) Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Identification (Psychology) Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Psychosexual Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory; Psychosexual Development Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms; Identification (Psychology) Knowing that one is male or female. It is differentiated from primary SEX CHARACTERISTICS, which are biologically determined. Identification (Psychology) (68-75); Sex (68-75) hsykU:Geminivirus B04.280.350; B04.715.270 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Plant Viruses A group of plant viruses where the virions possess an unusual morphology consisting of a pair of isometric particles. Transmission occurs via leafhoppers or whitefly and some viruses cause economically important diseases in cultivated plants. Plant Viruses (85-93) hw>6Gemfibrozil D02.241.081.465.895.593.350; D02.241.081.944.509.350; D10.162.350; D10.516.251.400.895.593.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Valerates; Pentanoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Valerates; Pentanoic Acids Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Valerates; Pentanoic Acids 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid. A lipid-regulating agent which lowers elevated serum lipids primarily by decreasing serum triglycerides with a variable reduction in total cholesterol. These decreases occur primarily in the VLDL fraction and less frequently in the LDL fraction. Gemfibrozil increases HDL subfractions HDL2 and HDL3 as well as apolipoproteins A-I and A-II. Its mechanism of action has not been definitely established. Side effects involve mainly the gastrointestinal system. Pentanoic Acids (75-88); Valerates (66-74) hyh:B4Gelsolin D12.776.157.125.350; D12.776.220.525.350 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins A 90-kD protein produced by macrophages that severs actin filaments and forms a cap on the newly exposed filament end. Gelsolin is activated by calcium ions and participates in the assembly and disassembly of actin, thereby increasing the motility of some cells. Calcium-Binding Proteins (80-93); Microfilament Proteins (80-93) h~E .H5KGels D26.394.225.220.442 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Colloids Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquifies; the resulting colloid is called a sol. h[,YGelatinases D08.586.277.656.732.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases A class of enzymes that catalyzes the degradation of gelatin by acting on the peptide bonds. EC 3.4.99.-. Gelatin (73-81); Pepsin A (75-92); Peptide Hydrolases (73-74); Peptide Peptidohydrolases (93) hFqGelatin Sponge, Absorbable D19.461.270.463.525 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics h# ,yGelatin D12.776.860.476 AAADAEAGAIANBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH) h BcGefarnate D02.241.081.436.310; D02.455.849.440; D10.516.251.355.350; D19.316.203.397 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester. A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue. Synonyms: Andoin; DA 688; Gefarnil; Gepharnate; Improfarm; Nolesil; Ulco; Ulsanax. Alkenes (66); Farnesol (66-69); Fatty Acids (69-73); Fatty Acids, Unsaturated (73-77); Terpenes (69-77) h T:hGeese B02.248.617.492 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Poultry Birds (66-67); Poultry (66-67) h. &#'Gaucher's Disease C15.604.667.358; C18.452.648.556.641.803.441; C18.452.648.595.803.441; F03.709.346.282 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Hereditary disorder of glucocerebroside metabolism, usually occurring in infancy, and characterized by mental retardation, bulbar palsy, opisthotonus, and enlargement of the spleen and liver. h`LGated Blood-Pool Imaging E01.145.077.805.902.350; E01.145.569.820.350; E01.289.806.800.902.350; E01.357.820.800.902.350 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Ventriculography, First-Pass Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography; Radionuclide Angiography; Radionuclide Ventriculography Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Radionuclide Ventriculography Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging; Radionuclide Angiography; Radionuclide Ventriculography Diagnosis; Diagnostic Imaging; Radionuclide Imaging; Radionuclide Angiography; Radionuclide Ventriculography Radionuclide ventriculography where scintigraphic data is acquired during repeated cardiac cycles at specific times in the cycle, using an electrocardiographic synchronizer or gating device. Analysis of right ventricular function is difficult with this technique; that is best evaluated by first-pass ventriculography (VENTRICULOGRAPHY, FIRST-PASS). hh&!Gastrula A16.254.412 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo The embryo in the early stage following the blastula, characterized by morphogenetic cell movements, cell differentiation, and the formation of the three germ layers. specific organism/EM (66-79) h$ *1#Gastrostomy E04.765.496; E04.579.408 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Gastric Fistula; Enteral Nutrition; Stomach Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgery, Operative; Ostomy Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression. h$5bGastrospirillum hominis B03.440.375.375; B03.825.380.375 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gastrospirillum Bacteria; Spiral and Curved Bacteria (Non MeSH); Gastrospirillum A species of gram-negative, spiral-shaped bacteria found in the gastric mucosa that is associated with chronic antral gastritis. This bacterium was first discovered in samples removed at endoscopy from patients investigated for HELICOBACTER PYLORI colonization. Gram-Negative Bacteria (89-93) h<&"-$Gastrospirillum B03.440.375; B03.825.380 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Bacteria; Spiral and Curved Bacteria (Non MeSH) Gastrospirillum hominis Gastrospirillum hominis A genus of gram-negative, spiral-shaped bacteria that is pathogenic and has been isolated from the gastric mucosa of mammals, including humans. Gram-Negative Bacteria (89-93)  h"_6$Gastroscopy E01.184.340.350.425; E01.418.340.350.425 AECLCTECHIISMOMTNUPXSNSTTDUTVE Stomach Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System; Endoscopy, Gastrointestinal Diagnosis; Endoscopy; Endoscopy, Digestive System; Endoscopy, Gastrointestinal Endoscopic examination of the interior of the stomach. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material and perform other surgical interventions, and for delivery of medication. h}." Gastroplasty E04.765.485 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Obesity, Morbid; Stomach Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgical treatment of the stomach or lower esophagus used to decrease the size of the stomach. The procedure is used mainly in the treatment of morbid obesity and to correct defects in the lower esophagus or the stomach. Different procedures employed include vertical (mesh) banded gastroplasty, silicone elastomer ring vertical gastroplasty and horizontal banded gastroplasty. Stomach/surgery (66-88)  h$CGastroparesis C06.405.748.543; C10.597.622.254; C23.888.592.636.263 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diabetes Mellitus Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Nervous System Diseases; Neurologic Manifestations; Paralysis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Paralysis of the muscular coat of the stomach. It is most often seen as a complication of DIABETES MELLITUS. (From Dorland, 27th ed and Stedman, 25th ed). Stomach Diseases (66-94)  h=NGastrointestinal Transit E01.184.380; G10.261.482.525 DEGEIMPHRE Diagnosis; Diagnosis, Digestive System (Non MeSH) Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH); Gastrointestinal Motility Passage of food (sometimes in the form of a test meal) through the gastrointestinal tract as measured in minutes or hours. The rate of passage through the intestine is an indicator of small bowel function. Gastrointestinal Motility (66-87); Gastrointestinal System (66-87) h`"MGastrointestinal System A03.492 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Gastroenterostomy Digestive System Intestines (+ 17); Stomach (+ 8) ABAHBLBSCFCHCICLCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI  h 8+hGastrointestinal Neoplasms C04.588.274.476; C06.240.476; C06.405.282 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms Digestive System Diseases; Digestive System Neoplasms Digestive System Diseases; Gastrointestinal Diseases Intestinal Neoplasms (+ 19); Stomach Neoplasms Intestinal Neoplasms (+ 19); Stomach Neoplasms Intestinal Neoplasms (+ 19); Stomach Neoplasms h1XGastrointestinal Motility G10.261.482 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) Gastric Emptying; Gastrointestinal Transit; Myoelectric Complex, Migrating; Peristalsis hTceGastrointestinal Hormones D06.472.317; D19.316.629 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Gastrointestinal Hormone Intestinal Secretions Hormones, Substitutes, Antagonists (Non MeSH); Hormones Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Cholecystokinin (+ 1); Enteroglucagon; Epidermal Growth Factor-Urogastrone; Gastric Inhibitory Polypeptide; Gastrins (+ 2); Motilin; Secretin; Vasoactive Intestinal Peptide Cholecystokinin (+ 1); Enteroglucagon; Epidermal Growth Factor-Urogastrone; Gastric Inhibitory Polypeptide; Gastrins (+ 2); Glucagon; Motilin; Secretin; Vasoactive Intestinal Peptide AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $hzB)FGastrointestinal Hemorrhage C06.405.270; C23.542.305 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemostasis, Endoscopic Digestive System Diseases; Gastrointestinal Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Hematemesis; Melena; Peptic Ulcer Hemorrhage Hematemesis; Melena; Peptic Ulcer Hemorrhage Bleeding in the gastrointestinal tract.  h N|j0Gastrointestinal Diseases C06.405 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gastroenterology Digestive System Diseases Abdominal Pain (+ 1); Gastroenteritis (+ 1); Gastrointestinal Hemorrhage (+ 3); Gastrointestinal Neoplasms (+ 21); Hernia (+ 8); Intestinal Diseases (+ 126); Peptic Ulcer (+ 8); Postgastrectomy Syndromes (+ 1); Stomach Diseases (+ 17); Tuberculosis, Gastrointestinal; Visceroptosis; Vomiting (+ 2) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  h NhZGastrointestinal Contents A12.464 CHDEENMIPSRARERI Fluids and Secretions (Non MeSH) The residue of ingested substances in the gastrointestinal tract. Excludes natural secretions and FECES. h` ({Gastrointestinal Agents D19.316 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH) Antidiarrheals (+ 5); Anti-Ulcer Agents (+ 23); Betazole; Bile Acids and Salts (+ 17); Bombesin; Caerulein (+ 1); Cathartics (+ 17); Cholagogues and Choleretics (+ 3); Gastrointestinal Hormones (+ 12); Pancreatin; Pepsin A; Simethicone; Trimebutine Agents acting on the gastrointestinal system to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  hc 861HGastroesophageal Reflux C06.306.418.484 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fundoplication Digestive System Diseases; Esophageal Diseases; Esophageal Motility Disorders Reflux of gastric juice and/or duodenal contents (bile acids, pancreatic juice) into the distal esophagus, commonly due to incompetence of the lower esophageal sphincter. Gastric regurgitation is an extension of this process with entry of fluid into the pharynx or mouth. hENZ>Gastroenterostomy E04.765.457; E04.035.398 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Gastrointestinal System; Stomach Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgery, Operative; Anastomosis, Surgical Gastric Bypass Gastric Bypass Surgical construction of a channel between the stomach and intestines.  h$'r$TGastroenterology G02.403.776.409.405 CLECEDHIISLJMAMTOGSNSTTD Gastrointestinal Diseases Health Occupations; Medicine; Specialties, Medical; Internal Medicine A subspecialty of internal medicine concerned with the study of the physiology and diseases of the digestive system and related structures (esophagus, liver, gallbladder, and pancreas). h&RGastroenteritis, Transmissible, of Swine C02.782.225.200.400; C22.905.469 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Coronaviridae Infections; Coronavirus Infections Animal Diseases; Swine Diseases A condition of chronic gastroenteritis in adult pigs and fatal gastroenteritis in piglets caused by a CORONAVIRUS. Swine Diseases (66-69) h/&JGastroenteritis Virus, Porcine Transmissible B04.820.155.150.410; B04.909.777.199.150.410 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS causing a fatal disease to pigs under 3 weeks old. h32]Gastroenteritis Virus, Murine B04.450.370; B04.820.155.150.390; B04.909.777.199.150.390 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Hepatitis Viruses Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of the CORONAVIRUS genus causing hepatitis in mice. Four strains have been identified as MHV 1, MHV 2, MHV 3, and MHV 4 (also known as JHM, which is neurotropic and causes disseminated encephalomyelitis with demyelination as well as focal liver necrosis). hy#A;Gastroenteritis C06.405.236 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases Cholera Morbus hN=Gastritis, Hypertrophic C06.405.748.369.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Gastritis Gastritis with hypertrophy of gastric mucosa folds. Symptoms include vomiting, diarrhea, weight loss, excessive mucus secretion, and hypoproteinemia. Gastritis (66-80); Hypertrophy (66-80) hN_/Gastritis, Atrophic C06.405.748.369.394 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Gastritis Chronic gastritis with mucosal atrophy. Atrophy (66-80); Gastritis (66-80) hN_0+Gastritis C06.405.748.369 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Gastritis, Atrophic; Gastritis, Hypertrophic h4 NR4Gastrins D06.472.317.413; D12.644.224; D12.776.641.650.320; D14.600.600.325; D19.316.629.441 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones Pentagastrin; Tetragastrin Pentagastrin; Tetragastrin A family of gastrointestinal peptide hormones that excite the secretion of gastric juices. They may also occur in the central nervous system where they are presumed to be neurotransmitters. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  hK _DAFGastrinoma C04.557.470.035.100.320 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Multiple Endocrine Neoplasia Type 1; Zollinger-Ellison Syndrome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Islet Cell Zollinger-Ellison Syndrome A gastrin-secreting tumor of the non-beta islet cells. It is usually located in the pancreas but is also found at other sites, as in the antrum of the stomach, hilus of the spleen, and regional lymph nodes. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN-1). Gastrinomas in patients with MEN-1 are usually diffuse in nature. Islet Cell Tumor (81); Zollinger-Ellison Syndrome (82-88) $hpXJ-EGastric Stump A03.492.766.578 BSIRPAPPRARISUUS Gastrectomy Digestive System; Gastrointestinal System; Stomach That portion of the stomach remaining after gastric surgery, usually gastrectomy or gastroenterostomy for cancer of the stomach or peptic ulcer. It is a common site of cancer referred to as stump cancer or carcinoma of the gastric stump. Gastrectomy (66-94); Gastroenterostomy (66-94); Stomach Neoplasms (66-94)  hχ<WGastric Outlet Obstruction C06.405.748.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Pyloric Stenosis The hindering of output from the stomach to the small intestine. Pyloric Stenosis (67-92); Stomach Diseases (78-92)  hѦ NRO=Gastric Mucosa Prolapse C06.405.748.333; C23.835.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Symptoms and General Pathology (Non MeSH); Prolapse Gastric mucosal invagination of the esophagus, the pylorus, or the stoma of a surgically created gastroduodenostomy or gastrojejunostomy. hE"NGastric Mucosa A03.492.766.440; A10.615.550.291 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Stomach Tissue Types (Non MeSH); Membranes; Mucous Membrane Parietal Cells, Gastric ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI h#&:z<Gastric Mucin D12.776.395.560.631.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins; Mucins h֑FoGastric Lavage E05.510.441 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Irrigation hג"9Gastric Juice A12.838.307 CHCYDEENIMMEMIPHPSRARERISEUSVI Achlorhydria; Pepsin A; Pepsinogen Fluids and Secretions (Non MeSH); Secretions (Non MeSH) Gastric Acid h."+DGastric Inhibitory Polypeptide D06.472.317.400; D12.644.220; D12.776.641.650.300; D14.600.600.320; D19.316.629.398 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones A gastrointestinal hormone consisting of a 43-amino acid polypeptide (molecular weight 5105). It inhibits gastric secretion and motility and stimulates release of insulin. Gastrointestinal Hormones (74-76); Peptides (74-76) h$_D=Gastric Fundus A03.492.766.419 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Fundoplication Digestive System; Gastrointestinal System; Stomach The superior portion of the body of the stomach above the level of the cardiac notch. Stomach (66-80)  h:<iGastric Fistula C06.185.600; C06.405.748.297; C23.439.185.600 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gastrostomy Digestive System Diseases; Digestive System Fistula (Non MeSH) Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH) Abnormal passage communicating with the stomach. hF5N:Gastric Emptying G10.261.482.400 DEGEIMPHRE Pylorus Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH); Gastrointestinal Motility The evacuation of food from the stomach into the duodenum. Gastrointestinal Motility (66-77); Stomach (66-77)  hN H<Gastric Bypass E04.035.398.385; E04.765.457.430 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Obesity, Morbid Surgery, Operative; Anastomosis, Surgical; Gastroenterostomy Surgery, Operative; Surgery, Digestive System (Non MeSH); Gastroenterostomy Surgical procedure in which the stomach is transected high on the body. The resulting proximal remnant is joined to a loop of the jejunum in an end-to-side anastomosis. This procedure is used frequently in the treatment of morbid obesity. Stomach/surgery (66-88)  h&$Gastric Bubble E07.435 AECLCTECHISDSNSTTDUTVE Obesity, Morbid; Balloon Dilatation Equipment and Supplies An inflatable device implanted in the stomach as an adjunct to therapy of morbid obesity. Specific types include the silicone Garren-Edwards Gastric Bubble (GEGB), approved by the FDA in 1985, and the Ballobes Balloon. Balloon Dilatation (88-89); Dilatation (80-87); Implants, Artificial (87-89); Intubation, Gastrointestinal (74-79); Obesity (77-87); Obesity, Morbid (87-89)  h1 +Gastric Acidity Determination E01.184.357; E01.223.411 ISVE Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Diagnosis, Laboratory Gastric analysis for determination of free acid or total acid. h#`LGastric Acid A12.838.307.603 CHENMEPHSE Achlorhydria Parietal Cells, Gastric; Hydrochloric Acid Fluids and Secretions (Non MeSH); Secretions (Non MeSH); Gastric Juice Hydrochloric acid present in gastric juice. Gastric Juice (66-80) $h3W5Gastrectomy E04.765.419 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Gastric Stump; Postgastrectomy Syndromes Peptic Ulcer; Stomach Surgery, Operative; Surgery, Digestive System (Non MeSH) Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 27th ed).  h$0CGasoline G03.230.132.258.630.540; J01.435.723.441; J01.740.400.700.400 AEANCLECHIMIPOPSRESDSNSTTOUTVI Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Fossil Fuels; Petroleum Technology, Industry, Agriculture (Non MeSH); Fossil Fuels; Petroleum Technology, Industry, Agriculture (Non MeSH); Oils; Industrial Oils; Petroleum Volative flammable fossil fuel (liquid hydrocarbons) derived from crude petroleum by processes such as distillation reforming, polymerization, etc. h E",Gases D01.362 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKRESDSTTOTUUR Inorganic Chemicals (Non MeSH) Ammonia; Carbon Dioxide; Carbon Monoxide; Chlorine; Hydrogen; Hydrogen Sulfide; Nitrogen; Nitrogen Oxides (+ 2); Noble Gases (+ 7); Oxygen (+ 1); Sulfur Dioxide; Sulfur Hexafluoride ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR h  6%<Gas Scavengers E07.427 CLECHISDSNSTTDUTVE Operating Rooms; Air Pollutants, Occupational Equipment and Supplies Apparatus for removing exhaled or leaked anesthetic gases or other volatile agents, thus reducing the exposure of operating room personnel to such agents, as well as preventing the buildup of potentially explosive mixtures in operating rooms or laboratories. Air Pollutants (72-83); Air Pollutants, Occupational (75-89); Anesthesia, Inhalation (72-89); Operating Rooms (77-89)  h 6,Gas Poisoning C21.613.455 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chemical Warfare Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Carbon Monoxide Poisoning; Inert Gas Narcosis h'LE7Gas Gangrene C01.252.410.090.217.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections; Clostridium Infections A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases. hLPGarlic B06.510.026.423; B06.560.401; J01.341.241.289 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Allium Plants; Plants, Medicinal Technology, Industry, Agriculture (Non MeSH); Food; Condiments Allium sativum. One of the Liliaceae used as a spice and home remedy for everything from nervousness to worms. It contains allicin, the pungent active ingredient, which may reduce blood cholesterol and inhibit platelet aggregation. h6 54Gardnerella vaginalis B03.325.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gardnerella The only species in the genus GARDNERELLA, and previously classed as Haemophilus vaginalis. This bacterium, also isolated from the female genital tract of healthy women, is implicated in the cause of bacterial vaginosis (VAGINOSIS, BACTERIAL). It occasionally causes postpartum bacteremia and bacteremia following a transurethral resection of the prostate. hj"Gardnerella B03.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Gardnerella vaginalis A genus of bacteria found in the human genital and urinary tract. It is considered to be a major cause of bacterial vaginosis (VAGINOSIS, BACTERIAL). Gardnerella vaginalis (75-91)  h " #Gardner Syndrome C04.588.274.476.411.510.393; C04.700.392; C04.799.411.393; C06.240.476.411.510.393; C06.405.282.411.510.393; C06.405.469.505.510.393; C06.405.469.583.393; C16.131.077.393; C16.466.700.392 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps Neoplasms; Neoplastic Syndromes, Hereditary Neoplasms; Polyps; Intestinal Polyps Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Intestinal Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Polyps Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary An autosomal dominant disease featuring multiple colonic polyposis with malignant tendency, subcutaneous fibromata and lipomata, exostoses and osteomas of the skull and facial bones, and epidermal inclusion cysts. Colonic Neoplasms (66-80); Intestinal Polyps/FG (68-80); Neoplasms, Multiple Primary (66-80) hLnGarbage G03.850.860.510.900.600.400 Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Waste Management; Refuse Disposal Discarded animal and vegetable matter from a kitchen or the refuse from food preparation. (From Random House College Dictionary, 1982). i Gap Junctions A11.195.443.471 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Connexins Synapses; Synaptic Transmission Cells; Cell Membrane; Intercellular Junctions Connections between cells which allow passage of small molecules and electric current. Gap junctions were first described anatomically as regions of close apposition between cells with a narrow (1-2 nm) gap between cell membranes. The variety in the properties of gap junctions is reflected in the number of CONNEXINS, the family of proteins which form the junctions. Intercellular Junctions (71-93) $i( &7%Gangrene C23.739.638.395 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Necrosis Death of tissue, usually in considerable mass and generally associated with loss of vascular (nutritive) supply and followed by bacterial invasion and putrefaction. (Dorland, 27th ed). i NfGangliosidosis G(M1) C10.228.140.163.300.360; C10.496.253.360; C18.452.648.556.641.803.350.360; C18.452.648.595.803.350.360; F03.709.346.250.360 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI G(M1) Ganglioside Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic; Gangliosidoses Nervous System Diseases; Mental Retardation; Gangliosidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses; Gangliosidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses; Gangliosidoses Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation; Gangliosidoses Form of gangliosidosis characterized by accumulation of G(M1) ganglioside and oligosaccharides, and caused by an absence or severe deficiency of beta-galactosidase A. The three phenotypes of G(M1) gangliosidosis are called infantile (generalized), juvenile, and adult (types 1, 2, and 3 respectively), referring to the age at which clinical manifestations appear. Gangliosidoses (76-91); Lipoidosis (66-75); Metabolism, Inborn Errors (66-75)  iL\Gangliosidoses C10.228.140.163.300; C10.496.253; C18.452.648.556.641.803.350; C18.452.648.595.803.350; F03.709.346.250 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Galactosidases; Hexosaminidases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Nervous System Diseases; Mental Retardation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Gangliosidosis G(M1); Sandhoff Disease; Tay-Sachs Disease Gangliosidosis G(M1); Sandhoff Disease; Tay-Sachs Disease Gangliosidosis G(M1); Sandhoff Disease; Tay-Sachs Disease Gangliosidosis G(M1); Sandhoff Disease; Tay-Sachs Disease Gangliosidosis G(M1); Sandhoff Disease; Tay-Sachs Disease A group of fatal inherited ganglioside storage diseases with onset in infancy or childhood and characterized by accumulation of a specific ganglioside caused by absence or severe deficiency of specific enzymes. They involve mental and motor deterioration, autosomal recessive inheritance, and neuronal lipoidosis. Lipoidosis (66-75); Gangliosides (66-75) $i fsL%WVi1Gangliosides D10.516.390.470.440; D10.516.808.530.490 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids G(M1) Ganglioside; G(M2) Ganglioside; G(M3) Ganglioside G(M1) Ganglioside; G(M2) Ganglioside; G(M3) Ganglioside AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR i.BDGanglionic Stimulants D16.050.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nicotinic Agonists; Receptors, Nicotinic Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Arecoline; DMPP; Lobeline; McN A 343; Nicotine Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. Autonomic Agents (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (i80J<@Ganglionic Blockers D16.050.340 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nicotinic Antagonists; Receptors, Nicotinic Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Chlorisondamine; Hexamethonium; Mecamylamine; Pempidine; Pentolinium Tartrate; Trimethaphan Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $iL83Jj:Ganglioneuroma C04.557.465.625.600.355; C04.557.470.670.355; C04.557.580.625.600.355 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial A benign neoplasm composed of mature ganglionic neurons, in varying numbers, scattered singly or in clumps within a relatively abundant and dense stroma of neurofibrils and collagenous fibers. It is usually found in the posterior mediastinum and retroperitoneum, sometimes in relation to the adrenal glands. (Stedman, 25th ed). iMV~Ganglioneuroblastoma C04.557.465.625.600.600.575.355; C04.557.470.670.600.575.355; C04.557.580.625.600.600.575.355 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral; Neuroblastoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral; Neuroblastoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral; Neuroblastoma A malignant neoplasm composed of nerve fibers and mature ganglion cells. It is regarded by many as a fully differentiated neuroblastoma. (From Dorland, 27th ed)). Ganglioneuroma (66-93); Neuroblastoma (66-93) i!$eXb6Ganglionectomy E04.530.324.084.800.300; E04.530.324.306 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Ganglia, Sympathetic Surgery, Operative; Neurosurgery; Denervation; Autonomic Denervation; Sympathectomy Surgery, Operative; Neurosurgery; Denervation Removal of an autonomic or sensory ganglion by any means. Ganglia, Autonomic or specific (66-88); Sympathectomy (66-88); Sympathectomy, Chemical (84-88)  i%z.$GoGanglioglioma C04.557.465.625.600.380.350; C04.557.470.670.380.350; C04.557.580.625.600.380.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma A rare form of glioma composed of nearly mature, slowly growing neuron-like cells. It is found in the optic chiasm or cerebral white matter. (Stedman, 25th ed). Neuroblastoma (66-93) i'mYXGanglia, Sympathetic A08.340.315.350; A08.800.050.300.300; A08.800.050.800.300 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Ganglionectomy Nervous System; Ganglia; Ganglia, Autonomic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Ganglia, Autonomic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Sympathetic Nervous System Stellate Ganglion; Superior Cervical Ganglion Stellate Ganglion; Superior Cervical Ganglion Stellate Ganglion; Superior Cervical Ganglion Ganglia of the sympathetic nervous system including the paravertebral and the prevertebral ganglia. Among these are the sympathetic chain ganglia, the superior, middle, and inferior cervical ganglia, and the aorticorenal, celiac, and stellate ganglia. Ganglia, Autonomic (66-79); Sympathetic Nervous System (66-79) $i+ A8"JGanglia, Spinal A08.340.390.340; A08.800.350.340; A08.800.800.720.725.350 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Sensory Nervous System; Peripheral Nervous System; Ganglia, Sensory Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Spinal Nerve Roots Sensory ganglia located on the dorsal spinal roots within the vertebral column. The spinal ganglion cells are pseudounipolar. The single primary branch bifurcates sending a peripheral process to carry sensory information from the periphery and a central branch which relays that information to the spinal cord or brain. i.A8uGanglia, Sensory A08.340.390; A08.800.350 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia Nervous System; Peripheral Nervous System Ganglia, Spinal; Geniculate Ganglion; Nodose Ganglion; Spiral Ganglion; Trigeminal Ganglion Ganglia, Spinal; Geniculate Ganglion; Nodose Ganglion; Spiral Ganglion; Trigeminal Ganglion Clusters of neurons in the somatic peripheral nervous system which contain the cell bodies of sensory nerve axons. Sensory ganglia may also have intrinsic interneurons and non-neuronal supporting cells. i18NGanglia, Parasympathetic A08.340.315.300; A08.800.050.300.250; A08.800.050.600.300 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia; Ganglia, Autonomic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Ganglia, Autonomic Nervous System; Peripheral Nervous System; Autonomic Nervous System; Parasympathetic Nervous System Ganglia of the parasympathetic nervous system, including the ciliary, pterygopalatine, submandibular, and otic ganglia in the cranial region and intrinsic (terminal) ganglia associated with target organs in the thorax and abdomen. Ganglia, Autonomic (66-79); Parasympathetic Nervous System (66-79) i4A8  NGanglia, Invertebrate A08.340.352 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia Clusters of neuronal cell bodies in invertebrates. Invertebrate ganglia may also contain neuronal processes and non-neuronal supporting cells. Many invertebrate ganglia are favorable subjects for research because they have small numbers of functional neuronal types which can be identified from one animal to another. Ganglia (66-93) i78oGanglia, Autonomic A08.340.315; A08.800.050.300 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Ganglia Nervous System; Peripheral Nervous System; Autonomic Nervous System Ganglia, Parasympathetic; Ganglia, Sympathetic (+ 2) Ganglia, Parasympathetic; Ganglia, Sympathetic (+ 2) Clusters of neurons and their processes in the autonomic nervous system. In the autonomic ganglia, the preganglionic fibers from the central nervous system synapse onto the neurons whose axons are the postganglionic fibers innervating target organs. The ganglia also contain intrinsic neurons and supporting cells and preganglionic fibers passing through to other ganglia. i9"8lzGanglia A08.340 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System Ganglia, Autonomic (+ 4); Ganglia, Invertebrate; Ganglia, Sensory (+ 5) A general term for a group of nerve cell bodies located outside the central nervous system. It is occasionally applied to certain nuclear groups within the brain or spinal cord, e.g., BASAL GANGLIA. (Dorland, 27th ed). i=  8WGanciclovir D03.438.759.758.399.454.250.300; D20.388.009.300; D26.087.009.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Hypoxanthines; Guanine; Acyclovir Anti-Infective Agents; Antiviral Agents; Acyclovir Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Acyclovir 2-Amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6H-purin-6-one. Acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. Acyclovir/analogs and derivatives (82-89); Guanine/analogs and derivatives (82-83) i>I:1aGammaherpesvirinae B04.280.382.400; B04.909.204.210.400; B04.909.204.382.400; B04.909.574.204.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses Herpesvirus 2, Gallid; Lymphocryptovirus (+ 1); Rhadinovirus (+ 1) Herpesvirus 2, Gallid; Lymphocryptovirus (+ 1); Rhadinovirus (+ 1) Herpesvirus 2, Gallid; Lymphocryptovirus (+ 1); Rhadinovirus (+ 1) Herpesvirus 2, Gallid; Lymphocryptovirus (+ 1); Rhadinovirus (+ 1) A subfamily of HERPESVIRIDAE characterized by variable reproductive cycles. There are two official genera, LYMPHOCRYPTOVIRUS and RHADINOVIRUS, and possibly a third, as yet unnamed, which includes Marek's Disease Virus (HERPESVIRUS 2, GALLID). iBWX+>gamma-Linolenic Acid D02.241.081.436.410.450; D10.516.251.355.310.640.425; D10.516.251.355.450.450 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Linolenic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Essential; Linolenic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Linolenic Acids (Z,Z,Z)-6,9,12-Octadecatrienoic acid. An omega-6 fatty acid produced in the body as the delta 6-desaturase metabolite of linoleic acid. It is converted to dihomo-gamma-linolenic acid, a biosynthetic precursor of monoenoic prostaglandins such as PGE1. (From Merck Index, 11th ed). Linolenic Acids (80-93) iFUDFgamma-Glutamyltransferase D08.586.913.050.574 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme that catalyzes reversibly the transfer of a glutamyl group from a glutamyl-peptide and an amino acid to a peptide and a glutamyl-amino acid. EC 2.3.2.2. Acyltransferases (66-71) iJgFigamma-Glutamylcyclotransferase D08.586.913.050.550 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme that catalyzes the synthesis of pyroglutamate from a gamma-glutamyl-amino acid, also releasing the free amino acid. The enzyme acts on derivatives of glutamate, 2-aminobutyrate, alanine and glycine. The enzyme has been proposed to have a role in a gamma-glutamyl cycle for amino acid transport into cells in the intestines. EC 2.3.2.4. Acyltransferases (70-74); Glutamates (70-74); Pyrrolidonecarboxylic Acid (72-74) iLP"Fi^gamma-Glutamyl-Cysteine Synthetase D08.586.464.677.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Peptide Synthetases One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of gamma-glutamylcysteine from glutamate and cysteine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.2. Cysteine (73-76); Glutamates (73-76); Peptide Synthetases (73-76) iOR'FhOgamma-Endorphin D12.644.468.241.360; D12.776.641.650.575.241.360; D14.600.600.577.241.360 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides; Endorphins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides; Endorphins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides; Endorphins An endogenous opioid peptide derived from the pro-opiomelanocortin precursor peptide. It differs from ALPHA-ENDORPHIN by one amino acid. Opioid Peptides (80-94) iQQF~Gamma Rays H01.671.768.513.400 AECLDUHITU Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Ionizing Very powerful and penetrating, high-energy electromagnetic radiation of shorter wavelength than that of x-rays; emitted by a decaying nucleus, usually between 0.01 and 10 MeV; also called nuclear x-rays. iTTGamma Globulins D12.776.124.790.522; D12.776.377.715.440 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins Serum globulins that migrate in the gamma region on electrophoresis. At one time, gamma globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. iVW.DbGamma Cameras E07.420 CLECHISDSNSTTDUTVE Scintillation Counting; Radionuclide Imaging; Tomography, Emission-Computed Equipment and Supplies Electronic instruments that produce photographs or cathode-ray tube images of the gamma-ray emissions from organs containing radionuclide tracers. Radiometry (66-72); Radionuclide Imaging/instrumentation (66-89); Scintillation Counting (79-89)  iY0 VpGametogenesis G08.520.310 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction Oogenesis (+ 1); Spermatogenesis (+ 1) The first phase of sexual reproduction which involves the transforming of certain cells in the parent into specialized reproductive cells. i[G1Gamete Intrafallopian Transfer E05.820.500 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fertilization Miscellaneous Techniques (Non MeSH); Reproduction Techniques A technique that came into use in the mid-1980's for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes. Embryo Transfer (85-88); Fallopian Tubes (85-88); Fertilization in Vitro (85-88); Insemination, Artificial (85-88)  i\$"GGames, Experimental F04.669.880.402.360; H01.548.490.356 Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Theoretical Techniques (Non MeSH); Game Theory Physical Sciences (Non MeSH); Mathematics; Game Theory Games designed to provide information on hypotheses, policies, procedure or strategies. i_f*fGame Theory F04.669.880.402; H01.548.490 Decision Making; Operations Research Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Theoretical Techniques (Non MeSH) Physical Sciences (Non MeSH); Mathematics Games, Experimental Games, Experimental A mathematical theory that deals with action in a conflict situation as if it were a game in which each player seeks to maximize his opponent's losses. Group Processes (66-68); Interpersonal Relations (66-68); Operations Research (66-68)  ia ",.eGambling F01.145.722.408; F03.709.597.460.372 PX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Risk-Taking Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Impulse Control Disorders An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money. ic *Gambia Z01.058.290.190.300 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western ien _Galvanic Skin Response F02.830.702.315; F04.669.332; G10.795.261 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Reflex Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH) Digestive, Oral, Skin Physiology (Non MeSH); Skin Physiology (Non MeSH) A change in electrical resistance of the skin, occurring in emotion and in certain other conditions. if1 xGallopamil D02.092.471.683.953.395; D18.097.953.395; D18.192.953.395; D18.918.173.950.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Verapamil Cardiovascular Agents; Anti-Arrhythmia Agents; Verapamil Cardiovascular Agents; Calcium Channel Blockers; Verapamil Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers; Verapamil alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)benzeneacetonitrile. Coronary vasodilator which is an analog of iproveratril (verapamil) with one more methoxy group on the benzene ring. Iproveratril (73-74) ihX:: Gallium Radioisotopes D01.496.360.400; D01.496.749.360 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Gallium Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of gallium that decay or disintegrate emitting radiation. Ga atoms with atomic weights 63-68, 70 and 72-76 are radioactive gallium isotopes. Gallium (66-74); Radioisotopes (66-74) ik>&4/Gallium Isotopes D01.496.360 Inorganic Chemicals (Non MeSH); Isotopes Gallium Radioisotopes Stable gallium atoms that have the same atomic number as the element gallium, but differ in atomic weight. Ga-71 is a stable gallium isotope. Gallium (66-74); Isotopes (74); Radioisotopes (66-73) ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  imJ2B4Gallium D01.268.334; D01.552.289 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals io :`Gallic Acid D02.241.223.106.505.350; D02.241.511.390.350; D02.755.410.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids Propyl Gallate Propyl Gallate Propyl Gallate ioE:,5Gallbladder Neoplasms C04.588.274.120.401; C06.130.320.401; C06.130.564.401; C06.240.120.401 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Biliary Tract Neoplasms Digestive System Diseases; Biliary Tract Diseases; Biliary Tract Neoplasms Digestive System Diseases; Biliary Tract Diseases; Gallbladder Diseases Digestive System Diseases; Digestive System Neoplasms; Biliary Tract Neoplasms iqPXqGallbladder Emptying G10.261.470 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) A process whereby bile is delivered from the gallbladder into the duodenum. The emptying is caused by both contraction of the gallbladder and relaxation of the sphincter mechanism at the choledochal terminus. Gallbladder (75-91) itLcGallbladder Diseases C06.130.564 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Cholecystitis; Cholelithiasis; Gallbladder Neoplasms BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI ivN;=XGallbladder A03.159.439 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Cholecystectomy; Cholecystography; Cholecystostomy Digestive System; Biliary Tract consider also terms at CHOLECYST-. iw8:'+Gallamine Triethiodide D02.092.102.400; D02.675.276.400; D14.100.120.200.600.270; D16.700.710.575.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents A synthetic nondepolarizing blocking drug. The actions of gallamine triethiodide are similar to those of TUBOCURARINE, but this agent blocks the cardiac vagus and may cause sinus tachycardia and, occasionally, hypertension and increased cardiac output. It should be used cautiously in patients at risk from increased heart rate but may be preferred for patients with bradycardia. (From AMA, Drug Evaluations Annual, 1992, p.198). ixX:Galanthamine D03.132.369; D08.373.275.467; D14.100.120.300.310; D16.050.675.280 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A cholinesterase inhibitor. It has been used to reverse the muscular effects of gallamine and tubocurarine and has been studied as a treatment for Alzheimer's disease and other central nervous system disorders. i}5L@Galago B02.649.801.700.572.408 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Strepsirhini; Lorisidae A genus of the family Lorisidae having four species which inhabit the forests and bush regions of Africa south of the Sahara and some nearby islands. The four species are G. alleni, G. crassicaudatus, G. demidovii, and G. senegalensis. There is another genus, Euoticus, containing two species which some authors have included in the Galago genus. Anthropoidea (66-74) i~ (CGalactosyltransferases D08.586.913.400.450.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases Glycoprotein 4-beta-Galactosyltransferase; Lactose Synthase (+ 1) Enzymes that catalyze the transfer of galactose from a nucleoside diphosphate galactose to an acceptor molecule which is frequently another carbohydrate. EC 2.4.1.-. Galactose (72-75); Hexosyltransferases (72-75)  iFK7Galactosylceramides D10.516.390.470.213.450; D10.516.808.530.288.450 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids; Cerebrosides Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids; Cerebrosides Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. Ceramides (72-78); Cerebrosides (66-78); Glycosphingolipids (75-78) iS6BFPGalactosylceramidase D08.586.277.450.410.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Galactosidases An enzyme that hydrolyzes galactose from ceramide monohexosides. EC 3.2.1.46. Cerebrosides (72-74); Galactose (72-74); Glycoside Hydrolases (72-74) iF~\SGalactosides D09.203.408.320 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Methylgalactosides; Nitrophenylgalactosides; Thiogalactosides (+ 1) Glycosides formed by the reaction of the hydroxyl group on the anomeric carbon atom of galactose with an alcohol to form an acetal. They include both alpha- and beta-galactosides. Galactose (66-74); Glycosides (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $iN>YM.DGalactosidases D08.586.277.450.410 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gangliosidoses Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases alpha-Galactosidase; beta-Galactosidase; Ceramide Trihexosidase; Galactosylceramidase A family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage.  iFl`iGalactosephosphates D09.203.894.417.370 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates Phosphoric acid esters of galactose. Galactose (66-77); Hexosephosphates (66-77) i>t-4Galactosephosphate Uridylyltransferase D08.586.913.696.445.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases An enzyme that catalyzes the synthesis of UDPgalactose from UTP and galactose-1-phosphate. It is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. EC 2.7.7.10. Galactose (74); Hexosephosphates (74); Nucleotidyltransferases (74); Uracil Nucleotides (74) i+FInGalactosemia C18.452.648.202.355 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Galactokinase Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors An inborn error of galactose metabolism due to congenital deficiency of the enzyme galactosyl-1-phosphate uridyltransferase, resulting in tissue accumulation of galactose 1-phosphate. It is manifested by nutritional failure, hepatosplenomegaly with cirrhosis, cataracts, mental retardation, galactosuria, aminoaciduria, and albuminuria which regress or disappear if galactose is removed from the diet. (Stedman, 25th ed). iLGalactose Oxidase D08.586.682.047.210 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme that oxidizes galactose in the presence of molecular oxygen to D-galacto-hexodialdose. It is a copper protein. EC 1.1.3.9. Alcohol Oxidoreductases (66-77); Galactose (66-74) i*Ft<Galactose Dehydrogenases D08.586.682.047.150.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases D-Galactose:NAD(P)+ 1-oxidoreductases. Catalyzes the oxidation of D-galactose in the presence of NAD+ or NADP+ to D-galactono-gamma-lactone and NADH or NADPH. Includes EC 1.1.1.48 and EC 1.1.1.120. Alcohol Oxidoreductases (66-77) iF%Galactose D09.203.546.359.377 AAADAEAGAIANBICFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses iW BiGalactosaminidase D08.586.277.450.483.356 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Hexosaminidases Glycoside Hydrolases (66-70) iEF"Galactosamine D09.203.067.342.356 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines Acetylgalactosamine Hexosamines (66-70) iDkGalactorrhea C13.703.844.506.389; C19.146.556.439 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lactation Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Puerperal Disorders; Lactation Disorders Endocrine Diseases; Breast Diseases; Lactation Disorders Excessive or spontaneous flow of milk. The milk secretion persists irrespective of nursing. (Dorland, 27th ed). i*LGalactokinase D08.586.913.696.620.240 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Galactosemia Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes reversibly the formation of galactose 1-phosphate and ADP from ATP and D-galactose. Galactosamine can also act as the acceptor. A deficiency of this enzyme results in GALACTOSEMIA. EC 2.7.1.6. Galactose (66-78); Phosphotransferases (66-73); Phosphotransferases, ATP (74-78)  iF^Galactans D09.203.698.360 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Agar Polysaccharides composed of repeating galactose units. They can consist of branched or unbranched chains in any linkages. Galactose (66-78); Polysaccharides (66-78)  iy @^3Gait E01.706.437; G11.427.614.389 DEGEIMPHRE Locomotion Diagnosis; Physical Examination Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement Manner or style of walking. i,"$Gagging C23.888.821.414; G11.561.730.251 DEPHRE Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Contraction of the constrictor muscle of the pharynx elicited by stimulation of sensory receptors on the soft palate, by psychic stimuli, or systemically by drugs. Reflex (66-70) i^ & Gadolinium D01.268.558.225; D01.552.550.344 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Gadolinium. An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors. i&:Gabon Z01.058.290.100.380 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central i _Gabexate D02.078.370.380; D08.373.745.800.380; D19.461.119.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants 4-((6-((Aminoiminomethyl)amino)-1-oxohexyl)oxy)benzoic acid ethyl ester. A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin. Anticoagulants (66-91); Guanidines (66-91); Protease Inhibitors (79-89); Serine Proteinase Inhibitors (90-91) iB =:2GABA Modulators D14.100.240.500 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anesthetics, General; Anti-Anxiety Agents, Benzodiazepine; Sedatives, Barbiturate Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents Alprazolam; Amobarbital; Barbital; Bromazepam; 4-Butyrolactone; Chlordiazepoxide; Chlormethiazole; Clonazepam; Clorazepate Dipotassium; Diazepam (+ 1); Estazolam; Flumazenil; Flunitrazepam; Flurazepam; Hexobarbital; Lorazepam; Medazepam; Mephobarbital; Midazolam; Nitrazepam; Oxazepam; Pentobarbital; Phenobarbital; Prazepam; Secobarbital; Temazepam; Thiopental; Triazolam Substances that do not act as agonists or antagonists but do affect the GABA receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of GABA-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. General anesthetics probably act at least partly by potentiating GABAergic responses, but they are not included here. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $iJ8]|DGABA Antagonists D14.100.240.300 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents Allylglycine; Bicuculline; Picrotoxin Drugs that bind to but do not activate GABA receptors, thereby blocking the actions of endogenous GABA or GABA agonists. GABA/antagonists and inhibitors (74-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $i54|-/:GABA Agonists D14.100.240.200 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents Baclofen; Muscimol Drugs that bind to and activate GABA receptors (RECEPTORS, GABA). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ib4|P:GABA Agents D14.100.240 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR GABA Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) GABA Agonists (+ 2); GABA Antagonists (+ 3); GABA Modulators (+ 29); 3-Mercaptopropionic Acid Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function. GABA/pharmacology (72-94) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (i4ktDGABA D02.241.081.161.125.439; D12.125.190.522; D14.600.050.350 AAADAEANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR GABA Agents; Receptors, GABA Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates; Aminobutyric Acids Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Aminobutyric Acids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Amino Acid Neurotransmitters Baclofen The most common inhibitory neurotransmitter in the central nervous system. Aminobutyric Acids (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (iAB$RX FG-Proteins D12.776.543.350 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins ras Proteins (+ 2); Transducin The mediators of activated cell-surface receptors and their enzymes or of ion channels. They are responsible for activating a chain of events that alters the concentration of intracellular signaling molecules (i.e., intracellular messengers) such as cyclic AMP and Ca2+. In turn, these intracellular messengers alter the behavior of other target proteins within the cell. Adenyl Cyclase (68-84); Carrier Proteins (66-84); Guanine Nucleotides (66-84); Guanosine Triphosphate (72-84); Receptors, Endogenous Substances (73-84) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $i$Z(HG(M3) Ganglioside D10.516.390.470.440.410; D10.516.808.530.490.510 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids; Gangliosides Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids; Gangliosides N-Acetylneuraminyl-galactosyl-glucosylceramide. This ganglioside is present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G(M3):UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G(M2) ganglioside from G(M3) ganglioside and is the cause of an anabolic sphingolipidosis. Gangliosides (66-76) if6DG(M2) Ganglioside D10.516.390.470.440.400; D10.516.808.530.490.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Sandhoff Disease; Tay-Sachs Disease Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids; Gangliosides Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids; Gangliosides N-acetylgalactosaminyl-galactosyl-(N-acetylneuraminyl)-glucosyl-ceramide. This is the defective ganglioside manifested in Tay-Sachs disease and Sandhoff disease. Gangliosides (74)  iį6D+G(M1) Ganglioside D10.516.390.470.440.390; D10.516.808.530.490.390 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Gangliosidosis G(M1) Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids; Gangliosides Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids; Gangliosides Galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)- galactosyl-glucosylceramide. Ganglioside present in abnormally large amounts in neurons and in elevated levels in liver and kidney due to a deficiency of beta-galactosidase in the genetically determined disease GM1-gangliosidosis. Gangliosides (66-76)  iC6BBG Suits E07.390 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Double-layered inflatable suits which, when inflated, exert pressure on the lower part of the wearer's body. The suits are used to improve or stabilize the circulatory state, i.e., to prevent hypotension, control hemorrhage, and regulate blood pressure. The suits are also used by pilots under positive acceleration. Clothing (66-74); Protective Clothing (70-74) iT  q7Fuzzy Logic H01.770.461.250; K01.752.448.250; L01.700.568.110.065.250 Physical Sciences (Non MeSH); Science; Models, Theoretical Humanities; Philosophy; Logic Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Artificial Intelligence Approximate, quantitative reasoning that is concerned with the linguistic ambiguity which exists in natural or synthetic language. At its core are variables such as good, bad, and young as well as modifiers such as more, less, and very. These ordinary terms represent fuzzy sets in a particular problem. Fuzzy logic plays a key role in many medical expert systems. Logic (77-92); Models, Theoretical (74-92) ipA4Fusobacterium nucleatum B03.440.425.410.194.389.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae; Fusobacterium A species of gram-negative, anaerobic, rod-shaped bacteria isolated from the gingival margin and sulcus and from infections of the upper respiratory tract and pleural cavity. Fusobacterium (77-91) i"Fusobacterium necrophorum B03.440.425.410.194.389.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae; Fusobacterium A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood. Fusobacterium (66-74) i"Fusobacterium Infections C01.252.400.110.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Bacteroidaceae Infections Infections with bacteria of the genus FUSOBACTERIUM. Fusobacterium (66-67) iP?Fusobacterium B03.440.425.410.194.389 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae Fusobacterium necrophorum; Fusobacterium nucleatum A genus of gram-negative, anaerobic, rod-shaped bacteria found in cavities of humans and other animals. No endospores are formed. Some species are pathogenic and occur in various purulent or gangrenous infections. iէ":Fusion Proteins, gag-pol D12.776.964.775.350.325; D12.776.964.775.375.325; D12.776.964.970.850.350.325; D12.776.964.970.850.375.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, gag Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, pol Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins; Gene Products, gag Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins; Viral Core Proteins; Gene Products, pol Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting. Retroviridae Proteins (86-89); Viral Proteins (80-85) itFZ@Fusion Proteins, gag-onc D12.776.677.500.320; D12.776.677.520.750.320; D12.776.964.690.320; D12.776.964.700.750.320; D12.776.964.775.350.320; D12.776.964.775.750.320 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Fusion Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Fusion Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Retroviridae Proteins, Oncogenic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Gene Products, gag Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Retroviridae Proteins; Retroviridae Proteins, Oncogenic Oncogene Protein p65(gag-jun) Oncogene Protein p65(gag-jun) Oncogene Protein p65(gag-jun) Oncogene Protein p65(gag-jun) Oncogene Protein p65(gag-jun) Oncogene Protein p65(gag-jun) General name for the translation products of a fusion mRNA consisting of a gag gene and a viral oncogene (v-onc). These products are thought to have the ability to transform cells. Retroviridae Proteins (86-89); Viral Proteins (80-85)  iܰF>@Fusion Proteins, bcr-abl D12.776.624.100; D12.776.677.500.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Philadelphia Chromosome Genes, abl; Proto-Oncogene Proteins c-abl Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Neoplasm Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Fusion Translation products of a fusion mRNA derived from the breakpoint cluster region (bcr) gene and a cellular abl (c-abl) gene translocated to chromosome 22. The p210(bcr-abl) fusion protein is found in patients with chronic myelogenous leukemia. The p190(bcr-abl) fusion protein is found in patients with acute lymphocytic leukemia. The activation of human c-abl by chromosomal translocation is essentially the same as the activation of murine c-abl by viral translocation in Abelson murine leukemia virus. Neoplasm Proteins (86-89) $i*F2KFusidic Acid D04.808.247.222.222.347.389; D04.808.247.808.489; D20.085.351 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestadienes; Cholestadienols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Anti-Infective Agents; Antibiotics iDE<Fused Teeth C07.650.800.370; C07.793.700.370; C16.131.850.800.370 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Two teeth united during development by the union of their tooth germs; the teeth may be joined by the enamel of their crowns, by their root dentin, or by both. i=LFFusarium B05.354.381.546.366 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes i "NFusaric Acid D03.066.707.200; D03.383.725.705.200; D14.100.150.600.300 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Picolinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolinic Acids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis. Picolinic Acids (69-74) i=A@cFurylfuramide D02.640.600.330; D03.383.312.649.330; D26.471.385.379 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives alpha-2-Furyl-5-nitro-2-furanacrylamide. Used formerly as antimicrobial food additive; causes mutations in many cell cultures and may be carcinogenic. Synonym: AF2. Acrylamides (73-77); Acrylates (66-72); Nitrofurans (66-77) i^=.HFurunculosis C01.252.410.868.820.270; C01.252.825.770.270; C01.539.800.720.770.270; C17.800.838.765.770.270 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Carbuncle Carbuncle Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections; Staphylococcal Skin Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections Carbuncle Carbuncle Carbuncle Carbuncle An infection where furuncles are present over a period of weeks to months. Species of STAPHYLOCOCCUS are usually the causative agents. $ihP  .Fursultiamin D03.383.742.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines N-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-1-methyl-2-(((tetrahydro-2-furanyl)methyl)dithio)-1-butenyl)formamide. Compound used for therapy of thiamine deficiency. It may have analgesic or antipyretic properties. Disulfides (73-74); Furans (73-74); Pyrimidines (73-74) io:WDFurosemide D02.065.884.725.300; D02.886.590.700.725.300; D19.770.224.516.488 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides; Sulfanilamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides; Sulfanilamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl 5-(Aminosulfonyl)-4-chloro-2-((furanylmethyl)amino)benzoic acid. A sulfamyl saluretic and diuretic. It has a fast onset and short duration of action and is used in edema and chronic renal insufficiency. iI:<Furcation Defects C07.465.714.204 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Conditions in which a bifurcation or trifurcation of the molar tooth root becomes denuded as a result of periodontal disease. It may be followed by tooth mobility, temperature sensitivity, pain, and alveolar bone resorption. Tooth Root (66-93) ilNHFurazolidone D02.640.600.313; D03.383.312.649.313; D20.187.298; D20.237.649.313; D21.370.370.313 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Anti-Infective Agents; Anti-Infective Agents, Local Anti-Infective Agents; Anti-Infective Agents, Urinary; Nitrofurans Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antitrichomonal Agents iq_:Furans D03.383.312 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) 4-Butyrolactone; Citraconic Anhydrides; Furaldehyde; Maleic Anhydrides; Monensin; Nafronyl; Nitrofurans (+ 10); Ranitidine AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR j 8GDFuraldehyde D02.047.466; D03.383.312.355 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans jQ":Furagin D02.640.600.308; D03.383.312.649.308; D20.187.277 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Anti-Infective Agents; Anti-Infective Agents, Local 1-[3-(5-Nitro-2-furyl)allylidenamino]hydantoin. Nitrofuran derivative anti-infective agent used for urinary tract infections. Synonyms: F 35. Hydantoins (66-77); Nitrofurans (66-77) j\ 9:0Fura-2 D03.383.548.285; D03.438.127.250; D26.241.630; D26.408.348.530 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzofurans Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes 2-(6-(Bis(carboxymethyl)amino)-5-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)-2-benzofuranyl)-5-oxazolecarboxylic acid. A fluorescent calcium chelating agent which is used to study intracellular calcium in many tissues. The fluorescent and chelating properties of Fura-2 aid in the quantitation of endothelial cell injury, in monitoring ATP-dependent calcium uptake by membrane vesicles, and in the determination of the relationship between cytoplasmic free calcium and oxidase activation in rat neutrophils. Benzofurans (66-90); Chelating Agents (66-90); Fluorescent Dyes (66-90); Oxazoles (66-90) j H.=TlFunnel Chest C05.116.099.386; C05.660.386; C16.131.621.386 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) A developmental anomaly in which the lower sternum is posteriorly dislocated and concavely deformed, resulting in a funnel-shaped thorax. j W5LFungicides, Industrial D05.723.288 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Fungi; Antifungal Agents Environmental Pollutants, Pesticides (Non MeSH); Pesticides Alkylmercury Compounds (+ 3); Benomyl; Captan; Carboxin; Chloranil; Dinitrophenols; Hexachlorobenzene; Maneb; Phenylmercury Compounds (+ 1); Thiophanate; Thiram; Zineb; Ziram Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. Antifungal Agents (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (j 8F:Fungi B05.354 CHCLCYDEENGDGEIMIPMEPHPYREULVI Antifungal Agents; Fungicides, Industrial Allergens; Microbiology Algae and Fungi (Non MeSH) Ascomycetes (+ 17); Basidiomycetes (+ 9); Blood-Borne Pathogens; Dermatophytes (+ 3); Deuteromycetes (+ 38); Myxomycota (+ 3); Phycomycetes (+ 11); Pneumocystis carinii; Yeasts (+ 14) consider also terms at MYCO-. CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI (j  "1"&&Fungemia C01.539.757.720.360; C01.703.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia Bacterial and Fungal Diseases (Non MeSH); Mycoses The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy. Mycoses (66-91); specific fungal infection (66-91) j &P$=Fungal Vaccines D24.310.894.354 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease. j->YFungal Proteins D12.776.354 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Proteins found in any species of fungus. Fungi (66-72); Proteins (66-72) jDD3(Funeral Rites I01.076.201.450.550 CLHIPX Social Sciences; Anthropology; Anthropology, Cultural; Culture Those customs and ceremonies pertaining to the dead. j J@Fundus Oculi A09.371.729.313 Ophthalmoscopy Sense Organs; Eye; Retina j"Fundoplication E04.765.390 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Gastroesophageal Reflux; Gastric Fundus; Stomach Surgery, Operative; Surgery, Digestive System (Non MeSH) Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 27th ed). Gastroesophageal Reflux/surgery (68-94)  j$:C/.Fund Raising N03.219.463.360 CLECHILJMAMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Usually organized community efforts to raise money to promote financial programs of institutions. The funds may include individual gifts. jd[Functional Residual Capacity E01.302.796.420.810.390; G09.772.521.700.810.390 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity Expiratory Reserve Volume; Residual Volume Expiratory Reserve Volume; Residual Volume The volume of air remaining in the lungs at the end of a normal, quiet expiration. It is the sum of the residual volume and the expiratory reserve volume. Common abbreviation is FRC. j"6<dFumigation G03.850.780.200.300 AEECHILJMTSNST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control The application of smoke, vapor, or gas for the purpose of disinfecting or destroying pests or microorganisms. jFumarates D02.241.081.337.302 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids j 9 8qFumarate Hydratase D08.586.520.497.410 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the reversible hydration of fumaric acid to yield L-malic acid. It is one of the citric acid cycle enzymes. EC 4.2.1.2. Hydro-Lyases (66-72) j!%F_Fuel Oils G03.230.132.258.630.500; J01.435.723.313; J01.740.400.700.350 AEANCLECHIMIPOPSRESDSNSTTOUTVI Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Fossil Fuels; Petroleum Technology, Industry, Agriculture (Non MeSH); Fossil Fuels; Petroleum Technology, Industry, Agriculture (Non MeSH); Oils; Industrial Oils; Petroleum Liquid products burned to generate heat. They includes heating oils, stove oils, and furnace oils. j"E",vFucosyltransferases D08.586.913.400.450.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases Enzymes catalyzing the transfer of fucose from a nucleoside diphosphate fucose to an acceptor molecule which is frequently another carbohydrate, a glycoprotein, or a glycolipid molecule. Elevated activity of some fucosyltransferases in human serum may serve as an indicator of malignancy. The class includes EC 2.4.1.65; EC 2.4.1.68; EC 2.4.1.69; EC 2.4.1.89. Hexosyltransferases (72-78); Transferases (66-71) j%!F:Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase D08.586.913.400.100.200.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; N-Acetylhexosaminyltransferases; N-Acetylgalactosaminyltransferases An enzyme that catalyzes the transfer of acetylgalactosamine from UDP N-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. EC 2.4.1.40. Galactosamine (71-74); Hexosyltransferases (73-74); Oligosaccharides (70-74) j("?FYFucosidosis C10.496.600.385; C18.452.648.595.635.385; C18.452.648.625.385 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fucosidase Nervous System Diseases; Mental Retardation; Mucolipidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Mucolipidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Mucolipidosis An autosomally recessive inherited metabolic disorder in which deficiency of alpha-1-fucosidase activity results in accumulation of fucose-containing sphingolipids, glycoproteins, and mucopolysaccharides in lysosomes. Carbohydrate Metabolism, Inborn Errors (66-84); Fucose (66-84); Fucosidase (75-84)  j*EL]bFucosidase D08.586.277.450.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Fucosidosis Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases An enzyme that catalyzes the hydrolysis of an alpha L-fucoside to yield an alcohol and L-fucose. Deficiency of this enzyme can cause alpha-fucosidosis. EC 3.2.1.51. Fucose (66-74); Glycoside Hydrolases (66-74)  j.6Fl6Fucose D09.203.254.488; D09.203.546.359.313 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Deoxy Sugars Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses j0@ *DFuchs' Endothelial Dystrophy C11.204.236.438; C11.270.162.438; C16.131.410.162.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases; Corneal Dystrophies, Hereditary Eye Diseases; Eye Diseases, Hereditary; Corneal Dystrophies, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary; Corneal Dystrophies, Hereditary Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain. j1"=N'FSH D06.472.351.576.288; D06.472.734.525.343.288 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, FSH Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gonadotropins; Gonadotropins, Pituitary Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Gonadotropins, Pituitary Follicle-stimulating hormone. A gonadotropic hormone found in the pituitary tissues of mammals. It regulates the metabolic activity of ovarian granulosa cells and testicular Sertoli cells, induces maturation of Graafian follicles in the ovary, and promotes the development of the germinal cells in the testis. j4j2DgFrustration F01.470.405 Behavior and Behavior Mechanisms (Non MeSH); Emotions The motivational and/or affective state resulting from being blocked, thwarted, disappointed or defeated. j7A{Fruit B06.510.380; J01.341.492 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food Citrus Fruits Citrus Fruits j8 4X"Fructuronate Reductase D08.586.682.047.150.225 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases An enzyme that catalyzes the reversible oxidation of mannonate to fructuronate in the presence of NAD. Also reduces D-tagaturonate to D-altronate. EC 1.1.1.57. Alcohol Oxidoreductases (74); Uronic Acids (74) j9F:Fructosephosphates D09.203.894.417.313 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates Fructosediphosphates Fructose (66-70); Hexosephosphates (66-70) j;>t3Fructosediphosphates D09.203.894.417.313.300; D09.203.894.417.592.300 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates; Fructosephosphates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Hexosephosphates; Hexosediphosphates Diphosphoric acid esters of fructose. The fructose-1,6- diphosphate isomer is most prevalent. It is an important intermediate in the glycolysis process. Fructosephosphates (71-77); Hexosediphosphates (73-77) j<6>?Fructosediphosphate Aldolase D08.586.520.110.563 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Aldehyde-Lyases j?!FbFructose-1,6-Diphosphatase Deficiency C18.452.648.202.251.221 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Fructose Metabolism, Inborn Errors An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal. Hexosediphosphatase/deficiency (70-88) j@*LU,Fructose-Bisphosphatase D08.586.277.352.650.200 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the conversion of D-fructose 1,6-bisphosphate and water to D-fructose 6-phosphate and orthophosphate. EC 3.1.3.11. jDDFructose Metabolism, Inborn Errors C18.452.648.202.251 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors Fructose-1,6-Diphosphatase Deficiency; Fructose Intolerance Inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency (essential fructosuria), hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. Essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosemia, but with no clinical dysfunction; may produce a false-positive diabetes test. Carbohydrate Metabolism, Inborn Errors (66-88); Fructose (66-88)  jFs)LCQLFructose Intolerance C18.452.648.202.251.271 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Fructose Metabolism, Inborn Errors An autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (EC 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet. jJLoFructose D09.203.546.359.250; D09.203.546.465.354 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Hexoses Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Ketoses jNy .DFructokinases D08.586.913.696.620.225 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) 6-Phosphofructokinase A class of enzymes that catalyzes the phosphorylation of fructose in the presence of ATP. EC 2.7.1.-. Phosphotransferases (66-73); Phosphotransferases, ATP (74-78)  jOF{GFructans D09.203.698.350 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Inulin Polysaccharides composed of D-fructose units. Fructose (73-74); Polysaccharides (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $jQ @^ 62FFrozen Sections E05.909.262.620.530.160.260; E05.909.432.600.530.160.260 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Microtomy; Cryoultramicrotomy Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Microtomy; Cryoultramicrotomy Thinly cut sections of frozen tissue specimens prepared with a cryostat or freezing microtome. jS>[pFrozen Foods J01.409.599.437 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Technology; Food Preservation jU"_Frostbite C21.866.417 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cold Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Chilblains Damage to tissues as the result of low environmental temperatures.  jV NQPFrontal Sinusitis C08.460.692.752.387; C08.730.749.387; C09.603.692.752.387 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Respiratory Tract Diseases; Respiratory Tract Infections; Sinusitis Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Inflammation of the frontal sinus; in most cases the infection is caused by the bacteria STREPTOCOCCUS PNEUMONIAE and HAEMOPHILUS INFLUENZAE. This condition may be acute or chronic. Sinusitis (66-89) jX ANFrontal Sinus A04.531.621.387 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Respiratory System; Nose; Paranasal Sinuses One of the paired, but seldom symmetrical, air spaces located between the inner and outer compact layers of the frontal bone. jZ85Frontal Lobe A08.186.211.730.885.213.270 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex Motor Cortex; Prefrontal Cortex The anterior part of the cerebral hemisphere. j\8o'8Frontal Bone A02.835.232.781.375 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull j]p:DFrigidity C13.371.665.520; F03.126.387; F03.709.597.608.780.480 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Sex Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Psychosexual Dysfunctions Psychogenically inhibited female sexual response manifested by a variety of difficulties ranging from complete lack of sexual response to incomplete orgastic climax. j^5 =FkFriend Virus B04.820.650.730.730.900.500.225; B04.909.574.807.730.730.900.500.225; B04.909.777.731.730.730.900.500.225 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A murine leukemia virus producing leukemia of the reticulum-cell type with massive infiltration of liver, spleen, and bone marrow. It infects DBA/2 and Swiss mice. jaqAFriedreich's Ataxia C10.228.140.252.253.871.562 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases; Cerebellar Ataxia; Spinocerebellar Degeneration An autosomal recessive disease, usually with childhood onset, characterized by sclerosis of the dorsal and lateral columns of the spinal column. Ataxia, speech impairment, lateral curvature of spine, swaying and irregular movements, and paralysis of muscles, particularly lower extremities are commonly present. (From Dorland, 27th ed). jdNFriction H01.671.287 Physical Sciences (Non MeSH); Physics Surface resistance to the relative motion of one body against the rubbing, sliding, rolling, or flowing of another with which it is in contact. jg /Freund's Adjuvant D24.611.062.262 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic jhDvFreudian Theory F02.739.794.297 HI Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Philosophic formulations which are basic to psychoanalysis. Some of the conceptual theories developed were of the libido, repression, regression, transference, id, ego, superego, Oedipus Complex, etc. jilFresh Water G03.230.700.250 ANCH Water Environment and Public Health (Non MeSH); Environment; Water Water (66-71) jkc JFreons D02.455.526.439.220.300; D02.455.526.510.140.300 AEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated; Chlorofluorocarbons Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Fluorinated; Chlorofluorocarbons A group of halogenated hydrocarbons, usually based on methane, containing one or more fluorine and/or other halogen atoms. jl 64 French Guiana Z01.107.757.435 EHEP Geographicals (Non MeSH); America; South America jnN<Freezing H01.671.868.272.437 Cryopreservation; Cryoprotective Agents; Cryosurgery; Ice; Refrigeration Physical Sciences (Non MeSH); Physics; Temperature; Cold jn UFFreeze Substitution E05.760.156.260.270; E05.909.262.620.760.160.260.270; E05.909.432.600.760.160.260.270 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Preservation, Biological; Cryopreservation; Freeze Drying Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Tissue Preservation; Cryopreservation; Freeze Drying Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Tissue Preservation; Cryopreservation; Freeze Drying A modification of the freeze-drying method in which the ice within the frozen tissue is replaced by alcohol or other solvent at a very low temperature. Cryopreservation (89-92); Freeze Drying (77-92); Freezing (66-92) jo]"OFreeze Fracturing E05.909.262.620.620.260; E05.909.432.600.620.260 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Replica Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Replica Techniques Freeze Etching Freeze Etching Preparation for electron microscopy of minute replicas of exposed surfaces of the cell which have been ruptured in the frozen state. The specimen is frozen, then cleaved under high vacuum at the same temperature. The exposed surface is shadowed with carbon and platinum and coated with carbon to obtain a carbon replica. Freeze Etching (69-74)  jsr6C$zFreeze Etching E05.909.262.620.620.260.400; E05.909.432.600.620.260.400 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Replica Techniques; Freeze Fracturing Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Replica Techniques; Freeze Fracturing A replica technique in which cells are frozen to a very low temperature and cracked with a knife blade to expose the interior surfaces of the cells or cell membranes. The cracked cell surfaces are then freeze-dried to expose their constituents. The surfaces are now ready for shadowing to be viewed using an electron microscope. This method differs from freeze-fracturing in that no cryoprotectant is used and, thus, allows for the sublimation of water during the freeze-drying process to etch the surfaces. Freezing (66-68); Histological Techniques (66-68); Microscopy, Electron (66-68) jv>oT^Freeze Drying E05.760.156.260; E05.909.262.620.760.160.260; E05.909.432.600.760.160.260 AECLCTECHIISMOMTNUPXSNSTTDUTVE Desiccation Miscellaneous Techniques (Non MeSH); Preservation, Biological; Cryopreservation Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Tissue Preservation; Cryopreservation Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Tissue Preservation; Cryopreservation Freeze Substitution Freeze Substitution Freeze Substitution Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products.  j{Q"DFreemartinism C22.196.339; G05.148.630.437 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Mosaicism Animal Diseases; Cattle Diseases Genetics; Cytogenetics; Mosaicism A condition occurring in dizygotic twins of different sexes in cattle, when anastomoses of placental vessels permit interchange of hormones and cells during fetal life. The female calf is a sterile intersex due to passage of androgens from the male, and both calves are blood cell chimeras with immune tolerance, due to interchange of cells in utero. Cattle (66-69); Infertility, Female (66-69)  je"J O5Freedom I01.880.604.473.380; N03.706.437.380 Social Sciences; Sociology; Social Control, Formal; Human Rights Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights The rights of individuals to act and make decisions without external constraints. Civil Rights (68-77); Human Rights (73-77); Philosophy (66-77) j: *aMFree Radicals D01.339; D02.389 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reactive Oxygen Species Inorganic Chemicals (Non MeSH) Organic Chemicals (Non MeSH) Hydroxyl Radical; Superoxides Spin Labels (+ 1) Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Chemistry (66); Chemistry, Physical (66); Electron Spin Resonance (66) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (j8F:V:Free Radical Scavengers D26.480 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Miscellaneous Drugs and Agents (Non MeSH) Substances that influence the course of a chemical reaction by ready combination with free radicals. Among other effects, this combining activity protects pancreatic islets against damage by cytokines and prevents myocardial and pulmonary perfusion injuries. Free Radicals (67-90) jn 82*Free Association F04.754.709.437 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Psychoanalytic Therapy Spontaneous verbalization of whatever comes to mind. Association (66-68) jlf?Fraud I01.198.240.300 CLECEHHILJPCPXSNTD Social Sciences; Criminology; Crime Exploitation through misrepresentation of the facts or concealment of the purposes of the exploiter. jt ,vFrancium D01.268.271.380; D01.268.549.250; D01.552.528.328 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Metals, Alkali Inorganic Chemicals (Non MeSH); Metals; Metals, Alkali Francium. A radioactive alkali metal with the atomic symbol Fr, atomic number 87, and atomic weight 223. The mass numbers of other known isotopes are 204-213, 217-222, and 224. Its valence is +1. jk 94Francisella tularensis B03.440.400.425.340.590 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Francisella The etiologic agent of TULAREMIA in man and other warm-blooded animals. j"VFrancisella B03.440.400.425.340 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Francisella tularensis An organism frequently found in natural waters. It can be parasitic on man, other mammals, birds, and arthropods. Pasteurella (66-75)  j4"France Z01.542.286 EHEP Geographicals (Non MeSH); Europe Paris j ) Framycetin D09.203.408.051.321; D20.085.060.550.300 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Neomycin j\.<Frameshift Mutation G05.632.300 DEGEIMPHRE Genetics; Mutation A type of mutation in which a number of nucleotides not divisible by three is deleted from or inserted into a coding sequence, thereby causing an alteration in the reading frame of the entire sequence downstream of the mutation. These mutations may be induced by certain types of mutagens or may occur spontaneously. Mutation (68-90) jvFrail Elderly M01.471.116.100.540 PXSN Health Services for the Aged; Homebound Persons Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Adult; Aged Older adults or aged individuals who are lacking in general strength and are unusually susceptible to disease or to other infirmity. Aged (77-90); Aged, 80 and over (87-90); Health Services for the Aged (83-90); Health Services Needs and Demand (86-90)  j:XFragile X Syndrome C16.131.280.748.360; F03.709.346.220 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chromosome Fragile Sites Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A condition characterized genotypically by a fragile site on the X chromosome (Xq27 or Xq28). Phenotypically, affected males usually, but not invariably, are mentally retarded (IQ between 30 and 70), have speech defects, enlarged ears, jaws and hands, and frequently macro-orchidism. Female carriers are usually normal, but may exhibit some degree of mental retardation. Mental Retardation/genetics (66-82); Sex Chromosomes (68-82); X Chromosome (78-82)  j*LcFractures, Ununited C21.866.405.341 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Pseudarthrosis A fracture in which union fails to occur, the ends of the bone becoming rounded and eburnated, and a false joint occurs. (Stedman, 25th ed). jN^Fractures, Stress C21.866.405.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Fractures due to the strain caused by repetitive exercise. They are thought to arise from a combination of muscle fatigue and bone failure, and occur in situations where bone remodeling predominates over repair. The classical stress fracture is the march fracture of military personnel, in which the metatarsal undergoes repeated stress during marching. The most common sites of stress fractures are the metatarsus, fibula, tibia, and femoral neck. Fractures (66-89); Repetition Strain Injury (87-89); Stress, Mechanical (71-89) jZN^ _Fractures, Spontaneous C21.866.405.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Fractures occurring as a result of disease of a bone or from some undiscoverable cause, and not due to trauma. (Dorland, 27th ed). jN^Fractures, Open C21.866.405.279 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Fractures in which there is an external wound communicating with the break of the bone. Fractures (66-72) j\N^jFractures, Malunited C21.866.405.263 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Union of the fragments of a fractured bone in a faulty or abnormal position. If two bones parallel to one another unite by osseous tissue, the result is a crossunion. (From Manual of Orthopaedic Terminology, 4th ed). jN^Fractures, Comminuted C21.866.405.255 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures A fracture in which the bone is splintered or crushed. (Dorland, 27th ed). specific fracture (66-94); Fractures (66-94) jN^]6Fractures, Closed C21.866.405.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Fractures in which the break in bone is not accompanied by an external wound. jhN^_Fractures C21.866.405 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Callus Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Femoral Fractures (+ 2); Fractures, Closed; Fractures, Comminuted; Fractures, Malunited; Fractures, Open; Fractures, Spontaneous; Fractures, Stress; Fractures, Ununited (+ 1); Humeral Fractures; Radius Fractures (+ 1); Rib Fractures; Shoulder Fractures; Skull Fractures (+ 5); Spinal Fractures; Tibial Fractures; Ulna Fractures (+ 1) j N QFracture Healing G04.185.753.891.500 DEGEIMPHRE Callus Bone Regeneration Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration; Wound Healing The physiological restoration of bone tissue and function after a fracture. It includes CALLUS formation and normal replacement of bone tissue. Fractures (66-92); Wound Healing (66-92) $j8 2Fracture Fixation, Intramedullary E04.557.435.436.436 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Internal Fixators Surgery, Operative; Orthopedics; Fracture Fixation; Fracture Fixation, Internal Fracture Fixation (66-69); specific fracture/surgery (66-69) j*'$]HFracture Fixation, Internal E04.557.435.436 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Internal Fixators Surgery, Operative; Orthopedics; Fracture Fixation Fracture Fixation, Intramedullary The use of internal devices (metal plates, nails, rods, etc.) to hold the position of a fracture in proper alignment. Fracture Fixation (66-69) $jn!$<'Fracture Fixation E04.557.435 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE External Fixators; Orthopedic Fixation Devices Surgery, Operative; Orthopedics Fracture Fixation, Internal (+ 1) The use of metallic devices inserted into or through bone to hold a fracture in a set position and alignment while it heals.  j$7&)Fractionation E05.196.489 ISMT Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Separation of a mixture in successive stages, each stage removing from the mixture some proportion of one of the substances, as by differential solubility in water-solvent mixtures. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). jE#Fractional Precipitation H01.181.529.741.519 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Precipitation j_ZFractals H01.548.438; H01.770.461.125 HI Nonlinear Dynamics Nonlinear Dynamics Physical Sciences (Non MeSH); Mathematics Physical Sciences (Non MeSH); Science; Models, Theoretical Patterns (real or mathematical) which look similar at different scales, for example the network of airways in the lung which shows similar branching patterns at progressively higher magnifications. Natural fractals are self-similar across a finite range of scales while mathematical fractals are the same across an infinite range. Many natural, including biological, structures are fractal (or fractal-like). Fractals are related to "chaos" (see NONLINEAR DYNAMICS) in that chaotic processes can produce fractal structures in nature, and appropriate representations of chaotic processes usually reveal self-similarity over time.  j "xFoxes B02.649.147.435 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Carnivora (66-67) j ('Fox-Fordyce Disease C17.800.805.843.492.285 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sweat Gland Diseases; Miliaria Chronic pruritic disease, usually in women, characterized by small follicular papular eruptions in apocrine areas. It is caused by obstruction and rupture of intraepidermal apocrine ducts. (From Dorland, 27th ed). jNFowlpox Virus B04.280.650.160.100.300; B04.909.204.783.160.100.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Avipoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Avipoxvirus The type species of the genus AVIPOXVIRUS. It is the etiologic agent of FOWLPOX. j:cFowlpox C02.256.743.366; C22.131.321 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Animal Diseases; Bird Diseases A poxvirus infection of poultry and other birds characterized by the formation of wart-like nodules on the skin and diphtheritic necrotic masses (cankers) in the upper digestive and respiratory tracts. Poultry Diseases (66-69); Poxvirus Infections (66-69) jZ "Jy@Fowl Plague C02.782.620.375; C22.131.276 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Orthomyxoviridae Infections Animal Diseases; Bird Diseases Infection of domestic and wild fowl and other birds with avian orthomyxovirus type A. Orthomyxovirus Infections (66-69); Poultry Diseases (66-69) j"JfFFovea Centralis A09.371.729.522.436 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Retina; Macula Lutea jj:3Fourier Analysis H01.548.386 Physical Sciences (Non MeSH); Mathematics j!3Founder Effect G05.414.305 Gene Pool Genetics; Genetics, Population The principle that when a small subgroup of a larger population establishes itself as a separate and isolated entity, its gene pool carries only a fraction of the genetic diversity of the parental population. This may result in an increased frequency of certain diseases in the subgroup, especially those diseases known to be autosomal recessive. Genetics, Population (69-83); Pedigree (83-94) j%8Foundations N03.219.483.311; N03.540.630.180 CLECHILJMAOGSDSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Support (Non MeSH) Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit Organizations established by endowments with provision for future maintenance. j&[Foster Home Care E02.472.352; N02.421.143.452 CLECHILJMAMTOGPXSNSTTDUT Child Welfare Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Private families who care for neglected children or patients unable to care for themselves. jp"mFossils I01.076.368.584.311 Social Sciences; Anthropology; Anthropology, Physical; Paleontology Remains, impressions, or traces of animals or plants of past geological times which have been preserved in the earth's crust. j OFossil Fuels G03.230.132.258; J01.435 AEANCLECHIMIPOPSRESDSNSTTOUTVI Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources Technology, Industry, Agriculture (Non MeSH) Coal (+ 1); Petroleum (+ 3) Coal (+ 1); Petroleum (+ 3) Any hydrocarbon deposit that may be used for fuel. Examples are petroleum, coal, and natural gas. j-"JvFosinopril D02.705.275; D08.373.745.085.350; D12.125.072.401.623.374; D18.162.050.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Imino Acids; Proline Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors (2 alpha,4 beta)-4-Cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-L-proline. A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat. Proline/analogs and derivatives (85-92) jT:]/Fosfomycin D02.705.265; D20.085.335 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Anti-Infective Agents; Antibiotics (-)-(1R,2S)-(1,2-Epoxypropyl)phosphonic acid. Antibiotic produced by Streptomyces fradiae. Antibiotics (71-74); Ethers, Cyclic (71-74); Organophosphorus Compounds (73-74) j<jh^Foscarnet D02.241.081.038.725.200; D02.705.644.200; D20.388.760.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Phosphonoacetic Acid Organic Chemicals (Non MeSH); Organophosphorus Compounds; Phosphonoacetic Acid Anti-Infective Agents; Antiviral Agents; Phosphonoacetic Acid Dihydroxyphosphinecarboxylic acid, oxide. An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Formates (78-80); Organophosphorus Compounds (78-80); Phosphonoacetic Acid (81-92) j A:$aForssman Antigen D24.611.216.244.436 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Heterophile j6Forskolin D02.455.849.291.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant Coleus forskohlii. Has antihypertensive, positive ionotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Diterpenes (74-85); Terpenes (66-73) j :Nw-Formyltetrahydrofolates D03.438.733.631.400.800.350; D08.176.840.300; D11.786.708.328.850.350 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins; Folic Acid; Tetrahydrofolates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes; Tetrahydrofolates Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Folic Acid; Tetrahydrofolates Leucovorin Leucovorin Tetrahydrofolates which are substituted by a formyl group at either the nitrogen atom in the 5 position or the nitrogen atom in the 10 position. N(5)-Formyltetrahydrofolate is leukovorin (citrovorum factor) while N(10)-formyltetrahydrofolate is an active coenzyme which functions as a carrier of the formyl group in a number of enzymatic reactions. Citrovorum Factor (66-75) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $jCM@^DFormyltetrahydrofolate Synthetase D08.586.464.430 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme that catalyzes the formation of 10-formyltetrahydrofolate from formate and tetrahydrofolate in the presence of ATP. This enzyme has been found in pigeon liver, human erythrocytes and some microorganisms. EC 6.3.4.3. Formic Acids (69-74); Ligases (69-74); Tetrahydrofolates (72-74) jَ&FPNFormycins D13.570.685.350; D13.570.800.410; D20.085.075.480; D22.204.106.450 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Coformycin (+ 1) Coformycin Coformycin (+ 1) Coformycin (+ 1) Pyrazolopyrimidine ribonucleosides isolated from Nocardia interforma. They are antineoplastic antibiotics with cytostatic properties. Antibiotics, Antineoplastic (73-74); Ribonucleotides (73-74); Pyrimidines (73-74); Pyrimidinones (73-74); Pyrazoles (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $j L:J<Formularies, Hospital L01.178.682.192.836.535.561; N04.452.350.436 CLHIST Pharmacy and Therapeutics Committee Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Formularies Health Services Administration (Non MeSH); Organization and Administration; Formularies Formularies concerned with pharmaceuticals prescribed in hospitals. Formularies (66-67)  j2 *NFormularies, Homeopathic L01.178.682.192.836.535.435 CLHIST Homeopathy Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Formularies j Formularies, Dental L01.178.682.192.836.535.310 CLHIST Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Formularies j Formularies L01.178.682.192.836.535; N04.452.350 CLHIST Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books Health Services Administration (Non MeSH); Organization and Administration Formularies, Dental; Formularies, Homeopathic; Formularies, Hospital Formularies, Hospital Current pharmaceutical compendia including drug formulas. j* gCForms and Records Control N04.452.758.572.180 CLECHILJMTOGSNSTTDUT Medical Records Systems, Computerized Hospital Records; Medical Records; Nursing Records Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Office Management A management function in which standards and guidelines are developed for the developing, maintaining, and handling of forms and records.  j ,=Formocresols D02.047.407.518; D02.755.239.611 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes; Formaldehyde Organic Chemicals (Non MeSH); Phenols; Cresols Cresols (66-71); Formaldehyde (66-71) j&8y.Formiminoglutamic Acid D02.241.081.337.351.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Glutarates 2-(Formylazo)glutaric acid. Measurement of this acid in the urine after oral administration of histidine provides the basis for the diagnostic test of folic acid deficiency and of megaloblastic anemia of pregnancy. Azo Compounds (71-74); Glutarates (70-74) j:3Formic Acids D02.241.081.504 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Formamides (+ 1); Formates; Formic Acid Esters (+ 1) Formates (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  j8YC:Formic Acid Esters D02.241.081.504.560 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Formic Acids Diethyl Pyrocarbonate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR j8k:Formazans D02.172.600; D26.550.355 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Colored azo compounds formed by the reduction of tetrazolium salts. Employing this reaction, oxidoreductase activity can be determined quantitatively in tissue sections by allowing the enzymes to act on their specific substrates in the presence of tetrazolium salts. Azo Compounds (72-74); Formic Acids (72-74) j ,56Formates D02.241.081.504.435 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Formic Acids jH 8kFormate Dehydrogenases D08.586.682.075.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Aldehyde Oxidoreductases Flavoproteins that catalyze reversibly the reduction of carbon dioxide to formate. Many compounds can act as acceptors, but the only physiologically active acceptor is NAD. The enzymes are active in the fermentation of sugars and other compounds to carbon dioxide and are the key enzymes in obtaining energy when bacteria are grown on formate as the main carbon source. They have been purified from bovine blood. EC 1.2.1.2. Aldehyde Oxidoreductases (73-79); Formates (66-67); Formic Acids (68-79); Oxidoreductases (66-72) j-FutFormamides D02.065.463; D02.241.081.504.310 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Formic Acids Dimethylformamide Dimethylformamide AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU j&,(.Formamidase D08.586.277.087.398 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases jFfFormaldehyde D02.047.407 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Formocresols j:1Form Perception F02.463.593.373; F02.463.593.932.869.435; G11.697.911.860.622 CLDEGEPHRE Visual Acuity Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception; Space Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception Stereognosis Contrast Sensitivity; Pattern Recognition, Visual Contrast Sensitivity The sensory discrimination of a pattern shape or outline. CLDEGEIMPHRE $jE__FForestry J01.576.430 CLECEDHIISLJMAMTOGSNSTTD Trees Technology, Industry, Agriculture (Non MeSH); Industry The science of developing, caring for, or cultivating forests. Trees (66-91)  j  AKForensic Psychiatry F04.096.544.335; G02.403.642.208; I01.198.560.469; I01.880.604.583.310; N03.706.535.351 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry Social Sciences; Criminology; Forensic Medicine Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Commitment of Mentally Ill; Confidentiality (+ 1); Insanity Defense Insanity Defense Insanity Defense Commitment of Mentally Ill; Insanity Defense Psychiatry in its legal aspects. This includes criminology, penology, commitment of mentally ill, the psychiatrist's role in compensation cases, the problems of releasing information to the court, and of expert testimony. CLECEDHIISLJMAMTOGPXSNSTTD  jcrForensic Medicine G02.403.790.200; I01.198.560 CLECEDHIISLJMAMTOGSNSTTD Jurisprudence Health Occupations; Medicine; Specialties, Other (Non MeSH) Social Sciences; Criminology  Autopsy; Blood Stains; Dermatoglyphics; DNA Fingerprinting; Forensic Anthropology; Forensic Psychiatry (+ 1); Lie Detection; Paternity The application of medical knowledge to questions of law. AECLCTECEDEHHIISLJMAMOMTNUOGPXSNSTTDUTVE $j"hF,Forensic Dentistry G02.163.285; I01.198.435 CLECEDHIISLJMAMTOGSNSTTD Jurisprudence Health Occupations; Dentistry Social Sciences; Criminology The application of dental knowledge to questions of law. kEEForensic Anthropology I01.076.368.400; I01.198.560.422 CLECEDHIISLJMAMTOGSNSTTD Social Sciences; Anthropology; Anthropology, Physical Social Sciences; Criminology; Forensic Medicine Scientific study of human skeletal remains with the express purpose of identification. This includes establishing individual identity, trauma analysis, facial reconstruction, photographic superimposition, determination of time interval since death, and crime-scene recovery. Forensic anthropologists do not certify cause of death but provide data to assist in determination of probable cause. This is a branch of the field of physical anthropology and qualified individuals are certified by the American Board of Forensic Anthropology. (From Am J Forensic Med Pathol 1992 Jun;13(2):146). Forensic Medicine (66-94) k&vForelimb A13.395 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Arm Animal Terms (Non MeSH) Carpus, Animal; Wing Extremities (66-67)  kp  :Foreign-Body Reaction C21.866.392.560; C23.739.487.351 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Foreign Bodies Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation Granuloma, Foreign-Body Granuloma, Foreign-Body Chronic inflammation and granuloma formation around irritating foreign bodies. Foreign Bodies (66-71)  kD&N6[Foreign-Body Migration C21.866.392.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Foreign Bodies Migration of a foreign body from its original location to some other location in the body. k vNdnForeign Professional Personnel M01.526.407 CLEDHILJPXSDSNSTUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Foreign Medical Graduates Persons who have acquired academic or specialized training in countries other than that in which they are working. The concept excludes physicians for which FOREIGN MEDICAL GRADUATES is the likely heading. Health Manpower (68-70) CLECEDHILJOGPXSDSNSTTDUT $k $MForeign Medical Graduates M01.526.407.435; M01.526.485.810.390; N02.360.810.390 CLECHILJOGPXSDSNSTTDUT International Educational Exchange Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Foreign Professional Personnel Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Physicians Facilities, Manpower and Services (Non MeSH); Health Personnel; Physicians Physicians who hold degrees from medical schools in countries other than the ones in which they practice. Physicians (66-67)  k =(8~Foreign Bodies C21.866.392 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Bezoars; Eye Foreign Bodies; Foreign-Body Migration; Foreign-Body Reaction (+ 1) kNQ`Forehead A01.456.505.580 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Head; Face The part of the face above the eyes. Face (66-76) k (/0Forefoot, Human A01.378.592.350.300 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Leg; Foot Metatarsus; Toes (+ 1) The forepart of the foot including the metatarsals and the TOES. ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI  k(=O*Forecasting I01.320 MT Social Sciences The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. k Forearm Injuries C21.866.088.268 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Arm Injuries Radius Fractures; Ulna Fractures Injuries to the part of the upper limb of the body between the wrist and elbow. kHNb(cForearm A01.378.209.350 ABAHBSEMGDIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Arm k &5Forced Expiratory Volume E01.302.796.624.430; G09.772.521.700.646.430 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow Measure of the maximum amount of air during a forced vital capacity determination that can be expelled in a given number of seconds. It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Spirometry (66-74); Vital Capacity (69-74) kj24Forced Expiratory Flow Rates E01.302.796.624.390; G09.772.521.700.646.390 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Respiratory Airflow Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Respiratory Airflow Maximal Expiratory Flow Rate; Maximal Expiratory Flow-Volume Curves; Maximal Midexpiratory Flow Rate; Peak Expiratory Flow Rate Maximal Expiratory Flow Rate; Maximal Expiratory Flow-Volume Curves; Maximal Midexpiratory Flow Rate; Peak Expiratory Flow Rate Measurements of rates of airflow during a forced vital capacity determination. Respiratory Airflow (71-74); Spirometry (66-74)  k#2(]9Foramen Magnum A02.835.232.781.572.434 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull; Occipital Bone k)8WFootball I03.450.642.845.300 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A competitive team sport played on a rectangular field. This is the American or Canadian version of the game and also includes the form known as rugby. It does not include non-North American football (= SOCCER). Sports (66-75) k RFoot-and-Mouth Disease C02.782.687.484; C22.380 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections Animal Diseases kJkFoot Ulcer C17.800.893.592.450; C23.304.351.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Ulcer; Leg Ulcer Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases Diabetic Foot Diabetic Foot Lesion on the surface of the skin of the foot, usually accompanied by inflammation. The lesion may become infected or necrotic and is frequently associated with diabetes or leprosy. Foot Diseases (66-91); Skin Ulcer (66-91)  k *N"4Foot Rot C22.394 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases A disease of the feet of cattle and sheep, marked by decay of the hoof and an offensive discharge. It is caused by Fusobacterium necrophorum in cattle and Bacteroides nodosus in sheep. It is common in wet pastures. (Dorland, 27th ed.). Cattle Diseases (66-69); Foot Diseases (66-69); Sheep Diseases (66-69); Swine Diseases (66-69) k#  JsFoot Injuries C21.866.558.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries General or unspecified injuries involving the foot. Foot/injuries (66-94) k%Nb>Foot Diseases C23.304.351 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Podiatry Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH) Ainhum; Foot Dermatoses (+ 1); Foot Ulcer (+ 1); Immersion Foot; Tarsal Tunnel Syndrome BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  k'N _nPFoot Dermatoses C17.800.305; C23.304.351.434 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases Tinea Pedis Tinea Pedis Skin diseases of the foot, general or unspecified. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  k("N>PFoot Deformities, Congenital C05.330.495; C05.660.585.380; C16.131.621.585.380 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Foot Deformities Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Alterations or deviations from normal shape or size which result in a disfigurement of the foot occurring at or before birth. k*"9LRFoot Deformities, Acquired C05.330.488 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Foot Deformities Distortion or disfigurement of the foot, or a part of the foot, acquired through disease or injury after birth. Foot Diseases (66-70) k- L2Foot Deformities C05.330 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Clubfoot; Equinus Deformity; Flatfoot; Foot Deformities, Acquired; Foot Deformities, Congenital; Hallux Valgus Alterations or deviations from normal shape or size which result in a disfigurement of the foot. Foot/abnormalities (66-87) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $k/ Lt NFoot Bones (Non MeSH) A02.835.232.262 Musculoskeletal System; Skeleton; Bone and Bones Metatarsal Bones; Tarsal Bones (+ 2) ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI k1-;.:Foot A01.378.592.350 AHBSEMGDIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Extremities; Leg Forefoot, Human (+ 3); Heel (+ 1) The distal portion of the primate leg, upon which an individual stands and walks. It consists, in man, of the tarsus, metatarsus, and phalanges and the tissues encompassing them. (Dorland, 27th ed). ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI  k2"&5-*Food, Fortified J01.341.468 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Any food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the fortified food. The supplementation of cereals with iron and vitamins is an example of fortified food. Fortified food includes also enriched food to which various nutrients have been added to compensate for those essential nutrients removed by refinement or processing. (From Segen, Dictionary of Modern Medicine, 1992). Food (66-69) k4"=1Food, Formulated J01.341.449 AEANCLECHIMIPOPSRESDSNSTTOUTVI Enteral Nutrition Technology, Industry, Agriculture (Non MeSH); Food Food and dietary formulations. The concept includes imitation foods such as egg, meat, and dairy substitutes, nutritionally complete formulas such as elemental (chemically defined, defined formula) diets, synthetic and semisynthetic diets, space diets, weight-reduction formulas, tube-feeding diets, and complete liquid diets, and supplemental liquid and solid diets. Food (66-71); specific food (66-71)  k6"=-Food-Processing Industry J01.576.416.428 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry; Food Handling The productive enterprises concerned with food processing. k9SEFood-Drug Interactions G12.361.738 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH); Drug Interactions The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed). Drug Interactions (72-94) k: KFood Technology J01.409 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH) Food Analysis; Food Inspection; Food Labeling; Food Microbiology; Food Parasitology; Food Preservation (+ 2) The application of knowledge to the food industry. AEANCLECEDHIISLJMAMIMTOGPOPSRESDSNSTTDTOUTVI  k; 4>0Food Supply J01.387 CLECHIISLJSNST Technology, Industry, Agriculture (Non MeSH) k=~ 4Food Services J01.364 CLECHIISLJMAOGSNSTTDUT Technology, Industry, Agriculture (Non MeSH) Cooking and Eating Utensils; Food Handling (+ 2); Menu Planning; Restaurants Functions, equipment, and facilities concerned with the preparation and distribution of ready-to-eat food. CLECHIISLJMAMTOGSNSTTDUT  k= 4^{Food Service, Hospital N02.278.354.422.374; N02.421.242.472; N04.452.442.422.374 CLECHILJMAOGSDSNSTTDUT Dietetics Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Health Services; Dietary Services Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments  Menu Planning Hospital department that manages and supervises the dietary program in accordance with the patients' requirements. CLECHILJMAMTOGSDSNSTTDUT $k?A hFood Preservatives D26.471.385 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Antioxidants Miscellaneous Drugs and Agents (Non MeSH); Food Additives Butylated Hydroxyanisole; Butylated Hydroxytoluene; Diethyl Pyrocarbonate; Furylfuramide; Nisin; Sodium Nitrite; Sorbic Acid Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods. Food Additives (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (kBY,FBFood Preservation J01.409.599 CLECHIISLJMAMTSNST Maillard Reaction Technology, Industry, Agriculture (Non MeSH); Food Technology Food Irradiation; Frozen Foods AEANCLECHIISLJMAMIMTPOPSRESDSNSTTOUTVI  kDI&*Food Preferences F01.145.407.516 CLDEEHPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Feeding Behavior The selection of one food over another. Behavior (66-68); Behavior, Animal (66-68); Diet (66-68); Food (66-68) kEV2XFood Poisoning C21.613.415 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Botulism; Favism; Mushroom Poisoning; Salmonella Food Poisoning; Staphylococcal Food Poisoning BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI kGLEoPFood Parasitology G01.273.688.500; G03.850.460.400.650; J01.409.557 LJST Parasites Biological Sciences; Biology; Parasitology Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Food Contamination Technology, Industry, Agriculture (Non MeSH); Food Technology The presence of parasites in food and food products. For the presence of bacteria, viruses, and fungi in food, FOOD MICROBIOLOGY is available. Food Contamination (66-90); specific parasite (66-90)  kH9 @Food Microbiology G01.273.540.274.332; G03.850.425.200; G03.850.460.400.300; J01.409.516 LJST Biological Sciences; Biology; Microbiology; Environmental Microbiology Environment and Public Health (Non MeSH); Public Health; Environmental Microbiology Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Food Contamination Technology, Industry, Agriculture (Non MeSH); Food Technology The presence of bacteria, viruses, and fungi in food and food products. This term is not restricted to pathogenic organisms: the presence of various non-pathogenic bacteria and fungi in cheeses and wines, for example, is included in this concept. kKPo"Food Labeling E05.780.390; J01.409.433; J01.790.390 CLECHIISLJMAMTSNSTTD Miscellaneous Techniques (Non MeSH); Product Labeling Technology, Industry, Agriculture (Non MeSH); Food Technology Technology, Industry, Agriculture (Non MeSH); Product Labeling Use of written, printed, or graphic materials upon or accompanying a food or its container or wrapper. The concept includes ingredients, nutritional value, directions, warnings, and other relevant information. kN3-Food Irradiation J01.409.599.309 AECLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Food Technology; Food Preservation kPo_Food Inspection G03.850.780.200.800.325; J01.409.350 ECHIISLJMTSNSTTD Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation Technology, Industry, Agriculture (Non MeSH); Food Technology Examination of foods to assure wholesome and clean products free from unsafe bacteria or chemical contamination, natural or added deleterious substances, and decomposition during production, processing, packaging, etc. kQ-*Food Hypersensitivity C20.543.480.370 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate Milk Hypersensitivity Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens ingested in food. kSLMFood Handling J01.364.434; J01.576.416 CLECHIISLJMAMTSNST Maillard Reaction Technology, Industry, Agriculture (Non MeSH); Food Services Technology, Industry, Agriculture (Non MeSH); Industry Cookery; Food Dispensers, Automatic Cookery; Food Dispensers, Automatic; Food-Processing Industry; Restaurants Any aspect of the operations in the preparation, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food. CLECEDHIISLJMAMTOGSNSTTDUT $kU Food Habits F01.145.407.432; F01.145.466.349 CLDEEHPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Feeding Behavior Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits Acquired or learned food preferences. Diet (66-68); Ethnology (66-68); Food (66-68); Nutrition Surveys (66-68) kW\&.ZFood Dispensers, Automatic J01.364.434.420; J01.576.416.420 CLECHIISLJSNSTUT Technology, Industry, Agriculture (Non MeSH); Food Services; Food Handling Technology, Industry, Agriculture (Non MeSH); Industry; Food Handling Mechanical food dispensing machines. kX &,Food Deprivation F01.658.433 PH Fasting; Hunger; Starvation Behavior and Behavior Mechanisms (Non MeSH); Motivation The withholding of food in a structured experimental situation. Hunger (66-68); Motivation (66-68)  kZC#CL+Food Contamination, Radioactive G03.850.810.125; G03.850.460.400.250 ANECLJPCSN Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Food Contamination k[u%*Food Contamination G03.850.460.400 ANECLJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Food Contamination, Radioactive; Food Microbiology; Food Parasitology The presence in food of harmful, unpalatable, or otherwise objectionable foreign substances, e.g. chemicals, microorganisms or diluents, before, during, or after processing or storage. ANECLJPCSNST  k\`QFood Coloring Agents D26.471.355 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Dyes Miscellaneous Drugs and Agents (Non MeSH); Food Additives Canthaxanthin; Carmine; Tartrazine Natural or synthetic dyes used as coloring agents in processed foods. Food Additives (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (k^,F*T<Food Analysis E05.362; J01.409.266 CLECHIISLJMAMTSNST Miscellaneous Techniques (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Food Technology k`rqFood Additives D26.471; J01.341.430 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Pharmaceutic Aids Miscellaneous Drugs and Agents (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Food Food Coloring Agents (+ 3); Food Preservatives (+ 7); Sodium Glutamate Substances which are of little or no nutritive value, but are used in the processing or storage of foods or animal feed, especially in the developed countries; includes ANTIOXIDANTS, FOOD PRESERVATIVES, FOOD COLORING AGENTS, FLAVORING AGENTS, ANTI-INFECTIVE AGENTS (both plain and LOCAL), VEHICLES, EXCIPIENTS and other similarly used substances. Many of the same substances are PHARMACEUTIC AIDS when added to pharmaceuticals rather than to foods. AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $kaD,mYBFood J01.341 AECLECHIRESNSTTOUT Diet; Plants, Edible Nutrition Technology, Industry, Agriculture (Non MeSH) Animal Feed (+ 2); Bread; Cacao; Candy; Cereals (+ 7); Chewing Gum; Condiments (+ 10); Crops, Agricultural; Dairy Products (+ 5); Dietary Fiber; Eggs (+ 2); Flavoring Agents (+ 2); Flour; Food Additives; Food, Formulated; Food, Fortified; Fruit (+ 1); Honey; Infant Food; Margarine; Meat (+ 1); Molasses; Nuts (+ 2); Poultry Products; Seafood (+ 4); Seeds; Vegetables (+ 12) Anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. (Dorland, 27th ed). ADAEAGAHAIANBIBLCFCHCLCSCTCYDEDFDUECEMENGDGEHIIMIPMEMIPAPDPHPKPOPSRARERISDSESNSTTOTRTUULURUSUTVI (kd  4dFontan Procedure E04.035.410.295; E04.752.376.410.295; E04.920.490.475.295 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Tricuspid Atresia Surgery, Operative; Anastomosis, Surgical; Heart Bypass, Right Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery; Heart Bypass, Right Surgery, Operative; Thoracic Surgery; Heart Surgery; Heart Bypass, Right A procedure in which total right atrial or total caval blood flow is channeled directly into the pulmonary artery or into a small right ventricle that serves only as a conduit. The principal congenital malformations for which this operation is useful are TRICUSPID ATRESIA and single ventricle with pulmonary stenosis. Heart Defects, Congenital/surgery (77-94)  khA$ u1Follow-Up Studies E05.318.760.500.750.500.350; G03.850.520.835.500.750.350; N05.715.360.775.175.250.350 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies; Longitudinal Studies Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH); Cohort Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. kk]Folliculitis C17.800.805.305.383 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases Acne Keloid Inflammation of follicles, primarily hair follicles. koNz>Follicular Phase G08.520.440.310 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle Follicular Atresia The period of the menstrual cycle that begins with menstruation and ends with ovulation. kq)[jFollicular Fluid A05.360.319.114.630.535.150; A06.407.312.497.535.150; A12.207.415 CHCYDEENIMMEMIPHPSRARERISEUSVI Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri; Ovary; Graafian Follicle Endocrine System (Non MeSH); Endocrine Glands; Gonads; Ovary; Graafian Follicle Fluids and Secretions (Non MeSH); Body Fluids A fluid consisting of sex steroid hormones, plasma proteins, mucopolysaccharides, and electrolytes that is present in the vesicular ovarian follicle (Graafian follicle) surrounding the ovum. Body Fluids (66-89); Graafian Follicle (66-89) krnI"9Follicular Cyst C04.182.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Cyst due to the occlusion of the duct of a follicle or small gland. ku(VUFollicular Atresia G08.520.440.310.358 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle; Follicular Phase The degeneration and resorption of an ovarian follicle before it reaches maturity and ruptures. Graafian Follicle (66-84); Ovulation (66-84) kv/pq6Folklore I01.076.201.450.515 Social Sciences; Anthropology; Anthropology, Cultural; Culture The common orally transmitted traditions, myths, festivals, songs, superstitions, and stories of all peoples. kw JFolic Acid Deficiency C18.654.223.133.699.308 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anemia, Sideroblastic; FIGLU Test Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency A nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. (Merck Manual, 16th ed, p. 1160). kxN)Folic Acid Antagonists D22.204.144.579; D26.087.393 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Aminopterin (+ 1); Trimetrexate Aminopterin (+ 1); Trimethoprim; Trimetrexate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR k}5"6^:Folic Acid D03.438.733.631.400; D11.786.708.328; D19.461.543.349 AAADAEAGANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics Pteroylpolyglutamic Acids; Tetrahydrofolates (+ 2) Pteroylpolyglutamic Acids; Tetrahydrofolates (+ 2) N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses. Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  k =B$uFFocus Groups E05.318.308.420.200; F01.829.316.137; G03.850.520.308.420.200; L01.280.520.200; N05.715.360.300.400.350 MTSTUT Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Interviews Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Interviews Information Science; Data Collection; Interviews Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Interviews A method of data collection and a qualitative research tool in which a small group of individuals are brought together and allowed to interact in a discussion of their opinions about topics, issues, or questions. Marketing of Health Services (87-92) kes ,Focal Infection, Dental C01.539.392.433; C07.793.348 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Focal Infection Stomatognathic Diseases; Tooth Diseases Secondary or systemic infections due to dissemination throughout the body of microorganisms whose primary focus of infection lies in the periodontal tissues. k_"PFocal Infection C01.539.392 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Focal Infection, Dental kHP?Focal Epithelial Hyperplasia C07.465.342 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Hyperplasia of the mucous membrane of the lips, tongue, and less commonly, the buccal mucosa, floor of the mouth, and palate, presenting soft, painless, round to oval sessile papules about 1 to 4 mm in diameter. The condition usually occurs in children and young adults and has familial predilection, lasting for several months, sometimes years, before running its course. A viral etiology is suspected, the isolated organism being usually the human papillomavirus. (Jablonski, Illustrated Dictionary of Dentistry; Belshe, Textbook of Human Virology, 2d ed, p.954). Hyperplasia (66-93); Mouth Diseases (66-93) k:"N/5Focal Dermal Hypoplasia C05.116.099.370.380; C16.131.077.350.424; C16.131.280.748.325.350; C16.131.831.350.424; C17.800.827.800.350.424 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple; Ectodermal Dysplasia Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities; Ectodermal Dysplasia Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ectodermal Dysplasia Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Ectodermal Dysplasia A genetic skin disease characterized by hypoplasia of the dermis, herniations of fat, and hand anomalies. It is found exclusively in females and transmitted as an X-linked dominant trait. Abnormalities, Multiple (68-84); Skin (66-84); Skin Diseases (66-84) k{LSFoam Cells A11.329.372.368; A11.733.397.368; A15.382.680.397.368; A15.382.812.522.368 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Lipid-laden macrophages originating from monocytes or from smooth muscle cells. Macrophages (66-76) kT*,]FMN D08.176.360; D13.695.827.349 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Riboflavin 5'-(dihydrogen phosphate). A coenzyme for a number of oxidative enzymes including NADH DEHYDROGENASE. It is the principal form in which RIBOFLAVIN is found in cells and tissues. k"HFluvoxamine D02.092.570.665.250; D14.100.600.850.290; D14.100.850.875.800.290; D15.085.025.300; D15.700.122.050.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Oximes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation 5-Methoxy-4'-(trifluoromethyl)valerophenone (E)-O-(2-aminoethyl)oxime. A selective serotonin reuptake inhibitor. It is effective in the treatment of depression, obsessive-compulsive disorders, anxiety, panic disorders, and alcohol amnestic disorders. Antidepressive Agents (79-91); Oximes (66-91); Serotonin Antagonists (78-91) k3s:[Flutamide D02.065.199.420; D06.347.065.340 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Androgen Antagonists 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide. An antiandrogen with about the same potency as cyproterone in rodent and canine species. Anilides (73-74); Nitro Compounds (73-74); Hydrocarbons, Fluorinated (74) kA &:XFluspirilene D03.383.374.290; D03.383.621.280; D04.615.885.350; D14.100.150.175.275; D15.150.315; D15.210.950.040.315; D15.700.872.331.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A long-acting injectable antipsychotic agent used for chronic schizophrenia. Fluorobenzenes (74); Piperidines (72-74); Spiro Compounds (69-74) kw:YOFlushing C23.888.398 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blushing Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Transient redness of the face and neck caused by cutaneous vasodilation due to a variety of causes, such as menopause, drugs, alcohol, and carcinoid tumors. It does not include BLUSHING. k N XFlurothyl D02.355.417.515; D15.220.224.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Ethyl Ethers Central Nervous System Agents; Central Nervous System Stimulants; Convulsants A convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy. Analeptics (66-72); Ethers (66-72) k &:+Flurbiprofen D02.241.081.751.700.350; D08.373.310.260; D16.850.015.050.280; D17.025.030.240; D17.050.030.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Propionates; Propionic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid. An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has also been proposed as an antirheumatic. Biphenyl Compounds (73-75); Fluorine (73-75); Propionates (73-75) kk:OFlurazepam D03.438.079.080.070.348; D14.100.240.500.300; D15.075.050.200; D15.210.350.800.225; D15.210.950.012.050.220; D15.325.875.275; D15.700.872.015.050.395 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine A benzodiazepine derivative used mainly as a hypnotic. Benzazepines (70-73); Benzodiazepinones (74); Hypnotics and Sedatives (67-74) k:B\Flurandrenolone D04.808.745.745.654.473; D04.808.908.537; D06.597.481.364.432; D06.597.481.561.353.520; D06.597.481.561.478.480; D17.025.050.170; D17.025.080.200.185; D23.037.200.185 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream or an ointment, and is also used as a polyethylene tape with an adhesive. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.733). k:Q"Fluprednisolone D04.808.745.432.769.795.307; D04.808.908.502; D06.597.481.561.353.744.349; D06.597.481.561.478.702.349; D17.025.050.625.250; D17.050.040.650.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols; Prednisolone Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Prednisolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic; Prednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal; Prednisolone A synthetic glucocorticoid with anti-inflammatory properties. kc:GFluphenazine D03.494.741.326; D14.100.150.175.255; D15.150.025.325; D15.210.950.040.025.325; D15.700.872.331.025.340 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of CHLORPROMAZINE. k^s:Flupenthixol D03.383.606.460; D03.494.953.704.360; D14.100.150.175.250; D15.150.300; D15.210.950.040.300; D15.700.872.331.390 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Thioxanthenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A thioxanthene neuroleptic which, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.595). Alcohol, Ethyl (70-74); Piperazines (70-74); Thioxanthenes (74) kb~:u MFluoxymesterone D04.808.054.079.429.154.349; D04.808.908.466; D06.597.100.194.289 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Androstenediols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids k3I:$Fluoxetine D02.092.831.280; D14.100.600.850.280; D14.100.850.875.800.280; D15.085.025.285; D15.700.122.050.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Propylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Phenyl Ethers (74-78); Propylamines (66-78) k o:5Fluorouracil D03.383.742.698.875.404; D22.204.144.545; D26.087.387 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Tegafur Tegafur Tegafur 5-Fluoro-2,4(1H,3H)-pyrimidinedione. A pyrimidine analog that acts as an antineoplastic antimetabolite and also has immunosuppressant. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid. kˏ=:(*Fluoroscopy E01.357.818.375 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Photofluorography Production of an image when x-rays strike a fluorescent screen. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE  kά"3M*Fluorophotometry E01.210.400; E05.196.712.382.410 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Eye (Non MeSH) Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Fluorometry Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics. Fluorometry (66-89); Photometry (66-89) k&"?0Fluorometry E05.196.712.382 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry Cytophotometry (+ 1); Fluorescence Polarization (+ 1); Fluorophotometry; Spectrometry, Fluorescence kY"SuFluorometholone D04.808.745.432.719.349; D04.808.908.431; D06.597.481.364.370; D06.597.481.561.353.500; D06.597.481.561.478.460; D17.025.050.150; D17.025.080.200.175; D23.037.200.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienediols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.732). kӈ:V+Fluoroimmunoassay E01.223.495.348.341; E05.478.588.375.341 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Fluorescent Antibody Technique Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry; Fluorescent Antibody Technique Fluorescence Polarization Immunoassay Fluorescence Polarization Immunoassay The use of fluorescence spectrometry to obtain quantitative results for the FLUORESCENT ANTIBODY TECHNIQUE. One advantage over the other methods (e.g., radioimmunoassay) is its extreme sensitivity, with a detection limit on the order of tenths of microgram/liter. Fluorescent Antibody Technique (75-88); Fluorometry (75-88); Immunoassay (75-88); Spectrometry, Fluorescence (75-88)  k1."T2Fluorodeoxyuridylate D13.695.201.200.270; D13.695.740.850.210.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides; Deoxyuracil Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides; Deoxyuracil Nucleotides 5-Fluoro-2'-deoxyuridylate. An inhibitor of thymidylate synthetase. Formed from 5-fluorouracil or 5-fluorodeoxyuridine. Deoxyribonucleotides (73-74); Fluorine (72-74); Uracil Nucleotides (72-74) kݰ2: XFluorocarbons D02.455.526.510.435 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Blood Substitutes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Fluorinated Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes. Fluorocarbon Polymers (74-76); Freons (74-76); Hydrocarbons, Fluorinated (74-76)  k[8p%_Fluorocarbon Polymers D25.720.395 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Hydrocarbons, Fluorinated Biomedical and Dental Materials (Non MeSH); Polymers Polytetrafluoroethylene (+ 1) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  k,@#.Fluorobenzenes D02.455.526.510.432 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Fluorinated k8pFluoroacetates D02.241.081.038.209.348 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetates Trifluoroacetic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR k8w:Fluorine Radioisotopes D01.496.749.340 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Fluorine (66-87); Radioisotopes (66-87) ke4C0Fluorine Compounds D01.303 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Hydrofluoric Acid (+ 6) Inorganic compounds that contain fluorine as an integral part of the molecule. Fluorine (66-93)  k 8%^Fluorine D01.268.380.300; D01.268.912.250 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Halogens Inorganic Chemicals (Non MeSH); Elements; Trace Elements Fluorine. A nonmetallic, gaseous element, belonging to the halogen group. It has the atomic symbol F, atomic number 9, and atomic weight 19. In the form of fluoride, it is incorporated into the structure of bone and teeth and provides protection against dental caries; an excess of fluorine may result in fluorosis. (From Dorland, 27th ed). kU &:Fluorides, Topical D25.223.432 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Cariostatic Agents Sodium Fluoride (+ 1); Tin Fluorides Fluorides, usually as pastes or gels, used for topical application to reduce the incidence of dental caries. k,K/Fluorides D01.248.497.158.380; D01.303.350.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKRESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Fluorine Compounds; Hydrofluoric Acid  Calcium Fluoride; Sodium Fluoride (+ 1); Sulfur Hexafluoride; Tin Fluorides Inorganic salts of hydrofluoric acid, HF, in which the fluorine atom is in the -1 oxidation state. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ko *6]8Fluoride Poisoning C21.613.380 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning GEN or unspecified fluoride; prefer /pois with specific fluoride term. kLEUFluoridation E06.761.382; G03.850.860.510.915.300; G03.890.235 AECLCTECHIISLJMAMOMTNUPXSNSTTDUTVE Cariostatic Agents Dentistry; Preventive Dentistry Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering; Water Supply Environment and Public Health (Non MeSH); Public Health Dentistry k*9&Fluorescent Treponemal Antibody-Absorption Test E01.223.495.826.895.188 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Syphilis Serodiagnosis Serologic assay that detects antibodies to Treponema pallidum, the etiologic agent of syphilis. After diluting the patient's serum to remove non-specific antibodies, the serum is mixed on a glass slide with Nichol's strain of Treponema pallidum. An antigen-antibody reaction occurs if the test is positive and the bound antibodies are detected with fluoresceinated antihuman gamma-globulin antibody. Syphilis Serodiagnosis (66-91) k6"i$Fluorescent Dyes D26.408.348 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes Acridine Orange; Acriflavine; Aminacrine; Chromomycins (+ 2); Diphenylhexatriene; Fluoresceins (+ 5); Fura-2; Hoe 33258; Quinacrine Mustard; Rhodamines Dyes that emit light when exposed to light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. They are used as markers in biochemistry and immunology. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  k,;<Fluorescent Antibody Technique E01.223.495.348; E05.478.588.375; E05.909.432.551.512.240 AECLCTECHIISMONUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytochemistry; Immunohistochemistry Antibody-Coated Bacteria Test, Urinary; Fluoroimmunoassay (+ 1) Antibody-Coated Bacteria Test, Urinary; Fluoroimmunoassay (+ 1) Test for tissue antigen using either a direct method (by conjugation of antibody with fluorescent dye) or an indirect method (by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody). The tissue is then examined by fluorescence microscopy. AECLCTECHIISMOMTNUPXSNSTTDUTVE  k$A $^"Fluorescence Polarization Immunoassay E01.223.495.348.341.350; E05.196.712.382.390.350; E05.478.588.375.341.350 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Fluorescent Antibody Technique; Fluoroimmunoassay Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Fluorometry; Fluorescence Polarization Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry; Fluorescent Antibody Technique; Fluoroimmunoassay Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations. Fluorescence Polarization (78-90); Fluorescent Antibody Technique (78-88); Fluoroimmunoassay (89-90) k+Q"UtFluorescence Polarization E05.196.712.382.390 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Fluorometry Fluorescence Polarization Immunoassay Measurement of the polarization of fluorescent light from solutions or microscopic specimens. It is used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. Fluorometry (66-78); Spectrometry, Fluorescence (72-78)  l"b+pAFluorescence H01.671.768.369 Physical Sciences (Non MeSH); Physics; Radiation The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis. l<<Fluoresceins D03.494.953.275; D04.615.885.347; D26.408.348.514; D26.550.342 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Eosine I Bluish; Eosine Yellowish-(YS); Erythrosine; Fluorescein-5-isothiocyanate; Rose Bengal Eosine I Bluish; Eosine Yellowish-(YS); Erythrosine; Fluorescein-5-isothiocyanate; Rose Bengal Eosine I Bluish; Eosine Yellowish-(YS); Erythrosine; Fluorescein-5-isothiocyanate; Rose Bengal Eosine I Bluish; Eosine Yellowish-(YS); Erythrosine; Fluorescein-5-isothiocyanate; Rose Bengal A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  l_H,T.Fluorescein-5-isothiocyanate D02.500.375.250; D02.886.250.250; D03.494.953.275.400; D04.615.885.347.400; D26.408.348.514.500; D26.550.342.400 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Isocyanates; Isothiocyanates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Isothiocyanates Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Fluoresceins Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Fluoresceins 3',6'-Dihydroxy-5-isothiocyanatospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one. Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques. Fluoresceins (66-91); Thiocyanates (66-91) l  ~.093Fluorescein Angiography E01.145.077.420; E01.210.380 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Retinal Vessels Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnosis, Eye (Non MeSH) Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature. Fluoresceins (66-72); Photography (66-72)  l"&s2Fluorescamine D04.615.885.345; D26.550.330 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 4-Phenylspiro[furan-2(3H),1'-phthalan]-3,3'-dione. A nonfluorescent reagent for the detection of primary amines, peptides and proteins. The reaction products are highly fluorescent. Synonym: Fluram. Benzofurans (74); Spiro Compounds (73-74) l".3Fluorenes D04.615.389; D26.191.372 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 2-Acetylaminofluorene (+ 2); Tilorone 2-Acetylaminofluorene (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR l/ 8M:Fluocortolone D04.808.745.432.719.320; D04.808.908.405; D06.597.481.364.325; D06.597.481.561.353.480; D17.025.050.147; D17.025.080.200.150; D23.037.200.155 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienediols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Diflucortolone Diflucortolone Diflucortolone Diflucortolone Diflucortolone Diflucortolone Diflucortolone 6 alpha-Fluoro-11 beta,21-dihydroxy-16 alpha-methylpregna-1,4-diene-3,20-diono. A topical glucocorticoid with anti-inflammatory activity used in the treatment of various skin disorders. It is used also as the acetate, caproate, and pivalate. Ketosteroids (74); Pregnadienediols (74); Steroids, Fluorinated (74)  l:rRFluocinonide D04.808.745.432.370.325; D04.808.908.394.300; D06.597.481.364.306.300; D06.597.481.561.353.460.300; D06.597.481.561.478.420.300; D17.025.050.145.250; D17.025.080.200.130.300; D23.037.200.140.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Fluocinolone Acetonide Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated; Fluocinolone Acetonide Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical; Fluocinolone Acetonide Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Fluocinolone Acetonide Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic; Fluocinolone Acetonide Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Fluocinolone Acetonide Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Fluocinolone Acetonide Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Fluocinolone Acetonide 6 alpha,9-Difluoro-11 beta,16 alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone,21-acetate. A topical glucocorticoid used in the treatment of eczemas. Acetic Acids (72-74); Fluocinolone Acetonide (72-74) lV:?Fluocinolone Acetonide D04.808.745.432.370; D04.808.908.394; D06.597.481.364.306; D06.597.481.561.353.460; D06.597.481.561.478.420; D17.025.050.145; D17.025.080.200.130; D23.037.200.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Fluocinonide Fluocinonide Fluocinonide Fluocinonide Fluocinonide Fluocinonide Fluocinonide Fluocinonide A corticosteroid used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.732). l":BrYFlunitrazepam D03.438.079.080.070.320; D14.100.240.500.292; D15.075.050.195; D15.210.950.012.050.185; D15.700.872.015.050.365 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Benzodiazepine with pharmacologic actions similar to those of DIAZEPAM. Benzodiazepinones (74); Fluorobenzenes (74); Nitro Compounds (74) l*{:TOFlunarizine D03.383.606.450; D18.192.375; D18.918.173.375 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 1-(Bis-(4-fluorophenyl)methyl) -4-cinnamylpiperazine. Flunarizine is a selective calcium entry blocker with calmodulin binding properties. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. Cinnarizine/analogs and derivatives (75-86); Piperazines (66-74) l.:5:kLFlumethasone D04.808.745.432.769.465; D04.808.908.359; D06.597.481.561.353.431; D06.597.481.561.478.403; D17.025.050.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal An anti-inflammatory glucocorticoid used in veterinary practice. l1pw:KFlumazenil D03.438.079.080.070.305; D14.100.240.500.285; D26.061.380 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Miscellaneous Drugs and Agents (Non MeSH); Antidotes 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol(1,5-a)(1,4)benzodiazepine-3-carboxylic acid ethyl ester. A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Azepines (66-73); Benzodiazepinones (74-86) l5SA:LB4Fluids and Secretions (Non MeSH) A12 Amniotic Fluid; Body Fluids (+ 18); Dental Deposits (+ 2); Exudates and Transudates; Feces (+ 1); Gastrointestinal Contents; Hyalin Substance; Secretions (Non MeSH) (+ 19) ADAEAGAIANBIBLCFCHCICLCNCOCSCTCYDEDHDIDTDUECEHEMENEPETGEHIIMIPMEMIMONUPAPCPDPHPKPOPPPSPXRARERHRIRTSESUTHTOTUULURUSVEVI l8(zFluid Therapy E02.319.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Rehydration Solutions Water-Electrolyte Imbalance; Water-Electrolyte Balance; Electrolytes; Dehydration; Infusions, Parenteral Therapeutics; Drug Therapy Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to water-electrolyte balance. Fluids may be administered intravenously, orally, by intermittent gavage, or by hypodermoclysis. Electrolytes (66-78); Infusions, Parenteral (66-78); Water-Electrolyte Balance (66-78) $l:^"w!eFluid Shifts G07.503; H01.671.799.096 DEGEIMPHRE Lower Body Negative Pressure Blood Volume; Body Fluids; Plasma Volume Physiology, General (Non MeSH) Physical Sciences (Non MeSH); Physics; Rheology Translocation of body fluids. Shifts from the lower body to the upper part of the body occur under conditions of actual and simulated weightlessness and have the effect of reducing the total body water content and producing a temporary hypovolemic state. Shifts are also seen following hemodialysis and are caused by electrolyte imbalances. (From Nicogossian, Space Physiology and Medicine, 2d ed, p. 151). Body Fluids/physiology (66-94) $l<#3^%Flufenamic Acid D02.241.223.106.061.105.431; D16.850.015.050.270; D17.025.030.236; D17.025.080.175; D17.050.030.270; D23.037.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; Anthranilic Acids Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Dermatologic Agents; Anti-Inflammatory Agents, Topical An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.16). l@~:oFludrocortisone D04.808.745.745.654.430; D04.808.908.323; D06.597.481.561.353.369; D06.597.481.561.478.348; D06.597.648.431; D17.025.050.135 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Mineralocorticoids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal A synthetic mineralocorticoid with anti-inflammatory activity. lE:HFlucytosine D03.383.742.698.421.431; D20.136.295; D26.087.372 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Cytosine Anti-Infective Agents; Antifungal Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Antifungal Agents (66-71); Cytosine (66-71) lI9:5Fluconazole D03.383.129.799.450; D03.383.946.450; D20.136.290 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Triazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazoles Anti-Infective Agents; Antifungal Agents alpha-(2,4-Difluorophenyl)-alpha (1H-1,2,4-triazol-1-ylmethyl) 1H-1,2,4-triazole-1-ethanol. Triazole antifungal agent which is used to treat oropharyngeal candidiasis and cryptococcal meningitis in AIDS. Triazoles (85-89) lK9:Floxuridine D13.570.230.430.432; D13.570.685.852.300.350; D20.388.365; D22.204.144.512; D26.087.274.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxyuridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine; Deoxyuridine Anti-Infective Agents; Antiviral Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Deoxyuridine 2'-Deoxy-5-fluorouridine. An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. lN8g:Floxacillin D20.085.099.739.681.205.379 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Oxacillin; Cloxacillin 6-(((3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl) carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo (3.2.0)heptane-2-carboxylic acid. Antibiotic analog of cloxacillin. Cloxacillin (74) lR:lFlow Injection Analysis E05.196.460 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical The analysis of a chemical substance by inserting a sample into a carrier stream of reagent using a sample injection valve that propels the sample downstream where mixing occurs in a coiled tube, then passes into a flow-through detector and a recorder or other data handling device. lTEMFlow Cytometry E05.196.712.382.240.350; E05.909.262.386.350 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Fluorometry; Cytophotometry Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Cytophotometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. lV2"AFlour J01.341.409 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food l[D "=Flounder B02.493.418.438 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Flatfishes Common name for two families of fish belonging to the order Pleuronectiformes and described as left-eye flounders and right-eye flounders. The latter is more commonly used in research. Fishes (66-86) l[ &'Florida Z01.107.567.875.100.274; Z01.107.567.875.600.820.274 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States l]Y :Floors and Floorcoverings J01.086.339.140 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction The surface of a structure upon which one stands or walks. l^lIFlocculation Tests E01.223.495.826.769.306 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Precipitin Tests Precipitin Tests (66-72); Serodiagnosis (66-72) l`"c9Flocculation H01.181.529.741.347 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Precipitation Precipitation (66-71) laZFlight, Animal G11.427.614.281 PH Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Movement Locomotion (66-71); specific animal la},Flicker Fusion E01.210.331; F02.463.593.932.458; G11.697.911.860.556 DEGEIMPHRE Diagnosis; Diagnosis, Eye (Non MeSH) Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception The point or frequency at which all flicker of an intermittent light stimulus disappears. lb=kFleroxacin D03.438.810.835.180.400; D20.220.050.180.400; D20.237.050.050.180.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones; Ciprofloxacin Anti-Infective Agents; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone; Ciprofloxacin Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone; Ciprofloxacin 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid. A third-generation fluoroquinolone derivative with a broad antimicrobial spectrum. The drug strongly inhibits the DNA-supercoiling activity of DNA gyrase which may account for its antibacterial activity. Anti-Infective Agents (66-88); Anti-Infective Agents, Quinolone (89-91); Ciprofloxacin/analogs and derivatives (87-91); Quinolines (66-86) ldM:YFlecainide D03.383.621.270; D18.097.375 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Cardiovascular Agents; Anti-Arrhythmia Agents N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide. A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients. Piperidines (66-86) li":Fleas B01.131.617.364 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Parasitic, blood-sucking, wingless insects comprising the order Siphonaptera. lk (*YFlavoxate D03.438.150.266.450.300; D16.050.650.260 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones; Flavones Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. Carboxylic Acids (72-74); Flavones (69-76); Piperidines (72-76) ll .:RMFlavoring Agents D26.456; J01.341.390 ADAEANCHCLCSCTDUECHIIPMEMIPDPKPOPSRESDSTTOTUVI Miscellaneous Drugs and Agents (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Food Chicory; Safrole; Sweetening Agents (+ 3) Chicory; Sweetening Agents AAADAEAHANCHCLCSCTCYDEDUECEMENGDGEHIIMIPMEMIPDPHPKPOPSRESDSTTOTUULVI lo2mSHFlavoproteins D12.776.331 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Flavodoxin FAD (66-70); FMN (66-70); Proteins (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  lqqDD7FFlavones D11.786.170.381; D03.438.150.266.450 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Bioflavonoids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones Quercetin Benzoflavones; Flavoxate; Isoflavones; Quercetin; Silymarin AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR lr *>R@Flavodoxin D12.776.097.400; D12.776.331.400 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Flavoproteins A low-molecular-weight (16,000) iron-free flavoprotein containing one molecule of flavin mononucleotide (FMN) and isolated from bacteria grown on an iron-deficient medium. It can replace ferredoxin in all the electron-transfer functions in which the latter is known to serve in bacterial cells. Bacterial Proteins (72-76); Flavoproteins (70-76) lt&DT;Flavobacterium B03.440.400.425.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in soil and water. Its organisms are also found in raw meats, milk and other foods, hospital environments, and human clinical specimens. Some species are pathogenic in humans. lw"$Flavivirus Infections C02.782.350.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections Dengue; Encephalitis, Japanese; Encephalitis, St. Louis; Encephalitis, Tick-Borne; Hemorrhagic Fever, Omsk; Kyasanur Forest Disease; Louping Ill; West Nile Fever; Yellow Fever Infections with viruses of the genus FLAVIVIRUS, family FLAVIVIRIDAE. lyPWRFlavivirus B04.820.250.350; B04.909.777.310.350 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae Dengue Virus; Encephalitis Viruses, Japanese (+ 4); Encephalitis Viruses, Tick-Borne; Yellow Fever Virus Dengue Virus; Encephalitis Viruses, Japanese (+ 4); Encephalitis Viruses, Tick-Borne; Yellow Fever Virus A genus of FLAVIVIRIDAE, also known as Group B arbovirus, containing several subgroups and species. Most are arboviruses transmitted by mosquitoes or ticks. The type species is YELLOW FEVER VIRUS. Arboviruses (66-80)  l{*yFlaviviridae Infections C02.782.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Flavivirus Infections (+ 9); Hepatitis C; Pestivirus Infections (+ 3) Infections with viruses of the family FLAVIVIRIDAE. l~P:U>Flaviviridae B04.820.250; B04.909.777.310 CHCLDEENGDGEIMIPMEPHPYREUL Arboviruses Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Flavivirus (+ 8); Hepatitis C Viruses; Pestivirus (+ 3) Flavivirus (+ 8); Hepatitis C Viruses; Pestivirus (+ 3) A family of RNA viruses, some formerly classified under Togoviridae, many of which cause disease in humans and domestic animals. The three genera are FLAVIVIRUS, PESTIVIRUS, and HEPATITIS C VIRUSES. Flavivirus (85-93) $l""YFlavins D11.557.405 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Riboflavin AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR l BFDFlatulence C23.888.821.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antifoaming Agents Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) Production or presence of gas in the gastrointestinal tract which may be expelled through the anus. lNwFlatfoot C05.330.448 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Foot Deformities A condition in which one or more of the arches of the foot have flattened out. l\ N2bFlatfishes B02.493.418 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Flounder Common name for the order Pleuronectiformes. A very distinctive group in that during development they become asymmetrical, i.e., one eye migrates to lie adjacent to the other. They swim on the eyeless side. Flounder, sole, and turbot, along with several others, are included in this order. Fishes (66-86)  l|& VFlame Retardants D26.439 ADAEANCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Materials applied to fabrics, bedding, furniture, plastics, etc. to retard their burning; many may leach out and cause allergies or other harm. specific substance (66-77); Fires (66-77) lx *23Flame Ionization E05.196.181.349.390 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Gas Pyrolysis of organic compounds at the temperature of a hydrogen-air flame to produce ionic intermediates which can be collected and the resulting ion current measured by gas chromatography. l"oFlail Chest C21.866.891.315 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Thoracic Injuries A complication of multiple rib fractures, rib and sternum fractures, or thoracic surgery. A portion of the chest wall becomes isolated from the thoracic cage and exhibits paradoxical respiration. Rib Fractures (66-79); Thoracic Injuries (66-79) lNg;Flagellin D12.776.097.380 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins A protein with a molecular weight of 40,000 isolated from bacterial flagella. At appropriate pH and salt concentration, three flagellin monomers can spontaneously reaggregate to form structures which appear identical to intact flagella. Bacterial Proteins (72-74) l D[ Flagella A11.368.702.783.513 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles; Pseudopodia In bacteria, a whiplike motility appendage present on the surface of some species. Flagella are composed of a protein called flagellin. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. (From King and Stansfield, A Dictionary of Genetics, 4th ed). l *3FLA 63 D03.383.374.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Bis[(3-methyl-1-imidazolidinyl)thiocarbonyl]disulfide. An inhibitor of the last step of noradrenaline biosynthesis. Synonym: Bis(4-methyl-1-homopiperazinyl)thiuram disulfide. Disulfides (72-74); Imidazoles (72-74) l :V/FK-506 D03.494.410; D22.569.740 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*, 18S*,19S*,26aR*))-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26 ,26a-Hexadecahydro-5,19-dihydroxy-3-(2-(4-hydroxy-3-methoxy cyclohexyl)-1-methylethenyl)-14,16-dimethoxy-4,10,12,18-tet ramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido(2,1-c)oxaazac yclotricosine-1,7,20,21(4H,23H)-tetrone. A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Antibiotics, Macrolide (87-91); Immunosuppressive Agents (87-91) l :KFK 33-824 D12.644.468.281.381.300 AAADAEAGAIANBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides; Enkephalins; Enkephalin, Methionine Stable, synthetic analog of methionine enkephalin (ENKEPHALIN, METHIONINE). Actions are similar to those of methionine enkephalin. Its effects can be reversed by narcotic antagonists such as naloxone. Enkephalin, Methionine/analogs and derivatives (83); Enkephalins (78-82) lBUFixatives D26.422 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Tissue Fixation; Preservation, Biological Miscellaneous Drugs and Agents (Non MeSH) Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifying and hardening agents. They must quickly kill and coagulate living tissue. Histological Techniques (66-76)  l  (12s%Fixation, Ocular G11.697.384.253 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements lrFistula C23.439 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) Cutaneous Fistula; Digestive System Fistula (Non MeSH) (+ 8); Oral Fistula (Non MeSH) (+ 3); Respiratory Tract Fistula (Non MeSH) (+ 2); Urinary Fistula (+ 2); Vaginal Fistula (+ 2); Vascular Fistula (Non MeSH) (+ 2) An abnormal passage or communication, usually between two internal organs, or leading from an internal organ to the surface of the body. It is frequently designated according to the organs or parts with which it communicates, as anovaginal, bronchocutaneous, etc. (From Dorland, 27th ed). lI  N2 SFissure in Ano C06.405.469.860.101.430 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Anus Diseases A painful linear ulcer at the margin of the anus. It appears as a crack or slit in the mucous membrane of the anus and is very painful and difficult to heal. (Dorland, 27th ed and Stedman, 25th ed). lcN{Fishes, Poisonous B02.158.286.400; B02.493.392 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Fish Venoms; Tetrodotoxin Vertebrates; Animals; Animals, Poisonous Vertebrates; Fishes Fishes (66-67) lr"& HFishes B02.493 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates Catfish (+ 1); Cyclostomes (+ 2); Cypriniformes (+ 5); Cyprinodontiformes (+ 3); Eels (+ 1); Electric Fish (+ 3); Fishes, Poisonous; Flatfishes (+ 1); Perciformes (+ 3); Salmoniformes (+ 9); Sharks (+ 1); Tuna lr  & Fisheries J01.040.168.300; J01.576.383 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Agriculture; Aquaculture Technology, Industry, Agriculture (Non MeSH); Industry Places for cultivation and harvesting of fish, particularly in sea waters. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). l "Fish Venoms D24.185.926.580.370; D24.185.965.370 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Fishes, Poisonous Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms Venoms produced by fishes, including sharks and sting rays, usually delivered by spines. They contain various substances, including very labile toxins that affect the heart specifically and all muscles generally. Fishes (66-77); Venoms (66-77)  l*<'Fish Products J01.341.838.400 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Seafood Fish Flour; Fish Oils Food products manufactured from fish (e.g., FISH FLOUR, fish meal). Fishes (66-67) ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEMIPDPKPOPSRESDSESNSTTOTUURUTVI $l#"HRHFish Oils D10.516.627.430; J01.341.838.400.400; J01.740.350 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEMIPDPKPOPSRESDSESTTOTUURVI Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils Technology, Industry, Agriculture (Non MeSH); Food; Seafood; Fish Products Technology, Industry, Agriculture (Non MeSH); Oils Cod Liver Oil; Fatty Acids, Omega-3 (+ 2) Cod Liver Oil; Fatty Acids, Omega-3 (+ 2) Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the livers. Those from the liver are usually high in vitamin A. The oils are used as dietary supplements, in soaps and detergents, as protective coatings, and as a base for other food products such as vegetable shortenings. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESTTOTUURVI  l9DisHFish Flour J01.341.838.400.380 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Seafood; Fish Products A flour made of pulverized, dried fish or fish parts. l\"ZCFish Diseases C22.362 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Diseases of freshwater, marine, hatchery or aquarium fish. This term includes diseases of both teleosts (true fish) and elasmobranchs (sharks, rays and skates). Animal Diseases (66-69); Fishes (66-69) ld H1First Aid E02.365.305 AECLCTECHIISMOMTNUPXSNSTTDUTVE Emergencies; Emergency Medical Services; Wounds and Injuries Therapeutics; Emergency Treatment (Non MeSH) l"H5Firesetting Behavior F03.709.597.460.308 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Impulse Control Disorders A compulsion to set fires. Fires (66-75) lF#Fires G03.230.100.120 ECHILJPCSN Smoke Inhalation Injury; Burns, Inhalation Environment and Public Health (Non MeSH); Environment; Disasters Fire Extinguishing Systems; Spontaneous Combustion CLECHILJPCSNST  l% 3N;Firearms J01.335 CLECHILJSNST Wounds, Gunshot Technology, Industry, Agriculture (Non MeSH) Small-arms weapons, including handguns, pistols, revolvers, rifles, shotguns, etc. lH  4_Fire Extinguishing Systems G03.230.100.120.110 CLHILJSNST Environment and Public Health (Non MeSH); Environment; Disasters; Fires Automatic or hand operated equipment used to control and extinguish fires. Fires (66-Jul 77) l= WYFinland Z01.542.267 EHEP Geographicals (Non MeSH); Europe lp )Fingersucking F01.145.466.263; F03.234.193.308.428 AEPXTH Behavior and Behavior Mechanisms (Non MeSH); Behavior; Habits Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders; Child Reactive Disorders; Habits Sucking of the finger. This is one of the most common manipulations of the body found in young children. l* Fingers A01.378.209.455.430 ABAHBSEMGDIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH); Extremities; Arm; Hand Thumb ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI l (= *Finger Joint A02.835.583.345 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Joints Metacarpophalangeal Joint ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI lf81:Finger Injuries C21.866.448.429 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Hand Injuries General or unspecified injuries involving the fingers. lrNcAFinasteride D04.808.054.079.500; D04.808.925.100.250; D08.373.384 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes Polycyclic Hydrocarbons; Steroids; Steroids, Heterocyclic; Azasteroids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors (5 alpha,17 beta)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide. An orally active TESTOSTERONE 5-ALPHA-REDUCTASE inhibitor. It is used as a surgical alternative for treatment of benign prostatic hyperplasia. Androstenes (88-93); Azasteroids (88-93) l=:1Financing, Personal N03.219.559 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics Payment by an individual or his family for health care services which are not covered by a third-party payer, either insurance or medical assistance. Economics (66-67) lnBFinancing, Organized N03.219.521 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics Financing, Government (+ 11); Insurance (+ 40); Insurance, Health, Reimbursement (+ 10) All organized methods of funding. Insurance (66-67) CLECHILJMAMTOGSNSTTDUT $lBj*Financing, Government N03.219.521.346 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized Public Assistance (+ 8); Veterans Disability Claims; Workers' Compensation Federal, state, or local government organized methods of financial assistance. Social Welfare (66-67)  lR[Y\Financing, Construction N03.219.463.300 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Funding resources and procedures for capital improvement or the construction of facilities. Financing, Government (68-77) l[k#Financial Support (Non MeSH) N03.219.483 Economics, Organizations, Control (Non MeSH); Economics Foundations; Health Planning Support; Research Support; Training Support (+ 1) CLECHILJMAMTOGSDSNSTTDUT lE#B^Financial Management, Hospital N02.278.354.180; N03.219.463.280; N04.452.442.180 CLECHILJMTOGSNSTTDUT Economics, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Economics, Organizations, Control (Non MeSH); Economics; Financial Management Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration The obtaining and management of funds for hospital needs and responsibility for fiscal affairs. Financial Management (78-81)  lV$92q"Financial Management N03.219.463 CLECHILJMTOGSNSTTDUT Income Economics, Organizations, Control (Non MeSH); Economics Accounting (+ 4); Bankruptcy; Budgets (+ 1); Capital Financing; Contract Services (+ 1); Financial Management, Hospital; Financing, Construction; Fund Raising; Group Purchasing; Leasing, Property; Marketing of Health Services; Risk Management The obtaining and management of funds for institutional needs and responsibility for fiscal affairs. CLECHILJMAMTOGSNSTTDUT $l B!vFinancial Audit N03.219.463.030.160 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management; Accounting An examination, review and verification of all financial accounts. l?iOFiltration E05.196.454; H01.181.529.365; H01.671.100.534 ISMT Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Physical Sciences (Non MeSH); Physics; Biophysics Ultrafiltration (+ 2) Micropore Filters; Ultrafiltration (+ 2) Ultrafiltration (+ 2) A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). AECLCTECHIISMOMTNUPXRHSDSNSTTDUTVE  l]5c&Filtering Surgery E04.792.450 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Molteno Implants Glaucoma Surgery, Operative; Surgery, Eye (Non MeSH) Sclerostomy; Trabeculectomy A surgical procedure used in treatment of glaucoma in which an opening is created through which aqueous fluid may pass from the anterior chamber into a sac created beneath the conjunctiva, thus lowering the pressure within the eye. (Hoffman, Pocket Glossary of Ophthalmologic Terminology, 1989). Glaucoma/surgery (66-94) (l7$ 5!ZFilovirus Infections C02.782.580.250.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Filoviridae Infections Marburg Virus Disease Infections with viruses of the genus FILOVIRUS, family FILOVIRIDAE. Hemorrhagic Fevers, Viral (90-94); Virus Diseases (90-94)  lѢPuPEFilovirus B04.820.455.300.300; B04.909.777.455.300.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Filoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Filoviridae Ebola Virus; Marburg Virus Ebola Virus; Marburg Virus A genus of the family FILOVIRIDAE containing two species: EBOLA VIRUS and MARBURG VIRUS. Both were originally associated with African monkeys but are capable of causing severe hemorrhagic disease in humans. The natural host of either virus is unknown. Transmission is by close personal contact. Filoviridae (92)  lr 2BZFiloviridae Infections C02.782.580.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections Filovirus Infections (+ 1) Infections with viruses of the family FILOVIRIDAE. The infections in humans consist of a variety of clinically similar viral hemorrhagic fevers but the natural reservoir host is unknown. lHPZ!Filoviridae B04.820.455.300; B04.909.777.455.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales Filovirus (+ 2) Filovirus (+ 2) A family of viruses, of the order MONONEGAVIRALES, containing filamentous virions. Although they resemble Rhabdoviridae in possessing helical nucleocapsids, Filoviridae differ in the length and degree of branching in their virions. There is one genus, FILOVIRUS. Rhabdoviridae (87-91)  lC*(0Film Dosimetry E05.799.638.420; G03.850.810.370.310; H01.671.768.765.588.379 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Radiometry; Radiation Monitoring Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Monitoring Physical Sciences (Non MeSH); Physics; Radiation; Radiometry; Radiation Monitoring Use of a device (film badge) for measuring exposure of individuals to radiation. It is usually made of metal, plastic, or paper and loaded with one or more pieces of x-ray film. Radiation Monitoring (66-70) lڶE"2"Filipin D02.455.326.271.665.325; D20.085.062.400; D20.136.073.400 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal 4,6,8,10,12,14,16,27-Octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethoxyoxacyclooctacosa-17,19,21,23,25-pentaen-2-one (filipin III). A complex of polyene, lactone, and macrolide antibiotics obtained from Streptomyces filipinensis. Filipin III alters membrane function by interfering with membrane sterols, inhibits mitochondrial respiration, and is proposed as an antifungal agent. Filipins I, II, and IV are less important. Fatty Acids, Essential (66-71); Fatty Acids, Unsaturated (72-74); Lactones (66-74); Polyenes (66-74) l݁ A<yFiling L01.300.390 CLECHIMTSNSTTDUT Information Science; Documentation Collections of related records treated as a unit; ordering of such files. l )ZFilarioidea B01.500.294.700.750.700.300 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina Brugia (+ 2); Dipetalonema; Dirofilaria (+ 1); Loa; Mansonella (+ 1); Microfilaria; Onchocerca (+ 1); Setaria; Wuchereria (+ 1) A superfamily of nematodes of the suborder SPIRURINA. Its organisms possess a filiform body and a mouth surrounded by papillae. lT*SFilaricides D21.201.287.278 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Arsenamide; Diethylcarbamazine; Hoe 33258; Ivermectin Pharmacological agents destructive to nematodes in the superfamily Filarioidea. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  l_8Q@\:Filariasis C03.335.508.700.750.361 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections Dipetalonema Infections; Dirofilariasis; Elephantiasis, Filarial; Loiasis; Mansonelliasis; Onchocerciasis (+ 1); Setariasis Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischaemic necrosis of the brain, blindness, and dermatosis of the face. l PtFiji Z01.782.590.373 EHEP Geographicals (Non MeSH); Pacific Islands; Melanesia lR@Figural Aftereffect F02.463.593.932.401; G11.697.911.860.492 CLDEGEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception A perceptual phenomenon used by Gestalt psychologists to demonstrate that events in one part of the perceptual field may affect perception in another part. l.FIGLU Test E01.223.459.404 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anemia, Macrocytic; Folic Acid Deficiency Diagnosis; Diagnosis, Laboratory; Hematologic Tests l"2=Field Dependence-Independence F02.463.593.343; F02.463.593.932.345 Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception The ability to respond to segments of the perceptual experience rather than to the whole. Perception (66-71); Visual Perception (66-71) l"*l7Ficusin D03.438.150.446.750.480 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; Psoralens Methoxsalen; Trioxsalen 7H-Furo[3,2-g][1]benzopyran-7-one. Proposed anthelmintic obtained from Psoralea corylifolia and other plants. Coumarins (66-74); Furans (66-74)  l :q|*Ficoll D09.203.698.330 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides beta-D-Fructofuranosyl alpha-D-glucopyranoside polymer. A sucrose polymer of high molecular weight. Polysaccharides (71-74); Propanediols (74); Sucrose (71-74) le <^rHFicin D08.586.277.656.732.215.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases A sulfhydryl proteinase with cysteine at the active site from ficus latex. Preferential cleavage is at tyrosine and phenylalanine residues. Acts on a wide variety of protein substrates. Formeryl EC 3.4.4.12. Peptide Peptidohydrolases (71-74) l F'Fibula A02.835.232.484.321 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Leg Bones (Non MeSH) lO :VFibrous Dysplasia, Polyostotic C05.116.099.708.375.381 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Fibrous Dysplasia of Bone A disease of bone marked by thinning of the cortex and replacement of bone marrow by gritty fibrous tissue containing bony spicules, producing pain, disability, and gradually increasing deformity. When associated with melanotic pigmentation of the skin and endocrine disorders, it is known as Albright's syndrome. (Dorland, 27th ed). l$NFibrous Dysplasia, Monostotic C05.116.099.708.375.372 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Fibrous Dysplasia of Bone l#NFibrous Dysplasia of Bone C05.116.099.708.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Cherubism; Fibrous Dysplasia, Monostotic; Fibrous Dysplasia, Polyostotic l NkTFibrosis C23.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. specific organ/pathology (66- ) l|  N2'Fibrosarcoma C04.557.450.565.590.350; C04.557.450.795.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Dermatofibrosarcoma; Neurofibrosarcoma Dermatofibrosarcoma; Neurofibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed). l2X<VFibronectins D12.776.377.715.390; D12.776.395.550.350; D12.776.543.550.350; D12.776.860.300.450 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Fibronectin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cryoglobulins (66-79); Glycoproteins (66-79); Membrane Proteins (77-79)  lY\FUFibromyalgia C05.651.324; C05.799.321 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fatigue Syndrome, Chronic Musculoskeletal Diseases; Muscular Diseases Musculoskeletal Diseases; Rheumatic Diseases A common nonarticular rheumatic syndrome characterized generally by chronic musculoskeletal pain and diagnosed chiefly by the presence of multiple tender points (tender muscular nodules) at characteristic locations. It is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, swelling, chronic headaches, and pain in neck and shoulders. The average duration is 5 years. Most patients are women aged 20 to 50 years. The cause is unknown and the treatment is not specific. mNeJFibromuscular Dysplasia C14.907.137.372 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases An idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries. Most commonly affected are the renal arteries; involvement of the axillary, iliac, basilar, carotid, hepatic and intracranial arteries have been reported. Arterial Occlusive Diseases (73-77); Carotid Artery Diseases (66-77); Renal Artery Obstruction (66-77); Vascular Diseases (66-77) muNSXFibromatosis, Aggressive C04.557.450.565.590.340.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Fibroma A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed). Fibroma (69-93) m ]N;Fibromatosis, Abdominal C04.557.450.565.590.340.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Fibroma A relatively large mass of unusually firm scarlike connective tissue resulting from active participation of fibroblasts, occurring most frequently in the abdominal muscles of women who have borne children. The fibroblasts infiltrate surrounding muscle and fascia. (Stedman, 25th ed). Fibroma (67-93) m "NIFibromatosis Gingivae C07.465.525.304; C07.465.714.258.225; C07.650.525.304; C16.131.850.525.304 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Mouth Abnormalities Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases; Gingival Diseases Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Mouth Abnormalities A generalized localized diffuse fibrous overgrowth of the gingival tissue, usually transmitted as an autosomal dominant trait, but some cases are idiopathic and others produced by drugs. (From Dorland, 27th ed). mTLFibroma, Ossifying C04.557.450.565.575.400; C04.557.450.565.590.340.360 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Fibroma A benign, relatively slow-growing, central bone tumor, usually of the jaws (especially the mandible) which is composed of fibrous connective tissue within which bone is formed. (Dorland, 27th ed). Fibroma (66-93); Ossification, Heterotopic (68-93) mk:Vz<Fibroma, Desmoplastic C04.557.450.565.590.340.345 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Fibroma A extremely rare bone tumor characterized by abundant collagen formation and a fibrous stroma, without evidence of mitosis or pleomorphism. It appears on x-rays as an osteolytic lesion with well-defined margins and must be differentiated from primary fibrosarcoma of bone. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Fibroma (66-93) mXFibroma Virus, Rabbit B04.280.650.160.500.250; B04.909.204.210.600.250; B04.909.204.783.160.500.250; B04.909.574.204.600.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Leporipoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; DNA Tumor Viruses; Leporipoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Leporipoxvirus Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; DNA Tumor Viruses; Leporipoxvirus A species of LEPORIPOXVIRUS causing subcutaneous localized swellings in rabbits, usually on the feet. mpwFibroma C04.557.450.565.590.340 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Tuberous Sclerosis Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue Fibroma, Desmoplastic; Fibroma, Ossifying; Fibromatosis, Abdominal; Fibromatosis, Aggressive A benign tumor composed mainly of fibrous or fully developed connective tissue. (Dorland, 27th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $m VjxXFibroin D12.776.860.392 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH) m HcFibrocystic Disease of Breast C04.182.289; C19.146.378 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Cysts Endocrine Diseases; Breast Diseases A chronic disorder comprising three variants which range from lesions consisting primarily of an overgrowth of fibrous tissue to those characterized by dominance of the proliferation of the epithelial parenchyma to a form of dysplasia characterized by both stromal and epithelial hyperplasia with the formation of cysts. Breast Diseases (66-79) m p$X?sFibroblasts A11.329.228; A11.872.228 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Connective Tissue Cells (Non MeSH) Cells; Stem Cells L Cells; 3T3 Cells Connective tissue cells which differentiate into chondroblasts, collagenoblasts, and osteoblasts. m#*IoFibroblast Growth Factor, Basic D11.303.400.300; D12.644.212.300; D24.185.348.383.300 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Fibroblast Growth Factor Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Fibroblast Growth Factor Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Fibroblast Growth Factor A single-chain polypeptide of approximately 15-16 kDa which has been isolated from a variety of cells. It has a 55% amino acid residue identity to acidic fibroblast growth factor and has potent heparin-binding activity. However, in contrast to the acidic fibroblast growth factor, heparin does not potentiate the biological activities of bFGF. The growth factor is an extremely potent inducer of DNA synthesis in a variety of normal diploid mammalian cell types from mesoderm and neuroectoderm lineages and promotes cellular differentiation in vitro. Fibroblast Growth Factor (84-90); Growth Substances (74-83) m$Q&=HLGFibroblast Growth Factor, Acidic D11.303.400.250; D12.644.212.250; D24.185.348.383.250 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Fibroblast Growth Factor Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Fibroblast Growth Factor Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Fibroblast Growth Factor A growth factor which has been isolated from a variety of cells. It contains 154 amino acid residues and has potent heparin-binding activity. Heparin potentiates the biological activities of aFGF. The growth factor is an extremely potent inducer of DNA synthesis in a variety of normal diploid mammalian cell types from mesoderm and neuroectoderm lineages and also has chemotactic and mitogenic activities. Fibroblast Growth Factor (84-90); Growth Substances (74-83) m)6'=HLGFibroblast Growth Factor D11.303.400; D12.644.212; D24.185.348.383 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Fibroblast Growth Factor Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Peptides Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Fibroblast Growth Factor, Acidic; Fibroblast Growth Factor, Basic Fibroblast Growth Factor, Acidic; Fibroblast Growth Factor, Basic Fibroblast Growth Factor, Acidic; Fibroblast Growth Factor, Basic Peptide isolated from the pituitary gland and from the brain. It is a potent mitogen which stimulates growth of a variety of mesodermal cells including chondrocytes, granulosa, and endothelial cells. The peptide may be active in wound healing and animal limb regeneration. Fibroblasts (74-83); Growth Substances (74-83); Mitogens (74-83); Nerve Tissue Proteins (74-83); Peptides (74-83); Pituitary Hormones (74-83) $m-w1H*@Fibroadenoma C04.557.450.565.590.595.350; C04.557.470.625.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Neoplasms, Fibroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Fibroepithelial Phyllodes Tumor Phyllodes Tumor An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed). Adenofibroma (66-93); Breast Neoplasms (66-93) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $m2&6V^&8XFibrinopeptides B D12.644.205; D12.776.124.270.320; D12.776.811.300.320 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Fibrin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors; Fibrinogen Two small peptide chains removed from the N-terminal segment of the beta chains of fibrinogen by the action of thrombin. Each peptide chain contains 20 amino acid residues. The removal of fibrinopeptides B is not required for coagulation. Fibrinogen (68-75); Peptides (68-75) m5=@ -Fibrinopeptides A D12.644.200; D12.776.124.270.310; D12.776.811.300.310 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Fibrin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors; Fibrinogen Two small peptide chains removed from the N-terminal segment of the alpha chains of fibrinogen by the action of thrombin. Each peptide chain contains 18 amino acid residues. The removal of fibrinopeptides A is required for blood coagulation. Fibrinogen (68-75); Peptides (68-75) m9=@ -Fibrinolytic Agents D19.461.427 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Brinolase; Heparin (+ 4); Hirudin; Plasmin; Plasminogen (+ 4); Reptilase; Streptokinase (+ 1) Fibrinolysin or agents that convert plasminogen to fibrinolysin. They may be endogenous or exogenous like the bacterial enzymes used in thromboembolism. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  m<6[uHFibrinolysis G09.188.560.150.390 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hemostasis; Blood Coagulation The dissolution of fibrin by enzymatic action. (Dorland, 27th ed.). m>b~SFibrinogens, Abnormal D12.776.124.050.250.260; D12.776.124.125.500.260; D19.461.270.229.385.260; D19.461.270.463.456.260 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins; Fibrinogen Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Fibrinogen Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Fibrinogen Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics; Fibrinogen Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. Fibrinogen (66-88) m?lDUFibrinogen D12.776.124.050.250; D12.776.124.125.500; D12.776.811.300; D19.461.270.229.385; D19.461.270.463.456 AAADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics Fibrinogens, Abnormal Fibrinogens, Abnormal Fibrin Fibrinogen Degradation Products; Fibrinopeptides A; Fibrinopeptides B Fibrinogens, Abnormal Fibrinogens, Abnormal Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  mEoD<FFibrin Tissue Adhesive D12.776.124.270.305; D19.461.270.463.400.714; D25.919.425; D26.016.920.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Fibrin Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics; Fibrin Biomedical and Dental Materials (Non MeSH); Tissue Adhesives Miscellaneous Drugs and Agents (Non MeSH); Adhesives; Tissue Adhesives An autologous or commercial tissue adhesive containing fibrinogen and thrombin. The commercial product is a two component system from human plasma that contains more than fibrinogen and thrombin. The first component contains highly concentrated fibrinogen, Factor VIII, fibronectin, and traces of other plasma proteins. The second component contains thrombin, calcium chloride, and antifibrinolytic agents such as aprotinin. Mixing of the two components promotes clotting and the formation and cross-linking of fibrin. The tissue adhesive is used for tissue sealing, hemostasis, and wound healing. Factor VIII (66-89); Fibrinogen (66-69); Hemostatics (66-89); Thrombin (66-89) mKT8|`Fibrin Foam D19.461.270.463.400.428 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics; Fibrin Hemostatics (66-72) mP^:Fibrin Fibrinogen Degradation Products D12.776.124.270.300; D12.776.811.300.290; D19.461.119.071.374 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Fibrin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors; Fibrinogen Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Antithrombins Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Synonyms: FDP; fibrinolytic degradation products; fibrin(ogen) degradation products; fibrin(ogen) derivatives. Fibrin/ME (70-75); Fibrinogen/ME (70-75) mQ-EBE3Fibrin D12.776.124.270; D19.461.270.463.400 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics Fibrin Fibrinogen Degradation Products; Fibrin Tissue Adhesive; Fibrinopeptides A; Fibrinopeptides B Fibrin Foam; Fibrin Tissue Adhesive AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR mUm *FHFiber Optics H01.671.606.400 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Physics; Optics Optics (66-69) mW9Fever of Unknown Origin C23.888.189.344.345 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Temperature Changes (Non MeSH); Fever Fever in which the etiology cannot be ascertained. Fever (66-70) mXrN>Fever C23.888.189.344 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Heat-Shock Proteins; Hyperthermia, Induced; Pyrogens Body Temperature Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Temperature Changes (Non MeSH) Fever of Unknown Origin; Malignant Hyperthermia; Sweating Sickness  mY NOFetus A16.378 ABAHBSCHCYDEEMENIMINIRMEMIPAPHPPPSRARERISESUTRULVI Fetoscopy; Gestational Age; Maternal-Fetal Exchange Embryo Embryonic Structures (Non MeSH) Fetal Blood; Fetal Heart (+ 2); Meconium; Vernix Caseosa ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $m[  6= &H:Fetoscopy E01.249.746.450; E01.418.426 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fetus Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Prenatal Diagnosis Diagnosis; Endoscopy Endoscopic visualization of the fetus through an abdominal and uterine entry. Endoscopy (66-76); Prenatal Diagnosis (73-76)  m]g "" `\7Fetomaternal Transfusion C15.378.071.363.511; C16.614.053.511 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Neonatal Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Anemia, Neonatal Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed). m^*L}Fetofetal Transfusion C15.378.071.363.344; C16.614.053.344 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Neonatal Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Anemia, Neonatal Passage of blood from one fetus to another via an arteriovenous communication or other shunt, in a monozygotic twin pregnancy. It results in anemia in one twin and polycythemia in the other. (Wintrobe, Clinical Hematology, 8th ed). Anemia (66-67); Infant, Newborn, Diseases (66-67) m`*L<Fetishism (Psychiatric) F03.709.597.608.700.260 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias A condition in which inanimate objects are utilized as a preferred or exclusive method of stimulating erotic arousal. mcFFetal Viability G07.553.370; G08.520.288.320 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fetal Development Fetal Movement The potential of the fetus-in-utero to survive after birth. Fetus (66-77)  mev"HFetal Tissue Transplantation E04.936.580.300 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Transplantation; Tissue Transplantation Transference of fetal tissue between individuals of the same species or between individuals of different species. Fetus (68-90); Transplantation, Homologous (68-90) mg"2E<Fetal Resorption C13.703.243.300; C23.240.477.300 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Death Symptoms and General Pathology (Non MeSH); Death; Fetal Death Death and resorption of the fetus at any stage after the completion of organogenesis. It does not include embryo resorption. Fetal Death (66-75) mh&LFetal Proteins D12.776.320 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins alpha Fetoproteins Alpha Globulins (66-69); Serum Globulins (66-69) mjDD;Fetal Organ Maturity G08.520.288.290 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fetal Development Functional competence of specific fetal organs or body systems. In humans, it is usually assessed by analysis of amniotic fluid, as in the assessment of fetal lung maturity by analysis for components of pulmonary surfactant. Amniotic Fluid (66-80); Fetus (66-80); Respiratory Distress Syndrome (66-80) mk]\Fetal Movement G07.553.370.300; G08.520.288.210 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Fetal Viability Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Fetal Development Motion of the fetus perceived by the mother and felt by palpation of the abdomen. Fetus/PH (66-84); Movement (66-84) mm&d,Fetal Monitoring E01.249.400; E01.621.390 AECLCTECHIISMOMTNUPXSNSTTDUTVE Signal Processing, Computer-Assisted Labor Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Monitoring, Physiologic Cardiotocography Cardiotocography Physiologic or biochemical monitoring of the fetus. It is usually done during labor and may be performed in conjunction with the monitoring of uterine activity. It may also be performed prenatally as when the mother is undergoing surgery. Fetal Heart (66-77); Fetus (66-77); Labor (66-77); Monitoring, Physiologic (66-77) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE ,mo"* W&e&Fetal Membranes, Premature Rupture C13.703.420.339 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Chorioamnionitis Spontaneous rupture of amniotic sac before the onset of uterine contractions. Fetal Membranes (66-74)  mr)L~\Fetal Membranes A16.254.403 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo Allantois; Amnion; Chorion (+ 1); Yolk Sac Thin layers of tissue which surround the embryo or fetus and provide for its nutrition, respiration, excretion and protection; they are the yolk sac, allantois, amnion, and chorion. mte:18Fetal Macrosomia C13.703.277.570; C13.703.766.570; C16.300.570; C18.452.297.820.570; C19.246.820.570 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Birth Weight Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy in Diabetes Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Pregnancy in Diabetes Endocrine Diseases; Diabetes Mellitus; Pregnancy in Diabetes A complication of gestational diabetes mellitus or prolonged pregnancy. A macrosomic fetus is defined as weighing more than 4000 grams. Birth Weight (66-86); Fetal Diseases (66-86); Infant, Newborn, Diseases (66-86); Pregnancy in Diabetes (66-86)  mv(_LFetal Hemoglobin D12.776.124.400.303; D12.776.422.512.320 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins mzM.FFetal Heart A07.541.278; A16.378.303 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart Embryonic Structures (Non MeSH); Fetus Ductus Arteriosus; Truncus Arteriosus Ductus Arteriosus; Truncus Arteriosus The heart of a fetus. m{8QXFetal Growth Retardation C13.703.277.370; C16.300.370; C23.509.370 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Infant, Small for Gestational Age Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Symptoms and General Pathology (Non MeSH); Growth Disorders The failure of a fetus to maintain its expected growth potential at any gestational stage. Fetal Diseases (66-77); Growth (66-71); Growth Disorders (72-77)  m}1L)mOFetal Distress C13.703.277.200; C16.300.200 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Adverse or threatening condition of the fetus identified by fetal bradycardia or tachycardia and passage of meconium in vertex presentation. Fetal Diseases (66-74) m"LFetal Diseases C13.703.277; C16.300 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Abnormalities; Chorionic Villi Sampling Perinatology Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Neonatal Diseases and Abnormalities (Non MeSH) Chorioamnionitis; Erythroblastosis, Fetal (+ 1); Fetal Alcohol Syndrome; Fetal Anoxia; Fetal Distress; Fetal Growth Retardation; Fetal Macrosomia; Meconium Aspiration Chorioamnionitis; Erythroblastosis, Fetal (+ 1); Fetal Alcohol Syndrome; Fetal Anoxia; Fetal Distress; Fetal Growth Retardation; Fetal Macrosomia; Meconium Aspiration BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $mJ/LFetal Development G08.520.288 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction Fetal Movement; Fetal Organ Maturity; Fetal Viability; Gestational Age; Sex Differentiation Morphologic and physiologic growth and development of the mammalian embryo or fetus. specific organ/embryology (66-94); Fetus/physiology (66-84); Growth (66-84)  m?Gmd[Fetal Death C13.703.243; C23.240.477; N01.224.935.698.302 BLCFCICLCODIECEHEMENEPETGEHIIMMEMIPAPCPPPSRARISUTHURUSVEVI Infant Mortality Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Symptoms and General Pathology (Non MeSH); Death Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality Embryo Resorption; Fetal Resorption Embryo Resorption; Fetal Resorption Death of the young developing in utero. BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $m5>U2LFetal Blood A12.207.152.200; A15.145.300; A16.378.200 CHCYDEENIMMEMIPHPSRARERIUSVI Fluids and Secretions (Non MeSH); Body Fluids; Blood Hemic and Immune Systems (Non MeSH); Blood Embryonic Structures (Non MeSH); Fetus Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the placenta. The cord blood is blood contained in the umbilical vessels at the time of delivery. Umbilical Cord (66-74) m1 Fetal Anoxia C13.703.277.100; C16.300.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Asphyxia Neonatorum Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Fetal oxygen deficiency. Fetal Diseases (66-74)  m"LFetal Alcohol Syndrome C13.703.277.080; C16.300.080; C21.613.053.270.397 BLCFCLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Alcoholism Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism A disorder occurring in children born to alcoholic women who continue to drink heavily during pregnancy. Common abnormalities are growth deficiency (prenatal and postnatal), altered morphogenesis, mental deficiency, and characteristic facies - small eyes and flattened nasal bridge. Fine motor dysfunction and tremulousness are observed in the newborn. Alcoholism (66-78)  m9J.Ferula B06.560.373; B06.660.357 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic A genus of poisonous, umbelliferous plants, including Ferula asafoetida, that yields pungent oils and resins used formerly as carminatives and now as cat and dog repellents. A related plant, F. galbanum, is used similarly. mL &:Fertilizers D26.025.300; J01.040.427 AEANCLECHIMIPOPSRESDSNSTTOUTVI Miscellaneous Drugs and Agents (Non MeSH); Agrochemicals Technology, Industry, Agriculture (Non MeSH); Agriculture  Manure Substances or mixtures that are added to the soil to supply nutrients or to make available nutrients already present in the soil, in order to increase plant growth and productivity. m" Fertilization in Vitro E05.820.490 AECLCTDEECHIISLJMOMTNUPXRESNSTTDUTVE Embryo Transfer; Ovarian Hyperstimulation Syndrome Insemination, Artificial Miscellaneous Techniques (Non MeSH); Reproduction Techniques Fertilization of an egg outside the body when the egg is normally fertilized in the body. Ectogenesis (75-79); Fertilization (66-79) $m(;Gm3Fertilization G08.520.277 DEGEIMPHRE Gamete Intrafallopian Transfer Reproduction, Urogenital Physiology (Non MeSH); Reproduction Ovum Transport; Sperm Capacitation; Sperm Motility; Sperm-Ovum Interactions; Sperm Transport m$GmFertility Agents, Male D07.552.510 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Fertility Agents Compounds which increase the capacity of the male to induce conception. Fertility Agents (73-74) m8DVFertility Agents, Female D07.552.344 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Fertility Agents Clomiphene; Cyclofenil; Gonadotropins, Pituitary (+ 1) Compounds which increase the capacity to conceive in females. Fertility Agents (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $m 8DAJDFertility Agents D07.552 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH) Fertility Agents, Female (+ 4); Fertility Agents, Male Fertility/drug effects (66-72); Gonadotropins (66-72); Ovulation/drug effects (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  m 8.CfDFertility G08.520.227 DEGEIMPHRE Infertility Reproduction, Urogenital Physiology (Non MeSH); Reproduction The capacity to conceive or to induce conception. It may refer to either the male or female. mm GrFerrozine D02.455.426.559.389.097.280; D02.886.645.600.080.050.100.325; D03.383.931.320; D26.241.608; D26.550.308 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzenesulfonates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Benzenesulfonates Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 4,4'-(3-(2-Pyridinyl)-1,2,4-triazine-5,6-diyl)bisbenzenesulfonic acid, disodium salt. A ferroin compound that forms a stable magenta-colored solution with the ferrous ion. The complex has an absorption peak at 562 nm and is used as a reagent and indicator for iron. Benzenesulfonates (74-75); Pyridines (72-75); Triazines (72-75) m s.?7LFerrous Compounds D01.485.275; D02.691.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Iron Inorganic Chemicals (Non MeSH); Iron Compounds Organic Chemicals (Non MeSH); Organometallic Compounds Ferrocyanides Inorganic or organic compounds that contain divalent iron. Iron (66-74) $m8xFFerrocyanides D01.248.497.158.291.370; D01.485.275.250; D01.625.400.100.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Cyanides Inorganic Chemicals (Non MeSH); Iron Compounds; Ferrous Compounds Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide; Cyanides Inorganic salts of the hypothetical acid ferrocyanic acid (H4Fe(CN)6). mE8VFerrochelatase D08.586.520.390 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme widely distributed in cells and tissues. It is located in the inner mitochondrial membrane and catalyzes the formation of heme from protoporphyrin IX and ferrous ions during the terminal step in the heme biosynthetic pathway. EC 4.99.1.1. Iron (66-76); Lyases (66-76); Porphyrins (66-76); Protoporphyrins (75-76) mFO%ZFerritin D12.776.556.365 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Iron Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins Apoferritin m HWFerricyanides D01.248.497.158.291.350; D01.485.250.300; D01.625.400.100.325 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Cyanides Inorganic Chemicals (Non MeSH); Iron Compounds; Ferric Compounds Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide; Cyanides Nitroprusside Nitroprusside Nitroprusside Inorganic salts of the hypothetical acid, H3Fe(CN)6. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  mE8/A:Ferrichrome D02.092.570.394.380; D02.241.511.372.380; D12.644.641.380; D24.310.678.275; D26.241.688.700.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Hydroxamic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxamic Acids Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Peptides, Cyclic Immunologic and Biologic Factors (Non MeSH); Biological Products; Siderophores Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents; Iron Chelates; Siderophores A cyclic peptide consisting of three residues of delta-N-hydroxy-delta-N-acetylornithine. It acts as an iron transport agent in Ustilago sphaerogena. Hydroxamic Acids (72-74); Iron Chelates (72-74); Peptides, Cyclic (73-74) m`k:YFerric Compounds D01.485.250; D02.691.340; D19.461.543.321 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Iron Inorganic Chemicals (Non MeSH); Iron Compounds Organic Chemicals (Non MeSH); Organometallic Compounds Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Hematinics Ferricyanides (+ 1) Iron-Dextran Complex Inorganic or organic compounds containing trivalent iron. Iron (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (m181D:Ferrets B02.649.147.400 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Semidomesticated variety of European polecat much used for hunting rodents and/or rabbits and as a laboratory animal. mg ('Ferredoxins D12.776.157.435.319; D12.776.556.580.302; D12.776.765.319; D12.776.097.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Iron-Sulfur Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins; Iron-Sulfur Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Molybdoferredoxin; Rubredoxins Molybdoferredoxin; Rubredoxins Molybdoferredoxin; Rubredoxins mTFiFerredoxin-NADP Reductase D08.586.682.608.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases An enzyme that catalyzes the oxidation and reduction of ferredoxin or adrenodoxin in the presence of NADP. EC 1.18.1.2. NADH, NADPH Oxidoreductases (74); Ferredoxins (74) mEFy=Fermium D01.268.271.545.275; D01.552.517.394 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Fermium. A man-made radioactive actinide with atomic symbol Fm, atomic number 100, and atomic weight 257. Its known isotopes range from 244-254 and 256-258. Its valence can be +2 or +3. Like einsteinium, it was discovered in 1952 in the debris from a thermonuclear explosion. m, *4HFermentation G06.184.405; G06.535.630.495 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) m"Fenthion D02.719.499; D05.723.491.657.527 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Phosphorothioic acid O,O-dimethyl O-(3-methyl-4- (methylthio)phenyl) ester. Potent cholinesterase inhibitor used as an insecticide and acaricide. Insecticides (66-71) m &:Fentanyl D03.383.621.265; D15.040.150.200; D15.045.250; D15.050.035.075.400; D15.210.100.175.075.400; D15.210.600.330 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Narcotics Alfentanil; Sufentanil Alfentanil Alfentanil Alfentanil Alfentanil Alfentanil N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide. A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078). m z:(XFenretinide D02.455.849.291.700.270; D11.557.261.700.270; D22.204.125.200; D22.204.421; D26.055.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Anticarcinogenic Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH); Anticarcinogenic Agents N-(4-Hydroxyphenyl)retinamide. A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. Tretinoin/analogs and derivatives (79-92) mc: 1Fenoterol D02.033.329.291.550.300; D02.092.063.291.550.300; D02.092.211.215.311.600.300; D02.092.311.660.300; D06.347.930.300; D14.100.050.100.200.300; D16.050.110.240; D16.050.870.240; D26.930.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines; Orciprenaline Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines; Orciprenaline Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines; Orciprenaline Organic Chemicals (Non MeSH); Amines; Catecholamines; Orciprenaline Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents Adrenergic beta-2 agonist used as a bronchodilator and tocolytic. Orciprenaline (73-74); Phenols (73-74) m :N/Fenoprofen D02.241.223.701.350; D08.373.310.250; D16.850.015.050.260; D17.025.030.232; D17.050.030.265 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylpropionates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal An anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to ASPIRIN, but causes less gastrointestinal bleeding. Anti-Inflammatory Agents (72-74); Ethers (72); Phenyl Ethers (74); Phenols (73); Propionates (72-74) m-g:{Fenoldopam D03.438.079.300; D14.100.150.151.337; D18.162.313; D18.918.351 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Vasodilator Agents A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation. Benzazepines (82-89); SK and F-38393/analogs and derivatives (89-94) mH:ORFenitrothion D02.719.456; D05.723.491.657.477 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71) m&:Fenfluramine D02.092.471.683.467; D14.100.600.850.260; D14.100.850.875.260; D14.100.850.875.800.260; D15.155.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Norfenfluramine Norfenfluramine Norfenfluramine Norfenfluramine Norfenfluramine A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release. It is used in the treatment of obesity, and has been suggested as treatment for several psychiatric disorders thought to involve serotonergic systems. Unlike most appetite depressants it tends to cause central nervous system depression rather than stimulation. mso:WFenestration E04.847.774.277 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Otosclerosis Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) m$eFendiline D02.092.471.683.450; D18.097.360; D18.192.360; D18.918.173.360 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers N-(3,3-Diphenylpropyl)-alpha-methylbenzylamine. Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents. Synonyms: HK 137; phenaxazan; phenoxan; Sensit. Phenethylamines (66-79) m H:Fenclonine D12.125.072.573.440; D14.100.850.875.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Phenylalanine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH) An inhibitor of serotonin biosynthesis used to study the effects of serotonin depletion. Phenylalanine (66-70) m.:)iFenchlorphos D02.719.435; D05.723.491.657.452 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71) m.&:Fenbendazole D02.241.081.251.320; D03.438.103.450; D21.201.287.269 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Methyl-5-(phenylthio)-2-benzimidazolecarbamate. Antinematodal benzimidazole used in veterinary medicine. Synonym: HOE 881. Benzimidazoles (74-76); Carbamates (74-76); Sulfides (74) m=:FFemur Neck A02.835.232.484.247.510 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Leg Bones (Non MeSH); Femur m*:`Femur Head Necrosis C05.116.852.175; C23.739.638.732.368 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Osteonecrosis Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Necrosis; Osteonecrosis Legg-Perthes Disease Aseptic or avascular necrosis of the femur head. the major types are idiopathic (primary), as a complication of fractures or dislocations, and LEGG-PERTHES DISEASE. Bone Diseases (66-72); Femur Head (66-72); Necrosis (66-72)  m *NJFemur Head A02.835.232.484.247.343 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Leg Bones (Non MeSH); Femur m:`Femur A02.835.232.484.247 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Thigh Musculoskeletal System; Skeleton; Bone and Bones; Leg Bones (Non MeSH) Femur Head; Femur Neck m : VFemoral Vein A07.231.908.314 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins The vein accompanying the femoral artery in the same sheath; it is a continuation of the popliteal vein and becomes the external iliac vein. m85Femoral Nerve A08.800.800.720.450.250 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Lumbosacral Plexus A nerve originating in the lumbar spinal cord (usually L2 to L4) and traveling through the lumbar plexus to provide motor innervation to extensors of the thigh and sensory innervation to parts of the thigh, lower leg, and foot, and to the hip and knee joints. m8q5Femoral Neoplasms C04.588.149.276; C05.116.231.343 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Bone Neoplasms Musculoskeletal Diseases; Bone Diseases; Bone Neoplasms m&XFemoral Neck Fractures C21.866.405.207.425.278; C21.866.558.276.425.278 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Femoral Fractures; Hip Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries; Femoral Fractures; Hip Fractures Fractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. Excludes intertrochanteric fractures. mH6NFemoral Fractures C21.866.405.207; C21.866.558.276 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries Hip Fractures (+ 1) Hip Fractures (+ 1) Fractures of the femur. m&N2Femoral Artery A07.231.114.351 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The main artery of the thigh, a continuation of the external iliac artery. m88[Feminization C19.391.301 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Gonadal Disorders (Non MeSH) Testicular Feminization Sex Characteristics (66) mN:Female Genital Diseases and Pregnancy Complications (Non MeSH) C13 Genital Diseases, Female (+ 116); Pregnancy Complications (+ 77) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI mINZFelypressin D06.472.734.692.781.400.350; D12.644.456.925.325; D18.793.370; D19.770.896.540.599 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior; Vasopressins; Lypressin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Cardiovascular Agents; Vasoconstrictor Agents Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Vasopressins; Lypressin Vasopressin 2-(L-phenylalanine)-8-L-lysine. Synthetic analog of lypressin with more vasoconstrictor than antidiuretic action. It is used as a hemostatic. m\:Felty's Syndrome C05.550.114.154.389; C05.799.114.389; C17.300.775.099.389; C20.111.199.389 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Immunologic Diseases; Autoimmune Diseases; Arthritis, Rheumatoid A combination of rheumatoid arthritis, splenomegaly, leukopenia, pigmented spots on lower extremities, and other evidence of hypersplenism (anemia and thrombocytopenia). (From Dorland, 27th ed). mTNtFelodipine D03.383.725.203.250; D18.097.350; D18.192.350; D18.918.173.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid ethyl methyl ester. A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. The drug has natriuretic-diuretic effects and has been effective in the treatment of chronic cardiac failure and angina. Nifedipine/analogs and derivatives (81-86); Nitrendipine/analogs and derivatives (87-89); Pyridines (66-80) mH:~Fellowships and Scholarships H01.770.878.276; N03.219.483.838.276 CLECHILJMTOGSNSTTD Physical Sciences (Non MeSH); Science; Training Support Economics, Organizations, Control (Non MeSH); Economics; Financial Support (Non MeSH); Training Support Stipends or grants-in-aid granted by foundations or institutions to individuals for study. Training Support (66-74) nH"*jFeline Infectious Peritonitis C02.782.225.200.360; C22.180.440 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Coronaviridae Infections; Coronavirus Infections Animal Diseases; Cat Diseases Common coronavirus infection of cats caused by the feline infectious peritonitis virus (INFECTIOUS PERITONITIS VIRUS, FELINE). The disease is characterized by a long incubation period, fever, depression, loss of appetite, wasting, and progressive abdominal enlargement. Infection of cells of the monocyte-macrophage lineage appears to be essential in FIP pathogenesis. Cat Diseases (66-91); Coronavirus Infections (78-91) n#&J?Feline Infectious Enteritis C02.256.700.363; C22.180.426 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Parvoviridae Infections Animal Diseases; Cat Diseases A highly contagious DNA virus infection of the cat family and of mink, characterized by fever, enteritis and bone marrow changes. It is also called feline ataxia, feline agranulocytosis, cat fever, cat plague, show fever. Cat Diseases (66-69); Virus Diseases (66-69) nM!"Jz7Feline Acquired Immunodeficiency Syndrome C02.782.815.616.350; C02.839.400; C22.180.350 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections Virus Diseases; Slow Virus Diseases Animal Diseases; Cat Diseases Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus (FIV) and in some cats infected with feline leukemia virus (FeLV). Cat Diseases (86-90); Immunologic Deficiency Syndromes (88-90) n05JJFees, Pharmaceutical N03.219.442.551 CLHILJSNSTTD Pharmacy Administration; Economics, Pharmaceutical Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges Prescription Fees Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc. Pharmacy (66-67); Prescriptions (66-67) $n Z:X0Fees, Medical N03.219.300.426; N03.219.442.426 CLHILJSNSTTD Relative Value Scales Economics, Organizations, Control (Non MeSH); Economics; Economics, Medical Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges Amounts charged to the patient as payer for medical services. Economics, Medical (66-67)  n S&K Fees, Dental N03.219.224.426; N03.219.442.301 CLHILJSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Economics, Dental Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges Amounts charged to the patient as payer for dental services. Economics, Dental (66-67) n &JFees and Charges N03.219.442 CLHILJSNSTTD Rate Setting and Review Fee Schedules Economics, Organizations, Control (Non MeSH); Economics Capitation Fee; Fee-for-Service Plans; Fees, Dental; Fees, Medical; Fees, Pharmaceutical (+ 1); Hospital Charges; Prescription Fees; Rate Setting and Review Amounts charged to the patient as payer for health care services. Economics (66-67) CLECHILJMTOGSNSTTDUT ,nBPFeeding Methods (Non MeSH) E02.421 Therapeutics Bottle Feeding; Enteral Nutrition; Parenteral Nutrition (+ 4) AECLCTECHIISMOMTNUPXSNSTTDUTVE n! J"Feeding Behavior F01.145.407 CLDEEHPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Fasting; Food Habits; Food Preferences Behavioral responses or sequences associated with eating including modes of feeding, rhythmic patterns of eating, and time intervals. Behavior (66-68); Nutrition (66-68) AEBLCFCLDEEHMEPHPXREUR $nbA0,Feedback F04.669.260; G07.621.475; L01.143.283.425 DEPHRE Biofeedback (Psychology) Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH) Physiology, General (Non MeSH); Homeostasis Information Science; Communication; Cybernetics The situation in which some aspect of the output regulates the state of the system. n 1 fFee-for-Service Plans N03.219.442.195; N03.219.521.710.305.090; N04.452.758.745.225 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Private Practice  Blue Cross; Blue Shield Method of charging whereby a physician or other practitioner bills for each encounter or service rendered. In addition to physicians, other health care professionals are reimbursed via this mechanism. Fee-for-service plans contrast with salary, per capita, and prepayment systems, where the payment does not change with the number of services actually used or if none are used. (From Discursive Dictionary of Health Care, 1976). Fees, Medical (69-94)  nEx!Fee Schedules N04.452.313 CLECHILJOGSNSTTDUT Fees and Charges Health Services Administration (Non MeSH); Organization and Administration Relative Value Scales A listing of established professional service charges, for specified dental and medical procedures. Economics (66-67) $nWtFeces, Impacted C06.405.469.531.424 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Obstruction Formation of a large firm mass of stood in the rectum or distal colon. nNpXFeces A12.459 CHCYENMIPS Manure; Melena Fluids and Secretions (Non MeSH) Meconium CHCYDEENIMMEMIPHPSRARERISEUSVI  n  ( "Fecal Incontinence C06.405.469.860.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Encopresis Defecation Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus.  nNiuFeathers A13.370 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Allergens Animal Terms (Non MeSH) nQ  : Feasibility Studies E05.318.760.550; G03.850.520.835.550; H01.770.644.300; N05.715.360.775.350 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH) Physical Sciences (Non MeSH); Science; Research Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH) Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. nTFear F01.470.361 CLDEPHRE Phobic Disorders Behavior and Behavior Mechanisms (Non MeSH); Emotions Dental Anxiety; Panic The affective response to an actual current external danger which subsides with the elimination of the threatening condition. BLCFCICLCODEDHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRISUTHURUSVI $n" ALFavre-Racouchot Syndrome C17.800.271.125.350; C17.800.805.711.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Facial Dermatoses; Acneiform Eruptions (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sebaceous Gland Diseases (Non MeSH) Actinic elastosis occurring primarily in elderly men, in which comedones, pilosebaceous cysts, and large folds of furrowed, yellowed skin are seen in the periorbital region. (From Dorland, 27th ed). n$.NFavism C15.378.071.141.150.480.370; C15.378.071.141.370; C21.613.415.341; C21.613.756.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Glucosephosphate Dehydrogenase Deficiency Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Food Poisoning Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Plant Poisoning Hemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the Vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes. n'I \NFatty Liver, Alcoholic C06.552.241.390; C06.552.645.390; C21.613.053.270.645.390 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Fatty Liver Digestive System Diseases; Liver Diseases; Liver Diseases, Alcoholic Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism; Liver Diseases, Alcoholic Fatty liver in alcoholics. It is potentially reversible and may be associated with alcoholic hepatitis or cirrhosis. Alcoholism (66-77); Fatty Liver (66-77) n*AL1Fatty Liver C06.552.241 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Fatty Liver, Alcoholic; Reye's Syndrome Yellow discoloration of the liver due to fatty degeneration of liver parenchymal cells. (Stedman, 25th ed). n-kN20Fatty Alcohols D02.033.555; D10.516.289 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids Alcohol, Propyl; Alcohols, Amyl; Alcohols, Butyl (+ 2); Alcohols, Hexyl; Alcohols, Octyl; Dolichol (+ 1); Farnesol; Lauryl Alcohol (+ 1); Sodium Tetradecyl Sulfate Alcohol, Propyl; Alcohols, Amyl; Alcohols, Butyl (+ 2); Alcohols, Hexyl; Alcohols, Octyl; Dolichol (+ 1); Farnesol; Lauryl Alcohol (+ 1); Sodium Tetradecyl Sulfate Alcohols (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  n.8jDFatty Acids, Volatile D02.241.081.465; D10.516.251.400 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Acetic Acids; Butyrates (+ 6); Caproates (+ 1); Propionates (+ 1); Valerates (+ 3) Acetic Acids (+ 1); Butyrates (+ 3); Caproates (+ 1); Propionates (+ 1); Valerates (+ 3) Fatty Acids (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  n1&@BFatty Acids, Unsaturated D02.241.081.436; D10.516.251.355 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Arachidonic Acids (+ 2); Cerulenin; Eicosanoids (+ 15); 5,8,11,14-Eicosatetraynoic Acid; 8,11,14-Eicosatrienoic Acid; Fatty Acids, Monounsaturated (+ 10); Fatty Acids, Omega-3 (+ 3); Gefarnate; Ionomycin; Linoleic Acids; Linolenic Acids (+ 2); Methoprene; Prostaglandins (+ 27); Sorbic Acid; Thromboxanes Arachidonic Acids (+ 2); Eicosanoids (+ 15); 5,8,11,14-Eicosatetraynoic Acid; 8,11,14-Eicosatrienoic Acid; Fatty Acids, Essential (+ 6); Fatty Acids, Monounsaturated (+ 10); Fatty Acids, Omega-3 (+ 3); Gefarnate; Ionomycin; Linoleic Acids; Linolenic Acids (+ 2); Prostaglandins (+ 27); Sorbic Acid; Thromboxanes Fatty Acids, Essential (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  n4L&@%DFatty Acids, Omega-3 D02.241.081.436.292; D10.516.212.302.380.410; D10.516.251.355.337; D10.516.627.430.450; J01.740.250.410; J01.740.350.450 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Fish Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Fish Oils alpha-Linolenic Acid; Docosahexaenoic Acids; 5,8,11,14,17-Eicosapentaenoic Acid alpha-Linolenic Acid; Docosahexaenoic Acids; 5,8,11,14,17-Eicosapentaenoic Acid alpha-Linolenic Acid; Docosahexaenoic Acids; 5,8,11,14,17-Eicosapentaenoic Acid Docosahexaenoic Acids; 5,8,11,14,17-Eicosapentaenoic Acid alpha-Linolenic Acid; Docosahexaenoic Acids; 5,8,11,14,17-Eicosapentaenoic Acid Docosahexaenoic Acids; 5,8,11,14,17-Eicosapentaenoic Acid A group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness. Fatty Acids (66-72); Fatty Acids, Unsaturated (73-89); Fish Oils (66-89) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $n8@E|YDFatty Acids, Nonesterified D10.516.251.310 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids n@4 @LFatty Acids, Monounsaturated D02.241.081.436.275; D10.516.251.355.325 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Alprostadil; Capsaicin; Cilastatin; Crotonic Acids (+ 1); Erucic Acids; 6-Ketoprostaglandin F1 alpha; Oleic Acids (+ 1); Undecylenic Acids Alprostadil; Capsaicin; Cilastatin; Crotonic Acids (+ 1); Erucic Acids; 6-Ketoprostaglandin F1 alpha; Oleic Acids (+ 1); Undecylenic Acids Fatty acids which are unsaturated in only one position. Fatty Acids (66-72); Fatty Acids, Unsaturated (73-87) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $nA".8NDADFatty Acids, Essential D10.516.251.355.310 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Arachidonic Acids (+ 1); Linoleic Acids; Linolenic Acids (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR nDBjNDFatty Acids D02.241.081.407; D10.516.251 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Lipids and Antilipemic Agents (Non MeSH); Lipids Caprylates (+ 1); Decanoic Acids (+ 1); Eicosanoic Acids (+ 1); Heptanoic Acids (+ 1); Lauric Acids (+ 1); Mycolic Acids; Myristic Acids (+ 1); Palmitic Acids (+ 2); Prostanoic Acids; Sodium Morrhuate; Stearic Acids (+ 1) Caprylates (+ 1); Decanoic Acids (+ 1); Eicosanoic Acids (+ 1); Fatty Acids, Nonesterified; Fatty Acids, Unsaturated (+ 79); Fatty Acids, Volatile (+ 14); Heptanoic Acids (+ 1); Lauric Acids (+ 1); Mycolic Acids; Mycophenolic Acid; Myristic Acids (+ 1); Palmitic Acids (+ 1); Prostanoic Acids; Sodium Morrhuate; Stearic Acids (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR nFX"@DFatty Acid Synthetase Complex D08.586.464.397; D08.586.600.317 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Fatty Acids/BI (66-70); Ligases (66-70) nJu$&F2Fatty Acid Desaturases D08.586.682.420.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases Stearoyl-CoA Desaturase Enzymes that catalyze the conversion of saturated fatty acid CoA complexes to unsaturated fatty acid CoA complexes in the presence of any acceptor. They include EC 1.3.1.8, EC 1.3.99.3 and EC 1.14.99.5. nLFhFats, Unsaturated D10.516.212.507 ADAEAGAIANCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats Castor Oil; Cod Liver Oil; Corn Oil; Cottonseed Oil; Croton Oil; Linseed Oil; Safflower Oil; Sesame Oil; Soybean Oil; Triolein AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR nN2D@Fats D10.516.212 ADAEAGAIANCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTU Lipids Lipids and Antilipemic Agents (Non MeSH); Lipids Dietary Fats (+ 15); Fats, Unsaturated (+ 10) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESNSTTOTUURUTVI  nO2 <:NFatigue Syndrome, Chronic C02.330; C05.651.310; C10.228.440.600; C23.888.391.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Neurasthenia; Fibromyalgia; Herpesvirus 4, Human Virus Diseases Musculoskeletal Diseases; Muscular Diseases Nervous System Diseases; Central Nervous System Diseases; Encephalomyelitis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Fatigue Syndrome of unknown cause, characterized by debilitating fatigue of at least six months' duration, diffuse pains, sore throat, tender lymph nodes, mild fever, decreased ability to concentrate, and depression. The etiology is suspected to be viral or immunologic. The syndrome has been linked to Epstein-Barr virus (HERPESVIRUS 4, HUMAN) by serologic tests but a causal relationship remains doubtful. There are suggestions that chronic fatigue syndrome (sometimes called myalgic encephalomyelitis) may be identical to neurasthenia and fibromyalgia. Encephalomyelitis (66-89); Fatigue (77-89); Muscular Diseases (66-89); Virus Diseases (86-89)  nQ@P:vpFatigue C23.888.391 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Exertion Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Fatigue Syndrome, Chronic That state, following a period of mental or bodily activity, characterized by a lessened capacity for work and reduced efficiency of accomplishment, usually accompanied by a feeling of weariness, sleepiness, or irritability. (Stedman, 25th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $nU N XPFathers F01.829.263.500.320.100; I01.880.225.500.340.210; M01.620.390 CLEDHILJPXSN Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Nuclear Family; Parents Social Sciences; Sociology; Family; Nuclear Family; Parents Named Groups (Non MeSH); Parents Male parents, human or animal. Father-Child Relations (68-77); Male (66-77); Paternal Behavior (69-77) nX} E'VFather-Child Relations F01.829.263.370.290.110 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Relations (Non MeSH); Parent-Child Relations Interaction between the father and the child. Parent-Child Relations (66-67) nZd8$Fatal Outcome E05.318.308.985.550.325; G03.850.505.400.975.550.325; G03.850.520.308.985.550.325; L01.280.975.550.325; N01.224.935.698.201 Mortality; Death Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Information Science; Data Collection; Vital Statistics; Mortality Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. specific disease (66-93); specific procedure (66-93) n[S??Fat Necrosis C23.739.638.365 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Necrosis A condition in which the neutral fats in the cells of adipose tissue are split into fatty acids and glycerol. Necrosis (66-76) n`^NfFat Emulsions, Intravenous D10.516.212.302.450; D26.394.225.220.345.375 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Parenteral Nutrition Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Colloids; Emulsions Emulsions of fats or lipids used primarily in parenteral feeding. Dietary Fats (66-78); Fats (66-78); Lipids (66-78); Oils (66-78)  na 2,ORFat Body A13.365 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) A nutritional reservoir of fatty tissue found mainly in insects and amphibians. Adipose Tissue (66-79) nd  :_Fasting E05.272.549; F01.145.407.400 AEBLCFMEPHPXUR Hunger; Starvation Food Deprivation Miscellaneous Techniques (Non MeSH); Diet Behavior and Behavior Mechanisms (Non MeSH); Behavior; Feeding Behavior Abstaining from all food.  ne% "!Fast Neutrons H01.671.579.404.645.368 AECLDUHITU Physical Sciences (Non MeSH); Physics; Nuclear Physics; Elementary Particles; Neutrons Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts. Neutrons (66-70) nfdhyFascioloidiasis C03.335.349.444; C03.335.865.399; C03.701.377.444; C22.674.377.444 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Helminthiasis; Trematode Infections Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Infection of cattle and other herbivores with the giant liver fluke Fascioloides magna. It is characterized by extensive destruction of the liver parenchyma. Trematode Infections (66-67) ngLJ_"Fasciolidae B01.500.736.715.408 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda Fasciola (+ 1) A family of flukes of the class Trematoda occurring primarily in the liver of animals and man. There are six genera: Fasciola, Fasciolopsis, Fascioloides, Tenuifasciola, Parafasciolopsis, and Protofasciola. The adult form of Fasciolopsis occurs in the intestines of pigs and man. Trematoda (66-81)  nj*=FFascioliasis C03.335.865.354; C03.518.424; C06.552.664.424 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections Parasitic Diseases; Liver Diseases, Parasitic Digestive System Diseases; Liver Diseases; Liver Diseases, Parasitic Helminth infection of the liver caused by species of Fasciola. nl5PLFasciola hepatica B01.500.736.715.408.380.420 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Fasciolidae; Fasciola A species of helminth commonly called the sheep liver fluke. It occurs in the biliary passages, liver, and gallbladder during various stages of development. Snails and aquatic vegetation are the intermediate hosts. Occasionally seen in man, it is most common in sheep and cattle. nn*XJFasciola B01.500.736.715.408.380 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Fasciolidae Fasciola hepatica A genus of trematode liver flukes of the family Fasciolidae. Two species of this genus are F. hepatica and F. gigantica. The parasites are found in the liver and gallbladder and associated ducts in mammals and occasionally man. F. gigantica occurs rarely in man. np *L9Fasciitis C05.321 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Inflammation of the fascia. There are three major types: 1) Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2) Necrotizing fasciitis, a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3) Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma. Eosinophilia (66-80); Eosinophils (66-80); Fascia (66-80); Inflammation (66-80); Necrosis (66-80) nr  NvFasciculation C10.597.370; C23.888.592.370 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Involuntary contraction of groups (fasciculi) of muscle fibers, usually at intervals of a half second or more. nw"NFascia Lata A02.340.424 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Fascia Fascia (66-71); Thigh (66-71) nx:%&Fascia A02.340 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System Fascia Lata ny  :Farnesol D02.033.555.600; D02.455.849.765.424; D10.516.289.600 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Sesquiterpenes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols nzW =:Farmer's Lung C08.381.483.125.365; C08.674.055.365; C20.543.480.680.075.365; C21.447.080.365 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Alveolitis, Extrinsic Allergic Respiratory Tract Diseases; Respiratory Hypersensitivity; Alveolitis, Extrinsic Allergic Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity; Alveolitis, Extrinsic Allergic Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Agricultural Workers' Diseases Systemic and pulmonary reactions resulting from inhalation of dust from moldy hay, threshing dust, or moldy straw, by persons who have become hypersensitive to antigens in the dust. It is most often associated with inhalation of spores of Micromonospora faeni or Thermoactinomyces vulgaris. (From Dorland, 27th ed). n{XLqFar East Z01.252.474 EHEP Geographicals (Non MeSH); Asia China (+ 1); Hong Kong; Japan (+ 1); Korea; Macao; Mongolia; Taiwan n 'ZFantasy F01.393.351; F02.463.188.634.507 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Psychologic Processes and Principles (Non MeSH); Mental Processes; Cognition; Imagination An imagined sequence of events or mental images, e.g., daydreams. Imagination (66-67) n &OFANFT D02.640.600.290; D03.383.312.649.290; D03.383.871.250; D26.191.365 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitro Compounds; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans; Nitrofurans Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Miscellaneous Drugs and Agents (Non MeSH); Carcinogens N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide. Potent nitrofuran derivative tumor initiator; causes bladder tumors in all animals studied; is mutagenic to many bacteria. Formamide (72-74); Nitrofurans (72-74); Thiazoles (70-74) n8 L.9FFanconi's Anemia C15.378.071.085.400 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Aplastic Congenital hypoplastic anemia, probably hereditary, with multiple abnormalities. n&Li\Fanconi Syndrome C12.777.419.250; C12.777.419.815.368.210; C18.452.648.851.368.210 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors; Cystinosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors; Cystinosis Constellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration. nILFamous Persons K01.517.211.506; M01.228 Humanities; Literature; Biography Named Groups (Non MeSH) nEFamotidine D03.383.871.215; D14.100.375.425.425.290; D19.316.203.308 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. The drug does not affect cardiovascular, renal, endocrine, pancreatic exocrine, or gastrointestinal motility functions. No clinically important interactions with other drugs have been described. It is an effective agent in the therapy of duodenal, gastric, and peptic ulcer, as well as of Zollinger-Ellison syndrome. Anti-Ulcer Agents (77-89); Histamine H2 Receptor Blockaders (77-89); Thiazoles (66-89) nUA:s^gFamily Therapy F04.754.864.581.273 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy; Psychotherapy, Group A form of group psychotherapy. It involves treatment of more than one member of the family simultaneously in the same session. n=Family Relations (Non MeSH) F01.829.263.370 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family Intergenerational Relations; Maternal Behavior; Maternal Deprivation; Parent-Child Relations (+ 2); Parenting; Paternal Behavior; Paternal Deprivation; Sibling Relations DEEHHIPHPXRETD n"VFamily Practice G02.403.776.230 CLECEDHIISLJMAMTOGSNSTTD Comprehensive Health Care; Physicians, Family Health Occupations; Medicine; Specialties, Medical A medical specialty concerned with the provision of continuing, comprehensive primary health care for the entire family. nF6<Family Planning Policy I01.880.604.710.608.200; N03.706.710.608.214 ECHILJTD Population Control Social Sciences; Sociology; Social Control, Formal; Policies (Non MeSH); Public Policy Economics, Organizations, Control (Non MeSH); Social Control, Formal; Policies (Non MeSH); Public Policy A course or method of action selected, usually by a government, to guide and determine present and future decisions on population control by limiting the number of children or controlling fertility, notably through family planning and contraception within the nuclear family. Family Planning (68-91); Public Policy (78-91)  n2 @9Family Planning N02.421.143.401 CLECEDHILJMAMTOGSDSNSTTDUT Contraception Population Control; Contraception Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Birth Intervals; Genetic Counseling; Knowledge, Attitudes, Practice Programs or services designed to assist the family in controlling reproduction by either improving or diminishing fertility. CLECEDHILJMAMTOGPXSDSNSTTDUT (n(iO Family Leave N01.824.417.700.162; N04.452.677.800.162 CLECHILJSNSTTDUT Population Characteristics (Non MeSH); Socioeconomic Factors; Income; Salaries and Fringe Benefits Health Services Administration (Non MeSH); Organization and Administration; Personnel Management; Salaries and Fringe Benefits Parental Leave Parental Leave The authorized absence from work of a family member to attend the illness or participate in the care of a parent, a sibling, or other family member. For the care of a parent for a child or for pre- or postnatal leave of a parent, PARENTAL LEAVE is available. Family (88-91); Parental Leave (88-92)  n.$80Family Health N01.407.540.205 EH Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Family (66-78); Health (66-78) n]6'Family Characteristics F01.829.263.315; G03.850.505.400.400; I01.240.361; I01.880.225.423; N01.224.361; N01.824.308 EH Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography Social Sciences; Demography Social Sciences; Sociology; Family Population Characteristics (Non MeSH); Demography Population Characteristics (Non MeSH); Socioeconomic Factors Marital Status (+ 5) Birth Order Birth Intervals; Birth Order; Marital Status (+ 5) Marital Status (+ 5) Birth Intervals; Birth Order; Marital Status (+ 5) Marital Status (+ 5) Size and composition of the family. Family (66-67) CLECEDEHHILJPCPXSNTD $nj-Family F01.829.263; I01.880.225 EHPX Consanguinity Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Social Sciences; Sociology Birth Order; Family Characteristics (+ 6); Family Relations (Non MeSH) (+ 10); Nuclear Family (+ 7) Adoption; Family Characteristics (+ 6); Illegitimacy; Nuclear Family (+ 7) A socially sanctioned unit consisting of parents or parent substitutes and children. CLDEECEDEHHILJPCPHPXRESNTD $n^ kdFalse Positive Reactions E01.223.366; E01.354.506 Predictive Value of Tests Diagnosis; Diagnosis, Laboratory Diagnosis; Diagnostic Errors specific disease/diagnosis (66-67); specific test (66-67) n HEFalse Negative Reactions E01.223.338; E01.354.340 Predictive Value of Tests Diagnosis; Diagnosis, Laboratory Diagnosis; Diagnostic Errors Diagnosis (66-69) n HFallopian Tubes A05.360.319.114.373 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Hysterosalpingography; Salpingostomy; Sterilization, Tubal Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri Two long muscular tubes that transport ova from the ovaries to the uterus. They extend from the horn of the uterus to the ovaries and consist of an ampulla, an infundibulum, an isthmus, two ostia, and a pars uterina. The walls of the tubes are composed of three layers: mucosal, muscular, and serosal. nx8CJhFallopian Tube Patency Tests E01.249.390; E05.820.390 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Miscellaneous Techniques (Non MeSH); Reproduction Techniques Methods for assessing the patency of the fallopian tubes. Fallopian Tubes (66-74); Hysterosalpingography (66-74); Infertility, Female/DI (66-74) n#"uFfFallopian Tube Neoplasms C04.588.945.418.365; C13.371.056.390.390; C13.371.270.500; C13.371.820.800.418.365 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Fallopian Tube Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female n\X=Fallopian Tube Diseases C13.371.056.390 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases Fallopian Tube Neoplasms; Salpingitis Adnexal Diseases (66-79); Fallopian Tubes (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  nN}-<XFailure to Thrive C23.509.350 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Growth Disorders The condition of an individual who is two standard deviations below the mean of weight or persistently below his own growth curve. Height and head circumference may also be affected. The failure may be due to organic disorders and/or psychosocial problems. Growth Disorders (69-83) nLH0Fadrozole D02.626.400; D03.383.374.270; D06.347.300.320; D08.373.382; D22.204.419 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile. A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer. Imidazoles (88-92); Nitriles (88-92) n S:-FAD D08.176.315; D13.695.667.138.506; D13.695.827.068.506 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides n =D=Faculty, Nursing I02.463.473; M01.526.339.473; M01.526.485.390; N02.360.390 HIOGSDSNSTUT Education; Faculty Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Faculty Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel The teaching staff and members of the administrative staff having academic rank in a nursing school. nDxFaculty, Medical I02.463.373; M01.526.339.373; M01.526.485.375; N02.360.375 HIOGSDSNSTUT Education; Faculty Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Faculty Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel The teaching staff and members of the administrative staff having academic rank in a medical school. n!DxFaculty, Dental I02.463.273; M01.526.339.273; M01.526.485.360; N02.360.360 HIOGSDSNSTUT Education; Faculty Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Faculty Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel The teaching staff and members of the administrative staff having academic rank in a dental school. n>DwFaculty I02.463; M01.526.339 HIOGSDSNSTUT Teaching Education Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Faculty, Dental; Faculty, Medical; Faculty, Nursing Faculty, Dental; Faculty, Medical; Faculty, Nursing The teaching staff and members of the administrative staff having academic rank in an educational institution. Teaching (66-67) $nY  XzFactor XIII Deficiency C15.378.463.134.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A deficiency of blood coagulation factor XIII or fibrin stabilizing factor (FSF) which enables fibrin to form a firm blood clot. Deficiency of this factor produces a clinical hemorrhagic diathesis. (Dorland, 27th ed). Hemorrhagic Diathesis (66-72) n2N#Factor XIII D12.776.124.125.475; D19.461.270.229.379 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Protein-Glutamine gamma-Glutamyltransferase Protein-Glutamine gamma-Glutamyltransferase Fibrin stabilizing factor. It is a glycoprotein activated by thrombin in the presence of calcium to form factor XIIIa. Factor XIII is found evenly distributed between plasma and platelets. Its function is to stabilize the formation of the fibrin polymer (clot) which culminates the coagulation cascade. ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  n.B^cDFactor XIIa D08.586.277.656.732.760.324; D12.776.124.125.450.324; D19.461.270.229.377.324 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor XII Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor XII Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein (with cofactor HMWK) cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments (Hageman-Factor fragments). These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII. Factor XII (66-89); Peptide Fragments (79-87); Serine Proteinases (88-89) n0UBYFactor XII Deficiency C15.378.463.134.420 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A condition in patients with no personal or family history of hemorrhagic diathesis and marked by greatly prolonged clotting time. It results from an inherited deficiency of blood coagulation factor XII. Blood Coagulation Disorders (66-77); Factor XII (66-77) nNCFactor XII D12.776.124.125.450; D19.461.270.229.377 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor XIIa Factor XIIa Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. nT.BFactor XIa D08.586.277.656.732.760.320; D12.776.124.125.425.320; D19.461.270.229.375.320 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor XI Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor XI Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK (high molecular weight kininogen). Factor XIa then activates factor IX to factor IXa in the presence of calcium. Factor XI (72-89); Serine Proteinases (88-89) nUB&8Factor XI Deficiency C15.378.463.134.395 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A deficiency of blood coagulation factor XI (known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting in a systemic blood-clotting defect called hemophilia C or Rosenthal's syndrome, that may resemble classical hemophilia. (Dorland, 27th ed). nҬN<Factor XI D12.776.124.125.425; D19.461.270.229.375 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor XIa Factor XIa Stable blood coagulation factor involved in the intrinsic pathway. The activated form XIa activates factor IX to IXa. Deficiency of factor XI is often called hemophilia C. n.BFactor Xa D08.586.277.656.732.760.315; D12.776.124.125.400.315; D19.461.270.229.373.315 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor X Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor X Activated form of factor X that participates in both the intrinsic and extrinsic pathways of blood coagulation. It catalyzes the conversion of prothrombin to thrombin in conjunction with other cofactors. Factor X (70-89); Serine Proteinases (88-89) nטUB7Factor X Deficiency C15.378.463.134.676.505 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders; Hypoprothrombinemias Blood coagulation disorder usually inherited as an autosomal recessive trait, though it can be acquired. It is characterized by defective activity in both the intrinsic and extrinsic pathways, impaired thromboplastin time, and impaired prothrombin consumption. n=N,Factor X D12.776.124.125.400; D19.461.270.229.373 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor Xa Factor Xa Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. nݫ .B'Factor VIIIa D12.776.124.125.350.300; D19.461.270.229.369.300 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor VIII Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor VIII Activated form of factor VIII. The B-domain of factor VIII is proteolytically cleaved by thrombin to form factor VIIIa. Factor VIIIa exists as a non-covalent dimer in a metal-linked (probably calcium) complex and functions as a cofactor in the enzymatic activation of factor X by factor IXa. Factor VIIIa is similiar in structure and generation to factor Va. Factor VIII (81-89) n6BFactor VIII D12.776.124.125.350; D19.461.270.229.369 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor VIIIa Factor VIIIa Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. n.B }Factor VIIa D08.586.277.656.732.760.300; D12.776.124.125.325.300; D19.461.270.229.367.300 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor VII Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor VII Activated form of factor VII. Factor VIIa activates factor X in the extrinsic pathway of blood coagulation. Factor VII (75-89) n[UBFactor VII Deficiency C15.378.463.134.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A deficiency of blood coagulation factor VII (known as proconvertin or prothrombokinase or serum prothrombin conversion accelerator (SPCA) or stable factor) resulting in a hemorrhagic tendency. It may be hereditary as an autosomal recessive trait or acquired in association with vitamin K deficiency. (Dorland, 27th ed). nzNuFactor VII D12.776.124.125.325; D19.461.270.229.367 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor VIIa Factor VIIa Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. The activated form then catalyzes the activation of factor X to factor Xa. n.BFactor Va D12.776.124.125.300.300; D19.461.270.229.365.300 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor V Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor V Activated form of factor V. It is an essential cofactor for the activation of prothrombin catalyzed by factor Xa. Factor V (74-89) n6BFactor V Deficiency C15.378.463.134.676.339 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders; Hypoprothrombinemias A deficiency of blood coagulation factor V (known as proaccelerin or accelerator globulin or labile factor) leading to a rare hemorrhagic tendency known as Owren's disease or parahemophilia. It varies greatly in severity. Factor V deficiency is an autosomal recessive trait. (Dorland, 27th ed). nBNZFactor V D12.776.124.125.300; D19.461.270.229.365 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor Va Factor Va Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor V accomplishes this by forming a complex with factor Xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor V leads to Owren's disease. n .BRFactor IXa D08.586.277.656.732.760.310; D12.776.124.125.375.310; D19.461.270.229.371.310 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors; Factor IX Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors; Factor IX Activated form of factor IX. This activation can take place via the intrinsic pathway by the action of factor XIa and calcium, or via the extrinsic pathway by the action of factor VIIa, thromboplastin, and calcium. Factor IXa serves to activate factor X to Xa by cleaving the arginyl-leucine peptide bond in factor X. Factor IX (75-89); Serine Proteinases (88-89) nUBx8Factor IX D12.776.124.125.375; D19.461.270.229.371 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Blood Coagulation Factors Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Factor IXa Factor IXa Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in hemophilia B or Christmas disease. n.B5Factor Analysis, Statistical E05.318.740.400; G03.850.520.830.400; H01.548.832.373; N05.715.360.750.350 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics A set of statistical methods for analyzing the correlations among several variables in order to estimate the number of fundamental dimensions that underlie the observed data and to describe and measure those dimensions. It is used frequently in the development of scoring systems for rating scales and questionnaires. n"TrFactitious Disorders F03.709.438.500 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders Munchausen Syndrome (+ 1) Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural, and which are under voluntary control. BLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI  oF` HFacility Regulation and Control N03.706.280; N05.700.300 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Formal voluntary or governmental procedures and standards required of hospitals and health or other facilities to improve operating efficiency, and for the protection of the consumer. o&Facility Design and Construction J01.086.339; N02.278.200 CLECHIISLJMAMTSNSTTD Building Codes Health Facility Planning Technology, Industry, Agriculture (Non MeSH); Architecture Facilities, Manpower and Services (Non MeSH); Health Facilities Architectural Accessibility; Elevators and Escalators; Floors and Floorcoverings; Hospital Design and Construction; Interior Design and Furnishings; Location Directories and Signs; Parking Facilities Building Codes; Hospital Design and Construction Architecture, exterior and interior design, and construction of facilities other than hospitals, e.g., dental schools, medical schools, ambulatory care clinics, and specified units of health care facilities. The concept also includes architecture, design, and construction of specialized contained, controlled, or closed research environments including those of space labs and stations. Architecture (66) CLECHIISLJMAMTOGSDSNSTTDUT ,o'Facilities, Manpower and Services (Non MeSH) N02 Health Facilities (+ 163); Health Manpower; Health Personnel (+ 61); Health Promotion; Health Services (+ 168); Housekeeping (+ 1); Maintenance (+ 1); Missions and Missionaries AECLCTECEDHIISLJMAMOMTNUOGPXRHSDSNSTTDUTVE o 5.Facial Paralysis C10.597.622.214; C10.772.204.266.297; C23.888.592.636.214 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Facial Nerve Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis Herpes Zoster Oticus Herpes Zoster Oticus; Melkersson-Rosenthal Syndrome Herpes Zoster Oticus BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI o aANElPFacial Pain C07.465.300; C10.597.617.363; C23.888.592.612.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Facial Neuralgia; Trigeminal Neuralgia; Temporomandibular Joint Syndrome Stomatognathic Diseases; Mouth Diseases Nervous System Diseases; Neurologic Manifestations; Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pain in the face including the orofacial and craniofacial regions. Face (66-85); Facial Neuralgia (66-85); Pain (66-85); Temporomandibular Joint Syndrome (73-85); Trigeminal Neuralgia (66-85)  o-9NTPFacial Neuralgia C10.772.204.266.234; C10.772.537.472 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Facial Pain Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Facial Nerve Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Neuralgia o*NFacial Nerve Diseases C10.772.204.266 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Facial Neuralgia; Facial Paralysis (+ 2) Facial Nerve (66-80); Peripheral Nerve Diseases (66-80) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  oNb2CPFacial Nerve A08.800.800.120.250 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves Chorda Tympani Nerve; Geniculate Ganglion The 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and salivary glands, and convey afferent information for taste from the anterior two-thirds of the tongue and for touch from the external ear. oq8[2Facial Neoplasms C04.588.443.392 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms ogXPFacial Muscles A02.633.567.400; A14.363 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Stomatognathic System Muscles of facial expression or mimetic muscles that include the numerous muscles supplied by the facial nerve that are attached to and move the skin of the face. (From Stedman, 25th ed). oV:SFacial Injuries C21.866.460.589.338 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries Eye Injuries (+ 3); Jaw Fractures (+ 2); Mandibular Injuries (+ 1); Zygomatic Fractures General or unspecified injuries to the soft tissue or bony portions of the face. oN~nbFacial Hemiatrophy C23.304.280.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Facial Asymmetry oNuFacial Expression E01.706.389; F01.145.209.530.385 Physiognomy Diagnosis; Physical Examination Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication  Smiling Observable changes of expression in the face in response to emotional stimuli. Facies, the characteristic expression of a particular condition, is also included in this concept. PHPX  o& Facial Dermatoses C17.800.271 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Acneiform Eruptions (Non MeSH) (+ 5) oNK-Facial Bones A02.835.232.781.324 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Head Musculoskeletal System; Skeleton; Bone and Bones; Skull Jaw (+ 7); Nasal Bone; Orbit; Turbinates; Zygoma o! :D@Facial Asymmetry C23.304.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH) Facial Hemiatrophy Congenital or acquired asymmetry of the face. Face (66-76)  o"!N_8Face A01.456.505 ABAHBSEMIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Head Cheek; Chin; Eye (+ 3); Forehead; Mouth (+ 1); Nose ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI o#}$'G:Fabry's Disease C18.452.648.556.641.803.300; C18.452.648.595.803.300 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses Lysosomal storage disease caused by a deficiency of alpha-galactosidase A and resulting in an accumulation of globotriaosylceramide in the renal and cardiovascular systems. The disease is X-linked and is characterized by telangiectatic skin lesions, renal failure, and disturbances of the cardiovascular, gastrointestinal, and central nervous systems. Angiokeratoma (66-72) o$:LTF Factor D13.444.308.212.500.300; D13.444.308.283.500.300 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids A plasmid whose presence in the cell, either extrachromosomal or integrated into the bacterial chromosome, determines the "sex" of the bacterium, host chromosome mobilization, transfer via conjugation of genetic material, and the formation of sex pili. Conjugation, Genetic (68-74); Genetics (66-67) o(H 6D$8Eyelids A01.456.505.420.504; A09.371.337 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Nictitating Membrane Body Regions (Non MeSH); Head; Face; Eye Sense Organs; Eye Eyelashes Eyelashes; Meibomian Glands consider also terms at BLEPHAR-.  o+A &:L-)Eyelid Neoplasms C04.588.364.421; C11.319.421; C11.338.526 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Eye Neoplasms Eye Diseases; Eye Neoplasms Eye Diseases; Eyelid Diseases Eye Neoplasms (66-69); Eyelids (66-69); Facial Neoplasms (66-69); Skin Neoplasms (66-69) o,1XlEyelid Diseases C11.338 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Blepharitis; Blepharophimosis; Blepharoptosis; Blepharospasm; Chalazion; Ectropion; Entropion; Eyelid Neoplasms; Hordeolum Eye Diseases (66-69); Eyelids (66-69); Skin Diseases (66-69) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  o.G NKZEyelashes A01.456.505.420.504.421; A01.835.288.421; A09.371.337.338 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Body Regions (Non MeSH); Head; Face; Eye; Eyelids Body Regions (Non MeSH); Skin; Hair Sense Organs; Eye; Eyelids o0$ A8Eyeglasses E07.532.504 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Lenses o1X&Eyebrows A01.456.505.420.338; A01.835.288.296 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISUTRULUSVI Body Regions (Non MeSH); Head; Face; Eye Body Regions (Non MeSH); Skin; Hair o1 *8cEye, Artificial E04.659.371; E04.792.421; E07.858.565.371 AECLCTECHIISMIMONUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Eye (Non MeSH) Equipment and Supplies; Surgical Equipment; Prosthesis A ready-made or custom-made prosthesis of glass or plastic shaped and colored to resemble the anterior portion of a normal eye and inserted for cosmetic reasons in the socket of an enucleated or eviscerated eye. (Dorland, 27th ed). o21(Eye Proteins D12.776.306 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Crystallins; Opsin (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR o5DD HEye Protective Devices E07.712.300 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation. o673Eye Neoplasms C04.588.364; C11.319 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Orbital Neoplasms Neoplasms; Neoplasms by Site (Non MeSH) Eye Diseases Conjunctival Neoplasms; Eyelid Neoplasms; Orbital Neoplasms; Uveal Neoplasms (+ 2) Conjunctival Neoplasms; Eyelid Neoplasms; Orbital Neoplasms; Uveal Neoplasms (+ 2) o7VX@Eye Movements E01.210.271; G11.697.384 DEGEIMPHRE Electrooculography; Nystagmus; Sleep, REM Diagnosis; Diagnosis, Eye (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) Electronystagmography; Electrooculography Convergence, Ocular; Fixation, Ocular; Nystagmus, Physiologic (+ 1); Pursuit, Smooth; Saccades; Vision Disparity AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE  o92,Eye Manifestations C11.300; C23.888.357 Eye Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Ocular disorders attendant upon non-ocular disease or injury. o;gIEye Injuries, Penetrating C11.299.369; C21.866.460.589.338.366.752; C21.866.986.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries; Eye Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Wounds, Penetrating Deeply perforating or puncturing type intraocular injuries. Eye Injuries (66-89); Wounds, Penetrating (74-89) o<AN*F<Eye Injuries C11.299; C21.866.460.589.338.366 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries Eye Burns; Eye Foreign Bodies; Eye Injuries, Penetrating Eye Burns; Eye Foreign Bodies; Eye Injuries, Penetrating Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries. o>&NEye Infections, Viral C02.325; C11.294.800 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Eye Diseases; Eye Infections Conjunctivitis, Viral (+ 1); Cytomegalovirus Retinitis; Herpes Zoster Ophthalmicus; Keratitis, Herpetic (+ 1) Conjunctivitis, Viral (+ 1); Cytomegalovirus Retinitis; Herpes Zoster Ophthalmicus; Keratitis, Herpetic (+ 1) Infections of the eye caused by minute intracellular agents. These infections may lead to severe inflammation in various parts of the eye - conjunctiva, iris, eyelids, etc. Several viruses have been identified as the causative agents. Among these are Herpesvirus, Adenovirus, Poxvirus, and Myxovirus. Eye Diseases (66-89); specific viral infection (66-89)  oAP5^BEye Infections, Parasitic C03.300; C11.294.725 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases Eye Diseases; Eye Infections Acanthamoeba Keratitis; Onchocerciasis, Ocular; Toxoplasmosis, Ocular Acanthamoeba Keratitis; Onchocerciasis, Ocular; Toxoplasmosis, Ocular Mild to severe infections of the eye and its adjacent structures (adnexa) by adult or larval protozoan or metazoan parasites. Eye Diseases (66-89); specific parasitic infection (66-89)  oDP9FEye Infections, Fungal C01.539.375.450; C01.703.343; C11.294.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections Bacterial and Fungal Diseases (Non MeSH); Mycoses Eye Diseases; Eye Infections Infection by a variety of fungi, usually through four possible mechanisms: superficial infection producing conjunctivitis, keratitis, or lacrimal obstruction; extension of infection from neighboring structures - skin, paranasal sinuses, nasopharynx; direct introduction during surgery or accidental penetrating trauma; or via the blood or lymphatic routes in patients with underlying mycoses. Eye Diseases (66-89); specific fungal infection (66-89) oF1PCEye Infections, Bacterial C01.252.354; C01.539.375.354; C11.294.354 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections Eye Diseases; Eye Infections Conjunctivitis, Bacterial (+ 3); Hordeolum; Keratoconjunctivitis, Infectious; Tuberculosis, Ocular; Uveitis, Suppurative (+ 1) Conjunctivitis, Bacterial (+ 3); Hordeolum; Keratoconjunctivitis, Infectious; Tuberculosis, Ocular Conjunctivitis, Bacterial (+ 3); Hordeolum; Keratoconjunctivitis, Infectious; Tuberculosis, Ocular Infections in the inner or external eye caused by microorganisms belonging to several families of bacteria. Some of the more common genera found are Haemophilus, Neisseria, Staphylococcus, Streptococcus, and Chlamydia. Eye Diseases (66-89); specific bacterial infection (66-89)  oJi1PsFEye Infections C01.539.375; C11.294 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Eye Diseases Corneal Ulcer; Eye Infections, Bacterial (+ 7); Eye Infections, Fungal; Uveitis, Suppurative (+ 2) Corneal Ulcer; Eye Infections, Bacterial (+ 7); Eye Infections, Fungal; Eye Infections, Parasitic (+ 3); Eye Infections, Viral (+ 6); Uveitis, Suppurative (+ 2) Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness. Eye Diseases (66-89)  oNPN8Eye Hemorrhage C11.290; C23.542.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Choroid Hemorrhage; Hyphema; Retinal Hemorrhage; Vitreous Hemorrhage Choroid Hemorrhage; Hyphema; Retinal Hemorrhage; Vitreous Hemorrhage Eye or specifics (66-86); Eye Diseases (66-86); Hemorrhage (66-86) oQNPREye Foreign Bodies C11.299.338; C21.866.392.421; C21.866.460.589.338.366.504 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Foreign Bodies Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries; Eye Injuries oSAN%Eye Evisceration E04.792.431 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Eye Enucleation; Orbit Evisceration Orbit Evisceration Surgery, Operative; Surgery, Eye (Non MeSH) The surgical removal of the inner contents of the eye, leaving the sclera intact. It should be differentiated from ORBIT EVISCERATION which removes the entire contents of the orbit, including eyeball, blood vessels, muscles, fat, nerve supply, and periosteum. Eye Enucleation (89-92); Eye/surgery (66-88) $oU$+5/7Eye Enucleation E04.792.429 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Eye Evisceration Surgery, Operative; Surgery, Eye (Non MeSH) The surgical removal of the eyeball leaving the eye muscles and remaining orbital contents intact. Eye/surgery (66-88)  oW$5uEye Diseases, Hereditary C11.270; C16.131.410 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Albinism; Albinism, Ocular; Albinism, Oculocutaneous; Aniridia (+ 1); Choroideremia; Corneal Dystrophies, Hereditary (+ 1); Gyrate Atrophy; Optic Atrophy, Hereditary; Retinal Dysplasia; Retinitis Pigmentosa Albinism (+ 3); Aniridia (+ 1); Choroideremia; Corneal Dystrophies, Hereditary (+ 1); Gyrate Atrophy; Optic Atrophy, Hereditary; Retinal Dysplasia; Retinitis Pigmentosa Transmission of gene defects or chromosomal aberrations/abnormalities which are expressed in extreme variation in the structure or function of the eye. These may be evident at birth, but may be manifested later with progression of the disorder. Eye Diseases/genetics (66-89) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $oYGLX$NEye Diseases C11 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ophthalmology Asthenopia; Conjunctival Diseases (+ 15); Corneal Diseases (+ 16); Eye Abnormalities (+ 9); Eye Diseases, Hereditary (+ 12); Eye Hemorrhage (+ 4); Eye Infections (+ 24); Eye Injuries (+ 3); Eye Manifestations; Eye Neoplasms (+ 6); Eyelid Diseases (+ 9); Lacrimal Apparatus Diseases (+ 6); Lens Diseases (+ 5); Ocular Hypertension (+ 5); Ocular Hypotension; Ocular Motility Disorders (+ 11); Optic Nerve Diseases (+ 6); Orbital Diseases (+ 5); Pupillary Functions, Abnormal (+ 8); Refractive Errors (+ 6); Retinal Diseases (+ 21); Scleral Diseases (+ 1); Uveal Diseases (+ 35); Vision Disorders (+ 8); Vitreoretinopathy, Proliferative BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI o]N ZEye Color G04.185.672.360; G11.697.340 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Pigmentation Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) Color of the iris. Color (66-75) or; Eye (66-75); Iris (66-75) or; Pigmentation (66-75) oa"UEye Burns C11.299.308; C21.866.200.503; C21.866.460.589.338.366.337 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Burns Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Maxillofacial Injuries; Facial Injuries; Eye Injuries Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation. ocLANlEye Banks N02.278.065.900.400 CLECHILJMAMTOGSDSNSTTDUT Corneal Transplantation Facilities, Manpower and Services (Non MeSH); Health Facilities; Biological Specimen Banks; Tissue Banks Centers for storing various parts of the eye for future use. oe|KEye Abnormalities C11.250; C16.131.384 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Aniridia (+ 1); Anophthalmos; Blepharophimosis; Coloboma; Ectopia Lentis; Hydrophthalmos; Microphthalmos; Retinal Dysplasia Aniridia (+ 1); Anophthalmos; Blepharophimosis; Coloboma; Ectopia Lentis; Hydrophthalmos; Microphthalmos; Retinal Dysplasia Congenital absence of or defects in structures of the eye; may also be hereditary. Eye/abnormalities (77-89); specific eye heading/abnormalities (77-89) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $ofLX"eRNEye A01.456.505.420; A09.371 AHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUTRULUSVI Intraocular Pressure; Refraction, Ocular; Vision Body Regions (Non MeSH); Head; Face Sense Organs Eyebrows; Eyelids (+ 1) Anterior Eye Segment (+ 9); Conjunctiva; Eyelids (+ 2); Lacrimal Apparatus (+ 1); Lens, Crystalline (+ 3); Oculomotor Muscles; Pigment Epithelium of Eye; Retina (+ 9); Sclera; Uvea (+ 5); Vitreous Body consider also terms at OCUL-, OPHTHALM-, OPT-, and VIS-. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $oj6:>E<Exudates and Transudates A12.383 CHCYDEENIMMEMIPHPSRARERISEUSVI Ascitic Fluid; Pericardial Effusion; Pleural Effusion Fluids and Secretions (Non MeSH) ol "@(Extremities A01.378 ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI Body Regions (Non MeSH) Arm (+ 7); Leg (+ 11) omz * Extraversion (Psychology) F01.752.747.246; F02.739.794.253 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory A state in which attention is largely directed outward from the self. Personality (66-67); Psychoanalytic Theory (66-67) on&U<Extravehicular Activity J01.095.850.400 AEPH Technology, Industry, Agriculture (Non MeSH); Aviation; Space Flight Activities by crew members conducted outside the pressurized hull of a spacecraft. Extraterrestrial Environment (66-94); Space Flight (66-94) ooRbEExtravascular Lung Water A04.411.300; A12.207.395.300 CHCYDEENIMMEMIPHPSRARERISEUSVI Respiratory System; Lung Fluids and Secretions (Non MeSH); Body Fluids; Extracellular Space Water present within the lungs; its volume is roughly equal to, or a little less than, the intracellular blood volume of the lungs. Accumulations of extravascular lung water result in pulmonary edema. Body Water (72-89); Extracellular Space (78-89); Lung (69-89) oq8""nLExtravasation of Diagnostic and Therapeutic Materials C21.866.371; C23.399 BLCFCLCNCODHDIDTECEHEMENEPETHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Contrast Media; Radiography Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Symptoms and General Pathology (Non MeSH) The escape of diagnostic or therapeutic material from the vessel into which it is introduced into the surrounding tissue or body cavity. Contrast Media (66-80); specific organ or disease/radiography (67-80)  osi>J"SExtraterrestrial Environment G03.230.230 Moon; Planets; Solar System Planets; Space Flight Environment and Public Health (Non MeSH); Environment The environment outside the earth or its atmosphere. The environment may refer to a closed cabin (such as a space shuttle or space station) or to space itself, the moon, or other planets. ou!$AExtrasystole C14.280.067.470 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Premature contraction of the heart that is independent of the normal rhythm and arises in response to an impulse in some part of the heart other than the sinoatrial node. owN=Extrapyramidal Tracts A08.186.854.253; A08.612.380.239 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Spinal Cord Nervous System; Neural Pathways; Efferent Pathways oy$&6zExtraoral Traction Appliances E06.658.453.578.360 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances; Orthodontic Appliances, Removable Extraoral devices for applying force to the dentition in order to avoid some of the problems in anchorage control met with in intermaxillary traction and to apply force in directions not otherwise possible. Orthodontic Appliances, Removable (71-76) oz3#_0Extramarital Relations F01.145.792.295 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Voluntary sexual intercourse between a married person and someone other than the spouse. o|0RiExtraction, Obstetrical E04.819.774.457.392 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Obstetrical Forceps Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery Vacuum Extraction, Obstetrical Extraction of the fetus by means of obstetrical instruments.  o}8$l$IExtracorporeal Membrane Oxygenation E02.472.440.301; E02.880.301; E04.292.451 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Oxygenators, Membrane Therapeutics; General Patient Care (Non MeSH); Life Support Care Therapeutics; Respiratory Therapy Surgery, Operative; Extracorporeal Circulation Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure. Extracorporeal Circulation (71-88); Oxygenators, Membrane (71-88)  o~)1$HMExtracorporeal Circulation E04.292 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Heart Bypass, Left; Hemofiltration (+ 1); Hemoperfusion; Perfusion, Regional; Photopheresis; Ultrafiltration (+ 2) Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation. Heart, Mechanical (66)  o $Extrachromosomal Inheritance G05.225 DEGEIMPHRE Plasmids Genetics Transmission of hereditary characters by non-chromosomal replicating cytoplasmic structures such as mitochondria, plastids, and plasmids. Genetics (66-67)  o!   Extracellular Space A11.470; A12.207.395 CHDEENGEIMMEMIPHPSRARERIUSVI Cells Fluids and Secretions (Non MeSH); Body Fluids Extracellular Matrix Extravascular Lung Water Interstitial space between cells, occupied by fluid as well as amorphous and fibrous substances. CHCLCYDEENGEIMMEMIPAPHPSRARERISETRULUSVI  o @5r,Extracellular Matrix Proteins D12.776.860.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Cytoadhesin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH) Collagen (+ 2); Elastin (+ 1); Fibronectins; Laminin Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN, ELASTIN, FIBRONECTINS AND LAMININ). Extracellular Matrix (84-90) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (oe#FcD"HExtracellular Matrix A11.470.310 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Extracellular Space A meshwork-like substance found within the extracellular space and in association with the basement membrane of the cell surface. It promotes cellular proliferation and provides a supporting structure to which cells or cell lysates in culture dishes adhere. Cells, Cultured (72-83); Extracellular Space (66-83) o*!,?Extinction (Psychology) F02.463.425.770.232 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Reinforcement (Psychology) The procedure of presenting the conditioned stimulus without reinforcement to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. o yExternal Fixators E07.858.442.660.450 AECLCTECHISDSNSTTDUTVE Fracture Fixation Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices External devices which hold wires or pins that are placed through one or both cortices of bone in order to hold the position of a fracture in proper alignment. These devices allow easy access to wounds, adjustment during the course of healing, and more functional use of the limbs involved. Fracture Fixation (79-90); Orthopedic Fixation Devices (79-90)  omYJExplosions G03.230.100.090 CLECHILJPCSN Blast Injuries Environment and Public Health (Non MeSH); Environment; Disasters oYNExploratory Behavior F01.145.387; F01.658.370 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Motivation The tendency to explore or investigate a novel environment. It is considered a motivation not clearly distinguishable from curiosity. o Expiratory Reserve Volume E01.302.796.420.810.390.360; E01.302.796.420.810.970.360; G09.772.521.700.810.390.360; G09.772.521.700.810.970.360 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity; Functional Residual Capacity Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity; Vital Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity; Functional Residual Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity; Vital Capacity The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is ERV. o|Expert Testimony I01.880.604.583.232; N03.706.535.253 ECLJMTSTTDUT Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Presentation of pertinent medical data by a qualified medical specialist before a court. o*iExpert Systems L01.700.568.110.065.190 IS Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Artificial Intelligence Computer programs based on knowledge developed from consultation with experts on a problem, and the processing and/or formalizing of this knowledge using these programs in such a manner that the problems may be solved. oExpeditions I03.883.420 CLECHILJPXSNSTTD Human Activities (Non MeSH); Travel Usually refers to planned scientific data-gathering excursions. ox-JExpectorants D26.415 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Antitussive Agents Cough; Antitussive Agents Miscellaneous Drugs and Agents (Non MeSH) Acetylcysteine; Ambroxol; Bromhexine; Carbocysteine; Guaiacol (+ 1); Ipecac (Syrup); Mesna Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (oD , 2o:Exotropia C10.772.204.410.810.440; C11.590.810.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders; Strabismus Eye Diseases; Ocular Motility Disorders; Strabismus Strabismus in which the deviating eye turns templeward. Strabismus (66-82) oe .NCExotoxins D24.185.926.350 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Bacterial Toxins (77); Toxins (66-77) o: BV/Exostoses, Multiple Hereditary C04.557.450.565.575.610.615.325; C05.116.099.708.670.615.325; C05.116.540.310.500; C23.739.415.310.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Bone Tissue; Osteochondroma; Osteochondromatosis Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Osteochondroma; Osteochondromatosis Musculoskeletal Diseases; Bone Diseases; Hyperostosis; Exostoses Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Hyperostosis; Exostoses Hereditary disorder transmitted by an autosomal dominant gene and characterized by multiple exostoses (multiple osteochondromas) near the ends of long bones. The genetic abnormality results in a defect in the osteoclastic activity at the metaphyseal ends of the bone during the remodeling process in childhood or early adolescence. The metaphyses develop benign, bony outgrowths often capped by cartilage. A small number undergo neoplastic transformation. Exostoses (66-67) o$pN1Exostoses C05.116.540.310; C23.739.415.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Hyperostosis Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Hyperostosis Exostoses, Multiple Hereditary Exostoses, Multiple Hereditary Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component. o( &NFExoribonucleases D08.586.277.352.365.300; D08.586.277.352.700.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Exonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases A family of enzymes that catalyze the exonucleolytic cleavage of RNA. It includes EC 3.1.13.-, EC 3.1.14.-, EC 3.1.15.-, and EC 3.1.16.-. EC 3.1.-. Exonucleases (73-82); Phosphatases (66-72); Ribonucleases (66-82) o>6FNExophthalmos C11.675.349 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Orbital Diseases Graves' Disease Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye. oN&Exophiala B05.354.381.546.355 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A normally saprophytic dematiaceous deuteromycetous fungal genus of the class Hyphomycetes, order Hyphomycetales. Infections in humans include phaeohyphomycosis, peritonitis, and chromoblastomycosis. Deuteromycetes (66-85); Hyphomycetes (66-85) oR "N5Exonucleases D08.586.277.352.365 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Exodeoxyribonucleases; Exoribonucleases Any of the enzymes of the hydrolase class that catalyze the hydrolysis of terminal bonds of deoxyribonucleotide or ribonucleotide chains, releasing mononucleotides. (Dorland, 27th ed) EC 3.1.-. Nucleotidyltransferases (66-72); Phosphatases (66-72)  o#F`->Exons G05.331.599.110.350; G06.184.599.110.350 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence Coding regions of messenger RNA included in the genetic transcript which survive the processing of RNA in cell nuclei to become part of a spliced messenger of structural RNA in the cytoplasm. They include joining and diversity exons of immunoglobulin genes. Base Sequence (77-86); Genes (77-80); Genes, Structural (77-86) og ./NExodeoxyribonucleases D08.586.277.352.335.375; D08.586.277.352.365.290 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Exonucleases A family of enzymes that catalyze the exonucleolytic cleavage of DNA. It includes members of the class EC 3.1.11 that produce 5'-phosphomonoesters as cleavage products. EC 3.1.-. Deoxyribonucleases (66-82); Exonucleases (73-82); Phosphatases (66-72) o;6FSExocytosis G04.335.532 DEGEIMPHRE Cell Degranulation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Cellular release of secretory products within membrane-limited vesicles or granules. Cells/SE (66-72)  ofbExocrine Glands A10.336 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH) Bartholin's Glands; Breast (+ 1); Bulbourethral Glands; Lacrimal Apparatus; Mammae; Pancreas; Prostate; Salivary Glands (+ 4); Sebaceous Glands (+ 1); Sweat Glands (+ 2) specific anatomic part (66); specific animal (66) oL :=Exobiology G01.273.295 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology The interdisciplinary science that studies evolutionary biology, including the origin and evolution of the major elements required for life, their processing in the interstellar medium and in protostellar systems. This field also includes the study of chemical evolution and the subsequent interactions between evolving biota and planetary evolution as well as the field of biology that deals with the study of extraterrestrial life. o#Existentialism F02.739.418; F04.754.709.294; K01.752.304 HIPX Psychologic Processes and Principles (Non MeSH); Psychological Theory Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Psychoanalytic Therapy Humanities; Philosophy A philosophical doctrine basic to Existential Psychology or Existential Psychiatry. It focuses on the individual's subjective awareness of his style of existence, his intimate interaction with himself, and his environment. ok1Exhibits L01.178.147.269 Information Science; Communications Media (Non MeSH); Audio-Visual Aids o UExhibitionism F03.709.597.608.700.190 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Paraphilias A disorder in which the act of exposing the genitals to an unsuspecting stranger produces sexual excitement with no attempt at further sexual activity with the stranger. o9FExfoliation Syndrome C11.941.375.285 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Glaucoma, Open-Angle Eye Diseases; Uveal Diseases; Iris Diseases The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. It sometimes forms a membrane on the anterior iris surface. Exfoliation refers to the shedding of pigment by the iris. (Newell: Ophthalmology, 7th ed). Eye Diseases (66-76); Glaucoma (72-93); Glaucoma, Open-Angle (82-93); Lens Diseases (77-93); Lens, Crystalline (66-76)  o#N6Exfoliatins D24.185.926.123.353; D24.185.926.275.353 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Dermotoxins Protein exotoxins from Staphylococcus aureus, phage type II, which cause epidermal necrolysis. They are proteins with a molecular weight of 26,000 to 32,000. They cause a condition variously called scaled skin, Lyell or Ritter syndrome, epidermal exfoliative disease, toxic epidermal necrolysis, etc. Bacterial Proteins (66-76); Bacterial Toxins (77); Staphylococcal Infections (66-77); Toxins (66-76) oĄ.:\xExertion G11.427.394 DEPHRE Exercise; Fatigue; Sports; Work Ergometry; Exercise Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Anaerobic Threshold; Exercise; Physical Endurance (+ 1) Expenditure of energy by skeletal muscles. Intensity of exertion may be measured by rate of oxygen consumption, heat produced, or heart rate. Perceived exertion, a psychological measure of exertion, is included. DEGEIMPHPXRE (o  )pCExercise Tolerance G11.427.394.625.270 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Exertion; Physical Endurance The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST. Exercise Test (66-92) oExercise Therapy E02.780.351; E02.831.578.391 AECLCTECEDHIISLJMAMTOGSNSTTD Therapeutics; Physical Therapy Therapeutics; Rehabilitation; Physical Therapy Motion Therapy, Continuous Passive Breathing Exercises; Motion Therapy, Continuous Passive Motion of the body or its parts to relieve symptoms or to improve function, including prescribed physical conditioning leading to PHYSICAL FITNESS, but not PHYSICAL EDUCATION AND TRAINING. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE  o" Zh*Exercise Test E01.145.569.418; E01.302.796.250; E05.333.250 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Miscellaneous Techniques (Non MeSH); Ergometry Controlled physical activity, more strenuous than at rest, which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. The intensity of exercise is often graded, using criteria such as rate of work done, oxygen consumption, and heart rate. Physiological data obtained from an exercise test may be used for diagnosis, prognosis, and evaluation of disease severity, and to evaluate therapy. Data may also be used in prescribing exercise by determining a person's exercise capacity. o&5&Exercise G11.427.394.380; I03.350 PHPX Exertion; Physical Fitness Exertion; Physical Fitness Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Exertion Human Activities (Non MeSH) Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure. Exertion (66-88); Physical Fitness (66-88) $oҒ !!4Excitatory Amino Acids D14.600.050.200 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Glutamate Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Amino Acid Neurotransmitters Aspartic Acid; Glutamic Acid Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear. Amino Acids (66-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (o!By$LFExcitatory Amino Acid Antagonists D14.100.190.300 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Dextrorphan; Dizocilpine Maleate; Ketamine; Kynurenic Acid; Phencyclidine Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. Glutamates/antagonists and inhibitors (68-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $o&(45:Excitatory Amino Acid Agonists D14.100.190.200 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Ibotenic Acid; Kainic Acid; N-Methylaspartate; Quisqualic Acid Drugs that bind to and activate excitatory amino acid receptors. Glutamates/pharmacology (66-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $o%4N%FExcitatory Amino Acid Agents D14.100.190 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Excitatory Amino Acid Agonists (+ 5); Excitatory Amino Acid Antagonists (+ 7) Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  oR#8k^JFExcipients D26.698.931.419 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids; Vehicles Gum Arabic; Karaya Gum; Tragacanth Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form; a binder, matrix, base or diluent in pills, tablets, creams, salves, etc. Pharmaceutic Aids (68-74); Pharmacy (66-67); Vehicles (66-74) ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR $o@,U,K@Exchange Transfusion, Whole Blood E02.095.135.469 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria. o($KExanthema Subitum C02.256.466.290; C02.825.290; C17.800.257.335; C17.800.838.790.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Herpesvirus 6, Human Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Virus Diseases; Skin Diseases, Viral Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Exanthema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral An acute, short-lived, viral disease of infants and young children characterized by a high fever at onset that drops to normal after 3-4 days and the concomitant appearance of a macular or maculopapular rash that appears first on the trunk and then spreads to other areas. It is the sixth of the classical exanthematous diseases and is caused by HHV-6 (HERPESVIRUS 6, HUMAN). (From Dorland, 27th ed). oLP[Exanthema C17.800.257 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Wissler's Syndrome Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Exanthema Subitum Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $o NKPEvolution G04.185.349 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) Phylogeny The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics. o- k Evoked Potentials, Visual G07.453.697.100.300.880; G11.561.450.100.300.880; G11.697.330 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials; Evoked Potentials Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials; Evoked Potentials Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Evoked Potentials (67-81); Photic Stimulation (72-81); Visual Cortex (68-81); Visual Perception (66-81) oE|Evoked Potentials, Somatosensory G07.453.697.100.300.800; G11.561.450.100.300.800 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials; Evoked Potentials Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials; Evoked Potentials The electric response evoked in the cerebral cortex by stimulation of afferent pathways from peripheral nerves to cerebrum. Evoked Potentials (67-81); Somatosensory Cortex (71-81) o&6*BEvoked Potentials, Auditory, Brain Stem G07.453.697.100.300.369.300; G11.561.450.100.300.369.300 DEGEIMPHRE Audiometry, Evoked Response Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials; Evoked Potentials; Evoked Potentials, Auditory Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials; Evoked Potentials; Evoked Potentials, Auditory Electrical waves in the cerebral cortex generated by brain stem structures in response to auditory click stimuli. These are found to be abnormal in many patients with cerebellopontine angle lesions, multiple sclerosis, or other demyelinating diseases. Evoked Potentials (70-79); Evoked Potentials, Auditory (79-90)  oK/>!l$JEvoked Potentials, Auditory G07.453.697.100.300.369; G11.561.450.100.300.369 DEGEIMPHRE Acoustic Stimulation Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials; Evoked Potentials Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials; Evoked Potentials Cochlear Microphonic Potentials; Evoked Potentials, Auditory, Brain Stem Cochlear Microphonic Potentials; Evoked Potentials, Auditory, Brain Stem The electric response evoked in the cerebral cortex by acoustic stimulation or stimulation of the auditory pathways. Acoustic Stimulation (72-79); Auditory Perception (67-79); Electrophysiology (66); Evoked Potentials (67-79); Hearing (66); Sound (66-71) $o!6*Evoked Potentials G07.453.697.100.300; G11.561.450.100.300 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials Evoked Potentials, Auditory (+ 2); Evoked Potentials, Somatosensory; Evoked Potentials, Visual Evoked Potentials, Auditory (+ 2); Evoked Potentials, Somatosensory; Evoked Potentials, Visual The electric response evoked in the cerebral cortex by stimulation of sensory perceptors or some point on the sensory pathway leading from the receptor to the cortex. Electrophysiology (66)  o.Evans Blue D02.172.560; D02.886.645.600.080.050.650.300; D04.615.638.555.400; D26.408.325 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Naphthalenesulfonates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Naphthalenesulfonates Miscellaneous Drugs and Agents (Non MeSH); Dyes 6,6'-((3,3'-Dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis (4-amino-5-hydroxy-1,3-naphthalenedisulfonic acid) tetrasodium salt. An azo dye used in blood volume and cardiac output measurement by the dye dilution method. It is very soluble, strongly bound to plasma albumin, and disappears very slowly. Azo Compounds (69-75); Naphthalenesulfonates (74-75) oX.Z>Evaluation Studies E05.337; N05.715.360.335 Program Evaluation Miscellaneous Techniques (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Clinical Trials (+ 7); Device Approval; Drug Approval (+ 6); Product Surveillance, Postmarketing (+ 2); Program Evaluation; Reproducibility of Results Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS, DRUG EVALUATION, and DRUG SCREENING are available. AECLCTECHIISLJMAMOMTNUOGPXSDSNSTTDUTVE  p*Evaluation Mechanisms, Health Care (Non MeSH) N05.715.360 Quality, Access, Evaluation (Non MeSH); Quality of Health Care Data Collection (+ 41); Epidemiologic Measurements (Non MeSH) (+ 7); Evaluation Studies; Outcome and Process Assessment (Health Care) (+ 5); Patient Satisfaction; Program Evaluation; Statistics (+ 45); Study Characteristics (Non MeSH) (+ 23); Study Design (Non MeSH) (+ 12); Technology Assessment, Biomedical AECLCTECEDEHHIISLJMAMOMTNUOGPXSDSNSTTDUTVE p6Lp.Eutrophication G04.185.320 DEPHRE Water Pollution, Chemical; Plankton Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) Growth of a superabundance of algae and other microscopic plant life usually from an enrichment of a natural body of water by the addition of dissolved nutrients, especially nitrogen and phosphorus. It may be natural, induced (water pollution), or controlled (harvesting phytoplankton for food in an aquaculture system). Water Microbiology (66-75); Water Pollution, Chemical (75)  p +kwFEuthyroid Sick Syndromes C19.874.255 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Thyroid Hormone Resistance Syndrome Thyroid Hormone Resistance Syndrome Endocrine Diseases; Thyroid Diseases Abnormalities in thyroid hormone and thyroid-stimulating hormone levels, often simulating hypothyroidism, in euthyroid patients suffering some other illness, such as diabetes mellitus or liver cirrhosis.  p N**,Euthanasia, Passive K01.316.333.366.175.500; K01.752.667.416.175.500; N05.350.340.500.345.350 CLHILJPXSNTD Resuscitation Orders Humanities; Ethics; Ethics, Professional; Ethics, Medical; Euthanasia Humanities; Philosophy; Philosophy, Medical; Ethics, Medical; Euthanasia Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional; Ethics, Medical; Euthanasia The withdrawing or withholding of extraordinary means used to prolong life. Ethics, Medical (66-77); Euthanasia (66-77)  p QZ5Euthanasia K01.316.333.366.175; K01.752.667.416.175; N05.350.340.500.345 CLHILJPXSNTDVE Humanities; Ethics; Ethics, Professional; Ethics, Medical Humanities; Philosophy; Philosophy, Medical; Ethics, Medical Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional; Ethics, Medical Euthanasia, Passive; Suicide, Assisted Euthanasia, Passive; Suicide, Assisted Euthanasia, Passive; Suicide, Assisted The act or practice of putting to death people or animals suffering from incurable conditions or diseases. CLECEHHILJPCPXSNTDVE  p$EEustachian Tube A09.246.397.369 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Ear, Middle p:(Europium D01.268.558.175; D01.552.550.292 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Europium. An element of the rare earth family of metals. It has the atomic symbol Eu, atomic number 63, and atomic weight 152. Europium is used in the form of its salts as coatings for cathode ray tubes and in the form of its organic derivatives as shift reagents in NMR spectroscopy. ph &:WEuropean Economic Community I01.534.300; Z01.586.300 ECHIOGSN Economics Social Sciences; International Cooperation Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Primarily an economic union with the principle objectives of free movement of goods, capital, and labor. Professional services, social, medical and paramedical, are subsumed under labor. The constituent countries are Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, and the United Kingdom. Economics (66-75); International Cooperation (66-75)  p!  y>Europe, Eastern Z01.542.248 EHEP Geographicals (Non MeSH); Europe Albania; Baltic States (+ 3); Bosnia-Herzegovina; Bulgaria; Byelarus; Croatia; Czech Republic; Hungary; Macedonia (Republic); Moldova; Poland; Romania; Russia (+ 4); Slovakia; Slovenia; Ukraine; Yugoslavia p)Europe Z01.542 EHEP Geographicals (Non MeSH) Andorra; Austria; Belgium; Europe, Eastern (+ 24); Finland; France (+ 1); Germany (+ 3); Gibraltar; Great Britain (+ 7); Greece; Iceland; Ireland; Italy (+ 2); Liechtenstein; Luxembourg; Mediterranean Islands (+ 2); Monaco; Netherlands; Portugal; San Marino; Scandinavia (+ 4); Spain; Switzerland; Transcaucasia (+ 3); Vatican City p  Euplotes B01.841.185.700.400.750.375 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Polymenophorea; Hypotrichida; Sporadotrichina A genus of ciliate protozoa having a dorsoventrally flattened body with widely spaced rows of short bristle-like cilia on the dorsal surface. Ciliophora (66-91) p  &`Euphoria F01.470.323 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Emotions An exaggerated feeling of physical and emotional well-being not consonant with apparent stimuli or events; usually of psychologic origin, but also seen in organic brain disease and toxic states. p  AEunuchism C19.391.482.293 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Castration Endocrine Diseases; Gonadal Disorders (Non MeSH); Hypogonadism The condition of being a eunuch or of having undeveloped sexual organs in which testicular hormones are not produced. (Dorland, 27th ed). p NKEumycetozoea B01.841.750.656.300 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina Dictyosteliida (+ 1); Physarida (+ 2) A class of protozoa comprising myxamoebae having filiform subpseudopodia. Aerial fruiting bodies are produced and the presence of a stalk tube in the fruiting body is observed in some species. p&?0Eukaryotic Cells A11.450 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells Cells of the higher organisms, containing a true nucleus bounded by a nuclear membrane. appropriate cell, organism, subcellular fraction, or process p j * iFEuglenida B01.841.750.443.575.250 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea Euglena (+ 1) An order of plantlike, flagellate protozoa commonly found in freshwater. Characteristics include one or two flagella emerging from an anterior invagination of the cell and chloroplasts absent in many genera. p! &XEuglena gracilis B01.841.750.443.575.250.320.418; B05.104.523.418 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea; Euglenida; Euglena Algae and Fungi (Non MeSH); Algae; Euglena An organism considered both a protozoon (Dorland, 27th ed) and an alga (Bold, Introduction to the Algae, 2d ed, p292). It is a flagellate organism commonly found in stagnant water. Euglena (66-71) p#e6&Euglena B01.841.750.443.575.250.320; B05.104.523 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea; Euglenida Algae and Fungi (Non MeSH); Algae Euglena gracilis Euglena gracilis An organism considered both a protozoon (Dorland, 27th ed) and an alga (Bold, Introduction to the Algae, 2d ed, p292). Characteristics include a pellicle usually marked by spiral or longitudinal striations. Most are found in stagnant water. p% .&(Eugenol D02.455.849.368; J01.740.700.375 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils p' &:Eugenics G05.358.368 HILJMTSNTD Genetic Counseling Genetics, Medical Genetics; Genetics, Medical p( "Eucoccidiida B01.841.075.762.167.275 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia Eimeriina (+ 8); Haemosporina (+ 10) An order of parasitic protozoa found in blood cells and epithelial cells of vertebrates and invertebrates. Life cycles involve both sexual and asexual phases. The order comprises three suborders: Adeleina, EIMERIINA, and HAEMOSPORINA. p)&E/Eucalyptus B06.560.343; B06.915.343 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Trees A genus of Australian trees of the Myrtaceae family that yields gums, oils, and resins which are used as flavoring agents, astringents, and aromatics, and formerly to treat diarrhea, asthma, bronchitis, and respiratory tract infections. p+&1Eubacterium B03.100.600.280; B03.510.460.400.400.600.280 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Propionibacteriaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Propionibacteriaceae A genus of gram-positive, rod-shaped bacteria found in cavities of man and animals, animal and plant products, infections of soft tissue, and soil. Some species may be pathogenic. No endospores are produced. p-P2"Etretinate D02.455.849.291.700.250; D11.557.261.700.250; D23.400.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids Dermatologic Agents; Keratolytic Agents trans-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid ethyl ester. An oral retinoid used in the treatment of keratotic genodermatosis, lichen planus, and psoriasis. Beneficial effects have also been claimed in the prophylaxis of epithelial neoplasia. The compound may be teratogenic. Tretinoin/analogs and derivatives (75-79); Vitamin A (66-74) p/A:dIEtorphine D03.132.610.422.270; D03.549.686.320; D03.605.497.320; D15.040.150.191; D15.210.600.310 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics 6,7,8,14-Tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine. A narcotic analgesic morphinan used as a sedative in veterinary practice. Alcohols, Amyl (73-74); Morphinans (69-74) p3$ c:4Etoposide D09.203.408.348.275; D22.204.179.612.696.339 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Podophyllin; Podophyllotoxin (5R-(5 alpha,5a beta,8a alpha,9 beta(R*)))-9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one. A semisynthetic derivative of podophyllotoxin that inhibits the entry of cells into mitosis, causes a decrease in DNA synthesis, and is effective against some neoplasms. Glucosides (75); Glycosides (73-74); Podophyllotoxin (73-74)/analogs and derivatives (75) p6n 2:jEtomidate D03.383.374.265; D15.050.035.075.375; D15.210.100.175.075.375; D15.210.350.800.212; D15.325.875.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate (+)-1-(alpha-Methylbenzyl)imidazol-5-carboxylic acid ethyl ester. Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic. Benzyl Compounds (69-75); Imidazoles (69-76) p: o:06Etodolac D03.066.288.200; D03.438.473.404.200; D08.373.310.225; D11.303.760.522.200; D16.850.015.050.230; D17.025.030.225; D17.050.030.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Indoleacetic Acids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Indoleacetic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators; Indoleacetic Acids Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid. A nonsteroidal anti-inflammatory agent with potent analgesic and antiarthritic properties. It has been shown to be effective in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and in the alleviation of postoperative pain. Acetic Acids (76-88); Indoleacetic Acids (76-92) p>j :h;Etioporphyrins D11.557.727.340 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Porphyrins with four methyl and four ethyl side chains attached to the pyrrole rings. Porphyrins (66-74) pD8TgEtiocholanolone D04.808.054.040.368; D04.808.578.502.583; D06.472.040.502.583; D06.472.079.500; D06.472.866.154.500; D24.185.733.418 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Androgens Immunologic and Biologic Factors (Non MeSH); Biological Factors; Pyrogens 3-alpha-Hydroxy-5-beta-androstan-17 one. A ketosteroid of mainly human origin; causes fever, immunostimulation and leukocytosis; used to evaluate adrenal cortex function, bone marrow performance and in neoplastic disease for immunostimulation. Synonym: 5-isoandrosterone. pF:5Etimizol D03.383.374.260 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles 1-Ethyl-N,N'-dimethyl-1H-imidazole-4,5-dicarboxamide. Russian drug with adrenergic properties. Synonyms: Aethimazole; Ethylnorantifeine. Amides (72-74); Dicarboxylic Acids (72-74); Imidazoles (72-74) pJ- :VLEtilefrine D02.033.329.291.617.300; D02.092.063.291.617.300; D14.100.050.100.100.270; D14.100.050.100.200.260; D16.050.870.220; D18.793.342 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines; Phenylephrine Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines; Phenylephrine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents An adrenergic agonist that appears to interact with beta-2 and some alpha adrenergic receptors. It has been used as a vasoconstrictor agent. Ethanolamines (70-74); Phenethylamines (70-74); Phenols (74); Phenylephrine/analogs and derivatives (75) pK:|Etidronate Disodium D02.705.206.830 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds; Diphosphonates Disodium 1-hydroxyethylidenediphosphonate. A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover. Organophosphorus Compounds (72) pP:U%Etidocaine D02.065.199.092.325; D15.050.050.220; D15.210.100.200.230; D16.850.025.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local 2-(Ethylpropylamino)-2',6'-butyroxylidide. A local anesthetic with rapid onset and long action, similar to BUPIVACAINE. Acetanilides (73-74)/analogs and derivatives (75); Ethylamines (74-75); Propylamines (73-75) pRT:vmEthynodiol Diacetate D04.808.668.651.693.279; D06.597.799.350; D07.360.276.210.443.706.303 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (3 beta,17 alpha)-19-Norpregn-4-en-20-yne-3,17-diol, diacetate. A synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. pUM:Ethylnitrosourea D02.654.692.300; D02.948.594.310; D26.191.345 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 1-Ethyl-1-nitrosourea. A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosourea Compounds (73-74) pX5.u#Ethylmorphine-N-Demethylase D08.586.682.107.582.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases; Oxidoreductases, N-Demethylating A drug-metabolizing enzyme of the hepatic microsomal oxidase system which catalyzes the oxidation of the N-methyl group of ethylmorphine with the formation of formaldehyde. Morphinans (73-74); Oxidoreductases, N-Demethylating (73-74) pZFFEthylmorphine D03.132.610.422.547.547.430; D03.549.686.575.547.460; D03.605.497.575.547.460; D15.040.150.189; D15.153.250; D15.210.600.305 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Narcotics A narcotic analgesic and antitussive. It is metabolized in the liver by ETHYLMORPHINE-N-DEMETHYLASE and used as an indicator of liver function. Morphinans (69-74); Morphine (66-68); Morphine Derivatives (75-77) p]?:@PEthylmercury Compounds D02.691.750.100.347; D05.723.288.050.355 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial; Alkylmercury Compounds Cialit; Ethylmercuric Chloride; Thimerosal Ethylmercuric Chloride Antifungal Agents (66-71); Mercury (66-71); Organometallic Compounds (68-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  pat.8L[:Ethylmercuric Chloride D02.691.750.100.347.417; D05.723.288.050.355.417 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds; Ethylmercury Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial; Alkylmercury Compounds; Ethylmercury Compounds Chloroethylmercury. A highly toxic compound used as a fungicide for treating seeds. Antifungal Agents (66-71); Mercury (66-71); Mercury Poisoning (66-71); Organometallic Compounds (68-71) pc6:(d{Ethylmaleimide D02.241.081.337.502.524.418; D02.478.440.418; D03.383.757.399.418; D08.373.830.417 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Maleates; Maleimides Organic Chemicals (Non MeSH); Imides; Maleimides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrroles; Maleimides Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents pf\:Ethylketocyclazocine D03.383.113.367.350; D03.605.168.350; D15.040.100.115.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azocines; Cyclazocine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Cyclazocine Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic; Cyclazocine 3-(Cyclopropylmethyl)-6-ethyl-3,4,5,6-tetrahydro-8-hydroxy-11-methyl-2,6-methano-3-benzazocin-1(2H)-one. A kappa opioid receptor agonist. The compound has analgesic action and shows positive inotropic effects on the electrically stimulated left atrium. It also affects various types of behavior in mammals such as locomotion, rearing, and grooming. Cyclazocine (66-90) phA:Ethylestrenol D04.808.668.651.693.223; D06.597.100.194.239 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic; Anabolic Steroids 19-Nor-17 alpha-pregn-4-en-17-ol. An anabolic steroid with some progestational activity and little androgenic effect. plv2:Ethylenethiourea D03.383.374.257; D26.191.335 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 2-Imidazolidinethione. A degradation product of ethylenebis(dithiocarbamate) fungicides. It has been found to be carcinogenic and to cause thyroid hyperplasia. Imidazoles (74-76); Thiones (74-75); Thiourea (66-76) pno".BEthylenes D02.455.326.271.367 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polyethylenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes Dichloroethylenes Derivatives of ethylene, a simple organic gas of biological origin with many industrial and biological use.  pp :gEthylenediamines D02.092.782.258.368 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines Aminophylline; Edetic Acid; Ethambutol; Methapyrilene; Triethylenetetramine; Tripelennamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR pr 8Hj:Ethylenebis(dithiocarbamates) D02.241.081.251.869.265; D02.886.706.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates Maneb; Zineb Maneb; Zineb A class of thiocarbamate derivatives whose salts possess fungicidal activity. Thiocarbamates (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ps".8"[:Ethylene Oxide D02.355.291.411.417 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Ethers, Cyclic; Epoxy Compounds pu:UEthylene Glycols D02.033.618.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols Chloral Hydrate (+ 1); Egtazic Acid 1,2-Ethanediol. An ethylene compound substituted with two hydroxyl groups. Glycols (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $pv8;.X:Ethylene Dichlorides D02.455.326.146.379.350; D02.455.526.439.458 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Ethane Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Toxic, chlorinated, saturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. The latter is considerably more toxic. It has a sweet taste, ethereal odor and has been used as a fumigant and intoxicant among sniffers. Has many household and industrial uses. Chlorine (74-75); Ethane (74) /AA (75) pxf28>1Ethylene Dibromide D02.455.526.368.225; D05.723.491.262 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Brominated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides 1,2-Dibromoethane. An effective soil fumigant, insecticide, and nematocide. In humans, it causes severe burning of skin and irritation of the eyes and respiratory tract. Prolonged inhalation may cause liver necrosis. It is also used in gasoline. Members of this group have caused liver and lung cancers in rodents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), 1,2-dibromoethane may reasonably be anticipated to be a carcinogen. Ethylene Dibromides (77-89); Hydrocarbons, Brominated (74) p{^*:EEthylene Chlorohydrin D02.033.057.310; D02.033.440.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Ethyl Organic Chemicals (Non MeSH); Alcohols; Chlorohydrins 2-Chloroethanol. Used as a solvent, in the manufacture of insecticides, and for treating sweet potatoes before planting. May cause nausea, vomiting, pains in head and chest, stupefaction. Irritates mucous membranes and causes kidney and liver degeneration. Alcohol, Ethyl (69-74); Chlorine (71-74) p&:+2Ethyldimethylaminopropyl Carbodiimide D02.491.203.425 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Imines; Carbodiimides 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide. Carbodiimide cross-linking reagent. Carbodiimides (73-74); Dimethylamines (73-74) p*:?]6Ethylamines D02.092.471 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Cystamine; Dibenamine; Diethylamines; Diethylpropion; Diphenhydramine (+ 1); Histamine (+ 1); Mercaptoethylamines (+ 1); Orphenadrine; Phenethylamines (+ 29); Phenoxybenzamine AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR p8.DEthyl Methanesulfonate D02.455.326.146.100.050.500.300; D02.886.645.600.055.050.510.300; D05.569.468.350; D22.204.418 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Alkanesulfonates; Mesylates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Alkanesulfonates; Mesylates Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Mutagens Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Methanesulfonic acid, ethyl ester. An antineoplastic agent with alkylating properties. It also acts as a mutagen by effecting damage to DNA. Alkanes (66-73); Methane (66-73); Methanesulfonates (74); Sulfonic Acids (66-73) ph:bEthyl Ethers D02.355.417 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers Ether, Ethyl; Flurothyl; Methoxyflurane; Phenetidine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR p8.?:Ethyl Chloride D02.455.526.439.447; D15.050.050.200; D15.210.100.200.210; D16.850.025.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A gas that condenses under slight pressure. Because of its low boiling point ethyl chloride sprayed on skin produces an intense cold by evaporation. Cold blocks nerve conduction. Ethyl chloride has been used in surgery but is primarily used to relieve local pain in sports medicine. pT:OEthyl Biscoumacetate D03.438.150.446.520.451; D19.461.119.196.475.349 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; 4-Hydroxycoumarins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Coumarins; 4-Hydroxycoumarins p{6: Ethoxzolamide D08.373.220.467; D19.770.224.266.467 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Carbonic Anhydrase Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Carbonic Anhydrase Inhibitors 6-Ethoxy-2-benzothiazolesulfonamide. Carbonic anhydrase inhibitor used as diuretic; also in glaucoma; may cause hypokalemia. Synonyms: Ethamide; Glaucotensil. Carbonic Anhydrase Inhibitors (66-74); Thiazoles (66-74) p,*:CEthoxyquin D03.438.810.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines 6-Ethoxy-1,2-dihydro-2,2,4-trimethylquinoline. Antioxidant; also a post-harvest dip to prevent scald on apples and pears. Synonyms: Santoquin; Stop-Scald. Ethyl Ethers (73-74); Quinolines (70-74) p:V2Ethosuximide D02.241.081.337.817.687.333; D02.478.770.333; D03.383.773.812.852.333; D15.080.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates; Succinimides Organic Chemicals (Non MeSH); Imides; Succinimides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones; Succinimides Central Nervous System Agents; Anticonvulsants An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. It is ineffective against tonic-clonic seizures. pu\:xEthopabate D02.241.223.106.061.300; D21.370.400.348 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 4-Acetamido-2-ethoxybenzoic acid methyl ester. Inhibitor of folate metabolism; used as a coccidiostat in poultry. Acetamides (73-75); Aminobenzoic Acids (66-76); Benzoates (66-75) pt.:OEthology F04.096.208 CLECEDHIISLJMAMTOGSNSTTD Behavior, Animal Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences The discipline pertaining to the study of animal behavior. Behavior, Animal (66-68)  p RGEthoglucid D02.355.354; D22.204.416 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,2:15,16-Diepopxy-4,7,10,13-tetraoxahexadecane. Alkylating antineoplastic agent used especially in bladder neoplasms; toxic to hair follicles, gastro-intestinal tract and vasculature. Synonyms: AY 62013; Epodil; Epodyl; ICI 32865. p:| Ethnopsychology F04.096.628.317 CLECEDHIISLJMAMTOGSNSTTD Anthropology, Cultural Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology Comparative psychology of races and peoples. p`6Ethnology I01.076.201.450.457 CLECEDHIISLJMAMTOGSNSTTD Social Sciences; Anthropology; Anthropology, Cultural; Culture The comparative and theoretical study of culture, often synonymous with cultural anthropology. p  JnEthnic Groups I01.076.201.450.416; I01.880.143.522; M01.194; N01.224.317 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture Social Sciences; Sociology; Culture Named Groups (Non MeSH) Population Characteristics (Non MeSH); Demography Aborigines; Asian Americans; Blacks; Eskimos; Gypsies; Hispanic Americans (+ 1); Indians, Central American; Indians, North American; Indians, South American; Jews; Whites Aborigines; Asian Americans; Blacks; Eskimos; Gypsies; Hispanic Americans (+ 1); Indians, Central American; Indians, North American; Indians, South American; Jews; Whites Aborigines; Asian Americans; Blacks; Eskimos; Gypsies; Hispanic Americans (+ 1); Indians, Central American; Indians, North American; Indians, South American; Jews; Whites A group of people with a common cultural heritage that sets them apart from others in a variety of social relationships. Ethnology (66-67)  p'DdEthmoid Sinusitis C08.460.692.752.267; C08.730.749.267; C09.603.692.752.267 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Respiratory Tract Diseases; Respiratory Tract Infections; Sinusitis Otorhinolaryngologic Diseases; Nose Diseases; Paranasal Sinus Diseases; Sinusitis Inflammation of the ethmoid sinus. It may present itself as an acute (associated with viral rhinitis) or chronic (associated with allergic or hyperplastic sinusitis) condition. Sinusitis (66-89) pANEthmoid Sinus A04.531.621.267 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Respiratory System; Nose; Paranasal Sinuses Numerous small thin-walled spaces or air cells in the ethmoid bone, where they form an ethmoidal labyrinth. pE85Ethmoid Bone A02.835.232.781.292 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull pz:DEthisterone D04.808.745.745.379; D06.597.799.322 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic 17 alpha-Hydroxypregn-4-en-20-yn-3-one. A synthetic steroid hormone with progestational effects. p?*:nEthiopia Z01.058.290.120.310 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern p _Ethionine D12.125.166.388; D26.087.325; D26.191.325 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 2-Amino-4-(ethylthio)butyric acid. An antimetabolite and methionine antagonist that interferes with amino acid incorporation into proteins and with cellular ATP utilization. It also produces liver neoplasms. p 1FEthionamide D03.066.349.220; D03.383.725.394.220; D20.338.366 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Isonicotinic Acids Anti-Infective Agents; Antitubercular Agents p9:Ethiodized Oil D10.516.627.700.550.300; D26.298.423.416; J01.740.700.550.300 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils; Iodized Oil Miscellaneous Drugs and Agents (Non MeSH); Contrast Media; Iodized Oil Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils; Iodized Oil Ethiodized oil. It contains 37% organically bound iodine and has been used as a diagnostic aid (radiopaque medium) and as an antineoplastic agent when part of the iodine is 131-I. (From Merck Index, 11th ed). pE,Ethinyl Estradiol D04.808.668.651.568.291; D06.597.378.379; D07.360.276.210.443.332.291 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnatrienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estrogens, Synthetic Mestranol; Quinestrol Mestranol; Quinestrol Mestranol; Quinestrol (17 alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol. A semisynthetic estrogen with high oral estrogenic potency. It is often used as the estrogenic component in oral contraceptives. peM:MEthidium D03.494.633.416; D08.373.379; D21.370.884.266 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenanthridines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents Antiprotozoal Agents (66-71); Antiviral Agents (66-71); Phenanthridines (69-71); appropriate enzyme/AI (68-71) p 5:Ethics, Professional K01.316.333; N05.350.340 EDHI Humanities; Ethics Quality, Access, Evaluation (Non MeSH); Ethics Ethics, Dental; Ethics, Medical (+ 6); Ethics, Nursing; Ethics, Pharmacy Ethics, Dental; Ethics, Medical (+ 6); Ethics, Nursing; Ethics, Pharmacy The principles of professional conduct concerning the rights and duties of the professional person himself and of his fellow professionals. Ethics (66-67) CLECEDEHHILJPCPXSNTDVE $pOEthics, Pharmacy K01.316.333.566; N05.350.340.625 EDHI Humanities; Ethics; Ethics, Professional Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional The principles of proper professional conduct concerning the rights and duties of the pharmacist himself, the patient, and his fellow practitioners. p*&Ethics, Nursing K01.316.333.466; K01.752.712.416; N05.350.340.550 EDHI Humanities; Ethics; Ethics, Professional Humanities; Philosophy; Philosophy, Nursing Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional The principles of proper professional conduct concerning the rights and duties of nurses themselves, their patients, and their fellow practitioners, as well as their actions in the care of patients and in relations with their families. p9Ethics, Medical K01.316.333.366; K01.752.667.416; N05.350.340.500 EDHI Human Experimentation Humanities; Ethics; Ethics, Professional Humanities; Philosophy; Philosophy, Medical Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional Euthanasia (+ 2); Helsinki Declaration; Hippocratic Oath; Medical Futility Euthanasia (+ 2); Helsinki Declaration; Hippocratic Oath; Medical Futility Euthanasia (+ 2); Helsinki Declaration; Hippocratic Oath; Medical Futility The principles of proper professional conduct concerning the rights and duties of the physician himself, his patients, and his fellow practitioners, as well as his actions in the care of patients and in relations with their families. (Stedman, 25th ed). CLECEDEHHILJPCPXSNTDVE $p9 +Ethics, Institutional K01.316.190; N05.350.325 EDHI Humanities; Ethics Quality, Access, Evaluation (Non MeSH); Ethics The moral and ethical obligations or responsibilities of institutions. pOSEthics, Dental K01.316.333.266; K01.752.622.416; N05.350.340.325 EDHI Humanities; Ethics; Ethics, Professional Humanities; Philosophy; Philosophy, Dental Quality, Access, Evaluation (Non MeSH); Ethics; Ethics, Professional The principles of proper professional conduct concerning the rights and duties of the dentist himself, his patients, and his fellow practitioners, as well as his actions in the care of patients and in relations with their families. p9Ethics Committees N04.452.758.788.300; N05.700.685.300 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Professional Practice; Professional Staff Committees Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Professional Staff Committees Committees whose purpose may be to direct educational programs; to provide forums for discussion of ethical issues among hospital or medical professionals and others; to serve in an advisory capacity and/or as a resource to health professionals involved in biomedical decision making; or to review and evaluate institutional experiences related to decisions having biomedical ethical implications. (From Hospital Administration Terminology, 2d ed). Ethics, Medical (66-91); Professional Staff Committees (75-91) p* JEthics F01.829.233; K01.316; K01.752.256; N05.350 CLHI Confidentiality; Duty to Warn; Human Rights Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Humanities Humanities; Philosophy Quality, Access, Evaluation (Non MeSH) Altruism Bioethics (+ 3); Conflict of Interest (+ 1); Ethics, Institutional; Ethics, Professional (+ 10); Humanism; Morals (+ 2); Scientific Misconduct Altruism; Conflict of Interest (+ 1); Humanism; Morals (+ 2); Scientific Misconduct Bioethics; Conflict of Interest (+ 1); Ethics, Institutional; Ethics, Professional (+ 10) The philosophy or code pertaining to what is ideal in human character and conduct. CLECEDEHHIISLJMAMTOGPCPXSNSTTDVE $pƲ 46d$Ethers, Cyclic D02.355.291 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers Epoxy Compounds (+ 3) Compounds of the general formula R-O-R arranged in a ring or crown formation. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  p 8.^:Ethers D02.355 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Acetals; Ethers, Cyclic (+ 4); Ethoglucid; Ethyl Ethers (+ 4); Glyceryl Ethers (+ 1); Methyl Ethers (+ 10); Phenyl Ethers (+ 7) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ps  8#:Ether, Ethyl D02.355.417.332; D15.050.035.060.215; D15.210.100.175.060.215 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Ethyl Ethers Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation 1,1'-Oxybisethane. A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes. pE:4 Ethenoadenosine Triphosphate D13.695.667.138.236.250; D13.695.827.068.236.250 AAADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Adenosine Triphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Adenosine Triphosphate 1,N-6-Ethenoadenosine triphosphate. A fluorescent analog of adenosine triphosphate. Adenosine Triphosphate (72-74); Imidazoles (72-74) p!6>.`<Ethchlorvynol D02.033.440.335; D15.210.350.800.200; D15.325.875.230 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Chlorohydrins Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate A sedative and hypnotic that has been used in the short-term management of insomnia. Its use has been superseded by other drugs. p\=:$Ethanolamines D02.033.057.291; D02.033.329.291; D02.092.063.291 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Ethyl Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols Organic Chemicals (Non MeSH); Amines; Amino Alcohols  Albuterol; Choline; Clenbuterol; Deanol; 2-Hydroxyphenethylamine; Isoproterenol; Labetalol; Midodrin; Octopamine; Orciprenaline (+ 1); Phenylephrine (+ 1); Procaterol; Sotalol; Sphingosine (+ 1); Synephrine; Terbutaline Albuterol; Choline; Clenbuterol; Deanol; 2-Hydroxyphenethylamine; Isoproterenol; Labetalol; Midodrin; Octopamine; Orciprenaline (+ 1); Phenylephrine (+ 1); Procaterol; Sotalol; Sphingosine (+ 1); Synephrine; Terbutaline Amino Alcohols (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  p98 DEthanolaminephosphotransferase D08.586.913.696.900.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Transferases (Other Substituted Phosphate Groups) An enzyme that catalyzes reversibly the transfer of phosphoethanolamine from CDP-ethanolamine to diacylglycerol to yield phosphatidylethanolamine (cephalin) and CMP. The enzyme is found in the endoplasmic reticulum. EC 2.7.8.1. Amino Alcohols (66-72); Ethanolamines (73-78); Phosphotransferases (66-78) pء"FXEthanolamine Ammonia-Lyase D08.586.520.161.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ammonia-Lyases An enzyme that catalyzes the deamination of ethanolamine to acetaldehyde. EC 4.3.1.7. Ammonia-Lyases (73-74); Ethanolamines (73-74) pNFaf6Ethane D02.455.326.146.379 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Ethylene Dichlorides Alkanes (66-72) p :gEthamsylate D02.455.426.559.389.097.250; D02.886.645.600.080.050.100.300; D19.461.270.463.340 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzenesulfonates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Benzenesulfonates Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics 2,5-Dihydroxybenzenesulfonic acid compound with diethylamine (1:1). Benzenesulfonate derivative used as a systemic hemostatic. Benzenesulfonates (74); Hydroquinones (74) pY:3Ethamoxytriphetol D02.033.057.270; D06.347.300.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohol, Ethyl Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists alpha-(4-(2-(Diethylamino)ethoxy)phenyl)-4-methoxy-alpha-phenylbenzeneethanol. A non-steroidal estrogen antagonist. Alcohol, Ethyl (69-74); Phenyl Ethers (74); Diethylamines (74) p`&:MEthambutol D02.092.782.258.368.265; D20.338.316 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Ethylenediamines Anti-Infective Agents; Antitubercular Agents pt*:Ethacrynic Acid D19.770.224.658 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics p:cEthacridine D03.494.046.250.450; D20.187.255 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Anti-Infective Agents; Anti-Infective Agents, Local 7-Ethoxy-3,9-acridinediamine. A topically applied anti-infective agent. Acridines (68-74); Diamines (73-74); Lactates (68-74) pv&:RBEtazolate D03.066.515.400; D03.383.725.547.400; D08.373.735.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors 1-Ethyl-4-((1-methylethylidene)hydrazino)-1H-pyrazolo(3,4-b) pyridine-5-carboxylic acid, ethyl ester. A potent phosphodiesterase inhibitor proposed as an antipsychotic agent. Hydrazines (73-75); Nicotinic Acids (75); Pyrazoles (73-75); Pyridines (73-74) pA =:+`Etanidazole D02.640.672.250; D03.383.374.658.250; D22.204.414; D26.776.310 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents N-(2-Hydroxyethyl)-2-nitro-1H-imidazole. A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy. Nitroimidazoles (81-92) p<H:REstrus Synchronization E05.820.150.370; G08.520.780.218.268 BLCFDEGEIMMEPHPXREUR Miscellaneous Techniques (Non MeSH); Reproduction Techniques; Breeding Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal; Estrus Occurrence or induction of estrus in all of the females in a group at the same time, applies only to animals. Estrus (66-74) p*Estrus Detection E05.820.150.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Reproduction Techniques; Breeding Methods for recognition of the state of estrus. p"S;Estrus G08.520.780.218 BLCFDEGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal Anestrus; Diestrus; Estrus Synchronization; Metestrus; Proestrus p ]MEstrone D04.808.365.415.414; D04.808.578.502.497; D06.472.040.502.497; D06.472.265.565; D06.472.866.540.565 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens Hydroxyestrones Hydroxyestrones 3-Hydroxyestra-1,3,5(10)-trien-17-one. A metabolite of estradiol but possessing less biological activity. It is found in the urine of pregnant women and mares, in the human placenta, and in the urine of bulls and stallions. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), estrone may reasonably be anticipated to be a carcinogen (Merck, 11th ed). p oD'Estrogens, Synthetic D06.597.378; D07.360.276.210.443.332 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic Epimestrol; Estrogens, Non-Steroidal (+ 5); Ethinyl Estradiol (+ 2) Ethinyl Estradiol (+ 2) Compounds obtained by chemical synthesis which possess estrogenic activity, but differ in structure from naturally occurring estrogens. Estrogens (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $p?*8n:Estrogens, Non-Steroidal D06.472.265.540; D06.472.866.540.540; D06.597.378.359 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic Coumestrol; Zearalenone Zearalenone Chlorotrianisene; Dienestrol; Diethylstilbestrol (+ 1); Zeranol Non-steroidal compounds with estrogenic activity. Estrogens (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $p7=8t:@Estrogens, Conjugated D06.472.265.525; D06.472.866.540.525 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens An amorphous preparation containing water-soluble, conjugated forms of mixed estrogens obtained from urine of pregnant mares. The principal estrogen present is sodium estrone sulfate. The total estrogenic potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. (From Merck Index, 11th ed). p*8Estrogens, Catechol D02.755.166.350; D06.472.265.515; D06.472.866.540.515 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Phenols; Catechols Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens Hydroxyestrones Hydroxyestrones Hydroxyestrones 2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system. specific estrogen (66-81); Catechols (66-81); Estrogens (66-81)  p=B5$MEstrogens D06.472.265; D06.472.866.540; D07.360.276.210.277.332 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Estrogen Antagonists; Receptors, Estrogen Hormones, Substitutes, Antagonists (Non MeSH); Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal Equilenin; Equilin; Estradiol; Estriol (+ 1); Estrogens, Catechol (+ 1); Estrogens, Conjugated; Estrogens, Non-Steroidal (+ 2); Estrone Equilenin; Equilin; Estradiol; Estriol (+ 1); Estrogens, Catechol (+ 1); Estrogens, Conjugated; Estrogens, Non-Steroidal (+ 1); Estrone A class of sex hormones associated with the development and maintenance of secondary female sex characteristics and control of the cyclical changes in the reproductive cycle. They are also required for pregnancy maintenance and have an anabolic effect on protein metabolism and water retention. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $q0 =@18IWDEstrogen Replacement Therapy E02.319.347 AECLCTECHIISMOMTNUPXSNSTTDUTVE Menopause Therapeutics; Drug Therapy The use of estrogenic substances in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, dyspareunia, and progressive development of osteoporosis. Estrogenic Substances, Conjugated (66-89); Estrogens (66-89); Estrogens, Synthetic (75-89); Menopause (66-89)  q6"" !Estrogen Antagonists D06.347.300 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Centchroman; Danazol; Estradiol Antagonists; Ethamoxytriphetol; Fadrozole; Nafoxidine; Nitromifene; Tamoxifen (+ 1) Compounds which inhibit or antagonize the action or biosynthesis of estrogen. specific estrogen(66-77); Estrogens (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (qX6 N\5:Estriol D04.808.365.415.331; D06.472.265.365; D06.472.866.540.365 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens Estetrol Estetrol Estetrol (16 alpha,17 beta)-Estra-1,3,5(10)-triene-3,16,17-triol. A metabolite of estradiol and usually the predominant estrogenic metabolite in urine. During pregnancy, large amounts of estriol are produced by the placenta. It has also been obtained from plant sources. The 16 beta-isomer has also been isolated from the urine of pregnant women. q  AD Estrenes D04.808.365.415 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes Allylestrenol; Epimestrol; Equilenin; Equilin; Estradiol (+ 1); Estriol (+ 1); Estrone (+ 1); Metribolone; Mifepristone; Nandrolone; Trenbolone Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds. Estranes (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $q  84DEstranes D04.808.365 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Estrenes (+ 14) A group of compounds forming the nucleus of the estrogenic steroid family. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  q 8(ZDEstramustine D02.455.526.728.650.275; D04.808.365.415.248.320; D22.204.585.342 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes; Estradiol Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds Estra-1,3,5(10)-triene-3,17-diol-3-N(bis-[2-chloroethyl]) carbamate-17-dihydrogenphosphate. A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. Synonyms: Estracyt; NSC 89199; Leo 299. Carbamates (72-74); Estranes (72-74); Nitrogen Mustard Compounds (72-74); Organophosphorus Compounds (73-74) qI:A6Estradiol Dehydrogenases D08.586.682.047.436.375.280 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases; 17-Hydroxysteroid Dehydrogenases Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62. Hydroxysteroid Dehydrogenase (73-74); Estradiol (73-74) qFAEstradiol Antagonists D06.347.300.292 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists Compounds which inhibit or antagonize the biosynthesis or action of estradiol. Estradiol (66-77) qC6g]Estradiol D04.808.365.415.248; D06.472.265.265; D06.472.866.540.265 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Estradiol Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens Estramustine (17 beta)-Estra-1,3,5(10)-triene-3,17-diol. The most potent mammalian estrogenic hormone. It is produced in the ovary, placenta, testis, and possibly the adrenal cortex. Although it has been used in estrogenic hormone therapy for the treatment of menopausal and postmenopausal symptoms, metastatic prostate cancer, and breast cancer, according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), it may reasonably be anticipated to be a carcinogen (Merck, 11th ed). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $q AB+DEstonia Z01.542.248.136.360; Z01.586.950.140.360 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern; Baltic States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Baltic States q .Estivation G07.062.415 DEGEIMPHRE Physiology, General (Non MeSH); Adaptation, Physiological qDEsthetics, Dental E06.420 CLHIPXSN Dentistry q   Esthetics F02.463.785.477; K01.752.210 CLEDHIPX Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking Humanities; Philosophy Beauty Beauty The branch of philosophy dealing with the nature of the beautiful. It includes beauty, esthetic experience, esthetic judgment, esthetic aspects of medicine, etc. q " tEsthesioneuroblastoma C04.557.465.625.600.380.300; C04.557.465.625.600.600.575.300; C04.557.470.670.380.300; C04.557.470.670.600.575.300; C04.557.580.625.600.380.300; C04.557.580.625.600.600.575.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral; Neuroblastoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral; Neuroblastoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Neuroectodermal Tumor, Peripheral; Neuroblastoma A malignant olfactory neuroblastoma arising from the olfactory epithelium of the superior nasal cavity and cribriform plate. It is uncommon (3% of nasal tumors) and its etiology is unknown. The type and extent of primary therapy depends on tumor size and location. Generally early-stage disease is treated with a single modality approach such as complete excision. Adjuvant radiotherapy is used for extensive tumors or for tumors where microscopic residual disease is suspected. It has a high propensity for multiple local recurrences. (Holland et al., Cancer Medicine, 3d ed, p. 1245). Neuroepithelioma (66-93) q!X8Estetrol D04.808.365.415.331.320; D06.472.265.365.320; D06.472.866.540.365.320 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes; Estriol Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens; Estriol Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens; Estriol Estra-1,3,5(10)-triene-3,15 alpha,16 alpha,17 beta-tetrol. A metabolite of estradiol in man, with estrogenic properties. Estriol (73-74) q) M: Esters D02.241.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids specific acid (68-90); specific alcohol (68-90) q,H 89:Esterification G06.535.630.475; H01.181.404.475 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic The process of converting an acid into an alkyl or aryl derivative. Most frequently the process consists of the reaction of an acid with an alcohol in the presence of a trace of mineral acid as catalyst or the reaction of an acyl chloride with an alcohol. Esterification can also be accomplished by enzymatic processes. Esters (68-75) q-/&|Esterases D08.586.277.352 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Carboxylic Ester Hydrolases (+ 14); Deoxyribonucleases (+ 13); Endonucleases (+ 16); Exonucleases (+ 2); Phosphoric Diester Hydrolases (+ 8); Phosphoric Monoester Hydrolases (+ 15); Ribonucleases (+ 7); Sulfatases (+ 6); Thiolester Hydrolases (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR q/ FS-HEstazolam D03.438.079.080.250; D14.100.240.500.242; D15.075.050.175; D15.080.220; D15.210.350.800.187; D15.210.950.012.050.175; D15.325.875.220; D15.525.230; D15.700.872.015.050.320; D16.700.600.230 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Muscle Relaxants, Central Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central 8-Chloro-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine. A benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. Benzazepines (72-74); Triazoles (72-74) q24 :X0Esotropia C10.772.204.410.810.400; C11.590.810.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders; Strabismus Eye Diseases; Ocular Motility Disorders; Strabismus Strabismus in which the deviating eye looks inwards towards the nose. Strabismus (66-79) q8 .NTEsophagus A03.365 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Esophagectomy; Esophagoplasty; Esophagoscopy; Esophagostomy Digestive System Esophagogastric Junction q:  :EEsophagostomy E04.579.358; E04.765.358 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Esophagus Surgery, Operative; Ostomy Surgery, Operative; Surgery, Digestive System (Non MeSH) Surgical formation of an external opening (stoma) into the esophagus. Esophagus/surgery (66-87)  q;$ bSEsophagoscopy E01.184.340.375; E01.418.340.375 AECLCTECHIISMOMTNUPXSNSTTDUTVE Esophagus Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System Diagnosis; Endoscopy; Endoscopy, Digestive System Endoscopic examination of the esophagus. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material and perform other surgical interventions, and for delivery of medication. q=3&" Esophagoplasty E04.765.355 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Esophagus Surgery, Operative; Surgery, Digestive System (Non MeSH) q?M$ CEsophagogastric Junction A03.365.414; A03.492.766.330 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Digestive System; Esophagus Digestive System; Gastrointestinal System; Stomach q@"8\Esophagitis, Peptic C06.306.620.420; C06.405.613.306 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophagitis Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer Inflammation of the esophagus caused by reflux of gastric juice and/or stomach and duodenal contents. q@&NyEsophagitis C06.306.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases Esophagitis, Peptic Inflammation, acute or chronic, of the esophagus caused by bacteria, chemicals, or trauma. qBN7kEsophagectomy E04.765.346 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Esophagus Surgery, Operative; Surgery, Digestive System (Non MeSH) Excision of part (partial) or all (total) of the esophagus. (Dorland 27th ed., p. 582). Esophagus/surgery (66-91)  qC$ ClEsophageal Stenosis C06.306.544 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases Stricture of the esophagus. qEHN7#Esophageal Spasm, Diffuse C06.306.418.450 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Motility Disorders A motor disorder of the esophagus characterized by chest pain and dysphagia. Pathogenesis is unclear. Strong, nonpropulsive contractions of the esophagus evoked by deglutition occur, especially in the elderly. Esophageal Diseases (66-88); Spasm (66-88) qF:NZ4Esophageal Perforation C06.306.468; C21.866.348 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Mallory-Weiss Syndrome An opening or hole in the esophagus as the result of an injury or pathological process. (From Dorland, 27th ed). qHcNEsophageal Neoplasms C04.588.274.306; C04.588.443.353; C06.240.306; C06.306.430 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms Digestive System Diseases; Digestive System Neoplasms Digestive System Diseases; Esophageal Diseases qJ=DXEsophageal Motility Disorders C06.306.418 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases CREST Syndrome; Deglutition Disorders (+ 1); Esophageal Achalasia; Esophageal Spasm, Diffuse; Gastroesophageal Reflux Disorders affecting the motor function of the upper or lower esophageal sphincters, the esophageal body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in the impeding of the passage of food, regurgitation of food, or reflux of gastric acid into the esophagus. Esophageal Diseases (66-88); Gastrointestinal Motility (66-88); Peristalsis ((75)-88)  qL##N7ueEsophageal Fistula C06.185.400; C06.306.392; C23.439.185.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Fistula (Non MeSH) Digestive System Diseases; Esophageal Diseases Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH) Tracheoesophageal Fistula Tracheoesophageal Fistula Tracheoesophageal Fistula Abnormal passage communicating with the esophagus. qOi1NV<Esophageal Diverticulum C06.306.354; C23.329.695 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases Symptoms and General Pathology (Non MeSH); Diverticulum Zenker's Diverticulum Zenker's Diverticulum Saccular, outward protrusion of all or a portion of the esophageal wall from the lumen of the esophagus. qQNx2~Esophageal Diseases C06.306 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Esophageal Atresia Digestive System Diseases Barrett Esophagus; Esophageal and Gastric Varices; Esophageal Atresia; Esophageal Cyst; Esophageal Diverticulum (+ 1); Esophageal Fistula (+ 1); Esophageal Motility Disorders (+ 6); Esophageal Neoplasms; Esophageal Perforation (+ 1); Esophageal Stenosis; Esophagitis (+ 1); Hernia, Diaphragmatic (+ 2) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  qSu NfXEsophageal Cyst C04.182.281; C06.306.316 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Digestive System Diseases; Esophageal Diseases qVVKEsophageal Atresia C06.175.330; C06.306.260; C16.131.314.330 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Esophageal Diseases Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Digestive System Diseases; Esophageal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Congenital failure of the full esophageal lumen to develop that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive salivation, gagging, cyanosis, and dyspnea. qV1LEsophageal and Gastric Varices C06.306.240; C06.552.494.414; C14.907.489.430.414 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Varicose Veins Digestive System Diseases; Esophageal Diseases Digestive System Diseases; Liver Diseases; Hypertension, Portal Cardiovascular Diseases; Vascular Diseases; Hypertension; Hypertension, Portal Submucosal varices of the lower esophagus or gastric fundus mucosa, frequently caused by the development of portal collateral vessels consequent to portal hypertension. qY%9NEsophageal Achalasia C06.306.418.432 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Motility Disorders Disorder of lower esophagogastric motility due to failure of the lower esophageal sphincter to relax with swallowing. It is sometimes caused by degeneration of the ganglion cells of the myenteric plexus or of the vagal motor nuclei. q\NZEsocidae B02.493.817.350 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Salmoniformes A family of freshwater fish of the order SALMONIFORMES, comprising the pikes, inhabiting the waters of the Northern Hemisphere. There is one genus, Esox, with three species: one in eastern North America, one in Siberia, one in the circumpolar region. Esox is from the Greek isox, a fish, itself of Celtic origin. (Nelson: Fishes of the World, 1976). q^$ &*Eskimos I01.076.201.450.416.247; I01.880.143.522.247; M01.194.247 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group of the Mongoloid racial stock inhabiting primarily arctic areas. q`U A`Esculin D03.438.150.446.400; D09.203.408.348.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides qa .:Escin D09.203.408.782.250 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Saponins Aescigenin-(2-methyl-3-acetoxybutyrate)-(2-xylosido 4-glucosidoglucuronoside). Saponin occurring in the seed of the horse chestnut tree. Inhibits edema formation and decreases vascular fragility. Synonyms: Feparil; Reparil; Aescusan. Glycosides (71-74); Saponins (71-75) qcX De -Escherichia coli Infections C01.252.400.310.330 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Infections with bacteria of the species ESCHERICHIA COLI. qe!PEEscherichia coli B03.440.450.425.325.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Escherichia Alkalescens-Dispar Group A species of gram-negative, facultatively anaerobic, rod-shaped bacteria commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce diarrhea and pyogenic infections. qg"} Escherichia B03.440.450.425.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Escherichia coli (+ 1) A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are nonpathogenic or opportunistic pathogens. qi9"nEscape Reaction F01.145.113.448; F01.145.367 CLDEPHRE Avoidance Learning Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal Behavior and Behavior Mechanisms (Non MeSH); Behavior Innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy. Behavior, Animal (66-67); Fear (66-67)  qk&" 0Erythrosine D03.494.953.275.350; D04.615.885.347.350; D26.408.348.514.335; D26.550.342.350 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Fluoresceins Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Fluoresceins 3',6'-Dihydroxy-2',4',5',7'-tetraiodospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one disodium salt. A vital stain and coloring agent used in dentistry to disclose plaque. It is used as a tissue stain and dye in foods and pharmaceuticals, may inhibit some enzymes, and is preferentially absorbed by certain tumor cells. Fluoresceins (66-78) qlX.rErythropoietin D12.776.395.240.150; D24.185.251; D24.185.348.453.240.150; D24.611.350.400.442.240.150 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Erythropoietin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Hematopoietic Cell Growth Factors; Colony-Stimulating Factors Glycoprotein hormone, secreted chiefly by the kidney in the adult and the liver in the fetus, that acts on erythroid stem cells of the bone marrow to stimulate proliferation and differentiation. qp`D(Erythropoiesis G09.188.544.414 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hematopoiesis qtkErythroplasia C04.834.288 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Precancerous Conditions A condition of the mucous membrane characterized by erythematous papular lesions. (Dorland, 27th ed). quX)yErythromycin Ethylsuccinate D20.085.115.250.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Erythromycin Erythromycin, 2'-(ethyl butanedioate). An ester of erythromycin having the same antibacterial effect as erythromycin but with better absorption and fewer side effects. Erythromycin (66-89) qv :TErythromycin Estolate D20.085.115.250.260 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Erythromycin Lauryl sulfate salt of propionic ester of erythromycin. Found to cause jaundice. Essential hepatotoxic property is due to the propionyl ester linkage at the 2' position. Erythromycin (70-74); Propionates (74); Sodium Dodecyl Sulfate (74) qx:TRErythromycin D20.085.115.250 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Azithromycin; Clarithromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Roxithromycin Antibiotic substance produced by Streptomyces erythreus found first in a soil sample from the Philippines. Three erythromycins are produced during fermentation - A, B, and C. Erythromycin A is the major component. qz<DmErythromelalgia C14.907.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness. q|N2Erythroid Progenitor Cells A11.118.413.350; A11.148.378.350; A11.872.378.350; A15.145.229.413.350; A15.378.316.378.350 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes Cells; Bone Marrow Cells (Non MeSH); Hematopoietic Stem Cells Cells; Stem Cells; Hematopoietic Stem Cells Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes Hemic and Immune Systems (Non MeSH); Hematopoietic System; Bone Marrow Cells (Non MeSH); Hematopoietic Stem Cells Erythroblasts Erythroblasts Erythroblasts Erythroblasts Committed, erythroid stem cells derived from myeloid stem cells. The progenitor cells develop in two phases: erythroid burst-forming units (BFU-E) followed by erythroid colony-forming units (CFU-E). BFU-E differentiate into CFU-E on stimulation by erythropoietin, and then further differentiate into erythroblasts when stimulated by other factors. Erythroblasts (77-89); Erythrocytes (72-89); Hematopoietic Stem Cells (77-89)  q~I g*?\Erythrocytes, Abnormal A11.118.413.330; A15.145.229.413.330 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes Acanthocytes; Erythrocyte Inclusions (+ 1); Megaloblasts; Spherocytes Acanthocytes; Erythrocyte Inclusions (+ 1); Megaloblasts; Spherocytes Erythrocytes (66-67) q**}Erythrocytes A11.118.413; A15.145.229.413 CHCLCYDEENIMMEMIPAPHPSRARERISEULUSVI Cells; Blood Cells Hemic and Immune Systems (Non MeSH); Blood; Blood Cells Erythrocyte Membrane; Erythrocytes, Abnormal (+ 5); Erythroid Progenitor Cells (+ 1); Reticulocytes Erythrocyte Membrane; Erythrocytes, Abnormal (+ 5); Erythroid Progenitor Cells (+ 1); Reticulocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing hemoglobin whose function is to transport oxygen. CHCLCYDEENGEIMMEMIPAPHPSRARERISETRULUSVI  q"(],Erythrocyte Volume G09.188.313.370; G09.330.612.214.370 DEGEIMPHREVE Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Volume Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Blood Volume Volume of circulating erythrocytes. It is usually measured by radioisotope dilution technique. Erythrocytes (66-77) q5*oErythrocyte Transfusion E02.095.135.140.275 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion; Blood Component Transfusion The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor. Blood Component Transfusion (92-93); Blood Transfusion (69-92); Erythrocytes (69-75); Erythrocytes/transplantation (68-92) q*$lgErythrocyte Membrane A11.118.413.270; A11.195.356; A15.145.229.413.270 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes Cells; Cell Membrane Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes The semipermeable outer portion of the red corpuscle. It is known as a 'ghost' after hemolysis. Erythrocytes (66-76) q 9*tErythrocyte Indices E01.223.459.380; G09.188.490 DEGEIMPHREVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Quantification of size and cell hemoglobin content or concentration of the erythrocyte, usually derived from erythrocyte count, blood hemoglobin concentration, and hematocrit. Includes the mean cell volume (MCV), mean cell hemoglobin (MCH), and mean cell hemoglobin concentration (MCHC). Use also for cell diameter and thickness. Erythrocyte Count (66-79); Erythrocyte Volume (78-79); Erythrocytes (66-79); Erythrocytes, Abnormal (68-79); Hematocrit (66-79); Hemoglobins (66-79) q"Erythrocyte Inclusions A11.118.413.330.340; A15.145.229.413.330.340 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes; Erythrocytes, Abnormal Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes; Erythrocytes, Abnormal Heinz Bodies Heinz Bodies Pathologic inclusions occurring in erythrocytes. q2( 9Erythrocyte Deformability G09.188.470 DEGEIMPHRE Hemorheology Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature. Erythrocytes (66-84); Erythrocytes, Abnormal (68-84)  qY}>Erythrocyte Count E01.223.459.107.330; G07.380.107.330 DEECISMTREVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count Physiology, General (Non MeSH); Cell Count; Blood Cell Count Reticulocyte Count Reticulocyte Count A count of the number of red blood cells per unit volume in a sample of venous blood. q6*,kErythrocyte Aging G04.335.119.260; G09.188.454 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Aging Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days. q"OErythrocyte Aggregation, Intravascular C15.378.329 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases The massing or clumping of erythrocytes in intact blood vessels in response to injury or in certain diseases, interfering with adequate blood flow. It is also called sludging of blood and intravascular agglutination. (Dorland, 24th ed). qe,NJErythrocyte Aggregation E01.223.459.360; G09.188.420 DEGEIMPHRE Diagnosis; Diagnosis, Laboratory; Hematologic Tests Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Aggregation of erythrocytes probably resulting from changes in the negative surface charge (zeta potential) of the cells caused by the dielectric effect of proteins in the surrounding plasma, especially asymmetric macromolecules like fibrinogen and gamma globulin. Erythrocytes (66-75) qr"0Erythrocruorins D12.776.124.400.220; D12.776.422.512.260 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins High molecular weight (1,500,000 to 3,000,000) hemoglobins found in the plasma of many polychete and oligochete annelid worms and various mollusks. They bind one mole of oxygen per heme and function as oxygen carriers. Hemeproteins (73-76) q.DErythrocebus patas B02.649.801.400.130.120.260.260 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Erythrocebus A species of the genus ERYTHROCEBUS, subfamily CERCOPITHECINAE, family CERCOPITHECIDAE. It inhabits the flat open arid country of Africa. It is also known as the patas monkey or the red monkey. qO#(jErythrocebus B02.649.801.400.130.120.260 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae Erythrocebus patas a genus of Old World monkeys of the family CERCOPITHECINAE that inhabit the forests and savannas of Africa. It contains only one species, ERYTHROCEBUS PATAS, also known as the patas monkey or red monkey. q$(ZErythroblasts A11.118.413.350.200; A11.148.378.350.200; A15.145.229.413.350.200; A15.378.316.378.350.200 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes; Erythroid Progenitor Cells Cells; Bone Marrow Cells (Non MeSH); Hematopoietic Stem Cells; Erythroid Progenitor Cells Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes; Erythroid Progenitor Cells Hemic and Immune Systems (Non MeSH); Hematopoietic System; Bone Marrow Cells (Non MeSH); Hematopoietic Stem Cells; Erythroid Progenitor Cells Immature, nucleated erythrocytes occupying the stage of erythropoiesis that follows formation of ERYTHROID PROGENITOR CELLS and precedes formation of RETICULOCYTES. Popularly called normoblasts. Erythrocytes (66-74) qd*Erythroblastosis, Fetal C13.703.277.060; C15.378.120.413; C16.300.060; C16.614.304; C20.188.413 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Jaundice, Neonatal Rh-Hr Blood-Group System; Rh Isoimmunization Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Group Incompatibility Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Immunologic Diseases; Blood Group Incompatibility Hydrops Fetalis Hydrops Fetalis; Kernicterus Hydrops Fetalis Kernicterus Hydrops Fetalis; Kernicterus Hemolytic anemia of the fetus or newborn infant, caused by the transplacental transmission of maternally formed antibody, usually secondary to an incompatibility between the blood group of the mother and that of her offspring. (From Dorland, 27th ed). $qSL5u'Erythroblastosis Virus, Avian B04.820.650.700.250; B04.909.574.807.720.250; B04.909.777.731.720.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, ALV-Related Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, ALV-Related A species of ALV-related retroviruses (RETROVIRUSES, ALV-RELATED) causing progressive anemia and weakness in domestic and wild fowl. q#M'Erythrityl Tetranitrate D18.918.287 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cardiovascular Agents; Vasodilator Agents q:1Erythritol D09.203.853.329; D02.033.800.329 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols q@&DErythrina B06.560.331 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A genus of leguminous shrubs or trees, mainly tropical, yielding certain alkaloids, lectins, and other useful compounds. qv & Erythrasma C01.252.410.040.246.430; C01.252.825.320; C01.539.800.720.320; C17.800.838.765.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Corynebacterium Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial A chronic bacterial infection of major folds of the skin, caused by Corynebacterium minutissimum. q\PsErythema Nodosum C17.800.174.600.375; C17.800.229.413; C20.543.206.380.375; C21.613.276.505.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Drug Eruptions Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema Immunologic Diseases; Hypersensitivity; Drug Hypersensitivity; Drug Eruptions Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Drug Toxicity (Non MeSH); Drug Eruptions  Sweet's Syndrome An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy. qXNErythema Multiforme C17.800.229.400; C17.800.865.475 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Reiter's Disease Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Stevens-Johnson Syndrome Stevens-Johnson Syndrome A disorder of the skin and mucous membranes characterized by the sudden onset of an erythematous eruption, with the characteristic lesion being a central papule with two or more concentric rings. This complex comprises a mild, self-limited form (erythema multiforme minor) and a severe, occasionally fatal, multisystemic form (STEVENS-JOHNSON SYNDROME). (Dorland, 27th ed).  qm&N8Erythema Infectiosum C02.256.700.300; C02.825.260; C17.800.229.335; C17.800.838.790.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parvovirus B19, Human Virus Diseases; DNA Virus Infections (Non MeSH); Parvoviridae Infections Virus Diseases; Skin Diseases, Viral Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral Contagious infection with human B19 Parvovirus most commonly seen in school age children and characterized by fever, headache, and rashes of the face, trunk, and extremities. It is often confused with rubella. Parvovirus Infections (86-91); Skin Diseases, Infectious (72-91); Virus Diseases (66-82)  qLPYiErythema Induratum C01.252.410.040.552.846.583.260; C01.252.825.820.260; C01.539.800.720.820.260; C17.300.710.329; C17.800.229.329; C17.800.566.329; C17.800.838.765.820.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Cutaneous Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial; Tuberculosis, Cutaneous Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial; Tuberculosis, Cutaneous Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Panniculitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Panniculitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial; Tuberculosis, Cutaneous A type of panniculitis characterized histologically by the presence of granulomas, vasculitis, and necrosis. It is traditionally considered to be the tuberculous counterpart of nodular vasculitis, but is now known to occur without tuberculous precedent. It is seen most commonly in adolescent and menopausal women, is initiated or exacerbated by cold weather, and typically presents as one or more recurrent erythrocyanotic nodules or plaques on the calves. The nodules may progress to form indurations, ulcerations, and scars. qPcErythema Chronicum Migrans C01.252.400.155.569.200; C01.252.400.825.480.400; C01.252.825.310; C01.252.847.193.569.200; C01.539.800.720.310; C17.800.229.200; C17.800.838.765.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Borrelia Infections; Lyme Disease Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases; Lyme Disease Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Borrelia Infections; Lyme Disease Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Erythema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial A deep type of gyrate erythema that follows a bite by an ixodid tick; it is a stage-1 manifestation of LYME DISEASE. The site of the bite is characterized by a red papule that expands peripherally as a nonscaling, palpable band that clears centrally. This condition is often associated with systemic symptoms such as chills, fever, headache, malaise, nausea, vomiting, fatigue, backache, and stiff neck. Borrelia (86-89); Erythema (66-87); Lyme Disease (84-89); Ticks (83-89) q PYErythema C17.800.229 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Erythema Chronicum Migrans; Erythema Induratum; Erythema Infectiosum; Erythema Multiforme (+ 1); Erythema Nodosum (+ 1) Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  q NKPErysipelothrix Infections C01.252.410.334; C22.331 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections Animal Diseases Erysipeloid; Swine Erysipelas Swine Erysipelas Infections with bacteria of the genus ERYSIPELOTHRIX. Erysipeloid (66-67) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $qJ7@PErysipelothrix B03.510.460.400.410.350 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Regular (Non MeSH) A genus of gram-positive, facultatively anaerobic, rod-shaped bacteria that has a tendency to form long filaments. Its organisms are widely distributed in nature and are parasitic on mammals, birds, and fish. q-"Erysipeloid C01.252.410.334.329 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Erysipelothrix Infections An infection caused by Erysipelothrix rhusiopathiae that is almost wholly restricted to persons who in their occupation handle infected fish, shellfish, poultry, or meat. Three forms of this condition exist: a mild localized form manifested by local swelling and redness of the skin; a diffuse form that might present with fever; and a rare systemic form associated with endocarditis. q2PErysipelas C01.252.410.890.328; C01.252.825.260; C01.539.800.720.260; C17.800.838.765.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face. qXPMErwinia chrysanthemi B03.440.450.425.300.250 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Erwinia A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes vascular wilts on a wide range of plant species. Erwinia (80-91) q;"yErwinia carotovora B03.440.450.425.300.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Erwinia A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that causes rotting, particularly of storage tissues, of a wide variety of plants and causes a vascular disease of carrot and potato plants. Erwinia (67-91) q"yErwinia B03.440.450.425.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Erwinia carotovora; Erwinia chrysanthemi A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora. q "n0Eructation C23.888.821.297 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) The act of belching, or of casting up wind from the stomach through the mouth. (Dorland, 27th ed). q߽NzErucic Acids D02.241.081.436.275.300; D10.516.251.355.325.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated cis-13-Docosenoic Acids. 22-Carbon monounsaturated, monocarboxylic acids. Fatty Acids, Unsaturated (73-74) qS68$T'Erotica L01.178.362 HILJPX Information Science; Communications Media (Non MeSH) Literary or artistic items having an erotic theme. It refers especially to books treating sexual love in a sensuous or voluptuous manner. (Webster, 3d ed). q  >Ergotism C21.613.327; C21.613.680.262; C21.613.756.262 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mycotoxins Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Mycotoxicosis Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Plant Poisoning Poisoning caused by ingesting ergotized grain or by the misdirected or excessive use of ergot as a medicine. q 5LErgothioneine D02.886.489.225; D03.132.327.537 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Heterocyclic Compounds; Alkaloids; Ergot Alkaloids q &:Ergotamine Derivatives D03.132.327.287.362.412; D03.549.439.362.412 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines; Ergotamine Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines; Ergotamine Dihydroergotamine Dihydroergotamine Analogs and derivatives of ergotamine. Ergolines (69-74); Ergotamine (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $q628(/.:Ergotamine D03.132.327.287.362; D03.549.439.362; D14.100.050.100.100.230; D18.793.328 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Cardiovascular Agents; Vasoconstrictor Agents Ergotamine Derivatives (+ 1) Ergotamine Derivatives (+ 1) 12'-Hydroxy-2'-methyl-5' alpha-(phenylmethyl)ergotaman-3',6',18-trione. A vasoconstrictor found in ergot of Central Europe. It is an alpha-1 selective adrenergic agonist and is commonly used in the treatment of migraine headaches. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  qmT:F <Ergot Alkaloids D03.132.327 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Dihydroergotoxine (+ 1); Ergolines (+ 13); Ergothioneine Alkaloids isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). The ergot alkaloids were the first alpha-adrenergic antagonists discovered, but side effects generally prevent their administration in doses that would produce more than a minimal blockade in humans. Their smooth muscle-stimulating activities may be attributed to alpha-agonistic properties, thus characterizing these alkaloids as a series of partial agonists. They have many clinical applications, notably in obstetrics and the treatment of migraine. (From Martindale, The Extra Pharmacopoeia, 28th ed, p662). AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  qP>(F@Ergosterol D04.808.247.222.537; D04.808.247.808.756.287; D11.786.763.562 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Phytosterols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D Ergocalciferol (66); Vitamin D (67-71) q,E@0Ergonovine D03.132.327.287.262; D03.549.439.262; D06.472.583.328 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Oxytocics Methylergonovine Methylergonovine q=:'Ergometry E05.333 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Exertion Miscellaneous Techniques (Non MeSH) Exercise Test Any method of measuring the amount of work done by an organism, usually during EXERTION. Ergometry also includes measures of power. Some instruments used in these determinations include the hand crank and the bicycle ergometer. Exercise Test (66-91); Exertion (66-91) $q  & * 1Ergoloid Mesylates D03.132.327.190.325; D15.590.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Dihydroergotoxine Central Nervous System Agents; Nootropic Agents Dihydroergotoxine monomethanesulfonate. A mixture of the mesylates of dihydroergocornine, dihydroergocristine, and the alpha- and beta-isomers of dihydroergocryptine. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly. q&8Ergolines D03.132.327.287; D03.549.439 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Bromocriptine; Ergonovine (+ 1); Ergotamine (+ 2); Lisuride; Lysergic Acid (+ 1); Methergoline; Methysergide; Nicergoline; Pergolide Bromocriptine; Ergonovine (+ 1); Ergotamine (+ 2); Lisuride; Lysergic Acid (+ 1); Methergoline; Methysergide; Nicergoline; Pergolide Ergonovine (66-68); Ergot Alkaloids (66-68); Ergotamine (66-68); Lysergic Acid Diethylamide (66-68); Methylergonovine (66-68); Methysergide (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  qo "8B<Ergocalciferols D04.808.247.222.474; D04.808.247.808.412; D04.808.812.537; D10.516.851.439; D11.786.763.462 ADAEAGAIANBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Polycyclic Hydrocarbons; Steroids; Secosteroids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D 25-Hydroxyvitamin D 2 25-Hydroxyvitamin D 2 25-Hydroxyvitamin D 2 25-Hydroxyvitamin D 2 25-Hydroxyvitamin D 2 Vitamin D2 analogs or derivatives. The compounds are used chiefly as oral antirachitic vitamins. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  qg@SsDErbium D01.268.558.150; D01.552.550.255 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Erbium. An element of the rare earth family of metals. It has the atomic symbol Er, atomic number 68, and atomic weight 167.26. r) &:Erabutoxins D24.185.965.850.480.345 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Hydrophid Venoms Toxins isolated from the venom of Laticauda semifasciata, a sea snake (Hydrophid); immunogenic, basic polypeptides of 62 amino acids, folded by four disulfide bonds, block neuromuscular end-plates irreversibly, thus causing paralysis and severe muscle damage; they are similar to Elapid neurotoxins. rB|[Equipment Safety E05.330 CLECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Freedom of equipment from actual or potential hazards. rH *BEquipment Reuse E05.328; G03.850.585 ECLJSNSTVE Miscellaneous Techniques (Non MeSH) Environment and Public Health (Non MeSH); Public Health Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions. rl"Equipment Failure E05.325 ECSNVE Miscellaneous Techniques (Non MeSH) Prosthesis Failure Failure of equipment to perform up to standards. The failure may be due to defects or improper use. r  *zEquipment Design E05.320 AECLECHIISMOMTPXSNSTTDVE Denture Design; Prosthesis Design Miscellaneous Techniques (Non MeSH) r  )*Equipment Contamination G03.850.540 ECLJPCSN Environment and Public Health (Non MeSH); Public Health The presence of an infectious agent on instruments, prostheses, or other inanimate articles. r  DmEquipment and Supplies, Hospital E07.325 AECLCTECHISDSNSTTDUTVE Purchasing, Hospital; Hospitals Equipment and Supplies Bedding and Linens; Beds; Hospitals, Packaged; Incubators, Infant; Patient Isolators Any materials used in providing care specifically in the hospital. AECLCTECHILJMAOGSDSNSTTDUTVE $r ' &eP Equipment and Supplies E07 AECLCTECHISDSNSTVE Catalogs, Commercial Amplifiers; Atmosphere Exposure Chambers; Bandages (+ 2); Blood Pressure Monitors; Catheters, Indwelling; Contraceptive Devices (+ 6); Dental Equipment (+ 7); Disposable Equipment; Durable Medical Equipment; Electrodes (+ 5); Emergency Medical Tags; Equipment and Supplies, Hospital (+ 5); G Suits; Gamma Cameras; Gas Scavengers; Gastric Bubble; Implants, Artificial (+ 25); Incontinence Pads; Incubators (+ 1); Infant Equipment; Infusion Pumps (+ 2); Lenses (+ 5); Micropore Filters; Microspheres; Nebulizers and Vaporizers; Needles; Oxygenators (+ 1); Power Sources (+ 1); Protective Devices (+ 13); Reagent Kits, Diagnostic (+ 1); Self-Help Devices (+ 2); Sensory Aids (+ 2); Surgical Equipment (+ 64); Syringes; Thermometers; Tomography Scanners, X-Ray Computed; Tourniquets; Transducers (+ 1); Ventilators, Mechanical (+ 1); X-Ray Film; X-Ray Intensifying Screens ADAEANCHCLCSCTDUECHIIPISLJMAMEMIMOMTNUOGPDPKPOPSPXRERHSDSNSTTDTOTUUTVEVI r ^LEquinus Deformity C05.330.408 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Foot Deformities Plantar declination of the foot. r9N2)Equine Infectious Anemia C02.782.815.616.300; C02.839.375; C22.488.304 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections Virus Diseases; Slow Virus Diseases Animal Diseases; Horse Diseases Viral disease of horses caused by the equine infectious anemia virus (EIAV; INFECTIOUS ANEMIA VIRUS, EQUINE). It is characterized by intermittent fever, weakness, and anemia. Chronic infection consists of acute episodes with remissions. Horse Diseases (66-69); Virus Diseases (66-69) r*5J9Equilin D04.808.365.415.220; D04.808.578.502.475; D06.472.265.245; D06.472.866.540.245 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens 3-Hydroxyestra-1,3,5(10)7-tetraen-17-one. A naturally occurring steroid with estrogenic activity obtained from the urine of pregnant mares. Estranes (73-74); Hydroxysteroids (74); 17-Ketosteroids (69-74) r XD4LEquilibrium G11.427.342; G11.561.796.541.328 DEPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Proprioception A state of being evenly balanced or the harmonious performance of function. Its physiological application is in the biomechanical responses of the musculoskeletal system during standing, walking, sitting, and other movements. Stability and equilibrium are related to the mathematics of the center of gravity of the body. r& uEquilenin D04.808.365.415.215; D04.808.578.502.470; D06.472.265.240; D06.472.866.540.240 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Estrogens 3-Hydroxyestra-1,3,5(10),6,8-pentaen-17-one. A naturally occurring steroid with estrogenic activity obtained from the urine of pregnant mares. Estranes (73-74); Hydroxysteroids (74); 17-Ketosteroids (69-74) r XD4LEquidae B02.649.709.235 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Perissodactyla Horses A family of hoofed mammals consisting of HORSES, asses, donkeys, and zebras. Members of this family are strict herbivores and can be classified as either browsers or grazers depending on how they feed. Horses (66-94); Perissodactyla (66-94)  r (, /Equatorial Guinea Z01.058.290.100.300 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central In central Africa, originally a Spanish colony comprising mainland Rio Muni and several offshore islands. The Spaniards left in 1968 and the subsequent local repressive ruler, Francisco Macias Nguema, was overthrown in 1979. Its capital is Malabo, its religions traditional and Catholic. (Rand-McNally Atlas). Africa, Central (66-91) rq_iEpoxy Resins D25.720.716.822.461 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic r!,bEpoxy Compounds D02.355.291.411 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Ethers, Cyclic Epichlorohydrin; Ethylene Oxide; Trichloroepoxypropane AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR r"8A?:Epoxide Hydrolases D08.586.277.340 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Enzymes that catalyze reversibly the formation of an epoxide or arene oxide from a glycol or aromatic diol, respectively. EC 3.3.2.3. Ethers, Cyclic (66-74); Hydro-Lyases (66-74) r#FS6Epoprostenol D02.241.081.436.213.100.650.125; D02.241.081.436.687.012; D10.516.251.355.255.100.650.150; D10.516.251.355.708.012; D17.350.050.175.725.200; D19.461.780.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Prostaglandins Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids; Prostaglandins Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Platelet Aggregation Inhibitors (5Z,9 alpha,1 alpha,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid. A prostaglandin that is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue. It is a potent inhibitor of platelet aggregation. Prostaglandins (66-77) r%DxEponyms L01.143.506.598.400.556.536 Information Science; Communication; Language; Linguistics; Nomenclature; Names r+R ]EPN D02.719.376; D05.723.491.657.386 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71) r+&:Epitope Mapping E05.478.280 AECLCTECHIISMOMTNUPXSNSTTDUTVE Antigenic Determinants Miscellaneous Techniques (Non MeSH); Immunologic Techniques Methods used for studying the interactions of antibodies with specific regions of protein antigens. Important applications of epitope mapping are found within the area of immunochemistry. Antigenic Determinants (82-94)  r-X"F$Epithelium A10.272 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cilia Tissue Types (Non MeSH) Basement Membrane (+ 1); Endothelium (+ 4); Epidermis; Pigment Epithelium of Eye; Seminiferous Epithelium r/' : Epithelioid Cells A11.329.372.300; A11.733.397.300; A15.382.680.397.300; A15.382.812.522.300 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Giant Cells Cells; Connective Tissue Cells (Non MeSH); Macrophages Cells; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Phagocytes; Macrophages Hemic and Immune Systems (Non MeSH); Immune System; Reticuloendothelial System; Macrophages Characteristic cells of granulomatous hypersensitivity. They appear as large, flattened cells with increased endoplasmic reticulum. They are believed to be activated macrophages that have differentiated as a result of prolonged antigenic stimulation. Further differentiation or fusion of epithelioid cells is thought to produce multinucleated giant cells (GIANT CELLS). Epithelium (66-89); Macrophages (66-89)  r0HT*,0Epithelial Cells (Non MeSH) A11.436 Cells Ameloblasts; Chromatophores (+ 1); Dendritic Cells (+ 1); Enterochromaffin Cells; Granulosa Cells; Keratinocytes; Labyrinth Supporting Cells; Melanocytes; Parietal Cells, Gastric; Sertoli Cells CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI r4"  *Epithelial Attachment A14.254.646.374 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Periodontium r5:7Epitestosterone D04.808.054.079.429.824.275; D06.472.079.864.250; D06.472.866.154.864.250 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols; Testosterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens; Testosterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Androgens; Testosterone 17 alpha-Hydroxy-androst-4-ene-3-one. A naturally occurring stereoisomer of testosterone with androgenic activity. Testosterone (69-74) r6AQD1Epistaxis C08.460.261; C09.603.261; C23.542.244 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Otorhinolaryngologic Diseases; Nose Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage Bleeding from the nose. It may be caused by a manifestation of a general disease, as in the early stages of acute fevers, from a local disease of the nasal passages, or from high blood pressure. r8 -NEpistasis, Genetic G05.735.340 Genetics; Phenotype A form of gene interaction whereby one gene interferes with the phenotypic expression of another nonallelic gene or genes. Genes whose expression is altered by nonallelic genes are said to be "hypostatic" or to exhibit "hypostasis". Genes, Dominant (68-78); Genetics (66-67); Phenotype (68-78) r;JEpispadias C12.740.700.374; C12.777.767.374; C13.371.820.700.374; C16.131.939.374 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Congenital absence of the upper wall of the urethra. r<PLAEpisode of Care E02.472.300; N02.421.589.350 Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) An interval of care by a health care facility or provider for a specific medical problem or condition. It may be continuous or it may consist of a series of intervals marked by one or more brief separations from care, and can also identify the sequence of care (e.g., emergency, inpatient, outpatient), thus serving as one measure of health care provided. r?"Episiotomy E04.819.774.457.328 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery An incision of the posterior vaginal wall and a portion of the pudenda which enlarges the vaginal introitus to facilitate delivery and prevent lacerations. rB$lEpirubicin D20.085.075.105.200.210.350; D22.204.106.125.200.210.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin; Doxorubicin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin; Doxorubicin 10-((3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl) oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8- (hydroxyacetyl)-1-methoxy-5,12-naphthacenedione. An anthracycline antibiotic which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA. Clinical studies indicate activity in breast cancer, non-Hodgkin's lymphomas, ovarian cancer, soft-tissue sarcomas, pancreatic cancer, gastric cancer, small-cell lung cancer and acute leukemia. It is equal in activity to doxorubicin but exhibits less acute toxicities and less cardiotoxicity. Doxorubicin (73-88) rD>:3Epirizole D03.383.694.200; D03.383.742.200; D16.850.015.050.210; D17.025.030.217; D17.050.030.232 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 4-Methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine. A pyrimidinyl pyrazole with antipyretic, analgesic, and anti-inflammatory activity. Pyrazoles (72-75); Pyrimidines (72-75) rH c:/Epiphyses, Slipped C05.116.425 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cartilage Diseases Musculoskeletal Diseases; Bone Diseases Bone Diseases (66); Epiphyses (66) rLN/,Epiphyses A02.835.232.251 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones Growth Plate The expanded articular ends of long bones, developed from a secondary ossification center, during which the period of growth is either entirely cartilaginous or is separated from the shaft by the epiphyseal cartilage. (Dorland, 27th ed). rN  :;Epinephrine D02.092.211.215.311.461; D02.092.311.461; D14.100.050.100.100.220; D14.100.050.100.200.250; D14.600.100.250; D16.050.110.200; D16.050.500.200; D16.050.870.200; D18.222.863.348; D18.793.315 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Adrenergic Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines Organic Chemicals (Non MeSH); Amines; Catecholamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents Metanephrine Deoxyepinephrine; Metanephrine; Norepinephrine (+ 1); Normetanephrine The active sympathomimetic hormone from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics.  rODhEpimestrol D04.808.365.415.200; D06.597.378.340 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic 3-Methoxy-estra-1,3,5(10)-triene-16 alpha,17 alpha-diol. A synthetic steroid with estrogenic activity. Estranes (72-74); Hydroxysteroids (72-74); Methyl Ethers (72-74) rWt*:vNEpimerases D08.586.399.461 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Uridine Diphosphate Glucose Epimerase rYvFS,Epilepsy, Tonic-Clonic C10.228.140.490.300.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Generalized Primary generalized epileptic seizures, starting without warning, characterized by loss of consciousness, tonic contraction of muscles, loss of postural control, and production of a cry by the forced expiration of air due to contraction of the respiratory muscles. The individual then falls to the floor and remains rigid for a few seconds, after which a series of rhythmic contractions occur in all four limbs. This clonic phase can last for a variable period, ending only upon muscle relaxation. Upon recovery, there is a gradual return to consciousness, disorientation, amnesia for the seizure, sometimes retrograde amnesia as well, headache, and drowsiness. The individual may not return to baseline functioning for days. rZN|KEpilepsy, Temporal Lobe C10.228.140.490.360.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Partial Epileptic seizures characterized by simple partial seizures, complex partial seizures, and secondary generalized seizures, or combinations of these. Seizures may present with autonomic and/or psychic symptoms and certain sensory phenomena such as olfactory and auditory. Most common is an epigastric rising sensation. Some seizures may begin with motor arrest and continue with oro-alimentary automatisms (with other automatisms following). Attacks are followed by amnesia and recovery is gradual. Usually, there is a history of febrile seizures in the individual or a history of seizures in the family. Seizures occur in clusters, randomly, or at intervals. r^NxEpilepsy, Post-Traumatic C10.228.140.490.380 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy Epileptic seizures occurring as the result of trauma such as a gunshot wound or other injury to the brain. rc NbEpilepsy, Partial C10.228.140.490.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy Epilepsy, Complex Partial; Epilepsy, Frontal Lobe; Epilepsy, Temporal Lobe Epileptic seizures that originate at a specific location or focal point in the cortex of the brain and either remain localized or may generalize. These seizures occur without the loss of consciousness of the individual. The specific clinical symptoms depend on the area of the cortex involved. Jacksonian Seizure (66-76)  rdNbXZ Epilepsy, Myoclonic C10.228.140.490.300.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Generalized MERRF Syndrome A progressive encephalopathy characterized by myoclonic jerks (single or repetitive muscle contractions involving one body part or the entire body), mental retardation, and ataxia. The disease, an autosomal recessive form of epilepsy, occurs usually at puberty. The most significant pathological findings are Lafora's inclusion bodies, which contain mucopolysaccharides. Epilepsy (66-76); Myoclonus (66-76)  rglN|,Epilepsy, Generalized C10.228.140.490.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy Epilepsy, Absence; Epilepsy, Myoclonic (+ 1); Epilepsy, Tonic-Clonic; Spasms, Infantile Epileptic seizures in which the first clinical changes indicate initial involvement of both hemispheres of the brain, as opposed to epileptic seizures involving a particular focal point of the brain (EPILEPSY, PARTIAL). Generalized seizures can be convulsive or non-convulsive. Consciousness may be impaired and this impairment may be the initial manifestation of the seizure. Motor manifestations, if present, are also bilateral. Epilepsy (66-91)  rj|NbhEpilepsy, Frontal Lobe C10.228.140.490.360.270 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Partial Epileptic seizures arising from the frontal lobe characterized by simple partial, complex partial, secondary generalized seizures, or combinations of these. The seizures, which are short in duration, may occur several times a day, mostly during sleep. Affected individuals usually have prominent motor manifestations which are tonic or postural, complex gestational automatisms at the onset, and fall to the ground when the discharge is bilateral. STATUS EPILEPTICUS is a frequent complication. Epilepsy (66-88); Epilepsy, Partial (80-91); Epilepsy, Temporal Lobe (66-91) rmNx;\Epilepsy, Complex Partial C10.228.140.490.360.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Partial Epileptic seizures that are episodic changes in behavior in which an individual loses conscious contact with the environment. The onset of such seizures involves any of a variety of auras: deja-vu, an unusual smell, a sudden intense emotional feeling, a sensory illusion such as micropsia (objects growing smaller) or macropsia (objects growing larger), or other sensory hallucination. There may be a cessation of activity with some minor motor activity such as lip smacking, walking aimlessly, or other automatisms. The seizures may also be accompanied by the unconscious performance of highly skilled activities such as driving a car. When the seizure ends, the individual is amnesic for events that took place during the seizure and may take minutes or hours to recover fully to consciousness. Epilepsy, Temporal Lobe (79-91) rqNx&Epilepsy, Absence C10.228.140.490.300.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Epilepsy, Generalized Epileptic seizures that consist of a sudden cessation of ongoing conscious activity without convulsive muscular activity or loss of postural control. These seizures may be so brief as to be inapparent, lasting seconds and occasionally several minutes. Absence seizures usually begin in otherwise neurologically normal children and rarely appear for the first time in adults. The seizures may occur hundreds of times per day and go on for weeks or months before it is recognized that a child is having seizures. rvN|VEpilepsy C10.228.140.490 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Kindling (Neurology) Convulsions Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Epilepsy, Generalized (+ 5); Epilepsy, Partial (+ 3); Epilepsy, Post-Traumatic; Status Epilepticus (+ 1) Paroxysmal transient disturbances of brain function that may be manifested as episodic impairment or loss of consciousness, abnormal motor phenomena, psychic or sensory disturbances, or perturbation of the autonomic nervous system. Symptoms are due to paroxysmal disturbance of the electrical activity of the brain. On the basis of origin, epilepsy is idiopathic (cryptogenic, essential, genetic) or symptomatic (acquired, organic). (Dorland, 27th ed). $rz NV~ Epilepsia Partialis Continua C10.228.140.490.690.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Epilepsy; Status Epilepticus Focal motor STATUS EPILEPTICUS characterized by high fever, delirium, localized muscular spasms and generalized convulsion, then clonic twitching of one group of muscles at regular intervals (seconds apart) lasting for hours or months, remaining localized. These continue throughout sleep, possibly at a reduced rate. Epilepsy (66-91); Epilepsy, Partial (77-91); Epilepsy, Temporal Lobe (66-91) r}"Nyn\Epikeratophakia E04.792.225.225; E04.936.580.225.225 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Surgery, Eye (Non MeSH); Corneal Transplantation Surgery, Operative; Transplantation; Tissue Transplantation; Corneal Transplantation A procedure that modifies the refractive error of the lens by the transplantation of a donor cornea to the anterior surface of the patient's cornea. The basic indication for epikeratophakia is the incapability of correcting refractive errors with conservative methods, such as glasses, contact lenses, or intraocular lenses. Corneal Transplantation (81-92) r*2y%Epiglottitis C08.730.368.351 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiratory Tract Infections; Laryngitis Inflammation of the epiglottis. Laryngitis (66-83) rNP'Epiglottis A02.165.507.411; A04.329.591.411 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage; Laryngeal Cartilages Respiratory System; Larynx; Laryngeal Cartilages Thin leaf-shaped cartilage, covered with mucous membrane, at the root of the tongue, which folds back over the entrance to the larynx, covering it, during the act of swallowing. r&:yEpidural Space A02.835.232.834.803.350 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine; Spinal Canal Space between the dura mater and the walls of the vertebral canal. Dura Mater (66-78); Meninges (66-78); Spinal Canal (66-78); Spinal Cord (66-78) r6URcEpidural Neoplasms C04.588.614.250.803.342; C10.228.250.803.342; C10.228.854.780.342; C10.551.250.803.342 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Spinal Cord Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Spinal Cord Neoplasms Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases; Spinal Cord Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Spinal Cord Neoplasms Neoplasms located in the epidural space, at or above the dura mater of the spinal cord. Spinal Cord Compression (66-88); Spinal Cord Diseases (66-88); Spinal Cord Neoplasms (66-88); Spinal Neoplasms (66-88) r)`XkEpididymitis C12.294.199 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male Inflammation of the epididymis. (Dorland, 27th ed). rNT@Epididymis A05.360.444.849.286 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male; Testis rB:AEpidermophyton B05.354.318.286; B05.354.381.546.340 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Dermatophytes Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus which grows in the epidermis and is the cause of tinea. r*"iEpidermolysis Bullosa, Junctional C16.131.831.493.170; C17.800.827.800.493.170; C17.800.865.410.170 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous; Epidermolysis Bullosa Form of epidermolysis bullosa having onset at birth or during the neonatal period and transmitted through autosomal recessive inheritance. It is characterized by generalized blister formation, extensive denudation, and separation and cleavage of the basal cell plasma membranes from the basement membrane. Epidermolysis Bullosa (66-90) rt'IL`#Epidermolysis Bullosa Simplex C16.131.831.493.180; C17.800.827.800.493.180; C17.800.865.410.180 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous; Epidermolysis Bullosa Form of epidermolysis bullosa characterized by autosomal dominant inheritance and by serous bullae that heal without scarring. Epidermolysis Bullosa (66-90) r#IL#Epidermolysis Bullosa Dystrophica C16.131.831.493.160; C17.800.827.800.493.160; C17.800.865.410.160 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous; Epidermolysis Bullosa Form of epidermolysis bullosa characterized by atrophy of blistered areas, severe scarring, and nail changes. It is most often present at birth or in early infancy and occurs in both autosomal dominant and recessive forms. Epidermolysis Bullosa (66-90) r'IL#Epidermolysis Bullosa Acquisita C16.131.831.493.080; C17.800.827.800.493.080; C17.800.865.410.080 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Epidermolysis Bullosa Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous; Epidermolysis Bullosa Form of epidermolysis bullosa characterized by trauma-induced, subepidermal blistering with no family history of the disease. Direct immunofluorescence shows IgG deposited at the dermo-epidermal junction. Epidermolysis Bullosa (66-90) r%IL#Epidermolysis Bullosa C16.131.831.493; C17.800.827.800.493; C17.800.865.410 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Epidermolysis Bullosa Acquisita; Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional; Epidermolysis Bullosa Simplex Epidermolysis Bullosa Acquisita; Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional; Epidermolysis Bullosa Simplex Epidermolysis Bullosa Acquisita; Epidermolysis Bullosa Dystrophica; Epidermolysis Bullosa, Junctional; Epidermolysis Bullosa Simplex Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties. rm=LqEpidermodysplasia Verruciformis C02.256.690.810.345; C02.825.810.260; C02.928.914.345; C04.925.744.500; C17.800.838.790.810.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Papovaviridae Infections; Warts Virus Diseases; Skin Diseases, Viral; Warts Virus Diseases; Tumor Virus Infections; Warts Neoplasms; Tumor Virus Infections; Warts Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral; Warts An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales. Papillomaviruses (78-86); Skin Diseases (66-86); Skin Neoplasms (68-86); Tumor Virus Infections (72-86); Warts (66-86) rc$kPLEpidermitis, Exudative, of Swine C22.905.382 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Swine Diseases An acute generalized dermatitis of pigs which occurs from 5 to 35 days of age, characterized by sudden onset, with morbidity of 10 to 90% and mortality of 5 to 90%. The lesions are caused by Staphylococcus hyos but the bacterial agent is unable to penetrate the intact skin. Abrasions on the feet and legs or lacerations on the body frequently precede infection. In acute cases, a vesicular-type virus may be the predisposing factor. The causative organism is inhibited by most antibiotics. (Merck Veterinary Manual, 5th ed, p. 939). Swine Diseases (66-69) r'J'xEpidermis A10.272.497 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Epithelium Nonvascular layer of the skin. It is made up, from within outward, of five layers: 1) basal layer (stratum basale epidermidis); 2) spinous layer (stratum spinosum epidermidis); 3) granular layer (stratum granulosum epidermidis); 4) clear layer (stratum lucidum epidermidis); and 5) horny layer (stratum corneum epidermidis). Skin (66-77) r, 8-Epidermal Necrolysis, Toxic C17.800.174.600.350; C20.543.206.380.350; C21.613.276.505.350 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Drug Eruptions Immunologic Diseases; Hypersensitivity; Drug Hypersensitivity; Drug Eruptions Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Drug Toxicity (Non MeSH); Drug Eruptions An exfoliative disease of skin seen primarily in adults and characterized by flaccid bullae and spreading erythema so that the skin has the appearance of being scalded. It results primarily from a toxic reaction to various drugs, but occasionally occurs as a result of infection, neoplastic conditions, or other exposure. re!EL:xEpidermal Growth Factor-Urogastrone D06.472.317.350; D12.644.170; D19.316.629.360; D24.185.348.360 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Epidermal Growth Factor-Urogastrone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Single chain, nonhelical, acidic polypeptide of about 52 amino acids found in most mammals; promotes growth of, and cell proliferation in, certain tissues, especially epidermal structures and inhibits acid secretion by the stomach; used to treat gastrointestinal ulcers. Gastrointestinal Hormones (66-74); Growth Substances (66-76); Peptides (66-76)  r)HB5q:]Epidermal Growth Factor Receptor Protein-Tyrosine Kinase D08.586.913.696.620.682.725.700.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Tyrosine Kinase; Receptor Protein-Tyrosine Kinase The catalytic PROTEIN-TYROSINE KINASE domain found on the cytoplasmic beta-portion of epidermal growth factor receptor. Protein Kinases (82-85); Protein-Tyrosine Kinase (86-93) rA'FCEpidermal Cyst C04.182.254 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Intradermal or subcutaneous saclike structure, the wall of which is stratified epithelium containing keratohyalin granules. rVEpidemiology, Molecular E05.318.416; E05.393.305; G01.273.595.300; G02.403.290.300; G03.850.520.438 CLECEDHIISLJMAMTOGSNSTTD Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Miscellaneous Techniques (Non MeSH); Genetic Techniques Biological Sciences; Biology; Molecular Biology Health Occupations; Medicine; Epidemiology Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples. rWIJEpidemiology G02.403.290 CLECEDHIISLJMAOGSNSTTD Health Occupations; Medicine Epidemiology, Molecular; Pharmacoepidemiology Field of medicine concerned with the determination of causes, incidence, and characteristic behavior of disease outbreaks affecting human populations. It includes the interrelationships of host, agent, and environment as related to the distribution and control of disease. CLECEDHIISLJMAMTOGSNSTTD  r##4:Epidemiologic Methods E05.318; G03.850.520 VE Pregnancy Outcome Miscellaneous Techniques (Non MeSH) Environment and Public Health (Non MeSH); Public Health Contact Tracing; Data Collection (+ 54); Disease Notification; Epidemiology, Molecular; Sentinel Surveillance; Statistics (+ 45); Study Characteristics (Non MeSH) (+ 23); Study Design (Non MeSH) (+ 12) Contact Tracing; Data Collection (+ 51); Disease Notification; Epidemiology, Molecular; Sentinel Surveillance; Statistics (+ 45); Study Characteristics (Non MeSH) (+ 23); Study Design (Non MeSH) (+ 12) AECLCTECEDEHHIISLJMAMOMTNUOGPXSDSNSTTDUTVE  r4l.Epidemiologic Measurements (Non MeSH) G03.850.505; N05.715.360.325 Environment and Public Health (Non MeSH); Public Health Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Biometry (+ 5); Demography (+ 28); Risk Assessment Biometry (+ 5); Risk Assessment AECLCTECEHHIISLJMOMTNUPXSNSTTDUTVE r),"h&Epidemiologic Factors G03.850.490; N05.715.350 Environment and Public Health (Non MeSH); Public Health Quality, Access, Evaluation (Non MeSH); Quality of Health Care Age Factors (+ 1); Bias (Epidemiology) (+ 2); Causality (+ 2); Comorbidity; Confounding Factors (Epidemiology); Effect Modifiers (Epidemiology) (+ 3); Observer Variation; Reproductive History; Sex Factors Age Factors (+ 1); Bias (Epidemiology) (+ 2); Causality (+ 2); Comorbidity; Confounding Factors (Epidemiology); Effect Modifiers (Epidemiology) (+ 3); Reproductive History; Sex Factors Events, characteristics, or other definable entities that have the potential to bring about a change in a health condition or other defined outcome. Epidemiology (66-89) TD  rEpichlorohydrin D02.033.440.310; D02.355.291.411.400; D07.360.443.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Chlorohydrins Organic Chemicals (Non MeSH); Ethers; Ethers, Cyclic; Epoxy Compounds Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Male (Chloromethyl)oxirane. A chlorinated epoxy compound used as a solvent in a variety of resins, gums, paints, etc. It has shown anti-fertility activity in males. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), epichlorohydrin may reasonably be anticipated to be a carcinogen. (Merck Index, 11th ed). Chlorine (73-74); Ethers, Cyclic (69-74); Propane (73-74) r~=:}GEphemeral Fever Virus, Bovine B04.820.455.750.500.200; B04.909.777.455.750.500.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Rhabdoviridae; Lyssavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Rhabdoviridae; Lyssavirus A species of LYSSAVIRUS causing disease in cattle. Transmission is by insects. Rhabdoviridae (77-93); RNA Viruses (69-78) r$:_4Ephemeral Fever C02.782.580.830.375; C22.196.274 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Mononegavirales Infections; Rhabdoviridae Infections Animal Diseases; Cattle Diseases A rhabdovirus infection of cattle, characterized by respiratory symptoms, increased oropharyngeal secretions and lacrimation, joint pains, tremor, and stiffness. Arbovirus Infections (66-69); Cattle Diseases (66-69) r&J@Ephedrine D02.033.329.624.302; D02.092.063.624.302; D14.100.050.100.100.210; D14.100.050.100.200.240; D14.100.050.600.275; D15.155.135; D15.220.340; D16.050.110.190; D16.050.870.190; D18.793.302 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Vasoconstrictor Agents An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists. r  :%Eperythrozoonosis C01.252.400.810.700.065.335 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Anaplasmataceae Infections Infection with bacteria of the genus EPERYTHROZOON. rEP>Eperythrozoon B03.700.651.129.493 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Anaplasmataceae A genus of gram-negative bacteria whose organisms are obligate parasites of various vertebrate species including rodents, ruminants, and pigs. Some species have been shown to be transmitted by arthropod vectors. r"^Ependymoma C04.557.465.625.600.380.290; C04.557.470.670.380.290; C04.557.580.625.600.380.290 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Glioma, Subependymal Glioma, Subependymal Glioma, Subependymal A glioma derived from relatively undifferentiated ependymal cells, comprising approximately 1%-3% of all intracranial neoplasms. Ependymomas occur in all age groups and may originate from the lining of any of the ventricles or, more commonly, from the central canal of the spinal cord. Over 60% occur below the tentorium and most of these are in the posterior fossa, predominantly in the fourth ventricle. Ependymomas constitute about 5% of adult intracranial gliomas and up to 10% of childhood central nervous system tumors. (Stedman 25th ed; Holland et al., Cancer Medicine, 3d ed, p. 1100). rYXGEpendyma A08.186.211.276.460; A08.561.326; A10.755.260 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Cerebral Ventricles Nervous System; Nerve Tissue Tissue Types (Non MeSH); Nerve Tissue The lining of the ventricles of the brain and of the central canal of the spinal cord (Dorland, 27th ed). rޑ 58Eosinophils A11.118.637.415.345; A15.145.229.637.415.345; A15.382.490.315.251 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Granulocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Granulocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Granulocytes Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. rOI*Eosinophilic Granuloma C05.116.391; C15.378.553.231.348; C15.604.667.400.400.360; C23.484.243 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Eosinophilia Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Reticuloendotheliosis; Histiocytosis; Histiocytosis, Langerhans-Cell Symptoms and General Pathology (Non MeSH); Granuloma The most benign clinical form of Langerhans-cell histiocytosis (HISTIOCYTOSIS, LANGERHANS-CELL), which involves localized nodular lesions of the gastric mucosa, small intestine, bones, lungs, or skin, with infiltration by eosinophils. The proliferating cell that appears to be responsible for the clinical manifestations is the Langerhans cell. rPN~Eosinophilia-Myalgia Syndrome C05.651.290; C15.378.553.231.335 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tryptophan Musculoskeletal Diseases; Muscular Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Eosinophilia A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. The varied symptoms include severe muscle pain and abnormally high numbers of eosinophils. This disease has presented itself only in people taking the amino acid L-tryptophan and it is believed that a specific impurity (probably stemming from a genetically engineered bacterial strain) in lots of L-tryptophan made by a single manufacturer may be the cause of the syndrome. Eosinophilia/chemically induced (89-90); Muscular Diseases/chemically induced (90); Tryptophan/adverse effects (89-90)  r"&N_Eosinophilia C15.378.553.231 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Angiolymphoid Hyperplasia with Eosinophilia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH) Angiolymphoid Hyperplasia with Eosinophilia; Eosinophilia-Myalgia Syndrome; Eosinophilic Granuloma; Hypereosinophilic Syndrome (+ 1) Abnormal increase in eosinophils in the blood, tissues or organs.  r$N2oOEosine Yellowish-(YS) D03.494.953.275.325; D04.615.885.347.325; D26.408.348.514.323; D26.550.342.325 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Fluoresceins Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Fluoresceins 2',4',5',7'-Tetrabromo-3',6'-dihydroxyspiro (isobenzofuran-1(3H),9'-(9H)xanthen)-3-one disodium salt. A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media. Fluoresceins (66-78); Stains and Staining (66-78) rFX.G<Eosine I Bluish D03.494.953.275.300; D04.615.885.347.300; D26.408.348.514.300; D26.550.342.300 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Fluoresceins Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes; Fluoresceins Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Fluoresceins 4',5'-Dibromo-3',6'-dihydroxy-3',7'-dinitrospiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one disodium salt. A red fluorescein dye used as a histologic stain. It may be cytotoxic, mutagenic, and inhibit certain mitochondrial functions. Bromine (66-78); Chlorine (66-78); Fluoresceins (66-78) r%X. DEnzymes, Immobilized D08.586.180 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzyme Stability Microspheres Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes Enzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity. Since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields. specific enzyme(66-76) $rFEGEnzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) D08 Coenzymes (+ 18); Cytochromes (+ 7); Enzyme Inhibitors (+ 171); Enzyme Precursors (+ 8); Enzyme Reactivators (+ 3); Enzymes (+ 772) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR r39HEnzymes D08.586 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Substrate Specificity Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) DNA Restriction-Modification Enzymes (+ 10); Enzymes, Immobilized; Hydrolases (+ 262); Isoenzymes (+ 4); Isomerases (+ 26); Ligases (+ 36); Lyases (+ 64); Multienzyme Complexes (+ 14); Oxidoreductases (+ 162); Permeases (+ 1); Transferases (+ 182) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  r  D90HEnzyme-Linked Immunosorbent Assay E01.223.495.567.350.170; E01.223.495.567.380.360; E05.478.567.350.170; E05.478.567.380.360; E05.478.588.400.170 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunosorbents Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunoenzyme Techniques Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunosorbent Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunoenzyme Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunosorbent Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry; Immunoenzyme Techniques An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. Immunoassay (66-76); Serodiagnosis (66-76)  r'{"&%3Enzyme Tests E01.223.174.493 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical sN"?Enzyme Stability E05.916.360; G06.184.378 DEGEIMPHRE Enzymes, Immobilized Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Drug Stability (66-86); Hydrogen-Ion Concentration (66-86); Kinetics (66-86); Temperature (66-86)  s tEnzyme Repression G05.331.370.380.435.340 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Enzymologic The interference in synthesis of an enzyme due to the elevated level of an effector substance, usually a metabolite, whose presence would cause depression of the gene responsible for enzyme synthesis. sEnzyme Reactivators D08.515 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) Cholinesterase Reactivators (+ 2) Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme. Enzymes (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $sy 89(:Enzyme Precursors D08.444 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein Precursors Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) Chymotrypsinogen; Pepsinogen; Plasminogen; Prekallikrein; Properdin Factor B; Protein C; Prothrombin; Trypsinogen AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  s< F9HEnzyme Multiplied Immunoassay Technique E01.223.495.567.350.180; E05.478.567.350.180; E05.478.588.400.180 AECLCTECHIISMONUPXSNSTTDUTVE Substance Abuse Detection Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunoenzyme Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunoenzyme Techniques Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry; Immunoenzyme Techniques An immunoenzyme test that uses antibodies to detect the presence of drugs and other substances in the urine and blood. The test uses antibodies that react only with the particular drug for which the sample is being tested. In the test mixture the antibodies attach themselves to the drug if it is present in the sample. It is not designed to measure amounts of the drug present, only its presence or absence. It is commonly seen in the literature as EMIT (d.a.u.) wherein the d.a.u. means "drugs of abuse in urine". Though launched in 1973 for the study of antiepilepsy drugs, it is now used predominantly, but not exclusively, for the detection of drugs of abuse in the urine. Immunoenzyme Techniques (76-92)  s.I O'%Enzyme Inhibitors D08.373 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) Allopurinol; Aminoglutethimide; Aminooxyacetic Acid; Aphidicolin; Benserazide; Benzoflavones; Brocresine; Carbidopa; Carbonic Anhydrase Inhibitors (+ 5); Cholinesterase Inhibitors (+ 14); Clavulanic Acids; Coformycin (+ 1); Cyclooxygenase Inhibitors (+ 21); Eflornithine; Ethidium; Fadrozole; Finasteride; Lipoxygenase Inhibitors (+ 3); Lovastatin; 3-Mercaptopropionic Acid; Monoamine Oxidase Inhibitors (+ 9); Oxypurinol; Phenylglyoxal; Phosphodiesterase Inhibitors (+ 8); Pravastatin; Protease Inhibitors (+ 50); Protein Synthesis Inhibitors; Sulbactam; Sulfhydryl Reagents (+ 12); Trichloroepoxypropane; Uncoupling Agents (+ 16); Valproic Acid Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzymes (66-67); Enzymes/antagonists and inhibitors (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $sh 69GHEnzyme Induction G05.331.370.380.435.294 DEGEIMPHRE Stimulation, Chemical Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Enzymologic An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. sZEnzyme Activation G06.184.368; G06.535.630.465 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1) activation by ions (activators); 2) activation by cofactors (coenzymes); and 3) conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. s".Enzymatic Zonulolysis E04.792.208.409 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Eye (Non MeSH); Cataract Extraction s$NEnzootic Bovine Leukosis C02.782.815.483.260; C04.557.337.100; C20.673.483.260; C22.196.260 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; HTLV-BLV Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia Immunologic Diseases; Immunologic Deficiency Syndromes; HTLV-BLV Infections Animal Diseases; Cattle Diseases A lymphoid neoplastic disease in cattle caused by the bovine leukemia virus. Enzootic bovine leukosis may take the form of lymphosarcoma, malignant lymphoma, or leukemia but the presence of malignant cells in the blood is not a consistent finding. Cattle Diseases (66-91); Leukemia/veterinary (66-91) sELJ2#?Environmental Pollution G03.850.460 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health Air Pollution (+ 7); Body Burden (+ 2); Environmental Exposure (+ 5); Food Contamination (+ 3); Noise (+ 2); Waste Products (+ 7); Water Pollution (+ 4) Environment (66-70) AEAGAIANBLCFCHCLCSCTDUECHIIMIPISLJMEMTPCPDPKPORESDSNSTTOUR  sD>Environmental Pollutants, Pesticides (Non MeSH) D05 Environmental Pollutants (+ 26); Noxae (Non MeSH) (+ 23); Pesticides (+ 121) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPLJMEPCPDPKPORESDSESNSTTOTUUR sx7_FEnvironmental Pollutants D05.284 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carcinogens, Environmental Environmental Pollutants, Pesticides (Non MeSH) Air Pollutants (+ 9); Aroclors; Hazardous Substances; Industrial Waste; Radioactive Pollutants (+ 5); Soil Pollutants (+ 2); Water Pollutants (+ 3) Substances which pollute the environment. Use for environmental pollutants in general or for which there is no specific heading. Environmental Pollution (71-74) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR (sz 67%>Environmental Monitoring G03.850.460.350.080; G03.850.780.375 ECHIISLJMTSNST Environmental Exposure Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Environmental Exposure Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH)  Radiation Monitoring The monitoring of the level of toxicants, pollutants, or other harmful chemicals in the environment or workplace by measuring the amounts of these toxicants in the bodies of people and animals in that environment, among other methods. It also includes the measurement of ENVIRONMENTAL EXPOSURE. Humans and animals are used as indicators of toxic levels of undesirable chemicals. Environmental Exposure (67-85) $s!*$Environmental Microbiology G01.273.540.274; G03.850.425 ST Biological Sciences; Biology; Microbiology Environment and Public Health (Non MeSH); Public Health Air Microbiology; Food Microbiology; Soil Microbiology; Water Microbiology Air Microbiology; Food Microbiology; Soil Microbiology; Water Microbiology The study of microorganisms living in a variety of environments (air, soil, water, etc.) and their pathogenic relationship to other organisms including man. LJST  s$"uEnvironmental Health G02.229; G03.300 ECHILJSNSTTD Health Occupations Environment and Public Health (Non MeSH) Health Physics; Sanitary Engineering; Sanitation The science of controlling or modifying those conditions, influences, or forces surrounding man which relate to promoting, establishing, and maintaining health. CLECEDHIISLJMAMTOGSNSTTD  s&F;Environmental Exposure G03.850.460.350 AEANCLECHILJPCSNST Air Pollutants, Environmental; Environmental Monitoring; Multiple Chemical Sensitivity; Occupational Exposure Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Environmental Monitoring; Maternal Exposure; Maximum Permissible Exposure Level; Occupational Exposure; Paternal Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. AEANCLECHIISLJMTPCSNST $s(}`Environment, Controlled G03.230.150 Atmosphere Exposure Chambers; Incubators; Patient Isolators Environment and Public Health (Non MeSH); Environment Air Conditioning; Diving; Ecological Systems, Closed; Heating; Housing (+ 4); Humidity; Life Support Systems; Lighting; Space Simulation (+ 1); Temperature; Ventilation A state in which the environs of hospitals, laboratories, domestic and animal housing, work places, spacecraft, and other surroundings are under technological control with regard to air conditioning, heating, lighting, humidity, ventilation, and other ambient features. The concept includes control of atmospheric composition. (From Jane's Aerospace Dictionary, 3d ed). Environment (66-72) AECLCTECEDHIINISLJMAMOMTNUOGPCPHPXSDSNSTTDUTVE $s+FA2Environment Design G03.230.200; I01.283; I01.880.709.359 ECLJSNSTTD Environment and Public Health (Non MeSH); Environment Social Sciences Social Sciences; Sociology; Social Planning The structuring of the environment to permit or promote specific patterns of behavior. Environment (66-71) s/%-gEnvironment and Public Health (Non MeSH) G03 Environment (+ 88); Environmental Health; Preventive Dentistry; Preventive Medicine (+ 3); Public Health (+ 350); Public Health Dentistry (+ 7) ADAEAGAIANBLCFCHCICLCNCOCSCTDEDHDIDTDUECEDEHEMENEPETGEHIIMINIPISLJMAMEMIMOMTNUOGPAPCPDPHPKPOPPPSPXRARERHRIRTSDSNSTSUTDTHTOTUURUSUTVEVI s01Environment G03.230 Social Environment Environment and Public Health (Non MeSH) Altitude; Conservation of Natural Resources (+ 1); Disasters (+ 9); Ecology (+ 2); Energy-Generating Resources (+ 12); Environment, Controlled (+ 16); Environment Design; Extraterrestrial Environment; Greenhouse Effect; Meteorological Factors (+ 28); Noise; Odors; Seasons; Soil; Water (+ 5) ADAEANCHCLCTDEDUECEDHIINISLJMAMEMIMOMTNUOGPCPDPHPOPSPXRESDSNSTTDTOTUUTVEVI s22 1`NEnviomycin D20.085.089.910.345; D20.085.116.900.345; D20.338.135.922.345 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular; Viomycin Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Viomycin Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular; Viomycin 1-(L-threo-3,6-Diamino-4-hydroxyhexanoic acid)-6-(L-2-(2- amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)viomycin. Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin. Antibiotics (66-74); Peptides (66-74) s4iE<v.Enuresis C12.777.934.284; F03.126.328 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urination Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Involuntary passage of urine continued past the usual age of establishing bladder control; often used with specific reference to involuntary urination during sleep. s7 "NEntropion C11.338.443 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eyelid Diseases The turning inward (inversion) of the edge of the eyelid, with the tarsal cartilage turned inward toward the eyeball. (Dorland, 27th ed). s9 N%Entrepreneurship J01.219.375; N04.452.610.250 CLECHILJOGSNSTTDUT Technology, Industry, Agriculture (Non MeSH); Commerce Health Services Administration (Non MeSH); Organization and Administration; Organizational Innovation The organization, management, and assumption of risks of a business or enterprise, usually implying an element of change or challenge and a new opportunity. Commerce (85-91); Organization and Administration (85-91); Organizational Innovation (85-91) s;5"lEntorhinal Cortex A08.186.211.577.225; A08.186.211.730.885.213.225 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Limbic System Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex The cytoarchitecturally well-defined area of multilaminate cerebral cortex on the medial aspect of the parahippocampal gyrus, immediately caudal to the olfactory cortex of the uncus. The entorhinal cortex is the origin of the major neural fiber system afferent to the hippocampus, the so-called perforant pathway. (Stedman, 25th ed). Cerebral Cortex (68-94); Hippocampus (72-94); Limbic System (69-94) s=68REntomopoxvirinae B04.280.650.250; B04.525.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae Viruses; Insect Viruses A subfamily of POXVIRIDAE comprising poxviruses infecting insects including members of Coleoptera, Diptera, Lepidoptera, and Orthoptera. Poxviridae (66-93) s@"EEntomophthora B05.354.730.944.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Zygomycotina A genus of fungi, subdivision Zygomycotina and order Entomorphthorales. They are primarily parasites of insects and spiders, but have been found to cause mycotic infections of the nose in man and horses. sB+"LEntomology G01.273.943.409 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology; Zoology sC.Enteroviruses, Porcine B04.820.565.284.550; B04.909.777.618.284.600 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus Species of ENTEROVIRUS causing mild to severe neurological diseases among pigs especially in Eastern Europe. Mild strains are also present in Canada, U.S., and Australia. sD^2Enterovirus Infections C02.782.687.359 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections Conjunctivitis, Acute Hemorrhagic; Coxsackievirus Infections (+ 4); Echovirus Infections; Encephalomyelitis, Enzootic Porcine; Hepatitis A; Poliomyelitis (+ 2); Swine Vesicular Disease sFOPYEnterovirus B04.820.565.284; B04.909.777.618.284 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae Coxsackieviruses (+ 2); Echoviruses (+ 2); Encephalomyelitis Virus, Avian; Enteroviruses, Porcine; Polioviruses (+ 2) Coxsackieviruses (+ 2); Echoviruses (+ 2); Encephalomyelitis Virus, Avian; Enteroviruses, Porcine; Hepatitis Virus, Duck; Polioviruses (+ 2) A genus of the family PICORNAVIRIDAE whose members preferentially inhabit the intestinal tract of a variety of hosts. The genus contains many species. Newly described members of human enteroviruses are assigned continuous numbers with the species designated "human enterovirus". sH *}1CEnterotoxins D24.185.926.330 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Staphylococcal Food Poisoning Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. sKB#VEnterotoxemia C01.252.410.090.217.325; C22.313 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections; Clostridium Infections Animal Diseases Disease caused by the liberation of exotoxins of CLOSTRIDIUM PERFRINGENS in the intestines of sheep, goats, cattle, foals, and piglets. Type B enterotoxemia in lambs is lamb dysentery; type C enterotoxemia in mature sheep produces "struck", and in calves, lambs and piglets it produces hemorrhagic enterotoxemia; type D enterotoxemia in sheep and goats is pulpy-kidney disease or overeating disease. Clostridium Infections/veterinary (66-68) sM2&J0Enterostomy E04.579.338; E04.765.338 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Intestines Surgery, Operative; Ostomy Surgery, Operative; Surgery, Digestive System (Non MeSH) Cecostomy; Colostomy; Duodenostomy; Ileostomy; Jejunostomy Cecostomy; Colostomy; Duodenostomy; Ileostomy; Jejunostomy Creation of an artificial external opening or fistula in the intestines. Colostomy (66-87); Ileostomy (66-87) $sP$bW-Enterosorption E02.912.300 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Sorption Detoxification Adsorption of substances from the gastrointestinal tract onto an orally administered sorbent medium like activated charcoal. This technique is used to eliminate toxic and some biologically active substances and serves to modify the lipid and amino acid spectrum of the intestinal contents. Adsorption (83-90); Intestinal Absorption (83-90) sR",P;Enteropeptidase D08.586.277.656.732.760.284 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases sTFEnterohepatic Circulation G06.535.355 DEGEIMPHRE Liver Circulation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Recycling through liver by excretion in bile, reabsorption from intestines into portal circulation, passage back into liver, and re-excretion in bile. Bile (66-74); Bile Acids and Salts (66-74); Intestinal Absorption (66-74); Intestine, Small (66-74); Intestines (66-74); Liver (66-74); Liver Circulation (66-74)  sUOEnteroglucagon D06.472.317.335; D12.644.168; D19.316.629.355 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones Glucagon-like polypeptide secreted in the intestinal tract. It does not share a common receptor site with pancreatic glucagon. The peptide has glycogenolytic activity. Gastrointestinal Hormones (66-78); Peptides (66-78) sX)5F=Enterocolitis, Pseudomembranous C01.252.410.090.217.310; C06.405.469.158.188.400.408; C06.405.469.314.307.491 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Clostridium difficile Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections; Clostridium Infections Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colitis; Enterocolitis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Enteritis; Enterocolitis Acute inflammation of the small and large intestinal mucosa with formation of pseudomembranous plaques over superficial ulceration. It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE is often implicated. In infants it is known as necrotizing enterocolitis. sZ$UPEEnterocolitis C06.405.469.158.188.400; C06.405.469.314.307 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Enteritis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colitis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Enteritis Enterocolitis, Pseudomembranous Enterocolitis, Pseudomembranous Inflammation of the intestinal mucosa of the small and large bowel. Colitis (66-84); Enteritis (66-84) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI (s^2N FR+PEnterococcus faecium B03.510.400.800.280.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Enterococcus A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source. Streptococcus (66-91) sa"c.Enterococcus faecalis B03.510.400.800.280.280 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae; Enterococcus A species of gram-positive, coccoid bacteria commonly isolated from clinical specimens and the human intestinal tract. Most strains are nonhemolytic. sc"cEnterococcus B03.510.400.800.280 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Positive Bacteria; Gram-Positive Cocci; Streptococcaceae Enterococcus faecalis; Enterococcus faecium A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus. Streptococcus (66-91)  seH"S3Enterochromaffin Cells A06.224.358; A11.436.280; A15.382.250 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Endocrine System (Non MeSH); Chromaffin System Cells; Epithelial Cells (Non MeSH) Hemic and Immune Systems (Non MeSH); Immune System Cells of the intestinal mucosa containing granules that stain with chromium salts. sg{-*bEnterobius B01.500.294.700.500.500.308 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Oxyurida; Oxyuroidea A genus of intestinal nematode worms which includes the pinworm or threadworm Enterobius vermicularis. si*SxEnterobiasis C03.335.508.700.550.550.375 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Oxyurida Infections; Oxyuriasis Infection with nematodes of the genus ENTEROBIUS. E. vermicularis, the pinworm of man, causes a crawling sensation and pruritus. This condition results in scratching the area, occasionally causing scarification. Oxyuriasis (66-92) sjVPEnterobactin D12.125.837.300; D24.310.678.250; D26.241.688.700.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Serine Immunologic and Biologic Factors (Non MeSH); Biological Products; Siderophores Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents; Iron Chelates; Siderophores (3S-(3R*,7R*,11R*))-N,N',N''-(2,6,10-Trioxacyclododecane-3,7,11-triyl)tris(2,3-dihydroxybenzamide). An iron-binding cyclic trimer of 2,3-dihydroxy-N-benzoyl-L-serine. It is produced by E. coli and other enteric bacteria. Benzoates (71-74); Catechol (71-74); Serine (71-74) sl=:@Enterobacteriaceae Infections C01.252.400.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Dysentery, Bacillary; Escherichia coli Infections; Klebsiella Infections (+ 1); Proteus Infections; Salmonella Infections (+ 4); Serratia Infections; Yersinia Infections (+ 2) Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacteriaceae (66-67)  so"PsEEnterobacteriaceae B03.440.450.425 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods Citrobacter (+ 1); Enterobacter (+ 1); Erwinia (+ 2); Escherichia (+ 2); Klebsiella (+ 2); Proteus (+ 2); Providencia; Salmonella (+ 7); Serratia (+ 1); Shigella (+ 4); Yersinia (+ 3) A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. sq"X{Enterobacter cloacae B03.440.450.425.275.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Enterobacter A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal. Enterobacter (66-91) su "~Enterobacter B03.440.450.425.275 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Enterobacter cloacae Gram-negative gas-producing rods found in feces of man and other animals, sewage, soil, water, and dairy products. sw"nEnteritis, Transmissible, of Turkeys C02.782.225.200.325; C22.131.220 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Coronaviridae Infections; Coronavirus Infections Animal Diseases; Bird Diseases An acute, highly contagious virus disease of turkeys characterized by chilling, anorexia, decreased water intake, diarrhea, dehydration and weight loss. The infectious agent is a CORONAVIRUS. Poultry Diseases (66-75) sx+&JEnteritis C06.405.469.314 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Duodenitis; Enterocolitis; Ileitis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Enterocolitis (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  sz N*UPEnteric Nervous System A08.800.050.150 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System Myenteric Plexus; Submucous Plexus Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p.766). s|r6P*Enteral Nutrition E02.421.360; E02.707.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Food, Formulated; Gastrostomy; Intubation, Gastrointestinal Therapeutics; Feeding Methods (Non MeSH) Therapeutics; Nutritional Support Nutritional support given via the alimentary canal or any route connected to the gastrointestinal system (i.e., the enteral route). This includes oral feeding, sip feeding, and tube feeding using nasogastric, gastrostomy, and jejunostomy tubes. sw"EWEntamoebiasis C03.752.700.700.055.407 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Sarcodina Infections; Amebiasis Dysentery, Amebic; Liver Abscess, Amebic Infection with amoebae of the genus ENTAMOEBA. Infection with E. histolytica causes DYSENTERY, AMEBIC and LIVER ABSCESS, AMEBIC. sPw1Entamoeba histolytica B01.841.750.656.475.100.700.335.330 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Tubulina; Entamoeba A species of parasitic protozoa causing ENTAMOEBIASIS and amebic dysentery (DYSENTERY, AMEBIC). Characteristics include a single nucleus containing a small central karyosome and peripheral chromatin that is finely and regularly beaded. s'&oEntamoeba B01.841.750.656.475.100.700.335 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Tubulina Entamoeba histolytica A genus of ameboid protozoa characterized by the presence of beaded chromatin on the inner surface of the nuclear membrane. Its organisms are parasitic in invertebrates and vertebrates, including humans. s #&bEnprostil D02.241.081.436.687.700.450.350; D10.516.251.355.708.700.450.350; D17.350.700.660.250; D19.316.203.290 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 7-(3-Hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl) methyl ester. A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers. Prostaglandins E, Synthetic (78-91) s~ p:o*Enoyl CoA Hydratases D08.586.520.497.308 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes reversibly the hydration of unsaturated fatty acyl-CoA to yield beta-hydroxyacyl-CoA. It plays a role in the oxidation of fatty acids and in mitochondrial fatty acid synthesis, has broad specificity, and is most active with crotonyl-CoA. EC 4.2.1.17. Coenzyme A (66-77); Hydro-Lyases (66-77) sF_B2Enoximone D03.383.374.253; D08.373.735.300; D18.222.250; D18.918.265 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors Cardiovascular Agents; Cardiotonic Agents Cardiovascular Agents; Vasodilator Agents 1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Imidazoles (82-92) s  D:#6Enoxaparin D09.203.698.373.400.300.200; D19.461.119.380.300.200; D19.461.427.400.300.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Heparin; Heparin, Low-Molecular-Weight Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed). s+U<YEnoxacin D03.438.612.320; D20.220.050.250; D20.237.050.050.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Naphthyridines Anti-Infective Agents; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine 3-carboxylic acid. An orally administered broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. Its clinical efficacy has been confirmed in a variety of systemic infections and particularly in urinary tract infections. The drug is well tolerated by adults, but should not be used in children and pregnant women. Anti-Infective Agents (83-88); Anti-Infective Agents, Urinary (83-88); Naphthyridines (83-88) s =:RmEnoplida Infections C03.335.508.100.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Adenophorea Infections Trichinosis; Trichuriasis Infections with nematodes of the order ENOPLIDA. s~P[;Enoplida B01.500.294.100.275 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea Dioctophymatoidea; Mermithoidea; Trichuroidea (+ 4) An order of nematodes of the subclass ADENOPHOREA. Its organisms commonly have a cylindrical esophagus. The superfamilies of this order are DIOCTOPHYMATOIDEA, MERMITHOIDEA, and TRICHUROIDEA. s *9=Enophthalmos C11.675.319 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Orbital Diseases Recession of the eyeball into the orbit. Eye Diseases (67-89); Orbit (66-89) sN&3-Enkephalins D12.644.468.281; D12.776.641.650.575.281; D14.600.600.577.281 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides Enkephalin, Leucine (+ 1); Enkephalin, Methionine (+ 1) Enkephalin, Leucine; Enkephalin, Methionine Enkephalin, Leucine; Enkephalin, Methionine One of the three major families of endogenous opioid peptides. The enkephalins are pentapeptides that are widespread in the central and peripheral nervous systems and in the adrenal medulla. Nerve Tissue Proteins (66-Jul 77); Oligopeptides (73-Jul 77) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (sEDTIFEnkephalin, Methionine D12.644.468.281.381; D12.776.641.650.575.281.381; D14.600.600.577.281.381 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides; Enkephalins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides; Enkephalins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides; Enkephalins FK 33-824 Tyrosylglycylglycylphenylalanylmethionine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is methionine. Enkephalins (Aug 77-82); Nerve Tissue Proteins (66-Jul 77); Peptides (66-Jul 77)  sQFbEnkephalin, Leucine-2-Alanine D12.644.468.281.231.300 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides; Enkephalins; Enkephalin, Leucine N-(N-(N-(N-L-Tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-D-leucine. A synthetic delta-selective opioid peptide with analgesic properties. Treatment with DADLE results in transient depression of mean arterial blood pressure and heart rate. Enkephalin, Leucine (83-90); Enkephalins (77-82) ss"F:Enkephalin, Leucine D12.644.468.281.231; D12.776.641.650.575.281.231; D14.600.600.577.281.231 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides; Enkephalins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides; Enkephalins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides; Enkephalins Enkephalin, Leucine-2-Alanine Tyrosylglycylglycylphenylalanylleucine. Endogenous pentapeptide with morphine-like activity. The amino acid in position 5 is leucine. Enkephalins (Aug 77-82); Nerve Tissue Proteins (66-Jul 77); Peptides (66-Jul 77)  sQF$bEnhancer Elements (Genetics) G05.275.470.790.330; G05.331.599.110.689.330; G06.184.599.110.689.330 DEGEIMPHRE Genetics; Genes; Genes, Regulator; Regulatory Sequences, Nucleic Acid Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence; Regulatory Sequences, Nucleic Acid HIV Enhancer HIV Enhancer HIV Enhancer Cis-acting DNA sequences, present in the genomes of higher eukaryotes and of various animal viruses, which can increase the transcription of genes into messenger RNA. Enhancers usually can function in either orientation and at various distances from a promoter. Gene Expression Regulation (81-84); Genes (66-67); Genes, Regulator (68-84); Transcription, Genetic (73-84)  s_"M/1Engraving and Engravings K01.093.346 CLHI Printing Humanities; Art su England Z01.542.363.300 EHEP Geographicals (Non MeSH); Europe; Great Britain London s ; Engineering J01.293 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH) Biomedical Engineering; Chemical Engineering; Human Engineering (+ 5); Sanitary Engineering CLECEDHIISLJMAMTOGPXSNSTTD s| 4lEnflurane D02.355.601.400; D15.050.035.060.200; D15.210.100.175.060.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Methyl Ethers Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Inhalation Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Inhalation 2-Chloro-1,1,2-trifluoroethyl difluoromethyl ether. An extremely stable inhalation anesthetic that allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate. Anesthesia, Inhalation (69-74); Anesthetics (69-74); Ethers (69-73); Hydrocarbons, Halogenated (69-74); Methyl Ethers (73-74) s E:5Energy-Generating Resources G03.230.132 CLECHILJSNST Power Plants; Power Sources Environment and Public Health (Non MeSH); Environment Electricity; Fossil Fuels (+ 6); Nuclear Energy (+ 2); Solar Energy Natural energy sources of power supply. AEANCLECHILJMIPOPSRESDSNSTTOUTVI $s #AV1$Energy Transfer G06.184.348; H01.181.529.328; H01.671.100.442 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Physical Sciences (Non MeSH); Physics; Biophysics Linear Energy Transfer Linear Energy Transfer Linear Energy Transfer The transfer of energy of a given form among different scales of motion. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). In biochemistry, this concept generally refers to the transfer of groups from compounds that contain energy-rich bonding arrangements to compounds that have relatively energy-poor bonding characteristics via thermodynamically permissible enzymatic reactions. This principle is a major premise of the interaction between energy-producing and energy-utilizing metabolic pathways in living cells. (From Devlin TM, ed. Textbook of biochemistry with clinical correlations, 3d ed, 1992). sm5PEnergy Metabolism G06.535.335 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Basal Metabolism; Oxidation-Reduction (+ 2); Oxidative Phosphorylation; Photosynthesis (+ 1); Substrate Cycling sOEnema E02.385 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics s!  "Endrin D02.455.526.439.416; D05.723.491.491.455 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Insecticides (66-72) s .:Endotoxins D24.185.926.310 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Limulus Test Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. sBVEndothelium, Vascular A07.231.330; A10.272.491.355 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels Tissue Types (Non MeSH); Epithelium; Endothelium Tunica Intima Tunica Intima Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components from interstitium to lumen; this function has been most intensively studied in the blood capillaries. Blood Vessels or specific (66-87); Capillaries (66-87); Endothelium (73-87)  s"8f"/[Endothelium, Lymphatic A10.272.491.332; A15.382.520.332 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Epithelium; Endothelium Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System Unbroken cellular lining (intima) of the lymph vessels (e.g., the high endothelial lymphatic venules). It is more permeable than vascular endothelium, lacking selective absorption and functioning mainly to remove plasma proteins that have filtered through the capillaries into the tissue spaces. Endothelium (73-87); Epithelium (66-87); Lymphatic System or specific (66-87) sĘ&:V]Endothelium, Corneal A09.371.060.067.318; A09.371.060.217.318; A10.272.491.318 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cornea Sense Organs; Eye; Anterior Eye Segment; Anterior Chamber Sense Organs; Eye; Anterior Eye Segment; Cornea Tissue Types (Non MeSH); Epithelium; Endothelium Single layer of large flattened cells covering the surface of the cornea. It includes the anterior chamber epithelium. Cornea (66-87); Corneal Diseases or specific (66-87); Endothelium (73-87); Epithelium (66-87)  s{A: qEndothelium-Derived Relaxing Factor D24.185.188 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nitric Oxide Immunologic and Biologic Factors (Non MeSH); Biological Factors A labile humoral agent released by the vascular endothelium that mediates the relaxation induced by some vasodilators such as acetylcholine and bradykinin. EDRF also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. These actions are believed to be mediated through stimulation of guanylate cyclase and the consequent elevation of cyclic guanosine 3',5'-monophosphate. EDRF is thought to be nitric oxide or a ready source of it. The factor is believed to be unstable and acts only locally in vivo. Biological Products (66-89); Vasodilator Agents (66-89)  s)DLBEndothelium A10.272.491 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Epithelium Endothelium, Corneal; Endothelium, Lymphatic; Endothelium, Vascular (+ 1) Epithelium (66-72) s:-VEndothelins D12.644.157; D24.185.170 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Endothelin Amino Acids, Peptides and Proteins (Non MeSH); Peptides Immunologic and Biologic Factors (Non MeSH); Biological Factors 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, endothelin-1, endothelin-2, and endothelin-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profile of the pharmacological activities are considerably different among the three isopeptides. Peptides (66-90)  sD<Endothelial Growth Factors D11.303.365; D24.185.348.356 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic fibroblast growth factors but have different amino acid sequences. Fibroblast Growth Factor (84-90); Growth Substances (66-83) sҙ "BGEndosulfan D03.438.197.408; D05.723.491.491.422 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiepins Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Insecticides (66-72) sK*:Endospore-Forming Bacteria (Non MeSH) B03.300 Bacteria Gram-Positive Endospore-Forming Bacteria (+ 22) CHCLCYDEENGDGEIMIPMEPHPYREULVI s,  7"Endosomes A11.368.702.160.260 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Endocytosis Endocytosis Cells; Cytoplasm; Organelles; Coated Vesicles Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface. Endocytosis (73-82) $s؆ *8Endoscopy, Gastrointestinal E01.184.340.350; E01.418.340.350 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System Diagnosis; Endoscopy; Endoscopy, Digestive System Colonoscopy (+ 1); Duodenoscopy; Gastroscopy; Proctoscopy; Sphincterotomy, Endoscopic Colonoscopy (+ 1); Duodenoscopy; Gastroscopy; Proctoscopy; Sphincterotomy, Endoscopic Visual examination of the gastrointestinal tract by means of a fiberoptic endoscope. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material and perform other surgical interventions, and for delivery of medication. Endoscopy (66-90); Gastroscopy (66-90) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE $s! &"*/$Endoscopy, Digestive System E01.184.340; E01.418.340 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Endoscopy Cholangiopancreatography, Endoscopic Retrograde; Endoscopy, Gastrointestinal (+ 6); Esophagoscopy Cholangiopancreatography, Endoscopic Retrograde; Endoscopy, Gastrointestinal (+ 6); Esophagoscopy Visual examination of the digestive tract by means of a fiberoptic endoscope. It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material and perform other surgical interventions, and for delivery of medication. Endoscopy (66-90) AECLCTDEECHIISMOMTNUPXRERHSNSTTDUTVE $sݓ!"S#(Endoscopy E01.418 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Amnioscopy; Angioscopy; Arthroscopy; Bronchoscopy; Colposcopy; Culdoscopy; Cystoscopy; Endoscopy, Digestive System (+ 9); Fetoscopy; Hysteroscopy; Laparoscopy; Laryngoscopy; Mediastinoscopy; Surgery, Laparoscopic (+ 1); Thoracoscopy; Ureteroscopy AECLCTDEECHIISMOMTNUPXRERHSNSTTDUTVE s  " !(Endorphins D12.644.468.241; D12.776.641.650.575.241; D14.600.600.577.241 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Opioid Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides alpha-Endorphin; beta-Endorphin; gamma-Endorphin alpha-Endorphin; beta-Endorphin; gamma-Endorphin alpha-Endorphin; beta-Endorphin; gamma-Endorphin One of the three major groups of endogenous opioid peptides. They are large peptides derived from the pro-opiomelanocortin precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Nerve Tissue Proteins (66-Jul 77); Peptides (66-Jul 77) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (sjEDTDFEndoribonucleases D08.586.277.352.355.350; D08.586.277.352.700.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases Aspergillus Nuclease S1; Micrococcal Nuclease; Ribonuclease H, Calf Thymus; Ribonuclease, Pancreatic; Ribonuclease T1 Aspergillus Nuclease S1; Micrococcal Nuclease; Ribonuclease H, Calf Thymus; Ribonuclease, Pancreatic; Ribonuclease T1 A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-. Endonucleases (73-82); Phosphatases (66-72); Ribonucleases (66-82)  sz6FOEndoplasmic Reticulum A11.368.702.248 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Nissl Bodies; Ribosomes (+ 1); Sarcoplasmic Reticulum A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced; otherwise it is said to be smooth-surfaced. (King and Stansfield, A Dictionary of Genetics, 4th ed). s*$BEndophthalmitis C01.252.354.900.350; C01.539.375.725.350; C11.294.900.350; C11.941.879.960.380 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Panophthalmitis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial; Uveitis, Suppurative Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Uveitis, Suppurative Eye Diseases; Eye Infections; Uveitis, Suppurative Eye Diseases; Uveal Diseases; Uveitis; Uveitis, Suppurative Suppurative inflammation of the tissues of the internal structures of the eye; not all layers of the uvea are affected. Fungi, necrosis of intraocular tumors, and retained intraocular foreign bodies often cause a purulent endophthalmitis. sXPmEndonucleases D08.586.277.352.355 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gene Products, pol Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Endodeoxyribonucleases (+ 9); Endoribonucleases (+ 5) Any of the enzymes of the hydrolase class that catalyze the hydrolysis of interior bonds of ribonucleotide or deoxyribonucleotide chains, producing poly- or oligonucleotides. (Dorland, 27th ed) EC 3.1.-. Nucleotidyltransferases (66-72); Phosphatases (66-72) $ssF`@>Endomyocardial Fibrosis C14.280.600.406 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases A disease characterized by thickening of the endocardium, and frequently the inner third of the myocardium. The left ventricle is most frequently involved. Cardiomegaly and congestive heart failure may also be present. sNGEndomycetales B05.354.107.292 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes Hansenula; Kluyveromyces; Pichia; Rhinosporidium; Saccharomyces (+ 1); Saccharomycopsis; Schizosaccharomyces An order of mostly saprophytic ascomycetous fungi. s";=Endometrium A05.360.319.679.490 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Female; Uterus Decidua s>:C Endometritis C13.371.852.299 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Inflammation of the endometrium. (Dorland, 27th ed). sN}AEndometriosis C13.371.163 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female A condition in which tissue more or less perfectly resembling the uterine mucous membrane (the endometrium) and containing typical endometrial granular and stromal elements occurs aberrantly in various locations in the pelvic cavity. saNhEndometrial Neoplasms C04.588.945.418.948.585; C13.371.270.875.750; C13.371.820.800.418.875.200; C13.371.852.762.200 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female; Uterine Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female; Uterine Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female; Uterine Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Uterine Neoplasms The most common invasive gynecologic malignancy in the United States, typically in postmenopausal women. The neoplasm originates on the endometrial mucosa and may be focal or diffuse. It may progress to invasion of the myometrium. The commonest histologic type is adenocarcinoma but adenoacanthoma, adenosquamous carcinoma, epidermoid carcinoma, and other histological types of cancer are possible. Uterine Neoplasms (66-91) shhXxEndometrial Hyperplasia C13.371.852.228 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Abnormal overgrowth of endometrium. (Dorland, 27th ed). tN}DEndolymphatic Shunt E04.035.335; E04.847.774.230 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Surgical fistulization of the membranous labyrinth of the inner ear with mastoid, subarachnoid or cochlear shunt; used in the treatment of Meniere's disease. Endolymphatic Sac/surgery (79-87); Labyrinth/surgery (66-87); Meniere's Disease/surgery (66-87) t-"$qEndolymphatic Sac A09.246.631.909.957.360.701 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule; Vestibular Aqueduct; Endolymphatic Duct The blind pouch at the end of the endolymphatic duct. Endolymph (75-78); Labyrinth (66-78); Labyrinthine Fluids (66-74) tp:aCOEndolymphatic Hydrops C09.218.568.217 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Meniere's Disease Meniere's Disease Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases Meniere's Disease An accumulation of endolymph in the inner ear resulting in deafness and tinnitus, and sometimes vertigo (MENIERE'S DISEASE). Induced experimentally, it often serves as an animal model for Meniere's disease. (From Dorland, 27th ed.). Labyrinthine Fluids (66-91); Meniere's Disease (66-93) (tNJAEndolymphatic Duct A09.246.631.909.957.360 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule; Vestibular Aqueduct Endolymphatic Sac Duct connecting the endolymphatic sac with the membranous labyrinth. Endolymph (75-78); Labyrinth (66-78); Labyrinthine Fluids (66-74)  t:JQOEndolymph A12.207.571.324 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Body Fluids; Labyrinthine Fluids t  "QEndolimax B01.841.750.656.475.100.700.325 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Tubulina A genus of ameboid protozoa found in the intestines of vertebrates and invertebrates. t  #&bfEndodontics E06.397; G02.163.876.213 CLECEDHIISLJMAMTOGSNSTTD Dental Pulp Diseases; Dental Pulp Test Dentistry Health Occupations; Dentistry; Specialties, Dental Apicoectomy; Dental Implantation, Endosseous, Endodontic; Dental Pulp Capping; Pulpectomy; Pulpotomy; Root Canal Therapy (+ 3); Tooth Replantation A dental specialty concerned with the maintenance of the dental pulp in a state of health and the treatment of the pulp cavity (pulp chamber and pulp canal). AECLCTECEDHIISLJMAMIMOMTNUOGPSPXSNSTTDUTVEVI $t 0G0Endodermal Sinus Tumor C04.557.465.510.350 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Mesonephroma An unusual and aggressive tumor of germ-cell origin that reproduces the extraembryonic structures of the early embryo. It is the most common malignant germ cell tumor found in children. It is characterized by a labyrinthine glandular pattern of flat epithelial cells and rounded papillary processes with a central capillary (Schiller-Duval body). The tumor is rarely bilateral. Before the use of combination chemotherapy, the tumor was almost invariably fatal. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Mesonephroma (68-93) tXxuEndoderm A16.254.425.407 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo; Germ Layers The inner of the three germ layers of the embryo. tS *A?Endodeoxyribonucleases D08.586.277.352.335.350; D08.586.277.352.355.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases Aspergillus Nuclease S1; Deoxyribonuclease I (+ 1); DNA Restriction Enzymes (+ 6); Micrococcal Nuclease Aspergillus Nuclease S1; DNA Restriction Enzymes (+ 6); Micrococcal Nuclease A group of enzymes catalyzing the endonucleolytic cleavage of DNA. They include members of EC 3.1.21.-, EC 3.1.22.-, EC 3.1.23.- (DNA RESTRICTION ENZYMES), EC 3.1.24.- (DNA RESTRICTION ENZYMES), and EC 3.1.25.-. Deoxyribonucleases (66-82); Endonucleases (73-82); Phosphatases (66-72)  t?6FTEndocytosis G04.335.487 DEGEIMPHRE Endosomes Endosomes Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Phagocytosis (+ 1); Pinocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Cells/physiology (66-72) (t   f(Endocrinology G01.782.323; G02.403.776.409.323 CLECEDHIISLJMAMTOGSNSTTD Endocrine Diseases Biological Sciences; Physiology Health Occupations; Medicine; Specialties, Medical; Internal Medicine Neuroendocrinology A subspecialty of internal medicine concerned with the metabolism, physiology, and disorders of the endocrine system.  t&vEndocrine System (Non MeSH) A06 Chromaffin System (+ 5); Endocrine Glands (+ 26); Neurosecretory Systems (+ 2) The system of glands that release their secretions (hormones) directly into the circulatory system. ABAHBSCHCLCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI tz"au>Endocrine Glands A06.407 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Hormones Endocrine System (Non MeSH) Adrenal Glands (+ 5); Gonads (+ 9); Islets of Langerhans; Parathyroid Glands; Pineal Body; Pituitary-Adrenal System; Pituitary Gland (+ 3); Thymus Gland; Thyroid Gland Ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $t : "<Endocrine Gland Neoplasms C04.588.322; C19.344 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Endocrine Diseases Adrenal Gland Neoplasms (+ 1); Multiple Endocrine Neoplasia (+ 3); Neoplastic Endocrine-Like Syndromes (+ 2); Ovarian Neoplasms (+ 1); Parathyroid Neoplasms; Pituitary Neoplasms (+ 1); Testicular Neoplasms; Thymus Neoplasms; Thyroid Neoplasms (+ 1) Adrenal Gland Neoplasms (+ 1); Multiple Endocrine Neoplasia (+ 3); Neoplastic Endocrine-Like Syndromes (+ 2); Ovarian Neoplasms (+ 1); Parathyroid Neoplasms; Pituitary Neoplasms (+ 1); Testicular Neoplasms; Thymus Neoplasms; Thyroid Neoplasms (+ 1) Tumor or cancer of the endocrine glands in general or unspecified. Endocrine Diseases (66-91)  tCXFPQ Endocrine Diseases C19 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrinology Adrenal Gland Diseases (+ 14); Breast Diseases (+ 9); Diabetes Mellitus (+ 19); Dwarfism (+ 3); Endocrine Gland Neoplasms (+ 18); Gonadal Disorders (Non MeSH) (+ 35); Hyperinsulinism; Neoplastic Endocrine-Like Syndromes (+ 2); Parathyroid Diseases (+ 6); Pituitary Diseases (+ 13); Polyendocrinopathies, Autoimmune; Progeria (+ 1); Thymus Hyperplasia; Thyroid Diseases (+ 22); Tuberculosis, Endocrine BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI t"NZEndocardium A07.541.207 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart The innermost layer of the heart, comprised of endothelial cells. t$8#OEndocarditis, Subacute Bacterial C01.252.300.407; C01.252.410.890.240; C14.280.282.407.407 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Endocarditis, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Cardiovascular Diseases; Heart Diseases; Endocarditis; Endocarditis, Bacterial Infection of the endocardium caused by species of STREPTOCOCCUS. This condition does not produce metastatic foci and if untreated may take up to a year to be fatal. t%&APNEndocarditis, Bacterial C01.252.300; C14.280.282.407 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Aneurysm, Infected Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Cardiovascular Diseases; Heart Diseases; Endocarditis Endocarditis, Subacute Bacterial Endocarditis, Subacute Bacterial t("PJEndocarditis C14.280.282 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases Endocarditis, Bacterial (+ 1) Exudative and proliferative inflammatory alterations of the endocardium, characterized by the presence of vegetations on the surface of the endocardium or in the endocardium itself, and most commonly involving a heart valve, but sometimes affecting the inner lining of the cardiac chambers or the endocardium elsewhere. It may occur as a primary disorder or as a complication of or in association with another disease. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  t*\N/$PEndocardial Fibroelastosis C14.280.600.281 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases A condition characterized by hypertrophy of the wall of the left ventricle and conversion of the endocardium into a thick fibroelastic coat, with the capacity of the ventricle sometimes reduced, but often increased. (Dorland, 27th ed). t-NGEndocardial Cushion Defects C14.240.400.560.350; C14.280.400.560.350; C16.131.240.400.560.350 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Heart Septal Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects A spectrum of septal defects associated with persistence of the embryonic atrioventricular canal due to incomplete growth and fusion of the endocardial cushion. Heart Defects, Congenital (66-82) t/!IL(Endo-1,3-beta-Glucanase D08.586.277.450.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases An enzyme that hydrolyzes 1,3-beta-D-glucosidic linkages in 1,3-beta-D-glucans including laminarin, paramylon and pachyman. EC 3.2.1.39. Glycoside Hydrolases (69-74); Polysaccharides (69-74) t2Fl?Endarteritis C14.907.184.281; C14.907.940.090.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Arteritis Cardiovascular Diseases; Vascular Diseases; Vasculitis; Arteritis Inflammation of the tunica intima of an artery. (Dorland, 27th ed). t4*NTEndarterectomy, Carotid E04.752.814.456.250 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Carotid Stenosis Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Endarterectomy The excision of the thickened, atheromatous tunica intima of a carotid artery. Endarterectomy (66-91)  t6^$h^Endarterectomy E04.752.814.456 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Angioplasty; Atherectomy Arteries; Angioplasty; Atherectomy Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Endarterectomy, Carotid Surgical excision, performed under general anesthesia, of the atheromatous tunica intima of an artery. When reconstruction of an artery is performed as an endovascular procedure through a catheter, it is called ATHERECTOMY. $t7$*VEncyclopedias L01.178.682.192.836.456 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books t: zEncounter Groups F01.829.316.697.406; F04.754.864.581.813.406 CLECHILJOGSNSTTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Group Processes; Sensitivity Training Groups Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Socioenvironmental Therapy; Psychotherapy, Group; Sensitivity Training Groups A form of sensitivity training that emphasizes the experiencing of individual relationships within the group and that minimizes intellectual and didactic input. Focus is on the present. t:2#Encopresis F03.126.316 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Fecal Incontinence; Defecation Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Incontinence of feces not due to organic defect or illness. t=GF%YIEnchondromatosis C05.116.099.708.338 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Benign growths of cartilage in the metaphyses of several bones. t>NkMEncephalopathy, Bovine Spongiform C10.228.228.800.260; C22.196.250 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Prion Diseases Animal Diseases; Cattle Diseases Scrapie-like neurological disorder of cattle. The infection appears to be caused by the consumption of scrapie-infected ruminant-derived protein (PRIONS). Brain Diseases/veterinary (88-91); Cattle Diseases (88-91) t?'&JFEncephalomyocarditis Virus B04.820.565.170.200; B04.909.777.618.170.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Cardiovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Cardiovirus A species of CARDIOVIRUS causing encephalomyelitis and myocarditis in rodents, pigs, and monkeys. Infection in man has been reported with CNS involvement but without myocarditis. tBU2Encephalomyelitis, Venezuelan Equine C02.081.355.355; C02.782.930.100.370.325; C10.228.228.291.323.325; C10.228.440.406.325 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Encephalomyelitis, Equine Virus Diseases; RNA Virus Infections (Non MeSH); Togaviridae Infections; Alphavirus Infections; Encephalomyelitis, Equine Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalomyelitis; Encephalomyelitis, Equine Nervous System Diseases; Central Nervous System Diseases; Encephalomyelitis; Encephalomyelitis, Equine An arthropod-borne viral encephalomyelitis of equidae and humans. Encephalomyelitis, Equine (66-75) tDR*`PM'Encephalomyelitis, Necrotizing Hemorrhagic C10.228.228.291.489; C10.228.337.323; C10.228.440.531 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalomyelitis Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Nervous System Diseases; Central Nervous System Diseases; Encephalomyelitis Demyelinating Diseases (66-71); Encephalomyelitis (66-71) tG0=N@CEncephalomyelitis, Equine C02.081.355; C02.782.930.100.370; C10.228.228.291.323; C10.228.440.406 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Togaviridae Infections; Alphavirus Infections Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalomyelitis Nervous System Diseases; Central Nervous System Diseases; Encephalomyelitis Encephalomyelitis, Venezuelan Equine Encephalomyelitis, Venezuelan Equine Encephalomyelitis, Venezuelan Equine Encephalomyelitis, Venezuelan Equine An ALPHAVIRUS infection of horses and mules, communicable to humans, occurring in the United States and parts of Central and South America. (From Dorland, 27th ed). tJPP|Encephalomyelitis, Enzootic Porcine C02.782.687.359.456; C22.905.323 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Animal Diseases; Swine Diseases A picornavirus infection producing symptoms similar to poliomyelitis in pigs. Enterovirus Infections (66-69); Swine Diseases (66-69) tM)&J[AEncephalomyelitis, Allergic C10.228.337.267; C10.228.440.281; C20.111.489 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Encephalitogenic Basic Proteins Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Nervous System Diseases; Central Nervous System Diseases; Encephalomyelitis Immunologic Diseases; Autoimmune Diseases An experimental demyelinating disease produced in animals by injections of myelin fractions in order to study the relationship between hypersensitivity and the demyelinating diseases. tO 5N%Encephalomyelitis, Acute Disseminated C10.228.140.437.404; C10.228.228.245.404 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypersensitivity, Delayed Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis An acute or subacute encephalomyelitis or myelitis characterized by perivascular lymphocyte and mononuclear cell infiltration and demyelination. It occurs most commonly following an acute viral infection, especially measles, but may occur without a recognizable antecedent, and formerly occurred as a complication of rabies and smallpox vaccination. (From Dorland, 27th ed). tR}+.NEncephalomyelitis Virus, Murine B04.820.565.170.190; B04.909.777.618.170.190 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Cardiovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Cardiovirus A species of CARDIOVIRUS usually causing an inapparent intestinal infection in mice. A small number of mice may show signs of flaccid paralysis. tV%2Encephalomyelitis Virus, Avian B04.820.565.284.500; B04.909.777.618.284.500 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus A species of ENTEROVIRUS infecting primarily young chicks, but also found in turkeys, pheasants, and guinea fowl. It causes a fatal neuronal degeneration and is transmitted by mechanical contact. tW$2Encephalomyelitis C10.228.228.291; C10.228.440 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Nervous System Diseases; Central Nervous System Diseases Encephalomyelitis, Equine (+ 1); Encephalomyelitis, Necrotizing Hemorrhagic; Visna Encephalomyelitis, Allergic; Encephalomyelitis, Equine (+ 1); Encephalomyelitis, Necrotizing Hemorrhagic; Fatigue Syndrome, Chronic; Visna BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI tY"NPEncephalomalacia C10.228.140.461 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Leukomalacia, Periventricular Softening of the brain. (Dorland, 27th ed). t\NV"8Encephalocele C10.500.680.488; C16.131.666.680.488 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Hernia of the brain, manifested by protrusion of brain substance through a congenital or traumatic opening of the skull. t]*LEncephalitozoonosis C03.752.550.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Microspora Infections Infection with protozoa of the genus ENCEPHALITOZOON. Lesions commonly occur in the brain and kidney tubules. Other sites of infection in mammals are the liver, adrenal glands, optic nerves, retina, and myocardium. Encephalitozoon cuniculi (82-91); Protozoa (78-81); Protozoan Infections (72-91); Sporozoea (72-81) t`(PJvEncephalitozoon cuniculi B01.841.500.500.500.100.175.175 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Microspora; Microsporea; Microsporida; Apansporoblastina; Encephalitozoon A species of parasitic protozoa. This intracellular parasite is found in the brain, heart, and kidneys of several mammals. Transmission is probably by ingestion of the spores. Protozoa (66-81); Sporozoa (66-81) tb#&r+Encephalitozoon B01.841.500.500.500.100.175 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Microspora; Microsporea; Microsporida; Apansporoblastina Encephalitozoon cuniculi A genus of parasitic protozoa originally considered a member of the class SPOROZOEA but now recognized as part of the class MICROSPOREA. Protozoa (77-91); Sporozoea (73-91)  td&_,Encephalitogenic Basic Proteins D12.776.641.580.356 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Encephalomyelitis, Allergic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Myelin Proteins Nerve Tissue Proteins (66-72) tfL%F s$Encephalitis, Viral C02.290; C10.228.140.437.340; C10.228.228.245.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis Encephalitis, Epidemic (+ 4) Encephalitis, Epidemic (+ 4) Encephalitis, Epidemic (+ 4) Inflammation of the brain caused by viruses. When this is caused by ENCEPHALITIS VIRUSES, a group of arboviruses, it is referred to as epidemic encephalitis (ENCEPHALITIS, EPIDEMIC). Other viruses, including some herpesviruses, also cause viral encephalitis. Encephalitis (66-94)  tg9Pe-Encephalitis, Tick-Borne C02.081.343.360; C02.081.885.400; C02.290.310.530; C02.782.310.360; C02.782.350.250.500; C10.228.140.437.340.310.530; C10.228.228.245.340.310.530 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Encephalitis, Epidemic Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; Encephalitis, Viral; Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic A disease caused by tick-borne encephalitis virus, a species of FLAVIVIRUS, and a member of the subgroup ENCEPHALITIS VIRUSES, TICK-BORNE. Tick-borne encephalitis appears to be a spectrum of disease caused by two related viruses: the European subtype - central European encephalitis virus and the eastern subtype - Russian spring-summer encephalitis virus. tk!PEncephalitis, St. Louis C02.081.343.350; C02.290.310.406; C02.782.310.350; C02.782.350.250.450; C10.228.140.437.340.310.406; C10.228.228.245.340.310.406 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Encephalitis, Epidemic Virus Diseases; Encephalitis, Viral; Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic A form of epidemic encephalitis, clinically similar to western equine encephalitis, occurring in late summer and early fall and transmitted usually by mosquitoes of the genus Culex. (From Dorland, 27th ed). tpPEncephalitis, Japanese C02.081.343.345; C02.290.310.280; C02.782.310.345; C02.782.350.250.300; C10.228.140.437.340.310.280; C10.228.228.245.340.310.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Encephalitis, Epidemic Virus Diseases; Encephalitis, Viral; Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis; Encephalitis, Viral; Encephalitis, Epidemic A form of epidemic encephalitis occurring in Japan and other Pacific islands, China, Manchuria, the former USSR, and probably much of the Far East. It may occur as a symptomless, subclinical infection, or as an acute meningoencephalomyelitis with cortical damage and cord lesions resembling those of poliomyelitis. (Dorland, 27th ed). tu}PEncephalitis, Epidemic C02.081.343; C02.290.310; C02.782.310; C10.228.140.437.340.310; C10.228.228.245.340.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parkinson Disease, Postencephalitic Virus Diseases; Arbovirus Infections Virus Diseases; Encephalitis, Viral Virus Diseases; RNA Virus Infections (Non MeSH) Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis; Encephalitis, Viral Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis; Encephalitis, Viral Encephalitis, California; Encephalitis, Japanese; Encephalitis, St. Louis; Encephalitis, Tick-Borne; West Nile Fever Encephalitis, Japanese; Encephalitis, St. Louis; Encephalitis, Tick-Borne; West Nile Fever Encephalitis, California; Encephalitis, Japanese; Encephalitis, St. Louis; Encephalitis, Tick-Borne; West Nile Fever Encephalitis, Japanese; Encephalitis, St. Louis; Encephalitis, Tick-Borne; West Nile Fever Encephalitis, Japanese; Encephalitis, St. Louis; Encephalitis, Tick-Borne; West Nile Fever A viral encephalitis caused by ENCEPHALITIS VIRUSES, all arboviruses. The severity of the encephalitis depends upon which virus strain causes the infection. The viruses are maintained by inapparent zoonoses in birds and lower vertebrates, and are transmitted to humans via arthropod vectors. (From Walton, Brain's Diseases of the Nervous System, 10th ed, p321).  tzcP)DEncephalitis, California C02.081.343.340; C02.782.147.340; C02.782.310.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI La Crosse Virus Virus Diseases; Arbovirus Infections; Encephalitis, Epidemic Virus Diseases; RNA Virus Infections (Non MeSH); Bunyaviridae Infections Virus Diseases; RNA Virus Infections (Non MeSH); Encephalitis, Epidemic Mosquito-borne infection with California group of the Bunyavirus genus. Most California encephalitis is caused by the La Crosse virus. ts9PEncephalitis Viruses, Tick-Borne B04.820.250.350.350; B04.909.777.270.511; B04.909.777.310.350.350 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus A subgroup of the genus FLAVIVIRUS that causes encephalitis and hemorrhagic fevers and is found in eastern and western Europe and the former Soviet Union. It is transmitted by tick vectors and there is an associated milk-borne transmission from viremic cattle, goats, and sheep. t&IGEncephalitis Viruses, Japanese B04.820.250.350.300; B04.909.777.270.475; B04.909.777.310.350.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus Encephalitis Virus, Japanese; Encephalitis Virus, Murray Valley; Encephalitis Virus, St. Louis; West Nile Virus Encephalitis Virus, Japanese; Encephalitis Virus, Murray Valley; Encephalitis Virus, St. Louis; West Nile Virus Encephalitis Virus, Japanese; Encephalitis Virus, Murray Valley; Encephalitis Virus, St. Louis; West Nile Virus A subgroup of the genus FLAVIVIRUS which comprises a number of viral species that are the etiologic agents of human encephalitis in many different geographical regions. These include Japanese encephalitis virus (ENCEPHALITIS VIRUS, JAPANESE), St. Louis encephalitis virus (ENCEPHALITIS VIRUS, ST. LOUIS), Kunjin virus, Murray Valley encephalitis virus (ENCEPHALITIS VIRUS, MURRAY VALLEY), and WEST NILE VIRUS. t$IEncephalitis Viruses B04.909.777.270 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses California Group Viruses (+ 1); Encephalitis Virus, Eastern Equine; Encephalitis Virus, Venezuelan Equine; Encephalitis Virus, Western Equine; Encephalitis Viruses, Japanese (+ 4); Encephalitis Viruses, Tick-Borne A collection of single-stranded RNA viruses scattered across the Bunyaviridae, Flaviviridae, and Togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts. t@Encephalitis Virus, Western Equine B04.820.850.054.360; B04.909.777.270.440; B04.909.777.923.054.360 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus A species of ALPHAVIRUS that is the etiologic agent of equine encephalomyelitis in humans and equines in the United States, southern Canada, and parts of South America. Encephalitis Viruses (66-70) t[)I"Encephalitis Virus, Venezuelan Equine B04.820.850.054.340; B04.909.777.270.369; B04.909.777.923.054.340 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus A species of ALPHAVIRUS that is the etiologic agent of equine encephalomyelitis in humans and equines. It is seen most commonly in parts of Central and South America. Encephalitis Viruses (66-70) t,I"Encephalitis Virus, St. Louis B04.820.250.350.300.330; B04.909.777.270.475.330; B04.909.777.310.350.300.330 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese A species of Flavivirus, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiologic agent of St. Louis encephalitis in the United States, the Caribbean, and Central and South America. Encephalitis Viruses (66-70) tr$UX "Encephalitis Virus, Murray Valley B04.820.250.350.300.300; B04.909.777.270.475.300; B04.909.777.310.350.300.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), found in Australia and New Guinea. It causes a fulminating viremia resembling Japanese encephalitis. t(UXEncephalitis Virus, Japanese B04.820.250.350.300.227; B04.909.777.270.475.227; B04.909.777.310.350.300.227 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses; Encephalitis Viruses, Japanese Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus; Encephalitis Viruses, Japanese A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE), which is the etiological agent of Japanese encephalitis found in Asia, southeast Asia, and the Indian subcontinent. Encephalitis Viruses (66-70) t"UX"Encephalitis Virus, Eastern Equine B04.820.850.054.320; B04.909.777.270.150; B04.909.777.923.054.320 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus A species of ALPHAVIRUS causing encephalomyelitis in Equidae and humans. The virus ranges along the Atlantic seaboard of the United States and Canada and as far south as the Caribbean, Mexico, and parts of Central and South America. Infections in horses show a mortality of up to 90 percent and in humans as high as 80 percent in epidemics. t)IEncephalitis Periaxialis C10.228.140.276.238; C10.228.140.437.321; C10.228.228.245.321; C10.228.337.144.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebral Sclerosis, Diffuse Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Encephalitis Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Encephalitis Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases; Cerebral Sclerosis, Diffuse Rare demyelinating disease characterized by massive destruction of the myelin in the cerebral hemispheres, cavity formation, and glial scarring. Clinical symptoms include bilateral spasticity, cortical blindness, and progressive dementia. Encephalitis periaxialis diffusa (= Schilder's disease) should be reserved for instances of myelinoclastic diffuse sclerosis that correspond to the case described by Schilder in 1912. Schilder's disease should not be confused with Addison-Schilder disease (= ADRENOLEUKODYSTROPHY). t\NQEncephalitis C10.228.140.437; C10.228.228.245 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Encephalitis Periaxialis; Encephalitis, Viral (+ 5); Encephalomyelitis, Acute Disseminated; Meningoencephalitis (+ 1); Parkinson Disease, Postencephalitic; Subacute Sclerosing Panencephalitis Encephalitis Periaxialis; Encephalitis, Viral (+ 5); Encephalomyelitis, Acute Disseminated; Meningoencephalitis (+ 1); Parkinson Disease, Postencephalitic; Subacute Sclerosing Panencephalitis BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI t9&NPEncainide D02.065.199.385; D18.097.295 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Cardiovascular Agents; Anti-Arrhythmia Agents (+-)-4-Methoxy-N-(2-(2-(1-methyl-2-piperidinyl)ethyl)phenyl)- benzamide. An effective and generally well-tolerated anti-arrhythmia agent for suppressing all forms of ventricular arrhythmia. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, encainide exacerbates the arrhythmia and is not recommended for use in these patients. The drug is a potent blocker of sodium channels and produces marked slowing of conduction within the His-Purkinje system and myocardium. Anilides (66-91); Anti-Arrhythmia Agents (66-91) t ":mS:Enbucrilate D02.241.081.069.366.350; D25.720.259.341; D25.919.367.341 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates; Cyanoacrylates Biomedical and Dental Materials (Non MeSH); Polymers; Cyanoacrylates Biomedical and Dental Materials (Non MeSH); Tissue Adhesives; Cyanoacrylates  Bucrylate Bucrylate 2-Cyano-2-propenoic acid, butyl ester. A tissue adhesive that is applied as a monomer to moist tissue and polymerizes to form a bond. It is slowly biodegradable and used in all kinds of surgery, including dental. Acrylates (66-71); Cyanoacrylates (72-74); Tissue Adhesives (66-71)  t>A."QEnamel Organ A14.254.860.851.530 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Tooth Germ Epithelial cells surrounding the dental papilla and differentiated into three layers: the inner enamel epithelium, consisting of ameloblasts which eventually form the enamel, and the enamel pulp and external enamel epithelium, both of which atrophy and disappear before and upon eruption of the tooth, respectively. tp:?lEnamel Cuticle A14.254.860.268.405 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Dental Enamel t:BEnalaprilat D08.373.745.085.335.300; D12.644.456.345.360.300; D18.162.050.335.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Enalapril Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides; Enalapril Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors; Enalapril (S)-1-(N-(1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate. The active metabolite of EMALAPRIL and a potent intravenously administered angiotensin-converting enzyme inhibitor. It is an effective agent for the treatment of essential hypertension and has beneficial hemodynamic effects in heart failure. The drug produces renal vasodilation with an increase in sodium excretion. Dipeptides (66-85); Enalapril (86-89) teM:.Enalapril D08.373.745.085.335; D12.644.456.345.360; D18.162.050.335 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors Enalaprilat Enalaprilat Enalaprilat (S)-1-(N-(1-Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L- proline. Orally active inhibitor of kininase II. It controls essential and renal hypertension, improves glomerular filtration rate and effective renal blood flow, and decreases renal vascular resistance without producing adverse effects on salt and water excretion or body fluid composition. Antihypertensive Agents (66-85); Dipeptides (66-85); Kininase II/antagonists and inhibitors (74-85)  t A:Y)uEmulsions D26.394.225.220.345 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Colloids Fat Emulsions, Intravenous Colloids of two immiscible liquids where either phase may be either fatty or aqueous; lipid-in-water emulsions are usually liquid, like milk or lotion and water-in-lipid emulsions tend to be creams. t ,Y Empyema, Tuberculous C01.252.410.040.552.846.877.405; C01.539.739.484.320; C01.539.830.305.310.320; C08.528.240.320; C08.528.928.405; C08.730.265.320; C08.730.912.405 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Mycobacterium Infections; Tuberculosis; Tuberculosis, Pleural Bacterial and Fungal Diseases (Non MeSH); Infection; Respiratory Tract Infections; Empyema, Pleural Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Empyema; Empyema, Pleural Respiratory Tract Diseases; Pleural Diseases; Empyema, Pleural Respiratory Tract Diseases; Pleural Diseases; Tuberculosis, Pleural Respiratory Tract Diseases; Respiratory Tract Infections; Empyema, Pleural Respiratory Tract Diseases; Respiratory Tract Infections; Tuberculosis, Pleural Empyema due to MYCOBACTERIUM TUBERCULOSIS. tP3Empyema, Subdural C01.539.830.305.330; C10.228.228.230 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Empyema Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) An intracranial suppurative process between the dura and the arachnoid. The infection gains entrance to the subdural space from the frontal and ethmoid sinuses, the middle ear, and the mastoid cells. Brain Abscess (66-83) t*PEmpyema, Pleural C01.539.739.484; C01.539.830.305.310; C08.528.240; C08.730.265 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Respiratory Tract Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Empyema Respiratory Tract Diseases; Pleural Diseases Respiratory Tract Diseases; Respiratory Tract Infections Empyema, Tuberculous Empyema, Tuberculous Empyema, Tuberculous Empyema, Tuberculous Suppurative inflammation of the pleural space. Empyema (66-91)  tÅHP+^8Empyema C01.539.830.305; C23.739.487.856.305 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Abscess Abscess Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation; Suppuration Empyema, Pleural (+ 1); Empyema, Subdural Presence of pus in a hollow organ or body cavity. $t2 *P  5?Empty Sella Syndrome C19.700.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sella Turcica Endocrine Diseases; Pituitary Diseases A condition, generally diagnosed radiographically, characterized by a defect in the diaphragma sellae such that the meninges extend down into the sella turcica and compress the pituitary against the wall of the sella. Sella Turcica (66-77)  t5N.Employment, Supported N01.824.245.350; N02.421.784.644.350 CLECHILJMAMTOGPXSNSTTD Sheltered Workshops; Disabled Population Characteristics (Non MeSH); Socioeconomic Factors; Employment Facilities, Manpower and Services (Non MeSH); Health Services; Rehabilitation; Rehabilitation, Vocational Paid work for mentally or physically disabled persons, taking place in regular or normal work settings. It may be competitive employment (work that pays minimum wage) or employment with subminimal wages in individualized or group placement situations. It is intended for persons with severe disabilities who require a range of support services to maintain employment. Supported employment differs from SHELTERED WORKSHOPS in that work in the latter takes place in a controlled working environment. Federal regulations are authorized and administered by the U.S. Department of Education, Office of Special Education and Rehabilitative Services. Rehabilitation, Vocational (88-91)  t0*$(Employment N01.824.245 CLECHILJMAMTOGPXSNSTTD Job Application; Job Satisfaction; Unemployment Work; Rehabilitation, Vocational Population Characteristics (Non MeSH); Socioeconomic Factors Employment, Supported; Unemployment; Workplace The state of being engaged in an activity or service for wages or salary. Occupations (66-69); Unemployment (66-69); Work (66-69) (tμ9'G7[DEmployer Health Costs N03.219.151.400.375; N05.300.375.350 CLHILJSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Health Care Costs Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Care Costs That portion of total HEALTH CARE COSTS borne by an individual's or group's employing organization. Costs and Cost Analysis (66-91); Health Expenditures (68-91) tУ*vIEmployee Performance Appraisal N04.452.677.370 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The assessment of the functioning of an employee in relation to his work. tҷ$pZEmployee Incentive Plans N04.452.677.368 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Programs designed by management to motivate employees to work more efficiently with increased productivity, and greater employee satisfaction. tpEmployee Grievances N04.452.677.362 CLECHILJSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Formal procedures whereby the employee expresses any dissatisfaction or feeling of injustice regarding the work situation. tqpEmployee Discipline N04.452.677.358 CLECHILJMTSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Personnel Management Regulations or conditions imposed on employees by management in order to correct or prevent behaviors which are counterproductive to the organization. Personnel Management (66-81) tp"Emphysema C23.390 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pulmonary Emphysema Symptoms and General Pathology (Non MeSH) Mediastinal Emphysema; Subcutaneous Emphysema A pathological accumulation of air in tissues or organs.  tz  N25EEmpathy F01.752.355 Behavior and Behavior Mechanisms (Non MeSH); Personality An individual's objective and insightful awareness of the feelings and behavior of another person. It should be distinguished from sympathy, which is usually nonobjective and noncritical. It includes caring, which is the demonstration of an awareness of and a concern for the good of others. (From Bioethics Thesaurus, 1992 ed). Emotions (66-70) t DEmotions F01.470 CLDEPHRE Affective Symptoms Behavior and Behavior Mechanisms (Non MeSH) Affect (+ 1); Anger (+ 1); Anxiety (+ 1); Bereavement (+ 1); Boredom; Euphoria; Fear (+ 2); Frustration; Guilt (+ 1); Happiness; Hate; Hostility; Jealousy; Laughter; Love Those affective states which can be experienced and have arousing and motivational properties. BLCFCICLCODEDHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRISUTHURUSVI $t   4oLEmollients D23.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Dermatologic Agents Lanolin; Mineral Oil; Petrolatum; Simethicone Oleagenous substances used topically to soothe, soften or protect skin or mucus membranes. They are usd also as vehicles for other dermatologic agents. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  t 88:Emodin D02.806.100.205.400; D04.615.117.159.205.400; D19.316.396.247.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Anthraquinones; Cascara Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes; Anthraquinones; Cascara Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics; Cascara 1,3,8-Trihydroxy-6-methylanthraquinone. Purgative anthraquinone found in several plants, especially Rhamnus frangula. It was formerly used as a laxative, but is now used mainly as tool in toxicity studies. t I:2Emigration and Immigration G03.850.505.400.700.350; I01.240.600.350; N01.224.625.350 CLHILJSNTD Transients and Migrants Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Population Dynamics Social Sciences; Demography; Population Dynamics Population Characteristics (Non MeSH); Demography; Population Dynamics The process of leaving one's country to establish residence in a foreign country. t A bEmetine D03.132.316; D03.438.531.321; D21.370.107.380 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Ipecac (Syrup) Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides 3-Ethyl-2,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2-(1,2,3,4-tetrahydro-6,7-dimethoxy-1-isoquinolylmethyl)-1H-benzo(a)quinolizine. The principal alkaloid of ipecac, from the ground roots of Uragoga (or Cephaelis) ipecacuanha or U. acuminata, of the Rubiaceae. It is used as an amebicide in many different preparations and may cause serious cardiac, hepatic, or renal damage and violent diarrhea and vomiting. t 5@Emetics D15.270; D16.050.225 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Vomiting; Nausea Central Nervous System Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Apomorphine; Ipecac (Syrup) Apomorphine; Ipecac (Syrup) Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $t* 8lB:Emergency Treatment (Non MeSH) E02.365 Therapeutics First Aid; Resuscitation (+ 4); Transportation of Patients AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE t% H*Emergency Services, Psychiatric F04.408.525; N02.421.297.200 CLECHILJMAMTOGSDSNSTTDUT Hotlines Disciplines, Tests, Therapy, Services (Non MeSH); Mental Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services Organized services to provide immediate psychiatric care to patients with acute psychological disturbances. Emergencies (66-75); Emergency Medical Services (68-75)  t%" |BEmergency Service, Hospital N02.278.354.422.336; N02.421.297.195; N04.452.442.422.336 CLECHILJMAOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Trauma Centers Trauma Centers Trauma Centers Hospital department responsible for the administration and provision of immediate medical or surgical care to the emergency patient. CLECHILJMAOGSDSNSTTDUT  t!As5Emergency Nursing G02.478.676.200; N02.421.533.200 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Nursing; Specialties, Nursing Facilities, Manpower and Services (Non MeSH); Health Services; Nursing Care The specialty or practice of nursing in the care of patients admitted to the emergency department. Emergencies/nursing (66-91); Emergency Service, Hospital (66-91); Specialties, Nursing (73-91) t&voEmergency Medicine G02.403.790.160 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH) A branch of medicine concerned with an individual's resuscitation, transportation and care from the point of injury or beginning of illness through the hospital or other emergency treatment facility. tGEmergency Medical Technicians M01.526.485.067.150; N02.360.067.150 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Paramedical personnel trained to provide basic emergency care and life support under the supervision of physicians and/or nurses. These services may be carried out at the site of the emergency, in the ambulance, or in a health care institution. Allied Health Personnel (71-78) tN#*!&Emergency Medical Tags E07.315 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Emergencies (66-68); Equipment and Supplies (66-68) t  >Emergency Medical Services N02.421.297 CLECHILJMAMTOGSDSNSTTDUT Ambulances; First Aid Facilities, Manpower and Services (Non MeSH); Health Services Emergency Medical Service Communication Systems; Emergency Service, Hospital (+ 1); Emergency Services, Psychiatric; Poison Control Centers; Transportation of Patients (+ 2); Triage Services specifically designed, staffed, and equipped for the emergency care of patients. Emergencies (66-67); First Aid (66-67) $t Ji0Emergency Medical Service Communication Systems N02.421.297.058 CLECHILJOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services The use of communication systems, such as telecommunication, to transmit emergency information to appropriate providers of health services. Communication (66-79); Emergency Medical Services (68-79); specific telecommunication (66-79) t7jmEmergencies C23.280.420 EPNUPXVE Crisis Intervention; Critical Care; First Aid; Hotlines Symptoms and General Pathology (Non MeSH); Disease Situations or conditions having a high probability of disabling or immediately life-threatening consequences or requiring first aid or other immediate intervention. t D>Emepronium D02.092.102.370; D02.675.276.370; D14.100.120.200.500.240; D16.050.650.230 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A muscarinic antagonist used mainly in the treatment of urinary syndromes. It is incompletely absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. Ammonium Compounds (70-74); Benzene Derivatives (74) tT:?Embryonic Structures (Non MeSH) A16 Embryo (+ 32); Fetus (+ 6); Ovum (+ 3); Placenta (+ 3); Zygote ABAEAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPOPPPSRARERISESUTOTRULUSVI u!&VBEmbryonic Induction G07.553.196.300 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Differentiation Embryonic cell differentiation in which one group of cells evokes and controls the differentiation of other groups of cells. utEmbryology G01.100.529; G01.273.200.350 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Anatomy Biological Sciences; Biology; Developmental Biology Teratology Teratology The study of the development of an organism during the embryonic and fetal stages of life. uh"^nEmbryo, Non-Mammalian A13.350; A16.254.300 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Embryonic Structures (Non MeSH); Embryo Chick Embryo Chick Embryo The embryo of species other than mammals. For the chicken, use the specific CHICK EMBRYO. Embryo (66-74)  u:M mEmbryo Transfer E05.820.330 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fertilization in Vitro Miscellaneous Techniques (Non MeSH); Reproduction Techniques Removal of a mammalian embryo from one environment and replacement in the same or a new environment. The embryo is usually in the pre-nidation phase, i.e., a blastocyst. The process includes embryo or blastocyst transplantation or transfer after in vitro fertilization and transfer of the inner cell mass of the blastocyst. It is not used for transfer of differentiated embryonic tissue, e.g., germ layer cells. Blastocyst/transplantation (74-79); Embryo/transplantation (66-79)  uG"GMEmbryo Resorption C13.703.243.200; C23.240.477.200 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Death Symptoms and General Pathology (Non MeSH); Death; Fetal Death Death and resorption of the embryo that takes place at any developmental stage after ovum implantation and before the completion of organogenesis. Does not include fetal resorption. u J&LEmbryo A16.254 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cell Differentiation; Fetus; Gestational Age Embryonic Structures (Non MeSH) Amniotic Fluid; Blastocyst (+ 2); Blastomeres; Branchial Region; Cleavage Stage, Ovum (+ 1); Cloaca; Embryo, Non-Mammalian (+ 1); Fetal Membranes (+ 5); Gastrula; Germ Layers (+ 3); Mesonephros; Mullerian Ducts; Neural Crest; Notochord; Umbilical Cord (+ 2); Urachus; Vitelline Duct; Wolffian Duct The prenatal stage of mammalian development characterized by rapid morphological changes and the differentiation of basic structures. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $u   86&m<Embolization, Therapeutic E02.520.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Hemostatic Techniques Chemoembolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and cerebral arteriovenous malformations, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolism (66-75); specific heading/surgery (66-75); specific heading/therapy (66-75)  u"*#eEmbolism, Fat C14.907.355.350.454 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism Embolism caused by fat entering the circulation. It is often seen after fractures of large bones or after corticosteriod administration. uNiEmbolism, Cholesterol C14.907.355.350.404 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blue Toe Syndrome Cholesterol; Atherosclerosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism Blue Toe Syndrome An embolism of lipid debris from an ulcerated atheromatous deposit, generally from a large artery to small arterial branches. It is usually small and rarely causes infarction. (Stedman, 25th ed). Cholesterol (66-93); Embolism (66-93) (ucN"i.Embolism, Amniotic Fluid C13.703.634.404; C14.583.404; C14.907.355.350.354 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Amniotic Fluid Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Cardiovascular Cardiovascular Diseases; Pregnancy Complications, Cardiovascular Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism Embolism caused by strong uterine contractions near the end of a normal pregnancy that force amniotic fluid into the maternal circulation. u9LAEmbolism, Air C14.907.355.350.254 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Decompression Sickness Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism Embolism due to air bubbles entering the blood vessels after trauma, surgical procedures, or changes in atmospheric pressure. uNiEmbolism and Thrombosis (Non MeSH) C14.907.355 Cardiovascular Diseases; Vascular Diseases Embolism (+ 11); Thrombosis (+ 9) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI uZ*2,NEmbolism C14.907.355.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Embolectomy Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH) Embolism, Air; Embolism, Amniotic Fluid; Embolism, Cholesterol (+ 1); Embolism, Fat; Pulmonary Embolism; Thromboembolism (+ 4) Blocking of a blood vessel by a blood clot or foreign matter that has been transported from a distant site by the blood stream.  ub N\Embolectomy E04.752.814.445 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Thrombectomy Embolism; Thrombectomy Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Surgical removal of an obstructing clot or foreign material which has been transported from a distant vessel by the bloodstream. Removal of a clot at its original site is called THROMBECTOMY. specific embolism/surgery (66-92) $u$V(Emblems and Insignia K01.419.255 CLHI Genealogy and Heraldry Genealogy and Heraldry Humanities; History Figures or symbols identifying or representing organizations or societies.  uWEmbalming G02.438.554 ECEDHIISLJMTSNST Mummies Health Occupations; Mortuary Practice Process of preserving a dead body to protect it from decay. u   -JEmaciation C23.888.220.354 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Thinness; Weight Loss Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Weight Changes (Non MeSH) Excessive leanness; a wasted condition of the body. (Dorland, 27th ed). u!vNYEllis-Van Creveld Syndrome C05.116.099.708.327; C16.131.077.350.398; C16.131.831.350.398; C17.800.827.800.350.398 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cartilage Diseases Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple; Ectodermal Dysplasia Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH); Ectodermal Dysplasia Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH); Ectodermal Dysplasia Achondroplasia occurring in association with defective development of skin, hair, and teeth, polydactyly, and defect of the cardiac septum. (Dorland, 27th ed). u# `LElliptocytosis, Hereditary C15.378.071.141.150.365 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anemia, Sideroblastic Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital An intrinsic defect of erythrocytes inherited as an autosomal dominant trait. The erythrocytes assume an oval or elliptical shape. u&LEllipticines D03.132.305; D22.204.179.391; D22.569.726 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents A group of antileukemic agents with immunosuppressive properties, isolated primarily from Ochrosia elliptica. They inhibit both DNA and RNA synthesis. Alkaloids (71-74); Carbazoles (71-74); Pyridines (72-74) u(18EEllagic Acid D03.438.150.500 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans 2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)(1)-benzopyran-5,10-dione. A fused four ring compound occurring free or combined in galls. Isolated from the kino of Eucalyptus maculata Hook and E. Hemipholia F. Muell. Activates Factor XII of the blood clotting system which also causes kinin release; used in research and as a dye. Benzopyrans (69-74) u+R:WEliminative Behavior, Animal F01.145.113.367 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal Behavior associated with the elimination of feces and urine from the body. u-" VZEligibility Determination N04.452.264 CLECHILJMTOGSNSTTDUT Disability Evaluation Health Services Administration (Non MeSH); Organization and Administration Criteria to determine eligibility of patients for medical care programs and services. Patients (66-67)  u.WeElevators and Escalators J01.086.339.115 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction Mechanical ascending and descending devices which convey objects and/or people. u07l^Elephants B02.649.352 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals u1k (Elephantiasis, Filarial C03.335.508.700.750.361.350; C15.604.496.320.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphedema; Elephantiasis Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis. Elephantiasis (75-86); Filariasis (66-86) u16P2Elephantiasis C15.604.496.320 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphedema Elephantiasis, Filarial Hypertrophy and thickening of the tissues from any cause. Elephantiasis caused by filarial infection is ELEPHANTIASIS, FILARIAL. (From Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  u4gNVPElements, Radioactive (Non MeSH) D01.268.271 Inorganic Chemicals (Non MeSH); Elements Astatine; Francium; Metals, Actinoid (+ 15); Polonium; Promethium; Radium; Radon (+ 1); Technetium ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR u6{'2{8Elements D01.268 Isotopes; Radioisotopes Inorganic Chemicals (Non MeSH) Aluminum; Antimony; Arsenic; Beryllium; Bismuth; Cadmium; Carbon (+ 3); Chalcogens (Non MeSH) (+ 6); Elements, Radioactive (Non MeSH) (+ 24); Gallium; Germanium; Gold; Hafnium; Halogens (+ 5); Hydrogen; Indium; Iridium; Lead; Magnesium; Mercury; Metals, Alkali (+ 6); Metals, Alkaline Earth (+ 4); Metals, Rare Earth (+ 17); Niobium; Nitrogen; Noble Gases (+ 6); Osmium; Palladium; Phosphorus; Platinum; Rhenium; Rhodium; Ruthenium; Silver; Tantalum; Thallium; Titanium; Trace Elements (+ 16); Tungsten; Zirconium Simple substances which cannot be decomposed by chemical means. They are made up of atoms which are alike in their peripheral electronic configurations, their chemical properties, and in the number of protons in their nuclei. They may differ in the number of neutrons in their nuclei. (From Dorland, 27th ed). ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  u7  %zo<Elementary Particles H01.671.579.404 AECLDUHITU Physical Sciences (Non MeSH); Physics; Nuclear Physics Electrons; Mesons; Neutrons (+ 1); Photons; Protons Individual components of atoms, usually subatomic; subnuclear particles are usually detected only when the atomic nucleus decays and then only transiently, as most of them are unstable, often yielding pure energy without substance, i.e., radiation. Nuclear Physics (66-70)  u F2_Electrosurgery E04.262 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative uD= $Electroshock E05.723.402.403; F04.669.224 AECLCTECHIISMOMTNUPXSNSTTDUTVE Electric Stimulation Miscellaneous Techniques (Non MeSH); Physical Stimulation; Electric Stimulation Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH) Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. uD""Electroretinography E01.210.203; E01.399.528 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Retina Diagnosis; Diagnosis, Eye (Non MeSH) Diagnosis; Electrodiagnosis Recording of electric potentials in the retina after stimulation by light. uF& LYElectroporation E05.909.262.410 AECLCTECHIISMOMTNUPXSNSTTDUTVE Transfection Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques A technique in which electric pulses of intensity in kilovolts per centimeter and of microsecond-to-millisecond duration cause a temporary loss of the semipermeability of cell membranes, thus leading to ion leakage, escape of metabolites, and increased uptake by cells of drugs, molecular probes, and DNA. Some applications of electroporation include introduction of plasmids or foreign DNA into living cells for transfection, fusion of cells to prepare hybridomas, and insertion of proteins into cell membranes. uG"^OElectroplating H01.181.529.307.365.348 CLECHIISMTSNSTTDUTVE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrolysis Coating with a metal or alloy by electrolysis. Electrolysis (66-84); Metallurgy (66-84) uK m:1Electrophysiology G01.344.528; G01.782.236; G07.453 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biophysics Biological Sciences; Physiology Physiology, General (Non MeSH)  Contingent Negative Variation; Electric Conductivity (+ 1); Membrane Potentials (+ 8); Signal Transduction (+ 1) AECLDEDUECEDGEHIIMISLJMAMTOGPHRESNSTTDTU uLQ)m,Electrophorus B02.493.200.328; B02.493.378.380 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cypriniformes Vertebrates; Fishes; Electric Fish uM&&SElectrophoresis, Starch Gel E05.196.401.485; H01.181.529.307.437.402 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Electrophoresis in which a starch gel (a mixture of amylose and amylopectin) is used as the diffusion medium. Electrophoresis (66-69) uN!."Electrophoresis, Polyacrylamide Gel E05.196.401.402; H01.181.529.307.437.319 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Electrophoresis, Disc; Electrophoresis, Gel, Two-Dimensional Electrophoresis, Disc; Electrophoresis, Gel, Two-Dimensional Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Acrylamides (71-72); Electrophoresis (66-72); Electrophoresis, Disc (67-72)  uP)."^YElectrophoresis, Paper E05.196.401.319; H01.181.529.307.437.236 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Nucleotide Mapping (+ 2); Peptide Mapping (+ 1) Electrophoresis in which paper is used as the diffusion medium. This technique is confined almost entirely to separations of small molecules such as amino acids, peptides, and nucleotides, and relatively high voltages are nearly always used. Electrophoresis (66-70)  uSi."=Electrophoresis, Gel, Two-Dimensional E05.196.401.250; E05.196.401.402.250; H01.181.529.307.437.230; H01.181.529.307.437.319.450 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Polyacrylamide Gel Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis; Electrophoresis, Polyacrylamide Gel Electrophoresis in which a second perpendicular electrophoretic transport is performed on the separate components resulting from the first electrophoresis. This technique is usually performed on polyacrylamide gels. Electrophoresis (75-88); Electrophoresis, Polyacrylamide Gel (75-88) uV8+d"OElectrophoresis, Gel, Pulsed-Field E05.196.401.220; H01.181.529.307.437.220 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length. Electrophoresis (86-91) uZ2(."Electrophoresis, Disc E05.196.401.402.236; H01.181.529.307.437.319.403 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Polyacrylamide Gel Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis; Electrophoresis, Polyacrylamide Gel Electrophoresis in which discontinuities in both the voltage and pH gradients are introduced by using buffers of different composition and pH in the different parts of the gel column. The term 'disc' was originally used as an abbreviation for 'discontinuous' referring to the buffers employed, and does not have anything to do with the shape of the separated zones. Electrophoresis (66) u]y6"Electrophoresis, Cellulose Acetate E05.196.401.200; H01.181.529.307.437.200 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Electrophoresis in which cellulose acetate is the diffusion medium. u`(."PElectrophoresis, Agar Gel E05.196.401.153; H01.181.529.307.437.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis Electrophoresis in which agar or agarose gel is used as the diffusion medium. ub."^Electrophoresis E05.196.401; H01.181.278.414; H01.181.529.307.437 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Protein Electrophoresis; Immunoelectrophoresis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry Electrophoresis, Agar Gel; Electrophoresis, Cellulose Acetate; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Paper (+ 5); Electrophoresis, Polyacrylamide Gel (+ 2); Electrophoresis, Starch Gel; Immunoelectrophoresis (+ 2); Isoelectric Focusing Electrophoresis, Agar Gel; Electrophoresis, Cellulose Acetate; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Paper; Electrophoresis, Polyacrylamide Gel (+ 2); Electrophoresis, Starch Gel; Immunoelectrophoresis (+ 2); Iontophoresis; Isoelectric Focusing An electrochemical process in which macromolecules or colloidal particles with a net electric charge migrate in a solution under the influence of an electric current.  udW9"<Electrooculography E01.210.271.403; E01.399.466 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Eye Movements Diagnosis; Diagnosis, Eye (Non MeSH); Eye Movements Diagnosis; Electrodiagnosis Recording of the average amplitude of the resting potential arising between the cornea and the retina in light and dark adaptation as the eyes turn a standard distance to the right and the left. The increase in potential with light adaptation is used to evaluate the condition of the retinal pigment epithelium. uiw"&_pElectronystagmography E01.210.271.380; E01.276.299.816.435; E01.399.435 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Nystagmus, Physiologic; Nystagmus Diagnosis; Diagnosis, Eye (Non MeSH); Eye Movements Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Vestibular Function Tests Diagnosis; Electrodiagnosis Recording of nystagmus based on changes in the electrical field surrounding the eye produced by the difference in potential between the cornea and the retina. Electrooculography (73-74)  uk9&(Electrons H01.671.579.404.335 AECLDUHITU Beta Rays Physical Sciences (Non MeSH); Physics; Nuclear Physics; Elementary Particles Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS or BETA RAYS, the latter being a high-energy biproduct of nuclear decay. un^ \Electronics, Medical H01.288.319 CLECEDHIISLJMAMTOGSNSTTD Biomedical Engineering Physical Sciences (Non MeSH); Electronics Electronics (66-67) up3Electronics H01.288 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH) Amplifiers; Electronics, Medical; Miniaturization; Robotics; Semiconductors (+ 1); Transducers (+ 1) AECLCTECEDHIISLJMAMTOGSDSNSTTDUTVE uq #x&Electronarcosis E03.340 AECLCTECHIISMOMTNUPXSNSTTDUTVE Electric Stimulation Therapy Electroconvulsive Therapy Anesthesia and Analgesia (Non MeSH) Profound stupor produced by passing an electric current through the brain.  ur ""+YElectron Transport G06.535.335.531.403 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism; Oxidation-Reduction ut|Electron Spin Resonance Spectroscopy E05.196.867.303; H01.671.579.340 AECLCTECHIISMOMTNUPXSNSTTDUTVE Spin Labels Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis Physical Sciences (Non MeSH); Physics; Nuclear Physics A technique applicable to the wide variety of substances which exhibit paramagnetism because of the magnetic moments of unpaired electrons. The spectra are useful for detection and identification, for determination of electron structure, for study of interactions between molecules, and for measurement of nuclear spins and moments. (From McGraw-Hill Encyclopedia of Science and Technology, 7th edition) Electron nuclear double resonance (ENDOR) spectroscopy is a variant of the technique which can give enhanced resolution. Electron spin resonance analysis can now be used in vivo, including imaging applications. ut+&"Electron Probe Microanalysis E05.196.867.800.360; E05.799.830.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis; Spectrometry, X-Ray Emission Miscellaneous Techniques (Non MeSH); Radiometry; Spectrometry, X-Ray Emission Identification and measurement of concentration of elements based on the fact that primary-emission x-rays emitted by an element excited by an electron beam have a wavelength characteristic of that element and an intensity related to its concentration. It may be performed by an electron probe microanalyzer, an electron microscope microanalyzer, or by an electron microscope, or scanning electron microscope, fitted with an x-ray spectrometer. Electrons (66); Spectrum Analysis (66) ux"*"0Electromyography E01.399.403; E01.642.403 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Electrodiagnosis Diagnosis; Myography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. u|&9vElectromagnetics H01.671.252.528; H01.671.493.403 CLECHIISLJMTSNSTTD Physical Sciences (Non MeSH); Physics; Electricity Physical Sciences (Non MeSH); Physics; Magnetics Electromagnetic Fields Electromagnetic Fields Phenomena involving magnets, electric currents through conductors and the electric and magnetic fields thus produced, as in electric motors. Electricity (66-72); Magnetics (66-72) AECLECHIISLJMTSNSTTD $u}&x4/Electromagnetic Fields H01.671.252.528.400; H01.671.493.403.400; H01.671.768.325 AE Physical Sciences (Non MeSH); Physics; Electricity; Electromagnetics Physical Sciences (Non MeSH); Physics; Magnetics; Electromagnetics Physical Sciences (Non MeSH); Physics; Radiation Fields representing the joint interplay of electric and magnetic forces. uAVElectrolytes D01.248 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Fluid Therapy; Water-Electrolyte Balance; Water-Electrolyte Imbalance Inorganic Chemicals (Non MeSH) Ions (+ 40) AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  u 8P%>Electrolysis H01.181.529.307.365 AECLCTECHIISMOMTNUPXSNSTTDUTVE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry Electroplating Destruction by passage of a galvanic electric current, as in disintegration of a chemical compound in solution. u"]Electrokymography E01.399.340; E01.528.402; E01.357.818.335 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Electrodiagnosis Diagnosis; Kymography Diagnosis; Diagnostic Imaging; Radiography Radiographic technique combining a photoelectric recording system with fluoroscopy. It is used especially with electrocardiography to study heart motion. u)1&kElectrogalvanism, Intraoral E06.377 Dentistry u   Electroencephalography E01.236.257.401; E01.399.277 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Cerebral Cortex Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH) Diagnosis; Electrodiagnosis Alpha Rhythm; Beta Rhythm; Cortical Synchronization; Delta Rhythm; Theta Rhythm Alpha Rhythm; Beta Rhythm; Cortical Synchronization; Delta Rhythm; Theta Rhythm Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain.  u'"&vElectrodiagnosis E01.399 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Electrocardiography (+ 5); Electroencephalography (+ 5); Electrokymography; Electromyography; Electronystagmography; Electrooculography; Electroretinography; Plethysmography, Impedance Diagnosis of disease states by recording the spontaneous electrical activity of tissues or organs or by the response to stimulation of electrically excitable tissue. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  u " &Electrodes, Implanted E07.296.319 AECLCTECHIMIPSSDSNSTTDUTVEVI Equipment and Supplies; Electrodes Cochlear Implant; Defibrillators, Implantable An electric conductor through which an electric current enters or leaves a medium. When inserted, usually surgically, it is referred to as an implanted electrode. Electrodes (68-70) AECLCTECHIMIPSPXSDSNSTTDUTVEVI $u *5"Electrodes E07.296; H01.671.252.402 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Physical Sciences (Non MeSH); Physics; Electricity Electrodes, Implanted (+ 2); Ion-Selective Electrodes; Microelectrodes Equipment and Supplies (66-67) AECLCTECHIMIPSPXSDSNSTTDUTVEVI  uXT%"Electroconvulsive Therapy F04.881.200.583 AECLECEDHIISLJMAMOMTOGSNSTTD Electronarcosis Disciplines, Tests, Therapy, Services (Non MeSH); Somatic Therapies, Psychiatric (Non MeSH); Convulsive Therapy Electrically induced convulsions primarily used in the treatment of severe affective disorders and schizophrenia. u/ Electrocoagulation E02.154.402 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cautery Therapeutics; Cautery Catheter Ablation Electrosurgical procedures used to treat hemorrhage (e.g., bleeding ulcers) and to ablate tumors, mucosal lesions, and refractory arrhythmias.  u" Electrochemistry H01.181.529.307 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Conductometry; Electric Conductivity (+ 1); Electrolysis (+ 1); Electrophoresis (+ 14); Polarography; Potentiometry AECLCTDUECEDHIISLJMAMOMTNUOGPXSNSTTDTUUTVE uI.Electrocardiography, Ambulatory E01.145.569.359.365; E01.399.214.365; E01.621.555.300 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Electrocardiography Diagnosis; Electrodiagnosis; Electrocardiography Diagnosis; Monitoring, Physiologic; Monitoring, Ambulatory Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia. Electrocardiography (66-89); Monitoring, Physiologic (66-89) u~$=&yFElectrocardiography E01.145.569.359; E01.399.214 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Heart Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Electrodiagnosis Body Surface Potential Mapping; Electrocardiography, Ambulatory; Vectorcardiography (+ 2) Body Surface Potential Mapping; Electrocardiography, Ambulatory; Vectorcardiography (+ 2) Recording of the moment-to-moment electromotive forces of the heart as projected onto various sites on the body's surface, delineated as a scalar function of time.  u"& rElectroacupuncture E02.030.325; E02.040.025.325; E02.040.335.325; E02.186.250; E02.780.335.325; E03.091.430; E03.155.519 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Acupuncture Therapeutics; Alternative Medicine; Acupuncture Therapeutics; Alternative Medicine; Electric Stimulation Therapy Therapeutics; Combined Modality Therapy Therapeutics; Physical Therapy; Electric Stimulation Therapy Anesthesia and Analgesia (Non MeSH); Analgesia Anesthesia and Analgesia (Non MeSH); Anesthesia A form of acupuncture using low frequency electrically stimulated needles to produce analgesia and anesthesia and to treat disease. Acupuncture (66-89) u^u"Electricity G03.230.132.200; H01.671.252 AEHI Bioelectric Energy Sources; Lightning Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources Physical Sciences (Non MeSH); Physics  Electric Conductivity (+ 1); Electric Wiring; Electrodes; Electromagnetics (+ 1); Power Plants AECLCTDUECEDHIISLJMAMTOGSDSNSTTDTUUTVE  uc"-t*Electric Wiring H01.671.252.310 CLECHIISLJMTSNSTTD Physical Sciences (Non MeSH); Physics; Electricity An arrangement of wires distributing electricity. u >;Electric Stimulation Therapy E02.040.335; E02.780.335 AECLCTECHIISMOMTNUPXSNSTTDUTVE Electronarcosis Therapeutics; Alternative Medicine Therapeutics; Physical Therapy Electroacupuncture; Transcutaneous Electric Nerve Stimulation Electroacupuncture; Transcutaneous Electric Nerve Stimulation Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.  u""L<Electric Stimulation E05.723.402 AEISMT Cardiac Pacing, Artificial; Chronaxy; Electric Countershock; Electroshock Miscellaneous Techniques (Non MeSH); Physical Stimulation Electroshock AECLCTECHIISMOMTNUPXSNSTTDUTVE  u VD"Electric Organ A13.332 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) u :Electric Injuries C21.866.324 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Burns, Electric; Lightning Injuries Injuries caused by electric currents. The concept excludes electric burns (BURNS, ELECTRIC), but includes accidental electrocution and electric shock. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  uiLQ+NElectric Impedance G07.453.401.350; H01.181.529.307.294.350; H01.671.252.277.350 AECLDUHITU Physiology, General (Non MeSH); Electrophysiology; Electric Conductivity Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electric Conductivity Physical Sciences (Non MeSH); Physics; Electricity; Electric Conductivity The opposition to the flow of an alternating current, which is the vector sum of ohmic resistance plus additional resistance, if any, due to induction, to capacity, or to both. (Dorland, 27th ed). Electric Conductivity (68-92); Electrophysiology (66-67) u~E BElectric Fish B02.493.378 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Electrophorus; Skates (Fish); Torpedo Fishes which generate an electric discharge. The voltage of the discharge varies from weak to strong in various groups of fish. Electric organ and electroplax are of prime interest in this group. They occur in more than one family. u\&/Electric Countershock E02.344 AECLCTECHIISMOMTNUPXSNSTTDUTVE Electric Stimulation Therapeutics u' "Electric Conductivity G07.453.401; H01.181.529.307.294; H01.671.252.277 AECLDUHITU Physiology, General (Non MeSH); Electrophysiology Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry Physical Sciences (Non MeSH); Physics; Electricity Electric Impedance Electric Impedance Electric Impedance The capacity to conduct an electric current. Conductivity is the reciprocal of resistance. (From Dorland, 27th ed). Electricity (66-67); Electrophysiology (66-67)  u9A7Elder Abuse F03.126.842.089.734.350.390; I01.198.240.856.350.390; I01.880.735.900.350.390 CLDIECEHHILJPCPXSNTD Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence; Domestic Violence Social Sciences; Criminology; Crime; Violence; Domestic Violence Social Sciences; Sociology; Social Problems; Violence; Domestic Violence Emotional, nutritional, or physical maltreatment of the older person generally by family members or by institutional personnel. Aged (66-83); Crime (68-83); Violence (68-83) uUJ:Elbow Joint A02.835.583.290 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints u81Elbow A01.378.209.235 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Tennis Elbow Body Regions (Non MeSH); Extremities; Arm u (5Elastin D12.776.860.300.350 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins Tropoelastin u/ HElasticity H01.671.231 DERE Physical Sciences (Non MeSH); Physics Compliance uS/Elastic Tissue A10.165.551 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Connective Tissue u:5Elapidae B02.833.672.350 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Elapid Venoms Vertebrates; Reptiles; Snakes Bungarus; Cobra A family of extremely venomous snakes, comprising coral snakes, cobras, mambas, kraits, and sea snakes. They are widely distributed, being found in the southern United States, South America, Africa, southern Asia, Australia, and the Pacific Islands. The elapids include three subfamilies: Elapinae, Hydrophiinae, and Lauticaudinae. Like the viperids, they have venom fangs in the front part of the upper jaw. The mambas of Africa are the most dangerous of all snakes by virtue of their size, speed, and highly toxic venom. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed). Snakes (66-93) $u &%Elapid Venoms D24.185.965.850.325 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Elapidae Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms Bungarotoxins; Cobra Venoms (+ 2) Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) ADAEAGAIANBIBLCFCHCLCSCTDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (u< g*fBDEl Salvador Z01.107.169.339 EHEP Geographicals (Non MeSH); America; Central America u&>Ejaculatory Ducts A05.360.444.251 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male u:7Ejaculation G08.520.900.138 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sex ugNEisenmenger Complex C14.240.400.450; C14.280.400.450; C16.131.240.400.450 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Defect of the interventricular septum with severe pulmonary hypertension, hypertrophy of the right ventricle, and latent or overt cyanosis. u=LKEinsteinium D01.268.271.545.250; D01.552.517.337 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Einsteinium. A man-made radioactive actinide with atomic symbol Es, atomic number 99, and atomic weight 252. Its known isotopes range in mass number from 243-246. Its valence can be +2 or +3. Einsteinium was originally discovered in the debris from a thermonuclear explosion in 1952. u*4PEimeriina B01.841.075.762.167.275.250 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida Cryptosporidium (+ 1); Eimeria (+ 1); Isospora; Neospora; Sarcocystis; Toxoplasma A suborder of homoxenous or heteroxenous protozoa in which the macrogamete and microgamont develop independently. The microgamont typically produces many microgametes. uG &UeEimeria tenella B01.841.075.762.167.275.250.276.650 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina; Eimeria A species of coccidian protozoa that mainly infects domestic poultry. Eimeria (66-91) u;'&mSEimeria B01.841.075.762.167.275.250.276 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina Eimeria tenella A genus of protozoan parasites of the subclass COCCIDIA. Various species are parasitic in the epithelial cells of the liver and intestines of man and other animals. u× #&bEikenella corrodens B03.440.450.400.275 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Eikenella Gram-negative bacteria isolated from infections of the respiratory and intestinal tracts and from the buccal cavity, intestinal tract, and urogenital tract. They are probably part of the normal flora of man and animals. Bacteroides (73-75); Bacteroides corrodens (76-90) uL"e<Eikenella B03.440.450.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods Eikenella corrodens A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the human mouth and intestine. Organisms of this genus can be opportunistic pathogens. Bacteroides (73-75); Eikenella corrodens (76-91)  uf "X:eIF-2 D12.776.835.725.210 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Ribosomal Proteins; Peptide Initiation Factors Eukaryotic initiation factor of protein synthesis. The factor consists of three subunits, alpha, beta, and gamma. As initiation proceeds, eIF-2 forms a ternary complex with Met-tRNAi and GTP. Peptide Initiation Factors (78-89) uF F{)eIF-1 D12.776.835.725.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Ribosomal Proteins; Peptide Initiation Factors Eukaryotic initiation factor that binds to 30s ribosomal subunits. It is called eIF-1 in eukaryotes and IF-1 in bacteria. Its role is not clear but it may be involved in stabilizing the 30s subunit or assisting in the release of bacterial IF-2. Peptide Initiation Factors (78-89) uX F{$)Eidetic Imagery F02.463.593.292 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception A visual image which is recalled in accurate detail. It is a sort of projection of an image on a mental screen. uͭ \Eicosanoids D02.241.081.436.213; D10.516.251.355.255; D17.350.050.175 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Eicosanoid Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids Arachidonic Acids (+ 14) Arachidonic Acids (+ 14) Leukotrienes (+ 6); Prostaglandins (+ 14); Thromboxanes (+ 2) A class of oxygenated, endogenous, unsaturated fatty acids derived from arachidonic acid. They include prostaglandins, leukotrienes, thromboxanes, and hydroxyeicosatetraenoic acid compounds (HETE). They are hormone-like substances that act near the site of synthesis without altering functions throughout the body. Arachidonic Acids (67-89); Fatty Acids, Unsaturated (73-89); Leukotrienes (89); Prostaglandins (66-89); Thromboxanes (78-89) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (uABhhDEicosanoic Acids D02.241.081.407.300; D10.516.251.220 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Phytanic Acid Phytanic Acid 20-carbon saturated monocarboxylic acids. Fatty Acids (66-74); Fatty Acids, Nonesterified (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $u*8"1C:Ehrlichiosis C01.252.400.810.700.810.275; C01.252.400.825.400 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases A tick-borne disease characterized by fever, headache, myalgias, anorexia, and occasionally rash. In humans the disease is caused by EHRLICHIA CHAFFEENSIS, in dogs it is caused by E. canis, and in horses, E. equi. Ehrlichia (75-91); Rickettsiaceae Infections (75-91) u!6Pq>Ehrlichieae B03.700.651.801.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae Cowdria; Ehrlichia (+ 1) A tribe of gram-negative bacteria of the family RICKETTSIACEAE whose organisms are pathogenic for certain mammals, including man. Certain species are adapted to existence in invertebrates, especially arthropods. uى"] Ehrlichia chaffeensis B03.700.651.801.325.325.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Ehrlichieae; Ehrlichia A species of gram-negative bacteria that is the causative agent of human EHRLICHIOSIS. This organism was first discovered at Fort Chaffee, Arkansas, when blood samples from suspected human ehrlichiosis patients were studied. Ehrlichia (91-94) ui"yEhrlichia B03.700.651.801.325.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Ehrlichieae Ehrlichia chaffeensis Small, often pleomorphic, coccoid to ellipsoidal organisms occurring intracytoplasmically in circulating lymphocytes. They are the etiologic agents of tick-borne diseases of humans, dogs, cattle, sheep, goats, and horses. u "lEhlers-Danlos Syndrome C16.131.831.428; C17.300.200.310; C17.800.827.800.428 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cutis Laxa Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) A group of inherited disorders of the connective tissue that vary in severity and are transmitted as autosomal recessive, autosomal dominant, or X-linked recessive traits. The primary characteristics are hyperextensible skin and joints, tendency to bruise, reduced wound healing capability, pseudotumors, and ocular defects. (From Dorland, 27th ed). ut=LqEgypt Z01.058.266.317; Z01.586.035.200; Z01.586.500.300 EHEP Geographicals (Non MeSH); Africa; Africa, Northern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Ancient Lands (Non MeSH) Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East uS 9Egtazic Acid D02.033.618.250.260; D02.241.081.038.455; D26.241.543 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Ethylene Glycols Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid. A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID (EDTA). It has been used in the treatment of urolithiasis. Acetic Acids (69-74); Glycols (69-74) u=./Ego F01.752.747.189; F02.739.794.206 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory Reality Testing Reality Testing The conscious portion of the personality structure which serves to mediate between the demands of the primitive instinctual drives, (the id), of internalized parental and social prohibitions or the conscience, (the superego), and of reality. Defense Mechanisms (66-67); Personality (66-67); Psychoanalytic Theory (66-67) u&&]Eggs J01.341.322 AEANCLECHIMIPOPSRESDSNSTTOUTVI Poultry Products Technology, Industry, Agriculture (Non MeSH); Food Egg White; Egg Yolk Animal reproductive bodies, or the contents thereof, used as food. The concept is differentiated from OVUM, the anatomic or physiologic entity. AEANCHCLCYDEECENHIIMMEMIPAPHPOPSRARERISDSESNSTTOTRULUSUTVI $u<"=>Egg Yolk A16.631.325; J01.341.322.484 AECHCLCYDEENIMMEMIPAPHPOPSRARERISETOTRULUSVI Embryonic Structures (Non MeSH); Ovum Technology, Industry, Agriculture (Non MeSH); Food; Eggs u "0rEgg White J01.341.322.317 AEANCLECHIMIPOPSRESDSNSTTOUTVI Ovalbumin Technology, Industry, Agriculture (Non MeSH); Food; Eggs u" EEgg Shell A13.316 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) u :Egg Proteins, Dietary D12.776.256.317; D12.776.290.300 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins Conalbumin; Ovalbumin (+ 1); Ovomucin; Phosvitin; Vitellogenin Proteins found in the egg which are consumed as a food. Egg Proteins (66-88) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $u0&BNFHEgg Proteins D12.776.290 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Conalbumin; Egg Proteins, Dietary; Ovalbumin (+ 1); Ovomucin; Phosvitin; Vitellogenin Proteins which are found in eggs or ova from any species. Egg White (66-72); Egg Yolk (66-72); Proteins (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $uBDhHDHEflornithine D08.373.340; D12.125.095.765.340; D21.370.884.255; D22.204.412 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Ornithine Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 2-(Difluoromethyl)-DL-ornithine. An inhibitor of ornithine decarboxylase, the rate limiting enzyme of the polyamine biosynthetic pathway. As a result of this inhibition of polyamine synthesis, the compound is effective in preventing cancer formation in many organ systems, inhibiting cancer growth, and reducing tumor size. It also has synergistic action with other antineoplastic agents. In addition, it has been found effective as a trypanocidal agent. Ornithine (66-74); Ornithine/analogs and derivatives (75-86) uH:aHEfficiency, Organizational N04.452.227 CLECHILJSNSTTD Health Services Administration (Non MeSH); Organization and Administration The capacity of an organization, institution, or business to produce desired results with a minimum expenditure of energy, time, money, personnel, materiel, etc. Efficiency (72-93) uWEfficiency F02.784.692.351 CLDEPHRE Work Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial Ratio of output to effort, or the ratio of effort produced to energy expended. u l`Efferent Pathways A08.612.380 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Neural Pathways Extrapyramidal Tracts; Pyramidal Tracts Nerve structures through which impulses are conducted from a nerve center toward a peripheral site. Neurons, Efferent (69-75); specific central nervous system heading  u6'/vOEffect Modifiers (Epidemiology) G03.850.490.734; N05.715.350.350 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors Cohort Effect; Healthy Worker Effect; Placebo Effect Cohort Effect; Healthy Worker Effect; Placebo Effect Factors that modify the effect of the putative causal factor(s) under study. u`%&~]Eels B02.493.338 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Anguilla uk& Edwards Personal Preference Schedule F04.711.647.513.200 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Personality Inventory A personality inventory which is used to measure the major personal or social motives of individuals. u+ yEducational Status N01.824.196 Population Characteristics (Non MeSH); Socioeconomic Factors Educational attainment or level of education of individuals. Sociology (66-67); Students (66-67) uZGH,Educational Measurement I02.399 ECHIMTSNST Aptitude Tests Education College Admission Test; Professional Competence (+ 1); School Admission Criteria; Self-Evaluation Programs The assessing of academic or educational achievement. It includes all aspects of testing and test construction. CLECHILJMAMTOGSNSTTD $v^  }Education, Veterinary I02.358.588 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH) Use for general articles concerning veterinary medical education. v6MEducation, Special I02.233.213 CLECHILJMAMTOGSNSTTD Disabled Education; Education, Nonprofessional (Non MeSH) Education of Mentally Retarded; Mainstreaming (Education) Education of the individual who markedly deviates intellectually, physically, socially, or emotionally from those considered to be normal, thus requiring special instruction.  v 9CEducation, Professional, Retraining I02.358.212.590 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Continuing Educational programs for individuals who have been inactive in their profession, or who wish to regain unused skills. v)QEducation, Professional (Non MeSH) I02.358 Education Education, Continuing (+ 5); Education, Dental (+ 2); Education, Graduate (+ 4); Education, Medical (+ 5); Education, Nursing (+ 6); Education, Pharmacy (+ 2); Education, Veterinary; Internship, Nonmedical CLECEDHIISLJMAMTOGSNSTTD v)  Education, Premedical I02.316 CLECHILJMAMTOGSNSTTD Education Preparatory education meeting the requirements for admission to medical school. vg  ]Education, Predental I02.275 CLECHILJMAMTOGSNSTTD Education Preparatory education meeting the requirements for admission to dental school. v1  \Education, Pharmacy, Graduate I02.358.337.550; I02.358.525.483 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Graduate Education; Education, Professional (Non MeSH); Education, Pharmacy Educational programs for pharmacists who have a bachelor's degree or a Doctor of Pharmacy degree entering a specific field of pharmacy. They may lead to an advanced degree. Education, Pharmacy (66-67) v#&!Education, Pharmacy, Continuing I02.358.212.550; I02.358.525.317 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Continuing Education; Education, Professional (Non MeSH); Education, Pharmacy Educational programs designed to inform graduate pharmacists of recent advances in their particular field. Education, Pharmacy (66-67) v %&|!Education, Pharmacy I02.358.525 CLECHILJMAMTOGSNSTTD Pharmacy Education; Education, Professional (Non MeSH) Education, Pharmacy, Continuing; Education, Pharmacy, Graduate Formal instruction, learning, or training in the preparation, dispensing, and proper utilization of drugs in the field of medicine.  v  6HEducation, Nursing, Graduate I02.358.337.450; I02.358.462.565 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Graduate Education; Education, Professional (Non MeSH); Education, Nursing Those educational activities engaged in by holders of a bachelor's degree in nursing, which are primarily designed to prepare them for entrance into a specific field of nursing, and may lead to board certification or a more advanced degree. v^"&Education, Nursing, Diploma Programs I02.358.462.482 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Nursing Programs usually offered in hospital schools of nursing leading to a registered nurse diploma (RN). Graduates are eligible for state examination for licensure as RN (Registered Nurse). Education, Nursing (66) v+NEducation, Nursing, Continuing I02.358.212.450; I02.358.462.399 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Continuing Education; Education, Professional (Non MeSH); Education, Nursing Educational programs designed to inform nurses of recent advances in their fields. vY$&bEducation, Nursing, Baccalaureate I02.358.462.316 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Nursing A four-year program in nursing education in a college or university leading to a B.S.N. (Bachelor of Science in Nursing). Graduates are eligible for state examination for licensure as RN (Registered Nurse). v'NEducation, Nursing, Associate I02.358.462.233 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Nursing A two-year program in nursing education in a community or junior college leading to an A.D. (Associate Degree). Graduates of this program are eligible for state examination for licensure as RN (Registered Nurse). v#NEducation, Nursing I02.358.462 CLECHILJMAMTOGSNSTTD Nursing Education; Education, Professional (Non MeSH) Education, Nursing, Associate; Education, Nursing, Baccalaureate; Education, Nursing, Continuing; Education, Nursing, Diploma Programs; Education, Nursing, Graduate; Nursing Education Research Use for general articles concerning nursing education. CLECEDHIISLJMAMTOGSNSTTD $vR 6AEducation, Nonprofessional (Non MeSH) I02.233 Education Education, Special (+ 2); Health Education (+ 4); Physical Education and Training (+ 1); Schools (+ 1); Students (+ 1); Vocational Education; Vocational Guidance CLECEDHIINLJMAMTOGPHPXSDSNSTTDUT v8,  $Education, Medical, Undergraduate I02.358.399.450 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Medical Clinical Clerkship The period of medical education in a medical school. In the United States it follows the baccalaureate degree and precedes the granting of the M.D. Education, Medical (66-70)  v'N Education, Medical, Graduate I02.358.337.350; I02.358.399.350 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Graduate Education; Education, Professional (Non MeSH); Education, Medical Educational programs for medical graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic medical sciences, and may lead to board certification or an advanced medical degree. v="&Education, Medical, Continuing I02.358.212.350; I02.358.399.250 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Continuing Education; Education, Professional (Non MeSH); Education, Medical Educational programs designed to inform physicians of recent advances in their field. vs$&eEducation, Medical I02.358.399 CLECHILJMAMTOGSNSTTD Medicine Education; Education, Professional (Non MeSH) Education, Medical, Continuing; Education, Medical, Graduate; Education, Medical, Undergraduate (+ 1); Internship and Residency Use for general articles concerning medical education.  v 6AEducation, Graduate I02.358.337 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH) Education, Dental, Graduate; Education, Medical, Graduate; Education, Nursing, Graduate; Education, Pharmacy, Graduate Studies beyond the bachelor's degree at an institution having graduate programs for the purpose of preparing for entrance into a specific field, and obtaining a higher degree. Education (66)  v!z6Education, Dental, Graduate I02.358.274.482; I02.358.337.249 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Dental Education; Education, Professional (Non MeSH); Education, Graduate Educational programs for dental graduates entering a specialty. They include formal specialty training as well as academic work in the clinical and basic dental sciences, and may lead to board certification or an advanced dental degree. v#!&Education, Dental, Continuing I02.358.212.249; I02.358.274.316 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH); Education, Continuing Education; Education, Professional (Non MeSH); Education, Dental Educational programs designed to inform dentists of recent advances in their fields. v%#&dEducation, Dental I02.358.274 CLECHILJMAMTOGSNSTTD Dentistry Education; Education, Professional (Non MeSH) Education, Dental, Continuing; Education, Dental, Graduate Use for articles concerning dental education in general.  v'8 6DDEducation, Continuing I02.358.212 CLECHILJMAMTOGSNSTTD Education; Education, Professional (Non MeSH) Education, Dental, Continuing; Education, Medical, Continuing; Education, Nursing, Continuing; Education, Pharmacy, Continuing; Education, Professional, Retraining Educational programs designed to inform individuals of recent advances in their particular field of interest. They do not lead to any formal advanced standing. v(k6Education of Mentally Retarded F02.784.629.375; I02.233.213.400 CLECHILJMAMTOGSNSTTD Mental Retardation Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Education; Education, Nonprofessional (Non MeSH); Education, Special The teaching or training of those individuals with subnormal intellectual functioning. v*~%&eEducation Department, Hospital N02.278.354.422.310; N04.452.442.422.310 CLECHILJMAOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for administering educational and training activities pertaining to health for patients and staff. v,@$. Education I02 CLECHILJMAMTOGSNSTTD Learning; Research Support; Students; Teaching; Training Support Curriculum (+ 3); Education, Nonprofessional (Non MeSH) (+ 16); Education, Predental; Education, Premedical; Education, Professional (Non MeSH) (+ 32); Educational Measurement (+ 5); Faculty (+ 3); Inservice Training (+ 1); Mentors; Preceptorship; Schools (+ 10); Students (+ 6); Teaching (+ 9) Acquisition of knowledge as a result of instruction in a formal course of study. CLDEECEDHIINISLJMAMTOGPHPXRESDSNSTTDUT  v.n Nfb*Edrophonium D02.092.102.352; D02.675.276.352; D08.373.275.371; D14.100.120.300.220; D16.050.675.210; D18.097.267 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics Cardiovascular Agents; Anti-Arrhythmia Agents A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. v1r:0Edetic Acid D02.092.782.258.368.250; D02.241.081.038.440; D26.241.504 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Ethylenediamines Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine). A chelating agent used mainly in the form of its salts for treatment of poisoning by substances such as heavy metals, cyanide, and organophosphorus compounds. The salts form chelates with metal ions such as lead and mercury and promote the excretion of the metals from the body in a relatively nontoxic form. v4A. Edentata B02.649.314 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Armadillos; Sloths v7 (Edema, Cardiac C14.280.434.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive A manifestation of congestive heart failure caused by increased venous and capillary pressures and often associated with the retention of sodium by the kidneys. (Dorland, 27th ed). v8NNEdema Disease of Swine C22.905.260 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases; Swine Diseases An acute disease of young pigs that is usually associated with weaning. It is characterized clinically by paresis and subcutaneous edema. Edema/veterinary (66-70); Gastrointestinal Diseases/veterinary (66-70); Swine Diseases (66-70) v:FJ'oEdema C23.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Angioneurotic Edema; Brain Edema; Hydrops Fetalis; Laryngeal Edema; Lymphedema; Macular Edema, Cystoid; Papilledema; Pulmonary Edema Symptoms and General Pathology (Non MeSH) The presence of abnormally large amounts of fluid in the intercellular tissue spaces of the body. It is usually applied to demonstrable accumulation of excessive fluid in the subcutaneous tissues. Edema may be localized, due to venous or lymphatic obstruction or to increased vascular permeability, or it may be systemic due to heart failure or renal disease. Collections of edema fluid are designated according to the site, e.g., ASCITES (peritoneal cavity), HYDROTHORAX (pleural cavity), and hydropericardium (pericardial sac). (Dorland, 27th ed). v<  N2Edeine D20.085.116.250 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Edeine. Basic peptide antibiotic from Bacillus brevis. It exhibits broad-spectrum antibacterial activity and inhibits bacterial DNA synthesis. Antibiotics (71-74); Peptides (72-74); Polyamines (73-74) v? <BFEczema, Dyshidrotic C17.800.174.620.300; C17.800.815.620.300; C17.800.865.385 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Eczema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Eczema Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous A recurrent eczematous reaction characterized by the development of vesicular eruptions on the palms and soles, particularly along the sides and between the digits. It is accompanied by pruritus, a burning sensation, and hyperhidrosis. The disease is self-limiting, lasting only a few weeks. (Dorland, 27th ed). vAANBmEczema C17.800.174.620; C17.800.815.620 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous Eczema, Dyshidrotic Eczema, Dyshidrotic A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed). vE &N.Ecuador Z01.107.757.362 EHEP Geographicals (Non MeSH); America; South America vG? <Ectropion C11.338.362 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eyelid Diseases The turning outward (eversion) of the edge of the eyelid, resulting in the exposure of the palpebral conjunctiva. (Dorland, 27th ed). vG N%Ectromelia, Infectious C02.256.743.239; C22.795.239 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Animal Diseases; Rodent Diseases A viral infection of mice, causing edema and necrosis followed by limb loss. vI"J{]Ectromelia Virus B04.280.650.160.650.200; B04.909.204.783.160.650.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus A species of ORTHOPOXVIRUS infecting mice and causing a disease that involves internal organs and produces characteristic skin lesions. vJ:Ectromelia C05.660.585.350; C16.131.621.585.350 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH) Gross hypo- or aplasia of one or more long bones of one or more limbs. The concept includes amelia, hemimelia, and phocomelia. vL*L"Ectopia Lentis C11.250.300; C11.510.598.373; C16.131.384.405 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Eye Diseases; Lens Diseases; Lens Subluxation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Congenital displacement of the lens resulting from defective zonule formation. Eye Diseases (66-77); Lens, Crystalline (66-77) vN5L\:Ectoparasitic Infestations C03.211 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Skin Diseases, Parasitic Parasitic Diseases Mite Infestations (+ 2); Myiasis (+ 2); Pediculosis; Tick Infestations Infestations by parasites which live on the outside of the body of the host. Parasitic Diseases (66-67); specific parasite $vP PX^7Ectogenesis G07.553.350 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Embryonal development or fetal maturation that takes place in an artificial environment. Embryo (66-74) vRZhEctodermal Dysplasia C16.131.077.350; C16.131.280.748.325; C16.131.831.350; C17.800.827.800.350 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Ellis-Van Creveld Syndrome; Focal Dermal Hypoplasia Focal Dermal Hypoplasia Ellis-Van Creveld Syndrome; Focal Dermal Hypoplasia Ellis-Van Creveld Syndrome; Focal Dermal Hypoplasia A group of hereditary disorders involving tissues and structures derived from the embryonic ectoderm. They are characterized by the presence of abnormalities at birth and involvement of both the epidermis and skin appendages. They are generally nonprogressive and diffuse. Various forms exist, including anhidrotic and hidrotic dysplasias, FOCAL DERMAL HYPOPLASIA, and aplasia cutis congenita. vSTLEctoderm A16.254.425.273 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo; Germ Layers The outer of the three germ layers of the embryo. vYB *A?Ecthyma, Contagious C02.256.743.193; C22.836.259 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections Animal Diseases; Sheep Diseases An infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips. It is caused by a poxvirus and may be transmitted to man. Ecthyma (66-69); Poxvirus Infections (66-69); Sheep Diseases (66-69) vZ."JzSEcthyma C01.252.410.890.210; C01.252.825.210; C01.539.800.720.210; C17.800.695.210; C17.800.838.765.210 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Streptococcal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pyoderma Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial An ulcerative pyoderma usually caused by group A beta-hemolytic streptococcal infection at the site of minor trauma. (Dorland, 27th ed). v\S kNLEcosystem G03.230.116.300 Environment and Public Health (Non MeSH); Environment; Ecology A functional system which includes the organisms of a natural community together with their environment. (McGraw Hill Dictionary of Scientific and Technical Terms, 4th ed). v`( LEconomics, Pharmaceutical N03.219.390 CLHILJOGSNSTTD Drug Costs; Fees, Pharmaceutical; Prescription Fees Economics, Organizations, Control (Non MeSH); Economics Economic aspects of the fields of pharmacy and pharmacology as they apply to the development and study of medical economics in rational drug therapy and the impact of pharmaceuticals on the cost of medical care. Pharmaceutical economics also includes the economic considerations of the pharmaceutical care delivery system and in drug prescribing, particularly of cost-benefit values. (From J Res Pharm Econ 1989;1(1); PharmacoEcon 1992;1(1)). Economics (66-79); Pharmacy (66-79); Pharmacy/economics (80-93)  va~>BMEconomics, Organizations, Control (Non MeSH) N03 Economics (+ 133); Health Planning (+ 23); Organizations (+ 72); Social Control, Formal (+ 62); State Dentistry; State Medicine; Technology Assessment, Biomedical (+ 1) CLECEDEHHIINISLJMAMTOGPCPXSDSNSTTDUT vd4(Economics, Nursing N03.219.338 CLHILJOGSNSTTD Nursing Economics, Organizations, Control (Non MeSH); Economics Economic aspects of the nursing profession. vf  B5Economics, Medical N03.219.300 CLHILJOGSNSTTD Office Management Medicine Economics, Organizations, Control (Non MeSH); Economics Fees, Medical Economic aspects of the field of medicine, the medical profession, and health care. It includes the economic and financial impact of disease in general on the patient, the physician, society, or government. $vf BEconomics, Hospital N03.219.262 CLHILJOGSNSTTD Financial Management, Hospital; Purchasing, Hospital Hospitals Economics, Organizations, Control (Non MeSH); Economics Hospital Charges; Hospital Costs Economic aspects related to the management and operation of a hospital. CLHILJOGSNSTTDUT (vh= B(VEconomics, Dental N03.219.224 CLHILJOGSNSTTD Office Management Dentistry Economics, Organizations, Control (Non MeSH); Economics Fees, Dental Economic aspects of the dental profession and dental care. $vjD BGEconomics N03.219 HILJSNTD European Economic Community; Models, Economic; Socioeconomic Factors Economics, Organizations, Control (Non MeSH) Costs and Cost Analysis (+ 14); Economic Competition; Economic Value of Life; Economics, Dental (+ 1); Economics, Hospital (+ 2); Economics, Medical (+ 1); Economics, Nursing; Economics, Pharmaceutical; Fees and Charges (+ 9); Financial Management (+ 18); Financial Support (Non MeSH) (+ 5); Financing, Organized (+ 64); Financing, Personal; Inflation, Economic; Investments; Medical Indigency; Taxes (+ 2) The science of utilization, distribution, and consumption of services and materials. CLECEHHILJMAMTOGPXSDSNSTTDUT $vkg   P4c Economic Value of Life N03.219.195 Economics, Organizations, Control (Non MeSH); Economics The evaluation of the monetary value of a life lost or a life saved. vnBVEconomic Competition N03.219.188 CLECHILJOGSNSTTDUT Antitrust Laws Commerce Economics, Organizations, Control (Non MeSH); Economics The effort of two or more parties to secure the business of a third party by offering, usually under fair or equitable rules of business practice, the most favorable terms.  vo BEconazole D03.383.374.250; D20.136.263 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Anti-Infective Agents; Antifungal Agents 1-[2,4-Dichloro-beta-[(p-chlorobenzyl)oxy]phenethyl]-imidazole. Broad spectrum antimycotic with some action against Gram positive bacteria; it is used topically in dermatomycoses also orally and parenterally. Synonyms: CC 2470; Pevaryl; R 14,827. Chlorobenzenes (74-75); Imidazoles (74-76) vq& ":3Ecology G01.273.248; G03.230.116 Conservation of Natural Resources Biological Sciences; Biology Environment and Public Health (Non MeSH); Environment Biomass Biomass; Ecosystem The branch of science concerned with the interrelationship of organisms and their environment, especially as manifested by natural cycles and rhythms, community development and structure, interactions between different kinds of organisms, geographic distributions, and population alterations. (Webster's, 3d ed). vs (b!eEcological Systems, Closed G03.230.150.225 Waste Management Space Flight; Submarine Medicine Environment and Public Health (Non MeSH); Environment; Environment, Controlled Systems that provide for the maintenance of life in an isolated living chamber through reutilization of the material available, in particular, by means of a cycle wherein exhaled carbon dioxide, urine, and other waste matter are converted chemically or by photosynthesis into oxygen, water, and food. (NASA Thesaurus, 1988). Environment, Controlled (73-94)  vu (]{%Eclecticism E02.040.325 HIPX Therapeutics; Alternative Medicine A nineteenth-century cult popular in America which treats diseases by application of single remedies to known pathologic conditions, without reference to nosology, special attention being given to developing indigenous plant remedies. (Dorland, 27th ed). vx)&Eclampsia C13.703.799.314 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pre-Eclampsia Convulsions Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Toxemias HELLP Syndrome; Pre-Eclampsia (+ 1) Onset of convulsions or coma in a previously diagnosed pre-eclamptic patient. $vz L},\Echoviruses B04.820.565.284.314; B04.909.777.618.284.314 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus Echovirus 6; Echovirus 9 Echovirus 6; Echovirus 9 A group of enteroviruses isolated from man and originally thought not to be associated with disease, whence the name Enteric Cytopathic Human Orphan; however, several serotypes have been found to cause meningitis, diarrhea, and respiratory disease. v{2>!Echovirus 9 B04.820.565.284.314.250; B04.909.777.618.284.314.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus; Echoviruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus; Echoviruses A species of ENTEROVIRUS associated with outbreaks of aseptic meningitis. v~Y:WEchovirus 6 B04.820.565.284.314.225; B04.909.777.618.284.314.225 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus; Echoviruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus; Echoviruses A species of ENTEROVIRUS that has caused outbreaks of aseptic meningitis in children and adults. v:sEchovirus Infections C02.782.687.359.347 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Infectious disease processes, including meningitis, diarrhea, and respiratory disorders, caused by echoviruses. Enterovirus Infections (66-67) vPt$Echothiophate Iodide D02.719.341; D08.373.275.314; D14.100.120.300.210; D16.050.495.200; D16.050.675.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A potent, long-acting cholinesterase inhibitor used as a miotic in the treatment of glaucoma. vi_:oEcholocation F01.145.209.103.273; F02.830.606.314 CLDEPHRE Sound Localization Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Animal Communication Psychologic Processes and Principles (Non MeSH); Psychophysiology; Orientation An auditory orientation mechanism involving the emission of high frequency sounds which are reflected back to the emitter (animal). Auditory Perception (67-71); Orientation (66-71)  v* :Echolalia C10.597.257.870.323; C23.888.592.257.870.323; F03.126.219.870.323 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders Meaningless repetition by a patient of words addressed to him. v IFLEchoencephalography E01.236.257.314; E01.357.947.324 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH) Diagnosis; Diagnostic Imaging; Ultrasonography Ultrasonography, Doppler, Transcranial Ultrasonography, Doppler, Transcranial Use of reflected ultrasound in the diagnosis of intracranial pathologic processes. vz&&VaEchocardiography, Transesophageal E01.145.569.314.350; E01.357.947.314.350 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Echocardiography Diagnosis; Diagnostic Imaging; Ultrasonography; Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues using a transducer placed in the esophagus. Echocardiography (77-93) vG&.&Echocardiography, Doppler, Pulsed E01.145.569.314.324.325; E01.357.947.314.324.325; E01.357.947.390.324.325; E01.357.947.390.800.325 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Echocardiography; Echocardiography, Doppler Diagnosis; Diagnostic Imaging; Ultrasonography; Echocardiography; Echocardiography, Doppler Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler; Echocardiography, Doppler Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler; Ultrasonography, Doppler, Pulsed Echocardiography applying the Doppler effect, with velocity detection combined with range discrimination. Short bursts of ultrasound are transmitted at regular intervals and the echoes are demodulated as they return. Echocardiography (72-88); Echocardiography, Doppler (89-94) vX'l&EEchocardiography, Doppler, Color E01.145.569.314.324.300; E01.357.947.314.324.300; E01.357.947.390.324.300; E01.357.947.390.775.750.300 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Echocardiography; Echocardiography, Doppler Diagnosis; Diagnostic Imaging; Ultrasonography; Echocardiography; Echocardiography, Doppler Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler; Echocardiography, Doppler Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler; Ultrasonography, Doppler, Duplex; Ultrasonography, Doppler, Color Echocardiography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. Echocardiography (85-88); Echocardiography, Doppler (89-94) vK&p&EEchocardiography, Doppler E01.145.569.314.324; E01.357.947.314.324; E01.357.947.390.324 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Echocardiography Diagnosis; Diagnostic Imaging; Ultrasonography; Echocardiography Diagnosis; Diagnostic Imaging; Ultrasonography; Ultrasonography, Doppler Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed Echocardiography, Doppler, Color; Echocardiography, Doppler, Pulsed Measurement of intracardiac blood flow using an M-mode and/or two-dimensional (2-D) echocardiogram while simultaneously recording the spectrum of the audible Doppler signal (e.g., velocity, direction, amplitude, intensity, timing) reflected from the moving column of red blood cells. Echocardiography (66-88); Ultrasonic Diagnosis (85-88); Ultrasonics (66-88)  v E&EYEchocardiography E01.145.569.314; E01.357.947.314 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnostic Imaging; Ultrasonography Echocardiography, Doppler (+ 2); Echocardiography, Transesophageal Echocardiography, Doppler (+ 2); Echocardiography, Transesophageal Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. Ultrasonics (66)  vD&&qEcho-Planar Imaging E01.357.578.250; E01.357.927.578.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Magnetic Resonance Imaging Diagnosis; Diagnostic Imaging; Tomography; Magnetic Resonance Imaging A type of MAGNETIC RESONANCE IMAGING that uses only one nuclear spin excitation per image and therefore can obtain images in a fraction of a second rather than the minutes required in traditional MRI techniques. It is used in a variety of medical and scientific applications. Magnetic Resonance Imaging (88-92); Nuclear Magnetic Resonance (84-87) vu*"FSEchinostomiasis C03.335.865.282 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections Infection by flukes of the genus Echinostoma. v-PA8Echinostomatidae (Non MeSH) B01.500.736.715.360 Invertebrates; Helminths; Platyhelminths; Trematoda Echinostoma AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI v?!=*Echinostoma B01.500.736.715.360.310 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Echinostomatidae (Non MeSH) A genus of intestinal flukes of the family Echinostomatidae which consists of many species. They occur in man and other vertebrates. The intermediate hosts are frequently mollusks. v*^Echinomycin D20.085.075.400; D20.085.116.225; D22.204.106.420 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Quinomycin A. A toxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis. It has antitumor and antibacterial activity. Antibiotics (68-75); Quinoxalines (72-75); Peptides, Cyclic (75) v9<NEchinodermata B01.408 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates Sea Cucumbers; Sea Urchins; Starfish A phylum of the most familiar marine invertebrates. Its class Stelleroidea contains two subclasses, the Asteroidea (the STARFISH or sea stars) and the Ophiuroidea (the brittle stars, also called basket stars and serpent stars). There are 1500 described species of STARFISH found throughout the world. The second class, Echinoidea, contains about 950 species of SEA URCHINS, heart urchins, and sand dollars. A third class, Holothuroidea, comprises about 900 echinoderms known as SEA CUCUMBERS. Echinoderms are used extensively in biological research. (From Barnes, Invertebrate Zoology, 5th ed). v (.Echinococcus B01.500.736.215.327 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda v*;Echinococcosis, Pulmonary C03.335.190.396.480; C03.582.314; C08.381.517.314; C08.730.450.314 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Cestode Infections; Echinococcosis Parasitic Diseases; Lung Diseases, Parasitic Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Parasitic Respiratory Tract Diseases; Respiratory Tract Infections; Lung Diseases, Parasitic Helminth infection of the lung caused by Echinococcus granulosus or Echinococcus multilocularis. vLP0pEchinococcosis, Hepatic C03.335.190.396.314; C03.518.314; C06.552.664.272 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Cestode Infections; Echinococcosis Parasitic Diseases; Liver Diseases, Parasitic Digestive System Diseases; Liver Diseases; Liver Diseases, Parasitic Helminth infection of the liver caused by Echinococcus granulosus or Echinococcus multilocularis. v9PqEchinococcosis C03.335.190.396 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Cestode Infections Echinococcosis, Hepatic; Echinococcosis, Pulmonary Infection caused by tapeworms of the genus Echinococcus. The larval stage is called hydatid or hydatid cyst and develops in almost all mammals, especially domestic and farm animals, and in man under certain epidemiological conditions. The liver, lungs, and kidney are particularly common sites of development and infestation. (Dorland, 27th ed; Stedman, 25th ed). ECHINOCOCCOSIS, HEPATIC and ECHINOCOCCOSIS, PULMONARY are also available. vP?:Echidna B02.649.627.300 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Monotremata An oviparous burrowing mammal of the order Monotremata native to Australia, Tasmania, and New Guinea. It has hair mingled with spines on the upper part of the body and is adapted for feeding on ants. v% ()Ecdysterone D04.808.247.222.265.180; D06.472.445.573.313 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestenones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Invertebrate Hormones; Insect Hormones 2 beta,3 beta,14,20,22R,25-Hexahydroxy-5 beta-cholest-7-en-6-one. An insect hormone which is active during the molting stage of the insect's development. Cholestanes (68-72); Ecdysone (66-74); Hormones (66); Insects (66); Invertebrate Hormones (67-74) v2BwEcdysone D04.808.247.222.265.150; D06.472.445.573.230 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestenones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Invertebrate Hormones; Insect Hormones v< 2BEccrine Glands A01.835.858.480; A10.336.899.480 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Body Regions (Non MeSH); Skin; Sweat Glands Tissue Types (Non MeSH); Exocrine Glands; Sweat Glands Simple sweat glands that secrete sweat directly onto the skin. v&:zLEcchymosis C23.542.202 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Purpura Symptoms and General Pathology (Non MeSH); Hemorrhage A small hemorrhagic spot, larger than a petechia, in the skin or mucous membrane forming a nonelevated, rounded or irregular, blue or purplish patch. (Dorland, 27th ed). vN AEbstein's Anomaly C14.240.400.395; C14.280.400.395; C16.131.240.400.395 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Congenital downward displacement of the tricuspid valve with the septal and posterior leaflets being attached to the wall of the right ventricle. v=LKEbola Virus B04.820.455.300.300.250; B04.909.777.455.300.300.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Mononegavirales; Filoviridae; Filovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Mononegavirales; Filoviridae; Filovirus A species of FILOVIRUS which causes a form of African viral hemorrhagic fever first reported from an outbreak in the Yambuku area of Zaire in 1976. Hemorrhagic Fevers, Viral (78-79); Rhabdoviridae (78-79); RNA Viruses (77-79) v\:]Eating Disorders C23.888.298; F03.126.298 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anorexia Nervosa; Obesity; Thinness Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Anorexia; Pica Anorexia Nervosa; Hyperphagia (+ 2); Pica A group of disorders characterized by physiological and psychological disturbances in appetite or food intake. They include anorexia, anorexia nervosa, bulimia, hyperphagia, pica, and rumination.  vN,GEating G10.261.396 DEGEIMPHPXRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) v_ cEarth (Planet) H01.091.800.700.200 Physical Sciences (Non MeSH); Astronomy; Solar System; Planets Moon Planet that is the third in order from the sun. It is one of the four inner or terrestrial planets of the SOLAR SYSTEM. Planets (91-94) v MEarly Intervention (Education) N02.421.143.130.320; N02.421.143.827.320; N02.421.726.320 CLECHILJMAMTOGSDSNSTTDUT Rehabilitation; Child, Exceptional; Disabled Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Child Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services Procedures and programs that facilitate the development or skill acquisition in infants and young children who have disabilities, who are at risk for developing disabilities, or who are gifted. It includes programs that are designed to prevent handicapping conditions in infants and young children and family-centered programs designed to affect the functioning of infants and children with special needs. (From Journal of Early Intervention, Editorial, 1989, vol. 13, no. 1, p. 3; A Discursive Dictionary of Health Care, prepared for the U.S. House of Representatives Committee on Interstate and Foreign Commerce, 1976). vX$A5sEarly Ambulation E02.831.280 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Rehabilitation Procedure characterized by a shorter period of hospitalization or recumbency or by more rapid mobilization than is normally practiced. specific heading/rehabilitation (66-75) v|"".Earache C09.218.350; C23.888.592.612.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pain in the ear. Ear (66-82); Ear Diseases (66-82); Pain (66-82) v &N=Ear, Middle A09.246.397 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Acoustic Impedance Tests; Tympanoplasty Sense Organs; Ear Ear Ossicles (+ 3); Eustachian Tube; Stapedius; Tensor Tympani; Tympanic Membrane v́:/dEar, External A09.246.272 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear Ear Canal; Ear Cartilages vͬ:!Ear Protective Devices E07.712.260 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Protective Devices Personal devices for protection of the ears from loud or high intensity noise, water, or cold. These include earmuffs and earplugs. vc3Ear Ossicles A09.246.397.247 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stapes Surgery Sense Organs; Ear; Ear, Middle Incus; Malleus; Stapes vϛ:(Ear Neoplasms C04.588.443.665.312; C09.218.334; C09.647.312 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Head and Neck Neoplasms; Otorhinolaryngologic Neoplasms Otorhinolaryngologic Diseases; Ear Diseases Otorhinolaryngologic Diseases; Otorhinolaryngologic Neoplasms Neoplasms of the internal, external, or middle ear. vy5X?Ear Diseases C09.218 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases Otorhinolaryngologic Diseases Cholesteatoma, Middle Ear; Ear Deformities, Acquired; Ear Neoplasms; Earache; Hearing Disorders (+ 13); Herpes Zoster Oticus; Labyrinth Diseases (+ 8); Otitis (+ 5); Otosclerosis; Retrocochlear Diseases (Non MeSH) (+ 6); Tympanic Membrane Perforation Diseases of the ear, general or unspecified. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $va N"",7ZEar Deformities, Acquired C09.218.271 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Distortion or disfigurement of the ear caused by disease or injury after birth. vL3`Ear Cartilages A02.165.207; A09.246.272.405 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage Sense Organs; Ear; Ear, External Cartilages of the auricle (pinna) and the external acoustic meatus. Cartilage (66-78); Ear, External (66-78) v+":PQ2Ear Canal A09.246.272.396 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cerumen Sense Organs; Ear; Ear, External vה8 *Ear A01.456.313; A09.246 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Head Sense Organs  Ear, External (+ 2); Ear, Middle (+ 8); Labyrinth (+ 26) consider also terms at OTI- and OTO-. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  vE(6K0<Dystrophin D12.776.210.500.250; D12.776.220.250; D12.776.543.250 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Mice, Inbred mdx Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa. Muscle Proteins (88-90)  v٦=H%Dystonia Musculorum Deformans C10.228.140.079.357 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases v[#NrDystonia C10.597.559.309; C23.888.592.574.309 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Muscle Tonus Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders An abnormal movement manifesting as maintenance of a posture by exaggerated muscle tone, the posture being an extreme degree of either flexion or extension. It often affects the large axial muscles of the trunk and limb girdles. Movement Disorders (66-78); Muscle Tonus (70-78)  vt *N;Dystocia C13.703.420.288 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Delivery Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Uterine Inertia Difficult childbirth or labor. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $v[ L ~&NDysprosium D01.268.558.125; D01.552.550.208 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Dysprosium. An element of the rare earth family that has the atomic symbol Dy, atomic number 66, and atomic weight 162.50. Dysprosium is a silvery metal used primarily in the form of various salts. v&:Dyspnea, Paroxysmal C08.618.326.396; C14.280.434.313; C23.888.852.371.396 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Dyspnea Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH); Dyspnea A form of respiratory distress related to posture (especially reclining at night) and usually attributed to congestive heart failure with pulmonary edema. It appears suddenly at night, usually wakening the patient after an hour or two of sleep. It is also called paroxysmal nocturnal dyspnea. (From Dorland, 27th ed; Stedman, 25th ed). v=N'Dyspnea C08.618.326; C23.888.852.371 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiration Respiratory Tract Diseases; Respiration Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Dyspnea, Paroxysmal Dyspnea, Paroxysmal Difficult or labored breathing.  v "N.'Dysplastic Nevus Syndrome C04.557.665.560.260; C04.700.305; C16.466.700.305 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Nevi and Melanomas (Non MeSH); Nevus Neoplasms; Neoplastic Syndromes, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed). Melanoma (66-86); Nevus (66-86); Nevus, Pigmented (66-86) v\9NGDyspepsia C23.888.821.236 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) Impairment of the power or function of digestion. It is usually applied to epigastric discomfort following meals. (Dorland, 27th ed). v3 NDyspareunia C13.371.665.313; C13.371.894.217; F03.126.286; F03.709.597.608.780.410 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Sex Disorders Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Psychosexual Disorders; Psychosexual Dysfunctions Painful sexual intercourse. vPF"Dysostoses C05.116.099.370 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Craniofacial Dysostosis (+ 4); Focal Dermal Hypoplasia; Klippel-Feil Syndrome; Orofaciodigital Syndromes; Rubinstein-Taybi Syndrome; Synostosis (+ 5) Defective bone formation involving individual bones, singly or in combination. Bone Diseases (66-69); Bone Diseases, Developmental (70-84)  vNQ\GDysmenorrhea C13.371.491.346 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Menstruation Disorders Painful menstruation. vNDyslexia, Acquired C10.597.257.543.307.311; C23.888.592.257.543.307.311; F03.126.219.543.307.311 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Reading Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders; Dyslexia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders; Dyslexia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders; Dyslexia Loss of previously possessed reading facility, visual aphasia, or word blindness due to a brain lesion. v,UF {Dyslexia C10.597.257.543.307; C23.888.592.257.543.307; F03.126.219.543.307 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Learning Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders Dyslexia, Acquired Dyslexia, Acquired Dyslexia, Acquired Impairment of the ability to learn to read, or to understand what one reads silently or aloud, independently of any speech defect.  vP IFADyskinesia, Drug-Induced C10.228.140.079.333; C21.613.276.521 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Akathisia, Drug-Induced Akathisia, Drug-Induced Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Drug Toxicity (Non MeSH) Abnormal movements induced as an adverse reaction of drug therapy. One particular movement disorder is the "on-off" effect. Tardive dyskinesia differs from AKATHISIA, DRUG-INDUCED in the repetitive nature of the movements rather than being associated with anxiety, restlessness, and agitation found in akathisia. Movement Disorders (66-76) $v*Li Dysgeusia C10.597.751.861.479; C23.888.592.763.861.479 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Taste Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Taste Disorders Distortion of the sense of taste. (Dorland, 27th ed). w 2NDDysgerminoma C04.557.465.330.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Germinoma Gonadoblastoma A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). wXuDysgammaglobulinemia C15.378.147.333; C20.673.430 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders Immunologic Diseases; Immunologic Deficiency Syndromes IgA Deficiency; IgG Deficiency IgA Deficiency; IgG Deficiency An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins. Immunologic Deficiency Syndromes (68-74); Immunity (66-70)  w "NJEDysentery, Bacillary C01.252.400.310.229; C06.405.469.237.479.479 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Shigella Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Enterobacteriaceae Infections Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Diarrhea; Dysentery An infectious disease caused by bacteria of the genus SHIGELLA. This condition is characterized by intestinal pain and diarrhea. w 2P Dysentery, Amebic C03.432.396; C03.752.700.700.055.407.310; C06.405.469.237.479.312; C06.405.469.452.396 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Intestinal Diseases, Parasitic Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Sarcodina Infections; Amebiasis; Entamoebiasis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Diarrhea; Dysentery Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic Dysentery resulting from ulcerative inflammation of the bowel, caused chiefly by infection with ENTAMOEBA HISTOLYTICA. This condition may be associated with amebic infection of the liver and other distant sites. w `PDysentery C06.405.469.237.479 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Diarrhea Dysentery, Amebic; Dysentery, Bacillary Any of various disorders marked by inflammation of the intestines, especially of the colon, and attended by pain in the abdomen, tenesmus, and frequent stools containing blood and mucus. Causes include chemical irritants, bacteria, protozoa, or parasitic worms. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  ws Na/IPDysautonomia, Familial C10.500.690.309; C10.772.150.200; C10.772.600.309; C16.131.666.690.309 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Sensory and Autonomic Nervous System Diseases; Peripheral Nervous System Diseases; Autonomic Nervous System Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Sensory and Autonomic Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Sensory and Autonomic An autosomal recessive inherited disorder seen predominantly in Jewish infants and children. The peripheral autonomic and sensory neurons are affected. The characteristic distinguishing this disorder from other hereditary sensory and autonomic neuropathies is the predominance of autonomic symptoms such as excessive perspiration, defective lacrimation, and hypertension. Insensitivity to pain and areflexia are also present. w9PLDysarthria C10.597.257.870.309; C23.888.592.257.870.309; F03.126.219.870.309 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders Impairment of motor control of speech due to faulty innervation of speech musculature or imperfect coordination of the musculature in complex acts. Speech Disorders (66-78) wIFDyphylline D03.438.759.758.824.751.250; D08.373.735.800.200; D16.050.110.872.200; D18.918.882.299 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines; Theophylline Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors; Theophylline Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents; Theophylline Cardiovascular Agents; Vasodilator Agents; Theophylline 7-(2,3-Dihydroxypropyl)-1,3-dimethylxanthine. A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. Theophylline (66-74) /analogs and derivatives (75-79) w9`:>Dynorphins D12.644.468.180; D12.776.641.650.575.180; D14.600.600.577.180 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Opioid, kappa Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters. Endorphins (Jul 77-84); Peptides (66-Jul 77)  wEDT7Dynein ATPase D08.586.277.040.025.150; D12.776.220.600.200; D12.776.275 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microtubule Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins A structural protein which forms the arms on the microtubule doublets of cilia and flagella. In the presence of divalent cations, dynein catalyzes the hydrolysis of ATP. This hydrolysis plays an important functional role in the motility process. EC 3.6.1.33. Adenosine Triphosphatase (66-76); Proteins (66-76) w!SAFD1<Dyfonate D02.719.318; D05.723.491.657.346 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate w$ &:Dyes D26.408 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Food Coloring Agents; Stains and Staining Miscellaneous Drugs and Agents (Non MeSH) Acridine Orange; Alcian Blue; Amaranth; Amido Black; p-Aminoazobenzene; o-Aminoazotoluene; Arsenazo III; Azure Stains; Benzophenoneidum; Carmine; Clofazimine; Congo Red; Curcumin; p-Dimethylaminoazobenzene; Evans Blue; Fluorescent Dyes (+ 17); Hair Dyes; Hematoxylin; Indigo Carmine; Indocyanine Green; Lissamine Green Dyes; Methylene Blue; Neutral Red; Phthalein Dyes (+ 4); Pyronine; Rosaniline Dyes (+ 2); Ruthenium Red; Tartrazine; Tolonium Chloride; Trypan Blue AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  w& ,32-<Dye Dilution Technique E01.145.643.312 AECLCTECHIISMONUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Indicator Dilution Techniques w)H \Dydrogesterone D04.808.745.432.296; D06.597.799.276 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic (9 beta,10 alpha)-Pregna-4,6-diene-3,20-dione. A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit ovulation. w**:!Dwarfism, Pituitary C05.116.099.343.445; C05.116.132.358; C19.297.312; C19.700.482.311 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dwarfism Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Endocrine (Non MeSH) Endocrine Diseases; Dwarfism Endocrine Diseases; Pituitary Diseases; Hypopituitarism A form of dwarfism due to absence or hypofunction of the anterior pituitary gland. w,LNdDwarfism C05.116.099.343; C19.297 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Growth Disorders Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Endocrine Diseases Achondroplasia; Cockayne Syndrome; Cretinism; Dwarfism, Pituitary; Progeria; Thanatophoric Dysplasia Cockayne Syndrome; Dwarfism, Pituitary; Thanatophoric Dysplasia The condition of being undersized as a result of premature arrest of skeletal growth. It may be caused by insufficient secretion of growth hormone.  w. NfDuty to Warn F04.096.544.335.240.270; I01.880.604.583.080.270; I01.880.604.583.427.270; N03.706.535.230.270; N03.706.535.489.270 LJPX Ethics Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry; Forensic Psychiatry; Confidentiality Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Confidentiality Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Informed Consent Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Confidentiality Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Informed Consent The legal, moral, or ethical responsibility of a health professional to warn an intended victim of specific threats of harm or to warn a person of potential risk for acquiring a disease as the result of a relationship to a patient. Confidentiality (76-91)  w1^ 3Dust G03.850.460.100.210 AEANPC Pneumoconiosis Allergens Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution w5  rDursban D02.719.296; D05.723.491.657.320 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-70) w6p &:Durapatite D01.146.360.050.300.200; D01.578.122.477.300; D01.695.625.675.650.075.025.300.150; D25.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds; Calcium Phosphates; Apatites; Hydroxyapatites Inorganic Chemicals (Non MeSH); Minerals; Apatites; Hydroxyapatites Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Calcium Phosphates; Apatites; Hydroxyapatites Biomedical and Dental Materials (Non MeSH) Hydroxylapatite. The mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis. Hydroxyapatites (81-93) w7d8Durable Medical Equipment E07.278 CLECHISDSNSTTDUTVE Equipment and Supplies Devices which are very resistant to wear and may be used over a long period of time. They include items such as wheelchairs, hospital beds, artificial limbs, etc. w;3 Dura Mater A08.186.566.395 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Meninges Subdural Space w &DHDuffy Blood-Group System D24.611.216.705.230.301; G04.610.241.301; G09.188.229.301 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups A blood group consisting mainly of the antigens Fy(a) and Fy(b), determined by allelic genes, the frequency of which varies profoundly in different races; amorphic genes are common. Blood Groups (66-75) wV\A2PDuctus Arteriosus, Patent C14.240.400.340; C14.280.400.340; C16.131.240.400.340 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Persistent Fetal Circulation Syndrome Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Abnormal persistence of an open lumen in the ductus arteriosus after birth, the direction of flow being from the aorta to the pulmonary artery, resulting in recirculation of arterial blood through the lungs. (Dorland, 27th ed). wYW=L,K Ductus Arteriosus A07.541.278.395; A16.378.303.395 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Fetal Heart Embryonic Structures (Non MeSH); Fetus; Fetal Heart A fetal blood vessel connecting the pulmonary artery with the descending aorta. w\&8q_Ducks B02.248.617.345 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Poultry Birds (66-67); Poultry (66-67) w^ &#'Duane's Syndrome C10.597.622.447.666; C10.772.204.410.472.300; C11.590.472.300; C23.888.592.636.447.666 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis; Ophthalmoplegia Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders; Ophthalmoplegia Eye Diseases; Ocular Motility Disorders; Ophthalmoplegia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Ophthalmoplegia A hereditary congenital syndrome in which the affected eye shows limitation or absence of abduction, restriction of adduction, retraction of the globe on adduction, narrowing of the palpebral fissure on adduction and widening on adduction, and deficient convergence. It is transmitted as an autosomal trait. (Dorland, 27th ed). w^`N~DTPA D02.092.782.275; D02.241.081.038.420; D26.241.429 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Polyamines Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Technetium Tc 99m Pentetate Technetium Tc 99m Pentetate Technetium Tc 99m Pentetate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR wb9.b:Dry Socket C07.465.227 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tooth Extraction Stomatognathic Diseases; Mouth Diseases A condition sometimes occurring after tooth extraction, particularly after traumatic extraction, resulting in a dry appearance of the exposed bone in the socket, due to disintegration or loss of the blood clot. It is basically a focal osteomyelitis without suppuration and is accompanied by severe pain (alveolalgia) and foul odor. It is also called alveolar osteitis and alveolitis sicca dolorosa. (Dorland, 27th ed). weN/Dry Ice D01.200.200.250; D01.650.550.200.250 AETU Ice Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH); Carbon Dioxide Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Carbon Dioxide A solid form of carbon dioxide used as a refrigerant. wg *CDry Eye Syndromes C11.496.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Lacrimal Apparatus Diseases Keratoconjunctivitis Sicca; Sjogren's Syndrome; Xerophthalmia Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur. wi?N2GxDrugs, Non-Prescription D26.394.393 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs Drugs (66-72) wk,<Drugs, Investigational D26.394.371 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Clinical Trials; Drug Evaluation; Investigational New Drug Application Drug Approval Miscellaneous Drugs and Agents (Non MeSH); Drugs Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries. Clinical Trials (66-89); Drug Evaluation (74-89); Drugs (66-89) $wl,S<RNDrugs, Generic D26.394.360 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies. Drugs (66-91) woY,<{Drugs, Chinese Herbal D24.310.674.350; D26.394.350; D26.714.350 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Medicine, Chinese Traditional; Medicine, Herbal Immunologic and Biologic Factors (Non MeSH); Biological Products; Plant Extracts Miscellaneous Drugs and Agents (Non MeSH); Drugs Miscellaneous Drugs and Agents (Non MeSH); Plant Extracts Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Medicine, Chinese Traditional (75-87); Medicine, Oriental Traditional (67-74); Plant Extracts (67-87); Plants, Medicinal (66-87)  wp1,8Drugs D26.394 ADAEANCHCLCSCTDUECHIIPMERESDSTTO Plants, Medicinal; Receptors, Drug Pharmacology Miscellaneous Drugs and Agents (Non MeSH) Designer Drugs; Dosage Forms (+ 36); Drug Combinations; Drug Residues; Drugs, Chinese Herbal; Drugs, Generic; Drugs, Investigational; Drugs, Non-Prescription; Materia Medica; Nostrums; Placebos; Prodrugs; Street Drugs (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPLJMEPDPKPORESDSTTOTUUR $ws  $*2 <Drug Utilization Review N04.452.706.477.400; N04.761.879.300; N05.700.900.300 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Organization and Administration; Pharmacy Administration; Drug Utilization Health Services Administration (Non MeSH); Quality of Health Care; Utilization Review Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Utilization Review Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993. Drug Utilization (67-93); Utilization Review (72-93) wu=U?Drug Utilization N04.452.706.477 CLECHILJSNSTTD Health Services Administration (Non MeSH); Organization and Administration; Pharmacy Administration Drug Utilization Review The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles. specific drug (66-72); specific drug class (66-72) CLECHILJMTOGSNSTTDUT $wys>Drug Toxicity (Non MeSH) C21.613.276 Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Akathisia, Drug-Induced; Drug Eruptions (+ 3); Dyskinesia, Drug-Induced; Neuroleptic Malignant Syndrome BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI w| EyNDrug Tolerance G12.454 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH) Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein a human, animal, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. w}h  4_Drug Therapy, Computer-Assisted E02.319.335; L01.700.508.100.710.180 CLECEDHIISLJMAMTOGSNSTTD Therapeutics; Drug Therapy Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted; Therapy, Computer-Assisted Adjunctive computer programs in providing drug treatment to patients. wH%*RDrug Therapy, Combination E02.319.310 Antibiotics, Combined; Antineoplastic Agents, Combined Therapeutics; Drug Therapy Drug therapy with two or more drugs given separately for a combined effect. w?!\Drug Therapy E02.319 AECLCTECHIISMOMTNUPXSNSTTDUTVE Medication Errors Therapeutics Chelation Therapy; Chemotherapy, Adjuvant; Drug Delivery Systems (+ 1); Drug Therapy, Combination; Drug Therapy, Computer-Assisted; Estrogen Replacement Therapy; Fluid Therapy; Home Infusion Therapy; Medication Errors; Orthomolecular Therapy; Photochemotherapy; Pleurodesis; Premedication; Prescriptions, Drug; Sclerotherapy; Self Administration; Self Medication; Thrombolytic Therapy AECLCTECEDHIISLJMAMIMOMTNUOGPSPXSDSNSTTDUTVEVI  w "2Drug Synergism G12.361.477 Cocarcinogenesis; Pesticide Synergists Chemical, Pharmacologic Phenomena (Non MeSH); Drug Interactions wn-KDrug Storage E05.916.350 ECMTSNST Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical Drugs (66-67); Pharmacy Service, Hospital (66-67) w' J<Drug Stability E05.916.330 Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical wJDrug Screening Assays, Antitumor E05.337.300.250.200; E05.909.262.388 AECLCTECHIISMOMTNUPXSNSTTDUTVE Tumor Cells, Cultured Miscellaneous Techniques (Non MeSH); Evaluation Studies; Drug Approval; Drug Screening Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Subrenal Capsule Assay; Tumor Stem Cell Assay Subrenal Capsule Assay; Tumor Stem Cell Assay Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Antineoplastic Agents or specific (66-87); Cell Line (71-87); Colony-Forming Units Assay (79-87); Drug Screening (74-87); Neoplasms, Experimental or specific (66-87); Tumor Stem Cell Assay (84-87) $w'*"n&Drug Screening E05.337.300.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Toxicity Tests Miscellaneous Techniques (Non MeSH); Evaluation Studies; Drug Approval Drug Screening Assays, Antitumor (+ 2) Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications.  w"T/Drug Resistance, Multiple G12.392.300 GEIMPHRE Tuberculosis, Multidrug-Resistant P-Glycoprotein Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance Simultaneous resistance to a broad spectrum of structurally and functionally distinct drugs following exposure to a single agent. It is thought to result from the overexpression of genes encoding an integral plasma membrane protein, P-GLYCOPROTEIN. Drug Resistance (81-94); Drug Resistance, Microbial (66-94) $w. &I GDrug Resistance, Microbial G04.185.515.286; G05.386.310; G05.706.310; G12.392.269 GEIMPHRE Microbial Sensitivity Tests; R Factors; Superinfection; Tuberculosis, Multidrug-Resistant Microbial Sensitivity Tests Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) Genetics; Genetics, Microbial Genetics; Pharmacogenetics Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance beta-Lactam Resistance (+ 4); Chloramphenicol Resistance; Kanamycin Resistance; Tetracycline Resistance; Trimethoprim Resistance beta-Lactam Resistance (+ 4); Chloramphenicol Resistance; Kanamycin Resistance; Tetracycline Resistance; Trimethoprim Resistance beta-Lactam Resistance (+ 4); Chloramphenicol Resistance; Kanamycin Resistance; Tetracycline Resistance; Trimethoprim Resistance beta-Lactam Resistance (+ 4); Chloramphenicol Resistance; Kanamycin Resistance; Tetracycline Resistance; Trimethoprim Resistance The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through plasmids containing resistance factors (R FACTORS). $w @ g!JDrug Resistance G12.392 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH) Drug Resistance, Microbial (+ 9); Drug Resistance, Multiple; Insecticide Resistance; Insulin Resistance Diminished or failed response of a human, animal, disease, or tissue to the intended effectiveness of a chemical or drug. It does not include the resistance of micro-organisms to drugs for which DRUG RESISTANCE, MICROBIAL is available. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. w  4zDrug Residues D26.394.330; G03.850.460.200.250 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Pesticide Residues Body Burden Miscellaneous Drugs and Agents (Non MeSH); Drugs Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Body Burden Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment. Drugs (66-87) $w&(Drug Packaging E05.916.320; J01.576.318.321 CLECHIISLJMAMTSNSTTD Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical Technology, Industry, Agriculture (Non MeSH); Industry; Drug Industry Drug Industry (66-67); Pharmacy (66-67) w"1Drug Monitoring E01.621.260 AECLCTECHIISMOMTNUPXSNSTTDUTVE Adverse Drug Reaction Reporting Systems Diagnosis; Monitoring, Physiologic The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. w"/)Drug Labeling E05.780.310; E05.916.310; J01.576.318.311; J01.790.310 CLECHIISLJMAMTSNSTTD Miscellaneous Techniques (Non MeSH); Product Labeling Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical Technology, Industry, Agriculture (Non MeSH); Industry; Drug Industry Technology, Industry, Agriculture (Non MeSH); Product Labeling Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information. Drug Industry (66-67); Drug Therapy (66-67); Medication Errors (66-67) w;@![VDrug Interactions G12.361 GEIMPHRE Chemical, Pharmacologic Phenomena (Non MeSH) Drug Antagonism; Drug Synergism; Food-Drug Interactions The action of one drug on the metabolism, effectiveness or toxicity of another. (Dorland, 27th ed). Drug Antagonism (66-71); Drug Synergism (66-71)  w  4By:Drug Information Services L01.453.270; N02.421.668.320 CLECHIISLJMAOGSDSNSTTDUT Information Science; Information Services Facilities, Manpower and Services (Non MeSH); Health Services; Pharmaceutical Services Adverse Drug Reaction Reporting Systems; Clinical Pharmacy Information Systems Adverse Drug Reaction Reporting Systems; Clinical Pharmacy Information Systems Services providing pharmaceutic and therapeutic drug information and consultation. Drug Therapy (66-76); Drugs (66-76); Information Services (66-76)  w"_PDrug Industry J01.576.318 CLECEDHIISLJMAMTOGSNSTTD Technology, Pharmaceutical Technology, Industry, Agriculture (Non MeSH); Industry Drug Labeling; Drug Packaging; Orphan Drug Production That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.  wAADrug Incompatibility E05.916.290 Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed). wJDrug Implants D26.394.225.276.315 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Delayed-Action Preparations Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Delayed-Action Preparations (66-74) w,m)Drug Hypersensitivity C20.543.206 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases; Hypersensitivity Drug Eruptions (+ 3) Immunologically mediated adverse reactions to medicinal substances used legally or illegally. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  wUL-lNDrug Evaluation E05.337.300.200 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Clinical Trials Drugs, Investigational Miscellaneous Techniques (Non MeSH); Evaluation Studies; Drug Approval Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.  w$T Drug Eruptions C17.800.174.600; C20.543.206.380; C21.613.276.505 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Immunologic Diseases; Hypersensitivity; Drug Hypersensitivity Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Drug Toxicity (Non MeSH) Epidermal Necrolysis, Toxic; Erythema Nodosum; Serum Sickness Epidermal Necrolysis, Toxic; Erythema Nodosum; Serum Sickness Epidermal Necrolysis, Toxic; Erythema Nodosum; Serum Sickness Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  w9LNDrug Design G12.350; H01.181.466.350 Designer Drugs Chemical, Pharmacologic Phenomena (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Pharmaceutical The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis. Chemistry, Pharmaceutical (66-88); Drugs (66-88) w :Drug Delivery Systems E02.319.300 AECLCTECHIISMOMTNUPXSNSTTDUTVE Drug Administration Routes; Drug Carriers Therapeutics; Drug Therapy Insulin Infusion Systems Systems of administering drugs through controlled delivery so that an optimum amount reaches the target site. Drug delivery systems encompass the carrier, route, and target. AECLCTECHIISMIMOMTNUPSPXSDSNSTTDUTVEVI $w"2!*Drug Costs N03.219.151.400.350; N05.300.375.300 CLHILJSNSTTD Economics, Pharmaceutical Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Health Care Costs Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Care Costs The amount that a health care institution or organization pays for its drugs. It is one component of the final price that is charged to the consumer (FEES, PHARMACEUTICAL or PRESCRIPTION FEES). Cost Control (79-91); Costs and Cost Analysis (66-91); Fees, Pharmaceutical (68-77)  w*eDrug Contamination G03.850.360 ECLJPCSN Environment and Public Health (Non MeSH); Public Health w DDrug Compounding E05.916.270 AECLCTECHIISMOMTNUPXSNSTTDUTVE Biopharmaceutics; Chemistry, Pharmaceutical Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical w"2JDrug Combinations D26.394.310 Miscellaneous Drugs and Agents (Non MeSH); Drugs Dosage Forms (66-70) w<Drug Carriers D26.394.225.300 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Drug Delivery Systems Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Substances that facilitate time-controlled delivery, organ-specific targeting, protection, prolonged in vivo function, and decrease of toxicity of drugs. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Delayed-Action Preparations (66-87); Drugs (66-87)  w,M<Drug Approval E05.337.300; I01.880.604.605.250.250 ECHILJMAMTOGSN Drugs, Investigational Clinical Trials Miscellaneous Techniques (Non MeSH); Evaluation Studies Social Sciences; Sociology; Social Control, Formal; Legislation, Drug; Drug and Narcotic Control Drug Evaluation; Drug Screening (+ 3); Investigational New Drug Application Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug. AECLCTECHIISLJMAMOMTNUOGPXSNSTTDUTVE (w7*\I(Drug Antagonism G12.361.310 Narcotic Antagonists Chemical, Pharmacologic Phenomena (Non MeSH); Drug Interactions wgKDrug and Narcotic Control I01.880.604.605.250; N03.706.615.402.250; N04.452.706.310 ECHILJMAMTOGSNTD Substance Abuse Social Sciences; Sociology; Social Control, Formal; Legislation, Drug Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation; Legislation, Drug Health Services Administration (Non MeSH); Organization and Administration; Pharmacy Administration Drug Approval Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.  w  A8Drug Administration Schedule E05.309 VE Miscellaneous Techniques (Non MeSH) Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. specific drug/administration and dosage (66-74) w$" *x8Drug Administration Routes E05.300 VE Dosage Forms Drug Delivery Systems; Dosage Forms Miscellaneous Techniques (Non MeSH) Administration, Inhalation; Administration, Intranasal; Administration, Oral (+ 2); Administration, Rectal; Administration, Topical (+ 6); Infusions, Parenteral (+ 3); Injections (+ 15); Instillation, Drug; Iontophoresis; Perfusion, Regional; Phonophoresis The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue. AECLCTECHIISMOMTNUPXRHSNSTTDUTVE (wX  ,*,$Drowning C21.866.304; C23.240.393; G03.850.110.500 BLCFCLDIECENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Near Drowning; Resuscitation Immersion Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Symptoms and General Pathology (Non MeSH); Death Environment and Public Health (Non MeSH); Public Health; Accidents Near Drowning Near Drowning BLCFCLCODIECENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $wJ 1@# #BDrosophilidae B01.131.617.289.310 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera Drosophila (+ 1) A family of the order DIPTERA. These flies are generally found around decaying vegetation and fruit. Several species, because of their short life span, giant salivary gland chromosomes, and ease of culturing, have been used extensively in studies of heredity. we(51Drosophila melanogaster B01.131.617.289.310.250.500 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Drosophilidae; Drosophila A species of fruit fly much used in genetics because of the large size of its chromosomes. Drosophila (66-71) wX(ToDrosophila B01.131.617.289.310.250 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Glue Proteins, Drosophila Invertebrates; Arthropods; Insects; Diptera; Drosophilidae Drosophila melanogaster A genus of small, two-winged flies containing approximately 900 described species. These organisms are the most extensively studied of all genera from the standpoint of genetics and cytology.  wͼ(FDroperidol D02.522.352.343; D03.438.103.393; D14.100.150.175.160; D15.045.212; D15.095.200; D15.150.015.200; D15.210.950.040.015.200; D15.700.872.331.015.343 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butyrophenones Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a state of neuroleptanalgesia in which he is calm and indifferent to his surroundings and able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitated patients in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p.593). wϙ::&Drive F01.658.293 Instinct; Motivation Behavior and Behavior Mechanisms (Non MeSH); Motivation Hunger; Thirst A state of internal activity of an organism that is a necessary condition before a given stimulus will elicit a class of responses; e.g., a certain level of hunger (drive) must be present before food will elicit an eating response. CLDEPHRE  w C Drinking Behavior F01.145.317 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Alcohol Drinking Behaviors associated with the ingesting of water and other liquids; includes rhythmic patterns of drinking (time intervals - onset and duration), frequency and satiety. Behavior (66-68); Thirst (66-68) AEBLCFCLDEDTECEHEPGEHIIMLJMEMOPAPCPHPPPXRETDTHUR $w A)4Drinking G10.261.350 DEGEIMPHRE Alcohol Drinking Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) wٴ cDreams F02.463.188.634.309; F02.830.855.268 CLDEPHPXRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Cognition; Imagination Psychologic Processes and Principles (Non MeSH); Psychophysiology; Sleep A series of thoughts, images, or emotions occurring during sleep which are dissociated from the usual stream of consciousness of the waking state. wx *Drama K01.517.333 HI Humanities; Literature wH Drainage, Sanitary G03.850.780.200.800.800.350 CLECHILJMTSNST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Sanitation; Sanitary Engineering A system of artificial or natural drains, generally used for the disposal of liquid wastes. Sanitary Engineering (66-74) wܡn"Drainage, Postural E02.306.500; E02.780.221; E02.831.578.195; E02.880.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Mucus; Sputum Therapeutics; Drainage Therapeutics; Physical Therapy Therapeutics; Rehabilitation; Physical Therapy Therapeutics; Respiratory Therapy Therapeutic drainage in bronchopulmonary diseases in which there is copious mucus secretion, such as chronic bronchitis, bronchiectasis, pulmonary abscess, or cystic fibrosis. The patient is placed with head downward, so that the trachea is inclined downward and below the affected area. It may be done in 15- to 20-minute sessions or by having the patient sleep in a head-down position. The therapy may be used in conjunction with forced expiration, bronchodilator agents, or expectorants. Drainage (66-89); Posture (66-89)  wW@";*Drainage E02.306; E04.237 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Surgery, Operative Drainage, Postural Suction AECLCTECHIISMOMTNUPXRHSNSTTDUTVE w  "% $Dracunculus B01.500.294.700.750.225.250.250 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Camallanina; Dracunculoidea A genus of nematode parasites which inhabit the body cavity, serous membranes, and connective tissues of vertebrates. The species parasitic in man is Dracunculus medinensis. w#*gDracunculoidea B01.500.294.700.750.225.250 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Camallanina Dracunculus A superfamily of nematodes of the suborder CAMALLANINA. Its organisms possess a poorly developed buccal cavity and a rudimentary esophagus and intestine. w*UDracunculiasis C03.335.508.700.750.299 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections Infection with nematodes of the genus DRACUNCULUS. One or more worms may be seen at a time, with the legs and feet being the most commonly infected areas. Symptoms include pruritus, nausea, vomiting, diarrhea, or asthmatic attacks. w,PtDoxylamine D03.383.725.259; D14.100.375.425.400.200; D15.095.192; D15.153.220; D15.210.350.800.175; D15.325.875.175; D16.050.030.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics Histamine H1 antagonist with pronounced sedative properties. It is used in allergies and as an antitussive, antiemetic, and hypnotic. Doxylamine has also been administered in veterinary applications and was formerly used in parkinsonism. Antiparkinson Agents (72); Pyridines (72) wR:3Doxycycline D20.085.868.293 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5 alpha,5a alpha,6 alpha,12a alpha)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide. A synthetic tetracycline derivative with a range of antimicrobial activity and mode of action similar to that of tetracycline, but more effective against many species. Animal studies suggest that it may cause less tooth staining than other tetracyclines. Oxytetracycline (66-70) wA::Doxorubicin D20.085.075.105.200.210; D22.204.106.125.200.210 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin Epirubicin Epirubicin (8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione. Antineoplastic antibiotic obtained from Streptomyces peucetics. It is a hydroxy derivative of daunorubicin and is used in treatment of both leukemia and solid tumors. Antibiotics, Antineoplastic (67-72)  w6<i)Doxepin D03.494.382.393; D14.100.050.600.050.200; D14.100.600.050.200; D15.075.200; D15.085.050.215; D15.210.950.012.200; D15.700.122.055.322; D15.700.872.015.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzoxepins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents A tricyclic antidepressant that has been used in the treatment of depression and anxiety disorders. wp :vDoxazosin D03.438.786.750.200; D10.162.202.340; D14.100.050.200.100.220; D16.050.850.200; D18.162.730.200; D18.918.244 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinazolines; Prazosin Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents; Prazosin Cardiovascular Agents; Vasodilator Agents A selective alpha-1-adrenergic blocker that lowers serum cholesterol. It is also effective in the treatment of hypertension. Prazosin/analogs and derivatives (80-92) w z:M0Doxapram D03.383.773.812.226; D15.220.308 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones Central Nervous System Agents; Central Nervous System Stimulants A central and respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225). w &:Down-Regulation (Physiology) G05.331.370.380.245; G06.184.320; G12.307 DEGEIMPHRE Up-Regulation (Physiology) Up-Regulation (Physiology) Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Chemical, Pharmacologic Phenomena (Non MeSH) Process that decreases ligand/receptor interactions due to a reduction in the number of available receptors. This can result from internalization of the ligand/receptor complex or from decreased expression of the receptor. Classically the concept referred to hormone receptors but contemporary usage includes other cell surface receptors.  w!1Down Syndrome C10.496.250; C16.131.077.327; C16.131.280.250; F03.709.346.200 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Amyloid beta-Protein; Amyloid beta-Protein Precursor Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A chromosome disorder characterized by a small, anteroposteriorly flattened skull, short, flat-bridge nose, epicanthal fold, short phalanges, widened spaces between the first and second digits of hands and feet, and moderate to severe mental retardation, with ALZHEIMER'S DISEASE developing in the fourth or fifth decade. The chromosomal abnormality is trisomy of chromosome 21 associated with late maternal age. Down syndrome is also called trisomy 21 and nondisjunction. This disease was formerly called mongolism. (Dorland, 27th ed). xHL=YmDourine C03.701.688.367; C03.752.625.367; C03.752.700.500.935.226; C22.674.710.367 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Trypanosomiasis Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) A disease of horses and donkeys caused by Trypanosoma equiperdum. The disease occurs in Africa, the Americas, and Asia. x TJDouglas' Pouch A01.047.596.225 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Culdoscopy Body Regions (Non MeSH); Abdomen; Peritoneum A sac or recess formed by a fold of the peritoneum. x (8BDouble-Blind Method E05.318.780.300; G03.850.520.840.300; H01.770.644.728.300; N05.715.360.780.320 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Physical Sciences (Non MeSH); Science; Research; Research Design Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. x XDouble Outlet Right Ventricle C14.240.400.915.300; C14.280.400.915.300; C16.131.240.400.915.300 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Transposition of Great Vessels Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Transposition of Great Vessels Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Transposition of Great Vessels Incomplete transposition of the great vessels in which both the aorta and the pulmonary artery arise from the right ventricle, often associated with a subaortic ventricular septal defect. Transposition of Great Vessels (66-86) x $IL.Double Bind Theory F02.739.308 Psychologic Processes and Principles (Non MeSH); Psychological Theory Contradictions in verbal and behavioral communication between parent and child (patient) which entrap the child because he is unable to comment on the incongruity or to escape from the situation. Psychological Theory (66-71) xtR"Dothiepin D03.494.311.250; D14.100.050.600.050.190; D14.100.600.050.190; D15.085.050.207; D15.700.122.055.319 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzothiepins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic 3-Dibenzo(b,e)thiepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine. A tricyclic antidepressant with some tranquilizing action. Dibenzothiepins (68-74) x o:Dose-Response Relationship, Radiation G03.850.810.250.180; H01.671.768.765.488.392 Radiation Dosage; Radiotherapy Dosage Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Dosage Physical Sciences (Non MeSH); Physics; Radiation; Radiometry; Radiation Dosage The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Radiation Dosage (72); Radiotherapy Dosage (66-72) xF+2-=Dose-Response Relationship, Immunologic G04.610.300 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. x-QDose-Response Relationship, Drug G12.297 Chemical, Pharmacologic Phenomena (Non MeSH) The relationship between the dose of an administered drug and the response of the organism to the drug. x& 4}Dosage Forms D26.394.225; E05.916.250 ST Drug Administration Routes Drug Administration Routes Miscellaneous Drugs and Agents (Non MeSH); Drugs Miscellaneous Techniques (Non MeSH); Technology, Pharmaceutical Capsules; Colloids (+ 6); Delayed-Action Preparations (+ 2); Drug Carriers; Liniments; Ointments; Powders (+ 2); Solutions (+ 14); Suppositories; Tablets (+ 1); Vaginal Creams, Foams and Jellies AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $x  .Dosage Compensation (Genetics) G05.331.370.380.235; G05.735.235 Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation Genetics; Phenotype A genetic regulatory mechanism which operates to equalize the phenotypic expression of characteristics determined by genes on the X chromosome so that they are equally expressed in the XY male and the XX female. Sex Chromosomes (68-81); X Chromosome (78-81) x0$&q8Dorsomedial Hypothalamic Nucleus A08.186.211.730.385.357.352.270 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Middle An aggregation of cells in the middle hypothalamus dorsal to the ventromedial nucleus and bordering the third ventricle. Hypothalamus (66-82) x ?&#6Doppler Effect H01.671.150 Physical Sciences (Non MeSH); Physics Changes in the observed frequency of waves (as sound, light, or radio waves) due to the relative motion of source and observer. The effect was named for the 19th century Austrian physicist Johann Christian Doppler. x"/Doping in Sports I01.880.735.265 CLECEHHILJMTPCPXSNTD Sports Social Sciences; Sociology; Social Problems Illegitimate use of drugs for a desired effect in competitive sports; includes humans and animals. x#} 5vDopamine Uptake Inhibitors D14.100.150.600.220; D14.100.600.220 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors Amphetamine (+ 1); Benzphetamine; Benztropine; Bupropion; Cocaine; Mazindol; Methamphetamine; Methylphenidate; Nomifensine; Phenmetrazine; Phentermine Amphetamine (+ 1); Benzphetamine; Benztropine; Bupropion; Cocaine; Mazindol; Methamphetamine; Methylphenidate; Nomifensine; Phenmetrazine; Phentermine Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. Dopamine Agents (89-94); Neurotransmitter Uptake Inhibitors (85-94) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (x$ *8";`O@Dopamine Neuron Agents (Non MeSH) D14.100.150.600 Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents Amantadine; Amphetamine (+ 1); Benserazide; Benzphetamine; Carbidopa; Dopa (+ 1); Dopamine Uptake Inhibitors (+ 12); Fusaric Acid; Memantine; Methamphetamine; Methylphenidate; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Phenmetrazine; Phentermine Drugs that act on dopaminergic systems but are not agonists or antagonists. Among these are drugs that affect dopamine synthesis, uptake, storage, and metabolism, and drugs that destroy dopaminergic neurons. Some of these agents are clinically very important for the treatment of parkinsonism and other movement disorders. Dopaminergic Agents (89-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  x)j)"w!FDopamine beta-Hydroxylase D08.586.682.420.292 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases Hydroxylases (66-70) x-QFhDopamine Antagonists D14.100.150.175 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antipsychotic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents Acepromazine; Azaperone; Benperidol; Butaclamol; Chlorpromazine; Chlorprothixene; Clopenthixol; Domperidone; Droperidol; Flupenthixol; Fluphenazine; Fluspirilene; Haloperidol; Loxapine; Mesoridazine; Methotrimeprazine; Metoclopramide; Penfluridol; Perazine; Perphenazine; Pimozide; Prochlorperazine; Promazine; Remoxipride; Sch-23390; Spiperone; Sulpiride; Thiethylperazine; Thioridazine; Thiothixene; Tiapride; Trifluoperazine; Trifluperidol; Triflupromazine Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine/antagonists and inhibitors (66-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (x.p4e3:Dopamine Agonists D14.100.150.151 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents Apomorphine; Bromocriptine; Dihydroergotoxine; Fenoldopam; Lisuride; Methergoline; Pergolide; Piribedil; SK&F-38393 Drugs that bind to and activate dopamine receptors. Dopamine Agents (89-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $x44?:Dopamine Agents D14.100.150 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Dopamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Dopamine Agonists (+ 9); Dopamine Antagonists (+ 34); Dopamine Neuron Agents (Non MeSH) (+ 28) Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. Dopamine/metabolism (66-88); Receptors, Dopamine (77-88) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (x64 ktCFDopamine D02.092.211.215.311.342; D02.092.311.342; D14.100.050.100.200.230; D14.600.100.200; D16.050.870.180; D18.222.863.267 AAADAEANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Dopamine Agents; Receptors, Dopamine Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines; Catecholamines Organic Chemicals (Non MeSH); Amines; Catecholamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Biogenic Amine Neurotransmitters Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics  Deoxyepinephrine; Hydroxydopamines (+ 1) A catecholamine intermediate in the synthesis of norepinephrine and epinephrine and itself an important neurotransmitter. Central dopaminergic systems appear to be involved in psychiatric disorders and in movement disorders, and several important classes of therapeutic drugs act on dopaminergic systems. Dopamine is also used pharmacologically for its direct (beta adrenergic agonist) and indirect (adrenergic releasing) sympathomimetic effects including its actions as an inotropic agent and a renal vasodilator agent. It is used in cardiac emergencies, heart failure, hypotension, and shock. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $x9M @,y5DDopa Decarboxylase D08.586.520.258.090.267 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases; Aromatic Amino Acid Decarboxylases x@FDopa D02.092.311.242; D12.125.072.573.400; D14.100.150.600.200 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Phenylalanine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Cysteinyldopa; Levodopa; Methyldopa (+ 1) Cysteinyldopa; Levodopa; Methyldopa Levodopa The racemic or DL form of DOPA, an amino acid found in various legumes. The dextro form has little physiologic activity but the levo form (LEVODOPA) is a very important physiologic mediator and precursor and pharmacological agent. xA2AFefDomperidone D03.383.621.210; D03.438.103.370; D14.100.150.175.150; D15.095.185 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms. Antiemetics (77-81); Benzimidazoles (77-81); Piperidines (77-81) xDL:wMDominican Republic Z01.107.084.900.300 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies xHODominance, Cerebral F02.830.297; G11.561.232 DEGEPHRE Aphasia Psychologic Processes and Principles (Non MeSH); Psychophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Laterality Laterality Dominance of one cerebral hemisphere over the other in cerebral functions. CLDEGEPHRE $xH  YDominance-Subordination F01.145.843.309 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Dominance Relationship between individuals when one individual threatens or becomes aggressive and the other individual remains passive or attempts to escape. xJmVDomestic Violence F03.126.842.089.734.350; I01.198.240.856.350; I01.880.735.900.350 CLECEHHILJPCPXSNTD Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence Social Sciences; Criminology; Crime; Violence Social Sciences; Sociology; Social Problems; Violence Child Abuse (+ 2); Elder Abuse; Spouse Abuse Child Abuse (+ 2); Elder Abuse; Spouse Abuse Child Abuse (+ 2); Elder Abuse; Spouse Abuse Deliberate, often repetitive, physical abuse by one family member against another: marital partners, parents, children, siblings, or any other member of a household. specific type of abuse (66-93); Violence (68-93) BLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISNSUTDTHURUSVI $xKI<LDOM D02.092.471.683.152.391; D14.100.850.800.200; D15.300.200; D15.700.372.367 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens 2,5-Dimethoxy-alpha,4-dimethylbenzeneethanamine. A psychedelic phenylisopropylamine derivative whose mood-altering effects and mechanism of action may be similar to those of LSD. xOZT:sDolphins B02.649.189.267 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Cetacea Cetacea (66-67) xRO (%Dolichol Phosphates D02.033.555.475.500; D02.455.849.291.250.300; D02.455.849.690.250; D02.705.690.200; D10.516.289.475.500 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols; Dolichol Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Dolichol Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Polyisoprenyl Phosphates Organic Chemicals (Non MeSH); Organophosphorus Compounds; Polyisoprenyl Phosphates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols; Dolichol Phosphoric acid esters of dolichol. Diterpenes (74); Dolichol (75-77); Organophosphorus Compounds (71-77) xRsD,SDolichol Monophosphate Mannose D02.455.849.690.700.700.250; D09.203.894.680.700.250; D10.516.390.700.700.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Polyisoprenyl Phosphates; Polyisoprenyl Phosphate Sugars; Polyisoprenyl Phosphate Monosaccharides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates; Polyisoprenyl Phosphate Sugars; Polyisoprenyl Phosphate Monosaccharides Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Polyisoprenyl Phosphate Sugars; Polyisoprenyl Phosphate Monosaccharides A lipophilic glycosyl carrier of the monosaccharide mannose in the biosynthesis of oligosaccharide phospholipids and glycoproteins. Diterpenes (74); Dolichol (75-77); Hexosephosphates (66-77) xV $U:HDolichol D02.033.555.475; D02.455.849.291.250; D10.516.289.475 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols Dolichol Phosphates Dolichol Phosphates Dolichol Phosphates Eicosamethyl octacontanonadecasen-1-o1. Polyprenol found in animal tissues that contains about 20 isoprene residues, the one carrying the alcohol group being saturated. Diterpenes (74); Fatty Alcohols (74)  xY =DD.Dogs B02.649.147.308 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora consider also terms at CANINE. x\(''Dogfish B02.493.853.392 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Sharks Sharks of the family Squalidae. The subfamily Squalinae are called dogfish sharks and comprise eight genera with about 44 species. Dogfish often appear in schools near shore and are destructive to fish and fishing gear. Their liver is valued for its oil and its flesh is often made into fertilizer. The Squalus acanthias or spiny dogfish figures heavily in biological research, especially with reference to its rectal gland in water-electrolyte studies. x]L &#Dog Diseases C22.268 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Distemper; Hepatitis, Infectious Canine; Hip Dysplasia, Canine Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, wolves, FOXES, and other Canidae for which the heading CARNIVORA is used. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  x_ HJJDocumentation L01.300 CLECHIMTSNSTTDUT Records Bibliography Information Science Abstracting and Indexing; Cataloging (+ 1); Filing; Subject Headings  xa  TDocosahexaenoic Acids D02.241.081.436.292.210; D10.516.212.302.380.410.210; D10.516.251.355.337.250; D10.516.627.430.450.375; J01.740.250.410.270; J01.740.350.450.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Fish Oils; Fatty Acids, Omega-3 Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated; Fatty Acids, Omega-3 Technology, Industry, Agriculture (Non MeSH); Oils; Fish Oils; Fatty Acids, Omega-3 C22-unsaturated fatty acids found predominantly in fish oils. Fatty Acids (66-72); Fatty Acids, Unsaturated (73-87) xb8IADobutamine D02.092.311.220; D02.092.471.683.410; D14.100.050.100.200.210; D16.050.870.170; D18.222.863.259 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Cardiovascular Agents; Cardiotonic Agents; Sympathomimetics (+-)-4-(2-(3-(4-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)-1,2-benzenediol. A beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery. Catecholamines (74-75); Phenethylamines (74-75); Phenols (74-75) xgSk::MDNA, Viral D13.444.308.568 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Genes, Viral; DNA Viruses Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Deoxyribonucleic acid that makes up the genetic material of viruses. xkD!ZRDNA, Superhelical D13.444.308.283.250 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity. DNA (66-77); DNA, Circular (73-77) xlDl%,DNA, Single-Stranded D13.444.308.497 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA DNA, Complementary A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle. DNA (66-71); DNA, Bacterial (66-71); DNA, Viral (66-71)  xoEDZFDNA, Satellite D13.444.308.480 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA A species of DNA, that is homogeneous, highly repetitive and different in base composition relative to the remainder of the organism's DNA. DNA (66-74) xq1DZDNA, Ribosomal D13.444.308.475 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription, Genetic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA DNA sequences encoding ribosomal RNA. These sequences regulate amplification and transcription initiation and contain transcribed and nontranscribed spacer segments. DNA (66-84); Ribosomes (66-84)  xrDZ'DNA, Recombinant D13.444.308.460 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSETOTUULUR Genetic Engineering; Genetic Vectors Gene Library; Cloning, Molecular; Genetic Vectors; Genomic Library; Genetic Engineering; Transformation, Genetic; DNA Insertion Elements Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. DNA (66-76); Recombination, Genetic (68-76) $xtB,Z5DNA, Protozoan D13.444.308.442 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA DNA, Kinetoplast Deoxyribonucleic acid that makes up the genetic material of protozoa. DNA (66-90); specific protozoa (66-90)  xwDZS0DNA, Plant D13.444.308.435 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA DNA, Chloroplast; Plasmids Deoxyribonucleic acid that makes up the genetic material of plants. specific plant (66-94); DNA (66-94); Plants (66-94)  xyLDZ!QADNA, Neoplasm D13.444.308.425 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Neoplasms Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA xzD ZDNA, Mitochondrial D13.444.308.354 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA DNA, Kinetoplast Double-stranded DNA of mitochondria. In eukaryotes, the mitochondrial genome is circular and codes for ribosomal RNAs, transfer RNAs, and about 10 proteins. DNA (66-72); Mitochondria (66-72)  x{DZ*DNA, Kinetoplast D13.444.308.283.200; D13.444.308.354.200; D13.444.308.442.200; D13.444.600.223.520; D26.651.600.223.520 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Mitochondrial Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Protozoan Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes; DNA Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes; DNA Probes Mitochondrial DNA of trypanosomes and related parasitic protozoa within the order KINETOPLASTIDA. Kinetoplast DNA is used as a DNA probe and consists of a complex network of numerous catenated rings of two classes; the first being a large number of small DNA duplex rings, called minicircles, approximately 2000 base pairs in length, and the second being several dozen much larger rings, called maxicircles, approximately 37 kb in length. DNA (69-73); DNA, Circular (73-93); DNA, Protozoan (91-93) x}sD-IDNA, Helminth D13.444.308.315 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Deoxyribonucleic acid that makes up the genetic material of helminths. DNA (66-94) x/DZTDNA, Fungal D13.444.308.300 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Plasmids Deoxyribonucleic acid that makes up the genetic material of fungi. DNA (66-79)  x}DZ PDNA, Complementary D13.444.308.497.220; D13.444.600.223.500; D26.651.600.223.500 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Single-Stranded Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes; DNA Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes; DNA Probes Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe. DNA (66-93) xEDZHDNA, Circular D13.444.308.283 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA DNA, Kinetoplast; DNA, Superhelical; Plasmids (+ 7) DNA (66-72) xNDZ?DNA, Chloroplast D13.444.308.275; D13.444.308.435.275 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Plant Deoxyribonucleic acid that makes up the genetic material of chloroplasts. Chloroplasts (66-94); DNA (66-94) x*DW*DNA, Bacterial D13.444.308.212 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Plasmids (+ 7) Deoxyribonucleic acid that makes up the genetic material of bacteria. xsDZSDNA, Antisense D13.150.200; D13.444.308.150 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Antisense Elements (Genetics) Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA A DNA molecule which is complementary to the sense strand (that which functions as a template for the synthesis of mRNA) but is not involved in transcription. Both strands are involved in replication. DNA (88-90) x"DDNA-Binding Proteins D12.776.260 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR DNA Replication; Leucine Zippers; Zinc Fingers Amino Acids, Peptides and Proteins (Non MeSH); Proteins Adenovirus E2 Proteins; Cell Cycle Proteins (+ 5); DNA-Binding Protein, Cyclic AMP-Responsive; Homeodomain Proteins; Myogenic Regulatory Factors (+ 2); NF-kappa B; Oncogene Protein p55(v-myc); Protein p53; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Retinoblastoma Protein; Transcription Factor, Sp1; Viral Regulatory Proteins (+ 7) Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. Carrier Proteins (78-81); DNA Unwinding Proteins (81-83) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (xD9DDHDNA-Binding Protein, Cyclic AMP-Responsive D12.776.260.225; D12.776.930.225 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors A protein that has been shown to function as a calcium regulated transcription factor as well as a substrate for depolarization-activated calcium calmodulin-dependent protein kinases I and II. This protein functions to integrate both calcium and cAMP signals. DNA-Binding Proteins (89-92) x1&D."DNA Viruses B04.280; B04.909.204 CHCLDEENGDGEIMIPMEPHPYREUL DNA, Viral Viruses Viruses; Vertebrate Viruses (Non MeSH) Adenoviridae (+ 5); African Swine Fever Virus; Baculoviridae (+ 1); Caudovirales (+ 11); Caulimovirus; Circoviridae (+ 2); Geminivirus; Hepadnaviridae (+ 5); Herpesviridae (+ 26); Inoviridae (+ 3); Iridoviridae (+ 2); Microviridae (+ 2); Papovaviridae (+ 8); Parvoviridae (+ 8); Phycodnaviridae; Polydnaviridae; Poxviridae (+ 23); Tectiviridae Adenoviridae (+ 5); African Swine Fever Virus; Circoviridae (+ 2); DNA Tumor Viruses (+ 21); Hepadnaviridae (+ 5); Herpesviridae (+ 26); Iridoviridae (+ 1); Papovaviridae (+ 8); Parvoviridae (+ 7); Poxviridae (+ 22) Viruses whose nucleic acid is DNA.  xQ8,DNA Virus Infections (Non MeSH) C02.256 Virus Diseases Adenoviridae Infections (+ 2); African Swine Fever; Circoviridae Infections; Hepadnaviridae Infections (+ 1); Herpesviridae Infections (+ 21); Papovaviridae Infections (+ 3); Parvoviridae Infections (+ 3); Poxviridae Infections (+ 11) BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMULURUSVEVI x' TDNA Tumor Viruses B04.909.204.210; B04.909.574.204 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses Gammaherpesvirinae (+ 5); Herpesvirus 1, Ranid; Leporipoxvirus (+ 2); Papovaviridae (+ 8); Yatapoxvirus (+ 1) Gammaherpesvirinae (+ 5); Herpesvirus 1, Ranid; Leporipoxvirus (+ 2); Papovaviridae (+ 8); Yatapoxvirus (+ 1) DNA viruses producing malignant tumors. Of the six major groupings of DNA viruses four contain members which are actually or potentially oncogenic: the Adenoviridae, the Herpesviridae, the Papovaviridae, and the Poxviridae. DNA Viruses (66-77); Oncogenic Viruses (66-77)  x& 9DNA Topoisomerase (ATP-Hydrolysing) D08.586.399.385 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases An ATP-requiring enzyme which, in the presence of magnesium ions, introduces negative supertwists into closed and possibly linear duplex DNA. The enzyme is implicated in DNA replication and transcription. It causes the storage of mechanical strain energy in the superhelical turns of DNA at the expense of ATP hydrolysis. EC 5.99.1.3. DNA (66-77); DNA Replication (68-79); DNA, Superhelical (78-79); DNA Untwisting Proteins (78-79) x)FSuDNA Topoisomerase D08.586.399.375 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR DNA Replication Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases An enzyme catalyzing ATP-independent breakage of single-stranded DNA, followed by passage and rejoining of another single-stranded DNA. This enzyme class brings about the conversion of one topological isomer of DNA into another, e.g., the relaxation of superhelical turns in DNA, the interconversion of simple and knotted rings of single-stranded DNA, and the intertwisting of single-stranded rings of complementary sequences. (From Enzyme Nomenclature, 1992) EC 5.99.1.2. specific protein (66-77); Deoxyribonucleases (66-77); DNA, Circular (73-77); Polynucleotide Synthetases (73-77); Proteins (66-77)  xFSDNA Restriction-Modification Enzymes D08.586.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes DNA Modification Methylases (+ 2); DNA Restriction Enzymes (+ 6) Systems consisting of two enzymes, a modification methylase and a restriction endonuclease. They are closely related in their specificity and protect the DNA of a given bacterial species. The methylase adds methyl groups to adenine or cytosine residues in the same target sequence that constitutes the restriction enzyme binding site. The methylation renders the target site resistant to restriction, thereby protecting DNA against cleavage. DNA Restriction Enzymes (75-88); Methyltransferases (71-88)  x*FEOFDNA Restriction Enzymes D08.586.150.280; D08.586.277.352.335.350.300; D08.586.277.352.355.325.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Polymorphism, Restriction Fragment Length; Restriction Mapping Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases Deoxyribonucleases, Type I Site-Specific; Deoxyribonucleases, Type II Site-Specific (+ 3); Deoxyribonucleases, Type III Site-Specific Deoxyribonucleases, Type I Site-Specific; Deoxyribonucleases, Type II Site-Specific (+ 3); Deoxyribonucleases, Type III Site-Specific Deoxyribonucleases, Type I Site-Specific; Deoxyribonucleases, Type II Site-Specific (+ 3); Deoxyribonucleases, Type III Site-Specific Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1. Deoxyribonucleases (74); Endonucleases (74) $x=QFHN4DNA Replication G05.331.232 DEGEIMPHRE DNA Helicases; DNA Topoisomerase; Virus Replication DNA-Binding Proteins Genetics; Genetics, Biochemical The process by which the two strands of a DNA double helix separate, allowing each strand to act as a template for the synthesis of a complementary strand by specific base pairing. Includes autonomous but not VIRUS REPLICATION. DNA/biosynthesis (66-67) $x7>&DNA Repair G05.331.187 DEGEIMPHRE Pyrimidine Dimers Genetics; Genetics, Biochemical SOS Response (Genetics) The reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule which contained damaged regions. The major repair mechanisms are excision repair, in which defective regions in one strand are excised and resynthesized using the complementary base pairing information in the intact strand; photoreactivation, in which the lethal and mutagenic effects of ultraviolet light are eliminated; and post-replication repair, in which the primary lesions are not repaired, but the gaps in one daughter duplex are filled in by incorporation of portions of the other (undamaged) daughter duplex. Excision repair and post-replication repair are sometimes referred to as "dark repair" because they do not require light. DNA (66-70); DNA/biosynthesis (66-70) $x@&Q/DNA Probes, HPV D13.444.600.223.555; D26.651.600.223.555 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes; DNA Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes; DNA Probes DNA probes specific for the identification of human papilloma virus. DNA or specific DNA (72-88); Nucleic Acid Hybridization (72-88); Papilloma Viruses (72-88) xt.DRmDNA Probes, HLA D13.444.600.223.550; D26.651.600.223.550 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes; DNA Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes; DNA Probes DNA probes specific for the human leukocyte antigen genes, which represent the major histocompatibility determinants in humans. The four known loci are designated as A, B, C, and D. Specific antigens are identified by a locus notation and number, e.g., HLA-A11. The inheritance of certain HLA alleles is associated with increased risk for certain diseases (e.g., insulin-dependent diabetes mellitus). DNA or specific DNA (72-88); HLA Antigens (74-88); Nucleic Acid Hybridization (72-88) x.DhDNA Probes D13.444.600.223; D26.651.600.223 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Chromosome Walking Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes DNA, Complementary; DNA, Kinetoplast; DNA Probes, HLA; DNA Probes, HPV DNA, Complementary; DNA, Kinetoplast; DNA Probes, HLA; DNA Probes, HPV Species- or subspecies-specific DNA (including complementary DNA (DNA, COMPLEMENTARY), conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure DNA-DNA homologies, to group subspecies, etc. The DNA probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the DNA probe include the radioisotope labels 32P and 125I and the chemical label biotin. The use of DNA probes provides a specific, sensitive, rapid, and inexpensive replacement for cell culture techniques for diagnosing infections. DNA or specific DNA (72-88); Nucleic Acid Hybridization (72-88) $x&DVMDNA Primers D13.695.578.424.450.275; D26.380 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR DNA Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Oligonucleotides; Oligodeoxyribonucleotides Miscellaneous Drugs and Agents (Non MeSH) Short sequences (generally about 10 base pairs) of DNA that are complementary to sequences of messenger RNA and allow reverse transcriptases to start copying the adjacent sequences of mRNA. Primers are used extensively in genetic and molecular biology techniques. DNA (66-93); Oligodeoxyribonucleotides (76-93)  xr&>37DNA Polymerases D08.586.913.696.445.308.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; DNA Nucleotidyltransferases DNA Polymerase I; DNA Polymerase II; DNA Polymerase III DNA-dependent DNA polymerases found in bacteria, animal and plant cells. During the replication process, these enzymes catalyze the addition of deoxyribonucleotide residues to the end of a DNA strand in the presence of DNA as template-primer. They also possess exonuclease activity and therefore function in DNA repair. EC 2.7.7.7. DNA Nucleotidyltransferases (68-76)  xFFE)DNA Polymerase III D08.586.913.696.445.308.300.235 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; DNA Nucleotidyltransferases; DNA Polymerases A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms but may be present in higher organisms. Use also for a more complex form of DNA polymerase III designated as DNA polymerase III* or pol III* which is 15 times more active biologically than DNA polymerase I in the synthesis of DNA. This polymerase has both 3'-5' and 5'-3' exonuclease activities, is inhibited by sulfhydryl reagents, and has the same template-primer dependence as pol II. EC 2.7.7.7. DNA Nucleotidyltransferases (68-76) xʂ#F7)DNA Polymerase II D08.586.913.696.445.308.300.230 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; DNA Nucleotidyltransferases; DNA Polymerases A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. It may be present in higher organisms and has an intrinsic molecular activity only 5% of that of DNA Polymerase I. This polymerase has 3'-5' exonuclease activity, is effective only on duplex DNA with gaps or single-strand ends of less than 100 nucleotides as template, and is inhibited by sulfhydryl reagents. EC 2.7.7.7. DNA Nucleotidyltransferases (68-76) xE#F)DNA Polymerase I D08.586.913.696.445.308.300.225 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; DNA Nucleotidyltransferases; DNA Polymerases A DNA-dependent DNA polymerase characterized in prokaryotes and may be present in higher organisms. It has both 3'-5' and 5'-3' exonuclease activity, but cannot use native double-stranded DNA as template-primer. It is not inhibited by sulfhydryl reagents and is active in both DNA synthesis and repair. EC 2.7.7.7. DNA Nucleotidyltransferases (68-76) xѫ#Fq)DNA Photolyase D08.586.520.340 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that catalyzes the reactivation by light of UV-irradiated DNA. It breaks two carbon-carbon bonds in pyrimidine dimers in DNA. EC 4.1.99.3. DNA (72-74); Lyases (72-74); Photochemistry (72-74) xԦFO@DNA Nucleotidyltransferases D08.586.913.696.445.308 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases DNA Nucleotidylexotransferase; DNA Polymerases (+ 3); Reverse Transcriptase Nucleotidyltransferases (66-67) xy FY$DNA Nucleotidylexotransferase D08.586.913.696.445.308.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases; DNA Nucleotidyltransferases A non-template-directed DNA polymerase normally found in vertebrate thymus and bone marrow. It catalyzes the elongation of oligo- or polydeoxynucleotide chains and is widely used as a tool in the differential diagnosis of acute leukemias in man. EC 2.7.7.31. DNA Nucleotidyltransferases (68-78); Transferases (66-67) x%"F/CDNA Mutational Analysis E05.393.760.700.300 Polymorphism, Single-Stranded Conformational Miscellaneous Techniques (Non MeSH); Genetic Techniques; Sequence Analysis; Sequence Analysis, DNA Biochemical identification of mutational changes in a nucleotide sequence. Base Sequence (78-87); Mutation (66-87) x2tW1DNA Modification Methylases (Cytosine-Specific) D08.586.150.240.260; D08.586.913.517.240.260 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Modification Methylases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases; DNA Modification Methylases Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern on cytosine residues in a specific short base sequence in the host cell's DNA. They catalyze the methylation of DNA cytosine in the presence of S-adenosyl-L-methionine to form DNA containing 5-methylcytosine and S-adenosyl-L-methionine. EC 2.1.1.73. DNA (Cytosine-5-)-Methyltransferase (75-88); Methyltransferases (71-88) xu62FRDNA Modification Methylases (Adenine-Specific) D08.586.150.240.250; D08.586.913.517.240.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Modification Methylases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases; DNA Modification Methylases Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern on adenine residues in a specific short base sequence in the host cell's DNA. They catalyze the methylation of DNA adenine in the presence of S-adenosyl-L-methionine to form DNA containing 6-methylaminopurine and S-adenosyl-L-homocysteine. EC 2.1.1.72. Methyltransferases (71-88) xy52FDNA Modification Methylases D08.586.150.240; D08.586.913.517.240 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases DNA Modification Methylases (Adenine-Specific); DNA Modification Methylases (Cytosine-Specific) DNA Modification Methylases (Adenine-Specific); DNA Modification Methylases (Cytosine-Specific) Enzymes that are part of the restriction-modification systems. They are responsible for producing a species-characteristic methylation pattern, on either adenine or cytosine residues, in a specific short base sequence in the host cell's own DNA. This methylated sequence will occur many times in the host-cell DNA and remain intact for the lifetime of the cell. Any DNA from another species which gains entry into a living cell and lacks the characteristic methylation pattern will be recognized by the restriction endonucleases of similar specificity and destroyed by cleavage. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. DNA (Cytosine-5-)-Methyltransferase (75-88); Methyltransferases (71-88)  xL!*FRDNA Insertion Elements D13.444.308.320; G05.275.180; G05.331.599.110.280 DEGEIMPHRE DNA, Recombinant; Mutagenesis, Insertional; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Genetics; Genes Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Retrotransposons Retrotransposons Retrotransposons Discrete transposable segments of DNA which can insert into chromosomal, phage, and plasmid DNA. Some insert at random while others are site-specific; most have not been found to exist except in the inserted state. Their insertion into a genome always produces a mutation ("insertion mutation"), and their excision frequently results in a loss of host genetic information. Types of transposable elements include IS elements (insertion sequence elements), which are composed of between 700 and 1400 bases and contain no genes unrelated to insertion function and Tn elements (transposon elements), which are generally larger than 1400 bases and contain genes unrelated to insertion function. The concept also includes the delta element of Saccharomyces cerevisiae and the integration site. Base Sequence (71-79); Mutation (66-79); Plasmids (75-79); Recombination, Genetic (68-79) $x9>8lDNA Helicases D08.586.399.340 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR DNA Replication Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Proteins that promote unwinding of duplex DNA during replication by binding cooperatively to single-stranded regions of DNA or to short regions of duplex DNA that are undergoing transient opening. EC 5.99.-. specific protein (66-77); Deoxyribonucleases (66-77); Endonucleases (73-77); Proteins (66-77)  xFSoDNA Fingerprinting E05.393.295; I01.198.560.375 AECLCTECHIISMOMTNUPXSNSTTDUTVE Paternity Variable Number of Tandem Repeats Miscellaneous Techniques (Non MeSH); Genetic Techniques Social Sciences; Criminology; Forensic Medicine A procedure in which multilocus band patterns of DNA fragment sizes obtained by digestion with restriction enzymes and hybridized with specific core probes are evaluated for similarities with DNA from another individual. Assessment of the individual specificity of the multilocus band patterns, known as "DNA fingerprints", is based on the probability that no two unrelated individuals share a band at the same position. Because of the extremely low probability that unrelated persons would share band patterns, the DNA fingerprint is considered to be unique to an individual. This technique is widely used in forensic medicine and paternity testing. DNA (86-90); Forensic Medicine (86-90); Nucleotide Mapping (86-90) $x@"" )yQDNA Damage G05.331.135; G05.632.135 DEGEIMPHRE Genetics; Genetics, Biochemical Genetics; Mutation Drug- or radiation-induced injuries in DNA that introduce deviations from its normal double-helical conformation. These changes include structural distortions which interfere with replication and transcription, as well as point mutations which disrupt base pairs and exert damaging effects on future generations through changes in DNA sequence. DNA (66-86); DNA Repair (71-86); DNA Replication (68-86) x<GDNA Adducts D13.444.308.135 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Mutagens Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA Covalent adducts between chemical mutagens and DNA. Such couplings activate DNA repair processes and, unless repaired prior to DNA replication, may lead to nucleotide substitutions, deletions, and chromosome rearrangements. (Rieger, et al., Glossary of Genetics: Classical and Molecular, 5th ed). DNA (76-94)  x-D ZWDNA (Cytosine-5-)-Methyltransferase D08.586.913.517.220 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases The enzyme that is not part of the restriction-modification systems. It catalyzes the transfer of a methyl group from S-adenosylmethionine to the 5-position of cytosine or to the 6-position in adenine in mammalian DNA. EC 2.1.1.37. Cytosine Nucleotides (73-74); DNA (73-74); Methyltransferases (73-74) x)FkSDNA D13.444.308 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR DNA Primers; Genetic Code; Nucleic Acid Denaturation; Nucleic Acid Hybridization; Repetitive Sequences, Nucleic Acid Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids DNA Adducts; DNA, Antisense; DNA, Bacterial (+ 8); DNA, Chloroplast; DNA, Circular (+ 10); DNA, Fungal (+ 1); DNA, Helminth; DNA Insertion Elements (+ 1); DNA, Mitochondrial (+ 1); DNA, Neoplasm; DNA, Plant (+ 2); DNA, Protozoan (+ 1); DNA, Recombinant; DNA, Ribosomal; DNA, Satellite; DNA, Single-Stranded (+ 1); DNA, Viral A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).  xDSwDMPP D03.383.606.390; D14.100.120.140.700.200; D16.050.400.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Nicotinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Stimulants A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction. Ganglionic Stimulants (71); Piperazines (66-71) yrA:j9DMF Index E05.318.308.250.300.350; E06.208.266; G03.850.520.308.250.300.350; G03.890.160.100; N05.715.360.300.375.300.340 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Dentistry; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health Dentistry; Dental Health Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Dental Health Surveys "Decayed, missing and filled teeth," a routinely used statistical concept in dentistry. y{vgDjibouti Z01.058.290.120.275 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern Formerly the capital of French Somaliland. The country is situated in eastern Africa on the Gulf of Aden. Djibouti is also the name of the capital. Africa, Eastern (66-89) y  _Dizziness C10.597.751.237; C23.888.592.763.237 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders A disturbed sense of relationship to space, manifesting as a sensation of unsteadiness or lightheadedness; it is not the same as VERTIGO, which is an illusion of movement. Vertigo (66-78) y  *NDizocilpine Maleate D04.615.181.384.380; D14.100.190.300.200; D15.575.125 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists Central Nervous System Agents; Neuroprotective Agents 10,11-Dihydro-5-methyl-5H-dibenzo(a,d)cyclohepten-5,10-imine maleate. A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects. Anticonvulsants (66-90); Dibenzocycloheptenes (68-90) y =:q>Divorce F01.829.263.315.500.300; I01.240.361.500.300; I01.880.225.423.500.300; I01.880.735.255; N01.224.361.500.300; N01.824.308.500.300 CLECEHHILJPCPXSNTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family; Family Characteristics; Marital Status Social Sciences; Demography; Family Characteristics; Marital Status Social Sciences; Sociology; Family; Family Characteristics; Marital Status Social Sciences; Sociology; Social Problems Population Characteristics (Non MeSH); Demography; Family Characteristics; Marital Status Population Characteristics (Non MeSH); Socioeconomic Factors; Family Characteristics; Marital Status Legal dissolution of an officially recognized marriage relationship. y` 6PDiving G03.230.150.150; I03.450.642.845.869.110 AECLECEDHIINLJPHPXSNSTTD Decompression Sickness; Inert Gas Narcosis Immersion; Naval Medicine Environment and Public Health (Non MeSH); Environment; Environment, Controlled Human Activities (Non MeSH); Leisure Activities; Recreation; Sports; Swimming A water sport or professional activity in which an individual plunges into water in a prescribed manner. It includes scuba and bell diving.  y .3 Diverticulum C23.329 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) Diverticulitis (+ 1); Diverticulosis, Colonic; Esophageal Diverticulum (+ 1); Stomach Diverticulum A circumscribed pouch or sac of variable size occurring normally or created by herniation of the lining mucous membrane through a defect in the muscular coat of a tubular organ. (Dorland, 27th ed.). y N2uDiverticulosis, Colonic C06.405.469.158.556; C23.329.543 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Symptoms and General Pathology (Non MeSH); Diverticulum Presence of multiple herniations of the mucosa and submucosa of the colon through the circular muscle layer. y&NDiverticulitis, Colonic C06.405.469.158.473; C23.329.391.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Symptoms and General Pathology (Non MeSH); Diverticulum; Diverticulitis Inflammatory complications of colonic diverticulosis in which diverticula may undergo perforation with abscess formation. y*NDiverticulitis C23.329.391 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Diverticulum Diverticulitis, Colonic Inflammation of a diverticulum. (Dorland, 27th ed). yNC@Diuron D02.948.511.266; D05.723.366.506.266 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea; Methylurea Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Urea Herbicides (66-71); Urea (66-71) y! *:)Diuretics, Thiazide D18.162.276; D19.770.224.578 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cardiovascular Agents; Antihypertensive Agents Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics Bendroflumethiazide; Chlorothiazide (+ 2); Cyclopenthiazide; Hydroflumethiazide; Methyclothiazide; Polythiazide Bendroflumethiazide; Chlorothiazide (+ 2); Cyclopenthiazide; Hydroflumethiazide; Methyclothiazide; Polythiazide Diuretics characterized as analogs of 1,2,4-benzothiadiazine-1,1-dioxide. All have a common mechanism of action and differ primarily in the dose required to produce a given effect. They act directly on the kidney to increase the excretion of sodium chloride and water and also increase excretion of potassium ions. Diuretics (66-73); Thiadiazines (66-73); Thiazines (66-73) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $y "8oG:Diuretics, Sulfamyl D19.770.224.516 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics Bumetanide; Chlorthalidone; Clopamide; Furosemide; Indapamide; Mefruside; Metolazone; Xipamide Diuretics containing one or more sulfonamide groups. They are similar to the benzothiazide diuretics in their pharmacological actions, but differ chemically in the nature of the heterocyclic ring. Diuretics (66-73); Sulfonamides (66-73) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $y$8cp0:Diuretics, Osmotic D19.770.224.453 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics Mannitol; Sorbitol (+ 1) Diuretics that are filtered at the glomerulus and reabsorbed in the renal tubule only to a limited extent. They thus increase the amount of osmotically active solute in the urine and a corresponding increase in urine volume. These compounds also increase the osmolality of plasma, thereby increasing the diffusion of water from the intraocular and cerebrospinal fluids; they can be used for reducing the pressure and volume of these fluids. (From Dorland, 27th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  y'a8c $:Diuretics, Mercurial D19.770.224.391 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organometallic Compounds Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics Chlormerodrin; Mersalyl A group of organometallic compounds, now rarely used, that promote diuresis by inhibiting tubular reabsorption of sodium and chloride. (From Dorland, 27th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $y*8c:Diuretics D19.770.224 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Diuresis Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH) Amiloride; Carbonic Anhydrase Inhibitors (+ 5); Diuretics, Mercurial (+ 2); Diuretics, Osmotic (+ 3); Diuretics, Sulfamyl (+ 8); Diuretics, Thiazide (+ 8); Ethacrynic Acid; Muzolimine; Spironolactone; Ticrynafen; Triamterene Agents that promote the excretion of urine through their effects on kidney function. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $y, 8 Ue:Diuresis G08.852.241 DEGEIMPHRE Diuretics; Osmolar Concentration Kidney Reproduction, Urogenital Physiology (Non MeSH); Urinary Tract Physiology (Non MeSH) Natriuresis  y/ ' bDitiocarb D02.241.081.251.869.220; D02.886.706.200; D26.241.255 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Disulfiram Disulfiram A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM and has varied neurobiological actions. Thiocarbamates (69-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $y0| =.:Dithizone D02.172.530; D02.442.726.200; D26.241.250; D26.550.276 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Organic Chemicals (Non MeSH); Hydrazines; Phenylhydrazines Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Phenylazothionoformic acid 2-phenylhydrazine. Chelating agent used for heavy metal poisoning and assay; causes diabetes. y3 @.Dithiothreitol D08.373.830.307; D09.203.853.196; D02.033.800.196 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols Dithioerythritol Alcohols (66-71); Tetroses (66-71) y59:+Dithionitrobenzoic Acid D02.241.223.106.650.250; D26.550.272 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Nitrobenzoates Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 3,3'-Dithiobis(6-nitrobenzoic acid). A standard reagent for the determination of reactive sulfhydryl groups by absorbance measurements. It is used primarily for the determination of sulfhydryl and disulfide groups in proteins. The color produced is due to the formation of a thio anion, 3-carboxyl-4-nitrothiophenolate. Benzoates (69-74); Disulfides (72-74); Nitro Compounds (72-74) y7*.rLDithionite D01.248.497.158.904.150; D01.875.750.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Sulfites Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfites Dithionite. The dithionous acid ion and its salts. y:.8?Dithioerythritol D08.373.830.307.391; D09.203.853.175; D02.033.800.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents; Dithiothreitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols (R*,S*)-1,4-Dimercapto-2,3-butanediol. A compound that, along with its isomer, Cleland's reagent (DITHIOTHREITOL), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups. yDisease-Free Survival E01.789.200; E05.318.740.998.300; G03.850.520.830.998.300; H01.548.832.975.300; N05.715.360.750.795.300 Remission Induction Diagnosis; Prognosis Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Survival Analysis Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Survival Analysis Physical Sciences (Non MeSH); Mathematics; Statistics; Survival Analysis Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Survival Analysis Period after successful treatment in which there is no appearance of the symptoms or effects of the disease. Prognosis (80-94) yw"sDisease Vectors B01.371; B02.389 CL Disease Reservoirs; Communicable Disease Control Invertebrates Vertebrates Arthropod Vectors (+ 2) Invertebrates or non-human vertebrates which transmit infective organisms from one host to another. For human vectors the preferred term is CARRIER STATE. AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI $yz9(Disease Transmission, Vertical G03.850.310.330 CLECHILJPCSNVE Environment and Public Health (Non MeSH); Public Health; Disease Transmission The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding. specific diseases/transmission (75-94) y|3$]-Disease Transmission, Professional-to-Patient G03.850.310.300.330 ANCLECHILJMTPCSNST Blood-Borne Pathogens Cross Infection; Iatrogenic Disease Environment and Public Health (Non MeSH); Public Health; Disease Transmission; Disease Transmission, Horizontal The transmission of infectious disease or pathogens from health professional or health care worker to patients. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents. specific disease/transmission (74-93); specific health profession (74-93); specific health professional (74-93) $y~$3+Disease Transmission, Patient-to-Professional G03.850.310.300.320 ANCLECHILJMTPCSNST Blood-Borne Pathogens Cross Infection Environment and Public Health (Non MeSH); Public Health; Disease Transmission; Disease Transmission, Horizontal The transmission of infectious disease or pathogens from patients to health professionals or health care workers. It includes transmission via direct or indirect exposure to bacterial, fungal, parasitic, or viral agents. specific disease/transmission (74-93); specific health profession (74-93); specific health professional (74-93); Occupational Diseases (66-93) $y3Disease Transmission, Horizontal G03.850.310.300 CLECHILJPCSNVE Environment and Public Health (Non MeSH); Public Health; Disease Transmission Disease Transmission, Patient-to-Professional; Disease Transmission, Professional-to-Patient The transmission of infectious disease or pathogens from one individual to another in the same generation. specific diseases/transmission (75-94) ANCLECHILJMTPCSNSTVE $y&]f~-Disease Transmission G03.850.310 CLECHILJPCSNVE Communicable Diseases Environment and Public Health (Non MeSH); Public Health Disease Transmission, Horizontal (+ 2); Disease Transmission, Vertical The transmission of infectious disease or pathogens. When transmission is within the same species, the mode can be horizontal (DISEASE TRANSMISSION, HORIZONTAL) or vertical (DISEASE TRANSMISSION, VERTICAL). Communicable Diseases/transmission (74-94) ANCLECHILJMTPCSNSTVE (yDS1Disease Susceptibility C23.280.341; G07.265.300 BLCFCICLCNCODHDIECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVEVI Hemorrhagic Diathesis Symptoms and General Pathology (Non MeSH); Disease Physiology, General (Non MeSH); Body Constitution A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. y7JxDisease Reservoirs G03.850.295 CLSNVE Carrier State; Disease Vectors Communicable Diseases; Communicable Disease Control; Zoonoses Environment and Public Health (Non MeSH); Public Health Animate or inanimate sources which harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs should be distinguished from vectors and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.  yc &HDODisease Progression C23.280.335 Prognosis Symptoms and General Pathology (Non MeSH); Disease The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. y >Disease Outbreaks G03.850.290 CLECHILJPCSNVE Communicable Diseases Space-Time Clustering Environment and Public Health (Non MeSH); Public Health Sudden increase in the incidence of a disease. The concept includes epidemics.  y6D_Disease Notification E05.318.362; G03.850.520.373; G03.850.780.200.262 ECHILJMTSNST Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Notification or reporting by a physician or other health care provider of the occurrence of specified contagious diseases such as tuberculosis and HIV infections to designated public health agencies. The United States system of reporting notifiable diseases evolved from the Quarantine Act of 1878, which authorized the US Public Health Service to collect morbidity data on cholera, smallpox, and yellow fever; each state in the US has its own list of notifiable diseases and depends largely on reporting by the individual health care provider. (From Segen, Dictionary of Modern Medicine, 1992). Communicable Disease Control (66-94) yo9/+Disease Models, Animal C23.280.329 Models, Biological Symptoms and General Pathology (Non MeSH); Disease Animal disease whose pathologic mechanisms are sufficiently similar to those of a different human disease for the animal disease to serve as a model. The animal disease may be either induced or naturally occurring so long as it is not the same clinical entity as the disease for which it serves as a model. E.g., scrapie is an animal model for multiple sclerosis, which has never been found or induced in an animal. Animal Diseases (66-69); Models, Biological (68-69) y>>Disease C23.280; N01.407.306 CLECEHETPX Symptoms and General Pathology (Non MeSH) Population Characteristics (Non MeSH); Health and Disease (Non MeSH) Acute Disease; Catastrophic Illness; Chronic Disease; Convalescence; Critical Illness; Disease Models, Animal; Disease Progression; Disease Susceptibility; Diseases in Twins; Emergencies; Iatrogenic Disease; Recurrence; Remission, Spontaneous; Stress (+ 1); Syndrome Acute Disease; Catastrophic Illness; Chronic Disease; Convalescence; Critical Illness; Recurrence The state of the organism when function is impaired. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  y ANDiscrimination Learning F02.463.425.280 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Learning that is manifested in the ability to respond differentially to various stimuli. y ZiDiscrimination (Psychology) F02.463.593.257 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Signal Detection (Psychology) Differential response to different stimuli. y  \#4Discriminant Analysis E05.318.740.350; G03.850.520.830.350; H01.548.832.346; N05.715.360.750.325 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics A statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis. Statistics (66-89) y.TDiscitis C05.116.165.762.301; C05.116.900.853.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Infectious (Non MeSH); Spondylitis Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spondylitis Inflammation of an intervertebral disk or disk space which may lead to disk erosion. Until recently, discitis has been defined as a nonbacterial inflammation and has been attributed to aseptic processes (e.g., chemical reaction to an injected substance). However, recent studies provide evidence that infection may be the initial cause, but perhaps not the promoter, of most cases of discitis. Discitis has been diagnosed in patients following discography, myelography, lumbar puncture, paravertebral injection, and obstetrical epidural anesthesia. Discitis following chemonucleolysis (especially with chymopapain) is attributed to chemical reaction by some and to introduction of microorganisms by others. Intervertebral Disk (66-88); Spinal Diseases (66-88); Spondylitis (66-88) yL .N,XDisciplines, Tests, Therapy, Services (Non MeSH) F04 Behavioral Sciences (+ 47); Mental Health; Mental Health Services (+ 6); Personality Assessment (+ 1); Psychiatric Status Rating Scales (+ 3); Psychoanalytic Interpretation (+ 1); Psychological Techniques (Non MeSH) (+ 13); Psychological Tests (+ 27); Psychotherapy (+ 47); Schizophrenic Psychology; Somatic Therapies, Psychiatric (Non MeSH) (+ 6) AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRERHSDSNSTTDUTVE y:98Disasters G03.230.100 CLECHIPCSN Relief Work Environment and Public Health (Non MeSH); Environment Disaster Planning; Explosions; Fires (+ 2); Natural Disasters (+ 1); Relief Work; Rescue Work AEANCLECHILJMAMTOGPCSNSTTDUT  yp Au Disaster Planning G03.230.100.035 ECHILJMTOGSNSTTD Civil Defense Environment and Public Health (Non MeSH); Environment; Disasters Procedures outlined for the care of casualties and the maintenance of services in disasters. Disasters (66-77)  yNnDisarticulation E04.557.069.472 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Orthopedics; Amputation Amputation (66-71) y$4Disaccharides D09.203.698.629.305 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides Cellobiose; Isomaltose; Ivermectin; Lactose; Lactulose; Maltose; Melibiose; Sucrose (+ 1); Trehalose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR y>r{DDisaccharidases D08.586.277.450.329 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases Sucrase (+ 1); Trehalase ymFl!Disabled M01.150 CLEDHILJPXRHSN Dental Care for Disabled; Early Intervention (Education); Education, Special; Employment, Supported; Mainstreaming (Education); Rehabilitation; Self-Help Devices Named Groups (Non MeSH) Amputees Those persons with physical and mental disabilities which limit or preclude their participation in certain activities.  y   Disability Evaluation E01.373 Veterans Disability Claims Workers' Compensation; Eligibility Determination; Rehabilitation Diagnosis Work Capacity Evaluation yQ  J Dirofilariasis C03.335.349.320; C03.335.508.700.750.361.290; C03.701.377.320; C22.674.377.320 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Infection with nematodes of the genus DIROFILARIA, usually in animals, especially dogs, but occasionally in man. Filariasis (66-67) y2XJDirofilaria immitis B01.500.294.700.750.700.300.230.300 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea; Dirofilaria A filarial parasite primarily of dogs but occurring also in foxes, wolves, and humans. The parasite is transmitted by mosquitoes. yH'*qDirofilaria B01.500.294.700.750.700.300.230 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea Dirofilaria immitis A genus of filarial nematodes. Various immature species have been found to infect the eyes or subcutaneous tissue in humans. y#*bDirectories L01.178.682.192.836.339 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books Lists of persons or organizations, systematically arranged, usually in alphabetic or classed order, giving address, affiliations, etc., for individuals, and giving address, officers, functions, and similar data for organizations. (ALA Glossary of Library and Information Science, 1983). yqzIDirect Service Costs N03.219.151.400.325; N05.300.375.250 CLHILJSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Health Care Costs Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Health Care Costs Costs which are directly identifiable with a particular service. y}*MDirect Lytic Factors D24.185.965.850.325.220.260 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Elapid Venoms; Cobra Venoms Most abundant proteins in cobra (Naja of the Elapids) venom; basic polypeptides of 57 to 62 amino acids with four disulfide bonds and a molecular weight of less than 7000; causes skeletal and cardiac muscle contracture, interferes with neuromuscular and ganglionic transmission, depolarizes nerve, muscle and blood cell membranes, thus causing hemolysis. Synonyms: cobramine A; cobramine B; cobra cytotoxin; gamma toxin; membrane-active polypeptide. Peptides (66-77); Proteins (66-77); Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) yB nDiquat D03.383.725.762.352; D05.723.366.313 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Herbicides (66-70); Pyridinium Compounds (68-70) y *::Dipyrone D03.383.694.050.150; D16.850.015.050.200; D17.025.030.213; D17.050.030.223 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Aminopyrine Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal ((2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonic acid. A drug that has analgesic, anti-inflammatory, and antipyretic properties. It is the sodium sulfonate of AMINOPYRINE. Because of the risk of serious adverse effects its use is justified only in serious situations where no alternative is available or suitable. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.13). Antipyrine (72-74); Methanesulfonates (74) yJ T:Z3Dipyridamole D03.383.621.190; D03.383.742.175; D18.918.222; D19.461.780.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Cardiovascular Agents; Vasodilator Agents Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Platelet Aggregation Inhibitors 2,2',2'',2'''-((4,8-Di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakisethanol. A coronary vasodilator often used in diagnostic imaging. It has been known to induce myocardial ischemia in patients with ischemic heart disease. ymH:ZDiptera B01.131.617.289 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Ceratopogonidae; Chironomidae; Culicidae (+ 3); Drosophilidae (+ 2); Glossinidae (+ 1); Muscidae (+ 1); Psychodidae (+ 1); Simuliidae An order of the class Insecta. Wings, when present, number two and distinguish Diptera from other so-called flies, while the halteres, or reduced hindwings, separate Diptera from other insects with one pair of wings. The order includes the families Calliphoridae, Oestridae, Phoridae, Sarcophagidae, Scatophagidae, Sciaridae, SIMULIIDAE, Tabanidae, Therevidae, Trypetidae, CERATOPOGONIDAE, CHIRONOMIDAE, CULICIDAE, DROSOPHILIDAE, GLOSSINIDAE, MUSCIDAE, and PSYCHODIDAE. AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI  yƑ (**Diprenorphine D03.132.610.422.250; D03.549.686.275; D03.605.497.280; D15.550.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Narcotic Antagonists 21-Cyclopropyl-6,7,8,14-tetrahydro-7 alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine. A narcotic antagonist similar in action to NALOXONE. It is used to remobilize animals after ETORPHINE neuroleptanalgesia and is considered a specific antagonist to etorphine. Cyclopropanes (73-75); Morphinans (73-75) yL:412Dipodomys B02.649.865.510 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia A genus of the family Heteromyidae which contains 22 species. Their physiology is adapted for the conservation of water, and they seldom drink water. They are found in arid or desert habitats and travel by hopping on their hind limbs. ye (&Diplopia C10.597.622.447.333; C10.597.751.941.339; C11.966.339; C23.888.592.636.447.333; C23.888.592.763.941.339 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis; Ophthalmoplegia Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Eye Diseases; Vision Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Ophthalmoplegia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders Condition in which a single object is perceived as two objects rather than one. y sNaDiplomonadida B01.841.750.443.950.250 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora Giardia (+ 1) An order of protozoa characterized by the presence of one or two karyomastigonts and either two-fold rotational or mirror symmetry. y{&UDiploidy G05.148.777.264 Genetics; Cytogenetics; Ploidies The chromosomal constitution of somatic cells, in which each type of chromosome is represented twice. Symbol: 2N or 2X. Chromosomes (66-67) y (Diphyllobothrium B01.500.736.215.228 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda Sparganum A genus of tapeworm containing several species which occurs in the intestine of fish, birds, and mammals including man. Infection in humans is usually by eating uncooked fish. The larval stage is known as SPARGANUM. y*; Diphyllobothriasis C03.335.190.304 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Sparganosis Sparganosis Parasitic Diseases; Helminthiasis; Cestode Infections Sparganosis Infection with tapeworms of the genus Diphyllobothrium. Cestode Infections (66-67) (yP?B Diphtheria-Tetanus-Pertussis Vaccine D24.310.794.263.300; D24.310.794.824.300; D24.310.894.135.378; D24.310.894.135.535.300; D24.310.894.815.300 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Diphtheria Toxoid Immunologic and Biologic Factors (Non MeSH); Biological Products; Toxoids; Diphtheria Toxoid Immunologic and Biologic Factors (Non MeSH); Biological Products; Toxoids; Tetanus Toxoid Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines; Pertussis Vaccine Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Vaccines, Combined A vaccine consisting of diphtheria toxoid, tetanus toxoid, and pertussis vaccine. It is usually given to infants three times at two-month intervals, generally at 2, 4, and 6 months of age. The vaccine protects against diphtheria, tetanus, and whooping cough. In most cases the vaccine causes only a temporary fever and discomfort, but in a few cases serious neurological side effects have been observed. Diphtheria Toxoid (66-89); Pertussis Vaccine (66-89); Tetanus Toxoid (66-89)  yF)w>7\Diphtheria Toxoid D24.310.794.263 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Diphtheria-Tetanus-Pertussis Vaccine Immunologic and Biologic Factors (Non MeSH); Biological Products; Toxoids Diphtheria-Tetanus-Pertussis Vaccine yB)X)Diphtheria Toxin D24.185.926.123.305 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Corynebacterium diphtheriae Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins A 60 kD single chain protein elaborated by Corynebacterium diphtheriae that causes the sign and symptoms of diphtheria; it can be broken into two unequal fragments, the smaller (A fragment) inhibits protein synthesis and is the lethal moiety that needs the larger (B fragment) for entry into cells. yB k_Diphtheria Antitoxin D24.310.121.388; D24.611.125.272.438 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Antitoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antitoxins y*6Diphtheria C01.252.410.040.246.388 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Corynebacterium Infections A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. yPfDiphosphotransferases D08.586.913.696.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases GTP Pyrophosphokinase; Ribose-Phosphate Pyrophosphokinase; Thiamin Pyrophosphokinase A class of phosphotransferases that catalyzes the transfer of diphosphate-containing groups. EC 2.7.6. Phosphotransferases (66-93)  yFl_x Diphosphonates D02.705.206 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Clodronic Acid; Etidronate Disodium; Technetium Tc 99m Medronate Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. Organophosphorus Compounds (71-76); Phosphonic Acids (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $y8CMnG:Diphosphoglyceric Acids D02.241.081.844.387.388; D02.241.511.902.387.388; D02.705.196; D09.203.811.366.388 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Glyceric Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Glyceric Acids Organic Chemicals (Non MeSH); Organophosphorus Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Glyceric Acids Glyceric Acids (68-72); Organophosphorus Compounds (71-72) y\8EDiphosphates D01.248.497.158.730.650.200; D01.695.625.675.650.775.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions; Phosphates; Polyphosphates Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Polyphosphates  Calcium Pyrophosphate; Technetium Tc 99m Pyrophosphate Inorganic salts of phosphoric acid that contain two phosphate groups. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ya>8AS:Diphenylhexatriene D02.455.326.271.665.250; D26.408.348.249 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes 1,6-Diphenyl-1,3,5-hexatriene. A fluorescent compound that emits light only in specific configurations in certain lipid media. It is used as a tool in the study of membrane lipids. Polyenes (66-79); Spectrometry, Fluorescence (74-79) y.:>Diphenylcarbazide D02.845.250; D26.550.265 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Semicarbazides Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents sym-Diphenylcarbazide. Used as an indicator in titrating iron and for the colorimetric determination of chromium and the detection of cadmium, mercury, magnesium, aldehydes and emetine. Benzene Derivatives (72-74); Semicarbazides (72-74) yV.=Diphenylamine D02.092.146.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds In humans it may be irritating to mucous membranes. Methemoglobinemia has been produced experimentally. In veterinary use, it is one of active ingredients in topical agents for prevention and treatment of screwworm infestation. An indicator in tests for nitrate poisoning. Aniline Compounds (69-74) yv:D?Diphenylacetic Acids D02.241.223.601.238 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Benzilates (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR y8p:Diphenoxylate D03.066.399.300; D03.383.621.349.300; D15.210.600.300; D19.316.161.209 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Isonipecotic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Isonipecotic Acids Central Nervous System Agents; Central Nervous System Depressants; Narcotics Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Antidiarrheals 1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-isonipecotic acid ethyl ester. A MEPERIDINE congener used as an antidiarrheal, usually in combination with atropine. At high doses, it acts like morphine. Its unesterified metabolite difenoxin has similar properties and is used similarly. It has little or no analgesic activity. Isonipecotic Acids (70-74); Nitriles (74) yP:q3Diphenhydramine D02.092.471.320; D02.455.426.559.389.115.250; D14.100.375.425.400.197; D15.090.050.190; D15.095.180; D15.153.200; D15.210.350.800.162; D15.325.875.167; D23.075.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzhydryl Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Dermatologic Agents; Antipruritics Dimenhydrinate Dimenhydrinate A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. y:q)2Dipetalonema Infections C03.335.508.700.750.361.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Spirurida Infections; Filariasis Infections with nematodes of the genus DIPETALONEMA. zP?Dipetalonema B01.500.294.700.750.700.300.208 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea A filarial nematode parasite of mammalian blood with the vector being a tick or small fly. z7#*bnDipeptidyl Peptidases D08.586.277.656.732.240 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Antigens, CD26 Dipeptidylpeptide hydrolases. Enzymes which cleave dipeptides from the amino terminal of a polypeptide. Dipeptidyl peptidase I, II, III, IV are known. They hydrolyze the beta-naphthylamides of glycine-arginine, lysine-alanine, arginine-arginine and glycine-proline, respectively. Dipeptidyl peptidase I is cathepsin C. EC 3.4.14. Cathepsins (66-79); Dipeptidases (66-79); Peptide Peptidohydrolases (66-79)  zFyYDipeptides D12.644.456.345 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Anserine; Aspartame; Carnosine; Enalapril (+ 1); Glycylglycine; Lisinopril AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR zDU[FDipeptidases D08.586.277.656.360 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases z FjDioxoles D03.383.246 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Dioxolanes; Piperonyl Butoxide; Safrole Heterocyclic Compounds (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  z  8G0$:Dioxolanes D03.383.246.238 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Dioxoles z e8TDioxins D03.383.231 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Dioxanes; Tetrachlorodibenzodioxin AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR z 1 8G(:Dioxanes D03.383.231.388 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Dioxins 1,4-Diethylene dioxides. Industrial solvents. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), dioxane itself may "reasonably be anticipated to be a carcinogen." (Merck Index, 11th ed). z S 8SDiosmin D09.203.408.134.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Bioflavonoids 3',5,7-Trihydroxy-4'-methoxyflavone-7-rutinoside. A bioflavonoid that strengthens vascular walls. Synonyms: Daflon; 4601 SE. Bioflavonoids (73-74) z DjDiosgenin D04.808.854.700.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Spirostans; Sapogenins (25R)-Spirost-5-en-3-beta-ol. A steroid sapogenin which is isolated from various plants. Can be converted to ecdysone, pregnenolone, and progesterone. Synonym: nitogenin. Hydroxysteroids (72-75); Saponins (66-75); Spirostans (68-78) z :DJDioctyl Sulfosuccinates D02.241.081.337.817.200; D19.316.396.298; D26.866.408 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents Bis(2-ethylhexyl) sulfosuccinates. All-purpose surfactants, wetting agents, solubilizers used in the drug, cosmetics and food industries; also in laxatives and as cerumenolytic. Exists as the sodium or calcium salt. Synonyms: Aerosol; Colace; Coprolax; Diosuccin; Laxinate; Molatoc; Softil; Waxol. For calcium salt: Surfak. Succinates (66-77); Surface-Active Agents (66-77) z=,)};Dioctophymatoidea B01.500.294.100.275.200 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida A superfamily of nematodes of the order ENOPLIDA. Characteristics include a well developed cylindrical esophagus. Nematoda (66-92) z*EDinucleoside Phosphates D13.695.250 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides A group of compounds which consist of a nucleotide molecule to which an additional nucleoside is attached through the phosphate molecule(s). The nucleotide can contain any number of phosphates. Oligonucleotides (72-88) z{BPDinoprostone D02.241.081.436.687.150.200; D06.472.583.190; D10.516.251.355.708.250.200; D17.350.050.175.725.780.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins E Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Oxytocics Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins E Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandins E 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid. The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. Prostaglandins (66-74); Prostaglandins E (75-88) zapD9:Dinoprost D02.241.081.436.687.250.200; D06.472.583.180; D07.131.100.250; D10.516.251.355.708.400.200; D17.350.050.175.725.790.185 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins F Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Oxytocics Reproductive Control Agents (Non MeSH); Abortifacient Agents; Abortifacient Agents, Non-Steroidal Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins F Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandins F 7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid. A natural prostaglandin F analog that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. Prostaglandins (66-74); Prostaglandins F (75-88) zN D):Dinoflagellida B01.841.750.443.575.214 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Saxitoxin Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea Protozoans of the class PHYTOMASTIGOPHORA, found mainly in the oceans. They are characterized by the presence of transverse and longitudinal flagella which propel the organisms in a rotating manner through the water. Mastigophora (66-74)  z#T& XDinitrophenols D02.640.743.304; D02.755.566.304; D05.723.288.263; D08.373.936.338 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitrophenols Organic Chemicals (Non MeSH); Phenols; Nitrophenols Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents z%ML8HDinitrogenase Reductase D08.586.682.647.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Nitrogenase A non-heme iron-sulfur protein isolated from Clostridium pasteurianum and other bacteria. It is a component of NITROGENASE along with molybdoferredoxin and is active in nitrogen fixation. Ferredoxins (77-91) z'JFgDinitrofluorobenzene D02.455.426.559.389.565.280; D02.640.529.240.280 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Nitrobenzenes Organic Chemicals (Non MeSH); Nitro Compounds; Nitrobenzenes; Dinitrobenzenes Irritants and reagents for labeling terminal amino acid groups. Fluorine (69-74); Nitrobenzenes (69-74) z)C6:L0Dinitrocresols D02.640.280; D02.755.239.493 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds Organic Chemicals (Non MeSH); Phenols; Cresols Cresols (66-71) z+u"8pDinitrochlorobenzene D02.455.426.559.389.261.250; D02.455.426.559.389.565.250; D02.455.526.439.202.200; D02.640.529.240.250; D24.611.216.119.480.350; D26.550.260 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Chlorobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Nitrobenzenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated; Chlorobenzenes Organic Chemicals (Non MeSH); Nitro Compounds; Nitrobenzenes; Dinitrobenzenes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Haptens Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 1-Chloro-2,4-dinitrobenzene. A skin irritant which may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds. Chlorine (71-74); Nitrobenzenes (71-74) z,6 G0Dinitrobenzenes D02.455.426.559.389.565.225; D02.640.529.240 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Nitrobenzenes Organic Chemicals (Non MeSH); Nitro Compounds; Nitrobenzenes  Dinitrochlorobenzene; Dinitrofluorobenzene Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. Dinitrophenols (66-76); Nitrobenzenes (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR $z2281y6DDinitolmide D02.065.277.225; D02.241.223.106.162.225; D21.370.400.310 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 3,5-Dinitro-o-toluamide. A coccidiostat for poultry. Benzamides (74); Nitrobenzenes (74) z4A:>,Dimyristoylphosphatidylcholine D10.516.695.300.700.710.200; D26.550.257 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids; Phosphatidylcholines Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Synthetic phospholipid used in liposomes and lipid bilayers for the study of biological membranes. Myristates (77-80); Phosphatidylcholines (80-83) z6".:t9Diminazene D02.078.100.260; D02.925.240; D21.370.884.240 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Benzamidines Organic Chemicals (Non MeSH); Triazenes Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Trypanocidal Agents 4,4'-(Triazene-1,3-ylen)-bis-(benzamidine aceturate). An effective trypanocidal agent. Amidines (69-74); Triazenes (74) z985:e)Dimetridazole D02.640.672.200; D03.383.374.658.200; D21.370.475 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitro Compounds; Nitroimidazoles Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Nitroimidazoles Antiparasitic Agents (Non MeSH); Antiprotozoal Agents 1,2-Dimethyl-5-nitroimidazole. Used to treat histomoniasis in poultry. Synonym: Emtryl. Nitroimidazoles (74) z;/9:fDimethylpolysiloxanes D02.715.650.700.150; D25.720.900.850.150 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Organosilicon Compounds; Siloxanes; Silicones Biomedical and Dental Materials (Non MeSH); Polymers; Siloxanes; Silicones Simethicone Simethicone Silicone polymers which consist of silicon atoms substituted with methyl groups and linked by oxygen atoms. They comprise a series of biocompatible materials used as liquids, gels or solids; as film for artificial membranes, gels for implants, and liquids for drug vehicles; and as antifoaming agents. Silicone Elastomers (72-74); Silicones (72-74) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $z=I.,b8.Dimethylnitrosamine D02.654.442.225; D26.191.646.308 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosamines Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Nitrosamines N-Nitrosodimethylamine. A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents. Amines (66-71); Dimethylamines (74); Methylamines (71-74); Nitrosamines (66-74) z@&:`Dimethylhydrazines D02.442.600.400; D26.191.302 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrazines; Methylhydrazines Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Hydrazines substituted with two methyl groups in any position. The 1,2-isomer has carcinogenic properties. Hydrazines (68-74) zB",}Dimethylformamide D02.065.463.387; D02.241.081.504.310.387 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amides; Formamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Formic Acids; Formamides zD..Dimethyldithiocarbamate D02.241.081.251.869.210; D02.886.706.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates; Thiocarbamates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiocarbamates Thiram; Ziram Thiram; Ziram A chemical that acts as a dopamine beta-hydroxylase inhibitor. Its salts are agricultural fungicides. It is inferior to diethyldithiocarbamate as a chelating agent. Thiocarbamates (66-74)  zE.:$Dimethylamines D02.092.668.387 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Methylamines Moxisylyte METHYLAMINES (72-73) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  zHI8>:Dimethylallyltransferase D08.586.913.322 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme that, in the pathway of cholesterol biosynthesis, catalyzes the condensation of isopentenyl pyrophosphate and dimethylallylpyrophosphate to yield pyrophosphate and geranylpyrophosphate. The enzyme then catalyzes the condensation of the latter compound with another molecule of isopentenyl pyrophosphate to yield pyrophosphate and farnesylpyrophosphate. EC 2.5.1.1. Allyl Compounds (71-78); Transferases (66-78) zIpFU7Dimethyl Sulfoxide D02.886.640.150; D17.025.080.142; D23.037.100; D26.328.304 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfoxides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical Miscellaneous Drugs and Agents (Non MeSH); Cryoprotective Agents An alkyl sulfoxide that is practically odorless in its purified form. As a highly polar organic liquid, it is a powerful solvent. Its biologic activities include the ability to penetrate plant and animal tissues and to preserve living cells during freezing. It has been used investigationally as a topical analgesic and anti-inflammatory agent, and as an agent to increase the penetrability of other substances. It is available as a 50 percent solution for direct instillation into the bladder for treatment of interstitial cystitis. (From Dorland, 27th ed). zLAD:Dimethyl Suberimidate D02.478.400.200; D26.550.430.200 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Imides; Imidoesters Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Imidoesters The methyl imidoester of suberic acid used to produce cross links in proteins. Each end of the imidoester will react with an amino group in the protein molecule to form an amidine. Dicarboxylic Acids (74); Imides (73-74) zQ &.1Dimethyl Adipimidate D02.241.081.337.052.250; D02.478.400.175; D26.550.430.175 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Adipic Acids Organic Chemicals (Non MeSH); Imides; Imidoesters Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Imidoesters Hexanediimidic acid, dimethyl ester. Bifunctional cross-linking agent that links covalently free amino groups of proteins or polypeptides, including those in cell membranes; used as reagent or fixative in immunohistochemistry; proposed antisickling agent. Synonym: adipimidic acid; dimethyl ester. Adipic Acids (66-77); Imides (66-77) zSBA.W.Dimethoxyphenylethylamine D02.092.471.683.386 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines zV:PDimethoate D02.719.245; D05.723.491.657.262 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71) zWm&:Dimethisterone D04.808.745.745.279; D06.597.799.241; D07.360.276.210.443.706.227 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (6 alpha,17 beta)-17-Hydroxy-6-methyl-17-(1-propynyl)androst-4-en-3-one. A synthetic progestational hormone without significant estrogenic or androgenic properties. It was formerly used as the progestational component in oral sequential contraceptives. zXI:Dimethindene D03.383.725.210; D04.615.486.250; D14.100.375.425.400.195; D23.075.210 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Indenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Dermatologic Agents; Antipruritics Histamine H1 antagonist. It is used in hypersensitivity reactions, in rhinitis, for pruritus, and in some common cold remedies. z\2P:Dimethadione D03.383.548.175; D15.080.207 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Central Nervous System Agents; Anticonvulsants 5,5-Dimethyl-2,4-oxazolidinedione. An anticonvulsant that is the active metabolite of TRIMETHADIONE. Oxazoles (70-74) z_":sDimercaprol D02.886.489.180; D26.241.245 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Unithiol Unithiol 2,3-Dimercapto-1-propanol. An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine). It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning. z`". Dimenhydrinate D02.092.471.320.250; D02.455.426.559.389.115.250.250; D03.132.956.826.250; D03.438.759.758.824.751.162; D14.100.375.425.400.192; D15.095.175; D16.050.030.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Diphenhydramine Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzhydryl Compounds; Diphenhydramine Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids; Theophylline Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines; Theophylline Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics A drug combination that contains DIPHENHYDRAMINE and THEOPHYLLINE. It is used for treating vertigo, motion sickness, and nausea associated with pregnancy. It is not effective in the treatment of nausea associated with cancer chemotherapy. zc:Dimaprit D02.886.904.282; D02.948.898.282; D14.100.375.400.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Agonists Carbamimidothioic acid 3-(dimethylamino)propyl ester. A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors. APT (80-92); APT/analogs and derivatives (79-80); Thiourea/analogs and derivatives (77-79) zhU =:mDiltiazem D03.438.079.150; D18.192.282; D18.918.173.280 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers (2S-cis)-3-(Acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3- dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one. A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions. It is also teratogenic. Anisoles (73-74); Benzazepines (71-74); Dimethylamines (73-74) zkF 5:8KDilazep D03.383.066.200; D18.918.208 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines Cardiovascular Agents; Vasodilator Agents 3,3'-(Perhydro-1,4-diazepin-1,4-diyl)-bis-(propyl-3,4,5-trimethoxybenzoate). Coronary vasodilator with some antiarrhythmic activity. Synonyms: Cormelian; ASTA C 4898. Azepines (72-74); Benzoates (72-74) znG ":,Dilatation, Pathologic C23.739.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) The condition of an anatomical structure's being dilated beyond normal dimensions. Dilatation (68-75) zpANYaDilatation and Curettage E04.157.310; E04.819.608.310 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Curettage Surgery, Operative; Curettage Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Gynecologic (Non MeSH) Vacuum Curettage Vacuum Curettage Dilatation of the cervix uteri followed by a scraping of the endometrium with a curette. Curettage (66-74) $zq"$ (kDilatation E05.284 AECLCTECHIISMOMTNUPXSNSTTDUTVE Balloon Dilatation Miscellaneous Techniques (Non MeSH) The act of dilating. zs{ "*Diiodotyrosine D06.472.931.208; D12.125.072.917.262 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Thyroid Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Tyrosine zt:*F Diiodothyronines D06.472.931.812.741.180; D12.125.072.734.741.180 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones; Thyroxine; Thyronines Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Thyroxine; Thyronines Endogenous thyronine derivatives formed by the deiodination of T3 or reverse T3. They are believed to stimulate thyroid hormone-regulated functions as weak agonists by acting via the same receptors that mediate T3 actions. Have been used to detect fetal or infantile hypothyroidism by determination of their concentration in amniotic fluid, maternal sera and cord sera. The 3,3'- and 3,5-isomers are known. Thyronines (66-78) zu6FDihydroxytryptamines D03.438.473.914.201 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine Tryptamine substituted with two hydroxyl groups in any position. Some are cytotoxic serotonin analogs that are preferentially taken up by serotonergic neurons and then destroy those neurons. Tryptamines (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $zyq8b6:Dihydroxydihydrobenzopyrenes D04.615.799.306.400; D26.191.262 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Pyrenes; Benzopyrenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide Benzopyrene saturated in any two adjacent positions and substituted with two hydroxyl groups in any position. The majority of these compounds have carcinogenic or mutagenic activity. Benzopyrenes (66-86) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $z{ &,p.Dihydroxycholecalciferols D04.808.247.222.159.478.387; D04.808.247.808.146.478.387; D04.808.812.221.478.387; D10.516.851.152.478.387; D11.786.763.196.478.387 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholecalciferol; Hydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholecalciferol; Hydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Secosteroids; Cholecalciferol; Hydroxycholecalciferols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholecalciferol; Hydroxycholecalciferols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D; Cholecalciferol; Hydroxycholecalciferols 24,25-Dihydroxyvitamin D 3 24,25-Dihydroxyvitamin D 3 Calcitriol; 24,25-Dihydroxyvitamin D 3 Calcitriol; 24,25-Dihydroxyvitamin D 3 Calcitriol; 24,25-Dihydroxyvitamin D 3 Cholecalciferols substituted with two hydroxy groups in any position. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  z~B9RDDihydroxyacetone Phosphate D09.203.894.150 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Phosphates 1,3-Dihydroxy-2-propanone monodihydrogen phosphate. An important intermediate in lipid biosynthesis and in glycolysis. Acetone (72-74); Organophosphorus Compounds (73-74); Trioses (72-74) zRD`RDihydroxyacetone D09.203.546.465.200; D09.203.546.894.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Ketoses Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Trioses 1,3-Dihydroxy-2-propanone. A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. Acetone (69-74); Trioses (69-74) z(.D|)Dihydrotachysterol D04.808.247.222.387; D04.808.247.808.337; D04.808.812.387; D10.516.851.359; D11.786.763.337 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Polycyclic Hydrocarbons; Steroids; Secosteroids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D 9,10-Secoergosta-5,7,22-trien-3 beta-ol. zJg:S.Dihydrostreptomycin D09.203.408.051.885.387; D20.085.060.790.200; D20.085.089.790.387; D20.338.135.810.387 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Streptomycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Streptomycin Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular; Streptomycin Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular; Streptomycin O-2-deoxy-2-(methylamino)-alpha-L-glucopyranosyl-(1-2)-O- 5-deoxy-3-C-(hydroxymethyl)-alpha-L-lyxofuranosyl-(1-4)- N,N'-bis(aminoiminomethyl)-D-streptamine. z`:Dihydropyridines D03.383.725.203 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Amlodipine; Bay K 8644; Dicarbethoxydihydrocollidine; Felodipine; Isradipine; Nicardipine; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position. Pyridines (66-87); Nifedipine/analogs and derivatives (75-87) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $z8UzI:Dihydropteroate Synthase D08.586.913.315 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme that catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. EC 2.5.1.15. Aminobenzoic Acids (69-74); Ligases (69-74); Pteridines (69-74) z5FUMDihydropteridine Reductase D08.586.682.608.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine. EC 1.6.99.7. NADH, NADPH Oxidoreductases (73-74); Pteridines (73-74) zFy|BDihydroprogesterone D04.808.745.745.654.829.200; D06.472.798.773.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Progesterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Progestational Hormones; Progesterone 20 alpha-Hydroxypregn-4-en-3-one. A naturally occurring progesterone derivative with progestational activity. Progesterone (74) z6D|Dihydroorotate Oxidase D08.586.682.310 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme that in the course of pyrimidine biosynthesis, catalyzes the oxidation of dihydro-orotic acid to orotic acid utilizing oxygen as the electron acceptor. This enzyme is a flavoprotein which contains both FAD and FMN as well as iron-sulfur centers. EC 1.3.3.1. Orotic Acid (66-76); Oxidoreductases (66-76) z FX;6Dihydroorotase D08.586.277.087.280 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases An enzyme that, in the course of pyrimidine biosynthesis, catalyzes ring closure by removal of water from N-carbamoylaspartate to yield dihydro-orotic acid. EC 3.5.2.3. Amidohydrolases (66-76); Orotic Acid (66-76) zqFf6Dihydromorphinone D03.132.610.422.547.547.362; D03.549.686.575.547.437; D03.605.497.575.547.437; D15.040.150.188; D15.210.600.297 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics  Oxymorphone Oxymorphone 4,5-alpha-Epoxy-3-hydroxy-17-methylmorphinan-6-one. A narcotic analgesic made from MORPHINE and used mainly as an analgesic. It has a shorter duration of action than morphine. zh{:Dihydromorphine D03.132.610.422.547.547.350; D03.549.686.575.547.420; D03.605.497.575.547.420; D15.040.150.186; D15.210.600.295 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics 4,5-Epoxy-17-methylmorphinan-3,6-alpha-diol. A semisynthetic endorphin analgesic used in the study of narcotic receptors. It has abuse potential. Morphine (66-68); Morphine Derivatives (69-78) zJ{:8Dihydroergotoxine D03.132.327.190; D14.100.050.200.100.210; D14.100.150.151.200; D15.575.117; D15.590.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Central Nervous System Agents; Neuroprotective Agents Central Nervous System Agents; Nootropic Agents Ergoloid Mesylates Dihydroergotoxine. A mixture of three different ergotaman-3',6',18-triones, dihydroergocornine, dihydroergocristine, and dihydroergocryptine. It has been proposed to be a neuroprotective agent and a nootropic agent. The mechanism of its therapeutic actions is not clear, but it can act as an alpha-adrenergic antagonist and a dopamine agonist. The combination of the methanesulfonate salts of these alkaloids is DIHYDROERGOTOXINE MESYLATE (see ERGOLOID MESYLATES). Ergot Alkaloids, Hydrogenated (73-74)  zc8,Dihydroergotamine D03.132.327.287.362.412.387; D03.549.439.362.412.387; D18.793.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines; Ergotamine; Ergotamine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines; Ergotamine; Ergotamine Derivatives Cardiovascular Agents; Vasoconstrictor Agents 9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotaman-3',6',18-trione. A derivative of ergotamine prepared by the catalytic hydrogenation of ergotamine. It is used as a vasoconstrictor, specifically for the therapy of migraine. Ergotamine (66-74) zVI:- Dihydroalprenolol D02.033.329.624.058.200; D02.092.063.624.058.200; D14.100.050.200.200.050.200; D16.050.850.030.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines; Alprenolol Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines; Alprenolol Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists; Alprenolol Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics; Alprenolol Hydrogenated alprenolol derivative where the extra hydrogens are often tritiated. This radiolabeled form of ALPRENOLOL, a beta-adrenergic blocker, is used to label the beta-adrenergic receptor for isolation and study. Alprenolol (72-74) /analogs and derivatives (75-79); Sympatholytics (66-71) zdl:XDihydro-beta-Erythroidine D03.132.285; D03.549.380 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Dihydro analog of beta-erythroidine, which is isolated from the seeds and other plant parts of Erythrina sp. Leguminosae. It is an alkaloid with curarimimetic properties. Alkaloids (69-74); Indoles (69-74) z:y+Dihydralazine D03.383.710.605.500.250; D18.162.450.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines; Phthalazines; Hydralazine Cardiovascular Agents; Antihypertensive Agents; Hydralazine 1,4-Dihydrazinophthalazine. Proposed antihypertensive agent. Synonyms: Hipopresol; Nepresol; Nonpressine; Pressalin. Heterocyclic Compounds (68-74); Hydrazines (68-75); Pyridazines (68-75) z.:UDihematoporphyrin Ether D11.557.727.462.400.200; D20.388.335; D22.204.436.200; D23.600.300.200; D26.776.819.250.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematoporphyrin Photoradiation Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Hematoporphyrins; Hematoporphyrin Derivative Anti-Infective Agents; Antiviral Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Hematoporphyrin Derivative Dermatologic Agents; Photosensitizing Agents; Hematoporphyrin Derivative Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents; Photosensitizing Agents; Hematoporphyrin Derivative 7-(1-(1-(8,12-Bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid. The purified component of HEMATOPORPHYRIN DERVIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION) to treat malignant lesions with visible light and experimentally as an antiviral agent. Hematoporphyrins (85-92)  zg:#Digoxin D04.808.155.160.349; D09.203.408.180.261.436; D18.222.175.324.386 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides Acetyldigoxins; Digoxigenin; Medigoxin Acetyldigoxins; Medigoxin Acetyldigoxins Toxic cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN; used in congestive heart failure; inhibits ATPase, leading to cardiac arrhythmias and heart block. Synonyms: Cardioxil; Digacin; Lanicor; Lanoxin; Rougoxin; Vanoxin. z I:.[UDigoxigenin D04.808.155.160.349.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Digoxin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. A cardenolide which is the aglycon of digoxin. Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh. Cardanolides (68-74); Digoxin/AA (75-76) z:S2Diglycerides D10.516.351.303 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycerides zBJDigitoxin D04.808.155.160.278; D09.203.408.180.261.336; D18.222.175.324.261 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides Acetyldigitoxins; Digitoxigenin Acetyldigitoxins Acetyldigitoxins AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR zM I:.I<Digitoxigenin D04.808.155.160.278.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Digitoxin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin. Cardanolides (68-74) z:UDigitonin D09.203.408.180.261.236; D26.550.226 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents A glycoside obtained from Digitalis purpurea; the aglycone is digitogenin which is bound to five sugars; it solubilizes lipids, especially in membranes and is used as a tool in cellular biochemistry, and reagent for precipitating cholesterol. It has no cardiac effects. Digitalis Glycosides (66-72); Indicators and Reagents (66-72) zi *@=IDigitalis Glycosides D09.203.408.180.261; D18.222.175.324 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides Digitonin; Digitoxin (+ 1); Digoxin (+ 2); Lanatosides (+ 1) Digitoxin (+ 1); Digoxin (+ 1); Lanatosides (+ 1); Medigoxin AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR zd*>DDigitalis B06.560.290; B06.660.282 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic A genus of toxic herbaceous Eurasian plants of the Scrophulaceae which yield cardiotonic glycosides. The most useful are Digitalis lanata and D. purpurea. zǡ &:Digestive, Oral, Skin Physiology (Non MeSH) G10 Digestive System Physiology (Non MeSH) (+ 18); Mouth Physiology (Non MeSH) (+ 17); Skin Physiology (Non MeSH) (+ 9) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI z4TDigestive System Physiology (Non MeSH) G10.261 Digestive, Oral, Skin Physiology (Non MeSH) Appetite (+ 1); Defecation; Deglutition; Digestion; Drinking; Eating; Gallbladder Emptying; Gastrointestinal Motility (+ 4); Hunger; Intestinal Absorption; Liver Regeneration; Mastication; Salivation CLDEGEIMPHPXRE z@. 4Digestive System Neoplasms C04.588.274; C06.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Digestive System Diseases Biliary Tract Neoplasms (+ 3); Esophageal Neoplasms; Gastrointestinal Neoplasms (+ 21); Liver Neoplasms (+ 1); Pancreatic Neoplasms; Peritoneal Neoplasms Biliary Tract Neoplasms (+ 3); Esophageal Neoplasms; Gastrointestinal Neoplasms (+ 21); Pancreatic Neoplasms; Peritoneal Neoplasms Gastrointestinal Neoplasms (66-79) z XNO(Digestive System Fistula (Non MeSH) C06.185; C23.439.185 Digestive System Diseases Symptoms and General Pathology (Non MeSH); Fistula Biliary Fistula; Esophageal Fistula (+ 1); Gastric Fistula; Intestinal Fistula (+ 2); Pancreatic Fistula Biliary Fistula; Esophageal Fistula (+ 1); Gastric Fistula; Intestinal Fistula (+ 2); Pancreatic Fistula BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI zM+[NDigestive System Diseases C06 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Abdominal Pain (+ 1); Biliary Tract Diseases (+ 32); Digestive System Abnormalities (Non MeSH) (+ 9); Digestive System Fistula (Non MeSH) (+ 8); Digestive System Neoplasms (+ 29); Esophageal Diseases (+ 24); Gastrointestinal Diseases (+ 200); Liver Diseases (+ 54); Pancreatic Diseases (+ 7); Peritoneal Diseases (+ 11) Gastrointestinal Diseases (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI zZN'ZDigestive System Abnormalities (Non MeSH) C06.175; C16.131.314 Digestive System Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Anus, Imperforate; Barrett Esophagus; Biliary Atresia; Caroli's Disease; Diaphragmatic Eventration; Esophageal Atresia; Hirschsprung Disease; Intestinal Atresia; Meckel's Diverticulum Anus, Imperforate; Barrett Esophagus; Biliary Atresia; Caroli's Disease; Diaphragmatic Eventration; Esophageal Atresia; Hirschsprung Disease; Intestinal Atresia; Meckel's Diverticulum BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI z1fLDigestive System A03 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Biliary Tract (+ 10); Esophagus (+ 1); Gastrointestinal System (+ 27); Liver (+ 2); Pancreas (+ 2) Gastrointestinal System (66-71) ABAHBLBSCFCHCICLCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI z8~%hDigestion G10.261.302 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) zF cDigeorge Syndrome C20.673.340 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases; Immunologic Deficiency Syndromes Congenital syndrome with the absence of the thymus and parathyroids causing impairment of cellular immunity. Immunoglobulin levels are normal. Parathyroid Glands (66-76); Thymus Gland (66-76) zN?;Diflunisal D02.241.223.106.505.700.300; D02.241.511.390.700.300; D02.755.410.700.300; D08.373.310.210; D16.850.015.050.190; D17.025.030.210; D17.050.030.215 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Salicylic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 2',4'-Difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid. A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN. Salicylic Acids (66-79) z٬:Diflucortolone D04.808.745.432.719.320.250; D04.808.908.405.250; D06.597.481.364.325.250; D06.597.481.561.353.480.250; D17.025.050.147.200; D17.025.080.200.150.200; D23.037.200.155.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienediols; Fluocortolone Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated; Fluocortolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical; Fluocortolone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Fluocortolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Fluocortolone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Fluocortolone Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Fluocortolone 6 alpha,9-Difluoro-11 beta,21-dihydroxy-16 alpha-methylpregna-1,4-diene-3,20-dione. A topical glucocorticoid used in various dermatoses. It is absorbed through the skin, bound to plasma albumin, and may cause adrenal suppression. It is also administered as the valerate. Fluocortolone/analogs and derivatives (75-79); Glucocorticoids (67); Glucocorticoids, Topical (73-79); Pregnadienediols (74-79); Pregnadienes (73); Pregnanes (68-72) zj:6Diflubenzuron D02.948.684.280; D06.472.445.573.666.170 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea; Phenylurea Compounds Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Invertebrate Hormones; Insect Hormones; Juvenile Hormones N-(((4-Chlorophenyl)amino)carbonyl)-2,6-difluorobenzamide. An insect growth regulator which interferes with the formation of the insect cuticle. It is effective in the control of mosquitoes and flies. Insect Control (74-76); Juvenile Hormones (75-76); Mosquito Control (74-76); Phenylurea Compounds (74-76) z.:~Diffusion of Innovation L01.143.320 Information Science; Communication Technology Transfer The broad dissemination of new ideas, procedures, techniques, materials, and devices and the degree to which these are accepted and used. zr)Diffusion Chambers, Culture E05.909.262.387; E05.909.813.387 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cells, Cultured Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Tissue Culture Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages. Cell Differentiation (66-71); Cells, Cultured (71-88); Diffusion (66-88); Tissue Culture (66-88)  z!&"tDiffusion G06.184.307; H01.671.100.349 DERE Biological Transport Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physical Sciences (Non MeSH); Physics; Biophysics The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space; a major mechanism of BIOLOGICAL TRANSPORT. Biophysics (66-67); Chemistry, Physical (66-67)  z "9Differential Threshold F02.463.593.230; F02.463.593.710.370 CLDEPHRE Psychophysics Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Sensory Thresholds The smallest difference which can be discriminated between two stimuli or one which is barely above the threshold. Psychophysics (70-71); appropriate perception or sensation heading  z_* NDifferential Thermal Analysis E05.196.370 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Calorimetry, Differential Scanning Technique by which phase transitions of chemical reactions can be followed by observation of the heat absorbed or liberated. Heat (66-76); Temperature (66-76); Thermodynamics (66-76)  z#"E(FDiethylstilbestrol D02.455.426.559.389.150.700.175; D06.597.378.359.275; D07.360.276.310.360.260; D26.191.235 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Estrogens, Non-Steroidal Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Hexestrol Hexestrol (E)-4,4'-(1,2-Diethyl-1,2-ethenediyl)bisphenol. A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed). zTd:7Diethylpropion D02.092.471.308; D15.155.110 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Central Nervous System Agents; Appetite Depressants A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p.2290). z":x-Diethylnitrosamine D02.654.442.200; D26.191.646.263 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosamines Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Nitrosamines N-Ethyl-N-nitrosoethanamine. A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. Nitrosamines (69-74) zU&.}Diethylhexyl Phthalate D02.241.223.805.250; D25.700.282 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phthalic Acids Biomedical and Dental Materials (Non MeSH); Plasticizers Bis(2-ethylhexyl)phthalate. A plasticizer. Esters (74); Phthalic Acids (69-74) z&.4-Diethylcarbamazine D02.241.081.251.240; D03.383.606.380; D08.373.390.230; D21.201.287.278.386 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Lipoxygenase Inhibitors Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents; Filaricides N,N-Diethyl-4-methyl-1-piperazinecarboxamide. An anthelmintic used, primarily as the citrate, in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa. zT:Diethylamines D02.092.471.302 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines {8=Diethyl Pyrocarbonate D02.241.081.504.560.250; D26.471.385.250 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Formic Acids; Formic Acid Esters Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives Pyrocarbonic acid diethyl ester. Preservative for wines, soft drinks, fruit juices. Gentle esterifying agent. Synonyms: Baycovin;Ue 5908. Formic Acids (74); Esters (74) {..(Dietetics G02.188 CLECEDHIISLJMAMTOGSNSTTD Dietary Services; Food Service, Hospital Health Occupations The study and regulation of the diet. {  10Dietary Services N02.421.242 CLECHILJMAMTOGSDSNSTTDUT Dietetics Facilities, Manpower and Services (Non MeSH); Health Services Food Service, Hospital (+ 1) Services provided by dietitians or nutritionists to meet the nutritional needs of individuals, including consultation with other professional personnel. Dietetics (66-67); Food Service, Hospital (66-67) ${ J$<Dietary Proteins D12.776.256 ADAEAGAIANBIBLCFCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Protein Deficiency Amino Acids, Peptides and Proteins (Non MeSH); Proteins Egg Proteins, Dietary (+ 6); Milk Proteins (+ 4); Vegetable Proteins AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  {@DVHDietary Fiber J01.341.285 ADAEANCLDFECHIPORESDSNSTTOTUUT Technology, Industry, Agriculture (Non MeSH); Food The remnants of plant cell walls that are resistant to digestion by the alimentary enzymes of man. It comprises various polysaccharides and lignins. { "=Dietary Fats, Unsaturated D10.516.212.302.380; J01.740.250 ADAEANCLMEPDTU Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats Technology, Industry, Agriculture (Non MeSH); Oils Cod Liver Oil; Corn Oil; Cottonseed Oil; Fatty Acids, Omega-3 (+ 3); Safflower Oil; Sesame Oil; Soybean Oil Cod Liver Oil; Corn Oil; Cottonseed Oil; Fatty Acids, Omega-3 (+ 3); Safflower Oil; Sesame Oil; Soybean Oil Unsaturated fats or oils used in foods or as a food. Dietary Fats (66-86); Oils (66-86) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ${ `& C,DDietary Fats D10.516.212.302 ADAEAGAIANBIBLCFCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats Butter; Cholesterol, Dietary; Dietary Fats, Unsaturated (+ 10); Fat Emulsions, Intravenous; Margarine AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESNSTTOTUURUTVI { 5<DyNDietary Carbohydrates D09.203.301 ADAEAGAIANBIBLCFCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates {<KDiet, Sodium-Restricted E02.293.510 AECLCTECHIISMOMTNUPXSNSTTDUTVE Sodium Chloride Therapeutics; Diet Therapy A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed). {"!Diet, Reducing E02.293.385 AECLCTECHIISMOMTNUPXSNSTTDUTVE Obesity Therapeutics; Diet Therapy {" !Diet, Protein-Restricted E02.293.330 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Diet Therapy A diet that contains limited amounts of protein. It is prescribed in some cases to slow the progression of renal failure. (From Segen, Dictionary of Modern Medicine, 1992). Dietary Proteins (66-94) {"!Diet, Macrobiotic E05.272.467; G06.696.384.220 AECLCTECHIMOPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Diet Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Diet An approach to nutrition based on whole cereal grains, beans, cooked vegetables and the Chinese yin-yang principle. It advocates a diet consisting of organic and locally grown foods, seasonal vegetables, complex carbohydrates, and fewer fats, sugars, and chemically processed foods. Diet (86-89); Diet Fads (66-89) {"G)Diet, Fat-Restricted E02.293.275 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Diet Therapy A diet that contains limited amounts of fat with less than 30% of calories from all fats and less than 10% from saturated fat. Such a diet is used in control of HYPERLIPIDEMIA. (From Bondy et al, Metabolic Control and Disease, 8th ed, p 468-70; Dorland, 27th ed). Dietary Fats (66-94) {"!?Diet, Cariogenic E05.272.385 Cariogenic Agents; Dental Caries Miscellaneous Techniques (Non MeSH); Diet Dental Caries (66-71); Diet (66-71) {n(3-Diet, Atherogenic E05.272.260 Cholesterol, Dietary Arteriosclerosis Miscellaneous Techniques (Non MeSH); Diet Arteriosclerosis (66); Diet (66) {=3)Diet Therapy E02.293 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Diabetic Diet; Diet, Fat-Restricted; Diet, Protein-Restricted; Diet, Reducing; Diet, Sodium-Restricted { "wDiet Surveys E05.318.308.250.600.350; E05.318.308.585.550.350; G03.850.520.308.250.600.350; G03.850.520.308.585.550.350; N05.715.360.300.375.560.300; N05.715.360.300.560.565.300 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Nutrition Surveys Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Nutrition Assessment; Nutrition Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Nutrition Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Nutrition Assessment; Nutrition Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Nutrition Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Nutrition Assessment; Nutrition Surveys Systematic collections of factual data pertaining to the diet of a human population within a given geographic area. {Diet Records N04.452.859.360 Health Services Administration (Non MeSH); Organization and Administration; Records Records of nutrient intake over a specific period of time, usually kept by the patient. Diet (66-89); Nutrition Surveys (71-89) {'bj1Diet Fads E02.040.287; I03.287 AEHIPX Therapeutics; Alternative Medicine Human Activities (Non MeSH) Diets which become fashionable, but which are not necessarily nutritious. { k IWDiet E05.272; G06.696.384 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cookery Nutrition; Food Miscellaneous Techniques (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition Diet, Atherogenic; Diet, Cariogenic; Diet, Macrobiotic; Fasting; Vegetarianism Caloric Intake; Diet, Macrobiotic; Vegetarianism Regular course of eating and drinking adopted by a person or animal. This does not include DIET THERAPY, a specific diet prescribed in the treatment of a disease. AEBLCFCLCTDEECGEHIIMISMEMOMTNUPHPXRESNSTTDURUTVE ({!`" v4Diestrus G08.520.780.218.200 BLCFDEGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal; Estrus Period of sexual quiescence separating phases of the estrous cycle in polyestrous animals. {# gkDientamoebiasis C03.432.275; C03.752.700.500.275; C06.405.469.452.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Intestinal Diseases, Parasitic Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic Infection with protozoa of the genus DIENTAMOEBA. {%)=P<Dientamoeba B01.841.750.443.950.725.180 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Trichomonadida A genus of minute protozoa that are characterized by the preponderance of binucleate over uninucleate forms, the presence of several distinct granules in the karyosome, and the lack of a cystic stage. It is parasitic in the large intestine of humans and certain monkeys. {'E&g?Dienestrol D02.755.290; D06.597.378.359.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Estrogens, Non-Steroidal 4,4'-(1,2-Diethylidene-1,2-ethanediyl)bisphenol. A synthetic, non-steroidal estrogen structurally related to stilbestrol. It is used, usually as the cream, in the treatment of menopausal and postmenopausal symptoms. Alkadienes (74); Phenols (69-74) {)b&:)Diencephalon A08.186.211.730.385 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon Hypothalamus (+ 16); Pineal Body; Thalamus (+ 2) The paired caudal parts of the prosencephalon from which the THALAMUS, HYPOTHALAMUS, epithalamus, and subthalamus are derived. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  {+8J>:Dieldrin D02.455.526.439.371; D05.723.491.491.366 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine {- .:DIDS D02.455.426.559.389.150.700.150; D02.500.375.125; D02.886.250.125 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes Organic Chemicals (Non MeSH); Isocyanates; Isothiocyanates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Isothiocyanates 2,2'-(1,2-Ethenediyl)bis(5-isothiocyanatobenzenesulfonic acid). An inhibitor of anion conductance including band 3-mediated anion transport. Stilbenes (77-80); SITS/analogs and derivatives (81-93) {/I:_CDideoxynucleosides D13.570.230.500; D20.388.330; D26.087.295 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Anti-Infective Agents; Antiviral Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Didanosine; Dideoxyadenosine; Stavudine; Zalcitabine; Zidovudine Didanosine; Dideoxyadenosine; Stavudine; Zalcitabine; Zidovudine Didanosine; Dideoxyadenosine; Stavudine; Zalcitabine; Zidovudine Nucleosides which have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. Deoxyribonucleosides (71-88) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ${218!:Dideoxyadenosine D13.570.230.229.105; D13.570.230.500.105; D13.570.583.138.325.105; D20.388.330.105; D26.087.295.105 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxyadenosines Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Dideoxynucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine; Deoxyadenosines Anti-Infective Agents; Antiviral Agents; Dideoxynucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Dideoxynucleosides 2',3'-Dideoxyadenosine. A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to didanosine (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite. Deoxyadenosine/analogs and derivatives (75-89); Dideoxynucleosides (89) {6Xo:SDidanosine D13.570.230.500.090; D13.570.583.616.130; D13.570.800.573.130; D20.388.330.090; D26.087.295.090 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Dideoxynucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Inosine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Inosine Anti-Infective Agents; Antiviral Agents; Dideoxynucleosides Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Dideoxynucleosides 2',3'-Dideoxyinosine. A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. Dideoxynucleosides (89); Inosine/analogs and derivatives (87-89) {<k:/LDicyclomine D02.241.223.268.300; D02.455.426.392.368.367.440; D14.100.120.200.500.200; D16.050.650.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics (Bicyclohexyl)-1-carboxylic acid-2-(diethylamino)ethyl ester. A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion, or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms. Cyclohexanes (72-75); Cyclohexanecarboxylic Acids (68-75); Diethylamines (74-75) {Ad:9|^Dicyclohexylcarbodiimide D02.491.203.385 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Imines; Carbodiimides {F:?Dictyostelium B01.841.750.656.300.250.300; B05.354.618.300 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Eumycetozoea; Dictyosteliida Algae and Fungi (Non MeSH); Fungi; Myxomycota An organism considered both a fungus and a protozoon (Dictionary of Microbiology and Molecular Biology, 2d ed). Its natural habitat is decaying forest leaves, where it feeds on bacteria. D. discoideum is the best-known species and is widely used in biomedical research. Myxomycetes (66-74) {G2&>Dictyosteliida B01.841.750.656.300.250 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Eumycetozoea Dictyostelium An order of protozoa characterized by their ability to aggregate to form multicellular pseudoplasmodium, which give rise to a multispored fruiting body. A stalk tube is present. {J &ODictyocaulus Infections C03.335.349.315; C03.335.508.700.775.825.315; C03.701.377.315; C22.674.377.315 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Helminthiasis; Helminthiasis, Animal (Non MeSH) Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections; Trichostrongyloidiasis Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Helminthiasis, Animal (Non MeSH) Infection with nematodes of the genus DICTYOCAULUS. In deer, cattle, sheep, and horses the bronchi are the site of infestation. Nematode Infections (66-67) {KXJ!Dictyocaulus B01.500.294.700.775.746.300 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Trichostrongyloidea Nematodes parasitic in the bronchi of herbivorous animals. {O*_FDictionaries, Polyglot L01.178.682.192.836.285.561 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Dictionaries {P8Dictionaries, Pharmaceutic L01.178.682.192.836.285.490 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Dictionaries {QDictionaries, Medical L01.178.682.192.836.285.419; L01.178.682.192.836.842.385 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Dictionaries Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Reference Books, Medical {Q> Dictionaries, Dental L01.178.682.192.836.285.348 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Dictionaries {SDictionaries, Classical L01.178.682.192.836.285.277 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Dictionaries {TjDictionaries, Chemical L01.178.682.192.836.285.206 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books; Dictionaries {UJDictionaries L01.178.682.192.836.285 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books Dictionaries, Chemical; Dictionaries, Classical; Dictionaries, Dental; Dictionaries, Medical; Dictionaries, Pharmaceutic; Dictionaries, Polyglot {V)zDicrocoelium B01.500.736.715.300.308 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Dicrocoeliidae (Non MeSH) A genus of trematode liver flukes of the family Dicrocoeliidae which includes the species dendriticum and hospes. It occurs in the biliary passages or liver of many vertebrates including man. The intermediate hosts are mainly mollusks but occasionally ants. {W*\.Dicrocoeliidae (Non MeSH) B01.500.736.715.300 Invertebrates; Helminths; Platyhelminths; Trematoda Dicrocoelium AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI {Y=*Dicrocoeliasis C03.335.865.224 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections Infection with flukes of the genus Dicrocoelium. Trematode Infections (66-67) {ZcPA;"Dicofol D05.723.491.491.350 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine 4,4'-dichloro-alpha-(trichloromethyl)benzhydrol. Miticide. Synonyms: Kelthane; DTMC; FW-293. Alcohol, Ethyl (73-74); Insecticides, Organochlorine (73-74) {[ :wlGDicloxacillin D20.085.099.739.681.205.289 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Oxacillin; Cloxacillin 6-(((3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolyl)-carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid. {]J:lDiclofenac D02.241.223.601.210; D08.373.310.200; D16.850.015.050.180; D17.025.030.200; D17.050.030.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal An anti-inflammatory agent with antipyretic and analgesic actions. It is pharmacologically similar to INDOMETHACIN. Aniline Compounds (73-75); Phenylacetates (73-76) {^g:;Dichotic Listening Tests E01.276.299.375.330 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests Tests for central hearing disorders based on the competing message technique (binaural separation). Auditory Perception (67-79); Hearing (66); Laterality (66-79); Perception (66) {cE"ru`Dichlorvos D02.705.190; D05.723.491.574.190; D08.373.275.282 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors An organophosphorus insecticide that inhibits acetylcholinesterase. Insecticides (66-70); Organophosphorus Compounds (66-70) {e 9:%MBDichlorphenamide D08.373.220.334; D19.770.224.266.334 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Carbonic Anhydrase Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Carbonic Anhydrase Inhibitors {gf*:Dichlororibofuranosylbenzimidazole D13.570.800.330 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides 5,6-Dichloro-1-beta-D-ribofuranosyl-1H-benzimidazol (DRB). Inhibits selectively and reversibly the synthesis of two-thirds of nuclear heterogeneous RNA and approximately 95% of mRNA. DRB can markedly increase interferon production by poly I-C-induced human fibroblasts. Used as a tool in the study of intracellular mechanisms. Synonym: DRB. Benzimidazoles (66-78); Nucleosides (66-70); Ribonucleosides (71-78) {h&:cQDichlorophen D02.755.190.270; D21.201.412.100.334 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Chlorophenols Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Anticestodal Agents 2,2"-methylene-bis-(4-chlorophenol). Nontoxic laxative vermicide effective for taenia infestation; tends to produce colic and nausea. Phenols (66-74) {k*:Dichloroethylenes D02.455.326.271.367.300; D02.455.526.439.350 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Ethylenes Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Toxic chlorinated unsaturated hydrocarbons. Include both the 1,1- and 1,2-dichloro isomers. Both isomers are toxic, but 1,1-dichloroethylene is the more potent CNS depressant and hepatotoxin. It is used in the manufacture of thermoplastic polymers. Ethylenes (74-75); Hydrocarbons, Chlorinated (74-75) {m28!>Dichloroacetate D02.241.081.038.209.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetates A derivative of acetic acid which increases the activity of pyruvate dehydrogenase and rate of lipogenesis. Acetates (66-77); Acetic Acids (68-77) {p:w0Dicarboxylic Acids D02.241.081.337 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Adipic Acids (+ 2); Fumarates; Glutarates (+ 3); Malates (+ 2); Maleates (+ 2); Malonates (+ 2); Oxalates (+ 2); Pimelic Acids (+ 1); Succinates (+ 8); Tartrates; Tartronates AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR {r[8YFDicarbethoxydihydrocollidine D03.383.725.203.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines 1,4-Dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylic acid diethyl ester. Dicarboxylic Acids (72-74); Pyridines (72-74) {tc :iP7Dicamba D02.241.223.106.312; D05.723.366.221 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Benzoates (66-71); Herbicides (66-71) {u *:.Dibutyryl Cyclic GMP D13.695.462.275.325; D13.695.667.454.160.325; D13.695.827.426.160.325 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic; Cyclic GMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides; Cyclic GMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides; Cyclic GMP N-(1-Oxobutyl)-cyclic 3',5'-(hydrogen phosphate)-2'-butanoate guanosine. A derivative of cyclic GMP. It has a higher resistance to extracellular and intracellular phosphodiesterase than cyclic GMP. Guanosine Cyclic Monophosphate (71-77) {whM@-Dibutyl Phthalate D02.241.223.805.225; D25.700.261 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phthalic Acids Biomedical and Dental Materials (Non MeSH); Plasticizers Phthalic acid, dibutyl ester. A plasticizer used in most plastics and found in water, air, soil, plants and animals. It may have some adverse effects with long-term exposure. Phthalic Acids (69-76) {z&.Dibucaine D02.065.355; D15.050.050.180; D15.210.100.200.180; D16.850.025.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1006). {} L:ZFDibromothymoquinone D02.806.250.280 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Benzoquinones 2,5-Dibromo-3-isopropyl-6-methyl-1,4-benzoquinone. At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. Bromine (74); Quinones (73-74) {Y:A'Dibenzoxepins D03.494.382 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Doxepin AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR {8G :Dibenzoxazepines D03.494.347 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Loxapine (+ 1); SC-19220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR {8G!:Dibenzothiepins D03.494.311 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Dothiepin; Methiothepin AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR {8G:Dibenzothiazepines D03.494.276 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) {8GDibenzocycloheptenes D04.615.181.384 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes Amitriptyline; Butaclamol; Cyproheptadine (+ 1); Dizocilpine Maleate; Nortriptyline; Protriptyline A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  {8gt:Dibenzazepines D03.494.240 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Carbamazepine; Clomipramine; Clozapine; Desipramine; Imipramine; Lofepramine; Mianserin; Opipramol; Trimipramine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR {)8G:Dibenamine D02.092.471.245; D14.100.050.200.100.200; D16.050.850.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic alpha-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics An alpha adrenergic antagonist. {A:S'Dibekacin D09.203.408.051.476.200; D20.085.060.425.200; D20.085.089.464.200; D20.338.135.501.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Kanamycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Kanamycin Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular; Kanamycin Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular; Kanamycin 0-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6- diamino-2,3,4,6-tetradeoxy-alpha-D-erythrohexopyranosyl- (1-4))-2-deoxy-D-streptamine. Analog of kanamycin with antitubercular as well as broad-spectrum antimicrobial properties. Deoxy Sugars (74); Kanamycin (73-74) { `:.Diazoxide D18.162.246 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cardiovascular Agents; Antihypertensive Agents {P :6Diazooxonorleucine D02.172.508; D20.085.075.394; D22.204.106.393; D22.204.144.430; D26.087.286 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Azo Compounds Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites {W<Diazonium Compounds D02.172.383 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Azo Compounds Diazomethane AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR {d86:Diazomethane D02.172.383.383 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Azo Compounds; Diazonium Compounds Methane (66) {j:NDiazinon D02.719.220; D05.723.491.657.235 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate O,O-Diethyl O-(2-isopropyl-6-methyl-4-pyrimidyl)phosphorothioate. An organothiophosphorus insecticide. Insecticides, Organothiophosphate (73-74); Pyrimidines (73-74) {I &:rHDiazepam D03.438.079.080.070.216; D14.100.240.500.200; D15.050.035.075.250; D15.075.050.150; D15.080.195; D15.095.168; D15.210.100.175.075.250; D15.210.350.800.150; D15.210.950.012.050.153; D15.325.875.160; D15.525.200; D15.700.872.015.050.275; D16.050.030.168; D16.700.600.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, GABA-A Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Antiemetics Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Muscle Relaxants, Central Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central Nordazepam Nordazepam Nordazepam Nordazepam Nordazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GABA activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589).  {W *:G Diatrizoate Meglumine D02.033.800.813.550.500; D02.241.223.106.530.718.210; D09.203.067.342.600.500; D09.203.853.813.550.500; D26.298.240.642 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Sorbitol; Meglumine Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines; Meglumine Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Sorbitol; Meglumine Miscellaneous Drugs and Agents (Non MeSH); Contrast Media; Diatrizoate 3,5-Bis(acetylamino)-2,4,6-triiodobenzoic acid compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1). Versatile x-ray contrast medium for diagnostic radiology. It can be administered by most routes. Amino Sugars (72-74); Diatrizoate (71-74); Sorbitol (72-74) {[.-IDiatrizoate D02.241.223.106.530.718.200; D26.298.240 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Iodobenzoates; Triiodobenzoic Acids Miscellaneous Drugs and Agents (Non MeSH); Contrast Media  Diatrizoate Meglumine {..Diatoms B05.104.430 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Plankton Algae and Fungi (Non MeSH); Algae Microscopic unicellular algae. Most are aquatic, being found in fresh, brackish, and salt water. Diatoms are noted for the symmetry and sculpturing of their siliceous cell walls. Algae (66-92)  {* & ,Diathermy E02.780.480.280 AECLCTECHIISMOMTNUPXSNSTTDUTVE Microwaves Therapeutics; Physical Therapy; Hyperthermia, Induced Short-Wave Therapy; Ultrasonic Therapy The induction of local hyperthermia by either short radio waves or high-frequency sound waves.  { "?.pDiastole G09.330.800.295 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Myocardial Contraction Period of relaxation of the heart, especially the ventricles. Heart (66-78); Heart Ventricle (66-78) {  J0Diastema A14.254.333; C07.793.494.466 EMETPAPCPPSUTH Labial Frenum Stomatognathic System; Dentition Stomatognathic Diseases; Tooth Diseases; Malocclusion A space between two adjacent teeth in the same dental arch. (Dorland, 27th ed). Dentition (66)  {^ "dcDiarrhea, Infantile C06.405.469.237.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Diarrhea {NaDiarrhea Virus, Bovine Viral B04.820.250.700.150; B04.909.777.310.700.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Pestivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Pestivirus The type species of the PESTIVIRUS genus causing diarrhea, fever, oral ulcerations, and various necrotic lesions among cattle and other domestic animals. {#2Diarrhea C06.405.469.237 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antidiarrheals; Rehydration Solutions Defecation Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Diarrhea, Infantile; Dysentery (+ 2) Passage of excessively liquid or excessively frequent stools. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI ({ N,U-IPDiaphyses A02.835.232.169 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones The elongated cylindrical portion (shaft) of long bones, between the ends or extremities (the EPIPHYSES), which are usually articular and wider than the shaft; the diaphysis consists of a tube of compact bone, enclosing the medullary (marrow) cavity. (Dorland, 27th ed). Bone and Bones (66-94) { :;?Diaphyseal Dysplasia, Progressive C05.116.099.708.281 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Progressive thickening of diaphyseal cortex of long bones. {'NkFDiaphragmatic Eventration C06.175.244; C16.131.314.244 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Elevation of the dome of the diaphragm, usually the result of paralysis of a phrenic nerve. (Dorland, 27th ed). {"LDiaphragm A02.633.567.900.300 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal; Respiratory Muscles The musculomembranous partition separating the abdominal and thoracic cavities, and serving as a major inspiratory muscle. (Dorland, 27th ed). { :SDiaper Rash C17.800.174.255.400.250; C17.800.815.255.400.250 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact; Dermatitis, Irritant Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact; Dermatitis, Irritant A type of irritant dermatitis localized to the area in contact with a diaper and occurring most often as a reaction to prolonged contact with urine, feces, or retained soap or detergent. {w6L#Dianisidine D02.455.426.559.389.185.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds 3,3'-Dimethoxybenzidine. Highly toxic compound which can cause skin irritation and sensitization. It is used in manufacture of azo dyes. Aniline Compounds (69-74); Biphenyl Compounds (69-74); Anisoles (74) {-:SDianhydrogalactitol D02.033.800.256.350; D09.203.853.256.350; D22.204.396 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Sugar Alcohols; Dulcitol Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Alcohols; Dulcitol Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 1,2:5,6-Dianhydrodulcitol. One of the cytotoxic dihalohexitols that may have alkylating antineoplastic activity; causes bone marrow toxicity; the active form is thought to be the diepoxide. Synonyms: dulcitol diepoxide; galactitol diepoxide; NSC 132313. Alcohols (66-71); Dulcitol (72-78); Ethers, Cyclic (66-78) {c=:'HDiamond D01.268.150.200 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Carbon Diamond. A crystalline form of carbon that occurs as hard, colorless or tinted isomeric crystals. It is used as a precious stone, for cutting glass, and as bearings for delicate mechanisms. (From Grant and Hackh's Chemical Dictionary, 5th ed). Carbon (80-93) { :<"Diaminopimelic Acid D02.241.081.337.699.250; D12.125.095.390 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Pimelic Acids Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino 2,6-Diaminoheptanedioic acid. Amino Acids, Diamino (74); Pimelic Acids (72-74) {|.:#<Diamines D02.092.782.258 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines Cadaverine; Ethylenediamines (+ 6); Phenylenediamines (+ 1); Putrescine Organic chemicals which have two amino groups in an aliphatic chain. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  {e 8<WS>Diamide D02.172.300; D08.373.830.290; D26.776.280; D26.550.844.271 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Sulfhydryl Reagents Tetramethyl diazenedicarboxamide. A sulfhydryl reagent which oxidizes sulfhydryl groups to the disulfide form. It is a radiation-sensitizing agent of anoxic bacterial and mammalian cells. Azo Compounds (66-76); Formamides (66-76) {  D.T3Diamfenetide D02.065.199.092.250; D21.201.412.257 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents N,N'-[Oxybis(2,1-ethanediyloxy-4,1-phenylene)]bis-acetamide. Proposed anthelmintic; has been shown useful in fasciola infections in sheep. Acetanilides (74); Ethyl Ethers (74); Phenyl Ethers (74) {*:GDialysis Solutions D26.394.225.766.220 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Peritoneal Dialysis Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Hemodialysis Solutions Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material. Dialysis (66-88); Hemodialysis (67-88); Peritoneal Dialysis (66-88); Peritoneal Dialysis, Continuous Ambulatory (82-88) ${-,ZDialysis E05.196.353; H01.181.529.272 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Microdialysis A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). {͈ ""HDiagnostic Tests, Routine E01.360 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis Diagnostic procedures, such as laboratory tests and x-rays, routinely performed on all individuals or specified categories of individuals in a specified situation, e.g., patients being admitted to the hospital. These include routine tests administered to neonates. { " 1Diagnostic Services N02.421.143.827.233; N02.421.726.233 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Preventive Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Preventive Health Services Mass Screening (+ 4); Mobile Health Units Mass Screening (+ 2); Mobile Health Units Organized services for the purpose of providing diagnosis to promote and maintain health. Diagnosis (66-67); Physical Examination (66-67) AECLCTECHIISLJMAMOMTNUOGPXSDSNSTTDUTVE ${ђ*hj9*Diagnostic Imaging E01.357 AECLCTECHIISMOMTNUPXSNSTTDUTVE Image Processing, Computer-Assisted Diagnosis Image Interpretation, Computer-Assisted (+ 4); Magnetic Resonance Imaging (+ 2); Microscopy, Electron (+ 4); Photography (+ 12); Radiography (+ 54); Radionuclide Imaging (+ 9); Subtraction Technique (+ 2); Thermography; Tomography (+ 7); Transillumination; Ultrasonography (+ 20) Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy. Nuclear Magnetic Resonance (75-87); Photography (66-71); Radiography (75-87); Radiology (71-87); Radionuclide Imaging (77-87); Technology, Radiologic (66-87); Thermography (66-87); Tomography, X-Ray Computed (77-87); Ultrasonic Diagnosis (85-87); Ultrasonics (71-87); specific radiographic technique (66-87) AECLCTDEECEDHIISLJMAMOMTNUOGPXRESNSTTDUTVE ({C ") Pi.Diagnostic Errors E01.354 VE Diagnosis False Negative Reactions; False Positive Reactions; Observer Variation Diagnosis (66-69) {  SDiagnosis, Urologic (Non MeSH) E01.341 Diagnosis Antibody-Coated Bacteria Test, Urinary; Cystoscopy; Kidney Function Tests (+ 3); Nephrostomy, Percutaneous; Ureteroscopy; Urinalysis; Urinary Catheterization; Urography AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE {ٞ%  ,Diagnosis, Surgical E01.315; E04.200 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Diagnosis Surgery, Operative {$"Diagnosis, Respiratory System (Non MeSH) E01.302 Diagnosis Bronchography; Bronchoscopy; Mass Chest X-Ray; Mucociliary Clearance; Respiratory Function Tests (+ 35); Respiratory Sounds AECLCTDEDIECETGEHIIMISMOMTNUPHPPPXRESNSTTDUTVE {ہ0  2Diagnosis, Radioisotope E01.289 AECLCTECHIISMOMTSNSTTDUTVE Diagnosis Protein-Bound Iodine Test; Radioimmunoassay; Radioisotope Dilution Technique; Radioligand Assay; Radionuclide Imaging (+ 9); Schilling Test Any diagnostic evaluation using radioactive (unstable) isotopes. This diagnosis includes many nuclear medicine procedures as well as radioimmunoassay tests. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  {ܰ  &Diagnosis, Otorhinolaryngologic (Non MeSH) E01.276 Diagnosis Diagnosis, Ear (Non MeSH) (+ 13); Laryngoscopy; Nasal Provocation Tests AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE {ު1  W&Diagnosis, Oral E01.262; E06.342 CLECEDHIISLJMAMTOGSNSTTD Mouth Diseases; Oral Health Diagnosis Dentistry Radiography, Dental (+ 3); Sialography Dental Caries Activity Tests; Dental Pulp Test; Radiography, Dental (+ 4) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE  {ߓ#*Diagnosis, Ob-Gyn (Non MeSH) E01.249 Diagnosis Colposcopy; Culdoscopy; Fallopian Tube Patency Tests; Fetal Monitoring (+ 1); Hysterosalpingography; Hysteroscopy; Ovarian Function Tests (+ 1); Pelvimetry; Placental Function Tests; Pregnancy Tests (+ 1); Prenatal Diagnosis (+ 5); Ultrasonography, Mammary; Uterine Monitoring; Vaginal Smears AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE {#  [&Diagnosis, Neurologic (Non MeSH) E01.236 Diagnosis Diagnosis, Brain (Non MeSH) (+ 12); Neurologic Examination (+ 9); Neuroradiography (+ 4); Spinal Puncture AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE {'  ,Diagnosis, Laboratory E01.223 AECLCTECHIISMOMTSNSTTDUTVE Technology, Medical Diagnosis Biopsy (+ 1); Breath Tests; Chemistry, Clinical (+ 13); Cytodiagnosis (+ 7); Cytopathogenic Effect, Viral; False Negative Reactions; False Positive Reactions; Gastric Acidity Determination; Hematologic Tests (+ 29); Immunologic Tests (+ 65); Limulus Test; Neonatal Screening; Occult Blood; Parasite Egg Count; Pregnancy Tests (+ 1); Radioligand Assay; Sex Determination; Specimen Handling (+ 13); Sperm Count; Urinalysis Diagnosis based on findings of laboratory tests. AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE ${  ;4Diagnosis, Eye (Non MeSH) E01.210 Diagnosis Electroretinography; Eye Movements (+ 2); Flicker Fusion; Fluorescein Angiography; Fluorophotometry; Gonioscopy; Ophthalmodynamometry; Ophthalmoscopy; Tonometry; Vision Tests (+ 4) AECLCTDEECGEHIIMISLJMOMTNUOGPHPXRESNSTTDUTVE {   0Diagnosis, Endocrine (Non MeSH) E01.197 Diagnosis Adrenal Cortex Function Tests; Blood Glucose Self-Monitoring; Glucose Tolerance Test; Ovarian Function Tests; Pituitary-Adrenal Function Tests; Pituitary Function Tests; Radioligand Assay; Thyroid Function Tests (+ 2) AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE {;&  ,Diagnosis, Ear (Non MeSH) E01.276.299 Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH) Hearing Tests (+ 9); Vestibular Function Tests (+ 2) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE { >B&Diagnosis, Dual (Psychiatry) E01.190 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis The co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity. specific mental disorder/diagnosis (89-93); specific substance abuse disorder/diagnosis (89-93) {" " #oDiagnosis, Digestive System (Non MeSH) E01.184 Diagnosis Cholangiography (+ 1); Cholecystography; Endoscopy, Digestive System (+ 9); Gastric Acidity Determination; Gastrointestinal Transit; Lactose Tolerance Test; Liver Function Tests; Pancreatic Function Tests; Portography; Sialography AECLCTDEECGEHIIMISMOMTNUPHPXRERHSNSTTDUTVE {.   .Diagnosis, Differential E01.171 Diagnosis Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. {v  Diagnosis, Computer-Assisted E01.158; L01.700.508.100.158 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Diagnosis Information Science; Medical Informatics; Medical Informatics Applications; Decision Making, Computer-Assisted Image Interpretation, Computer-Assisted (+ 1) Image Interpretation, Computer-Assisted (+ 1) Application of computer programs designed to assist the physician in solving a diagnostic problem. Computers (66-68)  {!"$htDiagnosis, Cardiovascular (Non MeSH) E01.145 Diagnosis Angiography (+ 14); Angioscopy; Blood Circulation Time; Blood Flow Velocity; Blood Pressure Determination (+ 1); Blood Volume Determination; Capillary Fragility; Heart Function Tests (+ 32); Indicator Dilution Techniques (+ 3); Laser-Doppler Flowmetry; Plethysmography (+ 3); Tilt-Table Test AECLCTDEECGEHIIMISMOMTNUPHPXRESNSTTDUTVE {+  [,Diagnosis, Brain (Non MeSH) E01.236.257 Diagnosis; Diagnosis, Neurologic (Non MeSH) Cerebral Angiography; Cerebral Ventriculography; Echoencephalography (+ 1); Electroencephalography (+ 5); Magnetoencephalography; Pneumoencephalography AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE {"4&Diagnosis-Related Groups N02.421.589.473.100; N03.219.521.710.305.200.080 CLECHILJOGSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms; Prospective Payment System Outliers, DRG; Severity of Illness Index (+ 2) A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system. Costs and Cost Analysis (66-85)  {6I;'Diagnosis E01 Diagnosis, Cardiovascular (Non MeSH) (+ 65); Diagnosis, Computer-Assisted (+ 2); Diagnosis, Differential; Diagnosis, Digestive System (Non MeSH) (+ 20); Diagnosis, Dual (Psychiatry); Diagnosis, Endocrine (Non MeSH) (+ 10); Diagnosis, Eye (Non MeSH) (+ 16); Diagnosis, Laboratory (+ 149); Diagnosis, Neurologic (Non MeSH) (+ 29); Diagnosis, Ob-Gyn (Non MeSH) (+ 22); Diagnosis, Oral (+ 5); Diagnosis, Otorhinolaryngologic (Non MeSH) (+ 16); Diagnosis, Radioisotope (+ 15); Diagnosis, Respiratory System (Non MeSH) (+ 41); Diagnosis, Surgical; Diagnosis, Urologic (Non MeSH) (+ 11); Diagnostic Errors (+ 3); Diagnostic Imaging (+ 125); Diagnostic Tests, Routine; Disability Evaluation (+ 1); Electrodiagnosis (+ 18); Endoscopy (+ 26); Insufflation; Kymography (+ 1); Mass Screening (+ 4); Medical History Taking (+ 2); Metabolic Clearance Rate; Monitoring, Physiologic (+ 12); Myography (+ 1); Neoplasm Staging; Physical Examination (+ 32); Plethysmography (+ 4); Pneumomediastinum, Diagnostic; Pneumoperitoneum, Artificial; Premarital Examinations; Prognosis (+ 6); Sensitivity and Specificity; Skin Tests (+ 6); Speech Production Measurement (+ 1) The determination of the nature of a disease or condition or the distinguishing of one disease or condition from another. Assessment may be made through physical examination, laboratory tests, or the like, and may be assisted by computerized programs designed to enhance the decision-making process. AECLCTDEDIECEDEHETGEHIIMISLJMAMOMTNUOGPHPPPXRERHSNSTTDUTVE { Y]>Diacylglycerol Cholinephosphotransferase D08.586.913.696.900.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Transferases (Other Substituted Phosphate Groups) An enzyme that catalyzes the synthesis of phosphatidylcholines from CDPcholine and 1,2-diacylglycerols. EC 2.7.8.2. Choline (73-74); Cytosine Nucleotides (73-74); Glycerides (73-74); Phosphotransferases (73-74) {-FpDiacetylmorphine D03.132.610.422.547.547.267; D03.549.686.575.547.332; D03.605.497.575.547.332; D15.040.150.182; D15.210.600.290 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics (5 alpha,6 alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate (ester). A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed). |:{:Diacetyl D02.522.296.400 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butanones 2,3-Butanedione. Carrier of aroma of butter, vinegar, coffee, and other foods. | :<^Diabetic Retinopathy C11.768.257; C14.907.320.382; C18.452.297.312.382; C19.246.312.382 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Retinal Diseases Cardiovascular Diseases; Vascular Diseases; Diabetic Angiopathies Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Diabetic Angiopathies Endocrine Diseases; Diabetes Mellitus; Diabetic Angiopathies Retinopathy associated with diabetes mellitus, which may be of the background type, progressively characterized by microaneurysms, interretinal punctuate macular edema, or of the proliferative type, characterized by neovascularization of the retina and optic disk, which may project into the vitreous, proliferation of fibrous tissue, vitreous hemorrhage, and retinal detachment. |LN1Diabetic Neuropathies C10.772.267; C18.452.297.447; C19.246.447 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Diabetic Foot Diabetic Foot Diabetic Foot | 1N2Diabetic Nephropathies C12.777.419.192; C18.452.297.402; C19.246.402 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Includes renal arteriosclerosis, renal arteriolosclerosis, Kimmelstiel-Wilson syndrome (intercapillary glomerulosclerosis), acute and chronic pyelonephritis, and kidney papillary necrosis in individuals with diabetes mellitus. | X5NDiabetic Ketoacidosis C18.452.076.176.390; C18.452.297.390; C19.246.390 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance; Acidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Complication of diabetes resulting from severe insulin deficiency coupled with an absolute or relative increase in glucagon concentration. The metabolic acidosis is caused by the breakdown of adipose stores and resulting increased levels of free fatty acids. Glucagon accelerates the oxidation of the free fatty acids producing excess ketone bodies (ketosis). |9NDiabetic Foot C10.772.267.250; C14.907.320.191; C17.800.893.592.450.200; C18.452.297.312.191; C18.452.297.447.250; C19.246.312.191; C19.246.447.250; C23.304.351.450.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Diabetic Neuropathies Cardiovascular Diseases; Vascular Diseases; Diabetic Angiopathies Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Ulcer; Leg Ulcer; Foot Ulcer Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Diabetic Angiopathies Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Diabetic Neuropathies Endocrine Diseases; Diabetes Mellitus; Diabetic Angiopathies Endocrine Diseases; Diabetes Mellitus; Diabetic Neuropathies Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases; Foot Ulcer Ulcers of the foot as a complication of diabetes. Diabetic foot, often with infection, is a common serious complication of diabetes and may require hospitalization and disfiguring surgery. The foot ulcers are probably secondary to neuropathies and vascular problems. Diabetes Mellitus (66-93); Foot Diseases (66-93); Foot Ulcer (92-93) |iN 7TDiabetic Diet E02.293.257 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diabetes Mellitus Therapeutics; Diet Therapy A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate. (Dorland, 27th ed). |G"!Diabetic Coma C18.452.297.357; C19.246.357 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Hyperglycemic Hyperosmolar Nonketotic Coma Hyperglycemic Hyperosmolar Nonketotic Coma |"N`Diabetic Angiopathies C14.907.320; C18.452.297.312; C19.246.312 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Diabetic Foot; Diabetic Retinopathy Diabetic Foot; Diabetic Retinopathy Diabetic Foot; Diabetic Retinopathy |/1N}Diabetes, Gestational C13.703.766.285; C18.452.297.820.285; C19.246.820.285 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pregnancy in Diabetes Pregnancy in Diabetes Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy in Diabetes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus; Pregnancy in Diabetes Endocrine Diseases; Diabetes Mellitus; Pregnancy in Diabetes Either symptomatic diabetes or impaired glucose tolerance induced by pregnancy but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETES). Pregnancy in Diabetes (66-91) $|'=LD$Diabetes Mellitus, Non-Insulin-Dependent C18.452.297.300; C19.246.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Diabetes characterized by the ability to survive without ketoacidosis in the absence of insulin therapy. It is usually of slow onset and patients exhibit a tendency to obesity. Diabetes Mellitus (66-83) |!."NDiabetes Mellitus, Lipoatrophic C17.800.849.391.280; C18.452.297.280; C19.246.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH); Lipodystrophy Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus A disorder characterized by complete absence of subcutaneous adipose tissue, insulin-resistant diabetes with little tendency to ketoacidosis, hyperlipidemia with subcutaneous xanthomatosis, hepatomegaly, and an elevated basal metabolic rate. Diabetes Mellitus (66-78); Lipodystrophy (66-78) |#%9N:Diabetes Mellitus, Insulin-Dependent C18.452.297.267; C19.246.267; C20.111.327 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mice, Inbred NOD Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Immunologic Diseases; Autoimmune Diseases Wolfram Syndrome Wolfram Syndrome Diabetes mellitus characterized by insulin deficiency, sudden onset, severe hyperglycemia, rapid progression to ketoacidosis, and death unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.  |'*1N)Diabetes Mellitus, Experimental C18.452.297.240; C19.246.240 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Mice, Inbred NOD Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Mellitus Endocrine Diseases; Diabetes Mellitus Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by pancreatectomy. Diabetes Mellitus (66-77)  |)%"JDiabetes Mellitus C18.452.297; C19.246 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diabetic Diet; Gastroparesis; Glucose Intolerance; Glycosylation End Products, Advanced; Prediabetic State; Scleredema Adultorum Glucose Intolerance Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Endocrine Diseases Diabetes Mellitus, Experimental; Diabetes Mellitus, Insulin-Dependent (+ 1); Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Non-Insulin-Dependent; Diabetic Angiopathies (+ 2); Diabetic Coma (+ 1); Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Neuropathies (+ 1); Obesity in Diabetes; Prediabetic State; Pregnancy in Diabetes (+ 2) Diabetes Mellitus, Experimental; Diabetes Mellitus, Insulin-Dependent (+ 1); Diabetes Mellitus, Lipoatrophic; Diabetes Mellitus, Non-Insulin-Dependent; Diabetic Angiopathies (+ 2); Diabetic Coma (+ 1); Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Neuropathies (+ 1); Obesity in Diabetes; Prediabetic State; Pregnancy in Diabetes (+ 2) A heterogeneous group of disorders that share glucose intolerance in common. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI (|+Nc$[PDiabetes Insipidus, Nephrogenic C12.777.419.430.102; C18.452.264.250; C19.700.482.215.250 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Kidney Failure Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Diabetes Insipidus Endocrine Diseases; Pituitary Diseases; Hypopituitarism; Diabetes Insipidus A rare congenital and familial form of diabetes insipidus, resulting from failure of the renal tubules to absorb water. There is excessive production of antidiuretic hormones but the tubules fail to respond to it. (Dorland, 27th ed). Diabetes Insipidus (66-94) |1%AL. Diabetes Insipidus C18.452.264; C19.700.482.215 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Endocrine Diseases; Pituitary Diseases; Hypopituitarism Diabetes Insipidus, Nephrogenic; Wolfram Syndrome Diabetes Insipidus, Nephrogenic; Wolfram Syndrome A metabolic disorder due to disorders in the production or release of vasopressin. It is characterized by the chronic excretion of large amounts of low specific gravity urine and great thirst. |4"NrDextrothyroxine D06.472.931.812.185; D10.162.202.319; D12.125.072.734.185 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Thyroid Hormones; Thyroxine Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Thyroxine O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-D-tyrosine. The dextrorotary isomer of thyroxine. It is used as an oral anticholesteremic agent, mainly to treat hypercholesteremia in euthyroid patients. |7RA:BDextrorphan D03.132.610.422.235; D03.549.686.260; D03.605.497.260; D14.100.190.300.180; D15.575.110 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists Central Nervous System Agents; Neuroprotective Agents Dextro form of levorphanol. It acts as a noncompetitive NMDA receptor antagonist, among other effects, and has been proposed as a neuroprotective agent. It is also a metabolite of dextromethorphan. Morphinans (69-74) |:&c:Dextromoramide D03.383.533.640.250; D15.040.150.165; D15.210.600.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazines; Morpholines Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics An opioid analgesic structurally related to METHADONE and used in the treatment of severe pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1070). |==:Dextromethorphan D03.132.610.422.463.382; D03.549.686.485.382; D03.605.497.485.382; D15.153.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Levorphanol Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Levorphanol Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Levorphanol Central Nervous System Agents; Antitussive Agents The d-isomer of the codeine analog of LEVORPHANOL. It acts on the medullary cough center to suppress cough but does not have the addictive, analgesic, and sedative effects of CODEINE and does not produce respiratory depression at usual doses. (From AMA, Drug Evaluations Annual, 1994, p.469). Antitussive Agents (66-71); Morphinans (69-71) |@KX:_Y8Dextrocardia C14.240.400.280; C14.280.400.280; C16.131.240.400.280; C16.131.810.501.282 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Situs Inversus; Kartagener's Syndrome Location of the heart in the right hemithorax, with the apex directed to the right. |DTLfDextroamphetamine D02.092.471.683.152.110.200; D14.100.050.600.050.040.200; D14.100.050.600.070.200; D14.100.150.600.040.200; D14.100.150.600.220.040.200; D14.100.600.050.040.200; D14.100.600.220.040.200; D15.155.040.200; D15.220.050.200; D16.050.870.040.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines; Amphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors; Amphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Amphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Amphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors; Amphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors; Amphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors; Amphetamine Central Nervous System Agents; Appetite Depressants; Amphetamine Central Nervous System Agents; Central Nervous System Stimulants; Amphetamine Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics; Amphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. |G: Dextrins D09.203.698.365.855.400 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Starch Cyclodextrins ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR |P} BsDDextrans D09.203.698.365.272; D19.461.140.500.500 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Blood Substitutes; Plasma Substitutes DEAE-Dextran; Dextran Sulfate; Iron-Dextran Complex Dextran Sulfate AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR |Q .@OBDextranase D08.586.277.450.283 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases Glycoside Hydrolases (66-70) |SFl"Dextran Sulfate D09.203.698.365.272.300; D19.461.119.225; D19.461.140.500.500.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Dextrans Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Blood Substitutes; Plasma Substitutes; Dextrans Long-chain polymer of glucose containing 17-20% sulfur. It has been used as an anticoagulant and also has been shown to inhibit the binding of HIV-1 to CD4+ T-lymphocytes. Dextrans (66-90) |UI<tDexetimide D03.383.621.808.250; D14.100.120.200.500.180; D15.090.050.175; D16.050.650.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Piperidones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A muscarinic antagonist that has been used to treat neuroleptic-induced parkinsonism. Benzetimide is the (-)-enantimorph of dexetimide. Benzyl Compounds (72-74); Piperidones (72-74) |X(X:7Dexamethasone Isonicotinate D04.808.745.432.769.344.300; D04.808.908.238.300; D06.597.481.364.150.200; D06.597.481.561.353.256.300; D06.597.481.561.478.242.300; D17.025.050.120.300; D17.025.080.200.115.300; D23.037.200.135.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols; Dexamethasone Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated; Dexamethasone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical; Dexamethasone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Dexamethasone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic; Dexamethasone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Dexamethasone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Dexamethasone Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Dexamethasone 9-Fluoro-11 beta,17,21-trihydroxy-16 alpha-methyl-pregna-1,4-diene-3,20-dione-21-isonicotinate. An anti-inflammatory, antiallergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. It may cause water and salt retention. Dexamethasone (72-74) /analogs and derivatives (75); Isonicotinic Acids (72-75) |[ :!]Dexamethasone D04.808.745.432.769.344; D04.808.908.238; D06.597.481.364.150; D06.597.481.561.353.256; D06.597.481.561.478.242; D15.095.162; D16.050.030.162; D17.025.050.120; D17.025.080.200.115; D17.050.040.175; D23.037.200.135 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Steroidal Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dexamethasone Isonicotinate Desoximetasone; Dexamethasone Isonicotinate Dexamethasone Isonicotinate Desoximetasone; Dexamethasone Isonicotinate Dexamethasone Isonicotinate Desoximetasone; Dexamethasone Isonicotinate Desoximetasone; Dexamethasone Isonicotinate Desoximetasone; Dexamethasone Isonicotinate (11 beta,16 alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione. An anti-inflammatory glucocorticoid used either in the free alcohol or esterified form in treatment of conditions that respond generally to cortisone. |cK:O Device Approval E05.337.275; G03.850.210.275 LJST Miscellaneous Techniques (Non MeSH); Evaluation Studies Environment and Public Health (Non MeSH); Public Health; Consumer Product Safety Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA. Consumer Product Safety (66-94) |l"_&Developmental Biology G01.273.200 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Biology Embryology (+ 1) The field of biology which deals with the process of the growth and differentiation of an organism. Cell Differentiation (68-89); Embryology (78-89); Models, Biological (68-72)  |o#x[Developing Countries I01.534.256 CLECHISN Social Sciences; International Cooperation Countries in the process of change directed toward economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. specific country (66-70); International Cooperation (66-70) |p 2fFDeuteroporphyrins D11.557.727.280 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Porphyrins with four methyl and two propionic acid side chains attached to the pyrrole rings. Porphyrins (70-74) |r@TpDeuteromycetes B05.354.381 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Blastomyces; Hyphomycetes (+ 36) A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Fungi (66-72)  |t.",(zDeuterium Oxide D01.435.256.250; D01.455.900.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Hydrogen; Deuterium Inorganic Chemicals (Non MeSH); Hydroxides; Water Water-d2. The isotopic compound of hydrogen of mass 2 (deuterium) with oxygen. (From Grant and Hackh's Chemical Dictionary, 5th ed). Deuterium (80-93); Water (80-93) |u|&8z)Deuterium D01.435.256; D01.496.289 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Hydrogen Inorganic Chemicals (Non MeSH); Isotopes Deuterium Oxide Deuterium. The stable isotope of hydrogen. It has one neutron and one proton in the nucleus. |wW 8brDetergents D26.866.265; J01.516.381 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents Technology, Industry, Agriculture (Non MeSH); Household Products Benzalkonium Compounds; Benzethonium; Cetrimonium Compounds; Cetylpyridinium; Soaps Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  |x,b:Desulfovibrio vulgaris B03.440.425.410.350.875; B03.900.350.875 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Desulfovibrio Bacteria; Sulfur-Reducing Bacteria; Desulfovibrio A species of gram-negative, anaerobic, rod-shaped bacteria isolated from soil, animal intestines and feces, and fresh and salt water. Desulfovibrio (68-91) |{."Desulfovibrio B03.440.425.410.350; B03.900.350 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH) Bacteria; Sulfur-Reducing Bacteria Desulfovibrio vulgaris Desulfovibrio vulgaris A genus of gram-negative, anaerobic, rod-shaped bacteria capable of reducing sulfur compounds to hydrogen sulfide. Organisms are isolated from anaerobic mud of fresh and salt water, animal intestines, manure, and feces. |}&"4Desoxycorticosterone D04.808.745.745.654.339; D06.472.040.668.478.298 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Mineralocorticoids; Hydroxycorticosteroids 18-Hydroxydesoxycorticosterone 18-Hydroxydesoxycorticosterone 21-Hydroxypregn-4-ene-3,20-dione. Mineralocorticoid. Desoxycorticosterone acetate (DOCA) is used as replacement therapy in Addison's Disease. |A6DBDesoximetasone D04.808.745.432.719.260; D04.808.908.238.250; D06.597.481.561.353.256.250; D17.025.050.120.280; D17.025.080.200.115.275; D23.037.200.135.275 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienediols Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated; Dexamethasone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic; Dexamethasone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal; Dexamethasone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Dexamethasone Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical; Dexamethasone 9-Fluoro-11-beta, 21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione. Topical anti-inflammatory glucocorticoid used in dermatoses, skin allergies, psoriasis, etc. Dexamethasone (66-78); Pregnadienediols (74); Steroids, Fluorinated (74) |:iVDesonide D04.808.745.432.769.325; D06.597.481.364.125; D17.025.050.107; D17.025.080.200.100; D23.037.200.125 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical 16-Hydroxyprednisolone 16,17-acetonide. Nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses. Acetals (74); Ketosteroids (74); Pregnadienetriols (74) |A o:DDesogestrel D04.808.668.651.693.175; D06.597.799.220; D07.360.276.210.443.706.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Norsteroids; Norpregnanes; Norpregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic (17 alpha)-13-Ethyl-11-methylene-18,19-dinorpregn-4-en-20-yn-17-ol. A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents. Norpregnenes (79-92); Progestational Hormones, Synthetic (79-92) |M:KDesmosterol D04.808.247.222.222.347.231; D04.808.247.808.197.250.281; D10.516.851.208.320.297 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestadienes; Cholestadienols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol; Dehydrocholesterols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol; Dehydrocholesterols Sterols (66-71) |Y:<Desmosomes A11.195.443.297 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cell Membrane; Intercellular Junctions A type of junction that attaches one cell to its neighbor. One of a number of differentiated regions which occur, for example, where the cytoplasmic membranes of adjacent epithelial cells are closely apposed. It consists of a circular region of each membrane together with associated intracellular microfilaments and an intercellular material which may include, for example, mucopolysaccharides. (From Glick, Glossary of Biochemistry and Molecular Biology, 1990; Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Cell Membrane (66-71) |*7wDesmosine D03.383.725.762.300; D12.125.072.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) 4-(4-Amino-4-carboxybutyl)-1-(5-amino-5-carboxypentyl)-3,5-bis(3-amino-3-carboxypropyl)pyridinium. A rare amino acid found in elastin, formed by condensation of four molecules of lysine into a pyridinium ring. Amino Acids (72-74); Pyridinium Compounds (70-74) |N *:<Desmopressin D06.472.734.692.781.100.250; D12.644.456.925.250; D19.770.896.036.260 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior; Vasopressins; Argipressin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Vasopressins; Argipressin 1-(3-Mercaptopropanoic acid)-8-D-argininevasopressin. A synthetic analog of ARGIPRESSIN with longer lasting and more potent antidiuretic action than argipressin. It is used to treat DIABETES INSIPIDUS. Arginine (66-74); Vasopressins (66-74) |M:q/Desmin D12.776.220.475.200 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Intermediate Filament Proteins An intermediate filament protein found predominantly in smooth, skeletal, and cardiac muscle cells. Localized at the Z line. MW 50,000 to 55,000 is species dependent. Intermediate Filament Proteins (83-84); Muscle Proteins (66-82) |3 HKDeslanoside D09.203.408.180.261.657.200; D18.222.175.324.542.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides; Lanatosides Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides; Lanatosides Deacetyllanatoside C. A cardiotonic glycoside from the leaves of Digitalis Lanata. Synonym: Cedilanid-D. Lanatosides (69-74) |U:DzDesipramine D03.494.240.281; D14.100.050.600.050.180; D14.100.600.050.180; D15.085.050.200; D15.700.122.055.298 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic A metabolite of IMIPRAMINE that is itself used in the treatment of psychiatric disorders. In addition to its use in depression, desipramine has also been tried in the treatment of panic disorder and attention-deficit disorders. |o: Designer Drugs D26.394.200 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Street Drugs Drug Design; Substance Dependence; Substance Abuse Miscellaneous Drugs and Agents (Non MeSH); Drugs Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines. Chemistry, Pharmaceutical (84-88); Street Drugs (85-88) $|0,=<BDesiccation E05.196.335; H01.181.529.260 ISMT Freeze Drying Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Removal of moisture from a substance (chemical, food, tissue, etc.). |"SDesert Climate G03.230.300.100.250.325 AE Heat Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Climate A type of climate characterized by insufficient moisture to support appreciable plant life. It is a climate of extreme aridity, usually of extreme heat, and of negligible rainfall. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). |du*Desensitization, Psychologic F04.754.137.506 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Behavior Therapy Implosive Therapy A behavior therapy technique in which deep muscle relaxation is used to inhibit the effects of graded anxiety-evoking stimuli. |f!`Desensitization, Immunologic E02.095.520.450.310; E05.478.610.310 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hypersensitivity Therapeutics; Biological Therapy (Non MeSH); Immunotherapy; Immunosuppression Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunosuppression Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IgG, suppression of specific IgE, and an increase in suppressor T-cell activity. |!*"5Descemet's Membrane A09.371.060.217.271 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Anterior Eye Segment; Cornea |y:<Dermotoxins D24.185.926.275 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Cantharidin; Exfoliatins Specific substances elaborated by plants, microorganisms or animals that cause damage to the skin; they may be proteins or other specific factors or substances; constituents of spider, jellyfish or other venoms cause dermonecrosis and certain bacteria synthesize dermolytic agents. specific skin heading (66-77); Skin (66-77); Toxins (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $|=BVFJDDermoid Cyst C04.182.201; C04.557.465.280 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. (Stedman, 25th ed). |"V|Dermatophytes B05.354.318 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Epidermophyton; Microsporum; Trichophyton A fungus parasitic upon the skin. The term embraces the imperfect fungi of the genera EPIDERMOPHYTON, MICROSPORUM and TRICHOPHYTON. |V",1Dermatomyositis C05.651.594.297; C17.300.250; C17.800.185 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Myositis Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases A polymyositis occurring in association with inflammatory skin changes, a purplish rash on the upper eyelids with edema of the lids and surrounding tissue, and an erythematous rash on the forehead, neck, shoulders, trunk, and arms. |1NDermatomycoses C01.539.800.200; C01.703.295; C17.800.838.208 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious Bacterial and Fungal Diseases (Non MeSH); Mycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious Blastomycosis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Cutaneous; Chromoblastomycosis; Maduromycosis; Paracoccidioidomycosis; Sporotrichosis; Tinea (+ 4); Tinea Versicolor Blastomycosis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Cutaneous; Chromoblastomycosis; Maduromycosis; Paracoccidioidomycosis; Sporotrichosis; Tinea (+ 4); Tinea Versicolor Blastomycosis; Candidiasis, Chronic Mucocutaneous; Candidiasis, Cutaneous; Chromoblastomycosis; Maduromycosis; Paracoccidioidomycosis; Sporotrichosis; Tinea (+ 4); Tinea Versicolor Superficial infections of the skin or its appendages by any of various fungi. |Z5Pi^Dermatology G02.403.776.185 CLECEDHIISLJMAMTOGSNSTTD Skin Diseases Health Occupations; Medicine; Specialties, Medical A medical specialty concerned with the skin, its structure, functions, diseases, and treatment. |<pDermatologic Agents D23 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents, Local Skin Diseases; Skin Anti-Inflammatory Agents, Topical (+ 30); Antipruritics (+ 13); Astringents (+ 1); Croton Oil; Emollients (+ 4); Keratolytic Agents (+ 8); Photosensitizing Agents (+ 4); Sunscreening Agents (+ 2); Zinc Oxide Drugs used to treat or prevent skin disorders or for the routine care of skin. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $|8"a@Dermatoglyphics E05.256; I01.198.560.343 CLHI Miscellaneous Techniques (Non MeSH) Social Sciences; Criminology; Forensic Medicine The study of the patterns of ridges of the skin of the fingers, palms, toes, and soles. |ealDermatofibrosarcoma C04.557.450.565.590.350.320; C04.557.450.795.350.320 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Fibrosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Fibrosarcoma A fibrosarcoma of the skin, beginning most often as an indurated nodule that grows slowly and hence is often ignored until it grows large. Dermatofibrosarcomas show an extremely aggressive tendency to invade local surrounding tissue. They do not metastasize, however, even after multiple recurrences. About 50% will recur after simple incision; hence wide excision should be resorted to. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Fibrosarcoma (66-93); Skin Neoplasms (66-93) |:X\6Dermatofibroma C04.557.450.565.590.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue Histiocytoma, Fibrous A slowly growing benign skin nodule consisting of poorly demarcated cellular fibrous tissue enclosing collapsed capillaries with scattered hemosiderin-pigmented and lipid macrophages. They are common, usually about 1 cm in diameter and occur in the dermis. Simple excision is always curative. (From Stedman, 25th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  | VXDermatitis, Toxicodendron C17.800.174.255.100.700; C17.800.815.255.100.700; C20.543.418.150.700 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Toxicodendron Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact; Dermatitis, Allergic Contact Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact; Dermatitis, Allergic Contact Immunologic Diseases; Hypersensitivity; Hypersensitivity, Delayed; Dermatitis, Allergic Contact An allergic contact dermatitis caused by exposure to plants of the genus Toxicodendron (formerly Rhus). These include poison ivy, poison oak, and poison sumac, all plants that contain the substance urushiol, a potent skin sensitizing agent. (From Dorland, 27th ed). |ɪML9Dermatitis, Seborrheic C17.800.174.580; C17.800.805.711.230; C17.800.815.580; C17.800.859.350 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sebaceous Gland Diseases (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous A chronic inflammatory disease of the skin of unknown etiology. It is characterized by moderate erythema, dry, moist, or greasy scaling, and yellow crusted patches on various areas, especially the scalp. On the scalp, it generally appears first as small patches of scales, progressing to involve the entire scalp with exfoliation of excessive amounts of dry scales (dandruff). |rPNDermatitis, Phototoxic C17.800.174.255.400.225; C17.800.600.335; C17.800.815.255.400.225 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact; Dermatitis, Irritant Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Photosensitivity Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact; Dermatitis, Irritant A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin. Photosensitivity Disorders (66-92) |IL(Dermatitis, Photoallergic C17.800.174.255.100.600; C17.800.600.325; C17.800.815.255.100.600; C20.543.418.150.600 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact; Dermatitis, Allergic Contact Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Photosensitivity Disorders Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact; Dermatitis, Allergic Contact Immunologic Diseases; Hypersensitivity; Hypersensitivity, Delayed; Dermatitis, Allergic Contact A delayed hypersensitivity involving the reaction between sunlight or other radiant energy source and a chemical substance to which the individual has been previously exposed and sensitized. It manifests as a papulovesicular, eczematous, or exudative dermatitis occurring chiefly on the light-exposed areas of the skin. Photosensitivity Disorders (66-92) |2`Lq(Dermatitis, Occupational C17.800.174.255.700; C17.800.815.255.700; C21.447.270 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dermatitis, Contact Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases A recurrent contact dermatitis caused by substances found in the work place. |=LA\Dermatitis, Irritant C17.800.174.255.400; C17.800.815.255.400 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact Dermatitis, Phototoxic; Diaper Rash Dermatitis, Phototoxic; Diaper Rash A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms. Dermatitis, Contact (66-92)  |F.LT!Dermatitis, Exfoliative C17.800.174.318; C17.800.815.318 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed). |&NDermatitis, Contact C17.800.174.255; C17.800.815.255 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dermatitis, Occupational Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous Dermatitis, Allergic Contact (+ 2); Dermatitis, Irritant (+ 2); Dermatitis, Occupational Dermatitis, Allergic Contact (+ 2); Dermatitis, Irritant (+ 2); Dermatitis, Occupational A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.  |6&LDermatitis, Atopic C17.800.174.193; C17.800.815.193; C17.800.827.300; C20.543.480.343 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH) Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. |LN~Dermatitis, Allergic Contact C17.800.174.255.100; C17.800.815.255.100; C20.543.418.150 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis; Dermatitis, Contact Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Eczematous; Dermatitis, Contact Immunologic Diseases; Hypersensitivity; Hypersensitivity, Delayed Dermatitis, Photoallergic; Dermatitis, Toxicodendron Dermatitis, Photoallergic; Dermatitis, Toxicodendron Dermatitis, Photoallergic; Dermatitis, Toxicodendron A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure. Dermatitis, Contact (66-92)  |"AL: !Dermatitis Herpetiformis C17.800.174.360; C17.800.865.360; C20.111.318 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Immunologic Diseases; Autoimmune Diseases Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis. |5NDermatitis C17.800.174 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Acrodermatitis; Dermatitis, Atopic; Dermatitis, Contact (+ 7); Dermatitis, Exfoliative; Dermatitis Herpetiformis; Dermatitis, Seborrheic; Drug Eruptions (+ 3); Eczema (+ 1); Intertrigo; Neurodermatitis; Radiodermatitis Any inflammation of the skin. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  |LK&NDermatan Sulfate D09.203.698.373.200.380 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans; Chondroitin Dermatan, 4-(hydrogen sulfate). A glycosaminoglycan found mostly in the skin but also in blood vessels, tendons, heart valves, and pulmonary connective tissue. |qFDermacentor B01.131.166.132.832.380 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida; Acari; Ticks A large, widely distributed genus of ticks, including a number that infest man and other mammals, and several that are vectors of diseases such as TULAREMIA, ROCKY MOUNTAIN SPOTTED FEVER, COLORADO TICK FEVER, and ANAPLASMOSIS. Ticks (66-72) |I(> Dermabrasion E04.860.296 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Plastic |$,Dequalinium D03.438.810.824.200; D20.187.208 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolinium Compounds Anti-Infective Agents; Anti-Infective Agents, Local 1,1'-(1,10-Decanediyl)bis(4-amino-2-methylquinolinium). A topical bacteriostat that is available as various salts. It is used in wound dressings and mouth infections and may also have antifungal action, but may cause skin ulceration. Quinolinium Compounds (70-75) |&:#Depth Perception F02.463.593.200; F02.463.593.932.869.255; G11.697.911.860.317 CLDEGEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception; Space Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception Distance Perception Distance Perception; Vision Disparity Vision Disparity Perception of three-dimensionality. CLDEGEIMPHRE  |E_V*Depressive Disorder F03.709.438.100.410; F03.709.680.080.300 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Affective Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Affective Disorders, Psychotic Neurasthenia Depression, Involutional An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Adjustment Disorders (66-80); Depression (66-80)  |.F+:Depression, Involutional F03.709.680.080.300.400 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Affective Disorders, Psychotic; Depressive Disorder Marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation. |FDepression, Chemical G12.254 Chemical, Pharmacologic Phenomena (Non MeSH) }P 4Depression F03.126.056.463 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Antidepressive Agents Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Affective Symptoms Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders. }FqDepreciation N03.219.463.030.120 LJTD Economics, Organizations, Control (Non MeSH); Economics; Financial Management; Accounting Decline in value of capital assets of a permanent or fixed nature over time with use. }oiiDepersonalization Disorder F03.126.056.296; F03.709.438.416.408 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Affective Symptoms Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Dissociative Disorders Koro Koro A disorder in which there is an alteration in the perception or experience of the self so that the feeling of one's own reality is temporarily lost or changed (feelings of unreality). This is often accompanied by various sensory anesthesias and a feeling of not being in control of one's actions. }*FaDependovirus B04.265.658.210; B04.280.580.210; B04.909.204.671.210 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses; Satellite Viruses Viruses; DNA Viruses; Parvoviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae A genus of PARVOVIRIDAE which are dependent on a coinfection with helper adenoviruses or herpesviruses for their efficient replication. Adenoviridae (66); Satellite Viruses (67-78); Viruses (66) }=HDependent Personality Disorder F03.709.597.160 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder in which the individual passively allows others to assume responsibility for major areas of his or her life because of lack of self-confidence and an inability to function independently. } $FcDependency (Psychology) F01.752.330 Behavior and Behavior Mechanisms (Non MeSH); Personality The tendency of an individual or individuals to rely on others for advice, guidance, or support. } DtDeoxyuridine D13.570.230.430; D13.570.685.852.300; D26.087.274 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Bromodeoxyuridine; Floxuridine; Idoxuridine Bromodeoxyuridine; Floxuridine; Idoxuridine Bromodeoxyuridine; Floxuridine; Idoxuridine 2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. } 9: Deoxyuracil Nucleotides D13.695.201.200; D13.695.740.850.210 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Uracil Nucleotides Fluorodeoxyuridylate Fluorodeoxyuridylate Uracil nucleotides which contain deoxyribose as the sugar moiety. Deoxyribonucleotides (73-77); Uracil Nucleotides (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $}(*B.NBDDeoxyribose D09.203.254.330 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Deoxy Sugars }D\Deoxyribonucleotides D13.695.201 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Deoxyadenine Nucleotides; Deoxycytosine Nucleotides (+ 1); Deoxyguanine Nucleotides; Deoxyuracil Nucleotides (+ 1); Nucleoside Diphosphate Sugars; Thymine Nucleotides (+ 1) specific nucleotide (66-72); Nucleotides (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  }@P:DDeoxyribonucleosides D13.570.230 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides Deoxyadenosines (+ 3); Deoxycytidine (+ 2); Deoxyguanosine; Deoxyuridine (+ 3); Dideoxynucleosides (+ 5); Pentostatin; Thymidine (+ 3) specific nucleoside (66-72); Nucleosides (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  }BP:DDeoxyribonucleoproteins D12.776.664.275 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins Proteins conjugated with deoxyribonucleic acids (DNA) or specific DNA. specific DNA (66-75); DNA (66-75); Nucleoproteins (66-75) }DVSGDeoxyribonucleases, Type III Site-Specific D08.586.150.280.270; D08.586.277.352.335.350.300.270; D08.586.277.352.355.325.300.270 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Restriction Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as ATPases. They exist as complexes with modification methylases of similar specificity listed under EC 2.1.1.72 or EC 2.1.1.73. The systems recognize specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.5. DNA Restriction Enzymes (75-88) }b1]F&Deoxyribonucleases, Type II Site-Specific D08.586.150.280.260; D08.586.277.352.335.350.300.260; D08.586.277.352.355.325.300.260 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Restriction Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes Deoxyribonuclease BamHI; Deoxyribonuclease EcoRI; Deoxyribonuclease HindIII Deoxyribonuclease BamHI; Deoxyribonuclease EcoRI; Deoxyribonuclease HindIII Deoxyribonuclease BamHI; Deoxyribonuclease EcoRI; Deoxyribonuclease HindIII Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4. DNA Restriction Enzymes (78-88)  }0]F&&Deoxyribonucleases, Type I Site-Specific D08.586.150.280.250; D08.586.277.352.335.350.300.250; D08.586.277.352.355.325.300.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Restriction Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes Enzyme systems containing three different subunits and requiring ATP, S-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent ATPases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognize specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.3. DNA Restriction Enzymes (78-88) }%/]F&Deoxyribonucleases D08.586.277.352.335 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Endodeoxyribonucleases (+ 11); Exodeoxyribonucleases Enzymes which catalyze the hydrolases of ester bonds within DNA. EC 3.1.-. }*F`=[Deoxyribonuclease I D08.586.277.352.335.350.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases Streptodornase and Streptokinase An enzyme capable of hydrolyzing highly polymerized DNA by splitting phosphodiester linkages, preferentially adjacent to a pyrimidine nucleotide. This catalyzes endonucleolytic cleavage of DNA yielding 5'-phosphodi- and oligonucleotide end-products. The enzyme has a preference for double-stranded DNA. EC 3.1.21.1 (formerly EC 3.1.4.5). Deoxyribonucleases (66-82); Endodeoxyribonucleases (83-84); Endonucleases (73-82)  },0F&^Deoxyribonuclease HindIII D08.586.150.280.260.400; D08.586.277.352.335.350.300.260.260; D08.586.277.352.355.325.300.260.260 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequence A/AGCTT at the slash. HindIII is from Haemophilus influenzae R(d). Numerous isoschizomers have been identified. EC 3.1.21.-. DNA Restriction Enzymes (75-88) }/oiFm&Deoxyribonuclease EcoRI D08.586.150.280.260.300; D08.586.277.352.335.350.300.260.250; D08.586.277.352.355.325.300.260.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequence G/AATTC at the slash. EcoRI is from E coliRY13. Several isoschizomers have been identified. EC 3.1.21.-. DNA Restriction Enzymes (75-88) }4iFm&Deoxyribonuclease BamHI D08.586.150.280.260.240; D08.586.277.352.335.350.300.260.240; D08.586.277.352.355.325.300.260.240 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; DNA Restriction-Modification Enzymes; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases; DNA Restriction Enzymes; Deoxyribonucleases, Type II Site-Specific One of the Type II site-specific deoxyribonucleases (EC 3.1.21.4). It recognizes and cleaves the sequence G/GATCC at the slash. BamHI is from Bacillus amyloliquefaciens N. Numerous isoschizomers have been identified. EC 3.1.21.-. DNA Restriction Enzymes (75-88) }8iFm&Deoxyguanosine D13.570.230.360; D13.570.583.454.240 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Guanosine A nucleoside consisting of the base guanine and the sugar deoxyribose. Deoxyribonucleosides (73-77); Guanosine (72-77) }=*DU8Deoxyguanine Nucleotides D13.695.201.175; D13.695.667.454.200 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Guanine nucleotides which contain deoxyribose as the sugar moiety. Deoxyribonucleotides (73-77); Guanine Nucleotides (66-77) }?)*BOCDeoxyglucose D09.203.254.229 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Deoxy Sugars 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. }APD\\Deoxyepinephrine D02.092.311.342.300; D02.092.311.461.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Dopamine Organic Chemicals (Non MeSH); Amines; Catecholamines; Epinephrine 4-[2-(Methylamino)ethyl]pyrocatechol. Sympathomimetic, vasoconstrictor agent. Synonym: Epinine. Dopamine (71-74); Methane (73-74) }B.:m*Deoxycytosine Nucleotides D13.695.201.150; D13.695.740.246.425 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides Deoxycytidine Monophosphate Deoxycytidine Monophosphate Cytosine nucleotides which contain deoxyribose as the sugar moiety. Cytosine Nucleotides (66-77); Deoxyribonucleotides (73-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $}De*B>PDDDeoxycytidylate Deaminase D08.586.277.151.653.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases; Nucleotide Deaminases An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12. Aminohydrolases (70-74); Cytosine Nucleotides (70-74); Deoxycytidine Monophosphate (75); Deoxyribonucleotides (73-74); Nucleotide Deaminases (75) }GFNDeoxycytidine Monophosphate D13.695.201.150.200; D13.695.740.246.425.300 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides; Deoxycytosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides; Deoxycytosine Nucleotides Deoxycytidine (dihydrogen phosphate). A deoxycytosine nucleotide containing one phosphate group esterified to the deoxyribose moiety in the 2'-,3'- or 5- positions. Cytosine Nucleotides (66-74) }J; 2D&"Deoxycytidine Kinase D08.586.913.696.620.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74. Deoxycytidine (73-78); Phosphotransferases (66-78) }LF;Deoxycytidine D13.570.230.329; D13.570.685.245.500 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Cytidine Bromodeoxycytidine; Zalcitabine Bromodeoxycytidine; Zalcitabine Nucleosides (66-72) }PP*@HDeoxycholic Acid D04.808.221.430.342; D19.316.246.225.272 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids Chenodeoxycholic Acid (+ 2); Glycodeoxycholic Acid (+ 1); Taurodeoxycholic Acid (+ 1); Ursodeoxycholic Acid Glycodeoxycholic Acid; Taurodeoxycholic Acid (+ 1) (3 alpha,5 beta,12 alpha)-3,12-Dihydroxy-5-cholan-24-oic acid. A bile acid formed by bacterial action from cholate. It is usually conjugated with glycine or taurine. Deoxycholic acid acts as a detergent to solubilize fats for intestinal absorption, is reabsorbed itself, and is used as a choleretic and detergent. Bile Acids and Salts (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $}R/.Bn$FDeoxyadenosines D13.570.230.229; D13.570.583.138.325 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides; Adenosine Cladribine; Dideoxyadenosine; Puromycin Aminonucleoside Cladribine; Dideoxyadenosine; Puromycin Aminonucleoside Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenosine (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $}V9*B~DDeoxyadenine Nucleotides D13.695.201.100; D13.695.667.138.410 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Deoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Adenine nucleotides which contain deoxyribose as the sugar moiety. Adenine Nucleotides (66-77); Deoxyribonucleotides (73-77) }Y7*BOCDeoxy Sugars D09.203.254 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Deoxyglucose; Deoxyribose; Fucose; Rhamnose AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR }[^BK5DDeodorants D26.313.295; J01.516.329 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Cosmetics Technology, Industry, Agriculture (Non MeSH); Household Products }\*Denturists M01.526.485.067.105.503.300; N02.360.067.105.503.300 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries; Dental Technicians Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries; Dental Technicians Dental technicians who provide dentures for patients without benefit of a dentist's professional services. Their duties include taking impressions and bite registrations for preparing and repairing dentures and fitting dentures. They are rarely found in the United States, where their practice is illegal in many states, but are becoming increasingly common in Canada. Dental Auxiliaries (79); Dental Technicians (66-78) }]:B>Dentures E06.780.345.760 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dental Prosthesis Dentistry; Prosthodontics; Dental Prosthesis Denture Bases; Denture, Complete (+ 3); Denture Design; Denture Liners; Denture, Overlay; Denture, Partial (+ 7); Denture Rebasing; Denture Repair; Denture Retention An appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues. It does not include CROWNS, DENTAL ABUTMENTS, nor TOOTH, ARTIFICIAL. AECLCTECHIISMAMOMTNUPXSDSNSTTDUTVE $}a` $5&Denture, Precision Attachment E06.780.345.760.433.555 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial A frictional retainer used in the construction of a partial denture. It consists of a crypt-like unit built into the abutment crown and an insert extending through a slot on the outside of the crypt. Denture, Partial (66-69); Denture, Partial, Removable (66-69) }c#VIDenture, Partial, Temporary E06.780.345.760.433.484 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial A partial denture intended for short-term use in a temporary or emergency situation. }e!VeDenture, Partial, Removable E06.780.345.760.433.413 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial Dental Clasps A partial denture designed and constructed to be removed readily from the mouth. }g!VaDenture, Partial, Immediate E06.780.345.760.433.342 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial A partial denture constructed before the teeth it replaces are removed. It is then inserted immediately after the removal of the natural teeth for functional and cosmetic reasons during the healing process. It is to be replaced later by the fitted partial denture. }h_!V9Denture, Partial, Fixed, Resin-Bonded E06.780.345.760.433.271.260 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial; Denture, Partial, Fixed A commonly used prosthesis that results in a strong, permanent restoration. It consists of an electrolytically etched cast-metal retainer that is cemented (bonded), using resins, to adjacent teeth whose enamel was previously acid-treated (acid-etched). This type of bridgework is sometimes referred to as a Maryland bridge. Acid Etching, Dental (82-91); Dental Bonding (82-91); Denture, Partial, Fixed (82-91) }ji,sygDenture, Partial, Fixed E06.780.345.760.433.271 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial Denture, Partial, Fixed, Resin-Bonded A partial denture attached to prepared natural teeth, roots, or implants by cementation. }mJV,iDenture, Partial E06.780.345.760.433 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures Denture, Partial, Fixed (+ 1); Denture, Partial, Immediate; Denture, Partial, Removable (+ 1); Denture, Partial, Temporary; Denture, Precision Attachment A denture replacing one or more (but not all) natural teeth. It is supported and retained by underlying tissue and some or all of the remaining teeth. }nADenture, Overlay E06.780.345.760.395 AECLCTECHISDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures Removable prosthesis constructed over natural teeth or implanted studs. }pATDenture, Complete, Upper E06.780.345.760.290.504 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Complete A complete denture replacing all the natural maxillary teeth and associated maxillary structures. It is completely supported by the oral tissue and underlying maxillary bone. }qWDenture, Complete, Lower E06.780.345.760.290.379 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Complete A complete denture replacing all the natural mandibular teeth and associated structures. It is completely supported by the oral tissue and underlying mandibular bone. }sdWDenture, Complete, Immediate E06.780.345.760.290.254 AECLCTECHIPXSDSNSTTDUTVE Alveoloplasty Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Complete A complete denture constructed for replacement of natural teeth immediately after their removal. It does not fit the mouth perfectly and is intended only for functional and cosmetic purposes during the healing process after total extraction. It is to be replaced by the fitted permanent denture. }t"W[Denture, Complete E06.780.345.760.290 AECLCTECHIPXSDSNSTTDUTVE Mouth, Edentulous Dentistry; Prosthodontics; Dental Prosthesis; Dentures Denture, Complete, Immediate; Denture, Complete, Lower; Denture, Complete, Upper A denture replacing all natural teeth and associated structures in both the maxilla and mandible.  }w9A^tDenture Retention E06.780.345.760.550 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures The retention of a denture in place by design, device, or adhesion. }x$ASDenture Repair E06.780.345.760.500; E06.912.285 AECLCTECHIISMTNUPXSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures Dentistry; Technology, Dental The process of reuniting or replacing broken or worn parts of a denture. Dental Prosthesis (66-71) }y& cYDenture Rebasing E06.780.345.760.471; E06.912.280 AECLCTECHIISMTNUPXSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures Dentistry; Technology, Dental The process of refitting a denture by replacing the denture base material without changing the occlusal relations of the teeth. Rebasing may include adding to the denture base to compensate for resorptive changes to subjacent structures. }{9& cDenture Liners E06.780.345.760.357 AECLCTECHISDSNSTTDUTVE Silicone Elastomers Dentistry; Prosthodontics; Dental Prosthesis; Dentures Material applied to the tissue side of a denture to provide a soft lining to the parts of a denture coming in contact with soft tissue. It cushions contact of the denture with the tissues. }}0ADenture Identification Marking E06.912.275 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Technology, Dental Any system of defining ownership of dentures or dental prostheses. Denture, Complete (66-83); Forensic Dentistry (66-83) }~$$$P@Denture Design E06.780.345.760.300; E06.912.250 AECLCTECHIISMTNUPXSNSTTDVE Prosthesis Design; Equipment Design Dentistry; Prosthodontics; Dental Prosthesis; Dentures Dentistry; Technology, Dental The plan, delineation, and location of actual structural elements of dentures. The design can relate to retainers, stress-breakers, occlusal rests, flanges, framework, lingual or palatal bars, reciprocal arms, etc. Cleft Palate Prosthesis (66-69); Dental Prosthesis (66-69); Mandibular Prosthesis (67-69)  } &+cjDenture Cleansers D25.376.262 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dentifrices Substances used to clean dentures; they are usually alkaline peroxides or hypochlorites, may contain enzymes and release oxygen. Use also for sonic action cleaners. Dental Prosthesis (66-78); Dentifrices (66-78); Oral Hygiene (73-78) }|*CSDenture Bases E06.780.345.760.281 AECLCTECHISDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures The part of a denture that overlies the soft tissue and supports the supplied teeth and is supported in turn by abutment teeth or the residual alveolar ridge. It is usually made of resins or metal or their combination. }JADentition, Primary A14.254.245 Tooth, Deciduous Stomatognathic System; Dentition The teeth first in order or time of development that will be replaced by permanent dentition upon their loss. Tooth, Deciduous (66-90) }'Dentition, Mixed A14.254.229 Serial Extraction Stomatognathic System; Dentition Dentition (66-70) }"'Dentition A14.254 Tooth Stomatognathic System Dentition, Mixed; Dentition, Primary; Diastema; Periodontium (+ 6); Tooth (+ 20) ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI }   cjDentists, Women M01.526.485.330.310; M01.975.310; N02.360.330.310 CLECHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Dentists Named Groups (Non MeSH); Women Facilities, Manpower and Services (Non MeSH); Health Personnel; Dentists Female dentists. }9Dentists M01.526.485.330; N02.360.330 CLECHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Dentists, Women Dentists, Women Individuals licensed to practice dentistry. }u "&4Dentistry, Operative E06.323; G02.163.180 CLECEDHIISLJMAMTOGSNSTTD Surgery, Oral Dentistry Health Occupations; Dentistry Crown Lengthening; Dental Cavity Lining; Dental Cavity Preparation (+ 1); Dental Restoration, Permanent (+ 3); Dental Restoration, Temporary AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE  }/,Dentistry E06; G02.163 CLMAMTOGSNSTTDVE Dental Equipment; Dental Instruments; Economics, Dental; Education, Dental; History of Dentistry; Legislation, Dental  Health Occupations Anesthesia, Dental (+ 1); Dental Bonding (+ 2); Dental Care (+ 3); Dental Debonding; Dental Equipment (+ 7); Dental Health Surveys (+ 4); Dental High-Speed Technique; Dental Implantation (+ 5); Dental Models; Dental Occlusion (+ 4); Dental Pins; Dental Polishing; Dental Stress Analysis; Dentistry, Operative (+ 9); Diagnosis, Oral (+ 7); Electrogalvanism, Intraoral; Endodontics (+ 10); Esthetics, Dental; Jaw Relation Record (+ 1); Mouth Rehabilitation; Odontometry; Orthodontics (+ 18); Pathology, Oral; Pediatric Dentistry; Periodontics (+ 12); Preventive Dentistry (+ 8); Prosthodontics (+ 40); Surgery, Oral (+ 20); Technology, Dental (+ 9); Tooth Bleaching; Tooth Remineralization Dentistry, Operative; Forensic Dentistry; General Practice, Dental; Geriatric Dentistry; Military Dentistry; Occupational Dentistry; Pediatric Dentistry; Preventive Dentistry; School Dentistry; Specialties, Dental (+ 9) The profession concerned with the teeth, oral cavity, and associated structures, and the diagnosis and treatment of their diseases including prevention and the restoration of defective and missing tissue. AEANCHCLCSCTDUECEDHIIPISLJMAMEMIMOMTNUOGPDPKPOPSPXRERHSDSNSTTDTOTUUTVEVI $}y <LDentist-Patient Relations F01.829.401.650.410; N05.300.660.325 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Interpersonal Relations; Professional-Patient Relations Quality, Access, Evaluation (Non MeSH); Delivery of Health Care; Professional-Patient Relations The psychological relations between the dentist and patient. }*HDentinogenesis Imperfecta C07.650.800.270; C07.793.700.270; C16.131.850.800.270 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Osteogenesis Imperfecta Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities An autosomal dominant disorder of tooth development characterized by opalescent dentin resulting in discoloration of the teeth, ranging from dusky blue to brownish. The dentin is poorly formed with an abnormally low mineral content; the pulp canal is obliterated, but the enamel is normal. The teeth usually wear down rapidly, leaving short, brown stumps. (Dorland, 27th ed). }=LFDentinogenesis G07.553.767.461 DEGEIMPHRE Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Odontogenesis }lDentin, Secondary A14.254.860.376.310; C07.793.237.378 ABAHBSCHCICYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Dentin Stomatognathic Diseases; Tooth Diseases; Dental Pulp Diseases Dentin formed and deposited in response to a normal or slightly abnormal stimulus, after the complete formation of the tooth. (Dorland, 27th ed). }A*<Dentin-Bonding Agents D25.339.291.300; D26.016.275.300 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements Miscellaneous Drugs and Agents (Non MeSH); Adhesives; Dental Cements Cements that act through infiltration and polymerization within the dentinal matrix and are used for dental restoration. They can be adhesive resins themselves, adhesion-promoting monomers, or polymerization initiators that act in concert with other agents to form a dentin-bonding system. Composite Resins (83-92); Dental Bonding (76-92) }&*N;Dentin Solubility G10.549.242 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) }WDentin Sensitivity C07.793.266 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases }N/Dentin Permeability G10.549.879.461 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH); Tooth Permeability }AoDentin Dysplasia C07.650.800.260; C07.793.700.260; C16.131.850.800.260 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities An apparently hereditary disorder of dentin formation, marked by a normal appearance of coronal dentin associated with pulpal obliteration, faulty root formation, and a tendency for peripheral lesions without obvious cause. (From Dorland, 27th ed). }=LF!Dentin A14.254.860.376 ABAHBSCHCYDEENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Odontoblasts Stomatognathic System; Dentition; Tooth Dentin, Secondary ABAHBSCHCICYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  }0 80<Dentigerous Cyst C04.182.089.530.690.310; C05.500.470.690.310; C07.320.450.670.275 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts; Odontogenic Cysts Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Stomatognathic Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Most common follicular odontogenic cyst. Occurs in relation to a partially erupted or unerupted tooth with at least the crown of the tooth to which the cyst is attached protruding into the cystic cavity. May give rise to an ameloblastoma and, in rare instances, undergo malignant transformation. }BIV\Dentifrices D25.376; D26.313.211; J01.516.278 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Mouthwashes Mouthwashes Biomedical and Dental Materials (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Cosmetics Technology, Industry, Agriculture (Non MeSH); Household Products Denture Cleansers; Toothpaste Toothpaste Toothpaste Any preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives. $}]),<Dental Waste G03.850.460.710.460.150 AEANCLECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Waste Products; Medical Waste Any waste product generated by a dental office, surgery, clinic, or laboratory including amalgams, saliva, and rinse water. Waste Products (76-93) } Dental Veneers E06.323.428.245; E06.780.345.750 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Dentistry, Operative; Dental Restoration, Permanent Dentistry; Prosthodontics; Dental Prosthesis The use of a layer of tooth-colored material, usually porcelain or acrylic resin, applied to the surface of natural teeth, crowns, or pontics by fusion, cementation, or mechanical retention. Crowns (66-83); Dental Porcelain (66-83); Dental Prosthesis (66-69); Dental Prosthesis Design (70-83) }&|zDental Technicians M01.526.485.067.105.503; N02.360.067.105.503 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries Denturists Denturists Individuals responsible for fabrication of dental appliances. }2HDental Stress Analysis E06.308 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry Dental Occlusion (66-69) } $ Dental Staff, Hospital M01.526.485.290.490; M01.526.485.740.322; N02.360.290.490; N02.360.740.322 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Dental Staff Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital Facilities, Manpower and Services (Non MeSH); Health Personnel; Dental Staff Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital Dental personnel practicing in hospitals. }T2Dental Staff M01.526.485.290; N02.360.290 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Dental Staff, Hospital Dental Staff, Hospital Personnel who provide dental service to patients in an organized facility, institution or agency. }"6sDental Soldering E06.912.190 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Technology, Dental The joining of pieces of metal through the use of an alloy which has a lower melting point, usually at least 100 degrees Celsius below the fusion temperature of the parts being soldered. In dentistry, soldering is used for joining components of a dental appliance, as in assembling a bridge, joining metals to orthodontic bands, or adding to the bulk of certain structures, such as the establishment of proper contact areas on inlays and crowns with adjacent teeth. (Illustrated Dictionary of Dentistry, 1982). Welding (66-72) }$$XDental Service, Hospital N02.278.354.422.298; N02.421.240.200; N04.452.442.422.298 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Facilities, Manpower and Services (Non MeSH); Health Services; Dental Health Services Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department providing dental care. }Ao3Dental Scaling E06.721.189.350; E06.761.227.350 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Periodontics; Dental Prophylaxis Dentistry; Preventive Dentistry; Dental Prophylaxis Root Planing Root Planing Removal of dental plaque and dental calculus from the surface of a tooth, from the surface of a tooth apical to the gingival margin accumulated in periodontal pockets, or from the surface coronal to the gingival margin. Dental Prophylaxis (66-71)  }"&$o  Dental Sac A14.254.860.851.378 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Tooth Germ Dense fibrous layer formed from mesodermal tissue that surrounds the epithelial enamel organ. The cells eventually migrate to the external surface of the newly formed root dentin and give rise to the cementoblasts that deposit cementum on the developing root, fibroblasts of the developing periodontal ligament, and osteoblasts of the developing alveolar bone. }]:?Dental Restoration, Temporary E06.323.528 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Acrylic Resins; Dental Materials Dentistry; Dentistry, Operative }#$(&Dental Restoration, Permanent E06.323.428 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Acrylic Resins; Dental Materials Dentistry; Dentistry, Operative Dental Veneers; Inlays; Marginal Adaptation (Dentistry) AECLCTECHIISMAMOMTNUPXSDSNSTTDUTVE  }#$(&B&Dental Records E05.318.308.940.375; G03.850.520.308.940.375; L01.280.900.375; N04.452.859.341; N05.715.360.300.715.330 CLECLJSNST Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records Information Science; Data Collection; Records Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records Data collected during dental examination for the purpose of study, diagnosis, or treatment planning. Medical Records (66) }svDental Pulp Test E06.342.377 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Endodontics Dentistry; Diagnosis, Oral }$!Dental Pulp Gangrene C07.793.237.315 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Dental Pulp Diseases }źNIDental Pulp Exposure C07.793.237.283 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Dental Pulp Diseases The result of pathological changes in the hard tissue of a tooth caused by carious lesions, mechanical factors, or trauma, which render the pulp susceptible to bacterial invasion from the external environment. }ƝNIDental Pulp Diseases C07.793.237 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endodontics Stomatognathic Diseases; Tooth Diseases Dental Pulp Autolysis; Dental Pulp Calcification; Dental Pulp Exposure; Dental Pulp Gangrene; Dentin, Secondary; Pulpitis ABAHBLBSCFCHCICLCNCOCYDEDHDIDTECEHEMENEPETGDGEHIIMINIRMEMIMONUPAPCPHPPPSPXRARERHRIRTSESUTHTRULURUSVEVI  }yN/jDental Pulp Devitalization E06.397.778.377 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Endodontics; Root Canal Therapy Dental Pulp (66-69) }S $4Dental Pulp Cavity A14.254.860.340 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Stomatognathic System; Dentition; Tooth The space in a tooth bounded by the dentin and containing the dental pulp. The portion of the cavity within the crown of the tooth is the pulp chamber; the portion within the root is the pulp canal or root canal. }80Dental Pulp Capping E06.397.370 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Calcium Hydroxide Dentistry; Endodontics Application of a protective agent to an exposed pulp (direct capping) or the remaining thin layer of dentin over a nearly exposed pulp (indirect capping) in order to allow the pulp to recover and maintain its normal vitality and function. }$Dental Pulp Calcification C07.793.237.252 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Dental Pulp Diseases }ΓNIDental Pulp Autolysis C07.793.237.190 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Dental Pulp Diseases Spontaneous disintegration of dental pulp tissue by the action of its endogenous enzymes. }{NIjDental Pulp A14.254.860.304 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISETRULUSVI Pulpectomy; Pulpotomy Stomatognathic System; Dentition; Tooth }80Dental Prosthesis Retention E06.780.345.687 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis The retention of a dental prosthesis in place by design, device, or adhesion. Dental Prosthesis Retention (66-89); Denture Retention (90-92) }і!$5^JDental Prosthesis Repair E06.780.345.656 AECLCTECHIISMTNUPXSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis The process of reuniting or replacing a broken or worn dental prosthesis or its part. Denture Repair (72-92) } 5hDental Prosthesis Design E06.780.345.625 AECLCTECHIISMTNUPXSNSTTDVE Dentistry; Prosthodontics; Dental Prosthesis The plan and delineation of dental prostheses in general or a specific dental prosthesis. It does not include DENTURE DESIGN. Denture Design (70-92) }#5Dental Prosthesis E06.780.345 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Dentures Dentistry; Prosthodontics Crowns (+ 1); Dental Abutments; Dental Prosthesis Design; Dental Prosthesis Repair; Dental Prosthesis Retention; Dental Veneers; Dentures (+ 19); Tooth, Artificial A replacement for one or more of the teeth or part of a tooth, or associated structures, ranging from a portion of a tooth to a complete denture. DENTURES and specific types of dentures are also available. Dentures (91-92) AECLCTECHIISMAMIMOMTNUPSPXSDSNSTTDUTVEVI (}Հ* ,Dental Prophylaxis E06.721.189; E06.761.227 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dental Calculus Dentistry; Periodontics Dentistry; Preventive Dentistry Dental Scaling (+ 1) Dental Scaling (+ 1) Treatment for the prevention of periodontal diseases or other dental diseases by the cleaning of the teeth in the dental office using the procedures of DENTAL SCALING and DENTAL POLISHING. The treatment may include plaque detection, removal of supra- and subgingival plaque and calculus, application of caries-preventing agents, checking of restorations and prostheses and correcting overhanging margins and proximal contours of restorations, and checking for signs of food impaction.  }*$A4.Dental Porcelain D25.264.377; D25.339.376 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Crowns; Tooth, Artificial Biomedical and Dental Materials (Non MeSH); Ceramics Biomedical and Dental Materials (Non MeSH); Dental Materials }e* Dental Polishing E06.298 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry Creation of a smooth and glossy surface finish on a denture or amalgam. Dental Restoration, Permanent (66-83); Surface Properties (68-83) }܌ $ XMDental Plaque Index E05.318.308.250.300.300; E06.208.250; G03.850.520.308.250.300.300; G03.890.160.090; N05.715.360.300.375.300.325 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Dentistry; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys; Dental Health Surveys Environment and Public Health (Non MeSH); Public Health Dentistry; Dental Health Surveys Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys; Dental Health Surveys An index which scores the degree of dental plaque accumulation. Dental Plaque (66-82); Periodontal Index (66-82) }ݩ{vM;Dental Plaque A12.300.300; C07.793.208.377 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Fluids and Secretions (Non MeSH); Dental Deposits Stomatognathic Diseases; Tooth Diseases; Dental Deposits A soft, thin film of food debris, mucin, and decayed epithelial cells deposited on the teeth, providing the medium for the growth of various bacteria. The main inorganic components are calcium and phosphorus. Plaque plays an important etiologic role in the development of dental caries and periodontal and gingival disease and provides the base for the development of materia alba. Calcified plaque forms dental calculus. (From Dorland, 27th ed). }^"R~ Dental Pins E06.292 AECLCTECHISDSNSTTDUTVE Dentistry Small cylindrical pieces of metal used to enhance retention. Dental Cavity Preparation (66-69); Inlays (66-69) }  I<Dental Papilla A14.254.860.851.252 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth; Tooth Germ Mesodermal tissue enclosed in the invaginated portion of the epithelial enamel organ and giving rise to the dentin and pulp. }:?Dental Offices N02.278.192.377 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Dental Facilities The room or rooms in which the dentist performs his services. Health Facilities (68-69) }bLDental Occlusion, Traumatic C07.793.494.293 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Malocclusion An occlusion resulting in overstrain and injury to teeth, periodontal tissue, or other oral structures. }!N?zDental Occlusion, Centric E06.276.459 ST Dentistry; Dental Occlusion Vertical Dimension }m"Dental Occlusion, Balanced E06.276.293 ST Dentistry; Dental Occlusion } "Dental Occlusion E06.276; G10.549.202 Jaw Relation Record; Malocclusion Dentistry Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) Bite Force; Dental Occlusion, Balanced; Dental Occlusion, Centric (+ 1) ST }s)bWDental Models E06.261 AECLCTECHISDSNSTTDUTVE Dentistry }  Dental Materials D25.339 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Dental Bonding; Inlays Acrylic Resins; Dental Restoration, Permanent; Dental Restoration, Temporary; Chromium Alloys Biomedical and Dental Materials (Non MeSH) Composite Resins (+ 1); Dental Alloys (+ 5); Dental Casting Investment; Dental Cements (+ 7); Dental Implants; Dental Impression Materials (+ 2); Dental Porcelain; Periodontal Dressings; Pit and Fissure Sealants; Root Canal Filling Materials (+ 1); Root Canal Irrigants ADAEANCHCLCSCTDUECHIIPMEMIPDPKPOPSRESDSNSTTDTOTUULUTVEVI $} *m3F<Dental Leakage C07.793.221 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases The seepage of fluids, debris, and micro-organisms between the walls of a prepared dental cavity and the restoration. Bonding, Dental (71-83); Composite Resins (72-83); Dental Restoration, Permanent (66-83) }N/iDental Instruments E06.186.501; E07.222.501 AECLCTECHISDSNSTTDUTVE Dentistry Dentistry; Dental Equipment Equipment and Supplies; Dental Equipment Matrix Bands Matrix Bands } Q Dental Impression Technique E06.912.130 AECLCTECHIISMAMONUPXSNSTTDUTVE Dentistry; Technology, Dental Procedure of producing an imprint or negative likeness of the teeth and/or edentulous areas. Impressions are made in plastic material which becomes hardened or set while in contact with the tissue. They are later filled with plaster of Paris or artificial stone to produce a facsimile of the oral structures present. Impressions may be made of a full complement of teeth, of areas where some teeth have been removed, or in a mouth from which all teeth have been extracted. (Illustrated Dictionary of Dentistry, 1982). }z!"$dDental Impression Materials D25.339.334 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Silicone Elastomers Biomedical and Dental Materials (Non MeSH); Dental Materials Alginates; Inlay Casting Wax ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTUUL  }w!*I$.Dental Implants D25.339.312; E04.833.800.310.655; E06.231.655; E06.780.314.655; E06.892.800.310.655; E07.450.350 AECLCTECHIMIPSSDSNSTTDUTVEVI Tooth, Artificial Biomedical and Dental Materials (Non MeSH); Dental Materials Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation Dentistry; Dental Implantation Dentistry; Prosthodontics; Dental Implantation Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation Equipment and Supplies; Implants, Artificial Biocompatible materials placed into (endosseous) or onto (subperiosteal) the jawbone to support a crown, bridge, or artificial tooth, or to stabilize a diseased tooth. Dental Implantation (66-89)  }n !Dental Implantation, Subperiosteal E04.833.800.310.482; E06.231.482; E06.780.314.482; E06.892.800.310.482 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation Dentistry; Dental Implantation Dentistry; Prosthodontics; Dental Implantation Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation The grafting or inserting of an appliance designed to fit over the surface of the mandible or the maxilla, beneath the specialized connective tissue that covers the bone (periosteum). Dental Implantation (66-90) }(P*!Dental Implantation, Endosseous, Endodontic E04.833.800.310.310.220; E06.231.310.360; E06.397.345; E06.780.314.310.360; E06.892.800.310.310.360 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation; Dental Implantation, Endosseous Dentistry; Dental Implantation; Dental Implantation, Endosseous Dentistry; Endodontics Dentistry; Prosthodontics; Dental Implantation; Dental Implantation, Endosseous Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation; Dental Implantation, Endosseous Insertion of a tapered rod through the root canal into the periapical osseous structure to lengthen the existing root and provide individual tooth stabilization. Dental Implantation (66-70); Root Canal Therapy (66-70) }2o*CDental Implantation, Endosseous E04.833.800.310.310; E06.231.310; E06.780.314.310; E06.892.800.310.310 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Osseointegration Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation Dentistry; Dental Implantation Dentistry; Prosthodontics; Dental Implantation Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation Blade Implantation; Dental Implantation, Endosseous, Endodontic Blade Implantation; Dental Implantation, Endosseous, Endodontic Blade Implantation; Dental Implantation, Endosseous, Endodontic Blade Implantation; Dental Implantation, Endosseous, Endodontic Insertion of an implant into the bone of the mandible or maxilla. The implant has an exposed head which protrudes through the mucosa and is a prosthodontic abutment. Dental Implantation (66-76) $}%P*!Dental Implantation E04.833.800.310; E06.231; E06.780.314; E06.892.800.310 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic Dentistry Dentistry; Prosthodontics Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic Dental Implantation, Endosseous (+ 2); Dental Implantation, Subperiosteal; Dental Implants Dental Implantation, Endosseous (+ 2); Dental Implantation, Subperiosteal; Dental Implants Dental Implantation, Endosseous (+ 2); Dental Implantation, Subperiosteal; Dental Implants Dental Implantation, Endosseous (+ 2); Dental Implantation, Subperiosteal; Dental Implants The grafting or inserting of a prosthetic device of alloplastic material into the oral tissue beneath the mucosal or periosteal layer or within the bone. Its purpose is to provide support and retention to a partial or complete denture. AECLCTECHIISMAMIMOMTNUPSPXSDSNSTTDUTVEVI  ~@*,Dental Hygienists M01.526.485.067.105.376; N02.360.067.105.376 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries Persons trained in an accredited school or dental college and licensed by the state in which they reside to provide dental prophylaxis under the direction of a licensed dentist. ~2Dental High-Speed Technique E06.216 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry ~ 3! $ Dental High-Speed Equipment E06.186.376; E07.222.376 AECLCTECHISDSNSTTDUTVE Dentistry; Dental Equipment Equipment and Supplies; Dental Equipment ~ !QDental Health Surveys E05.318.308.250.300; E06.208; G03.850.520.308.250.300; G03.890.160; N05.715.360.300.375.300 Oral Health Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Health Surveys Dentistry Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Health Surveys Environment and Public Health (Non MeSH); Public Health Dentistry Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Health Surveys Dental Plaque Index; DMF Index; Oral Hygiene Index; Periodontal Index Dental Plaque Index; DMF Index; Oral Hygiene Index; Periodontal Index Dental Plaque Index; DMF Index; Oral Hygiene Index; Periodontal Index Dental Plaque Index; DMF Index; Oral Hygiene Index; Periodontal Index Dental Plaque Index; DMF Index; Oral Hygiene Index; Periodontal Index A systematic collection of factual data pertaining to dental or oral health and disease in a human population within a given geographic area. Health Surveys (66-71)  ~ xgDental Health Services N02.421.240 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services Dental Care (+ 3); Dental Service, Hospital Services designed to promote, maintain, or restore dental health. Dental Care (73-77); Dental Service, Hospital (66-77) AECLCTECHIISLJMAMOMTNUOGPXSDSNSTTDUTVE $~J7NA*Dental Fistula C07.465.614.187; C23.439.600.187 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Oral Fistula (Non MeSH) Symptoms and General Pathology (Non MeSH); Fistula; Oral Fistula (Non MeSH) A sinus tract originating in a peripheral abscess and opening into the oral cavity on the gingiva. (Stedman, 25th). Periapical Abscess (66-69) ~7&N Dental Fissures C07.793.720.210.220 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Tooth Demineralization; Dental Caries Deep grooves or clefts in the surface of teeth equivalent to class 1 cavities in Black's classification of dental caries. Dental Caries (66-86) ~8N\Dental Facilities N02.278.192 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Dental Clinics; Dental Offices; Laboratories, Dental Use for material on dental facilities in general or for which there is no specific heading. Health Facilities (68-71)  ~L?oDental Equipment E06.186; E07.222 AECLCTECHISDSNSTTDUTVE Dentistry Dentistry Equipment and Supplies Dental Articulators; Dental Devices, Home Care; Dental High-Speed Equipment; Dental Instruments (+ 1); Occlusal Splints; Rubber Dams Dental Articulators; Dental Devices, Home Care; Dental High-Speed Equipment; Dental Instruments (+ 1); Occlusal Splints; Rubber Dams AECLCTECHIPXSDSNSTTDUTVE  ~e ':Dental Enamel Solubility G10.549.164 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) ~_WDental Enamel Proteins D12.776.231 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins ~FDDental Enamel Permeability G10.549.879.292 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH); Tooth Permeability ~ oDental Enamel Hypoplasia C07.650.800.065.300; C07.793.700.065.300; C16.131.850.800.065.300 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities; Amelogenesis Imperfecta Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities; Amelogenesis Imperfecta Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities; Amelogenesis Imperfecta A form of AMELOGENESIS IMPERFECTA characterized by incomplete formation of the dental enamel and transmitted as an X-linked or autosomal dominant trait. It is also associated with vitamin A, C, or D deficiency, infectious disease, prematurity, birth injury, Rh incompatibility, trauma, or local infection. Small grooves, pits, and fissures are seen in mild cases, deep horizontal rows of pits in severe cases, or absence of enamel in extreme cases. (Dorland, 27th ed). ~IL$Dental Enamel A14.254.860.268 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Ameloblasts; Amelogenesis Stomatognathic System; Dentition; Tooth Enamel Cuticle ~ G:0Dental Devices, Home Care E06.186.250; E06.761.726.292; E07.222.250 AECLCTECHISDSNSTTDUTVE Toothbrushing Oral Hygiene Dentistry; Dental Equipment Dentistry; Preventive Dentistry; Oral Hygiene Equipment and Supplies; Dental Equipment Devices used in the home by persons to maintain dental and periodontal health. The devices include toothbrushes, dental flosses, water irrigators, gingival stimulators, etc. Dental Prophylaxis (66-71); Oral Health (66-71) $~!/ 1:Dental Deposits A12.300; C07.793.208 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Fluids and Secretions (Non MeSH) Stomatognathic Diseases; Tooth Diseases Dental Calculus; Dental Plaque Dental Calculus; Dental Plaque ~#uRUJDental Debonding E06.178 AECLCTECHIISMTNUPXSNSTTDUTVE Dentistry Techniques used for removal of bonded orthodontic appliances, restorations, or fixed dentures from teeth. Dental Bonding (77-91) ~$   {Dental Clinics N02.278.192.250 CLECHILJMAMTOGSDSNSTTDUT Preventive Dentistry; Oral Health Facilities, Manpower and Services (Non MeSH); Health Facilities; Dental Facilities Facilities where dental care is provided to patients. ~%)bADental Clasps E06.780.345.760.433.413.220 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis; Dentures; Denture, Partial; Denture, Partial, Removable Metal devices, part of a removable partial denture, that act to retain the removable partial denture in place by providing two-arm attachments to the abutment teeth. The two arms may be connected by another metal piece that rests on the occlusal surface of the abutment teeth. Denture, Partial, Removable (66-91) ~&wG*Dental Cementum A14.254.646.267; A14.254.860.232 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Periodontium Stomatognathic System; Dentition; Tooth ~)S&:eDental Cements D25.339.291; D26.016.275 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Cementation Biomedical and Dental Materials (Non MeSH); Dental Materials Miscellaneous Drugs and Agents (Non MeSH); Adhesives Dentin-Bonding Agents; Glass Ionomer Cements (+ 1); Polycarboxylate Cement; Silicate Cement; Zinc Oxide-Eugenol Cement; Zinc Phosphate Cement Dentin-Bonding Agents Cementation (66-70) ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $~*K*,Dental Cavity Preparation E06.323.325 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Dentistry, Operative Smear Layer ~,n$&Dental Cavity Lining E06.323.225 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Calcium Hydroxide Dentistry; Dentistry, Operative An inner coating, as of varnish or other protective substance, to cover the dental cavity wall. It is usually a resinous film-forming agent dissolved in a volatile solvent, or a suspension of calcium hydroxide in a solution of a synthetic resin. The lining seals the dentinal tubules and protects the pulp before a restoration is inserted. (Jablonski, Illustrated Dictionary of Dentistry, 1982). ~-$&Dental Casting Technique E06.780.250; E06.912.115 AECLCTECHIISMAMONUPXSNSTTDUTVE Dentistry; Prosthodontics Dentistry; Technology, Dental The process of producing a form or impression made of metal or plaster using a mold. ~/"AhDental Casting Investment D25.339.250 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials ~0*IDental Caries Susceptibility G10.549.140 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Mouth Physiology (Non MeSH) ~1"WDental Caries Activity Tests E06.342.250 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Dentistry; Diagnosis, Oral Dental Caries Susceptibility (66-69); Diagnosis, Oral (66-79) ~29#$!IDental Caries C07.793.720.210 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cariogenic Agents; Cariostatic Agents; Diet, Cariogenic; Root Caries; Tooth Demineralization Tooth Demineralization Stomatognathic Diseases; Tooth Diseases; Tooth Demineralization Dental Fissures; Root Caries Localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp. The three most prominent theories used to explain the etiology of the disase are that acids produced by bacteria lead to decalcification; that micro-organisms destroy the enamel protein; or that keratolytic micro-organisms produce chelates that lead to decalcification. $~3NmJ$aDental Care for Disabled E06.170.310; N02.421.240.190.230 AECLCTECHIISLJMAMOMTNUOGPXSNSTTDUTVE Dental Care for Chronically Ill Disabled Dentistry; Dental Care Facilities, Manpower and Services (Non MeSH); Health Services; Dental Health Services; Dental Care Dental care for the emotionally, mentally, or physically disabled patient. It does not include dental care for the chronically ill ( = DENTAL CARE FOR CHRONICALLY ILL). specific disability (66-79); specific mouth or tooth disease (66-79); Dental Care (73-79); Handicapped (66-79) $~7&(' Dental Care for Chronically Ill E06.170.205; N02.421.240.190.220 AECLCTECHIISLJMAMOMTNUOGPXSNSTTDUTVE Dental Care for Disabled Dentistry; Dental Care Facilities, Manpower and Services (Non MeSH); Health Services; Dental Health Services; Dental Care Dental care for patients with chronic diseases. These diseases include chronic cardiovascular, endocrinologic, hematologic, immunologic, neoplastic, and renal diseases. The concept does not include dental care for the mentally or physically disabled which is DENTAL CARE FOR DISABLED. Dental Care for Disabled (80-93)  ~9'&(H(Dental Care for Aged E06.170.100; N02.421.240.190.210 AECLCTECHIISLJMAMOMTNUPXSNSTTDUTVE Geriatric Dentistry Dentistry; Dental Care Facilities, Manpower and Services (Non MeSH); Health Services; Dental Health Services; Dental Care The giving of attention to the special dental needs of the elderly for proper maintenance or treatment. The dental care may include the services provided by dental specialists. Dental Care (73-90); Dental Health Services (78-90); Health Services for the Aged (81-90); Health Services Needs and Demand (78-90)  ~<&&Dental Care E06.170; N02.421.240.190 AECLCTECHIISLJMAMOMTNUOGPXSNSTTDUTVE Comprehensive Dental Care Dentistry Facilities, Manpower and Services (Non MeSH); Health Services; Dental Health Services Dental Care for Aged; Dental Care for Chronically Ill; Dental Care for Disabled Dental Care for Aged; Dental Care for Chronically Ill; Dental Care for Disabled The total of dental diagnostic, preventive, and restorative services provided to meet the needs of a patient (from Illustrated Dictionary of Dentistry, 1982).  ~?-(qDental Calculus A12.300.250; C07.793.208.250; C23.146.398 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Dental Prophylaxis Fluids and Secretions (Non MeSH); Dental Deposits Stomatognathic Diseases; Tooth Diseases; Dental Deposits Symptoms and General Pathology (Non MeSH); Calculi Hard, stonelike concretion, varying in color from creamy yellow to black, that forms on the teeth or dental prostheses through calcification of DENTAL PLAQUE. (From Dorland, 27th ed). ~A1RDental Bonding E06.095 AECLCTECHIISMTNUPXSNSTTDUTVE Dental Materials; Orthodontic Appliances Dentistry Acid Etching, Dental; Cementation Surface Properties (66-70) AECLCTECHIISMOMTNUPXSNSTTDUTVE $~D   0 ) "Dental Auxiliaries M01.526.485.067.105; N02.360.067.105 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Dental Assistants; Dental Hygienists; Dental Technicians (+ 1) Dental Assistants; Dental Hygienists; Dental Technicians (+ 1) Personnel whose work is prescribed and supervised by the dentist. Allied Health Personnel (71-77); Dental Assistants (66-77)  ~E5*OFDental Assistants M01.526.485.067.105.250; N02.360.067.105.250 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel; Dental Auxiliaries Individuals who assist the dentist or the dental hygienist. ~G2HDental Articulators E06.186.210; E07.222.210 AECLCTECHISDSNSTTDUTVE Dentistry; Dental Equipment Equipment and Supplies; Dental Equipment Mechanical devices that simulate the temporomandibular joints and jaws to which maxillary and mandibular casts are attached. The entire assembly attempts to reproduce the movements of the mandible and the various tooth-to-tooth relationships that accompany those movements. Dental Equipment (66-76) ~IQ;Dental Arch A02.835.232.781.324.502.320; A14.521.320 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Alveolar Process; Jaw Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw Stomatognathic System; Jaw ~K.8{Dental Anxiety F01.470.132.300; F01.470.361.300; F03.126.056.100.300; F03.709.438.180.508.300 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Emotions; Anxiety Behavior and Behavior Mechanisms (Non MeSH); Emotions; Fear Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Affective Symptoms; Anxiety Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders; Phobic Disorders Abnormal fear or dread of visiting the dentist for preventive care or therapy and unwarranted anxiety over dental procedures. Anxiety (66-91); Dental Care (77-91); Fear (66-91) ~MXF@Dental Amalgam D25.339.208.291 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Alloys An alloy used in restorative dentistry that contains mercury, silver, tin, copper, and possibly zinc. ~PB*[xDental Alloys D25.339.208 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials Chromium Alloys (+ 1); Dental Amalgam; Gold Alloys; Metal Ceramic Alloys A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions for use in restorative or prosthetic dentistry. Alloys (66-72); Dental Materials (66-72) ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $~Q*IZ2,Dental Abutments E06.780.345.500 AECLCTECHIPXSDSNSTTDUTVE Dentistry; Prosthodontics; Dental Prosthesis Natural teeth or teeth roots used as anchorage for a fixed or removable denture or other prosthesis (such as an implant) serving the same purpose. Dental Cavity Preparation (66-69); Denture, Partial (66-69) ~S5GDensovirus B04.280.580.200; B04.525.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Parvoviridae Viruses; Insect Viruses A genus of PARVOVIRIDAE comprising helper-independent viruses which infect the arthropods Diptera, Lepidoptera, and Orthoptera. Parvoviridae (87-93) ~UP"GDensitometry, X-Ray E01.357.818.258; E05.196.712.224.375 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnostic Imaging; Radiography Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Densitometry Measurement of the degree of darkening of X-ray film by means of a photocell which measures light transmission through the film. Photometry (66) ~V*"Densitometry E05.196.712.224 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry Absorptiometry, Photon; Densitometry, X-Ray ~X"S3Dens in Dente C07.650.800.250; C07.793.700.250; C16.131.850.800.250 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Anomaly of the tooth, found chiefly in upper lateral incisors. It is characterized by invagination of the enamel at the incisal edge. ~Yq=LFDenmark Z01.542.808.224 EHEP Geographicals (Non MeSH); Europe; Scandinavia ~\ 8Denial (Psychology) F01.393.200; F03.407.200 Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Refusal to admit the truth or reality of a situation or experience. Defense Mechanisms (66-74) ~\S Dengue Virus B04.820.250.350.270; B04.909.777.310.350.270 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Flavivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Flavivirus A species of the genus FLAVIVIRUS which causes an acute febrile and sometimes hemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. ~]2Dengue C02.081.270; C02.782.350.250.214; C02.782.417.214 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Flavivirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Hemorrhagic Fevers, Viral An acute infectious, eruptive, febrile disease caused by an arthropod-borne virus of the FLAVIVIRUS genus. ~_ 9P}Denervation E04.530.324 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery Autonomic Denervation (+ 7); Cordotomy; Ganglionectomy; Muscle Denervation; Nerve Block; Nerve Crush; Vagotomy (+ 2) ~a$'Dendritic Cells A11.066.270; A11.436.270; A15.382.066.270 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Antigen-Presenting Cells Cells; Epithelial Cells (Non MeSH) Hemic and Immune Systems (Non MeSH); Immune System; Antigen-Presenting Cells Langerhans Cells Langerhans Cells Langerhans Cells Immunocompetent cells of the lymphoid and hemopoietic systems and skin. They are also called interdigitating, reticular, and veiled cells. They function morphologically and phenotypically by presenting or processing antigens, thereby stimulating cellular immunity. Antigen-Presenting Cells (85-86); Epidermis (78-86); Langerhans Cells (69-86); Lymph Nodes (75-86); Skin (66-86)  ~c 1*;/Dendrites A08.663.256; A11.671.240 CHCLDEENGEIMMEMIPAPHPSRARERISEULUSVI Nervous System; Neurons Cells; Neurons Neurites Neurites On of the threadlike extensions of the cytoplasm of a neuron. In unipolar and bipolar neurons, they resemble axons structurally, but typically, as in multipolar neurons, they branch into treelike processes. Dendrites comprise most of the receptive surfaces of a neuron. (Dorland, 27th ed). CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI  ~f? (0U*Demyelinating Diseases C10.228.337; C10.772.235 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myelin Sheath Nervous System Diseases; Central Nervous System Diseases Nervous System Diseases; Peripheral Nervous System Diseases Canavan Disease; Cerebral Sclerosis, Diffuse (+ 4); Encephalomyelitis, Allergic; Encephalomyelitis, Necrotizing Hemorrhagic; Leukoencephalopathy, Progressive Multifocal; Multiple Sclerosis; Myelinolysis, Central Pontine; Myelitis, Transverse; Neuromyelitis Optica; Scrapie; Swayback Neuromyelitis Optica; Swayback Any condition characterized by the destruction of myelin and extensive loss of the myelin sheaths of the nerve fibers. It affects both the central and peripheral nervous systems. Its etiology is at present unknown. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $~hNePDemography G03.850.505.400; I01.240; N01.224 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH) Social Sciences Population Characteristics (Non MeSH) Age Distribution; Family Characteristics (+ 1); Health Status; Population Density; Population Dynamics (+ 3); Residence Characteristics (+ 3); Sex Distribution; Vital Statistics (+ 13) Age Distribution; Family Characteristics (+ 8); Health Status; Population Dynamics (+ 3); Sex Distribution Age Distribution; Ethnic Groups; Family Characteristics (+ 8); Health Status (+ 1); Population Density; Population Dynamics (+ 3); Residence Characteristics (+ 5); Sex Distribution; Vital Statistics (+ 15) Statistical interpretation and description of a population with reference to distribution, composition, or structure. BLCFCICLCODEDIECEDEHEMENEPETGEHIIMLJMAMEMIMTOGPAPCPHPPPSPXRARERISDSNSTSUTDTHURUSUTVEVI ~l)RZDemocracy I01.696.374 Social Sciences; Political Systems A system of government in which there is free and equal participation by the people in the political decision-making process. ~p *Dementia, Vascular C10.228.140.300.470; C10.228.140.380.230; F03.709.508.460.245.240; F03.709.680.610.392.510 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Cerebral Arteriosclerosis Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia Dementia, Multi-Infarct Dementia, Multi-Infarct Dementia, Multi-Infarct Dementia, Multi-Infarct An organic mental disorder caused by systemic vascular disease such as arteriosclerotic changes in the vessels, valvular heart disease, hypertension, etc., and resulting in cerebral vascular disease with dementia. Cerebral Arteriosclerosis (66-88); Cerebrovascular Disorders (66-88); Dementia (81-88) $~qdFjeDementia, Senile C10.228.140.380.220; F03.709.508.460.245.230; F03.709.680.610.392.360 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia Alzheimer's Disease; Supranuclear Palsy, Progressive Alzheimer's Disease; Supranuclear Palsy, Progressive Alzheimer's Disease; Supranuclear Palsy, Progressive Psychotic organic mental disorder occurring usually after 65, and characterized by progressive dementia associated with generalized brain atrophy. ~vMFDementia, Presenile C10.228.140.380.150; F03.709.508.460.245.220; F03.709.680.610.392.300 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia Alzheimer's Disease; Creutzfeldt-Jakob Syndrome Alzheimer's Disease; Creutzfeldt-Jakob Syndrome Alzheimer's Disease; Creutzfeldt-Jakob Syndrome An organic mental disorder characterized by progressive brain deterioration and development of socially inappropriate and unacceptable behavior. It usually occurs in the fourth or fifth decade of life. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  ~zNMFPDementia, Multi-Infarct C10.228.140.300.470.408; C10.228.140.380.230.250; F03.709.508.460.245.240.225; F03.709.680.610.392.510.308 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Dementia, Vascular Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia; Dementia, Vascular Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Vascular Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Vascular Organic mental disorder caused by repetitive multiple cerebral infarcts which act cumulatively to produce dementia. Vascular disease is always presumed to be present. Dementia (81-88) ~~tF`Dementia C10.228.140.380; F03.709.508.460.245; F03.709.680.610.392 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic AIDS Dementia Complex; Dementia, Presenile (+ 2); Dementia, Senile (+ 2); Dementia, Vascular (+ 1) AIDS Dementia Complex; Dementia, Presenile (+ 2); Dementia, Senile (+ 2); Dementia, Vascular (+ 1) AIDS Dementia Complex; Dementia, Presenile (+ 2); Dementia, Senile (+ 2); Dementia, Vascular (+ 1) An organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The deficit is multifaceted and involves memory, judgment, and abstract thought. Behavioral and personality changes also occur. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  ~ AFng5PDemecolcine D03.132.225.374; D22.204.179.290 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Colchicine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic 6,7-Dihydro-1,2,3,10-tetramethoxy-7-(methylamino)benzo(a)heptalen-9(5H)-one. An alkaloid isolated from Colchicum autumnale L. and used as an antineoplastic. Alkaloids (66-71); Antineoplastic Agents (66-71); Colchicine (66-71) ~&:RDemeclocycline D20.085.868.224 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5a alpha,6 beta,12a alpha))-7-Chloro-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide. An antibiotic related to tetracycline and produced by Streptomyces aureofaciens. Because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time. ~$::Delusions F03.126.185.304; F03.709.680.610.360; F03.709.508.460.225 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic Koro Koro Koro A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates. ~z AFDelta Sleep-Inducing Peptide D12.644.456.300; D12.776.641.650.200; D14.600.600.220 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal. Oligopeptides (73-86); Peptides (66-72) ~"=F)0Delta Rhythm E01.236.257.401.530; E01.399.277.530 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH); Electroencephalography Diagnosis; Electrodiagnosis; Electroencephalography Waves in the electroencephalogram which have a frequency of less than 4 cycles per second. ~*&mDelta Infection C02.440.270; C02.782.270; C06.552.380.705.270 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Hepatitis, Viral, Human Virus Diseases; RNA Virus Infections (Non MeSH) Digestive System Diseases; Liver Diseases; Hepatitis; Hepatitis, Viral, Human Hepatitis caused by the DELTA AGENT in association with hepatitis B and chronic active hepatitis. It is endemic in some European countries and is seen in drug users, hemophiliacs, and polytransfused persons. Hepatitis B (77-85); Hepatitis B Antigens (77-85); Hepatitis, Viral, Human (77-85) ~%5PdDelta Agent B04.265.270; B04.450.270; B04.909.777.228 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Defective Viruses Viruses; Hepatitis Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic active hepatitis. Hepatitis B (77-85); Hepatitis B Antigens (77-85) ~1~=Delphi Technique L01.280.800.310 Information Science; Data Collection; Questionnaires An iterative questionnaire designed to measure consensus among individual responses. In the classic Delphi approach, there is no interaction between responder and interviewer. Questionnaires (73-79) ~>Delivery Rooms N02.278.388.150 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units Hospital units equipped for childbirth. ~c_0Delivery of Health Care N04.590.374; N05.300 CLECHILJMAMTOGSNSTTDUT Consumer Participation Health Services Administration (Non MeSH); Patient Care Management (Non MeSH) Quality, Access, Evaluation (Non MeSH) Health Care Reform; Health Services Accessibility; Managed Care Programs (+ 4); Product Line Management; Telemedicine; Uncompensated Care Attitude of Health Personnel (+ 2); Attitude to Death; Attitude to Health (+ 8); Health Care Costs (+ 4); Health Care Reform; Health Expenditures; Health Priorities; Health Resources (+ 1); Health Services Accessibility (+ 5); Health Services Needs and Demand (+ 1); Physician's Practice Patterns; Professional-Patient Relations (+ 3); Uncompensated Care The concept concerned with all aspects of providing and distributing health services to a patient population. Personal Health Services (68-70) CLECEHHIISLJMAMTOGPXSDSNSTTDUT (~UL'"Delivery E04.819.774.457 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Birth Injuries; Dystocia Trial of Labor; Labor Presentation Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH) Cesarean Section (+ 1); Episiotomy; Extraction, Obstetrical (+ 1); Home Childbirth; Labor, Induced; Natural Childbirth; Vaginal Birth after Cesarean; Version, Fetal  ~ $+_Delirium C10.597.332; C23.888.592.324; F03.126.185.259; F03.709.508.460.220; F03.709.680.610.308 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic A disorder of the sensorium, in which orientation is impaired, the critical faculty blunted or lost and thought content is irrelevant and incoherent. ~o cF8Delayed-Action Preparations D26.394.225.276 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Drug Implants; Tablets, Enteric-Coated Dosage forms of a drug that act over a period of time. ~/ ,M.FDelaware Z01.107.567.875.100.200; Z01.107.567.875.600.513.200 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Mid-Atlantic Region ~v :Deja Vu F03.126.185.597.457 PX Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Memory Disorders A subjective feeling that an experience which is occurring for the first time has been experienced before. ~ Deiters Nucleus A08.186.211.132.810.450.270 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon; Pons Lateral vestibular nucleus lying immediately cranial to the caudal vestibular nucleus and composed of large multipolar nerve cells. Its upper end becomes continuous with the cranial vestibular nucleus. (Dorland, 27th ed). ~I8bDeinstitutionalization N02.421.589.508.310 CLECHILJMAMTOGSDSNSTTDUT Institutionalization Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Institutionalization The practice of caring for individuals in the community, rather than in an institutional environment with resultant effects on the individual, the individual's family, the community, and the health care system. ~<Dehydrocholic Acid D04.808.221.430.265; D19.316.246.225.261 AAADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts; Cholic Acids (5 beta)-3,7,12-Trioxocholan-24-oic acid. A semisynthetic bile acid made from cholic acid. It is used as a cholagogue, hydrocholeretic, diuretic, and as a diagnostic aid. ~O.>Dehydrocholesterols D04.808.247.222.222.347.200; D04.808.247.808.197.250; D10.516.851.208.320 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestadienes; Cholestadienols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol  Desmosterol Desmosterol Cholesterol derivatives having an additional double bond in any position. 24-Dehydrocholesterol is DESMOSTEROL. The other most prevalent dehydrocholesterol is the 7-isomer. This compound is a precursor of cholesterol and of vitamin D3. Cholecalciferols (66); Cholestadienols (74-77); Cholesterol (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $~Q8P:Dehydroascorbic Acid D02.241.511.902.107.260; D02.540.260; D09.203.811.100.260; D11.786.100.260; D02.241.081.844.107.260 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Ascorbic Acid Organic Chemicals (Non MeSH); Lactones Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Ascorbic Acid Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Ascorbic Acid Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Ascorbic Acid L-threo-2,3-Hexodiulosonic acid gamma-lactone. The reversibly oxidized form of ascorbic acid. It is the lactone of 2,3-DIKETOGULONIC ACID and has antiscorbutic activity in man on oral ingestion. Ascorbic Acid (69-74) ~o:Dehydroascorbatase D08.586.277.352.100.220 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases Catalyzes the hydrolysis of the gamma lactone, dehydroascorbate, to diketogulonate. Ascorbic Acid (72-74); Esterases (72-74); Ketones (72-74) ~FaGDehydration C18.452.950.179 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fluid Therapy; Rehydration Solutions; Thirst Body Fluids Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Water-Electrolyte Imbalance The condition that results from excessive loss of body water.  ~N6nKDeglutition Disorders C06.306.418.408 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Motility Disorders Plummer-Vinson Syndrome ~3NZDeglutition G10.261.248 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) ~GcDefoliants, Chemical D05.723.366.181 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (From Hawley's Condensed Chemical Dictionary, 11th ed). ~8T+Deficiency Diseases C18.654.223 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders Avitaminosis (+ 20); Magnesium Deficiency; Potassium Deficiency; Protein Deficiency (+ 2); Swayback A condition produced by dietary or metabolic deficiency. The term includes all diseases caused by an insufficient supply of essential nutrients, i.e., protein (or amino acids), vitamins, and minerals. It also includes an inadequacy of calories. (From Dorland, 27th ed; Stedman, 25th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  ~NOxTPDefibrillators, Implantable E07.296.319.330; E07.450.330 AECLCTECHIMIPSSDSNSTTDUTVEVI Equipment and Supplies; Electrodes; Electrodes, Implanted Equipment and Supplies; Implants, Artificial Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia and ventricular fibrillation. They consist of an impulse generator, batteries, and electrodes. Electric Countershock/instrumentation (80-92); Implants, Artificial (82-92) ~ " wWDeferoxamine D02.092.570.394.265; D02.241.511.372.265; D24.310.678.225; D26.241.688.700.225 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Hydroxamic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxamic Acids Immunologic and Biologic Factors (Non MeSH); Biological Products; Siderophores Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents; Iron Chelates; Siderophores N'-(5-((4-((5-(Acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxybutanediamide. Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the form of its mesylate. Because of its ability to form nonabsorbable and rapidly excretable complexes with iron, it is effective in the treatment of conditions associated with excessive iron storage and iron poisoning. ~qX.v!Defensive Medicine I01.880.604.583.524.300; N03.706.535.606.300 CLECEDHIISLJMAMTOGSNSTTD Social Sciences; Sociology; Social Control, Formal; Jurisprudence; Malpractice Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Malpractice The alterations of modes of medical practice, induced by the threat of liability, for the principal purposes of forestalling lawsuits by patients as well as providing good legal defense in the event that such lawsuits are instituted. ~2Defense Mechanisms F01.393; F03.407 Behavior and Behavior Mechanisms (Non MeSH) Behavioral and Mental Disorders (Non MeSH) Acting Out; Conversion Disorder; Denial (Psychology); Displacement (Psychology) (+ 1); Dissociative Disorders; Fantasy; Identification (Psychology) (+ 1); Negativism; Perceptual Defense; Projection (+ 1); Rationalization; Regression (Psychology); Repression (+ 2); Sublimation Acting Out; Conversion Disorder; Denial (Psychology); Displacement (Psychology) (+ 2); Dissociative Disorders; Identification (Psychology) (+ 1); Negativism; Perceptual Defense; Projection (+ 1); Rationalization; Regression (Psychology); Repression (+ 2); Sublimation Unconscious process used by an individual or a group of individuals in order to cope with impulses, feelings or ideas which are not acceptable at their conscious level; various types include reaction formation, projection and self reversal. BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI ~'eFDefective Viruses B04.265 CHCLDEENGDGEIMIPMEPHPYREUL Viruses Delta Agent; Sarcoma Viruses, Murine (+ 3); Satellite Viruses (+ 1); SSPE Virus Viruses which lack a complete genome so that they cannot completely replicate or cannot form a protein coat. Some are host-dependent defectives, meaning they can replicate only in cell systems which provide the particular genetic function which they lack. Others, called SATELLITE VIRUSES, are able to replicate only when their genetic defect is complemented by a helper virus. specific virus (66)  ~  dDefecation G10.261.206 DEGEIMPHRE Constipation; Diarrhea; Encopresis; Fecal Incontinence Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH) ~nAcDeet D02.065.277.194; D02.241.223.106.162.194; D05.723.441.373 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insect Repellents N,N-Diethyl-3-methylbenzamide. An insect repellent that may cause irritation to eyes and mucous membranes, but not to skin. Benzoates (66-71); Insect Repellents (66-71) ~`A: 6Deer B02.649.077.380.373 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Muntjacs; Reindeer The family Cervidae of 17 genera and 45 species occurring nearly throughout North America, South America, and Eurasia, on most associated continental islands, and in northern Africa. Wild populations of deer have been established through introduction by people in Cuba, New Guinea, Australia, New Zealand, and other places where the family does not naturally occur. They are slim, long-legged and best characterized by the presence of antlers. Their habitat is forests, swamps, brush country, deserts, and arctic tundra. They are usually good swimmers; some migrate seasonally. (Walker's Mammals of the World, 5th ed). Artiodactyla (66-67)  ~(7Deductibles and Coinsurance N03.219.151.170.300; N03.219.521.576.090.300 CLECHILJSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Cost Sharing Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Cost Sharing Cost-sharing mechanisms that provide for payment by the insured of some portion of covered expenses. Deductibles are the amounts paid by the insured under a health insurance contract before benefits become payable; coinsurance is the provision under which the insured pays part of the medical bill, usually according to a fixed percentage, when benefits become payable. Insurance, Health (66-67) ~ي!2Decubitus Ulcer C17.800.893.289 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Ulcer An ulceration caused by prolonged pressure in patients permitted to lie too still for a long period of time. The bony prominences of the body are the most frequently affected sites. The ulcer is caused by ischemia of the underlying structures of the skin, fat, and muscles as a result of the sustained and constant pressure. ~NZDecoquinate D03.438.810.350.250; D21.370.400.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats Ethyl-6-(decyloxy)-7-ethoxy-4-hydroxy-3-quinolinecarboxylate. A coccidiostat for poultry. Synonym: Deccox. Ethers (72-74); Carboxylic Acids (72-74); Quinolines (72-74) ~@*:yJDecontamination G03.850.780.325 ECHIISLJMTSNST Chemical Warfare Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH) The freeing of a person or an object of some contaminating substance such as war gas, radioactive material, etc. (Dorland, 27th ed). ~WmDecompression Sickness C21.866.120.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Barotrauma; Atmospheric Pressure; Diving; Embolism, Air; Aerospace Medicine Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Barotrauma A disorder characterized by joint pains, respiratory manifestations, skin lesions, and neurologic signs, occurring in aviators flying at high altitudes and following rapid reduction of air pressure in persons who have been breathing compressed air in caissons and diving apparatus. (Dorland, 27th ed). ~NZ_^Decompression E05.245; H01.671.691.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Physics; Pressure Lower Body Negative Pressure Decompression external to the body, most often the slow lessening of external pressure on the whole body (especially in caisson workers, deep sea divers, and persons who ascend to great heights) to prevent DECOMPRESSION SICKNESS. It includes also sudden accidental decompression, but not surgical (local) decompression or decompression applied through body openings. ~"c$Decision Trees F04.669.880.308.310; H01.548.635.310.308.310; L01.700.568.110.680.310.480 Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Theoretical Techniques (Non MeSH); Decision Theory Physical Sciences (Non MeSH); Mathematics; Mathematical Computing; Decision Support Techniques; Decision Theory Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Mathematical Computing; Decision Support Techniques A graphic device used in decision analysis, series of decision options are represented as branches (hierarchical). ~8QDecision Theory F04.669.880.308; H01.548.635.310.308; L01.700.568.110.680.310.428 Operations Research Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Techniques (Non MeSH); Theoretical Techniques (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Mathematical Computing; Decision Support Techniques Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Mathematical Computing; Decision Support Techniques Decision Trees Decision Trees A theoretical technique utilizing a group of related constructs to describe or prescribe how individuals or groups of people choose a course of action when faced with several alternatives and a variable amount of knowledge about the determinants of the outcomes of those alternatives. ~I%LDecision Support Techniques H01.548.635.310; L01.700.568.110.680.310 Decision Making, Organizational; Decision Making Physical Sciences (Non MeSH); Mathematics; Mathematical Computing Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Mathematical Computing Data Interpretation, Statistical; Decision Theory (+ 1); Neural Networks (Computer) Data Interpretation, Statistical; Decision Theory; Decision Trees; Neural Networks (Computer) Mathematical or statistical procedures used as aids in making a decision. They are frequently used in medical decision-making. ~!.9Decision Support Systems, Management L01.700.508.300.680.135; N04.452.515.135 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems Computer-based systems that enable management to interrogate the computer on an ad hoc basis for various kinds of information in the organization, which predict the effect of potential decisions. ~+. Decision Making, Organizational N04.452.190 Decision Support Techniques; Policy Making Health Services Administration (Non MeSH); Organization and Administration The process by which decisions are made in an institution or other organization. Decision Making (66-85) ~W%3WaDecision Making, Computer-Assisted L01.700.508.100 Information Science; Medical Informatics; Medical Informatics Applications Diagnosis, Computer-Assisted (+ 2); Therapy, Computer-Assisted (+ 3) Use of an interactive computer system designed to assist the physician or other health professional in choosing between certain relationships or variables for the purpose of making a diagnostic or therapeutic decision. Computer Programs (83-86); Computers (66-86); Decision Making (66-86) AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE  ~(VQT*Decision Making F02.463.785.373 DEPHRE Decision Support Techniques; Game Theory; Policy Making Problem Solving Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking Choice Behavior (+ 1); Medical Futility; Negotiating The process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea. CLDEMTPHPXRE (~C CZADecidua A05.360.319.679.490.373; A16.759.289 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Female; Uterus; Endometrium Embryonic Structures (Non MeSH); Placenta ~ *:Decerebrate State C10.597.305; C23.888.592.298 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations A peculiar neurologic condition elicited in vertebrates as a consequence of the elimination of brain function by transecting the brain stem or interrupting function by other techniques. Clinically, brain damage can result in neurological signs resembling those of a decerebrate animal. The state consists of exaggerated postures, grossly abnormal reflexes, convulsions, and extreme muscular rigidity and spasticity. ~"NDeceleration H01.671.538.107.373 AE Physical Sciences (Non MeSH); Physics; Motion; Acceleration ~IDecarboxylation G06.535.630.454; H01.181.404.454 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Chemistry, Organic (66-70) ~c& Decanoic Acids D02.241.081.407.250; D10.516.251.175 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Decanoates Decanoates 10-carbon saturated monocarboxylic acids. Fatty Acids (66-74)  *81Decanoates D02.241.081.407.250.200; D10.516.251.175.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids; Decanoic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Decanoic Acids Salts and esters of the 10-carbon monocarboxylic acid-decanoic acid. Fatty Acids (66-74) Y28QDecamethonium Compounds D02.092.102.558.372; D02.675.276.558.372 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neuromuscular Depolarizing Agents Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Methonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Methonium Compounds Compounds that contain the decamethylenebis(trimethyl)ammonium radical. These compounds frequently act as neuromuscular depolarizing agents. <.8'Decalcification, Pathologic C05.116.198.247.400; C18.452.174.289 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Tooth Demineralization Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic; Bone Demineralization, Pathologic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders The loss of calcium salts from bones and teeth. Bacteria may be responsible for this occurrence in teeth. Old age may be a factor contributing to calcium loss, as is the presence of diseases such as rheumatoid arthritis. o *NDecalcification Technique E05.909.432.288 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques  3 _Debrisoquin D03.438.531.205; D14.100.050.600.200; D16.050.850.157; D18.162.212 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Antihypertensive Agents (66-72); Isoquinolines (69-72)  L:@Debridement E04.176 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative , $Death, Sudden, Cardiac C14.280.383.220; C23.240.322.250 EHEPETPAPCVE Cardiovascular Diseases; Heart Diseases; Heart Arrest Symptoms and General Pathology (Non MeSH); Death; Death, Sudden The sudden cessation of cardiac contraction, leading to death of the heart and, ultimately, of the individual, resulting from ventricular tachycardia-fibrillation or asystole. Death, Sudden (66-91) &Death, Sudden C23.240.322 EHEPETPAVE Resuscitation; Sudden Infant Death Symptoms and General Pathology (Non MeSH); Death Death, Sudden, Cardiac; Sudden Infant Death The sudden cessation of all vital bodily functions. Legally and medically, this includes the permanent cessation of total cerebral function, spontaneous function of the respiratory system, and spontaneous function of the circulatory system. BLCFCLDIEHEPETGEIMPAPCVE $*<5Death Certificates E05.318.308.940.350; G03.850.520.308.940.350; L01.280.900.350; N04.452.859.264; N05.715.360.300.715.315 HILJ Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records Information Science; Data Collection; Records Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records Official records of individual deaths including the cause of death certified by a physician, and any other required identifying information. sDeath C23.240 Attitude to Death; Bereavement; Cause of Death; Fatal Outcome; Homicide; Infanticide; Mortuary Practice; Suicide; Terminal Care; Thanatology Thanatology Symptoms and General Pathology (Non MeSH) Asphyxia; Brain Death; Cadaver (+ 3); Death, Sudden (+ 2); Drowning; Fetal Death (+ 2) The cessation of life; permanent cessation of all body functions. For legal and medical purposes it is the irreversible cessation of total cerebral function, spontaneous function of the respiratory system, and spontaneous function of the circulatory system. (From Dorland, 27th ed). consider also terms at THANATO-. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $"  2orPDeanol D02.033.329.291.274; D02.092.063.291.274; D15.085.200; D15.090.200; D15.700.122.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Anti-Dyskinesia Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents N,N-Dimethyl-2-hydroxyethylamine. An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.  _:pDeamination G06.535.630.413; H01.181.404.413 DERE Amination Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Chemistry, Organic (66-70) |&  Dealkylation G06.535.630.371; H01.181.404.371 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Alkylation (66-70) &Deafness, Sudden C09.218.458.288.460 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders; Deafness Sensorineural hearing loss which develops over a period of hours or a few days, varying in severity from mild to total. Deafness (66-78) NUDeafness C09.218.458.288; C10.597.257.443.271; C23.888.592.257.443.271 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hearing Aids; Lipreading Otorhinolaryngologic Diseases; Ear Diseases; Hearing Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Hearing Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Hearing Disorders Deafness, Sudden A condition in which the sense of hearing in both ears is not functional for ordinary purposes of life. The hearing level for speech is approximately 71 decibels I.S.O. (International Organization for Standardization) or 61 db A.S.A. (American Standards Association) or greater.    EN[GDEAE-Dextran D09.203.698.365.272.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Dextrans Diethylaminoethyldextran. Used as a support for ion-exchange chromatography. Dextrans (72-74); Diethylamines (74) $6:uY-DEAE-Cellulose D09.203.698.365.180.247 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Cellulose Diethylaminoethylcellulose. Cellulose derivative used in chromatography, as ion-exchange material, and for various industrial applications. %:vDe Lange's Syndrome C10.496.193; C16.131.077.272; F03.709.346.189 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation Syndrome characterized by mental retardation and multiple abnormalities. '[5LTDDT D02.455.526.439.337; D05.723.491.491.320 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine )a.:DDE D02.455.526.439.315; D05.723.491.491.287 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Insecticides (66-72) *.:DDD D02.455.526.439.294; D05.723.491.491.254 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine ,d.:Day Care E02.472.246; N02.421.589.309 CLECHILJMAMTOGPXSNSTTDUT Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Institutional health care of patients during the day. The patients return home at night. Halfway Houses (66-67); Outpatient Clinics, Hospital (66-67) - "kHDaunorubicin D20.085.075.105.200; D22.204.106.125.200 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline Carubicin; Doxorubicin (+ 1); Idarubicin; Nogalamycin (+ 1) Carubicin; Doxorubicin (+ 1); Idarubicin; Nogalamycin (+ 1) (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione. Very toxic anthracycline aminoglycoside antibiotic isolated from Streptomyces peucetius and others, used in treatment of leukemias and other neoplasms. /.<IDataphone L01.178.847.698.372 CLECHILJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Telecommunications; Telephone Computers (66) 3 bDatabases, Factual L01.700.508.300.333 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems National Practitioner Data Bank Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references. Information Systems (66-90)  3n&!Databases, Bibliographic L01.453.183.544; L01.700.508.300.259 CLECHILJSDSNSTTDUT Information Science; Information Services; Bibliography Information Science; Medical Informatics; Medical Informatics Applications; Information Systems  MEDLINE Extensive collections, reputedly complete, of references and citations to books, articles, publications, etc., generally on a single subject or specialized subject area. Databases can operate through automated files, libraries, or computer disks. The concept should be differentiated from DATABASES, FACTUAL which is used for collections of data and facts apart from bibliographic references to them. Bibliography (66-90); Information Systems (66-81) CLECHIISLJMAOGSDSNSTTDUT $6* ;Database Management Systems L01.700.508.300.680.110; L01.700.568.810.280; N04.452.515.110 CLECHIISLJMAOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Information Science; Medical Informatics; Medical Informatics Computing; Software Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems Software designed to store, manipulate, manage, and control data for specific uses. :&!EhcData Interpretation, Statistical E05.318.740.300; G03.850.520.830.300; H01.548.635.310.290; H01.548.832.319; L01.700.568.110.680.310.380; N05.715.360.750.300 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Mathematical Computing; Decision Support Techniques Physical Sciences (Non MeSH); Mathematics; Statistics Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Mathematical Computing; Decision Support Techniques Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Application of statistical procedures to analyze specific observed or assumed facts from a particular study. <&Data Display F02.784.412.221; L01.700.568.810.210 AECLECHILJSDSNSTTDUT Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Human Engineering Information Science; Medical Informatics; Medical Informatics Computing; Software  Computer Graphics (+ 1) The visual display of data in a man-machine system. An example is a cathode ray tube display in which certain data can be called for from the computer and presented on the screen. AECLECHIISLJSDSNSTTDUT  @*Data Collection E05.318.308; G03.850.520.308; L01.280; N05.715.360.300 CLECHIISLJMTSDSNSTTDUT Medical History Taking Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Information Science Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH) Geriatric Assessment; Health Surveys (+ 17); Interviews (+ 1); Nutrition Assessment (+ 2); Questionnaires; Records (+ 12); Registries (+ 1); Vital Statistics (+ 13) Geriatric Assessment; Health Surveys (+ 17); Interviews (+ 1); Nutrition Assessment (+ 2); Questionnaires; Records (+ 9); Registries (+ 1); Vital Statistics (+ 13) Geriatric Assessment; Interviews (+ 1); Questionnaires (+ 1); Records (+ 13); Registries (+ 1); Vital Statistics (+ 13) Geriatric Assessment; Health Surveys (+ 17); Interviews (+ 1); Nutrition Assessment (+ 2); Questionnaires; Records (+ 15) Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data. AECLCTECEHHIISLJMAMOMTNUOGPXSDSNSTTDUTVE $B@7,Darkness H01.671.606.288 AE Physical Sciences (Non MeSH); Physics; Optics H 9Dark Adaptation G11.697.154.371 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Adaptation, Ocular Adaptation, Ocular (66-67) IMw Daptomycin D20.085.116.200 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide N-(1-Oxodecyl)-L-tryptophyl-L-asparginyl-L-alpha-aspartyl-L-threonylglycyl-L-ornithyl-L-alpha-aspartyl-D-alanyl-L-alpha-aspartylglycyl-D-seryl-threo-3-methyl-L-alpha-glutamyl-gamma-(2-aminophenyl)-gamma-oxo-L-alpha-aminobutanoic acid epsilon 1-lactone. A lipopeptide antibiotic that inhibits gram-positive bacteria. Antibiotics (87-93); Peptides (87-93) J<<BO.Dapsone D02.886.590.263; D20.661.370 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones Anti-Infective Agents; Leprostatic Agents Acedapsone Acedapsone L ":Daphnia B01.131.365.405 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Crustacea A genus of minute freshwater brachiopod crustaceans of the order Cladocera. Crustacea (66-71) M (,ZDantrolene D03.383.374.411.287; D16.700.600.165 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Hydantoins Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants. Hydantoins (66-74) N*:UDansyl Compounds D02.886.590.192; D04.615.638.204; D26.550.166 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Naphthalenes (66-71); Sulfonic Acids (66-71) Q5,6Dangerous Behavior F03.126.842.089.734.325 Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence Actions which have a high risk of being harmful or injurious to oneself or others. Violence (68-77) SQeDandy-Walker Syndrome C10.228.140.602.288 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Hydrocephalus Congenital hydrocephalus due to obstruction of the foramina of Magendie and Luschka. (Dorland, 27th ed). Cerebral Ventricles/abnormalities (66-69); Hydrocephalus (66-69) TLg}KDancing I03.450.642.287 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation Rhythmic and patterned body movements which are usually performed to music. V HZDance Therapy E02.831.230; F04.754.278 CLECEDHIISLJMAMTOGSNSTTD Therapeutics; Rehabilitation Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy The use of dancing for therapeutic purposes. Dancing (66-79) Wk7Danazol D04.808.745.432.235; D06.347.300.270 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol. A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Alkynes (73-74); Hydroxysteroids (73-74); Oxazoles (73-74); Pregnadienes (73-74) X *:aDairying J01.040.246; J01.576.266 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Agriculture Technology, Industry, Agriculture (Non MeSH); Industry [ Dairy Products J01.341.273 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Butter; Cheese; Ice Cream; Milk; Yogurt AEANCHCLCYDEECENHIIMMEMIPHPOPSRARERISDSESNSTTOUSUTVI \"=48Dagestan Z01.542.248.775.310; Z01.586.200.775.310; Z01.586.950.775.310 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Russia One of the former Associated Soviet Socialist Republics, situated on the Caspian Sea in southwest Russia. ] E}Dactinomycin D20.085.075.041.371; D22.204.106.038.371 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Actinomycin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Actinomycin _.<Dacryocystorhinostomy E04.579.255; E04.792.255 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Lacrimal Apparatus Surgery, Operative; Ostomy Surgery, Operative; Surgery, Eye (Non MeSH) Surgical fistulization of the lacrimal sac for external drainage of an obstructed nasolacrimal duct. Dacryocystitis/surgery (66-87); Lacrimal Apparatus/surgery (66-87); Lacrimal Duct Obstruction/surgery (66-87)  a[$TvDacryocystitis C11.496.221 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Lacrimal Apparatus Diseases Inflammation of the lacrimal sac. (Dorland, 27th ed). cBN2CDacarbazine D02.925.200; D03.383.374.240; D22.204.367 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Triazenes Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide. An antineoplastic agent with significant activity against melanomas. Synonyms: DIC; NSC 45388. Amides (66-74); Azo Compounds (66-72); Imidazoles (66-74); Triazenes (72-74) dI1:^D-Amino-Acid Oxidase D08.586.682.135.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases fFxCzechoslovakia Z01.586.250 EHEP Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Czech Republic; Slovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993. gICzech Republic Z01.542.248.395; Z01.586.250.395 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Czechoslovakia Created 1 January 1993 as a result of the division of Czechoslovakia into the Czech Republic and Slovakia. Czechoslovakia (66-93) id&Cytotoxins D24.185.926.235 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Hemolysins (+ 1); Leukocidins; Lymphotoxin; Tumor Necrosis Factor Substances elaborated by microorganisms, plants or animals that are specifically toxic to individual cells; they may be involved in immunity or may be contained in venoms. specific cell (66-77); Cytotoxicity Tests, Immunologic (73-77); Toxins (66-77) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $jBVP^FCytotoxicity, Immunologic G04.610.270 DEGEIMPHRE Antibodies, Bispecific; Complement Membrane Attack Complex; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; T-Lymphocytes, Cytotoxic Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Antibody-Dependent Cell Cytotoxicity; Macrophage Activation The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Cytotoxicity Tests, Immunologic (71-77); Immunity, Cellular (70-77); Lymphocytes (66-77); T Lymphocytes (73-79) $mQDSCytotoxicity Tests, Immunologic E01.223.495.245; E05.478.245; E05.940.245 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques Miscellaneous Techniques (Non MeSH); Toxicity Tests Complement Hemolytic Activity Assay Complement Hemolytic Activity Assay The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. specific cell/immunology (66-70); specific immune factor (66-70)  q%1"SMCytosol A11.904.287 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Subcellular Fractions Subcellular Fractions (72) s (# Cytoskeleton A11.368.250 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm Intermediate Filaments; Microfilaments; Microtubules The network of filaments, tubules, and interconnecting filamentous bridges which give shape, structure, and organization to the cytoplasm. Cellular Inclusions (70-76); Cytoplasm (66-76); Organoids (66-76)  ty*=OCytoskeletal Proteins D12.776.220 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Dystrophin; Intermediate Filament Proteins (+ 5); Microfilament Proteins (+ 7); Microtubule Proteins (+ 5); Spectrin; Talin; Vinculin Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Cytoplasm (66-79); Cytoskeleton (77-84); Proteins or specific proteins (66-84) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $v/FD^HCytosine Nucleotides D13.695.740.246; D13.695.827.232 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Arabinofuranosylcytosine Triphosphate; Cyclic CMP; Cytidine Diphosphate (+ 2); Cytidine Monophosphate (+ 1); Cytidine Triphosphate; Deoxycytosine Nucleotides (+ 1) Cyclic CMP; Cytidine Diphosphate (+ 2); Cytidine Monophosphate (+ 1); Cytidine Triphosphate AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR yx&B,DCytosine D03.383.742.698.421 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones Flucytosine |\ >hCytoplasmic Streaming G04.335.418 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Axoplasmic Flow The movement of protoplasm within a cell. It serves as an internal transport system for moving essential substances throughout the cell, and in single-celled organisms, such as the amoeba, it is responsible for the movement of the entire cell. Cytoplasm (66)  }WfCytoplasmic Granules A11.368.246; A11.515.246 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cell Degranulation Cells; Cytoplasm Cells; Inclusion Bodies Chromaffin Granules Stored products of a cell's metabolic activity.  e*2:Cytoplasm A11.368 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells Cytoplasmic Granules (+ 1); Cytoskeleton (+ 3); Lewy Bodies; Organelles (+ 33) The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS, MITOCHONDRIA, and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990).   * bCytophotometry E05.196.712.382.240; E05.909.262.386 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Fluorometry Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Flow Cytometry Flow Cytometry A method for the study of certain organic compounds within cells, in situ, by measuring the light intensities of the selectively stained areas of cytoplasm. The compounds studied and their locations in the cells are made to fluoresce and are observed under a microscope. Flow Cytometry (82-85); Photometry (66-85)  A*"$?4Cytophagales B03.350.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH) Cytophagaceae (+ 2) An order of gram-negative, gliding bacteria showing gliding motility on solid surfaces. Bacteria (66-74); Myxobacterales (75)  ".g.Cytophagaceae B03.350.300.245 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Cytophagales Capnocytophaga; Cytophaga A family of gram-negative, gliding bacteria found in soil and sea water. Bacteria (66-74)  g"?XCytophaga B03.350.300.245.370 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Cytophagales; Cytophagaceae A genus of gram-negative gliding bacteria found in soil, decomposing organic matter, and freshwater and marine habitats.  "PCytopathogenic Effect, Viral E01.223.258; G04.185.515.880.225 DEGEIMPHRE Plaque Assay Diagnosis; Diagnosis, Laboratory Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. "&7Cytomegalovirus Retinitis C02.256.466.245.150; C02.325.270; C11.294.800.270; C11.768.773.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections; Cytomegalovirus Infections Virus Diseases; Eye Infections, Viral Eye Diseases; Eye Infections; Eye Infections, Viral Eye Diseases; Retinal Diseases; Retinitis Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness. Cytomegalovirus Infections (72-93); Retinitis (72-93) LP?Cytomegalovirus Infections C02.256.466.245 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Cytomegalovirus Retinitis Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. PXCytomegalovirus B04.280.382.150.150; B04.909.204.382.150.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae; Betaherpesvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae; Betaherpesvirinae A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. 2eCytology G01.100.433 CLECEDHIISLJMAOGSNSTTD Cells Biological Sciences; Anatomy y  #Cytological Techniques E05.909.262 AECLCTECHIISMONUPXSNSTTDUTVE Cytodiagnosis Miscellaneous Techniques (Non MeSH); Technology, Medical Autoradiography; Cell Count; Cell Fractionation; Cell Fusion; Cell Separation (+ 4); Colony-Forming Units Assay (+ 1); Cytophotometry (+ 1); Diffusion Chambers, Culture; Drug Screening Assays, Antitumor (+ 2); Electroporation; Histocytochemistry (+ 3); Histocytological Preparation Techniques (+ 22); Karyometry; Mitotic Index; Patch-Clamp Techniques Cytology (66-72) AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRESNSTTDUTVE $ C4Cytokinins D11.303.760.265 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators Isopentenyladenosine; Kinetins (+ 1) Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives. Adenine (73-74); Plant Growth Regulators (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $@m,;BCytokines D24.611.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Autocrine Motility Factor; Growth Substances (+ 22); Interferons (+ 8); Lymphokines (+ 10); Monokines (+ 2) Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Biological Factors (89-90); Biological Products (76-88) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ FZBHCytogenetics G05.148 CLECEDHIISLJMAMTOGSNSTTD Chromosome Abnormalities; Chromosome Mapping; Karyotyping Genetics Cell Cycle (+ 15); Chromosome Aberrations (+ 11); Crossing Over (Genetics) (+ 1); Mosaicism (+ 4); Ploidies (+ 3) A branch of genetics which deals with the cytological and molecular behavior of genes and chromosomes during cell division. Genetics, Medical (66) BLCFCICLCNCODEDHDIDTECEDEMENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERIRTSNSTSUTDTHTMURUSVI ( C bCytodiagnosis E01.223.230 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cytological Techniques Diagnosis; Diagnosis, Laboratory Amniocentesis; Biopsy (+ 2); Chorionic Villi Sampling; Spinal Puncture; Vaginal Smears AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  "'i&Cytochromes D08.262; D12.776.422.220 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins Cytochrome a; Cytochrome b (+ 1); Cytochrome c (+ 1); Cytochrome d; Cytochrome P-450 Cytochrome a; Cytochrome b (+ 1); Cytochrome c (+ 1); Cytochrome d; Cytochrome P-450 FCytochrome-c Peroxidase D08.586.682.732.380 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases A hemeprotein which catalyzes the oxidation of ferrocytochrome c to ferricytochrome c in the presence of hydrogen peroxide. EC 1.11.1.5. Cytochrome C (74-75); Peroxidases (74-75) Fg3Cytochrome-c Oxidase D08.586.682.285 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme complex of the inner mitochondrial membrane that catalyzes the reaction between ferrocytochrome c and oxygen to yield ferricytochrome c and water. It is associated with the pumping of protons and the resultant phosphorylation of ADP to ATP. The reaction is the terminal event in the electron transport scheme by which oxygen is used for fuel combustion. EC 1.9.3.1. FXCytochrome Reductases D08.586.682.608.191 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; NADH, NADPH Oxidoreductases NADH Dehydrogenase; NADPH-Ferrihemoprotein Reductase Oxidoreductases (66-72) Fy<Cytochrome P-450 D08.262.453; D08.586.682.420.170; D12.776.422.220.453 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes  Aromatase; Aryl Hydrocarbon Hydroxylases (+ 2); Cholesterol Desmolase; Cholesterol-7-Hydroxylase; Steroid 11-Hydroxylase; Steroid 12-Hydroxylase; Steroid 17-Hydroxylase; Steroid 21-Hydroxylase Isozymes which are key components of the mixed-function oxidase system responsible for the biotransformation of many foreign compounds to mutagens and carcinogens. Most mammals have several distantly related phenobarbital-inducible gene subfamilies. Cytochromes (66-72)  =FCytochrome d D08.262.300; D12.776.422.220.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes Cytochromes (electron-transporting proteins) with a tetrapyrrolic chelate of iron as a prosthetic group in which the degree of conjugation of double bonds is less than in porphyrin. (From Enzyme Nomenclature, 1992, p.539). Cytochromes (79-93) &FCytochrome c1 D08.262.286.370; D12.776.422.220.286.370 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes; Cytochrome c Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes; Cytochrome c The 30-kD membrane-bound c-type protein of mitochondria that functions as an electron donor to CYTOCHROME C in the mitochondrial and bacterial respiratory chain. (From Enzyme Nomenclature, 1992, p.545). U.FCytochrome c D08.262.286; D12.776.422.220.286 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes Cytochrome c1 Cytochrome c1 A group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. (Enzyme Nomenclature, 1992, p.539). Cytochromes (66-72)  &F"Cytochrome b5 D08.262.200.220; D12.776.422.220.200.210 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes; Cytochrome b Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes; Cytochrome b A cytochrome occurring in the endoplasmic reticulum that acts as an intermediate electron carrier in some reactions catalyzed by mixed function oxidases, e.g., fatty acid desaturation. It further activates molecular oxygen for an attack on the substrate. MW 16kDa. Cytochrome b (83-89); Cytochromes (66-82)  .F53Cytochrome b D08.262.200; D12.776.422.220.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes Cytochrome b5 Cytochrome b5 Cytochromes (electron-transporting proteins) with protoheme or a related heme as the prosthetic group. The prosthetic group is not covalently bound to the protein moiety. Cytochromes (66-82)  &F"Cytochrome a D08.262.175; D12.776.422.220.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Cytochromes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Cytochromes Cytochromes (electron-transporting proteins) in which the heme prosthetic group is heme a, i.e., the iron chelate of cytoporphyrin IX. (From Enzyme Nomenclature, 1992, p.539). Cytochromes (79-93) ?&FCytochalasins D03.438.473.231; D24.185.926.587.370 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Cytochalasin B; Cytochalasin D Cytochalasin B; Cytochalasin D A group of fungal metabolites that affect the motility of polymorphonuclear leukocytes. specific fungus (66-72); Indoles (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $r*:Jg2<Cytochalasin D D03.438.473.231.450; D24.185.926.587.370.450 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Cytochalasins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins; Cytochalasins 21-(Acetyloxy)-7,18-dihydroxy-16,18 dimethyl-10-phenyl-(11)cytochalasa 6(12),13,19-triene-1,17-dione. A fungal metabolite that blocks cytoplasmic cleavage by blocking formation of contractile microfilament structures resulting in multinucleated cell formation, reversible inhibition of cell movement, and the induction of cellular extrusion. Additional reported effects include the inhibition of actin polymerization, DNA synthesis, sperm motility, glucose transport, thyroid secretion, and growth hormone release. Cytochalasins (73-89) 2:ECytochalasin B D03.438.473.231.370; D24.185.926.587.370.370 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Cytochalasins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins; Cytochalasins Indoles (66-72); specific fungus 2:)Cytidine Triphosphate D13.695.740.246.400; D13.695.827.232.400 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides Cytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. Cytosine Nucleotides (66-77) h.D"Cytidine Monophosphate N-Acetylneuraminic Acid D02.241.081.844.562.668.250; D02.241.511.902.562.668.250; D09.203.067.687.668.250; D09.203.811.589.668.250; D13.695.740.246.370.250; D13.695.827.232.370.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Neuraminic Acids; Sialic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Neuraminic Acids; Sialic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Neuraminic Acids; Sialic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Neuraminic Acids; Sialic Acids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides; Cytidine Monophosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides; Cytidine Monophosphate A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. Cytosine Nucleotides (74); Neuraminic Acids (74) 5:@;Cytidine Monophosphate D13.695.740.246.370; D13.695.827.232.370 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides Cytidine Monophosphate N-Acetylneuraminic Acid Cytidine Monophosphate N-Acetylneuraminic Acid Cytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. Cytosine Nucleotides (66-74)   .Dh"Cytidine Diphosphate Diglycerides D09.203.408.620.569.200; D13.695.740.246.150.210; D13.695.827.232.150.210; D13.695.827.708.260 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides; Cytidine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides; Cytidine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars The ester of diacylglycerol with the terminal phosphate of cytidine diphosphate. It serves as an intermediate in the biosynthesis of phosphatidylethanolamine and phosphatidylserine in bacteria. Cytosine Nucleotides (72-74); Glycerophosphates (72-74); Phospholipids (72-74) 'hB=\Cytidine Diphosphate Choline D02.092.102.232.130; D02.675.276.232.130; D13.695.740.246.150.180; D13.695.827.232.150.180; D15.590.150 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides; Cytidine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides; Cytidine Diphosphate Central Nervous System Agents; Nootropic Agents Choline-cytidine-5'-pyrophosphate ester. Donor of choline in biosynthesis of choline-containing phosphoglycerides. Choline (73-74); Cytosine Nucleotides (69-74) ~"s@ 7Cytidine Diphosphate D13.695.740.246.150; D13.695.827.232.150 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides Cytidine Diphosphate Choline; Cytidine Diphosphate Diglycerides Cytidine Diphosphate Choline; Cytidine Diphosphate Diglycerides Cytidine 5'-(trihydrogen diphosphate). A cytosine nucleotide containing two phosphate groups esterified to the sugar moiety. Synonyms: CRPP; cytidine pyrophosphate. Cytosine Nucleotides (66-77)  ?.D"Cytidine Deaminase D08.586.277.151.486.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases; Nucleoside Deaminases An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. Aminohydrolases (73-74); Cytidine (73-74) eFc2Cytidine D13.570.685.245; D13.570.800.286 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Azacytidine; Cytarabine (+ 1); Deoxycytidine (+ 2) Azacytidine Nucleosides (66-71)  &DLCytarabine D13.570.065.300; D13.570.685.245.453; D20.388.320; D22.204.144.384; D26.087.242 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Arabinonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Cytidine Anti-Infective Agents; Antiviral Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Cyclocytidine Cyclocytidine Cyclocytidine Cyclocytidine [:?Cytapheresis E02.095.160; E02.110.285; E05.909.262.363.285 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunotherapy, Adoptive Therapeutics; Biological Therapy (Non MeSH) Therapeutics; Blood Component Removal Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Cell Separation Leukapheresis; Plateletpheresis Leukapheresis; Plateletpheresis Leukapheresis; Plateletpheresis Separation of one or more kinds of cells from whole blood with the return of other blood cell constituents to the patient or donor. This is accomplished with an instrument that uses centrifugation to separate the cells into different layers based on the differences in cell density (displacement) or drag coefficients in a current (elutriation). The procedure is commonly used in adoptive cell transfer to isolate NK cells, lymphocytes, or monocytes. Blood Component Removal (86-90); Cell Separation (78-90) $ߩ5"kDCysts C04.182 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms Arachnoid Cysts; Bone Cysts (+ 9); Branchioma; Bronchogenic Cyst; Chalazion; Choledochal Cyst; Dermoid Cyst; Epidermal Cyst; Esophageal Cyst; Fibrocystic Disease of Breast; Follicular Cyst; Kidney, Cystic (+ 4); Lymphocele; Macular Edema, Cystoid; Mediastinal Cyst; Mesenteric Cyst; Mucocele; Ovarian Cysts (+ 1); Pancreatic Cyst (+ 1); Parovarian Cyst; Pilonidal Cyst; Ranula; Synovial Cyst (+ 1); Thyroglossal Cyst; Urachal Cyst Any closed cavity or sac, normal or abnormal, lined by epithelium, and especially one that contains a liquid or semisolid material. (Dorland, 27th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI    V XCystoviridae B04.123.230; B04.123.691.230; B04.820.180 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses; Bacteriophages; RNA Phages Viruses; RNA Viruses Bacteriophage phi 6 Bacteriophage phi 6 Bacteriophage phi 6 A family of bacteriophages containing one genus (Cystovirus) with one member (BACTERIOPHAGE PHI 6). 1`GvCystostomy E04.579.240; E04.887.774.852.240 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Bladder Surgery, Operative; Ostomy Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Urinary Diversion Surgical creation of an opening (stoma) for drainage of the urinary bladder. Bladder/surgery (66-87); Urinary Catheterization (66-87); Urinary Diversion (66-87)  C&$ \cCystoscopy E01.341.220; E01.418.310 AECLCTECHIISMOMTNUPXSNSTTDUTVE Bladder Diagnosis; Diagnosis, Urologic (Non MeSH) Diagnosis; Endoscopy Endoscopic examination of the interior of the bladder. &" JBCystitis C12.777.103.495 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pyelocystitis Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Inflammation of the urinary bladder. (Dorland, 27th ed). 2 NcFCystinuria C12.777.419.815.191.250; C18.452.648.066.210.250; C18.452.648.851.191.250 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors; Aminoaciduria, Renal Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Aminoaciduria, Renal Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors; Aminoaciduria, Renal An inherited abnormality of renal tubular transport of dibasic amino acids leading to massive urinary excretion of cystine, lysine, arginine, and ornithine. QL  Cystinosis C12.777.419.815.368; C18.452.648.851.368 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors Fanconi Syndrome Fanconi Syndrome Lysosomal storage disorders of unknown molecular defect, characterized by widespread deposition of cystine crystals in reticuloendothelial cells. (From Dorland, 27th ed). .L)(Cystine D12.125.095.369; D12.125.119.369; D12.125.166.286 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTU Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur  9D&Cysticercus B01.500.736.215.895.286; B01.583.382.286 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Cestoda; Taenia Invertebrates; Life Stages (Non MeSH); Larva The larval form of various tapeworms of the genus Taenia. .*{GCysticercosis C03.335.190.902.185 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Taeniasis Parasitic Diseases; Helminthiasis; Cestode Infections; Taeniasis Infection with cysticerci, a larval form of tapeworm, Taenia solium. In man they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement may result in epilepsy, increased intracranial pressure, etc. (Dorland, 27th ed). P L\Cystic Fibrosis C06.689.202; C08.381.187; C16.614.213 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Mice, Inbred CFTR Sweating Digestive System Diseases; Pancreatic Diseases Respiratory Tract Diseases; Lung Diseases Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases An inherited disease of exocrine glands, affecting most characteristically the pancreas, respiratory system, and sweat glands, usually beginning in infancy and typified by chronic respiratory infections, pancreatic insufficiency, and susceptibility to heat prostration. Cirrhosis of liver occurring in childhood is common and may produce portal hypertension, splenomegaly, and hypersplenism.  N-L Cystic Duct A03.159.183.419 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Biliary Tract; Bile Ducts :6Cystic Adenomatoid Malformation of Lung, Congenital C08.381.150; C08.695.290; C16.131.740.290 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) A developmental anomaly that usually becomes apparent in the neonatal period with progressive respiratory distress. This malformation is a focal pulmonary dysplasia characterized by a multicystic mass of terminal bronchiolar structures. CCAM is classified into 3 separate types (I, II, III) depending on cyst size. Lung/abnormalities (66-89) T<1Lm Cysteinyldopa D02.092.311.242.180; D12.125.072.573.400.180; D12.125.166.230.330 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Dopa Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Phenylalanine; Dopa Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Cysteine 5-S-Cysteinyldopa. Found in large amounts in the plasma and urine of patients with malignant melanoma. It is therefore used in the diagnosis of melanoma and for the detection of postoperative metastases. Cysteinyldopa is believed to be formed by the rapid enzymatic hydrolysis of 5-S-glutathionedopa found in melanin-producing cells. Cysteine (66-76); Dopa (66-76) IF9'Cysteine Synthase D08.586.520.290 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that catalyzes the biosynthesis of cysteine in microorganisms and plants from O-acetyl-L-serine and hydrogen sulfide. EC 4.2.99.8. Cysteine (66-76); Lyases (66-76); Serine (66-76) iFO=Cysteine Proteinases D08.586.277.656.732.215 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Bromelains; Calpain; Cathepsin B; Chymopapain; Ficin; Papain; Pteroyl Polyglutamate Hydrolase Peptide hydrolases which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by sulfhydryl reagents. EC 3.4.22. Peptide Peptidohydrolases (66-87) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $/Dp'FCysteine Proteinase Inhibitors D08.373.745.325 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Cystatins (+ 1) Exogenous and endogenous compounds which inhibit cysteine proteinases. Enzyme Inhibitors (68-78); Protease Inhibitors (79-89) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $$@hRADCysteine D12.125.166.230 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Acetylcysteine; Carbocysteine; Cysteinyldopa; Selenocysteine   FaFCysteic Acid D12.125.166.215 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Beta-Sulfoalanine. An amino acid with a C-terminal sulfonic acid group which has been isolated from human hair oxidized with permanganate. It occurs normally in the outer part of the sheep's fleece, where the wool is exposed to light and weather. Alanine (74); Amino Acids, Sulfur (74)  :a$1Cystectomy E04.887.774.150 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Urinary Diversion Bladder Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH) Used for excision of the urinary bladder. Bladder (66-89); Bladder Neoplasms (66-89) $N$ `44Cysteamine D02.092.471.562.369; D02.886.489.472.369; D26.763.494 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Mercaptoethylamines Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfhydryl Compounds; Mercaptoethylamines Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents 2-Aminoethanethiol. A radiation-protective agent that oxidizes in air to form cystamine. It can be given intravenously or orally to treat radiation sickness. =:Cystatins D08.373.745.325.250 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Cysteine Proteinase Inhibitors Kininogens A homologous group of endogenous cysteine proteinase inhibitors. Four distinct families are recognized within the cystatin superfamily: cystatin B or stefins; cystatin C or post-gamma-globulin; egg-white or chicken cystatin; and kininogen cystatin. The cystatins inhibit most cysteine proteinases of the papain type, and other peptidases which have a sulfhydryl group at the active site. Enzyme Inhibitors (75-78); Protease Inhibitors (79-89) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $& BADCystathionine gamma-Lyase D08.586.520.280 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases A multifunctional pyridoxal phosphate enzyme. In the final step in the biosynthesis of cysteine it catalyzes the cleavage of cystathionine to yield cysteine, ammonia, and 2-ketobutyrate. EC 4.4.1.1. Cysteine (73-74); Homoserine (73-74); Lyases (73-74) FOACystathionine beta-Synthase D08.586.520.497.290 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Homocystinuria Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases A multifunctional pyridoxal phosphate enzyme. In the second stage of cysteine biosynthesis it catalyzes the reaction of homocysteine with serine to form cystathionine with the elimination of water. EC 4.2.1.22. Homocysteine (73-74); Hydro-Lyases (73-74); Serine (73-74)   F_GCystathionine D12.125.095.307; D12.125.119.307; D12.125.166.175 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur Amino Acids (66-70) 9F&Cystaphos D02.719.208; D26.763.488 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents 2-Aminoethyl dihydrogenphosphorothioate, sodium salt. Proposed as an adjuvant to cancer chemotherapy; may have radiation protective properties. Ethylamines (72-74); Organothiophosphorus Compounds (72-74)  .ECystamine D02.092.471.200; D26.763.483 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Ethylamines Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents 2,2'-Dithiobisethanamine. A radiation-protective agent that interferes with sulfhydryl enzymes. It may also protect against carbon tetrachloride liver damage.  ".Cystadenoma, Serous C04.557.470.035.320.240; C04.557.470.590.485.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Cystadenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Cystadenoma A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972). Cystadenoma (66-93) 6X4Cystadenoma, Papillary C04.557.470.035.320.230; C04.557.470.590.485.230 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Cystadenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Cystadenoma A benign neoplasm of the ovary. Adenolymphoma (66-93); Cystadenoma (66-93) #6V4)3Cystadenoma, Mucinous C04.557.470.035.320.225; C04.557.470.590.485.225 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Cystadenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Cystadenoma A multilocular tumor produced by the epithelial cells of the ovary and having mucin-filled cavities. The great majority of these tumors is benign. (Dorland, 27th ed). Cystadenoma (66-93) &6V4Cystadenoma C04.557.470.035.320; C04.557.470.590.485 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) Cystadenoma, Mucinous; Cystadenoma, Papillary; Cystadenoma, Serous Cystadenoma, Mucinous; Cystadenoma, Papillary; Cystadenoma, Serous A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  (.VXCystadenocarcinoma, Serous C04.557.470.200.025.480.240; C04.557.470.590.480.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Cystadenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Cystadenocarcinoma A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Obstetric-Gynecologic Terminology, 1972, p. 185). Cystadenocarcinoma (75-93); Cystadenoma (66-79) ,:XV68Cystadenocarcinoma, Papillary C04.557.470.200.025.480.230; C04.557.470.590.480.230 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Cystadenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Cystadenocarcinoma An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface. Cystadenocarcinoma (80-93); Cystadenoma (66-79) 1s":XV8Cystadenocarcinoma, Mucinous C04.557.470.200.025.480.225; C04.557.470.590.480.225 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Cystadenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH); Cystadenocarcinoma A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Obstetric-Gynecologic Terminology, 1972). Cystadenocarcinoma (66-93); Cystadenoma (69-79) 4!:XVj8Cystadenocarcinoma C04.557.470.200.025.480; C04.557.470.590.480 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed). 9b2X)Cyprus Z01.542.581.369 EHEP Geographicals (Non MeSH); Europe; Mediterranean Islands = CCyproterone Acetate D04.808.745.432.219.150; D04.808.883.419.150; D06.347.065.260.150; D07.360.443.319; D22.204.361 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Cyproterone Polycyclic Hydrocarbons; Steroids; Steroids, Chlorinated; Cyproterone Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Androgen Antagonists; Cyproterone Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Male Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 17-(Acetyloxy)-6-chloro-1,2-dihydro-3'H-cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione. An agent with anti-androgen and progestational properties. It is used in the treatment of male sex offenders, precocious puberty, prostatic and ovarian cancer, and severe hirsutism. Cyproterone/analogs and derivatives (80-92) >Ck:13Cyproterone D04.808.745.432.219; D04.808.883.419; D06.347.065.260 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Polycyclic Hydrocarbons; Steroids; Steroids, Chlorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Androgen Antagonists Cyproterone Acetate Cyproterone Acetate Cyproterone Acetate 6-Chloro-1,2-dihydro-17-hydroxy-3'H-cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione. An anti-androgen that, in the form of its acetate, also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Androgens/antagonists and inhibitors (68-71)  BV=:D4Cyproheptadine D03.383.621.160; D04.615.181.384.340; D14.100.375.425.400.190; D14.100.850.850.190; D23.075.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Dermatologic Agents; Antipruritics Loratadine Loratadine A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc. Fk:KCyprinodontiformes B02.493.280 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Killifish; Oryzias; Poecilia An order of fish with eight families and numerous species of both egg-laying and livebearing fish. It includes two suborders, Adrianichthyoidei (egg layers) and Cyprinodontoidei (egg layers and livebearers). The latter suborder comprises Cyprinodontidae (egg-laying KILLIFISH), Goodeidae (Mexican livebearers), Jenynsiidae (jenynsiids), Anablepidae (four-eyed fish), Poeciliidae (livebearers). Of the suborder Poeciliidae, the guppy and molly belong to the genus POECILIA. Fishes (66-86)  I&$ Cypriniformes B02.493.200 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Cyprinidae (+ 3); Electrophorus An order of fish with 26 families and over 3,000 species. This order includes the family CYPRINIDAE, loaches, carp, suckers, and electric fish. L&(Cyprinidae B02.493.200.244 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cypriniformes Carp (+ 1); Zebrafish Fishes (66-67) N>&*Cymarine D04.808.155.160.861.250; D09.203.408.180.810.250; D18.222.175.810.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Strophanthins Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Strophanthins Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Strophanthins 3-((2,6-Dideoxy-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy)-5,14-dihydroxy-19-oxo-card-20(22)-enolide. A cardiotonic cardiac glycoside isolated from Strophanthus kombe Oliv. Cardanolides (71-74); Cardiac Glycosides (74) O M:/7Cyclotrons H01.671.579.705.250 CLECHIISLJSDSNSTUT Physical Sciences (Non MeSH); Physics; Nuclear Physics; Particle Accelerators Devices for accelerating charged particles in a spiral path by a constant-frequency alternating electric field. This electric field is synchronized with the movement of the particles in a constant magnetic field. Fast Neutrons (71-77); Neutrons (66-77); Nuclear Medicine (67-77); Particle Accelerators (78-92) Q]tCyclothymic Disorder F03.709.438.100.208 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Affective Disorders A non-psychotic affective disorder characterized by periods of depression and hypomania. These may be separated by periods of normal mood. TFxCyclostomes B02.493.181 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Hagfish; Lampreys Eels (66-67) U&Cyclosteroids D04.808.294 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Steroid derivatives in which one or more bridges is formed between carbon atoms at any locant in any of the rings. Vq8(Cyclosporins D12.644.641.235; D22.569.550 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Peptides, Cyclic Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Cyclosporine Cyclosporine A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Immunosuppressive Agents (66-81); Peptides (66-70); Peptides, Cyclic (71-81)  W"@m[Cyclosporine D12.644.641.235.300; D17.050.160; D22.569.550.300 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Peptides, Cyclic; Cyclosporins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents; Cyclosporins Cyclo((3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl). A cyclic undecapeptide from an extract of soil fungi with immunosuppressant and antifungal effects. It is frequently used to prevent rejection of transplanted tissues and organs. Cyclosporins (82-91); Immunosuppressive Agents (66-91); Peptides (66-70); Peptides, Cyclic (71-81) Z9@CuCycloserine D20.085.089.260; D20.338.135.306; D26.087.208 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites D-4-Amino-3-isoxazolidinone. Antibiotic substance produced by Streptomyces garyphalus. ^5<bCyclopropanes D02.455.426.392.368.533 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins Cilastatin; Hypoglycins AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR `8:Cyclophosphamide D02.455.526.728.650.730.243; D02.705.670.243; D17.050.150; D22.204.585.748.243; D22.569.518 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds; Phosphoramide Mustards Organic Chemicals (Non MeSH); Organophosphorus Compounds; Phosphoramide Mustards Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds; Phosphoramide Mustards Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents  Ifosfamide Ifosfamide Ifosfamide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide. Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. It is used in the treatment of lymphomas, leukemias, etc. Its side effect, alopecia, has been made use of in defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. b4g:R(Cyclopentolate D02.241.223.601.200; D14.100.120.200.500.160; D16.050.500.120; D16.050.650.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics 1-Hydroxy-alpha-phenylcyclopentaneacetic acid, 2-(dimethylamino)ethyl ester. A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia. Cyclopentanes (69-74); Dimethylamines (74); Phenylacetates (69-74) gX:OCyclopenthiazide D03.438.174.285; D18.162.276.249; D19.770.224.578.249 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide 6-Chloro-3-(cyclopentylmethyl)-3,4-dihydro-2H-1,2,4-benzo thiadiazine-7-sulfonamide 1,1-dioxide. Thiazide diuretic also used as an antihypertensive agent. Cyclic S-Oxides (74); Cyclopentanes (74); Diuretics, Thiazide (74) k0=:"QCyclopentanes D02.455.426.392.368.450 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins Cycloleucine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR n8:Cycloparaffins D02.455.426.392.368 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH) Adamantane (+ 2); Cyclobutanes; Cycloheptanes (+ 2); Cyclohexanes (+ 10); Cyclopentanes (+ 1); Cyclopropanes (+ 2) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR om8:Cyclooxygenase Inhibitors D08.373.310 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Inflammatory Agents, Non-Steroidal Salicylates; Prostaglandin Antagonists Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Aspirin; BW-755C; Diclofenac; Diflunisal; Etodolac; Fenoprofen; Flurbiprofen; Ibuprofen; Indomethacin; Indoprofen; Ketoprofen; Meclofenamic Acid; Mefenamic Acid; Naproxen; Niflumic Acid; Nordihydroguaiaretic Acid; Piroxicam; Sodium Salicylate; Sulindac; Suprofen; Tolmetin Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. Prostaglandin-Endoperoxide Synthase/antagonists and inhibitors (81-91) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,qA4--PAO:Cycloleucine D02.455.426.392.368.450.350; D12.125.072.170 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclopentanes Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH) 1-Aminocyclopentanecarboxylic acid. Amino acid formed by cyclization of leucine. Has cytostatic, immunosuppressive and antineoplastic activities. Frequently encountered synonym: NSC-1026. Amino Acids (71-74); Cyclopentanes (70-74) uT2:4Cyclohexylamines D02.092.384; D02.455.426.392.368.367.418 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Bromhexine (+ 1) Amines (66-70); Cyclohexanes (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  x.8-:Cycloheximide D03.383.621.808.240; D20.085.062.340; D20.136.073.340 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Piperidones Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal 4-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-2,6- piperidinedione. Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. z =<Cyclohexanones D02.455.426.392.368.367.340; D02.522.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Organic Chemicals (Non MeSH); Ketones  Tiletamine Cyclohexane ring substituted by one or more ketones in any position. Cyclohexanes (69-74); Ketones (69-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $|c.8S.:Cyclohexanols D02.033.460; D02.455.426.392.368.367.318 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Menthol; Tramadol Menthol Alcohols (66-71); Cyclohexanes (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ~.8 /:Cyclohexanes D02.455.426.392.368.367 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins AY 9944; Cuprizone; Cyclohexanecarboxylic Acids; Cyclohexanols (+ 1); Cyclohexanones; Cyclohexylamines; Dicyclomine; Ketamine; Tiletamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8:Cyclohexanecarboxylic Acids D02.241.223.268; D02.455.426.392.368.367.218 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Aurintricarboxylic Acid; Chlorogenic Acid; Chorismic Acid; Dicyclomine; Quinic Acid; Shikimic Acid; Tilidine; Tranexamic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  28:Cycloheptanes D02.455.426.392.368.284 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins Bencyclane; Tropolone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8:Cyclofenil D02.755.239.402; D07.552.344.285 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Cresols Reproductive Control Agents (Non MeSH); Fertility Agents; Fertility Agents, Female 4-((4-(Acetyloxy)phenyl)cyclohexylidenemethyl)phenol acetate. A gonadal stimulant and inducer of ovulation. It is used in the treatment of infertility and amenorrhea, but is thought to be less effective than CLOMIPHENE. Cresols (69-71); Cyclohexanes (69-71); Phenols (69-71) &:CCyclodextrins D09.203.698.365.855.400.375 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Starch; Dextrins A homologous group of cyclic glucans consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Dextrins (75-79); Polysaccharides (66-74) B]2Cyclocytidine D13.570.065.300.250; D13.570.685.245.453.250; D22.204.144.384.232; D26.087.242.232 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Arabinonucleosides; Cytarabine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Cytidine; Cytarabine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic; Cytarabine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Cytarabine 2,2'-Anhydro-1-beta-D-arabinofuranosylcytosine. Congener of cytarabine that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action. Synonyms: Cyclo-C; NSC 145,668. Anhydrides (74-75); Cytarabine (74-76); Cytidine (73) \:BCyclobutanes D02.455.426.392.368.201 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins Cycloparaffins (66-71) t8Cyclizine D03.383.606.320; D14.100.375.425.400.180; D15.095.150; D16.050.030.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Antiemetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Antiemetics A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting, and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.935).  P:Cyclization G06.535.630.300; H01.181.404.325 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Chemistry, Organic (66-70) & Cyclins D11.303.330; D12.776.260.150.218; D24.185.348.353 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Maturation-Promoting Factor Maturation-Promoting Factor Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Cell Cycle Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Regulatory proteins that function in the cell cycle to activate maturation promoting factor. They complex with p34cdc2 (PROTEIN P34CDC2), the catalytic subunit of MATURATION-PROMOTING FACTOR, and modulate its protein kinase activity. Cyclins themselves have no enzymatic activity. Invertebrate Hormones (87-90) $! 9F  $D#Cyclin-Dependent Kinases D08.586.913.696.620.682.700.200; D12.776.260.150.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Cell Cycle Proteins CDC28 Protein Kinase; Maturation-Promoting Factor; Protein p34cdc2 CDC28 Protein Kinase; Maturation-Promoting Factor (+ 1) Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events. Protein Kinases (92-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $:FMHCyclic S-Oxides D03.661.493 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Oxides Heterocyclic Compounds; Heterocyclic Oxides Oxides (66-67) 8 3Cyclic P-Oxides D03.661.368 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Oxides Heterocyclic Compounds; Heterocyclic Oxides Oxides (66-67) 8 3Cyclic Nucleotide-Regulated Protein Kinases (Non MeSH) D08.586.913.696.620.682.700.150 Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Protamine Kinase A group of enzymes that catalyzes the phosphorylation of serine or threonine residues of proteins and is dependent on cyclic nucleotides. EC 2.7.10.-. Protein Kinases (73-93) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  g?#kFCyclic N-Oxides D03.661.243 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Oxides Heterocyclic Compounds; Heterocyclic Oxides 4-Hydroxyaminoquinoline-1-oxide; 4-Nitroquinoline-1-oxide; Triacetoneamine-N-Oxyl Oxides (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $M8 3Y:Cyclic IMP D13.695.462.300; D13.695.667.616.300; D13.695.827.519.300 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Inosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Inosine Nucleotides Inosine cyclic 3',5'-(hydrogen phosphate). An inosine nucleotide which acts as a mild inhibitor of the hydrolysis of cyclic AMP and cyclic GMP and as an inhibitor of cat heart cyclic AMP phosphodiesterase. Inosine Nucleotides (71-74); Nucleotides, Cyclic (74) AD^@Cyclic GMP-Dependent Protein Kinases D08.586.913.696.620.682.700.150.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Cyclic Nucleotide-Regulated Protein Kinases (Non MeSH) A group of enzymes that are dependent on cyclic GMP and catalyzes the phosphorylation of serine or threonine residues of proteins. EC 2.7.10.-. Protein Kinases (82-93) +'FCyclic GMP D13.695.462.275; D13.695.667.454.160; D13.695.827.426.160 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Guanine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Guanine Nucleotides Dibutyryl Cyclic GMP Dibutyryl Cyclic GMP Dibutyryl Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed). Guanine Nucleotides (66-71)  AD^J !Cyclic CMP D13.695.462.250; D13.695.740.246.115; D13.695.827.232.115 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Cytosine Nucleotides Cytidine cyclic 3',5'-(hydrogen phosphate). It is formed in mammalian tissue by the enzymatic conversion of cytidine triphosphate and may play a role in the bioregulation of proliferation of normal and malignant cells. Cytidine Monophosphate (66-74) /analogs and derivatives (75-79); Cytosine Nucleotides (66-79); Nucleotides, Cyclic (74-79) 9ADdCyclic AMP-Dependent Protein Kinases D08.586.913.696.620.682.700.150.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Cyclic AMP Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Cyclic Nucleotide-Regulated Protein Kinases (Non MeSH) A group of enzymes that are dependent on cyclic AMP and catalyze the phosphorylation of serine or threonine residues on proteins. EC 2.7.10.-. Protein Kinases (73-93)  +'FCyclic AMP Receptor Protein D12.776.930.165 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Cyclic AMP Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors A transcriptional regulator in prokaryotes which, when activated by binding cyclic AMP, acts at several promoters. Cyclic AMP receptor protein was originally identified as a catabolite gene activator protein. It was subsequently shown to regulate several functions unrelated to catabolism, and to be both a negative and a positive regulator of transcription. Cell surface cyclic AMP receptors are not included (CYCLIC AMP RECEPTORS), nor are the eukaryotic cytoplasmic cyclic AMP receptor proteins, which are the regulatory subunits of CYCLIC AMP-DEPENDENT PROTEIN KINASES. Amino Acid Sequence (75-87); Bacterial Proteins (72-87); Base Sequence (80-87); Receptors, Cyclic AMP (80-93); Transcription Factors (80-87); Transcription, Genetic (78-87)  "H^Cyclic AMP D13.695.462.200; D13.695.667.138.395; D13.695.827.068.395 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Cyclic AMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides 8-Bromo Cyclic Adenosine Monophosphate; Bucladesine 8-Bromo Cyclic Adenosine Monophosphate; Bucladesine 8-Bromo Cyclic Adenosine Monophosphate; Bucladesine Adenosine cyclic 3',5'-(hydrogen phosphate). An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenine Nucleotides (66-68) $)AD^!Cyclazocine D03.383.113.367; D03.605.168; D15.040.100.115; D15.550.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azocines Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH) Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic Central Nervous System Agents; Narcotic Antagonists Ethylketocyclazocine Ethylketocyclazocine Ethylketocyclazocine 3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol. An analgesic with mixed narcotic agonist-antagonist properties. D:'ECyclandelate D02.241.223.475.180; D02.241.511.536.180; D18.918.195 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Mandelic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Mandelic Acids Cardiovascular Agents; Vasodilator Agents 3,3,5-Trimethylcyclohexyl mandelate. A direct-acting smooth muscle relaxant used to dilate blood vessels. It may cause gastrointestinal distress and tachycardia. Cyclohexanes (68-74); Mandelic Acids (68-74) =:6Cyclamates D09.818.284; D26.456.609.284 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Sweetening Agents Miscellaneous Drugs and Agents (Non MeSH); Flavoring Agents; Sweetening Agents Sweetening Agents (66-69) #",Cyclacillin D20.085.099.739.243 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins 6-(((1-Aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. A cyclohexylamido analog of penicillanic acid. Cyclohexylamines (72-74); Penicillins (72-74) m:P6Cycasin D02.172.080.200; D26.191.090.200 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds; Azoxymethane Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Azoxymethane (Methyl-ONN-azoxy)methyl beta-D-glucopyranoside. Carcinogenic and neurotoxic glycoside occurring in a number of plant species, including Cycas revoluta. Azo Compounds (70-74); Glucose (70-74); Methylglycosides (74) * &.KCybernetics L01.143.283 CLECEDHIISLJMAMTOGSNSTTD Bionics Bionics Information Science; Communication Feedback That branch of learning which brings together theories and studies on communication and control in living organisms and machines. CLDEECEDHIISLJMAMTOGPHRESNSTTD (?  ) "Cyanosis C23.888.284 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) A bluish discoloration, applied especially to such discoloration of skin and mucous membranes due to excessive concentration of reduced hemoglobin in the blood. (Dorland, 27th ed). ȱ NXCyanoketone D04.808.054.079.429.320 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols 2 alpha-Cyano-17 beta-hydroxy-4,4',17 alpha-trimethylandrost-5-ene-3-one. An androstenolone-nitrile compound with steroidogenesis-blocking activity. Androstenols (74); Nitriles (74); Ketosteroids (74) i:V@Cyanogen Bromide D01.139.300.050.100; D01.625.175 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Bromine Compounds; Hydrobromic Acid; Bromides Inorganic Chemicals (Non MeSH); Nitrogen Compounds Cyanogen bromide (CNBr). A compound used in molecular biology to digest some proteins and as a coupling reagent for phosphoroamidate or pyrophosphate internucleotide bonds in DNA duplexes. Cyanides (66-70) -&8Cyanobacteria B03.440.200; B05.104.400 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Bacteria; Gram-Negative Bacteria Algae and Fungi (Non MeSH); Algae Anabaena; Synechococcus Group; Synechocystis Group Anabaena; Synechococcus Group; Synechocystis Group A widely distributed and diverse collection of unicellular to multicellular photosynthetic bacteria that possess chlorophyll A and carry out oxygenic photosynthesis. Cyanobacteria are the only organisms capable of fixing both carbon dioxide (in the presence of light) and nitrogen. This group of organisms, also called blue-green algae, were traditionally treated as algae. By late in the past century, however, it was realized that the blue-green algae were unique and lacked the traditional nucleus and chloroplasts of the green and other algae. The comparison of nucleotide base sequence data from 16S and 5S rRNA indicates that cyanobacteria represent a moderately deep phylogenetic unit within the gram-negative bacteria. Algae (66-69)  Q&QvHCyanoacrylates D02.241.081.069.366; D25.720.259; D25.919.367 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates Biomedical and Dental Materials (Non MeSH); Polymers Biomedical and Dental Materials (Non MeSH); Tissue Adhesives Bucrylate; Enbucrilate Enbucrilate (+ 1) Enbucrilate (+ 1) A group of compounds having the general formula CH2=C(CN)-COOR; it polymerizes on contact with moisture; used as tissue adhesive; higher homologs have hemostatic and antibacterial properties. Acetates (66-71); Acrylates (66-71); Tissue Adhesives (66-71) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $5,FK.Cyanides D01.248.497.158.291; D01.625.400.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nitriles Nitriles Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide Ferricyanides (+ 1); Ferrocyanides Cyanamide; Ferricyanides (+ 1); Ferrocyanides; Potassium Cyanide; Sodium Cyanide Inorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (! *8  :Cyanates D02.262 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Thiocyanates Organic salts of cyanic acid containing the -OCN radical.   8#FCyanamide D01.146.400; D01.625.400.100.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Hydrogen Cyanide; Cyanides Cyanamide (H2NCN). A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism. Amines (66-78); Cyanides (66-78)   &8;)Cutis Laxa C17.300.230; C17.800.150; C17.800.827.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ehlers-Danlos Syndrome Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH) A group of connective tissue diseases in which skin hangs in loose pendulous folds. It is believed to be associated with decreased elastic tissue formation as well as an abnormality in elastin formation. Cutis laxa is usually a genetic disease, but acquired cases have been reported. (From Dorland, 27th ed). ܙ1NnCutaneous Fistula C17.800.135; C23.439.092 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Symptoms and General Pathology (Non MeSH); Fistula An abnormal passage or communication leading from an internal organ to the surface of the body, as bronchocutaneous, vesicocutaneous, renocutaneous, colocutaneous, etc. Fistula (66-93); Skin Diseases (66-93) N0Custodial Care E02.472.215; N02.421.589.260 CLECHILJMAMTOGPXSNSTTDUT Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Board, room, and other personal assistance services generally provided on a long term basis. It excludes regular medical care.  "Cuspid A14.254.860.188 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth  :0Cushing's Syndrome C19.053.181.367 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Adenoma, Basophil Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Hyperfunction A condition, more commonly seen in females, due to hyperadrenocorticism resulting from neoplasms of the adrenal cortex or the anterior lobe of the pituitary, or to prolonged excessive intake of glucocorticoids for therapeutic purposes. The symptoms and signs may include rapidly developing adiposity of the face, neck, and trunk, kyphosis caused by osteoporosis of the spine, hypertension, diabetes mellitus, amenorrhea, hypertrichosis in females, impotence in males, dusky complexion with purple markings, polycythemia, pain in the abdomen and back, and muscular wasting and weakness. When secondary to excessive pituitary secretion of adrenocorticotropin, it is known as Cushing's disease. (Dorland, 27th ed). kNT3Curriculum I02.158 SNSTTD Education Competency-Based Education; Mainstreaming (Education); Problem-Based Learning A course of study offered by an educational institution. CLDEECHILJMAMTOGPHRESNSTTD     YECurling's Ulcer C06.405.469.275.520.200; C06.405.613.216.200 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Burns Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Duodenal Diseases; Duodenal Ulcer Digestive System Diseases; Gastrointestinal Diseases; Peptic Ulcer; Duodenal Ulcer Duodenal ulcer occurring in severe burns. 2L 3Curium D01.268.271.545.175; D01.552.517.272 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid A radioactive actinide with atomic symbol Cm, atomic number 96, and atomic weight 247. Thirteen curium isotopes have been produced with mass numbers ranging from 238-250. Its valence can be +3 or +4. It is intensely radioactive and decays by alpha-emission.  *41Curettage E04.157 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Dilatation and Curettage Surgery, Operative Dilatation and Curettage (+ 1)   $&Curcumin D02.755.166.200; D26.408.223 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Phenols; Catechols Miscellaneous Drugs and Agents (Non MeSH); Dyes 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione. A dye obtained from the root of Curcuma longa L., or turmeric. It is used in the preparation of curcuma paper and the detection of boron. It may have choleretic properties. Synonyms: curcuma; Indian saffron; CI Natural Yellow; turmeric; C.I. 75300. Alkadienes (74); Catechols (66-74)  ".uo+Curare D03.132.267; D14.100.120.200.600.170; D16.700.710.575.130; D24.310.674.200; D26.714.200 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents Immunologic and Biologic Factors (Non MeSH); Biological Products; Plant Extracts Miscellaneous Drugs and Agents (Non MeSH); Plant Extracts Toxiferine (+ 1); Tubocurarine Toxiferine; Tubocurarine Toxiferine; Tubocurarine A term applied to a wide variety of highly toxic extracts from numerous botanical sources, including various species of Strychnos. The extracts were used originally as arrow poisons in South America. A form extracted from Chondrodendron tomentosum has been used for the reduction of spasms in tetanus and in shock treatments, in plastic muscular rigidity, spastic paralysis, and similar conditions, and also as an adjunct to general anesthesia. (Dorland, 27th ed). N c@aCuprizone D02.455.426.392.368.367.190; D26.241.150 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Miscellaneous Drugs and Agents (Non MeSH); Chelating Agents Bis(Cyclohexylidene-hydrazide)oxalic acid. Copper chelator that inhibits monoamine oxidase and causes liver and brain damage. Synonym: Cuprizane. Cyclohexanes (69-74); Hydrazones (72-74)  ..1Culture Media, Serum-Free D26.342.270 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Miscellaneous Drugs and Agents (Non MeSH); Culture Media CULTURE MEDIA free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells. Culture Media (66-91) (ECulture Media, Conditioned D26.342.210 AEANCHCLCTDUECHIIPMEPDPKPORESDSTTO Miscellaneous Drugs and Agents (Non MeSH); Culture Media Culture media containing biologically active components obtained from previously cultured cells or tissues that have released into the media substances affecting certain cell functions (e.g., growth, lysis). Culture Media (67-92)   &ECulture Media D26.342 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Bacteriological Techniques Miscellaneous Drugs and Agents (Non MeSH) Agar; Culture Media, Conditioned; Culture Media, Serum-Free Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTUUL $ (2G.Culture I01.076.201.450; I01.880.143 Cross-Cultural Comparison Social Sciences; Anthropology; Anthropology, Cultural Social Sciences; Sociology Acculturation; Ceremonial; Civilization (+ 3); Cross-Cultural Comparison; Cultural Characteristics (+ 1); Cultural Evolution; Ethnic Groups (+ 12); Ethnology; Folklore; Funeral Rites; Human Body; Medicine, Traditional (+ 7); Superstitions (+ 3) Acculturation; Cross-Cultural Comparison; Cultural Characteristics; Cultural Deprivation; Ethnic Groups (+ 12); Psychosocial Deprivation A collective expression for all behavior patterns acquired and socially transmitted through symbols. Culture includes customs, traditions, and language. CLECEDGEHIISLJMAMTOGPXSNSTTD   "^ Cultural Evolution I01.076.201.450.370 Social Sciences; Anthropology; Anthropology, Cultural; Culture The continuous developmental process of a culture from simple to complex forms and from homogeneous to heterogeneous qualities. RJCultural Deprivation I01.880.143.400 Mental Retardation, Psychosocial Poverty Social Sciences; Sociology; Culture The absence of certain expected and acceptable cultural phenomena in the environment which results in the failure of the individual to communicate and respond in the most appropriate manner within the context of society. Language acquisition and language use are commonly used in assessing this concept. ~& ,bCultural Characteristics I01.076.201.450.324; I01.880.143.329 Cross-Cultural Comparison Social Sciences; Anthropology; Anthropology, Cultural; Culture Social Sciences; Sociology; Culture Cannibalism Those aspects or characteristics which identify a culture. HIPX  *tFCulicidae B01.131.617.289.275 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera Aedes; Anopheles; Culex A family of the order DIPTERA that comprises the mosquitoes. The larval stages are aquatic, and the adults can be recognized by the characteristic wing venation, the scales along the wing veins, and the long proboscis. Many species are of particular medical importance.  (5>Culex B01.131.617.289.275.225 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Culicidae A genus of mosquitoes (CULICIDAE) commonly found in tropical regions. Species of this genus are vectors for St. Louis encephalitis (ENCEPHALITIS, ST. LOUIS) as well as many other diseases of man and domestic and wild animals.   (B Culdoscopy E01.249.241; E01.418.268 AECLCTECHIISMOMTNUPXSNSTTDUTVE Douglas' Pouch Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Endoscopy  "HCues F02.463.425.234 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Signals for an action; that specific portion of a perceptual field or pattern of stimuli to which a subject has learned to respond.  ZCucumovirus B04.715.464.180; B04.820.464.180 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses A group of plant viruses which infect cucurbits and solanaceous plants. Transmission occurs via aphids in a non-persistent manner, and also via seeds. Cucumber mosaic virus, a CUCUMOVIRUS, should not be confused with cucumber green mottle mosaic virus, a TOBAMOVIRUS. Mosaic Viruses (73-93); Plant Viruses (66-93)  &\98Cucumbers B06.510.956.300; J01.341.956.427 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables A vine, Cucumis sativus, cultivated for its edible fruit and also the usually cylindrical fruit of the cucumber vine, having a hard green rind and white succulent flesh. (American Heritage Dictionary, 1982). Plants (66-94); Plants, Edible (66-94); Vegetables (66-94)  &4tHCuba Z01.107.084.900.225 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies 9OCrystallography, X-Ray E05.196.309.742.225; H01.181.529.240.742.225 HIISMT Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Crystallography; X-Ray Diffraction Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Crystallography; X-Ray Diffraction The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). 2 Crystallography E05.196.309; H01.181.529.240 HIISMTST Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical X-Ray Diffraction (+ 1) X-Ray Diffraction (+ 1) The branch of science that deals with the geometric description of crystals and their internal arrangement. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). " :Crystallization E05.196.300; H01.181.529.225 Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). "Crystallins D12.776.306.366 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Eye Proteins A heterogeneous family of water-soluble structural proteins found in cells of the vertebrate lens. The presence of these proteins accounts for the transparency of the lens. The family is composed of four major groups, alpha, beta, gamma, and delta, and several minor groups, which are classed on the basis of size, charge, immunological properties, and vertebrate source. Alpha, beta, and delta crystallins occur in avian and reptilian lenses, while alpha, beta, and gamma crystallins occur in all other lenses. <BUUCryptosporidium parvum B01.841.075.762.167.275.250.087.500 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina; Cryptosporidium A species of parasitic protozoa that infects humans and most domestic mammals. Its oocysts measure five microns in diameter. These organisms exhibit alternating cycles of sexual and asexual reproduction. Cryptosporidium (85-91) m'&uCryptosporidium B01.841.075.762.167.275.250.087 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Coccidia; Eucoccidiida; Eimeriina Cryptosporidium parvum A coccidian parasite occurring in the intestines of many vertebrates including man. Coccidia (75-84)  {#&bcCryptosporidiosis C03.432.269; C03.701.688.235; C03.752.625.235; C03.752.750.259.269; C06.405.469.452.269; C22.674.710.235 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Intestinal Diseases, Parasitic Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic intestinal infection with severe diarrhea caused by a protozoan, CRYPTOSPORIDIUM. It occurs in both animals and humans. Coccidiosis (66-84) vJFCryptorchidism C12.294.829.258; C12.740.700.258; C16.131.939.258; C19.391.829.258 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Testicular Diseases Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Endocrine Diseases; Gonadal Disorders (Non MeSH); Testicular Diseases A developmental defect characterized by failure of the testes to descend into the scrotum. (Dorland, 27th ed). "LLCryptococcus neoformans B05.354.381.546.258.366; B05.354.930.316.366 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Cryptococcus Algae and Fungi (Non MeSH); Fungi; Yeasts; Cryptococcus A species of the fungus Cryptococcus, which causes cryptococcosis. Cryptococcus (66-71) %2"OCryptococcus B05.354.381.546.258; B05.354.930.316 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Algae and Fungi (Non MeSH); Fungi; Yeasts Cryptococcus neoformans Cryptococcus neoformans '*"6Cryptococcosis C01.703.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Meningitis, Cryptococcal Infection with a fungus of the species CRYPTOCOCCUS NEOFORMANS. (P=LCryoultramicrotomy E05.909.262.620.530.160; E05.909.432.600.530.160 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Microtomy Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Microtomy Frozen Sections Frozen Sections The technique of using a cryostat or freezing microtome, in which the temperature is regulated to -20 degrees Celsius, to cut ultrathin frozen sections for microscopic (usually, electron microscopic) examination. Microtomy (75-91)  )6/&Cryotherapy E02.780.164 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hypothermia, Induced Cold Therapeutics; Physical Therapy Cryosurgery A form of therapy consisting in the local or general use of cold. The selective destruction of tissue by extreme cold or freezing is CRYOSURGERY. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Cryosurgery (66-93) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE ,,"%$Cryosurgery E02.780.164.143; E04.143 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Freezing; Cold Therapeutics; Physical Therapy; Cryotherapy Surgery, Operative The use of freezing as a special surgical technique to destroy or excise tissue. .$IbCryoprotective Agents D26.328 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Freezing; Preservation, Biological Miscellaneous Drugs and Agents (Non MeSH) Dimethyl Sulfoxide; Glycerin Freezing (66) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $0$ ,)2#:Cryopreservation E05.760.156; E05.909.262.620.760.160; E05.909.432.600.760.160 CLECHIISMTSNSTTDUTVE Freezing; Cold Miscellaneous Techniques (Non MeSH); Preservation, Biological Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Tissue Preservation Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Tissue Preservation Freeze Drying (+ 1) Freeze Drying (+ 1) Freeze Drying (+ 1) Preservation of cells, tissues, organs, or embryos by freezing. In histological preparations, cryopreservation or cryofixation is used to maintain the existing form, structure, and chemical composition of all the constituent elements of the specimens. Freezing (66-89); Preservation, Biological (75-89) AECLCTECHIISMOMTNUPXSNSTTDUTVE (1nEJ"<"Cryoglobulins D12.776.124.486.485.900.225; D12.776.124.790.651.900.225; D12.776.377.715.548.900.225 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Paraproteins 5{]DCryoglobulinemia C15.378.147.780.243; C20.683.780.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias A condition characterized by the presence of cryoglobulins in the blood. They are precipitated into the microvasculature on exposure to cold and cause restricted blood flow in exposed areas. Blood Protein Disorders (66-75); Cryoglobulins (66-81); Paraproteinemias (76-81) 7*N_Crying F01.145.209.530.258; F01.525.200.310.300 PHPX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication Behavior and Behavior Mechanisms (Non MeSH); Human Development; Child Development; Language Development To utter an inarticulate, characteristic sound in order to communicate or express a feeling, or desire for attention. Child Behavior (66-69); Infant, Newborn (66-69); Voice (66-69) : .MCruveilhier-Baumgarten Syndrome C06.552.494.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases; Hypertension, Portal Portal hypertension with extensive collateral circulation through the paraumbilical veins and abdominal vessels and associated with a vascular bruit over the distended veins. Distinction may be made between the disease (patent umbilical vein with absence of liver disease) and syndrome (paraumbilical vein involvement due to portal hypertension associated with liver cirrhosis). <$NKCrutches E07.858.442.281 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Orthopedic Equipment ?} LCrustacea B01.131.365 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Arthropods Artemia; Barnacles; Crabs; Crayfish; Daphnia; Lobsters; Shrimp A large class of arthropods including LOBSTERS, CRABS, SHRIMP, wood lice, water fleas, and BARNACLES. (Dorland, 27th ed).  @! ( NCrush Syndrome C21.866.797.240; C23.888.789.843.240 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Shock, Traumatic Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Shock; Shock, Traumatic Trauma and ischemia of soft tissues, principally skeletal muscle, due to prolonged severe crushing of the tissues, leading to increased permeability of the cell membrane and to the release of potassium, enzymes, and myoglobin from within cells. Ischemic renal dysfunction secondary to hypotension and diminished renal perfusion results in acute tubular necrosis and uremia. A*NCrowns E06.780.345.250 AECLCTECHIPXSDSNSTTDUTVE Dental Porcelain Dentistry; Prosthodontics; Dental Prosthesis Post and Core Technique A prosthetic restoration that reproduces the entire surface anatomy of the visible natural crown of a tooth. It may be partial (covering three or more surfaces of a tooth) or complete (covering all surfaces). It is made of gold or other metal, porcelain, or resin. AECLCTECHIISMAMONUPXSDSNSTTDUTVE $D 5<$Crown-Rump Length E05.118.090.400; G03.850.505.200.100.400; N05.715.360.325.150.100.400 Gestational Age Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH); Anthropometry Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry In utero measurement corresponding to the sitting height (crown to rump) of the fetus. Length is considered a more accurate criterion of the age of the fetus than is the weight. The average crown-rump length of the fetus at term is 36 cm. (From Williams Obstetrics, 18th ed, p. 91). GMTCrown Lengthening E06.323.115 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Orthodontics, Corrective Dentistry; Dentistry, Operative Technique combining controlled eruptive tooth movement and incision of the supracrestal gingival attachment to allow for proper restoration of a destroyed or damaged crown of a tooth. Controlled eruption of the tooth is obtained using orthodontic appliances. During this eruptive phase, repeated incisions are made at the junctional epithelium of the sulcus and the supracrestal connective tissue to prevent coronal displacement of the gingiva and of the attachment apparatus. J$&'Crowding F01.145.875.281 PPPX Stress, Psychological; Population Density Behavior and Behavior Mechanisms (Non MeSH); Behavior; Spatial Behavior Behavior with respect to an excessive number of individuals, human or animal, in relation to available space. M 1VCroup C08.360.535.365; C09.400.535.365 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases; Laryngitis Otorhinolaryngologic Diseases; Laryngeal Diseases; Laryngitis A condition characterized by resonant barking cough, hoarseness and persistant stridor and caused by allergy, foreign body, infection, or neoplasm. It occurs chiefly in infants and children. N &NCrotoxin D24.185.965.850.960.200.210 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Viper Venoms; Crotalid Venoms A specific complex of toxic proteins from the venom of Crotalus durissus terrificus (South American rattlesnake). It can be separated into a phospholipase A and crotapotin fragment; the latter consists of three different amino acid chains, potentiates the enzyme, and is specifically neurotoxic. Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) P DYBCrotonic Acids D02.241.081.161.430; D02.241.081.436.275.240; D02.241.081.465.240.380; D10.516.251.355.325.240; D10.516.251.400.240.380 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Butyrates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Butyrates Crotonates Crotonates Crotonates Crotonates Crotonates 2-Butenoic acids. 4-carbon monounsaturated monocarboxylic acids with the unsaturation in the 2 position. Crotonates (73-74)  S8{>zCrotonates D02.241.081.161.430.250; D02.241.081.436.275.240.250; D02.241.081.465.240.380.250; D10.516.251.355.325.240.250; D10.516.251.400.240.380.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates; Crotonic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated; Crotonic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Butyrates; Crotonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated; Crotonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Butyrates; Crotonic Acids Butyrates (66-72) W8Croton Oil D10.516.212.507.375; D10.516.627.700.315; D23.150; D26.191.208; J01.740.700.315 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Phorbols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Dermatologic Agents Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils  Phorbol Esters (+ 2) Phorbols (+ 3) Phorbol Esters (+ 2) Viscous, nauseating oil obtained from the shrub Croton tiglium (Euphorbaceae). It is a vesicant and skin irritant used as pharmacologic standard for skin inflammation and allergy and causes skin cancer. It was formerly used as emetic and cathartic with frequent mortality.  [[: KH@Crotalus B02.833.672.875.280 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes; Viperidae A genus of snakes of the family VIPERIDAE, one of the pit vipers, so-called from the pit hollowing out the maxillary bone, opening between the eye and the nostril. They are distinctively American serpents. Most of the 25 recognized species are found in the southwestern United States and northern Mexico. Several species are found as far north as Canada and east of the Mississippi, including southern Appalachia. They are named for the jointed rattle (Greek krotalon) at the tip of their tail. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980). Snakes (66-93) _ &2Crotalid Venoms D24.185.965.850.960.200 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Viper Venoms Ancrod; Crotoxin; Reptilase Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized. Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $c<x#BJCrossing Over (Genetics) G05.148.301; G05.825.210 DEGEIMPHRE Genetics; Cytogenetics Genetics; Recombination, Genetic Sister Chromatid Exchange Sister Chromatid Exchange The reciprocal exchange of segments at corresponding positions along pairs of homologous chromosomes by symmetrical breakage and crosswise rejoining. Cytogenetics (67); Genetics (66-67)  f]A<,Crosses, Genetic E05.393.281 Conjugation, Genetic; Hybridization; Transduction, Genetic; Transformation, Genetic Miscellaneous Techniques (Non MeSH); Genetic Techniques Genetic Complementation Test Genetics (66-67) AECLCTECHIISMOMTNUPXSNSTTDUTVE  h'`B""Cross-Sectional Studies E05.318.760.500.875; G03.850.520.835.500.875; N05.715.360.775.175.275 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) HIV Seroprevalence HIV Seroprevalence HIV Seroprevalence Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. TD iqM0AECross-Over Studies E05.318.780.150; G03.850.520.840.150; N05.715.360.780.150 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Design (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Design (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Design (Non MeSH) Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed). mA|MCross-Linking Reagents D26.550.155 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Indicators and Reagents (66-79); Protein Binding (66-79) q,PDCross-Cultural Comparison I01.076.201.450.281; I01.880.143.257 Cultural Characteristics; Culture Social Sciences; Anthropology; Anthropology, Cultural; Culture Social Sciences; Sociology; Culture Comparison of various psychological, sociological, or cultural factors in order to assess the similarities or diversities occurring in two or more different cultures or societies. Anthropology (66-67); Culture (66-67); Sociology (66-67) t*(tECross Reactions G04.610.143.281 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Antigen-Antibody Reactions (66-68) vp(Cross Infection C01.539.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Community-Acquired Infections; Disease Transmission, Patient-to-Professional; Disease Transmission, Professional-to-Patient; Infection Control; Patient Isolation; Patient Isolators Staphylococcal Infections; Community-Acquired Infections Bacterial and Fungal Diseases (Non MeSH); Infection Any infection which a patient contracts in a health-care institution.  xSP@?SCross Circulation E05.660.365 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Parabiosis The circulation in a portion of the body of one individual of blood supplied from another individual. z"9zCrops, Agricultural B06.510.344; J01.341.257 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food Cultivated plants or agricultural produce such as grain, vegetables, or fruit. (From American Heritage Dictionary, 1982). {4XCrop, Avian A13.265 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Birds (66-67) } :Cronolone D04.808.745.745.654.281; D04.808.908.186; D06.597.799.193 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Polycyclic Hydrocarbons; Steroids; Steroids, Fluorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic } A:Cromolyn Sodium D03.438.150.266.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones 5,5'-((2-Hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo-4H-1-benzopyran-2-carboxylic acid), disodium salt. A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Chromones (66-70) u:dCrohn Disease C06.405.469.220; C06.405.469.440.148 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Inflammatory Bowel Diseases Gastrointestinal disorder characterized by chronic inflammatory infiltrates, fibrosis affecting all layers of the serosa, and development of noncaseating granulomas. The most common site of involvement is the terminal ileum with the colon as the second most common.  *N3Croatia Z01.542.248.295; Z01.586.980.295 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Yugoslavia Created 7 April 1992 as a result of the division of Yugoslavia. Yugoslavia (66-92)  &OCritical Period (Psychology) F02.463.425.209 Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning A specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life.  "ZCritical Illness C23.280.276; N01.407.306.370 CLECEPMONUPXRHTH Symptoms and General Pathology (Non MeSH); Disease Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Disease A disease or state in which death is possible or imminent. Critical Care (75-91) T"ICritical Care E02.472.190; N02.421.589.230 CLECHILJMAMTOGPXSNSTTDUT Intensive Care Intensive Care; Emergencies Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Intensive Care (+ 1) Intensive Care (+ 1) Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care Units (66-74); Nursing Care (66-74) (""4h>Crithidia fasciculata B01.841.750.443.950.450.868.110.350 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina; Crithidia A species of monogenetic, parasitic protozoa usually found in insects. Crithidia (79-91); Mastigophora (66-78) '&T0Crithidia B01.841.750.443.950.450.868.110 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Zoomastigophora; Kinetoplastida; Trypanosomatina Crithidia fasciculata A genus of parasitic protozoans found in the digestive tract of invertebrates, especially insects. Organisms of this genus have an amastigote and choanomastigote stage in their life cycle. Mastigophora (66-78); Trypanosoma (66-78)   #&z2Crisscross Heart C14.240.400.220; C14.280.400.220; C16.131.240.400.220 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiac malformation characterized by an atrioventricular spatial relation that places or appears to place each ventricle in a contralateral position relative to its associated atrium. Heart Defects, Congenital (66-86) =LK(Crisis Intervention F04.754.252 CLECEDHIISLJMAMTOGSNSTTD Hotlines Emergencies Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Assistance provided a patient and/or his family in temporarily resolving an immediate psychiatric problem. Community Health Services (66-69); Community Mental Health Services (67-69); Emergency Medical Services (68-69); Mental Disorders/PC (66-69); Mental Health Services (66-69); Psychotherapy (66-69); Suicide/PC (66-69) $ K}Criminology I01.198 CLECEDHIISLJMAMTOGSNSTTD Social Sciences Crime (+ 16); Criminal Law; Forensic Dentistry; Forensic Medicine (+ 9) The study of crime and criminals with special reference to the personality factors and social conditions leading toward, or away from crime. AEBLCFCICLCOCTDHDIDTECEDEHENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPPPSPXRARHRISNSTSUTDTHURUSUTVEVI  # Y`Criminal Psychology F02.784.240 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH); Psychology, Applied Lie Detection The branch of psychology which investigates the psychology of crime with particular reference to the personality factors of the criminal. CLECEDHIISLJMAMTOGPXSNSTTD  QCriminal Law I01.198.290; I01.880.604.583.100 CLECEDHIISLJMAMTOGSNSTTD Social Sciences; Criminology Social Sciences; Sociology; Social Control, Formal; Jurisprudence A branch of law that defines criminal offenses, regulates the apprehension, charging and trial of suspected persons, and fixes the penalties and modes of treatment applicable to convicted offenders. Jurisprudence (66-77) &oCrime I01.198.240; I01.880.735.191 CLECEHHILJPCPXSNTD Social Sciences; Criminology Social Sciences; Sociology; Social Problems Abortion, Criminal; Fraud; Homicide (+ 1); Sex Offenses (+ 1); Theft; Violence (+ 6); War Crimes (+ 1) Theft A violation of the criminal law, i.e., a breach of the conduct code specifically sanctioned by the state, which through its administrative agencies prosecutes offenders and imposes and administers punishments. The concept includes unacceptable actions whether prosecuted or going unpunished. Criminology (66-67) BLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISNSUTDTHURUSVI $q "VPLCrigler-Najjar Syndrome C18.452.648.437.281; C23.888.498.329.396.281 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Hyperbilirubinemia, Hereditary Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Hyperbilirubinemia; Hyperbilirubinemia, Hereditary A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation. v2L,Cricoid Cartilage A02.165.507.211; A04.329.591.211 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage; Laryngeal Cartilages Respiratory System; Larynx; Laryngeal Cartilages The small thick cartilage that forms the lower and posterior parts of the laryngeal wall. Laryngeal Cartilages (66-78) o&:yl"Cricetulus B02.649.865.635.325.250 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Hamsters A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters (66-77) (=Cri-du-Chat Syndrome C10.496.151; C16.131.077.262; C16.131.280.200; F03.709.346.161 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An infantile syndrome characterized by cat-like cry, failure to thrive, microcephaly, mental retardation, spastic quadriparesis, micro- and retrognathia, glossoptosis, bilateral epicanthus, hypertelorism, and tiny external genitalia. It is due to chromosomal abnormality. HLY4Creutzfeldt-Jakob Syndrome C10.228.140.079.275; C10.228.140.380.150.230; C10.228.228.800.230; F03.709.508.460.245.220.230; F03.709.680.610.392.300.230 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia; Dementia, Presenile Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Prion Diseases Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Presenile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Presenile A rare, usually fatal, transmissible encephalopathy occurring in middle life, in which there is partial degeneration of the pyramidal and extrapyramidal systems accompanied by progressive dementia and sometimes muscle wasting, tremor, athetosis, and spastic dysarthria. A familial form has been shown to exhibit autosomal dominant inheritance. The more common sporadic form is probably caused by mutations that produce abnormal prion proteins (PRIONS). Central Nervous System Diseases (66-68) P /Cretinism C05.116.099.343.314; C05.116.132.256; C19.874.482.281 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Myxedema; Mental Retardation Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dwarfism Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Endocrine (Non MeSH) Endocrine Diseases; Thyroid Diseases; Hypothyroidism A chronic condition due to congenital lack of thyroid secretion, marked by arrested physical and mental development, dystrophy of the bones and soft parts, and lowered basal metabolism. It is the congenital form of this deficiency, while MYXEDEMA is the acquired form. (Dorland, 27th ed). F =N#TCREST Syndrome C06.306.418.204; C14.907.744.204; C14.907.823.225; C17.300.799.204; C17.800.784.204; C18.452.174.130.204 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Esophageal Diseases; Esophageal Motility Disorders Cardiovascular Diseases; Vascular Diseases; Raynaud's Disease Cardiovascular Diseases; Vascular Diseases; Telangiectasis Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Scleroderma, Systemic Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Scleroderma, Systemic Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders; Calcinosis A form of systemic scleroderma usually less severe than other forms, consisting of calcinosis cutis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasis. That in which esophageal function is not prominent is known as CRST syndrome. (Dorland, 27th ed). Calcinosis (75-93); Raynaud's Disease (75-93); Scleroderma, Systemic (75-93) mvN2D[Cresols D02.755.239 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Bisacodyl; Brocresine; Bromcresol Green; Bromcresol Purple; Butylated Hydroxytoluene; Creosote; Cyclofenil; Dinitrocresols; Formocresols; Tritolyl Phosphates AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR < 8/:Creosote D02.755.239.327 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Cresols  ::Credentialing N03.706.110; N05.700.200 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Social Control, Formal Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care Accreditation (+ 1); Certification (+ 1); Licensure (+ 5) Accreditation (+ 1); Certification (+ 1); Licensure (+ 5) The recognition of professional or technical competence through registration, certification, licensure, admission to association membership, the award of a diploma or degree, etc. CLECHILJMTOGSNSTTDUT  Creativeness F01.752.264; F02.463.785.302 Behavior and Behavior Mechanisms (Non MeSH); Personality Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking The ability to construct new ideas or images. "9Creatinine D03.383.374.207 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles 6:VCreatine Kinase Isoenzymes D08.586.348.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isoenzymes Three isoenzymes of creatine kinase have been identified in human tissues: MM from skeletal muscle, MB from myocardial tissue and BB from nervous tissue. Plasma from healthy humans contains MM almost exclusively. Elevated MB creatine kinase activity is a possible indicator of myocardial injury. EC 2.7.3.2. Creatine Kinase (66-79); Isoenzymes (66-79)  FSh5Creatine Kinase D08.586.913.696.640.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Nitrogenous Group Acceptor) A transferase that catalyzes the reaction of ATP + creatine to yield ADP + phosphocreatine. It is activated by Mg(2+). The reaction stores ATP energy as phosphocreatine in muscle and brain tissue and holds the muscle concentration of ATP constant during the initiation of exercise. EC 2.7.3.2. F]Creatine D02.078.370.280; D12.125.373 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids  Phosphocreatine . "FCrayfish B01.131.365.327 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Arthropods; Crustacea Various freshwater crustaceans resembling the lobster, but usually much smaller; common genera are Astacus, Cambarus, Oronectes, and Pacifastacus. It includes crayfish as food. Crustacea (66-71)  ] ( ,Craniotomy E04.530.264 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Skull Surgery, Operative; Neurosurgery $ 'Craniosynostoses C05.116.099.370.894.232; C05.660.906.364; C16.131.621.906.364 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Synostosis Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Synostosis Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Synostosis Acrocephalosyndactylia Acrocephalosyndactylia Acrocephalosyndactylia Premature closure of one or more sutures of the skull. ELKJDCraniopharyngioma C04.557.465.625.200; C04.557.580.625.200 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors A tumor arising from cell rests derived from the hypophyseal stalk or Rathke's pouch, frequently associated with increased intracranial pressure, and showing calcium deposits in the capsule or in the tumor proper. (Dorland, 27th ed). $.XCraniometry E01.706.273.200; E05.118.364.200; G03.850.505.200.100.300.200; N05.715.360.325.150.100.200.200 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cephalometry Cephalometry; Skull; Craniology Diagnosis; Physical Examination; Cephalometry Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH); Cephalometry Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry; Cephalometry Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry; Cephalometry The scientific measurement of the dimensions of the bones of the skull and face. It applies to measurement of the dead skull as opposed to CEPHALOMETRY, measurements performed on the living skull.  h"'Craniomandibular Disorders C05.500.607.221; C05.651.243; C07.320.610.291 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Jaw Diseases; Mandibular Diseases Musculoskeletal Diseases; Muscular Diseases Stomatognathic Diseases; Jaw Diseases; Mandibular Diseases Temporomandibular Joint Diseases (+ 1) Temporomandibular Joint Diseases (+ 1) Temporomandibular Joint Diseases (+ 1) Diseases or disorders of the muscles of the head and neck, with special reference to the masticatory muscles. The most notable examples are TEMPOROMANDIBULAR JOINT DISEASES and TEMPOROMANDIBULAR JOINT SYNDROME. Temporomandibular Joint Diseases (82-92); Temporomandibular Joint Syndrome (79-92)  5N_Craniology I01.076.368.239 HI Cephalometry; Craniometry Social Sciences; Anthropology; Anthropology, Physical The scientific study of variations in size, shape, and proportion of the cranium. D?bCraniofacial Dysostosis C05.116.099.370.231; C05.660.246; C16.131.621.246 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Hallermann's Syndrome; Hypertelorism; Mandibulofacial Dysostosis (+ 1) Hallermann's Syndrome; Hypertelorism; Mandibulofacial Dysostosis (+ 1) Hallermann's Syndrome; Hypertelorism; Mandibulofacial Dysostosis (+ 1) An autosomal dominant disorder characterized by acrocephaly, exophthalmos, hypertelorism, strabismus, parrot-beaked nose, and hypoplastic maxilla with relative mandibular prognathism. (Dorland, 27th ed). R9LCranial Sutures A02.835.232.781.200 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull A type of fibrous joint between bones of the head. Skull (66-80); specific skull bone (66-80) :D@5Cranial Sinuses A07.231.908.224 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cardiovascular System; Blood Vessels; Veins Cavernous Sinus Large endothelium-lined venous channels situated between the two layers of the dura mater; they are devoid of valves. W65Cranial Nerves A08.800.800.120 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves Abducens Nerve; Accessory Nerve; Acoustic Nerve (+ 3); Facial Nerve (+ 2); Glossopharyngeal Nerve; Hypoglossal Nerve; Oculomotor Nerve; Olfactory Nerve; Optic Nerve (+ 2); Trigeminal Nerve (+ 5); Trochlear Nerve; Vagus Nerve (+ 3) Twelve pairs of nerves originating in the brain stem that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers. װ8HCranial Nerve Neoplasms C04.588.614.596.240; C10.551.625.240; C10.772.204.192; C10.772.643.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Peripheral Nerve Neoplasms Nervous System Diseases; Nervous System Neoplasms; Peripheral Nerve Neoplasms Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Nervous System Diseases; Peripheral Nervous System Diseases; Peripheral Nerve Neoplasms Neuroma, Acoustic (+ 1) Neuroma, Acoustic (+ 1) Neuroma, Acoustic (+ 1) Neuroma, Acoustic (+ 1) Neoplasms of any of the cranial nerves. Peripheral Nerve Neoplasms (66-77)  YPXr2)Cranial Nerve Diseases C10.772.204 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases Acoustic Nerve Diseases (+ 2); Cranial Nerve Neoplasms (+ 2); Facial Nerve Diseases (+ 4); Ocular Motility Disorders (+ 11); Oculomotor Nerve Paralysis; Optic Nerve Diseases (+ 6); Trigeminal Neuralgia; Vocal Cord Paralysis Cranial Nerves (66-80); specific cranial nerve; Peripheral Nerve Diseases (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  ݣNFaZCranial Irradiation E02.810.190 AECLCTECHIISMOMTNUPXSNSTTDUTVE Pituitary Irradiation Therapeutics; Radiotherapy Pituitary Irradiation The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes.  W" Cranial Fossa, Posterior A02.835.232.781.176 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Skull :DCracked Tooth Syndrome C07.793.850.750.300; C21.866.900.750.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases; Tooth Injuries; Tooth Fractures Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Tooth Injuries; Tooth Fractures Incomplete fracture of any part of a tooth, characterized by pain during mastication and sensitivity to heat, cold, sweet or sour tastes, and alcohol; it is often undiagnosed because the tooth is usually X-ray negative and normal to pulp vitality tests. x.N+Crack Cocaine D03.132.889.354.250; D03.605.869.388.250; D26.394.878.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Tropanes; Cocaine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes; Cocaine Miscellaneous Drugs and Agents (Non MeSH); Drugs; Street Drugs The purified, alkaloidal, extra-potent form of cocaine. It is smoked (free-based), injected intravenously, and orally ingested. Use of crack results in alterations in function of the cardiovascular system, the autonomic nervous system, the central nervous system, and the gastrointestinal system. There are concomitant psychological and social alterations as well. The slang term "crack" was derived from the crackling sound made upon igniting of this form of cocaine for smoking. Cocaine (86-91) *A:.Crabs B01.131.365.256 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Shellfish Invertebrates; Arthropods; Crustacea Chiefly marine, largely carnivorous crustaceans including the genera Cancer, Uca, and Callinectes. It includes crabs as food. Crustacea (66-71)   ( ,Coxsackieviruses B B04.820.565.284.196.160; B04.909.777.618.284.196.160 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus; Coxsackieviruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus; Coxsackieviruses One of the two groups of COXSACKIEVIRUSES. It is divided into several serotypes and associated with epidemic pleurodynia (B1, B3), myocarditis and endocarditis (B3, B1), respiratory disorders (B3, B5), and kidney, pancreas, and liver disorders. Coxsackieviruses (66-78) ^:Coxsackieviruses A B04.820.565.284.196.150; B04.909.777.618.284.196.050 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus; Coxsackieviruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus; Coxsackieviruses One of the two groups of coxsackieviruses. Coxsackie A viruses are divided into 24 serotypes and are associated with or implicated in herpangina, aseptic meningitis, paralytic disease, encephalitis, ataxia, and cardiac diseases. Coxsackie A24 variant can cause acute hemorrhagic conjunctivitis. Coxsackieviruses (66-78) :TCoxsackieviruses B04.820.565.284.196; B04.909.777.618.284.196 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Enterovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Enterovirus Coxsackieviruses A; Coxsackieviruses B Coxsackieviruses A; Coxsackieviruses B A heterogeneous group of the genus ENTEROVIRUS found in association with various diseases in man and other animals. Two groups (A and B) have been identified with a number of serotypes in each. The name is derived from a village in New York State where the virus was first identified. 2ZTCoxsackievirus Infections C02.782.687.359.213 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Conjunctivitis, Acute Hemorrhagic; Hand, Foot and Mouth Disease; Herpangina; Pleurodynia, Epidemic A heterogeneous group of infections produced by COXSACKIEVIRUSES, including herpangina, aseptic meningitis, a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia, and a serious myocarditis. PtsCoxiella burnetii B03.700.651.801.700.225.150 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae; Coxiella A species of gram-negative bacteria that grows preferentially in the vacuoles of the host cell. It is the etiological agent of Q FEVER. Coxiella (67-91) '"yCoxiella B03.700.651.801.700.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Rickettsieae Coxiella burnetii A genus of gram-negative, rod-shaped bacteria that is widely distributed in ticks and various mammals throughout the world. Infection with this genus is particularly prevalent in cattle, sheep, and goats.  "mCowpox Virus B04.280.650.160.650.150; B04.909.204.783.160.650.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae; Orthopoxvirus A species of ORTHOPOXVIRUS that is the etiologic agent of COWPOX. It is closely related to but antigenically different from VACCINA VIRUS. Vaccinia Virus (67-89) :Cowpox C02.256.743.175 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections A mild, eruptive skin disease of milk cows caused by COWPOX VIRUS, with lesions occurring principally on the udder and teats. Human infection may occur while milking an infected animal. Vaccinia (66-89)  PUCowdria B03.700.651.801.325.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Rickettsiaceae; Ehrlichieae A genus of gram-negative bacteria characteristically localized in clusters inside vacuoles in the cytoplasm of vascular endothelial cells of ruminants. The species C. ruminantium is the causative agent of HEARTWATER DISEASE. Rickettsiaceae (81-91)  "lCourtship F01.145.792.279 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior The mutual attraction between individuals of the opposite sex.  RKCountertransference (Psychology) F04.754.919.864.363 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Therapeutic Processes (Non MeSH); Transference (Psychology) The psychiatrist's conscious or unconscious emotional reaction to his patient. Transference (Psychology) (66-67) y%\'Counterpulsation E04.050.215 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Heart-Assist Devices Surgery, Operative; Assisted Circulation Intra-Aortic Balloon Pumping A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole. Assisted Circulation (67-89); Blood Pressure (66-89); Heart-Assist Devices (86-89); Intra-Aortic Balloon Pumping (77-89) $$0"|Counterimmunoelectrophoresis E01.223.495.826.769.442.400.250; E05.196.401.568.250; H01.181.529.307.437.568.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Precipitin Tests; Immunodiffusion; Immunoelectrophoresis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Immunoelectrophoresis Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry; Electrophoresis; Immunoelectrophoresis Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow. Immunoelectrophoresis (66-75)  Y"'"Countercurrent Distribution E05.196.181.400.555; E05.196.278 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Liquid Miscellaneous Techniques (Non MeSH); Chemistry, Analytical A method of separation of two or more substances by repeated distribution between two immiscible liquid phases that move past each other in opposite directions. It is a form of liquid-liquid chromatography. (Stedman, 25th ed). g &" Counseling F02.784.176; F04.408.413; N02.421.143.303; N02.421.461.363 CLECEDHILJMAMTOGSDSNSTTDUT Vocational Guidance Psychologic Processes and Principles (Non MeSH); Psychology, Applied Disciplines, Tests, Therapy, Services (Non MeSH); Mental Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Mental Health Services Pastoral Care; Sex Counseling Sex Counseling Sex Counseling Sex Counseling The giving of advice and assistance to individuals with educational or personal problems. CLECEDHIISLJMAMTOGSDSNSTTDUT $ DpXj Coumestrol D03.438.150.446.350; D06.472.265.540.150 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Estrogens; Estrogens, Non-Steroidal 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one. A coumarin derivative occurring naturally in forage crops which has estrogenic activity. Coumarins (72-74); Benzofurans (72-74)  .@/Coumarins D03.438.150.446; D19.461.119.196 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants Chromonar; Coumestrol; Esculin; 4-Hydroxycoumarins (+ 5); Ochratoxins; Psoralens (+ 3); Umbelliferones (+ 3) 4-Hydroxycoumarins (+ 5) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  &8@Coumaric Acids D02.241.223.201.210 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cinnamates Hydroxycinnamic acid and its derivatives. Act as activators of the indoleacetic acid oxidizing system, thereby producing a decrease in the endogenous level of bound indoleacetic acid in plants. Cinnamates (69-75) 48lCoumaphos D02.719.199; D03.438.150.446.912.326; D05.723.491.657.213 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; Umbelliferones Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Coumarins (66-71) " A:5Cough C08.618.248; C23.888.852.293 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antitussive Agents; Expectorants Respiratory Tract Diseases; Respiration Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH)  "N'Cotyledon B06.413.500.600.250; B06.413.775.200 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plant Structures (Non MeSH); Plant Shoots; Plant Leaves Plants; Plant Structures (Non MeSH); Seeds A part of the embryo in a seed plant. The number of cotyledons is an important feature in classifying plants. In seeds without an endosperm, they store food which is used in germination. In some plants, they emerge above the soil surface and become the first photosynthetic leaves. (From Concise Dictionary of Biology, 1990). Plants (66-94)  *&Coturnix B02.248.801.350 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Quail A genus of birds (family Phasianidae) containing the common European and other Old World quails. = &!sCottonseed Oil D10.516.212.302.380.380; D10.516.212.507.350; D10.516.627.700.263; J01.740.250.250; J01.740.700.260 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Gossypol Gossypol Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils 9o,  Cotton B06.200; J01.637.879.238 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH); Textiles Any of the cultivated varieties of Gossypium, herbs or shrubs of the Malvaceae family that yield fiber for textiles and absorbent dressings, oil from seeds, and various chemicals. The fibers cause BYSSINOSIS if inhaled over a period. GOSSYPOL is a male anti-fertility agent from COTTONSEED OIL.  4dZCotinine D03.383.773.812.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones 1-Methyl-5-(3-pyridyl)-2-pyrrolidinone fumarate. Stimulant proposed as antidepressant. Synonym: Scotine. Pyridines (74); Pyrrolidinones (69-74) $ :jx/Cote d'Ivoire Z01.058.290.190.272 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western Formerly a province of French West Africa, it was given territorial status by the French Constitution in 1946. It achieved self-government in 1958 and became an independent republic in 1960.  _Cosyntropin D06.472.734.525.690.130.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pro-Opiomelanocortin; Corticotropin alpha(1-24)-Corticotropin. A synthetic polypeptide with adrenocorticotropic activity. Adrenocorticotropic Hormone (71-74) "M:c)Costs and Cost Analysis N03.219.151 CLECHILJMTSNSTTD Economics, Organizations, Control (Non MeSH); Economics Cost Allocation; Cost-Benefit Analysis; Cost Control (+ 1); Cost of Illness; Cost Sharing (+ 1); Health Care Costs (+ 4); Health Expenditures (+ 1) Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. CLECHILJMTOGSNSTTDUT  $ BCosta Rica Z01.107.169.238 EHEP Geographicals (Non MeSH); America; Central America &->Cost-Benefit Analysis N03.219.151.125 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results. Costs and Cost Analysis (66-75) &`'Cost Sharing N03.219.151.170; N03.219.521.576.090 CLECHILJMTSNSTTDUT Health Benefit Plans, Employee; Managed Care Programs Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance Deductibles and Coinsurance Deductibles and Coinsurance Provisions of an insurance policy that require the insured to pay some portion of covered expenses. Several forms of sharing are in use, e.g., deductibles, coinsurance, and copayments. Cost sharing does not refer to or include amounts paid in premiums for the coverage. (From Dictionary of Health Services Management, 2d ed). Deductibles and Coinsurance (68-91) $)k*@@*Cost Savings N03.219.151.160.200 CLECHILJMTSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Cost Control Reductions in all or any portion of the costs of providing goods or services. Savings may be incurred by the provider or the consumer. Cost Control (79-91) ,qCost of Illness I01.137; N03.219.151.165 Quality of Life Social Sciences Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or loss to himself, his family, or community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, QUALITY OF LIFE, etc. It differs from HEALTH CARE COSTS in that this concept is restricted to the cost of providing services related to the delivery of health care rather than an impact on the personal life of the patient. specific disease (66-92); Costs and Cost Analysis (66-92) .nrJFCost Control N03.219.151.160 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis Cost Savings The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed). Costs and Cost Analysis (66-78)  1`'Cost Allocation N03.219.151.080 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis The assignment, to each of several particular cost-centers, of an equitable proportion of the costs of activities that serve all of them. Cost-center usually refers to institutional departments or services. Costs and Cost Analysis (66-78) 4q`'Cosmids D13.444.308.212.500.250; D13.444.308.283.500.250 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cloning, Molecular Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids Plasmids containing at least one cos (cohesive-end site) of phage lambda. They are used as cloning vehicles for the study of aberrant eukaryotic structural genes and also as genetic vectors for introducing the nucleic acid of transforming viruses into cultured cells. Cloning, Molecular (80-85); Genetic Vectors (80-85); Plasmids (78-85)  6O 6D9TCosmic Radiation G03.230.300.100.300; H01.671.768.513.235 AE Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Ionizing High-energy radiation or particles from extraterrestrial space that strike the earth, its atmosphere, or spacecraft and may create secondary radiation as a result of collisions with the atmosphere or spacecraft. 9.Cosmetics D26.313; J01.516.213 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Household Products Dentifrices (+ 1); Deodorants; Hair Preparations (+ 1); Mouthwashes; Perfume; Sunscreening Agents Hair Preparations (+ 1); Sunscreening Agents; Talc ; ,|Cosmetic Techniques (Non MeSH) E02.218 Therapeutics Hair Removal; Tattooing AECLCTECHIISMOMTNUPXSNSTTDUTVE =U% "Corynebacterium pyogenes B03.100.067.595.200.513; B03.510.460.400.400.200.513; B03.510.595.200.513 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Corynebacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Corynebacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Corynebacterium A species of CORYNEBACTERIUM isolated from abscesses of warm-blooded animals. Corynebacterium (66-71) =Q"[Corynebacterium pseudotuberculosis B03.100.067.595.200.500; B03.510.460.400.400.200.500; B03.510.595.200.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Corynebacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Corynebacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Corynebacterium A species of gram-positive, asporogenous bacteria that was originally isolated from necrotic areas in the kidney of a sheep. It may cause ulcerative lymphangitis, abscesses, and other chronic purulent infections in sheep, horses, and other warm-blooded animals. Human disease may form from contact with infected animals. Corynebacterium (67-91) @'Q"tCorynebacterium Infections C01.252.410.040.246 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections Diphtheria; Erythrasma Infections with bacteria of the genus CORYNEBACTERIUM. Corynebacterium (66-71)  D}PACorynebacterium diphtheriae B03.100.067.595.200.313; B03.510.460.400.400.200.313; B03.510.595.200.313 CHCLCYDEENGDGEIMIPMEPHPYREULVI Diphtheria Toxin Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group; Corynebacterium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Corynebacterium Bacteria; Gram-Positive Bacteria; Nocardioform Group; Corynebacterium A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types (gravis, intermedius, and mitis) were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA. F9 Q"Corynebacterium B03.100.067.595.200; B03.510.460.400.400.200; B03.510.595.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Nocardioform Group Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH) Bacteria; Gram-Positive Bacteria; Nocardioform Group Corynebacterium diphtheriae; Corynebacterium pseudotuberculosis; Corynebacterium pyogenes Corynebacterium diphtheriae; Corynebacterium pseudotuberculosis; Corynebacterium pyogenes Corynebacterium diphtheriae; Corynebacterium pseudotuberculosis; Corynebacterium pyogenes A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens. J E"I(Cortodoxone D04.808.745.745.654.252; D06.472.040.322.478.478.225 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 17-Hydroxycorticosteroids 17,21-Dihydroxypregn-4-ene-3,20-dione. A 17-hydroxycorticosteroid with glucocorticoid and anti-inflammatory activities. 17-Hydroxycorticosteroids (74); Pregnenediones (74) M::<Cortisone Reductase D08.586.682.047.436.400.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases; 20-Hydroxysteroid Dehydrogenases An enzyme that catalyzes the interconversion of a ketone and hydroxy group at C-20 of cortisone and other 17,20,21-trihydroxy steroids. EC 1.1.1.53. Cortisone (72-74); Hydroxysteroid Dehydrogenases (72-74) PdFBCortisone D04.808.745.745.183; D06.472.040.322.478.478.195; D17.025.050.095 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 17-Hydroxycorticosteroids Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal A naturally occurring glucocorticoid. R ID-Cortinarius B05.354.179.100.220 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes; Agaricales A basidiomycetous fungal genus of the family Cortinariaceae, order Agaricales, some species of which cause renal failure in man. Basidiomycetes (66-85); Mushroom Poisoning (68-85) U-"L<Corticotropin-Releasing Hormone D06.472.709.195; D12.644.135; D12.776.641.650.125; D14.600.600.195 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Corticotropin-Releasing Hormone Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A neuropeptide released by the hypothalamus that stimulates the release of corticotropin by the anterior pituitary gland. Adrenocorticotropic Hormone (66-67); Hypothalamo-Hypophyseal System/physiology (66-67)  V$LF0bCorticotropin D06.472.734.525.690.130; D12.644.130; D12.776.641.650.120; D14.600.600.192 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Petrosal Sinus Sampling; Receptors, Corticotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pro-Opiomelanocortin Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides alpha-MSH; Cosyntropin Pituitary hormone that stimulates the secretion of adrenal cortical steroids and induces growth of the adrenal cortex. It is also present in human female urine and in the serum of pregnant mares. The substance is a single-chain polypeptide containing 39 amino acids, the first 24 of which are identical in all species. This 24-amino acid segment is said to be responsible for the biological activity of the peptide while the remaining 15-amino acid segment is said to be necessary for any immunological specificity. (From Merck Index, 11th ed).  Z>TF:Corticosterone D04.808.745.745.654.237; D06.472.040.322.478.353.237; D06.472.040.668.478.561.445; D17.025.050.085 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Glucocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Mineralocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal 18-Hydroxycorticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p.1437). _lDKCortical Synchronization E01.236.257.401.487; E01.399.277.487 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH); Electroencephalography Diagnosis; Electrodiagnosis; Electroencephalography Electroencephalography (66-71) c*&#Corrosion Casting E05.909.262.620.620.150; E05.909.432.600.620.150 CLECHIISMTSNSTTDUTVE Microscopy, Electron, Scanning Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques; Histocytological Preparation Techniques; Replica Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques; Histocytological Preparation Techniques; Replica Techniques A tissue preparation technique that involves the injecting of plastic (acrylates) into blood vessels or other hollow viscera and treating the tissue with a caustic substance. This results in a negative copy or a solid replica of the enclosed space of the tissue that is ready for viewing under a scanning electron microscope. e16$CCorrosion H01.181.529.205 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Chemistry, Physical (66-69) h I!Correspondence L01.143.506.423.906.377 HI Information Science; Communication; Language; Language Arts (Non MeSH); Writing Communication between persons or between institutions or organizations by an exchange of letters. Its use in indexing and cataloging will generally figure in historical and biographical material. iK`Corpus Striatum A08.186.211.730.885.105.487 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia Globus Pallidus; Neostriatum (+ 2) Striped gray and white matter consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the thalamus in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The white matter is the internal capsule. Basal Ganglia (66-71)  j8m+Corpus Luteum Regression G08.520.440.508.218 BLCFDEEHGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle; Ovulation Involution and cessation of endocrine function of a corpus luteum. Corpus Luteum (66-74) mhPCorpus Luteum Maintenance G08.520.769.100 DEGEIMPHRE Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy Physiologic and biochemical factors that maintain an actively functioning corpus luteum. Corpus Luteum (66-74) o!TgCorpus Luteum Hormones D06.472.866.362 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones Progesterone; Relaxin AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR p^BSDCorpus Luteum A05.360.319.114.630.278; A06.407.312.497.278 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Luteolytic Agents Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri; Ovary Endocrine System (Non MeSH); Endocrine Glands; Gonads; Ovary Lutein Cells Lutein Cells The yellow glandular mass formed in the ovary by an ovarian follicle that has ruptured and discharged its ovum. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $q2: <Corpus Callosum A08.186.211.730.885.362 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon Broad plate of dense myelinated fibers that reciprocally interconnect regions of the cortex in all lobes with corresponding regions of the opposite hemisphere. The corpus callosum is located deep in the longitudinal fissure. s8[Corpora Quadrigemina A08.186.211.132.659.237 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Mesencephalon Inferior Colliculus; Superior Colliculus u8X0Corpora Allata A08.713.100; A13.250 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurosecretory Systems Animal Terms (Non MeSH) Paired or fused ganglion-like bodies in the head of insects. The bodies secrete hormones important in the regulation of metamorphosis and the development of some adult tissues. Juvenile Hormones (72-76); Metamorphosis, Biological (66-76); Neurosecretion (66-67); Neurosecretory Systems (70-76) v8JCoroners and Medical Examiners M01.526.485.230; N02.360.230 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Physicians appointed to investigate all cases of sudden or violent death. y%"XCoronavirus, Turkey B04.820.155.150.300; B04.909.777.199.150.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS causing enteritis in turkeys and pullets. z2PCoronavirus, Rat B04.820.155.150.260; B04.909.777.199.150.260 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS causing pneumonia in newborn rats but a clinically inapparent infection in adults. It is separate but antigenetically related to mouse hepatitis virus (GASTROENTERITIS VIRUS, MURINE). Coronaviridae (77-93) |2Coronavirus, Human B04.820.155.150.200; B04.909.777.199.150.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS causing respiratory and enteric diseases in humans. Coronaviridae (74-93) ~I2[Coronavirus, Canine B04.820.155.150.160; B04.909.777.199.150.160 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS infecting dogs. Onset is usually sudden and includes vomiting, diarrhea, and dehydration. Coronaviridae (76-93) 2Coronavirus, Bovine B04.820.155.150.150; B04.909.777.199.150.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae; Coronavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae; Coronavirus A species of CORONAVIRUS infecting neonatal calves, presenting as acute diarrhea, and frequently leading to death. Coronaviridae (77-93) 2Coronavirus Infections C02.782.225.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Coronaviridae Infections Enteritis, Transmissible, of Turkeys; Feline Infectious Peritonitis; Gastroenteritis, Transmissible, of Swine Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS), FELINE INFECTIOUS PERITONITIS, and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE). vPX},Coronavirus B04.820.155.150; B04.909.777.199.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Coronaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Coronaviridae Coronavirus, Bovine; Coronavirus, Canine; Coronavirus, Human; Coronavirus, Rat; Coronavirus, Turkey; Gastroenteritis Virus, Murine; Gastroenteritis Virus, Porcine Transmissible; Infectious Bronchitis Virus, Avian; Infectious Peritonitis Virus, Feline Coronavirus, Bovine; Coronavirus, Canine; Coronavirus, Human; Coronavirus, Rat; Coronavirus, Turkey; Gastroenteritis Virus, Murine; Gastroenteritis Virus, Porcine Transmissible; Infectious Bronchitis Virus, Avian; Infectious Peritonitis Virus, Feline A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of vertebrates. *{:Coronaviridae Infections C02.782.225 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Coronavirus Infections (+ 3); Torovirus Infections Virus diseases caused by CORONAVIRIDAE. Virus Diseases (68-76)  P:=0Coronaviridae B04.820.155; B04.909.777.199 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Coronavirus (+ 9); Torovirus Coronavirus (+ 9); Torovirus Spherical RNA viruses infecting a wide range of animals including humans. Transmission is by fecal-oral and respiratory routes. Mechanical transmission is also common. There are two genera: CORONAVIRUS and TOROVIRUS. C"YHCoronary Vessels A07.231.114.269; A07.231.908.194 AHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Cardiovascular System; Blood Vessels; Veins The veins and arteries of the heart. Y&4k/Coronary Vessel Anomalies C14.240.400.210; C14.280.400.210; C16.131.240.400.210 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Defects of coronary arteries or veins including anomalous origin, arteriovenous fistula or aneurysm, myocardial bridging, or other abnormalities of structure or development. =LKCoronary Vasospasm C14.280.647.250.295; C14.907.553.470.250.295 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease Angina Pectoris, Variant Angina Pectoris, Variant Spasm of the large- or medium-sized coronary arteries. b2N:BCoronary Thrombosis C14.280.647.250.290; C14.907.355.830.220; C14.907.553.470.250.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease Presence of a thrombus in a coronary artery, often causing a myocardial infarction. Coronary Disease (66-86) aIN.dCoronary Disease C14.280.647.250; C14.907.553.470.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Angioplasty, Transluminal, Percutaneous Coronary; Coronary Artery Bypass; Myocardial Revascularization Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia Angina Pectoris (+ 3); Coronary Aneurysm; Coronary Arteriosclerosis; Coronary Thrombosis; Coronary Vasospasm (+ 1) Angina Pectoris (+ 3); Coronary Aneurysm; Coronary Arteriosclerosis; Coronary Thrombosis; Coronary Vasospasm (+ 1) Disorder of cardiac function due to an imbalance between myocardial function and the capacity of the coronary vessels to supply sufficient flow for normal function. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.  *NteCoronary Circulation G09.330.163.324 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation The circulation of blood through the coronary vessels of the heart. Coronary Vessels (66-71) !RCoronary Care Units N02.278.388.493.211 CLECHILJMAMTOGSDSNSTTDUT Cardiology Service, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units; Intensive Care Units The hospital unit in which patients with acute cardiac disorders receive intensive care. Coronary Disease (66-69); Intensive Care Units (66-69)  s"yiBCoronary Artery Bypass E04.752.376.719.332; E04.920.490.630.280 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Aorta; Coronary Disease Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery; Myocardial Revascularization Surgery, Operative; Thoracic Surgery; Heart Surgery; Myocardial Revascularization Internal Mammary-Coronary Artery Anastomosis Internal Mammary-Coronary Artery Anastomosis Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion. Coronary Disease/surgery (66-71); Coronary Vessels/surgery (66-71); Myocardial Infarct/surgery (66-71) $0.$dyCoronary Arteriosclerosis C14.280.647.250.260; C14.907.137.126.393; C14.907.553.470.250.260 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Atherectomy, Coronary Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases; Arteriosclerosis Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease Atherosclerosis of the coronary arteries. Coronary Disease (66-86)  IN*2Coronary Angiography E01.145.077.395; E01.145.569.300; E01.357.818.084.200 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnostic Imaging; Radiography; Angiography Radiography of the vascular system of the heart muscle after injection of a contrast medium. Angiography (66-91); Coronary Vessels/radiography (66-91) =&oDCoronary Aneurysm C14.280.647.250.250; C14.907.055.395; C14.907.553.470.250.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease Cardiovascular Diseases; Vascular Diseases; Aneurysm Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease Aneurysm of a coronary vessel. Aneurysm (66-86); Coronary Disease (66-86) LEN'4Cornell Medical Index E01.579.630 Diagnosis; Medical History Taking Self-administered health questionnaire developed to obtain details of the medical history as an adjunct to the medical interview. It consists of 195 questions divided into eighteen sections; the first twelve deal with somatic complaints and the last six with mood and feeling patterns. The Index is used also as a personality inventory or in epidemiologic studies. x)Corneal Ulcer C01.539.375.177; C11.204.564.225; C11.294.177 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ulcer Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections Eye Diseases; Corneal Diseases; Keratitis Eye Diseases; Eye Infections Loss of epithelial tissue from the surface of the cornea due to progressive erosion and necrosis of the tissue; usually caused by bacterial, fungal, or viral infection. 5N Corneal Transplantation E04.792.225; E04.936.580.225 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Eye Banks Surgery, Operative; Surgery, Eye (Non MeSH) Surgery, Operative; Transplantation; Tissue Transplantation Epikeratophakia; Keratoplasty, Penetrating Epikeratophakia; Keratoplasty, Penetrating Partial or total replacement of the cornea from one human or animal to another. Cornea/transplantation (66-89) $"2x`a$Corneal Stroma A09.371.060.217.228 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Anterior Eye Segment; Cornea The lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes. Cornea (66-82) :<Corneal Opacity C11.204.299 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases Arcus Senilis Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque. 9N&Corneal Neovascularization C11.204.290; C23.739.589.500.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Metaplasia; Neovascularization New blood vessels originating from the corneal veins and extending from the limbus into the adjacent corneal stroma. These vessels may lie in the superficial and/or deep corneal stroma. Neovascularization is a sequel to numerous inflammatory diseases of the ocular anterior segment, including trachoma, viral interstitial keratitis, microbial keratoconjunctivitis, and the immune response elicited by corneal transplantation. Cornea/blood supply (78-91); Neovascularization (80-91) &NBCorneal Edema C11.204.267 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity. Cornea (66-89); Corneal Diseases (74-89); Edema (66-89) 'N&ECorneal Dystrophies, Hereditary C11.204.236; C11.270.162; C16.131.410.162 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases Eye Diseases; Eye Diseases, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary Fuchs' Endothelial Dystrophy Fuchs' Endothelial Dystrophy Fuchs' Endothelial Dystrophy Bilateral hereditary disorders of the cornea, usually autosomal dominant, which may be present at birth but more frequently develop during adolescence and progress slowly throughout life. Central macular dystrophy is transmitted as an autosomal recessive defect. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  %1Lb/NCorneal Diseases C11.204 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Corneal Dystrophies, Hereditary (+ 1); Corneal Edema; Corneal Neovascularization; Corneal Opacity (+ 1); Keratitis (+ 7); Keratoconus; Trachoma Diseases of the cornea. Cornea (66-75); specific corneal disease heading BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $ N;PCornea A09.371.060.217 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Endothelium, Corneal; Keratotomy, Radial Sense Organs; Eye; Anterior Eye Segment Corneal Stroma; Descemet's Membrane; Endothelium, Corneal; Limbus Corneae consider also terms at KERAT-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $# 802W':Corn Oil D10.516.212.302.380.370; D10.516.212.507.340; D10.516.627.700.240; J01.740.250.225; J01.740.700.240 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils Oil from corn or corn plant. Oils (66-86)  o@&Corn B06.510.253.236; J01.341.182.236 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals A genus of tall cereal grasses, Zea mays, grown for its seed and used as food and animal fodder. It is also called Indian corn (American Indian) and maize. &4nCoriolis Force H01.671.538.311 Physical Sciences (Non MeSH); Physics; Motion L9Cordotomy E04.530.324.169 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Spinal Cord Surgery, Operative; Neurosurgery; Denervation  $6Cordocentesis E01.223.894.632.150.200 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures; Blood Specimen Collection The collecting of fetal blood samples via ultrasound-guided needle aspiration of the blood in the umbilical vein. Blood Specimen Collection (87-92) s"i(Cord Factors D10.516.390.240; D24.185.926.123.208 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins Trehalose-6,6'-dimycolate. A toxic glycolipid of Mycobacterium tuberculosis. Induces cellular biochemical disfunction in animals; used as immunoadjuvant. Glycolipids (71-74); Mycobacterium Tuberculosis (74); Trehalose (73-74) *>UCor Triatriatum C14.240.400.200; C14.280.400.200; C16.131.240.400.200 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital A congenital anomaly characterized by the presence in the atrium of a perforated muscular membrane which separates the atrium into upper and lower chambers. Heart Atrium (66-86); Heart Defects, Congenital (66-86) X=LKCCopyright L01.737.360 CLECHILJSDSNSTTDUT Information Science; Publishing The exclusive right, granted by law for a certain number of years, to make and dispose of copies of a literary, musical or artistic work. In the United States the copyright is granted for the life of the author plus 50 years. In the case of a joint work, it is for the life of the last joint author to die, plus 50 years. In either case the copyright runs until the end of the calendar year 50 years after the author's death. (Random House College Dictionary, rev ed; Strong, W.S.: The Copyright Book: a Practical Guide, 1981). b &{Copying Processes L01.240 CLECHILJMTSDSNSTTD Information Science Microfilming; Tape Recording (+ 1); Telefacsimile; Video Recording (+ 4) Reproduction of data in a new location or other destination, leaving the source data unchanged, although the physical form of the result may differ from that of the source. CLECHIISLJMAMTOGSDSNSTTDUT  X YCopulation F01.145.113.252.748.200; G08.520.900.110 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal; Consummatory Behavior; Sex Behavior, Animal Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sex Sexual contact of a male with a receptive female usually followed by emission of sperm. Limited to non-human species. For humans use coitus. Coitus (66-74) . Coproporphyrins D11.557.727.250 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Porphyrins with four methyl and four propionic acid side chains attached to the pyrrole rings. Coproporphyrin III is excreted in the feces of persons with hereditary coproporphyria. Porphyrins (69-74) BTCoproporphyrinogens D11.557.727.700.250 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Porphyrinogens Porphyrinogens which are intermediates in the heme biosynthesis. They have four methyl and four propionic acid side chains attached to the pyrrole rings. Coproporphyrinogens I and III are formed in the presence of uroporphyrinogen decarboxylase from the corresponding uroporphyrinogen. They can yield coproporphyrins by autooxidation or protoporphyrin by oxidative decarboxylation. Porphyrinogens (75); Porphyrins (71-74) @f0Coproporphyrinogen Oxidase D08.586.682.263 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases One of the enzymes active in heme biosynthesis. It catalyzes the oxidative decarboxylation of coproporphyrinogen III to protoporphyrinogen III by the conversion of two propionic acid groups to two vinyl groups. It can act under both aerobic and anaerobic conditions. EC 1.3.3.3. Carboxy-Lyases (72-74); Coproporphyrins (75); Oxidoreductases (75); Porphyrins (72-74) FXGgCoprophagia F03.126.231 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Eating of excrement. Feces (66-69) lFYCoprinus B05.354.179.100.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes; Agaricales A genus of black-spored basidiomycetous fungi of the family Coprinaceae, order Agaricales; some species are edible. } "LCopper Radioisotopes D01.496.749.270 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes. Copper (66-87); Radioisotopes (66-87) ٹ4C.Copper D01.268.912.135; D01.552.199 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Ceruloplasmin Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Copper. A trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63. It is essential in nutrition, being a component of various proteins, including ceruloplasmin, erythrocuprein, cytochrome c oxidase, tyrosinase, etc. Deficiency, which is rare, may result in hypochromic microcytic anemia, neutropenia, and bone changes. (From Dorland, 27th ed). j ":sCooperative Behavior F01.145.256 Behavior and Behavior Mechanisms (Non MeSH); Behavior The interaction of two or more persons directed toward a common goal which is mutually beneficial. Behavior (66-70); Behavior, Animal (66-70) (Av4Coombs' Test E01.223.495.826.461.361 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Groups Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Hemagglutination Tests Hemagglutination test in which Coombs' reagent (antiglobulin, or anti-human globulin rabbit immune serum) is added to detect incomplete (non-agglutinating, univalent, blocking) antibodies coating erythrocytes. The direct test is applied to red cells which have been coated with antibody in vivo (e.g., in hemolytic disease of newborn, autoimmune hemolytic anemia, and transfusion reactions). The indirect test is applied to serum to detect the presence of antibody (e.g., in detection of incompatibility in cross-matching tests, detection and identification of irregular antibodies, and in detection of antibodies not identifiable by other means). ^"iCooking and Eating Utensils J01.364.236; J01.494.444 CLECHILJSNST Technology, Industry, Agriculture (Non MeSH); Food Services Technology, Industry, Agriculture (Non MeSH); Household Articles 5"Cookery J01.364.434.360; J01.576.416.277 CLECHIISLJMAMTSNST Diet Technology, Industry, Agriculture (Non MeSH); Food Services; Food Handling Technology, Industry, Agriculture (Non MeSH); Industry; Food Handling 5 &Convulsive Therapy F04.881.200 AECLECEDHIISLJMAMOMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Somatic Therapies, Psychiatric (Non MeSH) Electroconvulsive Therapy The use of convulsive agents to influence favorably the course of a mental disorder. It is used primarily in the treatment of severe affective disorders and schizophrenia. Q kConvulsions, Febrile C10.597.742.286.275; C23.888.592.742.286.275 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Seizures; Convulsions Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Seizures; Convulsions Seizures occurring in young children during febrile episodes due to a low convulsive threshold. The convulsions are usually a self-limiting disorder after the age of 5 years. Convulsions (66-76) 2NConvulsions C10.597.742.286; C23.888.592.742.286 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anticonvulsants; Convulsants; Eclampsia; Epilepsy; Kindling (Neurology) Nervous System Diseases; Neurologic Manifestations; Seizures Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Seizures Convulsions, Febrile Convulsions, Febrile Seizures manifested by discontinuous involuntary skeletal muscular contractions, either brief contractions repeated at short intervals or longer ones interrupted by intervals of muscular relaxation.  *NT0Convulsants D15.220.224 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Convulsions Central Nervous System Agents; Central Nervous System Stimulants Allylglycine; Bemegride; Bicuculline; Flurothyl; 3-Mercaptopropionic Acid; Pentylenetetrazole; Picrotoxin; Soman; Strychnine; Thebaine Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. Central Nervous System Depressants (66-75) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (~8LI2@Conversion Disorder F01.393.181; F03.407.181; F03.709.438.710.380 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Somatoform Disorders A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need. Hysteria (66-68) 5F Convergence, Ocular G11.697.384.217 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Eye Movements The turning inward of the lines of sight toward each other. Accommodation, Ocular (66-84); Eye Movements (66-84); Fixation, Ocular (66-84) |rJ^Convection H01.671.912.230 Physical Sciences (Non MeSH); Physics; Thermodynamics Transmission of energy or mass by a medium involving movement of the medium itself. The circulatory movement that occurs in a fluid at a nonuniform temperature owing to the variation of its density and the action of gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed; Webster, 10th ed). Heat (66-94) ApConvalescence C23.280.224; N01.407.306.360 ECPX Symptoms and General Pathology (Non MeSH); Disease Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Disease The period of recovery following an illness. "7Contusions C21.866.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries +NQControlled Clinical Trials E05.318.760.535.365; E05.337.250.365; G03.850.520.835.535.365; N05.715.360.775.235.387 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Clinical Trials Miscellaneous Techniques (Non MeSH); Evaluation Studies; Clinical Trials Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Clinical Trials Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Clinical Trials Clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS. However, trials employing treatment allocation methods such as coin flips, odd-even numbers, patient social security numbers, days of the week, medical record numbers, or other such pseudo- or quasi-random processes, are simply designated as controlled clinical trials. Clinical Trials (80-94)  `$*BContrast Sensitivity F02.463.593.932.869.435.110; G11.697.911.800.110; G11.697.911.860.622.110 DEGEIMPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception; Space Perception; Form Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Acuity Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception; Form Perception The ability to detect sharp boundaries (stimuli) and to detect slight changes in luminance at regions without distinct contours. Psychophysical measurements of this visual function are used to evaluate visual acuity and to detect eye disease. Form Perception (69-88); Sensory Thresholds (79-88); Visual Acuity (72-88); Visual Perception (72-88) ZQzContrast Media D26.298 ADAEANCHCLCSCTECHIIPMEPDPKPORESDSTTOTU Extravasation of Diagnostic and Therapeutic Materials Radiography Miscellaneous Drugs and Agents (Non MeSH) Acetrizoic Acid; Barium Sulfate; Diatrizoate (+ 1); Iodamide; Iodipamide; Iodized Oil (+ 1); Iodohippuric Acid; Iodopyridones (+ 1); Ioglycamic Acid; Iohexol; Iopanoic Acid; Iophendylate; Iothalamic Acid (+ 2); Ioxaglic Acid; Ipodate; Metrizamide; Metrizoate; Propyliodone; Tyropanoate AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $5 *>2Y.Contracture C05.550.323; C05.651.197 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Musculoskeletal Diseases; Muscular Diseases Hip Contracture Dupuytren's Contracture; Hip Contracture NaBContractile Proteins D12.776.210 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Muscle Proteins (+ 14) Proteins which participate in contractile processes. They include MUSCLE PROTEINS as well as those found in other cells and tissues. In the latter, these proteins participate in localized contractile events in the cytoplasm, in motile activity, and in cell aggregation phenomena. specific protein (66-76); Proteins (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $FDF4HContract Services N03.219.463.100 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Competitive Bidding Outside services provided to an institution under a formal financial agreement. Economics (66-77)  [^Contraceptives, Postcoital, Synthetic D07.360.276.310.360 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital Centchroman; Diethylstilbestrol Postcoital contraceptives which owe their effectiveness to synthetic preparations. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  +8%_:Contraceptives, Postcoital, Hormonal D07.360.276.310.235 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital Postcoital contraceptives which owe their effectiveness to hormonal preparations.  *8^Contraceptives, Postcoital D07.360.276.310 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic (+ 2) Contraceptive Agents (67-70); Contraceptives, Oral (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  s8j]E:Contraceptives, Oral, Synthetic D07.360.276.210.443 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral Estrogens, Synthetic (+ 3); Mifepristone; Progestational Hormones, Synthetic (+ 16) Oral contraceptives which owe their effectiveness to synthetic preparations. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  N%8cY:Contraceptives, Oral, Sequential D07.360.276.210.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral Drugs administered orally and sequentially for contraceptive purposes. Contraceptives, Oral (70-75) f&8R"Contraceptives, Oral, Hormonal D07.360.276.210.277 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral Estrogens; Progestational Hormones Oral contraceptives which owe their effectiveness to hormonal preparations. ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  $8)XBContraceptives, Oral, Combined D07.360.276.210.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral Fixed drug combinations administered orally for contraceptive purposes. Contraceptives, Oral (70-75); Drug Combinations (72-75) $8SBContraceptives, Oral D07.360.276.210 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal (+ 2); Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic (+ 22) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 8jDContraceptive Devices, Male E07.190.270 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Contraceptive Devices Condoms Contraceptive devices used by males. Contraceptive Devices (66-74)  m!6 -#Contraceptive Devices, Female E07.190.250 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Contraceptive Devices Intrauterine Devices (+ 2) Contraceptive devices used by females. Contraceptive Devices (66-74)  s#6!/#Contraceptive Devices E07.190 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Contraceptive Devices, Female (+ 3); Contraceptive Devices, Male (+ 1)  UContraceptive Agents, Male D07.360.443 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Contraceptive Agents alpha-Chlorohydrin; Antispermatogenic Agents (+ 1); Cyproterone Acetate; Epichlorohydrin; Medroxyprogesterone 17-Acetate Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. Contraceptive Agents (67-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $f 8H":Contraceptive Agents, Female D07.360.276 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Vaginal Creams, Foams and Jellies Reproductive Control Agents (Non MeSH); Contraceptive Agents Contraceptives, Oral (+ 28); Contraceptives, Postcoital (+ 4); Luteolytic Agents; Medroxyprogesterone 17-Acetate; Menstruation-Inducing Agents (+ 1); Sperm Immobilizing Agents; Spermatocidal Agents Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. Contraceptive Agents (67-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ("8)H"DContraceptive Agents D07.360 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH) Contraceptive Agents, Female (+ 40); Contraceptive Agents, Male (+ 6) Contraceptive Devices (66) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  ! 8.T DContraception, Immunologic E02.197.300 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Contraception Contraceptive methods utilizing immunologic processes. #d"!?Contraception Behavior F01.145.792.210 EHHIPXSNTD Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Behavior patterns of those practicing contraception. Contraception (66-67); Sex Behavior (66-74) $7R>5Contraception E02.197 AECLCTECHIISMOMTNUPXSNSTTDUTVE Family Planning Population Control; Family Planning Therapeutics Coitus Interruptus; Contraception, Immunologic; Intrauterine Device Expulsion; Rhythm Method Use of agents, devices, methods, or procedures which diminish the likelihood of or prevent conception. $%_ "+kyContinuity of Patient Care N04.590.233.727.210 CLECHILJOGSNSTTD Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care; Primary Health Care Health care provided on a continuing basis from the initial contact with a physician or clinic and following the patient through all episodes of his medical care needs. &!Contingent Negative Variation G07.453.276; G11.561.150 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) An increasing negative shift of the cortical electrical potentials associated with an anticipated response to an expected stimulus. It is an electrical event indicative of a state of readiness or expectancy. It is also called Bereitschaftspotential. Electroencephalography (66-70); Electrophysiology (66-70) (##BContainment of Biohazards E05.235 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Provision of physical and biological barriers to the dissemination of potentially hazardous biologically active agents (bacteria, viruses, recombinant DNA, etc.). Physical containment involves the use of special equipment, facilities, and procedures to prevent the escape of the agent. Biological containment includes use of immune personnel and the selection of agents and hosts that will minimize the risk should the agent escape the containment facility. +G "*Contact Tracing E05.318.270; G03.850.520.270; G03.850.780.200.225 ECHIISLJMTSNTDUTVE Miscellaneous Techniques (Non MeSH); Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control Identification of those persons (or animals) who have had such an association with an infected person, animal, or contaminated environment as to have had the opportunity to acquire the infection. Contact tracing is a generally accepted method for the control of sexually transmitted diseases. Sexually Transmitted Diseases/prevention and control (66-90); specific disease/prevention and control (72-90); specific infection/prevention and control (86-90) -9/UContact Lenses, Hydrophilic E07.532.276.360 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Lenses; Contact Lenses Contact Lenses, Extended-Wear Soft, supple contact lenses made of plastic polymers which interact readily with water molecules. Many types are available, including continuous and extended-wear versions, which are gas-permeable and easily sterilized. Contact Lenses (66-70)  1!9#Contact Lenses, Extended-Wear E07.532.276.360.220 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Lenses; Contact Lenses; Contact Lenses, Hydrophilic Hydrophilic contact lenses worn for an extended period or permanently. Contact Lenses (66-69); Contact Lenses, Hydrophilic (71-83) 3#ZTGContact Lenses E07.532.276 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Lenses Contact Lenses, Hydrophilic (+ 1) 5&)Contact Lens Solutions D26.394.225.766.210 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Sterile solutions used to clean and disinfect contact lenses. Contact Lenses (66-94); Solutions (66-94) 5,ZJ3Contact Inhibition G04.335.355 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Arrest of cell locomotion or cell division when two cells come into contact. Cytology (66-67) 7'f]Consummatory Behavior F01.145.113.252 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal Nesting Behavior; Predatory Behavior; Sex Behavior, Animal (+ 2) An act which constitutes the termination of a given instinctive behavior pattern or sequence. Behavior, Animal (66-67)  8Z VNoConsumer Satisfaction N04.452.822.360 ECLJSN Health Services Administration (Non MeSH); Organization and Administration; Public Relations Patient Satisfaction Customer satisfaction or dissatisfaction with a benefit or service received. Attitude (66-67) ECEHLJSN $9 lZ Consumer Product Safety G03.850.210 LJST Environment and Public Health (Non MeSH); Public Health Device Approval Accident Prevention (66-81) ;UD!Consumer Participation N02.421.143.262; N03.540.245.360 ECHILJMTPXSNTDUT Delivery of Health Care; Patient Care Planning Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Economics, Organizations, Control (Non MeSH); Organizations; Consumer Organizations Patient Participation Patient Participation Community or individual involvement in the decision-making process.  <)&92OConsumer Organizations N03.540.245 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations Consumer Participation (+ 1) Organized groups of users of goods and services. CLECHILJMTOGPXSNSTTDUT  >+F#<Consumer Advocacy I01.880.604.473.368; N03.706.437.368 CLECEDHIINLJPXSNSTTD Social Sciences; Sociology; Social Control, Formal; Human Rights Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights The promotion and support of consumers' rights and interests. Consumer Organizations (68-81); Consumer Participation (74-81); Consumer Satisfaction (68-81) ?U*JmConsultants M01.120 CLHILJPXSN Named Groups (Non MeSH) Individuals referred to for expert or professional advice or services. Referral and Consultation (68-77) A9 T(Construction Materials J01.637.241 AEANCLECHIPORESDSNSTTOUT Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) B"OConstriction, Pathologic C23.739.220 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) The condition of an anatomical structure's being constricted beyond normal dimensions. Constriction (68-75) BNYeConstriction E05.225 Miscellaneous Techniques (Non MeSH) The act of constricting. DN * Constitution and Bylaws N04.452.150 Health Services Administration (Non MeSH); Organization and Administration The fundamental principles and laws adopted by an organization for the regulation and governing of its affairs. DWConstipation C06.405.469.187 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Defecation Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Infrequent or difficult evacuation of feces. ENU6Conserved Sequence G05.331.599.250; G06.184.599.250 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data A sequence of amino acids in a polypeptide or of nucleotides in genetic material that either has not changed or that has changed very little during an evolutionary period of time. Amino Acid Sequence (77-92); Base Sequence (73-92) G)&>Conservation of Natural Resources G03.230.080 ECHILJMTSNTD Ecology Environment and Public Health (Non MeSH); Environment Conservation of Energy Resources The protection, preservation, restoration, and rational use of all resources in the total environment.  Iv( A'xConservation of Energy Resources G03.230.080.078 ECHILJMTSNTD Environment and Public Health (Non MeSH); Environment; Conservation of Natural Resources Planned management, use, and preservation of energy resources. Conservation of Natural Resources (77-79) J'iJ1Consensus Sequence G05.331.599.110.200; G06.184.599.110.200 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Base Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Base Sequence A theoretical representative nucleotide sequence in which each nucleotide is the one which occurs most frequently at that site in the different forms of a genetic element which occur in nature. The phrase also refers to an actual sequence which approximates the theoretical consensus. Base Sequence (83-90); Molecular Sequence Data (88-90) L(.MBConsensus Development Conferences, NIH L01.178.682.759.150.500; N03.540.199.205.500 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Review Literature; Consensus Development Conferences Economics, Organizations, Control (Non MeSH); Organizations; Congresses; Consensus Development Conferences Articles on conferences sponsored by NIH presenting summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus on a subject of interest. This heading is used for NIH consensus conferences as a means of scientific communication. In indexing it is viewed as a type of review article and as a tag for any article appearing in any publication of the NIH Office of Medical Applications of Research (OMAR). Consensus Development Conferences (88-89); National Institutes of Health (U.S.) (82-87) O-2FfConsensus Development Conferences L01.178.682.759.150; N03.540.199.205 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Review Literature Economics, Organizations, Control (Non MeSH); Organizations; Congresses Consensus Development Conferences, NIH Consensus Development Conferences, NIH Presentations of summary statements representing the majority agreement of physicians, scientists, and other professionals convening for the purpose of reaching a consensus--often with findings and recommendations--on a subject of interest. The Conference, consisting of participants representing the scientific and lay viewpoints, is a significant means of evaluating current medical thought and reflects the latest advances in research for the respective field being addressed. S]'*X#Consciousness Disorders F03.126.185.199 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders Organic mental disorders in which there is marked impairment of awareness. WFrYConsciousness F02.463.188.409; F02.830.233 CLDEPHRE Unconsciousness Psychologic Processes and Principles (Non MeSH); Mental Processes; Cognition Psychologic Processes and Principles (Non MeSH); Psychophysiology Sense of awareness of self and of the environment. Xt" ?Conscious Sedation E03.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH) An alternative to general anesthesia in patients for whom general anesthesia is refused or considered inadvisable. It involves the administering of an antianxiety drug (minor tranquilizer) and an analgesic or local anesthetic. This renders the patient free of anxiety and pain while allowing the patient to remain in verbal contact with the physician or dentist. Anesthesia, Dental (73-90); Preanesthetic Medication (80-90) Y "+GConscience F01.829.500.359; K01.752.256.547.359; K01.316.630.350 Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Morals Humanities; Philosophy; Ethics; Morals Humanities; Ethics; Morals The cognitive and affective processes which constitute an internalized moral governor over an individual's moral conduct. \V=Consanguinity G05.358.209 Blood Groups; Inbreeding; Family Genetics; Genetics, Medical ])"Connexins D12.776.543.225 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Gap Junctions Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins Connexin 43 A group of homologous proteins which form the intermembrane channels of GAP JUNCTIONS. The connexins are the products of an identified gene family which has both highly conserved and highly divergent regions. The variety contributes to the wide range of functional properties of gap junctions. Membrane Proteins (81-93) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (^{ FZXHConnexin 43 D12.776.543.225.200 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Connexins A 43 kD peptide which is a member of the connexin family of gap junction proteins. Connexin 43 is a product of a gene in the alpha class of connexin genes (the alpha-1 gene). It was first isolated from mammalian heart, but is widespread in the body including the brain. Membrane Proteins (87-93) aOHgFConnective Tissue Diseases C17.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bone Diseases, Developmental; Collagen Diseases Skin and Connective Tissue Diseases (Non MeSH) Cartilage Diseases (+ 2); Cellulitis; Collagen Diseases (+ 8); Cutis Laxa; Dermatomyositis; Dupuytren's Contracture; Homocystinuria; Lupus Erythematosus, Cutaneous (+ 2); Lupus Erythematosus, Systemic (+ 1); Marfan Syndrome; Mixed Connective Tissue Disease; Mucinoses (+ 11); Neoplasms, Connective Tissue; Noonan Syndrome; Osteopoikilosis; Panniculitis (+ 4); Penile Induration; Pseudoxanthoma Elasticum; Rheumatic Diseases (+ 10); Scleroderma, Circumscribed; Scleroderma, Systemic (+ 1) A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. Collagen Diseases (66-79); Connective Tissue (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI (c  N88>?ZConnective Tissue Cells (Non MeSH) A11.329 Cells Adipocytes; Fibroblasts (+ 2); Macrophages (+ 8); Mast Cells; Odontoblasts; Osteoblasts; Osteoclasts; Osteocytes; Plasma Cells; Stromal Cells; Theca Cells CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI h*  *Connective Tissue A10.165 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cellulitis; Collagen Tissue Types (Non MeSH) Adipose Tissue (+ 1); Bone and Bones (+ 4); Cartilage (+ 1); Elastic Tissue i :bConnecticut Z01.107.567.875.100.177; Z01.107.567.875.600.595.177 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); New England k : Conjunctivitis, Viral C02.325.250; C11.187.183.240; C11.294.800.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Eye Infections, Viral Eye Diseases; Conjunctival Diseases; Conjunctivitis Eye Diseases; Eye Infections; Eye Infections, Viral Conjunctivitis, Acute Hemorrhagic Conjunctivitis, Acute Hemorrhagic Conjunctivitis, Acute Hemorrhagic Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection. Adenovirus Infections (66-85); Conjunctivitis (66-85); Virus Diseases (66-85)  l5Pq\Conjunctivitis, Inclusion C01.252.354.225.250; C01.252.400.810.200.195.250; C01.539.375.354.220.250; C11.187.183.220.250; C11.294.354.220.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Chlamydiaceae Infections; Chlamydia Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial Eye Diseases; Conjunctival Diseases; Conjunctivitis; Conjunctivitis, Bacterial Eye Diseases; Eye Infections; Eye Infections, Bacterial; Conjunctivitis, Bacterial An infection of the eyes characterized by the presence in conjunctival epithelial cells of inclusion bodies indistinguishable from those of trachoma. It is acquired by infants during birth and by adults from swimming pools. The etiological agent is CHLAMYDIA TRACHOMATIS whose natural habitat appears to be the genito-urinary tract. Inclusion conjunctivitis is a less severe disease than trachoma and usually clears up spontaneously. olPConjunctivitis, Bacterial C01.252.354.225; C01.539.375.354.220; C11.187.183.220; C11.294.354.220 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Eye Infections, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Eye Infections; Eye Infections, Bacterial Eye Diseases; Conjunctival Diseases; Conjunctivitis Eye Diseases; Eye Infections; Eye Infections, Bacterial Conjunctivitis, Inclusion; Ophthalmia Neonatorum; Trachoma Conjunctivitis, Inclusion; Ophthalmia Neonatorum; Trachoma Conjunctivitis, Inclusion; Ophthalmia Neonatorum; Trachoma Conjunctivitis, Inclusion; Ophthalmia Neonatorum; Trachoma Purulent infections of the conjunctiva by several species of gram-negative, gram-positive, or acid-fast organisms. Some of the more commonly found genera causing conjunctival infections are Haemophilus, Streptococcus, Neisseria, and Chlamydia. Bacterial Infections or specifics (66-85); Conjunctivitis (66-85)  u!PPU MConjunctivitis, Allergic C11.187.183.200; C20.543.480.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Conjunctival Diseases; Conjunctivitis Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate Conjunctivitis due to hypersensitivity to various allergens. Conjunctivitis (66-85); Hypersensitivity (66-85) y&NG9Conjunctivitis, Acute Hemorrhagic C02.325.250.250; C02.782.687.359.201; C02.782.687.359.213.165; C11.187.183.240.216; C11.294.800.250.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Eye Infections, Viral; Conjunctivitis, Viral Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections; Enterovirus Infections; Coxsackievirus Infections Eye Diseases; Conjunctival Diseases; Conjunctivitis; Conjunctivitis, Viral Eye Diseases; Eye Infections; Eye Infections, Viral; Conjunctivitis, Viral A highly contagious disease characterized by subconjunctival hemorrhage, sudden swelling of the eyelids and congestion, redness, and pain in the eye. Epidemic conjunctivitis caused by Enterovirus 70 (EV-70) was first described in Africa in 1969. It is caused also by Coxsackievirus A24 variant (CA24v). Epidemics by this organism have appeared most frequently in Asia. Conjunctivitis (66-85); Disease Outbreaks (66-85); Enterovirus Infections (66-85); Hemorrhage (66-85) {'sPxConjunctivitis C11.187.183 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Conjunctival Diseases Conjunctivitis, Allergic; Conjunctivitis, Bacterial (+ 3); Conjunctivitis, Viral (+ 1); Keratoconjunctivitis (+ 2); Reiter's Disease BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI N+PConjunctival Neoplasms C04.588.364.235; C11.187.169; C11.319.217 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Eye Neoplasms Eye Diseases; Conjunctival Diseases Eye Diseases; Eye Neoplasms Conjunctiva (66-80); Eye Neoplasms (66-80) g1X4Conjunctival Diseases C11.187 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Conjunctival Neoplasms; Conjunctivitis (+ 11); Pterygium; Xerophthalmia Conjunctiva (66-80); Eye Diseases (66-80) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI   NU3ZConjunctiva A09.371.192 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye :Conjugation, Genetic G05.386.192; G05.825.192 DEGEIMPHRE Crosses, Genetic Genetics; Genetics, Microbial Genetics; Recombination, Genetic A parasexual mechanism in bacteria for achieving unidirectional transfer of all or part of the chromosome from an F+ or Hfr donor ("male") to an F- ("female") recipient. Genetics (66-67)  ICongresses N03.540.199 CLECHILJOGSNSTTDUT International Cooperation Economics, Organizations, Control (Non MeSH); Organizations Consensus Development Conferences (+ 1) Conferences, conventions or formal meetings usually attended by delegates representing a special field of interest.  F/Congo Red D26.408.192 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Dyes 3.;Congo Z01.058.290.100.140 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central  _Conglutination Reaction E01.223.495.826.208.250 Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis; Complement Fixation Tests Clumping, by serum from ruminants containing the globulin conglutinin, of sensitized cells or of antigen-antibody complexes which have absorbed complement. ~mConfusion F03.126.185.154 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders A mental state characterized by bewilderment, emotional disturbance, lack of clear thinking, and perceptual disorientation.  FrConfounding Factors (Epidemiology) G03.850.490.718; N05.715.350.240 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors Factors that can cause or prevent the outcome of interest, are not intermediate variables, and are not associated with the factor(s) under investigation. They give rise to situations in which the effects of two processes are not separated, or the contribution of causal factors cannot be separated, or the measure of the effect of exposure or risk is distorted because of its association with other factors influencing the outcome of the study. }(& Conflict of Interest K01.316.130; K01.752.256.095; N05.350.225 LJ Morals Humanities; Ethics Humanities; Philosophy; Ethics Quality, Access, Evaluation (Non MeSH); Ethics Physician Self-Referral Physician Self-Referral Physician Self-Referral A situation in which a private person might benefit from his official or professional actions. It includes a conflict between his private interests or finances and his official responsibilities in his position of trust. The term is not restricted to private finances nor to only government officials. The concept refers both to actual or proven conflict of interest and the appearance or perception of conflict. Conflict (Psychology) (66-90); Ethics (66-90) LJSNTD (1 sP7 Conflict (Psychology) F01.658.209 Behavior and Behavior Mechanisms (Non MeSH); Motivation The state of being simultaneously motivated by opposing or mutually exclusive impulses, desires, or tendencies. +CConfidentiality F01.145.209.230; F04.096.544.335.240; I01.880.604.583.080; N03.706.535.230 LJPX Ethics Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry; Forensic Psychiatry Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence  Duty to Warn Duty to Warn Duty to Warn Entrusted communication of information which is considered private and implies an ethical or legal principle. Jurisprudence (66-74) $8T t3Confidence Intervals E05.318.740.275; G03.850.520.830.275; H01.548.832.292; N05.715.360.750.220 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics A range of values for a variable of interest, e.g., a rate, constructed so that this range has a specified probability of including the true value of the variable. Data Interpretation, Statistical (88-89); Statistics (72-89) !TGCones (Retina) A08.663.694.530.650.700.150; A08.800.550.700.730.750.150; A09.371.729.778.150; A11.671.677.530.650.700.150 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors; Rods and Cones Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Photoreceptors; Rods and Cones Sense Organs; Eye; Retina; Rods and Cones Cells; Neurons; Neuron Types (Non MeSH); Neurons, Afferent; Photoreceptors; Rods and Cones One of the two photoreceptor cell types in the vertebrate retina. In cones the photopigment is in invaginations of the cell membrane of the outer segment. Cones are less sensitive to light than rods, but they provide vision with higher spatial and temporal acuity, and the combination of signals from cones with different pigments allows color vision. Photoreceptors (71-93); Rods and Cones (66-93) Gt89Condylomata Acuminata C02.256.690.810.217; C02.800.801.220; C02.825.810.110; C02.928.914.217; C17.800.838.790.810.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Papillomavirus Virus Diseases; DNA Virus Infections (Non MeSH); Papovaviridae Infections; Warts Virus Diseases; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral Virus Diseases; Skin Diseases, Viral; Warts Virus Diseases; Tumor Virus Infections; Warts Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Viral; Warts Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses. kNjConductometry E05.196.922.500; H01.181.529.307.180 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Titrimetry Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Electrochemistry Determination of the quantity of a material present in a mixture by measurement of its effect on the electrical conductivity of the mixture. (Webster, 3d ed). *"Condoms E07.190.270.200; E07.712.195 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Contraceptive Devices; Contraceptive Devices, Male Equipment and Supplies; Protective Devices A sheath or cover for the penis, worn during coitus to prevent impregnation or infection. (Dorland 27th ed). Contraceptive Devices (66-74); Contraceptive Devices, Male (75-92)  "NConditioning, Operant F02.463.425.179.509 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Conditioning (Psychology) Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. | x#Conditioning, Eyelid F02.463.425.179.408 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Conditioning (Psychology) Reflex closure of the eyelid occurring as a result of classical conditioning. Conditioning (Psychology) (66-68); Conditioning, Classical (66-68); Eyelids (66-68) w x]bConditioning, Classical F02.463.425.179.308 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Conditioning (Psychology) Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus. REFLEX, CONDITIONED  xqConditioning (Psychology) F02.463.425.179 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Automatism; Conditioning, Classical; Conditioning, Eyelid; Conditioning, Operant A general term referring to the learning of some particular response. BLCFCICLCODEDHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRISUTHURUSVI  x Z]TLCondiments J01.341.241 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Garlic; Herbs (+ 1); Mustard; Sodium, Dietary (+ 1); Spices (+ 3) Aromatic substances added to food before or after cooking to enhance its flavor. These are of vegetable origin, with the exception of salt. ADAEAGAHAIANBLCFCHCLCSCTCYDEDUECEMENGDGEHIIMIPMEMIPDPHPKPOPSRESDSNSTTOTUULURUTVI  7"=VTConcurrent Review N04.761.879.200; N05.700.900.200 CLECHILJMTOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care; Utilization Review Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Utilization Review Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment. Professional Standards Review Organizations (74-Jul 77); Utilization Review (68-Jul 77) /&fConcept Formation F02.463.785.233 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking A cognitive process involving the formation of ideas generalized from the knowledge of qualities, aspects, and relations of objects.  ZConcentration Camps I01.880.604.787.358 CLHISN Holocaust Social Sciences; Sociology; Social Control, Formal; Prisons Facilities in which war or political prisoners are confined.   HIConcanavalin A D12.776.765.179; D24.185.526.545.358; D24.310.545.358; D24.611.125.044.545.358 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Receptors, Concanavalin A Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens; Lectins Immunologic and Biologic Factors (Non MeSH); Biological Products; Lectins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Lectins Concanavalin A. A lectin isolated from the jack bean (Canavalia envalin). It is a hemagglutinin that agglutinates mammalian erythrocytes and a mitogen that stimulates predominantly T-lymphocytes. (Dorland, 27th ed). Lectins (66-70)  XFConalbumin D12.776.034.180; D12.776.256.317.180; D12.776.290.180 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Egg Proteins, Dietary Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins A glycoprotein albumin from hen's egg white with strong iron-binding affinity. Albumins (69-74); Egg Proteins (73-74) =D]0Computing Milieu (Non MeSH) L01.700.568.180 Information Science; Medical Informatics; Medical Informatics Computing Computer-Assisted Instruction; Computer Literacy; Computer User Training CLECHIISLJMTSDSNSTTDUT  "STComputing Methodologies (Non MeSH) L01.700.568.110 Information Science; Medical Informatics; Medical Informatics Computing Algorithms; Artificial Intelligence (+ 5); Automatic Data Processing (+ 1); Computer Graphics (+ 1); Computer Simulation; Image Processing, Computer-Assisted (+ 3); Mathematical Computing (+ 6); Signal Processing, Computer-Assisted AECLCTECEDHIISLJMAMOMTNUOGPXSDSNSTTDUTVE &)S,Computers, Mainframe L01.700.568.080.260.308 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers Large computers in both size and capacity. Computers (66-86) u5Computers, Hybrid L01.700.568.080.260.280 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers Analog-Digital Conversion GuComputers, Analog L01.700.568.080.260.230 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers Computers in which quantities are represented by physical variables; problem parameters are translated into equivalent mechanical or electrical circuits as an analog for the physical phenomenon being investigated. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). DuEComputers L01.700.568.080.260 CLECHILJSDSNSTTDUT Attitude to Computers; Automatic Data Processing Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems Computer Peripherals (+ 5); Computers, Analog; Computers, Hybrid (+ 1); Computers, Mainframe; Microcomputers; Minicomputers h :hComputer-Assisted Instruction I02.903.573.208; L01.700.568.180.300 CLECHIISLJMTSDSNSTTDUT Education; Teaching; Programmed Instruction Information Science; Medical Informatics; Medical Informatics Computing; Computing Milieu (Non MeSH) A self-learning technique, usually online, involving interaction of the student with programmed instructional materials. "*Computer-Aided Design L01.700.568.110.108.150; L01.700.568.810.210.110.150 CLECHIISLJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH); Computer Graphics Information Science; Medical Informatics; Medical Informatics Computing; Software; Data Display; Computer Graphics The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics. Computers (68-92) ĸ:Computer User Training I02.903.080; L01.700.568.180.408 CLECHILJMTSDSNSTTDUT Education; Teaching Information Science; Medical Informatics; Medical Informatics Computing; Computing Milieu (Non MeSH) Process of teaching a person to interact and communicate with a computer. &YComputer Terminals L01.700.568.080.260.115.500 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers; Computer Peripherals Input/output devices designed to receive data in an environment associated with the job to be performed, and capable of transmitting entries to, and obtaining output from, the system of which it is a part. (Computer Dictionary, 4th ed.). Computer Systems (87-90) vComputer Systems L01.700.568.080 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing Computer Communication Networks (+ 1); Computers (+ 12) Systems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities. CLECHIISLJOGSDSNSTTDUT  ʯSDComputer Storage Devices L01.700.568.080.260.115.475 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers; Computer Peripherals Optical Storage Devices (+ 2) Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand. Computers (66-90)  n%Computer Simulation L01.700.568.110.160 CLECHILJSDSNSTTDUT Models, Theoretical Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Computer-based representation of physical systems and phenomena such as chemical processes. J|jComputer Security L01.209; N04.452.910.200 CLECHIISLJMASNSTTDUT Information Science Health Services Administration (Non MeSH); Organization and Administration; Security Measures Protective measures against unauthorized access to or interference with computer operating systems, telecommunications, or data structures, especially the modification, deletion, destruction, or release of data in computers. It includes methods of forestalling interference by computer viruses or so-called computer hackers aiming to compromise stored data. Computer Systems (87-91); Confidentiality (80-91); Information Systems (82-91) ϴ]Computer Peripherals L01.700.568.080.260.115 CLECHILJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers Computer Storage Devices (+ 3); Computer Terminals Various units or machines that operate in combination or in conjunction with a computer but are not physically part of it. Peripheral devices typically display computer data, store data from the computer and return the data to the computer on demand, prepare data for human use, or acquire data from a source and convert it to a form usable by a computer. (Computer Dictionary, 4th ed.). Computers (66-90)  Ҟu>Computer Literacy L01.700.568.180.380 Information Science; Medical Informatics; Medical Informatics Computing; Computing Milieu (Non MeSH) General learning, knowledge, and fluency with computer terms; also, becoming familiar with how computers operate and how they are programmed. ըuComputer Graphics L01.700.568.110.108; L01.700.568.810.210.110 CLECHIISLJSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Information Science; Medical Informatics; Medical Informatics Computing; Software; Data Display Computer-Aided Design Computer-Aided Design The process of pictorial communication, between human and computers, in which the computer input and output have the form of charts, drawings, or other appropriate pictorial representation. 22Computer Communication Networks L01.700.568.080.110 CLECHIISLJOGSDSNSTTDUT Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems Local Area Networks A configuration of two or more computers linked to share information and resources. َ%hdCompulsive Personality Disorder F03.709.597.138 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A personality disorder in which the following features are notable: restricted ability to express warm emotions, perfectionism, insistence that others do things as he or she wants, excessive devotion to work to the exclusion of pleasure, and indecisiveness. %Fc+Compulsive Behavior F01.145.527.100; F03.126.517.100 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Obsessive-Compulsive Disorder Behavior and Behavior Mechanisms (Non MeSH); Behavior; Impulsive Behavior Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Impulsive Behavior Behavior, Addictive Behavior, Addictive The behavior of performing an act persistently and repetitively without it leading to reward or pleasure. The act is usually a small, circumscribed behavior, almost ritualistic, yet not pathologically disturbing. Examples of compulsive behavior include twirling of hair, checking something constantly, not wanting pennies in change, straightening tilted pictures, etc.  &F".Comprehensive Health Care N04.590.233 CLECHILJMAMTOGSNSTTDUT Family Practice Health Services Administration (Non MeSH); Patient Care Management (Non MeSH) Comprehensive Dental Care; Nursing Process (+ 8); Patient Care Planning; Patient-Centered Care; Primary Health Care (+ 3); Progressive Patient Care Providing for the full range of personal health services for diagnosis, treatment, follow-up and rehabilitation of patients. Community Health Services (66-67); specific service CLECEDHIISLJMAMTOGSNSTTDUT (\>Comprehensive Dental Care N04.590.233.250 CLECHILJMAMTOGSNSTTDUT Dental Care Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Comprehensive Health Care Providing for the full range of dental health services for diagnosis, treatment, follow-up, and rehabilitation of patients. Comprehensive Health Care (68-71)  |(Compound 48-80 D26.283 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Histamine Liberation Miscellaneous Drugs and Agents (Non MeSH)  .2Composite Resins D25.339.149; D25.720.716.822.308 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic Bisphenol A-Glycidyl Methacrylate Bisphenol A-Glycidyl Methacrylate Dental Materials (66-71); Resins (66-71) &,L2Compliance H01.671.231.358 DERE Physical Sciences (Non MeSH); Physics; Elasticity @=Complement 9 D12.776.124.486.274.850; D24.611.333.850 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement The last component in the complement reaction sequence; it is an alpha globulin present in serum as a trace, with a molecular weight of 80,000 and a sedimentation coefficient of 4.5; for cell lysis, it can be replaced by a metal chelator. Bacteriolysis (66-74); Complement (68-74); Hemolysis (66-74); specific cell .D\Complement 8 D12.776.124.486.274.750; D24.611.333.750 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement The next to the last essential component for cell lysis in the complement reaction sequence; it is a gamma globulin with a molecular weight of 150,000, a sedimentation coefficient of 8. It is present in trace amounts in serum and can be inhibited, like complement 1, by cation chelators. Bacteriolysis (66-74); Complement (68-74); Hemolysis (66-74) .DVIComplement 7 D12.776.124.486.274.650; D24.611.333.650 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement The seventh component in the complement reaction sequence; it is a beta globulin probably in a complex with C5 and C6 and is activated by C5; the attachment of C7 renders the cell susceptible to lysis. Chemotaxis (66-74); Complement (68-74); Neutrophils (66-74)  .DHComplement 6 D12.776.124.486.274.550; D24.611.333.550 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement The sixth component in the complement reaction sequence; it is a beta globulin with a sedimentation coefficient of 8.7, molecular weight of 120,000 at 60 micrograms/ml in serum; it may exist in a complex with C5 and C7 and is activated by the binding of C5. Complement (68-74) .D6Complement 5a, des-Arginine D12.776.124.486.274.450.250.255; D24.185.030.270.255; D24.611.333.450.250.255 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 5; Complement 5a Immunologic and Biologic Factors (Non MeSH); Biological Factors; Anaphylatoxins; Complement 5a Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 5; Complement 5a Complement 5a with the carboxy-terminal arginine removed. The arginine is rapidly cleaved from the C5a fragment during complement activation by carboxypeptidase B present in normal human serum. C5a des-Arg shows complete loss of spasmogenic activity though it retains some chemotactic ability. Complement 5 (79-89) !UDTComplement 5a D12.776.124.486.274.450.250; D24.185.030.270; D24.611.333.450.250 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 5 Immunologic and Biologic Factors (Non MeSH); Biological Factors; Anaphylatoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 5 Complement 5a, des-Arginine Complement 5a, des-Arginine Complement 5a, des-Arginine Smaller fragment formed when C5 convertase splits C5 into C5a and C5b. C5a is a 74-amino acid peptide that includes a carboxy-terminal arginine crucial for its spasmogenic activity and a carbohydrate moiety. C5a is the most potent anaphylatoxin mediating immediate hypersensitivity. Anaphylatoxins (77-89); Complement (72-75); Complement 5 (75-89)  IDj_INComplement 5 D12.776.124.486.274.450; D24.611.333.450 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement Complement 5a (+ 1) Complement 5a (+ 1) The fifth component in the complement reaction sequence, probably exists in a complex with C6 and C7; it is a beta globulin with a sedimentation coefficient of 10, serum concentration of 75 micrograms/ml and molecular weight of 180,000. It is activated by C423 and releases fragments with anaphylatoxic, chemotactic, and histamine-releasing actions and affecting smooth muscle. Complement (68-74); Histamine Liberation (66-74)  .D2:Complement 4b D12.776.124.486.274.350.260; D24.611.333.350.260 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 4 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 4 Larger fragment formed when C1s splits C4 into C4a and C4b. C4b combines with C2b to form the activated C4b2b complex which is often called the classical pathway C3 convertase. Complement 4 (75-89) 6DComplement 4a D12.776.124.486.274.350.250; D24.185.030.260; D24.611.333.350.250 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 4 Immunologic and Biologic Factors (Non MeSH); Biological Factors; Anaphylatoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 4 Smaller fragment formed when C1s splits C4 into C4a and C4b. As an anaphylatoxin, C4a causes symptoms of immediate hypersensitivity but it has weaker activity than C3a or C5a. Anaphylatoxins (80-82); Complement 4 (78-89) CIDj6Complement 4 D12.776.124.486.274.350; D24.611.333.350 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement Complement 4a; Complement 4b Complement 4a; Complement 4b The second component to react in the complement sequence; it is a beta globulin with a sedimentation coefficient of 18.7, a molecular weight of 240,000 and a serum concentration of 430 micrograms/ml; it is activated by complement 1 and serves as a receptor for C2. Complement (68-74); Protein Binding (66-74)  z.DF<5Complement 3d D12.776.124.486.274.250.280; D24.611.333.250.280 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Complement 3d Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 3 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 3 An inactivated fragment of complement 3b (C3b). Factor H makes C3b susceptible to factor I (formerly called KAF, C3bINF, or enzyme 3b inactivator) to form iC3b. Then factor I and a trypsin-like proteolytic enzyme further cleave iC3b into C3c and C3dg. Serum proteases degrade C3dg into complement 3d (C3d) and C3g. Complement (73-76); Complement 3 (75-89)  6Du2Complement 3c D12.776.124.486.274.250.270; D24.611.333.250.270 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 3 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 3 An inactivated form of COMPLEMENT 3B (C3b). Complement 3b is inactivated with the help of two regulatory factors, COMPLEMENT FACTOR H and COMPLEMENT FACTOR I. COMPLEMENT FACTOR H (C3b inactivator accelerator) makes C3b susceptible to the serine protease, COMPLEMENT FACTOR I (formerly called KAF, C3bINF, or enzyme 3b inactivator), to form iC3b. Then COMPLEMENT FACTOR I and a trypsin-like proteolytic enzyme further cleave iC3b into C3c and C3dg. Complement 3 (74-89)  U6D Complement 3b Inactivators D12.776.124.486.274.920.325; D24.611.333.920.325 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Inactivators Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Inactivators Complement Factor H; Complement Factor I Complement Factor H; Complement Factor I Compounds which inhibit, antagonize, or inactivate Complement 3b. A well-known inhibitor is a beta globulin which cleaves C3b into inactive fragments C3c and C3d. C3bINA plays a key role in the regulation of the complement system by blocking the cytolytic sequence and preventing recruitment of the properdin amplification loop. Complement 3 (75-77); Serum Globulins (70-77)  ; 6D$b8Complement 3b D12.776.124.486.274.250.260; D24.611.333.250.260 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Complement 3b Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 3 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 3 The larger fragment formed when C3 convertase splits C3 into C3a and C3b. In both the classical and alternate pathway, C3b participates in immune adherence and enhances phagocytosis. It also forms a cellular intermediate which continues the complement process. In the alternate pathways, C3b initiates a positive feedback activation of C3Pase. Complement (68-74); Complement 3 (75-77)  =6B2Complement 3a D12.776.124.486.274.250.250; D24.185.030.250; D24.611.333.250.250 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 3 Immunologic and Biologic Factors (Non MeSH); Biological Factors; Anaphylatoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 3 Smaller fragment formed when C3 convertase splits C3 into C3a and C3b. C3a is a 77-amino acid peptide that includes a carboxy-terminal arginine which is crucial for its biological activities. C3a causes symptoms of immediate hypersensitivity (anaphylaxis) including smooth muscle contraction, mast cell histamine release, and local inflammation. It is considered an anaphylatoxin along with C4a, C5a, and C5a des-arginine. Anaphylatoxins (77-89); Complement (67-76); Complement 3 (75-89) IFjNComplement 3 Nephritic Factor D12.776.124.486.274.920.300; D24.611.125.308.300; D24.611.333.920.300 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Inactivators Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Inactivators A magnesium-dependent IgG autoantibody found in serum of patients with chronic mesangioproliferative hypocomplementemic glomerulonephritis. It causes inactivation of C3 in the alternate pathway by cleaving C3 into two inactive fragments, C3c and C3d, instead of the normal C3b. Blood Proteins (66-77); Complement 3 (75-77) J$MD@7Complement 3 Convertase D08.586.277.300.325; D12.776.124.486.274.860.325; D24.611.333.860.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Complement Activating Enzymes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Activating Enzymes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Activating Enzymes The enzyme which in both the classical and alternate complement pathways cleaves complement 3 into anaphylatoxin (C3a) and C3b. Complement 3 (75-77); Esterases (66-77); Peptide Peptidohydrolases (66-77)  :MFYComplement 3 D12.776.124.050.140; D12.776.124.486.274.250; D24.611.333.250 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement  Complement 3a; Complement 3b; Complement 3c; Complement 3d Complement 3a; Complement 3b; Complement 3c; Complement 3d The fourth component to attach in the complement reaction sequence; it is a beta globulin with a sedimentation coefficient of 5.5, a molecular weight of 185,000 and a serum concentration of 1.3 micrograms/ml. Its fragments have anaphylatoxic, chemotactic, and histaminic action and affect smooth muscle. Anaphylaxis (66-74); Chemotaxis (66-74); Complement (68-74); Immune Adherence Reaction (71-74); Neutrophils (66-74); Phagocytosis (66-74) AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $#ED[cFComplement 2 D12.776.124.486.274.150; D24.611.333.150 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement The third component in the complement reaction sequence; it is a beta globulin with a molecular weight of 117,000, a serum concentration of 30 micrograms/ml and a sedimentation coefficient of 4. It activates C3. Complement (68-74); Magnesium (66-74); Protein Binding (66-74) (.DLComplement 1s D08.586.277.300.290; D12.776.124.486.274.050.290; D12.776.124.486.274.860.290; D24.611.333.050.290; D24.611.333.860.290 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Complement Activating Enzymes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 1 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Activating Enzymes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 1 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Activating Enzymes The activated form of complement 1 which has hydrolase activity. In the classical pathway, it splits first C4 and then C2 into active components, thereby generating a new enzyme referred to as EAC142 or C42 or C3 convertase. Complement 1 (75-77); Esterases (66-77) +B 1Complement 1r D08.586.277.300.280; D12.776.124.486.274.050.280; D12.776.124.486.274.860.280; D24.611.333.050.280; D24.611.333.860.280 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Complement Activating Enzymes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 1 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Activating Enzymes Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 1 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Activating Enzymes Subcomponent of complement 1 which, when activated by C1q, activates subcomponent C1s by proteolytic cleavage. Complement Activating Enzymes (79-89); Complement 1 (79-89); Enzyme Precursors (79-82) 0pDgComplement 1q D12.776.124.486.274.050.270; D24.611.333.050.270 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement 1 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement 1 Subcomponent of complement 1 (C1) which recognizes and binds to the heavy chain of IgG or IgM initiating the classical complement pathway. The interaction of C1q and immunoglobulin activates C1r and C1s. The activated C1r and C1s molecules are cleaved off the complex by C1-inhibitor, allowing the collagen-like region of C1q to become accessible for interaction with cell membrane C1q receptors. Complement Activating Enzymes (79-89); Complement 1 (80-89) 5 6DGComplement 1 Inactivators D08.373.745.800.810.300; D12.776.124.486.274.920.250; D24.611.333.920.250 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Inactivators Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Inactivators Compounds which inhibit, antagonize, or inactivate complement 1. A well-known inhibitor is a serum glycoprotein believed to be alpha-2-neuroaminoglycoprotein. It inhibits the activated (esterase) form of complement 1 as well as kinin-forming, coagulation, and fibrinolytic systems. Deficiency of this inactivator has been found in patients with hereditary angioneurotic edema. These compounds are members of the serpin superfamily. Complement 1 (75-77); Enzyme Inhibitors (75-77); Enzymes (66-67) /antagonists and inhibitors (68-74); Glycoproteins (66-77) 8QBComplement 1 D12.776.124.486.274.050; D24.611.333.050 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement Complement 1q; Complement 1r; Complement 1s Complement 1q; Complement 1r; Complement 1s The first complement component to act in the cytolysis reaction. It is a trimolecular complex held together with Ca ions and when activated, has esterase activity which initiates the next step in the sequence. Calcium (66-74); Complement (68-74) ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $=.Bj,DComplement Pathway, Classical G04.610.255.698 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Complement Activation The sequential activation of complement, initiated by antigen-antibody complex and the binding of complement factor C1q to the Fc region of the antibody. Complement (66-78); Complement Fixation Tests (66-78) Aa#k@Complement Pathway, Alternative G04.610.255.695 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Complement Activation The complement activation sequence initiated by the activation of complement factor C3, which is triggered by the interaction of microbial polysaccharides and properdin without participation of an antigen-antibody reaction. Complement (66-78); Complement Fixation Tests (66-78) C+%k@Complement Membrane Attack Complex D12.776.124.486.274.930; D24.611.333.930 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cytotoxicity, Immunologic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement The assembly of complement plasma glycoproteins C5b, C6, C7, C8, and polymeric C9 as a group on biological membranes. The complex forms transmembrane channels which displace lipid molecules and other constituents, thus disrupting the phospholipid bilayer of target cells leading to cell lysis by osmotic leakage. The formation of the membrane attack complex is the terminal step in the complement cascade. Complement (73-89)  EC).DComplement Inactivators D12.776.124.486.274.920; D24.611.333.920 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement Complement 1 Inactivators; Complement 3 Nephritic Factor; Complement 3b Inactivators (+ 2) Complement 1 Inactivators; Complement 3 Nephritic Factor; Complement 3b Inactivators (+ 2) Serum proteins which act at key sites in the complement sequence to modulate or prevent the progression of the reaction. Absence of these factors leads to uncontrolled activation of the complement system with accompanying disease. Complement (68-77); specific complement/AI (75-77)  I.D=Complement Hemolytic Activity Assay E01.223.495.245.250; E01.223.495.826.250; E05.196.922.375; E05.478.245.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Cytotoxicity Tests, Immunologic Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Titrimetry Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Cytotoxicity Tests, Immunologic Usual screening assay for complement. Dilutions of the serum to be tested are added to antibody-coated erythrocytes and the percentage of lysis is measured. The values are expressed by CH50, hemolytic complement units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay. Complement/analysis (69-89) L*T"h!Complement Fixation Tests E01.223.495.826.208 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Conglutination Reaction; Wassermann Reaction Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. P"N4bComplement Factor I D08.586.277.656.732.760.210; D12.776.124.486.274.920.325.210; D24.611.333.920.325.210 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Inactivators; Complement 3b Inactivators Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Inactivators; Complement 3b Inactivators Serine proteinase that acts on iC3b (inactivated complement 3b) to cleave it into C3c and C3dg with the help of a trypsin-like proteolytic enzyme. Complement factor I was formerly called KAF, C3bINF, or enzyme 3b inactivator. EC 3.4.21.45. Peptide Peptidohydrolases (83-87); Serine Proteinases (88-92) S]DHComplement Factor H D12.776.124.486.274.920.325.200; D12.776.124.790.223.200; D12.776.377.715.182.200; D24.611.333.920.325.200 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement; Complement Inactivators; Complement 3b Inactivators Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Beta Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Beta Globulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement; Complement Inactivators; Complement 3b Inactivators A beta-globulin that binds to complement 3b and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also acts as an alternative pathway complement inhibitor by interfering with the binding of properdin factor B to C3b. Beta Globulins (78-79); Complement 3b Inactivators (80-92); Glycoproteins (78-79) X>tDV?aComplement Activation G04.610.255 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Complement Pathway, Alternative; Complement Pathway, Classical The sequential activation of serum components C1 through C9, initiated by an erythrocyte-antibody complex or by microbial polysaccharides and properdin, and producing an inflammatory response. Complement (66-78); Complement Fixation Tests (66-78)  ],QH@Complement Activating Enzymes D08.586.277.300; D12.776.124.486.274.860; D24.611.333.860 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Complement Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Complement Complement 1r; Complement 1s; Complement 3 Convertase; Properdin Factor D Complement 1r; Complement 1s; Complement 3 Convertase; Properdin Factor D Complement 1r; Complement 1s; Complement 3 Convertase; Properdin Factor D Enzymes present in the complement system which activate one or more components in the system. Complement (68-77); specific complement (75-77); Esterases (66-77); Hydrolases (66-77); Serum Globulins (70-77)  _D#AF=pComplement D12.776.124.486.274; D24.611.333 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Complement Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH) Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Complement 1 (+ 3); Complement 2; Complement 3 (+ 4); Complement 4 (+ 2); Complement 5 (+ 2); Complement 6; Complement 7; Complement 8; Complement 9; Complement Activating Enzymes (+ 4); Complement Inactivators (+ 5); Complement Membrane Attack Complex; Properdin Factor B Complement 1 (+ 3); Complement 2; Complement 3 (+ 4); Complement 4 (+ 2); Complement 5 (+ 2); Complement 6; Complement 7; Complement 8; Complement 9; Complement Activating Enzymes (+ 4); Complement Inactivators (+ 5); Complement Membrane Attack Complex; Properdin Factor B AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  cS&BHCompetitive Medical Plans N03.219.521.576.343.800.175; N04.590.374.410.175 CLECHILJOGSNSTTDUT Preferred Provider Organizations Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Managed Care Programs Health Services Administration (Non MeSH); Patient Care Management (Non MeSH); Delivery of Health Care; Managed Care Programs Alternative health care delivery mechanisms, such as PREFERRED PROVIDER ORGANIZATIONS or other health insurance services or prepaid plans (other than HEALTH MAINTENANCE ORGANIZATIONS), that meet Medicare qualifications for a risk-sharing contract. (From Facts on File Dictionary of Health Care Management, 1988). Health Maintenance Organizations (84-91)  g6&-h/Competitive Bidding N03.219.463.100.110 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management; Contract Services Pricing statements presented by more than one party for the purpose of securing a contract. Contract Services (78-85); Financial Management (78-85) k@qnBCompetitive Behavior F01.145.224 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior The direct struggle between individuals for environmental necessities or for a common goal. Behavior (66-67); Behavior, Animal (66-67); Motivation (66-67) l AlLCompetency-Based Education I02.158.210 CLECHILJMTOGSNSTTD Education; Curriculum Educational programs designed to ensure that students attain prespecified levels of competence in a given field or training activity. Emphasis is on achievement or specified objectives. n!Compartment Syndromes C05.651.180; C14.907.553.241 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nerve Compression Syndromes Musculoskeletal Diseases; Muscular Diseases Cardiovascular Diseases; Vascular Diseases; Ischemia Anterior Compartment Syndrome Anterior Compartment Syndrome Conditions in which increased pressure within a limited space compromises the circulation and function of tissue within that space. Compartmentation involves mainly the leg but also involved are the forearm, arm, thigh, shoulder, and buttock. Some of the causes of increased pressure are trauma, tight dressings, hemorrhage, and exercise. Sequelae include nerve compression, paralysis, and contracture. Anterior Compartment Syndrome (72-80); Ischemia (66-80); Muscles (66-80); Muscular Diseases (66-80) $o{"N!oDwCompact Disks L01.178.147.668.800.250; L01.178.147.898.800.250; L01.240.960.800.250; L01.700.568.080.260.115.475.600.325 CLECHILJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Optical Storage Devices; Videodisc Recording Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Television; Videodisc Recording Information Science; Copying Processes; Video Recording; Videodisc Recording Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers; Computer Peripherals; Computer Storage Devices; Optical Storage Devices CD-ROM CD-ROM CD-ROM Computer disks storing data with a maximum reduction of space and bandwidth. The compact size reduces cost of transmission and storage. sPt"Comovirus B04.715.464.150; B04.820.464.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses A group of plant viruses in which the bipartite genome is encapsidated in separate icosahedral particles. Transmission is mostly by leaf-feeding beetles though seed transmission occurs in some viruses. Mosaic Viruses (73-93); Plant Viruses (66-93) v &\8Comoros Z01.600.200 EHEP Geographicals (Non MeSH); Indian Ocean Islands The islands of Great Comoro, Anjouan, Mayotte, and Moheli lying between northeast Mozambique and northwest Madagascar. Africa, Eastern (83-92) x 9Comorbidity G03.850.490.687; N05.715.350.225 TD Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival. Diagnostic Related Groups (86-89); Length of Stay (86-89); specific disease/complications (77-89) z&tCommunity-Institutional Relations F01.829.674.210; N04.452.822.210 ECLJSTTD Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Public Relations Health Services Administration (Non MeSH); Organization and Administration; Public Relations The interactions between members of a community and representatives of the institutions within that community. }W&& Community-Acquired Infections C01.539.234 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Cross Infection Cross Infection Bacterial and Fungal Diseases (Non MeSH); Infection Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.  "P?Community Psychiatry F04.096.544.215; G02.403.642.150 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry Preventive Psychiatry (+ 1) Preventive Psychiatry Branch of psychiatry concerned with the provision and delivery of a coordinated program of mental health care to a specified population. The foci included in this concept are: all social, psychological and physical factors related to etiology, prevention, and maintaining positive mental health in the community. Psychiatry (66-70)  &:kCommunity Pharmacy Services N02.421.143.221; N02.421.668.274 CLECHILJMAOGSDSNSTTDUT Pharmacy Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Pharmaceutical Services Total pharmaceutical services provided to the public through community pharmacies. Pharmacies (66-67); Pharmacy (66-67)  !& `-Community Mental Health Services F04.408.307; N02.421.143.183; N02.421.461.232 CLECHILJMAMTOGSDSNSTTDUT Disciplines, Tests, Therapy, Services (Non MeSH); Mental Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Facilities, Manpower and Services (Non MeSH); Health Services; Mental Health Services Diagnostic, therapeutic and preventive mental health services provided for individuals in the community. Mental Health Services (66) s'5!y"Community Mental Health Centers N02.278.035.158 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities Child Guidance Clinics Facilities which administer the delivery of psychologic and psychiatric services to people living in a neighborhood or community. Community Mental Health Services (67-78) CLECHILJMAMTOGSDSNSTTDUT $&l0Community Medicine G02.403.220 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine A branch of medicine concerned with the total health of the individual within the home environment and in the community, and with the application of comprehensive care to the prevention and treatment of illness in the entire community. #Community Health Services N02.421.143 CLECHILJMAMTOGSDSNSTTDUT Social Work; Public Health Administration; Community Health Planning Facilities, Manpower and Services (Non MeSH); Health Services Child Health Services (+ 1); Community Health Nursing; Community Mental Health Services; Community Pharmacy Services; Consumer Participation (+ 1); Counseling (+ 1); Family Planning (+ 3); Foster Home Care; Home Care Services (+ 8); Hospices; Maternal Health Services (+ 3); Occupational Health Services; Preventive Health Services (+ 17) Diagnostic, therapeutic and preventive health services provided for individuals in the community. AECLCTECEDHIISLJMAMOMTNUOGPXRHSDSNSTTDUTVE $XQJq.Community Health Planning N03.349.650.185 CLECHILJMTOGSNSTTDUT Community Health Services Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning Planning that has the goals of improving health, improving accessibility to health services, and promoting efficiency in the provision of services and resources on a comprehensive basis for a whole community. (From Facts on File Dictionary of Health Care Management, 1988, p. 299). gJCommunity Health Nursing N02.421.143.150 CLECEDHIISLJMAMTOGSNSTTD Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services General and comprehensive nursing practice directed to individuals, families, or groups as it relates to and contributes to the health of a population. This is not an official program of a Public Health Department. iCommunity Health Centers N02.278.035.128 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities Substance Abuse Treatment Centers Facilities which administer the delivery of health care services to people living in a community or neighborhood. Community Health Services (66-74) CLECHILJMAMTOGSDSNSTTDUT $l((Community Health Aides M01.526.485.067.080; N02.360.067.080 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Persons trained to assist professional health personnel in communicating with residents in the community concerning needs and availability of health services. Community Health Services (66-70); Community Mental Health Services (67-70) *YCommunity Dentistry G02.163.876.770.357 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Dentistry; Specialties, Dental; Public Health Dentistry The practice of dentistry concerned with preventive as well as diagnostic and treatment programs in a circumscribed population. YCommunism I01.696.232 CLECHISNTD Social Sciences; Political Systems A totalitarian system of government in which a single authoritarian party controls state-owned means of production with the professed aim of establishing a classless society. l *Communicative Disorders C10.597.257; C23.888.592.257; F03.126.219 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Hearing Disorders (+ 4); Language Disorders (+ 8); Speech Disorders (+ 9); Voice Disorders (+ 2) Hearing Disorders (+ 4); Language Disorders (+ 8); Speech Disorders (+ 9); Voice Disorders (+ 2) Language Disorders (+ 10); Speech Disorders (+ 11); Voice Disorders (+ 1) Disorders characterized by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing. Hearing Disorders (66-84); Language Disorders (67-84); Speech Disorders (66-84) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $1FJ_NCommunications Media (Non MeSH) L01.178 Information Science Audio-Visual Aids (+ 20); Erotica; Mass Media; Publications (Non MeSH) (+ 58); Teaching Materials (+ 1); Telecommunications (+ 8) CLECEDHIISLJMAMTOGPXSDSNSTTDUT & "Communication Methods, Total E02.831.671.221 Therapeutics; Rehabilitation; Rehabilitation of Hearing Impaired (Non MeSH) Utilization of all available receptive and expressive modes for the purpose of achieving communication with the hearing impaired, such as gestures, postures, facial expression, types of voice, formal speech and non-speech systems, and simultaneous communication. Communication (66-79); Deafness (66) /rehabilitation (67-79) I"X-GCommunication Barriers F01.145.209.213; L01.143.230 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Information Science; Communication Those factors, such as language or sociocultural relationships, which interfere in the meaningful interpretation and transmission of ideas between individuals or groups. Communication (66-78) m"yCommunication Aids for Disabled E07.796.250 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Self-Help Devices Equipment that provides mentally or physically disabled persons, who cannot speak effectively, with a means of communication. The aids include display boards, typewriters, cathode ray tubes, computers, and speech synthesizers. The output of such aids includes written words, artificial speech, language signs, Morse code, and pictures. Communication (66-79); Nonverbal Communication (70-79) #&2@Communication F01.145.209; L01.143 HI Behavior and Behavior Mechanisms (Non MeSH); Behavior Information Science Animal Communication (+ 2); Communication Barriers; Confidentiality; Language; Negotiating; Nonverbal Communication (+ 9); Persuasive Communication (+ 1); Propaganda; Truth Disclosure; Verbal Behavior (+ 2) Advertising; Communication Barriers; Cybernetics (+ 1); Diffusion of Innovation (+ 1); Hotlines; Language (+ 21); Negotiating; Nonverbal Communication (+ 2); Persuasive Communication; Propaganda; Reminder Systems The exchange or transmission of ideas, attitudes, or beliefs between individuals or groups. CLDEECEDHIISLJMAMTOGPHPXRESDSNSTTDUT  Wl(Communicable Diseases C01.539.221 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPPPSPXRARHRIRTSUTHTMURUSVEVI Disease Reservoirs Disease Outbreaks; Disease Transmission Bacterial and Fungal Diseases (Non MeSH); Infection N/?Communicable Disease Control G03.850.780.200 ECHIISLJMTOGSNSTTD Disease Reservoirs; Disease Vectors; Infection Control Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH) Contact Tracing; Disease Notification; Fumigation; Handwashing; Immunization (+ 1); Infection Control (+ 6); Mandatory Testing; Pest Control (+ 5); Sanitation (+ 7); Universal Precautions Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $"Am*Commonwealth of Independent States Z01.586.200 EHEP Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Armenia; Azerbaijan; Byelarus; Georgia (Republic); Kazakhstan; Kyrgyzstan; Moldova; Russia (+ 4); Tajikistan; Turkmenistan; Ukraine; Uzbekistan specific Soviet republic (75-92); USSR (75-92) )I9Common Variable Immunodeficiency C20.673.330 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases; Immunologic Deficiency Syndromes Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections. Immunologic Deficiency Syndromes (75-92) S&N?/Common Cold C02.782.687.207; C08.730.162 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections Respiratory Tract Diseases; Respiratory Tract Infections A catarrhal disorder of the upper respiratory tract, which may be viral, a mixed infection, or an allergic reaction. It is marked by acute coryza, slight rise in temperature, chilly sensations, and general indisposition. (Dorland, 27th ed). ;"PCommon Bile Duct Neoplasms C04.588.274.120.250.250; C06.130.120.120.280; C06.130.120.250.280; C06.130.320.120.280; C06.240.120.250.280 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Biliary Tract Neoplasms; Bile Duct Neoplasms Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases; Bile Duct Neoplasms Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases; Common Bile Duct Diseases Digestive System Diseases; Biliary Tract Diseases; Biliary Tract Neoplasms; Bile Duct Neoplasms Digestive System Diseases; Digestive System Neoplasms; Biliary Tract Neoplasms; Bile Duct Neoplasms Neoplasms of the common bile duct including Vater's ampulla and Oddi's sphincter. Bile Duct Neoplasms (66-79); Common Bile Duct (66-79) !wXEaBCommon Bile Duct Diseases C06.130.120.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases Choledochal Cyst; Common Bile Duct Calculi; Common Bile Duct Neoplasms Diseases of the common bile duct, Vater's ampulla, or Oddi's sphincter. Biliary Tract Diseases (66-79); Common Bile Duct (66-79); specific biliary tract disease (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $ NSUVtXCommon Bile Duct Calculi C06.130.120.250.250; C06.130.409.357; C23.146.315.365 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases; Common Bile Duct Diseases Digestive System Diseases; Biliary Tract Diseases; Cholelithiasis Symptoms and General Pathology (Non MeSH); Calculi; Cholelithiasis The presence of gallstones in the common bile duct. It is usually the result of passage of gallstones formed in the gallbladder into the common duct. Less commonly, stones form in a duct behind an obstruction caused by a stricture or ampullary stenosis. Stone type helps to determine site of origin: cholesterol or black pigment stones more likely form in the gallbladder, while almost all brown pigment stones in patients from Western countries form in the bile ducts. (From Cecil Textbook of Medicine, 19th ed). =R _Common Bile Duct A03.159.183.079.300 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Choledochostomy Digestive System; Biliary Tract; Bile Ducts; Bile Ducts, Extrahepatic Vater's Ampulla (+ 1) The extrahepatic bile duct formed by the junction of the hepatic and cystic ducts. It is part of the excretory apparatus of the liver. (From Dorland, 27th ed). consider also terms at CHOLEDOCH-.  J:TCommitment of Mentally Ill F04.096.544.335.200; N03.706.535.351.200 ECHILJSNSTTD Patient Advocacy Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry; Forensic Psychiatry Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence; Forensic Psychiatry Legal process required for the institutionalization of a patient with severe mental problems. J!.nCommission on Professional and Hospital Activities N04.761.380.100; N05.700.500.200 CLECHILJOGSNSTTDUT Health Services Administration (Non MeSH); Quality of Health Care; Medical Audit Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Medical Audit The non-profit, non-governmental organization which collects, processes, and distributes data on hospital use. Two programs of the Commission are the Professional Activity Study and the Medical Audit Program. C;&Commerce J01.219 CLECEDHIISLJMAMTOGSNSTTD Antitrust Laws; Economic Competition; Industry Industry Technology, Industry, Agriculture (Non MeSH) Entrepreneurship CLECEDHIISLJMAMTOGSNSTTDUT $ē  8 4Combined Modality Therapy E02.186 AECLCTECHIISMOMTNUPXSNSTTDUTVE Antineoplastic Agents, Combined Therapeutics Chemotherapy, Adjuvant; Electroacupuncture; Photochemotherapy; Radioimmunotherapy; Radiotherapy, Adjuvant; Salvage Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Drug Therapy, Combination (74-83) $ş "%H(Combat Disorders F03.709.438.180.680.110 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI War Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders; Stress Disorders, Post-Traumatic Neurotic reactions to unusual, severe, or overwhelming military stress. JFTComb and Wattles A13.242 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Poultry (66-67)  :Coma C10.597.917.273; C23.888.592.925.273 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Persistent Vegetative State Nervous System Diseases; Neurologic Manifestations; Unconsciousness Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Unconsciousness A profound state of unconsciousness. It includes "stupor" from which the patient can be partially roused, as well as complete unconsciousness in which there is no response to sensory stimuli, even at the reflex level. ʎ*N!Columbia SK Virus B04.820.565.170.150; B04.909.777.618.170.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae; Cardiovirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae; Cardiovirus A species of CARDIOVIRUS that infects rodents. Encephalomyocarditis Virus (79-93) -29(Colubridae B02.833.672.280 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes The largest family of snakes, comprising five subfamilies: Colubrinae, Natricinae, Homalopsinae, Lycodontinae, and Xenodontinae. They show a great diversity of eating habits, some eating almost anything, others having a specialized diet. They can be oviparous, ovoviviparous, or viviparous. The majority of North American snakes are colubrines. Among the colubrids are king snakes, water moccasins, water snakes, and garter snakes. Some genera are poisonous. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed). Snakes (68-93) η&%XColtivirus B04.820.630.160; B04.909.777.714.160 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae Colorado Tick Fever Virus Colorado Tick Fever Virus A genus of REOVIRIDAE infecting Ixodidae ticks and transmitted by them to humans, deer, and small animals. The type species is COLORADO TICK FEVER VIRUS. ѵ*u>Colposcopy E01.249.169; E01.418.221 AECLCTECHIISMOMTNUPXSNSTTDUTVE Vagina; Cervix Uteri Diagnosis; Diagnosis, Ob-Gyn (Non MeSH) Diagnosis; Endoscopy Ӝ"HColostrum A12.838.194 CHCYDEENIMMEMIPHPSRARERISEUSVI Lactation Fluids and Secretions (Non MeSH); Secretions (Non MeSH) p " DColostomy E04.765.338.225; E04.579.338.225 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Colon Surgery, Operative; Surgery, Digestive System (Non MeSH); Enterostomy Surgery, Operative; Ostomy; Enterostomy " &$ Colorimetry E05.196.922.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Titrimetry Any technique by which an unknown color is evaluated in terms of standard colors. The technique may be visual, photoelectric, or indirect by means of spectrophotometry. It is used in chemistry and physics. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). &"SCColorectal Neoplasms, Hereditary Nonpolyposis C04.588.274.476.411.306.416.250; C04.700.250; C06.240.476.411.306.416.250; C06.405.282.411.306.416.250; C06.405.469.158.355.416.250; C06.405.469.505.306.416.250; C16.466.700.250 BLBSCFCHCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms; Colorectal Neoplasms Neoplasms; Neoplastic Syndromes, Hereditary Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms; Colorectal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms; Colorectal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colonic Neoplasms; Colorectal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Colonic Neoplasms; Colorectal Neoplasms Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary A syndrome characterized by autosomal dominant inheritance, a low mean age (41 years) for occurrence of colon cancer, and a marked increase in the proportion of tumors in the proximal colon. #4VColorectal Neoplasms C04.588.274.476.411.306.416; C06.240.476.411.306.416; C06.405.282.411.306.416; C06.405.469.158.355.416; C06.405.469.505.306.416 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Genes, DCC; Genes, MCC Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Colonic Neoplasms Colorectal Neoplasms, Hereditary Nonpolyposis Colorectal Neoplasms, Hereditary Nonpolyposis Colorectal Neoplasms, Hereditary Nonpolyposis Colorectal Neoplasms, Hereditary Nonpolyposis Colorectal Neoplasms, Hereditary Nonpolyposis Cancer of the colon and rectum. The most frequent malignant tumor in the United States. Etiological factors which increase the risk of colorectal cancer include chronic ulcerative colitis, familial polyposis of the colon, exposure to asbestos, irradiation of the cervix. Colonic Neoplasms (66-88); Rectal Neoplasms (66-88) $HX<>Colorado Tick Fever Virus B04.820.630.160.200; B04.909.777.714.160.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae; Coltivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae; Coltivirus A species of REOVIRUS transmitted by the tick Dermacentor andersonii and causing fever, chills, aching head and limbs, and often vomiting. It occurs in the northwestern United States, except the Pacific Coast.  2Colorado Tick Fever C02.081.885.200; C02.782.791.482 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; RNA Virus Infections (Non MeSH); Reoviridae Infections A febrile illness characterized by chills, aches, vomiting, leukopenia, and sometimes encephalitis. It is caused by the COLORADO TICK FEVER VIRUS, a reovirus transmitted by the tick Dermacentor andersoni. &PColorado Z01.107.567.875.100.166; Z01.107.567.875.600.822.166 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States   :Color Vision Defects C10.597.751.941.256; C11.966.256; C23.888.592.763.941.256 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Color Perception Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Eye Diseases; Vision Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders Mild to severe impairment in the ability to discriminate or differentiate hues. This disorder may be acquired as a result of diseases of the cones or X chromosome-linked where there is an abnormality but not a complete absence of one of the cone pigments. AN.0Color Therapy E02.040.215; E02.780.750.215; F04.754.215 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Alternative Medicine Therapeutics; Physical Therapy; Phototherapy Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion. Color (72-91); Phototherapy (72-91) 1"(,Color Perception Tests E01.210.935.231 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Eye (Non MeSH); Vision Tests ]"?Color Perception F02.463.593.932.217; G11.697.911.860.231 CLDEGEPHRE Color Vision Defects Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception The visual awareness of any particular hue or achromatic color.  .MColor H01.671.606.217 ST Physical Sciences (Non MeSH); Physics; Optics  9Colony-Stimulating Factors D12.776.395.240; D24.185.348.453.240; D24.611.350.400.442.240 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Colony-Stimulating Factor Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances; Hematopoietic Cell Growth Factors Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines; Growth Substances; Hematopoietic Cell Growth Factors Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-3; Macrophage Colony-Stimulating Factor Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-3; Macrophage Colony-Stimulating Factor Erythropoietin; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-3; Macrophage Colony-Stimulating Factor Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3 (IL-3), GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF), MACROPHAGE COLONY-STIMULATING FACTOR (M-CSF), and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF). Bone Marrow (66-75); Cell Division (66-75); Clone Cells (68-75); Glycoproteins (66-75) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (UEF*jHColony-Forming Units Assay E05.909.262.383 AECLCTECHIISMOMTNUPXSNSTTDUTVE Hematopoietic Stem Cells Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Tumor Stem Cell Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Bone Marrow (66-78); Erythropoiesis (66-78); Hematopoiesis (66-78); Hematopoietic Stem Cells (71-78); Spleen (66-78) $j "^xColony Count, Microbial E05.909.560.220 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques Enumeration by direct count of viable, isolated bacterial or fungal cells or spores capable of growth on solid culture media. Each colony (i.e., microbial colony-forming unit) represents the progeny of a single cell in the original inoculum. The method is used routinely by environmental microbiologists for quantifying organisms in air, food, and water; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing. Bacteriological Techniques (67-88); Microbiological Techniques (78-88) "bQColonoscopy E01.184.340.350.230; E01.418.340.350.230 AECLCTECHIISMOMTNUPXSNSTTDUTVE Colon Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System; Endoscopy, Gastrointestinal Diagnosis; Endoscopy; Endoscopy, Digestive System; Endoscopy, Gastrointestinal Sigmoidoscopy Sigmoidoscopy Examination of the luminal surface of the colon with a colonoscope (endoscope). It is used to localize, identify, and photograph pathologic alterations, to obtain biopsy material, and to perform other surgical interventions. Colonic Diseases (66-80); Colonic Neoplasms (66-80); Endoscopy (66-80) $."  UColonic Pseudo-Obstruction C06.405.469.158.272.217; C06.405.469.531.560.217 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colonic Diseases, Functional Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Obstruction; Intestinal Pseudo-Obstruction Functional obstruction of the colon. Colonic Diseases (66-86); Intestinal Obstruction (66-86); Intestinal Pseudo-Obstruction, Idiopathic (81-86) 6N-|Colonic Polyps C04.588.274.476.411.306.360; C04.588.274.476.411.510.235; C04.799.411.235; C06.240.476.411.306.360; C06.240.476.411.510.360; C06.405.282.411.306.360; C06.405.282.411.510.360; C06.405.469.158.355.360; C06.405.469.505.306.360; C06.405.469.505.510.360; C06.405.469.583.360 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps Neoplasms; Polyps; Intestinal Polyps Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Colonic Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Intestinal Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Polyps Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Adenomatous Polyposis Coli Colonic Neoplasms (66-83); Intestinal Polyps (68-83) 1%X|L?Colonic Neoplasms C04.588.274.476.411.306; C06.240.476.411.306; C06.405.282.411.306; C06.405.469.158.355; C06.405.469.505.306 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms Colonic Polyps (+ 1); Colorectal Neoplasms (+ 1); Sigmoid Neoplasms Colonic Polyps (+ 1); Colorectal Neoplasms (+ 1); Sigmoid Neoplasms Colonic Polyps (+ 1); Colorectal Neoplasms (+ 1); Sigmoid Neoplasms Colonic Polyps (+ 1); Colorectal Neoplasms (+ 1); Sigmoid Neoplasms Colonic Polyps (+ 1); Colorectal Neoplasms (+ 1); Sigmoid Neoplasms  wXFColonic Diseases, Functional C06.405.469.158.272 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Colonic Pseudo-Obstruction "NjColonic Diseases C06.405.469.158 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Colitis (+ 6); Colonic Diseases, Functional (+ 1); Colonic Neoplasms (+ 5); Diverticulitis, Colonic; Diverticulosis, Colonic; Megacolon (+ 2); Sigmoid Diseases (+ 2) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  NUZColonialism I01.696.116 CLHI Social Sciences; Political Systems The aggregate of various economic, political, and social policies by which an imperial power maintains or extends its control over other areas or peoples. It includes the practice of or belief in acquiring and retaining colonies. The emphasis is less on its identity as an ideological political system than on its designation in a period of history. (Webster, 3d ed; from Dr. J. Cassedy, NLM History of Medicine Division). !*Colon and Rectal Surgery (Specialty) G02.403.810.208 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Surgical A surgical specialty concerned with the diagnosis and treatment of disorders and abnormalities of the colon, rectum, and anal canal; replaced the Board of Proctology. ,=Colon A03.492.411.495.356 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Colectomy; Colonoscopy; Colostomy Digestive System; Gastrointestinal System; Intestines; Intestine, Large Sigmoid  :)T Colombia Z01.107.757.284 EHEP Geographicals (Non MeSH); America; South America  <Colobus B02.649.801.400.130.150.150 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Colobinae A genus of Old World monkeys, subfamily COLOBINAE, family CERCOPITHECIDAE, that inhabits the forests of Africa. It consists of eight species: C. angolensis (Angolan colobus), C. badius or C. rufomitratus (Red or Bay colobus), C. guereza (Guereza or Eastern black-and-white colobus), C. kirkii (Kirk's colobus), C. polykomos (King colobus or Western black-and-white colobus), C. satanas (Black colobus), and C. verus (Olive colobus). Some authors recognize Procolobus as a separate genus and then the olive colobus is recognized as the species P. verus.  (TColoboma C11.250.110; C16.131.384.282 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Congenital anomaly in which some of the structures of the eye are absent due to incomplete fusion of the fetal intraocular fissure during gestation.  "LColobinae B02.649.801.400.130.150 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae Colobus A subfamily of the Old World monkeys, CERCOPITHECIDAE, that inhabits the forests of Africa and Asia. The genera COLOBUS (Procolobus; colobus), Nasalis (proboscis monkey), Presbytis (Semnopithecus; leaf monkey), Pygathrix (Rhinopithecus; snub-nosed monkey), and Simias (pig-tailed langur) all belong to this subfamily.   (G rColloids D26.394.225.220; H01.181.529.183 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Aerosols (+ 1); Emulsions (+ 1); Gels; Suspensions Micelles Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other. " &,LcCollodion D25.720.157.439; D26.698.256 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Polymers; Cellulose Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids % ",Colles' Fracture C21.866.405.638.356 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Fractures; Radius Fractures Fracture of the lower end of the radius in which the lower fragment is displaced posteriorly. &NsqCollege Admission Test I02.399.272 HISN Education; Educational Measurement Test designed to identify students suitable for admission into a graduate or undergraduate curriculum. (G)xCollective Bargaining N03.540.571.356; N04.452.677.356 CLECHILJMTOGSNSTTDUT Labor Unions; Negotiating Economics, Organizations, Control (Non MeSH); Organizations; Labor Unions Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The process of negotiation between representatives of an employee organization, association or union, and representatives of the employer. Labor Unions (66-70)  )>& Collateral Ligaments A02.513.514.162; A02.835.583.512.162 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Ligaments; Ligaments, Articular Musculoskeletal System; Skeleton; Joints; Ligaments, Articular Lateral Ligament, Ankle; Medial Collateral Ligament, Knee Lateral Ligament, Ankle; Medial Collateral Ligament, Knee A number of ligaments on either side of, and serving as a radius of movement of, a joint having a hingelike movement. They occur at the elbow, knee, wrist, metacarpo- and metatarsophalangeal, proximal interphalangeal, and distal interphalangeal joints of the hands and feet. (Stedman, 25th ed). Ligaments (66-93); Ligaments, Articular (68-93)  +`*:[9Collateral Circulation G09.330.163.248 DEGEIMPHRE Angiogenesis Factor; Neovascularization Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation Compensatory circulation developed in secondary vessels following obstruction of a main blood vessel. ..vCollapse Therapy E04.920.800.250 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Tuberculosis, Pulmonary Surgery, Operative; Thoracic Surgery; Surgery, Lung (Non MeSH) Pneumothorax, Artificial 03$KCollagenases D08.586.277.656.732.480.205 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Metalloproteinases Microbial Collagenase Enzymes that catalyze the degradation of collagen by acting on the peptide bonds. EC 3.4.24.-. Clostridium histolyticum Collagenase (75-92)  1*Fr3Collagen Diseases C17.300.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antibodies, Antinuclear; Connective Tissue Diseases; Rheumatology Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Ehlers-Danlos Syndrome; Keloid (+ 1); Mucopolysaccharidosis I; Necrobiotic Disorders (+ 2); Osteogenesis Imperfecta Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed).  3'NLYCollagen D12.776.860.300.250 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Connective Tissue Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Scleroproteins (Non MeSH); Extracellular Matrix Proteins Procollagen; Tropocollagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of skin, connective tissue, and the organic substance of bones and teeth. Different forms of collagen are produced in the body but all consist of three alpha-polypeptide chains arranged in a triple helix. Collagen is differentiated from other fibrous proteins, such as elastin, by the content of proline, hydroxyproline, and hydroxylysine; by the absence of tryptophan; and particularly by the high content of polar groups which are responsible for its swelling properties.  8  H Colitis, Ulcerative C06.405.469.158.188.231; C06.405.469.440.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colitis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Inflammatory Bowel Diseases Megacolon, Toxic Inflammatory disease of unknown cause which involves the mucosa of the colon. Onset may be acute and fulminant, and its course often continues chronically in an intermittent or continuous form. Diarrhea is a common symptom and bleeding an almost constant concomitant symptom. <2NCColitis, Ischemic C06.405.469.158.188.115; C14.907.553.180 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colitis Cardiovascular Diseases; Vascular Diseases; Ischemia Acute vascular insufficiency of the colon usually involving the portion supplied by the inferior mesenteric artery. The symptoms include pain at the iliac fossa, bloody diarrhea, low-grade fever, abdominal distention, and abdominal tenderness. The classic radiologic sign is thumbprinting due to localized elevation of the mucosa by submucosal hemorrhage or edema. Ulceration may follow. (Dorland, 27th ed). Colitis (67-92); Ischemia (67-92) ?.N*Colitis C06.405.469.158.188 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases Colitis, Ischemic; Colitis, Ulcerative (+ 1); Enterocolitis (+ 1); Proctocolitis Inflammation of the colon. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  B Njb;PColistin D20.085.116.700.150 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Polymyxin Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally. Dt <O:Coliphages B04.123.205 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Bacteriophage lambda; Bacteriophage M13; Bacteriophage mu; Bacteriophage P1; Bacteriophage P2; Bacteriophage phi X 174; Leviviridae (+ 2); T-Phages (+ 3) Viruses whose host is Escherichia coli. F1Colipases D12.776.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Colipase I and II, consisting of 94-95 and 84-85 amino acid residues, respectively, have been isolated from porcine pancreas. Their role is to prevent the inhibitory effect of bile salts on the lipase-catalyzed intraduodenal hydrolysis of dietary long-chain triglycerides. Lipase (74-75); Proteins (74-75) G FD<)Colinus B02.248.801.300 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Quail A genus of birds (family Phasianidae) consisting of the bobwhites. J &!PColicins D12.776.097.200; D20.085.133.230; D24.310.125.230 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Anti-Infective Agents; Antibiotics; Bacteriocins Immunologic and Biologic Factors (Non MeSH); Biological Products; Bacteriocins Bacteriocins elaborated by strains of Escherichia coli and related species. They are proteins or protein-lipopolysaccharide complexes lethal to other strains of the same species. J 9BColicin Factors D13.444.308.212.500.200; D13.444.308.283.500.200 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Bacterial; Plasmids Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; DNA; DNA, Circular; Plasmids Plasmids determining the potentiality of a bacterium to produce colicins. They are cytoplasmic elements whose integration into the bacterial chromosome has not been demonstrated except for the Col B and Col V factors. Colicins (66-77); Extrachromosomal Inheritance (68-77); Plasmids (75-77) MW6DVColic C23.888.592.612.050.216; C23.888.592.612.216 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Abdominal Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Abdominal Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Paroxysms of pain. This condition usually occurs in the abdominal region but may occur in other body regions as well. PP 2NColestipol D02.092.782.200; D10.162.290; D25.720.200; D26.572.133.401 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Polyamines Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents Biomedical and Dental Materials (Non MeSH); Polymers Miscellaneous Drugs and Agents (Non MeSH); Ion Exchange Resins; Anion Exchange Resins Tetraethylene pentamine polymer with 1-chloro-2,3-epoxypropane. Highly crosslinked and insoluble basic anion exchange resin used as anticholesteremic; also may reduce triglyceride levels. Synonyms: Colestid; U 26,597A. Ethers, Cyclic (72-74); Polyamines (72-74); Polymers (71-74) RD,&JColeoptera B01.131.617.155 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects Beetles (+ 2) The largest order of insects, comprising the beetles and weevils. Insects (66-74)  U(*OColectomy E04.765.219 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Colon Surgery, Operative; Surgery, Digestive System (Non MeSH) Proctocolectomy, Restorative V $ C!Cold Climate G03.230.300.100.250.275 AE Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Climate WuCold G03.230.300.100.725.710.300; H01.671.868.272 AEDU Cryopreservation; Cryosurgery; Cryotherapy; Frostbite; Hypothermia; Hypothermia, Induced; Immersion Foot; Refrigeration; Shivering Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather; Temperature Physical Sciences (Non MeSH); Physics; Temperature  Freezing An absence of warmth or heat or a temperature notably below an accustomed norm. consider also terms at CRYO-.  Xn2 Colchicum B06.560.224 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A genus of poisonous, liliaceous plants. The roots (corms)of Colchicum autumnale, the fall crocus or meadow saffron, yield COLCHICINE, which is used as a biochemical tool and to treat gout. Other members of this genus yield saffron dye, flavoring agents, and aromatics. Z & >Colchicine D03.132.225; D17.050.337.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants Demecolcine; Lumicolchicines N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide. A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). \":#rCoke G03.230.132.258.108.110; J01.435.229.355 AEANCLECHIPORESDSNSTTOUT Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Fossil Fuels; Coal Technology, Industry, Agriculture (Non MeSH); Fossil Fuels; Coal A residue of coal, left after dry (destructive) distillation, used as a fuel. _e.^Coitus Interruptus E02.197.250; F01.145.792.188.300 PX Therapeutics; Contraception Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior; Coitus A contraceptive method whereby coitus is purposely interrupted in order to prevent ejaculation of semen into the vagina. Contraception (66-74); Coitus (66-74) `&{.Coitus F01.145.792.188; G08.520.900.100 PHPX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Sex Coitus Interruptus Sexual intercourse. b &Coin Lesion, Pulmonary C04.588.894.797.520.240; C08.381.540.150; C08.785.520.150 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms; Lung Neoplasms Respiratory Tract Diseases; Lung Diseases; Lung Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms; Lung Neoplasms Solitary, round, circumscribed shadows found in the lungs in x-ray examinations. Common causes are tuberculosis, neoplasms, cysts, or vascular anomalies. (Stedman, 25th ed). cAXCohort Studies E05.318.760.500.750; G03.850.520.835.500.750; N05.715.360.775.175.250 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Longitudinal Studies (+ 2) Follow-Up Studies; Longitudinal Studies; Prospective Studies Follow-Up Studies; Longitudinal Studies; Prospective Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Epidemiologic Methods (71-88); Follow-Up Studies (66-88); Prospective Studies (66-88) fM0eCohort Effect G03.850.490.734.500; N05.715.350.350.225 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Effect Modifiers (Epidemiology) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Effect Modifiers (Epidemiology) Variation in health status arising from different causal factors to which each birth cohort in a population is exposed as environment and society change. k. Cognitive Therapy F04.754.137.428 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Behavior Therapy A direct form of psychotherapy based on the interpretation of situations (cognitive structure of experiences) that determine how an individual feels and behaves. It is based on the premise that cognition, the process of acquiring knowledge and forming beliefs, is a primary determinant of mood and behavior. The therapy uses behavioral and verbal techniques to identify and correct negative thinking that is at the root of the aberrant behavior. Behavior Therapy (67-89); Cognition (67-89) n`5Cognitive Dissonance F02.463.188.305 Motivation Psychologic Processes and Principles (Non MeSH); Mental Processes; Cognition Motivational state produced by inconsistencies between simultaneously held cognitions or between a cognition and behavior; e.g., smoking enjoyment and believing smoking is harmful are dissonant. Cognition (66-68); Motivation (66-68) q [.Cognition Disorders F03.126.185 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Confusion; Consciousness Disorders; Delirium; Delusions (+ 1); Learning Disorders; Memory Disorders (+ 3); Overinclusion; Perceptual Disorders (+ 6); Response Interference Disturbances in the mental process related to thinking, reasoning, and judgment. Cognition (66-68); specific disorder BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $rFY_-TCognition F02.463.188 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes Awareness; Cognitive Dissonance; Consciousness; Imagination (+ 2) Intellectual or mental process whereby an organism becomes aware of or obtains knowledge. CLDEPHPXRE  uu  NNjCoformycin D08.373.300; D13.570.685.350.200; D13.570.800.410.200; D20.085.075.480.200; D22.204.106.450.154; D22.569.450 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Formycins Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Formycins Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Formycins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Formycins Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Pentostatin Pentostatin Pentostatin Pentostatin Pentostatin 3-(beta-D-Ribofuranosyl)-6,7,8-trihydroimidazo(4,5-d)(1,3)diazepin-8(R)-ol. A ribonucleoside antibiotic synergist and adenosine deaminase inhibitor isolated from Nocardia interforma and Streptomyces kaniharaensis. It is proposed as an antineoplastic synergist and immunosuppressant. Azepines (66-78); Nucleosides (66-70); Ribonucleosides (71-78)  vz<TD@KCoffee B06.510.308; J01.125.318 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Caffeine; Chicory Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Beverages Rubiaceous trees or shrubs, Coffea arabica and C. robusta, that yield CAFFEINE and THEOPHYLLINE. { 4]rCoercion F01.145.209.631.210; I01.880.630.200 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Persuasive Communication Social Sciences; Sociology; Social Control, Informal The process of compelling a person to act, or refrain from acting, contrary to his free choice often by use of threat of physical or moral force. }W *Coenzymes D08.176 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH) Biopterin; Biotin; Cobamides; Coenzyme A (+ 4); FAD; FMN; NAD; NADP; Pyridoxal Phosphate; Tetrahydrofolates (+ 1); Thiamine Pyrophosphate; Thioctic Acid; Ubiquinone AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR   F9HCoenzyme A-Transferases D08.586.913.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Enzymes which transfer coenzyme A moieties from acyl- or acetyl-CoA to various carboxylic acceptors forming a thiol ester. Enzymes in this group are instrumental in ketone body metabolism and utilization of acetoacetate in mitochondria. EC 2.8.3. Sulfurtransferases (72-88); Transferases (66-71) FU 9Coenzyme A Synthetases D08.586.464.271 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases Acetate-CoA Ligase; Succinyl Coenzyme A Synthetases Ligases (66-72) "FP=Coenzyme A D08.176.211; D13.695.667.138.382; D13.695.827.068.382 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides Acyl Coenzyme A (+ 3) Acetyl Coenzyme A; Acyl Coenzyme A (+ 2) Acetyl Coenzyme A; Acyl Coenzyme A (+ 2) _=F=Codon, Terminator D13.444.735.544.355.250 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Peptide Chain Termination; Translation, Genetic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Messenger; Codon Any codon that signals the termination of genetic translation (TRANSLATION, GENETIC) by triggering the hydrolysis of the aminoacyl bond connecting the completed polypeptide to the tRNA. Terminator codons (UAA, UAG, and UGA) do not specify amino acids. Codon (75-94); Genetic Code (67-74)  D8v%-Codon, Nonsense D13.444.735.544.355.235 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Messenger; Codon A codon that is not assigned to an amino acid or to any stop signal. It was originally thought that nonsense codons were synonymous with terminator codons (CODON, TERMINATOR) in that they signaled termination of a protein chain. Recent studies have found this not to be true. Codon (75-94); Genetic Code (66-74) rDvH-Codon, Initiator D13.444.735.544.355.225 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Peptide Chain Initiation; Translation, Genetic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Messenger; Codon Any codon that directs initiation of genetic translation (TRANSLATION, GENETIC) by stimulating the binding of initiator tRNA. In prokaryotes, the codons AUG or GUG can act as initiators while in eukaryotes, AUG is the only initiator codon. Codon (75-94)  D7vCodon D13.444.735.544.355 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Messenger Codon, Initiator; Codon, Nonsense; Codon, Terminator A set of three nucleotides in DNA or RNA that codes for a specific amino acid. The term is also used for the corresponding (and complementary) sequences of three nucleotides in messenger RNA into which the original DNA sequence is transcribed. n Dm?!Codeine D03.132.610.422.547.547.149; D03.549.686.575.547.204; D03.605.497.575.547.204; D15.040.150.097; D15.153.130; D15.210.600.165 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans; Morphine; Morphine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans; Morphine; Morphine Derivatives Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Antitussive Agents Central Nervous System Agents; Central Nervous System Depressants; Narcotics Hydrocodone; Oxycodone Hydrocodone; Oxycodone Hydrocodone; Oxycodone An opioid analgesic related to MORPHINE but with less potent analgesic properties and mild sedative effects. It also acts centrally to suppress cough.  :@SCod Liver Oil D10.516.212.302.380.360; D10.516.212.507.325; D10.516.627.430.354; J01.740.250.200; J01.740.350.300 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Fish Oils Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated Technology, Industry, Agriculture (Non MeSH); Oils; Fish Oils o@Coconut B06.510.645.271; J01.341.739.271 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Nuts Technology, Industry, Agriculture (Non MeSH); Food; Nuts A tropical palm tree, Cocos nucifera, that yields large, edible nuts from which oil and fiber are also obtained.  &4hCockroaches B01.131.617.678.108 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Orthoptera Periplaneta Insects of the family Blattidae, order ORTHOPTERA. The most common cockroaches are Periplaneta americana, the American cockroach; Blatta orientalis, the oriental cockroach; and Blatella germanica, the European cockroach. Insects (66-71)  (8Cockayne Syndrome C05.116.099.343.250; C16.131.077.250; C19.297.238; F03.709.346.120 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dwarfism Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Endocrine Diseases; Dwarfism Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation An inherited disorder characterized by disproportionate dwarfism and premature senility, often accompanied by mental deficiency, photosensitivity, retinal degeneration, optic atrophy, cataracts, and partial deafness. Dwarfism (66-80); Photosensitivity Disorders (66-80) LL?>Cochlear Nucleus A08.186.211.132.810.450.135 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Brain Stem; Rhombencephalon; Pons The brain stem nucleus that receives the central input from the cochlear nerve. The cochlear nucleus is located lateral and dorsolateral to the inferior cerebellar peduncles and is functionally divided into dorsal and ventral parts. It is tonotopically organized, performs the first stage of central auditory processing, and projects (directly or indirectly) to higher auditory areas including the superior olivary nuclei, the medial geniculi, the inferior colliculi, and the auditory cortex. Brain Stem (66-93) 18b9Cochlear Nerve A08.800.800.120.090.120 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Acoustic Nerve Spiral Ganglion The cochlear part of the acoustic (8th cranial) nerve. The cochlear nerve fibers originate from neurons of the spiral ganglion and project peripherally to cochlear hair cells and centrally to the cochlear nuclei of the brain stem. They mediate the sense of hearing. w8n:Cochlear Microphonic Potentials G07.453.697.100.300.369.223; G11.561.450.100.300.369.223 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials; Action Potentials; Evoked Potentials; Evoked Potentials, Auditory Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials; Action Potentials; Evoked Potentials; Evoked Potentials, Auditory The electric response of the cochlear hair cells to acoustic stimulation. Action Potentials (67-79); Cochlea (66-79); Electrophysiology (66); Evoked Potentials (67-79) %>lXpCochlear Implant E04.659.216; E04.847.774.216; E07.296.319.216; E07.450.216; E07.814.458.216; E07.858.565.216 AECLCTECHIMIPSPXSDSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH); Surgery, Ear (Non MeSH) Equipment and Supplies; Electrodes; Electrodes, Implanted Equipment and Supplies; Implants, Artificial Equipment and Supplies; Sensory Aids; Hearing Aids Equipment and Supplies; Surgical Equipment; Prosthesis An electronic device implanted beneath the skin with electrodes to the cochlear nerve to create sound sensation in persons with sensorineural deafness. Cochlea (66-79); Deafness (66-79); Electric Stimulation (66-79); Hearing Aids (66-79); Prosthesis (66-79) j"xCochlear Duct A09.246.631.246.292 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea Stria Vascularis; Tectorial Membrane Spiral tube in the bony canal of the cochlea, lying on its outer wall between the scala vestibuli and scala tympani. Labyrinth (66-78) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $:0,<Cochlear Diseases C09.218.568.120 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Labyrinth Diseases Diseases of the cochlea, the part of the inner ear that is concerned with hearing. Labyrinth Diseases (66-89) NJe Cochlear Aqueduct A09.246.631.246.280 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea A channel containing perilymph passing through the temporal bone, connecting the scala tympani of the cochlea to the subarachnoid space. Cochlea (66-78) 7:0Cochlea A09.246.631.246 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Otoacoustic Emissions, Spontaneous Sense Organs; Ear; Labyrinth Basilar Membrane; Cochlear Aqueduct; Cochlear Duct (+ 2); Organ of Corti (+ 4); Round Window; Scala Tympani; Spiral Ganglion; Spiral Lamina The part of the internal ear that is concerned with hearing. It forms the anterior part of the labyrinth, is conical, and is placed almost horizontally anterior to the vestibule. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $ :(%<Coccyx A02.835.232.834.229 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine : :DCoccidiostats D21.370.400 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Coccidia; Coccidiosis Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Amprolium; Clopidol; Decoquinate; Dinitolmide; Ethopabate; Lasalocid; Monensin; Nicarbazin; Robenidine; Roxarsone; Spiramycin Agents useful in the treatment or prevention of coccidiosis in man or animals. Antiprotozoal Agents (69-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8@_"<Coccidiosis C03.752.750.259 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Coccidiostats Parasitic Diseases; Protozoan Infections; Sporozoea Infections Cryptosporidiosis; Malaria (+ 6); Sarcocystosis; Toxoplasmosis (+ 4) Protozoan infection found in animals and man. It is caused by several different genera of COCCIDIA.  0PISxCoccidioidomycosis C01.703.203 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Infection with a fungus of the genus COCCIDIOIDES, species C. immitis. The primary form is an acute, benign, self-limited respiratory infection due to inhalation of spores and varying in severity. The secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. (From Dorland, 27th ed). P=Coccidioidin D24.611.216.202.180 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Fungal A sterile solution containing the by-products of growth products of Coccidioides immitis, injected intracutaneously as a test for coccidioidomycosis. Antigens, Fungal (73-74); Coccidioides/IM (73-74) L6|<Coccidioides B05.354.381.546.230 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus which causes coccidioidomycosis. 4"NJCoccidia B01.841.075.762.167 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Coccidiostats Invertebrates; Protozoa; Apicomplexa; Sporozoea Eucoccidiida (+ 20) A subclass of protozoans commonly parasitic in the epithelial cells of the intestinal tract but also found in the liver and other organs. Its organisms are found in both vertebrates and higher invertebrates and comprise three orders: Agamococcidiida, Protococcidiida, and EUCOCCIDIIDA. Sporozoa (66-74) $8 &9KCocarcinogenesis C04.697.160; C23.739.170 Drug Synergism; Carcinogens Neoplasms; Neoplastic Processes (Non MeSH) Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) The combination of two or more different factors in the production of cancer. Neoplasms (66-76) s"^Cocaine D03.132.889.354; D03.605.869.388; D14.100.150.600.220.240; D14.100.600.220.240; D15.050.050.140; D15.210.100.200.140; D15.210.600.160; D16.850.025.140 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Narcotics Heterocyclic Compounds; Alkaloids; Tropanes Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Narcotics Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local Crack Cocaine Crack Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine is classified as a narcotic according to the federal code.   @ (Coca B06.560.216 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Any of several South American shrubs of the Erythroxylon genus (and family) that yield COCAINE; the leaves are chewed with alum for CNS stimulation by the local people. Y& Cobra Venoms D24.185.965.850.325.220 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Cobra Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Elapid Venoms Cobra Neurotoxins; Direct Lytic Factors Venoms from snakes of the genus Naja (family Elapidae). They contain many specific proteins that have cytotoxic, hemolytic, neurotoxic, and other properties. Like other elapid venoms, they are rich in enzymes. They include cobramines and cobralysins. Snake Venoms (75-77); Snakes (66-74); Toxins (66-77); Venoms (66-74) ADAEAGAIANBIBLCFCHCLCSCTDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (Ǣ< y0&VDCobra Neurotoxins D24.185.926.640.190; D24.185.965.850.325.220.190 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Neurotoxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Elapid Venoms; Cobra Venoms Toxins, contained in cobra (Naja) venom that block cholinergic receptors; two specific proteins have been described, the small (short, Type I) and the large (long, Type II) which also exist in other Elapid venoms. Peptides (66-75); Snake Venoms (75-77); Snakes (66-74); Venoms (66-74) ʯ6<XCobra B02.833.672.350.275 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Cobra Venoms Vertebrates; Reptiles; Snakes; Elapidae A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. There are six recognized species, all inhabiting Africa except the Asiatic (Indian) cobra, Naja naja. Some species "spit" their venom into the eyes of their "enemies". So-called spitting cobras show a high degree of accuracy in aiming for the eyes. The ringhals, the most highly specialized of the spitting cobras, is limited to southern Africa. Its spray destroys eye tissue and can cause blindness; its bite can cause death. (Moore: Poisonous Snakes of the World, 1980). Snakes (66-93)  ͟ &1Cobamides D08.176.175; D11.786.708.950.270 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Vitamin B 12 Coenzymes (66-71); Vitamin B 12 (66-71)  &F2Cobalt Radioisotopes D01.496.239.354; D01.496.749.256 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Cobalt Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. r&4Cobalt Isotopes D01.496.239 Inorganic Chemicals (Non MeSH); Isotopes Cobalt Radioisotopes Stable cobalt atoms that have the same atomic number as the element cobalt, but differ in atomic weight. Co-59 is a stable cobalt isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR H24Cobalt D01.268.912.125; D01.552.181 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Trace Elements Inorganic Chemicals (Non MeSH); Metals Cobalt. A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis. ո ":sHCoated Vesicles A11.368.702.160 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles Endosomes Vesicles formed when cell-membrane coated pits (COATED PITS, CELL-MEMBRANE) invaginate and pinch off. The outer surface of these vesicles is covered with a lattice-like network of the protein CLATHRIN. Shortly after formation, however, the clathrin coat is removed and the vesicles are referred to as ENDOSOMES. Coated Pits, Cell-Membrane (83-94) CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI $($ k)*Coated Pits, Cell-Membrane A11.195.190 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Clathrin Cells; Cell Membrane Specialized regions of the cell membrane composed of pits coated with a bristle covering made of the protein CLATHRIN. These pits are the entry route for macromolecules bound by cell surface receptors. The pits are then internalized into the cytoplasm to form the COATED VESICLES. Cell Membrane (66-82); Endocytosis (73-82)  i * K4Coal Tar D23.400.150; D26.884.354 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Dermatologic Agents; Keratolytic Agents Miscellaneous Drugs and Agents (Non MeSH); Tars Tar, coal. A by-product of the destructive distillation of coal used as a topical antieczematic. It is an antipruritic and keratoplastic agent used also in the treatment of psoriasis and other skin conditions. Occupational exposure to soots, tars, and certain mineral oils is known to be carcinogenic according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985) (Merck Index, 11th ed). ܓ ,hCoal Mining J01.576.670.354 CLECEDHIISLJMAMTOGSNSTTD Anthracosilicosis; Pneumoconiosis; Silicosis Technology, Industry, Agriculture (Non MeSH); Industry; Mining G4KCoal G03.230.132.258.108; J01.435.229 AEANCLECHIPORESDSNSTTOUT Environment and Public Health (Non MeSH); Environment; Energy-Generating Resources; Fossil Fuels Technology, Industry, Agriculture (Non MeSH); Fossil Fuels Coke Coke A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions. (&|Coagulase D24.310.200 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products Any bacterial component or product which causes coagulation in plasma containing an anticoagulant such as citrate, heparin or oxalate. Coagulases are produced by certain staphylococci and by Yersinia pestis. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen. (Dictionary of Microbiology and Molecular Biology, 2nd ed).  BM[Coagulants D19.461.270 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Blood Coagulation Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Blood Coagulation Factors (+ 28); Hemostatics (+ 15); Heparin Antagonists (+ 5); Prothrombin Substances that promote blood coagulation. Hemostatics (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (8[r3HCo-Dependency (Psychology) F01.058.150; F01.752.250 CLDEPHRE Substance Dependence Behavior and Behavior Mechanisms (Non MeSH); Adaptation, Psychological Behavior and Behavior Mechanisms (Non MeSH); Personality The tendency of individuals close to or associated with a chemically dependent person to act as caregivers or rescuers for that person. This type of coping behavior, often seen in spouses or other family members, includes denial of the existence of a problem, blaming of themselves for the chemical dependence of the other, or playing a role in perpetuating the chemical dependence. Dependency (Psychology) (87-91)   %Cnidarian Venoms D24.185.926.580.230; D24.185.965.230 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms Venoms from jellyfish, coral, sea anemone, nematocysts, etc. They contain hemo-, cardio-, dermo- , and neurotoxic substances and probably enzymes. They include palytoxin, sarcophine, and anthopleurine. Coelenterata (66-77); Marine Toxins (74-77); Toxins (66-73); Venoms (66-77) *<]Cnidaria B01.308 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates Hydra; Jellyfish; Sea Anemones A phylum of radially symmetrical invertebrates having a body composed of two layers of cells which comprise definite tissues. It includes hydroids (HYDRA), JELLYFISH, SEA ANEMONES, and corals.   ('CME-Carbodiimide D02.491.203.340 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Imines; Carbodiimides 4-(2-((Cyclohexylimidocarbonyl)amino)ethyl)-4-methyl-morpholinium p-toluenesulfonate. Carbodiimides (74); Morpholines (74); Tosyl Compounds (74) ,:?`HCluster Headache C10.228.140.300.937.210; C14.907.253.937.210; C23.888.592.612.429.814.210 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Vascular Headache Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Vascular Headache Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Headache; Vascular Headache Vascular headache, predominantly unilateral, usually associated with flushing, sweating, rhinorrhea and increased lacrimation; brief in duration and usually occurring in close-packed groups separated by long remissions. Headache (66-77); Vascular Headache (66-77) QN5Cluster Analysis E05.318.740.250; G03.850.520.830.250; H01.548.832.266; N05.715.360.750.200 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Small-Area Analysis; Space-Time Clustering Small-Area Analysis; Space-Time Clustering Small-Area Analysis; Space-Time Clustering Small-Area Analysis; Space-Time Clustering A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Statistics (66-89) 2TtClupeine D12.776.660.750.270; D12.776.664.750.270 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nuclear Proteins; Protamines Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nucleoproteins; Protamines  .DClubfoot C05.330.110 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Foot Deformities A deformed foot in which the foot is plantarflexed, inverted and adducted.  L2ZClozapine D03.494.240.220; D15.150.175; D15.210.950.040.175; D15.700.872.331.345 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents An antipsychotic agent that has only weak dopamine antagonistic activity. Its therapeutic mechanism is not understood although it apparently can block some classes of alpha-adrenergic, muscarinic, and serotonergic receptors. It has been very useful for treatment of persons who do not respond to or cannot tolerate other antipsychotics. Clozapine is only rarely associated with extrapyramidal symptoms, but can cause agranulocytosis, so blood monitoring is necessary. Dibenzazepines (71-74); Piperazines (71-74)  P:}4Cloxacillin D20.085.099.739.681.205 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Oxacillin Dicloxacillin; Floxacillin 6-(((3-(2-Chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)- amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)- heptane-2-carboxylic acid. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  :] <Clotrimazole D03.383.374.175; D20.136.234 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Anti-Infective Agents; Antifungal Agents 1-(o-Chloro-alpha-diphenylbenzyl)imidazole. Broad spectrum antimycotic agent that can be used topically or orally with few side effects. Imidazoles (71-74); Trityl Compounds (74) ":3Clothing J01.193 AEECHIPXSDSNST Technology, Industry, Agriculture (Non MeSH) Protective Clothing (+ 2); Shoes AECLCTECHILJPXSDSNSTTDUTVE h  4*Clot Retraction E01.223.459.770.250 Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Platelet Function Tests Retraction of a clot resulting from contraction of platelet pseudopods attached to fibrin strands that is dependent on the contractile protein thrombosthenin. Used as a measure of platelet function. 4ZClostridium tetani B03.300.390.400.158.300.725; B03.510.415.400.158.300.725; B03.510.460.410.158.300.725 CHCLCYDEENGDGEIMIPMEPHPYREULVI Tetanus Toxin Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium The cause of TETANUS in humans and domestic animals. It is a common inhabitant of human and horse intestines as well as soil. Two components make up its potent exotoxin activity, a neurotoxin and a hemolytic toxin. ]"Clostridium perfringens B03.300.390.400.158.300.575; B03.510.415.400.158.300.575; B03.510.460.410.158.300.575 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins. ]"Clostridium Infections C01.252.410.090.217 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections Botulism; Enterocolitis, Pseudomembranous; Enterotoxemia; Gas Gangrene; Tetanus Infections with bacteria of the genus CLOSTRIDIUM. Clostridium (66-67)  P]=Clostridium difficile B03.300.390.400.158.300.250; B03.510.415.400.158.300.250; B03.510.460.410.158.300.250 CHCLCYDEENGDGEIMIPMEPHPYREULVI Enterocolitis, Pseudomembranous Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy. Clostridium (76-90)  ]"$Clostridium botulinum B03.300.390.400.158.300.228; B03.510.415.400.158.300.228; B03.510.460.410.158.300.228 CHCLCYDEENGDGEIMIPMEPHPYREULVI Botulinum Toxins Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Clostridium The etiologic agent of BOTULISM in man, wild ducks, and other waterfowl. It is also responsible for certain forms of forage poisoning in horses and cattle. The bacterium produces a powerful exotoxin that is resistant to proteolytic digestion. ]"Clostridium B03.300.390.400.158.300; B03.510.415.400.158.300; B03.510.460.410.158.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae Clostridium botulinum; Clostridium difficile; Clostridium perfringens; Clostridium tetani Clostridium botulinum; Clostridium difficile; Clostridium perfringens; Clostridium tetani Clostridium botulinum; Clostridium difficile; Clostridium perfringens; Clostridium tetani A genus of motile or nonmotile gram-positive bacteria of the family BACILLACEAE. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals. Q"1 Closterovirus B04.715.120; B04.820.120 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses A group of plant viruses with highly flexuous filaments; some members are important pathogens of crop plants. Some are transmitted by aphids in a semi-persistent manner. Plant Viruses (79-93) o6Closing Volume E01.302.796.420.810.250; G09.772.521.700.810.250 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Lung Volume Measurements; Total Lung Capacity Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics; Total Lung Capacity The lung volume at which the dependent lung zones cease to ventilate presumably as a result of airway closure. Lung Volume Measurements (75-77); Respiratory Function Tests (66-74) 6<QClorgyline D02.092.831.180; D08.373.616.150; D15.085.125; D15.700.122.125 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Propylamines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Monoamine Oxidase Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Alkynes (72-74); Phenyl Ethers (74); Propylamines (70-74) H:=[GClorazepate Dipotassium D03.438.079.080.180; D14.100.240.500.175; D15.075.050.130; D15.080.175; D15.210.950.012.050.131; D15.700.872.015.050.215 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. Benzazepines (71-74); Carboxylic Acids (71-74) !#:8Cloprostenol D02.241.081.436.687.700.500.175; D10.516.251.355.708.700.500.175; D17.350.700.670.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins F, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins F, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins F, Synthetic 7-(2-beta-(4-(3-chlorophenoxy)-3-hydroxy-1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoic acid. A synthetic prostaglandin F2alpha analog. The compound has luteolytic effects and is used for the synchronization of estrus in cattle. Prostaglandins F (75-77); Prostaglandins F, Synthetic (78) %]:<FClopidol D03.383.725.180; D21.370.400.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 3,5-Dichloro-2,6-dimethyl-4-pyridinol. A very effective anticoccidial agent used in poultry. Synonym: Coyden. Pyridines (73-74) * &:~Clopenthixol D03.494.953.704.269; D14.100.150.175.137; D15.150.162; D15.210.950.040.162; D15.700.872.331.325 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Thioxanthenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors. +k: Clopamide D02.065.884.390; D02.886.590.700.390; D19.770.224.516.303 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl / A:Clonorchis sinensis B01.500.736.715.520.210 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Platyhelminths; Trematoda; Opisthorchidae A species of trematode flukes of the family Opisthorchidae. Many authorities consider this genus belonging to Opisthorchis. It is common in China and other Asiatic countries. Snails and fish are the intermediate hosts. Opisthorchis (66-71) 1B*OClonorchiasis C03.335.865.148 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Trematode Infections Infection of the biliary passages with CLONORCHIS SINENSIS, also called Opisthorchis sinensis. It may lead to inflammation of the biliary tract, proliferation of biliary epithelium, progressive portal fibrosis, and sometimes bile duct carcinoma. Extension to the liver may lead to fatty changes and cirrhosis. (From Dorland, 27th ed). 30PAClonixin D03.066.515.375; D03.383.725.547.375; D16.850.015.050.162; D17.025.030.122; D17.050.030.179 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory analgesic. Nicotinic Acids (71-74); Toluidines (73-74) 5 g:"5Cloning, Molecular E05.393.220; G05.331.120 DEMTRE DNA, Recombinant; Genetic Engineering; Recombinant Fusion Proteins Cosmids Miscellaneous Techniques (Non MeSH); Genetic Techniques Genetics; Genetics, Biochemical The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. The concept includes gene fusion. DNA (66-76); DNA, Recombinant (77-79); Plasmids (75-79) $9k N fdEClonidine D03.383.374.165; D14.100.050.100.100.140; D16.050.850.146; D18.162.170 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents An alpha-2 adrenergic agonist that crosses the blood-brain barrier. Clonidine's central actions reduce sympathetic tone. It is used as an antihypertensive agent, and has also been used in the treatment of migraine and in the diagnosis or pheochromocytoma. Antihypertensive Agents (66-71); Imidazoles (66-71) Civil Disorders I01.880.735.140 CLECEHHILJPCPXSNTD Mass Behavior Social Sciences; Sociology; Social Problems Riots Deliberate and planned acts of unlawful behavior engaged in by aggrieved segments of the population in seeking social change. Disasters (66-68); Emergency Service, Hospital (66-68) $5 ACivil Defense I01.451.227 CLECEDHIISLJMAMTOGSNSTTD Disaster Planning Social Sciences; Government Programs (Non MeSH) Preventive emergency measures and programs designed to protect the individual or community in times of hostile attack. Ϯ9City Planning I01.880.709.202 CLECEDHILJMAMTOGSDSNSTTDUT Social Sciences; Sociology; Social Planning Comprehensive planning for the physical development of the city. 5MCitrus Fruits B06.510.380.175; J01.341.492.414 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Fruit Technology, Industry, Agriculture (Non MeSH); Food; Fruit Any tree or shrub of the rue family or the fruit of these plants. &4jSCitrulline D12.125.095.226 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino  FbCitrobacter freundii B03.440.450.425.200.275 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Citrobacter A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in man and other animals including mammals, birds, reptiles, and amphibians. Its organisms have also been isolated from soil and water as well as from clinical specimens such as urine, throat, sputum, blood, and wound swabs as an opportunistic pathogen. Citrobacter (75-91); Enterobacteriaceae (66-74); Escherichia (66-74) "}QCitrobacter B03.440.450.425.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae Citrobacter freundii A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon. Enterobacteriaceae (66-74); Escherichia (66-74)  "nz8Citrinin D03.438.150.320; D20.085.225 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans Anti-Infective Agents; Antibiotics 4,6-Dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-3H-2-benzopyran- 7-carboxylic acid. Antibiotic and mycotoxin from Aspergillus niveus and Penicillium citrinum. Benzopyrans (69-74) ؁ "<~Citric Acid Cycle G06.535.280 DEGEIMPHRE Citrates Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism A series of reactions involving oxidation of a two-carbon acetyl unit to carbon dioxide and water with the production of high-energy phosphate bonds by means of tricarboxylic acid intermediate. S OCitrates D02.241.081.901.434 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Citric Acid Cycle Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Tricarboxylic Acids Isocitrates  <rCitrate Synthase D08.586.520.567.434 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases  FbCitraconic Anhydrides D02.113.250; D03.383.312.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Anhydrides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Furans Methylmaleic anhydrides. Anhydrides (69-74); Maleates (72-74) "8-Cities (Non MeSH) Z01.433 Geographicals (Non MeSH) Baltimore; Berlin; Boston; Chicago; District of Columbia; London; Los Angeles; Moscow; New York City; Paris; Philadelphia; Rome; San Francisco; Tokyo EHEP d Citalopram D02.092.831.170; D14.100.600.850.140; D14.100.850.875.800.140; D15.085.115; D15.700.122.110 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Propylamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents 1-(3-(Dimethylamino)propyl-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile. A selective neuronal serotonin reuptake inhibitor and a clinically effective antidepressant with tolerable side effects. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia (TD) in preference to tricyclic antidepressants, which aggravate this condition. Antidepressive Agents (77-88); Propylamines (77-88); Serotonin Antagonists (78-88) g:KaCisterna Magna A08.186.566.166.686.351 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Ventriculostomy Nervous System; Central Nervous System; Meninges; Arachnoid; Subarachnoid Space 6_Cisplatin D01.210.375; D01.625.125; D01.710.100; D22.204.355; D26.776.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH) Inorganic Chemicals (Non MeSH); Nitrogen Compounds Inorganic Chemicals (Non MeSH); Platinum Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH); Radiation-Sensitizing Agents (SP-4-2)-Diamminedichloroplatinum. The cis isomer of a simple platinum compound that has antineoplastic action and may enhance tumor antigenicity as a result of binding to DNA. The compound also causes renal damage. Amines (66-73); Ammonium Compounds (66-73); Chlorides (66-73); Platinum (66-73)  K:`aCircumcision E04.887.774.692.226 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Penis Surgery, Operative; Surgery, Urogenital (Non MeSH); Surgery, Urologic (Non MeSH); Surgery, Urologic, Male (Non MeSH) Excision of the prepuce or part of it. d$ 2Circulatory, Respiratory Physiology (Non MeSH) G09 Blood Physiology (Non MeSH) (+ 33); Cardiovascular System Physiology (Non MeSH) (+ 62); Respiratory Tract Physiology (Non MeSH) (+ 42) ABADAEAHANBIBLCFCHCLCTCYDEDIDUECEDEMENETGDGEHIIMINIPIRISLJMAMEMIMTOGPAPDPHPOPPPSRARERISESNSTSUTDTOTUULURUSVEVI 6rCircular Dichroism E05.196.867.151 Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Spectrum Analysis A change from planar to elliptic polarization when an initially plane-polarized light wave traverses an optically active medium. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Spectrum Analysis (66-69)  [Circovirus B04.280.120.150; B04.909.204.120.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Circoviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Circoviridae Chicken Anemia Virus Chicken Anemia Virus A genus of the family CIRCOVIRIDAE that infects fowl, swine, and psittacine birds. It is the only DNA virus affecting mammals which contains a single-stranded circular genome. The three species are CHICKEN ANEMIA VIRUS causing transient anemia and immunosuppression in baby chicks; beak and feather disease virus causing a fatal disease in psittacine birds; and porcine circovirus, not yet associated with any disease. DNA Viruses (86-93)  *y2Circoviridae Infections C02.256.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Virus diseases caused by the CIRCOVIRIDAE. P:4Circoviridae B04.280.120; B04.909.204.120 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Circovirus (+ 1) Circovirus (+ 1) A family of very small viruses containing circular, single-stranded DNA and possessing no envelope. The modes of transmission are not known. There is one genus: CIRCOVIRUS. "Y*Circle of Willis A07.231.114.228.351 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cardiovascular System; Blood Vessels; Arteries; Cerebral Arteries A polygonal anastomosis at the base of the brain formed by the internal carotid, the anterior and posterior cerebral arteries, the anterior communicating artery and the posterior communicating arteries. 6NCircadian Rhythm G07.450.730.190 DEGEIMPHRE Photoperiod Periodicity; Biological Clocks Physiology, General (Non MeSH); Chronobiology; Periodicity Activity Cycles The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs and stimuli, hormone secretion, sleeping, feeding, etc. This rhythm seems to be set by a 'biological clock' which seems to be set by recurring daylight and darkness. $v%FQCiprofloxacin D03.438.810.835.180; D20.220.050.180; D20.237.050.050.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Quinolones Anti-Infective Agents; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone; Anti-Infective Agents, Fluoroquinolone Fleroxacin Fleroxacin Fleroxacin 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinolinecarboxylic acid. A carboxyquinoline antimicrobial agent which is effective against a wide range of microorganisms. It has been successfully and safely used in the treatment of resistant respiratory, skin, bone, joint, gastrointestinal, urinary, and genital infections. Quinolines (66-86)  A:\&Ciona intestinalis B01.272.727.300 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Chordata; Urochordata The only species of a cosmopolitan ascidian. It is useful as a research animal. (,bCinoxacin D03.066.160; D03.494.160; D20.220.160; D20.237.050.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH) Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Anti-Infective Agents; Anti-Infective Agents, Quinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone 1-Ethyl-1,4-dihydro-4-oxo(1,3)dioxolo(4,5-g)cinnoline-3-carboxylic acid. Synthetic antimicrobial related to oxolinic and nalidixic acids and used in urinary tract infections. Pyridazines (66-79)  @:%Cinnarizine D03.383.606.290; D14.100.375.425.400.150; D15.095.137 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Central Nervous System Agents; Antiemetics An antihistaminic with considerable antiemetic properties. It is used mainly for the symptomatic treatment of nausea and vertigo accompanying Meniere's disease and for the prevention and treatment of motion sickness. Cinnamates (71-74); Piperazines (68-74) >=:?0Cinnamon J01.341.241.850.225 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Condiments; Spices The dried inner bark of Cinnamonum species used as a spice or medicinally. U "U[Cinnamates D02.241.223.201 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Caffeic Acids; Cinanserin; Coumaric Acids AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR m8]3:Cineradiography E01.357.818.170 AECLCTECHIISMOMTNUPXSNSTTDUTVE Motion Pictures Diagnosis; Diagnostic Imaging; Radiography Cineangiography Motion picture study of successive images appearing on a fluoroscopic screen. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $"3\&Cineangiography E01.145.077.385; E01.357.818.084.160; E01.357.818.170.160 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Motion Pictures Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnostic Imaging; Radiography; Angiography Diagnosis; Diagnostic Imaging; Radiography; Cineradiography Motion pictures of the passage of contrast medium through blood vessels.  A&WCinchona Alkaloids D03.132.206 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Quinidine; Quinine Alkaloids extracted from various species of Cinchona. Cinchona (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $8(@@Cinchona B06.560.206; B06.915.206 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Trees A genus of rubiaceous South American trees that yields the toxic CINCHONA ALKALOIDS from their bark; QUININE, QUINIDINE, chinconine, cinchonidine and others are used to treat malaria and cardiac arrhythmias.  D &1Cinanserin D02.241.223.201.200; D14.100.850.850.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cinnamates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists A serotonin antagonist with limited antihistaminic, anticholinergic, and immunosuppressive activity. Anilides (69-74); Cinnamates (69-74); Sulfides (74)  .:r@Cimetidine D02.078.370.200; D03.383.374.130; D14.100.375.425.425.140; D19.316.203.219 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents Blocker of histamine H2 receptors that decreases gastric acid secretion and reduces pepsin output. It is used to treat gastrointestinal ulcers. Guanidines (66-77); Imidazoles (66-77) .T:/Ciliophora Infections C03.752.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections Balantidiasis Infections with protozoa of the phylum CILIOPHORA. yP0=Ciliophora B01.841.185 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa Kinetofragminophorea (+ 3); Oligohymenophorea (+ 8); Polymenophorea (+ 4) A phylum of protozoa characterized by the presence of cilia at some time during the life cycle. It comprises three classes: KINETOFRAGMINOPHOREA, OLIGOHYMENOPHOREA, and POLYMENOPHOREA. Protozoa (75-91)  &YCiliary Motility Disorders C08.200; C09.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases Otorhinolaryngologic Diseases Kartagener's Syndrome Kartagener's Syndrome Disorders characterized by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as Kartagener triad (KARTAGENER'S SYNDROME), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis. Cilia (66-83); Kartagener Triad (66-83); Nasal Mucosa (66-83)  f N@2|LCiliary Body A09.371.894.280 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Trabeculectomy Sense Organs; Eye; Uvea  A ring of tissue extending from the scleral spur to the ora serrata of the retina. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion. O: %Cilia A11.368.702.783.267 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Epithelium Cells; Cytoplasm; Organelles; Pseudopodia Populations of thin, motile processes found covering the surface of ciliates (CILIOPHORA) or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. (King and Stansfield, A Dictionary of Genetics, 4th ed). + *3'Cilazapril D03.383.710.100; D08.373.745.085.150; D18.162.050.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridazines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors (1S-(1 alpha,9 alpha(R*)))-9-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid monohydrate. An angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. Preliminary results also indicate its potential in the treatment of congestive heart failure. It is a prodrug that is hydrolysed after absorption to its main metabolite cilazaprilat. Pyridazines (84-92) =:MCilastatin D02.241.081.436.275.200; D02.455.426.392.368.533.200; D08.373.745.300; D10.516.251.355.325.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclopropanes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated 7-((2-Amino-2-carboxyethyl)thio) 2-(((2,2-dimethylcyclopropyl)carbonyl) amino)-2-heptenoic acid. A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukeotriene E4. Cyclopropanes (83-88); Dipeptidases/antagonists and inhibitors (83-88); Protease Inhibitors (83-88)  h:0tCiguatoxin D24.185.926.580.160 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Marine Toxins A toxin found in flesh of marine animals, especially some fishes, at some times, in some localities. It is probably of algal origin, causes paresthesia, gastrointestinal symptoms, neuromuscular blockade, and respiratory paralysis due to interference with membrane function. The poisoning is also called ciguatera. Fishes, Poisonous (68-77); Marine Toxins (74-77); Toxins (66-73) %q<hkOCicatrix, Hypertrophic C17.800.120.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Keloid Keloid Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Cicatrix An elevated scar, resembling a KELOID, but which does not spread into surrounding tissues. It is formed by enlargement and overgrowth of cicatricial tissue and regresses spontaneously. Cicatrix (66-92) $(N  WCicatrix A10.424.351; C17.800.120 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Keloid Wound Healing Tissue Types (Non MeSH); Granulation Tissue Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases  Cicatrix, Hypertrophic; Keloid (+ 1) The formation of new tissue in the process of wound healing. $* N .KCialit D02.691.750.100.347.350; D03.438.221.370 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds; Ethylmercury Compounds Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzoxazoles Ethylmercury(2-mercapto-5-benzoxazolecarboxylic acid)sodium salt. Tissue preservative. Benzoxazoles (72-74); Ethylmercury Compounds (72-74); Sulfides (72-74) + .:bTChymotrypsinogen D08.444.184 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Pancreatic Juice Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Precursors Chymotrypsin (66-71); Enzyme Precursors (66-71) .FP9Chymotrypsin D08.586.277.656.732.760.176 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Pancreatic Juice Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases /?FChymosin D08.586.277.656.732.066.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Aspartic Proteinases The predominant milk-clotting enzyme from the true stomach or abomasum of the suckling calf. It is secreted as an inactive precursor called prorennin and converted in the acid environment of the stomach to the active enzyme. EC 3.4.23.4. 0 FChymopapain D08.586.277.656.732.215.160 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Intervertebral Disk Chemolysis Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases A peptide peptidohydrolase with cysteine at the active center from papaya. Preferential cleavage at glutamic and aspartic acid residues. Also catalyzes the synthesis of hippuryl-aniline. Formerly EC 3.4.4.11. Papain (73-74)  2F$Chylothorax C08.528.142 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lymphatic Diseases Respiratory Tract Diseases; Pleural Diseases The presence of chyle in the thoracic cavity. (Dorland, 27th ed). 5CN5RChyloperitoneum C06.772.145 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Peritoneal Diseases The presence of effused chyle in the peritoneal cavity. (Dorland, 27th ed). 6tN7]Chylomicrons D10.516.532.183; D12.776.521.242 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Lipoproteins 7&DChyle A12.207.630.350; A15.382.520.436.350 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Body Fluids; Lymph Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymph 8 *"Churg-Strauss Syndrome C14.907.940.110; C23.484.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Vasculitis Symptoms and General Pathology (Non MeSH); Granuloma Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA. Granuloma (66-88); Vasculitis (66-88) 9"N~.Chrysosporium B05.354.381.546.170 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus which causes adiaspiromycosis, a pulmonary mycosis of man and rodents. Fungi (66-85); Hyphomycetes (66-85) Chromaffin Granules A06.224.207; A11.368.246.207 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Endocrine System (Non MeSH); Chromaffin System Cells; Cytoplasm; Cytoplasmic Granules Granules in the adrenal glands and various other organs, which are concerned with the synthesis, storage, metabolism, and secretion of epinephrine and norepinephrine. Chromaffin System (66-77); Cytoplasmic Granules (66-77) Y"*fBChristmas Disease C15.378.463.134.210 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A deficiency of blood coagulation factor IX inherited as an X-linked disorder. Historical and clinical features resemble those in classic hemophilia (hemophilia A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed). MNChristianity K01.844.188 HIPX Humanities; Religion Catholicism; Christian Science; Saints The religion stemming from the life, teachings, and death of Jesus Christ: the religion that believes in God as the Father Almighty who works redemptively through the Holy Spirit for men's salvation and that affirms Jesus Christ as Lord and Savior who proclaimed to man the gospel of salvation. (From Webster, 3d ed). /xChristian Science K01.844.188.431 HIPX Humanities; Religion; Christianity A religion discovered by Mary Baker Eddy in 1866 that was organized under the official name of the Church of Christ, Scientist, that derives its teachings from the Scriptures as understood by its adherents, and that includes a practice of spiritual healing based upon the teaching that cause and effect are mental, and that sin, sickness, and death will be destroyed by a full understanding of the divine principle of Jesus' teaching and healing. (Webster, 3d ed). *#Choroiditis C11.941.160.478; C11.941.879.780.900.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chorioretinitis Eye Diseases; Uveal Diseases; Choroid Diseases Eye Diseases; Uveal Diseases; Uveitis; Panuveitis; Uveitis, Posterior Chorioretinitis; Pars Planitis Chorioretinitis; Pars Planitis Inflammation of the choroid.  =.NH$Choroideremia C11.270.142; C11.941.160.300; C16.131.410.142 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Night Blindness Eye Diseases; Eye Diseases, Hereditary Eye Diseases; Uveal Diseases; Choroid Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary An X chromosome-linked abnormality characterized by atrophy of the choroid and degeneration of the retinal pigment epithelium causing night blindness. Choroid (66-89); Eye Diseases (66-74); Uveal Diseases/genetics (77-89)  5LVChoroid Plexus Neoplasms C04.588.614.250.195.280.300; C10.228.140.211.280.300; C10.228.250.195.280.300; C10.551.250.195.280.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms; Cerebral Ventricle Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Neoplasms; Cerebral Ventricle Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Brain Neoplasms; Cerebral Ventricle Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms; Cerebral Ventricle Neoplasms Neoplasms of the choroid plexus, blood vessels of the pia mater that project into the brain ventricles. Choroid Plexus (66-91); Cerebral Ventricle Neoplasms (66-91) pXk|HChoroid Plexus A08.186.211.276.298 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Cerebral Ventricles Infoldings of blood vessels of the pia mater covered by a thin coat of ependymal cells that form tufted projections into the third, fourth, and lateral ventricles of the brain. They secrete the cerebrospinal fluid. (Dorland, 27th ed). 6PChoroid Neoplasms C04.588.364.978.223; C11.319.494.198; C11.941.160.238; C11.941.855.198 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Eye Neoplasms; Uveal Neoplasms Eye Diseases; Eye Neoplasms; Uveal Neoplasms Eye Diseases; Uveal Diseases; Choroid Diseases Eye Diseases; Uveal Diseases; Uveal Neoplasms Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi). PX-Choroid Hemorrhage C11.290.195; C11.941.160.177; C23.542.290.195 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Hemorrhage Eye Diseases; Uveal Diseases; Choroid Diseases Symptoms and General Pathology (Non MeSH); Hemorrhage; Eye Hemorrhage Hemorrhage from the vessels of the choroid. Choroid (66-86); Hemorrhage (66-86) 5N6,Choroid Diseases C11.941.160 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Uveal Diseases Choroid Hemorrhage; Choroid Neoplasms; Choroideremia; Choroiditis (+ 2); Gyrate Atrophy Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  N$iXChoroid A09.371.894.223 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Uvea Bruch Membrane  : Choristoma C23.207 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) A mass of histologically normal tissue present in an abnormal location. i N2VChorismic Acid D02.241.223.268.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids trans-3[1-Carboxyvinyl-oxy]-4-hydroxy-1,5-cyclohexadiene-1-carboxylic acid. Cyclohexanecarboxylic Acids (69-74); Vinyl Compounds (72-74) {:~QGChorismate Mutase D08.586.399.310 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases An isomerase that catalyzes the conversion of chorismic acid to prephenic acid. Its molecular weight is approximately 55,000 kD. EC 5.4.99.5. Cyclohexanecarboxylic Acids (69-74); Isomerases (69-74); Vinyl Compounds (72-74) FS_Chorioretinitis C11.768.773.348; C11.941.160.478.400; C11.941.879.780.900.300.318 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Choroiditis Eye Diseases; Retinal Diseases; Retinitis Eye Diseases; Uveal Diseases; Choroid Diseases; Choroiditis Eye Diseases; Uveal Diseases; Uveitis; Panuveitis; Uveitis, Posterior; Choroiditis Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.  INChorionic Villi Sampling E01.223.230.143.225; E01.223.230.225; E01.223.894.143.225; E01.223.894.632.225; E01.249.746.225 AECLCTECHIISMOMTNUPXSNSTTDUTVE Fetal Diseases; Amniocentesis Diagnosis; Diagnosis, Laboratory; Cytodiagnosis; Biopsy Diagnosis; Diagnosis, Laboratory; Cytodiagnosis Diagnosis; Diagnosis, Laboratory; Specimen Handling; Biopsy Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Prenatal Diagnosis A method for diagnosis of fetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester. Biopsy (83-88); Chorionic Villi (83-88); Pregnancy (83-88); Prenatal Diagnosis (83-88)  k"$K;iChorionic Villi A16.254.403.473.200; A16.759.189 ABAHBSCHDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo; Fetal Membranes; Chorion Embryonic Structures (Non MeSH); Placenta The threadlike, vascular projections of the chorion which enter into the formation of the placenta. Fetal Membranes (66-74); Placenta (66-74)  &8v3Chorion A16.254.403.473 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo; Fetal Membranes Chorionic Villi The outermost extraembryonic membrane. Fetal Membranes (66-74)  M :E.Choriocarcinoma C04.557.465.955.348; C04.557.470.200.025.455; C04.850.908.348; C13.703.720.949.348 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Trophoblastic Neoplasms Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms An epithelial malignancy of trophoblastic cells, formed by the abnormal proliferation of cuboidal and syncytial cells of the placental epithelium, without the production of chorionic villi. Almost all cases arise in the uterus, developing from hydatidiform mole (50%), following abortion (25%), or during normal pregnancy (22%). The remainder occur in ectopic pregnancy and genital (ovarian and testicular) and extragenital teratomas. (Dorland, 27th ed).  t\XChorioamnionitis C13.703.277.030; C13.703.420.339.260; C13.703.590.268; C16.300.030 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Fetal Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications; Fetal Membranes, Premature Rupture Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Placenta Diseases Neonatal Diseases and Abnormalities (Non MeSH); Fetal Diseases An inflammatory process involving the chorion, its fetal blood vessels, the umbilical cord, and the amnion by extension of the inflammation, as the amnion itself has no blood supply. This inflammatory process is potentially fatal to mother and fetus. Amnion (66-84); Chorion (75-84); Fetal Membranes, Premature Rupture (75-84); Pregnancy Complications, Infectious (66-84) pLL&Chorea C10.228.140.079.255; C10.597.559.284; C23.888.592.574.288 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders Huntington's Disease The ceaseless occurrence of a wide variety of rapid, highly complex, jerky movements that appear to be well coordinated but are performed involuntarily. (Dorland, 27th ed).  ANNChordopoxvirinae B04.280.650.160; B04.909.204.783.160 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae Avipoxvirus (+ 1); Capripoxvirus (+ 1); Leporipoxvirus (+ 2); Molluscipoxvirus (+ 1); Orthopoxvirus (+ 5); Parapoxvirus (+ 2); Suipoxvirus; Yatapoxvirus (+ 1) Avipoxvirus (+ 1); Capripoxvirus (+ 1); Leporipoxvirus (+ 2); Molluscipoxvirus (+ 1); Orthopoxvirus (+ 5); Parapoxvirus (+ 2); Suipoxvirus; Yatapoxvirus (+ 1) A subfamily of the family POXVIRIDAE, containing eight genera comprising all the vertebrate poxviruses. *uyChordoma C04.557.465.220 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed).  XhChordata B01.272 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates Urochordata (+ 1) A phylum of the animal kingdom comprising all the animals that have a notochord (the primitive axis of the body) during some stage of their development. It includes the subphyla Cephalochordata, UROCHORDATA, and Vertebrata (VERTEBRATES). (Dorland, 27th ed).   (/Chordae Tendineae A07.541.510.240 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Papillary Muscles Cardiovascular System; Heart; Heart Valves The tendinous cords that connect each cusp of the two atrioventricular valves to appropriate papillary muscles in the heart ventricles, preventing the valves from reversing themselves when the ventricles contract.  B84Chorda Tympani Nerve A08.800.800.120.250.120 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves; Facial Nerve A branch of the facial (7th cranial) nerve which passes through the middle ear and continues through the petrotympanic fissure. The chorda tympani nerve carries taste sensation from the anterior two-thirds of the tongue and conveys parasympathetic efferents to the salivary glands. " 8lHChondrosarcoma, Mesenchymal C04.557.450.565.280.280; C04.557.450.795.300.280 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Chondrosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Chondrosarcoma A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Chondrosarcoma (66-93); Mesenchymoma (66-91) $O 6XA5Chondrosarcoma C04.557.450.565.280; C04.557.450.795.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Chondrosarcoma, Mesenchymal Chondrosarcoma, Mesenchymal A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed). (z.X>Chondromatosis, Synovial C05.550.287 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Rare, benign, chronic, progressive metaplasia in which cartilage is formed in the synovial membranes of joints, tendon sheaths, or bursae. Some of the metaplastic foci can become detached producing loose bodies. When the loose bodies undergo secondary calcification, the condition is called synovial osteochondromatosis. Chondroma (66-89) ,N0rChondromatosis C04.557.450.565.265.270 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Chondroma Multiple formation of chondromas. (Dorland, 27th ed). Chondroma (66-93); Chondromatosis, Synovial (90-93); Synovial Membrane (67-93); Synovitis (66-81) .pNBtChondroma C04.557.450.565.265 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue Chondromatosis A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone (true chondroma or enchondroma) or may develop on the surface of a cartilage (ecchondroma or ecchondrosis). (Dorland, 27th ed; Stedman, 25th ed). 0p VDChondroitinsulfatase D08.586.277.352.827.180.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Sulfatases; Chondroitinases An enzyme that catalyzes the hydrolysis of the 6-sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate G. EC 3.1.6.4. Chondroitin (70-75); Sulfatases (70-75) 3F0Chondroitinases D08.586.277.352.827.180; D08.586.520.726.180 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Sulfatases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Polysaccharide-Lyases Chondroitinsulfatase Chondroitin Lyases Enzymes which catalyze the elimination of glucuronate residues from chondroitin A,B, and C or which catalyze the hydrolysis of sulfate groups of the 2-acetamido-2-deoxy-D-galactose 6-sulfate units of chondroitin sulfate. Chondroitin (70-75); Lyases (70-74); Polysaccharide-Lyases (75); Sulfatases (70-75)  5 2F-dChondroitin Sulfates D09.203.698.373.200.300 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans; Chondroitin Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate. Chondroitin (71-75); Sulfuric Acids (71-75) 8$D5Chondroitin Lyases D08.586.520.726.180.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Polysaccharide-Lyases; Chondroitinases Enzymes which catalyze the elimination of delta-4,5-D-glucuronate residues from polysaccharides containing 1,4-beta-hexosaminyl and 1,3-beta-D-glucuronosyl or 1,3-alpha-L-iduronosyl linkages thereby bringing about depolymerization. EC 4.2.2.4 acts on chondroitin sulfate A and C as well as on dermatan sulfate and slowly on hyaluronate. EC 4.2.2.5 acts on chondroitin sulfate A and C. Chondroitin (70-75); Lyases (70-74); Polysaccharide-Lyases (75) ;MF{LChondroitin D09.203.698.373.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cartilage Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glycosaminoglycans Chondroitin Sulfates; Dermatan Sulfate Chondroitin. A mucopolysaccharide constituent of chondrin. (Grant and Hackh's Chemical Dictionary, 5th ed).  >iF t.Chondrodysplasia Punctata C05.116.099.708.195 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias A heterogeneous group of bone dysplasias, the common character of which is stippling of the epiphyses in infancy. The group includes a severe autosomal recessive form (rhizomelic dwarfism), an autosomal dominant form (Conradi-Hunermann syndrome), and a milder X-linked form. @.Nk@Chondrocalcinosis C05.550.114.264 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Calcinosis; Calcium Pyrophosphate Musculoskeletal Diseases; Joint Diseases; Arthritis Presence of calcium salts, especially calcium pyrophosphate, in the cartilaginous structures of one or more joints. When accompanied by attacks of goutlike symptoms, it is called pseudogout. (Dorland, 27th ed). Calcinosis (66-71); Joint Diseases (66-71)  BN(=4Chondroblastoma C04.557.450.565.250 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue A usually benign tumor composed of cells which arise from chondroblasts or their precursors and which tend to differentiate into cartilage cells. It occurs primarily in the epiphyses of adolescents. It is relatively rare and represents less than 2% of all primary bone tumors. The peak incidence is in the second decade of life; it is about twice as common in males as in females. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed). DXChondro-4-Sulfatase D08.586.277.352.827.070.275 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Sulfatases; Arylsulfatases An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the disaccharide repeating units from chondroitin sulfate N-acetylgalactosamine 4-sulfate. The deficiency of chondro-4-sulfatase has been proposed as the defect in Maroteaux-Lamy syndrome (MUCOPOLYSACCHARIDOSIS VI). EC 3.1.6.9. Chondroitin (74-75); Sulfatases (74-75) HFY0Cholinesterases D08.586.277.352.100.170 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases Acetylcholinesterase; Butyrylcholinesterase; Pseudocholinesterase JDICholinesterase Reactivators D08.515.347; D14.100.120.400 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organothiophosphorus Compounds; Antidotes; Organophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Reactivators Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents Obidoxime Chloride; Trimedoxime Obidoxime Chloride; Trimedoxime Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. Acetylcholinesterase (66-70); Cholinesterases (66-70); Oximes (66-70); Pralidoxime Compounds (66-70); Pyridines (66-70); Pyridinium Compounds (68-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (L "4OJ :Cholinesterase Inhibitors D08.373.275; D14.100.120.300 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Insecticides, Organophosphate; Insecticides, Organothiophosphate Organothiophosphorus Compounds; Insecticides; Organophosphorus Compounds; Miotics; Parasympathomimetics Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents Ambenonium Chloride; Armin; Carbaryl; Dichlorvos; Echothiophate Iodide; Edrophonium; Galanthamine; Isoflurophate; Neostigmine; Physostigmine; Pyridostigmine Bromide; Soman; Tacrine; Tetraisopropylpyrophosphamide Ambenonium Chloride; Armin; Carbaryl; Echothiophate Iodide; Edrophonium; Galanthamine; Isoflurophate; Neostigmine; Physostigmine; Pyridostigmine Bromide; Soman; Tacrine; Tetraisopropylpyrophosphamide Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR (P"4Hu[@Cholinergic Fibers A08.663.542.234 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Nerve Fibers Autonomic Fibers, Preganglionic; Parasympathetic Fibers, Postganglionic Nerve fibers liberating acetylcholine at the synapse after an impulse. Parasympathetic Nervous System (66-76) ABAHBSCHCLCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $V(/QT-:Cholinergic Antagonists D14.100.120.200 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents Muscarinic Antagonists (+ 21); Nicotinic Antagonists (+ 15) Drugs that bind to but do not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  X{4H@Cholinergic Agonists D14.100.120.140 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents Muscarinic Agonists (+ 9); Nicotinic Agonists (+ 7) Drugs that bind to and activate cholinergic receptors. Acetylcholine/pharmacology (67-94) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $Z4@B(DCholinergic Agents D14.100.120 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Botulinum Toxins; Bungarotoxins Acetylcholine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Cholinergic Agonists (+ 18); Cholinergic Antagonists (+ 38); Cholinesterase Inhibitors (+ 13); Cholinesterase Reactivators (+ 2) Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of ACETYLCHOLINE, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of MUSCARINIC AGONISTS, although most modern texts discourage that usage. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (\4&kDCholine Kinase D08.586.913.696.620.155 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that is active in the first step of choline phosphoglyceride (lecithin) biosynthesis by catalyzing the phosphorylation of choline to phosphorylcholine in the presence of ATP. Ethanolamine and its methyl and ethyl derivatives can also act as acceptors. EC 2.7.1.32. Choline (74-75); Phosphotransferases, ATP (74-75) `ZFA;Choline Deficiency C18.654.223.133.699.160 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the B vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. (From Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984). cNCholine Acetyltransferase D08.586.913.050.134.180 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Acetyltransferases An enzyme that catalyzes the formation of acetylcholine from acetyl-CoA and choline. EC 2.3.1.6. Acetyltransferases (73-74); Choline (66-74); Transferases (66-72) fFsNCholine D02.033.329.291.211; D02.092.063.291.211; D02.092.102.232; D02.675.276.232; D10.642.197 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Lipids and Antilipemic Agents (Non MeSH); Lipotropic Factors  Benzoylcholine; Carbachol; Cytidine Diphosphate Choline; Phosphorylcholine; Propylbenzilylcholine Mustard; Succinylcholine; Thiocholine (+ 2) Benzoylcholine; Carbachol; Cytidine Diphosphate Choline; Phosphorylcholine; Propylbenzilylcholine Mustard; Succinylcholine; Thiocholine (+ 2) 2-Hydroxy-N,N,N-trimethylethanaminium. Basic constituent of lecithin that is found in many plants and animal organs. h cB{ECholic Acids D04.808.221.430; D19.316.246.225 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts Dehydrocholic Acid; Deoxycholic Acid (+ 8); Glycocholic Acid (+ 2); Lithocholic Acid (+ 1); Taurocholic Acid (+ 3) Dehydrocholic Acid; Deoxycholic Acid (+ 3); Glycocholic Acid; Taurocholic Acid (+ 3) 3 alpha, 7 alpha, 12 alpha-Trihydroxy-5 beta-cholanic acid family. Bile acids in man, usually conjugated with glycine or taurine. They act as detergents to solubilize fats for intestinal absorption, are reabsorbed by the small intestine, and are used as laxatives, cholagogues, and choleretics. Bile Acids and Salts (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $l&BW$FCholestyramine D10.162.202.159; D25.720.716.579.159; D26.572.133.397 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Polystyrenes Miscellaneous Drugs and Agents (Non MeSH); Ion Exchange Resins; Anion Exchange Resins Main constituent: Polystyrene trimethylbenzylammonium as Cl(-) anion. Strongly basic anion exchange resin that exchanges chloride ions with bile salts, thus decreasing their concentration and that of cholesterol. It is used as a hypocholesteremic in diarrhea and biliary obstruction and as an antipruritic. p=.%bCholesterol, Dietary D10.516.212.302.347; D10.516.851.208.222 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hypercholesterolemia; Hypercholesterolemia, Familial Diet, Atherogenic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Cholesterol (66-72); Dietary Fats (66-72)  t.6;3Cholesterol-7-Hydroxylase D08.586.682.420.170.280; D08.586.682.420.783.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Steroid Hydroxylases An enzyme that catalyzes the hydroxylation of cholesterol to cholest-5-en-3 beta,7 alpha-diol. EC 1.14.13.17. Cholesterol (74); Steroid Hydroxylases (74) u6F5Cholesterol Oxidase D08.586.682.047.436.350.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases An enzyme that catalyzes the oxidation of cholesterol in the presence of molecular oxygen to 4-cholesten-3-one and hydrogen peroxide. The enzyme is not specific for cholesterol, but will also oxidize other 3-hydroxysteroids. EC 1.1.3.6. Cholesterol (66-77); Hydroxysteroid Dehydrogenases (66-77) xHFDCholesterol Esters D04.808.247.222.284.200; D04.808.247.808.197.200; D10.516.851.208.250 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholesterol Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol (66-77); Esters (68-77) zM>,Cholesterol Esterase D08.586.277.352.100.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases An enzyme that catalyzes the hydrolysis of cholesterol and some other sterol esters, to liberate cholesterol plus a fatty acid anion. EC 3.1.1.13. Esterases (73-74); Cholesterol (73-74) }F/Cholesterol Ester Storage Disease C18.452.648.556.641.201; C18.452.648.595.201 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases A rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase. It results in an accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells). It is an allelic variant of WOLMAN DISEASE. Cholesterol Esters (78-88); Lipase (66-88); Lipid Metabolism, Inborn Errors (66-88); Lipoidosis (66-88) (2L,h|Cholesterol Desmolase D08.586.600.200; D08.586.682.250; D08.586.682.420.170.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Multi-enzyme complex required for the conversion of cholesterol to adrenal cortex hormones. It releases methylpentanoate or isocaproaldehyde and pregnenolone. The complex contains cytochrome P-450, a flavoprotein, a non-heme iron protein and NADPH. EC 1.14.15.6. Cholesterol (71-74); Multienzyme Complexes (73-74); Oxidoreductases (71-74) AF0/YCholesterol Acyltransferase D08.586.913.050.380 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26. Acyltransferases (73-75); Cholesterol (73-75); Coenzyme A (73-75) < FiEOCholesterol D04.808.247.222.284; D04.808.247.808.197; D10.516.851.208 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Embolism, Cholesterol; Hypercholesterolemia Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols Azacosterol; Cholesterol Esters; Hydroxycholesterols; 19-Iodocholesterol; Ketocholesterols Azacosterol; Cholestanol; Cholesterol Esters; Dehydrocholesterols (+ 1); Hydroxycholesterols; 19-Iodocholesterol; Ketocholesterols Azacosterol; Cholestanol; Cholesterol, Dietary; Cholesterol Esters; Dehydrocholesterols (+ 1); Hydroxycholesterols; Ketocholesterols; Lipoproteins, HDL Cholesterol; Lipoproteins, LDL Cholesterol; Lipoproteins, VLDL Cholesterol Cholest-5-en-3 beta-ol. The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $AB2HCholestenones D04.808.247.222.265 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Ecdysone; Ecdysterone; Ketocholesterols CHOLESTENES with one or more double bonds and substituted by any number of keto groups. Cholestenes (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $8F/jDCholestenes D04.808.247.222 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes Cholecalciferol (+ 5); Cholestadienes (+ 6); Cholestenones (+ 3); Cholesterol (+ 5); Dihydrotachysterol; Ergocalciferols (+ 1); Ergosterol; Sitosterols Steroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Members include compounds with any degree of unsaturation; however, CHOLESTADIENES is available for derivatives containing two double bonds. Cholestanes (68-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $j87DCholesteatoma, Middle Ear C09.218.200; C17.800.428.260.300; C23.200.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis; Cholesteatoma Symptoms and General Pathology (Non MeSH); Cholesteatoma Cholesteatoma associated with chronic infection of the middle ear, formed of the outer desquamating layers of stratified squamous epithelium which has extended inward and upward to line the tympanum, epitympanum, and antrum. (Dorland, 27th ed). Cholesteatoma (66-94); Ear Diseases (66-94); Ear, Middle (66-94) E5NOCholesteatoma C17.800.428.260; C23.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Symptoms and General Pathology (Non MeSH) Cholesteatoma, Middle Ear Cholesteatoma, Middle Ear A cystlike mass with a lining of stratified squamous epithelium, usually of keratinizing type, filled with desquamating debris, frequently including cholesterol. Cholesteatomas occur in the meninges, central nervous system, and bones of the skull, but are most common in the middle ear and mastoid region. (Dorland, 27th ed). VN<|Cholestasis, Intrahepatic C06.130.450.250; C06.552.150; C23.888.498.250.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Cholestasis Digestive System Diseases; Liver Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Cholestasis Alagille Syndrome; Liver Cirrhosis, Biliary Alagille Syndrome; Liver Cirrhosis, Biliary Alagille Syndrome; Liver Cirrhosis, Biliary Intrahepatic impairment of bile flow. It is usually due to liver cell damage, but may be due to obstruction of intrahepatic bile ducts. It is also called hepatocellular jaundice and medical jaundice. Bile Ducts, Intrahepatic (66-79); Cholestasis (66-79); Liver (66-79)  :9NSCholestasis C06.130.450; C23.888.498.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice Bile Duct Obstruction, Extrahepatic; Cholestasis, Intrahepatic (+ 2) Bile Duct Obstruction, Extrahepatic; Cholestasis, Intrahepatic (+ 2) Impairment of biliary flow at any level from the hepatocyte to Vater's ampulla. "N`Cholestanones D04.808.247.125 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes CHOLESTANES substituted with any number of keto groups. Cholestanes (68-74) 87CCholestanols D04.808.247.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes Cholestanol Cholestanes substituted in any position with one or more hydroxy groups. They are found in feces and bile. In contrast to bile acids and salts, they are not reabsorbed. Cholestanes (68-77); Sterols (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $%87-DCholestanol D04.808.247.100.250; D04.808.247.808.197.135; D10.516.851.208.160 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestanols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol Cholestanol. Occurs in human feces, gallstones, eggs, and other biological matter. 1IDbCholestanes D04.808.247 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Cholestanols (+ 1); Cholestanones; Cholestenes (+ 28); Sterols (+ 26) Derivatives of the saturated steroid cholestane with methyl groups at C-18 and C-19 and an iso-octyl side chain at C-17. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  <8(WDCholestadienols D04.808.247.222.222.347 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholestadienes Dehydrocholesterols; Desmosterol; Fusidic Acid; Lanosterol; Stigmasterol Cholestadiene derivatives containing a hydroxy group anywhere in the molecule. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8XU\<Cholestadienes D04.808.247.222.222 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Cholestadienols (+ 5) Cholene derivatives with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. They must have two double bonds in the ring system. Cholestenes (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8F<Cholera Vaccine D24.310.894.135.222 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines >pCholera Toxin D24.185.926.123.194 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Vibrio cholerae Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins The exotoxin from Vibrio cholerae. It is a protein that consists of two major components, the heavy (H) or A peptide and the light (L) or B peptide or choleragenoid which binds the whole protein to cell membranes, is nontoxic, but immunogenic. The A fragment causes cholera, probably due to the activation of adenylate cyclase; it consists of two polypeptide fragments. Bacterial Proteins (66-77); Bacterial Toxins (77); Enterotoxins (66-77); Toxins (66-67)  :kjCholera Morbus C06.405.236.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Gastroenteritis A once popular name for an acute severe gastroenteritis of unknown etiology, with diarrhea, cramps, and vomiting, occurring in summer or autumn. It should be differentiated from classical CHOLERA which is also characterized by severe gastrointestinal and metabolic manifestations but is caused by a powerful enterotoxin produced by Vibrio cholerae. (Dorland, 27th ed). NPCholera C01.252.400.959.347 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Vibrio Infections An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.  PCholenes D04.808.221.263 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes Unsaturated derivatives of cholane with methyl groups at C-10 and C-13 and a branched five-carbon chain at C-17. They must have at least one double bond in the ring system. Cholanes (68-74)  84Cholelithiasis C06.130.409; C06.130.564.300; C23.146.315 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Digestive System Diseases; Biliary Tract Diseases Digestive System Diseases; Biliary Tract Diseases; Gallbladder Diseases Symptoms and General Pathology (Non MeSH); Calculi Common Bile Duct Calculi Common Bile Duct Calculi Presence or formation of gallstones. .1R=-Choledochostomy E04.035.200; E04.765.120.200 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Common Bile Duct Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Surgical formation of an opening (stoma) into the common bile duct for drainage or for direct communication with a site in the small intestine, primarily the duodenum or jejunum. Common Bile Duct/surgery (66-87); Common Bile Duct Calculi/surgery (66-87); Drainage (66-87); Duodenum/surgery (66-87); Jejunum/surgery (66-87)  "$Choledochal Cyst C04.182.198; C06.130.120.250.198 BLBSCFCHCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases; Common Bile Duct Diseases A congenital cystic dilatation of the common bile duct; this condition may be asymptomatic, or cause vomiting, fever, jaundice, or pain in the right upper quadrant. Biliary Tract Diseases (72-79); Common Bile Duct (66-79); Common Bile Duct Diseases (80-89); Cysts (66-89) &TCholecystostomy E04.035.195; E04.765.120.195 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Gallbladder Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Establishment of an opening into the gallbladder either for drainage or surgical communication with another part of the digestive tract, usually the duodenum or jejunum. Drainage (66-87); Gallbladder/surgery (66-87)  G"$7Cholecystokinin D06.472.317.152; D12.644.120; D12.776.641.650.105; D14.600.600.185; D19.316.629.159 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Cholecystokinin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Gastrointestinal Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Gastrointestinal Hormones Sincalide Sincalide Sincalide A 33-amino acid peptide secreted by the upper intestinal mucosa and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.  e_F%TCholecystography E01.184.179; E01.357.818.820.210 AECLCTECHIISMOMTNUPXSNSTTDUTVE Biliary Tract; Gallbladder Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography; Radiography, Abdominal (Non MeSH) Radiography of the gallbladder after ingestion of a contrast medium. &"!RCholecystitis C06.130.564.263 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Gallbladder Diseases Inflammation of the gallbladder. ONT(Cholecystectomy, Laparoscopic E01.418.784.500; E04.765.120.172.140; E04.799.500 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Diagnosis; Endoscopy; Surgery, Laparoscopic Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery; Cholecystectomy Surgery, Operative; Surgery, Laparoscopic Excision of the gallbladder through an abdominal incision using a laparoscope. Laparoscopy (89-92) `"9$]Cholecystectomy E04.765.120.172 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Postcholecystectomy Syndrome Gallbladder Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Cholecystectomy, Laparoscopic Surgical removal of the gallbladder. $N$!_"-Cholecalciferol D04.808.247.222.159; D04.808.247.808.146; D04.808.812.221; D10.516.851.152; D11.786.763.196 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Calcitriol Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols Polycyclic Hydrocarbons; Steroids; Secosteroids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D Hydroxycholecalciferols (+ 4) Hydroxycholecalciferols (+ 4) Hydroxycholecalciferols (+ 4) Hydroxycholecalciferols (+ 4) Hydroxycholecalciferols (+ 4) (3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol. An antirachitic vitamin that undergoes metabolic conversion before exerting biological effects. (From Dorland, 27th ed).  ǥgDSCholangitis, Sclerosing C06.130.120.200.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases; Cholangitis Chronic, nonbacterial inflammatory narrowing of the bile ducts. About 50% of the cases are associated with ulcerative colitis. Treatment is to relieve the obstruction by balloon dilatation or surgery. Cholangitis (66-88); Sclerosis (66-88) mNb/Cholangitis C06.130.120.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases Cholangitis, Sclerosing Inflammation of a bile duct. ͑NS%Cholangiopancreatography, Endoscopic Retrograde E01.184.138.195; E01.184.340.200; E01.357.818.820.200.240; E01.418.340.200 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Sphincterotomy, Endoscopic Bile Ducts; Oddi's Sphincter; Vater's Ampulla Diagnosis; Diagnosis, Digestive System (Non MeSH); Cholangiography Diagnosis; Diagnosis, Digestive System (Non MeSH); Endoscopy, Digestive System Diagnosis; Diagnostic Imaging; Radiography; Radiography, Abdominal (Non MeSH); Cholangiography Diagnosis; Endoscopy; Endoscopy, Digestive System Fiberoptic endoscopy designed for duodenal observation and cannulation of VATER'S AMPULLA, in order to visualize the pancreatic and biliary duct system by retrograde injection of contrast media. Endoscopic (Vater) papillotomy (SPHINCTEROTOMY, ENDOSCOPIC) may be performed during this procedure. Cholangiography (66-80); Endoscopy (66-80); Pancreas (66-80) $μ5T&8PQICholangiography E01.184.138; E01.357.818.820.200 AECLCTECHIISMOMTNUPXSNSTTDUTVE Biliary Tract Diseases; Biliary Tract; Bile Ducts Diagnosis; Diagnosis, Digestive System (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography; Radiography, Abdominal (Non MeSH) Cholangiopancreatography, Endoscopic Retrograde Cholangiopancreatography, Endoscopic Retrograde Radiographic examination of the bile ducts. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $&"=h5&Cholangiocarcinoma C04.557.470.200.025.450 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma A malignant tumor arising from the intrahepatic bile duct epithelium. It is composed of ducts lined by cuboidal or columnar cells that do not contain bile, with abundant stroma. (From Holland et al., Cancer Medicine, 3d ed; Stedman, 25th ed). Adenoma, Bile Duct (67-93); Bile Duct Neoplasms (66-93); Liver Neoplasms (66-93) X"bCholanes D04.808.221 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Cholenes; Cholic Acids (+ 19) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ״ 8(&FCholagogues and Choleretics D19.316.508 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Biliary Tract Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Anethole Trithione; Bile Acids and Salts; Hymecromone Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $!8SADChoice Behavior F02.463.785.373.346 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking; Decision Making Career Choice The act of making a selection among two or more alternatives, usually after a period of deliberation. Decision Making (74)   nzChoanal Atresia C08.460.171; C08.695.271; C09.603.171; C16.131.740.271 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Nose Diseases Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Otorhinolaryngologic Diseases; Nose Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) Congenital bony or membranous occlusion of one or both choanae, due to failure of the embryonic bucconasal membrane to rupture. Nasal Cavity/abnormalities (75-85); Nose/abnormalities (66-74) j@L/JCHO Cells A11.251.210.200 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Cells, Cultured; Cell Line Cell line derived from the ovary of the Chinese hamster, Cricetulus griseus. The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. Cell Line (72-91) A*+BChlorzoxazone D03.438.221.346; D15.525.140; D16.700.600.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzoxazoles Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p.1202). 75:;Chlorthalidone D02.065.884.365; D02.886.590.700.365; D19.770.224.516.196 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl A:Chlortetracycline D20.085.868.146 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Tetracyclines (4S-(4 alpha,4a alpha,5a alpha,6 beta,12a alpha))-7-Chloro-4-dimethylamino-1,4,4a,5,5a,6,11,12,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide. An antibiotic substance isolated from the substrate of Streptomyces aureofaciens and used as an antibacterial and antiprotozoal agent. <:[Chlorquinaldol D03.438.810.350.625.250.260; D20.136.172 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines; Oxyquinoline; Chloroquinolinols Anti-Infective Agents; Antifungal Agents 5,7-Dichloro-2-methyl-8-quinolinol. Local anti-infective agent used for skin, gastrointestinal, and vaginal infections with fungi, protozoa, and certain bacteria. In animals, it causes CNS damage and is not administered parenterally. It is also used as antiseptic, fungistat, or deodorant. .:MChlorprothixene D03.494.953.704.250; D14.100.150.175.125; D15.150.150; D15.210.950.040.150; D15.700.872.331.300 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Xanthenes; Thioxanthenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A thioxanthine with effects similar to the phenothiazine antipsychotics. k: UChlorpropham D02.241.081.251.200; D05.723.366.448.196 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Carbamate Carbamates (66-71); Herbicides (66-71) .:/Chlorpropamide D02.886.590.795.283; D02.948.828.283; D09.482.246 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents 9:Chlorpromazine D03.494.741.198; D14.100.150.175.120; D15.095.125; D15.150.025.150; D15.210.950.040.025.150; D15.700.872.331.025.208 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antiemetics Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking dopamine receptors. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. 6:Chlorphentermine D02.092.471.683.152.766.262; D16.050.870.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines; Phentermine Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1223). {2:0Chlorpheniramine D03.383.725.165; D14.100.375.425.400.140; D23.075.162 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Dermatologic Agents; Antipruritics A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE. =:3DChlorphenesin D02.033.618.706.345; D15.525.135; D16.700.600.135 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Propanediols Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A centrally acting muscle relaxant. Its mode of action is unknown. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1203). >9:Chlorphenamidine D02.078.200; D05.723.491.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides N'-(4-Chloro-o-tolyl)-N,N-dimethylformamidine. An acaricide used against many organophosphate and carbamate resistant pests. It acts as an uncoupling agent and monoamine oxidase inhibitor. Amidines (71-74); Toluene (72-74) t":*Chlorotrianisene D02.455.426.559.389.150.700.100; D06.597.378.359.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzylidene Compounds; Stilbenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Estrogens, Synthetic; Estrogens, Non-Steroidal 1,1',1''-(1-Chloro-1-ethenyl-2-ylidene)tris(4-methoxybenzene). A powerful synthetic, non-steroidal estrogen. ::E{Chlorothiazide D03.438.174.261; D18.162.276.237; D19.770.224.578.237 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide Hydrochlorothiazide (+ 1) Hydrochlorothiazide (+ 1) Hydrochlorothiazide (+ 1) =:"YChloroquinolinols D03.438.810.350.625.250; D21.370.107.230 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Hydroxyquinolines; Oxyquinoline Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides Chlorquinaldol 8-Hydroxyquinolinols chlorinated on the number 5 and/or 7 carbon atom(s). They are antibacterial, antiprotozoal, and antidiarrheal, especially in amebiasis, and have also been used as antiseborrheics. The compounds are mostly used topically, but have been used also as animal feed additives. They may cause optic and other neuropathies and are most frequently administered in combination with other agents. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  $.8:Chloroquine D03.438.810.050.180; D17.050.125; D21.370.107.185; D21.370.286.245 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Aminoquinolines Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Amebicides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials Hydroxychloroquine Hydroxychloroquine Hydroxychloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. L:}?Chloroprene D02.455.326.271.665.146.280 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes; Alkadienes 2-Chloro-1,3-butadiene. Toxic, possibly carcinogenic, monomer of neoprene, a synthetic rubber; causes damage to skin, lungs, CNS, kidneys, liver, blood cells and fetuses. Synonym: 2-chlorobutadiene. Butadienes (66-78); Neoprene (75-78)  1:-Chloroplasts A11.368.702.700.140 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Photosynthesis Cells; Cytoplasm; Organelles; Plastids Chlorophyll-containing plastids functioning in photosynthesis. S*0GChlorophyllides D11.557.727.220.180; D11.557.727.640.220.180 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Chlorophyll Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Metalloporphyrins; Chlorophyll Products of the hydrolysis of chlorophylls in which the phytic acid side chain has been removed and the carboxylic acids saponified. Chlorophyll (72-74) T2>Chlorophyll D11.557.727.220; D11.557.727.640.220 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Photosynthesis Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Metalloporphyrins Bacteriochlorophylls; Chlorophyllides; Pheophytins; Protochlorophyllide Bacteriochlorophylls; Chlorophyllides; Protochlorophyllide *DChlorophenols D02.455.426.559.389.261.190; D02.755.190 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Chlorobenzenes Organic Chemicals (Non MeSH); Phenols  Dichlorophen; Pentachlorophenol Phenols substituted with one or more chlorine atoms in any position. Chlorobenzenes (74-76); Phenols (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $.8&S0:Chloromercurinitrophenols D02.691.750.740.225; D08.373.830.240 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Phenylmercury Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Mercuriphenols substituted with one or more chlorine atoms and one or more nitro groups. They are sulfhydryl reagents which act as chromophoric probes in enzymes and other proteins. Mercury (68-76); Nitrophenols (68-76); Organometallic Compounds (68-76) *8UChloromercuribenzoates D02.241.223.106.604.261; D02.691.750.740.644.261; D08.373.830.699.261 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Mercuribenzoates Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Phenylmercury Compounds; Mercuribenzoates Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents; Mercuribenzoates Benzoates (66) M8Chlorohydrins D02.033.440 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols alpha-Chlorohydrin; Chlorobutanol; Epichlorohydrin; Ethchlorvynol; Ethylene Chlorohydrin Aliphatic alcohols which are substituted with chlorine. Alcohols (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $80eB:Chloroguanide D02.078.370.141.125; D21.370.286.195; D26.087.185 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines; Biguanides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 9:Chlorogenic Acid D02.241.223.268.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids *:~Chloroform D02.455.526.439.224; D26.191.191 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Bromotrichloromethane A colorless, volatile liquid with a strong characteristic odor and a sweetish, burning taste, a common laboratory solvent. It was once widely used as an inhalation anesthetic and analgesic, and as an antitussive, carminative, and counterirritant. It was banned by the FDA from use in drug, cosmetic, and food packaging products in 1976. This substance may reasonably be anticipated to be a carcinogen. (From Dorland, 27th ed; Merck Index, 11th ed). -&:Chlorofluorocarbons D02.455.526.439.220; D02.455.526.510.140 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Fluorinated Freons Freons A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses. ".8AChlorobutanol D02.033.210.345; D02.033.440.220; D02.033.555.233.345; D10.516.289.233.345 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohols, Butyl Organic Chemicals (Non MeSH); Alcohols; Chlorohydrins Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols; Alcohols, Butyl Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols; Alcohols, Butyl %rT:9Chlorobenzoates D02.241.223.106.260 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Benzoic acid or benzoic acid esters substituted with one or more chlorine atoms. Benzoates (66-74) 'i8kaChlorobenzenes D02.455.426.559.389.261; D02.455.526.439.202 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Chlorophenols; Dinitrochlorobenzene; Hexachlorobenzene Dinitrochlorobenzene; Hexachlorobenzene AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR (28 iDChlormezanone D03.383.855.150; D15.075.150; D15.210.950.012.150; D15.525.130; D15.700.872.015.269; D16.700.600.130 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazines Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Muscle Relaxants, Central Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm. +.r:!Chlormethiazole D03.383.871.180; D14.100.240.500.162; D15.080.155; D15.210.350.800.130; D15.325.875.125; D15.575.090 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anticonvulsants Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Neuroprotective Agents A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GABA receptors response and it may also affect glycine receptors. Hypnotics and Sedatives (66-67); Thiazoles (66-67) .r:8`=Chlormerodrin D02.691.750.100.229; D19.770.224.391.165 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds; Alkylmercury Compounds Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Mercurial 3.:Chlormequat D02.092.102.207; D02.675.276.207; D11.303.760.236 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators Ammonium Compounds (66-71); Plant Growth Regulators (66-71) 59:GChlormadinone D04.808.745.432.144; D04.808.883.294; D06.597.799.146; D07.360.276.210.443.706.139 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Polycyclic Hydrocarbons; Steroids; Steroids, Chlorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic 17-(Acetyloxy)-6-chloropregna-4,6-diene-3,20-dione (systematic name of ester, the active compound). An orally active synthetic progestational hormone used often in combinations as an oral contraceptive. 6\:Chlorisondamine D02.092.102.200; D02.675.276.200; D14.100.120.200.600.140; D16.050.340.130; D18.162.139 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Blockers Cardiovascular Agents; Antihypertensive Agents A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications. :pc:Chlorine Compounds (Non MeSH) D01.210 Inorganic Chemicals (Non MeSH) Chlorates; Cisplatin; Hydrochloric Acid (+ 8); Hypochlorous Acid (+ 1); Perchloric Acid; Ruthenium Red Inorganic compounds that contain chlorine as an integral part of the molecule. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR >$ %~^<Chlorine D01.268.380.150; D01.362.225 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Halogens Inorganic Chemicals (Non MeSH); Gases Chlorine. A greenish-yellow, diatomic gas that is a member of the halogen family of elements. It has the atomic symbol Cl, atomic number 17, and atomic weight 70.906. It is a powerful irritant that can cause fatal pulmonary edema. Chlorine is used in manufacturing, as a reagent in synthetic chemistry, for water purification, and in the production of chlorinated lime, which is used in fabric bleaching. ? ":kChlorides D01.210.450.150; D01.248.497.158.215 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Ammonium Chloride; Calcium Chloride; Lithium Chloride; Magnesium Chloride; Mercuric Chloride; Potassium Chloride; Sodium Chloride Inorganic compounds derived from hydrochloric acid that contain the Cl- ion. By *:[Chloride Peroxidase D08.586.682.732.360 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases An enzyme that catalyzes the chlorination of a range of organic molecules, forming stable carbon-chloride bonds. EC 1.11.1.10. Chlorine (73-75); Peroxidases (73-75) DFg.Chloride Channels D12.776.395.550.440.175; D12.776.543.550.425.175 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Ion Channels Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Ion Channels Cell membrane glycoproteins selective for chloride ions. Chlorides (79-93); Ion Channels (79-93); Membrane Proteins (88-93) Fr6FCQChlorhexidine D02.078.370.141.100; D20.187.182 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines; Biguanides Anti-Infective Agents; Anti-Infective Agents, Local 1,1-Hexamethylenebis(5-(p-chlorophenyl) biguanide)dihydrochloride. Disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. Synonyms: Hibiclens; Hibitane; Lisium; Nolvasan; Rotersept; Sterilon. Biguanides (68-74); Chlorobenzenes (74) H&: 0Chlorfenvinphos D02.705.150; D05.723.491.574.130 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organophosphate 2-Chloro-1-(2,4-dichlorophenyl)ethenyl diethyl phosphate. An organophorphorus insecticide; has cholinesterase inhibitory action. Synonyms: C-8949; GC-4072; SD-7859; Birlane; chlorfenvinfos; chlorphenvinfos; chlorphenvinphos; Sapecron. Insecticides (66-72); Insecticides, Organophosphate (73-79); Organophosphorus Compounds (71-79); Phosphoric Acids (66-70); Vinyl Compounds (71-74) K&: Chlorella B05.104.234.469 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae; Algae, Green Prototheca Nonmotile unicellular green algae potentially valuable as a source of high-grade protein and B-complex vitamins. Algae, Green (70-71)  N& &=Chlordiazepoxide D03.438.079.080.150; D14.100.240.500.150; D15.045.175; D15.075.050.125; D15.210.350.800.120; D15.210.950.012.050.109; D15.325.875.120; D15.700.872.015.050.165 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anesthesia Adjuvants Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawl. O:Chlordan D02.455.526.439.180; D05.723.491.491.193 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine U .:Chlorates D01.210.300; D01.248.497.158.190 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH) Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic salts of chloric acid that contain the ClO3- ion. Chlorine (66-70) V &8IChloranil D02.806.250.210; D05.723.288.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Benzoquinones Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial 2,3,5,6-Tetrachloro-1,4-benzoquinone. A quinone fungicide used for treatment of seeds and foliage. Chlorine (74-75); Quinones (68-75) X  &:r+Chloramphenicol Resistance G04.185.515.286.202; G05.386.310.202; G05.706.310.202; G12.392.269.202 GEIMPHRE Chloramphenicol Acetyltransferase Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial Genetics; Genetics, Microbial; Drug Resistance, Microbial Genetics; Pharmacogenetics; Drug Resistance, Microbial Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial Nonsusceptibility of a bacterium to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides. Chloramphenicol (66-87); Drug Resistance, Microbial (66-87)  YP &FChloramphenicol Acetyltransferase D08.586.913.050.134.170 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Chloramphenicol Resistance Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Acetyltransferases An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28. Acetyltransferases (73-88); Transferases (66-72)  ]s&F9Chloramphenicol D02.033.618.706.300; D20.085.215 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Propanediols Anti-Infective Agents; Antibiotics  Thiamphenicol `&<rChloramines D02.065.884.344; D02.886.590.700.344 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides a*8Chlorambucil D02.455.526.728.650.156; D22.204.585.186 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds Prednimustine Prednimustine 4-(Bis(2-chloroethyl)amino)benzenebutanoic acid. A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed). c+.: Chloralose D02.033.618.250.130.150; D09.203.408.348.150; D15.050.035.075.142.150; D15.210.100.175.075.142.150; D15.210.350.800.100.150; D15.325.875.100.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Ethylene Glycols; Chloral Hydrate Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Chloral Hydrate Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Chloral Hydrate Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate; Chloral Hydrate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate; Chloral Hydrate A derivative of CHLORAL HYDRATE that was used as a sedative but has been replaced by safer and more effective drugs. Its most common use is as a general anesthetic in animal experiments. f:Chloral Hydrate D02.033.618.250.130; D15.050.035.075.142; D15.210.100.175.075.142; D15.210.350.800.100; D15.325.875.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Ethylene Glycols Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Chloralose Chloralose Chloralose Chloralose Chloralose A hypnotic and sedative used in the treatment of insomnia. The safety margin is too narrow for chloral hydrate to be used as a general anesthetic in humans, but it is commonly used for that purpose in animal experiments. It is no longer considered useful as an anti-anxiety medication. kcs:*>TChlamydomonas reinhardtii B01.841.750.443.575.900.344.650; B05.104.234.344.650 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea; Volvocida; Chlamydomonas Algae and Fungi (Non MeSH); Algae; Algae, Green; Chlamydomonas An organism considered both a protozoon (Dorland, 27th ed) and an alga (Bold and Wynne, Introduction to the Algae, 2d ed, p.84). Delicate, hairlike appendages arise from the flagellar surface in these organisms. Algae, Green (70-71); Chlamydomonas (72-91) p:&5Chlamydomonas B01.841.750.443.575.900.344; B05.104.234.344 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Mastigophora; Phytomastigophorea; Volvocida Algae and Fungi (Non MeSH); Algae; Algae, Green Chlamydomonas reinhardtii Chlamydomonas reinhardtii A genus of organisms considered both a protozoon (Dorland, 27th ed) and an alga (Bold and Wynne, Introduction to the Algae, 2d ed, p.84). It consists of solitary biflagellated organisms common in fresh water and damp soil. Algae, Green (70-71)  r2&: Chlamydiales B03.700.300 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH) Chlamydiaceae (+ 4) Gram-negative parasites of vertebrates in which they may cause various diseases; occasionally found in arthropods. Bacteria (66-74); Micotatobiotes (75)  u."9.Chlamydiaceae Infections C01.252.400.810.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH) Chlamydia Infections (+ 4) Infections with bacteria of the family CHLAMYDIACEAE. Chlamydia Infections (67-76); Rickettsial Infections (66-76)  vP!@GChlamydiaceae B03.700.300.394 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Chlamydiales Chlamydia (+ 3) A family of gram-negative, coccoid microorganisms containing the genus CHLAMYDIA. x"J_Chlamydia trachomatis B03.700.300.394.260.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Chlamydiales; Chlamydiaceae; Chlamydia The etiological agent of a variety of ocular and urogenital diseases. Chlamydia (66-75) y"hTChlamydia psittaci B03.700.300.394.260.575 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Chlamydiales; Chlamydiaceae; Chlamydia Parasitic organisms of vertebrate cells. They have been detected in over 100 species of birds and in most domesticated and many wild mammals. They generally produce systemic infections in a broad range of hosts. Chlamydia (66-74) {"hChlamydia pneumoniae B03.700.300.394.260.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Chlamydiales; Chlamydiaceae; Chlamydia A species of gram-negative bacteria that causes acute respiratory infection, especially atypical pneumonia. Chlamydia (89-91) }"h|Chlamydia Infections C01.252.400.810.200.195; C01.252.810.301; C01.539.780.281.301 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Chlamydiaceae Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Sexually Transmitted Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Bacterial Conjunctivitis, Inclusion; Lymphogranuloma Venereum; Ornithosis; Trachoma Lymphogranuloma Venereum Lymphogranuloma Venereum Infections with bacteria of the genus CHLAMYDIA. Conjunctivitis (66); Trachoma (66)  ~EP;+Chlamydia B03.700.300.394.260 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Chlamydiales; Chlamydiaceae Chlamydia pneumoniae; Chlamydia psittaci; Chlamydia trachomatis A genus of gram-negative bacteria whose species cause a variety of diseases in humans, other mammals, and birds. $ "[JChitinase D08.586.277.450.207 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases  FlChitin Synthase D08.586.913.400.450.460.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Hexosyltransferases; Glucosyltransferases An enzyme that converts UDP glucosamine into chitin and UDP. EC 2.4.1.16. Chitin (74); Glucosamine (74); Hexosyltransferases (74); Uridine Diphosphate Sugars (74) FZkChitin D09.203.698.211 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Polysaccharides (66)  F^Chiroptera B02.649.225 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals (Chiropractic E02.040.200; E02.175; G02.110 AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUT Therapeutics; Alternative Medicine Therapeutics Health Occupations A system that seeks to utilize the recuperative powers of the body and the relationship between the musculoskeletal structures and functions of the body, particularly of the spinal column and the nervous system, in the restoration and maintenance of health. (From Stedman, 25th ed). -%(LLChironomidae B01.131.617.289.260 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera A family of the order DIPTERA. Salivary glands of the genus Chironomus are used in studies of cellular genetics and biochemistry. Diptera (75-80) E(5Chinchilla B02.649.865.328 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia A genus of the family Chinchillidae which consists of three genera: Lagidium, Lagostomus, and Chinchilla. They are used extensively in biomedical research. Rodentia (66-67) (&China Z01.252.474.164 EHEP Geographicals (Non MeSH); Asia; Far East Tibet  4 Chin A01.456.505.259; A02.835.232.781.324.502.632.130; A14.521.632.300 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Mandible Body Regions (Non MeSH); Head; Face Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw; Mandible Stomatognathic System; Jaw; Mandible The anatomical frontal portion of the mandible, also known as the mentum, that contains the line of fusion of the two separate halves of the mandible (symphysis menti). This line of fusion divides inferiorly to enclose a triangular area called the mental protuberance. On each side, inferior to the second premolar tooth, is the mental foramen for the passage of blood vessels and a nerve. I( Chimpansee troglodytes B02.649.801.400.650.130 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Pongidae This single species of Chimpansee, a member of the PONGIDAE family, lives in the tropical forests of Africa. The small or pygmy chimpansee, paniscus, is considered by some to be a subspecies of troglodytes and by others to be a separate genus, Bonobo. It is stated that this animal is the most intelligent of the apes. Pongidae (66-71) (@|Chimeric Proteins D12.776.828.300.220 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins; Recombinant Fusion Proteins Proteins in individuals that are derived from genetically different zygotes. F~ZChimera G05.148.630.218 DEGEIMPHRE Animals, Transgenic Animals, Transgenic Genetics; Cytogenetics; Mosaicism Transplantation Chimera An individual whose body contains cell populations derived from different zygotes. Genetics (66); Mosaicism (66-77) ( )a)Chile Z01.107.757.235 EHEP Geographicals (Non MeSH); America; South America  <Child, Unwanted I01.880.787.293.680; M01.471.392.465 CLEDHILJPXSN Social Sciences; Sociology; Social Welfare; Child Welfare Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child The child who is not wanted by one or both parents. Parent-Child Relations (66-77); Pregnancy, Unwanted (73-77) ^*BFChild, Preschool M01.471.392.448 CLEDHILJSN Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child A child between the ages of 2 and 5. P1Child, Institutionalized I01.880.787.293.493; M01.471.392.377 CLEDHILJPXSN Institutionalization Social Sciences; Sociology; Social Welfare; Child Welfare Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child The normal or defective child who is being cared for in an institution either because he is homeless or requires special care. *Child, Hospitalized M01.471.392.305; M01.643.259 CLEDHILJPXSN Hospitalization Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child Named Groups (Non MeSH); Patients "yChild, Gifted F02.784.629.228.350; M01.471.392.234.342 CLEDGEHILJPXSN Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational; Child, Exceptional Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Child, Exceptional A child whose intelligence is in the upper two percent of the total population of his age. A gifted child is a child having outstanding ability in any respect. .Child, Exceptional M01.471.392.234; F02.784.629.228 CLEDGEHILJPXSN Early Intervention (Education); Mainstreaming (Education) Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Child, Gifted Child, Gifted A child who deviates from the average in mental, physical, or social characteristics to such an extent that he requires a modification of services in order to develop his maximum potential.  &C"Child, Abandoned I01.880.787.293.192; M01.471.392.163 CLEDHILJPXSN Social Sciences; Sociology; Social Welfare; Child Welfare Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child A child who is deserted by parents or parent substitutes without regard for its future care. Child (66-68) *pChild Welfare I01.880.787.293 CLECEHHILJPXSNTD Foster Home Care Social Sciences; Sociology; Social Welfare Child, Abandoned; Child Abuse (+ 3); Child Advocacy; Child Custody; Child Day Care Centers; Child, Institutionalized; Child, Unwanted Organized efforts by communities or organizations to improve the health and well-being of the child. BLCFCICLCNCODHDIDTECEDEHEMENEPETGEHIIMINLJMAMEMIMOMTNUOGPAPCPPPSPXRARHRIRTSDSNSTSUTDTHURUSUTVEVI $4wdChild Rearing F01.318 EHHIPXTD Parenting Parenting; Child Care Behavior and Behavior Mechanisms (Non MeSH) Toilet Training The training or bringing-up of children by parents or parent-substitutes. It is used also for child rearing practices in different societies, at different economic levels, in different ethnic groups, etc. It differs from PARENTING in that in child rearing the emphasis is on the act of training or bringing up the child and the interaction between the parent and child, while parenting emphasizes the responsibility and qualities of exemplary behavior of the parent. $   4!Child Reactive Disorders F03.234.193 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders Habits (+ 3); Runaway Reaction Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns. AEBLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI  FR(HChild Psychology F04.096.628.193 CLECEDHIISLJMAMTOGSNSTTD Child Development Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology The study of normal and abnormal behavior of children. `CChild Psychiatry F04.096.544.193; G02.403.642.130; G02.403.790.600.258 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry Health Occupations; Medicine; Specialties, Other (Non MeSH); Psychiatry The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in children. !=Child of Impaired Parents M01.471.392.400 CLEDHILJPXSN Parents Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child A child of one or more parents afflicted by an organic, psychiatric, or behavioral disorder. Articles on this subject tend to focus on the child from the social, behavioral, or psychological viewpoint, rather than the genetic.   P Child Nutrition Disorders C18.654.180 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Infant Nutrition Disorders Infant Nutrition Disorders Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders Infant Nutrition Disorders Malnutrition, occurring in children ages 2 to 12 years, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected. Child (66-88); Child, Preschool (66-88); Nutrition Disorders (66-88) (N  O &SChild Nutrition G06.696.259 EDPH Adolescent Nutrition; Infant Nutrition Infant Nutrition Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition Adolescent Nutrition; Infant Nutrition (+ 2) Nutrition of children aged 2-12 years. Nutrition (66) EDEHPHPXSN ,.N60Child Language F01.525.200.310.250 Behavior and Behavior Mechanisms (Non MeSH); Human Development; Child Development; Language Development The language and sounds expressed by a child at a particular maturational stage in development. @zrChild Health Services N02.421.143.130 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services Early Intervention (Education) Organized services to provide health care for children. Child Care (66-67); Child Welfare (66-67) CLECHILJMAMTOGSDSNSTTDUT $ui$C4Child Guidance Clinics N02.278.035.158.300 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Ambulatory Care Facilities; Community Mental Health Centers Facilities which administer the delivery of mental health counseling services to children.  jChild Guidance F02.784.629.272; F04.408.192 CLECEDHIISLJMAMTOGSNSTTD Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Disciplines, Tests, Therapy, Services (Non MeSH); Mental Health Services The psychiatric, sociological and psychological study and treatment of the developing child with emphasis on preventive or prophylactic measures focused on the familial, educational and socio-environmental milieu of the child. z"Child Development Disorders, Pervasive F03.709.680.500 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders Autism, Infantile; Schizophrenia, Childhood Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements. -Fa3Child Development Disorders F03.305 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH) Articulation Disorders; Language Development Disorders Disorders in which there is a delay in development based on that expected for a given age level or stage of development. Biological and nonbiological factors are involved in these disorders. Child Behavior Disorders (66-67); Child Psychology (66-67)  ! F3?FChild Development F01.525.200 CLDEPHRE Growth; Motor Skills; Personality Development Child Psychology; Growth Behavior and Behavior Mechanisms (Non MeSH); Human Development Language Development (+ 2) The continuous sequential physiological and psychological maturing of the child from birth up to but not including adolescence. It includes healthy responses to situations, but does not include growth in stature or size (= GROWTH). Behavior (66-67); Child Psychology (66-67); Growth (66-67) CLDEPHPXRE ,C 7K!HChild Day Care Centers I01.880.787.293.392 CLECEDHILJMAMTOGSDSNSTTDUT Nurseries Schools, Nursery; Nurseries Social Sciences; Sociology; Social Welfare; Child Welfare Facilities which provide care for pre-school and school-age children. Child Care (66-72); Child Welfare (66-72) $ "FR4Child Custody I01.880.787.293.370 CLECEDHILJMAMTOGSDSNSTTDUT Social Sciences; Sociology; Social Welfare; Child Welfare The formally authorized guardianship or care of a child. Child Welfare (66-87) OFEChild Care N02.421.088 CLECHILJMAMTOGPXSDSNSTTDUT Child Rearing; Infant Care Infant Care Facilities, Manpower and Services (Non MeSH); Health Services Infant Care (+ 3) Care of children in the home or institution. CLECHIISLJMAMTOGPXSDSNSTTDUT (c"J8 Child Behavior Disorders F03.234 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH) Anxiety, Separation; Attention Deficit Disorder with Hyperactivity; Child Reactive Disorders (+ 5); Juvenile Delinquency Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns. AEBLCFCICLCODHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRISNSUTDTHURUSVI  þ F3NChild Behavior F01.145.179 CLDEEHPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Infant Behavior Any observable response or action of a child from 24 months through 12 years of age. For neonates or children younger than 24 months, INFANT BEHAVIOR is available. Behavior (66-67); Child Psychology (66-67)  wA4Child Advocacy I01.880.604.473.300; I01.880.787.293.350; N03.706.437.300 CLECEDHIINLJPXSNSTTD Social Sciences; Sociology; Social Control, Formal; Human Rights Social Sciences; Sociology; Social Welfare; Child Welfare Economics, Organizations, Control (Non MeSH); Social Control, Formal; Human Rights Promotion and protection of the rights of children; frequently through a legal process. Child Welfare (66-74) !AiChild Abuse, Sexual F03.126.842.089.734.350.250.255; I01.198.240.856.350.250.255; I01.880.735.900.350.250.255; I01.880.787.293.292.325 CLDIECEHHILJPCPXSNTD Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence; Domestic Violence; Child Abuse Social Sciences; Criminology; Crime; Violence; Domestic Violence; Child Abuse Social Sciences; Sociology; Social Problems; Violence; Domestic Violence; Child Abuse Social Sciences; Sociology; Social Welfare; Child Welfare; Child Abuse Sexual maltreatment of the child or minor. Child Abuse (66-86); Sex Offenses (68-86) *|54Child Abuse F03.126.842.089.734.350.250; I01.198.240.856.350.250; I01.880.735.900.350.250; I01.880.787.293.292 CLDIECEHHILJMOPCPXSNTD Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders; Aggression; Violence; Domestic Violence Social Sciences; Criminology; Crime; Violence; Domestic Violence Social Sciences; Sociology; Social Problems; Violence; Domestic Violence Social Sciences; Sociology; Social Welfare; Child Welfare Child Abuse, Sexual; Munchausen Syndrome by Proxy Child Abuse, Sexual; Munchausen Syndrome by Proxy Child Abuse, Sexual; Munchausen Syndrome by Proxy Battered Child Syndrome; Child Abuse, Sexual; Munchausen Syndrome by Proxy Emotional, nutritional, or physical maltreatment of the child usually by a parent or parent substitute. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMLJMEMIMONUPAPCPPPSPXRARHRIRTSNSUTDTHURUSVEVI  5lzTChild M01.471.392 Only Child Named Groups (Non MeSH); Named Groups by Age (Non MeSH) Adolescence (+ 3); Child, Abandoned; Child, Exceptional (+ 1); Child, Hospitalized; Child, Institutionalized; Child of Impaired Parents; Child, Preschool; Child, Unwanted; Homeless Youth; Infant (+ 5); Only Child BLCFCLEDEHGDGEHIIMLJMEMIPHPSPXSNURVI Y F(Chilblains C21.866.417.217 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Frostbite Recurrent localized itching, swelling and painful erythema on the fingers, toes or ears, produced by exposure to cold. It is also called pernio. N^Chikungunya Virus B04.820.850.054.198; B04.909.777.923.054.198 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae; Alphavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae; Alphavirus A species of ALPHAVIRUS causing an acute dengue-like fever. Ա2HChief Executive Officers, Hospital M01.526.070.490.490.100; M01.526.485.430.490.100; M01.526.485.740.380.100; N02.360.430.490.100; N02.360.740.380.100 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Administrative Personnel; Health Facility Administrators; Hospital Administrators Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Health Facility Administrators; Hospital Administrators Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Personnel, Hospital; Hospital Administrators Facilities, Manpower and Services (Non MeSH); Health Personnel; Health Facility Administrators; Hospital Administrators Facilities, Manpower and Services (Non MeSH); Health Personnel; Personnel, Hospital; Hospital Administrators Individuals who have the formal authority to manage a hospital, including its programs and services, in accordance with the goals and objectives established by a governing body (GOVERNING BOARD). Health Facility Administrators (75-91); Hospital Administrators (75-91) )SChicory B06.316.500; B06.510.280; D26.456.299; J01.341.241.310.500; J01.341.390.304 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Coffee Plants; Herbs Plants; Plants, Edible Miscellaneous Drugs and Agents (Non MeSH); Flavoring Agents Technology, Industry, Agriculture (Non MeSH); Food; Condiments; Herbs Technology, Industry, Agriculture (Non MeSH); Food; Flavoring Agents A thick-rooted perennial herb (Cichorium intybus) native to Europe but widely grown for its young leaves used as salad greens and for its roots, dried and ground-roasted, used to flavor or adulterate coffee. (From Webster, 3d ed).  W4 Chickens B02.248.617.192 ABAHBLCFCLGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds; Poultry Poultry (66-67)   $#Chickenpox C02.256.466.175 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed). ުPXLChicken Anemia Virus B04.280.120.150.140; B04.909.204.120.150.140 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Circoviridae; Circovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Circoviridae; Circovirus The type species of CIRCOVIRUS, a small, non-enveloped DNA virus originally isolated from contaminated vaccines in Japan. It causes chicken infectious anemia and may possibly play a key role in hemorrhagic anemia syndrome, anemia dermatitis, and blue wing disease. DNA Viruses (91-93); Viruses (83-93) 24.Chick Embryo A13.350.150; A16.254.300.200 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Embryo, Non-Mammalian Embryonic Structures (Non MeSH); Embryo; Embryo, Non-Mammalian j":Chicago Z01.107.567.875.100.370.305; Z01.107.567.875.600.313.370.305; Z01.107.567.875.600.516.370.305; Z01.433.305 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH); Illinois Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Great Lakes Region; Illinois Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Midwestern United States; Illinois Geographicals (Non MeSH); Cities (Non MeSH) x tChiari-Frommel Syndrome C13.703.844.506.192; C19.146.556.217 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Puerperal Disorders; Lactation Disorders Endocrine Diseases; Breast Diseases; Lactation Disorders Persistent lactation and amenorrhea following pregnancy. !*NBChi-Square Distribution E05.318.740.994.300; G03.850.520.830.994.300; H01.548.832.901.300; N05.715.360.750.750.200 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics; Statistical Distributions (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Statistical Distributions (Non MeSH) A distribution in which a variable is distributed like the sum of the the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another. d7Cheyne-Stokes Respiration C08.618.182; C23.888.852.227 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) The pattern of breathing with gradual increase in depth and sometimes in rate to a maximum, followed by a decrease resulting in apnea. The cycles ordinarily are 30 seconds to 2 minutes in duration, with 5 to 30 seconds of apnea. It is characteristically seen in coma from disorders of the nervous centers of respiration. (Stedman, 25th ed). "NChewing Gum J01.341.205 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication. "= Chest Tubes E07.858.150 AECLCTECHISDSNSTTDUTVE Thoracostomy; Intubation Equipment and Supplies; Surgical Equipment Plastic tubes used for drainage of air or fluid from the pleural space. Their surgical insertion is called tube thoracostomy. Catheterization (77-89); Catheters, Indwelling (80-82); Drainage (66-89); Intubation (66-89); Respiration, Artificial (83-85); Suction (77-89)  |3Chest Pain C23.888.592.612.195 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Angina Pectoris Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Pressure, burning, or numbness in the chest. Pain (66-86); Thorax (66-86)  qN7%Cherubism C05.116.099.708.375.199; C05.500.174; C07.320.173 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias; Fibrous Dysplasia of Bone Musculoskeletal Diseases; Jaw Diseases Stomatognathic Diseases; Jaw Diseases A fibro-osseous hereditary disease of the jaws. The swollen jaws and raised eyes give a cherubic appearance; multiple radiolucencies are evident upon radiographic examination.  9NChenodeoxycholic Acid D04.808.221.430.342.300; D19.316.246.175 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholanes; Cholic Acids; Deoxycholic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Bile Acids and Salts Glycochenodeoxycholic Acid; Taurochenodeoxycholic Acid Glycochenodeoxycholic Acid; Lithocholic Acid (+ 1); Taurochenodeoxycholic Acid; Ursodeoxycholic Acid 3 alpha,7 alpha-Dihydroxy-5 beta-cholanic acid. A bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones. Bile Acids and Salts (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $e.Dk$FChemotherapy, Adjuvant E02.186.170; E02.319.170 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Combined Modality Therapy Therapeutics; Drug Therapy Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Combined Modality Therapy (84-91); Drug Therapy, Combination (74-83); specific drug/therapeutic use (66-91) l"NChemotaxis, Leukocyte G04.335.283.424.233 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Movement; Chemotaxis The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Chemotaxis (66-76) Chemotaxis G04.335.283.424 DEGEIMPHRE Chemoreceptors; Chemotactic Factors Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Movement Chemotaxis, Leukocyte The movement of cells or organisms toward or away from a substance in response to its concentration gradient.  j*yChemotactic Factors, Macrophage D24.185.125.585 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Chemotactic Factors Cytotaxins liberated from normal or invading cells that specifically attract macrophages. They may be lymphokines, products of antigen, antibody and complement interactions or other. Chemotaxis (66-79); Chemotaxis, Leukocyte (77-79); Macrophages (66-79) %BdTChemotactic Factors, Eosinophil D24.185.125.320 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Chemotactic Factors N-Formylmethionine Leucyl-Phenylalanine Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells. Chemotaxis (66-79); Chemotaxis, Leukocyte (77-79); Eosinophils (66-79) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $0%Bd,"TDChemotactic Factors D24.185.125 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Pheromones Chemotaxis Immunologic and Biologic Factors (Non MeSH); Biological Factors Chemotactic Factors, Eosinophil (+ 1); Chemotactic Factors, Macrophage; N-Formylmethionine Leucyl-Phenylalanine Chemical substances that attract or repel cells or organisms. The concept denotes especially those factors released as a result of tissue injury, invasion, or immunologic activity, that attract leukocytes, macrophages, or other cells to the site of infection or insult. Chemotaxis (66-79); Chemotaxis, Leukocyte (77-79) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,#BL:;DChemosterilants D05.723.141 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Pest Control, Biological; Insect Control; Mosquito Control Environmental Pollutants, Pesticides (Non MeSH); Pesticides Altretamine; Hempa; Tepa (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  c8FF(:Chemoreceptors A08.800.550.700.120 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Chemotaxis Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory Olfactory Receptor Neurons; Paraganglia, Nonchromaffin (+ 3); Taste Buds Cells specialized to detect chemical substances and relay that information centrally in the nervous system. Chemoreceptors may monitor external stimuli, as in taste and olfaction, or internal stimuli, such as the concentrations of oxygen and carbon dioxide in the blood. Receptors, Sensory (66-67) ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI ( 6[W; 8Chemoembolization, Therapeutic E02.520.360.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Antineoplastic Agents Therapeutics; Hemostatic Techniques; Embolization, Therapeutic Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm. Embolization, Therapeutic (79-91)  #"H'Chemistry, Physical H01.181.529 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry Absorption; Adsorption; Air Ionization; Anisotropy; Catalysis; Colloids (+ 1); Corrosion; Crystallization; Crystallography (+ 2); Desiccation; Dialysis; Electrochemistry (+ 22); Energy Transfer (+ 1); Filtration (+ 4); Hydrogen Bonding; Hydrogen-Ion Concentration (+ 3); Hydrolysis; Ion Exchange; Maillard Reaction; Membranes, Artificial (+ 2); Molecular Conformation (+ 5); Molecular Structure (+ 5); Molecular Weight; Osmolar Concentration; Oxidation-Reduction; Particle Size; Permeability (+ 2); Photochemistry (+ 3); Precipitation (+ 2); Radiochemistry; Solubility; Specific Gravity; Spontaneous Combustion; Surface Properties (+ 4); Viscosity; Volatilization ADAEAGAIANBLCFCHCLCSCTDEDUECEDGEHIIMIPISLJMAMEMOMTNUOGPDPHPKPOPXRERHSDSNSTTDTOTUURUTVE 1ZChemistry, Pharmaceutical H01.181.466 CLECEDHIISLJMAMTOGSNSTTD Biopharmaceutics; Drug Compounding Physical Sciences (Non MeSH); Chemistry Drug Design; Structure-Activity Relationship Chemistry that deals with the composition and preparation of substances used in treatment of patients or diagnostic studies. (Dorland, 27th ed).  )14Chemistry, Organic H01.181.404 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry Acylation (+ 1); Alkylation (+ 1); Amination; Cyclization; Dealkylation; Deamination; Decarboxylation; Esterification; Glycosylation; Hydrogenation; Hydroxylation; Isomerism (+ 1); Nitrosation; Phosphorylation CLDEECEDHIISLJMAMTOGRESNSTTD N1 Chemistry, Inorganic H01.181.370 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry Chemistry, Bioinorganic A field of chemistry which pertains to chemical compounds or ions that do not contain the element carbon (with the exception of carbon dioxide and compounds containing a carbonate radical, e.g., calcium carbonate). Chemistry (66-88)  1Chemistry, Clinical E01.223.174; H01.181.341 CLECEDHIISLJMAMTOGSNSTTD Chemistry, Analytical Diagnosis; Diagnosis, Laboratory Physical Sciences (Non MeSH); Chemistry Blood Chemical Analysis (+ 11); Enzyme Tests Analytical chemistry applied to assays of physiologically important substances found in blood, urine, tissues, and other biological fluids for the purpose of aiding the physician in making a diagnosis or following therapy. AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $V9*Chemistry, Bioinorganic H01.181.370.310 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry; Chemistry, Inorganic A field of chemistry which pertains to the study of inorganic compounds or ions in biological systems. Chemistry (66-88) $J{Chemistry, Analytical E05.196; H01.181.278 CLECEDHIISLJMAMTOGSNSTTD Autoanalysis; Chemistry, Clinical Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Chemistry Activation Analysis (+ 1); Biuret Reaction; Calorimetry (+ 1); Chromatography (+ 18); Countercurrent Distribution; Crystallization; Crystallography (+ 2); Desiccation; Dialysis (+ 1); Differential Thermal Analysis (+ 1); Electrophoresis (+ 18); Filtration (+ 3); Flow Injection Analysis; Fractionation; Glucose Clamp Technique; Immunochemistry; Microchemistry; Nucleotide Mapping (+ 2); Peptide Mapping (+ 1); Photometry (+ 17); Polarography; Refractometry; Spectrum Analysis (+ 21); Thermogravimetry; Titrimetry (+ 6); Ultracentrifugation (+ 3) Electrophoresis; Immunochemistry; Microchemistry The branch of chemistry dealing with detection (qualitative) and determination (quantitative) of substances. (Grant and Hackh's Chemical Dictionary, 5th ed). AECLCTDUECEDHIISLJMAMOMTNUOGPXRHSNSTTDTUUTVE $q(Y0Chemistry, Agricultural H01.181.216 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH); Chemistry Maillard Reaction CLDEECEDHIISLJMAMTOGRESNSTTD #1 Chemistry H01.181 CLECEDHIISLJMAMTOGSNSTTD Alchemy; Brain Chemistry; Neurochemistry Physical Sciences (Non MeSH) Biochemistry (+ 2); Chemistry, Agricultural (+ 1); Chemistry, Analytical (+ 3); Chemistry, Clinical; Chemistry, Inorganic (+ 1); Chemistry, Organic (+ 17); Chemistry, Pharmaceutical (+ 2); Chemistry, Physical (+ 92) ADAEAGAIANBLCFCHCLCSCTDEDUECEDGEHIIMIPISLJMAMEMOMTNUOGPDPHPKPOPXRERHSDSNSTTDTOTUURUTVE  #  1#ZChemiluminescence H01.671.606.552.565.200 Luminescence Physical Sciences (Non MeSH); Physics; Optics; Light; Luminescence Emission of light as a result of a chemical reaction without an apparent change in temperature. (McGraw-Hill Dictionary of Scientific and Technical Terms, 3d ed). Luminescence (66-92) &RChemical, Pharmacologic Phenomena (Non MeSH) G12 Biopharmaceutics (+ 6); Depression, Chemical; Dose-Response Relationship, Drug; Down-Regulation (Physiology); Drug Design; Drug Interactions (+ 3); Drug Resistance (+ 13); Drug Tolerance; Lethal Dose 50; Radiation Tolerance; Stimulation, Chemical; Structure-Activity Relationship; Tachyphylaxis; Up-Regulation (Physiology) CLDEECEDGEHIIMISLJMAMTOGPHRESNSTTD '4x&Chemical Warfare Agents D26.253 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTO Tear Gases Miscellaneous Drugs and Agents (Non MeSH) Mustard Gas; Phosgene; Soman Chemical Warfare (66-67); Gases (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $) (2%1:Chemical Warfare I01.880.735.944.340 CLECEHHILJPCPXSNTD Decontamination; Gas Poisoning Social Sciences; Sociology; Social Problems; War Tactical warfare using incendiary mixtures, smokes, or irritant, burning, or asphyxiating gases. *%<pChemical Industry J01.576.207 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry ,AChemical Engineering J01.293.257 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Engineering ,DChemexfoliation E04.860.250 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Plastic Application of a cauterant to the skin for the purpose of causing a superficial destruction of the epidermis and upper layers of the dermis. After healing, the treated area has new epithelium. Face (66-76); Skin (66-76); Skin Diseases (66-76); Surgery, Plastic (66-76) -]$,^Chelation Therapy E02.319.155 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Drug Therapy Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body. Chelating Agents/therapeutic use (66-89) /9"!0Chelating Agents D26.241 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Iron Chelates Antidotes Miscellaneous Drugs and Agents (Non MeSH) Cuprizone; Dimercaprol (+ 1); Dithizone; Ditiocarb; DTPA (+ 1); Edetic Acid; Egtazic Acid; Ferrozine; Fura-2; Iron Chelates (+ 4); Penicillamine; Succimer; Thenoyltrifluoroacetone; Triethylenetetramine Organic chemicals that form two or more coordination bonds with a central metal ion. They are used chemically to remove ions from solutions, medicinally against microorganisms to treat metal poisoning, and in chemotherapy protocols. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (0 , 2DCheirogaleidae B02.649.801.700.200 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Strepsirhini A family of the order PRIMATES, suborder Strepsirhini (PROSIMII), containing five genera. All inhabitants of Madagascar, the genera are: Allocebus, Cheirogaleus (dwarf lemurs), Microcebus (mouse lemurs), Mirza, and Phaner. Lemur (76-91); Lemuridae (82-91); Strepsirhini (76-91) 3(6CCheilitis C07.465.409.215 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases; Lip Diseases Inflammation of the lips. It is of various etiologies and degrees of pathology. 5 N@aCheetahs B02.649.147.200 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Long-legged, swift-moving felines from Africa (and formerly Asia) about the size of a small leopard. 7 ('wCheese J01.341.273.290 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food; Dairy Products 8& "PCheek A01.456.505.173; A14.194 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Head; Face Stomatognathic System 8 (GChediak-Higashi Syndrome C15.378.553.774.257; C20.673.774.257 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Aleutian Mink Disease Albinism; Aleutian Mink Disease Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Phagocyte Bactericidal Dysfunction Immunologic Diseases; Immunologic Deficiency Syndromes; Phagocyte Bactericidal Dysfunction  Aleutian Mink Disease A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the Aleutian mink, and albino Hereford cattle. Immunologic Deficiency Syndromes (68-70); Leukocytes (66-70) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI ,9*N'GPCharities I01.880.787.190 CLECEDHILJMAMTOGSDSNSTTDUT Uncompensated Care Social Sciences; Sociology; Social Welfare Social welfare organizations with programs designed to assist individuals in times of need. >W 4lCharcot-Marie Disease C05.651.518.620.175; C05.651.661.468.620.175; C10.500.686.110; C10.668.468.620.175; C10.772.587.110; C16.131.666.686.110 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Muscular Atrophy; Muscular Atrophy, Spinal Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases; Muscular Atrophy; Muscular Atrophy, Spinal Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory Nervous System Diseases; Neuromuscular Diseases; Muscular Atrophy; Muscular Atrophy, Spinal Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Motor and Sensory Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Motor and Sensory A hereditary motor and sensory neuropathy transmitted as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (occasionally of the arms). Onset is usually in the second to fourth decades. ?sL1Charcoal D01.268.150.150; D26.061.362; D26.228; J01.637.189 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Elements; Carbon Miscellaneous Drugs and Agents (Non MeSH); Antidotes Miscellaneous Drugs and Agents (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Charcoal. An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant and Hackh's Chemical Dictionary, 5th ed). D <,Character F01.752.190 Behavior and Behavior Mechanisms (Non MeSH); Personality In current usage, approximately equivalent to personality. The sum of the relatively fixed personality traits and habitual modes of response of an individual. GG DChaplaincy Service, Hospital N02.278.354.422.270; N04.452.442.422.270 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department which administers religious activities within the hospital, e.g., pastoral care, religious services. H". Chaperonins D12.776.410.210; D12.776.580.210 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones Chaperonin 10 (+ 1); Chaperonin 60 (+ 1) Chaperonin 10 (+ 1); Chaperonin 60 (+ 1) A class of sequence-related MOLECULAR CHAPERONES found in bacteria, mitochondria, and plastids. Chaperonins are abundant constitutive proteins that increase in amount after stresses such as heat shock, bacterial infection of macrophages, and an increase in the cellular content of unfolded proteins. Bacterial chaperonins are major immunogens in human bacterial infections because of their accumulation during the stress of infection. Two members of this class of chaperones are CHAPERONIN 10 and CHAPERONIN 60. Heat-Shock Proteins (89-94); Proteins (89-94)  J&DhN7Chaperonin 60 D12.776.410.210.180; D12.776.580.210.180 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins; Chaperonins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones; Chaperonins GroEL Protein GroEL Protein Members of the chaperonin heat-shock protein family. Chaperonin 60 purified from bacteria, plastids, or mitochondria is an oligomeric protein with a distinctive structure of fourteen subunits, arranged in two rings of seven subunits each. Bacterial Proteins (89-94); Heat-Shock Proteins (89-94)  N.D"BChaperonin 10 D12.776.410.210.175; D12.776.580.210.175 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Heat-Shock Proteins; Chaperonins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Molecular Chaperones; Chaperonins GroES Protein GroES Protein Members of the chaperonin heat-shock protein family. Chaperonin 10 purified from bacteria, plastids, or mitochondria occurs as an oligomer of seven identical subunits arranged in a single ring. Heat-Shock Proteins (89-94)  Q.D"!Channel Islands Z01.542.363.161 EHEP Geographicals (Non MeSH); Europe; Great Britain T;Chancroid C01.252.400.700.433.257; C01.252.810.201; C01.539.780.281.201 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Haemophilus ducreyi Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections; Haemophilus Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Sexually Transmitted Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Bacterial Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas. U EP@Chancre C01.252.400.840.744.161; C01.252.847.840.744.161 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections; Syphilis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections; Syphilis The primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection. X 6P&Chalcone D02.522.818.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones 1,3-Diphenyl-2-propen-1-one. Alkenes (73-74); Propiophenones (69-74) [T :A!0Chalcogens (Non MeSH) D01.268.185 Inorganic Chemicals (Non MeSH); Elements Oxygen (+ 1); Polonium; Selenium; Sulfur; Tellurium A collective name for the group of elements that form group VI of the periodic table. ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR \f2Bi<Chalazion C04.182.197; C11.338.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Meibomian Glands Neoplasms; Cysts Eye Diseases; Eyelid Diseases An eyelid mass that results from chronic inflammation of a meibomian gland and shows a granulomatous reaction to liberated fat when subject to histopathological examination. (Dorland, 27th ed). Cysts (66-91); Eyelid Diseases (70-91); Meibomian Glands (75-90)  ] N9OChagas Disease C03.752.700.500.935.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Trypanosomiasis Chagas Cardiomyopathy A form of trypanosomiasis endemic in Central and South America, caused by TRYPANOSOMA CRUZI. It may follow either an acute or chronic course, the former commonly in children. _PChagas Cardiomyopathy C03.752.700.500.935.200.190; C14.280.600.190 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Mastigophora Infections; Trypanosomiasis; Chagas Disease Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Cardiomyopathy with conduction defects and cardiac enlargement characteristic of the last phase of CHAGAS DISEASE. Heart Diseases (66-80); specific heart disease (66-80); Trypanosomiasis, South American (66-80) b2PqChaetomium B05.354.107.150 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Ascomycetes A genus of ascomycetous fungi of the family Chaetomiaceae, order Sordariales including several that are destructive to paper, plastics, and other materials. d";Chad Z01.058.290.100.130 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central e_Cevanes D03.132.920.256; D03.549.256 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Veratrum Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Germine Acetates; Protoveratrines; Veratrine (+ 1) Germine Acetates; Protoveratrines; Veratrine (+ 1) Veratrum (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  f "8x<Cetylpyridinium D03.383.725.762.232; D20.187.145; D26.866.265.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Detergents 1-Hexadecylpyridinium, as bromide, chloride or other salt. Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; also as a mouthwash and lozenges. Synonyms: Biosept; Ceepryn; Cepacol; Cetamium; Dobendan; Germidin; Pristacin; Pyrisept. Anti-Infective Agents, Local (66-71); Pyridinium Compounds (68-71); Surface-Active Agents (66-71) hx9:\rCetrimonium Compounds D02.092.102.190; D02.675.276.190; D20.187.137; D26.866.265.190 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Detergents Cetyltrimethylammonium compounds which have cationic detergent, antiseptic and disinfectant activities; used in pharmaceuticals, foods and cosmetics as a preservative; on skin, mucous membranes, etc., as an antiseptic or a cleanser; also as an emulsifier; toxic orally due to neuromuscular blockade. Synonyms: Bromat; Cetab; Cetavlon; Cetylamine; Gomaxine; Lissolamine; Micol; Quamonium; Seboderm. Ammonium Compounds (68-74); Alkanes (72-74) kH,%5Cetomacrogol D02.033.618.690.200; D25.720.741.250; D26.866.762.171 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Alcohols; Glycols; Polyethylene Glycols Biomedical and Dental Materials (Non MeSH); Polymers; Polyethylene Glycols Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Polyethylene Glycols alpha-Hexadecyl-omega-hydroxypoly(oxy-1,2-ethanediyl). Non-ionic surfactant of the polyethylene glycol family; used as solubilizer and emulsifying agent in foods, cosmetics and pharmaceuticals, often as an ointment base; also as a research tool. Synonyms: Brij 52; Brij 56; Brij 58; Lubrol W. Polyethylene Glycols (74) o=.VCetirizine D03.383.606.515.200; D14.100.375.425.400.130 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines; Hydroxyzine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects. Hydroxyzine/analogs and derivatives (87-92) r2:%3Cetacea B02.649.189 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Dolphins; Whales v (Cestode Infections C03.335.190 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Anticestodal Agents Parasitic Diseases; Helminthiasis Diphyllobothriasis (+ 1); Echinococcosis (+ 2); Hymenolepiasis; Monieziasis; Taeniasis (+ 1) Infections with true tapeworms of the helminth subclass CESTODA.  vP(pMCestoda B01.500.736.215 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Anticestodal Agents Invertebrates; Helminths; Platyhelminths Diphyllobothrium (+ 1); Echinococcus; Hymenolepis; Mesocestoides; Spirometra (+ 1); Taenia (+ 1) A subclass of segmented worms comprising the tapeworms.  xB *0vCCesium Radioisotopes D01.496.180.300; D01.496.749.190 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Cesium Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of cesium that decay or disintegrate emitting radiation. Cs atoms with atomic weights of 123, 125-132, and 134-145 are radioactive cesium isotopes. Cesium Isotopes (66-74); Radioisotopes (66-74) y&48Cesium Isotopes D01.496.180 Inorganic Chemicals (Non MeSH); Isotopes Cesium Radioisotopes Stable cesium atoms that have the same atomic number as the element cesium, but differ in atomic weight. Cs-133 is a naturally occurring isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR {24Cesium D01.268.549.125; D01.552.528.160 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Alkali Inorganic Chemicals (Non MeSH); Metals; Metals, Alkali Cesium. A member of the alkali metals. It has an atomic symbol Cs, atomic number 50, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency. }H &:Cesarean Section, Repeat E04.819.774.457.145.150 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery; Cesarean Section Extraction of the fetus by abdominal hysterotomy anytime following a previous cesarean. Cesarean Section (71-93) u$gCesarean Section E04.819.774.457.145 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Vaginal Birth after Cesarean Trial of Labor Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Delivery Cesarean Section, Repeat Extraction of the fetus by means of abdominal hysterotomy. $$#lGCervix Uteri A05.360.319.679.256 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Colposcopy Urogenital System; Genitalia; Genitalia, Female; Uterus :CCervix Neoplasms C04.588.945.418.948.170; C13.371.270.875.170; C13.371.820.800.418.875.170; C13.371.852.150.310; C13.371.852.762.100 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Cervical Intraepithelial Neoplasia; Cervix Dysplasia Cervix Dysplasia; Cervical Intraepithelial Neoplasia Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Genital Neoplasms, Female; Uterine Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Genital Neoplasms, Female; Uterine Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Genital Neoplasms, Female; Uterine Neoplasms Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Cervix Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Uterine Neoplasms \X==Cervix Mucus A12.838.503.339 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH); Mucus "NCervix Incompetence C13.371.852.150.280; C13.703.039.089.339 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Cervix Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion; Abortion, Habitual Habitual abortion in which painless bloodless dilatation of the cervix in the second trimester of pregnancy is followed by rupture of membranes and expulsion of a fetus so immature that it usually dies. Abortion, Habitual (66-72); Cervix Diseases (66-72) .N>Cervix Hypertrophy C13.371.852.150.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Cervix Diseases NCervix Erosion C13.371.852.150.220 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Cervix Diseases NCervix Dysplasia C04.834.160 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Cervix Neoplasms Cervix Neoplasms Neoplasms; Precancerous Conditions A spectrum of histologic changes in the epithelium of the cervix uteri which may begin as a superficial lesion and progress to invasive carcinoma. Cervix Diseases (66-76); Cervix Neoplasms (66-76) $X)<Cervix Diseases C13.371.852.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases Cervicitis; Cervix Erosion; Cervix Hypertrophy; Cervix Incompetence; Cervix Neoplasms BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI N}eXCervico-Brachial Neuralgia C10.772.537.289 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Brachial Plexus Nervous System Diseases; Peripheral Nervous System Diseases; Neuralgia Neuralgic pain of acute onset caused by lesions of the peripheral nerves or nerve roots affecting the upper limb, shoulder girdle, or brachial plexus. NSCervicitis C13.371.852.150.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Uterine Diseases; Cervix Diseases Inflammation of the cervix uteri. (Dorland 27th ed). uNBCervical Vertebrae A02.835.232.834.151 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Neck Musculoskeletal System; Skeleton; Bone and Bones; Spine Atlas; Axis (+ 1) :DCervical Rib Syndrome C10.772.491.915.339 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Nerve Compression Syndromes; Thoracic Outlet Syndrome Pain over the shoulder, often extending down the arm (cervicobrachial) or radiating up the back of the neck due to compression of the nerve and vessels between a cervical rib and the scalenus anticus muscle. (Dorland, 27th ed). NCervical Plexus A08.800.800.720.150 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves Phrenic Nerve A network of nerve fibers originating in the upper four cervical spinal cord segments. The cervical plexus distributes cutaneous nerves to parts of the neck, shoulders, and back of the head, and motor fibers to muscles of the cervical spinal column, infrahyoid muscles, and the diaphragm. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI  6ZS8Cervical Intraepithelial Neoplasia C04.557.470.200.495 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Cervix Neoplasms Cervix Neoplasms Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 (formerly, mild dysplasia) to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. (Dictionary of Modern Medicine, 1992). Carcinoma in Situ (73-93); Carcinoma, Squamous Cell (66-93); Cervix Dysplasia (77-93); Cervix Neoplasms (66-93) $(XuZCerumen A12.838.147 CHCYDEENIMMEMIPHPSRARERISEUSVI Ear Canal; Waxes Fluids and Secretions (Non MeSH); Secretions (Non MeSH)  "DCeruloplasmin D08.586.682.226; D12.776.124.050.130; D12.776.124.790.106.214; D12.776.157.160; D12.776.377.715.085.214; D12.776.556.151 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Copper Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins F gCerulenin D02.241.081.436.200; D20.085.062.320 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal 2,3-Epoxy-4-oxo-7,10-dodecadionamide. Antifungal antibiotic isolated from several species, including Acremonium (Cephalosporium), Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function and is used as a biochemical tool. Antibiotics, Antifungal (73-74); Ethers, Cyclic (73-74); Fatty Acids, Unsaturated (74)  *<>gCertification N03.706.110.120; N05.700.200.190 CLECHILJMTOGSNSTTDUT Accreditation; Licensure; Specialty Boards Accreditation; Licensure Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing Specialty Boards Specialty Boards Compliance with a set of standards defined by non-governmental organizations. Certification is applied for by individuals on a voluntary basis and represents a professional status when achieved, e.g., certification for a medical specialty. Accreditation (66-67) (&3(Certificate of Need N03.349.650.120 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning A certificate issued by a governmental body to an individual or organization proposing to construct or modify a health facility, or to offer a new or different service. The process of issuing the certificate is also included. g Ceroid D10.516.150; D11.557.300 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments A naturally occurring lipid pigment with histochemical characteristics similar to lipofuscin. It accumulates in various tissues in certain experimental and pathological conditions. Pigments (70-74)  @Cermet Cements D25.339.291.402.120 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Cements; Glass Ionomer Cements Fluoride-releasing restorative materials made by the sintering of metal (usually silver) particles to glass ionomer powder. Glass ionomers are fluoride-releasing cements that are not very durable. Sintering of the metal particles is a means of improving those physical properties that will make the glass ionomer cement more durable. Dental Alloys (88-91); Dental Cements (88-91); Glass Ionomer Cements (85-91); Silver (88-91) ,wqCerium Radioisotopes D01.496.156.300; D01.496.749.185 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Cerium Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of cerium that decay or disintegrate emitting radiation. Ce atoms with atomic weights 132-135, 137, 139, and 141-148 are radioactive cerium isotopes. Cerium (66-74); Isotopes (66-74); Radioisotopes (66-74) &4DCerium Isotopes D01.496.156 Inorganic Chemicals (Non MeSH); Isotopes Cerium Radioisotopes Stable cerium atoms that have the same atomic number as the element cerium, but differ in atomic weight. Ce-136, 138, and 142 are stable cerium isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 24Cerium D01.268.558.075; D01.552.550.120 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Rare Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Rare Earth Cerium. An element of the rare earth family of metals. It has the atomic symbol Ce, atomic number 58, and atomic weight 140.12. Cerium is a malleable metal used in industrial applications. A &:Ceremonial F01.145.161; I01.076.201.450.172 Appetitive Behavior Appetitive Behavior Behavior and Behavior Mechanisms (Non MeSH); Behavior Social Sciences; Anthropology; Anthropology, Cultural; Culture A series of actions, sometimes symbolic actions which may be associated with a behavior pattern, and are often indispensable to its performance. Anthropology (66-67); Behavior, Animal (66-67); Culture (66-67); Sex Behavior (66-67)  A&hCerebrovascular Disorders C10.228.140.300; C14.907.253 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Cardiovascular Diseases; Vascular Diseases Carotid Artery Diseases (+ 3); Cerebral Amyloid Angiopathy; Cerebral Aneurysm; Cerebral Anoxia; Cerebral Arteriosclerosis; Cerebral Arteriovenous Malformations; Cerebral Artery Diseases; Cerebral Embolism and Thrombosis (+ 3); Cerebral Hemorrhage (+ 3); Cerebral Infarction; Cerebral Ischemia (+ 3); Dementia, Vascular (+ 1); Leukomalacia, Periventricular; Vascular Headache (+ 2) Carotid Artery Diseases (+ 3); Cerebral Amyloid Angiopathy; Cerebral Aneurysm; Cerebral Anoxia; Cerebral Arteriosclerosis; Cerebral Arteriovenous Malformations; Cerebral Artery Diseases; Cerebral Embolism and Thrombosis (+ 3); Cerebral Hemorrhage (+ 3); Cerebral Infarction; Cerebral Ischemia (+ 2); Leukomalacia, Periventricular; Vascular Headache (+ 2); Vertebrobasilar Insufficiency k"NCerebrovascular Circulation G09.330.163.159 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Blood Circulation The circulation of blood through the vessels of the brain. ! HCerebrospinal Rhinorrhea C21.866.460.175; C23.175 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Symptoms and General Pathology (Non MeSH) Discharge of cerebrospinal fluid through the nose. NN=Cerebrospinal Otorrhea C21.866.460.170; C23.170 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Symptoms and General Pathology (Non MeSH) Discharge of cerebrospinal fluid through the external auditory meatus or through the eustachian tube into the nasopharynx. NCerebrospinal Fluid Shunts E04.530.188; E04.035.188 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery Surgery, Operative; Anastomosis, Surgical Ventriculoperitoneal Shunt; Ventriculostomy Ventriculoperitoneal Shunt; Ventriculostomy Tubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles. Cerebral Ventricles (66-68); Hydrocephalus/surgery (66-68)   $Vb$ECerebrospinal Fluid Proteins D12.776.178 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins D"DDCerebrospinal Fluid Pressure G11.561.131 DEGEIMPHRE Intracranial Pressure Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Intracranial Pressure Manometric pressure of the cerebrospinal fluid as measured by lumbar, cerebroventricular, or cisternal puncture. Within the cranial cavity it is called INTRACRANIAL PRESSURE. Cerebrospinal Fluid (66-88); Intracranial Pressure (66-88); Pressure (66-88) $"h[Cerebrospinal Fluid A12.207.268 CHCYDEENIMMEMIPHPSRARERISEUSVI Blood-Brain Barrier Fluids and Secretions (Non MeSH); Body Fluids K"9Cerebrosides D10.516.390.470.213; D10.516.808.530.288 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids Galactosylceramides; Glucosylceramides; Sulfatides Galactosylceramides; Glucosylceramides; Sulfatides .BrCerebroside-Sulfatase D08.586.277.352.827.070.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Leukodystrophy, Metachromatic Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Sulfatases; Arylsulfatases An enzyme that catalyzes the hydrolysis of cerebroside 3-sulfate (sulfatide) to yield a cerebroside and inorganic sulfate. A marked deficiency of arylsulfatase A, which is considered the heat-labile component of cerebroside sulfatase, has been demonstrated in all forms of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.8. Arylsulfatases (75); Sulfatases (72-74)  F"0Cerebral Ventriculography E01.236.257.242; E01.236.688.242; E01.357.818.638.242 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Cerebral Ventricles Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH) Diagnosis; Diagnosis, Neurologic (Non MeSH); Neuroradiography Diagnosis; Diagnostic Imaging; Radiography; Neuroradiography Radiography of the ventricular system of the brain after injection of air or other contrast medium directly into the cerebral ventricles. It is used also for x-ray computed tomography of the cerebral ventricles. =&Cerebral Ventricles A08.186.211.276 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRERISESUULUSVI Cerebral Ventriculography; Injections, Intraventricular; Ventriculostomy Nervous System; Central Nervous System; Brain Cerebral Aqueduct; Choroid Plexus; Ependyma; Septum Pellucidum ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI  ΄4R8K8Cerebral Ventricle Neoplasms C04.588.614.250.195.280; C10.228.140.211.280; C10.228.250.195.280; C10.551.250.195.280 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Choroid Plexus Neoplasms Choroid Plexus Neoplasms Choroid Plexus Neoplasms Choroid Plexus Neoplasms Neoplasms located in the brain ventricles including the two lateral, third, and fourth ventricles. "`XrtCerebral Veins A07.231.908.155 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cerebral Angiography Cardiovascular System; Blood Vessels; Veins Veins draining the cerebrum. 85$Cerebral Sclerosis, Diffuse C10.228.140.276; C10.228.337.144 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Encephalitis Periaxialis; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic; Subacute Sclerosing Panencephalitis Adrenoleukodystrophy; Encephalitis Periaxialis; Leukodystrophy, Globoid Cell; Leukodystrophy, Metachromatic Diffuse progressive degeneration of the white matter of the brain, accompanied by mental deterioration, severe motor disturbances, and early death. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  !&NPCerebral Revascularization E04.494.150; E04.752.814.300 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Microsurgery Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Microsurgical revascularization to improve intracranial circulation. It usually involves joining the extracranial circulation to the intracranial circulation but may include extracranial revascularization (e.g., subclavian-vertebral artery bypass, subclavian-external carotid artery bypass). It is performed by joining two arteries (direct anastomosis or use of graft) or by free autologous transplantation of highly vascularized tissue to the surface of the brain. Arterial Occlusive Diseases/surgery (73-79); Brain/blood supply(66-79); Cerebral Arteries/surgery (66-79); Cerebrovascular Circulation (66-79); Cerebrovascular Disorders/surgery (66-79); specific cerebrovascular disorder/surgery (66-79); Temporal Arteries/surgery (66-79) J"${;Cerebral Palsy C10.228.140.140.254 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Damage, Chronic A persisting qualitative motor disorder appearing before the age of three years, due to nonprogressive damage to the brain. (Dorland, 27th ed). ܞNqCerebral Ischemia, Transient C10.228.140.300.459.278; C14.907.253.459.278 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Ischemia Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Ischemia Nonconvulsive, reversible, focal neurologic deficits lasting minutes up to about 24 hours, resulting mainly from arteriosclerosis, emboli, or hypertensive episodes. U"2NCerebral Ischemia C10.228.140.300.459; C14.907.253.459; C14.907.553.120 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Ischemia Cerebral Ischemia, Transient; Subclavian Steal Syndrome; Vertebrobasilar Insufficiency Cerebral Ischemia, Transient; Subclavian Steal Syndrome Deficiency in blood supply to the brain. Brain/blood supply (66-78); Cerebrovascular Disorders (66-78); Ischemia (66-78)  =N3_Cerebral Infarction C10.228.140.300.449; C14.907.253.449 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cerebral Embolism and Thrombosis Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Infarction of brain tissue. Brain (66-78); Cerebral Embolism and Thrombosis (66-78); Infarction (66-78)  *N'#[Cerebral Hemorrhage C10.228.140.300.420; C14.907.253.420; C23.542.115 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Symptoms and General Pathology (Non MeSH); Hemorrhage Hematoma, Epidural; Hematoma, Subdural; Subarachnoid Hemorrhage Hematoma, Epidural; Hematoma, Subdural; Subarachnoid Hemorrhage Hematoma, Epidural; Hematoma, Subdural; Subarachnoid Hemorrhage 9NCerebral Embolism and Thrombosis C10.228.140.300.378; C14.907.253.378; C14.907.355.350.850.213; C14.907.355.830.850.213 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cerebral Infarction Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism; Thromboembolism Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis; Thromboembolism Carotid Artery Thrombosis; Sinus Thrombosis; Wallenberg's Syndrome Carotid Artery Thrombosis; Sinus Thrombosis; Wallenberg's Syndrome Carotid Artery Thrombosis; Sinus Thrombosis; Wallenberg's Syndrome Carotid Artery Thrombosis; Sinus Thrombosis; Wallenberg's Syndrome Embolism or thrombosis occurring in a cerebral vessel often leading to cerebral infarction.  '`N2lCerebral Decortication E04.530.138 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Neurosurgery Partial or total removal, ablation, or destruction of the cerebral cortex; may be chemical. It is not used with animals that do not possess a cortex, i.e., it is used only with mammals. $'Cerebral Cortex A08.186.211.730.885.213 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Electroencephalography; Spreading Cortical Depression Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon Entorhinal Cortex; Frontal Lobe (+ 2); Occipital Lobe (+ 1); Parietal Lobe (+ 1); Pyramidal Cells; Temporal Lobe (+ 1) The thin layer of gray matter on the surface of the cerebral hemisphere that develops from the telencephalon and folds into gyri. It reaches its highest development in man and is responsible for intellectual faculties and higher mental functions.  h8=["Cerebral Artery Diseases C10.228.140.300.337; C14.907.253.337 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders I*NCerebral Arteriovenous Malformations C10.228.140.300.295; C14.240.150.295; C14.907.150.295; C14.907.253.295; C16.131.240.150.295 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Arteriovenous Malformations Cardiovascular Diseases; Vascular Diseases; Arteriovenous Malformations Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Arteriovenous Malformations Vascular anomalies in which tangles of arteries are connected directly to veins without intervening capillaries. The resulting vessels are thin-walled owing to poorly developed elastic and muscle tissue within the media. They can be located anywhere in the brain and can produce headaches, seizures, focal neurologic deficits, or intracranial hemorrhage. Familial cases are rare, indicating that the problem reflects sporadic abnormalities in embryologic development. (From Cecil Textbook of Medicine, 19th ed). Arteriovenous Fistula/congenital (66-72); Cerebrovascular Disorders (66-72) *gLOWCerebral Arteriosclerosis C10.228.140.300.254; C14.907.137.126.372; C14.907.253.254 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dementia, Vascular Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases; Arteriosclerosis Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders {AN'Cerebral Arteries A07.231.114.228 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cerebral Angiography Cardiovascular System; Blood Vessels; Arteries Circle of Willis The arteries supplying the cerebral cortex.  885Cerebral Aqueduct A08.186.211.276.187 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Cerebral Ventricles Cerebral Ventricles (66-70) 8P!Cerebral Anoxia C10.228.140.300.212; C14.907.253.212 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders A reduced supply of oxygen to the brain. *N4Cerebral Angiography E01.145.077.300; E01.236.257.170; E01.236.688.187; E01.357.818.084.155; E01.357.818.638.170 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Cerebral Veins; Cerebral Arteries Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH) Diagnosis; Diagnosis, Neurologic (Non MeSH); Neuroradiography Diagnosis; Diagnostic Imaging; Radiography; Angiography Diagnosis; Diagnostic Imaging; Radiography; Neuroradiography Radiography of the vascular system of the brain after injection of a contrast medium. Og&)igCerebral Aneurysm C10.228.140.300.170; C14.907.055.387; C14.907.253.170 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Aneurysm Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders A saccular aneurysm of a cerebral artery, usually at the junction of vessels in the circle of Willis, having a narrow opening into the artery. =NCerebral Amyloid Angiopathy C10.228.140.300.146; C14.907.253.146; C15.378.147.780.100.100; C15.604.515.056.100; C18.452.648.111.100; C20.683.780.100.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Amyloid beta-Protein Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias; Amyloidosis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Amyloidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amyloidosis Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias; Amyloidosis A pathological condition characterized by the deposition of amyloid in the walls of small vessels in the cerebral cortex and meninges. This biochemically heterogeneous entity is most commonly associated with stroke, Alzheimer's disease, Down's syndrome, and miscellaneous neurologic conditions. Cerebral hemorrhage is common in persons with this condition. Amyloidosis (74-91); Cerebrovascular Disorders (74-91)  !L@Cerebellum A08.186.211.212 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain Cerebellar Cortex (+ 1); Cerebellar Nuclei; Cerebellopontine Angle ABAHBSCHCLCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI  .88P:Cerebellopontine Angle A08.186.211.212.462 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Cerebellum Junction between the cerebellum and the pons.  p6F8Cerebellar Nuclei A08.186.211.212.337 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Cerebellum Cerebellum (66-70)  y6FCerebellar Neoplasms C04.588.614.250.195.254; C10.228.140.211.254; C10.228.140.252.420; C10.228.250.195.254; C10.551.250.195.254 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms; Brain Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms; Brain Neoplasms Infratentorial Neoplasms Infratentorial Neoplasms Infratentorial Neoplasms Infratentorial Neoplasms Infratentorial Neoplasms Neoplasms located in the cerebellum.  \wXO-Cerebellar Dyssynergia C10.228.140.252.253.871.337 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases; Cerebellar Ataxia; Spinocerebellar Degeneration A condition marked by generalized intention tremors associated with disturbance of muscle tone and of muscular coordination, caused by a disorder of cerebellar function. (Dorland, 27th ed.). Cerebellar Diseases (66-69) pN!Cerebellar Diseases C10.228.140.252 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Cerebellar Ataxia (+ 6); Cerebellar Neoplasms (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI NV@XCerebellar Cortex A08.186.211.212.212 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Cerebellum Purkinje Cells ABAHBSCHCLCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI R8F:Cerebellar Ataxia C10.228.140.252.253 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases Spinocerebellar Degeneration (+ 5) Ataxia (66-67); Cerebellar Diseases (66-67) qNn)5Cereals B06.510.253; J01.341.182 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food Barley; Corn; Millet; Oats; Rice; Rye; Wheat Barley; Corn; Millet; Oats; Rice; Rye; Wheat Those grasses, family Graminea, that yield edible seeds commonly recognized as food grains.  4XvlCercopithecus aethiops B02.649.801.400.130.120.126.110 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Cercopithecus A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannas of Africa. The African green monkey (C. pygerythrus) is the natural host of SIV and is used in AIDS research. #(k,Cercopithecus B02.649.801.400.130.120.126 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae Cercopithecus aethiops A genus of Old World monkeys found in Africa although some species have been introduced into the West Indies. This genus is composed of at least twenty species: C. AETHIOPS, C. ascanius, C. campbelli, C. cephus, C. denti, C. diana, C. dryas, C. erythrogaster, C. erythrotis, C. hamlyni, C. lhoesti, C. mitis, C. mona, C. neglectus, C. nictitans, C. petaurista, C. pogonias, C. preussi, C. salongo, and C. wolfi. Monkeys (66-74)  (ZCercopithecinae B02.649.801.400.130.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae Cercocebus (+ 1); Cercopithecus (+ 1); Erythrocebus (+ 1); Macaca (+ 4); Papio; Theropithecus (+ 1) A subfamily of the Old World monkeys, CERCOPITHECIDAE. They inhabit the forests and savannas of Africa. This subfamily contains the following genera: CERCOCEBUS, CERCOPITHECUS, ERYTHROCEBUS, MACACA, PAPIO, and THEROPITHECUS. (GCercopithecidae B02.649.801.400.130 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini Cercopithecinae (+ 14); Colobinae (+ 1) The family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia. (42Cercocebus atys B02.649.801.400.130.120.120.110 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae; Cercocebus A species of Old World monkeys from the genera CERCOCEBUS that is important in AIDS research. They may be naturally or experimentally infected with the simian immunodeficiency virus. They inhabit African forests from Sierra Leone to the Congo Republic. !#(h)Cercocebus B02.649.801.400.130.120.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cercopithecidae; Cercopithecinae Cercocebus atys A genus of the subfamily CERCOPITHECINAE inhabiting the African forests. They are also known as mangabeys. #(ZCeratopogonidae B01.131.617.289.208 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera A family of the order DIPTERA. It includes the insect vector Culicoides which transmits filarial parasites pathogenic to man and other primates. %(5Ceramides D10.516.808.187 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids Sphingomyelins Amino Alcohols (66-71); Fatty Acids (66-71); Glycols (66-71) &W BMKCeramide Trihexosidase D08.586.277.450.410.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Galactosidases An enzyme that catalyzes the hydrolysis of a ceramidetrihexoside to a ceramidedihexoside plus galactose. EC 3.2.1.47. Galactosidase (72-74); Cerebrosides (72-74) 'F~4Ceramics D25.264; J01.637.153 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Dental Porcelain Chemical Industry (66); Dental Materials (66); Minerals (66) )i *KCephradine D20.085.099.180.200.193 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephalexin 7-((Amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8- oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. A semi-synthetic cephalosporin antibiotic. Cephalosporins (72-74); Cyclohexane (72-74) *:a4Cephapirin D20.085.099.180.190.259 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile 3-((Acetyloxy)methyl)-8-oxo-7-(((4-pyridinylthio)acetyl) amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms. Acetamides (72-74); Cephalosporins (72-74); Pyridines (72-74); Sulfides (72-74) ,:c`Cephamycins D20.085.099.180.220 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins Cefmetazole; Cefotetan; Cefoxitin Naturally produced family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Cephalosporins (74); Methyl Ethers (74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $.:S)1<Cephalothin D20.085.099.180.190.243 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile 3-((Acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-5- thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. 1J:c}Cephalosporins D20.085.099.180 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam Cefamandole (+ 1); Cefazolin; Cefonicid; Cefsulodin; Cephacetrile (+ 8); Cephalexin (+ 5); Cephaloridine (+ 1); Cephamycins (+ 3) A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus Acremonium (Cephalosporium acremonium). They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  2:A <Cephalosporinase D08.586.277.087.180.229 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases; beta-Lactamases 5eFyCephalosporin Resistance G04.185.515.286.100.175; G05.386.310.100.175; G05.706.310.100.175; G12.392.269.100.175 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial; beta-Lactam Resistance Genetics; Genetics, Microbial; Drug Resistance, Microbial; beta-Lactam Resistance Genetics; Pharmacogenetics; Drug Resistance, Microbial; beta-Lactam Resistance Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial; beta-Lactam Resistance Non-susceptibility of an organism to the action of the cephalosporins. Cephalosporins/pharmacology (66-94); Drug Resistance, Microbial (77-94) 6r`  TSCephaloridine D20.085.099.180.210 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins Ceftazidime 1-((2-Carboxy-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1- azabicyclo(4.2.0)oct-2-en-3-yl)methyl)pyridinium hydroxide inner salt. 9:SCephalometry E01.706.273; E05.118.364; G03.850.505.200.100.300; N05.715.360.325.150.100.200 AECLCTECHIISMOMTNUPXSNSTTDUTVE Craniometry Maxillofacial Development; Craniometry; Skull; Craniology Diagnosis; Physical Examination Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry Craniometry Craniometry Craniometry Craniometry Scientific measurement of the dimensions of the head. In dentistry, certain combinations of measurements developed from tracing the oriented lateral and frontal radiographic head film are used to assess craniofacial growth and development and to determine the nature of the orthodontic treatment response. $;MX"D6aCephaloglycin D20.085.099.180.200.181 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephalexin 3-((Acetyloxy)methyl)-7-((aminophenylacetyl)amino)-8-oxo-5- thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. ?:aCephalexin D20.085.099.180.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins Cefaclor; Cefadroxil (+ 1); Cephaloglycin; Cephradine (6R-(6 alpha,7 beta(R*)))-7-((Aminophenylacetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. Cephalosporins (66-71)  A,:SBCephacetrile D20.085.099.180.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins Cefotaxime (+ 5); Cephalothin; Cephapirin 3-((Acetyloxy)methyl)-7-((cyanoacetyl)amino)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. Derivative of 7-aminocephalosporanic acid. Acetamides (73-74); Cephalosporins (73-74); Nitriles (73-74)  C:S4ICentrosome A11.368.702.150 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Mitotic Spindle Apparatus Cells; Cytoplasm; Organelles Centrioles The cell center, consisting of a pair of centrioles surrounded by a cloud of amorphous material. During interphase, the centrosome nucleates microtubule outgrowth. In prophase the centrosome duplicates and separates to form the two poles of the mitotic spindle (MITOTIC SPINDLE APPARATUS). Centrioles (82-94) CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI (E($R*Centromere A11.223.475.135 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Mitotic Spindle Apparatus Cells; Cell Nucleus; Chromosomes Kinetochores The clear constricted portion of the chromosome at which the chromatids are joined and by which the chromosome is attached to the spindle during cell division. Chromosomes (66-77) $HL*)Centrioles A11.368.702.150.130 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cells; Cytoplasm; Organelles; Centrosome Self-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder. Mitosis (68-78); Organoids (66-78) I*2+Centrifugation, Zonal E05.181.724.336.336; E05.196.941.336.419 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Centrifugation; Ultracentrifugation; Centrifugation, Density Gradient Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Ultracentrifugation; Centrifugation, Density Gradient Centrifugation using a rotating chamber of large capacity in which to separate cell organelles by density-gradient centrifugation. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). K."Centrifugation, Isopycnic E05.181.724.336.253; E05.196.941.336.253 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Centrifugation; Ultracentrifugation; Centrifugation, Density Gradient Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Ultracentrifugation; Centrifugation, Density Gradient Centrifugation in which the solvent is of the same density as the substance to be isolated. From the Greek iso-, equal and pyknos, thick. (From Dorland, 27th ed). N."Centrifugation, Density Gradient E05.181.724.336; E05.196.941.336 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Centrifugation; Ultracentrifugation Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Ultracentrifugation Centrifugation, Isopycnic; Centrifugation, Zonal Centrifugation, Isopycnic; Centrifugation, Zonal Separation of particles according to density by employing a gradient of varying densities. At equilibrium each particle settles in the gradient at a point equal to its density. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Pg&&"n Centrifugation E05.181 AECLCTECHIISMOMTNUPXSNSTTDUTVE Gravity, Altered; Hypergravity; Ultracentrifugation Rotation Miscellaneous Techniques (Non MeSH) Ultracentrifugation (+ 3) Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). $S8 "< *)Centric Relation E06.520.200 Temporomandibular Joint Dentistry; Jaw Relation Record The location of the maxillary and the mandibular condyles when they are in their most posterior and superior positions in their fossae of the temporomandibular joint. Dental Occlusion, Centric (66-90) V`&(Centralized Hospital Services N02.278.354.110; N04.452.442.110 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration The coordination of services in one area of a facility to improve efficiency. W#&^Central Venous Pressure G09.330.612.114.732.336 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Blood Pressure; Venous Pressure Blood Pressure (66-69); Veins (66-69) Y/Central Supply, Hospital N02.278.354.422.260; N04.452.442.422.260 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for receiving, storing, and distributing medical and surgical supplies and equipment. Z. Central Nervous System Stimulants D15.220 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amphetamines Central Nervous System Agents Amphetamine (+ 1); Bemegride; Benzphetamine; Caffeine; Convulsants (+ 10); Doxapram; Ephedrine; Lobeline; Mazindol; Methamphetamine; Methylphenidate; Nikethamide; Pemoline; Phenmetrazine; Phentermine; Picrotoxin A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not include here. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $\( 8$^DCentral Nervous System Neoplasms C04.588.614.250; C10.228.250; C10.551.250 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms Nervous System Diseases; Central Nervous System Diseases Nervous System Diseases; Nervous System Neoplasms Brain Neoplasms (+ 6); Meningeal Neoplasms; Spinal Cord Neoplasms (+ 1) Brain Neoplasms (+ 6); Meningeal Neoplasms; Spinal Cord Neoplasms (+ 1) Brain Neoplasms (+ 6); Meningeal Neoplasms; Spinal Cord Neoplasms (+ 1) Neoplasms located in the brain, spinal cord, or meninges. Brain Neoplasms (66-91); Nervous System Neoplasms (80-91); Spinal Cord Neoplasms (66-91)  `X'1XFjCentral Nervous System Infections (Non MeSH) C10.228.228 Nervous System Diseases; Central Nervous System Diseases AIDS Dementia Complex; Brain Abscess; Empyema, Subdural; Encephalitis (+ 12); Encephalomyelitis (+ 4); Malaria, Cerebral; Meningitis (+ 14); Meningoencephalitis (+ 1); Myelitis (+ 1); Neurosyphilis (+ 1); Poliomyelitis (+ 2); Prion Diseases (+ 5); Toxoplasmosis, Cerebral BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI c5CJTCentral Nervous System Diseases C10.228 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases Brain Diseases (+ 160); Central Nervous System Infections (Non MeSH) (+ 53); Central Nervous System Neoplasms (+ 10); Demyelinating Diseases (+ 15); Encephalomyelitis (+ 6); High Pressure Nervous Syndrome; Meningism; Spinal Cord Diseases (+ 14); Stiff-Man Syndrome BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI e& N>\Central Nervous System Depressants D15.210 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents Alcohol, Ethyl; Anesthetics (+ 45); Hypnotics and Sedatives (+ 40); Narcotics (+ 36); Tranquilizing Agents (+ 67) A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  hV) 8$6DCentral Nervous System Agents D15 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Analgesics (+ 42); Anesthesia Adjuvants (+ 16); Anesthetics (+ 45); Anti-Anxiety Agents (+ 26); Anticonvulsants (+ 24); Antidepressive Agents (+ 35); Anti-Dyskinesia Agents (+ 24); Antiemetics (+ 27); Antimanic Agents (+ 1); Antipsychotic Agents (+ 37); Antitussive Agents (+ 10); Appetite Depressants (+ 13); Central Nervous System Depressants (+ 193); Central Nervous System Stimulants (+ 27); Emetics (+ 2); Hallucinogens (+ 12); Hypnotics and Sedatives (+ 40); Muscle Relaxants, Central (+ 15); Narcotic Antagonists (+ 11); Neuroprotective Agents (+ 6); Nootropic Agents (+ 8); Psychotropic Drugs (+ 117) A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR k$8*DCentral Nervous System A08.186 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System Brain (+ 95); Meninges (+ 6); Neural Analyzers; Spinal Cord (+ 4) ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI q 6U<Central America Z01.107.169 EHEP Geographicals (Non MeSH); America Belize; Costa Rica; El Salvador; Guatemala; Honduras; Nicaragua; Panama (+ 1) s*aCentral African Republic Z01.058.290.100.120 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central s_Centers for Disease Control and Prevention (U.S.) N03.540.427.300.650.225 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations; Government Agencies; United States Dept. of Health and Human Services; United States Public Health Service National Institute for Occupational Safety and Health An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries. t;?Centchroman D03.438.150.240.225; D06.347.300.230; D07.360.276.310.360.230 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromans Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Estrogen Antagonists Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic 3,4-trans-2,2-Dimethyl-3-phenyl-4-p-(beta-pyrrolidinoethoxy)phenyl-7-methoxychroman. A non-steroidal anti-fertility agent with anti-hormonal properties. Benzopyrans (74); Phenyl Ethers (74); Pyrrolidines (74) w@E:zECementoma C04.557.695.210 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Odontogenic Tumors An odontogenic fibroma in which cells have developed into cementoblasts and which consists largely of cementum. Odontogenic Tumors (66-71) z[ VU Cementation E05.170; E06.095.170 AECLCTECHIISMOMTNUPXSNSTTDUTVE Dental Cements Miscellaneous Techniques (Non MeSH) Dentistry; Dental Bonding The joining of objects by means of a cement (e.g., in fracture fixation, such as in hip arthroplasty for joining of the acetabular component to the femoral component). In dentistry, it is used for the process of attaching parts of a tooth or restorative material to a natural tooth or for the attaching of orthodontic bands to teeth by means of an adhesive. {"HCellulose, Oxidized D09.203.698.365.180.200; D19.461.270.463.252 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Cellulose Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics Polyanhydroglucuronic Acid. A cellulose of varied carboxyl content retaining the fibrous structure; used as local hemostatic, as matrix for normal blood coagulation. Synonyms: HemoPak; Oxycel. ~g2,Cellulose D09.203.698.365.180; D25.720.157 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Cellophane; Paper Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans Biomedical and Dental Materials (Non MeSH); Polymers Cellobiose; Cellulose, Oxidized; DEAE-Cellulose; Lignin; Methylcellulose (+ 1) Cellophane; Collodion A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ &Bv|FCellulitis C01.539.800.130; C01.539.830.200; C17.300.185; C23.739.487.856.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Connective Tissue Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation; Suppuration An acute, diffuse, suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle. It occurs most commonly as a result of infection of a wound, ulcer, or other skin lesion by various bacteria, but may also occur in previously normal skin especially in the presence of edema of lymphatic, renal, or hypostatic origin. hLNxCellulase D08.586.277.450.162 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases An enzyme isolated from fungi and bacteria. It catalyzes the endohydrolysis of 1,4-beta-glucosidic linkages in cellulose, lichenin, and cereal beta-glucans. EC 3.2.1.4. Glycoside Hydrolases (66-72) v Fl"Cells, Cultured A11.251 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Diffusion Chambers, Culture Organ Culture; Tissue Culture Cells Cell Line (+ 9); Clone Cells (+ 4); Hybrid Cells (+ 1); Tumor Cells, Cultured (+ 3) Tissue Culture (66-71) $Y *!% mCells A11 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cytology Antibody-Producing Cells (+ 3); Antigen-Presenting Cells (+ 2); APUD Cells; Blastomeres; Blood Cells (+ 42); Bone Marrow Cells (Non MeSH) (+ 4); Cell Membrane (+ 22); Cell Nucleus (+ 49); Cells, Cultured (+ 21); Connective Tissue Cells (Non MeSH) (+ 21); Cytoplasm (+ 41); Epithelial Cells (Non MeSH) (+ 12); Eukaryotic Cells; Extracellular Space (+ 1); Germ Cells (+ 12); Giant Cells (+ 2); Inclusion Bodies (+ 3); Islets of Langerhans; Leydig Cells; Lutein Cells; Micronuclei; Muscle Fibers (+ 3); Neuroglia (+ 8); Neurons (+ 38); Organoids; Phagocytes (+ 12); Prokaryotic Cells; Protoplasts; Reed-Sternberg Cells; Spheroplasts; Stem Cells (+ 4); Subcellular Fractions (+ 12) Cytology (66-71) ABADAEAGAHAIANBIBLBSCFCHCLCSCTCYDEDFDUECEMENGDGEHIIMINIPIRMEMIPAPDPHPKPOPPPSPYRARERISDSESTSUTOTRTUULURUSVI   * BnCellophane D25.720.157.252; J01.637.118 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Cellulose Biomedical and Dental Materials (Non MeSH); Polymers; Cellulose Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) ", Cellobiose D09.203.698.365.180.180; D09.203.698.629.305.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Cellulose Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Oligosaccharides; Disaccharides 4-0-beta-D-Glucopyranosyl-D-glucopyranoside. A disaccharide consisting of two glucose units in beta (1-4) glycosidic linkage. Obtained from the partial hydrolysis of cellulose. Disaccharides (66-78) 6DCell-Free System A11.904.168 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Subcellular Fractions (#Cell Wall Skeleton A11.195.185.200; D12.776.097.162; D12.776.395.560.186; D24.611.062.100; D24.611.274.050.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cells; Cell Membrane; Cell Wall Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Mucoproteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Biological Response Modifiers; Adjuvants, Immunologic A mucoprotein found in the cell wall of various types of bacteria. It has adjuvant and antitumor activities and has been used to augment the production of lymphokine-activated killer (LAK) cells. Mucoproteins (76-92); Mycolic Acids (76-92); Peptides (74-75); Polysaccharides (74-75) gFhCell Wall A11.195.185 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Membranes Cells; Cell Membrane Cell Wall Skeleton In most algae, bacteria, and fungi, the structure which forms a (usually rigid) layer external to the CELL MEMBRANE and which is responsible for the shape of the organism and for protecting it from mechanical damage, osmotic lysis, etc. It may also serve as a permeability barrier, e.g., to antibiotics and other substances. (Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEMIPAPDPHPKPOPSRARERISDSESTTOTRTUULURUSVI $H* XCell Transplantation E04.936.225 AECLCTECHIISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Blood Component Transfusion; Transplantation Immunology Surgery, Operative; Transplantation Hematopoietic Stem Cell Transplantation; Islets of Langerhans Transplantation Transference of cells within an individual, between individuals of the same species, or between individuals of different species. specific cell/transplantation (66-93); Cells/transplantation (66-93) AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE (50@*YP2Cell Transformation, Viral G04.185.515.880.210; G05.386.185; G05.825.700.210 DEGEIMPHRE Antigens, Viral, Tumor Cell Line, Transformed Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH) Genetics; Genetics, Microbial Genetics; Recombination, Genetic; Transformation, Genetic An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Cell Transformation, Neoplastic (68-77); Cytopathogenic Effect, Viral (66-67); Neoplasms, Experimental (66-67) $ 9Cell Transformation, Neoplastic C04.697.152; G04.335.349 CHCICLDEGEIMMEPARESEUL Antigens, Differentiation Cell Line, Transformed Neoplasms; Neoplastic Processes (Non MeSH) Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Blast Crisis Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplasms (66-67); Neoplasms, Experimental (66-67) BLCFCHCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARERHRIRTSESUTHULURUSVEVI ,%?<XCell Survival G04.335.316 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cytology (66-70); specific cell (66-70) !f1Cell Size G04.335.310 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) The physical dimensions of a cell. It refers mainly to changes in dimensions correlated with physiological or pathological changes in cells. specific cell/cytology (66-92); specific organ/cytology (66-92) fLCell Separation E05.909.262.363 AECLCTECHIISMOMTNUPXSNSTTDUTVE Blood Component Removal; Plasmapheresis Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Cytapheresis (+ 2); Immunomagnetic Separation "/^7Cell Polarity G04.335.300 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Orientation of intracellular structures especially with respect to the apical and basolateral domains of the plasma membrane. Polarized cells must direct proteins from the Golgi apparatus to the appropriate domain since tight junctions prevent proteins from diffusing between the two domains. fRCell Physiology (Non MeSH) G04.335 Biological Phenomena, Cell Physiology, Immunity (Non MeSH) Cell Adhesion; Cell Aging (+ 1); Cell Communication; Cell Compartmentation; Cell Cycle (+ 15); Cell Death (+ 1); Cell Degranulation; Cell Differentiation; Cell Fusion; Cell Hypoxia; Cell Membrane Permeability; Cell Movement (+ 6); Cell Polarity; Cell Size; Cell Survival; Cell Transformation, Neoplastic; Contact Inhibition; Cytoplasmic Streaming (+ 1); Endocytosis (+ 3); Exocytosis; Ion Channel Gating; Lymphocyte Cooperation; Membrane Fusion; Mitochondrial Contraction; Mitochondrial Swelling; Receptor Aggregation (+ 1) CHCICLDEGEIMMEPAPHRESEUL ! DpCell Nucleus A11.223 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Cell Compartmentation; Karyometry Cells Cell Nucleolus; Chromatin (+ 3); Chromosomes (+ 41); Nuclear Matrix; Nuclear Membrane Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell many contain more than one nucleus. (From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). CHCLDEENGEIMIPMEMIPAPHPSRARERISETRULUSVI $ *( j,Cell Nucleolus A11.223.210 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Nucleolus Organizer Region Cells; Cell Nucleus Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). * 1Cell Movement G04.335.283 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Cell Aggregation; Chemotaxis (+ 1); Ovum Transport; Sperm Motility; Sperm Transport The movement of cells from one location to another. It includes movement of micro-organisms. Cytology (66-67); specific cell or tissue/CY (66-67)  ffoACell Migration Inhibition E01.223.495.168; E05.478.168 Macrophage Migration-Inhibitory Factors Hypersensitivity, Delayed Diagnosis; Diagnosis, Laboratory; Immunologic Tests Miscellaneous Techniques (Non MeSH); Immunologic Techniques Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration inhibitory factor, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Cell Movement (68-70); Hypersensitivity, Delayed (66-70); Lymphocytes/immunology (66-70); Tissue Culture (66-70)  "-Cell Membrane Permeability G04.335.250; G06.535.166.335 DEGEIMPHRE Biological Transport Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.  "zCell Membrane A11.195 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Intracellular Membranes; Membrane Fluidity; Membrane Lipids; Membrane Potentials; Membrane Proteins; Nuclear Membrane; Osmotic Fragility Membranes Cells Cell Wall (+ 1); Coated Pits, Cell-Membrane; Erythrocyte Membrane; Intercellular Junctions (+ 13); Microvilli; Purple Membrane; Sarcolemma; Synaptic Membranes The lipid- and protein-containing, selectively permeable membrane which surrounds the cytoplasm in prokaryotic and eukaryotic cells. In most types of microbial cell it is bordered externally by the CELL WALL. (Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). ABADAEAGAHAIANBIBLBSCFCHCLCSCTCYDEDFDUECEMENGDGEHIIMINIPMEMIPAPDPHPKPOPPPSRARERISDSESTSUTOTRTUULURUSVI ( *  TjCell Line, Transformed A11.251.210.172 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cell Transformation, Neoplastic; Cell Transformation, Viral Cells; Cells, Cultured; Cell Line Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Cell Line (66-87); Cell Transformation, Neoplastic (66-87); Cell Transformation, Viral (78-87); Cells, Cultured (66-87); Tissue Culture (66-76)  *E+9Cell Line A11.251.210 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Tissue Culture Cells; Cells, Cultured Cell Line, Transformed; CHO Cells; Hela Cells; KB Cells; L Cells; LLC-PK1 Cells; PC12 Cells; 3T3 Cells; Vero Cells Tissue Culture (66-68)  h*Cell Hypoxia G04.335.235 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) A condition of decreased oxygen content at the cellular level. Anoxia (68-89); Oxygen (85-89) ¶fL'Cell Fusion E05.909.262.307; G04.335.217 DEGEIMPHRE Hybrid Cells Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. Cytology (66-70)  "lCell Fractionation E05.909.262.251 ISMT Subcellular Fractions Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Cytology (66-70) ţ^Cell Extracts D24.185.893.162 ADAEAGAIANCHCLCSCTECGEHIIMIPPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts Preparations of cell constituents or subcellular materials, isolates, or substances. Tissue Extracts (66-76) Ɖ6`bCell Division Phases (Non MeSH) G04.335.135.220.225; G05.148.165.220.225; G07.553.135.220.225 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division Genetics; Cytogenetics; Cell Cycle; Cell Division Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division Anaphase; Metaphase; Prophase; Telophase Anaphase; Metaphase; Prophase; Telophase Anaphase; Metaphase; Prophase; Telophase DEGEIMPHRE 'E=Cell Division G04.335.135.220; G05.148.165.220; G07.553.135.220 DEGEIMPHRE Cell Cycle Proteins; Genes, cdc Cleavage Stage, Ovum Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle Genetics; Cytogenetics; Cell Cycle Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle Cell Division Phases (Non MeSH) (+ 4); Meiosis (+ 1); Mitosis (+ 1) Cell Division Phases (Non MeSH) (+ 4); Meiosis (+ 1); Mitosis (+ 1) Cell Division Phases (Non MeSH) (+ 4); Meiosis (+ 1); Mitosis (+ 1) The fission of a cell. $V9(Cell Differentiation G04.335.151; G07.553.196 DEGEIMPHRE Antigens, Differentiation Embryo; Gene Expression Regulation Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH)  Embryonic Induction Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs. $G*Cell Degranulation G04.335.143 DEGEIMPHRE Exocytosis Cytoplasmic Granules Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) The process of losing cytoplasmic granules. This occurs in mast cells, basophils, neutrophils, eosinophils, and platelets when secretory products are released from the granules.  fCell Death G04.335.139 DEGEIMPHRE Apoptosis; Necrosis Cell Aging Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Apoptosis The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Cell Survival (71-91) (ѕf Cell Cycle Proteins D12.776.260.150 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Phosphoprotein Phosphatase; Protein Kinases Genes, cdc; Cell Division Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Cyclin-Dependent Kinases (+ 3); Cyclins Proteins that control the cell division cycle. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and phosphoprotein phosphatases (PHOSPHOPROTEIN PHOSPHATASE) as well as their putative substrates such as chromatin-associated proteins, cytoskeletal proteins, and transcription factors. Cell Cycle (78-94); Cell Division (66-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,OD3!]14HCell Cycle G04.335.135; G05.148.165; G07.553.135 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Genetics; Cytogenetics Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Cell Division (+ 9); Interphase (+ 4) Cell Division (+ 9); Interphase (+ 4) Cell Division (+ 9); Interphase (+ 4) The complex series of phenomena, occurring between the end of one cell division and the end of the next, by which cellular material is divided between daughter cells. Cell Division (66-77); Meiosis (68-77); Mitosis (68-77)  -ECell Count E05.909.262.195; G07.380 DEISMTREVE Blood Cell Count; Sperm Count Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Physiology, General (Non MeSH)  Blood Cell Count (+ 7); Sperm Count Cytology (66-68) DEECISMTREVE $&0Cell Compartmentation G04.335.125 DEGEIMPHRE Cell Nucleus Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) A partitioning within cells due to the selectively permeable membranes which enclose each of the separate parts, e.g., mitochondria, lysosomes, etc. >fCell Communication G04.335.122 DEGEIMPHRE Intercellular Junctions; Second Messenger Systems; Signal Transduction Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Intercellular Junctions (70-77)  Rf%Cell Aging G04.335.119 DEGEIMPHRE Cell Death Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Erythrocyte Aging The decrease in the cell's ability to proliferate with the passing of time. Each cell is programmed for a certain number of cell divisions and at the end of that time proliferation halts. The cell enters a quiescent state after which it experiences cell death via the process of APOPTOSIS. Cell Survival (77-91); Erythrocyte Aging (67-91) $fY;Cell Aggregation G04.335.283.251 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Movement The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type. }yCell Adhesion Molecules, Neuronal D12.776.395.550.200.250; D12.776.543.550.200.250; D24.611.216.301.350.250 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Cell Adhesion Molecules Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Cell Adhesion Molecules Surface ligands that mediate cell-to-cell adhesion and function in the assembly and interconnection of the vertebrate nervous system. These molecules promote cell adhesion via a homophilic mechanism. Antigens, Surface (79-89); Glycoproteins (66-87); Membrane Glycoproteins (88-89) (Q6_Cell Adhesion Molecules D12.776.395.550.200; D12.776.543.550.200; D24.611.216.301.350 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface Cadherins; CD4 Immunoadhesins; Cell Adhesion Molecules, Neuronal; Intercellular Adhesion Molecule-1; Receptors, Lymphocyte Homing Cadherins; CD4 Immunoadhesins; Cell Adhesion Molecules, Neuronal; Intercellular Adhesion Molecule-1; Receptors, Lymphocyte Homing Cadherins; CD4 Immunoadhesins; Cell Adhesion Molecules, Neuronal; Intercellular Adhesion Molecule-1; Receptors, Lymphocyte Homing Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. These molecules promote cell adhesion via a homophilic mechanism. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis. Antigens, Surface (79-89); Glycoproteins (66-87); Membrane Glycoproteins (88-89) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR $E6^_<Cell Adhesion G04.335.117 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH) Adherence of cells to surfaces or to other cells. Cytology (66-69) f>Celiprolol D02.033.329.624.240; D02.092.063.624.240; D14.100.050.200.200.150; D16.050.850.135; D18.097.192; D18.162.116; D18.918.174 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Vasodilator Agents A cardioselective beta-1-adrenergic antagonist that may act as a partial agonist at some adrenergic sites. Propanolamines (82-92); Urea/analogs and derivatives (78-82) :Q}HCeliac Plexus A08.800.050.050.150; A08.800.800.060.150 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways A complex network of nerve fibers including sympathetic and parasympathetic efferents and visceral afferents. The celiac plexus is the largest of the autonomic plexuses and is located in the abdomen surrounding the celiac and superior mesenteric arteries. .6)Celiac Disease C06.405.469.637.250; C18.452.603.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Malabsorption Syndromes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Malabsorption Syndromes A disease characterized by intestinal malabsorption and precipitated by gluten-containing foods. The intestinal mucosa shows loss of villous structure. X*NCeliac Artery A07.231.114.207 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The arterial trunk that arises from the abdominal aorta and after a short course divides into the left gastric, common hepatic and splenic arteries. 88Cefuroxime D20.085.099.180.190.223.235 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile; Cefotaxime 3-(((Aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino) acetyl)amino)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid. Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus. Cephalosporins (66-79) :qcCeftriaxone D20.085.099.180.190.223.228 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile; Cefotaxime (6R-(6 alpha,7 beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. Broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to usually inaccessible infections, including those involving the meninges, eyes, inner ears, and urinary tract. Cefotaxime (82-85); Cephalosporins (66-81) s:q3Ceftizoxime D20.085.099.180.190.223.210 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile; Cefotaxime 7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo- 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. Cefotaxime/analogs and derivatives (82-88); Cephalosporins (79-81) w:qRNCeftazidime D20.085.099.180.210.120 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephaloridine (6R-(6 alpha,7 beta(Z)))-1-((7-((2-Amino-4-thiazolyl) (1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy- 8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl) pyridinium hydroxide inner salt pentahydrate. Semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Cephalosporins (66-84) :dCefsulodin D20.085.099.180.185 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins 4-(Aminocarbonyl)-1-((2-carboxy-8-oxo-7-((phenylsulfoacetyl) amino)-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl) pyridinium hydroxide inner salt. A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients. Cephalosporins (66-84) :S=Cefoxitin D20.085.099.180.220.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephamycins 3-(((Aminocarbonyl)oxy)methyl)-7-methoxy-8-oxo-7-((2- thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid. Semisynthetic cephamycin antibiotic resistant to beta-lactamase. Carbamates (74); Cephalosporins (74)  :b-Cefotiam D20.085.099.180.190.223.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile; Cefotaxime 7-((2-(2-Amino-4-thiazolyl)acetyl)amino)-3-(((1-(2- (dimethylamino)ethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo- 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. A cephalosporin antibiotic which has a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It is the drug of choice for biliary tract infections and is a safe drug for perinatal infections. Cefotaxime/analogs and derivatives (82-88); Cephalosporins (79-81)  :qNCefotetan D20.085.099.180.220.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephamycins 7-(((4-(2-Amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2- yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene- 2-carboxylic acid. A semisynthetic cephamycin antibiotic which is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infections and to date no severe side effects have been noted. Cephamycins (82-88)   :bCefotaxime D20.085.099.180.190.223 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile Cefmenoxime; Cefotiam; Ceftizoxime; Ceftriaxone; Cefuroxime 3-((Acetyloxy)methyl)-7-(((2-amino-4-thiazolyl) (methoxyimino)acetyl)amino)-8-oxo-5-thia-1-azabicyclo (4.2.0)oct-2-ene-2-carboxylic acid. Semisynthetic broad-spectrum cephalosporin proposed for Pseudomonas infections. Cephalosporins (66-81)  :cGCefoperazone D20.085.099.180.160.211 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cefamandole (6R-(6 alpha,7 beta(R*)))-7-(((((4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections. Cephalosporins (66-83) :bCefonicid D20.085.099.180.177 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins (6R-(6 alpha,7 beta(R*)))-7-((Hydroxyphenylacetyl)amino)-8-oxo-3-(((1-(sulfomethyl)-1H-tetrazol-5-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene 2-carboxylic acid. A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is effective in the treatment of urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. Cefamandole/analogs and derivatives (78-89); Cephalosporins (66-77)  :SOCefmetazole D20.085.099.180.220.145 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephamycins 7-((((Cyanomethyl)thio)acetyl)amino)-7-methoxy-3-(((1- methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. Cephamycins (79-88) :bCefmenoxime D20.085.099.180.190.223.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephacetrile; Cefotaxime 7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)- 3-(((1-methyl-1H-tetrazol-5 yl)thio)methyl)-8-oxo-5-thia- 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. A cephalosporin antibiotic which is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. Cefotaxime (82-88); Cephalosporins (79-81) :ql3Cefazolin D20.085.099.180.170 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins 3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-3- ((1H-1,2,3-triazol-4-ylthio)methyl)-5-thia-1-azabicyclo (4.2.0)oct-2-ene-2-carboxylic acid. Semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine. Side effects are similar to those of other cephalosporins. Cephalosporins (70-74); Sulfides (73-74); Tetrazoles (73-74); Thiadiazoles (73-74) & :ScCefatrizine D20.085.099.180.200.162.168 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephalexin; Cefadroxil 7-((2-Amino-(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1H- 1,2,3-triazol-4-ylthio)methyl)-5-thia-1-azabicyclo(4.2.0) oct-2-ene-2-carboxylic acid. Orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity. Cephalosporins (66-77)  (:oCefamandole D20.085.099.180.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins Cefoperazone 7-((Hydroxyphenylacetyl)amino)-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene- 2-carboxylic acid. Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate. Cephalosporins (66-77)  "=:S9Cefadroxil D20.085.099.180.200.162 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephalexin Cefatrizine 7-((Amino-(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5- thia-l-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate. Long-acting, broad-spectrum, water-soluble, cephalexin derivative proposed especially for children with upper respiratory infections. Cephalexin (72-74); Cephalexin/AA (75-83); Cephalosporins (66-71)  $:aOCefaclor D20.085.099.180.200.156 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Cephalosporins; Cephalexin (6R-(6 alpha,7 beta(R*)))-7((Aminophenylacetyl)amino) 3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene 2-carboxylic acid. Semisynthetic, broad-spectrum antibiotic derivative of cephalexin proposed for oral use. Cephalosporins (66-79) & :aCecum A03.492.411.495.209 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cecostomy Digestive System; Gastrointestinal System; Intestines; Intestine, Large Appendix ( : T Cecostomy E04.579.338.175; E04.765.338.175 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Cecum Surgery, Operative; Ostomy; Enterostomy Surgery, Operative; Surgery, Digestive System (Non MeSH); Enterostomy Surgical construction of an opening into the cecum with a tube through the abdominal wall (tube cecostomy) or by skin level approach, in which the cecum is sewn to the surrounding peritoneum. Its primary purpose is decompression of colonic obstruction. Cecal Diseases/surgery (66-87); Cecum/surgery (66-87)  ) &$ )ACecal Neoplasms C04.588.274.476.411.184; C06.240.476.411.184; C06.405.282.411.184; C06.405.469.110.417; C06.405.469.505.184 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Cecal Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms Appendiceal Neoplasms Appendiceal Neoplasms Appendiceal Neoplasms Appendiceal Neoplasms Appendiceal Neoplasms ,BwXDzCecal Diseases C06.405.469.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases Appendicitis; Cecal Neoplasms (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI 0NU,XCebus B02.649.801.400.120.120.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae; Cebinae A genus of the family CEBIDAE, subfamily CEBINAE, consisting of four species which are divided into two groups, the tufted and untufted. C. apella has tufts of hair over the eyes and sides of the head. The remaining species are without tufts - C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South America. Anthropoidea (66-80) 1z (JCebinae B02.649.801.400.120.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae Cebus A subfamily of New World monkeys in the family CEBIDAE. They inhabit the forests of South and Central America and comprise members of the genus CEBUS. 3 (? Cebidae B02.649.801.400.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini Alouattinae (+ 1); Aotinae (+ 1); Callimiconinae; Callitrichinae (+ 2); Cebinae (+ 1); Saimirinae (+ 1) The family of New World monkeys consisting of nine subfamilies: ALOUATTINAE (howler monkeys), AOTINAE (night monkeys), Atelinae (spider monkeys), Callicebinae (titis), CALLIMICONINAE (Goeldi's marmosets), CALLITRICHINAE (marmosets), CEBINAE (capuchin monkeys), Pithecinae (sakis), and SAIMIRINAE (squirrel monkeys). They inhabit the forests of South and Central America, comprising the largest family of South American monkeys. 5e (4CD8-Positive T-Lymphocytes A11.118.637.555.567.569.220; A15.145.229.637.555.567.569.220; A15.382.490.555.567.569.220; A15.382.520.520.604.220 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Antigens, CD8; CD4-CD8 Ratio Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes T-Lymphocytes, Cytotoxic; T-Lymphocytes, Suppressor-Effector T-Lymphocytes, Cytotoxic; T-Lymphocytes, Suppressor-Effector T-Lymphocytes, Cytotoxic; T-Lymphocytes, Suppressor-Effector T-Lymphocytes, Cytotoxic; T-Lymphocytes, Suppressor-Effector A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They are include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and suppressor T-lymphocytes (T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR). T-Lymphocyte Subsets (91-94); T-Lymphocytes (82-94) $8z|*$ =CD4-Positive T-Lymphocytes A11.118.637.555.567.569.200; A15.145.229.637.555.567.569.200; A15.382.490.555.567.569.200; A15.382.520.520.604.200 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Acquired Immunodeficiency Syndrome; Antigens, CD4; CD4-CD8 Ratio; T-Lymphocytopenia, Idiopathic CD4-Positive Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; T-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; T-Lymphocytes T-Lymphocytes, Helper-Inducer (+ 2); T-Lymphocytes, Suppressor-Inducer T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Suppressor-Inducer; Th1 Cells; Th2 Cells T-Lymphocytes, Helper-Inducer (+ 2); T-Lymphocytes, Suppressor-Inducer T-Lymphocytes, Helper-Inducer (+ 2); T-Lymphocytes, Suppressor-Inducer A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-LYMPHOCYTES, HELPER-INDUCER) and suppressor-inducer (T-LYMPHOCYTES, SUPPRESSOR-INDUCER) T-cells. T Lymphocytes (86-88) $=|*|Q9CD4-CD8 Ratio E01.223.459.107.595.500.150.160; G04.610.248; G07.380.107.595.500.150.160 DEISMTREVE T-Lymphocyte Subsets; T-Lymphocytes; CD8-Positive T-Lymphocytes; CD4-Positive T-Lymphocytes; Antigens, CD8; Antigens, CD4 Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count; Leukocyte Count; Lymphocyte Count; CD4 Lymphocyte Count Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Physiology, General (Non MeSH); Cell Count; Blood Cell Count; Leukocyte Count; Lymphocyte Count; CD4 Lymphocyte Count Ratio of T-lymphocytes that express the CD4 antigen to those that express the CD8 antigen. This value is commonly assessed in the diagnosis and staging of diseases affecting the immune system including HIV infection. Antigens, Differentiation, T-Lymphocyte (86-91); Leukocyte Count (86-91)  DQqTCD4 Lymphocyte Count E01.223.459.107.595.500.150; G07.380.107.595.500.150 DEECISMTREVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Blood Cell Count; Leukocyte Count; Lymphocyte Count Physiology, General (Non MeSH); Cell Count; Blood Cell Count; Leukocyte Count; Lymphocyte Count CD4-CD8 Ratio CD4-CD8 Ratio A count of the number of CD4-positive lymphocytes in the blood. Determination requires the use of a fluorescence-activated flow cytometer. Leukocyte Count (88-94)  H:"CD4 Immunoadhesins D12.776.124.486.485.230; D12.776.124.790.651.230; D12.776.377.715.548.230; D12.776.395.550.200.230; D12.776.543.550.200.230; D12.776.828.300.200; D24.611.125.600.230; D24.611.216.301.350.230 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Recombinant Proteins; Recombinant Fusion Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immunoglobulins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Cell Adhesion Molecules Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin. Antigens, CD (90-91); Antigens, Differentiation, T-Lymphocyte (89); IgG (89-91) K6%{_CDP Diacylglycerol-Serine O-Phosphatidyltransferase D08.586.913.696.900.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Transferases (Other Substituted Phosphate Groups) An enzyme that catalyzes the formation of phosphatidylserine and CMP from CDPdiglyceride plus serine. EC 2.7.8.8. Cephalins (72-74); Cytosine Nucleotides (72-74); Phosphotransferases (72-74) R`9FZCDC28 Protein Kinase D08.586.913.696.620.682.700.200.135; D12.776.260.150.200.135 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases; Cyclin-Dependent Kinases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins; Cell Cycle Proteins; Cyclin-Dependent Kinases A protein kinase encoded by the Saccharomyces cerevisiae CDC28 gene and required for progression from the G1 to the S phase in the cell cycle. It is a complex of approximately 160 kD containing a substrate called p40. (Cell 1988 Sep 23;54(7):1061) EC 2.7.1.-. Protein Kinases (88-92) TBF7CD-ROM L01.178.147.668.800.250.200; L01.178.147.898.800.250.200; L01.240.960.800.250.200; L01.700.568.080.260.115.475.600.300 CLECHILJSDSNSTTDUT Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Optical Storage Devices; Videodisc Recording; Compact Disks Information Science; Communications Media (Non MeSH); Audio-Visual Aids; Television; Videodisc Recording; Compact Disks Information Science; Copying Processes; Video Recording; Videodisc Recording; Compact Disks Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers; Computer Peripherals; Computer Storage Devices; Optical Storage Devices An optical disk storage system for computers on which data can be read or from which data can be retrieved but not entered or modified. A CD-ROM unit is almost identical to the compact disk playback device for home use. XJ XCavernous Sinus A07.231.908.224.334 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cardiovascular System; Blood Vessels; Veins; Cranial Sinuses An irregularly shaped venous space in the dura mater at either side of the sphenoid bone. \m6ImCautery E02.154 AECLCTECHIISMOMTNUPXSNSTTDUTVE Electrocoagulation Therapeutics Electrocoagulation (+ 1) ]  "Caustics D01.205; D05.569.185 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH) Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Lye; Potassium Dichromate; Sodium Hydroxide Lye; Potassium Dichromate; Sodium Hydroxide Strongly alkaline substances that are corrosive to skin and tissues and ingestion of them causes thousands of injuries each year. They are usually hydroxides of light metals. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ^J ,qh8Cause of Death E05.318.308.985.550.250; G03.850.505.400.975.550.250; G03.850.520.308.985.550.250; L01.280.975.550.250; N01.224.935.698.100 TD Death Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics; Mortality Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics; Mortality Information Science; Data Collection; Vital Statistics; Mortality Population Characteristics (Non MeSH); Demography; Vital Statistics; Mortality Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Mortality (66-87)  ` SCausality G03.850.490.625; N05.715.350.200 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors Precipitating Factors; Risk Factors Precipitating Factors; Risk Factors The relating of causes to the effects they produce. Causes are termed necessary when they must always precede an effect and sufficient when they initiate or produce an effect. Any of several factors may be associated with the potential disease causation or outcome, including predisposing factors, enabling factors, precipitating factors, reinforcing factors, and risk factors. Risk (66-89); specific disease/epidemiology (66-89); specific disease/etiology (66-89) dn &TgCausalgia C10.772.537.184 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases; Neuralgia A burning pain, often accompanied by trophic skin changes, due to injury of a peripheral nerve. (Dorland, 27th ed). Neuralgia (66-70) g NSCaulobacter crescentus B03.200.280.280; B03.440.400.280.280 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Budding or Appendaged Bacteria (Non MeSH); Caulobacter Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Caulobacter A species of gram-negative, aerobic bacteria that consist of slender vibroid cells. Bacteria (66-91) i*"cCaulobacter B03.200.280; B03.440.400.280 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Budding or Appendaged Bacteria (Non MeSH) Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria Caulobacter crescentus Caulobacter crescentus A genus of rod- or vibroid-shaped or fusiform bacteria that commonly produce a stalk. They are found in fresh water and soil and divide by binary transverse fission. Bacteria (66-91)  k1""4Caulimovirus B04.280.100; B04.715.464.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Plant Viruses; Mosaic Viruses A group of plant viruses that are transmitted by aphids in a semipersistent manner. Aphid-borne transmission of some caulimoviruses requires certain virus-coded proteins termed transmission factors. Mosaic Viruses (73-93); Plant Viruses (69-93) mE"I8Caudovirales B04.123.150; B04.280.090 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses; DNA Viruses Myoviridae (+ 4); Podoviridae (+ 3); Siphoviridae (+ 1) Myoviridae (+ 4); Podoviridae (+ 3); Siphoviridae (+ 1) An order comprising three families of tailed bacteriophages: MYOVIRIDAE, PODOVIRIDAE, and SIPHOVIRIDAE. o"6wCaudate Nucleus A08.186.211.730.885.105.487.550.184 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia; Corpus Striatum; Neostriatum Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. p'8qCauda Equina A08.800.800.720.725.150 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves; Spinal Nerve Roots The collection of spinal roots that descend from the lower part of the spinal cord and occupy the vertebral canal below the cord; their appearance resembles the tail of a horse. (Dorland, 27th ed). re6rCaucasoid Race I01.076.368.763.284 CLGEHI Whites Whites Social Sciences; Anthropology; Anthropology, Physical; Racial Stocks A major racial group distinguished by classification according to physical features. This group, also called Europoid, centers around the Mediterranean Sea but includes central and northern Europe. They are indigenous also to northern Africa, southwestern Asia, and India. (Winick: Dictionary of Anthropology, 1972; American Heritage Dictionary, 2d College ed).  tJ   QCattle Diseases C22.196 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Bovine Virus Diarrhea-Mucosal Disease; Brucellosis, Bovine; Encephalopathy, Bovine Spongiform; Enzootic Bovine Leukosis; Ephemeral Fever; Freemartinism; Infectious Bovine Rhinotracheitis; Lumpy Skin Disease; Malignant Catarrh; Mastitis, Bovine; Pasteurellosis, Pneumonic; Pneumonia, Atypical Interstitial, of Cattle; Theileriasis; Trypanosomiasis, Bovine; Tuberculosis, Bovine Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  v HqJCattle B02.649.077.380.271 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Domesticated bovine animals usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. consider also terms at BOVINE. y (7Cattell Personality Factor Questionnaire F04.711.647.513.146 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests; Personality Inventory Self report questionnaire which yields 16 scores on personality traits, such as reserved vs. outgoing, humble vs. assertive, etc. {)/ Cats B02.649.147.167 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora consider also terms at FELINE. |(''Cations, Monovalent D01.248.497.300.459 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Cations Protons Positively charged atoms, radicals or group of atoms with a valence of plus 1, which travel to the cathode or negative pole during electrolysis. specific element ( - ); Ions (66-72); Metals (66-72)  }l8I CCations, Divalent D01.248.497.300.333 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Cations Positively charged atoms, radicals or groups of atoms with a valence of plus 2, which travel to the cathode or negative pole during electrolysis. specific element(66-72); Ions (66-72); Metals (66-72) A8ICCations D01.248.497.300 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions Cations, Divalent; Cations, Monovalent (+ 1) Postively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cations, Divalent (73-77); Cations, Monovalent (73-77); Ions (66-77)   8>6SCation Exchange Resins D26.572.283 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Ion Exchange Resins High molecular weight insoluble polymers which contain functional cationic groups that are capable of undergoing exchange reactions; used in various types of chromatography; also to treat hyperkalemia. ,LCatholicism K01.844.188.250 HIPX Humanities; Religion; Christianity The Christian faith, practice, or system of the Catholic Church, specifically the Roman Catholic, the Christian church that is characterized by a hierarchic structure of bishops and priests in which doctrinal and disciplinary authority are dependent upon apostolic succession, with the pope as head of the episcopal college.(From Webster, 3d ed and American Heritage Dictionary, 2d college ed). *Cathexis F01.145.299.333; F03.407.246.333 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Displacement (Psychology) Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms; Displacement (Psychology) Attachment, conscious or unconscious, of emotional feeling and significance to an idea, object or most commonly a person.  &Catheters, Indwelling E07.145 AECLCTECHIMIPSSDSNSTTDUTVEVI Infusion Pumps, Implantable Catheterization Equipment and Supplies Catheters designed to be left within an organ or passage for an extended period of time. Catheterization (66-74); Heart Catheterization (66-74); Urinary Catheterization (66-74) $q  !lfCatheterization, Swan-Ganz E01.145.569.540.165; E02.148.224.165; E02.148.442.165 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Pulmonary Wedge Pressure Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Heart Catheterization Therapeutics; Catheterization; Catheterization, Peripheral Therapeutics; Catheterization; Heart Catheterization Placement of a flow-directed catheter (developed by cardiologists Swan and Ganz) by way of the heart, with or without a balloon tip, for hemodynamic and therapeutic monitoring and diagnosis. It is not restricted exclusively to cardiopulmonary procedures. Heart Catheterization (71-87)  =&(#Catheterization, Peripheral E02.148.224 AECLCTECHIISMOMTNUPXSNSTTDUTVE Bronchoscopy Therapeutics; Catheterization Catheterization, Swan-Ganz Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes. Bronchi (66-87); Bronchoscopy (66-87); Catheterization (66-87); Catheters, Indwelling (78-87); Heart Catheterization (66-87) AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE ( "#}&Catheterization, Central Venous E02.148.167 AECLCTECHIISMOMTNUPXSNSTTDUTVE Venous Cutdown Therapeutics; Catheterization Placement of an intravenous catheter in the subclavian, jugular, or other central vein for central venous pressure determination, chemotherapy, hemodialysis, or hyperalimentation. Catheterization (66-87); Catheters, Indwelling (78-87)  %"#@Catheterization E02.148; E05.157 AECLCTECHIISMOMTNUPXSNSTTDUTVE Catheters, Indwelling; Venous Cutdown Therapeutics Miscellaneous Techniques (Non MeSH) Angioplasty (+ 7); Balloon Dilatation (+ 3); Catheter Ablation; Catheterization, Central Venous; Catheterization, Peripheral (+ 1); Heart Catheterization (+ 2); Radiography, Interventional; Urinary Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. AECLCTDEECHIISMOMTNUPXRERHSNSTTDUTVE $"-8C(Catheter Ablation E01.145.569.540.110; E02.148.110; E02.148.442.110; E02.154.402.110 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Heart Catheterization Therapeutics; Catheterization Therapeutics; Catheterization; Heart Catheterization Therapeutics; Cautery; Electrocoagulation Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias. Catheterization (71-80); Heart Catheterization (81-92) L"@Cathepsins D08.586.277.656.732.133 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Cathepsin D Dipeptidylpeptide hydrolases. Intracellular acidic proteinases found in aqueous extracts of a variety of animal tissue. FCathepsin D D08.586.277.656.732.066.180; D08.586.277.656.732.133.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Aspartic Proteinases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cathepsins An intracellular proteinase found in a variety of tissue. It has specificity similar to but narrower than that of pepsin A. The enzyme is involved in catabolism of cartilage and connective tissue. EC 3.4.23.5. (Formerly EC 3.4.4.23). Cathepsins (66-84) >F5Cathepsin B D08.586.277.656.732.215.133 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases A lysosomal cysteine proteinase which hydrolyzes proteins, with a specificity resembling that of papain. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in demyelination, emphysema, rheumatoid arthritis, and neoplastic infiltration. EC 3.4.22.1. Cathepsins (66-86) FCathartics D19.316.396 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Agar; Bisacodyl; Cascara (+ 1); Castor Oil; Dioctyl Sulfosuccinates; Karaya Gum; Lactulose; Magnesium Hydroxide; Magnesium Oxide; Methylcellulose (+ 1); Mineral Oil; Oxyphenisatin Acetate; Psyllium; Senna; Tragacanth AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR ,SFCatharsis F04.754.919.107.333 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Therapeutic Processes (Non MeSH); Abreaction  Catgut E07.858.784.250 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Sutures Sterile collagen strands obtained from healthy mammals. They are used as absorbable surgical ligatures and are frequently impregnated with chromium or silver for increased strength. They tend to cause tissue reaction. Sutures (66-78)  >Catfish B02.493.080 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes Ictaluridae Common name to express the order Siluriformes. This order contains many families and over 2,000 species, including venomous species. Heteropneustes and Plotosus genera have dangerous stings and are aggressive. Most species are passive stingers. Fishes (66-86)  2 &Catechols D02.755.166 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Curcumin; Estrogens, Catechol (+ 1); Guaiacol (+ 1); 3-Methoxy-4-hydroxyphenylethanol; Nordihydroguaiaretic Acid; Tiron AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  8/DCatecholamines D02.092.211.215.311; D02.092.311 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Catecholamine Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Monoamines Organic Chemicals (Non MeSH); Amines Dopamine; Epinephrine (+ 1); Norepinephrine (+ 1); Orciprenaline (+ 1) Dobutamine; Dopa (+ 4); Dopamine (+ 3); Epinephrine (+ 5); Isoproterenol; Orciprenaline (+ 1) A general class of ortho-dihydroxyphenylalkylamines derived from tyrosine. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $p&BVFCatechol Oxidase D08.586.682.420.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between catechol and oxygen to yield benzoquinone and water. It is a complex of copper-containing proteins that acts also on a variety of substituted catechols. EC 1.10.3.1. Oxidoreductases (66-67); Tyrosine Decarboxylase (66-67)  $FhACatechol Methyltransferase D08.586.913.517.183 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases Methyltransferases (71); Transferase (66-71) Fk5Catechin D03.438.150.240.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromans 3,3',4',5,7-Flavanpentol. Extracted from Uncaria gambier, Acacia catechu and other plants; it stabilizes collagen and is therefore used in tanning and dyeing; it prevents capillary fragility and abnormal permeability, but was formerly used as an antidiarrheal. Synonyms: Cachou; Cashoo; Cutch. Benzopyrans (73-76); Catechols (73-76)  :cV/Catchment Area (Health) G03.850.505.400.800.200; N01.224.791.200; N03.349.650.095 ECLJSN Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Residence Characteristics Population Characteristics (Non MeSH); Demography; Residence Characteristics Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning A geographic area defined and served by a health program or institution. LA YXCatatoxic Steroids D04.808.183; D06.597.225 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic Pregnenolone Carbonitrile Pregnenolone Carbonitrile AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8t::Catatonia F03.126.720.396 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders A state characterized by immobility with muscular rigidity or inflexibility and at times by excitability.  Ft|Catastrophic Illness C23.280.150; N01.407.306.240 CLECEPMONUPXRHTH Insurance, Major Medical Insurance, Major Medical Symptoms and General Pathology (Non MeSH); Disease Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Disease An acute or prolonged illness usually considered to be life-threatening or with the threat of serious residual disability. Treatment may be radical and is frequently costly.  }"Cataract Extraction E04.792.208 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Aphakia, Postcataract; Lenses, Intraocular Surgery, Operative; Surgery, Eye (Non MeSH) Enzymatic Zonulolysis $25Cataract C11.510.245 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTTHURUSVEVI Eye Diseases; Lens Diseases Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed).  L#>Cataplexy C10.228.140.725.254; C10.597.232; C23.888.592.192; F03.126.720.333 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Narcolepsy Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Narcolepsy Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders A condition in which there are abrupt attacks of muscular weakness and hypotonia triggered by an emotional stimulus such as mirth, anger, fear, or surprise. It is often associated with narcolepsy. (Dorland, 27th ed). w LLCatalysis H01.181.122.249; H01.181.529.145 DERE Physical Sciences (Non MeSH); Chemistry; Biochemistry Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical  &Catalogs, Union L01.178.682.290.483 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Catalogs iCatalogs, Publishers' L01.178.682.290.183.416 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Catalogs; Catalogs, Commercial gCatalogs, Library L01.178.682.290.383 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Catalogs 9iCatalogs, Drug L01.178.682.290.283 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Catalogs iCatalogs, Commercial L01.178.682.290.183 Equipment and Supplies Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Catalogs Catalogs, Booksellers'; Catalogs, Publishers' i5Catalogs, Booksellers' L01.178.682.290.183.249 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Catalogs; Catalogs, Commercial ¥Catalogs L01.178.682.290 Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Catalogs, Commercial (+ 2); Catalogs, Drug; Catalogs, Library; Catalogs, Union Ordered compilations of item descriptions and sufficient information to afford access to them. x \_oCataloging L01.300.250 CLECHIMTSNSTTDUT Information Science; Documentation Book Classification )Catalepsy F03.126.720.270 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders Sustained immobility of postures or physical attitude. y FtACatalase D08.586.682.732.332 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Peroxidases Ʒ FgCat-Scratch Disease C01.252.400.200; C01.252.400.810.700.810.815.200; C15.604.315.249 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rochalimaea Infections Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphadenitis A self-limiting bacterial infection of the regional lymph nodes caused by Afipia felis, a gram-negative bacterium recently identified by the Centers for Disease Control and Prevention and by ROCHALIMAEA HENSELAE. It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom. ǦIPCat Diseases C22.180 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Feline Acquired Immunodeficiency Syndrome; Feline Infectious Enteritis; Feline Infectious Peritonitis; Leukemia, Feline Diseases of the domestic cat (Felis catus or F. domesticus). This term does not include diseases of the so-called big cats such as CHEETAHS, LIONS, tigers, cougars, panthers, leopards, and other Felidae for which the heading CARNIVORA is used. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI   H JCasts, Surgical E07.858.442.660.414 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices Dressings made of fiberglass, plastic, or bandage impregnated with plaster of paris used for immobilization of various parts of the body in cases of fractures, dislocations, and infected wounds. In comparison with plaster casts, casts made of fiberglass or plastic are lightweight, radiolucent, able to withstand moisture, and less rigid. ΂mCastration E04.779.282; E04.887.165 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Eunuchism Gonads Surgery, Operative; Surgery, Endocrine (Non MeSH) Surgery, Operative; Surgery, Urogenital (Non MeSH) Orchiectomy; Ovariectomy Orchiectomy; Ovariectomy Surgical removal or artificial destruction of gonads. $$  u:@Castor Oil D10.516.212.507.300; D10.516.627.700.132; D19.316.396.280; J01.740.400.200; J01.740.700.200 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Ricinus; Castor Bean Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Fats, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Oils; Plant Oils Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Technology, Industry, Agriculture (Non MeSH); Oils; Industrial Oils Technology, Industry, Agriculture (Non MeSH); Oils; Plant Oils An oil obtained from the seed of Ricinus communis. It is used as a cathartic and as a plasticizer for pharmaceutical preparations, and has been used as a bland emollient to the skin in certain dermatoses. (Dorland, 27th ed). eg@Castor Bean B06.660.751.332 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Castor Oil Ricinus Plants; Plants, Toxic; Ricinus The seed of the CASTOR BEAN or castor oil plant, Ricinus communis, which yields CASTOR OIL. (Dorland, 27th ed).  & 'Cassia B06.560.546.160 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Senna Plants; Plants, Medicinal; Legumes Leguminous plants Cassia senna L. (or C. acutifolia) and C. angustifolia that contain anthraquinones which are used as laxatives. Senna (66-77)  K & +Cassava B06.510.198 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Any of several species of the tropical plant, family Euphorbiaceae, that grow starchy roots used for food. Manihot esculenta is most often used, but contains high amounts of hydrogen cyanide and few essential nutrients. ؗ 4Caseins D12.776.256.626.207 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Milk Proteins A mixture of related phosphoproteins occurring in milk and cheese. The group is characterized as one of the most nutritive milk proteins, containing all of the common amino acids and rich in the essential ones. ' BkCase-Control Studies E05.318.760.500.500; G03.850.520.835.500.500; N05.715.360.775.175.200 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH); Analytic Studies (Epidemiology) (Non MeSH) Retrospective Studies Retrospective Studies Retrospective Studies Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group. Epidemiologic Methods (66-89) M0J{#Cascara D02.806.100.205; D04.615.117.159.205; D19.316.396.247; D24.310.674.175; D26.714.175 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Anthraquinones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes; Anthraquinones Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Immunologic and Biologic Factors (Non MeSH); Biological Products; Plant Extracts Miscellaneous Drugs and Agents (Non MeSH); Plant Extracts Emodin Emodin Emodin Component of the dried bark of a buckthorn (Rhamnus purshiana) that contains the anthraquinone EMODIN. It is used as a laxative. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   _8:Carubicin D20.085.075.105.200.180; D22.204.106.125.200.180 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline; Daunorubicin 8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-5,12-naphthacenedione. A very toxic anthracycline-type antibiotic related to DAUNORUBICIN, obtained from Actinomadura carminata. It is used in soft tissue neoplasms and leukemias. Antibiotics, Antineoplastic (67-74); Aminoglycosides (74); Naphthacenes (66-74) ( 6<A]Cartoons K01.093.206.332 CLHIPXSNTD Humanities; Art; Caricatures  $Cartilage, Articular A02.165.165; A02.835.583.192; A10.165.382.332 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage Musculoskeletal System; Skeleton; Joints Tissue Types (Non MeSH); Connective Tissue; Cartilage 5:Cartilage Diseases C05.182; C17.300.182 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Ellis-Van Creveld Syndrome; Epiphyses, Slipped; Osteochondritis Musculoskeletal Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases Polychondritis, Relapsing; Tietze's Syndrome Polychondritis, Relapsing; Tietze's Syndrome Cartilage (66-67); Cartilage, Articular (66-67); Osteochondritis (66-67)  /NJtfVCartilage A02.165; A10.165.382 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Chondroitin; Laryngeal Cartilages Musculoskeletal System Tissue Types (Non MeSH); Connective Tissue Cartilage, Articular; Ear Cartilages; Intervertebral Disk; Laryngeal Cartilages (+ 4); Menisci, Tibial; Nasal Septum Cartilage, Articular consider also terms at CHONDRO-.  S :(N)Carticaine D03.383.903.150; D15.050.050.120; D15.210.100.200.120; D16.850.025.120 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiophenes Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local 4-Methyl-3-((1-oxo-2-(propylamino)propyl)amino)-2-thiophenecarboxylic acid methyl ester. A thiophene-containing local anesthetic pharmacologically similar to MEPIVACAINE. Thiophenes (66-78)  P:Carteolol D02.033.329.624.210; D02.092.063.624.210; D14.100.050.200.200.145; D16.050.850.125; D18.097.168; D18.162.104 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent. Amino Alcohols (66-72); Bunolol (73-78); Quinolines (66-78) 8 z:"ICarrots B06.510.956.200; J01.341.956.285 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Vegetables Technology, Industry, Agriculture (Non MeSH); Food; Vegetables A widely cultivated plant, Daucus carota sativa, having finely divided leaves, flat clusters of small white flowers, and an edible, yellow-orange root and also the long tapering root of the carrot, eaten as a vegetable. (From American Heritage Dictionary, 1982). Plants (66-94); Plants, Edible (66-79); Vegetables (66-94) + &4t4HCarrier State C01.539.158 BLCFCLCNDHDIDTECEHENEPIMMEMINUPAPCPPPSPXRARITHTMURVEVI Disease Reservoirs Bacterial and Fungal Diseases (Non MeSH); Infection A condition in which a human who is not himself sick harbors an infective organism which may cause disease in those to whom it is transmitted. :?Carrier Proteins D12.776.157 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein Binding; Receptors, Transferrin Amino Acids, Peptides and Proteins (Non MeSH); Proteins ABC Transporters; Acyl Carrier Protein; Androgen-Binding Proteins; Antiporters (+ 2); Calcium-Binding Proteins (+ 14); Calmodulin-Binding Proteins; Ceruloplasmin; Hemerythrin; Iron-Sulfur Proteins (+ 4); Lactoferrin; Monosaccharide Transport Proteins; Neurophysins; P-Glycoprotein; Retinol-Binding Proteins; RNA-Binding Proteins; Sex Hormone-Binding Globulin; Thyroxine-Binding Proteins; Transcobalamins; Transcortin; Transferrin; Vitamin D-Binding Protein Transport proteins that carry specific substances in the blood or across cell membranes. Protein Binding (66-70); Proteins (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (+D/D i3HCarrageenan D09.203.698.152 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Seaweed Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides *@ ^Carpus, Animal A13.395.248 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Forelimb :+Carpal Tunnel Syndrome C10.772.491.206 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Median Nerve Nervous System Diseases; Peripheral Nervous System Diseases; Nerve Compression Syndromes A complex of symptoms resulting from compression of the median nerve in the carpal tunnel, with pain and burning or tingling paresthesias in the fingers and hand, sometimes extending to the elbow. (Dorland, 27th ed). NgCarpal Bones A02.835.232.087.144 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH) Semilunar Bone Wrist (66-71); Wrist Joint (66-71) :V,Carp B02.493.200.244.248 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Cypriniformes; Cyprinidae Goldfish &8 Carotid Stenosis C10.228.140.300.123.360; C14.907.137.230; C14.907.253.123.360 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endarterectomy, Carotid Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Carotid Artery Diseases Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Carotid Artery Diseases The narrowing or stricture of a carotid artery that may lead to transient ischemic attacks (see CEREBRAL ISCHEMIA, TRANSIENT) and stroke (see CEREBROVASCULAR DISORDERS). Carotid Artery Diseases (66-91)  ENM&Carotid Sinus A07.231.114.186.456 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Pressoreceptors Cardiovascular System; Blood Vessels; Arteries; Carotid Arteries The dilated portion of the common carotid artery at its bifurcation into external and internal carotids. It contains baroreceptors which, when stimulated, cause slowing of the heart, vasodilatation, and a fall in blood pressure. 8M Carotid Body Tumor C04.557.465.625.650.700.705.220; C04.557.580.625.650.700.705.220 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carotid Body Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma; Paraganglioma, Extra-Adrenal Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Paraganglioma; Paraganglioma, Extra-Adrenal An invariably benign, encapsulated, firm round mass at the bifurcation of the common carotid artery, with nests of large polyhedral cells in alveolar or organoid arrangement. It is usually asymptomatic but large masses may encroach upon the parapharyngeal space and produce dysphagia, pain, and cranial nerve palsies. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). FXCarotid Body A08.800.550.700.120.600.150 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Carotid Body Tumor Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Chemoreceptors; Paraganglia, Nonchromaffin A small cluster of chemoreceptive and supporting cells located near the bifurcation of the internal carotid artery. The carotid body, which is richly supplied with fenestrated capillaries, senses the pH, carbon dioxide, and oxygen concentrations in the blood and plays a crucial role in their homeostatic control.  8mCarotid Artery, Internal A07.231.114.186.200.230 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Carotid Arteries; Carotid Artery, Common Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose. Carotid Arteries (66-71)  8iCarotid Artery, External A07.231.114.186.200.210 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Carotid Arteries; Carotid Artery, Common Branch of the common carotid artery which supplies the exterior of the head, the face, and the greater part of the neck. Carotid Arteries (66-71) z8iCarotid Artery, Common A07.231.114.186.200 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Carotid Arteries Carotid Artery, External; Carotid Artery, Internal The two principal arteries supplying the structures of the head and neck. They ascend in the neck, one on each side, and at the level of the upper border of the thyroid cartilage, each divides into two branches, the external (CAROTID ARTERY, EXTERNAL) and internal (CAROTID ARTERY, INTERNAL) carotid arteries. Carotid Arteries (66-92)  +8M<lCarotid Artery Thrombosis C10.228.140.300.123.331; C10.228.140.300.378.206; C14.907.253.123.331; C14.907.253.378.206; C14.907.355.350.850.213.206; C14.907.355.830.850.213.206 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Carotid Artery Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Carotid Artery Diseases Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism; Thromboembolism; Cerebral Embolism and Thrombosis Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Thrombosis; Thromboembolism; Cerebral Embolism and Thrombosis Formation of a clot in a carotid artery often resulting from atherosclerosis. Patients are at high risk for developing stroke. NNCarotid Artery Diseases C10.228.140.300.123; C14.907.253.123 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebrovascular Disorders Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders Carotid Artery Thrombosis; Carotid Stenosis; Moyamoya Disease Carotid Artery Thrombosis; Carotid Stenosis; Moyamoya Disease *NCarotid Arteries A07.231.114.186 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Carotid Artery, Common (+ 2); Carotid Sinus Either of the two principal arteries on both sides of the neck that supply blood to the head and neck; each divides into two branches, the internal carotid artery and the external carotid artery. 887Carotenoids D02.455.849.131; D11.557.261 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Bacteriorhodopsin; Carotene (+ 1); Xanthophyll Bacteriorhodopsin; Carotene (+ 2); Retinal Pigments (+ 2); Retinoids (+ 7) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR "BHCarotene D02.455.849.131.247; D11.557.261.206 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Carotenoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids Canthaxanthin Canthaxanthin; Xanthophyll The general name for a group of pigments found in green, yellow, and leafy vegetables, and yellow fruits. The pigments are fat-soluble, unsaturated aliphatic hydrocarbons functioning as provitamins and are converted to vitamin A through enzymatic processes in the intestinal wall.  *D/FCaroli's Disease C06.130.120.175; C06.175.184; C16.131.314.184 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Congenital cystic dilatation of the intrahepatic bile ducts. It consists of 2 types: simple, with bile duct dilatation or ectasia alone, and complex, with associated extensive hepatic fibrosis and portal hypertension. Benign renal tubular ectasia is associated with both types. Bile Duct Diseases/congenital (66-92); Bile Ducts, Intrahepatic/abnormalities (85-92); Biliary Dyskinesia (66-84) !5LCCarnosine D12.644.456.345.331; D12.776.641.650.100; D14.600.600.177 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A naturally occurring dipeptide found in muscle of man and numerous animals, but some animals, e.g., pigeons and geese, have N-methylcarnosine in their muscles. (From Merck Index, 11th ed.). %% AD7Carnivora B02.649.147 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Bears; Cats; Cheetahs; Dogs; Ferrets; Foxes; Lions; Mink; Mongoose; Otters; Raccoons; Skunks ' (vCarnitine Palmitoyltransferase D08.586.913.050.350.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Carnitine Acyltransferases An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21. Acyltransferases (73-74); Palmitic Acids (73-74); Carnitine (73-74) (#FQCarnitine Acyltransferases D08.586.913.050.350 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases Carnitine Acetyltransferase; Carnitine Palmitoyltransferase Acyltransferases in the inner mitochondrial membrane that catalyze the reversible transfer of acyl groups from acylCoA to L-carnitine and thereby mediate the transport of activated fatty acids through that membrane. Acyltransferases (72-74)  +FiCCarnitine Acetyltransferase D08.586.913.050.134.150; D08.586.913.050.350.170 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Acetyltransferases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Carnitine Acyltransferases An enzyme that catalyzes the formation of O-acetylcarnitine from acetyl-CoA plus carnitine. EC 2.3.1.7. Acetyltransferases (73-74); Carnitine (73-74) -y 6Fz6Carnitine D11.786.708.168 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Acetylcarnitine; Palmitoylcarnitine 3-Carboxy-2-hydroxy-N,N,N-trimethylpropanaminium hydroxide, inner salt. Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. / D]) Carmustine D02.654.692.247; D02.948.594.247; D22.204.342 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosourea Compounds Organic Chemicals (Non MeSH); Urea; Nitrosourea Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Alkylating Agents (66-71); Nitroso Compounds (66-71); Urea (66-71) 2 5:QCarmine D02.806.100.200; D04.615.117.159.200; D26.408.168; D26.471.355.168 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Quinones; Anthraquinones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes; Anthraquinones Miscellaneous Drugs and Agents (Non MeSH); Dyes Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Coloring Agents Coloring matter from the insect Coccus cacti L. It is used in foods, pharmaceuticals, toiletries, etc., as a dye and also has use as a microscopic stain and biological marker. Aluminum (72-75); Anthraquinones (72-75); Calcium (72-75) 3 L.IFCarlavirus B04.715.100; B04.820.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses Viruses; RNA Viruses A group of plant viruses with slightly flexuous filaments, often transmitted by aphids in a non-persistent manner. Plant Viruses (76-93) 66Carisoprodol D02.241.081.251.165; D15.525.110; D16.700.600.110 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed., p.1202). 889:}Cariostatic Agents D25.223 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Fluoridation Dental Caries Biomedical and Dental Materials (Non MeSH) Fluorides, Topical (+ 3)  ;o ,3Cariogenic Agents D25.187 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Diet, Cariogenic Dental Caries Biomedical and Dental Materials (Non MeSH) <\ ,3Caricatures K01.093.206 CLHIPXSNTD Humanities; Art Cartoons =* Caribbean Region Z01.107.084 EHEP Geographicals (Non MeSH); America West Indies (+ 12) The area that lies between continental North and South America and comprises the Caribbean Sea, the West Indies, and the adjacent mainland regions of southern Mexico, Central America, Colombia, and Venezuela. West Indies (66-93)  =*Carfecillin D20.085.099.739.762.161.365 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Carbenicillin 6-((1,3-Dioxo-3-phenoxy-2-phenylpropyl)amino)-3,3-dimethyl- 7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. The phenyl ester of carbenicillin that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections. Carbenicillin (73-77); Penicillins (66-72) ?@:rO3Caregivers M01.085; M01.526.485.200; N02.360.200 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH) Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients, etc. A-Career Mobility I01.880.840.200; N01.824.175; N01.824.547.330; N04.452.677.300 Social Sciences; Sociology; Socioeconomic Factors Population Characteristics (Non MeSH); Socioeconomic Factors Population Characteristics (Non MeSH); Socioeconomic Factors; Occupations Health Services Administration (Non MeSH); Organization and Administration; Personnel Management The upward or downward mobility in an occupation or the change from one occupation to another. Health Occupations (66-71); Occupations (66-71); specific occupation (66-71) DHBr[Career Choice F02.463.785.373.346.400 Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking; Decision Making; Choice Behavior Selection of a type of occupation or profession. Gi<Cardiovirus Infections C02.782.687.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Picornaviridae Infections Infections caused by viruses of the genus CARDIOVIRUS, family PICORNAVIRIDAE. HsPY[Cardiovirus B04.820.565.170; B04.909.777.618.170 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae Columbia SK Virus; Encephalomyelitis Virus, Murine; Encephalomyocarditis Virus; Mengovirus; MM Virus Columbia SK Virus; Encephalomyelitis Virus, Murine; Encephalomyocarditis Virus; Mengovirus; MM Virus A genus of the family PICORNAVIRIDAE causing encephalitis and myocarditis in rodents. Encephalomyocarditis Virus (72-93); Picornaviridae (78-93)  I*}eDCardiovascular System Physiology (Non MeSH) G09.330 Circulatory, Respiratory Physiology (Non MeSH) Atrial Function (+ 2); Baroreflex; Blood Circulation (+ 13); Capillary Fragility; Capillary Permeability (+ 4); Cardiovascular Deconditioning; Hemodynamics (+ 28); Myocardial Contraction (+ 2); Vascular Patency; Ventricular Function (+ 3) ABAHCHCLCYDEECEDEMENGDGEHIIMINIRISLJMAMEMIMTOGPAPHPPPSRARERISESNSTSUTDULUSVEVI LZ3 6RCardiovascular System A07 AHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Blood Vessels (+ 85); Heart (+ 21) The heart and the blood vessels by which blood is pumped and circulated through the body. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI N`4.m:Cardiovascular Diseases C14 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiology Cardiovascular Abnormalities (Non MeSH) (+ 29); Heart Diseases (+ 130); Hyperemia; Pregnancy Complications, Cardiovascular (+ 1); Scimitar Syndrome; Syphilis, Cardiovascular; Tuberculosis, Cardiovascular (+ 1); Vascular Diseases (+ 183) BLBSCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI OL\Cardiovascular Deconditioning G09.330.494 DEGEIMPHRE Weightlessness Countermeasures Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) A change in cardiovascular function, especially after periods of actual or simulated weightlessness or diminished power or strength, probably related to the shift of a quantity of blood from the lower limbs to the thorax, resulting in reflex diuresis and a reduction of blood volume. (From Dorland, 27th ed). Cardiovascular System (66-94)  Q"#jk#Cardiovascular Agents D18 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Arrhythmia Agents (+ 40); Antihypertensive Agents (+ 77); Calcium Channel Agonists (+ 1); Calcium Channel Blockers (+ 18); Cardiotonic Agents (+ 30); Vasoconstrictor Agents (+ 22); Vasodilator Agents (+ 63) Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR TL8{FCardiovascular Abnormalities (Non MeSH) C14.240; C16.131.240 Cardiovascular Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Arterio-Arterial Fistula; Arteriovenous Malformations (+ 2); Heart Defects, Congenital (+ 22); Pulmonary Atresia; Scimitar Syndrome Arterio-Arterial Fistula; Arteriovenous Malformations (+ 2); Heart Defects, Congenital (+ 22); Pulmonary Atresia; Scimitar Syndrome BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI V.c4NCardiotonic Agents D18.222 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Myocardial Contraction; Heart Cardiovascular Agents Amrinone; Cardiac Glycosides (+ 12); Enoximone; Lisinopril; Sympathomimetics (+ 12); Xamoterol Agents that have a tonic effect on the heart or increase cardiac output. They may be glycosidic steroids related to Digitalis products, sympathomimetics, or other drugs and are used after myocardial infarcts, cardiac surgery, in shock, or in congestive heart failure. specific drug or agent (66-79); Cardiac Glycosides (66-79); Sympathomimetics (66-79) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (X 8$s9eDCardiotocography E01.145.569.278; E01.249.400.167; E01.621.390.167 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Uterine Contraction Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Fetal Monitoring Diagnosis; Monitoring, Physiologic; Fetal Monitoring Monitoring of fetal heart frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION. Fetal Heart (69-88); Fetal Monitoring (78-88); Labor, Premature (77-88); Uterine Contraction (74-88)  [9&yCardiopulmonary Resuscitation E02.365.647.110 AECLCTECEDHIISMOMTNUPXSNSTTDUTVE Therapeutics; Emergency Treatment (Non MeSH); Resuscitation The artificial substitution of heart and lung action as indicated for cardiac arrest or apparent sudden death resulting from electric shock, drowning, respiratory arrest, and other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation and closed-chest cardiac massage. (Dorland, 27th ed). Resuscitation (71-91) ^"$GzCardiopulmonary Bypass E04.292.413 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Heart Bypass, Left; Heart, Mechanical Surgery, Operative; Extracorporeal Circulation Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Extracorporeal Circulation (67-76)  a$.6(Cardioplegic Solutions D26.394.225.766.200 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heart Arrest, Induced Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. Used in the performance of heart surgery. Heart Arrest, Induced (66-87); Hypertonic Solutions (66-87); Hypotonic Solutions (66-87); Isotonic Solutions (66-87)  b,ZCardiomyoplasty E04.752.376.125; E04.920.490.125 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery Surgery, Operative; Thoracic Surgery; Heart Surgery A technique used in therapy for heart failure in which autologous skeletal muscle is wrapped around the heart and electrically stimulated in order to provide mechanical heart assistance. The latissimus dorsi muscle is commonly used to form this skeletal muscle ventricle that functions to independently augment cardiac performance by pumping in series with the heart. Heart Surgery (87-94) e&$Cardiomyopathy, Restrictive C14.280.600.160 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Myocardial disease in which the ventricular walls are excessively rigid, impeding ventricular filling; it is marked by abnormal diastolic function but by normal or nearly normal systolic function. Myocardial Diseases (79-85) g NG!Cardiomyopathy, Hypertrophic C14.280.600.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Aortic Valve Stenosis Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Aortic Subvalvular Stenosis; Pulmonary Subvalvular Stenosis A myocardial disease characterized by hypertrophy, involving mainly the interventricular septum, interfering with left ventricular emptying.  i!NGECardiomyopathy, Congestive C14.280.434.160; C14.280.445.160; C14.280.600.070 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Failure, Congestive Cardiovascular Diseases; Heart Diseases; Heart Hypertrophy Cardiovascular Diseases; Heart Diseases; Myocardial Diseases A syndrome characterized by cardiac enlargement and congestive heart failure. It probably represents the end result of many forms of myocardial damage produced by a variety of toxic, metabolic, or infectious agents. Heart Failure, Congestive (66-83); Myocardial Diseases (79-83) k9NJCardiomyopathy, Alcoholic C14.280.600.057; C21.613.053.270.250 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism Cardiomyopathy resulting from: 1) a toxic effect of alcohol on the myocardium; 2) thiamine deficiency due to malnutrition in alcoholics; or 3) a toxic effect of cobalt additives in beer in heavy beer drinkers. This disease is usually manifested by dyspnea and palpitations with cardiomegaly and congestive heart failure. Alcoholism (66-78); Heart Diseases (66-78); Myocardial Diseases (66-78) n*LxVCardiology Service, Hospital N02.278.354.422.215; N04.452.442.422.215 CLECHILJMAOGSNSTTDUT Coronary Care Units Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cardiac patient. q". Cardiology G02.403.776.409.163 CLECEDHIISLJMAMTOGSNSTTD Cardiovascular Diseases; Heart Diseases; Vascular Diseases Health Occupations; Medicine; Specialties, Medical; Internal Medicine The study of the heart, its physiology, and its functions. t8ERHCardiolipins D10.516.695.300.700.780.200; D24.611.216.119.480.330 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antibodies, Anticardiolipin; Antiphospholipid Syndrome Lipids and Antilipemic Agents (Non MeSH); Lipids; Phospholipids; Glycerophosphates; Phosphatidic Acids; Phosphatidylglycerols Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Haptens Phospholipids occurring primarily in mitochondrial inner membranes and in bacterial plasma membranes. Phospholipids (66-71)  u:6>uCardiography, Impedance E01.145.569.240; E01.145.811.611.250; E01.725.528.250 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Plethysmography; Plethysmography, Impedance Diagnosis; Plethysmography; Plethysmography, Impedance A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities. Cardiac Output (66-78); Plethysmography, Impedance (66-78) x=&ECardiac Volume G09.330.612.330 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Cardiac Output (66-67); Heart/physiology (66-67) {{;Cardiac Tamponade C14.280.155 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pericardial Effusion Cardiovascular Diseases; Heart Diseases |N/Cardiac Pacing, Artificial E02.145 AECLCTECHIMOMTNUPXSNSTTDUTVE Pacemaker, Artificial Electric Stimulation Therapeutics Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacemaker, Artificial (66-77) $}j   h#Cardiac Output, Low C14.280.148 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases A state of subnormal or depressed cardiac output, usually seen in patients with heart failure secondary to coronary artery, hypertensive, primary myocardial, valvular, or pericardial disease. Cardiac Output (66-79) ~N/Cardiac Output, High C14.280.142 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases A state of elevated cardiac output. Conditions that lower peripheral vascular resistance, such as anemia, arteriovenous fistulas, thyrotoxicosis, and pregnancy, are among the most important factors augmenting the venous return and therefore elevating cardiac output. Increased cardiac output also occurs in muscular exercise, fever, and severe anoxia. Cardiac Output (67-91) wN/Cardiac Output E01.145.569.205; G09.330.612.280 DEGEIMPHRE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Stroke Volume Stroke Volume The volume of blood passing through the heart per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with stroke volume (volume per beat). &"Cardiac Glycosides D09.203.408.180; D18.222.175 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Cardiovascular Agents; Cardiotonic Agents Digitalis Glycosides (+ 8); Proscillaridin; Strophanthins (+ 2) Digitalis Glycosides (+ 7); Proscillaridin; Strophanthins (+ 2) Substances obtained from species of Digitalis, Strophanthus, and other plants that contain specific steroid glycosides or their semisynthetic derivatives and are used in congestive heart failure. They increase the force of cardiac contraction without significantly affecting other parameters, but are very toxic at larger doses. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  +">zDCardiac Care Facilities N02.278.421.556.110 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Institutions specializing in the care of patients with heart disorders. pUCardia A03.492.766.163 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Stomach  :<Cardenolides D04.808.155.160 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides Digitoxin (+ 2); Digoxin (+ 3); Strophanthins (+ 3) C(23)-steroids with methyl groups at C-10 and C-13 and a five-membered lactone at C-17. They are aglycone constituents of CARDIAC GLYCOSIDES and must have at least one double bond in the molecule. The class includes cardadienolides and cardatrienolides. Members include DIGITOXIN and DIGOXIN and their derivatives and the STROPHANTHINS. Cardanolides (68-76) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $88CDCardanolides D04.808.155 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Cardenolides (+ 11) The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  8(DCarcinosarcoma C04.557.435.290; C04.557.450.795.290 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma Carcinoma 256, Walker Carcinoma 256, Walker A malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. (Stedman, 25th ed). P*X4Carcinoma, Verrucous C04.557.470.200.450; C04.557.470.700.450 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell A variant of well-differentiated epidermoid carcinoma that is most common in the oral cavity, but also occurs in the larynx, nasal cavity, esophagus, penis, anorectal region, vulva, vagina, uterine cervix, and skin, especially on the sole of the foot. Most intraoral cases occur in elderly male abusers of smokeless tobacco. The treatment is surgical resection. Radiotherapy is not indicated, as up to 30% treated with radiation become highly aggressive within six months. (Dictionary of Modern Medicine, 1992). Carcinoma, Papillary (69-93) .XU"Carcinoma, Transitional Cell C04.557.470.200.430 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma A malignant neoplasm derived from transitional epithelium, occurring chiefly in the urinary bladder, ureters or renal pelves (especially if well differentiated), frequently papillary. Transitional cell carcinomas are graded 1 to 3 or 4 according to the degree of anaplasia, grade 1 appearing histologically benign but being liable to recurrence. (Stedman, 25th ed). 5"XuCarcinoma, Squamous Cell C04.557.470.200.400; C04.557.470.700.400 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Non-Small-Cell Lung Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell Bowen's Disease Bowen's Disease A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed).  .X$&Carcinoma, Small Cell C04.557.465.625.650.240.390; C04.557.470.200.025.370.390; C04.557.580.625.650.240.390 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Non-Small-Cell Lung Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. There are admixtures of small cell lung carcinoma with other types of lung cancer. Small cell carcinomas are distinguished by their distinctive biological features, response to chemotherapy and radiotherapy, and by their nearly universal tendency to develop overt or subclinical metastases, which frequently eliminates surgery in most patients. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p. 1286-7).  ]X$7 Carcinoma, Skin Appendage C04.557.470.200.025.420; C04.557.470.550.420 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Adnexal and Skin Appendage (Non MeSH) A malignant tumor of the skin appendages, which include the hair, nails, sebaceous glands, sweat glands, and the mammary glands. (From Dorland, 27th ed). #2X'Carcinoma, Signet Ring Cell C04.557.470.200.025.415; C04.557.470.590.415 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) Krukenberg Tumor Krukenberg Tumor A highly malignant, mucus-secreting tumor in which the mucus-secreting cells are anaplastic and appear rounded, with the nucleus displaced to one side by a globule of mucus in the cytoplasm. (Dorland, 27th ed). Adenocarcinoma, Mucinous (66-93)  "2X)(&Carcinoma, Renal Cell C04.557.470.200.025.390 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Adenocarcinoma (66-84); Kidney Neoplasms (66-84) X:Carcinoma, Papillary, Follicular C04.557.470.200.025.060.225; C04.557.470.200.025.085.225 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Adenocarcinoma, Follicular Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Adenocarcinoma, Papillary A thyroid neoplasm of mixed papillary and follicular arrangement. Its biological behavior and prognosis is the same as that of a papillary adenocarcinoma of the thyroid. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Adenocarcinoma (70-93); Carcinoma, Papillary (70-93) "&>XI$>Carcinoma, Papillary C04.557.470.200.360; C04.557.470.700.360 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed). .XCarcinoma, Non-Small-Cell Lung C04.557.470.200.300 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Adenocarcinoma; Carcinoma, Large Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell Lung Neoplasms; Carcinoma, Small Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma A heterogeneous aggregate of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. They are dealt with collectively because of the shared properties of poor response to conventional chemotherapy and the potential for cure with surgical resection in a fraction of patients. Lung Neoplasms (66-86) $\$Xf.uCarcinoma, Neuroendocrine C04.557.465.625.650.240; C04.557.470.200.025.370; C04.557.580.625.650.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors Carcinoma, Islet Cell (+ 2); Carcinoma, Medullary; Carcinoma, Merkel Cell; Carcinoma, Small Cell Carcinoma, Islet Cell (+ 2); Carcinoma, Medullary; Carcinoma, Merkel Cell; Carcinoma, Small Cell Carcinoma, Islet Cell (+ 2); Carcinoma, Medullary; Carcinoma, Merkel Cell; Carcinoma, Small Cell A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Dictionary of Modern Medicine, 1992). QXX\Carcinoma, Mucoepidermoid C04.557.470.200.025.340; C04.557.470.590.340 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed; Holland et al., Cancer Medicine, 3d ed.). /2X)Carcinoma, Merkel Cell C04.557.465.625.650.240.325; C04.557.470.200.025.370.325; C04.557.580.625.650.240.325 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine A trabecular carcinoma of the skin. It is a rare malignant cutaneous tumor composed of dermal nodules of small round cells with scanty cytoplasm in a trabecular pattern. The tumor cells usually contain cytoplasmic dense core granules resembling neurosecretory granules seen in Merkel cells (specialized tactile sensory nerve endings in the epidermis). (Stedman, 25th ed). Skin Neoplasms (66-88) ]X Carcinoma, Medullary C04.557.465.625.650.240.315; C04.557.470.200.025.370.315; C04.557.470.615.315; C04.557.580.625.650.240.315 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed; Dictionary of Modern Medicine, 1992). Carcinoma (66-93)  ŃtXXCarcinoma, Lobular C04.557.470.200.025.305; C04.557.470.615.305 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) A infiltrating (invasive) breast cancer, relatively uncommon, accounting for only 5%-10% of breast tumors in most series. It is often an area of ill-defined thickening in the breast, in contrast to the dominant lump characteristic of ductal carcinoma. It is typically composed of small cells in a linear arrangement with a tendency to grow around ducts and lobules. There is likelihood of axillary nodal involvement with metastasis to meningeal and serosal surfaces. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Breast Neoplasms (66-93); Carcinoma (66-93) `2X+w5Carcinoma, Lewis Lung C04.557.470.200.280; C04.619.230 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Mice, Inbred C57BL Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms, Experimental A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy. Lung Neoplasms (72-94)  &RCarcinoma, Large Cell C04.557.470.200.260 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Non-Small-Cell Lung Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed). Carcinoma, Non-Small-Cell Lung (87-93); Carcinoma, Oat Cell (80-93)  qX$uPCarcinoma, Krebs 2 C04.557.470.200.255; C04.619.214 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms, Experimental ՙ&RCarcinoma, Islet Cell C04.557.465.625.650.240.285; C04.557.470.200.025.370.285; C04.557.580.625.650.240.285 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoma, Neuroendocrine Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoma, Neuroendocrine Somatostatinoma; Vipoma Somatostatinoma; Vipoma Somatostatinoma; Vipoma A carcinoma of the islets of Langerhans. Adenoma, Islet Cell (66-93)  ]X S3"Carcinoma, Intraductal, Noninfiltrating C04.557.470.200.025.275; C04.557.470.615.275 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) Paget's Disease, Mammary Paget's Disease, Mammary A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma. Its true incidence is uncertain but all noninvasive breast carcinomas comprise almost 5% of all neoplastic lesions of the female breast, with this carcinoma accounting for about 50% of these, or 2.5%-2.8% of all tumors. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed; Holland et al., Cancer Medicine, 3d ed). ڑ-2X+:Carcinoma, Infiltrating Duct C04.557.470.200.025.265; C04.557.470.615.265 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Ductal, Lobular, and Medullary (Non MeSH) An invasive (infiltrating) carcinoma of the breast. This carcinoma in which no special histological feature is recognized is designated NOS or Not Otherwise Specified and is by far the most common ductal tumor, accounting for almost 70% of breast cancers. It is characterized by stony hardness upon palpation. It commonly metastasizes to the axillary lymph nodes and its prognosis is the poorest of the various ductal types. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). ߐ"2X+HCarcinoma, Hepatocellular C04.557.470.200.025.255 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Primary carcinoma of the liver cells. It ranges from a well-differentiated tumor difficult to distinguish from normal hepatocytes to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic or may form giant cells. Several classification schemes have been suggested. Hepatocellular carcinoma is very rare in the United States and western Europe, but it is one of the most common cancers in eastern Asia and sub-Saharan Africa. The cases are preponderantly male and, racially, whites have the lowest rates. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed; Holland et al., Cancer Medicine, 3d ed). XCarcinoma, Giant Cell C04.557.470.200.220 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma An epithelial neoplasm characterized by unusually large anaplastic cells. It is highly malignant with fulminant clinical course, bizarre histologic appearance and poor prognosis. It is most common in the lung and thyroid. (From Stedman, 25th ed and Dictionary of Modern Medicine, 1992). Carcinoma (66-93); Giant Cell Tumors (66-89) XuP7Carcinoma, Endometrioid C04.557.470.200.025.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Ovarian carcinoma which resembles typical carcinoma of the endometrium and may be seen with a synchronous endometrial carcinoma. When they appear together, both tend to be of low stage. (From Holland et al., Cancer Medicine, 3d ed). Adenocarcinoma (66-93); Endometriosis (66-93); Ovarian Neoplasms (66-93) XVCarcinoma, Embryonal C04.557.465.200 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed and Holland et al., Cancer Medicine, 3d ed). Carcinoma (86-93); Neoplasms, Germ Cell and Embryonal (85-93); Tumor Cells, Cultured (87-93); Tumor Stem Cells (85-93) ZXh|Carcinoma, Ehrlich Tumor C04.557.470.200.200; C04.619.169 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms, Experimental A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. x&RCarcinoma, Brown-Pearce C04.619.124 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms, Experimental R)Carcinoma, Bronchogenic C04.588.894.797.520.220; C08.381.540.140; C08.785.520.140 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms; Lung Neoplasms Respiratory Tract Diseases; Lung Diseases; Lung Neoplasms Respiratory Tract Diseases; Respiratory Tract Neoplasms; Lung Neoplasms A cancer of the lung, so-called because it arises from the epithelium of the bronchial tree. It is not a histologic designation despite the name. YAXCarcinoma, Basosquamous C04.557.470.200.170; C04.557.470.565.170 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Basal Cell A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed). .X}Carcinoma, Basal Cell C04.557.470.200.165; C04.557.470.565.165 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Basal Cell Basal Cell Nevus Syndrome Basal Cell Nevus Syndrome A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). More than 95% of these carcinomas occur in patients over 40. They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed, p. 1471). *.X>Carcinoma, Adrenal Cortical C04.557.470.200.025.225 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma A malignant neoplasm of adrenal cortical cells demonstrating partial or complete histological and functional differentiation. They are rare, comprising between only 0.05% and 0.2% of all cancers. Women develop functional adrenal cortical carcinomas more commonly than men, but men develop nonfunctioning ones more often than women. Hypercortisolism is the most common presentation for this cancer. Virilism and Cushing's syndrome may also result. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Adrenal Cortex Neoplasms (70-93); Adrenal Gland Neoplasms (66-74); Carcinoma (66-93) !X`eCarcinoma, Adenosquamous C04.557.435.250; C04.557.470.200.150 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma A mixed adenocarcinoma and squamous cell or epidermoid carcinoma. Adenocarcinoma (68-93); Carcinoma, Squamous Cell (68-93) *XNCCarcinoma, Adenoid Cystic C04.557.470.200.025.220 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Carcinoma characterized by bands or cylinders of hyalinized or mucinous stroma separating or surrounded by nests or cords of small epithelial cells. When the cylinders occur within masses of epithelial cells, they give the tissue a perforated, sievelike, or cribriform appearance. Such tumors occur in the mammary glands, the mucous glands of the upper and lower respiratory tract, and the salivary glands. They are malignant but slow-growing, and tend to spread locally via the nerves. (Dorland, 27th ed). XQCarcinoma, Acinar Cell C04.557.470.200.025.215 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed; from DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Carcinoma (66-93) rX8Carcinoma 256, Walker C04.557.435.290.210; C04.557.450.795.290.210; C04.619.045 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH); Carcinosarcoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma; Carcinosarcoma Neoplasms; Neoplasms, Experimental A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed).  AR<Carcinoma in Situ C04.557.470.200.240 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma A neoplastic entity wherein the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. It is popularly applied to such cells in the uterine cervix. It is also called preinvasive carcinoma. (Dorland, 27th ed). Carcinoma (66-72) !Xu*Carcinoma C04.557.470.200 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Adenocarcinoma (+ 42); Carcinoma, Adenosquamous; Carcinoma, Basal Cell (+ 1); Carcinoma, Basosquamous; Carcinoma, Ehrlich Tumor; Carcinoma, Giant Cell; Carcinoma in Situ; Carcinoma, Krebs 2; Carcinoma, Large Cell; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma, Papillary; Carcinoma, Squamous Cell (+ 1); Carcinoma, Transitional Cell; Carcinoma, Verrucous; Cervical Intraepithelial Neoplasia A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed).  XhCarcinoid Tumor C04.557.465.625.650.200; C04.557.470.200.025.200; C04.557.580.625.650.200 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors Malignant Carcinoid Syndrome (+ 1) Malignant Carcinoid Syndrome (+ 1) Malignant Carcinoid Syndrome (+ 1) A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed and Holland et al., Cancer Medicine, 3d ed). QXzoCarcinoid Heart Disease C04.557.465.625.650.200.500.205; C04.557.470.200.025.200.500.205; C04.557.580.625.650.200.500.205; C14.280.129 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoid Tumor; Malignant Carcinoid Syndrome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma; Carcinoid Tumor; Malignant Carcinoid Syndrome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors; Carcinoid Tumor; Malignant Carcinoid Syndrome Cardiovascular Diseases; Heart Diseases Cardiac manifestation of MALIGNANT CARCINOID SYNDROME. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves. (DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). xNdCarcinogens, Environmental D05.569.162 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Environmental Pollutants Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH) Radon (+ 1) Carcinogenic substances which are found in the environment. Carcinogens (66-74) ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (,NG6Carcinogens D26.191 ADANCHCLCSCTDUECHIIPMEPDPKRESDSTTOTU Anticarcinogenic Agents; Cocarcinogenesis; Oncogenic Viruses Alkylating Agents; Neoplasms Miscellaneous Drugs and Agents (Non MeSH) Aflatoxins (+ 2); o-Aminoazotoluene; Anthracenes (+ 2); Asbestos (+ 4); Azoxymethane (+ 2); Benzene; Benzidines (+ 1); Benzo(a)pyrene; Bis(Chloromethyl) Ether; Busulfan; Chloroform; Croton Oil (+ 4); Diethylstilbestrol; Dihydroxydihydrobenzopyrenes (+ 1); p-Dimethylaminoazobenzene (+ 1); Dimethylhydrazines; Ethionine; Ethylenethiourea; Ethylnitrosourea; FANFT; Fluorenes (+ 3); 4-Hydroxyaminoquinoline-1-oxide; 3-Hydroxyanthranilic Acid; Indoprofen; Methylcholanthrene; Methylenebis(chloroaniline); Methylnitronitrosoguanidine; Methylnitrosourea; 1-Naphthylamine; 2-Naphthylamine; 4-Nitroquinoline-1-oxide; Nitrosamines (+ 5); Patulin; Penicillic Acid; Procarbazine; Propiolactone; Pyrenes (+ 1); Pyrrolizidine Alkaloids (+ 1); Safrole; Sterigmatocystin; Thioacetamide; Thorium Dioxide; Urethane; Vinyl Chloride AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $  (F#2FCarcinogenicity Tests E05.940.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Mutagenicity Tests Mutagenicity Tests Miscellaneous Techniques (Non MeSH); Toxicity Tests Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. Carcinogens (66-88); Mutagenicity Tests (81-88) $%">m9Carcinoembryonic Antigen D24.185.101.840.300; D24.611.216.285.329 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm ).6Carbutamide D02.886.590.795.204; D02.948.828.204; D09.482.179 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents *9:Carbuncle C01.252.410.868.820.270.200; C01.252.825.770.270.200; C01.539.800.720.770.270.200; C17.800.838.765.770.270.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Furunculosis Furunculosis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Furunculosis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Furunculosis Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Furunculosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Furunculosis An infection of cutaneous and subcutaneous tissue that consists of a cluster of boils. Commonly, the causative agent is STAPHYLOCOCCUS AUREUS. Carbuncles produce fever, leukocytosis, extreme pain, and prostration.  ,` xPCarboxypeptidases D08.586.277.656.245 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases Arginine Carboxypeptidase; Carboxypeptidase Transpeptidase 1@FjBCarboxypeptidase Transpeptidase D08.586.277.656.245.200; D08.586.913.050.325 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Carboxypeptidases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases Enzyme produced by Streptomyces strain R61 which catalyzes the peptide cross-linking of nascent cell-wall peptidoglycan. Acyltransferases (74); Carboxypeptidases (74); Peptidoglycan (74) 2$2FNCarboxymethylcellulose D09.203.698.365.180.663.329; D19.316.396.618.329; D26.698.179 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Cellulose; Methylcellulose Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics; Methylcellulose Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Polycarboxymethyl ether of cellulose. It is used as an emulsifier, thickener, suspending agent, etc., in cosmetics and pharmaceuticals; in research as a culture medium; in chromatography as a stabilizer for reagents; and therapeutically as a bulk laxative with antacid properties. Methylcellulose (66-74) 5E.BHCarboxylic Ester Hydrolases D08.586.277.352.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases Acetylesterase; Cholesterol Esterase; Cholinesterases (+ 3); Dehydroascorbatase; Lipase; Lipoprotein Lipase; Monoacylglycerol Lipases; Naphthol AS D Esterase; Phospholipases (+ 2) Enzymes which catalyze the hydrolysis of carboxylic acid esters with the formation of an alcohol and a carboxylic acid anion. Esterases (72-75)  8]!F`Carboxylic Acids D02.241 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Acids, Acyclic (Non MeSH) (+ 284); Acids, Aldehydic (Non MeSH) (+ 6); Acids, Carbocyclic (Non MeSH) (+ 112); Esters; Hydroxy Acids (+ 61); Keto Acids (+ 11) Acids (66-70); Fatty Acids (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  : 8#,FCarboxyhemoglobin D12.776.124.400.141; D12.776.422.512.149 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Hemoglobins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Hemeproteins; Hemoglobins <.FCarboxy-Lyases D08.586.520.258 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases S-Adenosylmethionine Decarboxylase; Aromatic Amino Acid Decarboxylases (+ 2); Glutamate Decarboxylase; Histidine Decarboxylase; Indole-3-Glycerol-Phosphate Synthase; Ornithine Decarboxylase; Orotidine-5'-Phosphate Decarboxylase; Phosphoenolpyruvate Carboxykinases; Phosphoenolpyruvate Carboxylase; Pyruvate Decarboxylase; Ribulosebiphosphate Carboxylase; Uroporphyrinogen Decarboxylase >-FOCarboxin D02.065.199.350; D03.383.517.200; D05.723.288.170 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxathiins Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial 5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide. A systemic agricultural fungicide and seed treatment agent. Anilides (72-74); Oxathiins (72-74) @ 9:,Carboprost D02.241.081.436.687.700.500.150; D07.131.100.200; D10.516.251.355.708.700.500.150; D17.350.700.670.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins F, Synthetic Reproductive Control Agents (Non MeSH); Abortifacient Agents; Abortifacient Agents, Non-Steroidal Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins F, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins F, Synthetic (5Z,9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxy-15-methylprosta-5,13-dien-1-oic acid. An abortifacient effective in both the first and second trimesters of pregnancy. Prostaglandins (66-74); Prostaglandins F (75-77); Prostaglandins F, Synthetic (78-79); Prostaglandins, Synthetic (77) Bp:Carboplatin D02.691.800.338; D22.204.338 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organoplatinum Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents (SP-4-2)-Diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')platinum. An organoplatinum compound which is advocated for use in the treatment of patients with ovarian cancer, small-cell lung cancer, squamous cell carcinomas of the head and neck, and seminomas. The compound has comparable efficacy with cisplatin but shows much lower toxicity. Nephrotoxicity, neurotoxicity, and ototoxicity occur only infrequently with carboplatin. Its dose-limiting toxicity is myelosuppression with severe thrombocytopenia and less often leukopenia. Antineoplastic Agents (66-90); Organoplatinum Compounds (78-90) G":^JCarbonyl Cyanide p-Trifluoromethoxyphenylhydrazone D02.626.270; D02.442.288.220; D08.373.936.270 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles Organic Chemicals (Non MeSH); Hydrazines; Hydrazones Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents ((4-(Trifluoromethoxy)phenyl)hydrazono-propanedinitrile. One of a group of compounds called uncoupling agents which inhibit energy metabolism. Hydrazones (73-74); Nitriles (73-74) K85:-Carbonyl Cyanide m-Chlorophenyl Hydrazone D02.442.288.200; D02.626.260; D08.373.936.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines; Hydrazones Organic Chemicals (Non MeSH); Nitriles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents An uncoupler of electron transport dependent ATP synthesis and photophosphorylation. Chlorobenzenes (74); Hydrazones (72-74); Nitriles (70-74) N05:bFCarbonic Anhydrase Inhibitors D08.373.220; D19.770.224.266 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics Acetazolamide; Benzolamide; Dichlorphenamide; Ethoxzolamide; Methazolamide Acetazolamide; Benzolamide; Dichlorphenamide; Ethoxzolamide; Methazolamide A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of carbonic anhydrase (CARBONATE DEHYDRATASE). Although their therapeutic use as diuretics is not frequent, they are used in clinical conditions where alkalinization of the urine is beneficial. Their most frequent application is in the reduction of intra-ocular pressure in the treatment of glaucoma. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  P_#"6:Carbonic Acid D01.029.260.150; D01.200.275 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH)  Carbonates (+ 4) Carbonic acid (H2C03). The hypothetical acid of carbon dioxide and water. It exists only in the form of its salts (carbonates), acid salts (hydrogen carbonates), amines (carbamic acid), and acid chlorides (carbonyl chloride). (From Grant and Hackh's Chemical Dictionary, 5th ed). Tv"8MCarbonates D01.045.125; D01.200.275.150; D01.248.497.158.165 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Alkalies Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH); Carbonic Acid Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Lithium Carbonate Bicarbonates (+ 1); Calcium Carbonate; Lithium Carbonate Bicarbonates Salts or ions of the theoretical carbonic acid, containing the radical CO2(3-). Carbonates are readily decomposed by acids. The carbonates of the alkali metals are water-soluble; all others are insoluble. (From Grant and Hackh's Chemical Dictionary, 5th ed). W98g3Carbonated Beverages J01.125.220 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Beverages Z1"BCarbonate Dehydratase D08.586.520.497.245 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases  A zinc-containing enzyme of erythrocytes with molecular weight of 30 kD. It is among the most active of known enzymes and catalyzes the reversible hydration of carbon dioxide, which is significant in the transport of CO2 from the tissues to the lungs. The enzyme is inhibited by ACETAZOLAMIDE. EC 4.2.1.1. ZD_kCarbon Tetrachloride Poisoning C21.613.177 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning ]>$LECarbon Tetrachloride D02.455.526.439.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKRESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Tetrachloromethane. A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed). ^!8p:Carbon Radioisotopes D01.496.123.328; D01.496.749.154 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Carbon Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. `V&4Carbon Monoxide Poisoning C21.613.455.245 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Gas Poisoning Toxic asphyxiation due to the displacement of oxygen from oxyhemoglobin by carbon monoxide. b(LWlCarbon Monoxide D01.200.250; D01.362.200; D01.650.550.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKRESDSTTOTUUR Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH) Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed). c16tCarbon Isotopes D01.496.123 Inorganic Chemicals (Non MeSH); Isotopes Carbon Radioisotopes Stable carbon atoms that have the same atomic number as the element carbon, but differ in atomic weight. C-13 is a stable carbon isotope. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR fp24Carbon Disulfide D01.200.210; D01.875.350.850.150.125 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH) Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Hydrogen Sulfide; Sulfides; Disulfides Carbon disulfide (CS2). A colorless, flammable, poisonous liquid, CS2. It is used as a solvent, and is a counterirritant and has local anesthetic properties but is not used as such. It is highly toxic with pronounced CNS, hematologic, and dermatologic effects. g*85Carbon Dioxide D01.200.200; D01.362.150; D01.650.550.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Hypercapnia; Hypocapnia Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH) Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Dry Ice Dry Ice Carbonic acid gas (CO2). A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals.  jx1:Carbon Compounds, Inorganic (Non MeSH) D01.200 Inorganic Chemicals (Non MeSH) Carbon Dioxide (+ 1); Carbon Disulfide; Carbon Monoxide; Carbonic Acid (+ 5) Inorganic compounds that contain carbon as an integral part of the molecule but are not derived from hydrocarbons. Carbon (66-93) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  l. %_:Carbon D01.268.150 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Charcoal; Diamond; Graphite Carbon. A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight 12.011. It may occur as several different allotropes including DIAMOND, CHARCOAL, and GRAPHITE. ADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR  n :2#<Carbolines D03.383.725.150; D03.438.473.155 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles A group of pyridoindole compounds. Allowed are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. Indoles (69-74); Pyridines (69-74) p}&8+Carbohydrates and Hypoglycemic Agents (Non MeSH) D09 Carbohydrates (+ 307); Hypoglycemic Agents (+ 15); Sweetening Agents (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR r9\HCarbohydrates D09.203 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Dietary Carbohydrates Carbohydrates and Hypoglycemic Agents (Non MeSH) Amino Sugars (+ 13); Blood Glucose; Deoxy Sugars (+ 4); Dietary Carbohydrates; Glycoconjugates (+ 8); Glycosides (+ 99); Monosaccharides (+ 27); Polysaccharides (+ 79); Sugar Acids (+ 20); Sugar Alcohols (+ 22); Sugar Phosphates (+ 24) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  s B9$HCarbohydrate Sequence G05.331.599.235; G06.184.599.235 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data The sequence of carbohydrates within polysaccharides, glycoproteins, and glycolipids. u&bCarbohydrate Metabolism, Inborn Errors C18.452.648.202 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Fructose Metabolism, Inborn Errors (+ 2); Galactosemia; Glucose Intolerance; Glycogen Storage Disease (+ 8); Hyperoxaluria (+ 1); Lactose Intolerance; Mannosidosis; Mucopolysaccharidoses (+ 6); Multiple Carboxylase Deficiency; Pyruvate Metabolism, Inborn Errors (+ 3) w-Lm;Carbohydrate Isomerases D08.586.399.278 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Glucosaminephosphate Isomerase (Glutamine-Forming); Glucosephosphate Isomerase; Inositol-1-Phosphate Synthase; Mannosephosphate Isomerase; Triosephosphate Isomerase; Uridine Diphosphate Glucose Epimerase Isomerases (66-72) yFSCarbohydrate Dehydrogenases D08.586.682.047.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases Fructuronate Reductase; Galactose Dehydrogenases; Glucose Dehydrogenases; Glucosephosphate Dehydrogenase; Phosphogluconate Dehydrogenase; Sugar Alcohol Dehydrogenases (+ 4); Uridine Diphosphate Glucose Dehydrogenase Reversibly catalyze the oxidation of a hydroxyl group of carbohydrates to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2.; and 1.1.99. Alcohol Oxidoreductases (66-77)  { Ft%Carbohydrate Conformation G06.184.580.235; H01.181.529.559.235 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Conformation Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Conformation The characteristic 3-dimensional shape of a carbohydrate. Molecular Conformation (73-79) ~*D$Carbofuran D02.241.081.251.156; D05.723.491.408.327 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Carbamate Carbamates (66-71); Insecticides (66-71) .:1Carbodiimides D02.491.203 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Imines CME-Carbodiimide; Dicyclohexylcarbodiimide; Ethyldimethylaminopropyl Carbodiimide Imines (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  T8.Z:Carbocysteine D12.125.119.270; D12.125.166.230.310; D20.187.133; D26.415.070 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Cysteine Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Expectorants A compound formed when iodoacetic acid reacts with sulfhydryl groups in proteins. It has been used as an anti-infective nasal spray with mucolytic and expectorant action. Amino Acids, Dicarboxylic (74); Amino Acids, Sulfur (74) H:MECarbocyanines D03.438.810.150; D26.550.150 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Cationic dyes used for differential staining of biological materials. Synonym: Stains-all. Alkenes (72-75); Quinolines (72-75) ",j,Carbimazole D03.383.374.108; D06.347.789.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Thyroid Antagonists Imidazoles (66-67); Thyroid Antagonists (66-67) &:9Carbidopa D02.092.311.242.538.200; D02.442.200; D08.373.210; D14.100.150.600.142; D15.090.050.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Catecholamines; Dopa; Methyldopa Organic Chemicals (Non MeSH); Hydrazines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents A peripheral inhibitor of DOPA DECARBOXYLASE. It is given in parkinsonism along with LEVODOPA to inhibit the conversion of levodopa to dopamine in the periphery, thereby reducing the peripheral adverse effects, increasing the amount of levodopa that reaches the central nervous system, and reducing the dose needed. It has no antiparkinson actions when given alone. Dopa (72-74); Hydrazines (72-74); Methyldopa (72-74)  c:ACarbenoxolone D02.455.849.919.300.250; D19.316.203.168 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Triterpenes; Glycyrrhetinic Acid Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents 3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic acid. An agent derived from licorice root. It is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity. Glycyrrhiza (66-74); Succinates (74); Triterpenes (74) .:0CCarbenicillin D20.085.099.739.762.161 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G Carfecillin 6-((Carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid. Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. Penicillins (66-70)  t:a%Carbazoles D03.494.148 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Ondansetron Azoles (66-68) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8G:Carbazilquinone D02.806.250.180; D03.383.097.217.300; D22.204.337 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones; Benzoquinones Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines; Aziridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 2-(2-((Aminocarbonyl)oxy)-1-methoxyethyl)-3,6-bis(1-aziridinyl)-5-methyl-2,5-cyclohexadiene-1,4-one. An alkylating agent structurally similar to mitomycin C found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients. Azirines (71-74); Carbamates (72-74); Quinones (72-74) 9:iCCarbaryl D02.241.081.251.150; D05.723.491.408.300; D08.373.275.250; D14.100.120.300.130 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Carbamate Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors l-Naphthalenol methylcarbamate. A carbamate insecticide and parasiticide. It is a potent anticholinesterase agent belonging to the carbamate group of reversible cholinesterase inhibitors. It has a particularly low toxicity from dermal absorption and is used for control of head lice in some countries. Carbamates (66-70); Insecticides (66-70)  X:^1Carbapenems D20.085.099.120 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam Thienamycins (+ 1) A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. Thienamycins are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain. Antibiotics (66-82); Antibiotics, Lactam (83-89) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $T:A.:<Carbanilides D02.065.199.326; D02.948.684.202 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Organic Chemicals (Non MeSH); Urea; Phenylurea Compounds Imidocarb; Nicarbazin Imidocarb; Nicarbazin Urea (70-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  &8}4:Carbamyl Phosphate Synthase (Glutamine) D08.586.464.255 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and glutamine. EC 6.3.5.5. Carbamates (74); Glutamine (74); Phosphotransferases, ATP (74) q.FPLCarbamyl Phosphate Synthase (Ammonia) D08.586.464.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. EC 6.3.4.16. Ammonia (74); Carbamates (74); Phosphotransferases, ATP (74) C,FPJCarbamyl Phosphate D02.241.081.251.145; D02.705.130 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Organic Chemicals (Non MeSH); Organophosphorus Compounds Phosphate salt of carbamic acid. Carbamates (73-74); Organophosphorus Compounds (73-74) &:)@Carbamazepine D03.494.240.127; D15.040.100.100; D15.080.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzazepines Central Nervous System Agents; Analgesics; Analgesics, Non-Narcotic Central Nervous System Agents; Anticonvulsants 5H-Dibenz(b,f)azepine-5-carboxamide. An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar. It has also been used to treat paroxysmal pain of CNS orgin. Anticonvulsants (66-67); Azepines (66-67) 5:2Carbamates D02.241.081.251 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Aldicarb; Aprocarb; Benomyl; Carbadox; Carbamyl Phosphate; Carbaryl; Carbofuran; Carisoprodol; Chlorpropham; Diethylcarbamazine; Fenbendazole; Meprobamate; Methocarbamol; Physostigmine; Pyridinolcarbamate; Thiocarbamates (+ 10); Thiophanate; Urethane (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR @8Y,:Carbadox D02.241.081.251.140; D03.438.857.140; D20.187.130 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinoxalines Anti-Infective Agents; Anti-Infective Agents, Local Methyl 3-(2-quinoxalinylmethylene)carbazate N(1),N(4)-dioxide. Bacteriostatic. Synonyms: Mecadox; Fortrigo; GS-6244. Carbamates (69-74); Quinoxalines (73-74)  9:1Carbachol D02.092.102.232.115; D02.675.276.232.115; D14.100.120.140.500.150; D14.100.120.140.700.150; D16.050.495.120; D16.050.675.120 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Nicotinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A slowly hydrolyzed cholinergic agonist that acts at both muscarinic and nicotinic receptors. Clinically it is used as a miotic, in ocular surgery, in the treatment of glaucoma, and in urinary incontinence. It is also commonly used as a research tool in animal studies.  :?Captopril D08.373.745.085.135; D12.125.072.401.623.270; D18.162.050.135 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Angiotensin-Converting Enzyme Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Imino Acids; Proline Cardiovascular Agents; Antihypertensive Agents; Angiotensin-Converting Enzyme Inhibitors (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline. An orally active inhibitor of angiotensin I-converting enzyme. It reduces elevated blood pressure by inhibiting the renin-angiotensin system and also inhibits pressure responses to exogenous angiotensin I. Kininase II/antagonists and inhibitors (73-79); Peptide Peptidohydrolases (66-67) /antagonists and inhibitors (68-72); Proline (66-74) /antagonists and inhibitors (75-79)  E:$Captan D03.438.473.133; D05.723.288.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Antifungal Agents (66-71); Indoles (66-71); Pesticides (66-71)  &:LCapsules D26.394.225.153 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms o ,MCapsid B04.950.250; D12.776.964.970.250 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Viruses; Virion Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Viral Structural Proteins The protein coat of the more complex viruses. It consists of many clusters of protein subunits called capsomers. The capsid encloses the genome and gives the virion its characteristic shape. The shapes are usually icosahedral or helical. Viral Proteins (68-74) & &FCapsicum B06.510.135; B06.560.147; J01.341.241.850.200 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Plants; Plants, Medicinal Technology, Industry, Agriculture (Non MeSH); Food; Condiments; Spices A genus of Solanaceous shrubs that yield CAPSAICIN. Several varieties have sweet or pungent edible fruits that are used as vegetables when fresh and spices when the pods are dried.  54Capsaicin D02.241.081.436.275.190; D03.132.760.200; D10.516.251.355.325.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Heterocyclic Compounds; Alkaloids; Solanaceous Alkaloids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Trans-8-Methyl-N-vanillyl-6-nonenamide. Cytotoxic alkaloid from various species of Capsicum (pepper, paprika), of the Solanaceae; causes pain, irritation and inflammation;, due to substance P depletion from sensory (afferent) nerve fibers; used mainly to study the physiology of pain and in the form of CAPSICUM as a counterirritant and gastrointestinal stimulant. Alkaloids (66-74); Amides (66-74); Capsicum (66-74); Catechols (66-74); Fatty Acids, Unsaturated (73-74) ~ I:dCaprylates D02.241.081.222; D02.241.081.407.177; D10.516.251.122 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids Octanoic Acids Octanoic Acids Octanoic Acids =8 5Caprolactam D02.065.589.200; D03.383.066.150; D03.383.411.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Lactams Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azepines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Lactams Hexahydro-2H-azepin-2-one. Cyclic amide of caproic acid used in manufacture of synthetic fibers of the polyamide type. Can cause local irritation. Azepines (68-74) â9:Caproates D02.241.081.193; D02.241.081.465.326; D10.516.251.400.326 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile Aminocaproic Acids (+ 1); Hexanoic Acids (+ 1); Mycophenolic Acid Hexanoic Acids Hexanoic Acids AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  A81t<Capripoxvirus B04.280.650.160.150; B04.909.204.783.160.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Lumpy Skin Disease Virus Lumpy Skin Disease Virus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising poxviruses infecting sheep, goats, and cattle. Transmission is usually mechanical by arthropods, but also includes contact, airborne routes, and non-living reservoirs (fomites). Poxviridae (85-93)  v2<Capreomycin D20.085.089.148; D20.085.116.165; D20.338.135.139 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antitubercular Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Anti-Infective Agents; Antitubercular Agents; Antibiotics, Antitubercular Capreomycin. Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus. Antitubercular Agents (66-71) 9<x#Capnocytophaga B03.350.300.245.340; B03.440.450.340 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Cytophagales; Cytophagaceae Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods A gram-negative gliding bacterium isolated from the oral cavity. It is a pathogen for PERIODONTITIS. Bacteroides (75-81); Cytophagaceae (75-81) 2*"x3Caplan's Syndrome C05.550.114.154.219; C05.799.114.219; C08.381.483.600.300; C17.300.775.099.219; C21.447.800.340 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis Pneumoconiosis associated with rheumatoid arthritis. kL=Capitation Fee N03.219.442.090 CLHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Fees and Charges A method of payment for health services in which an individual or institutional provider is paid a fixed, per capita amount without regard to the actual number or nature of services provided to each patient. %XCapital Punishment I01.880.604.160 HILJMTSNTD Social Sciences; Sociology; Social Control, Formal The use of the death penalty for certain crimes. ==Capital Financing N03.219.463.085 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Institutional funding for facilities and for equipment which becomes a part of the assets of the institution. Financial Management (78-79) ԥ["Capital Expenditures N03.219.151.450.200 CLHILJSNSTTD Economics, Organizations, Control (Non MeSH); Economics; Costs and Cost Analysis; Health Expenditures Those funds disbursed for facilities and equipment, particularly those related to the delivery of health care.  xCapillary Resistance G09.330.612.931.327 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics; Vascular Resistance iCapillary Permeability G06.535.166.330; G09.330.377 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Blood-Air Barrier; Blood-Brain Barrier; Blood-Retinal Barrier; Blood-Testis Barrier Blood-Air Barrier; Blood-Brain Barrier; Blood-Retinal Barrier; Blood-Testis Barrier Property of blood capillary walls that allows for the selective exchange of substances. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (tight junctions) which may limit large molecule movement. Y"Capillary Fragility E01.145.347; G09.330.277 DEGEIMPHRE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) The lack of resistance, or susceptibility, of capillaries to damage or disruption under conditions of increased stress. Capillaries (66-67); Capillary Resistance (66-67) ;Capillarity H01.181.529.875.327 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Surface Properties `Capillaries A07.231.432.410 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Microcirculation The minute vessels that connect the arterioles and venules. ޖ8@HCapillaria B01.500.294.100.275.780.180 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Adenophorea; Enoplida; Trichuroidea A genus of trichuroid nematodes parasitic in the liver and intestines of many mammals and birds. Two species, C. hepatica and C. philippinensis, produce often fatal infections in man. ߛ*UCapgras Syndrome F03.709.680.420 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders A psychotic disorder characterized by the patient's conviction that certain important or familiar persons in his environment are not real but are "doubles" of themselves or imposters. Psychoses (66-81) CFaCanthaxanthin D02.455.849.131.247.300; D11.557.261.206.300; D26.100.300; D26.471.355.150 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Carotenoids; Carotene Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Carotene Miscellaneous Drugs and Agents (Non MeSH); Antioxidants Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Coloring Agents beta,beta-Carotene-4,4'-dione. A trans-carotenoid pigment widely distributed in nature. The compound is used as an oral suntanning agent and as a food and drug coloring agent. It is believed that it inhibits development of tumor cells and neoplastic transformation through its antioxidant properties. Oral ingestion of the compound causes canthaxanthin retinopathy. Antioxidants (66-91); Carotene/analogs and derivatives (75-91) %T<YJCantharidin D24.185.926.275.162; D26.585.176 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Dermotoxins Miscellaneous Drugs and Agents (Non MeSH); Irritants Hexahydro-3a-alpha,7a-alpha-dimethyl-4-beta-epoxy- isobenzofuran-1,3-dione. Toxic compound from the Spanish fly or blistering beetle (Lytta (Cantharis) vesicatoria) and other insects. It was formerly an irritant, vesicant, and rubefacient paste of whole insects called cantharides. It is now used to produce skin inflammation. It causes gastroenteritis, nephritis, and circulatory failure if absorbed. Synonyms: cantharides camphor; Cantharone; Kantaridin. 7&.Canrenone D04.808.745.432.100.090; D06.347.050.200.210 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Canrenoate Potassium Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Aldosterone Antagonists; Canrenoate Potassium 17-Hydroxy-3-oxo-17 alpha-pregna-4,6-diene-21-carboxylic acid gamma-lactone. A synthetic pregnadiene compound with anti-aldosterone activity. Lactones (74); Ketosteroids (74); Pregnadienes (74) h 2:@Canrenoate Potassium D04.808.745.432.100; D06.347.050.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Aldosterone Antagonists Canrenone Canrenone Potassium 17-hydroxy-3-oxo-17 alpha-pregna-4,6-diene-21-carboxylate. A synthetic pregnadiene compound with anti-aldosterone activity. Carboxylic Acids (74); Ketosteroids (74); Pregnadienes (74)  *:ICannibalism F01.145.113.188; I01.076.201.450.324.150; F01.145.140 HIPX Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal Social Sciences; Anthropology; Anthropology, Cultural; Culture; Cultural Characteristics Behavior and Behavior Mechanisms (Non MeSH); Behavior Individuals who eat other individuals of their own species. =HCannabis B06.560.139 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Cannabinoids; Marijuana Abuse; Marijuana Smoking Plants; Plants, Medicinal The hemp plant Cannabis sativa. Hallucinogenic products prepared from the dried flowering tops of the plant include marijuana, hashish, bhang, and ganja.  &: Cannabinol D02.455.849.090.110 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Cannabinoids A physiologically inactive constituent of Cannabis sativa L. Cannabis (66-76); Tetrahydrocannabinol (75-76) =@PG7Cannabinoids D02.455.849.090 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Hallucinogens Cannabis Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes Cannabidiol; Cannabinol; Tetrahydrocannabinol Compounds extracted from Cannabis sativa L. and metabolites having the cannabinoid structure. The most active constituents are TETRAHYDROCANNABINOL, CANNABINOL, and CANNABIDIOL. Cannabis (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR ,> @5@Cannabidiol D02.455.849.090.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Cannabinoids 2-(3-Methyl-6-(1-methylethenyl)-3-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol. Compound isolated from Cannabis sativa extract. Cannabis (73-74); Resorcinol (69-74); Terpenes (73-74) :PCCanes E07.858.442.250 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Orthopedic Equipment Sticks used as walking aids. The canes may have three or four prongs at the end of the shaft.  LuCandy J01.341.152 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food  "=Candidiasis, Vulvovaginal C01.703.160.190; C13.371.894.190; C13.371.944.190 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses; Candidiasis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vaginal Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Vulvar Diseases Infection of the vulva and vagina with a fungus of the genus CANDIDA. 79PAVCandidiasis, Oral C01.703.160.180; C07.465.130 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses; Candidiasis Stomatognathic Diseases; Mouth Diseases Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed). "Py|Candidiasis, Cutaneous C01.539.800.200.105; C01.703.160.170; C01.703.295.170; C17.800.838.208.170 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Candidiasis Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed). 8TPCandidiasis, Chronic Mucocutaneous C01.539.800.200.100; C01.703.160.165; C01.703.295.165; C17.800.838.208.165 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Candidiasis Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy. Candidiasis (66-80); Candidiasis, Cutaneous (66-80) >(TP=Candidiasis C01.703.160 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Candidiasis, Chronic Mucocutaneous; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed). P=wCandida albicans B05.354.381.546.147.326; B05.354.930.176.326 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Candida Algae and Fungi (Non MeSH); Fungi; Yeasts; Candida A unicellular budding fungus which is the etiologic agent of moniliasis, also known as candidiasis. Candida (66-71) 2"vCandida B05.354.381.546.147; B05.354.930.176 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Algae and Fungi (Non MeSH); Fungi; Yeasts Candida albicans Candida albicans u *"(Candicidin D20.085.062.310; D20.085.115.200; D20.136.073.310 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Mixture of antifungal heptaene macrolides from Streptomyces griseus or Actinomyces levoris used topically in candidiasis. The antibiotic complex is composed of candicidins A, B, C, and D, of which D is the major component. Antibiotics, Antifungal (70-74); Polyenes (74)  9<8Cancer Care Facilities N02.278.421.556.070 CLECHILJMAOGSDSNSTTDUT Oncology Service, Hospital Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospitals; Hospitals, Special Institutions specializing in the care of cancer patients.  Q pECanavanine D12.125.311 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids  BHCanavan Disease C10.228.140.231; C10.228.337.072 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases Spongy degeneration of cerebral white matter, a rare autosomal recessive form of leukodystrophy. It is characterized by early onset, widespread demyelination and vacuolation of the white matter that gives rise to a spongy appearance, severe mental retardation, megalocephaly, atony of the neck muscles, spasticity of the extremities, and blindness. Death occurs at about 18 months of age. (Dorland, 27th ed). Cerebral Sclerosis, Diffuse (81-93); Demyelinating Diseases (67-93) `&NOCanaries B02.248.159 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Birds Birds (66-67)  &Canada Z01.107.567.176 EHEP Geographicals (Non MeSH); America; North America Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland; Northwest Territories; Nova Scotia; Ontario; Prince Edward Island; Quebec; Saskatchewan; Yukon Territory z <Campylobacter jejuni B03.440.180.425; B03.825.225.425 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Campylobacter Bacteria; Spiral and Curved Bacteria (Non MeSH); Campylobacter A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals. Campylobacter fetus (74-90) &"!Campylobacter Infections C01.252.400.177 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Infections with bacteria of the genus CAMPYLOBACTER. Vibrio (66-67); Vibrio Infections (68-76) Ps?3Campylobacter fetus B03.440.180.325; B03.825.225.325 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Campylobacter Bacteria; Spiral and Curved Bacteria (Non MeSH); Campylobacter A species of bacteria present in man and many kinds of animals and birds, often causing infertility and/or abortion. Vibrio (66-71) &"Campylobacter coli B03.440.180.200; B03.825.225.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Campylobacter Bacteria; Spiral and Curved Bacteria (Non MeSH); Campylobacter A species of gram-negative, rod-shaped bacteria isolated from the intestinal tract of swine, poultry, and man. It may be pathogenic. Campylobacter (83-91) 7&"Campylobacter B03.440.180; B03.825.225 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria Bacteria; Spiral and Curved Bacteria (Non MeSH) Campylobacter coli; Campylobacter fetus; Campylobacter jejuni Campylobacter coli; Campylobacter fetus; Campylobacter jejuni A genus of bacteria found in the reproductive organs, intestinal tract, and oral cavity of animals and man. Some species are pathogenic. Vibrio (68-75)  "_Camptothecin D03.132.151; D22.204.179.159 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic Alkaloids (66-72); Antineoplastic Agents (66-72) "::Camping I03.450.642.159 CLECHILJPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation Living outdoors as a recreational activity. { H5Camphor D02.455.849.618.234.326; D02.522.376; D20.187.115; D23.075.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Norbornanes; Bornanes Organic Chemicals (Non MeSH); Ketones Anti-Infective Agents; Anti-Infective Agents, Local Dermatologic Agents; Antipruritics A ketone obtained from the wood of Cinnamomum camphora, an evergreen tree native to eastern Asia, or produced synthetically, with a penetrating characteristic odor and a pungent, aromatic taste. It is applied topically to the skin as an antipruritic and anti-infective and is used as a pharmaceutic necessity in certain pharmaceutic preparations. (From Dorland, 27th ed). M H:Cameroon Z01.058.290.100.110 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Central " _Camels B02.649.077.380.201 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Artiodactyla (66-67) #A (7Camelids, New World B02.649.077.380.175 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Ruminant mammals of South America. They are related to camels. #(7MCambodia Z01.252.145.182 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern $ >Cambendazole D03.438.103.190; D21.201.287.149 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents Isopropyl 2(4-triazolyl)-5-benzimidazolecarbamate. A nematocide effective against a variety of gastrointestinal parasites in cattle, sheep and horses. Benzimidazoles (71-74); Carbamates (72-74); Thiazoles (71-74) %&:JCamallanina B01.500.294.700.750.225 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida Dracunculoidea (+ 1) A suborder of nematodes characterized by larvae lacking cephalic hooks and a tail that is generally long and pointed. '*FCalymmatobacterium B03.440.450.160 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods A genus of bacteria causing GRANULOMA INGUINALE and other granulomatous lesions. Bacteria (66-76); Granuloma Inguinale (66-76) )"X_7Calsequestrin D12.776.210.500.220 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Acidic protein found in sarcoplasmic reticulum that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle. Calcium (74-75); Muscle Proteins (74-75) *~Hq2Calpain D08.586.277.656.732.215.120 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including neuropeptides, cytoskeletal proteins, proteins from smooth muscle, cardiac muscle, liver, platelets and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. Peptide Peptidohydrolases (66-85) , F'Calorimetry, Indirect E05.145.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Calorimetry Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange. /":Calorimetry, Differential Scanning E05.196.131.310; E05.196.370.310 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Calorimetry Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Differential Thermal Analysis Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. Calorimetry (66-76) 1%(&"%Calorimetry E05.145; E05.196.131 AECLCTECHIISMOMTNUPXSNSTTDUTVE Basal Metabolism; Heat Miscellaneous Techniques (Non MeSH) Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Calorimetry, Indirect Calorimetry, Differential Scanning The measurement of the quantity of heat involved in various processes, such as chemical reactions, changes of state, and formations of solutions, or in the determination of the heat capacities of substances. The fundamental unit of measurement is the joule or the calorie (4.184 joules). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed).  3"m@Caloric Tests E01.276.299.816.250 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Vestibular Function Tests Elicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is dead. 6"Caloric Intake G06.696.384.160 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Diet Total number of calories taken in daily whether ingested or by parenteral routes. Diet (66-76); Nutrition (66-76) 9Vb(Calmodulin-Dependent Protein Kinases D08.586.913.696.620.682.700.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein-Serine-Threonine Kinases Myosin-Light-Chain Kinase A group of enzymes that catalyzes the phosphorylation of proteins. They are dependent on calmodulin and sometimes calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins. (From Enzyme Nomenclature, 1992, p. 277) EC 2.7.10.-. Protein Kinases (78-93)  :@*#FCalmodulin-Binding Proteins D12.776.157.142 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Proteins which bind calmodulin. They are found in many tissues and have a variety of functions including F-actin cross-linking properties, inhibition of cyclic nucleotide phosphodiesterase and calcium and magnesium ATPases. Calcium-Binding Proteins (80-85); Carrier Proteins (66-79); Phosphoprotein Phosphatases (82-85) = FYoCalmodulin D12.776.157.125.140 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium (66-78); Carrier Proteins (71-78); Enzyme Activation (69-78) ?HvqSCallus A10.165.265.276 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Fracture Healing; Bone Regeneration; Fractures Tissue Types (Non MeSH); Connective Tissue; Bone and Bones Fractures (66-72) B :8ICallosities C17.800.428.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Keratosis Localized hyperplasia of the horny layer of the epidermis due to pressure or friction. (Dorland, 27th ed). CNXCallitrichinae B02.649.801.400.120.114 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae Callithrix; Saguinus A subfamily of the order PRIMATES that consists of four genera: CALLITHRIX (marmosets), Cebuella (pygmy marmosets), Leontopithecus (golden tamarins), and SAGUINUS (tamarins). The members of this subfamily inhabit the tropical forests of South and Central America. Anthropoidea (66-74)  EN(?4Callithrix B02.649.801.400.120.114.114 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae; Callitrichinae A genus of CALLITRICHINAE occurring in forests of Brazil and Bolivia and containing eight species. They are C. jacchus (common marmoset), C. argentata (black-tailed marmoset), C. chrysoleuca (yellow-legged or golden marmoset), C. aurita (white-eared marmoset), C. flaviceps (buff-headed marmoset), C. penicillata (black-pencilled or black-eared marmoset), C. geoffroyi (white-fronted or Geoffrey's marmoset) and C. santaremensis (Santarem marmoset). Callithricidae (75-80) Gt(QCallimiconinae B02.649.801.400.120.110 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae A subfamily of the family of New World monkeys, CEBIDAE, inhabiting the upper Amazon basin. Members of the genus Callimico (Goeldi's marmosets) constitute this subfamily. Ja(?Californium D01.268.271.545.150; D01.552.517.200 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Californium. A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy. K*4California Group Viruses B04.820.087.150.160; B04.909.777.147.150.160; B04.909.777.270.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Bunyavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Bunyavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Encephalitis Viruses La Crosse Virus La Crosse Virus La Crosse Virus A group of viruses in the BUNYAVIRUS genus of the BUNYAVIRIDAE family. They are found in temperate and arctic regions and each is closely associated with a single species of vector mosquito. The vertebrate hosts are usually small mammals but several virus species infect humans. NI;ICalifornia Z01.107.567.875.100.127; Z01.107.567.875.600.822.127 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States Los Angeles; San Francisco Los Angeles; San Francisco Q3:BCalicivirus, Feline B04.820.095.250.150; B04.909.777.162.250.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Caliciviridae; Calicivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Caliciviridae; Calicivirus A species of the genus CALICIVIRUS, an RNA virus infecting cats. Transmission occurs via air and mechanical contact. Caliciviridae (75-93); Picornaviridae (72-75) S26Calicivirus B04.820.095.250; B04.909.777.162.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Caliciviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Caliciviridae Calicivirus, Feline; Vesicular Exanthema of Swine Virus Calicivirus, Feline; Vesicular Exanthema of Swine Virus A genus in the family Caliciviridae containing many species including feline calicivirus (CALICIVIRUS, FELINE), VESICULAR EXANTHEMA OF SWINE VIRUS, and San Miguel sea lion viruses. Caliciviridae (92-93)  T*{Caliciviridae Infections C02.782.160 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Hepatitis E; Vesicular Exanthema of Swine Virus diseases caused by CALICIVIRIDAE. They include HEPATITIS E, VESICULAR EXANTHEMA OF SWINE, acute respiratory infections in felines, rabbit hemorrhagic disease, and some cases of gastroenteritis in humans. Picornavirus Infections (80-92); Virus Diseases (75-79)  WXP:3BCaliciviridae B04.820.095; B04.909.777.162 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Calicivirus (+ 2); Hemorrhagic Disease Virus, Rabbit; Hepatitis E Virus; Norwalk Virus Calicivirus (+ 2); Hemorrhagic Disease Virus, Rabbit; Hepatitis E Virus; Norwalk Virus A family of RNA viruses. They possess a characteristic six-pointed starlike shape whose surfaces have cup-shaped (chalice) indentions. They differ from picornaviruses in size and shape, and most importantly, in genomic expression during replication cycles. Caliciviruses include the HEPATITIS E VIRUS, VESICULAR EXANTHEMA OF SWINE VIRUS, San Miguel sea lion viruses, feline calicivirus (CALICIVIRUS, FELINE), NORWALK VIRUS, and the rabbit hemorrhagic disease virus (HEMORRHAGIC DISEASE VIRUS, RABBIT). Picornaviridae (66-78)  Y"YACalibration E05.140; H01.939.155 ST Miscellaneous Techniques (Non MeSH) Physical Sciences (Non MeSH); Weights and Measures Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. ]fLCalculi C23.146 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Lithotripsy Symptoms and General Pathology (Non MeSH) Cholelithiasis (+ 1); Dental Calculus; Salivary Gland Calculi (+ 1); Urinary Calculi (+ 3) An abnormal concretion occurring within the animal body and usually composed of mineral salts.  _  R2ppCalcium, Dietary D01.146.315 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis. aY6< Calcium-Binding Proteins D12.776.157.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Annexins (+ 7); Calcium-Binding Protein, Vitamin D-Dependent; Calmodulin; Gelsolin; Nerve Tissue Protein S 100; Osteocalcin; Osteonectin Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins or activator proteins. Calcium (66-79); Carrier Proteins (71-79); Proteins (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $cFYIHCalcium-Binding Protein, Vitamin D-Dependent D12.776.157.125.130 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins A protein that plays a fundamental role in the Vitamin D mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent. Calcium (66-78); Carrier Proteins (71-78); Protein Binding (66-78); Vitamin D (66-78) e3Dv7iCalcium Sulfate D01.146.375; D01.578.215; D01.875.800.800.850.125; D25.150 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Minerals Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates Biomedical and Dental Materials (Non MeSH) Sulfuric acid, calcium salt (1:1) (CaO4S). It exists in an anhydrous form and in various states of hydration: the hemihydrate is plaster of Paris, the dihydrate is gypsum. It is used in building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. hD,Calcium Radioisotopes D01.496.098.325; D01.496.749.113 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Calcium Isotopes Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of calcium that decay or disintegrate emitting radiation. Ca atoms with atomic weights 39, 41, 45, 47, 49, and 50 are radioactive calcium isotopes. k&4Calcium Pyrophosphate D01.146.360.150; D01.695.625.675.650.075.150; D01.695.625.675.650.775.150.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Chondrocalcinosis Inorganic Chemicals (Non MeSH); Calcium Compounds; Calcium Phosphates Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Calcium Phosphates Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates; Polyphosphates; Diphosphates Diphosphoric acid, calcium salt. An inorganic pyrophosphate which affects calcium metabolism in mammals. Abnormalities in its metabolism occur in some human diseases, notably hypophosphatasia and pseudogout. Pyrophosphates (66-76)  mU8Calcium Phosphates D01.146.360; D01.695.625.675.650.075 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates Apatites (+ 2); Calcium Pyrophosphate Apatites (+ 2); Calcium Pyrophosphate Calcium salts of phosphoric acid. These compounds are frequently used as calcium supplements. q_*8\oCalcium Oxalate D02.241.081.337.635.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Oxalates Ethanedioic acid calcium salt. The calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi. Calcium (66-78); Oxalates (66-78) s:}*Calcium Metabolism Disorders C18.452.174 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Calcinosis (+ 3); Decalcification, Pathologic; Hypercalcemia; Hypocalcemia (+ 1); Osteomalacia; Pseudohypoparathyroidism; Rickets uS"NNCalcium Isotopes D01.496.098 Inorganic Chemicals (Non MeSH); Isotopes Calcium Radioisotopes Stable calcium atoms that have the same atomic number as the element calcium, but differ in atomic weight. Ca-42-44, 46, and 48 are stable calcium isotopes. ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR v24Calcium Hydroxide D01.146.335; D01.455.275 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Dental Cavity Lining; Dental Pulp Capping Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Hydroxides Calcium hydroxide (Ca(OH)2). A white powder that has many therapeutic uses. Because of its ability to stimulate mineralization, it is found in many dental formulations. Calcium (66); Hydroxides (66)  xa83n&Calcium Gluconate D02.241.081.844.322.200; D02.241.511.902.322.200; D09.203.811.308.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Gluconates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Gluconates Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Gluconates D-Gluconic acid calcium salt (2:1). The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states. Calcium (66-78); Gluconates (66-78) zM:F,Calcium Fluoride D01.146.325; D01.303.350.300.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Fluorine Compounds; Hydrofluoric Acid; Fluorides Calcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. (From Merck Index, 11th ed). }&8OCalcium Dobesilate D02.455.426.559.389.097.120; D02.886.645.600.080.050.100.075; D19.461.270.463.155 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzenesulfonates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Benzenesulfonates Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics 2,5-Dihydroxybenzenesulfonic acid, Ca salt (2:1). A drug used to reduce hemorrhage in diabetic retinopathy. Benzenesulfonates (74); Hydroquinones (72-74) Y:6Calcium Compounds D01.146 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Calcium Carbonate; Calcium Chloride; Calcium, Dietary; Calcium Fluoride; Calcium Hydroxide; Calcium Phosphates (+ 4); Calcium Sulfate; Cyanamide Inorganic compounds that contain calcium as an integral part of the molecule. Calcium (66-93)  c 8%]Calcium Chloride D01.146.300; D01.210.450.150.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Calcium chloride (CaCl2). A salt that occurs as white, hard fragments or granules. It is used as a calcium replenisher, administered intravenously, has been used as an acid-producing diuretic and urinary acidifier and to control bleeding in such conditions as purpura, intestinal bleeding, and small multiple hemorrhages. It is also a specific antidote for magnesium poisoning, administered intravenously. (From Dorland, 27th ed). )&8Calcium Channels D12.776.395.550.440.150; D12.776.543.550.425.150 ADAEANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ca(2+)-Transporting ATPase; Calcium Channel Agonists; Calcium Channel Blockers Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Ion Channels Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Ion Channels Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L, T, N, or P types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. Calcium (79-88); Ion Channels (79-88)  ]6B]/Calcium Channel Blockers D18.192; D18.918.173 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Calcium Channels Cardiovascular Agents Cardiovascular Agents; Vasodilator Agents Amlodipine; Amrinone; Bencyclane; Bepridil; Diltiazem; Felodipine; Fendiline; Flunarizine; Isradipine; Nicardipine; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine; Perhexiline; Prenylamine; Verapamil (+ 1) Amlodipine; Amrinone; Bencyclane; Bepridil; Diltiazem; Felodipine; Fendiline; Flunarizine; Isradipine; Nicardipine; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine; Perhexiline; Prenylamine; Verapamil (+ 1) A class of drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms. Calcium (66-67) /antagonists and inhibitors (68-81); Ion Channels (79-81) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (4IW:Calcium Channel Agonists D18.185; D18.793.250 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Calcium Channels Cardiovascular Agents Cardiovascular Agents; Vasoconstrictor Agents Bay K 8644 Bay K 8644 Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. Calcium/metab (66-87); Ion Channels (79-87) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (4M6:Calcium Carbonate D01.146.275; D01.200.275.150.150; D01.578.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Calcium Compounds Inorganic Chemicals (Non MeSH); Carbon Compounds, Inorganic (Non MeSH); Carbonic Acid; Carbonates Inorganic Chemicals (Non MeSH); Minerals Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.  58Calcium D01.268.552.100; D01.552.539.288; D19.461.270.229.185 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Hypercalcemia; Hypocalcemia Inorganic Chemicals (Non MeSH); Elements; Metals, Alkaline Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Alkaline Earth Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Blood Coagulation Factors Calcium. A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.  =:!(Calcitriol D04.808.247.222.159.478.300; D04.808.247.808.146.478.300; D04.808.812.221.478.387.300; D10.516.851.152.478.387.300; D11.786.763.196.478.387.300 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Calcitriol Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholecalciferol; Hydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholecalciferol; Hydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Secosteroids; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D; Cholecalciferol; Hydroxycholecalciferols; Dihydroxycholecalciferols (1 alpha,3 beta, 5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol). The physiologically active form of vitamin D. It is formed in kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (calcifediol) and its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus and in concert with parathyroid hormone increases bone resorption. It is used in the treatment of chronic kidney failure, hypoparathyroidism, osteomalacia, and osteoporosis. Cholecalciferols (66-72); Dihydroxycholecalciferols (73-81); Hydroxycholecalciferols (72-73)  DkiCalcitonin Gene-Related Peptide D12.776.641.650.097; D14.600.600.165 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Calcitonin Gene-Related Peptide Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Calcitonin gene-related peptide. A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Nerve Tissue Proteins (66-86); Neuropeptides (87-89)  (%*F1?Calcitonin D06.472.150; D12.644.110; D12.776.641.650.095; D14.600.600.150 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Calcitonin Ultimobranchial Body Hormones, Substitutes, Antagonists (Non MeSH); Hormones Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults.  =HFX^Calciphylaxis C18.452.174.130.186 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders; Calcinosis Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification. N~Calcinosis C18.452.174.130 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chondrocalcinosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Calcium Metabolism Disorders Calciphylaxis; CREST Syndrome; Nephrocalcinosis Pathologic deposition of calcium salts in tissues.  Np8=Calcimycin D08.373.936.500.200; D20.085.200 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Ionophores Anti-Infective Agents; Antibiotics 6S-(6 alpha,8 beta,9 beta,11 alpha)-5-(Methylamino)-2- ((3,9,11-trimethyl-8-(1-methyl-2-oxo-2-(1H-pyrrol-2-yl) ethyl)-1,7-dioxaspiro(5,5)undec-2-yl)methyl)-4- benzoxazolecarboxylic acid. An ionophorous, polyether antibiotic from Streptomyces chartreusensis. It binds and transports cations across membranes and uncouples oxidative phosphorylation while inhibiting ATPase of rat liver mitochondria. The substance is used mostly as a biochemical tool to study the role of divalent cations in various biological systems. Antibiotics (73-74); Carboxylic Acids (73-74) :&<M7Calcification, Physiologic G06.184.227; G07.553.121.175; G11.427.111.175 DEGEIMPHRE Bone Development; Osteogenesis Bone and Bones Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Bone Development Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Development Tooth Calcification Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. $5%ZoCalcifediol D04.808.247.222.159.478.250; D04.808.247.808.146.478.250; D04.808.812.221.478.250; D10.516.851.152.478.250; D11.786.763.196.478.250 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholecalciferol; Hydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholecalciferol; Hydroxycholecalciferols Polycyclic Hydrocarbons; Steroids; Secosteroids; Cholecalciferol; Hydroxycholecalciferols Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholecalciferol; Hydroxycholecalciferols Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin D; Cholecalciferol; Hydroxycholecalciferols (3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol. The major circulating metabolite of vitamin D3 produced in the liver and the best indicator of the body's vitamin D stores. It is effective in the treatment of rickets and osteomalacia, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. Cholecalciferols (66-72); Hydroxycholecalciferols (72-82) D9BCalcaneus A02.835.232.262.710.300 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Heel Musculoskeletal System; Skeleton; Bone and Bones; Foot Bones (Non MeSH); Tarsal Bones The largest of the tarsal bones and is situated at the lower and back part of the foot forming the heel.  :iCaffeine D03.132.956.200; D03.438.759.758.824.175; D08.373.735.150; D15.220.138 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Coffee Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors Central Nervous System Agents; Central Nervous System Stimulants A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling. # PD cCaffeic Acids D02.241.223.201.170 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cinnamates 3,4-Dihydroxycinnamic acids. A class of phenolic acids related to chlorogenic acid,p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation. Cinnamates (68-74); Catechol (72-74) j8l-Caerulein D12.644.456.241; D19.316.325 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents  Sincalide A specific decapeptide obtained from the skin of Hila caerulea, an Australian amphibian; it is similar in action and composition to cholecystokinin; stimulates gastric, biliary, and pancreatic secretion and certain smooth muscle; used in paralytic ileus and as diagnostic aid in pancreatic malfunction. Synonyms: Ceosumin; FI 6934; Takus. Gastrointestinal Agents (67-71); Peptides (66-71)  r "F;Caenorhabditis elegans B01.500.294.700.700.660.250.250 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida; Rhabditoidea; Caenorhabditis A species of nematode that is widely used in biological, biochemical, and genetic studies. Caenorhabditis (79-92); Nematoda (68-78) Í#*il1Caenorhabditis B01.500.294.700.700.660.250 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Rhabditida; Rhabditoidea Caenorhabditis elegans A genus of small free-living nematodes. Two species, CAENORHABDITIS ELEGANS and C. briggsae are much used in studies of genetics, development, aging, muscle chemistry, and neuroanatomy. Nematoda (66-78)  "*WCadmium Radioisotopes D01.496.749.108 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of cadmium that decay or disintegrate emitting radiation. Cd atoms with atomic weights 103-105, 107, 109, 115, and 117-119 are radioactive cadmium isotopes. Cadmium (66-87); Radioisotopes (66-87) 4C/Cadmium Poisoning C21.613.165 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Poisoning occurring after exposure to cadmium compounds or fumes. It may cause gastrointestinal syndromes, anemia, or pneumonitis. LECadmium D01.268.134; D01.552.129 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKRESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals Cadium. An element with atomic symbol Cd, atomic number 48, and atomic weight 114. It is a metal and ingestion will lead to CADMIUM POISONING. > 8`Cadherins D12.776.395.550.200.200; D12.776.543.550.200.200; D24.611.216.301.350.200 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Cell Adhesion Molecules Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Cell Adhesion Molecules Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Cell Adhesion Molecules A group of functionally related glycoproteins responsible for the calcium-dependent cell-to-cell adhesion mechanism. They are divided into subclasses E-, P-, and N-cadherins, which are distinct in immunological specificity and tissue distribution. They promote cell adhesion via a homophilic mechanism. These compounds play a role in the construction of tissues and of the whole animal body. Antigens, Surface (79-89); Calcium-Binding Proteins (80-89); Glycoproteins (66-87); Membrane Glycoproteins (88-89)  Q6Cadaverine D02.092.211.415.261; D02.092.782.258.174 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines; Biogenic Polyamines Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines 1,5-Pentanediamine. A foul-smelling diamine formed by bacterial decarboxylation of lysine. Amines (66-72); Polyamines (71-72) Ѝ.>i+Cadaver C23.240.224 Symptoms and General Pathology (Non MeSH); Death Postmortem Changes (+ 2) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI b <NCacodylic Acid D02.691.088.100; D05.723.366.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Hydroxydimethylarsine oxide. Herbicide. Arsenicals (69-74) H&:/Cachexia C23.888.220.174 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Body Weight Changes (Non MeSH) A profound and marked state of constitutional disorder; general ill health and malnutrition. (Dorland, 27th ed).  NCacao B06.510.103; J01.341.131 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food A tree of the Theobroma family, usually Theobroma cacao, or its seeds, which are used in making cocoa and chocolate. _ 4XCA-19-9 Antigen D24.185.101.840.075.119; D24.611.216.119.325.119; D24.611.216.285.050.119; D24.611.216.705.230.544.119 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups; Lewis Blood-Group System Sialylated Lewis blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors. Antigens, Neoplasm (84-88); Antigens, Tumor-Associated, Carbohydrate (89-94) p6XCA-15-3 Antigen D24.185.101.840.075.115; D24.611.216.119.325.115; D24.611.216.285.050.115 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigen elevated in patients with tumors of the breast, ovary, lung, and prostate as well as other disorders. Antigens, Neoplasm (86-88); Antigens, Tumor-Associated, Carbohydrate (89-94) ?Q6XCA-125 Antigen D24.185.101.840.075.225; D24.611.216.119.325.225; D24.611.216.285.050.225 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigen most commonly seen in tumors of the ovary and occasionally seen in breast, kidney, and gastrointestinal tract tumors and normal tissue. CA 125 is clearly tumor-associated but not tumor-specific. Antigens, Tumor-Associated, Carbohydrate (88-94) Q67Ca(2+)-Transporting ATPase D08.586.277.040.025.125; D12.776.543.400.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ca(2+) Mg(2+)-ATPase Calcium Channels; Ca(2+) Mg(2+)-ATPase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Ion Pumps An enzyme found in the sarcoplasmic reticulum vesicle membrane. During the relaxation of skeletal muscles and muscle rich in mitochondria, this enzyme catalyzes the active transport of calcium into the sarcoplasmic reticulum vesicles from the sarcoplasm. It requires micromolar concentrations of Ca(2+) and utilizes MgATP as a substrate. (Prog Biophys Mol Biol 1988;52(1):1). EC 3.6.1.38. Adenosine Triphosphatase (66-78); Calcium (66-78) $!2F1;Ca(2+) Mg(2+)-ATPase D08.586.277.040.025.095 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ca(2+)-Transporting ATPase Ca(2+)-Transporting ATPase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases; Adenosinetriphosphatase An enzyme that catalyzes the hydrolysis of ATP and is activated by millimolar concentrations of either Ca(2+) or Mg(2+). Unlike CA(2+)-TRANSPORTING ATPASE it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. (Prog Biophys Mol Biol 1988;52(1):1). A subgroup of EC 3.6.1.3. Adenosine Triphosphatase, Magnesium (86-92); Adenosinetriphosphatase (81-85); Ca(2+)-Transporting ATPase (86-92); Magnesium (79-80) $F!!C-Reactive Protein D12.776.034.145; D12.776.124.050.120; D12.776.124.486.157 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH) A plasma protein that circulates in increased amounts during inflammation and after tissue damage. AF3tC-Peptide D06.472.610.575.788.250; D12.644.100; D12.776.811.706.250 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pancreatic Hormones; Insulin; Proinsulin Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors; Proinsulin A 31-amino acid peptide which connects the A and B chains of proinsulin. The exact composition of the peptide is species dependent. In beta cells proinsulin is enzymatically converted to insulin with the liberation of the C-peptide. An immunoassay has been developed for assessing pancreatic beta cell secretory function in diabetic patients in whom circulating insulin antibodies and exogenous insulin interfere with insulin immunoassay. Peptides (73-76); Proinsulin (75-76)  AH-Byzantium Z01.586.035.175 EHEP Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Ancient Lands (Non MeSH) An ancient city, the site of modern Istanbul. From the 4th to 15th centuries the empire extended from southeastern Europe to western Asia, reaching its greatest extent under Justinian (527-565). By about 1000 A.D. it comprised the southern Balkans, Greece, Asia Minor, and parts of southern Italy. The capture of Constantinople in 1453 marked the formal end of the Byzantine Empire. (From Webster's New Geographical Dictionary, 1988).  iByssinosis C08.381.483.600.275; C21.447.800.323 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis An airway obstruction due to the dust inhaled during the processing of cotton. Pneumoconiosis (66-68) *L_Byelarus Z01.542.248.190; Z01.586.200.190; Z01.586.950.190 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR  9BW-755C D03.383.694.120; D08.373.310.180; D08.373.390.180; D16.850.015.050.145; D17.025.030.110; D17.050.030.158 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Lipoxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine. A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia. Anti-Inflammatory Agents (66-86); Anti-Inflammatory Agents, Non-Steroidal (87-89); Pyrazoles (66-89)  v:!tBW 284 C 51 D02.092.146.290 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds 1,3-Di(p-N1,3-di(p-N-allyl-N-methylaminophenyl)pentane-3-one. Proposed cholinesterase inhibitor. Aniline Compounds (71-74); Allyl Compounds (71-74); Ketones (71-74) :DlRButyrylthiocholine D02.092.102.232.800.200; D02.675.276.232.800.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline; Thiocholine Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline; Thiocholine N,N,N-Trimethyl-2-((1-oxobutyl)thio)-ethanaminium. A sulfur-containing analog of butyrylcholine which is hydrolyzed by butyrylcholinesterase to butyrate and thiocholine. It is used as a reagent in the determination of butyrylcholinesterase activity. Butyrates (72-74); Choline (68-74); Sulfhydryl Compounds (72-74) 6:NButyrylcholinesterase D08.586.277.352.100.170.250 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases; Cholinesterases An aspect of cholinesterase (EC 3.1.1.8). Butyrates (73-74); Cholinesterases (73-74) gD43Butyrophenones D02.522.352 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antipsychotic Agents, Butyrophenone Organic Chemicals (Non MeSH); Ketones Azaperone; Benperidol; Droperidol; Haloperidol; Spiperone; Trifluperidol AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8)/V:Butyric Acids D02.241.081.161.325; D02.241.081.465.240.230; D10.516.251.400.240.230 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile; Butyrates Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Butyrates Bezafibrate; Clofibric Acid Bezafibrate; Clofibric Acid 4-carbon saturated monocarboxylic acids. Butyrates (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $qM8YC0:Butyrates D02.241.081.161; D02.241.081.465.240; D10.516.251.400.240 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile Aminobutyric Acids (+ 2); Aminoisobutyric Acids; Butyric Acids (+ 2); Clofenapate; Clofibrate; Crotonic Acids (+ 1); Hydroxybutyrates (+ 1) Butyric Acids (+ 2); Clofibrate; Crotonic Acids (+ 1) Butyric Acids; Crotonic Acids (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR S A81FButylscopolammonium Bromide D03.132.889.848.661.200; D03.605.869.900.700.200; D14.100.120.200.500.125; D16.050.650.115 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Tropanes; Scopolamine; Scopolamine Derivatives Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes; Scopolamine; Scopolamine Derivatives Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract. Bromine (72-74); Scopolamine (69-75); Scopolamine Derivatives (75)   d:PButylhydroxybutylnitrosamine D02.654.442.100; D26.191.646.142 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Nitroso Compounds; Nitrosamines Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Nitrosamines N-Butyl-N-(4-hydroxybutyl)nitrosamine. A substituted carcinogenic nitrosamine. Alcohols, Butyl (74); Nitrosamines (74)  &.Z1Butylated Hydroxytoluene D02.755.239.216; D26.471.385.153 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Phenols; Cresols Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives 2,6-Bis(1,1-dimethylethyl)-4-methylphenol. Antioxidant used in foods, cosmetics, petroleum products, etc. It may inhibit some neoplasms and facilitate others. Cresols (66-74) o&.Butylated Hydroxyanisole D02.355.601.200.324; D02.355.726.158.324; D02.755.075.241; D26.471.385.148 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ethers; Methyl Ethers; Anisoles Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers; Anisoles Organic Chemicals (Non MeSH); Phenols; Anisoles Miscellaneous Drugs and Agents (Non MeSH); Food Additives; Food Preservatives (1,1-Dimethylethyl)-4-methoxyphenol. Mixture of 2- and 3-tertbutyl-4-methoxyphenols that is used as an antioxidant in foods, cosmetics, and pharmaceuticals. It may inhibit carcinogenesis. gT.*Butylamines D02.092.264 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines *8.Buttocks A01.258 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH)   (Butterflies B01.131.617.561.200 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lepidoptera Slender-bodies diurnal insects having large, broad wings often strikingly colored and patterned. I(9pButter D10.516.212.302.199; J01.341.273.174 AEANCLECHIMIPOPSRESDSNSTTOUTVI Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats Technology, Industry, Agriculture (Non MeSH); Food; Dairy Products c *"Butoxamine D02.033.329.624.180; D02.092.063.624.180; D14.100.050.200.200.140; D16.050.850.120 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics A beta-2 selective adrenergic antagonist. It is used primarily in animal and tissue experiments to characterize beta-2 receptor involvement and identify beta-2 receptors. Adrenergic Beta Receptor Blockaders (69-72); Amino Alcohols (66-72); Antilipemic Agents (66-72) {\:qButorphanol D03.132.610.422.165; D03.549.686.165; D03.605.497.165; D15.040.150.065; D15.210.600.127; D15.550.112 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Central Nervous System Agents; Narcotic Antagonists 17-(Cyclobutylmethyl)morphinan-3,14-diol. A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain. Morphinans (69-78) 8r:Butirosins D09.203.408.051.120; D20.085.060.120 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside A water-soluble aminoglycosidic antibiotic complex isolated from fermentation filtrates of Bacillus circulans. Two components (A and B) have been separated from the complex. Both are active against many gram-positive and some gram-negative bacteria. Antibiotics (73-74); Aminoglycosides (74)  *: 2Butanones D02.522.296 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Acetoin; Diacetyl; Thenoyltrifluoroacetone Ketones (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  #S 8/2:Butanes D02.455.326.146.216 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Alkanes (66-72) $ 8gButanediols D02.033.618.125 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols Busulfan 4-carbon straight chain aliphatic hydrocarbons substituted with two hydroxyl groups. The hydroxyl groups cannot be on the same carbon atom. Glycols (69-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $%y8; :Butadienes D02.455.326.271.665.146.240 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes; Alkadienes Four carbon unsaturated hydrocarbons containing two double bonds. ';8MButaclamol D04.615.181.384.230; D14.100.150.175.085; D15.150.125; D15.210.950.040.125; D15.700.872.331.178 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents A benzocycloheptapyridoisoquinolinol that has been used as an antipsychotic, especially in schizophrenia. Dibenzocycloheptenes (68-77) (k:9y!Busulfan D02.033.618.125.125; D02.455.326.146.100.050.500.100; D02.886.645.600.055.050.510.100; D22.204.232; D22.569.400; D26.191.174 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Glycols; Butanediols Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids; Alkanesulfonates; Mesylates Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids; Alkanesulfonates; Mesylates Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Miscellaneous Drugs and Agents (Non MeSH); Carcinogens 1,4-Butanediol dimethanesulfonate. An alkylating agent having a selective immunosuppressive effect on bone marrow. It has been used in the palliative treatment of chronic myeloid leukemia, but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. (Merck Index, 11th ed). ,> :kBuspirone D03.383.742.120; D04.615.885.120; D14.100.850.800.150; D15.075.100; D15.210.950.012.100; D15.700.872.015.220 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Spiro Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Agonists Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents An anxiolytic agent and a serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the benzodiazepines, but it has an efficacy comparable to DIAZEPAM. The drug alleviates anxiety without causing sedation or functional impairment and does not promote abuse or physical dependence. Studies have shown that it does not possess anticonvulsant or muscle relaxant properties and does not interact significantly with central nervous system depressants. Pyrimidines (72-87); Spiro Compounds (73-82) 1~ z:pO6Buserelin D06.472.709.429.150; D22.204.227 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormone-Releasing Hormones; Gonadorelin Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents 6-(O-(1,1-Dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamideluteinizing hormone-releasing factor (pig). Potent GONADORELIN analog agonist. It has potential use as a female or male contraceptive and has also been used in the treatment of prostatic carcinoma. FSH (66-73); LH (Luteinizing Hormone) (66-73); LH-FSH Releasing Hormone/analogs and derivatives (74-83); Pituitary Hormone Releasing Hormones (68-73) 7[ &:<Burundi Z01.058.290.120.180 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Eastern : _Bursitis C05.550.251 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Periarthritis Inflammation of a bursa, occasionally accompanied by a calcific deposit in the underlying supraspinatus tendon. The most common site is the subdeltoid bursa. (Dorland, 27th ed). ;L N0Bursa, Synovial A02.835.583.156 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Joints <:1Bursa of Fabricius A13.163; A15.382.520.604.114 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Thymus Gland Animal Terms (Non MeSH) Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphoid Tissue =":Burns, Inhalation C21.866.200.322 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fires Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Burns Smoke Inhalation Injury Burns of the respiratory tract caused by heat or inhaled chemicals. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $>L ZRNBurns, Electric C21.866.200.239; C21.866.324.323 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Burns Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Electric Injuries Burns produced by contact with electric current or from a sudden discharge of electricity. @&LlBurns, Chemical C21.866.200.156 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Burns BdLZBurns C21.866.200 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Curling's Ulcer Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Burns, Chemical; Burns, Electric; Burns, Inhalation (+ 1); Eye Burns; Sunburn Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $CP LQ`NBurnout, Professional F02.830.900.110; F03.126.903.110 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Psychologic Processes and Principles (Non MeSH); Psychophysiology; Stress, Psychological Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Stress, Psychological An excessive stress reaction to one's occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure. Stress, Psychological (69-82) E&F#Burning Mouth Syndrome C07.465.114 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders. Mouth Diseases (66-67) HN/Burn Units N02.278.388.493.160 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Units; Intensive Care Units Specialized hospital facilities which provide intensive care for burn patients. Intensive Care Units (66-81) Jy]#Burkitt's Lymphoma C02.256.466.114; C04.557.386.480.150.165; C04.557.386.480.175.425.775.165; C04.557.386.480.875.775.165; C15.604.515.569.480.150.165; C15.604.515.569.480.425.775.165; C15.604.515.569.480.875.775.165; C20.683.515.761.480.150.165; C20.683.515.761.480.425.775.165; C20.683.515.761.480.875.775.165 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Herpesviridae Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma by Grade (Non MeSH); Lymphoma, High-Grade; Lymphoma, Small Noncleaved-Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated; Lymphoma, Small Noncleaved-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade; Lymphoma, Small Noncleaved-Cell Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated; Lymphoma, Small Noncleaved-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, B-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, High-Grade; Lymphoma, Small Noncleaved-Cell Immunologic Diseases; Immunoproliferative Disorders; Lymphoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin's; Lymphoma, Undifferentiated; Lymphoma, Small Noncleaved-Cell A form of undifferentiated malignant lymphoma usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt's lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt's lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. Kt:RBurkina Faso Z01.058.290.190.245 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western Vi_Burimamide D02.886.904.200; D02.948.898.200; D14.100.375.425.425.090; D19.316.203.142 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents An antagonist of histamine that appears to block both H2 and H3 histamine receptors. It has been used in the treatment of ulcers. Imidazoles (72-74); Thiourea (72-74) WT:-Burial G02.438.173 ECHILJMTSNST Health Occupations; Mortuary Practice ZK -Bupropion D02.522.818.110; D14.100.150.600.220.220; D14.100.600.220.220; D15.085.025.075; D15.700.122.050.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Propiophenones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Second-Generation A unicyclic, aminoketone antidepressant. The mechanism of its therapeutic actions is not well understood, but it does appear to block dopamine uptake. The compound is metabolized to pharmacologically active plasma metabolites. It is effective in the treatment of major depression and has some beneficial effects in attention-deficit hyperactive children and adults. Its major adverse effect is dose-related seizures in a small number of patients. Antidepressive Agents (66-91); Propiophenones (66-91) Z o:?Buprenorphine D03.132.610.422.150; D03.549.686.150; D03.605.497.150; D15.040.150.050; D15.210.600.095; D15.550.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Morphinans Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Morphinans Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics Central Nervous System Agents; Narcotic Antagonists 17-(Cyclopropylmethyl)alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol. A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. Dihydromorphinone (66-68); Morphinans (69-78); Morphine (66-68) `r:FLBupranolol D02.033.329.624.160; D02.092.063.624.160; D14.100.050.200.200.136; D16.050.850.110; D18.097.156; D18.162.101 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma and as an antithrombotic. Amino Alcohols (66-74); Propanolamines (74-78) ez:"8Bupivacaine D02.065.199.239; D03.383.621.758.323; D15.050.050.060; D15.210.100.200.090; D16.850.025.090 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Pipecolic Acids Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide. A widely used local anesthetic agent. Anesthetics, Local (66-70) ig:k Bunyavirus B04.820.087.150; B04.909.777.147.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae Bunyamwera Group Viruses; California Group Viruses (+ 1); Simbu Group Viruses Bunyamwera Group Viruses; California Group Viruses (+ 1); Simbu Group Viruses A genus of the family BUNYAVIRIDAE containing over 150 viruses, most of which are transmitted by mosquitoes or gnats. They are arranged in serogroups which include BUNYAMWERA GROUP VIRUSES (containing the type species, Bunyamwera virus), CALIFORNIA GROUP VIRUSES, SIMBU GROUP VIRUSES, and Guama group viruses. Arboviruses (73-80); Bunyaviridae (79-91)  l*yh2Bunyaviridae Infections C02.782.147 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Encephalitis, California; Hantavirus Infections (+ 2); Hemorrhagic Fever, Crimean; Nairobi Sheep Disease; Phlebotomus Fever; Rift Valley Fever Virus diseases caused by the BUNYAVIRIDAE. Arbovirus Infections (66-80)  p5P:4"Bunyaviridae B04.820.087; B04.909.777.147 CHCLDEENGDGEIMIPMEPHPYREUL Arboviruses Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Bunyavirus (+ 4); Hantavirus (+ 1); Nairovirus (+ 2); Phlebovirus (+ 3); Tospovirus Bunyavirus (+ 4); Hantavirus (+ 1); Nairovirus (+ 2); Phlebovirus (+ 3) A family of viruses, mainly arboviruses, consisting of a single strand of RNA. Virions are enveloped particles 90-120 nm diameter. The complete family contains over 300 members arranged in five genera: BUNYAVIRUS, HANTAVIRUS, NAIROVIRUS, PHLEBOVIRUS, and TOSPOVIRUS. Arboviruses (66-80); Bunyamwera Group Viruses (75-80) $r"Y6@Bunyamwera Group Viruses B04.820.087.150.147; B04.909.777.147.150.147 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Bunyaviridae; Bunyavirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Bunyaviridae; Bunyavirus A large group of viruses from many parts of the world assigned to the BUNYAVIRUS genus of the family BUNYAVIRIDAE. They are transmitted by mosquitoes and infect humans in some areas. This group contains the type species of the genus, Bunyamwera virus. u52+Bungarus B02.833.672.350.225 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Bungarotoxins Vertebrates; Reptiles; Snakes; Elapidae A genus of poisonous snakes of the subfamily Elapinae of the family ELAPIDAE. They comprise the kraits. Twelve species are recognized and all inhabit southeast Asia. They are considered extremely dangerous. (Moore: Poisonous Snakes of the World, 1980). Snakes (66-93)  w &1+Bungarotoxins D24.185.965.850.325.139 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Bungarus; Cholinergic Agents Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Elapid Venoms Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms. yzB#y Bundle-Branch Block C14.280.067.558.323 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Heart Block A form of heart block in which one ventricle is excited before the other because of absence of conduction in one of the branches of the bundle of His. |NMBundle of His A07.541.409.273 ABAHCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Conduction System Small band of specialized cardiac muscle fibers that originates in the atrioventricular node and extends into the membranous part of the interventricular septum. ~Z6@Bunaftine D04.615.638.120; D18.097.145 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes Cardiovascular Agents; Anti-Arrhythmia Agents N-Butyl-N-(2-(diethylamino)ethyl)-1-naphthamide. Prolongs myocardial refractory period and stabilizes cell membranes; proposed as antiarrhythmic. Synonyms: Meregon; EU 16738. Butylamines (66-77); Naphthalenes (66-77)  ":2Bumetanide D02.065.884.150; D02.886.590.700.150; D19.770.224.516.135 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Sulfamyl 3-Butylamino-4-phenoxy-5-sulfamylbenzoic acid. A sulfamyl diuretic. Benzoates (74); Butylamines (74); Diuretics, Sulfamyl (74); Phenyl Ethers (74) A:MaBulinus B01.644.776.323 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca; Snails A genus of small freshwater snails of the order Pulmonata, found throughout Africa and the Middle East, where it is a vector of SCHISTOSOMA HAEMATOBIUM. Snails (66-71) k ('Bulimia F03.126.298.208.080 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Eating Disorders; Hyperphagia Episodic binge eating associated with the fear of not being able to stop eating, depressed mood, and self-deprecating thoughts. Binges are frequently terminated by self-induced vomiting. The bulimic episodes are not due to ANOREXIA NERVOSA or any known physical disorder. Hyperphagia (81-86)  F~=Bulgaria Z01.542.248.180 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern ) =Bulbourethral Glands A05.360.444.123; A10.336.197 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Male Tissue Types (Non MeSH); Exocrine Glands ":hBuilding Codes N02.278.200.100 CLECHILJMAMTOGSDSNSTTDUT Facility Design and Construction Facilities, Manpower and Services (Non MeSH); Health Facilities; Facility Design and Construction Standards or regulations for construction which are designed to ensure safety against electrical hazards, fires, etc. Facility Design and Construction (67-83); Hospital Design and Construction (66-83); Safety (75-83)  'suBufotenin D03.438.473.914.237.150; D03.438.473.914.814.150; D14.100.850.850.080; D15.300.100; D15.700.372.163; D24.185.965.033.163 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; N,N-Dimethyltryptamine Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles; Tryptamines; Serotonin Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Antagonists Central Nervous System Agents; Hallucinogens Central Nervous System Agents; Psychotropic Drugs; Hallucinogens Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Amphibian Venoms Methoxydimethyltryptamines Methoxydimethyltryptamines A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic.  Bh>Buformin D02.078.370.141.075; D09.482.140 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines; Biguanides Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents 1-Butylbiguanide. A biguanide, oral hypoglycemic agent which inhibits gluconeogenesis, increases glycolysis and decreases glucose oxidation. Biguanides (68-74); Butanes (73-74) n &:,Bufonidae B02.090.180.210 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura Bufo arenarum; Bufo bufo; Bufo marinus The family of true toads belonging to the order Anura. The genera include Bufo, Ansonia, Nectophrynoides, and Atelopus. Anura (66-71)  i &$1Bufo marinus B02.090.180.210.580 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Bufonidae A species of the true toads, Bufonidae, becoming fairly common in the southern United States and almost pantropical. The secretions from the skin glands of this species are very toxic to animals. Anura (66-71) &1Bufo bufo B02.090.180.210.108 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Bufonidae A species of the true toads, Bufonidae, widely distributed in the United States and Europe. Anura (66-71) o&1nBufo arenarum B02.090.180.210.080 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Anura; Bufonidae A species of the true toads, Bufonidae, found in South America. Anura (66-71) &1NBuffers D26.172; G06.184.029.322; G07.621.110.322; G09.188.051.322; H01.181.529.428.405 Miscellaneous Drugs and Agents (Non MeSH) Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Acid-Base Equilibrium Physiology, General (Non MeSH); Homeostasis; Acid-Base Equilibrium Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Acid-Base Equilibrium Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Hydrogen-Ion Concentration Ampholyte Mixtures; HEPES; Tromethamine AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  [4.Buffaloes B02.649.077.380.135 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Ruminants of the family Bovidae consisting of Bubalus arnee and Syncerus caffer. This concept is differentiated from BISON, which refers to Bison bison and Bison bonasus. Artiodactyla (66-67); Cattle (66-67) \ (7-Bufexamac D02.092.570.394.150; D02.241.511.372.150; D16.850.015.050.135; D17.025.030.105; D17.025.080.110; D17.050.030.150; D23.037.060 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Hydroxylamines; Hydroxamic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxamic Acids Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Dermatologic Agents; Anti-Inflammatory Agents, Topical 4-Butoxy-N-hydroxybenzeneacetamide. An anti-inflammatory analgesic with antipyretic action. It is administered topically, orally, or rectally. Hydroxamic Acids (71-74); Phenylacetates (71-74)  .:Bufanolides D04.808.122 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Proscillaridin Steroids derived from various Bufo species and often possessing cardiotonic properties. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  Q8(f:Budgets N03.219.463.060 CLHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Rate Setting and Review Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures. CLHILJMTOGSNSTTDUT   [Budding or Appendaged Bacteria (Non MeSH) B03.200 Bacteria Caulobacter (+ 1) Bacteria that commonly possess unusual shapes, have complex life cycles, and divide by budding. Many have appendages which are sufficiently prominent that they can be detected by phase-contrast light microscopy. CHCLCYDEENGDGEIMIPMEPHPYREULVI ;2  "Buddhism K01.844.117 HIPX Humanities; Religion The teaching ascribed to Gautama Buddha (ca. 483 B.C.) holding that suffering is inherent in life and that one can escape it into nirvana by mental and moral self-purification. (Webster, 3d ed).  Bucrylate D02.241.081.069.366.200; D25.720.259.341.110; D25.919.367.341.110 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates; Cyanoacrylates Biomedical and Dental Materials (Non MeSH); Polymers; Cyanoacrylates; Enbucrilate Biomedical and Dental Materials (Non MeSH); Tissue Adhesives; Cyanoacrylates; Enbucrilate 2-Cyano-2-propenoic acid 2-methylpropyl ester. Cyanoacrylate tissue adhesive also used to occlude blood vessels supplying neoplastic or other diseased tissue. Synonyms: IBC; isobutyl-2-cyanoacrylate. $ I.@Bucladesine D13.695.462.200.250; D13.695.667.138.395.250; D13.695.827.068.395.250 AAADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Nucleotides, Cyclic; Cyclic AMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Cyclic AMP Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Cyclic AMP N-(1-Oxobutyl)adenosine cyclic 3',5'-(hydrogen phosphate) 2'-butanoate. A cyclic nucleotide derivative that mimics the action of endogenous cyclic AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed). M>YBryozoa B01.217 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates A phylum of small sessile aquatic animals living as small tufted colonies. Some appear like hydroids or corals, but their internal structure is more advanced. Most bryozoans are matlike, forming thin encrustations on rocks, shells, or kelp. (Storer and Stebbins, General Zoology, 6th ed.).   (UBruxism C07.793.099 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Tooth Diseases An oral habit consisting of involuntary rhythmic or spasmodic nonfunctional gnashing, grinding, and clenching of teeth on other than chewing movements of the mandible, usually performed during sleep, which may lead to occlusal trauma. Causes are believed to be related to repressed aggression, emotional tension, anger, fear, and frustration.(Dorland, 27th ed). W N/Brunner's Glands A03.492.411.620.270.322 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Gastrointestinal System; Intestines; Intestine, Small; Duodenum :`Brunei Z01.252.145.130 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern  >Brugia pahangi B01.500.294.700.750.700.300.088.550 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea; Brugia A species of parasitic nematode found in man and other mammals. It has been reported from Malaya and East Pakistan and may produce symptoms of tropical eosinophilia. Brugia (75-92); Filarioidea (66-74) '*l,Brugia malayi B01.500.294.700.750.700.300.088.500 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea; Brugia A species of parasitic nematode causing Malayan filariasis and having a distribution centering roughly on the Malay peninsula. The life cycle of B. malayi is similar to that of WUCHERERIA BANCROFTI, except that in most areas the principal mosquito vectors belong to the genus Mansonia. Brugia (75-92); Filarioidea (66-74) '*lO,Brugia B01.500.294.700.750.700.300.088 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Spirurida; Spirurina; Filarioidea Brugia malayi; Brugia pahangi A filarial worm of Southeast Asia, producing filariasis and elephantiasis in various mammals including man. It was formerly included in the genus WUCHERERIA. x #*b%Bruch Membrane A09.371.894.223.250; A10.272.220.250; A10.615.179.250 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Uvea; Choroid Tissue Types (Non MeSH); Epithelium; Basement Membrane Tissue Types (Non MeSH); Membranes; Basement Membrane The membrane, also called the lamina basalis choroideae, that acts as a support structure on the inner side of the choroid (the vascular sheet that supplies the retinal pigment epithelium and the outer portion of the sensory retina adjacent to it). It is 7 microns thick and is composed of the basement membranes of the choriocapillaris endothelium and the retinal pigment epithelium. The membrane stops at the optic nerve, as does the retinal pigment epithelium. Basement Membrane (67-91); Choroid (66-91); Membranes (72-91) 6=:!KBrucellosis, Bovine C01.252.400.167.322; C22.021.322; C22.196.148 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Brucellosis Animal Diseases; Abortion, Veterinary Animal Diseases; Cattle Diseases A disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent. 5JBrucellosis C01.252.400.167 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Brucellosis, Bovine Infection caused by bacteria of the genus BRUCELLA mainly involving the reticuloendothelial system. This condition is characterized by fever, weakness, malaise, and weight loss. =PsBrucella Vaccine D24.310.894.135.134 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines />pBrucella melitensis B03.440.400.425.285.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Brucella A species of the genus BRUCELLA whose natural hosts are sheep and goats. Other mammals, including man, may be infected. In general, these organisms tend to be more virulent for laboratory animals than BRUCELLA ABORTUS and may cause fatal infections. Brucella (66-92) ("'Brucella abortus B03.440.400.425.285.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Brucella A species of the genus BRUCELLA whose natural hosts are cattle and other bovidae. Other mammals, including man, may be infected. Abortion and placentitis are frequently produced in the pregnant animal. q"Brucella B03.440.400.425.285 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Brucella abortus; Brucella melitensis A genus of gram-negative, aerobic bacteria that causes BRUCELLOSIS. Its cells are nonmotile coccobacilli and are animal parasites and pathogens. The bacterium is transmissible to humans through contact with infected dairy products or tissue. e "-Brown-Sequard Syndrome C10.597.622.669.300; C23.888.592.636.637.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Paralysis; Paraplegia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Paralysis; Paraplegia A syndrome due to damage of one half of the spinal cord, resulting in ipsilateral paralysis below the level of the lesion and loss of discriminatory and joint sensation, and contralateral loss of pain and temperature sensation. Brown-Sequard was a French physiologist, 1817-1894. The syndrome is also called Brown-Sequard disease and Brown-Sequard paralysis but this latter should not be confused with a flaccid paralysis seen in disorders of the urinary tract called by the same name. (From Dorland, 27th ed and Magalini, Dictionary of Medical Syndromes, 3d ed). Hemiplegia (70-94); Paralysis (68-94); Spinal Cord Diseases (75-91); Spinal Cord Injuries (70-94) ț2NvBrown Fat A10.165.114.322 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Adipose Tissue Tissue Types (Non MeSH); Connective Tissue; Adipose Tissue Adipose Tissue (66-67) L:HBronchospirometry E01.302.796.733.322 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Spirometry Spirometric technique in which the volume of air breathed in the right and left lung is recorded separately. E"lBronchoscopy E01.302.272; E01.418.148 AECLCTECHIISMOMTNUPXSNSTTDUTVE Catheterization, Peripheral Bronchi Diagnosis; Diagnosis, Respiratory System (Non MeSH) Diagnosis; Endoscopy Endoscopic examination of the bronchi.  Ϥ"  U/Bronchopulmonary Sequestration C08.695.214; C16.131.740.214 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) A developmental anomaly in which a mass of nonfunctioning lung tissue lacks normal connection with the tracheobroncheal tree and receives an anomalous blood supply originating from the descending thoracic or abdominal aorta. The mass may be extralobar, i.e., completely separated from normally connected lung, or intralobar, i.e., partly surrounded by normal lung. #"LBronchopulmonary Dysplasia C08.381.125; C16.614.521.125 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases; Infant, Premature, Diseases A chronic lung disease appearing in certain newborn infants treated for RESPIRATORY DISTRESS SYNDROME with mechanical ventilation and elevated concentration of inspired oxygen. Lung Diseases (66-81); Respiratory Tract Diseases (66-81) "LEBronchopneumonia C08.127.509; C08.381.677.127; C08.730.610.127 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Lung Diseases; Pneumonia Respiratory Tract Diseases; Respiratory Tract Infections; Pneumonia Acute inflammation of the walls of the smaller bronchial tubes, with varying amounts of pulmonary consolidation due to spread of the inflammation into peribronchiolar alveoli and the alveolar ducts. (Stedman, 25th ed). `5NBronchography E01.302.171; E01.357.818.910.140 AECLCTECHIISMOMTNUPXSNSTTDUTVE Bronchi Diagnosis; Diagnosis, Respiratory System (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography; Thoracic Radiography Radiography of the bronchial tree after injection of a contrast medium. &" VBronchogenic Cyst C04.182.195; C08.127.480; C08.695.195; C16.131.740.195 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Respiratory System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Respiratory System Abnormalities (Non MeSH) A usually spherical cyst, arising as an embryonic out-pouching of the foregut or trachea. It is generally found in the mediastinum or lung and is usually asymptomatic unless it becomes infected. Bronchial Diseases (66-86); Cysts (66-86); Mediastinal Cyst (66-86) C@VRBronchodilator Agents D16.050.110 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Bronchi; Histamine H1 Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Albuterol; Atropine; Clenbuterol; Ephedrine; Epinephrine; Fenoterol; Hexoprenaline; Ipratropium; Isoetharine; Isoproterenol; Orciprenaline; Procaterol; Terbutaline; Theobromine; Theophylline (+ 2); Tretoquinol Drugs that cause expansion of the lumina of the air passages of the lungs. (From Dorland, 27th ed). AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $d8)J{DBronchoconstrictor Agents D16.050.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Bronchoconstriction; Bronchi Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Methacholine Chloride Agents causing the narrowing of the lumen of a bronchus or bronchiole. Bronchi/drug effects (66-90) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8"JV#:Bronchoconstriction G09.772.521.700.282 DEGEIMPHRE Bronchial Provocation Tests; Bronchoconstrictor Agents Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Diminution of the caliber of a bronchus physiologically or as a result of pharmacological intervention. Bronchi/physiology (66-90)  ?z Bronchoalveolar Lavage Fluid C23.130 CHCYIMMIPSVI Irrigation Symptoms and General Pathology (Non MeSH) Fluid obtained by washout of the alveolar compartment of the lung. It is used to assess biochemical and inflammatory changes in and effects of therapy on the interstitial lung tissue. Bronchi (71-87); Irrigation (71-87); Lung (71-87); Pulmonary Alveoli (71-87)  " 2^Bronchitis C08.127.446; C08.381.495.146; C08.730.099 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive Respiratory Tract Diseases; Respiratory Tract Infections Bronchiolitis (+ 3) Bronchiolitis (+ 3) Bronchiolitis (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI 1NGPBronchiolitis, Viral C02.109; C08.127.446.135.321; C08.381.495.146.135.321; C08.730.099.135.321 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases Respiratory Tract Diseases; Bronchial Diseases; Bronchitis; Bronchiolitis Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis; Bronchiolitis Respiratory Tract Diseases; Respiratory Tract Infections; Bronchitis; Bronchiolitis An acute inflammatory disease of the upper respiratory tract, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are parainfluenza type 3 and respiratory syncytial virus. TP5Bronchiolitis Obliterans Organizing Pneumonia C08.127.446.135.140.200; C08.381.483.187.200; C08.381.495.146.135.140.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases; Bronchitis; Bronchiolitis; Bronchiolitis Obliterans Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Bronchiolitis Obliterans Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis; Bronchiolitis; Bronchiolitis Obliterans A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. "Organizing" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli. (From Segen, Dictionary of Modern Medicine, 1992; Stedman, 25th ed). Bronchiolitis Obliterans (88-94); Pneumonia (85-93) 4QNm1=Bronchiolitis Obliterans C08.127.446.135.140; C08.381.483.187; C08.381.495.146.135.140 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases; Bronchitis; Bronchiolitis Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis; Bronchiolitis Bronchiolitis Obliterans Organizing Pneumonia Bronchiolitis Obliterans Organizing Pneumonia Bronchiolitis Obliterans Organizing Pneumonia Inflammation of the bronchioles with obstruction by fibrous granulation tissue or bronchial exudate. It may follow inhalation of irritating gases or foreign bodies and it complicates pneumonia. Bronchial Diseases (66-87); Bronchitis (66-87); Bronchopneumonia (66-87)  ENVBronchiolitis C08.127.446.135; C08.381.495.146.135; C08.730.099.135 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases; Bronchitis Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive; Bronchitis Respiratory Tract Diseases; Respiratory Tract Infections; Bronchitis Bronchiolitis Obliterans (+ 1); Bronchiolitis, Viral Bronchiolitis Obliterans (+ 1); Bronchiolitis, Viral Bronchiolitis, Viral Inflammation of the bronchioles. Bronchiolitis, Viral (66-87); Bronchitis (66-87); Bronchopneumonia (66-87) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $h=N(XPBronchiectasis C08.127.384 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases Persistent abnormal dilatation of the bronchi. N78Bronchial Spasm C08.127.321 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases Spasmodic contraction of the smooth muscle of the bronchi. N7GBronchial Provocation Tests E01.302.796.170 AECLCTECHIISMOMTNUPXSNSTTDUTVE Bronchoconstriction Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergens (66-79); Asthma (66-79); Bronchi (66-79); Histamine (66-79); Respiratory Function Tests (66-79); specific respiratory function test (66-79)  !"^3Bronchial Neoplasms C04.588.894.797.265; C08.127.265; C08.785.265 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Thoracic Neoplasms; Respiratory Tract Neoplasms Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Respiratory Tract Neoplasms v5XBronchial Hyperreactivity C08.127.210 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Asthma Respiratory Tract Diseases; Bronchial Diseases Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory. Asthma (70-91); Bronchi (70-91); Respiratory Hypersensitivity (70-91)  N 7SBronchial Fistula C08.127.196; C08.702.196; C23.439.687.196 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Respiratory Tract Fistula (Non MeSH) Symptoms and General Pathology (Non MeSH); Fistula; Respiratory Tract Fistula (Non MeSH) An abnormal passage or communication between a bronchus and another part of the body. :1NgBronchial Diseases C08.127 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases Asthma (+ 2); Bronchial Fistula; Bronchial Hyperreactivity; Bronchial Neoplasms; Bronchial Spasm; Bronchiectasis; Bronchitis (+ 4); Bronchogenic Cyst; Bronchopneumonia; Tracheobronchomegaly BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI B N ZBronchial Arteries A07.231.114.158 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Left bronchial arteries arise from the thoracic aorta, the right from the first aortic intercostal or the upper left bronchial artery; they supply the bronchi and the lower trachea. 188Bronchi A04.125 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Bronchoconstrictor Agents; Bronchodilator Agents; Bronchography; Bronchoscopy Respiratory System The larger air passages of the lungs arising from the terminal bifurcation of the trachea.   8YmBromthymol Blue D02.455.426.559.389.832.200; D02.455.849.856.200; D02.886.590.887.200; D26.550.110 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Thymol Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents alpha,alpha-Bis(6-bromo-5-hydroxycarvacryl)-alpha-hydroxy-o-toluenesulfonic acid, gamma-sultone. a chemical indicator reagent. Thymol (74); Tosyl Compounds (74) \.+Bromphenol Blue D02.455.426.559.389.832.180; D02.755.150; D02.886.590.887.180; D26.550.106 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Phenols Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents alpha,alpha-Bis(3,5-dibromo-4-hydroxyphenyl)-alpha-hydroxy-o-toluenesulfonic acid, gamma-sultone. A chemical indicator reagent. Synonym: Albutest. Bromine (72-74); Phenols (69-74); Tosyl Compounds (72-74)  5T.GBrompheniramine D03.383.725.620.129; D14.100.375.425.400.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pheniramine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists Zimeldine Histamine H1 antagonist used in allergies, rhinitis, and urticaria. c2:PBromovirus B04.715.464.080; B04.820.464.080 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses A group of tripartite plant viruses transmitted by beetles. Mosaic Viruses (73-93); Plant Viruses (66-93) &\H8Bromouracil D03.383.742.698.875.237; D26.087.131 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Uracil Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 5-Bromo-2,4(1H,3H)pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA; used mainly as mutagen although its deoxyriboside is used to treat neoplasms. Synonym: 5-bromouracil. Uracil (66-70) *:Bromotrichloromethane D02.455.526.368.200; D02.455.526.439.224.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Brominated Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated; Chloroform A potent liver poison. In rats, bromotrichloromethane produces about three times the degree of liver microsomal lipid peroxidation as does carbon tetrachloride. Bromine (74-75); Chloroform (74) /AA (75) I2:4Bromosuccinimide D02.241.081.337.817.687.150; D02.478.770.150; D03.383.773.812.852.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates; Succinimides Organic Chemicals (Non MeSH); Imides; Succinimides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines; Pyrrolidinones; Succinimides N-Bromosuccinimide. Synonym: NBS. Bromine (72-74); Succinimides (72-74) M:C).Bromodeoxyuridine D13.570.230.430.196; D13.570.685.852.300.150; D26.087.274.175 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxyuridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine; Deoxyuridine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Deoxyuridine 5-Bromo-2'-deoxyuridine. A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite; it causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent, but is used mainly as a research tool. +E:P"Bromodeoxycytidine D13.570.230.329.100; D13.570.685.245.500.250 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Deoxyribonucleosides; Deoxycytidine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Cytidine; Deoxycytidine 5-Bromo-2'-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP. Bromine (74); Deoxycytidine (74) T2:|)Bromocriptine D03.132.327.287.131; D03.549.439.131; D06.347.150; D14.100.150.151.075; D15.090.050.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Ergot Alkaloids; Ergolines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Ergolines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents A semisynthetic ergot alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion and is used to treat amenorrhea, galactorrhea, and female infertility, and has been proposed for Parkinson disease. Ergot Alkaloids (66-74) c:Bromobenzoates D02.241.223.106.225 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Benzoic acid or benzoic acid esters substituted with one or more bromine atoms. Benzoates (66-74) "h8k`Bromobenzenes D02.455.426.559.389.220; D02.455.526.368.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Brominated Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms. Bromine (73-74); Hydrocarbons, Halogenated (69-74) #28 <Bromisovalum D02.948.160; D15.210.350.800.075; D15.325.875.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate (2-Bromo-3-methylbutyryl)urea. A sedative and mild hypnotic with potentially toxic effects. Urea (69-74); Valerates (72-74) &<9:k(Bromine Radioisotopes D01.496.749.090 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of bromine that decay or disintegrate emitting radiation. Br atoms with atomic weights 74-78, 80, and 82-90 are radioactive bromine isotopes. Bromine (66-87); Radioisotopes (66-87) (4C/Bromine Compounds D01.139 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Bromates; Hydrobromic Acid (+ 2) Inorganic compounds that contain bromine as an integral part of the molecule. Bromine (66-93)  *= 8%)]Bromine D01.268.380.112 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Halogens Bromine. A halogen with the atomic symbol Br, atomic number 36, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested. + :>Bromides D01.139.300.050; D01.248.497.158.125 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Bromine Compounds; Hydrobromic Acid Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Cyanogen Bromide Salts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). -S *8Bromhexine D02.092.146.271; D02.092.384.175; D26.415.055 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds Organic Chemicals (Non MeSH); Amines; Cyclohexylamines Miscellaneous Drugs and Agents (Non MeSH); Expectorants Ambroxol Ambroxol A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.744). /L5:Bromelains D08.586.277.656.732.215.096; D16.850.015.050.110; D17.025.030.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Cysteine Proteinases Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Protein-digesting and milk-clotting enzymes found in pineapple fruit juice and stem tissue. Enzymes from the two sources are distinguished as fruit bromelain and stem bromelain. They have anti-inflammatory activity and the enzymatic activity does not disappear as the fruit ripens. (From Merck Index, 11th ed). 1IFkBromcresol Purple D02.455.426.559.389.832.150; D02.755.239.195; D02.886.590.887.150; D26.550.100 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Phenols; Cresols Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents alpha-(5-Bromo-4-hydroxy-m-tolyl)-alpha-(3-bromo-5-methyl-4-oxo-2,5-cyclohexadien-1-ylidine)-o-toluenesulfonic acid. A chemical indicator reagent. Bromine (73-74); Cresols (69-74); Tosyl Compounds (73-74) 5X.GBromcresol Green D02.455.426.559.389.832.140; D02.755.239.190; D02.886.590.887.140; D26.550.090 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Toluene Organic Chemicals (Non MeSH); Phenols; Cresols Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Tosyl Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents alpha,alpha-Bis(3,5-dibromo-4-hydroxy-o-tolyl)-alpha-hydroxytoluenesulfonic acid, gamma-sultone. A chemical indicator reagent. Bromine (72-74); Cresols (69-74); Tosyl Compounds (74) 8X.DBromazepam D03.438.079.080.070.110; D14.100.240.500.125; D15.075.050.085; D15.210.950.012.050.087; D15.700.872.015.050.141 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine 7-Bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one. A benzodiazepine that is used in the treatment of anxiety disorders. Benzodiazepinones (74); Pyridines (74) <{:/Bromates D01.139.100; D01.248.497.158.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Bromine Compounds Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Negative ions or salts derived from bromic acid, HBRO3. Bromine (66-70) @e &8DBrocresine D02.755.239.180; D08.373.190 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Cresols Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors alpha-(Aminooxy)-6-bromo-m-cresol. A histidine decarboxylase inhibitor. Synonyms: NSD-1055;CL 54998; Contramine. Cresols (68-74); Hydroxylamines (71-74) A":0Broadsides L01.178.682.236 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH) C\Broad Ligament A02.513.170; A05.360.319.114.170 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Ligaments Urogenital System; Genitalia; Genitalia, Female; Adnexa Uteri A broad fold of peritoneum that extends from the side of the uterus to the wall of the pelvis. D=&:puBritish Columbia Z01.107.567.176.160 EHEP Geographicals (Non MeSH); America; North America; Canada EFBrinolase D08.586.277.656.200; D19.461.427.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents A fibrinolytic and thrombolytic enzyme from Aspergillus oryzae. Aspergillus/EN (72-74); Peptide Hydrolases (72-74) FQ *FK=Brill's Disease C01.252.400.810.700.810.800.950.135 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rickettsia Infections; Typhus, Epidemic Louse-Borne A recrudescent episode of epidemic typhus that occurs years after the initial attack. HY'P$fBrief Psychiatric Rating Scale F04.586.083 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychiatric Status Rating Scales A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. (From Hersen, M. and Bellack, A.S., Dictionary of Behavioral Assessment Techniques, p. 87). J% aBridged Compounds D02.219; D04.615.236 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Adamantane (+ 3); Bicyclo Compounds (+ 1) Adamantane (+ 3); Bicyclo Compounds (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR M8qh:Brevibacterium B03.100.067.100.230; B03.510.460.400.400.100.230 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Actinobacteria Group A gram-positive organism found in dairy products, fresh and salt water, marine organisms, insects, and decaying organic matter. N6")Bretylium Tosylate D02.092.102.175.150; D02.675.276.175.150; D14.100.050.600.120; D16.050.850.100; D18.097.141; D18.162.098 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Bretylium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Bretylium Compounds Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents An agent that blocks the release of adrenergic transmitters and may have other actions. It was formerly used as an antihypertensive agent, but is now proposed as an anti-arrhythmic. Aryl Sulfonates (74-75); Bretylium Compounds (69-75) Q v:!?Bretylium Compounds D02.092.102.175; D02.675.276.175 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Bretylium Tosylate Bretylium Tosylate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR U1&8,:Brenner Tumor C04.557.450.565.590.595.150; C04.557.470.625.150 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Neoplasms, Fibroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Fibroepithelial A tumor of the ovary whose structure consists of groups of epithelial cells lying in a fibrous connective tissue stroma. Brenner tumors are uncommon, representing less than 1% of all ovarian neoplasms. Malignant Brenner tumors are unilateral. Brenner tumors are ordinarily found incidentally in ovaries removed for other reasons, especially in postmenopausal women. (From Dorland, 27th ed; Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed). V6X^Breeding G05.414.133; E05.820.150 ECHILJMTSNST Genetics; Genetics, Population Miscellaneous Techniques (Non MeSH); Reproduction Techniques Inbreeding Estrus Detection; Estrus Synchronization; Inbreeding; Superovulation AEBLCFCLCTDEECEHGEHIIMISLJMEMOMTNUPHPXRESNSTTDURUTVE Z j\8Breech Presentation G08.520.769.362.150 Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy; Labor Presentation Labor Presentation (66-74) \Tk Breathing Exercises E02.831.578.391.320 AE Respiration Therapeutics; Rehabilitation; Physical Therapy; Exercise Therapy Therapeutic exercises aimed to deepen inspiration or expiration or even to alter the rate and rhythm of respiration. ]-LBreath Tests E01.223.125 ISMT Respiration Diagnosis; Diagnosis, Laboratory Any tests done on exhaled air. ^n'(Breast Self-Examination E01.706.860.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Physical Examination; Self-Examination The inspection of one's breasts, usually for signs of disease, especially neoplastic disease. Breast (80-91); Breast Neoplasms (66-91); Palpation (66-91) _":nIBreast Neoplasms, Male C04.588.180.260; C19.146.170.260 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Breast Neoplasms Endocrine Diseases; Breast Diseases; Breast Neoplasms Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Two-thirds of patients present with intraductal carcinoma. The average age of onset is 60 years for men. Orchiectomy was the standard treatment but it has been replaced by TAMOXIFEN as the initial therapy since estrogen-receptor-positive tumors are predominant in males. Orchiectomy and mastectomy may be used if initial drug therapy is not successful. The prognosis is worse than that for females. (From Holland, et al., Cancer Medicine, 3d ed, p1751). Breast Neoplasms (66-94) `&XBreast Neoplasms C04.588.180; C19.146.170 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Endocrine Diseases; Breast Diseases Breast Neoplasms, Male; Mammary Neoplasms; Mammary Neoplasms, Experimental Breast Neoplasms, Male dXZqBreast Implants E07.450.208 AECLCTECHIMIPSSDSNSTTDUTVEVI Equipment and Supplies; Implants, Artificial Inert sacs filled with silicone or other material, some of which are covered by polyurethane foam, used to augment the female form cosmetically. With time, the implants covered by polyurethane are hydrolyzed in vivo, yielding various degradation products including carcinogens. (From Segen, The Dictionary of Modern Medicine, 1992). Implants, Artificial (71-94); Prosthesis (67-94); Silicones (67-94) f 5QBreast Feeding G06.696.259.750.500 EHPXSN Bottle Feeding Lactation; Milk, Human Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Child Nutrition; Infant Nutrition The nursing of an infant at the mother's breast.  h w=Breast Diseases C19.146 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases Breast Neoplasms (+ 1); Fibrocystic Disease of Breast; Gynecomastia; Lactation Disorders (+ 2); Mastitis (+ 1) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI i NZBreast A01.236; A10.336.153 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULVI Lactation; Mammae; Mammaplasty; Mammography; Mastectomy Body Regions (Non MeSH) Tissue Types (Non MeSH); Exocrine Glands Nipples Nipples consider also terms at MAMMA- and MAST-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $k^ 6CO3:Bread J01.341.108 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food l "=Brazil Z01.107.757.176 EHEP Geographicals (Non MeSH); America; South America m <Brassica B06.510.092 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Mustard A large genus of edible, Cruciferous herbs including the large species Brassica oleracea - cabbage, cauliflower, broccoli, brussel sprouts, kale, and collard greens (all are the same species) and turnips (B. napa), rutabagas (B. napobrassica), rapeseed (B. napus), and mustards (B. nigra and B. alba). Plants (66-77); Plants, Edible (66-77)  n 4 a0Branchioma C04.182.117 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Cysts A tumor derived from branchial epithelium or branchial rests. (Dorland, 27th ed). pCXcBranchial Region A16.254.160 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Embryonic Structures (Non MeSH); Embryo Region containing paired arched columns that bear gills in lower aquatic vertebrates and appear in the embryos of higher vertebrates in comparable form. In higher vertebrates the arches are subsequently modified into structures of the neck and ear. qT81#Brain Tissue Transplantation E04.936.580.090 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Transplantation; Tissue Transplantation Transference of brain tissue, either from a fetus or from a born individual, between individuals of the same species or between individuals of different species. Brain/transplantation (66-90) s'"2E#Brain Stem A08.186.211.132 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain Mesencephalon (+ 10); Reticular Formation (+ 1); Rhombencephalon (+ 9); Trigeminal Nuclei (+ 2) t88vBrain Neoplasms C04.588.614.250.195; C10.228.140.211; C10.228.250.195; C10.551.250.195 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Nervous System Neoplasms; Central Nervous System Neoplasms Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Neoplasms Nervous System Diseases; Nervous System Neoplasms; Central Nervous System Neoplasms Cerebellar Neoplasms (+ 1); Cerebral Ventricle Neoplasms (+ 1); Hypothalamic Neoplasms; Supratentorial Neoplasms Cerebellar Neoplasms (+ 1); Cerebral Ventricle Neoplasms (+ 1); Hypothalamic Neoplasms; Supratentorial Neoplasms Cerebellar Neoplasms (+ 1); Cerebral Ventricle Neoplasms (+ 1); Hypothalamic Neoplasms; Supratentorial Neoplasms Cerebellar Neoplasms (+ 1); Cerebral Ventricle Neoplasms (+ 1); Hypothalamic Neoplasms; Supratentorial Neoplasms Neoplasms of the part of the central nervous system contained within the cranium. vPXbBrain Mapping E05.132 ISMT Stereotaxic Techniques Miscellaneous Techniques (Non MeSH) z *Brain Injuries C21.866.460.152 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Head Injuries, Closed; Head Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries Brain Concussion Acute injuries to the brain, general or unspecified.  {yN-c@Brain Edema C10.228.140.187 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Nervous System Diseases; Central Nervous System Diseases; Brain Diseases |N VBrain Diseases, Metabolic C10.228.140.163 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Abetalipoproteinemia; Gangliosidoses (+ 3); Hartnup Disease; Hepatic Encephalopathy; Hepatolenticular Degeneration; Homocystinuria; Kernicterus; Kinky Hair Syndrome; Leigh Disease; Lesch-Nyhan Syndrome; Maple Syrup Urine Disease; Mitochondrial Encephalomyopathies (+ 2); Myelinolysis, Central Pontine; Neuronal Ceroid-Lipofuscinosis; Niemann-Pick Disease; Phenylketonuria (+ 1); Pyruvate Carboxylase Deficiency; Pyruvate Dehydrogenase Complex Deficiency; Wernicke's Encephalopathy Metabolic disorders which lead to pathological changes and/or functional deviations of the brain. Brain Diseases (66-76)  }NV&sBrain Diseases C10.228.140 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Organic Mental Disorders, Psychotic Nervous System Diseases; Central Nervous System Diseases Akinetic Mutism; Auditory Diseases, Central (+ 2); Basal Ganglia Diseases (+ 16); Brain Abscess; Brain Damage, Chronic (+ 1); Brain Diseases, Metabolic (+ 25); Brain Edema; Brain Neoplasms (+ 6); Canavan Disease; Cerebellar Diseases (+ 9); Cerebral Sclerosis, Diffuse (+ 4); Cerebrovascular Disorders (+ 29); Dementia (+ 9); Encephalitis (+ 12); Encephalomalacia (+ 1); Epilepsy (+ 13); Hallervorden-Spatz Syndrome; Hydrocephalus (+ 2); Hypothalamic Diseases (+ 1); Malaria, Cerebral; Narcolepsy (+ 1); Poliomyelitis, Bulbar; Pseudotumor Cerebri; Rett Syndrome; Reye's Syndrome; Thalamic Diseases; Toxoplasmosis, Cerebral; Tuberculoma, Intracranial; Zellweger Syndrome BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  N*C!ZBrain Death C23.240.169 BLCFCLDIIMLJMEPAPPRARIURUSVE Symptoms and General Pathology (Non MeSH); Death Total cessation of brain function for 24 hours as manifested by absence of spontaneous movement, absence of spontaneous respiration, and absence of all brain stem reflexes. Death (66-68) ) <Brain Damage, Chronic C10.228.140.140 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Cerebral Palsy NVBrain Concussion C21.866.460.152.194; C21.866.974.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Head Injuries; Brain Injuries Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Wounds, Nonpenetrating Transient or prolonged unconsciousness with or without impairment of higher mental functions and/or brain stem functions, due to a violent blow to the head. *NBrain Chemistry G06.184.202 DEGEIMPHRE Chemistry Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH)  hBrain Abscess C01.539.830.025.160; C10.228.140.116; C10.228.228.114 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) An abscess affecting the brain as a result of extension of an infection (e.g., otitis media) from an adjacent area or through bloodborne infection. (Dorland, 27th ed). =P#Brain A08.186.211 ABAHBSCYDEEMENGDIMMEMIPAPHPPPSRARERISESUULVI Nervous System; Central Nervous System Brain Stem (+ 26); Cerebellum (+ 4); Cerebral Ventricles (+ 4); Limbic System (+ 11); Prosencephalon (+ 45) consider also terms at CEREBR- and ENCEPHAL-. ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  n 0/8<Bradykinin D12.644.320.169; D12.644.456.193; D12.776.641.650.090; D14.600.600.120; D17.350.050.375.110 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Bradykinin Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Kinins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Kinins Kallidin Kallidin Kallidin A nonapeptide messenger that is enzymatically produced from kallidin in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from mast cells during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.  gF"Bradycardia C14.280.067.319 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Excessive slowness in the action of the heart. It usually displays a heart rate below 60 beats per minute. N=Brachytherapy E02.810.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Radiotherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Neoplasms/radiotherapy (66-79); Radioisotopes/administration and dosage/therapeutic use (66-79); Radiotherapy (66-79); specific neoplasm/radiotherapy (66-79); specific radioisotope/administration and dosage/therapeutic use (66-79) 8"  Brachiocephalic Veins A07.231.908.130 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins Large veins on either side of the root of the neck formed by the junction of the internal jugular and subclavian veins. They drain blood from the head, neck, and upper extremities, and unite to form the superior vena cava. Innominate Vein (66-90) 85 Brachiocephalic Trunk A07.231.114.145 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The first and largest artery branching from the aortic arch. It distributes blood to the right side of the head and neck and to the right arm. Innominate Artery (66-90) 88Brachial Plexus A08.800.800.720.050 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Cervico-Brachial Neuralgia; Thoracic Outlet Syndrome Nervous System; Peripheral Nervous System; Peripheral Nerves; Spinal Nerves Median Nerve; Musculocutaneous Nerve; Radial Nerve; Ulnar Nerve The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments (C5-C8 and T1), but variations are not uncommon. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $^6=ZM|8Brachial Artery A07.231.114.139 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Radial Artery; Ulnar Artery The continuation of the axillary artery; it branches into the radial and ulnar arteries. 88#kBraces E07.858.442.743.319 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthotic Devices  aBoxing I03.450.642.845.210 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A two-person sport in which the fists are skillfully used to attack and defend.  RaBowen's Disease C04.557.470.200.400.130; C04.557.470.700.400.130 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Carcinoma, Squamous Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell; Carcinoma, Squamous Cell A persistent progressive non-elevated red scaly or crusted plaque which is due to an intradermal carcinoma and is potentially malignant. Atypical squamous cells proliferate through the whole thickness of the epidermis. The lesions may occur anywhere on the skin surface or on mucosal surfaces. The cause most frequently found is trivalent arsenic compounds. Freezing, cauterization or diathermy coagulation is often effective. (From Rook et al., Textbook of Dermatology, 4th ed, p. 2428-9). 6X5<Bovine Virus Diarrhea-Mucosal Disease C02.782.350.675.106; C22.196.106 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Pestivirus Infections Animal Diseases; Cattle Diseases Acute disease of cattle caused by the bovine viral diarrhea virus (DIARRHEA VIRUS, BOVINE VIRAL). Often mouth ulcerations are the only sign but fever, diarrhea, drop in milk yield, and loss of appetite are also seen. Mortality is high in animals showing clinical signs, especially diarrhea. Cattle Diseases (66-71); Virus Diseases/veterinary (66-71) ,&JWFBoutonneuse Fever C01.252.400.810.700.810.800.135; C01.252.400.825.175 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rickettsia Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with Rickettsia conorii. :PBotulism C01.252.410.090.217.151; C21.613.415.151 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Botulinum Toxins Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections; Clostridium Infections Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Food Poisoning A disease caused by potent protein neurotoxins produced by CLOSTRIDIUM BOTULINUM. Characteristics include abdominal pain, vomiting, motor disturbances, and visual difficulties. The Centers for Disease Control and Prevention classify botulism into four types: (1) food-borne; (2) infant; (3) wound; and (4) indeterminate.  .PsBotulinum Toxins D24.185.926.123.179 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Clostridium botulinum; Botulism; Cholinergic Agents Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Bacterial Toxins Toxins produced by Clostridium botulinum. There are at least seven different substances, most being proteins. They have neuro-, entero-, and hemotoxic properties, are immunogenic, and include the most potent poisons known. The most commonly used apparently blocks release of acetylcholine at cholinergic synapses. Clostridium Botulinum (66-68); Toxins (66-68)  :=kk7Botulinum Antitoxin D24.611.125.272.268 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antitoxins Antitoxins (66-71) 6wBottle Feeding E02.421.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Breast Feeding Therapeutics; Feeding Methods (Non MeSH) Use of nursing bottles for feeding. Applies to humans and animals. Infant Nutrition (66-74)  "1RBotswana Z01.058.290.175.230 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern  `Bothrops B02.833.672.875.200 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes; Viperidae A genus of poisonous snakes of the VIPERIDAE family. About 50 species are known and all are found in tropical America and southern South America. Bothrops atrox is the fer-de-lance and B. jararaca is the jararaca. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed). Snakes (66-93)  &2EBotany G01.273.118 CLECEDHIISLJMAMTOGSNSTTD Plants Biological Sciences; Biology Pharmacognosy   #Boston Z01.107.567.875.100.481.210; Z01.107.567.875.600.595.481.210; Z01.433.210 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH); Massachusetts Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); New England; Massachusetts Geographicals (Non MeSH); Cities (Non MeSH) Massachusetts (66-69) 1 QcBosnia-Herzegovina Z01.542.248.160; Z01.586.980.160 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Yugoslavia Created 7 April 1992 as a result of the division of Yugoslavia. Yugoslavia (66-92) 4&OBorrelia Infections C01.252.400.155; C01.252.847.193 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections Lyme Disease (+ 1); Relapsing Fever Lyme Disease (+ 1); Relapsing Fever Infections with bacteria of the genus BORRELIA. &PZ:Borrelia burgdorferi B03.851.595.193.150 CHCLCYDEENGDGEIMIPMEPHPYREULVI Lyme Disease Bacteria; Spirochaetales; Spirochaetaceae; Borrelia Gram-negative helical bacteria that are the etiologic agents of LYME DISEASE. These spirochetes are generally transmitted by several species of ixodid ticks. Borrelia (84-89); Lyme Disease (84-89)  "=0Borrelia B03.851.595.193 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Spirochaetales; Spirochaetaceae Borrelia burgdorferi A genus of gram-negative, anaerobic, helical bacteria, various species of which produce relapsing fever in man and other animals. n "1Boronic Acids D01.029.260.110; D01.132.285; D02.203.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Boron Compounds Organic Chemicals (Non MeSH); Boron Compounds Inorganic or organic compounds that contain the basic structure RB(OH)2. Boron (66-67) 18XBoron Neutron Capture Therapy E02.810.722.500.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Radiotherapy; Radiotherapy, High-Energy; Neutron Capture Therapy A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons. Boron (66-92); Neutrons (66-92); Radiotherapy, High-Energy (66-92) ‡$"[PBoron Compounds D01.132; D02.203 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Organic Chemicals (Non MeSH) Boranes (+ 1); Boric Acids (+ 1); Borinic Acids; Boronic Acids Boranes (+ 2); Boric Acids (+ 1); Borinic Acids; Boronic Acids Inorganic or organic compounds that contain boron as an integral part of the molecule. Boron (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $Ĕ8Fh:Boron D01.268.912.075 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Trace Elements Boron. A trace element with the atomic symbol B, atomic number 5, and atomic weight 10.81. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY. ƿ :EBorohydrides D01.132.105.050; D02.203.087.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Boron Compounds; Boranes Organic Chemicals (Non MeSH); Boron Compounds; Boranes  Tetraphenylborate A class of inorganic or organic compounds that contain the borohydride (BH4-) anion. Boron Compounds (68-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $\&8e:Borneo Z01.252.145.103 EHEP Geographicals (Non MeSH); Asia; Asia, Southeastern Q >Bornanes D02.455.849.618.234 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Norbornanes Camphor Bridged Compounds (66-70); Camphor (66-70); Terpenes (70-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   8O J:Borna Disease Virus B04.820.060.150; B04.909.777.090.150; B04.970.060.150 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arterivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arterivirus Viruses; Viruses, Unclassified; Arterivirus A species of virus, probably an ARTERIVIRUS, causing a rare and usually fatal encephalitic disease in horses and other domestic animals and possibly deer. Its name derives from the city in Saxony where the condition was first described in 1894, but the disease occurs in Europe, N. Africa, and the Near East. 7=mBorna Disease C02.081.135; C22.152 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; Arbovirus Infections Animal Diseases An encephalomyelitis of horses, sheep and cattle caused by an RNA virus. Cattle Diseases (66-69); Encephalomyelitis (66-69); Horse Diseases (66-69); Virus Diseases (66-69) J>XvBorinic Acids D01.029.260.100; D01.132.275; D02.203.187 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Boron Compounds Organic Chemicals (Non MeSH); Boron Compounds Inorganic or organic compounds that contain the general structure R2B(OH). Boron (66-67) Ѝ18ZBoric Acids D01.029.260.093; D01.132.250; D02.203.130 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Acids; Acids, Noncarboxylic (Non MeSH) Inorganic Chemicals (Non MeSH); Boron Compounds Organic Chemicals (Non MeSH); Boron Compounds  Borates Borates Inorganic and organic derivatives of boric acid either B(OH)3 or, preferably H3BO3. Borates (66-67)  ^18eBoredom F01.470.192 Behavior and Behavior Mechanisms (Non MeSH); Emotions A psychological state resulting from any activity that lacks motivation, or from enforced continuance in an uninteresting situation. Motivation (66-68) S ABordetella pertussis B03.440.400.425.210.550 CHCLCYDEENGDGEIMIPMEPHPYREULVI Pertussis Toxins; Pertussis Vaccine Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Bordetella A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath. Ղ"+Bordetella Infections C01.252.400.143 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Whooping Cough Infections with bacteria of the genus BORDETELLA. Bordetella (66-71)  ׀Ps<Bordetella bronchiseptica B03.440.400.425.210.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Bordetella A species of BORDETELLA that is parasitic and pathogenic. It is found in the respiratory tract of domestic and wild mammalian animals and can be transmitted from animals to man. It is a common cause of bronchopneumonia in lower animals. Bordetella (66-91) "Bordetella B03.440.400.425.210 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bordetella bronchiseptica; Bordetella pertussis A genus of gram-negative, aerobic bacteria whose cells are minute coccobacilli. It consists of both parasitic and pathogenic species. G"7Borderline Personality Disorder F03.709.597.090 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders A disorder characterized by instability in several areas--interpersonal relationships, marked shifts in mood, and uncertainty about identity issues--which causes impairment in social or occupational functioning or subjective distress.  %Fc Border Disease Virus B04.820.250.700.100; B04.909.777.310.700.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Flaviviridae; Pestivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Flaviviridae; Pestivirus A species of PESTIVIRUS causing a congenital sheep disease characterized by an abnormally hairy birth-coat, tremors, and poor growth. Pestivirus (82-93); RNA Viruses (76-79); Togaviridae (80-90) 2JBorder Disease C02.782.350.675.100; C22.836.160 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Flaviviridae Infections; Pestivirus Infections Animal Diseases; Sheep Diseases Congenital disorder of lambs caused by a virus closely related to or identical with certain strains of bovine viral diarrhea virus. Bovine Diarrhea Virus (75-84); Sheep Diseases (66-84) '&JABorates D01.132.250.075; D01.248.497.158.076; D02.203.130.075 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Boron Compounds; Boric Acids Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Organic Chemicals (Non MeSH); Boron Compounds; Boric Acids Inorganic or organic salts and esters of boric acid. D =8ABoranes D01.132.105; D02.203.087 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Boron Compounds Organic Chemicals (Non MeSH); Boron Compounds Borohydrides Borohydrides (+ 1) The collective name for the boron hydrides, which are analogous to the alkanes and silanes. Numerous boranes are known. Some have high calorific values and are used in high-energy fuels. (From Grant and Hackh's Chemical Dictionary, 5th ed). Boron (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ 8p&:Bookselling L01.737.150.340 CLECHILJMTSDSNSTTDUT Information Science; Publishing; Book Industry Book Prices 8Books, Illustrated L01.178.147.117; L01.178.682.192.289 HI Information Science; Communications Media (Non MeSH); Audio-Visual Aids Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books 3*Books L01.178.682.192 HI Bibliotherapy Information Science; Communications Media (Non MeSH); Publications (Non MeSH) Book Imprints (+ 1); Book Ornamentation; Bookplates; Books, Illustrated; Incunabula; Manuals (+ 1); Rare Books; Reference Books (+ 20); Textbooks CLHIST  R \ Bookplates L01.178.682.192.234 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books fBookbinding L01.737.150.317 CLECHILJMTSDSNSTTDUT Information Science; Publishing; Book Industry y8Book Selection L01.453.220 Information Science; Information Services  1Book Reviews L01.178.682.150 Information Science; Communications Media (Non MeSH); Publications (Non MeSH) x\Book Prices L01.737.150.340.250 Information Science; Publishing; Book Industry; Bookselling GBook Ornamentation L01.178.682.192.178 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books fBook Industry J01.576.154; L01.737.150 CLECHIISLJMAOGSDSNSTTDUT Publishing Publishing Technology, Industry, Agriculture (Non MeSH); Industry Information Science; Publishing  Bookbinding; Bookselling (+ 1) CLECHIISLJMAMTOGSDSNSTTDUT $Ue'Book Imprints L01.178.682.192.122 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books Printers' Marks fBook Collecting L01.040 CLECHILJSDSNSTTDUT Information Science b Book Classification L01.300.250.150 CLECHIMTSNSTTDUT Information Science; Documentation; Cataloging 7Bonnevie-Ullrich Syndrome C16.131.077.167; C16.131.280.748.175 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities; Sex Chromosome Abnormalities A congenital syndrome characterized by pterygium colli, lymphedema of the hands and feet, hypoplasia of the bones and muscles, syndactyly, laxity of the skin, dystrophy of the nails, disorders of the cranial nerves, and short stature. It is thought to be transmitted as either an X-linked or autosomal dominant trait and is similar to the KLIPPEL-FEIL SYNDROME and the NOONAN SYNDROME. (Jablonski's Dictionary of Syndromes and Eponymic Diseases, 2d ed). c*LBongkrekic Acid D20.085.140 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics (R*-(R*,S*-(E,Z,Z,E,E,Z,E)))-20-(Carboxymethyl)-6-methoxy- 2,5,17-trimethyl-2,4,8,10,14,18,20-docosaheptaenedioic acid. An antibiotic produced by Pseudomonas cocovenenans. It inhibits adenine nucleotide efflux from mitochondria by enhancing membrane binding. Antibiotics (73-74); Carboxylic Acids (73-74); Pseudomonas (68-74) <)!PBone Wires E07.858.442.660.383 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices Steel wire, often threaded through the skin, soft tissues, and bone, used to fix broken bones. Kirschner wires or apparatus also includes the application of traction to the healing bones through the wires. Fracture Fixation, Internal (70-85) 7m*Bone Transplantation E04.557.350; E04.936.450.050 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Surgery, Operative; Orthopedics Surgery, Operative; Transplantation; Organ Transplantation The grafting of bone from a donor site to a recipient site. Bone and Bones/transplantation (66-89) ("2hK.Bone Substitutes D25.130.325 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Osseointegration Biomedical and Dental Materials (Non MeSH); Biocompatible Materials Synthetic materials for the replacement of bones or bone tissue. They include hard tissue replacement polymers, natural coral, hydroxyapatite, beta-tricalcium phosphate, and various other biomaterials. The bone substitutes as inert materials can be incorporated into surrounding tissue or gradually replaced by original tissue. ,PxBone Screws E07.450.200; E07.858.442.660.315 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices Fracture Fixation (66-70); Fracture Fixation, Internal (70); Fracture Fixation, Intramedullary (70) &uBone Resorption C05.116.264; G11.427.150.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Remodeling Ainhum; Alveolar Bone Loss; Osteolysis (+ 1) Alveolar Bone Loss; Osteolysis Bone loss due to osteoclastic activity. x"N\1Bone Remodeling G04.185.753.150; G11.427.150 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Bone Regeneration (+ 1) Bone Regeneration (+ 1); Bone Resorption (+ 2) The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone remodeling's two contrasting events, bone resorption and bone formation, results in many of the metabolic bone diseases, such as OSTEOPOROSIS. Bone Development (67-91); Bone Regeneration (67-91); Bone Resorption (67-91) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $b"W\TBone Regeneration G04.185.753.150.150; G11.427.150.140 DEGEIMPHRE Callus; Fracture Healing Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Regeneration; Bone Remodeling Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Remodeling Osseointegration Osseointegration Renewal or repair of lost bone tissue. It excludes CALLUS formed after bone fracture but not yet replaced by hard bone.  a*&Bone Plates E07.450.180; E07.858.442.660.232 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices &Bone Neoplasms C04.588.149; C05.116.231 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Musculoskeletal Diseases; Bone Diseases Femoral Neoplasms; Skull Neoplasms (+ 6); Spinal Neoplasms Femoral Neoplasms; Skull Neoplasms (+ 6); Spinal Neoplasms X^Bone Nails E07.450.160; E07.858.442.660.149 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Orthopedic Equipment; Orthopedic Fixation Devices Rods of bone, metal, or other material used for fixation of the fragments or ends of fractured bones.  j&{Bone Matrix A10.165.265.166 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Connective Tissue; Bone and Bones Bone and Bones (66-71)  :IBone Marrow Transplantation E04.936.580.040 AECLCTECHIIMISLJMOMTNUPAPHPXRARHRISNSTTDUSUTVE Bone Marrow Purging; Hematopoietic Stem Cell Transplantation Surgery, Operative; Transplantation; Tissue Transplantation The transference of bone marrow from one human or animal to another. Bone Marrow/transplantation (66-89)  !2GET*Bone Marrow Purging E02.110.142 AECLCTECHIISMOMTNUPXSNSTTDUTVE Bone Marrow Transplantation Therapeutics; Blood Component Removal Immunomagnetic Separation Techniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic bone marrow transplantation. Bone Marrow (83-91); Bone Marrow Transplantation (88-91) $x"!-DBone Marrow Examination E01.223.459.246 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests Removal of bone marrow and evaluation of its histologic picture. e"=NBone Marrow Diseases C15.378.190 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Anemia, Aplastic; Myelodysplastic Syndromes (+ 5); Myeloproliferative Disorders (+ 8) eNJeBone Marrow Cells (Non MeSH) A11.148; A15.378.316 Cells Hemic and Immune Systems (Non MeSH); Hematopoietic System Hematopoietic Stem Cells (+ 2); Megakaryocytes Hematopoietic Stem Cells (+ 2); Megakaryocytes CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI $Mp*Bone Marrow A15.382.216 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Hemic and Immune Systems (Non MeSH); Immune System The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. consider also terms at MYEL-. 8?JBone Malalignment C05.116.214 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Displacement of bones out of line in relation to joints. It may be congenital or traumatic in origin. N/|Bone Lengthening E04.557.273 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Leg Length Inequality Surgery, Operative; Orthopedics Leg Length Inequality (66-71); Osteotomy (66-71); specific bone/SU (66-71) :$&[Bone Diseases, Metabolic C05.116.198 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases Bone Demineralization, Pathologic (+ 1); Osteomalacia; Osteoporosis (+ 2); Pseudohypoparathyroidism (+ 1); Rickets Bone Diseases (66-79) EN/Bone Diseases, Infectious (Non MeSH) C05.116.165 Musculoskeletal Diseases; Bone Diseases Osteitis; Osteomyelitis; Periostitis; Spondylitis (+ 1); Tuberculosis, Osteoarticular (+ 1) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI ,/mPBone Diseases, Endocrine (Non MeSH) C05.116.132 Musculoskeletal Diseases; Bone Diseases Acromegaly; Cretinism; Dwarfism, Pituitary; Gigantism; Osteitis Fibrosa Cystica; Progeria BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI +/jNBone Diseases, Developmental C05.116.099 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Growth Disorders; Connective Tissue Diseases Musculoskeletal Diseases; Bone Diseases Basal Cell Nevus Syndrome; Dwarfism (+ 6); Dysostoses (+ 15); Funnel Chest; Gigantism; Leg Length Inequality; Marfan Syndrome; Osteochondrodysplasias (+ 23); Osteolysis, Essential; Platybasia; Proteus Syndrome Bone Diseases (66-69) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI $H"N5/VBone Diseases C05.116 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases Bone Cysts (+ 1); Bone Diseases, Developmental (+ 55); Bone Diseases, Endocrine (Non MeSH) (+ 6); Bone Diseases, Infectious (Non MeSH) (+ 7); Bone Diseases, Metabolic (+ 9); Bone Malalignment; Bone Neoplasms (+ 9); Bone Resorption (+ 4); Eosinophilic Granuloma; Epiphyses, Slipped; Hyperostosis (+ 6); Osteitis Deformans; Osteoarthropathy, Primary Hypertrophic; Osteoarthropathy, Secondary Hypertrophic; Osteochondritis (+ 2); Osteonecrosis (+ 2); Spinal Diseases (+ 19) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI   N2ZBone Development G07.553.121; G11.427.111 DEGEIMPHRE Growth Plate; Calcification, Physiologic Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Calcification, Physiologic; Maxillofacial Development; Osteogenesis Calcification, Physiologic; Maxillofacial Development; Osteogenesis $0Bone Density G11.427.100 DEGEIMPHRE Absorptiometry, Photon Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) The amount of mineral per square centimeter of bone. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by photon absorptiometry or x-ray computed tomography. Bone and Bones (66-89)  %p*Bone Demineralization, Pathologic C05.116.198.247 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Osteoporosis Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Metabolic Decalcification, Pathologic Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. (From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed). Bone and Bones (66-94); Bone Diseases (66-94) $($'NM "9Bone Demineralization Technique E05.909.432.210 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques Removal of mineral constituents or salts from bone or bone tissue. Demineralization is used as a method of studying bone strength and bone chemistry. +%"_Bone Cysts, Aneurysmal C04.182.089.265; C05.116.070.265 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts; Bone Cysts Musculoskeletal Diseases; Bone Diseases; Bone Cysts Solitary lesions of bone that typically cause a bulging of the overlying cortex bearing some resemblance to the saccular protrusion of the aortic wall in aortic aneurysm, hence the name. (Dorland, 27th ed). -A&VaBone Cysts C04.182.089; C05.116.070 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Musculoskeletal Diseases; Bone Diseases Bone Cysts, Aneurysmal; Jaw Cysts (+ 7) Bone Cysts, Aneurysmal Pathological bone spaces in the metaphyses of long bones of growing children. They are of disputed origin. Cysts may be either empty or filled with fluid and have a delicate connective tissue lining. (Dorland, 27th ed at cyst, solitary). /RVCLBone Conduction G11.561.796.263.398 DEGEIMPHRE Hearing Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Hearing 1 Bone Cements D25.720.716.822.300; D26.016.125 AEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Tissue Adhesives Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic Miscellaneous Drugs and Agents (Non MeSH); Adhesives Tissue Adhesives (66-71) 2&*Bone Banks N02.278.065.900.205 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Biological Specimen Banks; Tissue Banks Centers for acquiring, characterizing, and storing bones or bone tissue for future use. Tissue Banks (66-94) 3|hBone and Bones A02.835.232; A10.165.265 ABAHBSCHCYDEEMENIMINIRMEMIPAPHPPPSRARERISESUULUSVI Arthrodesis; Calcification, Physiologic; Osteogenesis; Osteotomy Skeleton Musculoskeletal System; Skeleton Tissue Types (Non MeSH); Connective Tissue Arm Bones (Non MeSH) (+ 9); Diaphyses; Epiphyses (+ 1); Foot Bones (Non MeSH) (+ 4); Hyoid Bone; Leg Bones (Non MeSH) (+ 6); Pelvic Bones (+ 4); Sesamoid Bones; Skull (+ 25); Spine (+ 11); Thorax (+ 4) Bone Matrix; Callus; Haversian System; Periosteum consider also terms at OSSI- and OSTE-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI (5O6K Z?2:Bonding, Human-Pet F02.739.794.624.120 Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory; Object Attachment The emotional attachment of individuals to pets. 8F;Bombesin D12.644.075; D12.776.641.650.085; D14.600.600.100; D19.316.274; D24.185.965.033.137 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Bombesin Amino Acids, Peptides and Proteins (Non MeSH); Peptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Amphibian Venoms A tetradecapeptide originally obtained from the skins of toads Bombina bombina and B. variegata. It is also an endogenous neurotransmitter in many animals including mammals. Bombesin affects vascular and other smooth muscle, gastric secretion, and renal circulation and function. Anura (66-74); Peptides (66-74)  9P _DD(Bolivia Z01.107.757.136 EHEP Geographicals (Non MeSH); America; South America = <Boidae B02.833.672.250 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes A family of snakes comprising the boas, anacondas, and pythons. They occupy a variety of habitats through the tropics and subtropics and are arboreal, aquatic or fossorial (burrowing). Some are oviparous, others ovoviviparous. Contrary to popular opinion, they do not crush the bones of their victims: their coils exert enough pressure to stop a prey's breathing, thus suffocating it. There are five subfamilies: Boinae, Bolyerinae, Erycinae, Pythoninae, and Tropidophiinae.(Goin, Goin, and Zug: Introduction to Herpetology, 3d ed). Snakes (66-93) > &%lBody Weights and Measures (Non MeSH) E05.118 Miscellaneous Techniques (Non MeSH) Anthropometry (+ 2); Body Height; Body Surface Area; Body Weight; Cephalometry (+ 1); Odontometry; Organ Weight; Pelvimetry AECLCTDEECEHGEHIIMISMOMTNUPHPXRESNSTTDUTVE A- *.Body Weight Changes (Non MeSH) C23.888.220 Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Cachexia; Emaciation; Obesity; Thinness BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI BZ&X1NBody Weight E01.706.189.440; E05.118.287; G07.553.481.398 DEEHGEIMPHRE Obesity; Thinness Diagnosis; Physical Examination; Body Constitution Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth  Birth Weight; Obesity; Thinness; Weight Gain; Weight Loss BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI  C5JTBody Water A12.207.200 CHCYDEENIMMEMIPHPSRARERISEUSVI Water Fluids and Secretions (Non MeSH); Body Fluids Body Fluids (66-71); Water (66-71) E" 9,Body Temperature Regulation G07.315.232; G07.621.265 DEGEIMPHRE Thermoreceptors Physiology, General (Non MeSH); Body Temperature Physiology, General (Non MeSH); Homeostasis Hibernation; Shivering; Sweating; Water Loss, Insensible F!nEBody Temperature Changes (Non MeSH) C23.888.189 Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Fever (+ 3); Hypothermia BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI G+X!NBody Temperature E01.706.220; G07.315 DEGEIMPHRE Fever; Thermography; Thermometers Temperature Diagnosis; Physical Examination Physiology, General (Non MeSH)  Body Temperature Regulation (+ 4); Skin Temperature  H)I@Body Surface Potential Mapping E01.145.569.359.182; E01.145.569.359.731.307; E01.399.214.182; E01.399.214.731.307 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Electrocardiography Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Electrocardiography; Vectorcardiography Diagnosis; Electrodiagnosis; Electrocardiography Diagnosis; Electrodiagnosis; Electrocardiography; Vectorcardiography Recording of regional electrophysiological information by analysis of surface potentials to give a complete picture of the effects of the currents from the heart on the body surface. It has been applied to the diagnosis of old inferior myocardial infarction, localization of the bypass pathway in Wolff-Parkinson-White syndrome, recognition of ventricular hypertrophy, estimation of the size of a myocardial infarct, and the effects of different interventions designed to reduce infarct size. The limiting factor at present is the complexity of the recording and analysis, which requires 100 or more electrodes, sophisticated instrumentation, and dedicated personnel. (Braunwald, Heart Disease, 4th ed). Electrocardiography (66-94); Vectorcardiography (78-94) J%\&j+@Body Surface Area E01.706.189.315; E05.118.231 VE Diagnosis; Physical Examination; Body Constitution Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Anthropometry (66) O"Body Regions (Non MeSH) A01 Abdomen (+ 10); Axilla; Back (+ 2); Breast (+ 1); Buttocks; Extremities (+ 20); Head (+ 12); Neck; Pelvis (+ 1); Perineum; Skin (+ 9); Thorax (+ 1); Viscera ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI P:Body Mass Index E05.118.090.175; G03.850.505.200.100.175; N05.715.360.325.150.100.150 Skinfold Thickness Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH); Anthropometry Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH); Biometry; Anthropometry One of the anthropometric measures of body mass; it has the highest correlation with skinfold thickness or body density. Body Weight (66-89) R MBody Image F02.463.593.112 Self Concept Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception A term for the concept which each individual has of his own body as an object in and bound by space, independently and apart from all other objects. U\Body Height E01.706.189.190; E05.118.176; G07.553.481.231 DEEHGEIMPHRE Diagnosis; Physical Examination; Body Constitution Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth V{5Body Fluids A12.207 CHCYDEENIMMEMIPHPSRARERISEUSVI Dehydration; Fluid Shifts; Radioisotope Dilution Technique Fluids and Secretions (Non MeSH) Aqueous Humor; Blood (+ 2); Body Fluid Compartments; Body Water; Cerebrospinal Fluid; Extracellular Space (+ 1); Follicular Fluid; Intracellular Fluid; Labyrinthine Fluids (+ 2); Lymph (+ 1); Synovial Fluid; Urine Liquid components of living organisms. CHCYDEENGEIMMEMIPHPSRARERISEUSVI $W "E(/$Body Fluid Compartments A12.207.180; G06.184.179.180 DEGEIMPHRE Fluids and Secretions (Non MeSH); Body Fluids Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Body Composition The two phases between which water and other body fluids are distributed: extracellular and intracellular. Body Fluids (66-77); Body Water (74-77) Z"}2Body Constitution E01.706.189; G07.265 EHGEPH Diagnosis; Physical Examination Physiology, General (Non MeSH) Body Height; Body Surface Area; Body Weight Disease Susceptibility; Somatotypes The make-up of the body, determined by the genetic, biochemical, and physiologic endowment of the individual and modified in great measure by environmental factors. (From Dorland, 27th ed). BLCFCICLCNCODEDHDIECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRISUTHURUSVEVI  [ I_PBody Composition G06.184.179 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Body Fluid Compartments ^)hBody Burden E05.799.638.231; G03.850.460.200; H01.671.768.765.588.165 Drug Residues; Pesticide Residues Miscellaneous Techniques (Non MeSH); Radiometry; Radiation Monitoring Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Physical Sciences (Non MeSH); Physics; Radiation; Radiometry; Radiation Monitoring  Drug Residues; Pesticide Residues The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal. Radiation Monitoring (66-70) AEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOUR $_A)+"4Blushing F01.145.209.530.136; F02.830.158 CLDEPHPXRE Flushing Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication; Nonverbal Communication Psychologic Processes and Principles (Non MeSH); Psychophysiology Involuntary reddening, especially of the face, associated with feelings of embarrassment, confusion or shame. a & Bluetongue Virus B04.820.630.550.100; B04.909.777.714.550.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae; Orbivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae; Orbivirus The type species of ORBIVIRUS causing a serious disease in sheep, especially lambs. It may also infect wild ruminants and other domestic animals. c2Bluetongue C02.782.791.315; C02.081.125; C22.836.120 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Reoviridae Infections Virus Diseases; Arbovirus Infections Animal Diseases; Sheep Diseases A reovirus infection, chiefly of sheep, characterized by a swollen blue tongue, catarrhal inflammation of upper respiratory and gastrointestinal tracts, and often by inflammation of sensitive laminae of the feet and coronet. Sheep Diseases (66-67); Virus Diseases/veterinary (66-67) eI1JEBlue Toe Syndrome C14.907.355.350.404.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Embolism, Cholesterol Cardiovascular Diseases; Vascular Diseases; Embolism and Thrombosis (Non MeSH); Embolism; Embolism, Cholesterol Atherothrombotic microembolism of the lower extremities due to recurrent cholesterol embolic 'showers' with painful cyanotic discoloration of the toes and embolism to other sites that completely resolve between attacks. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation. (Segen, Dictionary of Modern Medicine, 1992). Embolism (76-94); Toes/blood supply (76-94)  gN6Blue Shield N03.219.521.576.343.616.315; N03.219.521.710.305.090.150 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Insurance, Physician Services Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms; Fee-for-Service Plans A prepaid health insurance plan for costs of physicians' services. k >WPBlue Cross N03.219.521.576.343.492.231; N03.219.521.710.305.090.100 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance; Insurance, Health; Insurance, Hospitalization Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Insurance, Health, Reimbursement; Reimbursement Mechanisms; Fee-for-Service Plans A prepaid health insurance plan for hospital costs and related services. It usually excludes physicians' services (which are covered under BLUE SHIELD). m:>SBlotting, Western E01.223.495.567.320.200; E05.196.181.400.454.720.200; E05.196.401.319.720.200; E05.196.700.200; E05.478.567.320.200 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Immunoassay; Immunoblotting Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Liquid; Chromatography, Paper; Peptide Mapping Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Paper; Peptide Mapping Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Peptide Mapping Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunoassay; Immunoblotting Identification of proteins or peptides that have been electrophoretically separated by blotting and transferred to strips of nitrocellulose paper. The blots are then detected by radiolabeled antibody probes. Electrophoresis, Polyacrylamide Gel (82-88); Enzyme-Linked Immunosorbent Assay (83-88); Immunoenzyme Techniques (81-88); Immunologic Techniques (81-88) o"=Blotting, Southern E05.196.181.400.454.655.150; E05.196.401.319.670.150; E05.196.680.150; E05.393.525.150; E05.601.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Nucleic Acid Hybridization Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Liquid; Chromatography, Paper; Nucleotide Mapping Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Paper; Nucleotide Mapping Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Nucleotide Mapping Miscellaneous Techniques (Non MeSH); Genetic Techniques; Molecular Probe Techniques Miscellaneous Techniques (Non MeSH); Molecular Probe Techniques A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane. DNA or specific (75-88); Electrophoresis, Agar Gel (79-88); Electrophoresis, Polyacrylamide Gel (80-88); Nucleic Acid Hybridization (80-88)  to" .Blotting, Northern E05.196.181.400.454.655.100; E05.196.401.319.670.100; E05.196.680.100; E05.393.525.100; E05.601.140 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Chromatography; Chromatography, Liquid; Chromatography, Paper; Nucleotide Mapping Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Electrophoresis; Electrophoresis, Paper; Nucleotide Mapping Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Nucleotide Mapping Miscellaneous Techniques (Non MeSH); Genetic Techniques; Molecular Probe Techniques Miscellaneous Techniques (Non MeSH); Molecular Probe Techniques Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane. Electrophoresis, Polyacrylamide Gel (84-88); Nucleic Acid Hybridization (79-88); RNA or specific (79-88) y,o".{Bloom Syndrome C16.131.077.137 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple An autosomal recessive disorder characterized by telangiectatic erythema of the face, photosensitivity, dwarfism, and other abnormalities. Abnormalities, Multiple (68-81); Dwarfism (66-81); Facial Dermatoses (66-81); Telangiectasis (66-81) }RLewBloodletting E01.223.894.632.175; E02.800.117 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures Therapeutics; Punctures Puncture of a vein for the drawing of blood. e&"e9Blood-Testis Barrier A11.195.443.100; G06.535.166.330.100; G08.100; G09.330.377.100 DEGEIMPHRE Cells; Cell Membrane; Intercellular Junctions Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport; Capillary Permeability Reproduction, Urogenital Physiology (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Capillary Permeability Specialized nonfenestrated tightly-joined endothelial cells that form a transport barrier for certain substances between the testis capillaries and seminiferous epithelium. Testis (66-74) ~HpBlood-Retinal Barrier A11.195.443.060; G06.535.166.330.060; G09.330.377.060; G11.697.199 DEGEIMPHRE Cells; Cell Membrane; Intercellular Junctions Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport; Capillary Permeability Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Capillary Permeability Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) Specialized nonfenestrated tightly-joined endothelial cells that form a transport barrier for certain substances between the retinal capillaries and the retinal tissue. Retina (66-86); Retinal Vessels (66-86) [L1Blood-Brain Barrier A11.195.443.050; G06.535.166.330.050; G09.330.377.050; G11.561.107 DEGEIMPHRE Astrocytes; Cerebrospinal Fluid Cells; Cell Membrane; Intercellular Junctions Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport; Capillary Permeability Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Capillary Permeability Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Specialized non-fenestrated tightly-joined endothelial cells (tight junctions) that form a transport barrier for certain substances between the cerebral capillaries and the brain tissue. L&Blood-Borne Pathogens B03.165; B03.700.150; B04.909.142; B05.104.352; B05.354.248 CLIPRE Universal Precautions Medical Waste; Disease Transmission, Patient-to-Professional; Disease Transmission, Professional-to-Patient Bacteria Bacteria; Rickettsias and Chlamydias (Non MeSH) Viruses; Vertebrate Viruses (Non MeSH) Algae and Fungi (Non MeSH); Algae Algae and Fungi (Non MeSH); Fungi Infectious organisms in the blood, of which the predominant medical interest is their contamination of blood-soiled linens, towels, gowns, bandages, other items from individuals in risk categories, needles and other sharp objects, and medical and dental waste, all of which health workers are exposed to. This concept is differentiated from the clinical conditions of BACTEREMIA, VIREMIA, and FUNGEMIA where the organism is present in the blood of a patient as the result of a natural infectious process. specific organism (87-93) $G xJBlood-Air Barrier A04.411.715.025; A11.195.443.025; G06.535.166.330.025; G09.330.377.025; G09.772.521.900.602.025 DEGEIMPHRE Respiratory System; Lung; Pulmonary Alveoli Cells; Cell Membrane; Intercellular Junctions Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport; Capillary Permeability Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Capillary Permeability Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Transport; Pulmonary Gas Exchange The barrier between capillary blood and alveolar air comprising the alveolar epithelium and capillary endothelium with their adherent basement membranes and epithelial cell cytoplasm. Gaseous exchange occurs across this membrane. Capillaries (69-89); Pulmonary Alveoli (69-89) k8Blood Volume Determination E01.145.289 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Method for determining the circulating blood volume by introducing a known quantity of foreign substance into the blood and determining its concentration some minutes later when thorough mixing has occurred. From these two values the blood volume can be calculated by dividing the quantity of injected material by its concentration in the blood at the time of uniform mixing. Generally expressed as cubic centimeters or liters per kilogram of body weight.  &8Blood Volume G09.188.313; G09.330.612.214 DEGEIMPHREVE Fluid Shifts Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Erythrocyte Volume; Plasma Volume Erythrocyte Volume; Plasma Volume Volume of circulating blood. It is the sum of the plasma volume and erythrocyte volume.  "PlBlood Viscosity G09.188.272; G09.330.612.164 DEGEIMPHRE Hemorheology Viscosity Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics The internal resistance of the blood to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as sickle cell anemia and polycythemia.  " Blood Vessels A07.231 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISETRULUSVI Angiogenesis Factor; Angiography; Vascular Resistance; Vascular Surgery; Vasomotor System Cardiovascular System Arteries (+ 42); Endothelium, Vascular (+ 1); Microcirculation (+ 4); Muscle, Smooth, Vascular (+ 1); Retinal Vessels (+ 2); Tunica Intima; Vasa Nervorum; Vasa Vasorum; Veins (+ 26) Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). consider also terms at ANGI-, VASA-, VASC-, and VASO-. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $  4i:Blood Vessel Prosthesis E04.659.164; E04.752.814.221; E07.450.130; E07.858.565.164 AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI Surgery, Operative; Prosthesis Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis Prosthesis, constructed of either synthetic or biological material, which is used for the repair of injured or diseased blood vessels. D*Blood Urea Nitrogen E01.223.174.229.277; E01.341.453.189 Urea Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Diagnosis; Diagnosis, Urologic (Non MeSH); Kidney Function Tests The urea concentration of the blood stated in terms of nitrogen content. Serum (plasma) urea nitrogen is approximately 12% higher than blood urea nitrogen concentration because of the greater protein content of red blood cells. Increases in blood or serum urea nitrogen are referred to as azotemia and may have prerenal, renal, or postrenal causes. (From Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984). *Blood Transfusion, Intrauterine E02.095.135.264 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion .%$KBlood Transfusion, Autologous E02.095.135.164 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed). Blood Transfusion (66-70) #$KzBlood Transfusion E02.095.135 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Blood Group Incompatibility; Blood Grouping and Crossmatching Therapeutics; Biological Therapy (Non MeSH) Blood Component Transfusion (+ 4); Blood Transfusion, Autologous; Blood Transfusion, Intrauterine; Exchange Transfusion, Whole Blood; Plasma Exchange The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed).  Y$H4|Blood Substitutes D19.461.140 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Plasma Substitutes Plasma Substitutes; Fluorocarbons Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Plasma Substitutes (+ 6) Substances that can carry oxygen to and carbon dioxide away from the tissues when introduced into the blood stream; used to replace hemoglobin in severe hemorrhage; also to perfuse isolated organs; the best known are perfluorocarbon emulsions and various hemoglobin solutions. Synonyms: artificial erythrocytes; artificial hemoglobin. Erythrocytes (68-80); Hemoglobins (68-80); Plasma Substitutes (68-80) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR ,s,([SBBlood Stains I01.198.560.206 Social Sciences; Criminology; Forensic Medicine Antigenic characteristics and DNA fingerprint patterns identified from blood stains. Their primary value is in criminal cases. 9Blood Specimen Collection E01.223.894.632.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures Cordocentesis; Petrosal Sinus Sampling The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. "J.Blood Sedimentation E01.223.459.199 DERE Diagnosis; Diagnosis, Laboratory; Hematologic Tests Measurement of rate of settling of erythrocytes in anticoagulated blood. =VBlood Proteins D12.776.124 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Protein Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins Acute Phase Proteins (+ 15); Amyloid Protein SAA; Ankyrins; Band 3 Protein; Blood Coagulation Factors (+ 31); Fibrin (+ 4); Glycophorin; Hemocyanin; Hemoglobins (+ 17); Immunoproteins (Non MeSH) (+ 72); Platelet-Derived Growth Factor; Protein C; Protein S; Serum Albumin (+ 4); Serum Globulins (+ 59); Somatomedins (+ 3); Spectrin; Thyroxine-Binding Proteins; Tumor Necrosis Factor AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $D DHBlood Protein Electrophoresis E01.223.174.229.206 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunoelectrophoresis Immunoelectrophoresis; Electrophoresis Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Electrophoresis applied to blood proteins.  #",\3Blood Protein Disorders C15.378.147 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Abetalipoproteinemia; Agammaglobulinemia; Dysgammaglobulinemia (+ 2); Hypergammaglobulinemia (+ 1); Hypoproteinemia; Paraproteinemias (+ 9); Protein S Deficiency  NJBlood Pressure Monitors E07.123 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Devices for continuously measuring and displaying the arterial blood pressure. Blood Pressure Determination/instrumentation (70-89); Monitoring, Physiologic/instrumentation (70-89)  \sBlood Pressure Monitoring, Ambulatory E01.145.244.050; E01.621.555.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Blood Pressure Determination Diagnosis; Monitoring, Physiologic; Monitoring, Ambulatory Method in which prolonged blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of hypertension, and can assess the effectiveness of antihypertensive therapy. Blood Pressure Determination (81-94); Blood Pressure Monitors (90-94) !,&"\RBlood Pressure Determination E01.145.244; E01.706.157 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Diagnosis; Physical Examination Blood Pressure Monitoring, Ambulatory Techniques for measuring blood pressure. ""\-1Blood Pressure G09.330.612.114 DEGEIMPHRE Hypertension; Hypotension Pressure Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics Pulmonary Wedge Pressure; Venous Pressure (+ 2)  J {:Blood Preservation E05.760.833.230 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Preservation, Biological; Tissue Preservation "`Blood Platelets A11.118.188; A15.145.229.188 CHCLCYDEENIMMEMIPAPHPSRARERISEULUSVI Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Transfusion; Plateletpheresis; Thrombocytopenia; Thrombocytosis Cells; Blood Cells Hemic and Immune Systems (Non MeSH); Blood; Blood Cells Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. T"(]Blood Platelet Disorders C15.378.463.205 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis Bernard-Soulier Syndrome; Hemolytic-Uremic Syndrome; Platelet Storage Pool Deficiency; Thrombasthenia; Thrombocythemia, Hemorrhagic; Thrombocytopenia (+ 4) NdBlood Physiology (Non MeSH) G09.188 Circulatory, Respiratory Physiology (Non MeSH) Acid-Base Equilibrium (+ 1); Blood Bactericidal Activity; Blood Groups (+ 10); Blood Viscosity; Blood Volume (+ 2); Erythrocyte Aggregation; Erythrocyte Aging; Erythrocyte Deformability; Erythrocyte Indices; Hematopoiesis (+ 2); Hemostasis (+ 5); Osmotic Fragility; Phagocytosis ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULURVE " 6L8Blood Patch, Epidural E02.095.125; E05.300.530.580.300.145 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Biological Therapy (Non MeSH) Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Injections; Injections, Spinal; Injections, Epidural The injection of autologous blood into the epidural space either as a prophylactic treatment immediately following an epidural puncture or for treatment of headache as a result of an epidural puncture. Blood (74-92); Injections, Epidural (89-92) *"5Blood Loss, Surgical C23.542.100; C23.612.100 MONUPCPPSNVE Hemostasis, Surgical Symptoms and General Pathology (Non MeSH); Hemorrhage Symptoms and General Pathology (Non MeSH); Intraoperative Complications Loss of blood during surgery. Hemorrhage (66-90)  &Blood Groups D24.611.216.705.230; G04.610.241; G09.188.229 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Consanguinity; Coombs' Test; Isoantibodies; Isoantigens; Paternity Isoantibodies; Isoantigens Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) ABO Blood-Group System; Duffy Blood-Group System; I Blood-Group System; Kell Blood-Group System; Kidd Blood-Group System; Lewis Blood-Group System (+ 1); Lutheran Blood-Group System; MNSs Blood-Group System; P Blood-Group System; Rh-Hr Blood-Group System ABO Blood-Group System; Duffy Blood-Group System; I Blood-Group System; Kell Blood-Group System; Kidd Blood-Group System; Lewis Blood-Group System; Lutheran Blood-Group System; MNSs Blood-Group System; P Blood-Group System; Rh-Hr Blood-Group System ABO Blood-Group System; Duffy Blood-Group System; I Blood-Group System; Kell Blood-Group System; Kidd Blood-Group System; Lewis Blood-Group System; Lutheran Blood-Group System; MNSs Blood-Group System; P Blood-Group System; Rh-Hr Blood-Group System ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR $\52O k6Blood Grouping and Crossmatching E01.223.459.180; E01.223.495.468.180 AECLCTECHIISMOMTNUPXSNSTTDUTVE Immunologic Techniques; Blood Transfusion Diagnosis; Diagnosis, Laboratory; Hematologic Tests Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Histocompatibility Testing Testing erythrocytes to determine presence or absence of blood-group antigens, testing of serum to determine the presence or absence of antibodies to these antigens, and selecting biocompatible blood by crossmatching samples from the donor against samples from the recipient. Crossmatching is performed prior to transfusion. Blood Group Incompatibility (66-79); Blood Groups (66-79); specific blood-group system (66-79); Blood Transfusion (66-79); Paternity (66-79)  /'*"1vBlood Group Incompatibility C15.378.120; C20.188 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Blood Transfusion Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Immunologic Diseases Erythroblastosis, Fetal (+ 2); Rh Isoimmunization Erythroblastosis, Fetal (+ 2); Rh Isoimmunization A mismatch between donor and recipient blood. Antibodies present in the recipient's serum are directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary and Encyclopedia of Laboratory Medicine and Technology, 1984).  β!NavBlood Glucose Self-Monitoring E01.197.100; E01.223.174.229.140; E01.621.100; E02.900.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Endocrine (Non MeSH) Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Diagnosis; Monitoring, Physiologic Therapeutics; Self Care Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes. Blood Glucose (78-88); Monitoring, Physiologic (78-88); Self Care (81-88) #D"YBlood Glucose D09.203.147 ANBICHDEGEIMIPMEPHRE Glucose Clamp Technique; Glucose Tolerance Test; Hemoglobin A, Glycosylated; Hyperglycemia; Hypoglycemia Glucose Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates ԫz KBlood Gas Monitoring, Transcutaneous E01.145.569.685.175; E01.223.174.229.134.582.175; E01.302.796.139.582.175 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests; Oximetry Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis; Blood Gas Analysis; Oximetry Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests; Blood Gas Analysis; Oximetry The noninvasive measurement or determination of the partial pressure (tension) of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced hemoglobin. Carbon Dioxide/blood (66-86); Monitoring, Physiological (66-86); Oxygen/blood (66-86); Partial Pressure (66-86) +Q"]Blood Gas Analysis E01.223.174.229.134; E01.302.796.139 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical; Blood Chemical Analysis Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Oximetry (+ 1) Oximetry (+ 1) Measurement of oxygen and carbon dioxide in the blood. .*"&CBlood Flow Velocity E01.145.198; G09.330.612.095 DEGEIMPHREVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Hemodynamics A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. "tBlood Donors M01.898.313 CLEDHILJPXSDSN Named Groups (Non MeSH); Tissue Donors m1Blood Component Transfusion E02.095.135.140 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Cell Transplantation Therapeutics; Biological Therapy (Non MeSH); Blood Transfusion Erythrocyte Transfusion; Leukocyte Transfusion (+ 1); Platelet Transfusion The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in PLASMAPHERESIS and types of CYTAPHERESIS (PLATELETPHERESIS and LEUKAPHERESIS) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor. Blood Transfusion (74-91) $!$KXBlood Component Removal E02.110 AECLCTECHIISMOMTNUPXSNSTTDUTVE Cell Separation Therapeutics Bone Marrow Purging (+ 1); Cytapheresis (+ 2); Plasmapheresis Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.   "MBlood Coagulation Tests E01.223.459.153 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Hematologic Tests Partial Thromboplastin Time; Prothrombin Time; Thrombelastography; Thrombin Time; Whole Blood Coagulation Time Laboratory tests for evaluating the individual's clotting mechanism. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE  "=P&Blood Coagulation Factors D12.776.124.125; D19.461.270.229 ADAEAGAIANBICFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants Factor V (+ 1); Factor VII (+ 1); Factor VIII (+ 1); Factor IX (+ 1); Factor X (+ 1); Factor XI (+ 1); Factor XII (+ 1); Factor XIII (+ 1); Fibrinogen (+ 1); Kallikrein (+ 1); Lupus Coagulation Inhibitor; Platelet Activating Factor; Platelet Factor 3; Platelet Factor 4; Platelet Membrane Glycoproteins (+ 2); Prothrombin; Thrombin; Thromboplastin; von Willebrand Factor Calcium; Factor V (+ 1); Factor VII (+ 1); Factor VIII (+ 1); Factor IX (+ 1); Factor X (+ 1); Factor XI (+ 1); Factor XII (+ 1); Factor XIII (+ 1); Fibrinogen (+ 1); Kallikrein (+ 1); Lupus Coagulation Inhibitor; Platelet Activating Factor; Platelet Factor 3; Platelet Factor 4; Prothrombin; Thromboplastin; von Willebrand Factor AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR P&BmHBlood Coagulation Disorders C15.378.463.134 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis Afibrinogenemia; Christmas Disease; Disseminated Intravascular Coagulation; Factor VII Deficiency; Factor XI Deficiency; Factor XII Deficiency; Factor XIII Deficiency; Hemophilia; Hypoprothrombinemias (+ 2); Shwartzman Phenomenon r!Nd Blood Coagulation G09.188.560.150 DEGEIMPHRE Anticoagulants; Coagulants; Hemostatics Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Hemostasis Fibrinolysis /hBlood Circulation Time E01.145.153 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points. &8XBlood Circulation G09.330.163 DEGEIMPHRE Hyperemia; Ischemia; Plethysmography Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Cerebrovascular Circulation; Collateral Circulation; Coronary Circulation; Microcirculation; Renal Circulation (+ 3); Respiratory Circulation (+ 1); Splanchnic Circulation (+ 1); Uteroplacental Circulation ABAHCHCYDEEMENGDGEIMINIRMEMIPAPHPPPSRARERISESUULUSVI  ,j8Blood Chemical Analysis E01.223.174.229 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Chemistry, Clinical Blood Gas Analysis (+ 2); Blood Glucose Self-Monitoring; Blood Protein Electrophoresis; Blood Urea Nitrogen; Glucose Clamp Technique; Glucose Tolerance Test; Lactose Tolerance Test; Petrosal Sinus Sampling; Protein-Bound Iodine Test "?Blood Cells A11.118; A15.145.229 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells Hemic and Immune Systems (Non MeSH); Blood Blood Platelets; Erythrocytes (+ 10); Hemocytes; Leukocytes (+ 28) Blood Platelets; Erythrocytes (+ 10); Hemocytes; Leukocytes (+ 28) CHCLCYDEENGEIMMEMIPAPHPSRARERISETRULUSVI n*=,Blood Cell Count E01.223.459.107; G07.380.107 DEECISMTREVE Cell Count Diagnosis; Diagnosis, Laboratory; Hematologic Tests Physiology, General (Non MeSH); Cell Count Erythrocyte Count (+ 1); Leukocyte Count (+ 3); Platelet Count Erythrocyte Count (+ 1); Leukocyte Count (+ 3); Platelet Count A count of the number of leukocytes and erythrocytes per unit volume in a sample of venous blood. A complete blood count (CBC) also includes measurement of the hemoglobin, hematocrit, and erythrocyte indices.  "pBlood Banks N02.278.065.200 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Biological Specimen Banks Centers for collecting, characterizing and storing human blood. xkKBlood Bactericidal Activity G04.610.575.204; G09.188.145 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Natural Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Native bactericidal property of blood due to normally occurring antibacterial substances such as beta lysin, leukin, etc. !"Blood A12.207.152; A15.145 DEIMMEMIPHPSRARERIUSVI Hematopoiesis; Occult Blood Fluids and Secretions (Non MeSH); Body Fluids Hemic and Immune Systems (Non MeSH) Fetal Blood; Plasma Blood Cells (+ 42); Fetal Blood; Plasma consider also terms at HEM-. CHCLCYDEENGEIMMEMIPAPHPSRARERISETRULUSVI $P "cL%,Blister C17.800.865.187 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Visible accumulations of fluid within or beneath the epidermis.  NoLBlinking G11.561.730.127; G11.697.182 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) Brief closing of the eyelids by involuntary normal periodic closing, as a protective measure, or by voluntary action. Eyelids (66-80); Reflex (66-80) ( "(Blindness C10.597.751.941.162; C11.966.075; C23.888.592.763.941.162 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sensory Aids; Vision, Subnormal Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Eye Diseases; Vision Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders  Hemianopsia The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of disorders in the organs of sight or of damage or injury to certain areas of the brain.   AN'.Blind Loop Syndrome C06.405.469.637.145; C18.452.603.145 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Malabsorption Syndromes Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Malabsorption Syndromes Malabsorption, especially of vitamin B12 or folic acid, due to metabolic competition by bacteria proliferating in a segment of small intestine excluded from normal peristaltic movement; it may occur as a postoperative complication of side-to-side anastomosis of intestine, as a result of intestinal diverticula, fistula, etc. Malabsorption Syndromes (66-68) -*Nx%Blepharospasm C11.338.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eyelid Diseases Excessive winking; tonic or clonic spasm of the orbicularis oculi muscle. [N%YBlepharoptosis C11.338.204 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eyelid Diseases Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle. jN%xBlepharophimosis C11.250.090; C11.338.190; C16.131.384.190 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Eye Diseases; Eyelid Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities The abnormal narrowness of the palpebral fissure in the horizontal direction caused by the lateral displacement of the medial canthi of the eyelids. (Dorland, 27th ed). Blepharoptosis (72-91); Eye (75-91); Eye Diseases (76-91); Eyelids/abnormalities (66-91); Eyelid Diseases (76-91) 1LBlepharitis C11.338.133 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eyelid Diseases Inflammation of the eyelids.  IN%$Bleomycins D20.085.075.236; D20.085.116.095.236; D22.204.106.244 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Anti-Infective Agents; Antibiotics; Antibiotics, Peptide; Antibiotics, Glycopeptide Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Peplomycin; Phleomycins Peplomycin; Phleomycins Peplomycin; Phleomycins A group of related glycopeptide antibiotics from Streptomyces verticillus. They inhibit DNA metabolism and are used as antineoplastics, especially for solid tumors. Antibiotics, Antineoplastic (67-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ !=:S)<Bleeding Time E01.223.459.770.150 VE Diagnosis; Diagnosis, Laboratory; Hematologic Tests; Platelet Function Tests Duration of blood flow after skin puncture. Used as a measure of capillary and platelet function. Synonyms: aspirin tolerance test; Duke method; Ivy method; template bleeding time. Blood Coagulation (66-79); Blood Coagulation Tests (66-79); Blood Platelet Disorders (66-79); Blood Platelets (66-79); Thrombocytosis (66-79); Thrombocytopenia (66-79)  aZBlastomycosis C01.539.800.200.055; C01.703.128; C01.703.295.055; C17.800.838.208.055 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Dermatomycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses Bacterial and Fungal Diseases (Non MeSH); Mycoses; Dermatomycoses Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Dermatomycoses A fungal infection that may appear in two forms: 1) a primary lesion characterized by the formation of a small cutaneous nodule and small nodules along the lymphatics that may heal within several months; and 2) chronic granulomatous lesions characterized by thick crusts, warty growths, and unusual vascularity and infection in the middle or upper lobes of the lung. PPrBlastomyces B05.354.381.125 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes A deuteromycetous fungal genus, a species of which, Blastomyces dermatitidis, causes blastomycosis. ">sBlastomeres A11.104; A16.254.090 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells Embryonic Structures (Non MeSH); Embryo The undifferentiated cells formed by cleavage of the fertilized ovum. This includes cells in the cleavage, morula, and blastula stages of the embryo. Blastocyst (74-79); Cell Division (66-79); Zygote (75-79) *8GBlastoderm A16.254.085.067 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Embryonic Structures (Non MeSH); Embryo; Blastocyst A single layer of cells produced by cleavage of the fertilized ovum and forming the outer cells of the blastula. Blastocyst (75-79); Germ Layers (66-74) e*?1Blastocystis Infections C03.432.250; C03.752.700.700.055.250; C06.405.469.452.250 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Intestinal Diseases, Parasitic Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Sarcodina Infections; Amebiasis Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic Infections with protozoa of the genus BLASTOCYSTIS. The species B. hominis is responsible for most infections. Surveys have generally found small numbers of this species in human stools submitted for parasitologic studies, with higher positivity rates and organism numbers being reported in AIDS patients and patients with other immunosuppressive diseases. Symptoms include abdominal pain, diarrhea, constipation, vomiting, and fatigue. Intestinal Diseases, Parasitic (83-91); Protozoan Infections (83-91) AP'PBlastocystis hominis B01.841.750.656.475.100.200.200.375 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Blastocystina; Blastocystis A species of parasitic protozoa found in the intestines of humans and other primates. It was classified as a yeast in 1912. Over the years, questions arose about this designation. In 1967, many physiological and morphological B. hominis characteristics were reported that fit a protozoan classification. Since that time, other papers have corroborated this work and the organism is now recognized as a protozoan parasite of humans causing intestinal disease with potentially disabling symptoms. Phycomycetes (71-79); Protozoa (86-91); Zygomycotina (80-85) '&w@IBlastocystis B01.841.750.656.475.100.200.200 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Blastocystina Blastocystis hominis A genus of protozoa of the suborder BLASTOCYSTINA. It was first classified as a yeast but further studies have shown it to be a protozoan. Phycomycetes (71-79); Protozoa (86-91); Zygomycotina (80-85)  #&gIBlastocystina B01.841.750.656.475.100.200 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida Blastocystis (+ 1) A suborder of protozoa of the class LOBOSEA. !&V8Blastocyst A16.254.085 CHCLCYDEENIMMEMIPAPHPSRARERISEULUSVI Preimplantation Phase Embryonic Structures (Non MeSH); Embryo Blastoderm; Trophoblast The mammalian embryo in the post-morula stage in which a fluid-filled cavity, enclosed primarily by trophoblast, contains an inner cell mass which becomes the embryonic disc. CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI $"(1*Blastocladiella B05.354.730.576.162 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Phycomycetes; Mastigomycotina A genus of aquatic fungi of the order Blastocladiales, subdivision Mastigomycotina, used in the study of zoospore formation. $"OBlast Injuries C21.866.120.126 BLCFCLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Explosions Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Barotrauma Injuries resulting when a person is struck by particles impelled with violent force from an explosion. Blast causes pulmonary concussion and hemorrhage, laceration of other thoracic and abdominal viscera, ruptured ear drums, and minor effects in the central nevous system. (From Dorland, 27th ed). %J_\Blast Crisis C04.557.337.539.250.200; C04.697.152.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Chronic Neoplasms; Neoplastic Processes (Non MeSH); Cell Transformation, Neoplastic Rapid increase in the proportion of blast cells in the blood and bone marrow. (7.N_Blade Implantation E04.833.800.310.310.150; E06.231.310.340; E06.780.314.310.340; E06.892.800.310.310.150 AECLCTECHIISMAMIMOMTNUPSPXSNSTTDUTVEVI Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation; Dental Implantation, Endosseous Dentistry; Dental Implantation; Dental Implantation, Endosseous Dentistry; Prosthodontics; Dental Implantation; Dental Implantation, Endosseous Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic; Dental Implantation; Dental Implantation, Endosseous Insertion of an endosseous implant with a narrow wedge-shaped infrastructure extending through the oral mucosa into the mouth and bearing openings or vents through which tissue grows to obtain retention. Dental Implantation (66-76); Dental Implantation, Endosseous (77-78) *`*PBladder, Neurogenic C10.597.192; C12.777.103.374; C23.888.592.162 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Any condition of dysfunction of the urinary bladder caused by a lesion of the central or peripheral nervous system. (Dorland, 27th ed). -5NBladder Neoplasms C04.588.945.947.125; C12.740.800.820.125; C12.777.103.312; C13.371.820.800.820.125 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Neoplasms; Urologic Neoplasms Cancers or tumors of the bladder. The majority of bladder neoplasms are of the transitional cell variety and are usually papillary and multicentric. 0:\XBladder Neck Obstruction C12.777.103.249; C12.777.767.700.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urethral Diseases; Urethral Obstruction 3*NBladder Fistula C12.777.103.187; C12.777.850.312; C23.439.731.312 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Fistula Symptoms and General Pathology (Non MeSH); Fistula; Urinary Fistula Vesicovaginal Fistula Vesicovaginal Fistula Vesicovaginal Fistula An abnormal passage in the bladder or between the bladder and another organ. 5Y9NJ]Bladder Exstrophy C12.740.700.132; C12.777.103.132; C13.371.820.700.132; C16.131.939.132 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Urogenital Diseases; Urogenital Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Urogenital Abnormalities (Non MeSH) Congenital eversion of the urinary bladder. It is characterized by the absence of a portion of the lower abdominal wall and the anterior vesical wall, with eversion of the posterior vesical wall through the deficit. 7PLBladder Diseases C12.777.103 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases Bladder Calculi; Bladder Exstrophy; Bladder Fistula (+ 1); Bladder Neck Obstruction; Bladder Neoplasms; Bladder, Neurogenic; Cystitis; Vesico-Ureteral Reflux BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI ;NNXBladder Calculi C12.777.103.124; C12.777.809.186; C23.146.935.202 BLCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHULURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Bladder Diseases Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Calculi Symptoms and General Pathology (Non MeSH); Calculi; Urinary Calculi Calculi of the urinary bladder; also known as vesical calculi, bladder stones or gravel, and cystoliths. Vesicoprostatic calculi are prostatic calculi extending into the bladder. =9RBladder A05.810.161 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Administration, Intravesical; Cystectomy; Cystoscopy; Cystostomy; Urinary Catheterization Urogenital System; Urinary Tract consider also terms at CYST- and VESIC-. @< :g(3Blackwater Fever C03.752.750.259.552.650.228 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Protozoan Infections; Sporozoea Infections; Coccidiosis; Malaria; Malaria, Falciparum A complication of MALARIA, FALCIPARUM characterized by the passage of dark red to black urine. AyP{qBlacks I01.076.201.450.416.100; I01.880.143.522.100; M01.194.100 CLEDHILJPXSN Negroid Race Negroid Race Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups An ethnic group belonging to the Negroid race.  C  A:Black Widow Spider B01.131.166.803.200 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida; Spiders A venomous New World spider with an hourglass-shaped red mark on the abdomen. D(7^Biuret Reaction E05.196.085 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical A reaction characterized by a violet color upon the addition of copper sulfate to all compounds with two amide or peptide bonds linked directly or through an intermediate carbon atom. Used in the detection and estimation of proteins and peptides having more than two amino acids. E"EJBiuret D02.948.130; D26.550.081 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Urea Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Imidodicarbonic diamide. Used as feed supplement for sheep and cattle since it is a good non-protein nitrogen source; in strongly alkaline solution biuret gives a violet color with copper sulfate. Synonyms: allophanic acid amide; ureidoformamide. Amides (74); Urea (68-74) G ,z!"Biureas D02.948.117 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Urea Hydrazines (66-67) I 8,Bithionol D02.755.120; D21.201.412.180 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents 2,2'-Thiobis(4,6-dichlorophenol). Halogenated disinfectant; used against trematode and cestode infestations. Synonyms: Actamer; Bitin; Lorothidol. Chlorobenzenes (74); Phenols (71-74); Sulfides (71-74) J ":CBites, Human C21.866.153.311 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Bites and Stings Bites inflicted by humans. Bites and Stings (66-71) LNg"Bites and Stings C21.613.127; C21.866.153 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Allergens Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Arachnidism; Insect Bites and Stings; Snake Bites; Tick Toxicoses (+ 1) Bites, Human MN gBite Force E06.276.125 Dentistry; Dental Occlusion The force applied by the masticatory muscles in dental occlusion. Dental Occlusion (66-83); Dental Stress Analysis (68-83); Mastication (66-83); Masticatory Muscles (66-83) O"OBisphosphoglycerate Mutase D08.586.399.665.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Phosphotransferases (Phosphomutases) An enzyme that catalyzes the transfer of phosphate from C-3 of 1,3-diphosphoglycerate to C-2 of 3-phosphoglycerate, forming 2,3-diphosphoglycerate. EC 5.4.2.4. Diphosphoglyceric Acids (73-74); Phosphotransferases (73-74) PF|FBisphenol A-Glycidyl Methacrylate D02.241.081.069.600.150; D02.755.100; D25.339.149.200; D25.720.716.822.308.200 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates; Methacrylates Organic Chemicals (Non MeSH); Phenols Biomedical and Dental Materials (Non MeSH); Dental Materials; Composite Resins Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic; Composite Resins The reaction product of bisphenol A and glycidyl methacrylate that undergoes polymerization when exposed to ultraviolet light or mixed with a catalyst. It is used as a bond implant material and as the resin component of dental sealants and composite restorative materials. Acrylic Resins (81-92); Composite Resins (80-92); Epoxy Resins (79-91); Methacrylates (75-82); Methacrylates (87-92); Polymethacrylic Acids (80-92); Resins, Synthetic (79-80) R'X,v?Bisoprolol D02.033.329.624.111; D02.092.063.624.111; D14.100.050.200.200.130; D16.050.850.090; D18.162.084 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents 1-(4-((2-(1-Methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-2-propanol. A cardioselective beta-1-adrenergic blocker. It is effective in the management of hypertension and angina pectoris. Propanolamines (84-92) WBk:Bison B02.649.077.380.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants A genus of the family Bovidae having two species: B. bison and B. bonasus. This concept is differentiated from BUFFALOES, which refers to Bubalus arnee and Syncerus caffer. Animal (67-90); Artiodactyla (73-90) [ (7-Bismuth D01.268.103; D01.552.105 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals A silver-white metal whose salts have been used in inflammatory diseases of the gastrointestinal tract and in the treatment of syphilis. Since the introduction of antibiotics, use of bismuth therapeutically has declined. (From Dorland, 27th ed). \ :` Bishydroxycoumarin D03.438.150.446.520.203; D08.373.936.161; D19.461.119.196.475.118 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; 4-Hydroxycoumarins Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Coumarins; 4-Hydroxycoumarins ^I:mBisexuality F01.145.792.090 CLDEEHHIPHPXRESN Behavior and Behavior Mechanisms (Non MeSH); Behavior; Sex Behavior Sexual behavior pattern in which individuals engage in heterosexual and homosexual relations. It excludes HERMAPHRODITISM. Homosexuality (66-87); Sex Behavior (66-87) `R5Bisacodyl D02.755.239.132; D19.316.396.160 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Phenols; Cresols Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Cathartics (66-71); Cresols (66-71) bK &:,Bis(Chloromethyl) Ether D02.355.601.250; D26.191.141 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ethers; Methyl Ethers Miscellaneous Drugs and Agents (Non MeSH); Carcinogens sym-Dlchloromethyl ether. A substance that is an irritant to the eyes and respiratory tract and may be carcinogenic. Ethers (66-73); Methyl Chloride (66-74); Methyl Ethers (74) c".JBirthing Centers N02.278.080 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Free-standing facilities that provide prenatal, childbirth, and postnatal care and usually incorporate family-centered maternity care concepts and practices. eLBirth Weight G07.553.481.398.186 DEGEIMPHRE Fetal Macrosomia; Infant, Low Birth Weight Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Growth; Body Weight f4uBirth Rate E05.318.308.985.200; G03.850.505.400.975.200; G03.850.520.308.985.200; L01.280.975.200; N01.224.935.161 EHTD Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Vital Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Vital Statistics Information Science; Data Collection; Vital Statistics Population Characteristics (Non MeSH); Demography; Vital Statistics The number of births in a given population per year or other unit of time. Population (66); Vital Statistics (66) gs]0Birth Order F01.829.263.132; G03.850.505.400.400.160; I01.240.361.160; N01.224.361.160 PX Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Family Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography; Family Characteristics Social Sciences; Demography; Family Characteristics Population Characteristics (Non MeSH); Demography; Family Characteristics The sequence in which children are born into the family. k;T}FBirth Intervals I01.240.361.150; N01.224.361.150; N02.421.143.401.090 Social Sciences; Demography; Family Characteristics Population Characteristics (Non MeSH); Demography; Family Characteristics Facilities, Manpower and Services (Non MeSH); Health Services; Community Health Services; Family Planning Interval between onset of sexual relations by a woman and the birth of her first child and intervals between successive births. This includes use of family planning to control birth intervals. Family Characteristics (68-79); Family Planning (68-79) m= BBirth Injuries C16.614.131; C21.866.141 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Delivery Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Paralysis, Obstetric Paralysis, Obstetric Mechanical or anoxic trauma incurred by the infant during labor or delivery.  p1L 0\Birth Certificates E05.318.308.940.250; G03.850.520.308.940.250; L01.280.900.250; N04.452.859.132; N05.715.360.300.715.175 HILJ Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Data Collection; Records Information Science; Data Collection; Records Health Services Administration (Non MeSH); Organization and Administration; Records Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records Official certifications by a physician recording the individual's birth date, place of birth, parentage and other required identifying data which are filed with the local registrar of vital statistics. rsBirnavirus B04.820.075.100; B04.909.777.123.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Birnaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Birnaviridae Infectious Bursal Disease Virus; Infectious Pancreatic Necrosis Virus Infectious Bursal Disease Virus; Infectious Pancreatic Necrosis Virus The sole genus in the family BIRNAVIRIDAE, comprising several viral species infecting fish, mollusks, chickens, ducks, turkeys, and Drosophila. Reoviridae (87-93); RNA Viruses (84-93)  u*y1Birnaviridae Infections C02.782.123 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Virus diseases caused by the BIRNAVIRIDAE. x;P:4Birnaviridae B04.820.075; B04.909.777.123 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Birnavirus (+ 2) Birnavirus (+ 2) A family of bisegmented, double-stranded RNA viruses causing infection in fish, mollusks, fowl, and Drosophila. There is one genus, BIRNAVIRUS. Horizontal and vertical transmission occurs for all viruses. Reoviridae (90-93)  yG"Y*Birefringence H01.671.606.116 Physical Sciences (Non MeSH); Physics; Optics {J9Birds B02.248 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates Canaries; Pigeons; Poultry (+ 4); Psittacines (+ 2); Quail (+ 2) {  &TBird Fancier's Lung C08.381.483.125.125; C08.674.055.125; C20.543.480.680.075.125; C21.447.125 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Alveolitis, Extrinsic Allergic Respiratory Tract Diseases; Respiratory Hypersensitivity; Alveolitis, Extrinsic Allergic Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity; Alveolitis, Extrinsic Allergic Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases A respiratory disorder due to an acquired hypersensitivity to the dust of bird droppings. Farmer's Lung (66-76); Respiratory Hypersensitivity (66-76) |TLkFBird Diseases C22.131 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Animal Diseases Avian Leukosis; Enteritis, Transmissible, of Turkeys; Fowl Plague; Fowlpox; Malaria, Avian; Marek's Disease; Newcastle Disease; Poultry Diseases; Sarcoma, Avian; Tuberculosis, Avian Diseases of birds not considered poultry, therefore usually found in zoos, parks, and the wild. The concept is differentiated from POULTRY DISEASES which is for birds raised as a source of meat or eggs for human consumption, and usually found in barnyards, hatcheries, etc. BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHTMULURUSVI   HBTBipolar Disorder F03.709.680.080.200 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Affective Disorders, Psychotic A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. FBiphenyl Compounds D02.455.426.559.389.185 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Aminobiphenyl Compounds; Benzidines; 3,3'-Diaminobenzidine; Dianisidine; 3,3'-Dichlorobenzidine; Niclofolan; Polybrominated Biphenyls; Polychlorinated Biphenyls AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8:Biperiden D03.383.621.110; D14.100.120.200.500.090; D15.090.050.060; D16.050.650.070 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.  T:aBiotransformation G06.535.780.202; G12.091.690.140 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Pharmacokinetics Chemical, Pharmacologic Phenomena (Non MeSH); Biopharmaceutics; Pharmacokinetics Metabolic Clearance Rate Metabolic Clearance Rate; Metabolic Detoxication, Drug The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alteration may be either non-synthetic (OXIDATION-REDUCTION, HYDROLYSIS) or synthetic (glucuronide formation, sulfate conjugation, ACETYLATION, METHYLATION). This also includes metabolic detoxication and clearance. &\Biotin D08.176.096; D11.786.708.118 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex Hexahydro-2-oxo-1H-thieno(3,4-d)imidazole-4-pentanoic acid. Growth factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk.The biotin content of cancerous tissue is higher than that of normal tissue.  "DgBiotechnology G01.550; J01.897.120 CLECEDHIISLJMAMTOGSNSTTD Genetic Engineering; Recombinant Proteins Biological Sciences Technology, Industry, Agriculture (Non MeSH); Technology  Industrial Microbiology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., genetic engineering) is a central focus; laboratory methods used include transfection and cloning technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.  1Y/Biosensors E05.601.123 CLHISDSTUT Miscellaneous Techniques (Non MeSH); Molecular Probe Techniques Any of a variety of types of biomolecular probes which measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal. Biotechnology (86-88); Electrodes (80-88); Monitoring, Physiologic/instrumentation (80-88) K-iBiopterin D03.438.733.100; D08.176.090; D11.303.180 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances 2-Amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone. A natural product that has been considered as a growth factor for some insects. Propanediols (72-74); Pteridines (70-74) ) 1D1Biopsy, Needle E01.223.088.130; E01.223.230.143.130; E01.223.894.143.130; E01.223.894.632.130 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Biopsy Diagnosis; Diagnosis, Laboratory; Cytodiagnosis; Biopsy Diagnosis; Diagnosis, Laboratory; Specimen Handling; Biopsy Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures Removal and examination of tissue obtained through a transdermal needle inserted into the specific region, organ, or tissue being analyzed. Biopsy (66-72) X"Biopsy E01.223.088; E01.223.230.143; E01.223.894.143; E04.074 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory Diagnosis; Diagnosis, Laboratory; Cytodiagnosis Diagnosis; Diagnosis, Laboratory; Specimen Handling Surgery, Operative Biopsy, Needle Biopsy, Needle; Chorionic Villi Sampling Biopsy, Needle; Chorionic Villi Sampling Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.  @"rBioprosthesis E04.659.140; E07.450.100; E07.858.565.140 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Prosthesis Equipment and Supplies; Implants, Artificial Equipment and Supplies; Surgical Equipment; Prosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1) mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2) chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Heart Valve Prosthesis (66-78) !1$e%Biopolymers D12.472.310 AEAGAIANBIBLCFCHCLDFDUECGEHIIMIPMEPDPHPKPORESETOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Macromolecular Systems Polymers formed in a living organism, as a polypeptide forms from amino acids (monomers). (Dorland, 27th ed). 8SBiophysics G01.344; H01.671.100 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences Physical Sciences (Non MeSH); Physics Bionics; Electrophysiology Biomechanics (+ 4); Bionics; Diffusion; Energy Transfer (+ 1); Filtration (+ 3); Membrane Potentials AECLCTDEECEDGEHIIMISLJMAMOMTNUOGPHPXRERHSNSTTDUTVE  E6Biopharmaceutics G12.091 CLECEDHIISLJMAMTOGSNSTTD Drug Compounding Chemistry, Pharmaceutical Chemical, Pharmacologic Phenomena (Non MeSH) Pharmacokinetics (+ 5) The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Chemistry, Pharmaceutical (66-69); Drug Compounding (66-69); Drugs (66-69); Pharmacology (66-69) CLDEECEDGEHIIMISLJMAMTOGPHRESNSTTD , 4s&Bionics G01.344.310; H01.671.100.202 CLECEDHIISLJMAMTOGSNSTTD Cybernetics Cybernetics; Models, Biological Biological Sciences; Biophysics Physical Sciences (Non MeSH); Physics; Biophysics The study of systems, particularly electronic systems, which function after the manner of, in a manner characteristic of, or resembling living systems. Also, the science of applying biological techniques and principles to the design of electronic systems.   "&a)Biomphalaria B01.644.776.185 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca; Snails A genus of planorbid freshwater snails, species of which are intermediate hosts of Schistosoma mansoni. Snails (66-71) ('zBiometry G03.850.505.200; H01.548.832.160; N05.715.360.325.150 HIISMT Anthropology, Physical; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH) Anthropometry (+ 4) Anthropometry (+ 4) That branch of statistics used to analyze and manipulate data obtained from biological systems. AECLCTECHIISMOMTNUPXSNSTTDUTVE $5 = )\1q"Biomedical Engineering G02.077; J01.293.143 CLECEDHIISLJMAMTOGSNSTTD Electronics, Medical; Medical Informatics Applications Health Occupations Technology, Industry, Agriculture (Non MeSH); Engineering Application of principles and practices of engineering science to biomedical research and health care. ?YxBiomedical and Dental Materials (Non MeSH) D25 Alloys (+ 6); Biocompatible Materials (+ 2); Calcium Sulfate; Cariogenic Agents; Cariostatic Agents (+ 4); Ceramics (+ 1); Dental Materials (+ 27); Dentifrices (+ 2); Durapatite; Mouthwashes (+ 1); Plasticizers (+ 2); Polymers (+ 61); Resins (+ 3); Tissue Adhesives (+ 4) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEMIPDPHPKPOPSRESDSESNSTTDTOTUULURUTVEVI 3SRBiomechanics G11.427.050; H01.671.100.131 Physical Medicine Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH) Physical Sciences (Non MeSH); Physics; Biophysics Lifting; Stress, Mechanical; Tensile Strength; Weight-Bearing Lifting; Stress, Mechanical; Tensile Strength; Weight-Bearing Biophysics (66-67) AEDEPHRE  " Biomass G01.273.248.150; G03.230.116.150 Biological Sciences; Biology; Ecology Environment and Public Health (Non MeSH); Environment; Ecology Total mass of all the organisms of a given type and/or in a given area. (From Concise Dictionary of Biology, 1990) It includes the yield of vegetative mass produced from any given crop. Ecology (82-94) W &xBiology G01.273 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences Botany (+ 1); Developmental Biology (+ 2); Ecology (+ 1); Exobiology; Genetics; Laboratory Animal Science; Marine Biology; Microbiology (+ 9); Molecular Biology (+ 2); Neurobiology; Parasitology (+ 1); Photobiology; Radiobiology; Zoology (+ 1) One of the biological sciences concerned with the origin, structure, development, growth, function, genetics, and reproduction of animals, plants, and microorganisms. CLDEECEDHIISLJMAMTOGRESNSTTD    * Biological Warfare I01.880.735.944.226 CLECEHHILJMTPCPXSNTD Social Sciences; Sociology; Social Problems; War Warfare involving the use of living organisms as disease etiologic agents against men, animals, or plants. <~Biological Transport, Active G06.535.166.310; G06.535.630.230 DEGEIMPHRE Ion Pumps Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Biological Transport Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Membrane Potentials The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy.  "&Biological Transport G06.535.166 DEGEIMPHRE Cell Membrane Permeability; Diffusion; Maternal-Fetal Exchange; Mucociliary Clearance; Permeases Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism Biological Transport, Active (+ 1); Capillary Permeability (+ 4); Cell Membrane Permeability; Ion Transport The movement of materials (including biochemical substances and drugs) across cell membranes and epithelial layers, usually by passive DIFFUSION.  pOBiological Therapy (Non MeSH) E02.095 Therapeutics Blood Patch, Epidural; Blood Transfusion (+ 9); Cytapheresis (+ 2); Gene Therapy; Immunotherapy (+ 12); Organotherapy; Tissue Therapy AECLCTECHIISLJMOMTNUPXSNSTTDUTVE 4$ $Biological Specimen Banks N02.278.065 CLECHILJOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Blood Banks; Milk Banks; Sperm Banks; Tissue Banks (+ 2) Centers for collecting, storing, and distributing human or other animal material or tissues for future use by other individuals, as BLOOD BANKS, bone banks, EYE BANKS, MILK BANKS, skin banks, SPERM BANKS, and TISSUE BANKS. (From Dorland, 27th ed). CLECHILJMAMTOGSDSNSTTDUT  ]LH$Biological Sciences G01 CLECEDHIISLJMAMTOGSNSTTD Anatomy (+ 10); Biochemistry (+ 5); Biology (+ 31); Biophysics (+ 2); Biotechnology; Neurosciences (+ 6); Pharmacology (+ 6); Physiology (+ 8) All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms. Biology (75-90) CLDEECEDHIISLJMAMTOGRESNSTTD   Biological Response Modifiers D24.611.274 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Antineoplastic Agents; Immunosuppressive Agents Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Adjuvants, Immunologic (+ 1) Biological or synthetic agents that are capable of eliciting specific and/or non-specific effects on immune responsiveness, thereby ultimately leading to an improvement in overall health of the patient. These agents can be further subcategorized into those that facilitate a normal immune response, those that stimulate the immune response, those that are capable of inducing noncytotoxic immunosuppression, and those that increase the ability of the host to tolerate damage by the cytotoxic modalities of the treatment. Adjuvants, Immunologic (66-89); Antineoplastic Agents (66-89); Immunosuppressive Agents (66-89) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (#@7Z#YoFBiological Psychiatry F04.096.544.090; G02.403.642.100 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry An interdisciplinary science concerned with studies of the biological bases of behavior - biochemical, genetic, physiological, and neurological - and applying these to the understanding and treatment of mental illness. Psychiatry (66-83) '&Biological Products D24.310 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH) Antitoxins (+ 3); Bacteriocins (+ 4); Coagulase; Hirudin; Immune Sera (+ 2); Lectins (+ 6); Picibanil; Plant Extracts (+ 6); Siderophores (+ 3); Toxoids (+ 5); Vaccines (+ 36) Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay, that depend for their action on the processes affecting immunity. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from BIOLOGICAL FACTORS in that the latter are compounds with biological or physiological activity made by living organisms. (From Webster's 3d ed). AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  J B4)HBiological Phenomena, Cell Physiology, Immunity (Non MeSH) G04 Biological Phenomena (Non MeSH) (+ 57); Cell Physiology (Non MeSH) (+ 54); Immunity (+ 88); Plant Physiology (Non MeSH) (+ 7); Species Specificity ADAEANBIBLCFCHCICLCNCOCTDEDHDIDTDUECEDEHEMENEPETGEHIIMIPISLJMAMEMIMOMTNUOGPAPCPDPHPOPPPSPXRARERHRIRTSESNSTSUTDTHTOTRTUULURUSVEVI _DBiological Phenomena (Non MeSH) G04.185 Biological Phenomena, Cell Physiology, Immunity (Non MeSH) Adaptation, Biological; Biodegradation; Biogenesis; Eutrophication; Evolution (+ 1); Host-Parasite Relations; Microbiologic Phenomena (Non MeSH) (+ 35); Pigmentation (+ 3); Regeneration (+ 7); Symbiosis; Tissue Survival CHCLDEENGEIMMEMIMTPAPHPSRARERISETRULUSVI & D,Biological Markers D24.185.101 ANBLCFCHUR Molecular Probes Immunologic and Biologic Factors (Non MeSH); Biological Factors Antigens, Differentiation (+ 43); Genetic Markers; Tumor Markers, Biological (+ 14) Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $LdHBiological Factors D24.185 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH) Anaphylatoxins (+ 4); Atrial Natriuretic Factor; Biological Markers (+ 60); Chemotactic Factors (+ 4); Endothelins; Endothelium-Derived Relaxing Factor; Erythropoietin; Growth Substances (+ 42); Mitogens (+ 9); Pheromones (+ 1); Pulmonary Surfactants (+ 1); Pyrogens (+ 1); Thrombopoietin; Tissue Extracts (+ 7); Toxins (+ 58); Venoms (+ 30) Compounds made by living organisms. They have biological or physiological activities. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  Y B4eJBiological Dressings E07.101.150 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Bandages Human or animal tissue used as temporary wound coverings. Bandages (66-77); Skin/transplantation (66-77) k(F8Biological Clocks G07.450.125 DEGEIMPHRE Circadian Rhythm Periodicity Physiology, General (Non MeSH); Chronobiology The physiological mechanisms that govern the rhythmic occurrence of certain biochemical, physiological, and behavioral phenomena in plants and animals. The pineal gland, which receives input from the optic nerves and connects to the hypothalamus, may be the biological clock in humans.  z7KBiological Availability G12.091.690.129 Chemical, Pharmacologic Phenomena (Non MeSH); Biopharmaceutics; Pharmacokinetics The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Biopharmaceutics (70-74); Chemical Pharmaceutics (66-69); Drug Compounding (66-69); Drugs (66-69); Pharmacology (66-69) ~]Biological Assay E05.091 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Limulus Test A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. ۞ "*Biography K01.517.211 Autobiography Humanities; Literature Autobiography; Famous Persons A written account of a person's life and the branch of literature concerned with the lives of people. (Harrod's Librarians' Glossary, 7th ed). 0 $Biogenic Polyamines D02.092.211.415 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines Cadaverine; Putrescine (+ 2) Biogenic amines having more than one amine group. These are long-chain aliphatic compounds that contain multiple amino and/or imino groups. Because of the linear arrangement of positive charge on these molecules, polyamines bind electrostatically to ribosomes, DNA, and RNA. Biogenic Amines (71-88) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $o<B$@>Biogenic Monoamines D02.092.211.215 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Biogenic Amines Catecholamines (+ 7); Histamine (+ 1); 2-Hydroxyphenethylamine; Tryptamines (+ 4); Tyramine (+ 2) Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids. Biogenic Amines (71-88); Catecholamines (66-88); Dopamine (66-88); Epinephrine (66-88); Norepinephrine (66-88) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $<BxDBiogenic Amines D02.092.211 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Biogenic Amine Neurotransmitters; Receptors, Biogenic Amine Organic Chemicals (Non MeSH); Amines Acetylcholine; Biogenic Monoamines (+ 19); Biogenic Polyamines (+ 4) A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology. Amines (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (<E.SrDBiogenic Amine Neurotransmitters D14.600.100 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Biogenic Amine Biogenic Amines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters Dopamine; Epinephrine; Histamine; Norepinephrine; Octopamine; Serotonin; Tyramine Biogenic amines released by neurons as intercellular messengers. The biogenic amines norepinephrine, dopamine, histamine, and serotonin are neurotransmitters in both the central and peripheral nervous systems. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (&BWaDBiogenesis G04.185.194 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) The origin of life. It includes studies of the potential basis for life in organic compounds but excludes studies of the development of altered forms of life through mutation and natural selection, which is EVOLUTION. kBioflavonoids D09.203.408.134; D11.786.170 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins Diosmin; Hesperidin; Rutin (+ 1) Flavones (+ 1); Hesperidin; Rutin AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR l"BTDBiofilms B03.150 CLDEGDRE Bacterial Adhesion; Prosthesis-Related Infections Implants, Artificial; Prosthesis-Related Infections Bacteria Films of bacteria or other microbial organisms, usually embedded in extracellular polymers such as implanted medical devices, which adhere to surfaces submerged in, or subjected to, aquatic environments (From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed). Biofilms consist of multilayers of microbial cells glued together to form microbial communities which are highly resistant to both phagocytes and antibiotics. Bacteria (81-94) $=   9; Biofeedback (Psychology) E02.040.120; F02.830.120; F04.754.137.350; F04.754.180 CLDEISMTPHRE Feedback Therapeutics; Alternative Medicine Psychologic Processes and Principles (Non MeSH); Psychophysiology Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Behavior Therapy Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy A process that uses instrumentation to give a person immediate and continuing signals of change in his bodily function of which he is usually unaware. Feedback (66-76)  *@ Bioethics K01.316.070; N05.350.200 HI Humanities; Ethics Quality, Access, Evaluation (Non MeSH); Ethics Animal Testing Alternatives; Animal Welfare (+ 1) A branch of applied ethics which studies the value implications of practices and developments in the life sciences. Ethics, Medical (66-77) CLECEDHIISLJMAMTOGSNSTTD $ O=Bioelectric Energy Sources E07.690.150 AECLCTECHISDSNSTTDUTVE Power Sources; Electricity Equipment and Supplies; Power Sources Implantable devices which convert biological energy (chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements) to electrical energy. The sources include biogalvanic cells, biofuel cells, and ionic concentration cells. _ !.?Biodegradation G03.850.860.510.090; G04.185.149 DERE Environment and Public Health (Non MeSH); Public Health; Sanitation; Sanitary Engineering Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) The series of processes by which living organisms degrade pollutant chemicals, organic wastes, pesticides, and implantable materials. Biophysics (66-68); Sanitary Engineering (66-68); appropriate material ]&TBiocompatible Materials D25.130 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Implants, Artificial Biomedical and Dental Materials (Non MeSH) Bone Substitutes; Polydioxanone Prosthesis (66-71) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $ ,3&.Biochemistry G01.201; H01.181.122 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences Physical Sciences (Non MeSH); Chemistry Histocytochemistry (+ 1); Immunochemistry (+ 1); Neurochemistry Catalysis; Structure-Activity Relationship CLDEECEDHIISLJMAMTOGRESNSTTD G| Biochemical Phenomena, Metabolism, Nutrition (Non MeSH) G06 Biochemical Phenomena (Non MeSH) (+ 86); Metabolism (+ 74); Nutrition (+ 13) AECLCTDEECEDEHGEHIIMIPISMOMTNUPHPXRESNSTTDUTVE @_2Biochemical Phenomena (Non MeSH) G06.184 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH) Acid-Base Equilibrium (+ 1); Allosteric Regulation; Base Composition; Binding Sites (+ 4); Body Composition (+ 1); Brain Chemistry; Calcification, Physiologic (+ 1); Diffusion; Down-Regulation (Physiology); Energy Transfer (+ 1); Enzyme Activation; Enzyme Stability; Fermentation; Ion Transport; Membrane Fluidity; Molecular Conformation (+ 5); Molecular Mimicry; Molecular Sequence Data (+ 34); Nitrogen Fixation; Nitrosation; Nucleic Acid Denaturation; Nucleic Acid Hybridization; Nucleic Acid Renaturation; Osmosis; Protein Binding; Protein Denaturation; Protein Folding; Protein Hybridization; Protein Structure (Non MeSH) (+ 4); Structure-Activity Relationship; Substrate Specificity; Up-Regulation (Physiology); Virus Replication; Water-Electrolyte Balance (+ 1) DEGEIMIPPHRE ' @Biobibliography L01.178.682.099.434; L01.453.183.392 Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Bibliography Information Science; Information Services; Bibliography 1*Binomial Distribution E05.318.740.994.250; G03.850.520.830.994.250; H01.548.832.901.250; N05.715.360.750.750.150 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Statistical Distributions (Non MeSH) Physical Sciences (Non MeSH); Mathematics; Statistics; Statistical Distributions (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Statistical Distributions (Non MeSH) The probability distribution associated with two mutually exclusive outcomes; used to model cumulative incidence rates and prevalence rates. The Bernoulli distribution is a special case of binomial distribution. 5d7Binding, Competitive G06.184.154.309 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Binding Sites Binding Sites (68-72) {Binding Sites, Antibody D24.611.125.345; G04.610.143.232; G06.184.154.408 DEGEIMPHRE Antibody Affinity Antigen-Antibody Reactions; Immunoglobulin Variable Region Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Binding Sites Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of the Fab fragment of the immunoglobulin. Antibodies (66-72); Antigens (66-72); Binding Sites (68-72) $9CPIBinding Sites G06.184.154 DEGEIMPHRE Protein Binding; Receptors, Cell Surface Protein Binding Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Allosteric Site; Bay Region (Chemistry); Binding, Competitive; Binding Sites, Antibody The reactive parts of a macromolecule that directly participate in its specific combination with another molecule. Antigen-Antibody Reactions (66-67); Enzymes (66-67) ( O1hg=Biliverdine D11.557.193.184.200 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Bile Pigments; Bilirubin 1,3,6,7-Tetramethyl-4,5-dicarboxyethyl-2,8-divinylbilenone. Biosynthesized from hemoglobin as a precursor of bilirubin. Occurs in the bile of amphibia and of birds, but not in normal human bile or serum. Bilirubin (69-75)  DeBilirubin D11.557.193.184 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hyperbilirubinemia Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Bile Pigments Biliverdine  DXBiliopancreatic Diversion E04.765.120.086; E04.765.169 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Obesity, Morbid Surgery, Operative; Surgery, Digestive System (Non MeSH); Biliary Tract Surgery Surgery, Operative; Surgery, Digestive System (Non MeSH) A surgical procedure which diverts pancreatobiliary secretions via the duodenum and the jejunum into the colon, the remaining small intestine being anastomosed to the stomach after antrectomy. The procedure produces less diarrhea than does jejunoileal bypass. Duodenum/surgery (77-86); Gastric Bypass (89); Jejunoileal Bypass (87-89); Jejunum/surgery (77-86); Obesity/therapy (77-89); Obesity, Morbid/therapy (87-89)  "$,Biliary Tract Surgery E04.765.120 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Digestive System (Non MeSH) Biliopancreatic Diversion; Cholecystectomy (+ 1); Cholecystostomy; Choledochostomy; Portoenterostomy, Hepatic; Sphincterotomy, Endoscopic; Sphincterotomy, Transhepatic Any surgical procedure performed on the biliary tract. Biliary Tract/surgery (66-87); Biliary Tract Diseases/surgery (66-87)  $CBSBiliary Tract Neoplasms C04.588.274.120; C06.130.320; C06.240.120 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms Digestive System Diseases; Biliary Tract Diseases Digestive System Diseases; Digestive System Neoplasms Bile Duct Neoplasms (+ 1); Gallbladder Neoplasms Bile Duct Neoplasms (+ 1); Gallbladder Neoplasms Bile Duct Neoplasms (+ 1); Gallbladder Neoplasms Bile Duct Neoplasms (66-79); Gallbladder Neoplasms (66-79) 1XFBiliary Tract Diseases C06.130 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cholangiography Digestive System Diseases Bile Duct Diseases (+ 10); Bile Reflux; Biliary Atresia; Biliary Dyskinesia; Biliary Fistula; Biliary Tract Neoplasms (+ 3); Cholelithiasis (+ 1); Cholestasis (+ 4); Gallbladder Diseases (+ 3); Hemobilia; Postcholecystectomy Syndrome BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  L NXBiliary Tract A03.159 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISEULUSVI Cholagogues and Choleretics; Cholangiography; Cholecystography Digestive System Bile Ducts (+ 8); Gallbladder ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI   6H':Biliary Fistula C06.130.246; C06.185.200; C23.439.185.200 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Digestive System Diseases; Digestive System Fistula (Non MeSH) Symptoms and General Pathology (Non MeSH); Fistula; Digestive System Fistula (Non MeSH) Abnormal passage communicating with the biliary tract. 1NABiliary Dyskinesia C06.130.184 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases N;Biliary Atresia C06.130.161; C06.175.125; C16.131.314.125 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Atresia of the biliary tract, most commonly of the extrahepatic bile ducts. Bile Ducts/abnormalities (66-86) {1L['Bile Reflux C06.130.140; C06.405.748.240.140 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Duodenogastric Reflux Reflux of bile mainly into the upper digestive tract, but also into the pancreas. Bile (66-80); Gastritis (66-80) &Nc(Bile Pigments D11.557.193 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Bilirubin (+ 1); Urobilin; Urobilinogen AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR !BF2DBile Ducts, Intrahepatic A03.159.183.158; A03.620.150 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Biliary Tract; Bile Ducts Digestive System; Liver Bile Canaliculi Bile Canaliculi Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct. "":R&Bile Ducts, Extrahepatic A03.159.183.079 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Biliary Tract; Bile Ducts Common Bile Duct (+ 2); Hepatic Duct, Common Passages external to the liver for the conveyance of bile. These include the COMMON BILE DUCT and the common hepatic duct (HEPATIC DUCT, COMMON). Common Bile Duct (66-93); Hepatic Duct, Common (66-93)  $:69CBile Ducts A03.159.183 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Portoenterostomy, Hepatic Digestive System; Biliary Tract Bile Ducts, Extrahepatic (+ 4); Bile Ducts, Intrahepatic (+ 1); Cystic Duct ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  &8f'^:Bile Duct Obstruction, Extrahepatic C06.130.120.150; C06.130.450.150; C23.888.498.250.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases Digestive System Diseases; Biliary Tract Diseases; Cholestasis Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Cholestasis Impairment of bile flow through the hepatic, cystic, or common bile ducts or Vater's ampulla. This is sometimes called surgical jaundice. specific extrahepatic bile duct (66-79); Bile Ducts (66-79); Biliary Tract Diseases (66-79); Cholestasis (66-79) (X*=N Bile Duct Neoplasms C04.588.274.120.250; C06.130.120.120; C06.130.320.120; C06.240.120.250 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Biliary Tract Neoplasms Digestive System Diseases; Biliary Tract Diseases; Bile Duct Diseases Digestive System Diseases; Biliary Tract Diseases; Biliary Tract Neoplasms Digestive System Diseases; Digestive System Neoplasms; Biliary Tract Neoplasms Common Bile Duct Neoplasms Common Bile Duct Neoplasms Common Bile Duct Neoplasms Common Bile Duct Neoplasms +kPXp~Bile Duct Diseases C06.130.120 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases Bile Duct Neoplasms (+ 1); Bile Duct Obstruction, Extrahepatic; Caroli's Disease; Cholangitis (+ 1); Common Bile Duct Diseases (+ 3) Bile Ducts (66-79); specific bile duct; Biliary Tract Diseases (66-79); Cholestasis (66-79) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  .=N;oXBile Canaliculi A03.159.183.158.125; A03.620.150.125 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Digestive System; Biliary Tract; Bile Ducts; Bile Ducts, Intrahepatic Digestive System; Liver; Bile Ducts, Intrahepatic Minute intercellular channels that occur between liver cells and carry bile towards interlobar bile ducts. Also called bile capillaries. Bile Ducts, Intrahepatic (66-80) 0*:'Bile Acids and Salts D19.316.246; D19.316.508.147 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cholagogues and Choleretics Chenodeoxycholic Acid (+ 5); Cholic Acids (+ 10) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 2t"B>FBile A12.838.087 CHCYDEENIMMEMIPHPSRARERISEUSVI Fluids and Secretions (Non MeSH); Secretions (Non MeSH) 4c"DBiguanides D02.078.370.141 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines Buformin; Chlorhexidine; Chloroguanide; Metformin; Phenformin AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 48>I:Bifidobacterium B03.100.067.100.137.230; B03.510.460.400.400.100.137.230 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group; Actinomycetaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Actinobacteria Group; Actinomycetaceae A rod-shaped, gram-positive, non-acid-fast, non-spore-forming, non-motile bacterium that is a genus of the family ACTINOMYCETACEAE. It inhabits the intestines and feces of humans as well as the human vagina. Actinomycetaceae (75-83); Actinomycetales (67-74) 6@>"Q:Bicyclo Compounds D02.219.308; D04.615.236.308 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Bridged Compounds Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Bridged Compounds Ramipril Ramipril AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 9V"8:Bicycling I03.450.642.845.140 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports Exercise Test (66-82); Exertion (66-82) : R1Bicuspid A14.254.860.094 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Stomatognathic System; Dentition; Tooth ; :0Bicuculline D03.132.130; D03.438.531.100; D14.100.240.300.100; D15.220.224.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Antagonists Central Nervous System Agents; Central Nervous System Stimulants; Convulsants Isoquinoline alkaloid from Dicentra cucullaria and other plants that is a competitive antagonist at GABA-A receptors and thus causes convulsions. Alkaloids (72-74); Dioxoles (72-74); Isoquinolines (71-74)  N|Bereavement F01.470.142 Grief Death Behavior and Behavior Mechanisms (Non MeSH); Emotions Grief Refers to the whole process of grieving and mourning and is associated with a deep sense of loss and sadness. Grief (68-87) $  A Berbines D03.132.117; D03.549.168 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Berberine Berberine Alkaloids (66-68) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  [ 8y:Berberine D03.132.117.100; D03.549.168.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Berbines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Berbines 5,6-Dihydro-9,10-dimethoxybenzo[g][1,3]benzodioxolo[5,6-a] quinolizinium hydroxide. An alkaloid from Hydrastis canadensis L., Berberidaceae. Also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal. Synonym: Umbellatine. Berbines (72-75); Dioxolanes (75); Dioxoles (72-74)  &:p@Bepridil D03.383.773.107; D18.162.062; D18.192.216; D18.918.173.215 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine. A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist. Anti-Arrhythmia Agents (76-89); Antihypertensive Agents (66-89); Calcium Channel Blockers (82-89); Pyrrolidines (66-89)  D:Bephenium Compounds D02.092.102.102; D02.675.276.102; D21.201.287.090 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents n98Benzylidene Compounds D02.455.426.559.389.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Polystyrenes; Stilbenes (+ 8); Styrenes Compounds containing the PhCH= radical. Benzene Derivatives (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $820!:Benzylamines D02.092.200; D02.455.426.559.389.140.210 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzyl Compounds Pargyline Pargyline Toluenes in which one hydrogen of the methyl group is substituted by an amino group. Permitted are any substituents on the benzene ring or the amino group. Amines (69-75); Benzyl Compounds (74-75) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $.82:Benzylamine Oxidase D08.586.682.135.697.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases; Monoamine Oxidase An aspect of monoamine oxidase, EC 1.4.3.4. Catalyzes the oxidation of benzylamine to form benzaldehyde, ammonia and hydrogen peroxide. Benzyl Compounds (73-74); Monoamine Oxidase (73-74) ǭF>Benzyl Viologen D03.383.725.762.925.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridinium Compounds; Viologens 1,1'-Bis(phenylmethyl)4,4'-bipyridinium dichloride. Oxidation-reduction indicator. Benzyl Compounds (72-74); Pyridinium Compounds (70-74) ɸ:{]ABenzyl Compounds D02.455.426.559.389.140 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Benzyl Alcohols; Benzylamines (+ 1); Bibenzyls; 2-Hydroxy-5-nitrobenzyl Bromide; Lignans Benzene Derivatives (68-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  a8i!<Benzyl Alcohols D02.033.390; D02.455.426.559.389.140.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Benzyl Compounds Alcohols derived from the aryl radical C7H7 and defined by C7H8O. The concept includes derivatives with any substituents on the benzene ring. Alcohols (72-74); Benzyl Compounds (72-74) V.84Benzydamine D03.383.694.487.130; D03.438.449.130; D16.850.015.050.075; D17.025.030.067; D17.025.080.100; D17.050.030.117; D23.037.042 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Indazoles Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indazoles Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Dermatologic Agents; Anti-Inflammatory Agents, Topical 1-Benzyl-3-(3-dimethylamino)propoxy)-1H-indazole monohydrochloride. An analgesic, antipyretic, and anti-inflammatory agent used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of rheumatic disease and inflammation of the mouth and throat. Benzyl Compounds (71-74); Dimethylamines (73-74); Indazoles (73-74); Pyrazoles (68-73) ϲ:fhBenztropine D03.132.889.244; D03.605.869.270; D14.100.120.200.500.067; D14.100.150.600.220.200; D14.100.600.220.200; D15.090.050.050; D16.050.650.065 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Tropanes Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A centrally active muscarinic antagonist that has been used in the symptomatic treatment of parkinsonism. Benztropine also inhibits the uptake of dopamine. Tropanes (72-90) :rBenzphetamine D02.092.471.683.152.619.307; D14.100.050.600.050.110; D14.100.050.600.085; D14.100.150.600.110; D14.100.150.600.220.120; D14.100.600.050.110; D14.100.600.220.120; D15.155.090; D15.220.110; D16.050.870.080 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines; Methamphetamine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics A sympathomimetic agent with properties similar to DEXTROAMPHETAMINE. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1222). K:Benzoylcholine D02.092.102.232.100; D02.241.223.106.210; D02.675.276.232.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline The benzoic acid ester of choline. Choline (68-74) /AA (75); Benzoates (72-75) E:,6Benzoylarginine-2-Naphthylamide D02.065.300; D12.125.095.104.095 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Arginine N-[4-Guanidino-1-(2-naphthylcarbamoyl)butyl]-DL-benzamide. An enzyme substrate which permits the measurement of peptide hydrolase activity, e.g. trypsin and thrombin. The enzymes liberate 2-naphthylamine, which is measured by colorimetric procedures. Arginine (73-74) /AA (75); Benzamides (74-75); Naphthalenes (73-75) #&:RBenzoylarginine Nitroanilide D02.065.199.200; D12.125.095.104.100; D26.550.152.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Arginine Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents; Chromogenic Compounds (+-)-N-(4-((Aminoiminomethyl)amino)-1-(((4-nitrophenyl)amino)carbonyl)butyl)benzamide. A chromogenic substrate that permits direct measurement of peptide hydrolase activity, e.g., papain and trypsin, by colorimetry. The substrate liberates p-nitroaniline as a chromogenic product. Arginine (71-74); Anilides (71-74); Nitro Compounds (71-74); Benzamides (74) !=:B^Benzoyl Peroxide D02.241.223.106.205; D23.400.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Peroxides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Dermatologic Agents; Keratolytic Agents Dibenzoyl peroxide. A peroxide derivative that has been used topically for burns and as a dermatologic agent in the treatment of acne and poison ivy. It is used also as a bleach in the food industry. Benzoates (72-75); Peroxides (72-75)  6&: -Benzoxepins D03.438.245 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) 8GBenzoxazoles D03.438.221 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Chlorzoxazone; Cialit; Zoxazolamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR U8G+:Benzothiepins D03.438.197 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Endosulfan AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8G:Benzothiadiazines D03.438.174 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Bendroflumethiazide; Chlorothiazide (+ 2); Cyclopenthiazide; Hydroflumethiazide; Methyclothiazide; Polythiazide AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8G:Benzoquinones D02.806.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones Carbazilquinone; Chloranil; Dibromothymoquinone; Plastoquinone; Ubiquinone Benzene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Quinones (66-90) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $80VFBenzopyrenes D04.615.799.306; D26.191.788.112 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Pyrenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Pyrenes Benzo(a)pyrene; Dihydroxydihydrobenzopyrenes (+ 1) AAADAEAIANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU &,=0Benzopyrene Hydroxylase D08.586.682.420.170.080.110 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450; Aryl Hydrocarbon Hydroxylases A drug-metabolizing, cytochrome P-448 enzyme which catalyzes the hydroxylation of benzopyrene to 3-hydroxybenzopyrene in the presence of reduced flavoprotein and molecular oxygen. Also acts on certain anthracene derivatives. An aspect of EC 1.14.14.1. Benzopyrenes (68-74); Hydroxylases (68-74) F"3Benzopyrans D03.438.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Chromans (+ 2); Chromones (+ 7); Citrinin; Coumarins (+ 18); Ellagic Acid; Hematoxylin AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR S8Gn@Benzophenones D02.522.223 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Ketones (66-67) 8/Benzophenoneidum D02.092.146.215; D26.408.124 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Aniline Compounds Miscellaneous Drugs and Agents (Non MeSH); Dyes 4,4'-bis-(Dimethylamino)-benzophenonimide. An aniline dye used as a disinfectant and an antiseptic agent; it is weakly fluorescing and binds specifically to certain proteins. Aniline Compounds (69-74); Imines (72-74); Dimethylamines (74) ".}LBenzomorphans D03.132.610.422.106 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Opium; Morphinans Pentazocine; Phenazocine Morphine derivatives of the methanobenzazocine family that act as potent analgesics. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8?c:Benzolamide D02.065.884.120; D02.886.590.700.120; D03.383.871.867.120; D08.373.220.200; D19.770.224.266.155 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Sulfonamides Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonamides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles; Thiadiazoles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Carbonic Anhydrase Inhibitors Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Carbonic Anhydrase Inhibitors 5-Benzenesulfonamido-1,3,4-thiadiazole-2-sulfonamide. Selective renal carbonic anhydrase inhibitor. It may also be of use in certain cases of respiratory failure. Sulfonamides (70-75); Thiadiazoles (72-75) (k:3Benzoin D02.522.120.100; D26.550.062 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Ketones; Acetophenones Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 2-Hydroxy-1,2-diphenylethanone. A white crystalline compound prepared by condensation of benzaldehyde in potassium cyanide and used in organic syntheses.  ".Benzofurans D03.438.127 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Amiodarone; Benzbromarone; Fura-2 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8G):Benzoflavones D03.438.150.266.450.175; D08.373.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Chromones; Flavones Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Potent arylhydrocarbon hydroxylase inhibitors. Also inhibit the binding of nucleic acids to benzopyrenes and related compounds. Include all isomers; the 7,8-isomer is most frequently encountered. Flavones (66-78) *8Benzodiazepinones D03.438.079.080.070 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Anthramycin; Bromazepam; Clonazepam; Diazepam (+ 1); Flumazenil; Flunitrazepam; Flurazepam; Lorazepam; Nitrazepam; Oxazepam; Pirenzepine; Prazepam; Temazepam AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8k<Benzodiazepines D03.438.079.080 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Anxiety Agents, Benzodiazepine; Receptors, GABA-A Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines Alprazolam; Benzodiazepinones (+ 14); Chlordiazepoxide; Clorazepate Dipotassium; Estazolam; Medazepam; Midazolam; Triazolam A two-ring heterocyclic compound consisting of a benzene ring fused to a diazepine ring. Permitted is any degree of hydrogenation, any substituents and any H-isomer. Benzazepines (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( 8?X<Benzocycloheptenes D04.615.181 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Dibenzocycloheptenes (+ 7) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8P :Benzocaine D02.241.223.106.061.075.100; D15.050.050.050; D15.210.100.200.070; D16.850.025.070 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; 4-Aminobenzoic Acid Central Nervous System Agents; Anesthetics; Anesthetics, Local Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, Local Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Anesthetics, Local 4-Aminobenzoic acid ethyl ester. A surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings. It is comparatively non-irritating and has low systemic toxicity.  \:Benzoates D02.241.223.106 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH) Aminobenzoic Acids (+ 14); Benzamides (+ 12); Benzoyl Peroxide; Benzoylcholine; Bromobenzoates; Chlorobenzoates; Dicamba; Hexobendine; Hydroxybenzoic Acids (+ 13); Iodobenzoates (+ 12); Mercuribenzoates (+ 1); Nitrobenzoates (+ 1); Quinic Acid; Trimebutine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8]4:Benzo(a)pyrene D04.615.799.306.300; D05.569.468.300; D26.191.126 AAADAEAIANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Bay Region (Chemistry) Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Pyrenes; Benzopyrenes Environmental Pollutants, Pesticides (Non MeSH); Noxae (Non MeSH); Mutagens Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Potent mutagen and carcinogen. Benzopyrenes (66-84)  90&Benzimidazoles D03.438.103 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Albendazole; Astemizole; Benomyl; Cambendazole; Domperidone; Droperidol; Fenbendazole; Hoe 33258; Mebendazole; Nocodazole; Omeprazole; Pimozide; Thiabendazole AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8G:Benzilates D02.241.223.601.238.306; D02.241.511.085 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates; Diphenylacetic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids Benactyzine; Quinuclidinyl Benzilate Benactyzine; Quinuclidinyl Benzilate AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR .8T:Benzidines D02.455.426.559.389.185.100; D26.191.111 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens  3,3'-Dichlorobenzidine P-Diaminobiphenyl. Very toxic industrial chemicals; absorbed through the skin, cause lethal blood, bladder, liver and kidney damage and are potent, broad spectrum carcinogens in most species. Synonym: 4,4'-Diphenyldiamine. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  .,.Benzhydryl Compounds D02.455.426.559.389.115 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Diphenhydramine (+ 1); Meclizine; Methylenebis(chloroaniline); Orphenadrine; Terfenadine Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed. Benzene Derivatives (68-74); Benzyl Compounds (72-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $b8i@:Benzethonium D02.092.102.090; D02.675.276.090; D20.187.100; D26.866.265.110 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Detergents N,N-Dimethyl-N-(2-(2-(4-(1,1,3,3-tetramethylbutyl)phenoxy) ethoxy)ethyl)benzenemethanaminium. Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade. RN given refers to the chloride salt. Ammonium Compounds (69-74); Benzyl Compounds (71-74); Phenyl Ethers (74) FH.%;XBenzenesulfonates D02.455.426.559.389.097; D02.886.645.600.080.050.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates Calcium Dobesilate; 4-Chloromercuribenzenesulfonate; Ethamsylate; Ferrozine; Polyanetholesulfonate; Tiron Calcium Dobesilate; 4-Chloromercuribenzenesulfonate; Ethamsylate; Ferrozine; Polyanetholesulfonate; Tiron Organic salts and esters of benzenesulfonic acid. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  ":8.<:Benzene Hexachloride D02.455.526.439.099; D05.723.491.491.122 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine %.:Benzene Derivatives D02.455.426.559.389 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH) Benzenesulfonates (+ 6); Benzhydryl Compounds (+ 6); Benzyl Compounds (+ 6); Benzylidene Compounds (+ 11); Biphenyl Compounds (+ 8); Bromobenzenes; Chlorobenzenes (+ 3); Iodobenzenes (+ 4); Nitrobenzenes (+ 5); Sulfanilic Acids; Terphenyl Compounds (+ 1); Toluene (+ 12); Trityl Compounds; Xylenes Benzene (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR  't8lDBenzene D02.455.426.559.222; D26.191.101 ADAEAIANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Cyclohexatriene. Toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation. It is used as an industrial solvent in paints, varnishes, lacquer thinners, gasoline, etc. Benzene causes central nervous system damage acutely and bone marrow damage chronically and is carcinogenic. It was formerly used as parasiticide. *M &.Benzbromarone D03.438.127.110; D17.050.337.900.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzofurans Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants; Uricosuric Agents 3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone. Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout. Benzoates (71-74); Benzofurans (71-74); Bromine (73-74) -*:DBenzazepines D03.438.079 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH) Benzodiazepines (+ 22); Diltiazem; Fenoldopam; Sch-23390; SK&F-38393 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR /8GS<Benzanthracenes D04.615.117.306; D26.191.072.122 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Anthracenes 9,10-Dimethyl-1,2-benzanthracene; Perylene 9,10-Dimethyl-1,2-benzanthracene AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 0&,R:Benzamidines D02.078.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines Diminazene; Pentamidine Amidines substituted with a benzene group. Benzamidine and its derivatives are known as peptidase inhibitors. Amidines (72-74); Benzene Derivatives (72-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $2807:Benzamides D02.065.277; D02.241.223.106.162 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Deet; Dinitolmide; Hippurates (+ 3); Indoramin; Metoclopramide; Procarbazine; Remoxipride; Sulpiride; Tiapride Deet; Dinitolmide; Hippurates (+ 3); Indoramin; Metoclopramide; Procarbazine; Remoxipride; Sulpiride; Tiapride Amides (66-72); Benzoates (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  4~&8*:Benzalkonium Compounds D02.092.102.080; D02.675.276.080; D20.187.083; D26.866.265.105 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents; Detergents A mixture of alkylbenzyldimethylammonium compounds; bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes; as surgical antiseptic; as preservative and emulsifier in drugs and cosmetics. Synonyms: Cequartyl; Germinol; Germitol; Osvan; Roccal; Rodalon; Zephirol. 7H,%`Benzaldehydes D02.047.222 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Aldehydes (66-71) :O81Bentonite D01.056.050.075.100; D01.578.725.025.100; D01.650.550.050.075.100; D01.837.725.700.760.050.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Aluminum Compounds; Aluminum Oxide; Aluminum Silicates Inorganic Chemicals (Non MeSH); Minerals; Silicates; Aluminum Silicates Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Aluminum Oxide; Aluminum Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Aluminum Silicates Bentonite. A native, colloidal, hydrated aluminum silicate which, on the addition of water, swells to produce a slippery paste. Its chief pharmaceutical use is as a suspending agent and it has also been used as a bulk laxative. (Dorland, 27th ed). Aluminum Silicates (66-72) ; h8( Benserazide D02.442.175; D08.373.125; D14.100.150.600.085; D15.090.050.043 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrazines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. Benzene (66-67); Benzene Derivatives (68-71); Benzyl Compounds (72); Hydrazines (66-72); Serine (66-72) >H:}~Benperidol D02.522.352.155; D14.100.150.175.067; D15.150.015.125; D15.210.950.040.015.125; D15.700.872.331.015.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butyrophenones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone A butyrophenone with general properties similar to those of HALOPERIDOL. It has been used in the treatment of aberrant sexual behavior. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.567). CHs:vBenomyl D02.241.081.251.125; D03.438.103.140; D05.723.288.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate. A systemic agricultural fungicide used for control of certain fungal diseases of stone fruit. Frequently encountered synonym: Benlate. Benzimidazoles (72-74); Carbamates (72-74) G =:3Benin Z01.058.290.190.200 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Western JT _Bendroflumethiazide D03.438.174.138; D18.162.276.126; D19.770.224.578.126 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzothiadiazines Cardiovascular Agents; Antihypertensive Agents; Diuretics, Thiazide Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Diuretics, Thiazide J=:"Bender-Gestalt Test F04.711.513.180; F04.711.647.138 HISNST Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Neuropsychological Tests Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests; Personality Tests A psychological test consisting of nine geometric designs on cards. The subject is asked to redraw them from memory after each one is presented individually. L& Bencyclane D02.455.426.392.368.284.100; D18.192.150; D18.918.173.150 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cycloheptanes Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers N,N-dimethyl-3-3-(1-benzylcycloheptyloxy)-propylamine. A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Synonyms: Fludilat; Halidor. Benzyl Compounds (72-74); Cycloheptanes (71-74); Dimethylamines (74) NA:+RBence Jones Protein D12.776.124.486.485.900.120; D12.776.124.790.651.900.120; D12.776.377.715.548.900.120 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Immunoproteins (Non MeSH); Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Immunoglobulins; Paraproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Immunoglobulins; Paraproteins R]FBenactyzine D02.241.223.601.238.306.140; D02.241.511.085.140; D14.100.120.200.500.056; D15.085.100; D15.700.122.100; D16.050.650.060 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Phenylacetates; Diphenylacetic Acids; Benzilates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Benzilates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics A centrally acting muscarinic antagonist. Benactyzine has been used in the treatment of depression and is used in research to investigate the role of cholinergic systems on behavior. T:Bemegride D03.383.725.791.100; D15.220.080; D15.220.224.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Pyridones Central Nervous System Agents; Central Nervous System Stimulants Central Nervous System Agents; Central Nervous System Stimulants; Convulsants A CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose. X 9:Belladonna Alkaloids D03.132.760.180; D03.132.889.180 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Solanaceous Alkaloids Heterocyclic Compounds; Alkaloids; Tropanes Atropine; Scopolamine Atropine (+ 2) Alkaloids obtained from various plants, especially the deadly nightshade (Atropa belladonna), variety acuminata; atropine, hyoscyamine and scopolamine are classical, specific antimuscarinic agents with many pharmacologic actions; used mainly as antispasmodics. Belladonna (68-74); Tropanes (68-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $[[&8t-)-@Belladonna B06.560.104; B06.660.105 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal Plants; Plants, Toxic A species of very poisonous Solanaceous plants yielding ATROPINE (hyoscyamine), SCOPOLAMINE, and other BELLADONNA ALKALOIDS, used to block the muscarinic autonomic nervous system. ^8&:Belize Z01.107.169.133 EHEP Geographicals (Non MeSH); America; Central America _ >Belgium Z01.542.115 EHEP Geographicals (Non MeSH); Europe `8 )Bejel C01.252.400.840.155; C01.252.847.840.155 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Treponemal Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Spirochaetales Infections; Treponemal Infections A nonvenereal infection by an organism indistinguishable from TREPONEMA PALLIDUM. It is transmitted by nonsexual body contact. The primary lesions are in the mouth followed by lesions in the axillae, inguinal region, and rectum. A latent period is followed by destruction of skin and bones. ` .PVBehcet's Syndrome C07.465.075; C11.941.879.780.880.200; C14.907.940.100; C17.800.862.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Mouth Diseases Eye Diseases; Uveal Diseases; Uveitis; Panuveitis; Uveitis, Anterior Cardiovascular Diseases; Vascular Diseases; Vasculitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. Synovitis, thrombophlebitis, gastrointestinal ulcerations, retinal vasculitis, and optic atrophy may be occur as well. cPN$Behaviorism F02.739.138 HI Psychologic Processes and Principles (Non MeSH); Psychological Theory A psychologic theory developed by James B. Watson concerned with studying and measuring behaviors that are observable. gXRBehavioral Symptoms (Non MeSH) F03.126 Behavioral and Mental Disorders (Non MeSH) Aerophagy; Affective Symptoms (+ 5); Autism; Cognition Disorders (+ 19); Communicative Disorders (+ 25); Coprophagia; Dyspareunia; Eating Disorders (+ 5); Encopresis; Enuresis; Frigidity; Hearing Loss, Functional; Helplessness, Learned; Hypochondriasis; Hysteria; Impotence (+ 1); Impulsive Behavior (+ 3); Malingering; Mental Fatigue; Paranoid Behavior; Psychomotor Disorders (+ 11); Schizophrenic Language; Self-Injurious Behavior (+ 1); Sleep Disorders (+ 5); Social Behavior Disorders (+ 15); Stereotyped Behavior; Stress, Psychological (+ 1); Suicide (+ 2) BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMLJMEMIMONUPAPCPHPPPSPXRARERHRIRTSNSUTDTHURUSVEVI h|% 3ZBehavioral Sciences F04.096 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH) Behavioral Medicine; Ethology; Genetics, Behavioral; Parapsychology; Psychiatry (+ 17); Psycholinguistics; Psychology (+ 11); Psychopathology; Psychopharmacology; Psychophysics (+ 2); Psychophysiology (+ 2); Social Sciences (+ 3) Disciplines concerned with the study of human and animal behavior. Behavior (66-69); specific discipline CLDEECEDHIISLJMAMTOGPHPXRESNSTTD $k 9P.$Behavioral Medicine F04.096.080; G02.403.090 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences Health Occupations; Medicine The interdisciplinary field concerned with the development and integration of behavioral and biomedical science, knowledge, and techniques relevant to health and illness and the application of this knowledge and these techniques to prevention, diagnosis, treatment, and rehabilitation. nUsFBehavioral and Mental Disorders (Non MeSH) F03 Behavioral Symptoms (Non MeSH) (+ 121); Child Behavior Disorders (+ 9); Child Development Disorders (+ 2); Defense Mechanisms (+ 19); Mental Disorders (+ 166) AEBLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMLJMEMIMONUPAPCPHPPPSPXRARERHRIRTSNSUTDTHTMURUSVEVI p3^Behavior, Animal F01.145.113 CLDEPHRE Ethology Behavior and Behavior Mechanisms (Non MeSH); Behavior Appetitive Behavior (+ 2); Cannibalism; Consummatory Behavior (+ 5); Eliminative Behavior, Animal; Escape Reaction; Home Range The observable response an animal makes to any situation. CLDEHIPHPXRE $q  AFBehavior, Addictive F01.145.527.100.120; F03.126.517.100.120 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Substance Use Disorders Behavior and Behavior Mechanisms (Non MeSH); Behavior; Impulsive Behavior; Compulsive Behavior Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Impulsive Behavior; Compulsive Behavior The observable, measurable, and often pathological activity of an organism that portrays its inability to overcome a habit resulting in an insatiable craving for a substance or for performing certain acts. The addictive behavior includes the emotional and physical overdependence on the object of habit in increasing amount or frequency. The behavior results in a biochemical level of addiction, since it is connected to the circuitry of reward and pleasure. Examples include: drug addiction, food addiction, running addiction, and sexual addiction. Behavior (74-91); Substance Abuse (80-91); Substance Dependence (74-91)  s.F}VBehavior Therapy F04.754.137 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Aversive Therapy; Biofeedback (Psychology); Cognitive Therapy; Desensitization, Psychologic (+ 1); Relaxation Techniques The application of modern theories of learning and conditioning in the treatment of behavior disorders. CLDEECEDHIISLJMAMTOGPHRESNSTTD  x3Kz"Behavior and Behavior Mechanisms (Non MeSH) F01 Adaptation, Psychological (+ 2); Behavior (+ 139); Child Rearing (+ 1); Defense Mechanisms (+ 19); Emotions (+ 22); Human Development (+ 4); Mental Competency; Motivation (+ 13); Personality (+ 33); Psychology, Social (+ 92) AEBLCFCICLCODEDHDIDTECEDEHENEPETGEHIIMISLJMAMEMIMOMTNUOGPAPCPHPPPSPXRARERHRISNSTSUTDTHURUSUTVI z4bBehavior F01.145 CLDEPHRE Genetics, Behavioral Behavior and Behavior Mechanisms (Non MeSH) Accident Proneness; Adolescent Behavior; Assertiveness (+ 2); Attitude (+ 16); Autism; Behavior, Animal (+ 13); Cannibalism; Ceremonial; Child Behavior (+ 1); Communication (+ 24); Competitive Behavior; Cooperative Behavior; Displacement (Psychology) (+ 2); Drinking Behavior (+ 1); Escape Reaction; Exploratory Behavior; Feeding Behavior (+ 3); Habits (+ 7); Imitative Behavior; Impulsive Behavior (+ 3); Inhibition (Psychology) (+ 2); Maternal Behavior; Motor Activity (+ 1); Paranoid Behavior; Paternal Behavior; Power (Psychology); Risk-Taking (+ 1); Self Stimulation; Sex Behavior (+ 14); Social Behavior (+ 5); Social Conformity; Social Dominance (+ 2); Social Facilitation; Spatial Behavior (+ 4); Stereotyped Behavior; Substance Abuse (+ 1); Sucking Behavior The observable response a person makes to any situation. AEBLCFCICLCODEDHDIDTECEHENEPETGEHIIMLJMEMIMOMTNUPAPCPHPPPSPXRARERHRISNSUTDTHURUSVI ${   4EVBeggiatoales B03.350.200; B03.440.400.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH) Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria Beggiatoaceae Beggiatoaceae An order of gliding bacteria consisting of cells of widely varying sizes that occur mostly as filaments. ""w }Beggiatoaceae B03.350.200.200; B03.440.400.200.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Beggiatoales Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Beggiatoales A family of gram-negative, gliding bacteria usually found in marine or freshwater environments. Bacteria (66-75) K*"pBeetles B01.131.617.155.304 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Coleoptera Tenebrio; Tribolium  (8Bees B01.131.617.479.387 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Honey; Propolis Invertebrates; Arthropods; Insects; Hymenoptera Insect members of the superfamily Apoidea, found almost everywhere, particularly on flowers. About 3500 species occur in North America. They differ from most wasps in that their young are fed honey and pollen rather than animal food. Honey is collected in the form of nectar from flowers and concentrated into honey by evaporation. For most people bee stings are of little significance and are treated locally; other persons, however, react with hypersensitivity putting them in serious danger. (Borror, et al., An Introduction to the Study of Insects, 4th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973). (9Beer J01.125.091.221 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Beverages; Alcoholic Beverages F"ZBee Venoms D24.185.965.065.115 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Arthropod Venoms Apamin; Melitten Venoms obtained from Apis mellifera (honey bee) and related species. They contain various enzymes, polypeptide toxins, and other substances, some of which are allergenic or immunogenic or both. These venoms were formerly used in rheumatism to stimulate the pituitary-adrenal system. Bees (66-77); Venoms (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $<kH%FBeds E07.325.220 AECLCTECHISDSNSTTDUTVE Equipment and Supplies; Equipment and Supplies, Hospital Equipment on which one may lie and sleep, especially as used to care for the hospital patient. CsBedding and Linens E07.325.137; J01.494.221 AECLCTECHISDSNSTTDUTVE Laundry Service, Hospital Equipment and Supplies; Equipment and Supplies, Hospital Technology, Industry, Agriculture (Non MeSH); Household Articles Articles of cloth, usually cotton or rayon and other synthetic or cotton-blend fabrics, used in households, hospitals, physicians' examining rooms, nursing homes, etc., for sheets, pillow cases, toweling, gowns, drapes, and the like. Bedbugs B01.131.617.412.304 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hemiptera Bugs of the family Cimicidae, genus Cimex. They are flattened, oval, reddish insects which inhabit houses, wallpaper, furniture, and beds. C. lectularius, of temperate regions, is the common bedbug that attacks man and is frequently a serious pest in houses, hotels, barracks, and other living quarters. It also attacks animals other than man. C. rotundatus (hemipterus) of the tropics, also bites man. Other species of this family attack bats and various birds. Although bedbugs attack man when he is sleeping only to obtain a meal of blood, man himself does not transport the infestation from place to place: furnishings removed for cleaning are likely to result in infestation. Experiments have shown that bedbugs can transmit a variety of diseases, but they are not normal vectors under natural conditions. (From Dorland, 27th ed; Borror, et al., An Introduction to the Study of Insects, 4th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973).  (7mBed Rest E02.075 AECLCTECHIISMOMTNUPXSNSTTDUTVE Rest Therapeutics Confinement of an individual to bed for therapeutic or experimental reasons. Immobilization (66-76); Rest (66-76)    "[-Bed Occupancy N02.278.050 CLECHILJMTSNSTTDUT Hospital Bed Capacity Hospital Bed Capacity Facilities, Manpower and Services (Non MeSH); Health Facilities A measure of inpatient health facility use based upon the average number or proportion of beds occupied for a given period of time.  LBed Conversion N03.349.650.250.080 ECHILJSNSTTDUT Economics, Organizations, Control (Non MeSH); Health Planning; Regional Health Planning; Health Facility Planning The reallocation of beds from one type of care service to another, as in converting acute care beds to long term care beds. Bed Occupancy (78-81); Hospital Planning (68-81) ;Beclomethasone D04.808.745.432.769.125; D04.808.883.154; D06.597.481.364.117; D06.597.481.561.353.090; D06.597.481.561.478.090; D17.025.050.050; D17.025.080.200.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnadienes; Pregnadienetriols Polycyclic Hydrocarbons; Steroids; Steroids, Chlorinated Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Glucocorticoids, Topical Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 11-Hydroxycorticosteroids, Synthetic Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Glucocorticoids, Synthetic; Hydroxycorticosteroids, Synthetic; 17-Hydroxycorticosteroids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical; Glucocorticoids, Topical An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of asthma. Pregnanetriol (66-72) M:Beckwith-Wiedemann Syndrome C16.131.077.133; C16.131.280.150 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hernia, Umbilical; Gigantism; Macroglossia Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities A syndrome of multiple defects characterized primarily by umbilical hernia, macroglossia, and gigantism and secondarily by visceromegaly, hypoglycemia, ear abnormalities, etc. Abnormalities, Multiple (68-82); Gigantism (66-82); Hernia, Umbilical (66-82); Macroglossia (75-82); Tongue/abnormalities (66-74)  ) &L3Beauty Culture J01.576.112 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry CABeauty F02.463.785.477.304; K01.752.210.304 Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking; Esthetics Humanities; Philosophy; Esthetics Characteristics or attributes of persons or things which elicit pleasurable feelings.  *dBears B02.649.147.125 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Carnivora Large heavy mammals of the family Ursidae feeding largely on fruit and insects as well as flesh. & ('uBeak A13.114 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Birds (66-67) ) :Bdellovibrio B03.440.400.425.180; B03.825.115 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Spiral and Curved Bacteria (Non MeSH) A genus of bacteria capable of developing within other bacteria. Bacteria (66-76) &"NBCG Vaccine D24.310.894.135.128; D24.611.062.075 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Bacterial Vaccines Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic Active immunizing agent; a viable attenuated strain of Mycobacterium tuberculosis, var. bovis which confers immunity to mycobacterial infections; used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. g*>!Bayes Theorem E05.318.740.600.200; G03.850.520.830.600.200; H01.548.832.672.137; N05.715.360.750.625.150 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics; Probability Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics; Probability Physical Sciences (Non MeSH); Mathematics; Statistics; Probability Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics; Probability A theorem in probability theory named for Thomas Bayes (1702-1761). In epidemiology, it is used to obtain the probability of disease in a group of people with some characteristic on the basis of the overall rate of that disease and of the likelihoods of that characteristic in healthy and diseased individuals. The most familiar application is in clinical decision analysis where it is used for estimating the probability of a particular diagnosis given the appearance of some symptoms or test result. Probability (66-74) dMBay Region (Chemistry) G06.184.154.290 Benzo(a)pyrene Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Binding Sites An indentation of three fused benzene rings. A common bay region is the site on BENZO(A)PYRENE, an indirect carcinogen that is metabolically activated by the P-450 system at the 7,8-double bond, leading to a 7,8-oxide, which is rapidly converted to a 7,8-dihydrodiol and later epoxidated near the bay region at the 9,10-double bond. The resulting product, a diol-epoxide is a poor substrate for epoxide hydratase and is released from the mitochondria into the cell as a highly reactive electrophil, becoming an 'ultimate' carcinogen, as it reacts with negative charges in DNA. (From Segen, Dictionary of Modern Medicine, 1992). {Bay K 8644 D03.383.725.203.130; D03.383.725.547.330; D18.185.110; D18.793.250.110 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Cardiovascular Agents; Calcium Channel Agonists Cardiovascular Agents; Vasoconstrictor Agents; Calcium Channel Agonists 1,4-Dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-3-pyridinecarboxylic acid methyl ester. A dihydropyridine derivative, which, in contrast to NIFEDIPINE, functions as a calcium channel agonist. The compound facilitates Ca2+ influx through partially activated voltage-dependent Ca2+ channels, thereby causing vasoconstrictor and positive inotropic effects. Nifedipine/analogs and derivatives (75-86); Pyridines (66-74) P:WIBattered Women M01.975.155 CLEDHILJPXSN Spouse Abuse Violence Named Groups (Non MeSH); Women Women who are physically and mentally abused over an extended period, usually by a husband or other dominant male figure. Characteristics of the battered woman syndrome are helplessness, constant fear, and a perceived inability to escape. (From American Heritage Dictionary of the English Language, 3d ed).   (gBattered Child Syndrome I01.880.787.293.292.304 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Violence Social Sciences; Sociology; Social Welfare; Child Welfare; Child Abuse Repeated physical injuries inflicted on the child by the parent, parents, or surrogate parent; often triggered by the child's minor and normal irritating behavior. N VBatrachotoxins D24.185.965.033.112 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Amphibian Venoms Batrachotoxin is the 20-alpha-bromobenzoate of batrachotoxin A; they are toxins from the venom of a small Colombian frog, Phyllobates aurotaenia, cause release of acetylcholine, destruction of synaptic vesicles and depolarization of nerve and muscle fibers. cBk)Baths, Finnish E02.780.108.115 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Balneology "3Baths E02.780.108.110 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Balneology  $3Bathing Beaches G03.850.860.410.110 CLECHILJSNST Environment and Public Health (Non MeSH); Public Health; Sanitation; Public Facilities (Non MeSH) Beaches, both natural and man-made, used for bathing and other activities. uYBass B02.493.602.105 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Perciformes Common name for fish belonging to the order Perciformes and occurring in three different families. Fishes (66-86) &(uBasophils A11.118.637.415.120; A15.145.229.637.415.120; A15.382.490.315.120 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Leukocytes; Granulocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Granulocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Granulocytes Granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes.  I*Basophil Degranulation Test E01.223.495.084 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests An in vitro test used in the diagnosis of allergies including drug hypersensitivity. The allergen is added to the patient's white blood cells and the subsequent histamine release is measured. Basophils (66-89) [!"=Basketball I03.450.642.845.117 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A competitive team sport played on a rectangular court having a raised basket at each end. Athletic Injuries (68-86); Sports (66-86) Rn3Basilar Membrane A09.246.631.246.125 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Cochlea A membrane that stretches from the spiral lamina to the basilar crest consisting of an inner and an outer part. The inner part supports the spiral organ of Corti. g:0Basilar Artery A07.231.114.106 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The artery formed by the union of the right and left vertebral arteries; it runs from the lower to the upper border of the pons, where it bifurcates into the two posterior cerebral arteries. 88Basil B06.510.059; J01.341.241.850.100 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible Technology, Industry, Agriculture (Non MeSH); Food; Condiments; Spices Any aromatic plant of the genus Ocimum, especially Ocimum basilicum. It is a condiment with carminative properties. It is also called sweet basil. (Dorland, 27th ed). ǂ &4pBasidiomycetes B05.354.179 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Agaricales (+ 4); Polyporaceae; Schizophyllum; Ustilaginales (+ 1) @",QBashkiria Z01.542.248.775.150; Z01.586.200.775.150; Z01.586.950.775.150 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States; Russia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR; Russia One of the former Associated Soviet Socialist Republics situated in the western portion of Russia. # EuBasement Membrane A10.272.220; A10.615.179 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Tissue Types (Non MeSH); Epithelium Tissue Types (Non MeSH); Membranes Bruch Membrane Bruch Membrane Ubiquitous supportive tissue adjacent to epithelium and around smooth and striated muscle cells. This tissue contains intrinsic macromolecular components such as collagen, laminin, and sulfated proteoglycans. As seen by light microscopy one of its subdivisions is the basal (basement) lamina. 1:W$RBaseball I03.450.642.845.110 CLECEDHIINLJPHPXSNSTTD Human Activities (Non MeSH); Leisure Activities; Recreation; Sports A competitive nine-member team sport including softball. Sports (66-76) Γ RCBase Sequence G05.331.599.110; G06.184.599.110 DEGEIMPHRE Genes; Nucleotides Genetics; Genetics, Biochemical; Molecular Sequence Data Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data Consensus Sequence; DNA Insertion Elements (+ 1); Exons; Gene Library (+ 2); Introns; Reading Frames (+ 1); Regulatory Sequences, Nucleic Acid (+ 7); Repetitive Sequences, Nucleic Acid (+ 4); Replicon (+ 1); Sequence Homology, Nucleic Acid Consensus Sequence; Exons; Introns; Reading Frames (+ 1); Regulatory Sequences, Nucleic Acid (+ 7); Repetitive Sequences, Nucleic Acid (+ 4); Replicon (+ 1); Sequence Homology, Nucleic Acid The sequence of purines and pyrimidines in nucleic acids and polynucleotides. It is also called nucleotide or nucleoside sequence and includes nucleotide-rich regions, conserved sequence, and DNA transforming region. Nucleotides/analysis (66-70); Polynucleotides (66-70); specific nucleic acid (66-70) DEGEIMIPPHRE (ϟ& dBase Composition G06.184.124 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) The relative amounts of the complementary purines and pyrimidines in a nucleic acid, usually expressed in mole percent. nhBasal Metabolism E01.197.882.220; G06.535.335.154 DEGEIMPHRE Calorimetry Diagnosis; Diagnosis, Endocrine (Non MeSH); Thyroid Function Tests Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Energy Metabolism Heat production, or its measurement, of an organism at the lowest level of cell chemistry in an inactive, awake, fasting state. It may be determined directly by means of a calorimeter or indirectly by calculating the heat production from an analysis of the end products of oxidation within the organism or from the amount of oxygen utilized. ո&Basal Ganglia Diseases C10.228.140.079 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Akathisia, Drug-Induced; Alzheimer's Disease; Chorea (+ 1); Creutzfeldt-Jakob Syndrome; Dyskinesia, Drug-Induced; Dystonia Musculorum Deformans; Hallervorden-Spatz Syndrome; Hepatolenticular Degeneration; Meige Syndrome; Neuroleptic Malignant Syndrome; Parkinson Disease (+ 2); Supranuclear Palsy, Progressive; Tourette Syndrome Movement Disorders (66-71); specific anatomic site BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  }NVy=PBasal Ganglia A08.186.211.730.885.105 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon Amygdaloid Body; Corpus Striatum (+ 4); Substantia Innominata Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres. ہ8[KBasal Cell Nevus Syndrome C04.182.089.530.690.150; C04.557.470.200.165.150; C04.557.470.565.165.150; C05.116.099.105; C05.500.470.690.150; C07.320.450.670.130; C16.131.077.130 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplasms; Cysts; Bone Cysts; Jaw Cysts; Odontogenic Cysts Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Carcinoma, Basal Cell Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Basal Cell; Carcinoma, Basal Cell Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental Musculoskeletal Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Stomatognathic Diseases; Jaw Diseases; Jaw Cysts; Odontogenic Cysts Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Hereditary disorder consisting of multiple basal cell carcinomas, odontogenic keratocysts, and multiple skeletal defects, e.g., frontal and temporoparietal bossing, bifurcated and splayed ribs, kyphoscoliosis, fusion of vertebrae, and cervicothoracic spina bifida. Genetic transmission is autosomal dominant. Bone Cyst (66-79); Carcinoma, Basal Cell (66-79); Jaw Diseases (67-79); Jaw Neoplasms (67-79); Skin Neoplasms (67-79); specific jaw disease (67-79); specific jaw neoplasm (67-79); Syndrome (72-79) F N]Bartter's Disease C19.053.181.604.304 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Juxtaglomerular Apparatus Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Hyperfunction; Hyperaldosteronism Hypertrophy and hyperplasia of the juxtaglomerular cells, producing hypokalemic alkalosis and hyperaldosteronism, characterized by absence of hypertension in the presence of markedly increased plasma renin concentrations, and by insensitivity to the pressor effects of angiotensin. It usually affects children, is perhaps hereditary, and may be associated with other anomalies, such as mental retardation and short stature. It is also called juxtaglomerular cell aplasia. (Dorland, 27th ed). Nj5Bartonellaceae Infections C01.252.400.810.700.115 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections Bartonella Infections Infections with bacteria of the family BARTONELLACEAE. Bartonella Infections (66-76); Rickettsial Infections (66-76)  PAHBartonellaceae B03.700.651.254 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales Bartonella A family of small gram-negative bacteria whose organisms are parasites of erythrocytes in man and other vertebrates and the etiologic agents of several diseases. Bacteria (66-74)  "KBartonella Infections C01.252.400.810.700.115.115 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Bartonellaceae Infections Infections, usually with Bartonella bacilliformis, found only in certain areas of Ecuador, Chile, and Peru. Two distinct clinical stages occur: an acute febrile anemia, designated Oroya fever, and a benign skin eruption, called verruga peruana. PBartonella B03.700.651.254.220 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Bartonellaceae A genus of gram-negative bacteria characteristically appearing in chains of several segmenting organisms. It occurs in man and arthropod vectors and is found only in the Andes region of South America. This genus is the etiologic agent of human bartonellosis. ]"]0Bartholin's Glands A05.360.319.887.220; A10.336.095 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Urogenital System; Genitalia; Genitalia, Female; Vulva Tissue Types (Non MeSH); Exocrine Glands T&:sBarrett Esophagus C06.175.102; C06.306.102; C16.131.314.102 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Digestive System Diseases; Esophageal Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Ectopic gastric mucosa in the lower esophagus that often becomes ulcerated (Barrett ulcer), leading to stricture formation (ESOPHAGEAL STENOSIS). Esophageal Stenosis (66-80); Esophagitis, Peptic (66-80) ]1LCBarre-Lieou Syndrome C05.116.900.802.303; C05.550.114.606.761.303; C05.799.613.678.303; C10.772.150.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Spinal Diseases; Spinal Osteophytosis Musculoskeletal Diseases; Joint Diseases; Arthritis; Osteoarthritis; Spinal Osteophytosis Musculoskeletal Diseases; Rheumatic Diseases; Osteoarthritis; Spinal Osteophytosis Nervous System Diseases; Peripheral Nervous System Diseases; Autonomic Nervous System Diseases A syndrome, usually occurring in middle-aged or older persons, characterized by trauma or arthritic changes involving the third and fourth cervical vertebrae or cervical disk lesions with irritation of the cranial nuclei, the fifth and eighth cranial nerves being chiefly affected. (From Jablonski's Dictionary of Syndromes and Eponymic Diseases, 2d ed). \NBarotrauma C21.866.120 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Decompression Sickness Atmospheric Pressure Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Blast Injuries; Decompression Sickness Injury following pressure changes; includes injury to the eustachian tube, ear drum, lung and stomach. Decompression Sickness (66-78); Pressure (66-78) ( NQ.z:Baroreflex G09.330.119; G11.561.730.063 DEGEIMPHRE Pressoreceptors; Vasomotor System Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Reflex A negative feedback system which buffers short-term changes in blood pressure. Increased pressure stretches blood vessels which activates PRESSORECEPTORS (baroreceptors) in the vessel walls. The net response of the central nervous system is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral vascular resistance and by lowering cardiac output. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure. Pressoreceptors (66-93)  "(eBarnacles B01.131.365.124 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Crustacea Various marine crustaceans, free swimming in the larval state, but permanently fixed as adults; there are some 800 described species, grouped in several genera, including Lepas, Balanus, and Scalpellum. Crustacea (66-71)  (,Barley B06.510.253.116; J01.341.182.116 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Cereals Technology, Industry, Agriculture (Non MeSH); Food; Cereals Annual grasses (Graminea) whose grains are used as food and for malting and distillation. Hordeum vulgare and Hordeum distichon are two of the more useful species.  &4nBarium Sulfate D01.103.075; D01.875.800.800.850.075; D26.298.105 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Barium Compounds Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates Miscellaneous Drugs and Agents (Non MeSH); Contrast Media Sulfuric acid, barium salt (1:1). A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield. S9,Barium Radioisotopes D01.496.749.075 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Isotopes; Radioisotopes Unstable isotopes of barium that decay or disintegrate emitting radiation. Ba atoms with atomic weights 126-129, 131, 133, and 139-143 are radioactive barium isotopes. Barium (68-87); Radioisotopes (66-87) 4C.Barium Compounds D01.103 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Barium Sulfate Inorganic compounds that contain barium as an integral part of the molecule. Barium (66-93)   8%\Barium D01.268.552.050; D01.552.539.124 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Metals, Alkaline Earth Inorganic Chemicals (Non MeSH); Metals; Metals, Alkaline Earth Barium. An element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.  &:Barbiturates D03.383.742.698.253 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anesthetics, Intravenous; Anticonvulsants; Sedatives, Barbiturate Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones Amobarbital; Barbital; Hexobarbital; Mephobarbital; Methohexital; Murexide; Pentobarbital; Phenobarbital (+ 1); Secobarbital; Thiobarbiturates (+ 2) A class of chemicals derived from barbituric acid or thiobarbituric acid. Many of these are medically important as sedatives and hypnotics (SEDATIVES, BARBITURATE), as anesthetics, or as anticonvulsants. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8Kh:Barbital D03.383.742.698.253.150; D14.100.240.500.100; D15.210.350.750.060; D15.325.850.060 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression. Barbiturates (68-75)   \:Barbering J01.576.082 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Industry  ABarbados Z01.107.084.900.140 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies ^ OBankruptcy N03.219.463.045 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management The state of legal insolvency with assets taken over by judicial process so that they may be distributed among creditors. [Bangladesh Z01.252.245.131 EHEP Geographicals (Non MeSH); Asia; Asia, Western =9Bandages E07.101 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Biological Dressings; Occlusive Dressings Material used for wrapping or binding any part of the body.   1JBand 3 Protein D12.776.124.110; D12.776.157.070.110; D12.776.395.550.070.110; D12.776.543.550.070.110 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Antiporters Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins; Antiporters Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins; Antiporters A ubiquitous membrane transport protein found in the plasma membrane of diverse cell types and tissues, and in nuclear, mitochondrial, and Golgi membranes. It is the major integral transmembrane protein of the erythrocyte membrane, comprising 25% of the total membrane protein and occurring at 1 million copies per cell. It exists as a dimer and provides a channel for the transport of anions across the membrane. Blood Proteins (66-83); Membrane Proteins (77-83) `F<Bambermycins D20.085.135 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Antibiotic complex obtained from Streptomyces bambergiensis containing mainly Moenomycins A and C. They are used as feed additives and growth promoters for poultry, swine, and cattle. Antibiotics (66-78); Glycolipids (66-78) k:)1Baltimore Z01.107.567.875.100.472.100; Z01.107.567.875.600.513.472.100; Z01.433.100 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH); Maryland Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Mid-Atlantic Region; Maryland Geographicals (Non MeSH); Cities (Non MeSH)  QaBaltic States Z01.542.248.136; Z01.586.950.140 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR Estonia; Latvia; Lithuania Estonia; Latvia; Lithuania The geographic area of the Baltic States (ESTONIA, LATVIA, and LITHUANIA) in general or when the specific countries or country are not indicated. &BBalsams D25.786.219 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Resins  ,>Balneology E02.780.108 CLECEDHIISLJMAMTOGSNSTTD Health Resorts; Mineral Waters Therapeutics; Physical Therapy Ammotherapy; Baths; Baths, Finnish; Mud Therapy Therapy by various hot or warm baths in natural mineral waters, spas, or "cures". It includes not only bathing in, but also drinking the waters, but it does not include whirlpool baths (HYDROTHERAPY). AECLCTECEDHIISLJMAMOMTNUOGPXSNSTTDUTVE $&%;*Balloon Dilatation E02.148.102 AECLCTECHIISMOMTNUPXSNSTTDUTVE Gastric Bubble Dilatation Therapeutics; Catheterization Angioplasty, Balloon (+ 2) Nonoperative repair of occluded vessels, ducts, or valves by insertion of a balloon catheter. It is used to treat varices, torn retinas, renal and biliary calculi, gastric, bronchial and rectal stenoses, and heart valves, and includes catheterization with Fogarty and Foley catheters. Angioplasty, Transluminal (82-87); Assisted Circulation (67-75); Catheterization or specific (66-87); Dilatation (76-87) AECLCTECHIISMOMTNUPXRHSNSTTDUTVE ,"#!K$Ballistocardiography E01.145.569.136 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Heart Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Technique of graphic representation of the movements of the body imparted by the ballistic forces (recoil and impact) associated with cardiac contraction and ejection of blood and with the deceleration of blood flow through the large blood vessels. These movements, quantitatively very minute, are translated by a pickup device (transducer) into an electrical potential which is suitably amplified and recorded on a conventional electrocardiograph or other recording machine. "l& S$Balkan Nephropathy C12.777.419.570.643.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Nephritis; Nephritis, Interstitial A tubulointerstitial disease of unknown etiology occurring in a limited geographic area including adjacent regions of Romania, Bulgaria, and Yugoslavia. Kidney Diseases (66-81); Nephritis (66-75); Nephritis, Interstitial (69-81); Pyelonephritis (66-69) %dNvBalantidium B01.841.185.375.650.650.153 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Ciliophora; Kinetofragminophorea; Trichostomatida; Trichostomatina A genus of protozoa parasitic in the digestive tract of vertebrate or invertebrate hosts. Asexual multiplication is accomplished by transverse binary fission. Its organisms are ovoidal in shape and have a ciliated covering over the entire body. '&iBalantidiasis C03.432.146; C03.752.200.146; C06.405.469.452.146 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Intestinal Diseases, Parasitic Parasitic Diseases; Protozoan Infections; Ciliophora Infections Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic Infection by protozoan parasites of the genus BALANTIDIUM. The presence of Balantidium in the large intestine leads to diarrhea, dysentery, and occasionally ulceration. )9PBalanitis C12.294.494.136 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Genital Diseases, Male; Penile Diseases Inflammation of the glans penis. It is usually associated with phimosis. (Dorland, 27th ed). ,6 NhqBahrain Z01.252.245.500.175; Z01.586.500.175 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East - *Bahamas Z01.107.084.900.100 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies . OBaculoviridae B04.280.065; B04.525.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Insect Viruses Nuclear Polyhedrosis Virus Nuclear Polyhedrosis Virus Family of INSECT VIRUSES containing two subfamilies: Eubaculovirinae (occluded baculoviruses) and Nudibaculovirinae (nonoccluded baculoviruses). The Eubaculovirinae, which contain polyhedron-shaped inclusion bodies, have two genera: NUCLEAR POLYHEDROSIS VIRUS and granulosis virus. Baculovirus vectors are used for expression of foreign genes in insects. Polyhedrosis Viruses (73-90)  /57>"Bacteroides Infections C01.252.400.110.109 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Bacteroidaceae Infections Infections with bacteria of the genus BACTEROIDES. Bacteroides (66-67) 1P=Bacteroides fragilis B03.440.425.410.194.152.400 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae; Bacteroides Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections. Bacteroides (66-75) 3e"Bacteroides B03.440.425.410.194.152 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH); Bacteroidaceae Bacteroides fragilis A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic. 5"Bacteroidaceae Infections C01.252.400.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections Bacteroides Infections; Fusobacterium Infections Infections with bacteria of the family BACTEROIDACEAE. 7Ps8ABacteroidaceae B03.440.425.410.194 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Anaerobic Bacteria; Gram-Negative Anaerobic Straight, Curved, and Helical Rods (Non MeSH) Bacteroides (+ 1); Fusobacterium (+ 2); Mobiluncus; Porphyromonas (+ 1); Prevotella (+ 2); Wolinella A family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic. Bacteria (66-74)  9j"~Bacteriuria C01.539.895.219; C12.777.892.219 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Urine Bacterial and Fungal Diseases (Non MeSH); Infection; Urinary Tract Infections Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Urinary Tract Infections The presence of bacteria in the urine with or without consequent urinary tract infection. Since BACTERIURIA is a clinical entity, the term does not preclude the use of URINE/microbiology for technical discussions on the isolation and segregation of bacteria in the urine. ;&P ?Bacteriorhodopsin D02.455.849.131.125; D11.557.261.125; D12.776.097.125 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Purple Membrane Purple Membrane Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Carotenoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins A rhodopsin-like protein found in the PURPLE MEMBRANE of Halobacterium halobium and other halophilic bacteria. Its molecular weight is 26,000 and it is bound to retinal in a 1:1 ratio. It has photoreactions similar to those observed in rhodopsin and functions as an energy transducer or proton pump. Bacterial Proteins (74-75); Retinal Pigments (74-75) $>=Fa?Bacteriophages B04.123 CHCLDEENGDGEIMIPMEPHPYREUL Lysogeny Viruses Bacillus Phages; Caudovirales (+ 11); Coliphages (+ 13); Cystoviridae (+ 1); Inoviridae (+ 3); Leviviridae (+ 2); Microviridae (+ 2); Mycobacteriophages; Pseudomonas Phages (+ 1); RNA Phages (+ 5); Salmonella Phages (+ 1); Staphylococcus Phages; Streptococcus Phages; Tectiviridae Viruses whose host is a bacterial cell.  B   W2Bacteriophage T7 B04.123.150.700.230; B04.123.205.891.230; B04.280.090.700.230 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Podoviridae Viruses; Bacteriophages; Coliphages; T-Phages Viruses; DNA Viruses; Caudovirales; Podoviridae Virulent bacteriophage of the family PODOVIRIDAE that infects E. coli. It consists of linear double-stranded DNA, terminally redundant, and non-permuted. Coliphages (66-79); T-Phages (80-92) DE-Bacteriophage T4 B04.123.150.500.350; B04.123.205.891.200; B04.280.090.500.350 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Myoviridae Viruses; Bacteriophages; Coliphages; T-Phages Viruses; DNA Viruses; Caudovirales; Myoviridae Virulent bacteriophage of the family PODOVIRIDAE that infects E. coli and is the best known of the T-even phages. Its virion contains linear double-stranded DNA, terminally redundant, and circularly permuted. Coliphages (66-79); T-Phages (80-92) F?E-Bacteriophage T3 B04.123.150.700.100; B04.123.205.891.100; B04.280.090.700.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Podoviridae Viruses; Bacteriophages; Coliphages; T-Phages Viruses; DNA Viruses; Caudovirales; Podoviridae Bacteriophage of the family PODOVIRIDAE which is very closely related to BACTERIOPHAGE T7. Coliphages (66-93) HEkBacteriophage Typing E05.909.560.150.125.150 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques; Bacteriological Techniques; Bacterial Typing Techniques A technique of bacterial typing which differentiates between bacteria or strains of bacteria by their susceptibility to one or more bacteriophages. Jo"Bacteriophage P22 B04.123.150.700.070; B04.123.706.070; B04.280.090.700.070 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Podoviridae Viruses; Bacteriophages; Salmonella Phages Viruses; DNA Viruses; Caudovirales; Podoviridae Temperate bacteriophage of the family PODOVIRIDAE that infects Salmonella species. The genome consists of double-stranded DNA, terminally redundant, and circularly permuted. Salmonella Phages (66-92) L6ABacteriophage P2 B04.123.150.500.305; B04.123.205.305; B04.280.090.500.305 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Myoviridae Viruses; Bacteriophages; Coliphages Viruses; DNA Viruses; Caudovirales; Myoviridae A temperate bacteriophage of the family MYOVIRIDAE which infects E. coli. It consists of linear double-stranded DNA with 19-base sticky ends. Coliphages (66-93) N]ABacteriophage P1 B04.123.150.500.300; B04.123.205.300; B04.280.090.500.300 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Myoviridae Viruses; Bacteriophages; Coliphages Viruses; DNA Viruses; Caudovirales; Myoviridae Temperate bacteriophage of the family MYOVIRIDAE which infects E. coli. It is the largest of the coliphages and consists of double-stranded DNA, terminally redundant, and circularly permuted. Coliphages (66-92) PQABacteriophage phi 6 B04.123.230.070; B04.123.660.070; B04.123.691.230.070; B04.820.180.070 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Cystoviridae Viruses; Bacteriophages; Pseudomonas Phages Viruses; Bacteriophages; RNA Phages; Cystoviridae Viruses; RNA Viruses; Cystoviridae Virulent bacteriophage and sole member of the genus Cystovirus that infects Pseudomonas species. The virion has a segmented genome consisting of three pieces of doubled-stranded DNA and also contains a unique lipid-containing membrane. Bacteriophages (66-92) R}PBacteriophage phi X 174 B04.123.205.320; B04.123.470.500.320; B04.280.470.500.320 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Coliphages Viruses; Bacteriophages; Microviridae; Microvirus Viruses; DNA Viruses; Microviridae; Microvirus The type species of the genus MICROVIRUS. A prototype of the small virulent DNA coliphages, it is composed of a single strand of supercoiled circular DNA, which on infection, is converted to a double-stranded replicative form by a host enzyme. Coliphages (66-79) UA Bacteriophage M13 B04.123.205.250; B04.123.370.400.250; B04.280.400.400.250 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Coliphages Viruses; Bacteriophages; Inoviridae; Inovirus Viruses; DNA Viruses; Inoviridae; Inovirus Temperate bacteriophage of the genus INOVIRUS which infects enterobacteria, especially E. coli. It is a filamentous phage consisting of single-stranded DNA and is circularly permuted. Coliphages (66-92) WABacteriophage mu B04.123.150.500.260; B04.123.205.260; B04.280.090.500.260 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Myoviridae Viruses; Bacteriophages; Coliphages Viruses; DNA Viruses; Caudovirales; Myoviridae A temperate coliphage composed of a linear, double-stranded molecule of DNA, which is able to insert itself at random at any point on the host chromosome. It frequently causes a mutation by interrupting the continuity of the bacterial operon at the site of insertion. Coliphages (66-79) YA<Bacteriophage lambda B04.123.150.800.230; B04.123.205.230; B04.280.090.800.230 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Caudovirales; Siphoviridae Viruses; Bacteriophages; Coliphages Viruses; DNA Viruses; Caudovirales; Siphoviridae A temperate inducible phage whose natural host is E. coli K12. Its virion contains linear double-stranded DNA, except for 12 complementary bases at the 5'-termini of the polynucleotide chains. The DNA circularizes on infection. Coliphages (66-79) \3A Bacteriolysis G04.185.515.120.120 DEGEIMPHRE Lysostaphin Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Bacterial Phenomena (Non MeSH) Disruption of the structural integrity of a bacterial cell resulting in release of the cell contents. (Dorland, 27th ed). ^Bacteriology G01.273.540.177 CLECEDHIISLJMAOGSNSTTD Biological Sciences; Biology; Microbiology `L3Bacteriological Techniques E05.909.560.150 AECLCTECHIISMONUPXSNSTTDUTVE Culture Media Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques Bacterial Typing Techniques (+ 2); Limulus Test AECLCTECHIISMOMTNUPXSNSTTDUTVE  ` b;"Bacteriocins D20.085.133; D24.310.125 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Immunologic and Biologic Factors (Non MeSH); Biological Products Cloacin; Colicins; Megacins; Pyocins Cloacin; Colicins; Megacins; Pyocins Substances elaborated by specific strains of bacteria that are lethal against other strains of the same or related species. They are protein or lipopolysaccharide-protein complexes used in taxonomy studies of bacteria. AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR  b)<tZDBacteriochlorophylls D11.557.727.220.100; D11.557.727.640.220.100 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Chlorophyll Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Porphyrins; Metalloporphyrins; Chlorophyll Photosynthetic pigments in which pyrrole ring II is more reduced than in plant chlorophylls. Different photosynthetic bacteria have different species of bacteriochlorophyll. Chlorophyll (74) d2>Bacterial Vaccines D24.310.894.135 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines BCG Vaccine; Brucella Vaccine; Cholera Vaccine; Diphtheria-Tetanus-Pertussis Vaccine; Haemophilus Vaccines; Pertussis Vaccine (+ 1); Plague Vaccine; Rickettsial Vaccines; Staphylococcal Vaccines; Typhoid-Paratyphoid Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. g3>YBacterial Typing Techniques E05.909.560.150.125 AECLCTECHIISMONUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Microbiological Techniques; Bacteriological Techniques Bacteriophage Typing; Serotyping Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping. Bacteriological Techniques (66-88); Bacteriophage Typing (66-88); Serotyping (66-88) AECLCTECHIISMOMTNUPXSNSTTDUTVE $i! 'c"Bacterial Toxins D24.185.926.123 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins Botulinum Toxins; Cholera Toxin; Cord Factors; Diphtheria Toxin; Exfoliatins; Leukocidins; Pertussis Toxins; Streptolysins; Tetanus Toxin Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacteria (66-76); Toxins (66-76) ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $l9:V)BBacterial Proteins D12.776.097 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Azurin; Bacterial Capsules; Bacterial Outer Membrane Proteins (+ 3); Bacteriorhodopsin; Cell Wall Skeleton; Colicins; Ferredoxins (+ 2); Flagellin; Flavodoxin; GroEL Protein; GroES Protein; Photosynthetic Reaction Center, Bacterial; Rec A Protein; Staphylococcal Protein A; Zinostatin Proteins found in any species of bacterium. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  oCDDQ6HBacterial Phenomena (Non MeSH) G04.185.515.120 Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) Bacterial Adhesion; Bacteriolysis; Luminescence, Bacterial; Nitrogen Fixation DEGEIMPHRE q%ZBacterial Outer Membrane Proteins D12.776.097.120; D12.776.543.100 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins Adhesins, Bacterial (+ 1); Porins Adhesins, Bacterial (+ 1); Porins Proteins isolated from the outer membrane of bacteria. Bacterial Proteins (66-84); Membrane Proteins (77-84)  sC(&DTB@Bacterial Infections C01.252 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH) Bacteremia (+ 1); Endocarditis, Bacterial (+ 1); Eye Infections, Bacterial (+ 9); Gram-Negative Bacterial Infections (+ 113); Gram-Positive Bacterial Infections (+ 81); Meningitis, Bacterial (+ 6); Pneumonia, Bacterial (+ 4); Sexually Transmitted Diseases, Bacterial (+ 6); Skin Diseases, Bacterial (+ 22); Spirochaetales Infections (+ 18); Vaginosis, Bacterial Infections by bacteria, general or unspecified. Infection (66-71)  u P19Bacterial Capsules D09.203.698.718.200; D12.776.097.110; D24.611.216.161.616.200 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Polysaccharides, Bacterial Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial; Polysaccharides, Bacterial An envelope of loose gel surrounding a bacterial cell which is associated with the virulence of pathogenic bacteria. Some capsules have a well-defined border, whereas others form a slime layer that trails off into the medium. Most capsules consist of relatively simple polysaccharides but there are some bacteria whose capsules are made of polypeptides. Polysaccharides, Bacterial (66-91) xWE6r(Bacterial and Fungal Diseases (Non MeSH) C01 Bacterial Infections (+ 272); Infection (+ 122); Mycoses (+ 40); Zoonoses BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI |G1]PBacterial Adhesion G04.185.515.120.100 DEGEIMPHRE Adhesins, Bacterial Biofilms; Adhesins, Bacterial Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Bacterial Phenomena (Non MeSH) Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. Adhesiveness (69-86); Bacteria (66-86); Pili, Bacterial (80-86) $}K$MBacteria, Anaerobic B03.130 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Anaerobiosis (71-83); Bacteria (66-83)  " /Bacteria, Aerobic B03.120 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Aerobiosis (71-83); Bacteria (66-83)  " -Bacteria B03 CHCLCYDEENGDGEIMIPMEPHPYREULVI Microbiology Actinomycetes and Related Organisms (Non MeSH) (+ 47); Archaeobacteria (+ 20); Atypical Bacterial Forms (+ 2); Bacteria, Aerobic; Bacteria, Anaerobic; Biofilms; Blood-Borne Pathogens; Budding or Appendaged Bacteria (Non MeSH) (+ 2); Endospore-Forming Bacteria (Non MeSH) (+ 23); Gardnerella (+ 1); Gliding Bacteria (Non MeSH) (+ 12); Gram-Negative Bacteria (+ 193); Gram-Positive Bacteria (+ 141); Phototrophic Bacteria (+ 10); Rickettsias and Chlamydias (Non MeSH) (+ 30); Sheathed Bacteria (Non MeSH) (+ 2); Spiral and Curved Bacteria (Non MeSH) (+ 12); Spirochaetales (+ 12); Spores (+ 1); Sulfur-Reducing Bacteria (+ 2) Unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI  * "&Bacteremia C01.252.100; C01.539.757.720.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Sepsis; Septicemia Hemorrhagic Bacteremia Hemorrhagic Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Septicemia (66-91); specific bacterial infection (66-91)  &P4sCBaclofen D02.241.081.161.125.439.200; D14.100.240.200.100; D15.525.080; D16.700.600.080 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates; Aminobutyric Acids; GABA Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Agonists Central Nervous System Agents; Muscle Relaxants, Central Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Muscle Relaxants, Central A GABA derivative that is a specific agonist at GABA-B receptors (RECEPTORS, GABA-B). It is used in the treatment of spasticity, especially that due to spinal cord damage. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission. Aminobutyric Acids (72-74); Chlorobenzenes (74)  X:`9Background Radiation H01.671.768.513.115 AE Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Ionizing Radiation from sources other than the source of interest. It is due to cosmic rays and natural radioactivity in the environment. Radiation (66-70); Radioactivity (66-70) T1Back Pain C10.597.617.152; C23.888.592.612.107 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Low Back Pain Nervous System Diseases; Neurologic Manifestations; Pain Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Low Back Pain Low Back Pain A continuous pain located in the back, usually below the cervical level. For lower back pain or pain in the lumbar region, LOW BACK PAIN is available.  n*N$Back A01.176 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH) Lumbosacral Region; Sacrococcygeal Region  (1Bacitracin D20.085.116.125 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Bacitracin. A complex of cyclic peptide antibiotics produced by the Tracy-I strain of Bacillus subtilis. The commercial preparation is a mixture of at least nine bacitracins with bacitracin A as the major constituent. It is used topically to treat open infections such as infected eczema and infected dermal ulcers. (From Goodman and Gilman, The Pharmacological Basis of Therapeutics, 8th ed). y<BBacillus thuringiensis B03.300.390.400.158.218.800; B03.510.415.400.158.218.800; B03.510.460.410.158.218.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus A species of gram-positive bacteria which may be pathogenic for certain insects. It is used for the biological control of the Gypsy moth. Bacillus (66-74)  ]"Bacillus subtilis B03.300.390.400.158.218.725; B03.510.415.400.158.218.725; B03.510.460.410.158.218.725 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus A species of gram-positive bacteria that is a common soil and water saprophyte. s]"`Bacillus stearothermophilus B03.300.390.400.158.218.700; B03.510.415.400.158.218.700; B03.510.460.410.158.218.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus A species of gram-positive bacteria found in soil, hot springs, Arctic waters, ocean sediments, and spoiled food products. Bacillus (66-74) z ]"Bacillus Phages B04.123.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages Viruses whose host is Bacillus. Frequently encountered Bacillus phages include bacteriophage phi 29 and bacteriophage phi 105. Bacteriophages (66-92) Bacillus megaterium B03.300.390.400.158.218.500; B03.510.415.400.158.218.500; B03.510.460.410.158.218.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus A species of bacteria whose spores vary from round to elongate. It is a common soil saprophyte. ]"uBacillus cereus B03.300.390.400.158.218.252; B03.510.415.400.158.218.252; B03.510.460.410.158.218.252 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus A species of rod-shaped bacteria that is a common soil saprophyte. Its spores are widespread and multiplication has been observed chiefly in foods. Contamination may lead to food poisoning. &]"Bacillus anthracis B03.300.390.400.158.218.151; B03.510.415.400.158.218.151; B03.510.460.410.158.218.151 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae; Bacillus A species of bacteria that causes ANTHRAX in humans and animals. ]"OBacillus B03.300.390.400.158.218; B03.510.415.400.158.218; B03.510.460.410.158.218 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH); Bacillaceae Bacillus anthracis; Bacillus cereus; Bacillus megaterium; Bacillus stearothermophilus; Bacillus subtilis; Bacillus thuringiensis Bacillus anthracis; Bacillus cereus; Bacillus megaterium; Bacillus stearothermophilus; Bacillus subtilis; Bacillus thuringiensis Bacillus anthracis; Bacillus cereus; Bacillus megaterium; Bacillus stearothermophilus; Bacillus subtilis; Bacillus thuringiensis A genus of BACILLACEAE that are spore-forming, rod-shaped cells. Most species are saprophytic soil forms with only a few species being pathogenic.  Q"Bacillaceae Infections C01.252.410.090 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections Anthrax; Clostridium Infections (+ 5) Infections with bacteria of the family BACILLACEAE. xPs.>Bacillaceae B03.300.390.400.158; B03.510.415.400.158; B03.510.460.410.158 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Endospore-Forming Bacteria (Non MeSH); Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Endospore-Forming Bacteria; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Endospore-Forming Rods (Non MeSH) Bacillus (+ 6); Clostridium (+ 4) Bacillus (+ 6); Clostridium (+ 4) Bacillus (+ 6); Clostridium (+ 4) A family of bacteria which produce endospores. They are mostly saprophytes from soil, but a few are insect or animal parasites or pathogens. Bacteria (66-74)  E"Babesiosis C03.701.188; C03.701.688.122; C03.752.625.122; C03.752.750.113; C03.752.875.175; C22.674.710.122 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH) Parasitic Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Protozoan Infections, Animal (Non MeSH) Parasitic Diseases; Protozoan Infections; Sporozoea Infections Parasitic Diseases; Protozoan Infections; Tick-Borne Diseases Animal Diseases; Parasitic Diseases, Animal (Non MeSH); Protozoan Infections, Animal (Non MeSH) A group of tick-borne diseases of cattle, sheep, goats, horses, swine, dogs, and cats. It is caused by protozoans of the genus BABESIA, which parasitize the red blood cells, producing hemolysis. Protozoan Infections (66-67) unJ"Babesia bovis B01.841.075.762.580.580.070.100 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Piroplasmia; Piroplasmida; Babesia A species of protozoa that is a cause of bovine babesiosis. Ticks of the genera Boophilus, Rhipicephalus, and Ixodes are the chief vectors. Babesia (75-91) y#&cBabesia B01.841.075.762.580.580.070 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Apicomplexa; Sporozoea; Piroplasmia; Piroplasmida Babesia bovis A genus of tick-borne protozoan parasites that infests the red blood cells of mammals, including humans. There are many recognized species, and the distribution is world-wide.  &XB-Lymphocytes A11.063.438; A11.118.637.555.567.562; A15.145.229.637.555.567.562; A15.382.490.555.567.562; A15.382.520.118.438; A15.382.520.520.438 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Lymphocyte Cooperation Cells; Antibody-Producing Cells Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Antibody-Producing Cells Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes B-Lymphocyte Subsets B-Lymphocyte Subsets B-Lymphocyte Subsets B-Lymphocyte Subsets B-Lymphocyte Subsets B-Lymphocyte Subsets Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. Lymphocytes (66-72) $*9B-Lymphocyte Subsets A11.063.438.450; A11.118.637.555.567.550.450; A11.118.637.555.567.562.450; A15.145.229.637.555.567.550.450; A15.145.229.637.555.567.562.450; A15.382.490.555.567.550.450; A15.382.490.555.567.562.450; A15.382.520.118.438.450; A15.382.520.520.430.450; A15.382.520.520.438.450 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Antibody-Producing Cells; B-Lymphocytes Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Lymphocyte Subsets Cells; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; B-Lymphocytes Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Lymphocyte Subsets Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; B-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; Lymphocyte Subsets Hemic and Immune Systems (Non MeSH); Immune System; Leukocytes; Leukocytes, Mononuclear; Lymphocytes; B-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Antibody-Producing Cells; B-Lymphocytes Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; Lymphocyte Subsets Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphocytes; B-Lymphocytes A classification of B-lymphocytes based on structurally or functionally different populations of cells. B-Lymphocytes/classification (80-90) &*x*B-Cell Activation Antigen D24.611.216.301.300 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface The natural ligand for the T-cell antigen CD28 (ANTIGENS, CD28) mediating T- and B-cell adhesion. B7 is expressed on activated B-cells and gamma-interferon-stimulated monocytes. The binding of B7 to CD28 provides a co-stimulatory signal to T-cells and leads to greatly upregulated lymphokine production. Antigens, Surface (91-93) e6}`Azygos Vein A07.231.908.106 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins A vein which arises from the right ascending lumbar vein or the vena cava, enters the thorax through the aortic orifice in the diaphragm, and terminates in the superior vena cava. 85Azurin D12.776.097.100; D12.776.556.080 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins A bacterial protein from Pseudomonas, Bordetella, or Alcaligenes which operates as an electron transfer unit associated with the cytochrome chain. The protein has a molecular weight of approximately 16,000, contains a single copper atom, is intensively blue, and has a fluorescence emission band centered at 308nm. Bacterial Proteins (70-74); Copper (70-74); Metalloproteins (73-74) } &DmQAzure Stains D03.494.741.080; D26.408.086 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Miscellaneous Drugs and Agents (Non MeSH); Dyes Green crystals or powder used as biological stains. Dimethylamines (74-75); Imines (74-75); Phenothiazines (69-75); Stains and Staining (66-75) ̆",?nAztreonam D20.085.099.598.092 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Monobactams 2-(((1-(2-Amino-4-thiazolyl)-2-((2-methyl-4-oxo-1-sulfo-3- azetidinyl)amino)-2-oxoethylidene)amino)oxy)-2-methyl- propanoic acid. A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Antibiotics (66-82); Antibiotics, Lactam (83-85) L <P:Azoxymethane D02.172.080; D26.191.090 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Azo Compounds Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Cycasin; Methylazoxymethanol Acetate Cycasin; Methylazoxymethanol Acetate A potent carcinogen and neurotoxic compound. It is particularly effective in inducing colon carcinomas. Azo Compounds (73-75); Nitrogen Oxides (73-74)  (:vTz9Azotobacteraceae B03.440.400.425.135 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Azotobacter (+ 1) A family of motile, gram-negative bacteria found in soil and water and capable of fixing atmospheric nitrogen. Bacteria (66-74)  8"Azotobacter vinelandii B03.440.400.425.135.135.850 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Azotobacteraceae; Azotobacter A species of gram-negative, aerobic bacteria first isolated from Vineland, New Jersey. Ammonium and nitrate are used as nitrogen sources by this bacterium. Azotobacter (66-91) "Azotobacter B03.440.400.425.135.135 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Azotobacteraceae Azotobacter vinelandii A genus of gram-negative, aerobic bacteria found in soil and water. Its organisms occur singly, in pairs or irregular clumps, and sometimes in chains of varying lengths. "Azospirillum brasilense B03.440.400.425.130.200; B03.825.100.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Azospirillum Bacteria; Spiral and Curved Bacteria (Non MeSH); Azospirillum Motile, free-living, gram-negative bacteria that occur in the soil. They are aerobic or microaerophilic and are sometimes capable of nitrogen fixation. Spirillum (78-89) ."Azospirillum B03.440.400.425.130; B03.825.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Bacteria; Spiral and Curved Bacteria (Non MeSH) Azospirillum brasilense Azospirillum brasilense A genus of gram-negative bacteria that occurs free-living in the soil or associated with the roots of cereal crops or grasses. &"6Azores Z01.295.218 EHEP Geographicals (Non MeSH); Atlantic Islands   4Azoles D03.383.129 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Tetrazoles (+ 2); Triazoles (+ 5) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ݁ 8G,:Azocines D03.383.113 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Cyclazocine (+ 1); Oxazocines (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ަ 8G.:Azo Compounds D02.172 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Amaranth; Amido Black; p-Aminoazobenzene; o-Aminoazotoluene; Arsenazo III; p-Azobenzenearsonate; Azoxymethane (+ 2); Diamide; Diazonium Compounds (+ 1); Diazooxonorleucine; Dithizone; Evans Blue; Formazans; Tartrazine AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR  8#DAzlocillin D20.085.099.739.762.057.094 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Ampicillin 3,3-Dimethyl-7-oxo-6-(((((2-oxo-1-imidazolidinyl)carbonyl) amino)phenyl)acetyl)amino)-4-thia-1-azabicyclo(3.2.0) heptane-2-carboxylic acid. A semisynthetic ampicillin-derived acylureido penicillin proposed for opportunistic Pseudomonas infections in debilitated patients. Penicillins (66-84) :o,Azithromycin D20.085.115.090; D20.085.115.250.050 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide; Erythromycin (2R-(2R*,3S*,4R*,5R*,8R*,10R*,11R*,12S*,13S*,14R*))-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6- azacyclopentadecan-15-one. A semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. Erythromycin/analogs and derivatives (87-93) *< 4Azirines D03.383.097 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Aziridines (+ 5); Mitomycins (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR d 8G-<Aziridines D03.383.097.217 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azirines Carbazilquinone; Tepa (+ 1); Triaziquone; Triethylenemelamine Saturated azacyclopropane compounds. Any substitutions on carbon or nitrogen atoms are permitted. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8TJr:Azinphosmethyl D02.719.094; D05.723.491.657.101 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71) \&:Azides D02.159 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH)   8#Azetines D03.383.082 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Azetidines (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Z 8G:Azetidines D03.383.082.301 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azetines Azetidinecarboxylic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR k8T:Azetidinecarboxylic Acid D02.241.081.583.100; D02.491.485.100; D03.383.082.301.100; D12.125.072.401.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Imino Acids Organic Chemicals (Non MeSH); Imines; Imino Acids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azetines; Azetidines Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Cyclic (Non MeSH); Imino Acids 2-Azetidinecarboxylic Acid. A proline analog. Acts as a stoichiometric replacement of proline causing the production of abnormal proteins having impaired biological activity. Azetines (74-75); Imino Acids (74) X:,Azerbaijan Z01.542.900.120; Z01.586.200.120; Z01.586.950.120 EHEP Geographicals (Non MeSH); Europe; Transcaucasia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR 9Azepines D03.383.066 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH) Caprolactam; Dilazep; Meptazinol; Oxazepines; Pentylenetetrazole; Thiazepines; Zolazepam AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR N 8Gh:Azauridine D02.145.451; D13.570.685.852.176; D13.570.800.892.176; D22.204.144.216; D26.087.095 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aza Compounds Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Uridine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione. A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic. Antimetabolites (66-71); Uridine (66-71) _:?1Azathioprine D03.438.759.534.090; D17.050.070; D22.204.144.183; D22.569.351; D26.087.072 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; 6-Mercaptopurine Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine. An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed). W:Azasteroids D04.808.925.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Steroids, Heterocyclic Finasteride Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms. Steroids (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8C:Azaserine D12.125.262; D20.085.062.217; D20.085.075.166; D20.136.073.217; D22.204.106.180; D22.204.144.149; D22.569.250; D26.087.060 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites L-Serine diazoacetate (ester). Antibiotic substance produced by various Streptomyces species. It is an inhibitor of enzymatic activities that involve glutamine and is used as an antineoplastic and immunosuppressive agent.  <Azaperone D02.522.352.110; D14.100.150.175.050; D15.150.015.050; D15.210.350.800.050; D15.210.950.040.015.050; D15.325.875.050; D15.700.872.331.015.095 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones; Butyrophenones Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Butyrophenone A butyrophenone used in the treatment of psychoses. Butyrophenones (71-74); Piperazines (71-74); Pyridines (71-74) 5 :Y?KAzaguanine D02.145.250; D03.438.759.758.399.454.300; D22.204.144.116; D26.087.036 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aza Compounds Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Hypoxanthines; Guanine Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites 5-Amino-1,4-dihydro-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one. One of the early purine analogs showing antineoplastic activity. It functions as an antimetabolite and is easily incorporated into ribonucleic acids. #P:fAzacytidine D02.145.150; D13.570.685.245.217; D13.570.800.286.300; D26.087.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aza Compounds Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Cytidine Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides; Cytidine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Nucleosides (66-71); Triazines (66-71)  4L:\/Azacosterol D04.808.247.222.284.070; D04.808.247.808.197.070; D10.516.851.208.070 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Cholestenes; Cholesterol Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols; Cholesterol Lipids and Antilipemic Agents (Non MeSH); Lipids; Sterols; Cholesterol 17-[[3-(Dimethylamino)propyl]methylamino]-androst-5-en-3-ol. Diaza derivative of cholesterol which acts as a hypocholesteremic agent by blocking delta-24-reductase, which causes the accumulation of desmosterol. Induces myotonia. It is also used as an avian chemosterilant. Synonym: SC-12937. Aza Compounds (72-77); Cholesterol (66-77)  wM:M4Aza Compounds D02.145 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Azacytidine; Azaguanine; Azauridine specific parent compound (72-73) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   8#+':AY 9944 D02.455.426.392.368.367.100; D10.162.202.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Cyclohexanes Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents; Anticholesteremic Agents N,N-Bis(o-chlorobenzyl)-trans-1,4-cyclohexanebis(methylamine). An anticholesteremic agent which inhibits sterol biosynthesis in animals. Benzyl Compounds (72-74); Cyclohexanes (68-74); Methylamines (72-74)  2: RAxoplasmic Flow G04.335.418.300 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cytoplasmic Streaming The continuous flow of new cytoplasm down the axon of a nerve cell. Axons (66-68); Cytoplasmic Streaming (67-68) sT6Axons A08.663.542.145; A11.671.137 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Nerve Fibers Cells; Neurons Neurites; Presynaptic Terminals Neurites; Presynaptic Terminals That process of a neuron by which impulses travel away from the body. At the terminal arborization of the axon, the impulses are transmitted to other nerve cells or to effector organs. In the peripheral nervous system, the larger (myelinated) axons are surrounded by a myelin sheath formed by concentric layers of plasma membrane of the Schwann cell. In the central nervous system, the function of the Schwann cell is supplied by oligodendrocytes (OLIGODENDROGLIA). (From Dorland, 27th ed).  "(AJBAxis A02.835.232.834.151.383 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine; Cervical Vertebrae Odontoid Process !:[Axillary Vein A07.231.908.077 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Veins The venous trunk of the upper limb; a continuation of the basilar and brachial veins running from the lower border of the teres major muscle to the outer border of the first rib where it becomes the subclavian vein. 85Axillary Artery A07.231.114.085 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries The continuation of the subclavian artery; it distributes over the upper limb, axilla, chest and shoulder. 88Axilla A01.133 ABAHBSEMGDINIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH)   (Awareness F02.463.188.150 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Cognition The act of "taking account" of an object or state of affairs. It does not imply assessment of nor attention to the qualities or nature of the object. |  [Awards and Prizes K01.150 Humanities Nobel Prize  Avoidance Learning F02.463.425.097 CLDEPHRE Escape Reaction Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning A response to a cue that is instrumental in avoiding a noxious experience. ; Z[Avitaminosis C18.654.223.133 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases Ascorbic Acid Deficiency (+ 1); Vitamin A Deficiency; Vitamin B Deficiency (+ 10); Vitamin D Deficiency (+ 2); Vitamin E Deficiency (+ 1); Vitamin K Deficiency A condition due to a deficiency of one or more essential vitamins. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  aNgkPAvipoxvirus B04.280.650.160.100; B04.909.204.783.160.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Poxviridae; Chordopoxvirinae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Poxviridae; Chordopoxvirinae Fowlpox Virus Fowlpox Virus A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising bird poxviruses. The type species is FOWLPOX VIRUS. Transmission is mechanical by arthropods. "2"Avihepadnavirus B04.280.375.100; B04.450.390.100; B04.909.204.340.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Hepadnaviridae Viruses; Hepatitis Viruses; Hepadnaviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Hepadnaviridae Hepatitis B Virus, Duck Hepatitis B Virus, Duck Hepatitis B Virus, Duck A genus of HEPADNAVIRIDAE infecting birds but rarely causing clinical problems. Transmission is predominantly vertical. $=VAvidin D12.776.034.614.300; D12.776.256.317.663.300; D12.776.290.663.100; D12.776.395.175 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Albumins; Ovalbumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Dietary Proteins; Egg Proteins, Dietary; Ovalbumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Egg Proteins; Ovalbumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins A specific protein in egg albumin that interacts with biotin to render it unavailable to mammals, thereby producing biotin deficiency. ' \DAviation J01.095 CLECEDHIISLJMAMTOGSNSTTD Aircraft Technology, Industry, Agriculture (Non MeSH) Aircraft (+ 1); Space Flight (+ 2) Design, development, manufacture, and operation of heavier-than-air aircraft. AECLECEDHIISLJMAMTOGPHSDSNSTTDUT $*    4.Y$Avian Leukosis C02.782.815.096; C02.928.120; C04.557.337.372.216; C04.619.531.216; C04.619.935.120; C04.925.120; C22.131.094 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections Virus Diseases; Tumor Virus Infections Neoplasms; Neoplasms by Histologic Type (Non MeSH); Leukemia; Leukemia, Experimental Neoplasms; Neoplasms, Experimental; Leukemia, Experimental Neoplasms; Neoplasms, Experimental; Tumor Virus Infections Neoplasms; Tumor Virus Infections Animal Diseases; Bird Diseases A group of transmissible, virus-induced diseases of chickens, characterized by proliferation of immature erythroid, myeloid, or lymphoid cells. It includes both leukemic and solid-tumor forms. (Dorland, 27th ed). +V}JAviadenovirus B04.280.030.100; B04.909.204.097.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Adenoviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Adenoviridae A genus of ADENOVIRIDAE that infects birds. The type species is Fowl Adenovirus 1 also called CELO Virus (chick embryo lethal orphan virus). Adenoviruses (66-74) /*yAversive Therapy F04.754.137.174 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Behavior Therapy A treatment that suppresses undesirable behavior by simultaneously exposing the subject to unpleasant consequences. Behavior Therapy (66-69) 0`Auxins D11.303.760.120 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Gravitropism Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators Organic compounds found in plant sprouts. They promote tissue growth through cell elongation rather than multiplication. 2* @mAutosuggestion F04.754.424.771.299 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Hypnosis; Suggestion Suggestion coming from the subject himself. 3e5Autoreceptors D12.776.543.750.050; D12.776.543.750.720.670.100 AGAIANBICHCLDEDFGEHIIMIPMEPHREUL Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Neurotransmitter; Receptors, Presynaptic Transmitter receptors on or near presynaptic terminals (or varicosities) which are sensitive to the transmitter(s) released by the terminal itself. Receptors for the hormones released by hormone-releasing cells are also included. 46$' Autoradiography E05.909.262.105; E05.909.432.132 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Technology, Medical; Cytological Techniques Miscellaneous Techniques (Non MeSH); Technology, Medical; Histological Techniques The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed). 7Y&"Autopsy E05.070; I01.198.560.120 ECEHHIISLJMTPXSNSTVE Miscellaneous Techniques (Non MeSH) Social Sciences; Criminology; Forensic Medicine Postmortem examination of the body. 9_ a,Autophagocytosis G04.335.487.350.091 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Endocytosis; Phagocytosis The segregation and degradation of damaged or unwanted cytoplasmic constituents by autophagic vacuoles (cytolysosomes) composed of lysosomes containing cellular components in the process of digestion; it plays an important role in metamorphosis of amphibians, in the removal of bone by osteoclasts, and in the degradation of normal cell components in nutritional deficiency states. Autolysis (68-78); Lysosomes (66-78); Phagocytosis (66-78) :PGAutonomic Pathways A08.800.050.050; A08.800.800.060 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Peripheral Nervous System; Autonomic Nervous System Nervous System; Peripheral Nervous System; Peripheral Nerves Autonomic Fibers, Postganglionic (+ 2); Autonomic Fibers, Preganglionic; Celiac Plexus; Hypogastric Plexus; Myenteric Plexus; Splanchnic Nerves; Submucous Plexus; Vagus Nerve (+ 3) Autonomic Fibers, Postganglionic (+ 2); Autonomic Fibers, Preganglionic; Celiac Plexus; Hypogastric Plexus; Myenteric Plexus; Splanchnic Nerves; Submucous Plexus; Vagus Nerve (+ 3) Nerves and plexuses of the autonomic nervous system. The central nervous system structures which regulate the autonomic nervous system are not included. Autonomic Nervous System (66-93) ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $=4&6'8Autonomic Nervous System Diseases C10.772.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases Adie's Syndrome; Barre-Lieou Syndrome; Dysautonomia, Familial; Horner's Syndrome; Reflex Sympathetic Dystrophy; Shy-Drager Syndrome Diseases that have their major effects on the autonomic nervous system. The autonomic nervous system may be seriously affected in many other disorders including other peripheral nervous system diseases, infectious diseases (e.g., tetanus, diphtheria), immunologic diseases (e.g., acquired immunodeficiency syndrome), and systemic disorders (e.g., diabetic neuropathy, amyloid neuropathy, thyroid diseases). Disorders of central autonomic control also contribute substantially to a wide variety of problems (e.g., eating disorders, panic disorder, water-electrolyte imbalance, cardiovascular diseases). Autonomic Nervous System (66-80); Nervous System Diseases (66-80)  A&(NFNAutonomic Nervous System A08.800.050 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Autonomic Denervation; Visceral Afferents Nervous System; Peripheral Nervous System Autonomic Pathways (+ 13); Enteric Nervous System (+ 2); Ganglia, Autonomic (+ 4); Parasympathetic Nervous System (+ 6); Sympathetic Nervous System (+ 6) The enteric, parasympathetic, and sympathetic nervous systems taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the central nervous system, especially the hypothalamus and the solitary nucleus, which receive information relayed from VISCERAL AFFERENTS; these and related central and sensory structures are sometimes (but not here) considered to be part of the autonomic nervous system itself. ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $E6128Autonomic Nerve Block E03.155.086.711.299 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Conduction; Nerve Block Interruption of sympathetic pathways, by local injection of an anesthetic agent, at any of four levels: peripheral nerve block, sympathetic ganglion block, extradural block, and subarachnoid block. J"eAutonomic Fibers, Preganglionic A08.663.542.122; A08.663.542.234.060; A08.800.050.050.060; A08.800.800.060.060; A11.671.107 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Nerve Fibers Nervous System; Neurons; Nerve Fibers; Cholinergic Fibers Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways Cells; Neurons Nerve fibers which project from the central nervous system to autonomic ganglia. In the sympathetic division most preganglionic fibers originate with neurons in the intermediolateral column of the spinal cord, exit via ventral roots from upper thoracic through lower lumbar segments, and project to the paravertebral ganglia; there they either terminate in synapses or continue through the splanchnic nerves to the prevertebral ganglia. In the parasympathetic division the fibers originate in neurons of the brain stem and sacral spinal cord. In both divisions the principal transmitter is acetylcholine but peptide cotransmitters may also be released. Ganglia, Autonomic (66-70) K%g8G Autonomic Fibers, Postganglionic A08.663.542.100; A08.800.050.050.050; A08.800.800.060.050; A11.671.078 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Neurons; Nerve Fibers Nervous System; Peripheral Nervous System; Autonomic Nervous System; Autonomic Pathways Nervous System; Peripheral Nervous System; Peripheral Nerves; Autonomic Pathways Cells; Neurons Parasympathetic Fibers, Postganglionic; Sympathetic Fibers, Postganglionic Parasympathetic Fibers, Postganglionic; Sympathetic Fibers, Postganglionic Parasympathetic Fibers, Postganglionic; Sympathetic Fibers, Postganglionic Parasympathetic Fibers, Postganglionic; Sympathetic Fibers, Postganglionic Nerve fibers which project from cell bodies of autonomic ganglia to synapses on target organs. Ganglia, Autonomic (66-70)  Q&P8Jq Autonomic Denervation E04.530.324.084 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Autonomic Nervous System Surgery, Operative; Neurosurgery; Denervation Parasympathectomy (+ 3); Sympathectomy (+ 2) The removal or interruption of some part of the autonomic nervous system for therapeutic or research purposes. Denervation (66-93); Sympathectomy (89-93) $T$673Autonomic Agents D16.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Peripheral Nervous System Agents (Non MeSH) Antiemetics (+ 15); Bronchoconstrictor Agents (+ 1); Bronchodilator Agents (+ 18); Emetics (+ 2); Ganglionic Blockers (+ 6); Ganglionic Stimulants (+ 5); Miotics (+ 8); Mydriatics (+ 9); Parasympatholytics (+ 21); Parasympathomimetics (+ 15); Sympatholytics (+ 41); Sympathomimetics (+ 39) Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  V 84bDAutomobiles J01.937.149 CLECHIISLJMTSNST Air Bags; Seat Belts Technology, Industry, Agriculture (Non MeSH); Transportation A usually four-wheeled automotive vehicle designed for passenger transportation and commonly propelled by an internal-combustion engine using a volatile fuel. (Webster, 1973). Z GAutomobile Exhaust D05.284.101.143.149; G03.850.460.100.165 AEANLJPCPOTO Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants; Air Pollutants, Environmental Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution [.Automobile Driving I03.125 EDLJPXSNST Accidents, Traffic Human Activities (Non MeSH) Automobile Driver Examination The effect of environmental or physiological factors on the driver and driving ability. Included are driving fatigue, and the effect of drugs, disease, and physical disabilities on driving. EDHILJPXSNST $] "#Automobile Driver Examination I03.125.299 HILJPXSN Human Activities (Non MeSH); Automobile Driving Government required written and driving test given to individuals prior to obtaining an operator's license. ^# :~Automatism F02.463.425.179.149; F03.126.720.174 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Conditioning (Psychology) Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders Automatic, mechanical, and apparently undirected behavior which is outside of conscious control. _*FpAutomation J01.897.104 CLECHIISLJMAMTSNST Technology, Industry, Agriculture (Non MeSH); Technology Robotics Controlled operation of an apparatus, process, or system by mechanical or electronic devices that take the place of human organs of observation, effort, and decision. (From Webster's Collegiate Dictionary, 1993). CLECEDHIISLJMAMTOGSNSTTDUT  aC Automatic Data Processing L01.700.568.110.085 CLECHIISLJMAMTOGSDSNSTTDUT Computers Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Punched-Card Systems Data processing largely performed by automatic means.  c |@Autolysis C23.240.224.617.236; C23.739.131 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Death; Cadaver; Postmortem Changes Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) The spontaneous disintegration of tissues or cells by the action of their own autogenous enzymes. Postmortem Changes (66-67) d &Nt Autokinetic Effect F02.463.593.446.215 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Illusions The apparent movement of a small stationary spot of light seen in the darkness. f iaAutoimmunity G04.610.192 DEGEIMPHRE Autoimmune Diseases; Autoantibodies Autoantibodies Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoantibodies (66-89); Autoimmune Diseases (66-89) $g*Q=Autoimmune Diseases C20.111 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Autoimmunity; Autoantibodies; Self Tolerance Immunologic Diseases Addison's Disease; Anemia, Hemolytic, Autoimmune; Antiphospholipid Syndrome; Arthritis, Rheumatoid (+ 5); Dermatitis Herpetiformis; Diabetes Mellitus, Insulin-Dependent; Encephalomyelitis, Allergic; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Goodpasture's Syndrome; Graves' Disease; Lambert-Eaton Myasthenic Syndrome; Lupus Erythematosus, Systemic (+ 1); Multiple Sclerosis; Myasthenia Gravis; Neuritis, Experimental Allergic; Ophthalmia, Sympathetic; Pemphigoid, Bullous; Pemphigus (+ 1); Polyendocrinopathies, Autoimmune; Purpura, Thrombocytopenic, Idiopathic; Reiter's Disease; Stiff-Man Syndrome; Thyroiditis, Autoimmune A disorder caused by an immune response directed against self antigens. Ideally there should be not only demonstrable circulating autoantibodies or cell-mediated immunity against autoantigens in conjunction with inflammatory lesions caused by immunologically competent cells or immune complexes in tissues containing the autoantigens, but also clinical or experimental evidence that the autoimmune process is pathogenic, not secondary to other tissue damage. In practice many diseases, such as systemic lupus erythematosus and rheumatoid arthritis, are often classified as autoimmune diseases although ther pathogenesis is unclear. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $i N5PAutogenic Training F04.754.103 CLECEDHIISLJMAMTOGSNSTTD Suggestion Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy Technique based on muscle relaxation during self-hypnotic exercises. It is used in conjunction with psychotherapy. pKAutocrine Motility Factor D12.776.624.050; D24.185.101.840.100; D24.611.350.050 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Neoplasm Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Cytokines A member of the class of cytokines secreted by tumor cells. It elicits increases in cell motility and phosphoinositide metabolism in the secreting or producing cell via a pertussis toxin-sensitive G-protein signal transduction pathway. The factor has also been used as a marker for bladder cancer. Neoplasm Proteins (66-91); Tumor Markers, Biological (88-91) r =H@]HAutobiography K01.517.211.215 Biography Humanities; Literature; Biography The life of a person written by himself or herself. (Harrod's Librarians' Glossary, 7th ed). u )qAutoantigens D24.611.216.422 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Antigens (66-72) v6gAutoantibodies D24.611.125.308 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Autoimmune Diseases; Autoimmunity Autoimmunity Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies, Antinuclear; Antibodies, Antiphospholipid (+ 2); Complement 3 Nephritic Factor; Immunoglobulins, Thyroid-Stimulating; Long-Acting Thyroid Stimulator; Rheumatoid Factor ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $w6(iFAutoanalysis E05.059 AECLCTECHIISMOMTNUPXSNSTTDUTVE Chemistry, Analytical Miscellaneous Techniques (Non MeSH) Automation (66); Chemistry, Analytical (66); Computers (66) y "*IAutism, Infantile F03.709.680.500.060 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Child Development Disorders, Pervasive A syndrome beginning in infancy and characterized by a lack of responsiveness to other people, gross impairment in verbal and nonverbal communication skills, and bizarre responses to the environment. Autism (66-70); Schizophrenia, Childhood (66-70) zF:Autism F01.145.092; F02.463.785.111; F03.126.108 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Behavior Psychologic Processes and Principles (Non MeSH); Mental Processes; Thinking Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Domination by subjective, self-centered trends of thought or behavior. } 1FSAuthorship L01.143.506.423.906.215 Information Science; Communication; Language; Language Arts (Non MeSH); Writing The profession of writing. Also the identity of the writer as the creator of a literary production. `yAuthoritarianism F01.752.098 Behavior and Behavior Mechanisms (Non MeSH); Personality The personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships. !DAutacoids D17.350.050 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Neurotransmitters Neurotransmitters Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators Angiotensins (+ 6); Eicosanoids (+ 25); Histamine; Kinins (+ 11); Platelet Activating Factor; Serotonin A chemically diverse group of substances produced by various tissues in the body that cause slow contraction of smooth muscle; they have other intense but varied pharmacologic activities. specific tissue (66); Muscle, Smooth/physiology (66) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR , B}@HAustria Z01.542.088 EHEP Geographicals (Non MeSH); Europe  )Australoid Race I01.076.368.763.148 CLGEHI Aborigines Social Sciences; Anthropology; Anthropology, Physical; Racial Stocks A racial group that includes the Australian aborigines, the Veddahs of Ceylon, the pre-Dravidian people of India, and possibly some other remnant populations of Malaysia. (From Molnar, Races, Types, and Ethnic Groups, 1975).   QAustralia Z01.338 EHEP Geographicals (Non MeSH) New South Wales; Northern Territory; Queensland; South Australia; Tasmania; Victoria; Western Australia   |Auscultation E01.706.110 AECLCTECHIISMOMTNUPXSNSTTDUTVE Heart Auscultation Diagnosis; Physical Examination Heart Auscultation Act of listening for sounds within the body. AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE $"&8&Aurovertins D03.383.663.075; D08.373.936.100; D26.550.043 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrans Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Very toxic and complex pyrone derivatives from the fungus Calcarisporium arbuscula; bind to and inhibit mitochondrial ATP-ase, thereby uncoupling oxidative phosphorylation; used as biochemical tool. Antibiotics (68-74) 58Aurothioglucose D02.691.220; D17.050.050.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Antirheumatic Agents, Gold Auranofin Auranofin (1-Thio-D-glucopyranosato)gold. A thioglucose derivative used as an antirheumatic and experimentally to produce obesity in animals. Gold (66-72)  q":Aurodox D20.085.117 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Antibiotic obtained from a Streptomyces variant considered as possibly effective against Streptococcus pyogenes infections. It may promote growth in poultry. Furans (74-75); Pyridones (74-75)  <)*Aurintricarboxylic Acid D02.241.223.268.070 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Cyclohexanecarboxylic Acids 5-((3-Carboxy-4-hydroxyphenyl)(3-carboxy-4-oxo-2,5-cyclohexadien-1-ylidene)methyl)-2-hydroxybenzoic acid. A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues. Benzoates (72-74); Cyclohexanecarboxylic Acids (69-74); Phenols (72-74) ,:~FUAurantin D20.085.075.135; D22.204.106.152 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic  &<Auranofin D02.691.220.150; D17.050.050.025.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Aurothioglucose Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Antirheumatic Agents, Gold; Aurothioglucose (1-Thio-beta-D-glucopyranase-2,3,4,6-tetraacetato-S)(triethylphosphine)gold. An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious. Gold (66-74); Gold Thioglucose/analogs and derivatives (75-86)  *:KAuditory Threshold F02.463.593.071.173; F02.463.593.710.190 CLDEPHRE Audiometry Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Sensory Thresholds Auditory Fatigue The audibility limit of discriminating sound intensity and pitch. Hearing (66-67) $. NAuditory Perceptual Disorders C09.218.807.186.094; C10.228.140.068.094; F03.126.185.794.151 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Otorhinolaryngologic Diseases; Ear Diseases; Retrocochlear Diseases (Non MeSH); Auditory Diseases, Central Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Auditory Diseases, Central Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Perceptual Disorders Disorders of auditory perception manifesting as difficulties with auditory memory, speech perception and sound localization. Lesions are usually in the temporal lobe. Auditory Perception (67-79); Hearing (66); Perception (66-68); Perceptual Disorders (69-79) #EFynAuditory Perception F02.463.593.071; G11.561.796.263.260 CLDEGEPHRE Hearing Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Sensation; Hearing Auditory Threshold (+ 1); Loudness Perception; Perceptual Masking; Pitch Perception (+ 1); Sound Localization The process whereby auditory stimuli are selected, organized and interpreted by the organism; includes speech discrimination. Hearing (66); Perception (66) $g* &Auditory Pathways A08.612.220.110 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Auditory Diseases, Central Nervous System; Neural Pathways; Afferent Pathways Auditory Cortex (68-70); Central Nervous System (66-70)  6 =CAuditory Fatigue F02.463.593.071.173.095 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Auditory Perception; Auditory Threshold Loss of sensitivity to sounds as a result of auditory stimulation, manifesting as a temporary shift in auditory threshold. The temporary threshold shift, TTS, is expressed in decibels. Auditory Threshold (68-79); Fatigue (66-79); Hearing (66-67) / JAuditory Diseases, Central C09.218.807.186; C10.228.140.068 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Auditory Cortex; Auditory Pathways Otorhinolaryngologic Diseases; Ear Diseases; Retrocochlear Diseases (Non MeSH) Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Auditory Perceptual Disorders; Hearing Loss, Central Auditory Perceptual Disorders; Hearing Loss, Central Diseases of the auditory pathways from the bulbar cochlear nuclei to the auditory cortex in the temporal lobe. Structures involved include the medial and lateral lemnisci, inferior colliculus, and the medial geniculate nucleus.  @ &N*z Auditory Cortex A08.186.211.730.885.213.863.297 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Auditory Diseases, Central Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Cerebral Cortex; Temporal Lobe Area of the temporal lobe concerned with hearing. Cerebral Cortex (66-67); Hearing (66-67)  [#8 =2Audiometry, Speech E01.276.299.375.297.105 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests; Audiometry Speech Discrimination Tests; Speech Reception Threshold Test Measurement of the ability to hear speech under various conditions of intensity and noise interference using sound-field as well as earphones and bone oscillators. Audiometry (66-79); Speech (66-79)  "G+Audiometry, Pure-Tone E01.276.299.375.297.092 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests; Audiometry Measurement of hearing based on the use of pure tones of various frequencies and intensities as auditory stimuli. Audiometry (66-79) 5"Audiometry, Evoked Response E01.276.299.375.297.045 AECLCTECHIISMOMTNUPXSNSTTDUTVE Evoked Potentials, Auditory, Brain Stem Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests; Audiometry A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry. Audiometry (66-79); Evoked Potentials (67-79)  !"/j7Audiometry E01.276.299.375.297 AECLCTECHIISMOMTNUPXSNSTTDUTVE Acoustic Impedance Tests Auditory Threshold Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests Audiometry, Evoked Response; Audiometry, Pure-Tone; Audiometry, Speech (+ 2)  "rZAudiology G02.010.150 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Allied Health Occupations The study of hearing and hearing impairment. Hearing (66-77)  67Audioanalgesia E03.091.214 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Analgesia "9Audio-Visual Aids I02.903.847.297; L01.178.147 CLECHILJSDSNSTTDUT Teaching Materials Education; Teaching; Teaching Materials Information Science; Communications Media (Non MeSH)  Books, Illustrated; Exhibits; Maps; Medical Illustration; Models, Structural (+ 2); Motion Pictures; Optical Storage Devices (+ 3); Radio; Tape Recording (+ 1); Television (+ 4) Auditory and visual instructional materials. CLECEDHIISLJMTSDSNSTTDUT $"l5Atypical Bacterial Forms B03.110 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria L Forms; Spheroplasts Microorganisms that have undergone greater changes than normal in morphology, physiology, or cultural characteristics. Bacteria (66-74)   " Attitude to Health F01.145.076.347; F01.829.092.380; N05.300.150 EH Patient Dropouts; Sick Role Public Opinion Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Attitude Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Health Behavior (+ 1); Patient Acceptance of Health Care (+ 3) Health Behavior; Health Services Misuse; Knowledge, Attitudes, Practice; Patient Acceptance of Health Care (+ 4) Layman attitudes toward health, disease, and the medical care system. Attitude (66-67) ECEHHILJMTPXSNTDUT ,5#SAttitude to Death F01.145.076.247; N05.300.125 EH Death Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Conceptual response of the individual to the various aspects of death, which are based on his psychosocial and cultural experience. " Attitude to Computers F01.145.076.180 Computers Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude The attitude and behavior associated with an individual using the computer.  MZAttitude of Health Personnel F01.145.076.147; F01.829.092.214; N05.300.100 EH Behavior and Behavior Mechanisms (Non MeSH); Behavior; Attitude Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Attitude Quality, Access, Evaluation (Non MeSH); Delivery of Health Care Refusal to Treat Refusal to Treat Physician's Role; Refusal to Treat Attitudes of personnel toward their patients, other professionals, toward the medical care system, etc. Attitude (66-67) EHLJSN $#5Sy Attitude F01.145.076; F01.829.092 EH Public Opinion; Set (Psychology) Behavior and Behavior Mechanisms (Non MeSH); Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Attitude of Health Personnel (+ 1); Attitude to Computers; Attitude to Death; Attitude to Health (+ 6); Knowledge, Attitudes, Practice; Permissiveness; Personal Satisfaction (+ 1); Rejection (Psychology) Attitude of Health Personnel (+ 1); Attitude to Health; Knowledge, Attitudes, Practice An enduring, learned predisposition to behave in a consistent way toward a given class of objects, or a persistent mental and/or neural state of readiness to react to a certain class of objects, not as they are but as they are conceived to be. ECEHLJMTPXSN $  (Y$Attention Deficit Disorder with Hyperactivity F03.234.096 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Onset is before the age of seven. Brain Damage, Chronic (66-68) 5FR$Attention F02.830.104.214 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology; Arousal Focusing on certain aspects of current experience to the exclusion of others. It is the act of heeding or taking notice or concentrating.   XAttachment Sites (Microbiology) G04.185.515.880.930.500.050; G05.386.930.500.050 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Viral Phenomena (Non MeSH); Virus Integration; Lysogeny Genetics; Genetics, Microbial; Virus Integration; Lysogeny Particular loci in both bacterial and phage DNA molecules at which phage DNA is integrated into the bacterial DNA by recombination between these sites. Coliphages (66-79); DNA, Viral (66-79); Lysogeny (68-79); Recombination, Genetic (68-79) %6kAtropine Derivatives D03.132.889.180.297.297; D03.605.869.189.297 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Tropanes; Belladonna Alkaloids; Atropine Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes; Atropine Ipratropium Ipratropium Analogs and derivatives of atropine. Atropine (66-74); Tropanes (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $28-+:Atropine D03.132.760.180.297; D03.132.889.180.297; D03.605.869.189; D14.100.120.200.500.045; D15.045.050; D16.050.110.040; D16.050.500.040; D16.050.650.040; D18.097.112 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Solanaceous Alkaloids; Belladonna Alkaloids Heterocyclic Compounds; Alkaloids; Tropanes; Belladonna Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, Bridged-Ring (Non MeSH); Tropanes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists Central Nervous System Agents; Anesthesia Adjuvants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Mydriatics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents  Atropine Derivatives (+ 1) Atropine Derivatives (+ 1) A toxic alkaloid, originally from Atropa belladonna, but found in other plants, mainly Solanaceae. It is used as an antimuscarinic agent for relaxation of smooth muscle, to increase heart rate, as an anesthetic premedication, as an antispasmotic, in anticholinesterase poisoning, in aspiration pneumonitis, in bronchial disorders, or to dilate the pupil, among other uses. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR   >:G@Atrophy C23.739.102 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) ΂ NYAtrioventricular Node A07.541.409.147 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Conduction System A small nodular mass of specialized muscle fibers located in the interatrial septum near the opening of the coronary sinus. It gives rise to the atrioventricular bundle of the conduction system of the heart. b8@Atrial Natriuretic Factor D12.644.047; D24.185.047 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Receptors, Atrial Natriuretic Factor Amino Acids, Peptides and Proteins (Non MeSH); Peptides Immunologic and Biologic Factors (Non MeSH); Biological Factors A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight peptides derived from a common precursor and secreted by the heart atria. All these peptides share a sequence of about 20 amino acids. Muscle Proteins (66-85)  F+Atrial Function, Right G09.330.075.200 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Atrial Function The hemodynamic and electrophysiological action of the right atrium. Heart/physiology (66-90); Heart Atrium/physiology (68-90) ӴQEAtrial Function, Left G09.330.075.100 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH); Atrial Function The hemodynamic and electrophysiological action of the left atrium. Heart/physiology (66-90); Heart Atrium/physiology (68-90) -PEAtrial Function G09.330.075 DEGEIMPHRE Heart Atrium Circulatory, Respiratory Physiology (Non MeSH); Cardiovascular System Physiology (Non MeSH) Atrial Function, Left; Atrial Function, Right The hemodynamic and electrophysiological action of the atria. Heart/physiology (66-90); Heart Atrium/physiology (68-90) $֤j7IEAtrial Flutter C14.280.067.248 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Rapid, irregular atrial contractions due to an abnormality of atrial excitation. DN=_Atrial Fibrillation C14.280.067.198 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Disorder of cardiac rhythm characterized by rapid, irregular atrial impulses and ineffective atrial contractions. wN=Atrazine D03.383.931.247; D05.723.366.477.213 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides; Herbicides, Triazine Herbicides (66-71); Triazines (66-71)  *:.Atracurium D03.438.531.070; D14.100.120.200.600.040; D16.700.710.575.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Isoquinolines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents. Isoquinolines (66-86) TE:CAtractyloside D09.203.408.105 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides 15 alpha-Hydroxy-2-[[2-O-)3-methyl-1-oxobutyl)-3,4-di-O-sulfo-alpha-D-glucopyranosyl]oxy]-19-norkaur-16-en-18-oic acid dipotassium salt. A toxic glycoside from Atractylis gummifera which inhibits the transfer of ADP and ATP across the mitochondrial membrane by a specific carrier. Also inhibits oxidative phosphorylation of externally added ADP in isolated mitochondria. Glycosides (68-75); Phenanthrenes (73-74) DY2ATP Phosphoribosyltransferase D08.586.913.400.725.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme of approximately 215 kD that catalyzes the first step of the pathway for histidine biosynthesis in Salmonella typhimurium. ATP reacts reversibly with 5-phosphoribosyl-1-pyrophosphate to yield N-1-(5'-phosphoribosyl)-ATP and pyrophosphate. EC 2.4.2.17. Adenosine Triphosphate (72-75); Pentosephosphates (71-75); Pentosyltransferases (71-75); Pyrophosphoric Acids (71-75) "F-ATP Citrate Lyase D08.586.520.567.213 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases An enzyme that, in the presence of ATP and CoA, catalyzes the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and orthophosphate. This reaction represents an important step in fatty acid biosynthesis. EC 4.1.3.8. Lyases (66-72) Fb Atmospheric Pressure G03.230.300.100.185 Altitude; Anoxia; Barotrauma; Decompression Sickness; Hyperbaric Oxygenation Pressure Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere Air Pressure; Vacuum The pressure at any point in an atmosphere due solely to the weight of the atmospheric gases above the point concerned.  Z jAtmosphere Exposure Chambers E07.079 AECLCTECHISDSNSTTDUTVE Environment, Controlled Equipment and Supplies " Atmosphere G03.230.300.100 Environment and Public Health (Non MeSH); Environment; Meteorological Factors Air (+ 3); Atmospheric Pressure (+ 2); Climate (+ 5); Cosmic Radiation; Weather (+ 12) Air (66-71); Extraterrestrial Environment (66-71) AEANCLDEDUECHILJPCPOPSRESNSTTOTU =\o;$Atlases L01.178.682.192.836.147 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books  zAtlas A02.835.232.834.151.213 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Spine; Cervical Vertebrae t :[Atlanto-Occipital Joint A02.835.583.101 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints L81Atlanto-Axial Joint A02.835.583.097 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints The joint involving the atlas and axis bones. Atlas (66-82); Axis (66-82) 819$Atlantic Ocean Z01.756.092 Geographicals (Non MeSH); Oceans and Seas North Sea 4Atlantic Islands Z01.295 EHEP Geographicals (Non MeSH) Azores; Bermuda  Athletic Injuries C21.866.115 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Sports Medicine; Sports Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Injuries incurred during participation in competitive or non-competitive sports. Sport Medicine (66-67); Sports (66-67)  NQ]0Athetosis C10.597.559.108; C23.888.592.574.122 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders A derangement marked by ceaseless occurrence of slow, sinuous, writhing movements, especially severe in the hands and performed involuntarily. It may occur after hemiplegia, and is then known as posthemiplegic chorea. (Dorland, 27th ed).  *NAtherosclerosis C14.907.137.126.259 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Atherectomy; Embolism, Cholesterol Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases; Arteriosclerosis A common form of arteriosclerosis characterized by deposits of plaques (atheromas) containing lipids, carbohydrates, blood and blood products, fibrous tissue, and calcium deposits. These plaques are found in the intima of large- and medium-sized arteries. RN)g'Atherectomy, Coronary E02.148.050.120.125; E04.752.376.719.125; E04.752.814.050.120.125; E04.920.490.630.125 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Coronary Arteriosclerosis Therapeutics; Catheterization; Angioplasty; Atherectomy Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery; Myocardial Revascularization Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty; Atherectomy Surgery, Operative; Thoracic Surgery; Heart Surgery; Myocardial Revascularization Percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. Both directional (for removing focal atheromas) and rotational (for removing concentric atheromatous plaque) atherectomy devices have been used. Coronary Arteriosclerosis (89-92)  `$'Atherectomy E02.148.050.120; E04.752.814.050.120 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Endarterectomy Endarterectomy; Atherosclerosis Therapeutics; Catheterization; Angioplasty Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty Atherectomy, Coronary Atherectomy, Coronary Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY. Angioplasty, Balloon (86-92); Angioplasty, Transluminal, Percutaneous Coronary (89-92); Atherosclerosis (87-92) (K*$%2Atenolol D02.033.329.624.085; D02.092.063.624.085; D14.100.050.200.200.070; D16.050.850.050; D18.162.056 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Antihypertensive Agents 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide. A cardioselective beta-adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect. Acetamides (74); Phenyl Ethers (74); Propanolamines (74)   k:FAtelectasis C08.381.069 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases Middle Lobe Syndrome N2Ataxia Telangiectasia C10.228.140.252.253.871.171; C14.907.823.213; C20.673.290 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Cerebellar Diseases; Cerebellar Ataxia; Spinocerebellar Degeneration Cardiovascular Diseases; Vascular Diseases; Telangiectasis Immunologic Diseases; Immunologic Deficiency Syndromes A syndrome characterized by choreoathetosis beginning in childhood, progressive cerebellar ataxia, telangiectasis of conjunctiva and skin, slowly progressive mental deterioration and increasing cerebellar degeneration. Ataxia (66-67) AN$Ataxia C10.597.559.077; C23.888.592.574.084 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Movement Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders Failure of muscular coordination or irregularity of muscular action. (Dorland, 27th ed).  *NjAstroviruses B04.820.070; B04.909.777.100; B04.970.070 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Viruses; Viruses, Unclassified Small (approximately 28nm diameter) circular viruses sometimes showing a star-shaped surface configuration, found in stools of vertebrates with infantile gastroenteritis. The taxonomic status is uncertain though a relationship to Picornaviridae has been suggested. Diarrhea, Infantile (75-78); Vertebrate Viruses (75-78); Vertebrate Viruses, Unclassified (75-78) 1|.rAstronomy H01.091 CLECEDHIISLJMAMTOGSNSTTD Physical Sciences (Non MeSH) Solar System (+ 12)  {  #Astronauts M01.770.100 CLECEDHILJOGPXSDSNSTTDUT Space Flight Named Groups (Non MeSH); Research Personnel Members of spacecraft crew including those who travel in space, and those in training for space flight. (From Webster, 10th ed; Jane's Aerospace Dictionary, 3d ed). Space Flight (66-94)  6Astrology K01.672.296 HIPX Humanities; Occultism   Astrocytoma C04.557.465.625.600.380.080; C04.557.470.670.380.080; C04.557.580.625.600.380.080 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Neuroepithelial; Glioma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neoplasms, Neuroepithelial; Glioma Glioblastoma Glioblastoma Glioblastoma A relatively well differentiated glioma composed of neoplastic cells that resemble one of the types of astrocytes, with varying amounts of fibrillary stroma. There are many grading systems. One popularly used is based on a classification in order of increasing malignancy (grades I through IV). In children and persons under 20 years of age, astrocytomas usually arise in a cerebellar hemisphere; in adults, they occur usually in the cerebrum, sometimes growing rapidly and invading extensively. (From Stedman, 25th ed; Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p. 1082).  YX,Astrocytes A08.637.200; A11.650.200 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Blood-Brain Barrier Nervous System; Neuroglia Cells; Neuroglia The largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the blood brain barrier. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with microglia) respond to injury. Astrocytes have high- affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitter, but their role in signaling (as in many other functions) is not well understood. Neuroglia (66-74)  *4Astringents D23.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Dermatologic Agents Tannic Acid Agents that cause contraction, usually locally after topical application. (From Dorland, 27th ed). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  f 8u:Astigmatism C11.744.212 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Refractive Errors Unequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. (Dorland, 27th ed). N'Asthma, Exercise-Induced C08.127.108.110; C08.674.095.110; C20.543.480.680.095.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Bronchial Diseases; Asthma Respiratory Tract Diseases; Respiratory Hypersensitivity; Asthma Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity; Asthma Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it). Asthma (66-78); Bronchial Spasm (66-78); Exertion (66-78) ANGAsthma C08.127.108; C08.381.495.108; C08.674.095; C20.543.480.680.095 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bronchial Hyperreactivity Respiratory Tract Diseases; Bronchial Diseases Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Obstructive Respiratory Tract Diseases; Respiratory Hypersensitivity Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity Asthma, Exercise-Induced; Status Asthmaticus Asthma, Exercise-Induced; Status Asthmaticus Asthma, Exercise-Induced; Status Asthmaticus A form of bronchial disorder associated with airway obstruction, marked by recurrent attacks of paroxysmal dyspnea, with wheezing due to spasmodic contraction of the bronchi.   HN2Asthenopia C11.093 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases Term generally used to describe complaints related to refractive error, ocular muscle imbalance, including pain or aching around the eyes, burning and itchiness of the eyelids, ocular fatigue, and headaches. !d NAsthenia C23.888.139 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neurasthenia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH) Lack or loss of strength and energy; weakness. (Dorland, 27th ed). " NXTAstemizole D03.438.103.105; D14.100.375.425.400.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists 1-((4-Fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl-4-piperidinyl)-1H-benzimidazol-2-amine. A long-acting, non-sedative antihistaminic used in the treatment of seasonal allergic rhinitis, asthma, allergic conjunctivitis, and chronic idiopathic urticaria. The drug is well tolerated and has no anticholinergic side effects. Benzimidazoles (66-91); Histamine H1 Receptor Blockaders (66-91) $<.:uLAstatine D01.268.271.110; D01.268.380.075 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH) Inorganic Chemicals (Non MeSH); Elements; Halogens Astatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism. ' &4.Association Learning F02.463.425.069.296 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning; Association The principle that items experienced together enter into a connection, so that one tends to reinstate the other. ) iAssociation F02.463.425.069; F04.754.919.346 Word Association Tests Psychologic Processes and Principles (Non MeSH); Mental Processes; Learning Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Therapeutic Processes (Non MeSH) Association Learning A functional relationship between psychological phenomena of such nature that the presence of one tends to evoke the other; also, the process by which such a relationship is established. CLDEPHRE  +E& Assisted Circulation E04.050 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Heart-Assist Devices Surgery, Operative Counterpulsation (+ 1); Heart-Assist Devices Pumping that aids the natural activity of the heart. (Dorland, 27th ed). Heart, Mechanical (66) AECLCTECHIISMOMTNUPXRHSDSNSTTDUTVE (- $6Z&Assertiveness F01.145.040 Behavior and Behavior Mechanisms (Non MeSH); Behavior Aggression (+ 1) Strongly insistent, self-assured, and demanding behavior. Aggression (66-79) CLDEPHPXRE  / ACAspirin D02.241.223.106.505.700.075; D02.241.511.390.700.075; D02.755.410.700.075; D08.373.310.050; D16.850.015.050.040; D17.025.030.035; D17.050.030.035; D19.461.780.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Salicylic Acids Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cyclooxygenase Inhibitors Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Platelet Aggregation Inhibitors The prototypical analgesic used in the treatment of mild to moderate pain. It also has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.5). 0 :IAspirations (Psychology) F01.658.100; F02.784.629.155 Behavior and Behavior Mechanisms (Non MeSH); Motivation Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Strong desires to accomplish something. This usually pertains to greater values or high ideals. Motivation (66-74) 7X"rAspiration G09.772.521.700.145 DEGEIMPHRE Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics The act of inhaling. 8Asphyxia Neonatorum C16.614.092 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fetal Anoxia Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Respiratory failure in the newborn. (Dorland, 27th ed). 9LWEAsphyxia C21.866.103; C23.240.095 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Symptoms and General Pathology (Non MeSH); Death A condition due to lack of oxygen in respired air, resulting in impending or actual cessation of apparent life. (Dorland, 27th ed). ;: LAspergillus oryzae B05.354.381.546.081.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Aspergillus Fungus present on most agricultural seeds and often responsible for the spoilage of seeds in bulk storage; also used in the production of fermented food or drink, especially in Japan. <"]Aspergillus ochraceus B05.354.381.546.081.480 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Aspergillus A deuteromycetous fungal species that produces ochratoxins and contaminates cereals and coffee beans. Aspergillus (66-85) >"]vAspergillus Nuclease S1 D08.586.277.352.335.350.025; D08.586.277.352.355.325.025; D08.586.277.352.355.350.025; D08.586.277.352.700.350.025 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Deoxyribonucleases; Endodeoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endodeoxyribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Endonucleases; Endoribonucleases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Ribonucleases; Endoribonucleases An enzyme that catalyzes endonucleolytic cleavage to 5-phosphomononucleotides and 5-phosphooligonucleotide end-products. It has a preference for single-stranded substrates but is active with either ribo- or deoxyribonucleic acids. (From Enzyme Nomenclature, 1992) EC 3.1.30.1. Endonucleases (73-89); Phosphodiesterases (72) @|F!;7Aspergillus niger B05.354.381.546.081.450 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Aspergillus A fungus causing smut or black mold of several fruits, vegetables, etc. Aspergillus (66-74) D"]WAspergillus nidulans B05.354.381.546.081.420 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Aspergillus A species of imperfect fungi from which the antibiotic Nidulin is obtained. Aspergillus (66-71) E"][Aspergillus fumigatus B05.354.381.546.081.295 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Aspergillus A species of imperfect fungi from which the antibiotic Fumigatin is obtained. Its spores may cause respiratory infection in birds and mammals. Aspergillus (66-71) G@"]Aspergillus flavus B05.354.381.546.081.170 CHCLCYDEENGDGEIMIPMEPHPYREULVI Aflatoxins Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes; Aspergillus A species of imperfect fungus which grows on peanuts and other plants and produces the carcinogenic substance aflatoxin. It is also used in the production of the antibiotic Flavicin. Aspergillus (66-71)  H"]Aspergillus B05.354.381.546.081 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Aspergillus ochraceus; Aspergillus oryzae A genus of fungi of the family Moniliaceae. J"N7Aspergillosis, Allergic Bronchopulmonary C01.703.078.074; C01.703.534.090; C08.381.472.090; C08.674.060; C08.730.435.090; C20.543.480.680.085 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses; Aspergillosis Bacterial and Fungal Diseases (Non MeSH); Mycoses; Lung Diseases, Fungal Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Fungal Respiratory Tract Diseases; Respiratory Hypersensitivity Respiratory Tract Diseases; Respiratory Tract Infections; Lung Diseases, Fungal Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity Aspergillosis of the lung occurring in an individual with long-standing bronchial asthma. It is characterized by pulmonary infiltrates, eosinophilia, elevated serum IgE and immediate type skin reactivity to aspergillus antigen. Aspergillosis (66-78); Lung Diseases, Fungal (66-78); Respiratory Hypersensitivity (66-78) L;.rPjAspergillosis C01.703.078 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Mycoses Aspergillosis, Allergic Bronchopulmonary Infections with fungi of the genus ASPERGILLUS. PP=.:Aspartylglucosylaminase D08.586.277.087.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases An enzyme that catalyzes the conversion of N(4)-(beta-N-acetyl-D-glucosaminyl)-L-asparagine and water to N-acetyl-beta-D-glucosaminylamine and L-aspartate. It acts only on asparagine oligosaccharides containing one amino acid, i.e. the asparagine has free alpha-amino and alpha-carboxyl groups. (From Enzyme Nomenclature, 1992) EC 3.5.1.26. Amidohydrolases (70-74); Aspartic Acid (70-74); Glucosamine (70-74) QFfQAspartyl T RNA Synthetase D08.586.464.136.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates aspartic acid with its specific transfer RNA. EC 6.1.1.12. Amino Acyl T RNA Synthetases (73-74); Aspartic Acid (73-74) T FteIAspartokinase Homoserine Dehydrogenase D08.586.600.130; D08.586.682.047.370.060; D08.586.913.696.630.050.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Homoserine Dehydrogenase Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Carboxyl Group Acceptor); Aspartate Kinase An enzyme complex consisting of aspartokinase, EC 2.7.2.4, and homoserine dehydrogenase, EC 1.1.1.3. The complex has been isolated from E. coli and consists of four identical subunits with a molecular weight of 85,000. The enzyme complex is involved in the biosynthesis of amino acids of the aspartate family. Alcohol Oxidoreductases (73-75); Aspartic Acid (73-75); Homoserine (73-75); Multienzyme Complexes (73-75); Phosphotransferases, ATP (74-75) V,MFkAspartic Proteinases D08.586.277.656.732.066 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases Cathepsin D; Chymosin; HIV Protease; Pepsin A; Renin A sub-subclass of proteolytic enzymes which, because of the involvement of an acidic residue in the catalytic process, hydrolyzes the peptide bonds at a pH optimum below 5. EC 3.4.23. Peptide Peptidohydrolases (66-90)  [+FC'Aspartic Acid D12.125.119.170; D14.600.050.200.040 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Amino Acid Neurotransmitters; Excitatory Amino Acids N-Methylaspartate; Potassium Magnesium Aspartate Aspartic acid. One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. ]*F9Aspartate-Semialdehyde Dehydrogenase D08.586.682.075.211 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Aldehyde Oxidoreductases An enzyme that catalyzes the conversion of L-aspartate 4-semialdehyde, orthophosphate, and NADP+ to yield L-4-aspartyl phosphate and NADPH. EC 1.2.1.11. `_)FuAspartate-Ammonia Ligase D08.586.464.165 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme that catalyzes the formation of asparagine from ammonia and aspartic acid, in the presence of ATP. EC 6.3.1.1. Ammonia (73-74); Aspartic Acid (73-74); Ligases (73-74) b.FPEAspartate Kinase D08.586.913.696.630.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Carboxyl Group Acceptor) Aspartokinase Homoserine Dehydrogenase An enzyme that catalyzes the formation of beta-aspartyl phosphate from aspartic acid and ATP. Threonine serves as an allosteric regulator of this enzyme to control the biosynthetic pathway from aspartic acid to threonine. EC 2.7.2.4. Aspartic Acid (74); Phosphotransferases, ATP (74)  cF,<Aspartate Carbamoyltransferase D08.586.600.116; D08.586.913.197 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases An enzyme that catalyzes the conversion of carbamoyl phosphate and L-aspartate to yield orthophosphate and N-carbamoyl-L-aspartate. (From Enzyme Nomenclature, 1992) EC 2.1.3.2. f#&FAspartate Ammonia-Lyase D08.586.520.161.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ammonia-Lyases An enzyme that catalyzes the conversion of aspartic acid to ammonia and fumaric acid in plants and some microorganisms. EC 4.3.1.1. Ammonia-Lyases (73-74); Aspartic Acid (73-74) hFa7Aspartate Aminotransferase D08.586.913.140.345 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Aminotransferases An enzyme of the transferase class that catalyzes the reaction of L-aspartate and 2-ketoglutarate to yield oxaloacetate and L-glutamate. The enzyme is a pyridoxal phosphate protein. In the liver the reaction transfers excess metabolic nitrogen into aspartate for disposal in the urea cycle. The enzyme occurs also in the cytoplasm and mitochondria of most cells and is released into the blood in tissue damage. Elevation in serum aspartate aminotransferase (SGOT) activity is used as a diagnostic test. (From Dorland, 27th ed) EC 2.6.1.1. jFjvAspartame D09.818.100; D12.644.456.345.190; D26.456.609.100 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Carbohydrates and Hypoglycemic Agents (Non MeSH); Sweetening Agents Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides Miscellaneous Drugs and Agents (Non MeSH); Flavoring Agents; Sweetening Agents N-L-alpha-Aspartyl-L-phenylalanine 1-methyl ester. Flavoring agent sweeter than sugar, metabolized as phenylalanine and aspartic acid. Aspartic Acid (74); Dipeptides (74-75); Phenylalanine (74) n/ 9. HAsparagine D12.125.119.107 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Dicarboxylic pFgAsparaginase D08.586.277.087.116; D22.204.222 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents An enzyme of the hydrolase class that catalyzes the conversion of L-asparagine and water to L-aspartate and NH3. This reaction occurs in normal mammalian and bacterial cells. The enzyme, preprared from bacterial sources, is used clinically in the treatment of childhood leukemia. (From Dorland, 27th ed) EC 3.5.1.1. Amidohydrolases (66-67) q&FrAsian Americans I01.076.201.450.416.050; I01.880.143.522.050; M01.194.050 CLEDGEHILJPXSN Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups Persons living in the United States having origins in any of the original peoples of the Far East, Southeast Asia, the Pacific Islands, or the Indian subcontinent. Ethnic Groups (68-74); United States (66-80); specific state (66-80); specific Asia heading (66-74) /ethnology (75-80) tAAsialoglycoproteins D12.776.395.140 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Sialoglycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Endogenous glycoproteins from which sialic acid has been removed by the action of sialidases. They bind tightly to their cell surface receptor which is located on hepatocyte plasma membranes. After internalization by adsorptive endocytosis they are delivered to lysosomes for degradation. Therefore receptor-mediated clearance of asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. They are elevated in serum of patients with hepatic cirrhosis or hepatitis. Glycoproteins (66-84)  w/FU5Asia, Western Z01.252.245 EHEP Geographicals (Non MeSH); Asia Bangladesh; Bhutan; India (+ 1); Middle East (+ 15); Nepal; Pakistan; Sri Lanka The countries of the Near East and the Middle East. The Near East comprises southwest Asia: Turkey, Lebanon, Syria, Israel, Jordan, Saudi Arabia, and the other countries of the Arabian Peninsula. Often the designation is extended to include Egypt and Sudan. As used by the U. S. Department of State, Libya and the Middle East are added. (Webster's New Geographical Dictionary, 1984). z'gAsia, Southeastern Z01.252.145 EHEP Geographicals (Non MeSH); Asia Borneo; Brunei; Cambodia; Indonesia; Laos; Malaysia; Mekong Valley; Myanmar; Philippines; Singapore; Thailand; Vietnam }('Asia, Central Z01.252.100 EHEP Geographicals (Non MeSH); Asia Kazakhstan; Kyrgyzstan; Tajikistan; Turkmenistan; Uzbekistan An area of Asia that includes Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. ~1'HoAsia Z01.252 EHEP Geographicals (Non MeSH) Asia, Central (+ 5); Asia, Southeastern (+ 12); Asia, Western (+ 23); Far East (+ 9) _ mAsepsis G03.850.780.200.450.150.160 HIISMTST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Infection Control; Antisepsis The prevention of access by infecting organisms to the locus of potential infection. (  eAscorbic Acid Deficiency C18.654.223.133.115 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Scurvy Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis Scurvy A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed).  N w Ascorbic Acid D02.241.081.844.107; D02.241.511.902.107; D09.203.811.100; D11.786.100 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins Dehydroascorbic Acid Dehydroascorbic Acid Dehydroascorbic Acid Dehydroascorbic Acid Water-soluble vitamin found in many fruits and vegetables. It is present in all animal and higher plant tissues and is required in the diet of human beings. Deficiency of this vitamin causes scurvy and impairs wound healing. PB`^ Ascorbate Oxidase D08.586.682.180 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases An enzyme that converts ascorbic acid to dehydroascorbic acid. EC 1.10.3.3. Ascorbic Acid (73-74); Oxidoreductases (73-74) xFX[8Ascomycetes B05.354.107 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi Chaetomium; Claviceps; Endomycetales (+ 8); Hypocreales (+ 1); Neurospora (+ 1); Pseudallescheria; Sphaeriales ",Ascitic Fluid C23.091.127 BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Peritoneal Lavage Peritoneal Cavity; Peritoneum; Exudates and Transudates Symptoms and General Pathology (Non MeSH); Ascites The serous fluid which accumulates in the peritoneal cavity in ascites. Ascites (66-67) $RB>VAscites C23.091 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) Ascitic Fluid Accumulation of free fluid within the peritoneal cavity. BLCFCHCICLCNCOCYDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI    N2DRAscaris suum B01.500.294.700.100.100.108.700 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea; Ascaris A species of parasitic nematode usually found in domestic pigs and a few other animals. Human infection can also occur, presumably as result of handling pig manure, and can lead to intestinal obstruction. Ascaris (66-92) #*bAscaris lumbricoides B01.500.294.700.100.100.108.425 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea; Ascaris A species of parasitic nematode that is the largest found in the human intestine. Its distribution is worldwide, but it is more prevalent in areas of poor sanitation. Human infection with A. lumbricoides is acquired by swallowing fully embryonated eggs from contaminated soil. Ascaris (66-92) #*bEAscaris B01.500.294.700.100.100.108 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea Ascaris lumbricoides; Ascaris suum A genus of nematodes of the superfamily ASCARIDOIDEA whose species usually inhabit the intestine. O *W*sAscaridoidea B01.500.294.700.100.100 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida Anisakis; Ascaridia; Ascaris (+ 2); Toxascaris; Toxocara (+ 1) A superfamily of polymyarian nematode worms. An important characteristic of this group is the presence of three prominant lips around the mouth of the organism. Nematoda (66-74)  *GOAscaridida Infections C03.335.508.700.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections Anisakiasis; Ascariasis; Ascaridiasis; Toxascariasis; Toxocariasis (+ 1) Infections with nematodes of the order ASCARIDIDA. P[V=Ascaridida B01.500.294.700.100 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea Ascaridoidea (+ 8) An order of nematodes of the subclass SECERNENTEA. Its organisms possess two or three pairs of dorsolateral caudal papillae. =*9Ascaridiasis C03.335.508.700.100.080 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Ascaridida Infections Infection with nematodes of the genus ASCARIDIA. This condition usually occurs in fowl, often manifesting diarrhea. PuAscaridia B01.500.294.700.100.100.082 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea A genus of nematode worms. A. galli and A. lineata are important intestinal parasites of domestic fowl. Nematoda (66-71) 3 *W}Ascariasis C03.335.508.700.100.070 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Ascaridida Infections Infection by nematodes of the genus ASCARIS. Ingestion of infective eggs causes diarrhea and pneumonitis. Its distribution is more prevalent in areas of poor sanitation and where human feces are used for fertilizer. PuAsbestosis C08.381.483.600.125; C21.447.800.127 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis A form of lung disease (pneumoconiosis) caused by inhaling fibers of asbestos and marked by interstitial fibrosis of the lung varying in extent from minor involvement of the basal areas to extensive scarring. It is associated with pleural mesothelioma and bronchogenic carcinoma. (Dorland, 27th ed). *L_Asbestos, Serpentine D01.524.500.050; D01.578.725.050.075; D01.578.725.500.050; D01.837.725.700.760.070.110; D01.837.725.700.760.535.400; D26.191.081.075 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Magnesium Compounds; Magnesium Silicates Inorganic Chemicals (Non MeSH); Minerals; Silicates; Asbestos Inorganic Chemicals (Non MeSH); Minerals; Silicates; Magnesium Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Asbestos Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Magnesium Silicates Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Asbestos A type of asbestos that occurs in nature as the dihydrate of magnesium silicate. It exists in two forms: antigorite, a plated variety, and chrysotile, a fibrous variety. The latter makes up 95% of all asbestos products. (From Merck Index, 11th ed, p.893). Asbestos (69-93) u8<2Asbestos, Crocidolite D01.578.725.050.050.100; D01.837.725.700.760.070.050.090; D26.191.081.050.150 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Minerals; Silicates; Asbestos; Asbestos, Amphibole Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Asbestos; Asbestos, Amphibole Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Asbestos; Asbestos, Amphibole Crocidolite. A lavender, acid-resistant asbestos. Asbestos (75-93) U,W;Asbestos, Amphibole D01.578.725.050.050; D01.837.725.700.760.070.050; D26.191.081.050 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Minerals; Silicates; Asbestos Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Asbestos Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Asbestos Asbestos, Amosite; Asbestos, Crocidolite Asbestos, Amosite; Asbestos, Crocidolite Asbestos, Amosite; Asbestos, Crocidolite A class of asbestos that includes silicates of magnesium, iron, calcium, and sodium. The fibers are generally brittle and cannot be spun, but are more resistant to chemicals and heat than ASBESTOS, SERPENTINE. (From Hawley's Condensed Chemical Dictionary, 11th ed). Asbestos (79-93); Silicon Dioxide (79-93)  kI,83Asbestos, Amosite D01.524.500.040; D01.578.725.050.050.050; D01.578.725.500.040; D01.837.725.700.760.070.050.060; D01.837.725.700.760.535.040; D26.191.081.050.050 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Magnesium Compounds; Magnesium Silicates Inorganic Chemicals (Non MeSH); Minerals; Silicates; Asbestos; Asbestos, Amphibole Inorganic Chemicals (Non MeSH); Minerals; Silicates; Magnesium Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Asbestos; Asbestos, Amphibole Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates; Magnesium Silicates Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Asbestos; Asbestos, Amphibole Asbestos, grunerite. A monoclinic amphibole form of asbestos having long fibers and a high iron content. It is used in insulation. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Asbestos (74-93) ),Asbestos D01.578.725.050; D01.837.725.700.760.070; D26.191.081 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Minerals; Silicates Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Asbestos, Amphibole (+ 2); Asbestos, Serpentine Asbestos, Amphibole (+ 2); Asbestos, Serpentine Asbestos, Amphibole (+ 2); Asbestos, Serpentine Asbestos. Fibrous incombustible mineral composed of magnesium and calcium silicates with or without other elements. It is relatively inert chemically and used in thermal insulation and fireproofing. Inhalation of dust causes asbestosis and later lung and gastrointestinal neoplasms. Minerals (66-68)   =8GArytenoid Cartilage A02.165.507.083; A04.329.591.085 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Cartilage; Laryngeal Cartilages Respiratory System; Larynx; Laryngeal Cartilages One of a pair of small pyramidal cartilages that articulate with the lamina of the cricoid cartilage. The corresponding vocal ligament and several muscles are attached to it. Laryngeal Cartilages (66-79) R&:y"Arylsulfotransferase D08.586.913.815.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Sulfotransferases A sulfotransferase that catalyzes the sulfation of a phenol in the presence of 3'-phosphoadenylylsulfate as sulfate donor to yield an aryl sulfate and adenosine 3',5'-bisphosphate. A number of aromatic compounds can act as acceptors; however, organic hydroxylamines are not substrates. Sulfate conjugation by this enzyme is a major pathway for the biotransformation of phenolic and catechol drugs as well as neurotransmitters. EC 2.8.2.1. Sulfurtransferases (72-88); Transferases (66-71) [Fj9Arylsulfonic Acids D02.886.645.600.080 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids Arylsulfonates (+ 14); Sulfanilic Acids; Trinitrobenzenesulfonic Acid Organic sulfonic acid derivatives which contain an aromatic hydrocarbon radical. Sulfonic Acids (66-93) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8kR^:Arylsulfonates D02.886.645.600.080.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids Benzenesulfonates (+ 6); Lissamine Green Dyes; Naphthalenesulfonates (+ 5) Organic sulfonic acid esters or salts which contain an aromatic hydrocarbon radical. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8Yd:Arylsulfatases D08.586.277.352.827.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Sulfatases Cerebroside-Sulfatase; Chondro-4-Sulfatase Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.1. Phenols (73-74); Sulfatases (73-74)  Fn06,Arylamine Acetyltransferases D08.586.913.050.134.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Acetyltransferases Enzymes that catalyze the transfer of acetyl groups from acetyl-CoA to arylamines. They have wide specificity for aromatic amines, particularly serotonin, and can also catalyze acetyl transfer between arylamines without CoA. EC 2.3.1.5. specific amine; Acetyltransferases (73-79); Acyltransferases (66-72); Serotonin (66-74) /analogs and derivatives (75-79) D!FAryl Hydrocarbon Hydroxylases D08.586.682.420.170.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 Aniline Hydroxylase; Benzopyrene Hydroxylase Hydroxylases which utilize reduced flavin or flavoprotein as one donor and incorporate one atom of oxygen. They act on many aromatic compounds. They are a component part of the mixed-function oxidase system and are important for the oxidation of many drugs and toxins such as phenobarbital, carcinogens and insecticides. These enzymes are considered to be an aspect of EC 1.14.14.1. Hydroxylases (71-74); Polycyclic Hydrocarbons (74)  #F}4<Artiodactyla B02.649.077 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals Ruminants (+ 11); Swine (+ 1) i((Artificial Organs E07.858.082 AECLCTECHIPXSDSNSTTDUTVE Equipment and Supplies; Surgical Equipment Artificial Limbs; Heart, Artificial; Heart, Mechanical; Infusion Pumps (+ 2); Kidney, Artificial; Larynx, Artificial; Pacemaker, Artificial; Skin, Artificial; Urinary Sphincter, Artificial AECLCTECHIISMIMONUPSPXRHSDSNSTTDUTVEVI 3*Artificial Limbs E04.557.210; E04.659.094; E07.858.082.127; E07.858.442.127; E07.858.565.094 AECLCTECHIISMONUPXRHSNSTTDUTVE Surgery, Operative; Orthopedics Surgery, Operative; Prosthesis Equipment and Supplies; Surgical Equipment; Artificial Organs Equipment and Supplies; Surgical Equipment; Orthopedic Equipment Equipment and Supplies; Surgical Equipment; Prosthesis ǷW"Artificial Intelligence L01.700.568.110.065 Neural Networks (Computer) Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) Expert Systems; Fuzzy Logic; Natural Language Processing; Neural Networks (Computer); Robotics The study and implementation of techniques and methods for designing computer systems to perform functions normally associated with human intelligence, such as understanding language, learning, reasoning, problem solving, etc. Computers (66-85) CLECEDHIISLJMAMTOGSNSTTDUT $} |qArtifacts E05.047 Miscellaneous Techniques (Non MeSH) Any visible result of a procedure which is caused by the procedure itself and not by the entity being analyzed. Common examples include histological structures introduced by tissue processing, radiographic images of structures that are not naturally present in living tissue, and products of chemical reactions that occur during analysis. #  *Articulation Disorders C10.597.257.870.080; C23.888.592.257.870.080; F03.126.219.870.080; F03.305.100 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders Behavioral and Mental Disorders (Non MeSH); Child Development Disorders Disorders of speech sound production characterized by substitution, omission, and distortion of sounds.  XFxArthus Reaction C20.543.520.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Immunologic Diseases; Hypersensitivity; Immune Complex Diseases A dermal inflammatory reaction produced under conditions of antibody excess, when a second injection of antigen produces intravascular antigen-antibody complexes which bind complement, causing cell clumping, endothelial damage, and vascular necrosis. ONJArthroscopy E01.418.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Joints Diagnosis; Endoscopy Endoscopic examination of the interior of a joint. Endoscopy (66-81); Joint Diseases (66-81); Knee Injuries (66-81); Knee Joint (66-81); other joint heading  N" >Arthropods B01.131 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates Arachnida (+ 9); Crustacea (+ 7); Horseshoe Crabs; Insects (+ 48) Members of the phylum Arthropoda of the animal kingdom, composed of organisms having a hard, jointed exoskeleton and paired jointed legs, and including among other classes, the ARACHNIDA and INSECTS, many species of which are important medically as parasites or as vectors of organisms capable of causing disease in man. (Dorland, 27th ed). AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI  ԝ (T*Arthropod Venoms D24.185.965.065 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms Ant Venoms; Bee Venoms (+ 2); Scorpion Venoms; Spider Venoms; Wasp Venoms Venoms from animals of the phylum Arthropoda. Those most investigated are from scorpions and spiders of the class Arachnidae and from ant, bee, and wasp families of the Insecta order Hymenoptera. The venoms contain protein toxins, enzymes, and other bioactive substances and may be lethal to man. Arthropods (66-77); Venoms (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $'<V]]+FArthropod Vectors B01.371.294 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Disease Vectors Arachnid Vectors; Insect Vectors Arthropods, other than insects and arachnids, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host. ARACHNID VECTORS and INSECT VECTORS are also available. ;(%(Arthroplasty E04.557.168 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Joints; Osseointegration Surgery, Operative; Orthopedics Joint Prosthesis (+ 2) Surgical reconstruction of a joint to relieve pain or restore motion. AECLCTECHIISMIMOMTNUPSPXRHSNSTTDUTVEVI $$&T*Arthropathy, Neurogenic C05.550.186 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. (Dorland, 27th ed). FN0Arthrogryposis C05.550.150; C05.651.102; C05.660.077; C16.131.621.077 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Musculoskeletal Diseases; Muscular Diseases Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH) Persistent flexure or contracture of a joint. (Dorland, 27th ed). ߵ@L!QArthrography E01.357.818.090 AECLCTECHIISMOMTNUPXSNSTTDUTVE Joints Diagnosis; Diagnostic Imaging; Radiography Roentgenography of a joint, usually after injection of either positive or negative contrast medium. specific joint/RA (67-85); Radiography (66-85)  " 3u9Arthrodesis E04.557.126 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Bone and Bones Surgery, Operative; Orthopedics Spinal Fusion C$&Arthrobacter B03.100.067.100.150; B03.510.460.400.400.100.150 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Actinobacteria Group A genus of asporogenous bacteria isolated from soil that displays a distinctive rod-coccus growth cycle. 6"){Arthritis, Rheumatoid C05.550.114.154; C05.799.114; C17.300.775.099; C20.111.199 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis Musculoskeletal Diseases; Rheumatic Diseases Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases Immunologic Diseases; Autoimmune Diseases Arthritis, Juvenile Rheumatoid; Caplan's Syndrome; Felty's Syndrome; Rheumatoid Nodule; Sjogren's Syndrome; Spondylitis, Ankylosing; Still's Disease, Adult-Onset Arthritis, Juvenile Rheumatoid; Caplan's Syndrome; Felty's Syndrome; Rheumatoid Nodule; Sjogren's Syndrome; Spondylitis, Ankylosing; Still's Disease, Adult-Onset Arthritis, Juvenile Rheumatoid; Caplan's Syndrome; Felty's Syndrome; Rheumatoid Nodule; Sjogren's Syndrome; Spondylitis, Ankylosing; Still's Disease, Adult-Onset Arthritis, Juvenile Rheumatoid; Felty's Syndrome; Sjogren's Syndrome; Spondylitis, Ankylosing; Still's Disease, Adult-Onset A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. 'DN Arthritis, Reactive C01.539.100.500; C02.093.500; C05.550.114.099.500 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Reiter's Disease Yersinia Infections Bacterial and Fungal Diseases (Non MeSH); Infection; Arthritis, Infectious Virus Diseases; Arthritis, Infectious Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Infectious An abacterial form of arthritis developing after infection at a site distant from the affected joint or joints. The causative bacteria cannot be cultured from synovial specimens but bacterial antigens have been demonstrated in cells from the synovial fluid and membrane. It often follows Yersinia infection. Arthritis, Infectious (66-91) $?9Pg#Arthritis, Psoriatic C05.550.114.145; C17.800.859.675.175 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Papulosquamous; Psoriasis Syndrome in which psoriasis is associated with arthritis, often involving inflammation in terminal interphalangeal joints. A rheumatoid factor is not usually present in the sera of affected individuals. Arthritis (66-89); Psoriasis (66-89) *N-Arthritis, Juvenile Rheumatoid C05.550.114.154.114; C05.799.114.114; C17.300.775.099.114; C20.111.199.114 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Arthritis, Rheumatoid Musculoskeletal Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Rheumatic Diseases; Arthritis, Rheumatoid Immunologic Diseases; Autoimmune Diseases; Arthritis, Rheumatoid Rheumatoid arthritis of children occurring in three major subtypes defined by the symptoms present during the first six months following onset: systemic-onset (Still's Disease, Juvenile-Onset) polyarticular-onset, and pauciarticular-onset. Adult-onset cases of Still's disease (STILL'S DISEASE, ADULT-ONSET) are also known. Only one subtype of juvenile rheumatoid arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent. %$TNtEArthritis, Infectious C01.539.100; C02.093; C05.550.114.099 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection Virus Diseases Musculoskeletal Diseases; Joint Diseases; Arthritis Arthritis, Reactive Arthritis, Reactive Arthritis, Reactive Arthritis caused by both bacteria and viruses. Bacterial arthritis is frequently caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria gonorrhoeae. Viral arthritis is less common than bacterial arthritis and may be a manifestation of such viral diseases as mumps, rubella, hepatitis, etc. -PD}Arthritis, Gouty C05.550.114.423.410; C05.799.414.410; C18.452.648.798.368.410 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis; Gout Musculoskeletal Diseases; Rheumatic Diseases; Gout Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Purine-Pyrimidine Metabolism, Inborn Errors; Gout Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular. Arthritis (66-88); Gout (66-88) EN$ (Arthritis, Adjuvant C05.550.114.015 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases; Arthritis An arthritis experimentally induced in animals with Freund's adjuvant. Arthritis, Rheumatoid (66-74); Arthritis (66-74) N=S:Arthritis-Encephalitis Virus, Caprine B04.820.650.589.600.070; B04.909.777.731.589.600.070 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Ovine-Caprine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Lentivirus; Lentiviruses, Ovine-Caprine A species of LENTIVIRUS, subgenus ovine-caprine lentiviruses (LENTIVIRUSES, OVINE-CAPRINE), closely related to VISNA-MAEDI VIRUS and causing acute encephalomyelitis, chronic arthritis, pneumonia, mastitis, and glomerulonephritis in goats. It is transmitted mainly in the colostrum and milk. Retroviridae (83-90); Visna Virus (83-90) c+:K3Arthritis C05.550.114 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Arthritis, Adjuvant; Arthritis, Infectious (+ 1); Arthritis, Psoriatic; Arthritis, Rheumatoid (+ 7); Chondrocalcinosis; Gout (+ 1); Osteoarthritis (+ 3); Periarthritis; Reiter's Disease; Rheumatic Fever (+ 2) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI ` N0PArthralgia C05.550.091; C10.597.617.076 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Nervous System Diseases; Neurologic Manifestations; Pain Severe pain in a joint, especially one not inflammatory in character. (Stedman, 25th ed). Arthritis (75-94); Joint Diseases (67-94); Pain (67-94) k"NqmEArterivirus Infections C02.782.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Infections caused by viruses of the genus ARTERIVIRUS. 3P:BArterivirus B04.820.060; B04.909.777.090; B04.970.060 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Viruses; Viruses, Unclassified Arteritis Virus, Equine; Borna Disease Virus; Lactate Dehydrogenase Virus Arteritis Virus, Equine; Borna Disease Virus; Lactate Dehydrogenase Virus Arteritis Virus, Equine; Borna Disease Virus; Lactate Dehydrogenase Virus A genus that is currently unclassified, Arterivirus is likely to be part of Coronaviridae or a new family. It was previously classified under Togaviridae. The type species is ARTERITIS VIRUS, EQUINE. L1|Arteritis Virus, Equine B04.820.060.100; B04.909.777.090.100; B04.970.060.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arterivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arterivirus Viruses; Viruses, Unclassified; Arterivirus The type species of the genus ARTERIVIRUS and the etiologic agent of an important equine respiratory disease causing abortion, pneumonia, or other infections. ARTERIVIRUS will probably be classed as a Coronaviridae or in a new family.  :=Arteritis C14.907.184; C14.907.940.090 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Cardiovascular Diseases; Vascular Diseases; Vasculitis Endarteritis; Polyarteritis Nodosa; Takayasu's Arteritis; Temporal Arteritis Endarteritis; Polyarteritis Nodosa; Takayasu's Arteritis; Temporal Arteritis Inflammation of an artery.   "Np"Arteriovenous Shunt, Surgical E04.752.814.143; E04.035.087 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Surgery, Operative; Anastomosis, Surgical Arteries/surgery (66-69); Arteriovenous Fistula (66-69)  w#"$BArteriovenous Malformations C14.240.150; C14.907.150; C16.131.240.150 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Angiomatosis; Arteriovenous Fistula; Hemangioma Arteriovenous Fistula Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH) Cardiovascular Diseases; Vascular Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH) Arteriovenous Fistula; Cerebral Arteriovenous Malformations Arteriovenous Fistula; Cerebral Arteriovenous Malformations Arteriovenous Fistula; Cerebral Arteriovenous Malformations Abnormal, tangled collections of dilated blood vessels that result from congenitally malformed vascular structures in which arterial afferents flow directly into venous efferents without the usual resistance of an intervening capillary bed. A common type is the congenital arteriovenous fistula (ARTERIOVENOUS FISTULA /congenital). For arteriovenous malformations in the brain, CEREBRAL ARTERIOVENOUS MALFORMATIONS is available. (From Merck Manual, 15th ed). Arteriovenous Fistula/congenital (66-68) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI , 1L8/NArteriovenous Fistula C14.240.150.125; C14.907.150.125; C14.907.933.125; C16.131.240.150.125; C23.439.850.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Arteriovenous Malformations Arteriovenous Malformations Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Arteriovenous Malformations Cardiovascular Diseases; Vascular Diseases; Arteriovenous Malformations Cardiovascular Diseases; Vascular Diseases; Vascular Fistula (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Arteriovenous Malformations Symptoms and General Pathology (Non MeSH); Fistula; Vascular Fistula (Non MeSH) An abnormal communication between an artery and a vein.  2cN  DArteriovenous Anastomosis A07.231.432.209 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Cardiovascular System; Blood Vessels; Microcirculation A vessel that directly interconnects an artery and a vein, and that acts as a shunt to bypass the capillary bed. Not to be confused with surgical anastomosis, nor with arteriovenous fistula. 6@Arteriosclerosis Obliterans C14.907.137.126.114 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases; Arteriosclerosis Arteriosclerosis in which proliferation of the intima leads to occlusion of the lumen of the arteries. [ NgzArteriosclerosis C14.907.137.126 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Diet, Atherogenic Cardiovascular Diseases; Vascular Diseases; Arterial Occlusive Diseases Arteriosclerosis Obliterans; Atherosclerosis; Cerebral Arteriosclerosis; Coronary Arteriosclerosis; Intermittent Claudication NSArterioles A07.231.114.060; A07.231.432.200 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries Cardiovascular System; Blood Vessels; Microcirculation The smallest divisions of the arteries located between the muscular arteries and the capillaries. Arteries (66-77); specific artery v&8vs*Arterio-Arterial Fistula C14.240.110; C14.907.933.110; C16.131.240.110; C23.439.850.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH) Cardiovascular Diseases; Vascular Diseases; Vascular Fistula (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH) Symptoms and General Pathology (Non MeSH); Fistula; Vascular Fistula (Non MeSH) Abnormal communication between two arteries. It may result from injury or occur as a congenital abnormality. specific arteries (66-86) HNoArteries A07.231.114 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Angiography; Endarterectomy Cardiovascular System; Blood Vessels Aorta (+ 3); Arterioles; Axillary Artery; Basilar Artery; Brachial Artery (+ 2); Brachiocephalic Trunk; Bronchial Arteries; Carotid Arteries (+ 4); Celiac Artery; Cerebral Arteries (+ 1); Coronary Vessels; Femoral Artery; Hepatic Artery; Iliac Artery; Maxillary Artery; Meningeal Arteries; Mesenteric Arteries (+ 2); Ophthalmic Artery; Popliteal Artery; Pulmonary Artery; Renal Artery; Retinal Artery; Splenic Artery; Subclavian Artery; Temporal Arteries; Thoracic Arteries (+ 1); Tibial Arteries; Umbilical Arteries; Vertebral Artery The vessels carrying blood away from the heart. ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $! 6!,;8Arterial Occlusive Diseases C14.907.137 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Arteriosclerosis (+ 5); Carotid Stenosis; Fibromuscular Dysplasia; Leriche's Syndrome; Mesenteric Vascular Occlusion; Moyamoya Disease; Renal Artery Obstruction; Retinal Artery Occlusion; Thromboangiitis Obliterans Diseases in which arterial vessels are partially or completely obstructed or in which the blood flow through the vessels is impeded. Vascular Diseases (66-72)  $!N2Artemia B01.131.365.060 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Crustacea A genus of crustaceans of the order Anostraca found in briny pools and lakes and often cultured for fish food. It has 168 chromosomes and differs from most crustaceans in that its blood contains hemoglobin. Crustacea (66-78); Shrimp (72-78) 'S (,*Art Therapy E02.831.100; F04.754.070 CLECEDHIISLJMAMTOGSNSTTD Therapeutics; Rehabilitation Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy The use of art as an adjunctive therapy in the treatment of neurological, mental, or behavioral disorders. ) kArt K01.093 HI Anatomy, Artistic; Medical Illustration; Medicine in Art Humanities Caricatures (+ 1); Engraving and Engravings; Human Body; Medical Illustration (+ 1); Medicine in Art; Numismatics; Paintings; Philately; Portraits; Sculpture CLECEDHIISLJMAMTOGPXSNSTTD  *c DArsphenamine D02.691.088.050; D20.288.293 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Anti-Infective Agents; Antitreponemal Agents (Non MeSH) +":Arsenites D01.079.050; D01.248.497.158.055 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Arsenic Compounds Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic salts of arsenious acid. Arsenic (66-93) , &8+Arsenicals D02.691.088; D08.373.830.126 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Sulfhydryl Reagents Arsanilic Acid; Arsenamide; Arsenazo III; Arsphenamine; p-Azobenzenearsonate; Cacodylic Acid; Melarsoprol; Roxarsone AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR .A"8DArsenic Compounds D01.079 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Arsenates; Arsenites Inorganic compounds that contain arsenic as an integral part of the molecule. Arsenic (66-93)  0E 8%]Arsenic D01.268.067; D01.268.912.035 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Elements; Trace Elements Arsenic. A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed). 1y ":uArsenazo III D02.172.040; D02.691.088.044; D26.408.082; D26.550.035 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Miscellaneous Drugs and Agents (Non MeSH); Dyes Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 2,7-Bis-(arsonophenylazo)- 1,8-dihydroxynaphthalene-3,6-disulfonic acid. Metallochrome indicator that changes color when complexed to the calcium ion under physiological conditions; used to measure local calcium ion concentrations in vivo. Arsenicals (66-79); Azo Compounds (66-79); Dyes (66-79); Indicators and Reagents (66-79) 40@. lArsenates D01.079.025; D01.248.497.158.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Arsenic Compounds Inorganic Chemicals (Non MeSH); Electrolytes; Ions; Anions Inorganic salts of arsenic acid. 7\ &8)Arsenamide D02.691.088.040; D21.201.287.278.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals Antiparasitic Agents (Non MeSH); Anthelmintics; Antinematodal Agents; Filaricides ([(p-Carbamoylphenyl)arsylene]dithio)diacetic acid. Proposed chemotherapeutic agent against filaria and trichomonas. Synonyms: Caparside; Caparsolate. Arsenicals (69-74); Benzamides (73-74); Sulfides (73-74) 8*:EArsanilic Acid D02.691.088.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Arsenicals (4-Aminophenyl)-arsonic acid monosodium salt. An arsenical which has been used as a feed additive for enteric conditions in pigs and poultry. It causes blindness and is ototoxic and nephrotoxic in animals. Arsenicals (66-78) ::OArrhythmia, Sinus C14.280.067.093 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia Irregularity of the heart rate related to functioning of the sinoatrial node. <N=]Arrhythmia C14.280.067 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Anti-Arrhythmia Agents Heart Conduction System Cardiovascular Diseases; Heart Diseases Arrhythmia, Sinus; Atrial Fibrillation; Atrial Flutter; Bradycardia; Extrasystole; Heart Block (+ 3); Long QT Syndrome; Parasystole; Pre-Excitation Syndromes (+ 3); Sick Sinus Syndrome; Tachycardia (+ 10); Ventricular Fibrillation Any variation from the normal rhythm of the heart beat. $=N/EArousal F02.830.104; G11.561.065 CLDEGEPHRE Psychologic Processes and Principles (Non MeSH); Psychophysiology Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH) Attention; Wakefulness Wakefulness Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. @9 )Aromatic Amino Acid Decarboxylases D08.586.520.258.090 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Carboxy-Lyases Dopa Decarboxylase; Tyrosine Decarboxylase An enzyme group with broad specificity. They decarboxylate a range of aromatic amino acids including dopa, tryptophan, and hydroxytryptophan. EC 4.1.1.28. Dopa Decarboxylase (66-79)  B )Fa2 Aromatase D08.586.682.170; D08.586.682.420.170.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450 An enzyme from human placenta which converts androgens to estrogens by desaturating ring A of the steroid. Androstanes (72-74); Estrogens (72-74); Oxidoreductases (72-74) D" .FLAroclors D02.455.526.439.773.292; D02.455.526.439.785.292; D05.284.125 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated; Polychlorinated Biphenyls Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated; Polychloroterphenyl Compounds Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Industrial chemicals which have become widespread environmental pollutants. Each aroclor is a mixture of chlorinated biphenyls (1200 series) or chlorinated terphenyls (5400 series) or a combination of both (4400 series). Fh E8qArnold-Chiari Deformity C10.500.680.291; C16.131.666.680.291 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Platybasia Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects A congenital anomaly in which the cerebellum and medulla oblongata, which is elongated and flattened, protrude down into the spinal canal through the foramen magnum. It may be associated with many other defects, including spina bifida occulta and meningomyelocele. (Dorland, 27th ed). I*LMArnica B06.560.090 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A genus of composite-flowered plants, known also as leopard's bane, wolf's bane, and mountain tobacco. The dried flowerheads of Arnica montana contain a volatile oil, arnicin, arnisterol, and anthoxanthine, tannin, and resin. It is used topically as a tincture for contusions, sprains, and superficial wounds, and as a counterirritant. (Dorland, 27th ed). Plants, Medicinal (66-84) L & Armin D02.705.065; D08.373.275.100; D14.100.120.300.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Ethyl-p-nitrophenyl ethylphosphonate. A reversible organophosphorus cholinesterase inhibitor. It also affects the presynaptic membrane and inhibits membrane postsynaptic cholinergic receptors. The compound had former use as a miotic. Cholinesterase Inhibitors (66-78); Nitrobenzenes (66-78); Organophosphorus Compounds (71-78) N 9:N kArmenia Z01.542.900.099; Z01.586.035.150; Z01.586.200.099; Z01.586.950.099 EHEP Geographicals (Non MeSH); Europe; Transcaucasia Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Ancient Lands (Non MeSH) Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Commonwealth of Independent States Geographicals (Non MeSH); Historical Geographicals (Non MeSH); USSR An ancient country in western Asia, by the twentieth century divided among the former USSR, Turkey, and Iran. It was attacked at various times from before the 7th century B.C. to 69 B.C. by Assyrians, Medes, Persians, the Greeks under Alexander, and the Romans. It changed hands frequently in wars between Neo-Persian and Roman Empires from the 3d to 7th centuries and later under Arabs, Seljuks, Byzantines, and Mongols. In the 19th century Armenian nationalism arose but suffered during Russo-Turkish hostilities. It became part of the Soviet Republic in 1921, with part remaining under Turkey. (Webster's New Geographical Dictionary, 1988). R: LbArmadillos B02.649.314.100 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Edentata Burrowing, chiefly nocturnal mammals of the family Dasypodidae having bodies and heads encased in small bony plates. They are widely distributed in the warmer parts of the Americas. W(&Arm Injuries C21.866.088 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Forearm Injuries (+ 2); Humeral Fractures; Shoulder Dislocation; Shoulder Fractures; Tennis Elbow; Wrist Injuries General or unspecified injuries involving the arm. XyNQ=Arm Bones (Non MeSH) A02.835.232.087 Musculoskeletal System; Skeleton; Bone and Bones Carpal Bones (+ 1); Clavicle; Humerus; Metacarpus; Radius; Scapula (+ 1); Ulna ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Z$;e:Arm A01.378.209 ABAHBSEMGDIRMIPAPHPPPSRARERISUTRUSVI Forelimb Body Regions (Non MeSH); Extremities Elbow; Forearm; Hand (+ 2); Shoulder; Wrist ABAHBSEMGDINIRMIPAPHPPPSRARERISUTRUSVI  [O( .:*Arkansas Z01.107.567.875.100.085; Z01.107.567.875.600.820.085 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States \V :Arizona Z01.107.567.875.100.076; Z01.107.567.875.600.822.076 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southwestern United States ] :Argyria C17.800.621.166; C21.613.068 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. (Dorland, 27th ed). _g "LArgon D01.268.613.050; D01.362.641.113 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Noble Gases Inorganic Chemicals (Non MeSH); Gases; Noble Gases Argon. A noble gas with the atomic symbol Ar, atomic number 18, and atomic weight 39.948. It is used in fluorescent tubes and wherever an inert atmosphere is desired and nitrogen cannot be used. a` &:Argipressin D06.472.734.692.781.100; D12.644.456.925.100; D12.776.641.650.900.050; D14.600.600.920.050; D19.770.896.036 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Posterior; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Vasopressins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Vasopressins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Vasopressins Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Vasopressins Desmopressin Desmopressin Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2, cyclic 1-6 disulfide. The usual mammalian antidiuretic hormone, it is a cyclic nonapeptide with arginine in position 8 of the chain. Argipressin is used to treat diabetes insipidus and as hemostatic because of its vasoconstrictor action. Arginine (66-74); Vasopressins (66-74)  cUwFG!A/Arginyl T RNA Synthetase D08.586.464.136.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates arginine with its specific transfer RNA. EC 6.1.1.19. Amino Acyl T RNA Synthetases (73-74); Arginine (73-74) h$Ft_CArgininosuccinic Acid D02.241.081.337.817.075; D12.125.095.104.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids; Succinates Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino; Arginine N-[(4-Amino-4-carboxybutyl)amidino]-L-aspartic acid. This amino acid is present in unusually large amounts in the blood, urine and cerebrospinal fluid of individuals suffering from argininosuccinic aciduria. It is also formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase. Arginine (71-74) /AA (75); Succinates (71-75) i2:8Argininosuccinate Synthetase D08.586.464.155 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or defect of this enzyme causes the metabolic disease citrullinemia in man. EC 6.3.4.5. Arginine (73-74); Ligases (73-74); Succinates (73-74) m>!FPBArgininosuccinate Lyase D08.586.520.190 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease argininosuccinic acidemia in man. EC 4.3.2.1. Arginine (73-74); Lyases (73-74); Succinates (73-74) oFOAArginine Kinase D08.586.913.696.640.025 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Nitrogenous Group Acceptor) An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3. Arginine (66-78); Phosphotransferases (66-73); Phosphotransferases, ATP (74-78) qF]Arginine Carboxypeptidase D08.586.277.656.245.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Carboxypeptidases Peptidyl-L-arginine hydrolase. A serine carboxypeptidase that removes C-terminal arginine from peptides and proteins. It inactivates bradykinin by this action. EC 3.4.17.3. Arginine (72-74); Carboxypeptidases (72-74); Peptides (72-74) sFJArginine D12.125.095.104; D12.125.142.087 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Diamino Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Essential Argininosuccinic Acid; Benzoylarginine-2-Naphthylamide; Benzoylarginine Nitroanilide; Homoarginine; Tosylarginine Methyl Ester An essential amino acid that is physiologically active in the L-form. It has also been used diagnostically as an indicator of pituitary function. v0 &FArginase D08.586.277.913.292 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Ureohydrolases A ureahydrolase that catalyzes the hydrolysis of arginine and canavanine to yield L-ornithine and urea. EC 3.5.3.1. x FeArgentina Z01.107.757.077 EHEP Geographicals (Non MeSH); America; South America zI <Arenavirus B04.820.057.070; B04.909.777.080.070 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Arenaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Arenaviridae LCM-Lassa Complex Viruses (+ 2); Tacaribe Complex Viruses (+ 2) LCM-Lassa Complex Viruses (+ 2); Tacaribe Complex Viruses (+ 2) The only genus in the family ARENAVIRIDAE. It contains two groups LCM-LASSA COMPLEX VIRUSES and TACARIBE COMPLEX VIRUSES, which are distinguished by antigenic relationships and geographic distribution. z*yArenaviridae Infections C02.782.082 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH) Hemorrhagic Fever, American; Lassa Fever; Lymphocytic Choriomeningitis Virus diseases caused by the ARENAVIRIDAE. Arenaviridae (78-80); Virus Diseases (66-80)  }EP:R46Arenaviridae B04.820.057; B04.909.777.080 CHCLDEENGDGEIMIPMEPHPYREUL Arboviruses Viruses; RNA Viruses Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses Arenavirus (+ 6) Arenavirus (+ 6) Family of RNA viruses naturally infecting rodents and consisting of one genus (ARENAVIRUS) with two groups: LCM-LASSA COMPLEX VIRUSES and TACARIBE COMPLEX VIRUSES. Infection in rodents is persistent and silent. Vertical transmission is through milk-, saliva-, or urine-borne routes. Horizontal transmission to humans, monkeys, and other animals is important. Intracytoplasmic inclusion bodies causing the sandy appearance (Latin arenosus = sandy), consist of ribosome masses. RNA Viruses (66-77) $~"Y*$Arecoline D03.066.515.292; D03.132.080; D03.383.725.547.292; D14.100.120.140.500.050; D14.100.120.140.700.040; D16.050.400.030; D16.050.675.030 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Acids, Heterocyclic (Non MeSH); Nicotinic Acids Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Nicotinic Acids Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Nicotinic Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Ganglionic Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetycholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands. Nicotinic Acids (69-72); Parasympatholytics (66-68) / @=Areca B06.560.077 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A small genus of East Indian palms (Palmae) whose leaves and nuts yield ARECOLINE. Its leaves and nuts have been used as masticatories, stimulants, and astringents in folk medicine.  & Area Health Education Centers I02.783.660.125 CLECHILJMAOGSNSTTD Education; Schools; Schools, Health Occupations Education centers authorized by the Comprehensive Health Manpower Training Act, 1971, for the training of health personnel in areas where health needs are the greatest. May be used for centers other than those established by the United States act. u$9#Arcus Senilis C11.204.299.070 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Corneal Diseases; Corneal Opacity A corneal disease in which there is a deposition of phospholipid and cholesterol in the corneal stroma and anterior sclera. AN:Arcuate Nucleus A08.186.211.730.385.357.352.081 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Central Nervous System; Brain; Prosencephalon; Diencephalon; Hypothalamus; Hypothalamus, Middle A nucleus located in the middle hypothalamus in the most ventral part of the third ventricle near the entrance of the infundibular recess. Its small cells are in close contact with the ependyma. Hypothalamus (66-82) #6Arctic Regions Z01.208 EHEP Geographicals (Non MeSH)  Archives K01.419.152; L01.346.208 HI Humanities; History Information Science; Information Centers Museums  G Architecture J01.086 CLECEDHIISLJMAMTOGSNSTTD Health Facility Planning Technology, Industry, Agriculture (Non MeSH) Facility Design and Construction (+ 7)  4/Architectural Accessibility J01.086.339.070 CLECHIISLJMTSNST Technology, Industry, Agriculture (Non MeSH); Architecture; Facility Design and Construction Designs for approaching areas inside or outside facilities. Architecture (66-Jul 77)  lGArchaeology I01.076.201.208 CLECEDHIISLJMAMTOGSNSTTD Paleography Social Sciences; Anthropology; Anthropology, Cultural The scientific study of past societies through artifacts, fossils, etc. ?UArchaeobacteria B03.107 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria Halobacteriales (+ 3); Methanogens (+ 10); Sulfolobales (+ 3); Thermoplasma A group of bacteria phylogenetically distinct from the Eubacteria. They are characterized by: 1) the presence of characteristic tRNAs and ribosomal RNAs; 2) the absence of peptidoglycan cell walls; 3) the presence of ether-linked lipids built from branched-chain subunits; and 4) their occurrence in unusual habitats. The group encompasses three distinct subgroups: the METHANOGENS, the extreme halophiles (HALOBACTERIALES), and the extreme thermoacidophiles (THERMOPLASMA and SULFOLOBALES). Bacteria (66-80)   " ^7Arbutin D09.203.408.348.075 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides   DgArboviruses B04.080 CHCLDEENGDGEIMIPMEPHPYREUL Arenaviridae; Bunyaviridae; Flaviviridae; Reoviridae; Togaviridae Viruses Arthropod-borne viruses. A non-taxonomic designation for viruses that can replicate in both vertebrate hosts and arthropod vectors. Included are some members of the following families: ARENAVIRIDAE, BUNYAVIRIDAE, REOVIRIDAE, TOGAVIRIDAE, and FLAVIVIRIDAE. (From Dictionary of Microbiology and Molecular Biology, 2nd ed).  M pArbovirus Infections C02.081 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases African Horsesickness; Bluetongue; Borna Disease; Dengue; Encephalitis, Epidemic (+ 5); Encephalomyelitis, Equine (+ 1); Phlebotomus Fever; Rift Valley Fever; Tick-Borne Diseases (+ 7); West Nile Fever; Yellow Fever Infections caused by arthropod-borne viruses, general or unspecified.  PRArbaprostil D02.241.081.436.687.700.450.050; D10.516.251.355.708.700.450.050; D17.350.700.660.050; D19.316.203.069 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Prostaglandins, Synthetic; Prostaglandins E, Synthetic Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents (5Z,11 alpha,13E,15R)-11,15-Dihydroxy-15-methyl-9-oxoprosta-5,13-dien-1-oic acid. A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and can inhibit the growth of experimental tumors. Prostaglandins (66-74); Prostaglandins E (75-77); Prostaglandins E, Synthetic (78-79); Prostaglandins, Synthetic (77) "p:Arachnoiditis C10.228.228.507.097 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH); Meningitis Inflammation of the arachnoid, the membrane beteen the dura mater and pia mater. (From Dorland, 27th ed0. Brain Diseases (66); Meningitis (66) N.Arachnoid Cysts C04.182.044 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Cysts Fluid-filled sacs between the layers of the pia mater and arachnoid. These lesions, which often mimic intracranial neoplasms, present clinically at all ages but are probably congenital in origin. Arachnoid (66-90); Cysts (66-90) V)Arachnoid A08.186.566.166 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Meninges Subarachnoid Space (+ 1) m 8;Arachnidism C21.613.127.141 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Bites and Stings The condition produced by the bite of a venomous spider; spider envenomation. (Dorland, 27th ed). BN[wArachnida B01.131.166 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods Acari (+ 5); Scorpions; Spiders (+ 1) A class of the Arthropoda, including the SPIDERS, TICKS, MITES, and SCORPIONS. Unlike insects, they have no antennae, wings, or compound eyes, nor are their bodies divided into head, thorax, and abdomen. (Dorland, 27th ed; Smith, Insects and Other Arthropods of Medical Importance, 1973).  (2TArachnid Vectors B01.371.294.207 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Disease Vectors; Arthropod Vectors Members of the class Arachnida, especially spiders, scorpions, mites, and ticks, which transmit infective organisms from one host to another or from an inanimate reservoir to an animate host. Arthropod Vectors (66-70) (;Arachidonic Acids D02.241.081.436.103; D02.241.081.436.213.100; D10.516.251.355.096; D10.516.251.355.255.100; D10.516.251.355.310.166 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Essential Arachidonic Acid; Hydroxyeicosatetraenoic Acids Arachidonic Acid; Hydroxyeicosatetraenoic Acids; Leukotrienes (+ 6); Prostaglandins (+ 1); Thromboxanes (+ 2) Arachidonic Acid; Hydroxyeicosatetraenoic Acids Arachidonic Acid; Hydroxyeicosatetraenoic Acids; Leukotrienes (+ 6); Prostaglandins (+ 1); Thromboxanes (+ 2) Arachidonic Acid Fatty Acids, Essential (66) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  hB`"DArachidonic Acid D02.241.081.436.103.100; D02.241.081.436.213.100.100; D10.516.251.355.096.100; D10.516.251.355.255.100.100; D10.516.251.355.310.166.100 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Arachidonic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Arachidonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Eicosanoids; Arachidonic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Essential; Arachidonic Acids (all Z)-5,8,11,14-Eicosatetraenoic acid. An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes, and leukotrienes. Arachidonic Acids (75-91) BArachidonate 5-Lipoxygenase D08.586.682.690.433.050.055 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases; Lipoxygenase; Arachidonate Lipoxygenases An enzyme that catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate (5-HPETE) which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate (5-HETE). The 5-hydroperoxides are preferentially formed in leukocytes. EC 1.13.11.34. Lipoxygenases (74-86); Oxygenases (66-73) V F92Arachidonate 15-Lipoxygenase D08.586.682.690.433.050.065 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases; Lipoxygenase; Arachidonate Lipoxygenases An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate (15-HPETE) which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate (15-HETE). The 15-hydroperoxides are preferentially formed in neutrophils and lymphocytes. EC 1.13.11.33. Lipoxygenases (74-86); Oxygenases (66-73) !F>2Arachidonate 12-Lipoxygenase D08.586.682.690.433.050.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases; Lipoxygenase; Arachidonate Lipoxygenases An enzyme that catalyzes the oxidation of arachidonic acid to yield 12-hydroperoxyarachidonate (12-HPETE) which is itself rapidly converted by a peroxidase to 12-hydroxy-5,8,10,14-eicosatetraenoate (12-HETE). The 12-hydroperoxides are preferentially formed in platelets. EC 1.13.11.31. Lipoxygenases (74-86); Oxygenases (66-73) !FE2Arachidonate Lipoxygenases D08.586.682.690.433.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Oxygenases; Lipoxygenase Arachidonate 5-Lipoxygenase; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase Enzymes catalyzing the oxidation of arachidonic acid to hydroperoxyarachidonates (HPETES). These products are then rapidly converted by a peroxidase to hydroxyeicosatetraenoic acids (HETES). The positional specificity of the enzyme reaction varies from tissue to tissue. The final lipoxygenase pathway leads to the leukotrienes. EC 1.13.11.- . Lipoxygenases (74-86); Oxygenases (66-73)  mFvb2Arabinose D09.203.546.627.166 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Monosaccharides; Pentoses  DjArabinonucleotides D13.695.065 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides Arabinofuranosyladenine Monophosphate; Arabinofuranosylcytosine Triphosphate Nucleotides containing arabinose as their sugar moiety. specific nucleotide (66-78); Nucleotides (66-78) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $BPTB:DArabinonucleosides D13.570.065 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides Arabinofuranosyluracil; Cytarabine (+ 1); Vidarabine Nucleosides containing arabinose as their sugar moiety. specific nucleoside (66-78); Nucleosides (66-78) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ÜBP?B:DArabinofuranosyluracil D13.570.065.090; D13.570.685.852.150 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Arabinonucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Pyrimidine Nucleosides; Uridine 1-beta-D-Arabinofuranosyluracil. A pyrimidine nucleoside formed in the body by the deamination of cytarabine. Arabinose (72-74)/analogs and derivatives (75); Nucleosides (72-74); Uracil (72-74); Uridine/analogs and derivatives (75) Ł*DArabinofuranosylcytosine Triphosphate D13.695.065.200; D13.695.740.246.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Arabinonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides; Cytosine Nucleotides 4-Amino-1-(5-O-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone. A triphosphate nucleotide analog of cytarabine, which is the biologically active form of cytarabine. It inhibits nuclear DNA synthesis. Cytarabine (66-78) **:"Arabinofuranosyladenine Monophosphate D13.695.065.050; D13.695.667.138.250; D20.388.975.050; D26.087.975.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Arabinonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Anti-Infective Agents; Antiviral Agents; Vidarabine Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Vidarabine 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine. An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of vidarabine with antiviral and possibly antineoplastic properties. Adenine Nucleotides (66-70); Adenosine Monophosphate (71-78); Vidarabine (75-78) *P:p_Arabidopsis B06.150 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants A genus of flowering plants found in north temperate regions. The species A. thaliana is used for experiments in classical plant genetics as well as molecular genetic studies in plant physiology, biochemistry, and development. Plants (66-92) α &  Arabia Z01.586.035.100 EHEP Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Ancient Lands (Non MeSH) > iArab World I01.076.201.450.226.200 HI Social Sciences; Anthropology; Anthropology, Cultural; Culture; Civilization A historical and cultural entity dispersed across a wide geographical area under the administrative, intellectual, social, and cultural domination of the Arab empire. The Arab world, under the impetus of Islam, by the eighth century A.D., extended from Arabia in the Middle East to all of northern Africa, southern Spain, Sardinia, and Sicily. Close contact was maintained with Greek and Jewish culture. While the principal service of the Arabs to medicine was the preservation of Greek culture, the Arabs themselves were the originators of algebra, chemistry, geology, and many of the refinements of civilization. (From A. Castiglioni, A History of Medicine, 2d ed, p. 260; from F. H. Garrison, An Introduction to the History of Medicine, 4th ed, p. 126). ZvAqueous Humor A09.371.060.067.070; A12.207.086 CHCYDEENIMMEMIPHPSRARERISEUSVI Sense Organs; Eye; Anterior Eye Segment; Anterior Chamber Fluids and Secretions (Non MeSH); Body Fluids &"~Aquaculture J01.040.168 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH); Agriculture Fisheries Cultivation of natural faunal resources of water. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). Fisheries (66-93)  D Apyrase D08.586.277.040.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases A calcium-activated enzyme that catalyzes the hydrolysis of ATP to yield AMP and orthophosphate. It can also act on ADP and other nucleoside triphosphates and diphosphates. EC 3.6.1.5. Adenosine Triphosphate (74-75); Phosphatases (74-75) \ Fr>Apurinic Acid D13.695.578.500.050; D13.695.740.050; D13.695.578.550.050 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polydeoxyribonucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Pyrimidine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Polynucleotides; Polyribonucleotides Hydrolysate of DNA in which purine bases have been removed. Polynucleotides (72-75); Pyrimidine Nucleotides (74) uAD`I>Apudoma C04.557.465.625.650.135; C04.557.470.035.250; C04.557.580.625.650.135 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Multiple Endocrine Neoplasia Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors A general term collectively applied to tumors associated with the APUD cell series irrespective of their specific identification.  MX"APUD Cells A11.070 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells Cells derived from primitive cell types in the neural crest. During ontogeny they migrate to the foregut and specific locations of the neuroendocrine system. Properly located these cells form part of the normal hormone producing tissues of the neuroendocrine system. If misdirected these cells may become hyperplastic, adenomatous, or malignant (cf. APUDOMA). F * Aptitude Tests F04.711.141 HISNST Educational Measurement Disciplines, Tests, Therapy, Services (Non MeSH); Psychological Tests Intelligence Tests (+ 2) Primarily non-verbal tests designed to predict an individual's future learning ability or performance.  Z RwAptitude F02.784.629.131 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational The ability to acquire general or special types of knowledge or skill.   mVAprotinin D08.373.745.800.900.500; D12.776.950.500 AAADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Trypsin Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Trypsin Inhibitors  .FAprocarb D02.241.081.251.093; D05.723.491.408.207 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Carbamate Carbamates (66-71); Insecticides (66-71) ` .:1Aprindine D04.615.486.487.060; D18.097.086 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Indenes; Indans Cardiovascular Agents; Anti-Arrhythmia Agents N-[3-(Diethylamino)propyl]N-phenyl-2-indamine. Cardiac depressant used in arrhythmias. Synonym: Ac 1802. Aniline Compounds (74); Diethylamines (74); Indenes (73-75)  &:yIApraxia C10.597.123; C23.888.592.123; F03.126.720.103 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders Neurological disorder characterized by the inability to perform purposeful movements although no muscular paralysis or sensory disturbance is present.  5F"Appointments and Schedules N04.452.095 Health Services Administration (Non MeSH); Organization and Administration Waiting Lists The different methods of scheduling patient visits, appointment systems, individual or group appointments, waiting times, waiting lists for hospitals, walk-in clinics, etc. Outpatient Clinics, Hospital (66-67) g W+Appetitive Behavior F01.145.113.111 CLDEPHRE Ceremonial Ceremonial Behavior and Behavior Mechanisms (Non MeSH); Behavior; Behavior, Animal Grooming; Predatory Behavior The variable introductory phase of an instinctive behavior pattern or sequence, e.g., looking for food, or as in sequential courtship patterns prior to mating. Behavior (66-67) ( V#Appetite Regulation G10.261.082.290 DEGEIMPHRE Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH); Appetite Physiologic mechanisms which regulate or control the appetite and food intake. p]Appetite Depressants D15.155 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Appetite; Obesity; Amphetamines Central Nervous System Agents Aminorex; Amphetamine (+ 1); Benzphetamine; Diethylpropion; Ephedrine; Fenfluramine (+ 1); Mazindol; Methamphetamine; Phenmetrazine; Phentermine; Phenylpropanolamine Agents that are used to decrease appetite. In man, tolerance to the appetite suppression develops rapidly. Hence, continuous weight reduction is not usually observed in obese individuals without dietary restrictions. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p.211). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ ,'$s:Appetite F02.830.071; G10.261.082 DEGEIMPHRE Appetite Depressants Psychologic Processes and Principles (Non MeSH); Psychophysiology Digestive, Oral, Skin Physiology (Non MeSH); Digestive System Physiology (Non MeSH)  Appetite Regulation Natural recurring desire for food.  I +Appendix A03.492.411.495.209.290 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Appendectomy Digestive System; Gastrointestinal System; Intestines; Intestine, Large; Cecum  :]Appendicitis C06.405.469.110.207 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Cecal Diseases Acute inflammation of the vermiform appendix. Nh7Appendiceal Neoplasms C04.588.274.476.411.184.290; C06.240.476.411.184.290; C06.405.282.411.184.290; C06.405.469.110.417.290; C06.405.469.505.184.290 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Pseudomyxoma Peritonei Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Cecal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Cecal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Cecal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Cecal Diseases; Cecal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Cecal Neoplasms XAppendectomy E04.765.078 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Appendix Surgery, Operative; Surgery, Digestive System (Non MeSH) $ CAppalachian Region Z01.107.567.875.600.066 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH) Kentucky; Pennsylvania (+ 1); Tennessee; West Virginia The geographic area Appalachian Region in general and when the specific state or states are not indicated. Usually includes Kentucky, Pennsylvania, Tennessee, and West Virginia. wyDAporphines D03.132.070; D03.549.095 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH) Apomorphine Apomorphine Apomorphine (66-68) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  d8y:Apoptosis G04.335.139.160 DEGEIMPHRE Necrosis Cell Death; Clonal Deletion; Superantigens Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Death One of the two mechanisms by which CELL DEATH occurs (the other being the pathological process of NECROSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Cell Survival (72-92) $  4vApoproteins D12.776.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins Apoenzymes; Apolipoproteins (+ 6) specific enzyme or protein (66-71); Enzymes (66-71); Proteins (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  FD)UHApomorphine D03.132.070.290; D03.549.095.290; D14.100.150.151.040; D15.090.050.035; D15.270.040; D16.050.225.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Aporphines Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Aporphines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Agonists Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Central Nervous System Agents; Emetics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Emetics A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. \r:$Apolipoproteins E D12.776.070.400.500 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins; Apolipoproteins Prominent protein constituents of plasma VLDL, chylomicrons, and a subfraction of HDL as well as of remnant lipoproteins which are derived from the lipoprotein lipase-mediated intravascular catabolism of triglyceride-rich lipoproteins. Apolipoproteins E are recognized by the LDL receptor and Apo E receptor. Any defect in the Apo E metabolism leads to increased plasma Apo E levels. A strong association has been found between high levels of Apo E and type III hyperlipoproteinemia. Apolipoproteins (77-84) ^Ff2Apolipoproteins C D12.776.070.400.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins; Apolipoproteins Lipoproteins located on the surface of VLDL. They are transferred to HDL throughout the catabolism of VLDL and affect lipoprotein lipase activity. A genetic lack of Apo C-II results in hyperglyceridemia and low levels of HDL. Another form of hyperglyceridemia with normal Apo C-II levels is caused by a high concentration of Apo C-III in VLDL. Apolipoproteins (77-84)  FfApolipoproteins B D12.776.070.400.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins; Apolipoproteins Structural proteins of chylomicrons, VLDL, and LDL. They are important in the secretion and transport of these lipoproteins and represent the binding proteins for the LDL receptor pathway. Atherosclerotic patients show high levels of Apo B in the blood while in the case of abetalipoproteinemia they are not detectable in serum. Apolipoproteins (77-84) ^FfApolipoproteins A D12.776.070.400.200 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins; Apolipoproteins Apolipoprotein A-I; Apolipoprotein A-II Lipoproteins found in human blood serum in the high-density and very-high-density lipoprotein fraction (HDL, VHDL). They consist of several different polypeptides, the most important of which are apolipoprotein A-I and A-II. They maintain the structural integrity of the HDL particles and are activators of lecithin:cholesterol acyltransferase (LCAT). Atherosclerotic patients show low apolipoprotein A levels and these apolipoproteins are either absent or present in extremely low plasma concentration in TANGIER DISEASE. Apolipoproteins (77-84) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $Ff/YHApolipoproteins D12.776.070.400 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Lipoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins Apolipoproteins A (+ 2); Apolipoproteins B; Apolipoproteins C; Apolipoproteins E The protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed. They play an important role in lipid transport and metabolism. Apoproteins (72-76); Lipoproteins (66-76); specific lipoprotein (72-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (FSaUHApolipoprotein A-II D12.776.070.400.200.150 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins; Apolipoproteins; Apolipoproteins A A component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolized and excreted from the body. This protein modulates the activation of lecithin-cholesterol acyltransferase in the presence of apolipoprotein A-I. Apolipoproteins (77-84); Apolipoproteins A (85-91) H|_<Apolipoprotein A-I D12.776.070.400.200.100 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins; Apolipoproteins; Apolipoproteins A The major protein component of high density lipoproteins. It is instrumental in promoting efflux of cholesterol from extrahepatic tissue to the liver where it is metabolized and excreted from the body. The compound is the activator of lecithin-cholesterol acyltransferase which forms cholesteryl esters in HDL. The gene for this apolipoprotein is found on the long arm of chromosome 11. Apolipoproteins (77-84); Apolipoproteins A (85-91) H|<Apoferritin D12.776.556.365.290 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins; Ferritin DcApoenzymes D12.776.070.290 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Apoproteins BSApocrine Glands A01.835.858.206; A10.336.899.206 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sweating Body Regions (Non MeSH); Skin; Sweat Glands Tissue Types (Non MeSH); Exocrine Glands; Sweat Glands Large, branched, specialized sweat glands that empty into the upper portion of a hair follicle instead of directly onto the skin. ^&: zApnea C08.618.085; C23.888.852.130 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiration Respiratory Tract Diseases; Respiration Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Sleep Apnea Syndromes (+ 1) Absence or cessation of breathing. (Stedman, 25th ed; Dorland, 27th ed).  ! "N$ZAplysia B01.644.060 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Mollusca An opisthobranch mollusk of the order Anaspidea. It is used frequently in studies of nervous system development because of its large identifiable neurons. Aplysiatoxin and its derivatives are not biosynthesized by Aplysia, but acquired by ingestion of Lyngbya (seaweed) species. Mollusca (66-77) # (DApicomplexa B01.841.075 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa Sporozoea (+ 29) A phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility. The phylum comprises two classes: Perkinsea and SPOROZOEA. $&zApicoectomy E04.833.164; E06.397.102; E06.892.164 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Tooth Root Surgery, Operative; Surgery, Oral Dentistry; Endodontics Dentistry; Surgery, Oral '-$`Aphthovirus B04.820.565.070; B04.909.777.618.070 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Picornaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Picornaviridae A genus of the family PICORNAVIRIDAE causing FOOT-AND-MOUTH DISEASE in cloven-hoofed animals. '*}mAphrodisiacs D26.115 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH) Yohimbine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR )[ ,2 :Aphorisms and Proverbs K01.517.116 Humanities; Literature *BAphonia C08.360.940.160; C09.400.940.160; C10.597.257.960.160; C23.888.592.257.960.160; F03.126.219.960.160 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Laryngeal Diseases; Voice Disorders Otorhinolaryngologic Diseases; Laryngeal Diseases; Voice Disorders Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Voice Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Voice Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Voice Disorders Loss of voice arising either from organic or psychic causes. Voice (66-68) * oN,JAphids B01.131.617.412.165 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hemiptera Small insects that suck the juices of plants. Some genera are Asterochiton, Eriosoma, and Phylloxera. Insects (66-71) . (7yAphidicolin D02.455.849.291.075; D08.373.105; D20.388.150 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Anti-Infective Agents; Antiviral Agents Tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-8,11a-methano-11aH-cyclohepta(a)naphthalene-4,9-dimethanol. An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells. Antiviral Agents (66-91); Diterpenes (74-91); DNA Polymerases/antagonists and inhibitors (77-91) /O5<krAphasia, Wernicke C10.597.257.543.074.090; C10.597.257.870.074.090; C23.888.592.257.543.074.090; C23.888.592.257.870.074.090; F03.126.219.543.074.090; F03.126.219.870.074.090 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders; Aphasia Difficulty in comprehension of written, spoken, manual, or tactile speech symbols. It is caused by damage to the temporoparietal cortex containing the sensory center for speech reception. Aphasia (66-79) 3F|Aphasia, Childhood F03.126.219.543.074.084; F03.126.219.870.074.084 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders; Aphasia Failure to develop or extreme difficulty in using language and speech, in the absence of mental retardation, deafness or primary emotional disturbance. The main types are congenital, developmental and idiopathic acquired. Aphasia (66-79); specific age group 946F,-Aphasia, Broca C10.597.257.543.074.073; C10.597.257.870.074.073; C23.888.592.257.543.074.073; C23.888.592.257.870.074.073; F03.126.219.543.074.073; F03.126.219.870.074.073 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders; Aphasia Loss of ability to express language by written, spoken, manual, or tactile speech symbols. It is caused by damage in the motor cortex of the cortical association area for motor control of speech. Aphasia (66-79) z%APACHE N02.421.589.473.100.608.200 Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH); Hospitalization; Diagnosis-Related Groups; Severity of Illness Index An acronym for Acute Physiology and Chronic Health Evaluation, a scoring system using routinely collected data and providing an accurate, objective description for a broad range of intensive care unit admissions, measuring severity of illness in critically ill patients. This classification system is composed of two parts: a physiology score representing the degree of acute illness and a preadmission health evaluation indicating health status before acute illness. Development of APACHE began in 1978 under a 3-year research grant from the U.S. Health Care Financing Administration. Revision and streamlining resulted in APACHE II. Its 12 routinely measured physiological variables were later amplified to become APACHE III. (From Crit Care Med 1981 Aug;9(8):591; 1989 Dec;17(12 Pt 2):S181, S199). Severity of Illness Index (86-94) ] )Aotus trivirgatus B02.649.801.400.120.092.092 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae; Aotinae A species of the subfamily AOTINAE, family CEBIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys. b(J,Aotinae B02.649.801.400.120.092 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae Aotus trivirgatus A subfamily of the New World monkeys, CEBIDAE, inhabiting the forests of South and Central America. The Aotinae are also referred to as night monkeys or owl monkeys. There are two species occurring in this subfamily: Aotus azarae (Southern night monkeys) and AOTUS TRIVIRGATUS (Northern night monkeys). d (?dAortopulmonary Septal Defect C14.240.400.560.098; C14.280.400.560.098; C16.131.240.400.560.098 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital; Heart Septal Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital; Heart Septal Defects A congenital anomaly in which there is abnormal communication between the ascending aorta and pulmonary artery just above the semilunar valves. Aorta/abnormalities (66-83); Aorta, Thoracic/abnormalities (66-83); Heart Defects, Congenital (66-83); Pulmonary Artery/abnormalities (66-83) f"ILAortography E01.145.077.181; E01.357.818.084.084 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Aorta Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnostic Imaging; Radiography; Angiography Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures. j*& Aortitis C14.907.109.320; C14.907.940.080 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aortic Diseases Cardiovascular Diseases; Vascular Diseases; Vasculitis Inflammation of the wall of the aorta. Aortic Diseases (66-79); Arteritis (66-79) lw &N14Aortic Valve Stenosis C14.280.484.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiomyopathy, Hypertrophic Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Narrowing of the aortic orifice of the heart or of the aorta itself. nN!IUAortic Valve Prolapse C14.280.484.400.100; C23.835.400.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases; Heart Valve Prolapse Symptoms and General Pathology (Non MeSH); Prolapse; Heart Valve Prolapse The downward displacement of the cuspal material (misalignment of the cusps) below a line joining points of attachment of the aortic valve leaflets. The prolapsed cusp may occlude the ventricular septal defect during ventricular diastole. Aortic Valve (66-87); Aortic Valve Insufficiency (67-87) oi*NDAortic Valve Insufficiency C14.280.484.095 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Heart Valve Diseases Backflow of blood from the aorta into the left ventricle, owing to imperfect functioning of the aortic semilunar valve. Heart Valve Diseases (66) r7 NI Aortic Valve A07.541.510.110 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Heart; Heart Valves The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. s84Aortic Subvalvular Stenosis C14.280.600.100.095 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Diseases; Cardiomyopathy, Hypertrophic u !NhAortic Rupture C14.907.055.185.125; C14.907.055.239.175; C14.907.109.139.175; C21.866.761.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm; Aneurysm, Ruptured Cardiovascular Diseases; Vascular Diseases; Aneurysm; Aortic Aneurysm Cardiovascular Diseases; Vascular Diseases; Aortic Diseases; Aortic Aneurysm Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Rupture Tearing of aortic tissue. It may be rupture of an aneurysm or it may be due to trauma. vXNWmAortic Diseases C14.907.109 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Aortic Aneurysm (+ 3); Aortic Arch Syndromes (+ 1); Aortitis; Leriche's Syndrome xN2dAortic Coarctation C14.240.400.090; C14.280.400.090; C16.131.240.400.090 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Cardiovascular Diseases; Heart Diseases; Heart Defects, Congenital Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Cardiovascular Abnormalities (Non MeSH); Heart Defects, Congenital Narrowing of the lumen of the aorta, caused by deformity of the aortic media. y=LK_Aortic Bodies A08.800.550.700.120.600.050 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Nerve Endings; Receptors, Sensory; Chemoreceptors; Paraganglia, Nonchromaffin Small clusters of chemoreceptive and supporting cells located near the aortic arch, the pulmonary arteries, and the coronary arteries. The aortic bodies sense pH, carbon dioxide, and oxygen concentrations in the blood and participate in the control of respiration. |O84Aortic Arch Syndromes C14.907.109.239 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aortic Diseases Takayasu's Arteritis Any of a group of disorders leading to occlusion of the arteries arising from the aortic arch. Such occlusion may be caused by atherosclerosis, arterial embolism, syphilitic or tuberculous arteritis, etc. (Dorland, 27th ed). ~NF Aortic Aneurysm, Thoracic C14.907.055.239.125; C14.907.109.139.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm; Aortic Aneurysm Cardiovascular Diseases; Vascular Diseases; Aortic Diseases; Aortic Aneurysm An aneurysm in the proximal portion of the descending aorta proceeding from the arch of the aorta and giving rise to the bronchial, esophageal, pericardiac, and mediastinal branches. Aortic Aneurysm (66-92) .NAortic Aneurysm, Abdominal C14.907.055.239.075; C14.907.109.139.075 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm; Aortic Aneurysm Cardiovascular Diseases; Vascular Diseases; Aortic Diseases; Aortic Aneurysm An aneurysm in that part of the aorta continuing from the thoracic region and giving rise to the inferior phrenic, lumbar, median sacral, mesenteric, renal, and ovarian or testicular arteries. Aortic Aneurysm (66-92)  .NAortic Aneurysm C14.907.055.239; C14.907.109.139 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm Cardiovascular Diseases; Vascular Diseases; Aortic Diseases Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture Aneurysm of the aorta. q&NAorta, Thoracic A07.231.114.056.372 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Aorta The portion of the descending aorta proceeding from the arch of the aorta and extending to the diaphragm. b8AAorta, Abdominal A07.231.114.056.205 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Cardiovascular System; Blood Vessels; Arteries; Aorta The aorta from the diaphragm to the bifurcation into the right and left common iliac arteries. 8ArAorta A07.231.114.056 ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRERISESUTRULUSVI Aortography; Coronary Artery Bypass Cardiovascular System; Blood Vessels; Arteries Aorta, Abdominal; Aorta, Thoracic; Sinus of Valsalva The main trunk of the systemic arteries. ABAHCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI $ 6+8@38Anxiety, Separation F03.234.080; F03.709.438.180.110 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Child Behavior Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders Anxiety experienced by an individual upon separation from a person or object of particular significance to him. Anxiety (66-67); Child Behavior Disorders (66-67); Child Psychology (66-67) q&F[Anxiety, Castration F03.709.438.180.080 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders Koro Anxiety due to fantasied injuries to or loss of the genitals. FvLAnxiety Disorders F03.709.438.180 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders Anxiety, Castration (+ 1); Anxiety, Separation; Neurocirculatory Asthenia; Obsessive-Compulsive Disorder (+ 1); Panic Disorder; Phobic Disorders (+ 2); Stress Disorders, Post-Traumatic (+ 1) Disorders in which anxiety (persistent feelings of apprehension, tension, or uneasiness) is the predominant disturbance. 'F`Anxiety F01.470.132; F03.126.056.100 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavior and Behavior Mechanisms (Non MeSH); Emotions Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Affective Symptoms Dental Anxiety Dental Anxiety Persistent feeling of dread, apprehension, and impending disaster.  "F$NAnus, Imperforate C06.175.094; C16.131.314.094 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Digestive System Abnormalities (Non MeSH) Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Digestive System Abnormalities (Non MeSH) Persistence of the anal membrane, so that the anus is closed. The defect is not always complete; sometimes a narrow opening permits the passage of the bowel contents. When completely imperforate, the anus is seen as a dimple (the proctodeal pit) in the skin of the perineum. The latter condition is often associated with atresia of the lower rectum. (Dorland, 27th ed). E"LAnus Neoplasms C04.588.274.476.411.792.288; C06.240.476.411.792.163; C06.405.282.411.792.163; C06.405.469.505.792.163; C06.405.469.860.101.163; C06.405.469.860.767.163 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Rectal Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Rectal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Rectal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Anus Diseases Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Rectal Neoplasms Anal Gland Neoplasms Anal Gland Neoplasms Anal Gland Neoplasms Anal Gland Neoplasms Anal Gland Neoplasms Anal Gland Neoplasms mX'Anus Diseases C06.405.469.860.101 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases Anus Neoplasms (+ 1); Fissure in Ano; Pruritus Ani BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI ZNiAXAnus A03.492.411.495.767.288 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Proctoscopy Digestive System; Gastrointestinal System; Intestines; Intestine, Large; Rectum consider also terms at PROCT-. :^'Anuria C12.777.419.078 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Kidney Failure, Acute; Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Oliguria Complete suppression of urinary secretion by the kidneys. (Dorland, 27th ed).   N$b ^Anura B02.090.180 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia Bufonidae (+ 3); Pipidae (+ 2); Ranidae (+ 5) An order of the class Amphibia, which includes several families of frogs and toads. They are characterized by well developed hind limbs adapted for jumping, fused head and trunk and webbed toes. The term "toad" is ambiguous and is properly applied only to the family Bufonidae. Amphibia (66-80)   &=IAnts B01.131.617.479.205 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Hymenoptera Insects of the family Formicidae, very common and widespread, probably the most successful of all the insect groups. All ants are social insects, and most colonies contain three castes, queens, males, and workers. Their habits are often very elaborate and a great many studies have been made of ant behavior. Ants produce a number of secretions that function in offense, defense, and communication. (From Borror, et al., An Introduction to the Study of Insects, 4th ed). (9+Antlers A13.507.288 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Horns  :(Antiviral Agents D20.388 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Virus Diseases; Viruses Anti-Infective Agents Acyclovir (+ 1); Amantadine; Aphidicolin; Cytarabine; 1-Deoxynojirimycin; Dideoxynucleosides (+ 5); Dihematoporphyrin Ether; Floxuridine; Gliotoxins; HIV Protease Inhibitors; Idoxuridine; Interferon Inducers (+ 3); Interferons (+ 8); Isoprinosine; Methisazone; Netropsin; Phosphonoacetic Acid (+ 1); Ribavirin; Rimantadine; Trifluridine; Tunicamycin; Vidarabine (+ 1) Agents used in the prophylaxis or therapy of virus diseases. They may act to prevent viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; blocking late stages of virus assembly; etc. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $  8jHAntivenins D24.310.121.163; D24.611.125.272.138 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Snake Venoms; Venoms; Snake Bites Immunologic and Biologic Factors (Non MeSH); Biological Products; Antitoxins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antitoxins Proteinaceous materials used in the treatment of poisoning by animal venom. (Dorland, 27th ed). D*6+sAntitussive Agents D15.153 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Expectorants Cough; Expectorants Central Nervous System Agents Codeine; Dextromethorphan; Diphenhydramine; Doxylamine; Ethylmorphine; Hydrocodone; Methadone; Noscapine; Oxycodone; Propoxyphene Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (G 8$:Antitubercular Agents D20.338 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Tuberculosis, Multidrug-Resistant Mycobacterium tuberculosis; Tuberculosis Anti-Infective Agents p-Aminosalicylic Acid; Antibiotics, Antitubercular (+ 10); Ethambutol; Ethionamide; Isoniazid (+ 1); Prothionamide; Pyrazinamide; Thiosemicarbazones (+ 1) Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( 8&/<Antitrust Laws N03.706.615.100 CLECHIOGSNSTTDUT Commerce; Economic Competition Economics, Organizations, Control (Non MeSH); Social Control, Formal; Legislation Those federal and state laws, and their enforcement, that protect trade and commerce from unlawful restraints and monopolies or unfair business practices. Economic Competition/legislation and jurisprudence (82-90); Economics/legislation and jurisprudence (82-90)  K%`{Antitrichomonal Agents D21.370.370 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Trichomonas; Trichomonas Infections Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Furazolidone; Metronidazole; Nifuratel; Nimorazole; Ornidazole; Tinidazole AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  d8*@X:Antitreponemal Agents (Non MeSH) D20.288 Anti-Infective Agents Arsphenamine AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ' :Antitoxins D24.310.121; D24.611.125.272 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Toxins Immunologic and Biologic Factors (Non MeSH); Biological Products Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antivenins; Diphtheria Antitoxin; Tetanus Antitoxin Antivenins; Botulinum Antitoxin; Diphtheria Antitoxin; Tetanus Antitoxin "6 Antithrombins D08.373.745.800.810.230; D19.461.119.071 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants Antithrombin III; Heparin Cofactor II Antithrombin III; Fibrin Fibrinogen Degradation Products; Heparin Cofactor II; Hirudin Any endogenous or administered substance that neutralizes the action of thrombin. Several specific antithrombins are now recognized. They are members of the serpin superfamily. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  .BHAntithrombin III D08.373.745.800.810.230.200; D12.776.124.790.106.125; D12.776.377.715.085.125; D19.461.119.071.046 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins; Antithrombins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Antithrombins A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes; it was formerly called Antithrombin II (AT II) which has now been shown to be identical to AT III; deficiency of AT III, hereditary or acquired, results in thromboembolism. It is a member of the serpin superfamily. lFAntistreptolysin D24.611.125.139.288 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Streptolysins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Antibodies, Bacterial x6Antispermatogenic Agents D07.360.443.288 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Sperm Maturation; Spermatogenesis; Spermatozoa Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Male Spermatogenesis-Blocking Agents Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis. Contraceptive Agents (67-74); Spermatogenesis/drug effects (71-74) $87h$NAntisocial Personality Disorder F03.709.597.055 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Social Behavior Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders The inability to form significant attachments or loyalties to others or to codes of living causing repeated conflict with society. ¼%FcAntisickling Agents D19.461.135 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anemia, Sickle Cell Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions. Anemia, Sickle Cell (66-76); Hemoglobin, Sickle (75-76); Hemoglobins, Abnormal (66-74)  }8[gAntisepsis G03.850.780.200.450.150 HIISMTST Environment and Public Health (Non MeSH); Public Health; Public Health Practice (Non MeSH); Communicable Disease Control; Infection Control Asepsis The destruction of germs causing disease. p  3Antisense Elements (Genetics) D13.150; D13.444.600.150; D26.651.600.150 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Transcription, Genetic Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH) Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; Nucleic Acid Probes Miscellaneous Drugs and Agents (Non MeSH); Molecular Probes; Nucleic Acid Probes DNA, Antisense; Oligonucleotides, Antisense; RNA, Antisense Nucleotide sequences which are not templates for synthesis but yet interact with complementary sequences in other molecules thereby causing function of those molecules to be affected.  ǰ#1D HAntirheumatic Agents, Gold D17.050.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Gold Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Aurothioglucose (+ 1); Gold Sodium Thiomalate; Gold Sodium Thiosulfate Gold salts that are effective in the therapy of rheumatoid arthritis. These compounds usually do not have analgesic activity. Since these compounds are poorly absorbed from the intestinal tract, they are usually given intramuscularly. Anti-Inflammatory Agents (66-86); Anti-Inflammatory Agents, Non-Steroidal (87-89); Gold (66-89) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (ʴ 8{Uo:Antirheumatic Agents D17.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antimalarials; Immunosuppressive Agents Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH) Anti-Inflammatory Agents, Non-Steroidal (+ 32); Anti-Inflammatory Agents, Steroidal (+ 8); Antirheumatic Agents, Gold (+ 4); Azathioprine; Chloroquine (+ 1); Cyclophosphamide; Cyclosporine; Gout Suppressants (+ 10); Levamisole; Methotrexate; Penicillamine; Sulfasalazine Drugs that are used to treat rheumatoid arthritis. AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $ 8.a>>BAntireticular Cytotoxic Serum D24.310.401.371; D24.611.125.573.371 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Immune Sera Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immune Sera й#*6Antipyrine D03.383.694.065; D16.850.015.050.025; D17.025.030.025; D17.050.030.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29). /P:K+Antipsychotic Agents, Phenothiazine D15.150.025; D15.210.950.040.025; D15.700.872.331.025 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Phenothiazines Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents Acepromazine; Chlorpromazine; Fluphenazine; Mesoridazine; Methotrimeprazine; Perazine; Perphenazine; Prochlorperazine; Promazine; Thioridazine; Trifluoperazine; Triflupromazine Acepromazine; Chlorpromazine; Fluphenazine; Mesoridazine; Methotrimeprazine; Perazine; Perphenazine; Prochlorperazine; Promazine; Thioridazine; Trifluoperazine; Triflupromazine Acepromazine; Chlorpromazine; Fluphenazine; Mesoridazine; Methotrimeprazine; Perazine; Perphenazine; Prochlorperazine; Promazine; Thioridazine; Trifluoperazine; Triflupromazine Phenothiazine derivatives used in the treatment of psychoses. Phenothiazines (66-72); Tranquilizing Agents (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (`)=8%ZI>:Antipsychotic Agents, Butyrophenone D15.150.015; D15.210.950.040.015; D15.700.872.331.015 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Butyrophenones Central Nervous System Agents; Antipsychotic Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents Azaperone; Benperidol; Droperidol; Haloperidol; Spiperone; Trifluperidol Azaperone; Benperidol; Droperidol; Haloperidol; Spiperone; Trifluperidol Azaperone; Benperidol; Droperidol; Haloperidol; Spiperone; Trifluperidol Those butyrophenone derivatives used in the treatment of psychoses. Butyrophenones (66-78); Tranquilizing Agents (66-74); Tranquilizing Agents, Major (75-78) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (ۃ)=8%Pi:Antipsychotic Agents D15.150; D15.210.950.040; D15.700.872.331 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Dopamine Antagonists Central Nervous System Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents Antipsychotic Agents, Butyrophenone (+ 6); Antipsychotic Agents, Phenothiazine (+ 12); Butaclamol; Chlorprothixene; Clopenthixol; Clozapine; Flupenthixol; Fluspirilene; Loxapine; Methiothepin; Molindone; Ondansetron; Penfluridol; Pimozide; Remoxipride; Sch-23390; Sulpiride; Thiothixene; Tiapride Antipsychotic Agents, Butyrophenone (+ 6); Antipsychotic Agents, Phenothiazine (+ 12); Butaclamol; Chlorprothixene; Clopenthixol; Clozapine; Flupenthixol; Fluspirilene; Loxapine; Methiothepin; Molindone; Ondansetron; Penfluridol; Pimozide; Remoxipride; Sch-23390; Sulpiride; Thiothixene; Tiapride Antipsychotic Agents, Butyrophenone (+ 6); Antipsychotic Agents, Phenothiazine (+ 12); Butaclamol; Chlorprothixene; Clopenthixol; Clozapine; Flupenthixol; Fluspirilene; Loxapine; Methiothepin; Molindone; Ondansetron; Penfluridol; Pimozide; Remoxipride; Sch-23390; Sulpiride; Thiothixene; Tiapride Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in schizophrenia, senile dementia, transient psychosis following surgery or myocardial infarction, etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Tranquilizing Agents (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (|18 P":Antipruritics D23.075 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Pruritus Dermatologic Agents Camphor; Chlorpheniramine; Clemastine; Cyproheptadine; Dimethindene; Diphenhydramine; Hydroxyzine; Ketotifen; Loratadine; Menthol; Pheniramine; Promethazine; Trimeprazine Agents, usually topical, that relieve itching (pruritus). AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ 8 E:Antiprotozoal Agents D21.370 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Parasites; Protozoa; Anti-Infective Agents; Protozoan Infections Antiparasitic Agents (Non MeSH) Amebicides (+ 8); Antimalarials (+ 11); Antimony Sodium Gluconate; Antitrichomonal Agents (+ 6); Coccidiostats (+ 11); Dimetridazole; Imidocarb; Ipronidazole; Ivermectin; Pentamidine; Ronidazole; Trypanocidal Agents (+ 8) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR   8L& @Antiporters D12.776.157.070; D12.776.395.550.070; D12.776.543.550.070 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Ion Transport Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Band 3 Protein; Sodium-Hydrogen Antiporter Band 3 Protein; Sodium-Hydrogen Antiporter Band 3 Protein; Sodium-Hydrogen Antiporter Membrane glycoproteins that transport substrates across the membrane in a tightly coupled stoichiometric manner. The stoichiometry of influx of one substrate and the efflux of another is fixed by a single transport catalytic cycle; that is, the membrane is not freely permeable to either substrate. Antiporters mediate secondary active transport, using the electrochemical energy of a primary gradient (mostly for sodium) that is built up by an ATP-consuming transporter (mostly sodium, potassium ATPase) to maintain transmembrane gradients for other electrolytes or metabolic substrates. Biological Transport (74-81); Carrier Proteins (79-93) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (AD:AHAntiplatyhelmintic Agents D21.201.412 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Trematode Infections; Trematoda Antiparasitic Agents (Non MeSH); Anthelmintics Anticestodal Agents (+ 3); Bithionol; Diamfenetide; Hexylresorcinol; Ivermectin; Nitroxinil; Oxyclozanide; Praziquantel; Rafoxanide; Schistosomicides (+ 7) Agents used to treat cestode, trematode, or other flatworm infestations in man or animals. Anthelmintics (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8&8l:Antiplasmin D08.373.745.800.810.200; D12.776.124.790.106.118; D12.776.377.715.085.118; D19.461.270.463.091.280 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics; Antifibrinolytic Agents A member of the serpin superfamily found in human plasma which inhibits the lysis of fibrin clots induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 which migrates in the alpha 2 region in immunoelectrophoresis. It is the principle plasmin inactivator in blood, rapidly forming a very stable complex with plasmin. Fibrinolysin/antagonists and inhibitors (68-79) LlB7Antiphospholipid Syndrome C20.111.197 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lupus Coagulation Inhibitor; Antibodies, Antiphospholipid; Cardiolipins; Phospholipids; Lupus Erythematosus, Systemic Immunologic Diseases; Autoimmune Diseases The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR). Phospholipids/immunology (77-91)  #N1Q&Antiparkinson Agents D15.090.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Parkinson Disease; Parasympatholytics Central Nervous System Agents; Anti-Dyskinesia Agents Amantadine; Apomorphine; Benserazide; Benztropine; Biperiden; Bromocriptine; Carbidopa; Dexetimide; Diphenhydramine; Levodopa; Lisuride; Memantine; Orphenadrine; Pergolide; Piribedil; Procyclidine; Selegiline; Trihexyphenidyl Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Parasympatholytics (66-72); Parkinsonism/drug therapy (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (8,?HDAntiparasitic Agents (Non MeSH) D21 Anthelmintics (+ 52); Antiprotozoal Agents (+ 56) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR m&=@Antipain D08.373.745.095; D12.644.456.120 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides N(2)-(((1-Carboxy-2-phenylethyl)amino)carbonyl)- L-arginyl-N-(4-((aminoiminomethyl)amino)- 1-formylbutyl)-L-valinamide. An oligopeptide produced by various bacteria which acts as a protease inhibitor. Oligopeptides (73-79); Peptide Hydrolases/AI (68-78); Peptide Peptidohydrolases/AI (68-78); Peptides (66-72); Protease Inhibitors (79) 6 &<Antioxidants D26.100 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Oxidative Stress; Pharmaceutic Aids Oxidation-Reduction; Oxidants; Food Preservatives Miscellaneous Drugs and Agents (Non MeSH) Canthaxanthin AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $  ,+:2<Antineoplastics, Immunosuppressives (Non MeSH) D22 Antineoplastic Agents (+ 169); Immunosuppressive Agents (+ 15) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR d5KHAntineoplastic Agents, Phytogenic D22.204.179 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Acronine; Amygdalin; Camptothecin; Demecolcine; Ellipticines; Harringtonines; Maytansine; Paclitaxel; Podophyllin (+ 3); Sizofiran; Swainsonine; Vinca Alkaloids (+ 3) Agents, obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastic Agents (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR $R':Pq#BAntineoplastic Agents, Combined D22.204.160 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Drug Therapy, Combination; Combined Modality Therapy Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form (= DRUG COMBINATIONS). Drug Therapy, Combination (74-83)  %8>P(Antineoplastic Agents D22.204 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anticarcinogenic Agents; Chemoembolization, Therapeutic; Infusions, Intra-Arterial; Perfusion, Regional; Tumor Lysis Syndrome Anticarcinogenic Agents; Alkylating Agents; Biological Response Modifiers; Neoplasms Antineoplastics, Immunosuppressives (Non MeSH) Altretamine; Aminoglutethimide; Amsacrine; Antibiotics, Antineoplastic (+ 40); Anticarcinogenic Agents (+ 1); Antimetabolites, Antineoplastic (+ 21); Antineoplastic Agents, Combined; Antineoplastic Agents, Phytogenic (+ 18); Asparaginase; Buserelin; Busulfan; Carbazilquinone; Carboplatin; Carmustine; Cisplatin; Cladribine; Cyproterone Acetate; Dacarbazine; Dianhydrogalactitol; Eflornithine; Etanidazole; Ethoglucid; Ethyl Methanesulfonate; Fadrozole; Fenretinide; Gold Colloid, Radioactive; Goserelin; Guanazole; Hematoporphyrin Derivative (+ 1); Hexestrol; Hydroxyurea; Interferons (+ 8); Leuprolide; Lomustine (+ 1); Medroxyprogesterone 17-Acetate; Methyl Methanesulfonate; Misonidazole; Mitobronitol; Mitoguazone; Mitolactol; Mitotane; Mitoxantrone; Mopidamol; Nimustine; Nitracrine; Nitrogen Mustard Compounds (+ 13); Nocodazole; Octreotide; Phenylalanine Ammonia-Lyase; Picibanil; Pipobroman; Prednisone; Procarbazine; Prospidium; Pyran Copolymer; Quinacrine; Razoxane; Suramin; Tamoxifen (+ 1); Testolactone; Thiotepa; Triaziquone; Triethylenemelamine; Triptorelin; Urethane AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $  8b5HAntinematodal Agents D21.201.287 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Nematoda; Nematode Infections Antiparasitic Agents (Non MeSH); Anthelmintics Bephenium Compounds; Cambendazole; Dithiazanine; Fenbendazole; Filaricides (+ 4); Gentian Violet; Hexylresorcinol; Hygromycin B; Ivermectin; Kainic Acid; Levamisole; Mebendazole; Morantel; Niclosamide; Pyrantel (+ 2); Pyrvinium Compounds; Quinacrine; Rafoxanide; Santonin; Suramin; Tetrachloroethylene; Thiabendazole Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. Anthelmintics (66-73) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8$8u<Antimycin A D20.085.062.148; D20.136.073.148 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Isovaleric acid, 8-ester with 3-formamido-N-(7-hexyl-8- hydroxy-4,9-dimethyl-2,6-dioxo-1,5-dioxonan-3-yl)- salicylamide. Antibiotic substance produced by Streptomyces spp. &<Antimutagenic Agents D26.092 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Anticarcinogenic Agents Mutagenesis; Mutation; Anticarcinogenic Agents Miscellaneous Drugs and Agents (Non MeSH) Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. Mutation (66-91) $ ,72Antimony Sodium Gluconate D02.241.081.844.322.060; D02.241.511.902.322.060; D02.691.080; D09.203.811.308.060; D21.201.412.596.064; D21.370.322 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Sugar Acids; Gluconates Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Sugar Acids; Gluconates Organic Chemicals (Non MeSH); Organometallic Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Gluconates Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis. Antimony (70-75); Gluconates (70-76) 8+-Antimony Potassium Tartrate D02.691.075; D21.201.412.596.058 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents; Schistosomicides Bis(mu-(2,3-dihydroxybutanedioato(4-)-O(1),O(2):O(3),O(4)))diantimonate(2-) dipotassium trihydrate, stereoisomer. An aenimonial schistosomicide possibly useful against other parasites, it has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects. Antimony (69-75); Tartrates (69-75) !&:J,Antimony D01.268.049; D01.552.070 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals  :`Antimetabolites, Antineoplastic D22.204.144 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antimetabolites Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Allopurinol; Azaguanine; Azaserine; Azathioprine; Azauridine; Cytarabine (+ 1); 3-Deazauridine; Diazooxonorleucine; Floxuridine; Fluorouracil (+ 1); Folic Acid Antagonists (+ 3); 6-Mercaptopurine; Puromycin Aminonucleoside; Thioguanine; Toyocamycin; Tubercidin Substances that, due to their close structural resemblance to normal physiological substances, combine with and thereby inhibit enzymes required for normal functioning. A number of these substances have been found to be effective antineoplastic agents. Antineoplastic Agents (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( $6P2$#<Antimetabolites D26.087 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH) Acyclovir (+ 1); Allopurinol; 2-Aminopurine; Azacytidine; Azaguanine; Azaserine; Azathioprine; Azauridine; Bromouracil; Chloroguanide; Cycloserine; Cytarabine (+ 1); 3-Deazauridine; Deoxyuridine (+ 3); Diazooxonorleucine; Dideoxynucleosides (+ 5); Ethionine; Flucytosine; Fluorouracil (+ 1); Folic Acid Antagonists (+ 4); 6-Mercaptopurine; Oxythiamine; Propylthiouracil; Puromycin (+ 1); Pyrithiamine; Ribavirin; Tetrahydrouridine; Thioguanine; Thioinosine; Thiouracil; Thiouridine; Toyocamycin; Trifluridine; Tubercidin; Vidarabine (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  $I ,$2{FAntimanic Agents D15.130; D15.210.950.025; D15.700.872.025 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents Lithium Carbonate Lithium Carbonate Lithium Carbonate Agents that are used to treat bipolar disorders or mania associated with other affective disorders. Antidepressive Agents (66-94); Bipolar Disorder/drug therapy (66-94); Bipolar Disorder/prevention and control (68-94)  '18>vAntimalarials D21.370.286 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Plasmodium; Malaria; Antirheumatic Agents Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Amodiaquine; Chloroguanide; Chloroquine (+ 1); Mefloquine; Primaquine; Pyrimethamine; Quinacrine; Quinine; Trimethoprim (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  *82@@Antilymphocyte Serum D22.569.137; D24.310.401.203; D24.611.125.573.203 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunosuppression; Lymphocytes; Immunosuppressive Agents Antineoplastics, Immunosuppressives (Non MeSH); Immunosuppressive Agents Immunologic and Biologic Factors (Non MeSH); Biological Products; Immune Sera Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Immune Sera Serum containing gamma globulins which are antibodies for lymphocyte antigens. It is used both as a test for histocompatibility and therapeutically in transplantation. Immune Sera (66-67); Lymphocytes (66-67)  ,a96A%2Antilipemic Agents D10.162 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hyperlipidemia Lipids and Antilipemic Agents (Non MeSH) Anticholesteremic Agents (+ 12); Bezafibrate; Clofenapate; Colestipol; Gemfibrozil; 3-Hydroxy-3-Methylglutaric Acid; Niceritrol; Procetofen; Pyridinolcarbamate AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  /o 81@Antihypertensive Agents D18.162 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hypertension Cardiovascular Agents Acebutolol; Alprenolol; Amlodipine; Angiotensin-Converting Enzyme Inhibitors (+ 10); Atenolol; Bepridil; Betaxolol; Bethanidine; Bisoprolol; Bretylium Tosylate; Bupranolol; Carteolol; Celiprolol; Chlorisondamine; Clonidine; Debrisoquin; Diazoxide; Diuretics, Thiazide (+ 8); Fenoldopam; Guanabenz; Guanethidine; Guanfacine; Hexamethonium Compounds; Hydralazine (+ 1); Indoramin; Isradipine; Ketanserin; Labetalol; Mecamylamine; Methyldopa; Metipranolol; Minoxidil; Nadolol; Nicardipine; Nimodipine; Nisoldipine; Nitrendipine; Nitroprusside; Pargyline; Pempidine; Penbutolol; Pentolinium Tartrate; Phenoxybenzamine; Phentolamine; Pindolol; Piperoxan; Prazosin (+ 1); Propranolol; Rauwolfia Alkaloids (+ 1); Ticrynafen; Timolol; Todralazine; Tolazoline; Trimethaphan; Veratrum Alkaloids (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  1/ 8FAntigua Z01.107.084.900.050 EHEP Geographicals (Non MeSH); America; Caribbean Region; West Indies 5 OAntigens, Viral, Tumor D24.611.216.285.062; D24.611.216.327.062 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Cell Transformation, Viral Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral Adenovirus E1A Proteins; Adenovirus E1B Proteins; Antigens, Polyomavirus Transforming Adenovirus E1A Proteins; Adenovirus E1B Proteins; Antigens, Polyomavirus Transforming Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation. Antigens (66-72); Antigens, Neoplasm (73-83); Antigens, Viral (73-83) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (6`.6 TFAntigens, Viral D24.611.216.327 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Adenovirus Early Proteins (+ 4); Antigens, Viral, Tumor (+ 3); Hemagglutinins, Viral (+ 1); Hepatitis B Antigens (+ 3); HIV Antigens (+ 3); HTLV-BLV Antigens (+ 2) Antigens (66-72); Viruses/IM (66-72) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  :6g.FAntigens, Tumor-Associated, Carbohydrate D24.611.216.119.325; D24.611.216.285.050; D24.185.101.840.075 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Antigens, CD15; CA-15-3 Antigen; CA-19-9 Antigen; CA-125 Antigen Antigens, CD15; CA-15-3 Antigen; CA-19-9 Antigen; CA-125 Antigen Antigens, CD15; CA-15-3 Antigen; CA-19-9 Antigen; CA-125 Antigen Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Neoplasm (73-88)  <.E6~ Antigens, Thy-1 D12.776.395.550.050; D12.776.543.550.050; D24.185.101.100.930; D24.611.216.301.264.930 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation A group of differentiation surface antigens, among the first to be discovered on thymocytes and T-lymphocytes. Originally identified in the mouse, they are also found in other species including humans, and are expressed on brain neurons and other cells. Antigens (79-80); Antigens, Surface (81-94); Membrane Glycoproteins (83-94); Membrane Proteins (79-82) @`6)zAntigens, T-Independent D24.611.216.324 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Antigens which may directly stimulate B lymphocytes without the cooperation ot T lymphocytes. Antibody Formation (69-71); Lymphocytes (69-72); B Lymphocytes (73-81); T Lymphocytes (73-81) EQ6gnqAntigens, Surface D24.611.216.301 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Antigens, Differentiation (+ 43); B-Cell Activation Antigen; Cell Adhesion Molecules (+ 5); Histocompatibility Antigens (+ 48); Minor Lymphocyte Stimulatory Antigens; Variant Surface Glycoproteins, Trypanosoma Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Antigens (66-78) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $G#6gFAntigens, Protozoan D24.611.216.293 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Variant Surface Glycoproteins, Trypanosoma Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Antigens (66-84); Antigens, Surface (79-84)  J16g15Antigens, Polyomavirus Transforming D12.776.677.520.090; D12.776.964.700.090; D24.611.216.285.062.090; D24.611.216.327.062.090 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Viral, Tumor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Antigens, Viral, Tumor Polyomavirus antigens which cause infection and cellular transformation. The large T antigen is necessary for the initiation of viral DNA synthesis, repression of transcription of the early region and is responsible in conjunction with the middle T antigen for the transformation of primary cells. Small T antigen is necessary for the completion of the productive infection cycle. Antigens, Viral, Tumor (84-87); Antigens, Viral (73-83); Oncogene Proteins, Viral (86-87); Viral Proteins (66-85) L?)d6Antigens, Neoplasm D24.611.216.285 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Neoplasms Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Antigens, CD30; Antigens, Tumor-Associated, Carbohydrate (+ 4); Antigens, Viral, Tumor (+ 3); Carcinoembryonic Antigen; Membrane Metallo-Endopeptidase; Prostate-Specific Antigen Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that cause the biosynthesis of antibodies. Many of these are of either embryonic or viral origin. specific neoplasm/immunology (66-72); Antigens (66-72); Neoplasms/immunology (66-72) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (Q6 gdFAntigens, Ly D24.185.101.100.920; D24.611.216.301.264.920 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation A group of lymphocyte surface antigens differentially located on subpopulations of mouse lymphocytes. This localization has been useful in distinguishing different functional subpopulations of lymphocytes. For example, cytotoxic T-cells bear primarily Lyt-23 on their surface and not Lyt-1, whereas helper cells bear Lyt-1 and not Lyt-23. Lymphocytes (66-81); T Lymphocytes (75-81) T264Antigens, Human Platelet D24.611.216.705.115 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy. Antigens (66-79); Isoantigens (76-91) XA6v.Antigens, Heterophile D24.611.216.244 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Forssman Antigen Antigens stimulating the formation of, or combining with heterophile antibodies. They are cross-reacting antigens found in phylogenetically unrelated species. Zg6gAntigens, Helminth D24.611.216.223 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Any part or derivative of a helminth that elicits an immune reaction. The most commonly seen helminth antigens are those of the schistosomes. Antigens (66-84); Antigens, Surface (79-84) \$6g5Antigens, Fungal D24.611.216.202 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Coccidioidin; Histoplasmin; Trichophytin Antigens (66-72) ]6g0Antigens, Differentiation, T-Lymphocyte D24.185.101.100.894; D24.611.216.301.264.894 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation Antigens, CD2; Antigens, CD3 (+ 1); Antigens, CD4; Antigens, CD8; Antigens, CD13; Antigens, CD18; Antigens, CD26; Antigens, CD27; Antigens, CD28 Antigens, CD2; Antigens, CD3 (+ 1); Antigens, CD4; Antigens, CD8; Antigens, CD13; Antigens, CD18; Antigens, CD26; Antigens, CD27; Antigens, CD28 Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens (71-78); Antigens, Surface (79-87); Cell Differentiation (66-87); T-Lymphocytes (73-87) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR $_!-26^(s<Antigens, Differentiation, Myelomonocytic D24.185.101.100.900; D24.611.216.301.264.900 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation Antigens, CD15 Antigens, CD15 Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas. Antigens, Neoplasm (75-88); Antigens, Surface (79-88); Granulocytes (78-88); Monocytes (76-88)  d4/26$(qAntigens, Differentiation, B-Lymphocyte D24.185.101.100.150; D24.611.216.301.264.051 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin. Antigens, Surface (79-87); Cell Differentiation (66-87); B-Lymphocytes (73-87) g-26^Antigens, Differentiation D24.185.101.100; D24.611.216.301.264 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Cell Differentiation; Cell Transformation, Neoplastic Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface Antigens, CD (+ 26); Antigens, Differentiation, B-Lymphocyte; Antigens, Differentiation, T-Lymphocyte (+ 10); Antigens, Differentiation, Myelomonocytic (+ 1); Antigens, Ly; Antigens, Thy-1 Antigens, CD (+ 26); Antigens, Differentiation, B-Lymphocyte; Antigens, Differentiation, T-Lymphocyte (+ 10); Antigens, Differentiation, Myelomonocytic (+ 1); Antigens, Ly; Antigens, Thy-1 Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Antigens (66-77); Antigens, Neoplasm (73-87); Antigens, Surface (79-87); Cell Differentiation (66-87); Cell Transformation, Neoplastic (70-87); specific cell or tissue (66-87) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (j*6>PFAntigens, CD8 D24.185.101.100.110.105; D24.185.101.100.894.105; D24.611.216.301.264.035.105; D24.611.216.301.264.894.105 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR CD4-CD8 Ratio CD8-Positive T-Lymphocytes Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. CD8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions. Antigens, Differentiation, T-Lymphocyte (86-91); Antigens, Surface (85-91) $pnt65VAntigens, CD45 D24.185.101.100.110.150; D24.611.216.301.264.035.150 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD High-molecular weight glycoproteins uniquely expressed on the surface of all leukocytes and their hemopoietic progenitors. The CD45 family consists of multiple members that are all products of a single gene. Antigens, CD (89-92); Antigens, Differentiation (84-91); Histocompatibility Antigens (84-92) u:6<lAntigens, CD4 D12.776.543.750.925.700.025; D24.185.101.100.110.100; D24.185.101.100.894.100; D24.611.216.301.264.035.100; D24.611.216.301.264.894.100 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR CD4-CD8 Ratio; HIV Envelope Protein gp120 CD4-Positive T-Lymphocytes Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Virus; Receptors, HIV Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte 55-kD Glycoproteins originally defined as differentiation antigens on T-lymphocytes, but also found on other cells including monocytes/macrophages. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MHC (Major Histocompatibility Complex) Class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as HIV receptors, binding directly to the envelope protein gp120 on HIV. Antigens, Differentiation, T-Lymphocyte (88-89); Antigens, Surface (79-87); Receptors, Antigen, T-Cell (80-89); Receptors, Virus (79-89) $y63K=Antigens, CD30 D24.185.101.100.110.135; D24.185.101.840.055; D24.611.216.285.025; D24.611.216.301.264.035.135 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Lymphoma, Large-Cell, Ki-1 Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Differentiation antigens normally present in a small number of cells in the lymph nodes and tonsils in vivo, but also capable of being induced in a wide range of cells in vitro. They are clinically useful as tumor markers for Ki-1 lymphoma (LYMPHOMA, LARGE-CELL, KI-1) and some cases of LYMPHOMATOID PAPULOSIS, MYCOSIS FUNGOIDES, and HODGKIN'S DISEASE. Antigens, CD (90-93); Antigens, Differentiation (88-93); Antigens, Neoplasm (85-93)  h6 8cAntigens, CD3 D24.185.101.100.110.095; D24.185.101.100.894.095; D24.611.216.301.264.035.095; D24.611.216.301.264.894.095 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Receptors, Antigen, T-Cell Receptors, Antigen, T-Cell Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Receptor-CD3 Complex, Antigen, T-Cell Receptor-CD3 Complex, Antigen, T-Cell Receptor-CD3 Complex, Antigen, T-Cell Receptor-CD3 Complex, Antigen, T-Cell Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA). Antigens (83-84); Antigens, Differentiation, T-Lymphocyte (88-92); Antigens, Surface (83-87); Receptors, Antigen, T-Cell (90-92) ADAEAGAIANBIBLCFCHCLCTDEDFDUECGEHIIMIPMEPDPHPORETOTUULUR ,t6  <Antigens, CD28 D12.776.543.750.705.816.824.133; D24.185.101.100.110.133; D24.185.101.100.894.133; D24.611.216.301.264.035.133; D24.611.216.301.264.894.133; D24.611.834.816.824.133 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Receptors, Antigen; Receptors, Antigen, T-Cell T-cell differentiation antigens that serve as the receptors for the B7 antigen (B-CELL ACTIVATION ANTIGEN) which modulates T-cell lymphokine production. Antigens, CD (90-93); Antigens, Differentiation, T-Lymphocyte (86-93) 6 QAntigens, CD27 D24.185.101.100.110.132; D24.185.101.100.894.132; D24.611.216.301.264.035.132; D24.611.216.301.264.894.132 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Dimeric membrane glycoproteins found on most T-lymphocytes. Activation of T-cells by the antigen receptor increases CD27 surface expression. Antigens, CD (89-93); Antigens, Differentiation, T-Lymphocyte (89-93) t6QAntigens, CD26 D08.586.277.656.732.240.131; D24.185.101.100.110.131; D24.185.101.100.894.131; D24.611.216.301.264.035.131; D24.611.216.301.264.894.131 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Dipeptidyl Peptidases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Cell-surface glycoproteins and serine protease, also known as dipeptidyl-pepidase IV, that play a role in T-lymphocyte activation. CD26 binds to adenosine deaminase on the T-cell surface. EC 3.4.14.5. Antigens, Differentiation, T-Lymphocyte (90-94); Carrier Proteins (78-94); Dipeptidyl Peptidases (80-94) w6NyAntigens, CD2 D24.185.101.100.110.090; D24.185.101.100.894.090; D24.611.216.301.264.035.090; D24.611.216.301.264.894.090 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Glycoprotein members of the immunoglobulin superfamily which participate in T-cell adhesion and activation. They are expressed on most peripheral T-lymphocytes, natural killer cells, and thymocytes, and function as co-receptors or accessory molecules in the T-cell receptor complex. Antigens, Differentiation (88); Antigens, Differentiation, T-Lymphocyte (89-94); Carrier Proteins (85-88); Receptors, Immunologic (89-94) +t6DAntigens, CD18 D24.185.101.100.110.118; D24.185.101.100.894.118; D24.611.216.301.264.035.118; D24.611.216.301.264.894.118 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigen p150,95; Leukocyte Adhesion Deficiency Syndrome; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Cell-surface glycoprotein beta-chains that are non-covalently linked to specific alpha-chains of the CD11 family of leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE ADHESION). A defect in the gene encoding CD18 causes LEUKOCYTE ADHESION DEFICIENCY SYNDROME. Antigens, CD (90-94); Membrane Glycoproteins (86-89); Membrane Proteins (86-87); Receptors, Leukocyte-Adhesion (89-91)  t6)Antigens, CD15 D09.203.400.410.420.050; D10.516.390.470.050; D10.516.808.530.050; D24.185.101.100.110.115; D24.185.101.100.900.050; D24.185.101.840.075.050; D24.611.216.119.325.050; D24.611.216.285.050.050; D24.611.216.301.264.035.115; D24.611.216.301.264.900.050 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycoconjugates; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Glycolipids; Glycosphingolipids Lipids and Antilipemic Agents (Non MeSH); Lipids; Sphingolipids; Glycosphingolipids Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, Myelomonocytic Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigenic Determinants; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, Myelomonocytic Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors. Antigenic Determinants (70-90); Antigens, Neoplasm (73-90); Glycolipids (66-90); Tumor Markers, Biological (88-90) q6Antigens, CD13 D08.586.277.656.081.160; D24.185.101.100.110.113; D24.185.101.100.894.113; D24.611.216.301.264.035.113; D24.611.216.301.264.894.113 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, Differentiation, T-Lymphocyte Glycoproteins expressed on human granulocyte-monocyte progenitor colony forming units (CFU-GM) and their more differentiated progeny. The enzymes are also found in a large number of tissues, often associated with membranes. EC 3.4.11.2. Alanine (75-80); Aminopeptidases (81-94); Antigens, CD (91-94); Antigens, Differentiation (88); Antigens, Differentiation, Myelomonocytic (89-94) O6)Antigens, CD11 D24.185.101.100.110.111; D24.611.216.301.264.035.111 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD Antigen p150,95; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen Antigen p150,95; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen A group of three different alpha chains (CD11a, CD11b, CD11c) that are associated with an invariant CD18 beta chain (ANTIGENS, CD18). The three resulting leukocyte-adhesion molecules (RECEPTORS, LEUKOCYTE ADHESION) are LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1, MACROPHAGE-1 ANTIGEN, and ANTIGEN, P150,95. Antigens, CD (90-94); Antigens, Differentiation (88-91)  3:6<\BAntigens, CD D24.185.101.100.110; D24.611.216.301.264.035 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation Antigens, CD2; Antigens, CD3 (+ 1); Antigens, CD4; Antigens, CD8; Antigens, CD11 (+ 3); Antigens, CD13; Antigens, CD15; Antigens, CD18; Antigens, CD26; Antigens, CD27; Antigens, CD28; Antigens, CD30; Antigens, CD45; Intercellular Adhesion Molecule-1; Membrane Metallo-Endopeptidase; 5'-Nucleotidase; Receptors, Complement 3b; Receptors, Complement 3d; Receptors, IgE; Receptors, IgG; Receptors, Interleukin-2; Receptors, Lymphocyte Homing Antigens, CD2; Antigens, CD3 (+ 1); Antigens, CD4; Antigens, CD8; Antigens, CD11 (+ 3); Antigens, CD13; Antigens, CD15; Antigens, CD18; Antigens, CD26; Antigens, CD27; Antigens, CD28; Antigens, CD30; Antigens, CD45; Intercellular Adhesion Molecule-1; Membrane Metallo-Endopeptidase; 5'-Nucleotidase; Receptors, Complement 3b; Receptors, Complement 3d; Receptors, IgE; Receptors, IgG; Receptors, Interleukin-2; Receptors, Lymphocyte Homing Differentiation antigens residing on human leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similiar reactivity with certain subpopulations of antigens. The subpopulations of antigens are also known by the same CD designation. Antigens, Differentiation (88-89); Antigens, Differentiation, T-Lymphocyte (88-89) ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $o26O^FAntigens, Bacterial D24.611.216.161 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Adhesins, Bacterial (+ 1); Lepromin; Polysaccharides, Bacterial (+ 4); Staphylococcal Protein A; Tuberculin Antigens (66-70); Polysaccharides, Bacterial (66-70) ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  (6g>DAntigens D24.611.216 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigen-Antibody Reactions; Receptors, Antigen Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Allergens; Antigenic Determinants (+ 12); Antigens, Bacterial (+ 10); Antigens, Fungal (+ 3); Antigens, Helminth; Antigens, Heterophile (+ 1); Antigens, Neoplasm (+ 13); Antigens, Protozoan (+ 1); Antigens, Surface (+ 102); Antigens, T-Independent; Antigens, Viral (+ 22); Autoantigens; Isoantigens (+ 62); Proliferating Cell Nuclear Antigen; Superantigens (+ 1); Vaccines, Synthetic (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR   66ZHAntigenic Variation G04.610.626.073; G05.386.073; G05.414.918.073; G05.511.073 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Genetics, Microbial Genetics; Genetics, Population; Variation (Genetics) Genetics; Immunogenetics Genetic alterations in antigenic characteristics (especially of microbial strains) which occur over time, by mutation or with conformational changes in genetic components; sometimes called antigen switching. In pathogenic organisms it is associated with genetic stability and regulation of host immune response. Antigenic Determinants (75-87); Genetics, Microbial (73-87); Variation (Genetics) (66-87) GDfiAntigenic Modulation G04.610.143.140 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions Loss of detectable antigen from the surface of a cell after incubation with antibodies. This is one method in which some tumors escape detection by the immune system. Antigenic modulation of target antigens also reduces the therapeutic effectiveness of treatment by monoclonal antibodies. Antigen-Antibody Reactions (68-89); Antigens, Surface/analysis (79-91); Antigens, Surface/immunology (79-88) ̈́pQ~Antigenic Determinants D24.611.216.119 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antibodies, Anti-Idiotypic; Antibody Affinity; Epitope Mapping; Molecular Mimicry Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens Antigens, Tumor-Associated, Carbohydrate (+ 4); Haptens (+ 5); Immunodominant Epitopes The molecular or chemical configurations of any antigenic molecule which form the operative part of the hapten and give the antigen specificity in the antigen-antibody reaction. Antigens (66-69) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR ($6_ggDAntigen-Presenting Cells A11.066; A15.382.066 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Antigen Presentation; Histocompatibility Antigens Class II; Lymphocyte Transformation Cells Hemic and Immune Systems (Non MeSH); Immune System Dendritic Cells (+ 1) Dendritic Cells (+ 1) Immunocompetent cells, usually Ia positive, that mediate the cellular immune response by processing and presenting antigens or mitogens which stimulate T-cell activation. Antigenic Determinants (70-84); Antigens, Immune Response (81-84); Lymphocyte Transformation (69-84); T Lymphocytes (73-84) $*bF6Antigen-Antibody Reactions G04.610.143 DEGEIMPHRE Binding Sites, Antibody; Hypersensitivity, Immediate Antibodies; Antigens Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Agglutination (+ 2); Antibody Affinity; Antigenic Modulation; Binding Sites, Antibody; Cross Reactions; Hemolysis; Immunologic Capping; Passive Cutaneous Anaphylaxis; Rh Isoimmunization BLCFCICLCNCODEDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPHPPPSPXRARERHRIRTSUTHURUSVEVI $=QTAntigen-Antibody Complex D24.611.171 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immune Complex Diseases Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Immunosorbents The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Antibodies (66-69); Antigens (66-69) ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSTTOTUULUR (6Z-BAntigen p150,95 D12.776.543.750.705.408.460.475.100; D24.185.101.100.110.111.100; D24.611.216.301.264.035.111.100; D24.611.834.408.460.475.100 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigens, CD18 Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Receptors, Cell Surface; Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Leukocyte-Adhesion Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Antigens, Differentiation; Antigens, CD; Antigens, CD11 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Surface; Antigens, Differentiation; Antigens, CD; Antigens, CD11 Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Receptors, Immunologic; Integrins; Receptors, Cytoadhesin; Receptors, Leukocyte-Adhesion A major adhesion-associated heterodimer molecule expressed by human monocytes, granulocytes, NK cells, and some lymphocytes. The alpha subunit is the CD11c antigen (also called Leu-M5), a surface antigen expressed on some myeloid cells. The beta subunit is the CD18 antigen (ANTIGENS, CD18). The p150,95 antigen has been shown to play an important role in cell-cell and cell-substrate adhesive interactions. Antigens, Differentiation (88-90); Receptors, Leukocyte-Adhesion (89-90)  n6SAntigen Presentation G04.610.555.070 DEGEIMPHRE Antigen-Presenting Cells Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunity, Cellular The process by which antigen is presented to lymphocytes in a form they can recognize. This is performed by antigen presenting cells (APCs). Some antigens require processing before they can be recognized. Antigen processing consists of ingestion and partial digestion of the antigen by the APC, followed by presentation of fragments on the cell surface. (From Dictionary of Immunology, 1989). Antigen-Presenting Cells/immunology (85-93); Antigens (77-84); Antigens/immunology (81-87); Macrophages/immunology (81-93)  hAntifungal Agents D20.136 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Fungicides, Industrial Mycoses; Fungi Anti-Infective Agents Antibiotics, Antifungal (+ 13); Chlorquinaldol; Clotrimazole; Econazole; Fluconazole; Flucytosine; Hexetidine; Itraconazole; Ketoconazole; Miconazole; Nifuratel; Thiram; Tolnaftate; Tomatine; Triacetin; Trichophytin; Undecylenic Acids AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ 8HAntifoaming Agents D26.866.048 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Flatulence Miscellaneous Drugs and Agents (Non MeSH); Surface-Active Agents Agents used to prevent the formation of foam or to treat flatulence or bloat. Silicones (66-76); Surface-Active Agents (66-76)  ,M_:Antifibrinolytic Agents D19.461.270.463.091 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Coagulants; Hemostatics 6-Aminocaproic Acid; Antiplasmin; Tranexamic Acid Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  8y;HAntiemetics D15.095; D16.050.030 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Vomiting; Nausea Central Nervous System Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents Chlorpromazine; Cinnarizine; Cyclizine; Dexamethasone; Diazepam; Dimenhydrinate; Diphenhydramine; Domperidone; Doxylamine; Droperidol; Granisetron; Haloperidol; Hydroxyzine; Lorazepam; Meclizine; Methylprednisolone (+ 1); Metoclopramide; Ondansetron; Prochlorperazine; Promazine; Promethazine; Scopolamine; Tetrahydrocannabinol; Thiethylperazine; Trifluoperazine; Triflupromazine Cyclizine; Dexamethasone; Diazepam; Dimenhydrinate; Doxylamine; Granisetron; Hydroxyzine; Lorazepam; Meclizine; Methylprednisolone (+ 1); Metoclopramide; Ondansetron; Scopolamine; Tetrahydrocannabinol Drugs used to prevent nausea or vomiting. Antiemetics act by a wide range of mechanisms. Some act on the medullary contol centers (the vomiting center and the chemoreceptive trigger zone) while others affect the peripheral receptors. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $8l@Antidotes D26.061 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Chelating Agents; Cholinesterase Reactivators Poisoning Miscellaneous Drugs and Agents (Non MeSH) Charcoal; Flumazenil; Picrotoxin; Succimer; Tetrathionic Acid; Trimedoxime AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $  ,5 2Y:Antidiarrheals D19.316.161 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Diarrhea Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Diphenoxylate; Kaolin; Loperamide; Opium; Pectins Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. Gastrointestinal Agents (67-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR (8 S=%BAntidepressive Agents, Tricyclic D15.085.050; D15.700.122.055 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents Amitriptyline; Amoxapine; Clomipramine; Desipramine; Dothiepin; Doxepin; Imipramine; Iprindole; Lofepramine; Maprotiline; Nortriptyline; Opipramol; Protriptyline; Trimipramine Amitriptyline; Amoxapine; Clomipramine; Desipramine; Dothiepin; Doxepin; Imipramine; Iprindole; Lofepramine; Maprotiline; Nortriptyline; Opipramol; Protriptyline; Trimipramine Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressive Agents (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (&"8" #:Antidepressive Agents, Second-Generation D15.085.025; D15.700.122.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents; Antidepressive Agents Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents Bupropion; Fluoxetine; Fluvoxamine; Maprotiline; Mianserin; Paroxetine; Quipazine; Sulpiride; Trazodone; Viloxazine Bupropion; Fluoxetine; Fluvoxamine; Maprotiline; Mianserin; Paroxetine; Quipazine; Sulpiride; Trazodone; Viloxazine A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. Antidepressive Agents (77-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $=."8#:Antidepressive Agents D15.085; D15.700.122 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Monoamine Oxidase Inhibitors Depression; Monoamine Oxidase Inhibitors Central Nervous System Agents Central Nervous System Agents; Psychotropic Drugs Antidepressive Agents, Second-Generation (+ 10); Antidepressive Agents, Tricyclic (+ 14); Benactyzine; Citalopram; Clorgyline; Deanol; Iproniazid; Isocarboxazid; Nialamide; Phenelzine; Tranylcypromine Antidepressive Agents, Second-Generation (+ 10); Antidepressive Agents, Tricyclic (+ 14); Benactyzine; Citalopram; Clorgyline; Deanol; Iproniazid; Isocarboxazid; Nialamide; Phenelzine; Tranylcypromine Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (8"0]n:Anticonvulsants D15.080 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Convulsions; Barbiturates Central Nervous System Agents Acetazolamide; Carbamazepine; Chlormethiazole; Clonazepam; Clorazepate Dipotassium; Diazepam; Dimethadione; Estazolam; Ethosuximide; Lorazepam; Magnesium Sulfate; Medazepam; Mephenytoin; Mephobarbital; Meprobamate; Nitrazepam; Paraldehyde; Phenobarbital (+ 1); Phenytoin; Thiopental; Tiletamine; Trimethadione; Valproic Acid Drugs used to prevent seizures or reduce their severity. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $ 8$zE:Anticodon D13.444.735.757.286 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleic Acids; RNA; RNA, Transfer A set of three nucleotides in transfer RNA that associates by complementary base pairing with a specific triplet (codon) in messenger RNA during its translation in the ribosome.  DlAnticoagulants D19.461.119 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Blood Coagulation Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH) Ancrod; Antithrombins (+ 4); Coumarins (+ 6); Dextran Sulfate; Gabexate; Heparin (+ 4); Heparinoid; Pentosan Sulfuric Polyester; Phenindione; Protein C; Protein S; Warfarin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  X8[HAnticholesteremic Agents D10.162.202 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lipids and Antilipemic Agents (Non MeSH); Antilipemic Agents AY 9944; Cholestyramine; Clofibrate (+ 1); Dextrothyroxine; Doxazosin; Halofenate; Lovastatin; Nafenopin; Pravastatin; Probucol; Triparanol AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR i8I@Anticestodal Agents D21.201.412.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Cestoda; Cestode Infections Antiparasitic Agents (Non MeSH); Anthelmintics; Antiplatyhelmintic Agents Dichlorophen; Niclosamide; Quinacrine Agents used to treat tapeworm infestations in man or animals. Anthelmintics (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( $8"V-K:Anticarcinogenic Agents D22.204.125; D26.055 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Antimutagenic Agents; Antineoplastic Agents Antimutagenic Agents; Antineoplastic Agents; Carcinogens; Neoplasms Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Miscellaneous Drugs and Agents (Non MeSH) Fenretinide Fenretinide Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. They differ from antineoplastic agents in that they prevent neoplasms from forming. The anticarcinogenic substances can be divided into three categories. The first consists of compounds that prevent the formation of carcinogens from precursor substances. The second group consists of "blocking agents" which inhibit carcinogenesis by preventing carcinogenic agents from reaching or reacting with critical target sites in the tissues. The third group is the "suppressor agents" which act by suppression of expression of neoplasia in cells previously exposed to carcinogens that would otherwise cause neoplasms. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( 83OD:Antibody-Producing Cells A11.063; A15.382.520.118 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Hemolytic Plaque Technique Cells Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System B-Lymphocytes (+ 1); Plasma Cells B-Lymphocytes (+ 1); Plasma Cells Cells of the lymphoid series that can react with antigen to produce specific cell products called antibodies. Various cell subpopulations, often B-lymphocytes, can be defined, based on the different classes of immunoglobulins that they synthesize. Antibody Formation (66-69) $;* [T Antibody-Dependent Cell Cytotoxicity G04.610.270.070 DEGEIMPHRE Killer Cells Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Cytotoxicity, Immunologic The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IgG whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. Cytotoxicity Tests, Immunologic (71-77); Immunity, Cellular (70-77); Lymphocytes (66-77)  *ohAntibody-Coated Bacteria Test, Urinary E01.223.495.348.050; E01.341.050; E05.478.588.375.050 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Fluorescent Antibody Technique Diagnosis; Diagnosis, Urologic (Non MeSH) Miscellaneous Techniques (Non MeSH); Immunologic Techniques; Immunohistochemistry; Fluorescent Antibody Technique Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively. Antibodies, Bacterial (74-79); Bacteriuria (74-79); Pyelonephritis (74-79); Urinary Tract Infections (74-79) T-="Antibody Specificity G04.610.106 DEGEIMPHRE Antibodies, Bispecific Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Organ Specificity; Species Specificity The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibodies (66-69) $Q.Antibody Formation G04.610.071 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity QAntibody Diversity G04.610.051; G04.610.626.051; G05.511.051 DEGEIMPHRE Gene Rearrangement Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Immunogenetics Genetics; Immunogenetics The phenomenon of immense variability characteristic of antibodies, which enables the immune system to react specifically against the essentially unlimited kinds of antigens it encounters. Antibody diversity is accounted for by three main theories: 1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; 2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and 3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of variable region gene segments during the differentiation of the antibody-producing cells. Antibodies (66-69); Antibody Specificity (70-79)  h1{:Antibody Affinity G04.610.143.125 DEGEIMPHRE Binding Sites, Antibody; Antigenic Determinants Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes. Antibodies (66-78); Antigen-Antibody Reactions (66-78); Antigenic Determinants (70-78); Binding Sites, Antibody (73-78)  "8p Antibodies, Viral D24.611.125.243 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Hepatitis Antibodies (+ 1); HTLV-BLV Antibodies (+ 3) Immunoglobulins produced as a response to viral antigens; includes all classes of immunoglobulins elicited by all viral components. Antibodies (66-72)  &$6iBAntibodies, Protozoan D24.611.125.235 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic protozoan antigens. Antibodies (66-87); Antigens, Protozoan/immunology (85-87) ( 6iEAntibodies, Neoplasm D24.611.125.217 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Neoplasms Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies (66-72) )6 iAntibodies, Monoclonal D24.611.125.200 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPKPORETOTUULUR Hybridomas Hybridomas Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Muromonab-CD3 Antibodies produced by clones of cells such as those isolated after hybridization of activated B lymphocytes with neoplastic cells. These hybrids are often referred to as hybridomas. Antibodies (75-81); B Lymphocytes (75-81) (*8i3Antibodies, Heterophile D24.611.125.191 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification. -6i4Antibodies, Helminth D24.611.125.180 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic helminth antigens. The IgE class of immunoglobulins is usually formed and released, but IgG, IgM, and IgA may also occur. Antibodies (66-87); Antigens, Helminth/immunology (85-87); IgE (71-87) 0B6iUAntibodies, Fungal D24.611.125.165 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies (66-72) 26iAntibodies, Catalytic D24.611.125.145 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies that can catalyze a wide variety of chemical reactions. They are characterized by high substrate specificity and share many mechanistic features with enzymes. Antibodies (86-92); Antibodies, Monoclonal (86-92); Catalysis (86-92) 36iSAntibodies, Bispecific D24.611.125.142 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPKPORETOTUULUR Immunotoxins; Radioimmunotherapy Antibody Specificity; Cytotoxicity, Immunologic Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate antigenic determinants. They are artificial antibodies produced by chemical crosslinking, fusion of hybridoma cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors. specific Antibodies (85-93); Antibodies (85-93) $58&7i9Antibodies, Bacterial D24.611.125.139 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antistreptolysin Antibodies (66-72) 9L6iAntibodies, Antiphospholipid D24.611.125.308.210 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antiphospholipid Syndrome Phospholipids Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies Antibodies, Anticardiolipin; Lupus Coagulation Inhibitor Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC), ANTIPHOSPHOLIPID SYNDROME, related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals. Autoantibodies (83-92) (:j!6{AGAntibodies, Antinuclear D24.611.125.308.204 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Collagen Diseases; LE Cells Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. =X6#{Antibodies, Anticardiolipin D24.611.125.308.210.100 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Cardiolipins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Autoantibodies; Antibodies, Antiphospholipid Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC), ANTIPHOSPHOLIPID SYNDROME, and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase immunoassay employing the purified phospholipid antigen cardiolipin. Antibodies (84-92); Autoantibodies (84-92)  @  6r3Antibodies, Anti-Idiotypic D24.611.125.120 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunoglobulin Idiotypes; Molecular Mimicry Antigenic Determinants Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.  B63iAntibodies D24.611.125 ADAEANBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Antigen-Antibody Reactions Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Agglutinins (+ 9); Antibodies, Anti-Idiotypic; Antibodies, Bacterial (+ 1); Antibodies, Bispecific; Antibodies, Catalytic; Antibodies, Fungal; Antibodies, Helminth; Antibodies, Heterophile; Antibodies, Monoclonal (+ 1); Antibodies, Neoplasm; Antibodies, Protozoan; Antibodies, Viral (+ 6); Antitoxins (+ 4); Autoantibodies (+ 8); Binding Sites, Antibody; Hemolysins; Immune Sera (+ 2); Immunoconjugates (+ 1); Immunoglobulin Allotypes (+ 2); Immunoglobulin Idiotypes; Immunoglobulins (+ 33); Insulin Antibodies; Isoantibodies; Opsonins; Precipitins; Reagins AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  D4ZHAntibiotics, Peptide D20.085.116 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Alamethicin; Antibiotics, Glycopeptide (+ 6); Bacitracin; Capreomycin; Daptomycin; Distamycins; Echinomycin; Edeine; Lysostaphin; Mycobacillin; Netropsin; Nisin; Polymyxin (+ 2); Streptothricins; Thiostrepton; Tyrothricin (+ 2); Valinomycin; Viomycin (+ 1); Virginiamycin Antibiotics whose structure contains one or more peptides, usually cyclic. They are generally effective against gram-positive bacteria and act by inhibiting peptidoglycan synthesis in bacterial cell walls. Antibiotics (66-93); Peptides (66-93) AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $H:)D.BAntibiotics, Macrolide D20.085.115 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Amphotericin B; Azithromycin; Candicidin; Erythromycin (+ 5); Leucomycins (+ 4); Lucensomycin; Miocamycin; Natamycin; Nystatin; Oleandomycin (+ 1) A group of antibiotics containing a macrocyclic lactone ring linked glycosidically to one or more sugar moieties. These antibiotics are produced by certain species of Streptomyces. They often inhibit protein synthesis by binding to the 50S subunits of 70S ribosomes. Antibiotics (66-89) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $K:)8<Antibiotics, Lactam D20.085.099 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Carbapenems (+ 2); Cephalosporins (+ 26); Clavulanic Acids; Monobactams (+ 1); Moxalactam; Penicillins (+ 24); Sulbactam Compounds containing a four-membered ring with an amide nitrogen and a keto group. This configuration includes bacteriostatic, cell-wall inhibiting antibiotics, such as penicillins and cephalosporins; their analogs and derivatives, such as the penem (or penam) compounds; clavulanic acids; and monobactams. They are substrates for and may act as inhibitors of bacterial beta-lactamases. Amides (66-73); Antibiotics (66-82); Lactams (74-82) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $N:)A<Antibiotics, Glycopeptide D20.085.116.095 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Peptide Bleomycins (+ 2); Ristocetin; Teicoplanin; Vancomycin Antibiotics whose structure contains one or more cyclic peptides to which are attached one or more deoxy sugars in glycosidic linkage. They are generally effective against gram-positive bacteria and act by inhibiting peptidoglycan synthesis in bacterial cell walls. Antibiotics (71-92); Glycopeptides (69-92) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $R{:BB43<Antibiotics, Combined D20.085.092 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Drug Therapy, Combination Anti-Infective Agents; Antibiotics Combination of antibiotics used against difficult-to-treat infections. Antibiotic combinations have been used mainly to broaden the antibacterial spectrum and prevent development of resistance. In some instances these combinations have shown lower toxicity, but drug antagonism may be one of the problems encountered by their use. They may be given simultaneously or sequentially. The drugs need not be in the same dosage form. Antibiotics (66-88)  U<:)Antibiotics, Antitubercular D20.085.089; D20.338.135 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Anti-Infective Agents; Antitubercular Agents Capreomycin; Cycloserine; Kanamycin (+ 1); Rifabutin; Rifampin; Streptomycin (+ 1); Viomycin (+ 1) Capreomycin; Cycloserine; Kanamycin (+ 1); Rifabutin; Rifampin; Streptomycin (+ 1); Viomycin (+ 1) Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antibiotics (66-74); Antitubercular Agents (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $X :[4<<Antibiotics, Antineoplastic D20.085.075; D22.204.106 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents Actinomycin (+ 1); Anthramycin; Antibiotics, Anthracycline (+ 8); Aurantin; Azaserine; Bleomycins (+ 2); Chromomycins (+ 3); Diazooxonorleucine; Echinomycin; Formycins (+ 2); Mitomycins (+ 2); Mycophenolic Acid; Pactamycin; Puromycin (+ 1); Showdomycin; Sparsomycin; Streptonigrin; Streptovaricin; Streptozocin; Tenuazonic Acid; Toyocamycin; Tubercidin; Zinostatin Actinomycin (+ 1); Anthramycin; Antibiotics, Anthracycline (+ 8); Aurantin; Azaserine; Bleomycins (+ 2); Chromomycins (+ 3); Diazooxonorleucine; Echinomycin; Formycins (+ 2); Mitomycins (+ 2); Mycophenolic Acid; Pactamycin; Puromycin Aminonucleoside; Showdomycin; Sparsomycin; Streptonigrin; Streptovaricin; Streptozocin; Tenuazonic Acid; Toyocamycin; Zinostatin Antibiotics (66); Antineoplastic Agents (66) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  [ :w`6<Antibiotics, Antifungal D20.085.062; D20.136.073 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Anti-Infective Agents; Antifungal Agents Amphotericin B; Antimycin A; Azaserine; Candicidin; Cerulenin; Cycloheximide; Filipin; Griseofulvin; Lucensomycin; Mycobacillin; Natamycin; Nystatin; Pyrrolnitrin; Rutamycin Amphotericin B; Antimycin A; Azaserine; Candicidin; Cycloheximide; Filipin; Griseofulvin; Lucensomycin; Mycobacillin; Natamycin; Nystatin; Pyrrolnitrin; Rutamycin Antibiotics (66); Antifungal Agents (66) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  `:W2<Antibiotics, Anthracycline D20.085.075.105; D22.204.106.125 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Aclarubicin; Daunorubicin (+ 6) Aclarubicin; Daunorubicin (+ 6) Antibiotics which have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to a sugar molecule. These antibiotics have potent antineoplastic activity. The two best known members of this group are daunorubicin and doxorubicin. Since these agents intercalate with DNA, many DNA functions are adversely affected. Futhermore they interact with cell membranes thereby altering their functions and also generate hydrogen peroxide and hydroxy radicals which are highly destructive to cells. Antibiotics, Antineoplastic (67-88); Daunorubicin/analogs and derivatives (75-88); Doxorubicin/analogs and derivatives (75-88); Naphthacenes (66-88) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $c&:LJ<Antibiotics, Aminoglycoside D20.085.060 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics Butirosins; Gentamicins (+ 2); Hygromycin B; Kanamycin (+ 4); Neomycin (+ 3); Streptomycin (+ 1) Antibiotics whose structure contains amino sugars attached to an aminocyclitol ring (hexose nucleus) by glycosidic bonds. Aminoglycoside antibiotics are derived from various species of Streptomyces and Micromonospora or are produced synthetically. They act by inhibiting protein synthesis. Aminoglycosides (74-87); Antibiotics (66-87); Glycosides (66-87); Nucleosides (66-87) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $hy :)zLf<Antibiotics D20.085 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents Anisomycin; Antibiotics, Aminoglycoside (+ 16); Antibiotics, Antifungal (+ 14); Antibiotics, Antineoplastic (+ 42); Antibiotics, Antitubercular (+ 10); Antibiotics, Combined; Antibiotics, Lactam (+ 60); Antibiotics, Macrolide (+ 20); Antibiotics, Peptide (+ 30); Aurodox; Bacteriocins (+ 4); Bambermycins; Bongkrekic Acid; Calcimycin; Chloramphenicol (+ 1); Citrinin; Fosfomycin; Fusidic Acid; Lasalocid; Lincomycin (+ 1); Mepartricin; Mupirocin; Nigericin; Novobiocin; Prodigiosin; Prodigiozan; Rifamycins (+ 2); Spectinomycin; Tetracyclines (+ 9); Tunicamycin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR k :HAntibiosis G04.185.515.070 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH) A property of microorganisms which enables one microorganism to kill, injure, or inhibit the growth of a different microorganism. Antibiosis includes microbial antagonism. oAnti-Ulcer Agents D19.316.203 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Histamine H2 Antagonists Peptic Ulcer; Parasympatholytics; Histamine H2 Antagonists Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents Antacids (+ 3); Arbaprostil; Burimamide; Carbenoxolone; Cimetidine; 16,16-Dimethylprostaglandin E2; Enprostil; Famotidine; Gefarnate; Metiamide; Misoprostol; Nizatidine; Omeprazole; Pirenzepine; Proglumide; Propantheline; Ranitidine; Rioprostil; Sucralfate; Vitamin U Various agents with different action mechanisms used to treat or ameliorate ulcers or irritation of the gastrointestinal tract. Antacids (66-76); Gastrointestinal Agents (66-76) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ,p8ES:;FAnti-Inflammatory Agents, Topical D17.025.080; D23.037 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Glucocorticoids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents Dermatologic Agents Algestone Acetophenide; Anthralin; Benzydamine; Bufexamac; Dimethyl Sulfoxide; Flufenamic Acid; Glucocorticoids, Topical (+ 21); Glycyrrhetinic Acid; Isothiuronium; Oxyphenbutazone Algestone Acetophenide; Anthralin; Benzydamine; Bufexamac; Dimethyl Sulfoxide; Flufenamic Acid; Glucocorticoids, Topical (+ 20); Glycyrrhetinic Acid; Isothiuronium; Oxyphenbutazone Anti-inflammatory agents that are applied to the skin and whose pharmacological effect only occurs at the area of application. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $td'8:Anti-Inflammatory Agents, Steroidal D17.025.050; D17.050.040 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Glucocorticoids, Synthetic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Algestone Acetophenide; Beclomethasone; Betamethasone (+ 2); Corticosterone; Cortisone; Desonide; Dexamethasone (+ 2); Fludrocortisone; Flumethasone; Fluocinolone Acetonide (+ 1); Fluocortolone (+ 1); Fluorometholone; Flurandrenolone; Halcinonide; Hydrocortisone (+ 1); Paramethasone; Prednisolone (+ 4); Prednisone; Triamcinolone (+ 1) Betamethasone; Dexamethasone; Prednisolone (+ 3); Prednisone; Triamcinolone Anti-inflammatory agents that are steroids. Anti-Inflammatory Agents (66-86) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (x1)84&DAnti-Inflammatory Agents, Non-Steroidal D16.850.015.050; D17.025.030; D17.050.030 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Fever; Cyclooxygenase Inhibitors; Salicylates Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents Aminopyrine (+ 1); Antipyrine; Apazone; Aspirin; Benzydamine; Bromelains; Bufexamac; BW-755C; Clofazimine; Clonixin; Diclofenac; Diflunisal; Dipyrone; Epirizole; Etodolac; Fenoprofen; Flufenamic Acid; Flurbiprofen; Ibuprofen; Indomethacin; Ketoprofen; Meclofenamic Acid; Mefenamic Acid; Naproxen; Niflumic Acid; Phenylbutazone (+ 1); Piroxicam; Prenazone; Sodium Salicylate; Sulindac; Suprofen; Tolmetin Aminopyrine (+ 1); Antipyrine; Apazone; Aspirin; Benzydamine; Bromelains; Bufexamac; BW-755C; Clofazimine; Clonixin; Diclofenac; Diflunisal; Dipyrone; Epirizole; Etodolac; Fenoprofen; Flufenamic Acid; Flurbiprofen; Ibuprofen; Indomethacin; Ketoprofen; Meclofenamic Acid; Mefenamic Acid; Naproxen; Niflumic Acid; Phenylbutazone (+ 1); Piroxicam; Prenazone; Sodium Salicylate; Sulindac; Suprofen; Tolmetin Aminopyrine (+ 1); Antipyrine; Apazone; Aspirin; Benzydamine; Bufexamac; BW-755C; Clonixin; Diclofenac; Diflunisal; Dipyrone; Epirizole; Etodolac; Fenoprofen; Flufenamic Acid; Flurbiprofen; Ibuprofen; Indomethacin; Ketoprofen; Meclofenamic Acid; Mefenamic Acid; Naproxen; Niflumic Acid; Phenylbutazone (+ 1); Piroxicam; Prenazone; Sodium Salicylate; Sulindac; Suprofen; Tolmetin Anti-inflammatory agents that are not steroids. They usually have an anesthetic effect. Anti-Inflammatory Agents (66-86); Analgesics, Anti-Inflammatory (66-86) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (|~-186qhRHAnti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH) D17 Anti-Inflammatory Agents (+ 101); Antirheumatic Agents (+ 67); Inflammation Mediators (+ 62) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR oaoHAnti-Inflammatory Agents D17.025 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Fever; Glucocorticoids, Synthetic; Inflammation Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH) Anti-Inflammatory Agents, Non-Steroidal (+ 34); Anti-Inflammatory Agents, Steroidal (+ 31); Anti-Inflammatory Agents, Topical (+ 31); Nedocromil; Sulfasalazine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR   88aHAnti-Infective Agents, Urinary D19.770.056; D20.237 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Urinary Tract Infections Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH) Anti-Infective Agents Nitrofurantoin Anti-Infective Agents, Quinolone (+ 10); Mandelic Acids; Methenamine; Methylene Blue; Nitrofurans (+ 3); Piromidic Acid (+ 1); Sulfachlorpyridazine; Trimethoprim (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  $8m:Anti-Infective Agents, Quinolone D20.220; D20.237.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Quinolones Anti-Infective Agents Anti-Infective Agents; Anti-Infective Agents, Urinary Anti-Infective Agents, Fluoroquinolone (+ 6); Cinoxacin; Nalidixic Acid; Oxolinic Acid Anti-Infective Agents, Fluoroquinolone (+ 6); Cinoxacin; Nalidixic Acid; Oxolinic Acid A group of synthetic antimicrobial agents which usually contain a 4-quinolinone ring structure. A few compounds belonging to this group have related nitrogen heterocyclic ring structures such as naphthyridine or phthalazine groups. All compounds in this group are substituted with an oxo group at the 4-position. The second-generation quinolones are also substituted with a 1-piperazinyl group at the 7-position and a fluorine moiety at the 6-position. The quinolones inhibit the A subunit of DNA gyrase and thus interfere with the ability of the enzyme to repair bacterial DNA breaks during replication. The compounds have a broad spectrum of activity against a variety of aerobic bacteria. Anti-Infective Agents (80-88); Quinolines (80-88); Pyridazines (80-88) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (&8V%T:Anti-Infective Agents, Local D20.187 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Disinfectants Dermatologic Agents Anti-Infective Agents Aminacrine; Benzalkonium Compounds; Benzethonium; Camphor; Carbadox; Carbocysteine; Cetrimonium Compounds; Cetylpyridinium; Chlorhexidine; Dequalinium; Disinfectants (+ 4); Ethacridine; Furagin; Furazolidone; Gentian Violet; Hexachlorophene; Hexetidine; Hexylresorcinol; Hydrogen Peroxide; Iodine; Iodophors (+ 1); Lysostaphin; Merbromine; Mercuric Chloride; Nitrofurazone; Noxythiolin; Phenethyl Alcohol; Proflavine; Propiolactone; Silver Nitrate; Silver Proteins; Thimerosal; Thiram; Triacetin; Triclosan; Tyrothricin (+ 2); Undecylenic Acids AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $" 8~DAnti-Infective Agents, Fluoroquinolone D20.220.050; D20.237.050.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Anti-Infective Agents, Quinolone Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Infective Agents, Quinolone Ciprofloxacin (+ 1); Enoxacin; Norfloxacin; Ofloxacin; Pefloxacin Ciprofloxacin (+ 1); Enoxacin; Norfloxacin; Ofloxacin; Pefloxacin Synthetic antimicrobial agents with the characteristic 4-quinolone ring structure and containing a fluorine moiety at the 6-position. Some members also have a 1-piperazinyl group at the 7-position. Fluoroquinolone agents have greater intrinsic antibacterial activity and a broader antibacterial spectrum than the quinolone agents. Anti-Infective Agents, Quinolone (89-92) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $9,"8{/:Anti-Infective Agents D20 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anthelmintics; Antiprotozoal Agents Parasites; Infection Antibiotics (+ 239); Antifungal Agents (+ 30); Anti-Infective Agents, Local (+ 44); Anti-Infective Agents, Quinolone (+ 10); Anti-Infective Agents, Urinary (+ 23); Antitreponemal Agents (Non MeSH) (+ 1); Antitubercular Agents (+ 20); Antiviral Agents (+ 41); Leprostatic Agents (+ 5); Muramidase; Sulfonamides (+ 26) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  8*~HAnti-Dyskinesia Agents D15.090 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents Antiparkinson Agents (+ 18); Deanol; Haloperidol; Pimozide; Tetrabenazine; Tiapride Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias. Antiparkinson Agents (76-94) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $ 8$e<"DAnti-Arrhythmia Agents D18.097 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Arrhythmia; Heart Cardiovascular Agents Acebutolol; Ajmaline (+ 1); Alprenolol; Amiodarone; Aprindine; Atropine; Bretylium Tosylate; Bunaftine; Bupranolol; Carteolol; Celiprolol; Disopyramide; Edrophonium; Encainide; Felodipine; Fendiline; Flecainide; Ipratropium; Lidocaine; Metipranolol; Mexiletine; Moricizine; Nadolol; Oxprenolol; Penbutolol; Phenytoin; Pindolol; Practolol; Procainamide (+ 1); Propafenone; Propranolol; Quinidine; Sotalol; Sparteine; Timolol; Tocainide; Verapamil (+ 1) Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $X 8@Anti-Anxiety Agents, Benzodiazepine D15.075.050; D15.210.950.012.050; D15.700.872.015.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR GABA Modulators; Benzodiazepines Central Nervous System Agents; Anti-Anxiety Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents Alprazolam; Bromazepam; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam (+ 1); Estazolam; Flunitrazepam; Flurazepam; Lorazepam; Medazepam; Midazolam; Nitrazepam; Oxazepam; Prazepam; Temazepam Alprazolam; Bromazepam; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam (+ 1); Estazolam; Flunitrazepam; Flurazepam; Lorazepam; Medazepam; Midazolam; Nitrazepam; Oxazepam; Prazepam; Temazepam Alprazolam; Bromazepam; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam (+ 1); Estazolam; Flunitrazepam; Flurazepam; Lorazepam; Medazepam; Midazolam; Nitrazepam; Oxazepam; Prazepam; Temazepam Substances with a benzodiazepine ring structure widely used to treat anxiety and neuroses. Drugs in this class also generally have sedative or weak hypnotic properties and may be effective as muscle relaxants, anticonvulsants, and anesthesia adjuvants. Benzazepines (68-73); Benzodiazepinones (74); Tranquilizing Agents (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ()=8'"%X:Anti-Anxiety Agents D15.075; D15.210.950.012; D15.700.872.015 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Adrenergic beta-Antagonists Central Nervous System Agents Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents Anti-Anxiety Agents, Benzodiazepine (+ 16); Buspirone; Chlormezanone; Doxepin; Hydroxyzine; Meprobamate; Ondansetron; Ritanserin; Tranylcypromine; Trazodone Anti-Anxiety Agents, Benzodiazepine (+ 16); Buspirone; Chlormezanone; Doxepin; Hydroxyzine; Meprobamate; Ondansetron; Ritanserin; Tranylcypromine; Trazodone Anti-Anxiety Agents, Benzodiazepine (+ 16); Buspirone; Chlormezanone; Doxepin; Hydroxyzine; Meprobamate; Ondansetron; Ritanserin; Tranylcypromine; Trazodone Agents that alleviate anxiety, tension, and neurotic symptoms, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. Some are also effective as anticonvulsants, muscle relaxants, or anesthesia adjuvants. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Tranquilizing Agents (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (18 !":Anthroposophy E02.040.060 HIPX Therapeutics; Alternative Medicine Knowledge of the nature of man. A spiritual and mystical doctrine that grew out of theosophy and derives mainly from the philosophy of Rudolph Steiner, Austrian social philosopher (1861-1925). (Webster, 3d ed). )Anthropometry E05.118.090; G03.850.505.200.100; N05.715.360.325.150.100 HIISMT Anthropology, Physical Miscellaneous Techniques (Non MeSH); Body Weights and Measures (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Biometry Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Epidemiologic Measurements (Non MeSH); Biometry Body Mass Index; Crown-Rump Length Body Mass Index; Cephalometry (+ 1); Crown-Rump Length Body Mass Index; Cephalometry (+ 1); Crown-Rump Length The technique that deals with the measurement of the size, weight, and proportions of the human or other primate body. AECLCTECHIISMOMTNUPXSNSTTDUTVE $KA "Anthropology, Physical I01.076.368 CLECEDHIISLJMAMTOGSNSTTD Anthropometry; Biometry; Genetics, Medical Social Sciences; Anthropology Craniology; Forensic Anthropology; Paleontology (+ 4); Racial Stocks (+ 4) The comparative science dealing with the physical characteristics of man as related to his origin, evolution, and development in his total environment. Anthropology (66-67); Anthropometry (66-67); Ethnology (66-67); Genetics, Medical (66-67) CLECEDGEHIISLJMAMTOGPARARISNSTTDUS (3$[k&Anthropology, Cultural I01.076.201 CLECEDHIISLJMAMTOGSNSTTD Ethnopsychology Social Sciences; Anthropology Archaeology; Culture (+ 39) The study of social phenomena which characterize the learned, shared, and transmitted social activities of a particular ethnic group. Anthropology (66-67); Australoid Race (66-67); Blacks (66-67); Caucasoid Race (66-67); Ethnology (66-67); Ethnopsychology (66-67); Mongoloid Race (66-67) CLECEDGEHIISLJMAMTOGPXSNSTTD (J$# Anthropology F04.096.879.201; I01.076 CLECEDHIISLJMAMTOGSNSTTD Hominidae Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Social Sciences Social Sciences  Anthropology, Cultural (+ 41); Anthropology, Physical (+ 12) The science devoted to the comparative study of man. CLECEDGEHIISLJMAMTOGPAPXRARISNSTTDUS $ xJA(Anthrax C01.252.410.090.072 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Bacillaceae Infections An acute bacterial infection caused by ingestion of BACILLUS organisms. Carnivores may become infected from ingestion of infected carcasses. It is transmitted to humans by contact with infected animals or contaminated animal products. The most common form in humans is cutaneous anthrax. C PPAnthraquinones D02.806.100; D04.615.117.159 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Quinones Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes Carmine; Cascara (+ 1); Mitoxantrone Carmine; Cascara (+ 1); Mitoxantrone An anthracene ring which contains two ketone moieties in any position. Can be substituted in any position except on the ketone groups. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  "8\:Anthranilic Acids D02.241.223.106.061.105 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids Flufenamic Acid; Glafenine; 3-Hydroxyanthranilic Acid; Meclofenamic Acid; Mefenamic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 8h:Anthranilate Synthase D08.586.520.567.175; D08.586.600.085 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes *FAnthranilate Phosphoribosyltransferase D08.586.600.075; D08.586.913.400.725.160 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Multienzyme Complexes Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme that catalyzes the formation of N-5'-phosphoribosylanthranilic acid from anthranilate and phosphoribosylpyrophosphate, the first step in tryptophan synthesis in E. coli. It exists in a complex with ANTHRANILATE SYNTHASE (EC 4.1.3.27) in bacteria. EC 2.4.2.18. Anthranilic Acids (72-74); Pentosephosphates (72-74); Pentosyltransferases (72-74); Pyrophosphoric Acids (72-74) .+.F7Anthramycin D03.438.079.080.070.050; D20.085.075.102; D22.204.106.114 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines; Benzodiazepinones Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic 3-(5,10,11,11a-Tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1H-pyrrolo(2,1-c)(1,4)benzodiazepin-2-yl)-2-propenamide. Broad spectrum antineoplastic antibiotic isolated from Streptomyces refuineus var. thermotolerans. It has low toxicity, some activity against trichomonas and endamoeba, and inhibits RNA and DNA synthesis. It binds irreversibly to DNA. Acrylamides (73-74); Benzodiazepinones (74); Pyrroles (72-74) ŐA<5JAnthralin D04.615.117.050; D17.025.080.075; D23.037.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Anthracenes Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical An anti-inflammatory anthracene derivative used for the treatment of dermatoses, especially psoriasis. It may cause folliculitis. Anthracenes (68-74) J 5:AAnthracosilicosis C08.381.483.600.760.125; C21.447.800.834.201 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Coal Mining Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial; Pneumoconiosis; Silicosis Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases; Pneumoconiosis; Silicosis A mixed condition of anthracosis and silicosis. (Dorland, 27th ed). 2LSAnthracenes D04.615.117; D26.191.072 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Anthralin; Anthraquinones (+ 4); Benzanthracenes (+ 2); Maprotiline Benzanthracenes (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,l:Anthocyanins D09.203.408.084; D11.557.124 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Growth Substances, Pigments, Vitamins (Non MeSH); Pigments Glycosidic pigments in blue, red, and purple flowers and also found as metabolic byproducts in blood and urine. ϐ">Anthelmintics D21.201 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Parasites; Anti-Infective Agents; Helminthiasis Antiparasitic Agents (Non MeSH) Albendazole; Antinematodal Agents (+ 28); Antiplatyhelmintic Agents (+ 20); Ivermectin AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  E 88&h<Anterior Horn Cells A08.663.694.560.500.050; A11.671.677.560.500.050 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Neuron Types (Non MeSH); Neurons, Efferent; Motor Neurons Cells; Neurons; Neuron Types (Non MeSH); Neurons, Efferent; Motor Neurons Motor neurons in the anterior (ventral) horn of the spinal cord which project to skeletal muscles. 6*vAnterior Eye Segment A09.371.060 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye Anterior Chamber (+ 2); Cornea (+ 4); Trabecular Meshwork That part of the eyeball anterior to the lens. Anterior Chamber (66-84); Cornea (66-84); Eye (66-84)  Ԗ:I;CAnterior Cruciate Ligament A02.513.514.100; A02.835.583.512.100 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Medial Collateral Ligament, Knee; Posterior Cruciate Ligament Posterior Cruciate Ligament; Patellar Ligament Musculoskeletal System; Ligaments; Ligaments, Articular Musculoskeletal System; Skeleton; Joints; Ligaments, Articular A strong ligament of the knee that originates from the posteromedial portion of the lateral condyle of the femur, passes anteriorly and inferiorly between the condyles, and attaches to the depression in front of the intercondylar eminence of the tibia. Knee Joint (66-90); Ligaments, Articular (66-90) $ *:H7(;Anterior Compartment Syndrome C05.651.180.063; C14.907.553.241.063 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Compartment Syndromes Cardiovascular Diseases; Vascular Diseases; Ischemia; Compartment Syndromes Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive exertion. Muscular Diseases (66-71); Tibia (66-71); Vascular Diseases (66-71) !#*NRAnterior Chamber A09.371.060.067 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Eye; Anterior Eye Segment Aqueous Humor; Endothelium, Corneal ۓ:2+Antelopes B02.649.077.380.100 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Artiodactyla; Ruminants Any of various ruminant mammals of the order Bovidae. They include numerous species in Africa and the American pronghorn. u (7Antazoline D03.383.374.040; D14.100.375.425.400.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Histamine Agents; Histamine Antagonists; Histamine H1 Antagonists An antagonist of histamine H1 receptors. Aniline Compounds (68-74); Benzyl Compounds (73-74); Imidazoles (68-75) ݬ.: 2VAntarctic Regions Z01.158 EHEP Geographicals (Non MeSH)  Antacids D19.316.203.059 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents Aluminum Hydroxide; Magnesium Hydroxide; Magnesium Oxide Substances that counteract or neutralize acidity. They are used mainly for the treatment of gastrointestinal irritation or ulcers. D 8iCAnt Venoms D24.185.965.065.055 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Arthropod Venoms Venoms from the superfamily Formicoidea, Ants. They may contain protein factors and toxins, histamine, enzymes, and alkaloids and are often allergenic or immunogenic. Ants (66-77); Venoms (66-77) <k%Anserine D12.644.456.345.159 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Dipeptides  BcAnoxia C23.888.852.079 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Atmospheric Pressure; Oxygen Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH) Altitude Sickness; Anoxemia A total lack of oxygen; often used interchangeably with hypoxia to mean a reduced supply of oxygen to the tissues. (Dorland, 27th ed).   N#"Anoxemia C23.888.852.079.367 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Oxygen Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH); Anoxia Reduction of oxygen content of the blood below physiologic levels. (Dorland, 27th ed).  N iAnovulation C13.371.056.630.050; C19.391.630.050; G08.520.440.508.080 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases; Ovarian Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH); Ovarian Diseases Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Menstrual Cycle; Ovulation Suspension or cessation of ovulation in animals and humans. Ovulation (66-74) vANFHAnosmia C10.597.751.117; C23.888.592.763.117 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Smell Nervous System Diseases; Neurologic Manifestations; Sensation Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders Absence of the sense of smell. (Dorland, 27th ed).  *N AAnorexia Nervosa F03.126.298.068 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Eating Disorders Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Eating Disorders Syndrome marked by severe and prolonged loss of appetite with marked weight loss and other symptoms resulting from emotional conflict. FoAnorexia C23.888.298.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Eating Disorders Loss of appetite. j LnAnoplura B01.131.617.564.159 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Lice Pediculus A suborder of insects comprising the sucking lice. Lice (66-71)  ~ (2 >Anophthalmos C11.250.080; C16.131.384.159 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Congenital absence of the eye or eyes. "L1Anopheles B01.131.617.289.275.120 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Culicidae A genus of mosquitoes (CULICIDAE) that are known vectors of MALARIA.  (BSAnonyms and Pseudonyms L01.143.506.598.400.556.283 Information Science; Communication; Language; Linguistics; Nomenclature; Names ]Anomie F01.829.056; I01.880.578.283 Personality Disorders; Social Behavior Disorders Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social Social Sciences; Sociology; Social Conditions Social Alienation A state of social disorganization and demoralization in society which is largely the result of disharmony between cultural goals and the means for attaining them. This may be reflected in the behavior of the individual in many ways - non-conformity, social withdrawal, deviant behavior, etc. Social Behavior Disorders (69-70); Social Problems (68-70) PX $ "9TFAnomia C10.597.257.543.074.065; C10.597.257.870.074.065; C23.888.592.257.543.074.065; C23.888.592.257.870.074.065; F03.126.219.543.074.065; F03.126.219.870.074.065 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Speech Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Speech Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Speech Disorders; Aphasia Inability to name objects, although they are subjectively perceived. Aphasia (66-79) _ F|QAnodontia C07.650.800.100; C07.793.700.100; C16.131.850.800.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Congenital absence of the teeth; it may involve all (total anodontia) or only some of the teeth (partial anodontia, hypodontia), and both the deciduous and the permanent dentition, or only teeth of the permanent dentition. (Dorland, 27th ed). a =LF Annual Reports N04.452.070 Health Services Administration (Non MeSH); Organization and Administration Annual statements concerning the administrative and operational functions of an institution or organization. W}Anniversaries and Special Events K01.419.095; N04.452.822.070 Humanities; History Health Services Administration (Non MeSH); Organization and Administration; Public Relations Occasions to commemorate an event or occasions designated for a specific purpose. '"aAnnexins D12.776.157.125.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins Annexin I; Annexin II; Annexin III; Annexin IV; Annexin V; Annexin VI; Annexin VII Family of calcium- and phospholipid-binding proteins which are structurally related and exhibit immunological cross-reactivity. Each member contains four homologous 70 kD repeats. The annexins are differentially distributed in vertebrate tissues (and lower eukaryotes) and appear to be involved in membrane fusion and signal transduction. Calcium-Binding Proteins (84-92) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ Fvi&HAnnexin VII D12.776.157.125.050.120 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins Protein of the annexin family that promotes the aggregation and fusion of chromaffin granules and can also act as a voltage-dependent calcium channel. Proteins (78-92) JHAnnexin VI D12.776.157.125.050.110 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins Protein of the annexin family with a probable role in exocytotic and endocytotic membrane events. Calcium-Binding Proteins (84-92) ,Ht&Annexin V D12.776.157.125.050.100 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins Protein of the annexin family isolated from human placenta and other tissues. Anticoagulant properties have been reported. Calcium-Binding Proteins (84-92); Pregnancy Proteins (84-92) HGAnnexin IV D12.776.157.125.050.080 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins Protein of the annexin family originally isolated from the electric organ of the electric ray Torpedo marmorata. It has also been found in a wide range of mammalian tissues. Calcium-Binding Proteins (82-92)  H&Annexin III D08.586.277.352.640.050; D12.776.157.125.050.070 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Diester Hydrolases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins A protein of the annexin family that catalyzes the conversion of 1-D-inositol 1,2-cyclic phosphate and water to 1-D-myo-inositol 1-phosphate. EC 3.1.4.36. Calcium-Binding Proteins (91-92)  6H&Annexin II D12.776.157.125.050.060 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins Protein (p36) of the annexin family that is a substrate for a tyrosine kinase (ONCOGENE PROTEIN PP60(V-SRC)) and for the cellular protein p11. Calcium-Binding Proteins (84-92) tH&Annexin I D12.776.157.125.050.050 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Calcium-Binding Proteins; Annexins Protein of the annexin family exhibiting lipid interaction and steroid-inducibility. Calcium-Binding Proteins (84-92) _Hb&Annelida B01.091 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates Leeches; Oligochaeta; Polychaeta A phylum of metazoan invertebrates comprising the segmented worms, and including marine annelids (POLYCHAETA), freshwater annelids, earthworms (OLIGOCHAETA), and LEECHES. Only the leeches are of medical interest. (Dorland, 27th ed).   ((Ankyrins D12.776.124.080; D12.776.543.080 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins A family of membrane-associated proteins responsible for the attachment of the cytoskeleton. Erythrocyte-related isoforms of ankyrin attach the SPECTRIN cytoskeleton to a transmembrane protein (BAND 3 PROTEIN) in the erythrocyte plasma membrane. Brain-related isoforms of ankyrin also exist. Blood Proteins (79-92); Membrane Proteins (79-92)  &DO<Ankyrin Repeat G05.331.599.056.075; G06.184.599.056.075 DEGEIMPHRE Genetics; Genetics, Biochemical; Molecular Sequence Data; Amino Acid Sequence Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data; Amino Acid Sequence Protein domains that contain 33-amino acid long sequences that often occur in tandem arrays. This repeating sequence of 33-amino acids was discovered in ANKYRIN and is involved in interaction with the anion exchanger (BAND 3 PROTEIN) and may perform a role in molecular recognition in diverse proteins. Amino Acid Sequence (90-92); Membrane Proteins (90-92) .bBAnkylosis C05.550.069 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Joint Diseases Spondylitis, Ankylosing Immobility and consolidation of a joint due to disease, injury, or surgical procedure. (Dorland, 27th ed).  N0Ankle Joint A02.835.583.062 ABAHBSCHCYDEEMENGDIMIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints The joint that is formed by the inferior articular and malleolar articular surfaces of the tibia, the malleolar articular surface of the fibula, and the medial malleolar, lateral malleolar, and superior surfaces of the talus. 61Ankle Injuries C21.866.558.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Leg Injuries Harm or hurt to the ankle or ankle joint usually inflicted by an external source. Ankle/injuries (66-91) NbdAnkle A01.378.592.116 ABAHBSEMGDIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH); Extremities; Leg That part of the lower limb directly above the foot. ( &5BAnistreplase D08.586.277.656.732.635.075; D08.586.277.656.732.775.075; D19.461.427.600.620.075; D19.461.427.684.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Plasminogen Activators Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Streptokinase Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Plasminogen; Plasminogen Activators Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Streptokinase An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA, 16 minutes for UROKINASE and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents. Fibrinolytic Agents (66-90); Plasminogen (66-90); Streptokinase (66-90) pFYUAnisotropy H01.181.529.105; H01.671.606.058 Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical Physical Sciences (Non MeSH); Physics; Optics A physical property showing different values in relation to the direction in or along which the measurement is made. The physical property may be with regard to thermal or electric conductivity or light refraction. In crystallography, it describes crystals whose index of refraction varies with the direction of the incident light. It is also called acolotropy and colotropy. The opposite of anisotropy is isotropy wherein the same values characterize the object when measured along axes in all directions. %c&PAnisomycin D03.383.773.050; D20.085.050 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrrolidines Anti-Infective Agents; Antibiotics 2-(p-Methoxyphenyl)methyl-3-acetoxy-4-hydroxypyrrolidine. An antibiotic isolated from various Streptomyces species. It interferes with protein and DNA synthesis by inhibiting peptidyl transferase or the 80S ribosome system. Antibiotics (68-74); Pyrrolidines (68-74); Benzyl Compounds (72-74) ("<QAnisometropia C11.744.126 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Refractive Errors A difference in the refractive power of the two eyes. (Dorland, 27th ed). Refractive Errors (66-89) *N'\Anisoles D02.355.601.200; D02.355.726.158; D02.755.075 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Methyl Ethers Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers Organic Chemicals (Non MeSH); Phenols Anethole Trithione; Butylated Hydroxyanisole Anethole Trithione; Butylated Hydroxyanisole Anethole Trithione; Butylated Hydroxyanisole; Guaiacol (+ 2) Ethers (66-70); Phenols (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  , 58(:Anisocoria C11.710.090 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Pupillary Functions, Abnormal Tonic Pupil (+ 1) A condition of abnormal pupillary reflexes in which pupils are of unequal size and the difference in diameter between the two is between 1 and 2 mm. Pathologic anisocoria reflects an abnormality in the musculature of the iris or in the parasympathetic or sympathetic pathway. Pupil (66-89); Iris Diseases (83-89)  .|N4E.Aniseikonia C11.744.116 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Refractive Errors A condition in which the ocular image of an object as seen by one eye differs in size and shape from that seen by the other. 0N'Anisakis B01.500.294.700.100.100.075 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Ascaridida; Ascaridoidea A genus of nematodes of the superfamily ASCARIDOIDEA. Its organisms are found in the stomachs of marine animals and birds. Human infection occurs by ingestion of raw fish that contain larvae. Ascaridoidea (75-88); Nematoda (66-74,89-92) 2! *W5Anisakiasis C03.335.508.700.100.060; C03.432.060; C06.405.469.452.060 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Ascaridida Infections Parasitic Diseases; Intestinal Diseases, Parasitic Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Diseases, Parasitic Infection with roundworms of the genus ANISAKIS. Human infection results from the consumption of fish harboring roundworm larvae. The worms may cause acute nausea and vomiting or may penetrate into the wall of the digestive tract, where they give rise to eosinophilic granulomas in the stomach, intestine, or the omentum. Nematode Infections (67-92) 4 AP%y!Aniridia C11.250.060; C11.270.060; C11.941.375.060; C16.131.384.079; C16.131.410.078 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Abnormalities Eye Diseases; Eye Diseases, Hereditary Eye Diseases; Uveal Diseases; Iris Diseases Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary WAGR Syndrome WAGR Syndrome WAGR Syndrome WAGR Syndrome WAGR Syndrome A congenital abnormality in which there is only a rudimentary iris. This is due to the failure of the optic cup to grow. Aniridia also occurs in a hereditary form, usually autosomal dominant. Chromosome Deletion (75-89); Iris/abnormalities (66-89) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $7 WLJRBNAnions D01.248.497.158 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Electrolytes; Ions Arsenates; Arsenites; Borates; Bromates; Bromides; Carbonates (+ 1); Chlorates; Chlorides; Chromates; Cyanides (+ 3); Fluorides; Hydroxides (+ 1); Iodates; Iodides; Nitrates; Nitrites; Oxides (+ 2); Phosphates (+ 2); Phosphites; Sulfates (+ 1); Sulfides (+ 1); Sulfites (+ 1); Vanadates AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR ; 8>f>Anion Exchange Resins D26.572.133 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Ion Exchange Resins Cholestyramine; Colestipol High-molecular-weight insoluble polymers that contain functional anionic groups capable of undergoing exchange reactions. These resins are used for ion exchange chromatography, as gastric antacids, hypocholesteremics, etc. AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU  =,L .Animals, Zoo B02.158.448 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals Animals (66-67) ?(Animals, Wild B02.158.300 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals Animals considered to be wild or feral or not adapted for domestic use. It does not include wild animals in zoos for which ANIMALS, ZOO is available. Animals (66-77) @(Animals, Transgenic B02.158.199.085; B02.158.296 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Chimera Chimera; Transplantation Chimera; Genetic Engineering Vertebrates; Animals; Animals, Laboratory Vertebrates; Animals Mice, Transgenic Mice, Transgenic Animals, or the offspring of such animals, into which cloned genetic material has been experimentally transferred by microinjection of foreign DNA, either directly or into embryos or differentiated cell types. Transgenic rabbits, mice, fish, Xenopus, sheep, pigs, and chickens have been produced using genes of sea urchins, Candida, Drosophila, and mice. $A"& ?J(Animals, Suckling B02.158.291 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals Young, unweaned mammals. Refers to nursing animals whether nourished by their biological mother, foster mother, or bottle fed. D(Animals, Poisonous B02.158.286 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Animals Fishes, Poisonous Animals (66-67) E&Animals, Newborn B02.158.282 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Pregnancy, Animal; Infant, Newborn Vertebrates; Animals F(*Animals, Laboratory B01.062; B02.158.199 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Animal Testing Alternatives; Laboratory Animal Science Invertebrates Vertebrates; Animals  Animals, Transgenic (+ 1) GS(@)!Animals, Inbred Strains B02.158.157 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Inbreeding Vertebrates; Animals Mice, Inbred Strains (+ 14); Rats, Inbred Strains (+ 9) Animals produced by the mating of littermates or siblings over multiple generations. The resultant strain of animals is virtually identical genotypically. Highly inbred animal lines allow the study of certain traits in a relatively pure form. (Dictionary of Modern Medicine, 1992). Inbreeding (70-93) ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI (H^&FJ(Animals, Domestic B02.158.116 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Animals Animals which have become adapted through breeding in captivity to a life intimately associated with man. They include animals domesticated by man to live and breed in a tame condition on farms or ranches (e.g., horses, cattle, sheep) and those raised or kept for pleasure and companionship (e.g., dogs, cats, horses). J(wAnimals B02.158 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Zoology Vertebrates Animals, Domestic; Animals, Inbred Strains (+ 25); Animals, Laboratory (+ 2); Animals, Newborn; Animals, Poisonous (+ 1); Animals, Suckling; Animals, Transgenic (+ 1); Animals, Wild; Animals, Zoo L  ( Animal Welfare I01.880.604.100; K01.316.070.100 ECHILJSNSTTD Animal Testing Alternatives Vivisection Social Sciences; Sociology; Social Control, Formal Humanities; Ethics; Bioethics Animal Rights Animal Rights The protection of animals in laboratories or other specific environments and the promotion of their health through better nutrition, housing, and care. This may be carried out through legislation or regulation. $NG&!`"Animal Testing Alternatives H01.770.644.045; K01.316.070.070 CLECEDHIISLJMAMTOGSNSTTD Animals, Laboratory; Animal Welfare Physical Sciences (Non MeSH); Science; Research Humanities; Ethics; Bioethics Procedures, such as tissue culture, mathematical models, etc., when used or advocated for use in place of the use of animals in research or diagnostic laboratories. Pg!&+^Animal Terms (Non MeSH) A13 Air Sacs; Anal Sacs; Beak; Bursa of Fabricius; Cloaca; Comb and Wattles; Corpora Allata; Crop, Avian; Egg Shell; Electric Organ; Embryo, Non-Mammalian (+ 1); Fat Body; Feathers; Forelimb (+ 2); Gills; Harderian Gland; Hemolymph; Hindlimb (+ 3); Hoof and Claw; Horns (+ 1); Interrenal Gland; Malpighian Tubules; Mammae; Metrial Gland; Milk; Nictitating Membrane; Optic Lobe; Oviducts; Perianal Glands; Salt Gland; Scent Glands; Stomach, Avian (+ 2); Stomach, Ruminant (+ 4); Tail; Ultimobranchial Body; Vibrissae; Wool ABAEAHBSCHCLCYDEECEMENGDHIIMINIRMEMIPAPHPOPPPSRARERISDSESNSTSUTOTRULUSUTVI R<}NAnimal Technicians M01.526.485.067.040; N02.360.067.040 CLEDHILJPXSN Veterinary Medicine; Veterinarians Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel; Allied Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel; Allied Health Personnel Assistants to a veterinarian, biological or biomedical researcher, or other scientist who are engaged in the care and management of animals, and who are trained in basic principles of animal life processes and routine laboratory and animal health care procedures. (Facts on File Dictionary of Health Care Management, 1988). Veterinary Medicine (66-93)  UK*)z!Animal Rights I01.880.604.100.100; K01.316.070.100.100 ECHILJSNSTTD Social Sciences; Sociology; Social Control, Formal; Animal Welfare Humanities; Ethics; Bioethics; Animal Welfare The moral and ethical bases of the protection of animals from cruelty and abuse. The rights are extended to domestic animals, laboratory animals, and wild animals. Animal Welfare (86-92) Xq.Animal Nutrition G06.696.116 Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition Nutrition (66-67) ZLNAnimal Identification Systems E05.035 CLECHIISMTSNSTTDUTVE Miscellaneous Techniques (Non MeSH) Procedures for recognizing individual animals and certain identifiable characteristics pertaining to them; includes computerized methods, ear tags, etc. Z# *Animal Husbandry J01.040.090 CLECEDHIISLJMAMTOGSNSTTD Veterinary Medicine Technology, Industry, Agriculture (Non MeSH); Agriculture The science of breeding, feeding and care of domestic animals; includes housing and nutrition. Agriculture (66-75)  \5DqAnimal Feed J01.341.052 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Food Alfalfa; Silage AEAHANCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSNSTTOULUTVI ]"=:Animal Diseases C22 BLCFCICLCNDHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Veterinary Medicine Abortion, Veterinary (+ 1); Actinobacillosis; Aleutian Mink Disease; Anal Gland Neoplasms; Anaplasmosis; Bird Diseases (+ 10); Borna Disease; Cat Diseases (+ 4); Cattle Diseases (+ 15); Dog Diseases (+ 3); Enterotoxemia; Erysipelothrix Infections (+ 1); Fish Diseases; Foot-and-Mouth Disease; Foot Rot; Goat Diseases; Heartwater Disease; Hepatitis, Animal (+ 3); Horse Diseases (+ 4); Keratoconjunctivitis, Infectious; Lameness, Animal; Mammary Neoplasms; Muscular Dystrophy, Animal (+ 1); Myxomatosis, Infectious; Parasitic Diseases, Animal (Non MeSH) (+ 15); Paratuberculosis; Parturient Paresis; Pleuropneumonia, Contagious; Primate Diseases (+ 4); Pseudorabies; Rinderpest; Rodent Diseases (+ 2); Salmonella Infections, Animal; Sheep Diseases (+ 10); Steatitis; Swine Diseases (+ 9); Venereal Tumors, Veterinary; Zoonoses BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI ^yHZAnimal Communication F01.145.209.103 Pheromones; Vocalization, Animal Behavior and Behavior Mechanisms (Non MeSH); Behavior; Communication Echolocation; Vocalization, Animal Communication between animals involving the giving off by one individual of some chemical or physical signal, that, on being received by another, influences its behavior. Communication (66-67) CLDEPHRE $cL'R) Anilino Naphthalenesulfonates D02.092.146.125; D02.886.645.600.080.050.650.050; D04.615.638.555.282 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Naphthalenesulfonates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Naphthalenesulfonates A class of organic compounds which contain an anilino (phenylamino) group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents. e6"M8gAniline Mustard D02.455.526.728.650.050; D22.204.585.062 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Mustard Compounds; Nitrogen Mustard Compounds Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Nitrogen Mustard Compounds N,N-bis(2-Chloroethyl)aniline. Alkylating anti-neoplastic agent effective in some mouse tumors, but less useful in man. Aniline Compounds (70-75); Nitrogen Mustard Compounds (70-75) hP.:IAniline Hydroxylase D08.586.682.420.170.080.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Hydroxylases; Cytochrome P-450; Aryl Hydrocarbon Hydroxylases A drug-metabolizing, cytochrome P-450 enzyme which catalyzes the hydroxylation of aniline to hydroxyaniline in the presence of reduced flavoprotein and molecular oxygen. Aniline Compounds (73-74); Hydroxylases (73-74) jF9Aniline Compounds D02.092.146 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Aminophenols (+ 1); Anilino Naphthalenesulfonates; Benzophenoneidum; Bromhexine (+ 1); BW 284 C 51; p-Dimethylaminoazobenzene; Diphenylamine; Methylenebis(chloroaniline); Phenylenediamines (+ 1); Toluidines (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR l8.:Anilides D02.065.199 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Acetanilides (+ 7); Benzoylarginine Nitroanilide; Bupivacaine; Carbanilides (+ 2); Carboxin; Encainide; Flutamide; Prilocaine; Propanil; Salicylanilides (+ 3); Tocainide AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR n 8.:Anhydrides D02.113 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Acetic Anhydrides; Citraconic Anhydrides; Maleic Anhydrides; Phthalic Anhydrides; Succinic Anhydrides p 8#vAnguilla B02.493.338.282 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Fishes; Eels Eels (66-71) q &!Angola Z01.058.290.175.095 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara; Africa, Southern r9 `Angiotensins D12.644.456.073; D12.776.641.650.070; D14.600.600.050; D17.350.050.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Angiotensin; Renin-Angiotensin System Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids Angiotensin I; Angiotensin II (+ 3); Angiotensin III; Angiotensinogen Angiotensin I; Angiotensin II; Angiotensin III Angiotensin I; Angiotensin II; Angiotensin III Angiotensin I; Angiotensin II (+ 3); Angiotensin III Oligopeptides ranging in size from angiotensin precursors with 14 amino acids to the active vasoconstrictor angiotensin II with 8 amino acids, or their analogs or derivatives. The amino acid content varies with the species and changes in that content produce antagonistic or inactive compounds. Angiotensin II (66-77); Angiotensin III (77) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (rPD8W7HAngiotensinogen D08.373.745.800.810.150; D12.644.456.073.070; D12.776.811.070 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors An alpha-globulin of which a fragment of 14 amino acids is converted by renin to angiotensin I, the inactive precursor of angiotensin II. It is a member of the serpin superfamily. Alpha Globulins (68-74); Angiotensin II (68-74); Protein Precursors (71-74) xzEHQ[Angiotensin-Converting Enzyme Inhibitors D08.373.745.085; D18.162.050 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Renin-Angiotensin System Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Cardiovascular Agents; Antihypertensive Agents Captopril; Cilazapril; Enalapril (+ 1); Fosinopril; Lisinopril; Ramipril; Saralasin; 1-Sarcosine-8-Isoleucine Angiotensin II; Teprotide Captopril; Cilazapril; Enalapril (+ 1); Fosinopril; Lisinopril; Ramipril; Saralasin; 1-Sarcosine-8-Isoleucine Angiotensin II; Teprotide A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. Enzyme Inhibitors (75-87); Enzymes/antagonists and inhibitors (68-74); Kininase II/antagonists and inhibitors (73-87) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ({."6>FAngiotensin III D12.644.456.073.055; D12.776.641.650.070.080; D14.600.600.050.060; D17.350.050.050.075 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Angiotensins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Angiotensins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Angiotensins A heptapeptide formed by the enzymatic hydrolysis of ANGIOTENSIN II. It has greater activity than angiotensin II for stimulating aldosterone synthesis and in the release of prostaglandins but only 20% of the pressor activity. Angiotensin II (66-76) `FAngiotensin II D12.644.456.073.041; D12.776.641.650.070.078; D14.600.600.050.050; D17.350.050.050.050; D18.793.103 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Renin-Angiotensin System Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Angiotensins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Angiotensins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Angiotensins Cardiovascular Agents; Vasoconstrictor Agents Angiotensin Amide; Saralasin; 1-Sarcosine-8-Isoleucine Angiotensin II Angiotensin Amide; Saralasin; 1-Sarcosine-8-Isoleucine Angiotensin II Angiotensin Amide The active form of angiotensin. An octapeptide found in blood, it is synthesized from ANGIOTENSIN I and quickly destroyed. Angiotensin II causes profound vasoconstriction with resulting increase in blood pressure. The clinically and experimentally used bovine form has valine in position 5 where the human form has isoleucine.  oF$}Angiotensin I D12.644.456.073.021; D12.776.641.650.070.075; D14.600.600.050.040; D17.350.050.050.025 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Angiotensins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Angiotensins Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Angiotensins The decapeptide precursor of ANGIOTENSIN II, generated by the action of renin on angiotensinogen. It has limited pharmacologic activity. Angiotensin II (66-77) L`FAngiotensin Amide D12.644.456.073.041.050; D17.350.050.050.050.050; D18.793.103.282 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides; Angiotensins; Angiotensin II Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Angiotensins; Angiotensin II Cardiovascular Agents; Vasoconstrictor Agents; Angiotensin II 1-L-Asparagine-5-L-valine-angiotensin II. The octapeptide amide of bovine angiotensin II used to increase blood pressure by vasoconstriction. Angiotensin II (66-74) IFiAngiostrongylus cantonensis B01.500.294.700.775.588.080.225 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Metastrongyloidea; Angiostrongylus A species of parasitic nematodes distributed throughout the Pacific islands that infests the lungs of domestic rats. Human infection, caused by consumption of raw slugs and land snails, results in eosinophilic meningitis. Angiostrongylus (81-92); Metastrongyloidea (66-90)  #*p;Angiostrongylus B01.500.294.700.775.588.080 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Metastrongyloidea Angiostrongylus cantonensis A genus of parasitic nematodes of the superfamily METASTRONGYLOIDEA. Two species, ANGIOSTRONGYLUS CANTONENSIS and A. vasorum, infest the lungs of rats and dogs, respectively. A. cantonensis is transmissible to man where it causes frequently fatal infection of the central nervous system. Metastrongyloidea (66-80)  *] NAngioscopy E01.145.090; E01.418.080 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Diagnosis; Endoscopy The visualization with a microscope of the passage of substances (e.g., contrast media, radiopaque agents) through capillaries after intravenous injection. (Stedman, 25th ed). Endoscopy (77-92) |"PAngioplasty, Transluminal, Percutaneous Coronary E02.148.050.060.100; E02.148.102.060.100; E04.752.376.719.100; E04.752.814.050.060.100; E04.920.490.630.100 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Coronary Disease Therapeutics; Catheterization; Angioplasty; Angioplasty, Balloon Therapeutics; Catheterization; Balloon Dilatation; Angioplasty, Balloon Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Heart Surgery; Myocardial Revascularization Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty; Angioplasty, Balloon Surgery, Operative; Thoracic Surgery; Heart Surgery; Myocardial Revascularization Dilatation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply. Angioplasty, Transluminal (82-89); Coronary Disease (80-89); Coronary Vessels (78-89); Dilatation (78-81); Heart Catheterization (76-81)  #7w$Angioplasty, Laser E02.148.050.075; E04.416.075; E04.752.814.050.075 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; Catheterization; Angioplasty Surgery, Operative; Laser Surgery Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty Angioplasty, Balloon, Laser-Assisted Angioplasty, Balloon, Laser-Assisted Angioplasty, Balloon, Laser-Assisted A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an excimer laser which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty (ANGIOPLASTY, BALLOON, LASER-ASSISTED). Angioplasty, Transluminal (82-90); Laser Surgery (87-90); Lasers (82-86)  N9$zWAngioplasty, Balloon, Laser-Assisted E02.148.050.060.080; E02.148.050.075.080; E02.148.102.060.080; E04.416.075.080; E04.752.814.050.060.080; E04.752.814.050.075.080 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; Catheterization; Angioplasty; Angioplasty, Balloon Therapeutics; Catheterization; Angioplasty; Angioplasty, Laser Therapeutics; Catheterization; Balloon Dilatation; Angioplasty, Balloon Surgery, Operative; Laser Surgery; Angioplasty, Laser Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty; Angioplasty, Balloon Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty; Angioplasty, Laser Techniques using laser energy in combination with a balloon catheter to perform angioplasty. These procedures can take several forms including: a) laser fiber delivering the energy while the inflated balloon centers the fiber and occludes the blood flow; b) balloon angioplasty immediately following laser angioplasty; or c) laser energy transmitted through angioplasty balloons that contain an internal fiber. Angioplasty, Balloon (85-92); Angioplasty, Laser (91-92); Laser Surgery (88-92); Lasers (85-92) *$sAngioplasty, Balloon E02.148.050.060; E02.148.102.060; E04.752.814.050.060 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Therapeutics; Catheterization; Angioplasty Therapeutics; Catheterization; Balloon Dilatation Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery; Angioplasty Angioplasty, Balloon, Laser-Assisted; Angioplasty, Transluminal, Percutaneous Coronary Angioplasty, Balloon, Laser-Assisted; Angioplasty, Transluminal, Percutaneous Coronary Angioplasty, Balloon, Laser-Assisted; Angioplasty, Transluminal, Percutaneous Coronary Use of a balloon catheter for dilatation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of balloon dilatation in coronary arteries, ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY is available. Arterial Occlusive Diseases (73-81); specific arterial occlusive disease (66-81); Catheterization (66-81); Dilatation (68-81); Heart Catheterization (76-81)  p=$uAngioplasty E02.148.050; E04.752.814.050 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Endarterectomy Endarterectomy Therapeutics; Catheterization Surgery, Operative; Surgery, Cardiovascular (Non MeSH); Vascular Surgery Angioplasty, Balloon (+ 2); Angioplasty, Laser (+ 1); Atherectomy (+ 1) Angioplasty, Balloon (+ 2); Angioplasty, Laser (+ 1); Atherectomy (+ 1) Endovascular reconstruction of an artery, which may include the removal of atheromatous plaque and/or the endothelial lining as well as simple dilatation. These are procedures performed by catheterization. When reconstruction of an artery is performed surgically, it is called ENDARTERECTOMY. Angioplasty, Balloon (82-92); Catheterization (66-81) (-"$wS?Angioneurotic Edema C14.907.079; C17.800.862.945.066; C20.543.480.904.066 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Edema Cardiovascular Diseases; Vascular Diseases Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular; Urticaria Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Urticaria Recurring attacks of transient edema suddenly appearing in areas of the skin or mucous membranes and occasionally of the viscera, often associated with dermatographism, urticaria, erythema, and purpura. =N Angiomyoma C04.557.450.590.450.125 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Muscle Tissue; Leiomyoma A leiomyoma arising from vascular smooth muscle, usually occurring as a solitary nodular, sometimes painful, tumor on the lower extremity in middle-aged women. It is usually more deeply situated than ordinary leiomyoma and is usually subcutaneous. (Dorland, 27th ed). Hemangioma (75-93); Leiomyoma (75-93) LV9.Angiomyolipoma C04.557.450.550.125 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Adipose Tissue A benign tumor containing vascular, adipose, and muscle elements. It occurs most often in the kidney with smooth muscle elements (angiolipoleiomyoma) in association with tuberous sclerosis. (Dorland, 27th ed). Hemangioma (67-93); Lipoma (66-93) V+Angiomatosis, Bacillary C01.252.400.810.700.810.815.050; C01.252.825.150; C01.539.800.720.150; C14.907.077.060; C17.800.838.765.150; C17.800.862.060 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Rickettsiaceae Infections; Rochalimaea Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Cardiovascular Diseases; Vascular Diseases; Angiomatosis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vascular An infectious bacterial disease characterized by cutaneous vascular lesions. It is caused by ROCHALIMAEA HENSELAE and is seen in AIDS patients and other immunocompromised hosts. Angiomatosis (89-91) [PAngiomatosis C14.907.077 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Telangiectasia, Hereditary Hemorrhagic Arteriovenous Malformations Cardiovascular Diseases; Vascular Diseases Angiomatosis, Bacillary; Hippel-Lindau Disease; Klippel-Trenaunay-Weber Syndrome; Sturge-Weber Syndrome BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $pN, 2uPAngiolymphoid Hyperplasia with Eosinophilia C15.378.553.231.085; C17.800.060; C23.484.085 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eosinophilia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Eosinophilia Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases Symptoms and General Pathology (Non MeSH); Granuloma Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells. Eosinophilia (66-84)  O25NAngiolipoma C04.557.450.550.100 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Adipose Tissue A benign neoplasm composed of a mixture of adipose tissue and blood vessels. (Dorland, 27th ed). Hemangioma (69-93); Lipoma (66-93) WVv+Angiokeratoma C04.557.645.115 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue A discrete, pink to red telangiectasia having a tendency to undergo secondary epithelial changes, including acanthosis and hyperkeratosis. An underlying vascular abnormality is present in many cases. The term angiokeratoma is applied to a number of quite distinct conditions which share a common clinical presentation with asymptomatic hyperkeratotic vascular skin lesions and a histological combination of superficial dermal vascular ectasia. (Dorland, 27th ed; Rook et al., Textbook of Dermatology, 4th ed., p. 211). 3V^XAngioid Streaks C11.768.094 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Retina Eye Diseases; Retinal Diseases Red to black irregular bands observed in the ocular fundus running outward from the region of the optic disk, which are seen in certain conditions, including pseudoxanthoma elasticum, osteitis deformans, and sickle-cell anemia. The lesions are thought to represent ruptures in Bruch's membrane. (Dorland, 27th ed). ĆN &oAngiography, Digital Subtraction E01.145.077.141; E01.357.710.500.802.225; E01.357.818.084.080; E01.357.818.802.225; E01.357.880.250; H01.671.606.799.484.802.225 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnostic Imaging; Photography; Image Enhancement; Radiographic Image Enhancement Diagnosis; Diagnostic Imaging; Radiography; Angiography Diagnosis; Diagnostic Imaging; Radiography; Radiographic Image Enhancement Diagnosis; Diagnostic Imaging; Subtraction Technique Physical Sciences (Non MeSH); Physics; Optics; Photography; Image Enhancement; Radiographic Image Enhancement A method of delineating blood vessels by subtracting a tissue background image from an image of tissue plus intravascular contrast material that attenuates the X-ray photons. The background image is determined from a digitized image taken a few moments before injection of the contrast material. The resulting angiogram is a high-contrast image of the vessel. This subtraction technique allows extraction of a high-intensity signal from the superimposed background information. The image is thus the result of the differential absorption of X-rays by different tissues. Angiography (80-89); Subtraction Technique (80-89) ƽ&&<Angiography E01.145.077; E01.357.818.084 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Arteries; Blood Vessels Diagnosis; Diagnosis, Cardiovascular (Non MeSH) Diagnosis; Diagnostic Imaging; Radiography Angiocardiography; Angiography, Digital Subtraction; Aortography; Cerebral Angiography; Cineangiography; Coronary Angiography; Fluorescein Angiography; Magnetic Resonance Angiography; Phlebography; Portography; Radionuclide Angiography (+ 3) Angiocardiography; Angiography, Digital Subtraction; Aortography; Cerebral Angiography; Cineangiography; Coronary Angiography; Phlebography (+ 1) Radiography of blood vessels after injection of a contrast medium.  ̓"&iPAngiogenesis Factor D11.303.132; D24.185.348.157; D24.185.526.198 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Blood Vessels; Collateral Circulation Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances Immunologic and Biologic Factors (Non MeSH); Biological Factors; Growth Substances Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens Substance causing proliferation of new blood vessels. It is found in tissues with high metabolic requirements, such as the retina, and in certain cancers. The factor is also released by hypoxic macrophages at the edges or outer surfaces of wounds and initiates revascularization in wound healing. Ϥ5@-]Angiofibroma C04.557.645.100 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Vascular Tissue A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. (Stedman, 25th ed). Dermatofibroma (66-93) V^Angiodysplasia C14.907.075 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Degenerative, acquired lesions consisting of distorted, dilated, thin-walled vessels lined by vascular endothelium. This pathological state is seen especially in the gastrointestinal tract and is frequently a cause of upper and lower gastrointestinal hemorrhage in the elderly. Angiomatosis (66-76); Arteriovenous Malformations (76-91); Gastrointestinal Hemorrhage (76-91) ԧL2?mAngiocardiography E01.145.077.102; E01.145.569.073; E01.357.818.084.077 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Heart Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Angiography Diagnosis; Diagnosis, Cardiovascular (Non MeSH); Heart Function Tests Diagnosis; Diagnostic Imaging; Radiography; Angiography Radiography of the heart and great vessels after injection of a contrast medium. =& aAngina, Unstable C14.280.647.250.125.150; C14.907.553.470.250.125.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease; Angina Pectoris Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease; Angina Pectoris Precordial pain at rest, which may precede a myocardial infarction. Angina Pectoris (66-83); Angina Pectoris, Variant (77-83); Coronary Disease (66-83) :NQdAngina Pectoris, Variant C14.280.647.250.125.130; C14.280.647.250.295.130; C14.907.553.470.250.125.130; C14.907.553.470.250.295.130 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease; Angina Pectoris Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease; Coronary Vasospasm Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease; Angina Pectoris Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease; Coronary Vasospasm A clinical syndrome characterized by development of chest pain at rest with concomitant transient ST segment elevation in the electrocardiogram, but exercise capacity is well preserved. Angina Pectoris (66-76) atNAngina Pectoris C14.280.647.250.125; C14.907.553.470.250.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chest Pain Cardiovascular Diseases; Heart Diseases; Myocardial Ischemia; Coronary Disease Cardiovascular Diseases; Vascular Diseases; Ischemia; Myocardial Ischemia; Coronary Disease Angina Pectoris, Variant; Angina, Unstable; Syndrome X Angina Pectoris, Variant; Angina, Unstable; Syndrome X The symptom of paroxysmal pain consequent to myocardial ischemia usually of distinctive character, location and radiation, and provoked by a transient stressful situation during which the oxygen requirements of the myocardium exceed the capacity of the coronary circulation to supply it.  :2NLAnger F01.470.093 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Emotions Rage A strong emotional feeling of displeasure aroused by being interfered with, injured or threatened. Hostility (68)    AtAngelman Syndrome C10.496.075; C10.597.559.038; C16.131.077.095; C16.131.280.075; C23.888.592.574.042; F03.709.346.060 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Mental Retardation Nervous System Diseases; Neurologic Manifestations; Movement Disorders Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Chromosome Abnormalities Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Movement Disorders Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Mental Retardation A syndrome characterized by multiple abnormalities, mental retardation, and movement disorders. Present usually are skull and other abnormalities, frequent infantile spasms, easily provoked and prolonged paroxysms of laughter (hence "happy") and jerky puppetlike movements (hence "puppet"), continuous tongue protrusion, motor retardation, ataxia, muscle hypotonia, and a peculiar facies. It is associated with deletions of chromosome 15q11-13. It differs from PRADER-WILLI SYNDROME in that Angelman is of maternal origin, Prader-Willi is paternal. Ataxia (72-92); Mental Disorders (67-92); Movement Disorders (67-92) rL5sSAneurysm, Ruptured C14.907.055.185 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm Aortic Rupture The tearing or herniation of the weakened wall of the aneurysmal sac. Aneurysm (66-92); Rupture, Spontaneous (68-92)  N>U8Aneurysm, Infected C01.539.069; C14.907.055.131 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Endocarditis, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection Cardiovascular Diseases; Vascular Diseases; Aneurysm Aneurysm due to growth of microorganisms in the arterial wall, or infection arising within preexisting arteriosclerotic aneurysms. 1"P{Aneurysm, False C14.907.055.090 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm An aneurysm in which the entire wall is injured and the blood is contained by the surrounding tissues, resulting in the eventual formation of a sac communicating with the artery or heart. (Dorland, 27th ed). Aneurysm (66-92) N>Aneurysm, Dissecting C14.907.055.050 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases; Aneurysm Splitting or dissection of an arterial wall by blood entering through an intimal tear or by interstitial hemorrhage. It is most common in the aorta. Aneurysm (66-76); Aortic Aneurysm (66-76) N>3Aneurysm C14.907.055 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Vascular Diseases Aneurysm, Dissecting; Aneurysm, False; Aneurysm, Infected; Aneurysm, Ruptured (+ 1); Aortic Aneurysm (+ 3); Cerebral Aneurysm; Coronary Aneurysm; Heart Aneurysm; Iliac Aneurysm A sac formed by the dilatation of the wall of an artery, a vein, or the heart. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI   N2cPAneuploidy G05.148.266.131 Genetics; Cytogenetics; Chromosome Aberrations Monosomy; Trisomy The chromosomal constitution of cells which deviate from the normal by the addition or subtraction of chromosomes or chromosome pairs. In a normally diploid cell the loss of a chromosome pair is termed nullisomy (symbol: 2N-2), the loss of a single chromosome is monosomy (symbol: 2N-1), the addition of a chromosome pair is tetrasomy (symbol: 2N+2), the addition of a single chromosome is trisomy (symbol: 2N+1). Chromosome Abnormalities (66-67) DIGEIMPAPP  7&Anethole Trithione D02.355.601.200.100; D02.355.726.158.100; D02.755.075.100; D19.316.508.062 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers; Methyl Ethers; Anisoles Organic Chemicals (Non MeSH); Ethers; Phenyl Ethers; Anisoles Organic Chemicals (Non MeSH); Phenols; Anisoles Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cholagogues and Choleretics 5-(p-Methoxyphenyl)-3H-1,2-dithiole-3-thione. Choleretic used to allay dry mouth and constipation due to tranquilizers. Anisoles (74-76); Heterocyclic Compounds (74-76); Thiones (74-75) T:AOAnestrus G08.520.780.218.080 BLCFDEGEIMMEPHPXREUR Reproduction, Urogenital Physiology (Non MeSH); Reproduction; Pregnancy, Animal; Estrus Period of sexual inactivity between estrus periods in animals.  gKAnesthetics, Local D15.050.050; D15.210.100.200; D16.850.025 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anesthesia, Local Central Nervous System Agents; Anesthetics Central Nervous System Agents; Central Nervous System Depressants; Anesthetics Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH) Benzocaine; Bupivacaine; Carticaine; Cocaine; Dibucaine; Ethyl Chloride; Etidocaine; Lidocaine; Mepivacaine; Phenazopyridine; Prilocaine; Procaine; Propoxycaine; Tetracaine; Trimecaine Benzocaine; Bupivacaine; Carticaine; Cocaine; Dibucaine; Ethyl Chloride; Etidocaine; Lidocaine; Mepivacaine; Phenazopyridine; Prilocaine; Procaine; Propoxycaine; Tetracaine; Trimecaine Benzocaine; Bupivacaine; Carticaine; Cocaine; Dibucaine; Ethyl Chloride; Etidocaine; Lidocaine; Mepivacaine; Phenazopyridine; Prilocaine; Procaine; Propoxycaine; Tetracaine; Trimecaine Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. They are commonly used not only in the peripheral nervous system, but also for spinal anesthesia. The many drugs that have local anesthetic actions as a side effect but are not used for their local anesthetic action are not included here. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $18@Anesthetics, Intravenous D15.050.035.075; D15.210.100.175.075 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Barbiturates Central Nervous System Agents; Anesthetics; Anesthetics, General Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General Anesthetics, Dissociative (+ 2); Chloral Hydrate (+ 1); Diazepam; Etomidate; Fentanyl (+ 1); Methohexital; Midazolam; Propanidid; Propofol; Sodium Oxybate; Sufentanil; Thiamylal; Thiopental; Urethane Anesthetics, Dissociative (+ 2); Chloral Hydrate (+ 1); Diazepam; Etomidate; Fentanyl (+ 1); Methohexital; Midazolam; Propanidid; Propofol; Sodium Oxybate; Sufentanil; Thiamylal; Thiopental; Urethane Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174). Anesthetics (68-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (*8 :Anesthetics, Inhalation D15.050.035.060; D15.210.100.175.060 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents; Anesthetics; Anesthetics, General Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General Enflurane; Ether, Ethyl; Halothane; Isoflurane; Methoxyflurane; Nitrous Oxide; Trichloroethylene; Xenon Enflurane; Ether, Ethyl; Halothane; Isoflurane; Methoxyflurane; Nitrous Oxide; Trichloroethylene; Xenon Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p.173). Anesthetics (66-94) AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR $v*8P>Anesthetics, General D15.050.035; D15.210.100.175 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR GABA Modulators Central Nervous System Agents; Anesthetics Central Nervous System Agents; Central Nervous System Depressants; Anesthetics Anesthetics, Inhalation (+ 8); Anesthetics, Intravenous (+ 18) Anesthetics, Inhalation (+ 8); Anesthetics, Intravenous (+ 18) Agents that induce various degrees of analgesia; depression of consciousness, circulation, and respiration; relaxation of skeletal muscle; reduction of reflex activity; and amnesia. There are two types of general anesthetics, inhalation and intravenous. With either type, the arterial concentration of drug required to induce anesthesia varies with the condition of the patient, the desired depth of anesthesia, and the concomitant use of other drugs. (From AMA Drug Evaluations Annual, 1994, p.173). Anesthetics (66-94) AAADAEAGAIANBLCFCHCLCSCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR ( |"8G>Anesthetics, Dissociative D15.050.035.075.035; D15.210.100.175.075.035 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous Ketamine; Tiletamine Ketamine; Tiletamine Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed). Anesthetics (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $282:Anesthetics D15.050; D15.210.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anesthesia Adjuvants Central Nervous System Agents Central Nervous System Agents; Central Nervous System Depressants Anesthetics, General (+ 28); Anesthetics, Local (+ 15) Anesthetics, General (+ 28); Anesthetics, Local (+ 15) Agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general anesthesia, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $8oIDAnesthesiology G02.403.790.080 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine; Specialties, Other (Non MeSH) A specialty concerned with the study of anesthetics and anesthesia. GQAnesthesia, Spinal E03.155.086.331 AECLCTECHIISMOMTNUPXSNSTTDUTVE Injections, Spinal Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Conduction "UAnesthesia, Rectal E03.155.197.364 AECLCTECHIISMOMTNUPXSNSTTDUTVE Administration, Rectal Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, General "RAnesthesia, Obstetrical E03.155.364 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia ":Anesthesia, Local E03.155.086.231 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthetics, Local Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Conduction p"UAnesthesia, Intravenous E03.155.308 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia J":Anesthesia, Intratracheal E03.155.253 AECLCTECHIISMOMTNUPXSNSTTDUTVE Trachea Anesthesia and Analgesia (Non MeSH); Anesthesia " :Anesthesia, Inhalation E03.155.197.197 AECLCTECHIISMOMTNUPXSNSTTDUTVE Administration, Inhalation Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, General Anesthesia, Closed-Circuit Anesthesia caused by the breathing of anesthetic gases or vapors or by insufflating anesthetic gases or vapors into the respiratory tract.  "RAnesthesia, General E03.155.197 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia Anesthesia, Inhalation (+ 1); Anesthesia, Rectal U":;Anesthesia, Epidural E03.155.086.131 AECLCTECHIISMOMTNUPXSNSTTDUTVE Injections, Epidural; Injections, Spinal Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Conduction Anesthesia, Caudal Anesthesia, Conduction (66-70); Anesthesia, Obstetrical (66-70)  6"0UJAnesthesia, Dental E03.155.141; E06.045 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia Dentistry Hypnosis, Dental Hypnosis, Dental !"E(Anesthesia, Conduction E03.155.086 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia Anesthesia, Epidural (+ 1); Anesthesia, Local; Anesthesia, Spinal; Nerve Block (+ 1) "x":gAnesthesia, Closed-Circuit E03.155.197.197.280 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, General; Anesthesia, Inhalation Inhalation anesthesia where the gases exhaled by the patient are rebreathed as some carbon dioxide is simultaneously removed and anesthetic gas and oxygen are added so that no anesthetic escapes into the room. Closed-circuit anesthesia is used especially with explosive anesthetics to prevent fires where electrical sparking from instruments is possible. Anesthesia, Inhalation (66-86) #"m$Anesthesia, Caudal E03.155.086.131.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Anesthesia; Anesthesia, Conduction; Anesthesia, Epidural Epidural anesthesia administered via the sacral canal. &2"nAAnesthesia Recovery Period E03.160; E04.630.055 Postanesthesia Nursing Anesthesia and Analgesia (Non MeSH) Surgery, Operative; Postoperative Period The period of emergence from general anesthesia, where different elements of consciousness return at different rates. Anesthesia or specific (66-85); Postoperative Care (66-85) 'T YFAnesthesia Department, Hospital N02.278.354.422.070; N04.452.442.422.070 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the administration of functions and activities pertaining to the delivery of anesthetics. Anesthesiology (66-Jul 77); Hospital Departments (68-Jul 77) (%. HAnesthesia and Analgesia (Non MeSH) E03 Analgesia (+ 8); Anesthesia (+ 20); Anesthesia Recovery Period; Conscious Sedation; Electronarcosis; Hypotension, Controlled; Hypothermia, Induced; Preanesthetic Medication AECLCTECHIISMOMTNUPXSNSTTDUTVE +r+"Anesthesia Adjuvants D15.045 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anesthetics Central Nervous System Agents Atropine; Chlordiazepoxide; Droperidol; Fentanyl (+ 1); Glycopyrrolate; Meperidine; Midazolam; Oxymorphone; Pentazocine; Pentobarbital; Scopolamine; Secobarbital; Sufentanil; Temazepam; Triazolam Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $, 8$@Anesthesia E03.155 AECLCTECHIMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH) Acupuncture Anesthesia; Anesthesia, Conduction (+ 6); Anesthesia, Dental (+ 1); Anesthesia, General (+ 3); Anesthesia, Intratracheal; Anesthesia, Intravenous; Anesthesia, Obstetrical; Electroacupuncture; Hypnosis, Anesthetic (+ 1) A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. AECLCTECHIISMOMTNUPXSNSTTDUTVE  /.  + "Anencephaly C10.500.680.196; C16.131.581.197; C16.131.666.680.196 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Monsters Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neural Tube Defects Hydranencephaly Hydranencephaly Hydranencephaly Congenital absence of the cranial vault, with cerebral hemispheres completely missing or reduced to small masses attached to the base of the skull. 1=LI5Anemia, Sideroblastic C15.378.071.419; C15.378.190.625.070 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Elliptocytosis, Hereditary; Spherocytosis, Hereditary; Folic Acid Deficiency; Pyridoxine Deficiency Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myelodysplastic Syndromes Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow. 4*Nr}Anemia, Sickle Cell C15.378.071.141.150.150; C15.378.420.155 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Antisickling Agents Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies Hemoglobin SC Disease; Sickle Cell Trait Hemoglobin SC Disease; Sickle Cell Trait A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.  7K.LbAnemia, Refractory, with Excess of Blasts C15.378.071.400.080; C15.378.190.625.062.080 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Refractory Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myelodysplastic Syndromes; Anemia, Refractory Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. Anemia, Aplastic (66-85) :D22NAnemia, Refractory C15.378.071.400; C15.378.190.625.062 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myelodysplastic Syndromes Anemia, Refractory, with Excess of Blasts Anemia, Refractory, with Excess of Blasts A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy. Anemia, Aplastic (66-85)  <*NbAnemia, Pernicious C15.378.071.252.196.500; C18.654.223.133.699.923.280 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Schilling Test Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Macrocytic; Anemia, Megaloblastic Nutritional and Metabolic Diseases (Non MeSH); Nutrition Disorders; Deficiency Diseases; Avitaminosis; Vitamin B Deficiency; Vitamin B 12 Deficiency A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed). ?:N2}Anemia, Neonatal C15.378.071.363; C16.614.053 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases Fetofetal Transfusion; Fetomaternal Transfusion Fetofetal Transfusion; Fetomaternal Transfusion The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation. Anemia (66-67); Infant, Newborn, Diseases (66-67)  C"Lli<Anemia, Myelophthisic C15.378.071.307; C15.378.190.636.085 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases; Myeloproliferative Disorders Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue. E*NAnemia, Megaloblastic C15.378.071.252.196 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Macrocytic Anemia, Pernicious Anemia characterized by the presence of megaloblasts in the bone marrow. (Dorland, 27th ed). GNkpAnemia, Macrocytic C15.378.071.252 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI FIGLU Test Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Anemia, Megaloblastic (+ 1) Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).  I{NT"Anemia, Iron-Deficiency C15.378.071.196.300 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hypochromic Anemia characterized by low or absent iron stores, low serum iron concentration, elevated free erythrocyte porphorin, low transferrin saturation, elevated transferrin, low serum ferritin, low hemoglobin concentration or hematocrit, and hypochromic microcytic red blood cells. Symptoms may include pallor, angular stomatitis and other oral lesions, gastrointestinal complaints, retinal hemorrhages and exudates, and thinning and brittleness of the nails. Among the causes of iron-deficiency anemia are inadequate iron intake, impaired iron absorption, increased blood loss and increased requirements such as infancy, pregnancy, and lactation. (Dorland, 27th ed; Lee, et al., Wintrobe's Clinical Hematology, 9th ed, p813). Anemia, Hypochromic (66-94) KKNl8!Anemia, Hypochromic C15.378.071.196 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Anemia, Iron-Deficiency Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393). ONTAnemia, Hemolytic, Congenital Nonspherocytic C15.378.071.141.150.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Triosephosphate Isomerase Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated. S}3LxAnemia, Hemolytic, Congenital C15.378.071.141.150 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Metabolism, Inborn Errors Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic Anemia, Dyserythropoietic, Congenital; Anemia, Hemolytic, Congenital Nonspherocytic; Anemia, Sickle Cell (+ 2); Elliptocytosis, Hereditary; Glucosephosphate Dehydrogenase Deficiency (+ 1); Hemoglobin C Disease; Spherocytosis, Hereditary; Thalassemia (+ 3) Hemolytic anemia due to various intrinsic defects of the erythrocyte. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $Va#Lj&SNAnemia, Hemolytic, Autoimmune C15.378.071.141.125; C20.111.196 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic Immunologic Diseases; Autoimmune Diseases Acquired hemolytic anemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red cells. Yf#&NAnemia, Hemolytic C15.378.071.141 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemolysis; Pyruvate Kinase Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Anemia, Hemolytic, Autoimmune; Anemia, Hemolytic, Congenital (+ 14); Favism; Hemoglobinuria (+ 1); Hemolytic-Uremic Syndrome Anemia due to decreased life span of erythrocytes. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $[EL!T>NAnemia, Dyserythropoietic, Congenital C15.378.071.141.150.095 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital A familial disorder characterized by anemia with multinuclear erythroblasts, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors. Type II is the most common of the 3 types of congenital dyserythropoietic anemia; it is often referred to as HEMPAS, based on the Hereditary Erythroblast Multinuclearity with Positive Acidified Serum test. Anemia (66-79); Erythropoiesis (66-79) ]}+L/Anemia, Aplastic C15.378.071.085; C15.378.190.196 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Bone Marrow Diseases Fanconi's Anemia A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. `&NAnemia C15.378.071 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases Anemia, Aplastic (+ 1); Anemia, Hemolytic (+ 20); Anemia, Hypochromic (+ 1); Anemia, Macrocytic (+ 2); Anemia, Myelophthisic; Anemia, Neonatal (+ 2); Anemia, Refractory (+ 1); Anemia, Sideroblastic; Red-Cell Aplasia, Pure A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin. b NJ iAnecdotes K01.517.067 Humanities; Literature e Androsterone D04.808.054.040.129; D04.808.578.502.195; D06.472.040.502.195; D06.472.079.195; D06.472.866.154.195 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstanols Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Androgens epoDAndrostenols D04.808.054.079.429 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes Androstenediols (+ 3); Cyanoketone; Prasterone; Testosterone (+ 4) Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  g8FQDAndrostenes D04.808.054.079 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes Androstadienes (+ 2); Androstatrienes; Androstenedione; Androstenols (+ 11); Finasteride Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings. Androstanes (68-72) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $i87jDAndrostenedione D04.808.054.079.329; D04.808.578.502.112; D06.472.040.502.112; D06.472.079.112; D06.472.866.154.112 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes Polycyclic Hydrocarbons; Steroids; Ketosteroids; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; 17-Ketosteroids Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Androgens Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Androgens koDAndrostenediols D04.808.054.079.429.154 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes; Androstenols 5-Androstene-3,17-diol; Fluoxymesterone; Methandriol Unsaturated androstane derivatives which are substituted with two hydroxy groups in any position in the ring system. Androstenes (73); Androstenols (74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $n8V<,:Androstatrienes D04.808.054.079.229 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes Derivatives of the steroid androstane having three double bonds at any site in any of the rings. p8FuAndrostanols D04.808.054.040 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes 5-Androstane-3,17-diol (+ 1); Androsterone; Etiocholanolone; Oxandrolone; Oxymetholone; Pancuronium; Stanolone (+ 1); Stanozolol; Vecuronium Bromide Androstanes and androstane derivatives which are substituted in any position with one or more hydroxyl groups. Androstanes (68-79); Hydroxysteroids (72-79); Steroids (66-67) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $q87KDAndrostanes D04.808.054 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids Androstanols (+ 11); Androstenes (+ 18) The family of steroids from which the androgens are derived. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  td8(2JDAndrostadienes D04.808.054.079.129 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Androstanes; Androstenes Methandrostenolone; Testolactone Derivatives of the steroid androstane having two double bonds at any site in any of the rings. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  u8F&s:Androgens, Synthetic D06.597.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic Anabolic Steroids (+ 13); Androgen-Binding Proteins; Methyltestosterone; Metribolone Compounds obtained by chemical synthesis which possess masculinizing activities, but differ in structure from naturally occurring androgens. Androgens (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $wr8NcHAndrogens D06.472.079; D06.472.866.154 ADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Androgen Antagonists; Receptors, Androgen Hormones, Substitutes, Antagonists (Non MeSH); Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones 5-Androstane-3,17-diol (+ 1); Androstenedione; Androsterone; Etiocholanolone; Prasterone; Stanolone; Testosterone (+ 1) Androstenedione; Androsterone; Etiocholanolone; Prasterone; Testosterone (+ 1) A class of sex hormones associated with the development and maintenance of the secondary male sex characteristics, sperm induction, and sexual differentiation. In addition to increasing virility and libido, they also increase nitrogen and water retention and stimulate skeletal growth. AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $y "@1JDAndrogen-Binding Proteins D06.472.866.900.075; D06.597.100.225; D12.776.157.065 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Sex Hormones; Testicular Hormones Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Carrier proteins produced in the Sertoli cells of the testis, secreted into the seminiferous tubules, and transported via the efferent ducts to the epididymis. Participate in the transport of androgens; include also synthetic androgens binding proteins. Carrier Proteins (71-79); Proteins (66-70); Receptors, Androgen (77-79); Receptors, Endogenous Substances (73-76) }=F''Androgen Antagonists D06.347.065 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Androgens Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Cyproterone (+ 1); Flutamide Compounds which inhibit or antagonize the biosynthesis or actions of androgens. specific androgen (66-77); Androgens (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR (#6 N%^6:Androblastoma C04.557.475.075 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue Sertoli-Leydig Cell Tumor A neoplasm of the ovary, arising from the ovarian stroma, mimicking to a greater or lesser extent derivatives of the sex cord mesenchyme of the testis, and sometimes causing defeminization and virilization. (From Dorland, 27th ed). X]Andorra Z01.542.049 EHEP Geographicals (Non MeSH); Europe 2 )Ancylostomiasis C03.335.508.700.775.455.154 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections; Secernentea Infections; Strongylida Infections; Hookworm Infections Infection of humans or animals with hookworms of the genus ANCYLOSTOMA. Characteristics include anemia, dyspepsia, eosinophilia, and abdominal swelling. Hookworm Infections (66-67) P!Ancylostomatoidea B01.500.294.700.775.100 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida Ancylostoma; Necator (+ 1) A superfamily of nematode parasitic hookworms consisting of four genera: ANCYLOSTOMA, NECATOR, Bunostomum, and Uncinaria. ANCYLOSTOMA and NECATOR occur in humans and other mammals. Bunostomum is common in ruminants and Uncinaria in wolves, foxes, and dogs. *H"*Ancylostoma B01.500.294.700.775.100.100 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda; Secernentea; Strongylida; Ancylostomatoidea A genus of nematode intestinal parasites that consists of several species. A. duodenale is the common hookworm in humans. A. braziliense, A. ceylonicum, and A. caninum occur primarily in cats and dogs, but all have been known to occur in humans. *]$Ancrod D08.586.277.656.732.760.050; D19.461.119.050; D24.185.965.850.960.200.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms; Snake Venoms; Viper Venoms; Crotalid Venoms An enzyme fraction from the venom of the Malayan pit viper, Agkistrodon rhodostoma. It catalyzes the hydrolysis of a number of amino acid esters and a limited proteolysis of fibrinogen. It is used clinically to produce controlled defibrination in patients requiring anticoagulant therapy. Peptide Hydrolases (72-74); Peptide Peptidohydrolases (66-74); Venoms (72-74)  QFQ\Ancillary Services, Hospital N02.278.354.060; N04.452.442.060 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration Those support services other than room, board, and medical and nursing services that are provided to hospital patients in the course of care. They include such services as laboratory, radiology, pharmacy, and physical therapy services. "&Ancient Lands (Non MeSH) Z01.586.035 Geographicals (Non MeSH); Historical Geographicals (Non MeSH) Arabia; Armenia; Byzantium; Egypt; Greece EHEP 0I5Anatomy, Veterinary G01.100.279 EDHI Biological Sciences; Anatomy #Anatomy, Regional G01.100.216 Biological Sciences; Anatomy x#Anatomy, Comparative G01.100.154 CLECEDHIISLJMAMTOGSNSTTD Biological Sciences; Anatomy The comparative study of animal structure with regard to homologous organs or parts. (Stedman, 25th ed). #~Anatomy, Artistic G01.100.091; K01.093.410.100 CLECEDHIISLJMAMTOGSNSTTD Art Biological Sciences; Anatomy Humanities; Art; Medical Illustration "OAnatomy G01.100 CLECEDHIISLJMAMTOGSNSTTD Dissection Biological Sciences Anatomy, Artistic; Anatomy, Comparative; Anatomy, Regional; Anatomy, Veterinary; Cytology; Embryology (+ 1); Histology (+ 1); Neuroanatomy   Anastomosis, Surgical E04.035 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative Anastomosis, Roux-en-Y; Arteriovenous Shunt, Surgical; Cerebrospinal Fluid Shunts (+ 2); Cholecystostomy; Choledochostomy; Endolymphatic Shunt; Gastroenterostomy (+ 1); Heart Bypass, Right (+ 1); Jejunoileal Bypass; Pancreaticojejunostomy; Pericardial Window Techniques; Peritoneovenous Shunt; Portasystemic Shunt, Surgical (+ 2); Portoenterostomy, Hepatic; Salpingostomy; Vasovasostomy Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side. organ/disease/surgery (66-87); specific surgical technique (66-87)   $OAnastomosis, Roux-en-Y E04.035.070; E04.765.070 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Anastomosis, Surgical Surgery, Operative; Surgery, Digestive System (Non MeSH) A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site. specific digestive system organ or disease/surgery (66-87) $rEAnaplasmosis C01.252.400.810.700.065.085; C01.252.400.825.100; C22.085 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections; Anaplasmataceae Infections Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Tick-Borne Diseases Animal Diseases A disease of cattle caused by parasitization of the red blood cells by bacteria of the genus ANAPLASMA. AJ}Anaplasmataceae Infections C01.252.400.810.700.065 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Rickettsial and Chlamydial Infections (Non MeSH); Rickettsiales Infections Anaplasmosis; Eperythrozoonosis Infections with bacteria of the family ANAPLASMATACEAE. Anaplasmosis (66-76); Rickettsial Infections (75-76)  P%B>Anaplasmataceae B03.700.651.129 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales Anaplasma; Eperythrozoon; Haemobartonella A family of bacteria which parasitize red blood cells and cause several animal diseases. Bacteria (66-74)  "K1jAnaplasma B03.700.651.129.278 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Rickettsias and Chlamydias (Non MeSH); Rickettsiales; Anaplasmataceae A genus of gram-negative bacteria whose organisms are obligate parasites of vertebrates. Species are transmitted by arthropod vectors with the host range limited to ruminants. Anaplasma marginale is the most pathogenic species and is the causative agent of severe bovine anaplasmosis. ' "^KAnaplasia C04.697.045; C23.739.065 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplastic Processes (Non MeSH) Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Loss of structural differentiation and useful function of neoplastic cells. 9 XYAnaphylaxis C20.543.480.099 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI SRS-A Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate Systemic or generalized anaphylaxis, anaphylactic shock, a manifestation of immediate hypersensitivity in which exposure of a sensitized individual to a specific antigen or hapten results in life-threatening respiratory distress usually followed by vascular collapse and shock and accompanied by urticaria, pruritus, and angioedema. Common agents causing anaphylaxis include Hymenoptera venom, pollen extracts, certain foods, horse and rabbit sera, heterologous enzymes and hormones, and certain drugs, such as penicillin and lidocaine. (Dorland, 27th ed). N M|Anaphylatoxins D24.185.030 ADAGAIANBICFCHCLCSCTDFECGEHIIMIPMEPDPHPKRESETUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors Complement 3a; Complement 4a; Complement 5a (+ 1) The family of peptides C3a, C4a, C5a, and C5a des-arginine produced in the serum during complement activation. They produce smooth muscle contraction, mast cell histamine release, affect platelet aggregation, and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from strongest to weakest is C5a, C3a, C4a, and C5a des-arginine. The latter is the so-called "classical" anaphylatoxin but shows no spasmogenic activity though it contains some chemotactic ability. Complement (68-76); Peptide Fragments (74-76); Peptides (66-76); specific complement (75-76) AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $+4L>BoFAnaphase G04.335.135.220.225.060; G05.148.165.220.225.060; G07.553.135.220.225.060 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Cell Physiology (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Genetics; Cytogenetics; Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Cell Cycle; Cell Division; Cell Division Phases (Non MeSH) The third phase of cell division, in which the chromatids separate and migrate to opposite poles of the spindle. Cell Division (66-77); Meiosis (68-77); Mitosis (68-77) 0 QEAnalytic Studies (Epidemiology) (Non MeSH) E05.318.760.500; G03.850.520.835.500; N05.715.360.775.175 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Study Characteristics (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Study Characteristics (Non MeSH) Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Study Characteristics (Non MeSH) Case-Control Studies (+ 1); Cohort Studies (+ 3); Cross-Sectional Studies (+ 1) Case-Control Studies (+ 1); Cohort Studies (+ 3); Cross-Sectional Studies (+ 1) Case-Control Studies (+ 1); Cohort Studies (+ 3); Cross-Sectional Studies (+ 1) Studies designed to examine associations, commonly, hypothesized causal relations. They are usually concerned with identifying or measuring the effects of risk factors or exposures. The common types of analytic study are CASE-CONTROL STUDIES, COHORT STUDIES, and CROSS-SECTIONAL STUDIES. TD @2A"KAnalysis of Variance E05.318.740.150; G03.850.520.830.150; H01.548.832.128; N05.715.360.750.125 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics Multivariate Analysis Multivariate Analysis Multivariate Analysis Multivariate Analysis A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. Statistics (66-67) TbAnalog-Digital Conversion L01.700.568.080.260.280.080 Information Science; Medical Informatics; Medical Informatics Computing; Computer Systems; Computers; Computers, Hybrid The process of converting analog data such as continually measured voltage to discrete, digital form. >xAnalgesics, Opioid D15.040.150 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Narcotics Narcotics Central Nervous System Agents; Analgesics Alphaprodine; Buprenorphine; Butorphanol; Codeine; Dextromoramide; Diacetylmorphine; Dihydromorphine; Dihydromorphinone; Ethylmorphine; Etorphine; Fentanyl (+ 1); Hydrocodone; Levorphanol; Meperidine (+ 1); Meptazinol; Methadone (+ 1); Morphine; Nalbuphine; Opium; Oxycodone; Oxymorphone; Pentazocine; Phenazocine; Phenoperidine; Pirinitramide; Propoxyphene; Sufentanil; Tilidine; Tramadol Narcotic or opioid substances, synthetic or semisynthetic agents producing profound analgesia, drowsiness, and changes in mood. Mood changes may be pleasurable, therefore creating a potential for the abuse of these agents; the prototype of these is morphine to which all other analgesics are compared. Analgesics (66-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,8  2_:Analgesics, Non-Narcotic D15.040.100; D16.850.015 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Central Nervous System Agents; Analgesics Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH) Carbamazepine; Cyclazocine (+ 1); Glafenine; Nefopam; Nitrous Oxide; Pizotyline; Quinine Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal (+ 34); Glafenine; Quinine Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the Controlled Substances Act. (From Drug Evaluations Annual, 1992, p.109). Analgesics (66-94) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $8HAnalgesics D15.040 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Pain Central Nervous System Agents Analgesics, Non-Narcotic (+ 8); Analgesics, Opioid (+ 32) Agents that relieve pain without causing loss of consciousness. (Dorland, 27th ed). AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR $V 8$Fe@Analgesia, Patient-Controlled E03.091.120 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Analgesia Relief of pain, without loss of consciousness, through an analgesic agent administered by the patient. It has been used successfully to control postoperative pain, during labor, after burns, and in terminal care. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval). Analgesia (75-90); Self Administration (79-90) ""98Analgesia, Obstetrical E03.091.110 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Analgesia The elimination of sensibility to pain, without the loss of consciousness, during labor, delivery, and possibly the postpartum period, usually through the administration of narcotic analgesics. Analgesia (66-90); Anesthesia, Epidural (76-90); Anesthesia, Obstetrical (76-90) "9_Analgesia, Epidural E03.091.080 AECLCTECHIISMOMTNUPXSNSTTDUTVE Anesthesia and Analgesia (Non MeSH); Analgesia The relief of pain without loss of consciousness through the introduction of an analgesic agent into the epidural space of the vertebral canal. It is differentiated from ANESTHESIA, EPIDURAL which refers to the state of insensitivity to sensation. Analgesia (66-88); Anesthesia, Epidural (66-88); Epidural Space (79-88); Pain/drug therapy (66-88); Pain, Postoperative/prevention and control (66-88) "9"Analgesia, Congenital C10.500.690.066; C10.772.600.066; C16.131.666.690.066 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pain Nervous System Diseases; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Sensory and Autonomic Nervous System Diseases; Peripheral Nervous System Diseases; Neuropathies, Hereditary Sensory and Autonomic Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Nervous System Abnormalities (Non MeSH); Neuropathies, Hereditary Sensory and Autonomic Absence of sensibility to pain or inability to feel pain, present at birth. ?=L\Analgesia E03.091 AECLCTECHIISMOMTNUPXSNSTTDUTVE Pain Anesthesia and Analgesia (Non MeSH) Acupuncture Analgesia; Analgesia, Epidural; Analgesia, Obstetrical; Analgesia, Patient-Controlled; Audioanalgesia; Electroacupuncture; Neuroleptanalgesia; Transcutaneous Electric Nerve Stimulation   "+Anal Stage F01.752.747.722.128; F02.739.794.793.128 Behavior and Behavior Mechanisms (Non MeSH); Personality; Personality Development; Psychosexual Development Psychologic Processes and Principles (Non MeSH); Psychological Theory; Psychoanalytic Theory; Psychosexual Development The period of pregenital psychosexual development, usually from 1 to 3 years, in which the child has particular interest in the process of defecation and sensations connected with the anus. Έ.Anal Sacs A13.073 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH) Anus (66-67); Carnivora (66-67)  :(Anal Gland Neoplasms C04.588.083; C04.588.274.476.411.792.288.083; C06.240.476.411.792.163.083; C06.405.282.411.792.163.083; C06.405.469.505.792.163.083; C06.405.469.860.101.163.083; C06.405.469.860.767.163.083; C22.073 BLBSCFCHCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSCSESUTHULURUSVI Neoplasms; Neoplasms by Site (Non MeSH) Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Rectal Neoplasms; Anus Neoplasms Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Rectal Neoplasms; Anus Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Rectal Neoplasms; Anus Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Neoplasms; Anus Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Anus Diseases; Anus Neoplasms Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Rectal Diseases; Rectal Neoplasms; Anus Neoplasms Animal Diseases Anus Neoplasms (66-67) уRAnaerobiosis G06.535.630.170 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Oxygen (66-70) tAnaerobic Threshold G06.535.723.110; G11.427.394.110 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Oxygen Consumption Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Exertion The oxygen consumption level above which aerobic energy production is supplemented by anaerobic mechanisms during exercise, resulting in a sustained increase in lactate concentration and metabolic acidosis. The anaerobic threshold is affected by factors that modify oxygen delivery to the tissues; it is low in patients with heart disease. Methods of measurement include direct measure of lactate concentration, direct measurement of bicarbonate concentration, and gas exchange measurements. Exertion (66-88); Oxygen Consumption (66-88) ׻&56Anabolic Steroids D06.597.100.194 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Androgens, Synthetic 5-Androstene-3,17-diol; Ethylestrenol; Fluoxymesterone; Mesterolone; Methandriol; Methandrostenolone; Methenolone; Nandrolone; Norethandrolone; Oxandrolone; Oxymetholone; Stanozolol; Trenbolone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR z8g:Anabasine D03.383.621.050; D05.723.491.324.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Botanical 2-(3-Pyridyl)piperidine. Botanical insecticide. Alkaloids (74); Piperidines (69-74); Pyridines (73-74) ݀ *:9CAnabaena B03.440.200.100; B05.104.400.100 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Bacteria; Gram-Negative Bacteria; Cyanobacteria Algae and Fungi (Non MeSH); Algae; Cyanobacteria A genus of CYANOBACTERIA consisting of trichomes that are untapered with conspicuous constrictions at cross-walls. A firm individual sheath is absent, but a soft covering is often present. Many species are known worldwide as major components of freshwater plankton and also of many saline lakes. The species Anabaena flos-aquae is responsible for acute poisonings of various animals. Algae (66-69); Cyanobacteria (70-91) [ &&s-Amyotrophic Lateral Sclerosis C05.651.661.139; C10.228.854.139; C10.668.139 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Nervous System Diseases; Neuromuscular Diseases A disease marked by progressive degeneration of the neurons giving rise to the corticospinal tract and of the motor cells of the brain stem and spinal cord, and resulting in a deficit of upper and lower motor neurons. It is usually fatal within two or three years. 9#5N<Amyotonia Congenita C05.651.661.083; C10.228.854.083; C10.668.083 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Muscular Diseases; Neuromuscular Diseases Nervous System Diseases; Central Nervous System Diseases; Spinal Cord Diseases Nervous System Diseases; Neuromuscular Diseases A vague term denoting any of several rare congenital diseases of children marked by general hypotonia of the muscles. (Dorland, 27th ed). 5LAmylose D09.203.698.365.855.361 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Starch ] FsAmylopectin D09.203.698.365.855.194 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Glucans; Starch [FsAmyloidosis C15.378.147.780.100; C15.604.515.056; C18.452.648.111; C20.683.780.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias Amyloid Neuropathies; Cerebral Amyloid Angiopathy Amyloid Neuropathies; Cerebral Amyloid Angiopathy Amyloid Neuropathies; Cerebral Amyloid Angiopathy Amyloid Neuropathies; Cerebral Amyloid Angiopathy A group of conditions of diverse etiologies characterized by the accumulation of insoluble fibrillar proteins (amyloid) in various organs and tissues of the body such that vital function is compromised. The associated disease states may be inflammatory, hereditary, or neoplastic, and the deposition can be localized or generalized or systemic. (Dorland, 27th ed). BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  ]PLNAmyloid Protein SAA D12.776.124.075; D12.776.395.090.075 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Amyloid A serum protein believed to be a circulating precursor to amyloid protein AA. It is present in low concentrations in normal sera, but found in much higher concentrations in sera of older persons and in patients with amyloidosis or with diseases known to predispose to amyloidosis. Very high levels of this protein have been reported during acute inflammatory episodes. Antisera to amyloid protein AA cross-react with protein SAA. Amyloid (66-78); Blood Proteins (66-78) *F1Amyloid Protein AA D12.776.124.050.095; D12.776.395.090.065 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Amyloid A nonimmunoglobulin amyloid isolated from amyloid fibrils deposited in amyloidosis secondary to chronic inflammatory diseases such as rheumatoid arthritis. Antisera to amyloid protein AA have been used to detect a related serum protein SAA. Amyloid (66-78) 4.FAmyloid P Component D12.776.124.050.090; D12.776.395.090.050 AAADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Amyloid Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It acts as an acute phase protein in the mouse, modulates immunologic responses in man, inhibits elastase, and has been suggested as an indicator of liver disease. Amyloid (66-86) .FsAmyloid Neuropathies C10.772.100; C15.378.147.780.100.050; C15.604.515.056.050; C18.452.648.111.050; C20.683.780.100.050 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Amyloid Nervous System Diseases; Peripheral Nervous System Diseases Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders; Paraproteinemias; Amyloidosis Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders; Amyloidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amyloidosis Immunologic Diseases; Immunoproliferative Disorders; Paraproteinemias; Amyloidosis Disorders of the peripheral nervous system associated with deposition of amyloid. Amyloid neuropathies may result from non-hereditary or hereditary amyloidosis. Several different forms of familial amyloid neuropathies have been described, most of which have specific mutations in the prealbumin gene. Amyloidosis (67-93); Peripheral Nervous System Diseases (67-93)  oN ZKAmyloid beta-Protein Precursor D12.776.395.090.025.150; D12.776.811.050 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Alzheimer's Disease; Down Syndrome Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Amyloid; Amyloid beta-Protein Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Protein Precursors A precursor to the AMYLOID-BETA PROTEIN (beta/A4). Alterations in the expression of the amyloid beta-protein precursor (ABPP) gene, located on chromosome 21, plays a role in the development of the neuropathology common to both ALZHEIMER'S DISEASE and DOWN SYNDROME. ABPP is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/A4 (695 amino acids) or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in ALZHEIMER'S DISEASE, DOWN SYNDROME and, to a limited extent, in normal aging. Amyloid (88-91); Protein Precursors (88-91)  $.H*5Amyloid beta-Protein D12.776.395.090.025 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Cerebral Amyloid Angiopathy Alzheimer's Disease; Down Syndrome; Neurofibrils Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Amyloid Amyloid beta-Protein Precursor A 42-kDa protein expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN'S SYNDROME). The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Amyloid (66-90) (H!:`$Amyloid D12.776.395.090 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amyloid Neuropathies Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins Amyloid beta-Protein (+ 1); Amyloid P Component; Amyloid Protein AA; Amyloid Protein SAA A general term for a variety of different proteins that accumulate as extracellular fibrils of 7-10 nm and have common structural features, including a beta-pleated sheet conformation and the ability to bind such dyes as Congo red and thioflavine (Kandel, Schwartz, and Jessel, Principles of Neural Science, 3rd ed).   HUlrAmylases D08.586.277.450.066 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases alpha-Amylase; beta-Amylase  Fl!Amyl Nitrite D02.633.025; D18.918.079 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitrites Cardiovascular Agents; Vasodilator Agents A vasodilator that is administered by inhalation. It is also used recreationally due to its supposed ability to induce euphoria and act as an aphrodisiac. :_Amygdaloid Body A08.186.211.577.090; A08.186.211.730.885.105.152 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Central Nervous System; Brain; Limbic System Nervous System; Central Nervous System; Brain; Prosencephalon; Telencephalon; Basal Ganglia Almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system.  68Amygdalin D02.626.175; D09.203.408.348.050; D22.204.179.050 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Nitriles Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Glucosides Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic ((6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy)- benzeneacetonitrile. A cyanogenic glycoside found in the seeds of Rosaceae. It has been used with questionable results in the prevention of tumors and in cancer chemotherapy. Cyanides (66-67); Glycosides (66-75); Mandelic Acid (66-75); Nitriles (68-75)   9@ _Amsacrine D03.494.046.250.225; D22.204.065 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents N-(4-(9-Acridinylamino)-3-methoxyphenyl)methanesulfonamide. Aminoacridine derivative which is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. Acridines (66-79); Aminoacridines (80-86)  &:2Amrinone D02.092.080.085; D03.383.725.050.085; D18.192.045; D18.222.045; D18.918.173.045 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aminopyridines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Aminopyridines Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Cardiotonic Agents Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 5-Amino(3,4'-bipyridine)-6(1H)-one. A positive inotropic cardiotonic agent with vasodilator properties, phosphodiesterase inhibitory activity and stimulation of calcium ion influx into the cardiac cell. Its therapeutic use in congestive heart or left ventricular failure is associated with significant increases in cardiac index, reductions in pulmonary capillary wedge pressure and systemic vascular resistance and little or no change in mean arterial pressure. One of its more serious side effects is thrombocytopenia in some patients. Aminopyridines (79-86); Pyridines (66-78) a [:Wk2Ampyrone D03.383.694.050.025; D16.850.015.050.020.025; D17.025.030.020.025; D17.050.030.020.025; D26.550.027 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles; Aminopyrine Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aminopyrine Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aminopyrine Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aminopyrine Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents 4-Amino-1,5-dimethyl-2-phenyl-3H-pyrazolone. A metabolite of AMINOPYRINE with analgesic and anti-inflammatory properties. It is used as a reagent for biochemical reactions producing peroxides or phenols. Ampyrone stimulates liver microsomes and is also used to measure extracellular water. Antipyrine (66-74) /analogs and derivatives (75-79)  o:K<Amputees M01.150.100 CLEDHILJPXRHSN Named Groups (Non MeSH); Disabled U +Amputation, Traumatic C21.866.062 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Replantation Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Loss of a limb or other bodily appendage by accidental injury. Amputation (66-71)  LQMAmputation Stumps E04.557.069.194 BSIRNUPAPPRARISUUSVE Phantom Limb Surgery, Operative; Orthopedics; Amputation The distal end of a limb left after amputation. (Dorland, 27th ed). 14UAmputation E04.557.069 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Orthopedics Amputation Stumps; Disarticulation; Hemipelvectomy AEBSCLCTECHIIRISMOMTNUPAPPPXRARHRISNSTSUTDUSUTVE  3$&;4Amprolium D03.383.725.676.152; D21.370.400.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Picolines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Coccidiostats 1-((4-Amino-2-propyl-5-pyrimidinyl)methyl)-2-methylpyridinium chloride. Veterinary coccidiostat that interferes with thiamine metabolism. It may cause thiamine deficiency. Antiprotozoal Agents (66-71); Picolines (66-71) !0 *:9Amplifiers E07.043; H01.288.110 AECLCTECHISDSNSTTDUTVE Equipment and Supplies Physical Sciences (Non MeSH); Electronics #tMAmpicillin Resistance G04.185.515.286.100.600.050; G05.386.310.100.600.050; G05.706.310.100.600.050; G12.392.269.100.600.050 GEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH); Microbiologic Phenomena (Non MeSH); Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Genetics; Genetics, Microbial; Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Genetics; Pharmacogenetics; Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Chemical, Pharmacologic Phenomena (Non MeSH); Drug Resistance; Drug Resistance, Microbial; beta-Lactam Resistance; Penicillin Resistance Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis. Ampicillin (66-87); Drug Resistance, Microbial (66-87) $"p qAAmpicillin D20.085.099.739.762.057 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G Amoxicillin; Azlocillin; Mezlocillin; Piperacillin; Pivampicillin; Talampicillin 6-((Aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1- azabicyclo(3.2.0)heptane-2-carboxylic acid. Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. ($:a^Amphotericin B D20.085.062.083; D20.085.115.080; D20.136.073.083 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antifungal Anti-Infective Agents; Antibiotics; Antibiotics, Macrolide Anti-Infective Agents; Antifungal Agents; Antibiotics, Antifungal Polyene antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. *Q9<Ampholyte Mixtures D26.172.045 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Buffers Such mixtures of amphoteric electrolytes or buffers that provide a continuous range of pH in an electric field; used for separating proteins by their isoelectric points, i.e., by isoelectric focusing. Buffers (66-79); Isoelectric Focusing (70-79) ,],>7Amphibian Venoms D24.185.965.033 ADAEAGAIANBIBLCFCHCLCSCTDUECENGEHIIMIPMEPDPKPORESETOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Venoms Batrachotoxins; Bombesin; Bufotenin; Physalaemin Venoms produced by frogs, toads, salamanders, etc. The venom glands are usually on the skin of the back and contain cardiotoxic glycosides, cholinolytics, and a number of other bioactive materials, many of which have been characterized. The venoms have been used as arrow poisons and include bufogenin, bufotoxin, bufagin, bufotalin, histrionicotoxins, and pumiliotoxin. Amphibia (66-77); Venoms (66-77) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $.6<V:)HAmphibia B02.090 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates Anura (+ 13); Urodela (+ 11) 1w  &'Amphetamines D02.092.471.683.152 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Appetite Depressants; Central Nervous System Stimulants Adrenergic Uptake Inhibitors Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Amphetamine (+ 1); p-Chloroamphetamine; DOM; p-Hydroxyamphetamine; Methamphetamine (+ 1); 3,4-Methylenedioxyamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Phentermine (+ 2) Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopression, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation; these agents may be used for fatigue, narcolepsy, parkinsonism, hypotension, or appetite depression; since tolerance is quickly developed, they are potentially prone to abuse and psychic dependence. Amphetamine (66-75) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,2 8A"P:Amphetamine D02.092.471.683.152.110; D14.100.050.600.050.040; D14.100.050.600.070; D14.100.150.600.040; D14.100.150.600.220.040; D14.100.600.050.040; D14.100.600.220.040; D15.155.040; D15.220.050; D16.050.870.040 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines; Amphetamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH); Dopamine Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Dopamine Uptake Inhibitors Central Nervous System Agents; Appetite Depressants Central Nervous System Agents; Central Nervous System Stimulants Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine Dextroamphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  6y8t:AMP Deaminase D08.586.277.151.653.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases; Nucleotide Deaminases An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6. Adenosine Monophosphate (74); Aminohydrolases (74) @MFT<Amoxicillin D20.085.099.739.762.057.052 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Penicillin G; Ampicillin (2S-(2 alpha,5 alpha,6 beta(S*)))-6-((Amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. A broad-spectrum semisynthetic antibiotic similar to ampicillin except that its resistance to gastric acid permits higher serum levels with oral administration. Ampicillin (75-74); Penicillins (72-74) A:o[0Amoxapine D03.494.347.500.040; D14.100.050.600.050.035; D14.100.600.050.035; D14.100.600.850.030; D14.100.850.875.800.030; D15.085.050.050; D15.700.122.055.118 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Dibenzoxazepines; Loxapine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Serotonin Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Serotonin Agents; Serotonin Neuron Agents (Non MeSH); Serotonin Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine. A tricyclic antidepressant that works by blocking the reuptake of norepinephrine, serotonin, or both. Dibenzoxazepines (71-74); Piperazines (71-74) D :56Amoebida B01.841.750.656.475.100 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea Acanthopodina (+ 1); Blastocystina (+ 2); Tubulina (+ 5) An order of ameboid protozoa that is commonly uninucleate and possess mitochondria. Most organisms are nonpathogenic. J &JHAmoeba B01.841.750.656.475.100.700.089 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Amebicides Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Tubulina A genus of ameboid protozoa. Characteristics include a vesicular nucleus and the formation of several lodopodia, one of which is dominant at a given time. Reproduction occurs asexually by binary fission. LB #&bAmodiaquine D03.438.810.050.060; D21.370.286.077 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines; Aminoquinolines Antiparasitic Agents (Non MeSH); Antiprotozoal Agents; Antimalarials N*:Amobarbital D03.383.742.698.253.077; D14.100.240.500.040; D15.210.350.750.025; D15.325.850.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones; Barbiturates Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Barbiturate Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Barbiturate A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.565). Of\:3Amniotic Fluid A12.098; A16.254.072 CHCYDEENIMMEMIPHPSRARERISEUSVI Amnioscopy; Embolism, Amniotic Fluid; Oligohydramnios; Polyhydramnios Fluids and Secretions (Non MeSH) Embryonic Structures (Non MeSH); Embryo SD"QWAmniotic Band Syndrome C16.614.042 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Infant, Newborn, Diseases A disorder present in the newborn infant in which constriction rings or bands, causing soft tissue depressions, encircle digits, extremities, or limbs and sometimes the neck, thorax, or abdomen. They may be associated with intrauterine amputations. specific anatomic heading/abnormalities (66-82); Amnion (66-82) T^LW!KAmnioscopy E01.249.746.090; E01.418.065 AECLCTECHIISMOMTNUPXSNSTTDUTVE Amnion; Amniotic Fluid Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Prenatal Diagnosis Diagnosis; Endoscopy Amnion (66-70); Endoscopy (66-70) V""`*Amnion A16.254.403.277 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Amnioscopy Embryonic Structures (Non MeSH); Embryo; Fetal Membranes W :EAmniocentesis E01.223.230.071; E01.223.894.632.085; E01.249.746.071 AECLCTECHIISMOMTNUPXSNSTTDUTVE Chorionic Villi Sampling Diagnosis; Diagnosis, Laboratory; Cytodiagnosis Diagnosis; Diagnosis, Laboratory; Specimen Handling; Punctures Diagnosis; Diagnosis, Ob-Gyn (Non MeSH); Prenatal Diagnosis Percutaneous transabdominal puncture of the uterus during pregnancy to obtain amniotic fluid. It is commonly used for fetal karyotype determination in order to diagnose abnormal fetal conditions. Amnion (66-70); Punctures (66-70)  X="*Amnesia, Retrograde C10.597.079.060; C23.888.592.077.060; F03.126.185.597.193.150 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations; Amnesia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Amnesia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Memory Disorders; Amnesia Amnesia for events that occurred before the onset of amnesia. Amnesia (66-75) [8EFVKAmnesia C10.597.079; C23.888.592.077; F03.126.185.597.193 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Memory Disorders Amnesia, Retrograde Amnesia, Retrograde Amnesia, Retrograde Pathologic loss of memory. May be of psychologic, organic or mixed origin. ] 9F5D[Ammotherapy E02.780.108.020; E02.780.480.020 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Physical Therapy; Balneology Therapeutics; Physical Therapy; Hyperthermia, Induced Treatment by application of hot sand. `<&"p/Ammonium Sulfate D01.625.075.050; D01.875.800.800.850.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Ammonium Compounds Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates Sulfuric acid diammonium salt. It is used in fractionation of proteins. Ammonium Compounds (66-70) aU.8W Ammonium Compounds D01.625.075; D02.092.102; D02.675.276 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Pyridinium Compounds; Quinolinium Compounds Inorganic Chemicals (Non MeSH); Nitrogen Compounds Organic Chemicals (Non MeSH); Amines Organic Chemicals (Non MeSH); Onium Compounds Ammonium Chloride; Ammonium Sulfate Ambenonium Chloride; Benzalkonium Compounds; Benzethonium; Bephenium Compounds; Betaine; Bethanechol Compounds (+ 1); Bretylium Compounds (+ 1); Cetrimonium Compounds; Chlorisondamine; Chlormequat; Choline (+ 9); Edrophonium; Emepronium; Gallamine Triethiodide; Glycopyrrolate; Hemicholinium 3; Lissamine Green Dyes; McN A 343; Methacholine Compounds (+ 1); Methonium Compounds (+ 3); Muscarine; Neostigmine; Oxyphenonium; Propantheline; Tetraethylammonium Compounds; Toxiferine (+ 1); Tubocurarine Ambenonium Chloride; Benzalkonium Compounds; Benzethonium; Bephenium Compounds; Betaine; Bethanechol Compounds (+ 1); Bretylium Compounds (+ 1); Cetrimonium Compounds; Chlorisondamine; Chlormequat; Choline (+ 9); Edrophonium; Emepronium; Gallamine Triethiodide; Glycopyrrolate; Hemicholinium 3; Lissamine Green Dyes; McN A 343; Methacholine Compounds (+ 1); Methonium Compounds (+ 3); Muscarine; Neostigmine; Oxyphenonium; Propantheline; Tetraethylammonium Compounds; Toxiferine (+ 1); Tubocurarine Inorganic and organic compounds that contain the hypothetical radical NH4. AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $c9-83XBAmmonium Chloride D01.210.450.150.050; D01.625.075.025 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Chlorine Compounds (Non MeSH); Hydrochloric Acid; Chlorides Inorganic Chemicals (Non MeSH); Nitrogen Compounds; Ammonium Compounds Ammonium chloride, (NH4)Cl. A systemic acidifying agent that has been used as a diuretic and an expectorant. (From Dorland, 27th ed). j *8Ammonia-Lyases D08.586.520.161 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases Aspartate Ammonia-Lyase; Ethanolamine Ammonia-Lyase; Histidase; Phenylalanine Ammonia-Lyase; Porphobilinogen Deaminase Lyases (66-72) l FOAmmonia D01.362.075; D01.625.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Gases Inorganic Chemicals (Non MeSH); Nitrogen Compounds Ammonia. A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. m 8jAmlodipine D03.383.725.203.065; D18.162.025; D18.192.022; D18.918.173.022 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines; Dihydropyridines Cardiovascular Agents; Antihypertensive Agents Cardiovascular Agents; Calcium Channel Blockers Cardiovascular Agents; Vasodilator Agents; Calcium Channel Blockers 2-((2-Aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of angina pectoris and hypertension. Nifedipine/analogs and derivatives (86-92) o1H: 2Amitrole D03.383.946.276; D05.723.366.055; D03.383.129.799.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazoles Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Herbicides Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Azoles; Triazoles Herbicides (66-71); Triazoles (66-71) rO =:.Amitriptyline D04.615.181.384.100; D14.100.050.600.050.030; D14.100.600.050.030; D15.085.050.025; D15.700.122.055.108 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Benzocycloheptenes; Dibenzocycloheptenes Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents; Adrenergic Uptake Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors; Adrenergic Uptake Inhibitors Central Nervous System Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic Central Nervous System Agents; Psychotropic Drugs; Antidepressive Agents; Antidepressive Agents, Tricyclic 3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine. Tricyclic antidepressant with anticholinergic and sedative properties. It prevents the re-uptake of norepinephrine and serotonin at nerve terminals and is used particularly in the treatment of endogenous depression. t's:QAmiodarone D03.438.127.075; D18.097.075; D18.918.062 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzofurans Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Vasodilator Agents (2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)methanone. An antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na,K-activated myocardial adenosine triphosphatase. There is a resulting decrease in heart rate and in vascular resistance. Benzofurans (68-74); Diethylamines (74); Iodobenzoates (73-74) y'1:rKAminotransferases D08.586.913.140 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Alanine Aminotransferase; Aminobutyrate Aminotransferase; Aspartate Aminotransferase; Glutamate Synthase; Ornithine Aminotransferase; Tyrosine Transaminase |=FUAminosalicylic Acids D02.241.223.106.505.700.050; D02.241.511.390.700.050; D02.755.410.700.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Carboxylic Acids; Hydroxy Acids; Hydroxybenzoic Acids; Salicylic Acids Organic Chemicals (Non MeSH); Phenols; Hydroxybenzoic Acids; Salicylic Acids p-Aminosalicylic Acid p-Aminosalicylic Acid p-Aminosalicylic Acid Amino-2-hydroxybenzoic acids. A group of hydroxybenzoic acids that include substitution by amino groups at the 3-, 4-, 5-, or 6-position. The 4-amino derivative, P-AMINOSALICYLIC ACID, is an antitubercular agent. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  }Q8hJ:Aminorex D03.383.548.050; D15.155.020 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles Central Nervous System Agents; Appetite Depressants 2-Amino-5-phenyl-2-oxazoline. An amphetamine-like anorectic agent. It may cause pulmonary hypertension. Amines (72-74); Oxazoles (68-74)  ":w)Aminoquinolines D03.438.810.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Quinolines Amodiaquine; Chloroquine (+ 1); 4-Hydroxyaminoquinoline-1-oxide Quinolines substituted in any position by one or more amino groups. Quinolines (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $@8VJR:Aminopyrine N-Demethylase D08.586.682.107.582.276 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amine Oxidoreductases; Oxidoreductases, N-Demethylating Oxidoreductases, N-Demethylating F%Aminopyrine D03.383.694.050; D16.850.015.050.020; D17.025.030.020; D17.050.030.020 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazoles Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Anti-Inflammatory Agents, Non-Steroidal Ampyrone; Dipyrone Ampyrone Ampyrone Ampyrone A drug with analgesic, anti-inflammatory, and antipyretic properties but, owing to the risk of agranulocytosis, whose use is discouraged. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.3). nP:K6Aminopyridines D02.092.080; D03.383.725.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyridines 4-Aminopyridine; Amrinone 4-Aminopyridine; Amrinone; Methapyrilene; Phenazopyridine; Pyrilamine; Tripelennamine Pyridines substituted in any position with an amino group. May be hydrogenated, but must retain at least one double bond. Amines (66-78); Pyridines (66-78) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $"8*:Aminopterin D03.438.733.631.192; D22.204.144.579.192; D26.087.393.052 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Pteridines; Pterins Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic; Folic Acid Antagonists Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites; Folic Acid Antagonists Methotrexate Methotrexate Methotrexate N-(4-(((2,4-Diamino-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid. A folic acid derivative used as a rodenticide. %A:O,Aminopropionitrile D02.626.151 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Lathyrism Organic Chemicals (Non MeSH); Nitriles 3-Aminopropanenitrile. Reagent used as an intermediate in the manufacture of beta-alanine and pantothenic acid. : 0Aminophylline D02.092.782.258.368.050; D03.132.956.826.075; D03.438.759.758.824.751.075; D08.373.735.800.040; D16.050.110.872.040; D18.918.882.053 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Polyamines; Diamines; Ethylenediamines Heterocyclic Compounds; Alkaloids; Xanthine Alkaloids; Theophylline Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Xanthines; Theophylline Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Phosphodiesterase Inhibitors; Theophylline Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents; Theophylline Cardiovascular Agents; Vasodilator Agents; Theophylline A drug combination that contains theophylline and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It is used mainly in bronchial asthma and as a myocardial stimulant. !:TAminophenols D02.092.146.100; D02.755.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds Organic Chemicals (Non MeSH); Phenols Phenetidine Phenols substituted in any position by an amino group. Amines (66-78); Aniline Compounds (66-78); Phenols (66-78) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $x"8qCH:Aminopeptidases D08.586.277.656.081 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases Amino Acid Naphthylamidases (+ 1); Antigens, CD13; Leucine Aminopeptidase (+ 1); Oxytocinase; Pyroglutamyl-Peptidase I WFjAminooxyacetic Acid D02.241.081.038.350; D02.092.570.050; D08.373.085 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Organic Chemicals (Non MeSH); Amines; Hydroxylamines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors (Aminooxy)acetic acid. A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues. Acetic Acids (72-74); Hydroxylamines (72-74) 9:6Aminolevulinic Acid Synthetase D08.586.913.050.276 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases Acyltransferases (66-71) {$FiAminolevulinic Acid Dehydratase D08.586.520.497.137 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the formation of porphobilinogen from two moles of 5-aminolevulinic acid. EC 4.2.1.24. Hydro-Lyases (66-72) %F_Aminolevulinic Acid D02.241.607.547.276 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids; Levulinic Acids J:\Aminoisobutyric Acids D02.241.081.161.226; D12.125.070.075; D12.125.190.192 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Branched-Chain Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Aminobutyric Acids .=8+Aminoimidazole Carboxamide D03.383.374.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles 5-Amino-1H-imidazole-4-carboxamide. An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases. Imidazoles (66-77) :VlAminohydrolases D08.586.277.151 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases GTP Cyclohydrolase; Guanine Deaminase; Nucleoside Deaminases (+ 2); Nucleotide Deaminases (+ 2) sFSrAminohippuric Acids D02.065.277.431.192; D02.241.223.106.162.431.151; D02.241.607.360.192 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Benzamides; Hippurates Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Benzamides; Hippurates Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids; Hippurates p-Aminohippuric Acid p-Aminohippuric Acid p-Aminohippuric Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR M8#G:Aminoglycosides D09.203.408.051 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides Butirosins; Framycetin; Gentamicins (+ 2); Hygromycin B; Kanamycin (+ 4); Metrizamide; Neomycin (+ 2); Puromycin (+ 1); Streptomycin (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR /BYDAminoglutethimide D03.383.621.808.425.100; D08.373.071; D14.100.050.600.060; D22.204.047 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Piperidones; Glutethimide Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents An aromatase inhibitor that produces a state of "medical" adrenalectomy and which has been used in the treatment of advanced breast and prostate cancer. It was formerly used for its weak anticonvulsant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p454). P:@Aminoethylphosphonic Acid D02.705.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organophosphorus Compounds (2-Aminoethyl)-phosphonic acid. An organophosphorus compound isolated from human and animal tissues. Ethylamines (73-74); Organophosphorus Compounds (73-74); Phosphonic Acids (73-74) :Cu`Aminocaproic Acids D02.241.081.193.150; D12.125.213 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Caproates Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids 6-Aminocaproic Acid 6-Aminocaproic Acid; Norleucine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR `&8<FAminobutyric Acids D02.241.081.161.125; D12.125.190 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, GABA-A Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Butyrates Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids GABA (+ 1) Aminoisobutyric Acids; GABA Aliphatic four carbon acids substituted in any position(s) with amino group(s). They are found in most living things. The best known is GABA. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $+&80FAminobutyrate Aminotransferase D08.586.913.140.160 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Aminotransferases An enzyme that converts brain gamma-aminobutyric acid (GABA) into succinate semialdehyde, which can be converted to succinic acid and enter the citric acid cycle. It also acts on beta-alanine. EC 2.6.1.19. Aminobutyric Acid (74); Aminotransferases (74) #Fj8Aminobiphenyl Compounds D02.455.426.559.389.185.060 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Aromatic (Non MeSH); Benzene Derivatives; Biphenyl Compounds Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings. Biphenyl Compounds (72-74) 8 Aminobenzoic Acids D02.241.223.106.061; D11.786.708.054 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex 4-Aminobenzoic Acid (+ 6); Anthranilic Acids (+ 5); Ethopabate 4-Aminobenzoic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR *8d:Aminoacridines D03.494.046.250 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines Acridine Orange; Acriflavine; Aminacrine; Amsacrine; Ethacridine; ICR 170; Nitracrine; Proflavine; Quinacrine (+ 1); Tacrine Acridines which are substituted in any position by one or more amino groups or substituted amino groups. Acridines (66-79) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $8U}:Aminoaciduria, Renal C12.777.419.815.191; C18.452.648.066.210; C18.452.648.851.191 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors Cystinuria; Hartnup Disease Cystinuria; Hartnup Disease Cystinuria; Hartnup Disease Impairment of renal tubular transport of amino acids.  <EL bAAminoacetonitrile D02.626.080.085 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles; Acetonitriles Cyanomethylamine. Methylamines (72-74); Nitriles (68-74) }:A/Amino Sugars D09.203.067 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates Hexosamines (+ 7); Muramic Acids (+ 1); Neuraminic Acids (+ 2) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR BKPFAmino Alcohols D02.033.329; D02.092.063 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Amines Ethanolamines (+ 19); Heptaminol; Isoetharine; Propanolamines (+ 33) Ethanolamines (+ 19); Heptaminol; Isoetharine; Propanolamines (+ 32) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 8\DAmino Acyl T RNA Synthetases D08.586.464.136 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acid Activation Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases Alanyl T RNA Synthetase; Arginyl T RNA Synthetase; Aspartyl T RNA Synthetase; Glutamyl T RNA Synthetase; Glycyl T RNA Synthetase; Histidyl T RNA Synthetase; Isoleucyl T RNA Synthetase; Leucyl T RNA Synthetase; Lysyl T RNA Synthetase; Methionyl T RNA Synthetase; Phenylalanyl T RNA Synthetase; Seryl T RNA Synthetase; Threonyl T RNA Synthetase; Tryptophanyl T RNA Synthetase; Tyrosyl T RNA Synthetase; Valyl T RNA Synthetase Ligases (66-71)  $FPAmino Acids, Sulfur D12.125.166 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Cystathionine; Cysteic Acid; Cysteine (+ 4); Cystine; Ethionine; Homocysteine (+ 1); Homocystine; Mercaptopropionylglycine (+ 1); Methionine (+ 6); Penicillamine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR DHHAmino Acids, Peptides and Proteins (Non MeSH) D12 Amino Acids (+ 145); Macromolecular Systems (+ 1); Peptides (+ 133); Proteins (+ 1311) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECENGEHIIMIPMEMIPAPDPHPKPOPSPYRARERISDSESTTOTRTUULURUSVI 7m\Amino Acids, Essential D12.125.142 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Arginine; Histidine; Isoleucine; Leucine; Lysine; Methionine; Phenylalanine; Threonine; Tryptophan; Valine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR DHFAmino Acids, Dicarboxylic D12.125.119 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids 2-Aminoadipic Acid; Asparagine; Aspartic Acid (+ 2); Carbocysteine; Cystathionine; Cystine; Glutamic Acid (+ 4); Glutamine (+ 1); Homocystine AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR ʛDHFAmino Acids, Diamino D12.125.095 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Arginine (+ 5); Citrulline; Cystathionine; Cystine; Diaminopimelic Acid; Homocystine; Lysine (+ 3); Ornithine (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR oDHFAmino Acids, Cyclic (Non MeSH) D12.125.072 Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Cycloleucine; Desmosine; Histidine (+ 1); Imino Acids (+ 6); Isodesmosine; Phenylalanine (+ 6); Thyroxine (+ 6); Tryptophan (+ 1); Tyrosine (+ 3) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR &HHAmino Acids, Branched-Chain D12.125.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Aminoisobutyric Acids; Isoleucine; Leucine; Valine (+ 1) Amino acids which have a branched carbon chain. Amino Acids (66-78) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $Ͼ!DHE;FAmino Acids D12.125 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Amino Acid Amino Acids, Peptides and Proteins (Non MeSH) Alanine (+ 3); Amino Acid Chloromethyl Ketones (+ 2); Amino Acids, Branched-Chain (+ 5); Amino Acids, Cyclic (Non MeSH) (+ 32); Amino Acids, Diamino (+ 17); Amino Acids, Dicarboxylic (+ 16); Amino Acids, Essential (+ 10); Amino Acids, Sulfur (+ 22); Aminobutyric Acids (+ 2); Aminocaproic Acids (+ 2); Azaserine; Canavanine; Creatine (+ 1); Glycine (+ 7); Homoserine; Kynurenine; Oxamic Acid; Quisqualic Acid; RNA, Transfer, Amino Acyl; Sarcosine; Serine (+ 3); Threonine (+ 1) Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ш D7LHAmino Acid Sequence G05.331.599.056; G06.184.599.056; G06.184.815.056; H01.181.529.570.575.056 DEGEIMPHRE Proteins; Peptides Genetics; Genetics, Biochemical; Molecular Sequence Data Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Molecular Sequence Data Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Protein Structure (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Molecular Structure; Protein Structure (Non MeSH) Ankyrin Repeat; Helix-Loop-Helix Motifs; Kringles; Leucine Zippers; Sequence Homology, Amino Acid; Zinc Fingers Ankyrin Repeat; Helix-Loop-Helix Motifs; Kringles; Leucine Zippers; Sequence Homology, Amino Acid; Zinc Fingers The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.  TAmino Acid Oxidoreductases D08.586.682.135 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Amine Oxidase (Copper-Containing); D-Amino-Acid Oxidase; Glutamate Dehydrogenase; Glutamate Dehydrogenase (NADP+); Monoamine Oxidase (+ 1); Protein-Lysine 6-Oxidase ^ FXAmino Acid Neurotransmitters D14.600.050 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Receptors, Amino Acid Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters Excitatory Amino Acids (+ 2); GABA; Glycine Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (GLUTAMIC ACID) and GABA which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $"BW8%FAmino Acid Naphthylamidases D08.586.277.656.081.150 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Aminopeptidases Leucyl-beta-Naphthylamidase !F}Amino Acid Metabolism, Inborn Errors C18.452.648.066 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors Albinism (+ 3); Alkaptonuria (+ 1); Aminoaciduria, Renal (+ 2); Homocystinuria; Maple Syrup Urine Disease; Multiple Carboxylase Deficiency; Phenylketonuria (+ 1)  ,LmAmino Acid Isomerases D08.586.399.124 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases Alanine Racemase Isomerases (66-71); specific amino acid FS1Amino Acid Chloromethyl Ketones D08.373.745.075; D12.125.065 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone Inhibitors of serine proteinases and sulfhydryl group containing enzymes. Act as alkylating agents and are known to interfere in the translation process. specific amino acid (66-76); Peptides (66-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $&"88:Amino Acid Activation G05.331.370.725.124; G06.535.770.124 DEGEIMPHRE Amino Acyl T RNA Synthetases Genetics; Genetics, Biochemical; Gene Expression; Translation, Genetic Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Peptide Synthesis (Non MeSH) The first step of protein synthesis, whereby an amino acid reacts with adenosine triphosphate in the presence of aminoacyl RNA synthetase to produce an amino acid adenylate, which provides the energy necessary for the attachment of the amino acid to a specific transfer RNA molecule. Peptides/biosynthesis (66-70)  ;*$L#Amines D02.092 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Allylamine; Amino Alcohols (+ 55); Aminopyridines (+ 2); Ammonium Compounds (+ 43); Aniline Compounds (+ 14); Benzylamines (+ 1); Biogenic Amines (+ 26); Butylamines; Catecholamines (+ 19); Cyclohexylamines (+ 2); Ethylamines (+ 42); Hydroxylamines (+ 11); Mannich Bases; Methylamines (+ 2); 1-Naphthylamine; 2-Naphthylamine; Polyamines (+ 19); Propylamines (+ 6) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR   8#FAmine Oxidoreductases D08.586.682.107 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Oxidoreductases, N-Demethylating (+ 2); Proline Oxidase; Pyridoxaminephosphate Oxidase; Pyrroline Carboxylate Reductases; Saccharopine Dehydrogenases; Tetrahydrofolate Dehydrogenase Enzymes catalyzing the dehydrogenation of secondary amines, introducing a C=N double bond as the primary reaction. In some cases this is later hydrolyzed. Oxidoreductases (66-74)  FXAmine Oxidase (Copper-Containing) D08.586.682.135.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Amino Acid Oxidoreductases A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6. ='Fx Amination G06.535.630.160; H01.181.404.190 DERE Deamination Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Chemistry, Organic (66-70) h & Aminacrine D03.494.046.250.200; D20.187.060; D26.408.348.060 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Anti-Infective Agents; Anti-Infective Agents, Local Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes 9-Acridinamine. Highly fluorescent anti-infective dye; used clinically as topical antiseptic and experimentally as mutagen, due to its interaction with DNA; also used as intracellular pH indicator. Synonyms: Acramidine; Acriflex; Acrisan; Cimlac; Flavacrin; Monacrin. Acridines (66-79) 9.9Amiloride D03.383.679.149; D19.770.224.087 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrazines Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics Diuretics (66-71); Pyrazines (66-71)  &:-Amikacin D09.203.408.051.476.060; D20.085.060.425.060 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Aminoglycosides; Kanamycin Anti-Infective Agents; Antibiotics; Antibiotics, Aminoglycoside; Kanamycin O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6- deoxy-alpha-D-glucopyranosyl-(1-4)-N(1)-(4-amino-2-hydroxy- 1-oxobutyl)-2-deoxy-D-streptamine. A broad-spectrum antibiotic derived from kanamycin. It is reno- and ototoxic like the other aminoglycoside antibiotics. Aminobutyric Acids (73-74); Kanamycin (73-74)  2:47Amifostine D02.719.060; D26.763.165 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents 2-((3-Aminopropyl)amino)ethanethiol dihydrogen phosphate (ester). A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia. Diamines (74-76); Organothiophosphorus Compounds (72-76) .BAmidophosphoribosyltransferase D08.586.913.400.725.130 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme involved in the early steps of purine nucleotide biosynthesis which catalyzes the formation of 5-phosphoribosylamine from glutamine and phosphoribosylpyrophosphate. EC 2.4.2.14. Glutamine (74); Pentosephosphates (74); Pentosyltransferases (74); Pyrophosphoric Acids (74) "FnAmidohydrolases D08.586.277.087 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases N-Acetylmuramoyl-L-alanine Amidase; Allophanate Hydrolase; Asparaginase; Aspartylglucosylaminase; beta-Lactamases (+ 2); Dihydroorotase; Formamidase; Glutaminase; Histone Deacetylase; Nicotinamidase; Penicillin Amidase; Pyroglutamate Hydrolase; Urease FSAmido Black D02.172.029; D02.886.645.600.080.050.650.025; D04.615.638.555.220; D26.408.058 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Naphthalenesulfonates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Naphthalenesulfonates Miscellaneous Drugs and Agents (Non MeSH); Dyes 4-Amino-5-hydroxy-3-((4-nitrophenyl)azo)-6-(phenylazo)-2,7- naphthalenedisulfonic acid disodium salt. A dye used to stain proteins in electrophoretic techniques. It is used interchangeably with its acid form. Azo Compounds (69-75); Naphthalenesulfonates (74-75); Nitrobenzenes (74-75) X.YAmidinotransferases D08.586.913.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases FUAmidines D02.078 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Benzamidines (+ 2); Chlorphenamidine; Guanidines (+ 21); Stilbamidines AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR   8#VFAmides D02.065 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Acetamides (+ 7); Acrylamides; Anilides (+ 23); Benzamides (+ 12); Benzoylarginine-2-Naphthylamide; Dibucaine; Formamides (+ 1); Lactams (+ 1); Salicylamides (+ 4); Sulfonamides (+ 38); Thioamides (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 5  8#:Americium D01.268.271.545.050; D01.552.517.086 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Americium. A completely man-made radioactive actinide with atomic symbol Am, atomic number 95, and atomic weight 243. Its valence can range from +3 to +6. Because of its nonmagnetic ground state, it is an excellent superconductor. It is also used in bone mineral analysis and as a radiation source for radiotherapy.  *4vAmerican Speech-Language-Hearing Association N03.540.828.105 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Societies A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders. Audiology (78-90); Hearing (66-74); Societies (66-90); Speech-Language Pathology (80-90); Speech Therapy (66-79)  2 SAmerican Nurses' Association N03.540.828.672.274 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Societies; Societies, Nursing Professional society representing the field of nursing.  " jBAmerican Medical Association N03.540.828.589.274 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Societies; Societies, Medical Professional society representing the field of medicine.  " jCAmerican Hospital Association N03.540.828.540.080 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Societies; Societies, Hospital A professional society in the United States whose membership is composed of hospitals.  # kgAmerican Heart Association N03.540.630.780.110 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit; Voluntary Health Agencies A voluntary organization concerned with the prevention and treatment of heart and vascular diseases. Cardiovascular Diseases (66-74); Heart Diseases (66-74); Societies, Medical (66-74); Voluntary Health Agencies (66-74)   vAmerican Dental Association N03.540.828.506.274 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Societies; Societies, Dental Professional society representing the field of dentistry. ! iDAmerican Cancer Society N03.540.630.780.080 ECHIOG Economics, Organizations, Control (Non MeSH); Organizations; Organizations, Nonprofit; Voluntary Health Agencies A voluntary organization concerned with the prevention and treatment of cancer through education and research. Neoplasms (66-74); specific neoplasm; Societies, Medical (66-74); Societies, Scientific (66-74); Voluntary Health Agencies (66-74)  America Z01.107 EHEP Geographicals (Non MeSH) Caribbean Region (+ 13); Central America (+ 8); Latin America; North America (+ 155); South America (+ 13)   Amenorrhea C13.371.491.124 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Menstruation Disorders Absence of menstruation. NAmelogenesis Imperfecta C07.650.800.065; C07.793.700.065; C16.131.850.800.065 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Stomatognathic Diseases; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Stomatognathic Diseases; Tooth Diseases; Tooth Abnormalities Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Stomatognathic System Abnormalities (Non MeSH); Tooth Abnormalities Dental Enamel Hypoplasia Dental Enamel Hypoplasia Dental Enamel Hypoplasia An autosomal dominant or X-linked disorder in which there is faulty development of the dental enamel owing to agenesis, hypoplasia, or hypocalcification of the enamel. It is marked by enamel that is very thin and friable and frequently stained in various shades of brown. (Dorland, 27th ed). =LFVYAmelogenesis G07.553.767.190 DEGEIMPHRE Dental Enamel Physiology, General (Non MeSH); Growth and Embryonic Development (Non MeSH); Odontogenesis lAmeloblasts A11.436.107 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Dental Enamel Cells; Epithelial Cells (Non MeSH) *+Ameloblastoma C04.557.695.065 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Odontogenic Tumors An epithelial tumor of the jaw originating from the epithelial rests of Malassez or from other epithelial remnants of the developing period of the enamel. SXUAmebicides D21.370.107 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amoeba; Amebiasis Antiparasitic Agents (Non MeSH); Antiprotozoal Agents Chloroquine; Chloroquinolinols; Clioquinol; Emetine; Glaucarubin; Iodoquinol; Ornidazole; Paromomycin AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR  8@w@Amebiasis C03.752.700.700.055 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Amebicides Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Sarcodina Infections Acanthamoeba Keratitis; Blastocystis Infections; Entamoebiasis (+ 2) Infection with any of various amebae. It is an asymptomatic carrier state in most individuals, but diseases ranging from chronic, mild diarrhea to fulminant dysentery may occur.   PjPAmdinocillin Pivoxil D20.085.099.739.049.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins; Amdinocillin 6-(((Hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl- 7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid (2,2-dimethyl-1-oxopropoxy)methyl ester. Pivaloyloxymethyl ester of amdinocillin that is well absorbed orally, but broken down to amdinocillin in the intestinal mucosa. It is active against gram-negative organisms and used as for amdinocillin. Antibiotics (66-72); Penicillanic Acids (73-77); Thiazoles (66-77)  :`PAmdinocillin D20.085.099.739.049 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Lactam; Penicillins Amdinocillin Pivoxil 6-(((Hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl- 7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid. Amidinopenicillanic acid derivative with broad spectrum antibacterial action. It is poorly absorbed if given orally and is used in urinary infections and typhus. Antibiotics (66-72); Penicillanic Acids (73-77); Thiazoles (66-72)  #:P?PAmbystomatidae B02.090.608.080 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela Ambystoma (+ 1) A family of the class Urodela which includes 4 living genera, about 33 species, and occurs only in North America. Adults are usually terrestrial, but the larval forms are aquatic. &&&&Ambystoma mexicanum B02.090.608.080.068.525 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Ambystomatidae; Ambystoma An axolotl found in Mexican mountain lakes and accounting for about 30 percent of the urodeles used in research. Ambystoma (72-80) '&EAmbystoma B02.090.608.080.068 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Amphibia; Urodela; Ambystomatidae Ambystoma mexicanum A genus of the Ambystomatidae family. The best known species of this genus are the axolotl forms AMBYSTOMA MEXICANUM and Ambystoma tigrinum. They may retain gills and remain aquatic without developing all of the adult characteristics. However, under proper changes in the environment they metamorphose. Urodela (66-71)  )  &8bAmbulatory Surgery E04.030 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgicenters Surgery, Operative Surgery performed on an outpatient basis. It may be hospital-based or performed in an office or surgicenter. Ambulatory Care (66-79); Outpatient Clinics, Hospital (66-79)  +F $IAmbulatory Care Information Systems L01.700.508.300.680.030; N04.452.515.050; N04.452.515.360.050 CLECHILJOGSNSTTDUT Information Science; Medical Informatics; Medical Informatics Applications; Information Systems; Management Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems Health Services Administration (Non MeSH); Organization and Administration; Management Information Systems; Hospital Information Systems Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of ambulatory care services and facilities. ,*E3Ambulatory Care Facilities N02.278.035 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Community Health Centers (+ 1); Community Mental Health Centers (+ 1); Maternal-Child Health Centers; Outpatient Clinics, Hospital (+ 1); Pain Clinics; Surgicenters Those facilities which administer health services to individuals who do not require hospitalization or institutionalization. Health Facilities (68-78) CLECHILJMAMTOGSDSNSTTDUT $0* LAmbulatory Care E02.472.106; N02.421.589.148 CLECHILJMAMTOGPXSNSTTDUT Outpatient Clinics, Hospital Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) Peritoneal Dialysis, Continuous Ambulatory Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility. AECLCTECHIISLJMAMOMTNUOGPXSNSTTDUTVE $2}""24(Ambulances N02.421.297.879.100 CLECHILJSDSNSTTDUT Emergency Medical Services Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services; Transportation of Patients Air Ambulances A vehicle equipped for transporting patients in need of emergency care.  5\ VAmbroxol D02.092.146.271.100; D02.092.384.175.100; D26.415.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Aniline Compounds; Bromhexine Organic Chemicals (Non MeSH); Amines; Cyclohexylamines; Bromhexine Miscellaneous Drugs and Agents (Non MeSH); Expectorants A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride. Aniline Compounds (74); Bromhexine/analogs and derivatives (75-76); Cyclohexylamines (74) 6 =:jAmblyopia C10.597.751.941.073; C10.772.204.410.048; C11.590.048; C11.966.073; C23.888.592.763.941.073 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Vision Disorders Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases; Ocular Motility Disorders Eye Diseases; Ocular Motility Disorders Eye Diseases; Vision Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Vision Disorders Condition in which there is a unilateral or bilateral decrease in form vision. Because of the defect in visual fixation, pursuit (following) movements are impaired when the amblyopic eye is used for fixation. 9 gNAmbergris D10.516.945.253 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Whales Lipids and Antilipemic Agents (Non MeSH); Lipids; Waxes A grayish waxy mass of material ejected from the intestinal tract of the sperm whale, Physeter catodon, and made up of cholesterol and varying amounts of fatty oil, benzoic acid, ambrein, and other materials. It is used as a fixative in perfumery. The word comes from the Latin, ambra grisea, gray amber. (Dorland, 27th ed). =A , EAmber D25.786.109 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Biomedical and Dental Materials (Non MeSH); Resins A yellowish fossil resin, the gum of several species of coniferous trees, found in the alluvial deposits of northeastern Germany. It is used in molecular biology in the analysis of organic matter fossilized in amber. Resins (69-94) ? ,>Ambenonium Chloride D02.092.102.046; D02.675.276.046; D08.373.275.079; D14.100.120.300.030; D16.050.675.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Cholinesterase Inhibitors Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinesterase Inhibitors Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A quaternary ammonium compound that is an inhibitor of cholinesterase activity with actions similar to those of NEOSTIGMINE, but of longer duration. Ambenonium is given by mouth in the treatment of myasthenia gravis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1112). ABc:EAmaranth D02.172.025; D02.886.645.600.080.050.650.012; D04.615.638.555.200; D26.408.054 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Azo Compounds Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Arylsulfonic Acids; Arylsulfonates; Naphthalenesulfonates Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Naphthalenes; Naphthalenesulfonates Miscellaneous Drugs and Agents (Non MeSH); Dyes 3-Hydroxy-4-((4-sulfo-1-naphthalenyl)azo)-2,7-naphthalenedisulfonic acid trisodium salt. A sulfonic acid-based naphthylazo dye used as a coloring agent for foodstuffs and medicines and as a dye and chemical indicator. It was banned by the FDA in 1976 for use in foods, drugs, and cosmetics. (From Merck Index, 11th ed). Azo Compounds (69-75); Naphthalenesulfonates (74) E\ X.w;Amantadine D02.219.075.080; D02.455.426.392.368.075.080; D04.615.236.075.080; D14.100.150.600.030; D15.090.050.025; D20.388.123 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Bridged Compounds; Adamantane Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins; Adamantane Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Bridged Compounds; Adamantane Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Neuron Agents (Non MeSH) Central Nervous System Agents; Anti-Dyskinesia Agents; Antiparkinson Agents Anti-Infective Agents; Antiviral Agents Memantine Memantine Memantine An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent and to treat extrapyramidal reactions. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. IY:&Amanitins D12.644.456.050; D12.644.641.050; D24.185.926.587.175 ADAEAGAIANBIBLCFCHCLCSCTDEECGEHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Oligopeptides Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Peptides, Cyclic Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins A group of very potent toxins from Amanita species which cause lethal liver and kidney damage and inhibit some RNA synthesis. Mycotoxins (74); Oligopeptides (74); Peptides, Cyclic (74) N =<HAmanita B05.354.179.100.110 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes; Agaricales A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous. Q= "LlAlzheimer's Disease C10.228.140.079.060; C10.228.140.380.150.060; C10.228.140.380.220.060; F03.709.508.460.245.220.140; F03.709.508.460.245.230.140; F03.709.680.610.392.300.060; F03.709.680.610.392.360.060 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI tau Proteins; Amyloid beta-Protein; Amyloid beta-Protein Precursor; Neurofibrillary Tangles; Neurofilament Proteins Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia; Dementia, Presenile Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia; Dementia, Senile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Presenile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Senile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Presenile Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia; Dementia, Senile A degenerative organic mental disease characterized by progressive brain deterioration and dementia. The disease was originally described as DEMENTIA, PRESENILE occurring in persons under the age of 65 (as opposed to DEMENTIA, SENILE with onset at or after 65); however, onset may occur at any age. There is no pathophysiological nor clinical distinction between the two stages of onset of Alzheimer's. Women appear to be affected twice as frequently as men. R\FAlveoloplasty E04.833.800.180; E06.892.800.180 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Denture, Complete, Immediate Alveolar Process Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic Zb&$"Alveolitis, Extrinsic Allergic C08.381.483.125; C08.674.055; C20.543.480.680.075 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Lung Diseases; Lung Diseases, Interstitial Respiratory Tract Diseases; Respiratory Hypersensitivity Immunologic Diseases; Hypersensitivity; Hypersensitivity, Immediate; Respiratory Hypersensitivity Bird Fancier's Lung; Farmer's Lung Bird Fancier's Lung; Farmer's Lung Bird Fancier's Lung; Farmer's Lung Conditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins. Respiratory Hypersensitivity (66-76)  [$9N}*Alveolectomy E04.833.800.140; E06.892.800.140 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Alveolar Process Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic ^&$Alveolar Ridge Augmentation E04.833.800.100; E06.892.800.100 AECLCTECHIISMAMOMTNUPXSNSTTDUTVE Surgery, Operative; Surgery, Oral; Surgery, Oral, Preprosthetic Dentistry; Surgery, Oral; Surgery, Oral, Preprosthetic Preprosthetic surgery involving rib, cartilage, or iliac crest bone grafts, usually autologous, or synthetic implants for rebuilding the alveolar ridge. Alveoloplasty (66-79); Mandible/surgery (66-79); Mandibular Diseases/surgery (66-79) _!&$dAlveolar Process A02.835.232.781.324.502.125; A14.254.646.094; A14.521.125 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Alveolectomy; Alveoloplasty; Dental Arch Musculoskeletal System; Skeleton; Bone and Bones; Skull; Facial Bones; Jaw Stomatognathic System; Dentition; Periodontium Stomatognathic System; Jaw b A:1Alveolar Bone Loss C05.116.264.150; C07.465.714.150; G11.427.150.150.140 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Resorption Stomatognathic Diseases; Mouth Diseases; Periodontal Diseases Musculoskeletal, Neural, Eye Physiology (Non MeSH); Musculoskeletal System Physiology (Non MeSH); Bone Remodeling; Bone Resorption The resorption of bone in the supporting structures of the maxilla or mandible as a result of periodontal disease. Bone Resorption (66-90) c=N Aluminum Silicates D01.056.050.075; D01.578.725.025; D01.650.550.050.075; D01.837.725.700.760.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Aluminum Compounds; Aluminum Oxide Inorganic Chemicals (Non MeSH); Minerals; Silicates Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides; Aluminum Oxide Inorganic Chemicals (Non MeSH); Silicon Compounds; Silicon Dioxide; Silicic Acid; Silicates Bentonite; Kaolin; Zeolites Bentonite; Kaolin; Zeolites Bentonite; Kaolin; Zeolites Bentonite; Kaolin; Zeolites Any of the numerous types of clay which contain varying proportions of Al2O3 and SiO2. They are made synthetically by heating aluminum fluoride at 1000-2000 degrees C with silica and water vapor. (From Hawley's Condensed Chemical Dictionary, 11th ed). fDX8])Aluminum Oxide D01.056.050; D01.650.550.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Aluminum Compounds Inorganic Chemicals (Non MeSH); Oxygen Compounds (Non MeSH); Oxides Aluminum Silicates (+ 3) Aluminum Silicates (+ 3) Aluminum oxide (Al2O3). An oxide of aluminum, occurring in nature as various minerals such as bauxite, corundum, etc. It is used as an adsorbent, desiccating agent, and catalyst, and in the manufacture of dental cements and refractories. Aluminum (66-77); Oxides (66-77)  j"8<)Aluminum Hydroxide D01.045.250.050; D01.056.037; D01.455.150; D19.316.203.059.026 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Alkalies; Hydroxides Inorganic Chemicals (Non MeSH); Aluminum Compounds Inorganic Chemicals (Non MeSH); Hydroxides Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Anti-Ulcer Agents; Antacids Hydrated aluminum. A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. Aluminum (66-77); Antacids (66-71); Hydroxides (66-77) lH8 CAluminum Compounds D01.056 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Alum Compounds; Aluminum Hydroxide; Aluminum Oxide (+ 4) Inorganic compounds that contain aluminum as an integral part of the molecule. Aluminum (66-93)  o 8%E^Aluminum D01.268.029; D01.552.045 ADAEAGAIANBLCFCHCLCTDFDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements Inorganic Chemicals (Non MeSH); Metals q9 :`Alum Compounds D01.056.025; D01.875.800.800.850.025 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Aluminum Compounds Inorganic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfuric Acids; Sulfates Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhea, conjunctivitis, pharyngitis, metritis, and minor wounds. Aluminum (73-74); Sulfates (73-74) r*,+Altruism F01.145.813.090; F01.829.233.070; F01.829.759.090; K01.752.256.070 Behavior and Behavior Mechanisms (Non MeSH); Behavior; Social Behavior Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Ethics Behavior and Behavior Mechanisms (Non MeSH); Psychology, Social; Social Behavior Humanities; Philosophy; Ethics Consideration and concern for other people, as opposed to self-love or egoism, which can be a motivating influence. Social Behavior (69-77) t L+Altretamine D03.383.931.135; D05.723.141.120; D22.204.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Chemosterilants Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents N,N,N',N',N'',N''-Hexamethyl-1,3,5-triazine-2,4,6-triamine. An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects. Dimethylamines (73-74); Triazines (70-74) v5:2Altitude Sickness C23.888.852.079.189 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Respiratory (Non MeSH); Anoxia A morbid condition of anoxia caused by the reduced pressure of oxygen at high altitudes. yNkAltitude G03.230.058 Mountaineering Atmospheric Pressure; Mountaineering; Aerospace Medicine Environment and Public Health (Non MeSH); Environment {3 BAAlthesin D04.808.745.558.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnanediones 3-Hydroxypregnane-11,20-dione mixture with 21-(acetyloxy)-3-hydroxypregnane-11,20-dione (3:1). A 3:1 mixture of alfaxalone with alfadolone acetate that previously had been used as a general anesthetic. It is no longer actively marketed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1445). Drug Combinations (74); Hydroxysteroids (74); Pregnanediones (74) | :GXOAlternative Splicing G05.331.370.380.812.610.100 DEGEIMPHRE Genetics; Genetics, Biochemical; Gene Expression; Gene Expression Regulation; RNA Processing, Post-Transcriptional; RNA Splicing A process whereby multiple protein isoforms are generated from a single gene. Alternative splicing involves the splicing together of nonconsecutive exons during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form messenger RNA. The alternative forms produce proteins in which one part is common while the other part is different. RNA Splicing (82-92) ~xAlternative Medicine E02.040 CLECEDHIISLJMAMTOGSNSTTDUTVE Therapeutics Acupuncture (+ 6); Anthroposophy; Biofeedback (Psychology); Chiropractic; Color Therapy; Diet Fads; Eclecticism; Electric Stimulation Therapy (+ 2); Homeopathy; Massage; Medicine, Traditional (+ 7); Mental Healing; Moxibustion; Music Therapy; Naturopathy; Radiesthesia; Reflexotherapy; Rejuvenation; Relaxation Techniques; Tissue Therapy Non-orthodox therapeutic systems which usually have no satisfactory scientific explanation for their effectiveness. AECLCTDEECEDHIISLJMAMOMTNUOGPHPXRESNSTTDUTVE    0Alternaria B05.354.381.546.075 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus including several plant pathogens and at least one species which produces a highly phytotoxic antibiotic. L"NAlteplase D08.586.277.656.732.635.035; D08.586.277.656.732.760.635.035; D19.461.427.600.620.035 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Plasminogen Activators Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases; Plasminogen Activators Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Fibrinolytic Agents; Plasminogen; Plasminogen Activators A proteolytic enzyme in the serine protease family found in many tissues which converts plasminogen to plasmin. This activator is immunologically different from urokinase and, in contrast to urokinase, has fibrin-binding activity. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Intravenous treatment with this agent produces prompt recanalization in more than half the patients with total coronary occlusion. Enzyme Activation (74-75); Peptide Hydrolases (75); Plasminogen Activators (76-85)  ]F-bAlprostadil D02.241.081.436.275.050; D02.241.081.436.687.150.050; D10.516.251.355.325.050; D10.516.251.355.708.250.050; D17.350.050.175.725.780.050 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins E Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Monounsaturated Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Prostaglandins; Prostaglandins E Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Inflammation Mediators; Autacoids; Eicosanoids; Prostaglandins; Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid. A potent vasodilator agent that increases peripheral blood flow. It inhibits platelet aggregation and has many other biological effects such as bronchodilation, mediation of inflammation, etc. Prostaglandins (66-74); Prostaglandins E (75-85) D$:Alprenolol D02.033.329.624.058; D02.092.063.624.058; D14.100.050.200.200.050; D16.050.850.030; D18.097.072; D18.162.018 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents Dihydroalprenolol Dihydroalprenolol Dihydroalprenolol Dihydroalprenolol 1-((1-Methylethyl)amino)-3-(2-(2-propenyl)phenoxy)-2-propanol. Adrenergic beta-blocker used as an antihypertensive, anti-anginal, and anti-arrhythmic agent. Amino Alcohols (66-71); Sympatholytics (66-71)  yz:"P8Alprazolam D03.438.079.080.030; D14.100.240.500.030; D15.075.050.050; D15.210.350.800.025; D15.210.950.012.050.043; D15.325.875.025; D15.700.872.015.050.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzazepines; Benzodiazepines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Modulators Central Nervous System Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Central Nervous System Depressants; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine Central Nervous System Agents; Hypnotics and Sedatives; Sedatives, Nonbarbiturate Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Anti-Anxiety Agents; Anti-Anxiety Agents, Benzodiazepine 8-Chloro-1-methyl-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine. A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of panic disorder, with or without agoraphobia, and in generalized anxiety disorder. (From AMA, Drug Evaluations Annual, 1994, p.238). Azepines (66-67); Benzazepines (68-73); Benzodiazepines (75-86) :wtLAlphavirus Infections C02.782.930.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Togaviridae Infections Encephalomyelitis, Equine (+ 1) Virus diseases caused by members of the ALPHAVIRUS genus of the family TOGAVIRIDAE.  PV&dAlphavirus B04.820.850.054; B04.909.777.923.054 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Togaviridae Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Togaviridae Chikungunya Virus; Encephalitis Virus, Eastern Equine; Encephalitis Virus, Venezuelan Equine; Encephalitis Virus, Western Equine; Ross River Virus; Semliki Forest Virus; Sindbis Virus Chikungunya Virus; Encephalitis Virus, Eastern Equine; Encephalitis Virus, Venezuelan Equine; Encephalitis Virus, Western Equine; Ross River Virus; Semliki Forest Virus; Sindbis Virus A genus of TOGAVIRIDAE, also known as Group A arboviruses, serologically related to each other but not to other Togaviridae. The viruses are transmitted by mosquitoes. The type species is the SINDBIS VIRUS. Arboviruses (66-80)  *wAlphaprodine D03.383.621.040; D15.040.150.030; D15.210.600.070 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines Central Nervous System Agents; Analgesics; Analgesics, Opioid Central Nervous System Agents; Central Nervous System Depressants; Narcotics An opioid analgesic chemically related to and with an action resembling that of MEPERIDINE, but more rapid in onset and of shorter duration. It has been used in obstetrics, as pre-operative medication, for minor surgical procedures, and for dental procedures. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1067). =9:wAlphaherpesvirinae B04.280.382.100; B04.909.204.382.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Herpesviridae Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Herpesviridae Simplexvirus (+ 3); Varicellovirus (+ 8) Simplexvirus (+ 3); Varicellovirus (+ 8) A subfamily of HERPESVIRIDAE characterized by a short replication cycle. There are two genera: SIMPLEXVIRUS and VARICELLOVIRUS. Herpesviridae (88-93)  P*{dalpha-Thalassemia C15.378.071.141.150.875.100; C15.378.420.826.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Anemia; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Thalassemia Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemoglobinopathies; Thalassemia Hydrops Fetalis Hydrops Fetalis A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted. Thalassemia (66-92)  g6L &alpha-MSH D06.472.734.525.690.130.050; D06.472.734.525.690.583.050; D12.644.360.050; D12.776.641.650.460.050; D14.600.600.480.050 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pro-Opiomelanocortin; Corticotropin Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pro-Opiomelanocortin; MSH Amino Acids, Peptides and Proteins (Non MeSH); Peptides; MSH Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; MSH Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; MSH A 13-amino acid peptide derived from the anterior pituitary gland in man and from the pars intermedia in lower vertebrates. Its amino acid sequence is identical to the first 13 amino acids of ACTH. It influences the formation of deposition of melanin in the body and produces color changes in the skin of amphibians, fishes and reptiles. It is secreted in humans only during fetal life and occasionally during pregnancy. MSH (66-87) Q Fgalpha-Linolenic Acid D02.241.081.436.292.100; D02.241.081.436.410.400; D10.516.212.302.380.410.100; D10.516.251.355.310.640.400; D10.516.251.355.337.100; D10.516.251.355.450.400; J01.740.250.410.100 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Fatty Acids, Omega-3 Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Unsaturated; Linolenic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fats; Dietary Fats; Dietary Fats, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Essential; Linolenic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Omega-3 Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Unsaturated; Linolenic Acids Technology, Industry, Agriculture (Non MeSH); Oils; Dietary Fats, Unsaturated; Fatty Acids, Omega-3 (Z,Z,Z)-9,12,15-Octadecatrienoic Acid. A fatty acid that is found in plants and involved in the formation of prostaglandins. Linolenic Acids (80-93) Dalpha-Glucosidases D08.586.277.450.420.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Glucosidases Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. EC 3.2.1.20. Glucosidases (66-77) ]F|alpha-Galactosidase D08.586.277.450.410.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Galactosidases An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids. EC 3.2.1.22. Galactosidases (66-78) F~alpha-Endorphin D12.644.468.241.030; D12.776.641.650.575.241.030; D14.600.600.577.241.030 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Opioid Peptides; Endorphins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins; Neuropeptides; Opioid Peptides; Endorphins Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters; Neuropeptides; Opioid Peptides; Endorphins An endogenous opioid peptide derived from the pro-opiomelanocortin precursor. It differs from GAMMA-ENDORPHIN by one amino acid. Opioid Peptides (80-94) 1QF~alpha-Chlorohydrin D02.033.440.100; D02.033.618.706.100; D07.360.443.200 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Chlorohydrins Organic Chemicals (Non MeSH); Alcohols; Glycols; Propanediols Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Male 3-Chloro-1,2-propanediol. A chlorinated propanediol compound that has shown anti-fertility activity in males and has been used as a chemosterilant in rodents. Chlorine (72-74); Propanediols (69-74) 3=:/alpha-Amylase D08.586.277.450.066.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Amylases An enzyme that catalyzes the endohydrolysis of 1,4-alpha-glycosidic linkages in starch, glycogen, and related polysaccharides and oligosaccharides containing 3 or more 1,4-alpha-linked D-glucose units. EC 3.2.1.1. Amylases (66-77) Fxalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid D03.383.548.332.025; D14.100.190.200.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Receptors, AMPA Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Oxazoles; Isoxazoles Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Excitatory Amino Acid Agents; Excitatory Amino Acid Agonists alpha-Amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid. An IBOTENIC ACID homolog and glutamate agonist that is used as a radionuclide imaging agent. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). Ibotenic Acid/analogs and derivatives (80-93)  =.:)6alpha 1-Antitrypsin D08.373.745.800.810.100; D08.373.745.800.900.100; D12.776.124.050.070; D12.776.124.790.106.085; D12.776.377.715.085.085 ADAEAGANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Trypsin Inhibitors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Plasma glycoprotein member of the serpin superfamily which inhibits trypsin, neutrophil elastase, and other proteolytic enzymes. Commonly referred to as alpha 1-proteinase inhibitor (A1PI), it exists in over 30 different biochemical variant forms known collectively as the Pi (protease inhibitor) system. Hereditary A1PI deficiency is associated with pulmonary emphysema. /Balpha 1-Antichymotrypsin D08.373.745.800.810.075; D12.776.124.050.050; D12.776.124.790.106.050; D12.776.377.715.085.050 AAADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Protease Inhibitors; Serine Proteinase Inhibitors; Serpins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Glycoprotein found in alpha(1)-globulin region in human serum. It inhibits chymotrypsin-like proteinases in vivo and cytotoxic killer cell activity in vitro. The protein also has a role as an acute phase protein and is active in the control of immunologic and inflammatory processes, and as a tumor marker. It is a member of the serpin superfamily. Chymotrypsin/antagonists and inhibitors (68-86); Glycoproteins (66-86); Protease Inhibitors (79-86) qhFtAlpha Rhythm E01.236.257.401.148; E01.399.277.148 AECLCTDEECHIISMOMTNUPXRESNSTTDUTVE Diagnosis; Diagnosis, Neurologic (Non MeSH); Diagnosis, Brain (Non MeSH); Electroencephalography Diagnosis; Electrodiagnosis; Electroencephalography Electroencephalography (66-71) l*&#Alpha Particles H01.671.579.055; H01.671.768.513.055 AECLDUHITU Physical Sciences (Non MeSH); Physics; Nuclear Physics Physical Sciences (Non MeSH); Physics; Radiation; Radiation, Ionizing Positively charged particles composed of two protons and two neutrons, i.e., helium nuclei, emitted during disintegration of very heavy isotopes; a beam of alpha particles or an alpha ray has very strong ionizing power, but weak penetrability. ;*alpha Macroglobulins D12.776.124.050.080; D12.776.124.790.106.100; D12.776.124.790.720.100; D12.776.377.715.085.100; D12.776.377.715.647.100 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Acute Phase Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins; Macroglobulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Alpha Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins; Macroglobulins Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters. alpha Globulins (74-75); Macroglobulins (73-75) DUp9Alpha Globulins D12.776.124.790.106; D12.776.377.715.085 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins; Serum Globulins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Globulins; Serum Globulins alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha Macroglobulins; Antiplasmin; Antithrombin III; Ceruloplasmin; Haptoglobins; Heparin Cofactor II; Orosomucoid; Progesterone-Binding Globulin; Retinol-Binding Proteins; Transcortin alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha Macroglobulins; Antiplasmin; Antithrombin III; Ceruloplasmin; Haptoglobins; Heparin Cofactor II; Orosomucoid; Progesterone-Binding Globulin; Retinol-Binding Proteins; Transcortin AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR .DHalpha Fetoproteins D12.776.320.050; D24.185.101.840.050 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Fetal Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Biological Markers; Tumor Markers, Biological The first alpha globulins to appear in mammalian sera during development of the embryo and the dominant serum proteins in early embryonic life. They reappear in the adult serum during certain pathologic states, primarily hepatocellular carcinoma. Fetal Proteins (70-74) ط*DAlouattinae B02.649.801.400.120.075 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae Alouatta A subfamily of CEBIDAE inhabiting the forests of Central and South America. The genus ALOUATTA, or howler monkeys, belongs to this subfamily of New World monkeys. u(? Alouatta B02.649.801.400.120.075.075 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Primates; Haplorhini; Cebidae; Alouattinae A genus of the subfamily ALOUATTINAE, family CEBIDAE, composed of six species. They are A. belzebul (black and red howler), A. caraya (black howler), A. fusca (brown howler), A. palliata (mantled howler), A. seniculus (red howler), and A. villosa (also known as A. pigra; Guatemalan howler). They inhabit the forests of Central and South America. Howlers travel in groups and define their territories by howling accompanied by vigorously shaking and breaking branches.  (N*Alopecia Areata C17.800.805.305.122.147 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases; Alopecia A microscopically inflammatory, usually reversible, patchy hair loss occurring in sharply defined areas and usually involving the beard or scalp. (Dorland, 27th ed). NAlopecia C17.800.805.305.122 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases Alopecia Areata; Hypotrichosis; Mucinosis, Follicular Absence of the hair from areas where it is normally present.  Nz?KAloe B06.560.050 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal A genus of the family Liliaceae containing anthraquinone glycosides such as aloin-emodin or aloe-emodin (EMODIN) that cause gastrointestinal irritation, purgation, and kidney damage. It was used formerly as a laxative and for treatment of dermatitis. l& "Almitrine D03.383.606.130; D03.383.931.095 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperazines Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Triazines 6-(4-(Bis(4-fluorophenyl)methyl)-1-piperazinyl)-N,N'-di-2-propenyl-1,3,5-triazine-2,4-diamine. A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. Analeptics (66-89); Piperazines (66-89)  &:10Almanacs L01.178.682.192.836.072 HI Information Science; Communications Media (Non MeSH); Publications (Non MeSH); Books; Reference Books  zAllylisopropylacetamide D02.065.064.189; D02.241.081.038.108.189; D02.455.326.271.122.272 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Acetamides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Allyl Compounds sI:,Allylglycine D02.455.326.271.122.260; D12.125.481.100; D14.100.240.300.050; D15.220.224.035 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Allyl Compounds Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Glycine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); GABA Agents; GABA Antagonists Central Nervous System Agents; Central Nervous System Stimulants; Convulsants A glutamate decarboxylase and GABA inhibitor. It is used to induce convulsions in experimental animals. Allyl Compounds (71-75); Analeptics (66-74); Convulsants (74-79); Glycine (66-74) /antagonists and inhibitors (75-79) \X:{Allylestrenol D04.808.365.415.050; D06.597.799.065 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Estranes; Estrenes Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic 17-Allylestr-4-en-17 beta-ol. A synthetic steroid with progestational activity. Allyl Compounds (73-74); Estranes (70-74); Hydroxysteroids (73-74) *:\PAllylamine D02.092.050; D02.455.326.271.122.100 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Allyl Compounds Possesses an unusual and selective cytotoxicity for vascular smooth muscle cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation. Allyl Compounds (74-75); Amines (74-75) *:1Allyl Compounds D02.455.326.271.122 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes Allylamine; Allylglycine; Allylisopropylacetamide Alkenes (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  28g9:Alloys D01.552.033; D25.058 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Metals Biomedical and Dental Materials (Non MeSH) Chromium Alloys (+ 1); Gold Alloys; Metal Ceramic Alloys; Steel (+ 1) Chromium Alloys (+ 1); Gold Alloys; Metal Ceramic Alloys; Steel (+ 1) A mixture of metallic elements or compounds with other metallic or metalloid elements in varying proportions.  ,aAlloxan D03.383.742.698.122 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Pyrimidines; Pyrimidinones  :hAllosteric Site G06.184.154.147 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH); Binding Sites {Allosteric Regulation G06.184.060 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Binding Sites (68-70); Chemistry (66-70); Enzyme Activation (69-70); Enzyme Induction (66-70); Kinetics (66-70) ghAllopurinol D03.438.759.160; D08.373.057; D17.050.337.075; D22.204.144.055; D26.087.012 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Antirheumatic Agents; Gout Suppressants Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antimetabolites, Antineoplastic Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites A xanthine oxidase inhibitor that, because of its ability to decrease uric acid production, is used therapeutically as a gout suppressant. Enzymes (66); Xanthine Oxidase (66) W:-Allophanate Hydrolase D08.586.277.087.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Amidohydrolases An enzyme that catalyzes the hydrolysis of allophanic acid to two molecules of ammonia plus two molecules of "active carbon dioxide". EC 3.5.1.54. Amidohydrolases (74); Carboxylic Acids (74); Urea (74) -FfDAllolevivirus B04.123.205.600.050; B04.123.450.050; B04.123.691.600.050; B04.820.410.050 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Bacteriophages; Coliphages; Leviviridae Viruses; Bacteriophages; Leviviridae Viruses; Bacteriophages; RNA Phages; Leviviridae Viruses; RNA Viruses; Leviviridae A bacteriophage genus of the family LEVIVIRIDAE, whose infectivity is UV-sensitive. #TbAllium B06.510.026 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Edible Garlic A genus of liliaceous herbs containing Allium cepa or onion, Allium sativum or garlic, Allium porrum or leeks, Allium ascalonicum or shallots, and others; many produce pungent, often bacteriostatic and physiologically active compounds and are used as food, condiment, and medicament, the latter in folk medicine. Garlic (66-85); Plants (66-85); Vegetables (66-85) AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI $ & k?4Alligators and Crocodiles B02.833.100 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles Large, long-tailed reptiles, including caimans, of the order Loricata. c&SAllied Health Personnel M01.526.485.067; N02.360.067 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH); Health Personnel Facilities, Manpower and Services (Non MeSH); Health Personnel Animal Technicians; Community Health Aides; Dental Auxiliaries (+ 4); Emergency Medical Technicians; Home Health Aides; Medical Record Administrators; Medical Secretaries (+ 1); Nurses' Aides (+ 1); Operating Room Technicians; Pharmacists' Aides; Physician Assistants (+ 2) Animal Technicians; Community Health Aides; Dental Auxiliaries (+ 4); Emergency Medical Technicians; Home Health Aides; Medical Record Administrators; Medical Secretaries (+ 1); Nurses' Aides (+ 1); Operating Room Technicians; Pharmacists' Aides; Physician Assistants (+ 2) Health care workers specially trained and licensed to assist and support the work of health professionals. Often used synonymously with paramedical personnel, the term generally refers to all health care workers who perform tasks which must otherwise be performed by a physician or other health professional. Health Manpower (68-70); Health Occupations (66-70)  H"g>Allied Health Occupations G02.010 CLECEDHILJSNSTTD Health Occupations Audiology; Occupational Therapy; Physical Therapy; Speech-Language Pathology; Technology, Dental; Technology, Medical; Technology, Radiologic Occupations of medical personnel who are not physicians, and are qualified by special training and, frequently, by licensure to work in supporting roles in the health care field. These occupations include, but are not limited to, medical technology, physical therapy, physician assistant, etc. Health Occupations (74-90) AECLCTECEDHIISLJMAMTNUOGPXSNSTTDUTVE $  U (Allethrin D02.455.849.700.272; D05.723.491.324.550.272 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Pyrethrins Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Botanical; Pyrethrins Cycloparaffins (66-71); Pyrethrum (66-71)  i 2:2Allergy and Immunology G02.403.776.030 CLECEDHIISLJMAOGSNSTTD Health Occupations; Medicine; Specialties, Medical A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder. <Allergens D24.611.216.063 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Bites and Stings; Dust; Feathers; Fungi Pollen Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens \ 63 gAlleles G05.275.077 Genetics; Genes Immunoglobulin Allotypes (+ 2) Mutually exclusive forms of the same gene, occupying the same locus on homologous chromosomes, and governing the same biochemical and developmental process. Syn: allelomorphs. Genes (66-67) ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR  } %6Allantois A16.254.403.147 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Embryonic Structures (Non MeSH); Embryo; Fetal Membranes An embryonic diverticulum of the hindgut of reptiles, birds, and mammals; in man its blood vessels give rise to those of the umbilical cord.  :EAllantoin D03.383.374.411.105 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Imidazoles; Hydantoins { DdAlkynes D02.455.326.397 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH) Acetylene AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR f 8[ :Alkylmercury Compounds D02.691.750.100; D05.723.288.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organometallic Compounds; Organomercury Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Fungicides, Industrial Chlormerodrin; Ethylmercury Compounds (+ 3); Mersalyl; Methylmercury Compounds Ethylmercury Compounds (+ 1); Methylmercury Compounds Organic mercury compounds in which the mercury is attached to an alkyl group. Mercury (66-76); Organometallic Compounds (68-76) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $&8^;:Alkylation G06.535.630.146; H01.181.404.146 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Methylation Methylation W&Alkylating Agents D26.550.025 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Antineoplastic Agents; Carcinogens; Nitrogen Mustard Compounds Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Most are very toxic, with carcinogenic, mutagenic, teratogenic and immunosuppressant actions; many are used as antineoplastic agents and formerly as poison gases. ,IPXAlkenes D02.455.326.271 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH) Allyl Compounds (+ 3); Ethylenes (+ 1); Polyenes (+ 12); Vinyl Compounds (+ 7) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  8[e<Alkaptonuria C18.452.648.066.187 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors Ochronosis An inborn error of amino acid metabolism resulting from a defect in the enzyme homogentisate 1,2-dioxygenase and causing an accumulation of homogentisic acid in the urine. The condition is characterized by ochronosis in various tissues and arthritis.  nL $Alkanesulfonic Acids D02.455.326.146.100; D02.886.645.600.055 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids Alkanesulfonates (+ 5); HEPES; Isethionic Acid; Taurine (+ 4) Alkanesulfonates (+ 5); HEPES; Isethionic Acid; Taurine (+ 4) Sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group. Sulfonic Acids (66-93) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $.8bFAlkanesulfonates D02.455.326.146.100.050; D02.886.645.600.055.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkanes; Alkanesulfonic Acids Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfur Acids; Sulfonic Acids; Alkanesulfonic Acids Mesna; Mesylates (+ 3) Mesna; Mesylates (+ 3) Organic esters or salts of sulfonic acid derivatives containing an aliphatic hydrocarbon radical. Alkylating Agents (66-72); Sulfonic Acids (66-72) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $"68:r<:Alkanes D02.455.326.146 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH) Alkanesulfonic Acids (+ 13); Butanes; Ethane (+ 1); Heptanes; Hexanes; Methane (+ 1); Nitroparaffins (+ 1); Octanes; Pentanes; Propane AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR % 8[FAlkalosis, Respiratory C08.618.501.271; C18.452.076.354.271 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hypocapnia Respiratory Tract Diseases; Respiration Disorders; Hyperventilation Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance; Alkalosis A state due to excess loss of carbon dioxide from the body. (Dorland, 27th ed). Alkalosis (66-70); Hyperventilation (66-70)  'V*Nd4Alkalosis C18.452.076.354 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Acid-Base Equilibrium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance Alkalosis, Respiratory A pathologic condition resulting from accumulation of base, or from loss of acid without comparable loss of base in the body fluids. It is characterized by decrease in hydrogen ion concentration (increase in pH). (Dorland, 27th ed).  )y NfAlkaloids D03.132 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Plants, Medicinal Heterocyclic Compounds Aconite (+ 1); Acronine; Aporphines (+ 1); Arecoline; Berbines (+ 1); Bicuculline; Camptothecin; Cinchona Alkaloids (+ 2); Colchicine (+ 2); Curare (+ 3); Dihydro-beta-Erythroidine; Ellipticines; Emetine; Ergot Alkaloids (+ 17); Galanthamine; Harmaline; Harmine; Harringtonines; Ibogaine; Ipecac (Syrup); Lobeline; Mescaline; Muscarine; Opium (+ 30); Paclitaxel; Physostigmine; Pilocarpine; Pyrrolizidine Alkaloids (+ 1); Ryanodine; Salsoline Alkaloids; Solanaceous Alkaloids (+ 7); Sparteine; Strychnine; Swainsonine; Tropanes (+ 10); Veratrum Alkaloids (+ 5); Vinca Alkaloids (+ 4); Xanthine Alkaloids (+ 7); Yohimbans (+ 5) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  +  8DAlkaline Phosphatase D08.586.277.352.650.035 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Hypophosphatasia Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1. /FAlkalies D01.045 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hypercalcemia Inorganic Chemicals (Non MeSH) Carbonates (+ 1); Hydroxides (+ 3) Usually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines. (Grant and Hackh's Chemical Dictionary, 5th ed).  1{  8%-Alkalescens-Dispar Group B03.440.450.425.325.300.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Enterobacteriaceae; Escherichia; Escherichia coli Non-motile anaerogenic enteric organisms that ferment lactose late or not at all. They were formerly classified with the SHIGELLA, but biochemically and antigenically resemble atypical strains of ESCHERICHIA. 33"Alkadienes D02.455.326.271.665.146 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkenes; Polyenes Butadienes; Chloroprene AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR 578s:Algorithms H01.548.035; H01.770.035; L01.700.568.110.050 Physical Sciences (Non MeSH); Mathematics Physical Sciences (Non MeSH); Science Information Science; Medical Informatics; Medical Informatics Computing; Computing Methodologies (Non MeSH) A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. 65Alginates D09.203.698.068; D25.339.334.187 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTUUL Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides Biomedical and Dental Materials (Non MeSH); Dental Materials; Dental Impression Materials 8T &.Algestone Acetophenide D04.808.745.745.654.829.025.025; D06.597.799.023.100; D07.360.276.210.443.706.069.025; D17.025.050.025; D17.025.080.050; D23.037.015 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Progesterone; Algestone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic; Algestone Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic; Algestone Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Steroidal Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation Mediators (Non MeSH); Anti-Inflammatory Agents; Anti-Inflammatory Agents, Topical Dermatologic Agents; Anti-Inflammatory Agents, Topical (16 alpha(R))-16,17-((1-Phenylethylidene)bis(oxy))pregn-4-ene-3,20-dione. A progesterone that has been used in estrus synchronization and has been evaluated as an injectable contraceptive in combination with estradiol enanthate. It is also used therapeutically as a topical anti-inflammatory and is applied topically in the treatment of acne. 9:TAlgestone D04.808.745.745.654.829.025; D06.597.799.023; D07.360.276.210.443.706.069 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones; Progesterone Hormones, Substitutes, Antagonists (Non MeSH); Hormones, Synthetic; Progestational Hormones, Synthetic Reproductive Control Agents (Non MeSH); Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Progestational Hormones, Synthetic Algestone Acetophenide Algestone Acetophenide Algestone Acetophenide 16 alpha,17-Dihydroxypregn-4-ene-3,20-dione. Progestational dihydroxy derivative of progesterone. Its acetonide possesses anti-inflammatory properties. ? Q:MAlgeria Z01.058.266.104 EHEP Geographicals (Non MeSH); Africa; Africa, Northern B >Algae, Red B05.104.305 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae Algae of the division Rhodophyta, in which the pigment is predominantly red; common genera are Gelidium, Gracilaria, and Polysiphonia. Algae (66-70) Cb&,Algae, Green B05.104.234 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae Acetabularia; Chlamydomonas (+ 1); Chlorella (+ 1) Algae of the division Chlorophyta, in which the green pigment of chlorophyll is not masked by other pigments. Classes include Charophyceae, Bryopsidophyceae, Conjugatophyceae, Oedogoniophyceae, Chlorophyceae, and Prasinophyceae. Common genera are ACETABULARIA, CHLAMYDOMONAS, CHLORELLA, Nitella, PROTOTHECA, Scenedesmus, Spiragyra, and Volvox. Algae (66-69)  D&,?Algae, Brown B05.104.163 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae Laminaria Predominantly marine algae of the division Phaeophyta, having chromatophores containing carotenoid pigments. Genera include Ascophyllum, Fucus, Eisenia, Petalonia, Ectocarpus. Algae (66-70)  G&, Algae and Fungi (Non MeSH) B05 Algae (+ 18); Fungi (+ 104); Lichens; Plankton (+ 1); Spores (+ 1) CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI H"Y&Algae B05.104 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH) Algae, Brown (+ 1); Algae, Green (+ 5); Algae, Red; Blood-Borne Pathogens; Cyanobacteria (+ 3); Diatoms; Euglena (+ 1); Seaweed A major group of lower plants that comprises, usually, photosynthetic plants of extremely varied morphology and physiology, and that is commonly considered to be a heterogeneous assemblage. They are freshwater and marine, terrestrial and subterranean; some are neustonic (living at the interface of water and the atmosphere). They live in various protozoa and within other plants. Among the vectors of aquatic algae are water movements (tides and currents), wind, ships, beetles, aquatic birds, etc. They live also in soil and on soil surfaces, on long-persistent snows, and in Antarctic rocks. Thermophilic algae inhabit hot springs. (From Webster, 3d ed; from Bold and Wynne, Introduction to the Algae, 2d ed). Ie  &"DAlfentanil D03.383.621.265.100; D15.040.150.200.025; D15.045.250.025; D15.050.035.075.400.025; D15.210.100.175.075.400.025; D15.210.600.330.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Piperidines; Fentanyl Central Nervous System Agents; Analgesics; Analgesics, Opioid; Fentanyl Central Nervous System Agents; Anesthesia Adjuvants; Fentanyl Central Nervous System Agents; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Fentanyl Central Nervous System Agents; Central Nervous System Depressants; Anesthetics; Anesthetics, General; Anesthetics, Intravenous; Fentanyl Central Nervous System Agents; Central Nervous System Depressants; Narcotics; Fentanyl N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)-4-piperidinyl)-N-phenylpropanamide. A short-acting opioid anesthetic and analgesic derivative of FENTANYL. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients. Fentanyl/analogs and derivatives (66-89) M:p0Alfalfa Mosaic Virus B04.715.464.050; B04.820.464.050 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; Plant Viruses; Mosaic Viruses Viruses; RNA Viruses; Mosaic Viruses A multicomponent plant virus transmitted by seeds and non-persistently by aphids. Mosaic Viruses (73-93); Plant Viruses (66-93) SW&\`8Alfalfa B06.510.570.042; J01.341.052.146 AEAHCHCLCYDEECEMENGDGEHIIMMEMIPHPOPSRESDSTTOULVI Plants; Plants, Edible; Legumes Technology, Industry, Agriculture (Non MeSH); Food; Animal Feed T &4sAleutian Mink Disease Parvovirus B04.280.580.600.100; B04.909.204.671.600.100 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Parvoviridae; Parvovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Parvoviridae; Parvovirus A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color. U'2Aleutian Mink Disease C02.256.700.091; C02.839.091; C20.673.774.257.270; C22.062 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Chediak-Higashi Syndrome Chediak-Higashi Syndrome Virus Diseases; DNA Virus Infections (Non MeSH); Parvoviridae Infections Virus Diseases; Slow Virus Diseases Immunologic Diseases; Immunologic Deficiency Syndromes; Phagocyte Bactericidal Dysfunction; Chediak-Higashi Syndrome Animal Diseases A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE PARVOVIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible. Carnivora (66-67); Mink (68-70); Virus Diseases (66-70) $WDJEAldrin D02.455.526.439.042; D05.723.491.491.053 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Halogenated; Hydrocarbons, Chlorinated Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organochlorine Hydrocarbons, Halogenated (66-70); Insecticides (66-70) [ .:AAldosterone Antagonists D06.347.050 ADAEAGANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists Canrenoate Potassium (+ 1); Spironolactone Compounds which inhibit or antagonize the biosynthesis or actions of aldosterone. Aldosterone (66-77) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $]6N4`:Aldosterone D04.808.745.745.654.062; D06.472.040.668.478.561.187 AAADAEAGANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Hyperaldosteronism; Hypoaldosteronism; Pseudohypoaldosteronism; Receptors, Aldosterone; Renin-Angiotensin System Polycyclic Hydrocarbons; Steroids; Pregnanes; Pregnenes; Pregnenediones Hormones, Substitutes, Antagonists (Non MeSH); Hormones; Adrenal Cortex Hormones; Mineralocorticoids; Hydroxycorticosteroids; 11-Hydroxycorticosteroids (11 beta)-11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al. A hormone secreted by the adrenal cortex that functions in the regulation of electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. _j:B~Aldicarb D02.241.081.251.046; D05.723.491.408.103 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Carbamates Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Carbamate 2-Methyl-2-(methylthio)propanal O-((methylamino)carbonyl)oxime. Carbamate derivative used as an insecticide, acaricide, and nematocide. Carbamates (66-71); Insecticides (66-71) b .:1Aldehydes D02.047 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Acetaldehyde (+ 1); Acrolein; Benzaldehydes; Formaldehyde (+ 1); Furaldehyde; Glutaral; Glyceraldehyde (+ 1); Glyoxal (+ 2); Malondialdehyde (+ 1); o-Phthalaldehyde; Retinaldehyde AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR d  8#DAldehyde-Lyases D08.586.520.110 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases Fructosediphosphate Aldolase; Phospho-2-keto-3-deoxyheptonate Aldolase fFONAldehyde Reductase D08.586.682.047.150.700.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases; Carbohydrate Dehydrogenases; Sugar Alcohol Dehydrogenases An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21. Alcohol Oxidoreductases (72-75); Sugar Alcohols (72-75) gFBAldehyde Oxidoreductases D08.586.682.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Aldehyde Dehydrogenase; Aspartate-Semialdehyde Dehydrogenase; Formate Dehydrogenases; Glyceraldehydephosphate Dehydrogenase Oxidoreductases (66-72) jFXAldehyde Dehydrogenase D08.586.682.075.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Aldehyde Oxidoreductases An enzyme that oxidizes an aldehyde in the presence of NAD+ and water to an acid and NADH. EC 1.2.1.3. Before 1978, it was classified as EC 1.1.1.70. Alcohol Oxidoreductases (74-79); Aldehyde Oxidoreductases (80-84) kFuLAlcuronium D02.092.102.844.050; D02.675.276.844.050; D03.132.267.712.050; D14.100.120.200.600.020; D16.700.710.575.012 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Toxiferine Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Toxiferine Heterocyclic Compounds; Alkaloids; Curare; Toxiferine Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Antagonists; Nicotinic Antagonists Peripheral Nervous System Agents (Non MeSH); Neuromuscular Agents; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents 4,4'-Didemethyl-4,4'-di-2-propenyltoxiferine I. A non-depolarizing skeletal muscle relaxant similar to TUBOCURARINE. It is used as an anesthesia adjuvant. Allyl Compounds (72-74); Toxiferine (72-74) mw:<5Alcohols, Octyl D02.033.286; D02.033.555.375; D10.516.289.375 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols q58Alcohols, Hexyl D02.033.248; D02.033.555.304; D10.516.289.304 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols s%58Alcohols, Butyl D02.033.210; D02.033.555.233; D10.516.289.233 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols Acetoin; Chlorobutanol Acetoin; Chlorobutanol Acetoin; Chlorobutanol Alcohols (66-71) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  t58P:Alcohols, Amyl D02.033.172; D02.033.555.162; D10.516.289.162 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols Alcohols (66-71) v58Alcohols D02.033 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH) Alcohol, Ethyl (+ 6); Alcohol, Methyl; Alcohol, Propyl (+ 2); Alcohols, Amyl; Alcohols, Butyl (+ 2); Alcohols, Hexyl; Alcohols, Octyl; Amino Alcohols (+ 56); Benzyl Alcohols; Chlorohydrins (+ 5); Cyclohexanols (+ 2); Fatty Alcohols (+ 13); Glycols (+ 22); Polyvinyl Alcohol; Sugar Alcohols (+ 25) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR x  8#nDAlcoholism C21.613.053.270; F03.709.597.780.660.080 BLCFCLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Alcohol Deterrents; Alcoholics Anonymous; Fetal Alcohol Syndrome; Psychoses, Alcoholic; Skid Row Alcoholics; Temperance Alcohol Drinking; Social Problems Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Personality Disorders; Substance Use Disorders; Substance Dependence Cardiomyopathy, Alcoholic; Fetal Alcohol Syndrome; Liver Diseases, Alcoholic (+ 3); Psychoses, Alcoholic (+ 2) A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse and Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4). BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI (zM.J)LAlcoholics Anonymous N03.540.782.270 ECHIOG Alcoholism Economics, Organizations, Control (Non MeSH); Organizations; Self-Help Groups An organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence. z [~Alcoholic Intoxication C21.613.053; F03.709.508.490.080 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Substance-Induced Alcoholism (+ 9) A condition caused by the ingestion of alcohol in which control of one's faculties is impaired and inhibitions are broken. In its later stages one tends toward or reaches insensibility. (Webster, 3d ed). &LAlcoholic Beverages J01.125.091 AEANCLECHIMIPOPSRESDSNSTTOUTVI Alcohol, Ethyl Technology, Industry, Agriculture (Non MeSH); Beverages Absinthe; Beer; Wine X"BAlcohol, Propyl D02.033.134; D02.033.555.091; D10.516.289.091 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols Propanolamines (+ 1) 95:Alcohol, Methyl D02.033.095 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols :0Alcohol, Ethyl D02.033.057; D15.210.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKRESDSTTOTUUR Alcoholic Beverages Organic Chemicals (Non MeSH); Alcohols Central Nervous System Agents; Central Nervous System Depressants Ethamoxytriphetol; Ethanolamines; Ethylene Chlorohydrin; Mercaptoethanol; Phenethyl Alcohol; Trifluoroethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $e8{~:Alcohol Withdrawal Delirium C21.613.053.270.750.148; F03.709.508.460.670.675.148; F03.709.680.610.580.510.148 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism; Psychoses, Alcoholic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Psychoses, Substance-Induced; Psychoses, Alcoholic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Psychoses, Substance-Induced; Psychoses, Alcoholic An acute organic mental disorder due to recent cessation or reduction in alcohol consumption with the essential characteristic being delirium. Autonomic hyperactivity - that is, tachycardia, sweating, and elevated blood pressure - is also present. It was formerly called delirium tremens. !YDMAlcohol Oxidoreductases D08.586.682.047 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases Acetoin Dehydrogenase; Alcohol Dehydrogenase; Carbohydrate Dehydrogenases (+ 11); Galactose Oxidase; Glucose Oxidase; Homoserine Dehydrogenase (+ 1); 3-Hydroxyacyl CoA Dehydrogenases (+ 1); Hydroxybutyrate Dehydrogenase; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases (+ 7); IMP Dehydrogenase; Isocitrate Dehydrogenase; Lactate Dehydrogenase (+ 1); Malate Dehydrogenase; Ribonucleotide Reductases (+ 1) A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99). FXdAlcohol Drinking F01.145.317.269 AEBLCFDTECEHEPGEHIIMLJMEMOPAPCPPPXTDTHUR Alcoholism; Temperance Drinking Behavior and Behavior Mechanisms (Non MeSH); Behavior; Drinking Behavior Behaviors associated with the ingesting of alcoholic beverages, including social drinking. Alcoholic Beverages (66-68) $M, Wi!Alcohol Deterrents D26.032 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Alcoholism Miscellaneous Drugs and Agents (Non MeSH) Disulfiram AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR   ,2:Alcohol Dehydrogenase D08.586.682.047.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme that catalyzes reversibly the final step of alcoholic fermentation by reducing an aldehyde to an alcohol. In the case of ethanol, acetaldehyde is reduced to ethanol in the presence of NADH and hydrogen. The enzyme is a zinc protein which acts on primary and secondary alcohols or hemiacetals. EC 1.1.1.1. Alcohol Oxidoreductases (66-86) Ftu%Alcohol Amnestic Disorder C21.613.053.270.750.141; F03.709.508.460.140; F03.709.508.460.670.675.141; F03.709.680.610.080; F03.709.680.610.580.510.141 BLCFCLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Alcoholic Intoxication; Alcoholism; Psychoses, Alcoholic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Psychoses, Substance-Induced; Psychoses, Alcoholic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Psychoses, Substance-Induced; Psychoses, Alcoholic A mental disorder with brain damage characterized by amnesia, compensatory confabulation, disturbance of attention, and peripheral neuritis. It is usually associated with alcoholism and dietary deficiencies. D+Alcian Blue D03.438.473.050; D26.408.050 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Miscellaneous Drugs and Agents (Non MeSH); Dyes A copper-containing dye used as a gelling agent for lubricants, for staining of bacteria and for the dyeing of histiocytes and fibroblasts in vivo. Synonyms: C.I. 74240; C.I. Ingrain Blue 1. Indoles (73-74); Onium Compounds (74) "./Alchemy K01.419.075 Chemistry Humanities; History   Alcaligenes B03.440.400.425.125 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) A genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans. 2"Albuterol D02.033.329.291.057; D02.092.063.291.057; D02.092.471.683.061; D06.347.930.050; D14.100.050.100.200.040; D16.050.110.020; D16.050.870.030; D26.930.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Ethanolamines Organic Chemicals (Non MeSH); Amines; Ethylamines; Phenethylamines Hormones, Substitutes, Antagonists (Non MeSH); Hormone Antagonists; Tocolytic Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists; Adrenergic beta-Agonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Bronchodilator Agents Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympathomimetics Miscellaneous Drugs and Agents (Non MeSH); Tocolytic Agents A direct-acting sympathomimetic agent with a relatively selective action on beta-2 adrenoceptors. Its main clinical use is in asthma. (From Martindale, The Extra Pharmacopoeia, 30th ed, p.1254).   : Albuminuria C12.777.584.269 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urine Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Proteinuria "N ]Albumins D12.776.034 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUL Prealbumin; Receptors, Albumin Amino Acids, Peptides and Proteins (Non MeSH); Proteins C-Reactive Protein; Conalbumin; Lactalbumin; Ovalbumin (+ 1); Parvalbumins; Ricin; Serum Albumin (+ 4); Technetium Tc 99m Aggregated Albumin Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ B%DHAlbinism, Oculocutaneous C11.270.055; C16.131.410.040.100; C17.800.621.440.102.100; C17.800.827.130.100; C18.452.648.066.102.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Diseases, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary; Albinism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hypopigmentation; Albinism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Albinism Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Albinism Heterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair, and eyes. The two most common are the tyrosinase-positive and tyrosinase-negative types. Albinism (66-90) sLF-Albinism, Ocular C11.270.050; C16.131.410.040.090; C17.800.621.440.102.090; C17.800.827.130.090; C18.452.648.066.102.090 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Eye Diseases; Eye Diseases, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary; Albinism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hypopigmentation; Albinism Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Albinism Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors; Albinism Albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. The classic type is X-linked (Nettleship-Falls), but an autosomal recessive form also exists. Ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity. Albinism (66-90) sLF|Albinism C11.270.040; C16.131.410.040; C17.800.621.440.102; C17.800.827.130; C18.452.648.066.102 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Chediak-Higashi Syndrome Monophenol Monooxygenase Eye Diseases; Eye Diseases, Hereditary Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Eye Diseases, Hereditary Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hypopigmentation Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH) Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Amino Acid Metabolism, Inborn Errors  Albinism, Ocular; Albinism, Oculocutaneous; Piebaldism Albinism, Ocular; Albinism, Oculocutaneous; Piebaldism Albinism, Ocular; Albinism, Oculocutaneous; Piebaldism Albinism, Ocular; Albinism, Oculocutaneous; Piebaldism General term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair. $ cLAlberta Z01.107.567.176.064 EHEP Geographicals (Non MeSH); America; North America; Canada  FAlbendazole D03.438.103.070; D21.201.143 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzimidazoles Antiparasitic Agents (Non MeSH); Anthelmintics (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester. A broad-spectrum anthelmintic effective against many diseases including ascariasis, ancylostomiasis, trichuriasis, taeniasis, enterobiasis, hymenolepiasis, and neurocysticerosis. The drug is well-tolerated with few side effects. Anthelmintics (66-89); Benzimidazoles (66-89) d":J6Albania Z01.542.248.064 EHEP Geographicals (Non MeSH); Europe; Europe, Eastern  =Alastrim C02.256.743.826.269 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH); Poxviridae Infections; Smallpox A mild form of smallpox, caused by a virus slightly less virulent for the chick embryo than the virus causing variola major, and distinguished from the latter disease by its much lower fatality rate.  PaAlaska Z01.107.567.875.100.036 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) l Alanyl T RNA Synthetase D08.586.464.136.040 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Amino Acyl T RNA Synthetases An enzyme that activates alanine with its specific transfer RNA. EC 6.1.1.7. Amino Acyl T RNA Synthetases (73-74); Alanine (73-74) <Ft]BAlanine Racemase D08.586.399.124.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Isomerases; Amino Acid Isomerases A pyridoxal-phosphate protein that reversibly catalyzes the conversion of L-alanine to D-alanine. EC 5.1.1.1. Alanine (74-75); Amino Acid Isomerases (70-75) Fn9Alanine Aminotransferase D08.586.913.140.119 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Aminotransferases An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. ±FjAlanine D12.125.042 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids beta-Alanine; Lysinoalanine; Mimosine b FH-Alamethicin D08.373.936.500.100; D20.085.116.050 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Uncoupling Agents; Ionophores Anti-Infective Agents; Antibiotics; Antibiotics, Peptide L-Prolyl-2-methylalanyl-L-alanyl-2-methylalanyl-L-alanyl-L-glutaminyl-2-methylalanyl-L-valyl-2-methylalanylglycyl-L-leucyl-2-methylalanyl-L-prolyl-L-valyl-2-methylalanyl-2-methylalanyl-L-alpha-glutamyl-L-glutamine cyclic peptide. A cyclic nonadecapeptide antibiotic that can act as an ionophore and is produced by strains of Trichoderma viride. (From Dictionary of Microbiology and Molecular Biology, 2d ed). Antibiotics (71-75); Peptides, Cyclic (73-74) Z*<7Alagille Syndrome C06.130.450.250.125; C06.552.150.125; C16.131.077.065; C23.888.498.250.250.306 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Biliary Tract Diseases; Cholestasis; Cholestasis, Intrahepatic Digestive System Diseases; Liver Diseases; Cholestasis, Intrahepatic Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Abnormalities, Multiple Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Jaundice; Cholestasis; Cholestasis, Intrahepatic Hypoplasia of the hepatic ducts, congenital pulmonary artery stenosis, facial abnormalities, and other congenital malformations, particularly skeletal. It is often presented as jaundice during the neonatal period. It is an autosomal recessive disease generally manifesting during childhood. "Arteriohepatic" refers to the pulmonary artery and the intrahepatic bile ducts, not to the hepatic artery. Abnormalities, Multiple (81-91); Bile Ducts, Intrahepatic/abnormalities (80-91); Cholestasis, Intrahepatic (79-91); Pulmonary Artery/abnormalities (88-91) ȞXLAlabama Z01.107.567.875.100.027; Z01.107.567.875.600.820.027 EHEP Geographicals (Non MeSH); America; North America; United States; United States by Individual State (Non MeSH) Geographicals (Non MeSH); America; North America; United States; United States by Region (Non MeSH); Southeastern United States ͤ :AKR Virus B04.820.650.730.730.900.500.050; B04.909.574.807.730.730.900.500.050; B04.909.777.731.730.730.900.500.050 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A murine leukemia virus isolated from spontaneous leukemia in AKR strain mice. ,qA^Akinetic Mutism C10.228.140.042 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases Mutism (66-70) ҋNVAkathisia, Drug-Induced C10.228.140.079.056; C21.613.276.140; F03.126.720.710.140 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Dyskinesia, Drug-Induced Dyskinesia, Drug-Induced Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Basal Ganglia Diseases Injury, Occupational Dis, Poisoning (Non MeSH); Poisoning; Drug Toxicity (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Psychomotor Disorders; Psychomotor Agitation Motor restlessness with sensations of quivering and an urge to move about constantly resulting from the use of certain drugs, such as neuroleptic drugs, which affect the extrapyramidal region of the brain. This differs from DYSKINESIA, DRUG-INDUCED in that long-term antipsychotic drug exposure is significantly correlated with the increased prevalence of akathisia while there is no such correlation with dyskinesia. The primary observable distinction between tardive akathisia and dyskinesia appears to be in the repetitive, stereotypy of the dyskinesic movements (lip smacking, for example), while akathisia is associated with anxiety, restlessness, and agitation (PSYCHOMOTOR AGITATION). Movement Disorders (68-77); Psychomotor Agitation (78-92) $ӌAL`DAjmaline D03.132.973.641.119; D03.549.937.641.144; D18.097.069 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Heterocyclic Compounds; Alkaloids; Yohimbans; Rauwolfia Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 4 or More Rings (Non MeSH); Yohimbans; Rauwolfia Alkaloids Cardiovascular Agents; Anti-Arrhythmia Agents Prajmaline Prajmaline Prajmaline An alkaloid found in the root of Rauwolfia serpentina, among other plant sources. It is a class Ia antiarrhythmic agent that apparently acts by changing the shape and threshold of cardiac action potentials. Rauwolfia (66-70)  \ =@&Airway Resistance E01.302.796.057; G09.772.521.700.069 DEGEIMPHRE Diagnosis; Diagnosis, Respiratory System (Non MeSH); Respiratory Function Tests Circulatory, Respiratory Physiology (Non MeSH); Respiratory Tract Physiology (Non MeSH); Respiration; Respiratory Mechanics Respiration (66-70); Respiratory System/physiology (66-70) 7*EAirway Obstruction C08.618.846.185 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Lung Diseases, Obstructive Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Nasal Obstruction Any hindrance to the passage of air into and out of the lungs. Respiratory Tract Diseases (66-70) $N XO)Aircraft J01.095.070; J01.937.070 CLECHIISLJSNST Aviation Technology, Industry, Agriculture (Non MeSH); Aviation Technology, Industry, Agriculture (Non MeSH); Transportation Air Ambulances Air Ambulances A weight-carrying structure for navigation of the air that is supported either by its own buoyancy or by the dynamic action of the air against its surfaces. (Webster, 1973). CLECHIISLJSDSNSTTDUT $߆  $Air Sacs A13.048 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Lung Animal Terms (Non MeSH) Thin-walled sacs or spaces which function as a part of the respiratory system in birds, fishes, insects, and mammals. Birds (66-67); Bronchi (66-67)    :'Air Pressure G03.230.300.100.185.100 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Atmospheric Pressure The force per unit area that the air exerts on any surface in contact with it. Primarily used for articles pertaining to air pressure within a closed environment. Air Pollution, Radioactive G03.850.810.080; G03.850.460.100.110 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH) Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution v *Air Pollution, Indoor G03.850.460.100.080 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Air Pollution The contamination of indoor air. Air Pollution (68-91) r)Air Pollution G03.850.460.100 AEANECHILJPCSN Environment and Public Health (Non MeSH); Public Health; Environmental Pollution Air Pollution, Indoor; Air Pollution, Radioactive; Automobile Exhaust; Dust; Smog; Smoke (+ 1) AEANECHILJPCPOSNTO `sAir Pollutants, Radioactive D05.284.101.393; D05.284.638.101 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Radon Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Radioactive Pollutants Pollutants, present in air, which exhibit radioactivity. 0!&6 CAir Pollutants, Occupational D05.284.101.268 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Gas Scavengers Occupational Exposure Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants Air pollutants found in the work area. They are usually produced by the specific nature of the occupation.  "6hAir Pollutants, Environmental D05.284.101.143 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Exposure Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants Acid Rain; Automobile Exhaust; Oxidants, Photochemical (+ 2); Sulfur Dioxide Air pollutants which affect environmental conditions. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR $#6h]?>Air Pollutants D05.284.101 ADAEAGAIANBLCFCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants Air Pollutants, Environmental (+ 6); Air Pollutants, Occupational; Air Pollutants, Radioactive Substances which pollute the air. Air Pollution (66-74) ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPLJMEPCPDPKPORESDSNSTTOTUUR $6Uo*>Air Movements G03.230.300.100.150.185 Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Air Wind Air (66-71); Weather (66-71) hq%Air Microbiology G01.273.540.274.110; G03.850.425.110 ST Biological Sciences; Biology; Microbiology; Environmental Microbiology Environment and Public Health (Non MeSH); Public Health; Environmental Microbiology The presence of bacteria, viruses, and fungi in the air. This term is not restricted to pathogenic organisms. V*Air Ionization G03.230.300.100.150.100; H01.181.529.065 DERE Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Air Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical .Air Conditioning G03.230.150.050 AEECHIISLJMTSNSTTD Environment and Public Health (Non MeSH); Environment; Environment, Controlled The maintenance of certain aspects of the environment within a defined space to facilitate the function of that space; aspects controlled include air temperature and motion, radiant heat level, moisture, and concentration of pollutants such as dust, microorganisms, and gases. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). ]Air Bags E07.712.130 AECLCTECHILJSDSNSTTDUTVE Seat Belts Seat Belts; Automobiles; Accidents, Traffic Equipment and Supplies; Protective Devices An automotive safety device consisting of a bag designed to inflate upon collision and prevent passengers from pitching forward. (American Heritage Dictionary, 1982). Protective Devices (80-92) $c 53 Air Ambulances J01.095.070.100; J01.937.070.100; N02.421.297.879.100.100 CLECHILJSDSNSTTDUT Technology, Industry, Agriculture (Non MeSH); Aviation; Aircraft Technology, Industry, Agriculture (Non MeSH); Transportation; Aircraft Facilities, Manpower and Services (Non MeSH); Health Services; Emergency Medical Services; Transportation of Patients; Ambulances Fixed-wing aircraft or helicopters equipped for air transport of patients. Aircraft (66-93); Ambulances (66-93) $A4X-Air G03.230.300.100.150 ANLJPSST Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere Air Ionization; Air Movements (+ 1) The gaseous mixture which makes up the earth's atmosphere. It is an odorless, colorless gas consisting of about 1 part by volume of oxygen and 4 parts of nitrogen, the proportion varying somewhat according to conditions. It also contains a small amount of carbon dioxide, ammonia, argon, nitrites, and organic matter. (Dorland, 27th ed). ANDELJPSREST  n j-Ainhum C05.116.264.143; C23.304.351.081 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Resorption Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH); Foot Diseases A disease affecting the toes, especially the fifth, and sometimes the fingers, seen chiefly in black adult males in Africa, in which a linear constriction around the affected digit leads to spontaneous amputation of its distal part. (Dorland, 27th ed).  &N*AIDS-Related Opportunistic Infections C01.539.597.050; C02.597.050; C02.782.815.616.400.100; C03.684.050; C20.673.480.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Opportunistic Infections Virus Diseases; Opportunistic Infections Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections; HIV Infections Parasitic Diseases; Opportunistic Infections Immunologic Diseases; Immunologic Deficiency Syndromes; HIV Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include Pneumocystis carinii pneumonia, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. specific opportunistic infection (83-92); specific HIV infection (83-92); Opportunistic Infections (83-92) w+_Pp|AIDS-Related Complex C02.782.815.616.400.080; C02.800.801.080; C02.839.080; C20.673.480.080 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections; HIV Infections Virus Diseases; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral Virus Diseases; Slow Virus Diseases Immunologic Diseases; Immunologic Deficiency Syndromes; HIV Infections A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS. Acquired Immunodeficiency Syndrome (83-86) PP]d1AIDS-Associated Nephropathy C02.782.815.616.400.050; C12.777.419.050; C20.673.480.050 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections; HIV Infections Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases Immunologic Diseases; Immunologic Deficiency Syndromes; HIV Infections Renal syndrome in human immunodeficiency virus-infected patients characterized by nephrotic syndrome, severe proteinuria, focal and segmental glomerulosclerosis with distinctive tubular and interstitial changes, enlarged kidneys, and peculiar tubuloreticular structures. The syndrome is distinct from heroin-associated nephropathy as well as other forms of kidney disease seen in HIV-infected patients. Acquired Immunodeficiency Syndrome (84-90); Kidney Diseases (84-90); specific kidney diseases (84-90)  AP4wAIDS Vaccines D24.310.894.899.050 ADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Products; Vaccines; Viral Vaccines Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent AIDS. Some vaccines containing antigens are recombinantly produced. Viral Vaccines (87-91)  >lAIDS Serodiagnosis E01.223.495.826.075 AECLCTECHIISLJMOMTNUPXSNSTTDUTVE HIV Seroprevalence HIV Antibodies; Acquired Immunodeficiency Syndrome Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis Immunologic tests for identification of HIV (HTLV-III/LAV) antibodies. They include assays for HIV SEROPOSITIVITY and HIV SERONEGATIVITY (ELISA, immunofluorescence, immunoblot, etc.) that have been developed for screening persons carrying the viral antibody from patients with overt symptoms of AIDS or AIDS-RELATED COMPLEX. Acquired Immunodeficiency Syndrome (84-88); Antibodies, Viral (83-88); HIV/immunology (88); HTLV-III/immunology (87); Human T-Cell Leukemia Virus/immunology (84-87) $ $;NuAIDS Dementia Complex C02.782.815.616.400.070; C02.800.801.070; C02.839.070; C10.228.140.380.070; C10.228.228.057; C20.673.480.070; F03.709.508.460.245.130; F03.709.680.610.392.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections; HIV Infections Virus Diseases; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral Virus Diseases; Slow Virus Diseases Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Dementia Nervous System Diseases; Central Nervous System Diseases; Central Nervous System Infections (Non MeSH) Immunologic Diseases; Immunologic Deficiency Syndromes; HIV Infections Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Organic Mental Disorders; Organic Mental Disorders, Psychotic; Dementia Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders; Organic Mental Disorders, Psychotic; Dementia Neurological syndrome characterized by abnormalities in cognition, motor performance, and behavior. It is partially or wholly due to a direct effect of the HIV virus on the brain rather than to opportunistic infection. Pathological findings include diffuse white matter pallor, multinucleated-cell encephalitis, and vacuolar myelopathy. Clinical manifestations may include apathy, mental slowing, and progressive paraparesis. Acquired Immunodeficiency Syndrome (83-89); Dementia (83-89) QNcGAid to Families with Dependent Children N03.219.521.346.506.849.095 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financing, Organized; Financing, Government; Public Assistance; Social Security Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the Social Security Act, Title IV, in the U.S. "0Agrochemicals D26.025 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Pesticides Miscellaneous Drugs and Agents (Non MeSH) Fertilizers Chemicals used in agriculture. These include pesticides, fumigants, fertilizers, plant hormones, steroids, antibiotics, mycotoxins, etc. ADAEANCHCLCSCTDUECHIIPMEMIPDPKPOPSRESDSNSTTOTUUTVI $  ,26Agrobacterium tumefaciens B03.440.400.425.700.143.700 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rhizobiaceae; Agrobacterium A species of gram-negative, aerobic bacteria isolated from soil and the stems and roots of plants. It causes oncogenic transformations (tumor formation) in a wide variety of higher plants after wounding. Agrobacterium (66-91) "Agrobacterium B03.440.400.425.700.143 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Rhizobiaceae Agrobacterium tumefaciens A genus of gram-negative, aerobic, rod-shaped bacteria. With the exception of Agrobacterium radiobacter, members of this genus invade the crown, roots, and stems of plants, via wounds, causing the transformation of the plant cells into proliferating tumor cells. "1Agrin D12.776.641.050 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Nerve Tissue Proteins A protein component of the synaptic basal lamina. It has been shown to induce clustering of acetylcholine receptors on the surface of muscle fibers and other synaptic molecules in both synapse regeneration and development. Nerve Tissue Proteins (88-93)  F H_$Agriculture J01.040 CLECEDHIISLJMAMTOGSNSTTD Technology, Industry, Agriculture (Non MeSH) Animal Husbandry; Aquaculture (+ 1); Dairying; Fertilizers (+ 1); Hydroponics; Plant Diseases The science of soil cultivation, crop production, and livestock raising. AEANCICLECEDETGEHIISLJMAMIMTOGPOPSRESDSNSTTDTOUTVI  "Y 4sV6Agricultural Workers' Diseases C21.447.080 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Rural Health Injury, Occupational Dis, Poisoning (Non MeSH); Occupational Diseases Farmer's Lung; Silo Filler's Disease Diseases in persons engaged in cultivating and tilling soil, growing plants, harvesting crops, raising livestock, or otherwise engaged in husbandry and farming. The diseases are not restricted to farmers in the sense of those who perform conventional farm chores: the heading applies also to those engaged in the individual activities named above, as in those only gathering harvest or in those only dusting crops. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI $#$JR-NAgraphia C10.597.257.543.074.059; C23.888.592.257.543.074.059; F03.126.219.543.074.059 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Handwriting Nervous System Diseases; Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Communicative Disorders; Language Disorders; Aphasia Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Communicative Disorders; Language Disorders; Aphasia Loss of the ability to express thoughts in writing. 'Z UF@Agranulocytosis C15.378.553.546.184 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Leukocyte Disorders (Non MeSH); Leukopenia Neutropenia A symptom complex characterized by a marked decrease in the number of granulocytes and by lesions of the throat and other mucous membranes, of the gastrointestinal tract, and of the skin. (Dorland, 27th ed). *9N~Agoraphobia F03.709.438.180.508.080 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders; Anxiety Disorders; Phobic Disorders Obsessive, persistent, intense fear of open places. ,\F>Agonistic Behavior F01.145.040.028.020 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Assertiveness; Aggression Any behavior associated with conflict between two individuals. - `JAgnosia C10.597.044; C23.888.592.043; F03.126.185.794.118 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Nervous System Diseases; Neurologic Manifestations Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Cognition Disorders; Perceptual Disorders Gerstmann's Syndrome Gerstmann's Syndrome Gerstmann's Syndrome Loss of the ability to recognize the significance of perceptions via one or more of the special senses (i.e., sight, taste, hearing, smell, and touch). In psychiatry, agnosia also refers to the loss or disuse of knowledge of objects, when the knowledge appears to have been altered by emotional circumstances. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  . 9F9GmNAgmatine D02.078.370.060 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amidines; Guanidines 4-(Aminobutyl)guanidine. Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle. Butylamines (73-74); Guanidines (68-74) 2 :>0Agkistrodon B02.833.672.875.120 ABAHBLCFCLEMGDGEIMINMEMIPHPSSUURVI Vertebrates; Reptiles; Snakes; Viperidae A genus of venomous snakes of the subfamily Crotalinae. Twelve species of this genus are found in North and Central America and Asia. Agkistrodon contortrix is the copperhead, A. piscivorus, the cottonmouth. The former is named for its russet or orange-brown color, the latter for the white interior of its mouth. (Goin, Goin, and Zug: Introduction to Herpetology, 3d ed; Moore: Poisonous Snakes of the World, 1980). Snakes (66-93) 4J&2Aging G07.168 BLCFDEEHGEIMMEPAPHPXREUR Physiology, General (Non MeSH) Longevity 6  % Aggression F01.145.040.028; F03.126.842.089 CLDEPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior; Assertiveness Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH); Social Behavior Disorders Agonistic Behavior Torture; Violence (+ 7) A goal-directed self assertion with an associated implication of attack, of hostile, destructive intent. BLCFCICLCODEDHDIDTECEHENEPETGEHIIMLJMEMIMONUPAPCPHPPPSPXRARERHRISNSUTDTHURUSVI  7u&4zRAgglutinins D24.611.125.044 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies Hemagglutinins (+ 1); Lectins (+ 6) Substances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other. They also include those antibodies which cause aggregation or agglutination of a particulate or insoluble antigen. Antibodies (66-72) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $96i.HAgglutination Tests E01.223.495.826.067 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Laboratory; Immunologic Tests; Serodiagnosis <>"NAgglutination G04.610.143.100 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Antigen-Antibody Reactions Hemagglutination; Sperm Agglutination <p,Ageusia C10.597.751.861.184; C23.888.592.763.861.184 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Neurologic Manifestations; Sensation Disorders; Taste Disorders Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Sensation Disorders; Taste Disorders Absence of the sense of taste. (Dorland, 27th ed). = 2NAAged, 80 and over M01.471.116.100.080 PX Longevity Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Adult; Aged Persons 80 years of age and older. Aged (66-86)  ? X-Aged M01.471.116.100 PX Health Services for the Aged; Homes for the Aged; Housing for the Elderly; Pensions; Retirement Longevity; Geriatrics Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Adult Aged, 80 and over; Frail Elderly PXSN $@uP*Age of Onset G03.850.490.250.100; N05.715.350.075.100 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors; Age Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors; Age Factors The age or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual. Age Factors (66-93) BI.Age Factors G03.850.490.250; N05.715.350.075 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Factors Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Epidemiologic Factors Age of Onset Age of Onset Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Aging (66-67) D>&"{Age Distribution G03.850.505.400.050; I01.240.050; N01.224.033 Environment and Public Health (Non MeSH); Public Health; Epidemiologic Measurements (Non MeSH); Demography Social Sciences; Demography Population Characteristics (Non MeSH); Demography The frequency of different ages or age groups in a given population. The distribution may refer to either how many or what proportion of the group. The population is usually patients with a specific disease but the concept is not restricted to humans and is not restricted to medicine. Age Factors (68-93); Aging (66-67) G 5T,Age Determination by Teeth E01.262.556.184; E01.357.818.827.184; E06.342.764.142 MTVE Diagnosis; Diagnosis, Oral; Radiography, Dental Diagnosis; Diagnostic Imaging; Radiography; Radiography, Dental Dentistry; Diagnosis, Oral; Radiography, Dental I!=Age Determination by Skeleton E01.357.818.043 MTVE Diagnosis; Diagnostic Imaging; Radiography K$3Agaricus B05.354.179.100.105 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes; Agaricales A basidiomycetous fungal genus of the family Agaricaceae, order Agaricales, which includes the field mushroom (A. campestris) and the commercial mushroom (A. bisporus). Agaricales (66-85); Basidiomycetes (66-85) K "L3Agaricales B05.354.179.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Basidiomycetes Agaricus; Amanita; Coprinus; Cortinarius An extensive order of basidiomycetous fungi that includes the gilled mushrooms and a number of related forms. Basidiomycetes (66-74)  MO">2Agar D09.203.698.360.041; D19.316.396.050; D26.342.050 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTUUL Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Polysaccharides; Galactans Hematologic, Gastric, Renal Agents (Non MeSH); Gastrointestinal Agents; Cathartics Miscellaneous Drugs and Agents (Non MeSH); Culture Media A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis. N9. Agammaglobulinemia C15.378.147.142; C15.604.515.032; C20.673.088 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders Hemic and Lymphatic Diseases (Non MeSH); Lymphatic Diseases; Lymphoproliferative Disorders Immunologic Diseases; Immunologic Deficiency Syndromes An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma globulin in the blood. Q5N Afterimage F02.463.593.932.073; G11.697.911.860.080 CLDEPHRE Psychologic Processes and Principles (Non MeSH); Mental Processes; Perception; Visual Perception Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH); Vision; Visual Perception Continuation of visual impression after cessation of stimuli causing the original image. TH. hAftercare E02.472.058; N02.421.589.079 CLECHILJMAMTOGPXSNSTTDUT Halfway Houses Patient Care Planning Therapeutics; General Patient Care (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Patient Care Characteristics (Non MeSH) The care and treatment of a convalescent patient, especially that of a patient after surgery. Progressive Patient Care (66-67) $V  "p'African Swine Fever Virus B04.280.035; B04.909.204.100; B04.970.035 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Viruses; Viruses, Unclassified A virus causing a fatal disease among domestic pigs in Africa and a less virulent infection in Europe. The virus is present in soft ticks (Ornithodoros moubata), warthogs, or domestic pigs. There is growing evidence based on genome structure and replication strategy that the African swine fever virus should no longer be classed as a member of the Iridoviridae family and that it is the only member of another as yet unnamed family. DNA Viruses (66-74) W 1|African Swine Fever C02.081.885.125; C02.256.142; C22.905.072 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; Arbovirus Infections; Tick-Borne Diseases Virus Diseases; DNA Virus Infections (Non MeSH) Animal Diseases; Swine Diseases A usually fatal iridovirus infection of pigs, characterized by fever, cough, diarrhea, hemorrhagic lymph nodes, and edema of the gallbladder. Swine Diseases (66-69); Virus Diseases (66-69) [$1J9African Horsesickness Virus B04.820.630.550.050; B04.909.777.714.550.050 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Reoviridae; Orbivirus Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Reoviridae; Orbivirus A species of ORBIVIRUS that causes disease in horses, mules, and donkeys. ]^!2YAfrican Horsesickness C02.782.791.142; C02.081.030; C22.488.088 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Virus Diseases; RNA Virus Infections (Non MeSH); Reoviridae Infections Virus Diseases; Arbovirus Infections Animal Diseases; Horse Diseases An insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck. Horse Diseases (66-69); Reovirus Infections (68-79) ^1J>Africa, Western Z01.058.290.190 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara Benin; Burkina Faso; Cote d'Ivoire; Gambia; Ghana; Guinea; Guinea-Bissau; Liberia; Mali; Mauritania; Niger; Nigeria; Senegal; Sierra Leone; Togo aNKAfrica, Southern Z01.058.290.175 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara Angola; Botswana; Lesotho; Malawi; Mozambique; Namibia; South Africa; Swaziland; Zambia; Zimbabwe bKxAfrica, Northern Z01.058.266 EHEP Geographicals (Non MeSH); Africa Algeria; Egypt; Libya; Morocco; Tunisia Comprises Algeria, Egypt, Libya, Morocco, and Tunisia. c)3AAfrica, Eastern Z01.058.290.120 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara Burundi; Djibouti; Ethiopia; Kenya; Rwanda; Somalia; Sudan; Tanzania; Uganda dK`Africa, Central Z01.058.290.100 EHEP Geographicals (Non MeSH); Africa; Africa South of the Sahara Cameroon; Central African Republic; Chad; Congo; Equatorial Guinea; Gabon; Zaire eKcAfrica South of the Sahara Z01.058.290 EHEP Geographicals (Non MeSH); Africa Africa, Central (+ 7); Africa, Eastern (+ 9); Africa, Southern (+ 10); Africa, Western (+ 15) All of Africa except Northern Africa (AFRICA, NORTHERN). f")vEAfrica Z01.058 EHEP Geographicals (Non MeSH) Africa, Northern (+ 5); Africa South of the Sahara (+ 45) g  IAflatoxins D24.185.926.587.142; D26.191.023 ADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Aspergillus flavus Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins Miscellaneous Drugs and Agents (Non MeSH); Carcinogens Aflatoxin B1; Aflatoxin M1 Aflatoxin B1; Aflatoxin M1 A group of closely related toxic metabolites that are designated mycotoxins. They are produced by Aspergillus flavus and A. parasiticus. Members of the group include AFLATOXIN B1, aflatoxin B2, aflatoxin G1, aflatoxin G2, AFLATOXIN M1, and aflatoxin M2. AAADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR $h&:B*<Aflatoxin M1 D24.185.926.587.142.100; D26.191.023.100 AAADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins; Aflatoxins Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Aflatoxins 6aR-cis-2,3,6a,9a-Tetrahydro-9a-hydroxy-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3h)(1)benzopyran-1,11-dione. Highly toxic 4-hydroxylated metabolite of AFLATOXIN B1 found in the milk of cows fed toxic meal. It has mutagenic, carcinogenic, and teratogenic activity. It is formed by the enzymatic hydroxylation of aflatoxin B1 by aflatoxin B1 4-hydroxylase, a cytochrome P-450-dependent enzyme. Aflatoxins (69-91) k.<Aflatoxin B1 D24.185.926.587.142.075; D26.191.023.075 AAADAEAGAIANBIBLCFCHCLCSCTECGEHIIMIPMEPDPKPORESDSTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Toxins; Mycotoxins; Aflatoxins Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Aflatoxins 6aR-cis-2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione. The compound is a potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1-2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1. Aflatoxins (66-91) n.<Afibrinogenemia C15.378.463.134.072 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Hemorrhagic Diathesis; Blood Coagulation Disorders A deficiency or absence of fibrinogen (coagulation factor I) in the blood. (Dorland, 27th ed). rNsAfghanistan Z01.252.245.500.125; Z01.586.500.125 EHEP Geographicals (Non MeSH); Asia; Asia, Western; Middle East Geographicals (Non MeSH); Historical Geographicals (Non MeSH); Middle East t]*Affinity Labels D26.550.020 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Indicators and Reagents Propylbenzilylcholine Mustard Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. Binding Sites (68-74); Indicators and Reagents (68-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $u^,P"@B:Afferent Pathways A08.612.220 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUULUSVI Nervous System; Neural Pathways Auditory Pathways; Olfactory Pathways; Spinothalamic Tracts; Visceral Afferents; Visual Pathways Nerve structures through which impulses are conducted from a peripheral part toward a nerve center. Neural Transmission (68-75); Neurons, Afferent (69-75); Receptors, Sensory (66-75); specific sensory receptor; specific central nervous system heading  x 6'qvAfferent Loop Syndrome C06.405.469.531.099; C23.814.066 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Obstruction Symptoms and General Pathology (Non MeSH); Postoperative Complications A complication of gastrojejunostomy, caused by acute or chronic obstruction of the afferent loop due to hernia, intussusception, kinking, volvulus, etc. It is characterized by pain and vomiting of bile-stained fluid and includes acute afferent loop obstruction and bilious vomiting. Dumping Syndrome (66-68) zO&LGAffective Symptoms F03.126.056 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Emotions Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Anxiety (+ 1); Depersonalization Disorder (+ 1); Depression Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus. Affect (66-68); Anxiety (66-68); Emotions (66-68) $}*F YJn>Affective Disorders, Psychotic F03.709.680.080 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Psychotic Disorders Bipolar Disorder; Depressive Disorder (+ 1); Manic Disorder Disorders in which the essential feature is a severe disturbance in mood (depression, anxiety, elation, and excitement) accompanied by psychotic symptoms such as delusions, hallucinations, gross impairment in reality testing, etc.  $FaI Affective Disorders F03.709.438.100 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders; Neurotic Disorders Cyclothymic Disorder; Depressive Disorder (+ 1); Seasonal Affective Disorder Long-standing illnesses characterized by either sustained or intermittent disturbance in mood with no psychotic features, such as delusions, hallucinations, etc. wF`[Affect F01.470.047 CLDEPHRE Behavior and Behavior Mechanisms (Non MeSH); Emotions Irritable Mood The feeling-tone accompaniment of an idea or mental representation. It is the most direct psychic derivative of instinct and the psychic representative of the various bodily changes by means of which instincts manifest themselves.   A AET D02.886.904.100; D02.948.898.100; D26.763.141 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Thiourea Organic Chemicals (Non MeSH); Urea; Thiourea Miscellaneous Drugs and Agents (Non MeSH); Radiation-Protective Agents Carbamimidothioic acid 2-aminoethyl ester dihydrobromide. A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis. 05.Aerospace Medicine G02.403.790.548.080 CLECEDHIISLJMAMTOGSNSTTD Accidents, Aviation; Altitude; Decompression Sickness; Space Flight Health Occupations; Medicine; Specialties, Other (Non MeSH); Preventive Medicine A specialty which is concerned with the health and medical problems of man in aviation (aviation medicine) and space (space medicine). Space Flight (75-79)  P`Aerosols D26.394.225.220.054 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Administration, Inhalation; Nebulizers and Vaporizers Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Colloids Aerosol Propellants Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellent agents.  t ,>YAerosol Propellants D26.394.225.220.054.266 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Drugs; Dosage Forms; Colloids; Aerosols specific chemical(66-72); Aerosols (66-72) k,e4Aerophagy C23.888.821.061; F03.126.036 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Signs and Symptoms, Digestive (Non MeSH) Behavioral and Mental Disorders (Non MeSH); Behavioral Symptoms (Non MeSH) Spasmodic swallowing of air.  "N$Aeromonas hydrophila B03.440.450.900.141.380 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae; Aeromonas A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that may be pathogenic for frogs, fish, and mammals, including man. In humans, cellulitis and diarrhea can result from infection with this organism. Aeromonas (67-91) +"uAeromonas B03.440.450.900.141 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Vibrionaceae Aeromonas hydrophila A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish. 4 "hAerobiosis G06.535.630.110 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) "tAequorin D12.776.532.020 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Luminescent Proteins A photoprotein isolated from the bioluminescent jellyfish Aequorea. It emits visible light by an intramolecular reaction when a trace amount of calcium ion is added. The light-emitting moiety in the bioluminescence reaction is believed to be 2-amino-3-benzyl-5-(p-hydroxyphenyl)pyrazine (AF-350). Coelenterata (72-74); Proteins (72-74)  H]W/Aedes B01.131.617.289.275.100 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Insects; Diptera; Culicidae A genus of mosquitoes (CULICIDAE) frequently found in tropical and subtropical regions. YELLOW FEVER and DENGUE are two of the diseases that can be transmitted by species of this genus. U (BAdvertising L01.143.050 CLECHILJMTSNSTTDUT Information Science; Communication )Adverse Drug Reaction Reporting Systems E05.337.800.120; L01.453.270.120; N02.421.668.320.120 CLECHIISLJMAOGSDSNSTTDUT Drug Monitoring Miscellaneous Techniques (Non MeSH); Evaluation Studies; Product Surveillance, Postmarketing Information Science; Information Services; Drug Information Services Facilities, Manpower and Services (Non MeSH); Health Services; Pharmaceutical Services; Drug Information Services Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions. specific drug/adverse effects (66-91); Drug Therapy/adverse effects (66-91)  ^/=<ZAdvance Directives I01.880.604.583.020; N03.706.535.020 CLECEHHILJPCPXSNTD Resuscitation Orders; Right to Die Social Sciences; Sociology; Social Control, Formal; Jurisprudence Economics, Organizations, Control (Non MeSH); Social Control, Formal; Jurisprudence Living Wills Living Wills Declarations by patients, made in advance of a situation in which they may be incompetent to decide about their own care, stating their treatment preferences or authorizing a third party to make decisions for them. (Bioethics Thesaurus). Right to Die (87-90); Wills (66-90) $f*+ .Adult M01.471.116 PHPX Named Groups (Non MeSH); Named Groups by Age (Non MeSH) Aged (+ 2); Middle Age PHPXSN + F  Adsorption H01.181.529.047 DERE Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical The condensation of gases, liquids, or dissolved substances on the surfaces of solids. It includes adsorptive phenomena of bacteria and viruses as well as of tissues treated with exogenous drugs and chemicals. IAdrenoleukodystrophy C10.228.337.144.030; C18.452.648.556.641.803.100; C18.452.648.595.803.100; C19.053.264.270 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Demyelinating Diseases; Cerebral Sclerosis, Diffuse Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Lipoidosis; Sphingolipidoses Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lysosomal Storage Diseases; Sphingolipidoses Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Hypofunction A sphingolipidosis which combines the features of leukodystrophy and Addison's disease. It was formerly considered part of Schilder's disease (ENCEPHALITIS PERIAXIALIS). Adrenomyeloneuropathy is a milder form of this sex-linked recessive disease, arising in adolescence and adulthood rather than in childhood. Adrenal Gland Hypofunction (68-82); Cerebral Sclerosis, Diffuse (66-82); Demyelinating Diseases (66-82) mdL"dyAdrenodoxin D12.776.157.435.050; D12.776.556.580.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins; Iron-Sulfur Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Metalloproteins; Iron-Sulfur Proteins An iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. The electron transport system which catalyzes this reaction consists of adrenodoxin reductase, NADP, adrenodoxin and cytochrome P-450. Ferredoxins (66-74); Carrier Proteins (74); Metalloproteins (74) [.F6NAdrenochrome D03.438.473.025; D11.557.061 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Indoles Growth Substances, Pigments, Vitamins (Non MeSH); Pigments 2,3-Dihydro-3-hydroxy-1-methyl-1H-indole-5,6-dione. Pigment obtained by the oxidation of epinephrine. i"DrAdrenergic Uptake Inhibitors D14.100.050.600.050; D14.100.600.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amphetamines; Antidepressive Agents, Tricyclic; Dopamine Uptake Inhibitors Serotonin Uptake Inhibitors; Sympathomimetics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Neuron Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Neurotransmitter Uptake Inhibitors Amitriptyline; Amoxapine; Amphetamine (+ 1); Benzphetamine; Desipramine; Dothiepin; Doxepin; Imipramine; Iprindole; Maprotiline; Mazindol; Methamphetamine (+ 1); 3,4-Methylenedioxyamphetamine; Methylphenidate; Nortriptyline; Opipramol; Phenmetrazine; Phentermine; Protriptyline; Reserpine; Tetrabenazine; Trimipramine; Tyramine; Viloxazine Amitriptyline; Amoxapine; Amphetamine (+ 1); Benzphetamine; Desipramine; Dothiepin; Doxepin; Imipramine; Iprindole; Maprotiline; Mazindol; Methamphetamine (+ 1); 3,4-Methylenedioxyamphetamine; Methylphenidate; Nortriptyline; Opipramol; Phenmetrazine; Phentermine; Protriptyline; Reserpine; Tetrabenazine; Trimipramine; Tyramine; Viloxazine Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR ( "*8V52>Adrenergic Neuron Agents D14.100.050.600 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Monoamine Oxidase Inhibitors Sympatholytics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents Adrenergic Uptake Inhibitors (+ 26); Aminoglutethimide; Amphetamine (+ 1); Benzphetamine; Bethanidine; Bretylium Tosylate; Debrisoquin; Ephedrine; Guanethidine; Mephentermine; Metaraminol; Methamphetamine; Methylphenidate; Oxidopamine; Phenmetrazine; Phentermine; Phenylpropanolamine; Tyramine Agents that affect the synthesis, packaging, uptake, or release of adrenergic transmitters or selectively destroy adrenergic neurons. Some of these drugs are used therapeutically and may cause a depletion of adrenergic transmitters, but their therapeutic effects in central nervous system disorders may depend on long-term compensatory changes in the central nervous system rather than on their acute effects. Sympatholytics (66-70) AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR ,k8"T>Adrenergic Fibers A08.663.542.075 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Nervous System; Neurons; Nerve Fibers Sympathetic Fibers, Postganglionic Nerve fibers liberating catecholamines at a synapse after an impulse. Sympathetic Nervous System (66-76) ABAHBSCHCLCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI $F(/(S):Adrenergic beta-Antagonists D14.100.050.200.200 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Anxiety Agents Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists Acebutolol; Alprenolol (+ 1); Atenolol; Betaxolol; Bisoprolol; Bupranolol; Butoxamine; Carteolol; Celiprolol; Labetalol; Levobunolol; Metipranolol; Metoprolol; Nadolol; Oxprenolol; Penbutolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Sympatholytics (66-68) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ( 4"5:Adrenergic beta-Agonists D14.100.050.100.200 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists Albuterol; Clenbuterol; Dobutamine; Dopamine; Ephedrine; Epinephrine; Etilefrine; Fenoterol; Hexoprenaline; Isoetharine; Isoproterenol; Isoxsuprine; Nylidrin; Orciprenaline; Prenalterol; Procaterol; Ritodrine; Terbutaline; Tretoquinol; Xamoterol Drugs that selectively bind to and activate beta-adrenergic receptors. Sympathomimetics (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $4SDAdrenergic Antagonists D14.100.050.200 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Sympatholytics Miotics; Sympatholytics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents Adrenergic alpha-Antagonists (+ 12); Adrenergic beta-Antagonists (+ 22) Drugs that bind to but do not activate adrenergic receptors. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters epinephrine and norepinephrine. Receptors, Adrenergic/antagonists and inhibitors (77-94); Sympatholytics (82-94) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR ,4T]:Adrenergic alpha-Antagonists D14.100.050.200.100 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists Dibenamine; Dihydroergotoxine; Doxazosin; Labetalol; Mianserin; Moxisylyte; Phenoxybenzamine; Phentolamine; Piperoxan; Prazosin; Tolazoline; Yohimbine Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Sympatholytics (66-68) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $!4D:Adrenergic alpha-Agonists D14.100.050.100.100 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Agonists Clonidine; Ephedrine; Epinephrine; Ergotamine; Etilefrine; Guanabenz; Guanfacine; Metaraminol; Methoxamine; Methyldopa; Midodrin; Norepinephrine; Octopamine; Phenylephrine; Phenylpropanolamine; Synephrine Drugs that selectively bind to and activate alpha adrenergic receptors. Sympathomimetics (66-68) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $W4UDAdrenergic Agonists D14.100.050.100 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Sympathomimetics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents Adrenergic alpha-Agonists (+ 16); Adrenergic beta-Agonists (+ 20) Drugs that bind to and activate adrenergic receptors. Sympathomimetics (66-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (-4NADAdrenergic Agents D14.100.050 ADAEANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Sympatholytics; Sympathomimetics Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH) Adrenergic Agonists (+ 38); Adrenergic Antagonists (+ 36); Adrenergic Neuron Agents (+ 45) Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. Sympathomimetics (77-94) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR (E4&kn#DAdrenalectomy E04.779.115 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Adrenal Glands Surgery, Operative; Surgery, Endocrine (Non MeSH) T$;Adrenal Rest Tumor C04.557.475.040 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Gonadal Tissue A rare, usually benign, ovarian tumor thought to be derived from embryonic rest cells of the adrenals. This tumor causes various degrees of masculinization.  V]Adrenal Medulla A06.224.115; A06.407.071.265 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Chromaffin System Endocrine System (Non MeSH); Endocrine Glands; Adrenal Glands The inner part of the adrenal gland; it synthesizes, stores and releases catecholamines. ":jAdrenal Hyperplasia, Congenital C19.053.440; C19.391.090 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Puberty, Precocious; Virilism Steroid 11-Hydroxylase Endocrine Diseases; Adrenal Gland Diseases Endocrine Diseases; Gonadal Disorders (Non MeSH) A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form.  B%L$kAdrenal Glands A06.407.071 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Adrenalectomy Endocrine System (Non MeSH); Endocrine Glands Adrenal Cortex (+ 3); Adrenal Medulla Paired glands situated in the retroperitoneal tissues at the superior pole of each kidney.  ):80lAdrenal Gland Neoplasms C04.588.322.078; C19.053.347; C19.344.078 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms Endocrine Diseases; Adrenal Gland Diseases Endocrine Diseases; Endocrine Gland Neoplasms Adrenal Cortex Neoplasms Adrenal Cortex Neoplasms Adrenal Cortex Neoplasms Օ1XVAdrenal Gland Hypofunction C19.053.264 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Adrenal Cortex Hormones Endocrine Diseases; Adrenal Gland Diseases Addison's Disease; Adrenoleukodystrophy; Hypoaldosteronism j N3CAdrenal Gland Hyperfunction C19.053.181 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Hyperandrogenism Adrenal Cortex Hormones Endocrine Diseases; Adrenal Gland Diseases Cushing's Syndrome; Hyperaldosteronism (+ 1)  ء!N35Adrenal Gland Diseases C19.053 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases Adrenal Cortex Diseases (+ 1); Adrenal Gland Hyperfunction (+ 3); Adrenal Gland Hypofunction (+ 3); Adrenal Gland Neoplasms (+ 1); Adrenal Hyperplasia, Congenital; Waterhouse-Friderichsen Syndrome BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI  NZAdrenal Cortex Neoplasms C04.588.322.078.265; C19.053.098.265; C19.053.347.265; C19.344.078.265 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Adrenal Gland Neoplasms Endocrine Diseases; Adrenal Gland Diseases; Adrenal Cortex Diseases Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Neoplasms Endocrine Diseases; Endocrine Gland Neoplasms; Adrenal Gland Neoplasms Adrenal Gland Neoplasms (66-74) PX[&Adrenal Cortex Hormones D06.472.040 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Adrenal Gland Hyperfunction; Adrenal Gland Hypofunction; Receptors, Glucocorticoid Hormones, Substitutes, Antagonists (Non MeSH); Hormones Glucocorticoids (+ 14); 17-Ketosteroids (+ 5); Mineralocorticoids (+ 7) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR  CB_BWDAdrenal Cortex Function Tests E01.197.086 AECLCTECHIISMOMTNUPXSNSTTDUTVE Diagnosis; Diagnosis, Endocrine (Non MeSH) $"3Adrenal Cortex Diseases C19.053.098 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Adrenal Gland Diseases Adrenal Cortex Neoplasms Adrenal Gland Diseases (66-74) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  N3%XAdrenal Cortex A06.407.071.140 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Endocrine System (Non MeSH); Endocrine Glands; Adrenal Glands Zona Fasciculata; Zona Glomerulosa; Zona Reticularis The outer layer of the adrenal gland. It secretes mineralocorticoids, androgens, and glucocorticoids. Adrenal Glands (66-74)  2:K?wAdosterol D04.808.247.808.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cholestanes; Sterols 6 beta-Iodomethyl-19-norcholest-5(10)-en-3 beta-ol. A sterol usually substituted with radioactive iodine. It is an adrenal cortex scanning agent with demonstrated high adrenal concentration and superior adrenal imaging. Cholestenes (73-78); Iodine Radioisotopes (66-78); Sterols (66-78)  :BPAdoption I01.880.225.140 EHLJPX Social Sciences; Sociology; Family Voluntary acceptance of a child of other parents to be as one's own child, usually with legal confirmation.   +Adolescent, Institutionalized M01.471.392.050.150 EDPXSN Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Adolescence Adolescent placed in institutions on a long term basis. Adolescence (66-82; Institutionalization (79-82); Residential Facilities (68-82) " _D]Adolescent, Hospitalized M01.471.392.050.100; M01.643.050 EDPXSN Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child; Adolescence Named Groups (Non MeSH); Patients Adolescent hospitalized for short term care. Adolescence (66-82; Hospitalization (66-82) P& 63Adolescent Psychology F04.096.628.065 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychology Field of psychology concerned with the normal and abnormal behavior of adolescents. It includes mental processes as well as observable responses. `Adolescent Psychiatry F04.096.544.065; G02.403.642.080 CLECEDHIISLJMAMTOGSNSTTD Disciplines, Tests, Therapy, Services (Non MeSH); Behavioral Sciences; Psychiatry Health Occupations; Medicine; Psychiatry The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years. Child Psychiatry (66); Psychiatry (66); Psychoanalysis (66) ,&IAdolescent Nutrition G06.696.259.500 EDPH Child Nutrition Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Nutrition; Child Nutrition Nutrition of children aged 13-18 years. Adolescence (70-92); Nutrition (70-92)  "b1/Adolescent Medicine G02.403.028 CLECEDHIISLJMAMTOGSNSTTD Health Occupations; Medicine A branch of medicine pertaining to the diagnosis and treatment of diseases occurring during the period beginning with puberty until the cessation of somatic growth. Adolescence (66-79) W#Adolescent Health Services N02.421.044 CLECHILJMAOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Services Organized services to provide health care to adolescents, ages ranging from 13 through 18 years. Health Services (72-91)  JsAdolescent Behavior F01.145.022 CLDEEHPHPXRE Behavior and Behavior Mechanisms (Non MeSH); Behavior Any observable response or action of an adolescent. Adolescent Psychology (67-80) A?#Adolescence M01.471.392.050 PH Named Groups (Non MeSH); Named Groups by Age (Non MeSH); Child Adolescent, Hospitalized; Adolescent, Institutionalized; Homeless Youth The period of life beginning with the appearance of secondary sex characteristics and terminating with the cessation of somatic growth. CLEDEHHILJPHPXSN  PRAdnexitis C13.371.056.114 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Pelvis Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female; Adnexal Diseases Oophoritis; Parametritis; Salpingitis  N }-Adnexal Diseases C13.371.056 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Genital Diseases, Female Adnexitis (+ 3); Fallopian Tube Diseases (+ 2); Ovarian Diseases (+ 8); Parovarian Cyst Diseases of the uterine appendages: the ovaries, uterine tubes, and ligaments of the uterus. (Dorland, 27th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  NhnXAdnexa Uteri A05.360.319.114 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Urogenital System; Genitalia; Genitalia, Female Broad Ligament; Fallopian Tubes; Ovary (+ 6); Round Ligament ABAHBSCHCLCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI K89L<Admitting Department, Hospital N02.278.354.422.040; N04.452.442.422.040 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities; Hospital Administration; Hospital Departments Health Services Administration (Non MeSH); Organization and Administration; Hospital Administration; Hospital Departments Hospital department responsible for the flow of patients and the processing of admissions, discharges, transfers, and also most procedures to be carried out in the event of a patient's death. $. Administrative Personnel M01.526.070 CLECEDHILJOGPXSDSNSTTDUT Named Groups (Non MeSH); Named Groups by Occupation (Non MeSH) Health Facility Administrators (+ 2); Medical Directors; Nurse Administrators; Trustees Individuals responsible for the development of policy and supervision of the execution of plans and functional operations. Organization and Administration (66-67)  Mh.Administration, Topical E05.300.120 Miscellaneous Techniques (Non MeSH); Drug Administration Routes Administration, Buccal; Administration, Cutaneous; Administration, Intranasal; Administration, Intravaginal; Administration, Intravesical; Administration, Rectal KAdministration, Sublingual E05.300.100.878 Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Oral Administration of a soluble dosage form by placement under the tongue. Administration, Oral (71-87) ;dU"Administration, Rectal E05.300.110; E05.300.120.610 Anesthesia, Rectal; Suppositories Miscellaneous Techniques (Non MeSH); Drug Administration Routes Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Topical The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose. Intestinal Absorption (66-86); Rectum (66-86); Suppositories (66-86) k"(RAdministration, Oral E05.300.100 Miscellaneous Techniques (Non MeSH); Drug Administration Routes Administration, Buccal; Administration, Sublingual The giving of drugs, chemicals, or other substances by mouth. specific drug/administration and dosage (66-69) K:K8Administration, Intravesical E05.300.120.505 Bladder Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Topical The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms. Administration, Topical (74-86); Bladder (66-86) ! g:Administration, Intravaginal E05.300.120.500 Vaginal Creams, Foams and Jellies Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Topical The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories. Administration, Topical (74-86); Vagina (66-86); Vaginal Creams, Foams and Jellies (75-86) !)glAdministration, Intranasal E05.300.080; E05.300.120.080 Nebulizers and Vaporizers Administration, Inhalation Miscellaneous Techniques (Non MeSH); Drug Administration Routes Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Topical specific drug/administration and dosage (66-72) "8Administration, Inhalation E05.300.050 Administration, Intranasal; Aerosols; Anesthesia, Inhalation; Respiratory Therapy Miscellaneous Techniques (Non MeSH); Drug Administration Routes The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Aerosols (66-86); Lung (66-86); Respiration (66-86); Respiratory Therapy (78-86) F^K~bAdministration, Cutaneous E05.300.120.060 Skin Absorption Skin Absorption Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Topical The application of suitable drug dosage forms to the skin for either local or systemic effects. Administration, Topical (66-86)  $gs%Administration, Buccal E05.300.100.028; E05.300.120.040 Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Oral Miscellaneous Techniques (Non MeSH); Drug Administration Routes; Administration, Topical Administration of a soluble dosage form between the cheek and gingiva. It may involve direct application of a drug onto the buccal mucosa, as by painting or spraying. Administration, Oral (71-87); Administration, Topical (75-87); Cheek (66-87)  &[Adjuvants, Pharmaceutic D26.698.064 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Pharmaceutic Aids Agents that aid or increase the action of the principle drug or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug in such a way as to enhance its effects. Pharmaceutic Aids (68-74)  ,IAdjuvants, Immunologic D24.611.062; D24.611.274.050 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH) Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Biological Response Modifiers Acetylmuramyl-Alanyl-Isoglutamine; BCG Vaccine; Cell Wall Skeleton; Freund's Adjuvant; Levamisole; Oxazolone; Sizofiran; Thymopentin Cell Wall Skeleton Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR  "@HAdjustment Disorders F03.709.080 BLCFCICLCODHDIDTECEHENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRISUTHURUSVI Behavioral and Mental Disorders (Non MeSH); Mental Disorders Maladaptive reactions to identifiable psychosocial stressors occurring within a short time after onset of the stressor. They are manifested by either impairment in social or occupational functioning or by symptoms (depression, anxiety, etc.) that are in excess of a normal and expected reaction to the stressor. EFIkAdiposis Dolorosa C17.800.849.077 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Metabolic (Non MeSH) A disease accompanied by painful localized fatty swellings and by various nerve lesions. It is usually seen in women and may cause death from pulmonary complications. (Dorland, 27th ed). NvAdipose Tissue A10.165.114 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Adipocytes; Brown Fat; Lipectomy Tissue Types (Non MeSH); Connective Tissue Brown Fat Connective tissue made up of fat cells (ADIPOCYTES) in a meshwork of areolar tissue. Pigmented, thermogenic adipose tissue present embryonically or in the newborns of many mammalian species is known as BROWN FAT. (From Dorland, 27th ed).  x:)5Adipocytes A11.329.114 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Adipose Tissue Cells; Connective Tissue Cells (Non MeSH) Connective tissue cells specialized for the synthesis and storage of fat. Such cells are bloated with globules of triglycerides, the nucleus being displaced to one side and the cytoplasm seen as a thin line around the fat droplet. (Dorland, 27th ed). Adipose Tissue (67-93)  *3*Adipic Acids D02.241.081.337.052 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Dicarboxylic Acids 2-Aminoadipic Acid; Dimethyl Adipimidate AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR 8q0FAdie's Syndrome C10.772.150.050; C11.710.090.800.100; C11.710.800.180 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Reflex, Pupillary Nervous System Diseases; Peripheral Nervous System Diseases; Autonomic Nervous System Diseases Eye Diseases; Pupillary Functions, Abnormal; Anisocoria; Tonic Pupil Eye Diseases; Pupillary Functions, Abnormal; Tonic Pupil A condition manifested by usually one tonic pupil with absent tendon reflexes, particularly ankle and knee jerk. =NAdhesives D26.016; J01.637.016 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Tissue Adhesives Miscellaneous Drugs and Agents (Non MeSH) Technology, Industry, Agriculture (Non MeSH); Materials (Non MeSH) Bone Cements; Dental Cements (+ 1); Tissue Adhesives (+ 1) Substances that cause the adherence of two surfaces. They include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins, or latex. ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $!Q ,K8Adhesiveness H01.181.529.875.139 DERE Platelet Adhesiveness Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Surface Properties Surface Properties (66-68) #` Adhesions C23.037 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Symptoms and General Pathology (Non MeSH) $  N2Adhesins, Escherichia coli D12.776.097.120.050.040; D12.776.543.100.050.040; D24.611.216.161.050.040 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins; Bacterial Outer Membrane Proteins; Adhesins, Bacterial Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Bacterial Outer Membrane Proteins; Adhesins, Bacterial Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial; Adhesins, Bacterial Thin, filamentous protein structures, including proteinaceous capsular antigens (fimbrial antigens), that mediate adhesion of E. coli to surfaces and play a role in pathogenesis. They have a high affinity for various epithelial cells. Antigens, Bacterial (82-94); Bacterial Outer Membrane Proteins (85-94); Bacterial Proteins (82-88) %L Q6tAdhesins, Bacterial D12.776.097.120.050; D12.776.543.100.050; D24.611.216.161.050 ADAEANBIBLCFCHCLCTDEDUECGEHIIMIPMEPDPHPORETOTUULUR Bacterial Adhesion Bacterial Adhesion; Fimbriae, Bacterial Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Bacterial Proteins; Bacterial Outer Membrane Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Bacterial Outer Membrane Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Bacterial Adhesins, Escherichia coli Adhesins, Escherichia coli Adhesins, Escherichia coli Cell-surface components or appendages of bacteria that facilitate adhesion (BACTERIAL ADHESION) to other cells or to inanimate surfaces. Most fimbriae (FIMBRIAE, BACTERIAL) of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin. specific Adhesins (75-94) ()gE6/\Adenylyl Imidodiphosphate D13.695.667.138.236.050; D13.695.827.068.236.050 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Adenosine Triphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Adenosine Triphosphate 5'-Adenylic acid, monoanhydride with imidodiphosphoric acid. An analog of ATP, in which the oxygen atom bridging the beta to the gamma phosphate is replaced by a nitrogen atom. It is a potent competitive inhibitor of soluble and membrane-bound mitochondrial ATPase and also inhibits ATP-dependent reactions of oxidative phosphorylation. Adenosine Diphosphate (73-74); Adenosine Triphosphate/analogs and derivatives (75); Imides (73-75); Phosphoric Acids (73-74) .[6D.Adenylosuccinate Synthetase D08.586.464.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases A carbon-nitrogen ligase. During purine ribonucleotide biosynthesis, this enzyme catalyzes the synthesis of adenylosuccinate from GTP, IMP, and aspartate with the formation of orthophosphate and GDP. EC 6.3.4.4. Aspartic Acid (66-78); Inosine Monophosphate (75-78); Inosine Nucleotides (71-78); Ligases (66-78) 2a FPvAdenylosuccinate Lyase D08.586.520.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme that, in the course of purine ribonucleotide biosynthesis, catalyzes the conversion of 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole to 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole and the conversion of adenylosuccinic acid to AMP. EC 4.3.2.2. Adenosine Monophosphate (71-78); Lyases (66-78); Succinates (66-78) 4FO1QAdenylate Kinase D08.586.913.696.650.025 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Phosphate Group Acceptor) An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3. Adenosine Monophosphate (74); Phosphotransferases, ATP (74) 7(FFAdenyl Cyclase D08.586.520.059 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases An enzyme of the lyase class that catalyzes the reaction of ATP to yield 3',5'-cyclic AMP and pyrophosphate. The enzyme occurs in plasma cell membranes and is activated by certain hormones (epinephrine, vasopressin, glucagon, and corticotropin). The resultant cyclic AMP serves as an important metabolic regulator. (Dorland, 27th ed) EC 4.6.1.1. Adenine Nucleotides (66-67); Enzymes (66-67) 9=FO6Adenoviruses, Simian B04.280.030.500.700; B04.909.204.097.500.700 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Adenoviridae; Mastadenovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Adenoviridae; Mastadenovirus Member of the genus MASTADENOVIRUS associated with respiratory and enteric infections in primate hosts. ;2yAdenoviruses, Human B04.280.030.500.350; B04.909.204.097.500.350 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Adenoviridae; Mastadenovirus Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Adenoviridae; Mastadenovirus Members of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. They are grouped into at least seven subgenera based on characteristics of DNA and antigens, morphology, oncogenicity, etc. The type species is Human Adenovirus 2. Adenoviridae (66-74) =2 Adenoviruses, Canine B04.280.030.500.200; B04.450.100; B04.909.204.097.500.200 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses; Adenoviridae; Mastadenovirus Viruses; Hepatitis Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses; Adenoviridae; Mastadenovirus Members of the genus MASTADENOVIRUS that causes fever, edema, vomiting, and diarrhea in dogs and encephalitis in foxes. ?AAdenovirus Infections, Human C02.256.076.045 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVI Virus Diseases; DNA Virus Infections (Non MeSH); Adenoviridae Infections Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses. A"NWpAdenovirus E4 Proteins D12.776.677.520.045.080; D12.776.964.700.045.080; D24.611.216.327.045.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Adenovirus Early Proteins Proteins transcribed from the E4 region of adenovirus. The E4 19K protein transactivates transcription of the adenovirus E2F protein and complexes with it. Oncogene Proteins, Viral (85-92) CAQF'Adenovirus E3 Proteins D12.776.677.520.045.070; D12.776.964.700.045.070; D24.611.216.327.045.070 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Adenovirus Early Proteins Proteins transcribed from the E3 region of adenovirus but not essential for viral replication. The E3 19K protein mediates adenovirus persistence by reducing the expression of class I major histocompatibility complex antigens on the surface of infected cells. Oncogene Proteins, Viral (85-92) FQF.'Adenovirus E2 Proteins D12.776.260.060; D12.776.677.520.045.060; D12.776.964.700.045.060; D24.611.216.327.045.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; DNA-Binding Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Adenovirus Early Proteins Proteins transcribed from the E2 region of adenovirus. Several of these are required for viral DNA replication. Oncogene Proteins (85-92) JdFAdenovirus E1B Proteins D12.776.460.050.110; D12.776.677.520.045.050.110; D12.776.930.110; D12.776.964.700.045.050.110; D24.611.216.285.062.050; D24.611.216.327.062.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Immediate-Early Proteins; Adenovirus E1 Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins; Adenovirus E1 Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins; Adenovirus E1 Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Viral, Tumor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Antigens, Viral, Tumor Proteins transcribed from the E1B region of adenovirus which are involved in regulation of the levels of early and late gene expression. Antigens, Viral, Tumor (85); Oncogene Proteins, Viral (86-92) NWFeJAdenovirus E1A Proteins D12.776.460.050.100; D12.776.677.520.045.050.100; D12.776.930.100; D12.776.964.700.045.050.100; D24.611.216.285.062.045; D24.611.216.327.062.045 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Immediate-Early Proteins; Adenovirus E1 Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins; Adenovirus E1 Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Transcription Factors Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins; Adenovirus E1 Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Neoplasm; Antigens, Viral, Tumor Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Antigens, Viral, Tumor Proteins transcribed from the E1A region of adenovirus which are involved in positive regulation of transcription of the early genes. Antigens, Viral, Tumor (85); Oncogene Proteins, Viral (85-92); Transcription Factors (85-92) SFenAdenovirus E1 Proteins D12.776.460.050; D12.776.677.520.045.050; D12.776.964.700.045.050; D24.611.216.327.045.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Immediate-Early Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral; Adenovirus Early Proteins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral; Adenovirus Early Proteins Adenovirus E1A Proteins; Adenovirus E1B Proteins Adenovirus E1A Proteins; Adenovirus E1B Proteins Adenovirus E1A Proteins; Adenovirus E1B Proteins The very first viral gene products synthesized after cells are infected with adenovirus. The E1 region of the genome has been divided into two major transcriptional units, E1A and E1B, each expressing proteins of the same name (ADENOVIRUS E1A PROTEINS and ADENOVIRUS E1B PROTEINS). Oncogene Proteins, Viral (86-92)  YhdF K'Adenovirus Early Proteins D12.776.677.520.045; D12.776.964.700.045; D24.611.216.327.045 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Oncogene Proteins; Oncogene Proteins, Viral Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Viral Proteins; Oncogene Proteins, Viral Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Antigens, Viral Adenovirus E1 Proteins (+ 2); Adenovirus E2 Proteins; Adenovirus E3 Proteins; Adenovirus E4 Proteins Adenovirus E1 Proteins (+ 2); Adenovirus E2 Proteins; Adenovirus E3 Proteins; Adenovirus E4 Proteins Adenovirus E1 Proteins; Adenovirus E2 Proteins; Adenovirus E3 Proteins; Adenovirus E4 Proteins Proteins encoded by adenoviruses that are synthesized prior to, and in the absence of, viral DNA replication. The proteins are involved in both positive and negative regulation of expression in viral and cellular genes, and also affect the stability of viral mRNA. Some are also involved in oncogenic transformation. Antigens, Viral, Tumor (85); Oncogene Proteins, Viral (85-92)  ^EFd^sJAdenoviridae Infections C02.256.076 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Virus Diseases; DNA Virus Infections (Non MeSH) Adenovirus Infections, Human; Hepatitis, Infectious Canine Virus diseases caused by the ADENOVIRIDAE. cP:D4Adenoviridae B04.280.030; B04.909.204.097 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; DNA Viruses Viruses; Vertebrate Viruses (Non MeSH); DNA Viruses Aviadenovirus; Mastadenovirus (+ 3) Aviadenovirus; Mastadenovirus (+ 3) A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. e>"YTAdenosinetriphosphatase D08.586.277.040.025 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Acid Anhydride Hydrolases Ca(2+) Mg(2+)-ATPase; Ca(2+)-Transporting ATPase; Dynein ATPase; H(+)-K(+)-Exchanging ATPase; H(+)-Transporting ATP Synthase; Kinesin; Myosin ATPase; Na(+)-K(+)-Exchanging ATPase A group of enzymes which catalyze the hydrolysis of ATP coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA. EC 3.6.1.3. g FrAdenosine Triphosphate D13.695.667.138.236; D13.695.827.068.236; D14.600.033 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters Adenylyl Imidodiphosphate; Ethenoadenosine Triphosphate Adenylyl Imidodiphosphate; Ethenoadenosine Triphosphate Adenosine 5'-(tetrahydrogen triphosphate). An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. j=DM}Adenosine Phosphosulfate D13.695.667.138.180.080; D13.695.827.068.180.080 AAADAEAGAIANBLCFCHCLCSCTDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Adenosine Monophosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Adenosine Monophosphate 5'-Adenylic acid, monoanhydride with sulfuric acid. The initial compound formed by the action of ATP sulfurylase on sulfate ions after sulfate uptake. Synonyms: adenosine sulfatophosphate; APS. Adenine Nucleotides (66-70); Adenosine Monophosphate (71-78); Sulfuric Acids (66-75) m6>0dAdenosine Monophosphate D13.695.667.138.180; D13.695.827.068.180 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides Adenosine Phosphosulfate Adenosine Phosphosulfate Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2'-, 3'-, or 5'-position. Adenine Nucleotides (66-70)  p.D8!Adenosine Kinase D08.586.913.696.620.010 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor) An enzyme that catalyzes the formation of ADP plus AMP from adenosine plus ATP. It can serve as a salvage mechanism for returning adenosine to nucleic acids. EC 2.7.1.20. Adenosine (74); Phosphotransferases, ATP (74) spF7Adenosine Diphosphate Sugars D09.203.408.620.569.070; D13.695.667.138.124.070; D13.695.827.068.124.070; D13.695.827.708.070 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Adenosine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Adenosine Diphosphate Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars Adenosine Diphosphate Glucose; Adenosine Diphosphate Ribose; Poly Adenosine Diphosphate Ribose Adenosine Diphosphate Glucose; Adenosine Diphosphate Ribose Adenosine Diphosphate Glucose; Adenosine Diphosphate Ribose Adenosine Diphosphate Glucose; Adenosine Diphosphate Ribose; Poly Adenosine Diphosphate Ribose Esters formed between the aldehydic carbon of sugars and the terminal phosphate of adenosine diphosphate. Adenosine (73-74); Nucleoside Diphosphate Sugars (73-74) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR $u"hB9^|CDAdenosine Diphosphate Ribose D09.203.408.620.569.070.125; D13.695.667.138.124.070.125; D13.695.827.068.124.070.125; D13.695.827.708.070.125 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Adenosine Diphosphate Sugars Adenosine 5'-(trihydrogen diphosphate),5'-5-ester with D-ribose. An ester formed between the aldehydic carbon of ribose and the terminal phosphate of adenosine diphosphate. Serves as a ribose carrier. Adenine Nucleotides (66-70); Adenosine Diphosphate Sugars (75-79); Nucleoside Diphosphate Sugars (71-74); Ribose (66-74) /AA (75-79) {E"xDAdenosine Diphosphate Glucose D09.203.408.620.569.070.075; D13.695.667.138.124.070.075; D13.695.827.068.124.070.075; D13.695.827.708.070.075 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Nucleotides; Nucleoside Diphosphate Sugars; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Adenosine Diphosphate; Adenosine Diphosphate Sugars Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Nucleoside Diphosphate Sugars; Adenosine Diphosphate Sugars Serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. Adenosine (73-74); Glucose (73-74); Nucleoside Diphosphate Sugars (73-74) #xDXAdenosine Diphosphate D13.695.667.138.124; D13.695.827.068.124 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides Adenosine Diphosphate Sugars (+ 2) Adenosine Diphosphate Sugars (+ 2) Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. Adenine Nucleotides (66-70)  B.DR!Adenosine Deaminase D08.586.277.151.486.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Aminohydrolases; Nucleoside Deaminases An enzyme that catalyzes the hydrolysis of adenosine to inosine with the elimination of ammonia. Since there are wide tissue and species variations in the enzyme, it has been used as a tool in the study of human and animal genetics and in medical diagnosis. EC 3.5.4.4. Aminohydrolases (72-74); Adenosine (72-74)  FB3Adenosine D13.570.583.138; D13.570.800.096; D14.600.030 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Purine Nucleosides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleosides; Ribonucleosides Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters S-Adenosylhomocysteine; S-Adenosylmethionine; 2-Chloroadenosine (+ 1); Deoxyadenosines (+ 3); Isopentenyladenosine; Phenylisopropyladenosine; Vidarabine S-Adenosylhomocysteine; S-Adenosylmethionine; 2-Chloroadenosine (+ 1); Isopentenyladenosine; Phenylisopropyladenosine A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Nucleosides (66-71) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $ 5D1HAdenosarcoma C04.557.435.135; C04.557.450.795.135 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Sarcoma A malignant neoplasm arising simultaneously or consecutively in mesodermal tissue and glandular epithelium of the same part. (Stedman, 25th ed). Neoplasms, Germ Cell and Embryonal (77-93); Nephroblastoma (66-93) *XOAdenophorea Infections C03.335.508.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Helminthiasis; Nematode Infections Enoplida Infections (+ 2) Infections with nematodes of the subclass ADENOPHOREA. P@ AAdenophorea B01.500.294.100 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths; Nematoda Enoplida (+ 7) A subclass of nematodes characterized by reduced or absent caudal papillae and an excretory system lacking lateral canals. Its organisms are usually infective to their final host. **Adenomyoma C04.557.435.110 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A benign neoplasm of muscle (usually smooth muscle) with glandular elements. It occurs most frequently in the uterus and uterine ligaments. (Stedman, 25th ed). Endometriosis (75-93) mVnAdenomatous Polyps C04.557.470.035.215 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Adenomatous Polyposis Coli Benign neoplasms derived from glandular epithelium. (From Stedman, 25th ed). Adenocarcinoma (66-93); Adenoma (68-93); Intestinal Polyps (67-84); Polyps (66-93)  QVs \dAdenomatous Polyposis Coli C04.557.470.035.215.100; C04.588.274.476.411.306.360.100; C04.588.274.476.411.510.235.100; C04.700.100; C04.799.411.235.100; C06.240.476.411.306.360.100; C06.240.476.411.510.360.100; C06.405.282.411.306.360.100; C06.405.282.411.510.360.100; C06.405.469.158.355.360.100; C06.405.469.505.306.360.100; C06.405.469.505.510.360.100; C06.405.469.583.360.100; C16.466.700.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Genes, APC Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenomatous Polyps Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms; Colonic Polyps Neoplasms; Neoplasms by Site (Non MeSH); Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps; Colonic Polyps Neoplasms; Neoplastic Syndromes, Hereditary Neoplasms; Polyps; Intestinal Polyps; Colonic Polyps Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms; Colonic Polyps Digestive System Diseases; Digestive System Neoplasms; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps; Colonic Polyps Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Colonic Neoplasms; Colonic Polyps Digestive System Diseases; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Intestinal Neoplasms; Intestinal Polyps; Colonic Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Colonic Diseases; Colonic Neoplasms; Colonic Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Colonic Neoplasms; Colonic Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Neoplasms; Intestinal Polyps; Colonic Polyps Digestive System Diseases; Gastrointestinal Diseases; Intestinal Diseases; Intestinal Polyps; Colonic Polyps Neonatal Diseases and Abnormalities (Non MeSH); Hereditary Diseases; Neoplastic Syndromes, Hereditary An autosomal dominant polyposis syndrome in which the colon contains few to thousands of adenomatous polyps, often occurring by age 15 to 25. S LzAdenomatosis, Pulmonary C04.557.470.035.210 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma A neoplastic disease in which the alveoli and distal bronchi are filled with mucus and mucus-secreting columnar epithelial cells. It is characterized by abundant, extremely tenacious sputum, chills, fever, cough, dyspnea, and pleuritic pain. (Stedman, 25th ed). Xs1Adenomatoid Tumor C04.557.470.035.200; C04.557.470.660.200 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Mesothelial A small, circumscribed, benign tumor of the genital tract, composed of small glandlike spaces lined by flattened or cuboidal mesothelium-like cells. (From Dorland, 27th ed). .VAdenoma, Villous C04.557.470.035.185 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma An adenoma of the large intestine. It is usually a solitary, sessile, often large, tumor of colonic mucosa composed of mucinous epithelium covering delicate vascular projections. Hypersecretion and malignant changes occur frequently. (Stedman, 25th ed). Adenoma (67-93) tXs(Adenoma, Sweat Gland C04.557.470.035.175; C04.557.470.550.175 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Adnexal and Skin Appendage (Non MeSH) Acrospiroma, Eccrine; Hidrocystoma; Syringoma Acrospiroma, Eccrine; Hidrocystoma; Syringoma A benign neoplasm derived from epithelial cells of sweat glands. (Stedman, 25th ed). .VjgAdenoma, Pleomorphic C04.557.435.090; C04.557.470.035.155 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma A benign, slow-growing tumor of the salivary gland, occurring as a small, painless, firm nodule, usually of the parotid gland, but also found in any major or accessory salivary gland anywhere in the oral cavity. It is most often seen in women in the fifth decade. Histologically, the tumor presents a variety of cells: cuboidal, columnar, and squamous cells, showing all forms of epithelial growth. (Dorland, 27th ed). w*VAdenoma, Oxyphilic C04.557.470.035.140 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma A tumor of the thyroid gland composed wholly or predominantly of large cells (Hurthle cells) having abundant granular, eosinophilic cytoplasm. This tumor is usually benign but on occasion may be locally invasive or may rarely metastasize (oxyphilic adenocarcinoma). (From Dorland, 27th ed). Adenoma (67-93) XsTAdenoma, Liver Cell C04.557.470.035.120 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma A benign epithelial tumor of the liver. Adenoma (66-93); Carcinoma, Hepatocellular (66-93); Liver Neoplasms (66-93) Vs2ZAdenoma, Islet Cell C04.557.470.035.100 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Gastrinoma (+ 1); Glucagonoma; Insulinoma A benign tumor of the islets of Langerhans that may occur anywhere throughout the pancreas. Such tumors may result in HYPERINSULINISM or ZOLLINGER-ELLISON SYNDROME. (From Dorland, 27th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  4Vs4XAdenoma, Chromophobe C04.557.465.625.650.095; C04.557.470.035.095; C04.557.580.625.650.095 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors A tumor of the anterior lobe of the pituitary gland whose cells do not stain readily with either acid or basic dyes and whose presence may be associated with hypopituitarism. Although classically these adenomas have been said to be composed of sparsely granulated or degranulated (nonfunctioning) cells, some contain functioning cells and may be associated with a hyperpituitary state, e.g., acromegaly or Cushing's syndrome. (Dorland, 27th ed). MVAdenoma, Bile Duct C04.557.470.035.085 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma A benign tumor of the intrahepatic bile ducts. FVs:Adenoma, Basophil C04.557.465.625.650.075; C04.557.470.035.075; C04.557.580.625.650.075 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Cushing's Syndrome Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors A small tumor of the anterior lobe of the pituitary gland whose cells stain with basic dyes. It may give rise to excessive secretion of ACTH, resulting in CUSHING'S SYNDROME. (Dorland, 27th ed). MVAdenoma, Adrenal Cortical C04.557.470.035.040 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma A benign neoplasm of adrenal cortical cells resembling normal adrenal cells histologically but possessing functional autonomy. In general it does not exceed 5 cm in its largest dimension, although benign tumors exceeding 20 cm have been reported. Adrenal cortical adenomas produce hypercortisolism and hyperaldosteronism, but seldom produce adrenogenital syndromes. For the most part the prognosis after surgery is reasonably favorable. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 3d ed). Adenoma (66-93) VsSAdenoma, Acidophil C04.557.465.625.650.025; C04.557.470.035.025; C04.557.580.625.650.025 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Acromegaly; Gigantism Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors; Neuroendocrine Tumors Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Nerve Tissue; Neuroectodermal Tumors; Neuroendocrine Tumors A benign tumor, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes. Such pituitary tumors may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhea. (Dorland, 27th ed). åMVAdenoma C04.557.470.035 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial Adenoma, Acidophil; Adenoma, Adrenal Cortical; Adenoma, Basophil; Adenoma, Bile Duct; Adenoma, Chromophobe; Adenoma, Islet Cell (+ 4); Adenoma, Liver Cell; Adenoma, Oxyphilic; Adenoma, Pleomorphic; Adenoma, Sweat Gland (+ 3); Adenoma, Villous; Adenomatoid Tumor; Adenomatosis, Pulmonary; Adenomatous Polyps (+ 1); Apudoma; Cystadenoma (+ 3); Mesothelioma (+ 1); Prolactinoma A benign epithelial tumor in which the cells form recognizable glandular structures or in which the cells are clearly derived from glandular epithelium. (Dorland, 27th ed). BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI  ǽ VhXAdenolymphoma C04.557.435.075 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Complex and Mixed (Non MeSH) A benign tumor characterized histologically by tall columnar epithelium within a lymphoid tissue stroma. It is usually found in the salivary glands, especially the parotid. ˦VnAdenoids A15.382.520.604.084 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Adenoidectomy Hemic and Immune Systems (Non MeSH); Immune System; Lymphatic System; Lymphoid Tissue { :hAdenoidectomy E04.847.068 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Adenoids Surgery, Operative; Surgery, Otorhinolaryngologic (Non MeSH) t$ FAdenofibroma C04.557.450.565.590.595.050; C04.557.470.625.050 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Connective and Soft Tissue (Non MeSH); Neoplasms, Connective Tissue; Neoplasms, Fibrous Tissue; Neoplasms, Fibroepithelial Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Fibroepithelial A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed). -6V^Adenocarcinoma, Sebaceous C04.557.470.200.025.105; C04.557.470.550.105 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Adnexal and Skin Appendage (Non MeSH) A malignant tumor composed of cells showing differentiation toward sebaceous epithelium. The tumor is solitary, firm, somewhat raised, more or less translucent, and covered with normal or slightly verrucose epidermis. It may be yellow or orange. The face and scalp are the commonest sites. The growth can be slow or rapid but metastasis is uncommon. Surgery cures most of the cases. (From Rook et al., Textbook of Dermatology, 4th ed). Adenocarcinoma (69-93); Sebaceous Gland Neoplasms (69-93) 2X'DAdenocarcinoma, Scirrhous C04.557.470.200.025.095 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Linitis Plastica An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed). XAdenocarcinoma, Papillary C04.557.470.200.025.085 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Carcinoma, Papillary, Follicular An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed). )X&'Adenocarcinoma, Mucinous C04.557.470.200.025.075; C04.557.470.590.075 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Cystic, Mucinous, and Serous (Non MeSH) An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed). ڵ2X)cAdenocarcinoma, Follicular C04.557.470.200.025.060 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma Carcinoma, Papillary, Follicular An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed). Adenocarcinoma (69-93); Thyroid Neoplasms (69-93)  X&;Adenocarcinoma, Clear Cell C04.557.470.200.025.045 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma An adenocarcinoma characterized by the presence of varying combinations of clear and hobnail-shaped tumor cells. There are three predominant patterns described as tubulocystic, solid, and papillary. These tumors, usually located in the female reproductive organs, have been seen more frequently in young women since 1970 as a result of the association with intrauterine exposure to diethylstilbestrol. (From Holland et al., Cancer Medicine, 3d ed). Adenocarcinoma (66-93) E XAdenocarcinoma, Bronchiolo-Alveolar C04.557.470.200.025.030 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma; Adenocarcinoma A carcinoma thought to be derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed). (XAdenocarcinoma C04.557.470.200.025 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Carcinoma, Non-Small-Cell Lung Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Carcinoma Adenocarcinoma, Bronchiolo-Alveolar; Adenocarcinoma, Clear Cell; Adenocarcinoma, Follicular (+ 1); Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary (+ 1); Adenocarcinoma, Scirrhous (+ 1); Adenocarcinoma, Sebaceous; Carcinoid Tumor (+ 2); Carcinoma, Acinar Cell; Carcinoma, Adenoid Cystic; Carcinoma, Adrenal Cortical; Carcinoma, Endometrioid; Carcinoma, Hepatocellular; Carcinoma, Infiltrating Duct; Carcinoma, Intraductal, Noninfiltrating (+ 1); Carcinoma, Lobular; Carcinoma, Mucoepidermoid; Carcinoma, Neuroendocrine (+ 6); Carcinoma, Renal Cell; Carcinoma, Signet Ring Cell (+ 1); Carcinoma, Skin Appendage; Cholangiocarcinoma; Choriocarcinoma; Cystadenocarcinoma (+ 3); Klatskin's Tumor; Paget's Disease, Extramammary A carcinoma derived from glandular tissue or in which the tumor cells form recognizable glandular structures. Adenocarcinomas may be classified according to the predominant pattern of cell arrangement, as papillary, alveolar, etc., or according to a particular product of the cells, as mucinous adenocarcinoma. (Dorland, 27th ed).  X$uEAdenine Phosphoribosyltransferase D08.586.913.400.725.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Glycosyltransferases; Pentosyltransferases An enzyme catalyzing the formation of AMP from adenine and phosphoribosylpyrophosphate. It can act as a salvage enzyme for recycling of adenine into nucleic acids. EC 2.4.2.7. Adenine (72-74); Pentosephosphates (72-74); Pentosyltransferases (72-74); Pyrophosphoric Acids (72-74) &FxAdenine Nucleotides D13.695.667.138; D13.695.827.068 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides Adenosine Diphosphate (+ 3); Adenosine Monophosphate (+ 1); Adenosine Triphosphate (+ 2); Arabinofuranosyladenine Monophosphate; Coenzyme A (+ 4); Cyclic AMP (+ 2); Deoxyadenine Nucleotides; FAD; NAD; NADP; Phosphoadenosine Phosphosulfate Adenosine Diphosphate (+ 3); Adenosine Monophosphate (+ 1); Adenosine Triphosphate (+ 2); Coenzyme A (+ 4); Cyclic AMP (+ 2); FAD; NAD; NADP; Phosphoadenosine Phosphosulfate AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR %&BHAdenine Nucleotide Translocase D08.586.913.696.445.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases Catalyzes the exchange between endogenous and exogenous adenine nucleotides in mitochondria. Adenine Nucleotides (72-75); Nucleotidyltransferases (72-75) $FkFAdenine D03.438.759.138 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPHPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines 2-Aminopurine  >SAddison's Disease C19.053.264.263; C20.111.163 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Endocrine Diseases; Adrenal Gland Diseases; Adrenal Gland Hypofunction Immunologic Diseases; Autoimmune Diseases A disease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin. It is due to tuberculosis- or autoimmune-induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol. In the absence of replacement therapy, it is usually fatal. "NAdaptation, Psychological F01.058 CLDEPHRE Social Adjustment Behavior and Behavior Mechanisms (Non MeSH) Co-Dependency (Psychology); Orientation Favorable changes experienced by an individual, either as regards himself or his relationship with his environment, which lead to adjustment - also a rearrangement in mental attitude.  U  4/Adaptation, Physiological G07.062 DEGEIMPHRE Physiology, General (Non MeSH) Acclimatization; Estivation; Hibernation  %0Adaptation, Ocular G11.697.154 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) Dark Adaptation _Adaptation, Biological G04.185.057 DEGEIMPHRE Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Biological Phenomena (Non MeSH) |kAdams-Stokes Syndrome C14.280.067.558.137 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Heart Block Transient asystole or ventricular fibrillation in the presence of atrioventricular block. >NMhAdamantane D02.219.075; D02.455.426.392.368.075; D04.615.236.075 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Bridged Compounds Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Cyclic (Non MeSH); Hydrocarbons, Alicyclic (Non MeSH); Cycloparaffins Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Bridged Compounds Amantadine (+ 1); Rimantadine Amantadine (+ 1) Amantadine (+ 1); Rimantadine Tricyclo[3.3.1/3,7]decane. A tricyclo bridged hydrocarbon. Bridged Compounds (66-74); Cycloparaffins (66-74)  =:4^E;Acyltransferases D08.586.913.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases Acetyl CoA Acyltransferase; Acetyltransferases (+ 6); Aminolevulinic Acid Synthetase; Carboxypeptidase Transpeptidase; Carnitine Acyltransferases (+ 2); Cholesterol Acyltransferase; gamma-Glutamylcyclotransferase; gamma-Glutamyltransferase; Glycerolphosphate Acyltransferase; Lecithin Acyltransferase; Lysolecithin Acyltransferase; 3-Oxoacyl (Acyl Carrier Protein) Synthase; Peptidyl Transferases; Protein-Glutamine gamma-Glutamyltransferase WFUAcylneuraminate Cytidylyltransferase D08.586.913.696.445.035 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Nucleotidyltransferases An enzyme that forms CMP-acylneuraminic acids, which donate the N-acylneuraminic acid residues to the terminal sugar residue of a ganglioside or glycoprotein. EC 2.7.7.43. Cytosine Nucleotides (73-74); Neuraminic Acids (73-74); Nucleotidyltransferases (73-74) ))FfAcylation G06.535.630.095; H01.181.404.095 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic Acetylation Acetylation Chemistry, Organic (66-70)  & Acyl Coenzyme A D08.176.211.300; D13.695.667.138.382.300; D13.695.827.068.382.300 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes; Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Coenzyme A Acetyl Coenzyme A; Malonyl Coenzyme A; Palmitoyl Coenzyme A Malonyl Coenzyme A; Palmitoyl Coenzyme A Malonyl Coenzyme A; Palmitoyl Coenzyme A S-Acyl coenzyme A. Fatty acid coenzyme A derivatives that are involved in the biosynthesis and oxidation of fatty acids as well as in ceramide formation. Coenzyme A (66-77)  IFjAcyl Carrier Protein D12.776.157.050 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Consists of a polypeptide chain and 4'-phosphopantetheine linked to a serine residue by a phosphodiester bond. Acyl groups are bound as thiol esters to the pantothenyl group. Acyl carrier protein is involved in every step of fatty acid synthesis by the cytoplasmic system. Carrier Proteins (71-77)  HYAAcyclovir D03.438.759.758.399.454.250; D20.388.009; D26.087.009 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Purines; Purinones; Hypoxanthines; Guanine Anti-Infective Agents; Antiviral Agents Miscellaneous Drugs and Agents (Non MeSH); Antimetabolites Ganciclovir Ganciclovir Ganciclovir 9-[(2-Hydroxyethoxy)methyl] guanine. Functional analog of the nucleoside guanosine; acts as antimetabolite, especially in viruses; proposed as antiviral agent, especially in herpes infections. Guanine (66-82)   =:)Acute-Phase Reaction C23.739.487.099 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Inflammation Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors. Acute Disease (68-86); Inflammation (66-86)  Nj5Acute Yellow Atrophy C06.552.045 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Liver Diseases Massive necrosis of the liver, a rare complication of viral hepatitis (fulminant hepatitis) that may also result from exposure to hepatotoxins or from drug hypersensitivity. A lobe or the entire liver shrinks, becoming a soft, flabby, yellow-brown to green mass with a wrinkled capsule. There is confluent necrosis of hepatocytes, often with fatty change. Mortality is 60% to 90%. (Dorland, 27th ed). N2Acute Phase Proteins D12.776.124.050 ADAEAGAIANBICFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Blood Proteins alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; alpha Macroglobulins; Amyloid P Component; Amyloid Protein AA; C-Reactive Protein; Ceruloplasmin; Complement 3; Fibrinogen (+ 1); Haptoglobins; Hemopexin; Orosomucoid; Serum Albumin; Transferrin Proteins which are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumor markers. Blood Proteins (66-86); C-Reactive Protein (66-86); Glycoproteins (66-86) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $'DWXHAcute Disease C23.280.050; N01.407.306.137 CLECEPMONUPXRHTH Symptoms and General Pathology (Non MeSH); Disease Population Characteristics (Non MeSH); Health and Disease (Non MeSH); Disease Disease having a short and relatively severe course. d"@Acupuncture Therapy E02.030.100; E02.040.025.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Acupuncture Therapeutics; Alternative Medicine; Acupuncture Acupuncture Analgesia Acupuncture Analgesia Treatment of disease by inserting needles along specific pathways or meridians. The placement varies with the disease being treated. Heat or moxibustion and acupressure may be used in conjunction. Acupuncture (66-89)  ""U2Acupuncture Points E02.030.510.035; E02.040.025.510.035 CL Therapeutics; Acupuncture; Meridians Therapeutics; Alternative Medicine; Acupuncture; Meridians Designated locations along nerves or organ meridians for inserting acupuncture needles. Acupuncture (66-89) *ofAcupuncture Anesthesia E02.030.070; E02.040.025.070; E03.155.043 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Acupuncture Therapeutics; Alternative Medicine; Acupuncture Anesthesia and Analgesia (Non MeSH); Anesthesia Insertion of acupuncture needles at specific points in the body to block the afferent nerve impulses from reaching the brain, thus producing the loss of sensation of pain. The technique is used in performing surgery. Acupuncture (71-89); Anesthesia (71-89) 1"0Acupuncture Analgesia E02.030.100.048; E02.040.025.100.048; E03.091.048 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics; Acupuncture; Acupuncture Therapy Therapeutics; Alternative Medicine; Acupuncture; Acupuncture Therapy Anesthesia and Analgesia (Non MeSH); Analgesia Analgesia produced by the insertion of acupuncture needles at certain points in the body. These activate the small myelinated nerve fibers in the muscle which transmit impulses to the spinal cord and then activate three centers - the spinal cord, midbrain and pituitary hypothalamus - to produce analgesia. Acupuncture (72-89); Analgesia (72-89)  c9"f/Acupuncture E02.030; E02.040.025 AECLCTECHIISMOMTNUPXSNSTTDUTVE Therapeutics Therapeutics; Alternative Medicine Acupuncture Anesthesia; Acupuncture Therapy (+ 1); Electroacupuncture; Meridians (+ 1) Acupuncture Anesthesia; Acupuncture Therapy (+ 1); Electroacupuncture; Meridians (+ 1) The practice of piercing specific peripheral nerves with needles to relieve the discomfort associated with painful disorders, to induce surgical anesthesia, and for therapeutic purposes. This procedure was originally introduced and practiced in China. #P"7"Actuarial Analysis E05.318.740.100; G03.850.520.830.100; H01.548.832.067; N05.715.360.750.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Statistics Environment and Public Health (Non MeSH); Public Health; Epidemiologic Methods; Statistics Physical Sciences (Non MeSH); Mathematics; Statistics Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Statistics  Life Tables The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. %T"Actomyosin D12.776.210.500.154 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins A protein complex of actin and myosin occurring in muscle. It is the essential contractile substance of muscle. Muscle Proteins (66-70) )HqActivity Cycles G07.450.730.190.025 DEGEIMPHRE Physiology, General (Non MeSH); Chronobiology; Periodicity; Circadian Rhythm Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system. +b[PActivities of Daily Living E02.831.067; I03.050; N02.421.784.110 CLPX Sickness Impact Profile Therapeutics; Rehabilitation Human Activities (Non MeSH) Facilities, Manpower and Services (Non MeSH); Health Services; Rehabilitation The performance of the basic activities of self care, such as dressing, ambulation, eating, etc., in rehabilitation. Rehabilitation (66-67)  -i!-Activator Appliances E06.658.453.560.100; E06.658.453.578.100 AECLCTECHISDSNSTTDUTVE Dentistry; Orthodontics; Orthodontic Appliances; Orthodontic Appliances, Functional Dentistry; Orthodontics; Orthodontic Appliances; Orthodontic Appliances, Removable Loose-fitting removable orthodontic appliances which redirect the pressures of the facial and masticatory muscles onto the teeth and their supporting structures to produce improvements in tooth arrangements and occlusal relations. /G.Activation Analysis E05.196.039 AECLCTECHIISMOMTNUPXSNSTTDUTVE Miscellaneous Techniques (Non MeSH); Chemistry, Analytical Neutron Activation Analysis A method of chemical analysis based on the detection of characteristic radionuclides following a nuclear bombardment. It is also known as radioactivity analysis. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed). 1"E! Action Potentials G07.453.697.100; G11.561.450.100 DEGEIMPHRE Physiology, General (Non MeSH); Electrophysiology; Membrane Potentials Musculoskeletal, Neural, Eye Physiology (Non MeSH); Nervous System Physiology (Non MeSH); Membrane Potentials Evoked Potentials (+ 5); Myoelectric Complex, Migrating Evoked Potentials (+ 5); Myoelectric Complex, Migrating The electric response of a nerve or muscle to its stimulation. Electrophysiology (66)  3r&MActins D12.776.210.500.100; D12.776.220.525.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with myosin, actin is responsible for the contraction and relaxation of muscle. Muscle Proteins (66-70) 5 .FActinomycosis, Cervicofacial C01.252.410.040.137.262; C01.252.825.110; C01.539.800.720.110; C17.800.838.765.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections; Actinomycosis Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Skin Diseases, Bacterial Bacterial and Fungal Diseases (Non MeSH); Infection; Skin Diseases, Infectious; Skin Diseases, Bacterial Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Infectious; Skin Diseases, Bacterial A form of ACTINOMYCOSIS characterized by slow-growing inflammatory lesions of the lymph nodes that drain the mouth (lumpy jaw), reddening of the overlying skin, and intraperitoneal abscesses. 9!!\P Actinomycosis C01.252.410.040.137 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections; Actinomycetales Infections Actinomycosis, Cervicofacial Infections with bacteria of the genus ACTINOMYCES. <P!=Actinomycin D20.085.075.041; D22.204.106.038 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic Dactinomycin Dactinomycin >&<Actinomycetes and Related Organisms (Non MeSH) B03.100 Bacteria Actinomycetales (+ 42); Propionibacteriaceae (+ 3) CHCLCYDEENGDGEIMIPMEPHPYREULVI ?7  ="Actinomycetales Infections C01.252.410.040 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Positive Bacterial Infections Actinomycosis (+ 1); Corynebacterium Infections (+ 2); Mycobacterium Infections (+ 40); Nocardia Infections (+ 1) Infections with bacteria of the order ACTINOMYCETALES. Actinomyces (66-71); Actinomycetales (66-71)  @PsA5Actinomycetales B03.100.067 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH) Actinobacteria Group (+ 8); Micromonosporaceae (+ 1); Nocardioform Group (+ 24); Saccharopolyspora; Streptomycetaceae (+ 4) An order of gram-positive, primarily aerobic bacteria that tend to form branching filaments. B"CmActinomycetaceae B03.100.067.100.137; B03.510.460.400.400.100.137 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Actinobacteria Group Actinomyces (+ 1); Bifidobacterium Actinomyces (+ 1); Bifidobacterium A family of bacteria including numerous parasitic and pathogenic forms. Actinomycetales (66-74)  D6")TUActinomyces viscosus B03.100.067.100.137.178.800; B03.510.460.400.400.100.137.178.800 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group; Actinomycetaceae; Actinomyces Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Actinobacteria Group; Actinomycetaceae; Actinomyces A species of ACTINOMYCES found in the oral cavity of man and hamsters. It has been isolated from actinomycotic lesions in swine, cats, and dogs and has been identified as a causative agent of animal diseases. Actinomyces (69-91) GF"oActinomyces B03.100.067.100.137.178; B03.510.460.400.400.100.137.178 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales; Actinobacteria Group; Actinomycetaceae Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH); Actinobacteria Group; Actinomycetaceae Actinomyces viscosus Actinomyces viscosus A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads. J=>"Q0Actinobacteria Group B03.100.067.100; B03.510.460.400.400.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Actinomycetes and Related Organisms (Non MeSH); Actinomycetales Bacteria; Gram-Positive Bacteria; Gram-Positive Rods; Gram-Positive Asporogenous Rods; Gram-Positive Asporogenous Rods, Irregular (Non MeSH) Actinomycetaceae (+ 3); Arthrobacter; Brevibacterium; Micrococcus (+ 1) Actinomycetaceae (+ 3); Arthrobacter; Brevibacterium A group of gram-positive, heterogeneous bacteria. This group encompasses a range of morphologically, physiologically, and chemically different organisms and includes bacteria that form cocci, short rods, irregular rods, and mycelia that fragment. M7."Actinobacillus pleuropneumoniae B03.440.450.600.082.525 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae; Actinobacillus A species of gram-negative, facultatively anaerobic coccobacillus-shaped bacteria that has been isolated from pneumonic lesions and blood. It produces pneumonia with accompanying fibrinous pleuritis in swine. Actinobacillus (85-91); Haemophilus (80-85) Pk$"}4Actinobacillus Infections C01.252.400.700.030 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections Actinobacillosis Infections with bacteria of the genus ACTINOBACILLUS. Actinobacillosis (68-71); Actinobacillus (66-71)  RP@9Actinobacillus actinomycetemcomitans B03.440.450.600.082.082 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae; Actinobacillus A species of gram-negative, facultatively anaerobic spherical or rod-shaped bacteria that associates with species of ACTINOMYCES in actinomycotic lesions. Actinobacillus (66-91) Tb)"}Actinobacillus B03.440.450.600.082 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Pasteurellaceae Actinobacillus actinomycetemcomitans; Actinobacillus pleuropneumoniae A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals. V8"kM Actinobacillosis C01.252.400.700.030.178; C22.039 BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Pasteurellaceae Infections; Actinobacillus Infections Animal Diseases A disease characterized by suppurative and granulomatous lesions in the respiratory tract, upper alimentary tract, skin, kidneys, joints, and other tissues. Actinobacillus lignieresii infects cattle and sheep while A. equuli infects horses and pigs. Cattle Diseases (66-67) Xo&J Actinium D01.268.271.545.033; D01.552.517.042 ADAEAGANBLCFCHCLCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH); Elements; Elements, Radioactive (Non MeSH); Metals, Actinoid Inorganic Chemicals (Non MeSH); Metals; Metals, Actinoid Actinium. A trivalent radioactive element and the prototypical member of the actinide family. It has the atomic symbol Ac, atomic number 89, and atomic weight 227.0278. Its principal isotope is 227 and decays primarily by beta-emission. [ *4Actinin D12.776.210.500.095; D12.776.220.525.065 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Contractile Proteins; Muscle Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Cytoskeletal Proteins; Microfilament Proteins A protein factor that regulates the length of R-actin. It is chemically similar, but immunochemically distinguishable from actin. Muscle Proteins (70-75) ]o .HActing Out F01.393.047; F03.407.047; F04.754.919.211 Psychodrama Behavior and Behavior Mechanisms (Non MeSH); Defense Mechanisms Behavioral and Mental Disorders (Non MeSH); Defense Mechanisms Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Therapeutic Processes (Non MeSH) Expressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behavior. Psychoanalytic Therapy (66-67) _1}$Actihaemyl D24.185.893.050 ADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Immunologic and Biologic Factors (Non MeSH); Biological Factors; Tissue Extracts An extract from calf blood containing inorganic salts, amino acids, polypeptides and purines, but no proteins nor antigenic substances or blood group characteristics. Its exact composition is unknown. It has been proposed as a radiation-protective agent. Blood (73-74); Tissue Extracts (73-74) aB`(0ACTH Syndrome, Ectopic C04.588.322.443.317; C04.730.713.317; C19.344.443.317; C19.576.317 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neoplastic Endocrine-Like Syndromes Neoplasms; Neoplasms by Site (Non MeSH); Endocrine Gland Neoplasms; Neoplastic Endocrine-Like Syndromes Neoplasms; Paraneoplastic Syndromes; Neoplastic Endocrine-Like Syndromes Endocrine Diseases; Endocrine Gland Neoplasms; Neoplastic Endocrine-Like Syndromes Endocrine Diseases; Neoplastic Endocrine-Like Syndromes Symptom complex due to ACTH production by non-pituitary neoplasms. Adrenocorticotropic Hormone (66-79)  dLN)fO)Acrylonitrile D02.626.095 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles A highly poisonous compound used widely in the manufacture of plastics, adhesives and synthetic rubber. Also used as fumigant. Synonyms: Fumigrain; Ventox. Acrylates (68-76); Nitriles (68-76); Vinyl Compounds (73-76) f:0JAcrylic Resins D25.720.716.822.111 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Dental Materials Dental Restoration, Permanent; Dental Restoration, Temporary; Tooth, Artificial Biomedical and Dental Materials (Non MeSH); Polymers; Plastics; Resins, Synthetic Polymethacrylic Acids (+ 2) AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU $h,\b".Acrylates D02.241.081.069 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Acrylamides; Cyanoacrylates (+ 2); Methacrylates (+ 1); Polymethacrylic Acids (+ 2); Urocanic Acid AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR jU 8Yy:Acrylamides D02.065.122; D02.241.081.069.094 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acrylates Acrylates (66-70) k&8Acrospiroma, Eccrine C04.557.470.035.175.125; C04.557.470.550.175.125 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSESUTHULURUSVEVI Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Adenoma; Adenoma, Sweat Gland Neoplasms; Neoplasms by Histologic Type (Non MeSH); Neoplasms, Glandular and Epithelial; Neoplasms, Adnexal and Skin Appendage (Non MeSH); Adenoma, Sweat Gland A tumor derived from eccrine sweat duct epithelium which may be intra-epidermal (hidro-acanthoma simplex), juxta-epidermal (eccrine poroma) or intradermal (dermal duct tumor). They are comparatively uncommon. There is no indication that heredity or external agents cause these tumors. (Rook et al., Textbook of Dermatology, 4th ed). Adenoma, Sweat Gland (79-93); Sweat Gland Neoplasms (69-84) m6VHHAcrosome A05.360.490.890.820.100; A11.497.760.400.100 CHCLDEENIMMEMIPAPHPSRARERISETRULUSVI Urogenital System; Genitalia; Germ Cells; Spermatozoa; Sperm Head Cells; Germ Cells; Spermatozoa; Sperm Head Cap-like structure covering the nucleus and anterior part of the sperm head. p 2(\Acrosin D08.586.277.656.732.760.030 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Peptide Hydrolases; Peptide Peptidohydrolases; Serine Proteinases A trypsin-like enzyme of spermatozoa which is not inhibited by alpha 1 antitrypsin. Peptide Peptidohydrolases (73-74) rb Fd'Acronine D03.132.035; D03.494.046.220; D22.204.179.015 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antineoplastic Agents, Phytogenic 3,12-Dihydro-6-methoxy-3,3,12-trimethyl-7H-pyrano(2,3-c)acridin-7-one. An alkalid antineoplastic agent isolated from Acronychia baueri. Disrupts the function of intracellular membranes. Alkaloids (71-74); Acridines (71-74) t# 5:-Acromion A02.835.232.087.783.261 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Arm Bones (Non MeSH); Scapula v :bAcromioclavicular Joint A02.835.583.032 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUULUSVI Musculoskeletal System; Skeleton; Joints Shoulder Joint (66-74) w81Acromegaly C05.116.132.082; C19.700.355.178 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Adenoma, Acidophil Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Endocrine (Non MeSH) Endocrine Diseases; Pituitary Diseases; Hyperpituitarism A disorder due to excessive secretion of pituitary growth hormone, characterized by progressive enlargement of the head and face, hands and feet, and thorax. xk&NAcrolein D02.047.122 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes z~ :1Acrodynia C10.772.056 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Peripheral Nervous System Diseases {# NFAcrodermatitis C16.131.831.066; C17.800.174.100; C17.800.827.800.066 BLCFCLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Skin Abnormalities (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Dermatitis Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Genetic (Non MeSH); Skin Abnormalities (Non MeSH) Inflammation involving the skin of the extremities, especially the hands and feet. Several forms are known, some idiopathic and some hereditary. {=L[Acrocephalosyndactylia C05.116.099.370.894.232.015; C05.116.099.370.894.819.100; C05.660.585.800.100; C05.660.906.364.100; C05.660.906.819.100; C16.131.621.585.800.100; C16.131.621.906.364.100; C16.131.621.906.819.100 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Synostosis; Craniosynostoses Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dysostoses; Synostosis; Syndactyly Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH); Syndactyly Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Synostosis; Craniosynostoses Musculoskeletal Diseases; Musculoskeletal Abnormalities (Non MeSH); Synostosis; Syndactyly Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Limb Deformities, Congenital (Non MeSH); Syndactyly Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Synostosis; Craniosynostoses Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities; Musculoskeletal Abnormalities (Non MeSH); Synostosis; Syndactyly Craniostenosis characterized by acrocephaly and syndactyly, probably occurring as an autosomal dominant trait and usually as a new mutation. (Dorland, 27th ed). ~L8Acriflavine D03.494.046.250.177; D26.408.348.042 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes 3,6-Diamino-10-methylacridinium chloride mixt. with 3,6-acridinediamine. Fluorescent dye used as a local antiseptic and also as a biological stain. It intercalates into nucleic acids thereby inhibiting bacterial and viral replication. *.Acridines D03.494.046 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH) Acronine; Aminoacridines (+ 11) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR S ,G':Acridine Orange D03.494.046.250.150; D26.408.024; D26.408.348.024 AAADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Acridines; Aminoacridines Miscellaneous Drugs and Agents (Non MeSH); Dyes Miscellaneous Drugs and Agents (Non MeSH); Dyes; Fluorescent Dyes N,N,N',N'-Tetramethyl-3,6-acridinediamine, monohydrochloride. Cationic cytochemical stain specific for cell nuclei, especially DNA. It is used as a supravital stain and in fluorescence cytochemistry. It may cause mutations in microorganisms. Acridines (66-78); Dimethylamines (74) j9./Acremonium B05.354.381.546.025 CHCLCYDEENGDGEIMIPMEPHPYREULVI Algae and Fungi (Non MeSH); Fungi; Deuteromycetes; Hyphomycetes A deuteromycetous fungal genus of the class Hyphomycetes. Cephalosporin antibiotics are derived from this genus. ="NAcquired Immunodeficiency Syndrome C02.782.815.616.400.040; C02.800.801.040; C02.839.040; C20.673.480.040 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI AIDS Serodiagnosis; HIV Seropositivity; HIV Seroprevalence; Lymphoma, AIDS-Related HIV-1; CD4-Positive T-Lymphocytes Virus Diseases; RNA Virus Infections (Non MeSH); Retroviridae Infections; Lentivirus Infections; HIV Infections Virus Diseases; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral Virus Diseases; Slow Virus Diseases Immunologic Diseases; Immunologic Deficiency Syndromes; HIV Infections An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. Immunologic Deficiency Syndromes (79-82) $y(PP`(]/Acoustics H01.671.031 IS Psychoacoustics; Speech Acoustics Physical Sciences (Non MeSH); Physics Psychoacoustics; Sound (+ 1); Ultrasonics (+ 2) AECLCTDUECHIISLJMOMTNUPCPXSNSTTDUTVE  y (/<(Acoustic Stimulation E05.723.136 AEISMT Evoked Potentials, Auditory Noise; Hearing; Sound Miscellaneous Techniques (Non MeSH); Physical Stimulation Sound (66-71)   !DAcoustic Nerve Diseases C09.218.807.023; C10.772.204.025 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Otorhinolaryngologic Diseases; Ear Diseases; Retrocochlear Diseases (Non MeSH) Nervous System Diseases; Peripheral Nervous System Diseases; Cranial Nerve Diseases Neuroma, Acoustic (+ 1) Neuroma, Acoustic (+ 1) Diseases of the eighth cranial nerve. These include vestibular neuronitis, cochlear neuritis and acoustic neuroma. Acoustic Nerve (66-78); Cochlear Nerve (66-78); Peripheral Nerve Diseases (66-78); Vestibular Nerve (66-78) BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI $r&N:XAcoustic Nerve A08.800.800.120.090 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves Cochlear Nerve (+ 1); Vestibular Nerve The 8th cranial nerve. The acoustic (or vestibulocochlear) nerve has a cochlear part which is concerned with hearing and a vestibular part which mediates the sense of balance and head position. The fibers of the cochlear nerve originate from neurons of the spiral ganglion and project to the cochlear nuclei. The fibers of the vestibular nerve arise from neurons of Scarpa's ganglion and project to the vestibular nuclei. 8[1Acoustic Maculae A09.246.631.909.625.125 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Sense Organs; Ear; Labyrinth; Vestibule; Saccule and Utricle Hair Cells, Vestibular; Otolithic Membrane Thickened areas of the saccule and utricle where the termination of the vestibular nerve occurs. Labyrinth (66-78)  :K3sAcoustic Impedance Tests E01.276.299.375.100 AECLCTECHIISMOMTNUPXSNSTTDUTVE Audiometry; Ear, Middle Diagnosis; Diagnosis, Otorhinolaryngologic (Non MeSH); Diagnosis, Ear (Non MeSH); Hearing Tests Objective tests of middle ear function based on the difficulty (impedance) or ease (admittance) of sound flow through the middle ear. These include static impedance and dynamic impedance (i.e., tympanometry and impedance tests in conjunction with intra-aural muscle reflex elicitation). This term is used also for various components of impedance and admittance (e.g., compliance, conductance, reactance, resistance, susceptance). Audiometry (66-77); Ear, Middle (66-77); Tympanic Membrane (66-77)  '"rQAconitine D03.132.026.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids; Aconite 16-Ethyl-l alpha,6 alpha,19 beta-trimethoxy-4-(methoxymethyl)-aconitane-3 alpha,8,10 alpha,11,18 alpha-pentol, 8-acetate 10-benzoate. A poisonous alkaloid from the root of Aconitum napellus L. Used to induce arrhythmia in experimental animals. Aconite (72-74) y :3Aconitic Acid D02.241.081.901.177 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Tricarboxylic Acids U:rAconite D03.132.026 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Alkaloids Aconitine I :( Aconitate Hydratase D08.586.520.497.066 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Hydro-Lyases An enzyme that catalyzes the reversible hydration of cis-aconitate to yield citrate or isocitrate. It is one of the citric acid cycle enzymes. EC 4.2.1.3. Hydro-Lyases (66-72) F_Acneiform Eruptions (Non MeSH) C17.800.271.125 Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Facial Dermatoses Acne Keloid; Acne Rosacea (+ 1); Acne Vulgaris; Favre-Racouchot Syndrome BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI %aYNAcne Vulgaris C17.800.271.125.200; C17.800.805.711.111 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Facial Dermatoses; Acneiform Eruptions (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Sebaceous Gland Diseases (Non MeSH) A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. %.N=Acne Rosacea C17.800.271.125.150 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Facial Dermatoses; Acneiform Eruptions (Non MeSH) Rhinophyma An acneiform eruption occurring mostly in middle-aged adults and appearing generally on the forehead, cheeks, nose, and chin. Three types are recognized: granulomatous, glandular hyperplastic with rhinophyma, and ocular. *NAcne Keloid C17.300.200.425.125; C17.800.120.425.125; C17.800.271.125.125; C17.800.805.305.383.261 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Connective Tissue Diseases; Collagen Diseases; Keloid Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Cicatrix; Keloid Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Facial Dermatoses; Acneiform Eruptions (Non MeSH) Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Appendage Diseases; Hair Diseases; Folliculitis A type of acneiform disorder in which secondary pyogenic infection in and around pilosebaceous structures ends in keloidal scarring. It manifests as persistent folliculitis of the back of the neck associated with occlusion of the follicular orifices. It is most often encountered in black or Asian men. Y`NcAclarubicin D20.085.075.105.050; D22.204.106.125.050 AAADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Anti-Infective Agents; Antibiotics; Antibiotics, Antineoplastic; Antibiotics, Anthracycline Antineoplastics, Immunosuppressives (Non MeSH); Antineoplastic Agents; Antibiotics, Antineoplastic; Antibiotics, Anthracycline Methyl 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11- dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxy-4-O-(tetrahydro- 6-methyl-5-oxo-2H-pyran-2-yl)-alpha-L-lyxo-hexapyranosyl)- 3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-1- naphthacenecarboxylate. An anthracycline antibiotic produced by Streptomyces galilaeus. It has potent antineoplastic activity, especially in the treatment of leukemias, with reduced cardiac toxicity in comparison to daunorubicin or doxorubicin. Antibiotics, Antineoplastic (67-88); Naphthacenes (66-88) .< CAcitretin D02.455.849.291.700.050; D11.557.261.700.050; D23.400.050 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Terpenes; Diterpenes; Retinoids Growth Substances, Pigments, Vitamins (Non MeSH); Pigments; Carotenoids; Retinoids Dermatologic Agents; Keratolytic Agents (all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid. An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate. Tretinoin/analogs and derivatives (77-92) e A:-1Acinetobacter Infections C01.252.400.625.022 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Bacterial Infections; Gram-Negative Bacterial Infections; Neisseriaceae Infections Infections with bacteria of the genus ACINETOBACTER. Acinetobacter (66-67) ZP?Acinetobacter calcoaceticus B03.440.400.425.550.100.200 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae; Acinetobacter A species of gram-negative, aerobic bacteria found in soil and water. Although considered to be normally nonpathogenic, this bacterium is a causative agent of nosocomial infections, particularly in debilitated individuals. Acinetobacter (75-91); Alcaligenes (71-74)  "3Acinetobacter B03.440.400.425.550.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Neisseriaceae Acinetobacter calcoaceticus A genus of gram-negative bacteria of the family NEISSERIACEAE, found in soil and water and of uncertain pathogenicity. Alcaligenes (74)  Q" Acidulated Phosphate Fluoride D01.303.350.300.875.050; D01.695.625.675.650.025; D01.857.725.050; D25.223.432.866.050 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Inorganic Chemicals (Non MeSH); Fluorine Compounds; Hydrofluoric Acid; Fluorides; Sodium Fluoride Inorganic Chemicals (Non MeSH); Phosphorus Compounds (Non MeSH); Phosphorus Acids; Phosphoric Acids; Phosphates Inorganic Chemicals (Non MeSH); Sodium Compounds; Sodium Fluoride Biomedical and Dental Materials (Non MeSH); Cariostatic Agents; Fluorides, Topical; Sodium Fluoride Phosphoric acid, mixt. with sodium fluoride (NaF). A sodium fluoride solution, paste or powder, which has been acidulated to pH 3 to 4 and buffered with a phosphate. It is used in the prevention of dental caries. Fluorides (66-76); Fluorides, Topical (66-76); Phosphates (66-76) !#`,OAcids, Noncarboxylic (Non MeSH) D01.029.260 Inorganic Chemicals (Non MeSH); Acids Boric Acids; Borinic Acids; Boronic Acids; Carbonic Acid; Hydrobromic Acid; Hydrochloric Acid; Hydrofluoric Acid; Hydrogen Cyanide; Hydrogen Sulfide; Hypochlorous Acid; Nitric Acid; Nitrous Acid; Perchloric Acid; Periodic Acid; Phosphorus Acids (+ 5); Silicic Acid; Sulfur Acids (+ 5) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR &/V:Acids, Heterocyclic (Non MeSH) D03.066 Heterocyclic Compounds Cinoxacin; Indoleacetic Acids (+ 2); Isonicotinic Acids (+ 6); Isonipecotic Acids (+ 5); Nicotinic Acids (+ 11); Nipecotic Acids; Orotic Acid; Picolinic Acids (+ 3); Pipecolic Acids; Xanthurenates (+ 1) AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR % DAcids, Carbocyclic (Non MeSH) D02.241.223 Organic Chemicals (Non MeSH); Carboxylic Acids Benzoates (+ 67); Cinnamates (+ 3); Cyclohexanecarboxylic Acids (+ 8); Mandelic Acids (+ 2); Phenylacetates (+ 12); Phenylbutyrates; Phenylpropionates (+ 5); Phenylpyruvic Acids; Phthalic Acids (+ 6) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $9:Acids, Aldehydic (Non MeSH) D02.241.152 Organic Chemicals (Non MeSH); Carboxylic Acids Glyoxylates (+ 1); Uronic Acids (+ 3) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR }"91:Acids, Acyclic (Non MeSH) D02.241.081 Organic Chemicals (Non MeSH); Carboxylic Acids Abscisic Acid; Acetic Acids (+ 27); Acrylates (+ 10); Butyrates (+ 13); Caproates (+ 5); Caprylates (+ 1); Carbamates (+ 29); Dicarboxylic Acids (+ 33); Fatty Acids (+ 20); Fatty Acids, Unsaturated (+ 74); Fatty Acids, Volatile (+ 16); Formic Acids (+ 5); Imino Acids (+ 1); Propionates (+ 6); Sugar Acids (+ 19); Tricarboxylic Acids (+ 4); Valerates (+ 4) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR u 9FAcids D01.029 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Inorganic Chemicals (Non MeSH) Acids, Noncarboxylic (Non MeSH) (+ 27) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR    8%/:Acidosis, Respiratory C08.618.846.093; C18.452.076.176.310 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Respiratory Tract Diseases; Respiration Disorders; Respiratory Insufficiency Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance; Acidosis A state due to excess carbon dioxide in the body. (Dorland, 27th ed). Acidosis (66)  *NXAcidosis, Renal Tubular C12.777.419.815.093; C18.452.076.176.210; C18.452.648.851.093 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Urologic and Male Genital Diseases (Non MeSH); Urologic Diseases; Kidney Diseases; Renal Tubular Transport, Inborn Errors Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance; Acidosis Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Renal Tubular Transport, Inborn Errors A rare sometimes familial disorder of the renal tubule characterized by the inability to excrete urine of normal acidity. This leads to a hyperchloremic acidosis which is often associated with one or more secondary complications such as hypercalcinuria with nephrolithiasis and nephrocalcinosis, rickets, or osteomalacia and severe potassium depletion. ENAcidosis, Lactic C18.452.076.176.180 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance; Acidosis Acidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as diabetes mellitus, leukemia, or liver failure. Acidosis (66-86); Lactates (66-86) Nr+Acidosis C18.452.076.176 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Acid-Base Equilibrium Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Acid-Base Imbalance Acidosis, Lactic; Acidosis, Renal Tubular; Acidosis, Respiratory; Diabetic Ketoacidosis; Ketosis A pathologic condition resulting from accumulation of acid or depletion of the alkaline reserve (bicarbonate) content of the blood and body tissues, and characterized by an increase in hydrogen ion concentration (decrease in pH). (Dorland, 27th ed).  " Nfq%Acid-Base Imbalance C18.452.076 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Acidosis (+ 5); Alkalosis (+ 1) Disturbances in the ACID-BASE EQUILIBRIUM of the body. Acid-Base Equilibrium (66-75)  NN*B#Acid-Base Equilibrium G06.184.029; G07.621.110; G09.188.051; H01.181.529.428.176 DEGEIMPHRE Acidosis; Alkalosis Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Biochemical Phenomena (Non MeSH) Physiology, General (Non MeSH); Homeostasis Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical; Hydrogen-Ion Concentration Buffers Buffers Buffers MDXAcid Rain D05.284.101.143.050; D05.284.756.050; D05.284.903.655.050; G03.230.300.100.725.450.050; G03.850.460.790.410.050 AEANECLJPCPOSNTO Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Air Pollutants; Air Pollutants, Environmental Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Soil Pollutants Environmental Pollutants, Pesticides (Non MeSH); Environmental Pollutants; Water Pollutants; Water Pollutants, Chemical Environment and Public Health (Non MeSH); Environment; Meteorological Factors; Atmosphere; Weather; Rain Environment and Public Health (Non MeSH); Public Health; Environmental Pollution; Water Pollution; Water Pollution, Chemical Acidic water usually pH 2.5 to 4.5, which poisons the ecosystem and adversely affects plants, fishes, and mammals. It is caused by industrial pollutants, mainly sulfur oxides and nitrogen oxides, emitted into the atmosphere and returning to earth in the form of acidic rain water. Air Pollutants, Environmental (75-88); Soil Pollutants (75-88); Water Pollutants, Chemical (75-88); Weather (75-88) o{JAcid Phosphatase D08.586.277.352.650.025 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Phosphoric Monoester Hydrolases An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2. ܌FAcid Etching, Dental E06.095.100 AECLCTECHIISMTPXSNSTTDUTVE Dentistry; Dental Bonding Pretreatment of tooth surfaces with etching agents, usually phosphoric acid, to increase the adhesion of various resin systems. Bonding, Dental (71-76); Dental Enamel (66-76); Phosphoric Acids (68-76) A XAcid Anhydride Hydrolases D08.586.277.040 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases Adenosinetriphosphatase (+ 8); Apyrase; GTP Phosphohydrolase; Pyrophosphatases (+ 1); Thiamin-Triphosphatase A group of enzymes that catalyze the hydrolysis of diphosphate bonds in compounds such as nucleoside di- and tri-phosphates, and sulfonyl-containing anhydrides such as adenylylsulfate. (Enzyme Nomenclature, 1992) EC 3.6. Hydrolases (66-93)  ߼FSAchromatium B03.350.100.100; B03.440.400.100.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH); Achromatiaceae Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Achromatiaceae A genus of gliding bacteria made up of spherical to ovoid to cylindrical cells with hemispherical ends. It is found in mud and freshwater environments. G*"Achromatiaceae B03.350.100; B03.440.400.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gliding Bacteria (Non MeSH) Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria Achromatium Achromatium A family of bacteria found in freshwater and marine environments. Bacteria (66-74)  ""wOAchondroplasia C05.116.099.708.017; C05.116.099.343.110 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Osteochondrodysplasias Musculoskeletal Diseases; Bone Diseases; Bone Diseases, Developmental; Dwarfism A hereditary, congenital disturbance of epiphyseal chondroblastic growth and maturation, causing inadequate enchondral bone formation and resulting in a peculiar form of dwarfism with short limbs, normal trunk, small face, normal vault, lordosis, and trident hand. It may be accompanied by other anomalies. (Dorland, 27th ed). .N{Acholeplasmataceae B03.440.560.580.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales Acholeplasma (+ 1) Gram-negative organisms including apparently free-living saprophytes as well as mammalian and avian parasites, and possibly pathogens. Bacteria (66-74); Mycoplasmataceae (75)  "H0Acholeplasma laidlawii B03.440.560.580.100.150.500 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Acholeplasmataceae; Acholeplasma An organism originally isolated from sewage, manure, humus, and soil, but recently found as a parasite in mammals and birds. Mycoplasma (66-71) $"nAcholeplasma B03.440.560.580.100.150 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Mollicutes; Mycoplasmatales; Acholeplasmataceae Acholeplasma laidlawii A genus of gram-negative organisms including saprophytic and parasitic or pathogenic species. Mycoplasma (66-75)  "^mAchlorhydria C06.405.748.045; C18.452.042 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Gastric Juice; Gastric Acid Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases Absence of hydrochloric acid from maximally stimulated gastric secretions. It is a result of gastric mucosal atrophy. (Dorland, 27th ed). 5"N#Achilles Tendon A02.633.837.176 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Heel Musculoskeletal System; Muscles; Tendons A:1Achievement F01.658.059; F02.784.629.054 Behavior and Behavior Mechanisms (Non MeSH); Motivation Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Educational Success in bringing an effort to the desired end; the degree or level of success attained in some specified area (esp. scholastic) or in general. "Acetyltransferases D08.586.913.050.134 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases Acetyl-CoA Acetyltransferase; Arylamine Acetyltransferases; Carnitine Acetyltransferase; Chloramphenicol Acetyltransferase; Choline Acetyltransferase; Phosphate Acetyltransferase Acyltransferases (66-72) FiAcetylthiocholine D02.092.102.232.800.030; D02.675.276.232.800.030 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amines; Ammonium Compounds; Choline; Thiocholine Organic Chemicals (Non MeSH); Onium Compounds; Ammonium Compounds; Choline; Thiocholine An agent used as a substrate in assays for cholinesterases, especially to discriminate among enzyme types. Acetylcholine (72-74); Sulfhydryl Compounds (73-74) 6:~=Acetylserotonin Methyltransferase D08.586.913.517.040 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Methyltransferases An enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine to N-acetylserotonin to form N-acetyl-5-methoxytryptamine (MELATONIN). EC 2.1.1.4. Methyltransferases (74); Serotonin (74) &Fk0Acetylprocainamide D02.241.223.106.061.075.040; D18.097.622.024 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Carbocyclic (Non MeSH); Benzoates; Aminobenzoic Acids; 4-Aminobenzoic Acid Cardiovascular Agents; Anti-Arrhythmia Agents; Procainamide 4-(Acetylamino)- N-(2-(diethylamino)ethyl)benzamide. Major metabolite of procainamide; its anti-arrhythmic action may cause cardiac toxicity in kidney failure. Procainamide (66-74) /AA (75-79) 2:'Acetylmuramyl-Alanyl-Isoglutamine D09.203.067.550.050; D09.203.811.522.050; D12.644.233.050; D24.611.062.040 AAADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Muramic Acids Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Sugar Acids; Muramic Acids Amino Acids, Peptides and Proteins (Non MeSH); Peptides; Glycopeptides Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Adjuvants, Immunologic Acetylmuramyl-L-alanyl-D-isoglutamine. Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity. Synonyms: N-acetylmuramylpeptide(s); N-acetylmuramyl dipeptide(s). Glycopeptides (71-78); Peptides (66-70); Polysaccharides (66-70) )%TBDMAcetylglucosaminidase D08.586.277.450.483.531.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Glycoside Hydrolases; Hexosaminidases; Glucosaminidase Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase 2-Acetamido-2-deoxy-beta-D-glucoside acetamidodeoxygluco-hydrolase. Catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as mucolipidosis and various inflammatory disorders of muscle and connective tissue. Acetamides (73-74); Glucosaminidase (72-74)  <F<4Acetylglucosamine D09.203.067.342.531.050 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines; Glucosamine 2-Acetamido-2-deoxyglucopyranose. The N-acetyl derivative of glucosamine. Glucosamine (73-74) DzTAcetylgalactosamine D09.203.067.342.356.050 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Amino Sugars; Hexosamines; Galactosamine 2-Acetamido-2-deoxygalactopyranose. The N-acetyl derivative of galactosamine. Galactosamine (73-74) 7D|XAcetylesterase D08.586.277.352.100.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases An enzyme that catalyzes the conversion of acetate esters and water to alcohols and acetate. EC 3.1.1.6. F~Acetylene D02.455.326.397.259 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Hydrocarbons; Hydrocarbons, Acyclic (Non MeSH); Alkynes W :gAcetyldigoxins D04.808.155.160.349.050; D09.203.408.180.261.436.050; D18.222.175.324.386.042 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Digoxin Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides; Digoxin Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides; Digoxin Alpha- or beta-acetyl derivatives of digoxin or lanatoside C from Digitalis lanata. They are better absorbed and longer acting than digoxin and are used in congestive heart failure. Digoxin (66-78) ;U8OAcetyldigitoxins D04.808.155.160.278.259; D09.203.408.180.261.336.259; D18.222.175.324.261.259 ADAEAGAIANBIBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Steroids; Cardanolides; Cardenolides; Digitoxin Carbohydrates and Hypoglycemic Agents (Non MeSH); Carbohydrates; Glycosides; Cardiac Glycosides; Digitalis Glycosides; Digitoxin Cardiovascular Agents; Cardiotonic Agents; Cardiac Glycosides; Digitalis Glycosides; Digitoxin 3 beta,14 beta-Dihydroxy-5 beta-card-20(22)-enolide 3-monoacetyl tridigitoxosides. Cardioactive derivatives of lanatoside A or of digitoxin. They are used for fast digitalization in congestive heart failure.  :U:UAcetylcysteine D12.125.166.230.259; D26.415.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Amino Acids, Peptides and Proteins (Non MeSH); Amino Acids; Amino Acids, Sulfur; Cysteine Miscellaneous Drugs and Agents (Non MeSH); Expectorants A white, crystalline powder used as a mucolytic agent for adjunct therapy in bronchopulmonary disorders to reduce the viscosity of mucus and facilitate its removal. It is administered by instillation or nebulization. (From Dorland, 27th ed).  D&:Acetylcholinesterase D08.586.277.352.100.170.176 ADAEAGANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Carboxylic Ester Hydrolases; Cholinesterases An enzyme that catalyzes the conversion of acetylcholine and water to choline and acetate. It is found in the gray matter of nerve tissue, in red blood cells, and in the motor endplates of skeletal muscle. The reaction destroys acetylcholine released at neurohumoral junctions, thus permitting recovery for transmission of further impulses. (From Dorland, 27th ed) EC 3.1.1.7. DAcetylcholine D02.092.211.111; D14.100.120.140.500.030; D14.100.120.140.700.030; D14.600.025; D16.050.495.020; D16.050.675.020 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Cholinergic Agents; Receptors, Cholinergic Organic Chemicals (Non MeSH); Amines; Biogenic Amines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Muscarinic Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Cholinergic Agents; Cholinergic Agonists; Nicotinic Agonists Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitters Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Miotics Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Parasympathomimetics A neurotransmitter. Acetylcholine in vertebrates is the major transmitter at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. It is generally not used as an administered drug because it is broken down very rapidly by cholinesterases, but it is useful in some ophthalmological applications. ~D2Acetylcarnitine D11.786.708.168.090; D15.590.025 AAADAEAGAIANBIBLCFCHCLCSCTDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Growth Substances, Pigments, Vitamins (Non MeSH); Vitamins; Vitamin B Complex; Carnitine Central Nervous System Agents; Nootropic Agents 2-(Acetyloxy)-3-carboxy-N,N,N-trimethyl-1-propanaminium. An acetic acid ester of carnitine that facilitates movement of acetyl CoA into the matrices of mammalian mitochondria during the oxidation of fatty acids. Carnitine (66-77) D&DAcetylation G06.535.630.095.052; H01.181.404.095.052 DERE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH); Acylation Physical Sciences (Non MeSH); Chemistry; Chemistry, Organic; Acylation Chemistry, Organic (66-72) . Acetyl-CoA Hydrolase D08.586.277.352.897.075 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Hydrolases; Esterases; Thiolester Hydrolases An enzyme that catalyzes reversibly the hydrolysis of acetyl-CoA to yield CoA and acetate. The enzyme is involved in the oxidation of fatty acids. EC 3.1.2.1. Thiolester Hydrolases (73-77) Fz#Acetyl-CoA Carboxylase D08.586.464.065 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases A carboxylating enzyme that catalyzes the conversion of ATP, acetyl-CoA, and HCO3- to ADP, orthophosphate, and malonyl-CoA. It is a biotinyl-protein that also catalzse transcarboxylation. The plant enzyme also carboxylates propanoyl-CoA and butanoyl-CoA (From Enzyme Nomenclature, 1992) EC 6.4.1.2. FPWAcetyl-CoA Acetyltransferase D08.586.913.050.134.060 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases; Acetyltransferases An enzyme that catalyzes the reversible formation of acetoacetyl-CoA from two molecules of acetyl-CoA. EC 2.3.1.9. Acetyltransferases (73-74); Acetyl Coenzyme A (73-74); Acetoacetates (74)  )!FXAcetyl Coenzyme A D08.176.211.300.075; D13.695.667.138.382.259; D13.695.827.068.382.259 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Coenzymes; Coenzyme A; Acyl Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Purine Nucleotides; Adenine Nucleotides; Coenzyme A Nucleic Acids, Nucleotides, and Nucleosides (Non MeSH); Nucleotides; Ribonucleotides; Adenine Nucleotides; Coenzyme A S-Acetate coenzyme A. Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. Coenzyme A (66-72) "0MFAcetyl CoA Acyltransferase D08.586.913.050.080 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Acyltransferases Enzyme that catalyzes the final step of fatty acid oxidation in which acetyl-CoA is released and the CoA ester of a fatty acid two carbons shorter is formed. EC 2.3.1.16. Acyltransferases (73-74); Acetyl Coenzyme A (73-74) % Fi>Acetrizoic Acid D26.298.045 ADAEANCHCLCSCTDUECHIIPMEPDPKPORESDSTTOTU Miscellaneous Drugs and Agents (Non MeSH); Contrast Media ',FAcetoxyacetylaminofluorene D02.065.064.150.100; D02.241.081.038.108.080.070; D04.615.389.050.060; D26.191.372.016.014 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Acetamides; 2-Acetylaminofluorene Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids; Acetamides; 2-Acetylaminofluorene Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH); Fluorenes; 2-Acetylaminofluorene Miscellaneous Drugs and Agents (Non MeSH); Carcinogens; Fluorenes; 2-Acetylaminofluorene N,O-Diacetyl-N-fluoren-2-ylhydroxylamine. A fluorene derivative with carcinogenic action. Acetamides (73-74); Acetates (66-67); Acetic Acids (68-72); Amides (66-72); Fluorenes (66-74) (ed:esAcetophenones D02.522.120 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Benzoin; omega-Chloroacetophenone AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR +8/':Acetonitriles D02.626.080 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Nitriles Aminoacetonitrile Compounds in which a methyl group is attached to the cyano moiety. Nitriles (69-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $,80R:Acetone D02.522.064; D02.522.585.342 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ketones Organic Chemicals (Non MeSH); Ketones; Ketone Bodies .\ ":nAcetolactate Synthase D08.586.520.567.100 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Lyases; Ketoacid-Lyases A flavoprotein that catalyzes the formation of acetolactate from 2 moles of pyruvate in the biosynthesis of valine and the formation of acetohydroxybutyrate from pyruvate and alpha-ketobutyrate in the biosynthesis of isoleucine. EC 4.1.3.18. Ketoacid-Lyases (72-74); Pyruvates (72-74) /PFb3Acetoin Dehydrogenase D08.586.682.047.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Oxidoreductases; Alcohol Oxidoreductases An enzyme that catalyzes the conversion of acetoin to diacetyl in the presence of NAD. EC 1.1.1.5. Alcohol Oxidoreductases (72-74); Butanones (72-74) 1Ftx<Acetoin D02.033.210.040; D02.033.555.233.040; D02.522.296.100; D10.516.289.233.040 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Alcohols, Butyl Organic Chemicals (Non MeSH); Alcohols; Fatty Alcohols; Alcohols, Butyl Organic Chemicals (Non MeSH); Ketones; Butanones Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Alcohols; Alcohols, Butyl 3-Hydroxy-2-butanone. A product of fermentation. It is a component of the butanediol cycle in microorganisms. In mammals it is oxidized to carbon dioxide. Alcohols, Butyl (72-74); Butanones (70-74) 3a T:44Acetohexamide D02.886.590.795.071; D02.948.828.071; D09.482.059 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Sulfonylurea Compounds Organic Chemicals (Non MeSH); Urea; Sulfonylurea Compounds Carbohydrates and Hypoglycemic Agents (Non MeSH); Hypoglycemic Agents 6A9:Acetobacteraceae B03.440.400.425.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH) Acetobacter A family of gram-negative bacteria consisting of ellipsoidal to rod-shaped cells that occur singly, in pairs, or in chains. 7"Acetobacter B03.440.400.425.100.100 CHCLCYDEENGDGEIMIPMEPHPYREULVI Bacteria; Gram-Negative Bacteria; Gram-Negative Aerobic Bacteria; Gram-Negative Aerobic Rods and Cocci (Non MeSH); Acetobacteraceae A species of gram-negative bacteria of the family ACETOBACTERACEAE found in flowers and fruits. Cells are ellipsoidal to rod-shaped and straight or slightly curved. 9"Acetoacetates D02.241.607.080; D02.522.585.175 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Keto Acids Organic Chemicals (Non MeSH); Ketones; Ketone Bodies ;I&8Acetic Anhydrides D02.113.075; D02.241.081.038.270 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Anhydrides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Anhydrides of acetic acid. Used extensively as acetylation, oxidation and dehydrating agents and in the modification of proteins and enzymes. Acetates (66-67); Acetic Acids (68-78); Anhydrides (66-78) <^&8HAcetic Acids D02.241.081.038; D02.241.081.465.092; D10.516.251.400.092 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Fatty Acids, Volatile Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile Acetamides (+ 7); Acetates (+ 5); Acetic Acid Esters; Acetic Anhydrides; Aminooxyacetic Acid; DTPA (+ 1); Edetic Acid; Egtazic Acid; Nitrilotriacetic Acid; Peracetic Acid; Phosphonoacetic Acid (+ 1); Thioglycolates; Trichloroacetic Acid Acetic Acid Esters Acetates (66-67) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  >A815:Acetic Acid Esters D02.241.081.038.250; D10.516.251.400.092.259 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Lipids and Antilipemic Agents (Non MeSH); Lipids; Fatty Acids; Fatty Acids, Volatile; Acetic Acids A28Acetazolamide D03.383.871.867.060; D08.373.220.109; D15.080.025; D19.770.224.266.109 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 1-Ring (Non MeSH); Thiazoles; Thiadiazoles Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzyme Inhibitors; Carbonic Anhydrase Inhibitors Central Nervous System Agents; Anticonvulsants Hematologic, Gastric, Renal Agents (Non MeSH); Renal Agents (Non MeSH); Diuretics; Carbonic Anhydrase Inhibitors A carbonic anhydrase inhibitor that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337). CnP:Acetates D02.241.081.038.209 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids Dichloroacetate; Fluoroacetates (+ 1); Iodoacetates (+ 1) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR H 8kF:Acetate-CoA Ligase D08.586.464.271.050 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Ligases; Coenzyme A Synthetases An enzyme that catalyzes the formation of CoA derivatives from ATP, acetate, and CoA to form AMP, pyrophosphate, and acetyl CoA. It acts also on propionates and acrylates. EC 6.2.1.1. Acetyl Coenzyme A (74-75); Coenzyme A Synthetases (74-75) JFlFAcetate Kinase D08.586.913.696.630.025 ADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Transferases; Phosphotransferases; Phosphotransferases (Carboxyl Group Acceptor) An enzyme found predominantly in microorganisms that catalyzes reversibly the phosphorylation of acetate in the presence of a divalent cation and ATP with the formation of acetylphosphate and ADP. It is important in the glycolysis process. EC 2.7.2.1. Acetates (66-78); Acetic Acids (68-78); Phosphotransferases (66-73); Phosphotransferases, ATP (74-78) LAF'xAcetanilides D02.065.199.092 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides Acetaminophen; Diamfenetide; Etidocaine; Isoprinosine; Lidocaine; Phenacetin; Trimecaine N-Phenylacetamide. Precursor of many drugs, dyes and other compounds in chemical synthesis; formerly used as analgesic and antipyretic, but often causes lethal methemoglobinemia. Synonyms: acetylaniline; acetylaminobenzene; antifebrin. AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR  O8:h:Acetaminophen D02.065.199.092.040; D16.850.015.025 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides; Anilides; Acetanilides Peripheral Nervous System Agents (Non MeSH); Sensory System Agents (Non MeSH); Analgesics, Non-Narcotic N-(4-Hydroxyphenyl)acetanilide. Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Q*:Acetamides D02.065.064; D02.241.081.038.108 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Amides Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH); Acetic Acids 2-Acetylaminofluorene (+ 2); Allylisopropylacetamide; Iodoacetamide; Piracetam; Thioacetamide 2-Acetylaminofluorene (+ 2); Allylisopropylacetamide; Iodoacetamide; Piracetam; Thioacetamide A group of compounds structurally related to acetamide, a white crystalline substance used as a solvent and acting as a mild irritant. Acetic Acids (66-70); Amides (66-70) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $S&8.:Acetals D02.355.071 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Ethers Ethers (66-71) V 8.Acetaldehyde D02.047.064 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Aldehydes Paraldehyde A colorless, flammable liquid used in the manufacture of acetic acid, perfumes, and flavors. It is also an intermediate in the metabolism of alcohol. It has a general narcotic action and also causes irritation of mucous membranes. Large doses may cause death from respiratory paralysis. W:1RAcetabulum A02.835.232.611.108 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Skeleton; Bone and Bones; Pelvic Bones Y:LAcetabularia B05.104.234.133 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Algae and Fungi (Non MeSH); Algae; Algae, Green A genus of green algae found in the Mediterranean and other warm seas. Algae, Green (70-71) Z|&=WAcepromazine D03.494.741.029; D14.100.150.175.020; D15.150.025.075; D15.210.950.040.025.075; D15.700.872.331.025.031 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 3-Ring (Non MeSH); Phenothiazines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Dopamine Agents; Dopamine Antagonists Central Nervous System Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Central Nervous System Depressants; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine Central Nervous System Agents; Psychotropic Drugs; Tranquilizing Agents; Antipsychotic Agents; Antipsychotic Agents, Phenothiazine A phenothiazine that is used in the treatment of psychoses. [s:IAcenocoumarol D03.438.150.446.520.079; D19.461.119.196.475.022 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Heterocyclic Compounds; Heterocyclic Cpds, 2-Ring (Non MeSH); Benzopyrans; Coumarins; 4-Hydroxycoumarins Hematologic, Gastric, Renal Agents (Non MeSH); Hematologic Agents (Non MeSH); Anticoagulants; Coumarins; 4-Hydroxycoumarins _R6: Acenaphthenes D04.615.050 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Polycyclic Hydrocarbons; Polycyclic Hydrocarbons, Aromatic (Non MeSH) Tricyclic ethylene-bridged naphthalene derivatives. They are found in petroleum residues and coal tar and used as dye intermediates, in the manufacture of plastics, and in insecticides and fungicides. Naphthalenes (66-71) `8PAcedapsone D02.886.590.263.050; D20.661.370.026 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Sulfur Compounds (Non MeSH); Sulfones; Dapsone Anti-Infective Agents; Leprostatic Agents; Dapsone 4',4'''-Sulfonylbis(acetanilide). Acetylated sulfone that is slowly metabolized to give long-term, low blood levels of dapsone. It has antimicrobial and antimalarial action, but is mainly used as a depot antileprotic agents. Acetanilides (72-74); Acetamides (75); Dapsone/analogs and derivatives (75); Sulfones (72-74) b*:qAcebutolol D02.033.329.624.025; D02.092.063.624.025; D14.100.050.200.200.030; D16.050.850.015; D18.097.030; D18.162.012 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Alcohols; Amino Alcohols; Propanolamines Organic Chemicals (Non MeSH); Amines; Amino Alcohols; Propanolamines Neurotransmitters and Neurotransmitter Agents (Non MeSH); Neurotransmitter Agents (Non MeSH); Adrenergic Agents; Adrenergic Antagonists; Adrenergic beta-Antagonists Peripheral Nervous System Agents (Non MeSH); Autonomic Agents; Sympatholytics Cardiovascular Agents; Anti-Arrhythmia Agents Cardiovascular Agents; Antihypertensive Agents N-(3-Acetyl-4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)phenyl)butanamide. A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action. Anilides (74); Ethanolamines (74); Phenyl Ethers (74); Propylamines (74) etz:"HZAcculturation I01.076.201.450.050; I01.880.143.079 Social Sciences; Anthropology; Anthropology, Cultural; Culture Social Sciences; Sociology; Culture Process of cultural change in which one group or members of a group assimilates various cultural patterns from another. j!*tAccreditation N03.706.110.070; N05.700.200.100 CLECHILJMTOGSNSTTDUT Certification; Licensure Certification; Licensure Economics, Organizations, Control (Non MeSH); Social Control, Formal; Credentialing Quality, Access, Evaluation (Non MeSH); Quality Assurance, Health Care; Credentialing Joint Commission on Accreditation of Healthcare Organizations Joint Commission on Accreditation of Healthcare Organizations Certification as complying with a standard set by non-governmental organizations, applied for by institutions, programs, and facilities on a voluntary basis. $k}&Accounts Payable and Receivable N03.219.463.030.080 Economics, Organizations, Control (Non MeSH); Economics; Financial Management; Accounting Short-term debt obligations and assets occurring in the regular course of operational transactions. Accounting (66-77) n>&itAccounting N03.219.463.030 CLECHILJMTOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Economics; Financial Management Accounts Payable and Receivable; Depreciation; Financial Audit; Patient Credit and Collection System of recording financial transactions. o[n4Accommodation, Ocular G11.697.079 DEGEIMPHRE Musculoskeletal, Neural, Eye Physiology (Non MeSH); Ocular Physiology (Non MeSH) p_Acclimatization G07.062.133 DEGEIMPHRE Climate Physiology, General (Non MeSH); Adaptation, Physiological q DAccidents, Traffic G03.850.110.320 CLECLJMOPCPXSNTD Air Bags; Seat Belts Automobile Driving Environment and Public Health (Non MeSH); Public Health; Accidents Accidents on streets, roads, and highways involving drivers, passengers, pedestrians, or vehicles. Traffic accidents refer to AUTOMOBILES (passenger cars, buses, and trucks), BICYCLING, and MOTORCYCLES but not OFF-ROAD MOTOR VEHICLES, RAILROADS nor snowmobiles.  rFQ,Accidents, Radiation G03.850.110.250.250; G03.850.110.285 CLECLJMOPCPXSNTD Radiation Injuries Nuclear Reactors; Radiation Injuries Environment and Public Health (Non MeSH); Public Health; Accidents; Accidents, Occupational Environment and Public Health (Non MeSH); Public Health; Accidents Accidental dispersal of radioactive materials from a radiation source. Accidents at nuclear reactors can involve large groups of the population from dispersion of radioactivity into the environment and through fallout or a few individuals with high injurious doses. Accidents (67-94); Nuclear Reactors (67-94); Radiation Injuries (66-94) $t_*,4VAccidents, Occupational G03.850.110.250 CLECLJMOPCPXSNTD Occupational Diseases Environment and Public Health (Non MeSH); Public Health; Accidents Accidents, Radiation wnQAccidents, Home G03.850.110.205 CLECLJMOPCPXSNTD Environment and Public Health (Non MeSH); Public Health; Accidents Accidents (66-68) x\QAccidents, Aviation G03.850.110.185 CLECLJMOPCPXSNTD Aerospace Medicine Environment and Public Health (Non MeSH); Public Health; Accidents y!QAccidents G03.850.110 CLECLJMOPXSNTD Environment and Public Health (Non MeSH); Public Health Accident Prevention (+ 2); Accidental Falls; Accidents, Aviation; Accidents, Home; Accidents, Occupational (+ 1); Accidents, Radiation; Accidents, Traffic; Drowning (+ 1) BLCFCLCODIECENEPETGEHIIMLJMEMIMOMTNUOGPAPCPPPSPXRARHRIRTSNSTSUTDTHURUSUTVEVI y DPAccidental Falls G03.850.110.085 ECMOPCSN Environment and Public Health (Non MeSH); Public Health; Accidents Falls due to slipping or tripping which result in injury. Accidents (66-86) { QGAccident Proneness F01.145.015 Behavior and Behavior Mechanisms (Non MeSH); Behavior Tendency toward involvement in accidents. Implies certain personality characteristics which predispose to accidents. Accidents (66-74) |AAccident Prevention G03.850.110.060 Protective Devices Environment and Public Health (Non MeSH); Public Health; Accidents Safety (+ 1) CLECHILJMTOGSNSTTDUT }QAccessory Nerve A08.800.800.120.060 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 11th cranial nerve. The accessory nerve originates from neurons in the medulla and in the cervical spinal cord. It has a cranial root, which joins the vagus (10th cranial) nerve and sends motor fibers to the muscles of the larynx, and a spinal root, which sends motor fibers to the trapezius and the sternocleidomastoid muscles. Damage to the nerve produces weakness in head rotation and shoulder elevation. ~8[Acceleration H01.671.538.107 AE Physical Sciences (Non MeSH); Physics; Motion Deceleration y9Accelerated Idioventricular Rhythm C14.280.067.845.880.025 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Cardiovascular Diseases; Heart Diseases; Arrhythmia; Tachycardia; Tachycardia, Supraventricular A transient and intermittent type of arrhythmia with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with digitalis toxicity. Suppressive therapy is rarely necessary because the ventricular rate is generally less than 100 beats per minute. Arrhythmia (75-90); Tachycardia (75-90) (Nnh0Acari B01.131.166.132 AHCHCLCYDEEMENGDGEIMMEMIPHPSPYREULVI Invertebrates; Arthropods; Arachnida Mites (+ 1); Sarcoptes scabiei; Ticks (+ 1) A large, cosmopolitan order of arachnids comprising the mites and ticks, including parasites of plants, animals, and man, as well as several important disease vectors. Arachnida (66-74)   (,9Acanthosis Nigricans C17.800.621.430.530.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Pigmentation Disorders; Hyperpigmentation; Melanosis A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder. zNGAcanthopodina B01.841.750.656.475.100.075 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida Acanthamoeba A suborder of ameboid protozoa. Characteristics include subpseudopodia that are more or less finely tipped, occasionally filiform, commonly furcate hyaline, and produced from a broad hyaline lobe. Cysts are usually formed and nuclear division is mesomitotic or metamitotic. &V=Acantholysis C17.800.865.070; C23.739.035 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Skin and Connective Tissue Diseases (Non MeSH); Skin Diseases; Skin Diseases, Vesiculobullous Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH) Separation of the prickle cells of the stratum spinosum of the epidermis, resulting in atrophy of the prickle cell layer. It is seen in diseases such as pemphigus vulgaris and keratosis follicularis. Skin/pathology (66-68); specific skin disease/pathology (66-68) "NLAcanthocytes A11.118.413.330.100; A15.145.229.413.330.100 CHCLCYDEENIMMEMIPAPHPSRARERISETRULUSVI Cells; Blood Cells; Erythrocytes; Erythrocytes, Abnormal Hemic and Immune Systems (Non MeSH); Blood; Blood Cells; Erythrocytes; Erythrocytes, Abnormal Erythrocytes with protoplasmic projections giving the cell a thorny appearance. 2*]Acanthocephala B01.500.132 AHCHCLCYDEEMENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Helminths Moniliformis A phylum of parasitic worms, closely related to tapeworms and containing two genera: Moniliformis, which sometimes infects man, and Macracanthorhynchus, which infects swine. R*Acanthamoeba Keratitis C03.300.125; C03.752.700.700.055.203; C11.204.564.112; C11.294.725.125 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Parasitic Diseases; Eye Infections, Parasitic Parasitic Diseases; Protozoan Infections; Sarcomastigophora Infections; Sarcodina Infections; Amebiasis Eye Diseases; Corneal Diseases; Keratitis Eye Diseases; Eye Infections; Eye Infections, Parasitic Infection of the cornea by an ameboid protozoan which may cause corneal ulceration leading to blindness. Amebiasis (75-89); Keratitis (75-89) PP|-Acanthamoeba B01.841.750.656.475.100.075.080 CHCLCYDEENGDGEIMIPMEMIPHPSPYREULVI Invertebrates; Protozoa; Sarcomastigophora; Sarcodina; Lobosea; Amoebida; Acanthopodina A genus of free-living soil amoebae that produces no flagellate stage. Its organisms are pathogens for several infections in humans and have been found in the eye, bone, brain, and respiratory tract. Amoeba (66-87) b#&gAcademies and Institutes N03.540.052 CLECHILJOGSNSTTDUT Economics, Organizations, Control (Non MeSH); Organizations Organizations representing specialized fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., National Academy of Sciences, Brookings Institution, etc. HFAcademic Medical Centers N02.278.020 CLECHILJMAMTOGSDSNSTTDUT Facilities, Manpower and Services (Non MeSH); Health Facilities Hospitals, Teaching (+ 1); Schools, Medical Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc. Hospitals, Teaching (68-74); Hospitals, University (75-79)  L6~EAcacia B06.560.546.080; B06.915.063 AHCHCLCYDEEMENGDGEIMMEMIPHPSREULVI Plants; Plants, Medicinal; Legumes Plants; Trees Any leguminous woody vine or tree of the genus Acacia, also called locust or wattle. The gums and tanning agents obtained from Acacia are called GUM ARABIC.  "&<Abstracting and Indexing L01.300.100 CLECHIMTSNSTTDUT Information Science; Documentation Shortening or summarizing of documents; assigning of descriptors for referencing documents. )kAbsorption G06.535.630.023; H01.181.529.023 DEGEIMPHRE Biochemical Phenomena, Metabolism, Nutrition (Non MeSH); Metabolism; Metabolic Processes (Non MeSH) Physical Sciences (Non MeSH); Chemistry; Chemistry, Physical The taking in or incorporation of gaseous or liquid substances, light, or heat. It includes the metabolic absorption of exogenous nutrients, chemicals, and drugs into microorganisms, tissues, and organs. &Absorptiometry, Photon E01.289.806.150; E01.357.820.150; E05.196.712.224.187 AECLCTECHIISMOMTNUSNSTTDUTVE Bone Density Diagnosis; Diagnosis, Radioisotope; Radionuclide Imaging Diagnosis; Diagnostic Imaging; Radionuclide Imaging Miscellaneous Techniques (Non MeSH); Chemistry, Analytical; Photometry; Densitometry A noninvasive method for quantitating bone mineral content. It is used especially in the diagnosis of osteoporosis and also in measuring bone mineralization in infants. Absorption (72-79); Densitometry (66-89); Radionuclide Imaging (77-89); Spectrophotometry, Atomic Absorption (74-82); Tomography, Emission Computed (80-89)  = Absinthe J01.125.091.110 AEANCLECHIMIPOPSRESDSNSTTOUTVI Technology, Industry, Agriculture (Non MeSH); Beverages; Alcoholic Beverages An extract of absinthium and other bitter herbs, containing 60% alcohol. Prolonged ingestion causes nervousness, convulsions, trismus, amblyopia, optic neuritis, and mental deterioration. (Dorland, 27th ed). * "ZAbsenteeism F02.784.692.107 Psychologic Processes and Principles (Non MeSH); Psychology, Applied; Psychology, Industrial Chronic absence from work or other duty. l3Abscisic Acid D02.241.081.018; D11.303.760.030 AAADAEAGAIANBIBLCFCHCLCSCTDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUUR Organic Chemicals (Non MeSH); Carboxylic Acids; Acids, Acyclic (Non MeSH) Growth Substances, Pigments, Vitamins (Non MeSH); Growth Substances; Plant Growth Regulators (S-(Z,E))-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic acid. Abscision-accelerating plant growth substance isolated from young cotton fruit, leaves of sycamore, birch, and other plants, and from potatoes, lemons, avocados, and other fruits. Cyclohexanecarboxylic Acids (74) &B6&Abscess C01.539.830.025; C23.739.487.856.025 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Empyema Empyema Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration Symptoms and General Pathology (Non MeSH); Pathologic Processes (Non MeSH); Inflammation; Suppuration Abdominal Abscess (+ 3); Brain Abscess; Lung Abscess; Periapical Abscess; Periodontal Abscess; Peritonsillar Abscess; Psoas Abscess; Retropharyngeal Abscess A localized collection of pus caused by suppuration buried in tissues, organs, or confined spaces. (Dorland, 27th ed). $y *P  Abruptio Placentae C13.703.420.078; C13.703.590.132 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Labor Complications Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Placenta Diseases Premature separation of the normally implanted placenta. P&LCAbrin D12.776.765.060; D24.185.526.545.060; D24.310.545.060; D24.611.125.044.545.060 AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPKPORESDSESTTOTUULUR Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Plant Proteins Immunologic and Biologic Factors (Non MeSH); Biological Factors; Mitogens; Lectins Immunologic and Biologic Factors (Non MeSH); Biological Products; Lectins Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antibodies; Agglutinins; Lectins Agglutinin. A toxic lectin from the seeds of jequirity, Abrus precatorius L. Very active poison. Five different proteins have so far been isolated: Abrus agglutinin, the component responsible for hemagglutininating activity, and abrins a-d, the toxic principles each consisting of two peptide chains are held together by disulfide bonds. Disulfides (73-74); Plant Proteins (71-75) 7 XF4Abreaction F04.754.919.107 Disciplines, Tests, Therapy, Services (Non MeSH); Psychotherapy; Therapeutic Processes (Non MeSH) Catharsis A process in psychotherapy in which the patient is "desensitized" to emotionally painful, often forgotten (repressed) memories by recalling and reacting to them in the "safety" of the treatment setting. Pr Abortion, Veterinary C13.703.039.422; C22.021 BLCFCICLCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion Animal Diseases  Brucellosis, Bovine Premature expulsion of the fetus in animals. BLCFCICLCNCODHDIDTECEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARIRTSUTHTMURUSVI  H7JAbortion, Threatened C13.703.039.339 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion Condition of vaginal bleeding with or without pain in early pregnancy which may presage an abortion. LrxAbortion, Therapeutic E04.819.774.173.340 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Abortion, Induced Pregnancy Reduction, Multifetal L$v%Abortion, Septic C01.539.674.173; C13.703.039.256; C13.703.700.173 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Pregnancy Complications, Infectious Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Pregnancy Complications, Infectious Infected abortion in which there is dissemination of microorganisms and their products into the maternal systemic circulation. _9LeAbortion, Missed C13.703.039.173 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion The retention in the uterus of a dead fetus two months or more after its death. LrcAbortion, Legal E04.819.774.173.173 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Population Control Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Abortion, Induced $vAbortion, Induced E04.819.774.173 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH) Abortion, Eugenic; Abortion, Legal; Abortion, Therapeutic (+ 1); Pregnancy Reduction, Multifetal Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978). Abortion, Criminal (66-70); Abortion, Legal (66-70); Abortion, Therapeutic (66-70)  $_rxbAbortion, Incomplete C13.703.039.093 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion Abortion in which not all the products of conception have been expelled. Abortion (66-74) JrXAbortion, Habitual C13.703.039.089 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications; Abortion Cervix Incompetence Three or more consecutive spontaneous abortions. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI  Lr:NAbortion, Eugenic E04.819.774.173.090 AECLCTECHIISMOMTNUPXRHSNSTTDUTVE Surgery, Operative; Surgery, Ob-Gyn (Non MeSH); Surgery, Obstetrical (Non MeSH); Abortion, Induced Abortion performed because of possible fetal defects. $v@Abortion, Criminal I01.198.240.089 CLECEHHILJPCPXSNTD Social Sciences; Criminology; Crime Illegal termination of pregnancy. ,)Abortion Applicants M01.050 CLEDHILJPXSN Named Groups (Non MeSH) Individuals requesting induced abortions. Abortion, Induced (70-74); Abortion, Therapeutic (66-74)  1CAbortion C13.703.039 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVI Abortifacient Agents Female Genital Diseases and Pregnancy Complications (Non MeSH); Pregnancy Complications Abortion, Habitual (+ 1); Abortion, Incomplete; Abortion, Missed; Abortion, Septic; Abortion, Threatened; Abortion, Veterinary Expulsion of the products of conception before the 20th completed week of gestation without deliberate interference. BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI $ JfPAbortifacient Agents, Steroidal D07.131.200 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Abortifacient Agents Mifepristone Steroidal compounds with abortifacient activity. Abortion, Induced (70-74); specific chemical (70-74) AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR $%8H9?:Abortifacient Agents, Non-Steroidal D07.131.100 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Reproductive Control Agents (Non MeSH); Abortifacient Agents Carboprost; Dinoprost; Misoprostol; Trichosanthin Non-steroidal chemical compounds with abortifacient activity. Abortion, Induced (70-74); specific chemical (71-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR $)8H;G?HAbortifacient Agents D07.131 ADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Abortion Reproductive Control Agents (Non MeSH) Abortifacient Agents, Non-Steroidal (+ 4); Abortifacient Agents, Steroidal (+ 1) Chemical substances that interrupt pregnancy after implantation. Abortion, Induced (70-74) AAADAEAGAIANBIBLCFCHCLCSCTDEDFDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR (Ǵ 8 ._KHAborigines I01.076.201.450.416.025; I01.880.143.522.025; M01.194.025 CLEDGEHILJPXSN Australoid Race Social Sciences; Anthropology; Anthropology, Cultural; Culture; Ethnic Groups Social Sciences; Sociology; Culture; Ethnic Groups Named Groups (Non MeSH); Ethnic Groups Native inhabitants or indigenous individuals of a country. ɎAFAbomasum A13.869.106 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Animal Terms (Non MeSH); Stomach, Ruminant Stomach (66-67) 7 :5ABO Blood-Group System D24.611.216.705.230.031; G04.610.241.031; G09.188.229.031 ADAEANBIBLCFCHCLCTDUECGEHIIMIPMEPDPHPOTOTUULUR Immunologic and Biologic Factors (Non MeSH); Immunologic Factors (Non MeSH); Antigens; Isoantigens; Blood Groups Biological Phenomena, Cell Physiology, Immunity (Non MeSH); Immunity; Blood Groups Circulatory, Respiratory Physiology (Non MeSH); Blood Physiology (Non MeSH); Blood Groups The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. A2P~Abnormalities, Radiation-Induced C16.131.080; C21.866.733.031; G03.850.810.300.360.031 BLCFCLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries; Radiation Injuries Environment and Public Health (Non MeSH); Public Health; Radiologic Health (Non MeSH); Radiation Effects; Radiation Injuries Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation. Abnormalities (66-78); Radiation Injuries (66-78) x%=HB};Abnormalities, Multiple C16.131.077 BLCFCICLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Alagille Syndrome; Angelman Syndrome; Basal Cell Nevus Syndrome; Beckwith-Wiedemann Syndrome; Bloom Syndrome; Bonnevie-Ullrich Syndrome; Cockayne Syndrome; Cri-du-Chat Syndrome; De Lange's Syndrome; Down Syndrome; Ectodermal Dysplasia (+ 2); Gardner Syndrome; Holoprosencephaly; Incontinentia Pigmenti; Laurence-Moon-Biedl Syndrome; Marfan Syndrome; Nail-Patella Syndrome; Oculocerebrorenal Syndrome; Orofaciodigital Syndromes; Prader-Willi Syndrome; Proteus Syndrome; Prune Belly Syndrome; Rubella Syndrome, Congenital; Rubinstein-Taybi Syndrome; Short Rib-Polydactyly Syndrome; Waardenburg's Syndrome; Wolfram Syndrome; Zellweger Syndrome Abnormalities (66-67) BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI  CJIPAbnormalities, Drug-Induced C16.131.042 BLCFCLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Teratogens Teratogens; Maternal-Fetal Exchange Neonatal Diseases and Abnormalities (Non MeSH); Abnormalities Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.  t H*IXAbnormalities C16.131 BLCFCLDHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Fetal Diseases Neonatal Diseases and Abnormalities (Non MeSH) Abnormalities, Drug-Induced; Abnormalities, Multiple (+ 30); Abnormalities, Radiation-Induced; Cardiovascular Abnormalities (Non MeSH) (+ 29); Chromosome Abnormalities (+ 19); Digestive System Abnormalities (Non MeSH) (+ 9); Eye Abnormalities (+ 9); Eye Diseases, Hereditary (+ 13); Hamartoma (+ 3); Monsters (+ 3); Musculoskeletal Abnormalities (Non MeSH) (+ 36); Nervous System Abnormalities (Non MeSH) (+ 20); Respiratory System Abnormalities (Non MeSH) (+ 7); Situs Inversus (+ 3); Skin Abnormalities (Non MeSH) (+ 22); Stomatognathic System Abnormalities (Non MeSH) (+ 24); Urogenital Abnormalities (Non MeSH) (+ 19) Congenital malformations of organs or parts. BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHTMULURUSVEVI $ H76ZAbetalipoproteinemia C10.228.140.163.047; C15.378.147.068; C18.452.648.556.485.131 BLCFCICLCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Nervous System Diseases; Central Nervous System Diseases; Brain Diseases; Brain Diseases, Metabolic Hemic and Lymphatic Diseases (Non MeSH); Hematologic Diseases; Blood Protein Disorders Nutritional and Metabolic Diseases (Non MeSH); Metabolic Diseases; Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Hypolipoproteinemia A disorder of lipoprotein and lipid metabolism caused by defective synthesis of apolipoprotein B (apo B) and characterized by acanthocytosis, hypocholesterolemia, progressive ataxic neuropathy, atypical retinitis pigmentosa with involvement of the macula, and fat malabsorption, and may be treated with vitamin E. (Dorland, 27th ed). =ELAbelson Leukemia Virus B04.820.650.730.730.900.500.020; B04.909.574.807.730.730.900.500.020; B04.909.777.731.730.730.900.500.020 CHCLDEENGDGEIMIPMEPHPYREUL Viruses; RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); Oncogenic Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine Viruses; Vertebrate Viruses (Non MeSH); RNA Viruses; Retroviridae; Retroviruses, MLV-Related; Retroviruses Type C, Mammalian; Tumor Viruses, Murine; Leukemia Viruses, Murine A defective murine leukemia virus capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with Friend, Moloney, or Rauscher virus. Mouse Leukemia Viruses (66-79)  qA%Abducens Nerve A08.800.800.120.030 ABAHBSCHCYDEEMENGDIMINMEMIPAPHPPPSRARERISESUTRULUSVI Nervous System; Peripheral Nervous System; Peripheral Nerves; Cranial Nerves The 6th cranial nerve. The abducens nerve originates in the abducens nucleus of the pons and sends motor fibers to the lateral rectus muscles of the eye. Damage to the nerve or its nucleus disrupts horizontal eye movement control. 8[Abdominal Pain C06.050; C06.405.050; C23.888.592.612.050 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Colic Digestive System Diseases Digestive System Diseases; Gastrointestinal Diseases Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain Abdomen, Acute Abdomen, Acute Abdomen, Acute; Colic Sensation of discomfort, distress, or agony in the abdominal region. Abdomen (66-89); Pain (66-89) $1N >R&Abdominal Neoplasms C04.588.033 BLBSCFCHCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSCSESUTHULURUSVEVI Neoplasms; Neoplasms by Site (Non MeSH) Peritoneal Neoplasms; Retroperitoneal Neoplasms eX17Abdominal Muscles A02.633.567.050 ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI Musculoskeletal System; Muscles; Muscle, Skeletal Rectus Abdominis Muscles forming the wall of the abdomen including rectus abdominis, external and internal oblique muscles, transversus abdominis, and quadratus abdominis. (Stedman, 25th ed). o:;Abdominal Injuries C21.866.017 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Injury, Occupational Dis, Poisoning (Non MeSH); Wounds and Injuries Hernia, Diaphragmatic, Traumatic; Splenic Rupture (+ 1); Stomach Rupture General or unspecified injuries involving organs in the abdominal cavity. NQWWAbdominal Abscess C01.539.830.025.020 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHTMURUSVEVI Bacterial and Fungal Diseases (Non MeSH); Infection; Suppuration; Abscess Liver Abscess (+ 1); Subphrenic Abscess An abscess located in the abdominal cavity, i.e., the cavity between the diaphragm above and the pelvis below. (From Dorland, 27th ed). Abdomen (66-94); Abscess (66-94)  PY2)Abdomen, Acute C06.050.100; C06.405.050.100; C23.304.061; C23.888.592.612.050.100 BLCFCICLCNCODHDIDTECEHEMENEPETGEHIIMMEMIMONUPAPCPPPSPXRARHRIRTSUTHURUSVEVI Digestive System Diseases; Abdominal Pain Digestive System Diseases; Gastrointestinal Diseases; Abdominal Pain Symptoms and General Pathology (Non MeSH); Diseases of Body Regions (Non MeSH) Symptoms and General Pathology (Non MeSH); Signs and Symptoms (Non MeSH); Neurologic Manifestations; Pain; Abdominal Pain Clinical syndrome characterized by abdominal pain of great severity associated with other symptoms and signs, usually those of acute peritonitis, which might well be the result of a ruptured abdominal viscus or a similar abdominal catastrophe requiring urgent surgical operation. LNmCAbdomen A01.047 ABAHBSEMGDIRMIPAPHPPPSRARERISUUSVI Body Regions (Non MeSH) Groin; Inguinal Canal; Peritoneum (+ 5); Retroperitoneal Space; Umbilicus That portion of the body that lies between the thorax and the pelvis. ABAHBSCHCYDEEMENGDIMINIRMEMIPAPHPPPSRARERISESUTRULUSVI  -  &ZV:ABC Transporters D08.586.747.020; D12.776.157.020; D12.776.395.550.020; D12.776.543.550.020 ADAEAGAIANBIBLCFCHCLCSCTDEDUECGEHIIMIPMEPDPHPKPORESDSESTTOTUULUR Enzymes, Coenzymes, Enzyme Inhibitors (Non MeSH); Enzymes; Permeases Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Carrier Proteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Glycoproteins; Membrane Glycoproteins Amino Acids, Peptides and Proteins (Non MeSH); Proteins; Membrane Proteins; Membrane Glycoproteins A superfamily of oligopeptide permease proteins responsible for transporting a wide range of substrates across membranes. Carrier Proteins (90-94) TDAbbreviations L01.143.506.598.400.556.131 Information Science; Communication; Language; Linguistics; Nomenclature; Names Shortened forms of written words or phrases used for brevity. ]KAbbreviated Injury Scale E05.318.308.940.968.875.125; E05.944.250; L01.280.900.968.875.125; N04.452.859.564.800.125; N05.715.360.300.715.500.800.100 Miscellaneous Techniques (Non MeSH); Epidemiologic Methods; Data Collection; Records; Medical Records; Trauma Severity Indices Miscellaneous Techniques (Non MeSH); Trauma Severity Indices Information Science; Data Collection; Records; Medical Records; Trauma Severity Indices Health Services Administration (Non MeSH); Organization and Administration; Records; Medical Records; Trauma Severity Indices Quality, Access, Evaluation (Non MeSH); Quality of Health Care; Evaluation Mechanisms, Health Care (Non MeSH); Data Collection; Records; Medical Records; Trauma Severity Indices Classification system for assessing impact injury severity developed and published by the American Association for Automotive Medicine. It is the system of choice for coding single injuries and is the foundation for methods assessing multiple injuries or for assessing cumulative effects of more than one injury. These include Maximum AIS (MAIS), Injury Severity Score (ISS), and Probability of Death Score (PODS). Wounds and Injuries/classification (66-89) 2Abattoirs J01.576.598.256 CLECHIISLJMASNST Technology, Industry, Agriculture (Non MeSH); Industry; Meat-Packing Industry Places where animals are slaughtered and dressed for market.  [IAbate D02.719.027; D05.723.491.657.031 AAADAEAGAIANBLCFCHCLCSCTDUECHIIMIPMEPDPKPORESDSTTOTUUR Organic Chemicals (Non MeSH); Organothiophosphorus Compounds Environmental Pollutants, Pesticides (Non MeSH); Pesticides; Insecticides; Insecticides, Organothiophosphate Insecticides (66-71)  &:Rats, Sprague-Dawley B02.649.865.635.560.670 ABAHBLCFCLEMGDGEIMINMEMIPHPSPXSUURVI Vertebrates; Mammals; Rodentia; Muridae; Rats A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Rats (66-82); Rats, Inbred Strains (82-92) ~(95Pili, Sex A11.368.702.679 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Conjugation, Genetic Cells; Cytoplasm; Organelles Filamentous or elongated proteinaceous structures which extend from the cell surface in gram-negative bacteria that contain certain types of conjugative plasmid. These pili are the organs associated with genetic transfer and have essential roles in conjugation. Normally, only one or a few pili occur on a given donor cell. (From Singleton and Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed, p675) This preferred use of "pili" refers to the sexual appendage, to be distinguished from bacterial fimbriae (FIMBRIAE, BACTERIAL), also known as common pili, which are usually concerned with adhesion. specific bacteria/cytology (69-74); specific bacteria/ultrastructure (75-79); Fimbriae, Bacterial (80-94)  /*${Fimbriae, Bacterial A11.368.702.292 CHCLDEENGEIMMEMIPAPHPSRARERISETRULUSVI Adhesins, Bacterial Cells; Cytoplasm; Organelles Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX). specific bacterium (66-79); Bacterial Proteins (66-79); Cell Wall (66-79)  '*$Y